-DOCSTART- (26797704)

The	O	O	O
Impact	O	O	O
of	O	O	O
Deployment	O	O	B-T052
on	O	O	O
Parental	O	O	B-T099
,	O	O	O
Family	O	O	B-T099
and	O	O	O
Child	O	O	B-T100
Adjustment	O	O	B-T055
in	O	O	O
Military	O	O	O
Families	O	O	O

Since	O	O	O
9/11	O	O	O
,	O	O	O
military	O	O	B-T097
service	O	O	I-T097
in	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
has	O	O	O
been	O	O	O
characterized	O	O	O
by	O	O	O
wartime	O	O	B-T079
deployments	O	O	B-T052
and	O	O	O
reintegration	O	O	O
challenges	O	O	O
that	O	O	O
contribute	O	O	O
to	O	O	O
a	O	O	O
context	O	O	O
of	O	O	O
stress	O	O	B-T033
for	O	O	O
military	O	O	B-T099
families	O	O	I-T099
.	O	O	O

Research	O	O	B-T062
indicates	O	O	O
the	O	O	O
negative	O	O	B-T033
impact	O	O	I-T033
of	O	O	O
wartime	O	O	O
deployment	O	O	B-T052
on	O	O	O
the	O	O	O
well	O	O	B-T078
being	O	O	I-T078
of	O	O	O
service	O	O	B-T097
members	O	O	B-T098
,	O	O	O
military	O	O	B-T097
spouses	O	O	B-T099
,	O	O	O
and	O	O	O
children	O	O	B-T100
.	O	O	O

Yet	O	O	O
,	O	O	O
few	O	O	O
studies	O	O	O
have	O	O	O
considered	O	O	O
how	O	O	O
parental	O	O	B-T099
deployments	O	O	B-T052
may	O	O	O
affect	O	O	O
adjustment	O	O	B-T055
in	O	O	O
young	O	O	B-T100
children	O	O	I-T100
and	O	O	O
their	O	O	O
families	O	O	B-T099
.	O	O	O

Using	O	O	O
deployment	O	O	B-T052
records	O	O	O
and	O	O	O
parent	O	O	B-T099
-	O	O	O
reported	O	O	B-T170
measures	O	O	O
from	O	O	O
primary	O	O	O
caregiving	O	O	B-T052
(	O	O	O
N	O	O	O
=	O	O	O
680	O	O	O
)	O	O	O
and	O	O	O
military	O	O	B-T097
(	O	O	O
n	O	O	O
=	O	O	O
310	O	O	O
)	O	O	O
parents	O	O	B-T099
,	O	O	O
we	O	O	O
examined	O	O	O
the	O	O	O
influence	O	O	O
of	O	O	O
deployment	O	O	O
on	O	O	O
adjustment	O	O	B-T055
in	O	O	O
military	O	O	B-T099
families	O	O	I-T099
with	O	O	O
children	O	O	B-T100
ages	O	O	O
0	O	O	O
-	O	O	O
10	O	O	O
years	O	O	O
.	O	O	O

Greater	O	O	O
deployment	O	O	B-T052
exposure	O	O	O
was	O	O	O
related	O	O	O
to	O	O	O
impaired	O	O	B-T169
family	O	O	B-T054
functioning	O	O	I-T054
and	O	O	O
marital	O	O	B-T033
instability	O	O	B-T033
.	O	O	O

Parental	O	O	B-T099
depressive	O	O	B-T048
and	O	O	O
posttraumatic	O	O	B-T048
stress	O	O	I-T048
symptoms	O	O	I-T048
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
impairments	O	O	B-T169
in	O	O	O
social	O	O	B-T054
emotional	O	O	B-T033
adjustment	O	O	B-T055
in	O	O	O
young	O	O	B-T100
children	O	O	I-T100
,	O	O	O
increased	O	O	O
anxiety	O	O	B-T033
in	O	O	O
early	O	O	O
childhood	O	O	B-T079
,	O	O	O
and	O	O	O
adjustment	O	O	O
problems	O	O	O
in	O	O	O
school-age	O	O	B-T100
children	O	O	I-T100
.	O	O	O

Conversely	O	O	O
,	O	O	O
parental	O	O	B-T099
sensitivity	O	O	B-T041
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
improved	O	O	O
social	O	O	B-T054
and	O	O	O
emotional	O	O	B-T033
outcomes	O	O	I-T033
across	O	O	O
childhood	O	O	B-T079
.	O	O	O

These	O	O	O
findings	O	O	B-T033
provide	O	O	O
guidance	O	O	O
to	O	O	O
developing	O	O	O
preventive	O	O	B-T080
approaches	O	O	O
for	O	O	O
military	O	O	B-T099
families	O	O	I-T099
with	O	O	O
young	O	O	O
children	O	O	B-T100
.	O	O	O

-DOCSTART- (26931495)

Beyond	O	O	O
neutral	O	O	B-T077
and	O	O	O
forbidden	O	O	B-T077
links	O	O	I-T077
:	O	O	O
morphological	O	O	B-T082
matches	O	O	B-T080
and	O	O	O
the	O	O	O
assembly	O	O	B-T078
of	O	O	O
mutualistic	O	O	B-T067
hawkmoth	O	O	B-T204
-	O	O	O
plant	O	O	B-T002
networks	O	O	O

A	O	O	O
major	O	O	O
challenge	O	O	O
in	O	O	O
evolutionary	O	O	B-T090
ecology	O	O	I-T090
is	O	O	O
to	O	O	O
understand	O	O	O
how	O	O	O
co-evolutionary	O	O	B-T067
processes	O	O	I-T067
shape	O	O	O
patterns	O	O	B-T082
of	O	O	O
interactions	O	O	B-T169
between	O	O	O
species	O	O	B-T185
at	O	O	O
community	O	O	B-T096
level	O	O	B-T080
.	O	O	O

Pollination	O	O	B-T040
of	O	O	O
flowers	O	O	B-T002
with	O	O	O
long	O	O	B-T002
corolla	O	O	I-T002
tubes	O	O	I-T002
by	O	O	O
long-tongued	O	O	B-T204
hawkmoths	O	O	I-T204
has	O	O	O
been	O	O	O
invoked	O	O	O
as	O	O	O
a	O	O	O
showcase	O	O	O
model	O	O	B-T075
of	O	O	O
co-evolution	O	O	B-T045
.	O	O	O

Recently	O	O	O
,	O	O	O
optimal	O	O	O
foraging	O	O	O
models	O	O	B-T075
have	O	O	O
predicted	O	O	O
that	O	O	O
there	O	O	O
might	O	O	O
be	O	O	O
a	O	O	O
close	O	O	O
association	O	O	B-T080
between	O	O	O
mouthparts	O	O	B-T081
'	O	O	I-T081
length	O	O	I-T081
and	O	O	O
the	O	O	O
corolla	O	O	B-T002
depth	O	O	B-T082
of	O	O	O
the	O	O	O
visited	O	O	O
flowers	O	O	B-T002
,	O	O	O
thus	O	O	O
favouring	O	O	O
trait	O	O	B-T032
convergence	O	O	B-T052
and	O	O	O
specialization	O	O	B-T090
at	O	O	O
community	O	O	B-T096
level	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
assessed	O	O	B-T052
whether	O	O	O
hawkmoths	O	O	B-T204
more	O	O	O
frequently	O	O	O
pollinate	O	O	B-T002
plants	O	O	I-T002
with	O	O	O
floral	O	O	B-T185
tube	O	O	I-T185
lengths	O	O	B-T081
similar	O	O	O
to	O	O	O
their	O	O	O
proboscis	O	O	B-T204
lengths	O	O	O
(	O	O	O
morphological	O	O	B-T082
match	O	O	B-T080
hypothesis	O	O	B-T078
)	O	O	O
against	O	O	O
abundance	O	O	B-T080
-based	O	O	O
processes	O	O	B-T067
(	O	O	O
neutral	O	O	B-T078
hypothesis	O	O	I-T078
)	O	O	O
and	O	O	O
ecological	O	O	B-T032
trait	O	O	I-T032
mismatches	O	O	B-T080
constraints	O	O	B-T057
(	O	O	O
forbidden	O	O	B-T077
links	O	O	I-T077
hypothesis	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
how	O	O	O
these	O	O	O
processes	O	O	O
structure	O	O	B-T082
hawkmoth	O	O	B-T204
-	O	O	O
plant	O	O	B-T002
mutualistic	O	O	B-T169
networks	O	O	I-T169
from	O	O	O
five	O	O	O
communities	O	O	B-T096
in	O	O	O
four	O	O	O
biogeographical	O	O	B-T083
regions	O	O	I-T083
of	O	O	O
South	O	O	B-T083
America	O	O	I-T083
.	O	O	O

We	O	O	O
found	O	O	O
convergence	O	O	B-T052
in	O	O	O
morphological	O	O	B-T082
traits	O	O	B-T032
across	O	O	O
the	O	O	O
five	O	O	O
communities	O	O	B-T096
and	O	O	O
that	O	O	O
the	O	O	O
distribution	O	O	B-T169
of	O	O	O
morphological	O	O	O
differences	O	O	O
between	O	O	O
hawkmoths	O	O	B-T204
and	O	O	O
plants	O	O	B-T002
is	O	O	O
consistent	O	O	O
with	O	O	O
expectations	O	O	O
under	O	O	O
the	O	O	O
morphological	O	O	O
match	O	O	B-T080
hypothesis	O	O	B-T078
in	O	O	O
three	O	O	O
of	O	O	O
the	O	O	O
five	O	O	O
communities	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
two	O	O	O
remaining	O	O	O
communities	O	O	B-T096
,	O	O	O
which	O	O	O
are	O	O	O
ecotones	O	O	O
between	O	O	O
two	O	O	O
distinct	O	O	O
biogeographical	O	O	B-T083
areas	O	O	I-T083
,	O	O	O
interactions	O	O	B-T169
are	O	O	O
better	O	O	O
predicted	O	O	O
by	O	O	O
the	O	O	O
neutral	O	O	B-T078
hypothesis	O	O	I-T078
.	O	O	O

Our	O	O	O
findings	O	O	B-T169
are	O	O	O
consistent	O	O	O
with	O	O	O
the	O	O	O
idea	O	O	O
that	O	O	O
diffuse	O	O	O
co-evolution	O	O	B-T045
drives	O	O	O
the	O	O	O
evolution	O	O	B-T045
of	O	O	O
extremely	O	O	O
long	O	O	B-T204
proboscises	O	O	I-T204
and	O	O	O
flower	O	O	B-T002
tubes	O	O	I-T002
,	O	O	O
and	O	O	O
highlight	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
morphological	O	O	B-T082
traits	O	O	B-T032
,	O	O	O
beyond	O	O	O
the	O	O	O
forbidden	O	O	B-T077
links	O	O	I-T077
hypothesis	O	O	B-T078
,	O	O	O
in	O	O	O
structuring	O	O	O
interactions	O	O	B-T169
between	O	O	O
mutualistic	O	O	B-T078
partners	O	O	I-T078
,	O	O	O
revealing	O	O	O
that	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
niche-based	O	O	B-T067
processes	O	O	I-T067
can	O	O	O
be	O	O	O
much	O	O	O
more	O	O	O
complex	O	O	O
than	O	O	O
previously	O	O	O
known	O	O	O
.	O	O	O

-DOCSTART- (27061776)

Nosocomial	O	O	B-T047
pneumonia	O	O	I-T047
caused	O	O	O
by	O	O	O
methicillin-resistant	O	O	B-T007
Staphylococcus	O	O	I-T007
aureus	O	O	I-T007
treated	O	O	B-T061
with	O	O	I-T061
linezolid	O	O	B-T109
or	O	O	O
vancomycin	O	O	B-T116
:	O	O	O
A	O	O	O
secondary	O	O	O
economic	O	O	B-T057
analysis	O	O	I-T057
of	O	O	O
resource	O	O	B-T078
use	O	O	I-T078
from	O	O	O
a	O	O	O
Spanish	O	O	B-T083
perspective	O	O	O

Adopting	O	O	O
a	O	O	O
unique	O	O	O
Spanish	O	O	B-T083
perspective	O	O	B-UnknownType
,	O	O	O
this	O	O	O
study	O	O	B-T062
aims	O	O	O
to	O	O	O
assess	O	O	O
healthcare	O	O	B-T078
resource	O	O	I-T078
utilization	O	O	I-T078
(	O	O	O
HCRU	O	O	B-T078
)	O	O	O
and	O	O	O
the	O	O	O
costs	O	O	B-T081
of	O	O	O
treating	O	O	B-T169
nosocomial	O	O	B-T047
pneumonia	O	O	I-T047
(	O	O	O
NP	O	O	B-T047
)	O	O	O
produced	O	O	O
by	O	O	O
methicillin-resistant	O	O	B-T007
Staphylococcus	O	O	I-T007
aureus	O	O	I-T007
(	O	O	O
MRSA	O	O	B-T007
)	O	O	O
in	O	O	O
hospitalized	O	O	B-T033
adults	O	O	I-T033
using	O	O	O
linezolid	O	O	B-T109
or	O	O	O
vancomycin	O	O	B-T116
.	O	O	O

An	O	O	O
evaluation	O	O	O
is	O	O	O
also	O	O	O
made	O	O	O
of	O	O	O
the	O	O	O
renal	O	O	B-T047
failure	O	O	I-T047
rate	O	O	B-T081
and	O	O	O
related	O	O	O
economic	O	O	B-T169
outcomes	O	O	I-T169
between	O	O	O
study	O	O	B-UnknownType
groups	O	O	I-UnknownType
.	O	O	O

An	O	O	O
economic	O	O	O
post	O	O	B-T058
hoc	O	O	I-T058
evaluation	O	O	I-T058
of	O	O	O
a	O	O	O
randomized	O	O	B-T062
,	O	O	O
double-blind	O	O	B-T062
,	O	O	O
multicenter	O	O	B-T062
phase	O	O	I-T062
4	O	O	I-T062
study	O	O	I-T062
was	O	O	O
carried	O	O	O
out	O	O	O
.	O	O	O

Nosocomial	O	O	B-T047
pneumonia	O	O	I-T047
due	O	O	O
to	O	O	O
MRSA	O	O	B-T007
in	O	O	O
hospitalized	O	O	B-T033
adults	O	O	I-T033
.	O	O	O

The	O	O	O
modified	O	O	B-T169
intent	O	O	I-T169
to	O	O	I-T169
treat	O	O	I-T169
(	O	O	O
mITT	O	O	B-T169
)	O	O	O
population	O	O	B-T098
comprised	O	O	O
224	O	O	O
linezolid	O	O	B-T109
-	O	O	O
and	O	O	O
224	O	O	O
vancomycin	O	O	B-T116
-	O	O	O
treated	O	O	B-T061
patients	O	O	B-T101
.	O	O	O

Costs	O	O	B-T081
and	O	O	O
HCRU	O	O	B-T078
were	O	O	O
evaluated	O	O	O
between	O	O	O
patients	O	O	B-T101
administered	O	O	B-T169
either	O	O	O
linezolid	O	O	B-T109
or	O	O	O
vancomycin	O	O	B-T116
,	O	O	O
and	O	O	O
between	O	O	O
patients	O	O	O
who	O	O	O
developed	O	O	O
renal	O	O	B-T047
failure	O	O	I-T047
and	O	O	O
those	O	O	O
who	O	O	O
did	O	O	O
not	O	O	O
.	O	O	O

Analysis	O	O	O
of	O	O	O
HCRU	O	O	B-T078
outcomes	O	O	B-T169
and	O	O	O
costs	O	O	B-T081
.	O	O	O

Total	O	O	O
costs	O	O	B-T081
were	O	O	O
similar	O	O	O
between	O	O	O
the	O	O	O
linezolid	O	O	B-T109
-	O	O	O
(	O	O	O
€	O	O	O
17,782±€9,615	O	O	O
)	O	O	O
and	O	O	O
vancomycin	O	O	B-T116
-	O	O	O
treated	O	O	B-T061
patients	O	O	B-T101
(	O	O	O
€	O	O	O
17,423±€9,460	O	O	O
)	O	O	O
(	O	O	O
P=.69	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
renal	O	O	B-T047
failure	O	O	I-T047
rate	O	O	B-T081
was	O	O	O
significantly	O	O	O
lower	O	O	O
in	O	O	O
the	O	O	O
linezolid	O	O	B-T109
-	O	O	O
treated	O	O	B-T061
patients	O	O	B-T101
(	O	O	O
4	O	O	O
%	O	O	O
vs.	O	O	O
15	O	O	O
%	O	O	O
;	O	O	O
P<.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
total	O	O	O
costs	O	O	B-T081
tended	O	O	O
to	O	O	O
be	O	O	O
higher	O	O	O
in	O	O	O
patients	O	O	B-T101
who	O	O	O
developed	O	O	O
renal	O	O	B-T047
failure	O	O	I-T047
(	O	O	O
€	O	O	O
19,626±€10,840	O	O	O
vs.	O	O	O
€	O	O	O
17,388±€9,369	O	O	O
;	O	O	O
P=.14	O	O	O
)	O	O	O
.	O	O	O

Among	O	O	O
the	O	O	O
patients	O	O	B-T101
who	O	O	O
developed	O	O	O
renal	O	O	B-T047
failure	O	O	I-T047
,	O	O	O
HCRU	O	O	B-T078
(	O	O	O
days	O	O	B-T079
on	O	O	O
mechanical	O	O	B-T061
ventilation	O	O	I-T061
:	O	O	O
13.2±10.7	O	O	O
vs.	O	O	O
7.6±3.6	O	O	O
days	O	O	O
;	O	O	O
P=.21	O	O	O
;	O	O	O
ICU	O	O	B-T079
stay	O	O	I-T079
:	O	O	O
14.4±10.5	O	O	O
vs.	O	O	O
9.9±6.6	O	O	O
days	O	O	O
;	O	O	O
P=.30	O	O	O
;	O	O	O
hospital	O	O	B-T079
stay	O	O	I-T079
:	O	O	O
19.5±9.5	O	O	O
vs.	O	O	O
16.1±11.0	O	O	O
days	O	O	O
;	O	O	O
P=.26	O	O	O
)	O	O	O
and	O	O	O
cost	O	O	B-T081
(	O	O	O
€	O	O	O
17,219±€8,792	O	O	O
vs.	O	O	O
€	O	O	O
20,263±€11,350	O	O	O
;	O	O	O
P=.51	O	O	O
)	O	O	O
tended	O	O	O
to	O	O	O
be	O	O	O
lower	O	O	O
in	O	O	O
the	O	O	O
linezolid	O	O	B-T109
-	O	O	O
vs.	O	O	O
vancomycin	O	O	B-T116
-	O	O	O
treated	O	O	B-T061
patients	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
statistically	O	O	O
significant	O	O	O
differences	O	O	O
in	O	O	O
costs	O	O	B-T081
per	O	O	O
patient	O	O	B-T101
-	O	O	O
day	O	O	B-T079
between	O	O	O
cohorts	O	O	B-T098
after	O	O	O
correcting	O	O	O
for	O	O	O
mortality	O	O	B-T081
(	O	O	O
€	O	O	O
1000	O	O	O
vs.	O	O	O
€	O	O	O
1,010	O	O	O
;	O	O	O
P=.98	O	O	O
)	O	O	O
.	O	O	O

From	O	O	O
a	O	O	O
Spanish	O	O	B-T083
perspective	O	O	B-UnknownType
,	O	O	O
there	O	O	O
were	O	O	O
no	O	O	O
statistically	O	O	O
significant	O	O	O
differences	O	O	O
in	O	O	O
total	O	O	O
costs	O	O	B-T081
between	O	O	O
the	O	O	O
linezolid	O	O	B-T109
and	O	O	O
vancomycin	O	O	B-T116
pneumonia	O	O	B-T047
cohorts	O	O	B-T098
.	O	O	O

The	O	O	O
drug	O	O	B-T081
cost	O	O	I-T081
corresponding	O	O	O
to	O	O	O
linezolid	O	O	B-T109
was	O	O	O
partially	O	O	O
offset	O	O	B-T081
by	O	O	O
fewer	O	O	O
renal	O	O	B-T047
failure	O	O	I-T047
adverse	O	O	B-T046
events	O	O	I-T046
.	O	O	O

-DOCSTART- (27131339)

HERG1	O	O	B-T116
potassium	O	O	B-T116
channel	O	O	I-T116
expression	O	O	B-T045
in	O	O	O
potentially	O	O	B-T080
malignant	O	O	B-T191
disorders	O	O	I-T191
of	O	O	O
the	O	O	O
oral	O	O	B-T023
mucosa	O	O	I-T023
and	O	O	O
prognostic	O	O	B-T170
relevance	O	O	B-T080
in	O	O	O
oral	O	O	O
squamous	O	O	O
cell	O	O	O
carcinoma	O	O	O

HERG1	O	O	B-T116
potassium	O	O	B-T116
channel	O	O	I-T116
plays	O	O	O
a	O	O	O
critical	O	O	B-T080
role	O	O	B-T077
in	O	O	O
the	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
.	O	O	O

HERG1	O	O	B-T116
protein	O	O	I-T116
expression	O	O	B-T045
was	O	O	O
analyzed	O	O	B-T062
by	O	O	O
immunohistochemistry	O	O	B-T060
(	O	O	O
IHC	O	O	B-T060
)	O	O	O
in	O	O	O
62	O	O	O
patients	O	O	B-T101
with	O	O	O
oral	O	O	B-T191
leukoplakias	O	O	I-T191
and	O	O	O
100	O	O	O
patients	O	O	O
with	O	O	O
oral	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinomas	O	O	I-T191
(	O	O	O
OSCC	O	O	B-T191
)	O	O	O
.	O	O	O

HERG1	O	O	B-T028
mRNA	O	O	B-T114
levels	O	O	B-T080
were	O	O	O
assessed	O	O	B-T052
by	O	O	O
real-time	O	O	B-T063
reverse	O	O	I-T063
transcriptase-polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(	O	O	O
RT-PCR	O	O	B-T063
)	O	O	O
in	O	O	O
22	O	O	O
patients	O	O	B-T101
with	O	O	O
primary	O	O	B-T080
head	O	O	B-T191
and	O	O	I-T191
neck	O	O	I-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
HNSCC	O	O	B-T191
)	O	O	O
.	O	O	O

Statistically	O	O	B-T081
significant	O	O	I-T081
associations	O	O	B-T080
were	O	O	O
found	O	O	O
between	O	O	O
HERG1	O	O	B-T116
expression	O	O	B-T045
and	O	O	O
tobacco	O	O	B-T055
consumption	O	O	I-T055
,	O	O	O
disease	O	O	B-T060
stage	O	O	I-T060
,	O	O	O
tumor	O	O	B-T191
differentiation	O	O	B-T043
,	O	O	O
tumor	O	O	B-T191
recurrence	O	O	I-T191
,	O	O	O
and	O	O	O
reduced	O	O	B-T080
survival	O	O	B-T052
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T169
association	O	O	B-T080
between	O	O	O
HERG1	O	O	B-T116
expression	O	O	B-T045
and	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
progression	O	O	B-T191
from	O	O	O
oral	O	O	B-T191
leukoplakia	O	O	I-T191
to	O	O	O
OSCC	O	O	B-T191
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
a	O	O	O
high	O	O	B-T080
proportion	O	O	B-T081
of	O	O	O
tumors	O	O	B-T191
(	O	O	O
80	O	O	O
%	O	O	O
)	O	O	O
showed	O	O	O
increased	O	O	B-T081
HERG1	O	O	B-T028
mRNA	O	O	B-T114
levels	O	O	B-T080
compared	O	O	B-T052
to	O	O	O
normal	O	O	B-T024
mucosa	O	O	I-T024
from	O	O	O
nononcologic	O	O	B-T101
patients	O	O	I-T101
.	O	O	O

Aberrant	O	O	B-T080
HERG1	O	O	B-T116
expression	O	O	B-T045
increases	O	O	B-T169
as	O	O	O
oral	O	O	O
tumorigenesis	O	O	B-T191
progresses	O	O	I-T191
from	O	O	O
oral	O	O	B-T046
hyperplasia	O	O	I-T046
to	O	O	O
OSCC	O	O	B-T191
.	O	O	O

Increased	O	O	B-T081
HERG1	O	O	B-T028
mRNA	O	O	B-T114
levels	O	O	B-T080
were	O	O	O
also	O	O	O
frequently	O	O	O
detected	O	O	B-T033
in	O	O	O
OSCC	O	O	B-T191
and	O	O	O
other	O	O	O
HNSCC	O	O	B-T191
subsites	O	O	B-T082
.	O	O	O

HERG1	O	O	B-T116
expression	O	O	B-T045
emerges	O	O	O
as	O	O	O
a	O	O	O
clinically	O	O	B-T080
relevant	O	O	B-T080
feature	O	O	B-T080
during	O	O	O
tumor	O	O	B-T191
progression	O	O	I-T191
and	O	O	O
a	O	O	O
potential	O	O	B-T080
poor	O	O	B-T080
prognostic	O	O	B-T170
biomarker	O	O	B-T201
for	O	O	O
OSCC	O	O	B-T191
.	O	O	O

©	O	O	O
2016	O	O	O
Wiley	O	O	O
Periodicals	O	O	O
,	O	O	O
Inc.	O	O	O
Head	O	O	O
Neck	O	O	O
38	O	O	O
:	O	O	O
1708	O	O	O
-	O	O	O
1716	O	O	O
,	O	O	O
2016	O	O	O
.	O	O	O

-DOCSTART- (27213687)

Nationwide	O	O	B-T082
reduction	O	O	B-T081
in	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
corneal	O	O	B-T061
transplantations	O	O	I-T061
for	O	O	O
keratoconus	O	O	B-T047
following	O	O	O
the	O	O	O
implementation	O	O	B-T052
of	O	O	O
cross-linking	O	O	O

Keratoconus	O	O	B-T047
is	O	O	O
characterized	O	O	O
by	O	O	O
corneal	O	O	B-T047
ectasia	O	O	I-T047
and	O	O	O
irregular	O	O	B-T047
astigmatism	O	O	I-T047
,	O	O	O
which	O	O	O
can	O	O	O
lead	O	O	O
to	O	O	O
diminished	O	O	B-T047
vision	O	O	I-T047
and	O	O	O
corneal	O	O	B-T033
scarring	O	O	I-T033
.	O	O	O

Approximately	O	O	O
10	O	O	O
-	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
keratoconus	O	O	B-T047
eventually	O	O	O
require	O	O	O
a	O	O	O
corneal	O	O	B-T061
transplant	O	O	I-T061
.	O	O	O

Corneal	O	O	B-T061
cross-linking	O	O	I-T061
(	O	O	O
CXL	O	O	B-T061
)	O	O	O
is	O	O	O
a	O	O	O
relatively	O	O	O
new	O	O	O
treatment	O	O	B-T061
that	O	O	O
may	O	O	O
help	O	O	O
prevent	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
corneal	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
whether	O	O	O
the	O	O	O
introduction	O	O	B-T169
of	O	O	O
CXL	O	O	B-T061
has	O	O	O
reduced	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
corneal	O	O	B-T061
transplants	O	O	I-T061
performed	O	O	B-T169
annually	O	O	B-T079
.	O	O	O

Data	O	O	B-T078
regarding	O	O	O
the	O	O	O
transplantation	O	O	B-T061
procedures	O	O	I-T061
performed	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
under	O	O	O
the	O	O	O
age	O	O	B-T032
of	O	O	O
50	O	O	O
years	O	O	B-T079
were	O	O	O
extracted	O	O	O
from	O	O	O
the	O	O	O
Dutch	O	O	B-T170
National	O	O	I-T170
Organ	O	O	I-T170
Transplant	O	O	I-T170
Registry	O	O	I-T170
.	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
corneal	O	O	B-T061
transplants	O	O	I-T061
performed	O	O	B-T169
prior	O	O	O
to	O	O	O
(	O	O	O
i.e.	O	O	O
in	O	O	O
2005	O	O	O
through	O	O	O
2007	O	O	O
)	O	O	O
and	O	O	O
following	O	O	O
the	O	O	O
introduction	O	O	B-T169
of	O	O	O
CXL	O	O	B-T061
(	O	O	O
i.e.	O	O	O
in	O	O	O
2012	O	O	O
through	O	O	O
2014	O	O	O
)	O	O	O
were	O	O	O
compared	O	O	B-T052
.	O	O	O

Furthermore	O	O	O
,	O	O	O
a	O	O	O
trend	O	O	B-UnknownType
analysis	O	O	I-UnknownType
on	O	O	O
annual	O	O	B-T079
keratoplasties	O	O	B-T061
over	O	O	O
time	O	O	O
was	O	O	O
performed	O	O	B-T169
.	O	O	O

Approximately	O	O	O
25	O	O	O
%	O	O	O
fewer	O	O	O
corneal	O	O	B-T061
transplants	O	O	B-T061
were	O	O	O
performed	O	O	B-T169
in	O	O	O
the	O	O	O
3-	O	O	O
year	O	O	B-T079
period	O	O	O
following	O	O	O
the	O	O	O
introduction	O	O	B-T169
of	O	O	O
CXL	O	O	B-T061
compared	O	O	B-T052
to	O	O	O
the	O	O	O
3-	O	O	O
year	O	O	O
period	O	O	O
prior	O	O	O
to	O	O	O
the	O	O	O
introduction	O	O	O
of	O	O	O
CXL	O	O	O
(	O	O	O
201	O	O	O
versus	O	O	O
269	O	O	O
transplants	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.005	O	O	O
)	O	O	O
.	O	O	O

Age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
and	O	O	O
visual	O	O	B-T201
acuity	O	O	I-T201
were	O	O	O
similar	O	O	O
between	O	O	O
the	O	O	O
patient	O	O	B-T101
groups	O	O	O
in	O	O	O
the	O	O	O
two	O	O	O
time	O	O	B-T079
periods	O	O	I-T079
.	O	O	O

Trend	O	O	B-UnknownType
analysis	O	O	I-UnknownType
also	O	O	O
demonstrated	O	O	O
a	O	O	O
significant	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
amount	O	O	O
of	O	O	O
corneal	O	O	B-T061
transplants	O	O	I-T061
(	O	O	O
p	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Significantly	O	O	O
fewer	O	O	O
corneal	O	O	B-T061
transplants	O	O	I-T061
were	O	O	O
performed	O	O	O
for	O	O	O
treating	O	O	O
keratoconus	O	O	B-T047
following	O	O	O
the	O	O	O
nationwide	O	O	B-T082
introduction	O	O	B-T169
of	O	O	O
CXL	O	O	B-T061
.	O	O	O

This	O	O	O
reduction	O	O	B-T081
suggests	O	O	O
that	O	O	O
corneal	O	O	B-T061
cross-linking	O	O	I-T061
can	O	O	O
significantly	O	O	O
reduce	O	O	B-T080
the	O	O	O
need	O	O	O
for	O	O	O
corneal	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

-DOCSTART- (27233918)

Basal	O	O	B-T040
and	O	O	O
maximal	O	O	B-T080
metabolic	O	O	B-T039
rates	O	O	I-T039
differ	O	O	O
in	O	O	O
their	O	O	O
response	O	O	B-T032
to	O	O	O
rapid	O	O	O
temperature	O	O	B-T080
change	O	O	I-T080
among	O	O	O
avian	O	O	B-T012
species	O	O	O

In	O	O	O
birds	O	O	B-T012
,	O	O	O
acclimation	O	O	B-T040
and	O	O	O
acclimatization	O	O	B-T040
to	O	O	O
temperature	O	O	B-T081
are	O	O	O
associated	O	O	O
with	O	O	O
changes	O	O	O
in	O	O	O
basal	O	O	B-T040
(	O	O	O
BMR	O	O	B-T040
)	O	O	O
,	O	O	O
summit	O	O	B-T039
(	O	O	O
Msum	O	O	B-T039
)	O	O	O
and	O	O	O
maximal	O	O	B-T080
(	O	O	O
MMR	O	O	B-T039
)	O	O	O
metabolic	O	O	B-T039
rates	O	O	I-T039
but	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
rate	O	O	B-T039
at	O	O	O
which	O	O	O
species	O	O	B-T185
adjust	O	O	O
their	O	O	O
phenotype	O	O	B-T032
to	O	O	O
short-term	O	O	B-T079
temperature	O	O	O
variations	O	O	B-T080
.	O	O	O

Our	O	O	O
aims	O	O	B-T078
were	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
pattern	O	O	B-T082
of	O	O	O
metabolic	O	O	B-T169
adjustments	O	O	O
following	O	O	O
a	O	O	O
rapid	O	O	O
temperature	O	O	B-T080
change	O	O	I-T080
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
performance	O	O	O
varies	O	O	O
at	O	O	O
similar	O	O	O
rates	O	O	B-T039
during	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
warm	O	O	B-T067
or	O	O	O
cold	O	O	B-T067
environments	O	O	I-T067
,	O	O	O
and	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
to	O	O	O
determine	O	O	O
if	O	O	O
BMR	O	O	B-T040
,	O	O	O
Msum	O	O	B-T039
and	O	O	O
MMR	O	O	B-T039
change	O	O	O
at	O	O	O
comparable	O	O	O
rates	O	O	O
during	O	O	O
thermal	O	O	B-T070
acclimation	O	O	B-T040
.	O	O	O

We	O	O	O
measured	O	O	O
these	O	O	O
parameters	O	O	O
in	O	O	O
white-throated	O	O	B-T012
sparrows	O	O	I-T012
(	O	O	O
Zonotrichia	O	O	B-T012
albicollis	O	O	I-T012
)	O	O	O
,	O	O	O
black-capped	O	O	B-T012
chickadees	O	O	I-T012
(	O	O	O
Poecile	O	O	B-T012
atricapillus	O	O	I-T012
)	O	O	O
,	O	O	O
and	O	O	O
snow	O	O	B-T012
buntings	O	O	I-T012
(	O	O	O
Plectrophenax	O	O	B-T012
nivalis	O	O	I-T012
)	O	O	O
after	O	O	O
acclimation	O	O	B-T040
to	O	O	O
10	O	O	O
°	O	O	O
C	O	O	O
(	O	O	O
day	O	O	B-T079
0	O	O	O
)	O	O	O
and	O	O	O
on	O	O	O
the	O	O	O
4th	O	O	O
and	O	O	O
8th	O	O	O
days	O	O	B-T079
of	O	O	O
acclimation	O	O	O
to	O	O	O
either	O	O	O
-5	O	O	O
or	O	O	O
28	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

Birds	O	O	B-T012
changed	O	O	O
their	O	O	O
metabolic	O	O	B-T169
phenotype	O	O	B-T032
within	O	O	O
8	O	O	O
days	O	O	B-T079
with	O	O	O
patterns	O	O	B-T082
differing	O	O	O
among	O	O	O
species	O	O	B-T185
.	O	O	O

Sparrows	O	O	B-T012
expressed	O	O	O
the	O	O	O
expected	O	O	O
metabolic	O	O	B-T169
increases	O	O	B-T169
in	O	O	O
the	O	O	O
cold	O	O	B-T067
and	O	O	O
decreases	O	O	O
at	O	O	O
thermoneutrality	O	O	B-T078
while	O	O	O
performance	O	O	O
in	O	O	O
chickadees	O	O	B-T012
and	O	O	O
buntings	O	O	B-T012
was	O	O	O
not	O	O	O
influenced	O	O	B-T077
by	O	O	O
temperature	O	O	B-T081
but	O	O	O
changed	O	O	O
over	O	O	O
time	O	O	O
with	O	O	O
inverse	O	O	O
patterns	O	O	B-T082
.	O	O	O

Our	O	O	O
results	O	O	B-T033
suggest	O	O	O
that	O	O	O
BMR	O	O	B-T040
varies	O	O	O
at	O	O	O
comparable	O	O	O
rates	O	O	B-T039
in	O	O	O
warm	O	O	B-T067
and	O	O	O
cold	O	O	B-T067
environments	O	O	I-T067
but	O	O	O
changes	O	O	O
faster	O	O	O
than	O	O	O
Msum	O	O	B-T039
and	O	O	O
MMR	O	O	B-T039
,	O	O	O
likely	O	O	O
due	O	O	O
to	O	O	O
limitations	O	O	B-T169
in	O	O	O
the	O	O	O
rate	O	O	B-T039
of	O	O	O
change	O	O	O
in	O	O	O
organ	O	O	B-T032
size	O	O	I-T032
and	O	O	O
function	O	O	B-T169
.	O	O	O

They	O	O	O
also	O	O	O
suggest	O	O	O
that	O	O	O
maximal	O	O	B-T080
metabolic	O	O	B-T169
capacity	O	O	B-T081
is	O	O	O
lost	O	O	B-T169
faster	O	O	O
in	O	O	O
a	O	O	O
warm	O	O	B-T067
environment	O	O	I-T067
than	O	O	O
it	O	O	O
is	O	O	O
gained	O	O	B-T081
in	O	O	O
a	O	O	O
cold	O	O	B-T067
environment	O	O	I-T067
.	O	O	O

With	O	O	O
the	O	O	O
expected	O	O	O
increase	O	O	O
in	O	O	O
temperature	O	O	B-T081
stochasticity	O	O	B-T081
at	O	O	O
northern	O	O	B-T083
latitudes	O	O	I-T083
,	O	O	O
a	O	O	O
loss	O	O	B-T081
of	O	O	O
thermogenic	O	O	B-T070
capacity	O	O	B-T081
during	O	O	O
warm	O	O	B-T067
winter	O	O	B-T079
days	O	O	B-T079
could	O	O	O
,	O	O	O
therefore	O	O	O
,	O	O	O
be	O	O	O
detrimental	O	O	O
if	O	O	O
birds	O	O	B-T012
are	O	O	O
slow	O	O	O
to	O	O	O
readjust	O	O	O
their	O	O	O
phenotype	O	O	B-T032
with	O	O	O
the	O	O	O
return	O	O	O
of	O	O	O
cold	O	O	B-T067
days	O	O	O
.	O	O	O

-DOCSTART- (27235824)

A	O	O	O
prime	O	O	B-T041
a	O	O	O
day	O	O	O
keeps	O	O	O
calories	O	O	B-T081
away	O	O	O
:	O	O	O
The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
supraliminal	O	O	B-T041
priming	O	O	I-T041
on	O	O	O
food	O	O	B-T052
consumption	O	O	I-T052
and	O	O	O
the	O	O	O
moderating	O	O	B-T170
role	O	O	I-T170
of	O	O	O
gender	O	O	B-T032
and	O	O	O
eating	O	O	O
restraint	O	O	O

The	O	O	O
link	O	O	O
between	O	O	O
intentions	O	O	B-T041
and	O	O	O
action	O	O	B-T052
in	O	O	O
weight	O	O	B-T061
control	O	O	I-T061
is	O	O	O
weaker	O	O	O
than	O	O	O
previously	O	O	O
thought	O	O	O
,	O	O	O
so	O	O	O
recent	O	O	O
research	O	O	B-T062
has	O	O	O
called	O	O	O
for	O	O	O
further	O	O	O
investigation	O	O	O
of	O	O	O
ways	O	O	O
to	O	O	O
improve	O	O	O
weight	O	O	O
control	O	O	O
that	O	O	O
bypass	O	O	O
conscious	O	O	B-T041
intentions	O	O	O
.	O	O	O

Priming	O	O	B-T041
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
have	O	O	O
effects	O	O	O
on	O	O	O
individual	O	O	O
behavior	O	O	O
in	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
contexts	O	O	O
by	O	O	O
influencing	O	O	O
subconscious	O	O	B-T041
cognition	O	O	B-T041
.	O	O	O

This	O	O	O
paper	O	O	O
investigates	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
semantic	O	O	B-T169
priming	O	O	I-T169
using	O	O	O
healthy	O	O	B-T080
body	O	O	B-T041
image	O	O	I-T041
,	O	O	O
goal-oriented	O	O	B-T170
words	O	O	I-T170
on	O	O	O
food	O	O	B-T052
consumption	O	O	I-T052
.	O	O	O

The	O	O	O
moderating	O	O	B-T170
role	O	O	I-T170
of	O	O	O
both	O	O	O
restrained	O	O	B-T170
eating	O	O	I-T170
and	O	O	O
gender	O	O	B-T032
is	O	O	O
investigated	O	O	O
.	O	O	O

161	O	O	O
participants	O	O	B-T098
were	O	O	O
involved	O	O	O
in	O	O	O
an	O	O	O
experiment	O	O	B-T062
using	O	O	O
a	O	O	O
novel	O	O	O
version	O	O	O
of	O	O	O
a	O	O	O
scrambled	O	O	O
sentence	O	O	B-T170
priming	O	O	B-T041
game	O	O	B-T056
.	O	O	O

The	O	O	O
outcome	O	O	O
measure	O	O	O
was	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
kilocalories	O	O	B-T081
consumed	O	O	B-T061
,	O	O	O
examined	O	O	O
using	O	O	O
a	O	O	O
between	O	O	O
subjects	O	O	O
ANCOVA	O	O	B-T081
with	O	O	O
priming	O	O	B-T041
,	O	O	O
gender	O	O	B-T032
,	O	O	O
restrained	O	O	B-T170
eating	O	O	I-T170
index	O	O	I-T170
,	O	O	O
self-reported	O	O	B-T062
BMI	O	O	B-T201
,	O	O	O
and	O	O	O
two	O	O	O
interaction	O	O	B-T169
terms	O	O	O
(	O	O	O
priming	O	O	O
x	O	O	O
gender	O	O	O
,	O	O	O
and	O	O	O
priming	O	O	O
x	O	O	O
restrained	O	O	O
eating	O	O	O
index	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
main	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
priming	O	O	B-T041
but	O	O	O
there	O	O	O
was	O	O	O
an	O	O	O
interaction	O	O	B-T169
of	O	O	O
priming	O	O	O
with	O	O	O
gender	O	O	B-T032
.	O	O	O

Females	O	O	B-T032
consumed	O	O	O
significantly	O	O	O
fewer	O	O	O
kilocalories	O	O	B-T081
after	O	O	O
being	O	O	O
exposed	O	O	O
to	O	O	O
priming	O	O	B-T041
words	O	O	B-T170
related	O	O	O
to	O	O	O
a	O	O	O
healthy	O	O	B-T080
body	O	O	B-T041
image	O	O	I-T041
(	O	O	O
i.e.	O	O	O
"	O	O	O
slim	O	O	O
"	O	O	O
,	O	O	O
"	O	O	O
fit	O	O	O
,	O	O	O
"	O	O	O
)	O	O	O
compared	O	O	O
to	O	O	O
females	O	O	B-T032
receiving	O	O	O
the	O	O	O
neutral	O	O	O
prime	O	O	B-T041
,	O	O	O
with	O	O	O
a	O	O	O
medium	O	O	O
effect	O	O	O
size	O	O	O
(	O	O	O
d	O	O	O
=	O	O	O
0.58	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
body	O	O	B-T041
image	O	O	I-T041
prime	O	O	B-T041
did	O	O	O
not	O	O	O
significantly	O	O	O
affect	O	O	O
food	O	O	B-T040
intake	O	O	I-T040
for	O	O	O
males	O	O	B-T032
,	O	O	O
nor	O	O	O
did	O	O	O
it	O	O	O
have	O	O	O
a	O	O	O
differential	O	O	O
effect	O	O	O
on	O	O	O
restrained	O	O	B-T098
eaters	O	O	I-T098
.	O	O	O

This	O	O	O
study	O	O	O
shows	O	O	O
that	O	O	O
priming	O	O	B-T041
can	O	O	O
be	O	O	O
an	O	O	O
effective	O	O	O
method	O	O	O
for	O	O	O
influencing	O	O	O
females	O	O	B-T032
to	O	O	O
reduce	O	O	O
food	O	O	B-T040
intake	O	O	I-T040
,	O	O	O
regardless	O	O	O
of	O	O	O
whether	O	O	O
they	O	O	O
are	O	O	O
restrained	O	O	B-T098
or	O	O	O
unrestrained	O	O	B-T098
eaters	O	O	I-T098
.	O	O	O

Future	O	O	O
studies	O	O	O
could	O	O	O
investigate	O	O	O
whether	O	O	O
different	O	O	O
priming	O	O	B-T041
words	O	O	B-T170
related	O	O	O
to	O	O	O
a	O	O	O
male	O	O	B-T032
's	O	O	I-T032
healthy	O	O	B-T080
body	O	O	B-T041
image	O	O	I-T041
goal	O	O	O
(	O	O	O
i.e.	O	O	O
"	O	O	O
buff	O	O	O
,	O	O	O
"	O	O	O
"	O	O	O
muscles	O	O	B-T024
,	O	O	O
"	O	O	O
etc	O	O	O
.	O	O	O
)	O	O	O
would	O	O	O
similarly	O	O	O
reduce	O	O	O
food	O	O	B-T040
intake	O	O	I-T040
for	O	O	O
males	O	O	B-T032
.	O	O	O

-DOCSTART- (27235870)

Neurotrophins	O	O	B-T116
and	O	O	O
specific	O	O	B-T116
receptors	O	O	I-T116
in	O	O	O
the	O	O	O
oviduct	O	O	B-T023
tracts	O	O	I-T023
of	O	O	O
Japanese	O	O	B-T012
quail	O	O	I-T012
(	O	O	O
Coturnix	O	O	B-T012
coturnix	O	O	I-T012
japonica	O	O	I-T012
)	O	O	O

Neurotrophins	O	O	B-T116
(	O	O	O
NGF	O	O	B-T116
,	O	O	O
BDNF	O	O	B-T116
and	O	O	O
NT-3	O	O	B-T116
)	O	O	O
and	O	O	O
their	O	O	O
specific	O	O	B-T116
receptors	O	O	I-T116
(	O	O	O
TrkA	O	O	B-T116
,	O	O	O
TrkB	O	O	B-T116
and	O	O	O
TrkC	O	O	B-T116
)	O	O	O
were	O	O	O
studied	O	O	B-T062
in	O	O	O
the	O	O	O
oviduct	O	O	B-T023
of	O	O	O
egg	O	O	B-T040
laying	O	O	I-T040
quails	O	O	B-T012
.	O	O	O

Neurotrophins	O	O	B-T116
(	O	O	O
NTs	O	O	B-T116
)	O	O	O
are	O	O	O
mainly	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
development	O	O	B-T169
and	O	O	O
maintenance	O	O	B-T169
of	O	O	O
neuronal	O	O	B-T025
populations	O	O	I-T025
in	O	O	O
the	O	O	O
central	O	O	B-T022
and	O	O	O
peripheral	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
,	O	O	O
but	O	O	O
also	O	O	O
in	O	O	O
reproductive	O	O	B-T022
system	O	O	I-T022
.	O	O	O

In	O	O	O
this	O	O	O
survey	O	O	O
,	O	O	O
we	O	O	O
first	O	O	O
studied	O	O	B-T062
the	O	O	O
morphological	O	O	B-T080
organization	O	O	B-T039
of	O	O	O
the	O	O	O
quail	O	O	B-T012
oviduct	O	O	B-T023
,	O	O	O
distinguished	O	O	O
in	O	O	O
infundibulum	O	O	B-T023
,	O	O	O
magnum	O	O	B-T023
,	O	O	O
isthmus	O	O	B-T023
,	O	O	O
uterus	O	O	B-T023
and	O	O	O
vagina	O	O	B-T023
,	O	O	O
and	O	O	O
then	O	O	O
we	O	O	O
analyzed	O	O	B-T062
the	O	O	O
expression	O	O	B-T045
and	O	O	O
localization	O	O	B-T043
of	O	O	O
NTs	O	O	B-T116
and	O	O	O
Trks	O	O	B-T116
receptors	O	O	I-T116
in	O	O	O
the	O	O	O
whole	O	O	O
tracts	O	O	B-T023
.	O	O	O

By	O	O	O
western	O	O	B-T059
blotting	O	O	I-T059
we	O	O	O
detected	O	O	O
that	O	O	O
the	O	O	O
investigated	O	O	B-T169
NTs	O	O	B-T116
and	O	O	O
Trks	O	O	B-T116
receptors	O	O	I-T116
are	O	O	O
expressed	O	O	B-T045
in	O	O	O
all	O	O	O
oviductal	O	O	B-T023
tracts	O	O	I-T023
.	O	O	O

By	O	O	O
immunohistochemistry	O	O	B-T060
we	O	O	O
were	O	O	O
able	O	O	O
to	O	O	O
define	O	O	O
the	O	O	O
distribution	O	O	B-T043
of	O	O	O
NTs	O	O	B-T116
and	O	O	O
Trks	O	O	B-T116
.	O	O	O

Specifically	O	O	O
,	O	O	O
NGF	O	O	B-T116
,	O	O	O
BDNF	O	O	B-T116
and	O	O	O
NT3	O	O	B-T116
were	O	O	O
localized	O	O	O
in	O	O	O
lining	O	O	B-T082
and	O	O	O
ductal	O	O	B-T025
epithelial	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
NGF	O	O	O
was	O	O	O
also	O	O	O
detected	O	O	O
in	O	O	O
secretory	O	O	B-T025
cells	O	O	I-T025
of	O	O	O
tubular	O	O	B-T023
glands	O	O	I-T023
and	O	O	O
in	O	O	O
nervous	O	O	B-T026
fibers	O	O	I-T026
of	O	O	O
vessel	O	O	B-T023
wall	O	O	I-T023
.	O	O	O

TrkA	O	O	B-T116
and	O	O	O
TrkB	O	O	B-T116
were	O	O	O
present	O	O	O
in	O	O	O
the	O	O	O
lining	O	O	B-T082
and	O	O	O
ductal	O	O	B-T024
epithelium	O	O	I-T024
;	O	O	O
TrkA	O	O	O
and	O	O	O
TrkC	O	O	B-T116
were	O	O	O
present	O	O	O
in	O	O	O
nervous	O	O	B-T026
fibers	O	O	I-T026
of	O	O	O
vessel	O	O	B-T023
wall	O	O	I-T023
in	O	O	O
all	O	O	O
oviductal	O	O	B-T023
tracts	O	O	I-T023
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
also	O	O	O
observed	O	O	O
NGF	O	O	B-T116
and	O	O	O
BDNF	O	O	B-T116
co-localized	O	O	O
with	O	O	O
TrkA	O	O	B-T116
and	O	O	O
TrkB	O	O	B-T116
in	O	O	O
cells	O	O	B-T025
of	O	O	O
the	O	O	O
lining	O	O	B-T082
and	O	O	O
ductal	O	O	B-T024
epithelium	O	O	I-T024
,	O	O	O
suggesting	O	O	O
an	O	O	O
autocrine	O	O	B-T043
mechanism	O	O	I-T043
of	O	O	O
action	O	O	B-T052
.	O	O	O

-DOCSTART- (27236097)

The	O	O	O
influence	O	O	O
of	O	O	O
liposomal	O	O	B-T109
formulation	O	O	B-T077
on	O	O	O
the	O	O	O
incorporation	O	O	B-T169
and	O	O	O
retention	O	O	B-T169
of	O	O	O
PNA	O	O	O
oligomers	O	O	O

Liposomal	O	O	B-T109
formulations	O	O	B-T077
composed	O	O	O
of	O	O	O
phospholipids	O	O	B-T109
with	O	O	O
different	O	O	O
unsaturation	O	O	B-T080
degrees	O	O	I-T080
,	O	O	O
head	O	O	B-T169
groups	O	O	I-T169
and	O	O	O
at	O	O	O
different	O	O	O
cholesterol	O	O	B-T059
content	O	O	I-T059
have	O	O	I-T059
been	O	O	I-T059
tested	O	O	I-T059
for	O	O	O
the	O	O	O
encapsulation	O	O	B-T067
of	O	O	O
Peptide	O	O	B-T114
Nucleic	O	O	I-T114
Acid	O	O	I-T114
(	O	O	I-T114
PNA	O	O	I-T114
)	O	O	I-T114
oligomers	O	O	I-T114
.	O	O	O

The	O	O	O
best	O	O	B-T081
loading	O	O	I-T081
capability	O	O	I-T081
(	O	O	O
177μg	O	O	O
,	O	O	O
ER	O	O	B-T081
%	O	O	O
=	O	O	O
87.2	O	O	O
)	O	O	O
was	O	O	O
obtained	O	O	O
for	O	O	O
pure	O	O	O
liposomes	O	O	B-T109
of	O	O	O
phosphatidylglycerol	O	O	B-T109
(	O	O	O
DOPG	O	O	B-T109
)	O	O	O
with	O	O	O
negatively	O	O	B-T196
charged	O	O	I-T196
head	O	O	B-T169
group	O	O	I-T169
.	O	O	O

The	O	O	O
insertion	O	O	B-T058
of	O	O	O
a	O	O	O
10	O	O	O
-	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
cholesterol	O	O	B-T109
in	O	O	O
DOPG	O	O	B-T109
based	O	O	O
liposomes	O	O	B-T109
provides	O	O	O
a	O	O	O
slight	O	O	O
decrease	O	O	B-T081
(	O	O	O
∼160μg	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
PNA	O	O	B-T114
loading	O	O	B-T052
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
the	O	O	O
cholesterol	O	O	B-T109
addition	O	O	B-T169
(	O	O	O
20	O	O	O
-	O	O	O
30	O	O	O
%	O	O	O
)	O	O	O
slows	O	O	O
down	O	O	O
the	O	O	O
PNA	O	O	B-T114
's	O	O	I-T114
release	O	O	B-T070
(	O	O	O
∼27	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
fetal	O	O	B-T130
bovine	O	O	I-T130
serum	O	O	I-T130
from	O	O	O
the	O	O	O
liposomal	O	O	B-T109
formulation	O	O	B-T077
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
encapsulation	O	O	B-T067
and	O	O	O
the	O	O	O
release	O	O	B-T070
properties	O	O	I-T070
,	O	O	O
PEGylated	O	O	B-T109
DOPG	O	O	B-T109
liposomes	O	O	B-T109
with	O	O	O
a	O	O	O
percentage	O	O	O
of	O	O	O
cholesterol	O	O	B-T109
of	O	O	O
10	O	O	O
-	O	O	O
20	O	O	O
%	O	O	O
are	O	O	O
the	O	O	O
optimal	O	O	B-T062
formulation	O	O	I-T062
for	O	O	O
the	O	O	O
loading	O	O	B-T052
of	O	O	O
PNA-a210	O	O	B-T114
.	O	O	O

-DOCSTART- (27236780)

Histopathology	O	O	B-T091
of	O	O	O
the	O	O	O
filum	O	O	B-T023
terminale	O	O	I-T023
in	O	O	O
children	O	O	B-T100
with	O	O	O
and	O	O	O
without	O	O	B-T080
tethered	O	O	B-T047
cord	O	O	I-T047
syndrome	O	O	I-T047
with	O	O	O
attention	O	O	O
to	O	O	O
the	O	O	O
elastic	O	O	B-T024
tissue	O	O	I-T024
within	O	O	O
the	O	O	O
filum	O	O	O

To	O	O	O
compare	O	O	B-T052
histologically	O	O	B-T169
transected	O	O	B-T169
fila	O	O	B-T023
from	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
with	O	O	O
tethered	O	O	B-T047
cord	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
TCS	O	O	B-T047
)	O	O	O
,	O	O	O
with	O	O	O
and	O	O	O
without	O	O	B-T080
a	O	O	O
low	O	O	B-T029
conus	O	O	B-T023
,	O	O	O
with	O	O	O
controls	O	O	O
,	O	O	O
focusing	O	O	O
on	O	O	O
collagenous	O	O	B-T024
and	O	O	O
elastic	O	O	B-T024
tissue	O	O	I-T024
.	O	O	O

Thirty	O	O	O
fila	O	O	B-T023
from	O	O	O
patients	O	O	B-T101
with	O	O	O
TCS	O	O	B-T047
,	O	O	O
including	O	O	O
5	O	O	O
where	O	O	O
minimal	O	O	B-T080
cautery	O	O	B-T061
was	O	O	O
used	O	O	O
prior	O	O	O
to	O	O	O
filum	O	O	B-T023
section	O	O	B-T059
,	O	O	O
were	O	O	O
compared	O	O	B-T052
with	O	O	O
fila	O	O	O
from	O	O	O
27	O	O	O
pediatric	O	O	B-T080
cadavers	O	O	B-T017
without	O	O	B-T080
TCS	O	O	O
(	O	O	O
controls	O	O	B-T096
)	O	O	O
.	O	O	O

Sections	O	O	B-T167
of	O	O	O
fila	O	O	B-T023
were	O	O	O
stained	O	O	B-T059
with	O	O	O
H&E	O	O	B-T059
,	O	O	O
Masson	O	O	B-T059
trichrome	O	O	I-T059
and	O	O	O
Verhoeff	O	O	B-T059
von	O	O	I-T059
Gieson	O	O	I-T059
elastic	O	O	I-T059
stains	O	O	I-T059
,	O	O	O
and	O	O	O
7	O	O	O
with	O	O	O
Gordon	O	O	B-T059
and	O	O	I-T059
Sweet	O	O	I-T059
's	O	O	I-T059
reticulin	O	O	I-T059
stain	O	O	I-T059
.	O	O	O

Fila	O	O	B-T023
from	O	O	O
controls	O	O	B-T096
showed	O	O	O
loose	O	O	B-T080
fibrous	O	O	B-T024
connective	O	O	I-T024
tissue	O	O	I-T024
(	O	O	O
FCT	O	O	B-T024
)	O	O	O
with	O	O	O
thin	O	O	B-T080
and	O	O	O
evenly	O	O	B-T169
dispersed	O	O	I-T169
elastic	O	O	B-T024
fibers	O	O	I-T024
(	O	O	O
EFs	O	O	B-T024
)	O	O	O
.	O	O	O

Reticulin	O	O	B-T116
fibers	O	O	I-T116
(	O	O	O
RFs	O	O	B-T116
)	O	O	O
were	O	O	O
seen	O	O	O
in	O	O	O
blood	O	O	B-T023
vessel	O	O	I-T023
walls	O	O	I-T023
and	O	O	O
nerve	O	O	B-T024
twigs	O	O	O
.	O	O	O

Fat	O	O	B-T109
was	O	O	O
identified	O	O	B-T080
microscopically	O	O	B-T080
in	O	O	O
2	O	O	O
fila	O	O	B-T023
.	O	O	O

All	O	O	O
fila	O	O	B-T023
from	O	O	O
patients	O	O	B-T101
with	O	O	O
TCS	O	O	B-T047
had	O	O	O
dense	O	O	B-T024
FCT	O	O	I-T024
.	O	O	O

The	O	O	O
EFs	O	O	B-T024
were	O	O	O
in	O	O	O
normal	O	O	B-T080
numbers	O	O	O
in	O	O	O
17	O	O	O
,	O	O	O
and	O	O	O
focally	O	O	B-T082
or	O	O	O
diffusely	O	O	B-T080
decreased	O	O	B-T081
in	O	O	O
13	O	O	O
.	O	O	O

All	O	O	O
25	O	O	O
patients	O	O	B-T101
where	O	O	O
the	O	O	O
fila	O	O	B-T023
were	O	O	O
cauterized	O	O	B-T061
during	O	O	O
resection	O	O	B-T061
had	O	O	O
thick	O	O	B-T080
and	O	O	O
coiled	O	O	B-T082
EFs	O	O	B-T024
.	O	O	O

Coiling	O	O	B-T082
was	O	O	O
not	O	O	O
seen	O	O	O
when	O	O	O
minimal	O	O	B-T080
cautery	O	O	B-T061
was	O	O	O
applied	O	O	O
.	O	O	O

RFs	O	O	B-T116
were	O	O	O
seen	O	O	O
in	O	O	O
blood	O	O	B-T023
vessel	O	O	I-T023
walls	O	O	I-T023
and	O	O	O
nerve	O	O	O
twigs	O	O	O
.	O	O	O

Fat	O	O	B-T109
was	O	O	O
identified	O	O	B-T080
in	O	O	O
19	O	O	O
patients	O	O	B-T101
.	O	O	O

Findings	O	O	B-T033
were	O	O	O
similar	O	O	B-T080
,	O	O	O
whether	O	O	O
the	O	O	O
conus	O	O	B-T023
termination	O	O	O
was	O	O	O
normal	O	O	B-T080
or	O	O	O
low	O	O	B-T082
.	O	O	O

The	O	O	O
fila	O	O	B-T023
of	O	O	O
all	O	O	O
patients	O	O	B-T101
with	O	O	O
TCS	O	O	B-T047
,	O	O	O
whether	O	O	O
or	O	O	O
not	O	O	O
the	O	O	O
conus	O	O	B-T023
was	O	O	O
low	O	O	B-T082
,	O	O	O
showed	O	O	O
abnormal	O	O	B-T033
FCT	O	O	B-T024
.	O	O	O

EFs	O	O	B-T024
were	O	O	O
decreased	O	O	B-T081
in	O	O	O
48	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
;	O	O	O
however	O	O	O
,	O	O	O
there	O	O	O
were	O	O	O
thick	O	O	B-T080
and	O	O	O
coiled	O	O	B-T082
EFs	O	O	O
in	O	O	O
all	O	O	O
patients	O	O	O
.	O	O	O

Coiling	O	O	B-T082
of	O	O	O
EFs	O	O	B-T024
,	O	O	O
initially	O	O	O
thought	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
abnormality	O	O	B-T033
in	O	O	O
patients	O	O	B-T101
,	O	O	O
is	O	O	O
considered	O	O	O
most	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
result	O	O	B-T033
of	O	O	O
cautery	O	O	B-T061
(	O	O	O
i.e.	O	O	O
,	O	O	O
artifactual	O	O	B-T068
/	O	O	O
iatrogenic	O	O	B-T080
coiling	O	O	B-T082
)	O	O	O
.	O	O	O

-DOCSTART- (27237301)

Clinical	O	O	B-T033
value	O	O	I-T033
of	O	O	O
pathologic	O	O	B-T060
examination	O	O	I-T060
of	O	O	O
non-neoplastic	O	O	B-T023
kidney	O	O	I-T023
in	O	O	O
patients	O	O	B-T101
with	O	O	O
upper	O	O	B-T022
urinary	O	O	I-T022
tract	O	O	I-T022
malignancies	O	O	O

While	O	O	O
surgical	O	O	B-T061
resection	O	O	I-T061
remains	O	O	O
the	O	O	O
standard	O	O	O
of	O	O	O
care	O	O	B-T052
in	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
upper	O	O	B-T022
urinary	O	O	I-T022
tract	O	O	I-T022
malignancies	O	O	B-T191
,	O	O	O
nephrectomy	O	O	B-T061
is	O	O	O
a	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CKD	O	O	B-T047
)	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
histologic	O	O	B-T169
evaluation	O	O	B-T058
of	O	O	O
non-neoplastic	O	O	B-T023
kidney	O	O	I-T023
could	O	O	O
enable	O	O	O
early	O	O	B-T061
identification	O	O	I-T061
of	O	O	O
unrecognized	O	O	O
kidney	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
could	O	O	O
be	O	O	O
of	O	O	O
prognostic	O	O	B-T170
value	O	O	O
in	O	O	O
predicting	O	O	O
postoperative	O	O	B-T079
renal	O	O	B-T023
outcomes	O	O	B-T080
.	O	O	O

We	O	O	O
retrospectively	O	O	B-T062
analyzed	O	O	I-T062
51	O	O	O
patients	O	O	B-T101
with	O	O	O
upper	O	O	B-T022
urinary	O	O	I-T022
tract	O	O	I-T022
malignancies	O	O	B-T191
who	O	O	O
received	O	O	O
uninephrectomy	O	O	B-T061
or	O	O	O
uninephroureterectomy	O	O	B-T061
.	O	O	O

A	O	O	O
thorough	O	O	O
pathologic	O	O	B-T169
evaluation	O	O	B-T058
of	O	O	O
non-neoplastic	O	O	B-T023
kidney	O	O	I-T023
including	O	O	O
special	O	O	B-T061
stains	O	O	I-T061
,	O	O	O
immunofluorescence	O	O	B-T059
,	O	O	O
and	O	O	O
electron	O	O	B-T059
microscopic	O	O	I-T059
studies	O	O	I-T059
was	O	O	O
performed	O	O	O
.	O	O	O

The	O	O	O
degree	O	O	B-T081
of	O	O	O
parenchymal	O	O	B-T023
changes	O	O	B-T169
was	O	O	O
graded	O	O	O
from	O	O	O
0	O	O	O
to	O	O	O
15	O	O	O
.	O	O	O

Of	O	O	O
51	O	O	O
patients	O	O	B-T101
,	O	O	O
only	O	O	O
13	O	O	O
showed	O	O	O
normal	O	O	O
kidney	O	O	B-T023
pathology	O	O	B-T091
.	O	O	O

Fifteen	O	O	O
patients	O	O	B-T101
showed	O	O	O
glomerular	O	O	B-T047
abnormalities	O	O	I-T047
,	O	O	O
14	O	O	O
showed	O	O	O
diabetic	O	O	B-T047
nephropathy	O	O	B-T061
,	O	O	O
and	O	O	O
11	O	O	O
showed	O	O	O
vascular	O	O	B-T023
nephropathy	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
one	O	O	O
case	O	O	O
each	O	O	O
of	O	O	O
reflux	O	O	B-T047
nephropathy	O	O	I-T047
and	O	O	O
chronic	O	O	B-T047
pyelonephritis	O	O	I-T047
.	O	O	O

The	O	O	O
median	O	O	O
histologic	O	O	B-T081
score	O	O	I-T081
was	O	O	O
5	O	O	O
points	O	O	O
.	O	O	O

Only	O	O	O
25.4	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
had	O	O	O
≤	O	O	O
3	O	O	O
points	O	O	O
.	O	O	O

Score	O	O	B-T081
more	O	O	O
than	O	O	O
5	O	O	O
was	O	O	O
observed	O	O	O
in	O	O	O
47.1	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
.	O	O	O

Postoperative	O	O	B-T079
estimated	O	O	B-T059
glomerular	O	O	I-T059
filtration	O	O	I-T059
rate	O	O	I-T059
(	O	O	O
eGFR	O	O	B-T059
)	O	O	O
at	O	O	O
3	O	O	O
to	O	O	O
36	O	O	O
months	O	O	B-T079
were	O	O	O
obtained	O	O	O
from	O	O	O
90.2	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
,	O	O	O
and	O	O	O
of	O	O	O
those	O	O	O
,	O	O	O
34.8	O	O	O
%	O	O	O
had	O	O	O
de	O	O	O
novo	O	O	O
CKD	O	O	B-T047
.	O	O	O

Since	O	O	O
no	O	O	O
one	O	O	O
had	O	O	O
CKD	O	O	B-T047
in	O	O	O
partial	O	O	O
nephrectomized	O	O	B-T101
patients	O	O	I-T101
,	O	O	O
we	O	O	O
determined	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
CKD	O	O	O
in	O	O	O
radical	O	O	O
nephrectomized	O	O	O
patients	O	O	O
.	O	O	O

Cox	O	O	B-T170
regression	O	O	I-T170
analysis	O	O	I-T170
revealed	O	O	O
that	O	O	O
postoperative	O	O	B-T079
AKI	O	O	B-T037
,	O	O	O
preoperative	O	O	B-T079
eGFR	O	O	B-T059
,	O	O	O
and	O	O	O
histologic	O	O	B-T169
score	O	O	O
of	O	O	O
non-neoplastic	O	O	B-T023
kidney	O	O	I-T023
were	O	O	O
the	O	O	O
independent	O	O	O
predictors	O	O	B-T078
for	O	O	O
CKD	O	O	B-T047
.	O	O	O

We	O	O	O
conclude	O	O	O
that	O	O	O
routine	O	O	O
pathologic	O	O	B-T169
evaluation	O	O	B-T058
of	O	O	O
non-neoplastic	O	O	B-T023
kidney	O	O	I-T023
provides	O	O	O
valuable	O	O	O
diagnostic	O	O	B-T169
and	O	O	O
prognostic	O	O	B-T170
information	O	O	O
.	O	O	O

-DOCSTART- (27239027)

Concordant	O	O	O
but	O	O	O
Varied	O	O	O
Phenotypes	O	O	B-T032
among	O	O	O
Duchenne	O	O	B-T047
Muscular	O	O	I-T047
Dystrophy	O	O	I-T047
Patient	O	O	B-T101
-Specific	O	O	O
Myoblasts	O	O	B-T025
Derived	O	O	O
using	O	O	O
a	O	O	O
Human	O	O	B-T016
iPSC	O	O	B-T025
-Based	O	O	O
Model	O	O	O

Duchenne	O	O	B-T047
muscular	O	O	I-T047
dystrophy	O	O	I-T047
(	O	O	O
DMD	O	O	B-T047
)	O	O	O
remains	O	O	O
an	O	O	O
intractable	O	O	O
genetic	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

Althogh	O	O	O
there	O	O	O
are	O	O	O
several	O	O	O
animal	O	O	B-T050
models	O	O	I-T050
of	O	O	O
DMD	O	O	B-T047
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
human	O	O	B-T025
cell	O	O	I-T025
model	O	O	O
that	O	O	O
carries	O	O	O
patient	O	O	B-T101
-specific	O	O	O
DYSTROPHIN	O	O	B-T028
mutations	O	O	B-T045
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
a	O	O	O
human	O	O	B-T016
DMD	O	O	B-T047
model	O	O	B-T050
using	O	O	O
human	O	O	B-T025
induced	O	O	I-T025
pluripotent	O	O	I-T025
stem	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
hiPSCs	O	O	B-T025
)	O	O	O
.	O	O	O

Our	O	O	O
model	O	O	O
reveals	O	O	O
concordant	O	O	O
disease	O	O	B-T047
-	O	O	O
related	O	O	B-T169
phenotypes	O	O	B-T032
with	O	O	O
patient	O	O	B-T101
-	O	O	O
dependent	O	O	B-T080
variation	O	O	B-T080
,	O	O	O
which	O	O	O
are	O	O	O
partially	O	O	O
reversed	O	O	O
by	O	O	O
genetic	O	O	B-T169
and	O	O	O
pharmacological	O	O	B-T169
approaches	O	O	O
.	O	O	O

Our	O	O	O
"	O	O	O
chemical-compound	O	O	B-T103
-based	O	O	O
"	O	O	O
strategy	O	O	B-T062
successfully	O	O	O
directs	O	O	O
hiPSCs	O	O	B-T025
into	O	O	O
expandable	O	O	O
myoblasts	O	O	B-T025
,	O	O	O
which	O	O	O
exhibit	O	O	O
a	O	O	O
myogenic	O	O	B-T045
transcriptional	O	O	I-T045
program	O	O	B-T169
,	O	O	O
forming	O	O	O
striated	O	O	B-T080
contractile	O	O	B-T026
myofibers	O	O	B-T026
and	O	O	O
participating	O	O	O
in	O	O	O
muscle	O	O	B-T033
regeneration	O	O	I-T033
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

DMD	O	O	B-T047
-	O	O	O
hiPSC	O	O	B-T025
-derived	O	O	O
myoblasts	O	O	B-T025
show	O	O	O
disease	O	O	B-T047
-	O	O	O
related	O	O	B-T169
phenotypes	O	O	B-T032
with	O	O	O
patient	O	O	B-T101
-to-	O	O	O
patient	O	O	O
variability	O	O	B-T077
,	O	O	O
including	O	O	O
aberrant	O	O	B-T080
expression	O	O	O
of	O	O	O
inflammation	O	O	B-T046
or	O	O	O
immune-response	O	O	B-T028
genes	O	O	I-T028
and	O	O	O
collagens	O	O	B-T116
,	O	O	O
increased	O	O	O
BMP	O	O	B-T044
/	O	O	O
TGFβ	O	O	B-T044
signaling	O	O	I-T044
,	O	O	O
and	O	O	O
reduced	O	O	O
fusion	O	O	O
competence	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
by	O	O	O
genetic	O	O	B-T169
correction	O	O	B-T169
and	O	O	O
pharmacological	O	O	B-T169
"	O	O	O
dual-	O	O	O
SMAD	O	O	B-T116
"	O	O	O
inhibition	O	O	B-T043
,	O	O	O
the	O	O	O
DMD	O	O	B-T047
-	O	O	O
hiPSC	O	O	B-T025
-derived	O	O	O
myoblasts	O	O	B-T025
and	O	O	O
genetically	O	O	B-T169
corrected	O	O	O
isogenic	O	O	B-T080
myoblasts	O	O	O
form	O	O	O
"	O	O	O
rescued	O	O	O
"	O	O	O
multi	O	O	B-T081
-	O	O	O
nucleated	O	O	B-T080
myotubes	O	O	B-T025
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	O
demonstrate	O	O	O
the	O	O	O
feasibility	O	O	O
of	O	O	O
establishing	O	O	O
a	O	O	O
human	O	O	B-T016
"	O	O	O
DMD	O	O	B-T047
-in-a-dish	O	O	O
"	O	O	O
model	O	O	B-T050
using	O	O	O
hiPSC	O	O	B-T025
-based	O	O	O
disease	O	O	B-T050
modeling	O	O	I-T050
.	O	O	O

-DOCSTART- (27239445)

SNAI1	O	O	B-T116
promotes	O	O	B-T052
the	O	O	O
development	O	O	B-T169
of	O	O	O
HCC	O	O	B-T191
through	O	O	O
the	O	O	O
enhancement	O	O	B-T052
of	O	O	O
proliferation	O	O	B-T169
and	O	O	O
inhibition	O	O	O
of	O	O	O
apoptosis	O	O	O

SNAI1	O	O	B-T116
,	O	O	O
a	O	O	O
zinc-finger	O	O	B-T116
transcription	O	O	I-T116
factor	O	O	I-T116
,	O	O	O
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
induction	O	O	B-T169
of	O	O	O
epithelial-mesenchymal	O	O	B-T043
transition	O	O	I-T043
(	O	O	O
EMT	O	O	B-T043
)	O	O	O
in	O	O	O
various	O	O	O
cancers	O	O	B-T191
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
possible	O	O	O
functions	O	O	O
of	O	O	O
SNAI1	O	O	B-T116
in	O	O	O
the	O	O	O
proliferation	O	O	B-T169
and	O	O	O
apoptosis	O	O	B-T043
of	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
have	O	O	O
not	O	O	O
been	O	O	O
clearly	O	O	O
identified	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
investigated	O	O	O
the	O	O	O
effects	O	O	B-T080
and	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
SNAI1	O	O	B-T116
in	O	O	O
the	O	O	O
proliferation	O	O	B-T169
and	O	O	O
apoptosis	O	O	B-T043
of	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
using	O	O	O
clinical	O	O	B-T080
samples	O	O	B-T167
and	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
SNAI1	O	O	B-T116
is	O	O	O
highly	O	O	O
expressed	O	O	B-T045
in	O	O	O
the	O	O	O
tissues	O	O	B-T024
of	O	O	O
liver	O	O	B-T191
cancer	O	O	I-T191
compared	O	O	O
with	O	O	O
adjacent	O	O	O
nontumor	O	O	B-T024
tissues	O	O	I-T024
.	O	O	O

SNAI1	O	O	B-T116
is	O	O	O
also	O	O	O
highly	O	O	O
expressed	O	O	B-T045
in	O	O	O
the	O	O	O
hepatoma	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
HepG2	O	O	I-T025
,	O	O	O
SMMC-7721	O	O	B-T025
,	O	O	O
and	O	O	O
BEL-7402	O	O	B-T025
compared	O	O	O
with	O	O	O
the	O	O	O
human	O	O	B-T025
normal	O	O	I-T025
liver	O	O	I-T025
cell	O	O	I-T025
line	O	O	I-T025
L02	O	O	I-T025
.	O	O	O

We	O	O	O
also	O	O	O
observed	O	O	O
that	O	O	O
SNAI1	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
correlated	O	O	O
with	O	O	O
distal	O	O	B-T046
metastasis	O	O	I-T046
,	O	O	O
incomplete	O	O	O
tumor	O	O	B-T191
capsule	O	O	I-T191
formation	O	O	I-T191
,	O	O	O
and	O	O	O
histological	O	O	B-T201
differentiation	O	O	I-T201
in	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
(	O	O	O
HCC	O	O	B-T191
)	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
we	O	O	O
demonstrated	O	O	O
that	O	O	O
knockdown	O	O	B-T063
of	O	O	O
SNAI1	O	O	B-T028
via	O	O	O
lentiviral	O	O	B-T005
vectors	O	O	B-T121
of	O	O	O
RNAi	O	O	B-T045
against	O	O	O
SNAI	O	O	B-T116
inhibited	O	O	O
cell	O	O	B-T169
proliferation	O	O	I-T169
by	O	O	O
inducing	O	O	O
G1	O	O	B-T043
arrest	O	O	I-T043
,	O	O	O
which	O	O	O
was	O	O	O
accompanied	O	O	O
by	O	O	O
the	O	O	O
downregulation	O	O	B-T044
of	O	O	O
cyclin	O	O	B-T116
D1	O	O	I-T116
but	O	O	O
not	O	O	O
that	O	O	O
of	O	O	O
cyclin	O	O	O
A.	O	O	O
In	O	O	O
addition	O	O	O
,	O	O	O
knockdown	O	O	O
of	O	O	O
SNAI1	O	O	O
promoted	O	O	B-T052
apoptosis	O	O	B-T043
by	O	O	O
decreasing	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
Bcl-2	O	O	B-T116
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	O
revealed	O	O	O
that	O	O	O
SNAI1	O	O	B-T116
is	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
via	O	O	O
regulating	O	O	B-T040
the	O	O	I-T040
growth	O	O	I-T040
and	O	O	O
apoptosis	O	O	B-T043
of	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (27240257)

Quantitative	O	O	B-T081
assessment	O	O	I-T081
of	O	O	O
fluorescent	O	O	O
proteins	O	O	O

The	O	O	O
advent	O	O	O
of	O	O	O
fluorescent	O	O	B-T116
proteins	O	O	I-T116
(	O	O	O
FPs	O	O	B-T116
)	O	O	O
for	O	O	O
genetic	O	O	B-T063
labeling	O	O	I-T063
of	O	O	O
molecules	O	O	B-T167
and	O	O	O
cells	O	O	B-T025
has	O	O	O
revolutionized	O	O	O
fluorescence	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

Genetic	O	O	B-T063
manipulations	O	O	I-T063
have	O	O	O
created	O	O	O
a	O	O	O
vast	O	O	O
array	O	O	O
of	O	O	O
bright	O	O	O
and	O	O	O
stable	O	O	O
FPs	O	O	B-T116
spanning	O	O	O
blue	O	O	B-T082
to	O	O	I-T082
red	O	O	I-T082
spectral	O	O	I-T082
regions	O	O	I-T082
.	O	O	O

Common	O	O	O
to	O	O	O
autofluorescent	O	O	B-T059
FPs	O	O	B-T116
is	O	O	O
their	O	O	O
tight	O	O	O
β-barrel	O	O	B-T087
structure	O	O	I-T087
,	O	O	O
which	O	O	O
provides	O	O	O
the	O	O	O
rigidity	O	O	B-T080
and	O	O	O
chemical	O	O	B-T103
environment	O	O	B-T082
needed	O	O	O
for	O	O	O
effectual	O	O	O
fluorescence	O	O	B-T070
.	O	O	O

Despite	O	O	O
the	O	O	O
common	O	O	O
structure	O	O	B-T085
,	O	O	O
each	O	O	O
FP	O	O	B-T116
has	O	O	O
unique	O	O	O
properties	O	O	B-T080
.	O	O	O

Thus	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
single	O	O	O
'	O	O	O
best	O	O	O
'	O	O	O
FP	O	O	B-T116
for	O	O	O
every	O	O	O
circumstance	O	O	O
,	O	O	O
and	O	O	O
each	O	O	O
FP	O	O	O
has	O	O	O
advantages	O	O	O
and	O	O	O
disadvantages	O	O	O
.	O	O	O

To	O	O	O
guide	O	O	O
decisions	O	O	O
about	O	O	O
which	O	O	O
FP	O	O	B-T116
is	O	O	O
right	O	O	O
for	O	O	O
a	O	O	O
given	O	O	O
application	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
quantitatively	O	O	B-T081
characterized	O	O	O
the	O	O	O
brightness	O	O	B-T070
,	O	O	O
photostability	O	O	B-T033
,	O	O	O
pH	O	O	B-T081
stability	O	O	B-T080
and	O	O	O
monomeric	O	O	B-T104
properties	O	O	B-T080
of	O	O	O
more	O	O	O
than	O	O	O
40	O	O	O
FPs	O	O	B-T116
to	O	O	O
enable	O	O	O
straightforward	O	O	B-T080
and	O	O	O
direct	O	O	O
comparison	O	O	B-T052
between	O	O	O
them	O	O	O
.	O	O	O

We	O	O	O
focus	O	O	O
on	O	O	O
popular	O	O	O
and/or	O	O	O
top-performing	O	O	O
FPs	O	O	B-T116
in	O	O	O
each	O	O	O
spectral	O	O	B-T082
region	O	O	I-T082
.	O	O	O

-DOCSTART- (27240560)

Consumption	O	O	B-T040
of	O	O	I-T040
fruits	O	O	I-T040
and	O	O	I-T040
vegetables	O	O	I-T040
associated	O	O	B-T080
with	O	O	I-T080
other	O	O	O
risk	O	O	B-T055
behaviors	O	O	I-T055
among	O	O	O
adolescents	O	O	B-T100
in	O	O	O
Northeast	O	O	O
Brazil	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
consumption	O	O	B-T052
of	O	O	I-T040
fruits	O	O	I-T040
and	O	O	I-T040
vegetables	O	O	I-T040
and	O	O	O
identify	O	O	O
the	O	O	O
association	O	O	B-T080
with	O	O	I-T080
low	O	O	B-T080
level	O	O	B-T080
of	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
,	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
sedentary	O	O	B-T033
behavior	O	O	I-T033
,	O	O	O
consumption	O	O	O
of	O	O	O
soft	O	O	B-T168
drinks	O	O	I-T168
and	O	O	O
overweight	O	O	B-T184
/	O	O	O
obesity	O	O	B-T047
in	O	O	O
adolescents	O	O	B-T100
.	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
school-based	O	O	I-T062
study	O	O	I-T062
with	O	O	O
a	O	O	O
representative	O	O	O
sample	O	O	B-T167
of	O	O	O
3992	O	O	O
students	O	O	B-T098
aged	O	O	O
14	O	O	O
-	O	O	O
19	O	O	O
years	O	O	B-T079
from	O	O	O
the	O	O	O
state	O	O	B-T083
of	O	O	I-T083
Sergipe	O	O	I-T083
,	O	O	O
Brazil	O	O	B-T083
.	O	O	O

The	O	O	O
outcome	O	O	B-T169
was	O	O	O
low	O	O	B-T080
consumption	O	O	B-T040
of	O	O	I-T040
fruits	O	O	I-T040
and	O	O	I-T040
vegetables	O	O	I-T040
(	O	O	O
<	O	O	O
5	O	O	O
servings/day	O	O	B-T079
)	O	O	O
.	O	O	O

Independent	O	O	B-T169
variables	O	O	I-T169
were	O	O	O
:	O	O	O
level	O	O	B-T080
of	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
,	O	O	O
sedentary	O	O	B-T033
behavior	O	O	I-T033
,	O	O	O
consumption	O	O	B-T052
of	O	O	O
soft	O	O	B-T168
drinks	O	O	I-T168
,	O	O	O
and	O	O	O
overweight	O	O	B-T184
/	O	O	O
obesity	O	O	B-T047
.	O	O	O

Global	O	O	B-T170
Student	O	O	I-T170
Health	O	O	I-T170
Survey	O	O	I-T170
questionnaire	O	O	I-T170
and	O	O	O
body	O	O	B-T058
mass	O	O	I-T058
and	O	O	O
height	O	O	B-T032
measurements	O	O	B-T058
were	O	O	O
used	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
chi-square	O	O	B-T170
test	O	O	I-T170
and	O	O	O
crude	O	O	B-T062
and	O	O	I-T062
adjusted	O	O	I-T062
binary	O	O	I-T062
logistic	O	O	I-T062
regression	O	O	I-T062
.	O	O	O

The	O	O	O
significance	O	O	B-T062
level	O	O	I-T062
adopted	O	O	O
was	O	O	O
5	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
inadequate	O	O	B-T080
consumption	O	O	B-T040
of	O	O	I-T040
fruits	O	O	I-T040
and	O	O	I-T040
vegetables	O	O	I-T040
was	O	O	O
high	O	O	B-T080
-	O	O	O
88.6	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
87.6	O	O	O
-	O	O	O
89.5	O	O	O
)	O	O	O
.	O	O	O

Higher	O	O	B-T080
likelihood	O	O	O
of	O	O	O
low	O	O	B-T080
consumption	O	O	B-T040
of	O	O	I-T040
fruits	O	O	I-T040
and	O	O	I-T040
vegetables	O	O	I-T040
was	O	O	O
verified	O	O	O
among	O	O	O
boys	O	O	B-T100
who	O	O	O
were	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
sedentary	O	O	B-T033
behavior	O	O	I-T033
(	O	O	O
OR	O	O	B-T081
=	O	O	O
1.63	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
1.18	O	O	O
-	O	O	O
2.24	O	O	O
)	O	O	O
,	O	O	O
who	O	O	O
consumed	O	O	B-T052
soft	O	O	B-T168
drinks	O	O	I-T168
(	O	O	O
OR	O	O	O
=	O	O	O
3.04	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
2.10	O	O	O
-	O	O	O
4.40	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
insufficiently	O	O	B-T080
physical	O	O	B-T056
activity	O	O	I-T056
(	O	O	O
OR	O	O	O
=	O	O	O
1.98	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
1.43	O	O	O
-	O	O	O
2.73	O	O	O
)	O	O	O
and	O	O	O
girls	O	O	B-T100
who	O	O	O
consumed	O	O	O
soft	O	O	O
drinks	O	O	O
(	O	O	O
OR	O	O	O
=	O	O	O
1.88	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
1.43	O	O	O
-	O	O	O
2.47	O	O	O
)	O	O	O
and	O	O	O
those	O	O	O
with	O	O	O
overweight	O	O	B-T184
/	O	O	O
obesity	O	O	B-T047
(	O	O	O
OR	O	O	O
=	O	O	O
1.63	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
1.19	O	O	O
-	O	O	O
2.23	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
need	O	O	O
of	O	O	O
public	O	O	B-T064
policies	O	O	I-T064
aimed	O	O	O
at	O	O	O
encouraging	O	O	O
the	O	O	O
consumption	O	O	B-T052
of	O	O	I-T052
healthy	O	O	I-T052
foods	O	O	I-T052
among	O	O	O
adolescents	O	O	B-T100
.	O	O	O

-DOCSTART- (27242761)

Cobalamin	O	O	B-T114
Protection	O	O	B-T033
against	O	O	O
Oxidative	O	O	B-T049
Stress	O	O	I-T049
in	O	O	O
the	O	O	O
Acidophilic	O	O	B-T169
Iron-oxidizing	O	O	B-T007
Bacterium	O	O	I-T007
Leptospirillum	O	O	O
Group	O	O	O
II	O	O	O
CF-1	O	O	O

Members	O	O	O
of	O	O	O
the	O	O	O
genus	O	O	O
Leptospirillum	O	O	B-T007
are	O	O	O
aerobic	O	O	B-T080
iron-oxidizing	O	O	B-T007
bacteria	O	O	I-T007
belonging	O	O	O
to	O	O	O
the	O	O	O
phylum	O	O	B-T007
Nitrospira	O	O	I-T007
.	O	O	O

They	O	O	O
are	O	O	O
important	O	O	O
members	O	O	O
of	O	O	O
microbial	O	O	B-T001
communities	O	O	B-T070
that	O	O	O
catalyze	O	O	B-T070
the	O	O	O
biomining	O	O	B-T057
of	O	O	O
sulfidic	O	O	B-T104
ores	O	O	I-T104
,	O	O	O
thereby	O	O	O
solubilizing	O	O	O
metal	O	O	B-T196
ions	O	O	I-T196
.	O	O	O

These	O	O	O
microorganisms	O	O	B-T001
live	O	O	O
under	O	O	O
extremely	O	O	O
acidic	O	O	O
and	O	O	O
metal	O	O	B-T197
-loaded	O	O	O
environments	O	O	B-T082
and	O	O	O
thus	O	O	O
must	O	O	O
tolerate	O	O	O
high	O	O	O
concentrations	O	O	B-T081
of	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
.	O	O	O

Cobalamin	O	O	B-T114
(	O	O	O
vitamin	O	O	B-T127
B12	O	O	I-T127
)	O	O	O
is	O	O	O
a	O	O	O
cobalt	O	O	B-T123
-containing	O	O	O
tetrapyrrole	O	O	B-T109
cofactor	O	O	B-T123
involved	O	O	O
in	O	O	O
intramolecular	O	O	B-T067
rearrangement	O	O	I-T067
reactions	O	O	I-T067
and	O	O	O
has	O	O	O
recently	O	O	O
been	O	O	O
suggested	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
intracellular	O	O	B-T082
antioxidant	O	O	B-T121
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
effect	O	O	B-T080
of	O	O	O
the	O	O	O
exogenous	O	O	B-T169
addition	O	O	O
of	O	O	O
cobalamin	O	O	B-T114
on	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
parameters	O	O	B-T077
in	O	O	O
Leptospirillum	O	O	B-T007
group	O	O	I-T007
II	O	O	I-T007
strain	O	O	I-T007
CF-1	O	O	I-T007
.	O	O	O

Our	O	O	O
results	O	O	O
revealed	O	O	B-T080
that	O	O	O
the	O	O	O
external	O	O	B-T168
supplementation	O	O	I-T168
of	O	O	O
cobalamin	O	O	B-T114
reduces	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
intracellular	O	O	B-T082
ROSs	O	O	B-T123
and	O	O	O
the	O	O	O
damage	O	O	B-T169
to	O	O	O
biomolecules	O	O	B-T123
,	O	O	O
and	O	O	O
also	O	O	O
stimulates	O	O	B-T070
the	O	O	O
growth	O	O	B-T040
and	O	O	O
survival	O	O	B-T043
of	O	O	I-T043
cells	O	O	I-T043
exposed	O	O	O
to	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
exerted	O	O	O
by	O	O	O
ferric	O	O	B-T196
ion	O	O	I-T196
,	O	O	O
hydrogen	O	O	B-T121
peroxide	O	O	I-T121
,	O	O	O
chromate	O	O	B-T197
and	O	O	O
diamide	O	O	B-T109
.	O	O	O

Furthermore	O	O	O
,	O	O	O
exposure	O	O	O
of	O	O	O
strain	O	O	B-T007
CF-1	O	O	I-T007
to	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
elicitors	O	O	O
resulted	O	O	O
in	O	O	O
the	O	O	O
transcriptional	O	O	B-T045
activation	O	O	I-T045
of	O	O	O
the	O	O	O
cbiA	O	O	B-T028
gene	O	O	I-T028
encoding	O	O	O
CbiA	O	O	B-T116
of	O	O	O
the	O	O	O
cobalamin	O	O	B-T114
biosynthetic	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

Altogether	O	O	O
,	O	O	O
these	O	O	O
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
cobalamin	O	O	B-T114
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
redox	O	O	B-T044
protection	O	O	B-T033
of	O	O	O
Leptospirillum	O	O	B-T007
strain	O	O	I-T007
CF-1	O	O	I-T007
,	O	O	O
supporting	O	O	O
survival	O	O	O
of	O	O	O
this	O	O	O
microorganism	O	O	B-T001
under	O	O	O
extremely	O	O	O
oxidative	O	O	B-T169
environmental	O	O	B-T080
conditions	O	O	I-T080
.	O	O	O

Understanding	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
underlying	O	O	O
the	O	O	O
protective	O	O	B-T033
effect	O	O	B-T080
of	O	O	O
cobalamin	O	O	B-T114
against	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
may	O	O	O
help	O	O	O
to	O	O	O
develop	O	O	O
strategies	O	O	O
to	O	O	O
make	O	O	O
biomining	O	O	B-T057
processes	O	O	B-T067
more	O	O	O
effective	O	O	B-T080
.	O	O	O

-DOCSTART- (27244222)

A	O	O	O
longitudinal	O	O	B-T062
study	O	O	I-T062
assessing	O	O	O
childcare	O	O	B-T057
services	O	O	B-T057
'	O	O	I-T057
adoption	O	O	O
of	O	O	O
obesity	O	O	B-T047
prevention	O	O	O
policies	O	O	O
and	O	O	O
practices	O	O	O

Despite	O	O	O
ongoing	O	O	O
investments	O	O	O
to	O	O	O
improve	O	O	O
the	O	O	O
obesogenic	O	O	B-T047
environments	O	O	B-T082
of	O	O	O
childcare	O	O	B-T057
settings	O	O	O
,	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
regarding	O	O	O
how	O	O	O
these	O	O	O
services	O	O	B-T057
have	O	O	O
changed	O	O	O
their	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
and	O	O	O
nutrition-promoting	O	O	B-T062
practices	O	O	I-T062
.	O	O	O

This	O	O	O
study	O	O	O
aims	O	O	O
to	O	O	O
describe	O	O	O
changes	O	O	O
in	O	O	O
the	O	O	O
proportion	O	O	O
of	O	O	O
Australian	O	O	B-T098
childcare	O	O	B-T057
services	O	O	B-T057
that	O	O	O
have	O	O	O
adopted	O	O	O
best-practice	O	O	B-T058
healthy	O	O	B-T061
eating	O	O	I-T061
and	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
practices	O	O	B-T058
between	O	O	O
2006	O	O	O
and	O	O	O
2013	O	O	O
and	O	O	O
to	O	O	O
assess	O	O	O
whether	O	O	O
adoption	O	O	O
varied	O	O	O
by	O	O	O
socio-economic	O	O	B-T080
status	O	O	I-T080
and	O	O	O
locality	O	O	B-T082
.	O	O	O

A	O	O	O
randomly	O	O	B-T062
selected	O	O	I-T062
sample	O	O	I-T062
of	O	O	O
nominated	O	O	O
supervisors	O	O	B-T097
(	O	O	O
n	O	O	O
=	O	O	O
358	O	O	O
)	O	O	O
from	O	O	O
childcare	O	O	B-T057
services	O	O	B-T057
located	O	O	O
in	O	O	O
New	O	O	B-T083
South	O	O	I-T083
Wales	O	O	I-T083
,	O	O	O
Australia	O	O	B-T083
,	O	O	O
participated	O	O	O
in	O	O	O
a	O	O	O
telephone	O	O	B-T062
survey	O	O	I-T062
in	O	O	O
2006	O	O	O
,	O	O	O
2009	O	O	O
,	O	O	O
2010	O	O	O
and	O	O	O
2013	O	O	O
.	O	O	O

Supervisors	O	O	B-T097
reported	O	O	O
on	O	O	O
their	O	O	O
service	O	O	B-T057
's	O	O	I-T057
adoption	O	O	O
of	O	O	O
six	O	O	O
practices	O	O	B-T058
:	O	O	O
(	O	O	O
i	O	O	O
)	O	O	O
having	O	O	O
written	O	O	O
nutrition	O	O	B-T062
and	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
policies	O	O	B-T170
;	O	O	O
(	O	O	O
ii	O	O	O
)	O	O	O
staff	O	O	B-T097
trained	O	O	O
in	O	O	O
physical	O	O	O
activity	O	O	O
and	O	O	O
nutrition	O	O	O
in	O	O	O
the	O	O	O
past	O	O	O
year	O	O	O
;	O	O	O
(	O	O	O
iii	O	O	O
)	O	O	O
scheduled	O	O	O
time	O	O	B-T079
for	O	O	O
fundamental	O	O	O
movement	O	O	B-T040
skills	O	O	B-T055
and	O	O	O
(	O	O	O
iv	O	O	O
)	O	O	O
outdoor	O	O	B-T056
play	O	O	I-T056
;	O	O	O
(	O	O	O
v	O	O	O
)	O	O	O
weekly	O	O	B-T079
or	O	O	O
less	O	O	O
screen	O	O	B-T033
time	O	O	I-T033
opportunitie	O	O	I-T033
s	O	O	O
;	O	O	O
and	O	O	O
(	O	O	O
vi	O	O	O
)	O	O	O
serving	O	O	O
only	O	O	O
non-sweetened	O	O	B-T168
beverages	O	O	I-T168
.	O	O	O

A	O	O	O
significant	O	O	O
increase	O	O	O
in	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
services	O	O	B-T057
adopting	O	O	O
all	O	O	O
but	O	O	O
one	O	O	O
practice	O	O	B-T058
,	O	O	O
between	O	O	O
2006	O	O	O
and	O	O	O
2013	O	O	O
was	O	O	O
identified	O	O	O
.	O	O	O

Ninety	O	O	O
one	O	O	O
percent	O	O	O
of	O	O	O
services	O	O	B-T057
adopted	O	O	O
four	O	O	O
or	O	O	O
more	O	O	O
practices	O	O	B-T058
,	O	O	O
a	O	O	O
significant	O	O	O
increase	O	O	O
from	O	O	O
38	O	O	O
%	O	O	O
in	O	O	O
2006	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
proportion	O	O	O
of	O	O	O
services	O	O	B-T057
adopting	O	O	O
each	O	O	O
practice	O	O	B-T058
by	O	O	O
locality	O	O	B-T082
and	O	O	O
socio-economic	O	O	B-T080
status	O	O	I-T080
.	O	O	O

Government	O	O	B-T092
investment	O	O	B-T081
in	O	O	O
obesity	O	O	B-T047
prevention	O	O	B-T058
programmes	O	O	I-T058
can	O	O	O
equitably	O	O	O
improve	O	O	O
childcare	O	O	B-T057
service	O	O	O
's	O	O	O
adoption	O	O	O
of	O	O	O
healthy	O	O	B-T061
eating	O	O	I-T061
and	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
promoting	O	O	O
practices	O	O	B-T058
on	O	O	O
a	O	O	O
jurisdiction	O	O	B-T170
-wide	O	O	O
basis	O	O	O
.	O	O	O

The	O	O	O
establishment	O	O	O
of	O	O	O
a	O	O	O
routine	O	O	O
system	O	O	O
to	O	O	O
monitor	O	O	O
adoption	O	O	O
of	O	O	O
a	O	O	O
broader	O	O	O
range	O	O	O
of	O	O	O
practices	O	O	B-T058
by	O	O	O
childcare	O	O	B-T057
services	O	O	B-T057
is	O	O	O
warranted	O	O	O
.	O	O	O

-DOCSTART- (27247892)

Isolation	O	O	B-T169
and	O	O	O
characterization	O	O	B-T052
of	O	O	O
Burkholderia	O	O	B-T007
sp.	O	O	I-T007
strain	O	O	I-T007
CCA53	O	O	I-T007
exhibiting	O	O	O
ligninolytic	O	O	B-T044
potential	O	O	O

Microbial	O	O	B-T001
degradation	O	O	B-T040
of	O	O	O
lignin	O	O	B-T109
releases	O	O	O
fermentable	O	O	B-T109
sugars	O	O	I-T109
,	O	O	O
effective	O	O	B-T080
utilization	O	O	B-T169
of	O	O	O
which	O	O	O
could	O	O	O
support	O	O	O
biofuel	O	O	B-T109
production	O	O	B-T057
from	O	O	O
lignocellulosic	O	O	B-T109
biomass	O	O	B-T081
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
a	O	O	O
lignin-degrading	O	O	B-T044
bacterium	O	O	B-T007
was	O	O	O
isolated	O	O	B-T169
from	O	O	O
leaf	O	O	B-T002
soil	O	O	B-T167
and	O	O	O
identified	O	O	O
as	O	O	O
Burkholderia	O	O	B-T007
sp.	O	O	I-T007
based	O	O	O
on	O	O	O
16S	O	O	B-T114
rRNA	O	O	I-T114
gene	O	O	B-T059
sequencing	O	O	I-T059
.	O	O	O

This	O	O	O
strain	O	O	B-T080
was	O	O	O
named	O	O	O
CCA53	O	O	B-T007
,	O	O	O
and	O	O	O
its	O	O	O
lignin-degrading	O	O	B-T044
capability	O	O	B-T080
was	O	O	O
assessed	O	O	B-T052
by	O	O	O
observing	O	O	O
its	O	O	O
growth	O	O	B-T040
on	O	O	O
medium	O	O	B-T130
containing	O	O	O
alkali	O	O	B-T109
lignin	O	O	B-T109
or	O	O	O
lignin	O	O	O
-associated	O	O	O
aromatic	O	O	B-T104
monomers	O	O	I-T104
as	O	O	O
the	O	O	O
sole	O	O	O
carbon	O	O	B-T196
source	O	O	B-T033
.	O	O	O

Alkali	O	O	B-T109
lignin	O	O	B-T109
and	O	O	O
at	O	O	O
least	O	O	O
eight	O	O	O
lignin	O	O	O
-associated	O	O	O
aromatic	O	O	B-T104
monomers	O	O	I-T104
supported	O	O	O
growth	O	O	B-T040
of	O	O	O
this	O	O	O
strain	O	O	B-T080
,	O	O	O
and	O	O	O
the	O	O	O
most	O	O	O
effective	O	O	B-T080
utilization	O	O	B-T169
was	O	O	O
observed	O	O	O
for	O	O	O
p-hydroxybenzene	O	O	B-T104
monomers	O	O	I-T104
.	O	O	O

These	O	O	O
findings	O	O	B-T033
indicate	O	O	O
that	O	O	O
Burkholderia	O	O	B-T007
sp.	O	O	I-T007
strain	O	O	I-T007
CCA53	O	O	I-T007
has	O	O	O
fragmentary	O	O	B-T052
activity	O	O	I-T052
for	O	O	O
lignin	O	O	B-T044
degradation	O	O	I-T044
.	O	O	O

-DOCSTART- (27250823)

Diagnostic	O	O	B-T169
utility	O	O	B-T169
of	O	O	O
additional	O	O	O
conventional	O	O	B-T081
techniques	O	O	B-T060
after	O	O	O
endobronchial	O	O	B-T060
ultrasonography	O	O	I-T060
guidance	O	O	B-T058
during	O	O	O
transbronchial	O	O	O
biopsy	O	O	O

Endobronchial	O	O	B-T060
ultrasonography	O	O	I-T060
with	O	O	O
a	O	O	O
guide	O	O	B-T074
sheath	O	O	I-T074
transbronchial	O	O	B-T060
biopsy	O	O	I-T060
(	O	O	O
EBUS	O	O	B-T060
-	O	O	O
GS	O	O	B-T074
TBB	O	O	B-T060
)	O	O	O
has	O	O	O
been	O	O	O
used	O	O	O
to	O	O	O
diagnose	O	O	B-T033
peripheral	O	O	B-T033
pulmonary	O	O	I-T033
lesions	O	O	I-T033
(	O	O	O
PPLs	O	O	B-T033
)	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
evaluated	O	O	O
the	O	O	O
diagnostic	O	O	B-T169
utility	O	O	B-T169
of	O	O	O
conventional	O	O	B-T081
TBB	O	O	B-T060
after	O	O	O
EBUS	O	O	B-T060
-	O	O	O
GS	O	O	B-T074
TBB	O	O	O
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
conventional	O	O	B-T081
TBB	O	O	B-T060
after	O	O	O
EBUS	O	O	B-T060
-	O	O	O
GS	O	O	B-T074
TBB	O	O	O
for	O	O	O
PPL	O	O	B-T033
between	O	O	O
August	O	O	O
1	O	O	O
,	O	O	O
2012	O	O	O
and	O	O	O
December	O	O	O
31	O	O	O
,	O	O	O
2014	O	O	O
.	O	O	O

We	O	O	O
performed	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
to	O	O	O
examine	O	O	O
the	O	O	O
association	O	O	B-T080
of	O	O	O
various	O	O	O
clinical	O	O	B-T080
factors	O	O	B-T169
,	O	O	O
including	O	O	O
EBUS	O	O	B-T060
probe	O	O	B-T074
distance	O	O	B-T081
and	O	O	O
sample	O	O	B-T081
size	O	O	I-T081
area	O	O	B-T082
,	O	O	O
with	O	O	O
diagnostic	O	O	B-T080
yield	O	O	I-T080
.	O	O	O

Of	O	O	O
88	O	O	O
eligible	O	O	O
patients	O	O	B-T101
,	O	O	O
57	O	O	O
(	O	O	O
65	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
successfully	O	O	O
diagnosed	O	O	B-T033
by	O	O	O
EBUS	O	O	B-T060
-	O	O	O
GS	O	O	B-T074
TBB	O	O	B-T060
.	O	O	O

In	O	O	O
31	O	O	O
patients	O	O	B-T101
not	O	O	O
diagnosed	O	O	B-T033
by	O	O	O
EBUS	O	O	B-T060
-	O	O	O
GS	O	O	B-T074
TBB	O	O	B-T060
,	O	O	O
15	O	O	O
(	O	O	O
48	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
successfully	O	O	O
diagnosed	O	O	O
by	O	O	O
additional	O	O	O
conventional	O	O	B-T081
TBB	O	O	O
.	O	O	O

Ground	O	O	B-T033
glass	O	O	I-T033
opacity	O	O	I-T033
(	O	O	O
GGO	O	O	B-T033
)	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	B-T078
factor	O	O	B-T169
associated	O	O	O
with	O	O	O
the	O	O	O
diagnostic	O	O	B-T080
yield	O	O	I-T080
of	O	O	O
additional	O	O	O
conventional	O	O	B-T081
TBB	O	O	B-T060
following	O	O	O
EBUS	O	O	B-T060
-	O	O	O
GS	O	O	B-T074
TBB	O	O	O
.	O	O	O

Multivariate	O	O	B-T081
analysis	O	O	I-T081
and	O	O	O
receiver	O	O	B-T081
operator	O	O	I-T081
curves	O	O	I-T081
revealed	O	O	O
that	O	O	O
distance	O	O	B-T081
between	O	O	O
the	O	O	O
PPL	O	O	B-T033
and	O	O	O
the	O	O	O
EBUS	O	O	B-T060
probe	O	O	B-T074
of	O	O	O
less	O	O	O
than	O	O	O
2.55	O	O	O
mm	O	O	O
favored	O	O	O
the	O	O	O
utility	O	O	B-T169
of	O	O	O
conventional	O	O	B-T081
TBB	O	O	B-T060
.	O	O	O

Additional	O	O	O
conventional	O	O	B-T081
TBB	O	O	B-T060
after	O	O	O
EBUS	O	O	B-T060
-	O	O	O
GS	O	O	B-T074
TBB	O	O	O
could	O	O	O
be	O	O	O
a	O	O	O
useful	O	O	O
procedure	O	O	B-T060
for	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
ground	O	O	B-T033
glass	O	O	I-T033
opacity	O	O	I-T033
PPLs	O	O	B-T033
and	O	O	O
in	O	O	O
cases	O	O	B-T169
of	O	O	O
a	O	O	O
distance	O	O	B-T081
of	O	O	O
less	O	O	O
than	O	O	O
2.55	O	O	O
mm	O	O	O
between	O	O	O
the	O	O	O
EBUS	O	O	O
probe	O	O	B-T074
and	O	O	O
the	O	O	O
lesion	O	O	B-T033
.	O	O	O

-DOCSTART- (27251117)

Active	O	O	B-T169
diffusion	O	O	B-T070
and	O	O	O
microtubule-based	O	O	B-T043
transport	O	O	I-T043
oppose	O	O	O
myosin	O	O	B-T116
forces	O	O	B-T067
to	O	O	O
position	O	O	B-T082
organelles	O	O	B-T026
in	O	O	O
cells	O	O	O

Even	O	O	O
distribution	O	O	B-T169
of	O	O	O
peroxisomes	O	O	B-T026
(	O	O	O
POs	O	O	B-T026
)	O	O	O
and	O	O	O
lipid	O	O	B-T109
droplets	O	O	I-T026
(	O	O	O
LDs	O	O	B-T026
)	O	O	O
is	O	O	O
critical	O	O	O
to	O	O	O
their	O	O	O
role	O	O	B-T077
in	O	O	O
lipid	O	O	O
and	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
homeostasis	O	O	B-T038
.	O	O	O

How	O	O	O
even	O	O	O
distribution	O	O	B-T169
is	O	O	O
achieved	O	O	O
remains	O	O	O
elusive	O	O	O
,	O	O	O
but	O	O	O
diffusive	O	O	B-T070
motion	O	O	I-T070
and	O	O	O
directed	O	O	O
motility	O	O	B-T040
may	O	O	O
play	O	O	O
a	O	O	O
role	O	O	B-T077
.	O	O	O

Here	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
fungus	O	O	B-T004
Ustilago	O	O	B-T004
maydis	O	O	I-T004
~95	O	O	O
%	O	O	O
of	O	O	O
POs	O	O	B-T026
and	O	O	O
LDs	O	O	B-T026
undergo	O	O	O
diffusive	O	O	B-T070
motions	O	O	I-T070
.	O	O	O

These	O	O	O
movements	O	O	B-T040
require	O	O	O
ATP	O	O	B-T114
and	O	O	O
involve	O	O	O
bidirectional	O	O	B-T080
early	O	O	O
endosome	O	O	B-T026
motility	O	O	B-T040
,	O	O	O
indicating	O	O	O
that	O	O	O
microtubule	O	O	B-T026
-	O	O	O
associated	O	O	B-T080
membrane	O	O	B-T026
trafficking	O	O	B-T043
enhances	O	O	B-T052
diffusion	O	O	B-T070
of	O	O	O
organelles	O	O	B-T026
.	O	O	O

When	O	O	O
early	O	O	O
endosome	O	O	B-T043
transport	O	O	I-T043
is	O	O	O
abolished	O	O	O
,	O	O	O
POs	O	O	B-T026
and	O	O	O
LDs	O	O	B-T026
drift	O	O	O
slowly	O	O	O
towards	O	O	O
the	O	O	O
growing	O	O	B-T026
cell	O	O	I-T026
end	O	O	I-T026
.	O	O	O

This	O	O	O
pole-ward	O	O	B-T043
drift	O	O	I-T043
is	O	O	O
facilitated	O	O	O
by	O	O	O
anterograde	O	O	B-T043
delivery	O	O	I-T043
of	O	O	O
secretory	O	O	B-T116
cargo	O	O	I-T116
to	O	O	O
the	O	O	O
cell	O	O	B-T026
tip	O	O	I-T026
by	O	O	O
myosin-5	O	O	B-T116
.	O	O	O

Modelling	O	O	B-T062
reveals	O	O	O
that	O	O	O
microtubule-based	O	O	B-T043
directed	O	O	I-T043
transport	O	O	I-T043
and	O	O	O
active	O	O	B-T169
diffusion	O	O	B-T070
support	O	O	O
distribution	O	O	B-T169
,	O	O	O
mobility	O	O	B-T043
and	O	O	O
mixing	O	O	O
of	O	O	O
POs	O	O	B-T026
.	O	O	O

In	O	O	O
mammalian	O	O	B-T015
COS-7	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
microtubules	O	O	B-T026
and	O	O	O
F-actin	O	O	B-T116
also	O	O	O
counteract	O	O	O
each	O	O	O
other	O	O	O
to	O	O	O
distribute	O	O	B-T169
POs	O	O	B-T026
.	O	O	O

This	O	O	O
highlights	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
opposing	O	O	O
cytoskeletal	O	O	B-T026
forces	O	O	B-T067
in	O	O	O
organelle	O	O	B-T026
positioning	O	O	B-T082
in	O	O	O
eukaryotes	O	O	B-T204
.	O	O	O

-DOCSTART- (27251918)

The	O	O	O
role	O	O	O
of	O	O	O
catheter	O	O	B-T061
ablation	O	O	I-T061
in	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
atrial	O	O	O
fibrillation	O	O	O

Atrial	O	O	B-T047
fibrillation	O	O	I-T047
is	O	O	O
driven	O	O	O
by	O	O	O
spontaneous	O	O	O
electrical	O	O	B-T040
activation	O	O	I-T040
emerging	O	O	O
from	O	O	O
the	O	O	O
pulmonary	O	O	B-T023
veins	O	O	I-T023
.	O	O	O

Catheter	O	O	B-T061
ablation	O	O	I-T061
using	O	O	O
either	O	O	O
radiofrequency	O	O	B-T061
or	O	O	O
cryothermal	O	O	B-T061
energy	O	O	I-T061
electrically	O	O	B-T169
isolates	O	O	B-T169
these	O	O	O
veins	O	O	B-T023
from	O	O	O
the	O	O	O
left	O	O	B-T023
atrium	O	O	I-T023
,	O	O	O
both	O	O	O
reducing	O	O	B-T080
the	O	O	O
burden	O	O	B-T078
of	O	O	O
atrial	O	O	B-T047
fibrillation	O	O	I-T047
episodes	O	O	B-T079
and	O	O	O
improving	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
symptoms	O	O	B-T184
.	O	O	O

Catheter	O	O	B-T061
ablation	O	O	I-T061
is	O	O	O
superior	O	O	O
to	O	O	O
antiarryhthmic	O	O	B-T121
drugs	O	O	I-T121
when	O	O	O
patients	O	O	B-T101
are	O	O	O
carefully	O	O	O
selected	O	O	O
.	O	O	O

Underlying	O	O	O
medical	O	O	B-T201
problems	O	O	I-T201
-	O	O	O
including	O	O	O
obesity	O	O	B-T047
,	O	O	O
hypertension	O	O	B-T047
and	O	O	O
obstructive	O	O	B-T047
sleep	O	O	I-T047
apnoea	O	O	I-T047
-	O	O	O
should	O	O	O
be	O	O	O
optimally	O	O	O
treated	O	O	B-T169
before	O	O	O
considering	O	O	O
ablation	O	O	B-T061
.	O	O	O

Although	O	O	O
this	O	O	O
treatment	O	O	B-T061
has	O	O	O
the	O	O	O
potential	O	O	B-T080
to	O	O	O
cure	O	O	B-T077
patients	O	O	B-T101
of	O	O	O
their	O	O	O
symptoms	O	O	B-T184
,	O	O	O
they	O	O	O
should	O	O	O
be	O	O	O
aware	O	O	O
of	O	O	O
the	O	O	O
important	O	O	O
associated	O	O	O
procedural	O	O	B-T033
complications	O	O	I-T033
.	O	O	O

-DOCSTART- (27252074)

The	O	O	O
Chinese	O	O	B-T080
Herbal	O	O	I-T080
Mixture	O	O	B-T167
Tien-Hsien	O	O	B-T109
Liquid	O	O	I-T109
Augments	O	O	B-T081
the	O	O	O
Anticancer	O	O	B-T080
Immunity	O	O	B-T039
in	O	O	O
Tumor	O	O	B-T025
Cell	O	O	I-T025
-	O	O	O
Vaccinated	O	O	B-T033
Mice	O	O	O

Background	O	O	O
The	O	O	O
Chinese	O	O	B-T080
herbal	O	O	I-T080
mixture	O	O	B-T167
,	O	O	O
Tien-Hsien	O	O	B-T109
liquid	O	O	I-T109
(	O	O	O
THL	O	O	B-T109
)	O	O	O
,	O	O	O
has	O	O	O
been	O	O	O
used	O	O	O
as	O	O	O
an	O	O	O
anticancer	O	O	B-T080
dietary	O	O	B-T168
supplement	O	O	I-T168
for	O	O	O
more	O	O	O
than	O	O	O
20	O	O	O
years	O	O	B-T079
.	O	O	O

Our	O	O	O
previous	O	O	B-T079
studies	O	O	B-T062
have	O	O	O
shown	O	O	O
that	O	O	O
THL	O	O	B-T109
can	O	O	O
modulate	O	O	B-T082
immune	O	O	B-T042
response	O	O	I-T042
and	O	O	O
inhibit	O	O	B-T052
tumor	O	O	B-T191
growth	O	O	I-T191
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
further	O	O	O
evaluated	O	O	B-T058
the	O	O	O
effect	O	O	B-T080
of	O	O	O
THL	O	O	B-T109
on	O	O	O
anticancer	O	O	B-T080
immune	O	O	B-T042
response	O	O	I-T042
in	O	O	O
mice	O	O	B-T015
vaccinated	O	O	B-T033
with	O	O	O
γ-ray	O	O	B-T070
-	O	O	O
irradiated	O	O	B-T070
tumor	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Methods	O	O	O
The	O	O	O
antitumor	O	O	B-T080
effect	O	O	B-T080
of	O	O	O
THL	O	O	B-T109
was	O	O	O
determined	O	O	B-T080
in	O	O	O
mice	O	O	B-T015
vaccinated	O	O	B-T033
with	O	O	O
low-tumorigenic	O	O	B-T025
CT-26-low	O	O	I-T025
colon	O	O	I-T025
cancer	O	O	I-T025
cells	O	O	I-T025
or	O	O	O
γ-ray-irradiated	O	O	B-T061
high-tumorigenic	O	O	B-T025
CT-26-high	O	O	I-T025
colon	O	O	I-T025
cancer	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
number	O	O	B-T081
of	O	O	O
natural	O	O	B-T025
killer	O	O	I-T025
(	O	O	I-T025
NK	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
T	O	O	B-T025
lymphocytes	O	O	I-T025
in	O	O	O
the	O	O	O
spleen	O	O	B-T023
was	O	O	O
analyzed	O	O	B-T062
by	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
.	O	O	O

The	O	O	O
tumor	O	O	B-T191
-	O	O	O
killing	O	O	B-T043
activities	O	O	B-T052
of	O	O	O
NK	O	O	B-T025
cells	O	O	B-T025
and	O	O	O
cytotoxic	O	O	B-T025
T	O	O	I-T025
lymphocytes	O	O	I-T025
(	O	O	O
CTLs	O	O	B-T025
)	O	O	O
were	O	O	O
analyzed	O	O	B-T062
by	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
using	O	O	O
YAC-1	O	O	B-T025
and	O	O	O
CT-26-high	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
respectively	O	O	O
,	O	O	O
as	O	O	O
target	O	O	B-T169
cells	O	O	O
.	O	O	O

The	O	O	O
levels	O	O	B-T080
of	O	O	O
IFN-γ	O	O	B-T116
,	O	O	O
IL-2	O	O	B-T116
,	O	O	O
and	O	O	O
TNF-α	O	O	B-T116
were	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
ELISA	O	O	B-T059
.	O	O	O

Results	O	O	O
THL	O	O	B-T109
suppressed	O	O	B-T169
the	O	O	O
growth	O	O	B-T040
of	O	O	O
CT-26-high	O	O	B-T025
tumor	O	O	I-T025
in	O	O	O
mice	O	O	B-T015
previously	O	O	O
vaccinated	O	O	B-T033
with	O	O	O
low-tumorigenic	O	O	B-T025
CT-26-low	O	O	I-T025
cells	O	O	I-T025
or	O	O	O
γ-irradiated	O	O	B-T061
CT-26-high	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

THL	O	O	B-T109
increased	O	O	B-T081
the	O	O	O
populations	O	O	O
of	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
CD4	O	O	B-T025
+	O	O	I-T025
T	O	O	I-T025
lymphocytes	O	O	I-T025
in	O	O	O
the	O	O	O
spleen	O	O	B-T023
and	O	O	O
enhanced	O	O	B-T052
the	O	O	O
tumor	O	O	B-T191
-	O	O	O
killing	O	O	B-T043
activities	O	O	B-T052
of	O	O	O
NK	O	O	O
cells	O	O	O
and	O	O	O
CTL	O	O	B-T025
in	O	O	O
mice	O	O	B-T015
vaccinated	O	O	B-T033
with	O	O	O
γ-irradiated	O	O	B-T061
CT-26-high	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

THL	O	O	B-T109
increased	O	O	B-T081
the	O	O	O
production	O	O	B-T169
of	O	O	O
IFN-γ	O	O	B-T116
,	O	O	O
IL-2	O	O	B-T116
,	O	O	O
and	O	O	O
TNF-α	O	O	B-T116
in	O	O	O
mice	O	O	B-T015
vaccinated	O	O	B-T033
with	O	O	O
γ-irradiated	O	O	B-T061
CT-26-high	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Conclusion	O	O	O
THL	O	O	B-T109
can	O	O	O
enhance	O	O	B-T052
the	O	O	O
antitumor	O	O	B-T080
immune	O	O	B-T042
responses	O	O	I-T042
in	O	O	O
mice	O	O	B-T015
vaccinated	O	O	B-T033
with	O	O	O
killed	O	O	B-T169
tumor	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

These	O	O	O
results	O	O	B-T169
suggest	O	O	O
that	O	O	O
THL	O	O	B-T109
may	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
complementary	O	O	B-T091
medicine	O	O	I-T091
for	O	O	O
cancer	O	O	B-T191
patients	O	O	B-T101
previously	O	O	B-T079
treated	O	O	B-T169
with	O	O	O
killed	O	O	B-T116
tumor	O	O	I-T116
cell	O	O	I-T116
vaccines	O	O	I-T116
,	O	O	O
radiotherapy	O	O	B-T061
,	O	O	O
or	O	O	O
chemotherapy	O	O	B-T061
.	O	O	O

-DOCSTART- (27252721)

Timing	O	O	B-T079
of	O	O	O
False	O	O	O
Ring	O	O	B-T039
Formation	O	O	I-T039
in	O	O	O
Pinus	O	O	B-T002
halepensis	O	O	I-T002
and	O	O	O
Arbutus	O	O	B-T002
unedo	O	O	I-T002
in	O	O	O
Southern	O	O	B-T082
Italy	O	O	B-T083
:	O	O	O
Outlook	O	O	B-T201
from	O	O	O
an	O	O	O
Analysis	O	O	B-T062
of	O	O	O
Xylogenesis	O	O	B-T039
and	O	O	O
Tree-Ring	O	O	B-T002
Chronologies	O	O	O

Mediterranean	O	O	B-T083
tree	O	O	B-T002
rings	O	O	I-T002
are	O	O	O
characterized	O	O	B-T052
by	O	O	O
intra-annual	O	O	B-T079
density	O	O	I-T079
fluctuations	O	O	I-T079
(	O	O	O
IADFs	O	O	B-T079
)	O	O	O
due	O	O	O
to	O	O	O
partly	O	O	O
climate-driven	O	O	B-T070
cambial	O	O	B-T039
activity	O	O	I-T039
.	O	O	O

IADFs	O	O	B-T079
are	O	O	O
used	O	O	O
as	O	O	O
structural	O	O	B-T082
signals	O	O	B-T078
to	O	O	O
gain	O	O	O
information	O	O	B-T078
on	O	O	O
relations	O	O	B-T080
between	O	O	B-T082
environmental	O	O	B-T082
conditions	O	O	B-T080
and	O	O	O
eco-physiological	O	O	B-T039
processes	O	O	B-T067
during	O	O	B-T079
xylogenesis	O	O	B-T039
,	O	O	O
with	O	O	O
intra-annual	O	O	B-T079
resolution	O	O	B-T077
.	O	O	O

To	O	O	O
reach	O	O	O
an	O	O	O
unbiased	O	O	B-T062
synchronization	O	O	B-T079
of	O	O	O
the	O	O	O
IADF	O	O	B-T079
position	O	O	B-T082
within	O	O	O
tree	O	O	B-T002
rings	O	O	B-T082
and	O	O	O
seasonal	O	O	B-T079
fluctuations	O	O	B-T184
in	O	O	O
environmental	O	O	B-T082
conditions	O	O	B-T080
,	O	O	O
it	O	O	O
is	O	O	O
necessary	O	O	O
to	O	O	O
know	O	O	O
the	O	O	O
timing	O	O	B-T079
of	O	O	O
cambial	O	O	B-T039
activity	O	O	I-T039
and	O	O	O
wood	O	O	B-T167
formation	O	O	B-T169
,	O	O	O
which	O	O	O
are	O	O	O
species-	O	O	B-T080
and	O	O	O
site-specific	O	O	B-T080
processes	O	O	B-T067
.	O	O	O

We	O	O	O
applied	O	O	B-T169
the	O	O	O
microcoring	O	O	B-T169
technique	O	O	I-T169
to	O	O	O
analyze	O	O	B-T062
xylogenesis	O	O	B-T039
in	O	O	O
Pinus	O	O	B-T002
halepensis	O	O	I-T002
and	O	O	O
Arbutus	O	O	B-T002
unedo	O	O	I-T002
.	O	O	O

To	O	O	O
the	O	O	O
best	O	O	O
of	O	O	O
our	O	O	O
knowledge	O	O	O
,	O	O	O
this	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
attempt	O	O	B-T051
to	O	O	O
study	O	O	B-T062
xylogenesis	O	O	B-T039
in	O	O	O
a	O	O	O
hardwood	O	O	B-T167
species	O	O	B-T185
forming	O	O	O
frequent	O	O	B-T079
IADFs	O	O	B-T079
.	O	O	O

Both	O	O	O
species	O	O	B-T185
co-occur	O	O	B-T052
at	O	O	O
a	O	O	O
site	O	O	B-T082
in	O	O	O
southern	O	O	B-T082
Italy	O	O	B-T083
characterized	O	O	B-T052
by	O	O	O
a	O	O	O
Mediterranean	O	O	B-T083
climate	O	O	B-T070
.	O	O	O

To	O	O	O
facilitate	O	O	O
tree-ring	O	O	B-T062
dating	O	O	I-T062
and	O	O	O
identification	O	O	B-T080
of	O	O	O
IADFs	O	O	B-T079
,	O	O	O
we	O	O	O
performed	O	O	B-T169
traditional	O	O	B-T169
dendroecological	O	O	B-T080
analysis	O	O	B-T062
.	O	O	O

We	O	O	O
analyzed	O	O	B-T062
xylogenesis	O	O	B-T039
during	O	O	B-T079
summer	O	O	B-T079
,	O	O	O
which	O	O	O
is	O	O	O
considered	O	O	B-T078
a	O	O	O
constraint	O	O	B-T169
for	O	O	O
xylogenesis	O	O	O
and	O	O	O
a	O	O	O
trigger	O	O	O
for	O	O	O
IADF	O	O	B-T079
formation	O	O	B-T169
.	O	O	O

We	O	O	O
followed	O	O	O
the	O	O	O
different	O	O	B-T080
phases	O	O	B-T079
of	O	O	O
cell	O	O	B-T043
development	O	O	I-T043
in	O	O	O
the	O	O	O
current	O	O	B-T079
wood	O	O	B-T167
increment	O	O	B-T081
with	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
evaluating	O	O	O
whether	O	O	O
and	O	O	O
which	O	O	O
type	O	O	O
of	O	O	O
IADFs	O	O	B-T079
were	O	O	O
formed	O	O	B-T169
.	O	O	O

We	O	O	O
additionally	O	O	O
analyzed	O	O	B-T062
the	O	O	O
same	O	O	O
phases	O	O	B-T079
again	O	O	O
in	O	O	O
September	O	O	B-T079
and	O	O	O
in	O	O	O
winter	O	O	B-T079
to	O	O	O
verify	O	O	B-T169
the	O	O	O
possible	O	O	B-T033
formation	O	O	B-T169
of	O	O	O
IADFs	O	O	B-T079
in	O	O	O
fall	O	O	B-T079
and	O	O	O
whether	O	O	O
cell	O	O	B-T025
production	O	O	B-T039
and	O	O	O
differentiation	O	O	B-T043
was	O	O	O
completed	O	O	B-T080
by	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
calendar	O	O	B-T079
year	O	O	I-T079
.	O	O	O

Both	O	O	O
species	O	O	B-T185
formed	O	O	B-T169
the	O	O	O
same	O	O	O
type	O	O	O
of	O	O	O
IADFs	O	O	B-T079
(	O	O	O
earlywood	O	O	B-T167
-like	O	O	O
cells	O	O	B-T025
within	O	O	O
latewood	O	O	B-T167
)	O	O	O
,	O	O	O
due	O	O	O
to	O	O	O
temporary	O	O	B-T079
growth	O	O	B-T067
restoration	O	O	B-T033
triggered	O	O	B-T080
by	O	O	I-T080
rain	O	O	B-T070
events	O	O	B-T051
during	O	O	B-T079
the	O	O	O
period	O	O	B-T079
of	O	O	O
summer	O	O	B-T079
drought	O	O	B-T070
.	O	O	O

At	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
calendar	O	O	B-T079
year	O	O	I-T079
,	O	O	O
no	O	O	O
cells	O	O	B-T025
in	O	O	O
the	O	O	O
phases	O	O	B-T079
of	O	O	O
enlargement	O	O	B-T080
and	O	O	O
secondary	O	O	B-T026
cell	O	O	I-T026
wall	O	O	I-T026
deposition	O	O	B-T169
occurred	O	O	B-T052
.	O	O	O

A.	O	O	B-T002
unedo	O	O	I-T002
was	O	O	O
more	O	O	O
sensitive	O	O	B-T169
than	O	O	O
P.	O	O	B-T002
halepensis	O	O	I-T002
because	O	O	O
IADF	O	O	B-T079
s	O	O	O
were	O	O	O
formed	O	O	B-T169
earlier	O	O	B-T079
in	O	O	O
the	O	O	O
season	O	O	B-T079
and	O	O	O
were	O	O	O
more	O	O	O
frequent	O	O	B-T079
in	O	O	O
the	O	O	O
tree-ring	O	O	B-T002
series	O	O	O
.	O	O	O

The	O	O	O
dendro-anatomical	O	O	B-T080
approach	O	O	O
,	O	O	O
combining	O	O	O
analysis	O	O	B-T062
of	O	O	O
tree-ring	O	O	B-T002
series	O	O	O
and	O	O	O
of	O	O	O
xylogenesis	O	O	B-T039
,	O	O	O
helped	O	O	O
to	O	O	O
detect	O	O	B-T033
the	O	O	O
period	O	O	B-T079
of	O	O	O
IADF	O	O	B-T079
formation	O	O	B-T169
in	O	O	O
the	O	O	O
two	O	O	O
species	O	O	B-T185
.	O	O	O

Results	O	O	B-T169
are	O	O	O
discussed	O	O	O
in	O	O	O
functional	O	O	B-T169
terms	O	O	B-T078
,	O	O	O
highlighting	O	O	O
the	O	O	O
environmental	O	O	B-T082
conditions	O	O	B-T080
triggering	O	O	B-T080
IADFs	O	O	B-T079
,	O	O	O
and	O	O	O
also	O	O	O
in	O	O	O
methodological	O	O	B-UnknownType
terms	O	O	O
,	O	O	O
evaluating	O	O	O
the	O	O	O
applicability	O	O	B-T169
of	O	O	O
xylogenesis	O	O	B-T039
analysis	O	O	B-T062
in	O	O	O
Mediterranean	O	O	B-T083
woods	O	O	B-T167
,	O	O	O
especially	O	O	O
when	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
IADFs	O	O	O
is	O	O	O
not	O	O	O
uniform	O	O	B-T080
around	O	O	O
the	O	O	O
stem	O	O	B-T002
.	O	O	O

-DOCSTART- (27254792)

Emergence	O	O	B-T080
of	O	O	O
family	O	O	B-T091
medicine	O	O	I-T091
in	O	O	O
Ethiopia	O	O	B-T083
[	O	O	O
corrected	O	O	O
]	O	O	O
:	O	O	O
an	O	O	O
international	O	O	B-T078
collaborative	O	O	B-T054
education	O	O	O
model	O	O	O

Family	O	O	B-T091
Medicine	O	O	I-T091
(	O	O	O
FM	O	O	B-T091
)	O	O	O
is	O	O	O
a	O	O	O
new	O	O	O
specialty	O	O	B-T091
in	O	O	O
Ethiopia	O	O	B-T083
.	O	O	O

The	O	O	O
first	O	O	B-T097
seven	O	O	I-T097
family	O	O	I-T097
physicians	O	O	I-T097
graduated	O	O	B-T098
in	O	O	O
February	O	O	B-T080
2016	O	O	O
from	O	O	O
the	O	O	O
inaugural	O	O	O
residency	O	O	B-T065
programme	O	O	B-T170
at	O	O	O
Addis	O	O	B-T073
Ababa	O	O	I-T073
University	O	O	I-T073
.	O	O	O

Cooperation	O	O	B-T054
amongst	O	O	O
Ethiopian	O	O	B-T098
and	O	O	O
expatriate	O	O	B-T033
decision-makers	O	O	B-T097
and	O	O	O
physicians	O	O	B-T097
was	O	O	O
needed	O	O	O
to	O	O	O
begin	O	O	B-T079
the	O	O	O
programme	O	O	B-T170
.	O	O	O

Intentional	O	O	B-T078
replacement	O	O	B-T169
of	O	O	O
expatriates	O	O	B-T033
with	O	O	O
Ethiopian	O	O	B-T098
family	O	O	B-T097
physicians	O	O	I-T097
has	O	O	O
begun	O	O	B-T079
.	O	O	O

Barriers	O	O	B-T080
include	O	O	O
lack	O	O	B-T080
of	O	O	I-T080
understanding	O	O	B-T041
of	O	O	O
FM	O	O	B-T091
and	O	O	O
the	O	O	O
human	O	O	B-T169
and	O	O	O
financial	O	O	B-T033
resources	O	O	I-T033
needed	O	O	O
for	O	O	O
scaling	O	O	B-T081
up	O	O	I-T081
the	O	O	O
programme	O	O	B-T170
.	O	O	O

Regular	O	O	B-T080
programme	O	O	B-T170
review	O	O	B-T080
with	O	O	O
resident	O	O	B-T097
physician	O	O	I-T097
involvement	O	O	B-T054
has	O	O	O
allowed	O	O	O
the	O	O	O
FM	O	O	B-T091
training	O	O	B-T065
programme	O	O	I-T065
to	O	O	O
adapt	O	O	B-T080
and	O	O	O
fit	O	O	B-T052
the	O	O	O
Ethiopian	O	O	B-T098
context	O	O	B-T078
.	O	O	O

Further	O	O	O
successes	O	O	B-T054
will	O	O	O
result	O	O	B-T169
from	O	O	O
ongoing	O	O	O
support	O	O	B-T054
and	O	O	O
advocacy	O	O	B-T054
from	O	O	O
the	O	O	O
Federal	O	O	B-T057
Ministry	O	O	I-T057
of	O	O	I-T057
Health	O	O	I-T057
and	O	O	O
other	O	O	O
Ethiopian	O	O	B-T098
,	O	O	O
African	O	O	B-T098
,	O	O	O
and	O	O	O
international	O	O	B-T093
primary	O	O	I-T093
care	O	O	I-T093
organisations	O	O	I-T093
.	O	O	O

-DOCSTART- (27256947)

The	O	O	O
Experience	O	O	B-T041
of	O	O	O
Women	O	O	B-T098
Veterans	O	O	B-T098
Coming	O	O	O
Back	O	O	O
from	O	O	O
War	O	O	O

Issues	O	O	B-T048
surrounding	O	O	I-T048
mental	O	O	I-T048
health	O	O	I-T048
are	O	O	O
common	O	O	O
for	O	O	O
women	O	O	B-T098
veterans	O	O	B-T098
who	O	O	O
have	O	O	O
served	O	O	O
in	O	O	O
Iraq	O	O	B-T083
and	O	O	O
Afghanistan	O	O	B-T083
wars	O	O	B-T052
.	O	O	O

The	O	O	O
goal	O	O	O
of	O	O	O
this	O	O	O
phenomenological	O	O	B-T078
study	O	O	B-T062
was	O	O	O
to	O	O	O
document	O	O	B-T170
themes	O	O	B-UnknownType
in	O	O	O
the	O	O	O
stories	O	O	B-T170
gathered	O	O	O
from	O	O	O
eight	O	O	O
women	O	O	B-T098
veterans	O	O	B-T098
who	O	O	O
had	O	O	O
come	O	O	O
back	O	O	O
from	O	O	O
war	O	O	B-T052
.	O	O	O

Themes	O	O	B-UnknownType
in	O	O	O
the	O	O	O
stories	O	O	B-T170
were	O	O	O
:	O	O	O
arriving	O	O	O
with	O	O	O
mixed	O	O	O
sentiments	O	O	B-T055
;	O	O	O
evolving	O	O	O
to	O	O	O
a	O	O	O
changed	O	O	B-T169
view	O	O	B-T041
of	O	O	I-T041
self	O	O	I-T041
;	O	O	O
permeating	O	O	B-T033
aggravation	O	O	I-T033
;	O	O	O
confounding	O	O	B-T054
broken	O	O	I-T054
relationships	O	O	I-T054
,	O	O	O
frequent	O	O	B-T033
deployments	O	O	I-T033
,	O	O	O
and	O	O	O
change	O	O	B-T033
in	O	O	I-T033
military	O	O	I-T033
status	O	O	I-T033
;	O	O	O
remembering	O	O	B-T041
war	O	O	B-T052
experiences	O	O	B-T041
;	O	O	O
and	O	O	O
seeking	O	O	B-T033
opportunity	O	O	I-T033
for	O	O	I-T033
what	O	O	I-T033
is	O	O	I-T033
possible	O	O	I-T033
.	O	O	O

Mental	O	O	B-T048
health	O	O	I-T048
issues	O	O	I-T048
can	O	O	O
be	O	O	O
observed	O	O	O
in	O	O	O
the	O	O	O
themes	O	O	B-UnknownType
.	O	O	O

Including	O	O	O
story	O	O	B-T170
as	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
visit	O	O	O
with	O	O	O
veterans	O	O	B-T098
may	O	O	O
be	O	O	O
beneficial	O	O	O
to	O	O	O
veterans	O	O	O
as	O	O	O
they	O	O	O
deal	O	O	O
with	O	O	O
the	O	O	O
transition	O	O	B-T052
of	O	O	I-T052
coming	O	O	I-T052
back	O	O	I-T052
.	O	O	O

-DOCSTART- (27257353)

Trajectories	O	O	B-T082
of	O	O	O
Health	O	O	B-T078
and	O	O	O
Behavioral	O	O	B-T058
Health	O	O	I-T058
Services	O	O	I-T058
Use	O	O	B-T169
among	O	O	O
Community	O	O	B-T096
Corrections	O	O	B-T169
-Involved	O	O	O
Rural	O	O	B-T033
Adults	O	O	O

This	O	O	O
article	O	O	O
seeks	O	O	O
to	O	O	O
establish	O	O	O
time-based	O	O	O
trajectories	O	O	B-T082
of	O	O	O
health	O	O	B-T078
and	O	O	O
behavioral	O	O	B-T058
health	O	O	I-T058
services	O	O	I-T058
utilization	O	O	B-T169
for	O	O	O
community	O	O	B-T078
corrections-involved	O	O	I-T078
(	O	O	O
CCI	O	O	B-T078
)	O	O	O
adults	O	O	B-T100
and	O	O	O
to	O	O	O
examine	O	O	O
demographic	O	O	B-T078
and	O	O	O
clinical	O	O	B-T080
correlates	O	O	O
associated	O	O	O
with	O	O	O
these	O	O	O
trajectories	O	O	O
.	O	O	O

To	O	O	O
accomplish	O	O	O
this	O	O	O
aim	O	O	O
,	O	O	O
the	O	O	O
authors	O	O	O
applied	O	O	O
a	O	O	O
latent	O	O	B-T062
class	O	O	I-T062
growth	O	O	I-T062
analysis	O	O	I-T062
(	O	O	O
LCGA	O	O	B-T062
)	O	O	O
to	O	O	O
services	O	O	B-T058
use	O	O	O
data	O	O	O
from	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
rural	O	O	B-T033
CCI	O	O	B-T078
adults	O	O	B-T100
who	O	O	O
reported	O	O	O
their	O	O	O
medical	O	O	B-T169
,	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
,	O	O	O
and	O	O	O
substance	O	O	B-T078
use	O	O	I-T078
treatment	O	O	B-UnknownType
utilization	O	O	I-UnknownType
behavior	O	O	B-T053
every	O	O	O
60	O	O	O
days	O	O	B-T079
for	O	O	O
1.5	O	O	O
years	O	O	B-T079
.	O	O	O

LCGA	O	O	B-T062
established	O	O	O
1.5-year	O	O	B-T079
trajectories	O	O	B-T082
and	O	O	O
demographic	O	O	B-T078
correlates	O	O	O
of	O	O	O
health	O	O	B-T058
services	O	O	I-T058
among	O	O	O
rural	O	O	B-T033
CCI	O	O	B-T078
adults	O	O	B-T100
.	O	O	O

For	O	O	O
medical	O	O	B-T058
services	O	O	I-T058
,	O	O	O
three	O	O	O
classes	O	O	O
emerged	O	O	O
(	O	O	O
stable-low	O	O	O
users	O	O	B-T098
,	O	O	O
13	O	O	O
%	O	O	O
;	O	O	O
stable-intermediate	O	O	O
users	O	O	O
,	O	O	O
40	O	O	O
%	O	O	O
;	O	O	O
and	O	O	O
stable-high	O	O	O
users	O	O	O
,	O	O	O
47	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

For	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
and	O	O	O
substance	O	O	B-T078
use	O	O	I-T078
services	O	O	B-T058
,	O	O	O
three	O	O	O
classes	O	O	O
emerged	O	O	O
(	O	O	O
stable-low	O	O	O
,	O	O	O
69	O	O	O
%	O	O	O
and	O	O	O
61	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
low-baseline-increase	O	O	O
,	O	O	O
10	O	O	O
%	O	O	O
and	O	O	O
12	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
high-baseline	O	O	O
decline	O	O	O
,	O	O	O
21	O	O	O
%	O	O	O
and	O	O	O
28	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Employment	O	O	B-T080
,	O	O	O
gender	O	O	B-T032
,	O	O	O
medication	O	O	B-T033
usage	O	O	I-T033
,	O	O	O
and	O	O	O
depression	O	O	B-T048
severity	O	O	B-T080
predicted	O	O	O
membership	O	O	B-T055
across	O	O	O
all	O	O	O
services	O	O	B-T058
.	O	O	O

Results	O	O	O
underscore	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
social	O	O	B-T097
workers	O	O	I-T097
and	O	O	O
other	O	O	O
community	O	O	B-T058
services	O	O	I-T058
providers	O	O	B-T097
aligning	O	O	O
health	O	O	B-T058
services	O	O	I-T058
access	O	O	O
with	O	O	O
the	O	O	O
needs	O	O	O
of	O	O	O
the	O	O	O
CCI	O	O	B-T078
population	O	O	O
,	O	O	O
and	O	O	O
highlight	O	O	O
CCI	O	O	O
adults	O	O	B-T100
as	O	O	O
being	O	O	O
at	O	O	O
risk	O	O	B-T078
of	O	O	O
underservice	O	O	O
in	O	O	O
critical	O	O	O
prevention	O	O	B-T061
and	O	O	O
intervention	O	O	B-T061
domains	O	O	I-T061
.	O	O	O

-DOCSTART- (27257613)

Data	O	O	B-T170
set	O	O	I-T170
of	O	O	O
interactomes	O	O	B-T044
and	O	O	O
metabolic	O	O	B-T169
pathways	O	O	I-T169
of	O	O	O
proteins	O	O	B-T116
differentially	O	O	O
expressed	O	O	B-T045
in	O	O	O
brains	O	O	B-T023
with	O	O	O
Alzheimer׳s	O	O	O
disease	O	O	O

Alzheimer׳s	O	O	B-T047
disease	O	O	I-T047
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
main	O	O	O
causes	O	O	O
of	O	O	O
dementia	O	O	B-T048
in	O	O	O
the	O	O	O
elderly	O	O	B-T098
and	O	O	O
its	O	O	O
frequency	O	O	B-T079
is	O	O	O
on	O	O	O
the	O	O	O
rise	O	O	O
worldwide	O	O	B-T098
.	O	O	O

It	O	O	O
is	O	O	O
considered	O	O	O
the	O	O	O
result	O	O	O
of	O	O	O
complex	O	O	B-T080
interactions	O	O	B-T169
between	O	O	O
genetic	O	O	B-T080
and	O	O	O
environmental	O	O	B-T080
factors	O	O	I-T080
,	O	O	O
being	O	O	O
many	O	O	O
of	O	O	O
them	O	O	O
unknown	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
dire	O	O	O
necessity	O	O	O
for	O	O	O
the	O	O	O
identification	O	O	O
of	O	O	O
novel	O	O	O
molecular	O	O	B-T116
players	O	O	I-T116
for	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
this	O	O	O
disease	O	O	B-T047
.	O	O	O

In	O	O	O
this	O	O	O
data	O	O	B-T078
article	O	O	B-T170
we	O	O	O
determined	O	O	O
the	O	O	O
protein	O	O	B-T116
expression	O	O	I-T045
profiles	O	O	O
of	O	O	O
whole	O	O	O
protein	O	O	O
extracts	O	O	B-T167
from	O	O	O
cortex	O	O	B-T029
regions	O	O	I-T029
of	O	O	I-T029
brains	O	O	I-T029
from	O	O	O
patients	O	O	B-T101
with	O	O	O
Alzheimer׳s	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
comparison	O	O	O
to	O	O	O
a	O	O	O
normal	O	O	B-T023
brain	O	O	I-T023
.	O	O	O

We	O	O	O
identified	O	O	B-T080
721	O	O	O
iTRAQ-labeled	O	O	B-T130
polypeptides	O	O	B-T116
with	O	O	O
more	O	O	O
than	O	O	O
95	O	O	O
%	O	O	O
in	O	O	O
confidence	O	O	O
.	O	O	O

We	O	O	O
analyzed	O	O	B-T062
all	O	O	O
proteins	O	O	B-T116
that	O	O	O
changed	O	O	O
in	O	O	O
their	O	O	O
expression	O	O	B-T081
level	O	O	I-T081
and	O	O	O
located	O	O	O
them	O	O	O
in	O	O	O
the	O	O	O
KEGG	O	O	B-T170
metabolic	O	O	I-T170
pathways	O	O	I-T170
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
the	O	O	O
mitochondrial	O	O	B-T026
complexes	O	O	I-T026
of	O	O	I-T026
the	O	O	I-T026
electron	O	O	I-T026
transport	O	O	I-T026
chain	O	O	I-T026
and	O	O	O
ATP	O	O	B-T116
synthase	O	O	I-T116
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
analyzed	O	O	B-T062
the	O	O	O
over-	O	O	B-T116
and	O	O	I-T116
sub-expressed	O	O	I-T116
polypeptides	O	O	I-T116
through	O	O	O
IPA	O	O	B-T073
software	O	O	I-T073
,	O	O	O
specifically	O	O	O
Core	O	O	B-T170
I	O	O	I-T170
and	O	O	I-T170
Biomarkers	O	O	I-T170
I	O	O	I-T170
modules	O	O	I-T170
.	O	O	O

Data	O	O	B-T078
in	O	O	O
this	O	O	O
article	O	O	B-T170
is	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
research	O	O	B-T062
article	O	O	O
"	O	O	O
Identification	O	O	O
of	O	O	O
proteins	O	O	B-T116
that	O	O	O
are	O	O	O
differentially	O	O	O
expressed	O	O	B-T045
in	O	O	O
brains	O	O	B-T023
with	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
using	O	O	O
iTRAQ	O	O	B-T059
labeling	O	O	I-T059
and	O	O	O
tandem	O	O	B-T063
mass	O	O	I-T063
spectrometry	O	O	I-T063
"	O	O	O
(	O	O	O
Minjarez	O	O	O
et	O	O	O
al.	O	O	O
,	O	O	O
2016	O	O	O
)	O	O	O
[	O	O	O
1	O	O	O
]	O	O	O
.	O	O	O

-DOCSTART- (27257694)

Emergency	O	O	B-T061
general	O	O	I-T061
surgery	O	O	I-T061
specific	O	O	B-T170
frailty	O	O	I-T170
index	O	O	I-T170
:	O	O	O
A	O	O	O
validation	O	O	O
study	O	O	O

Assessment	O	O	B-T058
of	O	O	O
operative	O	O	B-T078
risk	O	O	I-T078
in	O	O	O
geriatric	O	O	B-T101
patients	O	O	I-T101
undergoing	O	O	O
emergency	O	O	B-T061
general	O	O	I-T061
surgery	O	O	I-T061
(	O	O	O
EGS	O	O	B-T061
)	O	O	O
is	O	O	O
challenging	O	O	O
.	O	O	O

Frailty	O	O	B-T033
is	O	O	O
an	O	O	O
established	O	O	O
measure	O	O	B-T081
for	O	O	O
risk	O	O	B-T058
assessment	O	O	I-T058
in	O	O	O
surgical	O	O	B-T077
cases	O	O	I-T077
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
our	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
validate	O	O	B-T062
a	O	O	O
modified	O	O	O
15	O	O	O
variable	O	O	B-T080
emergency	O	O	B-T058
general	O	O	I-T058
surgery	O	O	I-T058
specific	O	O	I-T058
frailty	O	O	I-T058
index	O	O	I-T058
(	O	O	O
EGSFI	O	O	B-T058
)	O	O	O
.	O	O	O

We	O	O	O
prospectively	O	O	O
collected	O	O	B-T078
geriatric	O	O	B-T080
(	O	O	O
age	O	O	B-T100
>	O	O	I-T100
65	O	O	I-T100
)	O	O	O
emergency	O	O	B-T061
general	O	O	I-T061
surgery	O	O	I-T061
patients	O	O	B-T101
for	O	O	O
1-	O	O	O
year	O	O	B-T079
.	O	O	O

Post-operative	O	O	B-T046
complications	O	O	I-T046
were	O	O	O
collected	O	O	B-T078
.	O	O	O

Frailty	O	O	B-T170
Index	O	O	I-T170
was	O	O	O
calculated	O	O	B-T059
for	O	O	O
200	O	O	O
patients	O	O	B-T101
based	O	O	O
on	O	O	O
their	O	O	O
pre-admission	O	O	B-T079
condition	O	O	B-T080
using	O	O	O
50-	O	O	O
variable	O	O	B-T080
modified	O	O	O
Rockwood	O	O	B-T170
Frailty	O	O	I-T170
Index	O	O	I-T170
(	O	O	O
FI	O	O	B-T170
)	O	O	O
.	O	O	O

EGSFI	O	O	B-T058
was	O	O	O
developed	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
regression	O	O	B-T170
model	O	O	I-T170
for	O	O	O
complications	O	O	B-T046
and	O	O	O
the	O	O	O
most	O	O	O
significant	O	O	O
factors	O	O	O
in	O	O	O
the	O	O	O
FI	O	O	B-T170
.	O	O	O

ROC	O	O	B-T081
curve	O	O	I-T081
analysis	O	O	I-T081
was	O	O	O
performed	O	O	O
to	O	O	O
determine	O	O	O
cutoff	O	O	B-T169
for	O	O	O
frail	O	O	B-T033
status	O	O	B-T080
.	O	O	O

We	O	O	O
validated	O	O	B-T062
our	O	O	O
results	O	O	B-T169
using	O	O	O
60	O	O	O
patients	O	O	B-T101
for	O	O	O
predicting	O	O	B-T078
complications	O	O	B-T046
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
260	O	O	O
patients	O	O	B-T101
(	O	O	O
200	O	O	O
developing	O	O	O
,	O	O	O
60	O	O	O
Validation	O	O	B-T062
)	O	O	O
were	O	O	O
enrolled	O	O	B-T058
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

Mean	O	O	B-T032
age	O	O	I-T032
was	O	O	O
71	O	O	O
±	O	O	O
11	O	O	O
years	O	O	B-T079
,	O	O	O
and	O	O	O
33	O	O	O
%	O	O	O
developed	O	O	O
complications	O	O	B-T046
.	O	O	O

Most	O	O	O
common	O	O	B-T081
complications	O	O	B-T046
were	O	O	O
pneumonia	O	O	B-T047
(	O	O	O
12	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
UTI	O	O	B-T047
(	O	O	O
9	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
wound	O	O	B-T046
infection	O	O	I-T046
(	O	O	O
7	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Univariate	O	O	B-T062
analysis	O	O	I-T062
identified	O	O	O
15	O	O	O
variables	O	O	B-T080
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
complications	O	O	B-T046
that	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
develop	O	O	O
the	O	O	O
EGSFI	O	O	B-T058
.	O	O	O

A	O	O	O
cutoff	O	O	B-T169
frailty	O	O	B-T033
score	O	O	I-T033
of	O	O	O
0.325	O	O	O
was	O	O	O
identified	O	O	O
using	O	O	O
ROC	O	O	B-T081
curve	O	O	I-T081
analysis	O	O	I-T081
for	O	O	O
frail	O	O	B-T033
status	O	O	B-T080
.Sixty-	O	O	O
patients	O	O	B-T101
(	O	O	O
frail	O	O	O
:	O	O	O
18	O	O	O
,	O	O	O
non-frail	O	O	B-T033
:	O	O	O
42	O	O	O
)	O	O	O
were	O	O	O
enrolled	O	O	B-T058
in	O	O	O
the	O	O	O
validation	O	O	B-T062
cohort	O	O	B-T098
.	O	O	O

Frail	O	O	B-T033
patients	O	O	B-T101
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
post-operative	O	O	B-T046
complications	O	O	I-T046
(	O	O	O
47	O	O	O
%	O	O	O
vs.	O	O	O
20	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
compared	O	O	O
to	O	O	O
nonfrail	O	O	B-T101
patients	O	O	I-T101
.	O	O	O

Frail	O	O	B-T033
status	O	O	B-T080
based	O	O	O
on	O	O	O
EGSFI	O	O	B-T058
was	O	O	O
a	O	O	O
significant	O	O	B-T078
predictor	O	O	I-T078
of	O	O	O
post-operative	O	O	B-T046
complications	O	O	I-T046
(	O	O	O
OR	O	O	B-T081
=	O	O	O
7.3	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
1.7	O	O	O
-	O	O	O
19.8	O	O	O
;	O	O	O
p=0.006	O	O	O
)	O	O	O
.	O	O	O

Age	O	O	B-T032
was	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
postoperative	O	O	B-T046
complications	O	O	I-T046
(	O	O	O
OR	O	O	B-T081
=	O	O	O
0.99	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
0.92	O	O	O
-1.06	O	O	O
;	O	O	O
p=0.86	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
15-	O	O	O
variable	O	O	B-T080
validated	O	O	B-T062
EGSFI	O	O	B-T058
is	O	O	O
a	O	O	O
simple	O	O	O
and	O	O	O
reliable	O	O	O
bedside	O	O	B-T073
tool	O	O	I-T073
to	O	O	O
determine	O	O	O
the	O	O	O
frailty	O	O	B-T033
status	O	O	I-T033
of	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
emergency	O	O	B-T061
general	O	O	I-T061
surgery	O	O	I-T061
.	O	O	O

Frail	O	O	B-T033
status	O	O	B-T080
as	O	O	O
determined	O	O	O
by	O	O	O
Abstract	O	O	O
the	O	O	O
EGSFI	O	O	B-T058
is	O	O	O
an	O	O	O
independent	O	O	B-T078
predictor	O	O	I-T078
of	O	O	O
post-operative	O	O	B-T046
complications	O	O	I-T046
and	O	O	O
mortality	O	O	B-T081
in	O	O	O
geriatric	O	O	B-T080
emergency	O	O	B-T061
general	O	O	I-T061
surgery	O	O	I-T061
patients	O	O	B-T101
.	O	O	O

Level	O	O	O
II	O	O	O
,	O	O	O
Prognostic	O	O	B-T062
Studies	O	O	I-T062
-	O	O	O
Investigating	O	O	B-T169
the	O	O	O
Effect	O	O	B-T080
of	O	O	O
a	O	O	O
Patient	O	O	B-T201
Characteristic	O	O	I-T201
on	O	O	O
the	O	O	O
Outcome	O	O	B-T033
of	O	O	I-T033
Disease	O	O	I-T033
.	O	O	O

-DOCSTART- (27257822)

Comparative	O	O	O
Epidemiologic	O	O	B-T169
Characteristics	O	O	B-T080
of	O	O	O
Pertussis	O	O	B-T047
in	O	O	O
10	O	O	O
Central	O	O	B-T083
and	O	O	O
Eastern	O	O	B-T083
European	O	O	I-T083
Countries	O	O	I-T083
,	O	O	O
2000	O	O	O
-	O	O	O
2013	O	O	O

We	O	O	O
undertook	O	O	O
an	O	O	O
epidemiological	O	O	B-T062
survey	O	O	I-T062
of	O	O	O
the	O	O	O
annual	O	O	B-T079
incidence	O	O	B-T081
of	O	O	O
pertussis	O	O	B-T047
reported	O	O	B-T058
from	O	O	O
2000	O	O	O
to	O	O	O
2013	O	O	O
in	O	O	O
ten	O	O	O
Central	O	O	B-T083
and	O	O	O
Eastern	O	O	B-T083
European	O	O	I-T083
countries	O	O	B-T083
to	O	O	O
ascertain	O	O	O
whether	O	O	O
increased	O	O	O
pertussis	O	O	O
reports	O	O	B-T170
in	O	O	O
some	O	O	O
countries	O	O	O
share	O	O	O
common	O	O	O
underlying	O	O	O
drivers	O	O	O
or	O	O	O
whether	O	O	O
there	O	O	O
are	O	O	O
specific	O	O	O
features	O	O	B-T080
in	O	O	O
each	O	O	O
country	O	O	B-T083
.	O	O	O

The	O	O	O
annual	O	O	B-T079
incidence	O	O	B-T081
of	O	O	O
pertussis	O	O	B-T047
in	O	O	O
the	O	O	O
participating	O	O	O
countries	O	O	B-T083
was	O	O	O
obtained	O	O	O
from	O	O	O
relevant	O	O	O
government	O	O	B-T093
institutions	O	O	I-T093
and/or	O	O	O
national	O	O	B-T093
surveillance	O	O	I-T093
systems	O	O	I-T093
.	O	O	O

We	O	O	O
reviewed	O	O	B-T080
the	O	O	O
changes	O	O	B-T169
in	O	O	O
the	O	O	O
pertussis	O	O	B-T047
incidence	O	O	B-T081
rates	O	O	I-T081
in	O	O	O
each	O	O	O
country	O	O	B-T083
to	O	O	O
explore	O	O	O
differences	O	O	B-T080
and/or	O	O	O
similarities	O	O	B-T080
between	O	O	O
countries	O	O	B-T083
in	O	O	O
relation	O	O	O
to	O	O	O
pertussis	O	O	O
surveillance	O	O	B-T169
;	O	O	O
case	O	O	B-T170
definitions	O	O	I-T170
for	O	O	O
detection	O	O	B-T033
and	O	O	O
confirmation	O	O	B-T080
of	O	O	O
pertussis	O	O	O
;	O	O	O
incidence	O	O	O
and	O	O	O
number	O	O	B-T081
of	O	O	I-T081
cases	O	O	I-T081
of	O	O	O
pertussis	O	O	O
by	O	O	O
year	O	O	B-T079
,	O	O	O
overall	O	O	O
and	O	O	O
by	O	O	O
age	O	O	B-T100
group	O	O	I-T100
;	O	O	O
population	O	O	B-T098
by	O	O	O
year	O	O	O
,	O	O	O
overall	O	O	O
and	O	O	O
by	O	O	O
age	O	O	O
group	O	O	O
;	O	O	O
pertussis	O	O	O
immunization	O	O	B-T061
schedule	O	O	I-T061
and	O	O	O
coverage	O	O	B-T169
,	O	O	O
and	O	O	O
switch	O	O	O
from	O	O	O
whole-cell	O	O	B-T129
pertussis	O	O	I-T129
vaccines	O	O	I-T129
(	O	O	O
wP	O	O	B-T129
)	O	O	O
to	O	O	O
acellular	O	O	B-T129
pertussis	O	O	I-T129
vaccines	O	O	I-T129
(	O	O	O
aP	O	O	B-T129
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
heterogeneity	O	O	B-T080
in	O	O	O
the	O	O	O
reported	O	O	B-T058
annual	O	O	B-T079
incidence	O	O	B-T081
rates	O	O	I-T081
and	O	O	O
trends	O	O	O
observed	O	O	O
across	O	O	O
countries	O	O	B-T083
.	O	O	O

Reported	O	O	B-T058
pertussis	O	O	B-T047
incidence	O	O	B-T081
rates	O	O	B-T081
varied	O	O	O
considerably	O	O	O
,	O	O	O
ranging	O	O	O
from	O	O	O
0.01	O	O	O
to	O	O	O
96	O	O	O
per	O	O	O
100,000	O	O	O
population	O	O	B-T098
,	O	O	O
with	O	O	O
the	O	O	O
highest	O	O	B-T080
rates	O	O	O
generally	O	O	O
reported	O	O	B-T058
in	O	O	O
Estonia	O	O	B-T083
and	O	O	O
the	O	O	O
lowest	O	O	B-T080
in	O	O	O
Hungary	O	O	B-T083
and	O	O	O
Serbia	O	O	B-T083
.	O	O	O

The	O	O	O
greatest	O	O	O
burden	O	O	B-T078
appears	O	O	O
for	O	O	O
the	O	O	O
most	O	O	O
part	O	O	O
in	O	O	O
infants	O	O	B-T100
(	O	O	O
<	O	O	O
1	O	O	O
year	O	O	B-T079
)	O	O	O
in	O	O	O
Bulgaria	O	O	B-T083
,	O	O	O
Hungary	O	O	B-T083
,	O	O	O
Latvia	O	O	B-T083
,	O	O	O
Romania	O	O	B-T083
,	O	O	O
and	O	O	O
Serbia	O	O	B-T083
,	O	O	O
but	O	O	O
not	O	O	O
in	O	O	O
the	O	O	O
other	O	O	O
participating	O	O	O
countries	O	O	B-T083
where	O	O	O
the	O	O	O
burden	O	O	O
may	O	O	O
have	O	O	O
shifted	O	O	O
to	O	O	O
older	O	O	B-T100
children	O	O	I-T100
,	O	O	O
though	O	O	O
surveillance	O	O	B-T169
of	O	O	O
adults	O	O	B-T100
may	O	O	O
be	O	O	O
inappropriate	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
consistent	O	O	O
pattern	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
switch	O	O	O
from	O	O	O
wP	O	O	B-T129
to	O	O	O
aP	O	O	B-T129
vaccines	O	O	I-T129
on	O	O	O
reported	O	O	B-T058
pertussis	O	O	B-T047
incidence	O	O	B-T081
rates	O	O	I-T081
.	O	O	O

The	O	O	O
heterogeneity	O	O	B-T080
in	O	O	O
reported	O	O	B-T058
data	O	O	B-T078
may	O	O	O
be	O	O	O
related	O	O	O
to	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
factors	O	O	B-T169
including	O	O	O
surveillance	O	O	B-T169
system	O	O	B-T169
characteristics	O	O	B-T080
or	O	O	O
capabilities	O	O	B-T080
,	O	O	O
different	O	O	O
case	O	O	B-T170
definitions	O	O	I-T170
,	O	O	O
type	O	O	B-T080
of	O	O	O
pertussis	O	O	B-T047
confirmation	O	O	B-T059
tests	O	O	I-T059
used	O	O	O
,	O	O	O
public	O	O	B-T092
awareness	O	O	B-T033
of	O	O	O
the	O	O	O
disease	O	O	B-T047
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
real	O	O	O
differences	O	O	B-T081
in	O	O	O
the	O	O	O
magnitude	O	O	B-T081
of	O	O	O
the	O	O	O
disease	O	O	O
,	O	O	O
or	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
these	O	O	O
factors	O	O	O
.	O	O	O

Our	O	O	O
study	O	O	O
highlights	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
standardize	O	O	O
pertussis	O	O	B-T047
detection	O	O	B-T033
and	O	O	O
confirmation	O	O	B-T080
in	O	O	O
surveillance	O	O	B-T062
programs	O	O	I-T062
across	O	O	O
Europe	O	O	B-T083
,	O	O	O
complemented	O	O	O
with	O	O	O
carefully-designed	O	O	O
seroprevalence	O	O	B-T062
studies	O	O	I-T062
using	O	O	O
the	O	O	O
same	O	O	O
protocols	O	O	B-T170
and	O	O	O
methodologies	O	O	B-T062
.	O	O	O

-DOCSTART- (27259362)

Identification	O	O	B-T080
and	O	O	O
characterization	O	O	B-T052
of	O	O	O
Dichelobacter	O	O	B-T007
nodosus	O	O	I-T007
serogroup	O	O	B-T170
H	O	O	I-T170
from	O	O	O
ovine	O	O	B-T015
footrot	O	O	B-T047
in	O	O	O
India	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
56	O	O	O
foot	O	O	B-T167
swabs	O	O	I-T167
were	O	O	O
collected	O	O	O
from	O	O	O
inter	O	O	B-T030
digital	O	O	I-T030
spaces	O	O	I-T030
of	O	O	O
sheep	O	O	B-T015
with	O	O	O
footrot	O	O	B-T047
lesions	O	O	B-T033
were	O	O	O
screened	O	O	B-T060
for	O	O	O
16	O	O	O
rRNA	O	O	B-T114
of	O	O	O
Dichelobacter	O	O	B-T007
nodosus	O	O	I-T007
by	O	O	O
PCR	O	O	B-T063
.	O	O	O

Out	O	O	O
of	O	O	O
the	O	O	O
56	O	O	O
samples	O	O	B-T077
,	O	O	O
38(67.85	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
positive	O	O	B-T033
.	O	O	O

All	O	O	O
the	O	O	O
positive	O	O	B-T033
samples	O	O	B-T077
were	O	O	O
subjected	O	O	O
to	O	O	O
multiplex	O	O	B-T063
PCR	O	O	I-T063
targeting	O	O	B-T063
fimA	O	O	I-T063
gene	O	O	I-T063
for	O	O	O
identification	O	O	B-T080
of	O	O	O
serogroups	O	O	B-T170
of	O	O	O
D.	O	O	B-T007
nodosus	O	O	I-T007
.	O	O	O

Serogroup	O	O	B-T170
H	O	O	I-T170
was	O	O	O
found	O	O	O
along	O	O	O
with	O	O	O
serogroup	O	O	B-T170
B	O	O	I-T170
in	O	O	O
12	O	O	O
(	O	O	O
55.26	O	O	O
%	O	O	O
)	O	O	O
samples	O	O	B-T077
and	O	O	O
with	O	O	O
serogroup	O	O	B-T170
I	O	O	I-T170
in	O	O	O
8	O	O	O
(	O	O	O
22.2	O	O	O
%	O	O	O
)	O	O	O
samples	O	O	O
.	O	O	O

The	O	O	O
serogroup	O	O	B-T170
H	O	O	I-T170
was	O	O	O
identified	O	O	B-T080
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
from	O	O	O
the	O	O	O
Indian	O	O	B-T083
subcontinent	O	O	I-T083
.	O	O	O

The	O	O	O
phylogenetic	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
the	O	O	O
present	O	O	O
sequence	O	O	B-T086
with	O	O	O
the	O	O	O
available	O	O	O
serogroup	O	O	B-T170
H	O	O	I-T170
sequences	O	O	B-T086
of	O	O	O
GenBank	O	O	B-T170
revealed	O	O	O
to	O	O	O
be	O	O	O
in	O	O	O
close	O	O	O
association	O	O	O
with	O	O	O
the	O	O	O
serotype	O	O	B-T170
H1	O	O	I-T170
.	O	O	O

-DOCSTART- (27265654)

Conservation	O	O	B-T065
education	O	O	I-T065
and	O	O	O
habitat	O	O	B-T082
restoration	O	O	B-T169
for	O	O	O
the	O	O	O
endangered	O	O	B-T098
Sagalla	O	O	B-T011
caecilian	O	O	I-T011
(	O	O	O
Boulengerula	O	O	B-T011
niedeni	O	O	I-T011
)	O	O	O
in	O	O	O
Sagalla	O	O	B-T083
Hill	O	O	I-T083
,	O	O	O
Kenya	O	O	O

The	O	O	O
Sagalla	O	O	B-T011
caecilian	O	O	I-T011
(	O	O	O
Boulengerula	O	O	B-T011
niedeni	O	O	I-T011
)	O	O	O
is	O	O	O
an	O	O	O
endangered	O	O	B-T098
amphibian	O	O	B-T011
endemic	O	O	B-UnknownType
to	O	O	O
Sagalla	O	O	B-T083
Hill	O	O	I-T083
in	O	O	O
the	O	O	O
Taita	O	O	B-T083
Hills	O	O	I-T083
.	O	O	O

This	O	O	O
burrowing	O	O	B-T204
worm	O	O	I-T204
-like	O	O	O
species	O	O	B-T185
prefers	O	O	O
soft	O	O	B-T080
soil	O	O	B-T167
with	O	O	O
high	O	O	B-T080
moisture	O	O	B-T167
and	O	O	O
organic	O	O	B-T167
matter	O	O	I-T167
.	O	O	O

The	O	O	O
major	O	O	B-T080
threats	O	O	B-T078
to	O	O	O
the	O	O	O
Sagalla	O	O	B-T011
caecilian	O	O	I-T011
are	O	O	O
soil	O	O	B-T070
erosion	O	O	I-T070
caused	O	O	B-T169
by	O	O	O
steep	O	O	B-T082
slopes	O	O	I-T082
,	O	O	O
bare	O	O	O
ground	O	O	B-T083
and	O	O	O
water	O	O	B-T067
siphoning	O	O	I-T067
/	O	O	O
soil	O	O	B-T067
hardening	O	O	I-T067
from	O	O	O
exotic	O	O	B-T002
eucalyptus	O	O	I-T002
trees	O	O	I-T002
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
get	O	O	O
a	O	O	O
better	O	O	B-T080
understanding	O	O	B-T041
of	O	O	O
the	O	O	O
local	O	O	B-T082
people	O	O	B-T098
's	O	O	I-T098
attitude	O	O	B-T041
towards	O	O	O
this	O	O	O
species	O	O	B-T185
and	O	O	O
how	O	O	O
they	O	O	O
can	O	O	O
contribute	O	O	B-T052
to	O	O	O
its	O	O	O
continued	O	O	B-T078
conservation	O	O	B-T080
through	O	O	O
restoration	O	O	B-T169
of	O	O	O
its	O	O	O
remaining	O	O	B-T080
habitat	O	O	B-T082
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
it	O	O	O
was	O	O	O
found	O	O	B-T033
that	O	O	O
96	O	O	O
%	O	O	O
of	O	O	O
Sagalla	O	O	B-T083
people	O	O	B-T098
are	O	O	O
aware	O	O	B-T041
of	O	O	O
the	O	O	O
species	O	O	B-T185
,	O	O	O
its	O	O	O
habits	O	O	B-T055
and	O	O	O
its	O	O	O
association	O	O	O
with	O	O	O
soils	O	O	B-T167
high	O	O	B-T080
in	O	O	O
organic	O	O	B-T167
matter	O	O	I-T167
.	O	O	O

It	O	O	O
was	O	O	O
also	O	O	O
found	O	O	B-T033
that	O	O	O
96	O	O	O
%	O	O	O
of	O	O	O
Sagalla	O	O	B-T083
people	O	O	B-T098
use	O	O	O
organic	O	O	B-T080
manure	O	O	B-T167
from	O	O	O
cow	O	O	B-T015
dung	O	O	B-T031
in	O	O	O
their	O	O	O
farms	O	O	B-T082
.	O	O	O

Habitat	O	O	B-T082
restoration	O	O	B-T169
through	O	O	O
planting	O	O	B-T052
of	O	O	O
indigenous	O	O	B-T082
plants	O	O	B-T002
was	O	O	O
found	O	O	B-T033
to	O	O	O
be	O	O	O
ongoing	O	O	B-T078
,	O	O	O
especially	O	O	B-T080
on	O	O	O
compounds	O	O	B-T103
of	O	O	O
public	O	O	B-T092
institutions	O	O	I-T092
as	O	O	O
well	O	O	O
as	O	O	O
on	O	O	O
private	O	O	B-UnknownType
lands	O	O	I-UnknownType
.	O	O	O

Although	O	O	O
drought	O	O	B-T070
was	O	O	O
found	O	O	B-T033
to	O	O	O
be	O	O	O
a	O	O	O
challenge	O	O	O
for	O	O	O
seedlings	O	O	B-T002
development	O	O	B-T169
especially	O	O	O
on	O	O	O
the	O	O	O
low	O	O	B-T080
elevation	O	O	B-T082
sites	O	O	B-T082
,	O	O	O
destruction	O	O	B-T052
by	O	O	O
livestock	O	O	B-T008
especially	O	O	O
during	O	O	B-T079
the	O	O	O
dry	O	O	B-T080
season	O	O	B-T079
is	O	O	O
also	O	O	O
a	O	O	O
major	O	O	B-T080
threat	O	O	B-T078
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
it	O	O	O
was	O	O	O
recommended	O	O	B-T078
that	O	O	O
any	O	O	O
future	O	O	B-T079
habitat	O	O	B-T082
restoration	O	O	B-T169
initiative	O	O	B-T041
should	O	O	O
include	O	O	B-T169
strong	O	O	B-T080
chain-link	O	O	B-T073
fencing	O	O	B-T052
to	O	O	O
protect	O	O	O
the	O	O	O
seedlings	O	O	B-T002
from	O	O	O
livestock	O	O	B-T008
activity	O	O	B-T052
.	O	O	O

Recognizing	O	O	O
that	O	O	O
the	O	O	O
preferred	O	O	B-T078
habitats	O	O	B-T082
for	O	O	O
the	O	O	O
species	O	O	B-T185
are	O	O	O
in	O	O	O
the	O	O	O
valleys	O	O	B-T082
,	O	O	O
systematic	O	O	B-T169
planting	O	O	B-T052
of	O	O	O
keystone	O	O	B-T002
plant	O	O	I-T002
species	O	O	O
such	O	O	O
as	O	O	O
fig	O	O	B-T002
trees	O	O	I-T002
(	O	O	O
Ficus	O	O	B-T002
)	O	O	O
creates	O	O	B-T052
the	O	O	O
best	O	O	O
microhabitats	O	O	B-T082
.	O	O	O

These	O	O	O
are	O	O	O
better	O	O	B-T080
than	O	O	O
general	O	O	B-T082
woodlots	O	O	B-T082
of	O	O	O
indigenous	O	O	B-T082
trees	O	O	B-T002
.	O	O	O

-DOCSTART- (27266753)

The	O	O	O
clinical	O	O	B-T080
and	O	O	O
economic	O	O	B-T169
burden	O	O	B-T078
of	O	O	O
significant	O	O	B-T078
bleeding	O	O	B-T046
during	O	O	B-T079
lung	O	O	B-T061
resection	O	O	I-T061
surgery	O	O	I-T061
:	O	O	O
A	O	O	O
retrospective	O	O	B-T062
matched	O	O	I-T062
cohort	O	O	I-T062
analysis	O	O	I-T062
of	O	O	O
real	O	O	B-T080
-	O	O	O
world	O	O	B-T098
data	O	O	O

The	O	O	O
objective	O	O	B-T080
of	O	O	O
this	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
was	O	O	O
to	O	O	O
quantify	O	O	B-T081
the	O	O	O
clinical	O	O	B-T080
and	O	O	O
economic	O	O	B-T169
burden	O	O	B-T078
of	O	O	O
significant	O	O	B-T078
bleeding	O	O	B-T046
in	O	O	O
lung	O	O	B-T061
resection	O	O	I-T061
surgery	O	O	I-T061
in	O	O	O
the	O	O	O
US	O	O	B-T083
.	O	O	O

This	O	O	O
study	O	O	B-T062
utilized	O	O	B-T169
2009	O	O	O
-	O	O	O
2012	O	O	O
data	O	O	B-T078
from	O	O	O
the	O	O	O
Premier	O	O	B-T170
Perspective	O	O	I-T170
Database(TM	O	O	I-T170
)	O	O	I-T170
.	O	O	O

Adult	O	O	B-T100
patients	O	O	B-T101
with	O	O	O
primary	O	O	B-T060
pulmonary	O	O	I-T061
lobectomy	O	O	I-T061
or	O	O	O
segmentectomy	O	O	B-T061
procedures	O	O	I-T061
were	O	O	O
categorized	O	O	B-T052
by	O	O	O
the	O	O	O
surgical	O	O	B-T169
approach	O	O	I-T169
(	O	O	O
VATS	O	O	B-T061
vs	O	O	O
open	O	O	B-T061
)	O	O	O
and	O	O	O
primary	O	O	B-T080
diagnosis	O	O	I-T080
(	O	O	O
primary	O	O	O
or	O	O	O
metastatic	O	O	B-T060
lung	O	O	I-T060
cancer	O	O	I-T060
vs	O	O	O
non-lung	O	O	B-T060
cancer	O	O	I-T060
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
requiring	O	O	O
≥3	O	O	O
units	O	O	B-T081
of	O	O	O
blood	O	O	B-T121
products	O	O	I-T121
with	O	O	O
at	O	O	B-T080
least	O	O	I-T080
1	O	O	O
unit	O	O	B-T081
of	O	O	O
PRBCs	O	O	B-T116
:	O	O	O
"	O	O	O
significant	O	O	B-T078
bleeding	O	O	B-T046
"	O	O	O
cohort	O	O	B-T098
;	O	O	O
those	O	O	O
requiring	O	O	O
<3	O	O	O
units	O	O	O
:	O	O	O
"	O	O	O
non-significant	O	O	B-T033
bleeding	O	O	O
"	O	O	O
cohort	O	O	O
;	O	O	O
and	O	O	O
those	O	O	O
not	O	O	O
requiring	O	O	O
blood	O	O	O
products	O	O	O
:	O	O	O
"	O	O	O
no	O	O	B-T169
bleeding	O	O	O
"	O	O	O
cohort	O	O	O
.	O	O	O

A	O	O	O
matched	O	O	O
cohort	O	O	B-T098
analysis	O	O	I-T062
was	O	O	O
performed	O	O	B-T169
between	O	O	O
the	O	O	O
"	O	O	O
significant	O	O	B-T078
bleeding	O	O	B-T046
"	O	O	O
and	O	O	O
the	O	O	O
"	O	O	O
no	O	O	B-T169
bleeding	O	O	O
cohort	O	O	O
"	O	O	O
using	O	O	O
matching	O	O	B-UnknownType
variables	O	O	I-UnknownType
:	O	O	O
hospital	O	O	B-T093
,	O	O	O
lung	O	O	B-T060
cancer	O	O	I-T060
diagnosis	O	O	I-T060
,	O	O	O
year	O	O	B-T079
of	O	O	I-T079
surgery	O	O	I-T079
,	O	O	O
APR-DRG	O	O	B-T081
severity	O	O	I-T081
score	O	O	I-T081
,	O	O	O
procedure	O	O	B-T201
type	O	O	I-T201
and	O	O	O
approach	O	O	B-T169
,	O	O	O
age	O	O	B-T032
,	O	O	O
and	O	O	O
gender	O	O	B-T032
.	O	O	O

The	O	O	O
"	O	O	O
All	O	O	B-T081
-	O	O	O
patient	O	O	B-T101
"	O	O	O
cohort	O	O	B-T098
comprised	O	O	O
21,429	O	O	O
patients	O	O	B-T101
:	O	O	O
213	O	O	O
"	O	O	O
significant	O	O	B-T078
bleeding	O	O	B-T046
"	O	O	O
;	O	O	O
2,780	O	O	O
"	O	O	O
non-significant	O	O	B-T033
bleeding	O	O	O
"	O	O	O
;	O	O	O
and	O	O	O
18,436	O	O	O
"	O	O	O
no	O	O	B-T169
bleeding	O	O	O
"	O	O	O
.	O	O	O

Overall	O	O	B-T080
incidence	O	O	B-T081
of	O	O	O
significant	O	O	B-T078
chest	O	O	B-T029
bleeding	O	O	B-T046
was	O	O	O
0.99	O	O	O
%	O	O	O
.	O	O	O

Patients	O	O	B-T101
from	O	O	O
"	O	O	O
significant	O	O	B-T078
bleeding	O	O	B-T046
"	O	O	O
cohort	O	O	B-T098
and	O	O	O
"	O	O	O
non-significant	O	O	B-T033
bleeding	O	O	O
"	O	O	O
cohort	O	O	O
had	O	O	O
2.5	O	O	O
days	O	O	B-T079
and	O	O	O
2	O	O	O
days	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
longer	O	O	B-T080
length	O	O	B-T079
of	O	O	I-T079
stay	O	O	I-T079
in	O	O	O
the	O	O	O
hospital	O	O	B-T093
compared	O	O	B-T052
to	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
"	O	O	O
no	O	O	B-T169
bleeding	O	O	O
"	O	O	O
cohort	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Overall	O	O	B-T080
,	O	O	O
hospital	O	O	B-T081
costs	O	O	I-T081
for	O	O	O
"	O	O	O
significant	O	O	B-T078
bleeding	O	O	B-T046
"	O	O	O
cohort	O	O	B-T098
were	O	O	O
higher	O	O	B-T080
than	O	O	O
"	O	O	O
no	O	O	B-T169
bleeding	O	O	O
"	O	O	O
cohort	O	O	O
for	O	O	O
those	O	O	O
who	O	O	O
were	O	O	O
covered	O	O	B-T169
under	O	O	O
Medicare	O	O	B-T064
(	O	O	O
$	O	O	O
59,871	O	O	O
vs	O	O	O
$	O	O	O
23,641	O	O	O
)	O	O	O
,	O	O	O
were	O	O	O
≥76	O	O	O
years	O	O	B-T079
of	O	O	I-T079
age	O	O	I-T079
(	O	O	O
$	O	O	O
64,010	O	O	O
vs	O	O	O
$	O	O	O
24,243	O	O	O
)	O	O	O
,	O	O	O
had	O	O	O
greater	O	O	B-T081
severity	O	O	B-T080
of	O	O	I-T080
illness	O	O	I-T080
(	O	O	O
$	O	O	O
97,813	O	O	O
vs	O	O	O
$	O	O	O
51,871	O	O	O
)	O	O	O
and	O	O	O
underwent	O	O	O
open	O	O	O
segmentectomy	O	O	B-T061
(	O	O	O
$	O	O	O
74,220	O	O	O
vs	O	O	O
$	O	O	O
21,903	O	O	O
)	O	O	O
.	O	O	O

Hospital	O	O	B-T081
costs	O	O	I-T081
for	O	O	O
"	O	O	O
significant	O	O	B-T078
bleeding	O	O	B-T046
"	O	O	O
cohort	O	O	B-T098
and	O	O	O
"	O	O	O
non-significant	O	O	B-T033
bleeding	O	O	O
"	O	O	O
were	O	O	O
significantly	O	O	B-T078
higher	O	O	B-T080
(	O	O	O
$	O	O	O
11,589	O	O	O
and	O	O	O
$	O	O	O
5,280	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
than	O	O	O
no	O	O	B-T169
bleeding	O	O	O
cohort	O	O	O
.	O	O	O

Although	O	O	O
significant	O	O	B-T078
bleeding	O	O	B-T046
during	O	O	B-T079
lung	O	O	B-T061
resection	O	O	I-T061
surgery	O	O	I-T061
is	O	O	O
rare	O	O	B-T080
,	O	O	O
patients	O	O	B-T101
with	O	O	O
such	O	O	O
complication	O	O	B-T046
could	O	O	O
stay	O	O	B-T079
longer	O	O	B-T080
at	O	O	O
the	O	O	O
hospital	O	O	B-T093
and	O	O	O
cost	O	O	B-T081
an	O	O	O
average	O	O	O
of	O	O	O
$	O	O	O
13,103	O	O	O
more	O	O	O
than	O	O	O
those	O	O	O
without	O	O	O
.	O	O	O

-DOCSTART- (27266840)

Laceration	O	O	B-T037
of	O	O	O
a	O	O	O
branch	O	O	B-T082
of	O	O	I-T082
the	O	O	O
profunda	O	O	B-T023
femoris	O	O	I-T023
artery	O	O	I-T023
caused	O	O	B-T169
by	O	O	O
a	O	O	O
spike	O	O	B-T033
of	O	O	O
the	O	O	O
displaced	O	O	B-T082
lesser	O	O	B-T023
trochanter	O	O	I-T023
in	O	O	O
an	O	O	O
inter-trochanteric	O	O	B-T030
femoral	O	O	B-T037
fracture	O	O	I-T037
.	O	O	O
A	O	O	O
case	O	O	O
report	O	O	O

A	O	O	O
case	O	O	B-T170
report	O	O	I-T170
Injury	O	O	B-T037
of	O	O	O
femoral	O	O	B-T023
vessels	O	O	I-T023
is	O	O	O
an	O	O	O
extremely	O	O	B-T080
rare	O	O	B-T080
complication	O	O	B-T046
in	O	O	O
intertrochanteric	O	O	B-T030
femoral	O	O	B-T037
fractures	O	O	I-T037
.	O	O	O

In	O	O	O
most	O	O	O
cases	O	O	B-T169
reported	O	O	B-T058
,	O	O	O
the	O	O	O
vascular	O	O	B-T047
lesion	O	O	I-T047
involves	O	O	B-T169
the	O	O	O
superficial	O	O	B-T023
femoral	O	O	I-T023
artery	O	O	I-T023
,	O	O	O
whereas	O	O	O
in	O	O	O
very	O	O	O
few	O	O	O
cases	O	O	O
does	O	O	O
it	O	O	O
involve	O	O	B-T169
the	O	O	O
profunda	O	O	B-T023
femoris	O	O	I-T023
artery	O	O	I-T023
.	O	O	O

We	O	O	O
report	O	O	B-T170
a	O	O	O
case	O	O	B-T169
of	O	O	O
acute	O	O	B-T046
bleeding	O	O	I-T046
due	O	O	O
to	O	O	O
laceration	O	O	B-T037
of	O	O	O
a	O	O	O
perforating	O	O	B-T033
branch	O	O	B-T082
of	O	O	I-T082
the	O	O	O
profunda	O	O	B-T023
femoris	O	O	I-T023
artery	O	O	I-T023
caused	O	O	B-T169
by	O	O	O
a	O	O	O
sharp	O	O	B-T033
fragment	O	O	B-T169
of	O	O	I-T169
the	O	O	O
displaced	O	O	B-T082
lesser	O	O	B-T023
trochanter	O	O	I-T023
in	O	O	O
an	O	O	O
intertrochanteric	O	O	B-T030
femoral	O	O	B-T037
fracture	O	O	I-T037
;	O	O	O
the	O	O	O
lesion	O	O	B-T033
was	O	O	O
treated	O	O	B-T169
by	O	O	O
transcatheter	O	O	B-T061
embolization	O	O	I-T061
.	O	O	O

The	O	O	O
arterial	O	O	B-T037
injury	O	O	B-T037
may	O	O	O
be	O	O	O
iatrogenic	O	O	B-T080
,	O	O	O
occurring	O	O	B-T052
during	O	O	O
intramedullary	O	O	B-T082
internal	O	O	B-T061
fixation	O	O	I-T061
,	O	O	O
or	O	O	O
less	O	O	O
frequently	O	O	B-T079
,	O	O	O
the	O	O	O
injury	O	O	O
may	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
fracture	O	O	B-T037
itself	O	O	O
,	O	O	O
caused	O	O	B-T169
by	O	O	O
a	O	O	O
sharp	O	O	B-T033
bone	O	O	B-T037
fragment	O	O	I-T037
that	O	O	O
damages	O	O	B-T169
the	O	O	O
profunda	O	O	B-T023
femoris	O	O	I-T023
artery	O	O	I-T023
or	O	O	O
one	O	O	O
of	O	O	O
its	O	O	O
perforating	O	O	B-T033
branches	O	O	B-T082
.	O	O	O

We	O	O	O
believe	O	O	O
that	O	O	O
intertrochanteric	O	O	B-T030
femoral	O	O	B-T037
fractures	O	O	I-T037
with	O	O	O
avulsed	O	O	B-T037
lesser	O	O	B-T023
trochanter	O	O	I-T023
are	O	O	O
at	O	O	B-T080
risk	O	O	I-T080
for	O	O	O
femoral	O	O	B-T023
vessel	O	O	I-T023
injuries	O	O	B-T037
caused	O	O	B-T169
by	O	O	O
the	O	O	O
displaced	O	O	B-T082
bone	O	O	B-T023
spike	O	O	B-T033
,	O	O	O
and	O	O	O
we	O	O	O
advise	O	O	O
meticulous	O	O	B-T080
clinical	O	O	B-T080
and	O	O	O
laboratory	O	O	B-T058
monitoring	O	O	I-T058
pre-	O	O	B-T079
and	O	O	O
post-operatively	O	O	B-T079
to	O	O	O
prevent	O	O	B-T061
serious	O	O	I-T061
complications	O	O	I-T061
.	O	O	O

-DOCSTART- (27270311)

Direct	O	O	O
contact	O	O	O
with	O	O	O
perivascular	O	O	B-T023
tumor	O	O	B-T025
cells	O	O	I-T025
enhances	O	O	O
integrin	O	O	B-T116
αvβ3	O	O	I-T116
signaling	O	O	B-T044
and	O	O	O
migration	O	O	B-T043
of	O	O	O
endothelial	O	O	O
cells	O	O	O

The	O	O	O
secretion	O	O	B-T043
of	O	O	O
soluble	O	O	O
pro-angiogenic	O	O	B-T123
factors	O	O	I-T123
by	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
stromal	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
the	O	O	O
perivascular	O	O	B-T023
niche	O	O	O
promotes	O	O	O
the	O	O	O
aggressive	O	O	B-T191
angiogenesis	O	O	I-T191
that	O	O	O
is	O	O	O
typical	O	O	O
of	O	O	O
glioblastoma	O	O	B-T191
(	O	O	O
GBM	O	O	B-T191
)	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
angiogenesis	O	O	B-T191
also	O	O	O
can	O	O	O
be	O	O	O
promoted	O	O	O
by	O	O	O
a	O	O	O
direct	O	O	O
interaction	O	O	O
between	O	O	O
brain	O	O	B-T023
tumor	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
including	O	O	O
tumor	O	O	O
cells	O	O	O
with	O	O	O
cancer	O	O	B-T025
stem	O	O	I-T025
-like	O	O	O
properties	O	O	O
(	O	O	O
CSCs	O	O	B-T025
)	O	O	O
,	O	O	O
and	O	O	O
endothelial	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
ECs	O	O	B-T025
)	O	O	O
.	O	O	O

As	O	O	O
shown	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
,	O	O	O
this	O	O	O
direct	O	O	O
interaction	O	O	O
is	O	O	O
mediated	O	O	O
by	O	O	O
binding	O	O	B-T044
of	O	O	O
integrin	O	O	B-T116
αvβ3	O	O	I-T116
expressed	O	O	B-T045
on	O	O	O
ECs	O	O	B-T025
to	O	O	O
the	O	O	O
RGD-peptide	O	O	B-T116
in	O	O	O
L1CAM	O	O	B-T116
expressed	O	O	O
on	O	O	O
CSCs	O	O	B-T025
.	O	O	O

It	O	O	O
promotes	O	O	O
both	O	O	O
EC	O	O	B-T025
network	O	O	B-T043
formation	O	O	I-T043
and	O	O	O
enhances	O	O	O
directed	O	O	O
migration	O	O	B-T043
toward	O	O	O
basic	O	O	O
fibroblast	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
.	O	O	O

Activation	O	O	B-T052
of	O	O	O
αvβ3	O	O	B-T116
and	O	O	O
bone	O	O	B-T116
marrow	O	O	I-T116
tyrosine	O	O	I-T116
kinase	O	O	I-T116
on	O	O	I-T116
chromosome	O	O	I-T116
X	O	O	I-T116
(	O	O	O
BMX	O	O	B-T116
)	O	O	O
is	O	O	O
required	O	O	O
for	O	O	O
migration	O	O	B-T043
stimulated	O	O	O
by	O	O	O
direct	O	O	O
binding	O	O	B-T044
but	O	O	O
not	O	O	O
for	O	O	O
migration	O	O	O
stimulated	O	O	O
by	O	O	O
soluble	O	O	O
factors	O	O	O
.	O	O	O

RGD-peptide	O	O	B-T116
treatment	O	O	B-T169
of	O	O	O
mice	O	O	B-T015
with	O	O	O
established	O	O	O
intracerebral	O	O	B-T082
GBM	O	O	B-T191
xenografts	O	O	B-T122
significantly	O	O	O
reduced	O	O	O
the	O	O	O
percentage	O	O	O
of	O	O	O
Sox2	O	O	B-T116
-positive	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
CSCs	O	O	B-T025
in	O	O	O
close	O	O	O
proximity	O	O	O
to	O	O	O
ECs	O	O	B-T025
,	O	O	O
decreased	O	O	O
integrin	O	O	B-T116
αvβ3	O	O	I-T116
and	O	O	O
BMX	O	O	B-T116
activation	O	O	O
and	O	O	O
p130CAS	O	O	B-T116
phosphorylation	O	O	B-T044
in	O	O	O
the	O	O	O
ECs	O	O	O
,	O	O	O
and	O	O	O
reduced	O	O	O
the	O	O	O
vessel	O	O	B-T023
surface	O	O	B-T082
area	O	O	I-T082
.	O	O	O

These	O	O	O
results	O	O	O
reveal	O	O	O
a	O	O	O
previously	O	O	O
unrecognized	O	O	O
aspect	O	O	O
of	O	O	O
the	O	O	O
regulation	O	O	B-T038
of	O	O	O
angiogenesis	O	O	B-T191
in	O	O	O
GBM	O	O	B-T191
that	O	O	O
can	O	O	O
impact	O	O	O
therapeutic	O	O	B-T169
anti-angiogenic	O	O	B-T121
targeting	O	O	O
.	O	O	O

-DOCSTART- (27270753)

The	O	O	O
use	O	O	O
of	O	O	O
Ocimum	O	O	B-T002
americanum	O	O	I-T002
essential	O	O	B-T109
oil	O	O	I-T109
against	O	O	O
the	O	O	O
pathogens	O	O	B-T001
Aeromonas	O	O	B-T007
hydrophila	O	O	I-T007
and	O	O	O
Gyrodactylus	O	O	B-T204
sp.	O	O	I-T204
in	O	O	O
silver	O	O	B-T013
catfish	O	O	I-T013
(	O	O	O
Rhamdia	O	O	B-T013
quelen	O	O	I-T013
)	O	O	O

The	O	O	O
bactericidal	O	O	B-T034
activity	O	O	I-T034
(	O	O	O
MIC-test	O	O	B-T059
)	O	O	O
of	O	O	O
Ocimum	O	O	B-T002
americanum	O	O	I-T002
(	O	O	O
inflorescences	O	O	B-T002
)	O	O	O
essential	O	O	B-T109
oil	O	O	I-T109
(	O	O	O
OAEO	O	O	B-T109
)	O	O	O
against	O	O	O
Aeromonas	O	O	B-T007
hydrophila	O	O	I-T007
was	O	O	O
determined	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
.	O	O	O

It	O	O	O
was	O	O	O
also	O	O	O
investigated	O	O	O
the	O	O	O
potential	O	O	O
of	O	O	O
OAEO	O	O	B-T109
and	O	O	O
the	O	O	O
main	O	O	O
compound	O	O	B-T080
found	O	O	O
in	O	O	O
the	O	O	O
oil	O	O	B-T109
(	O	O	O
linalool	O	O	B-T109
)	O	O	O
at	O	O	O
subinhibitory	O	O	O
concentrations	O	O	O
to	O	O	O
be	O	O	O
inhibitors	O	O	B-T120
of	O	O	O
hemolysis	O	O	B-T046
caused	O	O	O
by	O	O	O
Aer	O	O	O
.	O	O	O

hydrophila	O	O	O
in	O	O	O
fish	O	O	B-T013
erythrocytes	O	O	B-T025
.	O	O	O

An	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
experiment	O	O	I-T062
was	O	O	O
conducted	O	O	O
to	O	O	O
evaluate	O	O	O
survival	O	O	B-T052
of	O	O	O
fish	O	O	B-T013
(	O	O	O
Rhamdia	O	O	B-T013
quelen	O	O	I-T013
)	O	O	O
experimentally	O	O	B-T062
infected	O	O	B-T033
with	O	O	O
Aer	O	O	O
.	O	O	O

hydrophila	O	O	O
and	O	O	O
exposed	O	O	B-T080
to	O	O	O
OAEO	O	O	B-T109
.	O	O	O

A	O	O	O
second	O	O	O
experiment	O	O	B-T062
was	O	O	O
conducted	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
and	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
activity	O	O	O
of	O	O	O
OAEO	O	O	B-T109
(	O	O	O
mix	O	O	O
from	O	O	O
inflorescences	O	O	B-T002
and	O	O	O
leaves	O	O	B-T002
)	O	O	O
against	O	O	O
the	O	O	O
parasite	O	O	B-T204
Gyrodactylus	O	O	I-T204
sp.	O	O	I-T204
The	O	O	O
OAEO	O	O	O
showed	O	O	O
weak	O	O	B-T080
in	O	O	O
vitro	O	O	O
activity	O	O	O
against	O	O	O
Aer	O	O	O
.	O	O	O

hydrophila	O	O	O
(	O	O	O
6400	O	O	O
μg	O	O	O
ml(-1	O	O	O
)	O	O	O
)	O	O	O
.	O	O	O

At	O	O	O
subinhibitory	O	O	O
concentrations	O	O	O
OAEO	O	O	B-T109
(	O	O	O
100	O	O	O
μg	O	O	O
ml(-1	O	O	O
)	O	O	O
)	O	O	O
inhibited	O	O	B-T052
hemolysis	O	O	B-T046
(	O	O	O
90	O	O	O
%	O	O	O
)	O	O	O
caused	O	O	O
by	O	O	O
Aer	O	O	O
.	O	O	O

hydrophila	O	O	O
in	O	O	O
fish	O	O	B-T013
erythrocytes	O	O	B-T025
,	O	O	O
however	O	O	O
,	O	O	O
linalool	O	O	B-T109
did	O	O	O
not	O	O	B-T169
present	O	O	I-T169
hemolysis	O	O	B-T046
inhibition	O	O	B-T052
activity	O	O	I-T052
.	O	O	O

At	O	O	O
low	O	O	O
concentrations	O	O	O
(	O	O	O
10	O	O	O
and	O	O	O
20	O	O	O
mg	O	O	O
l(-1	O	O	O
)	O	O	O
)	O	O	O
added	O	O	O
to	O	O	O
the	O	O	O
water	O	O	B-T121
OAEO	O	O	B-T109
promoted	O	O	B-T052
survival	O	O	B-T052
of	O	O	O
experimentally	O	O	O
infected	O	O	B-T033
fish	O	O	B-T013
with	O	O	O
Aer	O	O	O
.	O	O	O

hydrophila	O	O	O
.	O	O	O

Lastly	O	O	O
,	O	O	O
OAEO	O	O	B-T109
-mix	O	O	O
(	O	O	O
50	O	O	O
mg	O	O	O
l(-1	O	O	O
)	O	O	O
)	O	O	O
was	O	O	O
effective	O	O	B-T080
against	O	O	O
Gyrodactylus	O	O	B-T204
sp.	O	O	I-T204
significantly	O	O	B-T081
reducing	O	O	I-T081
(	O	O	O
60	O	O	O
%	O	O	O
)	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
parasites	O	O	B-T204
in	O	O	O
the	O	O	O
fish	O	O	B-T013
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
protected	O	O	O
by	O	O	O
copyright	O	O	O
.	O	O	O

All	O	O	O
rights	O	O	O
reserved	O	O	O
.	O	O	O

-DOCSTART- (27271770)

Interleukin-1β	O	O	B-T116
induced	O	O	O
Stress	O	O	B-T026
Granules	O	O	I-T026
Sequester	O	O	B-T169
COX-2	O	O	B-T116
mRNA	O	O	B-T114
and	O	O	O
Regulates	O	O	B-T038
its	O	O	O
Stability	O	O	B-T080
and	O	O	O
Translation	O	O	B-UnknownType
in	O	O	O
Human	O	O	B-T016
OA	O	O	B-T047
Chondrocytes	O	O	O

Enhanced	O	O	B-T052
and	O	O	O
immediate	O	O	O
expression	O	O	B-T045
of	O	O	O
cyclooxygenase-2	O	O	B-T028
(	O	O	O
COX-2	O	O	B-T028
)	O	O	O
mRNA	O	O	B-T114
is	O	O	O
observed	O	O	O
in	O	O	O
IL-1β	O	O	B-T116
-	O	O	O
stimulated	O	O	B-T061
OA	O	O	B-T047
chondrocytes	O	O	B-T025
but	O	O	O
the	O	O	O
synthesis	O	O	B-T044
of	O	O	I-T044
protein	O	O	I-T044
found	O	O	O
significantly	O	O	O
delayed	O	O	B-T079
.	O	O	O

Here	O	O	O
we	O	O	O
investigated	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
stress	O	O	B-T026
granules	O	O	I-T026
(	O	O	O
SGs	O	O	B-T026
)	O	O	O
,	O	O	O
ribonucleoprotein	O	O	B-T026
complexes	O	O	I-T026
that	O	O	O
regulate	O	O	B-T038
mRNA	O	O	B-UnknownType
translation	O	O	B-UnknownType
,	O	O	O
in	O	O	O
the	O	O	O
delayed	O	O	B-T079
translation	O	O	O
of	O	O	O
COX-2	O	O	B-T028
mRNAs	O	O	B-T114
in	O	O	O
IL-1β	O	O	B-T116
-	O	O	O
stimulated	O	O	B-T061
OA	O	O	B-T047
chondrocytes	O	O	B-T025
.	O	O	O

Stimulation	O	O	B-T061
of	O	O	O
human	O	O	B-T016
chondrocytes	O	O	B-T025
with	O	O	O
IL-1β	O	O	B-T116
activated	O	O	O
the	O	O	O
stress	O	O	B-T039
response	O	O	I-T039
genes	O	O	B-T028
and	O	O	O
the	O	O	O
phosphorylation	O	O	B-T044
of	O	O	O
eIF2α	O	O	B-T116
that	O	O	O
triggered	O	O	B-T080
the	O	O	O
assembly	O	O	B-T045
of	O	O	I-T045
SGs	O	O	I-T045
.	O	O	O

Using	O	O	O
combined	O	O	O
immunofluorescence	O	O	B-T059
staining	O	O	I-T059
of	O	O	O
SGs	O	O	B-T026
markers	O	O	B-T201
and	O	O	O
COX-2	O	O	B-T028
protein	O	O	I-T116
,	O	O	O
RNA	O	O	B-T114
fluorescence	O	O	B-T063
in	O	O	I-T063
situ	O	O	I-T063
hybridization	O	O	I-T063
and	O	O	O
RNA	O	O	O
immunoprecipitation	O	O	B-T059
,	O	O	O
the	O	O	O
COX-2	O	O	O
mRNAs	O	O	B-T114
were	O	O	O
found	O	O	O
sequestered	O	O	B-T169
in	O	O	O
SGs	O	O	O
in	O	O	O
IL-1β	O	O	B-T116
-	O	O	O
stimulated	O	O	B-T061
OA	O	O	B-T047
chondrocytes	O	O	B-T025
.	O	O	O

No	O	O	B-T033
increase	O	O	B-T169
in	O	O	O
COX-2	O	O	B-T116
protein	O	O	B-T045
expression	O	O	B-T045
was	O	O	O
observed	O	O	O
during	O	O	O
the	O	O	O
persistence	O	O	B-T079
of	O	O	O
SGs	O	O	B-T026
but	O	O	O
enhanced	O	O	B-T052
expression	O	O	O
of	O	O	O
COX-2	O	O	B-T116
protein	O	O	I-T116
was	O	O	O
noted	O	O	O
upon	O	O	O
clearance	O	O	B-T080
of	O	O	O
the	O	O	O
SGs	O	O	O
.	O	O	O

Inhibition	O	O	B-T052
of	O	O	O
SGs	O	O	B-T026
clearance	O	O	B-T080
blocked	O	O	B-T169
COX-2	O	O	B-T028
mRNA	O	O	B-T114
translation	O	O	B-UnknownType
whereas	O	O	O
blocking	O	O	B-T169
the	O	O	O
assembly	O	O	B-T045
of	O	O	I-T045
SGs	O	O	I-T045
by	O	O	O
TIA-1	O	O	B-T116
depletion	O	O	B-T169
resulted	O	O	O
in	O	O	O
rapid	O	O	O
and	O	O	O
increased	O	O	B-T081
production	O	O	B-T169
of	O	O	O
COX-2	O	O	O
and	O	O	O
PGE2	O	O	B-T125
.	O	O	O

Our	O	O	O
findings	O	O	O
show	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
assembly	O	O	B-T045
of	O	O	I-T045
SGs	O	O	I-T045
and	O	O	O
sequestration	O	O	B-T169
of	O	O	O
COX-2	O	O	B-T028
mRNAs	O	O	B-T114
in	O	O	O
human	O	O	B-T016
OA	O	O	B-T047
chondrocytes	O	O	B-T025
under	O	O	O
pathological	O	O	B-T184
conditions	O	O	I-T184
.	O	O	O

Post-transcriptional	O	O	B-T045
regulation	O	O	I-T045
of	O	O	O
COX-2	O	O	B-T028
mRNAs	O	O	B-UnknownType
translation	O	O	I-UnknownType
by	O	O	O
SGs	O	O	B-T026
indicates	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
IL-1β	O	O	B-T116
-mediated	O	O	O
catabolic	O	O	B-T169
response	O	O	B-T032
that	O	O	O
could	O	O	O
be	O	O	O
therapeutically	O	O	B-T061
targeted	O	O	O
in	O	O	O
OA	O	O	B-T047
.	O	O	O

-DOCSTART- (27271969)

Spatio-Temporal	O	O	B-T169
Distribution	O	O	I-T169
of	O	O	O
Bark	O	O	B-T002
and	O	O	O
Ambrosia	O	O	B-T002
Beetles	O	O	B-T204
in	O	O	O
a	O	O	O
Brazilian	O	O	B-T083
Tropical	O	O	O
Dry	O	O	O
Forest	O	O	O

Bark	O	O	B-T002
and	O	O	O
the	O	O	O
ambrosia	O	O	B-T002
beetles	O	O	B-T204
dig	O	O	O
into	O	O	O
host	O	O	B-UnknownType
plants	O	O	I-UnknownType
and	O	O	O
live	O	O	O
most	O	O	O
of	O	O	O
their	O	O	O
lives	O	O	O
in	O	O	O
concealed	O	O	O
tunnels	O	O	B-T082
.	O	O	O

We	O	O	O
assessed	O	O	B-T052
beetle	O	O	B-T204
community	O	O	B-T096
dynamics	O	O	B-T102
in	O	O	O
tropical	O	O	B-T070
dry	O	O	I-T070
forest	O	O	I-T070
sites	O	O	B-T082
in	O	O	O
early	O	O	B-T079
,	O	O	O
intermediate	O	O	B-T079
,	O	O	O
and	O	O	O
late	O	O	B-T079
successional	O	O	B-T079
stages	O	O	I-T079
,	O	O	O
evaluating	O	O	O
the	O	O	O
influence	O	O	O
of	O	O	O
resource	O	O	B-T078
availability	O	O	B-T169
and	O	O	O
seasonal	O	O	B-T079
variations	O	O	I-T079
in	O	O	O
guild	O	O	B-T080
structure	O	O	I-T080
.	O	O	O

We	O	O	O
collected	O	O	B-T078
a	O	O	O
total	O	O	O
of	O	O	O
763	O	O	O
beetles	O	O	B-T204
from	O	O	O
23	O	O	O
species	O	O	B-T185
,	O	O	O
including	O	O	O
14	O	O	O
bark	O	O	B-T002
beetle	O	O	B-T204
species	O	O	O
,	O	O	O
and	O	O	O
9	O	O	O
ambrosia	O	O	B-T002
beetle	O	O	O
species	O	O	O
.	O	O	O

Local	O	O	B-T082
richness	O	O	B-T080
of	O	O	O
bark	O	O	B-T002
and	O	O	O
ambrosia	O	O	B-T002
beetles	O	O	B-T204
was	O	O	O
estimated	O	O	O
at	O	O	O
31	O	O	O
species	O	O	B-T185
.	O	O	O

Bark	O	O	B-T002
and	O	O	O
ambrosia	O	O	B-T002
composition	O	O	B-T078
was	O	O	O
similar	O	O	O
over	O	O	O
the	O	O	O
successional	O	O	B-T079
stages	O	O	I-T079
gradient	O	O	B-T081
,	O	O	O
and	O	O	O
beta	O	O	B-T080
diversity	O	O	I-T080
among	O	O	O
sites	O	O	B-T082
was	O	O	O
primarily	O	O	O
determined	O	O	O
by	O	O	O
species	O	O	B-T185
turnover	O	O	O
,	O	O	O
mainly	O	O	O
in	O	O	O
the	O	O	O
bark	O	O	B-T002
beetle	O	O	B-T204
community	O	O	B-T096
.	O	O	O

Bark	O	O	B-T002
beetle	O	O	B-T204
richness	O	O	B-T080
and	O	O	O
abundance	O	O	B-T080
were	O	O	O
higher	O	O	O
at	O	O	O
intermediate	O	O	B-T079
stages	O	O	I-T079
;	O	O	O
availability	O	O	B-T169
of	O	O	I-T169
wood	O	O	B-T167
was	O	O	O
the	O	O	O
main	O	O	O
spatial	O	O	B-T169
mechanism	O	O	I-T169
.	O	O	O

Climate	O	O	B-T070
factors	O	O	B-T169
were	O	O	O
effectively	O	O	O
non-seasonal	O	O	B-T080
.	O	O	O

Ambrosia	O	O	B-T002
beetles	O	O	B-T204
were	O	O	O
not	O	O	O
influenced	O	O	O
by	O	O	O
successional	O	O	B-T079
stages	O	O	I-T079
,	O	O	O
however	O	O	O
the	O	O	O
increase	O	O	B-T169
in	O	O	O
wood	O	O	B-T167
resulted	O	O	O
in	O	O	O
increased	O	O	B-T081
abundance	O	O	B-T080
.	O	O	O

We	O	O	O
found	O	O	O
higher	O	O	O
richness	O	O	B-T080
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
dry	O	O	B-T079
and	O	O	O
wet	O	O	B-T079
seasons	O	O	I-T079
,	O	O	O
and	O	O	O
abundance	O	O	B-T080
increased	O	O	B-T081
with	O	O	O
air	O	O	B-T167
moisture	O	O	B-T167
and	O	O	O
decreased	O	O	O
with	O	O	O
higher	O	O	O
temperatures	O	O	B-T081
and	O	O	O
greater	O	O	O
rainfall	O	O	B-T070
.	O	O	O

In	O	O	O
summary	O	O	O
,	O	O	O
bark	O	O	B-T002
beetle	O	O	B-T204
species	O	O	B-T185
accumulation	O	O	B-T169
was	O	O	O
higher	O	O	O
at	O	O	O
sites	O	O	B-T082
with	O	O	O
better	O	O	O
wood	O	O	B-T167
production	O	O	B-T052
,	O	O	O
while	O	O	O
the	O	O	O
needs	O	O	O
of	O	O	O
fungi	O	O	B-T004
(	O	O	O
host	O	O	B-UnknownType
and	O	O	O
air	O	O	B-T167
moisture	O	O	B-T167
)	O	O	O
,	O	O	O
resulted	O	O	O
in	O	O	O
a	O	O	O
favorable	O	O	O
conditions	O	O	B-T080
for	O	O	O
species	O	O	O
accumulation	O	O	O
of	O	O	O
ambrosia	O	O	B-T002
.	O	O	O

The	O	O	O
overall	O	O	O
biological	O	O	B-T080
pattern	O	O	B-T080
among	O	O	O
guilds	O	O	O
differed	O	O	O
from	O	O	O
tropical	O	O	B-T070
rain	O	O	I-T070
forests	O	O	I-T070
,	O	O	O
showing	O	O	O
patterns	O	O	O
similar	O	O	O
to	O	O	O
dry	O	O	B-T070
forest	O	O	I-T070
areas	O	O	I-T070
.	O	O	O

-DOCSTART- (27272784)

Detection	O	O	B-T061
and	O	O	O
Characterization	O	O	O
of	O	O	O
Flat	O	O	B-T047
Aberrant	O	O	I-T047
Crypt	O	O	I-T047
Foci	O	O	I-T047
(	O	O	I-T047
Flat	O	O	I-T047
ACF	O	O	I-T047
)	O	O	I-T047
in	O	O	O
the	O	O	O
Novel	O	O	O
A/J	O	O	O
Min/+	O	O	O
Mouse	O	O	O

Flat	O	O	B-T047
aberrant	O	O	I-T047
crypt	O	O	I-T047
foci	O	O	I-T047
(	O	O	O
flat	O	O	B-T047
ACF	O	O	I-T047
)	O	O	O
and	O	O	O
mucin-depleted	O	O	B-T047
foci	O	O	I-T047
(	O	O	O
MDF	O	O	B-T047
)	O	O	O
have	O	O	O
previously	O	O	O
been	O	O	O
described	O	O	O
as	O	O	O
preneoplastic	O	O	B-T047
colonic	O	O	I-T047
lesions	O	O	I-T047
.	O	O	O

We	O	O	O
used	O	O	O
the	O	O	O
novel	O	O	O
A/J	O	O	B-T050
Min/+	O	O	I-T050
mouse	O	O	I-T050
model	O	O	I-T050
,	O	O	O
that	O	O	O
demonstrates	O	O	O
extensive	O	O	O
spontaneous	O	O	O
colon	O	O	B-T191
carcinogenesis	O	O	I-T191
to	O	O	O
refine	O	O	O
the	O	O	O
method	O	O	O
of	O	O	O
detection	O	O	B-T061
of	O	O	O
flat	O	O	B-T047
ACF	O	O	I-T047
and	O	O	O
further	O	O	O
characterize	O	O	O
and	O	O	O
define	O	O	O
them	O	O	O
as	O	O	O
early	O	O	O
lesions	O	O	B-T033
by	O	O	O
histological	O	O	B-T059
examination	O	O	I-T059
and	O	O	O
comparison	O	O	O
with	O	O	O
MDF	O	O	B-T047
.	O	O	O

Colons	O	O	B-T023
were	O	O	O
stained	O	O	B-T059
with	O	O	I-T059
methylene	O	O	I-T059
blue	O	O	I-T059
(	O	O	O
MB	O	O	B-T109
)	O	O	O
for	O	O	O
flat	O	O	B-T047
ACF	O	O	I-T047
detection	O	O	B-T061
and	O	O	O
restained	O	O	B-T059
with	O	O	O
high-iron	O	O	B-T109
diamine-alcian	O	O	I-T109
blue	O	O	I-T109
(	O	O	O
HID-AB	O	O	B-T109
)	O	O	O
for	O	O	O
MDF	O	O	B-T047
detection	O	O	O
.	O	O	O

Optimal	O	O	O
flat	O	O	B-T047
ACF	O	O	I-T047
recognition	O	O	O
required	O	O	O
at	O	O	O
least	O	O	O
24	O	O	O
h	O	O	O
of	O	O	O
storage	O	O	O
post-	O	O	O
MB	O	O	B-T059
staining	O	O	I-T059
and	O	O	O
adherence	O	O	O
to	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
characteristics	O	O	O
.	O	O	O

The	O	O	O
fraction	O	O	B-T081
of	O	O	I-T081
flat	O	O	B-T047
ACF	O	O	I-T047
corresponding	O	O	O
with	O	O	O
MDF	O	O	B-T047
was	O	O	O
93	O	O	O
%	O	O	O
.	O	O	O

Flat	O	O	B-T047
ACF	O	O	I-T047
/	O	O	O
MDF	O	O	B-T047
displayed	O	O	O
the	O	O	O
same	O	O	O
picture	O	O	O
of	O	O	O
severe	O	O	B-T049
dysplasia	O	O	I-T049
,	O	O	O
lack	O	O	B-T080
of	O	O	I-T080
mucus	O	O	B-T025
and	O	O	O
goblet	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
accumulation	O	O	B-T033
of	O	O	O
cytoplasmic	O	O	B-T026
β-catenin	O	O	B-T116
.	O	O	O

The	O	O	O
easily	O	O	O
detectable	O	O	O
flat	O	O	B-T047
ACF	O	O	I-T047
are	O	O	O
reliable	O	O	O
surface	O	O	B-T026
biomarkers	O	O	B-T201
of	O	O	O
Apc	O	O	B-T028
-driven	O	O	O
colon	O	O	B-T191
carcinogenesis	O	O	I-T191
.	O	O	O

-DOCSTART- (27273160)

Transcriptional	O	O	B-T045
enhancement	O	O	I-T045
of	O	O	O
Smn	O	O	B-T028
levels	O	O	B-T034
in	O	O	O
motoneurons	O	O	B-T025
is	O	O	O
crucial	O	O	O
for	O	O	O
proper	O	O	O
axon	O	O	B-T026
morphology	O	O	B-T080
in	O	O	O
zebrafish	O	O	O

An	O	O	O
unresolved	O	O	O
mystery	O	O	O
in	O	O	O
the	O	O	O
field	O	O	O
of	O	O	O
spinal	O	O	B-T047
muscular	O	O	I-T047
atrophy	O	O	I-T047
(	O	O	O
SMA	O	O	B-T047
)	O	O	O
is	O	O	O
why	O	O	O
a	O	O	O
reduction	O	O	O
of	O	O	O
the	O	O	O
ubiquitously	O	O	O
expressed	O	O	O
Smn	O	O	B-T116
protein	O	O	I-T116
causes	O	O	O
defects	O	O	B-T033
mostly	O	O	O
in	O	O	O
motoneurons	O	O	B-T025
.	O	O	O

We	O	O	O
addressed	O	O	O
the	O	O	O
possibility	O	O	O
that	O	O	O
this	O	O	O
restricted	O	O	O
vulnerability	O	O	O
stems	O	O	O
from	O	O	O
elevated	O	O	O
Smn	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
motoneurons	O	O	B-T025
.	O	O	O

To	O	O	O
explore	O	O	O
this	O	O	O
,	O	O	O
we	O	O	O
established	O	O	O
an	O	O	O
ex	O	O	B-T074
vivo	O	O	I-T074
zebrafish	O	O	B-T013
culture	O	O	I-T074
system	O	O	I-T074
of	O	O	O
GFP	O	O	B-T116
-	O	O	O
marked	O	O	B-T080
motoneurons	O	O	B-T025
to	O	O	O
quantitatively	O	O	O
measure	O	O	O
Smn	O	O	B-T034
protein	O	O	I-T034
and	O	O	O
smn	O	O	B-T114
mRNA	O	O	I-T114
levels	O	O	B-T081
as	O	O	O
well	O	O	O
as	O	O	O
promoter	O	O	O
activity	O	O	O
in	O	O	O
motoneurons	O	O	O
versus	O	O	O
other	O	O	O
cell	O	O	B-T025
types	O	O	O
.	O	O	O

Importantly	O	O	O
,	O	O	O
we	O	O	O
uncovered	O	O	O
that	O	O	O
Smn	O	O	B-T034
levels	O	O	I-T034
are	O	O	O
elevated	O	O	O
in	O	O	O
motoneurons	O	O	B-T025
by	O	O	O
means	O	O	O
of	O	O	O
transcriptional	O	O	B-T045
activation	O	O	I-T045
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
identified	O	O	O
the	O	O	O
ETS	O	O	B-T116
family	O	O	I-T116
transcription	O	O	I-T116
factor	O	O	I-T116
Etv5b	O	O	I-T116
to	O	O	O
be	O	O	O
responsible	O	O	O
for	O	O	O
increased	O	O	O
smn	O	O	B-T045
transcription	O	O	I-T045
in	O	O	O
motoneurons	O	O	B-T025
.	O	O	O

Moreover	O	O	O
,	O	O	O
we	O	O	O
established	O	O	O
that	O	O	O
the	O	O	O
additional	O	O	O
supply	O	O	O
of	O	O	O
Smn	O	O	B-T116
protein	O	O	I-T116
in	O	O	O
motoneurons	O	O	B-T025
is	O	O	O
necessary	O	O	O
for	O	O	O
proper	O	O	O
axonogenesis	O	O	B-T042
in	O	O	O
a	O	O	O
cell-autonomous	O	O	B-T043
manner	O	O	I-T043
.	O	O	O

These	O	O	O
findings	O	O	B-T034
demonstrate	O	O	O
the	O	O	O
reliance	O	O	O
of	O	O	O
motoneurons	O	O	B-T025
on	O	O	O
more	O	O	O
Smn	O	O	B-T116
,	O	O	O
thereby	O	O	O
adding	O	O	O
a	O	O	O
novel	O	O	O
piece	O	O	O
of	O	O	O
evidence	O	O	B-T078
for	O	O	O
their	O	O	O
increased	O	O	B-T081
vulnerability	O	O	B-T201
under	O	O	O
SMA	O	O	B-T047
conditions	O	O	I-T047
.	O	O	O

-DOCSTART- (27274281)

Evaluation	O	O	B-T058
of	O	O	O
response	O	O	O
from	O	O	O
axitinib	O	O	B-T109
per	O	O	O
Response	O	O	B-T170
Evaluation	O	O	I-T170
Criteria	O	O	I-T170
in	O	O	I-T170
Solid	O	O	I-T170
Tumors	O	O	I-T170
versus	O	O	O
Choi	O	O	B-T170
criteria	O	O	I-T170
in	O	O	O
previously	O	O	O
treated	O	O	B-T033
patients	O	O	B-T101
with	O	O	O
metastatic	O	O	O
renal	O	O	O
cell	O	O	O
carcinoma	O	O	O

Axitinib	O	O	B-T109
,	O	O	O
a	O	O	O
selective	O	O	O
and	O	O	O
potent	O	O	O
tyrosine	O	O	B-T121
kinase	O	O	I-T121
inhibitor	O	O	I-T121
of	O	O	O
vascular	O	O	B-T116
endothelial	O	O	I-T116
growth	O	O	I-T116
factor	O	O	I-T116
receptors	O	O	I-T116
,	O	O	O
was	O	O	O
available	O	O	O
to	O	O	O
patients	O	O	B-T101
from	O	O	O
Canada	O	O	B-T083
and	O	O	O
Australia	O	O	B-T083
,	O	O	O
prior	O	O	O
to	O	O	O
regulatory	O	O	O
approval	O	O	B-T170
of	O	O	O
axitinib	O	O	B-T109
in	O	O	O
these	O	O	O
countries	O	O	B-T083
,	O	O	O
for	O	O	O
treatment	O	O	B-T061
of	O	O	O
clear-cell	O	O	B-T191
metastatic	O	O	I-T191
renal	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
mRCC	O	O	B-T191
)	O	O	O
after	O	O	O
failure	O	O	O
of	O	O	O
one	O	O	O
prior	O	O	O
systemic	O	O	O
regimen	O	O	B-T061
.	O	O	O

This	O	O	O
single-arm	O	O	B-T062
,	O	O	O
open-label	O	O	B-T062
study	O	O	I-T062
of	O	O	O
axitinib	O	O	B-T109
evaluated	O	O	O
the	O	O	O
efficacy	O	O	B-T062
,	O	O	O
safety	O	O	B-T062
,	O	O	O
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
(	O	O	O
QoL	O	O	B-T078
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
mRCC	O	O	B-T191
whose	O	O	O
disease	O	O	B-T047
progressed	O	O	B-T046
after	O	O	O
one	O	O	O
prior	O	O	O
systemic	O	O	O
first-line	O	O	B-T061
regimen	O	O	I-T061
.	O	O	O

Primary	O	O	O
objective	O	O	O
was	O	O	O
objective	O	O	O
response	O	O	B-T079
rate	O	O	I-T079
evaluated	O	O	B-T058
per	O	O	O
Response	O	O	B-T170
Evaluation	O	O	I-T170
Criteria	O	O	I-T170
in	O	O	I-T170
Solid	O	O	I-T170
Tumors	O	O	I-T170
(	O	O	O
RECIST	O	O	B-T170
)	O	O	O
and	O	O	O
Choi	O	O	B-T170
criteria	O	O	I-T170
.	O	O	O

Progression-free	O	O	B-T081
survival	O	O	I-T081
,	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
,	O	O	O
safety	O	O	B-T062
,	O	O	O
and	O	O	O
QoL	O	O	B-T078
were	O	O	O
secondary	O	O	O
end	O	O	O
points	O	O	O
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
small	O	O	O
study	O	O	B-T062
size	O	O	O
,	O	O	O
analyses	O	O	O
comprised	O	O	O
of	O	O	O
descriptive	O	O	O
statistics	O	O	B-T062
.	O	O	O

Fifteen	O	O	O
patients	O	O	B-T101
were	O	O	O
recruited	O	O	O
,	O	O	O
five	O	O	O
from	O	O	O
Canada	O	O	B-T083
and	O	O	O
ten	O	O	O
from	O	O	O
Australia	O	O	B-T083
,	O	O	O
over	O	O	O
a	O	O	O
limited	O	O	O
recruitment	O	O	O
period	O	O	O
.	O	O	O

Thirteen	O	O	O
patients	O	O	B-T101
received	O	O	O
sunitinib	O	O	B-T109
as	O	O	O
prior	O	O	O
therapy	O	O	B-T061
.	O	O	O

All	O	O	O
patients	O	O	B-T101
had	O	O	O
clear-cell	O	O	B-T191
carcinoma	O	O	I-T191
,	O	O	O
eleven	O	O	O
had	O	O	O
prior	O	O	O
nephrectomy	O	O	B-T061
.	O	O	O

Liver	O	O	B-T023
,	O	O	O
lung	O	O	B-T023
,	O	O	O
and	O	O	O
lymph	O	O	B-T023
nodes	O	O	I-T023
were	O	O	O
the	O	O	O
most	O	O	O
frequent	O	O	O
sites	O	O	O
of	O	O	O
metastases	O	O	B-T191
;	O	O	O
one	O	O	O
patient	O	O	B-T101
had	O	O	O
brain	O	O	B-T191
metastasis	O	O	I-T191
.	O	O	O

Median	O	O	B-T081
time	O	O	O
on	O	O	O
axitinib	O	O	B-T109
was	O	O	O
118.0	O	O	O
days	O	O	B-T079
(	O	O	O
range	O	O	B-T081
:	O	O	O
3.5	O	O	O
-	O	O	O
645.0	O	O	O
days	O	O	O
)	O	O	O
;	O	O	O
estimated	O	O	O
survival	O	O	B-T052
probability	O	O	O
at	O	O	O
12	O	O	O
months	O	O	B-T079
was	O	O	O
57.8	O	O	O
%	O	O	O
.	O	O	O

Two	O	O	O
(	O	O	O
13.3	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
had	O	O	O
objective	O	O	O
responses	O	O	B-T032
per	O	O	O
RECIST	O	O	B-T170
versus	O	O	O
nine	O	O	O
(	O	O	O
60.0	O	O	O
%	O	O	O
)	O	O	O
per	O	O	O
Choi	O	O	B-T170
criteria	O	O	I-T170
.	O	O	O

Six	O	O	O
patients	O	O	B-T101
had	O	O	O
progressive	O	O	B-T046
disease	O	O	B-T047
based	O	O	O
on	O	O	O
RECIST	O	O	B-T170
versus	O	O	O
three	O	O	O
per	O	O	O
Choi	O	O	B-T170
criteria	O	O	I-T170
.	O	O	O

Nine	O	O	O
(	O	O	O
60.0	O	O	O
%	O	O	O
)	O	O	O
events	O	O	O
of	O	O	O
progression	O	O	B-T046
or	O	O	O
death	O	O	B-T040
occurred	O	O	O
by	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
study	O	O	B-T062
,	O	O	O
and	O	O	O
three	O	O	O
patients	O	O	B-T101
continued	O	O	O
to	O	O	O
receive	O	O	O
the	O	O	O
study	O	O	O
drug	O	O	B-T121
.	O	O	O

Fatigue	O	O	B-T184
(	O	O	O
33	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
diarrhea	O	O	B-T184
(	O	O	O
20	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
grade	O	O	O
≥3	O	O	O
all-causality	O	O	O
,	O	O	O
treatment	O	O	B-T061
-emergent	O	O	O
adverse	O	O	B-T046
events	O	O	I-T046
.	O	O	O

The	O	O	O
mean	O	O	B-T081
change	O	O	O
in	O	O	O
European	O	O	B-T083
Quality	O	O	B-T078
of	O	O	I-T078
Life	O	O	I-T078
-	O	O	O
5	O	O	O
Dimensions	O	O	O
score	O	O	B-T081
from	O	O	O
baseline	O	O	B-T081
to	O	O	O
end	O	O	O
of	O	O	O
treatment	O	O	B-T061
was	O	O	O
-0.0837	O	O	O
.	O	O	O

The	O	O	O
small	O	O	O
number	O	O	O
of	O	O	O
patients	O	O	B-T101
and	O	O	O
lack	O	O	O
of	O	O	O
a	O	O	O
comparator	O	O	O
arm	O	O	O
limit	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
draw	O	O	O
definitive	O	O	B-T079
conclusions	O	O	B-T078
;	O	O	O
however	O	O	O
,	O	O	O
safety	O	O	B-T062
and	O	O	O
efficacy	O	O	B-T062
profiles	O	O	O
of	O	O	O
axitinib	O	O	B-T109
were	O	O	O
consistent	O	O	O
with	O	O	O
reports	O	O	O
from	O	O	O
previous	O	O	O
studies	O	O	B-T062
in	O	O	O
patients	O	O	O
with	O	O	O
mRCC	O	O	B-T191
,	O	O	O
and	O	O	O
patients	O	O	O
generally	O	O	O
maintained	O	O	O
QoL.	O	O	O
The	O	O	O
sizeable	O	O	O
difference	O	O	O
observed	O	O	O
in	O	O	O
objective	O	O	O
response	O	O	B-T079
rate	O	O	I-T079
by	O	O	O
RECIST	O	O	B-T170
versus	O	O	O
Choi	O	O	B-T170
criteria	O	O	I-T170
merits	O	O	O
further	O	O	O
research	O	O	B-T062
.	O	O	O

-DOCSTART- (27274541)

Biochemical	O	O	B-T169
characteristics	O	O	B-T080
of	O	O	O
AtFAR2	O	O	B-T116
,	O	O	O
a	O	O	O
fatty	O	O	B-T116
acid	O	O	I-T116
reductase	O	O	I-T116
from	O	O	O
Arabidopsis	O	O	B-T002
thaliana	O	O	I-T002
that	O	O	O
reduces	O	O	O
fatty	O	O	B-T114
acyl-CoA	O	O	I-T114
and	O	O	O
-	O	O	O
ACP	O	O	B-T116
substrates	O	O	I-T116
into	O	O	O
fatty	O	O	O
alcohols	O	O	O

Fatty	O	O	B-T109
alcohols	O	O	I-T109
and	O	O	O
derivatives	O	O	B-T104
are	O	O	O
important	O	O	B-T080
for	O	O	O
proper	O	O	O
deposition	O	O	B-T169
of	O	O	O
a	O	O	O
functional	O	O	B-T169
pollen	O	O	B-T026
wall	O	O	I-T026
.	O	O	O

Mutations	O	O	B-T045
in	O	O	O
specific	O	O	O
genes	O	O	B-T028
encoding	O	O	O
fatty	O	O	B-T116
acid	O	O	I-T116
reductases	O	O	I-T116
(	O	O	O
FAR	O	O	B-T116
)	O	O	O
responsible	O	O	O
for	O	O	O
fatty	O	O	B-T109
alcohol	O	O	I-T109
production	O	O	B-T169
cause	O	O	O
abnormal	O	O	B-T033
development	O	O	B-T169
of	O	O	O
pollen	O	O	B-T002
.	O	O	O

A	O	O	O
disrupted	O	O	B-T080
AtFAR2	O	O	B-T028
(	O	O	I-T028
MS2	O	O	I-T028
)	O	O	I-T028
gene	O	O	I-T028
in	O	O	O
Arabidopsis	O	O	B-T002
thaliana	O	O	I-T002
results	O	O	B-T169
in	O	O	O
pollen	O	O	B-T002
developing	O	O	B-T169
an	O	O	O
abnormal	O	O	B-T033
exine	O	O	B-T026
layer	O	O	I-T026
and	O	O	O
a	O	O	O
reduced	O	O	B-T033
fertility	O	O	I-T033
phenotype	O	O	B-T032
.	O	O	O

AtFAR2	O	O	B-T116
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
targeted	O	O	B-T169
to	O	O	O
chloroplasts	O	O	B-T026
and	O	O	O
in	O	O	O
a	O	O	O
purified	O	O	B-T080
form	O	O	I-T080
to	O	O	O
be	O	O	O
specific	O	O	B-T080
for	O	O	O
acyl-ACP	O	O	B-T116
substrates	O	O	I-T116
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
data	O	O	B-T078
on	O	O	O
the	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	O
planta	O	O	B-T002
characterizations	O	O	B-T052
of	O	O	O
AtFAR2	O	O	B-T116
from	O	O	O
A.	O	O	B-T002
thaliana	O	O	I-T002
and	O	O	O
show	O	O	O
that	O	O	O
this	O	O	O
enzyme	O	O	B-T116
has	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
use	O	O	O
both	O	O	O
,	O	O	O
C16:0-ACP	O	O	B-T116
and	O	O	O
C16:0-CoA	O	O	B-T114
,	O	O	O
as	O	O	O
substrates	O	O	B-T120
to	O	O	O
produce	O	O	O
C16:0-alcohol	O	O	B-T109
.	O	O	O

Our	O	O	O
results	O	O	O
further	O	O	O
show	O	O	O
that	O	O	O
AtFAR2	O	O	B-T116
is	O	O	O
highly	O	O	O
similar	O	O	O
in	O	O	O
properties	O	O	B-T080
and	O	O	O
substrate	O	O	B-T120
specificity	O	O	B-T081
to	O	O	O
AtFAR6	O	O	B-T116
for	O	O	O
which	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
data	O	O	B-T078
has	O	O	O
been	O	O	O
published	O	O	O
,	O	O	O
and	O	O	O
which	O	O	O
is	O	O	O
also	O	O	O
a	O	O	O
chloroplast	O	O	B-T026
localized	O	O	B-T082
enzyme	O	O	B-T116
.	O	O	O

This	O	O	O
suggests	O	O	O
that	O	O	O
although	O	O	O
AtFAR2	O	O	B-T116
is	O	O	O
the	O	O	O
major	O	O	O
enzyme	O	O	B-T116
responsible	O	O	O
for	O	O	O
exine	O	O	B-T026
layer	O	O	I-T026
functionality	O	O	B-T169
,	O	O	O
AtFAR6	O	O	B-T116
might	O	O	O
provide	O	O	O
functional	O	O	B-T169
redundancy	O	O	B-T169
to	O	O	O
AtFAR2	O	O	O
.	O	O	O

-DOCSTART- (27274791)

Comparing	O	O	B-T052
Time	O	O	B-T041
Perception	O	O	I-T041
among	O	O	O
Morphine	O	O	B-T109
-	O	O	O
Derived	O	O	B-T080
Drugs	O	O	B-T121
Addicts	O	O	B-T101
and	O	O	O
Controls	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
compare	O	O	B-T052
time	O	O	B-T041
perception	O	O	I-T041
among	O	O	O
drug	O	O	B-T033
addicts	O	O	I-T033
and	O	O	O
controls	O	O	B-T096
.	O	O	O

30	O	O	O
drug	O	O	B-T033
addicts	O	O	I-T033
were	O	O	O
selected	O	O	B-T052
,	O	O	O
and	O	O	O
30	O	O	O
non-addict	O	O	B-T098
individuals	O	O	I-T098
were	O	O	O
selected	O	O	O
as	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

The	O	O	O
two	O	O	O
groups	O	O	B-T078
performed	O	O	O
three	O	O	O
tests	O	O	B-T170
of	O	O	O
time	O	O	B-T079
reproduction	O	O	B-T040
,	O	O	O
time	O	O	B-T079
estimation	O	O	I-T079
,	O	O	O
and	O	O	O
time	O	O	O
discrimination	O	O	B-T041
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	B-T078
difference	O	O	B-T080
between	O	O	O
the	O	O	O
addicts	O	O	B-T101
group	O	O	B-T078
and	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
regarding	O	O	O
the	O	O	O
error	O	O	B-T080
of	O	O	O
time	O	O	B-T079
reproduction	O	O	B-T040
and	O	O	O
time	O	O	B-T079
estimation	O	O	I-T079
.	O	O	O

The	O	O	O
addict	O	O	B-T101
group	O	O	B-T078
in	O	O	O
comparison	O	O	B-T052
to	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
had	O	O	O
a	O	O	O
lower	O	O	B-T052
under-	O	O	O
reproduction	O	O	B-T040
and	O	O	O
a	O	O	O
higher	O	O	B-T080
over-	O	O	O
reproduction	O	O	O
error	O	O	B-T080
,	O	O	O
and	O	O	O
also	O	O	O
a	O	O	O
lower	O	O	O
under-	O	O	O
estimation	O	O	B-T041
and	O	O	O
higher	O	O	O
over-	O	O	O
estimation	O	O	O
error	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
regarding	O	O	O
time	O	O	B-T079
discrimination	O	O	B-T041
,	O	O	O
no	O	O	O
significant	O	O	B-T078
difference	O	O	B-T080
was	O	O	O
observed	O	O	O
between	O	O	O
the	O	O	O
errors	O	O	B-T080
committed	O	O	O
by	O	O	O
both	O	O	O
groups	O	O	B-T078
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
when	O	O	O
showing	O	O	O
images	O	O	B-T170
of	O	O	O
drug	O	O	B-UnknownType
consumption	O	O	I-UnknownType
tools	O	O	B-T073
and	O	O	O
normal	O	O	B-T080
images	O	O	O
with	O	O	O
same	O	O	O
durations	O	O	B-T079
,	O	O	O
the	O	O	O
normal	O	O	O
group	O	O	B-T078
believed	O	O	O
that	O	O	O
the	O	O	O
images	O	O	O
related	O	O	O
to	O	O	O
drug	O	O	O
consumption	O	O	O
tools	O	O	O
were	O	O	O
shown	O	O	O
for	O	O	O
a	O	O	O
shorter	O	O	B-T081
period	O	O	B-T079
of	O	O	O
time	O	O	B-T079
.	O	O	O

Time	O	O	B-T041
perception	O	O	I-T041
is	O	O	O
different	O	O	B-T080
between	O	O	O
morphine	O	O	B-T109
-	O	O	O
derived	O	O	B-T080
drugs	O	O	B-T121
addicts	O	O	B-T101
and	O	O	O
controls	O	O	B-T096
.	O	O	O

-DOCSTART- (27277750)

Co-delivery	O	O	B-T169
of	O	O	O
pemetrexed	O	O	B-T109
and	O	O	O
miR-21	O	O	B-T114
antisense	O	O	I-T114
oligonucleotide	O	O	I-T114
by	O	O	O
lipid	O	O	B-T109
-	O	O	O
polymer	O	O	B-T122
hybrid	O	O	B-T073
nanoparticles	O	O	I-T073
and	O	O	O
effects	O	O	B-T080
on	O	O	O
glioblastoma	O	O	B-T191
cells	O	O	O

Combination	O	O	B-T061
therapy	O	O	I-T061
using	O	O	O
anticancer	O	O	B-T109
drugs	O	O	I-T109
and	O	O	O
nucleic	O	O	B-T114
acid	O	O	I-T114
is	O	O	O
a	O	O	O
more	O	O	O
promising	O	O	O
strategy	O	O	O
to	O	O	O
overcome	O	O	O
multidrug	O	O	B-T032
resistance	O	O	I-T032
in	O	O	O
cancer	O	O	B-T191
and	O	O	O
to	O	O	O
enhance	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
lipid	O	O	B-T109
-	O	O	O
polymer	O	O	B-T122
hybrid	O	O	B-T073
nanoparticles	O	O	I-T073
(	O	O	O
LPNs	O	O	B-T122
)	O	O	O
,	O	O	O
which	O	O	O
contain	O	O	O
both	O	O	O
pemetrexed	O	O	B-T109
and	O	O	O
miR-21	O	O	B-T114
antisense	O	O	I-T114
oligonucleotide	O	O	I-T114
(	O	O	O
anti-miR-21	O	O	B-T114
)	O	O	O
,	O	O	O
have	O	O	O
been	O	O	O
developed	O	O	O
for	O	O	O
treatment	O	O	B-T169
of	O	O	O
glioblastoma	O	O	B-T191
,	O	O	O
the	O	O	O
most	O	O	O
aggressive	O	O	B-T191
type	O	O	O
of	O	O	O
brain	O	O	B-T191
tumor	O	O	I-T191
.	O	O	O

Prepared	O	O	O
LPNs	O	O	B-T122
have	O	O	O
been	O	O	O
well	O	O	O
characterized	O	O	O
by	O	O	O
particle	O	O	B-T081
size	O	O	I-T081
distribution	O	O	B-T169
and	O	O	O
zeta	O	O	B-T067
potential	O	O	I-T067
measurements	O	O	B-T169
,	O	O	O
determination	O	O	O
of	O	O	O
encapsulation	O	O	B-T067
efficiency	O	O	B-T081
,	O	O	O
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
release	O	O	B-T062
experiments	O	O	I-T062
.	O	O	O

Morphology	O	O	B-T080
of	O	O	O
LPNs	O	O	B-T122
was	O	O	O
determined	O	O	O
by	O	O	O
transmission	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
.	O	O	O

LPNs	O	O	B-T122
had	O	O	O
a	O	O	O
hydrodynamic	O	O	B-T070
size	O	O	B-T082
below	O	O	O
100	O	O	O
nm	O	O	O
and	O	O	O
exhibited	O	O	O
sustained	O	O	B-T169
release	O	O	I-T169
of	O	O	O
pemetrexed	O	O	B-T109
up	O	O	O
to	O	O	O
10	O	O	O
h.	O	O	O
Encapsulation	O	O	B-T067
of	O	O	O
pemetrexed	O	O	O
in	O	O	O
LPNs	O	O	O
increased	O	O	O
cellular	O	O	B-T043
uptake	O	O	I-T043
from	O	O	O
6	O	O	O
%	O	O	O
to	O	O	O
78	O	O	O
%	O	O	O
.	O	O	O

Results	O	O	O
of	O	O	O
confocal	O	O	B-T059
microscopy	O	O	I-T059
analysis	O	O	I-T059
have	O	O	O
shown	O	O	O
that	O	O	O
co-delivery	O	O	B-T169
of	O	O	O
anti-miR-21	O	O	B-T114
significantly	O	O	O
improved	O	O	O
accumulation	O	O	B-T033
of	O	O	O
LPNs	O	O	B-T122
in	O	O	O
the	O	O	O
nucleus	O	O	B-T026
of	O	O	O
U87MG	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
more	O	O	O
effective	O	O	O
cytotoxicity	O	O	B-T049
results	O	O	B-T169
could	O	O	O
not	O	O	O
be	O	O	O
obtained	O	O	O
due	O	O	O
to	O	O	O
low	O	O	O
concentration	O	O	B-UnknownType
of	O	O	O
anti-miR-21	O	O	B-T114
,	O	O	O
loaded	O	O	O
in	O	O	O
LPNs	O	O	B-T122
.	O	O	O

We	O	O	O
expect	O	O	O
that	O	O	O
the	O	O	O
effective	O	O	O
drug	O	O	B-T074
delivery	O	O	I-T074
systems	O	O	I-T074
can	O	O	O
be	O	O	O
obtained	O	O	O
with	O	O	O
higher	O	O	O
concentration	O	O	B-UnknownType
of	O	O	O
anti-miR-21	O	O	B-T114
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
glioblastoma	O	O	B-T191
.	O	O	O

-DOCSTART- (27278134)

Expert	O	O	B-T097
position	O	O	B-T170
paper	O	O	I-T170
on	O	O	O
prolonged	O	O	B-T079
dual	O	O	B-T061
antiplatelet	O	O	I-T061
therapy	O	O	I-T061
in	O	O	O
secondary	O	O	B-T061
prevention	O	O	I-T061
following	O	O	O
myocardial	O	O	O
infarction	O	O	O

The	O	O	O
protective	O	O	B-T080
effect	O	O	I-T080
of	O	O	O
dual	O	O	B-T061
antiplatelet	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
DAPT	O	O	B-T061
)	O	O	O
following	O	O	O
acute	O	O	B-T047
coronary	O	O	I-T047
syndrome	O	O	I-T047
is	O	O	O
undisputed	O	O	O
,	O	O	O
but	O	O	O
its	O	O	O
duration	O	O	B-T079
is	O	O	O
subject	O	O	O
of	O	O	O
debate	O	O	B-T052
.	O	O	O

Several	O	O	O
studies	O	O	B-T062
show	O	O	O
that	O	O	O
prolonged	O	O	B-T079
therapy	O	O	B-T061
provides	O	O	O
a	O	O	O
clinical	O	O	B-T080
benefit	O	O	B-T081
in	O	O	O
patients	O	O	B-T101
following	O	O	O
acute	O	O	B-T047
coronary	O	O	I-T047
syndrome	O	O	I-T047
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
position	O	O	B-T170
paper	O	O	I-T170
authored	O	O	O
by	O	O	O
Austrian	O	O	B-T098
experts	O	O	B-T097
is	O	O	O
to	O	O	O
outline	O	O	O
the	O	O	O
current	O	O	B-T079
evidence	O	O	B-T078
and	O	O	O
provide	O	O	O
an	O	O	O
overview	O	O	O
of	O	O	O
recent	O	O	O
studies	O	O	B-T062
.	O	O	O

It	O	O	O
is	O	O	O
also	O	O	O
intended	O	O	O
to	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
practical	O	O	B-T170
guide	O	O	I-T170
to	O	O	O
identify	O	O	O
those	O	O	O
patients	O	O	B-T101
who	O	O	O
may	O	O	O
benefit	O	O	B-T081
from	O	O	O
prolonged	O	O	B-T079
DAPT	O	O	B-T061
.	O	O	O

-DOCSTART- (27279861)

Medulloblastoma	O	O	B-T191
:	O	O	O
molecular	O	O	B-T044
pathways	O	O	I-T044
and	O	O	O
histopathological	O	O	B-T169
classification	O	O	O

Malignant	O	O	B-T191
brain	O	O	I-T191
tumors	O	O	I-T191
are	O	O	O
the	O	O	O
leading	O	O	B-T169
cause	O	O	B-T169
of	O	O	O
cancer	O	O	B-T191
death	O	O	B-T033
among	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
,	O	O	O
and	O	O	O
medulloblastoma	O	O	B-T191
constitutes	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
them	O	O	O
.	O	O	O

Currently	O	O	O
,	O	O	O
the	O	O	O
treatment	O	O	B-T061
is	O	O	O
risk-adapted	O	O	O
.	O	O	O

Maximum	O	O	O
surgical	O	O	B-T061
resection	O	O	I-T061
is	O	O	O
recommended	O	O	B-T078
,	O	O	O
always	O	O	O
followed	O	O	O
by	O	O	O
chemotherapy	O	O	B-T061
and	O	O	O
neuroaxis	O	O	B-T022
radiotherapy	O	O	B-T061
.	O	O	O

In	O	O	O
spite	O	O	O
of	O	O	O
the	O	O	O
improving	O	O	B-T080
survival	O	O	B-T081
rate	O	O	I-T081
,	O	O	O
survivors	O	O	B-T101
succumb	O	O	O
to	O	O	O
treatment	O	O	B-T061
-	O	O	O
induced	O	O	B-T169
side	O	O	B-T046
effects	O	O	I-T046
.	O	O	O

To	O	O	O
reduce	O	O	B-T080
toxic	O	O	B-T037
effects	O	O	I-T037
,	O	O	O
molecular-targeted	O	O	B-T061
treatment	O	O	I-T061
is	O	O	O
proposed	O	O	O
.	O	O	O

Medulloblastoma	O	O	B-T191
research	O	O	B-T062
is	O	O	O
very	O	O	O
robust	O	O	B-T080
,	O	O	O
and	O	O	O
new	O	O	O
articles	O	O	B-T170
on	O	O	O
the	O	O	O
subject	O	O	O
are	O	O	O
published	O	O	B-T057
daily	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	O
review	O	O	B-T170
we	O	O	O
have	O	O	O
tried	O	O	O
to	O	O	O
bring	O	O	O
together	O	O	O
molecular	O	O	B-T080
pathophysiology	O	O	B-T169
of	O	O	O
the	O	O	O
neoplasm	O	O	B-T191
and	O	O	O
current	O	O	O
pathological	O	O	B-T169
classification	O	O	B-T185
,	O	O	O
thus	O	O	O
making	O	O	O
an	O	O	O
effort	O	O	O
to	O	O	O
relate	O	O	O
tumor	O	O	B-T062
biology	O	O	I-T062
and	O	O	O
the	O	O	O
histological	O	O	B-T201
picture	O	O	I-T201
.	O	O	O

-DOCSTART- (27280293)

Spatio-Temporal	O	O	B-T062
History	O	O	I-T062
of	O	O	O
HIV-1	O	O	B-T034
CRF35_AD	O	O	I-T034
in	O	O	O
Afghanistan	O	O	B-T083
and	O	O	O
Iran	O	O	O

HIV-1	O	O	B-T005
Circulating	O	O	I-T005
Recombinant	O	O	I-T005
Form	O	O	I-T005
35_AD	O	O	I-T005
(	O	O	O
CRF35_AD	O	O	B-T034
)	O	O	O
has	O	O	O
an	O	O	O
important	O	O	O
position	O	O	O
in	O	O	O
the	O	O	O
epidemiological	O	O	B-T091
profile	O	O	B-T169
of	O	O	O
Afghanistan	O	O	B-T083
and	O	O	O
Iran	O	O	B-T083
.	O	O	O

Despite	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
this	O	O	O
clade	O	O	B-T001
in	O	O	O
Afghanistan	O	O	B-T083
and	O	O	O
Iran	O	O	B-T083
for	O	O	O
over	O	O	O
a	O	O	O
decade	O	O	O
,	O	O	O
our	O	O	O
understanding	O	O	O
of	O	O	O
its	O	O	O
origin	O	O	O
and	O	O	O
dissemination	O	O	B-T080
patterns	O	O	O
is	O	O	O
limited	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
performed	O	O	O
a	O	O	O
Bayesian	O	O	B-T081
phylogeographic	O	O	I-T081
analysis	O	O	I-T081
to	O	O	O
reconstruct	O	O	O
the	O	O	O
spatio-temporal	O	O	B-T080
dispersion	O	O	I-T080
pattern	O	O	I-T080
of	O	O	O
this	O	O	O
clade	O	O	B-T001
using	O	O	O
eligible	O	O	O
CRF35_AD	O	O	B-T034
gag	O	O	B-T086
and	O	O	I-T086
pol	O	O	I-T086
sequences	O	O	B-T086
available	O	O	O
in	O	O	O
the	O	O	O
Los	O	O	B-T083
Alamos	O	O	I-T083
HIV	O	O	B-T170
database	O	O	I-T170
(	O	O	O
432	O	O	O
sequences	O	O	O
available	O	O	O
from	O	O	O
Iran	O	O	B-T083
,	O	O	O
16	O	O	O
sequences	O	O	O
available	O	O	O
from	O	O	O
Afghanistan	O	O	B-T083
,	O	O	O
and	O	O	O
a	O	O	O
single	O	O	O
CRF35_AD	O	O	O
-like	O	O	O
pol	O	O	B-T086
sequence	O	O	I-T086
available	O	O	O
from	O	O	O
USA	O	O	B-T083
)	O	O	O
.	O	O	O

Bayesian	O	O	B-T170
Markov	O	O	I-T170
Chain	O	O	I-T170
Monte	O	O	I-T170
Carlo	O	O	I-T170
algorithm	O	O	I-T170
was	O	O	O
implemented	O	O	O
in	O	O	O
BEAST	O	O	B-T073
v1.8.1	O	O	I-T073
.	O	O	O

Between-country	O	O	O
dispersion	O	O	O
rates	O	O	O
were	O	O	O
tested	O	O	O
with	O	O	O
Bayesian	O	O	B-T170
stochastic	O	O	I-T170
search	O	O	I-T170
variable	O	O	I-T170
selection	O	O	I-T170
method	O	O	I-T170
and	O	O	O
were	O	O	O
considered	O	O	O
significant	O	O	O
where	O	O	O
Bayes	O	O	B-T081
factor	O	O	I-T081
values	O	O	I-T081
were	O	O	O
greater	O	O	O
than	O	O	O
three	O	O	O
.	O	O	O

The	O	O	O
findings	O	O	O
suggested	O	O	O
that	O	O	O
CRF35_AD	O	O	B-T034
sequences	O	O	B-T086
were	O	O	O
genetically	O	O	O
similar	O	O	O
to	O	O	O
parental	O	O	B-T086
sequences	O	O	I-T086
from	O	O	O
Kenya	O	O	B-T083
and	O	O	O
Uganda	O	O	B-T083
,	O	O	O
and	O	O	O
to	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
subtype	O	O	B-T034
A1	O	O	I-T034
sequences	O	O	O
available	O	O	O
from	O	O	O
Afghan	O	O	B-T083
refugees	O	O	B-T098
living	O	O	O
in	O	O	O
Pakistan	O	O	B-T083
.	O	O	O

Our	O	O	O
results	O	O	O
also	O	O	O
showed	O	O	O
that	O	O	O
across	O	O	O
all	O	O	O
phylogenies	O	O	B-T078
,	O	O	O
Afghan	O	O	B-T083
and	O	O	O
Iranian	O	O	B-T083
CRF35_AD	O	O	B-T034
sequences	O	O	B-T086
formed	O	O	O
a	O	O	O
monophyletic	O	O	B-T081
cluster	O	O	I-T081
(	O	O	O
posterior	O	O	O
clade	O	O	O
credibility	O	O	O
>	O	O	O
0.7	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
divergence	O	O	O
date	O	O	O
of	O	O	O
this	O	O	O
cluster	O	O	B-T081
was	O	O	O
estimated	O	O	O
to	O	O	O
be	O	O	O
between	O	O	O
1990	O	O	O
and	O	O	O
1992	O	O	O
.	O	O	O

Within	O	O	O
this	O	O	O
cluster	O	O	B-T081
,	O	O	O
a	O	O	O
bidirectional	O	O	B-T080
dispersion	O	O	B-T080
of	O	O	O
the	O	O	O
virus	O	O	B-T005
was	O	O	O
observed	O	O	O
across	O	O	O
Afghanistan	O	O	B-T083
and	O	O	O
Iran	O	O	B-T083
.	O	O	O

We	O	O	O
could	O	O	O
not	O	O	O
clearly	O	O	O
identify	O	O	O
if	O	O	O
Afghanistan	O	O	B-T083
or	O	O	O
Iran	O	O	B-T083
first	O	O	O
established	O	O	O
or	O	O	O
received	O	O	O
this	O	O	O
epidemic	O	O	B-T047
,	O	O	O
as	O	O	O
the	O	O	O
root	O	O	O
location	O	O	O
of	O	O	O
this	O	O	O
cluster	O	O	B-T081
could	O	O	O
not	O	O	O
be	O	O	O
robustly	O	O	O
estimated	O	O	O
.	O	O	O

Three	O	O	O
CRF35_AD	O	O	B-T034
sequences	O	O	B-T086
from	O	O	O
Afghan	O	O	B-T083
refugees	O	O	B-T098
living	O	O	B-T082
in	O	O	I-T082
Pakistan	O	O	B-T083
nested	O	O	O
among	O	O	O
Afghan	O	O	O
and	O	O	O
Iranian	O	O	B-T083
CRF35_AD	O	O	O
branches	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
CRF35_AD	O	O	B-T034
-like	O	O	O
sequence	O	O	B-T086
available	O	O	O
from	O	O	O
USA	O	O	B-T083
diverged	O	O	O
independently	O	O	O
from	O	O	O
Kenyan	O	O	B-T083
subtype	O	O	B-T034
A1	O	O	I-T034
sequences	O	O	B-T086
,	O	O	O
suggesting	O	O	O
it	O	O	O
not	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
true	O	O	O
CRF35_AD	O	O	O
lineage	O	O	O
.	O	O	O

Potential	O	O	B-T080
factors	O	O	B-T169
contributing	O	O	O
to	O	O	O
viral	O	O	B-T005
exchange	O	O	O
between	O	O	O
Afghanistan	O	O	B-T083
and	O	O	O
Iran	O	O	B-T083
could	O	O	O
be	O	O	O
injection	O	O	O
drug	O	O	O
networks	O	O	O
and	O	O	O
mass	O	O	B-T054
migration	O	O	I-T054
of	O	O	O
Afghan	O	O	B-T083
refugees	O	O	B-T098
and	O	O	O
labours	O	O	B-T055
to	O	O	O
Iran	O	O	O
,	O	O	O
which	O	O	O
calls	O	O	O
for	O	O	O
extensive	O	O	B-T080
preventive	O	O	B-T080
efforts	O	O	O
.	O	O	O

-DOCSTART- (27282265)

The	O	O	O
Benefits	O	O	B-T081
of	O	O	O
Combination	O	O	B-T061
Therapy	O	O	I-T061
with	O	O	O
Esomeprazole	O	O	B-T109
and	O	O	O
Rebamipide	O	O	B-T109
in	O	O	O
Symptom	O	O	B-T184
Improvement	O	O	B-T077
in	O	O	O
Reflux	O	O	B-T047
Esophagitis	O	O	I-T047
:	O	O	O
An	O	O	O
International	O	O	B-T078
Multicenter	O	O	O
Study	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	O
esomeprazole	O	O	B-T109
and	O	O	O
rebamipide	O	O	B-T109
combination	O	O	B-T061
therapy	O	O	I-T061
on	O	O	O
symptomatic	O	O	B-T184
improvement	O	O	B-T077
in	O	O	O
patients	O	O	B-T101
with	O	O	O
reflux	O	O	B-T047
esophagitis	O	O	I-T047
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
501	O	O	O
patients	O	O	B-T101
with	O	O	O
reflux	O	O	B-T047
esophagitis	O	O	I-T047
were	O	O	O
randomized	O	O	B-T062
into	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
following	O	O	O
two	O	O	O
treatment	O	O	B-T061
regimens	O	O	I-T061
:	O	O	O
40	O	O	O
mg	O	O	O
esomeprazole	O	O	B-T109
plus	O	O	O
300	O	O	O
mg	O	O	O
rebamipide	O	O	B-T109
daily	O	O	B-T079
(	O	O	O
combination	O	O	B-T061
therapy	O	O	I-T061
group	O	O	B-T078
)	O	O	O
or	O	O	O
40	O	O	O
mg	O	O	O
esomeprazole	O	O	O
daily	O	O	O
(	O	O	O
monotherapy	O	O	B-T061
group	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
used	O	O	O
a	O	O	O
symptom	O	O	B-T184
questionnaire	O	O	B-T170
that	O	O	O
evaluated	O	O	B-T169
heartburn	O	O	B-T184
,	O	O	O
acid	O	O	B-T184
regurgitation	O	O	I-T184
,	O	O	O
and	O	O	O
four	O	O	O
upper	O	O	B-T047
gastrointestinal	O	O	I-T047
symptoms	O	O	I-T047
.	O	O	O

The	O	O	O
primary	O	O	O
efficacy	O	O	B-T080
end	O	O	O
point	O	O	O
was	O	O	O
the	O	O	O
mean	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
total	O	O	O
symptom	O	O	B-T033
score	O	O	I-T033
.	O	O	O

The	O	O	O
mean	O	O	O
decreases	O	O	B-T081
in	O	O	O
the	O	O	O
total	O	O	O
symptom	O	O	B-T033
score	O	O	I-T033
at	O	O	O
4	O	O	O
weeks	O	O	B-T079
were	O	O	O
estimated	O	O	O
to	O	O	O
be	O	O	O
-18.1±13.8	O	O	O
in	O	O	O
the	O	O	O
combination	O	O	B-T061
therapy	O	O	I-T061
group	O	O	B-T078
and	O	O	O
-15.1±11.9	O	O	O
in	O	O	O
the	O	O	O
monotherapy	O	O	B-T061
group	O	O	O
(	O	O	O
p=0.011	O	O	O
)	O	O	O
.	O	O	O

Changes	O	O	O
in	O	O	O
reflux	O	O	B-T047
symptom	O	O	B-T184
s	O	O	O
from	O	O	O
baseline	O	O	B-T081
after	O	O	O
4	O	O	O
weeks	O	O	B-T079
of	O	O	O
treatment	O	O	B-T061
were	O	O	O
-8.4±6.6	O	O	O
in	O	O	O
the	O	O	O
combination	O	O	B-T061
therapy	O	O	I-T061
group	O	O	B-T078
and	O	O	O
-6.8±5.9	O	O	O
in	O	O	O
the	O	O	O
monotherapy	O	O	B-T061
group	O	O	O
(	O	O	O
p=0.009	O	O	O
)	O	O	O
.	O	O	O

Over	O	O	O
a	O	O	O
4-	O	O	O
week	O	O	B-T079
treatment	O	O	B-T061
course	O	O	O
,	O	O	O
esomeprazole	O	O	B-T109
and	O	O	O
rebamipide	O	O	B-T109
combination	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
more	O	O	O
effective	O	O	B-T080
in	O	O	O
decreasing	O	O	B-T033
the	O	O	O
symptoms	O	O	B-T184
of	O	O	O
reflux	O	O	B-T047
esophagitis	O	O	I-T047
than	O	O	O
esomeprazole	O	O	O
monotherapy	O	O	B-T061
.	O	O	O

-DOCSTART- (27283167)

Integrating	O	O	B-T080
Palliative	O	O	B-T091
Care	O	O	I-T091
in	O	O	O
Pediatric	O	O	B-T091
Oncology	O	O	I-T091
:	O	O	O
Evidence	O	O	O
for	O	O	O
an	O	O	O
Evolving	O	O	B-T169
Paradigm	O	O	B-T062
for	O	O	O
Comprehensive	O	O	B-T058
Cancer	O	O	O
Care	O	O	O

The	O	O	O
demonstrated	O	O	O
benefit	O	O	O
of	O	O	O
integrating	O	O	B-T080
palliative	O	O	B-T091
care	O	O	I-T091
(	O	O	O
PC	O	O	B-T091
)	O	O	O
into	O	O	O
cancer	O	O	B-T061
treatment	O	O	I-T061
has	O	O	O
triggered	O	O	O
an	O	O	O
increased	O	O	B-T081
need	O	O	O
for	O	O	O
PC	O	O	O
services	O	O	O
.	O	O	O

The	O	O	O
trajectory	O	O	O
of	O	O	O
integrating	O	O	B-T080
PC	O	O	B-T091
in	O	O	O
comprehensive	O	O	B-T058
cancer	O	O	B-T093
centers	O	O	I-T093
,	O	O	I-T093
particularly	O	O	O
pediatric	O	O	B-T093
centers	O	O	I-T093
,	O	O	O
is	O	O	O
unknown	O	O	O
.	O	O	O

We	O	O	O
describe	O	O	O
our	O	O	O
8-	O	O	O
year	O	O	B-T079
experience	O	O	O
of	O	O	O
initiating	O	O	O
and	O	O	O
establishing	O	O	B-T080
PC	O	O	B-T091
with	O	O	O
the	O	O	O
Quality	O	O	B-T058
of	O	O	I-T058
Life	O	O	I-T058
Service	O	O	I-T058
(	O	O	O
QoLS	O	O	B-T058
)	O	O	O
at	O	O	O
St.	O	O	B-T093
Jude	O	O	I-T093
Children	O	O	I-T093
's	O	O	I-T093
Research	O	O	I-T093
Hospital	O	O	I-T093
.	O	O	O

We	O	O	O
retrospectively	O	O	O
reviewed	O	O	O
records	O	O	B-T170
of	O	O	I-T170
patients	O	O	I-T170
seen	O	O	O
by	O	O	O
the	O	O	O
QoLS	O	O	B-T058
(	O	O	O
n=615	O	O	O
)	O	O	O
from	O	O	O
March	O	O	B-T079
2007	O	O	O
to	O	O	O
December	O	O	B-T080
2014	O	O	O
.	O	O	O

Variables	O	O	B-T081
analyzed	O	O	O
for	O	O	O
each	O	O	O
year	O	O	B-T079
,	O	O	O
using	O	O	O
descriptive	O	O	O
statistics	O	O	B-T081
,	O	O	O
included	O	O	O
diagnostic	O	O	B-T170
groups	O	O	I-T170
,	O	O	O
QoLS	O	O	B-T058
encounters	O	O	B-T058
,	O	O	O
goals	O	O	B-T058
of	O	O	I-T058
care	O	O	I-T058
,	O	O	O
duration	O	O	B-T201
of	O	O	I-T201
survival	O	O	I-T201
,	O	O	O
and	O	O	O
location	O	O	B-T082
of	O	O	I-T082
death	O	O	I-T082
.	O	O	O

Total	O	O	O
QoLS	O	O	B-T058
patient	O	O	B-T101
encounters	O	O	B-T058
increased	O	O	B-T081
from	O	O	O
58	O	O	O
(	O	O	O
2007	O	O	O
)	O	O	O
to	O	O	O
1,297	O	O	O
(	O	O	O
2014	O	O	O
)	O	O	O
,	O	O	O
new	O	O	O
consults	O	O	B-T058
increased	O	O	O
from	O	O	O
17	O	O	O
(	O	O	O
2007	O	O	O
)	O	O	O
to	O	O	O
115	O	O	O
(	O	O	O
2014	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
mean	O	O	O
encounters	O	O	O
per	O	O	O
patient	O	O	O
increased	O	O	O
from	O	O	O
5.06	O	O	O
(	O	O	O
2007	O	O	O
)	O	O	O
to	O	O	O
16.11	O	O	O
(	O	O	O
2014	O	O	O
)	O	O	O
.	O	O	O

Goal	O	O	B-T058
of	O	O	I-T058
care	O	O	I-T058
at	O	O	O
initial	O	O	B-T058
consultation	O	O	I-T058
shifted	O	O	O
from	O	O	O
primarily	O	O	O
comfort	O	O	B-T041
to	O	O	O
an	O	O	O
increasing	O	O	B-T169
goal	O	O	B-T170
of	O	O	I-T170
cure	O	O	I-T170
.	O	O	O

The	O	O	O
median	O	O	O
number	O	O	O
of	O	O	O
days	O	O	O
from	O	O	O
initial	O	O	B-T058
consult	O	O	I-T058
to	O	O	O
death	O	O	B-T033
increased	O	O	B-T081
from	O	O	O
52	O	O	O
days	O	O	O
(	O	O	O
2008	O	O	O
)	O	O	O
to	O	O	O
223	O	O	O
days	O	O	O
(	O	O	O
2014	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
trend	O	O	O
toward	O	O	O
increased	O	O	B-T081
outpatient	O	O	B-T101
location	O	O	B-T082
of	O	O	I-T082
death	O	O	I-T082
was	O	O	O
noted	O	O	O
with	O	O	O
42	O	O	O
%	O	O	O
outpatient	O	O	O
deaths	O	O	B-T033
in	O	O	O
2007	O	O	O
,	O	O	O
increasing	O	O	B-T169
to	O	O	O
a	O	O	O
majority	O	O	B-T080
in	O	O	O
each	O	O	O
subsequent	O	O	O
year	O	O	B-T079
(	O	O	O
range	O	O	O
,	O	O	O
51%-74	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Hospital-wide	O	O	B-T080
,	O	O	O
patients	O	O	B-T101
receiving	O	O	O
PC	O	O	B-T091
services	O	O	O
before	O	O	O
death	O	O	B-T033
increased	O	O	B-T081
from	O	O	O
approximately	O	O	B-T080
50	O	O	O
%	O	O	O
to	O	O	O
nearly	O	O	O
100	O	O	O
%	O	O	O
.	O	O	O

Since	O	O	O
its	O	O	O
inception	O	O	O
,	O	O	O
the	O	O	O
QoLS	O	O	B-T058
experienced	O	O	O
a	O	O	O
dramatic	O	O	O
increase	O	O	B-T081
in	O	O	O
referrals	O	O	B-T058
and	O	O	O
encounters	O	O	B-T058
per	O	O	O
patient	O	O	B-T101
,	O	O	O
increased	O	O	B-T081
use	O	O	O
by	O	O	O
all	O	O	O
clinical	O	O	B-T058
services	O	O	I-T058
,	O	O	O
a	O	O	O
trend	O	O	O
toward	O	O	O
earlier	O	O	B-T079
consultation	O	O	B-T058
and	O	O	O
longer	O	O	B-T079
term	O	O	I-T079
follow-up	O	O	B-T058
,	O	O	O
increasing	O	O	B-T169
outpatient	O	O	B-T101
location	O	O	B-T082
of	O	O	I-T082
death	O	O	I-T082
,	O	O	O
and	O	O	O
near-	O	O	O
universal	O	O	B-T080
PC	O	O	B-T091
involvement	O	O	O
at	O	O	O
the	O	O	O
end-of-life	O	O	B-T058
.	O	O	O

The	O	O	O
successful	O	O	O
integration	O	O	B-T080
of	O	O	O
PC	O	O	B-T091
in	O	O	O
a	O	O	O
comprehensive	O	O	B-T058
cancer	O	O	B-T093
center	O	O	I-T093
,	O	O	O
and	O	O	O
the	O	O	O
resulting	O	O	O
potential	O	O	O
for	O	O	O
improved	O	O	O
care	O	O	B-T058
provision	O	O	I-T058
over	O	O	O
time	O	O	B-T079
,	O	O	O
can	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
model	O	O	B-T170
for	O	O	O
other	O	O	O
programs	O	O	B-T058
on	O	O	O
a	O	O	O
broad	O	O	O
scale	O	O	O
.	O	O	O

-DOCSTART- (27285457)

PROTECTIVE	O	O	B-T080
EFFECTS	O	O	I-T080
OF	O	O	I-T080
DIPEPTIDYL	O	O	B-T121
PEPTIDASE-4	O	O	I-T121
INHIBITORS	O	O	I-T121
ON	O	O	O
PROGRESSION	O	O	B-T046
OF	O	O	O
DIABETIC	O	O	B-T047
RETINOPATHY	O	O	I-T047
IN	O	O	O
PATIENTS	O	O	B-T101
WITH	O	O	O
TYPE	O	O	O
2	O	O	O
DIABETES	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
dipeptidyl	O	O	B-T121
peptidase-4	O	O	I-T121
inhibitors	O	O	I-T121
(	O	O	O
DPP4	O	O	B-T121
)	O	O	O
on	O	O	O
the	O	O	O
progression	O	O	B-T046
of	O	O	O
diabetic	O	O	B-T047
retinopathy	O	O	I-T047
(	O	O	O
DR	O	O	B-T047
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
Type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
based	O	O	O
on	O	O	O
the	O	O	O
DR	O	O	O
severity	O	O	B-T081
scale	O	O	I-T081
.	O	O	O

The	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
of	O	O	O
82	O	O	O
patients	O	O	B-T101
with	O	O	O
Type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
enrolled	O	O	O
from	O	O	O
2005	O	O	O
to	O	O	O
2015	O	O	O
were	O	O	O
retrospectively	O	O	B-T080
reviewed	O	O	B-T080
.	O	O	O

Fundus	O	O	B-T060
photographs	O	O	I-T060
were	O	O	O
graded	O	O	B-T185
using	O	O	O
Early	O	O	B-T170
Treatment	O	O	I-T170
Diabetic	O	O	I-T170
Retinopathy	O	O	I-T170
Study	O	O	I-T170
methods	O	O	I-T170
.	O	O	O

The	O	O	O
associations	O	O	B-T080
between	O	O	O
baseline	O	O	B-T081
risk	O	O	B-T033
factors	O	O	I-T033
and	O	O	O
progression	O	O	B-T046
of	O	O	O
DR	O	O	B-T047
were	O	O	O
investigated	O	O	B-T169
.	O	O	O

Seven	O	O	O
of	O	O	O
28	O	O	O
patients	O	O	B-T101
treated	O	O	B-T169
with	O	O	O
DPP4	O	O	B-T121
inhibitors	O	O	I-T121
and	O	O	O
26	O	O	O
of	O	O	O
54	O	O	O
treated	O	O	O
with	O	O	O
other	O	O	O
hypoglycemic	O	O	B-T121
agents	O	O	I-T121
showed	O	O	O
progression	O	O	B-T046
of	O	O	O
retinopathy	O	O	B-T047
,	O	O	O
defined	O	O	O
as	O	O	O
one	O	O	O
or	O	O	O
more	O	O	O
steps	O	O	O
on	O	O	O
the	O	O	O
Early	O	O	B-T081
Treatment	O	O	I-T081
Diabetic	O	O	I-T081
Retinopathy	O	O	I-T081
Study	O	O	I-T081
scale	O	O	I-T081
(	O	O	O
P	O	O	O
=	O	O	O
0.043	O	O	O
)	O	O	O
.	O	O	O

Only	O	O	O
treatment	O	O	B-T169
with	O	O	O
DPP4	O	O	B-T121
inhibitors	O	O	I-T121
significantly	O	O	O
reduced	O	O	B-T080
the	O	O	O
progression	O	O	B-T046
of	O	O	O
DR	O	O	B-T047
in	O	O	O
patients	O	O	B-T101
after	O	O	O
propensity	O	O	B-T081
score	O	O	I-T081
matching	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.009	O	O	O
)	O	O	O
.	O	O	O

Treatment	O	O	B-T169
with	O	O	O
DPP4	O	O	B-T121
inhibitors	O	O	I-T121
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
lower	O	O	B-T052
risk	O	O	B-T078
of	O	O	O
DR	O	O	B-T047
progression	O	O	B-T046
(	O	O	O
P	O	O	O
=	O	O	O
0.011	O	O	O
)	O	O	O
.	O	O	O

Treatment	O	O	B-T169
with	O	O	O
DPP4	O	O	B-T121
inhibitors	O	O	I-T121
was	O	O	O
the	O	O	O
independent	O	O	B-T078
protective	O	O	B-T169
factor	O	O	I-T169
against	O	O	O
the	O	O	O
progression	O	O	B-T046
of	O	O	O
DR	O	O	B-T047
,	O	O	O
aside	O	O	O
from	O	O	O
improving	O	O	B-T033
glycemic	O	O	I-T033
control	O	O	I-T033
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
study	O	O	O
to	O	O	O
show	O	O	O
the	O	O	O
benefits	O	O	B-T081
of	O	O	O
DPP4	O	O	B-T121
inhibitors	O	O	I-T121
in	O	O	O
reducing	O	O	B-T080
DR	O	O	B-T047
progression	O	O	B-T046
,	O	O	O
and	O	O	O
provides	O	O	O
encouraging	O	O	O
preliminary	O	O	B-T079
data	O	O	B-T078
for	O	O	O
further	O	O	O
evaluation	O	O	B-T058
of	O	O	O
DPP4	O	O	O
inhibitors	O	O	O
in	O	O	O
the	O	O	O
progression	O	O	O
of	O	O	O
DR	O	O	O
in	O	O	O
a	O	O	O
randomized	O	O	B-T062
,	O	O	O
double-blind	O	O	B-T062
,	O	O	O
placebo-controlled	O	O	B-T062
trial	O	O	I-T062
.	O	O	O

-DOCSTART- (27293894)

Production	O	O	B-T057
of	O	O	O
Laccase	O	O	B-T116
by	O	O	O
Cochliobolus	O	O	B-T004
sp.	O	O	I-T004
Isolated	O	O	B-T169
from	O	O	O
Plastic	O	O	B-T167
Dumped	O	O	B-T167
Soils	O	O	I-T167
and	O	O	O
Their	O	O	O
Ability	O	O	B-T032
to	O	O	O
Degrade	O	O	B-UnknownType
Low	O	O	O
Molecular	O	O	O
Weight	O	O	O
PVC	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
utmost	O	O	O
man-made	O	O	B-T068
problems	O	O	I-T068
faced	O	O	O
today	O	O	O
has	O	O	O
been	O	O	O
the	O	O	O
ever	O	O	B-T079
-	O	O	O
increasing	O	O	B-T169
plastic	O	O	B-T167
waste	O	O	B-T167
filling	O	O	B-T052
the	O	O	O
world	O	O	O
.	O	O	O

It	O	O	O
accounts	O	O	O
for	O	O	O
an	O	O	O
estimated	O	O	O
20	O	O	O
-	O	O	O
30	O	O	O
%	O	O	O
(	O	O	O
by	O	O	O
volume	O	O	O
)	O	O	O
of	O	O	O
municipal	O	O	B-T167
solid	O	O	I-T167
waste	O	O	I-T167
in	O	O	O
landfill	O	O	B-T073
sites	O	O	I-T073
worldwide	O	O	O
.	O	O	O

Research	O	O	O
on	O	O	O
plastic	O	O	B-T167
biodegradation	O	O	B-T070
has	O	O	O
been	O	O	O
steadily	O	O	O
growing	O	O	O
over	O	O	O
the	O	O	O
past	O	O	O
four	O	O	O
decades	O	O	O
.	O	O	O

Several	O	O	O
fungi	O	O	B-T004
have	O	O	O
been	O	O	O
identified	O	O	O
that	O	O	O
produce	O	O	O
enzymes	O	O	B-T116
capable	O	O	O
of	O	O	O
plastic	O	O	B-T167
degradation	O	O	B-T070
in	O	O	O
various	O	O	O
laboratory	O	O	B-T080
conditions	O	O	I-T080
.	O	O	O

This	O	O	O
paper	O	O	O
presents	O	O	O
a	O	O	O
study	O	O	O
that	O	O	O
determined	O	O	O
the	O	O	O
ability	O	O	B-T032
of	O	O	O
fungi	O	O	B-T004
to	O	O	O
degrade	O	O	B-UnknownType
low	O	O	B-T109
molecular	O	O	I-T109
weight	O	O	I-T109
polyvinyl	O	O	I-T109
chloride	O	O	I-T109
(	O	O	O
PVC	O	O	B-T109
)	O	O	O
by	O	O	O
the	O	O	O
enzyme	O	O	B-T116
laccase	O	O	I-T116
.	O	O	O

We	O	O	O
have	O	O	O
isolated	O	O	B-T169
a	O	O	O
fungal	O	O	B-T004
species	O	O	B-T185
,	O	O	O
Cochliobolus	O	O	B-T004
sp.	O	O	I-T004
,	O	O	O
from	O	O	O
plastic	O	O	B-T167
dumped	O	O	B-T167
soils	O	O	I-T167
and	O	O	O
they	O	O	O
were	O	O	O
cultured	O	O	B-T059
on	O	O	O
Czapek	O	O	B-T130
Dox	O	O	I-T130
Agar	O	O	I-T130
slants	O	O	I-T130
at	O	O	O
30	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

The	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
this	O	O	O
fungal	O	O	B-T004
species	O	O	B-T185
on	O	O	O
the	O	O	O
degradation	O	O	B-T070
of	O	O	O
commercial	O	O	O
low	O	O	B-T109
molecular	O	O	I-T109
weight	O	O	I-T109
polyvinyl	O	O	I-T109
chloride	O	O	I-T109
(	O	O	O
PVC	O	O	B-T109
)	O	O	O
was	O	O	O
studied	O	O	O
under	O	O	O
laboratory	O	O	B-T080
conditions	O	O	I-T080
.	O	O	O

Significant	O	O	O
differences	O	O	O
were	O	O	O
observed	O	O	O
from	O	O	O
the	O	O	O
FTIR	O	O	B-T062
,	O	O	O
GC-MS	O	O	B-T059
,	O	O	O
and	O	O	O
SEM	O	O	B-T059
results	O	O	O
in	O	O	O
between	O	O	O
control	O	O	B-T167
and	O	O	O
Cochliobolus	O	O	B-T004
sp.	O	O	I-T004
treated	O	O	O
PVC	O	O	B-T109
.	O	O	O

-DOCSTART- (27294945)

Effects	O	O	B-T080
of	O	O	I-T080
Cerium	O	O	B-T130
and	O	O	O
Titanium	O	O	B-T121
Oxide	O	O	I-T121
Nanoparticles	O	O	B-T073
in	O	O	O
Soil	O	O	B-T167
on	O	O	O
the	O	O	O
Nutrient	O	O	B-T168
Composition	O	O	B-T201
of	O	O	O
Barley	O	O	B-T002
(	O	O	O
Hordeum	O	O	B-T002
vulgare	O	O	I-T002
L	O	O	I-T002
.	O	O	O
)	O	O	O
Kernels	O	O	O

The	O	O	O
implications	O	O	B-T169
of	O	O	O
metal	O	O	B-T073
nanoparticles	O	O	I-T073
(	O	O	O
MeNPs	O	O	B-T073
)	O	O	I-T073
are	O	O	O
still	O	O	O
unknown	O	O	B-T080
for	O	O	O
many	O	O	B-T081
food	O	O	B-T002
crops	O	O	I-T002
.	O	O	O

The	O	O	O
purpose	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
cerium	O	O	B-T130
oxide	O	O	I-T130
(	O	O	O
nCeO₂	O	O	B-T130
)	O	O	O
and	O	O	O
titanium	O	O	B-T121
oxide	O	O	I-T121
(	O	O	O
nTiO₂	O	O	B-T121
)	O	O	O
nanoparticles	O	O	B-T073
in	O	O	O
soil	O	O	B-T167
at	O	O	O
0	O	O	O
,	O	O	O
500	O	O	O
and	O	O	O
1000	O	O	O
mg·kg(-1	O	O	O
)	O	O	O
on	O	O	O
the	O	O	O
nutritional	O	O	B-T080
parameters	O	O	I-T080
of	O	O	O
barley	O	O	B-T002
(	O	O	O
Hordeum	O	O	B-T002
vulgare	O	O	I-T002
L.	O	O	I-T002
)	O	O	O
kernels	O	O	B-T168
.	O	O	O

Mineral	O	O	B-T197
nutrients	O	O	I-T197
,	O	O	O
amylose	O	O	B-T109
,	O	O	O
β-glucans	O	O	B-T109
,	O	O	O
amino	O	O	B-T116
acid	O	O	I-T116
and	O	O	O
crude	O	O	B-T116
protein	O	O	I-T116
(	O	O	O
CP	O	O	B-T116
)	O	O	O
concentrations	O	O	B-T081
were	O	O	I-T081
measured	O	O	I-T081
in	O	O	O
kernels	O	O	B-T168
.	O	O	O

Whole	O	O	B-T081
flour	O	O	B-T168
samples	O	O	O
were	O	O	O
analyzed	O	O	O
by	O	O	O
ICP-AES/MS	O	O	B-T059
,	O	O	O
HPLC	O	O	B-T059
and	O	O	O
Elemental	O	O	B-T073
CHNS	O	O	I-T073
Analyzer	O	O	I-T073
.	O	O	O

Results	O	O	O
showed	O	O	O
that	O	O	O
Ce	O	O	B-T109
and	O	O	O
Ti	O	O	B-T196
accumulation	O	O	B-T033
under	O	O	O
MeNPs	O	O	B-T073
treatments	O	O	B-T169
did	O	O	O
not	O	O	O
differ	O	O	O
from	O	O	O
the	O	O	O
control	O	O	B-T169
treatment	O	O	I-T169
.	O	O	O

However	O	O	O
,	O	O	O
nCeO₂	O	O	B-T130
and	O	O	O
nTiO₂	O	O	B-T121
had	O	O	O
an	O	O	O
impact	O	O	B-T080
on	O	O	O
composition	O	O	B-T201
and	O	O	O
nutritional	O	O	B-T080
quality	O	O	I-T080
of	O	O	O
barley	O	O	B-T002
kernels	O	O	B-T168
in	O	O	O
contrasting	O	O	B-T080
ways	O	O	I-T080
.	O	O	O

Both	O	O	O
MeNPs	O	O	B-T073
left	O	O	O
β-glucans	O	O	B-T109
unaffected	O	O	B-T077
but	O	O	O
reduced	O	O	O
amylose	O	O	B-T109
content	O	O	O
by	O	O	O
approximately	O	O	O
21	O	O	O
%	O	O	O
.	O	O	O

Most	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
and	O	O	O
CP	O	O	B-T116
increased	O	O	B-T081
.	O	O	O

Among	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
,	O	O	O
lysine	O	O	B-T116
followed	O	O	O
by	O	O	O
proline	O	O	B-T116
saw	O	O	O
the	O	O	O
largest	O	O	B-T169
increase	O	O	I-T169
(	O	O	O
51	O	O	O
%	O	O	O
and	O	O	O
37	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Potassium	O	O	B-T123
and	O	O	O
S	O	O	B-T121
were	O	O	O
both	O	O	O
negatively	O	O	B-T080
impacted	O	O	I-T080
by	O	O	O
MeNPs	O	O	B-T073
,	O	O	O
while	O	O	O
B	O	O	O
was	O	O	O
only	O	O	O
affected	O	O	B-T169
by	O	O	O
500	O	O	O
mg	O	O	O
nCeO₂	O	O	B-T130
·	O	O	O
kg(-1	O	O	O
)	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
contrary	O	O	O
Zn	O	O	B-T059
and	O	O	O
Mn	O	O	B-T059
concentrations	O	O	I-T059
were	O	O	O
improved	O	O	O
by	O	O	O
500	O	O	O
mg	O	O	O
nTiO₂	O	O	B-T121
·	O	O	O
kg(-1	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
Ca	O	O	O
by	O	O	O
both	O	O	O
nTiO₂	O	O	O
treatments	O	O	B-T169
.	O	O	O

Generally	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	O
demonstrated	O	O	B-T052
that	O	O	O
kernels	O	O	B-T168
are	O	O	O
negatively	O	O	B-T033
affected	O	O	I-T033
by	O	O	O
nCeO₂	O	O	B-T130
while	O	O	O
nTiO₂	O	O	B-T121
can	O	O	O
potentially	O	O	O
have	O	O	O
beneficial	O	O	B-T080
effects	O	O	I-T080
.	O	O	O

However	O	O	O
,	O	O	O
both	O	O	O
MeNPs	O	O	B-T073
have	O	O	O
the	O	O	O
potential	O	O	O
to	O	O	O
negatively	O	O	B-T080
impact	O	O	I-T080
malt	O	O	B-T168
and	O	O	O
feed	O	O	B-T090
production	O	O	I-T090
.	O	O	O

-DOCSTART- (27305683)

Quantifying	O	O	B-T081
Nonlinear	O	O	O
Contributions	O	O	B-T052
to	O	O	O
Cortical	O	O	B-T059
Responses	O	O	I-T059
Evoked	O	O	I-T059
by	O	O	O
Continuous	O	O	O
Wrist	O	O	O
Manipulation	O	O	O

Cortical	O	O	B-T059
responses	O	O	I-T059
to	O	O	O
continuous	O	O	B-T039
stimuli	O	O	I-T039
as	O	O	O
recorded	O	O	O
using	O	O	O
either	O	O	O
magneto-	O	O	B-T060
or	O	O	O
electroencephalography	O	O	B-T060
(	O	O	O
EEG	O	O	B-T060
)	O	O	O
have	O	O	O
shown	O	O	O
power	O	O	O
at	O	O	O
harmonics	O	O	O
of	O	O	O
the	O	O	O
stimulated	O	O	B-T079
frequency	O	O	I-T079
,	O	O	O
indicating	O	O	O
nonlinear	O	O	B-T053
behavior	O	O	I-T053
.	O	O	O

Even	O	O	O
though	O	O	O
the	O	O	O
selection	O	O	O
of	O	O	O
analysis	O	O	B-T062
techniques	O	O	B-T169
depends	O	O	O
on	O	O	O
the	O	O	O
linearity	O	O	B-T082
of	O	O	O
the	O	O	O
system	O	O	O
under	O	O	O
study	O	O	O
,	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
nonlinear	O	O	O
contributions	O	O	B-T052
to	O	O	O
cortical	O	O	B-T059
responses	O	O	I-T059
has	O	O	O
not	O	O	O
been	O	O	O
formally	O	O	O
addressed	O	O	O
.	O	O	O

The	O	O	O
goal	O	O	B-T170
of	O	O	I-T170
this	O	O	I-T170
paper	O	O	I-T170
is	O	O	O
to	O	O	O
quantify	O	O	B-T081
the	O	O	O
nonlinear	O	O	O
contributions	O	O	B-T052
to	O	O	O
the	O	O	O
cortical	O	O	B-T059
response	O	O	I-T059
obtained	O	O	O
from	O	O	O
continuous	O	O	B-T078
sensory	O	O	B-T061
stimulation	O	O	I-T061
.	O	O	O

EEG	O	O	B-T060
was	O	O	O
used	O	O	O
to	O	O	O
record	O	O	O
the	O	O	O
cortical	O	O	B-T059
response	O	O	I-T059
evoked	O	O	I-T059
by	O	O	O
continuous	O	O	B-T033
movement	O	O	I-T033
of	O	O	I-T033
the	O	O	I-T033
wrist	O	O	I-T033
joint	O	O	I-T033
of	O	O	O
healthy	O	O	O
subjects	O	O	O
applied	O	O	O
with	O	O	O
a	O	O	O
robotic	O	O	B-T073
manipulator	O	O	I-T073
.	O	O	O

Multisine	O	O	O
stimulus	O	O	B-T067
signals	O	O	I-T067
(	O	O	O
i.e.	O	O	O
,	O	O	O
the	O	O	O
sum	O	O	O
of	O	O	O
several	O	O	B-T081
sinusoids	O	O	B-T030
)	O	O	O
elicit	O	O	O
a	O	O	O
periodic	O	O	B-T079
cortical	O	O	B-T059
response	O	O	I-T059
and	O	O	O
allow	O	O	O
to	O	O	O
assess	O	O	B-T052
the	O	O	O
nonlinear	O	O	O
contributions	O	O	B-T052
to	O	O	O
the	O	O	O
response	O	O	O
.	O	O	O

Wrist	O	O	B-T061
dynamics	O	O	I-T061
(	O	O	O
relation	O	O	O
between	O	O	O
joint	O	O	B-T030
angle	O	O	I-T030
and	O	O	O
torque	O	O	B-T067
)	O	O	O
were	O	O	O
successfully	O	O	O
linearized	O	O	B-T082
,	O	O	O
explaining	O	O	O
99	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
response	O	O	O
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
cortical	O	O	B-T059
response	O	O	I-T059
revealed	O	O	O
a	O	O	O
highly	O	O	O
nonlinear	O	O	O
relation	O	O	O
;	O	O	O
where	O	O	O
most	O	O	O
power	O	O	O
(	O	O	O
∼	O	O	O
80	O	O	O
%	O	O	O
)	O	O	O
occurred	O	O	O
at	O	O	O
non-stimulated	O	O	O
frequencies	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
only	O	O	O
10	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
response	O	O	O
could	O	O	O
be	O	O	O
explained	O	O	O
using	O	O	O
a	O	O	O
nonparametric	O	O	B-T081
linear	O	O	I-T081
model	O	O	I-T081
.	O	O	O

These	O	O	O
results	O	O	B-T033
indicate	O	O	O
that	O	O	O
the	O	O	O
recorded	O	O	O
evoked	O	O	B-T059
cortical	O	O	I-T059
responses	O	O	I-T059
are	O	O	O
governed	O	O	O
by	O	O	O
nonlinearities	O	O	O
and	O	O	O
that	O	O	O
linear	O	O	B-T082
methods	O	O	O
do	O	O	O
not	O	O	O
suffice	O	O	O
when	O	O	O
describing	O	O	O
the	O	O	O
relation	O	O	O
between	O	O	O
mechanical	O	O	B-T067
stimulus	O	O	I-T067
and	O	O	O
cortical	O	O	B-T033
response	O	O	I-T033
.	O	O	O

-DOCSTART- (27306679)

Using	O	O	B-T169
melanopsin	O	O	B-T116
to	O	O	O
study	O	O	B-T062
G	O	O	B-T044
protein	O	O	I-T044
signaling	O	O	I-T044
in	O	O	O
cortical	O	O	B-T023
neurons	O	O	O

Our	O	O	O
understanding	O	O	B-T041
of	O	O	O
G	O	O	B-T116
protein-coupled	O	O	I-T116
receptors	O	O	I-T116
(	O	O	O
GPCRs	O	O	B-T116
)	O	O	O
in	O	O	O
the	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
(	O	O	O
CNS	O	O	B-T022
)	O	O	O
has	O	O	O
been	O	O	O
hampered	O	O	O
by	O	O	O
the	O	O	O
limited	O	O	O
availability	O	O	O
of	O	O	O
tools	O	O	B-T073
allowing	O	O	O
for	O	O	O
the	O	O	O
study	O	O	B-T062
of	O	O	O
their	O	O	O
signaling	O	O	B-T038
with	O	O	O
precise	O	O	B-T079
temporal	O	O	I-T079
control	O	O	B-T169
.	O	O	O

To	O	O	O
overcome	O	O	B-T052
this	O	O	O
,	O	O	O
we	O	O	O
tested	O	O	B-T169
the	O	O	O
utility	O	O	O
of	O	O	O
the	O	O	O
bistable	O	O	B-T080
mammalian	O	O	B-T015
opsin	O	O	B-T116
melanopsin	O	O	B-T116
to	O	O	O
examine	O	O	O
G	O	O	B-T044
protein	O	O	I-T044
signaling	O	O	I-T044
in	O	O	O
CNS	O	O	B-T022
neurons	O	O	B-T025
.	O	O	O

Specifically	O	O	O
,	O	O	O
we	O	O	O
used	O	O	B-T169
biolistic	O	O	B-T063
(	O	O	O
gene	O	O	B-T075
gun	O	O	I-T075
)	O	O	O
approaches	O	O	O
to	O	O	O
transfect	O	O	B-T116
melanopsin	O	O	I-T116
into	O	O	O
cortical	O	O	B-T023
pyramidal	O	O	B-T025
cells	O	O	I-T025
maintained	O	O	B-T169
in	O	O	O
organotypic	O	O	B-T059
slice	O	O	I-T059
culture	O	O	I-T059
.	O	O	O

Whole	O	O	B-T062
cell	O	O	I-T062
recordings	O	O	I-T062
from	O	O	O
transfected	O	O	B-T025
neurons	O	O	I-T025
indicated	O	O	O
that	O	O	O
application	O	O	O
of	O	O	O
blue	O	O	B-T070
light	O	O	I-T070
effectively	O	O	B-T080
activated	O	O	B-T169
the	O	O	O
transfected	O	O	B-T116
melanopsin	O	O	B-T116
to	O	O	O
elicit	O	O	B-T080
the	O	O	O
canonical	O	O	O
biphasic	O	O	B-T079
modulation	O	O	B-UnknownType
of	O	O	O
membrane	O	O	B-T026
excitability	O	O	B-T184
previously	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
activation	O	O	B-T169
of	O	O	O
GPCRs	O	O	B-T116
coupling	O	O	B-T169
to	O	O	O
Gαq-11	O	O	B-T116
Remarkably	O	O	O
,	O	O	O
full	O	O	O
mimicry	O	O	O
of	O	O	O
exogenous	O	O	B-T169
agonist	O	O	B-T121
concentration	O	O	B-T081
could	O	O	O
be	O	O	O
obtained	O	O	B-T169
with	O	O	O
pulses	O	O	B-T067
as	O	O	O
short	O	O	O
as	O	O	O
a	O	O	O
few	O	O	B-T081
milliseconds	O	O	B-T079
,	O	O	O
suggesting	O	O	O
that	O	O	O
their	O	O	O
triggering	O	O	B-T080
required	O	O	O
a	O	O	O
single	O	O	B-T081
melanopsin	O	O	O
activation-deactivation	O	O	B-T079
cycle	O	O	I-T079
.	O	O	O

The	O	O	O
resulting	O	O	B-T169
temporal	O	O	B-T169
control	O	O	I-T169
over	O	O	O
melanopsin	O	O	B-T116
activation	O	O	B-T169
allowed	O	O	O
us	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
activation	O	O	O
kinetics	O	O	B-T070
of	O	O	O
different	O	O	O
components	O	O	O
of	O	O	O
the	O	O	O
electrophysiological	O	O	B-T042
response	O	O	B-T032
.	O	O	O

We	O	O	O
also	O	O	O
replaced	O	O	O
the	O	O	O
intracellular	O	O	B-T082
loops	O	O	B-T082
of	O	O	O
melanopsin	O	O	B-T116
with	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
5-HT2A	O	O	B-T116
receptor	O	O	I-T116
to	O	O	O
create	O	O	O
a	O	O	O
light-activated	O	O	B-T067
GPCR	O	O	B-T116
capable	O	O	O
of	O	O	O
interacting	O	O	B-T169
with	O	O	O
the	O	O	O
5-HT2A	O	O	O
receptor	O	O	O
interacting	O	O	O
proteins	O	O	B-T116
.	O	O	O

The	O	O	O
resulting	O	O	B-T169
chimera	O	O	B-T116
expressed	O	O	B-T169
weak	O	O	B-T080
activity	O	O	B-T052
but	O	O	O
validated	O	O	B-T062
the	O	O	O
potential	O	O	B-T080
usefulness	O	O	B-T080
of	O	O	O
melanopsin	O	O	B-T116
as	O	O	O
a	O	O	O
tool	O	O	B-T073
for	O	O	O
the	O	O	O
study	O	O	B-T062
of	O	O	O
G	O	O	B-T044
protein	O	O	I-T044
signaling	O	O	I-T044
in	O	O	O
CNS	O	O	B-T022
neurons	O	O	B-T025
.	O	O	O

-DOCSTART- (27308854)

Maternal	O	O	B-T099
vitamin	O	O	B-T127
D	O	O	I-T127
levels	O	O	B-T080
and	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
perinatal	O	O	O
death	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
maternal	O	O	B-T099
vitamin	O	O	B-T127
D	O	O	I-T127
levels	O	O	B-T080
and	O	O	O
perinatal	O	O	B-T046
death	O	O	I-T046
.	O	O	O

A	O	O	O
retrospective	O	O	B-T080
cross-sectional	O	O	B-T062
study	O	O	I-T062
of	O	O	O
all	O	O	O
non-anomalous	O	O	O
,	O	O	O
singleton	O	O	B-T099
births	O	O	B-T040
(	O	O	O
≥24	O	O	O
weeks	O	O	B-T079
)	O	O	O
with	O	O	O
perinatal	O	O	B-T046
death	O	O	I-T046
compared	O	O	O
to	O	O	O
a	O	O	O
matched	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

Only	O	O	O
pregnancies	O	O	B-T040
with	O	O	O
a	O	O	O
recorded	O	O	O
vitamin	O	O	B-T127
D	O	O	I-T127
level	O	O	B-T080
at	O	O	O
booking	O	O	O
(	O	O	O
8	O	O	O
-	O	O	O
19	O	O	O
weeks	O	O	B-T079
gestation	O	O	B-T040
)	O	O	O
were	O	O	O
included	O	O	O
for	O	O	O
analysis	O	O	B-T062
.	O	O	O

Maternal	O	O	B-T099
vitamin	O	O	B-T127
D	O	O	I-T127
levels	O	O	B-T080
were	O	O	O
categorized	O	O	O
into	O	O	O
normal	O	O	B-T080
,	O	O	O
deficient	O	O	B-T169
and	O	O	O
insufficient	O	O	B-T080
cohorts	O	O	B-T098
and	O	O	O
variables	O	O	B-T080
compared	O	O	O
between	O	O	O
the	O	O	O
three	O	O	O
groups	O	O	B-T098
.	O	O	O

There	O	O	O
were	O	O	O
31	O	O	O
perinatal	O	O	B-T046
deaths	O	O	I-T046
which	O	O	O
were	O	O	O
compared	O	O	O
to	O	O	O
111	O	O	O
controls	O	O	B-T096
.	O	O	O

Median	O	O	O
vitamin	O	O	B-T127
D	O	O	I-T127
levels	O	O	B-T080
were	O	O	O
lower	O	O	O
in	O	O	O
the	O	O	O
perinatal	O	O	B-T046
death	O	O	I-T046
cohort	O	O	B-T098
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
55	O	O	O
nmol/L	O	O	O
versus	O	O	O
64	O	O	O
nmol/L	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.43	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	O
increase	O	O	O
in	O	O	O
deaths	O	O	B-T040
between	O	O	O
the	O	O	O
normal	O	O	B-T080
and	O	O	O
deficient	O	O	B-T169
(	O	O	O
p	O	O	O
=	O	O	O
0.33	O	O	O
)	O	O	O
or	O	O	O
insufficient	O	O	B-T080
(	O	O	O
p	O	O	O
=	O	O	O
0.09	O	O	O
)	O	O	O
groups	O	O	B-T098
.	O	O	O

Low	O	O	O
maternal	O	O	B-T099
vitamin	O	O	B-T127
D	O	O	I-T127
levels	O	O	B-T080
at	O	O	O
booking	O	O	O
were	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
perinatal	O	O	B-T046
demise	O	O	I-T046
.	O	O	O

-DOCSTART- (27312354)

Effect	O	O	B-T080
of	O	O	O
constitutive	O	O	B-T045
inactivation	O	O	I-T045
of	O	O	O
the	O	O	O
myostatin	O	O	B-T028
gene	O	O	I-T028
on	O	O	O
the	O	O	O
gain	O	O	B-T081
in	O	O	O
muscle	O	O	B-T042
strength	O	O	I-T042
during	O	O	O
postnatal	O	O	B-T040
growth	O	O	I-T040
in	O	O	O
two	O	O	O
murine	O	O	B-T015
models	O	O	O

The	O	O	O
effect	O	O	B-T080
of	O	O	O
constitutive	O	O	B-T045
inactivation	O	O	I-T045
of	O	O	O
the	O	O	O
gene	O	O	B-T028
encoding	O	O	I-T028
myostatin	O	O	I-T028
on	O	O	O
the	O	O	O
gain	O	O	B-T081
in	O	O	O
muscle	O	O	B-T042
performance	O	O	I-T042
during	O	O	O
postnatal	O	O	B-T040
growth	O	O	I-T040
has	O	O	O
not	O	O	O
been	O	O	O
well	O	O	O
characterized	O	O	O
.	O	O	O

We	O	O	O
analyzed	O	O	O
2	O	O	O
murine	O	O	B-T015
myostatin	O	O	B-T028
knockout	O	O	B-T008
(	O	O	I-T008
KO	O	O	I-T008
)	O	O	I-T008
models	O	O	I-T008
,	O	O	O
(	O	O	O
i	O	O	O
)	O	O	O
the	O	O	O
Lee	O	O	B-T008
model	O	O	I-T008
(	O	O	O
KO(Lee	O	O	B-T015
)	O	O	O
)	O	O	O
and	O	O	O
(	O	O	O
ii	O	O	O
)	O	O	O
the	O	O	O
Grobet	O	O	B-T008
model	O	O	I-T008
(	O	O	O
KO(Grobet	O	O	B-T015
)	O	O	I-T015
)	O	O	O
,	O	O	O
and	O	O	O
measured	O	O	B-T080
the	O	O	O
contraction	O	O	B-T039
of	O	O	O
tibialis	O	O	B-T023
anterior	O	O	I-T023
muscle	O	O	I-T023
in	O	O	B-T082
situ	O	O	I-T082
.	O	O	O

Absolute	O	O	B-T042
maximal	O	O	I-T042
isometric	O	O	I-T042
force	O	O	I-T042
was	O	O	O
increased	O	O	B-T081
in	O	O	O
6-month-old	O	O	O
KO(Lee	O	O	B-T015
)	O	O	I-T015
and	O	O	O
KO(Grobet	O	O	B-T015
)	O	O	I-T015
mice	O	O	I-T015
,	O	O	O
as	O	O	O
compared	O	O	B-T052
to	O	O	O
wild-type	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Similarly	O	O	O
,	O	O	O
absolute	O	O	B-T042
maximal	O	O	I-T042
power	O	O	I-T042
was	O	O	O
increased	O	O	B-T081
in	O	O	O
6-month-old	O	O	O
KO(Lee	O	O	B-T015
)	O	O	I-T015
mice	O	O	I-T015
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
specific	O	O	B-T080
maximal	O	O	B-T042
force	O	O	I-T042
(	O	O	O
relative	O	O	B-T080
maximal	O	O	O
force	O	O	O
per	O	O	O
unit	O	O	O
of	O	O	O
muscle	O	O	B-T024
mass	O	O	B-T033
was	O	O	O
decreased	O	O	B-T081
in	O	O	O
all	O	O	O
6-month-old	O	O	O
male	O	O	B-T032
and	O	O	O
female	O	O	B-T032
KO	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
except	O	O	B-T169
in	O	O	O
6-month	O	O	B-T079
-old	O	O	O
female	O	O	O
KO(Grobet	O	O	B-T015
)	O	O	I-T015
mice	O	O	I-T015
,	O	O	O
whereas	O	O	O
specific	O	O	O
maximal	O	O	B-T040
power	O	O	I-T040
was	O	O	O
reduced	O	O	B-T080
only	O	O	O
in	O	O	O
male	O	O	O
KO(Lee	O	O	B-T015
)	O	O	I-T015
mice	O	O	I-T015
.	O	O	O

Genetic	O	O	B-T045
inactivation	O	O	I-T045
of	O	O	O
myostatin	O	O	B-T028
increases	O	O	B-T169
maximal	O	O	B-T042
force	O	O	I-T042
and	O	O	O
power	O	O	B-T040
,	O	O	O
but	O	O	O
in	O	O	O
return	O	O	B-T080
it	O	O	O
reduces	O	O	B-T080
muscle	O	O	B-T024
quality	O	O	B-T080
,	O	O	O
particularly	O	O	O
in	O	O	O
male	O	O	B-T032
mice	O	O	B-T015
.	O	O	O

Muscle	O	O	O
Nerve	O	O	O
55	O	O	O
:	O	O	O
254	O	O	O
-	O	O	O
261	O	O	O
,	O	O	O
2017	O	O	O
.	O	O	O

-DOCSTART- (27314612)

Methylation	O	O	B-T044
status	O	O	B-T080
of	O	O	O
the	O	O	O
promoter	O	O	B-T114
region	O	O	I-T114
of	O	O	O
the	O	O	O
human	O	O	B-T016
frizzled	O	O	B-T028
9	O	O	I-T028
gene	O	O	I-T028
in	O	O	O
acute	O	O	O
myeloid	O	O	O
leukemia	O	O	O

The	O	O	O
FZD9	O	O	B-T028
gene	O	O	I-T028
is	O	O	O
located	O	O	O
at	O	O	O
chromosome	O	O	B-T028
7q11.23	O	O	I-T028
,	O	O	O
and	O	O	O
has	O	O	O
been	O	O	O
indicated	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
tumor	O	O	B-T028
suppressor	O	O	I-T028
gene	O	O	I-T028
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
examined	O	O	B-T033
the	O	O	O
involvement	O	O	B-T169
of	O	O	O
FZD9	O	O	B-T028
promoter	O	O	B-T114
methylation	O	O	B-T044
in	O	O	O
the	O	O	O
downregulation	O	O	B-T044
of	O	O	O
FZD9	O	O	O
expression	O	O	B-T045
in	O	O	O
leukemia	O	O	B-T191
cells	O	O	B-T025
.	O	O	O

The	O	O	O
expression	O	O	B-T045
of	O	O	O
the	O	O	O
FZD9	O	O	B-T028
gene	O	O	I-T028
was	O	O	O
absent	O	O	B-T169
in	O	O	O
various	O	O	O
leukemic	O	O	B-T191
cell	O	O	B-T025
lines	O	O	I-T025
,	O	O	O
while	O	O	O
it	O	O	O
was	O	O	O
restored	O	O	O
following	O	O	O
treatment	O	O	B-T169
with	O	O	O
DNA	O	O	B-T109
demethylating	O	O	I-T109
agent	O	O	I-T109
5-aza-2'-deoxycytidine	O	O	B-T109
.	O	O	O

Bisulfite	O	O	B-T063
sequencing	O	O	I-T063
analysis	O	O	I-T063
of	O	O	O
the	O	O	O
FZD9	O	O	B-T028
promoter	O	O	B-T114
region	O	O	I-T114
showed	O	O	O
that	O	O	O
it	O	O	O
was	O	O	O
partially	O	O	O
methylated	O	O	B-T044
in	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
in	O	O	O
which	O	O	O
FZD9	O	O	B-T028
gene	O	O	I-T028
was	O	O	O
not	O	O	O
expressed	O	O	B-T045
.	O	O	O

Thus	O	O	O
,	O	O	O
DNA	O	O	B-T114
methylation	O	O	I-T044
in	O	O	O
the	O	O	O
promoter	O	O	B-T114
region	O	O	I-T114
may	O	O	O
lead	O	O	O
to	O	O	O
inactivation	O	O	B-T169
of	O	O	O
the	O	O	O
FZD9	O	O	B-T028
gene	O	O	I-T028
,	O	O	O
which	O	O	O
may	O	O	O
represent	O	O	O
and	O	O	O
aberration	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
leukemia	O	O	B-T191
,	O	O	O
since	O	O	O
DNA	O	O	O
was	O	O	O
not	O	O	O
methylated	O	O	B-T044
in	O	O	O
normal	O	O	O
peripheral	O	O	B-T025
blood	O	O	I-T025
mononuclear	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

Methylation	O	O	B-T044
-specific	O	O	O
polymerase	O	O	B-T063
chain	O	O	I-T063
reaction	O	O	I-T063
analysis	O	O	I-T063
revealed	O	O	O
that	O	O	O
the	O	O	O
promoter	O	O	B-T114
region	O	O	I-T114
of	O	O	O
the	O	O	O
FZD9	O	O	B-T028
gene	O	O	I-T028
was	O	O	O
frequently	O	O	B-T079
methylated	O	O	B-T044
in	O	O	O
primary	O	O	B-T080
or	O	O	O
relapse	O	O	B-T067
acute	O	O	B-T191
myeloid	O	O	I-T191
leukemia	O	O	I-T191
(	O	O	O
52.9	O	O	O
%	O	O	O
;	O	O	O
excluding	O	O	O
acute	O	O	B-T191
promyelocytic	O	O	I-T191
leukemia	O	O	I-T191
)	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
methylation	O	O	B-T044
was	O	O	O
infrequent	O	O	O
in	O	O	O
B-cell	O	O	B-T025
acute	O	O	B-T191
lymphocytic	O	O	I-T191
leukemia	O	O	I-T191
(	O	O	O
5.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
indicated	O	O	O
that	O	O	O
the	O	O	O
methylation	O	O	B-T044
profile	O	O	B-T059
of	O	O	O
the	O	O	O
FZD9	O	O	B-T028
gene	O	O	I-T028
corresponded	O	O	O
to	O	O	O
that	O	O	O
of	O	O	O
a	O	O	O
candidate	O	O	O
tumor-suppressor	O	O	B-T028
gene	O	O	I-T028
in	O	O	O
acute	O	O	B-T191
myeloid	O	O	I-T191
leukemia	O	O	I-T191
.	O	O	O

-DOCSTART- (27318197)

Identification	O	O	B-T080
of	O	O	O
a	O	O	O
group	O	O	B-T078
of	O	O	O
XTHs	O	O	B-T116
genes	O	O	B-T028
responding	O	O	O
to	O	O	O
heavy	O	O	B-T196
metal	O	O	I-T196
mercury	O	O	B-T131
,	O	O	O
salinity	O	O	B-T067
and	O	O	I-T067
drought	O	O	I-T067
stresses	O	O	I-T067
in	O	O	O
Medicago	O	O	O
truncatula	O	O	O

Xyloglucan	O	O	B-T116
endotransglucosylase/hydrolases	O	O	I-T116
(	O	O	O
XTH	O	O	B-T116
)	O	O	O
are	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
key	O	O	O
enzymes	O	O	B-T116
regulating	O	O	B-T038
cell	O	O	B-T043
wall	O	O	I-T043
construction	O	O	I-T043
,	O	O	O
extension	O	O	B-T169
and	O	O	O
metabolism	O	O	B-T025
.	O	O	O

In	O	O	O
the	O	O	O
study	O	O	B-T062
,	O	O	O
44	O	O	O
XTH	O	O	B-T116
protein	O	O	I-T116
genes	O	O	B-T028
from	O	O	O
Medicago	O	O	B-T002
truncatula	O	O	I-T002
genome	O	O	B-T028
were	O	O	O
identified	O	O	O
using	O	O	O
bioinformatics	O	O	B-T091
,	O	O	O
microarray	O	O	B-T073
and	O	O	O
RT-PCR	O	O	B-T063
.	O	O	O

Each	O	O	O
XTH	O	O	B-T116
was	O	O	O
showed	O	O	O
to	O	O	O
possess	O	O	O
a	O	O	O
highly	O	O	B-T087
conserved	O	O	I-T087
domain	O	O	I-T087
(	O	O	O
(D/N)-E-(I/L/F/V)-D-(F/I/L)-E-(F/L)-L-G	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
most	O	O	O
of	O	O	O
XTHs	O	O	B-T116
possess	O	O	O
four	O	O	O
Cys	O	O	B-T116
in	O	O	O
the	O	O	O
C	O	O	B-T087
terminal	O	O	I-T087
region	O	O	I-T087
,	O	O	O
which	O	O	O
suggests	O	O	O
the	O	O	O
potential	O	O	B-T080
for	O	O	O
generating	O	O	O
disulfide	O	O	B-T087
bonds	O	O	I-T087
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
XTH	O	O	B-T116
protein	O	O	B-T087
sequences	O	O	I-T087
,	O	O	O
these	O	O	O
XTHs	O	O	B-T116
can	O	O	O
be	O	O	O
classified	O	O	O
into	O	O	O
three	O	O	O
major	O	O	O
families	O	O	B-T116
and	O	O	O
each	O	O	O
family	O	O	B-T116
can	O	O	O
be	O	O	O
subdivided	O	O	O
into	O	O	O
more	O	O	O
groups	O	O	B-T078
.	O	O	O

Examination	O	O	O
of	O	O	O
the	O	O	O
genomic	O	O	B-T082
location	O	O	I-T082
of	O	O	O
XTH	O	O	B-T028
genes	O	O	B-T028
on	O	O	O
M.	O	O	B-T002
truncatula	O	O	I-T002
chromosomes	O	O	B-T026
showed	O	O	O
that	O	O	O
the	O	O	O
evolutional	O	O	B-T038
expansion	O	O	I-T038
of	O	O	O
the	O	O	O
genes	O	O	O
was	O	O	O
possibly	O	O	O
attributed	O	O	O
to	O	O	O
localized	O	O	B-T082
gene	O	O	B-T045
duplications	O	O	I-T045
.	O	O	O

To	O	O	O
investigate	O	O	O
the	O	O	O
possible	O	O	O
involvement	O	O	B-T169
of	O	O	O
the	O	O	O
XTHs	O	O	B-T116
responding	O	O	O
to	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
and	O	O	O
other	O	O	O
abiotic	O	O	B-T067
stresses	O	O	I-T067
,	O	O	O
the	O	O	O
XTH	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
exposed	O	O	O
to	O	O	O
heavy	O	O	B-T196
metal	O	O	I-T196
(	O	O	O
Hg	O	O	B-T131
or	O	O	O
Cu	O	O	B-T121
)	O	O	O
,	O	O	O
salt	O	O	B-T067
and	O	O	I-T067
drought	O	O	I-T067
stresses	O	O	I-T067
.	O	O	O

There	O	O	O
were	O	O	O
28	O	O	O
,	O	O	O
21	O	O	O
and	O	O	O
21	O	O	O
MtXTH	O	O	B-T028
genes	O	O	I-T028
found	O	O	O
to	O	O	O
respond	O	O	O
to	O	O	O
HgCl2	O	O	B-T121
,	O	O	O
salt	O	O	B-T067
and	O	O	I-T067
drought	O	O	I-T067
stresses	O	O	B-T067
,	O	O	O
respectively	O	O	O
,	O	O	O
but	O	O	O
their	O	O	O
expression	O	O	B-T045
were	O	O	O
different	O	O	O
under	O	O	O
the	O	O	O
stresses	O	O	O
.	O	O	O

Some	O	O	O
of	O	O	O
the	O	O	O
XTH	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
well	O	O	O
confirmed	O	O	O
by	O	O	O
quantitative	O	O	B-T081
RT-PCR	O	O	B-T063
(	O	O	O
qRT-PCR	O	O	B-T063
)	O	O	O
.	O	O	O

We	O	O	O
further	O	O	O
specified	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
a	O	O	O
XTH	O	O	B-T028
gene	O	O	I-T028
Medtr4g128580	O	O	B-T028
(	O	O	O
MtXTH3	O	O	B-T028
)	O	O	O
under	O	O	O
different	O	O	O
environmental	O	O	B-T067
stresses	O	O	I-T067
,	O	O	O
and	O	O	O
showed	O	O	O
that	O	O	O
MtXTH3	O	O	O
was	O	O	O
induced	O	O	O
by	O	O	O
Hg	O	O	B-T131
exposure	O	O	B-T080
.	O	O	O

These	O	O	O
results	O	O	B-T169
indicated	O	O	O
that	O	O	O
a	O	O	O
group	O	O	B-T078
of	O	O	O
MtXTHs	O	O	B-T028
could	O	O	O
be	O	O	O
differentially	O	O	O
expressed	O	O	B-T045
under	O	O	O
the	O	O	O
environmental	O	O	B-T067
stresses	O	O	I-T067
.	O	O	O

-DOCSTART- (27318553)

Vestibular	O	O	B-T047
disorders	O	O	I-T047
and	O	O	O
nausea	O	O	B-T184
during	O	O	O
head	O	O	B-T191
and	O	O	O
neck	O	O	B-T191
intensity-modulated	O	O	O
radiation	O	O	O
therapy	O	O	O

We	O	O	O
studied	O	O	O
whether	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
relationship	O	O	B-T080
between	O	O	O
nausea	O	O	B-T184
and	O	O	O
vestibular	O	O	B-T047
disorders	O	O	I-T047
in	O	O	O
patients	O	O	B-T101
treated	O	O	B-T061
with	O	O	I-T061
intensity	O	O	B-T061
modulated	O	O	I-T061
radiation	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
IMRT	O	O	B-T061
)	O	O	O
for	O	O	O
head	O	O	B-T191
and	O	O	O
neck	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
prospective	O	O	B-T062
single-centre	O	O	I-T062
study	O	O	I-T062
that	O	O	O
enrolled	O	O	B-T058
31	O	O	O
patients	O	O	B-T101
.	O	O	O

A	O	O	O
videonystagmography	O	O	B-T061
was	O	O	O
carried	O	O	O
out	O	O	O
before	O	O	O
and	O	O	O
within	O	O	O
15	O	O	O
days	O	O	O
after	O	O	O
radiation	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
each	O	O	O
patient	O	O	B-T101
.	O	O	O

Nausea	O	O	B-T184
was	O	O	O
assessed	O	O	O
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
every	O	O	O
week	O	O	O
,	O	O	O
and	O	O	O
at	O	O	O
the	O	O	O
post-radiotherapy	O	O	B-T061
videonystagmography	O	O	B-T061
visit	O	O	O
.	O	O	O

Twenty-six	O	O	O
patients	O	O	B-T101
had	O	O	O
benefited	O	O	O
from	O	O	O
a	O	O	O
complete	O	O	O
interpretable	O	O	O
videonystagmography	O	O	B-T061
.	O	O	O

For	O	O	O
14	O	O	O
of	O	O	O
these	O	O	O
patients	O	O	B-T101
vestibular	O	O	B-T033
damage	O	O	I-T033
was	O	O	O
diagnosed	O	O	B-T033
post-radiotherapy	O	O	B-T061
.	O	O	O

During	O	O	O
irradiation	O	O	B-T070
,	O	O	O
six	O	O	O
patients	O	O	B-T101
felt	O	O	O
nauseous	O	O	B-T184
,	O	O	O
but	O	O	O
without	O	O	O
dizziness	O	O	B-T184
.	O	O	O

In	O	O	O
univariate	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
we	O	O	O
found	O	O	O
a	O	O	O
relationship	O	O	B-T080
statistically	O	O	B-T081
significant	O	O	I-T081
between	O	O	O
the	O	O	O
average	O	O	O
dose	O	O	B-T081
received	O	O	O
by	O	O	O
the	O	O	O
vestibules	O	O	B-T030
and	O	O	O
vestibular	O	O	B-T047
disorder	O	O	I-T047
videonystagmography	O	O	B-T061
(	O	O	O
P=0.001	O	O	O
,	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
OR	O	O	B-T081
]	O	O	O
:	O	O	O
1.08	O	O	O
[	O	O	O
1.025-.138	O	O	O
]	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
relationship	O	O	O
between	O	O	O
vestibular	O	O	O
disorder	O	O	O
videonystagmography	O	O	O
and	O	O	O
nausea	O	O	B-T184
(	O	O	O
P=0.701	O	O	O
)	O	O	O
.	O	O	O

Irradiation	O	O	B-T070
of	O	O	O
the	O	O	O
vestibular	O	O	B-T022
system	O	O	I-T022
during	O	O	O
IMRT	O	O	B-T061
does	O	O	O
not	O	O	O
seem	O	O	O
to	O	O	O
explain	O	O	O
the	O	O	O
nausea	O	O	B-T184
.	O	O	O

-DOCSTART- (27318951)

Preventing	O	O	O
Youth	O	O	B-T100
Internalizing	O	O	B-T048
Symptoms	O	O	I-T048
Through	O	O	O
the	O	O	O
Familias	O	O	B-UnknownType
Unidas	O	O	I-UnknownType
Intervention	O	O	B-UnknownType
:	O	O	O
Examining	O	O	O
Variation	O	O	B-T081
in	O	O	O
Response	O	O	O

Prevention	O	O	B-T170
programs	O	O	I-T170
that	O	O	O
strengthen	O	O	O
parenting	O	O	B-T054
and	O	O	O
family	O	O	B-T054
functioning	O	O	I-T054
have	O	O	O
been	O	O	O
found	O	O	O
to	O	O	O
reduce	O	O	B-T061
poor	O	O	B-T184
behavioral	O	O	I-T184
outcomes	O	O	O
in	O	O	O
adolescents	O	O	B-T100
,	O	O	O
including	O	O	O
substance	O	O	B-T048
use	O	O	I-T048
,	O	O	O
HIV	O	O	B-T033
risk	O	O	I-T033
,	O	O	O
externalizing	O	O	O
and	O	O	O
internalizing	O	O	B-T048
problems	O	O	I-T048
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
evidence	O	O	O
that	O	O	O
not	O	O	O
all	O	O	O
youth	O	O	B-T100
benefit	O	O	O
similarly	O	O	O
from	O	O	O
these	O	O	O
programs	O	O	B-T170
.	O	O	O

Familias	O	O	B-UnknownType
Unidas	O	O	I-UnknownType
is	O	O	O
a	O	O	O
family-focused	O	O	B-UnknownType
intervention	O	O	I-UnknownType
designed	O	O	O
to	O	O	O
prevent	O	O	O
substance	O	O	B-T048
use	O	O	I-T048
and	O	O	O
sexual	O	O	B-T033
risk	O	O	I-T033
among	O	O	O
Hispanic	O	O	B-T098
youth	O	O	B-T100
and	O	O	O
has	O	O	O
recently	O	O	O
demonstrated	O	O	O
unanticipated	O	O	O
reductions	O	O	B-T061
in	O	O	O
internalizing	O	O	B-T048
symptoms	O	O	I-T048
for	O	O	O
some	O	O	O
youth	O	O	O
.	O	O	O

This	O	O	O
paper	O	O	O
examines	O	O	O
variation	O	O	O
in	O	O	O
intervention	O	O	B-UnknownType
response	O	O	O
for	O	O	O
internalizing	O	O	B-T048
symptoms	O	O	I-T048
using	O	O	O
individual-level	O	O	B-UnknownType
data	O	O	I-UnknownType
pooled	O	O	O
across	O	O	O
four	O	O	O
distinct	O	O	O
Familias	O	O	B-UnknownType
Unidas	O	O	I-UnknownType
trials	O	O	B-T062
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
266	O	O	O
eighth	O	O	B-T033
grade	O	O	I-T033
students	O	O	B-T098
recruited	O	O	O
from	O	O	O
the	O	O	O
general	O	O	O
school	O	O	B-T098
population	O	O	I-T098
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
160	O	O	O
ninth	O	O	B-T033
grade	O	O	I-T033
students	O	O	O
from	O	O	O
the	O	O	O
general	O	O	O
school	O	O	O
population	O	O	O
;	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
213	O	O	O
adolescents	O	O	B-T100
with	O	O	O
conduct	O	O	B-T048
,	O	O	O
aggression	O	O	B-T055
,	O	O	O
and/or	O	O	O
attention	O	O	B-T033
problems	O	O	I-T033
;	O	O	O
and	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
242	O	O	O
adolescents	O	O	O
with	O	O	O
a	O	O	O
delinquency	O	O	B-T048
history	O	O	O
.	O	O	O

Causal	O	O	B-UnknownType
inference	O	O	I-UnknownType
growth	O	O	I-UnknownType
mixture	O	O	I-UnknownType
modeling	O	O	I-UnknownType
suggests	O	O	O
a	O	O	O
three-	O	O	O
class	O	O	B-T185
model	O	O	B-T170
.	O	O	O

The	O	O	O
two	O	O	O
largest	O	O	O
classes	O	O	B-T185
represent	O	O	O
youth	O	O	B-T100
with	O	O	O
low	O	O	B-T080
(	O	O	O
60	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
medium	O	O	B-T081
(	O	O	O
27	O	O	O
%	O	O	O
)	O	O	O
internalizing	O	O	B-T048
symptoms	O	O	I-T048
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
and	O	O	O
both	O	O	O
intervention	O	O	B-UnknownType
and	O	O	O
control	O	O	B-T096
participants	O	O	B-T098
show	O	O	O
reductions	O	O	B-T061
in	O	O	O
internalizing	O	O	O
symptoms	O	O	O
.	O	O	O

The	O	O	O
third	O	O	O
class	O	O	B-T185
(	O	O	O
13	O	O	O
%	O	O	O
)	O	O	O
represents	O	O	O
youth	O	O	B-T100
with	O	O	O
high	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
baseline	O	O	B-T081
internalizing	O	O	B-T048
symptoms	O	O	B-T048
who	O	O	O
remain	O	O	O
at	O	O	O
steady	O	O	B-T080
levels	O	O	O
of	O	O	O
internalizing	O	O	O
symptoms	O	O	O
when	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
the	O	O	O
intervention	O	O	B-UnknownType
,	O	O	O
but	O	O	O
who	O	O	O
experience	O	O	O
an	O	O	O
increase	O	O	O
in	O	O	O
symptoms	O	O	O
under	O	O	O
the	O	O	O
control	O	O	B-T080
condition	O	O	I-T080
.	O	O	O

Female	O	O	B-T032
gender	O	O	I-T032
,	O	O	O
low	O	O	B-T080
baseline	O	O	B-T081
levels	O	O	B-T080
of	O	O	O
parent	O	O	B-T099
-	O	O	O
adolescent	O	O	B-T100
communication	O	O	B-T054
,	O	O	O
and	O	O	O
older	O	O	B-T098
age	O	O	I-T098
were	O	O	O
associated	O	O	O
with	O	O	O
membership	O	O	O
in	O	O	O
the	O	O	O
high-risk	O	O	B-T033
class	O	O	B-T185
.	O	O	O

These	O	O	O
synthesis	O	O	O
analyses	O	O	O
involving	O	O	O
a	O	O	O
large	O	O	O
sample	O	O	O
of	O	O	O
youth	O	O	B-T100
with	O	O	O
varying	O	O	O
initial	O	O	B-T080
risk	O	O	I-T080
levels	O	O	I-T080
represent	O	O	O
a	O	O	O
further	O	O	O
step	O	O	O
toward	O	O	O
strengthening	O	O	O
our	O	O	O
knowledge	O	O	O
of	O	O	O
preventive	O	O	B-UnknownType
intervention	O	O	I-UnknownType
response	O	O	B-T201
and	O	O	O
improving	O	O	O
preventive	O	O	B-UnknownType
interventions	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (27319985)

Acute	O	O	B-T037
Kidney	O	O	I-T037
Injury	O	O	I-T037
Severity	O	O	B-T080
and	O	O	O
Long-Term	O	O	B-T079
Readmission	O	O	B-T058
and	O	O	O
Mortality	O	O	B-T081
After	O	O	O
Cardiac	O	O	O
Surgery	O	O	O

Acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
(	O	O	O
AKI	O	O	B-T037
)	O	O	O
is	O	O	O
a	O	O	O
common	O	O	O
complication	O	O	B-T046
after	O	O	O
cardiac	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

While	O	O	O
AKI	O	O	B-T037
severity	O	O	B-T080
is	O	O	O
known	O	O	O
to	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
short-term	O	O	B-T079
outcomes	O	O	O
,	O	O	O
its	O	O	O
long-term	O	O	B-T079
impact	O	O	O
is	O	O	O
less	O	O	O
well	O	O	O
understood	O	O	O
.	O	O	O

Adult	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
isolated	O	O	O
coronary	O	O	B-T061
artery	O	O	I-T061
bypass	O	O	I-T061
graft	O	O	I-T061
surgery	O	O	I-T061
at	O	O	O
eight	O	O	O
centers	O	O	O
were	O	O	O
enrolled	O	O	O
into	O	O	O
the	O	O	O
Northern	O	O	B-T170
New	O	O	I-T170
England	O	O	I-T170
biomarker	O	O	I-T170
registry	O	O	I-T170
(	O	O	O
n	O	O	O
=	O	O	O
1,610	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
excluded	O	O	O
if	O	O	O
they	O	O	O
had	O	O	O
renal	O	O	B-T047
failure	O	O	I-T047
(	O	O	O
n	O	O	O
=	O	O	O
15	O	O	O
)	O	O	O
or	O	O	O
died	O	O	B-T033
during	O	O	O
index	O	O	B-T058
admission	O	O	I-T058
(	O	O	O
n	O	O	O
=	O	O	O
38	O	O	O
)	O	O	O
.	O	O	O

Severity	O	O	B-T080
of	O	O	O
AKI	O	O	B-T037
was	O	O	O
defined	O	O	O
using	O	O	O
the	O	O	O
Acute	O	O	B-T185
Kidney	O	O	I-T185
Injury	O	O	I-T185
Network	O	O	I-T185
(	O	O	O
AKIN	O	O	B-T185
)	O	O	O
.	O	O	O

We	O	O	O
linked	O	O	O
our	O	O	O
cohort	O	O	B-T081
to	O	O	O
national	O	O	B-T093
Medicare	O	O	I-T093
and	O	O	O
state	O	O	B-T170
all-payer	O	O	I-T170
claims	O	O	I-T170
to	O	O	O
ascertain	O	O	O
readmissions	O	O	B-T058
and	O	O	O
to	O	O	O
the	O	O	O
National	O	O	B-T170
Death	O	O	I-T170
Index	O	O	I-T170
to	O	O	O
ascertain	O	O	O
survival	O	O	B-T169
.	O	O	O

Kaplan-Meier	O	O	B-T081
and	O	O	O
multivariate	O	O	B-T081
Cox	O	O	I-T081
proportional	O	O	I-T081
hazards	O	O	I-T081
modeling	O	O	I-T081
was	O	O	O
conducted	O	O	O
for	O	O	O
time	O	O	O
to	O	O	O
readmission	O	O	B-T058
and	O	O	O
death	O	O	B-T033
over	O	O	O
5	O	O	O
years	O	O	O
.	O	O	O

Within	O	O	O
5	O	O	O
years	O	O	O
,	O	O	O
513	O	O	O
patients	O	O	B-T101
(	O	O	O
33.8	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
AKI	O	O	B-T037
with	O	O	O
AKIN	O	O	B-T185
stage	O	O	O
1	O	O	O
(	O	O	O
29.9	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
stage	O	O	O
2	O	O	O
to	O	O	O
3	O	O	O
(	O	O	O
3.9	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
620	O	O	O
readmissions	O	O	B-T058
(	O	O	O
39.9	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
370	O	O	O
deaths	O	O	B-T033
(	O	O	O
23.8	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
adjustment	O	O	O
,	O	O	O
stage	O	O	O
1	O	O	O
AKI	O	O	B-T037
patients	O	O	B-T101
had	O	O	O
a	O	O	O
31	O	O	O
%	O	O	O
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
readmission	O	O	B-T058
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
:	O	O	O
1.10	O	O	O
to	O	O	O
1.57	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
stage	O	O	O
2	O	O	O
or	O	O	O
3	O	O	O
patients	O	O	O
had	O	O	O
a	O	O	O
98	O	O	O
%	O	O	O
increased	O	O	O
risk	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.41	O	O	O
to	O	O	O
2.78	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
patients	O	O	O
having	O	O	O
no	O	O	B-T033
AKI	O	O	O
.	O	O	O

Relative	O	O	O
to	O	O	O
patients	O	O	B-T101
without	O	O	O
AKI	O	O	B-T037
,	O	O	O
stage	O	O	O
1	O	O	O
patients	O	O	O
had	O	O	O
a	O	O	O
56	O	O	O
%	O	O	O
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
mortality	O	O	B-T081
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
1.14	O	O	O
to	O	O	O
2.13	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
stage	O	O	O
2	O	O	O
or	O	O	O
3	O	O	O
patients	O	O	O
had	O	O	O
a	O	O	O
3.5	O	O	O
times	O	O	O
higher	O	O	O
risk	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
2.16	O	O	O
to	O	O	O
5.60	O	O	O
)	O	O	O
.	O	O	O

Severity	O	O	B-T080
of	O	O	O
AKI	O	O	B-T037
using	O	O	O
the	O	O	O
AKIN	O	O	B-T185
stage	O	O	O
criteria	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
significantly	O	O	O
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
5-year	O	O	O
readmission	O	O	B-T058
and	O	O	O
mortality	O	O	B-T081
.	O	O	O

Our	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
efforts	O	O	O
to	O	O	O
reduce	O	O	O
AKI	O	O	B-T037
in	O	O	O
the	O	O	O
perioperative	O	O	B-T079
period	O	O	I-T079
may	O	O	O
have	O	O	O
a	O	O	O
significant	O	O	O
long-term	O	O	B-T079
impact	O	O	O
on	O	O	O
patients	O	O	B-T101
and	O	O	O
payers	O	O	O
in	O	O	O
reducing	O	O	O
mortality	O	O	B-T081
and	O	O	O
health	O	O	B-T058
care	O	O	I-T058
utilization	O	O	I-T058
.	O	O	O

-DOCSTART- (27321338)

Association	O	O	B-T080
of	O	O	O
abdominal	O	O	B-T024
fat	O	O	I-T024
with	O	O	O
serum	O	O	B-T031
amylase	O	O	B-T116
in	O	O	O
an	O	O	O
older	O	O	B-T098
cohort	O	O	B-T098
:	O	O	O
The	O	O	O
Baltimore	O	O	B-T083
Longitudinal	O	O	B-T062
Study	O	O	I-T062
of	O	O	O
Aging	O	O	O

Abdominal	O	O	B-T024
fat	O	O	I-T024
is	O	O	O
a	O	O	O
major	O	O	O
determinant	O	O	B-T169
of	O	O	O
metabolic	O	O	B-T047
diseases	O	O	I-T047
in	O	O	O
older	O	O	B-T098
individuals	O	O	B-T098
.	O	O	O

Obesity	O	O	B-T047
and	O	O	O
diabetes	O	O	B-T047
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
low	O	O	B-T080
serum	O	O	B-T033
amylase	O	O	I-T033
(	O	O	I-T033
SA	O	O	B-T033
)	O	O	I-T033
levels	O	O	I-T033
,	O	O	O
but	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
SA	O	O	O
and	O	O	O
metabolic	O	O	B-T047
disease	O	O	I-T047
is	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
the	O	O	O
association	O	O	B-T080
of	O	O	O
low	O	O	B-T080
SA	O	O	B-T033
with	O	O	O
diabetes	O	O	B-T047
and	O	O	O
sex	O	O	B-T032
-	O	O	O
specific	O	O	B-T080
associations	O	O	B-T080
of	O	O	O
serum	O	O	B-T031
amylase	O	O	B-T116
with	O	O	O
abdominal	O	O	B-T024
fat	O	O	I-T024
in	O	O	O
older	O	O	B-T100
adults	O	O	I-T100
.	O	O	O

In	O	O	O
community-dwelling	O	O	B-T056
volunteers	O	O	B-T098
from	O	O	O
the	O	O	O
Baltimore	O	O	B-T083
Longitudinal	O	O	B-T062
Study	O	O	I-T062
of	O	O	O
Aging	O	O	B-T040
(	O	O	O
778	O	O	O
participants	O	O	B-T098
,	O	O	O
age	O	O	B-T032
66.8±13.6	O	O	O
years	O	O	B-T079
)	O	O	O
,	O	O	O
we	O	O	O
assessed	O	O	B-T052
abdominal	O	O	B-T024
fat	O	O	I-T024
by	O	O	O
computed	O	O	B-T060
tomography	O	O	I-T060
and	O	O	O
diabetes	O	O	B-T033
status	O	O	I-T033
using	O	O	O
the	O	O	O
American	O	O	B-T094
Diabetes	O	O	I-T094
Association	O	O	I-T094
criteria	O	O	B-T078
.	O	O	O

Linear	O	O	B-T081
regression	O	O	I-T081
analyses	O	O	I-T081
assessed	O	O	B-T052
the	O	O	O
cross-sectional	O	O	B-T080
associations	O	O	I-T080
between	O	O	O
abdominal	O	O	B-T024
fat	O	O	I-T024
and	O	O	O
SA	O	O	B-T033
,	O	O	O
and	O	O	O
logistic	O	O	B-T062
regression	O	O	I-T062
assessed	O	O	O
the	O	O	O
odds	O	O	B-T081
of	O	O	O
diabetes	O	O	B-T047
,	O	O	O
given	O	O	O
low	O	O	B-T080
SA	O	O	O
.	O	O	O

In	O	O	O
unadjusted	O	O	B-T062
analyses	O	O	I-T062
,	O	O	O
individuals	O	O	B-T098
in	O	O	O
the	O	O	O
lowest	O	O	B-T080
SA	O	O	B-T033
quartile	O	O	B-T080
(	O	O	O
<	O	O	O
48μ/L	O	O	O
)	O	O	O
had	O	O	O
1.97	O	O	O
greater	O	O	O
odds	O	O	B-T081
of	O	O	O
diabetes	O	O	B-T047
,	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
1.01	O	O	O
-	O	O	O
3.83	O	O	O
)	O	O	O
than	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
highest	O	O	O
quartile	O	O	O
(	O	O	O
⩾80μ/L	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
association	O	O	B-T080
was	O	O	O
no	O	O	O
longer	O	O	O
significant	O	O	B-T078
after	O	O	O
adjusting	O	O	O
for	O	O	O
visceral	O	O	B-T024
adipose	O	O	I-T024
tissue	O	O	I-T024
area	O	O	I-T024
(	O	O	O
VAT	O	O	B-T024
,	O	O	O
dm(2	O	O	O
)	O	O	O
)	O	O	O
,	O	O	O
abdominal	O	O	B-T024
subcutaneous	O	O	I-T024
adipose	O	O	I-T024
tissue	O	O	I-T024
(	O	O	O
SAT	O	O	B-T024
,	O	O	O
dm(2	O	O	O
)	O	O	O
)	O	O	O
or	O	O	O
BMI	O	O	B-T201
.	O	O	O

In	O	O	O
adjusted	O	O	B-T062
analyses	O	O	I-T062
,	O	O	O
VAT	O	O	B-T024
and	O	O	O
SAT	O	O	B-T024
were	O	O	O
significantly	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
SA	O	O	B-T033
in	O	O	O
both	O	O	O
sexes	O	O	B-T032
.	O	O	O

Among	O	O	O
women	O	O	B-T098
,	O	O	O
SA	O	O	B-T033
was	O	O	O
more	O	O	O
strongly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
VAT	O	O	B-T024
than	O	O	O
with	O	O	O
SAT	O	O	B-T024
or	O	O	O
BMI	O	O	B-T201
;	O	O	O
VAT	O	O	O
(	O	O	O
β=-0.117±0.048	O	O	O
,	O	O	O
P<0.001	O	O	O
)	O	O	O
,	O	O	O
SAT	O	O	O
(	O	O	O
β=-0.023±0.025	O	O	O
,	O	O	O
P=0.346	O	O	O
)	O	O	O
and	O	O	O
BMI	O	O	O
(	O	O	O
β=-0.0052±0.075	O	O	O
,	O	O	O
P=0.49	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
association	O	O	B-T080
between	O	O	O
SA	O	O	B-T116
and	O	O	O
diabetes	O	O	B-T047
was	O	O	O
explained	O	O	O
mainly	O	O	O
by	O	O	O
abdominal	O	O	B-T024
visceral	O	O	I-T024
fat	O	O	I-T024
.	O	O	O

In	O	O	O
women	O	O	B-T098
,	O	O	O
SA	O	O	B-T116
was	O	O	O
more	O	O	O
strongly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
VAT	O	O	B-T024
than	O	O	O
with	O	O	O
BMI	O	O	B-T201
or	O	O	O
SAT	O	O	B-T024
.	O	O	O

These	O	O	O
findings	O	O	O
provide	O	O	O
motivation	O	O	O
for	O	O	O
future	O	O	O
mechanistic	O	O	B-T089
studies	O	O	I-T089
on	O	O	O
SA	O	O	B-T116
's	O	O	I-T116
role	O	O	O
in	O	O	O
metabolic	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

-DOCSTART- (27321568)

Efficacy	O	O	B-T080
of	O	O	O
Intravenous	O	O	B-T082
Chlorothiazide	O	O	B-T109
for	O	O	O
Refractory	O	O	B-T169
Acute	O	O	B-T047
Decompensated	O	O	I-T047
Heart	O	O	I-T047
Failure	O	O	I-T047
Unresponsive	O	O	B-T169
to	O	O	O
Adjunct	O	O	B-T169
Metolazone	O	O	O

To	O	O	O
assess	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
intravenous	O	O	B-T082
chlorothiazide	O	O	B-T109
in	O	O	O
patients	O	O	B-T101
with	O	O	O
acute	O	O	B-T047
decompensated	O	O	I-T047
heart	O	O	I-T047
failure	O	O	I-T047
(	O	O	O
ADHF	O	O	B-T047
)	O	O	O
who	O	O	O
were	O	O	O
determined	O	O	O
to	O	O	O
be	O	O	O
loop	O	O	B-T121
diuretic	O	O	I-T121
resistant	O	O	B-T169
and	O	O	O
refractory	O	O	B-T169
to	O	O	O
metolazone	O	O	B-T109
.	O	O	O

Retrospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
with	O	O	O
patients	O	O	B-T101
serving	O	O	O
as	O	O	O
their	O	O	O
own	O	O	O
controls	O	O	B-T096
.	O	O	O

Large	O	O	B-T081
,	O	O	O
academic	O	O	B-T092
,	O	O	O
tertiary	O	O	B-T093
care	O	O	I-T093
hospital	O	O	I-T093
.	O	O	O

Forty-five	O	O	O
patients	O	O	B-T101
with	O	O	O
ADHF	O	O	B-T047
who	O	O	O
had	O	O	O
an	O	O	O
inadequate	O	O	B-T080
response	O	O	B-T032
to	O	O	O
high-dose	O	O	B-T081
loop	O	O	B-T121
diuretics	O	O	I-T121
and	O	O	O
then	O	O	O
received	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
dose	O	O	B-T081
of	O	O	O
oral	O	O	B-T082
metolazone	O	O	B-T109
5	O	O	O
mg	O	O	O
or	O	O	O
greater	O	O	B-T081
(	O	O	O
metolazone	O	O	O
index	O	O	B-T081
dose	O	O	I-T081
)	O	O	O
followed	O	O	O
by	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
dose	O	O	O
of	O	O	O
intravenous	O	O	B-T082
chlorothiazide	O	O	B-T109
500	O	O	O
mg	O	O	O
(	O	O	O
chlorothiazide	O	O	O
index	O	O	O
dose	O	O	O
)	O	O	O
if	O	O	O
the	O	O	O
response	O	O	O
to	O	O	O
metolazone	O	O	O
was	O	O	O
considered	O	O	O
inadequate	O	O	O
,	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
institutional	O	O	B-T170
protocol	O	O	I-T170
,	O	O	O
between	O	O	O
February	O	O	O
4	O	O	O
,	O	O	O
2013	O	O	O
,	O	O	O
and	O	O	O
February	O	O	O
28	O	O	O
,	O	O	O
2015	O	O	O
,	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

If	O	O	O
multiple	O	O	O
doses	O	O	B-T081
of	O	O	O
metolazone	O	O	B-T109
were	O	O	O
administered	O	O	B-T058
,	O	O	O
the	O	O	O
last	O	O	O
dose	O	O	B-T081
given	O	O	O
before	O	O	O
the	O	O	O
chlorothiazide	O	O	B-T109
index	O	O	B-T081
dose	O	O	I-T081
was	O	O	O
considered	O	O	O
the	O	O	O
index	O	O	O
dose	O	O	O
;	O	O	O
the	O	O	O
metolazone	O	O	O
index	O	O	O
dose	O	O	O
had	O	O	O
to	O	O	O
have	O	O	O
been	O	O	O
administered	O	O	O
more	O	O	O
than	O	O	O
2	O	O	O
hours	O	O	B-T079
before	O	O	O
the	O	O	O
chlorothiazide	O	O	O
index	O	O	O
dose	O	O	O
.	O	O	O

Data	O	O	B-T078
for	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
90	O	O	O
diuretic	O	O	B-T121
doses	O	O	B-T081
(	O	O	O
45	O	O	O
metolazone	O	O	B-T109
,	O	O	O
45	O	O	O
chlorothiazide	O	O	B-T109
)	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
analysis	O	O	B-T062
.	O	O	O

The	O	O	O
median	O	O	O
dose	O	O	B-T081
of	O	O	O
loop	O	O	B-T121
diuretic	O	O	I-T121
in	O	O	O
intravenous	O	O	B-T082
furosemide	O	O	B-T109
equivalents	O	O	O
given	O	O	O
over	O	O	O
the	O	O	O
24-	O	O	O
hour	O	O	B-T079
period	O	O	B-T079
before	O	O	O
the	O	O	O
metolazone	O	O	B-T109
index	O	O	B-T081
dose	O	O	I-T081
was	O	O	O
400	O	O	O
mg	O	O	O
.	O	O	O

The	O	O	O
average	O	O	O
length	O	O	O
of	O	O	O
stay	O	O	B-T079
was	O	O	O
34.7	O	O	O
days	O	O	B-T079
,	O	O	O
and	O	O	O
in-hospital	O	O	B-T080
mortality	O	O	I-T080
was	O	O	O
35.6	O	O	O
%	O	O	O
(	O	O	O
16/45	O	O	O
patients	O	O	B-T101
)	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	O
end	O	O	B-T080
point	O	O	I-T080
of	O	O	O
a	O	O	O
net-negative	O	O	B-T033
urine	O	O	B-T201
output	O	O	I-T201
of	O	O	O
500	O	O	O
ml	O	O	O
or	O	O	O
greater	O	O	O
during	O	O	O
the	O	O	O
12	O	O	O
hours	O	O	B-T079
after	O	O	O
the	O	O	O
index	O	O	B-T081
dose	O	O	I-T081
occurred	O	O	O
in	O	O	O
42.2	O	O	O
%	O	O	O
(	O	O	O
19/45	O	O	O
patients	O	O	B-T101
)	O	O	O
and	O	O	O
35.5	O	O	O
%	O	O	O
(	O	O	O
16/45	O	O	O
patients	O	O	O
)	O	O	O
for	O	O	O
the	O	O	O
chlorothiazide	O	O	B-T109
and	O	O	O
metolazone	O	O	B-T109
doses	O	O	B-T081
,	O	O	O
respectively	O	O	O
(	O	O	O
p=0.581	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
median	O	O	O
12-	O	O	O
hour	O	O	B-T079
urine	O	O	B-T201
output	O	O	I-T201
following	O	O	O
administration	O	O	B-T081
of	O	O	O
metolazone	O	O	B-T109
was	O	O	O
810	O	O	O
ml	O	O	O
(	O	O	O
interquartile	O	O	B-T081
range	O	O	I-T081
[	O	O	O
IQR	O	O	B-T081
]	O	O	O
866	O	O	O
ml	O	O	O
)	O	O	O
versus	O	O	O
1075	O	O	O
ml	O	O	O
(	O	O	O
IQR	O	O	O
940	O	O	O
ml	O	O	O
)	O	O	O
following	O	O	O
administration	O	O	O
of	O	O	O
chlorothiazide	O	O	B-T109
(	O	O	O
p=0.363	O	O	O
)	O	O	O
.	O	O	O

Compared	O	O	B-T052
with	O	O	O
metolazone	O	O	B-T109
,	O	O	O
the	O	O	O
chlorothiazide	O	O	B-T109
doses	O	O	B-T081
did	O	O	O
not	O	O	O
result	O	O	O
in	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
urine	O	O	B-T201
output	O	O	I-T201
of	O	O	O
at	O	O	O
least	O	O	O
500	O	O	O
ml	O	O	O
during	O	O	O
the	O	O	O
12	O	O	O
hours	O	O	B-T079
following	O	O	O
the	O	O	O
dose	O	O	B-T081
relative	O	O	O
to	O	O	O
the	O	O	O
12	O	O	O
hours	O	O	O
before	O	O	O
the	O	O	O
dose	O	O	O
(	O	O	O
31.1	O	O	O
%	O	O	O
vs	O	O	O
22.2	O	O	O
%	O	O	O
,	O	O	O
p=0.754	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
significant	O	O	O
difference	O	O	O
in	O	O	O
achievement	O	O	O
of	O	O	O
net-negative	O	O	B-T033
urine	O	O	B-T201
output	O	O	I-T201
of	O	O	O
500	O	O	O
ml	O	O	O
or	O	O	O
greater	O	O	O
during	O	O	O
the	O	O	O
12	O	O	O
hours	O	O	B-T079
following	O	O	O
the	O	O	O
chlorothiazide	O	O	B-T109
or	O	O	O
metolazone	O	O	B-T109
dose	O	O	B-T081
was	O	O	O
noted	O	O	O
(	O	O	O
42.2	O	O	O
%	O	O	O
for	O	O	O
chlorothiazide	O	O	O
vs	O	O	O
35.5	O	O	O
%	O	O	O
for	O	O	O
metolazone	O	O	O
,	O	O	O
p=0.581	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
addition	O	O	O
of	O	O	O
intravenous	O	O	B-T082
chlorothiazide	O	O	B-T109
did	O	O	O
not	O	O	O
result	O	O	O
in	O	O	O
improved	O	O	B-T033
diuresis	O	O	B-T042
in	O	O	O
patients	O	O	B-T101
with	O	O	O
ADHF	O	O	B-T047
determined	O	O	O
to	O	O	O
be	O	O	O
refractory	O	O	B-T169
to	O	O	O
loop	O	O	B-T121
diuretic	O	O	I-T121
s	O	O	O
and	O	O	O
adjunctive	O	O	B-T169
oral	O	O	B-T082
metolazone	O	O	B-T109
.	O	O	O

-DOCSTART- (27322653)

Comparisons	O	O	B-T052
of	O	O	O
Safety	O	O	B-T068
and	O	O	O
Clinical	O	O	B-T080
Outcomes	O	O	B-T169
Between	O	O	O
Multiple-level	O	O	B-T061
and	O	O	O
Single-level	O	O	B-T061
Cervical	O	O	I-T061
Disk	O	O	I-T061
Replacement	O	O	I-T061
for	O	O	O
Cervical	O	O	B-T047
Spondylosis	O	O	I-T047
:	O	O	O
A	O	O	O
Systematic	O	O	B-T170
Review	O	O	I-T170
and	O	O	O
Meta-analysis	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
and	O	O	O
meta-analysis	O	O	B-T170
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	B-T169
the	O	O	O
efficacy	O	O	B-T080
and	O	O	O
safety	O	O	B-T068
of	O	O	O
multiple-level	O	O	B-T061
cervical	O	O	I-T061
disk	O	O	I-T061
replacement	O	O	I-T061
(	O	O	O
CDR	O	O	B-T061
)	O	O	O
over	O	O	O
single-level	O	O	B-T061
CDR	O	O	I-T061
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
cervical	O	O	B-T047
spondylosis	O	O	I-T047
.	O	O	O

Some	O	O	O
authors	O	O	O
advocate	O	O	O
for	O	O	O
the	O	O	O
multiple-level	O	O	B-T061
CDR	O	O	I-T061
instead	O	O	O
of	O	O	O
anterior	O	O	B-T082
decompression	O	O	B-T061
and	O	O	O
fusion	O	O	B-T061
in	O	O	O
cervical	O	O	B-T047
multiple-level	O	O	I-T047
spondylosis	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
whether	O	O	O
the	O	O	O
efficacy	O	O	B-T080
and	O	O	O
safety	O	O	B-T068
of	O	O	O
multi-level	O	O	B-T061
CDR	O	O	I-T061
are	O	O	O
as	O	O	O
favorable	O	O	O
as	O	O	O
that	O	O	O
of	O	O	O
single-level	O	O	B-T061
CDR	O	O	I-T061
remains	O	O	O
controversial	O	O	O
.	O	O	O

MEDLINE	O	O	B-T170
,	O	O	O
EMBASE	O	O	B-T170
,	O	O	O
and	O	O	O
Cochrane	O	O	B-T170
library	O	O	I-T170
databases	O	O	I-T170
were	O	O	O
searched	O	O	O
up	O	O	O
to	O	O	O
November	O	O	O
2015	O	O	O
for	O	O	O
controlled	O	O	B-T062
studies	O	O	I-T062
that	O	O	O
compared	O	O	B-T052
the	O	O	O
clinical	O	O	B-T080
outcomes	O	O	B-T169
of	O	O	O
single-level	O	O	B-T061
and	O	O	O
multiple-level	O	O	B-T061
CDR	O	O	I-T061
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
cervical	O	O	B-T047
spondylosis	O	O	I-T047
.	O	O	O

The	O	O	O
following	O	O	O
outcomes	O	O	B-T169
were	O	O	O
extracted	O	O	O
and	O	O	O
analyzed	O	O	B-T062
:	O	O	O
prevalence	O	O	B-T081
of	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
and	O	O	O
reoperation	O	O	B-T061
,	O	O	O
preoperative	O	O	B-T079
and	O	O	O
postoperative	O	O	B-T079
Neck	O	O	B-T033
Disability	O	O	I-T033
Index	O	O	I-T033
scores	O	O	I-T033
,	O	O	O
preoperative	O	O	O
and	O	O	O
postoperative	O	O	O
Visual	O	O	B-T201
Analog	O	O	I-T201
Scale	O	O	I-T201
scores	O	O	I-T201
,	O	O	O
and	O	O	O
success	O	O	B-T080
rate	O	O	B-T081
using	O	O	O
the	O	O	O
Odom	O	O	B-T185
grading	O	O	I-T185
system	O	O	I-T185
.	O	O	O

Ten	O	O	O
studies	O	O	B-T062
involving	O	O	O
1402	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
:	O	O	O
including	O	O	O
3	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
,	O	O	O
5	O	O	O
prospective	O	O	B-T062
studies	O	O	I-T062
,	O	O	O
and	O	O	O
3	O	O	O
retrospective	O	O	B-T062
studies	O	O	I-T062
.	O	O	O

No	O	O	O
significant	O	O	O
differences	O	O	O
between	O	O	O
single-level	O	O	B-T061
and	O	O	O
multiple-level	O	O	B-T061
groups	O	O	O
were	O	O	O
found	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
and	O	O	O
reoperation	O	O	B-T061
rate	O	O	B-T081
,	O	O	O
Neck	O	O	B-T033
Disability	O	O	I-T033
Index	O	O	I-T033
score	O	O	I-T033
,	O	O	O
Visual	O	O	B-T201
Analog	O	O	I-T201
Scale	O	O	I-T201
score	O	O	I-T201
,	O	O	O
and	O	O	O
success	O	O	B-T080
rate	O	O	O
using	O	O	O
the	O	O	O
Odom	O	O	B-T185
grading	O	O	I-T185
system	O	O	I-T185
.	O	O	O

On	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
this	O	O	O
meta-analysis	O	O	B-T170
,	O	O	O
clinical	O	O	B-T080
outcomes	O	O	B-T169
of	O	O	O
multiple-level	O	O	B-T061
CDR	O	O	I-T061
are	O	O	O
similar	O	O	O
to	O	O	O
those	O	O	O
of	O	O	O
single-level	O	O	B-T061
CDR	O	O	I-T061
for	O	O	O
cervical	O	O	B-T047
spondylosis	O	O	I-T047
,	O	O	O
which	O	O	O
suggests	O	O	O
the	O	O	O
multiple-level	O	O	O
CDR	O	O	O
is	O	O	O
as	O	O	O
effective	O	O	B-T080
and	O	O	O
safe	O	O	B-T068
as	O	O	O
the	O	O	O
single-level	O	O	O
CDR	O	O	O
.	O	O	O

Nonetheless	O	O	O
,	O	O	O
more	O	O	O
well-designed	O	O	O
studies	O	O	B-T062
are	O	O	O
needed	O	O	O
for	O	O	O
further	O	O	O
evaluation	O	O	B-T062
.	O	O	O

-DOCSTART- (27330692)

Evaluation	O	O	B-T058
of	O	O	O
the	O	O	O
Effects	O	O	B-T080
of	O	O	I-T080
Intravenous	O	O	B-T082
and	O	O	O
Percutaneous	O	O	B-T082
Low	O	O	B-T061
Level	O	O	I-T061
Laser	O	O	I-T061
Therapy	O	O	I-T061
in	O	O	O
the	O	O	O
Management	O	O	B-T061
of	O	O	O
Shoulder	O	O	B-T029
Myofascial	O	O	O
Pain	O	O	O
Syndrome	O	O	O

Myofascial	O	O	B-T047
pain	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
MPS	O	O	B-T047
)	O	O	O
treatment	O	O	B-T061
is	O	O	O
challenging	O	O	O
with	O	O	O
a	O	O	O
high	O	O	O
recurrence	O	O	O
rate	O	O	O
and	O	O	O
still	O	O	O
lacks	O	O	O
a	O	O	O
clear	O	O	O
treatment	O	O	B-T061
frame	O	O	I-T061
.	O	O	O

Therefore	O	O	O
research	O	O	O
on	O	O	O
new	O	O	O
,	O	O	O
more	O	O	O
efficient	O	O	B-T080
and	O	O	O
long	O	O	O
lasting	O	O	O
effect	O	O	O
treatment	O	O	B-T061
modalities	O	O	B-T078
is	O	O	O
necessary	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
looked	O	O	O
at	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
intravenous	O	O	B-T082
laser	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
IVL	O	O	B-T061
)	O	O	O
and	O	O	O
percutaneous	O	O	B-T082
low	O	O	B-T061
level	O	O	I-T061
laser	O	O	I-T061
(	O	O	O
PLLL	O	O	B-T061
)	O	O	O
in	O	O	O
the	O	O	O
management	O	O	B-T061
of	O	O	O
shoulder	O	O	B-T029
MPS	O	O	B-T047
.	O	O	O

In	O	O	O
this	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
,	O	O	O
30	O	O	O
patients	O	O	B-T101
fulfilling	O	O	O
inclusion	O	O	B-T080
criteria	O	O	I-T080
were	O	O	O
randomly	O	O	O
equally	O	O	O
allocated	O	O	O
to	O	O	O
3	O	O	O
groups	O	O	O
,	O	O	O
control	O	O	B-T096
,	O	O	O
IVL	O	O	B-T098
and	O	O	O
PLLL	O	O	B-T098
.	O	O	O

Control	O	O	B-T096
group	O	O	I-T096
received	O	O	O
12	O	O	O
sessions	O	O	O
of	O	O	O
placebo	O	O	B-T062
low	O	O	B-T061
level	O	O	I-T061
laser	O	O	I-T061
,	O	O	O
IVL	O	O	B-T098
group	O	O	I-T098
received	O	O	O
12	O	O	O
sessions	O	O	O
of	O	O	O
IVL	O	O	B-T061
therapy	O	O	I-T061
,	O	O	O
and	O	O	O
PLLL	O	O	B-T098
group	O	O	I-T098
received	O	O	O
12	O	O	O
sessions	O	O	O
of	O	O	O
PLLL	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
trained	O	O	O
for	O	O	O
better	O	O	B-T080
body	O	O	B-T032
posture	O	O	I-T032
,	O	O	O
body	O	O	B-T022
mechanics	O	O	I-T022
,	O	O	O
gentle	O	O	B-T061
massage	O	O	I-T061
of	O	O	O
trigger	O	O	B-T029
points	O	O	I-T029
,	O	O	O
stretching	O	O	B-T061
exercises	O	O	I-T061
of	O	O	O
affected	O	O	B-T169
muscle	O	O	B-T024
(	O	O	O
trapezius	O	O	B-T023
)	O	O	O
,	O	O	O
and	O	O	O
received	O	O	O
10	O	O	O
mg	O	O	O
of	O	O	O
oral	O	O	B-T082
nortriptyline	O	O	B-T109
regimen	O	O	B-T061
every	O	O	O
night	O	O	O
for	O	O	O
3	O	O	O
months	O	O	O
.	O	O	O

Outcomes	O	O	O
included	O	O	O
pain	O	O	B-T080
severity	O	O	I-T080
,	O	O	O
functional	O	O	B-T033
disability	O	O	I-T033
,	O	O	O
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
assessed	O	O	O
using	O	O	O
Numeric	O	O	B-T170
Rating	O	O	I-T170
Scale	O	O	I-T170
(	O	O	O
NRS	O	O	B-T170
)	O	O	O
,	O	O	O
Pain	O	O	B-T170
Disability	O	O	I-T170
Index	O	O	I-T170
(	O	O	O
PDI	O	O	B-T170
)	O	O	O
,	O	O	O
and	O	O	O
Short	O	O	B-T170
Form	O	O	I-T170
Health	O	O	I-T170
Survey	O	O	I-T170
(	O	O	O
SF-12	O	O	B-T170
)	O	O	O
.	O	O	O

Data	O	O	B-T033
collected	O	O	I-T033
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
analysis	O	O	B-T081
of	O	O	I-T081
variance	O	O	I-T081
(	O	O	O
ANOVA	O	O	B-T081
)	O	O	O
,	O	O	O
Mann-Whitney	O	O	B-T170
and	O	O	O
t	O	O	B-T170
tests	O	O	I-T170
.	O	O	O

The	O	O	O
mean	O	O	O
of	O	O	O
PDI	O	O	B-T170
and	O	O	O
maximum	O	O	O
pain	O	O	B-T201
intensity	O	O	I-T201
during	O	O	O
day	O	O	O
and	O	O	O
night	O	O	O
significantly	O	O	O
reduced	O	O	B-T080
in	O	O	O
both	O	O	O
PLLL	O	O	B-T098
and	O	O	O
IVL	O	O	B-T098
groups	O	O	I-T098
compared	O	O	O
to	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

Although	O	O	O
pain	O	O	O
severity	O	O	O
and	O	O	O
PDI	O	O	B-T170
reduction	O	O	O
was	O	O	O
more	O	O	O
pronounced	O	O	O
in	O	O	O
IVL	O	O	B-T098
group	O	O	I-T098
compared	O	O	O
to	O	O	O
PLLL	O	O	B-T098
group	O	O	I-T098
,	O	O	O
the	O	O	O
differences	O	O	O
were	O	O	O
not	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
.	O	O	O

Also	O	O	O
,	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
statistically	O	O	B-T081
significantly	O	O	I-T081
improved	O	O	O
in	O	O	O
both	O	O	O
IVL	O	O	B-T098
and	O	O	O
PLLL	O	O	B-T098
groups	O	O	I-T098
compared	O	O	O
to	O	O	O
control	O	O	B-T096
group	O	O	I-T096
was	O	O	O
more	O	O	O
,	O	O	O
and	O	O	O
although	O	O	O
higher	O	O	O
in	O	O	O
IVL	O	O	B-T098
group	O	O	I-T098
,	O	O	O
the	O	O	O
difference	O	O	O
was	O	O	O
not	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
when	O	O	O
compared	O	O	O
to	O	O	O
PLLL	O	O	B-T098
group	O	O	I-T098
.	O	O	O

No	O	O	B-T033
side	O	O	I-T033
effects	O	O	I-T033
were	O	O	O
observed	O	O	O
in	O	O	O
the	O	O	O
intervention	O	O	B-T098
groups	O	O	I-T098
.	O	O	O

Intravenous	O	O	B-T082
laser	O	O	B-T061
and	O	O	O
PLLL	O	O	B-T061
therapy	O	O	I-T061
had	O	O	O
a	O	O	O
positive	O	O	O
effect	O	O	B-T080
on	O	O	O
pain	O	O	B-T080
severity	O	O	I-T080
and	O	O	O
PDI	O	O	B-T170
reduction	O	O	O
,	O	O	O
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
in	O	O	O
this	O	O	O
study	O	O	O
.	O	O	O

Also	O	O	O
no	O	O	B-T033
adverse	O	O	I-T033
event	O	O	I-T033
was	O	O	O
recorded	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
intravenous	O	O	B-T082
lasers	O	O	B-T061
and	O	O	O
PLLL	O	O	B-T061
therapy	O	O	I-T061
seem	O	O	O
to	O	O	O
be	O	O	O
effective	O	O	B-T080
complementary	O	O	O
modalities	O	O	B-T078
in	O	O	O
managing	O	O	B-T061
patients	O	O	B-T101
with	O	O	O
shoulder	O	O	B-T029
MPS	O	O	B-T047
.	O	O	O

-DOCSTART- (27331407)

Structural	O	O	B-T082
Insights	O	O	B-T041
into	O	O	O
5-HT1A	O	O	B-T116
/	O	O	O
D4	O	O	B-T116
Selectivity	O	O	B-T070
of	O	O	O
WAY-100635	O	O	B-T109
Analogues	O	O	B-T104
:	O	O	O
Molecular	O	O	B-T062
Modeling	O	O	I-T062
,	O	O	O
Synthesis	O	O	B-T052
,	O	O	O
and	O	O	O
in	O	O	B-T080
Vitro	O	O	I-T080
Binding	O	O	O

The	O	O	O
resurgence	O	O	O
of	O	O	O
interest	O	O	O
in	O	O	O
5-HT1A	O	O	B-T116
receptors	O	O	I-T116
as	O	O	O
a	O	O	O
therapeutic	O	O	B-T169
target	O	O	B-T169
requires	O	O	O
the	O	O	O
existence	O	O	O
of	O	O	O
highly	O	O	O
selective	O	O	B-T080
5-HT1A	O	O	O
ligands	O	O	B-T103
.	O	O	O

To	O	O	O
date	O	O	O
,	O	O	O
WAY-100635	O	O	B-T109
has	O	O	O
been	O	O	O
the	O	O	O
prototypical	O	O	B-T120
antagonist	O	O	I-T120
of	O	O	O
these	O	O	O
receptors	O	O	B-T116
.	O	O	O

However	O	O	O
,	O	O	O
this	O	O	O
compound	O	O	B-T080
also	O	O	O
has	O	O	O
significant	O	O	O
affinity	O	O	B-UnknownType
for	O	O	O
and	O	O	O
activity	O	O	O
at	O	O	O
D4	O	O	B-T116
dopamine	O	O	I-T116
receptors	O	O	I-T116
.	O	O	O

In	O	O	O
this	O	O	O
context	O	O	O
,	O	O	O
this	O	O	O
work	O	O	O
was	O	O	O
aimed	O	O	O
at	O	O	O
better	O	O	O
understanding	O	O	O
the	O	O	O
5-HT1A	O	O	B-T116
/	O	O	O
D4	O	O	B-T116
selectivity	O	O	B-T070
of	O	O	O
WAY-100635	O	O	B-T109
and	O	O	O
analogues	O	O	B-T104
from	O	O	O
a	O	O	O
structural	O	O	B-T082
point	O	O	O
of	O	O	O
view	O	O	O
.	O	O	O

In	O	O	B-T066
silico	O	O	I-T066
investigations	O	O	B-T169
revealed	O	O	O
two	O	O	O
key	O	O	O
interactions	O	O	B-T169
for	O	O	O
the	O	O	O
5-HT1A	O	O	B-T116
/	O	O	O
D4	O	O	B-T116
selectivity	O	O	B-T070
of	O	O	O
WAY-100635	O	O	B-T109
and	O	O	O
analogues	O	O	B-T104
.	O	O	O

First	O	O	O
,	O	O	O
a	O	O	O
hydrogen	O	O	B-T070
bond	O	O	I-T070
only	O	O	O
found	O	O	O
with	O	O	O
the	O	O	O
Ser	O	O	B-T116
7.36	O	O	I-T116
of	O	O	O
D4	O	O	B-T116
receptor	O	O	I-T116
appeared	O	O	O
to	O	O	O
be	O	O	O
the	O	O	O
key	O	O	O
for	O	O	O
a	O	O	O
higher	O	O	O
D4	O	O	O
affinity	O	O	B-UnknownType
for	O	O	O
newly	O	O	O
synthesized	O	O	B-T052
aza	O	O	B-T109
analogues	O	O	B-T104
.	O	O	O

The	O	O	O
role	O	O	O
of	O	O	O
Ser	O	O	B-T116
7.36	O	O	I-T116
was	O	O	O
confirmed	O	O	O
as	O	O	O
the	O	O	O
affinity	O	O	B-UnknownType
of	O	O	O
aza	O	O	B-T109
analogues	O	O	B-T104
for	O	O	O
the	O	O	O
mutant	O	O	B-T049
D4	O	O	B-T116
receptor	O	O	I-T116
S7.36A	O	O	I-T116
was	O	O	O
reduced	O	O	O
.	O	O	O

Then	O	O	O
,	O	O	O
the	O	O	O
formation	O	O	O
of	O	O	O
another	O	O	O
hydrogen	O	O	B-T070
bond	O	O	I-T070
with	O	O	O
the	O	O	O
conserved	O	O	O
Ser	O	O	B-T116
5.42	O	O	I-T116
residue	O	O	I-T116
appeared	O	O	O
to	O	O	O
be	O	O	O
also	O	O	O
critical	O	O	O
for	O	O	O
D4	O	O	B-T116
binding	O	O	B-T044
.	O	O	O

-DOCSTART- (27334470)

Genomic	O	O	B-T059
analysis	O	O	I-T059
of	O	O	O
nontypeable	O	O	B-T007
pneumococci	O	O	I-T007
causing	O	O	O
invasive	O	O	B-T047
pneumococcal	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
South	O	O	B-T083
Africa	O	O	I-T083
,	O	O	O
2003	O	O	O
-	O	O	O
2013	O	O	O

The	O	O	O
capsular	O	O	B-T109
polysaccharide	O	O	I-T109
is	O	O	O
the	O	O	O
principal	O	O	O
virulence	O	O	B-T109
factor	O	O	I-T109
of	O	O	O
Streptococcus	O	O	B-T007
pneumoniae	O	O	I-T007
and	O	O	O
a	O	O	O
target	O	O	B-T169
for	O	O	O
current	O	O	O
pneumococcal	O	O	B-T129
vaccines	O	O	I-T129
.	O	O	O

However	O	O	O
,	O	O	O
some	O	O	O
pathogenic	O	O	B-T033
pneumococci	O	O	B-T007
are	O	O	O
serologically	O	O	B-T170
nontypeable	O	O	I-T170
[	O	O	O
nontypeable	O	O	B-T007
pneumococci	O	O	I-T007
(	O	O	O
NTPn	O	O	B-T007
)	O	O	O
]	O	O	O
.	O	O	O

Due	O	O	O
to	O	O	O
their	O	O	O
relative	O	O	O
rarity	O	O	B-T080
,	O	O	O
NTPn	O	O	B-T007
are	O	O	O
poorly	O	O	O
characterized	O	O	B-T052
,	O	O	O
and	O	O	O
,	O	O	O
as	O	O	O
such	O	O	O
,	O	O	O
limited	O	O	O
data	O	O	B-T078
exist	O	O	O
which	O	O	O
describe	O	O	O
these	O	O	O
organisms	O	O	B-T001
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
describe	O	O	O
disease	O	O	B-T047
and	O	O	O
genotypically	O	O	B-T032
characterize	O	O	B-T052
NTPn	O	O	B-T007
causing	O	O	O
invasive	O	O	B-T047
pneumococcal	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
South	O	O	B-T083
Africa	O	O	I-T083
.	O	O	O

Isolates	O	O	B-T123
were	O	O	O
detected	O	O	O
through	O	O	O
national	O	O	O
,	O	O	O
laboratory	O	O	B-T093
-	O	O	O
based	O	O	B-T078
surveillance	O	O	B-T169
for	O	O	O
invasive	O	O	B-T047
pneumococcal	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
South	O	O	B-T083
Africa	O	O	I-T083
and	O	O	O
characterized	O	O	B-T052
by	O	O	O
whole	O	O	O
genome	O	O	B-T059
analysis	O	O	I-T059
.	O	O	O

We	O	O	O
predicted	O	O	O
ancestral	O	O	B-T169
serotypes	O	O	B-T170
(	O	O	O
serotypes	O	O	O
from	O	O	O
which	O	O	O
NTPn	O	O	B-T007
may	O	O	O
have	O	O	O
originated	O	O	O
)	O	O	O
for	O	O	O
Group	O	O	B-T078
I	O	O	I-T078
NTPn	O	O	O
using	O	O	O
multilocus	O	O	B-T062
sequence	O	O	I-T062
typing	O	O	I-T062
and	O	O	O
capsular	O	O	B-T082
region	O	O	I-T082
sequence	O	O	B-T059
analyses	O	O	I-T059
.	O	O	O

Antimicrobial	O	O	B-T201
resistance	O	O	I-T201
patterns	O	O	B-T082
and	O	O	O
mutations	O	O	B-T045
potentially	O	O	B-T080
causing	O	O	O
nontypeability	O	O	B-T170
were	O	O	O
identified	O	O	B-T080
.	O	O	O

From	O	O	O
2003	O	O	O
-	O	O	O
2013	O	O	O
,	O	O	O
39	O	O	O
(	O	O	O
0.1	O	O	O
%	O	O	O
,	O	O	O
39/32,824	O	O	O
)	O	O	O
NTPn	O	O	B-T007
were	O	O	O
reported	O	O	O
.	O	O	O

Twenty-two	O	O	B-T081
(	O	O	O
56	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
partial	O	O	B-T081
capsular	O	O	B-T028
genes	O	O	B-T028
(	O	O	O
Group	O	O	B-T078
I	O	O	I-T078
)	O	O	O
and	O	O	O
17	O	O	O
(	O	O	O
44	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
complete	O	O	B-T080
capsular	O	O	B-T045
deletion	O	O	I-T045
of	O	O	O
which	O	O	O
15	O	O	O
had	O	O	O
replacement	O	O	B-T169
by	O	O	O
other	O	O	O
genes	O	O	O
(	O	O	O
Group	O	O	B-T078
II	O	O	I-T078
)	O	O	O
.	O	O	O

Seventy-nine	O	O	B-T081
percent	O	O	B-T081
(	O	O	O
31/39	O	O	O
)	O	O	O
of	O	O	O
our	O	O	O
NTPn	O	O	B-T007
isolates	O	O	B-T123
were	O	O	O
derived	O	O	O
from	O	O	O
encapsulated	O	O	B-T080
S.	O	O	B-T007
pneumoniae	O	O	I-T007
.	O	O	O

Ancestral	O	O	O
serotypes	O	O	B-T170
1	O	O	O
(	O	O	O
27	O	O	O
%	O	O	O
,	O	O	O
6/22	O	O	O
)	O	O	O
and	O	O	O
8	O	O	O
(	O	O	O
14	O	O	O
%	O	O	O
,	O	O	O
3/22	O	O	O
)	O	O	O
were	O	O	O
most	O	O	O
prevalent	O	O	O
,	O	O	O
and	O	O	O
59	O	O	O
%	O	O	O
(	O	O	O
13/22	O	O	O
)	O	O	O
of	O	O	O
ancestral	O	O	B-T169
serotypes	O	O	O
were	O	O	O
serotypes	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
13-valent	O	O	B-T129
pneumococcal	O	O	I-T129
conjugate	O	O	I-T129
vaccine	O	O	I-T129
.	O	O	O

We	O	O	O
identified	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
mutations	O	O	B-T045
within	O	O	O
the	O	O	O
capsular	O	O	B-T082
region	O	O	I-T082
of	O	O	O
Group	O	O	B-T078
I	O	O	I-T078
NTPn	O	O	B-T007
,	O	O	O
some	O	O	O
of	O	O	O
which	O	O	O
may	O	O	O
be	O	O	O
responsible	O	O	O
for	O	O	O
the	O	O	O
nontypeable	O	O	B-T170
phenotype	O	O	B-T032
.	O	O	O

Nonsusceptibility	O	O	B-T034
to	O	O	O
tetracycline	O	O	B-T195
and	O	O	O
erythromycin	O	O	B-T195
was	O	O	O
higher	O	O	O
in	O	O	O
NTPn	O	O	B-T007
than	O	O	O
encapsulated	O	O	B-T080
S.	O	O	B-T007
pneumoniae	O	O	I-T007
.	O	O	O

NTPn	O	O	B-T007
are	O	O	O
currently	O	O	O
a	O	O	O
rare	O	O	O
cause	O	O	O
of	O	O	O
invasive	O	O	B-T047
pneumococcal	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
South	O	O	B-T083
Africa	O	O	I-T083
and	O	O	O
represent	O	O	O
a	O	O	O
genetically	O	O	O
diverse	O	O	O
collection	O	O	O
of	O	O	O
isolates	O	O	O
.	O	O	O

-DOCSTART- (27334522)

Pre-hypertension	O	O	B-T047
,	O	O	O
pre-diabetes	O	O	B-T047
or	O	O	O
both	O	O	O
:	O	O	O
which	O	O	O
is	O	O	O
best	O	O	O
at	O	O	O
predicting	O	O	B-T078
cardiovascular	O	O	B-T033
events	O	O	I-T033
in	O	O	O
the	O	O	O
long	O	O	B-T079
term	O	O	I-T079
?	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
value	O	O	O
of	O	O	O
pre-diabetes	O	O	B-T047
and	O	O	O
pre-hypertension	O	O	B-T047
in	O	O	O
predicting	O	O	B-T078
cardiovascular	O	O	B-T033
events	O	O	I-T033
.	O	O	O

A	O	O	O
population	O	O	B-T081
-based	O	O	O
,	O	O	O
cross-sectional	O	O	B-T062
survey	O	O	I-T062
was	O	O	O
conducted	O	O	O
,	O	O	O
representing	O	O	O
a	O	O	O
large	O	O	O
sample	O	O	O
of	O	O	O
the	O	O	O
general	O	O	O
Iranian	O	O	B-T098
population	O	O	O
aged	O	O	O
35	O	O	O
years	O	O	B-T079
and	O	O	O
older	O	O	O
from	O	O	O
the	O	O	O
Isfahan	O	O	B-T083
Province	O	O	I-T083
and	O	O	O
determined	O	O	O
using	O	O	O
a	O	O	O
random	O	O	B-T062
,	O	O	I-T062
multistage	O	O	I-T062
cluster-sampling	O	O	I-T062
10-year	O	O	O
cohort	O	O	B-T098
.	O	O	O

The	O	O	O
five	O	O	O
end	O	O	O
points	O	O	O
considered	O	O	O
as	O	O	O
study	O	O	B-T169
outcome	O	O	I-T169
were	O	O	O
unstable	O	O	B-T047
angina	O	O	I-T047
(	O	O	O
UA	O	O	B-T047
)	O	O	O
,	O	O	O
acute	O	O	B-T079
occurrence	O	O	B-T079
of	O	O	O
myocardial	O	O	B-T047
infarction	O	O	I-T047
(	O	O	O
MI	O	O	B-T047
)	O	O	O
,	O	O	O
sudden	O	O	B-T046
cardiac	O	O	I-T046
death	O	O	I-T046
(	O	O	O
SCD	O	O	B-T046
)	O	O	O
,	O	O	O
brain	O	O	B-T047
stroke	O	O	I-T047
and	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
CVD	O	O	B-T047
)	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
6323	O	O	O
subjects	O	O	O
scheduled	O	O	O
for	O	O	O
assessment	O	O	B-T058
of	O	O	O
diabetes	O	O	B-T047
state	O	O	I-T047
617	O	O	O
were	O	O	O
diabetics	O	O	B-T033
and	O	O	O
712	O	O	O
were	O	O	O
pre-diabetic	O	O	B-T033
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
of	O	O	O
these	O	O	O
subjects	O	O	O
,	O	O	O
1754	O	O	O
had	O	O	O
hypertension	O	O	B-T047
and	O	O	O
2500	O	O	O
had	O	O	O
pre-hypertension	O	O	B-T047
.	O	O	O

Analysing	O	O	O
only	O	O	O
pre-hypertension	O	O	B-T047
,	O	O	O
pre-diabetes	O	O	B-T047
and	O	O	O
its	O	O	O
combination	O	O	O
and	O	O	O
adjusted	O	O	O
for	O	O	O
gender	O	O	B-T032
and	O	O	O
age	O	O	O
variables	O	O	O
,	O	O	O
pre-hypertension	O	O	O
and	O	O	O
pre-diabetes	O	O	O
status	O	O	O
together	O	O	O
,	O	O	O
could	O	O	O
only	O	O	O
effectively	O	O	O
predict	O	O	O
occurrence	O	O	B-T079
of	O	O	O
MI	O	O	B-T047
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
(HR)=3.21	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
):	O	O	O
1.06	O	O	O
-	O	O	O
9.76	O	O	O
,	O	O	O
P=0.04	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
same	O	O	O
COX	O	O	B-T170
regression	O	O	I-T170
models	O	O	I-T170
,	O	O	O
pre-hypertension	O	O	B-T047
status	O	O	O
could	O	O	O
predict	O	O	O
UA	O	O	B-T047
and	O	O	O
CVD	O	O	B-T047
occurrence	O	O	B-T079
(	O	O	O
HR	O	O	B-T081
=	O	O	O
2.94	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
1.68	O	O	O
-	O	O	O
5.14	O	O	O
,	O	O	O
P<0.001	O	O	O
and	O	O	O
HR	O	O	O
=	O	O	O
1.74	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.23	O	O	O
-	O	O	O
2.47	O	O	O
,	O	O	O
P=0.002	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
pre-diabetes	O	O	B-T047
status	O	O	O
could	O	O	O
not	O	O	O
predict	O	O	O
any	O	O	O
of	O	O	O
these	O	O	O
events	O	O	O
after	O	O	O
adjustment	O	O	O
for	O	O	O
gender	O	O	B-T032
and	O	O	O
age	O	O	B-T032
.	O	O	O

Our	O	O	O
data	O	O	B-T078
provide	O	O	O
valuable	O	O	O
evidence	O	O	B-T078
of	O	O	O
the	O	O	O
triggering	O	O	O
role	O	O	O
of	O	O	O
pre-hypertension	O	O	B-T047
and	O	O	O
pre-diabetes	O	O	B-T047
together	O	O	O
,	O	O	O
on	O	O	O
appearance	O	O	B-T080
and	O	O	O
progression	O	O	B-T046
of	O	O	O
MI	O	O	B-T047
even	O	O	O
in	O	O	O
healthy	O	O	B-T098
individuals	O	O	I-T098
and	O	O	O
the	O	O	O
significant	O	O	O
predicting	O	O	B-T078
value	O	O	O
of	O	O	O
pre-hypertension	O	O	O
on	O	O	O
the	O	O	O
occurrence	O	O	B-T079
of	O	O	O
UA	O	O	B-T047
and	O	O	O
CVD	O	O	B-T047
.	O	O	O

In	O	O	O
this	O	O	O
regard	O	O	O
,	O	O	O
the	O	O	O
value	O	O	O
of	O	O	O
pre-hypertension	O	O	B-T047
and	O	O	O
pre-diabetes	O	O	B-T047
together	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
pre-hypertension	O	O	O
state	O	O	O
alone	O	O	O
,	O	O	O
are	O	O	O
clearly	O	O	O
superior	O	O	O
to	O	O	O
pre-diabetes	O	O	O
state	O	O	O
alone	O	O	O
in	O	O	O
predicting	O	O	B-T078
cardiovascular	O	O	B-T033
events	O	O	I-T033
.	O	O	O

-DOCSTART- (27336997)

Strategies	O	O	B-T065
for	O	O	O
Successful	O	O	B-T080
Clinical	O	O	B-T080
Teaching	O	O	O

This	O	O	O
article	O	O	B-T170
is	O	O	O
one	O	O	O
in	O	O	O
a	O	O	O
series	O	O	O
on	O	O	O
the	O	O	O
roles	O	O	B-T077
of	O	O	O
adjunct	O	O	B-T097
clinical	O	O	I-T097
faculty	O	O	I-T097
and	O	O	O
preceptors	O	O	B-T097
,	O	O	O
who	O	O	O
teach	O	O	B-T065
nursing	O	O	B-T097
students	O	O	I-T097
and	O	O	O
new	O	O	B-T080
graduates	O	O	B-T098
to	O	O	O
apply	O	O	B-T169
knowledge	O	O	B-T170
in	O	O	O
clinical	O	O	B-T082
settings	O	O	I-T082
.	O	O	O

This	O	O	O
article	O	O	B-T170
describes	O	O	O
teaching	O	O	B-T065
strategies	O	O	I-T065
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
the	O	O	O
learning	O	O	B-T082
environment	O	O	I-T082
.	O	O	O

-DOCSTART- (27337390)

Learned	O	O	B-T041
helplessness	O	O	I-T041
at	O	O	O
fifty	O	O	O
:	O	O	O
Insights	O	O	B-T041
from	O	O	O
neuroscience	O	O	O

Learned	O	O	B-T041
helplessness	O	O	I-T041
,	O	O	O
the	O	O	O
failure	O	O	B-T169
to	O	O	O
escape	O	O	B-T041
shock	O	O	B-T046
induced	O	O	B-T169
by	O	O	O
uncontrollable	O	O	O
aversive	O	O	B-T169
events	O	O	I-T169
,	O	O	O
was	O	O	O
discovered	O	O	O
half	O	O	O
a	O	O	O
century	O	O	O
ago	O	O	O
.	O	O	O

Seligman	O	O	B-T016
and	O	O	I-T016
Maier	O	O	I-T016
(	O	O	O
1967	O	O	O
)	O	O	O
theorized	O	O	B-T078
that	O	O	O
animals	O	O	B-T008
learned	O	O	B-T041
that	O	O	O
outcomes	O	O	B-T169
were	O	O	O
independent	O	O	B-T169
of	O	O	I-T169
their	O	O	O
responses	O	O	B-T032
-that	O	O	O
nothing	O	O	O
they	O	O	O
did	O	O	O
mattered-and	O	O	O
that	O	O	O
this	O	O	O
learning	O	O	B-T041
undermined	O	O	O
trying	O	O	O
to	O	O	O
escape	O	O	B-T041
.	O	O	O

The	O	O	O
mechanism	O	O	O
of	O	O	O
learned	O	O	B-T041
helplessness	O	O	I-T041
is	O	O	O
now	O	O	O
very	O	O	O
well-charted	O	O	B-T080
biologically	O	O	I-T080
,	O	O	O
and	O	O	O
the	O	O	O
original	O	O	O
theory	O	O	B-T078
got	O	O	O
it	O	O	O
backward	O	O	O
.	O	O	O

Passivity	O	O	B-T055
in	O	O	O
response	O	O	B-T032
to	O	O	O
shock	O	O	B-T046
is	O	O	O
not	O	O	O
learned	O	O	B-T041
.	O	O	O

It	O	O	O
is	O	O	O
the	O	O	O
default	O	O	O
,	O	O	O
unlearned	O	O	O
response	O	O	B-T032
to	O	O	O
prolonged	O	O	B-T079
aversive	O	O	B-T169
events	O	O	I-T169
and	O	O	O
it	O	O	O
is	O	O	O
mediated	O	O	O
by	O	O	O
the	O	O	O
serotonergic	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
the	O	O	O
dorsal	O	O	B-T023
raphe	O	O	I-T023
nucleus	O	O	I-T023
,	O	O	O
which	O	O	O
in	O	O	O
turn	O	O	O
inhibits	O	O	B-T052
escape	O	O	B-T041
.	O	O	O

This	O	O	O
passivity	O	O	B-T055
can	O	O	O
be	O	O	O
overcome	O	O	O
by	O	O	O
learning	O	O	B-T041
control	O	O	B-T080
,	O	O	O
with	O	O	O
the	O	O	O
activity	O	O	O
of	O	O	O
the	O	O	O
medial	O	O	B-T023
prefrontal	O	O	I-T023
cortex	O	O	I-T023
,	O	O	O
which	O	O	O
subserves	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
control	O	O	O
leading	O	O	O
to	O	O	O
the	O	O	O
automatic	O	O	B-T169
inhibition	O	O	B-T052
of	O	O	O
the	O	O	O
dorsal	O	O	B-T023
raphe	O	O	I-T023
nucleus	O	O	I-T023
.	O	O	O

So	O	O	O
animals	O	O	B-T008
learn	O	O	B-T041
that	O	O	O
they	O	O	O
can	O	O	O
control	O	O	B-T080
aversive	O	O	B-T169
events	O	O	I-T169
,	O	O	O
but	O	O	O
the	O	O	O
passive	O	O	B-T080
failure	O	O	B-T169
to	O	O	O
learn	O	O	O
to	O	O	O
escape	O	O	B-T041
is	O	O	O
an	O	O	O
unlearned	O	O	O
reaction	O	O	B-T169
to	O	O	O
prolonged	O	O	B-T079
aversive	O	O	B-T061
stimulation	O	O	I-T061
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
alterations	O	O	B-T078
of	O	O	O
the	O	O	O
ventromedial	O	O	B-T023
prefrontal	O	O	I-T023
cortex	O	O	I-T023
-	O	O	O
dorsal	O	O	B-T023
raphe	O	O	I-T023
pathway	O	O	B-T077
can	O	O	O
come	O	O	O
to	O	O	O
subserve	O	O	O
the	O	O	O
expectation	O	O	B-T078
of	O	O	O
control	O	O	B-T080
.	O	O	O

We	O	O	O
speculate	O	O	O
that	O	O	O
default	O	O	O
passivity	O	O	B-T055
and	O	O	O
the	O	O	O
compensating	O	O	B-T080
detection	O	O	B-T033
and	O	O	O
expectation	O	O	B-T078
of	O	O	O
control	O	O	B-T080
may	O	O	O
have	O	O	O
substantial	O	O	O
implications	O	O	O
for	O	O	O
how	O	O	O
to	O	O	O
treat	O	O	B-T169
depression	O	O	B-T048
.	O	O	O

(	O	O	O
PsycINFO	O	O	O
Database	O	O	O
Record	O	O	O

-DOCSTART- (27339305)

A	O	O	O
peptide	O	O	B-T116
from	O	O	O
human	O	O	B-T116
β	O	O	I-T116
thymosin	O	O	I-T116
as	O	O	O
a	O	O	O
platform	O	O	O
for	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
new	O	O	O
anti-biofilm	O	O	B-T024
agents	O	O	O
for	O	O	O
Staphylococcus	O	O	B-T007
spp	O	O	I-T007
.	O	O	I-T007
and	O	O	O
Pseudomonas	O	O	O
aeruginosa	O	O	O

and	O	O	O
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
Conventional	O	O	O
antibiotics	O	O	B-T195
might	O	O	O
fail	O	O	O
in	O	O	O
the	O	O	O
treatment	O	O	O
of	O	O	O
biofilm	O	O	B-T007
-associated	O	O	O
infections	O	O	B-T046
causing	O	O	O
infection	O	O	B-T046
recurrence	O	O	B-T046
and	O	O	O
chronicity	O	O	B-T079
.	O	O	O

The	O	O	O
search	O	O	O
for	O	O	O
antimicrobial	O	O	B-T116
peptides	O	O	I-T116
has	O	O	O
been	O	O	O
performed	O	O	O
with	O	O	O
the	O	O	O
aim	O	O	O
to	O	O	O
discover	O	O	B-T052
novel	O	O	O
anti-infective	O	O	B-T121
agents	O	O	I-T121
active	O	O	B-T169
on	O	O	O
pathogens	O	O	B-T001
in	O	O	O
both	O	O	O
planktonic	O	O	B-T007
and	O	O	O
biofilm	O	O	B-T007
associated	O	O	O
forms	O	O	O
.	O	O	O

The	O	O	O
fragment	O	O	B-T116
9	O	O	O
-	O	O	O
19	O	O	O
of	O	O	O
human	O	O	B-T116
thymosin	O	O	I-T116
β4	O	O	I-T116
was	O	O	O
studied	O	O	B-T062
through	O	O	O
1	O	O	O
μs	O	O	O
MD	O	O	B-T066
simulation	O	O	I-T066
.	O	O	O

Two	O	O	O
main	O	O	O
conformations	O	O	B-T082
of	O	O	I-T082
the	O	O	I-T082
peptide	O	O	I-T082
were	O	O	O
detected	O	O	O
,	O	O	O
both	O	O	O
constituted	O	O	O
by	O	O	O
a	O	O	O
central	O	O	B-T082
hydrophobic	O	O	I-T082
core	O	O	I-T082
and	O	O	O
by	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
peripheral	O	O	B-T082
charged	O	O	O
residues	O	O	B-T077
suggesting	O	O	O
a	O	O	O
possible	O	O	O
mechanism	O	O	O
of	O	O	O
interaction	O	O	B-T169
with	O	O	O
two	O	O	O
models	O	O	B-T170
of	O	O	O
biological	O	O	B-T026
membranes	O	O	I-T026
,	O	O	O
related	O	O	O
to	O	O	O
eukaryotic	O	O	B-T204
or	O	O	O
bacterial	O	O	B-T026
membrane	O	O	I-T026
respectively	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
peptide	O	O	B-T116
was	O	O	O
chemically	O	O	O
synthesized	O	O	O
and	O	O	O
its	O	O	O
antimicrobial	O	O	B-T034
activity	O	O	I-T034
was	O	O	O
tested	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
against	O	O	O
planktonic	O	O	B-T007
and	O	O	O
biofilm	O	O	B-T007
form	O	O	O
of	O	O	O
a	O	O	O
group	O	O	B-T078
of	O	O	O
reference	O	O	O
strains	O	O	B-T001
of	O	O	O
Staphylococcus	O	O	O
spp	O	O	O
.	O	O	O

and	O	O	O

one	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
strain	O	O	B-T001
.	O	O	O

The	O	O	O
human	O	O	B-T116
thymosin	O	O	I-T116
β4	O	O	I-T116
fragment	O	O	B-T116
EIEKFDKSKLK	O	O	B-T087
showed	O	O	O
antibacterial	O	O	B-T044
activity	O	O	I-T044
against	O	O	O
staphylococcal	O	O	B-T007
strains	O	O	B-T001
and	O	O	O
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
ATCC	O	O	O
15442	O	O	O
at	O	O	O
concentrations	O	O	B-T081
from	O	O	O
12.5	O	O	O
to	O	O	O
6.2	O	O	O
mg/ml	O	O	O
and	O	O	O
inhibited	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
at	O	O	O
sub-inhibitory	O	O	B-T081
concentrations	O	O	I-T081
(	O	O	O
3.1	O	O	O
-	O	O	O
0.75	O	O	O
mg/ml	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
activity	O	O	B-T052
of	O	O	O
the	O	O	O
fragment	O	O	B-T116
in	O	O	O
inhibiting	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
,	O	O	O
could	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
conformations	O	O	B-T082
highlighted	O	O	O
by	O	O	O
the	O	O	O
MD	O	O	B-T066
simulations	O	O	I-T066
,	O	O	O
suggesting	O	O	O
its	O	O	O
interaction	O	O	B-T169
with	O	O	O
the	O	O	O
bacterial	O	O	B-T026
membrane	O	O	I-T026
.	O	O	O

Human	O	O	B-T116
thymosin	O	O	I-T116
β4	O	O	I-T116
fragment	O	O	B-T116
can	O	O	O
be	O	O	O
considered	O	O	O
a	O	O	O
promising	O	O	O
lead	O	O	B-T121
compound	O	O	I-T121
to	O	O	O
develop	O	O	O
novel	O	O	O
synthetic	O	O	O
or	O	O	O
recombinant	O	O	B-T116
derivatives	O	O	I-T116
with	O	O	O
improved	O	O	O
pharmaceutical	O	O	B-T091
potential	O	O	O
.	O	O	O

-DOCSTART- (27339893)

Structural	O	O	B-T082
Basis	O	O	B-T169
for	O	O	O
Simvastatin	O	O	B-T109
Competitive	O	O	B-T044
Antagonism	O	O	I-T044
of	O	O	O
Complement	O	O	O
Receptor	O	O	O
3	O	O	O

The	O	O	O
complement	O	O	B-T116
system	O	O	I-T116
is	O	O	O
an	O	O	O
important	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
innate	O	O	B-T032
immune	O	O	I-T032
response	O	O	I-T032
to	O	O	O
infection	O	O	B-T047
but	O	O	O
may	O	O	O
also	O	O	O
cause	O	O	O
severe	O	O	B-T033
complications	O	O	I-T033
during	O	O	O
inflammation	O	O	B-T046
.	O	O	O

Small	O	O	B-T109
molecule	O	O	I-T109
antagonists	O	O	B-T120
to	O	O	O
complement	O	O	B-T116
receptor	O	O	I-T116
3	O	O	I-T116
(	O	O	O
CR3	O	O	B-T116
)	O	O	O
have	O	O	O
been	O	O	O
widely	O	O	O
sought	O	O	O
,	O	O	O
but	O	O	O
a	O	O	O
structural	O	O	B-T082
basis	O	O	B-T169
for	O	O	O
their	O	O	O
mode	O	O	B-T169
of	O	O	I-T169
action	O	O	I-T169
is	O	O	O
not	O	O	O
available	O	O	O
.	O	O	O

We	O	O	O
report	O	O	B-T170
here	O	O	O
on	O	O	O
the	O	O	O
structure	O	O	B-T082
of	O	O	O
the	O	O	O
human	O	O	B-T016
CR3	O	O	B-T116
ligand-binding	O	O	B-T087
I	O	O	I-T087
domain	O	O	I-T087
in	O	O	O
complex	O	O	B-T104
with	O	O	O
simvastatin	O	O	B-T109
.	O	O	O

Simvastatin	O	O	B-T109
targets	O	O	B-T169
the	O	O	O
metal	O	O	B-T197
ion-dependent	O	O	B-T080
adhesion	O	O	B-T082
site	O	O	I-T082
of	O	O	O
the	O	O	O
open	O	O	O
,	O	O	O
ligand-binding	O	O	B-T044
conformation	O	O	B-T082
of	O	O	O
the	O	O	O
CR3	O	O	B-T116
I	O	O	B-T087
domain	O	O	I-T087
by	O	O	O
direct	O	O	O
contact	O	O	B-T169
with	O	O	I-T169
the	O	O	O
chelated	O	O	B-T109
Mg(2	O	O	I-T109
+	O	O	I-T109
)	O	O	I-T109
ion	O	O	I-T109
.	O	O	O

Simvastatin	O	O	B-T109
antagonizes	O	O	B-T033
I	O	O	B-T087
domain	O	O	I-T087
binding	O	O	I-T087
to	O	O	O
the	O	O	O
complement	O	O	B-T116
fragments	O	O	I-T116
iC3b	O	O	B-T116
and	O	O	O
C3d	O	O	B-T116
but	O	O	O
not	O	O	O
to	O	O	O
intercellular	O	O	B-T116
adhesion	O	O	I-T116
molecule-1	O	O	I-T116
.	O	O	O

By	O	O	O
virtue	O	O	B-T078
of	O	O	O
the	O	O	O
I	O	O	B-T087
domain	O	O	I-T087
's	O	O	I-T087
wide	O	O	O
distribution	O	O	B-T082
in	O	O	O
binding	O	O	B-T039
kinetics	O	O	B-T039
to	O	O	O
ligands	O	O	B-T103
,	O	O	O
it	O	O	O
was	O	O	O
possible	O	O	B-T033
to	O	O	O
identify	O	O	O
ligand	O	O	B-T044
binding	O	O	I-T044
kinetics	O	O	O
as	O	O	O
discriminator	O	O	O
for	O	O	O
simvastatin	O	O	B-T109
antagonism	O	O	B-T044
.	O	O	O

In	O	O	O
static	O	O	B-T080
cellular	O	O	B-T059
experiments	O	O	B-T062
,	O	O	O
15	O	O	O
-	O	O	O
25	O	O	O
μm	O	O	O
simvastatin	O	O	B-T109
reduced	O	O	B-T080
adhesion	O	O	B-T067
by	O	O	O
K562	O	O	B-T025
cells	O	O	I-T025
expressing	O	O	B-T045
recombinant	O	O	B-T001
CR3	O	O	B-T116
and	O	O	O
by	O	O	O
primary	O	O	B-T080
human	O	O	B-T016
monocytes	O	O	B-T025
,	O	O	O
with	O	O	O
an	O	O	O
endogenous	O	O	B-T169
expression	O	O	B-T045
of	O	O	O
this	O	O	O
receptor	O	O	B-T116
.	O	O	O

Application	O	O	B-T058
of	O	O	O
force	O	O	B-T067
to	O	O	O
adhering	O	O	B-T067
monocytes	O	O	B-T025
potentiated	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
simvastatin	O	O	B-T109
where	O	O	O
only	O	O	O
a	O	O	O
50	O	O	O
-	O	O	O
100	O	O	O
nm	O	O	O
concentration	O	O	B-T081
of	O	O	O
the	O	O	O
drug	O	O	B-T121
reduced	O	O	B-T080
the	O	O	O
adhesion	O	O	B-T067
by	O	O	O
20	O	O	O
-	O	O	O
40	O	O	O
%	O	O	O
compared	O	O	B-T052
with	O	O	O
untreated	O	O	B-T080
cells	O	O	B-T025
.	O	O	O

The	O	O	O
ability	O	O	B-T032
of	O	O	O
simvastatin	O	O	B-T109
to	O	O	O
target	O	O	B-T169
CR3	O	O	B-T116
in	O	O	O
its	O	O	O
ligand	O	O	B-T044
binding	O	O	I-T044
-	O	O	O
activated	O	O	B-T052
conformation	O	O	B-T082
is	O	O	O
a	O	O	O
novel	O	O	B-T080
mechanism	O	O	B-T044
to	O	O	O
explain	O	O	O
the	O	O	O
known	O	O	O
anti-inflammatory	O	O	B-T080
effects	O	O	I-T080
of	O	O	O
this	O	O	O
compound	O	O	B-T103
,	O	O	O
in	O	O	O
particular	O	O	O
because	O	O	O
this	O	O	O
CR3	O	O	O
conformation	O	O	O
is	O	O	O
found	O	O	O
in	O	O	O
pro-inflammatory	O	O	B-T080
environments	O	O	B-T082
.	O	O	O

Our	O	O	O
report	O	O	B-T170
points	O	O	O
to	O	O	O
new	O	O	O
designs	O	O	B-T090
of	O	O	O
CR3	O	O	B-T116
antagonists	O	O	B-T120
and	O	O	O
opens	O	O	O
new	O	O	O
perspectives	O	O	O
and	O	O	O
identifies	O	O	B-T033
druggable	O	O	B-T080
receptors	O	O	B-T116
from	O	O	O
characterization	O	O	B-T052
of	O	O	O
the	O	O	O
ligand	O	O	B-T044
binding	O	O	I-T044
kinetics	O	O	B-T039
in	O	O	O
the	O	O	O
presence	O	O	B-T080
of	O	O	O
antagonists	O	O	O
.	O	O	O

-DOCSTART- (27346336)

Common	O	O	B-T081
Laboratory	O	O	B-T093
Parameters	O	O	B-T033
for	O	O	O
Differentiating	O	O	B-T169
Between	O	O	O
Community-Acquired	O	O	B-T047
and	O	O	O
Healthcare-Associated	O	O	O
Pneumonia	O	O	O

The	O	O	O
correct	O	O	B-T080
diagnosis	O	O	B-T033
of	O	O	O
healthcare-associated	O	O	B-T047
pneumonia	O	O	I-T047
(	O	O	O
HCAP	O	O	B-T047
)	O	O	O
as	O	O	O
opposed	O	O	O
to	O	O	O
community-acquired	O	O	B-T047
pneumonia	O	O	I-T047
is	O	O	O
essential	O	O	B-T080
for	O	O	O
the	O	O	O
selection	O	O	B-T052
of	O	O	O
a	O	O	O
correct	O	O	O
empirical	O	O	B-T080
antimicrobial	O	O	B-T121
approach	O	O	O
,	O	O	O
reserving	O	O	O
the	O	O	O
broad-spectrum	O	O	B-T077
or	O	O	O
highly	O	O	B-T080
potent	O	O	I-T080
antimicrobial	O	O	B-T061
therapies	O	O	I-T061
for	O	O	O
resistant	O	O	B-T169
strains	O	O	B-T001
most	O	O	O
commonly	O	O	O
present	O	O	O
in	O	O	O
HCAP	O	O	O
,	O	O	O
whereas	O	O	O
treating	O	O	B-T169
the	O	O	O
less	O	O	O
resistant	O	O	O
strains	O	O	O
,	O	O	O
most	O	O	O
commonly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
community	O	O	B-T096
and	O	O	O
long-term	O	O	B-T093
care	O	O	I-T093
facility	O	O	I-T093
-	O	O	O
acquired	O	O	B-T046
infections	O	O	I-T046
,	O	O	O
with	O	O	O
a	O	O	O
more	O	O	O
targeted	O	O	B-T169
empirical	O	O	B-T062
approach	O	O	I-T062
.	O	O	O

The	O	O	O
standard	O	O	B-T080
approach	O	O	I-T080
today	O	O	B-T079
is	O	O	O
to	O	O	O
differentiate	O	O	B-T169
between	O	O	O
the	O	O	O
two	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
medical	O	O	B-T033
history	O	O	I-T033
of	O	O	O
the	O	O	O
past	O	O	B-T079
90	O	O	O
days	O	O	B-T079
prior	O	O	O
to	O	O	O
admission	O	O	B-T058
.	O	O	O

Measurable	O	O	B-T169
,	O	O	O
quantitative	O	O	B-T081
assessment	O	O	B-T058
may	O	O	O
be	O	O	O
able	O	O	O
to	O	O	O
assist	O	O	B-T080
in	O	O	O
this	O	O	O
decision	O	O	B-T041
.	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
is	O	O	O
to	O	O	O
find	O	O	O
a	O	O	O
measurable	O	O	B-T169
method	O	O	B-T170
of	O	O	O
differentiating	O	O	B-T169
between	O	O	O
community-acquired	O	O	B-T047
and	O	O	O
healthcare-associated	O	O	B-T047
pneumonias	O	O	I-T047
.	O	O	O

The	O	O	O
records	O	O	B-T170
of	O	O	O
126	O	O	O
patients	O	O	B-T101
admitted	O	O	B-T058
with	O	O	O
a	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
pneumonia	O	O	B-T047
were	O	O	O
divided	O	O	O
into	O	O	O
two	O	O	O
groups	O	O	B-T078
based	O	O	O
on	O	O	O
the	O	O	O
probable	O	O	O
cause	O	O	B-UnknownType
of	O	O	I-UnknownType
their	O	O	I-UnknownType
disease	O	O	I-UnknownType
,	O	O	O
in	O	O	O
accordance	O	O	O
with	O	O	O
common	O	O	B-T041
practice	O	O	I-T041
.	O	O	O

The	O	O	O
routine	O	O	B-T080
laboratory	O	O	B-T059
work	O	O	I-T059
taken	O	O	O
upon	O	O	O
admittance	O	O	B-T058
was	O	O	O
analyzed	O	O	B-T062
using	O	O	O
logistical	O	O	B-T062
regression	O	O	I-T062
and	O	O	O
Student	O	O	B-T081
's	O	O	I-T081
t-test	O	O	I-T081
.	O	O	O

We	O	O	O
have	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
red	O	O	B-T059
blood	O	O	I-T059
cell	O	O	I-T059
distribution	O	O	I-T059
width	O	O	I-T059
and	O	O	O
the	O	O	O
neutrophil	O	O	B-T081
-to-	O	O	I-T081
lymphocyte	O	O	B-T025
ratio	O	O	I-T081
,	O	O	O
both	O	O	O
routine	O	O	B-T033
parameters	O	O	I-T033
obtained	O	O	O
in	O	O	O
a	O	O	O
simple	O	O	O
blood	O	O	B-T059
count	O	O	I-T059
,	O	O	O
can	O	O	O
each	O	O	O
assist	O	O	B-T080
in	O	O	O
differentiating	O	O	B-T169
between	O	O	O
community-acquired	O	O	B-T047
and	O	O	O
healthcare-associated	O	O	B-T047
pneumonias	O	O	I-T047
.	O	O	O

We	O	O	O
have	O	O	O
found	O	O	O
two	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
parameters	O	O	I-T081
that	O	O	O
may	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
adjuncts	O	O	O
to	O	O	O
the	O	O	O
medical	O	O	B-T033
history	O	O	I-T033
,	O	O	O
chest	O	O	B-T060
radiography	O	O	I-T060
and	O	O	O
other	O	O	B-T033
parameters	O	O	I-T033
in	O	O	O
forming	O	O	O
an	O	O	O
immediate	O	O	B-T079
clinical	O	O	B-T033
impression	O	O	I-T033
of	O	O	O
a	O	O	O
patient	O	O	B-T101
presenting	O	O	O
with	O	O	O
pneumonia	O	O	B-T047
.	O	O	O

-DOCSTART- (27347792)

A	O	O	O
quasi-experimental	O	O	B-T062
study	O	O	I-T062
of	O	O	O
a	O	O	O
reminiscence	O	O	B-T061
program	O	O	I-T061
focused	O	O	O
on	O	O	O
autobiographical	O	O	B-T041
memory	O	O	I-T041
in	O	O	O
institutionalized	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
with	O	O	O
cognitive	O	O	O
impairment	O	O	O

Working	O	O	O
with	O	O	O
past	O	O	B-T041
memories	O	O	I-T041
through	O	O	O
reminiscence	O	O	B-T061
interventions	O	O	I-T061
has	O	O	O
been	O	O	O
practiced	O	O	O
for	O	O	O
several	O	O	B-T081
decades	O	O	I-T081
with	O	O	O
successful	O	O	O
outcomes	O	O	B-T169
on	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
in	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
.	O	O	O

Few	O	O	O
studies	O	O	B-T062
however	O	O	O
have	O	O	O
focused	O	O	O
on	O	O	O
autobiographical	O	O	B-T041
memory	O	O	I-T041
recall	O	O	B-T041
in	O	O	O
older	O	O	B-T098
individuals	O	O	I-T098
with	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
.	O	O	O

This	O	O	O
study	O	O	B-T062
aims	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
impact	O	O	O
of	O	O	O
an	O	O	O
individual	O	O	B-T098
reminiscence	O	O	B-T061
program	O	O	I-T061
in	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
older	O	O	B-T098
persons	O	O	I-T098
with	O	O	O
cognitive	O	O	B-T046
decline	O	O	I-T046
living	O	O	O
in	O	O	O
nursing	O	O	B-T093
homes	O	O	I-T093
on	O	O	O
the	O	O	O
dimensions	O	O	O
of	O	O	O
cognition	O	O	B-T041
,	O	O	O
autobiographical	O	O	B-T041
memory	O	O	I-T041
,	O	O	O
mood	O	O	B-T041
,	O	O	O
behavior	O	O	B-T053
and	O	O	O
anxiety	O	O	B-T048
.	O	O	O

A	O	O	O
two-group	O	O	O
pre-test	O	O	B-T170
and	O	O	I-T170
post-test	O	O	I-T170
design	O	O	I-T170
with	O	O	O
single	O	O	B-T058
blinded	O	O	I-T058
assessment	O	O	I-T058
was	O	O	O
conducted	O	O	O
.	O	O	O

Forty-one	O	O	O
participants	O	O	B-T098
were	O	O	O
randomized	O	O	O
to	O	O	O
an	O	O	O
experimental	O	O	B-T098
group	O	O	I-T098
(	O	O	O
n=20	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
n=21	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
first	O	O	O
group	O	O	O
attended	O	O	O
five	O	O	O
weekly	O	O	O
individual	O	O	B-T098
reminiscence	O	O	B-T041
sessions	O	O	B-T051
.	O	O	O

Changes	O	O	O
in	O	O	O
the	O	O	O
outcome	O	O	B-T081
measures	O	O	I-T081
were	O	O	O
examined	O	O	B-T033
for	O	O	O
cognition	O	O	B-T041
(	O	O	O
Montreal	O	O	B-T170
Cognitive	O	O	I-T170
Assessment	O	O	I-T170
;	O	O	O
Autobiographical	O	O	B-T170
Memory	O	O	I-T170
Test	O	O	I-T170
)	O	O	O
,	O	O	O
behavior	O	O	B-T053
(	O	O	O
Alzheimer	O	O	B-T170
Disease	O	O	I-T170
Assessment	O	O	I-T170
Subscale	O	O	I-T170
Non-Cog	O	O	I-T170
)	O	O	O
and	O	O	O
emotional	O	O	B-T033
status	O	O	I-T033
(	O	O	O
Cornell	O	O	B-T170
Scale	O	O	I-T170
for	O	O	I-T170
Depression	O	O	I-T170
in	O	O	O
Dementia	O	O	B-T048
;	O	O	O
Geriatric	O	O	B-T170
Depression	O	O	I-T170
Scale	O	O	I-T170
,	O	O	O
and	O	O	O
Geriatric	O	O	B-T170
Anxiety	O	O	I-T170
Inventory	O	O	I-T170
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
attending	O	O	O
reminiscence	O	O	B-T051
sessions	O	O	I-T051
exhibited	O	O	O
better	O	O	O
outcomes	O	O	B-T169
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
in	O	O	O
cognition	O	O	B-T041
,	O	O	O
anxiety	O	O	B-T048
and	O	O	O
depression	O	O	B-T048
(	O	O	O
p<0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
presented	O	O	O
a	O	O	O
higher	O	O	O
number	O	O	O
of	O	O	O
retrieved	O	O	B-T041
autobiographical	O	O	B-T051
events	O	O	B-T051
,	O	O	O
specificity	O	O	O
of	O	O	O
evoked	O	O	O
memories	O	O	B-T041
and	O	O	O
positive	O	O	O
valence	O	O	O
of	O	O	O
events	O	O	O
(	O	O	O
p<0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
also	O	O	O
presented	O	O	O
lower	O	O	O
latency	O	O	O
time	O	O	O
for	O	O	O
recalling	O	O	B-T041
events	O	O	O
,	O	O	O
and	O	O	O
lower	O	O	O
negative	O	O	O
recalled	O	O	B-T041
events	O	O	O
(	O	O	O
p<0.01	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
supports	O	O	O
the	O	O	O
potential	O	O	O
value	O	O	O
of	O	O	O
reminiscence	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
improving	O	O	O
the	O	O	O
recall	O	O	B-T041
of	O	O	O
autobiographical	O	O	B-T041
memory	O	O	I-T041
.	O	O	O

Reminiscence	O	O	B-T061
therapy	O	O	I-T061
can	O	O	O
be	O	O	O
helpful	O	O	O
to	O	O	O
maintain	O	O	O
or	O	O	O
improve	O	O	O
cognitive	O	O	B-T041
function	O	O	I-T041
,	O	O	O
decrease	O	O	O
anxiety	O	O	B-T048
and	O	O	O
manage	O	O	O
depressive	O	O	B-T184
symptoms	O	O	I-T184
and	O	O	O
altered	O	O	B-T055
behavior	O	O	I-T055
,	O	O	O
but	O	O	O
further	O	O	O
investigation	O	O	O
is	O	O	O
needed	O	O	O
to	O	O	O
clarify	O	O	O
long-term	O	O	O
effects	O	O	O
.	O	O	O

-DOCSTART- (27348285)

Economic	O	O	B-T081
Burden	O	O	I-T081
of	O	O	O
Illness	O	O	B-T184
Among	O	O	O
Patients	O	O	B-T101
with	O	O	O
Severe	O	O	B-T033
Asthma	O	O	I-T033
in	O	O	O
a	O	O	O
Managed	O	O	O
Care	O	O	O
Setting	O	O	O

Despite	O	O	O
intensive	O	O	O
pharmacotherapy	O	O	B-T061
,	O	O	O
a	O	O	O
considerable	O	O	O
number	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
with	O	O	O
severe	O	O	B-T033
asthma	O	O	I-T033
have	O	O	O
inadequate	O	O	B-T080
disease	O	O	B-T047
control	O	O	B-T080
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
severe	O	O	B-T033
asthma	O	O	I-T033
who	O	O	O
experience	O	O	B-T041
exacerbations	O	O	B-T033
consume	O	O	O
significant	O	O	O
health	O	O	B-T081
care	O	O	I-T081
resources	O	O	I-T081
.	O	O	O

To	O	O	O
assess	O	O	B-T052
health	O	O	B-T081
care	O	O	I-T081
resource	O	O	I-T081
utilization	O	O	B-T169
and	O	O	O
associated	O	O	O
costs	O	O	B-T081
among	O	O	O
patients	O	O	B-T101
with	O	O	O
persistent	O	O	B-T079
severe	O	O	B-T033
asthma	O	O	B-T047
who	O	O	O
experienced	O	O	B-T041
exacerbations	O	O	B-T033
compared	O	O	O
with	O	O	O
patients	O	O	O
with	O	O	O
persistent	O	O	O
but	O	O	O
nonsevere	O	O	O
asthma	O	O	O
.	O	O	O

This	O	O	O
retrospective	O	O	B-T080
analysis	O	O	B-T062
of	O	O	O
a	O	O	O
national	O	O	B-T170
administrative	O	O	I-T170
claims	O	O	I-T170
database	O	O	I-T170
identified	O	O	B-T080
patients	O	O	B-T101
aged	O	O	B-T032
≥	O	O	O
12	O	O	O
years	O	O	B-T079
who	O	O	O
had	O	O	O
at	O	O	O
least	O	O	O
1	O	O	O
medical	O	O	B-T033
claim	O	O	I-UnknownType
with	O	O	O
an	O	O	O
asthma	O	O	B-T047
diagnosis	O	O	B-T033
in	O	O	O
2012	O	O	O
and	O	O	O
had	O	O	O
continuous	O	O	O
medical	O	O	O
and	O	O	O
pharmacy	O	O	B-T033
coverage	O	O	I-T033
under	O	O	O
a	O	O	O
commercial	O	O	B-T170
or	O	O	O
Medicare	O	O	B-T064
Advantage	O	O	I-T064
plan	O	O	I-T064
from	O	O	O
January	O	O	O
1	O	O	O
,	O	O	O
2012	O	O	O
,	O	O	O
to	O	O	O
December	O	O	O
31	O	O	O
,	O	O	O
2013	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
assigned	O	O	B-T169
to	O	O	O
1	O	O	O
of	O	O	O
2	O	O	O
mutually	O	O	O
exclusive	O	O	O
cohorts	O	O	B-T098
-	O	O	O
persistent	O	O	B-T047
asthma	O	O	B-T047
(	O	O	O
PA	O	O	B-T047
)	O	O	O
or	O	O	O
severe	O	O	B-T033
asthma	O	O	I-T033
(SA)-according	O	O	O
to	O	O	O
an	O	O	O
established	O	O	O
algorithm	O	O	B-T170
based	O	O	O
on	O	O	O
asthma	O	O	O
-related	O	O	O
health	O	O	B-T081
care	O	O	I-T081
resource	O	O	I-T081
use	O	O	B-T169
and	O	O	O
pharmacy	O	O	B-T033
claims	O	O	I-T033
for	O	O	O
controller	O	O	B-T121
medication	O	O	I-T121
.	O	O	O

SA	O	O	B-T033
patients	O	O	B-T101
were	O	O	O
required	O	O	O
to	O	O	O
meet	O	O	B-T067
PA	O	O	B-T047
criteria	O	O	B-T078
and	O	O	O
also	O	O	O
have	O	O	O
evidence	O	O	B-T078
of	O	O	O
≥2	O	O	O
asthma	O	O	B-T033
exacerbations	O	O	I-T033
in	O	O	O
2012	O	O	O
.	O	O	O

Asthma	O	O	B-T047
-related	O	O	O
health	O	O	B-T081
care	O	O	I-T081
resource	O	O	I-T081
utilization	O	O	B-T169
and	O	O	O
costs	O	O	B-T081
were	O	O	O
computed	O	O	B-T052
from	O	O	O
asthma	O	O	B-T047
medication	O	O	B-T058
use	O	O	B-T169
(	O	O	O
rescue	O	O	B-T169
and	O	O	O
controller	O	O	B-T169
therapy	O	O	I-T169
)	O	O	O
and	O	O	O
medical	O	O	B-UnknownType
claims	O	O	I-UnknownType
with	O	O	O
an	O	O	O
asthma	O	O	O
diagnosis	O	O	B-T033
in	O	O	O
the	O	O	O
primary	O	O	B-T082
position	O	O	I-T082
in	O	O	O
2012	O	O	O
and	O	O	O
2013	O	O	O
.	O	O	O

Adherence	O	O	B-T169
to	O	O	O
controller	O	O	B-T169
therapy	O	O	I-T169
was	O	O	O
assessed	O	O	B-T052
over	O	O	O
365	O	O	O
days	O	O	B-T079
by	O	O	O
using	O	O	O
the	O	O	O
proportion	O	O	B-T079
of	O	O	I-T079
days	O	O	I-T079
covered	O	O	I-T079
(	O	O	O
PDC	O	O	B-T079
)	O	O	O
,	O	O	O
starting	O	O	O
with	O	O	O
the	O	O	O
first	O	O	O
claim	O	O	B-UnknownType
for	O	O	O
controller	O	O	O
therapy	O	O	O
in	O	O	O
2012	O	O	O
.	O	O	O

Differences	O	O	B-T080
between	O	O	O
the	O	O	O
PA	O	O	B-T047
and	O	O	O
SA	O	O	B-T033
cohorts	O	O	B-T098
were	O	O	O
analyzed	O	O	B-T062
by	O	O	O
t-test	O	O	B-T170
for	O	O	O
continuous	O	O	B-T080
variables	O	O	I-T080
and	O	O	O
chi-square	O	O	B-T170
test	O	O	I-T170
for	O	O	O
categorical	O	O	B-T080
variables	O	O	I-T080
.	O	O	O

Asthma	O	O	B-T047
-related	O	O	O
costs	O	O	B-T081
in	O	O	O
2013	O	O	O
were	O	O	O
also	O	O	O
analyzed	O	O	B-T062
using	O	O	O
a	O	O	O
generalized	O	O	O
linear	O	O	B-T081
model	O	O	I-T081
with	O	O	O
a	O	O	O
gamma	O	O	B-T081
distribution	O	O	I-T081
and	O	O	O
log	O	O	B-T081
link	O	O	I-T081
,	O	O	O
adjusted	O	O	B-T169
for	O	O	O
patient	O	O	B-T101
demographics	O	O	B-T185
(	O	O	O
age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
region	O	O	B-T083
,	O	O	O
and	O	O	O
insurance	O	O	B-T170
type	O	O	I-T170
)	O	O	O
and	O	O	O
Quan-Charlson	O	O	B-T081
comorbidity	O	O	I-T081
score	O	O	I-T081
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
65,359	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
:	O	O	O
63,597	O	O	O
(	O	O	O
97.3	O	O	O
%	O	O	O
)	O	O	O
PA	O	O	B-T047
patients	O	O	O
and	O	O	O
1,762	O	O	O
SA	O	O	B-T033
patients	O	O	O
(	O	O	O
2.7	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Compared	O	O	B-T052
with	O	O	O
the	O	O	O
PA	O	O	B-T047
cohort	O	O	B-T098
,	O	O	O
the	O	O	O
SA	O	O	B-T033
cohort	O	O	O
was	O	O	O
older	O	O	B-T098
(	O	O	O
mean	O	O	B-T032
age	O	O	I-T032
=	O	O	O
50.8	O	O	O
years	O	O	B-T079
vs.	O	O	O
46.5	O	O	O
years	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
had	O	O	O
higher	O	O	O
mean	O	O	O
comorbidity	O	O	B-T081
score	O	O	I-T081
(	O	O	O
1.47	O	O	O
vs.	O	O	O
1.31	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	O
count	O	O	O
of	O	O	O
all	O	O	O
asthma	O	O	B-T047
medications	O	O	B-T058
fills	O	O	O
was	O	O	O
2.2-fold	O	O	O
(	O	O	O
2012	O	O	O
)	O	O	O
and	O	O	O
2.1-fold	O	O	O
(	O	O	O
2013	O	O	O
)	O	O	O
higher	O	O	O
in	O	O	O
the	O	O	O
SA	O	O	B-T033
cohort	O	O	B-T098
,	O	O	I-T098
compared	O	O	B-T052
with	O	O	O
the	O	O	O
PA	O	O	B-T047
cohort	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Mean	O	O	O
PDC	O	O	B-T079
for	O	O	O
all	O	O	O
oral	O	O	B-T122
and	O	O	O
inhaled	O	O	B-T040
controller	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
also	O	O	O
higher	O	O	O
in	O	O	O
the	O	O	O
SA	O	O	B-T033
cohort	O	O	B-T098
compared	O	O	B-T052
with	O	O	O
the	O	O	O
PA	O	O	B-T047
cohort	O	O	O
(	O	O	O
0.80	O	O	O
vs.	O	O	O
0.65	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

SA	O	O	B-T033
patients	O	O	B-T101
had	O	O	O
a	O	O	O
significantly	O	O	O
greater	O	O	B-T081
mean	O	O	I-T081
count	O	O	I-T081
of	O	O	O
asthma	O	O	B-T047
-related	O	O	O
hospitalizations	O	O	B-T058
,	O	O	O
emergency	O	O	B-T058
room	O	O	I-T058
visits	O	O	I-T058
,	O	O	O
and	O	O	O
ambulatory	O	O	B-T033
visits	O	O	I-T033
in	O	O	O
2012	O	O	O
and	O	O	O
2013	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Unadjusted	O	O	O
mean	O	O	O
annual	O	O	O
asthma	O	O	B-T047
-related	O	O	O
costs	O	O	B-T081
in	O	O	O
the	O	O	O
SA	O	O	B-T033
versus	O	O	O
PA	O	O	B-T047
cohorts	O	O	B-T098
were	O	O	O
$	O	O	O
6,496	O	O	O
versus	O	O	O
$	O	O	O
2,739	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
in	O	O	O
2012	O	O	O
and	O	O	O
$	O	O	O
5,174	O	O	O
versus	O	O	O
$	O	O	O
1,775	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
in	O	O	O
2013	O	O	O
.	O	O	O

Higher	O	O	O
asthma	O	O	B-T047
-related	O	O	O
costs	O	O	B-T081
were	O	O	O
driven	O	O	O
by	O	O	O
greater	O	O	O
mean	O	O	O
annual	O	O	O
asthma	O	O	O
medication	O	O	B-T058
costs	O	O	O
in	O	O	O
2012	O	O	O
(	O	O	O
$	O	O	O
4,545	O	O	O
vs.	O	O	O
$	O	O	O
1,738	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
2013	O	O	O
(	O	O	O
$	O	O	O
4,068	O	O	O
vs.	O	O	O
$	O	O	O
1,348	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Adjusted	O	O	B-T169
mean	O	O	O
annual	O	O	O
asthma	O	O	B-T047
-related	O	O	O
costs	O	O	B-T081
in	O	O	O
2013	O	O	O
were	O	O	O
$	O	O	O
3,336	O	O	O
greater	O	O	O
(	O	O	O
cost	O	O	B-T081
ratio	O	O	I-T081
=	O	O	O
2.878	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
SA	O	O	B-T033
cohort	O	O	B-T098
,	O	O	O
and	O	O	O
adjusted	O	O	B-T169
mean	O	O	O
annual	O	O	O
asthma	O	O	O
medication	O	O	B-T058
costs	O	O	O
were	O	O	O
$	O	O	O
2,672	O	O	O
higher	O	O	O
(	O	O	O
cost	O	O	O
ratio=2.982	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
SA	O	O	O
cohort	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
SA	O	O	B-T033
who	O	O	O
experienced	O	O	B-T041
2	O	O	O
or	O	O	O
more	O	O	O
exacerbations	O	O	B-T033
had	O	O	O
2.1-fold	O	O	O
greater	O	O	O
use	O	O	B-T169
of	O	O	O
controller	O	O	B-T061
medications	O	O	I-T061
across	O	O	O
both	O	O	O
study	O	O	O
years	O	O	B-T079
and	O	O	O
were	O	O	O
more	O	O	O
adherent	O	O	B-T169
to	O	O	O
controller	O	O	B-T169
therapy	O	O	I-T169
than	O	O	O
patients	O	O	B-T101
with	O	O	O
PA	O	O	B-T047
.	O	O	O

Despite	O	O	O
more	O	O	O
intensive	O	O	O
pharmacotherapy	O	O	B-T061
,	O	O	O
SA	O	O	B-T033
patients	O	O	B-T101
incurred	O	O	O
2.9-fold	O	O	O
higher	O	O	O
adjusted	O	O	B-T169
asthma	O	O	B-T047
-related	O	O	O
costs	O	O	B-T081
and	O	O	O
3-fold	O	O	O
higher	O	O	O
adjusted	O	O	O
asthma	O	O	O
medication	O	O	B-T058
costs	O	O	O
than	O	O	O
PA	O	O	B-T047
patients	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
SA	O	O	B-T033
consistently	O	O	B-T078
demonstrated	O	O	O
a	O	O	O
higher	O	O	O
rate	O	O	O
of	O	O	O
health	O	O	B-T058
care	O	O	I-T058
utilization	O	O	B-T169
.	O	O	O

Funding	O	O	B-T081
for	O	O	O
this	O	O	O
study	O	O	B-T062
(	O	O	O
HO-14	O	O	O
-	O	O	O
14443	O	O	O
)	O	O	O
was	O	O	O
provided	O	O	O
by	O	O	O
GlaxoSmithKline	O	O	B-T093
(	O	O	O
GSK	O	O	B-T093
)	O	O	O
.	O	O	O

All	O	O	O
listed	O	O	O
authors	O	O	B-T097
meet	O	O	B-T067
the	O	O	O
criteria	O	O	B-T078
for	O	O	O
authorship	O	O	B-T057
set	O	O	O
forth	O	O	O
by	O	O	O
the	O	O	O
International	O	O	B-T096
Committee	O	O	I-T096
for	O	O	I-T096
Medical	O	O	I-T096
Journal	O	O	I-T096
Editors	O	O	I-T096
.	O	O	O

Albers	O	O	B-T170
,	O	O	O
Forshag	O	O	B-T170
,	O	O	O
and	O	O	O
Yancey	O	O	B-T170
are	O	O	O
employees	O	O	B-T097
of	O	O	O
GSK	O	O	B-T093
and	O	O	O
hold	O	O	O
stock	O	O	O
in	O	O	O
GSK	O	O	O
.	O	O	O

Dalal	O	O	B-T170
,	O	O	O
Nagar	O	O	B-T170
,	O	O	O
and	O	O	O
Ortega	O	O	B-T170
were	O	O	O
employees	O	O	B-T097
of	O	O	O
GSK	O	O	B-T093
at	O	O	O
the	O	O	O
time	O	O	B-T079
this	O	O	O
research	O	O	B-T062
was	O	O	O
conducted	O	O	O
.	O	O	O

Chastek	O	O	B-T170
and	O	O	O
Korrer	O	O	B-T170
are	O	O	O
employees	O	O	B-T097
of	O	O	O
Optum	O	O	B-T093
,	O	O	O
which	O	O	O
received	O	O	O
consulting	O	O	B-T081
fees	O	O	I-T081
from	O	O	O
GSK	O	O	B-T093
for	O	O	O
research	O	O	B-T062
related	O	O	O
to	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

Study	O	O	B-T078
concept	O	O	I-T078
and	O	O	O
design	O	O	B-T052
were	O	O	O
contributed	O	O	B-T052
by	O	O	O
Chastek	O	O	B-T170
,	O	O	O
Nagar	O	O	B-T170
,	O	O	O
and	O	O	O
Dalal	O	O	B-T170
.	O	O	O

Korrer	O	O	B-T170
took	O	O	O
the	O	O	O
lead	O	O	O
in	O	O	O
data	O	O	B-T062
collection	O	O	I-T062
,	O	O	O
along	O	O	O
with	O	O	O
Chastek	O	O	B-T170
,	O	O	O
and	O	O	O
data	O	O	B-T081
interpretation	O	O	I-T081
was	O	O	O
performed	O	O	O
by	O	O	O
Chastek	O	O	O
,	O	O	O
Ortega	O	O	B-T170
,	O	O	O
Forshag	O	O	B-T170
,	O	O	O
and	O	O	O
Dalal	O	O	B-T170
.	O	O	O

The	O	O	O
manuscript	O	O	B-T073
was	O	O	O
written	O	O	O
by	O	O	O
Chastek	O	O	B-T170
and	O	O	O
Dalal	O	O	B-T170
and	O	O	O
revised	O	O	B-T169
by	O	O	O
Albers	O	O	B-T170
and	O	O	O
Yancy	O	O	B-T170
,	O	O	O
assisted	O	O	B-T080
by	O	O	O
the	O	O	O
other	O	O	O
authors	O	O	B-T097
.	O	O	O

-DOCSTART- (27348405)

Differential	O	O	B-T042
regulation	O	O	I-T042
of	O	O	O
spontaneous	O	O	B-T169
and	O	O	O
evoked	O	O	B-T080
inhibitory	O	O	B-T042
synaptic	O	O	I-T042
transmission	O	O	I-T042
in	O	O	O
somatosensory	O	O	B-T023
cortex	O	O	I-T023
by	O	O	O
retinoic	O	O	O
acid	O	O	O

Retinoic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
RA	O	O	B-T109
)	O	O	O
,	O	O	O
a	O	O	O
developmental	O	O	B-T080
morphogen	O	O	B-T121
,	O	O	O
has	O	O	O
emerged	O	O	O
in	O	O	O
recent	O	O	O
studies	O	O	O
as	O	O	O
a	O	O	O
novel	O	O	B-T080
synaptic	O	O	B-T043
signaling	O	O	B-T123
molecule	O	O	I-T123
that	O	O	O
acts	O	O	O
in	O	O	O
mature	O	O	B-T079
hippocampal	O	O	B-T023
neurons	O	O	B-T025
to	O	O	O
modulate	O	O	B-UnknownType
excitatory	O	O	B-T042
and	O	O	O
inhibitory	O	O	B-T042
synaptic	O	O	I-T042
transmission	O	O	I-T042
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
homeostatic	O	O	B-T038
synaptic	O	O	B-T042
plasticity	O	O	I-T042
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
unclear	O	O	O
whether	O	O	O
RA	O	O	B-T109
is	O	O	O
capable	O	O	O
of	O	O	O
modulating	O	O	B-UnknownType
neural	O	O	B-UnknownType
circuits	O	O	I-UnknownType
outside	O	O	B-T082
of	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
,	O	O	O
and	O	O	O
if	O	O	O
so	O	O	O
,	O	O	O
whether	O	O	O
the	O	O	O
mode	O	O	B-T169
of	O	O	I-T169
RA	O	O	I-T169
's	O	O	I-T169
action	O	O	I-T169
at	O	O	O
synapses	O	O	B-T030
is	O	O	O
similar	O	O	B-T080
to	O	O	O
that	O	O	O
within	O	O	B-T082
the	O	O	O
hippocampal	O	O	B-T023
network	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
explore	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
RA	O	O	B-T109
's	O	O	O
synaptic	O	O	B-T043
function	O	O	B-T169
outside	O	O	B-T082
the	O	O	O
hippocampus	O	O	B-T023
and	O	O	O
uncover	O	O	O
a	O	O	O
novel	O	O	B-T080
function	O	O	O
of	O	O	O
all-trans	O	O	B-T109
retinoic	O	O	I-T109
acid	O	O	I-T109
at	O	O	O
inhibitory	O	O	B-T026
synapses	O	O	I-T026
.	O	O	O

Acute	O	O	B-T079
RA	O	O	B-T109
treatment	O	O	B-T169
increases	O	O	B-T169
spontaneous	O	O	B-T169
inhibitory	O	O	B-T042
synaptic	O	O	I-T042
transmission	O	O	I-T042
in	O	O	O
L2/3	O	O	B-T025
pyramidal	O	O	I-T025
neurons	O	O	I-T025
of	O	O	O
the	O	O	O
somatosensory	O	O	B-T023
cortex	O	O	I-T023
,	O	O	O
and	O	O	O
this	O	O	O
effect	O	O	B-T080
requires	O	O	O
expression	O	O	B-T045
of	O	O	O
RA	O	O	B-T116
's	O	O	I-T116
receptor	O	O	I-T116
RARα	O	O	B-T116
both	O	O	O
pre-	O	O	B-T043
and	O	O	I-T043
post-synaptically	O	O	I-T043
.	O	O	O

Intriguingly	O	O	O
,	O	O	O
RA	O	O	B-T109
does	O	O	O
not	O	O	O
seem	O	O	O
to	O	O	O
affect	O	O	O
evoked	O	O	B-T080
inhibitory	O	O	B-T042
transmission	O	O	I-T042
assayed	O	O	O
with	O	O	O
either	O	O	O
extracellular	O	O	B-T026
stimulation	O	O	O
or	O	O	O
direct	O	O	O
activation	O	O	B-T043
of	O	O	I-T043
action	O	O	I-T043
potentials	O	O	I-T043
in	O	O	O
presynaptic	O	O	B-T026
interneurons	O	O	B-T025
at	O	O	O
connected	O	O	O
pairs	O	O	O
of	O	O	O
interneurons	O	O	O
and	O	O	O
pyramidal	O	O	B-T025
neurons	O	O	I-T025
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
these	O	O	O
results	O	O	B-T033
suggest	O	O	O
that	O	O	O
RA	O	O	B-T109
's	O	O	I-T109
action	O	O	B-T052
at	O	O	O
synapses	O	O	B-T030
is	O	O	O
not	O	O	O
monotonous	O	O	O
,	O	O	O
but	O	O	O
is	O	O	O
diverse	O	O	B-T080
depending	O	O	O
on	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
synaptic	O	O	B-T043
connection	O	O	I-T043
(	O	O	O
excitatory	O	O	B-T042
versus	O	O	O
inhibitory	O	O	B-T042
)	O	O	O
and	O	O	O
circuit	O	O	B-UnknownType
(	O	O	O
hippocampal	O	O	B-T023
versus	O	O	O
cortical	O	O	B-T023
)	O	O	I-T023
.	O	O	O

Thus	O	O	O
,	O	O	O
synaptic	O	O	B-T043
signaling	O	O	I-T043
of	O	O	O
RA	O	O	B-T109
may	O	O	O
mediate	O	O	O
multi-faceted	O	O	O
regulation	O	O	B-T042
of	O	O	I-T042
synaptic	O	O	I-T042
plasticity	O	O	I-T042
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
its	O	O	O
classic	O	O	B-T077
roles	O	O	I-T077
in	O	O	O
brain	O	O	B-T023
development	O	O	I-T042
,	O	O	O
retinoic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
RA	O	O	B-T109
)	O	O	O
has	O	O	O
recently	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
regulate	O	O	B-T042
excitatory	O	O	B-T042
and	O	O	O
inhibitory	O	O	B-T042
transmission	O	O	I-T042
in	O	O	O
the	O	O	O
adult	O	O	B-T100
brain	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
the	O	O	O
authors	O	O	B-T097
show	O	O	O
that	O	O	O
in	O	O	O
layer	O	O	B-T023
2/3	O	O	I-T023
(	O	O	O
L2/3	O	O	B-T023
)	O	O	O
of	O	O	O
the	O	O	O
somatosensory	O	O	B-T023
cortex	O	O	I-T023
(	O	O	O
S1	O	O	B-T023
)	O	O	O
,	O	O	O
acute	O	O	B-T079
RA	O	O	B-T109
induces	O	O	B-T169
increases	O	O	B-T169
in	O	O	O
spontaneous	O	O	B-T169
but	O	O	O
not	O	O	O
action-potential	O	O	B-T043
evoked	O	O	B-T080
transmission	O	O	B-T043
,	O	O	O
and	O	O	O
that	O	O	O
this	O	O	O
requires	O	O	O
retinoic	O	O	B-T116
acid	O	O	I-T116
receptor	O	O	I-T116
(	O	O	O
RARα	O	O	B-T116
)	O	O	O
both	O	O	O
in	O	O	O
presynaptic	O	O	B-T026
PV	O	O	B-T116
-positive	O	O	O
interneurons	O	O	B-T025
and	O	O	O
postsynaptic	O	O	B-UnknownType
pyramidal	O	O	B-T025
(	O	O	I-T025
PN	O	O	I-T025
)	O	O	I-T025
neurons	O	O	I-T025
.	O	O	O

-DOCSTART- (27348711)

Utilization	O	O	B-T081
Pattern	O	O	B-T082
and	O	O	O
Drug	O	O	B-T041
Use	O	O	I-T041
of	O	O	O
Traditional	O	O	B-T091
Chinese	O	O	B-T091
Medicine	O	O	I-T091
,	O	O	O
Western	O	O	B-T091
Medicine	O	O	I-T091
,	O	O	O
and	O	O	O
Integrated	O	O	B-T091
Chinese-Western	O	O	I-T091
Medicine	O	O	I-T091
Treatments	O	O	B-T061
for	O	O	O
Allergic	O	O	B-T047
Rhinitis	O	O	I-T047
Under	O	O	O
the	O	O	O
National	O	O	B-T058
Health	O	O	I-T058
Insurance	O	O	I-T058
Program	O	O	I-T058
in	O	O	O
Taiwan	O	O	O

Patients	O	O	B-T101
in	O	O	O
Taiwan	O	O	B-T083
with	O	O	O
allergic	O	O	B-T047
rhinitis	O	O	I-T047
seek	O	O	O
not	O	O	O
only	O	O	O
Western	O	O	B-T091
medicine	O	O	I-T091
treatment	O	O	B-T061
but	O	O	O
also	O	O	O
Traditional	O	O	B-T091
Chinese	O	O	I-T091
Medicine	O	O	I-T091
treatment	O	O	O
or	O	O	O
integrated	O	O	B-T091
Chinese-Western	O	O	I-T091
medicine	O	O	I-T091
treatment	O	O	O
.	O	O	O

Various	O	O	O
studies	O	O	O
have	O	O	O
conducted	O	O	O
pairwise	O	O	B-T081
comparison	O	O	I-T081
on	O	O	O
Traditional	O	O	B-T091
Chinese	O	O	I-T091
Medicine	O	O	I-T091
,	O	O	O
Western	O	O	B-T091
medicine	O	O	I-T091
,	O	O	O
and	O	O	O
integrated	O	O	B-T091
Chinese-Western	O	O	I-T091
medicine	O	O	I-T091
treatments	O	O	B-T061
.	O	O	O

However	O	O	O
,	O	O	O
none	O	O	O
conducted	O	O	O
simultaneous	O	O	B-T079
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
three	O	O	O
treatments	O	O	B-T061
.	O	O	O

This	O	O	O
study	O	O	O
analyzed	O	O	B-T062
patients	O	O	B-T101
with	O	O	O
allergic	O	O	B-T047
rhinitis	O	O	I-T047
receiving	O	O	O
the	O	O	O
three	O	O	O
treatments	O	O	B-T061
to	O	O	O
identify	O	O	O
differences	O	O	O
in	O	O	O
demographic	O	O	B-T090
characteristic	O	O	B-T080
and	O	O	O
medical	O	O	B-T169
use	O	O	B-T169
and	O	O	O
thereby	O	O	O
to	O	O	O
determine	O	O	O
drug	O	O	B-T041
use	O	O	I-T041
patterns	O	O	I-T041
of	O	O	O
different	O	O	O
treatments	O	O	O
.	O	O	O

The	O	O	O
National	O	O	B-T170
Health	O	O	I-T170
Insurance	O	O	I-T170
Research	O	O	I-T170
Database	O	O	I-T170
was	O	O	O
the	O	O	O
data	O	O	B-T081
source	O	O	I-T081
,	O	O	O
and	O	O	O
included	O	O	O
patients	O	O	B-T101
were	O	O	O
those	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
allergic	O	O	B-T047
rhinitis	O	O	I-T047
(	O	O	O
International	O	O	B-T170
Classification	O	O	I-T170
of	O	O	I-T170
Diseases	O	O	I-T170
,	O	O	I-T170
Ninth	O	O	I-T170
Revision	O	O	I-T170
,	O	O	O
Clinical	O	O	B-T170
Modification	O	O	I-T170
codes	O	O	I-T170
470	O	O	I-T170
-	O	O	I-T170
478	O	O	I-T170
)	O	O	O
.	O	O	O

Chi-square	O	O	B-T170
test	O	O	I-T170
and	O	O	O
Tukey	O	O	B-T170
studentized	O	O	I-T170
range	O	O	I-T170
(	O	O	I-T170
honest	O	O	I-T170
significant	O	O	I-T170
difference	O	O	I-T170
)	O	O	I-T170
test	O	O	I-T170
were	O	O	O
conducted	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
differences	O	O	O
among	O	O	O
the	O	O	O
three	O	O	O
treatments	O	O	B-T061
.	O	O	O

Visit	O	O	B-T081
frequency	O	O	I-T081
for	O	O	O
allergic	O	O	B-T047
rhinitis	O	O	I-T047
treatment	O	O	B-T061
was	O	O	O
higher	O	O	O
in	O	O	O
female	O	O	B-T098
than	O	O	O
male	O	O	B-T098
patients	O	O	B-T101
,	O	O	O
regardless	O	O	O
of	O	O	O
treatment	O	O	O
with	O	O	O
Traditional	O	O	B-T091
Chinese	O	O	I-T091
Medicine	O	O	I-T091
,	O	O	O
Western	O	O	B-T091
medicine	O	O	I-T091
,	O	O	O
or	O	O	O
integrated	O	O	B-T091
Chinese-Western	O	O	I-T091
medicine	O	O	I-T091
.	O	O	O

Persons	O	O	B-T098
aged	O	O	O
0	O	O	O
-	O	O	O
19	O	O	O
years	O	O	O
ranked	O	O	O
the	O	O	O
highest	O	O	B-T080
in	O	O	O
proportion	O	O	B-T081
of	O	O	O
visits	O	O	B-T058
for	O	O	O
allergic	O	O	B-T047
rhinitis	O	O	I-T047
.	O	O	O

Traditional	O	O	B-T091
Chinese	O	O	I-T091
Medicine	O	O	I-T091
treatment	O	O	B-T061
had	O	O	O
more	O	O	O
medical	O	O	B-T169
items	O	O	O
per	O	O	O
person-time	O	O	B-T098
and	O	O	O
daily	O	O	B-T079
drug	O	O	B-T081
cost	O	O	I-T081
per	O	O	O
person-time	O	O	O
and	O	O	O
had	O	O	O
the	O	O	O
lowest	O	O	B-T080
total	O	O	B-T080
expenditure	O	O	B-T081
per	O	O	O
person-time	O	O	O
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
Western	O	O	B-T091
medicine	O	O	I-T091
had	O	O	O
the	O	O	O
lowest	O	O	B-T080
daily	O	O	B-T079
drug	O	O	B-T081
cost	O	O	I-T081
per	O	O	O
person-time	O	O	B-T098
and	O	O	O
the	O	O	O
highest	O	O	B-T080
total	O	O	B-T080
expenditure	O	O	B-T081
per	O	O	O
person-time	O	O	O
.	O	O	O

The	O	O	O
total	O	O	B-T080
expenditure	O	O	B-T081
per	O	O	O
person-time	O	O	B-T098
,	O	O	O
daily	O	O	B-T079
drug	O	O	B-T081
cost	O	O	I-T081
per	O	O	O
person-time	O	O	O
,	O	O	O
and	O	O	O
medical	O	O	B-T169
items	O	O	B-T071
per	O	O	O
person-time	O	O	O
of	O	O	O
integrated	O	O	B-T091
Chinese-Western	O	O	I-T091
medicine	O	O	I-T091
treatment	O	O	B-T061
lay	O	O	O
between	O	O	O
those	O	O	O
seen	O	O	O
with	O	O	O
Traditional	O	O	B-T091
Chinese	O	O	I-T091
Medicine	O	O	I-T091
and	O	O	O
Western	O	O	B-T091
medicine	O	O	I-T091
treatments	O	O	B-T061
.	O	O	O

Although	O	O	O
only	O	O	O
6.82	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
allergic	O	O	B-T047
rhinitis	O	O	I-T047
chose	O	O	O
integrated	O	O	B-T091
Chinese-Western	O	O	I-T091
medicine	O	O	I-T091
treatment	O	O	B-T061
,	O	O	O
the	O	O	O
visit	O	O	B-T081
frequency	O	O	I-T081
per	O	O	O
person-year	O	O	O
of	O	O	O
integrated	O	O	O
Chinese-Western	O	O	O
medicine	O	O	O
ranked	O	O	O
highest	O	O	B-T080
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
multiple-composition	O	O	B-T081
medicines	O	O	B-T121
were	O	O	O
used	O	O	O
more	O	O	O
frequently	O	O	B-T079
than	O	O	O
single-composition	O	O	B-T081
medicines	O	O	O
,	O	O	O
and	O	O	O
mar	O	O	B-T109
huang	O	O	I-T109
(	O	O	O
Ephedra	O	O	B-T002
sinica	O	O	I-T002
Stapf	O	O	I-T002
)	O	O	O
was	O	O	O
seldom	O	O	O
used	O	O	O
to	O	O	O
decrease	O	O	B-T081
the	O	O	O
risk	O	O	B-T078
of	O	O	I-T078
combining	O	O	O
medications	O	O	B-T121
.	O	O	O

-DOCSTART- (27354219)

TLR9	O	O	B-T028
Deficiency	O	O	B-T169
Leads	O	O	O
to	O	O	O
Accelerated	O	O	B-T169
Renal	O	O	B-T047
Disease	O	O	I-T047
and	O	O	O
Myeloid	O	O	B-T025
Lineage	O	O	I-T025
Abnormalities	O	O	B-T033
in	O	O	O
Pristane	O	O	B-T109
-Induced	O	O	O
Murine	O	O	B-T015
Lupus	O	O	O

Systemic	O	O	B-T047
lupus	O	O	I-T047
erythematosus	O	O	I-T047
(	O	O	O
SLE	O	O	B-T047
)	O	O	I-T047
is	O	O	O
a	O	O	O
chronic	O	O	B-T079
,	O	O	O
life-threatening	O	O	B-T033
autoimmune	O	O	B-T047
disorder	O	O	I-T047
,	O	O	O
leading	O	O	O
to	O	O	O
multiple	O	O	O
organ	O	O	B-T023
pathologies	O	O	B-T091
and	O	O	O
kidney	O	O	B-T023
destruction	O	O	B-T052
.	O	O	O

Analyses	O	O	O
of	O	O	O
numerous	O	O	O
murine	O	O	B-T015
models	O	O	B-T050
of	O	O	O
spontaneous	O	O	O
SLE	O	O	B-T047
have	O	O	O
revealed	O	O	O
a	O	O	O
critical	O	O	O
role	O	O	O
for	O	O	O
endosomal	O	O	B-T026
TLRs	O	O	B-T116
in	O	O	O
the	O	O	O
production	O	O	O
of	O	O	O
autoantibodies	O	O	B-T116
and	O	O	O
development	O	O	O
of	O	O	O
other	O	O	O
clinical	O	O	B-T080
disease	O	O	B-T047
manifestations	O	O	B-T169
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
the	O	O	O
corresponding	O	O	O
TLR9	O	O	B-T028
-	O	O	O
deficient	O	O	B-T169
autoimmune	O	O	B-T046
-prone	O	O	O
strains	O	O	B-T001
consistently	O	O	O
develop	O	O	O
more	O	O	O
severe	O	O	O
disease	O	O	B-T047
pathology	O	O	B-T091
.	O	O	O

Injection	O	O	B-T061
of	O	O	O
BALB/c	O	O	B-T015
mice	O	O	I-T015
with	O	O	O
2,6,10,14-tetramethylpentadecane	O	O	B-T109
(	O	O	O
TMPD	O	O	B-T109
)	O	O	O
,	O	O	O
commonly	O	O	O
known	O	O	O
as	O	O	O
pristane	O	O	B-T109
,	O	O	O
also	O	O	O
results	O	O	O
in	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
SLE-like	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

We	O	O	O
now	O	O	O
show	O	O	O
that	O	O	O
Tlr9(-/-	O	O	B-T028
)	O	O	I-T028
BALB/c	O	O	B-T015
mice	O	O	I-T015
injected	O	O	O
i.p	O	O	O
.	O	O	O

with	O	O	O
TMPD	O	O	B-T109
develop	O	O	O
more	O	O	O
severe	O	O	O
autoimmunity	O	O	B-T046
than	O	O	O
do	O	O	O
their	O	O	O
TLR	O	O	B-T116
-sufficient	O	O	O
cohorts	O	O	O
.	O	O	O

Early	O	O	O
indications	O	O	O
include	O	O	O
an	O	O	O
increased	O	O	O
accumulation	O	O	B-T033
of	O	O	O
TLR7	O	O	B-T028
-	O	O	O
expressing	O	O	B-T045
Ly6C(hi	O	O	B-T129
)	O	O	I-T129
inflammatory	O	O	B-T169
monocytes	O	O	B-T025
at	O	O	O
the	O	O	O
site	O	O	B-T082
of	O	O	I-T082
injection	O	O	I-T082
,	O	O	O
upregulation	O	O	B-T044
of	O	O	O
IFN	O	O	B-T116
-regulated	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
the	O	O	O
peritoneal	O	O	B-T030
cavity	O	O	I-T030
,	O	O	O
and	O	O	O
an	O	O	O
increased	O	O	O
production	O	O	O
of	O	O	O
myeloid	O	O	B-T025
lineage	O	O	I-T025
precursors	O	O	I-T025
(	O	O	O
common	O	O	B-T025
myeloid	O	O	I-T025
progenitors	O	O	I-T025
and	O	O	O
granulocyte	O	O	B-T025
myeloid	O	O	B-T025
precursors	O	O	I-T025
)	O	O	O
in	O	O	O
the	O	O	O
bone	O	O	B-T024
marrow	O	O	I-T024
.	O	O	O

TMPD	O	O	B-T109
-	O	O	O
injected	O	O	B-T061
Tlr9(-/-	O	O	B-T028
)	O	O	I-T028
BALB/c	O	O	B-T015
mice	O	O	I-T015
develop	O	O	O
higher	O	O	O
autoantibody	O	O	B-T116
titers	O	O	O
against	O	O	O
RNA	O	O	B-T114
,	O	O	O
neutrophil	O	O	B-T025
cytoplasmic	O	O	B-T026
Ags	O	O	B-T129
,	O	O	O
and	O	O	O
myeloperoxidase	O	O	B-T116
than	O	O	O
do	O	O	O
TMPD	O	O	O
-	O	O	O
injected	O	O	O
wild-type	O	O	B-T015
BALB/c	O	O	I-T015
mice	O	O	I-T015
.	O	O	O

The	O	O	O
TMP	O	O	B-T109
-	O	O	O
injected	O	O	B-T061
Tlr9(-/-	O	O	B-T028
)	O	O	I-T028
mice	O	O	B-T015
,	O	O	O
and	O	O	O
not	O	O	O
the	O	O	O
wild-type	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
also	O	O	O
develop	O	O	O
a	O	O	O
marked	O	O	O
increase	O	O	O
in	O	O	O
glomerular	O	O	B-T116
IgG	O	O	I-T116
deposition	O	O	B-T169
and	O	O	O
infiltrating	O	O	O
granulocytes	O	O	B-T025
,	O	O	O
much	O	O	O
more	O	O	O
severe	O	O	O
glomerulonephritis	O	O	B-T047
,	O	O	O
and	O	O	O
a	O	O	O
reduced	O	O	B-T080
lifespan	O	O	B-T102
.	O	O	O

Collectively	O	O	O
,	O	O	O
the	O	O	O
data	O	O	O
point	O	O	O
to	O	O	O
a	O	O	O
major	O	O	O
role	O	O	O
for	O	O	O
TLR7	O	O	B-T028
in	O	O	O
the	O	O	O
response	O	O	B-T032
to	O	O	O
self-antigens	O	O	B-T129
in	O	O	O
this	O	O	O
model	O	O	B-T050
of	O	O	O
experimental	O	O	O
autoimmunity	O	O	B-T046
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
BALB/c	O	O	B-T015
pristane	O	O	B-T109
model	O	O	B-T050
recapitulates	O	O	O
other	O	O	O
TLR7	O	O	B-T028
-driven	O	O	O
spontaneous	O	O	O
models	O	O	B-T050
of	O	O	O
SLE	O	O	B-T047
and	O	O	O
is	O	O	O
negatively	O	O	B-T033
regulated	O	O	O
by	O	O	O
TLR9	O	O	B-T028
.	O	O	O

-DOCSTART- (27354640)

Effect	O	O	B-T080
of	O	O	O
Xenotransplantation	O	O	B-T061
Site	O	O	B-T082
on	O	O	O
MicroRNA	O	O	B-T114
Expression	O	O	B-T045
of	O	O	O
Human	O	O	B-T016
Colon	O	O	B-T191
Cancer	O	O	I-T191
Stem	O	O	O
Cells	O	O	O

Cancer	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
CSCs	O	O	B-T025
)	O	O	O
have	O	O	O
a	O	O	O
high	O	O	B-T080
tumorigenic	O	O	B-T191
ability	O	O	B-T032
to	O	O	O
form	O	O	O
patient-derived	O	O	B-T050
tumor	O	O	I-T050
xenografts	O	O	I-T050
(	O	O	O
PDXs	O	O	B-T050
)	O	O	O
.	O	O	O

PDXs	O	O	B-T050
are	O	O	O
an	O	O	O
attractive	O	O	B-T080
pre-clinical	O	O	B-T170
model	O	O	I-T170
,	O	O	O
but	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
biological	O	O	B-T070
behavior	O	O	I-T070
of	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
the	O	O	O
tumor	O	O	B-T191
will	O	O	O
change	O	O	B-T169
during	O	O	O
establishment	O	O	B-T080
and	O	O	O
passage	O	O	O
of	O	O	O
PDXs	O	O	O
.	O	O	O

Human	O	O	B-T016
colon	O	O	B-T191
cancer	O	O	I-T191
PDX	O	O	B-T050
was	O	O	O
established	O	O	B-T080
and	O	O	O
passaged	O	O	B-T059
either	O	O	O
subcutaneously	O	O	B-T082
or	O	O	O
orthotopically	O	O	B-T082
into	O	O	O
the	O	O	O
murine	O	O	B-T015
intestine	O	O	B-T023
.	O	O	O

Histology	O	O	B-T091
and	O	O	O
flow	O	O	B-T059
cytometric	O	O	I-T059
profile	O	O	B-T059
of	O	O	O
the	O	O	O
surgical	O	O	B-T061
specimen	O	O	B-T077
and	O	O	O
the	O	O	O
PDX	O	O	B-T050
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

CSCs	O	O	B-T025
were	O	O	O
then	O	O	O
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
tumors	O	O	B-T191
and	O	O	O
their	O	O	O
microRNA	O	O	B-T114
(	O	O	O
miRNA	O	O	B-T114
)	O	O	O
expression	O	O	B-T045
was	O	O	O
analyzed	O	O	B-T062
by	O	O	O
semi-quantitative	O	O	B-T059
polymerase	O	O	I-T059
chain	O	O	I-T059
reaction	O	O	I-T059
.	O	O	O

The	O	O	O
surgical	O	O	B-T061
specimens	O	O	B-T077
and	O	O	O
PDXs	O	O	B-T050
were	O	O	O
histologically	O	O	B-T091
similar	O	O	B-T080
.	O	O	O

The	O	O	O
size	O	O	B-T082
of	O	O	O
CSC	O	O	B-T025
population	O	O	B-T098
increased	O	O	B-T081
and	O	O	O
expression	O	O	B-T045
of	O	O	O
miRNA	O	O	B-T114
s	O	O	O
in	O	O	O
CSCs	O	O	B-T025
changed	O	O	B-T169
in	O	O	O
the	O	O	O
passaged	O	O	B-T059
PDXs	O	O	B-T050
.	O	O	O

Expression	O	O	B-T045
of	O	O	O
oncogenic	O	O	B-T131
miRNAs	O	O	B-T114
was	O	O	O
highly	O	O	B-T080
up-regulated	O	O	B-T044
in	O	O	O
the	O	O	O
CSCs	O	O	B-T025
of	O	O	O
the	O	O	O
orthotopically	O	O	B-T082
passaged	O	O	B-T059
PDXs	O	O	B-T050
.	O	O	O

The	O	O	O
xenotransplantation	O	O	B-T061
site	O	O	B-T082
and	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	O
tumor	O	O	B-T191
passages	O	O	B-T059
affect	O	O	B-T041
the	O	O	O
miRNA	O	O	B-T114
expression	O	O	B-T045
of	O	O	O
human	O	O	B-T016
colon	O	O	B-T023
CSCs	O	O	B-T025
.	O	O	O

-DOCSTART- (27355356)

Chemosensitivity	O	O	B-T033
,	O	O	O
Cardiovascular	O	O	B-T033
Risk	O	O	I-T033
,	O	O	O
and	O	O	O
the	O	O	O
Ventilatory	O	O	B-T201
Response	O	O	I-T201
to	O	O	O
Exercise	O	O	B-T056
in	O	O	O
COPD	O	O	O

COPD	O	O	B-T047
is	O	O	O
associated	O	O	O
with	O	O	O
elevated	O	O	B-T080
cardiovascular	O	O	B-T033
risk	O	O	I-T033
and	O	O	O
a	O	O	O
potentiated	O	O	B-T080
ventilatory	O	O	B-T201
response	O	O	I-T201
to	O	O	O
exercise	O	O	B-T056
.	O	O	O

Enhanced	O	O	O
carotid	O	O	B-T023
chemoreceptor	O	O	B-T025
(	O	O	O
CC	O	O	B-T025
)	O	O	O
activity	O	O	B-T042
/	O	O	O
sensitivity	O	O	B-T042
is	O	O	O
present	O	O	O
in	O	O	O
other	O	O	O
clinical	O	O	B-T201
conditions	O	O	I-T201
,	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
contribute	O	O	O
to	O	O	O
sympathetic	O	O	B-T022
vasoconstrictor	O	O	B-T046
outflow	O	O	I-T046
,	O	O	O
and	O	O	O
is	O	O	O
predictive	O	O	B-T080
of	O	O	O
mortality	O	O	B-T033
.	O	O	O

CC	O	O	B-T025
activity	O	O	B-T042
/	O	O	O
sensitivity	O	O	B-T042
,	O	O	O
and	O	O	O
the	O	O	O
resulting	O	O	O
functional	O	O	B-T169
significance	O	O	B-T078
,	O	O	O
has	O	O	O
not	O	O	B-T080
been	O	O	I-T080
well	O	O	I-T080
examined	O	O	I-T080
in	O	O	O
COPD	O	O	B-T047
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
CC	O	O	B-T025
activity	O	O	B-T042
/	O	O	O
sensitivity	O	O	B-T042
would	O	O	O
be	O	O	O
elevated	O	O	B-T080
in	O	O	O
COPD	O	O	B-T047
,	O	O	O
and	O	O	O
related	O	O	O
to	O	O	O
increased	O	O	B-T081
pulse	O	O	B-T081
wave	O	O	I-T081
velocity	O	O	I-T081
(	O	O	O
a	O	O	O
marker	O	O	B-T201
of	O	O	O
CV	O	O	B-T033
risk	O	O	I-T033
)	O	O	O
and	O	O	O
the	O	O	O
ventilatory	O	O	B-T201
response	O	O	I-T201
to	O	O	O
exercise	O	O	B-T056
.	O	O	O

30	O	O	O
COPD	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
10	O	O	O
healthy	O	O	B-T080
age-matched	O	O	O
controls	O	O	B-T096
were	O	O	O
examined	O	O	B-T033
.	O	O	O

Participants	O	O	B-T098
performed	O	O	O
baseline	O	O	B-T081
cardiopulmonary	O	O	B-T060
exercise	O	O	I-T060
and	O	O	O
pulmonary	O	O	B-T060
function	O	O	I-T060
testing	O	O	I-T060
.	O	O	O

CC	O	O	B-T025
activity	O	O	B-T042
was	O	O	O
later	O	O	O
evaluated	O	O	B-T058
by	O	O	O
the	O	O	O
drop	O	O	B-T033
in	O	O	I-T033
ventilation	O	O	B-T039
with	O	O	O
breathing	O	O	B-T039
100	O	O	O
%	O	O	O
O2	O	O	B-T121
,	O	O	O
and	O	O	O
CC	O	O	O
sensitivity	O	O	B-T042
was	O	O	O
then	O	O	O
assessed	O	O	O
by	O	O	O
the	O	O	O
ventilatory	O	O	B-T060
response	O	O	I-T060
to	O	O	I-T060
hypoxia	O	O	I-T060
(	O	O	O
ΔVE/ΔS	O	O	O
pO2	O	O	B-T059
)	O	O	O
.	O	O	O

Peripheral	O	O	B-T082
arterial	O	O	B-T039
stiffness	O	O	I-T039
was	O	O	O
subsequently	O	O	O
evaluated	O	O	B-T058
by	O	O	O
measurement	O	O	B-T169
of	O	O	O
pulse	O	O	B-T081
wave	O	O	I-T081
velocity	O	O	I-T081
(	O	O	O
PWV	O	O	B-T081
)	O	O	O
using	O	O	O
applanation	O	O	B-T060
tonometry	O	O	I-T060
while	O	O	O
the	O	O	O
subjects	O	O	O
were	O	O	O
breathing	O	O	B-T039
room	O	O	B-T033
air	O	O	I-T033
,	O	O	O
and	O	O	O
then	O	O	O
following	O	O	O
chemoreceptor	O	O	B-T025
inhibition	O	O	B-T052
by	O	O	O
breathing	O	O	O
100	O	O	B-T081
%	O	O	I-T081
O2	O	O	B-T121
for	O	O	O
2	O	O	O
minutes	O	O	O
.	O	O	O

CC	O	O	B-T025
activity	O	O	B-T042
,	O	O	O
CC	O	O	O
sensitivity	O	O	B-T042
,	O	O	O
PWV	O	O	B-T081
and	O	O	O
the	O	O	O
ventilatory	O	O	B-T201
response	O	O	I-T201
to	O	O	O
exercise	O	O	B-T056
were	O	O	O
all	O	O	O
increased	O	O	O
in	O	O	O
COPD	O	O	B-T047
relative	O	O	O
to	O	O	O
controls	O	O	B-T096
.	O	O	O

CC	O	O	B-T025
sensitivity	O	O	B-T042
was	O	O	O
related	O	O	O
to	O	O	O
PWV	O	O	B-T081
;	O	O	O
however	O	O	O
,	O	O	O
neither	O	O	O
CC	O	O	O
activity	O	O	B-T042
nor	O	O	O
CC	O	O	O
sensitivity	O	O	O
was	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
ventilatory	O	O	B-T201
response	O	O	I-T201
to	O	O	O
exercise	O	O	B-T056
in	O	O	O
COPD	O	O	B-T047
.	O	O	O

CC	O	O	B-T025
inhibition	O	O	O
by	O	O	O
breathing	O	O	B-T039
100	O	O	B-T081
%	O	O	I-T081
O2	O	O	B-T121
normalized	O	O	O
PWV	O	O	B-T081
in	O	O	O
COPD	O	O	B-T047
,	O	O	O
while	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
was	O	O	O
observed	O	O	O
in	O	O	O
controls	O	O	B-T096
.	O	O	O

CC	O	O	B-T025
activity	O	O	B-T042
and	O	O	O
sensitivity	O	O	B-T042
are	O	O	O
elevated	O	O	B-T080
in	O	O	O
COPD	O	O	B-T047
,	O	O	O
and	O	O	O
appear	O	O	O
related	O	O	O
to	O	O	O
cardiovascular	O	O	B-T033
risk	O	O	I-T033
;	O	O	O
however	O	O	O
,	O	O	O
CC	O	O	O
activity	O	O	O
/	O	O	O
sensitivity	O	O	O
does	O	O	O
not	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
potentiated	O	O	B-T080
ventilatory	O	O	B-T201
response	O	O	I-T201
to	O	O	O
exercise	O	O	B-T056
.	O	O	O

-DOCSTART- (27356972)

Isolation	O	O	B-T059
of	O	O	I-T059
Cells	O	O	I-T059
Specialized	O	O	B-T077
in	O	O	O
Anticancer	O	O	B-T109
Alkaloid	O	O	B-T044
Metabolism	O	O	I-T044
by	O	O	O
Fluorescence-Activated	O	O	O
Cell	O	O	O
Sorting	O	O	O

Plant	O	O	B-T002
specialized	O	O	B-T077
metabolism	O	O	B-T040
often	O	O	O
presents	O	O	O
a	O	O	O
complex	O	O	B-T080
cell	O	O	B-T025
-	O	O	O
specific	O	O	B-T080
compartmentation	O	O	B-T043
essential	O	O	O
to	O	O	O
accomplish	O	O	O
the	O	O	O
biosynthesis	O	O	B-T169
of	O	O	O
valuable	O	O	O
plant	O	O	B-T002
natural	O	O	B-T123
products	O	O	I-T123
.	O	O	O

Hence	O	O	O
,	O	O	O
the	O	O	O
disclosure	O	O	O
and	O	O	O
potential	O	O	O
manipulation	O	O	B-T169
of	O	O	O
such	O	O	O
pathways	O	O	B-T077
may	O	O	O
depend	O	O	O
on	O	O	O
the	O	O	O
capacity	O	O	O
to	O	O	O
isolate	O	O	B-T059
and	O	O	O
characterize	O	O	B-T052
specific	O	O	B-T080
cell	O	O	B-T170
types	O	O	I-T170
.	O	O	O

Catharanthus	O	O	B-T002
roseus	O	O	I-T002
is	O	O	O
the	O	O	O
source	O	O	O
of	O	O	O
several	O	O	O
medicinal	O	O	B-T121
terpenoid	O	O	B-T109
indole	O	O	I-T109
alkaloids	O	O	I-T109
,	O	O	O
including	O	O	O
the	O	O	O
low-level	O	O	O
anticancer	O	O	B-T109
vinblastine	O	O	B-T109
and	O	O	O
vincristine	O	O	B-T109
,	O	O	O
for	O	O	O
which	O	O	O
the	O	O	O
late	O	O	O
biosynthetic	O	O	B-T169
steps	O	O	I-T169
occur	O	O	O
in	O	O	O
specialized	O	O	B-T077
mesophyll	O	O	B-T025
cells	O	O	I-T025
called	O	O	O
idioblasts	O	O	B-T025
.	O	O	O

Here	O	O	O
,	O	O	O
the	O	O	O
optical	O	O	B-T090
,	O	O	O
fluorescence	O	O	B-T070
,	O	O	O
and	O	O	O
alkaloid	O	O	B-T109
-	O	O	O
accumulating	O	O	B-T033
properties	O	O	O
of	O	O	O
C.	O	O	B-T002
roseus	O	O	I-T002
leaf	O	O	B-T002
idioblasts	O	O	B-T025
are	O	O	O
characterized	O	O	B-T052
,	O	O	O
and	O	O	O
a	O	O	O
methodology	O	O	B-T078
for	O	O	O
the	O	O	O
isolation	O	O	B-T059
of	O	O	O
idioblast	O	O	B-T025
protoplasts	O	O	B-T025
by	O	O	O
fluorescence-activated	O	O	B-T059
cell	O	O	I-T059
sorting	O	O	I-T059
is	O	O	O
established	O	O	O
,	O	O	O
taking	O	O	O
advantage	O	O	O
of	O	O	O
the	O	O	O
distinctive	O	O	O
autofluorescence	O	O	B-T059
of	O	O	O
these	O	O	O
cells	O	O	B-T025
.	O	O	O

This	O	O	O
achievement	O	O	O
represents	O	O	O
a	O	O	O
crucial	O	O	O
step	O	O	O
for	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
differential	O	O	O
omic	O	O	B-T062
strategies	O	O	I-T062
leading	O	O	O
to	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
candidate	O	O	B-T028
genes	O	O	I-T028
putatively	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
biosynthesis	O	O	B-T169
,	O	O	O
pathway	O	O	B-T077
regulation	O	O	B-T038
,	O	O	O
and	O	O	O
transmembrane	O	O	B-T043
transport	O	O	I-T043
leading	O	O	O
to	O	O	O
the	O	O	O
anticancer	O	O	B-T033
alkaloids	O	O	B-T109
from	O	O	O
C.	O	O	B-T002
roseus	O	O	I-T002
.	O	O	O

-DOCSTART- (27357217)

Interaction	O	O	B-T169
of	O	O	O
the	O	O	O
Antimicrobial	O	O	B-T116
Peptides	O	O	I-T116
Rhesus	O	O	B-T116
θ-Defensin	O	O	I-T116
and	O	O	O
Porcine	O	O	B-T015
Protegrin-1	O	O	B-T116
with	O	O	O
Anionic	O	O	O
Phospholipid	O	O	O
Monolayers	O	O	O

A	O	O	O
combination	O	O	O
of	O	O	O
Langmuir	O	O	B-T170
isotherm	O	O	I-T170
,	O	O	O
Brewster	O	O	B-T059
angle	O	O	I-T059
microscopy	O	O	I-T059
(	O	O	O
BAM	O	O	B-T059
)	O	O	O
,	O	O	O
and	O	O	O
neutron	O	O	B-T062
reflectivity	O	O	I-T062
studies	O	O	I-T062
have	O	O	O
been	O	O	O
performed	O	O	O
to	O	O	O
gain	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
effects	O	O	O
on	O	O	O
model	O	O	B-T170
bacterial	O	O	B-T026
cell	O	O	I-T026
membranes	O	O	I-T026
of	O	O	O
the	O	O	O
antimicrobial	O	O	B-T116
peptides	O	O	I-T116
,	O	O	O
Rhesus	O	O	B-T116
θ-defensin	O	O	I-T116
1	O	O	I-T116
(	O	O	O
RTD-1	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
porcine	O	O	B-T015
protegrin	O	O	B-T116
1	O	O	I-T116
(	O	O	O
PG-1	O	O	B-T116
)	O	O	O
.	O	O	O

The	O	O	O
peptides	O	O	B-T116
were	O	O	O
interacted	O	O	B-T169
with	O	O	O
monolayers	O	O	B-T109
spread	O	O	O
at	O	O	O
the	O	O	O
air	O	O	B-T167
-	O	O	O
water	O	O	B-T121
interface	O	O	O
and	O	O	O
prepared	O	O	O
from	O	O	O
a	O	O	O
3:1	O	O	O
molar	O	O	O
mixture	O	O	O
of	O	O	O
phosphatidylethanolamine	O	O	B-T109
and	O	O	O
phosphatidylglycerol	O	O	B-T109
used	O	O	O
to	O	O	O
approximate	O	O	B-T080
the	O	O	O
cell	O	O	B-T026
membranes	O	O	I-T026
of	O	O	O
Gram	O	O	B-T007
positive	O	O	I-T007
bacteria	O	O	I-T007
.	O	O	O

The	O	O	O
Langmuir	O	O	B-T167
film	O	O	I-T167
balance	O	O	O
measurements	O	O	B-T169
show	O	O	O
that	O	O	O
both	O	O	O
peptides	O	O	B-T116
perturb	O	O	B-T169
the	O	O	O
lipid	O	O	B-T109
monolayers	O	O	I-T109
causing	O	O	O
an	O	O	O
increase	O	O	O
in	O	O	O
surface	O	O	B-T070
pressure	O	O	I-T070
,	O	O	O
and	O	O	O
the	O	O	O
BAM	O	O	B-T059
studies	O	O	O
show	O	O	O
that	O	O	O
each	O	O	O
results	O	O	O
in	O	O	O
the	O	O	O
formation	O	O	O
of	O	O	O
small	O	O	B-T087
domains	O	O	I-T087
within	O	O	O
the	O	O	O
lipid	O	O	B-T170
films	O	O	I-T170
,	O	O	O
around	O	O	O
5	O	O	O
μm	O	O	O
diameter	O	O	O
.	O	O	O

The	O	O	O
overall	O	O	O
change	O	O	O
in	O	O	O
monolayer	O	O	B-T109
surface	O	O	B-T070
pressure	O	O	I-T070
caused	O	O	O
by	O	O	O
PG-1	O	O	B-T116
,	O	O	O
however	O	O	O
,	O	O	O
is	O	O	O
a	O	O	O
little	O	O	O
more	O	O	O
pronounced	O	O	O
than	O	O	O
that	O	O	O
due	O	O	O
to	O	O	O
RTD-1	O	O	B-T116
(	O	O	O
+	O	O	O
8.5	O	O	O
mN·m(-1	O	O	O
)	O	O	O
vs	O	O	O
+	O	O	O
5.5	O	O	O
mN·m(-1	O	O	O
)	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
its	O	O	O
initial	O	O	O
interaction	O	O	B-T169
with	O	O	O
the	O	O	O
monolayer	O	O	O
is	O	O	O
a	O	O	O
little	O	O	O
more	O	O	O
rapid	O	O	O
than	O	O	O
that	O	O	O
for	O	O	O
RTD-1	O	O	O
.	O	O	O

The	O	O	O
neutron	O	O	B-T075
reflectivity	O	O	I-T075
studies	O	O	I-T075
also	O	O	O
show	O	O	O
differences	O	O	O
for	O	O	O
PG-1	O	O	B-T116
and	O	O	O
RTD-1	O	O	B-T116
,	O	O	O
with	O	O	O
the	O	O	O
model	O	O	B-T170
fits	O	O	O
to	O	O	O
these	O	O	O
data	O	O	O
showing	O	O	O
that	O	O	O
the	O	O	O
more	O	O	O
amphiphilic	O	O	B-T121
PG-1	O	O	O
becomes	O	O	O
fully	O	O	O
embedded	O	O	B-T059
within	O	O	O
the	O	O	O
lipid	O	O	B-T170
film	O	O	I-T170
-causing	O	O	O
an	O	O	O
extension	O	O	O
of	O	O	O
the	O	O	O
lipid	O	O	B-T120
acyl	O	O	I-T120
chains	O	O	I-T120
but	O	O	O
leaving	O	O	O
the	O	O	O
thickness	O	O	B-T080
of	O	O	O
the	O	O	O
lipid	O	O	B-T120
headgroup	O	O	I-T120
layer	O	O	I-T120
unaffected-while	O	O	O
RTD-1	O	O	O
is	O	O	O
seen	O	O	O
to	O	O	O
insert	O	O	O
less	O	O	O
deeply-causing	O	O	O
the	O	O	O
same	O	O	O
extension	O	O	O
of	O	O	O
the	O	O	O
lipid	O	O	O
acyl	O	O	O
chains	O	O	O
as	O	O	O
PG-1	O	O	O
but	O	O	O
also	O	O	O
causing	O	O	O
a	O	O	O
significant	O	O	O
increase	O	O	O
in	O	O	O
thickness	O	O	O
of	O	O	O
the	O	O	O
lipid	O	O	O
headgroup	O	O	O
layer	O	O	O
.	O	O	O

The	O	O	O
various	O	O	O
differing	O	O	O
effects	O	O	O
of	O	O	O
the	O	O	O
two	O	O	O
peptides	O	O	B-T116
on	O	O	O
anionic	O	O	B-T109
lipid	O	O	I-T109
monolayers	O	O	I-T109
are	O	O	O
discussed	O	O	O
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
their	O	O	O
differing	O	O	O
hemolytic	O	O	B-T059
activities	O	O	I-T059
,	O	O	O
and	O	O	O
their	O	O	O
proposed	O	O	O
differing	O	O	B-T081
propensities	O	O	I-T081
to	O	O	O
form	O	O	O
transmembrane	O	O	B-T026
pores	O	O	B-T026
.	O	O	O

-DOCSTART- (27357607)

Development	O	O	B-T039
of	O	O	O
chrysin	O	O	B-T109
loaded	O	O	O
poloxamer	O	O	B-T109
micelles	O	O	O
and	O	O	O
toxicity	O	O	B-T080
evaluation	O	O	B-T058
in	O	O	O
fish	O	O	B-T013
embryos	O	O	O

Poloxamer	O	O	B-T109
micelles	O	O	B-T109
promise	O	O	O
safety	O	O	B-T068
and	O	O	O
efficacy	O	O	B-T080
for	O	O	O
many	O	O	O
water	O	O	B-T121
insoluble	O	O	B-T080
drugs	O	O	B-T121
.	O	O	O

Chrysin	O	O	B-T109
has	O	O	O
been	O	O	O
reported	O	O	O
to	O	O	O
have	O	O	O
anticancer	O	O	B-T080
,	O	O	O
anti-inflammatory	O	O	B-T080
,	O	O	O
antioxidant	O	O	B-T039
,	O	O	O
and	O	O	O
anti-aromatase	O	O	B-T044
activities	O	O	I-T044
but	O	O	O
its	O	O	O
water	O	O	B-T121
insoluble	O	O	B-T080
properties	O	O	B-T080
limit	O	O	O
its	O	O	O
pharmaceutical	O	O	B-T091
application	O	O	I-T091
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
chrysin	O	O	B-T109
loaded	O	O	O
poloxamer	O	O	B-T109
micelles	O	O	B-T109
were	O	O	O
developed	O	O	O
.	O	O	O

Two	O	O	O
types	O	O	O
of	O	O	O
poloxamers	O	O	B-T109
,	O	O	O
Pluronic	O	O	B-T109
F-68	O	O	I-T109
and	O	O	O
Pluronic	O	O	B-T109
F-127	O	O	I-T109
were	O	O	O
compared	O	O	O
.	O	O	O

It	O	O	O
was	O	O	O
found	O	O	O
that	O	O	O
chrysin	O	O	B-T109
loaded	O	O	O
Pluronic	O	O	B-T109
F-68	O	O	I-T109
micelles	O	O	B-T109
(	O	O	O
CS-P68	O	O	B-T109
)	O	O	O
and	O	O	O
chrysin	O	O	O
loaded	O	O	O
Pluronic	O	O	B-T109
F-127	O	O	I-T109
micelles	O	O	O
(	O	O	O
CS-P127	O	O	B-T109
)	O	O	O
obviously	O	O	O
increase	O	O	B-T169
the	O	O	O
aqueous	O	O	B-T080
solubility	O	O	B-T080
of	O	O	O
chrysin	O	O	O
.	O	O	O

The	O	O	O
results	O	O	B-T169
also	O	O	O
indicated	O	O	O
that	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
polymer	O	O	B-T122
and	O	O	O
ratio	O	O	O
of	O	O	O
drug	O	O	B-T121
to	O	O	O
polymer	O	O	O
affected	O	O	O
size	O	O	B-T082
and	O	O	O
desirable	O	O	O
characteristics	O	O	B-T080
of	O	O	O
the	O	O	O
micelles	O	O	B-T109
.	O	O	O

The	O	O	O
micelle	O	O	B-T109
system	O	O	I-T109
of	O	O	O
CS-P68	O	O	B-T109
and	O	O	O
CS-P127	O	O	B-T109
formed	O	O	O
at	O	O	O
drug	O	O	B-T121
to	O	O	O
polymer	O	O	B-T122
ratios	O	O	B-T081
of	O	O	O
1:4	O	O	O
and	O	O	O
1:2	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
the	O	O	O
most	O	O	O
suitable	O	O	O
monodispersed	O	O	O
system	O	O	O
with	O	O	O
a	O	O	O
nanosize-range	O	O	B-T081
diameter	O	O	I-T081
.	O	O	O

The	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
study	O	O	I-T062
in	O	O	O
zebrafish	O	O	B-T013
eggs	O	O	B-T025
indicates	O	O	O
that	O	O	O
the	O	O	O
toxicity	O	O	B-T080
of	O	O	O
CS-P68	O	O	B-T109
and	O	O	O
CS-P127	O	O	B-T109
is	O	O	O
a	O	O	O
dose	O	O	B-T078
response	O	O	I-T078
.	O	O	O

CS-P68	O	O	B-T109
and	O	O	O
CS-P127	O	O	B-T109
at	O	O	O
a	O	O	O
drug	O	O	B-T081
dose	O	O	I-T081
of	O	O	O
10	O	O	O
ng/mL	O	O	O
or	O	O	O
less	O	O	B-T080
is	O	O	O
safe	O	O	O
for	O	O	O
zebrafish	O	O	B-T013
embryo	O	O	B-T018
growth	O	O	B-T040
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
indicate	O	O	O
enhanced	O	O	B-T052
water	O	O	B-T081
solubility	O	O	I-T081
of	O	O	O
chrysin	O	O	B-T109
.	O	O	O

Chrysin	O	O	B-T109
loaded	O	O	O
poloxamer	O	O	B-T109
micelles	O	O	B-T109
are	O	O	O
promising	O	O	O
for	O	O	O
further	O	O	O
use	O	O	O
in	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
studies	O	O	I-T062
in	O	O	O
mammalian	O	O	B-T015
animals	O	O	B-T008
and	O	O	O
humans	O	O	B-T016
.	O	O	O

-DOCSTART- (27357626)

Adenoviral	O	O	B-T005
Delivery	O	O	B-T061
of	O	O	O
Tumor	O	O	B-T116
Necrosis	O	O	I-T116
Factor-α	O	O	I-T116
and	O	O	O
Interleukin-2	O	O	B-T116
Enables	O	O	O
Successful	O	O	O
Adoptive	O	O	B-T061
Cell	O	O	I-T061
Therapy	O	O	I-T061
of	O	O	O
Immunosuppressive	O	O	B-T129
Melanoma	O	O	O

Adoptive	O	O	B-T061
T-cell	O	O	I-T061
transfer	O	O	I-T061
is	O	O	O
a	O	O	O
promising	O	O	O
treatment	O	O	B-UnknownType
approach	O	O	I-UnknownType
for	O	O	O
metastatic	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
but	O	O	O
efficacy	O	O	B-T080
in	O	O	O
solid	O	O	B-T191
tumors	O	O	I-T191
has	O	O	O
only	O	O	O
been	O	O	O
achieved	O	O	O
with	O	O	O
toxic	O	O	B-T080
pre-	O	O	O
and	O	O	O
postconditioning	O	O	O
regimens	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
adoptive	O	O	B-T061
T-cell	O	O	I-T061
therapies	O	O	I-T061
would	O	O	O
benefit	O	O	B-T081
from	O	O	O
complementary	O	O	O
modalities	O	O	B-T078
that	O	O	O
enable	O	O	O
their	O	O	O
full	O	O	B-T080
potential	O	O	B-T080
without	O	O	O
excessive	O	O	B-T080
toxicity	O	O	B-T080
.	O	O	O

We	O	O	O
aimed	O	O	B-T078
to	O	O	O
improve	O	O	B-T080
the	O	O	O
efficacy	O	O	B-T080
and	O	O	O
safety	O	O	B-T080
of	O	O	O
adoptive	O	O	B-T061
T-cell	O	O	I-T061
transfer	O	O	I-T061
by	O	O	O
using	O	O	O
adenoviral	O	O	B-T114
vectors	O	O	I-T114
for	O	O	O
direct	O	O	O
delivery	O	O	B-T169
of	O	O	O
immunomodulatory	O	O	B-T061
murine	O	O	B-T015
cytokines	O	O	B-T116
into	O	O	O
B16.OVA	O	O	B-T025
melanoma	O	O	B-T191
tumors	O	O	B-T191
with	O	O	O
concomitant	O	O	B-T079
T-cell	O	O	B-T116
receptor	O	O	I-T116
transgenic	O	O	B-T061
OT-I	O	O	I-T061
T-cell	O	O	I-T061
transfer	O	O	I-T061
.	O	O	O

Armed	O	O	O
adenoviruses	O	O	B-T005
expressed	O	O	O
high	O	O	O
local	O	O	O
and	O	O	O
low	O	O	O
systemic	O	O	O
levels	O	O	O
of	O	O	O
cytokine	O	O	B-T116
when	O	O	O
injected	O	O	B-T169
into	O	O	O
B16.OVA	O	O	B-T025
tumors	O	O	B-T191
,	O	O	O
suggesting	O	O	O
safety	O	O	B-T080
of	O	O	O
virus-mediated	O	O	B-T061
cytokine	O	O	I-T061
delivery	O	O	I-T061
.	O	O	O

Antitumor	O	O	B-T080
efficacy	O	O	B-T080
was	O	O	O
significantly	O	O	O
enhanced	O	O	B-T052
with	O	O	O
adenoviruses	O	O	B-T005
coding	O	O	O
for	O	O	O
murine	O	O	B-T015
interleukin-2	O	O	B-T116
(	O	O	O
mIL-2	O	O	B-T116
)	O	O	O
and	O	O	O
tumor	O	O	B-T116
necrosis	O	O	I-T116
factor-α	O	O	I-T116
(	O	O	O
mTNFα	O	O	B-T116
)	O	O	O
when	O	O	O
compared	O	O	O
with	O	O	O
T-cell	O	O	B-T061
transfer	O	O	I-T061
alone	O	O	O
or	O	O	O
viruses	O	O	B-T005
alone	O	O	O
.	O	O	O

Further	O	O	O
improvement	O	O	B-T077
in	O	O	O
efficacy	O	O	B-T080
was	O	O	O
achieved	O	O	O
with	O	O	O
a	O	O	O
triple	O	O	B-T081
combination	O	O	B-T080
of	O	O	O
mIL-2	O	O	B-T116
,	O	O	O
mTNFα	O	O	B-T116
,	O	O	O
and	O	O	O
OT-I	O	O	B-T025
T-cells	O	O	I-T025
.	O	O	O

Mechanistic	O	O	B-T169
studies	O	O	I-T169
suggest	O	O	O
that	O	O	O
mIL-2	O	O	B-T116
has	O	O	O
an	O	O	O
important	O	O	B-T080
role	O	O	B-T077
in	O	O	O
activating	O	O	B-T052
T-cells	O	O	B-T025
at	O	O	O
the	O	O	O
tumor	O	O	B-T191
,	O	O	O
while	O	O	O
mTNFα	O	O	B-T116
induces	O	O	O
chemokine	O	O	B-T116
expression	O	O	B-T045
.	O	O	O

Furthermore	O	O	O
,	O	O	O
adenovirus	O	O	B-T005
treatments	O	O	B-T061
enhanced	O	O	B-T052
tumor	O	O	B-T191
-	O	O	O
infiltration	O	O	O
of	O	O	O
OT-I	O	O	B-T025
T-cells	O	O	I-T025
as	O	O	O
demonstrated	O	O	B-T052
by	O	O	O
SPECT/CT	O	O	B-T060
imaging	O	O	I-T060
of	O	O	O
(111)In-labeled	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Our	O	O	O
results	O	O	B-T169
suggest	O	O	B-T078
the	O	O	O
utility	O	O	O
of	O	O	O
cytokine-coding	O	O	B-T116
adenoviruses	O	O	B-T005
for	O	O	O
improving	O	O	B-T080
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
adoptive	O	O	B-T061
T-cell	O	O	I-T061
therapies	O	O	I-T061
.	O	O	O

-DOCSTART- (27363786)

The	O	O	O
Maternal	O	O	B-T033
Legacy	O	O	B-T081
:	O	O	O
Female	O	O	B-T032
Identity	O	O	B-T054
Predicts	O	O	O
Offspring	O	O	B-T099
Sex	O	O	B-T081
Ratio	O	O	I-T081
in	O	O	O
the	O	O	O
Loggerhead	O	O	O
Sea	O	O	O
Turtle	O	O	O

In	O	O	O
organisms	O	O	B-T001
with	O	O	O
temperature-dependent	O	O	B-T081
sex	O	O	B-T038
determination	O	O	I-T038
,	O	O	O
the	O	O	O
incubation	O	O	B-T082
environment	O	O	I-T082
plays	O	O	O
a	O	O	O
key	O	O	O
role	O	O	O
in	O	O	O
determining	O	O	O
offspring	O	O	B-T099
sex	O	O	B-T081
ratios	O	O	I-T081
.	O	O	O

Given	O	O	O
that	O	O	O
global	O	O	B-T080
temperatures	O	O	B-T081
have	O	O	O
warmed	O	O	B-T070
approximately	O	O	O
0.6	O	O	O
°	O	O	O
C	O	O	O
in	O	O	O
the	O	O	O
last	O	O	O
century	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
necessary	O	O	O
to	O	O	O
consider	O	O	O
how	O	O	O
organisms	O	O	B-T001
will	O	O	O
adjust	O	O	B-T033
to	O	O	O
climate	O	O	B-T070
change	O	O	I-T070
.	O	O	O

To	O	O	O
better	O	O	O
understand	O	O	O
the	O	O	O
degree	O	O	B-T080
to	O	O	O
which	O	O	O
mothers	O	O	B-T099
influence	O	O	B-T077
the	O	O	O
sex	O	O	B-T081
ratios	O	O	I-T081
of	O	O	O
their	O	O	O
offspring	O	O	B-T099
,	O	O	O
we	O	O	O
use	O	O	O
24	O	O	O
years	O	O	B-T079
of	O	O	O
nesting	O	O	B-T078
data	O	O	I-T078
for	O	O	O
individual	O	O	B-T098
female	O	O	B-T032
loggerhead	O	O	B-T014
sea	O	O	I-T014
turtles	O	O	I-T014
(	O	O	O
Caretta	O	O	B-T014
caretta	O	O	I-T014
)	O	O	O
observed	O	O	O
on	O	O	O
Bald	O	O	B-T083
Head	O	O	I-T083
Island	O	O	I-T083
,	O	O	O
North	O	O	B-T083
Carolina	O	O	I-T083
.	O	O	O

We	O	O	O
find	O	O	O
that	O	O	O
maternal	O	O	B-T033
identity	O	O	B-T054
is	O	O	O
the	O	O	O
best	O	O	O
predictor	O	O	O
of	O	O	O
nest	O	O	B-T082
sex	O	O	B-T081
ratio	O	O	I-T081
in	O	O	O
univariate	O	O	B-T062
and	O	O	O
multivariate	O	O	B-T062
predictive	O	O	I-T062
models	O	O	I-T062
.	O	O	O

We	O	O	O
find	O	O	O
significant	O	O	O
variability	O	O	B-T077
in	O	O	O
estimated	O	O	O
nest	O	O	B-T082
sex	O	O	B-T081
ratios	O	O	I-T081
among	O	O	O
mothers	O	O	B-T099
,	O	O	O
but	O	O	O
a	O	O	O
high	O	O	O
degree	O	O	O
of	O	O	O
consistency	O	O	B-T080
within	O	O	O
mothers	O	O	O
,	O	O	O
despite	O	O	O
substantial	O	O	O
spatial	O	O	B-T082
and	O	O	O
temporal	O	O	B-T079
thermal	O	O	B-T070
variation	O	O	I-T070
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
individual	O	O	B-T098
differences	O	O	O
in	O	O	O
nesting	O	O	B-T054
preferences	O	O	I-T054
are	O	O	O
the	O	O	O
main	O	O	O
driver	O	O	O
behind	O	O	O
divergences	O	O	B-T082
in	O	O	O
nest	O	O	B-T082
sex	O	O	B-T081
ratios	O	O	I-T081
.	O	O	O

As	O	O	O
such	O	O	O
,	O	O	O
a	O	O	O
female	O	O	B-T032
's	O	O	I-T032
ability	O	O	O
to	O	O	O
plastically	O	O	O
adjust	O	O	O
her	O	O	O
nest	O	O	B-T082
sex	O	O	B-T081
ratios	O	O	I-T081
in	O	O	O
response	O	O	O
to	O	O	O
environmental	O	O	B-T082
conditions	O	O	B-T080
is	O	O	O
constrained	O	O	B-T077
,	O	O	O
potentially	O	O	O
limiting	O	O	O
how	O	O	O
individuals	O	O	B-T098
behaviorally	O	O	O
mitigate	O	O	B-T067
the	O	O	O
effects	O	O	O
of	O	O	O
environmental	O	O	B-T033
change	O	O	I-T033
.	O	O	O

Given	O	O	O
that	O	O	O
many	O	O	O
loggerhead	O	O	B-T014
populations	O	O	B-T098
already	O	O	O
show	O	O	O
female-biased	O	O	B-T078
offspring	O	O	B-T099
sex	O	O	B-T081
ratios	O	O	I-T081
,	O	O	O
understanding	O	O	O
maternal	O	O	B-T054
behavioral	O	O	I-T054
responses	O	O	O
is	O	O	O
critical	O	O	B-T080
for	O	O	O
predicting	O	O	O
the	O	O	O
future	O	O	O
of	O	O	O
long-lived	O	O	O
species	O	O	B-T185
vulnerable	O	O	B-T169
to	O	O	O
extinction	O	O	B-T070
.	O	O	O

-DOCSTART- (27364501)

Increased	O	O	O
RhoA	O	O	B-T116
Activity	O	O	B-T044
Predicts	O	O	O
Worse	O	O	B-T033
Overall	O	O	B-T081
Survival	O	O	I-T081
in	O	O	O
Patients	O	O	B-T101
Undergoing	O	O	O
Surgical	O	O	B-T061
Resection	O	O	I-T061
for	O	O	O
Lauren	O	O	B-T185
Diffuse-Type	O	O	O
Gastric	O	O	O
Adenocarcinoma	O	O	O

Several	O	O	O
studies	O	O	O
have	O	O	O
reported	O	O	O
a	O	O	O
high	O	O	O
rate	O	O	O
of	O	O	O
RHOA	O	O	B-T028
mutations	O	O	B-T045
in	O	O	O
the	O	O	O
Lauren	O	O	B-T185
diffuse-type	O	O	B-T191
gastric	O	O	I-T191
adenocarcinoma	O	O	I-T191
(	O	O	O
GA	O	O	B-T191
)	O	O	O
but	O	O	O
not	O	O	O
in	O	O	O
intestinal-type	O	O	B-T191
GA	O	O	I-T191
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
determine	O	O	O
if	O	O	O
RhoA	O	O	B-T116
activity	O	O	B-T044
is	O	O	O
prognostic	O	O	B-T201
for	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
OS	O	O	B-T081
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
resectable	O	O	O
GA	O	O	B-T191
.	O	O	O

Retrospective	O	O	B-T062
review	O	O	I-T062
was	O	O	O
performed	O	O	O
on	O	O	O
a	O	O	O
prospective	O	O	O
database	O	O	O
of	O	O	O
GA	O	O	B-T191
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
potentially	O	O	O
curative	O	O	B-T061
resection	O	O	I-T061
between	O	O	O
2003	O	O	O
and	O	O	O
2012	O	O	O
at	O	O	O
a	O	O	O
single	O	O	B-T093
institution	O	O	I-T093
.	O	O	O

Tissue	O	O	B-T024
microarrays	O	O	B-T073
were	O	O	O
constructed	O	O	O
from	O	O	O
surgical	O	O	B-T059
specimens	O	O	I-T059
and	O	O	O
analyzed	O	O	O
for	O	O	O
phosphorylated	O	O	B-T116
RhoA	O	O	B-T116
,	O	O	O
a	O	O	O
marker	O	O	B-T201
of	O	O	O
inactive	O	O	O
RhoA	O	O	O
signaling	O	O	B-T043
.	O	O	O

OS	O	O	B-T081
was	O	O	O
estimated	O	O	O
by	O	O	O
the	O	O	O
Kaplan-Meier	O	O	B-T062
method	O	O	I-T062
,	O	O	O
and	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
was	O	O	O
performed	O	O	O
by	O	O	O
Cox	O	O	B-T081
proportional	O	O	I-T081
hazards	O	O	I-T081
regression	O	O	I-T081
modeling	O	O	I-T081
.	O	O	O

One	O	O	O
hundred	O	O	O
thirty-six	O	O	O
patients	O	O	B-T101
with	O	O	O
diffuse-type	O	O	B-T191
GA	O	O	I-T191
and	O	O	O
129	O	O	O
patients	O	O	O
with	O	O	O
intestinal-type	O	O	B-T191
GA	O	O	I-T191
were	O	O	O
examined	O	O	O
.	O	O	O

Compared	O	O	O
to	O	O	O
intestinal-type	O	O	B-T191
GA	O	O	I-T191
,	O	O	O
diffuse-type	O	O	B-T191
GA	O	O	I-T191
tumors	O	O	B-T191
were	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	O
tumor	O	O	B-T082
size	O	O	I-T082
and	O	O	O
advanced	O	O	B-T185
tumor	O	O	I-T185
,	O	O	I-T185
node	O	O	I-T185
,	O	O	I-T185
metastasis	O	O	I-T185
(	O	O	I-T185
TNM	O	O	I-T185
)	O	O	I-T185
classification	O	O	I-T185
system	O	O	I-T185
stage	O	O	I-T185
.	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
diffuse-type	O	O	B-T191
GA	O	O	I-T191
,	O	O	O
high	O	O	O
RhoA	O	O	B-T116
activity	O	O	B-T044
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
significantly	O	O	O
worse	O	O	B-T033
OS	O	O	B-T081
when	O	O	O
compared	O	O	O
to	O	O	O
low	O	O	O
RhoA	O	O	O
activity	O	O	O
(	O	O	O
5-year	O	O	O
OS	O	O	O
52.5	O	O	O
vs.	O	O	O
81.0	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.017	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
difference	O	O	O
in	O	O	O
OS	O	O	B-T081
was	O	O	O
not	O	O	O
observed	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
intestinal-type	O	O	B-T191
GA	O	O	I-T191
(	O	O	O
5-year	O	O	O
OS	O	O	O
83.9	O	O	O
vs.	O	O	O
81.6	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.766	O	O	O
)	O	O	O
.	O	O	O

On	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
of	O	O	O
diffuse-type	O	O	B-T191
GA	O	O	I-T191
patients	O	O	B-T101
,	O	O	O
high	O	O	O
RhoA	O	O	B-T116
activity	O	O	B-T044
was	O	O	O
an	O	O	O
independent	O	O	O
negative	O	O	O
prognostic	O	O	B-T201
factor	O	O	I-T201
for	O	O	O
OS	O	O	B-T081
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
2.38	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
1.07	O	O	O
-	O	O	O
5.28	O	O	O
)	O	O	O
.	O	O	O

Increased	O	O	O
RhoA	O	O	B-T116
activity	O	O	B-T044
is	O	O	O
predictive	O	O	O
of	O	O	O
worse	O	O	B-T033
OS	O	O	B-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
diffuse-type	O	O	B-T191
GA	O	O	I-T191
who	O	O	O
undergo	O	O	O
potentially	O	O	O
curative	O	O	B-T061
surgical	O	O	I-T061
resection	O	O	I-T061
.	O	O	O

Along	O	O	O
with	O	O	O
findings	O	O	O
from	O	O	O
genomic	O	O	B-T091
studies	O	O	I-T091
,	O	O	O
these	O	O	O
results	O	O	O
suggest	O	O	O
RhoA	O	O	B-T116
may	O	O	O
be	O	O	O
a	O	O	O
novel	O	O	O
therapeutic	O	O	B-T061
target	O	O	B-T169
in	O	O	O
diffuse-type	O	O	B-T191
GA	O	O	I-T191
.	O	O	O

-DOCSTART- (27364610)

Doxifluridine	O	O	B-T114
-	O	O	O
conjugated	O	O	B-T082
2	O	O	B-T114
-	O	O	I-T114
5A	O	O	I-T114
analog	O	O	B-T104
shows	O	O	O
strong	O	O	B-T080
RNase	O	O	B-T116
L	O	O	I-T116
activation	O	O	B-T045
ability	O	O	B-T080
and	O	O	O
tumor	O	O	B-T044
suppressive	O	O	I-T044
effect	O	O	O

RNase	O	O	B-T116
L	O	O	I-T116
is	O	O	O
activated	O	O	B-T045
by	O	O	O
2',5'-oligoadenylates	O	O	B-T114
(	O	O	O
2	O	O	B-T114
-	O	O	I-T114
5A	O	O	I-T114
)	O	O	O
at	O	O	O
subnanomolar	O	O	B-T081
levels	O	O	B-T080
to	O	O	O
cleave	O	O	B-T082
single-stranded	O	O	B-T114
RNA	O	O	I-T114
.	O	O	O

We	O	O	O
previously	O	O	O
reported	O	O	B-T170
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
the	O	O	O
introduction	O	O	B-T169
of	O	O	O
an	O	O	O
8-methyladenosine	O	O	B-T114
residue	O	O	O
at	O	O	O
the	O	O	O
2'-	O	O	O
terminus	O	O	B-T082
of	O	O	O
the	O	O	O
2	O	O	B-T114
-	O	O	I-T114
5A	O	O	I-T114
tetramer	O	O	I-T114
shifts	O	O	B-T169
the	O	O	O
2	O	O	O
-	O	O	O
5A	O	O	O
binding	O	O	B-T192
site	O	O	I-T192
of	O	O	O
RNase	O	O	O
L.	O	O	O
In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
synthesized	O	O	B-T052
various	O	O	O
5'-	O	O	O
modified	O	O	B-T169
2	O	O	O
-	O	O	O
5A	O	O	O
analog	O	O	B-T104
s	O	O	O
with	O	O	O
8-methyladenosine	O	O	O
at	O	O	O
the	O	O	O
2'-	O	O	O
terminus	O	O	O
.	O	O	O

The	O	O	O
doxifluridine	O	O	B-T114
-	O	O	O
conjugated	O	O	B-T082
8-methyladenosine	O	O	B-T114
-	O	O	O
substituted	O	O	B-T052
2	O	O	B-T114
-	O	O	I-T114
5A	O	O	I-T114
analog	O	O	B-T104
was	O	O	O
significantly	O	O	B-T081
more	O	O	I-T081
effective	O	O	B-T080
as	O	O	O
an	O	O	O
activator	O	O	B-T052
of	O	O	O
RNase	O	O	B-T116
L	O	O	I-T116
than	O	O	O
the	O	O	O
parent	O	O	B-T077
5'-	O	O	O
monophophorylated	O	O	B-T044
2	O	O	B-T114
-	O	O	I-T114
5A	O	O	I-T114
tetramer	O	O	I-T114
and	O	O	O
showed	O	O	O
a	O	O	O
tumor	O	O	B-T044
suppressive	O	O	I-T044
effect	O	O	B-T080
against	O	O	B-T080
human	O	O	B-T016
cervical	O	O	B-T191
cancer	O	O	I-T191
cells	O	O	B-T025
.	O	O	O

-DOCSTART- (27366508)

Does	O	O	O
Video	O	O	B-T074
Laryngoscopy	O	O	I-T074
Offer	O	O	O
Advantages	O	O	B-T080
over	O	O	O
Direct	O	O	B-T060
Laryngoscopy	O	O	I-T060
during	O	O	B-T079
Cardiopulmonary	O	O	B-T061
Resuscitation	O	O	I-T061
?	O	O	O

Interruption	O	O	B-T079
of	O	O	O
chest	O	O	B-T058
compressions	O	O	I-T058
should	O	O	O
be	O	O	O
minimized	O	O	B-T080
because	O	O	O
of	O	O	O
its	O	O	O
negative	O	O	B-T033
effects	O	O	B-T080
on	O	O	O
survival	O	O	B-T081
.	O	O	O

This	O	O	O
randomized	O	O	B-T062
,	O	O	O
controlled	O	O	B-T169
,	O	O	O
cross-over	O	O	B-T062
study	O	O	I-T062
aimed	O	O	B-T078
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
Macintosh	O	O	B-T074
,	O	O	O
Miller	O	O	B-T074
,	O	O	O
McCoy	O	O	B-T074
and	O	O	O
McGrath	O	O	B-T074
laryngoscopes	O	O	I-T074
during	O	O	B-T079
with	O	O	O
or	O	O	O
without	O	O	O
chest	O	O	B-T058
compressions	O	O	I-T058
in	O	O	O
the	O	O	O
scope	O	O	B-T077
of	O	O	O
a	O	O	O
simulated	O	O	O
cardiopulmonary	O	O	B-T061
resuscitation	O	O	I-T061
scenario	O	O	B-T169
.	O	O	O

The	O	O	O
time	O	O	B-T079
required	O	O	B-T169
for	O	O	O
successful	O	O	B-T080
tracheal	O	O	B-T061
intubation	O	O	I-T061
,	O	O	O
number	O	O	B-T201
of	O	O	I-T201
attempts	O	O	I-T201
,	O	O	O
dental	O	O	B-T037
trauma	O	O	I-T037
severity	O	O	B-T080
and	O	O	O
the	O	O	O
need	O	O	B-T080
for	O	O	O
optimization	O	O	B-T052
manoeuvres	O	O	B-T052
were	O	O	O
recorded	O	O	B-T033
during	O	O	B-T079
cardiopulmonary	O	O	B-T061
resuscitation	O	O	I-T061
with	O	O	O
and	O	O	O
without	O	O	O
chest	O	O	B-T058
compressions	O	O	I-T058
.	O	O	O

The	O	O	O
experience	O	O	B-T041
with	O	O	O
computer	O	O	B-T073
games	O	O	I-T073
during	O	O	B-T079
the	O	O	O
last	O	O	O
10	O	O	O
years	O	O	B-T079
were	O	O	O
asked	O	O	O
to	O	O	O
the	O	O	O
participants	O	O	B-T098
and	O	O	O
recorded	O	O	B-T033
.	O	O	O

McCoy	O	O	B-T074
laryngoscope	O	O	I-T074
yielded	O	O	O
the	O	O	O
shortest	O	O	B-T079
time	O	O	I-T079
for	O	O	O
successful	O	O	B-T080
tracheal	O	O	B-T061
intubation	O	O	I-T061
both	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
and	O	O	O
without	O	O	O
chest	O	O	B-T058
compressions	O	O	I-T058
.	O	O	O

During	O	O	B-T079
the	O	O	O
use	O	O	B-T169
of	O	O	O
McCoy	O	O	B-T074
laryngoscopes	O	O	I-T074
,	O	O	O
fewer	O	O	B-T081
tracheal	O	O	B-T061
intubation	O	O	B-T061
attempts	O	O	B-T051
,	O	O	O
lower	O	O	B-T052
incidence	O	O	I-T081
of	O	O	O
dental	O	O	B-T037
trauma	O	O	I-T037
and	O	O	O
lower	O	O	O
visual	O	O	B-T201
analogue	O	O	I-T201
scale	O	O	I-T201
scores	O	O	I-T201
on	O	O	O
the	O	O	O
ease	O	O	O
of	O	O	O
intubation	O	O	O
were	O	O	O
recorded	O	O	B-T033
.	O	O	O

Participants	O	O	B-T098
who	O	O	O
are	O	O	O
experienced	O	O	B-T041
computer	O	O	B-T073
game	O	O	I-T073
players	O	O	B-T098
using	O	O	O
Macintosh	O	O	B-T074
,	O	O	O
McCoy	O	O	B-T074
and	O	O	O
McGrath	O	O	B-T074
achieved	O	O	B-T033
successful	O	O	B-T080
tracheal	O	O	B-T061
intubation	O	O	I-T061
in	O	O	O
a	O	O	O
significantly	O	O	B-T078
shorter	O	O	B-T079
time	O	O	I-T079
during	O	O	B-T079
resuscitation	O	O	B-T061
without	O	O	O
chest	O	O	B-T058
compressions	O	O	I-T058
.	O	O	O

Dental	O	O	B-T037
trauma	O	O	I-T037
incidence	O	O	B-T081
and	O	O	O
number	O	O	B-T081
of	O	O	O
tracheal	O	O	B-T061
intubation	O	O	I-T061
attempts	O	O	B-T051
did	O	O	O
not	O	O	O
show	O	O	O
any	O	O	O
significant	O	O	B-T078
difference	O	O	B-T080
between	O	O	O
the	O	O	O
four	O	O	B-T081
laryngoscopes	O	O	B-T074
being	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
playing	O	O	B-T052
computer	O	O	B-T073
games	O	O	I-T073
.	O	O	O

McGrath	O	O	B-T074
video	O	O	I-T074
laryngoscopes	O	O	I-T074
do	O	O	O
not	O	O	O
appear	O	O	O
to	O	O	O
have	O	O	O
advantages	O	O	B-T080
over	O	O	O
direct	O	O	B-T060
laryngoscopes	O	O	I-T060
for	O	O	O
securing	O	O	O
a	O	O	O
smooth	O	O	B-T080
and	O	O	O
successful	O	O	B-T080
tracheal	O	O	B-T061
intubation	O	O	I-T061
during	O	O	B-T079
rhythmic	O	O	B-T058
chest	O	O	I-T058
compressions	O	O	I-T058
.	O	O	O

We	O	O	O
believe	O	O	O
that	O	O	O
as	O	O	O
McCoy	O	O	B-T074
laryngoscope	O	O	B-T074
provided	O	O	B-T052
tracheal	O	O	B-T061
intubation	O	O	I-T061
in	O	O	O
a	O	O	O
shorter	O	O	B-T079
time	O	O	I-T079
and	O	O	O
with	O	O	O
fewer	O	O	B-T081
attempts	O	O	B-T051
,	O	O	O
this	O	O	O
laryngoscope	O	O	O
may	O	O	O
increase	O	O	B-T169
the	O	O	O
success	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
resuscitation	O	O	B-T061
.	O	O	O

-DOCSTART- (27371819)

The	O	O	O
nurse-patient	O	O	B-T054
communication	O	O	I-T054
:	O	O	O
voices	O	O	O
from	O	O	O
nursing	O	O	O
students	O	O	O

Effective	O	O	B-T032
communication	O	O	I-T032
skills	O	O	I-T032
have	O	O	O
been	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
pivotal	O	O	B-T169
factors	O	O	I-T169
in	O	O	O
building	O	O	O
positive	O	O	B-T054
interpersonal	O	O	I-T054
relationships	O	O	I-T054
.	O	O	O

Little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
nursing	O	O	B-T097
undergraduates	O	O	I-T097
'	O	O	O
perspectives	O	O	B-UnknownType
on	O	O	O
communicating	O	O	B-T169
with	O	O	O
patients	O	O	B-T101
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
explore	O	O	O
nursing	O	O	B-T097
students	O	O	I-T097
'	O	O	I-T097
perspectives	O	O	B-UnknownType
and	O	O	O
experiences	O	O	B-T041
of	O	O	O
nurse-patient	O	O	B-T054
communication	O	O	I-T054
in	O	O	O
their	O	O	O
clinical	O	O	B-T080
placement	O	O	B-T080
.	O	O	O

The	O	O	O
participants	O	O	B-T098
included	O	O	O
21	O	O	O
second-year	O	O	B-T098
undergraduates	O	O	I-T098
and	O	O	O
21	O	O	O
first-year	O	O	B-T098
master	O	O	I-T098
's	O	O	I-T098
students	O	O	I-T098
.	O	O	O

Interviews	O	O	B-T052
were	O	O	O
conducted	O	O	O
in	O	O	O
Cantonese	O	O	B-T171
and	O	O	O
then	O	O	O
transcribed	O	O	O
in	O	O	O
Chinese	O	O	B-T171
and	O	O	O
translated	O	O	O
into	O	O	O
English	O	O	B-T171
.	O	O	O

A	O	O	O
content	O	O	B-T062
analysis	O	O	I-T062
approach	O	O	B-T082
was	O	O	O
adopted	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
data	O	O	B-T078
.	O	O	O

Five	O	O	O
themes	O	O	B-UnknownType
emerged	O	O	O
from	O	O	O
the	O	O	O
interview	O	O	B-T078
data	O	O	I-T078
.	O	O	O
'	O	O	O
The	O	O	O
necessity	O	O	O
of	O	O	O
nurse-patient	O	O	B-T054
communication	O	O	I-T054
'	O	O	O
reveals	O	O	B-T080
why	O	O	O
the	O	O	O
students	O	O	B-T098
valued	O	O	O
nurse-patient	O	O	O
communication	O	O	O
.	O	O	O
'	O	O	O
The	O	O	O
conversation	O	O	B-T033
contents	O	O	I-T033
'	O	O	O
describes	O	O	O
the	O	O	O
content	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
conversations	O	O	I-T033
that	O	O	O
students	O	O	O
typically	O	O	O
had	O	O	O
with	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
third	O	O	O
theme	O	O	B-UnknownType
is	O	O	O
'	O	O	O
self-reflection	O	O	B-T033
on	O	O	O
the	O	O	O
nurse-patient	O	O	B-T054
communication	O	O	I-T054
'	O	O	O
.	O	O	O

The	O	O	O
last	O	O	O
two	O	O	O
themes	O	O	B-UnknownType
,	O	O	O
'	O	O	O
the	O	O	O
communication	O	O	B-T033
pattern	O	O	I-T033
in	O	O	I-T033
different	O	O	I-T033
hospital	O	O	B-T093
settings	O	O	I-T093
'	O	O	O
and	O	O	O
'	O	O	O
the	O	O	O
obstacles	O	O	O
impeding	O	O	O
nurse-patient	O	O	B-T054
communication	O	O	I-T054
'	O	O	O
,	O	O	O
are	O	O	O
about	O	O	O
the	O	O	O
students	O	O	B-T098
'	O	O	I-T098
communication	O	O	B-T080
styles	O	O	I-T080
in	O	O	O
different	O	O	O
hospitals	O	O	B-T093
and	O	O	O
the	O	O	O
barriers	O	O	O
they	O	O	O
encounter	O	O	B-T053
.	O	O	O

To	O	O	O
improve	O	O	B-T033
students	O	O	B-T098
'	O	O	I-T098
communication	O	O	B-T032
skills	O	O	I-T032
,	O	O	O
educators	O	O	B-T097
and	O	O	O
clinical	O	O	B-T097
staff	O	O	I-T097
should	O	O	O
listen	O	O	O
to	O	O	O
students	O	O	O
,	O	O	O
enhance	O	O	B-T052
students	O	O	B-T098
'	O	O	I-T098
reflective	O	O	B-T055
skills	O	O	I-T055
and	O	O	O
strengthen	O	O	O
their	O	O	O
confidence	O	O	B-T041
.	O	O	O

Through	O	O	O
understanding	O	O	B-T041
students	O	O	B-T098
'	O	O	I-T098
difficulties	O	O	B-T080
in	O	O	O
the	O	O	O
nurse-patient	O	O	B-T054
communication	O	O	I-T054
experience	O	O	B-T041
and	O	O	O
the	O	O	O
skills	O	O	B-T055
that	O	O	O
they	O	O	O
lack	O	O	O
,	O	O	O
educators	O	O	B-T097
can	O	O	O
provide	O	O	O
them	O	O	O
with	O	O	O
helpful	O	O	O
recommendations	O	O	B-T078
to	O	O	O
improve	O	O	B-T033
their	O	O	O
communication	O	O	B-T032
skills	O	O	I-T032
in	O	O	O
clinical	O	O	B-T057
practice	O	O	I-T057
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
reveal	O	O	B-T080
that	O	O	O
students	O	O	B-T098
'	O	O	I-T098
nurse-patient	O	O	B-T054
communication	O	O	I-T054
skills	O	O	B-T032
need	O	O	O
to	O	O	O
be	O	O	O
improved	O	O	B-T033
.	O	O	O

-DOCSTART- (27374165)

Early	O	O	O
hippocampal	O	O	B-T023
volume	O	O	B-T033
loss	O	O	I-T033
as	O	O	O
a	O	O	O
marker	O	O	B-T201
of	O	O	O
eventual	O	O	O
memory	O	O	B-T048
deficits	O	O	I-T048
caused	O	O	O
by	O	O	O
repeated	O	O	O
stress	O	O	O

Exposure	O	O	B-T080
to	O	O	I-T080
severe	O	O	B-T080
and	O	O	O
prolonged	O	O	B-T079
stress	O	O	B-T033
has	O	O	O
detrimental	O	O	B-T033
effects	O	O	I-T033
on	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
.	O	O	O

However	O	O	O
,	O	O	O
relatively	O	O	B-T080
little	O	O	B-T081
is	O	O	O
known	O	O	B-T080
about	O	O	O
the	O	O	O
gradual	O	O	B-T080
changes	O	O	B-T169
in	O	O	O
hippocampal	O	O	B-T023
structure	O	O	I-T023
,	O	O	O
and	O	O	O
its	O	O	O
behavioral	O	O	B-T053
consequences	O	O	B-T169
,	O	O	O
over	O	O	O
the	O	O	O
course	O	O	O
of	O	O	O
repeated	O	O	B-T033
stress	O	O	I-T033
.	O	O	O

Behavioral	O	O	B-T058
analyses	O	O	I-T058
during	O	O	O
10	O	O	O
days	O	O	O
of	O	O	O
chronic	O	O	B-UnknownType
stress	O	O	B-T033
pointed	O	O	O
to	O	O	O
a	O	O	O
delayed	O	O	O
decline	O	O	B-T081
in	O	O	O
spatial	O	O	B-T041
memory	O	O	I-T041
,	O	O	O
the	O	O	O
full	O	O	O
impact	O	O	B-T080
of	O	O	O
which	O	O	O
is	O	O	O
evident	O	O	O
only	O	O	O
after	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
stress	O	O	O
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
concurrent	O	O	B-T079
volumetric	O	O	B-T081
measurements	O	O	I-T081
in	O	O	O
the	O	O	O
same	O	O	O
animals	O	O	B-T008
revealed	O	O	O
significant	O	O	O
reduction	O	O	B-T080
in	O	O	O
hippocampal	O	O	B-T023
volumes	O	O	B-T081
in	O	O	O
stressed	O	O	B-T033
animals	O	O	O
relative	O	O	O
to	O	O	O
their	O	O	O
unstressed	O	O	B-T033
counterparts	O	O	I-T033
,	O	O	O
as	O	O	O
early	O	O	O
as	O	O	O
the	O	O	O
third	O	O	O
day	O	O	O
of	O	O	O
stress	O	O	B-T033
.	O	O	O

Notably	O	O	O
,	O	O	O
animals	O	O	B-T008
that	O	O	O
were	O	O	O
behaviorally	O	O	B-T053
the	O	O	O
worst	O	O	B-T080
affected	O	O	B-T169
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
chronic	O	O	B-UnknownType
stress	O	O	I-UnknownType
suffered	O	O	B-T048
the	O	O	O
most	O	O	O
pronounced	O	O	O
early	O	O	B-T033
loss	O	O	I-T033
in	O	O	I-T033
hippocampal	O	O	I-T033
volume	O	O	I-T033
.	O	O	O

Together	O	O	O
,	O	O	O
these	O	O	O
findings	O	O	O
support	O	O	O
the	O	O	O
view	O	O	O
that	O	O	O
not	O	O	O
only	O	O	O
is	O	O	O
smaller	O	O	O
hippocampal	O	O	B-T023
volume	O	O	B-T081
linked	O	O	O
to	O	O	O
stress	O	O	B-T033
-	O	O	O
induced	O	O	B-T169
memory	O	O	B-T048
deficits	O	O	I-T048
,	O	O	O
but	O	O	O
it	O	O	O
may	O	O	O
also	O	O	O
act	O	O	O
as	O	O	O
an	O	O	O
early	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
the	O	O	O
eventual	O	O	O
development	O	O	O
of	O	O	O
cognitive	O	O	B-T048
impairments	O	O	I-T048
seen	O	O	O
in	O	O	O
stress-related	O	O	B-T048
psychiatric	O	O	I-T048
disorders	O	O	I-T048
.	O	O	O

-DOCSTART- (27375918)

The	O	O	O
Association	O	O	B-T080
between	O	O	O
C9orf72	O	O	B-T028
Repeats	O	O	B-T086
and	O	O	O
Risk	O	O	B-T078
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
and	O	O	O
Amyotrophic	O	O	B-T047
Lateral	O	O	I-T047
Sclerosis	O	O	I-T047
:	O	O	O
A	O	O	O
Meta-Analysis	O	O	O

C9orf72	O	O	B-T028
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
genetic	O	O	B-T169
cause	O	O	B-T169
of	O	O	O
amyotrophic	O	O	B-T047
lateral	O	O	I-T047
sclerosis	O	O	I-T047
(	O	O	O
ALS	O	O	B-T047
)	O	O	O
and	O	O	O
frontotemporal	O	O	B-T047
dementia	O	O	I-T047
(	O	O	O
FTD	O	O	B-T047
)	O	O	O
in	O	O	O
Caucasian	O	O	B-T098
populations	O	O	I-T098
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
C9orf72	O	O	B-T028
repeats	O	O	B-T086
and	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
was	O	O	O
not	O	O	B-T033
clear	O	O	I-T033
.	O	O	O

Additionally	O	O	O
,	O	O	O
there	O	O	O
were	O	O	O
few	O	O	O
articles	O	O	B-T170
assessing	O	O	B-T052
C9orf72	O	O	B-T028
in	O	O	O
other	O	O	O
ethnicities	O	O	B-T080
with	O	O	O
ALS	O	O	B-T047
.	O	O	O

In	O	O	O
this	O	O	O
meta-analysis	O	O	B-T062
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
C9orf72	O	O	B-T028
repeat	O	O	B-T049
expansions	O	O	I-T049
(	O	O	O
≥30	O	O	O
repeats	O	O	B-T086
)	O	O	O
and	O	O	O
intermediate	O	O	B-T082
repeat	O	O	B-T086
copies	O	O	I-T086
(	O	O	O
20	O	O	O
-	O	O	O
29	O	O	O
repeats	O	O	O
)	O	O	O
and	O	O	O
AD	O	O	B-T047
or	O	O	O
ALS	O	O	B-T047
.	O	O	O

The	O	O	O
results	O	O	B-T169
suggested	O	O	O
positive	O	O	B-T033
correlations	O	O	B-T080
between	O	O	O
C9orf72	O	O	B-T028
repeat	O	O	B-T049
expansions	O	O	I-T049
and	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	B-T047
(	O	O	O
OR	O	O	B-T081
=	O	O	O
6.36	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
3.13	O	O	O
-	O	O	O
12.92	O	O	O
,	O	O	O
and	O	O	O
p	O	O	B-T081
<	O	O	O
0.00001	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
intermediate	O	O	B-T082
repeat	O	O	B-T086
copies	O	O	I-T086
of	O	O	O
C9orf72	O	O	B-T028
gene	O	O	I-T028
were	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
risk	O	O	O
of	O	O	O
the	O	O	O
disease	O	O	O
.	O	O	O

C9orf72	O	O	B-T028
repeat	O	O	B-T049
expansions	O	O	I-T049
were	O	O	O
positively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
familial	O	O	B-T047
and	O	O	O
sporadic	O	O	B-T047
ALS	O	O	I-T047
(	O	O	O
OR	O	O	B-T081
=	O	O	O
293.25	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
148.17	O	O	O
-	O	O	O
580.38	O	O	O
,	O	O	O
and	O	O	O
p	O	O	B-T081
<	O	O	O
0.00001	O	O	O
;	O	O	O
OR	O	O	O
=	O	O	O
35.57	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
19.61	O	O	O
-	O	O	O
64.51	O	O	O
,	O	O	O
and	O	O	O
p	O	O	O
<	O	O	O
0.00001	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
positive	O	O	B-T033
correlation	O	O	B-T080
between	O	O	O
the	O	O	O
gene	O	O	B-T070
variations	O	O	I-T070
and	O	O	O
ALS	O	O	B-T047
risk	O	O	B-T078
among	O	O	O
Caucasians	O	O	B-T098
and	O	O	O
Asians	O	O	B-T098
(	O	O	O
OR	O	O	B-T081
=	O	O	O
57.56	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
36.73	O	O	O
-	O	O	O
90.22	O	O	O
,	O	O	O
and	O	O	O
p	O	O	B-T081
<	O	O	O
0.00001	O	O	O
;	O	O	O
OR	O	O	O
=	O	O	O
6.35	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
1.39	O	O	O
-	O	O	O
29.02	O	O	O
,	O	O	O
and	O	O	O
p	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27378028)

Demonstration	O	O	O
and	O	O	O
validation	O	O	B-T062
of	O	O	O
a	O	O	O
new	O	O	O
pressure	O	O	B-T067
-based	O	O	O
MRI	O	O	B-T074
-safe	O	O	O
pain	O	O	B-T033
tolerance	O	O	I-T033
device	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
barriers	O	O	O
to	O	O	O
studying	O	O	O
the	O	O	O
behavioral	O	O	B-T053
and	O	O	O
emotional	O	O	B-T041
effects	O	O	B-T080
of	O	O	O
pain	O	O	B-T184
using	O	O	O
functional	O	O	B-T060
Magnetic	O	O	I-T060
Resonance	O	O	I-T060
Imaging	O	O	I-T060
(	O	O	O
fMRI	O	O	B-T060
)	O	O	O
is	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
a	O	O	O
commercially	O	O	O
available	O	O	O
,	O	O	O
MRI	O	O	B-T074
-	O	O	O
compatible	O	O	B-T080
,	O	O	O
pressure	O	O	B-T067
-based	O	O	O
algometer	O	O	B-T074
to	O	O	O
elicit	O	O	B-T080
pain	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
sought	O	O	O
to	O	O	O
address	O	O	O
this	O	O	O
barrier	O	O	O
through	O	O	O
creation	O	O	O
and	O	O	O
validation	O	O	O
of	O	O	O
a	O	O	O
novel	O	O	O
MRI	O	O	B-T074
-safe	O	O	O
apparatus	O	O	B-T074
capable	O	O	O
of	O	O	O
delivering	O	O	O
incremental	O	O	B-T081
,	O	O	O
measurable	O	O	B-T169
amounts	O	O	O
of	O	O	O
pressure	O	O	B-T067
inside	O	O	O
a	O	O	O
scanning	O	O	B-T074
bore	O	O	I-T074
.	O	O	O

We	O	O	O
introduced	O	O	O
an	O	O	O
MR-safe	O	O	O
device	O	O	B-T074
used	O	O	O
to	O	O	O
administer	O	O	O
pressure	O	O	B-T067
-based	O	O	O
pain	O	O	B-T184
.	O	O	O

To	O	O	O
test	O	O	B-T059
against	O	O	O
a	O	O	O
commercially	O	O	O
available	O	O	O
,	O	O	O
MRI	O	O	B-T074
-	O	O	O
incompatible	O	O	B-T080
algometer	O	O	B-T074
(	O	O	O
AlgoMed	O	O	B-T074
)	O	O	O
,	O	O	O
199	O	O	O
participants	O	O	O
reported	O	O	O
their	O	O	O
pain	O	O	B-T033
tolerance	O	O	I-T033
for	O	O	O
both	O	O	O
devices	O	O	O
.	O	O	O

A	O	O	O
second	O	O	O
experiment	O	O	O
tested	O	O	B-T059
the	O	O	O
validity	O	O	O
of	O	O	O
pressure	O	O	B-T067
-based	O	O	O
pain	O	O	B-T184
in	O	O	O
an	O	O	O
MRI	O	O	B-T074
environment	O	O	B-T082
by	O	O	O
comparing	O	O	O
brain	O	O	B-T023
activation	O	O	B-T052
with	O	O	O
established	O	O	O
neural	O	O	B-T023
networks	O	O	I-T023
for	O	O	O
pain	O	O	O
.	O	O	O

10	O	O	O
participants	O	O	O
performed	O	O	O
an	O	O	O
identical	O	O	O
procedure	O	O	O
to	O	O	O
test	O	O	B-T059
for	O	O	O
pain	O	O	B-T184
tolerance	O	O	O
while	O	O	O
being	O	O	O
scanned	O	O	B-T060
in	O	O	O
a	O	O	O
7	O	O	O
T	O	O	O
MRI	O	O	B-T074
scanner	O	O	I-T074
.	O	O	O

Results	O	O	O
support	O	O	O
the	O	O	O
validity	O	O	B-T080
and	O	O	I-T080
reliability	O	O	I-T080
of	O	O	O
our	O	O	O
novel	O	O	O
device	O	O	B-T074
.	O	O	O

In	O	O	O
Study	O	O	O
1	O	O	O
,	O	O	O
pain	O	O	B-T033
tolerance	O	O	I-T033
with	O	O	O
this	O	O	O
device	O	O	B-T074
was	O	O	O
strongly	O	O	O
correlated	O	O	O
with	O	O	O
pain	O	O	O
tolerance	O	O	O
as	O	O	O
measured	O	O	O
by	O	O	O
a	O	O	O
commercially	O	O	O
available	O	O	O
algometer	O	O	B-T074
(	O	O	O
r=0.78	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
Study	O	O	O
2	O	O	O
,	O	O	O
this	O	O	O
device	O	O	B-T074
yielded	O	O	O
BOLD	O	O	B-T042
activation	O	O	O
within	O	O	O
the	O	O	O
insula	O	O	B-T023
(	O	O	O
BA	O	O	B-T023
13	O	O	I-T023
)	O	O	O
and	O	O	O
anterior	O	O	B-T023
cingulate	O	O	I-T023
gyrus	O	O	I-T023
(	O	O	O
BA	O	O	B-T029
24	O	O	I-T029
)	O	O	O
;	O	O	O
as	O	O	O
pressure	O	O	B-T067
increased	O	O	B-T081
,	O	O	O
activation	O	O	O
in	O	O	O
these	O	O	O
areas	O	O	O
parametrically	O	O	B-UnknownType
increased	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
correspond	O	O	O
to	O	O	O
other	O	O	O
studies	O	O	O
using	O	O	O
thermal	O	O	B-T061
,	O	O	O
electrical	O	O	B-T061
,	O	O	O
or	O	O	O
mechanical	O	O	B-T061
pain	O	O	B-T184
applications	O	O	I-T184
.	O	O	O

Behavioral	O	O	B-T053
and	O	O	O
functional	O	O	B-T169
data	O	O	B-T078
demonstrate	O	O	O
that	O	O	O
this	O	O	O
new	O	O	O
device	O	O	B-T074
is	O	O	O
a	O	O	O
valid	O	O	O
method	O	O	O
of	O	O	O
administering	O	O	B-T061
pressure	O	O	B-T067
-related	O	O	O
pain	O	O	B-T184
in	O	O	O
MRI	O	O	B-T074
environments	O	O	B-T082
.	O	O	O

Our	O	O	O
novel	O	O	O
MRI	O	O	B-T074
-safe	O	O	O
device	O	O	B-T074
is	O	O	O
a	O	O	O
valid	O	O	O
instrument	O	O	B-T074
to	O	O	O
measure	O	O	B-T169
and	O	O	O
administer	O	O	B-T169
pressure	O	O	B-T067
-based	O	O	O
pain	O	O	B-T184
.	O	O	O

-DOCSTART- (27378927)

Anti-Inflammatory	O	O	B-T080
Properties	O	O	I-T080
of	O	O	O
Menthol	O	O	B-T109
and	O	O	O
Menthone	O	O	B-T109
in	O	O	O
Schistosoma	O	O	O
mansoni	O	O	O
Infection	O	O	O

Schistosomiasis	O	O	B-T047
is	O	O	O
a	O	O	O
parasitic	O	O	B-T047
disease	O	O	I-T047
caused	O	O	O
by	O	O	O
several	O	O	O
species	O	O	B-T185
of	O	O	O
trematode	O	O	B-T204
worms	O	O	I-T204
and	O	O	O
it	O	O	O
is	O	O	O
believed	O	O	O
that	O	O	O
more	O	O	O
than	O	O	O
261	O	O	O
million	O	O	O
people	O	O	B-T098
are	O	O	O
affected	O	O	B-T169
worldwide	O	O	O
.	O	O	O

New	O	O	O
drug	O	O	B-T121
development	O	O	I-T091
has	O	O	O
become	O	O	O
essential	O	O	B-T080
because	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
risk	O	O	O
of	O	O	O
the	O	O	O
parasite	O	O	B-T204
becoming	O	O	O
resistant	O	O	B-T039
to	O	O	O
Praziquantel	O	O	B-T109
,	O	O	O
the	O	O	O
only	O	O	O
drug	O	O	O
available	O	O	O
for	O	O	O
this	O	O	O
infection	O	O	B-T046
.	O	O	O

This	O	O	O
study	O	O	B-T062
evaluated	O	O	B-T058
parasitological	O	O	B-T080
,	O	O	O
immunological	O	O	B-T169
and	O	O	O
histological	O	O	B-T169
parameters	O	O	B-T033
in	O	O	O
mice	O	O	B-T015
infected	O	O	B-T033
with	O	O	O
Schistosoma	O	O	B-T204
mansoni	O	O	I-T204
and	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
an	O	O	O
herbal	O	O	B-T121
commercial	O	O	I-T121
medicine	O	O	I-T121
.	O	O	O

This	O	O	O
drug	O	O	B-T121
consists	O	O	O
of	O	O	O
menthol	O	O	B-T109
(	O	O	O
30	O	O	O
-	O	O	O
55	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
menthone	O	O	B-T109
(	O	O	O
14	O	O	O
-	O	O	O
32	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
60	O	O	O
day	O	O	O
treatment	O	O	B-T061
regimen	O	O	I-T061
with	O	O	O
the	O	O	O
herbal	O	O	B-T121
medicine	O	O	I-T121
decreased	O	O	B-T081
the	O	O	O
number	O	O	O
of	O	O	O
S.	O	O	B-T204
mansoni	O	O	I-T204
eggs	O	O	B-T204
in	O	O	O
the	O	O	O
feces	O	O	B-T031
,	O	O	O
liver	O	O	B-T023
,	O	O	O
and	O	O	O
intestine	O	O	B-T023
and	O	O	O
reduced	O	O	B-T080
the	O	O	O
number	O	O	O
of	O	O	O
hepatic	O	O	B-T047
granulomas	O	O	I-T047
.	O	O	O

We	O	O	O
observed	O	O	B-T169
a	O	O	O
reduction	O	O	B-T061
of	O	O	O
84	O	O	O
%	O	O	O
in	O	O	O
blood	O	O	B-T047
eosinophilia	O	O	I-T047
and	O	O	O
a	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
IL-4	O	O	B-T116
and	O	O	O
IL-10	O	O	B-T116
blood	O	O	B-T031
levels	O	O	I-T031
after	O	O	O
treatment	O	O	B-T061
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
propose	O	O	O
that	O	O	O
schistosomiasis	O	O	B-T047
treatment	O	O	B-T061
with	O	O	O
this	O	O	O
herbal	O	O	B-T121
medicine	O	O	I-T121
for	O	O	O
60	O	O	O
days	O	O	O
has	O	O	O
an	O	O	O
immunomodulatory	O	O	B-T080
and	O	O	O
anti-inflammatory	O	O	B-T080
action	O	O	I-T080
in	O	O	O
this	O	O	O
animal	O	O	B-T008
model	O	O	I-T008
for	O	O	O
schistosomiasis	O	O	O
thus	O	O	O
contributing	O	O	B-T052
to	O	O	O
the	O	O	O
decrease	O	O	B-T081
in	O	O	O
physio	O	O	O
pathological	O	O	B-T169
effects	O	O	B-T080
caused	O	O	O
by	O	O	O
S.	O	O	B-T047
mansoni	O	O	I-T047
infection	O	O	I-T047
.	O	O	O

-DOCSTART- (27381206)

Catastrophic	O	O	B-T047
health	O	O	B-T081
expenditure	O	O	I-T081
:	O	O	O
a	O	O	O
comparative	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
empty-nest	O	O	B-T078
and	O	O	O
non-empty-nest	O	O	B-T078
households	O	O	B-T099
with	O	O	O
seniors	O	O	B-T098
in	O	O	O
Shandong	O	O	O
,	O	O	O
China	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
catastrophic	O	O	B-T047
health	O	O	B-T081
expenditure	O	O	I-T081
(	O	O	O
CHE	O	O	B-T081
)	O	O	O
prevalence	O	O	B-T081
and	O	O	O
its	O	O	O
determinants	O	O	B-T169
between	O	O	O
empty-nest	O	O	B-T078
and	O	O	O
non-empty-nest	O	O	B-T078
elderly	O	O	B-T098
households	O	O	B-T099
.	O	O	O

Shandong	O	O	B-T083
province	O	O	I-T083
of	O	O	I-T083
China	O	O	I-T083
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
2761	O	O	O
elderly	O	O	B-T098
households	O	O	B-T099
are	O	O	O
included	O	O	B-T169
in	O	O	O
the	O	O	O
analysis	O	O	B-T062
.	O	O	O

CHE	O	O	B-T081
incidence	O	O	B-T081
among	O	O	O
elderly	O	O	B-T098
households	O	O	B-T099
was	O	O	O
44.9	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
CHE	O	O	B-T081
incidence	O	O	B-T081
of	O	O	O
empty-nest	O	O	B-T078
singles	O	O	B-T033
(	O	O	O
59.3	O	O	O
%	O	O	O
,	O	O	O
p=0.000	O	O	O
,	O	O	O
OR=3.19	O	O	O
)	O	O	O
and	O	O	O
empty-nest	O	O	O
couples	O	O	B-T099
(	O	O	O
52.9	O	O	O
%	O	O	O
,	O	O	O
p=0.000	O	O	O
,	O	O	O
OR=2.45	O	O	O
)	O	O	O
are	O	O	O
both	O	O	O
statistically	O	O	B-T081
higher	O	O	B-T080
than	O	O	O
that	O	O	O
of	O	O	O
non-empty-nest	O	O	B-T078
elderly	O	O	B-T098
households	O	O	B-T099
(	O	O	O
31.4	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

An	O	O	O
inverse	O	O	B-T077
association	O	O	I-T077
was	O	O	O
observed	O	O	B-T169
between	O	O	O
CHE	O	O	B-T081
incidence	O	O	B-T081
and	O	O	O
income	O	O	B-T080
level	O	O	I-T080
in	O	O	O
all	O	O	O
elderly	O	O	B-T098
household	O	O	B-T099
types	O	O	B-T080
.	O	O	O

Factors	O	O	B-T169
including	O	O	B-T169
1	O	O	O
or	O	O	O
more	O	O	O
household	O	O	B-T099
elderly	O	O	B-T098
members	O	O	I-T098
with	O	O	O
non-communicable	O	O	B-T047
chronic	O	O	I-T047
diseases	O	O	I-T047
in	O	O	O
the	O	O	O
past	O	O	O
6	O	O	O
months	O	O	O
,	O	O	O
1	O	O	O
or	O	O	O
more	O	O	O
elderly	O	O	O
household	O	O	B-T099
members	O	O	I-T099
being	O	O	O
hospitalised	O	O	B-T033
in	O	O	O
the	O	O	O
past	O	O	B-T079
year	O	O	I-T079
and	O	O	O
lower	O	O	B-T052
household	O	O	O
income	O	O	B-T081
,	O	O	O
are	O	O	O
significant	O	O	B-T078
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
CHE	O	O	B-T081
in	O	O	O
all	O	O	O
3	O	O	O
household	O	O	O
types	O	O	B-T080
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

Health	O	O	B-T058
insurance	O	O	I-T058
status	O	O	B-T080
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
significant	O	O	B-T078
determinant	O	O	B-T169
of	O	O	O
CHE	O	O	B-T081
among	O	O	O
empty-nest	O	O	B-T078
singles	O	O	B-T033
and	O	O	O
non-empty-nest	O	O	B-T078
households	O	O	B-T099
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

CHE	O	O	B-T081
incidence	O	O	B-T081
among	O	O	O
elderly	O	O	B-T098
households	O	O	B-T099
is	O	O	O
high	O	O	B-T080
in	O	O	O
China	O	O	B-T083
.	O	O	O

Empty-nest	O	O	B-T078
households	O	O	B-T099
are	O	O	O
at	O	O	O
higher	O	O	B-T080
risk	O	O	B-T078
for	O	O	O
CHE	O	O	B-T081
than	O	O	O
non-empty-nest	O	O	B-T078
households	O	O	O
.	O	O	O

Based	O	O	O
on	O	O	O
these	O	O	O
findings	O	O	B-T033
,	O	O	O
we	O	O	O
suggest	O	O	B-T078
that	O	O	O
special	O	O	B-T080
insurance	O	O	B-T058
be	O	O	O
developed	O	O	O
to	O	O	O
broaden	O	O	B-T082
the	O	O	O
coverage	O	O	B-T078
of	O	O	O
health	O	O	B-T058
services	O	O	I-T058
and	O	O	O
heighten	O	O	B-T080
the	O	O	O
reimbursement	O	O	B-T058
rate	O	O	I-T058
for	O	O	O
empty-nest	O	O	B-T078
elderly	O	O	B-T098
in	O	O	O
the	O	O	O
existing	O	O	O
health	O	O	B-T058
insurance	O	O	I-T058
schemes	O	O	B-T170
.	O	O	O

Financial	O	O	B-T080
and	O	O	O
social	O	O	B-T064
protection	O	O	I-T064
interventions	O	O	B-T058
are	O	O	O
also	O	O	O
essential	O	O	B-T080
for	O	O	O
identifie	O	O	B-T080
d	O	O	O
at-risk	O	O	B-T080
subgroups	O	O	B-T185
among	O	O	O
different	O	O	O
types	O	O	O
of	O	O	O
elderly	O	O	B-T098
households	O	O	B-T099
.	O	O	O

-DOCSTART- (27381670)

Role	O	O	O
of	O	O	O
agonistic	O	O	B-T116
autoantibodies	O	O	I-T116
against	O	O	O
type-1	O	O	B-T116
angiotensin	O	O	I-T116
II	O	O	I-T116
receptor	O	O	I-T116
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
retinopathy	O	O	B-T047
in	O	O	O
preeclampsia	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
mechanism	O	O	B-T169
underlying	O	O	O
AT1-AA	O	O	B-T129
-induced	O	O	O
retinopathy	O	O	B-T047
in	O	O	O
severe	O	O	B-T046
preeclampsia	O	O	I-T046
by	O	O	O
measuring	O	O	O
the	O	O	O
positive	O	O	B-T081
rate	O	O	I-T081
and	O	O	O
titer	O	O	B-T081
of	O	O	O
AT1-AA	O	O	O
in	O	O	O
plasma	O	O	B-T031
from	O	O	O
women	O	O	B-T098
with	O	O	O
severe	O	O	O
preeclampsia	O	O	O
and	O	O	O
normal	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
to	O	O	O
see	O	O	O
whether	O	O	O
AT1-AA	O	O	O
titer	O	O	O
was	O	O	O
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
grade	O	O	O
of	O	O	O
retinopathy	O	O	O
.	O	O	O

A	O	O	O
preeclampsia	O	O	B-T046
rat	O	O	B-T015
model	O	O	B-T008
was	O	O	O
also	O	O	O
established	O	O	O
by	O	O	O
intravenous	O	O	B-T169
injection	O	O	I-T169
of	O	O	O
AT1-AA	O	O	B-T129
extracted	O	O	O
from	O	O	O
the	O	O	O
plasma	O	O	B-T031
of	O	O	O
patient	O	O	B-T101
suffering	O	O	O
from	O	O	O
severe	O	O	B-T046
preeclampsia	O	O	I-T046
.	O	O	O

The	O	O	O
results	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
plasma	O	O	B-T031
titer	O	O	B-T081
and	O	O	O
positive	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
AT1-AA	O	O	B-T129
were	O	O	O
significantly	O	O	O
higher	O	O	O
in	O	O	O
women	O	O	B-T098
with	O	O	O
severe	O	O	B-T046
preeclampsia	O	O	I-T046
than	O	O	O
normal	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
.	O	O	O

The	O	O	O
antibody	O	O	B-T116
titer	O	O	B-T081
in	O	O	O
cases	O	O	O
of	O	O	O
severe	O	O	O
preeclampsia	O	O	B-T046
was	O	O	O
associated	O	O	O
with	O	O	O
the	O	O	O
grade	O	O	O
of	O	O	O
retinopathy	O	O	B-T047
,	O	O	O
and	O	O	O
positively	O	O	O
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
level	O	O	O
of	O	O	O
TNF-α	O	O	B-T116
and	O	O	O
VEGF	O	O	B-T116
.	O	O	O

The	O	O	O
animal	O	O	B-T062
experiment	O	O	I-T062
results	O	O	B-T169
showed	O	O	O
that	O	O	O
the	O	O	O
modeled	O	O	B-T015
rats	O	O	I-T015
presented	O	O	O
symptoms	O	O	B-T184
very	O	O	O
similar	O	O	O
to	O	O	O
symptoms	O	O	O
of	O	O	O
human	O	O	B-T016
preeclampsia	O	O	B-T046
,	O	O	O
including	O	O	O
retinopathy	O	O	B-T047
.	O	O	O

Ocular	O	O	B-T023
fundus	O	O	I-T023
examination	O	O	B-T058
showed	O	O	O
retinal	O	O	B-T033
microvascular	O	O	I-T033
abnormalities	O	O	I-T033
,	O	O	O
hemorrhaging	O	O	B-T046
and	O	O	O
leakage	O	O	B-T033
in	O	O	O
the	O	O	O
severe	O	O	B-T046
preeclampsia	O	O	I-T046
.	O	O	O

Morphological	O	O	B-T082
changes	O	O	I-T082
included	O	O	O
edema	O	O	B-T184
,	O	O	O
thickening	O	O	B-T033
of	O	O	O
the	O	O	O
INL	O	O	B-T023
and	O	O	O
ONL	O	O	B-T023
,	O	O	O
and	O	O	O
pigment	O	O	B-T033
atrophy	O	O	I-T033
.	O	O	O

TNF-α	O	O	B-T116
and	O	O	O
VEGF	O	O	B-T116
levels	O	O	O
were	O	O	O
increased	O	O	O
in	O	O	O
the	O	O	O
vitreous	O	O	B-T031
humor	O	O	I-T031
and	O	O	O
retina	O	O	B-T023
of	O	O	O
the	O	O	O
model	O	O	B-T015
rats	O	O	I-T015
.	O	O	O

Our	O	O	O
studies	O	O	B-T062
results	O	O	B-T169
suggest	O	O	O
that	O	O	O
abnormal	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
AT1-AA	O	O	B-T129
could	O	O	O
induce	O	O	O
damage	O	O	B-T169
to	O	O	O
retinal	O	O	B-T025
capillary	O	O	I-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
increase	O	O	O
vascular	O	O	B-T042
permeability	O	O	I-T042
,	O	O	O
resulting	O	O	B-T169
in	O	O	I-T169
retinopathy	O	O	B-T047
.	O	O	O

-DOCSTART- (27382289)

Characterizing	O	O	B-T052
sexual	O	O	B-T040
function	O	O	I-T040
in	O	O	O
patients	O	O	B-T101
with	O	O	O
generalized	O	O	B-T048
anxiety	O	O	I-T048
disorder	O	O	I-T048
:	O	O	O
a	O	O	O
pooled	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
three	O	O	O
vilazodone	O	O	B-T109
studies	O	O	O

Vilazodone	O	O	B-T109
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
reduce	O	O	B-T080
core	O	O	B-T184
symptoms	O	O	I-T184
of	O	O	O
generalized	O	O	B-T048
anxiety	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
GAD	O	O	B-T048
)	O	O	O
in	O	O	O
three	O	O	O
randomized	O	O	B-T062
,	O	O	O
double-blind	O	O	B-T062
,	O	O	O
placebo-controlled	O	O	B-T062
trials	O	O	I-T062
.	O	O	O

Since	O	O	O
sexual	O	O	B-T047
dysfunction	O	O	I-T047
(	O	O	O
SD	O	O	B-T047
)	O	O	O
is	O	O	O
not	O	O	O
well	O	O	O
characterized	O	O	O
in	O	O	O
GAD	O	O	B-T048
,	O	O	O
a	O	O	O
post	O	O	B-T062
hoc	O	O	I-T062
analysis	O	O	I-T062
of	O	O	O
these	O	O	O
trials	O	O	B-T062
was	O	O	O
conducted	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
vilazodone	O	O	B-T109
on	O	O	O
sexual	O	O	B-T040
functioning	O	O	I-T040
in	O	O	O
GAD	O	O	O
patients	O	O	B-T101
.	O	O	O

Data	O	O	B-T078
were	O	O	O
pooled	O	O	B-T169
from	O	O	O
one	O	O	O
fixed-dose	O	O	B-T062
trial	O	O	I-T062
of	O	O	O
vilazodone	O	O	B-T109
20	O	O	O
and	O	O	O
40	O	O	O
mg/day	O	O	B-T081
(	O	O	O
NCT01629966	O	O	B-T170
)	O	O	O
and	O	O	O
two	O	O	O
flexible-dose	O	O	B-T062
studies	O	O	I-T062
of	O	O	O
vilazodone	O	O	O
20	O	O	O
-	O	O	O
40	O	O	O
mg/day	O	O	O
(	O	O	O
NCT01766401	O	O	B-T170
,	O	O	O
NCT01844115	O	O	B-T170
)	O	O	O
in	O	O	O
adults	O	O	B-T100
with	O	O	O
GAD	O	O	B-T048
.	O	O	O

Sexual	O	O	B-T040
functioning	O	O	I-T040
was	O	O	O
assessed	O	O	B-T052
using	O	O	O
the	O	O	O
Changes	O	O	B-T170
in	O	O	I-T170
Sexual	O	O	I-T170
Functioning	O	O	I-T170
Questionnaire	O	O	I-T170
(	O	O	O
CSFQ	O	O	B-T170
)	O	O	O
.	O	O	O

Outcomes	O	O	B-T062
included	O	O	O
mean	O	O	B-T081
change	O	O	I-T081
from	O	O	I-T081
baseline	O	O	B-T081
to	O	O	I-T081
end	O	O	I-T081
of	O	O	I-T081
treatment	O	O	I-T081
(	O	O	O
EOT	O	O	B-T080
)	O	O	O
in	O	O	O
CSFQ	O	O	B-T033
total	O	O	I-T033
score	O	O	I-T033
and	O	O	O
percentage	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
shifting	O	O	B-T169
from	O	O	O
SD	O	O	B-T047
at	O	O	O
baseline	O	O	O
(	O	O	O
CSFQ	O	O	O
total	O	O	O
score	O	O	O
≤47	O	O	O
for	O	O	O
males	O	O	B-T098
,	O	O	O
≤41	O	O	O
for	O	O	O
females	O	O	B-T098
)	O	O	O
to	O	O	O
normal	O	O	B-T033
functioning	O	O	I-T033
at	O	O	O
EOT	O	O	O
.	O	O	O

Treatment-emergent	O	O	B-T046
adverse	O	O	I-T046
events	O	O	I-T046
related	O	O	O
to	O	O	O
sexual	O	O	B-T040
functioning	O	O	I-T040
were	O	O	O
also	O	O	O
analyzed	O	O	B-T062
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
1,373	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
analyses	O	O	B-T062
.	O	O	O

SD	O	O	B-T047
at	O	O	O
baseline	O	O	B-T081
was	O	O	O
more	O	O	O
common	O	O	O
in	O	O	O
females	O	O	B-T098
(	O	O	O
placebo	O	O	B-T122
,	O	O	O
46.4	O	O	O
%	O	O	O
;	O	O	O
vilazodone	O	O	B-T109
,	O	O	O
49	O	O	O
%	O	O	O
)	O	O	O
than	O	O	O
in	O	O	O
males	O	O	B-T098
(	O	O	O
placebo	O	O	O
,	O	O	O
35.1	O	O	O
%	O	O	O
;	O	O	O
vilazodone	O	O	O
,	O	O	O
40.9	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

CSFQ	O	O	B-T033
total	O	O	I-T033
score	O	O	I-T033
improvement	O	O	B-T077
was	O	O	O
found	O	O	O
in	O	O	O
both	O	O	O
females	O	O	B-T098
(	O	O	O
placebo	O	O	B-T122
,	O	O	O
+	O	O	O
1.2	O	O	O
;	O	O	O
vilazodone	O	O	B-T109
,	O	O	O
+	O	O	O
1.6	O	O	O
)	O	O	O
and	O	O	O
males	O	O	B-T098
(	O	O	O
placebo	O	O	O
,	O	O	O
+	O	O	O
2.1	O	O	O
;	O	O	O
vilazodone	O	O	O
,	O	O	O
+	O	O	O
1.0	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
no	O	O	B-T033
statistically	O	O	I-T033
significant	O	O	I-T033
differences	O	O	I-T033
between	O	O	O
treatment	O	O	B-T169
groups	O	O	B-T078
.	O	O	O

The	O	O	O
percentage	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
who	O	O	O
shifted	O	O	B-T169
from	O	O	O
SD	O	O	B-T047
at	O	O	O
baseline	O	O	B-T081
to	O	O	O
normal	O	O	B-T080
sexual	O	O	B-T040
functioning	O	O	I-T040
at	O	O	O
EOT	O	O	B-T080
was	O	O	O
higher	O	O	O
in	O	O	O
males	O	O	B-T098
(	O	O	O
placebo	O	O	B-T122
,	O	O	O
40.6	O	O	O
%	O	O	O
;	O	O	O
vilazodone	O	O	B-T109
,	O	O	O
35.7	O	O	O
%	O	O	O
)	O	O	O
than	O	O	O
in	O	O	O
females	O	O	B-T098
(	O	O	O
placebo	O	O	O
,	O	O	O
24.9	O	O	O
%	O	O	O
;	O	O	O
vilazodone	O	O	O
,	O	O	O
34.9	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
no	O	O	B-T033
statistical	O	O	I-T033
testing	O	O	I-T033
was	O	O	O
performed	O	O	O
.	O	O	O

Except	O	O	O
for	O	O	O
erectile	O	O	B-T047
dysfunction	O	O	I-T047
and	O	O	O
delayed	O	O	B-T046
ejaculation	O	O	I-T046
in	O	O	O
vilazodone	O	O	B-T109
-	O	O	O
treated	O	O	B-T169
males	O	O	B-T098
(	O	O	O
2.4	O	O	O
%	O	O	O
and	O	O	O
2.1	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
,	O	O	O
no	O	O	B-T033
treatment-emergent	O	O	I-T033
adverse	O	O	I-T033
events	O	O	I-T033
related	O	O	O
to	O	O	O
sexual	O	O	B-T040
functioning	O	O	I-T040
occurred	O	O	B-T052
in	O	O	O
≥2	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
in	O	O	O
either	O	O	O
treatment	O	O	B-T169
group	O	O	B-T078
.	O	O	O

Approximately	O	O	B-T080
35%-50	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
vilazodone	O	O	B-T109
GAD	O	O	B-T048
studies	O	O	B-T062
had	O	O	O
SD	O	O	B-T047
at	O	O	O
baseline	O	O	B-T081
.	O	O	O

Vilazodone	O	O	B-T109
and	O	O	O
placebo	O	O	B-T122
had	O	O	O
similar	O	O	O
effects	O	O	B-T080
on	O	O	O
CSFQ	O	O	B-T170
outcomes	O	O	B-T062
in	O	O	O
both	O	O	O
females	O	O	B-T098
and	O	O	O
males	O	O	B-T098
,	O	O	O
indicating	O	O	O
a	O	O	O
limited	O	O	B-T169
adverse	O	O	B-T046
impact	O	O	I-T046
on	O	O	O
sexual	O	O	B-T040
functioning	O	O	I-T040
with	O	O	O
vilazodone	O	O	B-T109
.	O	O	O

-DOCSTART- (27385165)

Biogeochemical	O	O	B-T169
Controls	O	O	B-T080
of	O	O	O
Uranium	O	O	B-T196
Bioavailability	O	O	B-T081
from	O	O	O
the	O	O	O
Dissolved	O	O	B-T080
Phase	O	O	I-T080
in	O	O	O
Natural	O	O	B-T169
Freshwaters	O	O	O

To	O	O	O
gain	O	O	O
insights	O	O	O
into	O	O	O
the	O	O	O
risks	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
uranium	O	O	B-T196
(	O	O	O
U	O	O	B-T196
)	O	O	O
mining	O	O	B-T057
and	O	O	O
processing	O	O	B-T052
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
biogeochemical	O	O	B-T169
controls	O	O	B-T080
of	O	O	O
U	O	O	O
bioavailability	O	O	B-T081
in	O	O	O
the	O	O	O
model	O	O	O
freshwater	O	O	B-T167
species	O	O	B-T185
Lymnaea	O	O	B-T204
stagnalis	O	O	I-T204
(	O	O	O
Gastropoda	O	O	B-T204
)	O	O	O
.	O	O	O

Bioavailability	O	O	B-T081
of	O	O	O
dissolved	O	O	B-T196
U(VI	O	O	I-T196
)	O	O	I-T196
was	O	O	O
characterized	O	O	B-T052
in	O	O	O
controlled	O	O	B-T169
laboratory	O	O	B-T093
experiments	O	O	B-T062
over	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
water	O	O	B-T121
hardness	O	O	B-T080
,	O	O	O
pH	O	O	B-T081
,	O	O	O
and	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
complexing	O	O	B-T103
ligands	O	O	I-T103
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
dissolved	O	O	B-T167
natural	O	O	I-T167
organic	O	O	I-T167
matter	O	O	I-T167
(	O	O	O
DOM	O	O	B-T167
)	O	O	O
.	O	O	O

Results	O	O	B-T034
show	O	O	O
that	O	O	O
dissolved	O	O	B-T196
U	O	O	I-T196
is	O	O	O
bioavailable	O	O	B-T080
under	O	O	O
all	O	O	O
the	O	O	O
geochemical	O	O	B-T090
conditions	O	O	I-T090
tested	O	O	B-T169
.	O	O	O

Uranium	O	O	B-T196
uptake	O	O	B-T039
rates	O	O	B-T081
follow	O	O	O
first	O	O	B-UnknownType
order	O	O	I-UnknownType
kinetics	O	O	I-UnknownType
over	O	O	O
a	O	O	O
range	O	O	O
encompassing	O	O	O
most	O	O	O
environmental	O	O	B-T082
concentrations	O	O	B-T081
.	O	O	O

Uranium	O	O	B-T196
uptake	O	O	B-T039
rates	O	O	B-T081
in	O	O	O
L.	O	O	B-T204
stagnalis	O	O	I-T204
ultimately	O	O	O
demonstrate	O	O	O
saturation	O	O	B-T070
uptake	O	O	O
kinetics	O	O	B-T070
when	O	O	O
exposure	O	O	B-T080
concentrations	O	O	B-T081
exceed	O	O	O
100	O	O	O
nM	O	O	O
,	O	O	O
suggesting	O	O	B-T078
uptake	O	O	O
via	O	O	O
a	O	O	O
finite	O	O	O
number	O	O	O
of	O	O	O
carriers	O	O	O
or	O	O	O
ion	O	O	B-T116
channels	O	O	I-T116
.	O	O	O

The	O	O	O
lack	O	O	O
of	O	O	O
a	O	O	O
relationship	O	O	O
between	O	O	O
U	O	O	B-T196
uptake	O	O	B-T039
rate	O	O	O
constants	O	O	B-T081
and	O	O	O
Ca	O	O	B-T121
uptake	O	O	O
rates	O	O	B-T081
suggest	O	O	B-T078
that	O	O	O
U	O	O	O
does	O	O	O
not	O	O	O
exclusively	O	O	O
use	O	O	O
Ca	O	O	O
membrane	O	O	B-T116
transporters	O	O	I-T116
.	O	O	O

In	O	O	O
general	O	O	O
,	O	O	O
U	O	O	B-T196
bioavailability	O	O	B-T081
decreases	O	O	B-T033
with	O	O	O
increasing	O	O	B-T169
pH	O	O	B-T081
,	O	O	O
increasing	O	O	O
Ca	O	O	B-T121
and	O	O	O
Mg	O	O	B-T123
concentrations	O	O	B-T081
,	O	O	O
and	O	O	O
when	O	O	O
DOM	O	O	B-T167
is	O	O	O
present	O	O	B-T033
.	O	O	O

Competing	O	O	O
ions	O	O	B-T196
did	O	O	O
not	O	O	O
affect	O	O	O
U	O	O	B-T196
uptake	O	O	B-T039
rates	O	O	B-T081
.	O	O	O

Speciation	O	O	B-T062
modeling	O	O	I-T062
that	O	O	O
includes	O	O	O
formation	O	O	B-T169
constants	O	O	B-T081
for	O	O	O
U	O	O	B-T196
ternary	O	O	B-T104
complexes	O	O	I-T104
reveals	O	O	B-T080
that	O	O	O
the	O	O	O
aqueous	O	O	B-T080
concentration	O	O	B-T081
of	O	O	O
dicarbonato	O	O	B-T196
U	O	O	I-T196
species	O	O	B-T185
(	O	O	O
UO2(CO3)2(-2	O	O	O
)	O	O	O
)	O	O	O
best	O	O	O
predicts	O	O	O
U	O	O	O
bioavailability	O	O	B-T081
to	O	O	O
L.	O	O	B-T204
stagnalis	O	O	I-T204
,	O	O	O
challenging	O	O	O
the	O	O	O
free-ion	O	O	B-T052
activity	O	O	I-T052
model	O	O	O
postulate	O	O	O
.	O	O	O

-DOCSTART- (27386263)

Interleukin-21	O	O	B-T116
plays	O	O	O
a	O	O	O
critical	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
and	O	O	O
severity	O	O	O
of	O	O	O
type	O	O	O
I	O	O	O
autoimmune	O	O	O
hepatitis	O	O	O

Recently	O	O	O
,	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
follicular	O	O	B-T023
helper	O	O	B-T025
T	O	O	I-T025
(	O	O	I-T025
Tfh	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
expressing	O	O	O
interleukin	O	O	B-T116
(IL)-21	O	O	I-T116
was	O	O	O
found	O	O	O
to	O	O	O
increase	O	O	O
in	O	O	O
peripheral	O	O	B-T031
blood	O	O	I-T031
of	O	O	O
human	O	O	B-T016
and	O	O	O
murine	O	O	B-T015
models	O	O	B-T050
of	O	O	O
autoimmune	O	O	B-T047
hepatitis	O	O	I-T047
(	O	O	O
AIH	O	O	B-T047
)	O	O	O
.	O	O	O

IL-21	O	O	B-T116
,	O	O	O
the	O	O	O
most	O	O	O
recently	O	O	O
discovered	O	O	O
member	O	O	O
of	O	O	O
the	O	O	O
type-I	O	O	B-T116
cytokine	O	O	I-T116
family	O	O	I-T116
,	O	O	O
exerts	O	O	O
various	O	O	O
effects	O	O	O
on	O	O	O
the	O	O	O
immune	O	O	B-T022
system	O	O	I-T022
,	O	O	O
including	O	O	O
B	O	O	B-T043
cell	O	O	I-T043
activation	O	O	I-T043
,	O	O	O
plasma	O	O	B-T043
cell	O	O	I-T043
differentiation	O	O	I-T043
,	O	O	O
and	O	O	O
immunoglobulin	O	O	B-T038
production	O	O	I-T038
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
relationship	O	O	O
of	O	O	O
serum	O	O	B-T031
IL-21	O	O	B-T116
levels	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
type	O	O	B-T047
I	O	O	I-T047
AIH	O	O	I-T047
with	O	O	O
clinical	O	O	B-T080
and	O	O	O
laboratory	O	O	B-T093
parameters	O	O	B-T077
and	O	O	O
histology	O	O	B-T091
.	O	O	O

Ninety-two	O	O	O
Japanese	O	O	B-T098
patients	O	O	B-T101
with	O	O	O
liver	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
22	O	O	O
AIH	O	O	B-T047
,	O	O	O
20	O	O	O
primary	O	O	B-T047
biliary	O	O	I-T047
cholangitis	O	O	I-T047
,	O	O	O
19	O	O	O
drug-induced	O	O	B-T047
liver	O	O	I-T047
injury	O	O	I-T047
,	O	O	O
8	O	O	O
acute	O	O	B-T047
hepatitis	O	O	I-T047
B	O	O	I-T047
,	O	O	O
8	O	O	O
chronic	O	O	B-T047
hepatitis	O	O	I-T047
C	O	O	I-T047
,	O	O	O
10	O	O	O
non-alcoholic	O	O	B-T047
steatohepatitis	O	O	I-T047
,	O	O	O
5	O	O	O
viral	O	O	B-T047
hepatitis	O	O	I-T047
)	O	O	O
and	O	O	O
10	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
were	O	O	O
recruited	O	O	O
.	O	O	O

Serum	O	O	B-T031
IL-21	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
detected	O	O	O
by	O	O	O
enzyme-linked	O	O	B-T059
immunosorbent	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

Real-time	O	O	B-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
measured	O	O	O
mRNA	O	O	B-T114
levels	O	O	B-T080
of	O	O	O
Bcl-6	O	O	B-T028
,	O	O	O
IL-21	O	O	B-T028
,	O	O	O
and	O	O	O
CXCR5	O	O	B-T028
(	O	O	O
Tfh-related	O	O	B-T116
factors	O	O	I-T116
)	O	O	O
in	O	O	O
peripheral	O	O	B-T082
mononuclear	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Mean	O	O	O
age	O	O	O
at	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
AIH	O	O	B-T047
was	O	O	O
58.6	O	O	O
years	O	O	O
,	O	O	O
male-to-female	O	O	B-T033
ratio	O	O	I-T033
was	O	O	O
4:18	O	O	O
,	O	O	O
18.2	O	O	O
%	O	O	O
of	O	O	O
participants	O	O	O
had	O	O	O
cirrhosis	O	O	B-T047
,	O	O	O
and	O	O	O
22.7	O	O	O
%	O	O	O
had	O	O	O
severe	O	O	B-T080
disease	O	O	B-T047
.	O	O	O

IL-21	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
significantly	O	O	O
increased	O	O	B-T081
in	O	O	O
the	O	O	O
serum	O	O	B-T031
of	O	O	O
patients	O	O	B-T101
with	O	O	O
AIH	O	O	B-T047
compared	O	O	O
to	O	O	O
those	O	O	O
with	O	O	O
other	O	O	B-UnknownType
liver	O	O	I-UnknownType
diseases	O	O	I-UnknownType
and	O	O	O
controls	O	O	B-T096
(	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
.	O	O	O

Particularly	O	O	O
,	O	O	O
serum	O	O	B-T031
IL-21	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
significantly	O	O	O
increased	O	O	B-T081
in	O	O	O
severe	O	O	B-T080
AIH	O	O	B-T047
cases	O	O	O
compared	O	O	O
to	O	O	O
non-severe	O	O	O
cases	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Serum	O	O	B-T031
IL-21	O	O	B-T116
levels	O	O	B-T080
correlated	O	O	O
positively	O	O	O
with	O	O	O
total	O	O	O
serum	O	O	B-T031
bilirubin	O	O	B-T059
levels	O	O	I-T059
(	O	O	O
r	O	O	O
=	O	O	O
0.46	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
,	O	O	O
grading	O	O	B-T033
of	O	O	I-T033
necroinflammatory	O	O	I-T033
activity	O	O	I-T033
(	O	O	O
r	O	O	O
=	O	O	O
0.68	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.005	O	O	O
)	O	O	O
and	O	O	O
negatively	O	O	O
with	O	O	O
serum	O	O	B-T034
albumin	O	O	I-T034
levels	O	O	I-T034
in	O	O	O
patients	O	O	B-T101
with	O	O	O
AIH	O	O	B-T047
(	O	O	O
r	O	O	O
=	O	O	O
-0.49	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
biochemical	O	O	B-T169
remission	O	O	B-T033
of	O	O	O
AIH	O	O	B-T047
,	O	O	O
serum	O	O	B-T031
IL-21	O	O	B-T116
levels	O	O	B-T080
remained	O	O	O
elevated	O	O	B-T080
and	O	O	O
correlated	O	O	B-T080
positively	O	O	B-T033
with	O	O	O
serum	O	O	B-T059
IgG	O	O	I-T059
levels	O	O	I-T059
(	O	O	O
r	O	O	O
=	O	O	O
0.84	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Expression	O	O	B-T045
of	O	O	O
Tfh-related	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
such	O	O	O
as	O	O	O
Bcl-6	O	O	B-T116
and	O	O	O
IL-21	O	O	B-T116
,	O	O	O
in	O	O	O
peripheral	O	O	B-T025
blood	O	O	I-T025
mononuclear	O	O	I-T025
cells	O	O	I-T025
of	O	O	O
patients	O	O	B-T101
with	O	O	O
AIH	O	O	B-T047
was	O	O	O
significantly	O	O	O
higher	O	O	B-T080
than	O	O	O
that	O	O	O
in	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
.	O	O	O

IL-21	O	O	B-T116
may	O	O	O
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
and	O	O	O
severity	O	O	O
of	O	O	O
AIH	O	O	B-T047
,	O	O	O
and	O	O	O
may	O	O	O
present	O	O	O
a	O	O	O
promising	O	O	O
target	O	O	O
for	O	O	O
AIH	O	O	O
therapy	O	O	B-T169
.	O	O	O

-DOCSTART- (27388962)

Resistance	O	O	B-T169
Exercise	O	O	B-T056
in	O	O	O
Pregnancy	O	O	B-T040
and	O	O	O
Outcome	O	O	O

As	O	O	O
the	O	O	O
health	O	O	B-T081
benefits	O	O	I-T081
of	O	O	O
exercise	O	O	B-T056
are	O	O	O
increasingly	O	O	O
recognized	O	O	O
,	O	O	O
the	O	O	O
traditional	O	O	B-T058
advice	O	O	I-T058
to	O	O	O
rest	O	O	B-T056
during	O	O	O
pregnancy	O	O	B-T040
has	O	O	O
changed	O	O	B-T169
toward	O	O	O
a	O	O	O
more	O	O	O
healthy	O	O	B-T080
and	O	O	O
active	O	O	B-T169
pregnancy	O	O	O
,	O	O	O
therefore	O	O	O
different	O	O	O
forms	O	O	O
of	O	O	O
exercise	O	O	O
have	O	O	O
been	O	O	O
integrated	O	O	O
into	O	O	O
the	O	O	O
life	O	O	B-T078
of	O	O	O
the	O	O	O
pregnant	O	O	B-T098
woman	O	O	I-T098
.	O	O	O

Although	O	O	O
the	O	O	O
benefits	O	O	B-T081
of	O	O	O
using	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
resistance	O	O	B-T169
and	O	O	O
aerobic	O	O	B-T061
exercises	O	O	I-T061
are	O	O	O
not	O	O	O
yet	O	O	O
determined	O	O	O
,	O	O	O
studies	O	O	B-T062
about	O	O	O
resistance	O	O	O
and	O	O	O
strengthen	O	O	O
training	O	O	B-T065
programs	O	O	I-T065
are	O	O	O
few	O	O	O
although	O	O	O
no	O	O	B-T184
adverse	O	O	I-T184
outcomes	O	O	B-T033
were	O	O	O
reported	O	O	O
.	O	O	O

-DOCSTART- (27390504)

Custom	O	O	O
ocular	O	O	B-T074
prosthesis	O	O	I-T074
in	O	O	O
rehabilitation	O	O	B-T061
of	O	O	O
a	O	O	O
child	O	O	B-T100
operated	O	O	O
for	O	O	O
retinoblastoma	O	O	O

A	O	O	O
maxillofacial	O	O	B-T061
prosthodontist	O	O	I-T061
forms	O	O	O
an	O	O	O
important	O	O	B-T080
link	O	O	O
in	O	O	O
the	O	O	O
interdisciplinary	O	O	O
management	O	O	B-T058
of	O	O	I-T058
a	O	O	I-T058
patient	O	O	I-T058
with	O	O	O
anopthalmosis	O	O	B-T019
.	O	O	O

Prosthetic	O	O	B-T061
management	O	O	I-T061
of	O	O	O
an	O	O	O
anopthalmic	O	O	B-T019
defect	O	O	I-T019
aims	O	O	O
to	O	O	O
deliver	O	O	O
a	O	O	O
well-fitting	O	O	O
ocular	O	O	B-T074
prosthesis	O	O	I-T074
that	O	O	O
can	O	O	O
mimic	O	O	O
the	O	O	O
original	O	O	O
eye	O	O	B-T023
as	O	O	O
closely	O	O	O
as	O	O	O
possible	O	O	O
,	O	O	O
and	O	O	O
thus	O	O	O
restoring	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
self-confidence	O	O	B-T041
and	O	O	O
thereby	O	O	O
rehabilitating	O	O	B-T169
them	O	O	O
in	O	O	O
the	O	O	O
society	O	O	B-T092
.	O	O	O

The	O	O	O
fabrication	O	O	B-T061
of	O	O	O
a	O	O	O
custom	O	O	O
ocular	O	O	B-T074
prosthesis	O	O	I-T074
is	O	O	O
a	O	O	O
demanding	O	O	O
art	O	O	O
.	O	O	O

This	O	O	O
case	O	O	B-T170
report	O	O	I-T170
presents	O	O	O
a	O	O	O
simplified	O	O	O
technique	O	O	B-T169
for	O	O	O
the	O	O	O
fabrication	O	O	B-T061
of	O	O	O
a	O	O	O
custom	O	O	O
ocular	O	O	B-T074
prosthesis	O	O	I-T074
for	O	O	O
a	O	O	O
child	O	O	B-T100
who	O	O	O
had	O	O	O
lost	O	O	B-T169
his	O	O	O
eye	O	O	B-T023
to	O	O	O
enucleation	O	O	B-T061
following	O	O	O
retinoblastoma	O	O	B-T191
.	O	O	O

Early	O	O	O
and	O	O	O
effective	O	O	O
rehabilitation	O	O	B-T061
of	O	O	O
the	O	O	O
defect	O	O	O
goes	O	O	O
a	O	O	O
long	O	O	O
way	O	O	O
in	O	O	O
restoring	O	O	O
the	O	O	O
self-image	O	O	B-T058
of	O	O	O
a	O	O	O
child	O	O	B-T100
in	O	O	O
its	O	O	O
early	O	O	O
character	O	O	O
building	O	O	O
age	O	O	O
.	O	O	O

-DOCSTART- (27390849)

Pulmonary	O	O	B-T042
function	O	O	I-T042
and	O	O	O
health-related	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
1-	O	O	O
year	O	O	B-T079
follow	O	O	B-T058
up	O	O	I-T058
after	O	O	O
cardiac	O	O	O
surgery	O	O	O

Pulmonary	O	O	B-T042
function	O	O	I-T042
is	O	O	O
severely	O	O	B-T080
reduced	O	O	B-T080
in	O	O	O
the	O	O	O
early	O	O	B-T079
period	O	O	B-T079
after	O	O	O
cardiac	O	O	B-T061
surgery	O	O	I-T061
,	O	O	O
and	O	O	O
impairments	O	O	B-T046
have	O	O	O
been	O	O	O
described	O	O	O
up	O	O	O
to	O	O	O
4	O	O	O
-	O	O	O
6	O	O	O
months	O	O	B-T079
after	O	O	B-T079
surgery	O	O	I-T079
.	O	O	O

Evaluation	O	O	B-T058
of	O	O	O
pulmonary	O	O	B-T042
function	O	O	I-T042
in	O	O	O
a	O	O	O
longer	O	O	O
perspective	O	O	O
is	O	O	O
lacking	O	O	B-T080
.	O	O	O

In	O	O	O
this	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
pulmonary	O	O	B-T042
function	O	O	I-T042
and	O	O	O
health-related	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
were	O	O	O
investigated	O	O	B-T169
1	O	O	O
year	O	O	B-T079
after	O	O	O
cardiac	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

Pulmonary	O	O	B-T042
function	O	O	I-T042
measurements	O	O	B-T169
,	O	O	O
health-related	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
(	O	O	O
SF-36	O	O	B-T170
)	O	O	O
,	O	O	O
dyspnoea	O	O	B-T184
,	O	O	O
subjective	O	O	B-T080
breathing	O	O	B-T039
and	O	O	O
coughing	O	O	B-T184
ability	O	O	B-T032
and	O	O	O
pain	O	O	B-T184
were	O	O	O
evaluated	O	O	B-T058
before	O	O	B-T079
and	O	O	O
1	O	O	O
year	O	O	B-T079
after	O	O	B-T079
surgery	O	O	B-T061
in	O	O	O
150	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
coronary	O	O	B-T061
artery	O	O	I-T061
bypass	O	O	I-T061
grafting	O	O	I-T061
,	O	O	O
valve	O	O	B-T061
surgery	O	O	I-T061
or	O	O	O
combined	O	O	O
surgery	O	O	O
.	O	O	O

One	O	O	O
year	O	O	B-T079
after	O	O	B-T079
surgery	O	O	I-T079
the	O	O	O
forced	O	O	B-T201
vital	O	O	I-T201
capacity	O	O	I-T201
and	O	O	O
forced	O	O	B-T042
expiratory	O	O	I-T042
volume	O	O	I-T042
in	O	O	O
1	O	O	O
s	O	O	O
were	O	O	O
significantly	O	O	O
decreased	O	O	B-T081
(	O	O	O
by	O	O	O
4	O	O	O
-	O	O	O
5	O	O	O
%	O	O	O
)	O	O	O
compared	O	O	B-T052
to	O	O	O
preoperative	O	O	B-T079
values	O	O	B-T081
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Saturation	O	O	B-T042
of	O	O	I-T042
peripheral	O	O	I-T042
oxygen	O	O	I-T042
was	O	O	O
unchanged	O	O	B-T033
1	O	O	O
year	O	O	B-T079
postoperatively	O	O	B-T079
compared	O	O	B-T052
to	O	O	O
baseline	O	O	B-T081
.	O	O	O

A	O	O	O
significantly	O	O	O
improved	O	O	B-T033
health-related	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
was	O	O	O
found	O	O	O
1	O	O	O
year	O	O	B-T079
after	O	O	B-T079
surgery	O	O	I-T079
,	O	O	O
with	O	O	O
improvements	O	O	B-T077
in	O	O	O
all	O	O	O
eight	O	O	O
aspects	O	O	B-T080
of	O	O	O
SF-36	O	O	B-T170
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Sternotomy	O	O	B-T061
-related	O	O	O
pain	O	O	B-T184
was	O	O	O
low	O	O	B-T080
1	O	O	O
year	O	O	B-T079
postoperatively	O	O	B-T079
at	O	O	B-T169
rest	O	O	I-T169
(	O	O	O
median	O	O	O
0	O	O	O
[	O	O	O
min-max	O	O	O
;	O	O	O
0	O	O	O
-	O	O	O
7	O	O	O
]	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
taking	O	O	O
a	O	O	O
deep	O	O	B-T184
breath	O	O	I-T184
(	O	O	O
0	O	O	O
[	O	O	O
0	O	O	O
-	O	O	O
4	O	O	O
]	O	O	O
)	O	O	O
and	O	O	O
while	O	O	O
coughing	O	O	B-T184
(	O	O	O
0	O	O	O
[	O	O	O
0	O	O	O
-	O	O	O
8	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
more	O	O	O
pronounced	O	O	O
decrease	O	O	O
in	O	O	O
pulmonary	O	O	B-T042
function	O	O	I-T042
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
dyspnoea	O	O	B-T184
limitations	O	O	B-T169
and	O	O	O
impaired	O	O	B-T046
subjective	O	O	B-T080
breathing	O	O	B-T039
and	O	O	O
coughing	O	O	B-T184
ability	O	O	B-T032
.	O	O	O

One	O	O	O
year	O	O	B-T079
after	O	O	O
cardiac	O	O	B-T061
surgery	O	O	I-T061
static	O	O	B-T080
and	O	O	O
dynamic	O	O	B-T169
lung	O	O	B-T060
function	O	O	I-T060
measurements	O	O	I-T060
were	O	O	O
slightly	O	O	O
decreased	O	O	B-T081
,	O	O	O
while	O	O	O
health-related	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
was	O	O	O
improved	O	O	B-T033
in	O	O	O
comparison	O	O	B-T052
to	O	O	O
preoperative	O	O	B-T079
values	O	O	B-T081
.	O	O	O

Measured	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
pain	O	O	B-T184
were	O	O	O
low	O	O	B-T080
and	O	O	O
saturation	O	O	B-T042
of	O	O	I-T042
peripheral	O	O	I-T042
oxygen	O	O	I-T042
was	O	O	O
same	O	O	B-T080
as	O	O	O
preoperatively	O	O	B-T079
.	O	O	O

-DOCSTART- (27391592)

Impact	O	O	B-T080
of	O	O	O
Soil	O	O	B-T167
Salinity	O	O	B-T081
on	O	O	O
the	O	O	O
Structure	O	O	B-T082
of	O	O	O
the	O	O	O
Bacterial	O	O	B-T007
Endophytic	O	O	B-T004
Community	O	O	B-T096
Identified	O	O	B-T080
from	O	O	O
the	O	O	O
Roots	O	O	B-T002
of	O	O	O
Caliph	O	O	B-T002
Medic	O	O	I-T002
(	O	O	O
Medicago	O	O	B-T002
truncatula	O	O	I-T002
)	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
being	O	O	O
a	O	O	O
forage	O	O	B-T002
crop	O	O	I-T002
,	O	O	O
Caliph	O	O	B-T002
medic	O	O	I-T002
(	O	O	O
Medicago	O	O	B-T002
truncatula	O	O	I-T002
)	O	O	O
is	O	O	O
also	O	O	O
a	O	O	O
model	O	O	B-T062
legume	O	O	I-T062
plant	O	O	I-T062
and	O	O	O
is	O	O	O
used	O	O	O
for	O	O	O
research	O	O	O
focusing	O	O	O
on	O	O	O
the	O	O	O
molecular	O	O	B-T052
characterization	O	O	I-T052
of	O	O	O
the	O	O	O
interaction	O	O	B-T169
between	O	O	O
rhizobia	O	O	B-T007
and	O	O	O
plants	O	O	B-T002
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
endophytic	O	O	B-T001
microbiome	O	O	I-T001
in	O	O	O
this	O	O	O
plant	O	O	B-T002
is	O	O	O
poorly	O	O	O
defined	O	O	O
.	O	O	O

Endophytic	O	O	B-T004
bacteria	O	O	B-T007
play	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
supplying	O	O	O
plants	O	O	B-T002
with	O	O	O
the	O	O	O
basic	O	O	O
requirements	O	O	B-T169
necessary	O	O	O
for	O	O	O
growth	O	O	B-T040
and	O	O	O
development	O	O	B-T040
.	O	O	O

Moreover	O	O	O
,	O	O	O
these	O	O	O
bacteria	O	O	B-T007
also	O	O	O
play	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
mechanism	O	O	B-T169
of	O	O	O
salinity	O	O	B-T070
stress	O	O	I-T070
adaptation	O	O	B-T038
in	O	O	O
plants	O	O	B-T002
.	O	O	O

As	O	O	O
a	O	O	O
prelude	O	O	O
to	O	O	O
the	O	O	O
isolation	O	O	B-T059
and	O	O	O
utilization	O	O	B-T169
of	O	O	O
these	O	O	O
bacteria	O	O	B-T007
in	O	O	O
Caliph	O	O	B-T002
medic	O	O	I-T002
farming	O	O	B-T082
,	O	O	O
41	O	O	O
bacterial	O	O	B-T007
OTUs	O	O	B-T185
were	O	O	O
identified	O	O	B-T080
in	O	O	O
this	O	O	O
project	O	O	O
from	O	O	O
within	O	O	O
the	O	O	O
interior	O	O	B-T082
of	O	O	O
the	O	O	O
roots	O	O	B-T002
of	O	O	O
this	O	O	O
plant	O	O	B-T002
by	O	O	O
pyrosequencing	O	O	B-T059
of	O	O	O
the	O	O	O
small	O	O	B-T028
ribosomal	O	O	I-T028
subunit	O	O	I-T028
gene	O	O	I-T028
(	O	O	O
16S	O	O	B-T028
rDNA	O	O	I-T028
)	O	O	O
using	O	O	O
a	O	O	O
cultivation-independent	O	O	B-T059
approach	O	O	I-T059
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
differential	O	O	B-T080
abundance	O	O	B-T080
of	O	O	O
these	O	O	O
bacteria	O	O	B-T007
was	O	O	O
studied	O	O	O
following	O	O	O
exposure	O	O	O
of	O	O	O
the	O	O	O
plants	O	O	B-T002
to	O	O	O
salinity	O	O	B-T070
stress	O	O	I-T070
.	O	O	O

About	O	O	O
29,064	O	O	O
high-quality	O	O	B-T081
reads	O	O	I-T081
were	O	O	O
obtained	O	O	O
from	O	O	O
the	O	O	O
sequencing	O	O	B-T059
of	O	O	O
six	O	O	O
libraries	O	O	B-T114
prepared	O	O	O
from	O	O	O
control	O	O	B-T024
and	O	O	O
salinity-treated	O	O	B-T024
tissues	O	O	I-T024
.	O	O	O

Statistical	O	O	B-T062
analysis	O	O	I-T062
revealed	O	O	O
that	O	O	O
the	O	O	O
abundance	O	O	B-T080
of	O	O	O
~70	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
OTUs	O	O	B-T185
was	O	O	O
significantly	O	O	O
(	O	O	O
p	O	O	O
≤	O	O	O
0.05	O	O	O
)	O	O	O
altered	O	O	O
in	O	O	O
roots	O	O	B-T002
that	O	O	O
were	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
salinity	O	O	B-T070
stress	O	O	I-T070
.	O	O	O

Sequence	O	O	B-T059
analysis	O	O	I-T059
showed	O	O	O
a	O	O	O
similarity	O	O	O
between	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
identified	O	O	B-T080
species	O	O	B-T185
and	O	O	O
other	O	O	O
,	O	O	O
known	O	O	O
,	O	O	O
growth-promoting	O	O	B-T007
bacteria	O	O	I-T007
,	O	O	O
marine	O	O	B-T001
and	O	O	O
salt-stressed	O	O	B-T007
soil-borne	O	O	I-T007
bacteria	O	O	I-T007
,	O	O	O
and	O	O	O
nitrogen-fixing	O	O	B-T007
bacterial	O	O	I-T007
isolates	O	O	B-T123
.	O	O	O

Determination	O	O	O
of	O	O	O
the	O	O	O
amendments	O	O	O
to	O	O	O
the	O	O	O
bacteria	O	O	B-T007
l	O	O	O
community	O	O	B-T096
due	O	O	O
to	O	O	O
salinity	O	O	B-T070
stress	O	O	I-T070
in	O	O	O
Caliph	O	O	B-T002
medic	O	O	I-T002
provides	O	O	O
a	O	O	O
crucial	O	O	O
step	O	O	O
toward	O	O	O
developing	O	O	O
an	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
association	O	O	B-T080
of	O	O	O
these	O	O	O
endophytes	O	O	B-T004
,	O	O	O
under	O	O	O
salt	O	O	B-T070
stress	O	O	I-T070
conditions	O	O	I-T070
,	O	O	O
in	O	O	O
this	O	O	O
model	O	O	B-T062
plant	O	O	I-T062
.	O	O	O

To	O	O	O
provide	O	O	O
direct	O	O	O
evidence	O	O	B-T078
regarding	O	O	O
their	O	O	O
growth	O	O	B-T052
promoting	O	O	I-T052
activity	O	O	I-T052
,	O	O	O
a	O	O	O
group	O	O	B-T078
of	O	O	O
endophytic	O	O	B-T004
bacteria	O	O	B-T007
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
inside	O	O	O
of	O	O	O
plant	O	O	B-T002
roots	O	O	I-T002
using	O	O	O
a	O	O	O
cultivation-dependent	O	O	B-T059
approach	O	O	I-T059
.	O	O	O

Several	O	O	O
of	O	O	O
these	O	O	O
isolates	O	O	B-T123
were	O	O	O
able	O	O	O
to	O	O	O
produce	O	O	O
ACC-deaminase	O	O	B-T116
,	O	O	O
ammonia	O	O	B-T121
and	O	O	O
IAA	O	O	B-T125
;	O	O	O
and	O	O	O
to	O	O	O
solubilize	O	O	B-T169
Zn+2	O	O	B-T121
and	O	O	O
PO4	O	O	B-T121
-	O	O	I-T121
3	O	O	I-T121
.	O	O	O

This	O	O	O
data	O	O	B-T078
is	O	O	O
consistent	O	O	O
with	O	O	O
the	O	O	O
predicted	O	O	O
occurrence	O	O	B-T079
(	O	O	O
based	O	O	O
on	O	O	O
cultivation-independent	O	O	B-T059
techniques	O	O	I-T059
)	O	O	O
of	O	O	O
these	O	O	O
bacteria	O	O	B-T007
and	O	O	O
provides	O	O	O
some	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
the	O	O	O
endophytic	O	O	B-T004
bacteria	O	O	O
in	O	O	O
Caliph	O	O	B-T002
medic	O	O	I-T002
when	O	O	O
grown	O	O	O
under	O	O	O
normal	O	O	B-T080
and	O	O	O
saline	O	O	B-T167
conditions	O	O	B-T080
.	O	O	O

-DOCSTART- (27392220)

Eliminating	O	O	O
Cancer	O	O	B-T025
Stem	O	O	I-T025
Cells	O	O	I-T025
in	O	O	O
CML	O	O	B-T191
with	O	O	O
Combination	O	O	O
Transcriptional	O	O	B-T045
Therapy	O	O	O

Leukemia	O	O	B-T191
stem	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
LSCs	O	O	B-T025
)	O	O	O
are	O	O	O
resistant	O	O	O
to	O	O	O
current	O	O	O
therapies	O	O	B-T061
used	O	O	O
to	O	O	O
treat	O	O	O
chronic	O	O	B-T191
myeloid	O	O	I-T191
leukemia	O	O	I-T191
(	O	O	O
CML	O	O	B-T191
)	O	O	O
.	O	O	O

Abraham	O	O	O
et	O	O	O
al.	O	O	O
(	O	O	O
2016	O	O	O
)	O	O	O
have	O	O	O
identified	O	O	O
a	O	O	O
molecular	O	O	B-T044
network	O	O	I-T044
critical	O	O	B-T169
for	O	O	O
CML	O	O	B-T191
LSC	O	O	B-T025
survival	O	O	B-T043
and	O	O	O
propose	O	O	O
that	O	O	O
simultaneously	O	O	O
targeting	O	O	O
two	O	O	O
of	O	O	O
their	O	O	O
major	O	O	O
transcriptional	O	O	B-T116
regulators	O	O	I-T116
,	O	O	O
p53	O	O	B-T028
and	O	O	O
c-Myc	O	O	B-T116
,	O	O	O
may	O	O	O
facilitate	O	O	O
their	O	O	O
eradication	O	O	B-T045
.	O	O	O

-DOCSTART- (27393222)

Crocetin	O	O	B-T109
improves	O	O	B-T033
the	O	O	O
quality	O	O	B-T080
of	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
-	O	O	O
produced	O	O	B-T169
bovine	O	O	B-T015
embryos	O	O	B-T018
:	O	O	O
Implications	O	O	O
for	O	O	O
blastocyst	O	O	B-T039
development	O	O	I-T039
,	O	O	O
cryotolerance	O	O	B-T080
,	O	O	O
and	O	O	O
apoptosis	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
work	O	O	O
was	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
effect	O	O	B-T080
of	O	O	O
supplementation	O	O	B-T061
of	O	O	O
bovine	O	O	B-T015
culture	O	O	B-T130
medium	O	O	I-T130
with	O	O	O
the	O	O	O
natural	O	O	B-T121
antioxidant	O	O	I-T121
crocetin	O	O	B-T109
on	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
blastocyst	O	O	B-T039
development	O	O	I-T039
and	O	O	O
quality	O	O	B-T080
.	O	O	O

This	O	O	O
was	O	O	O
evaluated	O	O	B-T058
as	O	O	O
cryotolerance	O	O	B-T080
,	O	O	O
apoptosis	O	O	B-T170
index	O	O	I-T170
,	O	O	O
and	O	O	O
total	O	O	B-T059
cells	O	O	I-T059
number	O	O	I-T059
and	O	O	O
allocation	O	O	B-T052
.	O	O	O

Abattoir	O	O	B-T073
-derived	O	O	O
oocytes	O	O	B-T025
were	O	O	O
matured	O	O	B-T079
and	O	O	O
fertilized	O	O	B-T169
in	O	O	B-T080
vitro	O	O	I-T080
according	O	O	O
to	O	O	O
standard	O	O	B-T077
procedure	O	O	I-T077
.	O	O	O

Twenty	O	O	O
hours	O	O	B-T079
after	O	O	O
IVF	O	O	B-T061
,	O	O	O
presumptive	O	O	B-T080
zygotes	O	O	B-T018
were	O	O	O
cultured	O	O	B-T059
in	O	O	O
synthetic	O	O	B-T023
oviduct	O	O	I-T023
fluid	O	O	B-T167
medium	O	O	I-T167
,	O	O	O
supplemented	O	O	O
with	O	O	O
0	O	O	O
,	O	O	O
1	O	O	O
,	O	O	O
2.5	O	O	O
,	O	O	O
and	O	O	O
5	O	O	O
μM	O	O	O
crocetin	O	O	B-T109
(	O	O	O
experiment	O	O	O
1	O	O	O
)	O	O	O
at	O	O	O
39	O	O	O
°	O	O	O
C	O	O	O
under	O	O	O
humidified	O	O	B-T061
air	O	O	I-T061
with	O	O	O
5	O	O	O
%	O	O	O
CO2	O	O	B-T123
,	O	O	O
7	O	O	O
%	O	O	O
O2	O	O	B-T121
,	O	O	O
and	O	O	O
88	O	O	O
%	O	O	O
N2	O	O	B-T123
.	O	O	O

On	O	O	O
Day	O	O	B-T079
7	O	O	O
,	O	O	O
embryo	O	O	B-T081
yields	O	O	I-T081
were	O	O	O
assessed	O	O	B-T052
and	O	O	O
the	O	O	O
blastocysts	O	O	B-T018
were	O	O	O
vitrified	O	O	O
by	O	O	O
Cryotop	O	O	B-T170
method	O	O	I-T170
in	O	O	O
16.5	O	O	O
%	O	O	O
ethylene	O	O	B-T109
glycol	O	O	I-T109
,	O	O	O
16.5	O	O	O
%	O	O	O
DMSO	O	O	B-T109
,	O	O	O
and	O	O	O
0.5	O	O	O
M	O	O	O
sucrose	O	O	B-T109
.	O	O	O

Finally	O	O	O
,	O	O	O
blastocysts	O	O	B-T018
produced	O	O	O
on	O	O	O
Day	O	O	B-T079
8	O	O	O
in	O	O	O
the	O	O	O
absence	O	O	B-T169
(	O	O	O
control	O	O	B-T096
)	O	O	O
and	O	O	O
presence	O	O	B-T033
of	O	O	O
1	O	O	O
μM	O	O	O
crocetin	O	O	B-T109
were	O	O	O
used	O	O	O
for	O	O	O
terminal	O	O	B-T063
deoxynucleotidyl	O	O	I-T063
transferase-mediated	O	O	I-T063
dUTP	O	O	I-T063
nick	O	O	I-T063
end	O	O	I-T063
labelling	O	O	I-T063
and	O	O	O
differential	O	O	B-T059
staining	O	O	I-T059
to	O	O	O
evaluate	O	O	B-T058
,	O	O	O
respectively	O	O	O
,	O	O	O
the	O	O	O
apoptotic	O	O	B-T081
rate	O	O	I-T081
and	O	O	O
the	O	O	O
allocation	O	O	B-T052
of	O	O	O
cells	O	O	B-T025
into	O	O	O
inner	O	O	B-T018
cell	O	O	I-T018
mass	O	O	I-T018
(	O	O	O
ICM	O	O	B-T018
)	O	O	O
and	O	O	O
trophectoderm	O	O	B-T018
(	O	O	O
TE	O	O	B-T018
)	O	O	O
lineages	O	O	B-T077
(	O	O	O
experiment	O	O	O
2	O	O	O
)	O	O	O
.	O	O	O

Embryo	O	O	B-T042
development	O	O	I-T042
was	O	O	O
higher	O	O	O
in	O	O	O
the	O	O	O
1	O	O	O
μM	O	O	O
crocetin	O	O	B-T078
group	O	O	I-T078
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
,	O	O	O
both	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
total	O	O	B-T080
embryo	O	O	B-T018
output	O	O	B-T033
(	O	O	O
37.7	O	O	O
±	O	O	O
4.2	O	O	O
%	O	O	O
,	O	O	O
52.9	O	O	O
±	O	O	O
6.3	O	O	O
%	O	O	O
,	O	O	O
40.9	O	O	O
±	O	O	O
7.6	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
42.4	O	O	O
±	O	O	O
8.7	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
with	O	O	O
0	O	O	O
,	O	O	O
1	O	O	O
,	O	O	O
2.5	O	O	O
,	O	O	O
and	O	O	O
5	O	O	O
μM	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
and	O	O	O
grade	O	O	B-T185
1	O	O	I-T185
and	O	O	O
2	O	O	B-T185
blastocysts	O	O	B-T018
(	O	O	O
33.6	O	O	O
±	O	O	O
4.9	O	O	O
%	O	O	O
,	O	O	O
46.1	O	O	O
±	O	O	O
7.3	O	O	O
%	O	O	O
,	O	O	O
37.8	O	O	O
±	O	O	O
7.9	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
39.4	O	O	O
±	O	O	O
7.9	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
with	O	O	O
0	O	O	O
,	O	O	O
1	O	O	O
,	O	O	O
2.5	O	O	O
,	O	O	O
and	O	O	O
5	O	O	O
μM	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
percentage	O	O	B-T078
of	O	O	O
fast-developing	O	O	B-T042
embryos	O	O	I-T042
increased	O	O	B-T081
in	O	O	O
1	O	O	O
μM	O	O	O
crocetin	O	O	B-T078
group	O	O	I-T078
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
(	O	O	O
23.4	O	O	O
±	O	O	O
4.7	O	O	O
%	O	O	O
,	O	O	O
32.7	O	O	O
±	O	O	O
6.6	O	O	O
%	O	O	O
,	O	O	O
27.2	O	O	O
±	O	O	O
6.6	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
30.1	O	O	O
±	O	O	O
7.2	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
with	O	O	O
0	O	O	O
,	O	O	O
1	O	O	O
,	O	O	O
2.5	O	O	O
,	O	O	O
and	O	O	O
5	O	O	O
μM	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
enrichment	O	O	B-T130
of	O	O	I-T130
culture	O	O	I-T130
medium	O	O	I-T130
with	O	O	O
1	O	O	O
μM	O	O	O
crocetin	O	O	B-T109
improved	O	O	B-T033
embryo	O	O	B-T018
cryotolerance	O	O	B-T080
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
,	O	O	O
as	O	O	O
indicated	O	O	O
by	O	O	O
higher	O	O	O
hatching	O	O	B-T040
rates	O	O	B-T081
recorded	O	O	O
after	O	O	O
48	O	O	O
hours	O	O	B-T079
postwarming	O	O	B-T130
culture	O	O	I-T130
(	O	O	O
46.5	O	O	O
%	O	O	O
vs.	O	O	O
60.4	O	O	O
%	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
1	O	O	O
μM	O	O	O
crocetin	O	O	B-T109
decreased	O	O	B-T081
both	O	O	O
the	O	O	O
average	O	O	O
number	O	O	O
(	O	O	O
9.9	O	O	O
±	O	O	O
0.4	O	O	O
vs.	O	O	O
7.1	O	O	O
±	O	O	O
0.3	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
percentage	O	O	B-T078
of	O	O	O
apoptotic	O	O	B-T080
cells	O	O	B-T025
(	O	O	O
7.1	O	O	O
±	O	O	O
0.4	O	O	O
vs.	O	O	O
4.2	O	O	O
±	O	O	O
0.2	O	O	O
)	O	O	O
in	O	O	O
blastocysts	O	O	B-T018
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
no	O	O	O
differences	O	O	O
were	O	O	O
recorded	O	O	O
in	O	O	O
the	O	O	O
average	O	O	O
number	O	O	O
of	O	O	O
ICM	O	O	B-T018
,	O	O	O
TE	O	O	B-T018
,	O	O	O
and	O	O	O
total	O	O	B-T080
cells	O	O	B-T025
between	O	O	O
1	O	O	O
μM	O	O	O
crocetin	O	O	B-T109
and	O	O	O
control	O	O	B-T096
groups	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
the	O	O	O
enrichment	O	O	B-T130
of	O	O	I-T130
bovine	O	O	I-T130
culture	O	O	I-T130
medium	O	O	I-T130
with	O	O	O
1	O	O	O
μM	O	O	O
crocetin	O	O	B-T109
increased	O	O	B-T081
both	O	O	O
blastocyst	O	O	B-T081
yield	O	O	I-T081
and	O	O	O
quality	O	O	B-T080
,	O	O	O
as	O	O	O
indicated	O	O	O
by	O	O	O
the	O	O	O
improved	O	O	B-T033
chronology	O	O	B-T170
of	O	O	O
embryo	O	O	B-T042
development	O	O	I-T042
,	O	O	O
increased	O	O	O
resistance	O	O	B-T169
to	O	O	O
cryopreservation	O	O	B-T059
,	O	O	O
and	O	O	O
reduced	O	O	B-T081
incidence	O	O	I-T081
of	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

-DOCSTART- (27401811)

Matrix	O	O	B-T059
solid-phase	O	O	I-T059
dispersion	O	O	I-T059
combined	O	O	O
to	O	O	O
liquid	O	O	B-T059
chromatography-tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
for	O	O	O
the	O	O	O
determination	O	O	B-T059
of	O	O	O
paraben	O	O	B-T109
preservatives	O	O	B-T122
in	O	O	O
mollusks	O	O	O

A	O	O	O
method	O	O	B-T170
for	O	O	I-T170
the	O	O	I-T170
extraction	O	O	I-T170
and	O	O	O
determination	O	O	B-T059
of	O	O	O
seven	O	O	O
parabens	O	O	B-T109
,	O	O	O
esters	O	O	B-T109
of	O	O	O
4-hydroxybenzoic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
widely	O	O	O
used	O	O	O
as	O	O	O
preservatives	O	O	B-T122
in	O	O	O
personal	O	O	B-T167
care	O	O	I-T167
products	O	O	I-T167
,	O	O	O
pharmaceuticals	O	O	B-T121
,	O	O	O
etc	O	O	O
.	O	O	O
,	O	O	O
and	O	O	O
two	O	O	O
chlorinated	O	O	B-T109
derivatives	O	O	I-T109
(	O	O	O
mono-	O	O	B-T109
and	O	O	O
di-chloro	O	O	B-T109
methyl	O	O	I-T109
paraben	O	O	I-T109
)	O	O	O
from	O	O	O
mollusk	O	O	B-T204
samples	O	O	B-T077
was	O	O	O
developed	O	O	O
by	O	O	O
combining	O	O	O
matrix	O	O	B-T059
solid-phase	O	O	I-T059
dispersion	O	O	I-T059
(	O	O	O
MSPD	O	O	B-T059
)	O	O	O
and	O	O	O
liquid	O	O	B-T059
chromatography-tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
.	O	O	O

MSPD	O	O	B-T170
parameters	O	O	I-T170
,	O	O	O
such	O	O	O
as	O	O	O
solvent	O	O	B-T130
,	O	O	O
solid	O	O	B-T130
support	O	O	I-T130
and	O	O	O
clean-up	O	O	B-T130
sorbent	O	O	I-T130
,	O	O	O
were	O	O	O
optimized	O	O	B-T052
.	O	O	O

Besides	O	O	O
,	O	O	O
since	O	O	O
blank	O	O	O
problems	O	O	O
were	O	O	O
observed	O	O	O
for	O	O	O
some	O	O	O
parabens	O	O	B-T109
,	O	O	O
these	O	O	O
were	O	O	O
investigated	O	O	B-T169
and	O	O	O
blanks	O	O	O
were	O	O	O
tackled	O	O	O
by	O	O	O
precleaning	O	O	B-T052
all	O	O	O
sorbents	O	O	B-T130
prior	O	O	O
to	O	O	O
use	O	O	O
.	O	O	O

Under	O	O	O
final	O	O	O
conditions	O	O	O
,	O	O	O
0.5	O	O	O
g	O	O	O
of	O	O	O
freeze-dried	O	O	B-T059
mollusk	O	O	B-T204
were	O	O	O
dispersed	O	O	B-T082
with	O	O	O
1.2	O	O	O
g	O	O	O
of	O	O	O
silica	O	O	B-T122
and	O	O	O
packed	O	O	B-T052
into	O	O	O
a	O	O	O
cartridge	O	O	B-T170
containing	O	O	O
3	O	O	O
g	O	O	O
of	O	O	O
C18	O	O	B-T109
,	O	O	O
as	O	O	O
on-line	O	O	O
clean-up	O	O	B-T130
sorbent	O	O	I-T130
.	O	O	O

This	O	O	O
cartridge	O	O	B-T170
was	O	O	O
eluted	O	O	O
with	O	O	O
10mL	O	O	O
of	O	O	O
acetonitrile	O	O	B-T109
,	O	O	O
evaporated	O	O	B-T070
and	O	O	O
reconstituted	O	O	B-T052
in	O	O	O
methanol	O	O	B-T109
for	O	O	O
analysis	O	O	B-T062
.	O	O	O

In	O	O	O
the	O	O	O
validation	O	O	B-T062
stage	O	O	O
,	O	O	O
successful	O	O	O
linearity	O	O	O
(	O	O	O
R(2)>0.999	O	O	O
)	O	O	O
,	O	O	O
recoveries	O	O	B-T052
(	O	O	O
between	O	O	O
71	O	O	O
and	O	O	O
117	O	O	O
%	O	O	O
for	O	O	O
most	O	O	O
analytes	O	O	B-T167
)	O	O	O
,	O	O	O
precision	O	O	B-T080
(	O	O	O
RSD	O	O	O
lower	O	O	O
than	O	O	O
21	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
limits	O	O	B-T081
of	O	O	I-T081
detection	O	O	I-T081
and	O	O	O
quantification	O	O	B-T081
(	O	O	O
LOD	O	O	B-T081
and	O	O	O
LOQ	O	O	B-T062
,	O	O	O
lower	O	O	O
than	O	O	O
0.4	O	O	O
and	O	O	O
1.4ngg(-1	O	O	O
)	O	O	O
dry	O	O	B-T081
weight	O	O	I-T081
respectively	O	O	O
)	O	O	O
levels	O	O	B-T080
were	O	O	O
achieved	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
new	O	O	O
methodology	O	O	B-T170
was	O	O	O
applied	O	O	O
to	O	O	O
mussel	O	O	B-T204
,	O	O	O
clam	O	O	B-T204
and	O	O	O
cockle	O	O	B-T204
samples	O	O	B-T077
.	O	O	O

Methyl	O	O	B-T109
paraben	O	O	I-T109
was	O	O	O
above	O	O	O
the	O	O	O
LOQ	O	O	B-T081
in	O	O	O
five	O	O	O
of	O	O	O
the	O	O	O
six	O	O	O
samples	O	O	B-T077
(	O	O	O
not	O	O	O
found	O	O	O
in	O	O	O
one	O	O	O
clam	O	O	B-T204
sample	O	O	B-T077
)	O	O	O
at	O	O	O
concentrations	O	O	B-T081
up	O	O	O
to	O	O	O
7ngg(-1	O	O	O
)	O	O	O
dry	O	O	B-T081
weight	O	O	I-T081
.	O	O	O

Ethyl	O	O	B-T109
paraben	O	O	I-T109
was	O	O	O
found	O	O	O
above	O	O	O
the	O	O	O
LOQ	O	O	B-T081
in	O	O	O
mussel	O	O	B-T204
and	O	O	O
cockle	O	O	B-T204
samples	O	O	B-T077
at	O	O	O
a	O	O	O
concentration	O	O	B-T081
level	O	O	I-T081
around	O	O	O
0.3ngg(-1	O	O	O
)	O	O	O
.	O	O	O

n-Propyl	O	O	B-T109
paraben	O	O	I-T109
was	O	O	O
only	O	O	O
above	O	O	O
the	O	O	O
LOQ	O	O	B-T081
in	O	O	O
one	O	O	O
mussel	O	O	B-T204
sample	O	O	B-T077
.	O	O	O

-DOCSTART- (27402799)

Two-stage	O	O	O
reconstructive	O	O	B-T061
overlapping	O	O	B-T074
stent	O	O	I-T074
LEO+	O	O	B-T074
and	O	O	O
SILK	O	O	B-T074
for	O	O	O
treatment	O	O	B-T061
of	O	O	O
intracranial	O	O	B-T029
circumferential	O	O	B-T082
fusiform	O	O	B-T190
aneurysms	O	O	I-T190
in	O	O	O
the	O	O	O
posterior	O	O	B-T082
circulation	O	O	O

Intracranial	O	O	B-T029
circumferential	O	O	B-T082
fusiform	O	O	B-T190
aneurysms	O	O	I-T190
of	O	O	O
the	O	O	O
posterior	O	O	B-T082
circulation	O	O	B-T039
involving	O	O	O
arterial	O	O	B-T023
branches	O	O	I-T023
or	O	O	O
perforating	O	O	B-T033
vessels	O	O	B-T023
are	O	O	O
difficult	O	O	B-T080
to	O	O	O
treat	O	O	B-T169
.	O	O	O

This	O	O	O
article	O	O	O
shows	O	O	O
an	O	O	O
endovascular	O	O	B-T029
reconstruction	O	O	B-T061
technique	O	O	I-T061
not	O	O	O
yet	O	O	O
described	O	O	O
,	O	O	O
using	O	O	O
a	O	O	O
telescoping	O	O	B-T074
self-expandable	O	O	I-T074
stent	O	O	I-T074
(	O	O	O
LEO+	O	O	B-T074
)	O	O	O
and	O	O	O
flow-diverter	O	O	B-T074
device	O	O	I-T074
(	O	O	O
SILK	O	O	B-T074
)	O	O	O
at	O	O	O
different	O	O	B-T080
surgical	O	O	B-T079
times	O	O	I-T079
.	O	O	O

Two	O	O	O
patients	O	O	B-T101
with	O	O	O
circumferential	O	O	B-T082
fusiform	O	O	B-T190
aneurysm	O	O	B-T047
,	O	O	O
one	O	O	O
being	O	O	O
an	O	O	O
aneurysm	O	O	O
of	O	O	O
the	O	O	O
segments	O	O	O
P2	O	O	O
and	O	O	O
P3	O	O	O
of	O	O	O
the	O	O	O
posterior	O	O	B-T023
cerebral	O	O	I-T023
artery	O	O	I-T023
,	O	O	O
diagnosed	O	O	B-T033
after	O	O	O
a	O	O	O
headache	O	O	B-T184
,	O	O	O
and	O	O	O
the	O	O	O
other	O	O	O
a	O	O	O
partially	O	O	B-T081
thrombosed	O	O	B-T047
aneurysm	O	O	I-T047
of	O	O	O
the	O	O	O
lower	O	O	B-T029
basilar	O	O	B-T023
artery	O	O	I-T023
,	O	O	O
diagnosed	O	O	O
following	O	O	O
ischemia	O	O	B-T046
of	O	O	O
the	O	O	O
brain	O	O	B-T023
stem	O	O	I-T023
.	O	O	O

Endovascular	O	O	B-T029
treatment	O	O	B-T061
was	O	O	O
performed	O	O	O
by	O	O	O
means	O	O	O
of	O	O	O
a	O	O	O
vascular	O	O	B-T023
reconstruction	O	O	B-T061
technique	O	O	I-T061
that	O	O	O
used	O	O	O
at	O	O	O
different	O	O	B-T080
surgical	O	O	B-T079
times	O	O	I-T079
:	O	O	O
overlapping	O	O	B-T061
;	O	O	I-T061
a	O	O	I-T061
telescoped	O	O	I-T061
self-expandable	O	O	I-T061
stent	O	O	I-T061
,	O	O	O
LEO+	O	O	B-T074
;	O	O	O
and	O	O	O
a	O	O	O
flow-diverter	O	O	B-T074
device	O	O	I-T074
,	O	O	O
SILK	O	O	B-T074
.	O	O	O

Angiographic	O	O	B-T060
control	O	O	B-T080
was	O	O	O
carried	O	O	O
out	O	O	O
at	O	O	O
6	O	O	O
and	O	O	O
12	O	O	O
months	O	O	B-T079
,	O	O	O
to	O	O	O
evaluate	O	O	O
arterial	O	O	B-T201
patency	O	O	I-T201
,	O	O	O
flow	O	O	B-T070
maintenance	O	O	B-T052
in	O	O	O
the	O	O	O
arterial	O	O	B-T023
branches	O	O	I-T023
and	O	O	O
perforating	O	O	B-T033
vessels	O	O	B-T023
,	O	O	O
and	O	O	O
thrombosis	O	O	B-T046
of	O	O	O
the	O	O	O
aneurysm	O	O	B-T047
.	O	O	O

The	O	O	O
combined	O	O	B-T080
use	O	O	O
at	O	O	O
different	O	O	B-T080
surgical	O	O	B-T079
times	O	O	I-T079
of	O	O	O
the	O	O	O
self-expandable	O	O	B-T074
stent	O	O	I-T074
and	O	O	O
flow-diverter	O	O	B-T074
device	O	O	I-T074
was	O	O	O
technically	O	O	O
successful	O	O	B-T080
in	O	O	O
both	O	O	O
patients	O	O	B-T101
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
complications	O	O	B-T046
during	O	O	O
the	O	O	O
procedure	O	O	B-T169
,	O	O	O
nor	O	O	O
in	O	O	O
the	O	O	O
long-term	O	O	B-T079
follow-up	O	O	B-T058
with	O	O	O
full	O	O	O
arterial	O	O	B-T023
vascular	O	O	B-T023
reconstruction	O	O	B-T061
,	O	O	O
maintenance	O	O	B-T052
of	O	O	O
cerebral	O	O	B-T061
perfusion	O	O	I-T061
and	O	O	O
complete	O	O	B-T080
aneurysm	O	O	B-T047
occlusion	O	O	B-T169
at	O	O	O
the	O	O	O
6-	O	O	O
and	O	O	O
12-	O	O	O
month	O	O	B-T079
angiographic	O	O	B-T060
follow-up	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
aneurysm	O	O	B-T037
recanalization	O	O	I-T037
nor	O	O	O
intra-stent	O	O	B-T046
stenosis	O	O	I-T046
.	O	O	O

Circumferential	O	O	B-T082
fusiform	O	O	B-T190
aneurysm	O	O	I-T190
of	O	O	O
the	O	O	O
posterior	O	O	B-T082
circulation	O	O	B-T039
involving	O	O	O
arterial	O	O	B-T023
branches	O	O	I-T023
or	O	O	O
perforating	O	O	B-T033
vessels	O	O	B-T023
to	O	O	O
the	O	O	O
brain	O	O	B-T023
stem	O	O	I-T023
may	O	O	O
be	O	O	O
treated	O	O	B-T169
with	O	O	O
this	O	O	O
arterial	O	O	B-T061
reconstruction	O	O	I-T061
technique	O	O	B-T061
at	O	O	O
different	O	O	B-T080
surgical	O	O	B-T079
times	O	O	I-T079
,	O	O	O
using	O	O	O
the	O	O	O
self-expandable	O	O	B-T074
stent	O	O	I-T074
called	O	O	O
LEO+	O	O	B-T074
and	O	O	O
the	O	O	O
flow-diverter	O	O	B-T074
device	O	O	I-T074
SILK	O	O	B-T074
,	O	O	O
minimizing	O	O	B-T080
the	O	O	O
risk	O	O	B-T078
of	O	O	O
complications	O	O	B-T046
and	O	O	O
failure	O	O	B-T169
of	O	O	O
the	O	O	O
endovascular	O	O	B-T029
technique	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
potential	O	O	B-T080
for	O	O	O
arterial	O	O	O
reconstruction	O	O	O
with	O	O	O
thrombosis	O	O	B-T046
of	O	O	O
the	O	O	O
aneurysmatic	O	O	B-T047
sac	O	O	I-T047
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
flow	O	O	B-T070
maintenance	O	O	B-T052
in	O	O	O
the	O	O	O
eloquent	O	O	B-T023
arteries	O	O	I-T023
,	O	O	O
in	O	O	O
this	O	O	O
type	O	O	O
of	O	O	O
cerebral	O	O	B-T047
aneurysm	O	O	I-T047
.	O	O	O

-DOCSTART- (27403678)

Polysaccharide	O	O	B-T129
-	O	O	O
Specific	O	O	B-T080
Memory	O	O	B-T025
B	O	O	I-T025
Cells	O	O	I-T025
Predict	O	O	O
Protection	O	O	B-T033
against	O	O	O
Experimental	O	O	B-T080
Human	O	O	B-T016
Pneumococcal	O	O	B-T007
Carriage	O	O	O

We	O	O	O
have	O	O	O
previously	O	O	B-T079
demonstrated	O	O	O
that	O	O	O
experimental	O	O	B-T080
pneumococcal	O	O	B-T007
carriage	O	O	B-T033
enhances	O	O	B-T052
immunity	O	O	B-T039
and	O	O	O
protects	O	O	B-T033
healthy	O	O	B-T080
adults	O	O	B-T100
against	O	O	B-T080
carriage	O	O	O
reacquisition	O	O	B-T052
after	O	O	O
rechallenge	O	O	B-T061
with	O	O	O
a	O	O	O
homologous	O	O	B-T032
strain	O	O	B-T001
.	O	O	O

To	O	O	O
investigate	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
naturally	O	O	B-T169
acquired	O	O	B-T080
pneumococcal	O	O	B-T116
protein	O	O	I-T116
and	O	O	O
polysaccharide	O	O	B-T129
(PS)-	O	O	O
specific	O	O	B-T080
immunity	O	O	B-T039
in	O	O	O
protection	O	O	B-T033
against	O	O	B-T080
carriage	O	O	B-T033
acquisition	O	O	B-T052
using	O	O	O
a	O	O	O
heterologous	O	O	B-T039
challenge	O	O	I-T039
model	O	O	O
.	O	O	O

We	O	O	O
identified	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
that	O	O	O
were	O	O	O
naturally	O	O	B-T169
colonized	O	O	B-T025
with	O	O	O
pneumococcus	O	O	B-T007
and	O	O	O
,	O	O	O
after	O	O	O
clearance	O	O	B-T080
of	O	O	O
their	O	O	O
natural	O	O	B-T169
carriage	O	O	B-T033
episode	O	O	B-T079
,	O	O	O
challenged	O	O	O
them	O	O	O
with	O	O	O
a	O	O	O
heterologous	O	O	B-T032
6B	O	O	B-T007
strain	O	O	I-T007
.	O	O	O

In	O	O	O
another	O	O	O
cohort	O	O	B-T098
of	O	O	O
volunteers	O	O	B-T098
we	O	O	O
assessed	O	O	O
6BPS	O	O	B-T129
-	O	O	O
specific	O	O	B-T080
,	O	O	O
PspA	O	O	B-T116
-	O	O	O
specific	O	O	O
,	O	O	O
and	O	O	O
PspC	O	O	B-T116
-	O	O	O
specific	O	O	O
IgG	O	O	B-T116
and	O	O	O
IgA	O	O	B-T116
plasma	O	O	B-T025
and	O	O	O
memory	O	O	B-T025
B-cell	O	O	I-T025
populations	O	O	I-T025
before	O	O	B-T079
and	O	O	O
7	O	O	O
,	O	O	O
14	O	O	O
,	O	O	O
and	O	O	O
35	O	O	O
days	O	O	O
after	O	O	B-T079
experimental	O	O	B-T080
pneumococcal	O	O	B-T007
inoculation	O	O	B-T061
.	O	O	O

Heterologous	O	O	B-T039
challenge	O	O	I-T039
with	O	O	O
6B	O	O	B-T007
resulted	O	O	O
in	O	O	O
50	O	O	O
%	O	O	O
carriage	O	O	B-T033
among	O	O	O
volunteers	O	O	B-T098
with	O	O	O
previous	O	O	B-T079
natural	O	O	B-T169
pneumococcal	O	O	B-T007
carriage	O	O	O
.	O	O	O

Protection	O	O	B-T033
from	O	O	O
carriage	O	O	B-T033
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
high	O	O	B-T080
number	O	O	O
of	O	O	O
circulating	O	O	B-T169
6BPS	O	O	B-T129
IgG	O	O	B-T116
-	O	O	O
secreting	O	O	B-T043
memory	O	O	B-T025
B	O	O	I-T025
cells	O	O	I-T025
at	O	O	O
baseline	O	O	B-T081
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
associations	O	O	B-T080
between	O	O	O
protection	O	O	B-T033
from	O	O	O
carriage	O	O	B-T033
and	O	O	O
baseline	O	O	B-T081
levels	O	O	B-T080
of	O	O	O
6BPS	O	O	B-T129
IgG	O	O	B-T116
in	O	O	O
serum	O	O	B-T031
or	O	O	O
nasal	O	O	B-T031
wash	O	O	I-T031
,	O	O	O
PspA	O	O	B-T116
-	O	O	O
specific	O	O	B-T080
,	O	O	O
or	O	O	O
PspC	O	O	B-T116
-	O	O	O
specific	O	O	O
memory	O	O	B-T025
B	O	O	I-T025
cells	O	O	I-T025
or	O	O	O
plasma	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

In	O	O	O
volunteers	O	O	B-T098
who	O	O	O
did	O	O	O
not	O	O	B-T033
develop	O	O	I-T033
carriage	O	O	B-T033
,	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
circulating	O	O	B-T169
6BPS	O	O	B-T129
memory	O	O	B-T025
B	O	O	I-T025
cells	O	O	I-T025
decreased	O	O	B-T081
and	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
6BPS	O	O	O
plasma	O	O	B-T025
cells	O	O	I-T025
increased	O	O	B-T081
postinoculation	O	O	B-T033
.	O	O	O

Our	O	O	O
data	O	O	O
indicate	O	O	O
that	O	O	O
naturally	O	O	B-T169
acquired	O	O	B-T080
PS	O	O	B-T129
-	O	O	O
specific	O	O	B-T080
memory	O	O	B-T025
B	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
but	O	O	O
not	O	O	B-T033
levels	O	O	I-T033
of	O	O	O
circulating	O	O	B-T169
IgG	O	O	B-T116
at	O	O	O
time	O	O	O
of	O	O	O
pneumococcal	O	O	B-T007
exposure	O	O	B-T080
,	O	O	O
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
protection	O	O	B-T033
against	O	O	B-T080
carriage	O	O	B-T033
acquisition	O	O	B-T052
.	O	O	O

-DOCSTART- (27405692)

Hounsfield	O	O	B-T081
unit	O	O	I-T081
recovery	O	O	B-T052
in	O	O	O
clinical	O	O	B-T080
cone	O	O	B-T060
beam	O	O	I-T060
CT	O	O	I-T060
images	O	O	B-T078
of	O	O	O
the	O	O	O
thorax	O	O	B-T029
acquired	O	O	O
for	O	O	O
image	O	O	O
guided	O	O	O
radiation	O	O	O
therapy	O	O	O

A	O	O	O
comprehensive	O	O	B-T080
artefact	O	O	B-T068
correction	O	O	B-T169
method	O	O	B-T170
for	O	O	O
clinical	O	O	B-T080
cone	O	O	B-T060
beam	O	O	I-T060
CT	O	O	I-T060
(	O	O	O
CBCT	O	O	B-T060
)	O	O	O
images	O	O	B-T078
acquired	O	O	O
for	O	O	O
image	O	O	B-T061
guided	O	O	I-T061
radiation	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
IGRT	O	O	B-T061
)	O	O	O
on	O	O	O
a	O	O	O
commercial	O	O	O
system	O	O	O
is	O	O	O
presented	O	O	O
.	O	O	O

The	O	O	O
method	O	O	B-T170
is	O	O	O
demonstrated	O	O	O
to	O	O	O
reduce	O	O	B-T080
artefacts	O	O	B-T068
and	O	O	O
recover	O	O	B-T052
CT	O	O	B-T060
-like	O	O	O
Hounsfield	O	O	B-T081
units	O	O	I-T081
(	O	O	O
HU	O	O	B-T081
)	O	O	O
in	O	O	O
reconstructed	O	O	B-T066
CBCT	O	O	B-T060
images	O	O	B-T078
of	O	O	O
five	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

Projection	O	O	B-T078
image	O	O	I-T078
based	O	O	O
artefact	O	O	B-T068
corrections	O	O	B-T169
of	O	O	O
image	O	O	B-T068
lag	O	O	I-T068
,	O	O	O
detector	O	O	B-T068
scatter	O	O	I-T068
,	O	O	O
body	O	O	B-T068
scatter	O	O	I-T068
and	O	O	O
beam	O	O	B-T033
hardening	O	O	I-T033
are	O	O	O
described	O	O	O
and	O	O	O
applied	O	O	O
to	O	O	O
CBCT	O	O	B-T060
images	O	O	B-T078
of	O	O	O
five	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

Image	O	O	B-T080
quality	O	O	I-T080
is	O	O	O
evaluated	O	O	B-T058
through	O	O	O
visual	O	O	B-T169
appearance	O	O	B-T080
of	O	O	O
the	O	O	O
reconstructed	O	O	B-T066
images	O	O	B-T078
,	O	O	O
HU	O	O	B-T081
-correspondence	O	O	O
with	O	O	O
the	O	O	O
planning	O	O	O
CT	O	O	B-T060
images	O	O	O
,	O	O	O
and	O	O	O
total	O	O	B-T081
volume	O	O	I-T081
HU	O	O	O
error	O	O	B-T080
.	O	O	O

Artefacts	O	O	B-T068
are	O	O	O
reduced	O	O	B-T080
and	O	O	O
CT	O	O	B-T060
-like	O	O	O
HUs	O	O	B-T081
are	O	O	O
recovered	O	O	B-T052
in	O	O	O
the	O	O	O
artefact	O	O	B-T068
corrected	O	O	B-T080
CBCT	O	O	B-T060
images	O	O	B-T078
.	O	O	O

Visual	O	O	B-T058
inspection	O	O	I-T058
confirms	O	O	B-T033
that	O	O	O
artefacts	O	O	B-T068
are	O	O	O
indeed	O	O	O
suppressed	O	O	B-T169
by	O	O	O
the	O	O	O
proposed	O	O	O
method	O	O	B-T170
,	O	O	O
and	O	O	O
the	O	O	O
HU	O	O	B-T081
root	O	O	B-T081
mean	O	O	I-T081
square	O	O	I-T081
difference	O	O	B-T081
between	O	O	O
reconstructed	O	O	B-T066
CBCTs	O	O	B-T060
and	O	O	O
the	O	O	O
reference	O	O	B-T077
CT	O	O	B-T060
images	O	O	B-T078
are	O	O	O
reduced	O	O	B-T080
by	O	O	O
31	O	O	O
%	O	O	O
when	O	O	O
using	O	O	O
the	O	O	O
artefact	O	O	B-T068
corrections	O	O	B-T169
compared	O	O	B-T052
to	O	O	O
the	O	O	O
standard	O	O	B-T080
clinical	O	O	B-T080
CBCT	O	O	B-T060
reconstruction	O	O	B-T066
.	O	O	O

A	O	O	O
versatile	O	O	O
artefact	O	O	B-T068
correction	O	O	B-T169
method	O	O	B-T170
for	O	O	O
clinical	O	O	B-T080
CBCT	O	O	B-T060
images	O	O	B-T078
acquired	O	O	O
for	O	O	O
IGRT	O	O	B-T061
has	O	O	O
been	O	O	O
developed	O	O	O
.	O	O	O

HU	O	O	B-T081
values	O	O	B-T081
are	O	O	O
recovered	O	O	B-T052
in	O	O	O
the	O	O	O
corrected	O	O	B-T080
CBCT	O	O	B-T060
images	O	O	B-T078
.	O	O	O

The	O	O	O
proposed	O	O	O
method	O	O	B-T170
relies	O	O	O
on	O	O	O
post	O	O	B-T170
processing	O	O	I-T170
of	O	O	O
clinical	O	O	B-T080
projection	O	O	B-T078
images	O	O	I-T078
,	O	O	O
and	O	O	O
does	O	O	O
not	O	O	O
require	O	O	O
patient	O	O	B-T101
specific	O	O	B-T080
optimisation	O	O	B-T052
.	O	O	O

It	O	O	O
is	O	O	O
thus	O	O	O
a	O	O	O
powerful	O	O	O
tool	O	O	B-T170
for	O	O	O
image	O	O	B-T078
quality	O	O	B-T080
improvement	O	O	B-T077
of	O	O	O
large	O	O	B-T081
numbers	O	O	B-T081
of	O	O	O
CBCT	O	O	B-T060
images	O	O	B-T078
.	O	O	O

-DOCSTART- (27407027)

Risk	O	O	B-T033
Factors	O	O	I-T033
for	O	O	O
Infection	O	O	B-T046
After	O	O	O
Knee	O	O	B-T060
Arthroscopy	O	O	I-T060
:	O	O	O
Analysis	O	O	B-T062
of	O	O	O
595,083	O	O	O
Cases	O	O	B-T169
From	O	O	O
3	O	O	O
United	O	O	B-T083
States	O	O	I-T083
Databases	O	O	O

To	O	O	O
identify	O	O	B-T080
and	O	O	O
quantify	O	O	B-T081
patient-	O	O	B-T033
and	O	O	O
procedure-related	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
for	O	O	O
post-arthroscopic	O	O	B-T079
knee	O	O	B-T047
infections	O	O	I-T047
using	O	O	O
a	O	O	O
large	O	O	O
dataset	O	O	B-T170
.	O	O	O

An	O	O	O
administrative	O	O	B-T170
health	O	O	I-T170
care	O	O	I-T170
database	O	O	I-T170
including	O	O	O
8	O	O	O
years	O	O	B-T079
of	O	O	O
records	O	O	O
from	O	O	O
2	O	O	O
large	O	O	O
commercial	O	O	O
insurers	O	O	B-T092
and	O	O	O
Medicare	O	O	B-T064
(	O	O	O
a	O	O	O
5	O	O	O
%	O	O	O
random	O	O	B-T062
sample	O	O	I-T062
)	O	O	O
was	O	O	O
queried	O	O	O
to	O	O	O
identify	O	O	O
all	O	O	O
knee	O	O	B-T060
arthroscopies	O	O	I-T060
performed	O	O	B-T169
on	O	O	O
patients	O	O	B-T101
aged	O	O	B-T032
at	O	O	O
least	O	O	O
15	O	O	O
years	O	O	O
using	O	O	O
Current	O	O	B-T170
Procedural	O	O	I-T170
Terminology	O	O	I-T170
(	O	O	I-T170
CPT	O	O	I-T170
)	O	O	I-T170
codes	O	O	I-T170
.	O	O	O

Each	O	O	O
CPT	O	O	B-T170
code	O	O	I-T170
was	O	O	O
designated	O	O	O
as	O	O	O
a	O	O	O
high-	O	O	B-T058
or	O	O	O
low-complexity	O	O	B-T058
procedure	O	O	I-T058
,	O	O	O
with	O	O	O
the	O	O	O
former	O	O	O
typically	O	O	O
requiring	O	O	O
accessory	O	O	O
incisions	O	O	B-T061
or	O	O	O
increased	O	O	O
operative	O	O	B-T079
time	O	O	I-T079
.	O	O	O

Deep	O	O	O
infections	O	O	B-T046
were	O	O	O
identified	O	O	O
by	O	O	O
a	O	O	O
CPT	O	O	B-T170
code	O	O	I-T170
for	O	O	O
incision	O	O	B-T061
and	O	O	O
drainage	O	O	B-T061
within	O	O	O
90	O	O	O
days	O	O	B-T079
of	O	O	O
surgery	O	O	B-T169
.	O	O	O

Superficial	O	O	B-T046
infections	O	O	I-T046
were	O	O	O
identified	O	O	O
by	O	O	O
International	O	O	B-T170
Classification	O	O	I-T170
of	O	O	I-T170
Diseases	O	O	I-T170
,	O	O	I-T170
Ninth	O	O	I-T170
Revision	O	O	I-T170
infection	O	O	I-T170
codes	O	O	I-T170
without	O	O	O
any	O	O	O
record	O	O	B-T170
of	O	O	O
incision	O	O	B-T061
and	O	O	O
drainage	O	O	B-T061
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
compared	O	O	O
based	O	O	O
on	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
,	O	O	O
tobacco	O	O	B-T055
use	O	O	I-T055
,	O	O	O
presence	O	O	B-T080
of	O	O	O
diabetes	O	O	B-T047
,	O	O	O
and	O	O	O
Charlson	O	O	B-T081
Comorbidity	O	O	I-T081
Index	O	O	I-T081
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
526,537	O	O	O
patients	O	O	B-T101
underwent	O	O	O
595,083	O	O	O
arthroscopic	O	O	B-T060
knee	O	O	I-T060
procedures	O	O	I-T060
.	O	O	O

Deep	O	O	O
postoperative	O	O	B-T046
infections	O	O	I-T046
occurred	O	O	O
at	O	O	O
a	O	O	O
rate	O	O	O
of	O	O	O
0.22	O	O	O
%	O	O	O
.	O	O	O

Superficial	O	O	B-T046
infections	O	O	I-T046
occurred	O	O	O
at	O	O	O
a	O	O	O
rate	O	O	O
of	O	O	O
0.29	O	O	O
%	O	O	O
.	O	O	O

Tobacco	O	O	B-T055
use	O	O	I-T055
and	O	O	O
morbid	O	O	B-T047
obesity	O	O	I-T047
were	O	O	O
the	O	O	O
largest	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
deep	O	O	B-T046
and	O	O	O
superficial	O	O	B-T046
infections	O	O	I-T046
,	O	O	O
respectively	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
;	O	O	O
relative	O	O	B-T081
risk	O	O	I-T081
of	O	O	O
1.90	O	O	O
and	O	O	O
2.19	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
also	O	O	O
higher	O	O	O
infection	O	O	B-T046
rates	O	O	I-T046
among	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
relatively	O	O	O
high-complexity	O	O	B-T060
arthroscopies	O	O	I-T060
,	O	O	O
men	O	O	B-T098
,	O	O	O
obese	O	O	B-T047
patients	O	O	O
,	O	O	O
diabetic	O	O	B-T047
patients	O	O	O
,	O	O	O
and	O	O	O
younger	O	O	B-T079
patients	O	O	O
(	O	O	O
in	O	O	O
order	O	O	O
of	O	O	O
decreasing	O	O	O
relative	O	O	B-T081
risk	O	O	I-T081
)	O	O	O
.	O	O	O

Increased	O	O	O
Charlson	O	O	B-T081
Comorbidity	O	O	I-T081
Index	O	O	I-T081
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
superficial	O	O	B-T046
and	O	O	O
total	O	O	B-T046
infections	O	O	I-T046
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
.	O	O	O

Post-arthroscopic	O	O	B-T079
knee	O	O	B-T047
infections	O	O	I-T047
were	O	O	O
more	O	O	O
frequent	O	O	O
among	O	O	O
morbidly	O	O	B-T047
obese	O	O	B-T101
patients	O	O	I-T101
,	O	O	O
tobacco	O	O	B-T033
users	O	O	I-T033
,	O	O	O
patients	O	O	O
undergoing	O	O	O
relatively	O	O	O
complex	O	O	B-T058
procedures	O	O	I-T058
,	O	O	O
men	O	O	B-T098
,	O	O	O
obese	O	O	O
patients	O	O	O
,	O	O	O
diabetic	O	O	B-T101
patients	O	O	I-T101
,	O	O	O
relatively	O	O	O
young	O	O	B-T101
patients	O	O	I-T101
,	O	O	O
and	O	O	O
patients	O	O	O
with	O	O	O
increased	O	O	O
comorbidity	O	O	B-T078
burdens	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
population	O	O	B-T081
.	O	O	O

This	O	O	O
knowledge	O	O	O
may	O	O	O
allow	O	O	O
more	O	O	O
informed	O	O	O
preoperative	O	O	B-T058
counseling	O	O	I-T058
,	O	O	O
aid	O	O	B-T097
surgeons	O	O	I-T097
in	O	O	O
patient	O	O	B-T062
selection	O	O	I-T062
,	O	O	O
and	O	O	O
facilitate	O	O	O
infection	O	O	B-T061
prevention	O	O	I-T061
by	O	O	O
targeting	O	O	O
individuals	O	O	B-T098
with	O	O	O
higher	O	O	O
inherent	O	O	B-T078
risk	O	O	I-T078
.	O	O	O

Level	O	O	O
IV	O	O	O
,	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
.	O	O	O

-DOCSTART- (27412368)

Association	O	O	B-T080
of	O	O	O
prenatal	O	O	B-T100
and	O	O	O
early	O	O	O
life	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
tetrachloroethylene	O	O	B-T109
(	O	O	O
PCE	O	O	B-T109
)	O	O	O
with	O	O	O
polycystic	O	O	B-T047
ovary	O	O	I-T047
syndrome	O	O	I-T047
and	O	O	O
other	O	O	O
reproductive	O	O	B-T047
disorders	O	O	I-T047
in	O	O	O
the	O	O	O
cape	O	O	B-T083
cod	O	O	I-T083
health	O	O	B-T062
study	O	O	I-T062
:	O	O	O
A	O	O	O
retrospective	O	O	O
cohort	O	O	O
study	O	O	O

Tetrachloroethylene	O	O	B-T109
(	O	O	O
PCE	O	O	B-T109
)	O	O	O
is	O	O	O
an	O	O	O
organic	O	O	B-T080
lipophilic	O	O	B-T081
solvent	O	O	B-T130
with	O	O	O
possible	O	O	O
neuroendocrine	O	O	B-T022
toxicity	O	O	B-T080
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
association	O	O	B-T080
of	O	O	O
prenatal	O	O	B-T100
and	O	O	O
early	O	O	B-T079
childhood	O	O	I-T079
exposure	O	O	B-T080
to	O	O	I-T080
PCE	O	O	B-T109
-	O	O	O
contaminated	O	O	B-T169
drinking	O	O	B-T167
water	O	O	I-T167
and	O	O	O
development	O	O	B-T039
of	O	O	O
adult-onset	O	O	B-T033
Polycystic	O	O	B-T047
Ovary	O	O	I-T047
Syndrome	O	O	I-T047
(	O	O	O
PCOS	O	O	B-T047
)	O	O	O
,	O	O	O
endometriosis	O	O	B-T047
,	O	O	O
difficulty	O	O	B-T033
conceiving	O	O	I-T033
and	O	O	O
miscarriage	O	O	B-T046
.	O	O	O

Five-hundred	O	O	O
exposed	O	O	B-T080
and	O	O	O
331	O	O	O
unexposed	O	O	B-T098
female	O	O	B-T032
participants	O	O	B-T098
born	O	O	O
between	O	O	O
1969	O	O	O
and	O	O	O
1983	O	O	O
completed	O	O	B-T080
questionnaires	O	O	B-T170
on	O	O	O
demographic	O	O	B-T078
and	O	O	O
lifestyle	O	O	B-T054
characteristics	O	O	B-T080
,	O	O	O
and	O	O	O
reproductive	O	O	B-T047
disorders	O	O	I-T047
.	O	O	O

Residential	O	O	B-T082
locations	O	O	I-T082
from	O	O	O
the	O	O	O
prenatal	O	O	B-T100
period	O	O	B-T079
through	O	O	O
five	O	O	O
years	O	O	O
of	O	O	O
age	O	O	B-T032
were	O	O	O
used	O	O	O
to	O	O	O
estimate	O	O	B-T081
early	O	O	O
life	O	O	O
PCE	O	O	B-T109
exposure	O	O	B-T080
with	O	O	O
water	O	O	B-T073
modeling	O	O	I-T073
software	O	O	I-T073
.	O	O	O

For	O	O	O
any	O	O	O
early	O	O	O
life	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
PCE	O	O	B-T109
,	O	O	O
the	O	O	O
adjusted	O	O	B-T081
risk	O	O	I-T081
ratio	O	O	I-T081
for	O	O	O
PCOS	O	O	B-T047
was	O	O	O
0.9	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.5	O	O	O
-	O	O	O
1.6	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
statistically	O	O	B-T081
significan	O	O	I-T081
t	O	O	O
associations	O	O	B-T080
were	O	O	O
observed	O	O	B-T169
for	O	O	O
increasing	O	O	B-T169
levels	O	O	B-T080
of	O	O	O
exposure	O	O	B-T080
with	O	O	O
PCOS	O	O	B-T047
or	O	O	O
the	O	O	O
other	O	O	O
reproductive	O	O	B-T047
disorders	O	O	I-T047
.	O	O	O

No	O	O	O
meaningful	O	O	O
associations	O	O	B-T080
were	O	O	O
found	O	O	B-T033
among	O	O	O
adult	O	O	B-T100
women	O	O	B-T098
with	O	O	O
early	O	O	O
life	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
PCE	O	O	B-T109
-	O	O	O
contaminated	O	O	B-T169
drinking	O	O	B-T167
water	O	O	I-T167
and	O	O	O
adult-onset	O	O	B-T033
reproductive	O	O	B-T047
disorders	O	O	I-T047
.	O	O	O

-DOCSTART- (27412452)

Host	O	O	B-T002
plant	O	O	I-T002
affects	O	O	O
the	O	O	O
sexual	O	O	B-T001
attractiveness	O	O	I-T001
of	O	O	O
the	O	O	O
female	O	O	B-T032
white-spotted	O	O	B-T204
longicorn	O	O	I-T204
beetle	O	O	I-T204
,	O	O	O
Anoplophora	O	O	O
malasiaca	O	O	O

Anoplophora	O	O	B-T204
malasiaca	O	O	I-T204
(	O	O	O
Coleoptera	O	O	B-T204
:	O	O	O
Cerambycidae	O	O	B-T204
)	O	O	O
is	O	O	O
a	O	O	O
serious	O	O	O
pest	O	O	O
that	O	O	O
destroys	O	O	O
various	O	O	O
landscape	O	O	B-T082
and	O	O	O
crop	O	O	B-T002
trees	O	O	B-T002
in	O	O	O
Japan	O	O	B-T083
.	O	O	O

We	O	O	O
evaluated	O	O	O
the	O	O	O
precopulatory	O	O	B-T080
responses	O	O	B-T032
of	O	O	O
three	O	O	O
different	O	O	O
A.	O	O	B-T204
malasiaca	O	O	I-T204
populations	O	O	B-T098
collected	O	O	O
from	O	O	O
mandarin	O	O	B-T002
orange	O	O	I-T002
,	O	O	O
willow	O	O	B-T002
and	O	O	O
blueberry	O	O	B-T002
trees	O	O	I-T002
.	O	O	O

Most	O	O	O
of	O	O	O
the	O	O	O
males	O	O	B-T032
accepted	O	O	O
mates	O	O	O
from	O	O	O
within	O	O	O
the	O	O	O
same	O	O	O
host	O	O	B-T002
plant	O	O	I-T002
population	O	O	B-T098
as	O	O	O
well	O	O	O
as	O	O	O
females	O	O	B-T032
from	O	O	O
the	O	O	O
willow	O	O	B-T002
and	O	O	O
blueberry	O	O	B-T002
populations	O	O	B-T081
.	O	O	O

However	O	O	O
,	O	O	O
significant	O	O	O
number	O	O	O
of	O	O	O
males	O	O	B-T032
from	O	O	O
the	O	O	O
blueberry	O	O	B-T002
and	O	O	O
willow	O	O	B-T002
populations	O	O	B-T098
rejected	O	O	O
females	O	O	B-T032
from	O	O	O
the	O	O	O
mandarin	O	O	B-T002
orange	O	O	I-T002
population	O	O	B-T081
immediately	O	O	O
after	O	O	O
touching	O	O	O
them	O	O	O
with	O	O	O
their	O	O	O
antennae	O	O	B-T023
.	O	O	O

Because	O	O	O
all	O	O	O
three	O	O	O
of	O	O	O
the	O	O	O
female	O	O	B-T032
populations	O	O	B-T098
produced	O	O	O
contact	O	O	O
sex	O	O	B-T123
pheromones	O	O	I-T123
on	O	O	O
their	O	O	O
elytra	O	O	B-T023
,	O	O	O
the	O	O	O
females	O	O	B-T032
of	O	O	O
the	O	O	O
mandarin	O	O	B-T002
orange	O	O	I-T002
population	O	O	B-T081
were	O	O	O
predicted	O	O	O
to	O	O	O
possess	O	O	O
extra	O	O	O
chemicals	O	O	B-T103
that	O	O	O
repelled	O	O	O
the	O	O	O
males	O	O	B-T032
of	O	O	O
the	O	O	O
other	O	O	O
two	O	O	O
populations	O	O	O
.	O	O	O

β-Elemene	O	O	B-T109
was	O	O	O
identified	O	O	O
as	O	O	O
a	O	O	O
key	O	O	O
component	O	O	O
that	O	O	O
was	O	O	O
only	O	O	O
found	O	O	O
in	O	O	O
mandarin	O	O	B-T002
orange	O	O	I-T002
-fed	O	O	O
females	O	O	B-T032
and	O	O	O
induced	O	O	O
a	O	O	O
rejection	O	O	B-T080
response	O	O	B-T032
in	O	O	O
willow	O	O	B-T002
-fed	O	O	O
males	O	O	B-T032
.	O	O	O

Our	O	O	O
results	O	O	O
represent	O	O	O
the	O	O	O
first	O	O	O
example	O	O	O
of	O	O	O
a	O	O	O
female	O	O	B-T032
-acquired	O	O	O
repellent	O	O	B-T131
against	O	O	O
conspecific	O	O	O
males	O	O	B-T032
of	O	O	O
different	O	O	O
host	O	O	B-T002
plant	O	O	I-T002
populations	O	O	B-T081
,	O	O	O
indicating	O	O	O
that	O	O	O
the	O	O	O
host	O	O	O
plant	O	O	O
greatly	O	O	O
affects	O	O	O
the	O	O	O
female	O	O	B-T032
's	O	O	I-T032
sexual	O	O	B-T001
attractiveness	O	O	I-T001
.	O	O	O

-DOCSTART- (27412759)

Molecular	O	O	B-T080
detection	O	O	B-T061
of	O	O	O
infection	O	O	B-T046
homogeneity	O	O	B-T080
and	O	O	O
impact	O	O	B-T080
of	O	O	O
miltefosine	O	O	B-T109
treatment	O	O	B-T169
in	O	O	O
a	O	O	O
Syrian	O	O	B-T015
golden	O	O	I-T015
hamster	O	O	I-T015
model	O	O	O
of	O	O	O
Leishmania	O	O	B-T204
donovani	O	O	I-T204
and	O	O	O
L.	O	O	B-T204
infantum	O	O	I-T204
visceral	O	O	O
leishmaniasis	O	O	O

Control	O	O	B-T169
of	O	O	O
visceral	O	O	B-T047
leishmaniasis	O	O	I-T047
caused	O	O	O
by	O	O	O
Leishmania	O	O	B-T204
infantum	O	O	I-T204
and	O	O	O
Leishmania	O	O	B-T204
donovani	O	O	I-T204
primarily	O	O	O
relies	O	O	O
on	O	O	O
chemotherapy	O	O	B-T061
using	O	O	O
an	O	O	O
increasingly	O	O	O
compromised	O	O	B-T033
repertoire	O	O	O
of	O	O	O
antileishmanial	O	O	B-T121
compounds	O	O	I-T121
.	O	O	O

For	O	O	O
evaluation	O	O	B-T058
of	O	O	O
novel	O	O	B-T080
drugs	O	O	B-T121
,	O	O	O
the	O	O	O
Syrian	O	O	B-T015
golden	O	O	I-T015
hamster	O	O	I-T015
is	O	O	O
considered	O	O	O
as	O	O	O
a	O	O	O
clinically	O	O	B-T080
relevant	O	O	B-T080
laboratory	O	O	B-T170
model	O	O	I-T170
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
two	O	O	O
molecular	O	O	B-T059
parasite	O	O	I-T059
detection	O	O	I-T059
assays	O	O	I-T059
were	O	O	O
developed	O	O	O
targeting	O	O	B-T169
cathepsin-like	O	O	B-T116
cysteine	O	O	I-T116
protease	O	O	I-T116
B	O	O	I-T116
(	O	O	O
CPB	O	O	B-T116
)	O	O	O
DNA	O	O	B-T114
and	O	O	O
18S	O	O	O
rRNA	O	O	B-T114
to	O	O	O
achieve	O	O	O
absolute	O	O	B-T080
amastigote	O	O	B-T204
quantification	O	O	B-T081
in	O	O	O
the	O	O	O
major	O	O	O
target	O	O	B-T169
organs	O	O	B-T023
liver	O	O	B-T023
and	O	O	O
spleen	O	O	B-T023
.	O	O	O

Both	O	O	O
quantitative	O	O	B-T063
PCR	O	O	I-T063
(	O	O	B-T063
qPCR	O	O	I-T063
)	O	O	I-T063
techniques	O	O	I-T063
showed	O	O	O
excellent	O	O	O
agreement	O	O	O
with	O	O	O
a	O	O	O
strong	O	O	O
correlation	O	O	B-T080
with	O	O	O
the	O	O	O
conventional	O	O	O
microscopic	O	O	B-T059
reading	O	O	I-T059
of	O	O	O
Giemsa-stained	O	O	B-T059
tissue	O	O	B-T024
smears	O	O	B-T059
.	O	O	O

Using	O	O	O
multiple	O	O	B-T081
single	O	O	B-T081
tissue	O	O	B-T024
pieces	O	O	I-T024
and	O	O	O
all	O	O	O
three	O	O	O
detection	O	O	B-T033
methods	O	O	B-T170
,	O	O	O
we	O	O	O
confirmed	O	O	O
homogeneity	O	O	B-T080
of	O	O	O
infection	O	O	B-T046
in	O	O	O
liver	O	O	B-T023
and	O	O	O
spleen	O	O	B-T023
and	O	O	O
the	O	O	O
robustness	O	O	B-T080
of	O	O	O
extrapolating	O	O	O
whole	O	O	B-T081
organ	O	O	I-T081
burdens	O	O	I-T081
from	O	O	O
a	O	O	O
small	O	O	B-T081
single	O	O	O
tissue	O	O	B-T024
piece	O	O	I-T024
.	O	O	O

Comparison	O	O	B-T052
of	O	O	O
pre	O	O	B-T079
-	O	O	O
and	O	O	O
post-treatment	O	O	B-T079
burdens	O	O	B-T078
in	O	O	O
infected	O	O	B-T033
hamsters	O	O	B-T015
using	O	O	O
the	O	O	O
three	O	O	O
detection	O	O	B-T033
methods	O	O	B-T170
consistently	O	O	O
revealed	O	O	B-T080
a	O	O	O
stronger	O	O	O
parasite	O	O	B-T204
reduction	O	O	B-T080
in	O	O	O
the	O	O	O
spleen	O	O	B-T023
compared	O	O	B-T052
to	O	O	O
the	O	O	O
liver	O	O	B-T023
,	O	O	O
indicating	O	O	O
an	O	O	O
organ	O	O	B-T023
-	O	O	O
dependent	O	O	B-T080
clearance	O	O	B-T080
efficacy	O	O	B-T080
for	O	O	O
miltefosine	O	O	B-T109
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
,	O	O	O
this	O	O	O
study	O	O	B-T062
in	O	O	O
the	O	O	O
hamster	O	O	B-T015
demonstrated	O	O	O
high	O	O	B-T080
homogeneity	O	O	B-T080
of	O	O	O
infection	O	O	B-T046
in	O	O	O
liver	O	O	B-T023
and	O	O	O
spleen	O	O	B-T023
and	O	O	O
advocates	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
molecular	O	O	B-T080
detection	O	O	B-T061
methods	O	O	B-T170
for	O	O	O
assessment	O	O	B-T058
of	O	O	O
low	O	O	B-T080
(	O	O	O
post-treatment	O	O	B-T079
)	O	O	O
tissue	O	O	B-T024
burdens	O	O	B-T078
.	O	O	O

-DOCSTART- (27415391)

Approximate	O	O	B-T080
Bayesian	O	O	B-T081
computation	O	O	I-T081
for	O	O	O
estimating	O	O	B-T081
number	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
monodisperse	O	O	B-T080
nanoparticles	O	O	B-T073
in	O	O	O
suspension	O	O	B-T167
by	O	O	O
optical	O	O	O
microscopy	O	O	O

We	O	O	O
present	O	O	B-T078
an	O	O	O
approximate	O	O	B-T080
Bayesian	O	O	B-T081
computation	O	O	I-T081
scheme	O	O	B-T170
for	O	O	O
estimating	O	O	B-T081
number	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
monodisperse	O	O	B-T080
diffusing	O	O	B-T070
nanoparticles	O	O	B-T073
in	O	O	O
suspension	O	O	B-T167
by	O	O	O
optical	O	O	B-T059
particle	O	O	I-T059
tracking	O	O	I-T059
microscopy	O	O	I-T059
.	O	O	O

The	O	O	O
method	O	O	B-T169
is	O	O	O
based	O	O	B-T078
on	O	O	O
the	O	O	O
probability	O	O	B-T081
distribution	O	O	I-T081
of	O	O	O
the	O	O	O
time	O	O	B-T079
spent	O	O	B-T081
by	O	O	O
a	O	O	O
particle	O	O	B-T104
inside	O	O	B-T082
a	O	O	O
detection	O	O	B-T061
region	O	O	B-T082
.	O	O	O

We	O	O	O
validate	O	O	O
the	O	O	O
method	O	O	B-T169
on	O	O	O
suspensions	O	O	B-T167
of	O	O	O
well-controlled	O	O	B-T169
reference	O	O	B-T077
particles	O	O	B-T104
.	O	O	O

We	O	O	O
illustrate	O	O	O
its	O	O	O
usefulness	O	O	B-T080
with	O	O	O
an	O	O	O
application	O	O	B-T169
in	O	O	O
gene	O	O	B-T061
therapy	O	O	I-T061
,	O	O	O
applying	O	O	B-T169
the	O	O	O
method	O	O	B-T169
to	O	O	O
estimate	O	O	B-T081
number	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
plasmid	O	O	B-T114
DNA	O	O	B-T114
molecules	O	O	I-T114
and	O	O	O
the	O	O	O
average	O	O	B-T081
number	O	O	I-T081
of	O	O	O
DNA	O	O	O
molecules	O	O	O
complexed	O	O	B-T104
with	O	O	O
liposomal	O	O	B-T109
drug	O	O	B-T074
delivery	O	O	I-T074
particles	O	O	B-T104
.	O	O	O

-DOCSTART- (27417076)

Gestational	O	O	B-T032
age	O	O	I-T032
specific	O	O	O
stillbirth	O	O	B-T033
risk	O	O	B-T078
among	O	O	O
Indigenous	O	O	B-T102
and	O	O	O
non	O	O	B-T169
-	O	O	O
Indigenous	O	O	O
women	O	O	B-T098
in	O	O	O
Queensland	O	O	B-T083
,	O	O	O
Australia	O	O	B-T083
:	O	O	O
a	O	O	O
population	O	O	O
based	O	O	O
study	O	O	O

In	O	O	O
Australia	O	O	B-T083
,	O	O	O
significant	O	O	O
disparity	O	O	O
persists	O	O	O
in	O	O	O
stillbirth	O	O	B-T033
rates	O	O	B-T081
between	O	O	O
Aboriginal	O	O	B-T098
and	O	O	O
Torres	O	O	B-T098
Strait	O	O	I-T098
Islander	O	O	I-T098
(	O	O	O
Indigenous	O	O	B-T102
Australian	O	O	I-T098
)	O	O	O
and	O	O	O
non	O	O	B-T169
-	O	O	O
Indigenous	O	O	O
women	O	O	B-T098
.	O	O	O

Diabetes	O	O	B-T047
,	O	O	O
hypertension	O	O	B-T047
,	O	O	O
antepartum	O	O	B-T046
haemorrhage	O	O	I-T046
and	O	O	O
small-for-gestational	O	O	B-T046
age	O	O	I-T046
(	O	O	O
SGA	O	O	B-T046
)	O	O	O
have	O	O	O
been	O	O	O
identified	O	O	B-T080
as	O	O	O
important	O	O	B-T080
contributors	O	O	O
to	O	O	O
higher	O	O	O
rates	O	O	B-T081
among	O	O	O
Indigenous	O	O	B-T102
women	O	O	B-T098
.	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
examine	O	O	O
gestational	O	O	B-T032
age	O	O	I-T032
specific	O	O	O
risk	O	O	B-T078
of	O	O	O
stillbirth	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
these	O	O	O
conditions	O	O	B-T080
among	O	O	O
Indigenous	O	O	B-T102
and	O	O	O
non	O	O	B-T169
-	O	O	O
Indigenous	O	O	O
women	O	O	B-T098
.	O	O	O

Retrospective	O	O	B-T080
population-based	O	O	B-T062
study	O	O	I-T062
of	O	O	O
all	O	O	O
singleton	O	O	B-T099
births	O	O	B-T081
of	O	O	O
at	O	O	O
least	O	O	O
20	O	O	O
weeks	O	O	B-T079
gestation	O	O	B-T040
or	O	O	O
at	O	O	O
least	O	O	O
400	O	O	O
grams	O	O	B-T081
birthweight	O	O	B-T032
in	O	O	O
Queensland	O	O	B-T083
between	O	O	O
July	O	O	B-T080
2005	O	O	O
and	O	O	O
December	O	O	B-T080
2011	O	O	O
using	O	O	O
data	O	O	B-T078
from	O	O	O
the	O	O	O
Queensland	O	O	O
Perinatal	O	O	B-T079
Data	O	O	B-T062
Collection	O	O	I-T062
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
routinely-maintained	O	O	B-T170
database	O	O	I-T170
that	O	O	O
collects	O	O	O
data	O	O	O
on	O	O	O
all	O	O	O
births	O	O	O
in	O	O	O
Queensland	O	O	O
.	O	O	O

Multivariate	O	O	B-T062
logistic	O	O	I-T062
regression	O	O	I-T062
was	O	O	O
used	O	O	O
to	O	O	O
calculate	O	O	O
adjusted	O	O	B-T081
odds	O	O	I-T081
ratios	O	O	I-T081
(	O	O	O
aOR	O	O	B-T081
)	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
,	O	O	O
adjusting	O	O	O
for	O	O	O
maternal	O	O	B-T033
demographic	O	O	B-T078
and	O	O	O
pregnancy	O	O	B-T033
factors	O	O	I-T033
.	O	O	O

Of	O	O	O
360987	O	O	O
births	O	O	B-T081
analysed	O	O	B-T062
,	O	O	O
20273	O	O	O
(	O	O	O
5.6	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
to	O	O	O
Indigenous	O	O	B-T102
women	O	O	B-T098
and	O	O	O
340714	O	O	O
(	O	O	O
94.4	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
to	O	O	O
non	O	O	B-T169
-	O	O	O
Indigenous	O	O	O
women	O	O	O
.	O	O	O

Stillbirth	O	O	B-T033
rates	O	O	B-T081
were	O	O	O
7.9	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
6.8	O	O	O
-	O	O	O
9.2	O	O	O
)	O	O	O
and	O	O	O
4.1	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
3.9	O	O	O
-	O	O	O
4.3	O	O	O
)	O	O	O
per	O	O	O
1000	O	O	O
births	O	O	B-T081
,	O	O	O
respectively	O	O	O
.	O	O	O

For	O	O	O
both	O	O	O
Indigenous	O	O	B-T102
and	O	O	O
non	O	O	B-T169
-	O	O	O
Indigenous	O	O	O
women	O	O	B-T098
across	O	O	O
most	O	O	O
gestational	O	O	B-T079
age	O	O	B-T100
groups	O	O	I-T100
,	O	O	O
antepartum	O	O	B-T046
haemorrhage	O	O	I-T046
,	O	O	O
SGA	O	O	B-T046
,	O	O	O
pre-existing	O	O	B-T033
diabetes	O	O	I-T033
and	O	O	O
pre-existing	O	O	B-T033
hypertension	O	O	I-T033
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
stillbirth	O	O	B-T033
.	O	O	O

There	O	O	O
were	O	O	O
mixed	O	O	O
results	O	O	O
for	O	O	O
pre-eclampsia	O	O	B-T046
and	O	O	O
eclampsia	O	O	B-T047
and	O	O	O
a	O	O	O
consistently	O	O	O
raised	O	O	O
risk	O	O	B-T078
of	O	O	O
stillbirth	O	O	B-T033
was	O	O	O
not	O	O	O
seen	O	O	O
for	O	O	O
gestational	O	O	B-T047
diabetes	O	O	I-T047
.	O	O	O

This	O	O	O
study	O	O	B-T062
highlights	O	O	O
gestational	O	O	B-T032
age	O	O	I-T032
specific	O	O	O
stillbirth	O	O	B-T033
risk	O	O	B-T078
for	O	O	O
Indigenous	O	O	B-T102
and	O	O	O
non	O	O	B-T169
-	O	O	O
Indigenous	O	O	O
women	O	O	B-T098
;	O	O	O
and	O	O	O
disparity	O	O	O
in	O	O	O
risk	O	O	O
at	O	O	O
term	O	O	B-T040
gestations	O	O	I-T040
.	O	O	O

Improving	O	O	O
access	O	O	O
to	O	O	O
and	O	O	O
utilisation	O	O	O
of	O	O	O
appropriate	O	O	B-T080
and	O	O	O
responsive	O	O	B-T169
healthcare	O	O	B-T058
may	O	O	O
help	O	O	O
to	O	O	O
address	O	O	O
disparities	O	O	O
in	O	O	O
stillbirth	O	O	B-T033
risk	O	O	B-T078
for	O	O	O
Indigenous	O	O	B-T102
women	O	O	B-T098
.	O	O	O

-DOCSTART- (27417211)

Defining	O	O	B-T058
,	O	O	O
Describing	O	O	B-T170
,	O	O	O
and	O	O	O
Categorizing	O	O	B-T052
Public	O	O	B-T058
Health	O	O	I-T058
Infrastructure	O	O	I-T058
Priorities	O	O	B-T079
for	O	O	O
Tropical	O	O	B-T070
Cyclone	O	O	I-T070
,	O	O	O
Flood	O	O	B-T070
,	O	O	O
Storm	O	O	B-T070
,	O	O	O
Tornado	O	O	B-T070
,	O	O	O
and	O	O	O
Tsunami-Related	O	O	O
Disasters	O	O	O

The	O	O	O
study	O	O	B-T062
aim	O	O	O
was	O	O	O
to	O	O	O
undertake	O	O	O
a	O	O	O
qualitative	O	O	O
research	O	O	O
literature	O	O	B-T170
review	O	O	I-T170
to	O	O	O
analyze	O	O	O
available	O	O	O
databases	O	O	B-T170
to	O	O	O
define	O	O	B-T058
,	O	O	O
describe	O	O	B-T170
,	O	O	O
and	O	O	O
categorize	O	O	B-T052
public	O	O	B-T058
health	O	O	I-T058
infrastructure	O	O	I-T058
(	O	O	O
PHI	O	O	B-T058
)	O	O	O
priorities	O	O	B-T079
for	O	O	O
tropical	O	O	B-T070
cyclone	O	O	I-T070
,	O	O	O
flood	O	O	B-T070
,	O	O	O
storm	O	O	B-T070
,	O	O	O
tornado	O	O	B-T070
,	O	O	O
and	O	O	O
tsunami-related	O	O	B-T070
disasters	O	O	I-T070
.	O	O	O

Five	O	O	O
electronic	O	O	O
publication	O	O	B-T170
databases	O	O	I-T170
were	O	O	O
searched	O	O	O
to	O	O	O
define	O	O	B-T058
,	O	O	O
describe	O	O	B-T170
,	O	O	O
or	O	O	O
categorize	O	O	B-T052
PHI	O	O	B-T058
and	O	O	O
discuss	O	O	B-T054
tropical	O	O	B-T070
cyclone	O	O	I-T070
,	O	O	O
flood	O	O	B-T070
,	O	O	O
storm	O	O	B-T070
,	O	O	O
tornado	O	O	B-T070
,	O	O	O
and	O	O	O
tsunami-related	O	O	B-T070
disasters	O	O	I-T070
and	O	O	O
their	O	O	O
impact	O	O	B-T080
on	O	O	O
PHI	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T078
were	O	O	O
analyzed	O	O	O
through	O	O	O
aggregation	O	O	B-T169
of	O	O	O
individual	O	O	O
articles	O	O	B-T170
to	O	O	O
create	O	O	O
an	O	O	O
overall	O	O	O
data	O	O	O
description	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T078
were	O	O	O
grouped	O	O	B-T169
into	O	O	O
PHI	O	O	B-T058
themes	O	O	B-UnknownType
,	O	O	O
which	O	O	O
were	O	O	O
then	O	O	O
prioritized	O	O	B-T079
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
degree	O	O	O
of	O	O	O
interdependency	O	O	O
.	O	O	O

Sixty-seven	O	O	O
relevant	O	O	O
articles	O	O	B-T170
were	O	O	O
identified	O	O	O
.	O	O	O

PHI	O	O	B-T058
was	O	O	O
categorized	O	O	B-T052
into	O	O	O
13	O	O	O
themes	O	O	B-UnknownType
with	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
158	O	O	O
descriptors	O	O	B-T170
.	O	O	O

The	O	O	O
highest	O	O	O
priority	O	O	B-T079
PHI	O	O	B-T058
identified	O	O	O
was	O	O	O
workforce	O	O	B-T169
.	O	O	O

This	O	O	O
was	O	O	O
followed	O	O	O
by	O	O	O
water	O	O	B-T167
,	O	O	O
sanitation	O	O	B-T090
,	O	O	O
equipment	O	O	B-T073
,	O	O	O
communication	O	O	B-T054
,	O	O	O
physical	O	O	B-T073
structure	O	O	I-T073
,	O	O	O
power	O	O	B-T073
,	O	O	O
governance	O	O	B-T089
,	O	O	O
prevention	O	O	B-T080
,	O	O	O
supplies	O	O	B-T169
,	O	O	O
service	O	O	B-T057
,	O	O	O
transport	O	O	B-T073
,	O	O	O
and	O	O	O
surveillance	O	O	B-T169
.	O	O	O

This	O	O	O
review	O	O	B-T170
identified	O	O	O
workforce	O	O	B-T169
as	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
of	O	O	O
the	O	O	O
13	O	O	O
thematic	O	O	B-UnknownType
areas	O	O	I-UnknownType
related	O	O	O
to	O	O	O
PHI	O	O	B-T058
and	O	O	O
disasters	O	O	B-T070
.	O	O	O

If	O	O	O
its	O	O	O
functionality	O	O	O
fails	O	O	O
,	O	O	O
workforce	O	O	B-T169
has	O	O	O
the	O	O	O
greatest	O	O	O
impact	O	O	O
on	O	O	O
the	O	O	O
performance	O	O	O
of	O	O	O
health	O	O	B-T058
services	O	O	I-T058
.	O	O	O

If	O	O	O
addressed	O	O	O
post-disaster	O	O	B-T079
,	O	O	O
the	O	O	O
remaining	O	O	O
forms	O	O	O
of	O	O	O
PHI	O	O	B-T058
will	O	O	O
then	O	O	O
be	O	O	O
progressively	O	O	O
addressed	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
are	O	O	O
a	O	O	O
step	O	O	O
toward	O	O	O
providing	O	O	O
an	O	O	O
evidence	O	O	O
base	O	O	O
to	O	O	O
inform	O	O	O
PHI	O	O	B-T058
priorities	O	O	B-T079
in	O	O	O
the	O	O	O
disaster	O	O	B-T070
setting	O	O	O
.	O	O	O

(	O	O	O
Disaster	O	O	O
Med	O	O	O
Public	O	O	O
Health	O	O	O
Preparedness	O	O	O
.	O	O	O

2016;10:598	O	O	O
-	O	O	O
610	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27418256)

Fragment	O	O	B-T116
-Based	O	O	O
Discovery	O	O	B-T052
of	O	O	O
5-Arylisatin	O	O	B-T109
-Based	O	O	O
Inhibitors	O	O	B-T121
of	O	O	O
Matrix	O	O	B-T116
Metalloproteinases	O	O	I-T116
2	O	O	I-T116
and	O	O	O
13	O	O	O

Matrix	O	O	B-T116
metalloproteinases	O	O	I-T116
(	O	O	O
MMPs	O	O	B-T116
)	O	O	O
are	O	O	O
well-established	O	O	O
targets	O	O	O
for	O	O	O
several	O	O	O
pathologies	O	O	B-T046
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
MMP-2	O	O	B-T116
and	O	O	O
MMP-13	O	O	B-T116
play	O	O	O
a	O	O	O
prominent	O	O	O
role	O	O	O
in	O	O	O
cancer	O	O	B-T046
progression	O	O	I-T046
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
a	O	O	O
structure-based	O	O	B-T058
screening	O	O	I-T058
campaign	O	O	O
was	O	O	O
applied	O	O	O
to	O	O	O
prioritize	O	O	O
metalloproteinase	O	O	B-T116
-oriented	O	O	O
fragments	O	O	B-T116
.	O	O	O

This	O	O	O
computational	O	O	B-T066
model	O	O	I-T066
was	O	O	O
applied	O	O	O
to	O	O	O
a	O	O	O
representative	O	O	O
fragment	O	O	B-T116
set	O	O	B-T077
from	O	O	O
the	O	O	O
publically	O	O	O
available	O	O	O
EDASA	O	O	B-T170
Scientific	O	O	I-T170
compound	O	O	I-T170
library	O	O	I-T170
.	O	O	O

These	O	O	O
fragments	O	O	B-T116
were	O	O	O
prioritized	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
top-ranking	O	O	O
hits	O	O	O
were	O	O	O
tested	O	O	O
in	O	O	O
a	O	O	O
biological	O	O	B-T059
assay	O	O	I-T059
to	O	O	O
validate	O	O	B-T062
the	O	O	O
model	O	O	B-T066
.	O	O	O

Two	O	O	O
scaffolds	O	O	B-T116
showed	O	O	O
consistent	O	O	O
activity	O	O	B-T052
in	O	O	O
the	O	O	O
assay	O	O	B-T059
,	O	O	O
and	O	O	O
the	O	O	O
isatin-based	O	O	B-T109
compounds	O	O	I-T109
were	O	O	O
the	O	O	O
most	O	O	O
interesting	O	O	O
.	O	O	O

These	O	O	O
latter	O	O	O
fragments	O	O	B-T116
have	O	O	O
significant	O	O	O
potential	O	O	O
as	O	O	O
tools	O	O	O
for	O	O	O
the	O	O	O
design	O	O	B-T052
and	O	O	O
realization	O	O	O
of	O	O	O
novel	O	O	O
MMP	O	O	B-T121
inhibitors	O	O	I-T121
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
their	O	O	O
micromolar	O	O	B-T052
activity	O	O	I-T052
,	O	O	O
the	O	O	O
chemical	O	O	B-T070
synthesis	O	O	I-T070
affords	O	O	O
flexible	O	O	B-T080
and	O	O	O
creative	O	O	B-T082
access	O	O	I-T082
to	O	O	O
their	O	O	O
analogues	O	O	B-T104
.	O	O	O

-DOCSTART- (27427129)

Incidence	O	O	B-T081
of	O	O	O
environmental	O	O	B-T080
and	O	O	O
genetic	O	O	B-T080
factors	O	O	I-T080
causing	O	O	O
congenital	O	O	B-T019
cataract	O	O	I-T019
in	O	O	O
Children	O	O	B-T100
of	O	O	O
Lahore	O	O	O

To	O	O	O
check	O	O	O
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
environmental	O	O	B-T080
and	O	O	O
genetic	O	O	B-T080
factors	O	O	I-T080
causing	O	O	O
congenital	O	O	B-T019
cataract	O	O	I-T019
in	O	O	O
infants	O	O	B-T100
.	O	O	O

The	O	O	O
descriptive	O	O	B-T062
study	O	O	I-T062
was	O	O	O
conducted	O	O	O
at	O	O	O
Layton	O	O	B-T093
Rahmatullah	O	O	I-T093
Benevolent	O	O	I-T093
Trust	O	O	I-T093
,	O	O	O
Lahore	O	O	B-UnknownType
,	O	O	O
Pakistan	O	O	B-T083
,	O	O	O
from	O	O	O
October	O	O	O
2013	O	O	O
to	O	O	O
April	O	O	O
2014	O	O	O
,	O	O	O
and	O	O	O
comprised	O	O	O
children	O	O	B-T100
under	O	O	O
15	O	O	O
years	O	O	B-T079
of	O	O	O
age	O	O	B-T032
who	O	O	O
had	O	O	O
rubella	O	O	B-T047
syndrome	O	O	I-T047
,	O	O	O
herpes	O	O	B-T047
simplex	O	O	I-T047
,	O	O	O
birth	O	O	B-T033
trauma	O	O	I-T033
,	O	O	O
trisomy	O	O	B-T049
21	O	O	I-T049
,	O	O	O
Nance-Horan	O	O	B-T047
syndrome	O	O	I-T047
or	O	O	O
Lowe	O	O	B-T047
's	O	O	I-T047
syndrome	O	O	I-T047
.	O	O	O

Of	O	O	O
the	O	O	O
38,000	O	O	O
cases	O	O	B-T081
examined	O	O	O
,	O	O	O
120(0.3	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
were	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
congenital	O	O	B-T019
cataract	O	O	I-T019
.	O	O	O

Of	O	O	O
them	O	O	O
,	O	O	O
52(43.33%)were	O	O	O
aged	O	O	B-T032
between	O	O	O
2	O	O	O
and	O	O	O
5	O	O	O
years	O	O	B-T079
,	O	O	O
22(18.33	O	O	O
%	O	O	O
)	O	O	O
<	O	O	O
11	O	O	O
years	O	O	O
and	O	O	O
10(8.33	O	O	O
%	O	O	O
)	O	O	O
?	O	O	O
15	O	O	O
years	O	O	O
.	O	O	O

Bilateral	O	O	B-T047
congenital	O	O	I-T047
cataract	O	O	I-T047
was	O	O	O
observed	O	O	O
in	O	O	O
91(75.83	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
and	O	O	O
unilateral	O	O	B-T047
congenital	O	O	I-T047
cataract	O	O	I-T047
in	O	O	O
29(24.17	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Environmental	O	O	B-T080
factors	O	O	I-T080
caused	O	O	O
72(62.07	O	O	O
%	O	O	O
)	O	O	O
cases	O	O	B-T081
and	O	O	O
genetic	O	O	B-T080
factors	O	O	I-T080
caused	O	O	O
44(37.93	O	O	O
%	O	O	O
)	O	O	O
..	O	O	O

Congenital	O	O	B-T019
cataract	O	O	I-T019
predominated	O	O	B-T080
in	O	O	O
boys	O	O	B-T100
compared	O	O	O
to	O	O	O
girls	O	O	B-T100
.	O	O	O

Early	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
adequate	O	O	O
therapy	O	O	B-T061
requires	O	O	O
specific	O	O	O
technology	O	O	B-T090
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
long-term	O	O	B-T079
and	O	O	O
permanent	O	O	B-T079
care	O	O	B-T052
..	O	O	O

-DOCSTART- (27428958)

Transcriptome	O	O	B-T086
and	O	O	O
Metabolome	O	O	B-T070
Analyses	O	O	B-T062
of	O	O	O
Glucosinolates	O	O	B-T109
in	O	O	O
Two	O	O	O
Broccoli	O	O	B-T002
Cultivars	O	O	I-T002
Following	O	O	O
Jasmonate	O	O	B-T109
Treatment	O	O	B-T169
for	O	O	O
the	O	O	O
Induction	O	O	B-T169
of	O	O	O
Glucosinolate	O	O	B-T109
Defense	O	O	B-T077
to	O	O	O
Trichoplusia	O	O	B-T204
ni	O	O	I-T204
(	O	O	O
Hübner	O	O	B-T170
)	O	O	O

Lepidopteran	O	O	B-T204
larvae	O	O	B-T204
growth	O	O	B-T040
is	O	O	O
influenced	O	O	B-T077
by	O	O	O
host	O	O	B-T001
plant	O	O	B-T002
glucosinolate	O	O	B-T109
(	O	O	O
GS	O	O	B-T109
)	O	O	O
concentrations	O	O	B-T081
,	O	O	O
which	O	O	O
are	O	O	O
,	O	O	O
in	O	O	O
turn	O	O	O
,	O	O	O
influenced	O	O	O
by	O	O	O
the	O	O	O
phytohormone	O	O	B-T116
jasmonate	O	O	B-T109
(	O	O	O
JA	O	O	B-T109
)	O	O	O
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
elucidate	O	O	O
insect	O	O	B-T204
resistance	O	O	B-T169
biomarkers	O	O	B-T045
to	O	O	O
lepidopteran	O	O	B-T204
pests	O	O	B-T008
,	O	O	O
transcriptome	O	O	B-T086
and	O	O	O
metabolome	O	O	B-T070
analyses	O	O	B-T062
following	O	O	O
JA	O	O	B-T109
treatments	O	O	B-T169
were	O	O	O
conducted	O	O	O
with	O	O	O
two	O	O	O
broccoli	O	O	B-T002
cultivars	O	O	I-T002
,	O	O	O
Green	O	O	B-T002
Magic	O	O	I-T002
and	O	O	O
VI-158	O	O	B-T002
,	O	O	O
which	O	O	O
have	O	O	O
differentially	O	O	O
induced	O	O	B-T169
indole	O	O	B-T109
GSs	O	O	I-T109
,	O	O	O
neoglucobrassicin	O	O	B-T109
and	O	O	O
glucobrassicin	O	O	B-T109
,	O	O	O
respectively	O	O	O
.	O	O	O

To	O	O	O
test	O	O	B-T169
these	O	O	O
two	O	O	O
inducible	O	O	B-T169
GSs	O	O	B-T109
on	O	O	O
growth	O	O	B-T040
of	O	O	O
cabbage	O	O	B-T204
looper	O	O	I-T204
(	O	O	O
Trichoplusia	O	O	B-T204
ni	O	O	I-T204
)	O	O	O
,	O	O	O
eight	O	O	O
neonate	O	O	O
cabbage	O	O	B-T204
looper	O	O	I-T204
larvae	O	O	I-T204
were	O	O	O
placed	O	O	O
onto	O	O	O
each	O	O	O
of	O	O	O
three	O	O	O
plants	O	O	B-T002
per	O	O	O
JA	O	O	B-T109
treatments	O	O	B-T169
(	O	O	O
0	O	O	O
,	O	O	O
100	O	O	O
,	O	O	O
200	O	O	O
,	O	O	O
400	O	O	O
µM	O	O	O
)	O	O	O
three	O	O	O
days	O	O	B-T079
after	O	O	O
treatment	O	O	B-T169
.	O	O	O

After	O	O	O
five	O	O	O
days	O	O	B-T079
of	O	O	O
feeding	O	O	B-T052
,	O	O	O
weight	O	O	B-T081
of	O	O	O
larvae	O	O	B-T204
and	O	O	O
their	O	O	O
survival	O	O	B-T081
rate	O	O	I-T081
was	O	O	O
found	O	O	O
to	O	O	O
decrease	O	O	B-T081
with	O	O	O
increasing	O	O	B-T169
JA	O	O	B-T109
concentrations	O	O	B-T081
in	O	O	O
both	O	O	O
broccoli	O	O	B-T002
cultivars	O	O	I-T002
.	O	O	O

JA	O	O	B-T109
-	O	O	O
inducible	O	O	B-T169
GSs	O	O	B-T109
were	O	O	O
measured	O	O	B-T080
by	O	O	O
high	O	O	B-T059
performance	O	O	I-T059
liquid	O	O	I-T059
chromatography	O	O	I-T059
.	O	O	O

Neoglucobrassicin	O	O	B-T109
in	O	O	O
Green	O	O	B-T002
Magic	O	O	I-T002
and	O	O	O
glucobrassicin	O	O	B-T109
in	O	O	O
VI-158	O	O	B-T002
leaves	O	O	B-T002
were	O	O	O
increased	O	O	B-T081
in	O	O	O
a	O	O	O
dose-dependent	O	O	B-T081
manner	O	O	O
.	O	O	O

One	O	O	O
or	O	O	O
both	O	O	O
of	O	O	O
these	O	O	O
glucosinolates	O	O	B-T109
and/or	O	O	O
their	O	O	O
hydrolysis	O	O	B-T070
products	O	O	B-T071
showed	O	O	O
significant	O	O	O
inverse	O	O	B-T080
correlations	O	O	B-T080
with	O	O	O
larval	O	O	B-T204
weight	O	O	B-T081
and	O	O	O
survival	O	O	B-T052
(	O	O	O
five	O	O	O
days	O	O	B-T079
after	O	O	O
treatment	O	O	B-T169
)	O	O	O
while	O	O	O
being	O	O	O
positively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
days	O	O	O
to	O	O	O
pupation	O	O	B-T040
.	O	O	O

This	O	O	O
implies	O	O	O
that	O	O	O
these	O	O	O
two	O	O	O
JA	O	O	B-T109
-	O	O	O
inducible	O	O	B-T169
glucosinolates	O	O	B-T109
can	O	O	O
influence	O	O	B-T077
the	O	O	O
growth	O	O	B-T040
and	O	O	O
survival	O	O	B-T052
of	O	O	O
cabbage	O	O	B-T204
looper	O	O	I-T204
larvae	O	O	I-T204
.	O	O	O

Transcriptome	O	O	B-T059
profiling	O	O	I-T059
supported	O	O	O
the	O	O	O
observed	O	O	O
changes	O	O	B-T169
in	O	O	O
glucosinolate	O	O	B-T109
and	O	O	O
their	O	O	O
hydrolysis	O	O	B-T070
product	O	O	B-T071
concentrations	O	O	B-T081
following	O	O	O
JA	O	O	B-T109
treatments	O	O	B-T169
.	O	O	O

Several	O	O	O
genes	O	O	B-T028
related	O	O	O
to	O	O	O
GS	O	O	B-T109
metabolism	O	O	B-T040
differentiate	O	O	B-T169
the	O	O	O
two	O	O	O
broccoli	O	O	B-T002
cultivars	O	O	I-T002
in	O	O	O
their	O	O	O
pattern	O	O	B-T082
of	O	O	O
transcriptional	O	O	B-T045
response	O	O	B-T032
to	O	O	O
JA	O	O	B-T109
treatments	O	O	B-T169
.	O	O	O

Indicative	O	O	O
of	O	O	O
the	O	O	O
corresponding	O	O	O
change	O	O	B-T169
in	O	O	O
indole	O	O	B-T109
GS	O	O	I-T109
concentrations	O	O	B-T081
,	O	O	O
transcripts	O	O	B-T114
of	O	O	O
the	O	O	O
transcription	O	O	B-T116
factor	O	O	I-T116
MYB122	O	O	B-T116
,	O	O	O
core	O	O	O
structure	O	O	O
biosynthesis	O	O	B-T169
genes	O	O	B-T028
(	O	O	O
CYP79B2	O	O	B-T028
,	O	O	O
UGT74B1	O	O	B-T028
,	O	O	O
SUR1	O	O	B-T028
,	O	O	O
SOT16	O	O	B-T028
,	O	O	O
SOT17	O	O	B-T028
,	O	O	O
and	O	O	O
SOT18	O	O	B-T028
)	O	O	O
,	O	O	O
an	O	O	O
indole	O	O	B-T104
glucosinolate	O	O	B-T109
side	O	O	O
chain	O	O	O
modification	O	O	B-T033
gene	O	O	B-T028
(	O	O	O
IGMT1	O	O	B-T028
)	O	O	O
,	O	O	O
and	O	O	O
several	O	O	O
glucosinolate	O	O	O
hydrolysis	O	O	B-T070
genes	O	O	O
(	O	O	O
TGG1	O	O	B-T028
,	O	O	O
TGG2	O	O	B-T028
,	O	O	O
and	O	O	O
ESM1	O	O	B-T028
)	O	O	O
were	O	O	O
significantly	O	O	O
increased	O	O	B-T081
in	O	O	O
Green	O	O	B-T002
Magic	O	O	I-T002
(	O	O	O
statistically	O	O	O
significant	O	O	O
in	O	O	O
most	O	O	O
cases	O	O	O
at	O	O	O
400	O	O	O
µM	O	O	O
)	O	O	O
while	O	O	O
UGT74B1	O	O	O
and	O	O	O
MYB122	O	O	O
were	O	O	O
significantly	O	O	O
increased	O	O	O
in	O	O	O
VI-158	O	O	B-T002
.	O	O	O

Therefore	O	O	O
,	O	O	O
these	O	O	O
metabolite	O	O	B-T123
and	O	O	O
transcript	O	O	B-T114
biomarker	O	O	B-T045
results	O	O	O
indicate	O	O	O
that	O	O	O
transcriptome	O	O	B-T059
profiling	O	O	I-T059
can	O	O	O
identify	O	O	B-T080
genes	O	O	B-T028
associated	O	O	O
with	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
two	O	O	O
different	O	O	O
indole	O	O	B-T109
GS	O	O	I-T109
and	O	O	O
their	O	O	O
hydrolysis	O	O	B-T070
products	O	O	B-T071
.	O	O	O

Therefore	O	O	O
,	O	O	O
these	O	O	O
metabolite	O	O	B-T123
and	O	O	O
transcript	O	O	B-T114
biomarkers	O	O	B-T045
could	O	O	O
be	O	O	O
useful	O	O	O
in	O	O	O
an	O	O	O
effective	O	O	B-T080
marker	O	O	B-T045
-	O	O	O
assisted	O	O	B-T080
breeding	O	O	B-T040
strategy	O	O	O
for	O	O	O
resistance	O	O	B-T169
to	O	O	O
generalist	O	O	O
lepidopteran	O	O	B-T204
pests	O	O	B-T008
in	O	O	O
broccoli	O	O	B-T002
and	O	O	O
potentially	O	O	O
other	O	O	O
Brassica	O	O	B-T168
vegetables	O	O	I-T168
.	O	O	O

-DOCSTART- (27429935)

The	O	O	O
clinical	O	O	B-T033
prognosis	O	O	I-T033
of	O	O	O
implants	O	O	B-T074
that	O	O	O
are	O	O	O
placed	O	O	O
against	O	O	O
super-erupted	O	O	B-T047
opposing	O	O	O
dentition	O	O	O

If	O	O	O
teeth	O	O	B-T023
are	O	O	O
missing	O	O	B-T020
,	O	O	O
super-eruption	O	O	B-T047
of	O	O	I-T047
teeth	O	O	I-T047
in	O	O	O
the	O	O	O
opposing	O	O	B-T082
arch	O	O	I-T082
can	O	O	O
occur	O	O	O
in	O	O	O
the	O	O	O
area	O	O	B-T082
and	O	O	O
can	O	O	O
change	O	O	O
the	O	O	O
occlusal	O	O	B-T042
plane	O	O	I-T042
.	O	O	O

When	O	O	O
missing	O	O	B-T020
teeth	O	O	I-T020
are	O	O	O
replaced	O	O	O
with	O	O	O
implants	O	O	B-T074
,	O	O	O
the	O	O	O
oral	O	O	B-T097
surgeon	O	O	I-T097
must	O	O	O
determine	O	O	O
whether	O	O	O
or	O	O	O
not	O	O	O
the	O	O	O
super-erupted	O	O	B-T023
teeth	O	O	I-T023
need	O	O	O
to	O	O	O
be	O	O	O
treated	O	O	B-T169
in	O	O	O
order	O	O	O
to	O	O	O
normalize	O	O	B-T062
the	O	O	O
occlusal	O	O	B-T042
plane	O	O	I-T042
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
evaluated	O	O	B-T058
the	O	O	O
clinical	O	O	B-T033
prognosis	O	O	I-T033
of	O	O	O
dentition	O	O	B-T023
after	O	O	O
implant	O	O	B-T061
placement	O	O	I-T061
and	O	O	O
prosthetic	O	O	B-T061
treatment	O	O	B-T169
were	O	O	O
completed	O	O	B-T080
in	O	O	O
an	O	O	O
occlusal	O	O	B-T042
plane	O	O	I-T042
altered	O	O	O
by	O	O	O
super-erupted	O	O	B-T023
teeth	O	O	I-T023
in	O	O	O
the	O	O	O
opposing	O	O	B-T082
arch	O	O	I-T082
without	O	O	O
additional	O	O	O
treatment	O	O	O
of	O	O	O
the	O	O	O
super-erupted	O	O	O
teeth	O	O	O
.	O	O	O

Twenty-two	O	O	O
patients	O	O	B-T101
(	O	O	O
9	O	O	O
males	O	O	B-T032
,	O	O	O
13	O	O	O
females	O	O	B-T032
)	O	O	O
were	O	O	O
treated	O	O	B-T169
with	O	O	O
implants	O	O	B-T074
and	O	O	O
prosthetics	O	O	B-T074
without	O	O	O
addressing	O	O	O
the	O	O	O
super-erupted	O	O	B-T047
opposing	O	O	O
dentition	O	O	B-T023
from	O	O	O
April	O	O	O
2004	O	O	O
to	O	O	O
August	O	O	O
2012	O	O	O
at	O	O	O
Seoul	O	O	B-T083
National	O	O	B-T093
University	O	O	I-T093
Bundang	O	O	I-T093
Hospital	O	O	I-T093
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
33	O	O	O
implants	O	O	B-T074
were	O	O	O
placed	O	O	O
.	O	O	O

Values	O	O	O
of	O	O	O
crestal	O	O	B-T047
bone	O	O	I-T047
loss	O	O	I-T047
,	O	O	O
survival	O	O	B-T081
rates	O	O	I-T081
,	O	O	O
and	O	O	O
surgical	O	O	B-T046
and	O	O	O
prosthetic	O	O	B-T046
complications	O	O	I-T046
for	O	O	O
an	O	O	O
average	O	O	O
of	O	O	O
29.6	O	O	O
months	O	O	B-T079
after	O	O	O
prosthetic	O	O	B-T061
loading	O	O	I-T061
were	O	O	O
recorded	O	O	O
.	O	O	O

In	O	O	O
one	O	O	O
case	O	O	B-T077
,	O	O	O
the	O	O	O
cover	O	O	B-T074
screw	O	O	I-T074
was	O	O	O
exposed	O	O	O
after	O	O	O
implant	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

The	O	O	O
mean	O	O	O
crestal	O	O	B-T047
bone	O	O	I-T047
loss	O	O	I-T047
was	O	O	O
0.09±0.30	O	O	O
mm	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
33	O	O	O
implants	O	O	B-T074
,	O	O	O
31	O	O	O
survived	O	O	B-T067
,	O	O	O
a	O	O	O
survival	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
93.94	O	O	O
%	O	O	O
.	O	O	O

A	O	O	O
prosthetic	O	O	B-T046
complication	O	O	I-T046
occurred	O	O	O
in	O	O	O
one	O	O	O
case	O	O	B-T077
but	O	O	O
functioned	O	O	O
well	O	O	O
after	O	O	O
correction	O	O	O
.	O	O	O

Favorable	O	O	O
clinical	O	O	B-T034
results	O	O	I-T034
from	O	O	O
prosthetic	O	O	B-T046
complications	O	O	I-T046
,	O	O	O
crestal	O	O	B-T047
bone	O	O	I-T047
loss	O	O	I-T047
,	O	O	O
and	O	O	O
implant	O	O	B-T074
survival	O	O	B-T081
rates	O	O	I-T081
were	O	O	O
exhibited	O	O	O
in	O	O	O
implants	O	O	B-T074
next	O	O	O
to	O	O	O
a	O	O	O
super-erupted	O	O	B-T023
opposing	O	O	I-T023
tooth	O	O	I-T023
.	O	O	O

-DOCSTART- (27430662)

Evaluation	O	O	B-T080
of	O	O	O
Mathisen	O	O	B-T169
's	O	O	I-T169
technique	O	O	I-T169
for	O	O	O
ureteral	O	O	B-T061
reimplantation	O	O	I-T061
in	O	O	O
children	O	O	B-T100
with	O	O	O
primary	O	O	B-T080
vesicoureteral	O	O	O
reflux	O	O	O

Although	O	O	O
cross-trigonal	O	O	B-T061
ureteral	O	O	I-T061
reimplantation	O	O	I-T061
(	O	O	I-T061
Cohen	O	O	I-T061
)	O	O	I-T061
is	O	O	O
a	O	O	O
commonly	O	O	O
used	O	O	O
technique	O	O	B-T169
in	O	O	O
children	O	O	B-T100
,	O	O	O
it	O	O	O
represents	O	O	O
a	O	O	O
non-physiological	O	O	B-T041
transfer	O	O	I-T041
of	O	O	O
the	O	O	O
ureteral	O	O	B-T030
orifices	O	O	I-T030
and	O	O	O
may	O	O	O
prove	O	O	O
challenging	O	O	O
with	O	O	O
regard	O	O	O
to	O	O	O
endoscopic	O	O	B-T061
ureteral	O	O	I-T061
operations	O	O	I-T061
in	O	O	O
later	O	O	B-T079
life	O	O	B-T078
.	O	O	O

In	O	O	O
1964	O	O	O
,	O	O	O
Mathisen	O	O	O
described	O	O	B-T078
an	O	O	O
alternative	O	O	B-T077
method	O	O	B-T169
of	O	O	O
ureteral	O	O	B-T061
reimplantation	O	O	I-T061
with	O	O	O
lateralization	O	O	B-T169
of	O	O	O
the	O	O	O
neohiatus	O	O	B-T082
,	O	O	O
creating	O	O	O
an	O	O	O
orthotopic	O	O	B-T082
course	O	O	B-T079
of	O	O	O
the	O	O	O
submucosal	O	O	B-T023
ureter	O	O	I-T023
.	O	O	O

We	O	O	O
have	O	O	O
evaluated	O	O	B-T052
success	O	O	B-T080
and	O	O	O
complication	O	O	B-T078
rates	O	O	B-T081
of	O	O	O
both	O	O	O
techniques	O	O	B-T169
that	O	O	O
were	O	O	O
applied	O	O	B-T169
sequentially	O	O	B-T169
at	O	O	O
our	O	O	O
departments	O	O	B-T092
.	O	O	O

Forty-eight	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
(	O	O	O
83	O	O	O
ureters	O	O	B-T098
,	O	O	O
24	O	O	O
males	O	O	B-T098
/24	O	O	O
females	O	O	B-T098
)	O	O	O
following	O	O	O
Mathisen	O	O	B-T061
reimplantation	O	O	I-T061
were	O	O	O
compared	O	O	B-T052
with	O	O	O
53	O	O	O
consecutive	O	O	O
patients	O	O	O
(	O	O	O
98	O	O	O
ureters	O	O	O
,	O	O	O
30	O	O	O
males	O	O	O
/23	O	O	O
females	O	O	O
)	O	O	O
following	O	O	O
Cohen	O	O	B-T061
reimplantation	O	O	I-T061
.	O	O	O

Inclusion	O	O	B-T080
criteria	O	O	B-T078
were	O	O	O
primary	O	O	B-T080
vesicoureteral	O	O	B-T047
reflux	O	O	I-T047
(	O	O	O
VUR	O	O	B-T047
)	O	O	O
and	O	O	O
no	O	O	O
previous	O	O	B-T079
intervention	O	O	B-T061
.	O	O	O

Reflux	O	O	B-T047
grades	O	O	B-T185
(	O	O	O
Mathisen	O	O	O
58	O	O	O
ureters	O	O	B-T098
/69.9	O	O	O
%	O	O	O
VUR	O	O	B-T033
≥	O	O	I-T033
III	O	O	I-T033
;	O	O	O
Cohen	O	O	O
66	O	O	O
ureters	O	O	O
/66.7	O	O	O
%	O	O	O
VUR	O	O	O
≥	O	O	O
III	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
occurence	O	O	O
of	O	O	O
other	O	O	O
complicating	O	O	B-T169
factors	O	O	B-T169
(	O	O	O
ureteroceles	O	O	B-T020
,	O	O	O
megaureters	O	O	B-T190
,	O	O	O
posterior	O	O	B-T019
urethral	O	O	I-T019
valves	O	O	I-T019
)	O	O	O
in	O	O	O
both	O	O	O
groups	O	O	B-T078
were	O	O	O
comparable	O	O	B-T052
.	O	O	O

After	O	O	O
Cohen	O	O	B-T061
's	O	O	I-T061
reimplantation	O	O	I-T061
there	O	O	O
were	O	O	O
no	O	O	O
immediate	O	O	B-T079
complications	O	O	B-T046
requiring	O	O	O
intervention	O	O	B-T061
;	O	O	O
during	O	O	B-T079
follow-up	O	O	B-T058
(	O	O	O
mean	O	O	B-T081
28.2	O	O	O
months	O	O	B-T079
)	O	O	O
three	O	O	O
patients	O	O	B-T101
(	O	O	O
5.6	O	O	O
%	O	O	O
)	O	O	O
suffered	O	O	B-T048
febrile	O	O	B-T047
urinary	O	O	I-T047
tract	O	O	I-T047
infections	O	O	I-T047
(	O	O	O
UTIs	O	O	B-T047
)	O	O	O
,	O	O	O
of	O	O	O
which	O	O	O
one	O	O	O
(	O	O	O
1.8	O	O	O
%	O	O	O
)	O	O	O
was	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
a	O	O	O
persisting	O	O	B-T078
VUR	O	O	B-T047
.	O	O	O

Persistent	O	O	B-T078
hydronephroses	O	O	B-T047
(	O	O	O
≥II	O	O	O
SFU	O	O	B-T047
)	O	O	O
were	O	O	O
recorded	O	O	O
in	O	O	O
six	O	O	O
patients	O	O	B-T101
(	O	O	O
13.2	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
reimplantation	O	O	B-T061
using	O	O	O
Mathisen	O	O	B-T169
's	O	O	I-T169
technique	O	O	I-T169
,	O	O	O
two	O	O	O
patients	O	O	B-T101
(	O	O	O
4.1	O	O	O
%	O	O	O
)	O	O	O
suffered	O	O	B-T048
significant	O	O	B-T078
intravesical	O	O	B-T047
bleeding	O	O	I-T047
;	O	O	O
during	O	O	O
follow-up	O	O	B-T058
(	O	O	O
mean	O	O	B-T081
23.06	O	O	O
months	O	O	B-T079
)	O	O	O
four	O	O	O
patients	O	O	O
(	O	O	O
8.3	O	O	O
%	O	O	O
)	O	O	O
suffered	O	O	O
febrile	O	O	B-T047
UTIs	O	O	I-T047
,	O	O	O
and	O	O	O
seven	O	O	O
patients	O	O	O
(	O	O	O
14.5	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
persisting	O	O	B-T078
VUR	O	O	B-T047
after	O	O	O
a	O	O	O
mean	O	O	O
follow-up	O	O	O
of	O	O	O
10.8	O	O	O
months	O	O	O
.	O	O	O

The	O	O	O
patients	O	O	B-T101
with	O	O	O
persistent	O	O	B-T078
VUR	O	O	B-T047
had	O	O	O
more	O	O	O
commonly	O	O	O
high-grade	O	O	B-T080
(	O	O	O
IV	O	O	O
and	O	O	O
V	O	O	O
)	O	O	O
VUR	O	O	O
initially	O	O	O
,	O	O	O
compared	O	O	B-T052
to	O	O	O
the	O	O	O
whole	O	O	B-T078
group	O	O	I-T078
.	O	O	O

Two	O	O	O
patients	O	O	B-T101
(	O	O	O
4.1	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
persistent	O	O	B-T078
hydronephroses	O	O	B-T047
(	O	O	O
≥II	O	O	O
SFU	O	O	B-T047
)	O	O	O
.	O	O	O

Mathisen	O	O	B-T169
's	O	O	I-T169
technique	O	O	I-T169
for	O	O	O
ureteral	O	O	B-T061
reimplantation	O	O	I-T061
yielded	O	O	O
a	O	O	O
significantly	O	O	B-T078
(	O	O	O
p	O	O	O
=	O	O	O
0.0256	O	O	O
patients	O	O	B-T101
,	O	O	O
p	O	O	O
=	O	O	O
0.006	O	O	O
ureterorenal	O	O	B-T081
units	O	O	I-T081
)	O	O	O
lower	O	O	B-T082
success	O	O	B-T080
rate	O	O	B-T081
(	O	O	O
85.5	O	O	O
%	O	O	O
patients	O	O	O
,	O	O	O
89.2	O	O	O
%	O	O	O
ureterorenal	O	O	O
units	O	O	O
)	O	O	O
in	O	O	O
comparison	O	O	B-T052
with	O	O	O
Cohen	O	O	B-T169
's	O	O	I-T169
technique	O	O	I-T169
(	O	O	O
98.2	O	O	O
%	O	O	O
patients	O	O	O
,	O	O	O
99	O	O	O
%	O	O	O
ureterorenal	O	O	O
units	O	O	O
)	O	O	O
.	O	O	O

Although	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
intervention	O	O	B-T061
for	O	O	O
obstruction	O	O	B-T046
,	O	O	O
persistent	O	O	B-T078
hydronephrosis	O	O	B-T047
was	O	O	O
more	O	O	O
common	O	O	O
in	O	O	O
the	O	O	O
Cohen	O	O	B-T078
group	O	O	I-T078
(	O	O	O
13.2	O	O	O
%	O	O	O
vs.	O	O	O
4.1	O	O	O
%	O	O	O
,	O	O	O
n.s	O	O	O
.	O	O	O
)	O	O	O
.	O	O	O

Despite	O	O	O
the	O	O	O
advantages	O	O	O
of	O	O	O
an	O	O	O
orthotopic	O	O	B-T082
ureteral	O	O	B-T030
orifice	O	O	I-T030
close	O	O	O
to	O	O	O
the	O	O	O
bladder	O	O	B-T023
neck	O	O	I-T023
,	O	O	O
as	O	O	O
achieved	O	O	O
by	O	O	O
Mathisen	O	O	B-T061
's	O	O	I-T061
reimplantation	O	O	I-T061
,	O	O	O
cross-trigonal	O	O	B-T061
ureteral	O	O	I-T061
reimplantation	O	O	I-T061
proved	O	O	O
more	O	O	O
reliable	O	O	B-T170
for	O	O	O
VUR	O	O	B-T047
correction	O	O	B-T169
.	O	O	O

As	O	O	O
regards	O	O	O
optimizing	O	O	O
the	O	O	O
results	O	O	O
,	O	O	O
patient	O	O	B-T062
selection	O	O	I-T062
for	O	O	O
either	O	O	O
technique	O	O	B-T169
could	O	O	O
prove	O	O	B-T080
essential	O	O	I-T080
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
as	O	O	O
regards	O	O	O
the	O	O	O
difficulties	O	O	B-T080
with	O	O	O
ectopic	O	O	B-T082
ureteral	O	O	B-T030
orifices	O	O	I-T030
in	O	O	O
the	O	O	O
Cohen	O	O	B-T169
technique	O	O	B-T169
in	O	O	O
the	O	O	O
long-term	O	O	B-T079
follow-up	O	O	B-T058
,	O	O	O
the	O	O	O
concept	O	O	B-T078
of	O	O	O
anatomic	O	O	B-T080
,	O	O	O
orthotopic	O	O	B-T082
ureteral	O	O	B-T061
reimplantation	O	O	I-T061
should	O	O	O
be	O	O	O
pursued	O	O	O
and	O	O	O
the	O	O	O
technique	O	O	O
should	O	O	O
be	O	O	O
further	O	O	O
refined	O	O	O
.	O	O	O

-DOCSTART- (27432486)

The	O	O	O
use	O	O	B-T169
of	O	O	I-T169
neonatal	O	O	B-T079
extracorporeal	O	O	B-T061
life	O	O	I-T061
support	O	O	I-T061
in	O	O	O
pediatric	O	O	B-T080
cardiac	O	O	O
intensive	O	O	O
care	O	O	O
unit	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	O
is	O	O	O
to	O	O	O
evaluate	O	O	B-T058
extracorporeal	O	O	B-T061
life	O	O	I-T061
support	O	O	I-T061
system	O	O	I-T061
(	O	O	O
ECLS	O	O	B-T061
)	O	O	O
employed	O	O	O
in	O	O	O
neonates	O	O	B-T100
in	O	O	O
pediatric	O	O	B-T080
cardiac	O	O	B-T093
intensive	O	O	I-T093
care	O	O	I-T093
unit	O	O	I-T093
.	O	O	O

Twenty-five	O	O	O
neonates	O	O	B-T100
that	O	O	O
required	O	O	O
ECLS	O	O	B-T061
in	O	O	O
between	O	O	O
November	O	O	O
2010	O	O	O
and	O	O	O
November	O	O	O
2015	O	O	O
were	O	O	O
evaluated	O	O	B-T058
.	O	O	O

The	O	O	O
median	O	O	B-T081
age	O	O	B-T032
was	O	O	O
12	O	O	O
days	O	O	B-T079
(	O	O	O
range	O	O	B-T081
3	O	O	O
-	O	O	O
28	O	O	O
days	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
median	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
was	O	O	O
3	O	O	O
kg	O	O	O
(	O	O	O
range	O	O	O
2.5	O	O	O
-	O	O	O
5	O	O	O
kg	O	O	O
)	O	O	O
.	O	O	O

Venoarterial	O	O	B-T082
ECLS	O	O	B-T061
was	O	O	O
performed	O	O	B-T169
in	O	O	O
all	O	O	O
of	O	O	O
the	O	O	O
cases	O	O	O
.	O	O	O

Ascendan	O	O	B-T023
aorta	O	O	I-T023
-	O	O	O
right	O	O	B-T023
atrial	O	O	I-T023
cannulation	O	O	B-T061
in	O	O	O
22	O	O	O
patients	O	O	B-T101
and	O	O	O
neck	O	O	B-T029
cannulation	O	O	O
in	O	O	O
three	O	O	O
patients	O	O	O
were	O	O	O
performed	O	O	B-T169
.	O	O	O

The	O	O	O
reason	O	O	O
for	O	O	O
ECLS	O	O	B-T061
was	O	O	O
E-CPR	O	O	B-T061
in	O	O	O
two	O	O	O
patients	O	O	B-T101
,	O	O	O
inability	O	O	B-T033
to	O	O	I-T033
wean	O	O	I-T033
from	O	O	O
cardiopulmonary	O	O	B-T061
bypass	O	O	I-T061
(	O	O	O
CPB	O	O	B-T061
)	O	O	O
in	O	O	O
seven	O	O	O
patients	O	O	O
,	O	O	O
respiratory	O	O	B-T046
insufficiency	O	O	I-T046
and	O	O	O
hypoxia	O	O	B-T046
in	O	O	O
nine	O	O	O
patients	O	O	O
,	O	O	O
low	O	O	B-T046
cardiac	O	O	I-T046
output	O	O	I-T046
(	O	O	O
LCOS	O	O	B-T046
)	O	O	O
in	O	O	O
seven	O	O	O
patients	O	O	O
.	O	O	O

Median	O	O	B-T081
duration	O	O	B-T079
of	O	O	O
ECLS	O	O	B-T061
was	O	O	O
four	O	O	O
days	O	O	B-T079
(	O	O	O
range	O	O	B-T081
1	O	O	O
-	O	O	O
15	O	O	O
)	O	O	O
.	O	O	O

Hemorrhagic	O	O	B-T080
complications	O	O	B-T046
developed	O	O	O
in	O	O	O
15	O	O	O
,	O	O	O
renal	O	O	B-T046
complications	O	O	I-T046
in	O	O	O
13	O	O	O
,	O	O	O
pulmonary	O	O	B-T046
complications	O	O	I-T046
in	O	O	O
12	O	O	O
,	O	O	O
infectious	O	O	B-T047
complications	O	O	O
in	O	O	O
11	O	O	O
,	O	O	O
neurologic	O	O	B-T046
complications	O	O	I-T046
in	O	O	O
three	O	O	O
and	O	O	O
mechanical	O	O	B-T046
complications	O	O	I-T046
in	O	O	O
two	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
.	O	O	O

Weaning	O	O	B-T033
was	O	O	O
successful	O	O	B-T080
in	O	O	O
15	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
.	O	O	O

Eleven	O	O	O
patients	O	O	B-T101
were	O	O	O
successfully	O	O	B-T080
discharged	O	O	B-T058
.	O	O	O

ECLS	O	O	B-T061
is	O	O	O
an	O	O	O
important	O	O	B-T080
treatment	O	O	B-T061
option	O	O	I-T061
that	O	O	O
is	O	O	O
performed	O	O	B-T169
successfully	O	O	B-T080
in	O	O	O
many	O	O	O
centers	O	O	B-T093
around	O	O	O
the	O	O	O
world	O	O	B-T098
to	O	O	O
maintain	O	O	B-T052
life	O	O	B-T061
support	O	O	I-T061
in	O	O	O
patients	O	O	B-T101
unresponsive	O	O	B-T169
to	O	O	I-T169
medical	O	O	I-T169
treatment	O	O	I-T169
.	O	O	O

The	O	O	O
utilization	O	O	B-T169
of	O	O	O
this	O	O	O
modality	O	O	B-T078
especially	O	O	O
in	O	O	O
newborns	O	O	B-T100
with	O	O	O
congenital	O	O	B-T019
heart	O	O	I-T019
disease	O	O	I-T019
should	O	O	O
be	O	O	O
taken	O	O	O
into	O	O	O
consideration	O	O	O
.	O	O	O

-DOCSTART- (27435204)

Medicare	O	O	B-T064
claims	O	O	B-T170
indicators	O	O	B-T169
of	O	O	O
healthcare	O	O	B-T058
utilization	O	O	B-T169
differences	O	O	B-T080
after	O	O	O
hospitalization	O	O	B-T058
for	O	O	O
ischemic	O	O	B-T047
stroke	O	O	I-T047
:	O	O	O
Race	O	O	B-T098
,	O	O	O
gender	O	O	B-T032
,	O	O	O
and	O	O	O
caregiving	O	O	B-T052
effects	O	O	O

Background	O	O	B-T077
Differences	O	O	B-T080
in	O	O	O
healthcare	O	O	B-T058
utilization	O	O	B-T169
after	O	O	O
stroke	O	O	B-T047
may	O	O	O
partly	O	O	O
explain	O	O	O
race	O	O	B-T098
or	O	O	O
gender	O	O	B-T032
differences	O	O	B-T080
in	O	O	O
stroke	O	O	O
outcomes	O	O	O
and	O	O	O
identify	O	O	O
factors	O	O	B-T169
that	O	O	O
might	O	O	O
reduce	O	O	B-T080
post	O	O	B-T079
-	O	O	O
acute	O	O	B-T047
stroke	O	O	I-T047
care	O	O	B-T081
costs	O	O	I-T081
.	O	O	O

Aim	O	O	O
To	O	O	O
examine	O	O	O
systematic	O	O	B-T169
differences	O	O	B-T080
in	O	O	O
Medicare	O	O	B-T064
claims	O	O	B-T170
for	O	O	O
healthcare	O	O	B-T058
utilization	O	O	B-T169
after	O	O	O
hospitalization	O	O	B-T058
for	O	O	O
ischemic	O	O	B-T047
stroke	O	O	I-T047
in	O	O	O
a	O	O	O
US	O	O	B-T083
population	O	O	B-T098
-based	O	O	O
sample	O	O	B-T096
.	O	O	O

Methods	O	O	O
Claims	O	O	B-T170
were	O	O	O
examined	O	O	B-T033
over	O	O	O
a	O	O	O
six-month	O	O	B-T079
period	O	O	B-T079
after	O	O	O
hospitalization	O	O	B-T058
for	O	O	O
279	O	O	O
ischemic	O	O	B-T047
stroke	O	O	I-T047
survivors	O	O	B-T101
65	O	O	O
years	O	O	B-T079
or	O	O	O
older	O	O	B-T098
from	O	O	O
the	O	O	O
REasons	O	O	B-T078
for	O	O	O
Geographic	O	O	B-T078
And	O	O	O
Racial	O	O	B-T033
Differences	O	O	I-T033
in	O	O	O
Stroke	O	O	B-T047
(	O	O	O
REGARDS	O	O	B-T047
)	O	O	O
study	O	O	O
.	O	O	O

Statistical	O	O	B-T062
analyses	O	O	I-T062
examined	O	O	B-T033
differences	O	O	B-T080
in	O	O	O
post	O	O	B-T079
-	O	O	O
acute	O	O	B-T058
healthcare	O	O	I-T058
utilization	O	O	B-T169
,	O	O	O
adjusted	O	O	O
for	O	O	O
pre	O	O	B-T079
-	O	O	O
stroke	O	O	B-T047
utilization	O	O	O
,	O	O	O
as	O	O	O
a	O	O	O
function	O	O	B-T169
of	O	O	O
race	O	O	B-T098
(	O	O	O
African-American	O	O	B-T098
vs.	O	O	O
White	O	O	B-T098
)	O	O	O
,	O	O	O
gender	O	O	B-T032
,	O	O	O
age	O	O	B-T032
,	O	O	O
stroke	O	O	B-UnknownType
belt	O	O	I-UnknownType
residence	O	O	B-T082
,	O	O	O
income	O	O	B-T081
,	O	O	O
Medicaid	O	O	B-T064
dual-eligibility	O	O	I-T064
,	O	O	O
Charlson	O	O	B-T170
comorbidity	O	O	I-T170
index	O	O	I-T170
,	O	O	O
and	O	O	O
whether	O	O	O
the	O	O	O
person	O	O	B-T098
lived	O	O	B-T052
with	O	O	O
an	O	O	O
available	O	O	B-T169
caregiver	O	O	B-T097
.	O	O	O

Results	O	O	O
After	O	O	O
adjusting	O	O	O
for	O	O	O
covariates	O	O	O
,	O	O	O
women	O	O	B-T098
were	O	O	O
more	O	O	O
likely	O	O	O
than	O	O	O
men	O	O	B-T098
to	O	O	O
receive	O	O	B-T080
home	O	O	B-T058
health	O	O	I-T058
care	O	O	I-T058
and	O	O	O
to	O	O	O
use	O	O	O
emergency	O	O	B-T058
department	O	O	I-T058
services	O	O	I-T058
during	O	O	O
the	O	O	O
post	O	O	B-T079
-	O	O	O
acute	O	O	B-T058
care	O	O	I-T058
period	O	O	B-T079
.	O	O	O

These	O	O	O
effects	O	O	B-T080
were	O	O	O
maintained	O	O	B-T169
even	O	O	O
after	O	O	O
further	O	O	B-T082
adjustment	O	O	B-T169
for	O	O	O
acute	O	O	B-T047
stroke	O	O	I-T047
severity	O	O	B-T080
.	O	O	O

African-Americans	O	O	B-T098
had	O	O	O
more	O	O	O
home	O	O	B-T058
health	O	O	I-T058
care	O	O	I-T058
visits	O	O	B-T058
than	O	O	O
Whites	O	O	B-T098
among	O	O	O
patients	O	O	B-T101
who	O	O	O
received	O	O	B-T080
some	O	O	O
home	O	O	O
health	O	O	O
care	O	O	O
.	O	O	O

Having	O	O	O
a	O	O	O
co-residing	O	O	B-T052
caregiver	O	O	B-T097
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
reduced	O	O	B-T080
acute	O	O	B-T058
hospitalization	O	O	I-T058
length	O	O	B-T079
of	O	O	I-T079
stay	O	O	I-T079
and	O	O	O
fewer	O	O	O
post	O	O	B-T079
-	O	O	O
acute	O	O	B-T058
emergency	O	O	I-T058
department	O	O	I-T058
and	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
physician	O	O	I-T058
visits	O	O	I-T058
.	O	O	O

Conclusions	O	O	O
Underutilization	O	O	B-T055
of	O	O	I-T055
healthcare	O	O	I-T055
after	O	O	O
stroke	O	O	B-T047
does	O	O	O
not	O	O	O
appear	O	O	O
to	O	O	O
explain	O	O	O
poorer	O	O	O
long-term	O	O	B-T079
stroke	O	O	O
outcomes	O	O	O
for	O	O	O
women	O	O	B-T098
and	O	O	O
African-Americans	O	O	B-T098
in	O	O	O
this	O	O	O
epidemiologically	O	O	B-T169
-derived	O	O	O
sample	O	O	B-T096
.	O	O	O

Caregiver	O	O	B-T097
availability	O	O	B-T169
may	O	O	O
contribute	O	O	B-T052
to	O	O	O
reduced	O	O	B-T080
formal	O	O	B-T052
care	O	O	I-T052
and	O	O	O
cost	O	O	B-T081
during	O	O	O
the	O	O	O
post	O	O	B-T079
-	O	O	O
acute	O	O	B-T058
period	O	O	B-T079
.	O	O	O

-DOCSTART- (27436068)

Do	O	O	O
dynamic	O	O	B-T170
global	O	O	I-T170
vegetation	O	O	I-T170
models	O	O	I-T170
capture	O	O	O
the	O	O	O
seasonality	O	O	B-T079
of	O	O	O
carbon	O	O	B-T070
fluxes	O	O	I-T070
in	O	O	O
the	O	O	O
Amazon	O	O	B-T083
basin	O	O	I-T083
?	O	O	O
A	O	O	O
data	O	O	B-T078
-	O	O	O
model	O	O	B-T170
intercomparison	O	O	O

To	O	O	O
predict	O	O	O
forest	O	O	B-T070
response	O	O	B-T032
to	O	O	O
long-term	O	O	B-T079
climate	O	O	B-T070
change	O	O	I-T070
with	O	O	O
high	O	O	O
confidence	O	O	O
requires	O	O	O
that	O	O	O
dynamic	O	O	B-T170
global	O	O	I-T170
vegetation	O	O	I-T170
models	O	O	I-T170
(	O	O	O
DGVMs	O	O	B-T170
)	O	O	O
be	O	O	O
successfully	O	O	O
tested	O	O	O
against	O	O	O
ecosystem	O	O	B-T070
response	O	O	O
to	O	O	O
short-term	O	O	B-T079
variations	O	O	B-T079
in	O	O	O
environmental	O	O	B-T082
drivers	O	O	I-T082
,	O	O	O
including	O	O	O
regular	O	O	O
seasonal	O	O	B-T079
patterns	O	O	I-T079
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
used	O	O	O
an	O	O	O
integrated	O	O	O
dataset	O	O	B-T170
from	O	O	O
four	O	O	O
forests	O	O	B-T070
in	O	O	O
the	O	O	O
Brasil	O	O	B-T170
flux	O	O	I-T170
network	O	O	I-T170
,	O	O	O
spanning	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
dry-season	O	O	B-T079
intensities	O	O	B-T080
and	O	O	O
lengths	O	O	B-T081
,	O	O	O
to	O	O	O
determine	O	O	O
how	O	O	O
well	O	O	O
four	O	O	O
state-of-the-art	O	O	O
models	O	O	B-T170
(	O	O	O
IBIS	O	O	B-T170
,	O	O	O
ED2	O	O	B-T170
,	O	O	O
JULES	O	O	B-T170
,	O	O	O
and	O	O	O
CLM3.5	O	O	B-T170
)	O	O	O
simulated	O	O	O
the	O	O	O
seasonality	O	O	B-T079
of	O	O	O
carbon	O	O	B-T070
exchanges	O	O	I-T070
in	O	O	O
Amazonian	O	O	B-T083
tropical	O	O	B-T070
forests	O	O	I-T070
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
most	O	O	O
DGVMs	O	O	B-T170
poorly	O	O	O
represented	O	O	O
the	O	O	O
annual	O	O	O
cycle	O	O	O
of	O	O	O
gross	O	O	B-T081
primary	O	O	I-T081
productivity	O	O	I-T081
(	O	O	O
GPP	O	O	B-T081
)	O	O	O
,	O	O	O
of	O	O	O
photosynthetic	O	O	B-T081
capacity	O	O	I-T081
(	O	O	O
Pc	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
of	O	O	O
other	O	O	O
fluxes	O	O	B-T070
and	O	O	O
pools	O	O	O
.	O	O	O

Models	O	O	B-T170
simulated	O	O	O
consistent	O	O	O
dry-season	O	O	B-T079
declines	O	O	B-T081
in	O	O	O
GPP	O	O	B-T081
in	O	O	O
the	O	O	O
equatorial	O	O	B-T083
Amazon	O	O	I-T083
(	O	O	O
Manaus	O	O	B-T083
K34	O	O	I-T083
,	O	O	O
Santarem	O	O	B-T083
K67	O	O	I-T083
,	O	O	O
and	O	O	O
Caxiuanã	O	O	B-T083
CAX	O	O	I-T083
)	O	O	O
;	O	O	O
a	O	O	O
contrast	O	O	O
to	O	O	O
observed	O	O	O
GPP	O	O	O
increases	O	O	O
.	O	O	O

Model	O	O	B-T170
simulated	O	O	O
dry-season	O	O	B-T079
GPP	O	O	B-T081
reductions	O	O	B-T080
were	O	O	O
driven	O	O	O
by	O	O	O
an	O	O	O
external	O	O	O
environmental	O	O	B-T082
factor	O	O	B-T169
,	O	O	O
'	O	O	O
soil	O	O	B-T033
water	O	O	I-T033
stress	O	O	I-T033
'	O	O	O
and	O	O	O
consequently	O	O	O
by	O	O	O
a	O	O	O
constant	O	O	O
or	O	O	O
decreasing	O	O	O
photosynthetic	O	O	B-T070
infrastructure	O	O	I-T070
(	O	O	O
Pc	O	O	B-T081
)	O	O	O
,	O	O	O
while	O	O	O
observed	O	O	O
dry-season	O	O	O
GPP	O	O	O
resulted	O	O	O
from	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
internal	O	O	O
biological	O	O	B-T080
(	O	O	O
leaf	O	O	B-T002
-flush	O	O	O
and	O	O	O
abscission	O	O	B-T040
and	O	O	O
increased	O	O	O
Pc	O	O	O
)	O	O	O
and	O	O	O
environmental	O	O	O
(	O	O	O
incoming	O	O	O
radiation	O	O	B-T070
)	O	O	O
causes	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
models	O	O	B-T170
generally	O	O	O
overestimated	O	O	O
observed	O	O	O
seasonal	O	O	O
net	O	O	B-T081
ecosystem	O	O	I-T081
exchange	O	O	I-T081
(	O	O	O
NEE	O	O	B-T081
)	O	O	O
and	O	O	O
respiration	O	O	B-T039
(	O	O	O
Re	O	O	B-T039
)	O	O	O
at	O	O	O
equatorial	O	O	O
locations	O	O	O
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
a	O	O	O
southern	O	O	B-T083
Amazon	O	O	I-T083
forest	O	O	B-T070
(	O	O	O
Jarú	O	O	O
RJA	O	O	O
)	O	O	O
exhibited	O	O	O
dry-season	O	O	B-T079
declines	O	O	B-T081
in	O	O	O
GPP	O	O	B-T081
and	O	O	O
Re	O	O	B-T039
consistent	O	O	O
with	O	O	O
most	O	O	O
DGVMs	O	O	B-T170
simulations	O	O	B-T062
.	O	O	O

While	O	O	O
water	O	O	O
limitation	O	O	O
was	O	O	O
represented	O	O	O
in	O	O	O
models	O	O	B-T170
and	O	O	O
the	O	O	O
primary	O	O	O
driver	O	O	O
of	O	O	O
seasonal	O	O	O
photosynthesis	O	O	B-T070
in	O	O	O
southern	O	O	B-T083
Amazonia	O	O	I-T083
,	O	O	O
changes	O	O	O
in	O	O	O
internal	O	O	O
biophysical	O	O	B-T038
processes	O	O	I-T038
,	O	O	O
light-harvesting	O	O	B-T044
adaptations	O	O	B-T070
(	O	O	O
e.g.	O	O	O
,	O	O	O
variations	O	O	O
in	O	O	O
leaf	O	O	B-T002
area	O	O	I-T170
index	O	O	I-T170
(	O	O	O
LAI	O	O	B-T170
)	O	O	O
and	O	O	O
increasing	O	O	O
leaf	O	O	O
-level	O	O	O
assimilation	O	O	B-T038
rate	O	O	B-T081
related	O	O	O
to	O	O	O
leaf	O	O	B-T090
demography	O	O	I-T090
)	O	O	O
,	O	O	O
and	O	O	O
allocation	O	O	O
lags	O	O	O
between	O	O	O
leaf	O	O	O
and	O	O	O
wood	O	O	B-T002
,	O	O	O
dominated	O	O	O
equatorial	O	O	B-T083
Amazon	O	O	I-T083
carbon	O	O	B-T070
flux	O	O	I-T070
dynamics	O	O	O
and	O	O	O
were	O	O	O
deficient	O	O	O
or	O	O	O
absent	O	O	O
from	O	O	O
current	O	O	O
model	O	O	B-T170
formulations	O	O	O
.	O	O	O

Correctly	O	O	O
simulating	O	O	O
flux	O	O	B-T070
seasonality	O	O	B-T079
at	O	O	O
tropical	O	O	B-T070
forests	O	O	I-T070
requires	O	O	O
a	O	O	O
greater	O	O	O
understanding	O	O	O
and	O	O	O
the	O	O	O
incorporation	O	O	O
of	O	O	O
internal	O	O	O
biophysical	O	O	B-T044
mechanisms	O	O	I-T044
in	O	O	O
future	O	O	O
model	O	O	B-T170
developments	O	O	I-T170
.	O	O	O

-DOCSTART- (27436635)

Blood	O	O	B-T040
Pressure	O	O	I-T040
and	O	O	O
All-Cause	O	O	B-T033
Mortality	O	O	I-T033
by	O	O	O
Level	O	O	B-T080
of	O	O	O
Cognitive	O	O	B-T041
Function	O	O	I-T041
in	O	O	O
the	O	O	O
Elderly	O	O	B-T098
:	O	O	O
Results	O	O	B-T033
From	O	O	O
a	O	O	O
Population-Based	O	O	B-T062
Study	O	O	I-T062
in	O	O	O
Rural	O	O	O
Greece	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	B-T078
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
(	O	O	O
BP	O	O	B-T040
)	O	O	O
on	O	O	O
mortality	O	O	B-T033
differs	O	O	O
by	O	O	O
levels	O	O	B-T080
of	O	O	O
cognitive	O	O	B-T041
function	O	O	I-T041
.	O	O	O

The	O	O	O
associations	O	O	B-T080
of	O	O	O
brachial	O	O	B-T082
systolic	O	O	B-T201
BP	O	O	I-T201
,	O	O	O
diastolic	O	O	B-T201
BP	O	O	I-T201
,	O	O	O
mean	O	O	B-T033
arterial	O	O	I-T033
pressure	O	O	I-T033
(	O	O	O
MAP	O	O	B-T033
)	O	O	O
,	O	O	O
and	O	O	O
pulse	O	O	B-T040
pressure	O	O	I-T040
with	O	O	O
all-cause	O	O	B-T033
mortality	O	O	I-T033
were	O	O	O
prospectively	O	O	B-T033
explored	O	O	I-T033
(	O	O	O
follow-up	O	O	B-T058
7.0±2.2	O	O	O
years	O	O	B-T079
)	O	O	O
in	O	O	O
660	O	O	O
community-dwelling	O	O	B-T056
individuals	O	O	B-T098
(	O	O	O
≥60	O	O	B-T033
years	O	O	I-T033
)	O	O	O
using	O	O	O
adjusted	O	O	B-T081
Cox	O	O	I-T081
models	O	O	I-T081
,	O	O	O
stratified	O	O	B-T080
by	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
(	O	O	O
Mini-Mental	O	O	B-T060
State	O	O	I-T060
Examination	O	O	I-T060
[	O	O	O
MMSE	O	O	B-T060
]	O	O	O
<	O	O	O
24	O	O	O
)	O	O	O
.	O	O	O

No	O	O	B-T080
association	O	O	I-T080
between	O	O	O
brachial	O	O	B-T082
BP	O	O	B-T040
variables	O	O	B-T080
and	O	O	O
mortality	O	O	B-T033
was	O	O	O
shown	O	O	O
for	O	O	O
the	O	O	O
total	O	O	B-T080
sample	O	O	B-T167
in	O	O	O
quartiles	O	O	B-T062
analysis	O	O	I-T062
;	O	O	O
however	O	O	O
,	O	O	O
MAP	O	O	B-T033
in	O	O	O
the	O	O	O
highest	O	O	B-T080
quartile	O	O	I-T080
,	O	O	O
compared	O	O	B-T052
with	O	O	O
the	O	O	O
second	O	O	B-T081
,	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
mortality	O	O	O
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
1.85	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
,	O	O	O
1.09	O	O	O
-	O	O	O
3.12	O	O	O
)	O	O	O
among	O	O	O
cognitively	O	O	B-T048
impaired	O	O	I-T048
individuals	O	O	B-T098
.	O	O	O

The	O	O	O
fractional-polynomials	O	O	B-T062
approach	O	O	I-T062
for	O	O	O
BP	O	O	B-T040
confirmed	O	O	B-T033
this	O	O	O
finding	O	O	B-T033
and	O	O	O
further	O	O	B-T082
showed	O	O	O
,	O	O	O
solely	O	O	B-T081
in	O	O	O
the	O	O	O
MMSE	O	O	B-T060
<	O	O	O
24	O	O	O
subcohort	O	O	B-T081
,	O	O	O
U-shaped	O	O	B-T079
trends	O	O	I-T079
of	O	O	O
MAP	O	O	B-T033
and	O	O	O
systolic	O	O	B-T201
BP	O	O	I-T201
,	O	O	O
with	O	O	O
increased	O	O	B-T081
mortality	O	O	B-T078
risk	O	O	I-T078
in	O	O	O
extremely	O	O	B-T080
low	O	O	B-T080
or	O	O	I-T080
high	O	O	I-T080
values	O	O	I-T080
;	O	O	O
no	O	O	O
such	O	O	O
pattern	O	O	B-T082
was	O	O	O
evident	O	O	B-T078
for	O	O	O
patients	O	O	B-T101
with	O	O	O
MMSE	O	O	O
≥24	O	O	O
.	O	O	O

Elderly	O	O	B-T098
individuals	O	O	B-T098
with	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
might	O	O	O
be	O	O	O
more	O	O	B-T081
susceptible	O	O	B-T169
to	O	O	O
the	O	O	O
detrimental	O	O	B-T046
effects	O	O	I-T046
of	O	O	O
low	O	O	B-T080
and	O	O	O
elevated	O	O	B-T080
MAP	O	O	B-T033
and	O	O	O
systolic	O	O	B-T201
BP	O	O	I-T201
.	O	O	O

-DOCSTART- (27437203)

Hypovitaminosis	O	O	B-T047
D	O	O	I-T047
and	O	O	O
Associated	O	O	O
Cardiometabolic	O	O	B-T078
Risk	O	O	I-T078
in	O	O	O
Women	O	O	B-T098
with	O	O	O
PCOS	O	O	O

Women	O	O	B-T098
with	O	O	O
Polycystic	O	O	B-T047
Ovary	O	O	I-T047
Syndrome	O	O	I-T047
(	O	O	O
PCOS	O	O	B-T047
)	O	O	O
frequently	O	O	O
suffer	O	O	O
from	O	O	O
metabolic	O	O	B-T047
disturbances	O	O	I-T047
like	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
,	O	O	O
hypertension	O	O	B-T047
and	O	O	O
atherogenic	O	O	B-T047
dyslipidemia	O	O	I-T047
.	O	O	O

Accumulating	O	O	B-T033
evidences	O	O	O
suggest	O	O	O
that	O	O	O
Vitamin	O	O	B-T047
D	O	O	I-T047
deficiency	O	O	I-T047
is	O	O	O
common	O	O	O
in	O	O	O
PCOS	O	O	B-T047
and	O	O	O
may	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
metabolic	O	O	B-T047
and	O	O	O
endocrinal	O	O	B-T047
dysfunctions	O	O	I-T047
in	O	O	O
PCOS	O	O	O
.	O	O	O

Thus	O	O	O
women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
may	O	O	O
be	O	O	O
at	O	O	O
elevated	O	O	O
risk	O	O	B-T078
of	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

Present	O	O	O
study	O	O	B-T062
aims	O	O	O
to	O	O	O
evaluate	O	O	O
Vitamin	O	O	B-T127
D	O	O	I-T127
status	O	O	O
and	O	O	O
to	O	O	O
assess	O	O	O
its	O	O	O
association	O	O	O
with	O	O	O
metabolic	O	O	B-T047
and	O	O	O
endocrinal	O	O	B-T047
dysregulations	O	O	I-T047
in	O	O	O
women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
,	O	O	O
which	O	O	O
might	O	O	O
help	O	O	O
in	O	O	O
early	O	O	B-T061
identification	O	O	I-T061
and	O	O	O
prevention	O	O	B-T061
of	O	O	O
future	O	O	O
symptomatic	O	O	B-T169
cardiac	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
44	O	O	O
women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
,	O	O	O
diagnosed	O	O	O
by	O	O	O
Rotterdam	O	O	B-T170
criteria	O	O	I-T170
and	O	O	O
45	O	O	O
healthy	O	O	B-T080
control	O	O	I-T080
without	O	O	O
PCOS	O	O	O
,	O	O	O
were	O	O	O
evaluated	O	O	O
for	O	O	O
Vitamin	O	O	B-T127
D	O	O	I-T127
and	O	O	O
cardiometabolic	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
,	O	O	O
including	O	O	O
fasting	O	O	B-T034
plasma	O	O	I-T034
glucose	O	O	I-T034
,	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
,	O	O	O
dyslipidemia	O	O	B-T047
,	O	O	O
hs-CRP	O	O	B-T033
.	O	O	O

That	O	O	O
apart	O	O	O
,	O	O	O
several	O	O	O
endocrinal	O	O	B-T169
parameters	O	O	B-T077
of	O	O	O
hyperandrogenism	O	O	B-T047
were	O	O	O
also	O	O	O
examined	O	O	O
.	O	O	O

Several	O	O	O
correlation	O	O	B-T062
studies	O	O	I-T062
were	O	O	O
determined	O	O	O
to	O	O	O
establish	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
Vitamin	O	O	B-T127
D	O	O	I-T127
as	O	O	O
a	O	O	O
cardiometabolic	O	O	B-T033
risk	O	O	I-T033
factor	O	O	I-T033
in	O	O	O
PCOS	O	O	B-T047
.	O	O	O

Results	O	O	O
were	O	O	O
expressed	O	O	O
as	O	O	O
mean±SD	O	O	O
and	O	O	O
were	O	O	O
statistically	O	O	B-T062
analysed	O	O	I-T062
using	O	O	O
SPSS	O	O	B-T073
software	O	O	I-T073
version	O	O	I-T073
16	O	O	I-T073
,	O	O	O
unpaired	O	O	B-T170
student	O	O	I-T170
's	O	O	I-T170
t-test	O	O	I-T170
and	O	O	O
Pearson	O	O	B-T081
's	O	O	I-T081
correlation	O	O	I-T081
coefficient	O	O	I-T081
.	O	O	O

We	O	O	O
found	O	O	O
lower	O	O	O
levels	O	O	O
of	O	O	O
Vitamin	O	O	B-T127
D	O	O	I-T127
,	O	O	O
which	O	O	O
was	O	O	O
statistically	O	O	O
significant	O	O	O
as	O	O	O
compared	O	O	O
to	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

Hyperinsulinemia	O	O	B-T047
,	O	O	O
rise	O	O	O
in	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
marked	O	O	O
dyslipidemia	O	O	B-T047
was	O	O	O
observed	O	O	O
in	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
.	O	O	O

Another	O	O	O
relevant	O	O	O
finding	O	O	O
was	O	O	O
significant	O	O	O
correlation	O	O	O
of	O	O	O
Vitamin	O	O	B-T127
D	O	O	I-T127
with	O	O	O
insulin	O	O	B-T116
and	O	O	O
Homeostatic	O	O	B-T059
Model	O	O	I-T059
of	O	O	I-T059
Assessment-	O	O	I-T059
Insulin	O	O	I-T059
Resistance	O	O	I-T059
Index	O	O	I-T059
(	O	O	O
HOMA-IR	O	O	B-T059
)	O	O	O
.	O	O	O

Hypovitaminosis	O	O	B-T047
D	O	O	I-T047
was	O	O	O
prevalent	O	O	O
in	O	O	O
PCOS	O	O	B-T047
.	O	O	O

This	O	O	O
was	O	O	O
related	O	O	O
to	O	O	O
metabolic	O	O	B-T047
and	O	O	O
hormonal	O	O	B-T033
disorders	O	O	I-T033
in	O	O	O
PCOS	O	O	B-T047
.	O	O	O

Possibly	O	O	O
this	O	O	O
combined	O	O	O
with	O	O	O
impaired	O	O	B-T033
fasting	O	O	I-T033
glucose	O	O	I-T033
,	O	O	O
IR	O	O	B-T046
and	O	O	O
dyslipidemia	O	O	B-T047
,	O	O	O
could	O	O	O
account	O	O	O
for	O	O	O
Cardio	O	O	B-T078
vascular	O	O	I-T078
risks	O	O	I-T078
in	O	O	O
PCOS	O	O	B-T047
.	O	O	O

Further	O	O	O
prospective	O	O	O
observational	O	O	B-T170
studies	O	O	I-T170
and	O	O	O
randomized	O	O	B-T062
control	O	O	I-T062
trials	O	O	I-T062
are	O	O	O
required	O	O	O
to	O	O	O
explore	O	O	O
the	O	O	O
above	O	O	O
hypothesis	O	O	B-T078
.	O	O	O

-DOCSTART- (27438380)

Family	O	O	B-T099
close	O	O	B-T033
but	O	O	O
friends	O	O	B-T098
closer	O	O	B-T033
:	O	O	O
exploring	O	O	O
social	O	O	B-T054
support	O	O	I-T054
and	O	O	O
resilience	O	O	B-T055
in	O	O	O
older	O	O	B-T098
spousal	O	O	B-T099
dementia	O	O	B-T048
carers	O	O	O

Spousal	O	O	B-T099
dementia	O	O	B-T048
carers	O	O	B-T097
have	O	O	O
unique	O	O	O
support	O	O	B-T054
needs	O	O	B-T080
;	O	O	O
they	O	O	O
are	O	O	O
likely	O	O	O
to	O	O	O
disengage	O	O	B-T080
from	O	O	O
their	O	O	O
existing	O	O	B-T077
social	O	O	B-T098
networks	O	O	I-T098
as	O	O	O
they	O	O	O
need	O	O	O
to	O	O	O
devote	O	O	O
more	O	O	O
time	O	O	B-T079
to	O	O	O
caring	O	O	B-T055
as	O	O	O
the	O	O	O
disease	O	O	B-T046
progresses	O	O	I-T046
.	O	O	O

Previously	O	O	O
we	O	O	O
showed	O	O	O
that	O	O	O
support	O	O	B-T054
resources	O	O	B-T078
can	O	O	O
facilitate	O	O	O
resilience	O	O	B-T055
in	O	O	O
carers	O	O	B-T097
,	O	O	O
but	O	O	O
the	O	O	O
relationship	O	O	B-T080
is	O	O	O
complex	O	O	B-T080
and	O	O	O
varies	O	O	O
by	O	O	O
relationship	O	O	B-T169
type	O	O	I-T169
.	O	O	O

The	O	O	O
current	O	O	O
paper	O	O	O
aims	O	O	O
to	O	O	O
explore	O	O	O
social	O	O	B-T054
support	O	O	B-T054
as	O	O	O
a	O	O	O
key	O	O	O
component	O	O	O
of	O	O	O
resilience	O	O	B-T055
to	O	O	O
identify	O	O	O
the	O	O	O
availability	O	O	B-T169
,	O	O	O
function	O	O	B-T169
and	O	O	O
perceived	O	O	B-T169
functional	O	O	I-T169
aspects	O	O	I-T169
of	O	O	O
support	O	O	O
provided	O	O	O
to	O	O	O
older	O	O	B-T098
spousal	O	O	B-T099
dementia	O	O	B-T048
carers	O	O	B-T097
.	O	O	O

We	O	O	O
conducted	O	O	O
23	O	O	O
in-depth	O	O	B-T052
qualitative	O	O	I-T052
interviews	O	O	I-T052
with	O	O	O
spousal	O	O	B-T099
carers	O	O	B-T097
from	O	O	O
two	O	O	O
carer	O	O	B-T097
support	O	O	B-T095
groups	O	O	I-T095
and	O	O	O
a	O	O	O
care	O	O	O
home	O	O	O
in	O	O	O
North	O	O	B-T083
West	O	O	I-T083
England	O	O	I-T083
.	O	O	O

Family	O	O	B-T099
and	O	O	O
friends	O	O	B-T098
served	O	O	O
a	O	O	O
wide	O	O	O
range	O	O	O
of	O	O	O
functions	O	O	B-T169
but	O	O	O
were	O	O	O
equally	O	O	O
available	O	O	O
to	O	O	O
resilient	O	O	B-T098
and	O	O	O
non-resilient	O	O	B-T098
participants	O	O	I-T098
.	O	O	O

Family	O	O	B-T061
support	O	O	I-T061
was	O	O	O
perceived	O	O	B-T041
as	O	O	O
unhelpful	O	O	O
if	O	O	O
it	O	O	O
created	O	O	B-T052
feelings	O	O	B-T041
of	O	O	O
over-dependence	O	O	B-T080
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
less	O	O	O
likely	O	O	O
to	O	O	O
resist	O	O	B-T169
involvement	O	O	I-T169
of	O	O	O
grandchildren	O	O	B-T099
due	O	O	O
to	O	O	O
their	O	O	O
relatively	O	O	O
narrow	O	O	B-T054
and	O	O	I-T054
low-level	O	O	I-T054
support	O	O	I-T054
functions	O	O	I-T054
.	O	O	O

Friend	O	O	B-T098
support	O	O	B-T054
was	O	O	O
perceived	O	O	B-T041
as	O	O	O
most	O	O	O
helpful	O	O	B-T080
when	O	O	O
it	O	O	O
derived	O	O	O
from	O	O	O
those	O	O	O
in	O	O	O
similar	O	O	O
circumstances	O	O	B-T080
.	O	O	O

Neighbours	O	O	B-T098
played	O	O	O
a	O	O	O
functionally	O	O	O
unique	O	O	O
role	O	O	O
of	O	O	O
crisis	O	O	B-T061
management	O	O	I-T061
.	O	O	O

These	O	O	O
perceptions	O	O	B-T041
may	O	O	O
moderate	O	O	B-T080
the	O	O	O
effect	O	O	B-T080
of	O	O	O
support	O	O	B-T054
on	O	O	O
resilience	O	O	B-T055
.	O	O	O

Family	O	O	B-T061
and	O	O	O
friend	O	O	B-T098
support	O	O	B-T054
is	O	O	O
not	O	O	O
always	O	O	O
sufficient	O	O	B-T080
to	O	O	O
facilitate	O	O	O
resilience	O	O	B-T055
.	O	O	O

Support	O	O	B-T054
functions	O	O	I-T054
facilitate	O	O	O
resilience	O	O	B-T055
only	O	O	O
if	O	O	O
they	O	O	O
are	O	O	O
perceived	O	O	B-T041
to	O	O	O
match	O	O	O
need	O	O	B-T080
.	O	O	O

Implications	O	O	B-T033
of	O	O	O
these	O	O	O
findings	O	O	B-T169
are	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (27440782)

Measure	O	O	B-T058
Up	O	O	I-T058
Pressure	O	O	I-T058
Down	O	O	I-T058
:	O	O	I-T058
Provider	O	O	I-T058
Toolkit	O	O	I-T058
to	O	O	O
Improve	O	O	B-T077
Hypertension	O	O	B-T047
Control	O	O	O

Hypertension	O	O	B-T047
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
heart	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
stroke	O	O	B-T047
,	O	O	O
kidney	O	O	B-T047
failure	O	O	I-T047
,	O	O	O
and	O	O	O
diabetes	O	O	B-T047
complications	O	O	I-T047
.	O	O	O

Nearly	O	O	O
one	O	O	O
in	O	O	O
three	O	O	O
Americans	O	O	B-T098
adults	O	O	B-T100
has	O	O	O
high	O	O	B-T047
blood	O	O	I-T047
pressure	O	O	I-T047
,	O	O	O
and	O	O	O
the	O	O	O
cost	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
treating	O	O	B-T061
this	O	O	O
condition	O	O	B-T047
is	O	O	O
staggering	O	O	O
.	O	O	O

The	O	O	O
Measure	O	O	B-T058
Up	O	O	I-T058
Pressure	O	O	I-T058
Down	O	O	I-T058
:	O	O	I-T058
Provider	O	O	I-T058
Toolkit	O	O	I-T058
to	O	O	O
Improve	O	O	B-T077
Hypertension	O	O	B-T047
Control	O	O	B-T040
is	O	O	O
a	O	O	O
resource	O	O	B-T078
developed	O	O	B-T169
by	O	O	O
the	O	O	O
American	O	O	B-T093
Medical	O	O	I-T093
Group	O	O	I-T093
Foundation	O	O	I-T093
in	O	O	O
partnership	O	O	B-T092
with	O	O	O
the	O	O	O
American	O	O	B-T093
Medical	O	O	I-T093
Group	O	O	I-T093
Association	O	O	I-T093
.	O	O	O

The	O	O	O
goal	O	O	B-T170
of	O	O	O
this	O	O	O
toolkit	O	O	B-T170
is	O	O	O
to	O	O	O
mobilize	O	O	O
health	O	O	B-T097
care	O	O	I-T097
practitioners	O	O	I-T097
to	O	O	O
work	O	O	B-T057
together	O	O	B-T080
through	O	O	O
team	O	O	B-T096
-based	O	O	O
approaches	O	O	O
to	O	O	O
achieve	O	O	O
an	O	O	O
80	O	O	O
%	O	O	O
control	O	O	B-T040
rate	O	O	B-T081
of	O	O	O
high	O	O	B-T047
blood	O	O	I-T047
pressure	O	O	I-T047
among	O	O	O
their	O	O	O
patient	O	O	B-T101
population	O	O	I-T101
.	O	O	O

The	O	O	O
toolkit	O	O	B-T170
can	O	O	O
be	O	O	O
used	O	O	O
by	O	O	O
health	O	O	B-T097
educators	O	O	I-T097
,	O	O	O
clinic	O	O	B-T097
administrators	O	O	I-T097
,	O	O	O
physicians	O	O	B-T097
,	O	O	O
students	O	O	B-T098
,	O	O	O
and	O	O	O
other	O	O	O
clinic	O	O	B-T097
staff	O	O	I-T097
as	O	O	O
a	O	O	O
step-by-step	O	O	O
resource	O	O	B-T078
for	O	O	O
developing	O	O	B-T169
the	O	O	O
infrastructure	O	O	B-T062
needed	O	O	O
to	O	O	O
better	O	O	O
identify	O	O	O
and	O	O	O
treat	O	O	B-T061
individuals	O	O	B-T098
with	O	O	O
high	O	O	B-T047
blood	O	O	I-T047
pressure	O	O	I-T047
or	O	O	O
other	O	O	O
chronic	O	O	O
conditions	O	O	O
.	O	O	O

-DOCSTART- (27441638)

Potentiation	O	O	B-T061
of	O	O	O
LPS	O	O	B-T109
-	O	O	O
Induced	O	O	B-T046
Apoptotic	O	O	B-T043
Cell	O	O	I-T043
Death	O	O	I-T043
in	O	O	O
Human	O	O	B-T025
Hepatoma	O	O	I-T025
HepG2	O	O	I-T025
Cells	O	O	I-T025
by	O	O	O
Aspirin	O	O	B-T109
via	O	O	O
ROS	O	O	B-T123
and	O	O	O
Mitochondrial	O	O	B-T033
Dysfunction	O	O	I-T033
:	O	O	O
Protection	O	O	B-T033
by	O	O	O
N-Acetyl	O	O	O
Cysteine	O	O	O

Cytotoxicity	O	O	B-T049
and	O	O	O
inflammation	O	O	B-T046
-	O	O	O
associated	O	O	B-T046
toxic	O	O	B-T080
responses	O	O	B-T032
have	O	O	O
been	O	O	O
observed	O	O	B-T169
to	O	O	O
be	O	O	O
induced	O	O	B-T169
by	O	O	O
bacterial	O	O	B-T080
lipopolysaccharides	O	O	B-T109
(	O	O	O
LPS	O	O	B-T109
)	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
respectively	O	O	O
.	O	O	O

Use	O	O	O
of	O	O	O
nonsteroidal	O	O	B-T121
anti-inflammatory	O	O	I-T121
drugs	O	O	I-T121
(	O	O	O
NSAIDs	O	O	B-T121
)	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
aspirin	O	O	B-T109
,	O	O	O
has	O	O	O
been	O	O	O
reported	O	O	B-T058
to	O	O	O
be	O	O	O
beneficial	O	O	O
in	O	O	O
inflammation	O	O	B-T046
-	O	O	O
associated	O	O	B-T046
diseases	O	O	I-T046
like	O	O	O
cancer	O	O	B-T191
,	O	O	O
diabetes	O	O	B-T047
and	O	O	O
cardiovascular	O	O	B-T047
disorders	O	O	I-T047
.	O	O	O

Their	O	O	O
precise	O	O	O
molecular	O	O	B-T080
mechanisms	O	O	B-T169
,	O	O	O
however	O	O	O
,	O	O	O
are	O	O	O
not	O	O	O
clearly	O	O	O
understood	O	O	O
.	O	O	O

Our	O	O	O
previous	O	O	O
studies	O	O	B-T062
on	O	O	O
aspirin	O	O	B-T109
treated	O	O	B-T061
HepG2	O	O	B-T025
cells	O	O	I-T025
strongly	O	O	O
suggest	O	O	O
cell	O	O	B-T043
cycle	O	O	I-T043
arrest	O	O	I-T043
and	O	O	O
induction	O	O	B-T169
of	O	O	O
apoptosis	O	O	B-T043
associated	O	O	B-T080
with	O	O	I-T080
mitochondrial	O	O	B-T033
dysfunction	O	O	I-T033
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
have	O	O	O
further	O	O	O
demonstrated	O	O	O
that	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
treated	O	O	B-T061
with	O	O	I-T061
LPS	O	O	B-T109
alone	O	O	O
or	O	O	O
in	O	O	O
combination	O	O	B-T080
with	O	O	O
aspirin	O	O	B-T109
induces	O	O	B-T169
subcellular	O	O	B-T026
toxic	O	O	B-T043
responses	O	O	I-T043
which	O	O	O
are	O	O	O
accompanied	O	O	O
by	O	O	O
increase	O	O	B-T169
in	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
production	O	O	O
,	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
,	O	O	O
mitochondrial	O	O	B-T033
respiratory	O	O	I-T033
dysfunction	O	O	I-T033
and	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

The	O	O	O
LPS	O	O	B-T109
/	O	O	O
Aspirin	O	O	B-T109
induced	O	O	B-T169
toxicity	O	O	B-T037
was	O	O	O
attenuated	O	O	B-T052
by	O	O	O
pre-treatment	O	O	B-T079
of	O	O	O
cells	O	O	B-T025
with	O	O	O
N-acetyl	O	O	B-T116
cysteine	O	O	I-T116
(	O	O	O
NAC	O	O	B-T116
)	O	O	O
.	O	O	O

Alterations	O	O	O
in	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
glutathione	O	O	B-T116
-	O	O	O
dependent	O	O	B-T080
redox-homeostasis	O	O	B-T043
were	O	O	O
more	O	O	O
pronounced	O	O	O
in	O	O	O
mitochondria	O	O	B-T026
compared	O	O	B-T052
to	O	O	O
extra	O	O	B-T082
-	O	O	O
mitochondrial	O	O	B-T026
cellular	O	O	B-T026
compartments	O	O	I-T026
.	O	O	O

Pre-treatment	O	O	B-T079
of	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
with	O	O	O
NAC	O	O	B-T116
exhibited	O	O	O
a	O	O	O
selective	O	O	O
protection	O	O	B-T033
in	O	O	O
redox	O	O	B-T043
homeostasis	O	O	I-T043
and	O	O	O
mitochondrial	O	O	B-T033
dysfunction	O	O	I-T033
.	O	O	O

Our	O	O	O
results	O	O	B-T033
suggest	O	O	O
that	O	O	O
the	O	O	O
altered	O	O	B-T169
redox	O	O	B-T043
metabolism	O	O	I-T043
,	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
mitochondrial	O	O	B-T026
function	O	O	B-T169
in	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
play	O	O	O
a	O	O	O
critical	O	O	O
role	O	O	O
in	O	O	O
LPS	O	O	B-T109
/	O	O	O
aspirin	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
cytotoxicity	O	O	B-T049
.	O	O	O

These	O	O	O
results	O	O	B-T033
may	O	O	O
help	O	O	O
in	O	O	O
better	O	O	O
understanding	O	O	O
the	O	O	O
pharmacological	O	O	B-T169
,	O	O	O
toxicological	O	O	B-T169
and	O	O	O
therapeutic	O	O	B-T169
properties	O	O	I-T169
of	O	O	O
NSAIDs	O	O	B-T121
in	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
exposed	O	O	B-T080
to	O	O	O
bacterial	O	O	B-T109
endotoxins	O	O	I-T109
.	O	O	O

-DOCSTART- (27442784)

Placental	O	O	B-T018
Pathologic	O	O	B-T169
Associations	O	O	B-T080
with	O	O	O
Morbidly	O	O	B-T046
Adherent	O	O	I-T046
Placenta	O	O	I-T046
:	O	O	O
Potential	O	O	O
insights	O	O	O
into	O	O	O
Pathogenesis	O	O	O

The	O	O	O
pathology	O	O	B-T169
that	O	O	O
underlies	O	O	O
morbidly	O	O	B-T046
adherent	O	O	I-T046
placenta	O	O	I-T046
(	O	O	O
MAP	O	O	B-T046
)	O	O	O
is	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
placental	O	O	B-T018
pathology	O	O	B-T169
,	O	O	O
especially	O	O	O
implantation	O	O	B-T082
site	O	O	I-T082
pathology	O	O	O
,	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
MAP	O	O	B-T046
.	O	O	O

This	O	O	O
was	O	O	O
a	O	O	O
single	O	O	B-T081
institution	O	O	B-T093
,	O	O	O
retrospective	O	O	B-T062
case-control	O	O	I-T062
study	O	O	I-T062
design	O	O	O
examining	O	O	O
placentas	O	O	B-T018
of	O	O	O
patients	O	O	B-T101
who	O	O	O
delivered	O	O	B-T033
between	O	O	O
January	O	O	O
2008	O	O	O
and	O	O	O
September	O	O	O
2013	O	O	O
.	O	O	O

MAP	O	O	B-T046
cases	O	O	B-T077
were	O	O	O
defined	O	O	O
by	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
clinical	O	O	B-T080
intervention	O	O	B-T058
at	O	O	O
delivery	O	O	B-T061
beyond	O	O	O
spontaneous	O	O	B-T169
placental	O	O	B-T061
delivery	O	O	I-T061
or	O	O	O
simple	O	O	O
manual	O	O	B-T061
extraction	O	O	I-T061
of	O	O	O
the	O	O	O
placenta	O	O	B-T018
.	O	O	O

Controls	O	O	B-T096
consisted	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
placentas	O	O	B-T018
sent	O	O	O
for	O	O	O
examination	O	O	B-T058
due	O	O	O
to	O	O	O
a	O	O	O
history	O	O	B-T033
of	O	O	O
maternal	O	O	B-T099
malignancy	O	O	B-T191
with	O	O	O
no	O	O	B-T033
clinical	O	O	B-T080
suspicion	O	O	B-T078
of	O	O	O
accreta	O	O	B-T046
.	O	O	O

Placental	O	O	B-T018
pathologic	O	O	B-T033
findings	O	O	I-T033
of	O	O	O
maternal	O	O	B-T047
vascular	O	O	I-T047
underperfusion	O	O	I-T047
(	O	O	O
MVU	O	O	B-T047
)	O	O	O
,	O	O	O
acute	O	O	B-T033
inflammation	O	O	I-T033
,	O	O	O
chronic	O	O	B-T046
inflammation	O	O	I-T046
,	O	O	O
fetal	O	O	B-T018
vascular	O	O	B-T047
obstruction	O	O	I-T047
and	O	O	O
hemorrhage	O	O	B-T046
were	O	O	O
recorded	O	O	O
and	O	O	O
compared	O	O	O
using	O	O	O
bivariable	O	O	B-UnknownType
and	O	O	I-UnknownType
multivariable	O	O	I-UnknownType
analyses	O	O	I-UnknownType
.	O	O	O

Three	O	O	O
categories	O	O	B-T170
of	O	O	O
pathologic	O	O	B-T169
changes	O	O	B-T169
were	O	O	O
seen	O	O	O
more	O	O	O
commonly	O	O	O
in	O	O	O
MAP	O	O	B-T046
placentas	O	O	B-T018
(	O	O	O
N=101	O	O	O
)	O	O	O
than	O	O	O
control	O	O	B-T096
placentas	O	O	O
(	O	O	O
N=110	O	O	O
):	O	O	O
chronic	O	O	B-T046
basal	O	O	I-T046
inflammation	O	O	I-T046
,	O	O	O
villous	O	O	O
changes	O	O	O
of	O	O	O
MVU	O	O	B-T047
and	O	O	O
retromembranous	O	O	B-T046
and	O	O	O
retromembranous	O	O	O
/	O	O	O
intervillous	O	O	B-T046
hemorrhage	O	O	I-T046
.	O	O	O

In	O	O	O
multivariable	O	O	B-T081
analyses	O	O	I-T081
adjusted	O	O	O
for	O	O	O
confounders	O	O	B-T169
,	O	O	O
chronic	O	O	B-T047
basal	O	O	I-T047
villitis	O	O	I-T047
(	O	O	O
aOR	O	O	B-T081
5.6	O	O	O
,	O	O	O
1.73	O	O	O
-	O	O	O
18.18	O	O	O
)	O	O	O
,	O	O	O
plasma	O	O	B-T033
cell	O	O	I-T033
deciduitis	O	O	I-T033
(	O	O	O
aOR	O	O	O
2.63	O	O	O
,	O	O	O
1.08	O	O	O
-	O	O	O
6.39	O	O	O
)	O	O	O
,	O	O	O
increased	O	O	B-T033
syncytial	O	O	I-T033
knots	O	O	I-T033
(	O	O	O
aOR	O	O	O
3.92	O	O	O
,	O	O	O
1.57	O	O	O
-	O	O	O
9.75	O	O	O
)	O	O	O
,	O	O	O
villous	O	O	O
agglutination	O	O	O
(	O	O	O
aOR	O	O	O
24.85	O	O	O
,	O	O	O
2.78	O	O	O
-	O	O	O
221.75	O	O	O
)	O	O	O
,	O	O	O
increased	O	O	B-T033
perivillous	O	O	I-T033
fibrin	O	O	I-T033
(	O	O	O
aOR	O	O	O
5.08	O	O	O
,	O	O	O
1.49	O	O	O
-	O	O	O
17.34	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
subchorionic	O	O	B-T046
/	O	O	O
intervillous	O	O	B-T033
thrombi	O	O	I-T033
(	O	O	O
aOR	O	O	O
4.01	O	O	O
,	O	O	O
1.63	O	O	O
-	O	O	O
9.86	O	O	O
)	O	O	O
remained	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
MAP	O	O	B-T046
.	O	O	O

MAP	O	O	B-T046
is	O	O	O
highly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
evidence	O	O	O
of	O	O	O
intraparenchymal	O	O	B-T046
placental	O	O	I-T046
hemorrhage	O	O	I-T046
villous	O	O	B-T080
changes	O	O	B-T169
of	O	O	O
MVU	O	O	B-T047
,	O	O	O
and	O	O	O
a	O	O	O
lymphoplasmacytic	O	O	B-T033
infiltrate	O	O	I-T033
at	O	O	O
the	O	O	O
implantation	O	O	B-T082
site	O	O	I-T082
.	O	O	O

The	O	O	O
contribution	O	O	O
of	O	O	O
this	O	O	O
basal	O	O	B-T033
chronic	O	O	I-T033
inflammatory	O	O	I-T033
infiltrate	O	O	I-T033
to	O	O	O
MAP	O	O	B-T046
requires	O	O	O
further	O	O	O
investigation	O	O	O
.	O	O	O

-DOCSTART- (27443504)

An	O	O	O
ion-gating	O	O	O
multinanochannel	O	O	O
system	O	O	O
based	O	O	O
on	O	O	O
a	O	O	O
copper	O	O	B-T121
-	O	O	O
responsive	O	O	B-T169
self	O	O	B-T078
-	O	O	O
cleaving	O	O	B-T082
DNAzyme	O	O	O

We	O	O	O
developed	O	O	O
an	O	O	O
ion-gating	O	O	O
nanochannel	O	O	O
composite	O	O	O
system	O	O	O
by	O	O	O
immobilizing	O	O	B-T169
a	O	O	O
Cu(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
-	O	O	O
responsive	O	O	B-T169
self	O	O	B-T078
-	O	O	O
cleaving	O	O	B-T082
DNAzyme	O	O	B-T114
into	O	O	O
PET	O	O	B-T109
conical	O	O	B-T122
multinanochannels	O	O	I-T122
,	O	O	O
which	O	O	O
could	O	O	O
control	O	O	B-T169
the	O	O	O
ion	O	O	B-T043
transport	O	O	I-T043
by	O	O	O
regulating	O	O	B-T038
the	O	O	O
surface	O	O	B-T082
charge	O	O	B-T032
density	O	O	B-T081
of	O	O	O
the	O	O	O
channels	O	O	B-T122
.	O	O	O

-DOCSTART- (27445856)

High-Intensity	O	O	B-T056
Intermittent	O	O	I-T056
Training	O	O	I-T056
Positively	O	O	B-T033
Affects	O	O	B-T080
Aerobic	O	O	B-T061
and	O	O	O
Anaerobic	O	O	B-T056
Performance	O	O	I-T056
in	O	O	O
Judo	O	O	B-T056
Athletes	O	O	B-T097
Independently	O	O	O
of	O	O	O
Exercise	O	O	O
Mode	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
investigated	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	O
high-intensity	O	O	B-T056
intermittent	O	O	I-T056
training	O	O	I-T056
(	O	O	O
HIIT	O	O	B-T056
)	O	O	O
on	O	O	O
lower	O	O	B-T023
-	O	O	O
and	O	O	O
upper-body	O	O	B-T023
graded	O	O	B-T056
exercise	O	O	I-T056
and	O	O	O
high-intensity	O	O	B-T056
intermittent	O	O	I-T056
exercise	O	O	I-T056
(	O	O	O
HIIE	O	O	B-T056
,	O	O	O
four	O	O	O
Wingate	O	O	O
bouts	O	O	O
)	O	O	O
performance	O	O	B-T052
,	O	O	O
and	O	O	O
on	O	O	O
physiological	O	O	B-T169
and	O	O	O
muscle	O	O	B-T020
damage	O	O	I-T020
markers	O	O	B-T033
responses	O	O	I-T033
in	O	O	O
judo	O	O	B-T056
athletes	O	O	B-T097
.	O	O	O

Thirty-five	O	O	O
subjects	O	O	B-T098
were	O	O	O
randomly	O	O	B-T062
allocated	O	O	I-T062
to	O	O	O
a	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
n	O	O	O
=	O	O	O
8)	O	O	O
or	O	O	O
to	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
following	O	O	O
HIIT	O	O	B-T056
groups	O	O	B-T078
(	O	O	O
n	O	O	O
=	O	O	O
9	O	O	O
for	O	O	O
each	O	O	O
)	O	O	O
and	O	O	O
tested	O	O	B-T170
pre-	O	O	I-T170
and	O	O	I-T170
post	O	O	I-T170
-four	O	O	O
weeks	O	O	O
(	O	O	O
2	O	O	O
training	O	O	O
d·wk(-1	O	O	O
)	O	O	O
):	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
lower-body	O	O	B-T023
cycle-ergometer	O	O	B-T061
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
upper-body	O	O	O
cycle-ergometer	O	O	O
;	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
uchi-komi	O	O	B-T169
(	O	O	O
judo	O	O	B-T169
technique	O	O	I-T169
entrance	O	O	I-T169
)	O	O	O
.	O	O	O

All	O	O	O
HIIT	O	O	B-T056
were	O	O	O
constituted	O	O	O
by	O	O	O
two	O	O	O
blocks	O	O	O
of	O	O	O
10	O	O	O
sets	O	O	O
of	O	O	O
20	O	O	O
s	O	O	O
of	O	O	O
all	O	O	O
out	O	O	O
effort	O	O	O
interspersed	O	O	O
by	O	O	O
10	O	O	O
s	O	O	O
set	O	O	O
intervals	O	O	O
and	O	O	O
5-min	O	O	O
between	O	O	O
blocks	O	O	O
.	O	O	O

For	O	O	O
the	O	O	O
upper-body	O	O	B-T023
group	O	O	B-T078
there	O	O	O
was	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
maximal	O	O	B-T201
aerobic	O	O	I-T201
power	O	O	I-T201
in	O	O	O
graded	O	O	O
upper-body	O	O	O
exercise	O	O	B-T033
test	O	O	I-T033
(	O	O	O
12.3	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
lower-body	O	O	B-T023
group	O	O	B-T078
increased	O	O	B-T169
power	O	O	B-T201
at	O	O	O
onset	O	O	B-T109
blood	O	O	I-T109
lactate	O	O	I-T109
in	O	O	O
graded	O	O	O
upper-body	O	O	B-T023
exercise	O	O	B-T033
test	O	O	I-T033
(	O	O	O
22.1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
uchi-komi	O	O	B-T078
group	O	O	I-T078
increased	O	O	B-T169
peak	O	O	O
power	O	O	O
in	O	O	O
upper	O	O	B-T023
-	O	O	O
(	O	O	O
16.7	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
lower-body	O	O	B-T023
(	O	O	O
8.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
lower-body	O	O	O
group	O	O	O
increased	O	O	O
lower-body	O	O	O
mean	O	O	O
power	O	O	O
(	O	O	O
14.2	O	O	O
%	O	O	O
)	O	O	O
during	O	O	O
the	O	O	O
HIIE	O	O	B-T056
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
delta	O	O	B-T109
blood	O	O	I-T109
lactate	O	O	I-T109
for	O	O	O
the	O	O	O
uchi-komi	O	O	B-T065
training	O	O	B-T065
group	O	O	B-T078
and	O	O	O
in	O	O	O
the	O	O	O
third	O	O	O
and	O	O	O
fourth	O	O	O
bouts	O	O	O
for	O	O	O
the	O	O	O
upper-body	O	O	B-T023
training	O	O	O
group	O	O	O
.	O	O	O

Training	O	O	B-T065
induced	O	O	O
testosterone-cortisol	O	O	B-T081
ratio	O	O	B-T081
increased	O	O	B-T169
in	O	O	O
the	O	O	O
lower-body	O	O	B-T023
HIIE	O	O	B-T056
for	O	O	O
the	O	O	O
lower-body	O	O	O
(	O	O	O
14.9	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
uchi-komi	O	O	B-T065
(	O	O	I-T065
61.4	O	O	I-T065
%	O	O	I-T065
)	O	O	I-T065
training	O	O	I-T065
groups	O	O	B-T078
.	O	O	O

Thus	O	O	O
,	O	O	O
short-duration	O	O	B-T080
low-volume	O	O	O
HIIT	O	O	B-T056
added	O	O	O
to	O	O	O
regular	O	O	B-T065
judo	O	O	I-T065
training	O	O	I-T065
was	O	O	O
able	O	O	O
to	O	O	O
increase	O	O	B-T169
upper-body	O	O	B-T023
aerobic	O	O	B-T201
power	O	O	I-T201
,	O	O	O
lower	O	O	B-T023
-	O	O	O
and	O	O	O
upper-body	O	O	O
HIIE	O	O	B-T056
performance	O	O	B-T052
.	O	O	O

-DOCSTART- (27445997)

Microbiomes	O	O	B-T001
of	O	O	O
Muricea	O	O	B-T204
californica	O	O	I-T204
and	O	O	O
M.	O	O	B-T204
fruticosa	O	O	I-T204
:	O	O	O
Comparative	O	O	B-T062
Analyses	O	O	I-T062
of	O	O	O
Two	O	O	O
Co-occurring	O	O	O
Eastern	O	O	B-T083
Pacific	O	O	I-T083
Octocorals	O	O	O

Octocorals	O	O	B-T204
are	O	O	O
sources	O	O	O
of	O	O	O
novel	O	O	O
but	O	O	O
understudied	O	O	B-T062
microbial	O	O	B-T001
diversity	O	O	B-T080
.	O	O	O

Conversely	O	O	O
,	O	O	O
scleractinian	O	O	B-T204
or	O	O	O
reef-building	O	O	B-T001
coral	O	O	I-T001
microbiomes	O	O	I-T001
have	O	O	O
been	O	O	O
heavily	O	O	O
examined	O	O	B-T033
in	O	O	O
light	O	O	O
of	O	O	O
the	O	O	O
threats	O	O	B-T078
of	O	O	O
climate	O	O	B-T070
change	O	O	I-T070
.	O	O	O

Muricea	O	O	B-T204
californica	O	O	I-T204
and	O	O	O
Muricea	O	O	B-T204
fruticosa	O	O	I-T204
are	O	O	O
two	O	O	O
co-occurring	O	O	B-T185
species	O	O	I-T185
of	O	O	O
gorgonian	O	O	B-T204
octocoral	O	O	B-T204
abundantly	O	O	B-T033
found	O	O	I-T033
in	O	O	O
the	O	O	O
kelp	O	O	B-T204
forests	O	O	B-T070
of	O	O	O
southern	O	O	B-T083
California	O	O	I-T083
,	O	O	O
and	O	O	O
thus	O	O	O
provide	O	O	O
an	O	O	O
excellent	O	O	B-T169
basis	O	O	I-T169
to	O	O	O
determine	O	O	O
if	O	O	O
octocoral	O	O	O
microbiomes	O	O	B-T001
are	O	O	O
host	O	O	B-T001
specific	O	O	B-T080
.	O	O	O

Using	O	O	O
Illumina	O	O	B-T170
MiSeq	O	O	I-T170
amplicon	O	O	I-T170
sequencing	O	O	I-T170
and	O	O	O
replicate	O	O	B-T169
samples	O	O	I-T169
,	O	O	O
we	O	O	O
evaluated	O	O	O
the	O	O	O
microbiomes	O	O	B-T001
collected	O	O	O
from	O	O	O
multiple	O	O	B-T081
colonies	O	O	I-T081
of	O	O	O
both	O	O	O
species	O	O	B-T185
of	O	O	O
Muricea	O	O	B-T204
to	O	O	O
measure	O	O	B-T081
both	O	O	O
inter-	O	O	B-T025
and	O	O	O
intra-colony	O	O	B-T025
microbiome	O	O	B-T001
variabilities	O	O	B-T077
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
microbiomes	O	O	B-T001
from	O	O	O
overlying	O	O	O
sea	O	O	B-T167
water	O	O	I-T167
and	O	O	O
nearby	O	O	O
zoanthids	O	O	B-T204
(	O	O	O
another	O	O	O
benthic	O	O	B-T204
invertebrate	O	O	I-T204
)	O	O	O
were	O	O	O
also	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
analysis	O	O	B-T062
to	O	O	O
evaluate	O	O	O
whether	O	O	O
bacterial	O	O	B-T170
taxa	O	O	I-T170
specifically	O	O	O
associate	O	O	B-T080
with	O	O	I-T080
octocorals	O	O	B-T204
.	O	O	O

This	O	O	O
is	O	O	O
also	O	O	O
the	O	O	O
first	O	O	B-T170
report	O	O	I-T170
of	O	O	O
microbiomes	O	O	B-T001
from	O	O	O
these	O	O	O
species	O	O	B-T185
of	O	O	O
Muricea	O	O	B-T204
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
microbiomes	O	O	B-T001
isolated	O	O	B-T169
from	O	O	O
each	O	O	O
sample	O	O	B-T080
type	O	O	B-T080
are	O	O	O
distinct	O	O	B-T080
,	O	O	O
and	O	O	O
specifically	O	O	O
,	O	O	O
that	O	O	O
octocoral	O	O	B-T204
species	O	O	B-T185
type	O	O	O
had	O	O	O
the	O	O	O
greatest	O	O	O
effect	O	O	O
on	O	O	O
predicting	O	O	B-T078
the	O	O	O
composition	O	O	B-T201
of	O	O	O
the	O	O	O
Muricea	O	O	B-T204
microbiome	O	O	B-T001
.	O	O	O

Bacterial	O	O	B-T170
taxa	O	O	I-T170
contributing	O	O	O
to	O	O	O
compositional	O	O	B-T081
differences	O	O	I-T081
include	O	O	O
distinct	O	O	B-T080
strains	O	O	B-T001
of	O	O	O
Mycoplasma	O	O	B-T007
associated	O	O	B-T080
with	O	O	I-T080
either	O	O	O
M.	O	O	B-T204
californica	O	O	I-T204
or	O	O	O
M.	O	O	B-T204
fruticosa	O	O	I-T204
,	O	O	O
an	O	O	O
abundance	O	O	B-T080
of	O	O	O
Spirochaetes	O	O	B-T007
observed	O	O	B-T169
on	O	O	O
M.	O	O	O
californica	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
greater	O	O	B-T081
diversity	O	O	B-T080
of	O	O	O
γ-Proteobacteria	O	O	B-T007
associated	O	O	O
with	O	O	O
M.	O	O	O
fruticosa	O	O	O
.	O	O	O

Many	O	O	O
of	O	O	O
the	O	O	O
bacterial	O	O	B-T170
taxa	O	O	I-T170
contributing	O	O	O
to	O	O	O
these	O	O	O
differences	O	O	B-T081
are	O	O	O
known	O	O	O
for	O	O	O
their	O	O	O
presence	O	O	B-T033
in	O	O	O
photosymbiont-containing	O	O	B-T204
invertebrate	O	O	I-T204
microbiomes	O	O	B-T001
.	O	O	O

-DOCSTART- (27447713)

2,8-Dihydroxyadenine	O	O	B-T114
Nephropathy	O	O	B-T047
Identified	O	O	O
as	O	O	O
Cause	O	O	B-T169
of	O	O	O
End-Stage	O	O	B-T047
Renal	O	O	I-T047
Disease	O	O	I-T047
After	O	O	O
Renal	O	O	O
Transplant	O	O	O

Adenine	O	O	B-T116
phosphoribosyltransferase	O	O	I-T116
deficiency	O	O	O
is	O	O	O
a	O	O	O
rare	O	O	O
autosomal	O	O	B-T047
recessive	O	O	I-T047
disorder	O	O	I-T047
of	O	O	O
uric	O	O	B-T109
acid	O	O	I-T109
metabolism	O	O	B-T040
that	O	O	O
leads	O	O	O
to	O	O	O
formation	O	O	B-T169
and	O	O	O
excretion	O	O	B-T039
of	O	O	O
2,8-dihydroxyadenine	O	O	B-T114
into	O	O	O
urine	O	O	B-T031
.	O	O	O

The	O	O	O
low	O	O	O
solubility	O	O	B-T080
of	O	O	O
2,8-dihydroxyadenine	O	O	B-T114
results	O	O	O
in	O	O	O
precipitation	O	O	B-T070
and	O	O	O
formation	O	O	B-T169
of	O	O	O
urinary	O	O	B-T034
crystals	O	O	I-T034
and	O	O	O
renal	O	O	B-T047
stones	O	O	I-T047
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
this	O	O	O
disorder	O	O	B-T047
usually	O	O	O
have	O	O	O
recurrent	O	O	B-T047
nephrolithiasis	O	O	I-T047
and	O	O	O
can	O	O	O
develop	O	O	O
nephropathy	O	O	B-T047
secondary	O	O	I-T047
to	O	O	O
crystal	O	O	B-T031
precipitation	O	O	B-T070
in	O	O	O
the	O	O	O
renal	O	O	B-T023
parenchyma	O	O	I-T023
.	O	O	O

The	O	O	O
disease	O	O	B-T047
is	O	O	O
most	O	O	O
often	O	O	O
underdiagnosed	O	O	B-T033
and	O	O	O
can	O	O	O
recur	O	O	B-T067
in	O	O	O
renal	O	O	B-T061
transplant	O	O	I-T061
,	O	O	O
causing	O	O	B-T169
graft	O	O	B-T046
failure	O	O	I-T046
.	O	O	O

Lack	O	O	O
of	O	O	O
specific	O	O	O
clinical	O	O	B-T080
manifestations	O	O	B-T169
,	O	O	O
chemical	O	O	B-T070
and	O	O	O
radiologic	O	O	B-T033
features	O	O	I-T033
identical	O	O	O
to	O	O	O
those	O	O	O
shown	O	O	O
with	O	O	O
uric	O	O	B-T109
acid	O	O	I-T109
stones	O	O	O
,	O	O	O
and	O	O	O
lack	O	O	B-T033
of	O	O	I-T033
awareness	O	O	I-T033
among	O	O	O
clinicians	O	O	B-T097
are	O	O	O
among	O	O	O
the	O	O	O
causes	O	O	B-T169
for	O	O	O
the	O	O	O
underdiagnoses	O	O	B-T033
of	O	O	O
this	O	O	O
treatable	O	O	B-T169
disease	O	O	B-T047
.	O	O	O

Allopurinol	O	O	B-T109
,	O	O	O
a	O	O	O
xanthine	O	O	B-T116
dehydrogenase	O	O	I-T116
inhibitor	O	O	B-T121
,	O	O	O
is	O	O	O
the	O	O	O
mainstay	O	O	O
of	O	O	O
treatment	O	O	B-T169
,	O	O	O
supported	O	O	O
by	O	O	O
high	O	O	O
fluid	O	O	B-T201
intake	O	O	I-T201
and	O	O	O
dietary	O	O	B-T061
modifications	O	O	I-T061
.	O	O	O

The	O	O	O
possibility	O	O	O
of	O	O	O
adenine	O	O	B-T116
phosphoribosyl	O	O	I-T116
transferase	O	O	I-T116
deficiency	O	O	O
should	O	O	O
be	O	O	O
considered	O	O	O
in	O	O	O
all	O	O	O
cases	O	O	O
of	O	O	O
urolithiasis	O	O	B-T047
in	O	O	O
children	O	O	B-T100
,	O	O	O
patients	O	O	B-T101
with	O	O	O
recurrent	O	O	B-UnknownType
urolithiasis	O	O	I-UnknownType
,	O	O	O
and	O	O	O
patients	O	O	O
with	O	O	O
urolithiasis	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
renal	O	O	B-T047
failure	O	O	I-T047
of	O	O	O
unknown	O	O	O
cause	O	O	B-T169
,	O	O	O
including	O	O	O
patients	O	O	O
with	O	O	O
end-stage	O	O	B-T047
renal	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
renal	O	O	B-T101
transplant	O	O	I-T101
recipients	O	O	I-T101
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
a	O	O	O
case	O	O	O
of	O	O	O
a	O	O	O
41-year-old	O	O	O
female	O	O	B-T032
patient	O	O	I-T032
who	O	O	O
had	O	O	O
a	O	O	O
late	O	O	B-T080
diagnosis	O	O	I-T080
of	O	O	O
2,8-dihydroxyadenine	O	O	B-T114
nephropathy	O	O	B-T047
-induced	O	O	O
end-stage	O	O	B-T047
renal	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
made	O	O	O
on	O	O	O
the	O	O	O
native	O	O	B-T169
nephrectomy	O	O	B-T061
that	O	O	O
accompanied	O	O	O
the	O	O	O
renal	O	O	B-T061
transplant	O	O	I-T061
,	O	O	O
and	O	O	O
who	O	O	O
had	O	O	O
a	O	O	O
timely	O	O	O
intervention	O	O	O
that	O	O	O
prevented	O	O	B-T080
recurrence	O	O	B-T046
in	O	O	O
the	O	O	O
graft	O	O	B-T061
.	O	O	O

-DOCSTART- (27449022)

Social	O	O	B-T169
capital	O	O	I-T169
and	O	O	O
healthy	O	O	B-T080
ageing	O	O	B-T040
in	O	O	O
Indonesia	O	O	O

A	O	O	O
large	O	O	B-T081
international	O	O	B-T078
literature	O	O	B-T170
has	O	O	O
found	O	O	O
a	O	O	O
positive	O	O	B-T033
association	O	O	B-T080
between	O	O	O
social	O	O	B-T169
capital	O	O	I-T169
and	O	O	O
measures	O	O	B-T081
of	O	O	O
physical	O	O	B-T033
and	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
paucity	O	O	O
of	O	O	O
research	O	O	B-T062
on	O	O	O
the	O	O	O
links	O	O	B-T080
between	O	O	O
social	O	O	B-T169
capital	O	O	I-T169
and	O	O	O
healthy	O	O	B-T080
ageing	O	O	B-T040
in	O	O	O
a	O	O	O
developing	O	O	B-T080
country	O	O	I-T080
environment	O	O	B-T082
,	O	O	O
where	O	O	O
universal	O	O	B-T064
social	O	O	I-T064
security	O	O	I-T064
coverage	O	O	I-T064
is	O	O	O
absent	O	O	B-T169
and	O	O	O
health	O	O	B-T078
infrastructure	O	O	I-T078
is	O	O	O
poor	O	O	B-T080
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
develop	O	O	O
and	O	O	O
empirically	O	O	O
test	O	O	B-T169
a	O	O	O
model	O	O	B-T170
of	O	O	O
the	O	O	O
linkages	O	O	B-T185
between	O	O	O
social	O	O	B-T169
capital	O	O	I-T169
and	O	O	O
the	O	O	O
health	O	O	B-T170
outcomes	O	O	I-T170
for	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
in	O	O	O
Indonesia	O	O	B-T083
,	O	O	O
using	O	O	O
data	O	O	B-T078
from	O	O	O
the	O	O	O
Indonesian	O	O	B-T170
Family	O	O	I-T170
Life	O	O	I-T170
Survey-East	O	O	I-T170
(	O	O	O
IFLS-East	O	O	B-T170
)	O	O	O
,	O	O	O
conducted	O	O	O
in	O	O	O
2012	O	O	O
.	O	O	O

Using	O	O	O
multivariate	O	O	B-T170
regression	O	O	I-T170
analysis	O	O	I-T170
,	O	O	O
we	O	O	O
examine	O	O	O
whether	O	O	O
social	O	O	B-T169
capital	O	O	I-T169
plays	O	O	O
a	O	O	O
role	O	O	B-T077
in	O	O	O
mitigating	O	O	B-T080
poor	O	O	B-T033
health	O	O	I-T033
among	O	O	O
older	O	O	B-T098
individuals	O	O	B-T098
aged	O	O	B-T032
50	O	O	O
years	O	O	B-T079
and	O	O	O
above	O	O	O
in	O	O	O
Indonesia	O	O	B-T083
's	O	O	O
most	O	O	O
vulnerable	O	O	B-T083
provinces	O	O	I-T083
.	O	O	O

We	O	O	O
test	O	O	B-T169
the	O	O	O
robustness	O	O	B-T080
of	O	O	O
these	O	O	O
social	O	O	B-T169
capital	O	O	I-T169
variables	O	O	B-T080
across	O	O	O
different	O	O	O
health	O	O	B-T078
measures	O	O	B-T081
(	O	O	O
self-assessed	O	O	B-T052
health	O	O	O
,	O	O	O
Activities	O	O	B-T056
of	O	O	I-T056
Daily	O	O	I-T056
Living	O	O	I-T056
(	O	O	O
ADL	O	O	B-T056
)	O	O	O
,	O	O	O
measures	O	O	O
of	O	O	O
chronic	O	O	B-T047
illness	O	O	I-T047
and	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
measures	O	O	O
)	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
across	O	O	O
different	O	O	O
demographic	O	O	B-T090
groups	O	O	B-T078
,	O	O	O
after	O	O	O
controlling	O	O	B-T169
for	O	O	O
an	O	O	O
array	O	O	B-T082
of	O	O	O
socio-economic	O	O	B-T080
,	O	O	O
demographic	O	O	O
and	O	O	O
geographic	O	O	B-T082
characteristics	O	O	B-T080
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
show	O	O	O
that	O	O	O
access	O	O	B-T082
to	O	O	O
better	O	O	O
social	O	O	B-T169
capital	O	O	I-T169
(	O	O	O
using	O	O	O
measures	O	O	B-T081
of	O	O	O
neighbourhood	O	O	B-T098
trust	O	O	B-T054
and	O	O	O
community	O	O	B-T054
participation	O	O	I-T054
)	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
higher	O	O	B-T080
degree	O	O	B-T081
of	O	O	O
physical	O	O	B-T040
mobility	O	O	I-T040
,	O	O	O
independence	O	O	B-T078
,	O	O	O
and	O	O	O
mental	O	O	B-T041
well-being	O	O	I-T041
among	O	O	O
older	O	O	B-T098
individuals	O	O	B-T098
but	O	O	O
has	O	O	O
no	O	O	O
influence	O	O	B-T077
on	O	O	O
chronic	O	O	B-T047
illnesses	O	O	I-T047
.	O	O	O

These	O	O	O
results	O	O	B-T169
are	O	O	O
consistent	O	O	B-T078
when	O	O	O
we	O	O	O
estimate	O	O	B-T081
samples	O	O	B-T096
disaggregated	O	O	O
by	O	O	O
gender	O	O	B-T032
,	O	O	O
rural	O	O	B-T033
/	O	O	O
urban	O	O	B-T080
residence	O	O	B-T082
,	O	O	O
and	O	O	O
by	O	O	O
age	O	O	B-T032
categories	O	O	B-T170
.	O	O	O

From	O	O	O
a	O	O	O
policy	O	O	B-T170
perspective	O	O	O
these	O	O	O
results	O	O	B-T169
point	O	O	O
to	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
social	O	O	B-T169
capital	O	O	I-T169
measures	O	O	B-T169
in	O	O	O
moderating	O	O	B-T080
the	O	O	O
influence	O	O	B-T077
of	O	O	O
poor	O	O	B-T033
health	O	O	I-T033
,	O	O	O
particularly	O	O	O
in	O	O	O
the	O	O	O
Activities	O	O	B-T056
of	O	O	I-T056
Daily	O	O	I-T056
Living	O	O	I-T056
.	O	O	O

-DOCSTART- (27449508)

Modulation	O	O	B-T082
of	O	O	O
Interleukins	O	O	B-T116
in	O	O	O
Sepsis	O	O	B-T047
-	O	O	O
Associated	O	O	B-T080
Clotting	O	O	B-T047
Disorders	O	O	I-T047
:	O	O	O
Interplay	O	O	O
With	O	O	O
Hemostatic	O	O	O
Derangement	O	O	O

Interleukins	O	O	B-T116
play	O	O	O
a	O	O	O
central	O	O	B-T082
role	O	O	B-T077
in	O	O	O
the	O	O	O
immune	O	O	B-T022
system	O	O	I-T022
and	O	O	O
are	O	O	O
involved	O	O	B-T169
in	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
immunological	O	O	B-T047
,	O	O	O
inflammatory	O	O	B-T047
,	O	O	O
and	O	O	O
infectious	O	O	B-T047
disease	O	O	I-T047
states	O	O	B-T169
including	O	O	O
sepsis	O	O	B-T047
syndrome	O	O	I-T047
.	O	O	O

Levels	O	O	B-T080
of	O	O	O
interleukins	O	O	B-T116
may	O	O	O
correlate	O	O	B-T080
with	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
and	O	O	O
may	O	O	O
directly	O	O	B-T080
or	O	O	O
indirectly	O	O	B-T080
affect	O	O	B-T041
some	O	O	O
of	O	O	O
the	O	O	O
regulators	O	O	B-T129
of	O	O	O
coagulation	O	O	B-T042
and	O	O	O
fibrinolysis	O	O	B-T039
,	O	O	O
thereby	O	O	O
disrupting	O	O	O
hemostasis	O	O	B-T042
and	O	O	O
thrombosis	O	O	B-T046
.	O	O	O

Our	O	O	O
hypothesis	O	O	B-T078
is	O	O	O
that	O	O	O
in	O	O	O
sepsis-associated	O	O	B-T047
coagulopathies	O	O	I-T047
(	O	O	O
SACs	O	O	B-T047
)	O	O	O
,	O	O	O
interleukins	O	O	B-T116
may	O	O	O
be	O	O	O
upregulated	O	O	B-T044
,	O	O	O
leading	O	O	O
to	O	O	O
hemostatic	O	O	B-T047
imbalance	O	O	I-T047
by	O	O	O
generating	O	O	O
thrombogenic	O	O	B-T123
mediators	O	O	I-T123
.	O	O	O

We	O	O	O
profiled	O	O	B-T169
the	O	O	O
levels	O	O	B-T080
of	O	O	O
interleukins	O	O	B-T116
IL-1α	O	O	B-T116
,	O	O	O
IL-1β	O	O	B-T116
,	O	O	O
IL-2	O	O	B-T116
,	O	O	O
IL-4	O	O	B-T116
,	O	O	O
IL-6	O	O	B-T116
,	O	O	O
IL-8	O	O	B-T116
,	O	O	O
and	O	O	O
IL-10	O	O	B-T116
in	O	O	B-T169
addition	O	O	I-T169
to	O	O	I-T169
d-dimer	O	O	B-T116
(	O	O	O
DD	O	O	B-T116
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
SAC	O	O	B-T047
and	O	O	O
in	O	O	O
normal	O	O	B-T080
donors	O	O	B-T098
.	O	O	O

We	O	O	O
observed	O	O	B-T169
the	O	O	O
highest	O	O	B-T080
increase	O	O	B-T169
in	O	O	O
interleukins	O	O	B-T116
IL-6	O	O	B-T116
(	O	O	O
322-fold	O	O	B-T081
)	O	O	O
,	O	O	O
IL-8	O	O	B-T116
(	O	O	O
48-fold	O	O	B-T081
)	O	O	O
,	O	O	O
IL-10	O	O	B-T116
(	O	O	O
72-fold	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
DD	O	O	B-T116
(	O	O	O
18-fold	O	O	B-T081
)	O	O	O
.	O	O	O

This	O	O	O
suggests	O	O	B-T078
that	O	O	O
interleukins	O	O	B-T116
such	O	O	O
as	O	O	O
IL-6	O	O	B-T116
and	O	O	O
IL-10	O	O	B-T116
have	O	O	O
a	O	O	O
close	O	O	O
association	O	O	B-T080
with	O	O	I-T080
coagulopathy	O	O	B-T047
and	O	O	O
fibrinolytic	O	O	B-UnknownType
dysregulation	O	O	I-UnknownType
in	O	O	O
sepsis	O	O	B-T047
and	O	O	O
can	O	O	O
be	O	O	O
considered	O	O	B-T078
as	O	O	O
candidates	O	O	B-T116
for	O	O	O
potential	O	O	B-T080
therapeutic	O	O	B-T169
targets	O	O	B-T169
in	O	O	O
SAC	O	O	B-T047
.	O	O	O

-DOCSTART- (27450737)

Thymosin	O	O	B-T116
β4	O	O	I-T116
:	O	O	O
Roles	O	O	O
in	O	O	O
Development	O	O	B-T169
,	O	O	O
Repair	O	O	B-T040
,	O	O	O
and	O	O	O
Engineering	O	O	B-T169
of	O	O	O
the	O	O	O
Cardiovascular	O	O	O
System	O	O	O

The	O	O	O
burden	O	O	O
of	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
is	O	O	O
a	O	O	O
growing	O	O	O
worldwide	O	O	O
issue	O	O	O
that	O	O	O
demands	O	O	O
attention	O	O	O
.	O	O	O

While	O	O	O
many	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
are	O	O	O
ongoing	O	O	O
to	O	O	O
test	O	O	B-T169
therapies	O	O	B-T061
for	O	O	O
treating	O	O	B-T169
the	O	O	O
heart	O	O	B-T023
after	O	O	O
myocardial	O	O	B-T047
infarction	O	O	I-T047
(	O	O	O
MI	O	O	B-T047
)	O	O	O
and	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
,	O	O	O
there	O	O	O
are	O	O	O
few	O	O	O
options	O	O	O
doctors	O	O	B-T097
able	O	O	O
to	O	O	O
currently	O	O	O
give	O	O	O
patients	O	O	B-T101
to	O	O	O
repair	O	O	B-T061
the	O	O	I-T061
heart	O	O	I-T061
.	O	O	O

This	O	O	O
eventually	O	O	O
leads	O	O	O
to	O	O	O
decreased	O	O	O
ventricular	O	O	B-T042
contractility	O	O	I-T042
and	O	O	O
increased	O	O	O
systemic	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
including	O	O	O
vascular	O	O	B-T047
disorders	O	O	I-T047
that	O	O	O
could	O	O	O
result	O	O	O
in	O	O	O
stroke	O	O	B-T047
.	O	O	O

Small	O	O	O
peptides	O	O	B-T116
such	O	O	O
as	O	O	O
thymosin	O	O	B-T116
β4	O	O	I-T116
(	O	O	O
Tβ4	O	O	B-T116
)	O	O	O
are	O	O	O
upregulated	O	O	O
in	O	O	O
the	O	O	O
cardiovascular	O	O	B-T029
niche	O	O	B-T030
during	O	O	O
fetal	O	O	B-T042
development	O	O	I-T042
and	O	O	O
after	O	O	O
injuries	O	O	B-T037
such	O	O	O
as	O	O	O
MI	O	O	B-T047
,	O	O	O
providing	O	O	O
increased	O	O	O
neovasculogenesis	O	O	B-T191
and	O	O	O
paracrine	O	O	B-T043
signals	O	O	I-T043
for	O	O	O
endogenous	O	O	B-T025
stem	O	O	I-T025
cell	O	O	I-T025
recruitment	O	O	O
to	O	O	O
aid	O	O	O
in	O	O	O
wound	O	O	B-T040
repair	O	O	I-T040
.	O	O	O

New	O	O	O
research	O	O	B-T062
is	O	O	O
looking	O	O	O
into	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
administration	O	O	B-T061
of	O	O	O
Tβ4	O	O	B-T116
through	O	O	O
injections	O	O	B-T061
and	O	O	O
coatings	O	O	B-T121
on	O	O	O
implants	O	O	B-T074
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
its	O	O	O
effect	O	O	O
on	O	O	O
cell	O	O	B-T043
differentiation	O	O	I-T043
.	O	O	O

Results	O	O	O
so	O	O	O
far	O	O	O
demonstrate	O	O	O
Tβ4	O	O	B-T116
administration	O	O	B-T061
leads	O	O	O
to	O	O	O
robust	O	O	O
increases	O	O	O
in	O	O	O
angiogenesis	O	O	B-T042
and	O	O	O
wound	O	O	B-T040
healing	O	O	I-T040
in	O	O	O
the	O	O	O
heart	O	O	B-T023
after	O	O	O
MI	O	O	B-T047
and	O	O	O
the	O	O	O
brain	O	O	B-T023
after	O	O	O
stroke	O	O	B-T047
,	O	O	O
and	O	O	O
can	O	O	O
differentiate	O	O	O
adult	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
toward	O	O	O
the	O	O	O
cardiac	O	O	B-T023
lineage	O	O	B-T078
for	O	O	O
implantation	O	O	B-T061
to	O	O	O
the	O	O	O
heart	O	O	O
to	O	O	O
increase	O	O	O
contractility	O	O	B-T042
and	O	O	O
survival	O	O	B-T169
.	O	O	O

Future	O	O	O
work	O	O	O
,	O	O	O
some	O	O	O
of	O	O	O
which	O	O	O
is	O	O	O
currently	O	O	O
in	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
,	O	O	O
will	O	O	O
demonstrate	O	O	O
the	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
effect	O	O	B-T080
of	O	O	O
these	O	O	O
therapies	O	O	B-T061
on	O	O	O
human	O	O	B-T016
patients	O	O	B-T101
,	O	O	O
with	O	O	O
the	O	O	O
goal	O	O	B-T170
of	O	O	O
helping	O	O	O
the	O	O	O
millions	O	O	O
of	O	O	O
people	O	O	B-T098
worldwide	O	O	O
affected	O	O	O
by	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

-DOCSTART- (27451448)

Yersinia	O	O	B-T007
ruckeri	O	O	I-T007
Isolates	O	O	B-T123
Recovered	O	O	B-T080
from	O	O	I-T080
Diseased	O	O	B-T047
Atlantic	O	O	B-T013
Salmon	O	O	I-T013
(	O	O	O
Salmo	O	O	B-T013
salar	O	O	I-T013
)	O	O	O
in	O	O	O
Scotland	O	O	B-T083
Are	O	O	O
More	O	O	O
Diverse	O	O	O
than	O	O	O
Those	O	O	O
from	O	O	O
Rainbow	O	O	B-T013
Trout	O	O	I-T013
(	O	O	O
Oncorhynchus	O	O	B-T013
mykiss	O	O	I-T013
)	O	O	O
and	O	O	O
Represent	O	O	B-T052
Distinct	O	O	O
Subpopulations	O	O	O

Yersinia	O	O	B-T007
ruckeri	O	O	I-T007
is	O	O	O
the	O	O	O
etiological	O	O	B-T169
agent	O	O	I-T169
of	O	O	O
enteric	O	O	B-T047
redmouth	O	O	I-T047
(	O	O	O
ERM	O	O	B-T047
)	O	O	O
disease	O	O	B-T047
of	O	O	O
farmed	O	O	O
salmonids	O	O	B-T013
.	O	O	O

Enteric	O	O	B-T047
redmouth	O	O	I-T047
disease	O	O	I-T047
is	O	O	O
traditionally	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
rainbow	O	O	B-T013
trout	O	O	I-T013
(	O	O	O
Oncorhynchus	O	O	B-T013
mykiss	O	O	I-T013
,	O	O	O
Walbaum	O	O	B-T013
)	O	O	O
,	O	O	O
but	O	O	O
its	O	O	O
incidence	O	O	B-T081
in	O	O	O
Atlantic	O	O	B-T013
salmon	O	O	I-T013
(	O	O	O
Salmo	O	O	B-T013
salar	O	O	I-T013
)	O	O	O
is	O	O	O
increasing	O	O	B-T169
.	O	O	O

Yersinia	O	O	B-T007
ruckeri	O	O	I-T007
isolates	O	O	B-T123
recovered	O	O	B-T080
from	O	O	I-T080
diseased	O	O	B-T047
Atlantic	O	O	B-T013
salmon	O	O	I-T013
have	O	O	O
been	O	O	O
poorly	O	O	B-T052
characterized	O	O	I-T052
,	O	O	O
and	O	O	O
very	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
relationship	O	O	B-T080
of	O	O	O
the	O	O	O
isolates	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
these	O	O	O
two	O	O	O
species	O	O	B-T185
.	O	O	O

Phenotypic	O	O	B-T032
approaches	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
characterize	O	O	O
109	O	O	O
Y.	O	O	B-T007
ruckeri	O	O	I-T007
isolates	O	O	B-T123
recovered	O	O	O
over	O	O	O
a	O	O	O
14-year	O	O	O
period	O	O	O
from	O	O	O
infected	O	O	B-T033
Atlantic	O	O	B-T013
salmon	O	O	I-T013
in	O	O	O
Scotland	O	O	B-T083
;	O	O	O
26	O	O	O
isolates	O	O	O
from	O	O	O
infected	O	O	O
rainbow	O	O	B-T013
trout	O	O	I-T013
were	O	O	O
also	O	O	O
characterized	O	O	B-T052
.	O	O	O

Biotyping	O	O	B-T059
,	O	O	O
serotyping	O	O	B-T059
,	O	O	O
and	O	O	O
comparison	O	O	B-T052
of	O	O	O
outer	O	O	B-T026
membrane	O	O	I-T026
protein	O	O	B-T034
profiles	O	O	I-T034
identified	O	O	O
19	O	O	O
Y.	O	O	B-T007
ruckeri	O	O	I-T007
clones	O	O	B-T024
associated	O	O	B-T080
with	O	O	I-T080
Atlantic	O	O	B-T013
salmon	O	O	I-T013
but	O	O	O
only	O	O	O
five	O	O	O
associated	O	O	O
with	O	O	O
rainbow	O	O	B-T013
trout	O	O	I-T013
;	O	O	O
none	O	O	O
of	O	O	O
the	O	O	O
Atlantic	O	O	O
salmon	O	O	O
clones	O	O	O
occurred	O	O	O
in	O	O	O
rainbow	O	O	O
trout	O	O	O
and	O	O	O
vice	O	O	O
versa	O	O	O
These	O	O	O
findings	O	O	B-T033
suggest	O	O	O
that	O	O	O
distinct	O	O	O
subpopulations	O	O	B-T098
of	O	O	O
Y.	O	O	O
ruckeri	O	O	O
are	O	O	O
associated	O	O	O
with	O	O	O
each	O	O	O
species	O	O	B-T185
.	O	O	O

A	O	O	O
new	O	O	O
O	O	O	B-T170
serotype	O	O	B-T170
(	O	O	O
designated	O	O	O
O8	O	O	O
)	O	O	O
was	O	O	O
identified	O	O	O
in	O	O	O
56	O	O	B-T170
biotype	O	O	I-T170
1	O	O	I-T170
Atlantic	O	O	B-T013
salmon	O	O	I-T013
isolates	O	O	B-T123
and	O	O	O
was	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
serotype	O	O	O
identified	O	O	O
from	O	O	O
2006	O	O	O
to	O	O	O
2011	O	O	O
and	O	O	O
in	O	O	O
2014	O	O	O
,	O	O	O
suggesting	O	O	O
an	O	O	O
increased	O	O	B-T081
prevalence	O	O	I-T081
during	O	O	O
the	O	O	O
time	O	O	O
period	O	O	O
sampled	O	O	O
.	O	O	O

Rainbow	O	O	B-T013
trout	O	O	I-T013
isolates	O	O	B-T123
were	O	O	O
represented	O	O	B-T052
almost	O	O	O
exclusively	O	O	O
by	O	O	O
the	O	O	O
same	O	O	O
biotype	O	O	B-T170
2	O	O	I-T170
,	O	O	O
serotype	O	O	B-T170
O1	O	O	I-T170
clone	O	O	O
that	O	O	O
has	O	O	O
been	O	O	O
responsible	O	O	O
for	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
ERM	O	O	B-T047
outbreaks	O	O	O
in	O	O	O
this	O	O	O
species	O	O	B-T185
within	O	O	O
the	O	O	O
United	O	O	B-T083
Kingdom	O	O	I-T083
since	O	O	O
the	O	O	O
1980s	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
identification	O	O	O
of	O	O	O
two	O	O	O
biotype	O	O	B-T170
2	O	O	I-T170
,	O	O	O
serotype	O	O	B-T170
O8	O	O	I-T170
isolates	O	O	B-T123
in	O	O	O
rainbow	O	O	B-T013
trout	O	O	I-T013
suggests	O	O	O
that	O	O	O
vaccines	O	O	B-T129
containing	O	O	O
serotypes	O	O	B-T170
O1	O	O	I-T170
and	O	O	I-T170
O8	O	O	I-T170
should	O	O	O
be	O	O	O
evaluated	O	O	O
in	O	O	O
both	O	O	O
rainbow	O	O	O
trout	O	O	O
and	O	O	O
Atlantic	O	O	B-T013
salmon	O	O	I-T013
for	O	O	O
application	O	O	O
in	O	O	O
Scotland	O	O	B-T083
.	O	O	O

Vaccination	O	O	B-T061
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
protecting	O	O	O
Atlantic	O	O	B-T013
salmon	O	O	B-T013
against	O	O	O
the	O	O	O
bacterial	O	O	B-T007
pathogen	O	O	O
Yersinia	O	O	B-T007
ruckeri	O	O	I-T007
,	O	O	O
but	O	O	O
,	O	O	O
in	O	O	O
recent	O	O	O
years	O	O	O
,	O	O	O
there	O	O	O
has	O	O	O
been	O	O	O
an	O	O	O
increasing	O	O	B-T169
incidence	O	O	B-T081
of	O	O	O
vaccine	O	O	B-T129
breakdown	O	O	O
in	O	O	O
salmon	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
largely	O	O	O
because	O	O	O
current	O	O	O
vaccines	O	O	B-T129
are	O	O	O
aimed	O	O	O
at	O	O	O
rainbow	O	O	B-T013
trout	O	O	I-T013
and	O	O	O
are	O	O	O
based	O	O	O
on	O	O	O
serotypes	O	O	B-T170
specific	O	O	O
for	O	O	O
this	O	O	O
species	O	O	B-T185
.	O	O	O

A	O	O	O
wider	O	O	O
range	O	O	O
of	O	O	O
serotypes	O	O	B-T170
is	O	O	O
responsible	O	O	O
for	O	O	O
infection	O	O	B-T046
in	O	O	O
Atlantic	O	O	B-T013
salmon	O	O	I-T013
,	O	O	O
but	O	O	O
very	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
diversity	O	O	O
of	O	O	O
these	O	O	O
strains	O	O	B-T013
and	O	O	O
their	O	O	O
relationships	O	O	B-T080
to	O	O	O
those	O	O	O
recovered	O	O	B-T080
from	O	O	I-T080
rainbow	O	O	B-T013
trout	O	O	I-T013
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
Y.	O	O	B-T007
ruckeri	O	O	I-T007
isolates	O	O	B-T123
recovered	O	O	B-T080
from	O	O	I-T080
diseased	O	O	B-T047
Atlantic	O	O	B-T013
salmon	O	O	I-T013
in	O	O	O
Scotland	O	O	B-T083
are	O	O	O
more	O	O	O
diverse	O	O	O
than	O	O	O
those	O	O	O
from	O	O	O
rainbow	O	O	B-T013
trout	O	O	I-T013
;	O	O	O
furthermore	O	O	O
,	O	O	O
isolates	O	O	O
from	O	O	O
the	O	O	O
two	O	O	O
species	O	O	B-T185
represent	O	O	B-T052
distinct	O	O	O
subpopulations	O	O	B-T098
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
a	O	O	O
new	O	O	O
O	O	O	B-T170
serotype	O	O	I-T170
was	O	O	O
identified	O	O	O
that	O	O	O
is	O	O	O
responsible	O	O	O
for	O	O	O
a	O	O	O
significant	O	O	B-T078
proportion	O	O	B-T081
of	O	O	O
the	O	O	O
disease	O	O	B-T047
in	O	O	O
Atlantic	O	O	B-T013
salmon	O	O	I-T013
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
are	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
important	O	O	O
implications	O	O	O
for	O	O	O
the	O	O	O
development	O	O	B-T062
of	O	O	I-T062
improved	O	O	I-T062
vaccines	O	O	I-T062
against	O	O	O
Y.	O	O	B-T007
ruckeri	O	O	I-T007
.	O	O	O

-DOCSTART- (27452524)

CD84	O	O	B-T116
mediates	O	O	O
CLL	O	O	B-T191
-	O	O	O
microenvironment	O	O	B-T070
interactions	O	O	O

Chronic	O	O	B-T191
lymphocytic	O	O	I-T191
leukemia	O	O	I-T191
(	O	O	O
CLL	O	O	B-T191
)	O	O	O
is	O	O	O
a	O	O	O
malignant	O	O	B-T047
disease	O	O	I-T047
of	O	O	O
small	O	O	O
mature	O	O	B-T025
lymphocytes	O	O	I-T025
.	O	O	O

Signals	O	O	B-T067
from	O	O	O
the	O	O	O
CLL	O	O	B-T191
microenvironment	O	O	B-T070
promote	O	O	B-T052
progression	O	O	B-T046
of	O	O	I-T046
the	O	O	I-T046
disease	O	O	I-T046
and	O	O	O
induce	O	O	B-T169
drug	O	O	B-T038
resistance	O	O	I-T038
.	O	O	O

This	O	O	O
phenomenon	O	O	B-T067
is	O	O	O
largely	O	O	O
dependent	O	O	B-T080
on	O	O	O
direct	O	O	O
contact	O	O	O
between	O	O	O
the	O	O	O
malignant	O	O	B-T191
B	O	O	I-T191
cells	O	O	I-T191
and	O	O	O
stromal	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

CD84	O	O	B-T116
belongs	O	O	O
to	O	O	O
the	O	O	O
signaling	O	O	B-T116
lymphocyte	O	O	I-T116
activation	O	O	I-T116
molecule	O	O	I-T116
family	O	O	I-T116
of	O	O	O
immunoreceptors	O	O	B-T116
,	O	O	O
which	O	O	O
self-associates	O	O	B-T044
,	O	O	O
forming	O	O	O
an	O	O	O
orthogonal	O	O	B-T104
homophilic	O	O	I-T104
dimer	O	O	I-T104
.	O	O	O

We	O	O	O
therefore	O	O	O
hypothesized	O	O	O
that	O	O	O
CD84	O	O	B-T116
may	O	O	O
bridge	O	O	O
between	O	O	O
CLL	O	O	B-T191
cells	O	O	B-T025
and	O	O	O
their	O	O	O
microenvironment	O	O	B-T070
,	O	O	O
promoting	O	O	B-T052
cell	O	O	B-T043
survival	O	O	I-T043
.	O	O	O

Our	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
results	O	O	B-T169
show	O	O	O
that	O	O	O
CD84	O	O	B-T045
expressed	O	O	I-T045
on	O	O	O
CLL	O	O	B-T191
cells	O	O	B-T025
interact	O	O	B-T169
with	O	O	O
CD84	O	O	O
expressed	O	O	O
on	O	O	O
cells	O	O	O
in	O	O	O
their	O	O	O
microenvironment	O	O	B-T070
,	O	O	O
inducing	O	O	B-T169
cell	O	O	B-T043
survival	O	O	I-T043
in	O	O	O
both	O	O	O
sides	O	O	O
.	O	O	O

Blocking	O	O	B-T169
CD84	O	O	B-T116
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
disrupt	O	O	B-T080
the	O	O	O
interaction	O	O	B-T169
of	O	O	O
CLL	O	O	B-T191
cells	O	O	B-T025
with	O	O	O
their	O	O	O
microenvironment	O	O	B-T070
,	O	O	O
resulting	O	O	B-T169
in	O	O	I-T169
induced	O	O	B-T169
cell	O	O	B-T043
death	O	O	I-T043
.	O	O	O

Thus	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	B-T033
suggest	O	O	O
novel	O	O	B-T080
therapeutic	O	O	B-T169
strategies	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
blockade	O	O	B-T121
of	O	O	O
this	O	O	O
CD84	O	O	B-T116
-	O	O	O
dependent	O	O	B-T080
survival	O	O	B-T043
pathway	O	O	B-T044
.	O	O	O

-DOCSTART- (27453213)

Aurantimonas	O	O	B-T007
endophytica	O	O	I-T007
sp.	O	O	I-T007
nov.	O	O	I-T007
,	O	O	O
a	O	O	O
novel	O	O	O
endophytic	O	O	B-T004
bacterium	O	O	I-T004
isolated	O	O	O
from	O	O	O
roots	O	O	B-T002
of	O	O	O
Anabasis	O	O	O
elatior	O	O	O
(	O	O	O
C.	O	O	O
A.	O	O	O
Mey	O	O	O
.	O	O	O
)	O	O	O
Schischk	O	O	O

An	O	O	O
orange-coloured	O	O	B-T080
,	O	O	O
aerobic	O	O	B-T080
,	O	O	O
motile	O	O	B-T033
and	O	O	O
short-rods	O	O	B-T007
bacterial	O	O	I-T007
strain	O	O	I-T007
,	O	O	O
designated	O	O	O
EGI	O	O	B-T007
6500337	O	O	I-T007
T	O	O	I-T007
,	O	O	O
was	O	O	O
isolated	O	O	O
from	O	O	O
the	O	O	O
surface-sterilized	O	O	O
root	O	O	B-T002
of	O	O	O
a	O	O	O
halophyte	O	O	B-T002
Anabasis	O	O	B-T002
elatior	O	O	I-T002
(	O	O	I-T002
C.	O	O	I-T002
A.	O	O	I-T002
Mey	O	O	I-T002
.	O	O	I-T002
)	O	O	I-T002
Schischk	O	O	I-T002
collected	O	O	O
from	O	O	O
Urumqi	O	O	B-T083
,	O	O	O
Xinjiang	O	O	B-T083
province	O	O	I-T083
,	O	O	O
north-west	O	O	B-T083
China	O	O	I-T083
.	O	O	O

Growth	O	O	B-T040
occurred	O	O	O
at	O	O	O
5	O	O	O
-	O	O	O
35	O	O	O
°	O	O	O
C	O	O	O
(	O	O	O
optimum	O	O	O
30	O	O	O
°	O	O	O
C	O	O	O
)	O	O	O
,	O	O	O
at	O	O	O
pH	O	O	B-T081
6.0	O	O	O
-	O	O	O
9.0	O	O	O
(	O	O	O
optimum	O	O	O
pH	O	O	O
7.0	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
0	O	O	O
-	O	O	O
6	O	O	O
%	O	O	O
NaCl	O	O	B-T121
(	O	O	O
w/v	O	O	O
)	O	O	O
(	O	O	O
optimum	O	O	O
0	O	O	O
-	O	O	O
1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Phylogenetic	O	O	B-T080
tree	O	O	I-T080
based	O	O	O
on	O	O	O
16S	O	O	B-T114
rRNA	O	O	I-T114
gene	O	O	B-T086
sequences	O	O	I-T086
indicated	O	O	O
that	O	O	O
strain	O	O	B-T007
EGI	O	O	I-T007
6500337	O	O	I-T007
T	O	O	I-T007
formed	O	O	O
a	O	O	O
distinct	O	O	O
lineage	O	O	O
in	O	O	O
the	O	O	O
cluster	O	O	O
that	O	O	O
comprised	O	O	O
the	O	O	O
genera	O	O	B-T007
Aurantimonas	O	O	I-T007
and	O	O	O
Aureimonas	O	O	B-T007
in	O	O	O
the	O	O	O
family	O	O	B-T007
Aurantimonadaceae	O	O	I-T007
.	O	O	O

The	O	O	O
16S	O	O	B-T114
rRNA	O	O	I-T114
gene	O	O	B-T086
sequence	O	O	I-T086
of	O	O	O
strain	O	O	B-T007
EGI	O	O	I-T007
6500337	O	O	I-T007
T	O	O	I-T007
shared	O	O	O
the	O	O	O
highest	O	O	O
similarities	O	O	O
to	O	O	O
those	O	O	O
of	O	O	O
Aurantimonas	O	O	B-T007
coralicida	O	O	I-T007
DSM	O	O	I-T007
14790	O	O	I-T007
T	O	O	I-T007
(	O	O	O
97.15	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
Aurantimonas	O	O	B-T007
manganoxydans	O	O	I-T007
DSM	O	O	I-T007
21871	O	O	I-T007
T	O	O	I-T007
(	O	O	O
97.15	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Strain	O	O	B-T007
EGI	O	O	I-T007
6500337	O	O	I-T007
T	O	O	I-T007
contained	O	O	O
Q-10	O	O	B-T109
as	O	O	O
the	O	O	O
dominant	O	O	O
isoprenoid	O	O	B-T109
quinone	O	O	I-T109
.	O	O	O

The	O	O	O
major	O	O	O
cellular	O	O	O
fatty	O	O	B-T109
acids	O	O	I-T109
were	O	O	O
C18:1	O	O	B-T109
7c	O	O	I-T109
(	O	O	O
66.4	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
C19:0	O	O	B-T109
8c	O	O	I-T109
cyclo	O	O	I-T109
(	O	O	O
23.3	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
polar	O	O	O
lipid	O	O	B-T109
profile	O	O	I-T109
of	O	O	O
strain	O	O	B-T007
EGI	O	O	I-T007
6500337	O	O	I-T007
T	O	O	I-T007
contained	O	O	O
diphosphatidylglycerol	O	O	B-T109
,	O	O	O
phosphatidylglycerol	O	O	B-T109
,	O	O	O
phosphatidylcholine	O	O	B-T109
,	O	O	O
phosphatidylethanolamine	O	O	B-T109
as	O	O	O
major	O	O	O
components	O	O	O
,	O	O	O
similarly	O	O	O
to	O	O	O
the	O	O	O
members	O	O	O
of	O	O	O
the	O	O	O
genus	O	O	B-T007
Aurantimonas	O	O	I-T007
.	O	O	O

The	O	O	O
DNA	O	O	B-T114
G+C	O	O	B-T081
content	O	O	I-T081
of	O	O	O
strain	O	O	B-T007
EGI	O	O	I-T007
6500337	O	O	I-T007
T	O	O	I-T007
was	O	O	O
66.8	O	O	O
mol%	O	O	O
.	O	O	O

The	O	O	O
DNA	O	O	B-T114
-	O	O	O
DNA	O	O	O
relatedness	O	O	O
between	O	O	O
strain	O	O	B-T007
EGI	O	O	I-T007
6500337	O	O	I-T007
T	O	O	I-T007
and	O	O	O
Aurantimonas	O	O	B-T007
coralicida	O	O	I-T007
DSM	O	O	I-T007
14790	O	O	I-T007
T	O	O	I-T007
was	O	O	O
24.7	O	O	O
±	O	O	O
2.9	O	O	O
%	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
the	O	O	O
phylogenetic	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
chemotaxonomic	O	O	B-T078
data	O	O	I-T078
and	O	O	O
phenotypic	O	O	B-T032
characteristics	O	O	I-T032
,	O	O	O
strain	O	O	B-T007
EGI	O	O	I-T007
6500337	O	O	I-T007
T	O	O	I-T007
represents	O	O	O
a	O	O	O
novel	O	O	O
species	O	O	O
of	O	O	O
the	O	O	O
genus	O	O	B-T007
Aurantimonas	O	O	I-T007
,	O	O	O
for	O	O	O
which	O	O	O
the	O	O	O
name	O	O	O
Aurantimonas	O	O	B-T007
endophytica	O	O	I-T007
sp.	O	O	I-T007
nov.	O	O	I-T007
is	O	O	O
proposed	O	O	O
.	O	O	O

The	O	O	O
type	O	O	O
strain	O	O	B-T007
is	O	O	O
EGI	O	O	B-T007
6500337	O	O	I-T007
T	O	O	I-T007
(=	O	O	O
KCTC	O	O	B-T007
52296	O	O	I-T007
T	O	O	I-T007
=	O	O	O
CPCC	O	O	B-T007
100904	O	O	I-T007
T	O	O	I-T007
)	O	O	O
.	O	O	O

-DOCSTART- (27453830)

Assessment	O	O	B-T058
and	O	O	O
classification	O	O	B-T185
of	O	O	O
protocol	O	O	O
deviations	O	O	O

Deviations	O	O	B-T033
from	O	O	O
the	O	O	O
approved	O	O	O
trial	O	O	B-T170
protocol	O	O	I-T170
are	O	O	O
common	O	O	O
during	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
.	O	O	O

They	O	O	O
have	O	O	O
been	O	O	O
conventionally	O	O	O
classified	O	O	B-T185
as	O	O	O
deviations	O	O	B-T033
or	O	O	O
violations	O	O	B-T062
,	O	O	O
depending	O	O	O
on	O	O	O
their	O	O	O
impact	O	O	B-T080
on	O	O	O
the	O	O	O
trial	O	O	B-T062
.	O	O	O

A	O	O	O
new	O	O	O
method	O	O	O
has	O	O	O
been	O	O	O
proposed	O	O	O
by	O	O	O
which	O	O	O
deviations	O	O	B-T033
are	O	O	O
classified	O	O	B-T185
in	O	O	O
five	O	O	O
grades	O	O	B-T185
from	O	O	I-T185
1	O	O	I-T185
to	O	O	I-T185
5	O	O	I-T185
.	O	O	O

A	O	O	O
deviation	O	O	B-T033
of	O	O	O
Grade	O	O	B-T033
1	O	O	I-T033
has	O	O	O
no	O	O	B-T033
impact	O	O	B-T080
on	O	O	O
the	O	O	O
subjects	O	O	B-T098
'	O	O	I-T098
well-being	O	O	B-T033
or	O	O	O
on	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	I-T080
data	O	O	I-T080
.	O	O	O

At	O	O	O
the	O	O	O
maximum	O	O	O
,	O	O	O
a	O	O	O
deviation	O	O	B-T033
Grade	O	O	B-T185
5	O	O	I-T185
leads	O	O	O
to	O	O	O
the	O	O	O
death	O	O	B-T033
of	O	O	O
the	O	O	O
subject	O	O	B-T098
.	O	O	O

This	O	O	O
method	O	O	O
of	O	O	O
classification	O	O	B-T185
was	O	O	O
applied	O	O	O
to	O	O	O
deviations	O	O	B-T033
noted	O	O	O
in	O	O	O
the	O	O	O
center	O	O	O
over	O	O	O
the	O	O	O
last	O	O	O
3	O	O	O
years	O	O	O
.	O	O	O

It	O	O	O
was	O	O	O
observed	O	O	O
that	O	O	O
most	O	O	O
deviations	O	O	B-T033
were	O	O	O
of	O	O	O
Grades	O	O	B-T185
1	O	O	I-T185
and	O	O	I-T185
2	O	O	I-T185
,	O	O	O
with	O	O	O
fewer	O	O	O
falling	O	O	O
in	O	O	O
Grades	O	O	B-T185
3	O	O	I-T185
and	O	O	I-T185
4	O	O	I-T185
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
deviations	O	O	B-T033
that	O	O	O
led	O	O	O
to	O	O	O
the	O	O	O
death	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
subject	O	O	I-T033
(	O	O	O
Grade	O	O	O
5	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
method	O	O	O
of	O	O	O
classification	O	O	B-T185
would	O	O	O
help	O	O	O
trial	O	O	B-T062
managers	O	O	B-T097
decide	O	O	O
on	O	O	O
the	O	O	O
action	O	O	O
to	O	O	O
be	O	O	O
taken	O	O	O
on	O	O	O
the	O	O	O
occurrence	O	O	B-T079
of	O	O	O
deviations	O	O	B-T033
,	O	O	O
which	O	O	O
would	O	O	O
be	O	O	O
based	O	O	O
on	O	O	O
their	O	O	O
impact	O	O	B-T080
.	O	O	O

-DOCSTART- (27454401)

Fabrication	O	O	B-T067
and	O	O	O
modelling	O	O	B-T062
of	O	O	O
fractal	O	O	B-T082
,	O	O	O
biomimetic	O	O	B-T082
,	O	O	O
micro	O	O	B-T082
and	O	O	O
nano-topographical	O	O	O
surfaces	O	O	O

Natural	O	O	B-T169
surface	O	O	B-UnknownType
topographies	O	O	I-UnknownType
are	O	O	O
often	O	O	O
self-similar	O	O	O
with	O	O	O
hierarchical	O	O	B-T080
features	O	O	I-T080
at	O	O	O
the	O	O	O
micro	O	O	B-T077
and	O	O	O
nanoscale	O	O	B-T077
,	O	O	O
which	O	O	O
may	O	O	O
be	O	O	O
mimicked	O	O	O
to	O	O	O
overcome	O	O	O
modern	O	O	B-T079
tissue	O	O	B-T061
engineering	O	O	I-T061
and	O	O	O
biomaterial	O	O	B-T122
design	O	O	B-T052
limitations	O	O	B-T169
.	O	O	O

Specifically	O	O	O
,	O	O	O
a	O	O	O
cell	O	O	B-T025
's	O	O	I-T070
microenvironment	O	O	I-T070
within	O	O	O
the	O	O	O
human	O	O	B-T016
body	O	O	I-T016
contains	O	O	O
highly	O	O	O
optimised	O	O	O
,	O	O	O
fractal	O	O	B-T029
topographical	O	O	I-T029
cues	O	O	I-T029
,	O	O	O
which	O	O	O
directs	O	O	O
precise	O	O	O
cell	O	O	O
behaviour	O	O	B-T053
.	O	O	O

However	O	O	O
,	O	O	O
recreating	O	O	B-T169
biomimetic	O	O	B-T082
,	O	O	O
fractal	O	O	B-T082
topographies	O	O	I-T082
in	O	O	B-T080
vitro	O	O	I-T080
is	O	O	O
not	O	O	O
a	O	O	O
trivial	O	O	B-T067
process	O	O	I-T067
and	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
fabrication	O	O	B-T067
methods	O	O	I-T067
have	O	O	O
been	O	O	O
proposed	O	O	O
but	O	O	O
often	O	O	O
fail	O	O	B-T169
to	O	O	O
precisely	O	O	O
control	O	O	B-T080
the	O	O	O
spatial	O	O	B-T082
resolution	O	O	I-T082
of	O	O	O
features	O	O	B-T080
at	O	O	O
different	O	O	B-T080
lengths	O	O	B-T081
scales	O	O	B-T074
and	O	O	O
hence	O	O	O
,	O	O	O
to	O	O	O
provide	O	O	O
true	O	O	O
biomimetic	O	O	B-T080
properties	O	O	I-T080
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
propose	O	O	O
a	O	O	O
method	O	O	B-T170
of	O	O	O
accurately	O	O	B-T080
reproducing	O	O	B-T169
the	O	O	O
self-similar	O	O	O
,	O	O	O
micro	O	O	B-T082
and	O	O	O
nanoscale	O	O	B-T082
topography	O	O	I-T082
of	O	O	O
a	O	O	O
human	O	O	B-T016
biological	O	O	B-T024
tissue	O	O	I-T024
into	O	O	O
a	O	O	O
synthetic	O	O	B-T109
polymer	O	O	I-T109
through	O	O	O
an	O	O	O
innovative	O	O	O
fabrication	O	O	B-T067
process	O	O	I-T067
.	O	O	O

The	O	O	O
biological	O	O	B-T024
tissue	O	O	I-T024
surface	O	O	B-T082
was	O	O	O
characterised	O	O	B-T052
using	O	O	O
atomic	O	O	B-T059
force	O	O	I-T059
microscopy	O	O	I-T059
(	O	O	O
AFM	O	O	B-T059
)	O	O	O
to	O	O	O
obtain	O	O	O
spatial	O	O	B-T082
data	O	O	B-T078
in	O	O	O
X	O	O	O
,	O	O	O
Y	O	O	O
and	O	O	O
Z	O	O	O
,	O	O	O
which	O	O	O
was	O	O	O
converted	O	O	O
into	O	O	O
a	O	O	O
grayscale	O	O	B-T071
'	O	O	I-T071
digital	O	O	I-T071
photomask	O	O	I-T071
'	O	O	I-T071
.	O	O	O

As	O	O	O
a	O	O	O
result	O	O	O
of	O	O	O
maskless	O	O	B-T057
grayscale	O	O	I-T057
optical	O	O	I-T057
lithography	O	O	I-T057
followed	O	O	O
by	O	O	O
modified	O	O	B-T067
deep	O	O	I-T067
reactive	O	O	I-T067
ion	O	O	I-T067
etching	O	O	I-T067
and	O	O	O
replica	O	O	B-T067
molding	O	O	I-T067
,	O	O	O
we	O	O	O
were	O	O	O
able	O	O	O
to	O	O	O
accurately	O	O	B-T080
reproduce	O	O	O
the	O	O	O
fractal	O	O	B-T082
topography	O	O	I-T082
of	O	O	O
acellular	O	O	B-T024
dermal	O	O	I-T024
matrix	O	O	I-T024
(	O	O	O
ADM	O	O	B-T024
)	O	O	O
into	O	O	O
polydimethylsiloxane	O	O	B-T109
(	O	O	O
PDMS	O	O	B-T109
)	O	O	O
.	O	O	O

Characterisation	O	O	B-T052
using	O	O	O
AFM	O	O	B-T059
at	O	O	O
three	O	O	O
different	O	O	B-T080
length	O	O	B-T081
scales	O	O	B-T074
revealed	O	O	O
that	O	O	O
the	O	O	O
nano	O	O	B-T082
and	O	O	O
micro-topographical	O	O	B-T082
features	O	O	B-T080
,	O	O	O
in	O	O	O
addition	O	O	O
to	O	O	O
the	O	O	O
fractal	O	O	B-T081
dimension	O	O	I-T081
,	O	O	O
of	O	O	O
native	O	O	B-T169
ADM	O	O	B-T024
were	O	O	O
reproduced	O	O	B-T169
in	O	O	O
PDMS	O	O	B-T109
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
that	O	O	O
the	O	O	O
fractal	O	O	B-T082
topography	O	O	I-T082
of	O	O	O
biological	O	O	B-T082
surfaces	O	O	I-T082
can	O	O	O
be	O	O	O
mimicked	O	O	O
in	O	O	O
synthetic	O	O	B-T073
materials	O	O	I-T073
using	O	O	O
the	O	O	O
novel	O	O	B-T080
fabrication	O	O	B-T067
process	O	O	I-T067
outlined	O	O	O
,	O	O	O
which	O	O	O
may	O	O	O
be	O	O	O
applied	O	O	O
to	O	O	O
significantly	O	O	O
enhance	O	O	O
medical	O	O	B-T074
device	O	O	I-T074
biocompatibility	O	O	B-T044
and	O	O	O
performance	O	O	B-T052
.	O	O	O

-DOCSTART- (27457339)

Investigating	O	O	B-T169
Effects	O	O	B-T080
of	O	O	I-T080
Acidic	O	O	B-T081
pH	O	O	I-T081
on	O	O	O
Proliferation	O	O	B-T043
,	O	O	O
Invasion	O	O	B-T046
and	O	O	O
Drug	O	O	B-T121
-	O	O	O
Induced	O	O	B-T169
Apoptosis	O	O	B-T043
in	O	O	O
Lymphoblastic	O	O	O
Leukemia	O	O	O

Some	O	O	O
studies	O	O	O
have	O	O	O
shown	O	O	O
that	O	O	O
extracellular	O	O	B-T030
pH	O	O	B-T081
in	O	O	O
tumors	O	O	B-T191
,	O	O	O
which	O	O	O
results	O	O	O
in	O	O	O
tumor	O	O	B-T191
progression	O	O	I-T191
,	O	O	O
is	O	O	O
less	O	O	O
than	O	O	O
that	O	O	O
in	O	O	O
normal	O	O	B-T080
tissues	O	O	B-T024
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
extracellular	O	O	B-T030
acidic	O	O	B-T081
pH	O	O	I-T081
on	O	O	O
proliferation	O	O	B-T043
,	O	O	O
invasion	O	O	B-T046
,	O	O	O
and	O	O	O
drug	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
in	O	O	O
acute	O	O	B-T025
lymphoblastic	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
cells	O	O	B-T025
were	O	O	O
cultured	O	O	O
in	O	O	O
different	O	O	B-T080
pH	O	O	B-T081
(	O	O	O
pH	O	O	O
6.6	O	O	O
and	O	O	O
pH	O	O	O
7.4	O	O	O
)	O	O	O
for	O	O	O
12	O	O	O
days	O	O	B-T079
.	O	O	O

Cell	O	O	B-T043
proliferation	O	O	I-T043
was	O	O	O
assessed	O	O	B-T052
by	O	O	O
MTT	O	O	B-T062
assay	O	O	I-T062
and	O	O	O
cell	O	O	B-T046
invasion	O	O	I-T046
was	O	O	O
assayed	O	O	O
by	O	O	O
invasion	O	O	B-T059
assay	O	O	I-T059
and	O	O	O
gene	O	O	B-T063
expression	O	O	I-T063
analysis	O	O	I-T063
of	O	O	O
MMP-9	O	O	B-T116
.	O	O	O

Drug	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
was	O	O	O
evaluated	O	O	O
after	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
doxorubicin	O	O	B-T195
for	O	O	O
24	O	O	O
hours	O	O	O
by	O	O	O
annexin	O	O	B-T116
V	O	O	I-T116
/	O	O	O
PI	O	O	B-T109
staining	O	O	B-T059
and	O	O	O
gene	O	O	B-T063
expression	O	O	I-T063
analysis	O	O	I-T063
of	O	O	O
BAX	O	O	B-T116
pro-apoptotic	O	O	I-T116
protein	O	O	I-T116
.	O	O	O

The	O	O	O
results	O	O	O
indicated	O	O	O
the	O	O	O
enhanced	O	O	O
growth	O	O	B-T043
and	O	O	O
invasion	O	O	B-T046
of	O	O	O
leukemic	O	O	B-T191
cells	O	O	B-T025
at	O	O	O
pH	O	O	B-T081
6.6	O	O	O
(	O	O	O
P	O	O	O
≤	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
cells	O	O	B-T025
at	O	O	O
pH	O	O	B-T081
6.6	O	O	O
were	O	O	O
resistant	O	O	B-T169
to	O	O	O
apoptosis	O	O	B-T043
by	O	O	O
doxorubicin	O	O	B-T195
(	O	O	O
P	O	O	O
≤	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

It	O	O	O
can	O	O	O
be	O	O	O
concluded	O	O	O
that	O	O	O
acidic	O	O	B-T081
pH	O	O	I-T081
increases	O	O	B-T169
the	O	O	O
proliferation	O	O	B-T043
,	O	O	O
invasion	O	O	B-T046
and	O	O	O
reduces	O	O	B-T080
the	O	O	O
drug	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
in	O	O	O
acute	O	O	B-T191
lymphoblastic	O	O	I-T191
leukemia	O	O	I-T191
.	O	O	O

Extracellular	O	O	B-T030
acidity	O	O	B-T081
can	O	O	O
influence	O	O	O
the	O	O	O
behavior	O	O	O
of	O	O	O
leukemic	O	O	B-T191
cells	O	O	B-T025
and	O	O	O
therefore	O	O	O
,	O	O	O
the	O	O	O
manipulation	O	O	B-T169
of	O	O	O
extracellular	O	O	B-T031
liquid	O	O	I-T031
can	O	O	O
be	O	O	O
selected	O	O	O
as	O	O	O
a	O	O	O
therapeutic	O	O	B-T061
strategy	O	O	I-T061
for	O	O	O
leukemia	O	O	B-T191
,	O	O	O
especially	O	O	O
for	O	O	O
acute	O	O	B-T191
lymphoblastic	O	O	I-T191
leukemia	O	O	I-T191
.	O	O	O

-DOCSTART- (27459898)

Gold	O	O	B-T121
-	O	O	O
Nanosponge	O	O	B-T074
-Based	O	O	O
Multistimuli-Responsive	O	O	B-T122
Drug	O	O	I-T122
Vehicles	O	O	I-T122
for	O	O	O
Targeted	O	O	B-T169
Chemo-Photothermal	O	O	O
Therapy	O	O	O

Gold	O	O	B-T121
-	O	O	O
nanosponge	O	O	B-T074
-based	O	O	O
multistimuli-responsive	O	O	B-T122
drug	O	O	B-T121
vehicles	O	O	I-T122
are	O	O	O
constructed	O	O	O
for	O	O	O
combined	O	O	O
chemo-photothermal	O	O	B-T061
therapy	O	O	I-T061
with	O	O	O
pinpointed	O	O	O
drug	O	O	O
delivery	O	O	B-T169
and	O	O	O
release	O	O	B-T169
capabilities	O	O	O
and	O	O	O
minimized	O	O	O
nonspecific	O	O	B-T078
systemic	O	O	B-T169
spread	O	O	B-T080
of	O	O	O
drugs	O	O	B-T121
,	O	O	O
remarkably	O	O	O
enhancing	O	O	B-T052
the	O	O	O
therapeutic	O	O	B-T080
efficiency	O	O	I-T080
while	O	O	O
minimizing	O	O	O
acute	O	O	B-T079
side	O	O	B-T046
effects	O	O	I-T046
.	O	O	O

-DOCSTART- (27462099)

Hemodynamic	O	O	B-T042
correlates	O	O	O
of	O	O	O
transient	O	O	B-T048
cognitive	O	O	I-T048
impairment	O	O	I-T048
after	O	O	O
transient	O	O	B-T047
ischemic	O	O	I-T047
attack	O	O	I-T047
and	O	O	O
minor	O	O	B-T047
stroke	O	O	I-T047
:	O	O	O
A	O	O	O
transcranial	O	O	O
Doppler	O	O	O
study	O	O	O

Transient	O	O	B-T048
cognitive	O	O	I-T048
impairment	O	O	I-T048
(	O	O	O
TCI	O	O	B-T048
)	O	O	O
on	O	O	O
the	O	O	O
Mini	O	O	B-T060
Mental	O	O	I-T060
State	O	O	I-T060
Evaluation	O	O	I-T060
score	O	O	B-T081
is	O	O	O
common	O	O	O
after	O	O	O
transient	O	O	B-T047
ischemic	O	O	I-T047
attack	O	O	I-T047
/	O	O	O
minor	O	O	B-T047
stroke	O	O	I-T047
and	O	O	O
might	O	O	O
identify	O	O	B-T080
patients	O	O	B-T101
at	O	O	O
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
dementia	O	O	B-T048
.	O	O	O

We	O	O	O
aimed	O	O	B-T078
to	O	O	O
replicate	O	O	B-T080
TCI	O	O	B-T048
using	O	O	O
the	O	O	O
Montreal	O	O	B-T170
Cognitive	O	O	I-T170
Assessment	O	O	I-T170
(	O	O	O
MoCA	O	O	B-T170
)	O	O	O
,	O	O	O
compare	O	O	B-T052
it	O	O	O
with	O	O	O
persistent	O	O	B-T048
Mild	O	O	I-T048
Cognitive	O	O	I-T048
Impairment	O	O	I-T048
(	O	O	O
PMCI	O	O	B-T048
)	O	O	O
,	O	O	O
and	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
global	O	O	B-T080
cerebral	O	O	B-T023
hemodynamic	O	O	B-T042
changes	O	O	B-T169
could	O	O	O
explain	O	O	O
transient	O	O	B-T079
impairment	O	O	B-T169
.	O	O	O

Consecutive	O	O	O
patients	O	O	B-T101
with	O	O	O
transient	O	O	B-T047
ischemic	O	O	I-T047
attack	O	O	I-T047
/	O	O	O
minor	O	O	B-T047
stroke	O	O	I-T047
(	O	O	O
NIHSS	O	O	O
≤	O	O	O
3	O	O	O
)	O	O	O
were	O	O	O
assessed	O	O	B-T052
with	O	O	O
the	O	O	O
MoCA	O	O	B-T170
and	O	O	O
transcranial	O	O	B-T060
Doppler	O	O	I-T060
ultrasound	O	O	I-T060
acutely	O	O	B-T079
and	O	O	O
at	O	O	O
1	O	O	O
month	O	O	O
.	O	O	O

We	O	O	O
compared	O	O	B-T052
patients	O	O	B-T101
with	O	O	O
TCI	O	O	B-T048
(	O	O	O
baseline	O	O	B-T081
MoCA	O	O	B-T170
<	O	O	O
26	O	O	O
with	O	O	O
≥	O	O	O
2	O	O	O
points	O	O	B-T081
increase	O	O	B-T169
at	O	O	O
1	O	O	O
month	O	O	O
)	O	O	O
,	O	O	O
PMCI	O	O	B-T048
(	O	O	O
MoCA	O	O	O
<	O	O	O
26	O	O	O
with	O	O	O
<	O	O	O
2	O	O	O
points	O	O	O
increase	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
no	O	O	B-T033
cognitive	O	O	I-T033
impairment	O	O	I-T033
(	O	O	O
NCI	O	O	B-T033
;	O	O	O
MoCA	O	O	O
≥	O	O	O
26	O	O	O
)	O	O	O
.	O	O	O

Of	O	O	O
326	O	O	O
patients	O	O	B-T101
,	O	O	O
46	O	O	O
(	O	O	O
14.1	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
PMCI	O	O	B-T048
,	O	O	O
98	O	O	O
(	O	O	O
30.1	O	O	O
%	O	O	O
)	O	O	O
TCI	O	O	B-T048
,	O	O	O
and	O	O	O
182	O	O	O
(	O	O	O
55.8	O	O	O
%	O	O	O
)	O	O	O
NCI	O	O	B-T033
.	O	O	O

At	O	O	O
baseline	O	O	B-T081
,	O	O	O
TCI	O	O	B-T048
patients	O	O	B-T101
had	O	O	O
higher	O	O	B-T033
systolic	O	O	I-T033
blood	O	O	I-T033
pressure	O	O	I-T033
(	O	O	O
150.95	O	O	O
±	O	O	O
21.52	O	O	O
vs	O	O	O
144.86	O	O	O
±	O	O	O
22.44	O	O	O
mmHg	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
and	O	O	O
lower	O	O	B-T080
cerebral	O	O	B-T081
blood	O	O	I-T081
flow	O	O	I-T081
velocities	O	O	I-T081
,	O	O	O
particularly	O	O	O
end-diastolic	O	O	B-T081
velocity	O	O	I-T081
(	O	O	O
30.16	O	O	O
±	O	O	O
9.63	O	O	O
vs	O	O	O
35.02	O	O	O
±	O	O	O
9.01	O	O	O
cm/s	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
mean	O	O	B-T033
flow	O	O	I-T033
velocity	O	O	I-T033
(	O	O	O
48.95	O	O	O
±	O	O	O
12.72	O	O	O
vs	O	O	O
54	O	O	O
±	O	O	O
12.46	O	O	O
cm/s	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
than	O	O	O
those	O	O	O
with	O	O	O
NCI	O	O	B-T033
,	O	O	O
but	O	O	O
similar	O	O	O
clinical	O	O	B-T080
and	O	O	O
hemodynamic	O	O	B-T042
profiles	O	O	B-T059
to	O	O	O
those	O	O	O
with	O	O	O
PMCI	O	O	B-T048
.	O	O	O

Systolic	O	O	B-T033
BP	O	O	I-T033
fell	O	O	I-T033
between	O	O	O
baseline	O	O	B-T081
and	O	O	O
1	O	O	O
month	O	O	O
(	O	O	O
mean	O	O	B-T081
reduction	O	O	B-T061
=	O	O	O
14.01	O	O	O
±	O	O	O
21.26	O	O	O
mmHg	O	O	O
)	O	O	O
and	O	O	O
end-diastolic	O	O	B-T081
velocity	O	O	I-T081
and	O	O	O
mean	O	O	B-T033
flow	O	O	I-T033
velocity	O	O	I-T033
increased	O	O	B-T169
(	O	O	O
mean	O	O	O
increase	O	O	B-T169
=	O	O	O
+	O	O	O
2.42	O	O	O
±	O	O	O
6.41	O	O	O
and	O	O	O
1.89	O	O	O
±	O	O	O
8.77	O	O	O
cm/s	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
these	O	O	O
changes	O	O	B-T169
did	O	O	O
not	O	O	B-T033
differ	O	O	I-T033
between	O	O	O
patients	O	O	B-T101
with	O	O	O
TCI	O	O	B-T048
,	O	O	O
PMCI	O	O	B-T048
,	O	O	O
and	O	O	O
NCI	O	O	B-T033
.	O	O	O

TCI	O	O	B-T048
is	O	O	O
detectable	O	O	B-T201
with	O	O	O
the	O	O	O
MoCA	O	O	B-T170
after	O	O	O
transient	O	O	B-T047
ischemic	O	O	I-T047
attack	O	O	I-T047
and	O	O	O
minor	O	O	B-T047
stroke	O	O	I-T047
and	O	O	O
has	O	O	O
similar	O	O	O
clinical	O	O	B-T080
and	O	O	O
hemodynamic	O	O	B-T042
profile	O	O	B-T059
to	O	O	O
PMCI	O	O	B-T048
.	O	O	O

However	O	O	O
,	O	O	O
TCI	O	O	B-T048
does	O	O	O
not	O	O	B-T169
appear	O	O	I-T169
to	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
exaggerated	O	O	B-T080
acute	O	O	B-T079
reversible	O	O	B-T169
global	O	O	B-T080
hemodynamic	O	O	B-T042
changes	O	O	B-T169
.	O	O	O

-DOCSTART- (27463942)

Apixaban	O	O	B-T109
5	O	O	O
mg	O	O	O
Twice	O	O	B-T081
Daily	O	O	B-T079
and	O	O	O
Clinical	O	O	B-T080
Outcomes	O	O	B-T169
in	O	O	O
Patients	O	O	B-T101
With	O	O	O
Atrial	O	O	B-T047
Fibrillation	O	O	I-T047
and	O	O	O
Advanced	O	O	B-T080
Age	O	O	B-T032
,	O	O	O
Low	O	O	B-T080
Body	O	O	B-T032
Weight	O	O	I-T032
,	O	O	O
or	O	O	O
High	O	O	B-T080
Creatinine	O	O	B-T109
:	O	O	O
A	O	O	O
Secondary	O	O	B-UnknownType
Analysis	O	O	I-UnknownType
of	O	O	O
a	O	O	O
Randomized	O	O	O
Clinical	O	O	O
Trial	O	O	O

In	O	O	O
the	O	O	O
Apixaban	O	O	B-T109
for	O	O	O
Reduction	O	O	B-T080
of	O	O	O
Stroke	O	O	B-T047
and	O	O	O
Other	O	O	O
Thromboembolic	O	O	B-T046
Complications	O	O	I-T046
in	O	O	O
Atrial	O	O	B-T047
Fibrillation	O	O	I-T047
(	O	O	O
ARISTOTLE	O	O	B-T062
)	O	O	O
trial	O	O	B-T062
,	O	O	O
the	O	O	O
standard	O	O	O
dose	O	O	B-T081
of	O	O	O
apixaban	O	O	B-T109
was	O	O	O
5	O	O	O
mg	O	O	O
twice	O	O	B-T081
daily	O	O	B-T079
;	O	O	O
patients	O	O	B-T101
with	O	O	O
at	O	O	O
least	O	O	O
2	O	O	O
dose	O	O	O
-	O	O	O
reduction	O	O	B-T080
criteria-80	O	O	O
years	O	O	B-T079
or	O	O	O
older	O	O	O
,	O	O	O
weight	O	O	B-T032
60	O	O	O
kg	O	O	O
or	O	O	O
less	O	O	O
,	O	O	O
and	O	O	O
creatinine	O	O	B-T033
level	O	O	B-T080
1.5	O	O	O
mg/dL	O	O	O
or	O	O	O
higher-received	O	O	O
a	O	O	O
reduced	O	O	B-T080
dose	O	O	O
of	O	O	O
apixaban	O	O	O
of	O	O	O
2.5	O	O	O
mg	O	O	O
twice	O	O	O
daily	O	O	O
.	O	O	O

Little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
patients	O	O	B-T101
with	O	O	O
1	O	O	O
dose	O	O	B-T081
-	O	O	O
reduction	O	O	B-T080
criterion	O	O	O
who	O	O	O
received	O	O	O
the	O	O	O
5	O	O	O
mg	O	O	O
twice	O	O	B-T081
daily	O	O	B-T079
dose	O	O	O
of	O	O	O
apixaban	O	O	B-T109
.	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
frequency	O	O	B-T079
of	O	O	O
1	O	O	O
dose	O	O	B-T081
-	O	O	O
reduction	O	O	B-T080
criterion	O	O	O
and	O	O	O
whether	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
5	O	O	O
mg	O	O	O
twice	O	O	B-T081
daily	O	O	B-T079
dose	O	O	O
of	O	O	O
apixaban	O	O	B-T109
on	O	O	O
stroke	O	O	B-T047
or	O	O	O
systemic	O	O	B-UnknownType
embolism	O	O	I-UnknownType
and	O	O	O
bleeding	O	O	B-T046
varied	O	O	O
among	O	O	O
patients	O	O	B-T101
with	O	O	O
1	O	O	O
or	O	O	O
no	O	O	O
dose	O	O	O
-	O	O	O
reduction	O	O	O
criteria	O	O	O
.	O	O	O

Among	O	O	O
18	O	O	O
201	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
ARISTOTLE	O	O	B-T062
trial	O	O	I-T062
,	O	O	O
17	O	O	O
322	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
this	O	O	O
analysis	O	O	B-T062
.	O	O	O

Annualized	O	O	O
event	O	O	O
rates	O	O	O
of	O	O	O
stroke	O	O	B-T047
or	O	O	O
systemic	O	O	B-UnknownType
embolism	O	O	I-UnknownType
and	O	O	O
major	O	O	O
bleeding	O	O	B-T046
and	O	O	O
hazard	O	O	B-T081
ratios	O	O	I-T081
(	O	O	O
HRs	O	O	B-T081
)	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
CIs	O	O	B-T081
were	O	O	O
evaluated	O	O	B-T058
.	O	O	O

Interactions	O	O	B-T169
between	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
apixaban	O	O	B-T109
vs	O	O	O
warfarin	O	O	B-T109
and	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
1	O	O	O
or	O	O	O
no	O	O	O
dose	O	O	B-T081
-	O	O	O
reduction	O	O	B-T080
criteria	O	O	O
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

The	O	O	O
first	O	O	O
patient	O	O	B-T101
was	O	O	O
enrolled	O	O	O
in	O	O	O
the	O	O	O
ARISTOTLE	O	O	B-T062
trial	O	O	I-T062
on	O	O	O
December	O	O	O
19	O	O	O
,	O	O	O
2006	O	O	O
,	O	O	O
and	O	O	O
follow-up	O	O	B-T058
was	O	O	O
completed	O	O	O
on	O	O	O
January	O	O	O
30	O	O	O
,	O	O	O
2011	O	O	O
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analyzed	O	O	O
from	O	O	O
January	O	O	O
2015	O	O	O
to	O	O	O
May	O	O	O
30	O	O	O
,	O	O	O
2016	O	O	O
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
major	O	O	O
bleeding	O	O	B-T046
included	O	O	O
events	O	O	O
during	O	O	O
study	O	O	B-T062
drug	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
stroke	O	O	B-T047
or	O	O	O
systemic	O	O	B-UnknownType
embolism	O	O	I-UnknownType
was	O	O	O
based	O	O	O
on	O	O	O
intention	O	O	B-T080
to	O	O	O
treat	O	O	B-T169
.	O	O	O

Of	O	O	O
the	O	O	O
patients	O	O	B-T101
with	O	O	O
1	O	O	O
or	O	O	O
no	O	O	O
dose	O	O	B-T081
-	O	O	O
reduction	O	O	B-T080
criteria	O	O	O
assigned	O	O	O
to	O	O	O
receive	O	O	O
the	O	O	O
5	O	O	O
mg	O	O	O
twice	O	O	B-T081
daily	O	O	B-T079
dose	O	O	O
of	O	O	O
apixaban	O	O	B-T109
or	O	O	O
warfarin	O	O	B-T109
,	O	O	O
3966	O	O	O
had	O	O	O
1	O	O	O
dose	O	O	O
-	O	O	O
reduction	O	O	O
criterion	O	O	O
;	O	O	O
these	O	O	O
patients	O	O	O
had	O	O	O
higher	O	O	O
rates	O	O	O
of	O	O	O
stroke	O	O	B-T047
or	O	O	O
systemic	O	O	B-UnknownType
embolism	O	O	I-UnknownType
(	O	O	O
HR	O	O	B-T081
,	O	O	O
1.47	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
1.20	O	O	O
-	O	O	O
1.81	O	O	O
)	O	O	O
and	O	O	O
major	O	O	O
bleeding	O	O	B-T046
(	O	O	O
HR	O	O	O
,	O	O	O
1.89	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.62	O	O	O
-	O	O	O
2.20	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
those	O	O	O
with	O	O	O
no	O	O	O
dose	O	O	O
-	O	O	O
reduction	O	O	O
criteria	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
13	O	O	O
356	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
benefit	O	O	B-T081
of	O	O	O
the	O	O	O
5	O	O	O
mg	O	O	O
twice	O	O	B-T081
daily	O	O	B-T079
dose	O	O	B-T081
of	O	O	O
apixaban	O	O	B-T109
(	O	O	O
n	O	O	O
=	O	O	O
8665	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
warfarin	O	O	B-T109
(	O	O	O
n	O	O	O
=	O	O	O
8657	O	O	O
)	O	O	O
on	O	O	O
stroke	O	O	B-T047
or	O	O	O
systemic	O	O	B-UnknownType
embolism	O	O	I-UnknownType
in	O	O	O
patients	O	O	B-T101
with	O	O	O
1	O	O	O
dose	O	O	O
-	O	O	O
reduction	O	O	B-T080
criterion	O	O	O
(	O	O	O
HR	O	O	B-T081
,	O	O	O
0.94	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0.66	O	O	O
-	O	O	O
1.32	O	O	O
)	O	O	O
and	O	O	O
no	O	O	O
dose	O	O	O
-	O	O	O
reduction	O	O	O
criterion	O	O	O
(	O	O	O
HR	O	O	O
,	O	O	O
0.77	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.62	O	O	O
-	O	O	O
0.97	O	O	O
)	O	O	O
were	O	O	O
similar	O	O	O
(	O	O	O
P	O	O	O
for	O	O	O
interaction	O	O	O
=	O	O	O
.36	O	O	O
)	O	O	O
.	O	O	O

Similarly	O	O	O
,	O	O	O
the	O	O	O
benefit	O	O	B-T081
of	O	O	O
5	O	O	O
mg	O	O	O
twice	O	O	B-T081
daily	O	O	B-T079
dose	O	O	B-T081
of	O	O	O
apixaban	O	O	B-T109
compared	O	O	O
with	O	O	O
warfarin	O	O	B-T109
on	O	O	O
major	O	O	O
bleeding	O	O	B-T046
in	O	O	O
patients	O	O	B-T101
with	O	O	O
1	O	O	O
dose	O	O	O
-	O	O	O
reduction	O	O	B-T080
criterion	O	O	O
(	O	O	O
HR	O	O	B-T081
,	O	O	O
0.68	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0.53	O	O	O
-	O	O	O
0.87	O	O	O
)	O	O	O
and	O	O	O
no	O	O	O
dose	O	O	O
-	O	O	O
reduction	O	O	O
criterion	O	O	O
(	O	O	O
HR	O	O	O
,	O	O	O
0.72	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.60	O	O	O
-	O	O	O
0.86	O	O	O
)	O	O	O
were	O	O	O
similar	O	O	O
(	O	O	O
P	O	O	O
for	O	O	O
interaction	O	O	O
=	O	O	O
.71	O	O	O
)	O	O	O
.	O	O	O

Similar	O	O	O
patterns	O	O	O
were	O	O	O
seen	O	O	O
for	O	O	O
each	O	O	O
dose	O	O	B-T081
-	O	O	O
reduction	O	O	B-T080
criterion	O	O	O
and	O	O	O
across	O	O	O
the	O	O	O
spectrum	O	O	O
of	O	O	O
age	O	O	B-T032
,	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
,	O	O	O
creatinine	O	O	B-T109
level	O	O	B-T080
,	O	O	O
and	O	O	O
creatinine	O	O	O
clearance	O	O	B-T201
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
atrial	O	O	B-T047
fibrillation	O	O	I-T047
and	O	O	O
isolated	O	O	O
advanced	O	O	O
age	O	O	B-T032
,	O	O	O
low	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
,	O	O	O
or	O	O	O
renal	O	O	B-T033
dysfunction	O	O	I-T033
have	O	O	O
a	O	O	O
higher	O	O	O
risk	O	O	B-T078
of	O	O	O
stroke	O	O	B-T047
or	O	O	O
systemic	O	O	B-UnknownType
embolism	O	O	I-UnknownType
and	O	O	O
major	O	O	O
bleeding	O	O	B-T046
but	O	O	O
show	O	O	O
consistent	O	O	O
benefits	O	O	B-T081
with	O	O	O
the	O	O	O
5	O	O	O
mg	O	O	O
twice	O	O	B-T081
daily	O	O	B-T079
dose	O	O	B-T081
of	O	O	O
apixaban	O	O	B-T109
vs	O	O	O
warfarin	O	O	B-T109
compared	O	O	O
with	O	O	O
patients	O	O	B-T101
without	O	O	O
these	O	O	O
characteristics	O	O	O
.	O	O	O

The	O	O	O
5	O	O	O
mg	O	O	O
twice	O	O	B-T081
daily	O	O	B-T079
dose	O	O	B-T081
of	O	O	O
apixaban	O	O	B-T109
is	O	O	O
safe	O	O	O
,	O	O	O
efficacious	O	O	O
,	O	O	O
and	O	O	O
appropriate	O	O	O
for	O	O	O
patients	O	O	B-T101
with	O	O	O
only	O	O	O
1	O	O	O
dose	O	O	O
-	O	O	O
reduction	O	O	B-T080
criterion	O	O	O
.	O	O	O

clinicaltrials.gov	O	O	O
Identifier	O	O	O
:	O	O	O
NCT00412984	O	O	O
.	O	O	O

-DOCSTART- (27465464)

Transition	O	O	B-T052
From	O	O	O
Hospital	O	O	B-T093
to	O	O	O
Home	O	O	B-T082
in	O	O	O
Preterm	O	O	B-T100
Infants	O	O	I-T100
and	O	O	O
Their	O	O	O
Families	O	O	O

When	O	O	O
the	O	O	O
day	O	O	B-T079
of	O	O	O
discharge	O	O	B-T058
from	O	O	O
a	O	O	O
neonatal	O	O	B-T093
intensive	O	O	I-T093
care	O	O	I-T093
unit	O	O	I-T093
(	O	O	O
NICU	O	O	B-T093
)	O	O	O
comes	O	O	O
for	O	O	O
the	O	O	O
parents	O	O	B-T099
of	O	O	O
newborn	O	O	B-T100
infants	O	O	I-T100
,	O	O	O
they	O	O	O
are	O	O	O
filled	O	O	O
with	O	O	O
long-awaited	O	O	O
joy	O	O	B-T041
and	O	O	O
happiness	O	O	B-T041
.	O	O	O

They	O	O	O
go	O	O	O
home	O	O	B-T082
feeling	O	O	B-T041
as	O	O	O
parents	O	O	B-T099
,	O	O	O
away	O	O	O
from	O	O	O
scheduled	O	O	B-T080
routines	O	O	I-T080
of	O	O	O
the	O	O	O
hospital	O	O	B-T093
,	O	O	O
monitor	O	O	B-T033
alarms	O	O	I-T033
,	O	O	O
clinical	O	O	B-T033
rounds	O	O	I-T033
,	O	O	O
numerous	O	O	B-T081
tests	O	O	B-T059
,	O	O	O
and	O	O	O
so	O	O	O
on	O	O	O
.	O	O	O
What	O	O	O
do	O	O	O
we	O	O	O
know	O	O	O
about	O	O	O
what	O	O	O
happens	O	O	B-T052
after	O	O	O
these	O	O	O
little	O	O	B-T101
patients	O	O	I-T101
and	O	O	O
their	O	O	O
families	O	O	B-T099
leave	O	O	B-T052
the	O	O	O
NICU	O	O	B-T093
?	O	O	O
What	O	O	O
happens	O	O	O
from	O	O	O
the	O	O	O
point	O	O	O
of	O	O	O
leaving	O	O	B-T052
the	O	O	O
hospital	O	O	O
until	O	O	O
when	O	O	O
things	O	O	O
get	O	O	O
settled	O	O	O
and	O	O	O
life	O	O	B-T078
becomes	O	O	O
perceived	O	O	B-T041
as	O	O	O
normal	O	O	B-T080
?	O	O	O

This	O	O	O
article	O	O	B-T170
presents	O	O	O
a	O	O	O
short	O	O	O
summary	O	O	B-T170
of	O	O	O
research	O	O	B-T062
conducted	O	O	O
with	O	O	O
the	O	O	O
vulnerable	O	O	B-T098
population	O	O	I-T098
of	O	O	O
high-risk	O	O	B-T033
and	O	O	O
preterm	O	O	B-T100
infants	O	O	I-T100
and	O	O	O
their	O	O	O
families	O	O	B-T099
postdischarge	O	O	B-T058
.	O	O	O

Available	O	O	O
evidence	O	O	B-T078
suggests	O	O	O
that	O	O	O
transition	O	O	B-T052
to	O	O	O
home	O	O	B-T082
after	O	O	O
hospital	O	O	B-T058
discharge	O	O	I-T058
,	O	O	O
a	O	O	O
phenomenon	O	O	B-T067
that	O	O	O
many	O	O	O
families	O	O	B-T099
experience	O	O	B-T041
,	O	O	O
is	O	O	O
challenging	O	O	B-T080
and	O	O	O
requires	O	O	O
attention	O	O	B-T058
from	O	O	O
clinicians	O	O	B-T097
and	O	O	O
researchers	O	O	B-T097
if	O	O	O
we	O	O	O
are	O	O	O
to	O	O	O
provide	O	O	O
effective	O	O	B-T080
,	O	O	O
efficient	O	O	B-T080
,	O	O	O
and	O	O	O
high-quality	O	O	B-T058
care	O	O	I-T058
.	O	O	O

-DOCSTART- (27466053)

Visual	O	O	B-T060
Analytics	O	O	I-T060
for	O	O	O
Pattern	O	O	B-T041
Discovery	O	O	I-T041
in	O	O	O
Home	O	O	B-T058
Care	O	O	I-T058
.	O	O	O
Clinical	O	O	B-T080
Relevance	O	O	I-T080
for	O	O	O
Quality	O	O	O
Improvement	O	O	O

Clinical	O	O	B-T080
Relevance	O	O	I-T080
for	O	O	O
Quality	O	O	B-T057
Improvement	O	O	I-T057
Visualization	O	O	B-T041
can	O	O	O
reduce	O	O	O
the	O	O	O
cognitive	O	O	B-T081
load	O	O	I-T081
of	O	O	I-T081
information	O	O	I-T081
,	O	O	O
allowing	O	O	O
users	O	O	O
to	O	O	O
easily	O	O	O
interpret	O	O	B-T169
and	O	O	O
assess	O	O	B-T058
large	O	O	I-T058
amounts	O	O	I-T058
of	O	O	I-T058
data	O	O	I-T058
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
our	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
examine	O	O	O
home	O	O	B-T170
health	O	O	I-T170
data	O	O	I-T170
using	O	O	O
visual	O	O	B-T060
analysis	O	O	I-T060
techniques	O	O	I-T060
to	O	O	O
discover	O	O	O
clinically	O	O	B-T080
salient	O	O	I-T080
associations	O	O	B-T078
between	O	O	O
patient	O	O	B-T201
characteristics	O	O	I-T201
with	O	O	O
problem-oriented	O	O	B-T170
health	O	O	I-T170
outcomes	O	O	I-T170
of	O	O	O
older	O	O	B-T058
adult	O	O	I-T058
home	O	O	I-T058
health	O	O	I-T058
patients	O	O	I-T058
during	O	O	O
the	O	O	O
home	O	O	B-T058
health	O	O	I-T058
service	O	O	I-T058
period	O	O	O
.	O	O	O

Knowledge	O	O	B-T170
,	O	O	O
Behavior	O	O	B-T053
and	O	O	O
Status	O	O	B-T081
ratings	O	O	I-T081
at	O	O	O
discharge	O	O	B-T058
as	O	O	O
well	O	O	O
as	O	O	O
change	O	O	O
from	O	O	O
admission	O	O	B-T058
to	O	O	O
discharge	O	O	O
that	O	O	O
was	O	O	O
coded	O	O	O
using	O	O	O
the	O	O	O
Omaha	O	O	B-T170
System	O	O	I-T170
was	O	O	O
collected	O	O	O
from	O	O	O
a	O	O	O
dataset	O	O	B-T170
on	O	O	O
988	O	O	O
de-identified	O	O	O
patient	O	O	B-T170
data	O	O	I-T170
from	O	O	O
15	O	O	O
home	O	O	B-T093
health	O	O	I-T093
agencies	O	O	I-T093
.	O	O	O

SPSS	O	O	B-T170
Visualization	O	O	I-T170
Designer	O	O	I-T170
v1.0	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
visually	O	O	B-T060
analyze	O	O	I-T060
patterns	O	O	I-T060
between	O	O	O
independent	O	O	O
and	O	O	O
outcome	O	O	O
variables	O	O	O
using	O	O	O
heat	O	O	B-T078
maps	O	O	I-T078
and	O	O	O
histograms	O	O	B-T073
.	O	O	O

Visualizations	O	O	B-T041
suggesting	O	O	O
clinical	O	O	B-T033
salience	O	O	I-T033
were	O	O	O
tested	O	O	B-T169
for	O	O	O
significance	O	O	O
using	O	O	O
correlation	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

The	O	O	O
mean	O	O	O
age	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
was	O	O	O
80	O	O	O
years	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
majority	O	O	O
female	O	O	B-T032
(	O	O	O
66	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
150	O	O	O
visualizations	O	O	B-T041
,	O	O	O
69	O	O	O
potentially	O	O	O
meaningful	O	O	B-T078
patterns	O	O	I-T078
were	O	O	O
statistically	O	O	O
evaluated	O	O	O
through	O	O	O
bivariate	O	O	B-UnknownType
associations	O	O	B-T078
,	O	O	O
revealing	O	O	O
21	O	O	O
significant	O	O	O
associations	O	O	O
.	O	O	O

Further	O	O	O
,	O	O	O
14	O	O	O
associations	O	O	B-T078
between	O	O	O
episode	O	O	O
length	O	O	O
and	O	O	O
Charlson	O	O	B-T170
co-morbidity	O	O	I-T170
index	O	O	I-T170
mainly	O	O	O
with	O	O	O
urinary	O	O	B-T080
related	O	O	O
diagnoses	O	O	B-T047
and	O	O	I-T047
problems	O	O	I-T047
remained	O	O	O
significant	O	O	O
after	O	O	O
adjustment	O	O	O
analyses	O	O	O
.	O	O	O

Through	O	O	O
visual	O	O	B-T060
analysis	O	O	I-T060
,	O	O	O
the	O	O	O
adverse	O	O	O
association	O	O	B-T078
of	O	O	O
the	O	O	O
longer	O	O	O
home	O	O	B-T058
health	O	O	I-T058
episode	O	O	I-T058
length	O	O	O
and	O	O	O
higher	O	O	O
Charlson	O	O	B-T170
co-morbidity	O	O	I-T170
index	O	O	I-T170
with	O	O	O
behavior	O	O	B-T033
or	O	O	I-T033
status	O	O	I-T033
outcomes	O	O	I-T033
for	O	O	O
patients	O	O	B-T101
with	O	O	O
impaired	O	O	B-T047
urinary	O	O	I-T047
function	O	O	I-T047
was	O	O	O
revealed	O	O	O
.	O	O	O

We	O	O	O
have	O	O	O
demonstrated	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
visual	O	O	B-T060
analysis	O	O	I-T060
to	O	O	O
discover	O	O	O
novel	O	O	O
patterns	O	O	O
that	O	O	O
described	O	O	O
high-needs	O	O	O
subgroups	O	O	B-T185
among	O	O	O
the	O	O	O
older	O	O	B-T081
home	O	O	I-T081
health	O	O	I-T081
patient	O	O	I-T081
population	O	O	I-T081
.	O	O	O

The	O	O	O
effective	O	O	O
presentation	O	O	O
of	O	O	O
these	O	O	O
data	O	O	B-T078
patterns	O	O	I-T078
can	O	O	O
allow	O	O	O
clinicians	O	O	B-T097
to	O	O	O
identify	O	O	O
areas	O	O	O
of	O	O	O
patient	O	O	B-T057
improvement	O	O	I-T057
,	O	O	O
and	O	O	O
time	O	O	O
periods	O	O	O
that	O	O	O
are	O	O	O
most	O	O	O
effective	O	O	O
for	O	O	O
implementing	O	O	O
home	O	O	B-T058
health	O	O	I-T058
interventions	O	O	I-T058
to	O	O	O
improve	O	O	O
patient	O	O	B-T058
outcomes	O	O	I-T058
.	O	O	O

-DOCSTART- (27466300)

Transforming	O	O	B-T116
Growth	O	O	I-T116
Factor	O	O	I-T116
Beta	O	O	I-T116
1	O	O	I-T116
(	O	O	O
TGF-β1	O	O	B-T116
)	O	O	O
in	O	O	O
Thyroid	O	O	B-T191
Cancer	O	O	I-T191
Patients	O	O	B-T101
:	O	O	O
a	O	O	O
View	O	O	O
from	O	O	O
the	O	O	O
Peripheral	O	O	O
Blood	O	O	O

Transforming	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
beta	O	O	I-T116
(	O	O	O
TGF-β	O	O	B-T116
)	O	O	O
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
many	O	O	O
pathophysiological	O	O	B-T169
conditions	O	O	B-T080
,	O	O	O
including	O	O	O
cancer	O	O	B-T191
.	O	O	O

The	O	O	O
level	O	O	B-T080
of	O	O	O
TGF-β	O	O	B-T116
in	O	O	O
patients	O	O	B-T101
with	O	O	O
differentiated	O	O	B-T191
thyroid	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
DTC	O	O	B-T191
)	O	O	O
has	O	O	O
not	O	O	O
been	O	O	O
examined	O	O	B-T033
so	O	O	O
far	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
measure	O	O	O
TGF-β	O	O	B-T116
concentration	O	O	B-T081
in	O	O	O
serum	O	O	B-T031
samples	O	O	I-T031
and	O	O	O
in	O	O	O
PHA	O	O	B-T116
-	O	O	O
stimulated	O	O	B-T044
whole	O	O	B-T031
blood	O	O	I-T031
culture	O	O	B-T059
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
to	O	O	O
analyze	O	O	B-T062
possible	O	O	O
associations	O	O	O
of	O	O	O
TGF-β1	O	O	B-T116
levels	O	O	B-T080
with	O	O	O
leukocyte	O	O	B-T025
,	O	O	O
lymphocyte	O	O	B-T025
and	O	O	O
platelets	O	O	B-T025
counts	O	O	B-T059
,	O	O	O
the	O	O	O
histological	O	O	B-T169
type	O	O	O
of	O	O	O
thyroid	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
and	O	O	O
stage	O	O	B-T060
of	O	O	I-T060
disease	O	O	I-T060
.	O	O	O

TGF-β1	O	O	B-T116
was	O	O	O
measured	O	O	O
in	O	O	O
22	O	O	O
DTC	O	O	B-T191
patients	O	O	B-T101
and	O	O	O
20	O	O	O
healthy	O	O	B-T080
controls	O	O	B-T096
using	O	O	O
the	O	O	O
duoSet	O	O	B-T074
ELISA	O	O	I-T074
Development	O	O	I-T074
kit	O	O	I-T074
for	O	O	O
human	O	O	B-T116
TGF-β1	O	O	I-T116
.	O	O	O

The	O	O	O
concentration	O	O	B-T081
of	O	O	O
TGF-β1	O	O	B-T116
in	O	O	O
serum	O	O	B-T031
samples	O	O	I-T031
from	O	O	O
both	O	O	O
groups	O	O	B-T098
correlated	O	O	O
positively	O	O	O
with	O	O	O
the	O	O	O
platelet	O	O	B-T025
counts	O	O	B-T059
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
difference	O	O	O
in	O	O	O
the	O	O	O
serum	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
TGF-β1	O	O	B-T116
between	O	O	O
DTC	O	O	B-T191
patients	O	O	B-T101
and	O	O	O
control	O	O	B-T096
subjects	O	O	I-T096
,	O	O	O
but	O	O	O
PHA	O	O	B-T116
stimulated	O	O	B-T044
whole	O	O	B-T031
blood	O	O	I-T031
cultures	O	O	B-T059
of	O	O	O
DTC	O	O	O
patients	O	O	O
produced	O	O	O
less	O	O	O
TGF-β1	O	O	O
than	O	O	O
those	O	O	O
from	O	O	O
controls	O	O	B-T096
.	O	O	O

Additional	O	O	O
studies	O	O	B-T062
are	O	O	O
needed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
significance	O	O	B-T078
of	O	O	O
these	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
findings	O	O	B-T033
.	O	O	O

-DOCSTART- (27466374)

P-glycoprotein	O	O	B-T116
traffics	O	O	B-T169
from	O	O	O
the	O	O	O
nucleus	O	O	B-T026
to	O	O	O
the	O	O	O
plasma	O	O	B-T026
membrane	O	O	I-T026
in	O	O	O
rat	O	O	B-T023
brain	O	O	I-T023
endothelium	O	O	B-T024
during	O	O	O
inflammatory	O	O	O
pain	O	O	O

P-glycoprotein	O	O	B-T116
(	O	O	O
PgP	O	O	B-T116
)	O	O	O
,	O	O	O
a	O	O	O
drug	O	O	B-T121
efflux	O	O	B-T024
pump	O	O	I-T024
in	O	O	O
blood-brain	O	O	B-T023
barrier	O	O	I-T023
endothelial	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
is	O	O	O
a	O	O	O
major	O	O	O
clinical	O	O	B-T080
obstacle	O	O	B-T080
for	O	O	O
effective	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
drug	O	O	B-T061
delivery	O	O	I-T061
.	O	O	O

Identifying	O	O	B-T058
PgP	O	O	B-T116
regulatory	O	O	B-T169
pathways	O	O	I-T169
that	O	O	O
can	O	O	O
be	O	O	O
exploited	O	O	O
clinically	O	O	O
is	O	O	O
critical	O	O	O
for	O	O	O
improving	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
drug	O	O	B-T061
delivery	O	O	I-T061
.	O	O	O

We	O	O	O
previously	O	O	O
found	O	O	O
that	O	O	O
PgP	O	O	B-T044
activity	O	O	I-T044
increases	O	O	B-T169
in	O	O	O
rat	O	O	B-T023
brain	O	O	I-T023
microvessels	O	O	B-T023
concomitant	O	O	B-T079
with	O	O	O
decreased	O	O	B-T081
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
drug	O	O	B-T061
delivery	O	O	I-T061
in	O	O	O
response	O	O	O
to	O	O	O
acute	O	O	B-T079
peripheral	O	O	B-T082
inflammatory	O	O	B-T184
pain	O	O	I-T184
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
tested	O	O	O
the	O	O	O
hypothesis	O	O	O
that	O	O	O
PgP	O	O	B-T116
traffics	O	O	B-T169
to	O	O	O
the	O	O	O
luminal	O	O	B-T082
plasma	O	O	B-T026
membrane	O	O	I-T026
of	O	O	O
the	O	O	O
microvessel	O	O	B-T023
endothelial	O	O	B-T025
cells	O	O	I-T025
from	O	O	O
intracellular	O	O	B-T082
stores	O	O	B-T169
during	O	O	O
peripheral	O	O	B-T082
inflammatory	O	O	B-T184
pain	O	O	I-T184
.	O	O	O

Using	O	O	O
immunofluorescence	O	O	B-T059
microscopy	O	O	I-T059
,	O	O	O
we	O	O	O
detected	O	O	B-T033
PgP	O	O	B-T116
in	O	O	O
endothelial	O	O	B-T025
cell	O	O	I-T025
nuclei	O	O	B-T026
and	O	O	O
in	O	O	O
the	O	O	O
luminal	O	O	B-T082
plasma	O	O	B-T026
membrane	O	O	I-T026
in	O	O	O
control	O	O	B-T008
animals	O	O	I-T008
.	O	O	O

Following	O	O	O
peripheral	O	O	B-T082
inflammatory	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
luminal	O	O	B-T082
PgP	O	O	B-T116
staining	O	O	B-T059
increased	O	O	B-T081
while	O	O	O
staining	O	O	O
in	O	O	O
the	O	O	O
nucleus	O	O	B-T026
decreased	O	O	B-T081
.	O	O	O

Biochemical	O	O	B-T059
analysis	O	O	I-T059
of	O	O	O
nuclear	O	O	B-T026
PgP	O	O	B-T116
content	O	O	B-T077
confirmed	O	O	O
our	O	O	O
visual	O	O	B-T169
observations	O	O	I-T169
.	O	O	O

Peripheral	O	O	B-T082
inflammatory	O	O	B-T184
pain	O	O	I-T184
also	O	O	O
increased	O	O	B-T081
endothelial	O	O	B-T025
cell	O	O	I-T025
luminal	O	O	B-T082
staining	O	O	B-T059
of	O	O	O
polymerase	O	O	B-T028
1	O	O	I-T028
and	O	O	I-T028
transcript	O	O	I-T028
release	O	O	I-T028
factor	O	O	I-T028
/	O	O	O
cavin1	O	O	B-T028
and	O	O	O
serum	O	O	B-T028
deprivation	O	O	I-T028
response	O	O	I-T028
protein	O	O	I-T028
/	O	O	O
cavin2	O	O	B-T028
,	O	O	O
two	O	O	O
caveolar	O	O	B-T116
scaffold	O	O	I-T116
proteins	O	O	I-T116
,	O	O	O
without	O	O	O
changing	O	O	O
caveolin1	O	O	B-T116
or	O	O	O
protein	O	O	B-T028
kinase	O	O	I-T028
C	O	O	I-T028
delta	O	O	I-T028
binding	O	O	I-T028
protein	O	O	I-T028
/	O	O	O
cavin3	O	O	B-T028
location	O	O	B-T082
.	O	O	O

Our	O	O	O
data	O	O	B-T078
(	O	O	O
a	O	O	O
)	O	O	O
indicate	O	O	O
that	O	O	O
PgP	O	O	B-T116
traffics	O	O	B-T169
from	O	O	O
stores	O	O	B-T169
in	O	O	O
the	O	O	O
nucleus	O	O	B-T026
to	O	O	O
the	O	O	O
endothelial	O	O	B-T025
cell	O	O	I-T025
luminal	O	O	B-T026
membrane	O	O	I-T026
in	O	O	O
response	O	O	O
to	O	O	O
peripheral	O	O	B-T082
inflammatory	O	O	B-T184
pain	O	O	I-T184
;	O	O	O
(	O	O	O
b	O	O	O
)	O	O	O
provide	O	O	O
an	O	O	O
explanation	O	O	O
for	O	O	O
our	O	O	O
previous	O	O	O
observation	O	O	B-T062
that	O	O	O
peripheral	O	O	O
inflammatory	O	O	O
pain	O	O	O
inhibits	O	O	B-T052
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
drug	O	O	B-T121
uptake	O	O	B-T039
;	O	O	O
and	O	O	O
(	O	O	O
c	O	O	O
)	O	O	O
suggest	O	O	O
a	O	O	O
novel	O	O	B-T080
regulatory	O	O	B-T033
mechanism	O	O	I-T033
for	O	O	O
PgP	O	O	B-T044
activity	O	O	I-T044
in	O	O	O
rat	O	O	B-T023
brain	O	O	I-T023
.	O	O	O

-DOCSTART- (27469396)

Functional	O	O	B-T169
Impairment	O	O	B-T169
in	O	O	O
Children	O	O	B-T100
With	O	O	O
Externalizing	O	O	B-T048
Behavior	O	O	I-T048
Disorders	O	O	I-T048
:	O	O	O
Psychometric	O	O	B-T060
Properties	O	O	B-T080
of	O	O	O
the	O	O	O
Weiss	O	O	B-T170
Functional	O	O	I-T170
Impairment	O	O	I-T170
Rating	O	O	I-T170
Scale-Parent	O	O	I-T170
Report	O	O	I-T170
in	O	O	O
a	O	O	O
German	O	O	B-T083
Clinical	O	O	O
Sample	O	O	O

To	O	O	O
examine	O	O	O
the	O	O	O
psychometric	O	O	B-T060
properties	O	O	B-T080
of	O	O	O
a	O	O	O
German	O	O	B-T083
adaptation	O	O	O
of	O	O	O
the	O	O	O
Weiss	O	O	B-T170
Functional	O	O	I-T170
Impairment	O	O	I-T170
Rating	O	O	I-T170
Scale-Parent	O	O	I-T170
Report	O	O	I-T170
(	O	O	O
WFIRS-P	O	O	B-T170
)	O	O	O
in	O	O	O
a	O	O	O
clinical	O	O	B-T167
sample	O	O	I-T167
of	O	O	O
children	O	O	B-T100
(	O	O	O
4	O	O	O
-	O	O	O
12	O	O	O
years	O	O	B-T079
)	O	O	O
with	O	O	O
externalizing	O	O	B-T048
behavior	O	O	I-T048
disorders	O	O	I-T048
.	O	O	O

Data	O	O	B-T078
were	O	O	O
collected	O	O	B-T169
within	O	O	O
two	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
(	O	O	O
N	O	O	O
=	O	O	O
264	O	O	O
)	O	O	O
.	O	O	O

Factorial	O	O	B-T080
validity	O	O	I-T080
,	O	O	O
reliability	O	O	B-T081
,	O	O	O
and	O	O	O
divergent	O	O	B-T081
validity	O	O	I-T081
from	O	O	O
symptoms	O	O	B-T184
of	O	O	O
ADHD	O	O	B-T048
and	O	O	O
oppositional	O	O	B-T048
defiant	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
ODD	O	O	B-T048
)	O	O	O
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

Confirmatory	O	O	B-T080
factor	O	O	I-T080
analyses	O	O	I-T080
revealed	O	O	B-T080
that	O	O	O
a	O	O	O
bifactor	O	O	B-T170
model	O	O	I-T170
consistent	O	O	B-T078
with	O	O	I-T078
the	O	O	O
theoretical	O	O	B-T078
assumption	O	O	I-T078
of	O	O	O
a	O	O	O
general	O	O	B-T185
construct	O	O	I-T185
of	O	O	O
impairment	O	O	B-T169
(	O	O	O
total	O	O	O
scale	O	O	O
)	O	O	O
and	O	O	O
additional	O	O	B-T169
specific	O	O	B-T169
factors	O	O	I-T169
(	O	O	O
subscales	O	O	O
)	O	O	O
provided	O	O	O
satisfactory	O	O	B-T080
data	O	O	B-T078
fit	O	O	I-T078
.	O	O	O

Model	O	O	B-T170
-based	O	O	O
reliability	O	O	B-T081
estimates	O	O	B-T081
showed	O	O	O
that	O	O	O
both	O	O	O
the	O	O	O
general	O	O	B-T185
construct	O	O	I-T185
and	O	O	O
specific	O	O	B-T169
factors	O	O	I-T169
accounted	O	O	O
for	O	O	O
item	O	O	O
variance	O	O	B-T080
.	O	O	O

Internal	O	O	O
consistencies	O	O	B-T080
were	O	O	O
>	O	O	O
.70	O	O	O
,	O	O	O
part-whole	O	O	O
corrected	O	O	O
item-scale	O	O	O
correlations	O	O	B-T080
mostly	O	O	O
>	O	O	O
.30	O	O	O
.	O	O	O

Correlations	O	O	B-T080
between	O	O	O
the	O	O	O
WFIRS-P	O	O	B-T170
Scales	O	O	I-T170
and	O	O	O
ADHD	O	O	B-T048
and	O	O	O
ODD	O	O	B-T048
symptoms	O	O	B-T184
were	O	O	O
low	O	O	B-T080
to	O	O	O
moderate	O	O	B-T080
.	O	O	O

The	O	O	O
results	O	O	B-T169
support	O	O	O
the	O	O	O
factorial	O	O	B-T080
validity	O	O	I-T080
,	O	O	O
reliability	O	O	B-T081
,	O	O	O
and	O	O	O
divergent	O	O	B-T081
validity	O	O	I-T081
of	O	O	O
the	O	O	O
WFIRS-P.	O	O	O

-DOCSTART- (27469581)

What	O	O	O
can	O	O	O
the	O	O	O
Canadians	O	O	B-T098
and	O	O	O
Americans	O	O	B-T098
learn	O	O	B-T041
from	O	O	O
each	O	O	O
other	O	O	O
's	O	O	O
health	O	O	B-T093
care	O	O	I-T093
systems	O	O	I-T093
?	O	O	O

Numerous	O	O	O
papers	O	O	B-T170
have	O	O	O
been	O	O	O
written	O	O	O
comparing	O	O	B-T052
the	O	O	O
Canadian	O	O	B-T098
and	O	O	O
US	O	O	B-T083
healthcare	O	O	B-T093
systems	O	O	I-T093
,	O	O	O
and	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
health	O	O	B-T089
policy	O	O	I-T089
experts	O	O	B-T097
have	O	O	O
recommended	O	O	B-T078
that	O	O	O
the	O	O	O
Americans	O	O	B-T098
implement	O	O	B-T052
their	O	O	O
single-payer	O	O	B-T058
system	O	O	I-T058
to	O	O	O
save	O	O	O
12	O	O	O
-	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
its	O	O	O
healthcare	O	O	B-T081
expenditures	O	O	I-T081
.	O	O	O

This	O	O	O
paper	O	O	B-T170
is	O	O	O
different	O	O	O
in	O	O	O
that	O	O	O
it	O	O	O
assumes	O	O	O
that	O	O	O
neither	O	O	O
country	O	O	B-T083
will	O	O	O
undertake	O	O	O
a	O	O	O
significant	O	O	B-T078
philosophic	O	O	B-T080
or	O	O	O
structural	O	O	B-T082
change	O	O	B-T169
in	O	O	O
their	O	O	O
healthcare	O	O	B-T093
system	O	O	I-T093
,	O	O	O
but	O	O	O
there	O	O	O
are	O	O	O
lessons	O	O	O
to	O	O	O
be	O	O	O
learned	O	O	B-T041
that	O	O	O
are	O	O	O
inherent	O	O	O
in	O	O	O
one	O	O	O
that	O	O	O
could	O	O	O
be	O	O	O
a	O	O	O
major	O	O	O
breakthrough	O	O	B-T080
for	O	O	O
the	O	O	O
other	O	O	O
.	O	O	O

Following	O	O	O
the	O	O	O
model	O	O	B-T083
in	O	O	O
Canada	O	O	B-T083
and	O	O	O
in	O	O	O
Western	O	O	B-T083
Europe	O	O	I-T083
,	O	O	O
the	O	O	O
USA	O	O	B-T083
could	O	O	O
implement	O	O	B-T052
universal	O	O	B-T080
health	O	O	B-T058
insurance	O	O	I-T058
so	O	O	O
that	O	O	O
the	O	O	O
32.0	O	O	O
million	O	O	O
(	O	O	O
2015	O	O	O
)	O	O	O
Americans	O	O	B-T098
still	O	O	O
uninsured	O	O	B-T098
would	O	O	O
have	O	O	O
at	O	O	O
least	O	O	O
minimal	O	O	B-T080
coverage	O	O	B-T078
when	O	O	O
incurring	O	O	O
medical	O	O	B-T081
expenditures	O	O	I-T081
.	O	O	O

Also	O	O	O
,	O	O	O
the	O	O	O
USA	O	O	B-T083
could	O	O	O
use	O	O	O
smart	O	O	B-T073
cards	O	O	I-T073
to	O	O	O
evaluate	O	O	B-T058
eligibility	O	O	I-T058
and	O	O	O
to	O	O	O
process	O	O	B-T067
health	O	O	B-T058
insurance	O	O	I-T058
claims	O	O	I-T058
;	O	O	O
these	O	O	O
changes	O	O	O
resulting	O	O	B-T169
in	O	O	I-T169
an	O	O	O
estimated	O	O	B-T081
15	O	O	O
%	O	O	O
reduction	O	O	B-T080
in	O	O	O
US	O	O	B-T083
health	O	O	B-T081
expenditures	O	O	I-T081
without	O	O	O
adversely	O	O	O
effecting	O	O	B-T080
access	O	O	B-T080
or	O	O	O
quality	O	O	B-T058
of	O	O	I-T058
care	O	O	I-T058
.	O	O	O

Such	O	O	O
a	O	O	O
strategy	O	O	O
would	O	O	O
result	O	O	B-T169
in	O	O	O
the	O	O	O
eventual	O	O	O
loss	O	O	B-T081
of	O	O	O
2.5	O	O	O
million	O	O	O
white-collar	O	O	B-T090
jobs	O	O	I-T090
at	O	O	O
hospitals	O	O	B-T093
,	O	O	O
physician	O	O	B-T093
offices	O	O	I-T093
and	O	O	O
insurance	O	O	B-T078
companies	O	O	I-T078
,	O	O	O
a	O	O	O
long-term	O	O	B-T079
economic	O	O	B-T169
gain	O	O	B-T081
.	O	O	O

Only	O	O	O
a	O	O	O
few	O	O	O
would	O	O	O
agree	O	O	O
with	O	O	O
the	O	O	O
statement	O	O	O
that	O	O	O
Canada	O	O	B-T083
already	O	O	O
functions	O	O	B-T169
with	O	O	O
a	O	O	O
multi-payer	O	O	B-T092
reimbursement	O	O	B-T170
system	O	O	I-T170
as	O	O	O
evidenced	O	O	O
by	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
a	O	O	O
federal	O	O	B-T092
-	O	O	O
provincial	O	O	B-T083
,	O	O	O
tax	O	O	B-T081
-	O	O	O
supported	O	O	B-T077
plan	O	O	B-T058
,	O	O	O
administered	O	O	O
by	O	O	O
each	O	O	O
of	O	O	O
the	O	O	O
provinces	O	O	B-T083
,	O	O	O
providing	O	O	O
universal	O	O	B-T078
coverage	O	O	I-T078
for	O	O	O
hospital	O	O	B-T093
and	O	O	O
physician	O	O	B-T058
services	O	O	I-T058
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
roughly	O	O	O
60	O	O	O
%	O	O	O
of	O	O	O
its	O	O	O
residents	O	O	B-T098
receiving	O	O	O
employer-paid	O	O	B-T081
health	O	O	B-T058
insurance	O	O	I-T058
benefits	O	O	B-T081
,	O	O	O
underwritten	O	O	O
primarily	O	O	O
by	O	O	O
investor-owned	O	O	O
plans	O	O	O
,	O	O	O
that	O	O	O
are	O	O	O
less	O	O	O
than	O	O	O
effective	O	O	B-T080
to	O	O	O
reimburse	O	O	B-T080
for	O	O	O
pharmaceuticals	O	O	B-T058
,	O	O	O
dental	O	O	B-T058
and	O	O	O
other	O	O	O
healthcare	O	O	B-T058
services	O	O	I-T058
.	O	O	O

What	O	O	O
could	O	O	O
be	O	O	O
learned	O	O	O
from	O	O	O
the	O	O	O
USA	O	O	B-T083
and	O	O	O
particularly	O	O	O
from	O	O	O
Western	O	O	B-T083
European	O	O	I-T083
countries	O	O	I-T083
is	O	O	O
possibly	O	O	O
implementing	O	O	B-T052
an	O	O	O
approach	O	O	O
,	O	O	O
whereby	O	O	O
at	O	O	O
least	O	O	O
upper-income	O	O	B-T080
Canadians	O	O	B-T098
could	O	O	O
opt	O	O	O
out	O	O	O
of	O	O	O
their	O	O	O
federal	O	O	B-T092
-	O	O	O
provincial	O	O	B-T083
plan	O	O	B-T058
and	O	O	O
purchase	O	O	O
private	O	O	B-T092
insurance	O	O	B-T078
coverage	O	O	I-T078
-	O	O	O
being	O	O	O
eligible	O	O	O
for	O	O	O
far	O	O	O
more	O	O	O
comprehensive	O	O	O
"	O	O	O
private	O	O	O
"	O	O	O
benefits	O	O	O
for	O	O	O
hospital	O	O	B-T093
,	O	O	O
physician	O	O	B-T058
,	O	O	O
pharmaceutical	O	O	B-T058
,	O	O	O
dental	O	O	B-T058
and	O	O	O
other	O	O	O
healthcare	O	O	B-T058
services	O	O	I-T058
.	O	O	O

Aside	O	O	O
from	O	O	O
generating	O	O	O
billions	O	O	O
of	O	O	O
additional	O	O	O
needed	O	O	O
revenues	O	O	B-T081
from	O	O	O
the	O	O	O
private	O	O	B-T093
sector	O	O	I-T098
,	O	O	O
it	O	O	O
could	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
help	O	O	O
eliminate	O	O	B-T052
long	O	O	O
waits	O	O	O
for	O	O	O
non-emergent	O	O	O
physicians	O	O	O
'	O	O	O
care	O	O	O
by	O	O	O
appointing	O	O	O
newly	O	O	O
minted	O	O	O
specialists	O	O	B-T097
to	O	O	O
their	O	O	O
medical	O	O	B-T097
staffs	O	O	I-T097
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
offer	O	O	O
prompt	O	O	B-T169
admissions	O	O	B-T058
for	O	O	O
elective	O	O	B-T033
cases	O	O	I-T033
to	O	O	O
"	O	O	O
private	O	O	O
"	O	O	O
wings	O	O	B-T093
of	O	O	I-T093
hospitals	O	O	I-T093
;	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
increase	O	O	B-T081
available	O	O	O
funding	O	O	B-T081
for	O	O	O
what	O	O	O
is	O	O	O
currently	O	O	B-T079
an	O	O	O
undercapitalized	O	O	B-T033
system	O	O	B-T169
;	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
enhance	O	O	B-T052
the	O	O	O
system	O	O	O
's	O	O	O
sluggish	O	O	B-T033
operations	O	O	B-T052
;	O	O	O
and	O	O	O
(	O	O	O
5	O	O	O
)	O	O	O
encourage	O	O	O
more	O	O	O
competition	O	O	B-T057
among	O	O	O
various	O	O	O
providers	O	O	O
.	O	O	O

Although	O	O	O
such	O	O	O
a	O	O	O
two-tier	O	O	B-T170
approach	O	O	I-T170
,	O	O	O
such	O	O	O
as	O	O	O
available	O	O	O
in	O	O	O
the	O	O	O
USA	O	O	B-T083
and	O	O	O
elsewhere	O	O	O
,	O	O	O
is	O	O	O
politically	O	O	O
dead	O	O	O
on	O	O	O
arrival	O	O	O
in	O	O	O
Canada	O	O	B-T083
today	O	O	O
,	O	O	O
private	O	O	B-T064
insurance	O	O	I-T064
being	O	O	O
already	O	O	O
legal	O	O	B-T169
and	O	O	O
commonly	O	O	O
available	O	O	O
there	O	O	O
.	O	O	O

Interestingly	O	O	O
,	O	O	O
this	O	O	O
recommended	O	O	B-T078
solution	O	O	O
is	O	O	O
utilized	O	O	O
in	O	O	O
most	O	O	O
western	O	O	B-T083
European	O	O	I-T083
countries	O	O	I-T083
where	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
higher	O	O	O
percentagea	O	O	B-T081
than	O	O	O
in	O	O	O
Canada	O	O	B-T083
of	O	O	O
public	O	O	B-T092
(	O	O	O
versus	O	O	O
private	O	O	O
)	O	O	O
funding	O	O	B-T081
of	O	O	O
their	O	O	O
total	O	O	O
health	O	O	B-T081
expenditures	O	O	I-T081
.	O	O	O

Because	O	O	O
of	O	O	O
various	O	O	O
vested	O	O	O
interests	O	O	O
,	O	O	O
attempts	O	O	B-T051
to	O	O	O
implement	O	O	B-T052
any	O	O	O
of	O	O	O
the	O	O	O
aforementioned	O	O	O
proposals	O	O	O
will	O	O	O
undoubtedly	O	O	O
result	O	O	B-T169
in	O	O	O
considerable	O	O	O
political	O	O	B-T057
rancor	O	O	B-T041
.	O	O	O

There	O	O	O
is	O	O	O
greater	O	O	O
likelihood	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
that	O	O	O
the	O	O	O
Canadians	O	O	B-T098
because	O	O	O
their	O	O	O
need	O	O	O
to	O	O	O
be	O	O	O
more	O	O	O
effective	O	O	B-T080
and	O	O	O
efficient	O	O	B-T080
in	O	O	O
their	O	O	O
delivery	O	O	B-T058
of	O	O	I-T058
care	O	O	I-T058
,	O	O	O
and	O	O	O
their	O	O	O
overall	O	O	O
long-term	O	O	B-T079
fiscal	O	O	B-T064
outlook	O	O	O
will	O	O	O
agree	O	O	B-T033
to	O	O	O
the	O	O	O
further	O	O	O
privatization	O	O	B-T064
of	O	O	O
their	O	O	O
healthcare	O	O	B-T093
system	O	O	I-T093
before	O	O	O
the	O	O	O
Americans	O	O	B-T098
will	O	O	O
mandate	O	O	O
universal	O	O	O
access	O	O	O
,	O	O	O
use	O	O	O
the	O	O	O
smart	O	O	B-T073
card	O	O	I-T073
to	O	O	O
process	O	O	O
insurance	O	O	B-UnknownType
eligibility	O	O	I-UnknownType
and	O	O	O
claims	O	O	O
or	O	O	O
will	O	O	O
impose	O	O	O
price	O	O	O
controls	O	O	B-T169
on	O	O	O
high-tech	O	O	O
services	O	O	O
and	O	O	O
on	O	O	O
pharmaceuticals	O	O	B-T121
.	O	O	O

Copyright	O	O	O
©	O	O	O
2016	O	O	O
John	O	O	O
Wiley	O	O	O
&	O	O	O
Sons	O	O	O
,	O	O	O
Ltd.	O	O	O

-DOCSTART- (27471363)

Optimal	O	O	B-T080
Duration	O	O	B-T079
of	O	O	O
Coronary	O	O	B-T061
Ligation	O	O	I-T061
and	O	O	O
Reperfusion	O	O	B-T061
for	O	O	O
Reperfusion	O	O	B-T037
Injury	O	O	I-T037
Study	O	O	B-T062
in	O	O	O
a	O	O	O
Rat	O	O	B-T015
Model	O	O	O

Reperfusion	O	O	B-T037
injury	O	O	I-T037
(	O	O	O
RI	O	O	B-T037
)	O	O	O
has	O	O	O
an	O	O	O
important	O	O	B-T080
impact	O	O	B-T080
on	O	O	O
the	O	O	O
clinical	O	O	B-T080
prognosis	O	O	B-T201
for	O	O	O
patients	O	O	B-T101
with	O	O	O
acute	O	O	B-T037
myocardial	O	O	I-T037
injury	O	O	I-T037
who	O	O	O
had	O	O	O
their	O	O	O
coronary	O	O	B-T082
blood	O	O	B-T039
flow	O	O	I-T039
reestablished	O	O	B-T080
.	O	O	O

However	O	O	O
,	O	O	O
no	O	O	O
studies	O	O	B-T062
to	O	O	O
date	O	O	O
have	O	O	O
investigated	O	O	B-T169
the	O	O	O
timeframe	O	O	B-T079
of	O	O	O
coronary	O	O	B-T047
occlusion	O	O	I-T047
and	O	O	O
reperfusion	O	O	B-T061
effects	O	O	B-T080
on	O	O	O
RI	O	O	B-T037
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
100	O	O	O
rats	O	O	B-T015
were	O	O	O
divided	O	O	O
into	O	O	O
4	O	O	O
groups	O	O	B-T078
based	O	O	O
on	O	O	O
the	O	O	O
coronary	O	O	B-T061
ligation	O	O	I-T061
period	O	O	B-T079
:	O	O	O
30	O	O	O
,	O	O	O
60	O	O	O
,	O	O	O
120	O	O	O
,	O	O	O
and	O	O	O
180	O	O	O
min	O	O	O
,	O	O	O
and	O	O	O
each	O	O	O
group	O	O	B-T078
was	O	O	O
further	O	O	O
divided	O	O	O
into	O	O	O
5	O	O	O
subgroups	O	O	B-T078
with	O	O	O
different	O	O	B-T080
reperfusion	O	O	B-T061
periods	O	O	B-T079
:	O	O	O
0	O	O	O
,	O	O	O
30	O	O	O
,	O	O	O
60	O	O	O
,	O	O	O
120	O	O	O
,	O	O	O
and	O	O	O
180	O	O	O
min	O	O	O
.	O	O	O

R0	O	O	O
was	O	O	O
the	O	O	O
baseline	O	O	B-T081
of	O	O	O
each	O	O	O
subgroup	O	O	B-T078
.	O	O	O

All	O	O	O
animals	O	O	B-T008
received	O	O	O
the	O	O	O
same	O	O	O
protocols	O	O	B-T170
for	O	O	O
designed	O	O	B-T052
ligation	O	O	B-T061
and	O	O	O
reperfusion	O	O	B-T061
periods	O	O	B-T079
.	O	O	O

Evans	O	O	B-T109
blue	O	O	I-T109
and	O	O	O
2,3,5-triphenyltetrazolium	O	O	B-T109
chloride	O	O	I-T109
were	O	O	O
used	O	O	O
to	O	O	O
distinguish	O	O	O
different	O	O	B-T080
myocardial	O	O	B-T037
injury	O	O	I-T037
areas	O	O	B-T082
:	O	O	O
area	O	O	B-T082
at	O	O	B-T080
risk	O	O	I-T080
(	O	O	O
AAR	O	O	B-T082
)	O	O	O
and	O	O	O
myocardial	O	O	B-T047
necrosis	O	O	I-T047
.	O	O	O

The	O	O	O
differences	O	O	B-T080
of	O	O	O
the	O	O	O
ratios	O	O	B-T081
of	O	O	O
the	O	O	O
necrotic	O	O	B-T042
area	O	O	B-T082
to	O	O	O
AAR	O	O	B-T082
between	O	O	O
each	O	O	O
subgroup	O	O	B-T078
and	O	O	O
baseline	O	O	B-T081
were	O	O	O
further	O	O	O
averaged	O	O	B-T081
to	O	O	O
calculate	O	O	B-T052
an	O	O	O
overall	O	O	B-T080
value	O	O	B-T081
of	O	O	O
each	O	O	O
heart	O	O	B-T023
.	O	O	O

The	O	O	O
relative	O	O	O
RI	O	O	B-T037
percentages	O	O	B-T081
showed	O	O	O
significant	O	O	B-T078
differences	O	O	B-T080
(	O	O	O
0.8	O	O	O
±	O	O	O
2.3	O	O	O
%	O	O	O
,	O	O	O
4.9	O	O	O
±	O	O	O
3.3	O	O	O
%	O	O	O
,	O	O	O
10.8	O	O	O
±	O	O	O
3.1	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
20.3	O	O	O
±	O	O	O
3.6	O	O	O
%	O	O	O
respectively	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
at	O	O	O
different	O	O	B-T080
time	O	O	B-T079
points	O	O	I-T079
of	O	O	O
reperfusion	O	O	B-T061
but	O	O	O
not	O	O	O
at	O	O	O
different	O	O	O
time	O	O	O
points	O	O	O
of	O	O	O
ligation	O	O	B-T061
(	O	O	O
p	O	O	O
=	O	O	O
0.593	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
effects	O	O	B-T080
of	O	O	O
different	O	O	B-T080
time	O	O	B-T079
courses	O	O	I-T079
in	O	O	O
RI	O	O	B-T037
showed	O	O	O
that	O	O	O
the	O	O	O
L120R180	O	O	O
group	O	O	B-T078
(	O	O	O
43.4	O	O	O
±	O	O	O
2.3	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
the	O	O	O
highest	O	O	B-T080
RI	O	O	O
difference	O	O	B-T080
with	O	O	O
the	O	O	O
baseline	O	O	B-T081
group	O	O	O
.	O	O	O

Maximal	O	O	B-T080
RI	O	O	B-T037
occurred	O	O	O
at	O	O	O
the	O	O	O
timeframe	O	O	B-T079
of	O	O	O
L120R180	O	O	O
in	O	O	O
our	O	O	O
animal	O	O	B-T075
model	O	O	I-T075
.	O	O	O

This	O	O	O
result	O	O	B-T169
may	O	O	O
be	O	O	O
utilized	O	O	O
to	O	O	O
assess	O	O	B-T052
the	O	O	O
substantial	O	O	O
benefits	O	O	B-T081
of	O	O	O
RI	O	O	B-T061
therapies	O	O	I-T061
in	O	O	O
an	O	O	O
experimental	O	O	B-T050
rat	O	O	I-T050
model	O	O	I-T050
setting	O	O	O
.	O	O	O

-DOCSTART- (27473209)

Derivation	O	O	B-T080
of	O	O	O
a	O	O	O
Predictive	O	O	B-T080
Score	O	O	B-T081
for	O	O	O
Hemorrhagic	O	O	B-T046
Progression	O	O	B-T169
of	O	O	O
Cerebral	O	O	B-T037
Contusions	O	O	I-T037
in	O	O	O
Moderate	O	O	B-T037
and	O	O	O
Severe	O	O	O
Traumatic	O	O	O
Brain	O	O	O
Injury	O	O	O

After	O	O	O
traumatic	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
(	O	O	O
TBI	O	O	B-T037
)	O	O	O
,	O	O	O
hemorrhagic	O	O	B-T046
progression	O	O	B-T169
of	O	O	O
contusions	O	O	B-T037
(	O	O	O
HPCs	O	O	B-T037
)	O	O	O
occurs	O	O	O
frequently	O	O	B-T079
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
established	O	O	B-T080
predictive	O	O	B-T080
score	O	O	B-T081
to	O	O	O
identify	O	O	O
high-risk	O	O	B-T033
patients	O	O	B-T101
for	O	O	O
HPC	O	O	B-T037
.	O	O	O

Consecutive	O	O	B-T080
patients	O	O	B-T101
who	O	O	O
were	O	O	O
hospitalized	O	O	B-T033
(	O	O	O
2008	O	O	O
-	O	O	O
2013	O	O	O
)	O	O	O
with	O	O	O
non-penetrating	O	O	O
moderate	O	O	B-T037
or	O	O	O
severe	O	O	B-T037
TBI	O	O	I-T037
were	O	O	O
studied	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	B-T080
outcome	O	O	I-T080
was	O	O	O
HPC	O	O	B-T037
,	O	O	O
defined	O	O	O
by	O	O	O
both	O	O	O
a	O	O	O
relative	O	O	O
increase	O	O	B-T169
in	O	O	O
contusion	O	O	B-T037
volume	O	O	B-T081
by	O	O	O
≥30	O	O	O
%	O	O	O
and	O	O	O
an	O	O	O
absolute	O	O	B-T080
increase	O	O	O
by	O	O	O
≥10	O	O	O
mL	O	O	O
on	O	O	O
serial	O	O	B-UnknownType
imaging	O	O	I-UnknownType
.	O	O	O

Logistic	O	O	B-T081
regression	O	O	I-T081
models	O	O	I-T081
were	O	O	O
created	O	O	B-T052
to	O	O	O
identify	O	O	O
independent	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
HPC	O	O	B-T037
.	O	O	O

The	O	O	O
HPC	O	O	B-T037
Score	O	O	B-T081
was	O	O	O
then	O	O	O
derived	O	O	B-T080
based	O	O	O
on	O	O	O
the	O	O	O
final	O	O	B-T170
model	O	O	I-T170
.	O	O	O

Among	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
286	O	O	O
eligible	O	O	O
patients	O	O	B-T101
,	O	O	O
61	O	O	O
(	O	O	O
21	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	O
developed	O	O	O
HPC	O	O	B-T037
.	O	O	O

On	O	O	O
univariate	O	O	B-T062
analyses	O	O	I-T062
,	O	O	O
HPC	O	O	B-T037
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
older	O	O	B-T032
age	O	O	I-T032
,	O	O	O
higher	O	O	B-T033
initial	O	O	I-T033
blood	O	O	I-T033
pressure	O	O	I-T033
,	O	O	O
antiplatelet	O	O	B-T121
medications	O	O	I-T121
,	O	O	O
anticoagulants	O	O	B-T121
,	O	O	O
subarachnoid	O	O	B-T047
hemorrhage	O	O	I-T047
(	O	O	O
SAH	O	O	B-T047
)	O	O	O
subdural	O	O	B-T046
hematoma	O	O	I-T046
(	O	O	O
SDH	O	O	B-T046
)	O	O	O
,	O	O	O
skull	O	O	B-T037
fracture	O	O	I-T037
,	O	O	O
frontal	O	O	B-T023
contusion	O	O	B-T037
,	O	O	O
larger	O	O	B-T081
contusion	O	O	O
volume	O	O	B-T081
,	O	O	O
and	O	O	O
shorter	O	O	B-T079
interval	O	O	I-T079
from	O	O	O
injury	O	O	B-T037
to	O	O	O
initial	O	O	B-T060
CT	O	O	I-T060
.	O	O	O

In	O	O	O
the	O	O	O
final	O	O	B-T170
model	O	O	I-T170
,	O	O	O
SAH	O	O	B-T047
(	O	O	O
OR	O	O	B-T081
6.33	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
1.80	O	O	O
-	O	O	O
22.23	O	O	O
)	O	O	O
,	O	O	O
SDH	O	O	B-T046
(	O	O	O
OR	O	O	O
3.46	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.39	O	O	O
-	O	O	O
8.63	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
skull	O	O	B-T037
fracture	O	O	I-T037
(	O	O	O
OR	O	O	O
2.67	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.28	O	O	O
-	O	O	O
5.58	O	O	O
)	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
HPC	O	O	B-T037
.	O	O	O

Based	O	O	O
on	O	O	O
these	O	O	O
factors	O	O	B-T169
,	O	O	O
the	O	O	O
HPC	O	O	B-T037
Score	O	O	B-T081
was	O	O	O
derived	O	O	B-T080
(	O	O	O
SAH	O	O	B-T047
=	O	O	O
2	O	O	O
points	O	O	O
,	O	O	O
SDH	O	O	B-T046
=	O	O	O
1	O	O	O
point	O	O	O
,	O	O	O
and	O	O	O
skull	O	O	B-T037
fracture	O	O	I-T037
=	O	O	O
1	O	O	O
point	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
score	O	O	B-T081
had	O	O	O
an	O	O	O
area	O	O	O
under	O	O	O
the	O	O	O
receiver	O	O	B-T081
operating	O	O	I-T081
curve	O	O	I-T081
of	O	O	O
0.77	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
a	O	O	O
score	O	O	B-T081
of	O	O	O
0	O	O	O
-	O	O	O
2	O	O	O
had	O	O	O
a	O	O	O
4.0	O	O	O
%	O	O	O
incidence	O	O	B-T081
of	O	O	O
HPC	O	O	B-T037
,	O	O	O
while	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
score	O	O	O
of	O	O	O
3	O	O	O
-	O	O	O
4	O	O	O
had	O	O	O
a	O	O	O
34.6	O	O	O
%	O	O	O
incidence	O	O	O
of	O	O	O
HPC	O	O	O
.	O	O	O

A	O	O	O
simple	O	O	O
HPC	O	O	B-T037
Score	O	O	B-T081
was	O	O	O
developed	O	O	O
for	O	O	O
early	O	O	O
risk	O	O	B-T078
stratification	O	O	B-T169
of	O	O	O
HPC	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
moderate	O	O	B-T037
or	O	O	O
severe	O	O	B-T037
TBI	O	O	I-T037
.	O	O	O

-DOCSTART- (27473877)

Expressing	O	O	B-T055
sexuality	O	O	B-T053
in	O	O	O
nursing	O	O	B-T093
homes	O	O	I-T093
.	O	O	O
The	O	O	O
experience	O	O	B-T055
of	O	O	O
older	O	O	B-T098
women	O	O	I-T098
:	O	O	O
A	O	O	O
qualitative	O	O	O
study	O	O	O

The	O	O	O
experience	O	O	B-T055
of	O	O	O
older	O	O	B-T098
women	O	O	I-T098
:	O	O	O
A	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
In	O	O	O
nursing	O	O	B-T093
homes	O	O	I-T093
,	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
barriers	O	O	B-T080
to	O	O	O
the	O	O	O
expression	O	O	B-T055
of	O	O	O
sexuality	O	O	B-T053
exist	O	O	B-T077
,	O	O	O
such	O	O	O
as	O	O	O
the	O	O	O
lack	O	O	B-T033
of	O	O	I-T033
privacy	O	O	I-T033
,	O	O	O
certain	O	O	O
attitudes	O	O	B-T041
on	O	O	O
behalf	O	O	O
of	O	O	O
the	O	O	O
staff	O	O	B-T097
and	O	O	O
the	O	O	O
family	O	O	B-T099
,	O	O	O
the	O	O	O
lack	O	O	O
of	O	O	O
a	O	O	O
sexual	O	O	B-T098
partner	O	O	I-T098
,	O	O	O
and	O	O	O
physical	O	O	B-T033
limitations	O	O	I-T033
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
lived	O	O	B-T055
experience	O	O	I-T055
of	O	O	O
sexuality	O	O	B-T053
in	O	O	O
elderly	O	O	B-T098
Spanish	O	O	I-T098
women	O	O	I-T098
residing	O	O	O
in	O	O	O
nursing	O	O	B-T093
homes	O	O	I-T093
.	O	O	O

A	O	O	O
qualitative	O	O	B-T062
phenomenological	O	O	I-T062
approach	O	O	I-T062
was	O	O	O
followed	O	O	O
.	O	O	O

Data	O	O	B-T078
were	O	O	O
collected	O	O	B-T062
over	O	O	O
an	O	O	O
18-	O	O	O
month	O	O	B-T079
period	O	O	I-T079
between	O	O	O
2013	O	O	O
and	O	O	O
2015	O	O	O
.	O	O	O

Purposeful	O	O	O
sampling	O	O	B-T078
was	O	O	O
conducted	O	O	O
with	O	O	O
Spanish	O	O	B-T098
residents	O	O	I-T098
in	O	O	O
nursing	O	O	B-T093
homes	O	O	I-T093
in	O	O	O
Madrid	O	O	B-T083
.	O	O	O

Data	O	O	B-T078
were	O	O	O
collected	O	O	O
using	O	O	O
unstructured	O	O	B-T052
and	O	O	I-T052
semi-structured	O	O	I-T052
interviews	O	O	I-T052
.	O	O	O

The	O	O	O
data	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
thematic	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

Twenty	O	O	O
female	O	O	B-T032
residents	O	O	B-T098
participated	O	O	O
.	O	O	O

Three	O	O	O
main	O	O	O
themes	O	O	B-UnknownType
emerged	O	O	O
from	O	O	O
the	O	O	O
data	O	O	B-T078
:	O	O	O
a	O	O	O
)	O	O	O
expressing	O	O	B-T055
sexuality	O	O	B-T053
,	O	O	O
b	O	O	O
)	O	O	O
sexuality	O	O	O
as	O	O	O
a	O	O	O
duty	O	O	B-T058
and	O	O	O
c	O	O	O
)	O	O	O
respecting	O	O	O
vows	O	O	B-T079
.	O	O	O

Female	O	O	B-T032
residents	O	O	B-T098
reported	O	O	O
key	O	O	O
elements	O	O	O
influencing	O	O	O
how	O	O	O
they	O	O	O
manage	O	O	B-T058
their	O	O	O
sexuality	O	O	B-T053
in	O	O	O
Nursing	O	O	B-T093
Homes	O	O	I-T093
.	O	O	O

These	O	O	O
results	O	O	O
serve	O	O	O
to	O	O	O
improve	O	O	O
our	O	O	O
understanding	O	O	O
regarding	O	O	O
the	O	O	O
expression	O	O	B-T055
of	O	O	O
sexuality	O	O	B-T053
in	O	O	O
older	O	O	B-T032
female	O	O	I-T032
nursing	O	O	B-T093
home	O	O	I-T093
residents	O	O	B-T098
.	O	O	O

-DOCSTART- (27474557)

Xylan-based	O	O	B-T109
temperature	O	O	B-T081
/	O	O	O
pH	O	O	B-T081
sensitive	O	O	B-T169
hydrogels	O	O	B-T122
for	O	O	O
drug	O	O	O
controlled	O	O	O
release	O	O	O

Xylan-based	O	O	B-T109
temperature	O	O	B-T081
/	O	O	O
pH	O	O	B-T081
sensitive	O	O	B-T169
hydrogels	O	O	B-T122
were	O	O	O
prepared	O	O	O
by	O	O	O
the	O	O	O
crosslinking	O	O	B-T044
copolymerization	O	O	I-T044
of	O	O	O
xylan	O	O	B-T109
with	O	O	O
N-isopropylacrylamide	O	O	B-T109
(	O	O	O
NIPAm	O	O	B-T109
)	O	O	O
and	O	O	O
acrylic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
AA	O	O	B-T109
)	O	O	O
using	O	O	O
N	O	O	B-T109
,	O	O	I-T109
Ń-methylenebis-acrylamide	O	O	I-T109
(	O	O	O
MBA	O	O	B-T109
)	O	O	O
as	O	O	O
a	O	O	O
cross-linker	O	O	B-T130
and	O	O	O
2,2-dimethoxy-2-phenylacetophenone	O	O	B-T109
as	O	O	O
a	O	O	O
photoinitiator	O	O	B-T109
via	O	O	O
ultraviolet	O	O	B-T070
irradiation	O	O	I-T070
.	O	O	O

The	O	O	O
influence	O	O	B-T077
of	O	O	O
the	O	O	O
NIPAm	O	O	B-T109
,	O	O	O
AA	O	O	B-T109
and	O	O	O
MBA	O	O	B-T109
amount	O	O	O
on	O	O	O
properties	O	O	O
of	O	O	O
xylan-based	O	O	B-T109
hydrogels	O	O	B-T122
was	O	O	O
discussed	O	O	O
.	O	O	O

The	O	O	O
morphology	O	O	B-T080
and	O	O	O
interactions	O	O	B-T169
of	O	O	O
hydrogels	O	O	B-T122
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
SEM	O	O	B-T059
and	O	O	O
FTIR	O	O	B-T062
.	O	O	O

The	O	O	O
lower	O	O	B-T081
critical	O	O	I-T081
solution	O	O	I-T081
temperature	O	O	I-T081
(	O	O	O
LCST	O	O	B-T081
)	O	O	O
of	O	O	O
hydrogels	O	O	B-T122
was	O	O	O
investigated	O	O	B-T169
by	O	O	O
DSC	O	O	B-T059
.	O	O	O

The	O	O	O
results	O	O	B-T033
indicated	O	O	O
that	O	O	O
the	O	O	O
LCST	O	O	B-T081
of	O	O	O
hydrogels	O	O	B-T122
emerged	O	O	O
at	O	O	O
around	O	O	O
34	O	O	O
°	O	O	O
C	O	O	O
and	O	O	O
increased	O	O	O
with	O	O	O
increasing	O	O	O
the	O	O	O
AA	O	O	B-T109
content	O	O	O
.	O	O	O

The	O	O	O
drug	O	O	B-T121
encapsulation	O	O	B-T067
efficiency	O	O	B-T081
of	O	O	O
as-prepared	O	O	O
hydrogels	O	O	B-T122
reached	O	O	O
to	O	O	O
97.60	O	O	O
%	O	O	O
and	O	O	O
the	O	O	O
cumulative	O	O	B-T080
release	O	O	B-T070
rate	O	O	B-T081
of	O	O	O
acetylsalicylic	O	O	B-T109
acid	O	O	I-T109
was	O	O	O
90.12	O	O	O
%	O	O	O
and	O	O	O
26.35	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
intestinal	O	O	B-T023
and	O	O	O
gastric	O	O	B-T031
fluid	O	O	I-T031
,	O	O	O
respectively	O	O	O
.	O	O	O

Xylan-based	O	O	B-T109
hydrogels	O	O	B-T122
were	O	O	O
proved	O	O	O
to	O	O	O
be	O	O	O
biocompatible	O	O	B-T080
with	O	O	O
NIH3T3	O	O	B-T025
cell	O	O	I-T025
by	O	O	O
MTT	O	O	B-T062
assay	O	O	I-T062
and	O	O	O
showed	O	O	O
the	O	O	O
promising	O	O	O
application	O	O	O
as	O	O	O
drug	O	O	B-T122
carriers	O	O	I-T122
for	O	O	O
the	O	O	O
intestinal	O	O	B-T023
-	O	O	O
targeted	O	O	B-T169
oral	O	O	B-T061
drug	O	O	I-T061
delivery	O	O	I-T061
.	O	O	O

-DOCSTART- (27474570)

Isolation	O	O	B-T059
and	O	O	O
prebiotic	O	O	B-T109
activity	O	O	B-T169
of	O	O	O
water-soluble	O	O	B-T130
polysaccharides	O	O	B-T109
fractions	O	O	B-T081
from	O	O	O
the	O	O	O
bamboo	O	O	B-T168
shoots	O	O	I-T168
(	O	O	O
Phyllostachys	O	O	B-T002
praecox	O	O	I-T002
)	O	O	O

The	O	O	O
water-soluble	O	O	B-T130
polysaccharides	O	O	B-T109
from	O	O	O
bamboo	O	O	B-T168
shoots	O	O	I-T168
(	O	O	O
Phyllostachys	O	O	B-T002
praecox	O	O	I-T002
)	O	O	O
(	O	O	O
WBP	O	O	B-T109
)	O	O	O
were	O	O	O
isolated	O	O	B-T169
,	O	O	O
and	O	O	O
the	O	O	O
characterizations	O	O	B-T185
as	O	O	O
well	O	O	O
as	O	O	O
prebiotic	O	O	B-T109
activities	O	O	B-T169
were	O	O	O
investigated	O	O	B-T169
.	O	O	O

The	O	O	O
yield	O	O	B-T081
of	O	O	O
WBP	O	O	B-T109
was	O	O	O
7.58±0.31	O	O	O
%	O	O	O
under	O	O	O
optimal	O	O	O
hot-water	O	O	B-T197
extraction	O	O	B-T059
conditions	O	O	O
.	O	O	O

Two	O	O	O
fractions	O	O	B-T081
,	O	O	O
i.e.	O	O	O
,	O	O	O
WBP-1	O	O	B-T109
and	O	O	O
WBP-2	O	O	B-T109
with	O	O	O
molecular	O	O	B-T081
weight	O	O	I-T081
of	O	O	O
83.50kDa	O	O	O
and	O	O	O
80.08kDa	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
were	O	O	O
purified	O	O	O
by	O	O	O
chromatography	O	O	B-T059
.	O	O	O

Both	O	O	O
the	O	O	O
polysaccharides	O	O	B-T109
fractions	O	O	B-T081
were	O	O	O
identified	O	O	O
as	O	O	O
heteropolysaccharides-protein	O	O	B-T104
complexes	O	O	I-T104
composed	O	O	O
of	O	O	O
15	O	O	O
kinds	O	O	O
of	O	O	O
common	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
in	O	O	O
protein	O	O	B-T116
part	O	O	O
and	O	O	O
rhamnose	O	O	B-T109
,	O	O	O
arabinose	O	O	B-T109
,	O	O	O
xylose	O	O	B-T109
,	O	O	O
mannose	O	O	B-T109
,	O	O	O
glucose	O	O	B-T109
and	O	O	O
galactose	O	O	B-T109
in	O	O	O
different	O	O	O
molar	O	O	B-T081
ratios	O	O	I-T081
in	O	O	O
polysaccharide	O	O	B-T109
part	O	O	O
.	O	O	O

The	O	O	O
existence	O	O	O
of	O	O	O
α-	O	O	B-T078
and	O	O	O
β-glycosidic	O	O	B-T078
linkages	O	O	I-T078
between	O	O	O
the	O	O	O
sugar	O	O	B-T109
units	O	O	O
was	O	O	O
confirmed	O	O	O
by	O	O	O
FTIR	O	O	B-T062
and	O	O	O
NMR	O	O	B-T060
spectra	O	O	I-T060
.	O	O	O

Compared	O	O	O
with	O	O	O
the	O	O	O
blank	O	O	O
control	O	O	O
and	O	O	O
the	O	O	O
reference	O	O	O
of	O	O	O
FOS	O	O	O
,	O	O	O
WBP-1	O	O	B-T109
and	O	O	O
WBP-2	O	O	B-T109
significantly	O	O	O
increased	O	O	O
the	O	O	O
numbers	O	O	O
of	O	O	O
Bifidobacterium	O	O	B-T007
adolescentis	O	O	I-T007
and	O	O	O
Bifidobacterium	O	O	B-T007
bifidum	O	O	I-T007
(	O	O	O
P<0.05	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
contributed	O	O	O
to	O	O	O
the	O	O	O
production	O	O	B-T169
of	O	O	O
organic	O	O	B-T109
acids	O	O	I-T109
,	O	O	O
suggesting	O	O	O
that	O	O	O
the	O	O	O
polysaccharides	O	O	B-T109
have	O	O	O
potential	O	O	B-T080
prebiotic	O	O	B-T109
properties	O	O	B-T080
.	O	O	O

-DOCSTART- (27478234)

Evaluation	O	O	O
of	O	O	O
nutraceutical	O	O	B-T033
and	O	O	O
antinutritional	O	O	B-T033
properties	O	O	I-T033
in	O	O	O
barnyard	O	O	B-T002
and	O	O	O
finger	O	O	B-T168
millet	O	O	I-T168
varieties	O	O	B-T077
grown	O	O	O
in	O	O	O
Himalayan	O	O	O
region	O	O	O

Five	O	O	O
elite	O	O	O
varieties	O	O	B-T077
of	O	O	O
barnyard	O	O	B-T002
(	O	O	O
Echinochloa	O	O	B-T002
frumentacea	O	O	I-T002
)	O	O	O
and	O	O	O
finger	O	O	B-T002
(	O	O	O
Eleusine	O	O	B-T002
coracana	O	O	I-T002
)	O	O	O
growing	O	O	O
at	O	O	O
northwestern	O	O	B-UnknownType
Himalaya	O	O	I-UnknownType
were	O	O	O
investigated	O	O	B-T169
for	O	O	O
nutraceutical	O	O	B-T033
and	O	O	O
antinutritional	O	O	B-T033
properties	O	O	I-T033
.	O	O	O

Barnyard	O	O	B-T168
millet	O	O	I-T168
contained	O	O	O
higher	O	O	O
amount	O	O	B-T081
of	O	O	O
crude	O	O	B-T109
fiber	O	O	I-T109
,	O	O	O
total	O	O	B-T168
dietary	O	O	I-T168
fiber	O	O	I-T168
,	O	O	O
tryptophan	O	O	B-T116
content	O	O	B-T077
,	O	O	O
total	O	O	B-T109
carotenoids	O	O	I-T109
,	O	O	O
α-tocopherol	O	O	B-T127
compared	O	O	O
to	O	O	O
the	O	O	O
finger	O	O	B-T168
millet	O	O	I-T168
whereas	O	O	O
the	O	O	O
finger	O	O	O
millet	O	O	O
contains	O	O	O
higher	O	O	O
amount	O	O	O
of	O	O	O
methionine	O	O	B-T116
and	O	O	O
ascorbic	O	O	B-T127
acid	O	O	I-T127
as	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
barnyard	O	O	B-T168
millet	O	O	I-T168
.	O	O	O

The	O	O	O
secondary	O	O	B-T123
metabolites	O	O	I-T123
of	O	O	O
biological	O	O	B-T038
functions	O	O	I-T038
were	O	O	O
analyzed	O	O	O
and	O	O	O
found	O	O	O
that	O	O	O
barnyard	O	O	B-T168
millet	O	O	I-T168
contained	O	O	O
the	O	O	O
higher	O	O	O
amount	O	O	B-T081
of	O	O	O
polyphenols	O	O	B-T109
,	O	O	O
tannins	O	O	B-T109
and	O	O	O
ortho-dihydroxy	O	O	B-T109
phenol	O	O	I-T109
content	O	O	B-T077
compared	O	O	O
to	O	O	O
finger	O	O	B-T168
millet	O	O	I-T168
.	O	O	O

Among	O	O	O
antinutitional	O	O	B-T109
compounds	O	O	I-T109
barnyard	O	O	B-T168
millet	O	O	I-T168
contained	O	O	O
lower	O	O	O
phytic	O	O	B-T109
acid	O	O	I-T109
content	O	O	B-T077
compare	O	O	O
to	O	O	O
finger	O	O	B-T168
millet	O	O	I-T168
whereas	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
in	O	O	O
trypsin	O	O	B-T044
inhibition	O	O	I-T044
activity	O	O	I-T044
of	O	O	O
barnyard	O	O	O
millet	O	O	O
and	O	O	O
finger	O	O	O
millet	O	O	O
varieties	O	O	B-T077
were	O	O	O
found	O	O	O
.	O	O	O

Barnyard	O	O	B-T168
millet	O	O	I-T168
contained	O	O	O
higher	O	O	O
acid	O	O	B-T116
phosphatase	O	O	I-T116
,	O	O	O
α-galactosidase	O	O	B-T116
and	O	O	O
α-amylase	O	O	B-T044
inhibitor	O	O	I-T044
activity	O	O	I-T044
compared	O	O	O
to	O	O	O
finger	O	O	B-T168
millet	O	O	I-T168
.	O	O	O

Finger	O	O	B-T168
millet	O	O	I-T168
seeds	O	O	I-T168
contained	O	O	O
about	O	O	O
10	O	O	O
-	O	O	O
13	O	O	O
folds	O	O	O
higher	O	O	O
calcium	O	O	B-T121
content	O	O	B-T077
and	O	O	O
double	O	O	O
amount	O	O	B-T081
of	O	O	O
manganese	O	O	B-T123
content	O	O	O
in	O	O	O
comparison	O	O	O
to	O	O	O
barnyard	O	O	B-T168
millet	O	O	I-T168
seeds	O	O	I-T168
.	O	O	O

Present	O	O	O
study	O	O	O
suggests	O	O	O
that	O	O	O
barnyard	O	O	B-T168
millet	O	O	I-T168
varieties	O	O	B-T077
studied	O	O	O
under	O	O	O
present	O	O	O
investigation	O	O	O
were	O	O	O
found	O	O	O
nutritionally	O	O	O
superior	O	O	O
compared	O	O	O
to	O	O	O
finger	O	O	B-T168
millet	O	O	I-T168
varieties	O	O	O
.	O	O	O

-DOCSTART- (27481922)

Polymorphisms	O	O	B-T086
in	O	O	O
Inflammatory	O	O	B-T169
Mediator	O	O	B-T028
Genes	O	O	I-T028
and	O	O	O
Risk	O	O	B-T078
of	O	O	O
Preeclampsia	O	O	B-T046
in	O	O	O
Taiyuan	O	O	B-UnknownType
,	O	O	O
China	O	O	O

Excessive	O	O	B-T080
maternal	O	O	B-T033
inflammatory	O	O	B-T046
response	O	O	I-T046
is	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
preeclampsia	O	O	B-T046
.	O	O	O

Few	O	O	O
epidemiologic	O	O	B-T062
studies	O	O	B-T062
have	O	O	O
investigated	O	O	B-T169
the	O	O	O
associations	O	O	B-T080
between	O	O	O
genetic	O	O	B-T070
variations	O	O	I-T070
in	O	O	O
the	O	O	O
inflammatory	O	O	B-T169
mediator	O	O	B-T028
genes	O	O	I-T028
and	O	O	O
preeclampsia	O	O	B-T046
risk	O	O	B-T078
,	O	O	O
and	O	O	O
these	O	O	O
studies	O	O	O
have	O	O	O
reached	O	O	O
inconsistent	O	O	O
results	O	O	O
.	O	O	O

We	O	O	O
examined	O	O	O
31	O	O	O
single-nucleotide	O	O	B-T086
polymorphisms	O	O	I-T086
in	O	O	O
IL-1A	O	O	B-T028
,	O	O	O
IL-1B	O	O	B-T028
,	O	O	O
IL-1R1	O	O	B-T116
,	O	O	O
IL-2RA	O	O	B-T116
,	O	O	O
IL-5RA	O	O	B-T116
,	O	O	O
IL-6	O	O	B-T028
,	O	O	O
IL-6R	O	O	B-T116
,	O	O	O
TNFSF11	O	O	B-T028
,	O	O	O
TNFRSF11A	O	O	B-T028
,	O	O	O
IL-28RA	O	O	B-T028
,	O	O	O
IRAK4	O	O	B-T028
,	O	O	O
and	O	O	O
KIT	O	O	B-T028
genes	O	O	I-T028
and	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
preeclampsia	O	O	B-T046
and	O	O	O
its	O	O	O
clinical	O	O	B-T080
subtypes	O	O	B-T185
in	O	O	O
a	O	O	O
nested	O	O	B-T062
case-control	O	O	I-T062
study	O	O	I-T062
including	O	O	O
203	O	O	O
preeclampsia	O	O	O
cases	O	O	B-T077
and	O	O	O
233	O	O	O
controls	O	O	B-T096
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
IL-1R1	O	O	B-T116
,	O	O	O
IL-5RA	O	O	B-T116
,	O	O	O
IL-6R	O	O	B-T116
,	O	O	O
and	O	O	O
TNFSF11	O	O	B-T028
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
risk	O	O	B-T078
of	O	O	O
preeclampsia	O	O	B-T046
.	O	O	O

Although	O	O	O
the	O	O	O
significant	O	O	B-T078
associations	O	O	B-T080
observed	O	O	O
for	O	O	O
preeclampsia	O	O	B-T046
overall	O	O	B-T080
were	O	O	O
mainly	O	O	O
seen	O	O	O
for	O	O	O
late-onset	O	O	B-T079
preeclampsia	O	O	O
and	O	O	O
severe	O	O	B-T080
preeclampsia	O	O	O
,	O	O	O
IL-6R	O	O	B-T116
(	O	O	O
rs2229238	O	O	B-T170
)	O	O	O
and	O	O	O
TNFSF11	O	O	B-T028
(	O	O	O
rs9525643	O	O	B-T170
)	O	O	O
polymorphisms	O	O	B-T086
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
risk	O	O	B-T078
of	O	O	O
early-onset	O	O	O
preeclampsia	O	O	O
.	O	O	O

TNFSF11	O	O	B-T028
(	O	O	O
rs2200287	O	O	B-T170
and	O	O	O
rs2148072	O	O	B-T170
)	O	O	O
polymorphisms	O	O	B-T086
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
risk	O	O	B-T078
of	O	O	O
mild	O	O	O
preeclampsia	O	O	B-T046
.	O	O	O

Our	O	O	O
study	O	O	B-T062
provided	O	O	O
the	O	O	O
first	O	O	O
evidence	O	O	B-T078
that	O	O	O
genetic	O	O	B-T070
variations	O	O	I-T070
in	O	O	O
inflammatory	O	O	B-T169
mediator	O	O	B-T028
genes	O	O	I-T028
IL-1R1	O	O	B-T116
,	O	O	O
IL-6R	O	O	B-T116
,	O	O	O
TNFSF11	O	O	B-T028
,	O	O	O
and	O	O	O
IL-5RA	O	O	B-T116
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
preeclampsia	O	O	B-T046
risk	O	O	B-T078
,	O	O	O
and	O	O	O
the	O	O	O
risk	O	O	O
varied	O	O	O
by	O	O	O
preeclampsia	O	O	O
subtypes	O	O	B-T185
.	O	O	O

-DOCSTART- (27484091)

A	O	O	O
closer	O	O	O
look	O	O	O
at	O	O	O
school	O	O	B-T073
bonding	O	O	B-T041
among	O	O	O
African	O	O	B-T098
American	O	O	I-T098
adolescents	O	O	B-T100
in	O	O	O
low-income	O	O	B-T098
communities	O	O	I-T098
:	O	O	O
A	O	O	O
latent	O	O	O
class	O	O	O
analysis	O	O	O

Positive	O	O	B-T033
school	O	O	B-T073
bonding	O	O	B-T041
is	O	O	O
a	O	O	O
significant	O	O	B-T078
precursor	O	O	B-T078
to	O	O	O
students	O	O	B-T098
'	O	O	O
school	O	O	O
success	O	O	B-T054
.	O	O	O

However	O	O	O
,	O	O	O
African	O	O	B-T098
American	O	O	I-T098
youth	O	O	B-T100
report	O	O	O
lower	O	O	B-T080
school	O	O	B-T073
success	O	O	B-T054
compared	O	O	O
with	O	O	O
their	O	O	O
White	O	O	B-T098
counterparts	O	O	I-T098
.	O	O	O

This	O	O	O
study	O	O	B-T062
examined	O	O	O
correlates	O	O	B-T080
of	O	O	O
school	O	O	B-T073
bonding	O	O	B-T041
among	O	O	O
633	O	O	O
African	O	O	B-T098
American	O	O	I-T098
youth	O	O	B-T100
who	O	O	O
were	O	O	O
recruited	O	O	B-T052
from	O	O	O
community	O	O	B-T096
settings	O	O	I-T096
in	O	O	O
Chicago	O	O	B-T083
.	O	O	O

Major	O	O	B-T080
findings	O	O	B-T033
indicated	O	O	O
that	O	O	O
negative	O	O	B-T033
peer	O	O	I-T033
norms	O	O	I-T033
,	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
community	O	O	B-T033
violence	O	O	I-T033
,	O	O	O
and	O	O	O
poor	O	O	B-T080
mental	O	O	B-T041
health	O	O	I-T041
were	O	O	O
negatively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
school	O	O	B-T073
bonding	O	O	B-T041
,	O	O	O
while	O	O	O
parental	O	O	B-UnknownType
monitoring	O	O	I-UnknownType
,	O	O	O
positive	O	O	B-T033
self-regard	O	O	I-T033
,	O	O	O
and	O	O	O
future	O	O	B-T079
orientation	O	O	B-T041
were	O	O	O
correlated	O	O	O
with	O	O	O
higher	O	O	B-T080
school	O	O	O
motivation	O	O	B-T041
.	O	O	O

Students	O	O	B-T098
classified	O	O	B-T185
as	O	O	O
having	O	O	O
high	O	O	B-T080
or	O	O	O
moderate	O	O	B-T080
school	O	O	B-T073
bonding	O	O	B-T041
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
live	O	O	B-T052
with	O	O	O
both	O	O	O
parents	O	O	B-T099
,	O	O	O
experience	O	O	B-T041
higher	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
parental	O	O	B-UnknownType
monitoring	O	O	I-UnknownType
,	O	O	O
and	O	O	O
exhibit	O	O	B-T033
positive	O	O	I-T033
self-regard	O	O	I-T033
.	O	O	O

Implications	O	O	O
are	O	O	O
discussed	O	O	O
in	O	O	O
view	O	O	O
of	O	O	O
these	O	O	O
findings	O	O	B-T033
.	O	O	O

-DOCSTART- (27487593)

DEPRESSION	O	O	B-T048
,	O	O	O
ANXIETY	O	O	B-T048
,	O	O	O
STRESS	O	O	B-T048
,	O	O	O
AND	O	O	O
THEIR	O	O	O
ASSOCIATED	O	O	B-T080
FACTORS	O	O	B-T169
AMONG	O	O	O
CORPS	O	O	B-T098
MEMBERS	O	O	I-T098
SERVING	O	O	O
IN	O	O	O
KEBBI	O	O	O
STATE	O	O	O

Depression	O	O	B-T048
,	O	O	O
anxiety	O	O	B-T048
and	O	O	O
stress	O	O	B-T048
,	O	O	O
are	O	O	O
not	O	O	O
only	O	O	O
health	O	O	B-T078
problems	O	O	I-T033
by	O	O	O
themselves	O	O	O
,	O	O	O
but	O	O	O
also	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
other	O	O	O
negative	O	O	B-T033
health	O	O	O
consequences	O	O	B-T169
.	O	O	O

The	O	O	O
national	O	O	B-T092
youth	O	O	I-T092
service	O	O	I-T092
is	O	O	O
usually	O	O	O
characterized	O	O	B-T052
by	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
new	O	O	O
challenges	O	O	O
and	O	O	O
experiences	O	O	B-T041
which	O	O	O
may	O	O	O
require	O	O	O
life	O	O	B-T054
style	O	O	I-T054
adjustments	O	O	B-T055
by	O	O	O
the	O	O	O
corps	O	O	B-T098
member	O	O	I-T098
.	O	O	O

However	O	O	O
,	O	O	O
no	O	O	O
previous	O	O	O
study	O	O	O
on	O	O	O
psychological	O	O	B-T041
factors	O	O	I-T041
has	O	O	O
been	O	O	O
conducted	O	O	O
among	O	O	O
corps	O	O	B-T098
members	O	O	I-T098
.	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
conducted	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
depression	O	O	B-T048
,	O	O	O
anxiety	O	O	B-T048
and	O	O	O
,	O	O	O
stress	O	O	B-T048
and	O	O	O
their	O	O	O
associated	O	O	B-T080
factors	O	O	B-T169
among	O	O	O
corps	O	O	B-T098
members	O	O	I-T098
serving	O	O	O
in	O	O	O
Kebbi	O	O	B-UnknownType
state	O	O	I-UnknownType
.	O	O	O

A	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
was	O	O	O
conducted	O	O	O
among	O	O	O
264	O	O	O
corps	O	O	B-T098
members	O	O	I-T098
from	O	O	O
four	O	O	O
local	O	O	B-UnknownType
government	O	O	I-UnknownType
areas	O	O	I-UnknownType
of	O	O	O
the	O	O	O
state	O	O	B-T083
.	O	O	O

Selection	O	O	O
of	O	O	O
the	O	O	O
local	O	O	B-UnknownType
government	O	O	I-UnknownType
areas	O	O	I-UnknownType
and	O	O	O
the	O	O	O
individual	O	O	O
participants	O	O	B-T098
was	O	O	O
by	O	O	O
simple	O	O	B-T062
random	O	O	I-T062
sampling	O	O	I-T062
.	O	O	O

Data	O	O	B-T078
was	O	O	O
collected	O	O	O
from	O	O	O
May	O	O	B-T079
to	O	O	O
June	O	O	B-T079
2014	O	O	O
using	O	O	O
a	O	O	O
self-administered	O	O	B-T170
questionnaire	O	O	I-T170
.	O	O	O

Data	O	O	B-T057
analysis	O	O	I-T057
used	O	O	O
chi-square	O	O	B-T170
test	O	O	I-T170
to	O	O	O
identify	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
categorical	O	O	B-T080
variables	O	O	I-T080
and	O	O	O
multivariate	O	O	B-T062
logistic	O	O	I-T062
regression	O	O	I-T062
to	O	O	O
identify	O	O	O
the	O	O	O
independent	O	O	O
factors	O	O	B-T169
for	O	O	O
depression	O	O	B-T048
,	O	O	O
anxiety	O	O	B-T048
and	O	O	O
stress	O	O	B-T048
each	O	O	O
.	O	O	O

The	O	O	O
response	O	O	B-T079
rate	O	O	I-T079
was	O	O	O
97	O	O	O
%	O	O	O
.	O	O	O

Most	O	O	O
of	O	O	O
the	O	O	O
respondents	O	O	B-T098
were	O	O	O
males	O	O	B-T032
(	O	O	O
63.6	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
single	O	O	B-T098
(	O	O	O
85.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
above	O	O	O
20	O	O	O
years	O	O	B-T079
of	O	O	O
age	O	O	B-T032
(	O	O	O
71.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
overall	O	O	O
prevalences	O	O	B-T081
of	O	O	O
depression	O	O	B-T048
,	O	O	O
anxiety	O	O	B-T048
and	O	O	O
stress	O	O	B-T048
among	O	O	O
the	O	O	O
respondents	O	O	B-T098
were	O	O	O
36.4	O	O	O
%	O	O	O
,	O	O	O
54.5	O	O	O
%	O	O	O
and	O	O	O
18.2	O	O	O
%	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
independent	O	O	O
factors	O	O	B-T169
for	O	O	O
depression	O	O	B-T048
were	O	O	O
;	O	O	O
being	O	O	O
from	O	O	O
the	O	O	O
North	O	O	B-T083
central	O	O	I-T083
(	O	O	O
OR	O	O	B-T081
=	O	O	O
5.99	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
2.194	O	O	O
-	O	O	O
16.354	O	O	O
)	O	O	O
or	O	O	O
South-south	O	O	B-T083
;	O	O	O
and	O	O	O
the	O	O	O
perception	O	O	B-T041
of	O	O	O
earning	O	O	B-T081
enough	O	O	O
income	O	O	B-T081
(	O	O	O
OR	O	O	O
=	O	O	O
2.987	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.062	O	O	O
-	O	O	O
8.400	O	O	O
)	O	O	O
.	O	O	O

For	O	O	O
anxiety	O	O	B-T048
,	O	O	O
male	O	O	B-T032
gender	O	O	I-T032
(	O	O	O
OR	O	O	B-T081
=	O	O	O
0.411	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.169	O	O	O
-	O	O	O
0.999	O	O	O
)	O	O	O
;	O	O	O
and	O	O	O
being	O	O	O
from	O	O	O
the	O	O	O
North	O	O	B-T083
central	O	O	I-T083
were	O	O	O
significant	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
(	O	O	O
OR	O	O	O
=	O	O	O
3.731	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.450	O	O	O
-	O	O	O
9.599	O	O	O
)	O	O	O
.	O	O	O

Being	O	O	O
above	O	O	O
26	O	O	O
years	O	O	B-T079
of	O	O	O
age	O	O	B-T032
was	O	O	O
an	O	O	O
independent	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
stress	O	O	B-T048
(	O	O	O
OR	O	O	B-T081
=	O	O	O
0.083	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.018	O	O	O
-	O	O	O
0.381	O	O	O
)	O	O	O
.	O	O	O

Also	O	O	O
,	O	O	O
those	O	O	O
who	O	O	O
had	O	O	O
ever	O	O	O
schooled	O	O	B-T033
outside	O	O	O
their	O	O	O
towns	O	O	B-T083
of	O	O	O
residence	O	O	B-T082
were	O	O	O
less	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
stressed	O	O	B-T041
compared	O	O	O
to	O	O	O
those	O	O	O
who	O	O	O
had	O	O	O
never	O	O	O
(	O	O	O
OR	O	O	B-T081
=	O	O	O
0.30	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.110	O	O	O
-	O	O	O
0.855	O	O	O
)	O	O	O
.	O	O	O

All	O	O	O
other	O	O	O
factors	O	O	B-T169
did	O	O	O
not	O	O	O
show	O	O	O
any	O	O	O
significant	O	O	B-T080
association	O	O	I-T080
with	O	O	O
any	O	O	O
of	O	O	O
the	O	O	O
outcome	O	O	B-T080
variables	O	O	I-T080
in	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
,	O	O	O
the	O	O	O
prevalences	O	O	B-T081
of	O	O	O
depression	O	O	B-T048
,	O	O	O
anxiety	O	O	B-T048
and	O	O	O
stress	O	O	B-T048
are	O	O	O
high	O	O	B-T080
among	O	O	O
corps	O	O	B-T098
members	O	O	I-T098
serving	O	O	O
in	O	O	O
Kebbi	O	O	B-UnknownType
state	O	O	I-UnknownType
.	O	O	O

There	O	O	O
is	O	O	O
need	O	O	O
to	O	O	O
expand	O	O	O
the	O	O	O
scope	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
to	O	O	O
a	O	O	O
national	O	O	B-T082
level	O	O	I-T082
so	O	O	O
as	O	O	O
to	O	O	O
get	O	O	O
a	O	O	O
bigger	O	O	O
picture	O	O	O
of	O	O	O
the	O	O	O
problem	O	O	B-T033
.	O	O	O

-DOCSTART- (27489015)

Trans-oral	O	O	B-T082
fine	O	O	B-T060
needle	O	O	I-T060
aspiration	O	O	I-T060
cytology	O	O	I-T060
in	O	O	O
cervical	O	O	B-T023
(	O	O	I-T023
C1	O	O	I-T023
and	O	O	I-T023
C2	O	O	I-T023
)	O	O	I-T023
vertebral	O	O	I-T023
lesions	O	O	B-T033
:	O	O	O
a	O	O	O
novel	O	O	O
diagnostic	O	O	O
approach	O	O	O

Fine	O	O	B-T060
needle	O	O	I-T060
aspiration	O	O	I-T060
(	O	O	I-T060
FNA	O	O	I-T060
)	O	O	I-T060
cytology	O	O	I-T060
is	O	O	O
a	O	O	O
relatively	O	O	O
non-invasive	O	O	B-T169
method	O	O	O
for	O	O	O
diagnosing	O	O	B-T033
both	O	O	O
superficial	O	O	B-T033
and	O	O	O
deep-seated	O	O	B-T191
neoplastic	O	O	I-T191
and	O	O	O
non-neoplastic	O	O	B-T033
lesions	O	O	I-T033
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
evaluated	O	O	O
the	O	O	O
diagnostic	O	O	B-T169
utility	O	O	I-T169
of	O	O	O
trans-oral	O	O	B-T082
FNA	O	O	B-T060
in	O	O	O
cervical	O	O	B-T023
(	O	O	I-T023
C1	O	O	I-T023
and	O	O	I-T023
C2	O	O	I-T023
)	O	O	I-T023
vertebral	O	O	I-T023
and	O	O	O
paravertebral	O	O	B-T029
lesions	O	O	B-T033
.	O	O	O

Eighteen	O	O	O
FNA	O	O	B-T060
cases	O	O	O
of	O	O	O
cervical	O	O	B-T023
vertebral	O	O	I-T023
and	O	O	O
paravertebral	O	O	B-T029
lesions	O	O	B-T033
performed	O	O	O
by	O	O	O
a	O	O	O
trans-oral	O	O	B-T082
route	O	O	I-T082
without	O	O	O
any	O	O	O
image-guidance	O	O	B-T058
between	O	O	O
1995	O	O	O
and	O	O	O
2014	O	O	O
were	O	O	O
retrieved	O	O	O
from	O	O	O
the	O	O	O
archives	O	O	O
of	O	O	O
the	O	O	O
cytology	O	O	B-T091
department	O	O	B-T092
at	O	O	O
PGIMER	O	O	B-T092
,	O	O	O
Chandigarh	O	O	B-UnknownType
and	O	O	O
reviewed	O	O	O
.	O	O	O

Out	O	O	O
of	O	O	O
18	O	O	O
cases	O	O	O
,	O	O	O
a	O	O	O
definite	O	O	O
diagnosis	O	O	B-T033
was	O	O	O
given	O	O	O
in	O	O	O
15	O	O	O
cases	O	O	O
(	O	O	O
83.3	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
commonest	O	O	O
diagnosis	O	O	B-T033
seen	O	O	O
was	O	O	O
granulomatous	O	O	B-T046
inflammation	O	O	I-T046
consistent	O	O	O
with	O	O	O
tuberculosis	O	O	B-T047
(	O	O	O
33.3	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Trans-oral	O	O	B-T082
FNA	O	O	B-T060
is	O	O	O
a	O	O	O
quick	O	O	O
,	O	O	O
inexpensive	O	O	O
and	O	O	O
relatively	O	O	O
safe	O	O	O
outpatient	O	O	B-T061
procedure	O	O	I-T061
for	O	O	O
sampling	O	O	O
C1	O	O	B-T023
and	O	O	I-T023
C2	O	O	I-T023
vertebral	O	O	I-T023
and	O	O	O
paravertebral	O	O	B-T029
lesions	O	O	B-T033
,	O	O	O
which	O	O	O
are	O	O	O
clinically	O	O	B-T201
and	O	O	O
radiologically	O	O	B-T091
difficult	O	O	O
to	O	O	O
approach	O	O	O
.	O	O	O

It	O	O	O
helps	O	O	O
in	O	O	O
the	O	O	O
early	O	O	B-T060
diagnosis	O	O	I-T060
and	O	O	O
management	O	O	B-T058
of	O	O	I-T058
these	O	O	I-T058
patients	O	O	I-T058
.	O	O	O

-DOCSTART- (27491687)

Neonatal	O	O	B-T047
infections	O	O	I-T047
:	O	O	O
Case	O	O	B-T170
definition	O	O	I-T170
and	O	O	O
guidelines	O	O	B-T170
for	O	O	O
data	O	O	B-T062
collection	O	O	I-T062
,	O	O	O
analysis	O	O	B-T062
,	O	O	O
and	O	O	O
presentation	O	O	B-T078
of	O	O	O
immunisation	O	O	B-T061
safety	O	O	O
data	O	O	O

Maternal	O	O	B-T033
vaccination	O	O	B-T061
is	O	O	O
an	O	O	O
important	O	O	O
area	O	O	O
of	O	O	O
research	O	O	B-T062
and	O	O	O
requires	O	O	O
appropriate	O	O	O
and	O	O	O
internationally	O	O	O
comparable	O	O	O
definitions	O	O	B-T170
and	O	O	O
safety	O	O	B-T170
standards	O	O	I-T170
.	O	O	O

The	O	O	O
GAIA	O	O	B-T097
group	O	O	I-T097
,	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
Brighton	O	O	B-T097
Collaboration	O	O	I-T097
was	O	O	O
created	O	O	O
with	O	O	O
the	O	O	O
mandate	O	O	O
of	O	O	O
proposing	O	O	O
standardised	O	O	O
definitions	O	O	B-T170
applicable	O	O	O
to	O	O	O
maternal	O	O	B-T033
vaccine	O	O	B-T129
research	O	O	B-T062
.	O	O	O

This	O	O	O
study	O	O	B-T062
proposes	O	O	O
international	O	O	O
definitions	O	O	B-T170
for	O	O	O
neonatal	O	O	B-T047
infections	O	O	I-T047
.	O	O	O

The	O	O	O
neonatal	O	O	B-T169
infections	O	O	I-T047
GAIA	O	O	B-T097
working	O	O	B-T098
group	O	O	I-T098
performed	O	O	O
a	O	O	O
literature	O	O	B-T170
review	O	O	B-T169
using	O	O	O
Medline	O	O	B-T170
,	O	O	O
EMBASE	O	O	B-T170
and	O	O	O
the	O	O	O
Cochrane	O	O	B-T169
collaboration	O	O	I-T169
and	O	O	O
collected	O	O	O
definitions	O	O	B-T170
in	O	O	O
use	O	O	O
in	O	O	O
neonatal	O	O	O
and	O	O	O
public	O	O	B-T169
health	O	O	I-T169
networks	O	O	I-T169
.	O	O	O

The	O	O	O
common	O	O	O
criteria	O	O	B-T078
derived	O	O	B-T080
from	O	O	O
the	O	O	O
extensive	O	O	O
search	O	O	O
formed	O	O	O
the	O	O	O
basis	O	O	O
for	O	O	O
a	O	O	O
consensus	O	O	B-T054
process	O	O	I-T054
that	O	O	O
resulted	O	O	O
in	O	O	O
three	O	O	O
separate	O	O	O
definitions	O	O	B-T170
for	O	O	O
neonatal	O	O	B-T100
blood	O	O	B-T046
stream	O	O	I-T046
infections	O	O	I-T046
(	O	O	O
BSI	O	O	B-T046
)	O	O	O
,	O	O	O
meningitis	O	O	B-T047
and	O	O	O
lower	O	O	B-T047
respiratory	O	O	I-T047
tract	O	O	I-T047
infections	O	O	I-T047
(	O	O	O
LRTI	O	O	B-T047
)	O	O	O
.	O	O	O

For	O	O	O
each	O	O	O
definition	O	O	B-T170
three	O	O	O
levels	O	O	O
of	O	O	O
evidence	O	O	O
are	O	O	O
proposed	O	O	O
to	O	O	O
ensure	O	O	O
the	O	O	O
applicability	O	O	O
of	O	O	O
the	O	O	O
definitions	O	O	B-T170
to	O	O	O
different	O	O	O
settings	O	O	O
.	O	O	O

Recommendations	O	O	O
about	O	O	O
data	O	O	B-T062
collection	O	O	I-T062
,	O	O	O
analysis	O	O	B-T062
and	O	O	O
presentation	O	O	B-T078
are	O	O	O
presented	O	O	O
and	O	O	O
harmonized	O	O	B-T062
with	O	O	O
the	O	O	O
Brighton	O	O	B-T097
Collaboration	O	O	I-T097
and	O	O	O
GAIA	O	O	B-T097
format	O	O	B-T170
and	O	O	O
other	O	O	O
existing	O	O	O
international	O	O	B-T170
standards	O	O	I-T170
for	O	O	O
study	O	O	B-T062
reporting	O	O	B-T062
.	O	O	O

-DOCSTART- (27491778)

Beneficial	O	O	B-T081
effects	O	O	B-T080
of	O	O	O
dark	O	O	B-T168
chocolate	O	O	I-T168
on	O	O	O
exercise	O	O	B-T056
capacity	O	O	B-T081
in	O	O	O
sedentary	O	O	B-T080
subjects	O	O	B-T098
:	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
.	O	O	O
A	O	O	O
double	O	O	B-T062
blind	O	O	I-T062
,	O	O	O
randomized	O	O	B-T062
,	O	O	O
placebo	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	O

A	O	O	O
double	O	O	B-T062
blind	O	O	I-T062
,	O	O	O
randomized	O	O	B-T062
,	O	O	O
placebo	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	B-T062
In	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
patients	O	O	B-T101
the	O	O	O
consumption	O	O	B-T039
of	O	O	O
(-)-epicatechin	O	O	B-T121
(	O	O	O
(-)-Epi)-rich	O	O	O
cocoa	O	O	B-T168
can	O	O	O
restore	O	O	O
skeletal	O	O	B-T024
muscle	O	O	I-T024
(	O	O	O
SkM	O	O	B-T024
)	O	O	O
mitochondrial	O	O	B-T026
structure	O	O	B-T082
and	O	O	O
decrease	O	O	B-T081
biomarkers	O	O	B-T201
of	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
.	O	O	O

However	O	O	O
,	O	O	O
nothing	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
its	O	O	O
effects	O	O	B-T080
on	O	O	O
exercise	O	O	B-T056
capacity	O	O	B-T081
and	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
in	O	O	O
normal	O	O	B-T080
,	O	O	O
sedentary	O	O	B-T080
subjects	O	O	B-T098
.	O	O	O

Twenty	O	O	O
normal	O	O	B-T080
,	O	O	O
sedentary	O	O	B-T080
subjects	O	O	B-T098
(	O	O	O
∼50	O	O	O
years	O	O	B-T100
old	O	O	I-T100
)	O	O	O
were	O	O	O
randomized	O	O	B-T062
to	O	O	O
placebo	O	O	B-T061
or	O	O	O
dark	O	O	B-T168
chocolate	O	O	I-T168
(	O	O	O
DC	O	O	B-T168
)	O	O	O
groups	O	O	B-T078
and	O	O	O
consumed	O	O	B-T052
20	O	O	O
g	O	O	O
of	O	O	O
the	O	O	O
products	O	O	O
for	O	O	O
3	O	O	O
months	O	O	B-T079
.	O	O	O

Subjects	O	O	B-T098
underwent	O	O	O
before	O	O	O
and	O	O	O
after	O	O	O
treatment	O	O	B-T061
,	O	O	O
bicycle	O	O	B-T060
ergometry	O	O	I-T060
to	O	O	O
assess	O	O	B-T058
VO2	O	O	B-T033
max	O	O	I-T033
and	O	O	O
work	O	O	B-T057
,	O	O	O
SkM	O	O	B-T060
biopsy	O	O	I-T060
to	O	O	O
assess	O	O	O
changes	O	O	O
in	O	O	O
mitochondrial	O	O	B-T026
density	O	O	B-T081
,	O	O	O
function	O	O	B-T169
and	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
blood	O	O	B-T060
sampling	O	O	I-T060
to	O	O	O
assess	O	O	O
metabolic	O	O	B-T169
endpoints	O	O	B-T080
.	O	O	O

Seventeen	O	O	O
subjects	O	O	B-T098
completed	O	O	O
the	O	O	O
trial	O	O	B-T062
.	O	O	O

In	O	O	O
the	O	O	O
DC	O	O	B-T168
group	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
9	O	O	O
)	O	O	O
,	O	O	O
VO2	O	O	B-T033
max	O	O	I-T033
increased	O	O	B-T169
(	O	O	O
17	O	O	O
%	O	O	O
increase	O	O	B-T169
,	O	O	O
p	O	O	O
=	O	O	O
0.056	O	O	O
)	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
maximum	O	O	O
work	O	O	B-T057
(	O	O	O
watts	O	O	B-T081
)	O	O	O
achieved	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.026	O	O	O
)	O	O	O
with	O	O	O
no	O	O	O
changes	O	O	O
with	O	O	O
placebo	O	O	B-T061
(	O	O	O
n	O	O	O
=	O	O	O
8)	O	O	O
.	O	O	O

The	O	O	O
DC	O	O	B-T168
group	O	O	O
evidenced	O	O	O
increases	O	O	B-T169
in	O	O	O
HDL	O	O	B-T116
levels	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.005	O	O	O
)	O	O	O
and	O	O	O
decreased	O	O	B-T081
triglycerides	O	O	B-T109
(	O	O	O
p	O	O	O
=	O	O	O
0.07	O	O	O
)	O	O	O
.	O	O	O

With	O	O	O
DC	O	O	B-T168
,	O	O	O
SkM	O	O	B-T024
evidenced	O	O	O
significant	O	O	B-T078
increases	O	O	B-T169
in	O	O	O
protein	O	O	B-T116
levels	O	O	O
for	O	O	O
LKB1	O	O	B-T116
,	O	O	O
AMPK	O	O	B-T116
and	O	O	O
PGC1α	O	O	B-T116
and	O	O	O
in	O	O	O
their	O	O	O
active	O	O	B-T169
forms	O	O	O
(	O	O	O
phosphorylated	O	O	B-T044
AMPK	O	O	O
and	O	O	O
LKB1	O	O	O
)	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
citrate	O	O	B-T044
synthase	O	O	I-T044
activity	O	O	I-T044
while	O	O	O
no	O	O	O
changes	O	O	O
were	O	O	O
observed	O	O	O
in	O	O	O
mitochondrial	O	O	B-T026
density	O	O	B-T081
.	O	O	O

With	O	O	O
DC	O	O	B-T168
,	O	O	O
significant	O	O	B-T078
increases	O	O	B-T169
in	O	O	O
SkM	O	O	B-T024
reduced	O	O	O
glutathione	O	O	B-T116
levels	O	O	O
and	O	O	O
decreases	O	O	B-T081
in	O	O	O
protein	O	O	B-T044
carbonylation	O	O	I-T044
were	O	O	O
observed	O	O	O
.	O	O	O

Improvements	O	O	O
in	O	O	O
maximum	O	O	O
work	O	O	B-T057
achieved	O	O	O
and	O	O	O
VO2	O	O	B-T033
max	O	O	I-T033
may	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
DC	O	O	B-T168
activation	O	O	B-T052
of	O	O	O
upstream	O	O	O
control	O	O	O
systems	O	O	O
and	O	O	O
enhancement	O	O	O
of	O	O	O
SkM	O	O	B-T024
mitochondria	O	O	B-T026
efficiency	O	O	B-T081
.	O	O	O

Larger	O	O	O
clinical	O	O	B-T062
studies	O	O	I-T062
are	O	O	O
warranted	O	O	O
to	O	O	O
confirm	O	O	O
these	O	O	O
observations	O	O	B-T062
.	O	O	O

-DOCSTART- (27494020)

Reduction	O	O	B-T080
in	O	O	O
Hospital-Wide	O	O	B-T093
Clinical	O	O	B-T059
Laboratory	O	O	I-T059
Specimen	O	O	I-T059
Identification	O	O	I-T059
Errors	O	O	B-T080
following	O	O	O
Process	O	O	B-UnknownType
Interventions	O	O	I-UnknownType
:	O	O	O
A	O	O	O
10-	O	O	O
Year	O	O	B-T079
Retrospective	O	O	O
Observational	O	O	O
Study	O	O	O

Accurate	O	O	B-T080
patient	O	O	B-T058
identification	O	O	I-T058
and	O	O	O
specimen	O	O	B-T058
labeling	O	O	I-T058
at	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
collection	O	O	O
are	O	O	O
crucial	O	O	B-T077
steps	O	O	I-T077
in	O	O	O
the	O	O	O
prevention	O	O	B-T062
of	O	O	O
medical	O	O	B-T080
errors	O	O	I-T080
,	O	O	O
thereby	O	O	O
improving	O	O	B-T080
patient	O	O	B-T058
safety	O	O	I-T058
.	O	O	O

All	O	O	O
patient	O	O	B-T031
specimen	O	O	I-T031
identification	O	O	B-T080
errors	O	O	B-T080
that	O	O	O
occurred	O	O	B-T052
in	O	O	O
the	O	O	O
outpatient	O	O	B-T082
department	O	O	I-T082
(	O	O	O
OPD	O	O	B-T082
)	O	O	O
,	O	O	O
emergency	O	O	B-T093
department	O	O	I-T093
(	O	O	O
ED	O	O	B-T093
)	O	O	O
,	O	O	O
and	O	O	O
inpatient	O	O	B-T082
department	O	O	I-T082
(	O	O	O
IPD	O	O	B-T082
)	O	O	O
of	O	O	O
a	O	O	O
3,800-	O	O	O
bed	O	O	B-T073
academic	O	O	B-T093
medical	O	O	I-T093
center	O	O	I-T093
in	O	O	O
Taiwan	O	O	B-T083
were	O	O	O
documented	O	O	B-T058
and	O	O	O
analyzed	O	O	B-T058
retrospectively	O	O	O
from	O	O	O
2005	O	O	O
to	O	O	O
2014	O	O	O
.	O	O	O

To	O	O	O
reduce	O	O	B-T080
such	O	O	O
errors	O	O	B-T080
,	O	O	O
the	O	O	O
following	O	O	O
series	O	O	B-T081
of	O	O	O
strategies	O	O	B-T170
were	O	O	O
implemented	O	O	O
:	O	O	O
a	O	O	O
restrictive	O	O	B-T089
specimen	O	O	I-T089
acceptance	O	O	I-T089
policy	O	O	I-T089
for	O	O	O
the	O	O	O
ED	O	O	B-T093
and	O	O	O
IPD	O	O	B-T082
in	O	O	O
2006	O	O	O
;	O	O	O
a	O	O	O
computer-assisted	O	O	B-T059
barcode	O	O	B-T170
positive	O	O	B-T073
patient	O	O	I-T073
identification	O	O	I-T073
system	O	O	I-T073
for	O	O	O
the	O	O	O
ED	O	O	O
and	O	O	O
IPD	O	O	O
in	O	O	O
2007	O	O	O
and	O	O	O
2010	O	O	O
,	O	O	O
and	O	O	O
automated	O	O	B-T169
sample	O	O	B-T058
labeling	O	O	I-T058
combined	O	O	B-T080
with	O	O	O
electronic	O	O	B-T058
identification	O	O	I-T058
systems	O	O	I-T058
introduced	O	O	B-T169
to	O	O	O
the	O	O	O
OPD	O	O	B-T082
in	O	O	O
2009	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
2000345	O	O	O
specimens	O	O	B-T031
collected	O	O	B-T169
in	O	O	O
2005	O	O	O
,	O	O	O
1023	O	O	O
(	O	O	O
0.0511	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
identified	O	O	B-T033
as	O	O	O
having	O	O	O
patient	O	O	B-T058
identification	O	O	I-T058
errors	O	O	B-T080
,	O	O	O
compared	O	O	O
with	O	O	O
58	O	O	O
errors	O	O	O
(	O	O	O
0.0015	O	O	O
%	O	O	O
)	O	O	O
among	O	O	O
3761238	O	O	O
specimens	O	O	O
collected	O	O	O
in	O	O	O
2014	O	O	O
,	O	O	O
after	O	O	O
serial	O	O	O
interventions	O	O	B-T058
;	O	O	O
this	O	O	O
represents	O	O	O
a	O	O	O
97	O	O	O
%	O	O	O
relative	O	O	B-T080
reduction	O	O	B-T080
.	O	O	O

The	O	O	O
total	O	O	B-T081
number	O	O	I-T081
(	O	O	O
rate	O	O	B-T081
)	O	O	O
of	O	O	O
institutional	O	O	B-T058
identification	O	O	I-T058
errors	O	O	B-T080
contributed	O	O	O
from	O	O	O
the	O	O	O
ED	O	O	B-T093
,	O	O	O
IPD	O	O	B-T082
,	O	O	O
and	O	O	O
OPD	O	O	B-T082
over	O	O	O
a	O	O	O
10-	O	O	O
year	O	O	B-T079
period	O	O	B-T079
were	O	O	O
423	O	O	O
(	O	O	O
0.1058	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
556	O	O	O
(	O	O	O
0.0587	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
44	O	O	O
(	O	O	O
0.0067	O	O	O
%	O	O	O
)	O	O	O
errors	O	O	O
before	O	O	B-T079
the	O	O	O
interventions	O	O	B-T058
,	O	O	O
and	O	O	O
3	O	O	O
(	O	O	O
0.0007	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
52	O	O	O
(	O	O	O
0.0045	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
3	O	O	O
(	O	O	O
0.0001	O	O	O
%	O	O	O
)	O	O	O
after	O	O	B-T079
interventions	O	O	O
,	O	O	O
representing	O	O	O
relative	O	O	B-T080
99	O	O	O
%	O	O	O
,	O	O	O
92	O	O	O
%	O	O	O
and	O	O	O
98	O	O	O
%	O	O	O
reductions	O	O	B-T080
,	O	O	O
respectively	O	O	O
.	O	O	O

Accurate	O	O	B-T080
patient	O	O	B-T058
identification	O	O	I-T058
is	O	O	O
a	O	O	O
challenge	O	O	O
of	O	O	O
patient	O	O	B-T058
safety	O	O	I-T058
in	O	O	O
different	O	O	O
health	O	O	B-T078
settings	O	O	B-T081
.	O	O	O

The	O	O	O
data	O	O	B-T033
collected	O	O	I-T033
in	O	O	O
our	O	O	O
study	O	O	B-T062
indicate	O	O	O
that	O	O	O
a	O	O	O
restrictive	O	O	B-T089
specimen	O	O	I-T089
acceptance	O	O	I-T089
policy	O	O	I-T089
,	O	O	O
computer-generated	O	O	B-T059
positive	O	O	B-T073
identification	O	O	I-T073
systems	O	O	I-T073
,	O	O	O
and	O	O	O
interdisciplinary	O	O	O
cooperation	O	O	O
can	O	O	O
significantly	O	O	O
reduce	O	O	B-T080
patient	O	O	B-T058
identification	O	O	I-T058
errors	O	O	B-T080
.	O	O	O

-DOCSTART- (27494908)

Management	O	O	B-T058
of	O	O	O
skin	O	O	B-T047
and	O	O	I-T047
soft-tissue	O	O	I-T047
infections	O	O	I-T047
at	O	O	O
a	O	O	O
community	O	O	O
teaching	O	O	B-T093
hospital	O	O	I-T093
using	O	O	O
a	O	O	O
severity-of-illness	O	O	O
tool	O	O	O

Skin	O	O	B-T047
and	O	O	I-T047
soft-tissue	O	O	I-T047
infections	O	O	B-T046
(	O	O	O
SSTIs	O	O	B-T047
)	O	O	O
encompass	O	O	O
a	O	O	O
diverse	O	O	B-T080
range	O	O	B-T081
of	O	O	O
infections	O	O	O
of	O	O	O
varying	O	O	O
severity	O	O	B-T080
.	O	O	O

The	O	O	O
Clinical	O	O	B-T170
Resource	O	O	I-T170
Efficiency	O	O	I-T170
Support	O	O	I-T170
Team	O	O	I-T170
(	O	O	I-T170
CREST	O	O	I-T170
)	O	O	I-T170
scoring	O	O	I-T170
system	O	O	I-T170
stratifies	O	O	B-T185
patients	O	O	B-T101
into	O	O	O
four	O	O	O
classes	O	O	B-T185
(	O	O	O
I	O	O	O
=	O	O	O
least	O	O	O
severe	O	O	B-T080
to	O	O	O
IV	O	O	O
=	O	O	O
most	O	O	O
severe	O	O	O
)	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
Standardized	O	O	B-T170
Early	O	O	I-T170
Warning	O	O	I-T170
Score	O	O	I-T170
(	O	O	O
SEWS	O	O	B-T170
)	O	O	O
.	O	O	O

The	O	O	O
objective	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
apply	O	O	O
CREST	O	O	B-T170
to	O	O	O
hospitalized	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
SSTIs	O	O	B-T047
in	O	O	O
order	O	O	O
to	O	O	O
quantify	O	O	O
disease	O	O	B-T080
severity	O	O	I-T080
and	O	O	O
evaluate	O	O	B-T058
appropriateness	O	O	O
of	O	O	O
antibiotic	O	O	B-T195
management	O	O	O
.	O	O	O

This	O	O	O
was	O	O	O
a	O	O	O
retrospective	O	O	B-T062
,	O	O	O
hypothesis	O	O	B-T078
-generating	O	O	O
,	O	O	O
single-centre	O	O	O
evaluation	O	O	B-T058
of	O	O	O
hospitalized	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
SSTIs	O	O	B-T047
admitted	O	O	B-T058
in	O	O	O
2011	O	O	O
.	O	O	O

Based	O	O	O
on	O	O	O
CREST	O	O	B-T170
classification	O	O	O
,	O	O	O
the	O	O	O
empirical	O	O	B-T080
antimicrobial	O	O	B-T121
choices	O	O	O
were	O	O	O
categorized	O	O	B-T052
as	O	O	O
appropriate	O	O	O
,	O	O	O
over-treatment	O	O	B-T058
or	O	O	O
under-treatment	O	O	B-T061
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
369	O	O	O
patients	O	O	B-T101
were	O	O	O
screened	O	O	O
and	O	O	O
200	O	O	O
met	O	O	O
the	O	O	O
inclusion	O	O	B-T080
criteria	O	O	I-T080
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
patients	O	O	B-T101
were	O	O	O
classified	O	O	B-T185
as	O	O	O
either	O	O	O
CREST	O	O	B-T170
class	O	O	B-T185
I	O	O	I-T185
(	O	O	O
n	O	O	O
=	O	O	O
68	O	O	O
)	O	O	O
or	O	O	O
class	O	O	O
I	O	O	O
I	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
102	O	O	O
)	O	O	O
.	O	O	O

Over-treatment	O	O	B-T058
was	O	O	O
more	O	O	O
common	O	O	O
in	O	O	O
the	O	O	O
less	O	O	O
severe	O	O	B-T080
classes	O	O	B-T185
(	O	O	O
88	O	O	O
%	O	O	O
and	O	O	O
32	O	O	O
%	O	O	O
in	O	O	O
class	O	O	B-T185
I	O	O	I-T185
and	O	O	O
class	O	O	B-T185
II	O	O	I-T185
,	O	O	O
respectively	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Sixty-three	O	O	O
percent	O	O	B-T081
of	O	O	O
class	O	O	B-T185
I	O	O	I-T185
(	O	O	O
n	O	O	O
=	O	O	O
43	O	O	O
)	O	O	O
were	O	O	O
over-treated	O	O	B-T058
due	O	O	O
to	O	O	O
both	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
intravenous	O	O	B-T169
antibiotic	O	O	B-T195
s	O	O	O
when	O	O	O
oral	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
sufficient	O	O	O
and	O	O	O
use	O	O	O
of	O	O	O
unnecessarily	O	O	O
broad-spectrum	O	O	B-T195
antibiotics	O	O	I-T195
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
25	O	O	O
%	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
26	O	O	O
)	O	O	O
of	O	O	O
class	O	O	B-T185
II	O	O	I-T185
were	O	O	O
over-treated	O	O	B-T058
due	O	O	O
to	O	O	O
use	O	O	O
of	O	O	O
unnecessarily	O	O	O
broad-spectrum	O	O	B-T195
antibiotics	O	O	I-T195
.	O	O	O

Overall	O	O	O
clinical	O	O	B-T033
failure	O	O	I-T033
rates	O	O	O
remained	O	O	O
low	O	O	O
with	O	O	O
only	O	O	O
1	O	O	O
%	O	O	O
,	O	O	O
4	O	O	O
%	O	O	O
and	O	O	O
17	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
unable	O	O	O
to	O	O	O
achieve	O	O	O
initial	O	O	O
response	O	O	B-T201
in	O	O	O
class	O	O	B-T185
II	O	O	I-T185
,	O	O	O
class	O	O	B-T185
III	O	O	I-T185
and	O	O	O
class	O	O	B-T185
IV	O	O	I-T185
.	O	O	O

Retrospective	O	O	B-T080
application	O	O	B-T058
of	O	O	O
CREST	O	O	B-T170
identified	O	O	O
opportunities	O	O	O
to	O	O	O
improve	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
SSTIs	O	O	B-T047
.	O	O	O

CREST	O	O	B-T170
can	O	O	O
be	O	O	O
of	O	O	O
great	O	O	O
value	O	O	O
in	O	O	O
discriminating	O	O	O
less-	O	O	O
severe	O	O	B-T080
SSTIs	O	O	B-T047
,	O	O	O
which	O	O	O
can	O	O	O
be	O	O	O
treated	O	O	B-T061
on	O	O	O
an	O	O	O
outpatient	O	O	B-T101
basis	O	O	O
.	O	O	O

-DOCSTART- (27495798)

Breakthrough	O	O	B-T080
viridans	O	O	B-T047
streptococcal	O	O	I-T047
bacteremia	O	O	I-T047
in	O	O	O
allogeneic	O	O	B-T061
hematopoietic	O	O	I-T061
stem	O	O	I-T061
cell	O	O	I-T061
transplant	O	O	I-T061
recipients	O	O	B-T101
receiving	O	O	B-T080
levofloxacin	O	O	B-T195
prophylaxis	O	O	B-T061
in	O	O	O
a	O	O	O
Japanese	O	O	B-T083
hospital	O	O	O

Breakthrough	O	O	B-T080
viridans	O	O	B-T047
streptococcal	O	O	I-T047
bacteremia	O	O	I-T047
(	O	O	O
VSB	O	O	B-T047
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
hematological	O	O	B-T191
malignancy	O	O	I-T191
receiving	O	O	B-T080
levofloxacin	O	O	B-T195
prophylaxis	O	O	B-T061
is	O	O	O
a	O	O	O
major	O	O	B-T080
blood	O	O	B-T047
stream	O	O	I-T047
infection	O	O	I-T047
(	O	O	O
BSI	O	O	B-T047
)	O	O	O
occurring	O	O	B-T052
during	O	O	B-T079
febrile	O	O	B-T047
neutropenia	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
clinical	O	O	B-T170
data	O	O	I-T170
focused	O	O	B-T169
on	O	O	O
VSB	O	O	B-T047
in	O	O	O
allogeneic	O	O	B-T061
hematopoietic	O	O	I-T061
stem	O	O	I-T061
cell	O	O	I-T061
transplant	O	O	I-T061
(	O	O	O
allo-HSCT	O	O	B-T061
)	O	O	O
recipients	O	O	B-T101
are	O	O	O
lacking	O	O	B-T080
.	O	O	O

The	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
of	O	O	O
allo-HSCT	O	O	B-T061
recipients	O	O	B-T101
who	O	O	O
received	O	O	B-T080
oral	O	O	B-T169
levofloxacin	O	O	B-T195
prophylaxis	O	O	B-T061
between	O	O	O
January	O	O	O
2011	O	O	O
and	O	O	O
August	O	O	O
2013	O	O	O
at	O	O	O
Toranomon	O	O	B-T093
Hospital	O	O	I-T093
were	O	O	O
reviewed	O	O	B-T080
to	O	O	O
evaluate	O	O	B-T058
breakthrough	O	O	B-T080
VSB	O	O	B-T047
.	O	O	O

Stored	O	O	O
viridans	O	O	B-T007
streptococcal	O	O	I-T007
(	O	O	O
VGS	O	O	B-T007
)	O	O	O
species	O	O	B-T185
were	O	O	O
identified	O	O	B-T080
by	O	O	O
using	O	O	B-T169
sodA	O	O	B-T028
gene	O	O	I-T028
sequencing	O	O	B-T059
,	O	O	O
and	O	O	O
were	O	O	O
assessed	O	O	B-T052
for	O	O	O
drug	O	O	B-T038
susceptibility	O	O	I-T038
.	O	O	O

Among	O	O	O
the	O	O	O
184	O	O	O
allo-HSCT	O	O	B-T061
recipients	O	O	B-T101
on	O	O	O
levofloxacin	O	O	B-T195
prophylaxis	O	O	B-T061
,	O	O	O
28	O	O	O
(	O	O	O
15.2	O	O	O
%	O	O	O
)	O	O	O
experienced	O	O	O
breakthrough	O	O	B-T080
VSB	O	O	B-T047
.	O	O	O

All	O	O	O
of	O	O	O
the	O	O	O
28	O	O	O
recipients	O	O	B-T101
with	O	O	O
VSB	O	O	B-T047
were	O	O	O
treated	O	O	B-T169
with	O	O	O
a	O	O	O
cefepime	O	O	B-T195
-	O	O	O
based	O	O	B-T169
or	O	O	O
piperacillin/tazobactam	O	O	B-T121
-	O	O	O
based	O	O	O
regimen	O	O	B-T061
.	O	O	O

The	O	O	O
susceptibility	O	O	B-T038
rates	O	O	B-T081
of	O	O	O
the	O	O	O
VGS	O	O	B-T007
strains	O	O	B-T001
for	O	O	O
levofloxacin	O	O	B-T195
,	O	O	O
cefepime	O	O	B-T195
,	O	O	O
piperacillin/tazobactam	O	O	B-T121
,	O	O	O
meropenem	O	O	B-T195
,	O	O	O
and	O	O	O
vancomycin	O	O	B-T116
were	O	O	O
0	O	O	O
%	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
,	O	O	O
100	O	O	O
%	O	O	O
,	O	O	O
100	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
100	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Both	O	O	O
the	O	O	O
MIC50	O	O	B-T059
(	O	O	O
minimum	O	O	B-T059
inhibitory	O	O	I-T059
concentration	O	O	I-T059
)	O	O	O
and	O	O	O
the	O	O	O
MIC90	O	O	B-T059
of	O	O	O
ceftazidim	O	O	B-T195
(	O	O	O
0.5	O	O	O
μg/mL	O	O	O
and	O	O	O
2	O	O	O
μg/mL	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
were	O	O	O
higher	O	O	B-T080
than	O	O	O
the	O	O	O
MIC90	O	O	O
of	O	O	O
all	O	O	O
the	O	O	O
other	O	O	O
anti-pseudomonal	O	O	B-T121
beta-lactams	O	O	I-T121
(	O	O	O
APBLs	O	O	B-T121
)	O	O	O
.	O	O	O

Only	O	O	O
1	O	O	O
VGS	O	O	B-T007
strain	O	O	B-T001
had	O	O	O
a	O	O	O
penicillin	O	O	B-T195
MIC	O	O	B-T059
≥	O	O	O
2	O	O	O
μg/mL	O	O	O
by	O	O	O
the	O	O	O
Etest	O	O	B-T059
(	O	O	O
3.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T169
cases	O	O	B-T169
with	O	O	O
acute	O	O	B-T033
respiratory	O	O	I-T033
distress	O	O	I-T033
syndrome	O	O	I-T033
(	O	O	O
ARDS	O	O	B-T033
)	O	O	O
that	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
VSB	O	O	B-T047
,	O	O	O
although	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
viridans	O	O	B-T047
group	O	O	I-T047
streptococcal	O	O	I-T047
shock	O	O	I-T047
syndrome	O	O	I-T047
was	O	O	O
high	O	O	B-T080
(	O	O	O
26	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
crude	O	O	O
30-day	O	O	B-T079
mortality	O	O	B-T081
rate	O	O	I-T081
in	O	O	O
the	O	O	O
VSB	O	O	B-T047
group	O	O	B-UnknownType
(	O	O	O
10.7	O	O	O
%	O	O	O
)	O	O	O
did	O	O	O
not	O	O	B-T169
differ	O	O	B-T080
significantly	O	O	B-T078
from	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
BSI	O	O	B-T047
without	O	O	B-T080
VSB	O	O	O
group	O	O	O
(	O	O	O
9.3	O	O	O
%	O	O	O
)	O	O	O
or	O	O	O
non	O	O	B-T169
-	O	O	O
BSI	O	O	O
group	O	O	O
(	O	O	O
7.0	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.77	O	O	O
)	O	O	O
.	O	O	O

Also	O	O	O
,	O	O	O
VSB	O	O	B-T047
was	O	O	O
not	O	O	B-T169
a	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
all-cause	O	O	O
mortality	O	O	B-T081
up	O	O	O
to	O	O	O
60	O	O	B-T079
days	O	O	I-T079
following	O	O	B-T079
allo-HSCT	O	O	B-T061
(	O	O	O
P	O	O	O
=	O	O	O
0.43	O	O	O
)	O	O	O
.	O	O	O

APBL	O	O	B-T121
with	O	O	O
increased	O	O	B-T081
anti-VGS	O	O	B-T033
activity	O	O	I-T033
(	O	O	O
APBL-VA	O	O	B-T033
)	O	O	O
monotherapy	O	O	B-T061
would	O	O	O
typically	O	O	O
be	O	O	O
optimal	O	O	B-T080
for	O	O	O
treating	O	O	B-T169
the	O	O	O
VGS	O	O	B-T007
strains	O	O	B-T001
in	O	O	O
this	O	O	O
setting	O	O	O
.	O	O	O

Indication	O	O	O
of	O	O	O
adding	O	O	O
an	O	O	O
empiric	O	O	O
anti-gram-positive	O	O	B-T121
agent	O	O	I-T121
to	O	O	O
APBL-VA	O	O	B-T033
for	O	O	O
treating	O	O	B-T169
VSB	O	O	B-T047
should	O	O	O
depend	O	O	O
on	O	O	O
local	O	O	B-T082
factors	O	O	B-T169
,	O	O	O
such	O	O	O
as	O	O	O
the	O	O	O
susceptibility	O	O	B-T038
results	O	O	B-T169
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
breakthrough	O	O	B-T080
VSB	O	O	B-T047
is	O	O	O
probably	O	O	O
not	O	O	B-T169
a	O	O	O
major	O	O	B-T080
cause	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
in	O	O	O
allo-HSCT	O	O	B-T061
settings	O	O	O
,	O	O	O
where	O	O	O
beta-lactam	O	O	B-T195
non-susceptible	O	O	B-T007
VGS	O	O	I-T007
and	O	O	O
the	O	O	O
ARDS	O	O	B-T033
are	O	O	O
rare	O	O	B-T080
.	O	O	O

-DOCSTART- (27497497)

The	O	O	O
lost	O	O	O
art	O	O	O
of	O	O	O
the	O	O	O
splenorrhaphy	O	O	O

In	O	O	O
the	O	O	O
case	O	O	O
of	O	O	O
the	O	O	O
hemodynamically	O	O	B-T047
unstable	O	O	I-T047
child	O	O	B-T100
,	O	O	O
splenorrhaphy	O	O	B-T061
is	O	O	O
preferred	O	O	O
to	O	O	O
splenectomy	O	O	B-T061
to	O	O	O
avert	O	O	O
postsplenectomy	O	O	B-T046
sepsis	O	O	B-T047
.	O	O	O

However	O	O	O
,	O	O	O
successful	O	O	O
splenorrhaphy	O	O	B-T061
requires	O	O	O
familiarity	O	O	B-T041
with	O	O	O
the	O	O	O
procedure	O	O	B-T061
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
determine	O	O	O
how	O	O	O
many	O	O	O
splenectomies	O	O	B-T061
or	O	O	O
splenorrhaphies	O	O	B-T061
for	O	O	O
trauma	O	O	B-T037
the	O	O	O
average	O	O	O
pediatric	O	O	B-T097
surgeon	O	O	I-T097
can	O	O	O
be	O	O	O
expected	O	O	O
to	O	O	O
perform	O	O	B-T169
during	O	O	O
their	O	O	O
career	O	O	B-T057
.	O	O	O

The	O	O	O
Pediatric	O	O	B-T170
Health	O	O	I-T170
Information	O	O	I-T170
System	O	O	I-T170
(	O	O	I-T170
PHIS	O	O	I-T170
)	O	O	I-T170
Database	O	O	I-T170
was	O	O	O
queried	O	O	O
for	O	O	O
patients	O	O	B-T101
≤18	O	O	O
years	O	O	B-T079
coded	O	O	O
with	O	O	O
an	O	O	O
International	O	O	B-T170
Classification	O	O	I-T170
of	O	O	I-T170
Diseases	O	O	I-T170
9th	O	O	I-T170
Edition	O	O	I-T170
diagnosis	O	O	B-T170
code	O	O	I-T170
of	O	O	O
a	O	O	O
splenic	O	O	B-T037
injury	O	O	I-T037
from	O	O	O
2004	O	O	O
to	O	O	O
2013	O	O	O
.	O	O	O

Age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
grade	O	O	B-T185
of	O	O	O
splenic	O	O	B-T037
injury	O	O	I-T037
,	O	O	O
and	O	O	O
operations	O	O	B-T061
performed	O	O	B-T169
were	O	O	O
extracted	O	O	B-T078
.	O	O	O

Numbers	O	O	O
of	O	O	O
pediatric	O	O	B-T097
surgeons	O	O	I-T097
per	O	O	O
hospital	O	O	B-T093
were	O	O	O
obtained	O	O	O
.	O	O	O

9567	O	O	O
children	O	O	B-T100
were	O	O	O
identified	O	O	B-T080
.	O	O	O

2.1	O	O	O
%	O	O	O
underwent	O	O	O
a	O	O	O
splenectomy	O	O	B-T061
and	O	O	O
0.8	O	O	O
%	O	O	O
underwent	O	O	O
a	O	O	O
splenorrhaphy	O	O	B-T061
.	O	O	O

The	O	O	O
average	O	O	O
surgeon	O	O	B-T097
performed	O	O	B-T169
0.6	O	O	O
(	O	O	O
SD=0.6	O	O	O
)	O	O	O
splenectomies	O	O	B-T061
and	O	O	O
0.2	O	O	O
(	O	O	O
SD=0.4	O	O	O
)	O	O	O
splenorrhaphies	O	O	B-T061
for	O	O	O
trauma	O	O	B-T037
.	O	O	O

If	O	O	O
these	O	O	O
rates	O	O	B-T081
remain	O	O	O
constant	O	O	B-T080
over	O	O	O
time	O	O	O
,	O	O	O
the	O	O	O
average	O	O	O
surgeon	O	O	B-T097
would	O	O	O
perform	O	O	B-T169
1.8	O	O	O
(	O	O	O
SD	O	O	O
=	O	O	O
1.7	O	O	O
)	O	O	O
splenectomies	O	O	B-T061
and	O	O	O
0.6	O	O	O
(	O	O	O
SD	O	O	O
=	O	O	O
1.1	O	O	O
)	O	O	O
splenorrhaphies	O	O	B-T061
for	O	O	O
trauma	O	O	B-T037
over	O	O	O
a	O	O	O
30-	O	O	O
year	O	O	B-T079
surgical	O	O	B-T057
career	O	O	I-T057
.	O	O	O

Nonoperative	O	O	B-T061
management	O	O	I-T061
is	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
host	O	O	O
of	O	O	O
benefits	O	O	O
,	O	O	O
but	O	O	O
has	O	O	O
resulted	O	O	O
in	O	O	O
a	O	O	O
decrease	O	O	O
in	O	O	O
the	O	O	O
experience	O	O	B-T080
level	O	O	I-T080
of	O	O	O
the	O	O	O
pediatric	O	O	B-T097
surgeons	O	O	I-T097
expected	O	O	O
to	O	O	O
perform	O	O	B-T169
an	O	O	O
emergency	O	O	O
splenectomy	O	O	B-T061
or	O	O	O
splenorrhaphy	O	O	B-T061
when	O	O	O
the	O	O	O
unusual	O	O	O
occasion	O	O	O
arises	O	O	O
.	O	O	O

-DOCSTART- (27498399)

Vestibular	O	O	B-T030
-dependent	O	O	O
inter-stimulus	O	O	B-T079
interval	O	O	I-T079
effects	O	O	B-T080
on	O	O	O
sound	O	O	B-T042
evoked	O	O	I-T042
potentials	O	O	I-T042
of	O	O	O
central	O	O	B-T082
origin	O	O	O

Todd	O	O	O
et	O	O	O
al.	O	O	O
(	O	O	O
2014ab	O	O	O
)	O	O	O
have	O	O	O
recently	O	O	O
demonstrated	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
vestibular	O	O	B-T030
-dependent	O	O	O
contributions	O	O	B-T052
to	O	O	O
auditory	O	O	B-T042
evoked	O	O	I-T042
potentials	O	O	I-T042
(	O	O	O
AEPs	O	O	B-T042
)	O	O	O
when	O	O	O
passing	O	O	O
through	O	O	O
the	O	O	O
vestibular	O	O	O
threshold	O	O	B-T081
as	O	O	O
determined	O	O	O
by	O	O	O
vestibular	O	O	B-T034
evoked	O	O	I-T034
myogenic	O	O	I-T034
potentials	O	O	I-T034
(	O	O	O
VEMPs	O	O	B-T034
)	O	O	O
,	O	O	O
including	O	O	O
a	O	O	O
particular	O	O	O
deflection	O	O	B-T082
labeled	O	O	B-T080
as	O	O	O
an	O	O	O
N42/P52	O	O	O
prior	O	O	B-T079
to	O	O	O
the	O	O	O
long	O	O	B-T080
-	O	O	O
latency	O	O	B-T079
AEPs	O	O	O
N1	O	O	O
and	O	O	O
P2	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
we	O	O	O
report	O	O	B-T058
the	O	O	O
results	O	O	B-T033
of	O	O	O
an	O	O	O
experiment	O	O	B-T062
to	O	O	O
determine	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
inter-stimulus	O	O	B-T079
interval	O	O	I-T079
(	O	O	O
ISI	O	O	B-T079
)	O	O	O
and	O	O	O
regularity	O	O	B-T080
on	O	O	O
potentials	O	O	B-T042
recorded	O	O	O
above	O	O	B-T082
and	O	O	O
below	O	O	B-T082
VEMP	O	O	B-T034
threshold	O	O	B-T081
.	O	O	O

Five	O	O	O
healthy	O	O	B-T080
,	O	O	O
right-handed	O	O	B-T032
subjects	O	O	B-T098
were	O	O	O
recruited	O	O	O
and	O	O	O
evoked	O	O	B-T042
potentials	O	O	I-T042
were	O	O	O
recorded	O	O	O
to	O	O	O
binaurally	O	O	O
presented	O	O	O
sound	O	O	B-T061
stimulation	O	O	I-T061
,	O	O	O
above	O	O	B-T082
and	O	O	O
below	O	O	B-T082
vestibular	O	O	B-T030
threshold	O	O	B-T081
,	O	O	O
at	O	O	O
seven	O	O	O
stimulus	O	O	B-T067
rates	O	O	B-T081
with	O	O	O
ISIs	O	O	B-T079
of	O	O	O
212	O	O	O
,	O	O	O
300	O	O	O
,	O	O	O
424	O	O	O
,	O	O	O
600	O	O	O
,	O	O	O
848	O	O	O
,	O	O	O
1200	O	O	O
and	O	O	O
1696	O	O	O
ms	O	O	O
.	O	O	O

The	O	O	O
inner	O	O	O
five	O	O	O
intervals	O	O	B-T079
,	O	O	O
i.e.	O	O	O
300	O	O	O
,	O	O	O
424	O	O	O
,	O	O	O
600	O	O	O
,	O	O	O
848	O	O	O
,	O	O	O
1200	O	O	O
ms	O	O	O
,	O	O	O
were	O	O	O
presented	O	O	B-T078
twice	O	O	O
in	O	O	O
both	O	O	O
regular	O	O	B-T080
and	O	O	O
irregular	O	O	B-T080
conditions	O	O	O
.	O	O	O

ANOVA	O	O	B-T081
on	O	O	O
the	O	O	O
global	O	O	B-T081
field	O	O	I-T081
power	O	O	I-T081
(	O	O	O
GFP	O	O	B-T081
)	O	O	O
were	O	O	O
conducted	O	O	O
for	O	O	O
each	O	O	O
of	O	O	O
four	O	O	O
waves	O	O	O
,	O	O	O
N42	O	O	O
,	O	O	O
P52	O	O	O
,	O	O	O
N1	O	O	O
and	O	O	O
P2	O	O	O
with	O	O	O
factors	O	O	O
of	O	O	O
intensity	O	O	B-T081
,	O	O	O
ISI	O	O	B-T079
and	O	O	O
regularity	O	O	B-T080
.	O	O	O

Both	O	O	O
N42	O	O	O
and	O	O	O
P52	O	O	O
waves	O	O	O
showed	O	O	O
significant	O	O	B-T078
ANOVA	O	O	B-T081
effects	O	O	B-T080
of	O	O	I-T080
intensity	O	O	B-T081
but	O	O	O
no	O	O	O
other	O	O	O
main	O	O	O
effects	O	O	O
or	O	O	O
interactions	O	O	B-T169
.	O	O	O

In	O	O	O
contrast	O	O	O
both	O	O	O
N1	O	O	O
and	O	O	O
P2	O	O	O
showed	O	O	O
additional	O	O	B-T169
effects	O	O	B-T080
of	O	O	I-T080
ISI	O	O	B-T079
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
intensity	O	O	B-T081
,	O	O	O
and	O	O	O
evidence	O	O	B-T169
of	O	O	I-T169
non	O	O	B-T169
-	O	O	O
linear	O	O	B-T082
interactions	O	O	B-T169
between	O	O	O
ISI	O	O	O
and	O	O	O
intensity	O	O	O
.	O	O	O

A	O	O	O
source	O	O	B-T062
analysis	O	O	I-T062
was	O	O	O
carried	O	O	O
out	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
prior	O	O	B-T079
work	O	O	O
suggesting	O	O	O
that	O	O	O
when	O	O	O
above	O	O	B-T082
vestibular	O	O	B-T030
threshold	O	O	B-T081
,	O	O	O
in	O	O	B-T169
addition	O	O	I-T169
to	O	O	I-T169
bilateral	O	O	B-T082
superior	O	O	B-T082
temporal	O	O	B-T023
cortex	O	O	I-T023
,	O	O	O
ocular	O	O	B-T023
,	O	O	O
cerebellar	O	O	B-T023
and	O	O	O
cingulate	O	O	B-T023
sources	O	O	B-T033
are	O	O	O
recruited	O	O	O
.	O	O	O

Further	O	O	O
statistical	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
the	O	O	O
source	O	O	B-T033
currents	O	O	B-T070
indicated	O	O	O
that	O	O	O
the	O	O	O
origin	O	O	O
of	O	O	O
the	O	O	O
interactions	O	O	B-T169
with	O	O	O
intensity	O	O	B-T081
may	O	O	O
be	O	O	O
the	O	O	O
ISI	O	O	B-T079
sensitivity	O	O	B-T081
of	O	O	O
the	O	O	O
vestibular	O	O	B-T030
-dependent	O	O	O
sources	O	O	B-T033
.	O	O	O

This	O	O	O
in	O	O	O
turn	O	O	O
may	O	O	O
reflect	O	O	O
a	O	O	O
specific	O	O	B-T080
vestibular	O	O	B-T030
preference	O	O	B-T078
for	O	O	O
stimulus	O	O	B-T067
rates	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
locomotion	O	O	B-T040
,	O	O	O
i.e.	O	O	O
rates	O	O	O
close	O	O	O
to	O	O	O
2	O	O	O
Hz	O	O	O
,	O	O	O
or	O	O	O
ISIs	O	O	B-T079
close	O	O	O
to	O	O	O
500	O	O	O
ms	O	O	O
,	O	O	O
where	O	O	O
saccular	O	O	B-T082
afferents	O	O	B-T082
show	O	O	O
increased	O	O	B-T081
gain	O	O	B-T081
and	O	O	O
the	O	O	O
corresponding	O	O	O
reflexes	O	O	B-T042
are	O	O	O
most	O	O	O
sensitive	O	O	B-T169
.	O	O	O

-DOCSTART- (27500198)

A	O	O	O
Systematic	O	O	B-T170
Review	O	O	I-T170
of	O	O	O
the	O	O	O
Diagnostic	O	O	B-T169
and	O	O	O
Prognostic	O	O	B-T080
Value	O	O	I-T080
of	O	O	O
Urinary	O	O	B-T080
Protein	O	O	B-T116
Biomarkers	O	O	B-T201
in	O	O	O
Urothelial	O	O	O
Bladder	O	O	O
Cancer	O	O	O

For	O	O	O
over	O	O	O
80	O	O	O
years	O	O	O
,	O	O	O
cystoscopy	O	O	B-T060
has	O	O	O
remained	O	O	O
the	O	O	O
gold-standard	O	O	B-T080
for	O	O	O
detecting	O	O	B-T033
tumours	O	O	B-T191
of	O	O	O
the	O	O	O
urinary	O	O	B-T023
bladder	O	O	I-T023
.	O	O	O

Since	O	O	O
bladder	O	O	B-T191
tumours	O	O	I-T191
have	O	O	O
a	O	O	O
tendency	O	O	O
to	O	O	O
recur	O	O	B-T067
and	O	O	O
progress	O	O	B-T046
,	O	O	O
many	O	O	O
patients	O	O	B-T101
are	O	O	O
subjected	O	O	O
to	O	O	O
repeated	O	O	O
cystoscopies	O	O	B-T060
during	O	O	O
long-term	O	O	B-T079
surveillance	O	O	B-T058
,	O	O	O
with	O	O	O
the	O	O	O
procedure	O	O	B-T061
being	O	O	O
both	O	O	O
unpleasant	O	O	O
for	O	O	O
the	O	O	O
patient	O	O	B-T101
and	O	O	O
expensive	O	O	O
for	O	O	O
healthcare	O	O	B-T097
providers	O	O	I-T097
.	O	O	O

The	O	O	O
identification	O	O	B-T080
and	O	O	O
validation	O	O	B-T062
of	O	O	O
bladder	O	O	B-T191
tumour	O	O	B-T191
specific	O	O	O
molecular	O	O	B-T201
markers	O	O	I-T201
in	O	O	O
urine	O	O	B-T031
could	O	O	O
enable	O	O	O
tumour	O	O	O
detection	O	O	B-T033
and	O	O	O
reduce	O	O	O
reliance	O	O	B-T055
on	O	O	O
cystoscopy	O	O	B-T060
,	O	O	O
and	O	O	O
numerous	O	O	O
classes	O	O	O
of	O	O	O
biomarkers	O	O	B-T201
have	O	O	O
been	O	O	O
studied	O	O	O
.	O	O	O

Proteins	O	O	B-T116
represent	O	O	O
the	O	O	O
most	O	O	O
intensively	O	O	O
studied	O	O	B-UnknownType
class	O	O	I-UnknownType
of	O	O	I-UnknownType
biomolecule	O	O	I-UnknownType
in	O	O	O
this	O	O	O
setting	O	O	O
.	O	O	O

As	O	O	O
an	O	O	O
aid	O	O	O
to	O	O	O
researchers	O	O	B-T097
searching	O	O	O
for	O	O	O
better	O	O	O
urinary	O	O	B-T080
biomarkers	O	O	B-T201
,	O	O	O
we	O	O	O
report	O	O	O
a	O	O	O
comprehensive	O	O	B-T170
systematic	O	O	I-T170
review	O	O	I-T170
of	O	O	O
the	O	O	O
literature	O	O	B-T170
and	O	O	O
a	O	O	O
searchable	O	O	O
database	O	O	B-T170
of	O	O	O
proteins	O	O	B-T116
that	O	O	O
have	O	O	O
been	O	O	O
investigated	O	O	B-T058
to	O	O	O
date	O	O	O
.	O	O	O

Our	O	O	O
objective	O	O	O
was	O	O	O
to	O	O	O
classify	O	O	O
these	O	O	O
proteins	O	O	B-T116
as	O	O	O
:	O	O	O
1	O	O	O
)	O	O	O
those	O	O	O
with	O	O	O
robustly	O	O	O
characterised	O	O	O
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
for	O	O	O
bladder	O	O	B-T191
cancer	O	O	I-T191
detection	O	O	B-T033
;	O	O	O
2	O	O	O
)	O	O	O
those	O	O	O
that	O	O	O
show	O	O	O
potential	O	O	O
but	O	O	O
further	O	O	O
investigation	O	O	B-T058
is	O	O	O
required	O	O	O
;	O	O	O
3	O	O	O
)	O	O	O
those	O	O	O
unlikely	O	O	O
to	O	O	O
warrant	O	O	O
further	O	O	O
investigation	O	O	O
;	O	O	O
and	O	O	O
4	O	O	O
)	O	O	O
those	O	O	O
investigated	O	O	B-T058
as	O	O	O
prognostic	O	O	B-T080
markers	O	O	I-T080
.	O	O	O

This	O	O	O
work	O	O	O
should	O	O	O
help	O	O	O
to	O	O	O
prioritise	O	O	O
certain	O	O	O
biomarkers	O	O	B-T201
for	O	O	O
rigorous	O	O	B-T062
validation	O	O	B-T062
,	O	O	O
whilst	O	O	O
preventing	O	O	B-T169
wasted	O	O	O
effort	O	O	O
on	O	O	O
proteins	O	O	B-T116
that	O	O	O
have	O	O	O
shown	O	O	O
no	O	O	O
association	O	O	O
whatsoever	O	O	O
with	O	O	O
the	O	O	O
disease	O	O	B-T047
,	O	O	O
or	O	O	O
only	O	O	O
modest	O	O	O
biomarker	O	O	B-T201
performance	O	O	O
despite	O	O	O
large-scale	O	O	B-UnknownType
efforts	O	O	I-UnknownType
at	O	O	O
validation	O	O	O
.	O	O	O

-DOCSTART- (27500262)

Well	O	O	O
,	O	O	O
I	O	O	O
Would	O	O	O
n't	O	O	O
be	O	O	O
Any	O	O	O
Worse	O	O	O
Off	O	O	O
,	O	O	O
Would	O	O	O
I	O	O	O
,	O	O	O
Than	O	O	O
I	O	O	O
am	O	O	O
Now	O	O	O
?	O	O	O
A	O	O	O
Qualitative	O	O	B-T062
Study	O	O	I-T062
of	O	O	O
Decision-Making	O	O	B-T041
,	O	O	O
Hopes	O	O	B-T041
,	O	O	O
and	O	O	O
Realities	O	O	B-T078
of	O	O	O
Adults	O	O	B-T100
With	O	O	O
Type	O	O	B-T047
1	O	O	I-T047
Diabetes	O	O	I-T047
Undergoing	O	O	O
Islet	O	O	O
Cell	O	O	O
Transplantation	O	O	O

For	O	O	O
selected	O	O	O
individuals	O	O	B-T098
with	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
,	O	O	O
pancreatic	O	O	B-T061
islet	O	O	I-T061
transplantation	O	O	I-T061
(	O	O	O
IT	O	O	B-T061
)	O	O	O
prevents	O	O	O
recurrent	O	O	O
severe	O	O	O
hypoglycemia	O	O	B-T047
and	O	O	O
optimizes	O	O	B-T061
glycemia	O	O	I-T061
,	O	O	O
although	O	O	O
ongoing	O	O	O
systemic	O	O	B-T061
immunosuppression	O	O	I-T061
is	O	O	O
needed	O	O	O
.	O	O	O

Our	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
explore	O	O	O
candidates	O	O	B-T098
and	O	O	O
recipients	O	O	B-T101
'	O	O	O
expectations	O	O	O
of	O	O	O
transplantation	O	O	B-T061
,	O	O	O
their	O	O	O
experience	O	O	O
of	O	O	O
being	O	O	O
on	O	O	O
the	O	O	O
waiting	O	O	B-T033
list	O	O	I-T033
,	O	O	O
and	O	O	O
(	O	O	O
for	O	O	O
recipients	O	O	O
)	O	O	O
the	O	O	O
procedure	O	O	O
and	O	O	O
life	O	O	O
posttransplant	O	O	B-T079
.	O	O	O

Cross-sectional	O	O	O
qualitative	O	O	B-T080
research	O	O	B-T062
design	O	O	I-T062
using	O	O	O
semistructured	O	O	O
interviews	O	O	B-T058
with	O	O	O
16	O	O	O
adults	O	O	B-T100
(	O	O	O
8	O	O	O
pretransplant	O	O	B-T079
,	O	O	O
8	O	O	O
posttransplant	O	O	B-T079
;	O	O	O
from	O	O	O
4	O	O	O
UK	O	O	B-T083
centers	O	O	B-T093
(	O	O	O
n	O	O	O
=	O	O	O
13	O	O	O
)	O	O	O
and	O	O	O
1	O	O	O
Canadian	O	O	B-T083
center	O	O	B-T093
(	O	O	O
n	O	O	O
=	O	O	O
3	O	O	O
)	O	O	O
)	O	O	O
.	O	O	O

Interviews	O	O	B-T058
were	O	O	O
audio-recorded	O	O	B-T058
,	O	O	O
transcribed	O	O	O
,	O	O	O
and	O	O	O
underwent	O	O	O
inductive	O	O	B-T062
thematic	O	O	I-T062
analysis	O	O	I-T062
.	O	O	O

Interviewees	O	O	B-T098
were	O	O	O
aged	O	O	O
(	O	O	O
mean	O	O	O
±	O	O	O
SD	O	O	O
)	O	O	O
52	O	O	O
±	O	O	O
10	O	O	O
years	O	O	B-T079
(	O	O	O
range	O	O	O
,	O	O	O
30	O	O	O
-	O	O	O
64	O	O	O
)	O	O	O
;	O	O	O
duration	O	O	B-T079
of	O	O	O
diabetes	O	O	B-T047
,	O	O	O
36	O	O	O
±	O	O	O
9	O	O	O
years	O	O	O
(	O	O	O
range	O	O	O
,	O	O	O
21	O	O	O
-	O	O	O
56	O	O	O
)	O	O	O
;	O	O	O
12	O	O	O
(	O	O	O
75	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
women	O	O	B-T098
.	O	O	O

Narrative	O	O	O
accounts	O	O	O
centered	O	O	O
on	O	O	O
expectations	O	O	B-T078
,	O	O	O
hopes	O	O	B-T041
,	O	O	O
and	O	O	O
realities	O	O	B-T078
;	O	O	O
decision-making	O	O	B-T041
;	O	O	O
waiting	O	O	O
and	O	O	O
uncertainty	O	O	O
;	O	O	O
the	O	O	O
procedure	O	O	O
,	O	O	O
hospital	O	O	B-T079
stay	O	O	I-T079
,	O	O	O
and	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Expected	O	O	O
benefits	O	O	O
included	O	O	O
fewer	O	O	O
severe	O	O	O
hypoglycemic	O	O	B-T047
episodes	O	O	I-T047
,	O	O	O
reduced	O	O	B-T080
need	O	O	O
for	O	O	O
insulin	O	O	B-T116
,	O	O	O
preventing	O	O	O
onset/progression	O	O	O
of	O	O	O
complications	O	O	B-T046
and	O	O	O
improved	O	O	O
psychological	O	O	B-T033
well-being	O	O	I-T033
.	O	O	O

These	O	O	O
were	O	O	O
realized	O	O	O
for	O	O	O
most	O	O	O
,	O	O	O
at	O	O	O
least	O	O	O
in	O	O	O
the	O	O	O
short	O	O	O
term	O	O	O
.	O	O	O

Most	O	O	O
interviewees	O	O	B-T098
described	O	O	O
well-informed	O	O	O
,	O	O	O
shared	O	O	O
decision-making	O	O	B-T041
with	O	O	O
clinicians	O	O	B-T097
and	O	O	O
family	O	O	B-T099
,	O	O	O
and	O	O	O
managing	O	O	O
their	O	O	O
expectations	O	O	O
.	O	O	O

Although	O	O	O
life	O	O	O
"	O	O	O
on	O	O	O
the	O	O	O
list	O	O	O
"	O	O	O
could	O	O	O
be	O	O	O
stressful	O	O	B-T169
,	O	O	O
and	O	O	O
immunosuppressant	O	O	B-T129
side	O	O	B-T046
effects	O	O	I-T046
were	O	O	O
severe	O	O	B-T080
,	O	O	O
interviewees	O	O	B-T098
reported	O	O	O
"	O	O	O
no	O	O	B-T033
regrets	O	O	B-T041
.	O	O	O
"	O	O	O
Posttransplant	O	O	B-T079
,	O	O	O
interviewees	O	O	O
experienced	O	O	O
increased	O	O	O
confidence	O	O	B-T041
,	O	O	O
through	O	O	O
freedom	O	O	B-T033
from	O	O	I-T033
hypoglycemia	O	O	I-T033
and	O	O	O
regained	O	O	O
glycemic	O	O	B-T061
control	O	O	I-T061
,	O	O	O
which	O	O	O
tempered	O	O	O
any	O	O	O
disappointment	O	O	O
about	O	O	O
continued	O	O	O
reliance	O	O	O
on	O	O	O
insulin	O	O	B-T116
.	O	O	O

Most	O	O	O
viewed	O	O	O
their	O	O	O
transplant	O	O	B-T061
as	O	O	O
a	O	O	O
success	O	O	O
,	O	O	O
though	O	O	O
several	O	O	O
reflected	O	O	O
upon	O	O	O
setbacks	O	O	O
and	O	O	O
hidden	O	O	O
hopes	O	O	B-T041
for	O	O	O
becoming	O	O	O
"	O	O	O
insulin-free	O	O	B-T033
.	O	O	O
"	O	O	O
Independently	O	O	O
undertaken	O	O	O
interviews	O	O	B-T058
demonstrated	O	O	O
realistic	O	O	O
and	O	O	O
balanced	O	O	O
expectations	O	O	O
of	O	O	O
IT	O	O	B-T061
and	O	O	O
indicate	O	O	O
how	O	O	O
to	O	O	O
optimize	O	O	O
the	O	O	O
process	O	O	O
and	O	O	O
support	O	O	O
for	O	O	O
future	O	O	O
IT	O	O	O
candidates	O	O	B-T098
.	O	O	O

-DOCSTART- (27500809)

The	O	O	O
nanocomposite	O	O	B-T080
nature	O	O	O
of	O	O	O
bone	O	O	B-T023
drives	O	O	O
its	O	O	O
strength	O	O	B-T081
and	O	O	O
damage	O	O	B-T169
resistance	O	O	O

In	O	O	O
human	O	O	B-T023
bone	O	O	I-T023
,	O	O	O
an	O	O	O
amorphous	O	O	B-T080
mineral	O	O	B-T197
serves	O	O	O
as	O	O	O
a	O	O	O
precursor	O	O	B-T078
to	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
a	O	O	O
highly	O	O	O
substituted	O	O	O
nanocrystalline	O	O	B-T073
apatite	O	O	B-T197
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
precise	O	O	O
role	O	O	O
of	O	O	O
this	O	O	O
amorphous	O	O	B-T080
mineral	O	O	B-T197
remains	O	O	O
unknown	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
by	O	O	O
using	O	O	O
transmission	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
that	O	O	O
100	O	O	O
-	O	O	O
300	O	O	O
nm	O	O	O
amorphous	O	O	B-T080
calcium	O	O	B-T121
phosphate	O	O	I-T121
regions	O	O	B-T029
are	O	O	O
present	O	O	O
in	O	O	O
the	O	O	O
disordered	O	O	B-T082
phase	O	O	I-T082
of	O	O	O
trabecular	O	O	B-T024
bone	O	O	I-T024
.	O	O	O

Nanomechanical	O	O	B-T062
experiments	O	O	I-T062
on	O	O	O
cylindrical	O	O	B-T082
samples	O	O	B-T167
,	O	O	O
with	O	O	O
diameters	O	O	B-T081
between	O	O	O
250	O	O	O
nm	O	O	O
and	O	O	O
3,000	O	O	O
nm	O	O	O
,	O	O	O
of	O	O	O
the	O	O	O
bone	O	O	B-T023
's	O	O	I-T023
ordered	O	O	B-T082
and	O	O	O
disordered	O	O	B-T082
phases	O	O	I-T082
revealed	O	O	O
a	O	O	O
transition	O	O	B-T052
from	O	O	O
plastic	O	O	B-T070
deformation	O	O	B-T033
to	O	O	O
brittle	O	O	B-T033
failure	O	O	B-T037
and	O	O	O
at	O	O	O
least	O	O	O
a	O	O	O
factor-of-2	O	O	O
higher	O	O	O
strength	O	O	B-T081
in	O	O	O
the	O	O	O
smaller	O	O	B-T080
samples	O	O	O
.	O	O	O

We	O	O	O
postulate	O	O	O
that	O	O	O
this	O	O	O
transition	O	O	B-T052
in	O	O	O
failure	O	O	B-T169
mechanism	O	O	B-T169
is	O	O	O
caused	O	O	O
by	O	O	O
the	O	O	O
suppression	O	O	B-T169
of	O	O	O
extrafibrillar	O	O	B-T026
shearing	O	O	B-T061
in	O	O	O
the	O	O	O
smaller	O	O	B-T080
samples	O	O	B-T167
,	O	O	O
and	O	O	O
that	O	O	O
the	O	O	O
emergent	O	O	O
smaller	O	O	O
-is-	O	O	O
stronger	O	O	B-T080
size	O	O	B-T081
effect	O	O	I-T081
is	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
sample-size	O	O	B-T081
scaling	O	O	B-T052
of	O	O	O
the	O	O	O
distribution	O	O	O
of	O	O	O
flaws	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
should	O	O	O
help	O	O	O
in	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
multi-scale	O	O	B-T078
nature	O	O	I-T078
of	O	O	O
bone	O	O	B-T023
and	O	O	O
provide	O	O	O
insights	O	O	O
into	O	O	O
the	O	O	O
biomineralization	O	O	B-T042
process	O	O	B-T067
.	O	O	O

-DOCSTART- (27501910)

Assessing	O	O	B-T052
the	O	O	O
physiological	O	O	B-T169
relevance	O	O	B-T080
of	O	O	O
alternate	O	O	O
architectures	O	O	B-T082
of	O	O	O
the	O	O	O
p7	O	O	B-T116
protein	O	O	I-T116
of	O	O	O
hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
in	O	O	O
different	O	O	O
environments	O	O	O

The	O	O	O
viroporin	O	O	B-T038
p7	O	O	B-T116
of	O	O	O
the	O	O	O
hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
forms	O	O	O
multimeric	O	O	B-T116
channels	O	O	I-T116
eligible	O	O	O
for	O	O	O
ion	O	O	B-T043
transport	O	O	I-T043
across	O	O	O
the	O	O	O
endoplasmic	O	O	B-T026
reticulum	O	O	I-T026
membrane	O	O	I-T026
.	O	O	O

Currently	O	O	O
the	O	O	O
subject	O	O	B-T078
of	O	O	O
many	O	O	O
studies	O	O	B-T062
and	O	O	O
discussion	O	O	O
,	O	O	O
the	O	O	O
molecular	O	O	B-T044
assembly	O	O	I-T044
of	O	O	O
the	O	O	O
ion	O	O	B-T116
channel	O	O	I-T116
and	O	O	O
the	O	O	O
structural	O	O	B-T082
characteristics	O	O	B-T080
of	O	O	O
the	O	O	O
p7	O	O	B-T116
monomer	O	O	B-T104
are	O	O	O
not	O	O	O
yet	O	O	O
fully	O	O	O
understood	O	O	O
.	O	O	O

Structural	O	O	B-T082
investigation	O	O	B-T169
of	O	O	O
p7	O	O	B-T116
has	O	O	O
been	O	O	O
carried	O	O	O
out	O	O	O
only	O	O	O
in	O	O	O
detergent	O	O	B-T120
environments	O	O	B-T082
,	O	O	O
making	O	O	O
the	O	O	O
interpretation	O	O	O
of	O	O	O
the	O	O	O
experimental	O	O	O
results	O	O	O
somewhat	O	O	O
questionable	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
analyze	O	O	B-T062
by	O	O	O
means	O	O	O
of	O	O	O
molecular	O	O	B-T066
dynamics	O	O	I-T066
simulations	O	O	I-T066
the	O	O	O
structure	O	O	B-T082
of	O	O	O
the	O	O	O
p7	O	O	B-T116
monomer	O	O	B-T104
as	O	O	O
a	O	O	O
function	O	O	O
of	O	O	O
its	O	O	O
sequence	O	O	B-T087
,	O	O	O
initial	O	O	O
conformation	O	O	B-T082
and	O	O	O
environment	O	O	B-T082
.	O	O	O

We	O	O	O
investigate	O	O	O
the	O	O	O
conductance	O	O	B-UnknownType
properties	O	O	O
of	O	O	O
three	O	O	O
models	O	O	B-T075
of	O	O	O
a	O	O	O
hexameric	O	O	B-T104
p7	O	O	B-T116
ion	O	O	B-T116
channel	O	O	I-T116
by	O	O	O
examining	O	O	O
ion	O	O	B-T043
translocation	O	O	I-T043
in	O	O	O
a	O	O	O
pure	O	O	O
lipid	O	O	B-T026
bilayer	O	O	I-T026
.	O	O	O

It	O	O	O
is	O	O	O
noteworthy	O	O	O
that	O	O	O
although	O	O	O
none	O	O	O
of	O	O	O
the	O	O	O
models	O	O	B-T075
reflects	O	O	O
the	O	O	O
experimentally	O	O	O
observed	O	O	O
trend	O	O	O
to	O	O	O
conduct	O	O	O
preferentially	O	O	O
cations	O	O	B-T104
,	O	O	O
we	O	O	O
were	O	O	O
able	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
position	O	O	B-T082
and	O	O	O
orientation	O	O	B-T082
of	O	O	O
titratable	O	O	O
acidic	O	O	B-T077
or	O	O	I-T077
basic	O	O	I-T077
residues	O	O	I-T077
playing	O	O	O
a	O	O	O
crucial	O	O	O
role	O	O	O
in	O	O	O
ion	O	O	B-T196
selectivity	O	O	B-T052
and	O	O	O
in	O	O	O
the	O	O	O
overall	O	O	O
conductance	O	O	B-UnknownType
of	O	O	O
the	O	O	O
channel	O	O	B-T116
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
too	O	O	O
compact	O	O	O
a	O	O	O
packing	O	O	B-T044
of	O	O	O
the	O	O	O
monomers	O	O	B-T104
leads	O	O	O
to	O	O	O
channel	O	O	B-T116
collapse	O	O	B-T067
rather	O	O	O
than	O	O	O
formation	O	O	O
of	O	O	O
a	O	O	O
reasonable	O	O	O
pore	O	O	B-T026
,	O	O	O
amenable	O	O	O
to	O	O	O
ion	O	O	B-T043
translocation	O	O	I-T043
.	O	O	O

The	O	O	O
present	O	O	O
findings	O	O	O
are	O	O	O
envisioned	O	O	O
to	O	O	O
help	O	O	O
assess	O	O	O
the	O	O	O
physiological	O	O	B-T169
relevance	O	O	B-T080
of	O	O	O
p7	O	O	B-T116
ion	O	O	B-T116
channel	O	O	I-T116
models	O	O	B-T075
consisting	O	O	O
of	O	O	O
multimeric	O	O	B-T082
structures	O	O	I-T082
obtained	O	O	O
in	O	O	O
non-native	O	O	O
environments	O	O	B-T082
.	O	O	O

-DOCSTART- (27502941)

The	O	O	O
genome	O	O	B-T028
-scale	O	O	O
DNA-binding	O	O	B-T045
profile	O	O	B-T059
of	O	O	O
BarR	O	O	B-T116
,	O	O	O
a	O	O	O
β-alanine	O	O	B-T116
responsive	O	O	B-T169
transcription	O	O	B-T116
factor	O	O	I-T116
in	O	O	O
the	O	O	O
archaeon	O	O	B-T194
Sulfolobus	O	O	O
acidocaldarius	O	O	O

The	O	O	O
Leucine-responsive	O	O	B-T116
Regulatory	O	O	I-T116
Protein	O	O	I-T116
(	O	O	O
Lrp	O	O	B-T116
)	O	O	O
family	O	O	B-T116
is	O	O	O
a	O	O	O
widespread	O	O	O
family	O	O	O
of	O	O	O
regulatory	O	O	B-T116
transcription	O	O	I-T116
factors	O	O	I-T116
in	O	O	O
prokaryotes	O	O	B-T001
.	O	O	O

BarR	O	O	B-T116
is	O	O	O
an	O	O	O
Lrp	O	O	B-T116
-like	O	O	O
transcription	O	O	B-T116
factor	O	O	I-T116
in	O	O	O
the	O	O	O
model	O	O	O
archaeon	O	O	B-T194
Sulfolobus	O	O	B-T194
acidocaldarius	O	O	I-T194
that	O	O	O
activates	O	O	B-T052
the	O	O	O
expression	O	O	B-T045
of	O	O	O
a	O	O	O
β-alanine	O	O	B-T028
aminotransferase	O	O	I-T028
gene	O	O	I-T028
,	O	O	O
which	O	O	O
is	O	O	O
involved	O	O	O
in	O	O	O
β-alanine	O	O	B-T044
degradation	O	O	I-T044
.	O	O	O

In	O	O	O
contrast	O	O	O
to	O	O	O
classical	O	O	O
Lrp	O	O	B-T116
-like	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
BarR	O	O	B-T116
is	O	O	O
not	O	O	B-T033
responsive	O	O	I-T033
to	O	O	O
any	O	O	O
of	O	O	O
the	O	O	O
α-amino	O	O	B-T116
acids	O	O	I-T116
but	O	O	O
interacts	O	O	O
specifically	O	O	O
with	O	O	O
β-alanine	O	O	B-T116
.	O	O	O

Besides	O	O	O
the	O	O	O
juxtaposed	O	O	O
β-alanine	O	O	B-T116
aminotransferase	O	O	I-T028
gene	O	O	I-T028
,	O	O	O
other	O	O	O
regulatory	O	O	O
targets	O	O	O
of	O	O	O
BarR	O	O	B-T116
have	O	O	O
not	O	O	O
yet	O	O	O
been	O	O	O
identified	O	O	O
although	O	O	O
β-alanine	O	O	O
is	O	O	O
the	O	O	O
precursor	O	O	B-T116
of	O	O	O
coenzyme	O	O	B-T114
A	O	O	I-T114
and	O	O	O
thus	O	O	O
an	O	O	O
important	O	O	O
central	O	O	O
metabolite	O	O	B-T123
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
extend	O	O	O
the	O	O	O
knowledge	O	O	O
of	O	O	O
the	O	O	O
DNA-binding	O	O	B-T045
characteristics	O	O	B-T080
of	O	O	O
BarR	O	O	B-T116
and	O	O	O
of	O	O	O
its	O	O	O
corresponding	O	O	O
regulon	O	O	B-T028
from	O	O	O
a	O	O	O
local	O	O	B-T082
to	O	O	O
a	O	O	O
genome	O	O	B-T028
-wide	O	O	O
perspective	O	O	O
.	O	O	O

We	O	O	O
characterized	O	O	O
the	O	O	O
genome-wide	O	O	B-T059
binding	O	O	I-T059
profile	O	O	I-T059
of	O	O	O
BarR	O	O	B-T116
using	O	O	O
chromatin	O	O	B-T059
immunoprecipation	O	O	I-T059
combined	O	O	O
with	O	O	O
high-throughput	O	O	B-T063
sequencing	O	O	I-T063
(	O	O	O
ChIP-seq	O	O	B-T063
)	O	O	O
.	O	O	O

This	O	O	O
revealed	O	O	O
21	O	O	O
genomic	O	O	B-T028
binding	O	O	B-T044
loci	O	O	B-T082
.	O	O	O

High-enrichment	O	O	O
binding	O	O	B-T045
regions	O	O	I-T045
were	O	O	O
validated	O	O	O
to	O	O	O
interact	O	O	O
with	O	O	O
purified	O	O	O
BarR	O	O	B-T116
protein	O	O	I-T116
in	O	O	B-T080
vitro	O	O	I-T080
using	O	O	O
electrophoretic	O	O	B-T059
mobility	O	O	I-T059
shift	O	O	I-T059
assays	O	O	I-T059
and	O	O	O
almost	O	O	O
all	O	O	O
targets	O	O	O
were	O	O	O
also	O	O	O
shown	O	O	O
to	O	O	O
harbour	O	O	O
a	O	O	O
conserved	O	O	B-T086
semi-palindromic	O	O	B-T114
binding	O	O	B-T087
motif	O	O	I-T087
.	O	O	O

Only	O	O	O
a	O	O	O
small	O	O	O
subset	O	O	O
of	O	O	O
enriched	O	O	O
genomic	O	O	B-T028
sites	O	O	I-T028
are	O	O	O
located	O	O	O
in	O	O	O
intergenic	O	O	B-T114
regions	O	O	I-T114
at	O	O	O
a	O	O	O
relative	O	O	O
short	O	O	O
distance	O	O	O
to	O	O	O
a	O	O	O
promoter	O	O	B-T114
,	O	O	O
and	O	O	O
qRT-PCR	O	O	B-T059
analysis	O	O	I-T059
demonstrated	O	O	O
that	O	O	O
only	O	O	O
one	O	O	O
additional	O	O	O
operon	O	O	B-T028
is	O	O	O
under	O	O	O
activation	O	O	B-T045
of	O	O	O
BarR	O	O	B-T116
,	O	O	O
namely	O	O	O
the	O	O	O
glutamine	O	O	B-T028
synthase	O	O	I-T028
operon	O	O	I-T028
.	O	O	O

The	O	O	O
latter	O	O	O
is	O	O	O
also	O	O	O
a	O	O	O
target	O	O	O
of	O	O	O
other	O	O	O
Lrp	O	O	B-T116
-like	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
.	O	O	O

Detailed	O	O	O
inspection	O	O	O
of	O	O	O
the	O	O	O
BarR	O	O	B-T116
ChIP-seq	O	O	B-T034
profile	O	O	I-T034
at	O	O	O
the	O	O	O
β-alanine	O	O	B-T114
aminotransferase	O	O	I-T114
promoter	O	O	I-T114
region	O	O	I-T114
in	O	O	O
combination	O	O	B-T080
with	O	O	O
binding	O	O	B-T087
motif	O	O	I-T087
predictions	O	O	O
indicate	O	O	O
that	O	O	O
the	O	O	O
operator	O	O	B-T114
structure	O	O	I-T114
is	O	O	O
more	O	O	O
complicated	O	O	B-T169
than	O	O	O
previously	O	O	O
anticipated	O	O	O
,	O	O	O
consisting	O	O	O
of	O	O	O
multiple	O	O	B-T114
(	O	O	I-T114
major	O	O	I-T114
and	O	O	I-T114
auxiliary	O	O	I-T114
)	O	O	I-T114
operators	O	O	I-T114
.	O	O	O

BarR	O	O	B-T116
has	O	O	O
a	O	O	O
limited	O	O	B-T169
regulon	O	O	B-T028
,	O	O	O
and	O	O	O
includes	O	O	O
also	O	O	O
glutamine	O	O	B-T028
synthase	O	O	I-T028
genes	O	O	I-T028
besides	O	O	O
the	O	O	O
previously	O	O	O
characterized	O	O	O
β-alanine	O	O	B-T028
aminotransferase	O	O	I-T028
.	O	O	O

Regulation	O	O	B-T038
of	O	O	O
glutamine	O	O	B-T116
synthase	O	O	I-T116
is	O	O	O
suggestive	O	O	O
of	O	O	O
a	O	O	O
link	O	O	O
between	O	O	O
β-alanine	O	O	B-T044
and	O	O	O
α-amino	O	O	B-T044
acid	O	O	I-T044
metabolism	O	O	I-T044
in	O	O	O
S.	O	O	B-T194
acidocaldarius	O	O	I-T194
.	O	O	O

Furthermore	O	O	O
,	O	O	O
this	O	O	O
work	O	O	O
reveals	O	O	O
that	O	O	O
the	O	O	O
BarR	O	O	B-T116
regulon	O	O	B-T028
overlaps	O	O	O
with	O	O	O
that	O	O	O
of	O	O	O
other	O	O	O
Lrp	O	O	B-T116
-like	O	O	O
regulators	O	O	B-T077
.	O	O	O

-DOCSTART- (27503472)

GH32	O	O	B-T116
family	O	O	I-T116
activity	O	O	B-T044
:	O	O	O
a	O	O	O
topological	O	O	B-T082
approach	O	O	O
through	O	O	O
protein	O	O	O
contact	O	O	O
networks	O	O	O

The	O	O	O
application	O	O	O
of	O	O	O
Protein	O	O	B-T169
Contact	O	O	I-T169
Networks	O	O	I-T169
methodology	O	O	I-T169
allowed	O	O	O
to	O	O	O
highlight	O	O	O
a	O	O	O
novel	O	O	O
response	O	O	O
of	O	O	O
border	O	O	B-T082
region	O	O	I-T082
between	O	O	O
the	O	O	O
two	O	O	O
domains	O	O	B-T087
to	O	O	I-T087
substrate	O	O	I-T087
binding	O	O	I-T087
.	O	O	O

Glycoside	O	O	B-T116
hydrolases	O	O	I-T116
(	O	O	O
GH	O	O	B-T116
)	O	O	O
are	O	O	O
enzymes	O	O	B-T116
that	O	O	O
mainly	O	O	O
hydrolyze	O	O	B-T070
the	O	O	O
glycosidic	O	O	B-T044
bond	O	O	I-T044
between	O	O	O
two	O	O	O
carbohydrates	O	O	B-T109
or	O	O	O
a	O	O	O
carbohydrate	O	O	B-T109
and	O	O	O
a	O	O	O
non-carbohydrate	O	O	B-T104
moiety	O	O	I-T104
.	O	O	O

These	O	O	O
enzymes	O	O	B-T116
are	O	O	O
involved	O	O	O
in	O	O	O
many	O	O	O
fundamental	O	O	O
and	O	O	O
diverse	O	O	O
biological	O	O	B-T038
processes	O	O	I-T038
in	O	O	O
plants	O	O	B-T002
.	O	O	O

We	O	O	O
have	O	O	O
focused	O	O	O
on	O	O	O
the	O	O	O
GH32	O	O	B-T116
family	O	O	I-T116
,	O	O	O
including	O	O	O
enzymes	O	O	B-T116
very	O	O	O
similar	O	O	O
in	O	O	O
both	O	O	O
sequence	O	O	B-T087
and	O	O	O
structure	O	O	B-T116
,	O	O	O
each	O	O	O
having	O	O	O
however	O	O	O
clear	O	O	O
specificities	O	O	O
of	O	O	O
substrate	O	O	B-T120
preferences	O	O	B-T078
and	O	O	O
kinetic	O	O	B-T169
properties	O	O	I-T169
.	O	O	O

Structural	O	O	B-T116
and	O	O	O
topological	O	O	B-T082
differences	O	O	O
among	O	O	O
proteins	O	O	B-T116
of	O	O	O
the	O	O	O
GH32	O	O	B-T116
family	O	O	I-T116
have	O	O	O
been	O	O	O
here	O	O	O
identified	O	O	O
by	O	O	O
means	O	O	O
of	O	O	O
an	O	O	O
emerging	O	O	O
approach	O	O	O
(	O	O	O
Protein	O	O	B-T169
Contact	O	O	I-T169
network	O	O	I-T169
,	O	O	O
PCN	O	O	B-T169
)	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
formalization	O	O	O
of	O	O	O
3D	O	O	B-T082
structures	O	O	I-T082
as	O	O	O
contact	O	O	B-T169
networks	O	O	I-T169
among	O	O	O
amino-acid	O	O	B-T087
residues	O	O	I-T087
.	O	O	O

The	O	O	O
PCN	O	O	B-T169
approach	O	O	O
proved	O	O	O
successful	O	O	O
in	O	O	O
both	O	O	O
reconstructing	O	O	O
the	O	O	O
already	O	O	O
known	O	O	O
functional	O	O	B-T169
domains	O	O	B-T087
and	O	O	O
in	O	O	O
identifying	O	O	O
the	O	O	O
structural	O	O	B-T116
counterpart	O	O	O
of	O	O	O
the	O	O	O
properties	O	O	O
of	O	O	O
GH32	O	O	B-T116
enzymes	O	O	I-T116
,	O	O	O
which	O	O	O
remain	O	O	O
uncertain	O	O	O
,	O	O	O
like	O	O	O
their	O	O	O
allosteric	O	O	B-T169
character	O	O	O
.	O	O	O

The	O	O	O
main	O	O	O
outcome	O	O	O
of	O	O	O
the	O	O	O
study	O	O	O
was	O	O	O
the	O	O	O
discovery	O	O	O
of	O	O	O
the	O	O	O
activation	O	O	B-T044
upon	O	O	O
binding	O	O	B-T044
of	O	O	I-T044
the	O	O	I-T044
border	O	O	I-T044
(	O	O	I-T044
cleft	O	O	I-T044
)	O	O	I-T044
region	O	O	I-T044
between	O	O	O
the	O	O	O
two	O	O	O
domains	O	O	B-T087
.	O	O	O

This	O	O	O
reveals	O	O	O
the	O	O	O
allosteric	O	O	B-T169
nature	O	O	O
of	O	O	O
the	O	O	O
enzymatic	O	O	B-T044
activity	O	O	I-T044
for	O	O	O
all	O	O	O
the	O	O	O
analyzed	O	O	O
forms	O	O	O
in	O	O	O
the	O	O	O
GH32	O	O	B-T116
family	O	O	I-T116
,	O	O	O
a	O	O	O
character	O	O	O
yet	O	O	O
to	O	O	O
be	O	O	O
highlighted	O	O	O
in	O	O	O
biochemical	O	O	B-T059
studies	O	O	I-T059
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
been	O	O	O
able	O	O	O
to	O	O	O
recognize	O	O	O
a	O	O	O
topological	O	O	B-T082
signature	O	O	I-T082
(	O	O	O
graph	O	O	O
energy	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
different	O	O	O
affinity	O	O	B-T070
of	O	O	O
the	O	O	O
enzymes	O	O	B-T116
towards	O	O	O
small	O	O	O
and	O	O	O
large	O	O	O
substrates	O	O	B-T120
.	O	O	O

-DOCSTART- (27503979)

Grasping	O	O	B-T040
At	O	O	O
The	O	O	O
Moon	O	O	B-T083
:	O	O	O
Enhancing	O	O	B-T052
Access	O	O	B-T082
To	O	O	O
Careers	O	O	B-T057
In	O	O	O
The	O	O	O
Health	O	O	O
Professions	O	O	O

A	O	O	O
former	O	O	B-T078
HHS	O	O	B-T093
secretary	O	O	B-T097
reflects	O	O	B-T041
on	O	O	O
what	O	O	O
's	O	O	O
needed	O	O	O
to	O	O	O
enable	O	O	O
more	O	O	O
minorities	O	O	B-T098
to	O	O	O
become	O	O	O
doctors	O	O	B-T097
and	O	O	O
other	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
.	O	O	O

-DOCSTART- (27504100)

Multivariate	O	O	B-T081
Imaging	O	O	B-T060
Genetics	O	O	B-T062
Study	O	O	I-T062
of	O	O	O
MRI	O	O	B-T060
Gray	O	O	B-T024
Matter	O	O	I-T024
Volume	O	O	B-T081
and	O	O	O
SNPs	O	O	B-T086
Reveals	O	O	O
Biological	O	O	B-T080
Pathways	O	O	B-T077
Correlated	O	O	B-T080
with	O	O	O
Brain	O	O	B-T023
Structural	O	O	B-T082
Differences	O	O	B-T081
in	O	O	O
Attention	O	O	O
Deficit	O	O	O
Hyperactivity	O	O	O
Disorder	O	O	O

Attention	O	O	B-T048
deficit	O	O	I-T048
hyperactivity	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
ADHD	O	O	B-T048
)	O	O	O
is	O	O	O
a	O	O	O
prevalent	O	O	B-T081
neurodevelopmental	O	O	B-T048
disorder	O	O	I-T048
affecting	O	O	B-T169
children	O	O	B-T100
,	O	O	O
adolescents	O	O	B-T100
,	O	O	O
and	O	O	O
adults	O	O	B-T100
.	O	O	O

Its	O	O	O
etiology	O	O	B-T169
is	O	O	O
not	O	O	O
well	O	O	O
understood	O	O	O
,	O	O	O
but	O	O	O
it	O	O	O
is	O	O	O
increasingly	O	O	O
believed	O	O	O
to	O	O	O
result	O	O	B-T169
from	O	O	O
diverse	O	O	B-T080
pathophysiologies	O	O	B-T046
that	O	O	O
affect	O	O	B-T169
the	O	O	O
structure	O	O	B-T082
and	O	O	O
function	O	O	B-T169
of	O	O	O
specific	O	O	B-T080
brain	O	O	B-UnknownType
circuits	O	O	I-UnknownType
.	O	O	O

Although	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
best-studied	O	O	O
neurobiological	O	O	B-T047
abnormalities	O	O	I-T047
in	O	O	O
ADHD	O	O	B-T048
is	O	O	O
reduced	O	O	B-T080
fronto-striatal-cerebellar	O	O	B-T023
gray	O	O	I-T023
matter	O	O	I-T023
(	O	O	O
GM	O	O	B-T024
)	O	O	O
volume	O	O	B-T081
,	O	O	O
its	O	O	O
specific	O	O	O
genetic	O	O	B-T169
correlates	O	O	B-T080
are	O	O	O
largely	O	O	O
unknown	O	O	B-T080
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
T1-weighted	O	O	B-T060
MR	O	O	I-T060
images	O	O	I-T060
of	O	O	I-T060
brain	O	O	I-T060
structure	O	O	I-T060
were	O	O	O
collected	O	O	O
from	O	O	O
198	O	O	O
adolescents	O	O	B-T100
(	O	O	O
63	O	O	O
ADHD	O	O	B-T048
-	O	O	O
diagnosed	O	O	B-T033
)	O	O	O
.	O	O	O

A	O	O	O
multivariate	O	O	B-T081
parallel	O	O	I-T081
independent	O	O	I-T081
component	O	O	I-T081
analysis	O	O	I-T081
(	O	O	O
Para-ICA	O	O	B-T081
)	O	O	O
technique	O	O	B-T169
-identified	O	O	O
imaging	O	O	B-T060
genetic	O	O	B-T169
relationships	O	O	B-T080
between	O	O	O
regional	O	O	B-T082
GM	O	O	B-T024
volume	O	O	B-T081
and	O	O	O
single	O	O	B-T086
nucleotide	O	O	I-T086
polymorphism	O	O	I-T086
data	O	O	B-T078
.	O	O	O

Para-ICA	O	O	B-T081
analyses	O	O	I-T081
extracted	O	O	O
14	O	O	O
components	O	O	O
from	O	O	O
genetic	O	O	B-T170
data	O	O	B-T078
and	O	O	O
9	O	O	O
from	O	O	O
MR	O	O	B-T060
data	O	O	O
.	O	O	O

An	O	O	O
iterative	O	O	B-T062
cross-validation	O	O	I-T062
using	O	O	O
randomly	O	O	O
chosen	O	O	O
subsamples	O	O	O
indicated	O	O	O
acceptable	O	O	O
stability	O	O	B-T080
of	O	O	O
these	O	O	O
ICA	O	O	B-T081
solutions	O	O	B-T077
.	O	O	O

A	O	O	O
series	O	O	O
of	O	O	O
partial	O	O	B-UnknownType
correlation	O	O	I-UnknownType
analyses	O	O	I-UnknownType
controlling	O	O	B-T067
for	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
and	O	O	O
ethnicity	O	O	B-T080
revealed	O	O	O
two	O	O	O
genotype-phenotype	O	O	B-T032
component	O	O	B-T077
pairs	O	O	B-T080
significantly	O	O	O
differed	O	O	O
between	O	O	O
ADHD	O	O	B-T048
and	O	O	O
non-ADHD	O	O	B-T033
groups	O	O	B-T078
,	O	O	O
after	O	O	O
a	O	O	O
Bonferroni	O	O	B-T081
correction	O	O	I-T081
for	O	O	O
multiple	O	O	B-T081
comparisons	O	O	B-T052
.	O	O	O

The	O	O	O
brain	O	O	B-T023
phenotype	O	O	B-T032
component	O	O	B-T077
not	O	O	O
only	O	O	O
included	O	O	O
structures	O	O	B-T082
frequently	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
abnormally	O	O	B-T080
low	O	O	I-T080
volume	O	O	B-T081
in	O	O	O
previous	O	O	O
ADHD	O	O	B-T048
studies	O	O	B-T062
but	O	O	O
was	O	O	O
also	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
ADHD	O	O	O
differences	O	O	O
in	O	O	O
symptom	O	O	B-T033
severity	O	O	I-T033
and	O	O	O
performance	O	O	B-T052
on	O	O	O
cognitive	O	O	B-T170
tests	O	O	I-T170
frequently	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
impaired	O	O	O
in	O	O	O
patients	O	O	B-T101
diagnosed	O	O	B-T033
with	O	O	O
the	O	O	O
disorder	O	O	B-T047
.	O	O	O

Pathway	O	O	B-T170
analysis	O	O	I-T170
of	O	O	O
the	O	O	O
genotype	O	O	B-T032
component	O	O	B-T077
identified	O	O	O
several	O	O	O
different	O	O	O
biological	O	O	B-T080
pathways	O	O	B-T077
linked	O	O	O
to	O	O	O
these	O	O	O
structural	O	O	B-T082
abnormalities	O	O	B-T033
in	O	O	O
ADHD	O	O	B-T048
.	O	O	O

Some	O	O	O
of	O	O	O
these	O	O	O
pathways	O	O	B-T077
implicate	O	O	O
well-known	O	O	O
dopaminergic	O	O	B-T042
neurotransmission	O	O	I-T042
and	O	O	O
neurodevelopment	O	O	B-T042
hypothesized	O	O	B-T078
to	O	O	O
be	O	O	O
abnormal	O	O	B-T033
in	O	O	O
ADHD	O	O	B-T048
.	O	O	O

Other	O	O	O
more	O	O	O
recently	O	O	O
implicated	O	O	O
pathways	O	O	B-T077
included	O	O	O
glutamatergic	O	O	B-T043
and	O	O	O
GABA-eric	O	O	B-T042
physiological	O	O	I-T042
systems	O	O	I-T042
;	O	O	O
others	O	O	O
might	O	O	O
reflect	O	O	O
sources	O	O	O
of	O	O	O
shared	O	O	O
liability	O	O	O
to	O	O	O
disturbances	O	O	O
commonly	O	O	O
found	O	O	O
in	O	O	O
ADHD	O	O	B-T048
,	O	O	O
such	O	O	O
as	O	O	O
sleep	O	O	B-T184
abnormalities	O	O	I-T184
.	O	O	O

-DOCSTART- (27504422)

Clinicopathological	O	O	B-T058
and	O	O	O
Immunohistochemical	O	O	B-T059
Characteristics	O	O	O
of	O	O	O
Verruciform	O	O	B-T047
Xanthoma	O	O	I-T047
of	O	O	O
the	O	O	O
Lower	O	O	B-T023
Gingiva	O	O	I-T023
:	O	O	O
A	O	O	O
Case	O	O	O
Report	O	O	O

Verruciform	O	O	B-T047
xanthoma	O	O	I-T047
(	O	O	O
VX	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
rare	O	O	O
benign	O	O	B-T191
lesion	O	O	I-T191
and	O	O	O
mainly	O	O	O
effects	O	O	O
the	O	O	O
oral	O	O	B-T023
mucosa	O	O	I-T023
.	O	O	O

This	O	O	O
slow-growing	O	O	B-T033
asymptomatic	O	O	B-T033
lesion	O	O	B-T191
typically	O	O	O
develops	O	O	O
along	O	O	O
the	O	O	O
gingival	O	O	B-T029
margin	O	O	I-T029
of	O	O	O
the	O	O	O
masticatory	O	O	B-T169
mucosa	O	O	B-T024
,	O	O	O
followed	O	O	O
by	O	O	O
the	O	O	O
hard	O	O	B-T023
palate	O	O	I-T023
,	O	O	O
tongue	O	O	B-T023
,	O	O	O
buccal	O	O	B-T023
mucosa	O	O	I-T023
,	O	O	O
floor	O	O	B-T029
of	O	O	I-T029
the	O	O	I-T029
mouth	O	O	I-T029
,	O	O	O
alveolar	O	O	B-T029
mucosa	O	O	I-T029
,	O	O	O
soft	O	O	B-T023
palate	O	O	I-T023
and	O	O	O
junction	O	O	B-T082
between	O	O	O
the	O	O	O
hard	O	O	O
and	O	O	O
soft	O	O	O
palate	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
this	O	O	O
lesion	O	O	B-T191
can	O	O	O
also	O	O	O
affect	O	O	O
the	O	O	O
skin	O	O	B-T022
and	O	O	O
genital	O	O	B-T023
organs	O	O	I-T023
.	O	O	O

Clinically	O	O	B-T080
,	O	O	O
VX	O	O	B-T047
generally	O	O	O
presents	O	O	O
a	O	O	O
sessile	O	O	B-T033
or	O	O	O
pedunculated	O	O	B-T033
appearance	O	O	I-T033
,	O	O	O
forming	O	O	O
a	O	O	O
papule	O	O	B-T033
or	O	O	O
single	O	O	B-T033
plaque	O	O	I-T033
with	O	O	O
verrucous	O	O	B-T191
or	O	O	O
papillomatous	O	O	B-T191
mucosal	O	O	B-T024
growth	O	O	B-T042
.	O	O	O

The	O	O	O
colour	O	O	B-T080
(	O	O	O
white	O	O	B-T080
,	O	O	O
pink	O	O	B-T080
,	O	O	O
grey	O	O	B-T080
,	O	O	O
or	O	O	O
yellow	O	O	B-T080
)	O	O	O
depends	O	O	O
on	O	O	O
the	O	O	O
thickness	O	O	B-T080
of	O	O	O
the	O	O	O
overlying	O	O	O
epidermis	O	O	B-T024
.	O	O	O

In	O	O	O
fact	O	O	O
,	O	O	O
the	O	O	O
clinical	O	O	B-T080
findings	O	O	B-T033
of	O	O	O
VX	O	O	B-T047
are	O	O	O
similar	O	O	O
to	O	O	O
those	O	O	O
of	O	O	O
verrucous	O	O	B-T191
carcinoma	O	O	I-T191
and	O	O	O
other	O	O	O
benign	O	O	B-T191
tumours	O	O	I-T191
,	O	O	O
such	O	O	O
as	O	O	O
squamous	O	O	B-T191
papilloma	O	O	I-T191
,	O	O	O
verruca	O	O	B-T047
vulgaris	O	O	I-T047
and	O	O	O
mucosal	O	O	B-T191
fibroma	O	O	I-T191
.	O	O	O

For	O	O	O
this	O	O	O
reason	O	O	O
,	O	O	O
clinical	O	O	B-T080
and	O	O	O
histopathological	O	O	B-T169
examinations	O	O	B-T058
are	O	O	O
essential	O	O	O
for	O	O	O
accurate	O	O	B-T060
differential	O	O	I-T060
diagnosis	O	O	I-T060
.	O	O	O

Histologically	O	O	B-T169
,	O	O	O
VX	O	O	B-T047
is	O	O	O
characterized	O	O	O
by	O	O	O
parakeratosis	O	O	B-T047
,	O	O	O
rete	O	O	B-T024
ridges	O	O	I-T024
of	O	O	O
uniform	O	O	O
depth	O	O	O
and	O	O	O
the	O	O	O
accumulation	O	O	B-T033
of	O	O	O
foam	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
which	O	O	O
are	O	O	O
also	O	O	O
called	O	O	O
"	O	O	O
xanthoma	O	O	B-T025
cells	O	O	I-T025
"	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
the	O	O	O
clinicopathological	O	O	B-T058
and	O	O	O
immunohistochemical	O	O	B-T059
findings	O	O	B-T033
of	O	O	O
a	O	O	O
VX	O	O	B-T047
located	O	O	O
on	O	O	O
the	O	O	O
lower	O	O	B-T023
gingiva	O	O	I-T023
of	O	O	O
a	O	O	O
64-year-old	O	O	O
male	O	O	B-T032
patient	O	O	I-T032
.	O	O	O

-DOCSTART- (27507301)

MicroRNA	O	O	B-T028
101b	O	O	I-T028
Is	O	O	O
Downregulated	O	O	B-T044
in	O	O	O
the	O	O	O
Prefrontal	O	O	B-T023
Cortex	O	O	I-T023
of	O	O	O
a	O	O	O
Genetic	O	O	B-T170
Model	O	O	I-T170
of	O	O	O
Depression	O	O	B-T048
and	O	O	O
Targets	O	O	B-T169
the	O	O	O
Glutamate	O	O	B-T116
Transporter	O	O	I-T116
SLC1A1	O	O	B-T116
(	O	O	O
EAAT3	O	O	B-T116
)	O	O	O
in	O	O	O
Vitro	O	O	O

MicroRNAs	O	O	B-T114
(	O	O	O
miRNAs	O	O	B-T114
)	O	O	O
are	O	O	O
small	O	O	B-T081
regulatory	O	O	B-T077
molecules	O	O	B-T167
that	O	O	O
cause	O	O	O
translational	O	O	B-T045
repression	O	O	I-T045
by	O	O	O
base	O	O	B-T044
pairing	O	O	I-T044
with	O	O	I-T044
target	O	O	I-T044
mRNAs	O	O	I-T044
.	O	O	O

Cumulative	O	O	B-T080
evidence	O	O	B-T078
suggests	O	O	O
that	O	O	O
changes	O	O	B-T169
in	O	O	O
miRNA	O	O	B-T028
expression	O	O	B-T045
may	O	O	O
in	O	O	O
part	O	O	O
underlie	O	O	O
the	O	O	O
pathophysiology	O	O	B-T169
and	O	O	O
treatment	O	O	B-T061
of	O	O	O
neuropsychiatric	O	O	B-T047
disorders	O	O	I-T047
,	O	O	O
including	O	O	O
major	O	O	B-T048
depressive	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
MDD	O	O	B-T048
)	O	O	O
.	O	O	O

A	O	O	O
miRNA	O	O	B-T028
expression	O	O	B-T045
assay	O	O	B-T059
that	O	O	O
can	O	O	O
simultaneously	O	O	B-T079
detect	O	O	O
423	O	O	O
rat	O	O	O
miRNAs	O	O	B-T028
(	O	O	O
miRBase	O	O	O
v.17	O	O	O
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
profile	O	O	B-T059
the	O	O	O
prefrontal	O	O	B-T023
cortex	O	O	I-T023
(	O	O	O
PFC	O	O	B-T023
)	O	O	O
of	O	O	O
a	O	O	O
genetic	O	O	B-T170
rat	O	O	I-T170
model	O	O	I-T170
of	O	O	O
MDD	O	O	B-T048
(	O	O	O
the	O	O	O
Flinders	O	O	B-T170
Sensitive	O	O	I-T170
Line	O	O	I-T170
[	O	O	O
FSL	O	O	B-T170
]	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
controls	O	O	B-T096
,	O	O	O
the	O	O	O
Flinders	O	O	B-T170
Resistant	O	O	I-T170
Line	O	O	I-T170
(	O	O	O
FRL	O	O	B-T170
)	O	O	O
.	O	O	O

Gene	O	O	B-T045
expression	O	O	I-T045
data	O	O	B-T078
from	O	O	O
the	O	O	O
PFC	O	O	B-T023
of	O	O	O
FSL	O	O	B-T170
/	O	O	O
FRL	O	O	B-T170
animals	O	O	B-T008
(	O	O	O
GEO	O	O	O
accession	O	O	O
no.	O	O	O
GSE20388	O	O	O
)	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
guide	O	O	O
mRNA	O	O	B-T114
target	O	O	B-T169
selection	O	O	B-T052
.	O	O	O

Luciferase	O	O	B-T059
reporter	O	O	I-T059
assays	O	O	I-T059
were	O	O	O
used	O	O	O
to	O	O	O
verify	O	O	B-T169
miRNA	O	O	B-T028
targets	O	O	B-T169
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

We	O	O	O
identified	O	O	B-T080
23	O	O	O
miRNAs	O	O	B-T028
that	O	O	O
were	O	O	O
downregulated	O	O	B-T044
in	O	O	O
the	O	O	O
PFC	O	O	B-T023
of	O	O	O
the	O	O	O
FSL	O	O	B-T170
model	O	O	I-T170
compared	O	O	B-T052
with	O	O	O
controls	O	O	B-T096
.	O	O	O

Interestingly	O	O	O
,	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
identified	O	O	B-T080
miRNAs	O	O	B-T028
(	O	O	O
miR-101b	O	O	B-T028
)	O	O	O
is	O	O	O
highly	O	O	O
conserved	O	O	B-T080
between	O	O	O
rat	O	O	B-T015
and	O	O	O
human	O	O	B-T016
and	O	O	O
was	O	O	O
recently	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
downregulated	O	O	B-T044
in	O	O	O
the	O	O	O
PFC	O	O	B-T023
of	O	O	O
depressed	O	O	B-T184
suicide	O	O	B-T033
subjects	O	O	B-T096
.	O	O	O

Using	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
in	O	O	B-T066
silico	O	O	I-T066
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
analyses	O	O	B-T062
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
miR-101b	O	O	B-T028
targets	O	O	B-T169
the	O	O	O
neuronal	O	O	B-T025
glutamate	O	O	B-T116
transporter	O	O	I-T116
SLC1A1	O	O	B-T116
(	O	O	O
also	O	O	O
known	O	O	O
as	O	O	O
EAAC1	O	O	B-T116
or	O	O	O
EAAT3	O	O	B-T116
)	O	O	O
.	O	O	O

Accordingly	O	O	O
,	O	O	O
both	O	O	O
mRNA	O	O	B-T114
and	O	O	O
protein	O	O	B-T034
levels	O	O	I-T034
of	O	O	O
SLC1A1	O	O	B-T116
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
upregulated	O	O	B-T044
in	O	O	O
the	O	O	O
PFC	O	O	B-T023
of	O	O	O
the	O	O	O
FSL	O	O	B-T170
model	O	O	I-T170
.	O	O	O

Besides	O	O	O
providing	O	O	O
a	O	O	O
list	O	O	O
of	O	O	O
novel	O	O	O
miRNAs	O	O	B-T028
associated	O	O	B-T080
with	O	O	I-T080
depression-like	O	O	B-T033
states	O	O	I-T033
,	O	O	O
this	O	O	O
preclinical	O	O	B-T062
study	O	O	I-T062
replicated	O	O	B-T169
the	O	O	O
human	O	O	B-T016
association	O	O	B-T080
of	O	O	O
miR-101	O	O	B-T028
with	O	O	O
depression	O	O	B-T048
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
since	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
targets	O	O	B-T169
of	O	O	O
miR-101b	O	O	B-T028
appears	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
glutamate	O	O	B-T116
transporter	O	O	I-T116
,	O	O	O
our	O	O	O
preclinical	O	O	B-T080
data	O	O	B-T078
support	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
of	O	O	O
a	O	O	O
glutamatergic	O	O	B-T121
dysregulation	O	O	B-T033
being	O	O	O
implicated	O	O	O
in	O	O	O
the	O	O	O
etiology	O	O	B-T169
of	O	O	O
depression	O	O	B-T048
.	O	O	O

-DOCSTART- (27507385)

A	O	O	O
Practical	O	O	B-T097
Guide	O	O	I-T097
to	O	O	O
Forensic	O	O	B-T091
Nursing	O	O	I-T091
:	O	O	O
Incorporating	O	O	B-T169
forensic	O	O	B-T091
principles	O	O	B-T081
into	O	O	O
nursing	O	O	B-T058
practice	O	O	I-T058
Amar	O	O	B-T016
Angela	O	O	I-T016
F	O	O	I-T016
and	O	O	O
Sekula	O	O	B-T016
L	O	O	I-T016
Kathleen	O	O	I-T016
A	O	O	O
Practical	O	O	O
Guide	O	O	O
to	O	O	O
Forensic	O	O	O
Nursing	O	O	O
:	O	O	O
Incorporating	O	O	O
forensic	O	O	O
principles	O	O	O
into	O	O	O
nursing	O	O	O
practice	O	O	O
392pp	O	O	O
US$	O	O	O
59.95	O	O	O
Sigma	O	O	O
Theta	O	O	O
Tau	O	O	O
International	O	O	O
Honor	O	O	O
Society	O	O	O
of	O	O	O
Nursing	O	O	O
9781940446349	O	O	O
1940446341	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O

George	O	O	B-T016
Bernard	O	O	I-T016
Shaw	O	O	I-T016
described	O	O	O
Britons	O	O	B-T098
and	O	O	O
Americans	O	O	B-T098
as	O	O	O
'	O	O	O
divided	O	O	B-T169
by	O	O	O
a	O	O	O
common	O	O	B-T171
language	O	O	I-T171
'	O	O	O
,	O	O	O
and	O	O	O
that	O	O	O
is	O	O	O
made	O	O	O
very	O	O	O
clear	O	O	O
in	O	O	O
this	O	O	O
fascinating	O	O	B-T073
publication	O	O	I-T073
that	O	O	O
describes	O	O	O
in	O	O	O
depth	O	O	O
the	O	O	O
roles	O	O	B-T170
and	O	O	I-T170
responsibilities	O	O	I-T170
of	O	O	O
forensic	O	O	B-T097
nurses	O	O	I-T097
in	O	O	O
the	O	O	O
US	O	O	B-T083
.	O	O	O

-DOCSTART- (27508301)

Incidence	O	O	B-T081
of	O	O	O
Diabetes	O	O	B-T047
Mellitus	O	O	I-T047
and	O	O	O
Obesity	O	O	B-T047
and	O	O	O
the	O	O	O
Overlap	O	O	B-T079
of	O	O	O
Comorbidities	O	O	B-T078
in	O	O	O
HIV+	O	O	B-T034
Hispanics	O	O	B-T098
Initiating	O	O	B-T169
Antiretroviral	O	O	O
Therapy	O	O	O

Cardiovascular	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
CVD	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
leading	O	O	O
health	O	O	B-T078
threat	O	O	B-T078
for	O	O	O
HIV+	O	O	B-T034
patients	O	O	B-T101
on	O	O	O
antiretroviral	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
ART	O	O	B-T061
)	O	O	O
;	O	O	O
cardiometabolic	O	O	B-T047
comorbidities	O	O	B-T078
are	O	O	O
key	O	O	O
predictors	O	O	B-T033
of	O	O	I-T033
risk	O	O	I-T033
.	O	O	O

Data	O	O	B-T078
are	O	O	O
limited	O	O	O
on	O	O	O
incidence	O	O	B-T081
of	O	O	O
metabolic	O	O	B-T169
comorbidities	O	O	B-T078
in	O	O	O
HIV+	O	O	B-T034
individuals	O	O	B-T098
initiating	O	O	B-T169
ART	O	O	B-T061
in	O	O	O
low	O	O	B-T080
and	O	O	O
middle	O	O	B-T080
income	O	O	I-T080
countries	O	O	B-T083
(	O	O	O
LMICs	O	O	B-T083
)	O	O	O
,	O	O	O
particularly	O	O	B-T080
for	O	O	O
Hispanics	O	O	B-T098
.	O	O	O

We	O	O	O
examined	O	O	B-T033
incidence	O	O	B-T081
of	O	O	O
diabetes	O	O	B-T047
and	O	O	O
obesity	O	O	B-T047
in	O	O	O
a	O	O	O
prospective	O	O	B-T098
cohort	O	O	I-T098
of	O	O	O
those	O	O	O
initiating	O	O	B-T169
ART	O	O	B-T061
in	O	O	O
the	O	O	O
Dominican	O	O	B-T083
Republic	O	O	I-T083
.	O	O	O

Participants	O	O	B-T098
≥18	O	O	O
years	O	O	B-T079
,	O	O	O
initiating	O	O	B-T169
ART	O	O	B-T061
<	O	O	O
90	O	O	O
days	O	O	B-T079
prior	O	O	O
to	O	O	O
study	O	O	B-T062
enrollment	O	O	B-T058
,	O	O	O
were	O	O	O
examined	O	O	B-T033
for	O	O	O
incidence	O	O	B-T081
of	O	O	O
impaired	O	O	B-T033
fasting	O	O	I-T033
glucose	O	O	I-T033
(	O	O	O
IFG	O	O	B-T033
)	O	O	O
,	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
(	O	O	O
DM	O	O	B-T047
)	O	O	O
,	O	O	O
overweight	O	O	B-T047
,	O	O	I-T047
and	O	O	I-T047
obesity	O	O	I-T047
.	O	O	O

Fasting	O	O	B-T059
plasma	O	O	I-T059
glucose	O	O	I-T059
(	O	O	O
FPG	O	O	B-T059
)	O	O	O
100	O	O	O
-	O	O	O
125mg/dl	O	O	O
defined	O	O	O
IFG	O	O	B-T033
;	O	O	O
FPG	O	O	O
≥126	O	O	O
mg/dl	O	O	O
,	O	O	O
diagnosis	O	O	B-T062
per	O	O	O
medical	O	O	B-T170
record	O	O	I-T170
,	O	O	O
or	O	O	O
use	O	O	O
of	O	O	O
hypoglycemic	O	O	B-T121
medication	O	O	I-T121
defined	O	O	O
DM	O	O	B-T047
.	O	O	O

Overweight	O	O	B-T047
and	O	O	I-T047
obesity	O	O	I-T047
were	O	O	O
BMI	O	O	B-T201
25	O	O	O
-	O	O	O
30	O	O	O
and	O	O	O
≥30kg/m2	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Dyslipidemia	O	O	B-T047
was	O	O	O
total	O	O	B-T109
cholesterol	O	O	I-T109
≥240mg/dl	O	O	O
or	O	O	O
use	O	O	B-T169
of	O	O	I-T169
lipid-lowering	O	O	B-T121
medication	O	O	I-T121
.	O	O	O

Framingham	O	O	B-T170
risk	O	O	B-T058
equation	O	O	I-T170
was	O	O	O
used	O	O	B-T033
to	O	O	O
determine	O	O	B-T080
ten-year	O	O	B-T079
CVD	O	O	B-T047
risk	O	O	O
at	O	O	O
the	O	O	O
end	O	O	B-T062
of	O	O	I-T062
observation	O	O	I-T062
.	O	O	O

Of	O	O	O
153	O	O	O
initiating	O	O	B-T169
ART	O	O	B-T061
,	O	O	O
8	O	O	O
(	O	O	O
6	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
DM	O	O	B-T047
and	O	O	O
23	O	O	O
(	O	O	O
16	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
IFG	O	O	B-T033
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
6	O	O	O
developed	O	O	O
DM	O	O	O
(	O	O	O
28/1000	O	O	O
person	O	O	B-T098
-	O	O	O
years	O	O	B-T079
follow	O	O	B-T058
up	O	O	I-T058
[	O	O	O
PYFU	O	O	B-T058
]	O	O	O
)	O	O	O
and	O	O	O
46	O	O	O
developed	O	O	O
IFG	O	O	O
(	O	O	O
329/1000	O	O	O
PYFU	O	O	O
)	O	O	O
.	O	O	O

At	O	O	O
baseline	O	O	B-T081
,	O	O	O
24	O	O	O
(	O	O	O
18	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
obese	O	O	B-T047
and	O	O	O
36	O	O	O
(	O	O	O
27	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
overweight	O	O	B-T184
,	O	O	O
15	O	O	O
became	O	O	O
obese	O	O	O
(	O	O	O
69/1000	O	O	O
PYFU	O	O	B-T058
)	O	O	O
and	O	O	O
22	O	O	O
became	O	O	O
overweight	O	O	O
(	O	O	O
163/1000	O	O	O
PYFU	O	O	O
)	O	O	O
.	O	O	O

Median	O	O	B-T082
observation	O	O	B-T058
periods	O	O	B-T079
for	O	O	O
the	O	O	O
diabetes	O	O	B-T047
and	O	O	O
obesity	O	O	B-T047
analyses	O	O	B-T062
were	O	O	O
23.5	O	O	O
months	O	O	B-T079
and	O	O	O
24.3	O	O	O
months	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Increased	O	O	B-T081
CVD	O	O	B-T047
risk	O	O	B-T058
(	O	O	O
≥10	O	O	O
%	O	O	O
10-year	O	O	B-T033
Framingham	O	O	I-T033
risk	O	O	I-T033
score	O	O	I-T033
)	O	O	O
was	O	O	O
present	O	O	B-T033
for	O	O	O
13	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
cohort	O	O	B-T098
;	O	O	O
79	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
cohort	O	O	O
had	O	O	O
≥1	O	O	O
cardiometabolic	O	O	B-T078
comorbidity	O	O	I-T078
,	O	O	O
48	O	O	O
%	O	O	O
had	O	O	O
≥2	O	O	O
,	O	O	O
and	O	O	O
13	O	O	O
%	O	O	O
had	O	O	O
all	O	O	O
three	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
Hispanic	O	O	B-T098
cohort	O	O	B-T098
in	O	O	O
an	O	O	O
LMIC	O	O	B-T083
,	O	O	O
incidences	O	O	B-T081
of	O	O	O
IFG	O	O	B-T033
/	O	O	O
DM	O	O	B-T047
and	O	O	O
overweight	O	O	B-T184
/	O	O	O
obesity	O	O	B-T047
were	O	O	O
similar	O	O	B-T080
to	O	O	O
or	O	O	O
higher	O	O	B-T080
than	O	O	I-T080
that	O	O	O
found	O	O	B-T033
in	O	O	O
high	O	O	B-T033
income	O	O	I-T033
countries	O	O	B-T083
,	O	O	O
and	O	O	O
cardiometabolic	O	O	B-T047
disorders	O	O	I-T047
affected	O	O	B-T169
three-quarters	O	O	O
of	O	O	O
those	O	O	O
initiating	O	O	B-T169
ART	O	O	B-T061
.	O	O	O

Care	O	O	B-T170
models	O	O	I-T170
incorporating	O	O	O
cardiovascular	O	O	B-T047
risk	O	O	I-T047
reduction	O	O	B-T061
into	O	O	O
HIV	O	O	B-T047
treatment	O	O	B-T058
programs	O	O	I-T058
are	O	O	O
needed	O	O	B-T080
to	O	O	O
prevent	O	O	B-T169
CVD	O	O	B-T047
-	O	O	O
associated	O	O	B-T080
mortality	O	O	B-T081
in	O	O	O
this	O	O	O
vulnerable	O	O	B-T098
population	O	O	I-T098
.	O	O	O

-DOCSTART- (27508328)

Laparoscopic	O	O	B-T060
Approach	O	O	I-T060
for	O	O	O
Thermoablation	O	O	B-T061
Microwave	O	O	I-T061
in	O	O	O
the	O	O	O
Treatment	O	O	B-T061
of	O	O	O
Hepatocellular	O	O	B-T191
Carcinoma	O	O	I-T191
:	O	O	O
A	O	O	O
Single	O	O	O
Center	O	O	O
Experience	O	O	O

The	O	O	O
surgical	O	O	B-T061
therapy	O	O	I-T061
of	O	O	O
choice	O	O	O
for	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
(	O	O	O
HCC	O	O	B-T191
)	O	O	O
is	O	O	O
liver	O	O	B-T061
transplantation	O	O	I-T061
(	O	O	O
LT	O	O	B-T061
)	O	O	O
or	O	O	O
hepatic	O	O	B-T061
resection	O	O	I-T061
,	O	O	O
although	O	O	O
only	O	O	O
a	O	O	O
small	O	O	B-T081
percentage	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
can	O	O	O
undergo	O	O	O
these	O	O	O
procedures	O	O	B-T169
.	O	O	O

Microwave	O	O	B-T061
thermal	O	O	I-T061
ablation	O	O	I-T061
(	O	O	O
MWTA	O	O	B-T061
)	O	O	O
can	O	O	O
be	O	O	O
an	O	O	O
effective	O	O	B-T080
alternative	O	O	B-T077
treatment	O	O	B-T061
for	O	O	O
HCC	O	O	B-T191
that	O	O	O
complicates	O	O	B-T169
a	O	O	O
cirrhotic	O	O	B-T047
liver	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
either	O	O	O
as	O	O	O
a	O	O	O
final	O	O	B-T079
procedure	O	O	B-T169
or	O	O	O
for	O	O	O
downstaging	O	O	B-T060
patients	O	O	B-T101
on	O	O	O
the	O	O	O
waiting	O	O	O
list	O	O	O
for	O	O	O
LT	O	O	B-T061
,	O	O	O
or	O	O	O
in	O	O	O
combination	O	O	B-T080
with	O	O	O
resective	O	O	B-T061
surgery	O	O	B-T061
to	O	O	O
achieve	O	O	O
oncological	O	O	B-T191
radicality	O	O	B-T080
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
was	O	O	O
to	O	O	O
evaluate	O	O	B-T058
experience	O	O	B-T041
with	O	O	O
the	O	O	O
laparoscopic	O	O	B-T060
approach	O	O	I-T060
of	O	O	O
MWTA	O	O	B-T061
at	O	O	O
our	O	O	O
center	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
35	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
undergoing	O	O	O
MWTA	O	O	B-T061
with	O	O	O
laparoscopic	O	O	B-T060
approach	O	O	I-T060
between	O	O	O
January	O	O	O
,	O	O	O
2013	O	O	O
and	O	O	O
May	O	O	O
,	O	O	O
2016	O	O	O
,	O	O	O
we	O	O	O
reviewed	O	O	O
the	O	O	O
demographic	O	O	B-T062
data	O	O	I-T062
,	O	O	O
the	O	O	O
Barcelona	O	O	B-T185
clinic	O	O	I-T185
liver	O	O	I-T185
cancer	O	O	I-T185
stage	O	O	I-T185
,	O	O	O
the	O	O	O
severity	O	O	B-T080
of	O	O	O
cirrhotic	O	O	B-T047
liver	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
the	O	O	O
size	O	O	B-T082
of	O	O	O
the	O	O	O
ablated	O	O	B-T061
lesion	O	O	B-T033
,	O	O	O
the	O	O	O
duration	O	O	B-T079
of	O	O	O
the	O	O	O
procedure	O	O	B-T169
,	O	O	O
and	O	O	O
complications	O	O	B-T169
occurring	O	O	O
within	O	O	O
90	O	O	O
days	O	O	B-T079
of	O	O	O
surgery	O	O	B-T061
.	O	O	O

MWTA	O	O	B-T061
was	O	O	O
performed	O	O	O
by	O	O	O
applying	O	O	O
one	O	O	O
to	O	O	O
three	O	O	O
hepatic	O	O	B-T029
parenchymal	O	O	B-T024
insertions	O	O	B-T058
(	O	O	O
mean	O	O	B-T081
1.8	O	O	O
)	O	O	O
per	O	O	O
patient	O	O	B-T101
.	O	O	O

The	O	O	O
mean	O	O	B-T081
duration	O	O	B-T079
of	O	O	O
surgery	O	O	B-T061
was	O	O	O
163	O	O	O
±	O	O	O
18	O	O	O
minutes	O	O	B-T079
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
blood	O	O	B-T033
loss	O	O	I-T033
in	O	O	O
any	O	O	O
of	O	O	O
the	O	O	O
procedures	O	O	B-T169
.	O	O	O

Complete	O	O	O
necrosis	O	O	B-T042
on	O	O	O
CT	O	O	B-T060
scan	O	O	I-T060
was	O	O	O
achieved	O	O	O
in	O	O	O
26/35	O	O	O
patients	O	O	B-T101
(	O	O	O
75	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
hospital	O	O	B-T079
stay	O	O	I-T079
was	O	O	O
4.6	O	O	O
(	O	O	O
range	O	O	O
2	O	O	O
-	O	O	O
7	O	O	O
)	O	O	O
days	O	O	B-T079
;	O	O	O
major	O	O	O
complications	O	O	B-T169
were	O	O	O
postablation	O	O	B-T079
syndrome	O	O	B-T047
in	O	O	O
2/35	O	O	O
(	O	O	O
5.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
peritoneal	O	O	B-T031
fluid	O	O	I-T031
in	O	O	O
4/35	O	O	O
(	O	O	O
11.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
transient	O	O	B-T079
jaundice	O	O	B-T047
in	O	O	O
1/35	O	O	O
(	O	O	O
2.8	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
mortality	O	O	I-T033
.	O	O	O

Laparoscopic	O	O	B-T060
MWTA	O	O	B-T061
is	O	O	O
a	O	O	O
safe	O	O	O
and	O	O	O
effective	O	O	B-T080
treatment	O	O	B-T061
for	O	O	O
unresectable	O	O	B-T201
HCC	O	O	B-T191
and	O	O	O
when	O	O	O
a	O	O	O
percutaneous	O	O	B-T082
procedure	O	O	B-T169
is	O	O	O
not	O	O	O
feasible	O	O	O
.	O	O	O

-DOCSTART- (27510571)

Structured	O	O	B-T082
Instruction	O	O	B-T170
With	O	O	O
Modified	O	O	B-T169
Storybooks	O	O	B-UnknownType
to	O	O	O
Teach	O	O	B-T065
Morphosyntax	O	O	B-T090
and	O	O	O
Vocabulary	O	O	B-T170
to	O	O	O
Preschoolers	O	O	B-T100
Who	O	O	O
are	O	O	O
Deaf	O	O	B-T101
/	O	O	O
Hard	O	O	O
of	O	O	O
Hearing	O	O	O

Children	O	O	B-T100
who	O	O	O
are	O	O	O
deaf	O	O	B-T101
/	O	O	O
hard	O	O	B-T101
of	O	O	I-T101
hearing	O	O	I-T101
(	O	O	O
D	O	O	B-T101
/	O	O	O
HH	O	O	B-T101
)	O	O	O
are	O	O	O
at	O	O	B-T080
risk	O	O	I-T080
for	O	O	O
diminished	O	O	B-T081
morphosyntactical	O	O	B-T090
and	O	O	O
vocabulary	O	O	B-T170
development	O	O	B-T169
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
repeated	O	O	B-T169
reading	O	O	B-T056
combined	O	O	B-T080
with	O	O	O
structured	O	O	B-T082
instruction	O	O	B-T170
.	O	O	O

Targets	O	O	B-T169
were	O	O	O
a	O	O	O
morphosyntactical	O	O	B-T090
form	O	O	I-T090
and	O	O	O
novel	O	O	O
vocabulary	O	O	B-T170
words	O	O	I-T170
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
3	O	O	O
preschoolers	O	O	B-T100
who	O	O	O
are	O	O	O
D	O	O	B-T101
/	O	O	O
HH	O	O	B-T101
who	O	O	O
were	O	O	O
receiving	O	O	B-T080
instruction	O	O	B-T170
with	O	O	O
an	O	O	O
oral	O	O	B-T082
approach	O	O	O
.	O	O	O

Data	O	O	B-T078
from	O	O	O
a	O	O	O
multiple	O	O	B-T081
baseline	O	O	B-T062
design	O	O	I-T062
indicated	O	O	O
that	O	O	O
all	O	O	O
children	O	O	B-T100
acquired	O	O	B-T052
the	O	O	O
targeted	O	O	B-T169
skills	O	O	B-T055
and	O	O	O
demonstrated	O	O	O
high	O	O	O
levels	O	O	O
of	O	O	O
generalization	O	O	B-T041
of	O	O	O
these	O	O	O
skills	O	O	O
to	O	O	O
untrained	O	O	B-T033
context	O	O	B-T078
.	O	O	O

Implications	O	O	B-T080
for	O	O	O
teaching	O	O	B-T065
young	O	O	B-T079
children	O	O	B-T100
who	O	O	O
are	O	O	O
D	O	O	B-T101
/	O	O	O
HH	O	O	B-T101
using	O	O	B-T169
repeated	O	O	B-T169
storybook	O	O	B-UnknownType
reading	O	O	B-T056
are	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (27510784)

Application	O	O	B-T058
of	O	O	O
BRAF	O	O	B-T033
V600E	O	O	I-T033
mutation	O	O	B-T045
-	O	O	O
specific	O	O	B-T080
immunohistochemistry	O	O	B-T060
in	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
gastrointestinal	O	O	O
stromal	O	O	O
tumors	O	O	O

To	O	O	O
evaluate	O	O	B-T058
the	O	O	O
utility	O	O	O
of	O	O	O
BRAF	O	O	B-T033
V600E	O	O	I-T033
allele	O	O	B-T028
-	O	O	O
specific	O	O	B-T080
antibody	O	O	B-T116
in	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
gastrointestinal	O	O	B-T191
stromal	O	O	I-T191
tumors	O	O	I-T191
(	O	O	O
GISTs	O	O	B-T191
)	O	O	O
.	O	O	O

BRAF	O	O	B-T028
V600E	O	O	I-T033
mutation	O	O	B-T045
-	O	O	O
specific	O	O	B-T080
immunohistochemistry	O	O	B-T060
and	O	O	O
BRAF	O	O	O
sequencing	O	O	B-T169
were	O	O	O
performed	O	O	O
in	O	O	O
24	O	O	O
consecutive	O	O	B-T080
GISTs	O	O	B-T191
,	O	O	O
including	O	O	O
14	O	O	O
cases	O	O	B-T169
of	O	O	O
KIT	O	O	B-T049
or	O	O	O
PDGFRA	O	O	B-T049
mutations	O	O	I-T049
and	O	O	O
10	O	O	O
cases	O	O	O
of	O	O	O
KIT	O	O	O
/	O	O	O
PDGFRA	O	O	B-T028
wild	O	O	I-T028
GISTs	O	O	O
.	O	O	O

GISTs	O	O	B-T191
of	O	O	O
11	O	O	O
men	O	O	B-T098
and	O	O	O
13	O	O	O
women	O	O	B-T098
with	O	O	O
a	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
54	O	O	O
years(range	O	O	O
29	O	O	O
-	O	O	O
75	O	O	O
years	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
with	O	O	O
tumors	O	O	B-T191
arising	O	O	O
from	O	O	O
stomach	O	O	B-T023
(	O	O	O
16	O	O	O
cases	O	O	B-T169
)	O	O	O
,	O	O	O
small	O	O	B-T023
bowel	O	O	I-T023
(	O	O	O
7	O	O	O
cases	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
peritoneal	O	O	B-T030
cavity	O	O	I-T030
(	O	O	O
1	O	O	O
case	O	O	B-T169
)	O	O	O
.	O	O	O

Strong	O	O	B-T080
and	O	O	O
diffuse	O	O	B-T082
cytoplasmic	O	O	B-T026
BRAF	O	O	B-T116
staining	O	O	B-T033
was	O	O	O
noted	O	O	B-T080
in	O	O	O
4	O	O	O
of	O	O	O
24	O	O	O
cases	O	O	B-T169
(	O	O	O
17	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
1	O	O	O
of	O	O	O
24	O	O	O
cases	O	O	O
(	O	O	O
4	O	O	O
%	O	O	O
)	O	O	O
showed	O	O	O
weak	O	O	B-T080
staining	O	O	O
,	O	O	O
and	O	O	O
19	O	O	O
of	O	O	O
24	O	O	O
cases	O	O	O
(	O	O	O
79	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
no	O	O	B-T169
staining	O	O	O
.	O	O	O

The	O	O	O
four	O	O	O
cases	O	O	B-T169
with	O	O	O
strong	O	O	B-T080
BRAF	O	O	B-T116
immunostain	O	O	B-T130
were	O	O	O
confirmed	O	O	B-T080
to	O	O	O
have	O	O	O
BRAF	O	O	B-T049
mutations	O	O	I-T049
,	O	O	O
including	O	O	O
3	O	O	O
cases	O	O	O
in	O	O	O
the	O	O	O
stomach	O	O	B-T023
and	O	O	O
1	O	O	O
case	O	O	B-T169
in	O	O	O
the	O	O	O
small	O	O	B-T023
intestine	O	O	I-T023
.	O	O	O

All	O	O	O
tumors	O	O	B-T191
showed	O	O	O
spindle	O	O	B-T025
cell	O	O	I-T025
morphology	O	O	B-T080
.	O	O	O

Only	O	O	O
one	O	O	O
case	O	O	B-T169
had	O	O	O
progressive	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

No	O	O	B-T169
BRAF	O	O	B-T116
mutations	O	O	I-T049
were	O	O	O
detected	O	O	B-T033
in	O	O	O
cases	O	O	B-T169
with	O	O	O
weak	O	O	B-T080
or	O	O	O
negative	O	O	B-T033
BRAF	O	O	O
immunostain	O	O	B-T130
.	O	O	O

BRAF	O	O	B-T033
V600E	O	O	I-T033
mutation	O	O	B-T045
-	O	O	O
specific	O	O	B-T080
immunohistochemistry	O	O	B-T060
is	O	O	O
a	O	O	O
highly	O	O	B-T080
sensitive	O	O	I-T080
and	O	O	O
specific	O	O	O
marker	O	O	B-T201
for	O	O	O
detecting	O	O	B-T033
BRAF-mutated	O	O	B-T049
GISTs	O	O	B-T191
.	O	O	O

-DOCSTART- (27511525)

Efficacy	O	O	O
of	O	O	O
pegylated	O	O	B-T109
liposomal	O	O	I-T109
etoposide	O	O	I-T109
nanoparticles	O	O	I-T109
on	O	O	O
breast	O	O	O
cancer	O	O	O
cell	O	O	O
lines	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	I-T080
pegylated	O	O	B-T109
liposomal	O	O	I-T109
etoposide	O	O	I-T109
nanoparticles	O	O	I-T109
(	O	O	O
NPs	O	O	O
)	O	O	O
against	O	O	O
T-47D	O	O	B-T050
and	O	O	O
MCF-7	O	O	B-T025
breast	O	O	I-T025
cancer	O	O	I-T025
cell	O	O	I-T025
lines	O	O	I-T025
.	O	O	O

Pegylated	O	O	B-T109
liposomal	O	O	I-T109
etoposide	O	O	I-T109
NPs	O	O	I-T109
were	O	O	O
prepared	O	O	O
by	O	O	O
reverse	O	O	B-T070
phase	O	O	I-T070
evaporation	O	O	I-T070
method	O	O	I-T070
.	O	O	O

The	O	O	O
size	O	O	B-T082
,	O	O	O
size	O	O	B-T082
distribution	O	O	I-T082
,	O	O	O
and	O	O	O
zeta	O	O	B-T067
potential	O	O	I-T067
of	O	O	O
the	O	O	O
NPs	O	O	B-T109
was	O	O	O
measured	O	O	O
by	O	O	O
a	O	O	O
Zetasizer	O	O	B-T074
instrument	O	O	I-T074
.	O	O	O

The	O	O	O
cytotoxicity	O	O	B-T049
of	O	O	O
NPs	O	O	B-T109
was	O	O	O
inspected	O	O	O
by	O	O	O
methyl	O	O	B-T062
thiazol	O	O	I-T062
tetrazolium	O	O	I-T062
assay	O	O	I-T062
.	O	O	O

The	O	O	O
release	O	O	B-UnknownType
pattern	O	O	I-UnknownType
of	O	O	I-UnknownType
the	O	O	I-UnknownType
drug	O	O	I-UnknownType
from	O	O	I-UnknownType
the	O	O	I-UnknownType
vesicles	O	O	I-UnknownType
was	O	O	O
studied	O	O	O
by	O	O	O
the	O	O	O
dialysis	O	O	B-T061
method	O	O	I-T061
.	O	O	O

Drug	O	O	B-UnknownType
loading	O	O	I-UnknownType
and	O	O	O
encapsulation	O	O	B-T067
efficiency	O	O	I-T067
(	O	O	O
EE	O	O	B-T067
)	O	O	O
were	O	O	O
also	O	O	O
measured	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T082
size	O	O	I-T082
,	O	O	O
size	O	O	B-T082
distribution	O	O	I-T082
,	O	O	O
and	O	O	O
zeta	O	O	B-T067
potential	O	O	I-T067
of	O	O	O
pegylated	O	O	B-T109
liposomal	O	O	I-T109
etoposide	O	O	I-T109
NPs	O	O	I-T109
were	O	O	O
491	O	O	O
±	O	O	O
15.5	O	O	O
nm	O	O	O
,	O	O	O
0.504	O	O	O
±	O	O	O
0.14	O	O	O
,	O	O	O
and	O	O	O
-35.8	O	O	O
±	O	O	O
2.5	O	O	O
mV	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Drug	O	O	B-UnknownType
loading	O	O	I-UnknownType
and	O	O	O
EE	O	O	B-T067
were	O	O	O
10.3	O	O	O
±	O	O	O
1.6	O	O	O
%	O	O	O
and	O	O	O
99.1	O	O	O
±	O	O	O
2.8	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
etoposide	O	O	B-T073
release	O	O	I-T073
in	O	O	I-T073
the	O	O	I-T073
formulation	O	O	I-T073
was	O	O	O
estimated	O	O	O
at	O	O	O
about	O	O	O
3.48	O	O	O
%	O	O	O
after	O	O	O
48	O	O	O
h.	O	O	O
The	O	O	O
cytotoxicity	O	O	B-T049
effect	O	O	I-T049
of	O	O	O
etoposide	O	O	B-T109
NPs	O	O	I-T109
on	O	O	O
T-47D	O	O	B-T050
and	O	O	O
MCF-7	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
of	O	O	I-T025
breast	O	O	I-T025
cancer	O	O	I-T025
showed	O	O	O
higher	O	O	O
antitumor	O	O	B-T080
activity	O	O	I-T080
as	O	O	O
compared	O	O	O
with	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
free	O	O	B-T081
drug	O	O	I-T081
.	O	O	O

Liposome-based	O	O	B-T109
NPs	O	O	I-T109
may	O	O	O
hold	O	O	O
great	O	O	O
potential	O	O	O
as	O	O	O
a	O	O	O
drug	O	O	B-T074
delivery	O	O	I-T074
system	O	O	I-T074
.	O	O	O

-DOCSTART- (27511629)

The	O	O	O
Bindex	O	O	B-T074
(	O	O	I-T074
®	O	O	I-T074
)	O	O	I-T074
ultrasound	O	O	I-T074
device	O	O	I-T074
:	O	O	O
reliability	O	O	B-T081
of	O	O	O
cortical	O	O	B-T023
bone	O	O	I-T023
thickness	O	O	B-T080
measures	O	O	B-T081
and	O	O	O
their	O	O	O
relationship	O	O	B-T080
to	O	O	O
regional	O	O	B-T082
bone	O	O	O
mineral	O	O	O
density	O	O	O

The	O	O	O
Bindex	O	O	B-T074
(	O	O	I-T074
®	O	O	I-T074
)	O	O	I-T074
quantitative	O	O	I-T074
ultrasound	O	O	I-T074
(	O	O	I-T074
QUS	O	O	I-T074
)	O	O	I-T074
device	O	O	I-T074
is	O	O	O
currently	O	O	O
available	O	O	O
and	O	O	O
this	O	O	O
study	O	O	B-T062
analyzed	O	O	B-T062
(	O	O	O
I	O	O	O
)	O	O	O
its	O	O	O
relative	O	O	B-T080
and	O	O	O
absolute	O	O	B-T080
intra-	O	O	B-T081
and	O	O	I-T081
inter-session	O	O	I-T081
reliability	O	O	I-T081
and	O	O	O
(	O	O	O
II	O	O	O
)	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
data	O	O	B-T078
provided	O	O	O
by	O	O	O
Bindex(	O	O	B-T074
®	O	O	I-T074
)-QUS	O	O	I-T074
and	O	O	O
the	O	O	O
bone	O	O	B-T201
mineral	O	O	I-T201
density	O	O	I-T201
(	O	O	O
BMD	O	O	B-T201
)	O	O	O
measured	O	O	B-T080
by	O	O	O
dual-energy	O	O	B-T060
x-ray	O	O	I-T060
absorptiometry	O	O	I-T060
at	O	O	O
corresponding	O	O	O
skeletal	O	O	B-T082
sites	O	O	I-T082
in	O	O	O
young	O	O	B-T098
and	O	O	O
healthy	O	O	B-T098
subjects	O	O	I-T098
(	O	O	O
age	O	O	B-T032
:	O	O	O
25.0	O	O	O
±	O	O	O
3.6	O	O	O
years	O	O	B-T079
)	O	O	O
.	O	O	O

Bindex(	O	O	B-T074
®	O	O	I-T074
)-QUS	O	O	I-T074
calculates	O	O	B-T052
a	O	O	O
density	O	O	B-T201
index	O	O	I-T201
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
the	O	O	O
thickness	O	O	B-T080
of	O	O	O
cortical	O	O	B-T023
bone	O	O	I-T023
measured	O	O	B-T080
at	O	O	O
the	O	O	O
distal	O	O	B-T023
radius	O	O	I-T023
and	O	O	O
the	O	O	O
distal	O	O	O
plus	O	O	O
proximal	O	O	B-T023
tibia	O	O	I-T023
.	O	O	O

The	O	O	O
data	O	O	B-T078
show	O	O	O
a	O	O	O
very	O	O	O
good	O	O	O
relative	O	O	B-T080
and	O	O	O
absolute	O	O	B-T080
intra-	O	O	B-T081
(	O	O	O
ICC	O	O	B-T081
=	O	O	O
0.977	O	O	O
,	O	O	O
CV	O	O	B-T081
=	O	O	O
1.5	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
inter-session	O	O	B-T081
reliability	O	O	I-T081
(	O	O	O
ICC	O	O	O
=	O	O	O
0.978	O	O	O
,	O	O	O
CV	O	O	O
=	O	O	O
1.4	O	O	O
%	O	O	O
)	O	O	O
for	O	O	O
the	O	O	O
density	O	O	B-T201
index	O	O	I-T201
.	O	O	O

The	O	O	O
highest	O	O	B-T080
positive	O	O	B-T033
correlations	O	O	B-T080
were	O	O	O
found	O	O	O
between	O	O	O
cortical	O	O	B-T023
thickness	O	O	B-T080
and	O	O	O
BMD	O	O	B-T201
for	O	O	O
the	O	O	O
distal	O	O	B-T023
radius	O	O	I-T023
and	O	O	O
distal	O	O	B-T023
tibia	O	O	I-T023
(	O	O	O
r	O	O	O
⩾	O	O	O
0.71	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T078
indicate	O	O	O
that	O	O	O
the	O	O	O
Bindex(	O	O	B-T074
®	O	O	I-T074
)-QUS	O	O	I-T074
parameters	O	O	B-T033
are	O	O	O
repeatable	O	O	O
within	O	O	O
and	O	O	O
between	O	O	O
measurement	O	O	B-T169
sessions	O	O	B-T077
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
measurements	O	O	B-T169
reflect	O	O	O
the	O	O	O
BMD	O	O	B-T201
at	O	O	O
specific	O	O	B-T080
skeletal	O	O	B-T082
sites	O	O	I-T082
.	O	O	O

Bindex(	O	O	B-T074
®	O	O	I-T074
)-QUS	O	O	I-T074
might	O	O	O
be	O	O	O
a	O	O	O
useful	O	O	O
tool	O	O	O
for	O	O	O
the	O	O	O
measurement	O	O	B-T169
of	O	O	O
skeletal	O	O	B-T039
adaptations	O	O	I-T039
.	O	O	O

-DOCSTART- (27514242)

Botulinum	O	O	B-T116
Toxin	O	O	I-T116
Use	O	O	O
in	O	O	O
Refractory	O	O	B-T184
Pain	O	O	I-T184
and	O	O	O
Other	O	O	O
Symptoms	O	O	B-T184
in	O	O	O
Parkinsonism	O	O	O

Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PD	O	O	B-T047
)	O	O	O
and	O	O	O
other	O	O	O
parkinsonian	O	O	B-T047
syndromes	O	O	I-T047
are	O	O	O
chronic	O	O	B-T079
,	O	O	O
progressive	O	O	B-T169
neurodegenerative	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

With	O	O	O
advancing	O	O	O
disease	O	O	B-T047
,	O	O	O
both	O	O	O
motor	O	O	B-T184
and	O	O	O
non-motor	O	O	B-T184
symptoms	O	O	I-T184
represent	O	O	O
a	O	O	O
considerable	O	O	O
burden	O	O	B-T078
and	O	O	O
symptom	O	O	B-T184
relief	O	O	B-T033
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
improvement	O	O	B-T077
become	O	O	O
the	O	O	O
main	O	O	O
goal	O	O	B-T170
of	O	O	O
treatment	O	O	B-T061
.	O	O	O

Botulinum	O	O	B-T116
toxins	O	O	I-T116
(	O	O	O
BTX	O	O	B-T116
)	O	O	O
are	O	O	O
an	O	O	O
effective	O	O	B-T080
treatment	O	O	B-T061
modality	O	O	B-T078
for	O	O	O
many	O	O	O
neurological	O	O	B-T047
conditions	O	O	I-T047
.	O	O	O

To	O	O	O
understand	O	O	O
the	O	O	O
potential	O	O	B-T080
usefulness	O	O	B-T080
of	O	O	O
BTX	O	O	B-T116
in	O	O	O
this	O	O	O
population	O	O	B-T098
,	O	O	O
we	O	O	O
performed	O	O	B-T169
a	O	O	O
retrospective	O	O	B-T080
chart	O	O	B-T058
review	O	O	I-T058
of	O	O	O
all	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
clinical	O	O	B-T060
diagnosis	O	O	I-T060
of	O	O	O
idiopathic	O	O	B-T047
PD	O	O	I-T047
and	O	O	O
atypical	O	O	B-T047
parkinsonism	O	O	I-T047
who	O	O	O
received	O	O	O
treatment	O	O	B-T169
with	O	O	O
BTX	O	O	B-T061
injections	O	O	I-T061
in	O	O	O
our	O	O	O
center	O	O	B-T093
from	O	O	O
1995	O	O	O
to	O	O	O
2014	O	O	O
for	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
symptoms	O	O	B-T184
.	O	O	O

Response	O	O	B-T032
to	O	O	O
BTX	O	O	B-T116
was	O	O	O
assessed	O	O	B-T052
using	O	O	O
a	O	O	O
subjective	O	O	B-T170
Clinical	O	O	I-T170
Global	O	O	I-T170
Impression	O	O	I-T170
.	O	O	O

Records	O	O	B-T170
of	O	O	O
160	O	O	O
patients	O	O	B-T101
were	O	O	O
reviewed	O	O	B-T080
.	O	O	O

Probable	O	O	O
idiopathic	O	O	B-T047
PD	O	O	I-T047
was	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
in	O	O	O
117	O	O	O
patients	O	O	B-T101
(	O	O	O
73.1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
main	O	O	O
indication	O	O	B-T078
for	O	O	O
BTX	O	O	B-T116
treatment	O	O	B-T061
was	O	O	O
pain	O	O	B-T184
(	O	O	O
50.6	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	O
)	O	O	O
.	O	O	O

Other	O	O	O
indications	O	O	B-T078
were	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
functional	O	O	B-T033
impairment	O	O	I-T033
resulting	O	O	B-T169
from	O	O	O
dystonia	O	O	B-T184
(	O	O	O
26.25	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
sialorrhea	O	O	B-T047
(	O	O	O
18.75	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
freezing	O	O	B-T184
of	O	O	I-T184
gait	O	O	I-T184
,	O	O	O
and	O	O	O
camptocormia	O	O	B-T020
.	O	O	O

Considering	O	O	O
pain	O	O	B-T184
as	O	O	O
indication	O	O	B-T078
,	O	O	O
81	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
patients	O	O	B-T101
with	O	O	O
PD	O	O	B-T047
reported	O	O	B-T058
benefits	O	O	B-T081
after	O	O	O
the	O	O	O
first	O	O	O
BTX	O	O	B-T061
injections	O	O	I-T061
.	O	O	O

This	O	O	O
benefit	O	O	B-T081
was	O	O	O
maintained	O	O	B-T169
after	O	O	O
the	O	O	O
last	O	O	B-T058
recorded	O	O	I-T058
visit	O	O	I-T058
without	O	O	O
significant	O	O	O
difference	O	O	B-T080
in	O	O	O
outcome	O	O	B-T169
compared	O	O	B-T052
with	O	O	O
the	O	O	O
first	O	O	O
injection	O	O	B-T061
(	O	O	O
p=0.067	O	O	O
)	O	O	O
.	O	O	O

Similar	O	O	O
results	O	O	B-T169
were	O	O	O
observed	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
atypical	O	O	B-T047
parkinsonism	O	O	I-T047
.	O	O	O

Our	O	O	O
results	O	O	B-T169
confirm	O	O	O
the	O	O	O
safety	O	O	O
and	O	O	O
efficacy	O	O	B-T080
of	O	O	O
different	O	O	B-T080
uses	O	O	B-T169
of	O	O	O
BTX	O	O	B-T116
in	O	O	O
the	O	O	O
symptomatic	O	O	B-T169
treatment	O	O	B-T169
of	O	O	O
patients	O	O	B-T101
with	O	O	O
parkinsonism	O	O	B-T047
even	O	O	O
in	O	O	O
advanced	O	O	B-T080
stages	O	O	B-T079
of	O	O	O
the	O	O	O
disease	O	O	B-T047
,	O	O	O
and	O	O	O
suggest	O	O	B-T078
BTX	O	O	O
treatment	O	O	O
could	O	O	O
have	O	O	O
a	O	O	O
safe	O	O	O
and	O	O	O
useful	O	O	O
role	O	O	B-T077
in	O	O	O
the	O	O	O
treatment	O	O	O
of	O	O	O
pain	O	O	B-T184
in	O	O	O
this	O	O	O
population	O	O	B-T098
.	O	O	O

-DOCSTART- (27516217)

Chronic	O	O	B-T033
exposure	O	O	I-T033
to	O	O	I-T033
haloperidol	O	O	B-T109
and	O	O	O
olanzapine	O	O	B-T109
leads	O	O	O
to	O	O	O
common	O	O	O
and	O	O	O
divergent	O	O	O
shape	O	O	B-T033
changes	O	O	I-T033
in	O	O	O
the	O	O	O
rat	O	O	B-T015
hippocampus	O	O	B-T023
in	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
grey-matter	O	O	B-T024
volume	O	O	O
loss	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
consistently	O	O	O
reported	O	O	O
brain	O	O	B-T190
abnormalities	O	O	I-T190
in	O	O	O
schizophrenia	O	O	B-T048
(	O	O	O
SCZ	O	O	B-T048
)	O	O	O
is	O	O	O
decreased	O	O	O
volume	O	O	B-T033
and	O	O	I-T033
shape	O	O	I-T033
deformation	O	O	I-T033
of	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
potential	O	O	O
contribution	O	O	O
of	O	O	O
chronic	O	O	B-T121
antipsychotic	O	O	I-T121
medication	O	O	I-T121
exposure	O	O	B-T033
to	O	O	O
these	O	O	O
phenomena	O	O	O
remains	O	O	O
unclear	O	O	O
.	O	O	O

We	O	O	O
examined	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
chronic	O	O	B-T033
exposure	O	O	I-T033
(	O	O	O
8	O	O	O
weeks	O	O	O
)	O	O	O
to	O	O	O
clinically	O	O	O
relevant	O	O	B-T081
doses	O	O	I-T081
of	O	O	O
either	O	O	O
haloperidol	O	O	B-T109
(	O	O	O
HAL	O	O	B-T109
)	O	O	O
or	O	O	O
olanzapine	O	O	B-T109
(	O	O	O
OLZ	O	O	B-T109
)	O	O	O
on	O	O	O
adult	O	O	O
rat	O	O	B-T015
hippocampal	O	O	B-T029
volume	O	O	B-T033
and	O	O	I-T033
shape	O	O	I-T033
using	O	O	O
ex	O	O	B-T169
vivo	O	O	I-T169
structural	O	O	B-T060
MRI	O	O	I-T060
with	O	O	O
the	O	O	O
brain	O	O	B-T023
retained	O	O	I-T023
inside	O	O	I-T023
the	O	O	I-T023
cranium	O	O	I-T023
to	O	O	O
prevent	O	O	O
distortions	O	O	B-T190
due	O	O	O
to	O	O	O
dissection	O	O	B-T061
,	O	O	O
followed	O	O	O
by	O	O	O
tensor-based	O	O	B-T059
morphometry	O	O	I-T059
(	O	O	O
TBM	O	O	B-T059
)	O	O	O
and	O	O	O
elastic	O	O	B-T062
surface-based	O	O	I-T062
shape	O	O	I-T062
deformation	O	O	I-T062
analysis	O	O	I-T062
.	O	O	O

The	O	O	O
volume	O	O	O
of	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
was	O	O	O
also	O	O	O
measured	O	O	O
post-mortem	O	O	B-T060
from	O	O	O
brain	O	O	B-T023
tissue	O	O	I-T023
sections	O	O	O
in	O	O	O
each	O	O	O
group	O	O	O
.	O	O	O

Chronic	O	O	B-T033
exposure	O	O	I-T033
to	O	O	O
either	O	O	O
HAL	O	O	B-T109
or	O	O	O
OLZ	O	O	B-T109
had	O	O	O
no	O	O	O
effect	O	O	O
on	O	O	O
the	O	O	O
volume	O	O	O
of	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
,	O	O	O
even	O	O	O
at	O	O	O
exploratory	O	O	B-T060
thresholds	O	O	I-T060
,	O	O	O
which	O	O	O
was	O	O	O
confirmed	O	O	O
post-mortem	O	O	B-T060
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
shape	O	O	B-T062
deformation	O	O	I-T062
analysis	O	O	I-T062
revealed	O	O	O
that	O	O	O
chronic	O	O	O
HAL	O	O	B-T109
and	O	O	O
OLZ	O	O	B-T109
exposure	O	O	B-T033
lead	O	O	O
to	O	O	O
both	O	O	O
common	O	O	O
and	O	O	O
divergent	O	O	B-T033
shape	O	O	I-T033
deformations	O	O	I-T033
(	O	O	O
q	O	O	O
=	O	O	O
0.05	O	O	O
,	O	O	O
FDR-corrected	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
rat	O	O	B-T015
hippocampus	O	O	B-T023
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
in	O	O	O
the	O	O	O
dorsal	O	O	B-T023
hippocampus	O	O	I-T023
,	O	O	O
HAL	O	O	B-T109
exposure	O	O	B-T033
led	O	O	O
to	O	O	O
inward	O	O	B-T033
shape	O	O	I-T033
deformation	O	O	I-T033
,	O	O	O
whereas	O	O	O
OLZ	O	O	B-T109
exposure	O	O	O
led	O	O	O
to	O	O	O
outward	O	O	B-T033
shape	O	O	I-T033
deformation	O	O	I-T033
.	O	O	O

Interestingly	O	O	O
,	O	O	O
outward	O	O	B-T033
shape	O	O	I-T033
deformations	O	O	I-T033
that	O	O	O
were	O	O	O
common	O	O	O
to	O	O	O
both	O	O	O
drugs	O	O	B-T121
occurred	O	O	O
in	O	O	O
the	O	O	O
ventral	O	O	B-T023
hippocampus	O	O	I-T023
.	O	O	O

These	O	O	O
effects	O	O	O
remained	O	O	O
significant	O	O	O
after	O	O	O
controlling	O	O	O
for	O	O	O
hippocampal	O	O	B-T023
volume	O	O	O
suggesting	O	O	O
true	O	O	O
shape	O	O	B-T033
changes	O	O	I-T033
.	O	O	O

Chronic	O	O	B-T033
exposure	O	O	I-T033
to	O	O	O
either	O	O	O
HAL	O	O	B-T109
or	O	O	O
OLZ	O	O	B-T109
leads	O	O	O
to	O	O	O
both	O	O	O
common	O	O	O
and	O	O	O
divergent	O	O	O
effects	O	O	O
on	O	O	O
rat	O	O	B-T015
hippocampal	O	O	B-T023
shape	O	O	I-T023
in	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
volume	O	O	O
change	O	O	O
.	O	O	O

The	O	O	O
implications	O	O	O
of	O	O	O
these	O	O	O
findings	O	O	O
for	O	O	O
the	O	O	O
clinic	O	O	O
are	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (27516254)

Shear	O	O	B-T070
and	O	O	O
extensional	O	O	B-T070
properties	O	O	I-T070
of	O	O	O
kefiran	O	O	O

Kefiran	O	O	B-T109
is	O	O	O
a	O	O	O
neutral	O	O	B-T109
polysaccharide	O	O	I-T109
constituted	O	O	O
by	O	O	O
glucose	O	O	B-T109
and	O	O	O
galactose	O	O	B-T109
produced	O	O	O
by	O	O	O
Lactobacillus	O	O	B-T007
kefiranofaciens	O	O	I-T007
.	O	O	O

It	O	O	O
is	O	O	O
included	O	O	O
into	O	O	O
kefir	O	O	B-T168
grains	O	O	I-T168
and	O	O	O
has	O	O	O
several	O	O	O
health	O	O	B-T070
promoting	O	O	I-T070
properties	O	O	I-T070
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
work	O	O	O
,	O	O	O
shear	O	O	B-T070
and	O	O	O
extensional	O	O	B-T070
properties	O	O	I-T070
of	O	O	O
different	O	O	B-T080
kefiran	O	O	B-T109
aqueous	O	O	B-T167
dispersions	O	O	I-T167
(	O	O	O
0.5	O	O	O
,	O	O	O
1	O	O	O
and	O	O	O
2	O	O	O
%	O	O	O
wt	O	O	O
.	O	O	O
)	O	O	O
were	O	O	O
assessed	O	O	B-T052
and	O	O	O
compared	O	O	B-T052
to	O	O	O
other	O	O	O
neutral	O	O	B-T109
gums	O	O	I-T109
commonly	O	O	O
used	O	O	O
in	O	O	O
food	O	O	B-T168
,	O	O	O
cosmetic	O	O	B-T073
and	O	O	O
pharmaceutics	O	O	B-T093
industries	O	O	I-T093
(	O	O	O
methylcellulose	O	O	B-T109
,	O	O	O
locust	O	O	B-T200
bean	O	O	I-T200
gum	O	O	I-T200
and	O	O	O
guar	O	O	B-T109
gum	O	O	I-T109
)	O	O	O
.	O	O	O

Kefiran	O	O	B-T109
showed	O	O	O
shear	O	O	B-T070
flow	O	O	I-T070
characteristics	O	O	I-T070
similar	O	O	O
to	O	O	O
that	O	O	O
displayed	O	O	O
by	O	O	O
other	O	O	O
representative	O	O	O
neutral	O	O	B-T109
gums	O	O	I-T109
,	O	O	O
although	O	O	O
it	O	O	O
always	O	O	O
yielded	O	O	O
lower	O	O	B-T080
viscosities	O	O	B-T070
at	O	O	O
a	O	O	O
given	O	O	O
concentration	O	O	B-T081
.	O	O	O

For	O	O	O
each	O	O	O
gum	O	O	B-T109
system	O	O	B-T169
it	O	O	O
was	O	O	O
possible	O	O	O
to	O	O	O
find	O	O	O
a	O	O	O
correlation	O	O	B-T080
between	O	O	O
dynamic	O	O	B-T070
and	O	O	I-T070
steady	O	O	I-T070
shear	O	O	I-T070
properties	O	O	I-T070
by	O	O	O
a	O	O	O
master	O	O	B-T082
curve	O	O	I-T082
including	O	O	O
both	O	O	O
the	O	O	O
apparent	O	O	B-T078
and	O	O	O
complex	O	O	B-T080
viscosities	O	O	B-T070
.	O	O	O

When	O	O	O
studying	O	O	O
extensional	O	O	B-T070
properties	O	O	I-T070
of	O	O	O
selected	O	O	O
gums	O	O	B-T109
at	O	O	O
2	O	O	O
%	O	O	O
wt	O	O	O
.	O	O	O

by	O	O	O
means	O	O	O
of	O	O	O
a	O	O	O
capillary	O	O	B-T073
break-up	O	O	I-T073
rheometer	O	O	I-T073
,	O	O	O
kefiran	O	O	B-T109
solutions	O	O	B-T167
did	O	O	O
not	O	O	O
show	O	O	O
important	O	O	O
extensional	O	O	B-T070
properties	O	O	I-T070
,	O	O	O
displaying	O	O	O
a	O	O	O
behaviour	O	O	B-T080
close	O	O	O
the	O	O	O
Newtonian	O	O	B-T080
.	O	O	O

-DOCSTART- (27516791)

Air	O	O	B-T167
tamponade	O	O	B-T169
of	O	O	O
the	O	O	O
heart	O	O	O

Pneumopericardium	O	O	B-T047
is	O	O	O
a	O	O	O
rare	O	O	B-T047
disease	O	O	I-T047
defined	O	O	O
as	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
air	O	O	B-T167
or	O	O	O
gas	O	O	B-T104
in	O	O	O
the	O	O	O
pericardial	O	O	B-T023
sac	O	O	I-T023
.	O	O	O

Among	O	O	O
the	O	O	O
etiological	O	O	B-T169
factors	O	O	B-T169
,	O	O	O
the	O	O	O
following	O	O	O
stand	O	O	O
out	O	O	O
:	O	O	O
chest	O	O	B-T037
trauma	O	O	I-T037
,	O	O	O
barotrauma	O	O	B-T037
,	O	O	O
air	O	O	B-T167
-containing	O	O	O
fistulas	O	O	B-T190
between	O	O	O
the	O	O	O
pericardium	O	O	B-T023
and	O	O	O
the	O	O	O
surrounding	O	O	B-T082
structures	O	O	B-T082
,	O	O	O
secondary	O	O	B-T169
gas	O	O	I-T169
production	O	O	I-T169
by	O	O	O
microorganisms	O	O	B-T001
growing	O	O	O
in	O	O	O
the	O	O	O
pericardial	O	O	B-T023
sac	O	O	I-T023
,	O	O	O
and	O	O	O
iatrogenic	O	O	B-T080
factors	O	O	O
.	O	O	O

Until	O	O	O
now	O	O	O
,	O	O	O
spontaneous	O	O	B-T169
pneumopericardium	O	O	B-T047
has	O	O	O
been	O	O	O
considered	O	O	B-T078
a	O	O	O
harmless	O	O	B-T080
and	O	O	O
temporary	O	O	B-T079
state	O	O	B-T169
,	O	O	O
but	O	O	O
a	O	O	O
review	O	O	B-T169
of	O	O	I-T169
clinical	O	O	B-T077
cases	O	O	I-T077
indicates	O	O	O
that	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
air	O	O	B-T167
in	O	O	O
the	O	O	O
pericardium	O	O	B-T023
can	O	O	O
lead	O	O	O
to	O	O	O
cardiac	O	O	B-T047
tamponade	O	O	I-T047
and	O	O	O
life-threatening	O	O	B-T033
hemodynamic	O	O	B-T042
disturbances	O	O	B-T080
.	O	O	O

We	O	O	O
present	O	O	B-T033
the	O	O	O
case	O	O	O
of	O	O	O
an	O	O	O
80-	O	O	O
year-old	O	O	B-T079
patient	O	O	B-T101
with	O	O	O
a	O	O	O
chronic	O	O	B-T079
bronchopericardial	O	O	B-T023
fistula	O	O	B-T190
,	O	O	O
who	O	O	O
suffered	O	O	O
from	O	O	O
a	O	O	O
cardiac	O	O	B-T047
arrest	O	O	I-T047
due	O	O	O
to	O	O	O
air	O	O	B-T167
tamponade	O	O	B-T169
of	O	O	O
the	O	O	O
heart	O	O	B-T023
.	O	O	O

-DOCSTART- (27517885)

The	O	O	O
Complete	O	O	B-T080
Chloroplast	O	O	B-T028
Genome	O	O	I-T028
Sequence	O	O	B-T086
of	O	O	O
the	O	O	O
Medicinal	O	O	B-T002
Plant	O	O	I-T002
Swertia	O	O	B-T002
mussotii	O	O	I-T002
Using	O	O	O
the	O	O	O
PacBio	O	O	O
RS	O	O	O
II	O	O	O
Platform	O	O	O

Swertia	O	O	B-T002
mussotii	O	O	I-T002
is	O	O	O
an	O	O	O
important	O	O	O
medicinal	O	O	B-T002
plant	O	O	I-T002
that	O	O	O
has	O	O	O
great	O	O	B-T081
economic	O	O	B-T081
and	O	O	O
medicinal	O	O	B-T121
value	O	O	I-T121
and	O	O	O
is	O	O	O
found	O	O	O
on	O	O	O
the	O	O	O
Qinghai	O	O	B-UnknownType
Tibetan	O	O	I-UnknownType
Plateau	O	O	I-UnknownType
.	O	O	O

The	O	O	O
complete	O	O	B-T080
chloroplast	O	O	B-T028
(	O	O	I-T028
cp	O	O	I-T028
)	O	O	I-T028
genome	O	O	I-T028
of	O	O	O
S.	O	O	B-T002
mussotii	O	O	I-T002
is	O	O	O
153,431	O	O	O
bp	O	O	O
in	O	O	O
size	O	O	B-T081
,	O	O	O
with	O	O	O
a	O	O	O
pair	O	O	B-T080
of	O	O	O
inverted	O	O	B-T114
repeat	O	O	I-T114
(	O	O	I-T114
IR	O	O	I-T114
)	O	O	I-T114
regions	O	O	I-T114
of	O	O	O
25,761	O	O	O
bp	O	O	O
each	O	O	O
that	O	O	O
separate	O	O	B-T080
an	O	O	O
large	O	O	B-T086
single-copy	O	O	I-T086
(	O	O	I-T086
LSC	O	O	I-T086
)	O	O	I-T086
region	O	O	I-T086
of	O	O	O
83,567	O	O	O
bp	O	O	O
and	O	O	O
an	O	O	O
a	O	O	O
small	O	O	B-T086
single-copy	O	O	I-T086
(	O	O	I-T086
SSC	O	O	I-T086
)	O	O	I-T086
region	O	O	I-T086
of	O	O	O
18,342	O	O	O
bp	O	O	O
.	O	O	O

The	O	O	O
S.	O	O	B-T002
mussotii	O	O	I-T002
cp	O	O	B-T028
genome	O	O	I-T028
encodes	O	O	B-T052
84	O	O	O
protein-coding	O	O	B-T028
genes	O	O	B-T028
,	O	O	O
37	O	O	O
transfer	O	O	B-T114
RNA	O	O	I-T114
(	O	O	O
tRNA	O	O	B-T114
)	O	O	O
genes	O	O	O
,	O	O	O
and	O	O	O
eight	O	O	O
ribosomal	O	O	B-T028
RNA	O	O	I-T028
(	O	O	I-T028
rRNA	O	O	I-T028
)	O	O	I-T028
genes	O	O	I-T028
.	O	O	O

The	O	O	O
identity	O	O	O
,	O	O	O
number	O	O	O
,	O	O	O
and	O	O	O
GC	O	O	B-T081
content	O	O	I-T081
of	O	O	O
S.	O	O	B-T002
mussotii	O	O	I-T002
cp	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
similar	O	O	O
to	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
genomes	O	O	B-T028
of	O	O	O
other	O	O	O
Gentianales	O	O	B-T002
species	O	O	B-T185
.	O	O	O

Via	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
repeat	O	O	B-T086
structure	O	O	I-T086
,	O	O	O
11	O	O	O
forward	O	O	O
repeats	O	O	B-T086
,	O	O	O
eight	O	O	O
palindromic	O	O	B-T114
repeats	O	O	I-T114
,	O	O	O
and	O	O	O
one	O	O	O
reverse	O	O	O
repeat	O	O	O
were	O	O	O
detected	O	O	B-T033
in	O	O	O
the	O	O	O
S.	O	O	B-T002
mussotii	O	O	I-T002
cp	O	O	B-T028
genome	O	O	I-T028
.	O	O	O

There	O	O	O
are	O	O	O
45	O	O	O
SSRs	O	O	B-T114
in	O	O	O
the	O	O	O
S.	O	O	B-T002
mussotii	O	O	I-T002
cp	O	O	B-T028
genome	O	O	I-T028
,	O	O	O

the	O	O	O
majority	O	O	B-T080
of	O	O	O
which	O	O	O
are	O	O	O
mononucleotides	O	O	B-T114
found	O	O	O
in	O	O	O
all	O	O	O
other	O	O	O
Gentianales	O	O	B-T002
species	O	O	B-T185
.	O	O	O

An	O	O	O
entire	O	O	B-T081
cp	O	O	B-T028
genome	O	O	I-T028
comparison	O	O	B-T062
study	O	O	I-T062
of	O	O	O
S.	O	O	B-T002
mussotii	O	O	I-T002
and	O	O	O
two	O	O	O
other	O	O	O
species	O	O	B-T185
in	O	O	O
Gentianaceae	O	O	B-T002
was	O	O	O
conducted	O	O	O
.	O	O	O

The	O	O	O
complete	O	O	B-T080
cp	O	O	B-T026
genome	O	O	I-T028
sequence	O	O	B-T086
provides	O	O	O
intragenic	O	O	B-T028
information	O	O	B-T078
for	O	O	O
the	O	O	O
cp	O	O	O
genetic	O	O	B-T063
engineering	O	O	I-T063
of	O	O	O
this	O	O	O
medicinal	O	O	B-T002
plant	O	O	I-T002
.	O	O	O

-DOCSTART- (27519886)

Meta-Analysis	O	O	B-T062
of	O	O	O
29	O	O	O
Experiments	O	O	B-T062
Evaluating	O	O	B-T058
the	O	O	O
Effects	O	O	B-T080
of	O	O	I-T080
Rapamycin	O	O	B-T195
on	O	O	O
Life	O	O	B-T102
Span	O	O	I-T102
in	O	O	O
the	O	O	O
Laboratory	O	O	O
Mouse	O	O	O

Rapamycin	O	O	B-T195
has	O	O	O
favorable	O	O	O
effects	O	O	B-T080
on	O	O	O
aging	O	O	B-T040
in	O	O	O
mice	O	O	B-T015
and	O	O	O
may	O	O	O
eventually	O	O	O
be	O	O	O
applied	O	O	B-T169
to	O	O	O
encourage	O	O	O
"	O	O	O
healthy	O	O	B-T080
aging	O	O	O
"	O	O	O
in	O	O	O
humans	O	O	B-T016
.	O	O	O

This	O	O	O
study	O	O	B-T062
analyzed	O	O	B-T062
raw	O	O	B-T080
data	O	O	B-T078
from	O	O	O
29	O	O	O
survival	O	O	B-T062
studies	O	O	I-T062
of	O	O	O
rapamycin	O	O	B-T195
-	O	O	O
and	O	O	O
control	O	O	B-T167
-	O	O	O
treated	O	O	B-T169
mice	O	O	B-T015
,	O	O	O
with	O	O	O
the	O	O	O
goals	O	O	B-T170
of	O	O	O
estimating	O	O	B-T081
summary	O	O	B-T170
statistics	O	O	B-T170
and	O	O	O
identifying	O	O	B-T080
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
effect	O	O	B-T081
size	O	O	I-T081
heterogeneity	O	O	B-T080
.	O	O	O

Meta-analysis	O	O	B-T062
demonstrated	O	O	B-T080
significant	O	O	B-T078
heterogeneity	O	O	B-T080
across	O	O	O
studies	O	O	B-T059
,	O	O	O
with	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
(	O	O	B-T081
HR	O	O	I-T081
)	O	O	I-T081
estimates	O	O	B-T081
ranging	O	O	B-T081
from	O	O	O
0.22	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	B-T081
CI	O	O	B-T081
]	O	O	I-T081
:	O	O	O
0.06	O	O	O
-	O	O	O
0.82	O	O	O
)	O	O	O
to	O	O	O
0.92	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.65	O	O	O
-	O	O	O
1.28	O	O	O
)	O	O	O
.	O	O	O

Sex	O	O	B-T032
was	O	O	O
the	O	O	O
major	O	O	B-T080
factor	O	O	B-T169
accounting	O	O	B-T169
for	O	O	O
effect	O	O	B-T081
size	O	O	I-T081
variation	O	O	B-T080
,	O	O	O
and	O	O	O
mortality	O	O	B-T081
was	O	O	O
decreased	O	O	B-T081
more	O	O	B-T081
in	O	O	O
females	O	O	B-T032
(	O	O	O
HR	O	O	B-T081
=	O	O	O
0.41	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.35	O	O	O
-	O	O	O
0.48	O	O	O
)	O	O	O
as	O	O	O
compared	O	O	B-T052
with	O	O	O
males	O	O	B-T032
(	O	O	O
HR	O	O	O
=	O	O	O
0.63	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.55	O	O	O
-	O	O	O
0.71	O	O	O
)	O	O	O
.	O	O	O

Rapamycin	O	O	B-T195
effects	O	O	B-T080
were	O	O	O
also	O	O	O
genotype	O	O	B-T032
dependent	O	O	B-T080
,	O	O	O
however	O	O	O
,	O	O	O
with	O	O	O
stronger	O	O	B-T080
survivorship	O	O	B-T079
increases	O	O	B-T169
in	O	O	O
hybrid	O	O	B-T001
mice	O	O	B-T015
(	O	O	O
14.4	O	O	O
%	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
12.5	O	O	O
-	O	O	O
16.3	O	O	O
%	O	O	O
)	O	O	O
relative	O	O	B-T080
to	O	O	O
pure	O	O	B-T001
inbred	O	O	B-T015
strains	O	O	I-T015
(	O	O	O
8.8	O	O	O
%	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
6.2	O	O	O
-	O	O	O
11.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Number	O	O	B-T081
needed	O	O	B-T169
to	O	O	O
treat	O	O	B-T169
was	O	O	O
applied	O	O	B-T169
as	O	O	O
an	O	O	O
effect	O	O	B-T081
size	O	O	I-T081
metric	O	O	B-T081
,	O	O	O
which	O	O	O
consistently	O	O	O
identified	O	O	B-T080
early	O	O	O
senescence	O	O	B-T033
as	O	O	O
the	O	O	O
age	O	O	B-T032
of	O	O	O
peak	O	O	B-T080
treatment	O	O	B-T169
benefit	O	O	B-T081
.	O	O	O

These	O	O	O
results	O	O	B-T169
provide	O	O	B-T052
synthesis	O	O	B-T052
of	O	O	O
existing	O	O	B-T077
data	O	O	B-T078
to	O	O	O
support	O	O	B-T077
the	O	O	O
potential	O	O	O
translation	O	O	B-T062
of	O	O	O
findings	O	O	B-T033
from	O	O	O
mouse	O	O	B-T015
to	O	O	O
primate	O	O	B-T015
species	O	O	I-T015
.	O	O	O

Because	O	O	O
rapamycin	O	O	B-T195
's	O	O	I-T195
effect	O	O	B-T080
on	O	O	O
survival	O	O	B-T052
depends	O	O	B-T080
on	O	O	O
sex	O	O	B-T032
and	O	O	O
genotype	O	O	B-T032
,	O	O	O
further	O	O	O
work	O	O	O
is	O	O	O
justified	O	O	O
to	O	O	O
understand	O	O	O
how	O	O	O
these	O	O	O
factors	O	O	B-T169
shape	O	O	O
treatment	O	O	B-T169
response	O	O	B-T032
.	O	O	O

-DOCSTART- (27521864)

Transfusion	O	O	B-T091
medicine	O	O	I-T091
in	O	O	O
medical	O	O	B-T065
education	O	O	I-T065
:	O	O	O
an	O	O	O
analysis	O	O	B-T062
of	O	O	O
curricular	O	O	B-UnknownType
grids	O	O	I-UnknownType
in	O	O	O
Brazil	O	O	B-T083
and	O	O	O
a	O	O	O
review	O	O	B-T078
of	O	O	O
the	O	O	O
current	O	O	O
literature	O	O	O

Blood	O	O	B-T061
transfusions	O	O	I-T061
are	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
performed	O	O	O
medical	O	O	B-T058
procedures	O	O	I-T058
in	O	O	O
the	O	O	O
world	O	O	B-T098
.	O	O	O

Thus	O	O	O
,	O	O	O
as	O	O	O
education	O	O	B-T065
in	O	O	O
transfusion	O	O	B-T091
medicine	O	O	I-T091
is	O	O	O
vital	O	O	B-T080
to	O	O	O
medical	O	O	B-T033
care	O	O	I-T033
,	O	O	O
it	O	O	O
should	O	O	O
aim	O	O	O
to	O	O	O
promote	O	O	B-T052
a	O	O	O
responsible	O	O	O
practice	O	O	B-T057
with	O	O	O
the	O	O	O
rational	O	O	O
use	O	O	O
of	O	O	O
blood	O	O	B-T031
by	O	O	O
doctors	O	O	B-T097
.	O	O	O

This	O	O	O
study	O	O	O
aims	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
situation	O	O	O
of	O	O	O
the	O	O	O
teaching	O	O	B-T065
of	O	O	O
transfusion	O	O	B-T091
medicine	O	O	I-T091
in	O	O	O
medical	O	O	B-T093
schools	O	O	I-T093
in	O	O	O
Brazil	O	O	B-T083
.	O	O	O

The	O	O	O
websites	O	O	B-T170
of	O	O	O
the	O	O	O
249	O	O	O
Brazilian	O	O	B-T098
medical	O	O	B-T093
schools	O	O	I-T093
in	O	O	O
operation	O	O	B-T052
in	O	O	O
June	O	O	O
2015	O	O	O
were	O	O	O
visited	O	O	O
and	O	O	O
the	O	O	O
curricula	O	O	B-T170
of	O	O	O
the	O	O	O
medical	O	O	B-T065
courses	O	O	I-T065
were	O	O	O
investigated	O	O	B-T169
in	O	O	O
respect	O	O	O
to	O	O	O
the	O	O	O
presence	O	O	O
or	O	O	O
absence	O	O	O
of	O	O	O
a	O	O	O
transfusion	O	O	B-T091
medicine	O	O	I-T091
discipline	O	O	I-T091
.	O	O	O

When	O	O	O
available	O	O	O
,	O	O	O
the	O	O	O
subject	O	O	O
grids	O	O	O
were	O	O	O
analyzed	O	O	B-T062
to	O	O	O
verify	O	O	O
whether	O	O	O
a	O	O	O
description	O	O	B-T170
of	O	O	I-T170
content	O	O	I-T170
regarding	O	O	O
transfusion	O	O	B-T091
medicine	O	O	I-T091
was	O	O	O
given	O	O	O
within	O	O	O
other	O	O	O
disciplines	O	O	B-T090
.	O	O	O

Of	O	O	O
the	O	O	O
249	O	O	O
medical	O	O	B-T093
school	O	O	I-T093
sites	O	O	O
visited	O	O	O
,	O	O	O
information	O	O	B-T078
on	O	O	O
the	O	O	O
curriculum	O	O	B-T170
was	O	O	O
obtained	O	O	O
from	O	O	O
178	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
medical	O	O	B-T093
schools	O	O	I-T093
that	O	O	O
published	O	O	B-T057
their	O	O	O
curriculum	O	O	B-T170
,	O	O	O
132	O	O	O
(	O	O	O
74.1	O	O	O
%	O	O	O
)	O	O	O
did	O	O	O
not	O	O	O
have	O	O	O
disciplines	O	O	B-T091
of	O	O	I-T091
transfusion	O	O	I-T091
medicine	O	O	I-T091
or	O	O	O
hematology	O	O	B-T091
and	O	O	O
only	O	O	O
seven	O	O	O
(	O	O	O
3.9	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
a	O	O	O
discipline	O	O	B-T091
of	O	O	I-T091
transfusion	O	O	I-T091
medicine	O	O	I-T091
in	O	O	O
the	O	O	O
curricular	O	O	B-UnknownType
grid	O	O	I-UnknownType
.	O	O	O

Education	O	O	B-T065
on	O	O	O
transfusion	O	O	B-T091
medicine	O	O	I-T091
is	O	O	O
of	O	O	O
fundamental	O	O	B-T080
importance	O	O	I-T080
for	O	O	O
safe	O	O	B-T061
and	O	O	I-T061
efficient	O	O	I-T061
transfusion	O	O	I-T061
practices	O	O	I-T061
.	O	O	O

Deficiencies	O	O	B-T169
in	O	O	O
medical	O	O	B-T169
knowledge	O	O	B-T170
of	O	O	O
this	O	O	O
subject	O	O	O
have	O	O	O
been	O	O	O
found	O	O	O
worldwide	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
indicate	O	O	O
a	O	O	O
possible	O	O	O
deficiency	O	O	B-T169
in	O	O	O
teaching	O	O	B-T065
the	O	O	O
basics	O	O	B-T169
of	O	O	O
this	O	O	O
specialty	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
additional	O	O	O
prospective	O	O	B-T062
studies	O	O	I-T062
to	O	O	O
assess	O	O	B-T058
the	O	O	O
knowledge	O	O	B-T170
and	O	O	O
practice	O	O	O
of	O	O	O
transfusion	O	O	B-T091
medicine	O	O	I-T091
in	O	O	O
Brazilian	O	O	B-T098
medical	O	O	B-T093
schools	O	O	I-T093
are	O	O	O
warranted	O	O	O
,	O	O	O
which	O	O	O
could	O	O	O
prompt	O	O	O
a	O	O	O
discussion	O	O	O
on	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
offering	O	O	O
training	O	O	B-T065
in	O	O	O
transfusion	O	O	O
medicine	O	O	O
to	O	O	O
medical	O	O	B-T097
students	O	O	I-T097
.	O	O	O

-DOCSTART- (27524031)

Advanced	O	O	B-T080
interlocking	O	O	B-T074
systems	O	O	I-T074
to	O	O	O
improve	O	O	B-T033
heavy	O	O	B-T080
-	O	O	O
load-bearing	O	O	B-T032
characteristics	O	O	B-T080
of	O	O	O
flexible	O	O	B-T080
intramedullary	O	O	O
nailing	O	O	O

Flexible	O	O	B-T080
intramedullary	O	O	B-T061
nailing	O	O	I-T061
(	O	O	O
FIN	O	O	B-T061
)	O	O	O
is	O	O	O
a	O	O	O
minimally	O	O	B-T061
invasive	O	O	I-T061
and	O	O	O
widespread	O	O	B-T082
standard	O	O	B-T080
method	O	O	B-T061
for	O	O	O
osteosynthesis	O	O	B-T061
of	O	O	O
pediatric	O	O	B-T080
long	O	O	B-T033
bone	O	O	I-T033
fractures	O	O	I-T033
.	O	O	O

In	O	O	O
the	O	O	O
case	O	O	O
of	O	O	O
unstable	O	O	B-T037
fractures	O	O	I-T037
of	O	O	O
the	O	O	O
lower	O	O	B-T023
extremity	O	O	I-T023
,	O	O	O
interlocking	O	O	B-T074
systems	O	O	I-T074
need	O	O	O
to	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
prevent	O	O	O
axial	O	O	B-T082
shortening	O	O	B-T061
and	O	O	O
subsequent	O	O	B-T079
perforation	O	O	B-T046
of	O	O	O
the	O	O	O
nail	O	O	B-T074
at	O	O	O
its	O	O	O
insertion	O	O	B-T082
site	O	O	I-T082
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
four	O	O	O
different	O	O	O
screw	O	O	B-T074
-fixed	O	O	O
interlocking	O	O	B-T074
systems	O	O	I-T074
for	O	O	O
FINs	O	O	B-T061
(	O	O	O
Hofer	O	O	B-T074
TwinPlug	O	O	I-T074
with	O	O	O
two	O	O	O
3-mm	O	O	O
titanium	O	O	B-T196
interlocking	O	O	B-T074
screws	O	O	I-T074
,	O	O	O
Hofer	O	O	B-T074
FixPlug	O	O	I-T074
with	O	O	O
3-mm	O	O	O
titanium	O	O	O
interlocking	O	O	B-T074
screw	O	O	I-T074
,	O	O	O
Hofer	O	O	B-T074
Plug	O	O	I-T074
with	O	O	O
3.5-mm	O	O	O
titanium	O	O	O
interlocking	O	O	O
screw	O	O	O
,	O	O	O
and	O	O	O
Hofer	O	O	O
Plug	O	O	O
with	O	O	O
3-mm	O	O	O
titanium	O	O	O
interlocking	O	O	O
screw	O	O	O
)	O	O	O
in	O	O	O
comparison	O	O	B-T052
with	O	O	O
the	O	O	O
commonly	O	O	O
used	O	O	O
Ender	O	O	O
stainless	O	O	B-T122
steel	O	O	I-T122
nails	O	O	B-T074
(	O	O	O
locked	O	O	O
with	O	O	O
3.5-mm	O	O	O
screw	O	O	O
)	O	O	O
were	O	O	O
experimentally	O	O	B-T169
investigated	O	O	I-T169
in	O	O	O
cadaveric	O	O	B-T017
lamb	O	O	B-T015
tibiae	O	O	B-T023
,	O	O	O
regarding	O	O	O
their	O	O	O
load	O	O	B-T052
characteristics	O	O	B-T080
and	O	O	O
failure	O	O	B-T066
modes	O	O	B-T169
in	O	O	O
the	O	O	O
case	O	O	O
of	O	O	O
heavy	O	O	B-T080
loading	O	O	B-T052
.	O	O	O

The	O	O	O
specimens	O	O	B-T167
were	O	O	O
subjected	O	O	O
to	O	O	O
sequential	O	O	B-T080
axial	O	O	B-T082
cyclic	O	O	B-T079
loading	O	O	B-T052
of	O	O	O
5000	O	O	O
cycles	O	O	B-T079
with	O	O	O
stepwise	O	O	B-T169
increase	O	O	I-T169
of	O	O	O
the	O	O	O
load	O	O	B-T052
amplitude	O	O	B-T082
until	O	O	O
failure	O	O	B-T066
.	O	O	O

Migration	O	O	B-T067
of	O	O	O
locking	O	O	B-T074
screws	O	O	I-T074
and	O	O	O
internal	O	O	B-T082
damage	O	O	B-T037
of	O	O	O
bone	O	O	B-T024
tissue	O	O	I-T024
was	O	O	O
quantified	O	O	O
by	O	O	O
micro-computed	O	O	B-T060
tomography	O	O	I-T060
(	O	O	I-T060
CT	O	O	I-T060
)	O	O	I-T060
imaging	O	O	I-T060
.	O	O	O

Ender	O	O	B-T074
nails	O	O	I-T074
failed	O	O	B-T169
on	O	O	O
average	O	O	B-T081
at	O	O	O
a	O	O	O
peak	O	O	B-T080
load	O	O	B-T052
of	O	O	O
800	O	O	O
N	O	O	O
,	O	O	O
TwinPlugs	O	O	B-T074
at	O	O	O
1367	O	O	O
N	O	O	O
,	O	O	O
FixPlugs	O	O	B-T074
at	O	O	O
1222	O	O	O
N	O	O	O
,	O	O	O
Plugs	O	O	B-T074
3.5	O	O	O
mm	O	O	O
at	O	O	O
1225	O	O	O
N	O	O	O
and	O	O	O
Plugs	O	O	O
3.0	O	O	O
mm	O	O	O
at	O	O	O
971	O	O	O
N.	O	O	O
TwinPlugs	O	O	O
,	O	O	O
FixPlugs	O	O	O
,	O	O	O
and	O	O	O
Plugs	O	O	O
3.5	O	O	O
mm	O	O	O
failed	O	O	O
in	O	O	O
a	O	O	O
slow	O	O	O
manner	O	O	O
over	O	O	O
several	O	O	O
hundred	O	O	O
loading	O	O	B-T052
cycles	O	O	B-T079
,	O	O	O
whereas	O	O	O
Ender	O	O	O
nails	O	O	O
and	O	O	O
Plugs	O	O	O
3.0	O	O	O
mm	O	O	O
exhibited	O	O	O
abrupt	O	O	B-T080
failure	O	O	B-T066
without	O	O	O
any	O	O	O
prior	O	O	B-T079
indication	O	O	B-T078
.	O	O	O

Our	O	O	O
results	O	O	O
confirm	O	O	O
that	O	O	O
axial	O	O	B-T082
stability	O	O	B-T080
of	O	O	O
FIN	O	O	B-T061
can	O	O	O
be	O	O	O
further	O	O	O
improved	O	O	B-T033
by	O	O	O
screw	O	O	B-T074
-fixed	O	O	O
plugs	O	O	B-T074
by	O	O	O
simultaneously	O	O	B-T079
avoiding	O	O	O
shortcomings	O	O	O
of	O	O	O
an	O	O	O
eye-locked	O	O	B-T073
system	O	O	I-T073
,	O	O	O
which	O	O	O
the	O	O	O
Ender	O	O	B-T074
nails	O	O	I-T074
are	O	O	O
.	O	O	O

Considering	O	O	O
biomechanical	O	O	B-T070
results	O	O	B-T033
,	O	O	O
plug	O	O	B-T074
interlocking	O	O	B-T074
systems	O	O	I-T074
with	O	O	O
3.5-mm	O	O	O
screws	O	O	B-T074
should	O	O	O
be	O	O	O
favored	O	O	O
over	O	O	O
conventional	O	O	B-T080
Ender	O	O	B-T074
nails	O	O	I-T074
and	O	O	O
plugs	O	O	B-T074
with	O	O	O
3-mm	O	O	O
screws	O	O	O
.	O	O	O

-DOCSTART- (27524875)

Surgical	O	O	B-T061
Guidance	O	O	B-T061
via	O	O	O
Multiplexed	O	O	B-T060
Molecular	O	O	I-T060
Imaging	O	O	I-T060
of	O	O	O
Fresh	O	O	O
Tissues	O	O	B-T024
Labeled	O	O	B-T130
with	O	O	O
SERS	O	O	B-T070
-Coded	O	O	O
Nanoparticles	O	O	O

The	O	O	O
imaging	O	O	B-T060
of	O	O	O
dysregulated	O	O	O
cell-surface	O	O	B-T116
receptors	O	O	I-T116
(	O	O	O
or	O	O	O
biomarkers	O	O	B-T201
)	O	O	I-T201
is	O	O	O
a	O	O	O
potential	O	O	O
means	O	O	O
of	O	O	O
identifying	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
cancer	O	O	B-T191
with	O	O	O
high	O	O	O
sensitivity	O	O	B-T169
and	O	O	O
specificity	O	O	B-T081
.	O	O	O

However	O	O	O
,	O	O	O
due	O	O	O
to	O	O	O
heterogeneities	O	O	B-T080
in	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	I-T045
protein	O	O	I-T045
biomarkers	O	O	B-T123
in	O	O	O
tumors	O	O	B-T191
,	O	O	O
molecular	O	O	B-T060
imaging	O	O	I-T060
technologies	O	O	B-T058
should	O	O	O
ideally	O	O	O
be	O	O	O
capable	O	O	O
of	O	O	O
visualizing	O	O	O
a	O	O	O
multiplexed	O	O	B-T130
panel	O	O	I-T130
of	O	O	O
cancer	O	O	B-T123
biomarkers	O	O	I-T123
.	O	O	O

Recently	O	O	O
,	O	O	O
surface-enhanced	O	O	B-T070
Raman-scattering	O	O	I-T070
(	O	O	O
SERS	O	O	B-T070
)	O	O	O
nanoparticles	O	O	B-T073
(	O	O	O
NPs	O	O	B-T073
)	O	O	O
have	O	O	O
attracted	O	O	O
wide	O	O	O
interest	O	O	O
due	O	O	O
to	O	O	O
their	O	O	O
potential	O	O	O
for	O	O	O
sensitive	O	O	B-T169
and	O	O	O
multiplexed	O	O	B-T130
biomarker	O	O	I-T130
detection	O	O	B-T061
.	O	O	O

In	O	O	O
this	O	O	O
review	O	O	B-T170
,	O	O	O
we	O	O	O
focus	O	O	O
on	O	O	O
the	O	O	O
most	O	O	O
recent	O	O	O
advances	O	O	O
in	O	O	O
tumor	O	O	B-T191
imaging	O	O	B-T060
using	O	O	O
SERS	O	O	B-T070
-coded	O	O	O
NPs	O	O	B-T073
.	O	O	O

A	O	O	O
brief	O	O	O
introduction	O	O	O
of	O	O	O
the	O	O	O
structure	O	O	B-T082
and	O	O	O
optical	O	O	B-T070
properties	O	O	I-T070
of	O	O	O
SERS	O	O	B-T070
NPs	O	O	B-T073
is	O	O	O
provided	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
a	O	O	O
detailed	O	O	O
discussion	O	O	O
of	O	O	O
key	O	O	O
imaging	O	O	B-T060
issues	O	O	O
such	O	O	O
as	O	O	O
the	O	O	O
administration	O	O	B-T169
of	O	O	O
NPs	O	O	O
in	O	O	O
tissue	O	O	B-T024
(	O	O	O
topical	O	O	B-T082
versus	O	O	O
systemic	O	O	B-T169
)	O	O	O
,	O	O	O
the	O	O	O
optical	O	O	B-UnknownType
configuration	O	O	I-UnknownType
and	O	O	O
imaging	O	O	O
approach	O	O	O
of	O	O	O
Raman	O	O	B-T059
imaging	O	O	I-T059
systems	O	O	I-T059
,	O	O	O
spectral	O	O	B-T060
demultiplexing	O	O	I-T060
methods	O	O	I-T060
for	O	O	O
quantifying	O	O	B-T081
NP	O	O	B-T073
concentrations	O	O	B-T081
,	O	O	O
and	O	O	O
the	O	O	O
disambiguation	O	O	B-T080
of	O	O	O
specific	O	O	B-T080
vs.	O	O	O
nonspecific	O	O	B-T078
sources	O	O	O
of	O	O	O
contrast	O	O	O
through	O	O	O
ratiometric	O	O	B-T060
imaging	O	O	I-T060
of	O	O	O
targeted	O	O	B-T169
and	O	O	O
untargeted	O	O	B-T167
(	O	O	O
control	O	O	B-T167
)	O	O	O
NP	O	O	O
pairs	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
future	O	O	O
challenges	O	O	O
and	O	O	O
directions	O	O	O
are	O	O	O
briefly	O	O	O
outlined	O	O	O
.	O	O	O

-DOCSTART- (27526315)

Expression	O	O	B-T045
and	O	O	O
methylation	O	O	B-T044
in	O	O	O
posttraumatic	O	O	B-T048
stress	O	O	I-T048
disorder	O	O	I-T048
and	O	O	O
resilience	O	O	B-T055
;	O	O	O
evidence	O	O	B-T078
of	O	O	O
a	O	O	O
role	O	O	B-T077
for	O	O	O
odorant	O	O	O
receptors	O	O	O

Post-traumatic	O	O	B-T048
stress	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
PTSD	O	O	B-T048
)	O	O	O
is	O	O	O
a	O	O	O
common	O	O	O
and	O	O	O
potentially	O	O	B-T080
disabling	O	O	B-T047
disorder	O	O	I-T047
that	O	O	O
develops	O	O	O
in	O	O	O
1/5	O	O	O
to	O	O	O
1/3	O	O	O
of	O	O	O
people	O	O	B-T098
exposed	O	O	B-T080
to	O	O	I-T080
severe	O	O	B-T080
trauma	O	O	B-T037
.	O	O	O

Twin	O	O	B-T170
studies	O	O	I-T170
indicate	O	O	O
that	O	O	O
genetic	O	O	B-T169
factors	O	O	B-T169
account	O	O	O
for	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
third	O	O	O
of	O	O	O
the	O	O	O
variance	O	O	B-T080
in	O	O	O
the	O	O	O
risk	O	O	O
for	O	O	O
developing	O	O	O
PTSD	O	O	B-T048
,	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
specific	O	O	B-T080
role	O	O	B-T077
for	O	O	O
genetic	O	O	O
factors	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
PTSD	O	O	O
is	O	O	O
not	O	O	O
well	O	O	O
understood	O	O	O
.	O	O	O

We	O	O	O
studied	O	O	O
genome-wide	O	O	B-T063
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
DNA	O	O	B-T044
methylation	O	O	I-T044
profiles	O	O	B-T081
in	O	O	O
12	O	O	O
participants	O	O	B-T098
with	O	O	O
PTSD	O	O	B-T048
and	O	O	O
12	O	O	O
participants	O	O	O
who	O	O	O
were	O	O	O
resilient	O	O	B-T055
to	O	O	O
similar	O	O	O
severity	O	O	B-T080
trauma	O	O	B-T037
exposure	O	O	B-T080
.	O	O	O

Close	O	O	O
to	O	O	O
4000	O	O	O
genes	O	O	B-T028
were	O	O	O
differentially	O	O	B-T080
expressed	O	O	B-T045
with	O	O	O
adjusted	O	O	B-T169
p<0.05	O	O	O
,	O	O	O
fold-change	O	O	B-T081
>	O	O	O
2	O	O	O
,	O	O	O
with	O	O	O
all	O	O	O
but	O	O	O
3	O	O	O
upregulated	O	O	B-T044
with	O	O	O
PTSD	O	O	B-T048
.	O	O	O

Eight	O	O	O
odorant/olfactory	O	O	B-T116
receptor	O	O	I-T116
related	O	O	O
genes	O	O	B-T028
were	O	O	O
up-regulated	O	O	B-T044
with	O	O	O
PTSD	O	O	B-T048
as	O	O	O
well	O	O	O
as	O	O	O
genes	O	O	O
related	O	O	O
to	O	O	O
immune	O	O	B-T043
activation	O	O	I-T043
,	O	O	O
the	O	O	O
Gamma-Aminobutyric	O	O	B-T116
Acid	O	O	I-T116
A	O	O	I-T116
(	O	O	I-T116
GABAA	O	O	I-T116
)	O	O	I-T116
receptor	O	O	I-T116
,	O	O	O
and	O	O	O
vitamin	O	O	B-T044
D	O	O	I-T044
synthesis	O	O	I-T044
.	O	O	O

No	O	O	O
differences	O	O	O
with	O	O	O
adjusted	O	O	B-T169
significance	O	O	B-T078
for	O	O	O
DNA	O	O	B-T044
methylation	O	O	I-T044
were	O	O	O
found	O	O	O
.	O	O	O

We	O	O	O
conclude	O	O	O
that	O	O	O
increased	O	O	B-T081
gene	O	O	B-T045
expression	O	O	B-T045
may	O	O	O
play	O	O	O
an	O	O	O
important	O	O	B-T080
role	O	O	B-T077
in	O	O	O
PTSD	O	O	B-T048
and	O	O	O
this	O	O	O
expression	O	O	O
may	O	O	O
not	O	O	O
be	O	O	O
a	O	O	O
consequence	O	O	B-T169
of	O	O	I-T169
DNA	O	O	B-T044
methylation	O	O	I-T044
.	O	O	O

The	O	O	O
role	O	O	B-T077
of	O	O	O
odorant	O	O	B-T116
receptor	O	O	I-T116
expression	O	O	B-T045
warrants	O	O	O
independent	O	O	B-T169
replication	O	O	B-T045
.	O	O	O

-DOCSTART- (27532629)

Absorption	O	O	B-T169
Characteristics	O	O	I-T169
of	O	O	O
Vertebrate	O	O	B-T010
Non	O	O	B-T169
-	O	O	O
Visual	O	O	B-T169
Opsin	O	O	O
,	O	O	O
Opn3	O	O	O

Most	O	O	O
animals	O	O	B-T008
possess	O	O	B-T078
multiple	O	O	B-T081
opsins	O	O	B-T116
which	O	O	O
sense	O	O	B-T040
light	O	O	B-T070
for	O	O	O
visual	O	O	B-T169
and	O	O	O
non	O	O	B-T169
-	O	O	O
visual	O	O	B-T040
functions	O	O	I-T040
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
spectral	O	O	B-T081
characteristics	O	O	B-T080
of	O	O	O
non	O	O	B-T169
-	O	O	O
visual	O	O	B-T169
opsins	O	O	B-T116
,	O	O	O
vertebrate	O	O	B-T010
Opn3s	O	O	B-T116
,	O	O	O
which	O	O	O
are	O	O	O
widely	O	O	O
distributed	O	O	B-T169
among	O	O	O
vertebrates	O	O	B-T010
.	O	O	O

We	O	O	O
successfully	O	O	B-T080
expressed	O	O	B-T045
zebrafish	O	O	B-T013
Opn3	O	O	B-T116
in	O	O	O
mammalian	O	O	B-T015
cultured	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
measured	O	O	B-T080
its	O	O	O
absorption	O	O	B-T059
spectrum	O	O	I-T059
spectroscopically	O	O	I-T059
.	O	O	O

When	O	O	O
incubated	O	O	B-T059
with	O	O	O
11-cis	O	O	B-T109
retinal	O	O	I-T109
,	O	O	O
zebrafish	O	O	B-T013
Opn3	O	O	B-T116
formed	O	O	O
a	O	O	O
blue-sensitive	O	O	B-T109
photopigment	O	O	I-T109
with	O	O	O
an	O	O	O
absorption	O	O	B-T043
maximum	O	O	B-T081
around	O	O	O
465	O	O	O
nm	O	O	O
.	O	O	O

The	O	O	O
Opn3	O	O	B-T116
converts	O	O	B-T169
to	O	O	O
an	O	O	O
all-trans	O	O	B-T127
retinal-bearing	O	O	I-T127
photoproduct	O	O	B-T167
with	O	O	O
an	O	O	O
absorption	O	O	B-T059
spectrum	O	O	I-T059
similar	O	O	B-T080
to	O	O	O
the	O	O	O
dark	O	O	B-T042
state	O	O	I-T042
following	O	O	O
brief	O	O	B-T079
blue-light	O	O	B-T070
irradiation	O	O	B-T070
.	O	O	O

The	O	O	O
photoproduct	O	O	B-T167
experienced	O	O	O
a	O	O	O
remarkable	O	O	O
blue-shift	O	O	B-T081
,	O	O	O
with	O	O	O
changes	O	O	O
in	O	O	B-T082
position	O	O	I-T082
of	O	O	O
the	O	O	O
isosbestic	O	O	B-T081
point	O	O	I-T081
,	O	O	O
during	O	O	O
further	O	O	O
irradiation	O	O	B-T070
.	O	O	O

We	O	O	O
then	O	O	O
used	O	O	O
a	O	O	O
cAMP	O	O	B-T114
-	O	O	O
dependent	O	O	B-T169
luciferase	O	O	B-T116
reporter	O	O	B-T130
assay	O	O	B-T059
to	O	O	O
investigate	O	O	B-T169
light	O	O	B-T070
-	O	O	O
dependent	O	O	O
cAMP	O	O	O
responses	O	O	B-T043
in	O	O	O
cultured	O	O	B-T025
cells	O	O	I-T025
expressing	O	O	B-T045
zebrafish	O	O	B-T013
,	O	O	O
pufferfish	O	O	B-T013
,	O	O	O
anole	O	O	B-T014
and	O	O	O
chicken	O	O	B-T012
Opn3	O	O	B-T116
.	O	O	O

The	O	O	O
wild	O	O	B-T028
type	O	O	I-T028
opsins	O	O	B-T116
did	O	O	O
not	O	O	O
produce	O	O	O
responses	O	O	B-T043
,	O	O	O
but	O	O	O
cells	O	O	B-T025
expressing	O	O	B-T045
chimera	O	O	B-T001
mutants	O	O	B-T116
(	O	O	O
WT	O	O	B-T116
Opn3s	O	O	I-T116
in	O	O	O
which	O	O	O
the	O	O	O
third	O	O	B-T082
intracellular	O	O	I-T082
loops	O	O	B-T087
were	O	O	O
replaced	O	O	B-T169
with	O	O	O
the	O	O	O
third	O	O	O
intracellular	O	O	O
loop	O	O	B-T087
of	O	O	O
a	O	O	O
Gs-coupled	O	O	B-T116
jellyfish	O	O	B-T204
opsin	O	O	B-T116
)	O	O	O
displayed	O	O	B-T169
light	O	O	B-T070
-	O	O	O
dependent	O	O	B-T169
changes	O	O	B-T081
in	O	O	O
cAMP	O	O	B-T114
.	O	O	O

The	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
Opn3	O	O	B-T116
is	O	O	O
capable	O	O	O
of	O	O	O
activating	O	O	B-T045
G	O	O	B-T116
protein(s	O	O	I-T116
)	O	O	I-T116
in	O	O	O
a	O	O	O
light	O	O	B-T070
-	O	O	O
dependent	O	O	B-T169
manner	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
used	O	O	O
this	O	O	O
assay	O	O	B-T059
to	O	O	O
measure	O	O	B-T081
the	O	O	O
relative	O	O	B-T080
wavelength	O	O	B-T081
-	O	O	O
dependent	O	O	B-T169
response	O	O	B-T032
of	O	O	O
cells	O	O	B-T025
expressing	O	O	B-T045
Opn3	O	O	B-T116
chimeras	O	O	B-T001
to	O	O	O
multiple	O	O	B-T081
quantally	O	O	B-T170
-	O	O	O
matched	O	O	B-T080
stimuli	O	O	B-T067
.	O	O	O

The	O	O	O
inferred	O	O	B-T078
spectral	O	O	B-T041
sensitivity	O	O	I-T041
curve	O	O	B-T082
of	O	O	O
zebrafish	O	O	B-T013
Opn3	O	O	B-T116
accurately	O	O	B-T080
matched	O	O	B-T080
the	O	O	O
measured	O	O	B-T080
absorption	O	O	B-T059
spectrum	O	O	I-T059
.	O	O	O

We	O	O	O
were	O	O	O
unable	O	O	O
to	O	O	O
estimate	O	O	O
the	O	O	O
spectral	O	O	B-T041
sensitivity	O	O	I-T041
curve	O	O	B-T082
of	O	O	O
mouse	O	O	B-T015
or	O	O	O
anole	O	O	B-T014
Opn3	O	O	B-T116
,	O	O	O
but	O	O	O
,	O	O	O
like	O	O	O
zebrafish	O	O	B-T013
Opn3	O	O	O
,	O	O	O
the	O	O	O
chicken	O	O	B-T012
and	O	O	O
pufferfish	O	O	B-T013
Opn3-JiL3	O	O	B-T116
chimeras	O	O	B-T001
also	O	O	O
formed	O	O	O
blue-sensitive	O	O	B-T116
pigments	O	O	I-T116
.	O	O	O

These	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
vertebrate	O	O	B-T010
Opn3s	O	O	B-T116
may	O	O	O
form	O	O	O
blue-sensitive	O	O	B-T116
G	O	O	I-T116
protein-coupled	O	O	I-T116
pigments	O	O	I-T116
.	O	O	O

Further	O	O	O
,	O	O	O
we	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
method	O	O	O
described	O	O	O
here	O	O	O
,	O	O	O
combining	O	O	O
a	O	O	O
cAMP	O	O	B-T114
-	O	O	O
dependent	O	O	B-T169
luciferase	O	O	B-T116
reporter	O	O	B-T130
assay	O	O	B-T059
with	O	O	O
chimeric	O	O	B-T001
opsins	O	O	B-T116
possessing	O	O	O
the	O	O	O
third	O	O	B-T082
intracellular	O	O	I-T082
loop	O	O	B-T087
of	O	O	O
jellyfish	O	O	B-T204
opsin	O	O	B-T116
,	O	O	O
is	O	O	O
a	O	O	O
versatile	O	O	O
approach	O	O	O
for	O	O	O
estimating	O	O	B-T081
absorption	O	O	B-T059
spectra	O	O	I-T059
of	O	O	O
opsins	O	O	O
with	O	O	O
unknown	O	O	O
signaling	O	O	B-T043
cascades	O	O	I-T043
or	O	O	O
for	O	O	O
which	O	O	O
absorption	O	O	O
spectra	O	O	O
are	O	O	O
difficult	O	O	B-T080
to	O	O	O
obtain	O	O	O
.	O	O	O

-DOCSTART- (27532798)

Effectiveness	O	O	B-T080
of	O	O	O
offloading	O	O	B-T061
methods	O	O	B-T061
in	O	O	O
preventing	O	O	B-T061
primary	O	O	B-T080
diabetic	O	O	B-T047
foot	O	O	I-T047
ulcers	O	O	I-T047
in	O	O	O
adults	O	O	B-T100
with	O	O	O
diabetes	O	O	B-T047
:	O	O	O
a	O	O	O
systematic	O	O	O
review	O	O	O

The	O	O	O
incidence	O	O	B-T081
of	O	O	O
foot	O	O	B-T047
ulceration	O	O	I-T047
related	O	O	O
to	O	O	O
diabetes	O	O	B-T047
is	O	O	O
increasing	O	O	B-T169
.	O	O	O

Many	O	O	O
foot	O	O	B-T061
care	O	O	I-T061
professionals	O	O	B-T097
recommend	O	O	O
offloading	O	O	B-T061
measures	O	O	O
as	O	O	O
part	O	O	O
of	O	O	O
management	O	O	B-T058
strategies	O	O	I-T058
for	O	O	O
modulating	O	O	O
excess	O	O	B-T080
pressure	O	O	B-T081
to	O	O	O
prevent	O	O	B-T061
development	O	O	O
of	O	O	O
diabetic	O	O	B-T047
foot	O	O	I-T047
ulcers	O	O	I-T047
(	O	O	O
DFUs	O	O	B-T047
)	O	O	O
.	O	O	O

These	O	O	O
measures	O	O	B-T081
may	O	O	O
include	O	O	O
padding	O	O	B-T061
,	O	O	O
insoles	O	O	B-T074
/	O	O	O
orthotic	O	O	B-T074
devices	O	O	I-T074
and	O	O	O
footwear	O	O	B-T073
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
lack	O	O	O
of	O	O	O
evidence	O	O	B-T078
-based	O	O	O
guidance	O	O	O
on	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
the	O	O	O
different	O	O	O
offloading	O	O	B-T061
options	O	O	O
for	O	O	O
preventing	O	O	B-T061
primary	O	O	B-T080
ulceration	O	O	B-T047
in	O	O	O
those	O	O	O
with	O	O	O
diabetes	O	O	B-T047
.	O	O	O

To	O	O	O
identify	O	O	O
,	O	O	O
critically	O	O	O
appraise	O	O	O
and	O	O	O
synthesize	O	O	O
the	O	O	O
best	O	O	O
available	O	O	O
evidence	O	O	B-T078
on	O	O	O
methods	O	O	B-T061
of	O	O	O
offloading	O	O	B-T061
to	O	O	O
prevent	O	O	B-T061
the	O	O	O
development	O	O	B-T169
,	O	O	O
and	O	O	O
reduce	O	O	B-T080
the	O	O	O
risk	O	O	B-T078
,	O	O	O
of	O	O	O
primary	O	O	B-T080
foot	O	O	B-T047
ulceration	O	O	I-T047
in	O	O	O
adults	O	O	B-T100
with	O	O	O
diabetes	O	O	B-T047
.The	O	O	O
question	O	O	B-T078
addressed	O	O	B-T170
by	O	O	O
the	O	O	O
review	O	O	B-T170
was	O	O	O
:	O	O	O
what	O	O	O
is	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
methods	O	O	O
of	O	O	O
offloading	O	O	O
in	O	O	O
preventing	O	O	B-T061
primary	O	O	O
DFUs	O	O	B-T047
in	O	O	O
adults	O	O	O
with	O	O	O
diabetes	O	O	O
?	O	O	O

Adults	O	O	B-T100
18	O	O	O
years	O	O	B-T079
and	O	O	O
older	O	O	O
with	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
,	O	O	O
regardless	O	O	O
of	O	O	O
age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
ethnicity	O	O	B-T080
,	O	O	O
duration	O	O	B-T079
or	O	O	O
type	O	O	B-T080
of	O	O	O
diabetes	O	O	O
,	O	O	O
with	O	O	O
no	O	O	O
history	O	O	B-T033
of	O	O	O
DFUs	O	O	B-T047
and	O	O	O
in	O	O	O
any	O	O	O
clinical	O	O	B-T082
setting	O	O	I-T082
will	O	O	O
be	O	O	O
included	O	O	O
.	O	O	O

Interventions	O	O	B-T061
will	O	O	O
include	O	O	O
all	O	O	O
external	O	O	O
methods	O	O	B-T061
of	O	O	O
offloading	O	O	B-T061
.	O	O	O

All	O	O	O
comparators	O	O	O
will	O	O	O
be	O	O	O
considered	O	O	O
.	O	O	O

Studies	O	O	B-T062
that	O	O	O
utilize	O	O	O
interventions	O	O	B-T061
not	O	O	O
considered	O	O	O
usual	O	O	B-T080
practice	O	O	B-T061
in	O	O	O
the	O	O	O
prevention	O	O	B-T061
of	O	O	O
DFUs	O	O	B-T047
will	O	O	O
be	O	O	O
excluded	O	O	B-T078
.	O	O	O

The	O	O	O
primary	O	O	B-T080
outcome	O	O	B-T169
will	O	O	O
be	O	O	O
primary	O	O	O
foot	O	O	B-T047
ulceration	O	O	I-T047
.	O	O	O

The	O	O	O
secondary	O	O	B-T081
outcome	O	O	B-T169
will	O	O	O
be	O	O	O
indications	O	O	O
of	O	O	O
changes	O	O	O
in	O	O	O
plantar	O	O	B-T029
pressure	O	O	B-T081
.	O	O	O

This	O	O	O
review	O	O	B-T170
will	O	O	O
consider	O	O	O
all	O	O	O
quantitative	O	O	B-T081
study	O	O	B-T062
designs	O	O	I-T062
.	O	O	O

A	O	O	O
three-step	O	O	O
strategy	O	O	O
for	O	O	O
published	O	O	O
and	O	O	O
unpublished	O	O	O
literature	O	O	B-T170
will	O	O	O
be	O	O	O
used	O	O	O
.	O	O	O

Fourteen	O	O	O
databases	O	O	B-T170
will	O	O	O
be	O	O	O
searched	O	O	O
for	O	O	O
studies	O	O	B-T062
in	O	O	O
English	O	O	B-T171
up	O	O	O
to	O	O	O
November	O	O	O
2013	O	O	O
.	O	O	O

The	O	O	O
JBI-MAStARI	O	O	B-T170
extraction	O	O	I-T170
tool	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
extract	O	O	O
relevant	O	O	O
data	O	O	B-T078
.	O	O	O

Results	O	O	B-T169
were	O	O	O
summarized	O	O	B-T170
using	O	O	O
narrative	O	O	B-UnknownType
and	O	O	O
tables	O	O	B-T170
.	O	O	O

Three	O	O	O
studies	O	O	B-T062
which	O	O	O
examined	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
four	O	O	O
different	O	O	O
offloading	O	O	B-T061
interventions	O	O	B-T061
met	O	O	O
the	O	O	O
inclusion	O	O	B-T080
criteria	O	O	I-T080
.	O	O	O

There	O	O	O
is	O	O	O
limited	O	O	O
evidence	O	O	B-T078
that	O	O	O
use	O	O	O
of	O	O	O
a	O	O	O
footwear	O	O	B-T073
system	O	O	O
(	O	O	O
prototype	O	O	B-T073
shoe	O	O	B-T073
plus	O	O	I-T073
polyurethane	O	O	I-T073
or	O	O	O
cork	O	O	B-T073
insole	O	O	B-T073
)	O	O	O
may	O	O	O
prevent	O	O	B-T061
a	O	O	O
break	O	O	O
in	O	O	O
the	O	O	O
skin	O	O	B-T022
;	O	O	O
use	O	O	O
of	O	O	O
customized	O	O	O
rigid	O	O	O
orthotic	O	O	B-T074
devices	O	O	I-T074
may	O	O	O
contribute	O	O	O
to	O	O	O
a	O	O	O
reduction	O	O	B-T080
in	O	O	O
the	O	O	O
grade	O	O	B-T080
and	O	O	O
number	O	O	B-T081
of	O	O	O
calluses	O	O	B-T020
;	O	O	O
and	O	O	O
a	O	O	O
manufactured	O	O	O
shoe	O	O	O
plus	O	O	O
customized	O	O	O
insole	O	O	O
may	O	O	O
reduce	O	O	O
plantar	O	O	B-T029
pressure	O	O	B-T081
and	O	O	O
therefore	O	O	O
reduce	O	O	O
the	O	O	O
potential	O	O	O
risk	O	O	B-T078
of	O	O	O
skin	O	O	B-T047
ulceration	O	O	I-T047
.	O	O	O

There	O	O	O
is	O	O	O
limited	O	O	O
and	O	O	O
low-quality	O	O	O
evidence	O	O	B-T078
that	O	O	O
in	O	O	O
a	O	O	O
population	O	O	B-T098
of	O	O	O
adults	O	O	B-T100
with	O	O	O
diabetes	O	O	B-T047
with	O	O	O
no	O	O	O
history	O	O	B-T033
of	O	O	O
DFU	O	O	B-T047
,	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
footwear	O	O	B-T073
with	O	O	O
customized	O	O	O
or	O	O	O
prefabricated	O	O	O
orthotic	O	O	B-T074
devices	O	O	I-T074
may	O	O	O
provide	O	O	O
some	O	O	O
reduction	O	O	O
in	O	O	O
plantar	O	O	B-T029
pressure	O	O	B-T081
and	O	O	O
therefore	O	O	O
help	O	O	O
to	O	O	O
prevent	O	O	B-T061
a	O	O	O
primary	O	O	B-T080
DFU	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
lack	O	O	O
of	O	O	O
evidence	O	O	B-T078
on	O	O	O
the	O	O	O
relative	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
different	O	O	O
offloading	O	O	B-T061
options	O	O	O
.	O	O	O

-DOCSTART- (27534567)

Punch	O	O	B-T048
injury	O	O	B-T037
self-harm	O	O	B-T037
in	O	O	O
young	O	O	O
people	O	O	O

Punch	O	O	B-T048
injuries	O	O	B-T037
are	O	O	O
a	O	O	O
form	O	O	B-T080
of	O	O	O
self-harm	O	O	B-T037
characterised	O	O	B-T052
by	O	O	O
the	O	O	O
intentional	O	O	B-T080
act	O	O	B-T052
of	O	O	I-T052
striking	O	O	I-T052
an	O	O	O
object	O	O	B-T072
with	O	O	O
a	O	O	O
closed	O	O	B-T169
fist	O	O	B-T072
.	O	O	O

We	O	O	O
aimed	O	O	B-T078
to	O	O	O
describe	O	O	O
the	O	O	O
characteristics	O	O	B-T080
and	O	O	O
trends	O	O	B-T079
in	O	O	O
young	O	O	B-T100
people	O	O	I-T100
presenting	O	O	B-T078
with	O	O	O
injuries	O	O	B-T037
sustained	O	O	B-T169
via	O	O	O
the	O	O	O
punch	O	O	B-T048
mechanism	O	O	B-T169
.	O	O	O

A	O	O	O
comprehensive	O	O	B-T080
retrospective	O	O	B-T062
review	O	O	I-T062
of	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
was	O	O	O
completed	O	O	B-T080
of	O	O	O
all	O	O	O
young	O	O	B-T100
people	O	O	I-T100
aged	O	O	B-T032
10	O	O	O
-	O	O	O
18	O	O	O
years	O	O	B-T079
presenting	O	O	B-T078
to	O	O	O
our	O	O	O
Central	O	O	B-T093
London	O	O	I-T093
Emergency	O	O	I-T093
Department	O	O	I-T093
over	O	O	O
a	O	O	O
12-month	O	O	B-T079
period	O	O	I-T079
.	O	O	O

A	O	O	O
subset	O	O	B-T185
of	O	O	I-T185
the	O	O	I-T185
total	O	O	I-T185
group	O	O	I-T185
was	O	O	O
identified	O	O	B-T080
as	O	O	O
the	O	O	O
punch	O	O	B-T048
injury	O	O	B-T037
subgroup	O	O	B-T185
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
78	O	O	O
punch	O	O	B-T048
injury	O	O	B-T037
presentations	O	O	B-T078
were	O	O	O
identified	O	O	B-T080
.	O	O	O

In	O	O	O
this	O	O	O
subgroup	O	O	B-T185
,	O	O	O
the	O	O	O
male	O	O	B-T032
:	O	O	O
female	O	O	B-T032
ratio	O	O	B-T081
is	O	O	O
4.57:1	O	O	O
;	O	O	O
37.18	O	O	O
%	O	O	O
of	O	O	O
presentations	O	O	B-T078
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
fracture	O	O	B-T037
(	O	O	O
n	O	O	O
=	O	O	O
29	O	O	O
)	O	O	O
and	O	O	O
35.90	O	O	O
%	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
28	O	O	O
)	O	O	O
of	O	O	O
patients	O	O	B-T101
re-presented	O	O	B-T078
following	O	O	O
another	O	O	O
punch	O	O	B-T048
injury	O	O	B-T037
,	O	O	O
as	O	O	O
a	O	O	O
victim	O	O	B-T033
of	O	O	I-T033
violence	O	O	I-T033
,	O	O	O
or	O	O	O
by	O	O	O
other	O	O	O
psychiatric	O	O	B-T169
presentation	O	O	B-T078
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
,	O	O	O
a	O	O	O
male	O	O	B-T033
preponderance	O	O	I-T033
was	O	O	O
observed	O	O	B-T169
,	O	O	O
with	O	O	O
frequent	O	O	B-T079
re-presentations	O	O	B-T078
,	O	O	O
often	O	O	O
in	O	O	O
high-risk	O	O	B-T033
circumstances	O	O	B-T169
.	O	O	O

An	O	O	O
opportunity	O	O	O
for	O	O	O
screening	O	O	B-T058
,	O	O	O
including	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
,	O	O	O
social	O	O	B-T169
and	O	O	O
substance	O	O	B-T033
misuse	O	O	I-T033
,	O	O	O
was	O	O	O
identified	O	O	B-T080
.	O	O	O

Further	O	O	O
research	O	O	B-T062
is	O	O	O
needed	O	O	B-T080
to	O	O	O
enable	O	O	O
targeted	O	O	B-T169
effective	O	O	B-T080
interventions	O	O	B-T058
in	O	O	O
this	O	O	O
group	O	O	B-T100
.	O	O	O

-DOCSTART- (27537689)

Delayed	O	O	B-T079
Recognition	O	O	B-T041
of	O	O	O
Deterioration	O	O	B-T033
of	O	O	O
Patients	O	O	B-T101
in	O	O	O
General	O	O	B-T073
Wards	O	O	I-T073
Is	O	O	O
Mostly	O	O	O
Caused	O	O	O
by	O	O	O
Human	O	O	B-T016
Related	O	O	O
Monitoring	O	O	B-T058
Failures	O	O	B-T169
:	O	O	O
A	O	O	O
Root	O	O	B-T080
Cause	O	O	I-T080
Analysis	O	O	I-T080
of	O	O	O
Unplanned	O	O	O
ICU	O	O	O
Admissions	O	O	O

An	O	O	O
unplanned	O	O	O
ICU	O	O	B-T058
admission	O	O	I-T058
of	O	O	O
an	O	O	O
inpatient	O	O	B-T101
is	O	O	O
a	O	O	O
serious	O	O	B-T033
adverse	O	O	I-T033
event	O	O	I-T033
(	O	O	O
SAE	O	O	B-T033
)	O	O	O
.	O	O	O

So	O	O	O
far	O	O	O
,	O	O	O
no	O	O	O
in	O	O	O
depth-study	O	O	O
has	O	O	O
been	O	O	O
performed	O	O	O
to	O	O	O
systematically	O	O	O
analyse	O	O	O
the	O	O	O
root	O	O	B-T080
causes	O	O	I-T080
of	O	O	O
unplanned	O	O	O
ICU-admissions	O	O	B-T058
.	O	O	O

The	O	O	O
primary	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
healthcare	O	O	B-T097
worker	O	O	I-T097
-	O	O	O
,	O	O	O
organisational	O	O	B-T080
-	O	O	O
,	O	O	O
technical	O	O	B-T097
,	O	O	O
-	O	O	O
disease	O	O	B-T047
-	O	O	O
and	O	O	O
patient	O	O	B-T101
-	O	O	O
related	O	O	O
causes	O	O	O
that	O	O	O
contribute	O	O	O
to	O	O	O
acute	O	O	O
unplanned	O	O	O
ICU	O	O	B-T058
admissions	O	O	I-T058
from	O	O	O
general	O	O	B-T073
wards	O	O	I-T073
using	O	O	O
a	O	O	O
Root-Cause	O	O	B-T080
Analysis	O	O	I-T080
Tool	O	O	I-T080
called	O	O	O
PRISMA-medical	O	O	B-T058
.	O	O	O

Although	O	O	O
a	O	O	O
Track	O	O	B-T057
and	O	O	I-T057
Trigger	O	O	I-T057
System	O	O	I-T057
(	O	O	I-T057
MEWS	O	O	I-T057
)	O	O	I-T057
was	O	O	O
introduced	O	O	O
in	O	O	O
our	O	O	O
hospital	O	O	B-T093
a	O	O	O
few	O	O	O
years	O	O	O
ago	O	O	O
,	O	O	O
it	O	O	O
was	O	O	O
implemented	O	O	O
without	O	O	O
a	O	O	O
clear	O	O	O
protocol	O	O	B-T061
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
secondary	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
adherence	O	O	O
to	O	O	O
a	O	O	O
Track	O	O	B-T057
and	O	O	I-T057
Trigger	O	O	I-T057
system	O	O	I-T057
to	O	O	O
identify	O	O	O
deterioration	O	O	B-T033
on	O	O	O
general	O	O	B-T073
hospital	O	O	I-T073
wards	O	O	I-T073
in	O	O	O
patients	O	O	B-T101
eventually	O	O	O
transferred	O	O	O
to	O	O	O
the	O	O	O
ICU	O	O	B-T093
.	O	O	O

Retrospective	O	O	B-T062
observational	O	O	I-T062
study	O	O	I-T062
in	O	O	O
49	O	O	O
consecutive	O	O	O
adult	O	O	O
patients	O	O	B-T101
acutely	O	O	O
admitted	O	O	B-T058
to	O	O	O
the	O	O	O
Intensive	O	O	B-T093
Care	O	O	I-T093
Unit	O	O	I-T093
from	O	O	O
a	O	O	O
general	O	O	B-T058
nursing	O	O	I-T058
ward	O	O	I-T058
.	O	O	O

1	O	O	O
.	O	O	O
PRISMA-analysis	O	O	B-T062
on	O	O	O
root	O	O	B-T080
causes	O	O	I-T080
of	O	O	O
unplanned	O	O	O
ICU	O	O	B-T058
admissions	O	O	I-T058
2	O	O	O
.	O	O	O

Assessment	O	O	O
of	O	O	O
protocol	O	O	B-T061
adherence	O	O	O
to	O	O	O
the	O	O	O
early	O	O	B-T033
warning	O	O	I-T033
score	O	O	I-T033
system	O	O	I-T033
.	O	O	O

Out	O	O	O
of	O	O	O
49	O	O	O
cases	O	O	O
,	O	O	O
156	O	O	O
root	O	O	B-T080
causes	O	O	I-T080
were	O	O	O
identified	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
frequent	O	O	O
root	O	O	B-T080
causes	O	O	I-T080
were	O	O	O
healthcare	O	O	B-T097
worker	O	O	I-T097
related	O	O	O
(	O	O	O
46	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
were	O	O	O
mainly	O	O	O
failures	O	O	B-T169
in	O	O	O
monitoring	O	O	B-T058
the	O	O	O
patient	O	O	B-T101
.	O	O	O

They	O	O	O
were	O	O	O
followed	O	O	O
by	O	O	O
disease	O	O	B-T047
-related	O	O	O
(	O	O	O
45	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
patient	O	O	B-T101
-related	O	O	O
causes	O	O	O
(	O	O	O
7	O	O	O
,	O	O	O
5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
organisational	O	O	B-T080
root	O	O	B-T080
causes	O	O	I-T080
(	O	O	O
3	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
only	O	O	O
40	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
vital	O	O	B-T077
parameters	O	O	I-T077
were	O	O	O
monitored	O	O	O
as	O	O	O
was	O	O	O
instructed	O	O	O
by	O	O	O
the	O	O	O
doctor	O	O	B-T097
.	O	O	O

477	O	O	O
vital	O	O	B-T077
parameter	O	O	I-T077
sets	O	O	O
were	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
48	O	O	O
hours	O	O	O
before	O	O	O
ICU	O	O	B-T058
admission	O	O	I-T058
,	O	O	O
in	O	O	O
only	O	O	O
1	O	O	O
%	O	O	O
a	O	O	O
correct	O	O	O
MEWS	O	O	B-T057
was	O	O	O
explicitly	O	O	O
documented	O	O	B-T058
in	O	O	O
the	O	O	O
record	O	O	O
.	O	O	O

This	O	O	O
in-depth	O	O	B-T062
analysis	O	O	I-T062
demonstrates	O	O	O
that	O	O	O
almost	O	O	O
half	O	O	O
of	O	O	O
the	O	O	O
unplanned	O	O	O
ICU	O	O	B-T058
admissions	O	O	I-T058
from	O	O	O
the	O	O	O
general	O	O	B-T073
ward	O	O	I-T073
had	O	O	O
healthcare	O	O	B-T097
worker	O	O	I-T097
related	O	O	O
root	O	O	B-T080
causes	O	O	I-T080
,	O	O	O
mostly	O	O	O
due	O	O	O
to	O	O	O
monitoring	O	O	B-T058
failures	O	O	B-T169
in	O	O	O
clinically	O	O	B-T033
deteriorating	O	O	I-T033
patients	O	O	B-T101
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
reduce	O	O	O
unplanned	O	O	O
ICU	O	O	B-T058
admissions	O	O	I-T058
,	O	O	O
improving	O	O	O
the	O	O	O
monitoring	O	O	B-T058
of	O	O	O
patients	O	O	B-T101
is	O	O	O
therefore	O	O	O
warranted	O	O	O
.	O	O	O

-DOCSTART- (27539962)

Effects	O	O	O
of	O	O	O
a	O	O	O
novel	O	O	O
phosphodiesterase	O	O	B-T121
10A	O	O	I-T121
inhibitor	O	O	I-T121
in	O	O	O
non-human	O	O	B-T015
primates	O	O	I-T015
:	O	O	O
A	O	O	O
therapeutic	O	O	B-T169
approach	O	O	I-T169
for	O	O	O
schizophrenia	O	O	B-T048
with	O	O	O
improved	O	O	O
side	O	O	O
effect	O	O	O
profile	O	O	O

Schizophrenia	O	O	B-T048
symptoms	O	O	B-T184
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
alterations	O	O	B-T047
in	O	O	I-T047
basal	O	O	I-T047
ganglia-cortical	O	O	I-T047
networks	O	O	I-T047
that	O	O	O
include	O	O	O
the	O	O	O
cyclic	O	O	B-T114
nucleotides	O	O	I-T114
(	O	O	O
cAMP	O	O	B-T114
/	O	O	O
cGMP	O	O	B-T114
)	O	O	O
signaling	O	O	B-T044
pathways	O	O	I-T044
.	O	O	O

Phosphodiesterase	O	O	B-T121
10A	O	O	I-T121
(	O	O	I-T121
PDE10A	O	O	B-T116
)	O	O	I-T121
inhibitors	O	O	I-T121
have	O	O	O
been	O	O	O
considered	O	O	O
as	O	O	O
therapeutic	O	O	B-T121
agents	O	O	I-T121
for	O	O	O
schizophrenia	O	O	B-T048
because	O	O	O
the	O	O	O
regulation	O	O	B-T044
of	O	O	I-T044
cAMP	O	O	I-T044
and	O	O	O
cGMP	O	O	B-T044
in	O	O	O
the	O	O	O
striatum	O	O	B-T023
by	O	O	O
PDE10A	O	O	O
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
signaling	O	O	B-T044
mechanisms	O	O	I-T044
of	O	O	O
the	O	O	O
striatal-cortical	O	O	B-UnknownType
network	O	O	I-UnknownType
,	O	O	O
and	O	O	O
thereby	O	O	O
in	O	O	O
cognitive	O	O	B-T041
function	O	O	I-T041
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
we	O	O	O
assessed	O	O	O
in	O	O	O
non-human	O	O	B-T015
primates	O	O	I-T015
(	O	O	O
NHPs	O	O	B-T015
)	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
a	O	O	O
novel	O	O	O
PDE10A	O	O	B-T121
inhibitor	O	O	I-T121
(	O	O	O
FRM-6308	O	O	B-T121
)	O	O	O
that	O	O	O
has	O	O	O
demonstrated	O	O	O
high	O	O	B-T121
potency	O	O	I-T121
and	O	O	O
selectivity	O	O	O
for	O	O	O
human	O	O	B-T116
recombinant	O	O	I-T116
PDE10A	O	O	I-T116
in	O	O	B-T062
vitro	O	O	I-T062
.	O	O	O

The	O	O	O
behavioral	O	O	B-T033
effects	O	O	I-T033
of	O	O	O
FRM-6308	O	O	B-T121
in	O	O	O
a	O	O	O
dose	O	O	B-T081
range	O	O	I-T081
were	O	O	O
determined	O	O	O
in	O	O	O
rhesus	O	O	B-T015
monkeys	O	O	I-T015
using	O	O	O
a	O	O	O
standardized	O	O	B-T033
motor	O	O	I-T033
disability	O	O	I-T033
scale	O	O	I-T033
for	O	O	O
primates	O	O	B-T015
,	O	O	O
motor	O	O	B-T061
tasks	O	O	I-T061
,	O	O	O
and	O	O	O
the	O	O	O
"	O	O	O
drug	O	O	B-UnknownType
effects	O	O	I-UnknownType
on	O	O	I-UnknownType
the	O	O	I-UnknownType
nervous	O	O	I-UnknownType
system	O	O	I-UnknownType
"	O	O	I-UnknownType
(	O	O	I-UnknownType
DENS	O	O	I-UnknownType
)	O	O	I-UnknownType
scale	O	O	I-UnknownType
.	O	O	O

The	O	O	O
neuronal	O	O	B-T129
metabolic	O	O	B-T039
effects	O	O	I-T039
of	O	O	O
FRM-6308	O	O	B-T121
were	O	O	O
determined	O	O	O
with	O	O	O
[(18)F]-fluorodeoxyglucose	O	O	B-T060
PET	O	O	I-T060
imaging	O	O	I-T060
.	O	O	O

Results	O	O	O
showed	O	O	O
that	O	O	O
FRM-6308	O	O	B-T121
did	O	O	O
not	O	O	O
have	O	O	O
any	O	O	O
specific	O	O	O
effects	O	O	O
on	O	O	O
the	O	O	O
motor	O	O	B-UnknownType
system	O	O	I-UnknownType
at	O	O	O
s.c	O	O	O
.	O	O	O

doses	O	O	O
up	O	O	O
to	O	O	O
0.32	O	O	O
mg/kg	O	O	O
in	O	O	O
NHPs	O	O	B-T015
,	O	O	O
which	O	O	O
induced	O	O	O
a	O	O	O
significant	O	O	O
increase	O	O	O
in	O	O	O
the	O	O	O
FDG	O	O	B-T109
-	O	O	O
SUV	O	O	B-T081
in	O	O	O
striatum	O	O	B-T023
(	O	O	O
F	O	O	O
16.069	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
and	O	O	O
cortical	O	O	B-T029
(	O	O	O
F	O	O	O
15.181	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
regions	O	O	O
.	O	O	O

Higher	O	O	B-T081
doses	O	O	I-T081
induced	O	O	O
sedation	O	O	B-T033
and	O	O	O
occasional	O	O	B-T184
involuntary	O	O	I-T184
movements	O	O	I-T184
with	O	O	O
clear	O	O	O
development	O	O	O
of	O	O	O
tolerance	O	O	B-T033
after	O	O	I-T033
repeated	O	O	I-T033
exposures	O	O	I-T033
.	O	O	O

These	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
FRM-6308	O	O	B-T121
has	O	O	O
the	O	O	O
adequate	O	O	B-T061
pharmacological	O	O	I-T061
profile	O	O	I-T061
to	O	O	O
advance	O	O	O
testing	O	O	O
in	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
and	O	O	O
demonstrate	O	O	O
antipsychotic	O	O	B-T039
efficacy	O	O	I-T039
of	O	O	O
PDE10A	O	O	B-T116
inhibition	O	O	B-T052
for	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
schizophrenia	O	O	B-T048
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27541815)

Agglomeration	O	O	B-T081
of	O	O	O
Luminescent	O	O	B-T070
Porous	O	O	B-T082
Silicon	O	O	B-T196
Nanoparticles	O	O	B-T073
in	O	O	O
Colloidal	O	O	O
Solutions	O	O	O

We	O	O	O
have	O	O	O
prepared	O	O	B-T033
colloidal	O	O	B-T122
solutions	O	O	I-T122
of	O	O	O
clusters	O	O	B-T081
composed	O	O	O
from	O	O	O
porous	O	O	B-T082
silicon	O	O	B-T196
nanoparticles	O	O	B-T073
in	O	O	O
methanol	O	O	B-T109
,	O	O	O
water	O	O	B-T121
and	O	O	O
phosphate-buffered	O	O	B-T167
saline	O	O	I-T167
(	O	O	O
PBS	O	O	B-T167
)	O	O	O
.	O	O	O

Even	O	O	O
if	O	O	O
the	O	O	O
size	O	O	B-T082
of	O	O	O
the	O	O	O
nanoclusters	O	O	B-T081
is	O	O	O
between	O	O	O
60	O	O	O
and	O	O	O
500	O	O	O
nm	O	O	O
,	O	O	O
due	O	O	O
to	O	O	O
their	O	O	O
highly	O	O	B-T080
porous	O	O	B-T082
"	O	O	B-T082
cauliflower"-like	O	O	I-T082
structure	O	O	I-T082
,	O	O	O
the	O	O	O
porous	O	O	O
silicon	O	O	B-T196
nanoparticles	O	O	B-T073
are	O	O	O
composed	O	O	O
of	O	O	O
interconnected	O	O	B-T082
nanocrystals	O	O	B-T073
having	O	O	O
around	O	O	O
2.5	O	O	O
nm	O	O	O
in	O	O	O
size	O	O	O
and	O	O	O
showing	O	O	O
strong	O	O	B-T080
visible	O	O	B-T080
luminescence	O	O	B-T070
in	O	O	O
the	O	O	O
orange	O	O	B-T080
-	O	O	O
red	O	O	B-T080
spectral	O	O	B-T077
region	O	O	B-T082
(	O	O	O
centred	O	O	O
at	O	O	O
600	O	O	O
-	O	O	O
700	O	O	O
nm	O	O	O
)	O	O	O
.	O	O	O

Hydrophilic	O	O	B-T080
behaviour	O	O	I-T080
and	O	O	O
good	O	O	B-T080
solubility	O	O	B-T080
of	O	O	O
the	O	O	O
nanoclusters	O	O	B-T081
in	O	O	O
water	O	O	B-T121
and	O	O	O
water	O	O	O
-	O	O	O
based	O	O	B-T078
solutions	O	O	B-T167
were	O	O	O
obtained	O	O	B-T169
by	O	O	O
adding	O	O	O
hydrogen	O	O	B-T121
peroxide	O	O	I-T121
into	O	O	O
the	O	O	O
etching	O	O	B-T070
solution	O	O	B-T167
during	O	O	O
preparation	O	O	B-T052
and	O	O	O
16	O	O	O
min	O	O	O
long	O	O	O
after-bath	O	O	B-T169
in	O	O	O
hydrogen	O	O	O
peroxide	O	O	O
.	O	O	O

By	O	O	O
simple	O	O	B-T080
filtration	O	O	B-T068
of	O	O	O
the	O	O	O
solutions	O	O	B-T167
with	O	O	O
syringe	O	O	B-T074
filters	O	O	I-T074
,	O	O	O
we	O	O	O
have	O	O	O
extracted	O	O	B-T080
smaller	O	O	B-T081
nanoclusters	O	O	B-T081
with	O	O	O
sizes	O	O	B-T082
of	O	O	O
approx	O	O	B-T080
.	O	O	O

60	O	O	O
-	O	O	O
70	O	O	O
nm	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
these	O	O	O
nanoclusters	O	O	B-T081
in	O	O	O
water	O	O	B-T121
and	O	O	O
PBS	O	O	B-T167
solution	O	O	I-T167
(	O	O	O
pH	O	O	B-T080
neutral	O	O	I-T080
)	O	O	O
are	O	O	O
prone	O	O	B-T169
to	O	O	O
agglomeration	O	O	B-T081
,	O	O	O
as	O	O	O
was	O	O	O
confirmed	O	O	B-T033
by	O	O	O
zeta	O	O	B-T067
potential	O	O	I-T067
measurements	O	O	B-T169
.	O	O	O

When	O	O	O
the	O	O	O
samples	O	O	B-T167
were	O	O	O
left	O	O	O
at	O	O	O
ambient	O	O	B-T080
conditions	O	O	I-T080
for	O	O	O
several	O	O	B-T081
weeks	O	O	O
,	O	O	O
the	O	O	O
typical	O	O	B-T080
nanocluster	O	O	B-T081
size	O	O	B-T082
increased	O	O	B-T081
to	O	O	O
approx	O	O	B-T080
.	O	O	O

330	O	O	O
-	O	O	O
400	O	O	O
nm	O	O	O
and	O	O	O
then	O	O	O
remained	O	O	O
stable	O	O	B-T080
.	O	O	O

However	O	O	O
,	O	O	O
both	O	O	O
freshly	O	O	B-T080
filtered	O	O	B-T077
and	O	O	O
aged	O	O	B-T079
samples	O	O	B-T167
(	O	O	O
with	O	O	O
agglomerated	O	O	B-T081
porous	O	O	B-T082
silicon	O	O	B-T196
nanoparticles	O	O	B-T073
)	O	O	O
of	O	O	O
porous	O	O	O
silicon	O	O	O
in	O	O	O
water	O	O	B-T121
and	O	O	O
PBS	O	O	B-T167
solutions	O	O	I-T167
can	O	O	O
be	O	O	O
further	O	O	O
used	O	O	O
for	O	O	O
biological	O	O	B-T080
studies	O	O	B-T062
or	O	O	O
as	O	O	O
luminescent	O	O	B-T070
markers	O	O	B-T201
in	O	O	O
living	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (27542694)

Development	O	O	B-T169
of	O	O	O
a	O	O	O
liquid	O	O	B-T059
chromatography-tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
method	O	O	B-T169
for	O	O	O
quantitative	O	O	B-UnknownType
analysis	O	O	I-UnknownType
of	O	O	O
trace	O	O	B-T081
d-amino	O	O	O
acids	O	O	O

d-Amino	O	O	B-T116
acids	O	O	I-T116
have	O	O	O
recently	O	O	B-T079
attracted	O	O	O
much	O	O	O
attention	O	O	B-T041
in	O	O	O
various	O	O	O
research	O	O	B-T062
fields	O	O	I-T062
including	O	O	B-T169
medical	O	O	B-T169
,	O	O	O
clinical	O	O	B-T080
and	O	O	O
food	O	O	B-T057
industry	O	O	I-T057
due	O	O	O
to	O	O	O
their	O	O	O
important	O	O	B-T080
biological	O	O	B-T038
functions	O	O	I-T038
that	O	O	O
differ	O	O	O
from	O	O	O
l-amino	O	O	B-T116
acid	O	O	I-T116
.	O	O	O

Most	O	O	O
chiral	O	O	B-T067
amino	O	O	B-T116
acid	O	O	I-T116
separation	O	O	B-T059
techniques	O	O	B-T169
require	O	O	B-T169
complicated	O	O	B-T169
derivatization	O	O	B-T067
procedures	O	O	B-T169
in	O	O	O
order	O	O	O
to	O	O	O
achieve	O	O	O
the	O	O	O
desirable	O	O	B-T080
chromatographic	O	O	B-T080
behavior	O	O	O
and	O	O	O
detectability	O	O	B-T033
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
research	O	O	B-T062
is	O	O	O
to	O	O	O
develop	O	O	B-T169
a	O	O	O
highly	O	O	B-T080
sensitive	O	O	I-T080
analytical	O	O	B-T170
method	O	O	I-T170
for	O	O	O
the	O	O	O
enantioseparation	O	O	B-T059
of	O	O	O
chiral	O	O	B-T067
amino	O	O	B-T116
acids	O	O	I-T116
without	O	O	O
any	O	O	O
derivatization	O	O	B-T067
process	O	O	B-T067
using	O	O	O
liquid	O	O	B-T059
chromatography-tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	O
LC-MS/MS	O	O	B-T059
)	O	O	O
.	O	O	O

By	O	O	O
optimizing	O	O	B-T052
MS/MS	O	O	B-T059
parameters	O	O	B-T077
,	O	O	O
we	O	O	O
established	O	O	B-T080
a	O	O	O
quantification	O	O	B-T081
method	O	O	B-T169
that	O	O	O
allowed	O	O	O
the	O	O	O
simultaneous	O	O	B-T079
analysis	O	O	B-T062
of	O	O	O
18	O	O	O
d-amino	O	O	B-T116
acids	O	O	I-T116
with	O	O	O
high	O	O	B-T067
sensitivity	O	O	I-T067
and	O	O	O
reproducibility	O	O	B-T080
.	O	O	O

Additionally	O	O	O
,	O	O	O
we	O	O	O
applied	O	O	B-T169
the	O	O	O
method	O	O	B-T169
to	O	O	O
food	O	O	B-T167
sample	O	O	I-T167
(	O	O	O
vinegar	O	O	B-T109
)	O	O	O
for	O	O	O
the	O	O	O
validation	O	O	B-T062
,	O	O	O
and	O	O	O
successfully	O	O	O
quantified	O	O	B-T081
trace	O	O	B-T081
levels	O	O	I-T081
of	O	O	O
d-amino	O	O	B-T116
acids	O	O	I-T116
in	O	O	O
samples	O	O	B-T167
.	O	O	O

These	O	O	O
results	O	O	B-T034
demonstrated	O	O	O
the	O	O	O
applicability	O	O	B-T080
and	O	O	O
feasibility	O	O	B-T080
of	O	O	O
the	O	O	O
LC-MS/MS	O	O	B-T059
method	O	O	B-T169
as	O	O	O
a	O	O	O
novel	O	O	B-T080
,	O	O	O
effective	O	O	B-T080
tool	O	O	O
for	O	O	O
d-amino	O	O	B-T116
acid	O	O	I-T116
measurement	O	O	B-T169
in	O	O	O
various	O	O	O
biological	O	O	B-T077
samples	O	O	I-T077
.	O	O	O

-DOCSTART- (27542782)

The	O	O	O
Multi-center	O	O	B-T170
Evaluation	O	O	I-T170
of	O	O	I-T170
the	O	O	I-T170
Accuracy	O	O	I-T170
of	O	O	I-T170
the	O	O	I-T170
Contrast	O	O	I-T170
MEdium	O	O	I-T170
INduced	O	O	I-T170
Pd/Pa	O	O	I-T170
RaTiO	O	O	I-T170
in	O	O	O
Predicting	O	O	O
FFR	O	O	B-T201
(	O	O	O
MEMENTO	O	O	B-T170
-	O	O	O
FFR	O	O	O
)	O	O	O
Study	O	O	O

Adenosine	O	O	B-T114
administration	O	O	B-T061
is	O	O	O
needed	O	O	O
for	O	O	O
the	O	O	O
achievement	O	O	O
of	O	O	O
maximal	O	O	B-T080
hyperaemia	O	O	B-T047
fractional	O	O	B-T201
flow	O	O	I-T201
reserve	O	O	I-T201
(	O	O	O
FFR	O	O	B-T201
)	O	O	O
assessment	O	O	B-T058
.	O	O	O

The	O	O	O
objective	O	O	O
was	O	O	O
to	O	O	O
test	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
Pd	O	O	B-T034
/	O	O	O
Pa	O	O	B-T034
ratio	O	O	B-T081
registered	O	O	O
during	O	O	O
submaximal	O	O	B-T080
hyperaemia	O	O	B-T047
induced	O	O	O
by	O	O	O
non-ionic	O	O	B-T130
contrast	O	O	I-T130
medium	O	O	I-T130
(	O	O	O
contrast	O	O	B-T201
FFR	O	O	B-T201
[	O	O	O
cFFR	O	O	B-T201
]	O	O	O
)	O	O	O
in	O	O	O
predicting	O	O	O
FFR	O	O	O
and	O	O	O
comparing	O	O	O
it	O	O	O
to	O	O	O
the	O	O	O
performance	O	O	O
of	O	O	O
resting	O	O	B-T033
Pd	O	O	O
/	O	O	O
Pa	O	O	O
in	O	O	O
a	O	O	O
collaborative	O	O	B-T062
registry	O	O	O
of	O	O	O
926	O	O	O
patients	O	O	B-T101
enrolled	O	O	O
in	O	O	O
10	O	O	O
hospitals	O	O	B-T093
from	O	O	O
four	O	O	B-T081
European	O	O	B-UnknownType
countries	O	O	I-UnknownType
(	O	O	O
Italy	O	O	B-T083
,	O	O	O
Spain	O	O	B-T083
,	O	O	O
France	O	O	B-T083
and	O	O	O
Portugal	O	O	B-T083
)	O	O	O
.	O	O	O

Resting	O	O	B-T033
Pd	O	O	B-T034
/	O	O	O
Pa	O	O	B-T034
,	O	O	O
cFFR	O	O	B-T201
and	O	O	O
FFR	O	O	B-T201
were	O	O	O
measured	O	O	O
in	O	O	O
1,026	O	O	O
coronary	O	O	B-T047
stenoses	O	O	I-T047
functionally	O	O	B-T169
evaluated	O	O	O
using	O	O	O
commercially	O	O	O
available	O	O	O
pressure	O	O	B-T074
wires	O	O	I-T074
.	O	O	O

cFFR	O	O	B-T201
was	O	O	O
obtained	O	O	O
after	O	O	O
intracoronary	O	O	B-T169
injection	O	O	I-T169
of	O	O	O
contrast	O	O	B-T130
medium	O	O	I-T130
,	O	O	O
while	O	O	O
FFR	O	O	B-T201
was	O	O	O
measured	O	O	O
after	O	O	O
administration	O	O	B-T061
of	O	O	O
adenosine	O	O	B-T114
.	O	O	O

Resting	O	O	B-T033
Pd	O	O	B-T034
/	O	O	O
Pa	O	O	B-T034
and	O	O	O
cFFR	O	O	B-T201
were	O	O	O
significantly	O	O	O
higher	O	O	B-T080
than	O	O	O
FFR	O	O	B-T201
(	O	O	O
0.93±0.05	O	O	O
vs.	O	O	O
0.87±0.08	O	O	O
vs.	O	O	O
0.84±0.08	O	O	O
,	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
strong	O	O	O
correlation	O	O	B-T080
and	O	O	O
a	O	O	O
close	O	O	O
agreement	O	O	O
at	O	O	O
Bland-Altman	O	O	B-T170
analysis	O	O	I-T170
between	O	O	O
cFFR	O	O	B-T201
and	O	O	O
FFR	O	O	B-T201
were	O	O	O
observed	O	O	O
(	O	O	O
r=0.90	O	O	O
,	O	O	O
p<0.001	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
of	O	O	O
disagreement	O	O	O
:	O	O	O
from	O	O	O
-0.042	O	O	O
to	O	O	O
0.11	O	O	O
)	O	O	O
.	O	O	O

ROC	O	O	B-T081
curve	O	O	I-T081
analysis	O	O	B-T062
showed	O	O	O
an	O	O	O
excellent	O	O	O
accuracy	O	O	B-T080
(	O	O	O
89	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
cFFR	O	O	B-T201
cut-off	O	O	O
of	O	O	O
≤0.85	O	O	O
in	O	O	O
predicting	O	O	O
an	O	O	O
FFR	O	O	B-T201
value	O	O	O
≤0.80	O	O	O
(	O	O	O
AUC	O	O	O
0.95	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.94	O	O	O
-	O	O	O
0.96	O	O	O
]	O	O	O
)	O	O	O
,	O	O	O
significantly	O	O	O
better	O	O	O
than	O	O	O
that	O	O	O
observed	O	O	O
using	O	O	O
resting	O	O	B-T033
Pd	O	O	B-T034
/	O	O	O
Pa	O	O	B-T034
(	O	O	O
AUC	O	O	O
:	O	O	O
0.90	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.88	O	O	O
-	O	O	O
0.91	O	O	O
;	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
cFFR	O	O	B-T201
/	O	O	O
FFR	O	O	B-T201
hybrid	O	O	B-T170
approach	O	O	I-T170
showed	O	O	O
a	O	O	O
significantly	O	O	O
lower	O	O	B-T080
number	O	O	O
of	O	O	O
lesions	O	O	B-T033
requiring	O	O	O
adenosine	O	O	B-T114
than	O	O	O
a	O	O	O
resting	O	O	B-T033
Pd	O	O	B-T034
/	O	O	O
Pa	O	O	B-T034
/	O	O	O
FFR	O	O	O
hybrid	O	O	O
approach	O	O	O
(	O	O	O
22	O	O	O
%	O	O	O
vs.	O	O	O
44	O	O	O
%	O	O	O
,	O	O	O
p<0.0001	O	O	O
)	O	O	O
.	O	O	O

cFFR	O	O	B-T201
is	O	O	O
accurate	O	O	B-T080
in	O	O	O
predicting	O	O	O
the	O	O	O
functional	O	O	B-T169
significance	O	O	O
of	O	O	O
coronary	O	O	B-T047
stenosis	O	O	I-T047
.	O	O	O

This	O	O	O
could	O	O	O
allow	O	O	O
limiting	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
adenosine	O	O	B-T114
to	O	O	O
obtain	O	O	O
FFR	O	O	B-T201
to	O	O	O
a	O	O	O
minority	O	O	O
of	O	O	O
stenoses	O	O	B-T046
with	O	O	O
considerable	O	O	O
savings	O	O	O
of	O	O	O
time	O	O	B-T079
and	O	O	O
costs	O	O	B-T081
.	O	O	O

-DOCSTART- (27542789)

Transfemoral	O	O	B-T061
aortic	O	O	I-T061
valve	O	O	I-T061
implantation	O	O	I-T061
with	O	O	O
the	O	O	O
repositionable	O	O	B-T074
Lotus	O	O	I-T074
valve	O	O	I-T074
for	O	O	O
treatment	O	O	B-T061
of	O	O	O
patients	O	O	B-T101
with	O	O	O
symptomatic	O	O	B-T169
severe	O	O	B-T080
aortic	O	O	B-T047
stenosis	O	O	I-T047
:	O	O	O
results	O	O	B-T169
from	O	O	O
a	O	O	O
single-centre	O	O	O
experience	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
procedural	O	O	O
and	O	O	O
30-	O	O	O
day	O	O	B-T079
results	O	O	B-T169
for	O	O	O
the	O	O	O
repositionable	O	O	B-T074
Lotus	O	O	I-T074
valve	O	O	I-T074
in	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
transfemoral	O	O	B-T061
aortic	O	O	I-T061
valve	O	O	I-T061
implantation	O	O	I-T061
in	O	O	O
a	O	O	O
single-centre	O	O	B-T041
experience	O	O	I-T041
.	O	O	O

We	O	O	O
prospectively	O	O	O
enrolled	O	O	O
110	O	O	O
patients	O	O	B-T101
with	O	O	O
severe	O	O	B-T080
symptomatic	O	O	B-T169
aortic	O	O	B-T047
stenosis	O	O	I-T047
(	O	O	O
NCT02162069	O	O	B-T170
)	O	O	O
.	O	O	O

All	O	O	O
procedures	O	O	B-T169
were	O	O	O
performed	O	O	O
without	O	O	O
general	O	O	B-T061
anaesthesia	O	O	I-T061
by	O	O	O
the	O	O	O
transfemoral	O	O	B-T061
approach	O	O	I-T061
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
followed	O	O	O
for	O	O	O
30	O	O	O
days	O	O	B-T079
.	O	O	O

Patients	O	O	B-T101
received	O	O	B-T080
the	O	O	O
23	O	O	O
mm	O	O	O
(	O	O	O
n=20	O	O	O
)	O	O	O
,	O	O	O
25	O	O	O
mm	O	O	O
(	O	O	O
n=43	O	O	O
)	O	O	O
or	O	O	O
27	O	O	O
mm	O	O	O
(	O	O	O
n=47	O	O	O
)	O	O	O
Lotus	O	O	B-T074
device	O	O	I-T074
.	O	O	O

Mean	O	O	B-T081
oversizing	O	O	I-T081
in	O	O	O
relation	O	O	O
to	O	O	O
annulus	O	O	B-T026
or	O	O	O
left	O	O	B-T023
ventricular	O	O	I-T023
outflow	O	O	I-T023
tract	O	O	I-T023
(	O	O	O
LVOT	O	O	B-T023
)	O	O	O
did	O	O	O
not	O	O	O
differ	O	O	O
among	O	O	O
groups	O	O	B-T078
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-UnknownType
residual	O	O	I-UnknownType
moderate	O	O	B-T080
or	O	O	O
severe	O	O	B-T080
aortic	O	O	B-T047
regurgitation	O	O	I-T047
.	O	O	O

The	O	O	O
rate	O	O	B-T081
of	O	O	I-T081
mild	O	O	I-T081
aortic	O	O	B-T047
regurgitation	O	O	I-T047
was	O	O	O
low	O	O	O
at	O	O	O
9.1	O	O	O
%	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
valve	O	O	B-T023
embolisation	O	O	B-T061
,	O	O	O
no	O	O	O
need	O	O	O
for	O	O	O
a	O	O	O
second	O	O	B-T081
valve	O	O	O
and	O	O	O
no	O	O	B-T033
conversion	O	O	I-T033
to	O	O	O
surgery	O	O	B-T061
.	O	O	O

The	O	O	O
need	O	O	O
for	O	O	O
a	O	O	O
new	O	O	O
pacemaker	O	O	B-T061
implantation	O	O	I-T061
due	O	O	O
to	O	O	O
complete	O	O	B-T047
(	O	O	O
third	O	O	B-T047
degree	O	O	I-T047
)	O	O	O
or	O	O	O
type	O	O	B-T047
II	O	O	I-T047
(	O	O	I-T047
Mobitz	O	O	I-T047
)	O	O	I-T047
second	O	O	I-T047
degree	O	O	I-T047
atrioventricular	O	O	I-T047
block	O	O	I-T047
was	O	O	O
24.1	O	O	O
%	O	O	O
,	O	O	O
excluding	O	O	O
patients	O	O	B-T101
with	O	O	O
previously	O	O	O
implanted	O	O	B-T061
devices	O	O	I-T061
.	O	O	O

Within	O	O	O
30	O	O	O
days	O	O	B-T079
the	O	O	O
rates	O	O	B-T081
of	O	O	O
all-cause	O	O	B-T081
mortalit	O	O	I-T081
y	O	O	O
and	O	O	O
stroke	O	O	B-T047
were	O	O	O
low	O	O	B-T080
.	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
severe	O	O	B-T080
aortic	O	O	B-T047
stenosis	O	O	I-T047
,	O	O	O
transfemoral	O	O	B-T061
TAVI	O	O	I-T061
with	O	O	O
the	O	O	O
repositionable	O	O	B-T074
Lotus	O	O	I-T074
valve	O	O	I-T074
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
high	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
device	O	O	B-T074
success	O	O	B-T080
,	O	O	O
no	O	O	O
moderate	O	O	B-T080
or	O	O	O
severe	O	O	O
residual	O	O	B-T080
aortic	O	O	B-T047
regurgitation	O	O	I-T047
,	O	O	O
low	O	O	B-T080
rates	O	O	B-T081
of	O	O	O
major	O	O	B-T080
vascular	O	O	B-T047
complications	O	O	I-T047
and	O	O	O
mortality	O	O	B-T081
within	O	O	O
30	O	O	O
days	O	O	B-T079
.	O	O	O

-DOCSTART- (27542814)

A	O	O	O
Comparison	O	O	B-T052
Between	O	O	O
Measured	O	O	B-T080
Concentration	O	O	B-T081
of	O	O	O
3H	O	O	B-T196
in	O	O	O
Kalpakkam	O	O	B-UnknownType
Environment	O	O	I-UnknownType
with	O	O	O
Predicted	O	O	O
Atmospheric	O	O	O
Dispersion	O	O	O
Model	O	O	O

The	O	O	O
field	O	O	B-T082
measurements	O	O	B-T169
of	O	O	O
3H	O	O	B-T196
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
HTO	O	O	B-T197
present	O	O	O
in	O	O	O
air	O	O	B-T070
moisture	O	O	B-T167
carried	O	O	O
out	O	O	O
around	O	O	O
Madras	O	O	B-T073
Atomic	O	O	I-T073
Power	O	O	I-T073
Station	O	O	I-T073
were	O	O	O
compared	O	O	B-T052
with	O	O	O
predicted	O	O	O
values	O	O	O
using	O	O	O
atmospheric	O	O	B-T075
dispersion	O	O	I-T075
modeling	O	O	I-T075
.	O	O	O

Air	O	O	B-T167
3H	O	O	I-T167
samples	O	O	I-T167
were	O	O	O
collected	O	O	B-T078
from	O	O	O
different	O	O	O
sectors	O	O	B-T083
at	O	O	O
the	O	O	O
site	O	O	B-T082
boundary	O	O	B-T185
of	O	O	O
the	O	O	O
operating	O	O	B-T052
reactors	O	O	B-T073
for	O	O	O
the	O	O	O
period	O	O	B-T079
of	O	O	O
2	O	O	O
y	O	O	B-T079
and	O	O	O
compared	O	O	B-T052
with	O	O	O
Gaussian	O	O	B-T075
Plume	O	O	I-T075
model	O	O	I-T075
.	O	O	O

The	O	O	O
predictions	O	O	B-T078
were	O	O	O
comparable	O	O	O
with	O	O	O
the	O	O	O
measured	O	O	B-T080
value	O	O	B-T081
.	O	O	O

The	O	O	O
slight	O	O	B-T080
variation	O	O	B-T080
observed	O	O	B-T169
between	O	O	O
the	O	O	O
two	O	O	O
methods	O	O	B-T170
is	O	O	O
attributed	O	O	O
to	O	O	O
the	O	O	O
uncertainty	O	O	B-T033
involved	O	O	O
in	O	O	O
the	O	O	O
measurement	O	O	B-T169
of	O	O	O
air	O	O	B-T167
3H	O	O	B-T196
concentration	O	O	B-T081
and	O	O	O
in	O	O	O
the	O	O	O
measurement	O	O	O
of	O	O	O
site-specific	O	O	B-T082
meteorological	O	O	B-T070
parameters	O	O	I-T070
.	O	O	O

The	O	O	O
radiation	O	O	B-T081
dose	O	O	I-T081
imparted	O	O	B-T169
to	O	O	O
members	O	O	B-T092
of	O	O	I-T092
public	O	O	I-T092
due	O	O	O
to	O	O	O
the	O	O	O
levels	O	O	B-T080
observed	O	O	B-T169
is	O	O	O
well	O	O	O
within	O	O	O
station	O	O	B-T073
technical	O	O	B-T169
specification	O	O	I-T169
limit	O	O	I-T169
for	O	O	O
3H	O	O	B-T196
.	O	O	O

-DOCSTART- (27543814)

The	O	O	O
four-component	O	O	O
aureocin	O	O	B-T116
A70	O	O	I-T116
as	O	O	O
a	O	O	O
promising	O	O	B-T120
agent	O	O	I-T120
for	O	O	O
food	O	O	O
biopreservation	O	O	O

Aureocin	O	O	B-T116
A70	O	O	I-T116
is	O	O	O
the	O	O	O
only	O	O	O
four-component	O	O	O
bacteriocin	O	O	B-T116
described	O	O	O
to	O	O	O
date	O	O	O
.	O	O	O

As	O	O	O
it	O	O	O
inhibits	O	O	B-T040
the	O	O	I-T040
growth	O	O	I-T040
of	O	O	O
a	O	O	O
wide	O	O	O
range	O	O	O
of	O	O	O
Gram-positive	O	O	B-T007
bacteria	O	O	I-T007
,	O	O	O
including	O	O	O
Listeria	O	O	B-T007
monocytogenes	O	O	I-T007
strains	O	O	B-T001
isolated	O	O	O
from	O	O	O
food	O	O	B-T168
,	O	O	O
its	O	O	O
potential	O	O	O
for	O	O	O
improving	O	O	O
food	O	O	B-T057
safety	O	O	I-T057
was	O	O	O
investigated	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
.	O	O	O

Aureocin	O	O	B-T116
A70	O	O	I-T116
(	O	O	O
10,240AU/mL	O	O	O
)	O	O	O
proved	O	O	O
to	O	O	O
be	O	O	O
bactericidal	O	O	B-T195
,	O	O	O
but	O	O	O
not	O	O	O
extensively	O	O	O
lytic	O	O	B-T080
,	O	O	O
against	O	O	O
listerial	O	O	B-T007
strains	O	O	B-T001
.	O	O	O

The	O	O	O
antibacterial	O	O	B-T052
activity	O	O	I-T052
of	O	O	O
aureocin	O	O	B-T116
A70	O	O	I-T116
(	O	O	O
16AU/mL	O	O	O
)	O	O	O
was	O	O	O
then	O	O	O
tested	O	O	O
in	O	O	O
UHT-treated	O	O	B-T061
skimmed	O	O	B-T168
milk	O	O	I-T168
inoculated	O	O	B-T059
with	O	O	O
the	O	O	O
food	O	O	B-T168
-associated	O	O	O
L.	O	O	B-T007
monocytogenes	O	O	I-T007
L12	O	O	I-T007
strain	O	O	I-T007
(	O	O	O
4-log	O	O	O
CFU/mL	O	O	O
)	O	O	O
during	O	O	O
storage	O	O	B-T169
at	O	O	O
4	O	O	O
°	O	O	O
C	O	O	O
for	O	O	O
one	O	O	O
week	O	O	O
.	O	O	O

Aureocin	O	O	B-T116
A70	O	O	I-T116
caused	O	O	O
a	O	O	O
time-dependent	O	O	O
reduction	O	O	B-T070
in	O	O	O
the	O	O	O
listerial	O	O	B-T007
viable	O	O	B-T059
cell	O	O	I-T059
counts	O	O	I-T059
(	O	O	O
5.51-log	O	O	O
units	O	O	O
)	O	O	O
up	O	O	O
to	O	O	O
7days	O	O	O
of	O	O	O
incubation	O	O	B-T059
.	O	O	O

Aureocin	O	O	B-T116
A70	O	O	I-T116
was	O	O	O
neither	O	O	O
toxic	O	O	B-T080
to	O	O	O
the	O	O	O
Vero	O	O	B-T025
and	O	O	O
the	O	O	O
L-929	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
nor	O	O	O
exhibited	O	O	O
a	O	O	O
hemolytic	O	O	B-T049
activity	O	O	I-T049
against	O	O	O
sheep	O	O	B-T015
red	O	O	B-T025
blood	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

Aureocin	O	O	B-T116
A70	O	O	I-T116
proved	O	O	O
to	O	O	O
be	O	O	O
completely	O	O	O
stable	O	O	O
for	O	O	O
one	O	O	O
month	O	O	O
at	O	O	O
25	O	O	O
°	O	O	O
C	O	O	O
,	O	O	O
16weeks	O	O	O
at	O	O	O
4	O	O	O
°	O	O	O
C	O	O	O
and	O	O	O
20weeks	O	O	O
at	O	O	O
-20	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

Aureocin	O	O	B-T116
A70	O	O	I-T116
exhibited	O	O	O
a	O	O	O
time-dependent	O	O	O
susceptibility	O	O	B-T081
to	O	O	O
simulated	O	O	B-T070
gastric	O	O	B-T031
juice	O	O	I-T031
and	O	O	O
bile	O	O	B-T109
salts	O	O	I-T109
mimicking	O	O	O
gastrointestinal	O	O	B-T033
conditions	O	O	I-T033
.	O	O	O

The	O	O	O
entrapment	O	O	B-T044
of	O	O	O
aureocin	O	O	B-T116
A70	O	O	I-T116
in	O	O	O
an	O	O	O
alginate	O	O	B-T109
/	O	O	O
gelatin	O	O	B-T116
matrix	O	O	I-T116
revealed	O	O	O
that	O	O	O
this	O	O	O
bacteriocin	O	O	B-T116
can	O	O	O
be	O	O	O
released	O	O	O
from	O	O	O
this	O	O	O
matrix	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
it	O	O	O
remained	O	O	O
adsorbed	O	O	O
to	O	O	O
and	O	O	O
active	O	O	O
on	O	O	O
a	O	O	O
low-density	O	O	B-T109
polyethylene	O	O	I-T109
plastic	O	O	I-T109
surface	O	O	O
suggesting	O	O	O
that	O	O	O
aureocin	O	O	B-T116
A70	O	O	I-T116
may	O	O	O
be	O	O	O
employed	O	O	O
in	O	O	O
bioactive	O	O	B-T167
packaging	O	O	B-T052
to	O	O	O
control	O	O	B-T040
the	O	O	I-T040
growth	O	O	I-T040
of	O	O	O
undesirable	O	O	O
bacteria	O	O	B-T007
.	O	O	O

Taken	O	O	O
together	O	O	O
these	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
aureocin	O	O	B-T116
A70	O	O	I-T116
is	O	O	O
a	O	O	O
promising	O	O	B-T120
alternative	O	O	I-T120
to	O	O	O
be	O	O	O
used	O	O	O
in	O	O	O
food	O	O	B-T057
applications	O	O	I-T057
.	O	O	O

-DOCSTART- (27544926)

Folate	O	O	B-T127
-	O	O	O
conjugated	O	O	B-T082
gene	O	O	B-T028
-	O	O	O
carrying	O	O	B-T045
microbubbles	O	O	B-T074
with	O	O	O
focused	O	O	B-T061
ultrasound	O	O	I-T061
for	O	O	O
concurrent	O	O	B-T079
blood-brain	O	O	B-T023
barrier	O	O	I-T023
opening	O	O	B-T082
and	O	O	O
local	O	O	B-T082
gene	O	O	O
delivery	O	O	O

Previous	O	O	B-T079
studies	O	O	B-T062
have	O	O	O
demonstrated	O	O	O
that	O	O	O
circulating	O	O	B-T169
DNA	O	O	B-T114
-	O	O	O
encapsulated	O	O	B-T080
microbubbles	O	O	B-T074
(	O	O	O
MBs	O	O	B-T074
)	O	O	O
combined	O	O	B-T080
with	O	O	O
focused	O	O	B-T061
ultrasound	O	O	I-T061
(	O	O	O
FUS	O	O	B-T061
)	O	O	O
can	O	O	O
be	O	O	O
used	O	O	B-T169
for	O	O	O
local	O	O	B-T082
blood-brain	O	O	B-T023
barrier	O	O	I-T023
(	O	O	O
BBB	O	O	B-T023
)	O	O	O
opening	O	O	B-T082
and	O	O	O
gene	O	O	B-T045
delivery	O	O	I-T045
.	O	O	O

However	O	O	O
,	O	O	O
few	O	O	O
studies	O	O	B-T062
focused	O	O	B-T169
on	O	O	O
how	O	O	O
to	O	O	O
increase	O	O	B-T169
the	O	O	O
efficiency	O	O	B-T081
of	O	O	O
gene	O	O	B-T028
delivery	O	O	I-T045
to	O	O	O
brain	O	O	B-T191
tumors	O	O	I-T191
after	O	O	O
the	O	O	O
released	O	O	B-T169
gene	O	O	O
penetrating	O	O	B-T169
the	O	O	O
BBB	O	O	B-T023
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
proposed	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
folate	O	O	B-T127
-	O	O	O
conjugated	O	O	O
DNA	O	O	O
-	O	O	O
loaded	O	O	O
cationic	O	O	B-T074
MBs	O	O	I-T074
(	O	O	O
FCMBs	O	O	B-T074
)	O	O	O
.	O	O	O

When	O	O	O
combined	O	O	B-T080
with	O	O	O
FUS	O	O	B-T061
as	O	O	O
a	O	O	O
trigger	O	O	B-T080
for	O	O	O
BBB	O	O	B-T023
opening	O	O	O
,	O	O	O
FCMBs	O	O	B-T074
were	O	O	O
converted	O	O	O
into	O	O	O
nanometer	O	O	B-T081
-	O	O	O
sized	O	O	B-T082
vesicles	O	O	B-T026
that	O	O	O
were	O	O	O
transported	O	O	B-T043
to	O	O	O
the	O	O	O
brain	O	O	B-T023
parenchyma	O	O	B-T023
.	O	O	O

The	O	O	O
FCMBs	O	O	B-T074
can	O	O	O
selectively	O	O	O
aggregate	O	O	B-T080
around	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
that	O	O	O
overexpressed	O	O	B-T045
the	O	O	O
folate	O	O	B-T116
receptor	O	O	I-T116
,	O	O	O
thus	O	O	O
enhancing	O	O	B-T052
gene	O	O	B-T045
delivery	O	O	I-T045
via	O	O	O
folate	O	O	O
-	O	O	O
stimulated	O	O	B-T070
endocytosis	O	O	B-T043
.	O	O	O

Our	O	O	O
results	O	O	B-T169
confirmed	O	O	B-T080
that	O	O	O
FCMBs	O	O	B-T074
can	O	O	O
carry	O	O	B-T045
DNA	O	O	B-T114
on	O	O	O
the	O	O	O
surface	O	O	B-T082
of	O	O	O
the	O	O	O
MB	O	O	B-T074
shell	O	O	B-T080
and	O	O	O
have	O	O	O
good	O	O	B-T080
targeting	O	O	B-T169
ability	O	O	B-T081
on	O	O	O
C6	O	O	B-T025
glioma	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
optimized	O	O	O
FUS	O	O	B-T061
parameters	O	O	B-T077
for	O	O	O
FCMBs	O	O	B-T074
-	O	O	O
enhanced	O	O	B-T052
gene	O	O	B-T045
delivery	O	O	I-T045
were	O	O	O
confirmed	O	O	B-T080
by	O	O	I-T080
cell	O	O	B-T025
experiments	O	O	B-T062
(	O	O	O
center	O	O	B-T081
frequency	O	O	B-T081
=	O	O	O
1	O	O	O
MHz	O	O	O
;	O	O	O
acoustic	O	O	B-T081
pressure	O	O	I-T081
=	O	O	O
700	O	O	O
kPa	O	O	O
;	O	O	O
pulse	O	O	B-T067
repetition	O	O	B-T169
frequency	O	O	O
=	O	O	O
5	O	O	O
Hz	O	O	O
;	O	O	O
cycle	O	O	B-T079
number	O	O	B-T081
=	O	O	O
10000	O	O	O
;	O	O	O
exposure	O	O	B-T080
time	O	O	B-T079
=	O	O	O
1	O	O	O
min	O	O	O
;	O	O	O
FCMBs	O	O	O
concentration	O	O	B-T081
=	O	O	O
4	O	O	O
×	O	O	O
10(7	O	O	O
)	O	O	O
MB/mL	O	O	O
)	O	O	O
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
data	O	O	B-T078
also	O	O	O
indicated	O	O	B-T033
that	O	O	O
FCMBs	O	O	B-T074
show	O	O	O
better	O	O	B-T080
gene	O	O	B-T028
transfection	O	O	B-T045
efficiency	O	O	B-T081
than	O	O	O
MBs	O	O	B-T074
without	O	O	B-T080
folate	O	O	B-T116
conjugation	O	O	B-T043
and	O	O	O
the	O	O	O
traditional	O	O	B-T169
approach	O	O	B-T082
of	O	O	O
directly	O	O	B-T080
injecting	O	O	B-T061
the	O	O	O
gene	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
described	O	O	O
our	O	O	O
novel	O	O	B-T080
development	O	O	B-T169
of	O	O	O
multifunctional	O	O	B-T169
MBs	O	O	B-T074
for	O	O	O
FUS	O	O	B-T061
-	O	O	O
triggered	O	O	B-T080
gene	O	O	B-T045
delivery	O	O	I-T045
/	O	O	O
therapy	O	O	B-T061
.	O	O	O

-DOCSTART- (27550416)

Modulation	O	O	B-T082
of	O	O	O
IL-6	O	O	B-T116
induced	O	O	B-T169
RANKL	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
arthritic	O	O	B-T047
synovium	O	O	B-T023
by	O	O	O
a	O	O	O
transcription	O	O	O
factor	O	O	O
SOX5	O	O	O

Receptor	O	O	B-T116
activator	O	O	I-T116
of	O	O	I-T116
nuclear	O	O	I-T116
factor	O	O	I-T116
κB	O	O	I-T116
ligand	O	O	I-T116
(	O	O	O
RANKL	O	O	B-T116
)	O	O	O
is	O	O	O
critically	O	O	B-T080
involved	O	O	O
in	O	O	O
bone	O	O	B-T046
erosion	O	O	I-T046
of	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
(	O	O	O
RA	O	O	B-T047
)	O	O	O
.	O	O	O

We	O	O	O
previously	O	O	B-T079
reported	O	O	O
association	O	O	O
between	O	O	O
younger	O	O	B-T032
age	O	O	I-T032
at	O	O	O
onset	O	O	O
of	O	O	O
RA	O	O	B-T047
and	O	O	O
a	O	O	O
RANKL	O	O	B-T116
promoter	O	O	O
SNP	O	O	B-T086
that	O	O	O
conferred	O	O	O
an	O	O	O
elevated	O	O	B-T080
promoter	O	O	O
activity	O	O	O
via	O	O	O
binding	O	O	B-T052
to	O	O	O
a	O	O	O
transcription	O	O	B-T116
factor	O	O	I-T116
SOX5	O	O	I-T116
.	O	O	O

Here	O	O	O
we	O	O	O
study	O	O	B-T062
the	O	O	O
regulation	O	O	B-T043
of	O	O	O
SOX5	O	O	B-T116
levels	O	O	O
in	O	O	O
relation	O	O	O
to	O	O	O
RANKL	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
RA	O	O	B-T047
synovial	O	O	B-T023
fibroblasts	O	O	B-T025
(	O	O	O
SF	O	O	B-T025
)	O	O	O
and	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
bone	O	O	B-T046
erosion	O	O	I-T046
in	O	O	O
the	O	O	O
collagen-induced	O	O	B-T050
arthritis	O	O	I-T050
(	O	O	O
CIA	O	O	B-T050
)	O	O	O
mouse	O	O	B-T015
.	O	O	O

Our	O	O	O
data	O	O	B-T170
indicated	O	O	B-T033
SOX5	O	O	B-T116
levels	O	O	O
were	O	O	O
higher	O	O	O
in	O	O	O
synovium	O	O	B-T023
and	O	O	O
synovial	O	O	B-T031
fluid	O	O	I-T031
from	O	O	O
RA	O	O	B-T047
compared	O	O	B-T052
to	O	O	O
osteoarthritis	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

Pro-inflammatory	O	O	B-T169
cytokines	O	O	B-T116
upregulated	O	O	B-T044
SOX5	O	O	B-T116
and	O	O	O
RANKL	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
both	O	O	O
primary	O	O	O
RA	O	O	B-T047
SF	O	O	B-T025
and	O	O	O
the	O	O	O
rheumatoid	O	O	O
synovial	O	O	O
fibroblast	O	O	B-UnknownType
cell	O	O	I-UnknownType
line	O	O	I-UnknownType
,	O	O	O
MH7A	O	O	B-T025
.	O	O	O

Overexpression	O	O	B-T045
of	O	O	O
SOX5	O	O	B-T116
resulted	O	O	B-T169
in	O	O	O
significantly	O	O	B-T081
increased	O	O	I-T081
RANKL	O	O	B-T116
levels	O	O	O
,	O	O	O
while	O	O	O
knockdown	O	O	B-T063
of	O	O	O
SOX5	O	O	O
resulted	O	O	O
in	O	O	O
diminished	O	O	B-T081
IL-6	O	O	B-T116
mediated	O	O	O
RANKL	O	O	O
upregulation	O	O	B-T044
in	O	O	O
MH7A	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Chromatin	O	O	B-T059
immunoprecipitation	O	O	I-T059
(	O	O	O
ChIP	O	O	B-T059
)	O	O	O
showed	O	O	O
approximately	O	O	B-T080
3-fold	O	O	O
enrichment	O	O	O
of	O	O	O
RANKL-specific	O	O	B-T114
DNA	O	O	I-T114
in	O	O	O
anti-SOX5	O	O	B-T129
immunoprecipitate	O	O	I-T129
in	O	O	O
IL-6	O	O	B-T116
treated	O	O	B-T169
MH7A	O	O	B-T025
cells	O	O	I-T025
as	O	O	O
compared	O	O	B-T052
to	O	O	O
untreated	O	O	B-T033
cells	O	O	I-T033
.	O	O	O

Locally	O	O	O
silencing	O	O	B-T045
SOX5	O	O	B-T028
gene	O	O	I-T028
significantly	O	O	B-T081
diminished	O	O	I-T081
RANKL	O	O	B-T116
positive	O	O	B-T033
cells	O	O	B-T025
and	O	O	O
bone	O	O	B-T046
erosion	O	O	I-T046
in	O	O	O
CIA	O	O	B-T050
mice	O	O	B-T015
.	O	O	O

These	O	O	O
findings	O	O	B-T033
suggest	O	O	B-T078
SOX5	O	O	B-T116
is	O	O	O
an	O	O	O
important	O	O	O
regulator	O	O	B-T077
of	O	O	O
IL-6	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
RANKL	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
RA	O	O	B-T047
SF	O	O	B-T025
.	O	O	O

-DOCSTART- (27553051)

Intracameral	O	O	B-T082
cefuroxime	O	O	B-T195
in	O	O	O
the	O	O	O
prevention	O	O	B-T061
of	O	O	O
postoperative	O	O	B-T047
endophthalmitis	O	O	I-T047
:	O	O	O
an	O	O	O
experience	O	O	B-T041
from	O	O	O
Hong	O	O	O
Kong	O	O	O

The	O	O	O
purpose	O	O	O
was	O	O	O
to	O	O	O
study	O	O	B-T062
the	O	O	O
effect	O	O	B-T080
of	O	O	O
introducing	O	O	B-T169
intracameral	O	O	B-T082
cefuroxime	O	O	B-T195
,	O	O	O
which	O	O	O
was	O	O	O
compounded	O	O	B-T058
by	O	O	O
a	O	O	O
hospital	O	O	B-T093
pharmacy	O	O	I-T093
,	O	O	O
on	O	O	O
postoperative	O	O	B-T047
endophthalmitis	O	O	I-T047
in	O	O	O
a	O	O	O
tertiary	O	O	B-T093
eye	O	O	I-T093
centre	O	O	I-T093
in	O	O	O
Hong	O	O	B-T083
Kong	O	O	I-T083
.	O	O	O

All	O	O	O
cases	O	O	O
that	O	O	O
underwent	O	O	O
cataract	O	O	B-T061
surgeries	O	O	I-T061
over	O	O	O
a	O	O	O
12-year	O	O	O
period	O	O	O
(	O	O	O
January	O	O	O
2004	O	O	O
to	O	O	O
December	O	O	O
2015	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

The	O	O	O
routine	O	O	B-T080
use	O	O	B-T169
of	O	O	O
intracameral	O	O	B-T082
cefuroxime	O	O	B-T195
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
cataract	O	O	B-T061
surgery	O	O	I-T061
was	O	O	O
introduced	O	O	O
at	O	O	O
our	O	O	O
centre	O	O	O
after	O	O	O
April	O	O	O
2010	O	O	O
.	O	O	O

All	O	O	O
cefuroxime	O	O	B-T195
aliquots	O	O	B-T081
were	O	O	O
prepared	O	O	O
by	O	O	O
the	O	O	O
hospital	O	O	B-T093
pharmacy	O	O	I-T093
using	O	O	O
an	O	O	O
aseptic	O	O	B-T080
compounding	O	O	O
technique	O	O	O
.	O	O	O

The	O	O	O
rates	O	O	B-T081
of	O	O	O
postoperative	O	O	B-T047
endophthalmitis	O	O	I-T047
before	O	O	O
April	O	O	O
2010	O	O	O
(	O	O	O
Group	O	O	B-UnknownType
1	O	O	O
,	O	O	O
no	O	O	B-T169
intracameral	O	O	B-T082
cefuroxime	O	O	B-T195
)	O	O	O
and	O	O	O
after	O	O	O
April	O	O	O
2010	O	O	O
(	O	O	O
Group	O	O	O
2	O	O	O
,	O	O	O
routine	O	O	O
use	O	O	O
of	O	O	O
intracameral	O	O	O
cefuroxime	O	O	O
)	O	O	O
were	O	O	O
compared	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
30,428	O	O	O
eyes	O	O	B-T023
(	O	O	O
7,332	O	O	O
in	O	O	O
Group	O	O	B-UnknownType
1	O	O	O
and	O	O	O
23,096	O	O	O
in	O	O	O
Group	O	O	O
2	O	O	O
)	O	O	O
were	O	O	O
studied	O	O	O
.	O	O	O

Eight	O	O	O
cases	O	O	O
developed	O	O	O
postoperative	O	O	B-T047
endophthalmitis	O	O	B-T047
(	O	O	O
1.09	O	O	O
in	O	O	O
1000	O	O	O
;	O	O	O
0.11	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
Group	O	O	B-UnknownType
1	O	O	O
whereas	O	O	O
no	O	O	O
cases	O	O	O
developed	O	O	O
endophthalmitis	O	O	O
(	O	O	O
0	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
Group	O	O	O
2	O	O	O
.	O	O	O

The	O	O	O
rate	O	O	B-T081
of	O	O	O
reduction	O	O	B-T080
was	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
(	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
.	O	O	O

Seven	O	O	O
out	O	O	O
of	O	O	O
eight	O	O	O
cases	O	O	O
of	O	O	O
endophthalmitis	O	O	B-T047
were	O	O	O
confirmed	O	O	O
by	O	O	O
positive	O	O	B-T033
culture	O	O	I-T033
.	O	O	O

Organisms	O	O	B-T001
identified	O	O	O
were	O	O	O
Group	O	O	B-T007
G	O	O	I-T007
Streptococcus	O	O	I-T007
(	O	O	O
two	O	O	O
cases	O	O	O
)	O	O	O
,	O	O	O
Group	O	O	B-T007
B	O	O	I-T007
Streptococcus	O	O	I-T007
,	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
,	O	O	O
Serratia	O	O	B-T007
marcescens	O	O	I-T007
,	O	O	O
and	O	O	O
coagulase-negative	O	O	B-T007
Staphylococcus	O	O	I-T007
(	O	O	O
two	O	O	O
cases	O	O	O
)	O	O	O
.	O	O	O

Antibiotic	O	O	B-T033
susceptibility	O	O	I-T033
testing	O	O	B-T034
results	O	O	I-T034
were	O	O	O
available	O	O	O
in	O	O	O
six	O	O	O
cases	O	O	O
.	O	O	O

Four	O	O	O
out	O	O	O
of	O	O	O
six	O	O	O
organisms	O	O	B-T001
were	O	O	O
susceptible	O	O	B-T169
to	O	O	O
the	O	O	O
penicillin	O	O	B-T195
group	O	O	I-T195
.	O	O	O

No	O	O	B-T033
adverse	O	O	I-T033
events	O	O	I-T033
related	O	O	O
to	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	O
intracameral	O	O	B-T082
cefuroxime	O	O	B-T195
were	O	O	O
encountered	O	O	O
.	O	O	O

The	O	O	O
use	O	O	B-T169
of	O	O	O
intracameral	O	O	B-T082
cefuroxime	O	O	B-T195
could	O	O	O
significantly	O	O	O
reduce	O	O	B-T081
the	O	O	O
rate	O	O	B-T081
of	O	O	O
postoperative	O	O	B-T047
endophthalmitis	O	O	I-T047
in	O	O	O
a	O	O	O
tertiary	O	O	B-T093
centre	O	O	I-T093
in	O	O	O
Hong	O	O	B-T083
Kong	O	O	I-T083
.	O	O	O

The	O	O	O
use	O	O	B-T169
of	O	O	O
aseptic	O	O	B-T080
compounding	O	O	O
to	O	O	O
prepare	O	O	O
cefuroxime	O	O	B-T195
aliquots	O	O	B-T081
by	O	O	O
hospital	O	O	B-T093
pharmacy	O	O	I-T093
appeared	O	O	O
to	O	O	O
be	O	O	O
safe	O	O	O
and	O	O	O
efficacious	O	O	O
.	O	O	O

-DOCSTART- (27554917)

A	O	O	O
standardized	O	O	O
approach	O	O	O
for	O	O	O
the	O	O	O
assessment	O	O	B-T058
and	O	O	O
treatment	O	O	B-T061
of	O	O	O
internationally	O	O	B-T078
adopted	O	O	B-T099
children	O	O	I-T099
with	O	O	O
a	O	O	O
previously	O	O	O
repaired	O	O	O
anorectal	O	O	B-T190
malformation	O	O	I-T190
(	O	O	O
ARM	O	O	B-T190
)	O	O	O

A	O	O	O
significant	O	O	O
number	O	O	O
of	O	O	O
internationally	O	O	B-T078
adopted	O	O	B-T099
children	O	O	I-T099
have	O	O	O
congenital	O	O	B-T019
birth	O	O	I-T019
defects	O	O	I-T019
.	O	O	O

As	O	O	O
a	O	O	O
specialist	O	O	O
center	O	O	O
for	O	O	O
colorectal	O	O	B-T082
diagnoses	O	O	B-T060
,	O	O	O
we	O	O	O
evaluate	O	O	O
such	O	O	O
children	O	O	B-T100
with	O	O	O
an	O	O	O
anorectal	O	O	B-T190
malformation	O	O	I-T190
(	O	O	O
ARM	O	O	B-T190
)	O	O	O
and	O	O	O
have	O	O	O
found	O	O	O
that	O	O	O
a	O	O	O
significant	O	O	O
number	O	O	O
need	O	O	O
a	O	O	O
reoperation	O	O	B-T061
.	O	O	O

Knowledge	O	O	B-T033
of	O	O	O
the	O	O	O
common	O	O	O
complications	O	O	B-T046
following	O	O	O
ARM	O	O	B-T190
surgery	O	O	B-T061
has	O	O	O
led	O	O	O
us	O	O	O
to	O	O	O
develop	O	O	O
treatment	O	O	B-T061
algorithms	O	O	B-T170
for	O	O	O
patients	O	O	B-T101
with	O	O	O
unknown	O	O	O
past	O	O	B-T033
medical	O	O	I-T033
and	O	O	O
surgical	O	O	B-T033
history	O	O	I-T033
,	O	O	O
a	O	O	O
situation	O	O	O
typically	O	O	O
encountered	O	O	O
in	O	O	O
the	O	O	O
adopted	O	O	B-T033
population	O	O	B-T098
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
investigations	O	O	B-T058
,	O	O	O
indications	O	O	B-T078
,	O	O	O
and	O	O	O
rate	O	O	B-T081
of	O	O	O
reoperation	O	O	B-T061
were	O	O	O
assessed	O	O	O
for	O	O	O
adopted	O	O	B-T099
children	O	O	I-T099
with	O	O	O
an	O	O	O
ARM	O	O	B-T190
evaluated	O	O	O
between	O	O	O
2014	O	O	O
and	O	O	O
2016	O	O	O
.	O	O	O

56	O	O	O
patients	O	O	B-T101
(	O	O	O
28	O	O	O
males	O	O	B-T032
)	O	O	O
were	O	O	O
identified	O	O	O
.	O	O	O

76.8	O	O	O
%	O	O	O
required	O	O	O
reoperative	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

Mislocation	O	O	O
of	O	O	O
the	O	O	O
anus	O	O	B-T023
outside	O	O	B-T082
the	O	O	O
sphincter	O	O	B-T023
complex	O	O	O
was	O	O	O
seen	O	O	O
in	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
males	O	O	B-T032
and	O	O	O
39.3	O	O	O
%	O	O	O
of	O	O	O
females	O	O	B-T032
.	O	O	O

Anal	O	O	B-T019
stricture	O	O	I-T019
,	O	O	O
rectal	O	O	B-T047
prolapse	O	O	I-T047
,	O	O	O
retained	O	O	B-T169
vaginal	O	O	B-T019
septum	O	O	I-T019
,	O	O	O
and	O	O	O
a	O	O	O
strictured	O	O	B-T046
vaginal	O	O	B-T030
introitus	O	O	I-T030
were	O	O	O
also	O	O	O
common	O	O	O
.	O	O	O

The	O	O	O
reoperative	O	O	B-T061
surgery	O	O	I-T061
rate	O	O	B-T081
in	O	O	O
the	O	O	O
internationally	O	O	B-T078
adopted	O	O	B-T099
child	O	O	I-T099
with	O	O	O
an	O	O	O
ARM	O	O	B-T190
is	O	O	O
high	O	O	O
.	O	O	O

Complete	O	O	O
,	O	O	O
systematic	O	O	O
evaluation	O	O	O
of	O	O	O
these	O	O	O
children	O	O	B-T100
is	O	O	O
required	O	O	O
to	O	O	O
identify	O	O	O
complications	O	O	B-T046
following	O	O	O
initial	O	O	O
repair	O	O	B-T058
.	O	O	O

Development	O	O	O
of	O	O	O
mechanisms	O	O	O
to	O	O	O
improve	O	O	O
the	O	O	O
primary	O	O	O
surgical	O	O	B-T058
care	O	O	I-T058
these	O	O	O
children	O	O	B-T100
receive	O	O	O
is	O	O	O
needed	O	O	O
.	O	O	O

-DOCSTART- (27558793)

Highly	O	O	O
fluorescent	O	O	B-T070
gold	O	O	B-T121
nanoclusters	O	O	B-T073
stabilized	O	O	O
by	O	O	O
food	O	O	B-T168
proteins	O	O	I-T116
:	O	O	O
From	O	O	O
preparation	O	O	O
to	O	O	O
application	O	O	O
in	O	O	O
detection	O	O	B-T061
of	O	O	O
food	O	O	O
contaminants	O	O	B-T167
and	O	O	O
bioactive	O	O	O
nutrients	O	O	O

Applications	O	O	O
of	O	O	O
nanotechnology	O	O	B-T090
in	O	O	O
food	O	O	B-T168
have	O	O	O
rapidly	O	O	O
increased	O	O	O
in	O	O	O
the	O	O	O
past	O	O	O
decades	O	O	O
.	O	O	O

Ultra-small	O	O	B-T073
gold	O	O	I-T073
nanoclusters	O	O	I-T073
(	O	O	O
Au	O	O	B-T073
NCs	O	O	I-T073
)	O	O	O
,	O	O	O
composed	O	O	O
of	O	O	O
several	O	O	O
to	O	O	O
roughly	O	O	O
a	O	O	O
hundred	O	O	O
atoms	O	O	O
,	O	O	O
represent	O	O	O
a	O	O	O
kind	O	O	O
of	O	O	O
novel	O	O	O
nanomaterials	O	O	B-T073
.	O	O	O

The	O	O	O
Au	O	O	B-T073
NCs	O	O	I-T073
directed	O	O	O
by	O	O	O
food	O	O	B-T116
proteins	O	O	I-T116
have	O	O	O
drawn	O	O	O
considerable	O	O	O
research	O	O	O
attention	O	O	O
due	O	O	O
to	O	O	O
their	O	O	O
environmentally	O	O	B-T057
friendly	O	O	I-T057
preparation	O	O	I-T057
,	O	O	O
strong	O	O	O
fluorescence	O	O	B-T070
,	O	O	O
excellent	O	O	O
photo-stability	O	O	B-T080
and	O	O	O
favorable	O	O	O
biocompatibility	O	O	B-T044
.	O	O	O

These	O	O	O
interesting	O	O	O
protein-Au	O	O	B-T073
hybrids	O	O	I-T073
have	O	O	O
opened	O	O	O
up	O	O	O
a	O	O	O
new	O	O	O
area	O	O	O
at	O	O	O
the	O	O	O
nano-bio-food	O	O	B-T093
interface	O	O	I-T093
,	O	O	O
not	O	O	O
only	O	O	O
did	O	O	O
they	O	O	O
provide	O	O	O
the	O	O	O
missing	O	O	O
link	O	O	O
between	O	O	O
single	O	O	B-T196
metal	O	O	I-T196
atoms	O	O	I-T196
and	O	O	O
plasmonic	O	O	B-T062
metal	O	O	B-T073
nanoparticles	O	O	I-T073
,	O	O	O
but	O	O	O
also	O	O	O
developed	O	O	O
the	O	O	O
hybrid	O	O	B-T122
system	O	O	I-T122
between	O	O	O
biomacromolecule	O	O	B-T167
and	O	O	O
inorganic	O	O	B-T077
ions	O	O	B-T196
.	O	O	O

In	O	O	O
this	O	O	O
review	O	O	O
,	O	O	O
we	O	O	O
highlighted	O	O	O
the	O	O	O
synthesis	O	O	B-T052
strategies	O	O	O
and	O	O	O
optical	O	O	B-T080
properties	O	O	I-T080
of	O	O	O
the	O	O	O
Au	O	O	B-T073
NCs	O	O	I-T073
stabilized	O	O	O
by	O	O	O
typical	O	O	O
food	O	O	B-T168
proteins	O	O	I-T116
as	O	O	O
well	O	O	O
as	O	O	O
their	O	O	O
applications	O	O	O
in	O	O	O
detection	O	O	B-T061
of	O	O	O
food	O	O	O
contaminants	O	O	B-T167
or	O	O	O
bioactive	O	O	B-T167
nutrients	O	O	I-T167
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
discussed	O	O	O
current	O	O	O
challenges	O	O	O
and	O	O	O
future	O	O	O
development	O	O	O
in	O	O	O
food	O	O	B-T116
proteins	O	O	I-T116
directed	O	O	O
gold	O	O	B-T073
nanoclusters	O	O	I-T073
for	O	O	O
size-controlled	O	O	O
synthesis	O	O	B-T052
and	O	O	O
multifunctional	O	O	O
applications	O	O	O
.	O	O	O

-DOCSTART- (27562025)

Sub-lethal	O	O	B-T033
effects	O	O	I-T033
of	O	O	O
dietary	O	O	B-T168
neonicotinoid	O	O	B-T131
insecticide	O	O	I-T131
exposure	O	O	B-T080
on	O	O	O
honey	O	O	B-T204
bee	O	O	I-T204
queen	O	O	I-T204
fecundity	O	O	B-T040
and	O	O	O
colony	O	O	B-T025
development	O	O	O

Many	O	O	O
factors	O	O	B-T169
can	O	O	O
negatively	O	O	B-T033
affect	O	O	O
honey	O	O	B-T204
bee	O	O	I-T204
(	O	O	O
Apis	O	O	B-T204
mellifera	O	O	I-T204
L.	O	O	I-T204
)	O	O	O
health	O	O	B-T078
including	O	O	O
the	O	O	O
pervasive	O	O	B-T082
use	O	O	O
of	O	O	O
systemic	O	O	B-T169
neonicotinoid	O	O	B-T131
insecticides	O	O	I-T131
.	O	O	O

Through	O	O	O
direct	O	O	O
consumption	O	O	B-T039
of	O	O	O
contaminated	O	O	B-T169
nectar	O	O	B-T123
and	O	O	O
pollen	O	O	B-T002
from	O	O	O
treated	O	O	B-T169
plants	O	O	B-T002
,	O	O	O
neonicotinoids	O	O	B-T131
can	O	O	O
affect	O	O	O
foraging	O	O	B-T055
,	O	O	O
learning	O	O	B-T041
,	O	O	O
and	O	O	O
memory	O	O	B-T041
in	O	O	O
worker	O	O	B-T204
bees	O	O	I-T204
.	O	O	O

Less	O	O	O
well	O	O	O
studied	O	O	O
are	O	O	O
the	O	O	O
potential	O	O	O
effects	O	O	O
of	O	O	O
neonicotinoids	O	O	B-T131
on	O	O	O
queen	O	O	B-T204
bees	O	O	I-T204
,	O	O	O
which	O	O	O
may	O	O	O
be	O	O	O
exposed	O	O	O
indirectly	O	O	O
through	O	O	O
trophallaxis	O	O	B-T054
,	O	O	O
or	O	O	O
food	O	O	B-T168
-	O	O	O
sharing	O	O	B-T054
.	O	O	O

To	O	O	O
assess	O	O	B-T058
effects	O	O	O
on	O	O	O
queen	O	O	B-T204
productivity	O	O	B-T081
,	O	O	O
small	O	O	B-T081
colonies	O	O	B-T025
of	O	O	O
different	O	O	O
sizes	O	O	B-T082
(	O	O	O
1500	O	O	O
,	O	O	O
3000	O	O	O
,	O	O	O
and	O	O	O
7000	O	O	O
bees	O	O	B-T204
)	O	O	O
were	O	O	O
fed	O	O	B-T052
imidacloprid	O	O	B-T109
(	O	O	O
0	O	O	O
,	O	O	O
10	O	O	O
,	O	O	O
20	O	O	O
,	O	O	O
50	O	O	O
,	O	O	O
and	O	O	O
100	O	O	O
ppb	O	O	O
)	O	O	O
in	O	O	O
syrup	O	O	B-T168
for	O	O	O
three	O	O	O
weeks	O	O	B-T079
.	O	O	O

We	O	O	O
found	O	O	O
adverse	O	O	B-T046
effects	O	O	I-T046
of	O	O	O
imidacloprid	O	O	B-T109
on	O	O	O
queens	O	O	B-T204
(	O	O	O
egg-laying	O	O	B-T040
and	O	O	O
locomotor	O	O	B-T040
activity	O	O	I-T040
)	O	O	O
,	O	O	O
worker	O	O	B-T204
bees	O	O	I-T204
(	O	O	O
foraging	O	O	B-T055
and	O	O	O
hygienic	O	O	B-T091
activities	O	O	B-T052
)	O	O	O
,	O	O	O
and	O	O	O
colony	O	O	B-T025
development	O	O	B-T040
(	O	O	O
brood	O	O	B-T204
production	O	O	O
and	O	O	O
pollen	O	O	B-T002
stores	O	O	O
)	O	O	O
in	O	O	O
all	O	O	O
treated	O	O	B-T169
colonies	O	O	B-T025
.	O	O	O

Some	O	O	O
effects	O	O	O
were	O	O	O
less	O	O	B-T080
evident	O	O	O
as	O	O	O
colony	O	O	B-T025
size	O	O	B-T082
increased	O	O	B-T081
,	O	O	O
suggesting	O	O	O
that	O	O	O
larger	O	O	B-T081
colony	O	O	O
populations	O	O	B-T098
may	O	O	O
act	O	O	O
as	O	O	O
a	O	O	O
buffer	O	O	O
to	O	O	O
pesticide	O	O	B-T033
exposure	O	O	I-T033
.	O	O	O

This	O	O	O
study	O	O	B-T062
is	O	O	O
the	O	O	O
first	O	O	O
to	O	O	O
show	O	O	O
adverse	O	O	B-T046
effects	O	O	I-T046
of	O	O	O
imidacloprid	O	O	B-T109
on	O	O	O
queen	O	O	B-T204
bee	O	O	I-T204
fecundity	O	O	B-T040
and	O	O	O
behavior	O	O	B-T053
and	O	O	O
improves	O	O	B-T080
our	O	O	O
understanding	O	O	B-T041
of	O	O	O
how	O	O	O
neonicotinoids	O	O	B-T131
may	O	O	O
impair	O	O	B-T169
short-term	O	O	O
colony	O	O	B-T025
functioning	O	O	B-T169
.	O	O	O

These	O	O	O
data	O	O	B-T078
indicate	O	O	O
that	O	O	O
risk-mitigation	O	O	B-T170
efforts	O	O	I-T170
should	O	O	O
focus	O	O	O
on	O	O	O
reducing	O	O	B-T080
neonicotinoid	O	O	B-T131
exposure	O	O	B-T080
in	O	O	O
the	O	O	O
early	O	O	B-T079
spring	O	O	I-T079
when	O	O	O
colonies	O	O	B-T025
are	O	O	O
smallest	O	O	B-T081
and	O	O	O
queens	O	O	B-T204
are	O	O	O
most	O	O	O
vulnerable	O	O	B-T169
to	O	O	O
exposure	O	O	O
.	O	O	O

-DOCSTART- (27562951)

Therapeutic	O	O	B-T169
applications	O	O	I-T169
of	O	O	O
CRISPR	O	O	B-T114
RNA-guided	O	O	B-T114
genome	O	O	O
editing	O	O	O

The	O	O	O
rapid	O	O	O
development	O	O	O
of	O	O	O
programmable	O	O	B-T116
nuclease	O	O	I-T116
-based	O	O	O
genome	O	O	B-T063
editing	O	O	I-T063
technologies	O	O	B-T090
has	O	O	O
enabled	O	O	O
targeted	O	O	B-T169
gene	O	O	B-T028
disruption	O	O	B-T169
and	O	O	O
correction	O	O	B-T061
both	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
This	O	O	O
revolution	O	O	O
opens	O	O	O
up	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
precise	O	O	O
genome	O	O	O
editing	O	O	O
at	O	O	O
target	O	O	B-T169
genomic	O	O	B-T082
sites	O	O	I-T082
to	O	O	O
modulate	O	O	O
gene	O	O	B-T045
function	O	O	I-T045
in	O	O	O
animals	O	O	B-T008
and	O	O	O
plants	O	O	B-T002
.	O	O	O

Among	O	O	O
several	O	O	O
programmable	O	O	B-T116
nucleases	O	O	I-T116
,	O	O	O
the	O	O	O
type	O	O	B-T114
II	O	O	I-T114
clustered	O	O	I-T114
regularly	O	O	I-T114
interspaced	O	O	I-T114
short	O	O	I-T114
palindromic	O	O	I-T114
repeats	O	O	I-T114
(CRISPR)-	O	O	O
CRISPR-associated	O	O	B-T044
nuclease	O	O	I-T044
9	O	O	I-T044
(	O	O	I-T044
Cas9	O	O	I-T044
)	O	O	I-T044
system	O	O	I-T044
has	O	O	O
progressed	O	O	O
remarkably	O	O	O
in	O	O	O
recent	O	O	O
years	O	O	O
,	O	O	O
leading	O	O	O
to	O	O	O
its	O	O	O
widespread	O	O	O
use	O	O	O
in	O	O	O
research	O	O	B-T062
,	O	O	O
medicine	O	O	B-T091
and	O	O	O
biotechnology	O	O	B-T091
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
CRISPR-Cas9	O	O	B-T044
shows	O	O	O
highly	O	O	O
efficient	O	O	O
gene	O	O	B-T063
editing	O	O	I-T063
activity	O	O	O
for	O	O	O
therapeutic	O	O	B-T169
purposes	O	O	I-T169
in	O	O	O
systems	O	O	O
ranging	O	O	O
from	O	O	O
patient	O	O	B-T101
stem	O	O	B-T025
cells	O	O	I-T025
to	O	O	O
animal	O	O	B-T008
models	O	O	I-T008
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
therapeutic	O	O	B-T169
approaches	O	O	I-T169
and	O	O	O
delivery	O	O	B-T061
methods	O	O	I-T061
remains	O	O	O
a	O	O	O
great	O	O	O
challenge	O	O	O
for	O	O	O
biomedical	O	O	B-T091
applications	O	O	B-T169
.	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
review	O	O	O
therapeutic	O	O	B-T169
applications	O	O	I-T169
that	O	O	O
use	O	O	O
the	O	O	O
CRISPR-Cas9	O	O	B-T044
system	O	O	I-T044
and	O	O	O
discuss	O	O	O
the	O	O	O
possibilities	O	O	O
and	O	O	O
challenges	O	O	O
ahead	O	O	O
.	O	O	O

-DOCSTART- (27563235)

Design	O	O	B-T052
and	O	O	O
characteristics	O	O	B-T080
of	O	O	O
cytotoxic	O	O	B-T169
fibroblast	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
1	O	O	I-T116
conjugate	O	O	B-T121
for	O	O	O
fibroblast	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
receptor	O	O	I-T116
-	O	O	O
targeted	O	O	O
cancer	O	O	O
therapy	O	O	O

Fibroblast	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
receptors	O	O	I-T116
(	O	O	O
FGFRs	O	O	B-T116
)	O	O	O
are	O	O	O
attractive	O	O	O
candidate	O	O	O
cancer	O	O	B-T061
therapy	O	O	I-T061
targets	O	O	B-T169
as	O	O	O
they	O	O	O
are	O	O	O
overexpressed	O	O	B-T045
in	O	O	O
multiple	O	O	B-T081
types	O	O	O
of	O	O	O
tumors	O	O	B-T191
,	O	O	O
such	O	O	O
as	O	O	O
breast	O	O	B-T191
,	O	O	O
prostate	O	O	B-T191
,	O	O	O
bladder	O	O	B-T191
,	O	O	O
and	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
a	O	O	O
natural	O	O	B-T044
ligand	O	O	I-T044
of	O	O	O
FGFR	O	O	B-T116
,	O	O	O
an	O	O	O
engineered	O	O	B-T116
variant	O	O	I-T116
of	O	O	O
fibroblast	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
1	O	O	I-T116
(	O	O	O
FGF1V	O	O	B-T116
)	O	O	O
,	O	O	O
was	O	O	O
conjugated	O	O	B-T082
to	O	O	O
a	O	O	O
potent	O	O	B-T121
cytotoxic	O	O	I-T121
drug	O	O	I-T121
,	O	O	O
monomethyl	O	O	B-T116
auristatin	O	O	I-T116
E	O	O	I-T116
(	O	O	O
MMAE	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
targeting	O	O	B-T043
agent	O	O	I-T043
for	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
overexpressing	O	O	B-T045
FGFRs	O	O	B-T116
,	O	O	O
similar	O	O	O
to	O	O	O
antibodies	O	O	B-T116
in	O	O	O
antibody-drug	O	O	B-T061
conjugates	O	O	I-T061
.	O	O	O

The	O	O	O
FGF1V-valine-citrulline-MMAE	O	O	B-T121
conjugate	O	O	B-T121
showed	O	O	O
a	O	O	O
favorable	O	O	O
stability	O	O	B-T044
profile	O	O	I-T044
,	O	O	O
bound	O	O	B-T044
FGFRs	O	O	B-T116
on	O	O	O
the	O	O	O
cell	O	O	B-T026
surface	O	O	I-T026
specifically	O	O	B-T080
,	O	O	O
and	O	O	O
efficiently	O	O	B-T080
released	O	O	B-T169
the	O	O	O
drug	O	O	B-T116
(	O	O	I-T116
MMAE	O	O	I-T116
)	O	O	I-T116
upon	O	O	O
cleavage	O	O	B-T044
by	O	O	O
the	O	O	O
lysosomal	O	O	O
protease	O	O	O
cathepsin	O	O	O
B.	O	O	O
Importantly	O	O	O
,	O	O	O
the	O	O	O
conjugate	O	O	O
showed	O	O	O
a	O	O	O
prominent	O	O	B-T080
cytotoxic	O	O	B-T049
effect	O	O	I-T049
toward	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
expressing	O	O	B-T045
FGFR	O	O	B-T116
.	O	O	O

FGF1V-vcMMAE	O	O	B-T121
was	O	O	O
highly	O	O	O
cytotoxic	O	O	B-T169
at	O	O	O
concentrations	O	O	B-T081
even	O	O	O
an	O	O	O
order	O	O	O
of	O	O	O
magnitude	O	O	O
lower	O	O	B-T052
than	O	O	O
those	O	O	O
found	O	O	O
for	O	O	O
free	O	O	O
MMAE	O	O	B-T116
.	O	O	O

This	O	O	O
effect	O	O	O
was	O	O	O
FGFR	O	O	B-T116
-specific	O	O	O
as	O	O	O
cells	O	O	B-T025
lacking	O	O	B-T080
FGFR	O	O	O
did	O	O	B-T033
not	O	O	I-T033
show	O	O	I-T033
any	O	O	O
increased	O	O	B-T081
mortality	O	O	B-T043
.	O	O	O

-DOCSTART- (27565311)

Effects	O	O	O
of	O	O	O
morphology	O	O	B-T080
and	O	O	O
surface	O	O	B-T197
hydroxyl	O	O	I-T197
on	O	O	O
the	O	O	O
toxicity	O	O	B-T037
of	O	O	O
BiOCl	O	O	B-T121
in	O	O	O
human	O	O	B-T016
HaCaT	O	O	O
cells	O	O	O

Recently	O	O	O
,	O	O	O
bismuth	O	O	B-T121
oxychloride	O	O	I-T121
nanomaterials	O	O	B-T185
(	O	O	O
BiOCls	O	O	B-T121
)	O	O	O
are	O	O	O
showing	O	O	O
great	O	O	O
promise	O	O	O
in	O	O	O
pollutant	O	O	B-T131
removal	O	O	B-T052
.	O	O	O

Residues	O	O	B-T131
from	O	O	O
these	O	O	O
environmental	O	O	B-T069
remediations	O	O	I-T069
are	O	O	O
potential	O	O	O
hazardous	O	O	B-T131
materials	O	O	I-T131
.	O	O	O

Unfortunately	O	O	O
,	O	O	O
human	O	O	B-T016
health	O	O	B-T058
risks	O	O	I-T058
of	O	O	O
BiOCls	O	O	B-T121
are	O	O	O
still	O	O	O
unexplored	O	O	O
widely	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
focused	O	O	O
on	O	O	O
the	O	O	O
influence	O	O	O
of	O	O	O
physicochemical	O	O	B-T080
properties	O	O	I-T080
on	O	O	O
the	O	O	O
cytotoxicity	O	O	B-T049
of	O	O	O
BiOCls	O	O	B-T121
toward	O	O	O
a	O	O	O
human	O	O	B-T016
skin	O	O	B-T022
derived	O	O	O
cell	O	O	B-T025
line	O	O	I-T025
(	O	O	O
HaCaT	O	O	B-T025
)	O	O	O
.	O	O	O

Results	O	O	O
showed	O	O	O
that	O	O	O
morphology	O	O	B-T080
and	O	O	O
surface	O	O	B-T197
hydroxyl	O	O	I-T197
both	O	O	O
had	O	O	O
a	O	O	O
profound	O	O	O
effect	O	O	O
on	O	O	O
the	O	O	O
toxicity	O	O	B-T037
of	O	O	O
BiOCls	O	O	B-T121
.	O	O	O

Microsphere-shaped	O	O	B-T082
BiOCl	O	O	B-T121
caused	O	O	O
less	O	O	O
toxicity	O	O	B-T037
than	O	O	O
nanosheet-shaped	O	O	B-T082
BiOCl	O	O	O
because	O	O	O
of	O	O	O
weaker	O	O	B-T043
particle-membrane	O	O	I-T043
interactions	O	O	I-T043
,	O	O	O
while	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
surface	O	O	B-T197
hydroxyl	O	O	I-T197
on	O	O	O
microsphere-shaped	O	O	B-T082
BiOCl	O	O	O
significantly	O	O	O
raised	O	O	O
the	O	O	O
toxicity	O	O	O
owing	O	O	O
to	O	O	O
the	O	O	O
increased	O	O	O
interaction	O	O	B-T043
with	O	O	O
cell	O	O	B-T026
membrane	O	O	I-T026
.	O	O	O

Both	O	O	O
microsphere-shaped	O	O	B-T082
BiOCl	O	O	B-T121
with	O	O	O
surface	O	O	B-T197
hydroxyl	O	O	I-T197
and	O	O	O
nanosheet-shaped	O	O	B-T082
BiOCl	O	O	O
caused	O	O	O
significant	O	O	O
cell	O	O	B-T026
membrane	O	O	I-T026
damage	O	O	B-T049
(	O	O	O
PI	O	O	B-T109
uptake	O	O	O
and	O	O	O
LDH	O	O	B-T116
release	O	O	O
)	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
different	O	O	O
mechanism	O	O	B-T043
.	O	O	O

The	O	O	O
former	O	O	O
may	O	O	O
be	O	O	O
a	O	O	O
predominant	O	O	O
"	O	O	B-T043
chemical	O	O	I-T043
"	O	O	I-T043
mechanism	O	O	I-T043
involved	O	O	O
an	O	O	O
oxidative	O	O	B-T062
stress	O	O	I-T062
paradigm	O	O	I-T062
,	O	O	O
as	O	O	O
manifested	O	O	O
by	O	O	O
elevated	O	O	O
ROS	O	O	B-T123
and	O	O	O
depleted	O	O	O
GSH	O	O	B-T116
,	O	O	O
while	O	O	O
the	O	O	O
latter	O	O	O
is	O	O	O
mainly	O	O	O
due	O	O	O
to	O	O	O
a	O	O	O
direct	O	O	O
"	O	O	O
physical	O	O	B-T169
"	O	O	O
damage	O	O	B-T049
to	O	O	O
cell	O	O	B-T026
membrane	O	O	I-T026
.	O	O	O

Both	O	O	O
"	O	O	O
physical	O	O	B-T043
"	O	O	O
and	O	O	O
"	O	O	B-T043
chemical	O	O	I-T043
"	O	O	I-T043
response	O	O	I-T043
led	O	O	O
to	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
.	O	O	O

Furthermore	O	O	O
,	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
experiments	O	O	B-T062
including	O	O	O
MMP	O	O	B-T043
collapse	O	O	O
,	O	O	O
cell	O	O	B-T043
cycle	O	O	I-T043
arrest	O	O	I-T043
,	O	O	O
and	O	O	O
apoptosis	O	O	B-T043
/	O	O	O
necrosis	O	O	B-T042
were	O	O	O
conducted	O	O	O
to	O	O	O
propose	O	O	O
a	O	O	O
scenario	O	O	O
for	O	O	O
toxicological	O	O	B-T080
aspects	O	O	I-T080
of	O	O	O
BiOCls	O	O	B-T121
.	O	O	O

Data	O	O	B-T078
presented	O	O	O
here	O	O	O
would	O	O	O
help	O	O	O
to	O	O	O
enable	O	O	O
the	O	O	O
rational	O	O	B-T052
design	O	O	I-T052
of	O	O	O
BiOCls	O	O	B-T121
for	O	O	O
either	O	O	O
reducing	O	O	O
their	O	O	O
unintended	O	O	B-T080
consequences	O	O	I-T080
or	O	O	O
increasing	O	O	O
their	O	O	O
application	O	O	B-T080
potentials	O	O	I-T080
.	O	O	O

-DOCSTART- (27566296)

Reduced	O	O	B-T080
haemodynamic	O	O	B-T042
coupling	O	O	I-T042
and	O	O	O
exercise	O	O	B-T056
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
vascular	O	O	B-T046
stiffening	O	O	I-T046
in	O	O	O
pulmonary	O	O	O
arterial	O	O	O
hypertension	O	O	O

Inadequate	O	O	B-T080
right	O	O	B-T023
ventricular	O	O	I-T023
(	O	O	O
RV	O	O	B-T023
)	O	O	O
and	O	O	O
pulmonary	O	O	B-T023
arterial	O	O	I-T023
(	O	O	O
PA	O	O	B-T023
)	O	O	O
functional	O	O	B-T169
responses	O	O	B-T169
to	O	O	O
exercise	O	O	B-T056
are	O	O	O
important	O	O	O
yet	O	O	O
poorly	O	O	O
understood	O	O	O
features	O	O	O
of	O	O	O
pulmonary	O	O	B-T047
arterial	O	O	I-T047
hypertension	O	O	I-T047
(	O	O	O
PAH	O	O	B-T047
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
combined	O	O	O
invasive	O	O	B-T061
catheterisation	O	O	B-T061
with	O	O	O
echocardiography	O	O	B-T060
to	O	O	O
assess	O	O	B-T052
RV	O	O	B-T023
afterload	O	O	O
,	O	O	O
RV	O	O	B-T042
function	O	O	I-T042
and	O	O	O
ventricular	O	O	B-T023
-	O	O	O
vascular	O	O	B-T023
coupling	O	O	B-T042
in	O	O	O
subjects	O	O	B-T098
with	O	O	O
PAH	O	O	B-T047
.	O	O	O

Twenty-six	O	O	O
subjects	O	O	B-T098
with	O	O	O
PAH	O	O	B-T047
were	O	O	O
prospectively	O	O	O
recruited	O	O	O
to	O	O	O
undergo	O	O	O
right	O	O	B-T029
heart	O	O	I-T029
catheterisation	O	O	B-T061
and	O	O	O
Doppler	O	O	B-T060
echocardiography	O	O	I-T060
at	O	O	O
rest	O	O	B-T056
and	O	O	O
during	O	O	O
incremental	O	O	B-T081
exercise	O	O	B-T056
,	O	O	O
and	O	O	O
cardiac	O	O	B-T060
MRI	O	O	I-T060
at	O	O	O
rest	O	O	O
.	O	O	O

Measurements	O	O	B-T169
at	O	O	O
rest	O	O	B-T056
included	O	O	O
basic	O	O	O
haemodynamics	O	O	B-T042
,	O	O	O
RV	O	O	B-T042
function	O	O	I-T042
and	O	O	O
coupling	O	O	B-T081
efficiency	O	O	I-T081
(	O	O	O
η	O	O	B-T081
)	O	O	O
.	O	O	O

Measurements	O	O	B-T169
during	O	O	O
incremental	O	O	B-T081
exercise	O	O	B-T056
included	O	O	O
pulmonary	O	O	B-T033
vascular	O	O	I-T033
resistance	O	O	I-T033
(	O	O	O
Z0	O	O	B-T033
)	O	O	O
,	O	O	O
characteristic	O	O	B-T060
impedance	O	O	I-T060
(	O	O	O
ZC	O	O	B-T060
,	O	O	O
a	O	O	O
measure	O	O	B-T169
of	O	O	O
proximal	O	O	B-T082
PA	O	O	B-T023
stiffness	O	O	B-T039
)	O	O	O
and	O	O	O
proximal	O	O	O
and	O	O	O
distal	O	O	B-T082
PA	O	O	O
compliance	O	O	O
(	O	O	O
CPA	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
PAH	O	O	B-T047
,	O	O	O
the	O	O	O
proximal	O	O	B-T082
PAs	O	O	B-T023
were	O	O	O
significantly	O	O	B-T078
stiffer	O	O	B-T033
at	O	O	O
maximum	O	O	B-T081
exercise	O	O	B-T056
(	O	O	O
ZC	O	O	B-T060
=	O	O	O
2.31±0.38	O	O	O
vs	O	O	O
1.33±0.15	O	O	O
WU	O	O	O
×	O	O	O
m(2	O	O	O
)	O	O	O
at	O	O	O
rest	O	O	B-T056
;	O	O	O
p=0.003	O	O	O
)	O	O	O
and	O	O	O
PA	O	O	O
compliance	O	O	O
was	O	O	O
decreased	O	O	B-T081
(	O	O	O
CPA	O	O	O
=	O	O	O
0.88±0.10	O	O	O
vs	O	O	O
1.32±0.17	O	O	O
mL/mm	O	O	O
Hg/m(2	O	O	O
)	O	O	O
at	O	O	O
rest	O	O	O
;	O	O	O
p=0.0002	O	O	O
)	O	O	O
.	O	O	O

Z0	O	O	B-T033
did	O	O	O
not	O	O	O
change	O	O	O
with	O	O	O
exercise	O	O	B-T056
.	O	O	O

As	O	O	O
a	O	O	O
result	O	O	O
,	O	O	O
the	O	O	O
resistance-compliance	O	O	B-T081
(	O	O	I-T081
RC	O	O	I-T081
)	O	O	I-T081
time	O	O	I-T081
decreased	O	O	B-T081
with	O	O	O
exercise	O	O	B-T056
(	O	O	O
0.67±0.05	O	O	O
vs	O	O	O
1.00±0.07	O	O	O
s	O	O	O
at	O	O	O
rest	O	O	B-T056
;	O	O	O
p<10(-6	O	O	O
)	O	O	O
)	O	O	O
.	O	O	O

When	O	O	O
patients	O	O	B-T101
were	O	O	O
grouped	O	O	O
according	O	O	O
to	O	O	O
resting	O	O	B-T056
coupling	O	O	B-T081
efficiency	O	O	I-T081
,	O	O	O
those	O	O	O
with	O	O	O
poorer	O	O	O
η	O	O	B-T081
exhibited	O	O	O
stiffer	O	O	B-T033
proximal	O	O	B-T082
PAs	O	O	B-T023
at	O	O	O
rest	O	O	B-T056
,	O	O	O
a	O	O	O
lower	O	O	O
maximum	O	O	B-T081
exercise	O	O	B-T056
level	O	O	B-T080
,	O	O	O
and	O	O	O
more	O	O	O
limited	O	O	O
CPA	O	O	O
reduction	O	O	B-T080
at	O	O	O
maximum	O	O	O
exercise	O	O	O
.	O	O	O

In	O	O	O
PAH	O	O	B-T047
,	O	O	O
exercise	O	O	B-T056
causes	O	O	O
proximal	O	O	B-T082
and	O	O	O
distal	O	O	B-T082
PA	O	O	B-T023
stiffening	O	O	B-T039
,	O	O	O
which	O	O	O
combined	O	O	O
with	O	O	O
preserved	O	O	O
Z0	O	O	B-T033
results	O	O	O
in	O	O	O
decreased	O	O	B-T081
RC	O	O	B-T081
time	O	O	I-T081
with	O	O	O
exercise	O	O	O
.	O	O	O

Stiff	O	O	B-T023
PAs	O	O	I-T023
at	O	O	O
rest	O	O	B-T056
may	O	O	O
also	O	O	O
contribute	O	O	O
to	O	O	O
poor	O	O	O
haemodynamic	O	O	B-T042
coupling	O	O	I-T042
,	O	O	O
reflecting	O	O	O
reduced	O	O	B-T080
pulmonary	O	O	B-T023
vascular	O	O	I-T023
reserve	O	O	O
that	O	O	O
contributes	O	O	B-T052
to	O	O	O
limit	O	O	O
the	O	O	O
maximum	O	O	B-T081
exercise	O	O	B-T056
level	O	O	B-T080
tolerated	O	O	O
.	O	O	O

-DOCSTART- (27566564)

Altered	O	O	B-T081
pH	O	O	I-T081
gradient	O	O	I-T081
at	O	O	O
the	O	O	O
plasma	O	O	B-T026
membrane	O	O	I-T026
of	O	O	O
osteosarcoma	O	O	B-T191
cells	O	O	B-T025
is	O	O	O
a	O	O	O
key	O	O	O
mechanism	O	O	B-T169
of	O	O	O
drug	O	O	O
resistance	O	O	O

Current	O	O	O
therapy	O	O	B-T061
of	O	O	O
osteosarcoma	O	O	B-T191
(	O	O	O
OS	O	O	B-T191
)	O	O	O
,	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
primary	O	O	B-T191
bone	O	O	I-T191
malignancy	O	O	I-T191
,	O	O	O
is	O	O	O
based	O	O	O
on	O	O	O
a	O	O	O
combination	O	O	B-T061
of	O	O	I-T061
surgery	O	O	I-T061
and	O	O	I-T061
chemotherapy	O	O	I-T061
.	O	O	O

Multidrug	O	O	B-T032
resistance	O	O	I-T032
mediated	O	O	O
by	O	O	O
P-glycoprotein	O	O	B-T116
(	O	O	O
P-gp	O	O	B-T116
)	O	O	O
overexpression	O	O	B-T045
has	O	O	O
been	O	O	O
previously	O	O	O
associated	O	O	O
with	O	O	O
treatment	O	O	B-T033
failure	O	O	I-T033
and	O	O	O
progression	O	O	B-T046
of	O	O	O
OS	O	O	B-T191
,	O	O	O
although	O	O	O
other	O	O	O
mechanisms	O	O	B-T169
may	O	O	O
also	O	O	O
play	O	O	O
a	O	O	O
role	O	O	O
.	O	O	O

We	O	O	O
considered	O	O	O
the	O	O	O
typical	O	O	O
acidic	O	O	B-T081
extracellular	O	O	I-T081
pH	O	O	I-T081
(	O	O	O
pHe	O	O	B-T081
)	O	O	O
of	O	O	O
sarcomas	O	O	B-T191
,	O	O	O
and	O	O	O
found	O	O	O
that	O	O	O
doxorubicin	O	O	B-T195
(	O	O	O
DXR	O	O	B-T195
)	O	O	O
cytotoxicity	O	O	B-T049
is	O	O	O
reduced	O	O	B-T080
in	O	O	O
P-gp	O	O	B-T028
negative	O	O	O
OS	O	O	B-T191
cells	O	O	B-T025
cultured	O	O	I-T025
at	O	O	O
pHe	O	O	O
6.5	O	O	O
compared	O	O	O
to	O	O	O
standard	O	O	O
7.4	O	O	O
.	O	O	O

Short-time	O	O	B-T079
(	O	O	O
24	O	O	O
-	O	O	O
48	O	O	O
hours	O	O	O
)	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
low	O	O	O
pHe	O	O	B-T081
significantly	O	O	B-T081
increased	O	O	I-T081
the	O	O	O
number	O	O	O
and	O	O	O
acidity	O	O	B-T034
of	O	O	O
lysosomes	O	O	B-T026
,	O	O	O
and	O	O	O
the	O	O	O
combination	O	O	B-T080
of	O	O	O
DXR	O	O	B-T195
with	O	O	O
omeprazole	O	O	B-T109
,	O	O	O
a	O	O	O
proton	O	O	B-T121
pump	O	O	I-T121
inhibitor	O	O	I-T121
targeting	O	O	O
lysosomal	O	O	B-T043
acidity	O	O	I-T043
,	O	O	O
significantly	O	O	B-T081
enhanced	O	O	I-T081
DXR	O	O	O
cytotoxicity	O	O	B-T049
.	O	O	O

In	O	O	O
OS	O	O	B-T191
xenografts	O	O	B-T122
,	O	O	O
the	O	O	O
combination	O	O	B-T061
treatment	O	O	I-T061
of	O	O	O
DXR	O	O	B-T195
and	O	O	O
omeprazole	O	O	B-T109
significantly	O	O	B-T038
reduced	O	O	I-T038
tumor	O	O	B-T081
volume	O	O	I-T081
and	O	O	O
body	O	O	B-T033
weight	O	O	I-T033
loss	O	O	I-T033
.	O	O	O

The	O	O	O
impaired	O	O	B-T037
toxicity	O	O	I-T037
of	O	O	O
DXR	O	O	B-T195
at	O	O	O
low	O	O	O
pHe	O	O	B-T081
was	O	O	O
not	O	O	O
associated	O	O	O
with	O	O	O
increased	O	O	B-T081
autophagy	O	O	B-T043
or	O	O	O
lysosomal	O	O	B-T043
acidification	O	O	I-T043
,	O	O	O
but	O	O	O
rather	O	O	O
,	O	O	O
as	O	O	O
shown	O	O	O
by	O	O	O
SNARF	O	O	B-T130
staining	O	O	B-T059
,	O	O	O
with	O	O	O
a	O	O	O
reversal	O	O	B-T169
of	O	O	O
the	O	O	O
pH	O	O	B-T081
gradient	O	O	I-T081
at	O	O	O
the	O	O	O
plasma	O	O	B-T026
membrane	O	O	I-T026
(	O	O	O
ΔpHcm	O	O	B-T081
)	O	O	O
,	O	O	O
eventually	O	O	O
leading	O	O	O
to	O	O	O
a	O	O	O
reduced	O	O	B-T080
DXR	O	O	O
intracellular	O	O	B-T082
accumulation	O	O	B-T033
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
reversal	O	O	B-T169
of	O	O	O
ΔpHcm	O	O	B-T081
in	O	O	O
OS	O	O	B-T191
cells	O	O	B-T025
promoted	O	O	O
resistance	O	O	B-T169
not	O	O	O
only	O	O	O
to	O	O	O
DXR	O	O	B-T195
,	O	O	O
but	O	O	O
also	O	O	O
to	O	O	O
cisplatin	O	O	B-T121
and	O	O	O
methotrexate	O	O	B-T109
,	O	O	O
and	O	O	O
,	O	O	O
to	O	O	O
a	O	O	O
lesser	O	O	O
extent	O	O	O
,	O	O	O
to	O	O	O
vincristine	O	O	B-T109
.	O	O	O

Altogether	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	O
show	O	O	O
that	O	O	O
,	O	O	O
in	O	O	O
OS	O	O	B-T191
cells	O	O	B-T025
,	O	O	O
short-term	O	O	B-T079
acidosis	O	O	B-T046
induces	O	O	O
resistance	O	O	B-T169
to	O	O	O
different	O	O	O
chemotherapeutic	O	O	B-T109
drugs	O	O	I-T109
by	O	O	O
a	O	O	O
reversal	O	O	B-T169
of	O	O	O
ΔpHcm	O	O	B-T081
,	O	O	O
suggesting	O	O	O
that	O	O	O
buffer	O	O	B-T121
therapies	O	O	B-T061
or	O	O	O
regimens	O	O	B-T170
including	O	O	O
proton	O	O	B-T121
pump	O	O	I-T121
inhibitors	O	O	I-T121
in	O	O	O
combination	O	O	B-T080
to	O	O	O
low	O	O	O
concentrations	O	O	B-T081
of	O	O	O
conventional	O	O	O
anticancer	O	O	B-T109
agents	O	O	I-T109
may	O	O	O
offer	O	O	O
novel	O	O	B-T080
solutions	O	O	O
to	O	O	O
overcome	O	O	B-T052
drug	O	O	B-T038
resistance	O	O	I-T038
.	O	O	O

-DOCSTART- (27566854)

Boston	O	O	B-T074
Keratoprosthesis	O	O	I-T074
Type	O	O	I-T074
1	O	O	I-T074
:	O	O	O
A	O	O	O
Randomized	O	O	B-T062
Controlled	O	O	I-T062
Trial	O	O	I-T062
of	O	O	O
Fresh	O	O	B-T080
versus	O	O	O
Frozen	O	O	B-T080
Corneal	O	O	B-T101
Donor	O	O	I-T101
Carriers	O	O	I-T101
with	O	O	O
Long-Term	O	O	B-T079
Follow-up	O	O	O

To	O	O	O
compare	O	O	B-T052
the	O	O	O
long-term	O	O	B-T079
clinical	O	O	B-T169
outcomes	O	O	I-T169
of	O	O	O
fresh	O	O	B-T080
versus	O	O	O
frozen	O	O	B-T080
corneal	O	O	B-T101
graft	O	O	I-T101
carriers	O	O	I-T101
for	O	O	O
the	O	O	O
Boston	O	O	B-T074
Keratoprosthesis	O	O	I-T074
type	O	O	I-T074
1	O	O	I-T074
(	O	O	O
B-KPro	O	O	B-T074
)	O	O	O
.	O	O	O

Prospective	O	O	O
,	O	O	O
single-center	O	O	O
,	O	O	O
nonblinded	O	O	B-T077
,	O	O	O
randomized	O	O	O
controlled	O	O	O
trial	O	O	O
.	O	O	O

All	O	O	O
participants	O	O	B-T098
were	O	O	O
followed	O	O	O
through	O	O	O
the	O	O	O
initial	O	O	B-T079
study	O	O	B-T170
protocol	O	O	I-T170
of	O	O	O
24	O	O	O
months	O	O	B-T079
and	O	O	O
were	O	O	O
approached	O	O	O
to	O	O	O
enter	O	O	O
an	O	O	O
extension	O	O	B-T169
phase	O	O	B-T079
,	O	O	O
with	O	O	O
continuing	O	O	O
follow-up	O	O	B-T058
visits	O	O	I-T058
to	O	O	O
60	O	O	O
months	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
B-KPro	O	O	B-T061
surgery	O	O	I-T061
between	O	O	O
October	O	O	O
2008	O	O	O
and	O	O	O
December	O	O	O
2009	O	O	O
by	O	O	O
a	O	O	O
single	O	O	O
experienced	O	O	B-T097
surgeon	O	O	I-T097
at	O	O	O
the	O	O	O
Centre	O	O	O
Hospitalier	O	O	B-T093
de	O	O	I-T093
l'Université	O	O	I-T093
de	O	O	I-T093
Montréal	O	O	I-T093
using	O	O	O
an	O	O	O
allograft	O	O	B-T024
carrier	O	O	I-T024
were	O	O	O
considered	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
excluded	O	O	B-T052
if	O	O	O
they	O	O	O
had	O	O	O
previously	O	O	B-T079
undergone	O	O	O
B-KPro	O	O	B-T074
implantation	O	O	B-T061
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
randomized	O	O	B-T033
individually	O	O	O
to	O	O	O
receive	O	O	B-T080
a	O	O	O
B-KPro	O	O	B-T074
using	O	O	O
a	O	O	O
frozen	O	O	B-T080
or	O	O	O
a	O	O	O
fresh	O	O	B-T080
corneal	O	O	B-T024
graft	O	O	I-T024
carrier	O	O	I-T024
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
tissue	O	O	B-T024
availability	O	O	B-T169
on	O	O	O
the	O	O	O
day	O	O	B-T079
of	O	O	O
surgery	O	O	B-T061
,	O	O	O
as	O	O	O
determined	O	O	O
by	O	O	O
the	O	O	O
local	O	O	O
eye	O	O	B-T093
bank	O	O	I-T093
.	O	O	O

The	O	O	O
primary	O	O	O
outcome	O	O	B-T081
measure	O	O	I-T081
was	O	O	O
device	O	O	B-T033
retention	O	O	I-T033
at	O	O	O
24	O	O	O
and	O	O	O
60	O	O	O
months	O	O	B-T079
.	O	O	O

Secondary	O	O	O
outcome	O	O	O
measures	O	O	O
included	O	O	O
surgical	O	O	B-T033
feasibility	O	O	I-T033
,	O	O	O
visual	O	O	B-T201
acuity	O	O	I-T201
(	O	O	O
VA	O	O	B-T201
)	O	O	O
,	O	O	O
and	O	O	O
complications	O	O	B-T046
.	O	O	O

Thirty-seven	O	O	O
eyes	O	O	B-T023
of	O	O	O
37	O	O	O
patients	O	O	B-T101
were	O	O	O
enrolled	O	O	O
in	O	O	O
the	O	O	O
initial	O	O	B-T079
study	O	O	B-T170
protocol	O	O	I-T170
,	O	O	O
with	O	O	O
19	O	O	O
eyes	O	O	O
randomized	O	O	B-T062
to	O	O	O
fresh	O	O	B-T080
and	O	O	O
18	O	O	O
to	O	O	O
frozen	O	O	B-T080
carrier	O	O	B-T024
grafts	O	O	I-T024
.	O	O	O

Thirty-six	O	O	O
eyes	O	O	B-T023
were	O	O	O
followed	O	O	O
through	O	O	O
to	O	O	O
24	O	O	O
months	O	O	B-T079
,	O	O	O
with	O	O	O
1	O	O	O
lost	O	O	O
to	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Of	O	O	O
these	O	O	O
,	O	O	O
26	O	O	O
were	O	O	O
enrolled	O	O	O
in	O	O	O
the	O	O	O
extension	O	O	B-T169
(	O	O	O
11	O	O	O
eyes	O	O	B-T023
with	O	O	O
a	O	O	O
frozen	O	O	B-T080
and	O	O	O
15	O	O	O
eyes	O	O	O
with	O	O	O
a	O	O	O
fresh	O	O	B-T080
carrier	O	O	B-T024
graft	O	O	I-T024
)	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
differences	O	O	I-T033
in	O	O	O
the	O	O	O
baseline	O	O	B-T081
characteristics	O	O	B-T080
of	O	O	O
patients	O	O	B-T101
enrolled	O	O	O
in	O	O	O
the	O	O	O
extension	O	O	B-T169
phase	O	O	B-T079
versus	O	O	O
those	O	O	O
who	O	O	O
were	O	O	O
not	O	O	O
.	O	O	O

At	O	O	O
60	O	O	O
months	O	O	B-T079
,	O	O	O
median	O	O	O
corrected	O	O	O
distance	O	O	O
VA	O	O	B-T201
)	O	O	O
in	O	O	O
the	O	O	O
fresh	O	O	B-T078
group	O	O	I-T078
had	O	O	O
improved	O	O	B-T033
to	O	O	O
20/150	O	O	O
from	O	O	O
a	O	O	O
baseline	O	O	B-T081
of	O	O	O
counting	O	O	O
fingers	O	O	O
,	O	O	O
whereas	O	O	O
the	O	O	O
frozen	O	O	B-T078
group	O	O	I-T078
improved	O	O	O
to	O	O	O
20/400	O	O	O
from	O	O	O
a	O	O	O
baseline	O	O	O
of	O	O	O
hand	O	O	O
motions	O	O	O
.	O	O	O

Device	O	O	B-T033
retention	O	O	I-T033
was	O	O	O
100	O	O	O
%	O	O	O
at	O	O	O
24	O	O	O
months	O	O	B-T079
and	O	O	O
96	O	O	O
%	O	O	O
at	O	O	O
60	O	O	O
months	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
significant	O	O	O
differences	O	O	B-T080
in	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
complications	O	O	B-T046
between	O	O	O
groups	O	O	B-T078
.	O	O	O

Fresh	O	O	B-T080
and	O	O	O
frozen	O	O	B-T080
corneal	O	O	B-T098
donors	O	O	I-T098
offer	O	O	O
similar	O	O	O
clinical	O	O	B-T169
outcomes	O	O	I-T169
when	O	O	O
used	O	O	O
as	O	O	O
carriers	O	O	B-T024
for	O	O	O
the	O	O	O
B-KPro	O	O	B-T074
,	O	O	O
with	O	O	O
no	O	O	O
significant	O	O	O
differences	O	O	B-T080
in	O	O	O
device	O	O	B-T033
retention	O	O	I-T033
,	O	O	O
visual	O	O	B-T033
rehabilitation	O	O	I-T033
,	O	O	O
or	O	O	O
rates	O	O	B-T081
of	O	O	O
complications	O	O	B-T046
at	O	O	O
24	O	O	O
or	O	O	O
60	O	O	O
months	O	O	B-T079
.	O	O	O

-DOCSTART- (27567148)

Impact	O	O	B-T080
of	O	O	O
an	O	O	O
Educational	O	O	B-T061
Intervention	O	O	I-T061
to	O	O	O
Improve	O	O	B-T033
Antibiotic	O	O	B-T195
Prescribing	O	O	B-T058
for	O	O	O
Nurse	O	O	B-T097
Practitioners	O	O	I-T097
in	O	O	O
a	O	O	O
Pediatric	O	O	B-T100
Urgent	O	O	O
Care	O	O	O
Center	O	O	O

Up	O	O	O
to	O	O	O
21	O	O	O
%	O	O	O
of	O	O	O
pediatric	O	O	B-T058
visits	O	O	I-T058
result	O	O	O
in	O	O	O
an	O	O	O
antibiotic	O	O	B-T195
prescription	O	O	B-T058
,	O	O	O
and	O	O	O
a	O	O	O
large	O	O	O
portion	O	O	O
of	O	O	O
these	O	O	O
are	O	O	O
unnecessary	O	O	O
.	O	O	O

To	O	O	O
determine	O	O	O
if	O	O	O
educational	O	O	B-T065
sessions	O	O	I-T065
would	O	O	O
reduce	O	O	B-T080
inappropriate	O	O	B-T080
antibiotic	O	O	B-T195
use	O	O	B-T169
.	O	O	O

Intervention	O	O	B-T170
study	O	O	I-T170
evaluating	O	O	B-T058
antibiotic	O	O	B-T195
prescribing	O	O	B-T058
following	O	O	O
educational	O	O	B-T065
sessions	O	O	I-T065
for	O	O	O
urinary	O	O	B-T047
tract	O	O	I-T047
infection	O	O	I-T047
,	O	O	O
skin	O	O	B-T047
and	O	O	O
soft	O	O	B-T047
tissue	O	O	I-T047
infection	O	O	I-T047
,	O	O	O
pharyngitis	O	O	B-T047
,	O	O	O
upper	O	O	B-T047
respiratory	O	O	I-T047
tract	O	O	I-T047
infection	O	O	I-T047
,	O	O	O
acute	O	O	B-T047
otitis	O	O	I-T047
media	O	O	I-T047
,	O	O	O
and	O	O	O
acute	O	O	B-T047
bacterial	O	O	I-T047
sinusitis	O	O	I-T047
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
26	O	O	O
out	O	O	O
of	O	O	O
43	O	O	O
(	O	O	O
60	O	O	O
%	O	O	O
)	O	O	O
nurse	O	O	B-T097
practitioners	O	O	I-T097
in	O	O	O
4	O	O	O
urgent	O	O	B-T093
care	O	O	I-T093
centers	O	O	I-T093
were	O	O	O
enrolled	O	O	B-T058
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
rate	O	O	B-T081
of	O	O	O
inappropriate	O	O	B-T080
antibiotic	O	O	B-T195
use	O	O	B-T169
among	O	O	O
all	O	O	O
conditions	O	O	O
was	O	O	O
10	O	O	O
%	O	O	O
before	O	O	O
and	O	O	O
8	O	O	O
%	O	O	O
after	O	O	O
the	O	O	O
intervention	O	O	B-T061
(	O	O	O
p	O	O	O
=	O	O	O
.02	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
decrease	O	O	B-T081
in	O	O	O
inappropriate	O	O	B-T080
antibiotic	O	O	B-T195
prescribing	O	O	B-T058
was	O	O	O
seen	O	O	O
after	O	O	O
the	O	O	O
educational	O	O	B-T065
session	O	O	I-T065
(	O	O	O
p	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
reasons	O	O	O
for	O	O	O
inappropriate	O	O	B-T080
antibiotic	O	O	B-T195
prescribing	O	O	B-T058
were	O	O	O
too	O	O	O
broad	O	O	O
(	O	O	O
41	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
wrong	O	O	B-T033
dosage	O	O	I-T033
(	O	O	O
22	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
not	O	O	B-T033
indicated	O	O	I-T033
(	O	O	O
17	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Educational	O	O	B-T065
sessions	O	O	I-T065
led	O	O	O
to	O	O	O
improvement	O	O	B-T077
in	O	O	O
overall	O	O	O
inappropriate	O	O	B-T080
antibiotic	O	O	B-T195
use	O	O	B-T169
.	O	O	O

Additional	O	O	O
stewardship	O	O	B-T170
interventions	O	O	B-T061
are	O	O	O
needed	O	O	O
to	O	O	O
further	O	O	O
reduce	O	O	B-T080
unnecessary	O	O	O
antibiotic	O	O	B-T195
use	O	O	B-T169
.	O	O	O

-DOCSTART- (27568284)

Zika	O	O	B-T005
Virus	O	O	I-T005
Disrupts	O	O	B-T080
Phospho-TBK1	O	O	B-T116
Localization	O	O	B-T043
and	O	O	O
Mitosis	O	O	B-T043
in	O	O	O
Human	O	O	B-T016
Neuroepithelial	O	O	B-T080
Stem	O	O	B-T025
Cells	O	O	I-T025
and	O	O	O
Radial	O	O	O
Glia	O	O	O

The	O	O	O
mechanisms	O	O	B-T169
underlying	O	O	O
Zika	O	O	B-T005
virus	O	O	I-T005
(ZIKV)-related	O	O	O
microcephaly	O	O	B-T019
and	O	O	O
other	O	O	O
neurodevelopment	O	O	B-T042
defects	O	O	B-T169
remain	O	O	O
poorly	O	O	B-T080
understood	O	O	B-T041
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
the	O	O	O
derivation	O	O	B-T080
and	O	O	O
characterization	O	O	B-T052
,	O	O	O
including	O	O	O
single-cell	O	O	B-T086
RNA-seq	O	O	I-T086
,	O	O	O
of	O	O	O
neocortical	O	O	B-T023
and	O	O	O
spinal	O	O	B-T023
cord	O	O	I-T023
neuroepithelial	O	O	B-T080
stem	O	O	B-T025
(	O	O	I-T025
NES	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
to	O	O	O
model	O	O	O
early	O	O	B-T079
human	O	O	B-T016
neurodevelopment	O	O	B-T042
and	O	O	O
ZIKV	O	O	B-T005
-related	O	O	O
neuropathogenesis	O	O	B-T047
.	O	O	O

By	O	O	O
analyzing	O	O	O
human	O	O	B-T016
NES	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
organotypic	O	O	B-T080
fetal	O	O	B-T018
brain	O	O	B-T023
slices	O	O	B-T167
,	O	O	O
and	O	O	O
a	O	O	O
ZIKV	O	O	B-T005
-	O	O	O
infected	O	O	B-T033
micrencephalic	O	O	B-T019
brain	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
ZIKV	O	O	O
infects	O	O	B-T033
both	O	O	O
neocortical	O	O	B-T023
and	O	O	O
spinal	O	O	B-T023
NES	O	O	O
cells	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
their	O	O	O
fetal	O	O	O
homolog	O	O	O
,	O	O	O
radial	O	O	B-T025
glial	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
RGCs	O	O	B-T025
)	O	O	O
,	O	O	O
causing	O	O	O
disrupted	O	O	B-T080
mitoses	O	O	B-T043
,	O	O	O
supernumerary	O	O	B-T081
centrosomes	O	O	B-T026
,	O	O	O
structural	O	O	B-T082
disorganization	O	O	B-T033
,	O	O	O
and	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
.	O	O	O

ZIKV	O	O	B-T047
infection	O	O	I-T047
of	O	O	O
NES	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
RGCs	O	O	B-T025
causes	O	O	O
centrosomal	O	O	B-T026
depletion	O	O	B-T169
and	O	O	O
mitochondrial	O	O	B-T026
sequestration	O	O	B-T169
of	O	O	O
phospho-TBK1	O	O	B-T116
during	O	O	O
mitosis	O	O	B-T043
.	O	O	O

We	O	O	O
also	O	O	O
found	O	O	O
that	O	O	O
nucleoside	O	O	B-T114
analogs	O	O	I-T114
inhibit	O	O	B-T052
ZIKV	O	O	B-T005
replication	O	O	B-T043
in	O	O	O
NES	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
protecting	O	O	O
them	O	O	O
from	O	O	O
ZIKV	O	O	O
-	O	O	O
induced	O	O	B-T169
pTBK1	O	O	B-T116
relocalization	O	O	B-T043
and	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
.	O	O	O

We	O	O	O
established	O	O	B-T080
a	O	O	O
model	O	O	B-T170
system	O	O	I-T170
of	O	O	O
human	O	O	B-T016
neural	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
to	O	O	O
reveal	O	O	O
cellular	O	O	B-T025
and	O	O	O
molecular	O	O	B-T080
mechanisms	O	O	B-T169
underlying	O	O	O
neurodevelopmental	O	O	B-T042
defects	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
ZIKV	O	O	B-T047
infection	O	O	I-T047
and	O	O	O
its	O	O	O
potential	O	O	B-T080
treatment	O	O	B-T061
.	O	O	O

-DOCSTART- (27569088)

Prevalence	O	O	B-T081
of	O	O	O
HPV	O	O	B-T005
genotypes	O	O	B-T032
in	O	O	O
cervical	O	O	B-T191
adenocarcinoma	O	O	I-T191
:	O	O	O
a	O	O	O
study	O	O	B-T062
in	O	O	O
Greek	O	O	B-T098
women	O	O	O

To	O	O	O
study	O	O	B-T062
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
human	O	O	B-T005
papillomavirus	O	O	I-T005
(	O	O	O
HPV	O	O	B-T005
)	O	O	O
genotypes	O	O	B-T032
among	O	O	O
cervical	O	O	B-T191
adenocarcinomas	O	O	I-T191
in	O	O	O
Greek	O	O	B-T098
women	O	O	B-T098
.	O	O	O

The	O	O	O
study	O	O	B-UnknownType
group	O	O	I-UnknownType
comprised	O	O	O
78	O	O	O
adenocarcinoma	O	O	B-T191
cases	O	O	B-T077
(	O	O	O
20	O	O	O
in	O	O	B-T191
situ	O	O	I-T191
and	O	O	O
58	O	O	O
invasive	O	O	B-T191
)	O	O	O
.	O	O	O

HPV	O	O	B-T005
DNA	O	O	I-T114
was	O	O	O
amplified	O	O	B-T045
using	O	O	O
polymerase	O	O	B-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(	O	O	O
PCR	O	O	B-T063
)	O	O	O
and	O	O	O
HPV	O	O	O
genotypes	O	O	B-T032
were	O	O	O
identified	O	O	B-T080
by	O	O	O
reverse	O	O	B-T063
hybridization	O	O	I-T063
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
high	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
HPV	O	O	B-T047
infection	O	O	I-T047
both	O	O	O
for	O	O	O
in	O	O	B-T191
situ	O	O	I-T191
(	O	O	O
95	O	O	O
%	O	O	O
)	O	O	O
or	O	O	O
invasive	O	O	B-T191
(	O	O	I-T191
94.83	O	O	I-T191
%	O	O	I-T191
)	O	O	I-T191
adenocarcinomas	O	O	I-T191
,	O	O	O
comprising	O	O	O
also	O	O	O
cancers	O	O	B-T191
of	O	O	O
unusual	O	O	B-T080
morphology	O	O	I-T080
.	O	O	O

HPV	O	O	B-T005
16	O	O	I-T005
was	O	O	O
the	O	O	O
commonest	O	O	B-T081
strain	O	O	B-T001
(	O	O	O
N=57	O	O	O
,	O	O	O
73.08	O	O	O
%	O	O	O
)	O	O	O
followed	O	O	O
by	O	O	O
HPV	O	O	B-T005
18	O	O	I-T005
(	O	O	O
N=28	O	O	O
,	O	O	O
35.90	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Interestingly	O	O	O
,	O	O	O
13	O	O	O
cases	O	O	B-T077
(	O	O	O
16.67	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
also	O	O	O
HPV	O	O	B-T005
52	O	O	I-T005
positive	O	O	I-T005
(	O	O	O
as	O	O	O
co-infection	O	O	B-T047
with	O	O	O
HPV	O	O	B-T005
16	O	O	I-T005
or	O	O	O
18	O	O	B-T005
)	O	O	O
.	O	O	O

All	O	O	O
other	O	O	O
strains	O	O	B-T001
with	O	O	O
the	O	O	O
exception	O	O	B-T077
of	O	O	O
HPV	O	O	B-T005
66	O	O	I-T005
were	O	O	O
found	O	O	O
only	O	O	O
as	O	O	O
co-infections	O	O	B-T047
.	O	O	O

No	O	O	O
significant	O	O	O
age	O	O	B-T100
difference	O	O	I-T100
was	O	O	O
noted	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
any	O	O	O
HPV	O	O	B-T005
strain	O	O	B-T001
positivity	O	O	B-T033
.	O	O	O

HPV	O	O	B-T114
DNA	O	O	I-T114
was	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
large	O	O	B-T054
majority	O	O	I-T054
of	O	O	O
cervical	O	O	B-T191
adenocarcinomas	O	O	I-T191
.	O	O	O

As	O	O	O
opposed	O	O	O
to	O	O	O
other	O	O	O
studies	O	O	B-T062
,	O	O	O
HPV	O	O	B-T005
52	O	O	I-T005
was	O	O	O
the	O	O	O
third	O	O	O
most	O	O	O
commonly	O	O	B-T081
encountered	O	O	B-T058
strain	O	O	B-T001
after	O	O	O
HPV	O	O	B-T005
16	O	O	I-T005
and	O	O	O
HPV	O	O	B-T005
18	O	O	I-T005
.	O	O	O

The	O	O	O
above	O	O	O
findings	O	O	O
would	O	O	O
probably	O	O	O
be	O	O	O
of	O	O	O
help	O	O	B-T080
in	O	O	O
decision	O	O	B-T041
making	O	O	I-T041
concerning	O	O	O
vaccination	O	O	B-T061
policy	O	O	B-T170
for	O	O	O
the	O	O	O
prevention	O	O	B-T080
of	O	O	O
HPV	O	O	B-T047
infection	O	O	I-T047
in	O	O	O
Greece	O	O	B-T083
.	O	O	O

-DOCSTART- (27570111)

Glucose	O	O	B-T044
metabolism	O	O	I-T044
-	O	O	O
weighted	O	O	B-T060
imaging	O	O	I-T060
with	O	O	O
chemical	O	O	B-T060
exchange-sensitive	O	O	I-T060
MRI	O	O	I-T060
of	O	O	O
2-deoxyglucose	O	O	B-T109
(	O	O	O
2DG	O	O	B-T109
)	O	O	O
in	O	O	O
brain	O	O	B-T023
:	O	O	O
Sensitivity	O	O	B-T081
and	O	O	O
biological	O	O	B-T080
sources	O	O	O

Recent	O	O	B-T062
proof-of-principle	O	O	I-T062
studies	O	O	I-T062
have	O	O	O
demonstrated	O	O	O
the	O	O	O
feasibility	O	O	O
of	O	O	O
measuring	O	O	O
the	O	O	O
uptake	O	O	B-T039
and	O	O	O
metabolism	O	O	B-T040
of	O	O	O
non-labeled	O	O	O
2-deoxy-D-glucose	O	O	B-T109
(	O	O	O
2DG	O	O	B-T109
)	O	O	O
by	O	O	O
a	O	O	O
chemical	O	O	B-T060
exchange-sensitive	O	O	I-T060
spin-lock	O	O	I-T060
(	O	O	I-T060
CESL	O	O	I-T060
)	O	O	I-T060
MRI	O	O	I-T060
approach	O	O	I-T060
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
gain	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
this	O	O	O
new	O	O	O
approach	O	O	O
,	O	O	O
we	O	O	O
performed	O	O	O
dynamic	O	O	B-T169
in	O	O	B-T082
vivo	O	O	I-T082
CESL	O	O	B-T060
MRI	O	O	I-T060
on	O	O	O
healthy	O	O	B-T080
rat	O	O	B-T015
brains	O	O	B-T023
with	O	O	O
an	O	O	O
intravenous	O	O	B-T169
injection	O	O	I-T169
of	O	O	O
2DG	O	O	B-T109
under	O	O	O
various	O	O	O
conditions	O	O	O
at	O	O	O
9.4	O	O	O
T	O	O	O
.	O	O	O

For	O	O	O
three	O	O	O
2DG	O	O	B-T109
doses	O	O	B-T081
of	O	O	O
0.25	O	O	O
,	O	O	O
0.5	O	O	O
and	O	O	O
1g/kg	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
2DG	O	O	O
-	O	O	O
CESL	O	O	B-T060
signals	O	O	B-T067
increased	O	O	B-T081
linearly	O	O	O
with	O	O	O
injection	O	O	B-T061
dose	O	O	B-T081
at	O	O	O
the	O	O	O
initial	O	O	O
(	O	O	O
<	O	O	O
20min	O	O	O
)	O	O	O
but	O	O	O
not	O	O	O
the	O	O	O
later	O	O	O
period	O	O	O
(	O	O	O
>	O	O	O
40min	O	O	O
)	O	O	O
suggesting	O	O	O
time-dependent	O	O	O
differential	O	O	O
weightings	O	O	O
of	O	O	O
2DG	O	O	O
transport	O	O	B-T043
and	O	O	O
metabolism	O	O	B-T040
.	O	O	O

Remaining	O	O	O
2DG	O	O	B-T109
-	O	O	O
CESL	O	O	B-T060
studies	O	O	O
were	O	O	O
performed	O	O	O
with	O	O	O
0.25g/kg	O	O	O
2DG	O	O	O
.	O	O	O

Since	O	O	O
a	O	O	O
higher	O	O	B-T080
isoflurane	O	O	B-T109
level	O	O	B-T080
reduces	O	O	B-T080
glucose	O	O	B-T044
metabolism	O	O	I-T044
and	O	O	O
increases	O	O	B-T169
blood	O	O	B-T039
flow	O	O	I-T039
,	O	O	O
2DG	O	O	B-T109
-	O	O	O
CESL	O	O	B-T060
was	O	O	O
measured	O	O	B-T080
under	O	O	O
0.5	O	O	O
%	O	O	O
,	O	O	O
1.5	O	O	O
%	O	O	O
and	O	O	O
2.2	O	O	O
%	O	O	O
isoflurane	O	O	O
.	O	O	O

The	O	O	O
2DG	O	O	B-T109
-	O	O	O
CESL	O	O	B-T060
signal	O	O	B-T067
was	O	O	O
reduced	O	O	B-T080
at	O	O	O
higher	O	O	B-T080
isoflurane	O	O	B-T109
levels	O	O	O
correlating	O	O	O
well	O	O	O
with	O	O	O
the	O	O	O
2DG	O	O	O
phosphorylation	O	O	B-T044
in	O	O	O
the	O	O	O
intracellular	O	O	B-T030
space	O	O	I-T030
.	O	O	O

To	O	O	O
detect	O	O	O
regional	O	O	B-T102
heterogeneities	O	O	I-T102
of	O	O	O
glucose	O	O	B-T044
metabolism	O	O	I-T044
,	O	O	O
2DG	O	O	B-T109
-	O	O	O
CESL	O	O	B-T060
with	O	O	O
0.33	O	O	O
×	O	O	O
0.33	O	O	O
×	O	O	O
1.50mm(3	O	O	O
)	O	O	O
resolution	O	O	O
was	O	O	O
obtained	O	O	O
,	O	O	O
which	O	O	O
indeed	O	O	O
showed	O	O	O
a	O	O	O
higher	O	O	B-T080
response	O	O	O
in	O	O	O
the	O	O	O
cortex	O	O	B-T023
compared	O	O	O
to	O	O	O
the	O	O	O
corpus	O	O	B-T023
callosum	O	O	I-T023
.	O	O	O

Lastly	O	O	O
,	O	O	O
unlike	O	O	O
CESL	O	O	B-T060
MRI	O	O	I-T060
with	O	O	O
the	O	O	O
injection	O	O	B-T061
of	O	O	O
non-transportable	O	O	B-T109
mannitol	O	O	I-T109
,	O	O	O
the	O	O	O
2DG	O	O	B-T109
-	O	O	O
CESL	O	O	O
response	O	O	O
decreased	O	O	B-T081
with	O	O	O
an	O	O	O
increased	O	O	B-T081
spin-lock	O	O	B-T081
pulse	O	O	I-T081
power	O	O	I-T081
confirming	O	O	O
that	O	O	O
2DG	O	O	O
-	O	O	O
CESL	O	O	O
is	O	O	O
dominated	O	O	O
by	O	O	O
chemical	O	O	B-T103
exchange	O	O	B-T201
processes	O	O	B-T067
in	O	O	O
the	O	O	O
extravascular	O	O	B-T082
space	O	O	I-T082
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
showed	O	O	O
that	O	O	O
2DG	O	O	B-T109
-	O	O	O
CESL	O	O	B-T060
MRI	O	O	I-T060
signals	O	O	B-T067
mainly	O	O	O
indicate	O	O	O
glucose	O	O	B-T043
transport	O	O	I-T043
and	O	O	O
metabolism	O	O	B-T044
and	O	O	O
may	O	O	O
be	O	O	O
a	O	O	O
useful	O	O	O
biomarker	O	O	B-T201
for	O	O	O
metabolic	O	O	B-T169
studies	O	O	B-T062
of	O	O	O
normal	O	O	B-T023
and	O	O	O
diseased	O	O	B-T047
brains	O	O	B-T023
.	O	O	O

-DOCSTART- (27570362)

Parental	O	O	B-T099
perceptions	O	O	B-T041
of	O	O	O
children´s	O	O	B-T092
agency	O	O	I-T092
:	O	O	O
Parental	O	O	B-UnknownType
warmth	O	O	I-UnknownType
,	O	O	O
school	O	O	B-T055
achievement	O	O	I-T055
and	O	O	O
adjustment	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
examined	O	O	O
Swedish	O	O	B-T098
mothers	O	O	B-T099
'	O	O	I-T099
and	O	O	O
fathers	O	O	B-T099
'	O	O	I-T099
warmth	O	O	B-UnknownType
towards	O	O	O
their	O	O	O
children	O	O	B-T100
in	O	O	O
relation	O	O	O
to	O	O	O
their	O	O	O
children´s	O	O	B-T092
agency	O	O	I-T092
.	O	O	O

It	O	O	O
also	O	O	O
examined	O	O	O
the	O	O	O
longitudinal	O	O	O
relation	O	O	O
between	O	O	O
agency	O	O	B-T092
and	O	O	O
children	O	O	B-T100
's	O	O	I-T100
externalizing	O	O	O
,	O	O	O
internalizing	O	O	O
,	O	O	O
and	O	O	O
school	O	O	B-T055
achievement	O	O	I-T055
.	O	O	O

Swedish	O	O	B-T098
children	O	O	B-T100
's	O	O	I-T100
mothers	O	O	B-T099
and	O	O	O
fathers	O	O	B-T099
(	O	O	O
N	O	O	O
=	O	O	O
103	O	O	O
)	O	O	O
were	O	O	O
interviewed	O	O	B-T052
at	O	O	O
three	O	O	O
time	O	O	B-T079
points	O	O	I-T079
(	O	O	O
when	O	O	O
children	O	O	O
were	O	O	O
8	O	O	O
,	O	O	O
9	O	O	O
,	O	O	O
and	O	O	O
10	O	O	O
years	O	O	B-T079
old	O	O	O
)	O	O	O
about	O	O	O
their	O	O	O
warmth	O	O	B-UnknownType
towards	O	O	O
their	O	O	O
children	O	O	O
,	O	O	O
children	O	O	B-T100
's	O	O	I-T100
agency	O	O	I-T092
,	O	O	O
and	O	O	O
children	O	O	O
's	O	O	O
externalizing	O	O	O
and	O	O	O
internalizing	O	O	O
behaviors	O	O	O
and	O	O	O
school	O	O	B-T055
achievement	O	O	I-T055
.	O	O	O

Parental	O	O	B-UnknownType
warmth	O	O	I-UnknownType
at	O	O	O
Time	O	O	B-T079
1	O	O	O
was	O	O	O
significantly	O	O	O
correlated	O	O	B-T080
with	O	O	O
child	O	O	B-T100
agency	O	O	I-T092
at	O	O	O
Time	O	O	O
2	O	O	O
,	O	O	O
which	O	O	O
was	O	O	O
significantly	O	O	O
correlated	O	O	O
with	O	O	O
child	O	O	O
externalizing	O	O	O
and	O	O	O
internalizing	O	O	O
behaviors	O	O	O
and	O	O	O
academic	O	O	B-T055
achievement	O	O	I-T055
at	O	O	O
Time	O	O	O
3	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
differences	O	O	O
between	O	O	O
girls	O	O	B-T100
and	O	O	O
boys	O	O	B-T100
.	O	O	O

Results	O	O	O
from	O	O	O
this	O	O	O
study	O	O	B-T062
indicate	O	O	O
that	O	O	O
Swedish	O	O	B-T098
parents	O	O	B-UnknownType
'	O	O	I-UnknownType
warmth	O	O	I-UnknownType
is	O	O	O
directly	O	O	O
related	O	O	O
to	O	O	O
subsequent	O	O	O
perceptions	O	O	B-T041
of	O	O	O
children	O	O	B-T092
's	O	O	I-T092
agency	O	O	I-T092
,	O	O	O
which	O	O	O
in	O	O	O
turn	O	O	O
are	O	O	O
related	O	O	O
to	O	O	O
subsequently	O	O	O
lower	O	O	O
child	O	O	B-T100
externalizing	O	O	O
and	O	O	O
internalizing	O	O	O
problems	O	O	B-T033
and	O	O	O
higher	O	O	O
academic	O	O	B-T055
achievement	O	O	I-T055
.	O	O	O

These	O	O	O
findings	O	O	B-T033
held	O	O	O
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
a	O	O	O
three-	O	O	O
year	O	O	B-T079
longitudinal	O	O	B-T062
study	O	O	I-T062
and	O	O	O
for	O	O	O
both	O	O	O
boys	O	O	B-T100
and	O	O	O
girls	O	O	B-T100
,	O	O	O
suggesting	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
child	O	O	B-T092
agency	O	O	I-T092
in	O	O	O
the	O	O	O
link	O	O	O
between	O	O	O
parental	O	O	B-UnknownType
warmth	O	O	I-UnknownType
and	O	O	O
children	O	O	B-T100
's	O	O	I-T100
adjustment	O	O	B-T055
.	O	O	O

-DOCSTART- (27571215)

Vasopressin	O	O	B-T116
regulates	O	O	B-T043
the	O	O	I-T043
growth	O	O	I-T043
of	O	O	O
the	O	O	O
biliary	O	O	B-T025
epithelium	O	O	I-T025
in	O	O	O
polycystic	O	O	O
liver	O	O	O
disease	O	O	O

The	O	O	O
neurohypophysial	O	O	B-T116
hormone	O	O	I-T116
arginine	O	O	B-T116
vasopressin	O	O	I-T116
(	O	O	O
AVP	O	O	B-T116
)	O	O	O
acts	O	O	O
by	O	O	O
three	O	O	O
distinct	O	O	O
receptor	O	O	B-T116
subtypes	O	O	O
:	O	O	O
V1a	O	O	B-T116
,	O	O	O
V1b	O	O	B-T116
,	O	O	O
and	O	O	O
V2	O	O	B-T116
.	O	O	O

In	O	O	O
the	O	O	O
liver	O	O	B-T023
,	O	O	O
AVP	O	O	B-T116
is	O	O	O
involved	O	O	B-T169
in	O	O	O
ureogenesis	O	O	B-T044
,	O	O	O
glycogenolysis	O	O	B-T044
,	O	O	O
neoglucogenesis	O	O	B-T044
and	O	O	O
regeneration	O	O	B-T042
.	O	O	O

No	O	O	O
data	O	O	O
exist	O	O	O
about	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
AVP	O	O	B-T116
in	O	O	O
the	O	O	O
biliary	O	O	B-T025
epithelium	O	O	I-T025
.	O	O	O

Cholangiocytes	O	O	B-T025
are	O	O	O
the	O	O	O
target	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
animal	O	O	B-T050
models	O	O	I-T050
of	O	O	O
cholestasis	O	O	B-T047
,	O	O	O
including	O	O	O
bile	O	O	B-T023
duct	O	O	I-T023
ligation	O	O	B-T061
(	O	O	O
BDL	O	O	B-T061
)	O	O	O
,	O	O	O
and	O	O	O
in	O	O	O
several	O	O	O
human	O	O	B-T016
pathologies	O	O	B-T091
,	O	O	O
such	O	O	O
as	O	O	O
polycystic	O	O	B-T047
liver	O	O	I-T047
disease	O	O	I-T047
characterized	O	O	B-T052
by	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
cysts	O	O	B-T047
that	O	O	O
bud	O	O	O
from	O	O	O
the	O	O	O
biliary	O	O	B-T025
epithelium	O	O	I-T025
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
,	O	O	O
liver	O	O	B-T023
fragments	O	O	B-T031
from	O	O	O
normal	O	O	O
and	O	O	O
BDL	O	O	B-T061
mice	O	O	B-T015
and	O	O	O
rats	O	O	B-T015
as	O	O	O
well	O	O	O
as	O	O	O
liver	O	O	B-T024
samples	O	O	I-T024
from	O	O	O
normal	O	O	O
and	O	O	O
ADPKD	O	O	B-T047
patients	O	O	B-T101
were	O	O	O
collected	O	O	O
to	O	O	O
evaluate	O	O	O
:	O	O	O
(	O	O	O
i	O	O	O
)	O	O	O
intrahepatic	O	O	B-T082
bile	O	O	B-T023
duct	O	O	I-T023
mass	O	O	B-T033
by	O	O	O
immunohistochemistry	O	O	B-T060
for	O	O	O
cytokeratin-19	O	O	B-T116
;	O	O	O
and	O	O	O
(	O	O	O
ii	O	O	O
)	O	O	O
expression	O	O	B-T045
of	O	O	O
V1a	O	O	B-T116
,	O	O	O
V1b	O	O	B-T116
and	O	O	O
V2	O	O	B-T116
by	O	O	O
immunohistochemistry	O	O	O
,	O	O	O
immunofluorescence	O	O	B-T059
and	O	O	O
real-time	O	O	B-T063
PCR	O	O	I-T063
.	O	O	O

In	O	O	B-T080
vitro	O	O	I-T080
,	O	O	O
small	O	O	O
and	O	O	O
large	O	O	O
mouse	O	O	B-T015
cholangiocytes	O	O	B-T025
,	O	O	O
H69	O	O	B-T025
(	O	O	O
non-malignant	O	O	B-T080
human	O	O	B-T016
cholangiocytes	O	O	O
)	O	O	O
and	O	O	O
LCDE	O	O	B-T025
(	O	O	O
human	O	O	O
cholangiocytes	O	O	O
from	O	O	O
the	O	O	O
cystic	O	O	B-T190
epithelium	O	O	I-T190
)	O	O	O
were	O	O	O
stimulated	O	O	B-T044
with	O	O	O
vasopressin	O	O	B-T116
in	O	O	O
the	O	O	O
absence/	O	O	O
presence	O	O	B-T033
of	O	O	O
AVP	O	O	B-T116
antagonists	O	O	I-T116
such	O	O	O
as	O	O	O
OPC-31260	O	O	B-T109
and	O	O	O
Tolvaptan	O	O	B-T109
,	O	O	O
before	O	O	O
assessing	O	O	O
cellular	O	O	B-T043
growth	O	O	I-T043
by	O	O	O
MTT	O	O	B-T059
assay	O	O	I-T059
and	O	O	O
cAMP	O	O	B-T114
levels	O	O	O
.	O	O	O

Cholangiocytes	O	O	B-T025
express	O	O	O
V2	O	O	B-T116
receptor	O	O	I-T116
that	O	O	O
was	O	O	O
upregulated	O	O	B-T044
following	O	O	O
BDL	O	O	B-T061
and	O	O	O
in	O	O	O
ADPKD	O	O	B-T047
liver	O	O	B-T024
samples	O	O	I-T024
.	O	O	O

Administration	O	O	B-T061
of	O	O	O
AVP	O	O	B-T116
increased	O	O	B-T081
proliferation	O	O	B-T043
and	O	O	O
cAMP	O	O	B-T114
levels	O	O	O
of	O	O	O
small	O	O	O
cholangiocytes	O	O	B-T025
and	O	O	O
LCDE	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

We	O	O	O
found	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
in	O	O	O
the	O	O	O
proliferation	O	O	B-T043
of	O	O	O
large	O	O	O
mouse	O	O	B-T015
cholangiocytes	O	O	B-T025
and	O	O	O
H69	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Increases	O	O	B-T169
were	O	O	O
blocked	O	O	B-T169
by	O	O	O
preincubation	O	O	B-T059
with	O	O	O
the	O	O	O
AVP	O	O	B-T116
antagonists	O	O	I-T116
.	O	O	O

These	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
AVP	O	O	B-T116
and	O	O	O
its	O	O	O
receptors	O	O	B-T116
may	O	O	O
be	O	O	O
important	O	O	O
in	O	O	O
the	O	O	O
modulation	O	O	B-UnknownType
of	O	O	O
the	O	O	O
proliferation	O	O	B-T034
rate	O	O	I-T034
of	O	O	O
the	O	O	O
biliary	O	O	B-T025
epithelium	O	O	I-T025
.	O	O	O

-DOCSTART- (27571223)

Central	O	O	B-T201
Corneal	O	O	I-T201
Thickness	O	O	I-T201
Reproducibility	O	O	B-T081
among	O	O	O
Ten	O	O	O
Different	O	O	O
Instruments	O	O	O

To	O	O	O
assess	O	O	B-T058
agreement	O	O	O
between	O	O	O
one	O	O	O
ultrasonic	O	O	B-T074
(	O	O	O
US	O	O	B-T074
)	O	O	O
and	O	O	O
nine	O	O	O
optical	O	O	B-T073
instruments	O	O	I-T073
for	O	O	O
the	O	O	O
measurement	O	O	B-T169
of	O	O	O
central	O	O	B-T201
corneal	O	O	I-T201
thickness	O	O	I-T201
(	O	O	O
CCT	O	O	B-T201
)	O	O	O
,	O	O	O
and	O	O	O
to	O	O	O
evaluate	O	O	B-T058
intra-	O	O	B-T081
and	O	O	I-T081
inter-operator	O	O	I-T081
reproducibility	O	O	I-T081
.	O	O	O

In	O	O	O
this	O	O	O
observational	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
,	O	O	O
two	O	O	O
masked	O	O	O
operators	O	O	O
measured	O	O	O
CCT	O	O	B-T201
thickness	O	O	O
twice	O	O	O
in	O	O	O
28	O	O	O
healthy	O	O	B-T080
eyes	O	O	B-T023
.	O	O	O

We	O	O	O
used	O	O	O
seven	O	O	O
spectral-domain	O	O	B-T074
optical	O	O	I-T074
coherence	O	O	I-T074
tomography	O	O	I-T074
(	O	O	I-T074
SD-OCT	O	O	I-T074
)	O	O	I-T074
devices	O	O	I-T074
,	O	O	O
one	O	O	B-T074
time-domain	O	O	I-T074
OCT	O	O	I-T074
,	O	O	O
one	O	O	O
Scheimpflug	O	O	B-T074
camera	O	O	I-T074
,	O	O	O
and	O	O	O
one	O	O	O
US-based	O	O	B-T074
instrument	O	O	I-T074
.	O	O	O

Inter-	O	O	B-T080
and	O	O	I-T080
intra-operator	O	O	I-T080
reproducibility	O	O	I-T080
was	O	O	O
evaluated	O	O	B-T058
by	O	O	O
intraclass	O	O	B-T081
correlation	O	O	I-T081
coefficient	O	O	I-T081
(	O	O	O
ICC	O	O	B-T081
)	O	O	O
,	O	O	O
coefficient	O	O	B-T081
of	O	O	I-T081
variation	O	O	I-T081
(	O	O	O
CV	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
Bland-Altman	O	O	B-T170
test	O	O	I-T170
analysis	O	O	B-T062
.	O	O	O

Instrument	O	O	B-T074
-to-	O	O	O
instrument	O	O	B-T074
reproducibility	O	O	B-T081
was	O	O	O
determined	O	O	O
by	O	O	O
ANOVA	O	O	B-T081
for	O	O	O
repeated	O	O	O
measurements	O	O	O
.	O	O	O

We	O	O	O
also	O	O	O
tested	O	O	B-T169
how	O	O	O
the	O	O	O
devices	O	O	B-T074
disagreed	O	O	O
regarding	O	O	O
systemic	O	O	B-T169
bias	O	O	B-T078
and	O	O	O
random	O	O	B-T080
error	O	O	B-T080
using	O	O	O
a	O	O	O
structural	O	O	B-T062
equation	O	O	I-T062
model	O	O	I-T062
.	O	O	O

Mean	O	O	O
CCT	O	O	B-T201
of	O	O	O
all	O	O	O
instruments	O	O	B-T074
ranged	O	O	O
from	O	O	O
536	O	O	O
±	O	O	O
42	O	O	O
μm	O	O	O
to	O	O	O
577	O	O	O
±	O	O	O
40	O	O	O
μm	O	O	O
.	O	O	O

An	O	O	O
instrument	O	O	B-T074
-to-	O	O	O
instrument	O	O	O
correlation	O	O	B-T170
test	O	O	I-T170
showed	O	O	O
high	O	O	B-T080
values	O	O	B-T080
among	O	O	O
the	O	O	O
10	O	O	O
investigated	O	O	B-T169
devices	O	O	B-T074
(	O	O	O
correlation	O	O	B-T081
coefficient	O	O	I-T081
range	O	O	B-T081
0.852	O	O	O
-	O	O	O
0.995	O	O	O
;	O	O	O
p	O	O	B-T081
values	O	O	I-T081
<	O	O	O
0.0001	O	O	O
in	O	O	O
all	O	O	O
cases	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
highest	O	O	O
correlation	O	O	O
coefficient	O	O	O
values	O	O	O
were	O	O	O
registered	O	O	O
between	O	O	O
3D	O	O	O
OCT-2000	O	O	O
Topcon-Spectral	O	O	B-T073
OCT/SLO	O	O	I-T073
Opko	O	O	I-T073
(	O	O	O
0.995	O	O	O
)	O	O	O
and	O	O	O
Cirrus	O	O	B-T073
HD-OCT	O	O	I-T073
Zeiss-RS-3000	O	O	I-T073
Nidek	O	O	I-T073
(	O	O	O
0.995	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
the	O	O	O
lowest	O	O	O
were	O	O	O
seen	O	O	O
between	O	O	O
SS-1000	O	O	B-T073
CASIA	O	O	I-T073
and	O	O	O
Spectral	O	O	B-T073
OCT/SLO	O	O	I-T073
Opko	O	O	I-T073
(	O	O	O
0.852	O	O	O
)	O	O	O
.	O	O	O

ICC	O	O	B-T081
and	O	O	O
CV	O	O	B-T081
showed	O	O	O
excellent	O	O	O
inter-	O	O	B-T080
and	O	O	I-T080
intra-operator	O	O	I-T080
reproducibility	O	O	I-T080
for	O	O	O
all	O	O	O
optic	O	O	B-T090
-based	O	O	O
devices	O	O	B-T074
,	O	O	O
except	O	O	O
for	O	O	O
the	O	O	O
US	O	O	B-T074
-based	O	O	O
device	O	O	B-T074
.	O	O	O

Bland-Altman	O	O	B-T170
analysis	O	O	B-T062
demonstrated	O	O	O
low	O	O	O
mean	O	O	O
biases	O	O	B-T078
between	O	O	O
operators	O	O	O
.	O	O	O

Despite	O	O	O
highlighting	O	O	O
good	O	O	O
intra-	O	O	B-T080
and	O	O	I-T080
inter-operator	O	O	I-T080
reproducibility	O	O	I-T080
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
a	O	O	O
scale	O	O	B-T170
bias	O	O	B-T078
between	O	O	O
instruments	O	O	B-T074
might	O	O	O
interfere	O	O	B-T169
with	O	O	I-T169
thorough	O	O	O
CCT	O	O	B-T201
monitoring	O	O	B-T058
.	O	O	O

We	O	O	O
suggest	O	O	O
that	O	O	O
optimal	O	O	B-T080
monitoring	O	O	B-T058
is	O	O	O
achieved	O	O	O
with	O	O	O
the	O	O	O
same	O	O	O
operator	O	O	O
and	O	O	O
the	O	O	O
same	O	O	O
device	O	O	B-T074
.	O	O	O

-DOCSTART- (27571883)

Predictors	O	O	B-T078
of	O	O	O
neurologic	O	O	B-T046
and	O	O	O
nonneurologic	O	O	B-T033
death	O	O	I-T033
in	O	O	O
patients	O	O	B-T101
with	O	O	O
brain	O	O	B-T191
metastasis	O	O	I-T191
initially	O	O	O
treated	O	O	B-T169
with	O	O	O
upfront	O	O	B-T061
stereotactic	O	O	I-T061
radiosurgery	O	O	I-T061
without	O	O	O
whole-brain	O	O	O
radiation	O	O	O
therapy	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
we	O	O	O
attempted	O	O	O
to	O	O	O
discern	O	O	O
the	O	O	O
factors	O	O	B-T169
predictive	O	O	B-T080
of	O	O	O
neurologic	O	O	B-T046
death	O	O	I-T046
in	O	O	O
patients	O	O	B-T101
with	O	O	O
brain	O	O	B-T191
metastasis	O	O	I-T191
treated	O	O	B-T169
with	O	O	O
upfront	O	O	B-T061
stereotactic	O	O	I-T061
radiosurgery	O	O	I-T061
(	O	O	O
SRS	O	O	B-T061
)	O	O	O
without	O	O	O
whole	O	O	B-T061
brain	O	O	I-T061
radiation	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
WBRT	O	O	B-T061
)	O	O	O
while	O	O	O
accounting	O	O	O
for	O	O	O
the	O	O	O
competing	O	O	B-T078
risk	O	O	I-T078
of	O	O	O
nonneurologic	O	O	B-T033
death	O	O	I-T033
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
retrospective	O	O	B-T080
single-institution	O	O	B-T093
analysis	O	O	B-T062
of	O	O	O
patients	O	O	B-T101
with	O	O	O
brain	O	O	B-T191
metastasis	O	O	I-T191
treated	O	O	B-T169
with	O	O	O
upfront	O	O	O
SRS	O	O	B-T061
without	O	O	O
WBRT	O	O	B-T061
.	O	O	O

Competing	O	O	B-T080
risks	O	O	I-T080
analysis	O	O	I-T080
was	O	O	O
performed	O	O	O
to	O	O	O
estimate	O	O	O
the	O	O	O
subdistribution	O	O	O
hazard	O	O	B-T081
ratios	O	O	I-T081
(	O	O	O
HRs	O	O	B-T081
)	O	O	O
for	O	O	O
neurologic	O	O	B-T046
and	O	O	O
nonneurologic	O	O	B-T033
death	O	O	I-T033
for	O	O	O
predictor	O	O	B-T078
variables	O	O	O
of	O	O	O
interest	O	O	O
.	O	O	O

Of	O	O	O
738	O	O	O
patients	O	O	B-T101
treated	O	O	B-T169
with	O	O	O
upfront	O	O	B-T061
SRS	O	O	I-T061
alone	O	O	O
,	O	O	O
neurologic	O	O	B-T046
death	O	O	I-T046
occurred	O	O	O
in	O	O	O
226	O	O	O
(	O	O	O
30.6	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
nonneurologic	O	O	B-T033
death	O	O	I-T033
occurred	O	O	O
in	O	O	O
309	O	O	O
(	O	O	O
41.9	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Multivariate	O	O	B-T081
competing	O	O	I-T081
risks	O	O	I-T081
analysis	O	O	I-T081
identified	O	O	O
an	O	O	O
increased	O	O	B-T081
hazard	O	O	B-T081
of	O	O	O
neurologic	O	O	B-T046
death	O	O	I-T046
associated	O	O	O
with	O	O	O
diagnosis-specific	O	O	B-T170
graded	O	O	I-T170
prognostic	O	O	I-T170
assessment	O	O	I-T170
(	O	O	O
DS-GPA	O	O	B-T170
)	O	O	O
≤	O	O	O
2	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
.005	O	O	O
)	O	O	O
,	O	O	O
melanoma	O	O	B-T191
histology	O	O	B-T059
(	O	O	O
P	O	O	O
=	O	O	O
.009	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
increased	O	O	O
number	O	O	O
of	O	O	O
brain	O	O	B-T191
metastases	O	O	I-T191
(	O	O	O
P<.001	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
decreased	O	O	B-T081
hazard	O	O	O
associated	O	O	O
with	O	O	O
higher	O	O	O
SRS	O	O	B-T061
dose	O	O	B-T081
(	O	O	O
P	O	O	O
=	O	O	O
.004	O	O	O
)	O	O	O
.	O	O	O

Targeted	O	O	B-T121
agents	O	O	I-T121
were	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
decreased	O	O	B-T081
HR	O	O	B-T081
of	O	O	O
neurologic	O	O	B-T046
death	O	O	I-T046
in	O	O	O
the	O	O	O
first	O	O	O
1.5	O	O	O
years	O	O	B-T079
(	O	O	O
P	O	O	O
=	O	O	O
.04	O	O	O
)	O	O	O
but	O	O	O
not	O	O	O
afterwards	O	O	O
.	O	O	O

An	O	O	O
increased	O	O	B-T081
hazard	O	O	B-T081
of	O	O	O
nonneurologic	O	O	B-T033
death	O	O	I-T033
was	O	O	O
seen	O	O	O
with	O	O	O
increasing	O	O	O
age	O	O	B-T032
(	O	O	O
P	O	O	O
=	O	O	O
.03	O	O	O
)	O	O	O
,	O	O	O
nonmelanoma	O	O	B-T059
histology	O	O	I-T059
(	O	O	O
P<.001	O	O	O
)	O	O	O
,	O	O	O
presence	O	O	O
of	O	O	O
extracranial	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
P<.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
progressive	O	O	B-T169
systemic	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
P	O	O	O
=	O	O	O
.004	O	O	O
)	O	O	O
.	O	O	O

Melanoma	O	O	B-T191
,	O	O	O
DS-GPA	O	O	B-T170
,	O	O	O
number	O	O	B-T081
of	O	O	O
brain	O	O	B-T191
metastases	O	O	I-T191
,	O	O	O
and	O	O	O
SRS	O	O	B-T061
dose	O	O	B-T081
are	O	O	O
predictive	O	O	B-T080
of	O	O	O
neurologic	O	O	B-T046
death	O	O	I-T046
,	O	O	O
while	O	O	O
age	O	O	B-T032
,	O	O	O
nonmelanoma	O	O	B-T059
histology	O	O	I-T059
,	O	O	O
and	O	O	O
more	O	O	O
advanced	O	O	O
systemic	O	O	B-T047
disease	O	O	I-T047
are	O	O	O
predictive	O	O	O
of	O	O	O
nonneurologic	O	O	B-T033
death	O	O	I-T033
.	O	O	O

Targeted	O	O	B-T121
agents	O	O	I-T121
appear	O	O	O
to	O	O	O
delay	O	O	B-T079
neurologic	O	O	B-T046
death	O	O	I-T046
.	O	O	O

-DOCSTART- (27572131)

Pharmacological	O	O	B-T038
Actions	O	O	I-T038
of	O	O	O
Glucagon-Like	O	O	B-T116
Peptide-1	O	O	I-T116
,	O	O	O
Gastric	O	O	B-T116
Inhibitory	O	O	I-T116
Polypeptide	O	O	I-T116
,	O	O	O
and	O	O	O
Glucagon	O	O	O

Glucagon	O	O	B-T116
family	O	O	I-T116
of	O	O	O
peptide	O	O	B-T116
hormones	O	O	I-T116
is	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
structurally	O	O	O
related	O	O	O
brain-gut	O	O	B-T116
peptides	O	O	I-T116
that	O	O	O
exert	O	O	O
their	O	O	O
pleiotropic	O	O	B-T045
actions	O	O	I-T045
through	O	O	O
interactions	O	O	B-T045
with	O	O	O
unique	O	O	B-T185
members	O	O	I-T185
of	O	O	I-T185
class	O	O	I-T185
B1	O	O	I-T185
G	O	O	B-T116
protein-coupled	O	O	I-T116
receptors	O	O	I-T116
(	O	O	O
GPCRs	O	O	B-T116
)	O	O	O
.	O	O	O

They	O	O	O
are	O	O	O
key	O	O	O
regulators	O	O	B-T077
of	O	O	O
hormonal	O	O	B-T080
homeostasis	O	O	B-T038
and	O	O	O
are	O	O	O
important	O	O	O
drug	O	O	B-T074
targets	O	O	I-T074
for	O	O	O
metabolic	O	O	B-T047
disorders	O	O	I-T047
such	O	O	O
as	O	O	O
type-2	O	O	B-T047
diabetes	O	O	I-T047
mellitus	O	O	I-T047
(	O	O	O
T2DM	O	O	B-T047
)	O	O	O
,	O	O	O
obesity	O	O	B-T047
,	O	O	O
and	O	O	O
dysregulations	O	O	B-T047
of	O	O	I-T047
the	O	O	I-T047
nervous	O	O	I-T047
systems	O	O	I-T047
such	O	O	O
as	O	O	O
migraine	O	O	B-T047
,	O	O	O
anxiety	O	O	B-T048
,	O	O	O
depression	O	O	B-T048
,	O	O	O
neurodegeneration	O	O	B-T049
,	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
and	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

The	O	O	O
current	O	O	O
review	O	O	O
aims	O	O	O
to	O	O	O
provide	O	O	O
a	O	O	O
detailed	O	O	O
overview	O	O	B-T170
of	O	O	O
the	O	O	O
current	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
pharmacological	O	O	B-T038
actions	O	O	I-T038
and	O	O	O
therapeutic	O	O	B-T061
advances	O	O	I-T061
of	O	O	O
three	O	O	O
members	O	O	O
within	O	O	O
this	O	O	O
family	O	O	O
including	O	O	O
glucagon-like	O	O	B-T116
peptide-1	O	O	I-T116
(	O	O	O
GLP-1	O	O	B-T116
)	O	O	O
,	O	O	O
gastric	O	O	B-T116
inhibitory	O	O	I-T116
polypeptide	O	O	I-T116
(	O	O	O
GIP	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
glucagon	O	O	B-T116
.	O	O	O

-DOCSTART- (27573109)

Endemic	O	O	B-T082
hydrothermal	O	O	B-T070
vent	O	O	I-T070
species	O	O	B-T185
identified	O	O	B-T080
in	O	O	O
the	O	O	O
open	O	O	O
ocean	O	O	B-T170
seed	O	O	O
bank	O	O	O

Hydrothermal	O	O	B-T070
vent	O	O	I-T070
systems	O	O	B-T169
host	O	O	O
microbial	O	O	B-T001
communities	O	O	B-T096
among	O	O	O
which	O	O	O
several	O	O	B-T081
microorganisms	O	O	B-T001
have	O	O	O
been	O	O	O
considered	O	O	B-T078
endemic	O	O	B-T082
to	O	O	O
this	O	O	O
type	O	O	O
of	O	O	O
habitat	O	O	B-T082
.	O	O	O

It	O	O	O
is	O	O	O
still	O	O	O
unclear	O	O	B-T033
how	O	O	O
these	O	O	O
organisms	O	O	B-T001
colonize	O	O	B-T033
geographically	O	O	B-T083
distant	O	O	B-T082
hydrothermal	O	O	B-T080
environments	O	O	B-T082
.	O	O	O

Based	O	O	O
on	O	O	O
16S	O	O	B-T114
rRNA	O	O	I-T114
gene	O	O	B-T086
sequences	O	O	I-T086
,	O	O	O
we	O	O	O
compare	O	O	B-T052
the	O	O	O
bacterial	O	O	B-T080
communities	O	O	B-T096
of	O	O	O
sixteen	O	O	O
Atlantic	O	O	B-T083
hydrothermal	O	O	B-T070
vent	O	O	I-T070
samples	O	O	B-T077
with	O	O	O
our	O	O	O
own	O	O	O
and	O	O	O
publicly	O	O	O
available	O	O	B-T169
global	O	O	B-T080
open	O	O	O
ocean	O	O	B-T170
samples	O	O	O
.	O	O	O

Analysing	O	O	B-T062
sequences	O	O	B-T086
obtained	O	O	B-T169
from	O	O	O
63	O	O	O
million	O	O	O
16S	O	O	B-T114
rRNA	O	O	I-T114
genes	O	O	B-T028
,	O	O	O
the	O	O	O
genera	O	O	B-T185
we	O	O	O
could	O	O	O
identify	O	O	O
in	O	O	O
the	O	O	O
open	O	O	O
ocean	O	O	B-T170
waters	O	O	I-T170
contained	O	O	B-T169
99.9	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
vent	O	O	B-T070
reads	O	O	O
.	O	O	O

This	O	O	O
suggests	O	O	B-T078
that	O	O	O
previously	O	O	B-T079
observed	O	O	B-T169
vent	O	O	B-T070
exclusiveness	O	O	B-T033
is	O	O	O
,	O	O	O
in	O	O	O
most	O	O	O
cases	O	O	B-T169
,	O	O	O
probably	O	O	B-T078
an	O	O	O
artefact	O	O	B-T033
of	O	O	O
lower	O	O	B-T052
sequencing	O	O	B-T059
depth	O	O	B-T080
.	O	O	O

These	O	O	O
findings	O	O	B-T033
are	O	O	O
a	O	O	O
further	O	O	O
step	O	O	O
towards	O	O	O
elucidating	O	O	O
the	O	O	O
role	O	O	B-T170
of	O	O	O
the	O	O	O
open	O	O	O
ocean	O	O	B-T170
as	O	O	O
a	O	O	O
seed	O	O	B-T002
bank	O	O	I-T002
.	O	O	O

They	O	O	O
can	O	O	O
explain	O	O	O
the	O	O	O
predicament	O	O	B-T033
of	O	O	O
how	O	O	O
species	O	O	B-T185
expected	O	O	B-T170
to	O	O	O
be	O	O	O
endemic	O	O	B-T082
to	O	O	O
vent	O	O	B-T070
systems	O	O	B-T169
are	O	O	O
able	O	O	B-T033
to	O	O	O
colonize	O	O	B-T033
geographically	O	O	B-T083
distant	O	O	B-T082
hydrothermal	O	O	B-T080
habitats	O	O	B-T082
and	O	O	O
contribute	O	O	B-T052
to	O	O	O
our	O	O	O
understanding	O	O	B-T041
of	O	O	O
whether	O	O	O
'	O	O	O
everything	O	O	O
is	O	O	O
really	O	O	O
everywhere	O	O	O
'	O	O	O
.	O	O	O

-DOCSTART- (27573702)

Cerebral	O	O	B-T047
toxoplasmosis	O	O	I-T047
in	O	O	O
patients	O	O	B-T101
with	O	O	O
acquired	O	O	B-T047
immune	O	O	I-T047
deficiency	O	O	I-T047
syndrome	O	O	I-T047
in	O	O	O
the	O	O	O
neurological	O	O	B-T093
emergency	O	O	I-T093
department	O	O	I-T093
of	O	O	O
a	O	O	O
tertiary	O	O	O
hospital	O	O	O

Cerebral	O	O	B-T047
toxoplasmosis	O	O	I-T047
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
cause	O	O	B-T169
of	O	O	O
space	O	O	B-T082
occupying	O	O	O
brain	O	O	B-T047
lesion	O	O	I-T047
in	O	O	O
patients	O	O	B-T101
with	O	O	O
HIV/AIDS	O	O	B-T047
in	O	O	O
Brazil	O	O	B-T083
.	O	O	O

In	O	O	O
the	O	O	O
post-HAART	O	O	B-T079
era	O	O	I-T079
,	O	O	O
it	O	O	O
is	O	O	O
responsible	O	O	O
for	O	O	O
high	O	O	B-T080
rates	O	O	B-T081
of	O	O	O
morbidity	O	O	B-T081
and	O	O	O
mortality	O	O	B-T081
worldwide	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
consists	O	O	O
of	O	O	O
a	O	O	O
case	O	O	B-T062
series	O	O	I-T062
of	O	O	O
56	O	O	O
patients	O	O	B-T101
diagnosed	O	O	B-T033
with	O	O	O
cerebral	O	O	B-T047
toxoplasmosis	O	O	I-T047
whose	O	O	O
clinical	O	O	B-T080
features	O	O	B-T080
,	O	O	O
brain	O	O	B-T060
imaging	O	O	I-T060
and	O	O	O
cerebrospinal	O	O	B-T031
fluid	O	O	I-T031
aspects	O	O	B-T080
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Cerebral	O	O	B-T047
toxoplasmosis	O	O	I-T047
led	O	O	O
to	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
infection	O	O	B-T046
by	O	O	O
the	O	O	O
human	O	O	B-T005
immunodeficiency	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
HIV	O	O	B-T005
)	O	O	O
in	O	O	O
27	O	O	O
(	O	O	O
48.2	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
,	O	O	O
while	O	O	O
29	O	O	O
(	O	O	O
51.2	O	O	O
%	O	O	O
)	O	O	O
others	O	O	O
already	O	O	O
knew	O	O	O
to	O	O	O
be	O	O	O
HIV	O	O	B-T034
seropositive	O	O	I-T034
.	O	O	O

However	O	O	O
,	O	O	O
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
cerebral	O	O	B-T047
toxoplasmosis	O	O	B-T047
,	O	O	O
only	O	O	O
9	O	O	O
(	O	O	O
16.6	O	O	O
%	O	O	O
)	O	O	O
reported	O	O	B-T058
being	O	O	O
under	O	O	O
antiretroviral	O	O	B-T061
therapy	O	O	I-T061
and	O	O	O
5	O	O	O
(	O	O	O
8.9	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
receiving	O	O	B-T080
primary	O	O	B-T080
prophylaxis	O	O	B-T061
for	O	O	O
toxoplasmosis	O	O	O
.	O	O	O

Headache	O	O	B-T184
,	O	O	O
strength	O	O	B-T184
deficit	O	O	I-T184
and	O	O	O
fever	O	O	B-T184
were	O	O	O
the	O	O	O
most	O	O	O
frequent	O	O	O
signs	O	O	B-T184
and	O	O	I-T184
symptoms	O	O	I-T184
throughout	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

Fifty-three	O	O	O
patients	O	O	B-T101
showed	O	O	O
changes	O	O	B-T169
consistent	O	O	B-T078
with	O	O	I-T078
toxoplasmosis	O	O	B-T047
in	O	O	O
CT	O	O	B-T060
or	O	O	O
MRI	O	O	B-T060
.	O	O	O

Thirty-four	O	O	O
(	O	O	O
60.7	O	O	O
%	O	O	O
)	O	O	O
CSF	O	O	B-T031
samples	O	O	I-T031
were	O	O	O
positive	O	O	B-T033
in	O	O	O
the	O	O	O
indirect	O	O	B-T059
haemagglutination	O	O	I-T059
test	O	O	I-T059
and	O	O	O
for	O	O	O
the	O	O	O
reaction	O	O	B-T169
of	O	O	O
Toxoplasma	O	O	B-T116
gondii	O	O	I-T116
IgG	O	O	I-T116
ELISA	O	O	B-T059
,	O	O	O
while	O	O	O
31	O	O	O
(	O	O	O
55.4	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
positive	O	O	O
in	O	O	O
the	O	O	O
direct	O	O	B-T059
haemagglutination	O	O	I-T059
test	O	O	I-T059
.	O	O	O

Fifty	O	O	O
(	O	O	O
89.3	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
underwent	O	O	O
first-line	O	O	B-T061
treatment	O	O	I-T061
for	O	O	O
toxoplasmosis	O	O	B-T047
.	O	O	O

Cerebral	O	O	B-T047
toxoplasmosis	O	O	I-T047
is	O	O	O
still	O	O	O
a	O	O	O
very	O	O	O
relevant	O	O	B-T080
neurological	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
individuals	O	O	B-T098
with	O	O	O
AIDS	O	O	B-T047
admitted	O	O	B-T058
to	O	O	O
neurology	O	O	B-T091
emergency	O	O	B-T093
departments	O	O	I-T093
.	O	O	O

Early	O	O	B-T060
diagnosis	O	O	I-T060
and	O	O	O
initiation	O	O	B-T169
of	O	O	O
empiric	O	O	B-T033
treatment	O	O	I-T033
and	O	O	O
antiretroviral	O	O	B-T061
therapy	O	O	I-T061
are	O	O	O
important	O	O	O
for	O	O	O
good	O	O	O
prognosis	O	O	B-T058
.	O	O	O

-DOCSTART- (27575455)

Maf1	O	O	B-T028
-mediated	O	O	O
regulation	O	O	B-T038
of	O	O	O
yeast	O	O	B-T004
RNA	O	O	B-T116
polymerase	O	O	I-T116
III	O	O	I-T116
is	O	O	O
correlated	O	O	B-T080
with	O	O	O
CCA	O	O	B-T045
addition	O	O	I-T045
at	O	O	I-T045
the	O	O	I-T045
3	O	O	I-T045
'	O	O	I-T045
end	O	O	I-T045
of	O	O	I-T045
tRNA	O	O	I-T045
precursors	O	O	O

In	O	O	O
eukaryotic	O	O	B-T025
cells	O	O	I-T025
tRNA	O	O	B-T045
synthesis	O	O	I-T045
is	O	O	O
negatively	O	O	B-T033
regulated	O	O	B-T038
by	O	O	O
the	O	O	O
protein	O	O	B-T116
Maf1	O	O	I-T116
,	O	O	O
conserved	O	O	O
from	O	O	O
yeast	O	O	B-T004
to	O	O	O
humans	O	O	B-T016
.	O	O	O

Maf1	O	O	B-T028
from	O	O	O
yeast	O	O	B-T004
Saccharomyces	O	O	B-T004
cerevisiae	O	O	I-T004
mediates	O	O	O
repression	O	O	B-T045
of	O	O	O
trna	O	O	B-T045
transcription	O	O	I-T045
when	O	O	O
cells	O	O	B-T025
are	O	O	O
transferred	O	O	O
from	O	O	O
medium	O	O	B-T130
with	O	O	O
glucose	O	O	B-T109
to	O	O	O
medium	O	O	O
with	O	O	O
glycerol	O	O	B-T109
,	O	O	O
a	O	O	O
non-fermentable	O	O	B-T044
carbon	O	O	B-T196
source	O	O	B-T033
.	O	O	O

The	O	O	O
strain	O	O	B-T001
with	O	O	O
deleted	O	O	B-T033
gene	O	O	B-T028
encoding	O	O	B-T052
Maf1	O	O	B-T028
(	O	O	O
maf1Δ	O	O	B-T028
)	O	O	O
is	O	O	O
viable	O	O	B-T080
but	O	O	O
accumulates	O	O	O
tRNA	O	O	B-T114
precursors	O	O	I-T114
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
tRNA	O	O	B-T114
precursors	O	O	I-T114
were	O	O	O
analysed	O	O	B-T062
by	O	O	O
RNA-Seq	O	O	B-T059
and	O	O	O
Northern	O	O	B-T059
hybridization	O	O	I-T059
in	O	O	O
wild	O	O	B-T028
type	O	O	I-T028
strain	O	O	B-T001
and	O	O	O
maf1Δ	O	O	B-T028
mutant	O	O	B-T028
grown	O	O	O
in	O	O	O
glucose	O	O	B-T109
medium	O	O	B-T130
or	O	O	O
upon	O	O	O
shift	O	O	O
to	O	O	O
repressive	O	O	B-T080
conditions	O	O	I-T080
.	O	O	O

A	O	O	O
negative	O	O	B-T033
effect	O	O	B-T080
of	O	O	O
maf1Δ	O	O	B-T028
mutant	O	O	B-T028
on	O	O	O
the	O	O	O
addition	O	O	B-T045
of	O	O	I-T045
the	O	O	I-T045
auxiliary	O	O	I-T045
CCA	O	O	I-T045
nucleotides	O	O	I-T045
to	O	O	I-T045
the	O	O	I-T045
3	O	O	I-T045
'	O	O	I-T045
end	O	O	I-T045
of	O	O	I-T045
pre-tRNAs	O	O	I-T045
was	O	O	O
observed	O	O	O
in	O	O	O
cells	O	O	B-T025
shifted	O	O	O
to	O	O	O
unfavourable	O	O	O
growth	O	O	B-T040
conditions	O	O	B-T080
.	O	O	O

This	O	O	O
effect	O	O	B-T080
was	O	O	O
reduced	O	O	B-T080
by	O	O	O
overexpression	O	O	B-T045
of	O	O	O
the	O	O	O
yeast	O	O	B-T004
CCA1	O	O	B-T028
gene	O	O	I-T028
encoding	O	O	B-T052
ATP(CTP):tRNA	O	O	B-T116
nucleotidyltransferase	O	O	I-T116
.	O	O	O

The	O	O	O
CCA	O	O	B-T086
sequence	O	O	I-T086
at	O	O	O
the	O	O	O
3	O	O	O
'	O	O	O
end	O	O	O
is	O	O	O
important	O	O	O
for	O	O	O
export	O	O	B-T067
of	O	O	O
tRNA	O	O	B-T114
precursors	O	O	I-T114
from	O	O	O
the	O	O	O
nucleus	O	O	B-T026
and	O	O	O
essential	O	O	O
for	O	O	O
tRNA	O	O	B-T045
charging	O	O	I-T045
with	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
.	O	O	O

Data	O	O	B-T078
presented	O	O	O
here	O	O	O
indicate	O	O	O
that	O	O	O
CCA-addition	O	O	B-T045
to	O	O	I-T045
intron	O	O	B-T114
-containing	O	O	I-T045
end-processed	O	O	I-T045
tRNA	O	O	I-T045
precursors	O	O	I-T045
is	O	O	O
a	O	O	O
limiting	O	O	B-T077
step	O	O	I-T077
in	O	O	O
tRNA	O	O	B-T045
maturation	O	O	I-T045
when	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
Maf1	O	O	B-T028
mediated	O	O	O
RNA	O	O	B-T116
polymerase	O	O	I-T116
III	O	O	I-T116
(	O	O	O
Pol	O	O	B-T116
III	O	O	I-T116
)	O	O	O
repression	O	O	B-T045
.	O	O	O

The	O	O	O
correlation	O	O	B-T080
between	O	O	O
CCA	O	O	B-T086
synthesis	O	O	B-T044
and	O	O	O
Pol	O	O	B-T116
III	O	O	I-T116
regulation	O	O	B-T038
by	O	O	O
Maf1	O	O	B-T028
could	O	O	O
be	O	O	O
important	O	O	O
in	O	O	O
coordination	O	O	B-T169
of	O	O	O
tRNA	O	O	B-T045
transcription	O	O	I-T045
,	O	O	O
processing	O	O	B-T045
and	O	O	O
regulation	O	O	B-T043
of	O	O	I-T043
translation	O	O	I-T043
.	O	O	O

-DOCSTART- (27575503)

Pre-existing	O	O	B-T080
renal	O	O	B-T023
lesions	O	O	B-T033
revealed	O	O	O
after	O	O	O
renal	O	O	O
trauma	O	O	B-T037
,	O	O	O
Difficulties	O	O	O
in	O	O	O
diagnosis	O	O	B-T062
and	O	O	O
accountability	O	O	B-T078
:	O	O	O
About	O	O	O
14	O	O	O
cases	O	O	O

Pre-existing	O	O	B-T080
renal	O	O	B-T023
lesions	O	O	B-T033
(	O	O	O
PERL	O	O	B-T033
)	O	O	O
may	O	O	O
interfere	O	O	O
with	O	O	O
the	O	O	O
patho-physiology	O	O	B-T169
of	O	O	O
trauma	O	O	B-T037
,	O	O	O
alter	O	O	O
the	O	O	O
radiographic	O	O	B-T060
imaging	O	O	I-T060
and	O	O	O
influence	O	O	B-T077
the	O	O	O
therapeutic	O	O	B-T061
approach	O	O	O
.	O	O	O

The	O	O	O
aims	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
were	O	O	O
to	O	O	O
record	O	O	O
the	O	O	O
PERL	O	O	B-T033
found	O	O	O
incidentally	O	O	O
during	O	O	O
blunt	O	O	B-T080
renal	O	O	B-T023
trauma	O	O	B-T037
,	O	O	O
to	O	O	O
specify	O	O	O
the	O	O	O
place	O	O	O
for	O	O	O
effective	O	O	O
conservative	O	O	B-T061
management	O	O	I-T061
and	O	O	O
to	O	O	O
determin	O	O	O
the	O	O	O
estimated	O	O	O
partial	O	O	B-T033
permanent	O	O	I-T033
disability	O	O	I-T033
(	O	O	O
PPD	O	O	B-T033
)	O	O	O
.	O	O	O

The	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
of	O	O	O
14	O	O	O
patients	O	O	B-T101
with	O	O	O
PERL	O	O	B-T033
and	O	O	O
blunt	O	O	B-T080
renal	O	O	B-T023
trauma	O	O	B-T037
were	O	O	O
reviewed	O	O	O
.	O	O	O

In	O	O	O
each	O	O	O
patient	O	O	B-T101
,	O	O	O
pre-existing	O	O	B-T080
renal	O	O	B-T023
abnormalities	O	O	O
,	O	O	O
clinical	O	O	B-T080
symptoms	O	O	B-T184
,	O	O	O
CT	O	O	B-T060
scan	O	O	I-T060
study	O	O	B-T062
findings	O	O	B-T033
,	O	O	O
associated	O	O	O
injuries	O	O	B-T037
,	O	O	O
therapeutic	O	O	B-T061
approach	O	O	O
,	O	O	O
the	O	O	O
accountability	O	O	B-T078
criteria	O	O	O
and	O	O	O
the	O	O	O
estimated	O	O	O
PPD	O	O	B-T033
were	O	O	O
recorded	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
11	O	O	O
men	O	O	B-T098
and	O	O	O
3	O	O	O
women	O	O	B-T098
with	O	O	O
a	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
of	O	O	O
35,6	O	O	O
years	O	O	B-T079
(	O	O	O
range	O	O	O
19	O	O	O
-	O	O	O
66	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

Renal	O	O	B-T023
trauma	O	O	B-T037
was	O	O	O
due	O	O	O
to	O	O	O
a	O	O	O
traffic	O	O	B-T037
accident	O	O	I-T037
in	O	O	O
8	O	O	O
patients	O	O	B-T101
.	O	O	O

Renal	O	O	B-T023
damage	O	O	O
appeared	O	O	O
to	O	O	O
be	O	O	O
disproportionate	O	O	O
to	O	O	O
the	O	O	O
severity	O	O	B-T080
of	O	O	O
the	O	O	O
trauma	O	O	B-T037
(	O	O	O
minor	O	O	O
trauma	O	O	O
)	O	O	O
.	O	O	O

They	O	O	O
had	O	O	O
a	O	O	O
lower	O	O	O
rate	O	O	O
of	O	O	O
associated	O	O	O
trauma	O	O	B-T037
to	O	O	O
other	O	O	O
abdominal	O	O	B-T023
organs	O	O	I-T023
(	O	O	O
four	O	O	O
patients	O	O	B-T101
only	O	O	O
)	O	O	O
.	O	O	O

Urinary	O	O	B-T031
stones	O	O	I-T031
were	O	O	O
present	O	O	O
in	O	O	O
5	O	O	O
patients	O	O	B-T101
,	O	O	O
pelvi-ureteric	O	O	B-T046
junction	O	O	I-T046
obstruction	O	O	I-T046
in	O	O	O
3	O	O	O
,	O	O	O
horseshoe	O	O	B-T019
kidny	O	O	I-T019
in	O	O	O
3	O	O	O
,	O	O	O
ectopic	O	O	B-T019
kidney	O	O	I-T019
in	O	O	O
2	O	O	O
and	O	O	O
upper	O	O	O
urinary	O	O	B-T191
tract	O	O	I-T191
carcinoma	O	O	I-T191
in	O	O	O
one	O	O	O
case	O	O	O
.	O	O	O

Early	O	O	O
nephrectomy	O	O	B-T061
was	O	O	O
required	O	O	O
in	O	O	O
three	O	O	O
cases	O	O	B-T077
for	O	O	O
hemodynamic	O	O	B-T047
instability	O	O	I-T047
.	O	O	O

Ureteral	O	O	B-T074
stenting	O	O	I-T074
was	O	O	O
indicated	O	O	O
in	O	O	O
3	O	O	O
cases	O	O	B-T077
.	O	O	O

Six	O	O	O
patients	O	O	B-T101
were	O	O	O
operated	O	O	B-T061
later	O	O	O
because	O	O	O
of	O	O	O
their	O	O	O
underlying	O	O	O
renal	O	O	B-T023
pathology	O	O	B-T059
.	O	O	O

A	O	O	O
conservative	O	O	B-T061
treatment	O	O	I-T061
was	O	O	O
possible	O	O	O
only	O	O	O
in	O	O	O
7	O	O	O
of	O	O	O
cases	O	O	B-T077
.	O	O	O

The	O	O	O
PPD	O	O	B-T033
related	O	O	O
to	O	O	O
renal	O	O	B-T023
trauma	O	O	B-T037
varide	O	O	O
from	O	O	O
0	O	O	O
to	O	O	O
13	O	O	O
%	O	O	O
in	O	O	O
all	O	O	O
cases	O	O	B-T077
.	O	O	O

PERL	O	O	B-T033
may	O	O	O
complicate	O	O	O
a	O	O	O
negligible	O	O	O
renal	O	O	B-T023
trauma	O	O	B-T037
while	O	O	O
in	O	O	O
some	O	O	O
cases	O	O	B-T077
they	O	O	O
may	O	O	O
be	O	O	O
of	O	O	O
vital	O	O	O
importance	O	O	O
for	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
final	O	O	O
outcome	O	O	O
.	O	O	O

The	O	O	O
imaging	O	O	O
findings	O	O	B-T033
are	O	O	O
crucial	O	O	O
but	O	O	O
may	O	O	O
be	O	O	O
confusing	O	O	O
.	O	O	O

The	O	O	O
therapeutic	O	O	B-T061
approach	O	O	O
is	O	O	O
,	O	O	O
to	O	O	O
a	O	O	O
large	O	O	O
extent	O	O	O
,	O	O	O
dependent	O	O	O
on	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
PERL	O	O	B-T033
and	O	O	O
the	O	O	O
severity	O	O	B-T080
of	O	O	O
damage	O	O	B-T169
,	O	O	O
and	O	O	O
is	O	O	O
often	O	O	O
conservative	O	O	O
in	O	O	O
the	O	O	O
hemo-dynamically	O	O	B-T033
stable	O	O	I-T033
patient	O	O	B-T101
.	O	O	O

Accountability	O	O	B-T078
link	O	O	O
may	O	O	O
be	O	O	O
difficult	O	O	O
to	O	O	O
establish	O	O	O
and	O	O	O
the	O	O	O
PPD	O	O	B-T033
depends	O	O	O
on	O	O	O
the	O	O	O
PERL	O	O	B-T033
and	O	O	O
the	O	O	O
renal	O	O	B-T037
injuries	O	O	I-T037
severity	O	O	B-T080
.	O	O	O

We	O	O	O
have	O	O	O
no	O	O	O
involvement	O	O	O
with	O	O	O
funding	O	O	O
in	O	O	O
this	O	O	O
case	O	O	O
.	O	O	O

Ethical	O	O	O
approval	O	O	O
:	O	O	O
Not	O	O	O
required	O	O	O
Conflicts	O	O	O
of	O	O	O
interest	O	O	O
:	O	O	O
None	O	O	O
.	O	O	O

-DOCSTART- (27576084)

Polymeric	O	O	B-T122
Nanostructure	O	O	B-T073
Compiled	O	O	O
with	O	O	O
Multifunctional	O	O	B-T077
Components	O	O	I-T077
To	O	O	O
Exert	O	O	O
Tumor	O	O	B-T191
-	O	O	O
Targeted	O	O	B-T063
Delivery	O	O	I-T063
of	O	O	O
Antiangiogenic	O	O	B-T039
Gene	O	O	B-T028
for	O	O	O
Tumor	O	O	B-T191
Growth	O	O	I-T191
Suppression	O	O	O

Nucleic	O	O	B-T114
acid-based	O	O	I-T114
therapy	O	O	B-T061
has	O	O	O
emerged	O	O	O
as	O	O	O
a	O	O	O
revolutionary	O	O	B-T078
methodology	O	O	I-T078
for	O	O	O
treatment	O	O	B-T169
of	O	O	O
the	O	O	O
diseases	O	O	B-T047
related	O	O	O
to	O	O	O
protein	O	O	B-T116
dysfunction	O	O	B-T077
;	O	O	O
however	O	O	O
,	O	O	O
lack	O	O	B-T080
of	O	O	I-T080
systemically	O	O	B-T169
applicable	O	O	B-T080
synthetic	O	O	B-T063
delivery	O	O	I-T063
systems	O	O	I-T063
limits	O	O	O
its	O	O	O
current	O	O	O
usage	O	O	O
in	O	O	O
local	O	O	B-T046
applications	O	O	I-T046
,	O	O	O
particularly	O	O	O
for	O	O	O
DNA-based	O	O	B-T114
therapy	O	O	O
with	O	O	O
regard	O	O	O
to	O	O	O
the	O	O	O
poor	O	O	B-T081
bioavailability	O	O	I-T081
in	O	O	O
the	O	O	O
systemic	O	O	B-UnknownType
administrations	O	O	I-UnknownType
.	O	O	O

To	O	O	O
overcome	O	O	O
this	O	O	O
obstacle	O	O	O
,	O	O	O
we	O	O	O
compiled	O	O	O
multiple	O	O	B-T081
chemistry-based	O	O	B-T059
strategies	O	O	I-T059
into	O	O	O
the	O	O	O
manufacture	O	O	B-T057
of	O	O	O
the	O	O	O
gene	O	O	B-T063
delivery	O	O	I-T063
formulations	O	O	I-T063
to	O	O	O
pursue	O	O	O
improved	O	O	B-T033
tolerability	O	O	B-T080
of	O	O	O
DNA	O	O	B-T114
to	O	O	O
the	O	O	O
enzymatic	O	O	B-T044
degradation	O	O	B-T044
in	O	O	O
the	O	O	O
biological	O	O	B-T080
milieu	O	O	B-T082
and	O	O	O
prolonged	O	O	B-T043
retention	O	O	I-T043
in	O	O	O
the	O	O	O
systemic	O	O	O
circulation	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
constructed	O	O	O
a	O	O	O
distinctive	O	O	B-T080
multilayered	O	O	I-T080
functional	O	O	B-T169
architecture	O	O	B-T082
:	O	O	O
plasmid	O	O	B-T114
DNA	O	O	I-T114
(	O	O	O
pDNA	O	O	B-T114
)	O	O	O
was	O	O	O
electrostatically	O	O	B-T067
complexed	O	O	I-T067
with	O	O	O
cationic	O	O	B-T104
poly(lysine	O	O	B-T116
)	O	O	I-T116
(	O	O	O
polyplex	O	O	B-T122
)	O	O	O
as	O	O	O
the	O	O	O
interior	O	O	B-T082
pDNA	O	O	O
reservoir	O	O	B-T082
,	O	O	O
which	O	O	O
was	O	O	O
further	O	O	O
cross-linked	O	O	B-T070
by	O	O	O
redox	O	O	B-T044
-	O	O	O
responsive	O	O	B-T169
disulfide	O	O	B-T104
cross-linking	O	O	B-T169
to	O	O	O
minimize	O	O	O
the	O	O	O
occurrence	O	O	B-T079
of	O	O	O
polyplex	O	O	O
disassembly	O	O	B-T052
through	O	O	O
exchange	O	O	B-T044
reaction	O	O	I-T044
with	O	O	O
the	O	O	O
biological	O	O	B-T080
charged	O	O	B-T196
components	O	O	I-T196
.	O	O	O

Still	O	O	O
,	O	O	O
the	O	O	O
pDNA	O	O	B-T114
reservoir	O	O	B-T082
was	O	O	O
spatially	O	O	O
protected	O	O	O
by	O	O	O
a	O	O	O
sequential	O	O	B-T080
thermoresponsive	O	O	B-T169
poly(N-isopropylacrylamide	O	O	B-T109
)	O	O	I-T109
palisade	O	O	B-T033
as	O	O	O
the	O	O	O
intermediate	O	O	B-T033
barrier	O	O	I-T033
and	O	O	O
a	O	O	O
biocompatible	O	O	B-T122
hydrophilic	O	O	B-T080
poly(ethylene	O	O	B-T109
glycol	O	O	I-T109
)	O	O	I-T109
(	O	O	O
PEG	O	O	B-T109
)	O	O	O
shell	O	O	B-T080
with	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
preventing	O	O	O
the	O	O	O
accessibility	O	O	B-T080
of	O	O	O
the	O	O	O
biological	O	O	B-T080
species	O	O	B-T185
,	O	O	O
particularly	O	O	O
the	O	O	O
nuclease	O	O	B-T116
degradation	O	O	B-T169
to	O	O	O
the	O	O	O
pDNA	O	O	O
payload	O	O	O
.	O	O	O

Subsequent	O	O	O
investigations	O	O	B-T058
validated	O	O	O
the	O	O	O
utilities	O	O	O
of	O	O	O
these	O	O	O
strategies	O	O	B-T041
in	O	O	O
accomplishing	O	O	O
prolonged	O	O	O
blood	O	O	B-T031
retention	O	O	B-T046
.	O	O	O

In	O	O	O
an	O	O	O
attempt	O	O	O
to	O	O	O
apply	O	O	O
this	O	O	O
method	O	O	B-T170
for	O	O	O
tumor	O	O	B-T191
therapy	O	O	B-T061
,	O	O	O
ligand	O	O	B-T116
cyclic	O	O	I-T116
(	O	O	I-T116
Arg-Gly-Asp	O	O	I-T116
)	O	O	I-T116
peptide	O	O	I-T116
was	O	O	O
attached	O	O	O
at	O	O	O
the	O	O	O
distal	O	O	O
end	O	O	O
of	O	O	O
PEG	O	O	B-T109
,	O	O	O
validating	O	O	O
prompted	O	O	O
tumor	O	O	O
-	O	O	O
targeted	O	O	B-T169
delivery	O	O	B-T077
and	O	O	O
gene	O	O	B-T028
expression	O	O	I-T045
of	O	O	O
the	O	O	O
loaded	O	O	O
antiangiogenic	O	O	B-T039
gene	O	O	O
at	O	O	O
the	O	O	O
targeted	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
accordingly	O	O	O
exerting	O	O	B-T040
antiangiogenesis	O	O	B-T039
of	O	O	O
the	O	O	O
tumors	O	O	B-T191
for	O	O	O
abrogation	O	O	B-T079
of	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
.	O	O	O

Together	O	O	O
with	O	O	O
its	O	O	O
excellent	O	O	O
safe	O	O	O
profile	O	O	O
,	O	O	O
the	O	O	O
proposed	O	O	O
formulation	O	O	O
suggests	O	O	O
potential	O	O	B-T080
utility	O	O	O
as	O	O	O
a	O	O	O
practical	O	O	O
gene	O	O	B-T063
delivery	O	O	I-T063
system	O	O	I-T063
for	O	O	O
treatment	O	O	B-T169
of	O	O	O
intractable	O	O	B-T169
diseases	O	O	B-T047
.	O	O	O

-DOCSTART- (27578508)

Evaluation	O	O	B-T058
of	O	O	O
the	O	O	O
VIDAS	O	O	B-T059
Anti-HCV	O	O	I-T059
Assay	O	O	I-T059
for	O	O	O
Detection	O	O	B-T061
of	O	O	O
Hepatitis	O	O	O
C	O	O	O
Virus	O	O	O
Infection	O	O	O

Anti-hepatitis	O	O	B-T116
C	O	O	I-T116
virus	O	O	I-T116
antibody	O	O	I-T116
(	O	O	O
anti-HCV	O	O	B-T116
)	O	O	O
assays	O	O	B-T059
are	O	O	O
recommended	O	O	O
for	O	O	O
screening	O	O	B-T058
HCV	O	O	B-T098
-infected	O	O	I-T098
persons	O	O	I-T098
.	O	O	O

The	O	O	O
VIDAS	O	O	B-T059
Anti-HCV	O	O	I-T059
Assay	O	O	I-T059
(	O	O	O
bioMérieux	O	O	O
,	O	O	O
France	O	O	B-T083
)	O	O	O
,	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
enzyme-linked	O	O	B-T059
fluorescence	O	O	I-T059
test	O	O	I-T059
principle	O	O	B-T078
,	O	O	O
was	O	O	O
recently	O	O	O
introduced	O	O	O
in	O	O	O
Korea	O	O	B-T083
.	O	O	O

We	O	O	O
evaluated	O	O	O
the	O	O	O
clinical	O	O	B-T080
performance	O	O	B-T052
of	O	O	O
the	O	O	O
VIDAS	O	O	B-T059
assay	O	O	I-T059
.	O	O	O

One	O	O	O
hundred	O	O	O
HCV-positive	O	O	B-T034
and	O	O	O
1,002	O	O	O
HCV-negative	O	O	B-T034
blood	O	O	B-T031
samples	O	O	I-T031
confirmed	O	O	O
by	O	O	O
Architect	O	O	B-T059
anti-HCV	O	O	I-T059
(	O	O	O
Abbott	O	O	B-T093
Laboratories	O	O	I-T093
,	O	O	O
USA	O	O	B-T083
)	O	O	O
and	O	O	O
COBAS	O	O	B-T063
TaqMan	O	O	I-T063
HCV	O	O	I-T063
real-time	O	O	I-T063
PCR	O	O	I-T063
(	O	O	O
Roche	O	O	B-T092
Diagnostics	O	O	I-T092
,	O	O	O
USA	O	O	O
)	O	O	O
or	O	O	O
the	O	O	O
Procleix	O	O	B-T059
Ultrio	O	O	I-T059
Plus	O	O	I-T059
Assay	O	O	I-T059
(	O	O	O
Gen-Probe	O	O	O
Incorporated	O	O	O
,	O	O	O
USA	O	O	O
)	O	O	O
were	O	O	O
obtained	O	O	O
from	O	O	O
the	O	O	O
Human	O	O	B-T093
Serum	O	O	I-T093
Bank	O	O	I-T093
(	O	O	O
HSB	O	O	B-T093
)	O	O	O
and	O	O	O
tested	O	O	O
by	O	O	O
VIDAS	O	O	B-T059
.	O	O	O

In	O	O	O
case	O	O	O
of	O	O	O
discrepant	O	O	B-T033
results	O	O	I-T033
,	O	O	O
we	O	O	O
conducted	O	O	O
a	O	O	O
recombinant	O	O	B-T059
immunoblot	O	O	I-T059
assay	O	O	I-T059
(	O	O	O
RIBA	O	O	B-T059
)	O	O	O
.	O	O	O

The	O	O	O
agreement	O	O	B-T081
rates	O	O	I-T081
for	O	O	O
known	O	O	O
HCV-positive	O	O	B-T034
and	O	O	O
HCV-negative	O	O	B-T034
samples	O	O	B-T031
between	O	O	O
the	O	O	O
VIDAS	O	O	B-T059
assay	O	O	I-T059
and	O	O	O
the	O	O	O
HSB	O	O	B-T093
testing	O	O	O
were	O	O	O
100	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
:	O	O	O
96.4	O	O	O
-	O	O	O
100	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
99.5	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
98.8	O	O	O
-	O	O	O
99.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
five	O	O	O
discrepant	O	O	B-T033
samples	O	O	B-T031
was	O	O	O
positive	O	O	B-T033
for	O	O	O
Core	O	O	B-T129
2	O	O	I-T129
+	O	O	I-T129
and	O	O	O
NS3	O	O	B-T129
-	O	O	I-T129
2	O	O	I-T129
2	O	O	I-T129
+	O	O	I-T129
reactivity	O	O	O
,	O	O	O
two	O	O	O
samples	O	O	O
were	O	O	O
negative	O	O	B-T033
,	O	O	O
and	O	O	O
the	O	O	O
other	O	O	O
two	O	O	O
were	O	O	O
indeterminate	O	O	O
regarding	O	O	O
NS4	O	O	B-T129
2	O	O	I-T129
+	O	O	I-T129
reactivity	O	O	O
in	O	O	O
RIBA	O	O	B-T059
.	O	O	O

We	O	O	O
observed	O	O	O
a	O	O	O
significant	O	O	O
but	O	O	O
weak	O	O	O
positive	O	O	O
correlation	O	O	B-T080
between	O	O	O
the	O	O	O
titers	O	O	B-T081
of	O	O	O
VIDAS	O	O	B-T059
and	O	O	O
Architect	O	O	B-T059
assays	O	O	I-T059
(	O	O	O
r=0.315	O	O	O
,	O	O	O
P<0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
VIDAS	O	O	B-T059
anti-HCV	O	O	I-T059
assay	O	O	I-T059
,	O	O	O
developed	O	O	O
on	O	O	O
the	O	O	O
VIDAS	O	O	O
automated	O	O	B-T059
immunoassay	O	O	I-T059
platform	O	O	I-T059
based	O	O	O
on	O	O	O
the	O	O	O
ready-to-use	O	O	O
,	O	O	O
single-sample	O	O	O
test	O	O	O
concept	O	O	O
may	O	O	O
be	O	O	O
useful	O	O	O
in	O	O	O
small-to-medium-sized	O	O	O
laboratories	O	O	B-T093
.	O	O	O

It	O	O	O
showed	O	O	O
good	O	O	O
agreement	O	O	O
with	O	O	O
Architect	O	O	B-T059
anti-HCV	O	O	I-T059
and	O	O	O
COBAS	O	O	B-T063
PCR	O	O	I-T063
assays	O	O	I-T063
and	O	O	O
is	O	O	O
therefore	O	O	O
useful	O	O	O
for	O	O	O
detection	O	O	O
of	O	O	O
HCV	O	O	B-T047
infection	O	O	I-T047
.	O	O	O

Weakly	O	O	B-T034
test-positive	O	O	I-T034
(	O	O	I-T034
ambiguous	O	O	I-T034
)	O	O	I-T034
samples	O	O	B-T031
require	O	O	O
additional	O	O	O
testing	O	O	O
by	O	O	O
another	O	O	O
anti-HCV	O	O	B-T116
,	O	O	O
RIBA	O	O	B-T059
,	O	O	O
or	O	O	O
HCV	O	O	B-T059
RNA	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

-DOCSTART- (27581456)

Reassembly	O	O	B-T042
of	O	O	I-T042
Excitable	O	O	I-T042
Domains	O	O	I-T042
after	O	O	O
CNS	O	O	B-T022
Axon	O	O	O
Regeneration	O	O	O

Action	O	O	B-T043
potential	O	O	I-T043
initiation	O	O	I-T043
and	O	O	O
propagation	O	O	B-T043
in	O	O	O
myelinated	O	O	B-UnknownType
axons	O	O	I-UnknownType
require	O	O	O
ion	O	O	B-T043
channel	O	O	I-T043
clustering	O	O	I-T043
at	O	O	O
axon	O	O	B-T026
initial	O	O	I-T026
segments	O	O	I-T026
(	O	O	B-T026
AIS	O	O	I-T026
)	O	O	O
and	O	O	O
nodes	O	O	B-T030
of	O	O	I-T030
Ranvier	O	O	I-T030
.	O	O	O

Disruption	O	O	B-T169
of	O	O	O
these	O	O	O
domains	O	O	O
after	O	O	O
injury	O	O	B-T037
impairs	O	O	B-T169
nervous	O	O	B-T042
system	O	O	I-T042
function	O	O	I-T042
.	O	O	O

Traditionally	O	O	O
,	O	O	O
injured	O	O	B-T169
CNS	O	O	B-T022
axons	O	O	B-T026
are	O	O	O
considered	O	O	O
refractory	O	O	B-T040
to	O	O	O
regeneration	O	O	B-T042
,	O	O	O
but	O	O	O
some	O	O	O
recent	O	O	O
approaches	O	O	O
challenge	O	O	O
this	O	O	O
view	O	O	O
by	O	O	O
showing	O	O	O
robust	O	O	B-T080
long-distance	O	O	B-T081
regeneration	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
whether	O	O	O
these	O	O	O
approaches	O	O	O
allow	O	O	O
remyelination	O	O	B-T042
and	O	O	O
promote	O	O	O
the	O	O	O
reestablishment	O	O	B-T042
of	O	O	O
AIS	O	O	B-T026
and	O	O	O
nodes	O	O	B-T030
of	O	O	I-T030
Ranvier	O	O	I-T030
is	O	O	O
unknown	O	O	B-T080
.	O	O	O

Using	O	O	O
mouse	O	O	B-T015
optic	O	O	B-T023
nerve	O	O	B-T037
crush	O	O	I-T037
as	O	O	O
a	O	O	O
model	O	O	B-T050
for	O	O	O
CNS	O	O	B-T022
traumatic	O	O	B-T037
injury	O	O	I-T037
,	O	O	O
we	O	O	O
performed	O	O	O
a	O	O	O
detailed	O	O	O
analysis	O	O	B-T062
of	O	O	O
AIS	O	O	B-T026
and	O	O	O
node	O	O	B-T030
disruption	O	O	B-T169
after	O	O	O
nerve	O	O	O
crush	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
significant	O	O	O
disruption	O	O	B-T169
of	O	O	O
AIS	O	O	B-T026
and	O	O	O
loss	O	O	B-T081
of	O	O	O
nodes	O	O	B-T030
within	O	O	O
days	O	O	O
of	O	O	O
the	O	O	O
crush	O	O	B-T037
,	O	O	O
and	O	O	O
complete	O	O	O
loss	O	O	O
of	O	O	O
nodes	O	O	O
1	O	O	O
week	O	O	O
after	O	O	O
injury	O	O	B-T037
.	O	O	O

Genetic	O	O	B-T045
deletion	O	O	I-T045
of	O	O	O
the	O	O	O
tumor	O	O	B-T028
suppressor	O	O	I-T028
phosphatase	O	O	I-T028
and	O	O	I-T028
tensin	O	O	I-T028
homolog	O	O	I-T028
(	O	O	O
Pten	O	O	B-T028
)	O	O	O
in	O	O	O
retinal	O	O	B-T025
ganglion	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
RGCs	O	O	B-T025
)	O	O	O
,	O	O	O
coupled	O	O	O
with	O	O	O
stimulation	O	O	B-T043
of	O	O	O
RGCs	O	O	O
by	O	O	O
inflammation	O	O	B-T046
and	O	O	O
cAMP	O	O	B-T114
,	O	O	O
dramatically	O	O	O
enhanced	O	O	O
regeneration	O	O	B-T042
.	O	O	O

With	O	O	O
this	O	O	O
treatmen	O	O	B-T062
t	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
significant	O	O	O
reestablishment	O	O	B-T042
of	O	O	O
RGC	O	O	B-T025
AIS	O	O	B-T026
,	O	O	O
remyelination	O	O	B-T042
,	O	O	O
and	O	O	O
even	O	O	O
reassembly	O	O	B-T042
of	O	O	O
nodes	O	O	B-T030
in	O	O	O
regions	O	O	B-T082
proximal	O	O	I-T082
,	O	O	O
within	O	O	B-T082
,	O	O	O
and	O	O	O
distal	O	O	B-T082
to	O	O	O
the	O	O	O
crush	O	O	B-T037
site	O	O	B-T029
.	O	O	O

Remyelination	O	O	B-T042
began	O	O	O
near	O	O	B-T029
the	O	O	I-T029
retina	O	O	I-T029
,	O	O	O
progressed	O	O	B-T169
distally	O	O	B-T082
,	O	O	O
and	O	O	O
was	O	O	O
confirmed	O	O	O
by	O	O	O
electron	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

Although	O	O	O
axons	O	O	B-T026
grew	O	O	B-T043
rapidly	O	O	B-T080
,	O	O	O
remyelination	O	O	B-T042
and	O	O	O
nodal	O	O	B-T043
ion	O	O	I-T043
channel	O	O	I-T043
clustering	O	O	I-T043
was	O	O	O
much	O	O	O
slower	O	O	B-T080
.	O	O	O

Finally	O	O	O
,	O	O	O
genetic	O	O	B-T045
deletion	O	O	I-T045
of	O	O	O
ankyrinG	O	O	B-T116
from	O	O	O
RGCs	O	O	B-T025
to	O	O	O
block	O	O	B-T169
AIS	O	O	B-T026
reassembly	O	O	B-T042
did	O	O	O
not	O	O	O
affect	O	O	O
axon	O	O	B-T042
regeneration	O	O	I-T042
,	O	O	O
indicating	O	O	O
that	O	O	O
preservation	O	O	O
of	O	O	O
neuronal	O	O	B-T082
polarity	O	O	I-T082
is	O	O	O
not	O	O	B-T033
required	O	O	I-T033
for	O	O	O
axon	O	O	O
regeneration	O	O	O
.	O	O	O

Together	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
demonstrate	O	O	O
,	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
,	O	O	O
that	O	O	O
regenerating	O	O	B-T042
CNS	O	O	B-T022
axons	O	O	B-T026
can	O	O	O
be	O	O	O
remyelinated	O	O	B-T042
and	O	O	O
reassemble	O	O	B-T042
new	O	O	O
AIS	O	O	B-T026
and	O	O	O
nodes	O	O	B-T030
of	O	O	I-T030
Ranvier	O	O	I-T030
.	O	O	O

We	O	O	O
show	O	O	O
,	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
,	O	O	O
that	O	O	O
regenerated	O	O	B-T042
CNS	O	O	B-T022
axons	O	O	B-T026
have	O	O	O
the	O	O	O
capacity	O	O	B-T081
to	O	O	O
both	O	O	O
remyelinate	O	O	B-T042
and	O	O	O
reassemble	O	O	B-T042
the	O	O	O
axon	O	O	B-T026
initial	O	O	I-T026
segments	O	O	I-T026
and	O	O	O
nodes	O	O	B-T030
of	O	O	I-T030
Ranvier	O	O	I-T030
necessary	O	O	O
for	O	O	O
rapid	O	O	B-T080
and	O	O	O
efficient	O	O	B-T080
action	O	O	B-T043
potential	O	O	I-T043
propagation	O	O	I-T043
.	O	O	O

-DOCSTART- (27588139)

Clinicopathological	O	O	B-T091
relevance	O	O	O
of	O	O	O
kinesin	O	O	B-T116
family	O	O	I-T116
member	O	O	I-T116
18A	O	O	I-T116
expression	O	O	B-T045
in	O	O	O
invasive	O	O	O
breast	O	O	O
cancer	O	O	O

Recently	O	O	O
,	O	O	O
kinesin	O	O	B-T116
motor	O	O	B-T116
proteins	O	O	I-T116
have	O	O	O
been	O	O	O
focused	O	O	O
on	O	O	O
as	O	O	O
targets	O	O	B-T169
for	O	O	O
cancer	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

Kinesins	O	O	B-T116
are	O	O	O
microtubule	O	O	B-T116
-based	O	O	O
motor	O	O	B-T116
proteins	O	O	I-T116
that	O	O	O
mediate	O	O	O
diverse	O	O	B-T169
functions	O	O	I-T169
within	O	O	O
the	O	O	O
cell	O	O	B-T025
,	O	O	O
including	O	O	O
the	O	O	O
transport	O	O	B-T043
of	O	O	O
vesicles	O	O	B-T026
,	O	O	O
organelles	O	O	B-T026
,	O	O	O
chromosomes	O	O	B-T026
and	O	O	O
protein	O	O	B-T116
complexes	O	O	I-T116
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
movement	O	O	B-T043
of	O	O	I-T043
microtubules	O	O	I-T043
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	O
study	O	O	O
,	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
kinesin	O	O	B-T116
family	O	O	I-T116
member	O	O	I-T116
18A	O	O	I-T116
(	O	O	O
KIF18A	O	O	B-T116
)	O	O	O
,	O	O	O
a	O	O	O
member	O	O	B-T116
of	O	O	I-T116
kinesin	O	O	I-T116
superfamily	O	O	I-T116
,	O	O	O
was	O	O	O
investigated	O	O	B-T169
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
using	O	O	O
immunohistochemistry	O	O	B-T060
,	O	O	O
and	O	O	O
its	O	O	O
effect	O	O	O
on	O	O	O
breast	O	O	O
cancer	O	O	O
prognosis	O	O	O
was	O	O	O
examined	O	O	O
.	O	O	O

KIF18A	O	O	B-T116
expression	O	O	B-T081
level	O	O	I-T081
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
lymph	O	O	B-T191
node	O	O	I-T191
metastasis	O	O	I-T191
(	O	O	O
P=0.047	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
high	O	O	O
levels	O	O	O
of	O	O	O
KIF18A	O	O	B-T116
expression	O	O	B-T045
,	O	O	O
survival	O	O	B-T052
was	O	O	O
significantly	O	O	O
poorer	O	O	O
compared	O	O	O
to	O	O	O
patients	O	O	O
with	O	O	O
low	O	O	O
levels	O	O	O
of	O	O	O
KIF18A	O	O	O
expression	O	O	O
(	O	O	O
disease-free	O	O	B-T081
survival	O	O	I-T081
,	O	O	O
P=0.030	O	O	O
)	O	O	O
.	O	O	O

Multivariate	O	O	B-T081
analysis	O	O	I-T081
revealed	O	O	O
that	O	O	O
venous	O	O	B-T033
invasion	O	O	I-T033
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
9.22	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
,	O	O	O
3.90	O	O	O
-	O	O	O
23.66	O	O	O
;	O	O	O
P<0.001	O	O	O
)	O	O	O
and	O	O	O
KIF18A	O	O	B-T116
expression	O	O	B-T045
(	O	O	O
hazard	O	O	O
ratio	O	O	O
,	O	O	O
3.20	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	O
interval	O	O	O
,	O	O	O
1.34	O	O	O
-	O	O	O
6.09	O	O	O
;	O	O	O
P=0.010	O	O	O
)	O	O	O
were	O	O	O
independent	O	O	O
predictive	O	O	B-T170
factors	O	O	I-T170
for	O	O	O
lymph	O	O	B-T191
node	O	O	I-T191
metastasis	O	O	I-T191
.	O	O	O

KIF18A	O	O	B-T116
may	O	O	O
be	O	O	O
a	O	O	O
useful	O	O	O
predictive	O	O	B-T170
marker	O	O	B-T201
for	O	O	O
lymph	O	O	B-T191
node	O	O	I-T191
metastasis	O	O	I-T191
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
which	O	O	O
could	O	O	O
facilitate	O	O	O
curative	O	O	B-T033
adjuvant	O	O	I-T033
treatment	O	O	B-T061
.	O	O	O

-DOCSTART- (27589009)

The	O	O	O
underlying	O	O	O
inflammatory	O	O	B-T047
chronic	O	O	I-T047
disease	O	O	I-T047
influences	O	O	B-T077
infliximab	O	O	B-T116
pharmacokinetics	O	O	O

Infliximab	O	O	B-T116
is	O	O	O
an	O	O	O
anti-tumor	O	O	B-T121
necrosis	O	O	I-T121
factor	O	O	I-T121
monoclonal	O	O	B-T116
antibody	O	O	I-T116
approved	O	O	O
in	O	O	O
chronic	O	O	B-T047
inflammatory	O	O	I-T047
diseases	O	O	I-T047
such	O	O	O
as	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
(	O	O	O
RA	O	O	B-T047
)	O	O	O
,	O	O	O
psoriatic	O	O	B-T047
arthritis	O	O	I-T047
(	O	O	O
PsA	O	O	B-T047
)	O	O	O
,	O	O	O
ankylosing	O	O	B-T047
spondylitis	O	O	I-T047
(	O	O	O
AS	O	O	B-T047
)	O	O	O
,	O	O	O
Crohn	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CD	O	O	B-T047
)	O	O	O
and	O	O	O
ulcerative	O	O	B-T047
colitis	O	O	I-T047
(	O	O	O
UC	O	O	B-T047
)	O	O	O
.	O	O	O

Infliximab	O	O	B-T116
pharmacokinetics	O	O	B-T169
is	O	O	O
variable	O	O	O
between	O	O	O
patients	O	O	B-T101
,	O	O	O
but	O	O	O
influence	O	O	B-T077
of	O	O	O
the	O	O	O
underlying	O	O	B-T047
disease	O	O	I-T047
was	O	O	O
never	O	O	O
assessed	O	O	B-T052
.	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
at	O	O	O
assessing	O	O	O
this	O	O	O
influence	O	O	B-T077
using	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
patients	O	O	B-T058
monitored	O	O	I-T058
in	O	O	O
a	O	O	O
single	O	O	O
center	O	O	O
and	O	O	O
with	O	O	O
the	O	O	O
same	O	O	O
assay	O	O	B-T059
.	O	O	O

Infliximab	O	O	B-T116
trough	O	O	O
concentrations	O	O	B-T081
were	O	O	O
determined	O	O	B-T080
on	O	O	O
samples	O	O	B-T059
collected	O	O	I-T059
between	O	O	O
weeks	O	O	O
0	O	O	O
and	O	O	O
22	O	O	O
after	O	O	O
treatment	O	O	B-T169
initiation	O	O	B-T169
in	O	O	O
218	O	O	O
patients	O	O	B-T101
treated	O	O	B-T169
for	O	O	O
RA	O	O	B-T047
,	O	O	O
PsA	O	O	B-T047
,	O	O	O
AS	O	O	B-T047
,	O	O	O
CD	O	O	B-T047
or	O	O	O
UC	O	O	B-T047
.	O	O	O

Infliximab	O	O	B-T116
pharmacokinetics	O	O	B-T169
was	O	O	O
analyzed	O	O	B-T062
by	O	O	O
a	O	O	O
one-compartment	O	O	O
population	O	O	B-T098
model	O	O	O
with	O	O	O
first-order	O	O	O
elimination	O	O	B-T033
rate	O	O	B-T081
constant	O	O	I-T081
.	O	O	O

In	O	O	O
AS	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
volume	O	O	B-T081
of	O	O	I-T081
distribution	O	O	I-T081
(	O	O	O
V	O	O	B-T081
)	O	O	O
and	O	O	O
elimination	O	O	B-T033
clearance	O	O	B-T080
(	O	O	O
CL	O	O	B-T080
)	O	O	O
were	O	O	O
5.4	O	O	O
L	O	O	O
and	O	O	O
0.24	O	O	O
L/day	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
CD	O	O	B-T047
and	O	O	O
UC	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
V	O	O	O
was	O	O	O
49	O	O	O
%	O	O	O
and	O	O	O
52	O	O	O
%	O	O	O
higher	O	O	O
than	O	O	O
in	O	O	O
AS	O	O	B-T047
,	O	O	O
respectively	O	O	O
,	O	O	O
and	O	O	O
CL	O	O	B-T080
was	O	O	O
47	O	O	O
%	O	O	O
and	O	O	O
60	O	O	O
%	O	O	O
higher	O	O	O
than	O	O	O
in	O	O	O
AS	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
RA	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
CL	O	O	B-T080
was	O	O	O
49	O	O	O
%	O	O	O
higher	O	O	O
than	O	O	O
in	O	O	O
AS	O	O	B-T047
patients	O	O	O
.	O	O	O

Simulations	O	O	B-T062
showed	O	O	O
that	O	O	O
without	O	O	O
methotrexate	O	O	B-T109
,	O	O	O
a	O	O	O
3	O	O	O
mg/kg	O	O	O
dosing	O	O	B-T081
regimen	O	O	B-T061
would	O	O	O
lead	O	O	O
only	O	O	O
16	O	O	O
%	O	O	O
of	O	O	O
RA	O	O	B-T047
patients	O	O	B-T101
to	O	O	O
reach	O	O	O
the	O	O	O
target	O	O	B-T169
concentration	O	O	B-T081
(	O	O	O
2.5	O	O	O
mg/L	O	O	O
)	O	O	O
at	O	O	O
week	O	O	O
22	O	O	O
,	O	O	O
whereas	O	O	O
target	O	O	O
concentrations	O	O	B-T081
would	O	O	O
be	O	O	O
reached	O	O	O
in	O	O	O
approximately	O	O	B-T080
half	O	O	O
of	O	O	O
RA	O	O	O
patients	O	O	O
cotreated	O	O	B-T169
with	O	O	O
methotrexate	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
half	O	O	O
of	O	O	O
CD	O	O	B-T047
(	O	O	O
3.5	O	O	O
mg/L	O	O	O
)	O	O	O
and	O	O	O
UC	O	O	B-T047
(	O	O	O
3.7	O	O	O
mg/L	O	O	O
)	O	O	O
patients	O	O	O
.	O	O	O

The	O	O	O
suboptimality	O	O	O
of	O	O	O
approved	O	O	O
dosing	O	O	B-T081
regimens	O	O	B-T061
supports	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
dosing	O	O	O
optimization	O	O	B-T052
based	O	O	O
on	O	O	O
concentration	O	O	B-T081
measurements	O	O	I-T081
.	O	O	O

-DOCSTART- (27590021)

International	O	O	B-T078
validation	O	O	B-T062
of	O	O	O
a	O	O	O
urinary	O	O	B-T031
biomarker	O	O	B-T201
panel	O	O	B-T059
for	O	O	O
identification	O	O	O
of	O	O	O
active	O	O	B-T169
lupus	O	O	B-T047
nephritis	O	O	I-T047
in	O	O	O
children	O	O	O

Conventional	O	O	O
markers	O	O	B-T201
of	O	O	O
juvenile-onset	O	O	B-T047
systemic	O	O	I-T047
lupus	O	O	I-T047
erythematosus	O	O	I-T047
(	O	O	O
JSLE	O	O	B-T047
)	O	O	O
disease	O	O	B-T060
activity	O	O	I-T060
fail	O	O	O
to	O	O	O
adequately	O	O	O
identify	O	O	O
lupus	O	O	B-T047
nephritis	O	O	I-T047
(	O	O	O
LN	O	O	B-T047
)	O	O	O
.	O	O	O

While	O	O	O
individual	O	O	O
novel	O	O	B-T080
urine	O	O	B-T031
biomarkers	O	O	B-T201
are	O	O	O
good	O	O	O
at	O	O	O
detecting	O	O	B-T061
LN	O	O	B-T047
flares	O	O	B-T184
,	O	O	O
biomarker	O	O	B-T201
panels	O	O	B-T059
may	O	O	O
improve	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
assess	O	O	B-T052
the	O	O	O
performance	O	O	O
of	O	O	O
a	O	O	O
biomarker	O	O	B-T201
panel	O	O	B-T059
to	O	O	O
identify	O	O	O
active	O	O	B-T169
LN	O	O	B-T047
in	O	O	O
two	O	O	O
international	O	O	B-T078
JSLE	O	O	B-T047
cohorts	O	O	B-T098
.	O	O	O

Novel	O	O	O
urinary	O	O	B-T031
biomarkers	O	O	B-T201
,	O	O	O
namely	O	O	O
vascular	O	O	B-T116
cell	O	O	I-T116
adhesion	O	O	I-T116
molecule-1	O	O	I-T116
(	O	O	O
VCAM-1	O	O	B-T116
)	O	O	O
,	O	O	O
monocyte	O	O	B-T116
chemoattractant	O	O	I-T116
protein	O	O	I-T116
1	O	O	I-T116
(	O	O	O
MCP-1	O	O	B-T116
)	O	O	O
,	O	O	O
lipocalin-like	O	O	B-T116
prostaglandin	O	O	I-T116
D	O	O	I-T116
synthase	O	O	I-T116
(	O	O	O
LPGDS	O	O	B-T116
)	O	O	O
,	O	O	O
transferrin	O	O	B-T116
(	O	O	O
TF	O	O	B-T116
)	O	O	O
,	O	O	O
ceruloplasmin	O	O	B-T116
,	O	O	O
alpha-1-acid	O	O	B-T116
glycoprotein	O	O	I-T116
(	O	O	O
AGP	O	O	B-T116
)	O	O	O
and	O	O	O
neutrophil	O	O	B-T116
gelatinase-associated	O	O	I-T116
lipocalin	O	O	I-T116
(	O	O	O
NGAL	O	O	B-T116
)	O	O	O
,	O	O	O
were	O	O	O
quantified	O	O	B-T081
in	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
that	O	O	O
included	O	O	O
participants	O	O	B-T098
of	O	O	O
the	O	O	O
UK	O	O	B-T083
JSLE	O	O	B-T047
Cohort	O	O	B-T098
Study	O	O	I-T081
(	O	O	O
Cohort	O	O	B-T098
1	O	O	I-T098
)	O	O	O
and	O	O	O
validated	O	O	O
within	O	O	O
the	O	O	O
Einstein	O	O	B-T093
Lupus	O	O	I-T093
Cohort	O	O	O
(	O	O	O
Cohort	O	O	B-T098
2	O	O	I-T098
)	O	O	O
.	O	O	O

Binary	O	O	B-T080
logistic	O	O	B-T062
regression	O	O	I-T062
modelling	O	O	I-T062
and	O	O	O
receiver	O	O	B-T081
operating	O	O	I-T081
characteristic	O	O	I-T081
curve	O	O	B-T081
analysis	O	O	I-T081
[	O	O	O
area	O	O	B-T081
under	O	O	I-T081
the	O	O	I-T081
curve	O	O	I-T081
(	O	O	O
AUC	O	O	B-T081
)	O	O	O
]	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
identify	O	O	O
and	O	O	O
assess	O	O	B-T052
combinations	O	O	B-T080
of	O	O	O
biomarkers	O	O	B-T201
for	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
91	O	O	O
JSLE	O	O	B-T047
patients	O	O	B-T101
were	O	O	O
recruited	O	O	O
across	O	O	O
both	O	O	O
cohorts	O	O	B-T098
,	O	O	O
of	O	O	O
whom	O	O	O
31	O	O	O
(	O	O	O
34	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
active	O	O	B-T169
LN	O	O	B-T047
and	O	O	O
60	O	O	O
(	O	O	O
66	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
no	O	O	O
LN	O	O	O
.	O	O	O

Urinary	O	O	B-T031
AGP	O	O	B-T116
,	O	O	O
ceruloplasmin	O	O	B-T116
,	O	O	O
VCAM-1	O	O	B-T116
,	O	O	O
MCP-1	O	O	B-T116
and	O	O	O
LPGDS	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
in	O	O	O
those	O	O	O
patients	O	O	B-T101
with	O	O	O
active	O	O	B-T169
LN	O	O	B-T047
than	O	O	O
in	O	O	O
non	O	O	B-T169
-	O	O	O
LN	O	O	O
patients	O	O	O
[	O	O	O
all	O	O	O
corrected	O	O	O
p	O	O	O
values	O	O	O
(	O	O	O
p	O	O	O
c	O	O	O
)	O	O	O
<	O	O	O
0.05	O	O	O
]	O	O	O
across	O	O	O
both	O	O	O
cohorts	O	O	B-T098
.	O	O	O

Urinary	O	O	B-T031
TF	O	O	B-T116
also	O	O	O
differed	O	O	O
between	O	O	O
patient	O	O	B-T101
groups	O	O	O
in	O	O	O
Cohort	O	O	B-T098
2	O	O	I-T098
(	O	O	O
p	O	O	O
c	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Within	O	O	O
Cohort	O	O	B-T098
1	O	O	I-T098
,	O	O	O
the	O	O	O
optimal	O	O	B-T080
biomarker	O	O	B-T201
panel	O	O	B-T059
included	O	O	O
AGP	O	O	B-T116
,	O	O	O
ceruloplasmin	O	O	B-T116
,	O	O	O
LPGDS	O	O	B-T116
and	O	O	O
TF	O	O	B-T116
(	O	O	O
AUC	O	O	B-T081
0.920	O	O	O
for	O	O	O
active	O	O	B-T169
LN	O	O	B-T047
identification	O	O	O
)	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
were	O	O	O
validated	O	O	O
in	O	O	O
Cohort	O	O	B-T098
2	O	O	I-T098
,	O	O	O
with	O	O	O
the	O	O	O
same	O	O	O
markers	O	O	B-T201
resulting	O	O	O
in	O	O	O
the	O	O	O
optimal	O	O	B-T080
urine	O	O	B-T031
biomarker	O	O	B-T201
panel	O	O	B-T059
(	O	O	O
AUC	O	O	B-T081
0.991	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
two	O	O	O
international	O	O	B-T078
JSLE	O	O	B-T047
cohorts	O	O	B-T098
,	O	O	O
urinary	O	O	B-T031
AGP	O	O	B-T116
,	O	O	O
ceruloplasmin	O	O	B-T116
,	O	O	O
LPGDS	O	O	B-T116
and	O	O	O
TF	O	O	B-T116
demonstrate	O	O	O
an	O	O	O
'	O	O	O
excellent	O	O	O
'	O	O	O
ability	O	O	O
for	O	O	O
accurately	O	O	O
identifying	O	O	O
active	O	O	B-T169
LN	O	O	B-T047
in	O	O	O
children	O	O	B-T100
.	O	O	O

-DOCSTART- (27593389)

Fine	O	O	O
structure	O	O	O
of	O	O	O
interleukin	O	O	B-T116
18	O	O	I-T116
(	O	O	I-T116
IL-18	O	O	I-T116
)	O	O	I-T116
receptor	O	O	I-T116
-	O	O	O
immunoreactive	O	O	B-T022
neurons	O	O	B-T025
in	O	O	O
the	O	O	O
retrosplenial	O	O	B-T023
cortex	O	O	I-T023
and	O	O	O
its	O	O	O
changes	O	O	O
in	O	O	O
IL18	O	O	B-T028
knockout	O	O	O
mice	O	O	O

Interleukin	O	O	B-T116
18	O	O	I-T116
(	O	O	O
IL-18	O	O	B-T116
)	O	O	O
participates	O	O	O
in	O	O	O
the	O	O	O
inflammatory	O	O	B-T169
immune	O	O	B-T042
response	O	O	I-T042
of	O	O	O
lymphocytes	O	O	B-T025
.	O	O	O

Delay	O	O	B-T079
in	O	O	I-T079
learning	O	O	I-T079
or	O	O	I-T079
memory	O	O	I-T079
are	O	O	O
common	O	O	O
in	O	O	O
the	O	O	O
IL-18	O	O	B-T028
knockout	O	O	B-T015
mouse	O	O	I-T015
.	O	O	O

Many	O	O	O
IL-18	O	O	B-T116
-	O	O	O
immunoreactive	O	O	B-T022
neurons	O	O	B-T025
are	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
retrosplenial	O	O	B-T023
cortex	O	O	I-T023
(	O	O	O
RSC	O	O	B-T023
)	O	O	O
and	O	O	O
the	O	O	O
subiculum	O	O	B-T023
.	O	O	O

These	O	O	O
neurons	O	O	B-T025
also	O	O	O
contain	O	O	O
the	O	O	O
IL-18	O	O	B-T116
receptor	O	O	I-T116
.	O	O	O

We	O	O	O
determined	O	O	O
the	O	O	O
location	O	O	O
and	O	O	O
the	O	O	O
ultrastructure	O	O	B-T078
of	O	O	O
the	O	O	O
IL-18	O	O	B-T028
receptor	O	O	I-T116
-	O	O	O
immunoreactive	O	O	B-T022
neurons	O	O	B-T025
in	O	O	O
the	O	O	O
RSC	O	O	B-T023
and	O	O	O
observed	O	O	O
changes	O	O	O
in	O	O	O
the	O	O	O
IL-18	O	O	O
receptor	O	O	O
-	O	O	O
immunoreactive	O	O	O
neurons	O	O	O
of	O	O	O
the	O	O	O
IL-18	O	O	O
knockout	O	O	B-T015
mouse	O	O	I-T015
.	O	O	O

The	O	O	O
IL-18	O	O	B-T116
receptor	O	O	I-T116
-	O	O	O
immunoreactive	O	O	B-T022
neurons	O	O	B-T025
were	O	O	O
found	O	O	O
specifically	O	O	O
in	O	O	O
layer	O	O	B-T029
V	O	O	I-T029
of	O	O	I-T029
the	O	O	I-T029
granular	O	O	I-T029
RSC	O	O	I-T029
.	O	O	O

They	O	O	O
were	O	O	O
medium-sized	O	O	O
neurons	O	O	B-T025
with	O	O	O
a	O	O	O
light	O	O	O
oval	O	O	B-T026
nucleus	O	O	I-T026
and	O	O	O
had	O	O	O
little	O	O	O
cytoplasm	O	O	B-T026
with	O	O	O
many	O	O	O
free	O	O	B-T026
ribosomes	O	O	I-T026
,	O	O	O
rough	O	O	O
endoplasmic	O	O	B-T026
reticulum	O	O	I-T026
and	O	O	O
many	O	O	O
mitochondria	O	O	B-T026
,	O	O	O
but	O	O	O
no	O	O	O
Nissl	O	O	B-T026
bodies	O	O	I-T026
.	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
axosomatic	O	O	B-T030
terminals	O	O	I-T030
was	O	O	O
about	O	O	O
six	O	O	O
per	O	O	O
section	O	O	O
.	O	O	O

The	O	O	O
IL-18	O	O	B-T028
receptor	O	O	I-T116
-	O	O	O
immunoreactive	O	O	B-T022
neurons	O	O	B-T025
were	O	O	O
not	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
RSC	O	O	B-T023
in	O	O	O
the	O	O	O
IL-18	O	O	O
knockout	O	O	B-T015
mouse	O	O	I-T015
at	O	O	O
5	O	O	O
or	O	O	O
9	O	O	O
weeks	O	O	O
of	O	O	O
age	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
many	O	O	O
small	O	O	B-T085
electron-dense	O	O	B-T085
neurons	O	O	B-T025
were	O	O	O
found	O	O	O
in	O	O	O
layer	O	O	O
V.	O	O	O
Both	O	O	O
the	O	O	O
nucleus	O	O	B-T026
and	O	O	O
cytoplasm	O	O	B-T026
were	O	O	O
electron-dense	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
necrotic	O	O	O
.	O	O	O

The	O	O	O
mitochondria	O	O	B-T026
and	O	O	O
rough	O	O	B-T026
endoplasmic	O	O	I-T026
reticulum	O	O	I-T026
were	O	O	O
swollen	O	O	B-T033
.	O	O	O

The	O	O	O
IL-18	O	O	B-T116
receptor	O	O	I-T116
-	O	O	O
immunoreactive	O	O	B-T022
neurons	O	O	B-T025
were	O	O	O
presumed	O	O	O
to	O	O	O
be	O	O	O
degenerating	O	O	B-T033
.	O	O	O

The	O	O	O
degeneration	O	O	B-T049
of	O	O	O
the	O	O	O
IL18-receptor	O	O	B-T116
-	O	O	O
immunoreactive	O	O	B-T022
neurons	O	O	B-T025
in	O	O	O
the	O	O	O
RSC	O	O	B-T023
may	O	O	O
cause	O	O	O
the	O	O	O
abnormal	O	O	B-T048
behaviors	O	O	I-T048
of	O	O	O
the	O	O	O
IL-18	O	O	B-T028
knockout	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

-DOCSTART- (27593461)

Exploring	O	O	O
the	O	O	O
genetic	O	O	B-T169
variability	O	O	B-T077
in	O	O	O
water	O	O	B-T121
use	O	O	B-T169
efficiency	O	O	B-T081
:	O	O	O
Evaluation	O	O	O
of	O	O	O
inter	O	O	B-T079
and	O	O	O
intra	O	O	B-T002
cultivar	O	O	I-T002
genetic	O	O	B-T070
diversity	O	O	I-T070
in	O	O	O
grapevines	O	O	O

Genetic	O	O	B-T169
improvement	O	O	B-T077
of	O	O	O
crop	O	O	B-T002
Water	O	O	B-T121
Use	O	O	B-T169
Efficiency	O	O	B-T081
(	O	O	O
WUE	O	O	B-T081
)	O	O	O
is	O	O	O
a	O	O	O
general	O	O	O
goal	O	O	B-T078
because	O	O	O
the	O	O	O
increasing	O	O	B-T169
water	O	O	B-T121
scarcity	O	O	B-T169
and	O	O	O
the	O	O	O
trend	O	O	O
to	O	O	O
a	O	O	O
more	O	O	O
sustainable	O	O	B-T169
agriculture	O	O	B-T090
.	O	O	O

For	O	O	O
grapevines	O	O	B-T002
,	O	O	O
this	O	O	O
subject	O	O	B-T078
is	O	O	O
relevant	O	O	B-T080
and	O	O	O
need	O	O	O
an	O	O	O
urgent	O	O	O
response	O	O	O
because	O	O	O
their	O	O	O
wide	O	O	O
distribution	O	O	B-T169
in	O	O	O
semi-arid	O	O	B-T070
areas	O	O	B-T082
.	O	O	O

New	O	O	O
cultivars	O	O	B-T002
are	O	O	O
difficult	O	O	B-T080
to	O	O	O
introduce	O	O	B-T169
in	O	O	O
viticulture	O	O	B-UnknownType
due	O	O	O
to	O	O	O
the	O	O	O
narrow	O	O	O
dependency	O	O	O
of	O	O	O
consumer	O	O	B-T098
appreciation	O	O	B-T077
often	O	O	O
linked	O	O	O
to	O	O	O
a	O	O	O
certain	O	O	O
particular	O	O	O
wine	O	O	B-T168
taste	O	O	B-T081
.	O	O	O

Clones	O	O	B-T024
of	O	O	O
reputed	O	O	O
cultivars	O	O	B-T002
would	O	O	O
presumably	O	O	O
be	O	O	O
more	O	O	O
accepted	O	O	B-T080
but	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
on	O	O	O
the	O	O	O
intra-cultivar	O	O	B-T002
genetic	O	O	B-T169
variability	O	O	B-T077
of	O	O	O
the	O	O	O
WUE	O	O	B-T081
.	O	O	O

The	O	O	O
present	O	O	O
work	O	O	O
compares	O	O	B-T052
,	O	O	O
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
two	O	O	O
field	O	O	B-T090
assays	O	O	O
,	O	O	O
the	O	O	O
variability	O	O	B-T077
of	O	O	O
intrinsic	O	O	O
water	O	O	B-T121
use	O	O	B-T169
efficiency	O	O	B-T081
(	O	O	O
WUEi	O	O	B-T081
)	O	O	O
in	O	O	O
a	O	O	O
large	O	O	O
collection	O	O	B-T169
of	O	O	O
cultivars	O	O	B-T002
in	O	O	O
contrast	O	O	B-T080
with	O	O	O
a	O	O	O
collection	O	O	O
of	O	O	O
clones	O	O	B-T024
of	O	O	O
Tempranillo	O	O	B-T002
cultivar	O	O	I-T002
.	O	O	O

The	O	O	O
results	O	O	B-T169
show	O	O	O
that	O	O	O
clonal	O	O	B-T080
variability	O	O	B-T077
of	O	O	O
WUEi	O	O	B-T081
was	O	O	O
around	O	O	B-T078
80	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
inter-cultivar	O	O	B-T002
,	O	O	O
thus	O	O	O
providing	O	O	O
a	O	O	O
first	O	O	O
assessment	O	O	B-T052
on	O	O	O
the	O	O	O
opportunity	O	O	O
for	O	O	O
clonal	O	O	O
selection	O	O	B-T052
by	O	O	O
WUE	O	O	B-T081
.	O	O	O

Plotting	O	O	O
the	O	O	O
WUEi	O	O	B-T081
data	O	O	B-T078
against	O	O	O
stem	O	O	B-T002
water	O	O	B-T121
potential	O	O	B-T080
or	O	O	O
stomatal	O	O	B-T039
conductance	O	O	I-T039
it	O	O	O
was	O	O	O
possible	O	O	B-T033
to	O	O	O
identify	O	O	B-T080
cultivars	O	O	B-T002
and	O	O	O
clones	O	O	B-T024
out	O	O	O
of	O	O	O
the	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
of	O	O	O
this	O	O	O
linear	O	O	B-T081
regression	O	O	I-T081
thus	O	O	O
with	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
and	O	O	O
lower	O	O	B-T081
WUEi	O	O	O
values	O	O	B-T081
.	O	O	O

The	O	O	O
present	O	O	O
results	O	O	B-T169
contribute	O	O	B-T052
to	O	O	O
open	O	O	O
the	O	O	O
expectative	O	O	O
for	O	O	O
a	O	O	O
genetic	O	O	B-T169
improvement	O	O	B-T077
of	O	O	O
grapevine	O	O	B-T002
WUE	O	O	B-T081
.	O	O	O

-DOCSTART- (27596934)

Comparison	O	O	O
of	O	O	O
methods	O	O	O
for	O	O	O
isolating	O	O	B-T059
primary	O	O	B-T080
hepatocytes	O	O	B-T025
from	O	O	O
mini	O	O	O
pigs	O	O	O

Successful	O	O	O
porcine	O	O	B-T015
hepatocyte	O	O	B-T025
isolation	O	O	B-T059
is	O	O	O
crucial	O	O	O
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
bioartificial	O	O	B-T074
liver	O	O	I-T074
devices	O	O	I-T074
and	O	O	O
hepatocyte	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

Serva	O	O	B-T116
collagenase	O	O	I-T116
NB	O	O	I-T116
grades	O	O	I-T116
are	O	O	O
formulated	O	O	O
collagenases	O	O	B-T116
that	O	O	O
are	O	O	O
suitable	O	O	O
for	O	O	O
various	O	O	O
tissue	O	O	B-T024
isolation	O	O	B-T059
applications	O	O	O
.	O	O	O

N-acetylcysteine	O	O	B-T116
(	O	O	O
NAC	O	O	B-T116
)	O	O	O
can	O	O	O
improve	O	O	O
the	O	O	O
viability	O	O	B-T080
of	O	O	O
human	O	O	B-T016
hepatocytes	O	O	B-T025
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
compare	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
two	O	O	O
collagenases	O	O	B-T116
and	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
NAC	O	O	B-T116
on	O	O	O
hepatocyte	O	O	B-T025
isolation	O	O	B-T059
from	O	O	O
porcine	O	O	B-T015
liver	O	O	B-T023
tissue	O	O	I-T023
.	O	O	O

Porcine	O	O	B-T015
hepatocytes	O	O	B-T025
were	O	O	O
isolated	O	O	B-T059
using	O	O	O
the	O	O	O
perfusion	O	O	B-T061
method	O	O	I-T061
from	O	O	O
Bama	O	O	O
mini	O	O	B-T015
pigs	O	O	I-T015
assigned	O	O	O
to	O	O	O
the	O	O	O
Serva	O	O	B-T116
NB	O	O	I-T116
4	O	O	I-T116
group	O	O	B-T078
(	O	O	O
n=6	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
Serva	O	O	B-T116
NB	O	O	B-T116
8	O	O	I-T116
group	O	O	O
(	O	O	O
n=6	O	O	O
)	O	O	O
,	O	O	O
or	O	O	O
the	O	O	O
NB	O	O	O
8	O	O	O
+	O	O	O
NAC	O	O	B-T116
group	O	O	O
(	O	O	O
n=6	O	O	O
)	O	O	O
.	O	O	O

Viability	O	O	B-T080
and	O	O	O
yield	O	O	O
were	O	O	O
defined	O	O	O
as	O	O	O
fresh	O	O	O
hepatocytes	O	O	B-T025
and	O	O	O
their	O	O	O
spheroids	O	O	B-T033
formation	O	O	I-T033
after	O	O	O
24-hour	O	O	O
rocker	O	O	B-T059
culture	O	O	I-T059
in	O	O	O
serum-free	O	O	B-T130
medium	O	O	I-T130
.	O	O	O

Metabolic	O	O	B-T040
function	O	O	I-T040
was	O	O	O
assessed	O	O	O
by	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
,	O	O	O
albumin	O	O	B-T116
,	O	O	O
and	O	O	O
urea	O	O	B-T109
synthesis	O	O	B-T038
.	O	O	O

All	O	O	O
procedures	O	O	O
resulted	O	O	O
in	O	O	O
successful	O	O	O
hepatocyte	O	O	B-T025
isolation	O	O	B-T059
.	O	O	O

Cells	O	O	B-T025
from	O	O	O
the	O	O	O
NB	O	O	B-T116
8	O	O	I-T116
+	O	O	O
NAC	O	O	B-T116
group	O	O	B-T078
had	O	O	O
(97.8±1.9)%	O	O	O
viability	O	O	B-T080
,	O	O	O
which	O	O	O
was	O	O	O
higher	O	O	O
than	O	O	O
the	O	O	O
NB	O	O	O
8	O	O	O
group	O	O	O
with	O	O	O
(94.4±2.4)%	O	O	O
and	O	O	O
the	O	O	O
NB	O	O	B-T116
4	O	O	I-T116
group	O	O	O
with	O	O	O
(94.5±3.2)%	O	O	O
(	O	O	O
P<.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
final	O	O	O
cell	O	O	B-T025
yield	O	O	O
reached	O	O	O
(11.8±1.0)	O	O	O
×	O	O	O
10(9	O	O	O
)	O	O	O
cells	O	O	B-T025
in	O	O	O
the	O	O	O
NB	O	O	B-T116
8	O	O	I-T116
+	O	O	O
NAC	O	O	B-T116
group	O	O	B-T078
,	O	O	O
compared	O	O	O
to	O	O	O
(9.5±2.1)	O	O	O
×	O	O	O
10(9	O	O	O
)	O	O	O
cells	O	O	O
in	O	O	O
the	O	O	O
NB	O	O	O
8	O	O	O
group	O	O	O
(	O	O	O
P<.01	O	O	O
)	O	O	O
and	O	O	O
(	O	O	O
9.1±1.1	O	O	O
)	O	O	O
×10(9	O	O	O
)	O	O	O
cells	O	O	O
in	O	O	O
the	O	O	O
NB	O	O	B-T116
4	O	O	I-T116
group	O	O	O
(	O	O	O
P<.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
secretion	O	O	B-T038
of	O	O	O
albumin	O	O	B-T116
was	O	O	O
superior	O	O	O
in	O	O	O
the	O	O	O
NB	O	O	B-T116
8	O	O	I-T116
+	O	O	O
NAC	O	O	B-T116
group	O	O	B-T078
at	O	O	O
a	O	O	O
concentration	O	O	O
of	O	O	O
(	O	O	O
425.8±35.3	O	O	O
)	O	O	O
ng/mL	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
NB	O	O	O
8	O	O	O
group	O	O	O
(	O	O	O
339.1±32.6	O	O	O
)	O	O	O
ng/mL	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
and	O	O	O
NB	O	O	B-T116
4	O	O	I-T116
group	O	O	O
(	O	O	O
293.6±43.3	O	O	O
)	O	O	O
ng/mL	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
injury	O	O	B-T037
of	O	O	O
hepatocytes	O	O	B-T025
also	O	O	O
decreased	O	O	O
in	O	O	O
the	O	O	O
NB	O	O	B-T116
8	O	O	I-T116
+	O	O	O
NAC	O	O	B-T116
group	O	O	B-T078
(	O	O	O
P<.01	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
data	O	O	O
are	O	O	O
presented	O	O	O
as	O	O	O
means	O	O	B-T081
±	O	O	I-T081
SD	O	O	I-T081
.	O	O	O

Formulated	O	O	O
collagenase	O	O	B-T116
Serva	O	O	I-T116
NB	O	O	I-T116
8	O	O	I-T116
and	O	O	O
NAC	O	O	B-T116
could	O	O	O
improve	O	O	O
the	O	O	O
porcine	O	O	B-T015
hepatocyte	O	O	B-T025
isolation	O	O	B-T059
,	O	O	O
resulting	O	O	O
in	O	O	O
higher	O	O	O
yields	O	O	O
of	O	O	O
viable	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (27598472)

Endothermal	O	O	B-T061
venous	O	O	I-T061
ablation	O	O	I-T061
of	O	O	O
the	O	O	O
saphenous	O	O	B-T023
vein	O	O	I-T023
on	O	O	O
patients	O	O	B-T101
who	O	O	O
are	O	O	O
on	O	O	O
anticoagulation	O	O	O
therapy	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
risks	O	O	B-T078
of	O	O	O
bleeding	O	O	B-T046
,	O	O	O
deep	O	O	B-T047
venous	O	O	I-T047
thrombosis	O	O	I-T047
(	O	O	O
DVT	O	O	B-T047
)	O	O	O
,	O	O	O
endovenous	O	O	B-T046
heat	O	O	I-T046
induced	O	O	I-T046
thrombosis	O	O	I-T046
(	O	O	O
EHIT	O	O	B-T046
)	O	O	O
and	O	O	O
failure	O	O	B-T169
of	O	O	O
ablation	O	O	B-T061
on	O	O	O
patients	O	O	B-T101
who	O	O	O
undergo	O	O	O
ablation	O	O	O
while	O	O	O
on	O	O	O
oral	O	O	B-T061
anticoagulation	O	O	I-T061
.	O	O	O

We	O	O	O
compared	O	O	B-T052
378	O	O	O
(	O	O	O
3.4	O	O	O
%	O	O	O
)	O	O	O
out	O	O	O
of	O	O	O
11252	O	O	O
patients	O	O	B-T101
(	O	O	O
group	O	O	B-T185
A	O	O	I-T185
)	O	O	O
who	O	O	O
had	O	O	O
undergone	O	O	O
724	O	O	O
endovenous	O	O	B-T061
ablation	O	O	I-T061
of	O	O	O
the	O	O	O
saphenous	O	O	B-T023
veins	O	O	I-T023
from	O	O	O
January	O	O	O
1	O	O	O
,	O	O	O
2011	O	O	O
to	O	O	O
September	O	O	O
30	O	O	O
,	O	O	O
2014	O	O	O
while	O	O	O
on	O	O	O
oral	O	O	B-T061
anticoagulation	O	O	B-T061
to	O	O	O
a	O	O	O
randomly	O	O	O
selected	O	O	O
375	O	O	O
patients	O	O	O
(	O	O	O
group	O	O	B-T185
B	O	O	I-T185
)	O	O	O
who	O	O	O
underwent	O	O	O
641	O	O	O
endovenous	O	O	O
ablation	O	O	O
in	O	O	O
the	O	O	O
same	O	O	O
time	O	O	B-T079
period	O	O	I-T079
but	O	O	O
were	O	O	O
not	O	O	O
on	O	O	O
anticoagulation	O	O	O
.	O	O	O

The	O	O	O
demographic	O	O	B-T081
data	O	O	I-T081
,	O	O	O
history	O	O	B-T033
of	O	O	I-T033
DVT	O	O	B-T047
,	O	O	O
the	O	O	O
Clinical	O	O	B-T080
,	O	O	O
Etiologic	O	O	B-T080
,	O	O	O
Anatomic	O	O	B-T080
,	O	O	O
Pathologic	O	O	B-T169
(	O	O	O
CEAP	O	O	B-T080
)	O	O	O
classification	O	O	B-T185
and	O	O	O
the	O	O	O
VCSS	O	O	B-T081
(	O	O	O
Venous	O	O	B-T081
Clinical	O	O	I-T081
Severity	O	O	I-T081
Score	O	O	I-T081
)	O	O	O
scores	O	O	O
were	O	O	O
analyzed	O	O	O
.	O	O	O

The	O	O	O
indications	O	O	B-T078
for	O	O	O
anticoagulation	O	O	B-T061
,	O	O	O
the	O	O	O
anticoagulants	O	O	B-T121
used	O	O	O
were	O	O	O
recorded	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	O
endpoints	O	O	O
were	O	O	O
bleeding	O	O	B-T046
,	O	O	O
development	O	O	O
of	O	O	O
DVT	O	O	B-T047
or	O	O	O
EHIT	O	O	B-T046
,	O	O	O
and	O	O	O
failure	O	O	B-T169
of	O	O	O
ablation	O	O	B-T061
.	O	O	O

Patients	O	O	B-T101
in	O	O	O
group	O	O	B-T185
A	O	O	I-T185
were	O	O	O
older	O	O	B-T098
,	O	O	O
had	O	O	O
more	O	O	O
men	O	O	B-T098
,	O	O	O
more	O	O	O
history	O	O	O
of	O	O	O
DVT	O	O	B-T047
and	O	O	O
PE	O	O	B-T047
,	O	O	O
had	O	O	O
higher	O	O	O
CEAP	O	O	B-T080
and	O	O	O
VCSS	O	O	B-T081
scores	O	O	O
compared	O	O	O
to	O	O	O
group	O	O	O
B.	O	O	O
The	O	O	O
type	O	O	O
of	O	O	O
anticoagulation	O	O	B-T061
used	O	O	O
was	O	O	O
warfarin	O	O	B-T109
in	O	O	O
77.2	O	O	O
%	O	O	O
direct	O	O	B-T121
oral	O	O	I-T121
inhibitors	O	O	I-T121
(	O	O	O
DOIs	O	O	B-T121
)	O	O	O
in	O	O	O
22.8	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
rate	O	O	B-T081
of	O	O	O
failure	O	O	B-T169
of	O	O	O
ablation	O	O	B-T061
at	O	O	O
3	O	O	O
days	O	O	B-T079
was	O	O	O
39	O	O	O
(	O	O	O
5.6	O	O	O
%	O	O	O
)	O	O	O
for	O	O	O
Group	O	O	B-T185
A	O	O	I-T185
and	O	O	O
3	O	O	O
(	O	O	O
0.5	O	O	O
%	O	O	O
)	O	O	O
for	O	O	O
Group	O	O	B-T185
B	O	O	I-T185
(	O	O	O
P<0.0001	O	O	O
)	O	O	O
and	O	O	O
at	O	O	O
one	O	O	B-T079
month	O	O	I-T079
it	O	O	O
was	O	O	O
46	O	O	O
(	O	O	O
10.1	O	O	O
%	O	O	O
)	O	O	O
vs.	O	O	O
27	O	O	O
(	O	O	O
6.7	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
P=0.086	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
EHIT	O	O	B-T046
cases	O	O	B-T169
in	O	O	O
group	O	O	B-T185
A	O	O	I-T185
at	O	O	O
3	O	O	O
days	O	O	B-T079
was	O	O	O
2	O	O	O
(	O	O	O
0.3	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
compared	O	O	O
to	O	O	O
6	O	O	O
(	O	O	O
0.9	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
group	O	O	B-T185
B	O	O	I-T185
(	O	O	O
P=0.016	O	O	O
)	O	O	O
and	O	O	O
at	O	O	O
1	O	O	B-T079
month	O	O	I-T079
it	O	O	O
was	O	O	O
0	O	O	O
compared	O	O	O
to	O	O	O
4	O	O	O
(	O	O	O
1.0	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
P=0.0483	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
DVT	O	O	B-T047
,	O	O	O
SVT	O	O	B-T047
,	O	O	O
hematoma	O	O	B-T046
and	O	O	O
wound	O	O	B-T046
infection	O	O	I-T046
rates	O	O	B-T081
were	O	O	O
similar	O	O	O
in	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T078
.	O	O	O

Ablation	O	O	B-T061
of	O	O	O
the	O	O	O
saphenous	O	O	B-T023
veins	O	O	I-T023
in	O	O	O
patients	O	O	B-T101
who	O	O	O
are	O	O	O
on	O	O	O
oral	O	O	B-T061
anticoagulation	O	O	I-T061
is	O	O	O
safe	O	O	O
and	O	O	O
does	O	O	O
not	O	O	O
increase	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
bleeding	O	O	B-T046
or	O	O	O
hematoma	O	O	B-T046
,	O	O	O
but	O	O	O
it	O	O	O
may	O	O	O
slightly	O	O	O
lower	O	O	O
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
EHIT	O	O	B-T046
and	O	O	O
increase	O	O	O
the	O	O	O
incidence	O	O	O
of	O	O	O
failure	O	O	B-T169
of	O	O	O
ablation	O	O	B-T061
.	O	O	O

-DOCSTART- (27599756)

Variation	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
PRIM1	O	O	B-T028
gene	O	O	I-T028
in	O	O	O
Chinese	O	O	B-T098
patients	O	O	B-T101
with	O	O	O
primary	O	O	O
ovarian	O	O	O
insufficiency	O	O	O

Insights	O	O	O
into	O	O	O
common	O	O	O
genetic	O	O	B-T032
susceptibility	O	O	I-T032
between	O	O	O
primary	O	O	B-T047
ovarian	O	O	I-T047
insufficiency	O	O	I-T047
(	O	O	O
POI	O	O	B-T047
)	O	O	O
and	O	O	O
natural	O	O	B-T040
or	O	O	O
early	O	O	B-T047
menopause	O	O	I-T047
have	O	O	O
delivered	O	O	B-T169
an	O	O	O
innovative	O	O	O
way	O	O	O
of	O	O	O
assessing	O	O	O
the	O	O	O
genetic	O	O	B-T169
mechanisms	O	O	I-T169
involved	O	O	O
in	O	O	O
POI	O	O	O
.	O	O	O

PRIM1	O	O	B-T028
plays	O	O	O
a	O	O	O
crucial	O	O	O
role	O	O	O
in	O	O	O
DNA	O	O	B-T045
replication	O	O	I-T045
by	O	O	O
synthesizing	O	O	B-T052
RNA	O	O	B-T114
primers	O	O	I-T114
for	O	O	O
Okazaki	O	O	B-T114
fragments	O	O	I-T114
.	O	O	O

It	O	O	O
is	O	O	O
closely	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
age	O	O	B-T032
at	O	O	O
natural	O	O	B-T040
menopause	O	O	I-T040
,	O	O	O
early	O	O	B-T047
menopause	O	O	I-T047
and	O	O	O
POI	O	O	B-T047
in	O	O	O
European	O	O	B-T098
women	O	O	B-T098
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
mutations	O	O	B-T045
in	O	O	O
PRIM1	O	O	B-T028
contribute	O	O	O
to	O	O	O
POI	O	O	B-T047
in	O	O	O
Chinese	O	O	B-T098
women	O	O	B-T098
.	O	O	O

All	O	O	O
exons	O	O	B-T114
and	O	O	O
exon-intron	O	O	B-T114
boundaries	O	O	I-T114
of	O	O	O
PRIM1	O	O	B-T028
gene	O	O	I-T028
were	O	O	O
sequenced	O	O	B-T059
in	O	O	O
192	O	O	O
Han	O	O	B-UnknownType
Chinese	O	O	I-UnknownType
women	O	O	B-T098
with	O	O	O
non-syndromic	O	O	O
POI	O	O	B-T047
.	O	O	O

No	O	O	O
plausible	O	O	O
mutations	O	O	B-T045
were	O	O	O
identified	O	O	B-T080
.	O	O	O

The	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
perturbations	O	O	B-T169
in	O	O	O
PRIM1	O	O	B-T028
gene	O	O	I-T028
are	O	O	O
not	O	O	O
a	O	O	O
common	O	O	O
explanation	O	O	O
for	O	O	O
POI	O	O	B-T047
in	O	O	O
Chinese	O	O	B-T098
women	O	O	B-T098
.	O	O	O

-DOCSTART- (27602302)

Selection	O	O	B-T052
of	O	O	O
a	O	O	O
marker	O	O	B-T028
gene	O	O	I-T028
to	O	O	O
construct	O	O	O
a	O	O	O
reference	O	O	B-T073
library	O	O	I-T073
for	O	O	O
wetland	O	O	B-T070
plants	O	O	B-T002
,	O	O	O
and	O	O	O
the	O	O	O
application	O	O	O
of	O	O	O
metabarcoding	O	O	B-T062
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
diet	O	O	B-T168
of	O	O	O
wintering	O	O	B-T079
herbivorous	O	O	B-T008
waterbirds	O	O	O

Food	O	O	B-T168
availability	O	O	B-T169
and	O	O	O
diet	O	O	B-T168
selection	O	O	B-T052
are	O	O	O
important	O	O	O
factors	O	O	B-T169
influencing	O	O	B-T077
the	O	O	O
abundance	O	O	B-T080
and	O	O	O
distribution	O	O	B-T169
of	O	O	O
wild	O	O	B-T170
waterbirds	O	O	B-T012
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
better	O	O	O
understand	O	O	O
changes	O	O	B-T169
in	O	O	O
waterbird	O	O	B-T012
population	O	O	B-T081
,	O	O	O
it	O	O	O
is	O	O	O
essential	O	O	O
to	O	O	O
figure	O	O	O
out	O	O	O
what	O	O	O
they	O	O	O
feed	O	O	B-T052
on	O	O	I-T052
.	O	O	O

However	O	O	O
,	O	O	O
analyzing	O	O	B-T062
their	O	O	O
diet	O	O	B-T168
could	O	O	O
be	O	O	O
difficult	O	O	B-T080
and	O	O	O
inefficient	O	O	B-T169
using	O	O	O
traditional	O	O	O
methods	O	O	B-T169
such	O	O	O
as	O	O	O
microhistologic	O	O	B-T059
observation	O	O	I-T059
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
addressed	O	O	O
this	O	O	O
gap	O	O	O
of	O	O	O
knowledge	O	O	O
by	O	O	O
investigating	O	O	O
the	O	O	O
diet	O	O	B-T168
of	O	O	O
greater	O	O	B-T012
white-fronted	O	O	I-T012
goose	O	O	I-T012
Anser	O	O	I-T012
albifrons	O	O	I-T012
and	O	O	O
bean	O	O	B-T012
goose	O	O	I-T012
Anser	O	O	I-T012
fabalis	O	O	I-T012
,	O	O	O
which	O	O	O
are	O	O	O
obligate	O	O	B-T008
herbivores	O	O	I-T008
wintering	O	O	B-T079
in	O	O	O
China	O	O	B-T083
,	O	O	O
mostly	O	O	O
in	O	O	O
the	O	O	O
Middle	O	O	B-T083
and	O	O	O
Lower	O	O	B-T083
Yangtze	O	O	I-T083
River	O	O	I-T083
floodplain	O	O	I-T083
.	O	O	O

First	O	O	O
,	O	O	O
we	O	O	O
selected	O	O	B-T052
a	O	O	O
suitable	O	O	B-T080
and	O	O	O
high-resolution	O	O	O
marker	O	O	B-T028
gene	O	O	I-T028
for	O	O	O
wetland	O	O	B-T070
plants	O	O	B-T002
that	O	O	O
these	O	O	O
geese	O	O	B-T012
would	O	O	O
consume	O	O	O
during	O	O	O
the	O	O	O
wintering	O	O	B-T079
period	O	O	I-T079
.	O	O	O

Eight	O	O	O
candidate	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
included	O	O	O
:	O	O	O
rbcL	O	O	B-T028
,	O	O	O
rpoC1	O	O	B-T028
,	O	O	O
rpoB	O	O	B-T028
,	O	O	O
matK	O	O	B-T028
,	O	O	O
trnH-psbA	O	O	B-T087
,	O	O	O
trnL	O	O	B-T028
(	O	O	O
UAA	O	O	B-T086
)	O	O	O
,	O	O	O
atpF-atpH	O	O	B-T087
,	O	O	O
and	O	O	O
psbK-psbI.	O	O	O
The	O	O	O
selection	O	O	B-T052
was	O	O	O
performed	O	O	O
via	O	O	O
analysis	O	O	B-T062
of	O	O	O
representative	O	O	B-T052
sequences	O	O	B-T086
from	O	O	O
NCBI	O	O	B-T092
and	O	O	O
comparison	O	O	B-T052
of	O	O	O
amplification	O	O	B-T045
efficiency	O	O	B-T081
and	O	O	O
resolution	O	O	O
power	O	O	O
of	O	O	O
plant	O	O	B-T002
samples	O	O	B-T167
collected	O	O	O
from	O	O	O
the	O	O	O
wintering	O	O	B-T083
area	O	O	I-T083
.	O	O	O

The	O	O	O
trnL	O	O	B-T028
gene	O	O	B-T028
was	O	O	O
chosen	O	O	O
at	O	O	O
last	O	O	O
with	O	O	O
c/h	O	O	B-T114
primers	O	O	I-T114
,	O	O	O
and	O	O	O
a	O	O	O
local	O	O	B-T082
plant	O	O	B-T002
reference	O	O	B-T073
library	O	O	I-T073
was	O	O	O
constructed	O	O	B-T185
with	O	O	O
this	O	O	O
gene	O	O	O
.	O	O	O

Then	O	O	O
,	O	O	O
utilizing	O	O	O
DNA	O	O	B-T062
metabarcoding	O	O	I-T062
,	O	O	O
we	O	O	O
discovered	O	O	B-T052
15	O	O	O
food	O	O	B-T168
items	O	O	I-T168
in	O	O	O
total	O	O	O
from	O	O	O
the	O	O	O
feces	O	O	B-T031
of	O	O	O
these	O	O	O
birds	O	O	B-T012
.	O	O	O

Of	O	O	O
the	O	O	O
15	O	O	O
unique	O	O	O
dietary	O	O	B-T168
sequences	O	O	B-T086
,	O	O	O
10	O	O	O
could	O	O	O
be	O	O	O
identified	O	O	O
at	O	O	O
specie	O	O	B-T185
level	O	O	B-T080
.	O	O	O

As	O	O	O
for	O	O	O
greater	O	O	B-T012
white-fronted	O	O	I-T012
goose	O	O	I-T012
,	O	O	O
73	O	O	O
%	O	O	O
of	O	O	O
sequences	O	O	B-T086
belonged	O	O	O
to	O	O	O
Poaceae	O	O	B-T002
spp	O	O	I-T002
.	O	O	I-T002
,	O	O	O
and	O	O	O
26	O	O	O
%	O	O	O
belonged	O	O	O
to	O	O	O
Carex	O	O	B-T002
spp	O	O	I-T002
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
almost	O	O	O
all	O	O	O
sequences	O	O	B-T086
of	O	O	O
bean	O	O	B-T012
goose	O	O	I-T012
belonged	O	O	O
to	O	O	O
Carex	O	O	B-T002
spp	O	O	I-T002
.	O	O	O

(	O	O	O
99	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Using	O	O	O
the	O	O	O
same	O	O	O
samples	O	O	B-T167
,	O	O	O
microhistology	O	O	B-T059
provided	O	O	O
consistent	O	O	B-T078
food	O	O	B-T168
composition	O	O	I-T168
with	O	O	O
metabarcoding	O	O	B-T062
results	O	O	B-T169
for	O	O	O
greater	O	O	B-T012
white-fronted	O	O	I-T012
goose	O	O	I-T012
,	O	O	O
while	O	O	O
13	O	O	O
%	O	O	O
of	O	O	O
Poaceae	O	O	B-T002
was	O	O	O
recovered	O	O	O
for	O	O	O
bean	O	O	B-T012
goose	O	O	I-T012
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
two	O	O	O
other	O	O	O
taxa	O	O	B-T077
were	O	O	O
discovered	O	O	B-T052
only	O	O	O
through	O	O	O
microhistologic	O	O	B-T059
analysis	O	O	I-T059
.	O	O	O

Although	O	O	O
most	O	O	O
of	O	O	O
the	O	O	O
identified	O	O	O
taxa	O	O	B-T077
matched	O	O	B-T080
relatively	O	O	O
well	O	O	O
between	O	O	O
the	O	O	O
two	O	O	O
methods	O	O	B-T169
,	O	O	O
DNA	O	O	B-T062
metabarcoding	O	O	I-T062
gave	O	O	O
taxonomically	O	O	B-T169
more	O	O	O
detailed	O	O	B-T078
information	O	O	I-T078
.	O	O	O

Discrepancies	O	O	B-T033
were	O	O	O
likely	O	O	O
due	O	O	O
to	O	O	O
biased	O	O	B-T078
PCR	O	O	B-T063
amplification	O	O	B-T045
in	O	O	O
metabarcoding	O	O	B-T062
,	O	O	O
low	O	O	O
discriminating	O	O	B-T054
power	O	O	B-T081
of	O	O	O
current	O	O	O
marker	O	O	B-T028
genes	O	O	I-T028
for	O	O	O
monocots	O	O	B-T002
,	O	O	O
and	O	O	O
biases	O	O	B-T078
in	O	O	O
microhistologic	O	O	B-T059
analysis	O	O	I-T059
.	O	O	O

The	O	O	O
diet	O	O	B-T168
differences	O	O	B-T080
between	O	O	O
two	O	O	O
geese	O	O	B-T012
species	O	O	B-T185
might	O	O	O
indicate	O	O	O
deeper	O	O	O
ecological	O	O	B-T070
significance	O	O	B-T078
beyond	O	O	O
the	O	O	O
scope	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

We	O	O	O
concluded	O	O	O
that	O	O	O
DNA	O	O	B-T062
metabarcoding	O	O	I-T062
provides	O	O	O
new	O	O	O
perspectives	O	O	B-T170
for	O	O	O
studies	O	O	B-T062
of	O	O	O
herbivorous	O	O	B-T008
waterbird	O	O	B-T012
diets	O	O	B-T168
and	O	O	O
inter-specific	O	O	B-T169
interactions	O	O	B-T169
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
new	O	O	O
possibilities	O	O	O
to	O	O	O
investigate	O	O	B-T169
interactions	O	O	O
between	O	O	O
herbivores	O	O	B-T008
and	O	O	O
plants	O	O	B-T002
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
microhistologic	O	O	B-T059
analysis	O	O	I-T059
should	O	O	O
be	O	O	O
used	O	O	O
together	O	O	O
with	O	O	O
metabarcoding	O	O	B-T062
methods	O	O	I-T062
to	O	O	O
integrate	O	O	O
this	O	O	O
information	O	O	B-T078
.	O	O	O

-DOCSTART- (27602763)

Expressions	O	O	B-T045
of	O	O	O
CD8	O	O	B-T129
+	O	O	O
TILs	O	O	B-T025
,	O	O	O
PD-L1	O	O	B-T116
and	O	O	O
Foxp3	O	O	B-T116
+	O	O	O
TILs	O	O	O
in	O	O	O
stage	O	O	B-T191
I	O	O	I-T191
NSCLC	O	O	I-T191
guiding	O	O	O
adjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
decisions	O	O	O

Currently	O	O	O
,	O	O	O
adjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
is	O	O	O
recommended	O	O	B-T078
for	O	O	O
patients	O	O	B-T101
with	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
stage	O	O	B-T191
I	O	O	I-T191
non-small	O	O	I-T191
cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
NSCLC	O	O	B-T191
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
identifying	O	O	B-T080
high	O	O	B-T033
risk	O	O	I-T033
patients	O	O	B-T101
remains	O	O	O
a	O	O	O
challenge	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
aims	O	O	B-T078
to	O	O	O
identify	O	O	B-T080
the	O	O	O
patient	O	O	B-T101
cohorts	O	O	B-T098
more	O	O	O
likely	O	O	O
to	O	O	O
benefit	O	O	O
from	O	O	O
adjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
based	O	O	O
on	O	O	O
the	O	O	O
tumor	O	O	B-T191
micro-immune	O	O	B-T169
environment	O	O	B-T082
.	O	O	O

CD8	O	O	B-T129
+	O	O	O
TILs	O	O	B-T025
significantly	O	O	B-T080
associated	O	O	I-T080
with	O	O	I-T080
disease-free	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
DFS	O	O	B-T081
)	O	O	O
and	O	O	O
overall	O	O	B-T081
survial	O	O	I-T081
(	O	O	O
OS	O	O	B-T081
)	O	O	O
(	O	O	O
p=0.002	O	O	O
;	O	O	O
0.040	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
may	O	O	O
also	O	O	O
predict	O	O	O
shorter	O	O	O
DFS	O	O	B-T081
(	O	O	O
P=0.056	O	O	O
)	O	O	O
.	O	O	O

When	O	O	O
compared	O	O	B-T052
together	O	O	O
,	O	O	O
patients	O	O	B-T101
with	O	O	O
high	O	O	B-T080
-	O	O	O
CD8	O	O	B-T129
+	O	O	O
TILs	O	O	B-T025
showed	O	O	O
better	O	O	O
DFS	O	O	B-T081
than	O	O	O
patients	O	O	O
with	O	O	O
low	O	O	B-T080
-	O	O	O
CD8	O	O	O
+	O	O	O
TILs	O	O	O
,	O	O	O
no	O	O	O
matter	O	O	O
their	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
status	O	O	O
.	O	O	O

There	O	O	O
's	O	O	O
no	O	O	B-T033
correlation	O	O	I-T033
between	O	O	O
PD-L1	O	O	B-T116
expressions	O	O	B-T045
and	O	O	O
survival	O	O	B-T169
.	O	O	O

PD-L1	O	O	B-T116
was	O	O	O
highly	O	O	B-T080
expressed	O	O	B-T045
in	O	O	O
men	O	O	B-T098
,	O	O	O
squamous	O	O	B-T080
and	O	O	O
well	O	O	B-T080
differentiated	O	O	I-T080
carcinoma	O	O	B-T191
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
Foxp3	O	O	B-T116
+	O	O	O
TILs	O	O	B-T025
alone	O	O	O
did	O	O	O
n't	O	O	O
show	O	O	O
any	O	O	O
prognostic	O	O	O
effects	O	O	O
,	O	O	O
but	O	O	O
low	O	O	B-T080
-	O	O	O
Foxp3	O	O	O
/	O	O	O
high	O	O	B-T080
-	O	O	O
CD8	O	O	B-T129
+	O	O	O
TILs	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
prolonged	O	O	B-T079
DFS	O	O	B-T081
(	O	O	O
p=0.031	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
126	O	O	O
patients	O	O	B-T101
with	O	O	O
surgically	O	O	B-T080
resected	O	O	I-T080
stage	O	O	B-T191
I	O	O	I-T191
NSCLC	O	O	I-T191
were	O	O	O
included	O	O	B-T169
to	O	O	O
perform	O	O	O
immunohistochemistry	O	O	B-T060
of	O	O	O
CD8	O	O	B-T129
+	O	O	O
tumor	O	O	B-T025
infiltrating	O	O	I-T025
lymphocytes	O	O	I-T025
(	O	O	O
TILs	O	O	B-T025
)	O	O	O
,	O	O	O
programmed	O	O	B-T116
death	O	O	I-T116
ligand-1	O	O	I-T116
(	O	O	O
PD-L1	O	O	B-T116
)	O	O	O
and	O	O	O
forkhead	O	O	B-T116
box	O	O	I-T116
P3	O	O	I-T116
(Foxp3)+	O	O	O
TILs	O	O	O
.	O	O	O

CD8	O	O	B-T129
+	O	O	O
TILs	O	O	B-T025
are	O	O	O
effective	O	O	B-T080
prognostic	O	O	O
predictors	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
surgically	O	O	B-T080
resected	O	O	I-T080
stage	O	O	B-T191
I	O	O	I-T191
NSCLC	O	O	I-T191
showing	O	O	O
low	O	O	O
CD8	O	O	B-T129
+	O	O	O
TILs	O	O	B-T025
could	O	O	O
be	O	O	O
considered	O	O	O
for	O	O	O
adjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
,	O	O	O
even	O	O	O
if	O	O	O
they	O	O	O
have	O	O	O
no	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
features	O	O	O
.	O	O	O

-DOCSTART- (27604681)

Unaffected	O	O	O
twins	O	O	B-T046
discordant	O	O	I-T046
for	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
show	O	O	O
changes	O	O	O
in	O	O	O
anterior	O	O	B-T023
callosal	O	O	I-T023
white	O	O	B-T024
matter	O	O	I-T024
microstructure	O	O	O

The	O	O	O
neurobiological	O	O	B-T091
mechanisms	O	O	B-T169
mediating	O	O	O
an	O	O	O
increased	O	O	O
risk	O	O	B-T078
to	O	O	O
develop	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
remain	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
group	O	O	B-T098
of	O	O	I-T098
individuals	O	O	I-T098
with	O	O	O
a	O	O	O
family	O	O	B-T033
history	O	O	I-T033
of	O	O	O
major	O	O	B-T048
depressive	O	O	I-T048
(	O	O	O
MDD	O	O	B-T048
)	O	O	O
or	O	O	O
bipolar	O	O	B-T048
disorder	O	O	I-T048
(	O	O	O
BD	O	O	B-T048
)	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	O
the	O	O	O
microstructural	O	O	O
properties	O	O	O
of	O	O	O
white	O	O	B-T024
matter	O	O	I-T024
fiber	O	O	B-T023
tracts	O	O	I-T023
,	O	O	O
that	O	O	O
is	O	O	O
,	O	O	O
cingulum	O	O	B-T023
bundle	O	O	I-T023
,	O	O	O
uncinate	O	O	B-T023
fasciculus	O	O	I-T023
,	O	O	O
anterior	O	O	B-T023
limb	O	O	I-T023
of	O	O	I-T023
the	O	O	I-T023
internal	O	O	I-T023
capsule	O	O	I-T023
,	O	O	O
and	O	O	O
corpus	O	O	B-T023
callosum	O	O	I-T023
,	O	O	O
that	O	O	O
facilitate	O	O	O
the	O	O	O
communication	O	O	O
between	O	O	O
brain	O	O	B-T029
regions	O	O	I-T029
implicated	O	O	O
in	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Eighty-nine	O	O	O
healthy	O	O	B-T080
mono	O	O	B-T099
-	O	O	O
or	O	O	O
dizygotic	O	O	B-T099
twins	O	O	B-T099
with	O	O	O
a	O	O	O
co-twin	O	O	B-T099
diagnosed	O	O	B-T033
with	O	O	O
MDD	O	O	B-T048
or	O	O	O
BD	O	O	B-T048
(	O	O	O
high-risk	O	O	B-T098
)	O	O	O
and	O	O	O
57	O	O	O
healthy	O	O	O
twins	O	O	O
with	O	O	O
a	O	O	O
co-twin	O	O	O
with	O	O	O
no	O	O	B-T033
familial	O	O	I-T033
history	O	O	I-T033
of	O	O	I-T033
affective	O	O	B-T048
disorders	O	O	I-T048
(	O	O	O
low-risk	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
a	O	O	O
diffusion	O	O	B-T060
tensor	O	O	I-T060
imaging	O	O	I-T060
study	O	O	I-T060
.	O	O	O

The	O	O	O
high-risk	O	O	B-T098
group	O	O	I-T098
showed	O	O	O
decreased	O	O	O
fractional	O	O	B-T060
anisotropy	O	O	I-T060
(	O	O	O
FA	O	O	B-T060
)	O	O	O
,	O	O	O
a	O	O	O
measure	O	O	O
of	O	O	O
water	O	O	B-T121
diffusion	O	O	B-T070
directionality	O	O	B-T169
,	O	O	O
and	O	O	O
increased	O	O	O
radial	O	O	B-T077
diffusivity	O	O	B-T077
in	O	O	O
the	O	O	O
anterior	O	O	B-T023
region	O	O	I-T023
of	O	O	I-T023
corpus	O	O	I-T023
callosum	O	O	I-T023
compared	O	O	O
to	O	O	O
the	O	O	O
low-risk	O	O	B-T098
group	O	O	I-T098
.	O	O	O

This	O	O	O
abnormality	O	O	B-T033
was	O	O	O
not	O	O	O
associated	O	O	O
with	O	O	O
zygosity	O	O	B-T169
or	O	O	O
type	O	O	O
of	O	O	O
depressive	O	O	B-T048
disorder	O	O	I-T048
of	O	O	O
co-twin	O	O	B-T099
.	O	O	O

The	O	O	O
observed	O	O	O
decreased	O	O	O
anterior	O	O	B-T023
callosal	O	O	I-T023
fiber	O	O	I-T023
FA	O	O	B-T060
in	O	O	O
the	O	O	O
high-risk	O	O	B-T098
group	O	O	I-T098
may	O	O	O
be	O	O	O
indicative	O	O	O
of	O	O	O
a	O	O	O
compromised	O	O	O
interhemispheric	O	O	B-T041
communication	O	O	I-T041
between	O	O	O
left	O	O	B-T023
and	O	O	O
right	O	O	B-T023
frontal	O	O	I-T023
regions	O	O	I-T023
critically	O	O	O
involved	O	O	O
in	O	O	O
mood	O	O	B-T041
regulation	O	O	I-T041
.	O	O	O

Reduced	O	O	O
anterior	O	O	B-T023
callosal	O	O	I-T023
FA	O	O	B-T060
may	O	O	O
act	O	O	O
as	O	O	O
a	O	O	O
vulnerability	O	O	B-UnknownType
marker	O	O	B-T201
for	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
in	O	O	O
individuals	O	O	B-T098
at	O	O	O
familial	O	O	B-T078
risk	O	O	I-T078
.	O	O	O

-DOCSTART- (27605910)

A	O	O	O
Window	O	O	O
on	O	O	O
the	O	O	O
Study	O	O	B-T061
of	O	O	I-T061
Aversive	O	O	I-T061
Instrumental	O	O	B-T041
Learning	O	O	I-T041
:	O	O	O
Strains	O	O	B-T001
,	O	O	O
Performance	O	O	B-T052
,	O	O	O
Neuroendocrine	O	O	B-T022
,	O	O	O
and	O	O	O
Immunologic	O	O	O
Systems	O	O	O

The	O	O	O
avoidance	O	O	B-T041
response	O	O	B-T032
is	O	O	O
present	O	O	O
in	O	O	O
pathological	O	O	B-T169
anxiety	O	O	B-T033
and	O	O	O
interferes	O	O	O
with	O	O	O
normal	O	O	B-T169
daily	O	O	I-T169
functions	O	O	I-T169
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
article	O	O	O
is	O	O	O
to	O	O	O
shed	O	O	O
light	O	O	O
on	O	O	O
performance	O	O	B-T052
markers	O	O	O
of	O	O	O
active	O	O	B-T041
avoidance	O	O	I-T041
(	O	O	O
AA	O	O	B-T041
)	O	O	O
using	O	O	O
two	O	O	O
different	O	O	O
rat	O	O	B-T015
strains	O	O	I-T015
,	O	O	O
Sprague-Dawley	O	O	B-T015
(	O	O	O
SD	O	O	B-T015
)	O	O	O
and	O	O	O
Wistar	O	O	B-T015
.	O	O	O

Specifically	O	O	O
,	O	O	O
good	O	O	O
and	O	O	O
poor	O	O	O
performers	O	O	B-T169
were	O	O	O
evaluated	O	O	B-T058
regarding	O	O	O
anxiety	O	O	B-T033
traits	O	O	B-T032
exhibited	O	O	O
in	O	O	O
the	O	O	O
elevated	O	O	B-T073
plus	O	O	I-T073
maze	O	O	I-T073
(	O	O	O
EPM	O	O	B-T073
)	O	O	O
and	O	O	O
corticosterone	O	O	B-T059
levels	O	O	I-T059
and	O	O	O
motor	O	O	B-T038
activity	O	O	I-T038
in	O	O	O
the	O	O	O
open	O	O	B-T059
field	O	O	I-T059
test	O	O	I-T059
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
plasma	O	O	B-T059
levels	O	O	I-T059
of	O	O	O
Interleukin-6	O	O	B-T116
(	O	O	O
IL-6	O	O	B-T116
)	O	O	O
,	O	O	O
Interleukin-1Beta	O	O	B-T116
(	O	O	O
IL-1beta	O	O	B-T116
)	O	O	O
,	O	O	O
Nerve	O	O	B-T116
Growth	O	O	I-T116
Factor	O	O	I-T116
Beta	O	O	I-T116
(	O	O	O
NGF-beta	O	O	B-T116
)	O	O	O
,	O	O	O
Tumor	O	O	B-T116
Necrosis	O	O	I-T116
Factor-Alpha	O	O	I-T116
(	O	O	O
TNF-alpha	O	O	B-T116
)	O	O	O
and	O	O	O
cytokine-induced	O	O	B-T116
neutrophil	O	O	I-T116
chemoattractant	O	O	I-T116
1	O	O	I-T116
(	O	O	O
CINC-1	O	O	B-T116
)	O	O	O
were	O	O	O
compared	O	O	O
in	O	O	O
the	O	O	O
good	O	O	O
and	O	O	O
poor	O	O	O
performers	O	O	B-T169
to	O	O	O
better	O	O	O
understand	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
immunologic	O	O	B-T022
system	O	O	I-T022
in	O	O	O
aversive	O	O	B-T061
learning	O	O	I-T061
.	O	O	O

Behavioral	O	O	B-T170
criteria	O	O	I-T170
were	O	O	O
employed	O	O	O
to	O	O	O
identify	O	O	O
subpopulations	O	O	B-T098
of	O	O	O
SD	O	O	B-T015
and	O	O	O
Wistar	O	O	B-T015
rats	O	O	I-T015
based	O	O	O
on	O	O	O
their	O	O	O
behavioral	O	O	B-T170
scores	O	O	I-T170
during	O	O	O
a	O	O	O
two-way	O	O	O
AA	O	O	B-T041
test	O	O	B-T170
.	O	O	O

The	O	O	O
animals	O	O	B-T008
were	O	O	O
tested	O	O	B-T170
for	O	O	O
anxiety	O	O	B-T033
-like	O	O	O
behavior	O	O	B-T053
in	O	O	O
the	O	O	O
EPM	O	O	B-T073
and	O	O	O
motor	O	O	B-T038
activity	O	O	I-T038
in	O	O	O
the	O	O	O
open-field	O	O	B-T059
test	O	O	I-T059
.	O	O	O

Plasma	O	O	B-T059
corticosterone	O	O	I-T059
levels	O	O	I-T059
were	O	O	O
measured	O	O	B-T080
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
avoidance	O	O	B-T041
test	O	O	B-T170
.	O	O	O

Cytokine	O	O	B-T059
levels	O	O	I-T059
of	O	O	O
IL-6	O	O	B-T116
,	O	O	O
IL-1beta	O	O	B-T116
,	O	O	O
NGF-beta	O	O	B-T116
,	O	O	O
TNF-alpha	O	O	B-T116
,	O	O	O
and	O	O	O
CINC-1	O	O	B-T116
were	O	O	O
measured	O	O	B-T080
in	O	O	O
the	O	O	O
plasma	O	O	B-T031
of	O	O	O
the	O	O	O
Wistar	O	O	B-T015
rats	O	O	I-T015
.	O	O	O

Sixty-six	O	O	O
percent	O	O	O
of	O	O	O
the	O	O	O
Wistar	O	O	B-T015
rats	O	O	I-T015
and	O	O	O
35	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
SD	O	O	B-T015
rats	O	O	I-T015
exhibited	O	O	O
a	O	O	O
poor	O	O	O
performance	O	O	B-T052
.	O	O	O

This	O	O	O
feature	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
decrease	O	O	O
in	O	O	O
anxiety	O	O	B-T033
-like	O	O	O
behavior	O	O	B-T053
in	O	O	O
the	O	O	O
EPM	O	O	B-T073
.	O	O	O

The	O	O	O
poor	O	O	O
and	O	O	O
good	O	O	O
performers	O	O	B-T169
exhibited	O	O	O
lower	O	O	O
levels	O	O	B-T059
of	O	O	I-T059
corticosterone	O	O	I-T059
compared	O	O	O
with	O	O	O
the	O	O	O
control	O	O	B-T008
animals	O	O	I-T008
,	O	O	O
which	O	O	O
suggests	O	O	O
that	O	O	O
training	O	O	O
alters	O	O	O
corticosterone	O	O	B-T059
levels	O	O	I-T059
,	O	O	O
thereby	O	O	O
leading	O	O	O
to	O	O	O
hypocortisolism	O	O	B-T047
,	O	O	O
independent	O	O	O
of	O	O	O
the	O	O	O
performance	O	O	B-T052
.	O	O	O

The	O	O	O
CINC-1	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
increased	O	O	O
in	O	O	O
the	O	O	O
poor	O	O	O
performers	O	O	B-T169
,	O	O	O
which	O	O	O
reinforces	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
immunologic	O	O	B-T022
system	O	O	I-T022
activation	O	O	B-T052
in	O	O	O
learning	O	O	B-T048
deficits	O	O	I-T048
.	O	O	O

Our	O	O	O
study	O	O	O
provides	O	O	O
a	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
complex	O	O	B-T080
interactions	O	O	B-T169
that	O	O	O
underlie	O	O	O
neuroimmune	O	O	B-UnknownType
consequences	O	O	B-T169
and	O	O	O
their	O	O	O
implications	O	O	O
for	O	O	O
performance	O	O	B-T052
.	O	O	O

-DOCSTART- (27609696)

Costing	O	O	B-T169
'	O	O	O
healthy	O	O	B-T168
'	O	O	I-T168
food	O	O	B-T168
baskets	O	O	I-T168
in	O	O	O
Australia	O	O	B-T083
-	O	O	O
a	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
of	O	O	O
food	O	O	O
price	O	O	B-T081
and	O	O	O
affordability	O	O	B-T081
monitoring	O	O	B-T170
tools	O	O	I-T170
,	O	O	O
protocols	O	O	B-T170
and	O	O	O
methods	O	O	O

To	O	O	O
undertake	O	O	O
a	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
to	O	O	O
determine	O	O	O
similarities	O	O	B-T080
and	O	O	O
differences	O	O	B-T080
in	O	O	O
metrics	O	O	B-T081
and	O	O	O
results	O	O	B-T169
between	O	O	O
recently	O	O	B-T079
and/or	O	O	O
currently	O	O	B-T079
used	O	O	O
tools	O	O	B-T170
,	O	O	O
protocols	O	O	B-T170
and	O	O	O
methods	O	O	B-T170
for	O	O	O
monitoring	O	O	B-T058
Australian	O	O	B-T083
healthy	O	O	B-T168
food	O	O	I-T168
prices	O	O	B-T081
and	O	O	O
affordability	O	O	B-T081
.	O	O	O

Electronic	O	O	B-T170
databases	O	O	I-T170
of	O	O	O
peer-reviewed	O	O	B-T170
literature	O	O	I-T170
and	O	O	O
online	O	O	B-T170
grey	O	O	I-T170
literature	O	O	I-T170
were	O	O	O
systematically	O	O	B-T169
searched	O	O	B-T052
using	O	O	O
the	O	O	O
PRISMA	O	O	B-T062
approach	O	O	O
for	O	O	O
articles	O	O	B-T170
and	O	O	O
reports	O	O	B-T170
relating	O	O	O
to	O	O	O
healthy	O	O	B-T168
food	O	O	I-T168
and	O	O	O
diet	O	O	B-T170
price	O	O	I-T170
assessment	O	O	I-T170
tools	O	O	I-T170
,	O	O	O
protocols	O	O	B-T170
,	O	O	O
methods	O	O	B-T170
and	O	O	O
results	O	O	B-T169
that	O	O	O
utilised	O	O	O
retail	O	O	B-T081
pricing	O	O	I-T081
.	O	O	O

National	O	O	B-UnknownType
,	O	O	O
state	O	O	B-T083
,	O	O	O
regional	O	O	B-T082
and	O	O	O
local	O	O	B-T083
areas	O	O	I-T083
of	O	O	O
Australia	O	O	B-T083
from	O	O	O
1995	O	O	O
to	O	O	O
2015	O	O	O
.	O	O	O

Assessment	O	O	B-T170
tools	O	O	I-T170
,	O	O	O
protocols	O	O	B-T170
and	O	O	O
methods	O	O	B-T170
to	O	O	O
measure	O	O	B-T081
the	O	O	O
price	O	O	B-T081
of	O	O	O
'	O	O	B-T168
healthy	O	O	I-T168
'	O	O	I-T168
foods	O	O	I-T168
and	O	O	O
diets	O	O	B-T168
.	O	O	O

The	O	O	O
search	O	O	O
identified	O	O	B-T080
fifty-nine	O	O	O
discrete	O	O	O
surveys	O	O	B-T170
of	O	O	O
'	O	O	O
healthy	O	O	B-T168
'	O	O	I-T168
food	O	O	I-T168
pricing	O	O	B-T081
incorporating	O	O	O
six	O	O	O
major	O	O	O
food	O	O	B-T170
pricing	O	O	I-T170
tools	O	O	I-T170
(	O	O	O
those	O	O	O
used	O	O	O
in	O	O	O
multiple	O	O	B-T082
areas	O	O	I-T082
and	O	O	O
time	O	O	B-T079
periods	O	O	I-T079
)	O	O	O
and	O	O	O
five	O	O	O
minor	O	O	B-T080
food	O	O	O
pricing	O	O	O
tools	O	O	O
(	O	O	O
those	O	O	O
used	O	O	O
in	O	O	O
a	O	O	O
single	O	O	B-T082
survey	O	O	I-T082
area	O	O	I-T082
or	O	O	O
time	O	O	B-T079
period	O	O	I-T079
)	O	O	O
.	O	O	O

Analysis	O	O	B-T062
demonstrated	O	O	O
methodological	O	O	B-T078
differences	O	O	B-T080
regarding	O	O	O
:	O	O	O
included	O	O	B-T169
foods	O	O	B-T168
;	O	O	O
reference	O	O	B-T099
households	O	O	I-T099
;	O	O	O
use	O	O	O
of	O	O	O
availability	O	O	B-T169
and/or	O	O	O
quality	O	O	B-T170
measures	O	O	I-T170
;	O	O	O
household	O	O	B-T033
income	O	O	I-T033
sources	O	O	B-T033
;	O	O	O
store	O	O	B-T073
sampling	O	O	B-T170
methods	O	O	B-T170
;	O	O	O
data	O	O	B-T062
collection	O	O	I-T062
protocols	O	O	B-T170
;	O	O	O
analysis	O	O	B-T062
methods	O	O	I-T062
;	O	O	O
and	O	O	O
results	O	O	B-T169
.	O	O	O
'	O	O	O
Healthy	O	O	B-T168
'	O	O	I-T168
food	O	O	I-T168
price	O	O	B-T081
assessment	O	O	B-T052
methods	O	O	O
used	O	O	O
in	O	O	O
Australia	O	O	B-T083
lack	O	O	B-T080
comparability	O	O	B-T052
across	O	O	O
all	O	O	O
metrics	O	O	B-T081
and	O	O	O
most	O	O	O
do	O	O	O
not	O	O	O
fully	O	O	O
align	O	O	O
with	O	O	O
a	O	O	O
'	O	O	O
healthy	O	O	B-T168
'	O	O	I-T168
diet	O	O	I-T168
as	O	O	O
recommended	O	O	B-T078
by	O	O	O
the	O	O	O
current	O	O	O
Australian	O	O	B-T170
Dietary	O	O	I-T170
Guidelines	O	O	I-T170
.	O	O	O

None	O	O	O
have	O	O	O
been	O	O	O
applied	O	O	O
nationally	O	O	O
.	O	O	O

Assessment	O	O	B-T052
of	O	O	O
the	O	O	O
price	O	O	B-T081
,	O	O	O
price	O	O	B-T078
differential	O	O	I-T078
and	O	O	O
affordability	O	O	B-T081
of	O	O	O
healthy	O	O	B-T061
(	O	O	O
recommended	O	O	B-T078
)	O	O	O
and	O	O	O
current	O	O	B-T079
(	O	O	B-T055
unhealthy	O	O	I-T055
)	O	O	I-T055
diets	O	O	I-T055
would	O	O	O
provide	O	O	B-T052
more	O	O	O
robust	O	O	B-T080
and	O	O	O
meaningful	O	O	O
data	O	O	B-T078
to	O	O	O
inform	O	O	O
health	O	O	B-T064
and	O	O	I-T064
fiscal	O	O	I-T064
policy	O	O	I-T064
in	O	O	O
Australia	O	O	B-T083
.	O	O	O

The	O	O	O
INFORMAS	O	O	B-T170
'	O	O	O
optimal	O	O	B-T080
'	O	O	O
approach	O	O	O
provides	O	O	O
a	O	O	O
potential	O	O	B-T080
framework	O	O	O
for	O	O	O
development	O	O	B-T169
of	O	O	O
these	O	O	O
methods	O	O	B-T170
.	O	O	O

-DOCSTART- (27610122)

Consecutive	O	O	B-T080
Endovascular	O	O	B-T061
Treatment	O	O	I-T061
of	O	O	O
20	O	O	O
Ruptured	O	O	B-T169
Very	O	O	O
Small	O	O	B-T081
(	O	O	O
<3	O	O	O
mm	O	O	O
)	O	O	O
Anterior	O	O	O
Communicating	O	O	O
Artery	O	O	O
Aneurysms	O	O	O

Small	O	O	B-T081
aneurysms	O	O	B-T047
located	O	O	O
at	O	O	O
the	O	O	O
anterior	O	O	B-T023
communicating	O	O	I-T023
artery	O	O	I-T023
carry	O	O	O
significant	O	O	O
procedural	O	O	O
challenges	O	O	O
due	O	O	O
to	O	O	O
a	O	O	O
complex	O	O	O
anatomy	O	O	B-T017
.	O	O	O

Recent	O	O	O
advances	O	O	O
in	O	O	O
endovascular	O	O	B-T061
technologies	O	O	I-T061
have	O	O	O
expanded	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
coil	O	O	B-T061
embolization	O	O	I-T061
for	O	O	O
small	O	O	B-T081
aneurysm	O	O	B-T047
treatment	O	O	B-T169
.	O	O	O

However	O	O	O
,	O	O	O
limited	O	O	O
reports	O	O	O
describe	O	O	O
their	O	O	O
safety	O	O	B-T068
and	O	O	O
efficacy	O	O	B-T080
profiles	O	O	O
in	O	O	O
very	O	O	O
small	O	O	B-T081
anterior	O	O	B-T047
communicating	O	O	I-T047
artery	O	O	I-T047
aneurysms	O	O	I-T047
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
review	O	O	O
and	O	O	O
report	O	O	O
the	O	O	O
immediate	O	O	O
and	O	O	O
long-term	O	O	B-T080
clinical	O	O	I-T080
as	O	O	O
well	O	O	O
as	O	O	O
radiographic	O	O	B-T080
outcomes	O	O	I-T080
of	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
with	O	O	O
ruptured	O	O	B-T169
very	O	O	O
small	O	O	B-T081
anterior	O	O	B-T047
communicating	O	O	I-T047
artery	O	O	I-T047
aneurysms	O	O	I-T047
treated	O	O	O
with	O	O	O
current	O	O	O
endovascular	O	O	B-T061
coil	O	O	I-T061
embolization	O	O	I-T061
techniques	O	O	I-T061
.	O	O	O

A	O	O	O
prospectively	O	O	O
maintained	O	O	O
single-institution	O	O	O
neuroendovascular	O	O	B-T170
database	O	O	I-T170
was	O	O	O
accessed	O	O	O
to	O	O	O
identify	O	O	O
consecutive	O	O	O
cases	O	O	O
of	O	O	O
very	O	O	O
small	O	O	B-T081
(	O	O	O
<3	O	O	O
mm	O	O	O
)	O	O	O
ruptured	O	O	B-T169
anterior	O	O	B-T047
communicating	O	O	I-T047
artery	O	O	I-T047
aneurysms	O	O	I-T047
treated	O	O	O
endovascularly	O	O	O
between	O	O	O
2006	O	O	O
and	O	O	O
2013	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
20	O	O	O
patients	O	O	B-T101
with	O	O	O
ruptured	O	O	B-T169
very	O	O	O
small	O	O	B-T081
(	O	O	O
<3	O	O	O
mm	O	O	O
)	O	O	O
anterior	O	O	B-T047
communicating	O	O	I-T047
artery	O	O	I-T047
aneurysms	O	O	I-T047
were	O	O	O
consecutively	O	O	B-T080
treated	O	O	O
with	O	O	O
coil	O	O	B-T061
embolization	O	O	I-T061
.	O	O	O

The	O	O	O
average	O	O	O
maximum	O	O	O
diameter	O	O	B-T081
was	O	O	O
2.66	O	O	O
±	O	O	O
0.41	O	O	O
mm	O	O	O
.	O	O	O

Complete	O	O	O
aneurysm	O	O	B-T061
occlusion	O	O	I-T061
was	O	O	O
achieved	O	O	O
for	O	O	O
17	O	O	O
(	O	O	O
85	O	O	O
%	O	O	O
)	O	O	O
aneurysms	O	O	B-T047
and	O	O	O
near-complete	O	O	O
aneurysm	O	O	O
occlusion	O	O	O
for	O	O	O
3	O	O	O
(	O	O	O
15	O	O	O
%	O	O	O
)	O	O	O
aneurysms	O	O	O
.	O	O	O

Intraoperative	O	O	B-T079
perforation	O	O	B-T033
was	O	O	O
seen	O	O	O
in	O	O	O
2	O	O	O
(	O	O	O
10	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
without	O	O	O
any	O	O	O
clinical	O	O	B-T078
worsening	O	O	I-T078
or	O	O	O
need	O	O	O
for	O	O	O
an	O	O	O
external	O	O	B-T061
ventricular	O	O	I-T061
drain	O	O	I-T061
.	O	O	O

A	O	O	O
thromboembolic	O	O	B-T046
event	O	O	I-T046
occurred	O	O	O
in	O	O	O
1	O	O	O
(	O	O	O
5	O	O	O
%	O	O	O
)	O	O	O
patient	O	O	B-T101
without	O	O	O
clinical	O	O	B-T078
worsening	O	O	I-T078
or	O	O	O
radiologic	O	O	B-T046
infarct	O	O	I-T046
.	O	O	O

Median	O	O	O
clinical	O	O	O
follow-up	O	O	B-T058
was	O	O	O
12	O	O	O
(	O	O	O
±14.1	O	O	O
)	O	O	O
months	O	O	B-T079
and	O	O	O
median	O	O	O
imaging	O	O	O
follow-up	O	O	O
was	O	O	O
12	O	O	O
(	O	O	O
±18.4	O	O	O
)	O	O	O
months	O	O	O
.	O	O	O

This	O	O	O
report	O	O	O
describes	O	O	O
the	O	O	O
largest	O	O	O
series	O	O	O
of	O	O	O
consecutive	O	O	B-T080
endovascular	O	O	B-T061
treatments	O	O	I-T061
of	O	O	O
ruptured	O	O	B-T169
very	O	O	O
small	O	O	B-T081
anterior	O	O	B-T047
communicating	O	O	I-T047
artery	O	O	I-T047
aneurysms	O	O	I-T047
.	O	O	O

These	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
coil	O	O	B-T061
embolization	O	O	I-T061
of	O	O	O
very	O	O	O
small	O	O	B-T081
aneurysms	O	O	B-T047
in	O	O	O
this	O	O	O
location	O	O	B-T082
can	O	O	O
be	O	O	O
performed	O	O	O
with	O	O	O
acceptable	O	O	O
rates	O	O	O
of	O	O	O
complications	O	O	B-T046
and	O	O	O
recanalization	O	O	B-T061
.	O	O	O

-DOCSTART- (27613669)

Factors	O	O	B-T169
affecting	O	O	B-T169
the	O	O	O
formation	O	O	B-T169
of	O	O	O
nitrogenous	O	O	B-T061
disinfection	O	O	I-T061
by-products	O	O	B-T104
during	O	O	O
chlorination	O	O	B-T057
of	O	O	O
aspartic	O	O	B-T116
acid	O	O	I-T116
in	O	O	O
drinking	O	O	O
water	O	O	O

The	O	O	O
formation	O	O	B-T169
of	O	O	O
emerging	O	O	O
nitrogenous	O	O	B-T061
disinfection	O	O	I-T061
by-products	O	O	B-T104
(	O	O	O
N-DBPs	O	O	B-T104
)	O	O	O
from	O	O	O
the	O	O	O
chlorination	O	O	B-T057
of	O	O	O
aspartic	O	O	B-T116
acid	O	O	I-T116
(	O	O	O
Asp	O	O	B-T116
)	O	O	O
was	O	O	O
investigated	O	O	B-T169
.	O	O	O

The	O	O	O
yield	O	O	O
of	O	O	O
dichloroacetonitrile	O	O	B-T109
(	O	O	O
DCAN	O	O	B-T109
)	O	O	O
was	O	O	O
higher	O	O	O
than	O	O	O
other	O	O	O
N-DBPs	O	O	B-T104
,	O	O	O
such	O	O	O
as	O	O	O
dichloroacetamide	O	O	B-T109
(	O	O	O
DCAcAm	O	O	B-T109
)	O	O	O
and	O	O	O
chloropicrin	O	O	B-T109
(	O	O	O
TCNM	O	O	B-T109
)	O	O	O
during	O	O	O
the	O	O	O
chlorination	O	O	B-T057
of	O	O	O
Asp	O	O	B-T116
.	O	O	O

The	O	O	O
formation	O	O	B-T169
of	O	O	O
DCAN	O	O	B-T109
,	O	O	O
DCAcAm	O	O	B-T109
,	O	O	O
and	O	O	O
TCNM	O	O	B-T109
all	O	O	O
showed	O	O	O
a	O	O	O
trend	O	O	O
of	O	O	O
first	O	O	O
increasing	O	O	B-T169
and	O	O	O
then	O	O	O
decreasing	O	O	B-T033
during	O	O	O
the	O	O	O
chlorination	O	O	B-T057
of	O	O	O
Asp	O	O	B-T116
with	O	O	O
increasing	O	O	O
contact	O	O	B-T079
time	O	O	I-T079
.	O	O	O

The	O	O	O
dosage	O	O	B-T081
of	O	O	O
chlorine	O	O	B-T131
had	O	O	O
an	O	O	O
impact	O	O	O
on	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
DCAN	O	O	B-T109
,	O	O	O
DCAcAm	O	O	B-T109
,	O	O	O
and	O	O	O
TCNM	O	O	B-T109
.	O	O	O

The	O	O	O
highest	O	O	O
yields	O	O	B-T081
of	O	O	O
DCAN	O	O	B-T109
and	O	O	O
DCAcAm	O	O	B-T109
appeared	O	O	O
when	O	O	O
the	O	O	O
Cl2	O	O	B-T131
/	O	O	O
Asp	O	O	B-T116
molar	O	O	B-T081
ratio	O	O	B-T081
was	O	O	O
about	O	O	O
20	O	O	O
,	O	O	O
the	O	O	O
yield	O	O	B-T081
of	O	O	O
TCNM	O	O	B-T109
increased	O	O	B-T081
with	O	O	O
increasing	O	O	B-T169
the	O	O	O
Cl2	O	O	O
/	O	O	O
Asp	O	O	O
molar	O	O	O
ratio	O	O	O
from	O	O	O
5	O	O	O
to	O	O	O
30	O	O	O
and	O	O	O
TCNM	O	O	O
was	O	O	O
not	O	O	O
produced	O	O	O
when	O	O	O
the	O	O	O
ratio	O	O	O
was	O	O	O
less	O	O	O
than	O	O	O
5	O	O	O
.	O	O	O

Cyanogen	O	O	B-T109
chloride	O	O	I-T109
(	O	O	O
CNCl	O	O	B-T109
)	O	O	O
was	O	O	O
detected	O	O	O
when	O	O	O
the	O	O	O
Cl2	O	O	B-T131
/	O	O	O
Asp	O	O	B-T116
molar	O	O	B-T081
ratio	O	O	I-T081
was	O	O	O
lower	O	O	O
than	O	O	O
5	O	O	O
.	O	O	O

N-DBPs	O	O	B-T104
formation	O	O	B-T169
was	O	O	O
influenced	O	O	O
by	O	O	O
pH.	O	O	O
DCAN	O	O	B-T109
formation	O	O	O
increased	O	O	B-T081
with	O	O	O
increasing	O	O	B-T169
pH	O	O	B-T081
from	O	O	O
5	O	O	O
to	O	O	O
6	O	O	O
and	O	O	O
then	O	O	O
decreased	O	O	B-T081
with	O	O	O
increasing	O	O	O
pH	O	O	O
from	O	O	O
6	O	O	O
to	O	O	O
9	O	O	O
,	O	O	O
but	O	O	O
DCAcAm	O	O	B-T109
and	O	O	O
TCNM	O	O	B-T109
increased	O	O	O
with	O	O	O
increasing	O	O	O
pH	O	O	O
from	O	O	O
5	O	O	O
to	O	O	O
8	O	O	O
and	O	O	O
then	O	O	O
decreased	O	O	O
.	O	O	O

Higher	O	O	O
temperatures	O	O	B-T081
reduced	O	O	B-T080
the	O	O	O
formation	O	O	B-T169
of	O	O	O
DCAN	O	O	B-T109
and	O	O	O
DCAcAm	O	O	B-T109
,	O	O	O
but	O	O	O
increased	O	O	B-T081
TCNM	O	O	B-T109
formation	O	O	O
.	O	O	O

DCAN	O	O	B-T109
and	O	O	O
DCAcAm	O	O	B-T109
formation	O	O	B-T169
decreased	O	O	B-T081
,	O	O	O
and	O	O	O
relatively	O	O	O
stable	O	O	B-T080
TCNM	O	O	B-T109
formation	O	O	O
increased	O	O	B-T081
,	O	O	O
with	O	O	O
increasing	O	O	B-T169
free	O	O	O
chlorine	O	O	B-T131
contact	O	O	B-T079
time	O	O	I-T079
during	O	O	O
chloramination	O	O	B-T067
.	O	O	O

N-nitrosodimethylamine	O	O	B-T109
(	O	O	O
NDMA	O	O	B-T109
)	O	O	O
was	O	O	O
produced	O	O	O
during	O	O	O
chloramination	O	O	B-T067
of	O	O	O
Asp	O	O	B-T116
and	O	O	O
increased	O	O	B-T081
with	O	O	O
prolonged	O	O	B-T079
chloramination	O	O	O
contact	O	O	B-T079
time	O	O	I-T079
.	O	O	O

The	O	O	O
presence	O	O	O
of	O	O	O
bromide	O	O	B-T121
ions	O	O	I-T121
enhanced	O	O	B-T052
the	O	O	O
yields	O	O	B-T081
of	O	O	O
haloacetonitriles	O	O	B-T109
and	O	O	O
shifted	O	O	O
N-DBPs	O	O	B-T104
to	O	O	O
more	O	O	O
brominated	O	O	B-T109
species	O	O	I-T109
.	O	O	O

-DOCSTART- (27614145)

Midodrine	O	O	B-T109
and	O	O	O
tolvaptan	O	O	B-T109
in	O	O	O
patients	O	O	B-T101
with	O	O	O
cirrhosis	O	O	B-T047
and	O	O	O
refractory	O	O	B-T033
or	O	O	O
recurrent	O	O	B-UnknownType
ascites	O	O	I-UnknownType
:	O	O	O
a	O	O	O
randomised	O	O	B-T062
pilot	O	O	O
study	O	O	O

Splanchnic	O	O	B-T042
arterial	O	O	I-T042
vasodilatation	O	O	I-T042
and	O	O	O
subsequent	O	O	O
sodium	O	O	B-T047
and	O	O	O
water	O	O	B-T033
retention	O	O	I-T033
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
cirrhotic	O	O	B-T047
ascites	O	O	I-T047
.	O	O	O

Midodrine	O	O	B-T109
and	O	O	O
tolvaptan	O	O	B-T109
have	O	O	O
been	O	O	O
used	O	O	O
separately	O	O	O
in	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
are	O	O	O
no	O	O	O
reports	O	O	O
on	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
combination	O	O	B-T061
of	O	O	O
midodrine	O	O	B-T109
and	O	O	O
tolvaptan	O	O	B-T109
in	O	O	O
the	O	O	O
control	O	O	O
of	O	O	O
ascites	O	O	B-T047
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
safety	O	O	B-T068
and	O	O	O
efficacy	O	O	B-T080
of	O	O	O
midodrine	O	O	B-T109
,	O	O	O
tolvaptan	O	O	B-T109
and	O	O	O
their	O	O	O
combination	O	O	B-T061
in	O	O	O
control	O	O	O
of	O	O	O
refractory	O	O	B-T033
or	O	O	O
recurrent	O	O	B-UnknownType
ascites	O	O	I-UnknownType
in	O	O	O
cirrhotics	O	O	B-T047
.	O	O	O

Fifty	O	O	O
cirrhotic	O	O	B-T080
patients	O	O	B-T101
with	O	O	O
refractory	O	O	B-T033
or	O	O	O
recurrent	O	O	B-UnknownType
ascites	O	O	I-UnknownType
were	O	O	O
randomised	O	O	B-T062
to	O	O	O
receive	O	O	O
midodrine	O	O	B-T109
(	O	O	O
n=13	O	O	O
)	O	O	O
,	O	O	O
tolvaptan	O	O	B-T109
(	O	O	O
n=12	O	O	O
)	O	O	O
or	O	O	O
both	O	O	O
(	O	O	O
n=13	O	O	O
)	O	O	O
plus	O	O	O
standard	O	O	O
medical	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
SMT	O	O	B-T061
)	O	O	O
or	O	O	O
SMT	O	O	O
alone	O	O	O
(	O	O	O
n=12	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
significant	O	O	B-T033
increase	O	O	I-T033
in	O	O	I-T033
urinary	O	O	I-T033
volume	O	O	I-T033
and	O	O	O
urinary	O	O	B-T047
sodium	O	O	I-T047
at	O	O	O
1	O	O	O
and	O	O	O
3	O	O	O
months	O	O	B-T079
(	O	O	O
P<.05	O	O	O
)	O	O	O
was	O	O	O
observed	O	O	O
in	O	O	O
all	O	O	O
groups	O	O	B-T098
except	O	O	O
SMT	O	O	B-T061
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
worsening	O	O	B-T080
of	O	O	O
renal	O	O	B-T033
or	O	O	O
hepatic	O	O	B-T042
function	O	O	I-T042
in	O	O	O
any	O	O	O
group	O	O	B-T098
.	O	O	O

There	O	O	O
was	O	O	O
deterioration	O	O	B-T067
of	O	O	O
model	O	O	B-T185
for	O	O	I-T185
end-stage	O	O	I-T185
liver	O	O	I-T185
disease	O	O	I-T185
(	O	O	O
MELD	O	O	B-T185
)	O	O	O
in	O	O	O
SMT	O	O	O
.	O	O	O

Midodrine	O	O	B-T109
as	O	O	O
well	O	O	O
as	O	O	O
combination	O	O	B-T061
of	O	O	O
midodrine	O	O	B-T109
and	O	O	O
tolvaptan	O	O	B-T109
but	O	O	O
not	O	O	O
tolvaptan	O	O	O
alone	O	O	O
was	O	O	O
superior	O	O	O
to	O	O	O
SMT	O	O	B-T061
in	O	O	O
control	O	O	O
of	O	O	O
ascites	O	O	B-T047
at	O	O	O
3	O	O	O
months	O	O	B-T079
(	O	O	O
P<.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
combination	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
also	O	O	O
superior	O	O	O
to	O	O	O
midodrine	O	O	B-T109
in	O	O	O
the	O	O	O
control	O	O	O
of	O	O	O
ascites	O	O	B-T047
at	O	O	O
1	O	O	O
month	O	O	B-T079
.	O	O	O

The	O	O	O
morbidity	O	O	B-T081
and	O	O	O
mortality	O	O	B-T081
were	O	O	O
similar	O	O	O
in	O	O	O
all	O	O	O
the	O	O	O
groups	O	O	B-T098
except	O	O	O
SMT	O	O	B-T061
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
this	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
suggest	O	O	O
that	O	O	O
midodrine	O	O	B-T109
and	O	O	O
combination	O	O	B-T061
with	O	O	O
tolvaptan	O	O	B-T109
better	O	O	O
controls	O	O	O
ascites	O	O	B-T047
without	O	O	O
any	O	O	O
renal	O	O	B-T047
or	O	O	O
hepatic	O	O	B-T046
dysfunction	O	O	I-T046
.	O	O	O

The	O	O	O
combination	O	O	B-T061
therapy	O	O	I-T061
rapidly	O	O	O
controls	O	O	O
ascites	O	O	B-T047
as	O	O	O
compared	O	O	O
to	O	O	O
midodrine	O	O	B-T109
or	O	O	O
tolvaptan	O	O	B-T109
alone	O	O	O
.	O	O	O

-DOCSTART- (27618138)

Acute	O	O	B-T047
Complicated	O	O	I-T047
Sinusitis	O	O	I-T047
:	O	O	O
Ten	O	O	O
Years	O	O	B-T079
Experience	O	O	B-T041
from	O	O	O
the	O	O	O
University	O	O	B-T093
Hospital	O	O	I-T093
of	O	O	O
the	O	O	O
West	O	O	O
Indies	O	O	O

Complicated	O	O	B-T047
sinusitis	O	O	I-T047
is	O	O	O
rare	O	O	B-T047
.	O	O	O

It	O	O	O
might	O	O	O
not	O	O	O
be	O	O	O
identified	O	O	O
early	O	O	O
and	O	O	O
might	O	O	O
expose	O	O	O
the	O	O	O
patient	O	O	B-T101
to	O	O	O
an	O	O	O
unfavourable	O	O	B-T169
outcome	O	O	I-T169
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
paucity	O	O	O
of	O	O	O
data	O	O	B-T078
regarding	O	O	O
this	O	O	O
condition	O	O	B-T047
in	O	O	O
the	O	O	O
Caribbean	O	O	B-T083
.	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
undertaken	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
clinical	O	O	B-T201
characteristics	O	O	I-T201
and	O	O	O
treatment	O	O	B-T080
outcomes	O	O	I-T080
of	O	O	O
patients	O	O	B-T101
admitted	O	O	B-T058
with	O	O	O
this	O	O	O
condition	O	O	B-T047
.	O	O	O

A	O	O	O
retrospective	O	O	B-T080
chart	O	O	B-UnknownType
review	O	O	I-UnknownType
was	O	O	O
performed	O	O	O
on	O	O	O
patients	O	O	B-T101
admitted	O	O	B-T058
to	O	O	O
the	O	O	O
University	O	O	B-T093
Hospital	O	O	I-T093
of	O	O	I-T093
the	O	O	I-T093
West	O	O	I-T093
Indies	O	O	I-T093
(	O	O	O
UHWI	O	O	B-T093
)	O	O	O
with	O	O	O
complicated	O	O	B-T047
sinusitis	O	O	I-T047
between	O	O	O
1999	O	O	O
to	O	O	O
2011	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T078
was	O	O	O
analysed	O	O	B-T062
using	O	O	O
SPSS	O	O	B-T170
statistics	O	O	I-T170
22	O	O	I-T170
software	O	O	I-T170
.	O	O	O

There	O	O	O
were	O	O	O
30	O	O	O
patients	O	O	B-T101
(	O	O	O
23	O	O	O
males	O	O	B-T032
and	O	O	O
7	O	O	O
females	O	O	B-T032
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
(	O	O	O
SD	O	O	B-T081
)	O	O	O
age	O	O	B-T032
was	O	O	O
19	O	O	O
(	O	O	O
13.96	O	O	O
)	O	O	O
years	O	O	B-T079
.	O	O	O

Twenty-two	O	O	O
had	O	O	O
orbital	O	O	B-T030
complications	O	O	B-T046
,	O	O	O
two	O	O	O
had	O	O	O
intracranial	O	O	B-T029
complications	O	O	O
and	O	O	O
one	O	O	O
had	O	O	O
both	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	B-T081
organisms	O	O	B-T001
isolated	O	O	B-T169
were	O	O	O
streptococcus	O	O	B-T007
and	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
sensitivity	O	O	B-T032
was	O	O	O
to	O	O	O
amoxicillin	O	O	B-T195
and	O	O	O
clavulinic	O	O	B-T195
acid	O	O	I-T195
.	O	O	O

Sixteen	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
an	O	O	O
external	O	O	B-T082
surgical	O	O	B-T169
approach	O	O	I-T169
had	O	O	O
a	O	O	O
mean	O	O	B-T081
(	O	O	O
SD	O	O	B-T081
)	O	O	O
hospital	O	O	B-T079
stay	O	O	I-T079
of	O	O	O
8.8	O	O	O
(	O	O	O
3.71	O	O	O
)	O	O	O
days	O	O	B-T079
compared	O	O	O
to	O	O	O
three	O	O	O
patients	O	O	O
who	O	O	O
had	O	O	O
a	O	O	O
purely	O	O	O
endoscopic	O	O	B-T082
approach	O	O	I-T082
who	O	O	O
had	O	O	O
a	O	O	O
mean	O	O	O
(	O	O	O
SD	O	O	O
)	O	O	O
hospital	O	O	O
stay	O	O	O
of	O	O	O
7.67	O	O	O
(	O	O	O
0.577	O	O	O
)	O	O	O
days	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
statistical	O	O	B-T081
difference	O	O	I-T081
in	O	O	O
mean	O	O	B-T081
hospital	O	O	B-T079
stay	O	O	I-T079
between	O	O	O
these	O	O	O
two	O	O	O
groups	O	O	B-T078
(	O	O	O
95	O	O	O
%	O	O	O
CI,-3.49	O	O	O
-	O	O	O
5.78	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.609	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
duration	O	O	B-T079
of	O	O	O
hospital	O	O	B-T079
stay	O	O	I-T079
for	O	O	O
those	O	O	O
treated	O	O	B-T058
medically	O	O	I-T058
was	O	O	O
six	O	O	O
days	O	O	B-T079
versus	O	O	O
ten	O	O	O
days	O	O	O
for	O	O	O
the	O	O	O
surgical	O	O	B-T169
group	O	O	B-T078
.	O	O	O

The	O	O	O
mean	O	O	B-T081
difference	O	O	B-T081
was	O	O	O
three	O	O	O
days	O	O	B-T079
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.193	O	O	O
-	O	O	O
6.595	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.039	O	O	O
)	O	O	O
.	O	O	O

Acute	O	O	B-T047
complicated	O	O	I-T047
sinusitis	O	O	I-T047
is	O	O	O
seen	O	O	O
more	O	O	O
commonly	O	O	B-T081
in	O	O	O
adolescent	O	O	B-T100
males	O	O	I-T100
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	B-T081
complication	O	O	B-T046
was	O	O	O
orbital	O	O	B-T030
.	O	O	O

Surgical	O	O	B-T061
treatment	O	O	I-T061
is	O	O	O
indicated	O	O	O
for	O	O	O
those	O	O	O
patients	O	O	B-T101
who	O	O	O
fail	O	O	B-T169
medical	O	O	B-T169
management	O	O	B-T057
and	O	O	O
should	O	O	O
consist	O	O	O
of	O	O	O
an	O	O	O
endoscopic	O	O	B-T082
approach	O	O	I-T082
which	O	O	O
may	O	O	O
be	O	O	O
combined	O	O	O
with	O	O	O
open	O	O	O
approaches	O	O	O
if	O	O	O
indicated	O	O	O
.	O	O	O

-DOCSTART- (27619227)

Comparative	O	O	O
proteomic	O	O	B-T059
analysis	O	O	I-T059
reveals	O	O	O
alterations	O	O	B-T078
in	O	O	O
development	O	O	B-T040
and	O	O	O
photosynthesis	O	O	B-T070
-related	O	O	O
proteins	O	O	B-T116
in	O	O	O
diploid	O	O	B-T032
and	O	O	O
triploid	O	O	B-T049
rice	O	O	O

Polyploidy	O	O	B-T049
has	O	O	O
pivotal	O	O	O
influences	O	O	B-T077
on	O	O	O
rice	O	O	B-T002
(	O	O	O
Oryza	O	O	B-T002
sativa	O	O	I-T002
L.	O	O	I-T002
)	O	O	O
morphology	O	O	B-T080
and	O	O	O
physiology	O	O	B-T039
,	O	O	O
and	O	O	O
is	O	O	O
very	O	O	O
important	O	O	O
for	O	O	O
understanding	O	O	O
rice	O	O	O
domestication	O	O	B-T078
and	O	O	O
improving	O	O	O
agricultural	O	O	B-T032
traits	O	O	I-T032
.	O	O	O

Diploid	O	O	B-T032
(	O	O	O
DP	O	O	B-T032
)	O	O	O
and	O	O	O
triploid	O	O	B-T049
(	O	O	O
TP	O	O	B-T049
)	O	O	O
rice	O	O	B-T002
shows	O	O	O
differences	O	O	B-T080
in	O	O	O
morphological	O	O	B-T080
parameters	O	O	B-T033
,	O	O	O
such	O	O	O
as	O	O	O
plant	O	O	B-T002
height	O	O	B-T032
,	O	O	O
leaf	O	O	B-T002
length	O	O	B-T081
,	O	O	O
leaf	O	O	O
width	O	O	B-T081
and	O	O	O
the	O	O	O
physiological	O	O	B-T169
index	O	O	B-T170
of	O	O	O
chlorophyll	O	O	B-T109
content	O	O	B-T077
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
determining	O	O	O
these	O	O	O
morphological	O	O	B-T080
differences	O	O	B-T080
are	O	O	O
remain	O	O	O
to	O	O	O
be	O	O	O
defined	O	O	O
.	O	O	O

To	O	O	O
better	O	O	O
understand	O	O	O
the	O	O	O
proteomic	O	O	B-T116
changes	O	O	B-T169
between	O	O	O
DP	O	O	B-T032
and	O	O	O
TP	O	O	B-T049
,	O	O	O
tandem	O	O	B-T059
mass	O	O	I-T059
tags	O	O	I-T059
(	O	O	I-T059
TMT	O	O	I-T059
)	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	I-T059
MS	O	O	B-T059
)	O	O	I-T059
/	O	O	O
MS	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
detect	O	O	O
the	O	O	O
significant	O	O	O
changes	O	O	O
to	O	O	O
protein	O	O	B-T045
expression	O	O	I-T045
between	O	O	O
DP	O	O	O
and	O	O	O
TP	O	O	O
.	O	O	O

Results	O	O	O
indicated	O	O	O
that	O	O	O
both	O	O	O
photosynthesis	O	O	B-T070
and	O	O	O
metabolic	O	O	B-T169
pathways	O	O	B-T044
were	O	O	O
highly	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
proteomic	O	O	B-T044
alteration	O	O	I-T044
between	O	O	O
DP	O	O	B-T032
and	O	O	O
TP	O	O	B-T049
based	O	O	O
on	O	O	O
biological	O	O	B-T038
process	O	O	I-T038
and	O	O	O
pathway	O	O	B-T059
enrichment	O	O	I-T059
analysis	O	O	I-T059
,	O	O	O
and	O	O	O
13	O	O	O
higher	O	O	O
abundance	O	O	B-T080
chloroplast	O	O	B-T116
proteins	O	O	I-T116
involving	O	O	O
in	O	O	O
these	O	O	O
two	O	O	O
pathways	O	O	O
were	O	O	O
identified	O	O	B-T080
in	O	O	O
TP	O	O	O
.	O	O	O

Quantitative	O	O	B-T063
real-time	O	O	I-T063
PCR	O	O	I-T063
analysis	O	O	I-T063
demonstrated	O	O	O
that	O	O	O
5	O	O	O
of	O	O	O
the	O	O	O
13	O	O	O
chloroplast	O	O	B-T116
proteins	O	O	I-T116
ATPF	O	O	B-T116
,	O	O	O
PSAA	O	O	B-T116
,	O	O	O
PSAB	O	O	B-T116
,	O	O	O
PSBB	O	O	B-T116
and	O	O	O
RBL	O	O	B-T116
in	O	O	O
TP	O	O	B-T049
were	O	O	O
higher	O	O	O
abundance	O	O	B-T080
compared	O	O	O
with	O	O	O
those	O	O	O
in	O	O	O
DP	O	O	B-T032
.	O	O	O

This	O	O	O
study	O	O	B-T062
integrates	O	O	O
morphology	O	O	B-T080
,	O	O	O
physiology	O	O	B-T039
and	O	O	O
proteomic	O	O	B-T059
profiling	O	O	I-T059
alteration	O	O	B-T078
of	O	O	O
DP	O	O	B-T032
and	O	O	O
TP	O	O	B-T049
to	O	O	O
address	O	O	O
their	O	O	O
underlying	O	O	O
different	O	O	O
molecular	O	O	B-T044
mechanisms	O	O	I-T044
.	O	O	O

Our	O	O	O
finding	O	O	O
revealed	O	O	O
that	O	O	O
ATPF	O	O	B-T116
,	O	O	O
PSAA	O	O	B-T116
,	O	O	O
PSAB	O	O	B-T116
,	O	O	O
PSBB	O	O	B-T116
and	O	O	O
RBL	O	O	B-T116
can	O	O	O
induce	O	O	O
considerable	O	O	O
expression	O	O	B-T045
changes	O	O	B-T169
in	O	O	O
TP	O	O	B-T049
and	O	O	O
may	O	O	O
affect	O	O	O
the	O	O	O
development	O	O	B-T040
and	O	O	O
growth	O	O	B-T040
of	O	O	O
rice	O	O	B-T002
through	O	O	O
photosynthesis	O	O	B-T070
and	O	O	O
metabolic	O	O	B-T169
pathways	O	O	I-T169
.	O	O	O

-DOCSTART- (27621870)

Correlation	O	O	B-T080
of	O	O	O
cardiopulmonary	O	O	B-T060
exercise	O	O	I-T060
testing	O	O	I-T060
parameters	O	O	B-T077
with	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
in	O	O	O
stable	O	O	B-T033
COPD	O	O	B-T047
patients	O	O	O

The	O	O	O
precise	O	O	O
head	O	O	O
to	O	O	O
head	O	O	O
relationships	O	O	B-T080
between	O	O	O
Cardio-pulmonary	O	O	B-T060
exercise	O	O	I-T060
testing	O	O	I-T060
(	O	O	O
CPET	O	O	B-T060
)	O	O	O
parameters	O	O	B-T077
and	O	O	O
patients	O	O	B-T101
'	O	O	O
daily	O	O	B-T033
symptoms	O	O	I-T033
/	O	O	O
activities	O	O	B-T056
and	O	O	O
the	O	O	O
disease	O	O	B-T047
social	O	O	B-T080
/	O	O	O
emotional	O	O	B-T201
impact	O	O	I-T201
are	O	O	O
less	O	O	O
well	O	O	O
defined	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
the	O	O	O
correlation	O	O	B-T080
of	O	O	O
COPD	O	O	B-T047
daily	O	O	B-T033
symptoms	O	O	I-T033
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
[	O	O	O
assessed	O	O	O
by	O	O	O
St.	O	O	B-T170
George	O	O	I-T170
's	O	O	I-T170
Respiratory	O	O	I-T170
Questionnaire	O	O	I-T170
(	O	O	O
SGRQ	O	O	B-T170
)	O	O	O
]	O	O	O
and	O	O	O
COPD	O	O	O
severity	O	O	B-T170
index	O	O	I-T170
(	O	O	O
BODE-index	O	O	B-T170
)	O	O	O
with	O	O	O
CPET	O	O	B-T060
parameters	O	O	B-T077
were	O	O	O
investigated	O	O	O
.	O	O	O

Symptom	O	O	B-T184
-limited	O	O	O
CPET	O	O	B-T060
was	O	O	O
performed	O	O	O
in	O	O	O
37	O	O	O
consecutive	O	O	B-T080
COPD	O	O	B-T047
(	O	O	O
GOLD	O	O	B-T060
I-III	O	O	I-T060
)	O	O	O
subjects	O	O	O
during	O	O	O
non-	O	O	O
exacerbation	O	O	B-T047
phase	O	O	B-T079
.	O	O	O

The	O	O	O
SGRQ	O	O	B-T170
was	O	O	O
also	O	O	O
completed	O	O	O
by	O	O	O
each	O	O	O
patient	O	O	B-T101
.	O	O	O

SGRQ-score	O	O	B-T201
correlated	O	O	B-T080
negatively	O	O	B-T033
with	O	O	O
FEV1	O	O	B-T060
(	O	O	O
r=-0.49	O	O	O
,	O	O	O
P<0.01	O	O	O
)	O	O	O
,	O	O	O
predicted	O	O	B-T078
maximal	O	O	B-T033
work-rate	O	O	I-T033
(	O	O	O
%	O	O	B-T033
WR-max	O	O	I-T033
)	O	O	O
(	O	O	O
r=-0.44	O	O	O
,	O	O	O
P<0.01	O	O	O
)	O	O	O
,	O	O	O
V'O2	O	O	B-T033
/	O	O	O
WR	O	O	B-T201
(	O	O	O
r=-0.52	O	O	O
,	O	O	O
P<0.01	O	O	O
)	O	O	O
and	O	O	O
breathing	O	O	B-T081
reserve	O	O	I-T081
(	O	O	O
r=-0.50	O	O	O
,	O	O	O
P<0.01	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
it	O	O	O
did	O	O	B-T033
not	O	O	I-T033
correlate	O	O	I-T033
with	O	O	O
Peak-V'O2	O	O	B-T033
%	O	O	O
predicted	O	O	O
(	O	O	O
r=-0.27	O	O	O
,	O	O	O
P=0.10	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
20	O	O	O
(	O	O	O
54.1	O	O	O
%	O	O	O
)	O	O	O
subjects	O	O	O
in	O	O	O
which	O	O	O
leg	O	O	B-T033
fatigue	O	O	I-T033
was	O	O	I-T033
the	O	O	I-T033
main	O	O	I-T033
cause	O	O	I-T033
for	O	O	I-T033
stopping	O	O	I-T033
the	O	O	I-T033
test	O	O	I-T033
,	O	O	O
Peak-V'O2	O	O	B-T033
,	O	O	O
%	O	O	B-T033
WR-max	O	O	I-T033
,	O	O	O
HR-Reserve	O	O	B-T081
and	O	O	O
Breathing	O	O	B-T081
reserve	O	O	I-T081
were	O	O	O
higher	O	O	O
(	O	O	O
P=0.04	O	O	O
,	O	O	O
<	O	O	O
0.01	O	O	O
,	O	O	O
0.04	O	O	O
and	O	O	O
<	O	O	O
0.01	O	O	O
respectively	O	O	O
)	O	O	O
than	O	O	O
the	O	O	O
others	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
also	O	O	O
a	O	O	O
significant	O	O	B-T081
correlation	O	O	B-T080
between	O	O	O
BODE-index	O	O	B-T170
and	O	O	O
∆VO2	O	O	B-T033
/	O	O	O
∆WR	O	O	B-T201
(	O	O	O
r=-0.64	O	O	O
,	O	O	O
P<0.001	O	O	O
)	O	O	O
and	O	O	O
breathing-reserve	O	O	B-T081
(	O	O	O
r=-0.38	O	O	O
,	O	O	O
P=0.018	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
observed	O	O	O
relationships	O	O	B-T080
between	O	O	O
CPET	O	O	B-T060
parameter	O	O	B-T077
and	O	O	O
daily	O	O	B-T079
subjective	O	O	B-T041
complaints	O	O	I-T041
in	O	O	O
COPD	O	O	B-T047
were	O	O	O
not	O	O	O
strong	O	O	O
.	O	O	O

Those	O	O	O
who	O	O	O
discontinued	O	O	O
the	O	O	O
CPET	O	O	B-T060
because	O	O	B-T033
of	O	O	I-T033
leg	O	O	I-T033
fatigue	O	O	I-T033
were	O	O	O
in	O	O	O
the	O	O	O
earlier	O	O	B-T079
stages	O	O	I-T079
of	O	O	O
COPD	O	O	B-T047
.	O	O	O

Significant	O	O	O
negative	O	O	B-T033
correlation	O	O	B-T080
between	O	O	O
∆VO2	O	O	B-T033
/	O	O	O
∆WR	O	O	B-T201
and	O	O	O
BODE-index	O	O	B-T170
suggests	O	O	O
that	O	O	O
along	O	O	O
with	O	O	O
COPD	O	O	B-T047
progression	O	O	B-T046
,	O	O	O
regardless	O	O	O
of	O	O	O
negative	O	O	B-T033
past	O	O	I-T033
history	O	O	I-T033
,	O	O	O
other	O	O	O
comorbidities	O	O	B-T078
such	O	O	O
as	O	O	O
cardiac	O	O	B-T033
/	O	O	O
musculoskeletal	O	O	B-T033
problems	O	O	I-T033
should	O	O	O
be	O	O	O
sought	O	O	O
.	O	O	O

-DOCSTART- (27621953)

Intrapartum	O	O	B-T079
Cervical	O	O	B-T037
Laceration	O	O	I-T037
and	O	O	O
Subsequent	O	O	O
Pregnancy	O	O	O
Outcomes	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
describe	O	O	O
pregnancy	O	O	B-T040
outcomes	O	O	I-T033
,	O	O	O
including	O	O	O
cervical	O	O	B-T047
insufficiency	O	O	I-T047
and	O	O	O
preterm	O	O	B-T033
birth	O	O	I-T033
,	O	O	O
in	O	O	O
the	O	O	O
subsequent	O	O	O
pregnancy	O	O	O
following	O	O	B-T079
an	O	O	O
intrapartum	O	O	B-T079
cervical	O	O	B-T037
laceration	O	O	I-T037
.	O	O	O

Retrospective	O	O	O
cohort	O	O	B-T098
of	O	O	O
women	O	O	B-T098
with	O	O	O
their	O	O	O
first	O	O	O
two	O	O	O
consecutive	O	O	B-T080
singleton	O	O	B-T040
pregnancies	O	O	I-T040
carried	O	O	O
to	O	O	O
≥	O	O	O
20(0/7	O	O	O
)	O	O	O
weeks	O	O	B-T079
'	O	O	O
gestation	O	O	B-T040
within	O	O	O
a	O	O	O
tertiary	O	O	B-T093
health	O	O	I-T093
care	O	O	I-T093
system	O	O	I-T093
from	O	O	O
2002	O	O	O
to	O	O	O
2012	O	O	O
.	O	O	O

Cervical	O	O	B-T037
laceration	O	O	I-T037
cases	O	O	B-T077
were	O	O	O
identified	O	O	B-T080
by	O	O	O
ICD9	O	O	B-T170
codes	O	O	I-T170
and	O	O	O
included	O	O	B-T169
if	O	O	O
suture	O	O	B-T061
repair	O	O	I-T061
was	O	O	O
required	O	O	B-T169
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
55	O	O	O
women	O	O	B-T098
were	O	O	O
confirmed	O	O	B-T033
to	O	O	O
have	O	O	O
a	O	O	O
cervical	O	O	B-T037
laceration	O	O	I-T037
in	O	O	O
the	O	O	O
first	O	O	O
delivery	O	O	B-T040
;	O	O	O
43	O	O	O
lacerations	O	O	B-T037
after	O	O	O
vaginal	O	O	B-T061
delivery	O	O	I-T061
(	O	O	B-T061
VD	O	O	I-T061
)	O	O	I-T061
and	O	O	O
12	O	O	O
after	O	O	O
cesarean	O	O	B-T061
delivery	O	O	I-T061
(	O	O	B-T061
CD	O	O	I-T061
)	O	O	I-T061
.	O	O	O

The	O	O	O
median	O	O	B-T081
gestational	O	O	B-T032
age	O	O	I-T032
of	O	O	O
the	O	O	O
first	O	O	O
delivery	O	O	B-T040
was	O	O	O
40(0/7	O	O	O
)	O	O	O
weeks	O	O	B-T079
and	O	O	O
the	O	O	O
median	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
3,545	O	O	O
g	O	O	O
;	O	O	O
these	O	O	O
did	O	O	O
not	O	O	O
differ	O	O	B-T080
between	O	O	O
VD	O	O	B-T061
and	O	O	O
CD	O	O	B-T061
.	O	O	O

In	O	O	O
the	O	O	O
second	O	O	O
pregnancy	O	O	B-T040
,	O	O	O
2	O	O	O
of	O	O	O
55	O	O	O
women	O	O	B-T098
(	O	O	O
4.6	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
a	O	O	O
prophylactic	O	O	B-T169
cerclage	O	O	B-T061
placed	O	O	O
;	O	O	O
1	O	O	O
carried	O	O	B-T052
to	O	O	O
term	O	O	B-T040
and	O	O	O
the	O	O	O
other	O	O	O
delivered	O	O	B-T033
at	O	O	O
35(6/7	O	O	O
)	O	O	O
weeks	O	O	B-T079
.	O	O	O

In	O	O	O
total	O	O	B-T080
,	O	O	O
four	O	O	O
women	O	O	B-T098
(	O	O	O
9.3	O	O	O
%	O	O	O
)	O	O	O
delivered	O	O	B-T033
the	O	O	O
second	O	O	O
pregnancy	O	O	B-T040
<	O	O	O
37	O	O	O
weeks	O	O	B-T079
:	O	O	O
three	O	O	O
had	O	O	O
a	O	O	O
prior	O	O	B-T079
term	O	O	B-T040
VD	O	O	B-T061
and	O	O	O
one	O	O	O
had	O	O	O
a	O	O	O
prior	O	O	O
34	O	O	O
weeks	O	O	O
VD	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
only	O	O	O
one	O	O	O
case	O	O	B-T077
of	O	O	O
recurrent	O	O	B-T079
cervical	O	O	B-T037
laceration	O	O	I-T037
,	O	O	O
occurring	O	O	B-T052
in	O	O	O
the	O	O	O
setting	O	O	B-T169
of	O	O	O
vaginal	O	O	B-T061
deliveries	O	O	I-T061
.	O	O	O

Obstetric	O	O	B-T169
cervical	O	O	B-T037
lacerations	O	O	I-T037
are	O	O	O
uncommon	O	O	B-T080
.	O	O	O

Complications	O	O	B-T046
in	O	O	O
the	O	O	O
following	O	O	B-T079
pregnancy	O	O	B-T040
were	O	O	O
low	O	O	B-T080
,	O	O	O
despite	O	O	O
lack	O	O	B-T080
of	O	O	O
additional	O	O	O
prophylactic	O	O	B-T169
cerclage	O	O	B-T061
use	O	O	O
.	O	O	O

-DOCSTART- (27623760)

A	O	O	O
Wnt	O	O	B-T044
Pathway	O	O	I-T044
Activator	O	O	B-T109
Induces	O	O	B-T043
Apoptosis	O	O	I-T043
and	O	O	O
Cell	O	O	B-T043
Death	O	O	I-T043
in	O	O	O
Mouse	O	O	B-T191
Monocytic	O	O	I-T191
Leukemia	O	O	I-T191
Cells	O	O	O

A	O	O	O
Wnt	O	O	B-T116
agonist	O	O	I-T109
,	O	O	I-T109
2-amino-4-[3,4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl	O	O	B-T109
)	O	O	I-T109
pyrimidine	O	O	I-T109
,	O	O	O
is	O	O	O
a	O	O	O
cell-permeable	O	O	B-T043
pyrimidine	O	O	B-T109
compound	O	O	I-T109
that	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
mimic	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
Wnt	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
leukemic	O	O	B-T025
mouse	O	O	I-T025
cell	O	O	I-T025
lines	O	O	I-T025
,	O	O	O
RAW	O	O	B-T025
264.7	O	O	I-T025
and	O	O	O
J774.1	O	O	B-T025
,	O	O	O
were	O	O	O
incubated	O	O	O
with	O	O	O
the	O	O	O
Wnt	O	O	B-T109
agonist	O	O	I-T109
.	O	O	O

The	O	O	O
Wnt	O	O	B-T109
agonist	O	O	I-T109
showed	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
in	O	O	O
the	O	O	O
concentration	O	O	O
of	O	O	O
1	O	O	O
-	O	O	O
10	O	O	O
μM.	O	O	O
The	O	O	O
Wnt	O	O	O
agonist	O	O	O
did	O	O	O
not	O	O	O
show	O	O	O
inhibition	O	O	B-T052
of	O	O	O
GSK-3β	O	O	B-T116
activity	O	O	B-T044
but	O	O	O
induced	O	O	B-T169
β-catenin	O	O	B-T044
accumulation	O	O	I-T044
in	O	O	O
the	O	O	O
nucleus	O	O	B-T026
.	O	O	O

The	O	O	O
Wnt	O	O	B-T109
agonist	O	O	I-T109
showed	O	O	O
caspase-independent	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
,	O	O	O
but	O	O	O
no	O	O	O
further	O	O	O
involvement	O	O	O
in	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
ER	O	O	I-T043
stress	O	O	I-T043
signaling	O	O	I-T043
.	O	O	O

Here	O	O	O
we	O	O	O
discuss	O	O	O
the	O	O	O
possible	O	O	O
mechanism	O	O	O
of	O	O	O
Wnt	O	O	B-T109
agonist	O	O	I-T109
-	O	O	O
induced	O	O	B-T043
apoptotic	O	O	I-T043
cell	O	O	I-T043
death	O	O	I-T043
in	O	O	O
RAW	O	O	B-T025
264.7	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (27625333)

Extracorporeal	O	O	B-T061
membrane	O	O	I-T061
oxygenation	O	O	I-T061
outcomes	O	O	B-T169
in	O	O	O
children	O	O	B-T100
with	O	O	O
hemophagocytic	O	O	O
lymphohistiocytosis	O	O	O

Pediatric	O	O	B-T080
patients	O	O	B-T101
with	O	O	O
hemophagocytic	O	O	B-T047
lymphohistiocytosis	O	O	I-T047
(	O	O	O
HLH	O	O	B-T047
)	O	O	O
may	O	O	O
develop	O	O	O
refractory	O	O	B-T169
respiratory	O	O	B-T047
or	O	O	O
cardiac	O	O	B-T047
failure	O	O	I-T047
that	O	O	O
warrants	O	O	O
consideration	O	O	B-T033
for	O	O	O
extracorporeal	O	O	B-T061
membrane	O	O	I-T061
oxygenation	O	O	I-T061
(	O	O	O
ECMO	O	O	B-T061
)	O	O	O
support	O	O	B-T074
.	O	O	O

The	O	O	O
purposes	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
were	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
use	O	O	B-T169
and	O	O	O
outcomes	O	O	B-T080
of	O	O	O
ECMO	O	O	B-T061
in	O	O	O
pediatric	O	O	B-T080
HLH	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
to	O	O	O
identify	O	O	B-T080
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
hospital	O	O	B-T080
mortality	O	O	I-T080
and	O	O	O
to	O	O	O
compare	O	O	B-T052
their	O	O	O
ECMO	O	O	O
use	O	O	O
and	O	O	O
outcomes	O	O	O
to	O	O	O
the	O	O	O
ECMO	O	O	O
population	O	O	B-T098
as	O	O	O
a	O	O	O
whole	O	O	O
.	O	O	O

Pediatric	O	O	B-T080
patients	O	O	B-T101
(	O	O	O
⩽	O	O	O
18	O	O	O
years	O	O	B-T079
)	O	O	O
with	O	O	O
a	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
HLH	O	O	B-T047
in	O	O	O
the	O	O	O
Extracorporeal	O	O	B-T058
Life	O	O	I-T058
Support	O	O	I-T058
Organization	O	O	I-T058
(	O	O	O
ELSO	O	O	B-T058
)	O	O	O
Registry	O	O	B-T170
were	O	O	O
included	O	O	B-T169
.	O	O	O

Between	O	O	O
1983	O	O	O
and	O	O	O
2014	O	O	O
,	O	O	O
data	O	O	B-T078
for	O	O	O
30	O	O	O
children	O	O	B-T100
with	O	O	O
HLH	O	O	B-T047
were	O	O	O
available	O	O	O
in	O	O	O
the	O	O	O
ELSO	O	O	B-T058
registry	O	O	B-T170
and	O	O	O
all	O	O	O
were	O	O	O
included	O	O	B-T169
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

All	O	O	O
cases	O	O	B-T077
occurred	O	O	B-T052
in	O	O	O
the	O	O	O
last	O	O	B-T079
decade	O	O	B-T081
.	O	O	O

Of	O	O	O
the	O	O	O
30	O	O	O
HLH	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
24	O	O	O
(	O	O	O
80	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
a	O	O	O
respiratory	O	O	B-T047
indication	O	O	B-T078
for	O	O	O
ECMO	O	O	B-T061
and	O	O	O
six	O	O	O
(	O	O	O
20	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
a	O	O	O
cardiac	O	O	B-T047
indication	O	O	O
(	O	O	O
of	O	O	O
which	O	O	O
4	O	O	O
were	O	O	O
E	O	O	B-T082
-	O	O	O
CPR	O	O	B-T061
and	O	O	O
2	O	O	O
cardiac	O	O	B-T047
failure	O	O	I-T047
)	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
24	O	O	O
respiratory	O	O	B-T047
ECMO	O	O	B-T061
patients	O	O	B-T101
,	O	O	O
63	O	O	O
%	O	O	O
were	O	O	O
placed	O	O	O
on	O	O	O
VA	O	O	B-T061
ECMO	O	O	I-T061
.	O	O	O

Compared	O	O	B-T052
with	O	O	O
all	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
in	O	O	O
the	O	O	O
ELSO	O	O	B-T058
registry	O	O	B-T170
during	O	O	O
the	O	O	O
study	O	O	B-T079
period	O	O	I-T079
(	O	O	O
n=17,007	O	O	O
)	O	O	O
,	O	O	O
HLH	O	O	B-T047
patients	O	O	O
had	O	O	O
worse	O	O	O
hospital	O	O	B-T169
survival	O	O	I-T169
(	O	O	O
non-HLH	O	O	O
59	O	O	O
%	O	O	O
vs	O	O	O
HLH	O	O	O
30	O	O	O
%	O	O	O
,	O	O	O
p	O	O	B-T081
=	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
pediatric	O	O	B-T080
HLH	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
no	O	O	O
pre-	O	O	O
ECMO	O	O	B-T061
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
mortality	O	O	B-T081
were	O	O	O
identified	O	O	B-T080
.	O	O	O

The	O	O	O
development	O	O	B-T169
of	O	O	O
a	O	O	O
hemorrhagic	O	O	B-T080
complication	O	O	B-T046
on	O	O	O
ECMO	O	O	B-T061
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
decreased	O	O	B-T081
mortality	O	O	B-T081
(	O	O	O
p	O	O	B-T081
=	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Comparing	O	O	B-T052
HLH	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
respiratory	O	O	B-T047
failure	O	O	I-T047
to	O	O	O
patients	O	O	O
with	O	O	O
other	O	O	O
immune	O	O	B-T201
compromised	O	O	I-T201
conditions	O	O	I-T201
,	O	O	O
the	O	O	O
overall	O	O	O
survival	O	O	B-T081
rate	O	O	I-T081
is	O	O	O
similar	O	O	O
(	O	O	O
HLH	O	O	O
38	O	O	O
%	O	O	O
vs.	O	O	O
non-HLH	O	O	O
immune	O	O	O
compromised	O	O	O
31	O	O	O
%	O	O	O
,	O	O	O
p	O	O	B-T081
=	O	O	O
0.64	O	O	O
)	O	O	O
.	O	O	O

HLH	O	O	B-T047
is	O	O	O
an	O	O	O
uncommon	O	O	B-T080
indication	O	O	B-T078
for	O	O	O
ECMO	O	O	B-T061
and	O	O	O
these	O	O	O
patients	O	O	B-T101
have	O	O	O
increased	O	O	B-T081
mortality	O	O	B-T081
compared	O	O	B-T052
to	O	O	O
the	O	O	O
overall	O	O	O
pediatric	O	O	B-T080
ECMO	O	O	O
population	O	O	B-T098
.	O	O	O

These	O	O	O
data	O	O	B-T078
should	O	O	O
be	O	O	O
factored	O	O	O
into	O	O	O
decision-making	O	O	B-T041
when	O	O	O
considering	O	O	O
ECMO	O	O	B-T061
for	O	O	O
pediatric	O	O	B-T080
HLH	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27625705)

Gut	O	O	B-T001
microbiome	O	O	I-T001
alterations	O	O	B-T078
in	O	O	O
patients	O	O	B-T101
with	O	O	O
stage	O	O	B-T080
4	O	O	I-T080
hepatitis	O	O	O
C	O	O	O

Hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
HCV	O	O	B-T005
)	O	O	O
causes	O	O	O
debilitating	O	O	O
liver	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
which	O	O	O
may	O	O	O
progress	O	O	O
to	O	O	O
cirrhosis	O	O	B-T047
and	O	O	O
cancer	O	O	B-T191
,	O	O	O
and	O	O	O
claims	O	O	O
500,000	O	O	O
annual	O	O	O
lives	O	O	O
worldwide	O	O	B-T078
.	O	O	O

While	O	O	O
HCV	O	O	B-T005
epidemiology	O	O	B-T062
,	O	O	O
pathophysiology	O	O	B-T046
,	O	O	O
and	O	O	O
therapy	O	O	B-T169
are	O	O	O
being	O	O	O
deeply	O	O	O
studied	O	O	O
,	O	O	O
rare	O	O	O
attention	O	O	O
is	O	O	O
given	O	O	O
to	O	O	O
reciprocal	O	O	B-T040
interactions	O	O	I-T040
between	O	O	O
HCV	O	O	B-T047
infection	O	O	I-T047
,	O	O	O
HCV	O	O	O
-induced	O	O	O
chronic	O	O	B-T047
liver	O	O	I-T047
diseases	O	O	I-T047
,	O	O	O
and	O	O	O
the	O	O	O
human	O	O	B-T016
gut	O	O	B-T001
microbiome	O	O	I-T001
.	O	O	O

As	O	O	O
Egypt	O	O	B-T083
has	O	O	O
the	O	O	O
world	O	O	B-T098
's	O	O	I-T098
highest	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
HCV	O	O	B-T005
infections	O	O	I-T047
,	O	O	O
we	O	O	O
launched	O	O	O
this	O	O	O
study	O	O	B-T062
to	O	O	O
monitor	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
gut	O	O	B-T001
microbial	O	O	I-T001
community	O	O	I-T001
composition	O	O	B-T201
of	O	O	O
Egyptian	O	O	B-T098
HCV	O	O	O
patients	O	O	B-T101
that	O	O	O
may	O	O	O
affect	O	O	O
,	O	O	O
or	O	O	O
result	O	O	O
from	O	O	O
,	O	O	O
the	O	O	O
patients	O	O	O
'	O	O	O
liver	O	O	B-T023
state	O	O	B-T169
.	O	O	O

To	O	O	O
this	O	O	O
end	O	O	O
,	O	O	O
we	O	O	O
analyzed	O	O	O
stool	O	O	B-T031
samples	O	O	I-T031
from	O	O	O
six	O	O	O
stage	O	O	B-T080
4	O	O	I-T080
-	O	O	O
HCV	O	O	B-T005
patients	O	O	B-T101
and	O	O	O
eight	O	O	O
healthy	O	O	B-T098
individuals	O	O	I-T098
by	O	O	O
high-throughput	O	O	B-T060
16S	O	O	B-T059
rRNA	O	O	I-T059
gene	O	O	I-T059
sequencing	O	O	I-T059
using	O	O	O
Illumina	O	O	B-T074
MiSeq	O	O	I-T074
.	O	O	O

Overall	O	O	O
,	O	O	O
the	O	O	O
alpha-diversity	O	O	B-T080
of	O	O	O
the	O	O	O
healthy	O	O	B-T098
persons	O	O	I-T098
'	O	O	I-T098
gut	O	O	B-T001
microbiomes	O	O	I-T001
was	O	O	O
higher	O	O	B-T080
than	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
HCV	O	O	B-T005
patients	O	O	B-T101
.	O	O	O

Whereas	O	O	O
members	O	O	O
of	O	O	O
phylum	O	O	B-T007
Bacteroidetes	O	O	I-T007
were	O	O	O
more	O	O	O
abundant	O	O	O
in	O	O	O
HCV	O	O	B-T005
patients	O	O	B-T101
,	O	O	O
healthy	O	O	B-T098
individuals	O	O	I-T098
had	O	O	O
higher	O	O	B-T080
abundance	O	O	B-T080
of	O	O	O
Firmicutes	O	O	B-T007
,	O	O	O
Proteobacteria	O	O	B-T007
,	O	O	O
and	O	O	O
Actinobacteria	O	O	B-T007
.	O	O	O

Genus	O	O	B-T185
-level	O	O	O
analysis	O	O	B-T062
showed	O	O	O
differential	O	O	O
abundance	O	O	B-T080
of	O	O	O
Prevotella	O	O	B-T007
and	O	O	O
Faecalibacterium	O	O	B-T007
(	O	O	O
higher	O	O	B-T080
in	O	O	O
HCV	O	O	B-T005
patients	O	O	B-T101
)	O	O	O
vs.	O	O	O

Ruminococcus	O	O	B-T007
and	O	O	O
Clostridium	O	O	B-T007
(	O	O	O
healthy	O	O	B-T078
group	O	O	I-T078
)	O	O	O
,	O	O	O
indicating	O	O	O
that	O	O	O
the	O	O	O
higher	O	O	B-T080
abundance	O	O	B-T080
of	O	O	O
Bacteroidetes	O	O	B-T007
in	O	O	O
HCV	O	O	B-T005
patients	O	O	B-T101
is	O	O	O
most	O	O	O
likely	O	O	O
due	O	O	O
to	O	O	O
Prevotella	O	O	B-T007
overabundance	O	O	B-T080
.	O	O	O

The	O	O	O
probiotic	O	O	B-T007
genus	O	O	I-T007
,	O	O	O
Bifidobacterium	O	O	B-T007
,	O	O	O
was	O	O	O
only	O	O	O
observed	O	O	O
in	O	O	O
the	O	O	O
microbiotas	O	O	B-T001
of	O	O	O
healthy	O	O	B-T098
individuals	O	O	I-T098
.	O	O	O

To	O	O	O
the	O	O	O
best	O	O	O
of	O	O	O
our	O	O	O
knowledge	O	O	O
,	O	O	O
this	O	O	O
study	O	O	B-T062
provides	O	O	O
a	O	O	O
first	O	O	O
overview	O	O	O
of	O	O	O
major	O	O	O
phyla	O	O	B-T185
and	O	O	O
genera	O	O	B-T185
differentiating	O	O	O
stage	O	O	B-T080
4	O	O	I-T080
-	O	O	O
HCV	O	O	B-T005
patients	O	O	B-T101
from	O	O	O
healthy	O	O	B-T098
individuals	O	O	I-T098
and	O	O	O
suggests	O	O	O
possible	O	O	O
microbiome	O	O	B-T001
remodeling	O	O	O
in	O	O	O
chronic	O	O	B-T047
hepatitis	O	O	I-T047
C	O	O	I-T047
,	O	O	O
possibly	O	O	O
shaped	O	O	O
by	O	O	O
bacterial	O	O	B-T043
translocation	O	O	I-T043
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
liver	O	O	B-T023
's	O	O	I-T023
impaired	O	O	B-T033
role	O	O	I-T033
in	O	O	O
digestion	O	O	B-T040
and	O	O	O
protein	O	O	B-T044
synthesis	O	O	I-T044
.	O	O	O

Future	O	O	O
studies	O	O	O
will	O	O	O
investigate	O	O	O
the	O	O	O
microbiome	O	O	B-T001
composition	O	O	B-T201
and	O	O	O
functional	O	O	O
capabilities	O	O	B-T080
in	O	O	O
more	O	O	O
patients	O	O	B-T101
while	O	O	O
tracing	O	O	O
some	O	O	O
potential	O	O	O
biomarker	O	O	B-T201
taxa	O	O	O
(	O	O	O
e.g.	O	O	O
,	O	O	O
Prevotella	O	O	B-T007
,	O	O	O
Faecalibacterium	O	O	B-T007
vs.	O	O	O
Bifidobacterium	O	O	B-T007
)	O	O	O
.	O	O	O

-DOCSTART- (27626099)

Peptide	O	O	B-T116
-Mediated	O	O	O
Interference	O	O	B-T070
of	O	O	O
PB2	O	O	B-T116
-	O	O	O
eIF4G1	O	O	B-T116
Interaction	O	O	B-T044
Inhibits	O	O	B-T052
Influenza	O	O	B-T005
A	O	O	I-T005
Viruses	O	O	I-T005
'	O	O	O
Replication	O	O	B-T043
in	O	O	B-T062
Vitro	O	O	I-T062
and	O	O	O
in	O	O	O
Vivo	O	O	O

Influenza	O	O	B-T005
viruses	O	O	I-T005
are	O	O	O
obligate	O	O	B-T204
parasites	O	O	I-T204
that	O	O	O
hijack	O	O	B-T043
the	O	O	I-T043
host	O	O	I-T043
cellular	O	O	I-T043
system	O	O	I-T043
.	O	O	O

Previous	O	O	O
results	O	O	O
have	O	O	O
shown	O	O	O
that	O	O	O
the	O	O	O
influenza	O	O	B-T116
virus	O	O	I-T116
PB2	O	O	I-T116
subunit	O	O	O
confers	O	O	O
a	O	O	O
dependence	O	O	O
of	O	O	O
host	O	O	B-T116
eukaryotic	O	O	I-T116
translation	O	O	I-T116
initiation	O	O	I-T116
factor	O	O	I-T116
4-γ	O	O	I-T116
1	O	O	I-T116
(	O	O	O
eIF4G1	O	O	B-T116
)	O	O	O
for	O	O	O
viral	O	O	B-T046
mRNA	O	O	I-T046
translation	O	O	I-T046
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
demonstrated	O	O	O
that	O	O	O
peptide	O	O	B-T116
-mediated	O	O	O
interference	O	O	B-T070
of	O	O	O
the	O	O	O
PB2	O	O	B-T116
-	O	O	O
eIF4G1	O	O	B-T116
interaction	O	O	B-T044
inhibited	O	O	B-T052
virus	O	O	B-T043
replication	O	O	I-T043
in	O	O	B-T062
vitro	O	O	I-T062
and	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
.	O	O	O

Remarkably	O	O	O
,	O	O	O
intranasal	O	O	B-T061
administration	O	O	I-T061
of	O	O	O
the	O	O	O
peptide	O	O	B-T116
provided	O	O	O
100	O	O	O
%	O	O	O
protection	O	O	B-T033
against	O	O	O
lethal	O	O	B-T033
challenges	O	O	B-T058
of	O	O	O
influenza	O	O	B-T005
A	O	O	I-T005
viruses	O	O	I-T005
in	O	O	O
BALB/c	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
including	O	O	O
H1N1	O	O	B-T005
,	O	O	O
H5N1	O	O	B-T005
,	O	O	O
and	O	O	O
H7N9	O	O	B-T005
influenza	O	O	I-T005
virus	O	O	I-T005
subtypes	O	O	I-T005
.	O	O	O

Mapping	O	O	B-T063
of	O	O	O
the	O	O	O
PB2	O	O	B-T116
protein	O	O	I-T116
indicated	O	O	O
that	O	O	O
the	O	O	O
eIF4G1	O	O	B-T116
binding	O	O	B-T192
sites	O	O	I-T192
resided	O	O	O
within	O	O	O
the	O	O	O
PB2	O	O	B-T116
cap	O	O	I-T116
-	O	O	O
binding	O	O	B-T044
domain	O	O	I-T044
.	O	O	O

Virtual	O	O	B-T170
docking	O	O	I-T170
analysis	O	O	I-T170
suggested	O	O	O
that	O	O	O

the	O	O	O
inhibitory	O	O	B-T052
peptide	O	O	B-T116
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
conserved	O	O	O
amino	O	O	B-T116
acid	O	O	I-T116
residues	O	O	I-T116
that	O	O	O
were	O	O	O
essential	O	O	O
to	O	O	O
PB2	O	O	B-T116
cap-binding	O	O	B-T059
activity	O	O	I-T059
.	O	O	O

Overall	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
identified	O	O	O
the	O	O	O
PB2	O	O	B-T116
-	O	O	O
eIF4G1	O	O	B-T116
interactive	O	O	B-T192
site	O	O	I-T192
as	O	O	O
a	O	O	O
druggable	O	O	B-T121
target	O	O	O
for	O	O	O
influenza	O	O	B-T047
therapeutics	O	O	B-T061
.	O	O	O

-DOCSTART- (27626498)

DRG1	O	O	B-T028
is	O	O	O
a	O	O	O
potential	O	O	O
oncogene	O	O	B-T028
in	O	O	O
lung	O	O	B-T191
adenocarcinoma	O	O	I-T191
and	O	O	O
promotes	O	O	B-T052
tumor	O	O	B-T191
progression	O	O	I-T191
via	O	O	O
spindle	O	O	B-T043
checkpoint	O	O	I-T043
signaling	O	O	I-T043
regulation	O	O	O

Developmentally	O	O	O
regulated	O	O	O
GTP	O	O	B-T116
binding	O	O	I-T116
protein	O	O	I-T116
1	O	O	I-T116
(	O	O	O
DRG1	O	O	B-T116
)	O	O	O
,	O	O	O
a	O	O	O
member	O	O	O
of	O	O	O
the	O	O	O
DRG	O	O	B-T116
family	O	O	I-T116
,	O	O	O
plays	O	O	O
important	O	O	O
roles	O	O	O
in	O	O	O
regulating	O	O	B-T043
cell	O	O	I-T043
growth	O	O	I-T043
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
molecular	O	O	B-T078
basis	O	O	I-T078
of	O	O	O
DRG1	O	O	B-T116
in	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
regulation	O	O	I-T043
and	O	O	O
the	O	O	O
relationship	O	O	O
between	O	O	O
DRG1	O	O	O
and	O	O	O
tumor	O	O	B-T191
progression	O	O	I-T191
remain	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
DRG1	O	O	B-T116
is	O	O	O
elevated	O	O	O
in	O	O	O
lung	O	O	B-T023
adenocarcinomas	O	O	I-T191
while	O	O	O
weakly	O	O	O
expressed	O	O	B-T045
in	O	O	O
adjacent	O	O	O
lung	O	O	O
tissues	O	O	B-T024
.	O	O	O

DRG1	O	O	B-T028
knockdown	O	O	B-T063
causes	O	O	O
growth	O	O	B-T043
inhibition	O	O	I-T043
of	O	O	O
tumor	O	O	B-T025
cells	O	O	B-T025
by	O	O	O
significantly	O	O	O
increasing	O	O	O
the	O	O	O
proportion	O	O	O
of	O	O	O
cells	O	O	O
in	O	O	O
M	O	O	B-T043
phase	O	O	I-T043
.	O	O	O

Overexpression	O	O	B-T045
of	O	O	O
DRG1	O	O	B-T116
leads	O	O	O
to	O	O	O
chromosome	O	O	B-T026
missegregation	O	O	B-T045
which	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
index	O	O	O
for	O	O	O
tumorigenesis	O	O	B-T191
.	O	O	O

Interestingly	O	O	O
,	O	O	O
ectopic	O	O	B-T045
of	O	O	O
DRG1	O	O	B-T028
reduces	O	O	O
taxol	O	O	B-T109
induced	O	O	B-T169
apoptosis	O	O	B-T043
of	O	O	O
lung	O	O	B-T191
adenocarcinoma	O	O	I-T191
cells	O	O	B-T025
.	O	O	O

Mechanistic	O	O	B-T022
analyses	O	O	B-T062
confirm	O	O	O
that	O	O	O
DRG1	O	O	B-T116
localizes	O	O	B-T082
at	O	O	O
mitotic	O	O	B-T026
spindles	O	O	I-T026
in	O	O	O
dividing	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
binds	O	O	B-T044
to	O	O	O
spindle	O	O	B-T043
checkpoint	O	O	I-T043
signaling	O	O	I-T043
proteins	O	O	B-T116
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

These	O	O	O
studies	O	O	B-T062
highlight	O	O	O
the	O	O	O
expanding	O	O	O
role	O	O	O
of	O	O	O
DRG1	O	O	B-T028
in	O	O	O
tumorigenesis	O	O	B-T191
and	O	O	O
reveal	O	O	O
a	O	O	O
mechanism	O	O	B-T169
of	O	O	O
DRG1	O	O	O
in	O	O	O
taxol	O	O	B-T109
resistance	O	O	O
.	O	O	O

-DOCSTART- (27627778)

Gelsolin	O	O	B-T116
in	O	O	O
Onychophora	O	O	B-T204
and	O	O	O
Tardigrada	O	O	B-T204
with	O	O	O
notes	O	O	O
on	O	O	O
its	O	O	O
variability	O	O	B-T077
in	O	O	O
the	O	O	O
Ecdysozoa	O	O	O

Rearrangements	O	O	B-T067
of	O	O	O
the	O	O	O
filamentous	O	O	B-T116
actin	O	O	I-T116
network	O	O	I-T116
involve	O	O	O
a	O	O	O
broad	O	O	O
range	O	O	B-T081
of	O	O	O
actin	O	O	B-T116
binding	O	O	I-T116
proteins	O	O	I-T116
.	O	O	O

Among	O	O	O
these	O	O	O
,	O	O	O
the	O	O	O
gelsolin	O	O	B-T116
proteins	O	O	I-T116
sever	O	O	O
actin	O	O	B-T026
filaments	O	O	I-T026
,	O	O	O
cap	O	O	O
their	O	O	O
fast	O	O	B-T033
growing	O	O	I-T033
end	O	O	O
and	O	O	O
nucleate	O	O	B-T044
actin	O	O	B-T043
assembly	O	O	I-T043
in	O	O	O
a	O	O	O
calcium	O	O	B-T121
-	O	O	O
dependent	O	O	B-T080
manner	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
focus	O	O	O
on	O	O	O
the	O	O	O
gelsolin	O	O	B-T116
of	O	O	O
the	O	O	O
onychophoran	O	O	B-T204
Peripatoides	O	O	B-T204
novaezealandiae	O	O	I-T204
and	O	O	O
the	O	O	O
eutardigrade	O	O	B-T204
Hypsibius	O	O	B-T204
dujardini	O	O	I-T204
.	O	O	O

From	O	O	O
the	O	O	O
cDNA	O	O	B-T114
of	O	O	O
P.	O	O	B-T204
novaezealandiae	O	O	I-T204
we	O	O	O
obtained	O	O	B-T169
the	O	O	O
complete	O	O	O
coding	O	O	B-T028
sequence	O	O	I-T028
with	O	O	O
an	O	O	O
open	O	O	B-T028
reading	O	O	I-T028
frame	O	O	I-T028
of	O	O	O
2178	O	O	O
bp	O	O	B-T044
.	O	O	O

It	O	O	O
encodes	O	O	B-T052
a	O	O	O
protein	O	O	B-T116
of	O	O	O
726	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
with	O	O	O
a	O	O	O
calculated	O	O	B-T052
molecular	O	O	B-T081
mass	O	O	I-T081
of	O	O	O
82,610.9Da	O	O	O
and	O	O	O
a	O	O	O
pI	O	O	O
of	O	O	O
5.57	O	O	O
.	O	O	O

This	O	O	O
sequence	O	O	B-T087
is	O	O	O
comprised	O	O	B-T052
of	O	O	O
six	O	O	O
segments	O	O	B-T082
(	O	O	O
S1-S6	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
analysis	O	O	B-T062
of	O	O	O
data	O	O	B-T078
from	O	O	O
TardiBase	O	O	B-T170
reveals	O	O	B-T080
that	O	O	O
the	O	O	O
gelsolin	O	O	B-T116
of	O	O	O
the	O	O	O
eutardigrade	O	O	B-T204
Hypsibius	O	O	B-T204
dujardini	O	O	I-T204
has	O	O	O
only	O	O	O
three	O	O	O
segments	O	O	B-T082
(	O	O	O
S1-S3	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
coding	O	O	B-T028
sequence	O	O	I-T028
consist	O	O	O
of	O	O	O
1119	O	O	O
bp	O	O	B-T044
for	O	O	O
373	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
with	O	O	O
a	O	O	O
calculated	O	O	B-T052
molecular	O	O	B-T081
mass	O	O	I-T081
of	O	O	O
42,440.95Da	O	O	O
and	O	O	O
a	O	O	O
pI	O	O	O
of	O	O	O
6.17	O	O	O
.	O	O	O

The	O	O	O
Peripatoides	O	O	B-T204
and	O	O	O
Hypsibius	O	O	B-T204
gelsolin	O	O	B-T116
revealed	O	O	B-T080
both	O	O	O
conserved	O	O	B-T086
binding	O	O	B-T044
motifs	O	O	I-T116
for	O	O	O
G-actin	O	O	B-T116
,	O	O	O
F-actin	O	O	B-T116
and	O	O	O
phosphatidylinositol	O	O	B-T109
4,5-bisphosphate	O	O	I-T109
(	O	O	O
PIP2	O	O	B-T109
)	O	O	O
,	O	O	O
along	O	O	O
with	O	O	O
a	O	O	O
full	O	O	O
set	O	O	O
of	O	O	O
type-1	O	O	B-T192
and	O	O	O
type-2	O	O	B-T192
Ca(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
-	O	O	O
binding	O	O	B-T192
sites	O	O	I-T192
which	O	O	O
could	O	O	O
result	O	O	B-T169
in	O	O	O
the	O	O	O
binding	O	O	O
of	O	O	O
eight	O	O	O
and	O	O	O
four	O	O	O
calcium	O	O	B-T121
ions	O	O	I-T121
,	O	O	O
respectively	O	O	O
.	O	O	O

Both	O	O	O
gelsolin	O	O	B-T116
proteins	O	O	I-T116
lack	O	O	B-T080
a	O	O	O
C-terminal	O	O	B-T087
latch-helix	O	O	B-T082
indicating	O	O	O
a	O	O	O
more	O	O	O
rapid	O	O	B-T080
activation	O	O	B-T052
in	O	O	O
the	O	O	O
submicromolar	O	O	O
Ca(2	O	O	B-T059
+	O	O	I-T059
)	O	O	I-T059
range	O	O	I-T059
.	O	O	O

We	O	O	O
suggest	O	O	O
that	O	O	O
a	O	O	O
gelsolin	O	O	B-T116
with	O	O	O
three	O	O	O
segments	O	O	B-T082
was	O	O	O
present	O	O	B-T033
in	O	O	O
the	O	O	O
last	O	O	O
common	O	O	O
ancestor	O	O	B-T099
of	O	O	O
the	O	O	O
ecdysozoan	O	O	B-T204
clade	O	O	O
Panarthropoda	O	O	B-T204
(	O	O	O
Onychophora	O	O	B-T204
,	O	O	O
Tardigrada	O	O	B-T204
,	O	O	O
Arthropoda	O	O	B-T204
)	O	O	O
,	O	O	O
primarily	O	O	B-T080
because	O	O	O
the	O	O	O
gelsolin	O	O	O
of	O	O	O
all	O	O	O
non-Ecdysozoa	O	O	O
studied	O	O	B-T062
so	O	O	O
far	O	O	O
(	O	O	O
except	O	O	O
Chordata	O	O	B-T008
)	O	O	O
reveals	O	O	B-T080
this	O	O	O
number	O	O	O
of	O	O	O
segments	O	O	O
.	O	O	O

Mapping	O	O	B-T059
of	O	O	O
our	O	O	O
molecular	O	O	B-T170
data	O	O	I-T170
onto	O	O	O
a	O	O	O
well-established	O	O	B-T080
phylogeny	O	O	B-T078
revealed	O	O	B-T080
that	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
gelsolin	O	O	B-T116
segments	O	O	B-T082
does	O	O	O
not	O	O	O
correlate	O	O	B-T080
with	O	O	O
the	O	O	O
phylogenetic	O	O	B-T078
lineage	O	O	B-T077
but	O	O	O
rather	O	O	O
with	O	O	O
particular	O	O	O
functional	O	O	B-T169
demands	O	O	O
to	O	O	O
alter	O	O	B-T169
the	O	O	O
kinetics	O	O	B-T070
of	O	O	O
actin	O	O	B-T043
polymerization	O	O	I-T043
.	O	O	O

-DOCSTART- (27628042)

MiR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
participates	O	O	B-T169
in	O	O	O
esophageal	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
invasion	O	O	B-T046
and	O	O	O
metastasis	O	O	B-T191
via	O	O	O
SMAD7	O	O	B-T028
pathway	O	O	B-T044
mediated	O	O	O
EMT	O	O	O

ESCC	O	O	B-T191
is	O	O	O
a	O	O	O
life-threatening	O	O	B-T033
disease	O	O	B-T047
due	O	O	O
to	O	O	O
invasion	O	O	B-T046
and	O	O	O
metastasis	O	O	B-T191
in	O	O	O
the	O	O	O
early	O	O	B-T079
stage	O	O	I-T079
.	O	O	O

Great	O	O	O
efforts	O	O	O
had	O	O	O
been	O	O	O
made	O	O	O
to	O	O	O
detect	O	O	B-T033
the	O	O	O
molecular	O	O	B-T080
mechanisms	O	O	B-T169
which	O	O	O
led	O	O	O
to	O	O	O
the	O	O	O
invasion	O	O	B-T046
and	O	O	O
metastasis	O	O	B-T191
in	O	O	O
ESCC	O	O	B-T191
.	O	O	O

Recent	O	O	O
evidence	O	O	B-T078
had	O	O	O
suggested	O	O	O
that	O	O	O
deregulation	O	O	B-T052
of	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
took	O	O	O
an	O	O	O
important	O	O	O
role	O	O	B-T077
in	O	O	O
cancers	O	O	B-T191
.	O	O	O

However	O	O	O
,	O	O	O
its	O	O	O
role	O	O	B-T077
and	O	O	O
functional	O	O	B-T169
mechanism	O	O	B-T169
in	O	O	O
ESCC	O	O	B-T191
had	O	O	O
seldom	O	O	B-T080
been	O	O	O
elucidated	O	O	O
.	O	O	O

The	O	O	O
expression	O	O	B-T081
levels	O	O	I-T081
of	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
were	O	O	O
detected	O	O	B-T033
in	O	O	O
ESCC	O	O	B-T191
tissues	O	O	B-T024
and	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
by	O	O	O
real-time	O	O	B-T063
PCR	O	O	I-T063
methods	O	O	I-T063
.	O	O	O

Then	O	O	O
,	O	O	O
the	O	O	O
invasion	O	O	B-T046
,	O	O	O
metastasis	O	O	B-T191
and	O	O	O
proliferation	O	O	B-T043
ability	O	O	O
of	O	O	O
ESCC	O	O	B-T191
cell	O	O	B-T025
lines	O	O	I-T025
transfected	O	O	B-T045
with	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
mimics	O	O	O
were	O	O	O
analyzed	O	O	B-T062
separately	O	O	O
by	O	O	O
transwell	O	O	B-T059
invasion	O	O	I-T059
assay	O	O	I-T059
,	O	O	O
wound	O	O	B-T059
healing	O	O	I-T059
assay	O	O	I-T059
and	O	O	O
cell	O	O	B-T062
proliferation	O	O	I-T062
assay	O	O	I-T062
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
target	O	O	B-T028
gene	O	O	I-T028
of	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
was	O	O	O
studied	O	O	O
and	O	O	O
verified	O	O	B-T169
by	O	O	O
luciferase	O	O	B-T059
activity	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

And	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
in	O	O	O
EMT	O	O	B-T043
was	O	O	O
also	O	O	O
investigated	O	O	B-T169
by	O	O	O
real-time	O	O	B-T063
PCR	O	O	I-T063
and	O	O	O
western	O	O	B-T059
blot	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

We	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
expression	O	O	B-T081
levels	O	O	I-T081
of	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
were	O	O	O
decreased	O	O	B-T081
both	O	O	O
in	O	O	O
ESCC	O	O	B-T191
tissues	O	O	B-T024
and	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
expression	O	O	B-T081
levels	O	O	I-T081
of	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
were	O	O	O
negatively	O	O	O
linked	O	O	O
to	O	O	O
lymph	O	O	B-T023
node	O	O	I-T023
metastasis	O	O	B-T191
in	O	O	O
ESCC	O	O	B-T191
tissues	O	O	B-T024
.	O	O	O

Restoration	O	O	O
of	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
in	O	O	O
EC-1	O	O	B-T025
cells	O	O	B-T025
by	O	O	O
using	O	O	O
miR-424	O	O	O
-	O	O	O
5p	O	O	O
mimics	O	O	O
could	O	O	O
decrease	O	O	B-T081
the	O	O	O
invasion	O	O	B-T046
,	O	O	O
metastasis	O	O	B-T191
and	O	O	O
proliferation	O	O	B-T043
of	O	O	O
EC-1	O	O	O
cells	O	O	O
,	O	O	O
indicating	O	O	O
its	O	O	O
role	O	O	B-T077
in	O	O	O
inhibition	O	O	B-T052
on	O	O	O
the	O	O	O
invasion	O	O	O
and	O	O	O
metastasis	O	O	O
ability	O	O	O
of	O	O	O
ESCC	O	O	B-T191
cells	O	O	O
and	O	O	O
tissues	O	O	B-T024
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
demonstrated	O	O	O
that	O	O	O
SMAD7	O	O	B-T028
was	O	O	O
a	O	O	O
specific	O	O	O
target	O	O	B-T028
gene	O	O	I-T028
for	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
by	O	O	O
luciferase	O	O	B-T059
activity	O	O	I-T059
assay	O	O	I-T059
and	O	O	O
miR-424	O	O	O
-	O	O	O
5p	O	O	O
could	O	O	O
not	O	O	O
only	O	O	O
negatively	O	O	B-T033
regulate	O	O	B-T045
SMAD7	O	O	O
expression	O	O	B-T045
but	O	O	O
also	O	O	O
participate	O	O	O
in	O	O	O
EMT	O	O	B-T043
via	O	O	O
SMAD7	O	O	O
,	O	O	O
because	O	O	O
overexpression	O	O	B-T045
of	O	O	O
SMAD7	O	O	O
could	O	O	O
partly	O	O	O
enhance	O	O	B-T052
the	O	O	O
miR-424	O	O	O
-	O	O	O
5p	O	O	O
anti-EMT	O	O	B-T033
function	O	O	B-T169
.	O	O	O

Our	O	O	O
results	O	O	B-T169
described	O	O	O
that	O	O	O
miR-424	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
-	O	O	O
SMAD7	O	O	B-T028
pathway	O	O	B-T044
contributed	O	O	O
to	O	O	O
ESCC	O	O	B-T191
invasion	O	O	B-T046
and	O	O	O
metastasis	O	O	B-T191
and	O	O	O
up-regulation	O	O	B-T044
of	O	O	O
miR-424	O	O	O
-	O	O	O
5p	O	O	O
perhaps	O	O	O
provided	O	O	O
a	O	O	O
strategy	O	O	O
for	O	O	O
preventing	O	O	B-T169
tumor	O	O	B-T033
invasion	O	O	I-T033
,	O	O	O
metastasis	O	O	O
.	O	O	O

-DOCSTART- (27628933)

Double-Network	O	O	B-T109
Hydrogel	O	O	I-T109
with	O	O	O
Tunable	O	O	B-T080
Mechanical	O	O	B-T052
Performance	O	O	I-T052
and	O	O	O
Biocompatibility	O	O	B-T044
for	O	O	O
the	O	O	O
Fabrication	O	O	B-T170
of	O	O	O
Stem	O	O	B-T025
Cells	O	O	I-T025
-	O	O	O
Encapsulated	O	O	B-T109
Fibers	O	O	I-T109
and	O	O	O
3D	O	O	O
Assemble	O	O	O

Fabrication	O	O	B-T170
of	O	O	O
cell	O	O	B-T025
-	O	O	O
encapsulated	O	O	B-T109
fibers	O	O	I-T109
could	O	O	O
greatly	O	O	O
contribute	O	O	B-T052
to	O	O	O
tissue	O	O	B-T061
engineering	O	O	I-T061
and	O	O	O
regenerative	O	O	B-T091
medicine	O	O	I-T091
.	O	O	O

However	O	O	O
,	O	O	O
existing	O	O	B-T080
methods	O	O	B-T169
suffered	O	O	O
from	O	O	O
not	O	O	O
only	O	O	O
unavoidability	O	O	B-T080
of	O	O	O
cell	O	O	B-T049
damaging	O	O	I-T049
conditions	O	O	B-T080
and/or	O	O	O
sophisticated	O	O	B-T073
equipment	O	O	I-T073
,	O	O	O
but	O	O	O
also	O	O	O
unavailability	O	O	B-T080
of	O	O	O
proper	O	O	O
materials	O	O	B-T167
to	O	O	O
satisfy	O	O	O
both	O	O	O
mechanical	O	O	B-T169
and	O	O	O
biological	O	O	B-T080
expectations	O	O	B-T078
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	B-T057
,	O	O	O
a	O	O	O
simple	O	O	B-T080
method	O	O	B-T169
is	O	O	O
proposed	O	O	B-T080
to	O	O	O
prepare	O	O	B-T052
cell	O	O	B-T025
-	O	O	O
encapsulated	O	O	B-T109
fibers	O	O	I-T109
with	O	O	O
tunable	O	O	B-T080
mechanical	O	O	B-T081
strength	O	O	I-T081
and	O	O	O
stretching	O	O	B-T080
behavior	O	O	I-T080
as	O	O	O
well	O	O	O
as	O	O	O
diameter	O	O	B-T081
and	O	O	O
microstructure	O	O	B-T104
.	O	O	O

The	O	O	O
hydrogel	O	O	B-T109
fibers	O	O	B-T109
are	O	O	O
made	O	O	O
from	O	O	O
optimal	O	O	B-T080
combination	O	O	B-T080
of	O	O	O
alginate	O	O	B-T109
and	O	O	O
poly(N-iso-propylacrylamide)-poly(ethylene	O	O	B-T122
glycol	O	O	I-T122
)	O	O	I-T122
,	O	O	O
characteristics	O	O	O
of	O	O	O
double-network	O	O	B-T109
hydrogel	O	O	I-T109
,	O	O	O
with	O	O	O
enough	O	O	O
stiffness	O	O	B-T184
and	O	O	O
flexibility	O	O	B-T080
to	O	O	O
create	O	O	B-T052
a	O	O	O
variety	O	O	B-T077
of	O	O	O
three	O	O	B-T082
dimensional	O	O	I-T082
structures	O	O	I-T082
like	O	O	O
parallel	O	O	B-T082
helical	O	O	I-T082
and	O	O	O
different	O	O	B-T080
knots	O	O	B-T082
without	O	O	I-T082
crack	O	O	I-T082
.	O	O	O

Furthermore	O	O	O
,	O	O	O
such	O	O	O
hydrogel	O	O	B-T109
fibers	O	O	B-T109
exhibit	O	O	O
better	O	O	B-T080
compatibility	O	O	B-T044
as	O	O	O
indicated	O	O	B-T033
by	O	O	O
the	O	O	O
viability	O	O	B-T080
,	O	O	O
proliferation	O	O	B-T169
and	O	O	O
expression	O	O	B-T169
of	O	O	O
pluripotency	O	O	B-T169
markers	O	O	B-T201
of	O	O	O
embryonic	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
encapsulated	O	O	B-T080
after	O	O	O
4-day	O	O	B-T033
culture	O	O	B-T059
.	O	O	O

The	O	O	O
double-network	O	O	B-T109
hydrogel	O	O	I-T109
possesses	O	O	B-T048
specific	O	O	B-T080
quick	O	O	B-T080
responses	O	O	B-T032
to	O	O	O
either	O	O	O
of	O	O	O
alginate	O	O	B-T116
lyase	O	O	I-T116
,	O	O	O
EDTA	O	O	B-T109
or	O	O	O
lower	O	O	O
environmental	O	O	B-T081
temperature	O	O	I-T081
which	O	O	O
facilitate	O	O	O
the	O	O	O
optional	O	O	O
degradation	O	O	B-T169
of	O	O	O
fibers	O	O	B-T109
or	O	O	O
fibrous	O	O	B-T082
assemblies	O	O	I-T082
to	O	O	O
release	O	O	O
the	O	O	O
cells	O	O	B-T025
encapsulated	O	O	B-T080
for	O	O	O
subsequent	O	O	B-T079
assay	O	O	B-T059
or	O	O	O
treatment	O	O	B-T061
.	O	O	O

-DOCSTART- (27629246)

Synchronous	O	O	B-T079
vitellogenin	O	O	B-T116
expression	O	O	B-T045
and	O	O	O
sexual	O	O	B-T040
maturation	O	O	I-T040
during	O	O	O
migration	O	O	B-T039
are	O	O	O
negatively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
juvenile	O	O	B-T125
hormone	O	O	I-T125
levels	O	O	B-T080
in	O	O	O
Mythimna	O	O	O
separata	O	O	O

Annual	O	O	O
migration	O	O	B-T039
of	O	O	O
pests	O	O	B-T008
between	O	O	O
different	O	O	B-T080
seasonal	O	O	B-T079
habitats	O	O	B-T082
can	O	O	O
lead	O	O	B-T169
to	O	O	O
serious	O	O	O
crop	O	O	B-T002
damage	O	O	B-T169
.	O	O	O

Reproductive	O	O	B-T040
immaturity	O	O	B-T080
is	O	O	O
generally	O	O	O
associated	O	O	O
with	O	O	O
the	O	O	O
migratory	O	O	B-T039
process	O	O	I-T039
(	O	O	O
oogenesis	O	O	B-T042
-	O	O	O
flight	O	O	B-T047
syndrome	O	O	I-T047
)	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
mechanism	O	O	B-T169
of	O	O	O
reproductive	O	O	B-T040
development	O	O	I-T040
during	O	O	O
migration	O	O	B-T039
varies	O	O	O
unpredictably	O	O	B-T033
.	O	O	O

Here	O	O	O
,	O	O	O
the	O	O	O
vitellogenin	O	O	B-T028
gene	O	O	I-T028
(	O	O	O
MsVg	O	O	B-T028
)	O	O	O
and	O	O	O
three	O	O	O
key	O	O	B-T077
regulatory	O	O	B-T028
enzyme	O	O	I-T028
genes	O	O	I-T028
(	O	O	O
MsJhamt	O	O	B-T028
,	O	O	O
MsJheh	O	O	B-T028
and	O	O	O
MsJhe	O	O	B-T028
)	O	O	O
related	O	O	O
to	O	O	O
juvenile	O	O	B-T125
hormone	O	O	I-T125
(	O	O	O
JH	O	O	B-T125
)	O	O	O
synthesis	O	O	B-T052
and	O	O	O
degradation	O	O	B-T044
were	O	O	O
identified	O	O	B-T080
and	O	O	O
characterized	O	O	B-T052
in	O	O	O
Mythimna	O	O	B-T204
separata	O	O	I-T204
.	O	O	O

The	O	O	O
relative	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
MsVg	O	O	B-T028
varied	O	O	O
significantly	O	O	O
in	O	O	O
response	O	O	B-T032
to	O	O	O
seasonal	O	O	B-T079
changes	O	O	B-T169
and	O	O	O
was	O	O	O
significantly	O	O	O
correlated	O	O	B-T080
with	O	O	O
stages	O	O	B-T079
of	O	O	O
ovarian	O	O	B-T042
development	O	O	I-T042
.	O	O	O

The	O	O	O
relatively	O	O	O
low	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
JH	O	O	B-T125
titer	O	O	B-T081
did	O	O	O
not	O	O	B-T033
differ	O	O	I-T033
significantly	O	O	O
in	O	O	O
male	O	O	B-T032
moths	O	O	B-T204
but	O	O	O
slightly	O	O	O
increased	O	O	B-T081
in	O	O	O
female	O	O	B-T098
adults	O	O	I-T098
during	O	O	O
the	O	O	O
migratory	O	O	B-T039
season	O	O	I-T039
,	O	O	O
which	O	O	O
was	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
changes	O	O	B-T169
in	O	O	O
mRNA	O	O	B-T114
levels	O	O	O
for	O	O	O
MsJhamt	O	O	B-T028
,	O	O	O
MsJheh	O	O	B-T028
and	O	O	O
MsJhe	O	O	B-T028
.	O	O	O

JH	O	O	B-T125
titer	O	O	B-T081
was	O	O	O
negatively	O	O	B-T033
associated	O	O	O
with	O	O	O
relative	O	O	O
seasonal	O	O	B-T079
levels	O	O	B-T080
of	O	O	O
vitellogenin	O	O	B-T116
mRNA	O	O	B-T114
transcripts	O	O	B-T114
and	O	O	O
with	O	O	O
ovarian	O	O	B-T042
development	O	O	I-T042
in	O	O	O
migrating	O	O	B-T039
M.	O	O	B-T204
separata	O	O	I-T204
.	O	O	O

The	O	O	O
synchrony	O	O	B-T079
of	O	O	O
MsVg	O	O	B-T028
expression	O	O	I-T045
with	O	O	O
sexual	O	O	B-T040
maturation	O	O	I-T040
highlighted	O	O	O
the	O	O	O
potential	O	O	B-T080
of	O	O	O
MsVg	O	O	O
transcript	O	O	B-T114
levels	O	O	B-T080
to	O	O	O
serve	O	O	O
as	O	O	O
an	O	O	O
index	O	O	B-T170
to	O	O	O
monitor	O	O	O
the	O	O	O
adult	O	O	B-T100
reproductive	O	O	B-T040
status	O	O	B-T080
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
JH	O	O	B-T125
and	O	O	O
sexual	O	O	B-T040
maturity	O	O	I-T040
were	O	O	O
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
extent	O	O	O
of	O	O	O
JH	O	O	O
in	O	O	O
regulating	O	O	B-T038
the	O	O	O
MsVg	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
reproduction	O	O	B-T040
during	O	O	O
seasonal	O	O	B-T079
northern	O	O	B-T039
and	O	O	I-T039
southern	O	O	I-T039
migration	O	O	B-T039
.	O	O	O

-DOCSTART- (27631656)

Functional	O	O	B-T169
Result	O	O	I-T169
After	O	O	O
Cochlear	O	O	B-T061
Implantation	O	O	I-T061
in	O	O	O
Children	O	O	B-T100
and	O	O	O
Adults	O	O	B-T100
With	O	O	O
Single-sided	O	O	O
Deafness	O	O	O

Patients	O	O	B-T101
with	O	O	O
single-sided	O	O	B-T047
deafness	O	O	I-T047
(	O	O	O
SSD	O	O	B-T047
)	O	O	O
suffer	O	O	O
from	O	O	O
reduced	O	O	B-T080
binaural	O	O	B-T042
hearing	O	O	I-T042
(	O	O	O
i.e.	O	O	O
,	O	O	O
sound	O	O	B-T041
localization	O	O	I-T041
and	O	O	O
speech	O	O	B-T040
in	O	O	O
noise	O	O	B-T041
discrimination	O	O	I-T041
)	O	O	O
.	O	O	O

Cochlear	O	O	B-T061
implantation	O	O	I-T061
has	O	O	O
recently	O	O	O
been	O	O	O
introduced	O	O	O
for	O	O	O
patients	O	O	B-T101
with	O	O	O
SSD	O	O	B-T047
,	O	O	O
as	O	O	O
an	O	O	O
alternative	O	O	B-T077
to	O	O	O
hearing	O	O	B-T074
devices	O	O	I-T074
that	O	O	O
employ	O	O	O
contralateral	O	O	B-T082
routing	O	O	O
of	O	O	O
the	O	O	O
signal	O	O	B-T067
.	O	O	O

Application	O	O	B-T058
to	O	O	O
children	O	O	B-T100
has	O	O	O
also	O	O	O
been	O	O	O
started	O	O	O
.	O	O	O

We	O	O	O
retrospectively	O	O	B-T062
analyze	O	O	O
a	O	O	O
case	O	O	O
series	O	O	O
of	O	O	O
4	O	O	O
children	O	O	B-T100
and	O	O	O
17	O	O	O
adults	O	O	B-T100
with	O	O	O
SSD	O	O	B-T047
,	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
cochlear	O	O	B-T061
implantation	O	O	I-T061
.	O	O	O

The	O	O	O
outcome	O	O	B-T169
of	O	O	O
adult	O	O	B-T100
patients	O	O	B-T101
was	O	O	O
compared	O	O	O
with	O	O	O
a	O	O	O
control	O	O	B-T096
group	O	O	I-T096
of	O	O	O
27	O	O	O
patients	O	O	O
with	O	O	O
bilateral	O	O	B-T047
profound	O	O	I-T047
hearing	O	O	I-T047
loss	O	O	I-T047
using	O	O	O
a	O	O	O
cochlear	O	O	B-T074
implant	O	O	I-T074
.	O	O	O

During	O	O	O
12	O	O	O
months	O	O	O
,	O	O	O
the	O	O	O
mean	O	O	B-T033
speech	O	O	B-T041
recognition	O	O	I-T041
score	O	O	B-T081
increased	O	O	O
from	O	O	O
30	O	O	O
to	O	O	O
41	O	O	O
%	O	O	O
for	O	O	O
monosyllabic	O	O	B-T170
words	O	O	O
in	O	O	O
adults	O	O	B-T100
,	O	O	O
and	O	O	O
from	O	O	O
58	O	O	O
to	O	O	O
89	O	O	O
%	O	O	O
for	O	O	O
multisyllabic	O	O	B-T170
numbers	O	O	O
.	O	O	O

The	O	O	O
cochlear	O	O	B-T074
implant	O	O	I-T074
(	O	O	O
CI	O	O	B-T074
)	O	O	O
improved	O	O	B-T033
hearing	O	O	I-T033
in	O	O	O
noise	O	O	B-T067
in	O	O	O
all	O	O	O
SSD	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
as	O	O	O
was	O	O	O
demonstrated	O	O	O
by	O	O	O
a	O	O	O
significant	O	O	O
improvement	O	O	B-T077
of	O	O	O
the	O	O	O
speech	O	O	B-T201
reception	O	O	I-T201
threshold	O	O	I-T201
in	O	O	O
different	O	O	O
speech	O	O	O
and	O	O	O
noise	O	O	O
configurations	O	O	O
.	O	O	O

Sound	O	O	B-T041
localization	O	O	I-T041
-correlated	O	O	O
angle	O	O	B-T170
detection	O	O	I-T170
error	O	O	I-T170
improved	O	O	B-T077
with	O	O	O
CI	O	O	B-T074
use	O	O	O
at	O	O	O
every	O	O	O
time	O	O	O
point	O	O	O
.	O	O	O

The	O	O	O
maximum	O	O	O
word	O	O	B-T041
recognition	O	O	I-T041
score	O	O	B-T081
for	O	O	O
monosyllabic	O	O	B-T170
words	O	O	O
in	O	O	O
quiet	O	O	O
correlated	O	O	O
with	O	O	O
the	O	O	O
logarithm	O	O	B-T081
of	O	O	O
the	O	O	O
duration	O	O	B-T079
of	O	O	I-T079
deafness	O	O	B-T033
;	O	O	O
improvement	O	O	B-T077
of	O	O	O
the	O	O	O
speech	O	O	B-T201
reception	O	O	I-T201
threshold	O	O	I-T201
and	O	O	O
RMS	O	O	B-T170
angle	O	O	I-T170
detection	O	O	I-T170
error	O	O	I-T170
by	O	O	O
the	O	O	O
CI	O	O	B-T074
did	O	O	O
not	O	O	O
.	O	O	O

All	O	O	O
SSD	O	O	B-T047
patients	O	O	B-T101
benefitted	O	O	O
from	O	O	O
the	O	O	O
CI	O	O	B-T074
in	O	O	O
different	O	O	O
hearing	O	O	B-T039
situations	O	O	B-T080
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
SSD	O	O	B-T047
for	O	O	O
a	O	O	O
long	O	O	O
period	O	O	O
can	O	O	O
improve	O	O	B-T080
after	O	O	O
cochlear	O	O	B-T061
implantation	O	O	I-T061
.	O	O	O

-DOCSTART- (27632714)

CHOROIDAL	O	O	B-T081
VASCULARITY	O	O	I-T081
INDEX	O	O	I-T081
:	O	O	O
A	O	O	O
Novel	O	O	O
Optical	O	O	B-T060
Coherence	O	O	I-T060
Tomography	O	O	I-T060
Based	O	O	O
Parameter	O	O	B-T077
in	O	O	O
Patients	O	O	B-T101
With	O	O	O
Exudative	O	O	O
Age-Related	O	O	O
Macular	O	O	O
Degeneration	O	O	O

To	O	O	O
evaluate	O	O	O
choroidal	O	O	B-T023
structural	O	O	B-T082
changes	O	O	O
in	O	O	O
exudative	O	O	B-T047
age-related	O	O	I-T047
macular	O	O	I-T047
degeneration	O	O	I-T047
(	O	O	O
AMD	O	O	B-T047
)	O	O	O
using	O	O	O
choroidal	O	O	B-T081
vascularity	O	O	I-T081
index	O	O	I-T081
computed	O	O	B-T052
from	O	O	O
image	O	O	O
binarization	O	O	O
on	O	O	O
spectral	O	O	B-T060
domain	O	O	I-T060
optical	O	O	I-T060
coherence	O	O	I-T060
tomography	O	O	I-T060
with	O	O	O
enhanced	O	O	O
depth	O	O	B-T060
imaging	O	O	I-T060
.	O	O	O

This	O	O	O
prospective	O	O	O
case	O	O	B-T062
series	O	O	I-T062
included	O	O	O
42	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
with	O	O	O
unilateral	O	O	B-T082
exudative	O	O	B-T047
AMD	O	O	I-T047
.	O	O	O

Choroidal	O	O	B-T023
images	O	O	B-T060
were	O	O	O
segmented	O	O	O
into	O	O	O
luminal	O	O	B-T082
area	O	O	B-T082
and	O	O	O
stromal	O	O	O
area	O	O	O
.	O	O	O

Choroidal	O	O	B-T081
vascularity	O	O	I-T081
index	O	O	I-T081
was	O	O	O
defined	O	O	O
as	O	O	O
the	O	O	O
ratio	O	O	B-T081
of	O	O	O
luminal	O	O	B-T082
area	O	O	B-T082
to	O	O	O
total	O	O	O
choroid	O	O	O
area	O	O	O
.	O	O	O

Mean	O	O	B-T081
choroidal	O	O	B-T081
vascularity	O	O	I-T081
index	O	O	I-T081
and	O	O	O
mean	O	O	B-T081
choroidal	O	O	B-T081
thickness	O	O	I-T081
between	O	O	O
study	O	O	B-T062
and	O	O	O
fellow	O	O	O
eyes	O	O	B-T023
of	O	O	O
the	O	O	O
same	O	O	O
patient	O	O	B-T101
with	O	O	O
dry	O	O	O
AMD	O	O	B-T047
were	O	O	O
compared	O	O	O
using	O	O	O
Student	O	O	B-T081
's	O	O	I-T081
t-test	O	O	I-T081
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
choroidal	O	O	B-T081
vascularity	O	O	I-T081
index	O	O	I-T081
in	O	O	O
eyes	O	O	B-T023
with	O	O	O
exudative	O	O	B-T047
AMD	O	O	I-T047
(	O	O	O
60.14	O	O	O
±	O	O	O
4.55	O	O	O
vs.	O	O	O
62.75	O	O	O
±	O	O	O
4.82	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Luminal	O	O	B-T082
area	O	O	B-T082
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
was	O	O	O
decreased	O	O	B-T081
in	O	O	O
eyes	O	O	B-T023
with	O	O	O
exudative	O	O	B-T047
AMD	O	O	I-T047
but	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
in	O	O	O
total	O	O	O
choroid	O	O	O
area	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.05	O	O	O
)	O	O	O
and	O	O	O
choroidal	O	O	O
thickness	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.93	O	O	O
)	O	O	O
between	O	O	O
study	O	O	B-T062
and	O	O	O
fellow	O	O	O
eyes	O	O	O
.	O	O	O

Eyes	O	O	B-T023
with	O	O	O
exudative	O	O	B-T047
AMD	O	O	I-T047
demonstrated	O	O	O
reduced	O	O	B-T080
choroidal	O	O	B-T081
vascularity	O	O	I-T081
index	O	O	I-T081
but	O	O	O
insignificant	O	O	O
differences	O	O	B-T080
in	O	O	O
choroidal	O	O	O
thickness	O	O	O
compared	O	O	O
with	O	O	O
their	O	O	O
fellow	O	O	O
eyes	O	O	B-T023
.	O	O	O

Choroidal	O	O	B-T081
vascularity	O	O	I-T081
index	O	O	I-T081
may	O	O	O
be	O	O	O
a	O	O	O
potential	O	O	B-T080
noninvasive	O	O	B-T033
tool	O	O	I-T033
for	O	O	O
studying	O	O	B-T062
structural	O	O	B-T082
changes	O	O	O
in	O	O	O
choroid	O	O	B-T023
and	O	O	O
monitoring	O	O	O
choroidal	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
exudative	O	O	B-T047
AMD	O	O	I-T047
.	O	O	O

-DOCSTART- (27632886)

Comparison	O	O	B-T052
of	O	O	O
Esophageal	O	O	B-T201
,	O	O	O
Rectal	O	O	B-T033
,	O	O	O
and	O	O	O
Gastrointestinal	O	O	B-T029
Temperatures	O	O	B-T081
During	O	O	O
Passive	O	O	B-T056
Rest	O	O	I-T056
After	O	O	O
Exercise	O	O	B-T056
in	O	O	O
The	O	O	O
Heat	O	O	B-T070
:	O	O	O
The	O	O	O
Influence	O	O	B-T077
of	O	O	O
Hydration	O	O	O

It	O	O	O
is	O	O	O
unknown	O	O	O
how	O	O	O
valid	O	O	O
esophageal	O	O	B-T201
,	O	O	O
rectal	O	O	B-T033
,	O	O	O
and	O	O	O
gastrointestinal	O	O	B-T029
temperatures	O	O	B-T081
(	O	O	O
TES	O	O	B-T201
,	O	O	O
TRE	O	O	B-T033
,	O	O	O
and	O	O	O
TGI	O	O	B-T081
)	O	O	O
compare	O	O	O
after	O	O	O
exercise-induced	O	O	B-T184
hyperthermia	O	O	B-T184
in	O	O	O
various	O	O	O
hydration	O	O	B-T033
states	O	O	I-T033
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
differences	O	O	O
between	O	O	O
TES	O	O	B-T201
,	O	O	O
TRE	O	O	B-T033
,	O	O	O
and	O	O	O
TGI	O	O	B-T081
during	O	O	O
passive	O	O	B-T056
rest	O	O	I-T056
following	O	O	O
exercise-induced	O	O	B-T184
hyperthermia	O	O	B-T184
under	O	O	O
two	O	O	O
different	O	O	O
hydration	O	O	B-T033
states	O	O	I-T033
:	O	O	O
euhydrated	O	O	B-T033
(	O	O	O
EU	O	O	B-T033
)	O	O	O
and	O	O	O
hypohydrated	O	O	B-T047
(	O	O	O
HY	O	O	B-T047
)	O	O	O
.	O	O	O

Randomized-crossover	O	O	B-T062
design	O	O	I-T062
.	O	O	O

Controlled	O	O	B-T067
laboratory	O	O	B-T093
setting	O	O	I-T093
.	O	O	O

Nine	O	O	O
recreationally	O	O	B-T056
active	O	O	B-T169
male	O	O	B-T032
participants	O	O	B-T098
(	O	O	O
mean±	O	O	O
SD	O	O	B-T081
;	O	O	O
age	O	O	B-T032
,	O	O	O
24±4	O	O	O
;	O	O	O
height	O	O	B-T032
,	O	O	O
177.3±9.9	O	O	O
cm	O	O	O
;	O	O	O
body	O	O	B-T032
mass	O	O	I-T032
,	O	O	O
76.7±11.6	O	O	O
kg	O	O	O
;	O	O	O
body	O	O	B-T201
fat	O	O	I-T201
,	O	O	O
14.7±5.8	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
completed	O	O	O
two	O	O	O
trials	O	O	B-T062
(	O	O	O
EU	O	O	B-T033
and	O	O	O
HY	O	O	B-T047
)	O	O	O
consisting	O	O	O
of	O	O	O
a	O	O	O
bout	O	O	B-T079
of	O	O	O
treadmill	O	O	B-T056
exercise	O	O	I-T056
(	O	O	O
a	O	O	O
10	O	O	O
minute	O	O	B-T079
walk	O	O	O
ranging	O	O	B-T081
4.8	O	O	O
-	O	O	O
7.2km·hr(-1	O	O	O
)	O	O	O
at	O	O	O
a	O	O	O
5	O	O	O
%	O	O	O
grade	O	O	B-T185
followed	O	O	O
by	O	O	O
a	O	O	O
20	O	O	O
minute	O	O	O
jog	O	O	B-T056
ranging	O	O	O
8.0	O	O	O
-	O	O	O
12.1km·hr(-1	O	O	O
)	O	O	O
at	O	O	O
a	O	O	O
1	O	O	O
%	O	O	O
grade	O	O	O
)	O	O	O
in	O	O	O
a	O	O	O
hot	O	O	B-T067
environment	O	O	I-T067
(	O	O	O
ambient	O	O	B-T070
temperature	O	O	I-T070
,	O	O	O
39.3±1.0	O	O	O
°	O	O	O
C	O	O	O
;	O	O	O
relative	O	O	B-T081
humidity	O	O	I-T081
,	O	O	O
37.6±6.0	O	O	O
%	O	O	O
;	O	O	O
wet	O	O	B-T169
bulb	O	O	I-T169
globe	O	O	I-T169
temperature	O	O	I-T169
,	O	O	O
31.3±1.5	O	O	O
°	O	O	O
C	O	O	O
)	O	O	O
followed	O	O	O
by	O	O	O
passive	O	O	B-T056
rest	O	O	I-T056
.	O	O	O

Root	O	O	B-T081
mean	O	O	I-T081
squared	O	O	I-T081
difference	O	O	I-T081
(	O	O	O
RMSD	O	O	B-T081
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
compare	O	O	O
the	O	O	O
variance	O	O	B-T080
of	O	O	O
temperature	O	O	B-T032
readings	O	O	I-T032
at	O	O	O
corresponding	O	O	O
time	O	O	B-T079
points	O	O	I-T079
for	O	O	O
TRE	O	O	B-T033
vs	O	O	O
TGI	O	O	B-T081
,	O	O	O
TRE	O	O	O
vs	O	O	O
TES	O	O	B-T201
,	O	O	O
and	O	O	O
TGI	O	O	O
vs	O	O	O
TES	O	O	O
in	O	O	O
EU	O	O	B-T033
and	O	O	O
HY	O	O	B-T047
.	O	O	O

RMSD	O	O	B-T081
values	O	O	O
were	O	O	O
compared	O	O	O
using	O	O	O
three-way	O	O	B-T081
repeated	O	O	I-T081
measures	O	O	I-T081
ANOVA	O	O	I-T081
.	O	O	O

Post	O	O	O
hoc	O	O	O
analysis	O	O	B-T062
of	O	O	O
significant	O	O	O
main	O	O	O
effects	O	O	B-T080
was	O	O	O
done	O	O	O
using	O	O	O
Tukey	O	O	B-T170
's	O	O	I-T170
HSD	O	O	I-T170
with	O	O	O
significance	O	O	O
set	O	O	O
at	O	O	O
p<0.05	O	O	O
.	O	O	O

RMSD	O	O	B-T081
values	O	O	I-T081
(	O	O	O
°	O	O	O
C	O	O	O
)	O	O	O
for	O	O	O
all	O	O	O
device	O	O	B-T074
comparisons	O	O	B-T052
were	O	O	O
significantly	O	O	B-T081
different	O	O	O
in	O	O	O
EU	O	O	B-T033
(	O	O	O
TRE	O	O	B-T033
-	O	O	O
TGI	O	O	B-T081
,	O	O	O
0.11±0.12	O	O	O
;	O	O	O
TRE	O	O	O
-	O	O	O
TES	O	O	B-T201
,	O	O	O
1.58±1.01	O	O	O
;	O	O	O
TGI	O	O	O
-	O	O	O
TES	O	O	O
,	O	O	O
2.04±1.19	O	O	O
)	O	O	O
than	O	O	O
HY	O	O	B-T047
(	O	O	O
TRE	O	O	O
-	O	O	O
TGI	O	O	O
,	O	O	O
0.22±0.28	O	O	O
;	O	O	O
TRE	O	O	O
-	O	O	O
TES	O	O	O
,	O	O	O
1.27±0.61	O	O	O
;	O	O	O
TGI	O	O	O
-	O	O	O
TES	O	O	O
,	O	O	O
1.16±0.76	O	O	O
)	O	O	O
(	O	O	O
p<0.01	O	O	O
)	O	O	O
.	O	O	O

Across	O	O	O
the	O	O	O
45-	O	O	O
minute	O	O	B-T079
bout	O	O	B-T079
of	O	O	O
passive	O	O	B-T056
rest	O	O	I-T056
,	O	O	O
there	O	O	O
were	O	O	O
no	O	O	O
differences	O	O	O
in	O	O	O
TRE	O	O	B-T033
,	O	O	O
TGI	O	O	B-T081
and	O	O	O
TES	O	O	B-T201
between	O	O	O
EU	O	O	B-T033
and	O	O	O
HY	O	O	B-T047
trials	O	O	B-T062
(	O	O	O
p=0.468	O	O	O
)	O	O	O
.	O	O	O

During	O	O	O
passive	O	O	B-T056
rest	O	O	I-T056
after	O	O	O
exercise	O	O	B-T056
in	O	O	O
the	O	O	O
heat	O	O	B-T070
,	O	O	O
TRE	O	O	B-T033
and	O	O	O
TGI	O	O	B-T081
were	O	O	O
in	O	O	O
good	O	O	O
agreement	O	O	O
when	O	O	O
tracking	O	O	O
body	O	O	B-T032
temperature	O	O	I-T032
,	O	O	O
with	O	O	O
a	O	O	O
better	O	O	O
agreement	O	O	O
appearing	O	O	O
in	O	O	O
those	O	O	O
maintaining	O	O	O
a	O	O	O
state	O	O	O
of	O	O	O
euhydration	O	O	B-T033
versus	O	O	O
those	O	O	O
who	O	O	O
became	O	O	O
hypohydrated	O	O	B-T047
during	O	O	O
exercise	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
this	O	O	O
small	O	O	O
difference	O	O	O
does	O	O	O
not	O	O	O
appear	O	O	O
to	O	O	O
be	O	O	O
of	O	O	O
clinical	O	O	B-T033
significance	O	O	I-T033
.	O	O	O

-DOCSTART- (27633771)

Annexin	O	O	B-T116
A1	O	O	I-T116
restores	O	O	O
Aβ1	O	O	B-T116
-	O	O	I-T116
42	O	O	I-T116
-induced	O	O	O
blood-brain	O	O	B-T061
barrier	O	O	I-T061
disruption	O	O	I-T061
through	O	O	O
the	O	O	O
inhibition	O	O	B-T044
of	O	O	O
RhoA-ROCK	O	O	O
signaling	O	O	O
pathway	O	O	O

The	O	O	O
blood-brain	O	O	B-T023
barrier	O	O	I-T023
(	O	O	O
BBB	O	O	B-T023
)	O	O	O
is	O	O	O
composed	O	O	O
of	O	O	O
brain	O	O	B-T023
capillary	O	O	I-T023
endothelial	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
has	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
maintaining	O	O	O
homeostasis	O	O	B-T038
of	O	O	O
the	O	O	O
brain	O	O	O
separating	O	O	O
the	O	O	O
blood	O	O	B-T031
from	O	O	O
the	O	O	O
parenchyma	O	O	B-T023
of	O	O	O
the	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
(	O	O	O
CNS	O	O	B-T022
)	O	O	O
.	O	O	O

It	O	O	O
is	O	O	O
widely	O	O	O
known	O	O	O
that	O	O	O
disruption	O	O	B-T061
of	O	O	I-T061
the	O	O	I-T061
BBB	O	O	I-T061
occurs	O	O	O
in	O	O	O
various	O	O	O
neurodegenerative	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
including	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
.	O	O	O

Annexin	O	O	B-T116
A1	O	O	I-T116
(	O	O	O
ANXA1	O	O	B-T116
)	O	O	O
,	O	O	O
an	O	O	O
anti-inflammatory	O	O	B-T116
messenger	O	O	I-T116
,	O	O	O
is	O	O	O
expressed	O	O	B-T045
in	O	O	O
brain	O	O	B-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
regulates	O	O	O
the	O	O	O
BBB	O	O	B-T023
integrity	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
its	O	O	O
role	O	O	O
and	O	O	O
mechanism	O	O	B-T044
for	O	O	O
protecting	O	O	O
BBB	O	O	B-T023
in	O	O	O
AD	O	O	B-T047
have	O	O	O
not	O	O	O
been	O	O	O
identified	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
β-Amyloid	O	O	B-T116
1	O	O	I-T116
-	O	O	I-T116
42	O	O	I-T116
(Aβ42)-induced	O	O	O
BBB	O	O	B-T061
disruption	O	O	I-T061
was	O	O	O
rescued	O	O	O
by	O	O	O
human	O	O	B-T116
recombinant	O	O	I-T116
ANXA1	O	O	I-T116
(	O	O	O
hrANXA1	O	O	B-T116
)	O	O	O
in	O	O	O
the	O	O	O
murine	O	O	B-T109
brain	O	O	O
endothelial	O	O	O
cell	O	O	O
line	O	O	O
bEnd.3	O	O	O
.	O	O	O

Also	O	O	O
,	O	O	O
ANXA1	O	O	B-T116
was	O	O	O
decreased	O	O	O
in	O	O	O
the	O	O	O
bEnd.3	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
the	O	O	O
capillaries	O	O	B-T023
of	O	O	O
5XFAD	O	O	B-T001
mice	O	O	I-T001
,	O	O	O
and	O	O	O
the	O	O	O
human	O	O	B-T031
serum	O	O	I-T031
of	O	O	O
patients	O	O	B-T101
with	O	O	O
AD	O	O	B-T047
.	O	O	O

To	O	O	O
find	O	O	O
out	O	O	O
the	O	O	O
mechanism	O	O	B-T044
by	O	O	O
which	O	O	O
ANXA1	O	O	B-T116
recovers	O	O	O
the	O	O	O
BBB	O	O	B-T023
integrity	O	O	O
in	O	O	O
AD	O	O	B-T047
,	O	O	O
the	O	O	O
RhoA-ROCK	O	O	B-T044
signaling	O	O	I-T044
pathway	O	O	I-T044
was	O	O	O
examined	O	O	O
in	O	O	O
both	O	O	O
Aβ42	O	O	B-T116
-treated	O	O	O
bEnd.3	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
the	O	O	O
capillaries	O	O	B-T023
of	O	O	O
5XFAD	O	O	B-T001
mice	O	O	I-T001
as	O	O	O
RhoA	O	O	B-T116
was	O	O	O
activated	O	O	B-T045
in	O	O	O
both	O	O	O
cases	O	O	O
.	O	O	O

RhoA	O	O	B-T116
inhibitors	O	O	I-T080
alleviated	O	O	O
Aβ42	O	O	B-T116
-induced	O	O	O
BBB	O	O	B-T061
disruption	O	O	I-T061
and	O	O	O
constitutively	O	O	O
overexpressed	O	O	B-T045
RhoA-GTP	O	O	B-T116
(	O	O	O
active	O	O	O
form	O	O	O
of	O	O	O
RhoA	O	O	O
)	O	O	O
attenuated	O	O	O
the	O	O	O
protective	O	O	O
effect	O	O	O
of	O	O	O
ANXA1	O	O	B-T116
.	O	O	O

When	O	O	O
pericytes	O	O	B-T025
were	O	O	O
cocultured	O	O	B-T059
with	O	O	O
bEnd.3	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
Aβ42	O	O	B-T116
-induced	O	O	O
RhoA	O	O	B-T045
activation	O	O	I-T045
of	O	O	O
bEnd.3	O	O	O
cells	O	O	O
was	O	O	O
inhibited	O	O	B-T080
by	O	O	O
the	O	O	O
secretion	O	O	B-T038
of	O	O	O
ANXA1	O	O	B-T116
from	O	O	O
pericytes	O	O	O
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
ANXA1	O	O	B-T116
restores	O	O	O
Aβ42	O	O	B-T116
-induced	O	O	O
BBB	O	O	B-T061
disruption	O	O	I-T061
through	O	O	O
inhibition	O	O	B-T044
of	O	O	O
RhoA-ROCK	O	O	B-T044
signaling	O	O	I-T044
pathway	O	O	I-T044
and	O	O	O
we	O	O	O
propose	O	O	O
ANXA1	O	O	O
as	O	O	O
a	O	O	O
therapeutic	O	O	B-T121
reagent	O	O	I-T121
,	O	O	O
protecting	O	O	O
against	O	O	O
the	O	O	O
breakdown	O	O	B-T061
of	O	O	I-T061
the	O	O	I-T061
BBB	O	O	I-T061
in	O	O	O
AD	O	O	B-T047
.	O	O	O

-DOCSTART- (27634799)

Association	O	O	B-T080
of	O	O	O
kidney	O	O	B-T047
disease	O	O	I-T047
with	O	O	O
obstructive	O	O	B-T047
sleep	O	O	I-T047
apnea	O	O	I-T047
in	O	O	O
a	O	O	O
population	O	O	B-T062
study	O	O	I-T062
of	O	O	O
men	O	O	O

To	O	O	O
determine	O	O	B-T059
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
obstructive	O	O	B-T047
sleep	O	O	I-T047
apnea	O	O	I-T047
(	O	O	O
OSA	O	O	B-T047
)	O	O	O
and	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CKD	O	O	B-T047
)	O	O	O
.	O	O	O

Previous	O	O	O
population	O	O	B-T062
studies	O	O	B-T062
of	O	O	O
the	O	O	O
association	O	O	B-T080
are	O	O	O
sparse	O	O	B-T079
,	O	O	O
conflicting	O	O	B-T033
and	O	O	O
confined	O	O	B-T169
largely	O	O	O
to	O	O	O
studies	O	O	O
of	O	O	O
administrative	O	O	B-T033
data	O	O	B-T078
.	O	O	O

Cross-sectional	O	O	B-T062
analysis	O	O	I-T062
in	O	O	O
unselected	O	O	O
participants	O	O	B-T098
of	O	O	O
the	O	O	O
Men	O	O	B-T081
Androgens	O	O	I-T081
Inflammation	O	O	I-T081
Lifestyle	O	O	I-T081
Environment	O	O	I-T081
and	O	O	I-T081
Stress	O	O	I-T081
(	O	O	I-T081
MAILES	O	O	I-T081
)	O	O	I-T081
study	O	O	I-T081
,	O	O	O
aged	O	O	B-T032
>	O	O	O
40	O	O	O
y.	O	O	O
Renal	O	O	B-T023
data	O	O	B-T078
were	O	O	O
available	O	O	O
on	O	O	O
812	O	O	O
men	O	O	B-T098
without	O	O	O
a	O	O	O
prior	O	O	B-T079
OSA	O	O	B-T047
diagnosis	O	O	B-T033
who	O	O	O
underwent	O	O	O
full	O	O	O
in-home	O	O	B-T082
polysomnography	O	O	B-T060
(	O	O	O
Embletta	O	O	B-T074
X100	O	O	I-T074
)	O	O	O
in	O	O	O
2010	O	O	O
-	O	O	O
2011	O	O	O
.	O	O	O

CKD	O	O	B-T047
was	O	O	O
defined	O	O	O
as	O	O	O
an	O	O	O
estimated	O	O	B-T059
glomerular	O	O	I-T059
filtration	O	O	I-T059
rate	O	O	I-T059
(	O	O	O
eGFR	O	O	B-T059
)	O	O	O
<	O	O	O
60	O	O	O
mL/min/1.73m2	O	O	O
or	O	O	O
eGFR	O	O	O
≥60	O	O	O
and	O	O	O
albuminuria	O	O	B-T033
(	O	O	O
albumin	O	O	B-T059
creatinine	O	O	I-T059
ratio	O	O	I-T059
≥3.0	O	O	O
mg/mmol	O	O	O
)	O	O	O
.	O	O	O

CKD	O	O	B-T047
[	O	O	O
10.5	O	O	O
%	O	O	O
,	O	O	O
n=85	O	O	O
(	O	O	O
Stage	O	O	B-T079
1	O	O	O
-	O	O	O
3	O	O	O
,	O	O	O
9.7	O	O	O
%	O	O	O
;	O	O	O
Stage	O	O	O
4	O	O	O
-	O	O	O
5	O	O	O
,	O	O	O
0.7	O	O	O
%	O	O	O
)	O	O	O
]	O	O	O
of	O	O	O
predominantly	O	O	B-T080
mild	O	O	B-T033
severity	O	O	I-T033
showed	O	O	O
significant	O	O	B-T078
association	O	O	B-T080
s	O	O	O
with	O	O	O
OSA	O	O	B-T047
(	O	O	O
AHI≥10	O	O	O
):	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
(OR)=1.9	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(CI):1.02	O	O	O
-	O	O	O
3.5	O	O	O
,	O	O	O
severe	O	O	B-T080
OSA	O	O	O
(	O	O	O
AHI	O	O	O
≥30/h	O	O	O
):	O	O	O
OR	O	O	B-T081
=	O	O	O
2.6	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI:1.1	O	O	O
-	O	O	O
6.2	O	O	O
,	O	O	O
and	O	O	O
respiratory	O	O	B-T169
related	O	O	O
arousal	O	O	B-T039
index	O	O	B-T170
:	O	O	O
≥7.6/h	O	O	O
OR	O	O	O
=	O	O	O
2.3	O	O	O
,	O	O	O
95%CI	O	O	O
:	O	O	O
1.1	O	O	O
-	O	O	O
4.7	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
measures	O	O	B-T081
of	O	O	O
hypoxemia	O	O	B-T033
after	O	O	O
adjustment	O	O	B-T169
for	O	O	O
age	O	O	B-T032
,	O	O	O
hypertension	O	O	B-T047
,	O	O	O
diabetes	O	O	B-T047
,	O	O	O
smoking	O	O	B-T055
,	O	O	O
obesity	O	O	B-T047
,	O	O	O
and	O	O	O
NSAID	O	O	B-T121
use	O	O	B-T169
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
association	O	O	B-T080
of	O	O	O
CKD	O	O	B-T047
with	O	O	O
daytime	O	O	B-T033
sleepiness	O	O	I-T033
.	O	O	O

In	O	O	O
men	O	O	B-T098
with	O	O	O
CKD	O	O	B-T047
,	O	O	O
those	O	O	O
with	O	O	O
OSA	O	O	B-T047
were	O	O	O
not	O	O	B-T033
significantly	O	O	I-T033
more	O	O	B-T081
likely	O	O	B-T081
to	O	O	O
report	O	O	B-T058
symptoms	O	O	B-T184
(	O	O	O
sleepiness	O	O	B-T033
,	O	O	O
snoring	O	O	B-T184
,	O	O	O
apneas	O	O	B-T046
)	O	O	O
or	O	O	O
be	O	O	O
identified	O	O	B-T080
with	O	O	O
the	O	O	O
STOP	O	O	B-T062
OSA	O	O	I-T062
screening	O	O	I-T062
questionnaire	O	O	I-T062
,	O	O	O
compared	O	O	O
to	O	O	O
men	O	O	O
without	O	O	O
OSA	O	O	O
.	O	O	O

Predominantly	O	O	B-T080
mild	O	O	B-T080
CKD	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
severe	O	O	B-T080
OSA	O	O	B-T047
and	O	O	O
arousals	O	O	B-T041
.	O	O	O

Further	O	O	O
population	O	O	B-T062
studies	O	O	I-T062
examining	O	O	B-T033
the	O	O	O
longitudinal	O	O	B-T082
relationship	O	O	B-T080
between	O	O	O
CKD	O	O	B-T047
and	O	O	O
OSA	O	O	B-T047
are	O	O	O
warranted	O	O	B-T169
.	O	O	O

Better	O	O	O
methods	O	O	B-T170
are	O	O	O
needed	O	O	B-T080
to	O	O	O
identify	O	O	B-T041
OSA	O	O	B-T047
in	O	O	O
CKD	O	O	B-T047
which	O	O	O
may	O	O	O
have	O	O	O
few	O	O	B-T081
symptoms	O	O	B-T184
.	O	O	O

-DOCSTART- (27634880)

Evidence	O	O	O
that	O	O	O
vitronectin	O	O	B-T116
is	O	O	O
a	O	O	O
potent	O	O	O
migration-enhancing	O	O	B-T123
factor	O	O	I-T123
for	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
chaperoned	O	O	B-T116
by	O	O	O
fibrinogen	O	O	B-T116
:	O	O	O
a	O	O	O
novel	O	O	O
view	O	O	O
of	O	O	O
the	O	O	O
metastasis	O	O	B-T046
of	O	O	O
cancer	O	O	O
cells	O	O	O
to	O	O	O
low-	O	O	O
fibrinogen	O	O	O
lymphatics	O	O	B-T022
and	O	O	O
body	O	O	O
cavities	O	O	O

Diluted	O	O	B-T169
(	O	O	O
1	O	O	O
%	O	O	O
)	O	O	O
plasma	O	O	B-T031
induces	O	O	O
migration	O	O	B-T043
of	O	O	O
malignant	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
much	O	O	O
more	O	O	O
strongly	O	O	O
than	O	O	O
potent	O	O	O
pro-metastatic	O	O	B-T169
factors	O	O	I-T169
.	O	O	O

To	O	O	O
characterize	O	O	O
the	O	O	O
factor(s	O	O	B-T169
)	O	O	I-T169
present	O	O	O
in	O	O	O
diluted	O	O	B-T169
plasma	O	O	B-T031
responsible	O	O	O
for	O	O	O
this	O	O	O
phenomenon	O	O	B-T067
we	O	O	O
performed	O	O	O
i	O	O	O
)	O	O	O
heat	O	O	B-T070
inactivation	O	O	B-T169
,	O	O	O
ii	O	O	O
)	O	O	O
dialysis	O	O	B-T070
,	O	O	O
iii	O	O	O
)	O	O	O
proteinase	O	O	B-T116
K	O	O	I-T116
treatment	O	O	B-T169
,	O	O	O
and	O	O	O
iv	O	O	O
)	O	O	O
molecular	O	O	B-T068
size	O	O	I-T068
filtration	O	O	I-T068
studies	O	O	I-T068
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
this	O	O	O
remarkable	O	O	O
pro-migratory	O	O	B-T052
activity	O	O	I-T052
of	O	O	O
diluted	O	O	B-T169
normal	O	O	O
plasma	O	O	B-T031
is	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
~50	O	O	O
-	O	O	O
100-kD	O	O	O
protein	O	O	B-T116
that	O	O	O
interacts	O	O	O
with	O	O	O
GαI	O	O	B-T116
protein-coupled	O	O	I-T116
receptors	O	O	I-T116
and	O	O	O
activates	O	O	O
p42/44	O	O	B-T116
MAPK	O	O	I-T116
and	O	O	O
AKT	O	O	B-T044
signaling	O	O	I-T044
in	O	O	O
target	O	O	O
cells	O	O	B-T025
.	O	O	O

Since	O	O	O
this	O	O	O
pro-migratory	O	O	B-T052
activity	O	O	I-T052
of	O	O	O
1	O	O	O
%	O	O	O
plasma	O	O	B-T031
decreases	O	O	O
at	O	O	O
higher	O	O	O
plasma	O	O	B-T081
concentrations	O	O	I-T081
(	O	O	O
>	O	O	O
20	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
is	O	O	O
retained	O	O	O
in	O	O	O
serum	O	O	B-T031
,	O	O	O
we	O	O	O
hypothesized	O	O	O
that	O	O	O
fibrinogen	O	O	B-T116
may	O	O	O
be	O	O	O
involved	O	O	O
as	O	O	O
a	O	O	O
chaperone	O	O	B-T116
of	O	O	O
the	O	O	O
protein(s	O	O	B-T116
)	O	O	I-T116
.	O	O	O

To	O	O	O
identify	O	O	O
the	O	O	O
pro-migratory	O	O	B-T116
protein(s	O	O	I-T116
)	O	O	I-T116
present	O	O	O
in	O	O	O
diluted	O	O	B-T169
plasma	O	O	B-T031
and	O	O	O
fibrinogen	O	O	B-T116
-depleted	O	O	O
serum	O	O	B-T031
,	O	O	O
we	O	O	O
performed	O	O	O
gel	O	O	B-T059
filtration	O	O	I-T059
and	O	O	O
hydrophobic	O	O	B-T059
interaction	O	O	I-T059
chromatography	O	O	I-T059
followed	O	O	O
by	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
analysis	O	O	I-T059
.	O	O	O

We	O	O	O
identified	O	O	O
several	O	O	O
putative	O	O	O
protein	O	O	B-T116
candidates	O	O	O
that	O	O	O
were	O	O	O
further	O	O	O
tested	O	O	O
in	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
experiments	O	O	B-T062
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
this	O	O	O
pro-migratory	O	O	B-T123
factor	O	O	I-T123
chaperoned	O	O	B-T116
by	O	O	O
fibrinogen	O	O	B-T116
is	O	O	O
vitronectin	O	O	B-T116
,	O	O	O
which	O	O	O
activates	O	O	O
uPAR	O	O	O
,	O	O	O
and	O	O	O
that	O	O	O
this	O	O	O
effect	O	O	O
can	O	O	O
be	O	O	O
inhibited	O	O	O
by	O	O	O
fibrinogen	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
provide	O	O	O
a	O	O	O
novel	O	O	O
mechanism	O	O	B-T044
for	O	O	O
the	O	O	O
metastasis	O	O	B-T046
of	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
to	O	O	O
lymphatics	O	O	B-T022
and	O	O	O
body	O	O	B-T030
cavities	O	O	I-T030
,	O	O	O
in	O	O	O
which	O	O	O
the	O	O	O
concentration	O	O	B-T081
of	O	O	O
fibrinogen	O	O	B-T116
is	O	O	O
low	O	O	O
,	O	O	O
and	O	O	O
thus	O	O	O
suggests	O	O	O
that	O	O	O
free	O	O	O
vitronectin	O	O	B-T116
stimulates	O	O	O
migration	O	O	B-T043
of	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (27636378)

Development	O	O	B-T169
and	O	O	O
initial	O	O	B-T079
validation	O	O	B-T062
of	O	O	O
the	O	O	O
Respirator	O	O	B-T074
Comfort	O	O	B-T041
,	O	O	O
Wearing	O	O	B-T041
Experience	O	O	I-T041
,	O	O	O
and	O	O	O
Function	O	O	B-T169
Instrument	O	O	B-T074
[	O	O	O
R-COMFI	O	O	O

Filtering	O	O	B-T074
face-piece	O	O	I-T074
respirators	O	O	I-T074
(	O	O	O
FFRs	O	O	B-T074
)	O	O	O
are	O	O	O
worn	O	O	O
to	O	O	O
protect	O	O	B-T033
health	O	O	B-T097
care	O	O	I-T097
personnel	O	O	I-T097
from	O	O	O
airborne	O	O	B-T131
particles	O	O	I-T131
;	O	O	O
however	O	O	O
,	O	O	O
clinical	O	O	B-T062
studies	O	O	I-T062
have	O	O	O
demonstrated	O	O	O
that	O	O	O
FFR	O	O	B-T074
adherence	O	O	B-T169
is	O	O	O
relatively	O	O	O
low	O	O	B-T080
in	O	O	O
some	O	O	O
settings	O	O	O
,	O	O	O
in	O	O	O
part	O	O	B-T082
,	O	O	O
due	O	O	O
to	O	O	O
discomfort	O	O	B-T184
and	O	O	O
intolerance	O	O	B-T040
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
develop	O	O	O
and	O	O	O
initially	O	O	B-T079
evaluate	O	O	B-T052
the	O	O	O
psychometric	O	O	B-T080
properties	O	O	I-T080
of	O	O	O
an	O	O	O
instrument	O	O	B-T074
designed	O	O	B-T057
to	O	O	O
measure	O	O	B-T081
the	O	O	O
comfort	O	O	B-T041
and	O	O	O
tolerability	O	O	B-T080
of	O	O	O
FFRs	O	O	B-T074
.	O	O	O

Instrument	O	O	B-T074
items	O	O	O
were	O	O	O
developed	O	O	O
through	O	O	O
literature	O	O	B-T170
reviews	O	O	I-T170
,	O	O	O
focus	O	O	B-T096
groups	O	O	I-T096
,	O	O	O
and	O	O	O
several	O	O	B-T081
iterations	O	O	B-T033
of	O	O	O
ranking	O	O	B-T170
and	O	O	O
refining	O	O	O
by	O	O	O
experts	O	O	B-T097
.	O	O	O

Psychometric	O	O	B-T060
evaluation	O	O	I-T060
of	O	O	O
the	O	O	O
instrument	O	O	B-T074
was	O	O	O
conducted	O	O	O
using	O	O	O
Rasch	O	O	B-T170
partial	O	O	I-T170
credit	O	O	I-T170
model	O	O	I-T170
(	O	O	O
PCM	O	O	B-T170
)	O	O	O
analysis	O	O	B-T062
.	O	O	O

Pivot	O	O	B-T170
anchoring	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
specify	O	O	O
the	O	O	O
threshold	O	O	B-T080
defining	O	O	O
item	O	O	O
difficulty	O	O	B-T080
;	O	O	O
in	O	O	O
our	O	O	O
analyses	O	O	B-T062
,	O	O	O
this	O	O	O
was	O	O	O
the	O	O	O
point	O	O	B-T081
that	O	O	O
participants	O	O	B-T098
moved	O	O	O
from	O	O	O
possessing	O	O	B-T078
none	O	O	O
of	O	O	O
the	O	O	O
trait	O	O	B-T032
to	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
trait	O	O	O
.	O	O	O

The	O	O	O
final	O	O	B-T079
instrument	O	O	B-T074
was	O	O	O
completed	O	O	B-T080
by	O	O	O
165	O	O	O
health	O	O	B-T097
care	O	O	I-T097
personnel	O	O	I-T097
from	O	O	O
3	O	O	O
Veterans	O	O	B-T098
Health	O	O	B-T058
Administration	O	O	I-T058
facilities	O	O	I-T058
,	O	O	O
and	O	O	O
data	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
Rasch	O	O	B-T170
PCM	O	O	I-T170
.	O	O	O

Seven	O	O	O
items	O	O	O
were	O	O	O
removed	O	O	B-T080
because	O	O	O
they	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
violated	O	O	B-T080
the	O	O	I-T080
assumption	O	O	I-T080
of	O	O	I-T080
independence	O	O	I-T080
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
were	O	O	O
mis-fitting	O	O	B-T080
;	O	O	O
and/or	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
were	O	O	O
deemed	O	O	O
not	O	O	B-T080
relevant	O	O	I-T080
.	O	O	O

Category	O	O	B-T170
function	O	O	B-T169
analysis	O	O	B-T062
demonstrated	O	O	O
that	O	O	O
all	O	O	O
categories	O	O	B-T170
progressed	O	O	B-T169
monotonically	O	O	B-T080
.	O	O	O

Principal	O	O	B-T081
components	O	O	I-T081
analysis	O	O	I-T081
demonstrated	O	O	O
the	O	O	O
existence	O	O	B-T081
of	O	O	O
three	O	O	O
subscales	O	O	B-T081
(	O	O	O
Discomfort	O	O	B-T184
,	O	O	O
General	O	O	O
Wearing	O	O	B-T041
Experience	O	O	I-T041
,	O	O	O
and	O	O	O
Function	O	O	B-T169
)	O	O	O
.	O	O	O

Final	O	O	B-T079
reliability	O	O	B-T081
analyses	O	O	B-T062
showed	O	O	O
that	O	O	O
the	O	O	O
scale	O	O	B-T081
had	O	O	O
moderate	O	O	B-T080
to	O	O	O
high	O	O	B-T081
person	O	O	I-T081
reliability	O	O	I-T081
and	O	O	O
high	O	O	O
item	O	O	O
reliability	O	O	O
.	O	O	O

The	O	O	O
final	O	O	O
instrument	O	O	B-T074
contained	O	O	B-T169
21	O	O	O
items	O	O	O
.	O	O	O

Until	O	O	O
now	O	O	O
,	O	O	O
to	O	O	O
our	O	O	O
knowledge	O	O	B-T041
no	O	O	O
instrument	O	O	B-T074
with	O	O	O
evidence	O	O	B-T078
supporting	O	O	O
its	O	O	O
reliability	O	O	B-T080
and	O	O	I-T080
validity	O	O	I-T080
to	O	O	O
assess	O	O	B-T052
discomfort	O	O	B-T184
and	O	O	O
tolerance	O	O	B-T080
of	O	O	O
FFRs	O	O	B-T074
among	O	O	O
health	O	O	B-T097
care	O	O	I-T097
personnel	O	O	I-T097
has	O	O	O
been	O	O	O
published	O	O	B-T057
.	O	O	O

A	O	O	O
21-item	O	O	O
psychometrically	O	O	B-T081
sound	O	O	I-T081
measure	O	O	I-T081
of	O	O	O
comfort	O	O	B-T041
and	O	O	O
tolerability	O	O	B-T080
of	O	O	O
FFRs	O	O	B-T074
,	O	O	O
Respirator	O	O	B-T074
Comfort	O	O	B-T041
,	O	O	O
Wearing	O	O	B-T041
Experience	O	O	I-T041
,	O	O	O
and	O	O	O
Function	O	O	B-T169
Instrument	O	O	B-T074
(	O	O	O
R-COMFI	O	O	B-T074
)	O	O	O
,	O	O	O
was	O	O	O
developed	O	O	O
.	O	O	O

The	O	O	O
significance	O	O	B-T078
of	O	O	O
developing	O	O	O
such	O	O	O
an	O	O	O
instrument	O	O	B-T074
is	O	O	O
that	O	O	O
it	O	O	O
will	O	O	O
help	O	O	O
identify	O	O	O
respirators	O	O	B-T074
that	O	O	O
are	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
better	O	O	O
adherence	O	O	B-T169
in	O	O	O
practice	O	O	B-T041
settings	O	O	O
.	O	O	O

The	O	O	O
R-COMFI	O	O	B-T074
may	O	O	O
be	O	O	O
used	O	O	O
within	O	O	B-T082
and	O	O	O
beyond	O	O	O
the	O	O	O
VA	O	O	B-T093
healthcare	O	O	I-T093
system	O	O	I-T093
as	O	O	O
a	O	O	O
psychometrically	O	O	B-T074
sound	O	O	I-T074
instrument	O	O	I-T074
to	O	O	O
evaluate	O	O	B-T052
the	O	O	O
comfort	O	O	B-T041
and	O	O	O
tolerability	O	O	B-T080
of	O	O	O
respirators	O	O	B-T074
,	O	O	O
including	O	O	O
developmental	O	O	B-T080
prototypes	O	O	O
.	O	O	O

-DOCSTART- (27638250)

Kidney	O	O	B-T033
transplant	O	O	I-T033
recipients	O	O	I-T033
after	O	O	O
nonrenal	O	O	B-T061
solid	O	O	I-T061
organ	O	O	I-T061
transplantation	O	O	I-T061
show	O	O	O
low	O	O	O
alloreactivity	O	O	B-T039
but	O	O	O
an	O	O	O
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
infection	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
kidney	O	O	B-T033
transplant	O	O	I-T033
recipients	O	O	I-T033
(	O	O	O
KTRs	O	O	B-T033
)	O	O	O
after	O	O	O
nonrenal	O	O	B-T061
solid	O	O	I-T061
organ	O	O	I-T061
transplantation	O	O	I-T061
(	O	O	O
SOT	O	O	B-T061
)	O	O	O
has	O	O	O
increased	O	O	O
to	O	O	O
almost	O	O	O
5	O	O	O
%	O	O	O
.	O	O	O

Knowledge	O	O	O
on	O	O	O
patient	O	O	B-T101
and	O	O	O
allograft	O	O	B-T061
outcomes	O	O	B-T080
,	O	O	O
infections	O	O	B-T046
,	O	O	O
and	O	O	O
alloreactivity	O	O	B-T039
,	O	O	O
however	O	O	O
,	O	O	O
remains	O	O	O
scarce	O	O	O
.	O	O	O

We	O	O	O
studied	O	O	B-T062
40	O	O	O
KTRs	O	O	B-T033
after	O	O	O
nonrenal	O	O	B-T061
SOT	O	O	I-T061
.	O	O	O

Seven	O	O	O
hundred	O	O	O
and	O	O	O
twenty	O	O	O
primary	O	O	O
KTRs	O	O	B-T033
and	O	O	O
119	O	O	O
repeat	O	O	O
KTRs	O	O	O
were	O	O	O
used	O	O	O
for	O	O	O
comparison	O	O	O
.	O	O	O

Samples	O	O	B-T031
were	O	O	O
collected	O	O	O
pretransplantation	O	O	B-T079
,	O	O	O
at	O	O	O
+	O	O	O
1	O	O	O
,	O	O	O
+	O	O	O
2	O	O	O
,	O	O	O
and	O	O	O
+	O	O	O
3	O	O	O
months	O	O	O
post-transplantation	O	O	B-T079
.	O	O	O

Alloreactive	O	O	B-T039
and	O	O	O
CMV-specific	O	O	B-T005
T	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
measured	O	O	O
by	O	O	O
interferon-γ	O	O	B-T059
ELISPOT	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

Patient	O	O	B-T101
survival	O	O	B-T052
in	O	O	O
KTRs	O	O	B-T033
after	O	O	O
SOT	O	O	B-T061
,	O	O	O
primary	O	O	O
and	O	O	O
repeat	O	O	O
KTRs	O	O	O
was	O	O	O
comparable	O	O	O
.	O	O	O

While	O	O	O
death	O	O	B-T040
-censored	O	O	O
allograft	O	O	B-T061
survival	O	O	B-T052
was	O	O	O
comparable	O	O	O
between	O	O	O
KTRs	O	O	B-T033
after	O	O	O
SOT	O	O	B-T061
and	O	O	O
primary	O	O	O
KTRs	O	O	O
,	O	O	O
KTRs	O	O	O
after	O	O	O
SOT	O	O	O
showed	O	O	O
superior	O	O	O
5-year	O	O	B-T079
death	O	O	O
-censored	O	O	O
allograft	O	O	O
survival	O	O	O
of	O	O	O
92.5	O	O	O
%	O	O	O
compared	O	O	O
to	O	O	O
81.2	O	O	O
%	O	O	O
in	O	O	O
repeat	O	O	O
KTRs	O	O	O
.	O	O	O

Interestingly	O	O	O
,	O	O	O
KTRs	O	O	B-T033
after	O	O	O
SOT	O	O	B-T061
show	O	O	O
less	O	O	O
preformed	O	O	O
panel-reactive	O	O	B-T059
antibodies	O	O	I-T059
,	O	O	O
frequencies	O	O	B-T079
of	O	O	O
alloreactive	O	O	B-T039
T	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
acute	O	O	B-T033
rejections	O	O	I-T033
compared	O	O	O
to	O	O	O
repeat	O	O	O
KTRs	O	O	O
.	O	O	O

KTRs	O	O	B-T033
after	O	O	O
SOT	O	O	B-T061
,	O	O	O
however	O	O	O
,	O	O	O
show	O	O	O
higher	O	O	O
incidences	O	O	B-T081
of	O	O	O
EBV	O	O	B-T047
viremia	O	O	I-T047
and	O	O	O
PTLD	O	O	B-T191
,	O	O	O
sepsis	O	O	B-T047
,	O	O	O
and	O	O	O
death	O	O	B-T040
from	O	O	O
sepsis	O	O	O
.	O	O	O

Impaired	O	O	O
CMV-specific	O	O	B-T005
cellular	O	O	B-T040
immunity	O	O	I-T040
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
more	O	O	O
CMV	O	O	B-T005
replication	O	O	B-T043
compared	O	O	O
to	O	O	O
repeat	O	O	O
KTRs	O	O	B-T033
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
comparable	O	O	O
patient	O	O	B-T101
and	O	O	O
allograft	O	O	B-T061
outcomes	O	O	B-T080
in	O	O	O
KTRs	O	O	B-T033
after	O	O	O
SOT	O	O	B-T061
and	O	O	O
primary	O	O	O
KTRs	O	O	O
.	O	O	O

The	O	O	O
observed	O	O	O
low	O	O	O
alloreactivity	O	O	B-T039
may	O	O	O
contribute	O	O	O
to	O	O	O
excellent	O	O	O
allograft	O	O	B-T061
outcomes	O	O	B-T080
.	O	O	O

Caution	O	O	O
should	O	O	O
be	O	O	O
taken	O	O	O
in	O	O	O
KTRs	O	O	B-T033
after	O	O	O
SOT	O	O	B-T061
regarding	O	O	O
infectious	O	O	B-T047
complications	O	O	I-T047
due	O	O	O
to	O	O	O
overimmunosuppression	O	O	B-T047
.	O	O	O

-DOCSTART- (27639061)

Improved	O	O	B-T033
protocol	O	O	B-T170
for	O	O	O
the	O	O	O
isolation	O	O	B-T059
of	O	O	O
naïve	O	O	O
follicular	O	O	O
dendritic	O	O	O
cells	O	O	O

Follicular	O	O	B-T025
dendritic	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
FDCs	O	O	B-T025
)	O	O	O
in	O	O	O
lymphoid	O	O	B-T023
organs	O	O	I-T023
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	B-T077
in	O	O	O
the	O	O	O
humoral	O	O	B-T043
immune	O	O	I-T043
response	O	O	I-T043
.	O	O	O

However	O	O	O
,	O	O	O
because	O	O	O
the	O	O	O
isolation	O	O	B-T061
of	O	O	O
FDCs	O	O	B-T025
is	O	O	O
difficult	O	O	B-T080
due	O	O	O
to	O	O	O
their	O	O	O
very	O	O	O
small	O	O	B-T081
population	O	O	B-T081
size	O	O	I-T081
and	O	O	O
fragility	O	O	B-T049
under	O	O	O
mechanical	O	O	B-T070
and	O	O	O
chemical	O	O	B-T070
stresses	O	O	I-T070
,	O	O	O
the	O	O	O
genetic	O	O	B-T169
and	O	O	O
biochemical	O	O	B-T169
characteristics	O	O	B-T080
of	O	O	O
FDCs	O	O	O
remain	O	O	O
unclear	O	O	B-T033
.	O	O	O

Previously	O	O	O
,	O	O	O
we	O	O	O
identified	O	O	O
FDCs	O	O	B-T025
as	O	O	O
ICAM-1(+	O	O	B-T116
)	O	O	I-T116
cells	O	O	B-T025
in	O	O	O
the	O	O	O
CD45	O	O	B-T116
(	O	O	B-T033
-	O	O	I-T033
)	O	O	I-T033
non-hematopoietic	O	O	B-T026
cell	O	O	I-T026
fraction	O	O	I-T026
from	O	O	O
naïve	O	O	O
mouse	O	O	B-T024
spleen	O	O	I-T024
after	O	O	O
cell	O	O	B-T059
separation	O	O	I-T059
by	O	O	O
means	O	O	O
of	O	O	O
digestion	O	O	O
with	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
enzymes	O	O	B-T116
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
using	O	O	O
a	O	O	O
new	O	O	B-T080
combination	O	O	B-T080
of	O	O	O
enzymes	O	O	B-T116
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
FDCs	O	O	B-T025
are	O	O	O
highly	O	O	O
enriched	O	O	O
in	O	O	O
the	O	O	O
CD45	O	O	B-T116
(	O	O	B-T033
-	O	O	I-T033
)	O	O	I-T033
ICAM-1(+	O	O	B-T116
)	O	O	I-T116
CD21	O	O	B-T116
/	O	O	O
35(+	O	O	B-T116
)	O	O	I-T116
cell	O	O	B-T026
fraction	O	O	I-T026
.	O	O	O

CD45	O	O	B-T116
(	O	O	B-T033
-	O	O	I-T033
)	O	O	I-T033
ICAM-1(+	O	O	B-T116
)	O	O	I-T116
CD21	O	O	B-T116
/	O	O	O
35(+	O	O	B-T116
)	O	O	I-T116
cells	O	O	B-T025
in	O	O	O
the	O	O	O
mouse	O	O	B-T024
spleen	O	O	I-T024
retained	O	O	O
an	O	O	O
antigen	O	O	B-T129
administered	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
for	O	O	O
more	O	O	O
than	O	O	O
7	O	O	O
days	O	O	B-T079
.	O	O	O

Moreover	O	O	O
,	O	O	O
CD45	O	O	B-T116
(	O	O	B-T033
-	O	O	I-T033
)	O	O	I-T033
ICAM-1(+	O	O	B-T116
)	O	O	I-T116
CD21	O	O	B-T116
/	O	O	O
35(+	O	O	B-T116
)	O	O	I-T116
cells	O	O	B-T025
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
spleen	O	O	B-T024
of	O	O	I-T024
mice	O	O	I-T024
administered	O	O	O
with	O	O	O
a	O	O	O
cognate	O	O	B-T129
antigen	O	O	I-T129
enhanced	O	O	B-T052
the	O	O	O
survival	O	O	B-T043
and	O	O	O
proliferation	O	O	B-T169
of	O	O	O
antigen-specific	O	O	B-T025
B	O	O	I-T025
cells	O	O	I-T025
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

Our	O	O	O
improved	O	O	B-T033
protocol	O	O	B-T170
for	O	O	O
the	O	O	O
isolation	O	O	B-T059
of	O	O	O
naïve	O	O	O
FDCs	O	O	B-T025
will	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
FDCs	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

-DOCSTART- (27643784)

Dental	O	O	B-T080
enamel	O	O	B-T033
defects	O	O	I-T033
in	O	O	O
German	O	O	B-T098
medieval	O	O	B-T079
and	O	O	O
early-modern-age	O	O	B-T079
populations	O	O	O

Aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
frequency	O	O	B-T079
and	O	O	O
type	O	O	B-T080
of	O	O	O
developmental	O	O	B-T033
defects	O	O	I-T033
of	O	O	I-T033
enamel	O	O	I-T033
(	O	O	O
DDE	O	O	B-T033
)	O	O	O
in	O	O	O
a	O	O	O
medieval	O	O	B-T079
and	O	O	O
an	O	O	O
early-modern-age	O	O	B-T079
population	O	O	B-T098
from	O	O	O
Thuringia	O	O	B-T083
,	O	O	I-T083
Germany	O	O	I-T083
.	O	O	O

Sixty-six	O	O	O
skeletons	O	O	B-T022
subdivided	O	O	B-T169
into	O	O	O
31	O	O	O
single	O	O	B-T081
burials	O	O	B-T052
(	O	O	O
12(th)/13(th	O	O	O
)	O	O	O
c.	O	O	O
)	O	O	O
and	O	O	O
35	O	O	O
individuals	O	O	B-T098
buried	O	O	B-T052
in	O	O	O
groups	O	O	B-T078
(	O	O	O
15(th)/16(th	O	O	O
)	O	O	O
c.	O	O	O
)	O	O	O
were	O	O	O
examined	O	O	B-T033
.	O	O	O

DDE	O	O	B-T033
were	O	O	O
classified	O	O	B-T185
on	O	O	O
1,246	O	O	O
teeth	O	O	B-T023
according	O	O	O
to	O	O	O
the	O	O	O
DDE	O	O	O
index	O	O	B-T170
.	O	O	O

Molar-incisor-hypomineralisation	O	O	B-T047
(	O	O	O
MIH	O	O	B-T047
)	O	O	O
,	O	O	O
a	O	O	O
special	O	O	O
type	O	O	B-T080
of	O	O	O
DDE	O	O	B-T033
,	O	O	O
was	O	O	O
recorded	O	O	B-T170
according	O	O	O
to	O	O	O
the	O	O	O
European	O	O	B-T092
Academy	O	O	I-T092
of	O	O	I-T092
Paediatric	O	O	I-T092
Dentistry	O	O	I-T092
(	O	O	O
EAPD	O	O	B-T092
)	O	O	O
criteria	O	O	B-T078
.	O	O	O

DDE	O	O	B-T033
was	O	O	O
found	O	O	O
in	O	O	O
89.4	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
individuals	O	O	B-T098
(	O	O	O
single	O	O	B-T081
burials	O	O	B-T052
90.3	O	O	O
%	O	O	O
and	O	O	O
group	O	O	B-T078
burials	O	O	O
88.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Hypoplastic	O	O	B-T169
pits	O	O	B-T033
were	O	O	O
the	O	O	O
most	O	O	O
frequent	O	O	B-T079
defect	O	O	B-T169
in	O	O	O
primary	O	O	B-T023
teeth	O	O	I-T023
and	O	O	O
linear	O	O	B-T047
enamel	O	O	I-T047
hypoplasia	O	O	I-T047
(	O	O	O
LEH	O	O	B-T047
)	O	O	O
in	O	O	O
permanent	O	O	B-T023
teeth	O	O	I-T023
.	O	O	O

13	O	O	O
individuals	O	O	B-T098
(	O	O	O
24.1	O	O	O
%	O	O	O
)	O	O	O
showed	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
hypomineralised	O	O	B-T047
permanent	O	O	B-T023
tooth	O	O	I-T023
,	O	O	O
12.2	O	O	O
%	O	O	O
had	O	O	O
MIH	O	O	B-T047
on	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
first	O	O	O
permanent	O	O	B-T023
molar	O	O	I-T023
and	O	O	O
10.0	O	O	O
%	O	O	O
in	O	O	O
permanent	O	O	B-T023
incisors	O	O	I-T023
.	O	O	O

Second	O	O	B-T023
primary	O	O	I-T023
molars	O	O	I-T023
were	O	O	O
affected	O	O	B-T169
in	O	O	O
8.0	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
children	O	O	B-T100
and	O	O	O
juveniles	O	O	B-T100
.	O	O	O

No	O	O	O
individual	O	O	B-T098
suffered	O	O	O
from	O	O	O
affected	O	O	B-T169
molars	O	O	B-T023
and	O	O	O
incisors	O	O	B-T023
in	O	O	O
combination	O	O	B-T080
.	O	O	O

Endogenous	O	O	B-T169
factors	O	O	B-T169
like	O	O	O
nutritional	O	O	B-T047
deficiencies	O	O	I-T047
and	O	O	O
health	O	O	B-T033
problems	O	O	I-T033
in	O	O	O
early	O	O	B-T079
childhood	O	O	B-T079
could	O	O	O
have	O	O	O
been	O	O	O
aetiological	O	O	B-T169
reasons	O	O	B-T078
of	O	O	O
DDE	O	O	B-T033
and	O	O	O
MIH	O	O	B-T047
.	O	O	O

The	O	O	O
frequency	O	O	B-T079
of	O	O	O
DDE	O	O	B-T033
and	O	O	O
MIH	O	O	B-T047
might	O	O	O
have	O	O	O
been	O	O	O
masked	O	O	B-T062
by	O	O	O
extended	O	O	B-T082
carious	O	O	B-T047
lesions	O	O	I-T047
,	O	O	O
dental	O	O	B-T037
wear	O	O	I-T037
and	O	O	O
ante-mortem	O	O	B-T033
tooth	O	O	B-T020
loss	O	O	I-T020
.	O	O	O

-DOCSTART- (27644674)

Breast	O	O	B-T191
Cancer	O	O	B-T191
Detection	O	O	B-T081
Rate	O	O	I-T081
,	O	O	O
Incidence	O	O	B-T081
,	O	O	O
Prevalence	O	O	B-T081
and	O	O	O
Interval	O	O	B-T079
Cancer	O	O	O
-related	O	O	O
Mammography	O	O	B-T061
Screening	O	O	I-T061
Times	O	O	B-T079
among	O	O	O
Thai	O	O	B-T098
Women	O	O	O

A	O	O	O
recent	O	O	O
guideline	O	O	B-T170
by	O	O	O
the	O	O	O
American	O	O	B-T094
Cancer	O	O	I-T094
Society	O	O	I-T094
recommended	O	O	O
that	O	O	O
mammography	O	O	B-T060
(	O	O	O
MMG	O	O	B-T060
)	O	O	O
should	O	O	O
be	O	O	O
done	O	O	O
for	O	O	O
women	O	O	B-T098
starting	O	O	O
in	O	O	O
their	O	O	O
mid-40s	O	O	O
.	O	O	O

In	O	O	O
Thailand	O	O	B-T083
,	O	O	O
information	O	O	O
on	O	O	O
opportunistic	O	O	B-T058
mammography	O	O	I-T058
screening	O	O	I-T058
is	O	O	O
limited	O	O	B-T169
and	O	O	O
data	O	O	B-T078
on	O	O	O
the	O	O	O
total	O	O	O
incidence	O	O	B-T081
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
are	O	O	O
also	O	O	O
lacking	O	O	O
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
estimate	O	O	B-T081
the	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
detection	O	O	B-T058
,	O	O	O
incident	O	O	B-T067
and	O	O	O
prevalence	O	O	B-T081
rates	O	O	I-T081
among	O	O	O
Thai	O	O	B-T098
women	O	O	B-T098
.	O	O	O

We	O	O	O
retrospectively	O	O	O
reviewed	O	O	O
the	O	O	O
opportunistic	O	O	B-T058
mammography	O	O	I-T058
screening	O	O	I-T058
of	O	O	O
normal	O	O	O
women	O	O	B-T098
between	O	O	O
30	O	O	O
and	O	O	O
80	O	O	O
years	O	O	B-T079
who	O	O	O
underwent	O	O	O
the	O	O	O
procedure	O	O	B-T058
between	O	O	O
2001	O	O	O
and	O	O	O
2010	O	O	O
.	O	O	O

All	O	O	O
cases	O	O	O
were	O	O	O
followed	O	O	O
until	O	O	O
2012	O	O	O
.	O	O	O

The	O	O	O
detection	O	O	B-T081
rate	O	O	I-T081
was	O	O	O
calculated	O	O	O
for	O	O	O
the	O	O	O
whole	O	O	O
period	O	O	O
of	O	O	O
observation	O	O	B-T062
using	O	O	O
'	O	O	O
number	O	O	B-T081
of	O	O	O
women	O	O	B-T098
with	O	O	O
positive	O	O	B-T033
findings	O	O	I-T033
'	O	O	O
divided	O	O	O
by	O	O	O
'	O	O	O
total	O	O	B-T081
number	O	O	I-T081
of	O	O	O
women	O	O	O
screened	O	O	B-T060
'	O	O	O
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
rate	O	O	I-T081
was	O	O	O
calculated	O	O	B-T169
only	O	O	O
at	O	O	O
the	O	O	O
first	O	O	O
MMG	O	O	B-T060
while	O	O	O
the	O	O	O
subsequence	O	O	O
rate	O	O	O
was	O	O	O
calculated	O	O	O
based	O	O	O
on	O	O	O
all	O	O	O
new	O	O	O
cases	O	O	O
detected	O	O	B-T033
at	O	O	O
each	O	O	O
subsequent	O	O	O
MMG	O	O	O
.	O	O	O

Among	O	O	O
the	O	O	O
47,430	O	O	O
women	O	O	B-T098
,	O	O	O
there	O	O	O
were	O	O	O
152,091	O	O	O
MMGs	O	O	B-T060
or	O	O	O
approximately	O	O	O
3.2	O	O	O
occasions	O	O	O
per	O	O	O
person	O	O	B-T098
(	O	O	O
range	O	O	O
,	O	O	O
1	O	O	O
-	O	O	O
10	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
average	O	O	O
duration	O	O	B-T079
of	O	O	O
the	O	O	O
interval	O	O	B-T079
between	O	O	O
each	O	O	O
subsequence	O	O	O
visit	O	O	O
was	O	O	O
1.8	O	O	O
years	O	O	B-T079
.	O	O	O

Overall	O	O	O
,	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
was	O	O	O
detected	O	O	B-T033
in	O	O	O
543	O	O	O
women	O	O	B-T098
,	O	O	O
with	O	O	O
a	O	O	O
detection	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
10.3	O	O	O
per	O	O	O
1,000	O	O	O
persons	O	O	B-T098
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
at	O	O	O
the	O	O	O
first	O	O	O
visit	O	O	O
was	O	O	O
5.78	O	O	O
per	O	O	O
1,000	O	O	O
person	O	O	B-T098
s.	O	O	O
The	O	O	O
incidence	O	O	B-T081
or	O	O	O
new	O	O	O
cases	O	O	O
detected	O	O	B-T033
at	O	O	O
any	O	O	O
follow-up	O	O	O
visit	O	O	O
was	O	O	O
10.4	O	O	O
per	O	O	O
1,000	O	O	O
person	O	O	O
s.	O	O	O
The	O	O	O
overall	O	O	O
interval	O	O	B-T079
cancer	O	O	O
was	O	O	O
0.91	O	O	O
per	O	O	O
1,000	O	O	O
women	O	O	B-T098
,	O	O	O
mainly	O	O	O
detected	O	O	O
before	O	O	O
their	O	O	O
second	O	O	O
and	O	O	O
third	O	O	O
MMG	O	O	B-T060
,	O	O	O
with	O	O	O
a	O	O	O
rate	O	O	O
of	O	O	O
0.0.47	O	O	O
and	O	O	O
0.76	O	O	O
per	O	O	O
1,000	O	O	O
women	O	O	O
.	O	O	O

Opportunistic	O	O	B-T058
mammography	O	O	I-T058
screening	O	O	I-T058
in	O	O	O
Thailand	O	O	B-T083
detected	O	O	B-T033
10	O	O	O
cases	O	O	O
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
from	O	O	O
each	O	O	O
1,000	O	O	O
women	O	O	B-T098
.	O	O	O

This	O	O	O
paper	O	O	O
indicated	O	O	O
a	O	O	O
high	O	O	O
rate	O	O	O
of	O	O	O
cancer	O	O	B-T058
detection	O	O	I-T058
during	O	O	O
a	O	O	O
two	O	O	O
year	O	O	O
interval	O	O	B-T079
,	O	O	O
hence	O	O	O
,	O	O	O
a	O	O	O
screening	O	O	B-T061
mammogram	O	O	I-T061
should	O	O	O
be	O	O	O
performed	O	O	O
more	O	O	O
often	O	O	O
.	O	O	O

-DOCSTART- (27644855)

Assessment	O	O	O
of	O	O	O
groundwater	O	O	B-T082
vulnerability	O	O	B-T080
in	O	O	O
the	O	O	O
Daule	O	O	B-T070
aquifer	O	O	I-T070
,	O	O	O
Ecuador	O	O	B-T083
,	O	O	O
using	O	O	O
the	O	O	O
susceptibility	O	O	O
index	O	O	O
method	O	O	O

The	O	O	O
Guayas	O	O	B-T083
region	O	O	I-T083
in	O	O	O
Ecuador	O	O	B-T083
is	O	O	O
economically	O	O	O
very	O	O	O
important	O	O	O
,	O	O	O
producing	O	O	O
68	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
national	O	O	B-T002
crops	O	O	I-T002
.	O	O	O

The	O	O	O
main	O	O	O
agricultural	O	O	B-T090
activities	O	O	I-T090
threaten	O	O	O
the	O	O	O
groundwater	O	O	B-T082
therein	O	O	O
with	O	O	O
nitrate	O	O	B-T197
contamination	O	O	B-T078
given	O	O	O
the	O	O	O
large	O	O	O
fertiliser	O	O	B-T131
and	O	O	O
water	O	O	B-T121
needs	O	O	B-T080
.	O	O	O

The	O	O	O
present	O	O	O
work	O	O	O
tests	O	O	O
the	O	O	O
applicability	O	O	O
of	O	O	O
the	O	O	O
susceptibility	O	O	B-T059
index	O	O	I-T059
assessment	O	O	I-T059
method	O	O	I-T059
in	O	O	O
evaluating	O	O	O
the	O	O	O
impact	O	O	O
of	O	O	O
agricultural	O	O	B-T090
activities	O	O	I-T090
on	O	O	O
groundwater	O	O	B-T082
quality	O	O	B-T080
,	O	O	O
using	O	O	O
as	O	O	O
a	O	O	O
case	O	O	O
study	O	O	O
an	O	O	O
aquifer	O	O	B-T070
of	O	O	O
the	O	O	O
Guayas	O	O	B-T083
river	O	O	B-T082
basin	O	O	I-T082
in	O	O	O
Ecuador	O	O	B-T083
.	O	O	O

The	O	O	O
index	O	O	O
adapts	O	O	O
four	O	O	O
parameters	O	O	O
of	O	O	O
the	O	O	O
DRASTIC	O	O	B-T059
method	O	O	I-T059
and	O	O	O
incorporated	O	O	O
a	O	O	O
new	O	O	O
land	O	O	B-UnknownType
use	O	O	I-UnknownType
parameter	O	O	O
.	O	O	O

Results	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
areas	O	O	B-T082
highly	O	O	B-T080
vulnerable	O	O	B-T080
to	O	O	O
contamination	O	O	B-T078
are	O	O	O
located	O	O	O
in	O	O	O
irrigation	O	O	B-T068
perimeters	O	O	B-T082
of	O	O	O
dominant	O	O	O
paddy	O	O	B-T082
fields	O	O	I-T082
associated	O	O	O
with	O	O	O
the	O	O	O
high	O	O	O
recharge	O	O	O
rates	O	O	O
in	O	O	O
the	O	O	O
alluvial	O	O	B-T197
deposits	O	O	I-T197
.	O	O	O

Respectively	O	O	O
,	O	O	O
moderately	O	O	B-T080
vulnerable	O	O	B-T080
and	O	O	O
low	O	O	B-T080
-	O	O	O
vulnerability	O	O	B-T080
areas	O	O	B-T082
correspond	O	O	O
to	O	O	O
aquatic	O	O	B-T067
environments	O	O	I-T067
and	O	O	O
forests	O	O	B-T070
,	O	O	O
semi-natural	O	O	B-T082
zones	O	O	I-T082
and	O	O	O
water	O	O	B-T067
bodies	O	O	I-T067
.	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
main	O	O	O
contributions	O	O	O
of	O	O	O
the	O	O	O
Daule	O	O	B-T070
aquifer	O	O	I-T070
vulnerability	O	O	B-T080
is	O	O	O
likely	O	O	O
its	O	O	O
wide	O	O	B-T082
,	O	O	O
flat	O	O	B-T082
topography	O	O	I-T082
.	O	O	O

A	O	O	O
great	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
aquifer	O	O	B-T070
is	O	O	O
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
contamination	O	O	I-T033
by	O	O	O
nitrates	O	O	B-T197
if	O	O	O
a	O	O	O
code	O	O	O
of	O	O	O
good	O	O	B-T080
agricultural	O	O	B-T090
practices	O	O	I-T090
is	O	O	O
not	O	O	O
applied	O	O	O
.	O	O	O

Therefore	O	O	O
the	O	O	O
implementation	O	O	O
of	O	O	O
a	O	O	O
monitoring	O	O	B-T033
network	O	O	I-T033
to	O	O	I-T033
control	O	O	I-T033
the	O	O	O
nitrates	O	O	B-T197
concentrations	O	O	B-T081
is	O	O	O
the	O	O	O
first	O	O	O
step	O	O	O
to	O	O	O
assure	O	O	O
groundwater	O	O	B-T082
quality	O	O	B-T080
for	O	O	O
drinking	O	O	B-T167
purposes	O	O	B-T169
.	O	O	O

-DOCSTART- (27645367)

Heterogeneous	O	O	B-T080
depression	O	O	B-T048
trajectories	O	O	B-T079
in	O	O	O
multiple	O	O	B-T047
sclerosis	O	O	I-T047
patients	O	O	O

Trajectories	O	O	B-T079
of	O	O	O
depression	O	O	B-T048
over	O	O	O
time	O	O	O
may	O	O	O
be	O	O	O
heterogeneous	O	O	B-T080
in	O	O	O
Multiple	O	O	B-T047
Sclerosis	O	O	I-T047
(	O	O	O
MS	O	O	B-T047
)	O	O	O
patients	O	O	B-T101
.	O	O	O

Describing	O	O	O
these	O	O	O
trajectories	O	O	B-T079
will	O	O	O
help	O	O	O
clinicians	O	O	B-T097
understand	O	O	O
better	O	O	O
the	O	O	O
progression	O	O	B-T169
of	O	O	O
depression	O	O	B-T048
in	O	O	O
MS	O	O	B-T047
patients	O	O	B-T101
to	O	O	O
aid	O	O	O
in	O	O	O
patient	O	O	O
care	O	O	O
decisions	O	O	O
.	O	O	O

Latent	O	O	B-T062
class	O	O	I-T062
growth	O	O	I-T062
analysis	O	O	I-T062
(	O	O	O
LCGA	O	O	B-T062
)	O	O	O
was	O	O	O
applied	O	O	O
to	O	O	O
3507	O	O	O
MS	O	O	B-T047
patients	O	O	B-T101
using	O	O	O
an	O	O	O
electronic	O	O	B-T170
health	O	O	I-T170
records	O	O	I-T170
(	O	O	I-T170
EHR	O	O	I-T170
)	O	O	I-T170
data	O	O	I-T170
base	O	O	I-T170
to	O	O	O
identify	O	O	O
subgroups	O	O	B-T098
of	O	O	O
MS	O	O	O
patients	O	O	O
based	O	O	O
on	O	O	O
self-reported	O	O	O
depression	O	O	B-T061
screening	O	O	I-T061
(	O	O	O
PHQ-9	O	O	B-T170
)	O	O	O
.	O	O	O

Latent	O	O	B-T080
trajectory	O	O	B-T079
classes	O	O	O
were	O	O	O
used	O	O	O
for	O	O	O
group	O	O	B-T098
comparisons	O	O	O
based	O	O	O
on	O	O	O
baseline	O	O	B-T081
clinical	O	O	B-T201
characteristics	O	O	I-T201
.	O	O	O

Three	O	O	O
subgroups	O	O	B-T098
were	O	O	O
found	O	O	O
characterized	O	O	O
by	O	O	O
high	O	O	B-T080
(	O	O	O
10.0	O	O	O
%	O	O	O
[	O	O	O
of	O	O	O
participants	O	O	B-T098
]	O	O	O
)	O	O	O
,	O	O	O
wavering	O	O	O
above	O	O	O
and	O	O	O
below	O	O	O
moderate	O	O	B-T080
(	O	O	O
26.2	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
low	O	O	B-T080
and	O	O	O
variable	O	O	B-T080
(	O	O	O
63.8	O	O	O
%	O	O	O
)	O	O	O
depression	O	O	B-T033
level	O	O	I-T033
trajectories	O	O	B-T079
.	O	O	O

The	O	O	O
subpopulation	O	O	B-T098
trajectories	O	O	B-T079
,	O	O	O
respectively	O	O	O
,	O	O	O
were	O	O	O
also	O	O	O
characterized	O	O	O
by	O	O	O
high	O	O	B-T080
,	O	O	O
moderate	O	O	B-T080
and	O	O	O
low	O	O	B-T080
MS	O	O	B-T047
disability	O	O	B-T033
at	O	O	O
baseline	O	O	B-T081
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
overall	O	O	O
average	O	O	O
trajectory	O	O	B-T079
was	O	O	O
slightly	O	O	O
declining	O	O	O
and	O	O	O
below	O	O	O
the	O	O	O
moderate	O	O	B-T080
depression	O	O	B-T048
threshold	O	O	B-T080
.	O	O	O

The	O	O	O
LCGA	O	O	B-T062
approach	O	O	O
described	O	O	O
in	O	O	O
this	O	O	O
paper	O	O	O
and	O	O	O
applied	O	O	O
to	O	O	O
MS	O	O	B-T047
patients	O	O	B-T101
provides	O	O	O
a	O	O	O
template	O	O	B-T078
for	O	O	O
improved	O	O	O
use	O	O	O
of	O	O	O
an	O	O	O
EHR	O	O	B-T170
data	O	O	I-T170
base	O	O	I-T170
for	O	O	O
understanding	O	O	O
heterogeneous	O	O	B-T080
depression	O	O	B-T061
screening	O	O	I-T061
trajectories	O	O	B-T079
.	O	O	O

Clinicians	O	O	B-T097
may	O	O	O
use	O	O	O
such	O	O	O
information	O	O	B-T078
to	O	O	O
more	O	O	O
closely	O	O	O
monitor	O	O	B-T058
patients	O	O	I-T058
that	O	O	O
are	O	O	O
expected	O	O	O
to	O	O	O
maintain	O	O	O
high	O	O	B-T080
or	O	O	O
unstable	O	O	B-T033
depression	O	O	B-T033
levels	O	O	I-T033
.	O	O	O

-DOCSTART- (27646139)

The	O	O	O
PLA2	O	O	B-T028
gene	O	O	I-T028
mediates	O	O	O
the	O	O	O
humoral	O	O	B-T043
immune	O	O	I-T043
responses	O	O	I-T043
in	O	O	O
Bactrocera	O	O	O
dorsalis	O	O	O
(	O	O	O
Hendel	O	O	O
)	O	O	O

The	O	O	O
phospholipase	O	O	B-T028
A2	O	O	I-T028
(	O	O	I-T028
PLA2	O	O	I-T028
)	O	O	I-T028
gene	O	O	I-T028
encodes	O	O	B-T052
the	O	O	O
enzyme	O	O	B-T116
that	O	O	O
catalyzes	O	O	B-T169
the	O	O	O
hydrolysis	O	O	B-T070
of	O	O	O
phospholipids	O	O	B-T109
(	O	O	O
PLs	O	O	B-T109
)	O	O	O
from	O	O	O
the	O	O	O
sn-2	O	O	B-T082
position	O	O	I-T082
.	O	O	O

However	O	O	O
,	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
its	O	O	O
role	O	O	B-T170
in	O	O	O
humoral	O	O	B-T043
immune	O	O	I-T043
responses	O	O	I-T043
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
expression	O	O	B-T081
profile	O	O	I-T081
of	O	O	O
PLA2	O	O	B-T028
in	O	O	O
different	O	O	B-T080
tissues	O	O	B-T024
and	O	O	O
developmental	O	O	B-T079
stages	O	O	I-T079
in	O	O	O
Bactrocera	O	O	B-T204
dorsalis	O	O	I-T204
(	O	O	I-T204
Hendel	O	O	I-T204
)	O	O	I-T204
,	O	O	O
and	O	O	O
the	O	O	O
results	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
transcriptional	O	O	B-T045
level	O	O	B-T080
of	O	O	O
PLA2	O	O	O
was	O	O	O
high	O	O	B-T080
in	O	O	O
the	O	O	O
egg	O	O	B-T042
and	O	O	O
mature	O	O	B-T042
stage	O	O	I-T042
and	O	O	O
in	O	O	O
the	O	O	O
testis	O	O	B-T023
tissue	O	O	B-T024
.	O	O	O

Bacterial	O	O	B-T047
infection	O	O	I-T047
increased	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
PLA2	O	O	B-T028
,	O	O	O
and	O	O	O
the	O	O	O
highest	O	O	O
degree	O	O	O
of	O	O	O
up-regulation	O	O	B-T044
appeared	O	O	O
in	O	O	O
the	O	O	O
fat	O	O	B-T023
body	O	O	I-T023
.	O	O	O

Silencing	O	O	B-T045
PLA2	O	O	B-T028
influenced	O	O	B-T077
the	O	O	O
expression	O	O	B-T045
of	O	O	O
immune-related	O	O	B-T028
genes	O	O	I-T028
,	O	O	O
including	O	O	O
MyD88	O	O	B-T028
and	O	O	O
defensin	O	O	B-T116
in	O	O	O
the	O	O	O
Toll	O	O	B-T044
pathway	O	O	I-T044
and	O	O	O
relish	O	O	B-T116
and	O	O	O
diptericin	O	O	B-T116
in	O	O	O
the	O	O	O
Imd	O	O	B-T077
pathway	O	O	I-T077
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
MyD88	O	O	B-T028
and	O	O	O
defensin	O	O	B-T116
was	O	O	O
down-regulated	O	O	B-T044
significantly	O	O	O
in	O	O	O
the	O	O	O
ds-PLA2	O	O	B-T028
group	O	O	B-T078
compared	O	O	O
with	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
ds-egfp	O	O	B-T116
group	O	O	O
when	O	O	O
B.	O	O	B-T204
dorsalis	O	O	I-T204
was	O	O	O
infected	O	O	B-T033
with	O	O	O
L.	O	O	B-T007
monocytogenes	O	O	I-T007
and	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
,	O	O	O
indicating	O	O	O
that	O	O	O
PLA2	O	O	B-T028
was	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
activation	O	O	B-T045
of	O	O	O
the	O	O	O
Toll	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
infection	O	O	B-T046
with	O	O	O
L.	O	O	B-T007
monocytogenes	O	O	I-T007
and	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
,	O	O	O
which	O	O	O
activate	O	O	B-T169
the	O	O	O
Imd	O	O	B-T077
pathway	O	O	I-T077
,	O	O	O
does	O	O	O
not	O	O	O
increase	O	O	B-T169
the	O	O	O
mRNA	O	O	B-T114
levels	O	O	B-T080
of	O	O	O
relish	O	O	B-T116
and	O	O	O
diptericin	O	O	B-T116
in	O	O	O
the	O	O	O
ds-PLA2	O	O	B-T028
group	O	O	B-T078
as	O	O	O
severely	O	O	O
as	O	O	O
it	O	O	O
increases	O	O	B-T169
those	O	O	O
in	O	O	O
the	O	O	O
ds-egfp	O	O	B-T116
group	O	O	O
,	O	O	O
indicating	O	O	O
that	O	O	O
the	O	O	O
Imd	O	O	O
pathway	O	O	O
was	O	O	O
also	O	O	O
repressed	O	O	B-T169
after	O	O	O
silencing	O	O	B-T045
PLA2	O	O	B-T028
.	O	O	O

Notably	O	O	O
,	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
lipid	O	O	B-T026
droplets	O	O	I-T026
in	O	O	O
fat	O	O	B-T023
body	O	O	I-T023
cells	O	O	B-T025
was	O	O	O
influenced	O	O	B-T077
by	O	O	O
silencing	O	O	B-T045
PLA2	O	O	B-T028
,	O	O	O
implying	O	O	O
that	O	O	O
PLA2	O	O	O
affects	O	O	O
the	O	O	O
function	O	O	B-T169
of	O	O	O
fat	O	O	O
body	O	O	O
tissue	O	O	B-T024
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
PLA2	O	O	B-T028
gene	O	O	O
may	O	O	O
mediate	O	O	O
humoral	O	O	B-T043
immune	O	O	I-T043
responses	O	O	I-T043
by	O	O	O
reducing	O	O	B-T080
lipid	O	O	B-T043
storage	O	O	I-T043
in	O	O	O
fat	O	O	B-T023
body	O	O	I-T023
cells	O	O	B-T025
in	O	O	O
B.	O	O	B-T204
dorsalis	O	O	I-T204
.	O	O	O

-DOCSTART- (27648744)

Gambling	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
gambling	O	O	B-T055
type	O	O	O
preferences	O	O	O
,	O	O	O
and	O	O	O
psychiatric	O	O	B-T169
comorbidity	O	O	B-T078
among	O	O	O
the	O	O	O
Thai	O	O	B-T098
general	O	O	I-T098
population	O	O	I-T098
:	O	O	O
Results	O	O	O
of	O	O	O
the	O	O	O
2013	O	O	O
National	O	O	O
Mental	O	O	O
Health	O	O	O
Survey	O	O	O

Background	O	O	O
and	O	O	O
aims	O	O	O
To	O	O	O
estimate	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
problem	O	O	B-T048
and	O	O	O
pathological	O	O	B-T048
gambling	O	O	I-T048
,	O	O	O
gender	O	O	B-T032
and	O	O	O
age-group	O	O	B-T100
differences	O	O	O
in	O	O	O
gambling	O	O	B-T055
types	O	O	I-T055
,	O	O	O
and	O	O	O
comorbidities	O	O	B-T078
with	O	O	O
other	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
among	O	O	O
the	O	O	O
Thai	O	O	B-T098
general	O	O	I-T098
population	O	O	I-T098
.	O	O	O

Methods	O	O	O
Analysis	O	O	O
was	O	O	O
conducted	O	O	O
on	O	O	O
4,727	O	O	O
participants	O	O	B-T098
of	O	O	O
Thailand	O	O	B-T083
's	O	O	I-T083
2013	O	O	O
National	O	O	B-T170
Mental	O	O	I-T170
Health	O	O	I-T170
Survey	O	O	I-T170
,	O	O	O
a	O	O	O
multistage	O	O	B-T170
stratified	O	O	I-T170
cluster	O	O	I-T170
survey	O	O	I-T170
,	O	O	O
using	O	O	O
the	O	O	O
Composite	O	O	B-T170
International	O	O	I-T170
Diagnostic	O	O	I-T170
Interview	O	O	I-T170
.	O	O	O

Diagnoses	O	O	B-T033
of	O	O	O
problem	O	O	B-T048
and	O	O	O
pathological	O	O	B-T048
gambling	O	O	B-T055
and	O	O	O
other	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
were	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
DSM-IV-TR	O	O	B-T170
criteria	O	O	B-T078
with	O	O	O
the	O	O	O
following	O	O	O
additional	O	O	O
criteria	O	O	O
for	O	O	O
gamblers	O	O	B-T055
:	O	O	O
more	O	O	O
than	O	O	O
10	O	O	O
lifetime	O	O	B-T079
gambling	O	O	O
episodes	O	O	O
and	O	O	O
a	O	O	O
single	O	O	B-T081
year	O	O	I-T081
loss	O	O	I-T081
of	O	O	O
at	O	O	O
least	O	O	O
365	O	O	O
USD	O	O	B-T081
from	O	O	O
gambling	O	O	O
.	O	O	O

Results	O	O	O
The	O	O	O
estimated	O	O	O
lifetime	O	O	B-T079
prevalence	O	O	B-T081
rates	O	O	I-T081
of	O	O	O
pathological	O	O	B-T048
and	O	O	O
problem	O	O	B-T048
gambling	O	O	I-T048
were	O	O	O
0.90	O	O	O
%	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
):	O	O	O
0.51	O	O	O
-	O	O	O
1.29	O	O	O
]	O	O	O
and	O	O	O
1.14	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.58	O	O	O
-	O	O	O
1.70	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
popular	O	O	O
type	O	O	O
of	O	O	O
gambling	O	O	B-T055
was	O	O	O
playing	O	O	B-T055
lotteries	O	O	I-T055
[	O	O	O
69.5	O	O	O
%	O	O	O
,	O	O	O
standard	O	O	B-T081
error	O	O	I-T081
(	O	O	O
SE	O	O	B-T081
)	O	O	O
=	O	O	O
1.9	O	O	O
]	O	O	O
,	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
which	O	O	O
was	O	O	O
significantly	O	O	O
higher	O	O	O
among	O	O	O
females	O	O	B-T032
and	O	O	O
older	O	O	B-T098
age	O	O	I-T098
groups	O	O	I-T098
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
seen	O	O	O
among	O	O	O
pathological	O	O	B-T048
gamblers	O	O	I-T048
were	O	O	O
alcohol	O	O	B-T048
abuse	O	O	I-T048
(	O	O	O
57.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
nicotine	O	O	B-T048
dependence	O	O	I-T048
(	O	O	O
49.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
any	O	O	O
drug	O	O	B-T048
use	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
16.2	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Pathological	O	O	B-T048
gambling	O	O	I-T048
was	O	O	O
highly	O	O	O
prevalent	O	O	O
among	O	O	O
those	O	O	O
who	O	O	O
ever	O	O	O
experienced	O	O	O
major	O	O	B-T048
depressive	O	O	I-T048
episodes	O	O	I-T048
(	O	O	O
5.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
any	O	O	O
drug	O	O	B-T048
dependence	O	O	I-T048
(	O	O	O
5.1	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
intermittent	O	O	B-T048
explosive	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
4.8	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
association	O	O	O
between	O	O	O
pathological	O	O	B-T048
gambling	O	O	I-T048
was	O	O	O
strongest	O	O	O
with	O	O	O
a	O	O	O
history	O	O	O
of	O	O	O
major	O	O	B-T048
depressive	O	O	I-T048
episode	O	O	I-T048
[	O	O	O
adjusted	O	O	B-T081
odds	O	O	I-T081
ratio	O	O	I-T081
(	O	O	O
AOR	O	O	B-T081
)	O	O	O
=	O	O	O
10.4	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
2.80	O	O	O
-	O	O	O
38.4	O	O	O
]	O	O	O
.	O	O	O

Conclusion	O	O	O
The	O	O	O
study	O	O	O
confirms	O	O	O
the	O	O	O
recognition	O	O	B-T041
of	O	O	O
gambling	O	O	B-T048
disorders	O	O	I-T048
as	O	O	O
a	O	O	O
public	O	O	B-T170
health	O	O	I-T170
concern	O	O	O
in	O	O	O
Thailand	O	O	B-T083
and	O	O	O
suggests	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
culturally	O	O	B-T169
specific	O	O	O
preventive	O	O	B-T080
measures	O	O	O
for	O	O	O
pathological	O	O	B-T048
gamblers	O	O	I-T048
and	O	O	O
those	O	O	O
with	O	O	O
a	O	O	O
history	O	O	O
of	O	O	O
substance	O	O	B-T048
use	O	O	I-T048
disorders	O	O	I-T048
or	O	O	O
major	O	O	B-T048
depression	O	O	I-T048
.	O	O	O

-DOCSTART- (27649458)

Synovial	O	O	B-T191
sarcoma	O	O	I-T191
of	O	O	O
the	O	O	O
hypopharynx	O	O	B-T029
in	O	O	O
a	O	O	O
pediatric	O	O	B-T080
patient	O	O	B-T101
:	O	O	O
Case	O	O	O
report	O	O	O

Synovial	O	O	B-T191
sarcoma	O	O	B-T191
(	O	O	O
SS	O	O	B-T191
)	O	O	O
is	O	O	O
uncommon	O	O	O
high	O	O	O
grade	O	O	O
soft	O	O	B-T024
tissue	O	O	I-T024
sarcoma	O	O	O
,	O	O	O
accounting	O	O	O
for	O	O	O
less	O	O	O
than	O	O	O
10	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
head	O	O	B-T191
and	O	O	I-T191
neck	O	O	I-T191
sarcomas	O	O	I-T191
.	O	O	O

Also	O	O	O
,	O	O	O
about	O	O	O
10	O	O	O
%	O	O	O
of	O	O	O
SS	O	O	B-T191
occur	O	O	O
within	O	O	O
the	O	O	O
Head	O	O	B-T029
&	O	O	O
Neck	O	O	B-T029
.	O	O	O

In	O	O	O
the	O	O	O
pediatric	O	O	B-T080
population	O	O	B-T098
,	O	O	O
SS	O	O	B-T191
is	O	O	O
an	O	O	O
extremely	O	O	O
rare	O	O	B-T080
head	O	O	B-T191
&	O	O	I-T191
neck	O	O	I-T191
malignancy	O	O	I-T191
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
case	O	O	O
of	O	O	O
sixteen	O	O	O
years	O	O	O
old	O	O	O
boy	O	O	B-T100
diagnosed	O	O	B-T033
with	O	O	O
SS	O	O	B-T191
situated	O	O	O
of	O	O	O
the	O	O	O
hypopharynx	O	O	B-T029
treated	O	O	B-T061
by	O	O	I-T061
surgical	O	O	B-T061
excision	O	O	I-T061
and	O	O	O
post	O	O	B-T033
operative	O	O	I-T033
radio	O	O	B-T061
-	O	O	O
chemotherapy	O	O	B-T061
.	O	O	O

This	O	O	O
anatomical	O	O	B-T029
location	O	O	I-T029
brings	O	O	O
additional	O	O	O
functional	O	O	B-T169
challenges	O	O	B-T058
(	O	O	O
swallowing	O	O	B-T040
,	O	O	O
phonation	O	O	B-T042
,	O	O	O
respiration	O	O	B-T039
)	O	O	O
,	O	O	O
especially	O	O	O
in	O	O	O
the	O	O	O
pediatric	O	O	B-T080
population	O	O	B-T098
.	O	O	O

Pre-operative	O	O	B-T079
and	O	O	O
even	O	O	O
post-operative	O	O	B-T033
histopathological	O	O	B-T169
diagnosis	O	O	B-T033
of	O	O	O
SS	O	O	B-T191
remains	O	O	O
difficult	O	O	O
.	O	O	O

Optimal	O	O	B-T080
treatment	O	O	B-T061
of	O	O	O
Head	O	O	B-T029
&	O	O	O
Neck	O	O	B-T029
SS	O	O	B-T191
has	O	O	O
to	O	O	O
balance	O	O	O
functional	O	O	B-T169
and	O	O	O
oncologic	O	O	B-T091
aspects	O	O	B-T080
.	O	O	O

SS	O	O	B-T191
is	O	O	O
an	O	O	O
extremely	O	O	O
rare	O	O	B-T080
head	O	O	B-T191
&	O	O	I-T191
neck	O	O	I-T191
malignancy	O	O	I-T191
in	O	O	O
pediatric	O	O	B-T080
population	O	O	B-T098
.	O	O	O

It	O	O	O
has	O	O	O
multifaceted	O	O	B-T082
challenges	O	O	B-T058
including	O	O	O
pre	O	O	O
and	O	O	O
post-operative	O	O	B-T033
histopathological	O	O	B-T169
diagnosis	O	O	B-T033
and	O	O	O
optimal	O	O	B-T080
modality	O	O	B-T078
of	O	O	O
treatment	O	O	B-T061
.	O	O	O

Clinical	O	O	B-T170
judgment	O	O	I-T170
,	O	O	O
especially	O	O	O
in	O	O	O
the	O	O	O
pediatric	O	O	B-T080
population	O	O	B-T098
,	O	O	O
needs	O	O	O
to	O	O	O
balance	O	O	O
tumor	O	O	B-T034
free	O	O	I-T034
margins	O	O	I-T034
and	O	O	O
organ	O	O	B-T061
preservation	O	O	I-T061
in	O	O	O
head	O	O	B-T029
and	O	O	O
neck	O	O	B-T029
region	O	O	B-T029
.	O	O	O

-DOCSTART- (27649982)

Ocular	O	O	B-T047
hypotensive	O	O	I-T047
effect	O	O	B-T080
of	O	O	O
the	O	O	O
novel	O	O	O
EP3	O	O	B-T116
/	O	O	O
FP	O	O	B-T116
agonist	O	O	B-T121
ONO-9054	O	O	B-T109
versus	O	O	O
Xalatan	O	O	B-T109
:	O	O	O
results	O	O	O
of	O	O	O
a	O	O	O
28-	O	O	O
day	O	O	B-T079
,	O	O	O
double-masked	O	O	B-T062
,	O	O	O
randomised	O	O	B-T080
study	O	O	O

ONO-9054	O	O	B-T109
is	O	O	O
being	O	O	O
developed	O	O	O
for	O	O	O
the	O	O	O
reduction	O	O	B-T080
of	O	O	O
intraocular	O	O	B-T042
pressure	O	O	I-T042
(	O	O	O
IOP	O	O	B-T042
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
ocular	O	O	B-T047
hypertension	O	O	I-T047
(	O	O	O
OHT	O	O	B-T047
)	O	O	O
and	O	O	O
open-angle	O	O	B-T047
glaucoma	O	O	I-T047
(	O	O	O
OAG	O	O	B-T047
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
compared	O	O	O
the	O	O	O
novel	O	O	O
dual	O	O	O
EP3	O	O	B-T116
/	O	O	O
FP	O	O	B-T116
agonist	O	O	B-T121
ONO-9054	O	O	B-T109
with	O	O	O
the	O	O	O
FP	O	O	O
agonist	O	O	O
Xalatan	O	O	B-T109
.	O	O	O

Adults	O	O	B-T100
(	O	O	O
n=123	O	O	O
)	O	O	O
with	O	O	O
bilateral	O	O	O
mild/moderate	O	O	O
OAG	O	O	B-T047
or	O	O	O
OHT	O	O	B-T047
,	O	O	O
with	O	O	O
unmedicated	O	O	O
IOP	O	O	B-T042
of	O	O	O
≥24	O	O	O
mm	O	O	O
Hg	O	O	O
at	O	O	O
8:00	O	O	O
hours	O	O	O
,	O	O	O
≥21	O	O	O
mm	O	O	O
Hg	O	O	O
at	O	O	O
10:00	O	O	O
hours	O	O	O
and	O	O	O
≤36	O	O	O
mm	O	O	O
Hg	O	O	O
,	O	O	O
were	O	O	O
randomised	O	O	O
1:1	O	O	O
to	O	O	O
receive	O	O	O
ONO-9054	O	O	B-T109
(	O	O	O
0.003	O	O	O
%	O	O	O
,	O	O	O
30	O	O	O
μg/mL	O	O	O
)	O	O	O
or	O	O	O
Xalatan	O	O	B-T109
(	O	O	O
0.005	O	O	O
%	O	O	O
,	O	O	O
50	O	O	O
μg/mL	O	O	O
)	O	O	O
once	O	O	O
daily	O	O	B-T079
for	O	O	O
28	O	O	O
days	O	O	B-T079
.	O	O	O

Day	O	O	B-T079
29	O	O	O
mean	O	O	O
diurnal	O	O	O
IOP	O	O	B-T042
was	O	O	O
-7.2	O	O	O
mm	O	O	O
Hg	O	O	O
for	O	O	O
ONO-9054	O	O	B-T109
vs	O	O	O
-6.6	O	O	O
mm	O	O	O
Hg	O	O	O
for	O	O	O
Xalatan	O	O	B-T109
.	O	O	O

At	O	O	O
08:00	O	O	O
hours	O	O	O
,	O	O	O
the	O	O	O
IOPs	O	O	B-T042
were	O	O	O
comparable	O	O	O
,	O	O	O
and	O	O	O
at	O	O	O
all	O	O	O
later	O	O	O
time	O	O	O
points	O	O	O
the	O	O	O
decrease	O	O	B-T081
in	O	O	O
IOP	O	O	B-T042
was	O	O	O
greater	O	O	O
for	O	O	O
ONO-9054	O	O	B-T109
.	O	O	O

On	O	O	O
day	O	O	B-T079
29	O	O	O
,	O	O	O
the	O	O	O
odds	O	O	O
of	O	O	O
a	O	O	O
mean	O	O	O
IOP	O	O	B-T042
reduction	O	O	B-T080
of	O	O	O
≤-25	O	O	O
%	O	O	O
,	O	O	O
≤-30	O	O	O
%	O	O	O
and	O	O	O
≤-35	O	O	O
%	O	O	O
for	O	O	O
ONO-9054	O	O	B-T109
were	O	O	O
2.39	O	O	O
,	O	O	O
2.37	O	O	O
and	O	O	O
4.85	O	O	O
times	O	O	O
more	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
than	O	O	O
the	O	O	O
odds	O	O	O
for	O	O	O
Xalatan	O	O	B-T109
(	O	O	O
p<0.05	O	O	O
,	O	O	O
post	O	O	B-T062
hoc	O	O	I-T062
analyses	O	O	I-T062
)	O	O	O
.	O	O	O

The	O	O	O
percentage	O	O	O
of	O	O	O
subjects	O	O	O
achieving	O	O	O
target	O	O	O
IOPs	O	O	B-T042
on	O	O	O
day	O	O	B-T079
29	O	O	O
(	O	O	O
≤17	O	O	O
,	O	O	O
≤16	O	O	O
and	O	O	O
≤15	O	O	O
mm	O	O	O
Hg	O	O	O
)	O	O	O
was	O	O	O
greater	O	O	O
for	O	O	O
ONO-9054	O	O	B-T109
than	O	O	O
for	O	O	O
Xalatan	O	O	B-T109
;	O	O	O
the	O	O	O
odds	O	O	O
of	O	O	O
achieving	O	O	O
an	O	O	O
IOP	O	O	B-T042
≤15	O	O	O
mm	O	O	O
Hg	O	O	O
for	O	O	O
ONO-9054	O	O	O
were	O	O	O
2.4	O	O	O
times	O	O	O
more	O	O	O
than	O	O	O
the	O	O	O
odds	O	O	O
for	O	O	O
Xalatan	O	O	O
(	O	O	O
p<0.01	O	O	O
,	O	O	O
post	O	O	B-T062
hoc	O	O	I-T062
analysis	O	O	I-T062
)	O	O	O
.	O	O	O

Subjects	O	O	O
randomised	O	O	O
to	O	O	O
receive	O	O	O
ONO-9054	O	O	B-T109
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
achieve	O	O	O
a	O	O	O
greater	O	O	O
per	O	O	O
cent	O	O	O
reduction	O	O	O
in	O	O	O
IOP	O	O	B-T042
and	O	O	O
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
achieve	O	O	O
target	O	O	O
IOPs	O	O	B-T042
than	O	O	O
those	O	O	O
receiving	O	O	O
Xalatan	O	O	B-T109
.	O	O	O

The	O	O	O
effects	O	O	O
of	O	O	O
ONO-9054	O	O	B-T109
in	O	O	O
reducing	O	O	O
IOP	O	O	B-T042
appear	O	O	O
to	O	O	O
persist	O	O	O
longer	O	O	O
than	O	O	O
those	O	O	O
of	O	O	O
Xalatan	O	O	B-T109
.	O	O	O

NCT02083289	O	O	O
,	O	O	O
Results	O	O	O
.	O	O	O

-DOCSTART- (27650531)

Whole-body	O	O	B-T061
strength	O	O	I-T061
training	O	O	I-T061
with	O	O	O
Huber	O	O	B-T073
Motion	O	O	I-T073
Lab	O	O	I-T073
and	O	O	O
traditional	O	O	B-T061
strength	O	O	I-T061
training	O	O	I-T061
in	O	O	O
cardiac	O	O	B-T061
rehabilitation	O	O	I-T061
:	O	O	O
A	O	O	O
randomized	O	O	O
controlled	O	O	O
study	O	O	O

Isometric	O	O	B-T061
strengthening	O	O	I-T061
has	O	O	O
been	O	O	O
rarely	O	O	O
studied	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
coronary	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CHD	O	O	B-T047
)	O	O	O
,	O	O	O
mainly	O	O	O
because	O	O	O
of	O	O	O
possible	O	O	O
potential	O	O	B-T046
side	O	O	I-T046
effects	O	O	I-T046
and	O	O	O
lack	O	O	B-T080
of	O	O	O
appropriate	O	O	B-T080
and	O	O	O
reliable	O	O	B-T170
devices	O	O	B-T073
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
compare	O	O	O
2	O	O	O
different	O	O	O
modes	O	O	B-T169
of	O	O	O
resistance	O	O	B-T061
training	O	O	I-T061
,	O	O	O
an	O	O	O
isometric	O	O	O
mode	O	O	B-T169
with	O	O	O
the	O	O	O
Huber	O	O	B-T073
Motion	O	O	I-T073
Lab	O	O	I-T073
(	O	O	O
HML	O	O	B-T073
)	O	O	O
and	O	O	O
traditional	O	O	B-T061
strength	O	O	I-T061
training	O	O	I-T061
(	O	O	O
TST	O	O	B-T061
)	O	O	O
,	O	O	O
in	O	O	O
CHD	O	O	B-T047
patients	O	O	B-T101
undergoing	O	O	O
a	O	O	O
cardiac	O	O	B-T061
rehabilitation	O	O	I-T061
program	O	O	O
.	O	O	O

We	O	O	O
randomly	O	O	O
assigned	O	O	O
50	O	O	O
patients	O	O	B-T101
to	O	O	O
HML	O	O	B-T073
or	O	O	O
TST	O	O	B-T061
.	O	O	O

Patients	O	O	B-T101
underwent	O	O	O
complete	O	O	O
blinded	O	O	B-T062
evaluation	O	O	B-T058
before	O	O	O
and	O	O	O
after	O	O	O
the	O	O	O
rehabilitation	O	O	B-T061
program	O	O	I-T061
,	O	O	O
including	O	O	O
testing	O	O	B-T060
for	O	O	I-T060
cardiopulmonary	O	O	I-T060
exercise	O	O	I-T060
,	O	O	O
maximal	O	O	B-T060
isometric	O	O	I-T060
voluntary	O	O	I-T060
contraction	O	O	I-T060
,	O	O	O
endothelial	O	O	B-T024
function	O	O	B-T042
and	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
.	O	O	O

After	O	O	O
4	O	O	O
weeks	O	O	B-T079
of	O	O	O
training	O	O	B-T065
(	O	O	O
16	O	O	O
sessions	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
groups	O	O	B-T078
did	O	O	O
not	O	O	O
differ	O	O	O
in	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
,	O	O	O
anthropometric	O	O	B-T062
characteristics	O	O	B-T080
,	O	O	O
or	O	O	O
endothelial	O	O	B-T024
function	O	O	B-T042
.	O	O	O

With	O	O	O
HML	O	O	B-T073
,	O	O	O
peak	O	O	B-T080
power	O	O	B-T070
output	O	O	I-T070
(	O	O	O
P=0.035	O	O	O
)	O	O	O
,	O	O	O
maximal	O	O	B-T080
heart	O	O	B-T201
rate	O	O	I-T201
(	O	O	O
P<0.01	O	O	O
)	O	O	O
and	O	O	O
gain	O	O	B-T081
of	O	O	O
force	O	O	B-T067
measured	O	O	B-T080
in	O	O	O
the	O	O	O
chest	O	O	O
press	O	O	O
position	O	O	O
(	O	O	O
P<0.02	O	O	O
)	O	O	O
were	O	O	O
greater	O	O	B-T081
after	O	O	O
versus	O	O	O
before	O	O	O
training	O	O	B-T056
.	O	O	O

Both	O	O	O
protocols	O	O	B-T170
appeared	O	O	O
to	O	O	O
be	O	O	O
well	O	O	O
tolerated	O	O	O
,	O	O	O
safe	O	O	O
and	O	O	O
feasible	O	O	O
for	O	O	O
these	O	O	O
CHD	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

A	O	O	O
training	O	O	B-T170
protocol	O	O	I-T170
involving	O	O	O
6s	O	O	O
phases	O	O	O
of	O	O	O
isometric	O	O	B-T042
contractions	O	O	I-T042
with	O	O	O
10s	O	O	O
of	O	O	O
passive	O	O	B-T080
recovery	O	O	B-T040
on	O	O	O
an	O	O	O
HML	O	O	B-T073
device	O	O	O
could	O	O	O
be	O	O	O
safely	O	O	O
implemented	O	O	O
in	O	O	O
rehabilitation	O	O	B-T061
programs	O	O	I-T061
for	O	O	O
patients	O	O	B-T101
with	O	O	O
CHD	O	O	B-T047
and	O	O	O
improve	O	O	O
functional	O	O	B-T080
outcomes	O	O	I-T080
.	O	O	O

-DOCSTART- (27653173)

Percutaneous	O	O	B-T061
coronary	O	O	I-T061
intervention	O	O	I-T061
and	O	O	O
heart	O	O	B-T061
surgery	O	O	I-T061
learning	O	O	B-T041
needs	O	O	B-T169
of	O	O	I-T169
patients	O	O	I-T169
in	O	O	O
Jordan	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
identify	O	O	O
and	O	O	O
prioritize	O	O	B-T079
the	O	O	O
perceived	O	O	B-T041
learning	O	O	B-T041
needs	O	O	B-T169
of	O	O	I-T169
patients	O	O	I-T169
who	O	O	O
underwent	O	O	O
percutaneous	O	O	B-T061
coronary	O	O	I-T061
intervention	O	O	I-T061
or	O	O	O
open-heart	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

Identifying	O	O	O
learning	O	O	B-T041
needs	O	O	O
for	O	O	O
post-cardiac	O	O	B-T061
intervention	O	O	I-T061
patients	O	O	B-T101
is	O	O	O
essential	O	O	O
to	O	O	O
establish	O	O	O
successful	O	O	O
health	O	O	B-T058
education	O	O	I-T058
programmes	O	O	I-T058
based	O	O	O
on	O	O	O
patient	O	O	B-T101
central	O	O	B-T058
care	O	O	I-T058
.	O	O	O

A	O	O	O
descriptive	O	O	O
comparative	O	O	O
design	O	O	B-T052
was	O	O	O
employed	O	O	O
on	O	O	O
a	O	O	O
convenience	O	O	B-T080
sample	O	O	B-T098
of	O	O	O
260	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
a	O	O	O
percutaneous	O	O	B-T061
coronary	O	O	I-T061
intervention	O	O	I-T061
and	O	O	O
105	O	O	O
patients	O	O	O
who	O	O	O
underwent	O	O	O
open-heart	O	O	B-T061
surgery	O	O	I-T061
patients	O	O	O
.	O	O	O

Participants	O	O	B-T098
had	O	O	O
completed	O	O	O
the	O	O	O
Patient	O	O	B-T101
Learning	O	O	B-T170
Needs	O	O	I-T170
Scale	O	O	I-T170
.	O	O	O

Data	O	O	B-T078
were	O	O	O
collected	O	O	O
between	O	O	O
1	O	O	O
October	O	O	O
2014	O	O	O
and	O	O	O
31	O	O	O
June	O	O	O
2015	O	O	O
.	O	O	O

Patients	O	O	B-T101
from	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T078
highly	O	O	O
requesting	O	O	O
health	O	O	B-T058
and	O	O	I-T058
recovery	O	O	I-T058
related	O	O	I-T058
information	O	O	I-T058
.	O	O	O

They	O	O	O
scored	O	O	O
all	O	O	O
learning	O	O	B-T041
need	O	O	I-T041
topics	O	O	B-T170
as	O	O	O
important	O	O	O
or	O	O	O
highly	O	O	O
important	O	O	O
for	O	O	O
them	O	O	O
.	O	O	O

The	O	O	O
top	O	O	O
priority	O	O	B-T079
learning	O	O	B-T041
need	O	O	O
for	O	O	O
both	O	O	O
patient	O	O	B-T101
groups	O	O	I-T101
was	O	O	O
'	O	O	O
information	O	O	B-T078
about	O	O	O
wound	O	O	B-T061
care	O	O	I-T061
'	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
lowest	O	O	O
priority	O	O	O
learning	O	O	O
need	O	O	O
topic	O	O	B-T170
was	O	O	O
'	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
'	O	O	O
.	O	O	O

The	O	O	O
learning	O	O	B-T041
needs	O	O	B-T080
of	O	O	O
both	O	O	O
groups	O	O	B-T078
were	O	O	O
very	O	O	O
close	O	O	O
,	O	O	O
which	O	O	O
indicated	O	O	O
that	O	O	O
educational	O	O	B-T170
secondary	O	O	I-T170
prevention	O	O	I-T170
programmes	O	O	I-T170
'	O	O	O
content	O	O	O
can	O	O	O
be	O	O	O
prepared	O	O	O
in	O	O	O
a	O	O	O
unified	O	O	O
structure	O	O	O
for	O	O	O
those	O	O	O
patients	O	O	B-T101
.	O	O	O

Although	O	O	O
,	O	O	O
specific	O	O	O
headings	O	O	B-T170
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
address	O	O	O
the	O	O	O
unique	O	O	O
needs	O	O	B-T080
that	O	O	O
emerge	O	O	O
from	O	O	O
having	O	O	O
a	O	O	O
specific	O	O	O
cardiac	O	O	B-T023
interventional	O	O	B-T061
procedure	O	O	I-T061
.	O	O	O

The	O	O	O
fact	O	O	O
that	O	O	O
wound	O	O	B-T061
care	O	O	I-T061
and	O	O	O
medications	O	O	B-T058
are	O	O	O
areas	O	O	O
of	O	O	O
highest	O	O	O
learning	O	O	B-T041
needs	O	O	B-T080
for	O	O	O
patients	O	O	B-T101
requires	O	O	O
health	O	O	B-T089
policy	O	O	I-T089
decision	O	O	B-T097
makers	O	O	I-T097
to	O	O	O
address	O	O	O
these	O	O	O
topics	O	O	B-T170
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	O
hospital	O	O	B-T058
discharge	O	O	I-T058
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
a	O	O	O
policy	O	O	B-T089
focus	O	O	O
on	O	O	O
considering	O	O	O
patients	O	O	B-T101
'	O	O	O
actual	O	O	O
learning	O	O	B-T041
needs	O	O	B-T080
requires	O	O	O
establishment	O	O	B-T073
and	O	O	O
managerial	O	O	B-T054
support	O	O	I-T054
.	O	O	O

As	O	O	O
patients	O	O	B-T101
'	O	O	O
learning	O	O	B-T041
needs	O	O	B-T080
might	O	O	O
change	O	O	O
later	O	O	O
after	O	O	O
discharge	O	O	B-T058
,	O	O	O
the	O	O	O
health	O	O	B-T058
services	O	O	I-T058
should	O	O	O
be	O	O	O
proactive	O	O	O
and	O	O	O
focus	O	O	O
on	O	O	O
continuous	O	O	O
support	O	O	B-T054
for	O	O	O
patients	O	O	O
after	O	O	O
hospital	O	O	B-T058
discharge	O	O	I-T058
.	O	O	O

Secondary	O	O	B-T170
prevention	O	O	I-T170
programmes	O	O	I-T170
should	O	O	O
incorporate	O	O	O
health	O	O	B-T065
education	O	O	I-T065
topics	O	O	B-T170
based	O	O	O
on	O	O	O
patients	O	O	B-T101
'	O	O	O
own	O	O	O
views	O	O	O
.	O	O	O

This	O	O	O
can	O	O	O
be	O	O	O
done	O	O	O
by	O	O	O
giving	O	O	O
higher	O	O	O
priority	O	O	B-T079
to	O	O	O
understand	O	O	O
patients	O	O	B-T101
'	O	O	I-T169
needs	O	O	B-T080
,	O	O	O
put	O	O	O
much	O	O	O
more	O	O	O
effort	O	O	O
into	O	O	O
how	O	O	O
to	O	O	O
meet	O	O	O
patients	O	O	O
'	O	O	O
information	O	O	B-T078
needs	O	O	O
and	O	O	O
to	O	O	O
create	O	O	O
a	O	O	O
more	O	O	O
engaging	O	O	O
learning	O	O	B-T041
environment	O	O	B-T082
for	O	O	O
patients	O	O	O
and	O	O	O
their	O	O	O
families	O	O	B-T099
.	O	O	O

-DOCSTART- (27653736)

Complications	O	O	B-T046
and	O	O	O
Near-Miss	O	O	O
Events	O	O	B-T051
After	O	O	O
Hepatectomy	O	O	B-T061
for	O	O	O
Living-Related	O	O	B-T061
Liver	O	O	I-T061
Donation	O	O	I-T061
:	O	O	O
An	O	O	O
Italian	O	O	B-T083
Single	O	O	B-T093
Center	O	O	I-T093
Report	O	O	B-T170
of	O	O	O
One	O	O	O
Hundred	O	O	O
Cases	O	O	O

BACKGROUND	O	O	O
In	O	O	O
healthy	O	O	B-T080
individuals	O	O	B-T098
,	O	O	O
such	O	O	O
as	O	O	O
liver	O	O	B-T098
living	O	O	I-T098
donors	O	O	I-T098
,	O	O	O
potential	O	O	O
complications	O	O	B-T046
may	O	O	O
occur	O	O	O
during	O	O	O
surgery	O	O	B-T061
.	O	O	O

Reporting	O	O	O
such	O	O	O
complications	O	O	B-T046
and	O	O	O
near-miss	O	O	O
events	O	O	O
is	O	O	O
mandatory	O	O	O
to	O	O	O
improve	O	O	O
living	O	O	B-T098
donor	O	O	I-T098
management	O	O	B-T057
and	O	O	O
safety	O	O	B-T068
.	O	O	O

MATERIAL	O	O	O
AND	O	O	O
METHODS	O	O	O
This	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
was	O	O	O
performed	O	O	O
on	O	O	O
a	O	O	O
prospective	O	O	O
database	O	O	B-T170
with	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
providing	O	O	O
a	O	O	O
brief	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
perioperative	O	O	B-T079
,	O	O	O
medium-term	O	O	B-T079
,	O	O	O
and	O	O	O
long-term	O	O	B-T079
complications	O	O	B-T046
,	O	O	O
and	O	O	O
the	O	O	O
near-miss	O	O	O
events	O	O	B-T051
in	O	O	O
a	O	O	O
single	O	O	B-T093
center	O	O	I-T093
series	O	O	O
of	O	O	O
100	O	O	O
consecutive	O	O	O
liver	O	O	B-T061
resections	O	O	I-T061
for	O	O	O
adult	O	O	B-T100
-to-	O	O	O
adult	O	O	O
living-donor	O	O	B-T098
liver	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

RESULTS	O	O	O
Only	O	O	O
23.3	O	O	O
%	O	O	O
of	O	O	O
potential	O	O	O
living	O	O	B-T098
donors	O	O	I-T098
underwent	O	O	O
surgery	O	O	B-T061
.	O	O	O

No	O	O	B-T033
living	O	O	B-T098
donor	O	O	I-T098
mortality	O	O	B-T081
was	O	O	O
reported	O	O	O
;	O	O	O
29	O	O	O
patients	O	O	B-T101
(	O	O	O
29	O	O	O
%	O	O	O
)	O	O	O
experienced	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
complication	O	O	B-T046
.	O	O	O

Five	O	O	O
patients	O	O	B-T101
developed	O	O	O
mild	O	O	B-T080
long-term	O	O	B-T079
dysfunction	O	O	B-T077
;	O	O	O
two	O	O	O
aborted	O	O	O
hepatectomies	O	O	B-T061
,	O	O	O
and	O	O	O
there	O	O	O
were	O	O	O
two	O	O	O
near-miss	O	O	O
events	O	O	B-T051
reported	O	O	O
.	O	O	O

CONCLUSIONS	O	O	O
A	O	O	O
strategy	O	O	B-T041
for	O	O	O
an	O	O	O
accurate	O	O	O
assessment	O	O	B-T058
of	O	O	O
living	O	O	B-T098
donor	O	O	I-T098
complications	O	O	B-T046
and	O	O	O
strict	O	O	O
selection	O	O	B-T052
criterion	O	O	O
can	O	O	O
not	O	O	O
be	O	O	O
overemphasized	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
continuously	O	O	O
update	O	O	O
center	O	O	B-T093
patient	O	O	B-T078
outcome	O	O	I-T078
reports	O	O	B-T170
.	O	O	O

-DOCSTART- (27658531)

Tooth	O	O	B-T037
wear	O	O	I-T037
as	O	O	O
a	O	O	O
means	O	O	O
to	O	O	O
quantify	O	O	B-T081
intra-specific	O	O	B-T080
variations	O	O	B-T080
in	O	O	O
diet	O	O	B-T168
and	O	O	O
chewing	O	O	B-T042
movements	O	O	O

In	O	O	O
mammals	O	O	B-T015
,	O	O	O
tooth	O	O	B-T023
function	O	O	B-T169
,	O	O	O
and	O	O	O
its	O	O	O
efficiency	O	O	B-T081
,	O	O	O
depends	O	O	O
both	O	O	O
on	O	O	O
the	O	O	O
mechanical	O	O	B-T070
properties	O	O	B-T080
of	O	O	O
the	O	O	O
food	O	O	B-T168
and	O	O	O
on	O	O	O
chewing	O	O	B-T042
dynamics	O	O	B-T169
.	O	O	O

These	O	O	O
aspects	O	O	B-T080
have	O	O	O
rarely	O	O	O
been	O	O	O
studied	O	O	B-T062
in	O	O	O
combination	O	O	O
and/or	O	O	O
at	O	O	O
the	O	O	O
intra-specific	O	O	B-T080
level	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
applied	O	O	O
3D	O	O	B-T082
dental	O	O	B-T023
surface	O	O	B-T082
texture	O	O	B-T080
analysis	O	O	B-T062
to	O	O	O
a	O	O	O
sample	O	O	B-T077
of	O	O	O
field	O	O	B-T015
voles	O	O	I-T015
(	O	O	O
Microtus	O	O	B-T015
agrestis	O	O	I-T015
)	O	O	O
trapped	O	O	O
from	O	O	O
Finnish	O	O	B-T083
Lapland	O	O	I-T083
at	O	O	O
different	O	O	O
seasons	O	O	B-T079
and	O	O	O
localities	O	O	B-T083
to	O	O	O
test	O	O	B-T169
for	O	O	O
inter-population	O	O	B-T098
variations	O	O	B-T080
.	O	O	O

We	O	O	O
also	O	O	O
explored	O	O	O
intra-individual	O	O	B-T098
variation	O	O	B-T080
in	O	O	O
chewing	O	O	B-T042
dynamics	O	O	B-T169
by	O	O	O
analysing	O	O	B-T062
two	O	O	O
facets	O	O	B-T082
on	O	O	O
the	O	O	O
second	O	O	B-T023
upper	O	O	I-T023
molars	O	O	I-T023
.	O	O	O

Our	O	O	O
results	O	O	B-T033
confirm	O	O	O
that	O	O	O
the	O	O	O
two	O	O	O
localities	O	O	B-T083
have	O	O	O
similar	O	O	O
environments	O	O	B-T082
and	O	O	O
that	O	O	O
the	O	O	O
voles	O	O	B-T015
feed	O	O	B-T052
on	O	O	O
the	O	O	O
same	O	O	O
items	O	O	O
there	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
the	O	O	O
texture	O	O	B-T080
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
diets	O	O	B-T168
are	O	O	O
seasonally	O	O	O
variable	O	O	B-T080
,	O	O	O
probably	O	O	O
due	O	O	O
to	O	O	O
varying	O	O	O
concentrations	O	O	B-T081
of	O	O	O
abrasives	O	O	B-T120
.	O	O	O

Lastly	O	O	O
,	O	O	O
the	O	O	O
textures	O	O	B-T080
on	O	O	O
the	O	O	O
buccal	O	O	B-T029
facets	O	O	B-T082
are	O	O	O
more	O	O	O
isotropic	O	O	B-T067
and	O	O	O
their	O	O	O
direction	O	O	B-T082
deviates	O	O	B-T082
more	O	O	O
from	O	O	O
the	O	O	O
mesial	O	O	B-T029
chewing	O	O	B-T042
direction	O	O	O
than	O	O	O
the	O	O	O
lingual	O	O	B-T023
facets	O	O	O
.	O	O	O

We	O	O	O
interpret	O	O	B-T169
these	O	O	O
results	O	O	B-T033
as	O	O	O
reflecting	O	O	O
food	O	O	B-T168
,	O	O	O
rather	O	O	O
than	O	O	O
chewing	O	O	B-T042
,	O	O	O
movements	O	O	B-T040
,	O	O	O
where	O	O	O
food	O	O	B-T168
particles	O	O	I-T168
are	O	O	O
more	O	O	O
guided	O	O	O
on	O	O	O
the	O	O	O
lingual	O	O	B-T023
side	O	O	O
of	O	O	O
the	O	O	O
molars	O	O	B-T023
.	O	O	O

This	O	O	O
has	O	O	O
implications	O	O	O
for	O	O	O
the	O	O	O
application	O	O	O
of	O	O	O
dental	O	O	B-T037
microwear	O	O	I-T037
analysis	O	O	B-T062
to	O	O	O
fossils	O	O	B-T167
:	O	O	O
only	O	O	O
homologous	O	O	B-T032
facets	O	O	B-T082
can	O	O	O
be	O	O	O
compared	O	O	O
,	O	O	O
even	O	O	O
when	O	O	O
the	O	O	O
molar	O	O	B-T023
row	O	O	O
seems	O	O	O
to	O	O	O
constitute	O	O	O
a	O	O	O
functional	O	O	B-T169
unit	O	O	I-T169
.	O	O	O

-DOCSTART- (27659310)

Human	O	O	B-T116
cathelicidin	O	O	I-T116
LL-37	O	O	I-T116
enhance	O	O	O
the	O	O	O
antibiofilm	O	O	B-T033
effect	O	O	I-T033
of	O	O	O
EGCG	O	O	B-T109
on	O	O	O
Streptococcus	O	O	O
mutans	O	O	O

Streptococcus	O	O	B-T007
mutans	O	O	I-T007
forms	O	O	O
biofilms	O	O	B-T007
as	O	O	O
a	O	O	O
resistance	O	O	B-T169
mechanism	O	O	B-T169
against	O	O	O
antimicrobial	O	O	B-T121
agents	O	O	I-T121
in	O	O	O
the	O	O	O
human	O	O	B-T016
oral	O	O	B-T030
cavity	O	O	I-T030
.	O	O	O

We	O	O	O
recently	O	O	O
showed	O	O	O
that	O	O	O
human	O	O	B-T116
cathelicidin	O	O	I-T116
LL-37	O	O	I-T116
exhibits	O	O	O
inhibitory	O	O	B-T080
effects	O	O	I-T080
on	O	O	O
biofilm	O	O	B-T007
formation	O	O	I-T043
of	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
through	O	O	O
interaction	O	O	B-T169
with	O	O	O
lipoteichoic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
LTA	O	O	B-T109
)	O	O	O
,	O	O	O
but	O	O	O
without	O	O	O
antibacterial	O	O	B-T033
or	O	O	O
biofilm	O	O	O
dispersal	O	O	B-T082
abilities	O	O	I-T082
.	O	O	O

(-)-Epigallocatechin	O	O	B-T109
gallate	O	O	I-T109
(	O	O	O
EGCG	O	O	B-T109
)	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
abundant	O	O	O
constituent	O	O	O
of	O	O	O
tea	O	O	B-T168
catechins	O	O	B-T109
that	O	O	O
has	O	O	O
the	O	O	O
greatest	O	O	O
anti-infective	O	O	B-T033
potential	O	O	I-T033
to	O	O	O
inhibit	O	O	B-T040
the	O	O	I-T040
growth	O	O	I-T040
of	O	O	O
various	O	O	O
microorganisms	O	O	B-T001
and	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
.	O	O	O

Therefore	O	O	O
,	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
evaluated	O	O	B-T058
whether	O	O	O
LL-37	O	O	B-T116
interacts	O	O	O
with	O	O	O
EGCG	O	O	B-T109
to	O	O	O
enhance	O	O	O
the	O	O	O
antibiofilm	O	O	B-T033
effect	O	O	I-T033
of	O	O	O
EGCG	O	O	O
on	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
biofilm	O	O	B-T043
formation	O	O	I-T043
.	O	O	O

Clinical	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
strains	O	O	B-T001
(	O	O	O
n	O	O	O
=	O	O	O
10	O	O	O
)	O	O	O
isolated	O	O	O
from	O	O	O
children	O	O	B-T100
's	O	O	I-T100
saliva	O	O	B-T031
were	O	O	O
tested	O	O	B-T169
in	O	O	O
a	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
assay	O	O	B-T059
.	O	O	O

The	O	O	O
antibiofilm	O	O	B-T033
effect	O	O	I-T033
of	O	O	O
EGCG	O	O	B-T109
with	O	O	O
and	O	O	O
without	O	O	O
LL-37	O	O	B-T116
was	O	O	O
analyzed	O	O	B-T062
by	O	O	O
the	O	O	O
minimum	O	O	O
biofilm	O	O	B-T007
eradication	O	O	B-T080
concentration	O	O	B-T081
assay	O	O	B-T059
and	O	O	O
confirmed	O	O	O
using	O	O	O
field	O	O	O
emission-scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
interaction	O	O	B-T169
among	O	O	O
EGCG	O	O	B-T109
,	O	O	O
LL-37	O	O	B-T116
,	O	O	O
and	O	O	O
LTA	O	O	B-T109
of	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
was	O	O	O
determined	O	O	O
using	O	O	O
quartz	O	O	B-T062
crystal	O	O	I-T062
microbalance	O	O	I-T062
analysis	O	O	I-T062
.	O	O	O

EGCG	O	O	B-T109
killed	O	O	O
100	O	O	O
%	O	O	O
of	O	O	O
planktonic	O	O	B-T007
S.	O	O	B-T007
mutans	O	O	I-T007
within	O	O	O
5	O	O	O
h	O	O	O
,	O	O	O
inhibited	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
within	O	O	O
24	O	O	O
h	O	O	O
,	O	O	O
and	O	O	O
reduced	O	O	O
bacteria	O	O	B-T007
cells	O	O	I-T007
in	O	O	O
preformed	O	O	O
biofilms	O	O	B-T007
within	O	O	O
3	O	O	O
h	O	O	O
at	O	O	O
a	O	O	O
concentration	O	O	B-T081
of	O	O	O
0.2	O	O	O
mg/mL.	O	O	O
However	O	O	O
,	O	O	O
EGCG	O	O	O
did	O	O	O
not	O	O	O
appear	O	O	O
to	O	O	O
interact	O	O	O
with	O	O	O
LTA	O	O	B-T109
.	O	O	O

LL-37	O	O	B-T116
effectively	O	O	O
enhanced	O	O	O
the	O	O	O
bactericidal	O	O	B-T039
activity	O	O	I-T039
of	O	O	O
EGCG	O	O	B-T109
against	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
and	O	O	O
preformed	O	O	O
biofilms	O	O	B-T007
as	O	O	O
determined	O	O	O
by	O	O	O
quantitative	O	O	B-T081
crystal	O	O	B-T109
violet	O	O	I-T109
staining	O	O	B-T059
and	O	O	O
field	O	O	O
emission-scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
quartz	O	O	B-T062
crystal	O	O	I-T062
microbalance	O	O	I-T062
analysis	O	O	I-T062
revealed	O	O	O
that	O	O	O
LL-37	O	O	B-T116
interacted	O	O	B-T169
with	O	O	O
EGCG	O	O	B-T109
and	O	O	O
promoted	O	O	O
binding	O	O	B-T044
between	O	O	O
EGCG	O	O	O
and	O	O	O
LTA	O	O	B-T109
of	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
LL-37	O	O	B-T116
enhances	O	O	O
the	O	O	O
antibiofilm	O	O	B-T033
effect	O	O	I-T033
of	O	O	O
EGCG	O	O	B-T109
on	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
.	O	O	O

This	O	O	O
finding	O	O	O
provides	O	O	O
new	O	O	O
knowledge	O	O	O
for	O	O	O
dental	O	O	B-T061
treatment	O	O	I-T061
by	O	O	O
using	O	O	O
LL-37	O	O	B-T116
as	O	O	O
a	O	O	O
potential	O	O	O
antibiofilm	O	O	B-T121
compound	O	O	I-T121
.	O	O	O

-DOCSTART- (27660855)

Discovery	O	O	B-T052
of	O	O	O
Orally	O	O	B-T030
Efficacious	O	O	B-T080
Phosphoinositide-3-Kinase	O	O	B-T116
delta	O	O	I-T116
Inhibitors	O	O	B-T121
with	O	O	O
Improved	O	O	B-T033
Metabolic	O	O	B-T169
Stability	O	O	O

Aberrant	O	O	B-T038
signaling	O	O	I-T038
of	O	O	O
phosphoinositide-3-kinase	O	O	B-T116
delta	O	O	I-T116
(	O	O	O
PI3K-delta	O	O	B-T116
)	O	O	O
has	O	O	O
been	O	O	O
implicated	O	O	O
in	O	O	O
numerous	O	O	O
pathologies	O	O	B-T046
including	O	O	O
hematological	O	O	B-T191
malignancies	O	O	I-T191
and	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
.	O	O	O

Described	O	O	O
in	O	O	O
this	O	O	O
manuscript	O	O	O
is	O	O	O
the	O	O	O
discovery	O	O	B-T052
,	O	O	O
optimization	O	O	B-T052
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
evaluation	O	O	B-T058
of	O	O	O
a	O	O	O
novel	O	O	O
series	O	O	O
of	O	O	O
pyridine-containing	O	O	B-T109
PI3K-delta	O	O	B-T116
inhibitors	O	O	B-T121
.	O	O	O

This	O	O	O
work	O	O	O
led	O	O	O
to	O	O	O
the	O	O	O
discovery	O	O	B-T052
of	O	O	O
35	O	O	B-T121
,	O	O	O
a	O	O	O
highly	O	O	O
selective	O	O	O
inhibitor	O	O	B-T121
of	O	O	O
PI3K-delta	O	O	B-T116
which	O	O	O
displays	O	O	O
an	O	O	O
excellent	O	O	O
pharmacokinetic	O	O	B-T169
profile	O	O	I-T169
and	O	O	O
is	O	O	O
efficacious	O	O	B-T080
in	O	O	O
a	O	O	O
rodent	O	O	B-T050
model	O	O	I-T050
of	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
.	O	O	O

-DOCSTART- (27665258)

Mobile	O	O	B-T073
phone	O	O	I-T073
use	O	O	B-T169
,	O	O	O
behavioural	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
concentration	O	O	B-T041
capacity	O	O	B-T081
in	O	O	O
adolescents	O	O	B-T100
:	O	O	O
A	O	O	O
prospective	O	O	O
study	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
prospectively	O	O	O
investigate	O	O	B-T169
whether	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
radiofrequency	O	O	B-T070
electromagnetic	O	O	I-T070
fields	O	O	I-T070
(	O	O	O
RF-EMF	O	O	B-T070
)	O	O	O
emitted	O	O	O
by	O	O	O
mobile	O	O	B-T073
phones	O	O	I-T073
and	O	O	O
other	O	O	O
wireless	O	O	B-T073
communication	O	O	I-T073
devices	O	O	I-T073
is	O	O	O
related	O	O	O
to	O	O	O
behavioural	O	O	B-T048
problems	O	O	I-T048
or	O	O	O
concentration	O	O	B-T041
capacity	O	O	B-T081
in	O	O	O
adolescents	O	O	B-T100
.	O	O	O

The	O	O	O
HERMES	O	O	B-T062
(	O	O	O
Health	O	O	B-T078
Effects	O	O	B-T080
Related	O	O	B-T080
to	O	O	O
Mobile	O	O	B-T073
phonE	O	O	I-T073
use	O	O	O
in	O	O	O
adolescentS	O	O	B-T100
)	O	O	O
study	O	O	O
sample	O	O	B-T096
consisted	O	O	O
of	O	O	O
439	O	O	O
Swiss	O	O	B-T098
adolescents	O	O	B-T100
aged	O	O	B-T032
12	O	O	O
-	O	O	O
17	O	O	O
years	O	O	B-T079
.	O	O	O

Behavioural	O	O	B-T048
problems	O	O	I-T048
were	O	O	O
assessed	O	O	B-T052
using	O	O	O
the	O	O	O
Strengths	O	O	B-T170
and	O	O	I-T170
Difficulties	O	O	I-T170
Questionnaire	O	O	I-T170
(	O	O	O
SDQ	O	O	B-T170
)	O	O	O
,	O	O	O
concentration	O	O	B-T041
capacity	O	O	B-T081
of	O	O	O
the	O	O	O
adolescents	O	O	B-T100
was	O	O	O
measured	O	O	B-T080
by	O	O	O
means	O	O	O
of	O	O	O
a	O	O	O
standardized	O	O	B-T170
computerized	O	O	I-T170
cognitive	O	O	I-T170
test	O	O	I-T170
named	O	O	O
FAKT	O	O	B-T170
.	O	O	O

Cross-sectional	O	O	B-T062
and	O	O	O
longitudinal	O	O	B-T062
(	O	O	O
1year	O	O	B-T079
of	O	O	O
follow-up	O	O	B-T033
)	O	O	O
analyses	O	O	B-T062
were	O	O	O
performed	O	O	B-T169
to	O	O	O
investigate	O	O	B-T169
possible	O	O	O
associations	O	O	B-T080
between	O	O	O
behavioural	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
concentration	O	O	B-T041
capacity	O	O	B-T081
and	O	O	O
different	O	O	B-T080
exposure	O	O	B-T080
measures	O	O	B-T081
:	O	O	O
self-reported	O	O	B-T062
and	O	O	O
operator	O	O	B-T097
-recorded	O	O	O
wireless	O	O	B-T073
communication	O	O	I-T073
device	O	O	I-T073
use	O	O	O
,	O	O	O
cumulative	O	O	B-T080
RF-EMF	O	O	B-T070
brain	O	O	B-T023
and	O	O	O
whole	O	O	B-T017
body	O	O	I-T017
dose	O	O	O
and	O	O	O
measured	O	O	B-T080
personal	O	O	O
RF-EMF	O	O	O
exposure	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
cross-sectional	O	O	B-T062
analyses	O	O	I-T062
behavioural	O	O	B-T048
problems	O	O	I-T048
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
several	O	O	O
self-reported	O	O	B-T170
wireless	O	O	B-T073
device	O	O	I-T073
use	O	O	B-T169
measures	O	O	B-T081
but	O	O	O
not	O	O	O
operator	O	O	B-T097
-recorded	O	O	O
mobile	O	O	B-T073
phone	O	O	I-T073
use	O	O	O
measures	O	O	O
,	O	O	O
concentration	O	O	B-T041
capacity	O	O	B-T081
was	O	O	O
associated	O	O	O
with	O	O	O
several	O	O	O
self-reported	O	O	O
and	O	O	O
operator	O	O	O
-recorded	O	O	O
exposures	O	O	B-T080
.	O	O	O

The	O	O	O
longitudinal	O	O	B-T062
analyses	O	O	I-T062
point	O	O	O
towards	O	O	O
absence	O	O	B-T169
of	O	O	O
associations	O	O	B-T080
.	O	O	O

The	O	O	O
lack	O	O	B-T080
of	O	O	O
consistent	O	O	B-T078
exposure	O	O	B-T080
-response	O	O	O
patterns	O	O	B-T082
in	O	O	O
the	O	O	O
longitudinal	O	O	B-T062
analyses	O	O	I-T062
suggests	O	O	O
that	O	O	O
behavioural	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
concentration	O	O	B-T041
capacity	O	O	B-T081
are	O	O	O
not	O	O	O
affected	O	O	B-T169
by	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
wireless	O	O	B-T073
communication	O	O	I-T073
devices	O	O	I-T073
or	O	O	O
RF-EMF	O	O	B-T070
exposure	O	O	O
.	O	O	O

Information	O	O	B-T078
bias	O	O	B-T078
and	O	O	O
reverse	O	O	O
causality	O	O	O
are	O	O	O
likely	O	O	O
explanations	O	O	B-T170
for	O	O	O
the	O	O	O
observed	O	O	O
cross-sectional	O	O	B-T062
findings	O	O	I-T062
.	O	O	O

-DOCSTART- (27665545)

Twisting	O	O	B-T169
method	O	O	I-T169
for	O	O	O
reducing	O	O	B-T080
friction	O	O	B-T070
during	O	O	O
insertion	O	O	B-T061
of	O	O	O
a	O	O	O
sheath	O	O	B-T074
introducer	O	O	B-T074
and	O	O	O
a	O	O	O
sheathless	O	O	O
guiding	O	O	O
catheter	O	O	O

A	O	O	O
sheathless	O	O	B-T169
system	O	O	I-T169
that	O	O	O
inserts	O	O	B-T058
a	O	O	O
catheter	O	O	B-T074
directly	O	O	B-T080
into	O	O	O
the	O	O	O
artery	O	O	B-T023
can	O	O	O
reduce	O	O	B-T080
puncture	O	O	B-T067
site	O	O	B-T082
-related	O	O	O
complications	O	O	B-T046
through	O	O	O
a	O	O	O
2-Fr	O	O	B-T080
reduction	O	O	I-T080
of	O	O	O
the	O	O	O
outer	O	O	B-T082
diameter	O	O	I-T082
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
gap	O	O	B-T082
between	O	O	O
the	O	O	O
dilator	O	O	B-T074
and	O	O	O
the	O	O	O
guiding	O	O	B-T074
catheter	O	O	I-T074
of	O	O	O
the	O	O	O
sheathless	O	O	B-T169
system	O	O	I-T169
is	O	O	O
larger	O	O	B-T081
than	O	O	O
the	O	O	O
gap	O	O	O
between	O	O	O
the	O	O	O
dilator	O	O	O
and	O	O	O
sheath	O	O	B-T074
of	O	O	O
the	O	O	O
introducer	O	O	B-T074
system	O	O	I-T074
,	O	O	O
resulting	O	O	O
in	O	O	O
stronger	O	O	O
insertion	O	O	B-T061
resistance	O	O	B-T067
.	O	O	O

A	O	O	O
twisting	O	O	B-T169
method	O	O	I-T169
with	O	O	O
rapid	O	O	B-T080
alternating	O	O	B-T169
rotation	O	O	B-T169
of	O	O	O
a	O	O	O
device	O	O	B-T074
to	O	O	O
the	O	O	O
left	O	O	O
and	O	O	O
right	O	O	O
during	O	O	O
insertion	O	O	B-T061
can	O	O	O
reduce	O	O	B-T080
the	O	O	O
insertion	O	O	O
resistance	O	O	B-T067
.	O	O	O

This	O	O	O
method	O	O	O
can	O	O	O
be	O	O	O
effective	O	O	B-T080
with	O	O	O
the	O	O	O
sheathless	O	O	B-T169
system	O	O	I-T169
which	O	O	O
has	O	O	O
a	O	O	O
larger	O	O	B-T081
gap	O	O	B-T082
.	O	O	O

To	O	O	O
examine	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
size	O	O	B-T082
reduction	O	O	B-T080
on	O	O	O
the	O	O	O
sheathless	O	O	B-T169
system	O	O	I-T169
and	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
insertion	O	O	B-T061
resistance	O	O	B-T067
reduction	O	O	O
using	O	O	O
the	O	O	O
twisting	O	O	B-T169
method	O	O	I-T169
,	O	O	O
we	O	O	O
developed	O	O	O
an	O	O	O
insertion	O	O	O
simulator	O	O	B-T074
and	O	O	O
compared	O	O	B-T052
insertion	O	O	O
resistance	O	O	O
to	O	O	O
a	O	O	O
5-Fr	O	O	B-T074
sheath	O	O	I-T074
introducer	O	O	B-T074
and	O	O	O
a	O	O	O
5-Fr	O	O	B-T169
sheathless	O	O	I-T169
system	O	O	I-T169
,	O	O	O
with	O	O	O
and	O	O	O
without	O	O	O
the	O	O	O
twisting	O	O	O
method	O	O	O
.	O	O	O

The	O	O	O
insertion	O	O	B-T061
simulator	O	O	B-T074
pushed	O	O	O
a	O	O	O
sheath	O	O	B-T074
introducer	O	O	B-T074
or	O	O	O
a	O	O	O
sheathless	O	O	B-T169
system	O	O	I-T169
toward	O	O	O
a	O	O	O
mock	O	O	B-T033
artery	O	O	B-T023
consisted	O	O	O
with	O	O	O
a	O	O	O
5-mm	O	O	B-T074
urethane	O	O	I-T074
and	O	O	O
a	O	O	O
1-mm	O	O	B-T074
rubber	O	O	I-T074
sheet	O	O	I-T074
by	O	O	O
an	O	O	O
electrical	O	O	B-T073
motor	O	O	I-T073
with	O	O	O
or	O	O	O
without	O	O	O
twisting	O	O	B-T169
motion	O	O	B-T070
generated	O	O	O
by	O	O	O
a	O	O	O
crank	O	O	B-T073
shaft	O	O	I-T073
.	O	O	O

Insertion	O	O	B-T061
resistance	O	O	B-T067
during	O	O	O
the	O	O	O
penetration	O	O	B-T169
was	O	O	O
measured	O	O	B-T080
by	O	O	O
a	O	O	O
tension	O	O	B-T074
meter	O	O	I-T074
.	O	O	O

The	O	O	O
insertion	O	O	B-T061
resistance	O	O	B-T067
was	O	O	O
less	O	O	O
with	O	O	O
the	O	O	O
5-Fr	O	O	B-T169
sheathless	O	O	I-T169
system	O	O	I-T169
than	O	O	O
with	O	O	O
the	O	O	O
5-Fr	O	O	B-T074
sheath	O	O	I-T074
introducer	O	O	B-T074
.	O	O	O

The	O	O	O
resistance	O	O	B-T067
reduced	O	O	B-T080
further	O	O	O
with	O	O	O
use	O	O	O
of	O	O	O
twisting	O	O	B-T169
for	O	O	O
both	O	O	O
the	O	O	O
sheathed	O	O	B-T074
and	O	O	O
sheathless	O	O	B-T074
catheters	O	O	I-T074
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
,	O	O	O
the	O	O	O
experiment	O	O	O
suggests	O	O	O
the	O	O	O
benefits	O	O	B-T081
of	O	O	O
twisting	O	O	B-T169
insertion	O	O	B-T061
of	O	O	O
a	O	O	O
sheathless	O	O	B-T074
guiding	O	O	I-T074
catheter	O	O	I-T074
for	O	O	O
reduction	O	O	B-T080
of	O	O	O
puncture	O	O	B-T067
site	O	O	B-T082
-related	O	O	O
complications	O	O	B-T046
.	O	O	O

-DOCSTART- (27665550)

Unconventional	O	O	B-T080
Protein	O	O	B-T043
Secretion	O	O	I-T043
in	O	O	O
Plants	O	O	O

Unconventional	O	O	B-T080
protein	O	O	B-T043
secretion	O	O	B-T038
(	O	O	O
UPS	O	O	B-T043
)	O	O	O
describes	O	O	B-T078
secretion	O	O	B-T043
pathways	O	O	I-T043
that	O	O	O
bypass	O	O	O
one	O	O	O
or	O	O	O
several	O	O	B-T081
of	O	O	O
the	O	O	O
canonical	O	O	B-T081
secretion	O	O	O
pit-stops	O	O	O
on	O	O	O
the	O	O	O
way	O	O	O
to	O	O	O
the	O	O	O
plasma	O	O	B-T026
membrane	O	O	I-T026
,	O	O	O
and/or	O	O	O
involve	O	O	B-T169
the	O	O	O
secretion	O	O	O
of	O	O	O
leaderless	O	O	O
proteins	O	O	B-T116
.	O	O	O

So	O	O	O
far	O	O	O
,	O	O	O
alternatives	O	O	B-T077
to	O	O	O
conventional	O	O	B-T080
secretion	O	O	B-T038
were	O	O	O
primarily	O	O	B-T080
observed	O	O	B-T169
and	O	O	O
studied	O	O	B-T062
in	O	O	O
yeast	O	O	B-T004
and	O	O	O
animal	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
sessile	O	O	B-T080
lifestyle	O	O	O
of	O	O	O
plants	O	O	B-T002
brings	O	O	O
with	O	O	O
it	O	O	O
unique	O	O	B-T080
restraints	O	O	O
on	O	O	O
how	O	O	O
they	O	O	O
adapt	O	O	B-T040
to	O	O	I-T040
adverse	O	O	I-T040
conditions	O	O	I-T040
and	O	O	O
environmental	O	O	B-T082
challenges	O	O	I-T082
.	O	O	O

Recently	O	O	O
,	O	O	O
attention	O	O	B-T041
towards	O	O	O
unconventional	O	O	B-T080
secretion	O	O	B-T043
pathways	O	O	I-T043
in	O	O	O
plant	O	O	B-T025
cells	O	O	I-T025
has	O	O	O
substantially	O	O	O
increased	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
large	O	O	O
number	O	O	O
of	O	O	O
leaderless	O	O	O
proteins	O	O	B-T116
identified	O	O	B-T080
through	O	O	O
proteomic	O	O	B-T091
studies	O	O	I-T091
.	O	O	O

While	O	O	O
UPS	O	O	B-T043
pathways	O	O	B-T077
in	O	O	O
plants	O	O	B-T002
are	O	O	O
certainly	O	O	O
not	O	O	O
yet	O	O	O
exhaustively	O	O	O
researched	O	O	O
,	O	O	O
an	O	O	O
emerging	O	O	O
notion	O	O	O
is	O	O	O
that	O	O	O
induction	O	O	B-T169
of	O	O	O
UPS	O	O	O
pathways	O	O	O
is	O	O	O
correlated	O	O	B-T080
with	O	O	O
pathogenesis	O	O	B-T046
and	O	O	O
stress	O	O	B-T039
responses	O	O	I-T039
.	O	O	O

Given	O	O	O
the	O	O	O
multitude	O	O	O
UPS	O	O	B-T043
events	O	O	O
observed	O	O	O
,	O	O	O
comprehensively	O	O	B-T080
organizing	O	O	B-T169
the	O	O	O
routes	O	O	O
proteins	O	O	B-T116
take	O	O	O
to	O	O	O
the	O	O	O
apoplast	O	O	B-T026
in	O	O	O
defined	O	O	O
UPS	O	O	O
categories	O	O	O
is	O	O	O
challenging	O	O	O
.	O	O	O

With	O	O	O
the	O	O	O
establishment	O	O	B-T080
of	O	O	O
a	O	O	O
larger	O	O	O
collection	O	O	B-T169
of	O	O	O
studied	O	O	O
plant	O	O	B-T116
proteins	O	O	I-T116
taking	O	O	O
these	O	O	O
UPS	O	O	B-T043
pathways	O	O	B-T077
,	O	O	O
a	O	O	O
clearer	O	O	O
picture	O	O	O
of	O	O	O
endomembrane	O	O	B-T026
trafficking	O	O	B-T043
as	O	O	O
a	O	O	O
whole	O	O	O
will	O	O	O
emerge	O	O	O
.	O	O	O

There	O	O	O
are	O	O	O
several	O	O	B-T081
novel	O	O	B-T080
enabling	O	O	B-T041
technologies	O	O	B-T090
,	O	O	O
such	O	O	O
as	O	O	O
vesicle	O	O	B-T026
proteomics	O	O	B-T091
and	O	O	O
chemical	O	O	B-T103
genomics	O	O	B-T091
,	O	O	O
with	O	O	O
great	O	O	O
potential	O	O	B-T080
for	O	O	O
dissecting	O	O	B-T169
secretion	O	O	B-T043
pathways	O	O	I-T043
,	O	O	O
providing	O	O	B-T052
information	O	O	B-T078
about	O	O	O
the	O	O	O
cargo	O	O	O
that	O	O	O
travels	O	O	O
along	O	O	O
them	O	O	O
and	O	O	O
the	O	O	O
conditions	O	O	O
that	O	O	O
induce	O	O	B-T169
them	O	O	O
.	O	O	O

-DOCSTART- (27669010)

Neospora	O	O	B-T204
caninum	O	O	I-T204
in	O	O	O
Axis	O	O	B-T015
Deer	O	O	I-T015
(	O	O	O
Axis	O	O	B-T015
axis	O	O	I-T015
)	O	O	O
and	O	O	O
Fallow	O	O	B-T015
Deer	O	O	I-T015
(	O	O	O
Dama	O	O	B-T015
dama	O	O	I-T015
)	O	O	O
in	O	O	O
Northern	O	O	B-T082
Mexico	O	O	O

Serum	O	O	B-T031
samples	O	O	I-T031
from	O	O	O
18	O	O	O
axis	O	O	B-T015
deer	O	O	I-T015
(	O	O	O
Axis	O	O	B-T015
axis	O	O	I-T015
)	O	O	O
and	O	O	O
19	O	O	O
fallow	O	O	B-T015
deer	O	O	I-T015
(	O	O	O
Dama	O	O	B-T015
dama	O	O	I-T015
)	O	O	O
were	O	O	O
analyzed	O	O	O
with	O	O	O
an	O	O	O
enzyme-linked	O	O	B-T059
immunosorbent	O	O	I-T059
assay	O	O	I-T059
for	O	O	O
Neospora	O	O	B-T116
caninum	O	O	I-T116
antibodies	O	O	I-T116
.	O	O	O

Two	O	O	O
axis	O	O	B-T015
(	O	O	O
11	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
two	O	O	O
fallow	O	O	B-T015
deer	O	O	I-T015
(	O	O	O
11	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
positive	O	O	B-T033
for	O	O	O
N.	O	O	B-T116
caninum	O	O	I-T116
antibodies	O	O	I-T116
.	O	O	O

-DOCSTART- (27670138)

The	O	O	O
ABBA	O	O	B-T062
study	O	O	I-T062
-	O	O	O
approach	O	O	O
bias	O	O	O
modification	O	O	O
in	O	O	O
bulimia	O	O	B-T048
nervosa	O	O	I-T048
and	O	O	O
binge	O	O	B-T048
eating	O	O	I-T048
disorder	O	O	I-T048
:	O	O	O
study	O	O	O
protocol	O	O	O
for	O	O	O
a	O	O	O
randomised	O	O	O
controlled	O	O	O
trial	O	O	O

The	O	O	O
core	O	O	O
symptoms	O	O	B-T184
of	O	O	O
bulimia	O	O	B-T048
nervosa	O	O	I-T048
(	O	O	O
BN	O	O	B-T048
)	O	O	O
and	O	O	O
binge	O	O	B-T048
eating	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
BED	O	O	B-T048
)	O	O	O
are	O	O	O
recurrent	O	O	B-T033
episodes	O	O	I-T033
of	O	O	I-T033
binge	O	O	I-T033
eating	O	O	I-T033
.	O	O	O

Despite	O	O	O
negative	O	O	B-T048
psychological	O	O	I-T048
and	O	O	O
physical	O	O	B-T033
consequences	O	O	I-T033
,	O	O	O
BN/BED	O	O	B-T048
patients	O	O	B-T101
show	O	O	O
uncontrollable	O	O	O
approach	O	O	O
tendencies	O	O	B-T040
towards	O	O	I-T040
food	O	O	I-T040
.	O	O	O

This	O	O	O
cognitive	O	O	B-T078
bias	O	O	I-T078
occurs	O	O	O
at	O	O	O
an	O	O	O
early	O	O	O
stage	O	O	O
of	O	O	O
information	O	O	B-T041
processing	O	O	I-T041
.	O	O	O

Cognitive	O	O	B-T061
bias	O	O	I-T061
modification	O	O	I-T061
(	O	O	O
CBM	O	O	B-T061
)	O	O	O
directly	O	O	O
targets	O	O	O
such	O	O	O
biases	O	O	B-T078
and	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
effective	O	O	O
in	O	O	O
treating	O	O	B-T061
several	O	O	O
mental	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

In	O	O	O
alcohol	O	O	B-T048
addiction	O	O	I-T048
,	O	O	O
automatic	O	O	O
action	O	O	O
tendencies	O	O	O
towards	O	O	O
alcohol	O	O	B-UnknownType
cues	O	O	I-UnknownType
and	O	O	O
relapse	O	O	B-T067
rates	O	O	B-T081
were	O	O	O
successfully	O	O	O
reduced	O	O	O
by	O	O	O
a	O	O	O
specific	O	O	O
form	O	O	O
of	O	O	O
CBM	O	O	B-T061
,	O	O	O
termed	O	O	O
approach	O	O	O
bias	O	O	B-T169
modification	O	O	I-T169
.	O	O	O

Based	O	O	O
on	O	O	O
these	O	O	O
findings	O	O	O
and	O	O	O
data	O	O	B-T078
from	O	O	O
a	O	O	O
proof-of-concept	O	O	B-T062
study	O	O	I-T062
in	O	O	O
people	O	O	B-T098
with	O	O	O
high	O	O	O
levels	O	O	O
of	O	O	O
food	O	O	B-T055
craving	O	O	I-T055
,	O	O	O
CBM	O	O	B-T169
is	O	O	O
considered	O	O	O
a	O	O	O
promising	O	O	O
new	O	O	O
treatment	O	O	B-UnknownType
approach	O	O	I-UnknownType
for	O	O	O
BN/BED	O	O	B-T048
.	O	O	O

Given	O	O	O
the	O	O	O
similarities	O	O	O
between	O	O	O
BN/BED	O	O	B-T048
and	O	O	O
addictive	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
the	O	O	O
rationale	O	O	B-T078
for	O	O	O
using	O	O	O
approach	O	O	O
bias	O	O	B-T169
modification	O	O	I-T169
appears	O	O	O
to	O	O	O
be	O	O	O
particularly	O	O	O
strong	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
is	O	O	O
to	O	O	O
examine	O	O	O
whether	O	O	O
,	O	O	O
compared	O	O	O
to	O	O	O
a	O	O	O
sham	O	O	B-T062
training	O	O	I-T062
,	O	O	O
computerised	O	O	O
approach	O	O	O
bias	O	O	B-T169
modification	O	O	I-T169
(	O	O	O
10	O	O	O
sessions	O	O	O
)	O	O	O
can	O	O	O
reduce	O	O	O
binge-eating	O	O	B-T033
episodes	O	O	I-T033
in	O	O	O
BN/BED	O	O	B-T048
patients	O	O	B-T101
from	O	O	O
pre-treatment	O	O	B-T079
to	O	O	O
follow-up	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
we	O	O	O
will	O	O	O
investigate	O	O	O
whether	O	O	O
this	O	O	O
CBM	O	O	B-T061
programme	O	O	O
also	O	O	O
reduces	O	O	O
global	O	O	B-T080
eating	O	O	B-T048
disorder	O	O	I-T048
psychopathology	O	O	I-T048
,	O	O	O
trait	O	O	B-T032
and	O	O	O
cue-elicited	O	O	B-T055
food	O	O	I-T055
craving	O	O	I-T055
,	O	O	O
food	O	O	B-T040
intake	O	O	I-T040
as	O	O	O
well	O	O	O
as	O	O	O
approach	O	O	O
and	O	O	O
attentional	O	O	B-T041
bias	O	O	I-T041
towards	O	O	O
visual	O	O	B-T078
food	O	O	I-T078
cues	O	O	I-T078
.	O	O	O

Treatment	O	O	B-T061
acceptance	O	O	I-T061
will	O	O	O
be	O	O	O
determined	O	O	O
by	O	O	O
attrition	O	O	B-UnknownType
rates	O	O	I-UnknownType
and	O	O	O
responses	O	O	B-T170
on	O	O	O
a	O	O	O
feedback	O	O	O
form	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
double-blind	O	O	B-T062
,	O	O	O
randomised	O	O	B-T062
,	O	O	O
placebo-controlled	O	O	B-T062
,	O	O	O
parallel-group	O	O	B-T078
superiority	O	O	I-T078
trial	O	O	I-T078
with	O	O	O
two	O	O	O
parallel	O	O	O
arms	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
54	O	O	O
BN/BED	O	O	B-T048
patients	O	O	B-T101
will	O	O	O
be	O	O	O
recruited	O	O	O
.	O	O	O

Approach	O	O	O
bias	O	O	B-T078
towards	O	O	I-T078
food	O	O	I-T078
will	O	O	O
be	O	O	O
retrained	O	O	O
by	O	O	O
a	O	O	O
computer	O	O	O
task	O	O	O
adopting	O	O	O
an	O	O	O
implicit	O	O	B-T062
learning	O	O	I-T062
paradigm	O	O	I-T062
.	O	O	O

Patients	O	O	B-T101
in	O	O	O
the	O	O	O
control	O	O	O
condition	O	O	O
(	O	O	O
sham	O	O	B-T062
)	O	O	O
will	O	O	O
conduct	O	O	O
a	O	O	O
similar	O	O	B-T057
task	O	O	I-T057
but	O	O	O
will	O	O	O
not	O	O	O
be	O	O	O
trained	O	O	O
to	O	O	O
avoid	O	O	O
food	O	O	B-T078
cues	O	O	I-T078
.	O	O	O

Methods	O	O	O
against	O	O	O
bias	O	O	B-T078
include	O	O	O
public	O	O	B-T170
registration	O	O	I-T170
,	O	O	O
randomisation	O	O	B-T062
by	O	O	O
a	O	O	O
central	O	O	B-T097
study	O	O	I-T097
office	O	O	I-T097
,	O	O	O
standardisation	O	O	B-T062
of	O	O	I-T062
the	O	O	I-T062
treatments	O	O	I-T062
and	O	O	O
blinding	O	O	B-T062
of	O	O	I-T062
assessors	O	O	I-T062
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
session	O	O	O
number	O	O	O
and	O	O	O
duration	O	O	O
will	O	O	O
be	O	O	O
equivalent	O	O	O
in	O	O	O
the	O	O	O
two	O	O	O
conditions	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
registered	O	O	O
randomised	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
of	O	O	O
approach	O	O	O
bias	O	O	B-T169
modification	O	O	I-T169
in	O	O	O
a	O	O	O
clinical	O	O	B-T062
BN/BED	O	O	I-T062
sample	O	O	I-T062
.	O	O	O

Results	O	O	O
from	O	O	O
this	O	O	O
study	O	O	O
will	O	O	O
provide	O	O	O
an	O	O	O
indication	O	O	O
of	O	O	O
the	O	O	O
efficacy	O	O	O
of	O	O	O
approach	O	O	O
bias	O	O	B-T169
modification	O	O	I-T169
training	O	O	O
for	O	O	O
BN/BED	O	O	B-T048
and	O	O	O
the	O	O	O
potential	O	O	O
mechanisms	O	O	O
of	O	O	O
action	O	O	O
underlying	O	O	O
this	O	O	O
treatment	O	O	B-T061
.	O	O	O

DRKS00010231	O	O	O
(	O	O	O
retrospectively	O	O	O
registered	O	O	O
on	O	O	O
24	O	O	O
March	O	O	O
2016	O	O	O
;	O	O	O
first	O	O	O
version	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27677517)

Protein	O	O	B-T116
Design	O	O	B-T052
for	O	O	O
Nanostructural	O	O	B-T059
Engineering	O	O	I-T059
:	O	O	O
Concluding	O	O	O
Remarks	O	O	B-T170
and	O	O	O
Future	O	O	O
Directions	O	O	O

This	O	O	O
final	O	O	O
chapter	O	O	B-T170
aims	O	O	O
to	O	O	O
summarize	O	O	O
the	O	O	O
main	O	O	O
conclusions	O	O	B-T170
of	O	O	O
the	O	O	O
book	O	O	B-T170
and	O	O	O
to	O	O	O
point	O	O	O
to	O	O	O
possible	O	O	O
directions	O	O	O
for	O	O	O
further	O	O	O
research	O	O	B-T062
in	O	O	O
the	O	O	O
field	O	O	B-UnknownType
of	O	O	O
protein	O	O	B-T116
design	O	O	B-T052
for	O	O	O
nanostructural	O	O	B-T059
engineering	O	O	I-T059
.	O	O	O

Even	O	O	O
though	O	O	O
this	O	O	O
research	O	O	B-UnknownType
field	O	O	I-UnknownType
is	O	O	O
still	O	O	O
at	O	O	O
its	O	O	O
infancy	O	O	O
,	O	O	O
multidisciplinary	O	O	B-T080
research	O	O	B-T062
efforts	O	O	I-T062
in	O	O	O
the	O	O	O
design	O	O	B-T052
of	O	O	O
synthetic	O	O	B-T116
protein	O	O	I-T116
-based	O	O	O
nanostructures	O	O	B-T073
and	O	O	O
functional	O	O	B-T169
materials	O	O	B-T167
have	O	O	O
resulted	O	O	O
in	O	O	O
significant	O	O	O
progress	O	O	B-T169
.	O	O	O

The	O	O	O
chapters	O	O	B-T170
in	O	O	O
this	O	O	O
book	O	O	B-T170
cover	O	O	O
several	O	O	O
selected	O	O	O
examples	O	O	B-T077
of	O	O	O
the	O	O	O
most	O	O	O
recent	O	O	O
advances	O	O	B-T079
concerning	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
proteins	O	O	B-T116
and	O	O	O
peptides	O	O	B-T116
as	O	O	O
building	O	O	B-T077
blocks	O	O	I-T077
for	O	O	O
the	O	O	O
fabrication	O	O	B-T067
of	O	O	O
architectures	O	O	B-T077
and	O	O	O
functional	O	O	B-T169
nanostructures	O	O	B-T073
,	O	O	O
assemblies	O	O	B-T052
,	O	O	O
and	O	O	O
materials	O	O	B-T167
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
provide	O	O	O
a	O	O	O
general	O	O	O
overview	O	O	O
of	O	O	O
the	O	O	O
strategies	O	O	B-T169
that	O	O	O
can	O	O	O
be	O	O	O
employed	O	O	O
to	O	O	O
prepare	O	O	B-T052
functional	O	O	B-T169
protein	O	O	B-T116
-based	O	O	O
nanostructures	O	O	B-T073
,	O	O	O
and	O	O	O
nanostructured	O	O	B-T073
materials	O	O	I-T073
and	O	O	O
devices	O	O	B-T073
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
highlight	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
main	O	O	O
aspects	O	O	B-T080
to	O	O	O
be	O	O	O
considered	O	O	O
by	O	O	O
the	O	O	O
research	O	O	B-T062
community	O	O	B-T096
to	O	O	O
set	O	O	O
the	O	O	O
path	O	O	O
for	O	O	O
the	O	O	O
near	O	O	O
future	O	O	O
developments	O	O	B-T062
.	O	O	O

-DOCSTART- (27677842)

Synthesis	O	O	B-T052
,	O	O	O
characterization	O	O	B-T052
and	O	O	O
drug	O	O	B-T121
loading	O	O	B-T052
property	O	O	B-T080
of	O	O	O
Monomethoxy-Poly(ethylene	O	O	O
glycol)-Poly(ε-caprolactone)-Poly(D	O	O	O
,	O	O	O
L-lactide	O	O	O
)	O	O	O
(	O	O	O
MPEG-PCLA	O	O	O
)	O	O	O
copolymers	O	O	O

Amphiphilic	O	O	B-T122
block	O	O	I-T122
copolymers	O	O	I-T122
have	O	O	O
attracted	O	O	O
a	O	O	O
great	O	O	O
deal	O	O	O
of	O	O	O
attention	O	O	O
in	O	O	O
drug	O	O	B-T074
delivery	O	O	I-T074
systems	O	O	I-T074
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
a	O	O	O
series	O	O	O
of	O	O	O
monomethoxy-poly	O	O	B-T122
(	O	O	I-T122
ethylene	O	O	I-T122
glycol)-poly	O	O	I-T122
(	O	O	I-T122
ε-caprolactone-co-D	O	O	I-T122
,	O	O	I-T122
L-lactide	O	O	I-T122
)	O	O	I-T122
(	O	O	I-T122
MPEG-PCLA	O	O	I-T122
)	O	O	I-T122
copolymers	O	O	I-T122
with	O	O	O
variable	O	O	O
composition	O	O	B-T070
of	O	O	O
poly	O	O	B-T109
(	O	O	I-T109
ε-caprolactone	O	O	I-T109
)	O	O	I-T109
(	O	O	O
PCL	O	O	B-T109
)	O	O	O
and	O	O	O
poly	O	O	B-T122
(	O	O	I-T122
D	O	O	I-T122
,	O	O	I-T122
L-lactide	O	O	I-T122
)	O	O	I-T122
(	O	O	O
PDLLA	O	O	B-T122
)	O	O	O
were	O	O	O
prepared	O	O	O
via	O	O	O
ring-opening	O	O	B-T044
copolymerization	O	O	I-T044
of	O	O	O
ε-CL	O	O	B-T109
and	O	O	O
D	O	O	B-T109
,	O	O	I-T109
L-LA	O	O	I-T109
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
MPEG	O	O	B-T109
and	O	O	O
stannous	O	O	B-T109
octoate	O	O	I-T109
.	O	O	O

The	O	O	O
structure	O	O	B-T082
and	O	O	O
molecular	O	O	B-T081
weight	O	O	I-T081
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
nuclear	O	O	B-T070
magnetic	O	O	I-T070
resonance	O	O	I-T070
(	O	O	O
NMR	O	O	B-T070
)	O	O	O
and	O	O	O
gel	O	O	B-T059
permeation	O	O	I-T059
chromatography	O	O	I-T059
(	O	O	O
GPC	O	O	B-T059
)	O	O	O
.	O	O	O

The	O	O	O
crystallinity	O	O	B-T104
,	O	O	O
hydrophilicity	O	O	B-T080
,	O	O	O
thermal	O	O	B-T070
stability	O	O	B-T080
and	O	O	O
hydrolytic	O	O	B-T070
degradation	O	O	B-T169
behavior	O	O	I-T169
were	O	O	O
investigated	O	O	O
in	O	O	O
detail	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
prepared	O	O	O
amphiphilic	O	O	B-T122
MPEG-PCLA	O	O	I-T122
copolymers	O	O	I-T122
have	O	O	O
adjustable	O	O	O
properties	O	O	B-T080
by	O	O	O
altering	O	O	O
the	O	O	O
composition	O	O	B-T070
of	O	O	O
PCLA	O	O	B-T109
,	O	O	O
which	O	O	O
make	O	O	O
it	O	O	O
convenient	O	O	O
for	O	O	O
clinical	O	O	B-T201
applications	O	O	I-T201
.	O	O	O

Besides	O	O	O
,	O	O	O
the	O	O	O
drug	O	O	B-T121
loading	O	O	B-T052
properties	O	O	B-T080
were	O	O	O
also	O	O	O
studied	O	O	O
.	O	O	O

Docetaxel	O	O	B-T109
(	O	O	O
DTX	O	O	B-T109
)	O	O	O
could	O	O	O
be	O	O	O
entrapped	O	O	O
in	O	O	O
MPEG-PCLA	O	O	B-T122
micelles	O	O	B-T109
with	O	O	O
high	O	O	B-T080
loading	O	O	B-T052
capacity	O	O	B-T081
and	O	O	O
encapsulation	O	O	B-T067
efficiency	O	O	B-T081
.	O	O	O

And	O	O	O
all	O	O	O
lyophilized	O	O	B-T080
DTX	O	O	B-T109
-loaded	O	O	O
MPEG-PCLA	O	O	B-T122
micelles	O	O	B-T109
except	O	O	O
MPEG-PCL	O	O	B-T122
micelles	O	O	O
were	O	O	O
readily	O	O	O
re-dissolved	O	O	B-T169
in	O	O	O
normal	O	O	B-T121
saline	O	O	I-T121
at	O	O	O
25	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
DTX	O	O	B-T109
-loaded	O	O	O
MPEG-PCLA	O	O	B-T122
micelles	O	O	B-T109
showed	O	O	O
a	O	O	O
slightly	O	O	O
enhanced	O	O	B-T052
antitumor	O	O	B-T080
activity	O	O	B-T052
compared	O	O	O
with	O	O	O
free	O	O	O
DTX	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
DTX	O	O	B-T109
micelles	O	O	B-T109
exhibited	O	O	O
a	O	O	O
slower	O	O	B-T080
and	O	O	O
sustained	O	O	B-T169
release	O	O	B-T169
behavior	O	O	B-T080
in	O	O	B-T080
vitro	O	O	I-T080
,	O	O	O
and	O	O	O
higher	O	O	B-T080
DTX	O	O	O
concentration	O	O	B-T081
and	O	O	O
longer	O	O	O
retention	O	O	B-T081
time	O	O	I-T081
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

The	O	O	O
results	O	O	O
suggested	O	O	O
that	O	O	O
the	O	O	O
MPEG-PCLA	O	O	B-T122
copolymer	O	O	I-T122
with	O	O	O
the	O	O	O
adjustable	O	O	O
ratio	O	O	B-T081
of	O	O	O
PCL	O	O	B-T109
to	O	O	O
PDLLA	O	O	B-T122
may	O	O	O
be	O	O	O
a	O	O	O
promising	O	O	O
drug	O	O	B-T122
delivery	O	O	I-T122
carrier	O	O	I-T122
for	O	O	O
DTX	O	O	B-T109
.	O	O	O

-DOCSTART- (27678317)

Thyroid	O	O	B-T191
cancer	O	O	I-T191
burden	O	O	B-T081
in	O	O	O
Central	O	O	B-T083
and	O	O	O
South	O	O	O
America	O	O	O

Incidence	O	O	B-T081
of	O	O	O
thyroid	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
TC	O	O	B-T191
)	O	O	O
is	O	O	O
rapidly	O	O	B-T080
increasing	O	O	B-T169
worldwide	O	O	B-T078
,	O	O	O
but	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
TC	O	O	O
burden	O	O	B-T081
in	O	O	O
Central	O	O	B-T083
and	O	O	O
South	O	O	B-T083
America	O	O	I-T083
(	O	O	O
CSA	O	O	B-T083
)	O	O	O
.	O	O	O

We	O	O	O
describe	O	O	O
the	O	O	O
geographic	O	O	B-T082
patterns	O	O	I-T082
and	O	O	O
trends	O	O	B-T079
of	O	O	O
TC	O	O	B-T191
by	O	O	O
sex	O	O	B-T032
in	O	O	O
CSA	O	O	B-T083
.	O	O	O

We	O	O	O
obtained	O	O	O
regional	O	O	B-UnknownType
-	O	O	O
and	O	O	O
national-level	O	O	B-T082
incidence	O	O	B-T081
data	O	O	B-T078
from	O	O	O
48	O	O	O
population-based	O	O	B-T170
cancer	O	O	I-T170
registries	O	O	I-T170
in	O	O	O
13	O	O	O
countries	O	O	B-T083
and	O	O	O
nationwide	O	O	O
cancer	O	O	B-T081
deaths	O	O	I-T081
from	O	O	O
the	O	O	O
WHO	O	O	B-T093
mortality	O	O	B-T081
database	O	O	B-T170
for	O	O	O
18	O	O	O
countries	O	O	O
.	O	O	O

We	O	O	O
estimated	O	O	O
world	O	O	B-T098
population	O	O	O
age-standardized	O	O	B-T081
incidence	O	O	I-T081
rates	O	O	I-T081
(	O	O	O
ASRs	O	O	B-T081
)	O	O	O
and	O	O	O
age-standardized	O	O	B-T081
mortality	O	O	I-T081
rates	O	O	I-T081
(	O	O	O
ASMRs	O	O	B-T081
)	O	O	O
per	O	O	O
100,000	O	O	O
person	O	O	B-T098
-	O	O	O
years	O	O	B-T079
.	O	O	O

We	O	O	O
calculated	O	O	O
ASRs	O	O	B-T081
by	O	O	O
histological	O	O	B-T201
subtype	O	O	I-T201
.	O	O	O

We	O	O	O
estimated	O	O	B-T081
the	O	O	I-T081
annual	O	O	I-T081
percentage	O	O	I-T081
change	O	O	I-T081
(	O	O	O
EAPC	O	O	B-T081
)	O	O	O
to	O	O	O
describe	O	O	O
time	O	O	B-T079
trends	O	O	I-T079
.	O	O	O

Between	O	O	O
CSA	O	O	B-T083
countries	O	O	B-T083
,	O	O	O
TC	O	O	B-T191
incidence	O	O	B-T081
and	O	O	O
mortality	O	O	B-T081
rates	O	O	I-T081
varied	O	O	O
from	O	O	O
8-fold	O	O	O
to	O	O	O
12-fold	O	O	O
and	O	O	O
from	O	O	O
2-fold	O	O	O
to	O	O	O
5-fold	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
2003	O	O	O
-	O	O	O
2007	O	O	O
,	O	O	O
the	O	O	O
highest	O	O	B-T080
TC	O	O	B-T191
ASRs	O	O	B-T081
in	O	O	O
females	O	O	B-T032
and	O	O	O
males	O	O	B-T032
were	O	O	O
in	O	O	O
Ecuador	O	O	B-T083
(	O	O	O
16.0	O	O	O
and	O	O	O
3.5	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
,	O	O	O
Brazil	O	O	B-T083
(	O	O	O
14.4	O	O	O
and	O	O	O
3.4	O	O	O
)	O	O	O
,	O	O	O
Costa	O	O	B-T083
Rica	O	O	I-T083
(	O	O	O
12.6	O	O	O
and	O	O	O
2.1	O	O	O
)	O	O	O
and	O	O	O
Colombia	O	O	B-T083
(	O	O	O
10.7	O	O	O
and	O	O	O
2.5	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
highest	O	O	B-T080
ASMRs	O	O	B-T081
were	O	O	O
in	O	O	O
Ecuador	O	O	B-T083
,	O	O	O
Colombia	O	O	B-T083
,	O	O	O
Mexico	O	O	B-T083
,	O	O	O
Peru	O	O	B-T083
and	O	O	O
Panama	O	O	B-T083
(	O	O	O
0.68	O	O	O
-	O	O	O
0.91	O	O	O
in	O	O	O
females	O	O	B-T032
and	O	O	O
0.41	O	O	O
-	O	O	O
0.48	O	O	O
in	O	O	O
males	O	O	B-T032
)	O	O	O
.	O	O	O

Papillary	O	O	B-T191
TC	O	O	B-T191
was	O	O	O
the	O	O	O
most	O	O	O
commonly	O	O	O
diagnosed	O	O	B-T033
histological	O	O	B-T201
subtype	O	O	I-T201
,	O	O	O
following	O	O	O
the	O	O	O
same	O	O	O
incidence	O	O	B-T081
pattern	O	O	I-T081
as	O	O	O
overall	O	O	O
TC	O	O	O
.	O	O	O

In	O	O	O
Argentinean	O	O	B-T098
,	O	O	O
Brazilian	O	O	B-T033
,	O	O	O
Chilean	O	O	B-T098
and	O	O	O
Costa	O	O	B-T098
Rican	O	O	I-T098
females	O	O	B-T032
TC	O	O	B-T191
incidence	O	O	B-T081
increased	O	O	B-T081
by	O	O	O
2.2	O	O	O
-	O	O	O
17.9	O	O	O
%	O	O	O
annually	O	O	B-T079
,	O	O	O
and	O	O	O
papillary	O	O	B-T191
TC	O	O	I-T191
increased	O	O	O
by	O	O	O
9.1	O	O	O
-	O	O	O
15.0	O	O	O
%	O	O	O
annually	O	O	O
,	O	O	O
while	O	O	O
mortality	O	O	B-T081
remained	O	O	O
stable	O	O	B-T080
between	O	O	O
1997	O	O	O
and	O	O	O
2008	O	O	O
.	O	O	O

In	O	O	O
males	O	O	B-T032
,	O	O	O
trends	O	O	B-T079
in	O	O	O
TC	O	O	B-T191
were	O	O	O
stable	O	O	B-T080
.	O	O	O

TC	O	O	B-T191
occurred	O	O	B-T052
more	O	O	O
frequently	O	O	B-T079
in	O	O	O
females	O	O	B-T032
than	O	O	O
in	O	O	O
males	O	O	B-T032
.	O	O	O

The	O	O	O
overall	O	O	B-T080
high	O	O	B-T080
incidence	O	O	B-T081
and	O	O	O
low	O	O	B-T080
mortality	O	O	B-T081
of	O	O	O
TC	O	O	B-T191
suggest	O	O	B-T078
identification	O	O	O
of	O	O	O
subclinical	O	O	B-T047
disease	O	O	I-T047
due	O	O	O
to	O	O	O
improved	O	O	B-T080
detection	O	O	B-T170
methods	O	O	I-T170
.	O	O	O

-DOCSTART- (27679696)

Histopathological	O	O	B-T169
Evaluation	O	O	B-T058
of	O	O	O
the	O	O	O
Effectiveness	O	O	B-T080
of	O	O	O
Glycyrrhizic	O	O	B-T109
Acid	O	O	I-T109
as	O	O	O
a	O	O	O
Radioprotector	O	O	B-T061
Against	O	O	O
the	O	O	O
Development	O	O	B-T169
of	O	O	O
Radiation-Induced	O	O	O
Lung	O	O	O
Fibrosis	O	O	O

Radiotherapy	O	O	B-T061
of	O	O	O
the	O	O	O
thorax	O	O	B-T029
often	O	O	O
causes	O	O	O
lung	O	O	B-T047
inflammation	O	O	I-T047
leading	O	O	O
to	O	O	O
fibrosis	O	O	B-T047
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
glycyrrhizic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
GLA	O	O	B-T109
)	O	O	O
could	O	O	O
improve	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
lung	O	O	B-T047
fibrosis	O	O	I-T047
in	O	O	O
irradiated	O	O	B-T061
animals	O	O	B-T008
.	O	O	O

Wistar	O	O	B-T015
rats	O	O	I-T015
were	O	O	O
divided	O	O	O
into	O	O	O
four	O	O	O
groups	O	O	B-T078
.	O	O	O

Group	O	O	B-T078
A	O	O	I-T078
rats	O	O	B-T015
received	O	O	O
thoracic	O	O	B-T061
irradiation	O	O	I-T061
.	O	O	O

Rats	O	O	B-T015
in	O	O	O
group	O	O	B-T078
B	O	O	I-T078
received	O	O	O
GLA	O	O	B-T109
and	O	O	O
irradiation	O	O	B-T061
.	O	O	O

Group	O	O	B-T078
C	O	O	I-T078
received	O	O	O
GLA	O	O	B-T109
and	O	O	O
no	O	O	O
irradiation	O	O	B-T061
.	O	O	O

Group	O	O	B-T078
D	O	O	I-T078
received	O	O	O
no	O	O	O
GLA	O	O	B-T109
and	O	O	O
irradiation	O	O	B-T061
.	O	O	O

GLA	O	O	B-T109
was	O	O	O
administered	O	O	B-T169
at	O	O	O
a	O	O	O
dose	O	O	B-T081
of	O	O	O
4	O	O	O
mg/kg	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
using	O	O	O
an	O	O	O
intraperitoneal	O	O	B-T061
injection	O	O	I-T061
one	O	O	O
hour	O	O	O
before	O	O	O
thoracic	O	O	B-T061
irradiation	O	O	I-T061
.	O	O	O

Radiation	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
delivered	O	O	O
on	O	O	O
a	O	O	O
Cobalt-60	O	O	B-T130
unit	O	O	O
using	O	O	O
a	O	O	O
single	O	O	O
fraction	O	O	O
of	O	O	O
16	O	O	O
Gy	O	O	O
.	O	O	O

The	O	O	O
animals	O	O	B-T008
were	O	O	O
sacrificed	O	O	O
at	O	O	O
32	O	O	O
weeks	O	O	O
following	O	O	O
thoracic	O	O	B-T061
irradiation	O	O	I-T061
.	O	O	O

The	O	O	O
lungs	O	O	B-T023
were	O	O	O
dissected	O	O	B-T169
and	O	O	O
blind	O	O	O
histopathological	O	O	B-T169
evaluation	O	O	B-T058
was	O	O	O
performed	O	O	O
.	O	O	O

Histopathologically	O	O	B-T169
,	O	O	O
a	O	O	O
decrease	O	O	B-T081
(	O	O	O
statistically	O	O	O
not	O	O	O
significant	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
thickening	O	O	B-T033
of	O	O	O
alveolar	O	O	B-T023
or	O	O	O
bronchial	O	O	B-T023
wall	O	O	I-T023
,	O	O	O
formation	O	O	O
of	O	O	O
fibrous	O	O	B-T020
bands	O	O	I-T020
,	O	O	O
and	O	O	O
superimposed	O	O	O
collagen	O	O	B-T116
were	O	O	O
noted	O	O	O
in	O	O	O
the	O	O	O
animals	O	O	B-T008
in	O	O	O
group	O	O	B-T078
B	O	O	I-T078
as	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
animals	O	O	O
in	O	O	O
group	O	O	O
A.	O	O	O
In	O	O	O
this	O	O	O
experimental	O	O	B-T062
study	O	O	I-T062
,	O	O	O
administration	O	O	B-T081
of	O	O	O
GLA	O	O	B-T109
one	O	O	O
hour	O	O	O
before	O	O	O
thoracic	O	O	B-T061
irradiation	O	O	I-T061
may	O	O	O
be	O	O	O
a	O	O	O
protective	O	O	B-T121
agent	O	O	I-T121
against	O	O	O
radiation-induced	O	O	B-T047
fibrosis	O	O	I-T047
in	O	O	O
animals	O	O	O
and	O	O	O
this	O	O	O
model	O	O	B-T050
could	O	O	O
be	O	O	O
used	O	O	O
in	O	O	O
future	O	O	O
studies	O	O	O
.	O	O	O

-DOCSTART- (27682280)

Avulsions	O	O	B-T037
of	O	O	O
Triceps	O	O	B-T023
Brachii	O	O	I-T023
:	O	O	O
associated	O	O	O
injuries	O	O	B-T037
and	O	O	O
surgical	O	O	B-T061
treatment	O	O	I-T061
;	O	O	O
a	O	O	O
case	O	O	O
series	O	O	O

This	O	O	O
study	O	O	B-T062
reports	O	O	O
the	O	O	O
clinical	O	O	B-T170
presentations	O	O	I-T170
,	O	O	O
intra	O	O	B-T079
-operative	O	O	I-T079
findings	O	O	B-T033
,	O	O	O
type	O	O	O
of	O	O	O
the	O	O	O
treatments	O	O	B-T061
,	O	O	O
outcome	O	O	B-T169
of	O	O	O
the	O	O	O
treatment	O	O	B-T061
and	O	O	O
specially	O	O	O
associated	O	O	O
injuries	O	O	B-T037
in	O	O	O
patients	O	O	B-T101
with	O	O	O
the	O	O	O
avulsion	O	O	B-T037
of	O	O	O
the	O	O	O
distal	O	O	B-T082
end	O	O	I-T082
of	O	O	O
the	O	O	O
triceps	O	O	B-T023
brachii	O	O	I-T023
(	O	O	I-T023
TB	O	O	I-T023
)	O	O	I-T023
tendon	O	O	I-T023
.	O	O	O

We	O	O	O
studied	O	O	O
6	O	O	O
patients	O	O	B-T101
with	O	O	O
rupture	O	O	B-T037
or	O	O	O
avulsion	O	O	B-T037
of	O	O	O
the	O	O	O
distal	O	O	B-T082
end	O	O	I-T082
of	O	O	O
the	O	O	O
TB	O	O	B-T023
tendon	O	O	I-T023
.	O	O	O

The	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
,	O	O	O
imaging	O	O	B-T170
files	O	O	I-T170
,	O	O	O
clinical	O	O	B-T080
outcomes	O	O	B-T169
at	O	O	O
the	O	O	O
final	O	O	O
follow	O	O	B-T058
up	O	O	I-T058
visit	O	O	I-T058
were	O	O	O
reviewed	O	O	O
.	O	O	O

The	O	O	O
clinical	O	O	B-T080
outcomes	O	O	B-T169
were	O	O	O
assessed	O	O	O
by	O	O	O
Mayo	O	O	B-T170
Elbow	O	O	I-T170
Score	O	O	I-T170
at	O	O	O
the	O	O	O
final	O	O	O
follow-up	O	O	B-T058
visit	O	O	I-T058
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
male	O	O	B-T032
,	O	O	O
4	O	O	O
of	O	O	O
them	O	O	O
having	O	O	O
injury	O	O	B-T037
in	O	O	O
the	O	O	O
left	O	O	B-T023
hand	O	O	B-T023
as	O	O	O
the	O	O	O
non-dominant	O	O	O
hand	O	O	O
.	O	O	O

Mean	O	O	O
age	O	O	B-T032
of	O	O	O
them	O	O	O
was	O	O	O
34.5	O	O	O
years	O	O	B-T079
.	O	O	O

All	O	O	O
cases	O	O	O
had	O	O	O
small	O	O	O
bony	O	O	B-T169
fleck	O	O	B-T037
in	O	O	O
the	O	O	O
posterior	O	O	O
of	O	O	O
elbow	O	O	B-T029
in	O	O	O
lateral	O	O	B-T060
radiograph	O	O	I-T060
.	O	O	O

Three	O	O	O
patients	O	O	B-T101
had	O	O	O
associated	O	O	O
injuries	O	O	B-T037
-including	O	O	O
intra-articular	O	O	B-T082
fractures	O	O	B-T037
and	O	O	O
medial	O	O	B-T037
collateral	O	O	I-T037
ligament	O	O	I-T037
rupture	O	O	I-T037
.	O	O	O

In	O	O	O
one	O	O	O
case	O	O	O
V-Y	O	O	B-T061
plasty	O	O	I-T061
of	O	O	O
the	O	O	O
distal	O	O	B-T082
TB	O	O	B-T023
was	O	O	O
done	O	O	O
.	O	O	O

In	O	O	O
4	O	O	O
patients	O	O	B-T101
the	O	O	O
results	O	O	O
of	O	O	O
surgery	O	O	B-T061
were	O	O	O
excellent	O	O	O
,	O	O	O
one	O	O	O
was	O	O	O
good	O	O	O
and	O	O	O
one	O	O	O
was	O	O	O
fair	O	O	O
.	O	O	O

Although	O	O	O
TB	O	O	B-T023
tendon	O	O	I-T023
rupture	O	O	B-T037
is	O	O	O
rare	O	O	O
,	O	O	O
it	O	O	O
should	O	O	O
be	O	O	O
-considered	O	O	O
in	O	O	O
differential	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
the	O	O	O
upper	O	O	B-UnknownType
-extremity	O	O	I-UnknownType
trauma	O	O	I-UnknownType
and	O	O	O
its	O	O	O
associated	O	O	O
injuries	O	O	B-T037
should	O	O	O
be	O	O	O
addressed	O	O	O
properly	O	O	O
.	O	O	O

-DOCSTART- (27683416)

Prolyl-4-hydroxylase	O	O	B-T116
2	O	O	I-T116
and	O	O	O
3	O	O	B-T116
coregulate	O	O	O
murine	O	O	B-T109
erythropoietin	O	O	B-T116
in	O	O	O
brain	O	O	B-T023
pericytes	O	O	O

A	O	O	O
classic	O	O	O
response	O	O	B-T033
to	O	O	O
systemic	O	O	B-T169
hypoxia	O	O	B-T046
is	O	O	O
the	O	O	O
increased	O	O	B-T081
production	O	O	B-T042
of	O	O	I-T042
red	O	O	I-T042
blood	O	O	I-T042
cells	O	O	I-T042
due	O	O	O
to	O	O	O
hypoxia-inducible	O	O	B-T116
factor	O	O	I-T116
(HIF)-mediated	O	O	O
induction	O	O	B-T169
of	O	O	O
erythropoietin	O	O	B-T116
(	O	O	O
EPO	O	O	B-T116
)	O	O	O
.	O	O	O

EPO	O	O	B-T116
is	O	O	O
a	O	O	O
glycoprotein	O	O	B-T125
hormone	O	O	I-T125
that	O	O	O
is	O	O	O
essential	O	O	O
for	O	O	O
normal	O	O	B-T042
erythropoiesis	O	O	I-T042
and	O	O	O
is	O	O	O
predominantly	O	O	O
synthesized	O	O	O
by	O	O	O
peritubular	O	O	B-T082
renal	O	O	B-T025
interstitial	O	O	I-T025
fibroblast-like	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
which	O	O	O
express	O	O	O
cellular	O	O	B-T201
markers	O	O	I-T201
characteristic	O	O	O
of	O	O	O
neuronal	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
pericytes	O	O	B-T025
.	O	O	O

To	O	O	O
investigate	O	O	B-T169
whether	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
synthesize	O	O	O
EPO	O	O	B-T116
is	O	O	O
a	O	O	O
general	O	O	O
functional	O	O	B-T169
feature	O	O	B-T080
of	O	O	O
pericytes	O	O	B-T025
,	O	O	O
we	O	O	O
used	O	O	O
conditional	O	O	O
gene	O	O	B-T063
targeting	O	O	I-T063
to	O	O	O
examine	O	O	O
the	O	O	O
von	O	O	B-T047
Hippel-Lindau	O	O	I-T047
/	O	O	O
prolyl-4-hydroxylase	O	O	B-T116
domain	O	O	I-T116
(PHD)/HIF	O	O	I-T116
axis	O	O	O
in	O	O	O
cell	O	O	B-T025
-	O	O	O
expressing	O	O	B-T045
neural	O	O	B-T116
glial	O	O	I-T116
antigen	O	O	I-T116
2	O	O	I-T116
,	O	O	O
a	O	O	O
known	O	O	O
molecular	O	O	B-T201
marker	O	O	I-T201
of	O	O	O
pericytes	O	O	O
in	O	O	O
multiple	O	O	B-T023
organs	O	O	I-T023
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
pericytes	O	O	B-T025
in	O	O	O
the	O	O	O
brain	O	O	B-T023
synthesized	O	O	O
EPO	O	O	B-T116
in	O	O	O
mice	O	O	B-T015
with	O	O	O
genetic	O	O	B-T169
HIF	O	O	B-T116
activation	O	O	B-T052
and	O	O	O
were	O	O	O
capable	O	O	O
of	O	O	O
responding	O	O	O
to	O	O	O
systemic	O	O	B-T169
hypoxia	O	O	B-T046
with	O	O	O
the	O	O	O
induction	O	O	B-T169
of	O	O	O
Epo	O	O	B-T116
.	O	O	O

Using	O	O	O
high-resolution	O	O	B-T059
multiplex	O	O	O
in	O	O	B-T063
situ	O	O	I-T063
hybridization	O	O	I-T063
,	O	O	O
we	O	O	O
determined	O	O	O
that	O	O	O
brain	O	O	B-T023
pericytes	O	O	B-T025
represent	O	O	O
an	O	O	O
important	O	O	O
cellular	O	O	B-T025
source	O	O	I-T025
of	O	O	O
Epo	O	O	B-T116
in	O	O	O
the	O	O	O
hypoxic	O	O	B-T046
brain	O	O	O
(	O	O	O
up	O	O	O
to	O	O	O
70	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
Epo	O	O	O
-	O	O	O
expressing	O	O	B-T045
cells	O	O	B-T025
)	O	O	O
.	O	O	O

We	O	O	O
furthermore	O	O	O
determined	O	O	O
that	O	O	O
Epo	O	O	B-T116
transcription	O	O	B-T045
in	O	O	O
brain	O	O	B-T023
pericytes	O	O	B-T025
was	O	O	O
HIF-2	O	O	B-T116
dependent	O	O	O
and	O	O	O
cocontrolled	O	O	O
by	O	O	O
PHD2	O	O	B-T116
and	O	O	O
PHD3	O	O	B-T116
,	O	O	O
oxygen	O	O	B-T121
-	O	O	O
and	O	O	O
2-oxoglutarate	O	O	B-T109
-dependent	O	O	O
prolyl-4-hydroxylases	O	O	B-T116
that	O	O	O
regulate	O	O	O
HIF	O	O	B-T116
activity	O	O	B-T044
.	O	O	O

In	O	O	O
summary	O	O	O
,	O	O	O
our	O	O	O
studies	O	O	O
provide	O	O	O
experimental	O	O	B-T080
evidence	O	O	B-T078
that	O	O	O
pericytes	O	O	B-T025
in	O	O	O
the	O	O	O
brain	O	O	B-T023
have	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
function	O	O	O
as	O	O	O
oxygen	O	O	B-T074
sensors	O	O	I-T074
and	O	O	O
respond	O	O	O
to	O	O	O
hypoxia	O	O	B-T046
with	O	O	O
EPO	O	O	B-T116
synthesis	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	B-T169
furthermore	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
synthesize	O	O	O
EPO	O	O	B-T116
may	O	O	O
represent	O	O	O
a	O	O	O
functional	O	O	B-T169
feature	O	O	B-T080
of	O	O	O
pericytes	O	O	B-T025
in	O	O	O
the	O	O	O
brain	O	O	B-T023
and	O	O	O
kidney	O	O	B-T023
.	O	O	O

-DOCSTART- (27686752)

Patient	O	O	B-T080
Satisfaction	O	O	I-T080
with	O	O	O
Pharmacist	O	O	B-T097
-Led	O	O	O
Collaborative	O	O	B-T054
Follow-Up	O	O	B-T058
Care	O	O	I-T058
in	O	O	O
an	O	O	O
Ambulatory	O	O	B-T078
Rheumatology	O	O	O
Clinic	O	O	O

Patient	O	O	B-T080
satisfaction	O	O	I-T080
is	O	O	O
known	O	O	O
to	O	O	O
increase	O	O	O
with	O	O	O
pharmacist	O	O	B-T097
intervention	O	O	B-T061
in	O	O	O
general	O	O	B-T093
outpatient	O	O	I-T093
clinics	O	O	I-T093
and	O	O	O
with	O	O	O
nurse-led	O	O	B-T058
care	O	O	I-T058
in	O	O	O
rheumatology	O	O	B-T093
clinics	O	O	I-T093
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
describe	O	O	O
and	O	O	O
compare	O	O	O
patient	O	O	B-T080
satisfaction	O	O	I-T080
with	O	O	O
two	O	O	O
different	O	O	O
types	O	O	O
of	O	O	O
care	O	O	B-T058
:	O	O	O
a	O	O	O
pharmacist	O	O	B-T097
physician	O	O	B-T097
collaborative	O	O	B-T170
model	O	O	I-T170
and	O	O	O
a	O	O	O
traditional	O	O	B-T170
physician	O	O	I-T170
model	O	O	I-T170
in	O	O	O
a	O	O	O
rheumatology	O	O	B-T093
clinic	O	O	I-T093
setting	O	O	O
.	O	O	O

A	O	O	O
cross-sectional	O	O	B-T062
survey	O	O	I-T062
of	O	O	O
inflammatory	O	O	B-T047
arthritis	O	O	I-T047
patients	O	O	B-T101
seen	O	O	O
during	O	O	O
a	O	O	O
follow-up	O	O	B-T058
visit	O	O	I-T058
in	O	O	O
Edmonton	O	O	B-UnknownType
,	O	O	O
Alberta	O	O	B-UnknownType
,	O	O	O
Canada	O	O	B-T083
,	O	O	O
was	O	O	O
conducted	O	O	O
over	O	O	O
a	O	O	O
ten-week	O	O	B-T062
period	O	O	I-T062
.	O	O	O

Patient	O	O	B-T080
satisfaction	O	O	B-T080
was	O	O	O
measured	O	O	O
using	O	O	O
a	O	O	O
modified	O	O	O
version	O	O	O
of	O	O	O
the	O	O	O
validated	O	O	O
Leeds	O	O	B-T058
Satisfaction	O	O	I-T058
Questionnaire	O	O	I-T058
,	O	O	O
which	O	O	O
uses	O	O	O
a	O	O	O
five-point	O	O	O
Likert	O	O	B-T170
scale	O	O	I-T170
to	O	O	O
measure	O	O	O
six	O	O	B-T082
dimensions	O	O	I-T082
of	O	O	O
satisfaction	O	O	O
,	O	O	O
and	O	O	O
compared	O	O	O
between	O	O	O
the	O	O	O
collaborative	O	O	B-T058
care	O	O	I-T058
and	O	O	O
traditional	O	O	B-T170
physician	O	O	I-T170
models	O	O	I-T170
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
62	O	O	O
patients	O	O	B-T101
completed	O	O	O
the	O	O	O
questionnaire	O	O	B-T170
(	O	O	O
21	O	O	O
collaborative	O	O	B-T058
care	O	O	I-T058
and	O	O	O
41	O	O	O
traditional	O	O	B-T170
physician	O	O	I-T170
model	O	O	I-T170
)	O	O	O
.	O	O	O

The	O	O	O
average	O	O	O
age	O	O	O
of	O	O	O
respondents	O	O	B-T098
was	O	O	O
52	O	O	O
years	O	O	O
and	O	O	O
the	O	O	O
majority	O	O	O
were	O	O	O
female	O	O	B-T032
.	O	O	O

The	O	O	O
mean	O	O	B-T170
score	O	O	I-T170
for	O	O	I-T170
satisfaction	O	O	I-T170
across	O	O	O
the	O	O	O
six	O	O	B-T082
dimensions	O	O	I-T082
was	O	O	O
4.56	O	O	O
in	O	O	O
the	O	O	O
collaborative	O	O	B-T093
care	O	O	I-T093
group	O	O	I-T093
and	O	O	O
4.30	O	O	O
in	O	O	O
the	O	O	O
traditional	O	O	B-T097
physician	O	O	I-T097
group	O	O	I-T097
(	O	O	O
p	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
.	O	O	O

Patient	O	O	B-T080
satisfaction	O	O	I-T080
in	O	O	O
the	O	O	O
collaborative	O	O	B-T093
care	O	O	I-T093
group	O	O	I-T093
was	O	O	O
consistently	O	O	O
higher	O	O	O
across	O	O	O
all	O	O	O
dimensions	O	O	O
.	O	O	O

No	O	O	B-T033
difference	O	O	I-T033
was	O	O	O
noted	O	O	O
between	O	O	O
participants	O	O	B-T098
seen	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
compared	O	O	O
with	O	O	O
those	O	O	O
seen	O	O	O
two	O	O	O
or	O	O	O
more	O	O	O
times	O	O	O
by	O	O	O
the	O	O	O
pharmacist	O	O	B-T097
.	O	O	O

A	O	O	O
collaborative	O	O	B-T170
care	O	O	I-T170
model	O	O	I-T170
can	O	O	O
exceed	O	O	O
the	O	O	O
already	O	O	O
high	O	O	B-T078
expectations	O	O	I-T078
for	O	O	O
care	O	O	B-T058
of	O	O	I-T058
patients	O	O	I-T058
with	O	O	O
inflammatory	O	O	B-T047
arthritis	O	O	I-T047
.	O	O	O

Our	O	O	O
findings	O	O	O
support	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
pharmacists	O	O	B-T097
using	O	O	O
a	O	O	O
collaborative	O	O	B-T058
care	O	O	I-T058
approach	O	O	O
to	O	O	O
care	O	O	B-T058
for	O	O	I-T058
patients	O	O	I-T058
in	O	O	O
rheumatology	O	O	B-T093
clinics	O	O	I-T093
.	O	O	O

-DOCSTART- (27690050)

Ontology	O	O	B-T090
-Based	O	O	O
High	O	O	B-T080
-	O	O	O
Level	O	O	B-T080
Context	O	O	B-T078
Inference	O	O	B-T041
for	O	O	O
Human	O	O	B-T055
Behavior	O	O	I-T055
Identification	O	O	O

Recent	O	O	O
years	O	O	O
have	O	O	O
witnessed	O	O	O
a	O	O	O
huge	O	O	O
progress	O	O	B-T169
in	O	O	O
the	O	O	O
automatic	O	O	B-T169
identification	O	O	B-T080
of	O	O	O
individual	O	O	B-T098
primitives	O	O	B-T170
of	O	O	O
human	O	O	B-T055
behavior	O	O	I-T055
,	O	O	O
such	O	O	O
as	O	O	O
activities	O	O	B-T056
or	O	O	O
locations	O	O	B-T082
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
complex	O	O	B-T080
nature	O	O	B-T169
of	O	O	O
human	O	O	B-T055
behavior	O	O	I-T055
demands	O	O	O
more	O	O	O
abstract	O	O	O
contextual	O	O	B-T078
information	O	O	B-T078
for	O	O	O
its	O	O	O
analysis	O	O	O
.	O	O	O

This	O	O	O
work	O	O	O
presents	O	O	O
an	O	O	O
ontology	O	O	B-T090
-based	O	O	O
method	O	O	B-T170
that	O	O	O
combines	O	O	O
low	O	O	B-T080
-	O	O	O
level	O	O	B-T080
primitives	O	O	B-T170
of	O	O	O
behavior	O	O	B-T053
,	O	O	O
namely	O	O	O
activity	O	O	B-T056
,	O	O	O
locations	O	O	B-T082
and	O	O	O
emotions	O	O	B-T041
,	O	O	O
unprecedented	O	O	B-T080
to	O	O	O
date	O	O	B-T079
,	O	O	O
to	O	O	O
intelligently	O	O	O
derive	O	O	O
more	O	O	O
meaningful	O	O	O
high	O	O	B-T080
-	O	O	O
level	O	O	O
context	O	O	B-T078
information	O	O	B-T078
.	O	O	O

The	O	O	O
paper	O	O	O
contributes	O	O	B-T052
with	O	O	O
a	O	O	O
new	O	O	O
open	O	O	O
ontology	O	O	B-T090
describing	O	O	O
both	O	O	O
low	O	O	B-T080
-	O	O	O
level	O	O	B-T080
and	O	O	O
high	O	O	B-T080
-	O	O	O
level	O	O	O
context	O	O	B-T078
information	O	O	B-T078
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
their	O	O	O
relationships	O	O	B-T080
.	O	O	O

Furthermore	O	O	O
,	O	O	O
a	O	O	O
framework	O	O	B-T077
building	O	O	O
on	O	O	O
the	O	O	O
developed	O	O	O
ontology	O	O	B-T090
and	O	O	O
reasoning	O	O	O
models	O	O	B-T170
is	O	O	O
presented	O	O	O
and	O	O	O
evaluated	O	O	O
.	O	O	O

The	O	O	O
proposed	O	O	O
method	O	O	O
proves	O	O	O
to	O	O	O
be	O	O	O
robust	O	O	O
while	O	O	O
identifying	O	O	O
high	O	O	B-T080
-	O	O	O
level	O	O	B-T080
contexts	O	O	B-T078
even	O	O	O
in	O	O	O
the	O	O	O
event	O	O	B-T051
of	O	O	O
erroneously	O	O	B-T080
-	O	O	O
detected	O	O	B-T033
low	O	O	B-T080
-l	O	O	O
evel	O	O	B-T080
context	O	O	B-T078
s.	O	O	O
Despite	O	O	O
reasonable	O	O	O
inference	O	O	B-T041
times	O	O	O
being	O	O	O
obtained	O	O	O
for	O	O	O
a	O	O	O
relevant	O	O	B-T080
set	O	O	B-T041
of	O	O	O
users	O	O	B-T098
and	O	O	O
instances	O	O	B-T078
,	O	O	O
additional	O	O	O
work	O	O	O
is	O	O	O
required	O	O	O
to	O	O	O
scale	O	O	O
to	O	O	O
long-term	O	O	O
scenarios	O	O	B-T169
with	O	O	O
a	O	O	O
large	O	O	O
number	O	O	O
of	O	O	O
users	O	O	O
.	O	O	O

-DOCSTART- (27692572)

Characterization	O	O	B-T052
of	O	O	O
exposure	O	O	B-T037
in	O	O	O
epidemiological	O	O	B-T062
studies	O	O	I-T062
on	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
from	O	O	O
biodegradable	O	O	B-T080
wastes	O	O	B-T167
:	O	O	O
Misclassification	O	O	B-T185
and	O	O	O
comparison	O	O	B-T052
of	O	O	O
exposure	O	O	O
assessment	O	O	B-T058
strategies	O	O	O

The	O	O	O
assignment	O	O	O
of	O	O	O
exposure	O	O	B-T037
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
main	O	O	O
challenges	O	O	O
faced	O	O	O
by	O	O	O
environmental	O	O	B-T082
epidemiologists	O	O	B-T097
.	O	O	O

However	O	O	O
,	O	O	O
misclassification	O	O	B-T185
of	O	O	O
exposures	O	O	B-T037
has	O	O	O
not	O	O	O
been	O	O	O
explored	O	O	O
in	O	O	O
population	O	O	B-T098
epidemiological	O	O	B-T062
studies	O	O	I-T062
on	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
from	O	O	O
biodegradable	O	O	B-T080
wastes	O	O	B-T167
.	O	O	O

The	O	O	O
objective	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
use	O	O	O
of	O	O	O
different	O	O	O
approaches	O	O	O
for	O	O	O
assessing	O	O	O
exposure	O	O	B-T037
to	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
from	O	O	O
biodegradable	O	O	B-T080
wastes	O	O	B-T167
by	O	O	O
analyzing	O	O	B-T062
(	O	O	O
1	O	O	O
)	O	O	O
the	O	O	O
misclassification	O	O	B-T185
of	O	O	O
exposure	O	O	O
that	O	O	O
is	O	O	O
committed	O	O	O
by	O	O	O
using	O	O	O
these	O	O	O
surrogates	O	O	B-T096
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
the	O	O	O
existence	O	O	O
of	O	O	O
differentia	O	O	B-T080
l	O	O	O
misclassification	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
the	O	O	O
effects	O	O	B-T080
that	O	O	O
misclassification	O	O	O
may	O	O	O
have	O	O	O
on	O	O	O
health	O	O	B-T078
effect	O	O	B-T080
estimates	O	O	B-T081
and	O	O	O
the	O	O	O
interpretation	O	O	B-T169
of	O	O	O
epidemiological	O	O	B-T062
results	O	O	B-T033
,	O	O	O
and	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
the	O	O	O
ability	O	O	O
of	O	O	O
the	O	O	O
exposure	O	O	O
measures	O	O	O
to	O	O	O
predict	O	O	O
health	O	O	B-T170
outcomes	O	O	I-T170
using	O	O	O
10-fold	O	O	O
cross	O	O	B-T062
validation	O	O	I-T062
.	O	O	O

Four	O	O	O
different	O	O	O
exposure	O	O	B-T037
assessment	O	O	B-T058
approaches	O	O	O
were	O	O	O
studied	O	O	B-T062
:	O	O	O
ammonia	O	O	B-T121
concentrations	O	O	B-T081
at	O	O	O
the	O	O	O
residence	O	O	B-T082
(	O	O	O
Metric	O	O	B-T081
I	O	O	I-T081
)	O	O	O
,	O	O	O
distance	O	O	B-T081
to	O	O	O
the	O	O	O
closest	O	O	O
source	O	O	B-T033
(	O	O	O
Metric	O	O	B-T081
II	O	O	I-T081
)	O	O	O
,	O	O	O
number	O	O	O
of	O	O	O
sources	O	O	B-T033
within	O	O	O
certain	O	O	O
distances	O	O	B-T081
from	O	O	O
the	O	O	O
residence	O	O	O
(	O	O	O
Metric	O	O	B-T081
IIIa	O	O	I-T081
,	O	O	O
b	O	O	B-T081
)	O	O	O
and	O	O	O
location	O	O	B-T082
in	O	O	O
a	O	O	O
specific	O	O	O
region	O	O	B-T083
(	O	O	O
Metric	O	O	B-T081
IV	O	O	I-T081
)	O	O	O
.	O	O	O

Exposure-response	O	O	B-T170
models	O	O	I-T170
based	O	O	O
on	O	O	O
Metric	O	O	B-T081
I	O	O	I-T081
provided	O	O	O
the	O	O	O
highest	O	O	O
predictive	O	O	O
ability	O	O	O
(	O	O	O
72.3	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
goodness-of-fit	O	O	B-T080
,	O	O	O
followed	O	O	O
by	O	O	O
IV	O	O	B-T081
,	O	O	O
III	O	O	B-T081
and	O	O	O
II	O	O	B-T081
.	O	O	O

When	O	O	O
compared	O	O	O
to	O	O	O
Metric	O	O	B-T081
I	O	O	I-T081
,	O	O	O
Metric	O	O	B-T081
IV	O	O	I-T081
yielded	O	O	O
the	O	O	O
best	O	O	O
results	O	O	B-T033
for	O	O	O
exposure	O	O	B-T037
misclassification	O	O	B-T185
analysis	O	O	B-T062
and	O	O	O
interpretation	O	O	B-T169
of	O	O	O
health	O	O	B-T078
effect	O	O	B-T080
estimates	O	O	B-T081
,	O	O	O
followed	O	O	O
by	O	O	O
Metric	O	O	B-T081
IIIb	O	O	I-T081
,	O	O	O
IIIa	O	O	B-T081
and	O	O	O
II	O	O	B-T081
.	O	O	O

The	O	O	O
study	O	O	B-T062
showed	O	O	O
that	O	O	O
modelled	O	O	O
NH3	O	O	B-T121
concentrations	O	O	B-T081
provide	O	O	O
more	O	O	O
accurate	O	O	O
estimations	O	O	B-T081
of	O	O	O
true	O	O	O
exposure	O	O	B-T037
than	O	O	O
distances-based	O	O	O
surrogates	O	O	B-T096
,	O	O	O
and	O	O	O
that	O	O	O
distance-based	O	O	O
surrogates	O	O	O
(	O	O	O
especially	O	O	O
those	O	O	O
based	O	O	O
on	O	O	O
distance	O	O	B-T081
to	O	O	O
the	O	O	O
closest	O	O	O
point	O	O	O
source	O	O	B-T033
)	O	O	O
are	O	O	O
imprecise	O	O	O
methods	O	O	O
to	O	O	O
identify	O	O	O
exposed	O	O	O
populations	O	O	B-T098
,	O	O	O
although	O	O	O
they	O	O	O
may	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
initial	O	O	O
studies	O	O	B-T062
.	O	O	O

-DOCSTART- (27692696)

De	O	O	B-T201
Ritis	O	O	I-T201
Ratio	O	O	I-T201
(	O	O	I-T201
AST/ALT	O	O	I-T201
)	O	O	I-T201
as	O	O	O
a	O	O	O
Significant	O	O	B-T201
Prognostic	O	O	I-T201
Factor	O	O	I-T201
in	O	O	O
Patients	O	O	B-T101
With	O	O	O
Upper	O	O	B-T191
Tract	O	O	I-T191
Urothelial	O	O	I-T191
Cancer	O	O	I-T191
Treated	O	O	B-T169
With	O	O	O
Surgery	O	O	O

We	O	O	O
investigated	O	O	B-T169
the	O	O	O
clinical	O	O	B-T170
prognostic	O	O	I-T170
value	O	O	I-T170
of	O	O	O
preoperative	O	O	B-T079
De	O	O	B-T201
Ritis	O	O	I-T201
ratio	O	O	I-T201
(	O	O	I-T201
aspartate	O	O	I-T201
aminotransferase	O	O	I-T201
[AST]/alanine	O	O	I-T201
aminotransferase	O	O	I-T201
[	O	O	I-T201
ALT	O	O	I-T201
]	O	O	I-T201
)	O	O	I-T201
on	O	O	O
postsurgical	O	O	B-T033
survival	O	O	B-T052
outcomes	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
upper	O	O	B-T191
tract	O	O	I-T191
urothelial	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
UTUC	O	O	B-T191
)	O	O	O
.	O	O	O

We	O	O	O
retrospectively	O	O	B-T062
analyzed	O	O	I-T062
the	O	O	O
data	O	O	B-T078
of	O	O	O
623	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
radical	O	O	B-T061
nephrouretectomy	O	O	I-T061
for	O	O	O
UTUC	O	O	B-T191
.	O	O	O

Multivariate	O	O	B-T080
regression	O	O	I-T080
tests	O	O	B-T170
were	O	O	O
performed	O	O	O
to	O	O	O
identify	O	O	O
possible	O	O	B-T080
associations	O	O	I-T080
between	O	O	O
adverse	O	O	B-T046
pathologic	O	O	I-T046
events	O	O	I-T046
and	O	O	O
AST/ALT	O	O	B-T201
.	O	O	O

The	O	O	O
risk	O	O	O
of	O	O	O
postoperative	O	O	B-T079
progression	O	O	B-T169
and	O	O	O
survival	O	O	B-T052
were	O	O	O
tested	O	O	B-T169
using	O	O	O
Kaplan-Meier	O	O	B-T081
analyses	O	O	I-T081
and	O	O	O
Cox	O	O	B-T081
proportional	O	O	I-T081
hazards	O	O	I-T081
models	O	O	I-T081
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
receiver	O	O	B-T081
operator	O	O	I-T081
characteristic	O	O	I-T081
curve	O	O	I-T081
of	O	O	O
AST/ALT	O	O	B-T201
for	O	O	O
cancer-specific	O	O	B-T081
mortality	O	O	I-T081
,	O	O	O
patients	O	O	B-T101
with	O	O	O
AST/ALT	O	O	O
value	O	O	O
≥1.5	O	O	O
were	O	O	O
regarded	O	O	O
as	O	O	O
the	O	O	O
high	O	O	O
AST/ALT	O	O	O
group	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
remaining	O	O	O
patients	O	O	O
formed	O	O	O
the	O	O	O
low	O	O	O
AST/ALT	O	O	O
group	O	O	O
.	O	O	O

In	O	O	O
Kaplan-Meier	O	O	B-T081
analyses	O	O	I-T081
,	O	O	O
the	O	O	O
high	O	O	O
AST/ALT	O	O	B-T201
group	O	O	O
showed	O	O	O
worse	O	O	O
progression-free	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
PFS	O	O	B-T081
)	O	O	O
,	O	O	O
cancer-specific	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
CSS	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
all	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
.	O	O	O

Elevated	O	O	O
AST/ALT	O	O	B-T201
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
higher	O	O	O
T	O	O	B-T185
stage	O	O	I-T185
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
HR	O	O	B-T081
]	O	O	O
,	O	O	O
1.577	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
,	O	O	O
1.077	O	O	O
-	O	O	O
2.311	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.033	O	O	O
)	O	O	O
and	O	O	O
higher	O	O	B-T185
cellular	O	O	I-T185
grade	O	O	I-T185
(	O	O	O
HR	O	O	O
,	O	O	O
1.538	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.034	O	O	O
-	O	O	O
2.287	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.041	O	O	O
)	O	O	O
in	O	O	O
multivariate	O	O	B-T080
regression	O	O	I-T080
tests	O	O	B-T170
.	O	O	O

In	O	O	O
multivariate	O	O	B-T081
Cox	O	O	I-T081
analyses	O	O	I-T081
,	O	O	O
high	O	O	O
AST/ALT	O	O	B-T201
was	O	O	O
revealed	O	O	O
as	O	O	O
an	O	O	O
independent	O	O	B-T078
predictor	O	O	I-T078
of	O	O	O
PFS	O	O	B-T081
(	O	O	O
HR	O	O	B-T081
,	O	O	O
2.335	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
1.633	O	O	O
-	O	O	O
3.340	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
,	O	O	O
CSS	O	O	B-T081
(	O	O	O
HR	O	O	O
,	O	O	O
2.550	O	O	O
;	O	O	O
1.689	O	O	O
-	O	O	O
3.851	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
HR	O	O	O
,	O	O	O
2.069	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.409	O	O	O
-	O	O	O
3.038	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
.	O	O	O

Elevated	O	O	O
preoperative	O	O	B-T079
AST/ALT	O	O	B-T201
was	O	O	O
a	O	O	O
significant	O	O	B-T078
predictor	O	O	I-T078
of	O	O	O
worse	O	O	B-T033
postoperative	O	O	B-T079
survival	O	O	B-T052
in	O	O	O
patients	O	O	B-T101
surgically	O	O	B-T061
treated	O	O	I-T061
for	O	O	O
UTUC	O	O	B-T191
.	O	O	O

Further	O	O	O
large	O	O	O
prospective	O	O	B-T062
studies	O	O	I-T062
are	O	O	O
needed	O	O	O
for	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
prognostic	O	O	B-T170
value	O	O	I-T170
of	O	O	O
preoperative	O	O	B-T079
AST/ALT	O	O	B-T201
.	O	O	O

-DOCSTART- (27693948)

Molecular	O	O	B-T066
simulation	O	O	I-T066
study	O	O	B-T062
on	O	O	O
concentration	O	O	B-T081
effects	O	O	B-T080
of	O	O	I-T080
rofecoxib	O	O	B-T109
with	O	O	O
POPC	O	O	B-T109
bilayer	O	O	O

The	O	O	O
interactions	O	O	B-T044
between	O	O	O
rofecoxib	O	O	B-T109
and	O	O	O
POPC	O	O	B-T109
(	O	O	B-T109
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine	O	O	I-T109
)	O	O	I-T109
bilayer	O	O	B-T026
were	O	O	O
studied	O	O	B-T062
using	O	O	B-T169
all-atom	O	O	B-T066
molecular	O	O	I-T066
dynamics	O	O	I-T066
simulation	O	O	I-T066
method	O	O	B-T170
.	O	O	O

Four	O	O	O
POPC	O	O	B-T109
bilayer	O	O	B-T026
systems	O	O	B-T169
with	O	O	O
different	O	O	B-T080
number	O	O	B-T081
of	O	O	O
rofecoxib	O	O	B-T109
molecules	O	O	B-T167
were	O	O	O
constructed	O	O	B-T169
to	O	O	O
simulate	O	O	B-T080
different	O	O	O
drug	O	O	B-T121
concentration	O	O	B-T081
.	O	O	O

The	O	O	O
free	O	O	B-T070
energy	O	O	I-T070
of	O	O	O
rofecoxib	O	O	B-T109
passing	O	O	B-T077
across	O	O	O
pure	O	O	B-T080
POPC	O	O	B-T109
bilayer	O	O	B-T026
has	O	O	O
two	O	O	O
minima	O	O	B-T080
(	O	O	O
at	O	O	O
z	O	O	O
∼1.2	O	O	O
nm	O	O	O
or	O	O	O
1.6	O	O	O
nm	O	O	O
)	O	O	O
.	O	O	O

As	O	O	O
for	O	O	O
the	O	O	O
high	O	O	B-T080
concentration	O	O	B-T081
model	O	O	B-T170
,	O	O	O
the	O	O	O
minimum	O	O	B-T080
of	O	O	O
the	O	O	O
free	O	O	B-T070
energy	O	O	I-T070
profile	O	O	O
slightly	O	O	O
shifts	O	O	O
to	O	O	O
the	O	O	O
bilayer	O	O	B-T026
center	O	O	B-T082
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
energy	O	O	B-UnknownType
change	O	O	I-UnknownType
from	O	O	O
bulk	O	O	B-T121
water	O	O	I-T121
to	O	O	O
POPC	O	O	B-T109
bilayer	O	O	B-T026
increases	O	O	B-T169
while	O	O	O
the	O	O	O
central	O	O	B-T082
barrier	O	O	B-T046
to	O	O	O
cross	O	O	B-T077
the	O	O	O
hydrophobic	O	O	B-T120
core	O	O	I-T120
of	O	O	O
bilayer	O	O	O
slightly	O	O	B-T080
decreases	O	O	B-T081
,	O	O	O
suggesting	O	O	B-T078
that	O	O	O
increasing	O	O	B-T169
drug	O	O	B-T121
concentration	O	O	B-T081
makes	O	O	O
it	O	O	O
favorable	O	O	B-T033
for	O	O	O
rofecoxib	O	O	B-T109
to	O	O	O
partition	O	O	B-T169
into	O	O	O
the	O	O	O
bilayer	O	O	O
and	O	O	O
easier	O	O	O
to	O	O	O
pass	O	O	B-T077
across	O	O	O
bialyer	O	O	B-T026
center	O	O	B-T082
.	O	O	O

Energy	O	O	B-T081
analysis	O	O	B-T062
show	O	O	O
that	O	O	O
the	O	O	O
stabilization	O	O	B-T080
between	O	O	O
the	O	O	O
selected	O	O	B-T052
rofecoxib	O	O	B-T109
and	O	O	O
other	O	O	O
pre-inserted	O	O	B-T169
rofecoxib	O	O	O
molecule	O	O	B-T167
is	O	O	O
mainly	O	O	O
due	O	O	O
to	O	O	O
van	O	O	B-T067
der	O	O	I-T067
Waals	O	O	I-T067
interaction	O	O	I-T067
energy	O	O	B-T081
.	O	O	O

The	O	O	O
predicted	O	O	B-T078
permeability	O	O	B-T070
of	O	O	O
rofecoxib	O	O	B-T109
in	O	O	O
high	O	O	B-T080
concentration	O	O	B-T081
model	O	O	B-T170
slightly	O	O	O
weakens	O	O	B-T080
as	O	O	O
compared	O	O	B-T052
with	O	O	O
low	O	O	B-T080
concentration	O	O	O
model	O	O	O
.	O	O	O

-DOCSTART- (27694392)

Short-term	O	O	B-T077
Variability	O	O	I-T077
of	O	O	O
Vitamin	O	O	B-T127
D	O	O	I-T127
-Related	O	O	O
Biomarkers	O	O	O

Quantifying	O	O	B-T081
the	O	O	O
variability	O	O	B-T077
of	O	O	O
biomarkers	O	O	B-T201
is	O	O	O
important	O	O	B-T080
,	O	O	O
as	O	O	O
high	O	O	O
within-person	O	O	O
variability	O	O	O
can	O	O	O
lead	O	O	O
to	O	O	O
misclassification	O	O	B-T185
of	O	O	O
individuals	O	O	B-T098
.	O	O	O

Short-term	O	O	O
variability	O	O	B-T077
of	O	O	O
important	O	O	B-T080
markers	O	O	B-T201
of	O	O	O
vitamin	O	O	B-T044
D	O	O	I-T044
metabolism	O	O	I-T044
is	O	O	O
relatively	O	O	O
unknown	O	O	O
.	O	O	O

A	O	O	O
repeatability	O	O	B-T062
study	O	O	I-T062
was	O	O	O
conducted	O	O	O
in	O	O	O
160	O	O	O
Atherosclerosis	O	O	B-T047
Risk	O	O	B-T078
in	O	O	O
Communities	O	O	B-T098
study	O	O	I-T098
participants	O	O	I-T098
(	O	O	O
60	O	O	O
%	O	O	O
female	O	O	B-T032
,	O	O	O
28	O	O	O
%	O	O	O
black	O	O	B-T098
,	O	O	O
mean	O	O	O
age	O	O	B-T032
76	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

Fasting	O	O	B-T033
serum	O	O	B-T031
was	O	O	O
drawn	O	O	O
at	O	O	O
2	O	O	O
time	O	O	O
points	O	O	O
,	O	O	O
a	O	O	O
median	O	O	O
of	O	O	O
6	O	O	O
(	O	O	O
range	O	O	O
3	O	O	O
-	O	O	O
13	O	O	O
)	O	O	O
weeks	O	O	B-T079
apart	O	O	O
.	O	O	O

Vitamin	O	O	B-T116
D	O	O	I-T116
binding	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
VDBP	O	O	B-T116
)	O	O	O
and	O	O	O
25-hydroxyvitamin	O	O	B-T127
D	O	O	I-T127
[	O	O	O
25(OH)D	O	O	B-T127
]	O	O	O
were	O	O	O
measured	O	O	B-T080
by	O	O	O
LC-MS	O	O	B-T059
,	O	O	O
fibroblast	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
(	O	O	O
FGF23	O	O	B-T116
)	O	O	O
and	O	O	O
parathyroid	O	O	B-T116
hormone	O	O	I-T116
(	O	O	O
PTH	O	O	B-T116
)	O	O	O
by	O	O	O
enzyme-linked	O	O	B-T059
immunoassay	O	O	I-T059
,	O	O	O
and	O	O	O
calcium	O	O	B-T121
and	O	O	O
phosphorus	O	O	B-T196
by	O	O	O
Roche	O	O	B-T059
Cobas	O	O	I-T059
6000	O	O	I-T059
.	O	O	O

Free	O	O	B-T080
and	O	O	O
bioavailable	O	O	B-T080
25(OH)D	O	O	B-T127
were	O	O	O
calculated	O	O	B-T052
.	O	O	O

We	O	O	O
calculated	O	O	B-T052
the	O	O	O
within-person	O	O	B-T081
CV	O	O	I-T081
(	O	O	O
CVW	O	O	B-T081
)	O	O	O
,	O	O	O
intraclass	O	O	B-T081
correlation	O	O	I-T081
coefficient	O	O	I-T081
(	O	O	O
ICC	O	O	B-T081
)	O	O	O
,	O	O	O
Spearman	O	O	B-T081
rank	O	O	I-T081
correlation	O	O	I-T081
coefficient	O	O	I-T081
(	O	O	O
r	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
percent	O	O	B-T081
reclassified	O	O	B-T080
.	O	O	O

The	O	O	O
CVW	O	O	B-T081
was	O	O	O
lowest	O	O	B-T080
for	O	O	O
calcium	O	O	B-T121
(	O	O	O
2.0	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
albumin	O	O	B-T116
(	O	O	O
3.6	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
25(OH)D	O	O	B-T127
(	O	O	O
6.9	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
VDBP	O	O	B-T116
(	O	O	O
7.0	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
phosphorus	O	O	B-T196
(	O	O	O
7.6	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
intermediate	O	O	B-T034
for	O	O	O
free	O	O	B-T080
25(OH)D	O	O	O
(	O	O	O
9.0	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
bioavailable	O	O	B-T080
25(OH)D	O	O	O
(	O	O	O
9.9	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
and	O	O	O
highest	O	O	B-T080
for	O	O	O
PTH	O	O	B-T116
(	O	O	O
16.7	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
FGF23	O	O	B-T116
(	O	O	O
17.8	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Reclassification	O	O	B-T185
was	O	O	O
highest	O	O	B-T080
for	O	O	O
PTH	O	O	B-T116
,	O	O	O
VDBP	O	O	B-T116
,	O	O	O
and	O	O	O
phosphorus	O	O	B-T196
(	O	O	O
all	O	O	O
7.5	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
ICC	O	O	B-T081
and	O	O	O
r	O	O	B-T081
were	O	O	O
highest	O	O	B-T080
(	O	O	O
≥0.80	O	O	O
)	O	O	O
for	O	O	O
25(OH)D	O	O	B-T127
,	O	O	O
free	O	O	B-T080
25(OH)D	O	O	O
,	O	O	O
bioavailable	O	O	B-T080
25(OH)D	O	O	O
and	O	O	O
PTH	O	O	B-T116
,	O	O	O
but	O	O	O
somewhat	O	O	O
lower	O	O	B-T080
(	O	O	O
approximately	O	O	B-T080
0.60	O	O	O
-	O	O	O
0.75	O	O	O
)	O	O	O
for	O	O	O
the	O	O	O
other	O	O	O
biomarkers	O	O	B-T201
.	O	O	O

Six-	O	O	O
week	O	O	B-T079
short-term	O	O	B-T077
variability	O	O	I-T077
,	O	O	O
as	O	O	O
assessed	O	O	B-T052
by	O	O	O
CVW	O	O	B-T081
,	O	O	O
was	O	O	O
quite	O	O	B-T080
low	O	O	I-T080
for	O	O	O
VDBP	O	O	B-T116
,	O	O	O
calcium	O	O	B-T121
and	O	O	O
phosphorus	O	O	B-T196
,	O	O	O
but	O	O	O
fairly	O	O	B-T080
high	O	O	I-T080
for	O	O	O
FGF23	O	O	B-T116
and	O	O	O
PTH	O	O	B-T116
.	O	O	O

As	O	O	O
such	O	O	O
,	O	O	O
multiple	O	O	B-T169
measurements	O	O	I-T169
of	O	O	O
FGF23	O	O	B-T116
and	O	O	O
PTH	O	O	B-T116
may	O	O	O
be	O	O	O
needed	O	O	O
to	O	O	O
minimize	O	O	B-T080
misclassification	O	O	B-T185
.	O	O	O

These	O	O	O
results	O	O	B-T169
provide	O	O	O
insight	O	O	B-T041
into	O	O	O
the	O	O	O
extent	O	O	O
of	O	O	O
potential	O	O	B-T080
misclassification	O	O	B-T185
of	O	O	O
vitamin	O	O	B-T127
D	O	O	I-T127
markers	O	O	B-T201
in	O	O	O
research	O	O	B-T062
and	O	O	O
clinical	O	O	B-T169
settings	O	O	I-T169
.	O	O	O

-DOCSTART- (27695327)

Fabrication	O	O	B-T067
of	O	O	O
gelatin	O	O	B-T109
methacrylate	O	O	I-T109
/	O	O	O
nanohydroxyapatite	O	O	B-T197
microgel	O	O	B-T122
arrays	O	O	B-T082
for	O	O	O
periodontal	O	O	O
tissue	O	O	O
regeneration	O	O	O

Periodontitis	O	O	B-T047
is	O	O	O
a	O	O	O
chronic	O	O	B-T047
infectious	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
is	O	O	O
the	O	O	O
major	O	O	B-T033
cause	O	O	I-T033
of	O	O	O
tooth	O	O	B-T020
loss	O	O	I-T020
and	O	O	O
other	O	O	O
oral	O	O	B-T058
health	O	O	I-T058
issues	O	O	B-T033
around	O	O	O
the	O	O	O
world	O	O	B-T098
.	O	O	O

Periodontal	O	O	B-T061
tissue	O	O	I-T061
regeneration	O	O	I-T061
has	O	O	O
therefore	O	O	O
always	O	O	O
been	O	O	O
the	O	O	O
ultimate	O	O	B-T170
goal	O	O	I-T170
of	O	O	O
dentists	O	O	B-T097
and	O	O	O
researchers	O	O	B-T097
.	O	O	O

Existing	O	O	O
fabrication	O	O	B-T067
methods	O	O	B-T170
mainly	O	O	O
focused	O	O	B-T169
on	O	O	O
a	O	O	O
top-down	O	O	B-T061
tissue	O	O	I-T061
engineering	O	O	I-T061
strategy	O	O	B-T041
in	O	O	O
which	O	O	O
several	O	O	O
drawbacks	O	O	B-T080
remain	O	O	B-T033
,	O	O	O
including	O	O	O
low	O	O	B-T080
throughput	O	O	I-T080
and	O	O	O
limited	O	O	O
diffusion	O	O	B-T070
properties	O	O	B-T080
resulting	O	O	B-T169
from	O	O	O
a	O	O	O
large	O	O	B-T081
sample	O	O	I-T081
size	O	O	I-T081
.	O	O	O

Gelatin	O	O	B-T109
methacrylate	O	O	I-T109
(	O	O	O
GelMA	O	O	B-T109
)	O	O	O
is	O	O	O
a	O	O	O
kind	O	O	O
of	O	O	O
photocrosslinkable	O	O	B-T070
and	O	O	O
biocompatible	O	O	B-T122
hydrogel	O	O	B-T109
,	O	O	O
with	O	O	O
the	O	O	O
capacities	O	O	B-T081
of	O	O	O
enabling	O	O	B-T041
cell	O	O	B-T059
encapsulation	O	O	I-T059
and	O	O	O
regeneration	O	O	B-T042
of	O	O	I-T042
functional	O	O	I-T042
tissues	O	O	I-T042
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
developed	O	O	O
a	O	O	O
novel	O	O	B-T080
method	O	O	B-T169
to	O	O	O
fabricate	O	O	B-T067
GelMA	O	O	B-T109
/	O	O	O
nanohydroxylapatite	O	O	B-T197
(	O	O	O
nHA	O	O	B-T197
)	O	O	O
microgel	O	O	B-T122
arrays	O	O	B-T082
using	O	O	O
a	O	O	O
photocrosslinkable	O	O	B-T070
strategy	O	O	B-T041
.	O	O	O

The	O	O	O
viability	O	O	B-T043
,	O	O	O
proliferation	O	O	B-T043
,	O	O	O
and	O	O	O
osteogenic	O	O	B-T043
differentiation	O	O	I-T043
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
osteogenesis	O	O	B-T042
of	O	O	O
human	O	O	B-T016
periodontal	O	O	B-T023
ligament	O	O	I-T023
stem	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
hPDLSCs	O	O	B-T025
)	O	O	O
encapsulated	O	O	B-T080
in	O	O	O
microgels	O	O	B-T122
were	O	O	O
evaluated	O	O	B-T058
.	O	O	O

The	O	O	O
results	O	O	B-T169
suggested	O	O	B-T078
that	O	O	O
such	O	O	O
microgels	O	O	B-T122
provide	O	O	B-T052
great	O	O	O
potential	O	O	B-T080
for	O	O	O
periodontal	O	O	B-T061
tissue	O	O	I-T061
repair	O	O	I-T061
and	O	O	I-T061
regeneration	O	O	I-T061
.	O	O	O

Microgel	O	O	B-T122
arrays	O	O	B-T082
were	O	O	O
fabricated	O	O	B-T067
by	O	O	O
blending	O	O	B-T068
different	O	O	B-T080
weight	O	O	B-T081
ratios	O	O	I-T081
of	O	O	O
GelMA	O	O	B-T109
and	O	O	O
nHA	O	O	B-T197
.	O	O	O

hPDLSCs	O	O	B-T025
were	O	O	O
encapsulated	O	O	B-T080
in	O	O	O
GelMA	O	O	B-T109
/	O	O	O
nHA	O	O	B-T197
microgels	O	O	B-T122
of	O	O	O
various	O	O	O
ratios	O	O	B-T081
for	O	O	O
a	O	O	O
systematic	O	O	B-T169
evaluation	O	O	B-T058
of	O	O	O
cell	O	O	B-T043
viability	O	O	I-T043
,	O	O	O
proliferation	O	O	B-T043
,	O	O	O
and	O	O	O
osteogenic	O	O	B-T043
differentiation	O	O	I-T043
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
osteogenesis	O	O	B-T042
in	O	O	O
nude	O	O	B-T015
mice	O	O	I-T015
was	O	O	O
also	O	O	O
studied	O	O	O
.	O	O	O

The	O	O	O
GelMA	O	O	B-T109
/	O	O	O
nHA	O	O	B-T197
microgels	O	O	B-T122
exhibited	O	O	O
appropriate	O	O	B-T080
microarchitecture	O	O	B-T080
,	O	O	O
mechanical	O	O	B-T078
strength	O	O	I-T078
,	O	O	O
and	O	O	O
surface	O	O	B-T082
roughness	O	O	B-T080
,	O	O	O
thus	O	O	O
enabling	O	O	O
cell	O	O	B-T043
adhesion	O	O	I-T043
and	O	O	O
proliferation	O	O	B-T043
.	O	O	O

Additionally	O	O	O
,	O	O	O
the	O	O	O
GelMA	O	O	B-T109
/	O	O	O
nHA	O	O	B-T197
microgels	O	O	B-T122
(	O	O	O
10%/2	O	O	O
%	O	O	O
w/v	O	O	O
)	O	O	O
enhanced	O	O	B-T052
the	O	O	O
osteogenic	O	O	B-T043
differentiation	O	O	I-T043
of	O	O	O
hPDLSCs	O	O	B-T025
by	O	O	O
elevating	O	O	B-T080
the	O	O	O
expression	O	O	B-T081
levels	O	O	I-T081
of	O	O	O
osteogenic	O	O	B-T201
biomarker	O	O	I-T201
genes	O	O	B-T028
,	O	O	O
such	O	O	O
as	O	O	O
ALP	O	O	B-T028
,	O	O	O
BSP	O	O	B-T028
,	O	O	O
OCN	O	O	B-T028
,	O	O	O
and	O	O	O
RUNX2	O	O	B-T028
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
ectopic	O	O	B-T082
transplantation	O	O	B-T061
results	O	O	B-T169
showed	O	O	O
that	O	O	O
GelMA	O	O	B-T109
/	O	O	O
nHA	O	O	B-T197
microgels	O	O	B-T122
(	O	O	O
10%/2	O	O	O
%	O	O	O
w/v	O	O	O
)	O	O	O
increased	O	O	B-T081
mineralized	O	O	B-T024
tissue	O	O	I-T024
formation	O	O	B-T169
with	O	O	O
abundant	O	O	B-T080
vascularization	O	O	B-T169
,	O	O	O
compared	O	O	B-T052
with	O	O	O
the	O	O	O
1	O	O	O
%	O	O	O
,	O	O	O
3	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
pure	O	O	O
GelMA	O	O	B-T109
group	O	O	I-T109
.	O	O	O

The	O	O	O
GelMA	O	O	B-T109
/	O	O	O
nHA	O	O	B-T197
microgels	O	O	B-T122
(	O	O	O
10%/2	O	O	O
%	O	O	O
w/v	O	O	O
)	O	O	O
facilitated	O	O	O
hPDLSCs	O	O	B-T025
viability	O	O	B-T043
,	O	O	O
proliferation	O	O	B-T043
,	O	O	O
and	O	O	O
osteogenic	O	O	B-T043
differentiation	O	O	I-T043
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
further	O	O	B-T082
promoted	O	O	B-T052
new	O	O	B-T080
bone	O	O	B-T042
formation	O	O	I-T042
in	O	O	B-T082
vivo	O	O	I-T082
,	O	O	O
suggesting	O	O	O
that	O	O	O
the	O	O	O
GelMA	O	O	O
/	O	O	O
nHA	O	O	O
microgels	O	O	O
(	O	O	O
10%/2	O	O	O
%	O	O	O
w/v	O	O	O
)	O	O	O
provide	O	O	B-T052
great	O	O	O
potential	O	O	B-T080
for	O	O	O
periodontal	O	O	B-T061
tissue	O	O	I-T061
regeneration	O	O	I-T061
.	O	O	O

-DOCSTART- (27698544)

Esomeprazole	O	O	B-T109
-	O	O	O
or	O	O	O
rabeprazole	O	O	B-T109
-based	O	O	O
triple	O	O	B-T081
therapy	O	O	B-T061
eradicated	O	O	O
Helicobacter	O	O	B-T007
pylori	O	O	I-T007
comparably	O	O	O
regardless	O	O	B-T080
of	O	O	O
clarithromycin	O	O	B-T195
susceptibility	O	O	B-T169
and	O	O	O
CYP2C19	O	O	B-T028
genotypes	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
assess	O	O	B-T052
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
esomeprazole	O	O	B-T109
-based	O	O	O
triple	O	O	B-T081
therapy	O	O	B-T061
compared	O	O	B-T052
with	O	O	O
rabeprazole	O	O	B-T109
-based	O	O	O
triple	O	O	O
therapy	O	O	O
according	O	O	O
to	O	O	O
CYP2C19	O	O	B-T028
genotype	O	O	B-T032
and	O	O	O
clarithromycin	O	O	B-T195
susceptibility	O	O	B-T169
status	O	O	B-T080
for	O	O	O
first-line	O	O	O
eradication	O	O	B-T061
therapy	O	O	I-T061
of	O	O	I-T061
Helicobacter	O	O	I-T061
pylori	O	O	I-T061
(	O	O	O
H.	O	O	B-T007
pylori	O	O	I-T007
)	O	O	O
in	O	O	O
Japan	O	O	B-T083
.	O	O	O

We	O	O	O
enrolled	O	O	O
219	O	O	O
H.	O	O	B-T007
pylori	O	O	I-T007
-	O	O	O
infected	O	O	B-T101
patients	O	O	B-T101
,	O	O	O
and	O	O	O
randomly	O	O	B-T080
allocated	O	O	B-T052
patients	O	O	O
to	O	O	O
the	O	O	O
EAC	O	O	B-T101
group	O	O	I-T101
(	O	O	O
esomeprazole	O	O	B-T109
20	O	O	O
mg	O	O	O
,	O	O	O
clarithromycin	O	O	B-T195
200	O	O	O
mg	O	O	O
,	O	O	O
amoxicillin	O	O	B-T195
750	O	O	O
mg	O	O	O
for	O	O	O
one	O	O	O
week	O	O	B-T079
,	O	O	O
with	O	O	O
all	O	O	O
drugs	O	O	B-T121
given	O	O	B-T169
twice	O	O	B-T079
daily	O	O	I-T079
)	O	O	O
or	O	O	O
RAC	O	O	B-T101
group	O	O	I-T101
(	O	O	O
rabeprazole	O	O	B-T109
10	O	O	O
mg	O	O	O
,	O	O	O
clarithromycin	O	O	O
200	O	O	O
mg	O	O	O
,	O	O	O
amoxicillin	O	O	O
750	O	O	O
mg	O	O	O
for	O	O	O
one	O	O	O
week	O	O	O
,	O	O	O
with	O	O	O
all	O	O	O
drugs	O	O	O
given	O	O	O
twice	O	O	O
daily	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
H.	O	O	B-T007
pylori	O	O	I-T007
eradication	O	O	B-T081
rate	O	O	I-T081
according	O	O	O
to	O	O	O
the	O	O	O
PP	O	O	B-T062
analyses	O	O	I-T062
was	O	O	O
75.0	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
65.2	O	O	O
-	O	O	O
82.8	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
EAC	O	O	B-T101
group	O	O	I-T101
and	O	O	O
71.4	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
61.4	O	O	O
-	O	O	O
79.1	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
RAC	O	O	B-T101
group	O	O	I-T101
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
statistically	O	O	O
significant	O	O	O
differences	O	O	B-T080
.	O	O	O

The	O	O	O
eradication	O	O	B-T081
rates	O	O	I-T081
of	O	O	O
the	O	O	O
clarithromycin	O	O	B-T195
-resistant	O	O	O
/-	O	O	O

sensitive	O	O	B-T169
strains	O	O	B-T007
were	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
45.0	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
30.7	O	O	O
-	O	O	O
60.2%)/98.0	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
88.7	O	O	O
-	O	O	O
100	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
EAC	O	O	B-T101
group	O	O	I-T101
and	O	O	O
39.5	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
25.6	O	O	O
-	O	O	O
55.3%)/93.5	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
81.9	O	O	O
-	O	O	O
98.4	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
RAC	O	O	B-T101
group	O	O	I-T101
.	O	O	O

The	O	O	O
eradication	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
the	O	O	O
clarithromycin	O	O	B-T195
-	O	O	O
sensitive	O	O	B-T169
strains	O	O	B-T007
was	O	O	O
significantly	O	O	O
higher	O	O	B-T080
than	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
resistant	O	O	B-T046
strains	O	O	I-T046
in	O	O	O
both	O	O	B-T080
groups	O	O	B-T078
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
EAC	O	O	B-T101
and	O	O	O
RAC	O	O	B-T101
therapies	O	O	B-T061
show	O	O	O
a	O	O	O
comparable	O	O	O
efficacy	O	O	B-T080
regardless	O	O	B-T080
of	O	O	O
the	O	O	O
CYP2C19	O	O	B-T028
genotype	O	O	B-T032
and	O	O	O
clarithromycin	O	O	B-T195
susceptibility	O	O	B-T169
status	O	O	B-T080
in	O	O	O
Japan	O	O	B-T083
.	O	O	O

-DOCSTART- (27698942)

Optimization	O	O	O
of	O	O	O
Early	O	O	B-T079
Response	O	O	B-T058
Monitoring	O	O	I-T058
and	O	O	O
Prediction	O	O	O
of	O	O	O
Cancer	O	O	B-T191
Antiangiogenesis	O	O	B-T061
Therapy	O	O	I-T061
via	O	O	O
Noninvasive	O	O	B-T185
PET	O	O	B-T060
Molecular	O	O	I-T060
Imaging	O	O	I-T060
Strategies	O	O	O
of	O	O	O
Multifactorial	O	O	B-T033
Bioparameters	O	O	O

Objective	O	O	O
:	O	O	O
Antiangiogenesis	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
AAT	O	O	B-T061
)	O	O	O
has	O	O	O
provided	O	O	O
substantial	O	O	O
benefits	O	O	O
regarding	O	O	O
improved	O	O	O
outcomes	O	O	O
and	O	O	O
survival	O	O	B-T052
for	O	O	O
suitable	O	O	O
patients	O	O	B-T101
in	O	O	O
clinical	O	O	B-T082
settings	O	O	I-T082
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
early	O	O	B-T079
definition	O	O	O
of	O	O	O
therapeutic	O	O	B-T201
effects	O	O	I-T201
is	O	O	O
urgently	O	O	O
needed	O	O	O
to	O	O	O
guide	O	O	O
cancer	O	O	B-T191
AAT	O	O	B-T061
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
optimize	O	O	O
the	O	O	O
early	O	O	B-T079
response	O	O	B-T058
monitoring	O	O	I-T058
and	O	O	O
prediction	O	O	O
of	O	O	O
AAT	O	O	B-T061
efficacy	O	O	B-T080
,	O	O	O
as	O	O	O
indicated	O	O	O
by	O	O	O
the	O	O	O
multi-targeted	O	O	O
anti-angiogenic	O	O	B-T121
drug	O	O	I-T121
sunitinib	O	O	B-T109
in	O	O	O
U87MG	O	O	B-T191
tumors	O	O	I-T191
,	O	O	O
using	O	O	O
noninvasive	O	O	B-T185
positron	O	O	B-T060
emission	O	O	I-T060
computed	O	O	I-T060
tomography	O	O	I-T060
(	O	O	I-T060
PET	O	O	I-T060
)	O	O	I-T060
molecular	O	O	I-T060
imaging	O	O	I-T060
strategies	O	O	O
of	O	O	O
multifactorial	O	O	B-T033
bioparameters	O	O	B-T077
.	O	O	O

Methods	O	O	O
:	O	O	O
U87MG	O	O	B-T191
tumor	O	O	I-T191
mice	O	O	B-T015
were	O	O	O
treated	O	O	O
via	O	O	O
intragastric	O	O	B-T082
injections	O	O	B-T061
of	O	O	O
sunitinib	O	O	B-T109
(	O	O	O
80	O	O	O
mg/kg	O	O	O
)	O	O	O
or	O	O	O
vehicle	O	O	B-T122
for	O	O	O
7	O	O	O
consecutive	O	O	O
days	O	O	O
.	O	O	O

Longitudinal	O	O	B-T082
MicroPET/CT	O	O	B-T060
scans	O	O	I-T060
with	O	O	O
(18)F-FDG	O	O	B-T109
,	O	O	O
(18)F-FMISO	O	O	B-T109
,	O	O	I-T109
(18)F-ML-10	O	O	B-T109
and	O	O	O
(18)F-Alfatide	O	O	B-T116
II	O	O	I-T116
were	O	O	O
acquired	O	O	O
to	O	O	O
quantitatively	O	O	O
measure	O	O	O
metabolism	O	O	B-T040
,	O	O	O
hypoxia	O	O	B-T046
,	O	O	O
apoptosis	O	O	B-T043
and	O	O	O
angiogenesis	O	O	B-T191
on	O	O	O
days	O	O	O
0	O	O	O
,	O	O	O
1	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
7	O	O	O
and	O	O	O
13	O	O	O
following	O	O	O
therapy	O	O	B-T061
initiation	O	O	O
.	O	O	O

Tumor	O	O	B-T024
tissues	O	O	I-T024
from	O	O	O
a	O	O	O
dedicated	O	O	O
group	O	O	O
of	O	O	O
mice	O	O	B-T015
were	O	O	O
collected	O	O	O
for	O	O	O
immunohistochemical	O	O	B-T059
(	O	O	O
IHC	O	O	B-T059
)	O	O	O
analysis	O	O	O
of	O	O	O
key	O	O	O
biomarkers	O	O	B-T123
(	O	O	O
Glut-1	O	O	B-T116
,	O	O	O
CA-IX	O	O	B-T116
,	O	O	O
TUNEL	O	O	B-T063
,	O	O	O
ανβ3	O	O	B-T116
and	O	O	O
CD31	O	O	B-T116
)	O	O	O
at	O	O	O
the	O	O	O
time	O	O	O
points	O	O	O
of	O	O	O
PET	O	O	B-T060
imaging	O	O	I-T060
.	O	O	O

The	O	O	O
tumor	O	O	B-T082
sizes	O	O	I-T082
and	O	O	O
mouse	O	O	B-T015
weights	O	O	B-T032
were	O	O	O
measured	O	O	O
throughout	O	O	O
the	O	O	O
study	O	O	O
.	O	O	O

The	O	O	O
tumor	O	O	B-T191
uptake	O	O	B-T039
(	O	O	O
ID%/gmax	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
ratios	O	O	B-T081
of	O	O	O
the	O	O	O
tumor	O	O	O
/	O	O	O
muscle	O	O	B-T024
(	O	O	O
T	O	O	B-T191
/	O	O	O
M	O	O	B-T024
)	O	O	O
for	O	O	O
each	O	O	O
probe	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
ratios	O	O	O
(	O	O	O
TGR	O	O	B-T081
)	O	O	O
were	O	O	O
calculated	O	O	O
and	O	O	O
used	O	O	O
for	O	O	O
statistical	O	O	B-T062
analyses	O	O	I-T062
of	O	O	O
the	O	O	O
differences	O	O	O
and	O	O	O
correlations	O	O	O
.	O	O	O

Results	O	O	O
:	O	O	O
Sunitinib	O	O	B-T109
successfully	O	O	O
inhibited	O	O	O
U87MG	O	O	B-T191
tumor	O	O	I-T191
growth	O	O	I-T191
with	O	O	O
significant	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
tumor	O	O	B-T082
size	O	O	I-T082
from	O	O	O
day	O	O	O
9	O	O	O
after	O	O	O
sunitinib	O	O	B-T109
treatment	O	O	B-T061
compared	O	O	O
with	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
uptakes	O	O	B-T039
of	O	O	O
(18)F-FMISO	O	O	B-T109
(	O	O	O
reduced	O	O	O
hypoxia	O	O	B-T046
)	O	O	O
,	O	O	O
(18)F-ML-10	O	O	B-T109
(	O	O	O
increased	O	O	O
apoptosis	O	O	B-T043
)	O	O	O
and	O	O	O
(18)F-Alfatide	O	O	B-T116
II	O	O	I-T116
(	O	O	O
decreased	O	O	O
angiogenesis	O	O	B-T191
)	O	O	O
in	O	O	O
the	O	O	O
tumor	O	O	B-T191
lesions	O	O	B-T033
significantly	O	O	O
changed	O	O	O
during	O	O	O
the	O	O	O
early	O	O	B-T079
stage	O	O	O
(	O	O	O
days	O	O	O
1	O	O	O
to	O	O	O
3	O	O	O
)	O	O	O
of	O	O	O
sunitinib	O	O	B-T109
treatment	O	O	B-T061
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
uptake	O	O	B-T039
of	O	O	O
(18)F-FDG	O	O	B-T109
(	O	O	O
increased	O	O	O
glucose	O	O	B-T044
metabolism	O	O	I-T044
)	O	O	O
was	O	O	O
significantly	O	O	O
different	O	O	O
during	O	O	O
the	O	O	O
late	O	O	B-T079
stage	O	O	I-T079
.	O	O	O

The	O	O	O
PET	O	O	B-T060
imaging	O	O	I-T060
data	O	O	O
of	O	O	O
each	O	O	O
probe	O	O	O
were	O	O	O
all	O	O	O
confirmed	O	O	O
via	O	O	O
ex	O	O	B-T169
vivo	O	O	I-T169
IHC	O	O	B-T059
of	O	O	O
the	O	O	O
relevant	O	O	O
biomarkers	O	O	B-T123
.	O	O	O

Notably	O	O	O
,	O	O	O
the	O	O	O
PET	O	O	B-T060
imaging	O	O	I-T060
of	O	O	O
(18)F-Alfatide	O	O	B-T116
II	O	O	I-T116
and	O	O	O
(18)F-FMISO	O	O	B-T109
was	O	O	O
significantly	O	O	O
correlated	O	O	O
(	O	O	O
all	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
with	O	O	O
TGR	O	O	B-T081
,	O	O	O
whereas	O	O	O
the	O	O	O
imaging	O	O	O
of	O	O	O
(18)F-FDG	O	O	B-T109
and	O	O	O
(18)F-ML-10	O	O	B-T109
was	O	O	O
not	O	O	O
significantly	O	O	O
correlated	O	O	O
with	O	O	O
TGR	O	O	O
.	O	O	O

Conclusion	O	O	O
:	O	O	O
Based	O	O	O
on	O	O	O
the	O	O	O
tumor	O	O	B-T191
uptake	O	O	B-T039
of	O	O	O
the	O	O	O
PET	O	O	B-T060
probes	O	O	O
and	O	O	O
their	O	O	O
correlations	O	O	O
with	O	O	O
MVD	O	O	B-T080
and	O	O	O
TGR	O	O	B-T081
,	O	O	O
(18)F-Alfatide	O	O	B-T116
II	O	O	I-T116
PET	O	O	O
may	O	O	O
not	O	O	O
only	O	O	O
monitor	O	O	O
the	O	O	O
early	O	O	B-T079
response	O	O	B-T058
but	O	O	O
also	O	O	O
precisely	O	O	O
predict	O	O	O
the	O	O	O
therapeutic	O	O	B-T080
efficacy	O	O	I-T080
of	O	O	O
the	O	O	O
multi-targeted	O	O	O
,	O	O	O
anti-angiogenic	O	O	B-T121
drug	O	O	I-T121
sunitinib	O	O	B-T109
in	O	O	O
U87MG	O	O	B-T191
tumors	O	O	I-T191
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
feasible	O	O	O
to	O	O	O
optimize	O	O	O
the	O	O	O
early	O	O	B-T079
response	O	O	B-T058
monitoring	O	O	I-T058
and	O	O	O
efficacy	O	O	B-T080
prediction	O	O	O
of	O	O	O
cancer	O	O	B-T191
AAT	O	O	B-T061
using	O	O	O
noninvasive	O	O	B-T185
PET	O	O	B-T060
molecular	O	O	I-T060
imaging	O	O	B-T060
strategies	O	O	O
of	O	O	O
multifactorial	O	O	B-T033
bioparameters	O	O	B-T077
,	O	O	O
such	O	O	O
as	O	O	O
angiogenesis	O	O	B-T191
imaging	O	O	O
with	O	O	O
(18)F-Alfatide	O	O	B-T116
II	O	O	I-T116
,	O	O	O
which	O	O	O
represents	O	O	O
an	O	O	O
RGD	O	O	B-T116
-based	O	O	O
probe	O	O	O
.	O	O	O

-DOCSTART- (27704589)

Identifying	O	O	O
research	O	O	B-T062
priorities	O	O	I-T062
with	O	O	O
nurses	O	O	B-T097
at	O	O	O
a	O	O	O
tertiary	O	O	O
children	O	O	B-T100
's	O	O	I-T100
hospital	O	O	B-T093
in	O	O	O
the	O	O	O
United	O	O	O
Kingdom	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
undertake	O	O	O
a	O	O	O
research	O	O	B-T062
priority	O	O	I-T062
setting	O	O	O
exercise	O	O	O
with	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
maximizing	O	O	O
efficiency	O	O	B-T081
and	O	O	O
impact	O	O	B-T080
in	O	O	O
research	O	O	B-T062
activity	O	O	I-T062
undertaken	O	O	O
by	O	O	O
nurses	O	O	B-T097
at	O	O	O
one	O	O	O
children	O	O	B-T100
's	O	O	I-T100
tertiary	O	O	O
healthcare	O	O	B-T093
institution	O	O	I-T093
by	O	O	O
ensuring	O	O	O
the	O	O	O
clinical	O	O	B-T097
staff	O	O	I-T097
directly	O	O	O
shaped	O	O	O
a	O	O	O
coherent	O	O	B-T033
,	O	O	O
transparent	O	O	B-T080
and	O	O	O
consensus	O	O	B-T054
driven	O	O	O
nurse-led	O	O	B-T062
research	O	O	I-T062
agenda	O	O	I-T062
.	O	O	O

In	O	O	O
Round	O	O	O
1	O	O	O
,	O	O	O
the	O	O	O
research	O	O	B-UnknownType
topics	O	O	I-UnknownType
of	O	O	O
147	O	O	O
nurses	O	O	B-T097
were	O	O	O
elicited	O	O	O
using	O	O	O
a	O	O	O
modified	O	O	B-T062
nominal	O	O	I-T062
group	O	O	I-T062
technique	O	O	I-T062
as	O	O	O
the	O	O	O
consensus	O	O	B-T170
method	O	O	I-T170
.	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
participants	O	O	B-T098
in	O	O	O
the	O	O	O
24	O	O	O
separate	O	O	O
discussions	O	O	O
ranged	O	O	O
from	O	O	O
3	O	O	O
to	O	O	O
21	O	O	O
,	O	O	O
generating	O	O	O
lists	O	O	O
of	O	O	O
between	O	O	O
6	O	O	O
and	O	O	O
23	O	O	O
topics	O	O	O
.	O	O	O

In	O	O	O
Round	O	O	O
2	O	O	O
,	O	O	O
nurses	O	O	B-T097
from	O	O	O
the	O	O	O
clinical	O	O	B-T078
areas	O	O	I-T078
ranked	O	O	B-T170
topics	O	O	O
of	O	O	O
importance	O	O	O
resulting	O	O	O
in	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
four	O	O	O
to	O	O	O
five	O	O	O
priorities	O	O	B-T062
.	O	O	O

In	O	O	O
Round	O	O	O
3	O	O	O
,	O	O	O
the	O	O	O
divisional	O	O	B-T097
heads	O	O	I-T097
of	O	O	O
nursing	O	O	B-T091
consulted	O	O	O
with	O	O	O
staff	O	O	B-T097
in	O	O	O
all	O	O	O
of	O	O	O
their	O	O	O
clinical	O	O	B-T078
areas	O	O	I-T078
to	O	O	O
each	O	O	O
finalize	O	O	O
their	O	O	O
five	O	O	O
divisional	O	O	B-T062
priorities	O	O	I-T062
.	O	O	O

The	O	O	O
Nursing	O	O	B-T097
Research	O	O	I-T097
Working	O	O	I-T097
Group	O	O	I-T097
discussed	O	O	O
and	O	O	O
refined	O	O	O
the	O	O	O
divisions	O	O	B-T062
'	O	O	I-T062
priorities	O	O	I-T062
and	O	O	O
voted	O	O	B-T055
on	O	O	O
the	O	O	O
final	O	O	O
list	O	O	O
to	O	O	O
agree	O	O	O
the	O	O	O
top	O	O	O
five	O	O	O
research	O	O	B-T062
priorities	O	O	I-T062
for	O	O	O
the	O	O	O
organization	O	O	B-T093
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
269	O	O	O
research	O	O	B-UnknownType
topics	O	O	I-UnknownType
were	O	O	O
initially	O	O	O
generated	O	O	O
.	O	O	O

Following	O	O	O
three	O	O	O
rounds	O	O	O
of	O	O	O
ranking	O	O	B-T170
and	O	O	O
prioritizing	O	O	O
,	O	O	O
five	O	O	O
priorities	O	O	B-T062
were	O	O	O
agreed	O	O	O
at	O	O	O
Divisional	O	O	B-T092
level	O	O	I-T092
,	O	O	O
and	O	O	O
from	O	O	O
these	O	O	O
,	O	O	O
the	O	O	O
five	O	O	O
top	O	O	O
organizational	O	O	B-T062
priorities	O	O	I-T062
were	O	O	O
selected	O	O	O
.	O	O	O

These	O	O	O
were	O	O	O
(	O	O	O
i	O	O	O
)	O	O	O
understanding	O	O	O
and	O	O	O
improving	O	O	O
all	O	O	O
aspects	O	O	O
of	O	O	O
the	O	O	O
patient	O	O	B-T101
journey	O	O	O
through	O	O	O
the	O	O	O
hospital	O	O	B-T093
system	O	O	I-T093
;	O	O	O
(	O	O	O
ii	O	O	O
)	O	O	O
play	O	O	B-T056
;	O	O	O
(	O	O	O
iii	O	O	O
)	O	O	O
staff	O	O	B-T078
wellbeing	O	O	I-T078
,	O	O	O
patient	O	O	B-T058
care	O	O	I-T058
and	O	O	O
productivity	O	O	B-T081
;	O	O	O
(	O	O	O
iv	O	O	O
)	O	O	O
team	O	O	B-T057
work	O	O	I-T057
-	O	O	O
linking	O	O	O
to	O	O	O
a	O	O	O
more	O	O	O
efficient	O	O	O
service	O	O	B-T057
;	O	O	O
and	O	O	O
(	O	O	O
v	O	O	O
)	O	O	O
supporting	O	O	B-T099
parents	O	O	I-T099
/	O	O	O
parent	O	O	B-T099
pathway	O	O	O
.	O	O	O

Divisional	O	O	O
priorities	O	O	B-T062
have	O	O	O
been	O	O	O
disseminated	O	O	O
widely	O	O	O
to	O	O	O
clinical	O	O	B-T058
teams	O	O	I-T058
to	O	O	O
inform	O	O	O
a	O	O	O
patient-specific	O	O	B-T062
nurse-led	O	O	I-T062
research	O	O	I-T062
agenda	O	O	I-T062
.	O	O	O

Organizational	O	O	B-T062
priorities	O	O	I-T062
agreed	O	O	O
upon	O	O	O
have	O	O	O
been	O	O	O
disseminated	O	O	O
through	O	O	O
management	O	O	B-T090
structures	O	O	I-T090
and	O	O	O
processes	O	O	O
to	O	O	O
ensure	O	O	O
engagement	O	O	O
at	O	O	O
all	O	O	O
levels	O	O	O
.	O	O	O

A	O	O	O
subgroup	O	O	B-T097
of	O	O	O
the	O	O	O
Nursing	O	O	B-T097
Research	O	O	I-T097
Working	O	O	I-T097
Group	O	O	I-T097
has	O	O	O
been	O	O	O
delegated	O	O	O
to	O	O	O
take	O	O	O
this	O	O	O
work	O	O	O
forward	O	O	O
so	O	O	O
that	O	O	O
the	O	O	O
agreed	O	O	O
priorities	O	O	B-T062
continue	O	O	O
to	O	O	O
contribute	O	O	O
towards	O	O	O
shaping	O	O	O
nurse-led	O	O	B-T062
research	O	O	I-T062
activity	O	O	I-T062
,	O	O	O
thereby	O	O	O
going	O	O	O
some	O	O	O
way	O	O	O
to	O	O	O
inform	O	O	O
and	O	O	O
embed	O	O	O
an	O	O	O
evidence-based	O	O	O
culture	O	O	O
of	O	O	O
inquiry	O	O	B-T052
.	O	O	O

-DOCSTART- (27705854)

Accurate	O	O	B-T080
Lungs	O	O	B-T023
Segmentation	O	O	B-T058
on	O	O	O
CT	O	O	B-T060
Chest	O	O	B-T029
Images	O	O	B-T170
by	O	O	O
Adaptive	O	O	O
Appearance-Guided	O	O	O
Shape	O	O	O
Modeling	O	O	O

To	O	O	O
accurately	O	O	B-T080
segment	O	O	B-T058
pathological	O	O	B-T169
and	O	O	O
healthy	O	O	B-T080
lungs	O	O	B-T023
for	O	O	O
reliable	O	O	B-T080
computer-aided	O	O	B-T060
disease	O	O	I-T060
diagnostics	O	O	I-T060
,	O	O	O
a	O	O	O
stack	O	O	B-T082
of	O	O	O
chest	O	O	B-T029
CT	O	O	B-T060
scans	O	O	B-T060
is	O	O	O
modeled	O	O	B-T062
as	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
a	O	O	O
spatially	O	O	B-T082
inhomogeneous	O	O	I-T082
joint	O	O	B-T080
3D	O	O	I-T080
Markov-Gibbs	O	O	I-T080
random	O	O	I-T080
field	O	O	I-T080
(	O	O	O
MGRF	O	O	B-T080
)	O	O	O
of	O	O	O
voxel-wise	O	O	B-T077
lung	O	O	B-T023
and	O	O	O
chest	O	O	O
CT	O	O	O
image	O	O	B-T170
signals	O	O	B-T067
(	O	O	O
intensities	O	O	B-T081
)	O	O	O
.	O	O	O

The	O	O	O
proposed	O	O	B-T080
learnable	O	O	O
MGRF	O	O	B-T080
integrates	O	O	B-T066
two	O	O	O
visual	O	O	B-T169
appearance	O	O	B-T080
sub-models	O	O	B-T075
with	O	O	O
an	O	O	O
adaptive	O	O	O
lung	O	O	B-T023
shape	O	O	O
submodel	O	O	B-T075
.	O	O	O

The	O	O	O
first-order	O	O	O
appearance	O	O	B-T080
submodel	O	O	B-T075
accounts	O	O	O
for	O	O	O
both	O	O	O
the	O	O	O
original	O	O	B-T078
CT	O	O	B-T060
image	O	O	B-T170
and	O	O	O
its	O	O	O
Gaussian	O	O	B-T080
scale	O	O	I-T080
space	O	O	I-T080
(	O	O	I-T080
GSS	O	O	I-T080
)	O	O	I-T080
filtered	O	O	I-T080
version	O	O	I-T080
to	O	O	O
specify	O	O	O
local	O	O	O
and	O	O	O
global	O	O	O
signal	O	O	B-T067
properties	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Each	O	O	O
empirical	O	O	B-T080
marginal	O	O	B-T080
probability	O	O	B-T081
distribution	O	O	I-T081
of	O	O	O
signals	O	O	B-T067
is	O	O	O
closely	O	O	O
approximated	O	O	O
with	O	O	O
a	O	O	O
linear	O	O	B-T080
combination	O	O	I-T080
of	O	O	I-T080
discrete	O	O	I-T080
Gaussians	O	O	I-T080
(	O	O	O
LCDG	O	O	B-T080
)	O	O	O
,	O	O	O
containing	O	O	O
two	O	O	O
positive	O	O	B-T080
dominant	O	O	I-T080
and	O	O	I-T080
multiple	O	O	I-T080
sign-alternate	O	O	I-T080
subordinate	O	O	I-T080
DGs	O	O	I-T080
.	O	O	O

The	O	O	O
approximation	O	O	O
is	O	O	O
separated	O	O	O
into	O	O	O
two	O	O	O
LCDGs	O	O	B-T080
to	O	O	O
describe	O	O	O
individually	O	O	O
the	O	O	O
lungs	O	O	B-T023
and	O	O	O
their	O	O	O
background	O	O	O
,	O	O	O
i.e.	O	O	O
,	O	O	O
all	O	O	O
other	O	O	O
chest	O	O	B-T029
tissues	O	O	B-T024
.	O	O	O

The	O	O	O
second-order	O	O	O
appearance	O	O	B-T080
submodel	O	O	B-T075
quantifies	O	O	B-T081
conditional	O	O	B-T080
pairwise	O	O	B-T081
intensity	O	O	B-T081
dependencies	O	O	B-T170
in	O	O	O
the	O	O	O
nearest	O	O	O
voxel	O	O	O
26-neighborhood	O	O	O
in	O	O	O
both	O	O	O
the	O	O	O
original	O	O	B-T078
and	O	O	O
GSS-filtered	O	O	B-T080
images	O	O	B-T170
.	O	O	O

The	O	O	O
shape	O	O	O
submodel	O	O	B-T075
is	O	O	O
built	O	O	O
for	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
training	O	O	B-T078
data	O	O	I-T078
and	O	O	O
is	O	O	O
adapted	O	O	O
during	O	O	O
segmentation	O	O	B-T058
using	O	O	O
both	O	O	O
the	O	O	O
lung	O	O	B-T023
and	O	O	O
chest	O	O	B-T029
appearances	O	O	B-T080
.	O	O	O

The	O	O	O
accuracy	O	O	B-T080
of	O	O	O
the	O	O	O
proposed	O	O	B-T080
segmentation	O	O	B-T058
framework	O	O	O
is	O	O	O
quantitatively	O	O	B-T081
assessed	O	O	B-T052
using	O	O	O
two	O	O	O
public	O	O	O
databases	O	O	B-T170
(	O	O	O
ISBI	O	O	B-T170
VESSEL12	O	O	I-T170
challenge	O	O	I-T170
and	O	O	O
MICCAI	O	O	B-T170
LOLA11	O	O	I-T170
challenge	O	O	I-T170
)	O	O	O
and	O	O	O
our	O	O	O
own	O	O	O
database	O	O	B-T170
with	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
20	O	O	O
,	O	O	O
55	O	O	O
,	O	O	O
and	O	O	O
30	O	O	O
CT	O	O	B-T060
images	O	O	B-T170
of	O	O	O
various	O	O	O
lung	O	O	B-T023
pathologies	O	O	B-T169
acquired	O	O	O
with	O	O	O
different	O	O	O
scanners	O	O	B-T074
and	O	O	O
protocols	O	O	B-T061
.	O	O	O

Quantitative	O	O	B-T081
assessment	O	O	B-T052
of	O	O	O
our	O	O	O
framework	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
Dice	O	O	B-T081
similarity	O	O	I-T081
coefficients	O	O	I-T081
,	O	O	O
95-percentile	O	O	B-T081
bidirectional	O	O	I-T081
Hausdorff	O	O	I-T081
distances	O	O	I-T081
,	O	O	O
and	O	O	O
percentage	O	O	B-T081
volume	O	O	I-T081
differences	O	O	I-T081
confirms	O	O	O
the	O	O	O
high	O	O	O
accuracy	O	O	B-T080
of	O	O	O
our	O	O	O
model	O	O	B-T075
on	O	O	O
both	O	O	O
our	O	O	O
database	O	O	B-T170
(	O	O	O
98.4±1.0	O	O	O
%	O	O	O
,	O	O	O
2.2±1.0	O	O	O
mm	O	O	O
,	O	O	O
0.42±0.10	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
VESSEL12	O	O	B-T170
database	O	O	I-T170
(	O	O	O
99.0±0.5	O	O	O
%	O	O	O
,	O	O	O
2.1±1.6	O	O	O
mm	O	O	O
,	O	O	O
0.39±0.20	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Similarly	O	O	O
,	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
our	O	O	O
approach	O	O	B-T078
is	O	O	O
further	O	O	O
verified	O	O	B-T169
via	O	O	O
a	O	O	O
blind	O	O	B-T170
evaluation	O	O	B-T170
by	O	O	O
the	O	O	O
organizers	O	O	O
of	O	O	O
the	O	O	O
LOLA11	O	O	B-T170
competition	O	O	B-T052
,	O	O	O
where	O	O	O
an	O	O	O
average	O	O	B-T081
overlap	O	O	O
of	O	O	O
98.0	O	O	O
%	O	O	O
with	O	O	O
the	O	O	O
expert	O	O	O
's	O	O	O
segmentation	O	O	B-T058
is	O	O	O
yielded	O	O	O
on	O	O	O
all	O	O	O
55	O	O	O
subjects	O	O	O
with	O	O	O
our	O	O	O
framework	O	O	O
being	O	O	O
ranked	O	O	O
first	O	O	O
among	O	O	O
all	O	O	O
the	O	O	O
state-of-the-art	O	O	B-T080
techniques	O	O	B-T169
compared	O	O	B-T052
.	O	O	O

-DOCSTART- (27706190)

Influence	O	O	B-T077
of	O	O	O
Different	O	O	B-T080
Levels	O	O	B-T079
of	O	O	O
Lipoic	O	O	B-T028
Acid	O	O	I-T028
Synthase	O	O	I-T028
Gene	O	O	B-T045
Expression	O	O	I-T045
on	O	O	O
Diabetic	O	O	O
Nephropathy	O	O	O

Oxidative	O	O	B-T049
stress	O	O	I-T049
is	O	O	O
implicated	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
diabetic	O	O	B-T047
nephropathy	O	O	I-T047
(	O	O	O
DN	O	O	B-T047
)	O	O	O
but	O	O	O
outcomes	O	O	B-T169
of	O	O	O
many	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
are	O	O	O
controversial	O	O	O
.	O	O	O

To	O	O	O
define	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
antioxidants	O	O	B-T121
in	O	O	O
kidney	O	O	B-T023
protection	O	O	O
during	O	O	B-T079
the	O	O	O
development	O	O	B-T169
of	O	O	O
diabetic	O	O	B-T047
nephropathy	O	O	I-T047
,	O	O	O
we	O	O	O
have	O	O	O
generated	O	O	B-T052
a	O	O	O
novel	O	O	B-T080
genetic	O	O	B-T050
antioxidant	O	O	I-T050
mouse	O	O	I-T050
model	O	O	I-T050
with	O	O	O
over-	O	O	B-T045
or	O	O	I-T045
under-expression	O	O	I-T045
of	O	O	O
lipoic	O	O	B-T028
acid	O	O	I-T028
synthase	O	O	I-T028
gene	O	O	I-T028
(	O	O	O
Lias	O	O	B-T028
)	O	O	O
.	O	O	O

These	O	O	O
models	O	O	B-T050
have	O	O	O
been	O	O	O
mated	O	O	B-T040
with	O	O	O
Ins2Akita/+	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
a	O	O	O
type	O	O	B-T047
I	O	O	I-T047
diabetic	O	O	I-T047
mouse	O	O	B-T050
model	O	O	I-T050
.	O	O	O

We	O	O	O
compare	O	O	B-T052
the	O	O	O
major	O	O	B-T080
pathologic	O	O	B-T034
changes	O	O	I-T034
and	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
status	O	O	B-T080
in	O	O	O
two	O	O	O
new	O	O	O
strains	O	O	O
of	O	O	O
the	O	O	O
mice	O	O	B-T015
with	O	O	O
controls	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	B-T169
show	O	O	O
that	O	O	O
Ins2Akita/+	O	O	B-T015
mice	O	O	I-T015
with	O	O	O
under-expressed	O	O	B-T045
Lias	O	O	B-T028
gene	O	O	I-T028
,	O	O	O
exhibit	O	O	O
higher	O	O	B-T080
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
more	O	O	B-T081
severe	O	O	B-T080
DN	O	O	B-T047
features	O	O	B-T080
(	O	O	O
albuminuria	O	O	B-T033
,	O	O	O
glomerular	O	O	B-T033
basement	O	O	I-T033
membrane	O	O	I-T033
thickening	O	O	I-T033
and	O	O	O
mesangial	O	O	B-T033
matrix	O	O	I-T033
expansion	O	O	I-T033
)	O	O	O
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
Ins2Akita/+	O	O	B-T015
mice	O	O	I-T015
with	O	O	O
highly	O	O	B-T080
-	O	O	O
expressed	O	O	B-T045
Lias	O	O	B-T028
gene	O	O	I-T028
display	O	O	B-T169
lower	O	O	B-T080
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
less	O	O	B-T080
DN	O	O	B-T047
pathologic	O	O	B-T034
changes	O	O	I-T034
.	O	O	O

Our	O	O	O
study	O	O	B-T062
demonstrates	O	O	B-T052
that	O	O	O
strengthening	O	O	O
endogenous	O	O	B-T169
antioxidant	O	O	B-T121
capacity	O	O	B-T081
could	O	O	O
be	O	O	O
an	O	O	O
effective	O	O	B-UnknownType
strategy	O	O	I-UnknownType
for	O	O	I-UnknownType
prevention	O	O	I-UnknownType
and	O	O	O
treatment	O	O	B-T169
of	O	O	O
DN	O	O	B-T047
.	O	O	O

-DOCSTART- (27706588)

Assessment	O	O	B-T052
of	O	O	O
genetic	O	O	B-T169
relationship	O	O	B-T080
among	O	O	O
Rhododendron	O	O	B-T002
cultivars	O	O	B-T077
using	O	O	O
amplified	O	O	B-T063
fragment	O	O	I-T063
length	O	O	I-T063
polymorphism	O	O	I-T063
and	O	O	O
inter-simple	O	O	B-UnknownType
sequence	O	O	I-UnknownType
repeat	O	O	I-UnknownType
markers	O	O	O

Genetic	O	O	B-T169
relationships	O	O	B-T080
of	O	O	O
17	O	O	O
Rhododendron	O	O	B-T002
cultivars	O	O	B-T077
,	O	O	O
China	O	O	B-T083
,	O	O	O
were	O	O	O
assessed	O	O	B-T052
using	O	O	O
inter-simple	O	O	B-UnknownType
sequence	O	O	I-UnknownType
repeat	O	O	I-UnknownType
(	O	O	O
ISSR	O	O	B-UnknownType
)	O	O	O
and	O	O	O
amplified	O	O	B-T063
fragment	O	O	I-T063
length	O	O	I-T063
polymorphism	O	O	I-T063
(	O	O	O
AFLP	O	O	B-T063
)	O	O	O
markers	O	O	B-T086
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
133	O	O	O
bands	O	O	O
were	O	O	O
obtained	O	O	O
using	O	O	O
nine	O	O	O
selected	O	O	O
ISSR	O	O	B-UnknownType
primers	O	O	B-T114
,	O	O	O
129	O	O	O
(	O	O	O
96.99	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
which	O	O	O
were	O	O	O
polymorphic	O	O	B-T080
;	O	O	O
267	O	O	O
bands	O	O	O
were	O	O	O
amplified	O	O	O
by	O	O	O
four	O	O	O
AFLP	O	O	B-T063
primer	O	O	B-T114
pairs	O	O	I-T114
,	O	O	O
251	O	O	O
(	O	O	O
94.01	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
which	O	O	O
exhibited	O	O	O
polymorphism	O	O	B-T080
.	O	O	O

Based	O	O	O
on	O	O	O
these	O	O	O
polymorphic	O	O	B-T080
products	O	O	B-T071
,	O	O	O
a	O	O	O
cluster	O	O	B-T062
analysis	O	O	I-T062
revealed	O	O	O
similarities	O	O	B-T080
between	O	O	O
the	O	O	O
results	O	O	B-T169
of	O	O	O
the	O	O	O
ISSR	O	O	B-UnknownType
and	O	O	O
AFLP	O	O	B-T063
.	O	O	O

All	O	O	O
of	O	O	O
the	O	O	O
cultivars	O	O	B-T077
were	O	O	O
clustered	O	O	B-T169
into	O	O	O
two	O	O	O
major	O	O	O
branches	O	O	B-T078
;	O	O	O
one	O	O	O
branch	O	O	B-T078
contained	O	O	O
the	O	O	O
same	O	O	O
four	O	O	O
cultivars	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
other	O	O	O
cultivars	O	O	O
were	O	O	O
separated	O	O	O
into	O	O	O
different	O	O	O
groups	O	O	B-T078
in	O	O	O
the	O	O	O
other	O	O	O
branch	O	O	O
.	O	O	O

The	O	O	O
cluster	O	O	B-T081
results	O	O	B-T169
showed	O	O	O
that	O	O	O
the	O	O	O
genetic	O	O	B-T169
relationships	O	O	B-T080
of	O	O	O
the	O	O	O
17	O	O	O
cultivars	O	O	B-T077
were	O	O	O
partly	O	O	O
related	O	O	B-T080
to	O	O	O
their	O	O	O
morphological	O	O	B-T082
characteristics	O	O	B-T080
,	O	O	O
particularly	O	O	O
the	O	O	O
flowering	O	O	B-T040
phase	O	O	B-T079
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
results	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
support	O	O	O
the	O	O	O
classification	O	O	B-T185
of	O	O	O
Rhododendron	O	O	B-T002
cultivars	O	O	B-T077
according	O	O	O
to	O	O	O
flowering	O	O	B-T040
phase	O	O	B-T079
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
cluster	O	O	B-T081
results	O	O	B-T169
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
select	O	O	B-T052
suitable	O	O	O
parents	O	O	O
for	O	O	O
breeding	O	O	B-T040
.	O	O	O

-DOCSTART- (27707812)

Spontaneous	O	O	B-T039
activity	O	O	I-T039
is	O	O	O
correlated	O	O	B-T080
with	O	O	O
coding	O	O	B-T052
density	O	O	B-T081
in	O	O	O
primary	O	O	O
auditory	O	O	O
cortex	O	O	O

Sensory	O	O	B-T025
neurons	O	O	I-T025
across	O	O	O
sensory	O	O	B-T067
modalities	O	O	I-T067
and	O	O	O
specific	O	O	O
processing	O	O	B-T052
areas	O	O	O
have	O	O	O
diverse	O	O	O
levels	O	O	O
of	O	O	O
spontaneous	O	O	B-T039
firing	O	O	I-T039
rates	O	O	I-T039
(	O	O	O
SFRs	O	O	B-T039
)	O	O	O
in	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
sensory	O	O	B-UnknownType
stimuli	O	O	I-UnknownType
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
functional	O	O	B-T169
significance	O	O	B-T078
of	O	O	O
this	O	O	O
spontaneous	O	O	B-T039
activity	O	O	I-T039
is	O	O	O
not	O	O	O
well-understood	O	O	O
.	O	O	O

Previous	O	O	O
studies	O	O	B-T062
in	O	O	O
the	O	O	O
auditory	O	O	B-T022
system	O	O	I-T022
have	O	O	O
demonstrated	O	O	O
that	O	O	O
different	O	O	O
levels	O	O	O
of	O	O	O
spontaneous	O	O	B-T039
activity	O	O	I-T039
are	O	O	O
correlated	O	O	B-T080
with	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
physiological	O	O	B-T169
and	O	O	O
anatomic	O	O	B-T080
properties	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
neurons	O	O	B-T025
with	O	O	O
differing	O	O	O
SFRs	O	O	B-T039
make	O	O	O
unique	O	O	O
contributions	O	O	O
to	O	O	O
the	O	O	O
encoding	O	O	B-T052
of	O	O	O
auditory	O	O	B-T039
stimuli	O	O	I-T039
.	O	O	O

Additionally	O	O	O
,	O	O	O
altered	O	O	O
SFRs	O	O	B-T039
are	O	O	O
a	O	O	O
correlate	O	O	O
of	O	O	O
tinnitus	O	O	B-T033
,	O	O	O
arising	O	O	O
in	O	O	O
several	O	O	O
auditory	O	O	B-T023
areas	O	O	I-T023
after	O	O	O
exposure	O	O	O
to	O	O	O
ototoxic	O	O	B-T037
substances	O	O	B-T167
and	O	O	O
noise	O	O	B-T067
trauma	O	O	B-T037
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
recorded	O	O	B-T059
single-unit	O	O	I-T059
activity	O	O	I-T059
from	O	O	O
primary	O	O	B-T029
auditory	O	O	I-T029
cortex	O	O	I-T029
of	O	O	O
awake	O	O	O
marmoset	O	O	B-T015
monkeys	O	O	B-T015
while	O	O	O
delivering	O	O	O
wide-band	O	O	B-T067
random-spectrum	O	O	I-T067
stimuli	O	O	I-T067
and	O	O	O
white	O	O	B-T170
Gaussian	O	O	I-T170
noise	O	O	I-T170
(	O	O	O
WGN	O	O	B-T170
)	O	O	O
to	O	O	O
examine	O	O	O
any	O	O	O
divergences	O	O	B-T082
in	O	O	O
stimulus	O	O	B-T067
encoding	O	O	B-T052
properties	O	O	O
across	O	O	O
SFR	O	O	O
classes	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
higher	O	O	O
levels	O	O	O
of	O	O	O
spontaneous	O	O	B-T039
activity	O	O	I-T039
were	O	O	O
associated	O	O	O
with	O	O	O
both	O	O	O
higher	O	O	O
levels	O	O	O
of	O	O	O
activation	O	O	B-T052
relative	O	O	O
to	O	O	O
suppression	O	O	B-T169
across	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
wide-band	O	O	B-T067
stimuli	O	O	I-T067
and	O	O	O
higher	O	O	O
driven	O	O	O
rates	O	O	O
in	O	O	O
response	O	O	B-T032
to	O	O	O
WGN	O	O	B-T170
.	O	O	O

Moreover	O	O	O
,	O	O	O
response	O	O	B-T032
latencies	O	O	I-T079
to	O	O	O
WGN	O	O	B-T170
were	O	O	O
negatively	O	O	O
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
level	O	O	O
of	O	O	O
activation	O	O	B-T052
in	O	O	O
response	O	O	O
to	O	O	O
both	O	O	O
stimulus	O	O	B-T067
types	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
are	O	O	O
consistent	O	O	O
with	O	O	O
a	O	O	O
novel	O	O	O
view	O	O	O
of	O	O	O
the	O	O	O
role	O	O	O
spontaneous	O	O	B-T039
spiking	O	O	I-T039
may	O	O	O
play	O	O	O
during	O	O	O
normal	O	O	O
stimulus	O	O	B-T067
processing	O	O	B-T052
in	O	O	O
primary	O	O	B-T029
auditory	O	O	I-T029
cortex	O	O	I-T029
and	O	O	O
how	O	O	O
it	O	O	O
may	O	O	O
malfunction	O	O	B-T169
in	O	O	O
cases	O	O	O
of	O	O	O
tinnitus	O	O	B-T033
.	O	O	O

-DOCSTART- (27708057)

Systematic	O	O	B-T062
mapping	O	O	I-T062
of	O	O	O
functional	O	O	B-T169
enhancer	O	O	B-T114
-	O	O	O
promoter	O	O	B-T114
connections	O	O	B-T169
with	O	O	O
CRISPR	O	O	B-T114
interference	O	O	O

Gene	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
mammals	O	O	B-T015
is	O	O	O
regulated	O	O	B-T045
by	O	O	O
noncoding	O	O	B-T114
elements	O	O	I-T114
that	O	O	O
can	O	O	O
affect	O	O	O
physiology	O	O	B-T039
and	O	O	O
disease	O	O	B-T047
,	O	O	O
yet	O	O	O
the	O	O	O
functions	O	O	B-T169
and	O	O	O
target	O	O	B-T028
genes	O	O	I-T028
of	O	O	O
most	O	O	O
noncoding	O	O	O
elements	O	O	O
remain	O	O	O
unknown	O	O	B-T080
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
high-throughput	O	O	B-T170
approach	O	O	I-T170
that	O	O	O
uses	O	O	O
clustered	O	O	B-T059
regularly	O	O	I-T059
interspaced	O	O	I-T059
short	O	O	I-T059
palindromic	O	O	I-T059
repeats	O	O	I-T059
(	O	O	I-T059
CRISPR	O	O	B-T114
)	O	O	I-T059
interference	O	O	I-T059
(	O	O	O
CRISPRi	O	O	B-T059
)	O	O	O
to	O	O	O
discover	O	O	O
regulatory	O	O	B-T114
elements	O	O	I-T114
and	O	O	O
identify	O	O	O
their	O	O	O
target	O	O	B-T028
genes	O	O	I-T028
.	O	O	O

We	O	O	O
assess	O	O	B-T058
>	O	O	O
1	O	O	O
megabase	O	O	B-T081
of	O	O	O
sequence	O	O	B-T086
in	O	O	O
the	O	O	O
vicinity	O	O	O
of	O	O	O
two	O	O	O
essential	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
MYC	O	O	B-T116
and	O	O	O
GATA1	O	O	B-T116
,	O	O	O
and	O	O	O
identify	O	O	O
nine	O	O	O
distal	O	O	B-T082
enhancers	O	O	B-T114
that	O	O	O
control	O	O	B-T080
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
cellular	O	O	B-T043
proliferation	O	O	I-T043
.	O	O	O

Quantitative	O	O	B-T081
features	O	O	B-T080
of	O	O	O
chromatin	O	O	B-T116
state	O	O	B-T169
and	O	O	O
chromosome	O	O	B-T026
conformation	O	O	B-T033
distinguish	O	O	O
the	O	O	O
seven	O	O	O
enhancers	O	O	B-T114
that	O	O	O
regulate	O	O	O
MYC	O	O	B-T116
from	O	O	O
other	O	O	O
elements	O	O	B-T086
that	O	O	O
do	O	O	O
not	O	O	O
,	O	O	O
suggesting	O	O	O
a	O	O	O
strategy	O	O	B-T169
for	O	O	O
predicting	O	O	O
enhancer	O	O	B-T114
-	O	O	O
promoter	O	O	B-T114
connectivity	O	O	B-T169
.	O	O	O

This	O	O	O
CRISPRi	O	O	B-T059
-based	O	O	O
approach	O	O	B-T169
can	O	O	O
be	O	O	O
applied	O	O	O
to	O	O	O
dissect	O	O	B-T169
transcriptional	O	O	B-T044
networks	O	O	I-T044
and	O	O	O
interpret	O	O	B-T169
the	O	O	O
contributions	O	O	B-T052
of	O	O	O
noncoding	O	O	B-T070
genetic	O	O	I-T070
variation	O	O	I-T070
to	O	O	O
human	O	O	B-T016
disease	O	O	B-T047
.	O	O	O

-DOCSTART- (27710899)

Proliferation	O	O	B-T043
-enhancing	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
gastrodin	O	O	B-T109
on	O	O	O
RSC96	O	O	B-T025
Schwann	O	O	I-T025
cells	O	O	I-T025
by	O	O	O
regulating	O	O	B-T038
ERK1	O	O	B-T116
/	O	O	O
2	O	O	B-T116
and	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
signaling	O	O	O
pathways	O	O	O

The	O	O	O
proliferation	O	O	B-T043
and	O	O	O
migration	O	O	B-T043
of	O	O	O
Schwann	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
SCs	O	O	B-T025
)	O	O	O
are	O	O	O
essential	O	O	O
in	O	O	O
the	O	O	O
process	O	O	B-T067
of	O	O	O
peripheral	O	O	B-T061
nerve	O	O	I-T061
repair	O	O	I-T061
.	O	O	O

A	O	O	O
large	O	O	O
amount	O	O	O
of	O	O	O
studies	O	O	O
focused	O	O	O
on	O	O	O
the	O	O	O
promotion	O	O	B-T052
of	O	O	O
the	O	O	O
growth	O	O	B-T043
of	O	O	O
SCs	O	O	B-T025
for	O	O	O
cell	O	O	B-T061
based	O	O	I-T061
therapy	O	O	I-T061
.	O	O	O

Gastrodin	O	O	B-T109
(	O	O	O
GAS	O	O	B-T109
)	O	O	O
,	O	O	O
the	O	O	O
main	O	O	O
constituent	O	O	O
of	O	O	O
a	O	O	O
Chinese	O	O	B-T091
traditional	O	O	I-T091
herbal	O	O	B-T121
medicine	O	O	I-T121
named	O	O	O
Gastrodia	O	O	B-T002
elata	O	O	I-T002
Blume	O	O	I-T002
,	O	O	O
has	O	O	O
been	O	O	O
reported	O	O	B-T058
to	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
neuroprotective	O	O	B-T043
properties	O	O	I-T043
.	O	O	O

Besides	O	O	O
,	O	O	O
GAS	O	O	B-T109
activated	O	O	B-T052
MAPK	O	O	B-T116
and	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
signaling	O	O	B-T044
pathways	O	O	I-T044
which	O	O	O
are	O	O	O
often	O	O	O
involved	O	O	O
in	O	O	O
growth	O	O	B-T043
of	O	O	O
nerve	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
also	O	O	O
reported	O	O	B-T058
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
GAS	O	O	B-T109
may	O	O	O
have	O	O	O
an	O	O	O
effect	O	O	O
on	O	O	O
SCs	O	O	B-T025
growth	O	O	B-T043
,	O	O	O
we	O	O	O
studied	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
GAS	O	O	O
on	O	O	O
rat	O	O	B-T015
RSC96	O	O	B-T025
Schwann	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
SCs	O	O	O
)	O	O	O
and	O	O	O
further	O	O	O
explored	O	O	O
the	O	O	O
underlying	O	O	O
mechanism	O	O	B-T169
.	O	O	O

Various	O	O	O
concentration	O	O	B-T081
of	O	O	O
GAS	O	O	B-T109
(	O	O	O
0μM	O	O	O
,	O	O	O
50μM	O	O	O
,	O	O	O
100μM	O	O	O
,	O	O	O
and	O	O	O
200μM	O	O	O
)	O	O	O
was	O	O	O
used	O	O	O
for	O	O	O
treatment	O	O	B-T061
of	O	O	O
RSC96	O	O	B-T025
SCs	O	O	I-T025
,	O	O	O
with	O	O	O
the	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
and	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
several	O	O	O
neurotrophic	O	O	B-T116
factors	O	O	I-T116
to	O	O	O
be	O	O	O
detected	O	O	O
.	O	O	O

Regulation	O	O	B-T038
of	O	O	I-T038
MAPK	O	O	B-T116
and	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
signaling	O	O	B-T044
pathways	O	O	I-T044
were	O	O	O
assayed	O	O	O
by	O	O	O
detecting	O	O	O
phosphorylation	O	O	B-T044
of	O	O	O
ERK1	O	O	B-T116
/	O	O	O
2	O	O	B-T116
and	O	O	O
Akt	O	O	B-T116
.	O	O	O

The	O	O	O
results	O	O	O
showed	O	O	O
that	O	O	O
GAS	O	O	B-T109
could	O	O	O
effectively	O	O	O
promote	O	O	B-T052
proliferation	O	O	B-T043
of	O	O	O
RSC96	O	O	B-T025
SCs	O	O	I-T025
in	O	O	O
a	O	O	O
dose	O	O	B-T081
-	O	O	O
and	O	O	O
time	O	O	B-T079
-dependent	O	O	O
manner	O	O	O
.	O	O	O

The	O	O	O
best	O	O	O
performance	O	O	O
was	O	O	O
obtained	O	O	O
at	O	O	O
the	O	O	O
concentration	O	O	B-T081
of	O	O	O
200μM.	O	O	O
Exploration	O	O	B-T061
of	O	O	O
the	O	O	O
underlying	O	O	O
mechanism	O	O	B-T169
showed	O	O	O
that	O	O	O
GAS	O	O	B-T109
probably	O	O	O
affects	O	O	O
SCs	O	O	B-T025
metabolism	O	O	B-T043
through	O	O	O
inhibiting	O	O	B-T052
ERK1	O	O	B-T116
/	O	O	O
2	O	O	B-T116
phosphorylation	O	O	B-T044
and	O	O	O
activating	O	O	B-T052
Akt	O	O	B-T116
phosphorylation	O	O	O
in	O	O	O
RSC96	O	O	B-T025
SCs	O	O	I-T025
.	O	O	O

This	O	O	O
study	O	O	O
may	O	O	O
provide	O	O	O
reference	O	O	O
for	O	O	O
its	O	O	O
application	O	O	O
in	O	O	O
treatment	O	O	B-T061
of	O	O	O
peripheral	O	O	B-T037
nerve	O	O	I-T037
injuries	O	O	I-T037
.	O	O	O

-DOCSTART- (27713074)

An	O	O	O
influenza	O	O	B-T005
A	O	O	I-T005
virus	O	O	I-T005
(	O	O	I-T005
H7N9	O	O	I-T005
)	O	O	I-T005
anti-neuraminidase	O	O	B-T033
monoclonal	O	O	B-T116
antibody	O	O	I-T116
with	O	O	O
prophylactic	O	O	B-T061
and	O	O	I-T061
therapeutic	O	O	I-T061
activity	O	O	I-T061
in	O	O	O
vivo	O	O	O

Zoonotic	O	O	B-T047
A(H7N9	O	O	B-T005
)	O	O	I-T005
avian	O	O	I-T005
influenza	O	O	I-T005
viruses	O	O	I-T005
emerged	O	O	O
in	O	O	O
China	O	O	B-T083
in	O	O	O
2013	O	O	O
and	O	O	O
continue	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
threat	O	O	B-T078
to	O	O	O
human	O	O	B-T016
public	O	O	B-T058
health	O	O	I-T058
,	O	O	O
having	O	O	O
infected	O	O	B-T033
over	O	O	O
800	O	O	O
individuals	O	O	B-T098
with	O	O	O
a	O	O	O
mortality	O	O	B-T081
rate	O	O	I-T081
approaching	O	O	O
40	O	O	O
%	O	O	O
.	O	O	O

Treatment	O	O	B-T061
options	O	O	I-T061
for	O	O	O
people	O	O	O
infected	O	O	B-T033
with	O	O	O
A(H7N9	O	O	B-T005
)	O	O	I-T005
include	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
neuraminidase	O	O	B-T121
(	O	O	I-T121
NA	O	O	I-T121
)	O	O	I-T121
inhibitors	O	O	I-T121
.	O	O	O

However	O	O	O
,	O	O	O
like	O	O	O
other	O	O	O
influenza	O	O	B-T005
viruses	O	O	I-T005
,	O	O	O
A(H7N9	O	O	B-T005
)	O	O	I-T005
can	O	O	O
become	O	O	O
resistant	O	O	B-T169
to	O	O	O
these	O	O	O
drugs	O	O	B-T121
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
monoclonal	O	O	B-T116
antibodies	O	O	I-T116
is	O	O	O
a	O	O	O
rapidly	O	O	O
developing	O	O	O
strategy	O	O	B-T041
for	O	O	O
controlling	O	O	O
influenza	O	O	B-T005
virus	O	O	I-T005
infection	O	O	B-T046
.	O	O	O

Here	O	O	O
we	O	O	O
generated	O	O	O
a	O	O	O
murine	O	O	B-T015
monoclonal	O	O	B-T116
antibody	O	O	I-T116
(	O	O	O
3c10	O	O	B-T129
-	O	O	I-T129
3	O	O	I-T129
)	O	O	O
directed	O	O	O
against	O	O	O
the	O	O	O
NA	O	O	B-T116
of	O	O	O
A(H7N9	O	O	B-T005
)	O	O	I-T005
and	O	O	O
show	O	O	O
that	O	O	O
prophylactic	O	O	B-T169
systemic	O	O	B-UnknownType
administration	O	O	I-UnknownType
of	O	O	O
3c10	O	O	O
-	O	O	O
3	O	O	O
fully	O	O	O
protected	O	O	O
mice	O	O	O
from	O	O	O
lethal	O	O	O
challenge	O	O	O
with	O	O	O
wild-type	O	O	B-T028
A/Anhui/1/2013	O	O	B-T005
(	O	O	O
H7N9	O	O	B-T005
)	O	O	O
.	O	O	O

Further	O	O	O
,	O	O	O
post-	O	O	O
infection	O	O	B-T046
treatment	O	O	B-T061
with	O	O	O
a	O	O	O
single	O	O	O
systemic	O	O	B-T169
dose	O	O	B-T081
of	O	O	O
3c10	O	O	B-T129
-	O	O	I-T129
3	O	O	I-T129
at	O	O	O
either	O	O	O
24	O	O	O
,	O	O	O
48	O	O	O
or	O	O	O
72	O	O	O
h	O	O	O
post	O	O	O
A(H7N9	O	O	B-T005
)	O	O	I-T005
challenge	O	O	O
resulted	O	O	O
in	O	O	O
both	O	O	O
dose	O	O	O
-	O	O	O
and	O	O	O
time	O	O	B-T079
-	O	O	O
dependent	O	O	B-T169
protection	O	O	B-T033
of	O	O	O
up	O	O	O
to	O	O	O
100	O	O	O
%	O	O	O
of	O	O	O
mice	O	O	B-T015
,	O	O	O
demonstrating	O	O	O
therapeutic	O	O	B-T169
potential	O	O	B-T080
for	O	O	O
3c10	O	O	O
-	O	O	O
3	O	O	O
.	O	O	O

Epitope	O	O	B-T059
mapping	O	O	I-T059
revealed	O	O	O
that	O	O	O
3c10	O	O	B-T129
-	O	O	I-T129
3	O	O	I-T129
binds	O	O	B-T044
near	O	O	O
the	O	O	O
enzyme	O	O	B-T116
active	O	O	B-T169
site	O	O	I-T169
of	O	O	O
NA	O	O	B-T116
,	O	O	O
and	O	O	O
functional	O	O	B-T169
characterization	O	O	O
showed	O	O	O
that	O	O	O
3c10	O	O	O
-	O	O	O
3	O	O	O
inhibits	O	O	O
the	O	O	O
enzyme	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
NA	O	O	O
and	O	O	O
restricts	O	O	O
the	O	O	O
cell	O	O	O
-to-	O	O	O
cell	O	O	O
spread	O	O	B-T080
of	O	O	O
the	O	O	O
virus	O	O	B-T005
in	O	O	O
cultured	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Affinity	O	O	B-T070
analysis	O	O	B-T062
also	O	O	O
revealed	O	O	O
that	O	O	O
3c10	O	O	B-T129
-	O	O	I-T129
3	O	O	I-T129
binds	O	O	B-T044
equally	O	O	O
well	O	O	O
to	O	O	O
recombinant	O	O	B-T116
NA	O	O	B-T116
of	O	O	O
wild-type	O	O	B-T028
A/Anhui/1/2013	O	O	B-T005
and	O	O	O
to	O	O	O
a	O	O	O
variant	O	O	B-T080
NA	O	O	O
carrying	O	O	O
a	O	O	O
R289	O	O	O
K	O	O	O
mutation	O	O	B-T045
known	O	O	O
to	O	O	O
infer	O	O	O
NAI	O	O	B-T121
resistance	O	O	B-T169
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
3c10	O	O	B-T129
-	O	O	I-T129
3	O	O	I-T129
has	O	O	O
the	O	O	O
potential	O	O	B-T080
to	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
therapeutic	O	O	B-T169
to	O	O	O
treat	O	O	O
A(H7N9	O	O	B-T005
)	O	O	I-T005
infections	O	O	B-T046
either	O	O	O
as	O	O	O
an	O	O	O
alternative	O	O	B-T077
to	O	O	O
,	O	O	O
or	O	O	O
in	O	O	O
combination	O	O	B-T080
with	O	O	O
,	O	O	O
current	O	O	O
NA	O	O	B-T116
antiviral	O	O	B-T121
inhibitors	O	O	I-T121
.	O	O	O

-DOCSTART- (27714497)

Mechanisms	O	O	B-T169
of	O	O	O
ear	O	O	B-T023
trauma	O	O	B-T037
and	O	O	O
reconstructive	O	O	B-T061
techniques	O	O	B-T169
in	O	O	O
105	O	O	O
consecutive	O	O	B-T080
patients	O	O	O

Acquired	O	O	B-T080
auricular	O	O	B-T023
deformities	O	O	B-T190
may	O	O	O
diminish	O	O	B-T081
facial	O	O	B-T032
esthetics	O	O	I-T032
and	O	O	O
cause	O	O	O
psychological	O	O	B-T048
distress	O	O	I-T048
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
article	O	O	O
is	O	O	O
to	O	O	O
provide	O	O	O
an	O	O	O
overview	O	O	O
of	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
injuries	O	O	B-T037
and	O	O	O
applied	O	O	B-T061
reconstructive	O	O	I-T061
techniques	O	O	B-T169
in	O	O	O
a	O	O	O
large	O	O	O
academic	O	O	B-T093
hospital	O	O	I-T093
in	O	O	O
The	O	O	O
Netherlands	O	O	B-T083
.	O	O	O

A	O	O	O
retrospective	O	O	B-T080
chart	O	O	B-UnknownType
review	O	O	I-UnknownType
was	O	O	O
conducted	O	O	O
for	O	O	O
the	O	O	O
last	O	O	O
105	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
auricular	O	O	B-T023
reconstruction	O	O	B-T061
for	O	O	O
an	O	O	O
acquired	O	O	B-T020
deformity	O	O	I-T020
.	O	O	O

Data	O	O	B-T078
concerning	O	O	O
gender	O	O	B-T032
,	O	O	O
affected	O	O	B-T033
side	O	O	I-T033
,	O	O	O
cause	O	O	B-T033
of	O	O	I-T033
injury	O	O	I-T033
,	O	O	O
anatomical	O	O	B-T029
region	O	O	I-T029
,	O	O	O
the	O	O	O
previous	O	O	O
and	O	O	O
further	O	O	O
surgeries	O	O	B-T061
,	O	O	O
type	O	O	O
of	O	O	O
cartilage	O	O	B-T024
,	O	O	O
and	O	O	O
skin	O	O	B-T074
cover	O	O	I-T074
used	O	O	I-T074
were	O	O	O
collected	O	O	O
and	O	O	O
analyzed	O	O	B-T062
.	O	O	O

105	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
.	O	O	O

Acquired	O	O	B-T080
auricular	O	O	B-T023
deformities	O	O	B-T190
were	O	O	O
mainly	O	O	O
caused	O	O	O
by	O	O	O
bite	O	O	B-T037
injuries	O	O	I-T037
(	O	O	O
22	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
traffic	O	O	B-T037
accidents	O	O	I-T037
(	O	O	O
17	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
burns	O	O	B-T037
(	O	O	O
9.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
post-otoplasty	O	O	B-T061
complications	O	O	B-T046
(	O	O	O
9.5	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
upper	O	O	B-T023
third	O	O	I-T023
of	O	O	I-T023
the	O	O	I-T023
auricle	O	O	I-T023
was	O	O	O
most	O	O	O
often	O	O	O
injured	O	O	B-T169
(	O	O	O
41	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
the	O	O	O
entire	O	O	B-T023
auricle	O	O	I-T023
(	O	O	O
19	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

70	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	B-T169
required	O	O	O
reconstruction	O	O	B-T061
with	O	O	O
costal	O	O	B-T024
cartilage	O	O	I-T024
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
form	O	O	O
of	O	O	O
cutaneous	O	O	B-T082
cover	O	O	I-T082
was	O	O	O
a	O	O	O
postauricular	O	O	B-T061
skin	O	O	I-T061
flap	O	O	I-T061
(	O	O	O
40	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	B-T169
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
gives	O	O	O
a	O	O	O
complete	O	O	O
overview	O	O	O
of	O	O	O
causes	O	O	O
and	O	O	O
treatment	O	O	B-T169
of	O	O	O
acquired	O	O	B-T080
auricular	O	O	B-T023
deformities	O	O	B-T190
.	O	O	O

The	O	O	O
results	O	O	B-T169
are	O	O	O
comparable	O	O	O
with	O	O	O
the	O	O	O
results	O	O	O
of	O	O	O
similar	O	O	O
studies	O	O	B-T062
found	O	O	O
in	O	O	O
literature	O	O	B-T170
.	O	O	O

Bite	O	O	B-T037
wounds	O	O	I-T037
are	O	O	O
the	O	O	O
leading	O	O	O
cause	O	O	O
of	O	O	O
acquired	O	O	B-T080
auricular	O	O	B-T023
injuries	O	O	B-T037
.	O	O	O

The	O	O	O
upper	O	O	B-T023
third	O	O	I-T023
is	O	O	O
most	O	O	O
commonly	O	O	O
affected	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
largest	O	O	O
percentage	O	O	O
of	O	O	O
reconstructions	O	O	B-T061
,	O	O	O
costal	O	O	B-T024
cartilage	O	O	I-T024
and	O	O	O
a	O	O	O
postauricular	O	O	B-T023
flap	O	O	I-T023
were	O	O	O
used	O	O	O
to	O	O	O
correct	O	O	O
the	O	O	O
deformity	O	O	B-T190
.	O	O	O

-DOCSTART- (27714730)

Anatomic	O	O	B-T080
assessment	O	O	B-T058
of	O	O	O
the	O	O	O
left	O	O	B-T082
main	O	O	I-T082
bifurcation	O	O	I-T082
and	O	O	O
dynamic	O	O	B-T082
bifurcation	O	O	I-T082
angles	O	O	I-T082
using	O	O	O
computed	O	O	O
tomography	O	O	O
angiography	O	O	O

An	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
left	O	O	B-T023
main	O	O	I-T023
coronary	O	O	I-T023
artery	O	O	I-T023
(	O	O	O
LMCA	O	O	B-T023
)	O	O	O
anatomy	O	O	B-T017
is	O	O	O
important	O	O	O
for	O	O	O
accurate	O	O	O
diagnosis	O	O	B-T080
and	O	O	O
therapeutic	O	O	B-T061
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
LMCA	O	O	B-T023
anatomy	O	O	B-T017
via	O	O	O
128-multisliced	O	O	B-T060
coronary	O	O	I-T060
computed-tomography-angiography	O	O	I-T060
(	O	O	O
CCTA	O	O	B-T060
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
normal	O	O	O
LMCA	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
201	O	O	O
CCTA	O	O	B-T060
studies	O	O	B-T062
were	O	O	O
included	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

Anatomical	O	O	B-T017
features	O	O	I-T017
of	O	O	O
LMCA	O	O	B-T023
including	O	O	O
cross-sectional	O	O	B-T082
areas	O	O	I-T082
of	O	O	O
the	O	O	O
LMCA	O	O	O
ostial	O	O	B-T030
,	O	O	O
LMCA	O	O	O
distal	O	O	B-T082
,	O	O	O
LAD	O	O	B-T023
ostial	O	O	I-T023
and	O	O	O
LCX	O	O	B-T023
ostial	O	O	O
,	O	O	O
and	O	O	O
degree	O	O	O
of	O	O	O
tapering	O	O	O
and	O	O	O
LMCA	O	O	O
bifurcation	O	O	B-T082
angles	O	O	I-T082
(	O	O	O
BA	O	O	B-T082
)	O	O	O
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
LMCA	O	O	O
-	O	O	O
LCX	O	O	O
BA	O	O	O
,	O	O	O
LMCA	O	O	O
-	O	O	O
LAD	O	O	O
BA	O	O	O
,	O	O	O
LAD	O	O	O
-	O	O	O
LCX	O	O	O
BA	O	O	O
at	O	O	O
end-diastole	O	O	B-T079
and	O	O	O
end-systole	O	O	B-T079
.	O	O	O

The	O	O	O
mean	O	O	O
age	O	O	B-T032
was	O	O	O
55	O	O	O
±	O	O	O
11	O	O	O
with	O	O	O
55.7	O	O	O
%	O	O	O
males	O	O	B-T032
.	O	O	O

RCA	O	O	B-T023
was	O	O	O
dominant	O	O	B-T169
in	O	O	O
173	O	O	O
(	O	O	O
86.1	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
.	O	O	O

Mean	O	O	O
LMCA	O	O	B-T023
length	O	O	B-T081
was	O	O	O
10.0±4.5	O	O	O
mm	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	O
values	O	O	O
of	O	O	O
LMCA	O	O	B-T023
ostial	O	O	B-T030
,	O	O	O
LMCA	O	O	O
distal	O	O	B-T082
,	O	O	O
LAD	O	O	B-T023
ostial	O	O	I-T023
and	O	O	O
LCX	O	O	B-T023
ostial	O	O	O
areas	O	O	B-T082
were	O	O	O
18.2±5.1	O	O	O
mm²	O	O	O
,	O	O	O
13.2±4.0	O	O	O
,	O	O	O
9.0±3.2	O	O	O
mm²	O	O	O
and	O	O	O
7.6±2.8	O	O	O
mm²	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

LMCA	O	O	B-T023
ostial	O	O	B-T030
-	O	O	O
distal	O	O	B-T082
area	O	O	B-T082
,	O	O	O
LMCA	O	O	O
distal	O	O	O
-	O	O	O
LAD	O	O	B-T023
ostial	O	O	I-T023
area	O	O	O
and	O	O	O
LMCA	O	O	O
distal	O	O	O
-	O	O	O
LCX	O	O	B-T023
ostial	O	O	O
area	O	O	B-T081
ratios	O	O	I-T081
were	O	O	O
≥1.44	O	O	O
-	O	O	O
<	O	O	O
1.69	O	O	O
in	O	O	O
47	O	O	O
(	O	O	O
23.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
53	O	O	O
(	O	O	O
26.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
47	O	O	O
(	O	O	O
23.4	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
,	O	O	O
respectively	O	O	O
,	O	O	O
and	O	O	O
were	O	O	O
≥1.69-<1.96	O	O	O
in	O	O	O
19	O	O	O
(	O	O	O
9.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
24(11.9	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
40(19.9	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	O
respectively	O	O	O
.	O	O	O

Systolic	O	O	B-T070
motion	O	O	I-T070
modifies	O	O	O
LMCA	O	O	B-T023
BAs	O	O	B-T082
;	O	O	O
systolic	O	O	B-T070
motion	O	O	I-T070
begets	O	O	O
an	O	O	O
increment	O	O	O
of	O	O	O
LMCA	O	O	O
-	O	O	O
LAD	O	O	B-T023
angle	O	O	O
in	O	O	O
72.6	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
and	O	O	O
decrement	O	O	O
of	O	O	O
LAD	O	O	O
-	O	O	O
LCX	O	O	B-T023
angle	O	O	O
in	O	O	O
75.6	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
T-shaped	O	O	O
LAD	O	O	B-T023
-	O	O	O
LCX	O	O	B-T023
BA	O	O	B-T082
was	O	O	O
shown	O	O	O
to	O	O	O
have	O	O	O
significantly	O	O	O
longer	O	O	O
LMCA	O	O	B-T023
,	O	O	O
larger	O	O	O
LAD	O	O	B-T023
ostial	O	O	B-T030
area	O	O	B-T082
,	O	O	O
larger	O	O	O
LCX	O	O	O
ostial	O	O	O
area	O	O	O
and	O	O	O
higher	O	O	O
diastolic-to-systolic	O	O	B-T081
range	O	O	I-T081
(	O	O	O
DSR	O	O	B-T081
)	O	O	O
of	O	O	O
LAD	O	O	O
-	O	O	O
LCX	O	O	O
BA	O	O	O
compared	O	O	O
to	O	O	O
patients	O	O	B-T101
with	O	O	O
Y-shaped	O	O	O
LAD	O	O	O
-	O	O	O
LCX	O	O	O
BA	O	O	O
.	O	O	O

LMCA	O	O	B-T023
with	O	O	O
T-shaped	O	O	B-T082
distal	O	O	B-T082
BA	O	O	B-T082
was	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
significantly	O	O	O
longer	O	O	O
LMCA	O	O	O
,	O	O	O
larger	O	O	O
LAD	O	O	B-T023
ostial	O	O	B-T030
area	O	O	B-T082
,	O	O	O
larger	O	O	O
LCX	O	O	B-T023
ostial	O	O	O
area	O	O	O
and	O	O	O
higher	O	O	O
DSR	O	O	B-T081
of	O	O	O
distal	O	O	O
BA	O	O	O
compared	O	O	O
to	O	O	O
patients	O	O	B-T101
with	O	O	O
Y-shaped	O	O	B-T082
distal	O	O	I-T082
BA	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	B-T033
may	O	O	O
provide	O	O	O
useful	O	O	O
information	O	O	O
for	O	O	O
LMCA	O	O	B-T023
bifurcation	O	O	B-T061
stenting	O	O	I-T061
or	O	O	O
designing	O	O	O
dedicated	O	O	O
stents	O	O	B-T074
for	O	O	O
LMCA	O	O	O
.	O	O	O

-DOCSTART- (27716187)

A	O	O	O
three	O	O	B-T081
perspective	O	O	B-T062
study	O	O	I-T062
of	O	O	O
the	O	O	O
sense	O	O	O
of	O	O	O
home	O	O	B-T082
of	O	O	O
nursing	O	O	B-T098
home	O	O	I-T098
residents	O	O	B-T098
:	O	O	O
the	O	O	O
views	O	O	O
of	O	O	O
residents	O	O	O
,	O	O	O
care	O	O	B-T097
professionals	O	O	I-T097
and	O	O	O
relatives	O	O	O

The	O	O	O
sense	O	O	O
of	O	O	O
home	O	O	B-T082
of	O	O	O
nursing	O	O	B-T098
home	O	O	I-T098
residents	O	O	I-T098
is	O	O	O
a	O	O	O
multifactorial	O	O	B-T033
phenomenon	O	O	B-T067
which	O	O	O
is	O	O	O
important	O	O	B-T080
for	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
living	O	O	B-T078
.	O	O	O

The	O	O	O
purpose	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
factors	O	O	B-T169
influencing	O	O	B-T077
the	O	O	O
sense	O	O	O
of	O	O	O
home	O	O	B-T082
of	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
residing	O	O	B-T052
in	O	O	O
the	O	O	O
nursing	O	O	B-T093
home	O	O	I-T093
from	O	O	O
the	O	O	O
perspective	O	O	O
of	O	O	O
residents	O	O	B-T098
,	O	O	O
relatives	O	O	B-T099
and	O	O	O
care	O	O	B-T097
professionals	O	O	I-T097
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
78	O	O	O
participants	O	O	B-T098
(	O	O	O
n	O	O	O
=	O	O	O
24	O	O	O
residents	O	O	B-T098
,	O	O	O
n	O	O	O
=	O	O	O
18	O	O	O
relatives	O	O	B-T099
and	O	O	O
n	O	O	O
=	O	O	O
26	O	O	O
care	O	O	B-T097
professionals	O	O	I-T097
)	O	O	O
from	O	O	O
4	O	O	O
nursing	O	O	B-T093
homes	O	O	I-T093
in	O	O	O
the	O	O	O
Netherlands	O	O	B-T083
engaged	O	O	O
in	O	O	O
a	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
,	O	O	O
in	O	O	O
which	O	O	O
photography	O	O	O
was	O	O	O
as	O	O	O
a	O	O	O
supportive	O	O	O
tool	O	O	O
for	O	O	O
subsequent	O	O	B-T079
interviews	O	O	B-T052
and	O	O	O
focus	O	O	B-T096
groups	O	O	I-T096
.	O	O	O

The	O	O	O
data	O	O	B-T078
were	O	O	O
analyzed	O	O	O
based	O	O	O
on	O	O	O
open	O	O	B-T080
ended	O	O	I-T080
coding	O	O	I-T080
,	O	O	O
axial	O	O	B-T080
coding	O	O	I-T080
and	O	O	O
selective	O	O	B-T080
coding	O	O	I-T080
.	O	O	O

The	O	O	O
sense	O	O	O
of	O	O	O
home	O	O	B-T082
of	O	O	O
nursing	O	O	B-T098
home	O	O	I-T098
residents	O	O	I-T098
is	O	O	O
influenced	O	O	B-T077
by	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
jointly	O	O	O
identified	O	O	O
factors	O	O	B-T169
,	O	O	O
including	O	O	O
the	O	O	O
building	O	O	B-T073
and	O	O	O
interior	O	O	B-T073
design	O	O	I-T073
;	O	O	O
eating	O	O	B-T055
and	O	O	O
drinking	O	O	B-T055
;	O	O	O
autonomy	O	O	B-T078
and	O	O	O
control	O	O	B-T169
;	O	O	O
involvement	O	O	B-T169
of	O	O	O
relatives	O	O	B-T099
;	O	O	O
engagement	O	O	O
with	O	O	O
others	O	O	O
and	O	O	O
activities	O	O	B-T052
;	O	O	O
quality	O	O	B-T058
of	O	O	I-T058
care	O	O	I-T058
are	O	O	O
shared	O	O	O
themes	O	O	O
.	O	O	O

Residents	O	O	B-T098
and	O	O	O
relatives	O	O	B-T099
stressed	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
having	O	O	O
a	O	O	O
connection	O	O	O
with	O	O	O
nature	O	O	B-T078
and	O	O	O
the	O	O	O
outdoors	O	O	B-T083
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
coping	O	O	B-T055
strategies	O	O	I-T055
.	O	O	O

Relatives	O	O	B-T099
and	O	O	O
care	O	O	B-T052
professionals	O	O	I-T097
emphasized	O	O	O
the	O	O	O
role	O	O	O
the	O	O	O
organization	O	O	B-T092
of	O	O	O
facilitation	O	O	B-T058
of	O	O	O
care	O	O	O
played	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
making	O	O	O
residents	O	O	B-T098
feel	O	O	O
like	O	O	O
they	O	O	O
still	O	O	O
matter	O	O	O
.	O	O	O

The	O	O	O
sense	O	O	O
of	O	O	O
home	O	O	B-T082
of	O	O	O
nursing	O	O	B-T098
home	O	O	I-T098
residents	O	O	B-T098
is	O	O	O
influenced	O	O	B-T077
by	O	O	O
a	O	O	O
multitude	O	O	B-T081
of	O	O	O
factors	O	O	B-T169
related	O	O	O
to	O	O	O
the	O	O	O
psychology	O	O	B-T169
of	O	O	O
the	O	O	O
residents	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
social	O	O	B-T078
and	O	O	I-T078
built	O	O	I-T078
environmental	O	O	I-T078
contexts	O	O	I-T078
.	O	O	O

A	O	O	O
holistic	O	O	B-T078
understanding	O	O	O
of	O	O	O
which	O	O	O
factors	O	O	B-T169
influence	O	O	B-T077
the	O	O	O
sense	O	O	O
of	O	O	O
home	O	O	B-T082
of	O	O	O
residents	O	O	B-T098
can	O	O	O
lead	O	O	O
to	O	O	O
strategies	O	O	O
to	O	O	O
optimize	O	O	B-T052
this	O	O	O
sense	O	O	O
of	O	O	O
home	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
also	O	O	O
indicated	O	O	O
that	O	O	O
the	O	O	O
nursing	O	O	B-T093
home	O	O	I-T093
has	O	O	O
a	O	O	O
dual	O	O	O
nature	O	O	B-T078
as	O	O	O
a	O	O	O
place	O	O	B-T082
of	O	O	O
residence	O	O	B-T082
and	O	O	O
a	O	O	O
place	O	O	O
where	O	O	O
people	O	O	B-T098
are	O	O	O
supported	O	O	O
through	O	O	O
numerous	O	O	B-T081
care	O	O	O
strategies	O	O	O
.	O	O	O

-DOCSTART- (27716352)

Integrating	O	O	O
one	O	O	B-T091
health	O	O	I-T091
in	O	O	O
national	O	O	B-T170
health	O	O	I-T170
policies	O	O	I-T170
of	O	O	O
developing	O	O	B-T080
countries	O	O	I-T080
:	O	O	O
India	O	O	B-T083
's	O	O	I-T083
lost	O	O	O
opportunities	O	O	O

Globally	O	O	B-T080
,	O	O	O
the	O	O	O
threat	O	O	B-T078
of	O	O	O
infectious	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
particularly	O	O	O
emerging	O	O	B-T047
infectious	O	O	I-T047
diseases	O	O	I-T047
,	O	O	O
originating	O	O	B-T079
at	O	O	O
the	O	O	O
human	O	O	B-T016
-	O	O	O
animal	O	O	B-T008
-	O	O	O
environment	O	O	B-T082
interface	O	O	B-T169
,	O	O	O
has	O	O	O
caught	O	O	O
health	O	O	B-T064
systems	O	O	I-T064
off	O	O	O
guard	O	O	O
.	O	O	O

With	O	O	O
forecasts	O	O	O
that	O	O	O
future	O	O	O
pathogen	O	O	B-T001
emergence	O	O	B-T047
will	O	O	O
be	O	O	O
centred	O	O	O
in	O	O	O
hotspots	O	O	O
in	O	O	O
Asia	O	O	B-T083
,	O	O	O
Africa	O	O	B-T083
,	O	O	O
and	O	O	O
Latin	O	O	B-T083
America	O	O	I-T083
,	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
prepare	O	O	O
policy	O	O	B-T170
frameworks	O	O	I-T170
that	O	O	O
can	O	O	O
combat	O	O	O
this	O	O	O
threat	O	O	B-T078
is	O	O	O
urgent	O	O	B-T079
.	O	O	O

Emergence	O	O	B-T047
of	O	O	I-T047
diseases	O	O	I-T047
such	O	O	O
as	O	O	O
avian	O	O	B-T047
influenza	O	O	I-T047
and	O	O	O
Ebola	O	O	B-T047
virus	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
which	O	O	O
threatened	O	O	B-T078
social	O	O	B-T169
disruption	O	O	B-T169
,	O	O	O
have	O	O	O
established	O	O	B-T080
the	O	O	O
need	O	O	O
for	O	O	O
intersectoral	O	O	B-T058
coordination/collaboration	O	O	I-T058
.	O	O	O

These	O	O	O
events	O	O	B-T051
led	O	O	O
to	O	O	O
the	O	O	O
initiation	O	O	B-T169
of	O	O	O
establishing	O	O	B-T080
institutionalised	O	O	B-T033
collaborative	O	O	B-T054
frameworks	O	O	I-T054
in	O	O	O
India	O	O	B-T083
to	O	O	O
adopt	O	O	O
a	O	O	O
One	O	O	B-T091
Health	O	O	I-T091
approach	O	O	I-T091
to	O	O	O
disease	O	O	B-T058
prevention	O	O	I-T058
and	O	O	I-T058
control	O	O	I-T058
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
gains	O	O	B-T081
made	O	O	O
in	O	O	O
influenza	O	O	B-T047
control	O	O	B-T067
could	O	O	O
not	O	O	O
be	O	O	O
adapted	O	O	O
to	O	O	O
other	O	O	O
infectious	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

Intersectoral	O	O	B-T058
coordination	O	O	I-T058
was	O	O	O
briefly	O	O	O
carried	O	O	O
out	O	O	O
,	O	O	O
more	O	O	O
as	O	O	O
a	O	O	O
reactive	O	O	B-T080
response	O	O	O
to	O	O	O
threats	O	O	B-T078
.	O	O	O

The	O	O	O
systemic	O	O	B-T169
failure	O	O	B-T169
to	O	O	O
sustain	O	O	B-T169
such	O	O	O
efforts	O	O	O
have	O	O	O
therefore	O	O	O
,	O	O	O
only	O	O	O
undermined	O	O	O
a	O	O	O
coordinated	O	O	B-T169
response	O	O	B-T169
.	O	O	O

The	O	O	O
recent	O	O	O
draft	O	O	B-T170
National	O	O	B-T170
Health	O	O	I-T170
Policy	O	O	I-T170
,	O	O	O
2015	O	O	O
,	O	O	O
has	O	O	O
also	O	O	O
failed	O	O	B-T169
to	O	O	O
establish	O	O	B-T080
the	O	O	O
need	O	O	O
for	O	O	O
intersectoral	O	O	B-T058
coordination	O	O	I-T058
in	O	O	O
disease	O	O	B-T058
control	O	O	I-T058
approaches	O	O	I-T058
.	O	O	O

Neglecting	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
endorse	O	O	O
linkages	O	O	B-T185
between	O	O	O
human	O	O	B-T016
health	O	O	B-T078
,	O	O	O
animal	O	O	B-T008
health	O	O	O
and	O	O	O
husbandry	O	O	B-T090
,	O	O	O
agriculture	O	O	B-T090
,	O	O	O
and	O	O	O
environmental	O	O	B-T082
sectors	O	O	B-T083
,	O	O	O
has	O	O	O
led	O	O	O
to	O	O	O
duplicative	O	O	B-T169
and	O	O	O
weak	O	O	B-T033
response	O	O	I-T033
systems	O	O	I-T033
.	O	O	O

The	O	O	O
absence	O	O	B-T169
of	O	O	O
health	O	O	B-T078
impact	O	O	I-T058
assessment	O	O	I-T058
with	O	O	O
respect	O	O	O
to	O	O	O
the	O	O	O
development	O	O	B-T169
agenda	O	O	B-T170
in	O	O	O
policies	O	O	B-T170
,	O	O	O
has	O	O	O
cast	O	O	O
negative	O	O	B-T033
effects	O	O	B-T080
on	O	O	O
the	O	O	O
health	O	O	O
and	O	O	O
wellbeing	O	O	B-T170
of	O	O	I-T170
man	O	O	I-T170
,	O	O	O
animal	O	O	B-T008
,	O	O	O
and	O	O	O
the	O	O	O
environment	O	O	B-T082
.	O	O	O

Lack	O	O	B-T033
of	O	O	I-T033
attention	O	O	I-T033
to	O	O	O
building	O	O	O
core	O	O	O
capacity	O	O	B-T081
in	O	O	O
these	O	O	O
critical	O	O	B-T080
sectors	O	O	B-T083
has	O	O	O
further	O	O	O
raised	O	O	B-T080
challenges	O	O	B-T058
in	O	O	O
designing	O	O	O
and	O	O	O
deploying	O	O	B-T052
mitigation	O	O	B-T067
strategies	O	O	B-T041
.	O	O	O

With	O	O	O
developing	O	O	B-T080
countries	O	O	I-T080
like	O	O	O
India	O	O	B-T083
being	O	O	O
home	O	O	O
to	O	O	O
a	O	O	O
major	O	O	O
portion	O	O	B-T082
of	O	O	O
the	O	O	O
world	O	O	B-T098
's	O	O	I-T098
poorest	O	O	B-T080
livestock	O	O	B-T097
farmers	O	O	I-T097
,	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
a	O	O	O
policy	O	O	B-T170
discourse	O	O	B-T054
that	O	O	O
endorses	O	O	O
the	O	O	O
One	O	O	B-T091
Health	O	O	I-T091
approach	O	O	I-T091
in	O	O	O
development	O	O	B-T169
and	O	O	O
health	O	O	B-T089
policies	O	O	I-T089
is	O	O	O
a	O	O	O
major	O	O	O
hurdle	O	O	B-T046
in	O	O	O
eliminating	O	O	B-T052
poverty	O	O	B-T102
and	O	O	O
poverty	O	O	O
-	O	O	O
related	O	O	B-T080
diseases	O	O	B-T047
.	O	O	O

The	O	O	O
adoption	O	O	B-T080
of	O	O	O
One	O	O	B-T091
Health	O	O	I-T091
approaches	O	O	I-T091
in	O	O	O
health	O	O	B-T078
and	O	O	O
related	O	O	O
sectoral	O	O	B-T082
policies	O	O	B-T170
is	O	O	O
a	O	O	O
critical	O	O	B-T080
policy	O	O	B-T170
requirement	O	O	O
for	O	O	O
India	O	O	B-T083
and	O	O	O
other	O	O	O
developing	O	O	B-T080
countries	O	O	I-T080
.	O	O	O

The	O	O	O
goal	O	O	O
should	O	O	O
be	O	O	O
to	O	O	O
not	O	O	O
just	O	O	O
establish	O	O	B-T080
preparedness	O	O	B-T033
plans	O	O	B-T041
,	O	O	O
but	O	O	O
also	O	O	O
to	O	O	O
encourage	O	O	B-T169
a	O	O	O
policy	O	O	B-T064
environment	O	O	I-T064
where	O	O	O
assessment	O	O	B-T058
and	O	O	O
mitigation	O	O	B-T067
of	O	O	O
downstream	O	O	B-T082
impacts	O	O	B-T080
of	O	O	O
different	O	O	O
agenda	O	O	B-T170
are	O	O	O
incorporated	O	O	B-T169
.	O	O	O

-DOCSTART- (27717972)

Assessment	O	O	B-T058
of	O	O	O
demographic	O	O	B-T078
and	O	O	O
pathoanatomic	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
in	O	O	O
recurrent	O	O	B-T079
patellofemoral	O	O	B-T030
instability	O	O	O

The	O	O	O
WARPS/STAID	O	O	B-T185
classification	O	O	I-T185
employs	O	O	O
clinical	O	O	B-T080
assessment	O	O	B-T058
of	O	O	O
presenting	O	O	O
features	O	O	B-T080
and	O	O	O
anatomic	O	O	B-T080
characteristics	O	O	B-T080
to	O	O	O
identify	O	O	O
two	O	O	O
distinct	O	O	O
subsets	O	O	B-T185
of	O	O	O
patients	O	O	B-T101
within	O	O	O
the	O	O	O
patellofemoral	O	O	B-T033
instability	O	O	I-T033
population	O	O	B-T101
.	O	O	O

The	O	O	O
purpose	O	O	B-UnknownType
of	O	O	I-UnknownType
this	O	O	I-UnknownType
study	O	O	I-UnknownType
was	O	O	O
to	O	O	O
further	O	O	O
define	O	O	O
the	O	O	O
specific	O	O	O
demographics	O	O	B-T185
and	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
risky	O	O	B-T080
pathoanatomies	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
classified	O	O	O
as	O	O	O
either	O	O	O
WARPS	O	O	B-T185
or	O	O	O
STAID	O	O	B-T185
presenting	O	O	O
with	O	O	O
recurrent	O	O	B-T079
patellofemoral	O	O	B-T030
instability	O	O	B-T033
.	O	O	O

A	O	O	O
secondary	O	O	O
purpose	O	O	O
was	O	O	O
to	O	O	O
further	O	O	O
validate	O	O	O
the	O	O	O
WARPS/STAID	O	O	B-T185
classification	O	O	I-T185
with	O	O	O
the	O	O	O
Banff	O	O	B-T170
Patella	O	O	I-T170
Instability	O	O	I-T170
Instrument	O	O	I-T170
(	O	O	O
BPII	O	O	B-T170
)	O	O	O
,	O	O	O
the	O	O	O
Marx	O	O	B-T170
activity	O	O	I-T170
scale	O	O	I-T170
and	O	O	O
the	O	O	O
Patellar	O	O	B-T023
Instability	O	O	B-T170
Severity	O	O	I-T170
Score	O	O	I-T170
(	O	O	O
ISS	O	O	B-T170
)	O	O	O
.	O	O	O

A	O	O	O
convenience	O	O	O
sample	O	O	O
of	O	O	O
50	O	O	O
patients	O	O	B-T101
with	O	O	O
recurrent	O	O	B-T079
patellofemoral	O	O	B-T030
instability	O	O	B-T033
,	O	O	O
including	O	O	O
25	O	O	O
WARPS	O	O	B-T185
and	O	O	O
25	O	O	O
STAID	O	O	B-T185
subtype	O	O	I-T185
patients	O	O	O
,	O	O	O
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

Clinical	O	O	B-T170
data	O	O	I-T170
were	O	O	O
collected	O	O	O
including	O	O	O
assessment	O	O	B-T058
of	O	O	O
demographic	O	O	B-T078
risk	O	O	B-T033
factors	O	O	I-T033
(	O	O	O
sex	O	O	B-T032
,	O	O	O
BMI	O	O	B-T201
,	O	O	O
bilaterality	O	O	B-T082
of	O	O	O
symptoms	O	O	B-T184
,	O	O	O
affected	O	O	B-T082
limb	O	O	B-T023
side	O	O	I-T023
and	O	O	O
age	O	O	B-T032
at	O	O	O
first	O	O	O
dislocation	O	O	B-T037
)	O	O	O
and	O	O	O
pathoanatomic	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
(	O	O	O
TT-TG	O	O	B-T081
distance	O	O	I-T081
,	O	O	O
patella	O	O	B-T023
height	O	O	B-T032
,	O	O	O
patellar	O	O	O
tilt	O	O	O
,	O	O	O
grade	O	O	B-T185
of	O	O	O
trochlear	O	O	B-T047
dysplasia	O	O	I-T047
,	O	O	O
Beighton	O	O	B-T033
score	O	O	I-T033
and	O	O	O
rotational	O	O	B-T033
abnormalities	O	O	I-T033
of	O	O	O
the	O	O	O
tibia	O	O	B-T023
or	O	O	O
femur	O	O	B-T023
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
completed	O	O	O
the	O	O	O
BPII	O	O	B-T170
and	O	O	O
the	O	O	O
Marx	O	O	B-T170
activity	O	O	I-T170
scale	O	O	I-T170
.	O	O	O

The	O	O	O
ISS	O	O	B-T170
was	O	O	O
calculated	O	O	B-T059
from	O	O	O
the	O	O	O
clinical	O	O	B-T170
assessment	O	O	I-T170
data	O	O	I-T170
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
stratified	O	O	O
into	O	O	O
the	O	O	O
WARPS	O	O	B-T185
or	O	O	O
STAID	O	O	B-T185
subtypes	O	O	I-T185
for	O	O	O
comparative	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

An	O	O	O
independent	O	O	O
t	O	O	B-T170
test	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
compare	O	O	O
demographics	O	O	B-T185
,	O	O	O
the	O	O	O
pathoanatomic	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
and	O	O	O
subjective	O	O	O
measures	O	O	O
between	O	O	O
the	O	O	O
groups	O	O	B-UnknownType
.	O	O	O

Convergent	O	O	B-T080
validity	O	O	I-T080
was	O	O	O
tested	O	O	O
with	O	O	O
a	O	O	O
Pearson	O	O	B-T081
r	O	O	I-T081
correlation	O	O	I-T081
coefficient	O	O	I-T081
between	O	O	O
the	O	O	O
WARPS/STAID	O	O	B-T081
and	O	O	O
ISS	O	O	B-T170
scores	O	O	I-T170
.	O	O	O

Demographic	O	O	B-T078
risk	O	O	I-T078
factors	O	O	I-T078
statistically	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
WARPS	O	O	B-T185
subtype	O	O	I-T185
included	O	O	O
female	O	O	B-T032
sex	O	O	I-T032
,	O	O	O
age	O	O	B-T032
at	O	O	O
first	O	O	O
dislocation	O	O	B-T037
and	O	O	O
bilaterality	O	O	B-T082
.	O	O	O

Pathoanatomic	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
statistically	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
WARPS	O	O	B-T185
subtype	O	O	I-T185
included	O	O	O
trochlear	O	O	B-T047
dysplasia	O	O	I-T047
,	O	O	O
TT-TG	O	O	B-T081
distance	O	O	I-T081
,	O	O	O
generalized	O	O	O
ligamentous	O	O	B-T046
laxity	O	O	I-T046
,	O	O	O
patellar	O	O	O
tilt	O	O	O
and	O	O	O
rotational	O	O	B-T033
abnormalities	O	O	I-T033
.	O	O	O

The	O	O	O
independent	O	O	O
t	O	O	B-T170
test	O	O	I-T170
revealed	O	O	O
a	O	O	O
significant	O	O	O
difference	O	O	O
between	O	O	O
the	O	O	O
ISS	O	O	B-T170
scores	O	O	O
:	O	O	O
WARPS	O	O	B-T185
subtype	O	O	I-T185
(	O	O	O
M	O	O	O
=	O	O	O
4.4	O	O	O
,	O	O	O
SD	O	O	O
=	O	O	O
1.1	O	O	O
)	O	O	O
and	O	O	O
STAID	O	O	B-T185
subtype	O	O	I-T185
(	O	O	O
M	O	O	O
=	O	O	O
2.5	O	O	O
,	O	O	O
SD	O	O	O
=	O	O	O
1.5	O	O	O
)	O	O	O
;	O	O	O
t(48	O	O	O
)	O	O	O
=	O	O	O
5.2	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
.	O	O	O

The	O	O	O
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
WARPS/STAID	O	O	B-T081
and	O	O	O
the	O	O	O
ISS	O	O	B-T170
scores	O	O	I-T170
,	O	O	O
measured	O	O	O
using	O	O	O
a	O	O	O
Pearson	O	O	B-T081
r	O	O	I-T081
correlation	O	O	I-T081
coefficient	O	O	I-T081
,	O	O	O
demonstrated	O	O	O
a	O	O	O
strong	O	O	O
relationship	O	O	O
:	O	O	O
r	O	O	O
=	O	O	O
-0.61	O	O	O
,	O	O	O
n	O	O	O
=	O	O	O
50	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
has	O	O	O
demonstrated	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
evidence	O	O	B-T078
that	O	O	O
certain	O	O	O
demographics	O	O	B-T185
and	O	O	O
pathoanatomies	O	O	B-T080
are	O	O	O
more	O	O	O
prevalent	O	O	O
in	O	O	O
each	O	O	O
of	O	O	O
the	O	O	O
WARPS	O	O	B-T185
and	O	O	O
STAID	O	O	B-T185
patellofemoral	O	O	B-T030
instability	O	O	B-T033
subtypes	O	O	B-T185
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
difference	O	O	O
in	O	O	O
quality-of-life	O	O	B-T078
or	O	O	O
activity	O	O	B-T033
level	O	O	I-T033
between	O	O	O
the	O	O	O
subtypes	O	O	B-T185
.	O	O	O

The	O	O	O
WARPS/STAID	O	O	B-T081
score	O	O	I-T081
demonstrated	O	O	O
convergent	O	O	B-T080
validity	O	O	I-T080
to	O	O	O
the	O	O	O
ISS	O	O	B-T170
and	O	O	O
divergent	O	O	B-T081
validity	O	O	I-T081
to	O	O	O
the	O	O	O
BPII	O	O	B-T170
score	O	O	I-T170
and	O	O	O
the	O	O	O
Marx	O	O	B-T170
activity	O	O	I-T170
scale	O	O	I-T170
.	O	O	O

This	O	O	O
study	O	O	B-T062
has	O	O	O
further	O	O	O
validated	O	O	O
both	O	O	O
the	O	O	O
WARPS/STAID	O	O	B-T185
classification	O	O	I-T185
and	O	O	O
the	O	O	O
ISS	O	O	B-T170
of	O	O	O
patients	O	O	B-T101
that	O	O	O
present	O	O	O
with	O	O	O
recurrent	O	O	B-T079
patellofemoral	O	O	B-T030
instability	O	O	B-T033
.	O	O	O

III	O	O	O
.	O	O	O

-DOCSTART- (27718023)

Expression	O	O	B-T045
of	O	O	O
caspase	O	O	B-T116
3	O	O	I-T116
in	O	O	O
ovarian	O	O	B-T023
follicle	O	O	I-T023
cells	O	O	B-T025
of	O	O	O
the	O	O	O
lizard	O	O	B-T014
Podarcis	O	O	O
sicula	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O

our	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
caspase	O	O	B-T116
3	O	O	I-T116
plays	O	O	O
a	O	O	O
role	O	O	O
,	O	O	O
during	O	O	O
previtellogenesis	O	O	B-T042
,	O	O	O
in	O	O	O
the	O	O	O
ovarian	O	O	B-T023
follicular	O	O	B-T024
epithelium	O	O	I-T024
of	O	O	O
the	O	O	O
lizard	O	O	B-T014
Podarcis	O	O	B-T014
sicula	O	O	I-T014
.	O	O	O

We	O	O	O
investigated	O	O	O
the	O	O	O
presence	O	O	O
and	O	O	O
localization	O	O	B-T169
of	O	O	O
proform	O	O	O
and	O	O	O
active	O	O	O
caspase	O	O	B-T116
3	O	O	I-T116
by	O	O	O
enzyme	O	O	B-T059
assay	O	O	I-T059
,	O	O	O
Western	O	O	B-T059
blotting	O	O	I-T059
and	O	O	O
immunocytochemistry	O	O	B-T059
.	O	O	O

In	O	O	O
parallel	O	O	O
,	O	O	O
a	O	O	O
fragment	O	O	B-T080
of	O	O	O
caspase	O	O	B-T028
3	O	O	I-T028
was	O	O	O
cloned	O	O	B-T059
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
in	O	O	O
this	O	O	O
species	O	O	B-T185
,	O	O	O
sequenced	O	O	B-T169
and	O	O	O
used	O	O	O
for	O	O	O
in	O	O	B-T063
situ	O	O	I-T063
hybridization	O	O	I-T063
to	O	O	O
localize	O	O	B-T082
messengers	O	O	B-UnknownType
and	O	O	O
analysed	O	O	O
by	O	O	O
a	O	O	O
phylogenetic	O	O	B-T062
survey	O	O	I-T062
to	O	O	O
shed	O	O	O
light	O	O	O
on	O	O	O
its	O	O	O
homology	O	O	B-T080
with	O	O	O
reptilian	O	O	B-T014
caspases	O	O	B-T116
.	O	O	O

Results	O	O	O
demonstrated	O	O	O
that	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
the	O	O	O
follicle	O	O	B-T023
cells	O	O	B-T025
expressed	O	O	B-T045
a	O	O	O
caspase	O	O	B-T116
of	O	O	O
the	O	O	O
3/7	O	O	O
group	O	O	O
and	O	O	O
the	O	O	O
mRNA	O	O	B-T114
for	O	O	O
caspase	O	O	B-T116
3	O	O	I-T116
was	O	O	O
transcribed	O	O	B-T045
in	O	O	O
the	O	O	O
stem	O	O	B-T079
phase	O	O	I-T079
and	O	O	O
was	O	O	O
completely	O	O	O
translated	O	O	B-T044
during	O	O	O
cell	O	O	B-T043
differentiation	O	O	I-T043
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
the	O	O	O
proform	O	O	B-T116
protein	O	O	I-T116
was	O	O	O
stored	O	O	O
during	O	O	O
the	O	O	O
differentiated	O	O	B-T080
(	O	O	I-T080
nurse	O	O	I-T080
)	O	O	I-T080
stage	O	O	I-T080
and	O	O	O
activated	O	O	B-T045
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
previtellogenesis	O	O	B-T042
provoking	O	O	O
the	O	O	O
degeneration	O	O	B-T046
of	O	O	I-T046
cells	O	O	I-T046
;	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
the	O	O	O
predicted	O	O	O
protein	O	O	B-T087
sequence	O	O	I-T087
,	O	O	O
although	O	O	O
partial	O	O	O
,	O	O	O
had	O	O	O
a	O	O	O
strong	O	O	O
similarity	O	O	O
with	O	O	O
the	O	O	O
known	O	O	O
reptilian	O	O	B-T014
caspases	O	O	B-T116
3	O	O	I-T116
.	O	O	O

The	O	O	O
epithelial	O	O	B-T025
cells	O	O	I-T025
of	O	O	O
the	O	O	O
ovarian	O	O	B-T023
follicle	O	O	I-T023
,	O	O	O
therefore	O	O	O
,	O	O	O
do	O	O	O
not	O	O	O
employ	O	O	O
caspase	O	O	B-T116
3	O	O	I-T116
during	O	O	O
the	O	O	O
nurse	O	O	B-T080
stage	O	O	I-T080
but	O	O	O
,	O	O	O
instead	O	O	O
,	O	O	O
prepare	O	O	O
for	O	O	O
apoptosis	O	O	B-T043
long	O	O	O
before	O	O	O
the	O	O	O
process	O	O	O
actually	O	O	O
begins	O	O	O
.	O	O	O

The	O	O	O
relevance	O	O	O
of	O	O	O
this	O	O	O
strategy	O	O	O
is	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (27720129)

Increased	O	O	B-T081
acute	O	O	B-T079
mortality	O	O	B-T081
with	O	O	O
chemoradiotherapy	O	O	B-T061
for	O	O	O
locally	O	O	B-T191
advanced	O	O	I-T191
head	O	O	I-T191
and	O	O	I-T191
neck	O	O	I-T191
cancer	O	O	I-T191
in	O	O	O
patients	O	O	B-T101
≥70	O	O	O
years	O	O	O

Concurrent	O	O	B-T061
chemoradiotherapy	O	O	I-T061
(	O	O	O
CRT	O	O	B-T061
)	O	O	O
is	O	O	O
the	O	O	O
standard	O	O	B-T061
of	O	O	I-T061
care	O	O	I-T061
for	O	O	O
many	O	O	O
sites	O	O	B-T082
of	O	O	O
locally	O	O	B-T191
advanced	O	O	I-T191
head	O	O	I-T191
and	O	O	I-T191
neck	O	O	I-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinomas	O	O	I-T191
(	O	O	O
LAHNC	O	O	B-T191
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
on	O	O	O
meta-analysis	O	O	B-T062
,	O	O	O
the	O	O	O
addition	O	O	O
of	O	O	O
chemotherapy	O	O	B-T061
did	O	O	O
not	O	O	O
improve	O	O	O
survival	O	O	B-T169
for	O	O	O
patients	O	O	B-T101
>	O	O	O
70	O	O	O
years	O	O	B-T079
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
elderly	O	O	B-T098
patients	O	O	B-T101
treated	O	O	B-T169
with	O	O	O
CRT	O	O	B-T061
would	O	O	O
have	O	O	O
increased	O	O	B-T081
toxicity	O	O	B-T037
without	O	O	O
similar	O	O	O
improvements	O	O	B-T077
in	O	O	O
survival	O	O	B-T169
.	O	O	O

A	O	O	O
single-institution	O	O	B-T093
,	O	O	O
IRB-approved	O	O	B-T170
retrospective	O	O	B-T062
study	O	O	I-T062
took	O	O	O
place	O	O	O
from	O	O	O
2005	O	O	O
to	O	O	O
2012	O	O	O
including	O	O	O
369	O	O	O
patients	O	O	B-T101
treated	O	O	B-T169
with	O	O	O
CRT	O	O	B-T061
for	O	O	O
LAHNC	O	O	B-T191
.	O	O	O

Multivariate	O	O	B-T081
models	O	O	I-T081
for	O	O	O
death	O	O	B-T033
at	O	O	O
3	O	O	O
months	O	O	B-T079
and	O	O	O
death	O	O	O
over	O	O	O
time	O	O	B-T079
were	O	O	O
developed	O	O	O
using	O	O	O
logistic	O	O	B-T062
regression	O	O	I-T062
and	O	O	O
Cox	O	O	B-T062
modeling	O	O	I-T062
,	O	O	O
respectively	O	O	O
.	O	O	O

Patients	O	O	B-T101
≥70	O	O	O
years	O	O	B-T079
were	O	O	O
treated	O	O	B-T169
less	O	O	O
often	O	O	O
with	O	O	O
concurrent	O	O	B-T079
cisplatin	O	O	B-T121
dosed	O	O	O
every	O	O	O
3	O	O	O
weeks	O	O	B-T079
(	O	O	O
25.5	O	O	O
%	O	O	O
vs.	O	O	O
71.4	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
and	O	O	O
more	O	O	O
often	O	O	O
with	O	O	O
weekly	O	O	B-T079
carboplatin	O	O	B-T109
(	O	O	O
31.9	O	O	O
%	O	O	O
vs.	O	O	O
3.4	O	O	O
%	O	O	O
)	O	O	O
than	O	O	O
patients	O	O	B-T101
<	O	O	O
70	O	O	O
years	O	O	O
(	O	O	O
n=322	O	O	O
;	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
≥70	O	O	O
years	O	O	B-T079
experienced	O	O	O
increased	O	O	B-T081
toxicity	O	O	B-T037
during	O	O	O
treatment	O	O	B-T061
with	O	O	O
more	O	O	O
frequently	O	O	O
hospitalizations	O	O	B-T058
(	O	O	O
36.2	O	O	O
%	O	O	O
vs.	O	O	O
21.1	O	O	O
%	O	O	O
;	O	O	O
p=0.02	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
lower	O	O	O
rate	O	O	O
of	O	O	O
PEG	O	O	B-T061
removal	O	O	I-T061
at	O	O	O
last	O	O	O
follow-up	O	O	B-T058
or	O	O	O
death	O	O	B-T033
(	O	O	O
77.1	O	O	O
%	O	O	O
vs.	O	O	O
92.9	O	O	O
%	O	O	O
;	O	O	O
p=0.004	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
higher	O	O	O
proportion	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
≥70	O	O	O
years	O	O	B-T079
died	O	O	O
within	O	O	O
3	O	O	O
months	O	O	B-T079
(	O	O	O
12.8	O	O	O
%	O	O	O
vs.	O	O	O
2.8	O	O	O
%	O	O	O
;	O	O	O
p=0.001	O	O	O
)	O	O	O
following	O	O	O
CRT	O	O	B-T061
.	O	O	O

Patients	O	O	B-T101
≥70	O	O	O
had	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
death	O	O	B-T033
at	O	O	O
3	O	O	O
months	O	O	B-T079
following	O	O	O
CRT	O	O	B-T061
(	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
5.19	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
1.64	O	O	O
-	O	O	O
16.41	O	O	O
;	O	O	O
p=0.005	O	O	O
)	O	O	O
and	O	O	O
worse	O	O	O
survival	O	O	B-T169
over	O	O	O
time	O	O	B-T079
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
2.30	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.34	O	O	O
-	O	O	O
3.93	O	O	O
;	O	O	O
p=0.002	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
≥70	O	O	O
years	O	O	B-T079
were	O	O	O
more	O	O	O
often	O	O	O
treated	O	O	B-T169
with	O	O	O
less	O	O	O
toxic	O	O	B-T080
chemotherapy	O	O	B-T061
,	O	O	O
yet	O	O	O
experienced	O	O	O
higher	O	O	O
rates	O	O	B-T081
of	O	O	O
hospitalization	O	O	B-T058
during	O	O	O
treatment	O	O	B-T061
and	O	O	O
increased	O	O	B-T081
rates	O	O	O
of	O	O	O
acute	O	O	B-T079
mortality	O	O	B-T081
following	O	O	O
CRT	O	O	B-T061
.	O	O	O

The	O	O	O
efficacy	O	O	B-T080
of	O	O	O
chemoradiotherapy	O	O	B-T061
for	O	O	O
elderly	O	O	B-T098
patients	O	O	B-T101
should	O	O	O
be	O	O	O
evaluated	O	O	O
in	O	O	O
a	O	O	O
prospective	O	O	B-T080
setting	O	O	I-T080
.	O	O	O

-DOCSTART- (27733749)

Food	O	O	B-T080
security	O	O	I-T080
and	O	O	O
the	O	O	O
nutritional	O	O	B-T033
status	O	O	I-T033
of	O	O	O
children	O	O	B-T100
in	O	O	O
foster	O	O	B-T073
care	O	O	I-T073
:	O	O	O
new	O	O	O
horizons	O	O	O
in	O	O	O
the	O	O	O
protection	O	O	O
of	O	O	O
a	O	O	O
fragile	O	O	O
population	O	O	O

The	O	O	O
nutritional	O	O	B-T033
status	O	O	I-T033
of	O	O	O
foster	O	O	B-T099
children	O	O	I-T099
,	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
daily	O	O	B-T168
menus	O	O	I-T168
in	O	O	O
group	O	O	B-T093
homes	O	O	I-T093
and	O	O	O
the	O	O	O
Food	O	O	B-T080
Security	O	O	I-T080
inside	O	O	O
these	O	O	O
organizations	O	O	B-T092
have	O	O	O
been	O	O	O
poorly	O	O	O
studied	O	O	O
and	O	O	O
this	O	O	O
study	O	O	B-T062
means	O	O	O
to	O	O	O
investigate	O	O	O
them	O	O	O
.	O	O	O

A	O	O	O
sample	O	O	O
of	O	O	O
125	O	O	O
children	O	O	B-T100
,	O	O	O
ranging	O	O	O
in	O	O	O
age	O	O	O
from	O	O	O
0	O	O	O
-	O	O	O
17	O	O	O
years	O	O	O
,	O	O	O
among	O	O	O
seven	O	O	O
group	O	O	B-T093
homes	O	O	I-T093
(	O	O	O
group	O	O	B-UnknownType
A	O	O	I-UnknownType
)	O	O	O
was	O	O	O
compared	O	O	O
with	O	O	O
121	O	O	O
children	O	O	O
of	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
we	O	O	O
(	O	O	O
group	O	O	B-UnknownType
B	O	O	I-UnknownType
)	O	O	O
.	O	O	O

To	O	O	O
evaluate	O	O	O
nutritional	O	O	B-T033
status	O	O	I-T033
,	O	O	O
BMI	O	O	B-T033
percentiles	O	O	I-T033
were	O	O	O
used	O	O	O
.	O	O	O

Mean	O	O	B-T081
percentiles	O	O	B-T081
of	O	O	O
both	O	O	O
groups	O	O	B-UnknownType
were	O	O	O
compared	O	O	O
through	O	O	O
statistical	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

Both	O	O	O
nutritional	O	O	B-T033
and	O	O	O
caloric	O	O	B-T033
daily	O	O	I-T033
distributions	O	O	I-T033
in	O	O	O
each	O	O	O
organization	O	O	B-T092
were	O	O	O
obtained	O	O	O
using	O	O	O
the	O	O	O
24-hour	O	O	O
recall	O	O	B-T170
method	O	O	I-T170
.	O	O	O

A	O	O	O
specific	O	O	O
questionnaire	O	O	B-T170
was	O	O	O
administered	O	O	O
to	O	O	O
evaluate	O	O	O
Food	O	O	B-T080
Security	O	O	I-T080
.	O	O	O

From	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
mean	O	O	B-T081
BMI	O	O	B-T201
-for-	O	O	O
age	O	O	B-T032
(	O	O	O
or	O	O	O
height-for-length	O	O	O
)	O	O	O
percentiles	O	O	B-T081
,	O	O	O
did	O	O	O
not	O	O	O
observe	O	O	O
statistically	O	O	O
significant	O	O	O
differences	O	O	B-T033
between	O	O	O
group	O	O	B-UnknownType
A	O	O	I-UnknownType
and	O	O	O
group	O	O	O
B.	O	O	O
The	O	O	O
average	O	O	B-T081
daily	O	O	B-T079
nutrient	O	O	B-T033
and	O	O	O
calorie	O	O	B-T033
distribution	O	O	I-T033
in	O	O	O
group	O	O	B-T093
homes	O	O	I-T093
proves	O	O	O
to	O	O	O
be	O	O	O
nearly	O	O	B-T033
optimal	O	O	I-T033
with	O	O	O
the	O	O	O
exception	O	O	O
of	O	O	O
a	O	O	O
slight	O	O	O
excess	O	O	B-T080
in	O	O	O
proteins	O	O	B-T168
and	O	O	O
a	O	O	O
slight	O	O	O
deficiency	O	O	B-T169
in	O	O	O
PUFAs	O	O	B-T109
.	O	O	O

Moreover	O	O	O
,	O	O	O
a	O	O	O
low	O	O	B-T033
intake	O	O	I-T033
of	O	O	O
iron	O	O	B-T033
and	O	O	O
calcium	O	O	B-T201
was	O	O	O
revealed	O	O	O
.	O	O	O

All	O	O	O
organizations	O	O	B-T092
obtained	O	O	O
a	O	O	O
"	O	O	O
High	O	O	B-T080
Food	O	O	I-T080
Security	O	O	I-T080
"	O	O	O
profile	O	O	O
.	O	O	O

Nutritional	O	O	B-T033
conditions	O	O	I-T033
of	O	O	O
foster	O	O	B-T099
children	O	O	B-T100
are	O	O	O
no	O	O	O
worse	O	O	O
than	O	O	O
that	O	O	O
of	O	O	O
children	O	O	O
of	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
.	O	O	O

Foster	O	O	B-T073
care	O	O	I-T073
provides	O	O	O
the	O	O	O
necessary	O	O	B-T080
conditions	O	O	I-T080
to	O	O	O
support	O	O	O
their	O	O	O
growth	O	O	B-T040
.	O	O	O

-DOCSTART- (27734729)

Incontinence	O	O	B-T047
-associated	O	O	O
dermatitis	O	O	B-T047
:	O	O	O
reducing	O	O	B-T080
adverse	O	O	O
events	O	O	O

Incontinence	O	O	B-T047
-associated	O	O	O
dermatitis	O	O	B-T047
(	O	O	O
IAD	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
common	O	O	O
problem	O	O	B-T033
in	O	O	O
patients	O	O	B-T101
with	O	O	O
faecal	O	O	B-T047
and/or	O	O	O
urinary	O	O	B-T046
incontinence	O	O	I-T046
.	O	O	O

Urine	O	O	B-T031
alters	O	O	O
the	O	O	O
normal	O	O	O
skin	O	O	B-T022
flora	O	O	B-T033
and	O	O	O
increases	O	O	O
permeability	O	O	B-T070
of	O	O	O
the	O	O	O
stratum	O	O	B-T024
corneum	O	O	I-T024
and	O	O	O
faecal	O	O	B-T031
enzymes	O	O	B-T116
on	O	O	O
the	O	O	O
skin	O	O	O
contribute	O	O	O
to	O	O	O
skin	O	O	B-T184
damage	O	O	I-T184
.	O	O	O

Faecal	O	O	B-T031
bacteria	O	O	B-T007
can	O	O	O
then	O	O	O
penetrate	O	O	B-T169
the	O	O	O
skin	O	O	B-T022
,	O	O	O
increasing	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
secondary	O	O	B-T047
infection	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
IAD	O	O	B-T047
can	O	O	O
be	O	O	O
prevented	O	O	B-T061
and	O	O	O
healed	O	O	B-T169
with	O	O	O
timely	O	O	O
and	O	O	O
appropriate	O	O	B-T080
skin	O	O	B-T061
cleansing	O	O	I-T061
and	O	O	O
skin	O	O	B-T201
protection	O	O	I-T201
.	O	O	O

This	O	O	O
includes	O	O	O
appropriate	O	O	B-T080
use	O	O	O
of	O	O	O
containment	O	O	B-T074
devices	O	O	I-T074
.	O	O	O

This	O	O	O
article	O	O	O
also	O	O	O
looks	O	O	O
at	O	O	O
HARTMANN	O	O	B-T074
incontinence	O	O	I-T074
pads	O	O	I-T074
that	O	O	O
have	O	O	O
been	O	O	O
developed	O	O	O
to	O	O	O
absorb	O	O	O
the	O	O	O
fluids	O	O	B-T167
that	O	O	O
cause	O	O	O
IAD	O	O	B-T047
and	O	O	O
maintain	O	O	O
the	O	O	O
skin	O	O	B-T022
's	O	O	I-T022
acidic	O	O	O
pH.	O	O	O
The	O	O	O
acidic	O	O	B-T081
pH	O	O	I-T081
of	O	O	O
the	O	O	O
skin	O	O	O
contributes	O	O	O
to	O	O	O
its	O	O	O
barrier	O	O	B-T042
function	O	O	I-T042
and	O	O	O
defence	O	O	O
against	O	O	O
infection	O	O	B-T046
.	O	O	O

Therefore	O	O	O
,	O	O	O
maintaining	O	O	O
an	O	O	O
acidic	O	O	B-T081
pH	O	O	I-T081
will	O	O	O
help	O	O	O
protect	O	O	O
the	O	O	O
skin	O	O	B-T022
from	O	O	O
damage	O	O	B-T169
.	O	O	O

-DOCSTART- (27740919)

Feasibility	O	O	B-T062
of	O	O	O
a	O	O	O
transition	O	O	B-T052
intervention	O	O	B-T061
aimed	O	O	B-T078
at	O	O	O
adolescents	O	O	B-T100
with	O	O	O
chronic	O	O	O
illness	O	O	O

International	O	O	B-T078
guidelines	O	O	B-T170
recommend	O	O	O
planned	O	O	O
and	O	O	O
structured	O	O	O
transition	O	O	B-T052
programmes	O	O	B-T058
for	O	O	O
adolescents	O	O	B-T100
with	O	O	O
chronic	O	O	B-T047
illness	O	O	I-T047
because	O	O	O
inadequate	O	O	B-T080
transition	O	O	O
may	O	O	O
lead	O	O	O
to	O	O	O
poor	O	O	B-T033
disease	O	O	I-T033
control	O	O	I-T033
and	O	O	O
risk	O	O	B-T078
of	O	O	O
lacking	O	O	B-T080
outpatient	O	O	B-T058
follow-up	O	O	I-T058
.	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
feasibility	O	O	B-T062
of	O	O	O
a	O	O	O
transition	O	O	B-T052
intervention	O	O	B-T061
aimed	O	O	B-T078
at	O	O	O
adolescents	O	O	B-T100
with	O	O	O
chronic	O	O	B-T047
illness	O	O	I-T047
focusing	O	O	B-T041
on	O	O	O
declines	O	O	B-T055
,	O	O	O
drop-outs	O	O	B-T098
,	O	O	O
no-shows	O	O	B-T081
and	O	O	O
advantages	O	O	B-T078
and	O	O	O
disadvantages	O	O	B-T078
of	O	O	O
participating	O	O	B-T169
.	O	O	O

We	O	O	O
invited	O	O	O
236	O	O	O
adolescents	O	O	B-T100
(	O	O	O
12	O	O	O
-	O	O	O
20	O	O	O
years	O	O	O
)	O	O	O
with	O	O	O
juvenile	O	O	B-T047
idiopathic	O	O	I-T047
arthritis	O	O	I-T047
(	O	O	O
JIA	O	O	B-T047
)	O	O	O
to	O	O	O
participate	O	O	B-T169
in	O	O	O
a	O	O	O
randomised	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
(	O	O	O
RCT	O	O	B-T062
)	O	O	O
transition	O	O	B-T052
intervention	O	O	B-T061
.	O	O	O

Reasons	O	O	B-T078
for	O	O	O
decline	O	O	B-T055
and	O	O	O
drop-outs	O	O	B-T098
were	O	O	O
calculated	O	O	B-T169
.	O	O	O

Adolescents	O	O	B-T100
'	O	O	O
experiences	O	O	B-T041
of	O	O	O
advantages	O	O	B-T078
and	O	O	O
disadvantages	O	O	B-T078
of	O	O	O
participating	O	O	B-T169
and	O	O	O
reasons	O	O	B-T078
for	O	O	O
no-shows	O	O	B-T081
were	O	O	O
investigated	O	O	B-T169
through	O	O	O
focus	O	O	B-T096
groups	O	O	I-T096
and	O	O	O
telephone	O	O	B-T062
interviews	O	O	I-T062
,	O	O	O
which	O	O	O
were	O	O	O
analysed	O	O	B-T062
using	O	O	O
thematic	O	O	B-T062
analysis	O	O	B-T062
.	O	O	O

One	O	O	O
hundred	O	O	O
and	O	O	O
twenty	O	O	O
of	O	O	O
the	O	O	O
236	O	O	O
eligible	O	O	O
patients	O	O	B-T101
declined	O	O	B-T055
to	O	O	I-T055
participate	O	O	I-T055
in	O	O	O
the	O	O	O
intervention	O	O	B-T061
and	O	O	O
20	O	O	O
%	O	O	O
dropped	O	O	B-T098
out	O	O	I-T098
during	O	O	O
the	O	O	O
intervention	O	O	O
.	O	O	O

Unspecified	O	O	B-T080
declines	O	O	B-T055
and	O	O	O
practical	O	O	B-T033
issues	O	O	I-T033
were	O	O	O
the	O	O	O
most	O	O	O
common	O	O	B-T081
reason	O	O	B-T078
to	O	O	O
decline	O	O	B-T055
,	O	O	O
and	O	O	O
'	O	O	O
do	O	O	B-T053
not	O	O	I-T053
wish	O	O	I-T053
to	O	O	I-T053
continue	O	O	I-T053
'	O	O	O
was	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
reason	O	O	O
to	O	O	O
drop-out	O	O	B-T098
.	O	O	O

Reasons	O	O	B-T078
for	O	O	O
no-shows	O	O	B-T081
were	O	O	O
forgetting	O	O	B-T048
and	O	O	O
being	O	O	O
too	O	O	O
busy	O	O	O
.	O	O	O

Advantages	O	O	B-T078
of	O	O	O
participating	O	O	B-T169
were	O	O	O
stated	O	O	O
as	O	O	O
'	O	O	O
participating	O	O	O
without	O	O	B-T080
parents	O	O	B-T099
'	O	O	O
,	O	O	O
'	O	O	O
trust	O	O	B-T054
and	O	O	O
confidentiality	O	O	B-T078
'	O	O	O
,	O	O	O
'	O	O	O
being	O	O	O
able	O	O	O
to	O	O	O
set	O	O	O
the	O	O	O
agenda	O	O	B-T170
'	O	O	O
and	O	O	O
'	O	O	O
responsiveness	O	O	B-T169
'	O	O	O
.	O	O	O

Disadvantages	O	O	B-T078
were	O	O	O
'	O	O	O
unclear	O	O	B-T033
aim	O	O	B-T078
of	O	O	O
the	O	O	O
study	O	O	B-T062
'	O	O	O
,	O	O	O
'	O	O	O
meeting	O	O	O
others	O	O	O
with	O	O	O
JIA	O	O	B-T047
'	O	O	O
,	O	O	O
'	O	O	O
too	O	O	O
few	O	O	O
conversations	O	O	B-T054
'	O	O	O
and	O	O	O
'	O	O	O
transport	O	O	B-T056
issues	O	O	B-T033
'	O	O	O
.	O	O	O

Many	O	O	O
adolescents	O	O	B-T100
had	O	O	O
difficulties	O	O	B-T033
understanding	O	O	B-T041
the	O	O	O
aim	O	O	B-T078
of	O	O	O
the	O	O	O
intervention	O	O	B-T061
.	O	O	O

However	O	O	O
,	O	O	O
most	O	O	O
participants	O	O	B-T100
appreciated	O	O	O
the	O	O	O
conversations	O	O	B-T054
about	O	O	O
identity	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
trust	O	O	B-T054
and	O	O	O
confidentiality	O	O	B-T078
in	O	O	O
the	O	O	O
communication	O	O	B-T054
.	O	O	O

In	O	O	O
the	O	O	O
future	O	O	O
,	O	O	O
adolescents	O	O	B-T100
should	O	O	O
be	O	O	O
offered	O	O	O
more	O	O	O
individually	O	O	O
organised	O	O	O
programmes	O	O	B-T058
according	O	O	O
to	O	O	O
their	O	O	O
preferences	O	O	B-T078
and	O	O	O
needs	O	O	O
in	O	O	O
cooperation	O	O	B-T054
with	O	O	O
parents	O	O	B-T099
and	O	O	O
health	O	O	B-T097
care	O	O	I-T097
providers	O	O	I-T097
.	O	O	O

-DOCSTART- (27743356)

High-Throughput	O	O	B-T060
Analysis	O	O	I-T060
of	O	O	O
the	O	O	O
IgG	O	O	B-T116
N-Glycome	O	O	I-T116
by	O	O	O
UPLC	O	O	B-T059
-	O	O	O
FLR	O	O	O

As	O	O	O
biological	O	O	B-T080
and	O	O	O
clinical	O	O	B-T080
relevance	O	O	B-T080
of	O	O	O
glycosylation	O	O	B-T070
is	O	O	O
becoming	O	O	O
more	O	O	O
apparent	O	O	B-T078
,	O	O	O
interest	O	O	O
in	O	O	O
large	O	O	B-T062
scale	O	O	I-T062
studies	O	O	I-T062
of	O	O	O
the	O	O	O
glycome	O	O	B-T109
is	O	O	O
growing	O	O	O
.	O	O	O

Glycans	O	O	B-T109
attached	O	O	O
to	O	O	O
immunoglobulin	O	O	B-T116
G	O	O	I-T116
(	O	O	O
IgG	O	O	B-T116
)	O	O	O
were	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
essential	O	O	B-T080
for	O	O	O
its	O	O	O
function	O	O	B-T039
and	O	O	O
IgG	O	O	O
glycosylation	O	O	B-T070
was	O	O	O
shown	O	O	O
to	O	O	O
change	O	O	B-T169
with	O	O	O
various	O	O	O
processes	O	O	B-T067
,	O	O	O
making	O	O	O
IgG	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
studied	O	O	O
glycoproteins	O	O	B-T116
.	O	O	O

Many	O	O	O
approaches	O	O	B-T082
including	O	O	O
liquid	O	O	B-T059
chromatography	O	O	I-T059
,	O	O	O
capillary	O	O	B-T059
gel	O	O	I-T059
electrophoresis	O	O	I-T059
,	O	O	O
and	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
were	O	O	O
developed	O	O	O
to	O	O	O
study	O	O	B-T062
IgG	O	O	B-T116
glycosylation	O	O	B-T070
.	O	O	O

Generation	O	O	B-T052
of	O	O	O
high-quality	O	O	B-T080
glycomics	O	O	B-T090
data	O	O	B-T078
in	O	O	O
a	O	O	O
high-throughput	O	O	B-T170
fashion	O	O	O
requires	O	O	O
reproducible	O	O	B-T081
and	O	O	O
robust	O	O	B-T080
sample	O	O	B-T059
preparation	O	O	I-T059
and	O	O	O
accurate	O	O	B-T080
and	O	O	O
reliable	O	O	O
quantitative	O	O	B-UnknownType
analysis	O	O	I-UnknownType
.	O	O	O

This	O	O	O
chapter	O	O	B-T078
presents	O	O	O
a	O	O	O
protocol	O	O	B-T170
for	O	O	O
an	O	O	O
optimized	O	O	O
and	O	O	O
high-throughput	O	O	B-T170
IgG	O	O	B-T116
N-glycan	O	O	I-T116
release	O	O	B-T169
,	O	O	O
fluorescent	O	O	B-T059
labeling	O	O	I-T059
and	O	O	O
cleanup	O	O	B-T169
,	O	O	O
and	O	O	O
analysis	O	O	B-T062
of	O	O	O
fluorescently	O	O	B-T080
labeled	O	O	I-T080
IgG	O	O	B-T116
N-glycans	O	O	I-T116
by	O	O	O
hydrophilic	O	O	B-T059
interaction	O	O	I-T059
liquid	O	O	I-T059
chromatography	O	O	I-T059
(	O	O	O
HILIC	O	O	B-T059
)	O	O	O
on	O	O	O
an	O	O	O
ultra	O	O	B-T059
performance	O	O	I-T059
liquid	O	O	I-T059
chromatography	O	O	I-T059
(	O	O	O
UPLC	O	O	B-T059
)	O	O	O
system	O	O	O
with	O	O	O
fluorescence	O	O	B-T070
(	O	O	O
FLR	O	O	B-T074
)	O	O	O
detection	O	O	B-T061
.	O	O	O

-DOCSTART- (27744219)

Biomimetic	O	O	B-T073
whitlockite	O	O	B-T122
inorganic	O	O	B-T077
nanoparticles	O	O	B-T073
-mediated	O	O	O
in	O	O	B-T082
situ	O	O	I-T082
remodeling	O	O	B-T042
and	O	O	O
rapid	O	O	O
bone	O	O	O
regeneration	O	O	O

Bone	O	O	B-T042
remodeling	O	O	I-T042
process	O	O	O
relies	O	O	O
on	O	O	O
complex	O	O	B-T080
signaling	O	O	B-T044
pathway	O	O	I-T044
between	O	O	O
osteoblasts	O	O	B-T025
and	O	O	O
osteoclasts	O	O	B-T025
and	O	O	O
control	O	O	O
mechanisms	O	O	B-T169
to	O	O	O
achieve	O	O	O
homeostasis	O	O	B-T038
of	O	O	O
their	O	O	O
growth	O	O	B-T043
and	O	O	O
differentiation	O	O	B-T043
.	O	O	O

Despite	O	O	O
previous	O	O	O
achievements	O	O	O
in	O	O	O
understanding	O	O	O
complicated	O	O	O
signaling	O	O	B-T044
pathways	O	O	I-T044
between	O	O	O
cells	O	O	B-T025
and	O	O	O
bone	O	O	B-T023
extracellular	O	O	B-T024
matrices	O	O	I-T024
during	O	O	O
bone	O	O	B-T042
remodeling	O	O	I-T042
process	O	O	O
,	O	O	O
a	O	O	O
role	O	O	O
of	O	O	O
local	O	O	O
ionic	O	O	B-T196
concentration	O	O	B-T081
remains	O	O	O
to	O	O	O
be	O	O	O
elucidated	O	O	B-T052
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
synthetic	O	O	B-T052
whitlockite	O	O	B-T122
(	O	O	O
WH	O	O	B-T122
:	O	O	I-T122
Ca18Mg2(HPO4)2(PO4)12	O	O	I-T122
)	O	O	I-T122
nanoparticles	O	O	B-T073
can	O	O	O
recapitulate	O	O	B-T169
early-stage	O	O	O
of	O	O	O
bone	O	O	B-T042
regeneration	O	O	I-T042
through	O	O	O
stimulating	O	O	B-T070
osteogenic	O	O	B-T043
differentiation	O	O	I-T043
,	O	O	O
prohibiting	O	O	B-T169
osteoclastic	O	O	B-T025
activity	O	O	B-T052
,	O	O	O
and	O	O	O
transforming	O	O	B-T043
into	O	O	O
mechanically	O	O	O
enhanced	O	O	O
hydroxyapatite	O	O	B-T197
(HAP)-	O	O	O
neo	O	O	B-T024
bone	O	O	I-T024
tissues	O	O	I-T024
by	O	O	O
continuous	O	O	O
supply	O	O	O
of	O	O	O
PO4(3-	O	O	B-T121
)	O	O	I-T121
and	O	O	O
Mg(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
under	O	O	O
physiological	O	O	B-T169
conditions	O	O	B-T080
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
based	O	O	O
on	O	O	O
their	O	O	O
structural	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
the	O	O	O
dynamic	O	O	O
phase	O	O	B-T079
transformation	O	O	B-T043
from	O	O	O
WH	O	O	B-T122
into	O	O	O
HAP	O	O	B-T197
contributed	O	O	O
as	O	O	O
a	O	O	O
key	O	O	O
factor	O	O	B-T169
for	O	O	O
rapid	O	O	O
bone	O	O	B-T042
regeneration	O	O	I-T042
with	O	O	O
denser	O	O	B-T080
hierarchical	O	O	B-T169
neo-bone	O	O	B-T023
structure	O	O	B-T082
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
suggest	O	O	O
a	O	O	O
groundbreaking	O	O	O
concept	O	O	O
of	O	O	O
'	O	O	O
living	O	O	B-T078
bone	O	O	B-T023
minerals	O	O	B-T197
'	O	O	O
that	O	O	O
actively	O	O	B-T169
communicate	O	O	B-T043
with	O	O	O
the	O	O	O
surrounding	O	O	O
system	O	O	O
to	O	O	O
induce	O	O	B-T169
self-healing	O	O	B-T042
,	O	O	O
while	O	O	O
previous	O	O	O
notions	O	O	O
about	O	O	O
bone	O	O	O
minerals	O	O	O
have	O	O	O
been	O	O	O
limited	O	O	O
to	O	O	O
passive	O	O	B-T080
products	O	O	O
of	O	O	O
cellular	O	O	B-T025
mineralization	O	O	B-T042
.	O	O	O

-DOCSTART- (27745773)

Is	O	O	O
the	O	O	O
inactivation	O	O	B-T169
of	O	O	O
dentin	O	O	B-T031
proteases	O	O	B-T116
by	O	O	O
crosslinkers	O	O	B-T130
reversible	O	O	B-T169
?	O	O	O

Inactivation	O	O	B-T169
of	O	O	O
dentin	O	O	B-T031
proteases	O	O	B-T116
by	O	O	O
crosslinkers	O	O	B-T130
has	O	O	O
been	O	O	O
suggested	O	O	B-T078
as	O	O	O
a	O	O	O
way	O	O	O
to	O	O	O
prevent	O	O	B-T080
the	O	O	O
degradation	O	O	B-T044
of	O	O	O
dentin	O	O	O
collagen	O	O	B-T116
in	O	O	O
the	O	O	O
hybrid	O	O	B-T116
layer	O	O	B-T082
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
not	O	O	B-T080
known	O	O	I-T080
if	O	O	O
the	O	O	O
inhibition	O	O	B-T052
is	O	O	O
reversible	O	O	B-T169
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	B-T052
the	O	O	O
inactivation	O	O	B-T169
effect	O	O	B-T080
of	O	O	O
various	O	O	O
crosslinkers	O	O	B-T130
on	O	O	O
dentin	O	O	B-T031
protease	O	O	B-T116
activity	O	O	B-T044
over	O	O	O
a	O	O	O
period	O	O	B-T079
of	O	O	O
6	O	O	O
months	O	O	O
.	O	O	O

Demineralized	O	O	B-T122
dentin	O	O	I-T122
beams	O	O	I-T122
(	O	O	O
1	O	O	O
×	O	O	O
2	O	O	O
×	O	O	O
6	O	O	O
mm	O	O	O
,	O	O	O
n=10/group	O	O	O
)	O	O	O
were	O	O	O
treated	O	O	B-T169
with	O	O	I-T169
(	O	O	O
1	O	O	O
)	O	O	O
1	O	O	O
%	O	O	O
glutaraldehyde	O	O	B-T109
(	O	O	O
GA1	O	O	B-T109
)	O	O	O
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
5	O	O	O
%	O	O	O
glutaraldehyde	O	O	O
(	O	O	O
GA5	O	O	B-T109
)	O	O	O
,	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
1	O	O	O
%	O	O	O
grape	O	O	B-T109
seed	O	O	I-T109
extract	O	O	I-T109
(	O	O	O
GS1	O	O	B-T109
)	O	O	O
,	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
5	O	O	O
%	O	O	O
grape	O	O	O
seed	O	O	O
extract	O	O	O
(	O	O	O
GS5	O	O	B-T109
)	O	O	O
,	O	O	O
(	O	O	O
5	O	O	O
)	O	O	O
10	O	O	O
%	O	O	O
sumac	O	O	B-T002
berry	O	O	I-T002
extract	O	O	I-T002
(	O	O	O
S	O	O	B-T002
)	O	O	O
,	O	O	O
(	O	O	O
6	O	O	O
)	O	O	O
20μM	O	O	B-T109
curcumin	O	O	B-T109
(	O	O	O
CR20	O	O	B-T109
)	O	O	O
,	O	O	O
and	O	O	O
(	O	O	O
7	O	O	O
)	O	O	O
200μM	O	O	O
curcumin	O	O	O
(	O	O	O
CR200	O	O	B-T109
)	O	O	O
for	O	O	O
5min	O	O	O
.	O	O	O

Untreated	O	O	B-T033
beams	O	O	B-T122
served	O	O	O
as	O	O	O
control	O	O	B-T096
.	O	O	O

The	O	O	O
beams	O	O	B-T122
were	O	O	O
incubated	O	O	B-T059
up	O	O	O
to	O	O	O
6	O	O	O
months	O	O	O
and	O	O	O
incubation	O	O	B-T059
media	O	O	I-T130
were	O	O	O
used	O	O	O
to	O	O	O
analyze	O	O	B-T062
solubilized	O	O	B-T080
telopeptide	O	O	B-T116
(	O	O	O
ICTP	O	O	B-T116
and	O	O	O
CTX	O	O	B-T116
)	O	O	O
fragments	O	O	B-T116
as	O	O	O
indicators	O	O	B-T169
of	O	O	O
MMP	O	O	B-T116
-	O	O	O
and	O	O	O
cathepsin	O	O	B-T116
K	O	O	I-T116
-mediated	O	O	O
degradation	O	O	B-T044
after	O	O	O
1	O	O	O
,	O	O	O
3	O	O	O
and	O	O	O
6	O	O	O
months	O	O	O
of	O	O	O
incubation	O	O	O
.	O	O	O

The	O	O	O
relative	O	O	B-T080
MMP	O	O	B-T116
activity	O	O	B-T044
of	O	O	O
dentin	O	O	B-T122
beams	O	O	I-T122
was	O	O	O
tested	O	O	O
using	O	O	O
a	O	O	O
generic	O	O	B-T077
MMP	O	O	O
assay	O	O	B-T059
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
repeated-measures	O	O	B-T062
ANOVA	O	O	B-T081
,	O	O	O
α=0.05	O	O	O
.	O	O	O

All	O	O	O
treated	O	O	B-T169
groups	O	O	B-T078
showed	O	O	O
significant	O	O	B-T078
decrease	O	O	B-T081
in	O	O	O
CTX	O	O	B-T116
release	O	O	O
(	O	O	O
32.2	O	O	O
-	O	O	O
469.5pg/mg	O	O	O
dentin	O	O	B-T031
)	O	O	O
and	O	O	O
ICTP	O	O	B-T116
(	O	O	O
1.8	O	O	O
-	O	O	O
47.6ng/mg	O	O	O
dentin	O	O	O
)	O	O	O
fragments	O	O	B-T116
during	O	O	O
the	O	O	O
first	O	O	O
month	O	O	O
of	O	O	O
incubation	O	O	B-T059
compared	O	O	B-T052
to	O	O	O
control	O	O	B-T096
(	O	O	O
1159pg/mg	O	O	O
and	O	O	O
72.9ng/mg	O	O	O
dentin	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

GA5	O	O	B-T109
,	O	O	O
GS5	O	O	B-T109
and	O	O	O
CR200	O	O	B-T109
maintained	O	O	B-T169
their	O	O	O
inhibitory	O	O	B-T052
effect	O	O	B-T080
during	O	O	O
6-month	O	O	O
incubation	O	O	B-T059
.	O	O	O

The	O	O	O
results	O	O	B-T034
were	O	O	O
confirmed	O	O	O
by	O	O	O
dry	O	O	B-T067
mass	O	O	I-T067
loss	O	O	I-T067
and	O	O	O
relative	O	O	B-T080
MMP	O	O	B-T116
activity	O	O	B-T044
following	O	O	O
6	O	O	O
months	O	O	O
.	O	O	O

The	O	O	O
results	O	O	B-T033
of	O	O	O
this	O	O	O
study	O	O	B-T062
indicate	O	O	O
that	O	O	O
the	O	O	O
long-term	O	O	B-T067
effect	O	O	I-T067
is	O	O	O
both	O	O	O
crosslinker	O	O	B-T130
and	O	O	O
dose	O	O	B-T081
dependent	O	O	I-T081
.	O	O	O

-DOCSTART- (27752082)

Inhibition	O	O	B-T044
of	O	O	O
STEP61	O	O	B-T116
ameliorates	O	O	B-T080
deficits	O	O	B-T080
in	O	O	O
mouse	O	O	B-T015
and	O	O	O
hiPSC	O	O	B-T025
-based	O	O	O
schizophrenia	O	O	B-T048
models	O	O	O

The	O	O	O
brain	O	O	B-T023
-	O	O	O
specific	O	O	B-T080
tyrosine	O	O	B-T116
phosphatase	O	O	I-T116
,	O	O	O
STEP	O	O	B-T116
(	O	O	O
STriatal-Enriched	O	O	B-T116
protein	O	O	I-T116
tyrosine	O	O	I-T116
Phosphatase	O	O	I-T116
)	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
regulator	O	O	B-T077
of	O	O	O
synaptic	O	O	B-T043
function	O	O	I-T043
.	O	O	O

STEP	O	O	B-T116
normally	O	O	O
opposes	O	O	O
synaptic	O	O	B-T030
strengthening	O	O	B-T080
by	O	O	O
increasing	O	O	B-T081
N-methyl	O	O	B-T116
D-aspartate	O	O	I-T116
glutamate	O	O	I-T116
receptor	O	O	I-T116
(	O	O	O
NMDAR	O	O	B-T116
)	O	O	O
internalization	O	O	B-T067
through	O	O	O
dephosphorylation	O	O	B-T044
of	O	O	O
GluN2B	O	O	B-T116
and	O	O	O
inactivation	O	O	B-T044
of	O	O	O
the	O	O	O
kinases	O	O	B-T116
extracellular	O	O	B-T116
signal-regulated	O	O	I-T116
kinase	O	O	I-T116
1	O	O	I-T116
/	O	O	O
2	O	O	B-T116
and	O	O	O
Fyn	O	O	B-T116
.	O	O	O

Here	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
STEP61	O	O	B-T116
is	O	O	O
elevated	O	O	B-T080
in	O	O	O
the	O	O	O
cortex	O	O	B-T023
in	O	O	O
the	O	O	O
Nrg1(+/-	O	O	B-T028
)	O	O	I-T028
knockout	O	O	B-T050
mouse	O	O	B-T050
model	O	O	I-T050
of	O	O	O
schizophrenia	O	O	B-T048
(	O	O	O
SZ	O	O	B-T048
)	O	O	O
.	O	O	O

Genetic	O	O	B-T169
reduction	O	O	B-T061
or	O	O	O
pharmacological	O	O	B-T169
inhibition	O	O	B-T052
of	O	O	O
STEP	O	O	B-T116
prevents	O	O	B-T169
the	O	O	O
loss	O	O	O
of	O	O	O
NMDARs	O	O	B-T116
from	O	O	O
synaptic	O	O	B-T026
membranes	O	O	I-T026
and	O	O	O
reverses	O	O	O
behavioral	O	O	B-T048
deficits	O	O	I-T048
in	O	O	O
Nrg1(+/-	O	O	B-T028
)	O	O	I-T028
mice	O	O	B-T015
.	O	O	O

STEP61	O	O	B-T116
protein	O	O	I-T116
is	O	O	O
also	O	O	O
increased	O	O	B-T081
in	O	O	O
cortical	O	O	B-T023
lysates	O	O	B-T072
from	O	O	O
the	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
-	O	O	O
specific	O	O	B-T080
ErbB2	O	O	B-T116
/	O	O	O
4	O	O	B-T116
mouse	O	O	B-T050
model	O	O	I-T050
of	O	O	O
SZ	O	O	B-T048
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
human	O	O	B-T025
induced	O	O	B-T169
pluripotent	O	O	I-T025
stem	O	O	I-T025
cell	O	O	I-T025
(hiPSC)-derived	O	O	O
forebrain	O	O	B-T023
neurons	O	O	B-T025
and	O	O	O
Ngn2	O	O	B-T028
-	O	O	O
induced	O	O	O
excitatory	O	O	B-T025
neurons	O	O	I-T025
,	O	O	O
from	O	O	O
two	O	O	O
independent	O	O	B-T169
SZ	O	O	O
patient	O	O	B-T101
cohorts	O	O	B-T098
.	O	O	O

In	O	O	O
these	O	O	O
selected	O	O	B-T052
SZ	O	O	B-T048
models	O	O	B-T050
,	O	O	O
increased	O	O	B-T081
STEP61	O	O	B-T116
protein	O	O	B-T059
levels	O	O	I-T059
likely	O	O	O
reflect	O	O	O
reduced	O	O	B-T080
ubiquitination	O	O	B-T044
and	O	O	O
degradation	O	O	B-T044
.	O	O	O

These	O	O	O
convergent	O	O	B-T080
findings	O	O	B-T033
from	O	O	O
mouse	O	O	B-T015
and	O	O	O
hiPSC	O	O	B-T025
SZ	O	O	B-T048
models	O	O	B-T050
provide	O	O	B-T052
evidence	O	O	B-T078
for	O	O	O
STEP61	O	O	B-T116
dysfunction	O	O	B-T077
in	O	O	O
SZ	O	O	O
.Molecular	O	O	O
Psychiatry	O	O	O
advance	O	O	O
online	O	O	O
publication	O	O	O
,	O	O	O
18	O	O	O
October	O	O	O
2016	O	O	O
;	O	O	O
doi:10.1038/mp.2016.163	O	O	O
.	O	O	O

-DOCSTART- (27752744)

Incident	O	O	B-T067
fracture	O	O	B-T037
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
mortality	O	O	B-T081
even	O	O	O
after	O	O	O
adjusting	O	O	O
for	O	O	O
frailty	O	O	B-T033
status	O	O	B-T080
in	O	O	O
elderly	O	O	B-T098
Japanese	O	O	B-T098
men	O	O	B-T098
:	O	O	O
the	O	O	O
Fujiwara-kyo	O	O	O
Osteoporosis	O	O	O
Risk	O	O	O
in	O	O	O
Men	O	O	O
(	O	O	O
FORMEN	O	O	O
)	O	O	O
Cohort	O	O	O
Study	O	O	O

Frail	O	O	B-T033
elderly	O	O	B-T098
individuals	O	O	B-T098
have	O	O	O
elevated	O	O	B-T080
risks	O	O	B-T078
of	O	O	O
both	O	O	O
fracture	O	O	B-T037
and	O	O	O
mortality	O	O	B-T081
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
incident	O	O	B-T067
fractures	O	O	B-T037
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
death	O	O	B-T033
even	O	O	O
after	O	O	O
adjusting	O	O	O
for	O	O	O
pre-fracture	O	O	B-T037
frailty	O	O	B-T033
status	O	O	B-T080
as	O	O	O
represented	O	O	O
by	O	O	O
physical	O	O	B-T060
performance	O	O	I-T060
tests	O	O	I-T060
and	O	O	O
laboratory	O	O	B-T059
tests	O	O	I-T059
for	O	O	O
common	O	O	O
geriatric	O	O	B-T080
diseases	O	O	B-T047
in	O	O	O
community-dwelling	O	O	B-T056
elderly	O	O	B-T098
Japanese	O	O	B-T098
men	O	O	B-T098
.	O	O	O

While	O	O	O
fractures	O	O	B-T037
reportedly	O	O	O
increase	O	O	B-T169
the	O	O	O
risk	O	O	B-T078
of	O	O	O
mortality	O	O	B-T081
,	O	O	O
frailty	O	O	B-T033
may	O	O	O
complicate	O	O	B-T169
this	O	O	O
association	O	O	B-T080
,	O	O	O
generating	O	O	O
a	O	O	O
false-positive	O	O	B-T033
result	O	O	I-T033
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
this	O	O	O
association	O	O	B-T080
after	O	O	O
adjusting	O	O	O
for	O	O	O
pre-fracture	O	O	B-T037
levels	O	O	B-T080
of	O	O	O
frailty	O	O	B-T033
.	O	O	O

We	O	O	O
examined	O	O	B-T033
1998	O	O	O
community-dwelling	O	O	B-T056
ambulatory	O	O	B-T169
men	O	O	B-T098
aged	O	O	B-T032
≥65	O	O	O
years	O	O	B-T079
at	O	O	O
baseline	O	O	B-T081
in	O	O	O
the	O	O	O
Fujiwara-kyo	O	O	B-T081
Osteoporosis	O	O	I-T081
Risk	O	O	I-T081
in	O	O	I-T081
Men	O	O	I-T081
Study	O	O	I-T081
for	O	O	O
frailty	O	O	B-T033
status	O	O	B-T080
as	O	O	O
represented	O	O	O
by	O	O	O
activities	O	O	B-T056
of	O	O	I-T056
daily	O	O	I-T056
living	O	O	I-T056
(	O	O	O
ADL	O	O	B-T056
)	O	O	O
,	O	O	O
physical	O	O	B-T060
performance	O	O	I-T060
tests	O	O	I-T060
(	O	O	O
grip	O	O	B-T081
strength	O	O	I-T081
,	O	O	O
one-foot	O	O	B-T033
standing	O	O	I-T033
balance	O	O	I-T033
with	O	O	I-T033
eyes	O	O	I-T033
open	O	O	I-T033
,	O	O	O
timed	O	O	B-T060
10-m	O	O	I-T060
walk	O	O	I-T060
)	O	O	O
,	O	O	O
and	O	O	O
laboratory	O	O	B-T059
sera	O	O	B-T031
tests	O	O	I-T059
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
then	O	O	O
followed	O	O	O
for	O	O	O
5	O	O	O
years	O	O	B-T079
for	O	O	O
incident	O	O	B-T067
clinical	O	O	B-T080
fractures	O	O	B-T037
and	O	O	O
death	O	O	B-T033
.	O	O	O

Effects	O	O	B-T080
of	O	O	I-T080
incident	O	O	B-T067
fracture	O	O	B-T037
on	O	O	O
death	O	O	B-T033
were	O	O	O
determined	O	O	O
by	O	O	O
Cox	O	O	B-T081
proportional	O	O	I-T081
hazards	O	O	I-T081
model	O	O	I-T081
with	O	O	O
the	O	O	O
first	O	O	O
fracture	O	O	O
during	O	O	O
follow-up	O	O	B-T058
as	O	O	O
a	O	O	O
time-dependent	O	O	B-T078
predictor	O	O	I-T078
and	O	O	O
with	O	O	O
frailty	O	O	B-T170
status	O	O	I-T170
indices	O	O	I-T170
as	O	O	O
covariates	O	O	B-T080
.	O	O	O

We	O	O	O
identified	O	O	B-T080
111	O	O	O
fractures	O	O	B-T037
in	O	O	O
99	O	O	O
men	O	O	B-T098
and	O	O	O
138	O	O	O
deaths	O	O	B-T033
during	O	O	O
the	O	O	O
follow-up	O	O	B-T058
period	O	O	B-T079
(	O	O	O
median	O	O	B-T082
follow-up	O	O	O
,	O	O	O
4.5	O	O	O
years	O	O	B-T079
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
with	O	O	O
incident	O	O	B-T067
fractures	O	O	B-T037
did	O	O	O
not	O	O	B-T033
have	O	O	I-T033
significantly	O	O	B-T078
worse	O	O	I-T033
frailty	O	O	B-T033
statuses	O	O	B-T080
,	O	O	O
but	O	O	O
did	O	O	O
show	O	O	O
a	O	O	O
significantly	O	O	O
higher	O	O	B-T080
cumulative	O	O	B-T080
mortality	O	O	B-T081
rate	O	O	I-T081
than	O	O	O
those	O	O	O
without	O	O	O
fractures	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.0047	O	O	O
)	O	O	O
.	O	O	O

Age-adjusted	O	O	B-T081
hazard	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
HR	O	O	B-T081
)	O	O	O
of	O	O	O
death	O	O	B-T033
for	O	O	O
incident	O	O	B-T067
fracture	O	O	B-T037
was	O	O	O
3.57	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
:	O	O	O
2.05	O	O	O
,	O	O	O
6.24	O	O	O
)	O	O	O
.	O	O	O

When	O	O	O
adjusted	O	O	O
for	O	O	O
physical	O	O	B-T032
performance	O	O	I-T032
,	O	O	O
this	O	O	O
decreased	O	O	B-T081
to	O	O	O
2.77	O	O	O
(	O	O	O
1.51	O	O	O
,	O	O	O
5.06	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
remained	O	O	O
significant	O	O	B-T078
.	O	O	O

The	O	O	O
HR	O	O	B-T081
showed	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
change	O	O	I-T033
when	O	O	O
adjusted	O	O	O
for	O	O	O
laboratory	O	O	B-T034
test	O	O	I-T034
results	O	O	I-T034
(	O	O	O
3.96	O	O	O
(	O	O	O
2.26	O	O	O
,	O	O	O
6.94	O	O	O
)	O	O	O
)	O	O	O
.	O	O	O

Exclusion	O	O	B-T052
of	O	O	O
deaths	O	O	B-T033
within	O	O	O
the	O	O	O
first	O	O	O
24	O	O	O
months	O	O	B-T079
of	O	O	O
follow-up	O	O	B-T058
did	O	O	O
not	O	O	B-T033
alter	O	O	I-T033
these	O	O	O
results	O	O	B-T034
.	O	O	O

Incident	O	O	B-T067
clinical	O	O	B-T080
fracture	O	O	B-T037
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
elevated	O	O	B-T080
risk	O	O	B-T078
of	O	O	O
death	O	O	B-T033
independently	O	O	B-T033
of	O	O	O
pre-fracture	O	O	B-T037
levels	O	O	B-T080
of	O	O	O
frailty	O	O	B-T033
in	O	O	O
community-dwelling	O	O	B-T056
elderly	O	O	B-T098
men	O	O	B-T098
.	O	O	O

-DOCSTART- (27754397)

Total	O	O	B-T033
Energy	O	O	I-T033
Expenditure	O	O	I-T033
in	O	O	O
Obese	O	O	B-T047
Kuwaiti	O	O	B-T073
Primary	O	O	I-T073
School	O	O	I-T073
Children	O	O	B-T100
Assessed	O	O	B-T052
by	O	O	O
the	O	O	O
Doubly-Labeled	O	O	O
Water	O	O	O
Technique	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
was	O	O	O
to	O	O	O
assess	O	O	B-T052
body	O	O	O
composition	O	O	O
and	O	O	O
total	O	O	B-T033
energy	O	O	I-T033
expenditure	O	O	I-T033
(	O	O	O
TEE	O	O	B-T033
)	O	O	O
in	O	O	O
35	O	O	O
obese	O	O	B-T047
7	O	O	O
-	O	O	O
9	O	O	O
years	O	O	B-T079
old	O	O	O
Kuwaiti	O	O	B-T098
children	O	O	B-T100
(	O	O	O
18	O	O	O
girls	O	O	B-T100
and	O	O	O
17	O	O	O
boys	O	O	B-T100
)	O	O	O
.	O	O	O

Total	O	O	B-T033
body	O	O	I-T033
water	O	O	I-T033
(	O	O	O
TBW	O	O	B-T033
)	O	O	O
and	O	O	O
TEE	O	O	B-T033
were	O	O	O
assessed	O	O	B-T052
by	O	O	O
doubly-labeled	O	O	B-T169
water	O	O	I-T169
technique	O	O	I-T169
.	O	O	O

TBW	O	O	B-T033
was	O	O	O
derived	O	O	O
from	O	O	O
the	O	O	O
intercept	O	O	B-T081
of	O	O	O
the	O	O	O
elimination	O	O	B-T033
rate	O	O	I-T033
of	O	O	O
deuterium	O	O	B-T196
and	O	O	O
TEE	O	O	B-T033
from	O	O	O
the	O	O	O
difference	O	O	B-T081
in	O	O	O
elimination	O	O	B-T033
rates	O	O	I-T033
of	O	O	O
(18)O	O	O	B-T121
and	O	O	O
deuterium	O	O	O
.	O	O	O

TBW	O	O	B-T033
was	O	O	O
used	O	O	O
to	O	O	O
estimate	O	O	B-T081
fat-free	O	O	B-T033
mass	O	O	I-T033
(	O	O	O
FFM	O	O	B-T033
)	O	O	O
,	O	O	O
using	O	O	O
hydration	O	O	B-T067
factors	O	O	B-T169
for	O	O	O
different	O	O	O
ages	O	O	B-T032
and	O	O	O
gender	O	O	B-T032
.	O	O	O

Fat	O	O	B-T032
mass	O	O	I-T032
(	O	O	O
FM	O	O	B-T032
)	O	O	O
was	O	O	O
calculated	O	O	B-T052
as	O	O	O
the	O	O	O
difference	O	O	B-T081
between	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
FFM	O	O	B-T033
.	O	O	O

Body	O	O	B-T032
weight	O	O	I-T032
was	O	O	O
not	O	O	O
statistically	O	O	B-T081
different	O	O	I-T081
but	O	O	O
TBW	O	O	B-T033
was	O	O	O
significantly	O	O	B-T080
higher	O	O	I-T080
(	O	O	O
p	O	O	O
=	O	O	O
0.018	O	O	O
)	O	O	O
in	O	O	O
boys	O	O	B-T100
(	O	O	O
44.9	O	O	O
%	O	O	O
±	O	O	O
3.3	O	O	O
%	O	O	O
)	O	O	O
than	O	O	O
girls	O	O	B-T100
(	O	O	O
42.4	O	O	O
%	O	O	O
±	O	O	O
3.0	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
girls	O	O	O
had	O	O	O
significantly	O	O	O
higher	O	O	O
estimated	O	O	B-T081
FM	O	O	B-T032
(	O	O	O
45.2	O	O	O
±	O	O	O
3.9	O	O	O
weight	O	O	O
%	O	O	O
versus	O	O	O
41.6	O	O	O
%	O	O	O
±	O	O	O
4.3	O	O	O
%	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.014	O	O	O
)	O	O	O
.	O	O	O

TEE	O	O	B-T033
was	O	O	O
significantly	O	O	B-T080
higher	O	O	I-T080
in	O	O	O
boys	O	O	B-T100
(	O	O	O
2395	O	O	O
±	O	O	O
349	O	O	O
kcal/day	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
girls	O	O	B-T100
(	O	O	O
1978	O	O	O
±	O	O	O
169	O	O	O
kcal/day	O	O	O
)	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.001	O	O	O
.	O	O	O

Estimated	O	O	B-T081
physical	O	O	B-T033
activity	O	O	I-T033
level	O	O	I-T033
(	O	O	O
PAL	O	O	B-T033
)	O	O	O
was	O	O	O
significantly	O	O	B-T080
higher	O	O	I-T080
in	O	O	O
boys	O	O	B-T100
;	O	O	O
1.61	O	O	O
±	O	O	O
0.167	O	O	O
versus	O	O	O
1.51	O	O	O
±	O	O	O
0.870	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.034	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	B-T169
provide	O	O	O
the	O	O	O
first	O	O	O
dataset	O	O	B-T170
of	O	O	O
TEE	O	O	B-T033
in	O	O	O
7	O	O	O
-	O	O	O
9	O	O	O
years	O	O	B-T079
old	O	O	O
obese	O	O	B-T047
Kuwaiti	O	O	B-T098
children	O	O	B-T100
and	O	O	O
highlight	O	O	O
important	O	O	O
gender	O	O	B-T032
differences	O	O	I-T032
to	O	O	O
be	O	O	O
considered	O	O	O
during	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
school	O	O	B-T058
based	O	O	I-T058
interventions	O	O	I-T058
targeted	O	O	O
to	O	O	O
combat	O	O	O
childhood	O	O	B-T047
obesity	O	O	I-T047
.	O	O	O

-DOCSTART- (27755168)

Mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
clinical	O	O	B-T080
kidney	O	O	B-T061
transplantation	O	O	I-T061
:	O	O	O
how	O	O	O
tolerant	O	O	B-T169
can	O	O	O
it	O	O	O
be	O	O	O
?	O	O	O

Progress	O	O	B-T169
in	O	O	O
the	O	O	O
improvement	O	O	B-T077
of	O	O	O
short-term	O	O	B-T079
and	O	O	O
long-term	O	O	B-T079
outcomes	O	O	B-T080
of	O	O	O
kidney	O	O	B-T061
transplantation	O	O	I-T061
seems	O	O	O
to	O	O	O
have	O	O	O
reached	O	O	O
a	O	O	O
plateau	O	O	B-T081
,	O	O	O
partially	O	O	O
due	O	O	O
to	O	O	O
consequences	O	O	B-T169
of	O	O	I-T169
very	O	O	O
efficient	O	O	B-T080
,	O	O	O
but	O	O	O
nonspecific	O	O	B-T078
immunosuppressive	O	O	B-T129
drugs	O	O	I-T129
.	O	O	O

In	O	O	O
recent	O	O	O
years	O	O	O
,	O	O	O
various	O	O	O
forms	O	O	O
of	O	O	O
cell	O	O	B-T061
therapy	O	O	B-T061
,	O	O	O
including	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
have	O	O	O
been	O	O	O
put	O	O	O
forward	O	O	O
as	O	O	O
an	O	O	O
alternative	O	O	B-T077
strategy	O	O	B-T170
for	O	O	O
more	O	O	O
defined	O	O	O
therapy	O	O	O
.	O	O	O

It	O	O	O
is	O	O	O
thought	O	O	O
that	O	O	O
these	O	O	O
therapies	O	O	B-T061
will	O	O	O
not	O	O	O
only	O	O	O
allow	O	O	O
controlled	O	O	B-T169
tapering	O	O	B-T058
of	O	O	O
immunosuppressive	O	O	B-T129
medication	O	O	I-T129
,	O	O	O
but	O	O	O
might	O	O	O
bring	O	O	O
us	O	O	O
also	O	O	O
closer	O	O	O
to	O	O	O
the	O	O	O
ambition	O	O	B-T041
of	O	O	O
generating	O	O	B-T052
donor	O	O	B-T098
-specific	O	O	O
immune	O	O	B-T040
regulation	O	O	I-T040
and	O	O	O
tolerance	O	O	B-T046
.	O	O	O

Different	O	O	O
forms	O	O	O
of	O	O	O
alloimmunity	O	O	B-T042
,	O	O	O
including	O	O	O
direct	O	O	B-T080
,	O	O	O
indirect	O	O	B-T080
and	O	O	O
semi-direct	O	O	B-T080
alloantigen	O	O	B-T129
presentation	O	O	O
have	O	O	O
to	O	O	O
be	O	O	O
controlled	O	O	O
before	O	O	O
donor	O	O	B-T098
-specific	O	O	O
immune	O	O	B-T040
regulation	O	O	I-T040
can	O	O	O
be	O	O	O
reached	O	O	O
.	O	O	O

Several	O	O	O
mechanisms	O	O	B-T169
have	O	O	O
been	O	O	O
described	O	O	O
how	O	O	O
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
can	O	O	O
affect	O	O	O
alloimmunity	O	O	B-T042
.	O	O	O

Especially	O	O	O
,	O	O	O
the	O	O	O
interaction	O	O	B-T043
with	O	O	O
professional	O	O	O
antigen	O	O	B-T025
presenting	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
like	O	O	O
dendritic	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
is	O	O	O
of	O	O	O
critical	O	O	B-T080
importance	O	O	B-T080
.	O	O	O

This	O	O	O
review	O	O	O
will	O	O	O
discuss	O	O	O
the	O	O	O
current	O	O	B-T079
status	O	O	B-T080
of	O	O	O
ongoing	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
with	O	O	O
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
kidney	O	O	B-T061
transplantation	O	O	I-T061
and	O	O	O
specifically	O	O	O
concentrate	O	O	O
on	O	O	O
the	O	O	O
possibilities	O	O	O
and	O	O	O
impossibilities	O	O	O
of	O	O	O
how	O	O	O
these	O	O	O
therapeutic	O	O	B-T061
strategies	O	O	I-T061
can	O	O	O
contribute	O	O	B-T052
to	O	O	O
control	O	O	B-T080
of	O	O	O
the	O	O	O
different	O	O	O
forms	O	O	O
of	O	O	O
alloreactivity	O	O	B-T042
operation	O	O	O
in	O	O	O
organ	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

-DOCSTART- (27760552)

Facilitating	O	O	B-T169
factors	O	O	I-T169
and	O	O	O
barriers	O	O	B-T080
to	O	O	O
malaria	O	O	B-T047
research	O	O	B-T062
utilization	O	O	B-T169
for	O	O	O
policy	O	O	B-T064
development	O	O	I-T064
in	O	O	O
Malawi	O	O	O

Research	O	O	B-T062
on	O	O	O
various	O	O	O
determinants	O	O	B-T169
of	O	O	O
health	O	O	B-T078
is	O	O	O
key	O	O	O
in	O	O	O
providing	O	O	B-T052
evidence	O	O	B-T078
for	O	O	O
policy	O	O	B-T064
development	O	O	I-T064
,	O	O	O
thereby	O	O	O
leading	O	O	O
to	O	O	O
successful	O	O	B-T080
interventions	O	O	O
.	O	O	O

Utilization	O	O	B-T169
of	O	O	O
research	O	O	B-T062
is	O	O	O
an	O	O	O
intricate	O	O	B-T080
process	O	O	B-T067
requiring	O	O	O
an	O	O	O
understanding	O	O	O
of	O	O	O
contextual	O	O	B-UnknownType
factors	O	O	I-UnknownType
.	O	O	O

The	O	O	O
study	O	O	O
was	O	O	O
conducted	O	O	O
to	O	O	O
assess	O	O	O
enhancing	O	O	B-T052
factors	O	O	B-T169
and	O	O	O
barriers	O	O	B-T080
of	O	O	O
research	O	O	B-T062
utilization	O	O	B-T169
for	O	O	O
malaria	O	O	B-T047
policy	O	O	B-T064
development	O	O	I-T064
in	O	O	O
Malawi	O	O	B-T083
.	O	O	O

Qualitative	O	O	B-T080
research	O	O	B-T062
approach	O	O	O
was	O	O	O
used	O	O	O
through	O	O	O
in-depth	O	O	O
interviews	O	O	B-T052
with	O	O	O
39	O	O	O
key	O	O	O
informants	O	O	B-T098
that	O	O	O
included	O	O	O
malaria	O	O	B-T047
researchers	O	O	B-T097
,	O	O	O
policy	O	O	B-T097
makers	O	O	I-T097
,	O	O	O
programme	O	O	B-T057
managers	O	O	B-T097
,	O	O	O
and	O	O	O
key	O	O	B-T098
stakeholders	O	O	I-T098
.	O	O	O

Purposive	O	O	B-T062
sampling	O	O	I-T062
and	O	O	O
snowballing	O	O	B-T062
techniques	O	O	I-T062
were	O	O	O
used	O	O	O
in	O	O	O
identifying	O	O	B-T080
key	O	O	O
informants	O	O	B-T098
.	O	O	O

Interview	O	O	B-T052
transcripts	O	O	B-T170
were	O	O	O
entered	O	O	B-T080
in	O	O	O
QSR	O	O	B-T073
Nvivo	O	O	I-T073
11	O	O	I-T073
software	O	O	I-T073
for	O	O	O
coding	O	O	O
and	O	O	O
analysis	O	O	B-T062
.	O	O	O

Respondents	O	O	B-T098
identified	O	O	B-T080
global	O	O	B-T080
efforts	O	O	B-T052
as	O	O	O
key	O	O	O
in	O	O	O
advancing	O	O	O
knowledge	O	O	B-T062
translation	O	O	I-T062
,	O	O	O
while	O	O	O
local	O	O	B-T082
political	O	O	B-T068
will	O	O	I-T068
has	O	O	O
been	O	O	O
conducive	O	O	B-T080
for	O	O	O
research	O	O	B-T062
utilization	O	O	B-T169
.	O	O	O

Other	O	O	O
factors	O	O	B-T169
were	O	O	O
availability	O	O	B-T169
of	O	O	I-T169
research	O	O	B-T062
,	O	O	O
availability	O	O	O
of	O	O	O
diverse	O	O	O
local	O	O	B-T082
researchers	O	O	B-T097
and	O	O	O
stakeholders	O	O	B-T098
supporting	O	O	B-T077
knowledge	O	O	B-T062
translation	O	O	I-T062
.	O	O	O

While	O	O	O
barriers	O	O	B-T080
included	O	O	O
:	O	O	O
lack	O	O	B-T080
of	O	O	O
platforms	O	O	O
for	O	O	O
researcher	O	O	B-T097
-	O	O	O
public	O	O	B-T092
engagement	O	O	B-T033
,	O	O	O
politics	O	O	B-T057
,	O	O	O
researchers	O	O	B-T097
'	O	O	I-T097
lack	O	O	O
of	O	O	O
communication	O	O	B-T032
skills	O	O	I-T032
,	O	O	O
lack	O	O	O
of	O	O	O
research	O	O	B-T062
collaborations	O	O	B-T054
,	O	O	O
funder	O	O	B-T062
driven	O	O	I-T062
research	O	O	I-T062
,	O	O	O
unknown	O	O	B-T080
World	O	O	B-T093
Health	O	O	I-T093
Organization	O	O	I-T093
policy	O	O	B-T170
position	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
lack	O	O	O
of	O	O	O
a	O	O	O
malaria	O	O	B-T047
research	O	O	O
repository	O	O	B-T073
.	O	O	O

Overall	O	O	O
,	O	O	O
the	O	O	O
study	O	O	O
identified	O	O	B-T080
facilitating	O	O	B-T169
factors	O	O	I-T169
to	O	O	O
malaria	O	O	B-T047
research	O	O	B-T062
utilization	O	O	B-T169
for	O	O	O
policy	O	O	B-T064
development	O	O	I-T064
in	O	O	O
Malawi	O	O	B-T083
.	O	O	O

These	O	O	O
factors	O	O	B-T169
need	O	O	O
to	O	O	O
be	O	O	O
systematically	O	O	B-T169
coordinated	O	O	B-T169
to	O	O	O
address	O	O	O
the	O	O	O
identified	O	O	B-T080
barriers	O	O	B-T080
and	O	O	O
improve	O	O	B-T033
on	O	O	O
malaria	O	O	B-T047
research	O	O	B-T062
utilization	O	O	B-T169
in	O	O	O
policy	O	O	B-T064
development	O	O	I-T064
.	O	O	O

Malaria	O	O	B-T047
research	O	O	B-T062
can	O	O	O
be	O	O	O
key	O	O	O
in	O	O	O
the	O	O	O
implementation	O	O	B-T052
of	O	O	O
evidence-based	O	O	B-T078
interventions	O	O	O
to	O	O	O
reduce	O	O	B-T080
the	O	O	O
malaria	O	O	B-T047
burden	O	O	B-T078
and	O	O	O
assist	O	O	O
in	O	O	O
the	O	O	O
paradigm	O	O	B-T062
shift	O	O	I-T062
from	O	O	O
malaria	O	O	O
control	O	O	B-T169
to	O	O	O
elimination	O	O	B-T052
in	O	O	O
Malawi	O	O	B-T083
.	O	O	O

-DOCSTART- (27760700)

Altered	O	O	B-T169
interregional	O	O	B-T029
correlations	O	O	B-T080
between	O	O	O
serotonin	O	O	B-T116
transporter	O	O	I-T116
availability	O	O	B-T169
and	O	O	O
cerebral	O	O	B-T109
glucose	O	O	B-T044
metabolism	O	O	I-T044
in	O	O	O
schizophrenia	O	O	B-T048
:	O	O	O
A	O	O	O
high-resolution	O	O	B-T060
PET	O	O	I-T060
study	O	O	O
using	O	O	O
[(11)C]DASB	O	O	B-T109
and	O	O	O
[(18)F]FDG	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
patterns	O	O	O
of	O	O	O
interregional	O	O	B-T029
correlations	O	O	B-T080
of	O	O	O
serotonin	O	O	B-T116
transporter	O	O	I-T116
(	O	O	O
SERT	O	O	B-T116
)	O	O	O
availability	O	O	B-T169
with	O	O	O
glucose	O	O	B-T044
metabolism	O	O	I-T044
using	O	O	O
7-Tesla	O	O	B-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
MRI	O	O	B-T060
)	O	O	O
and	O	O	O
high-resolution	O	O	B-T060
positron	O	O	I-T060
emission	O	O	I-T060
tomography	O	O	I-T060
(	O	O	O
PET	O	O	B-T060
)	O	O	O
with	O	O	O
(11)C-3-amino-4-(2-dimethylaminomethylphenylthio)benzonitrile	O	O	B-T109
(	O	O	O
[(11)C]DASB	O	O	B-T109
)	O	O	O
and	O	O	O
[(18)F]fluorodeoxyglucose	O	O	B-T109
(	O	O	O
[(18)F]FDG	O	O	B-T109
)	O	O	O
in	O	O	O
antipsychotic-free	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
schizophrenia	O	O	B-T048
in	O	O	O
order	O	O	O
to	O	O	O
shed	O	O	O
new	O	O	O
light	O	O	O
on	O	O	O
the	O	O	O
disrupted	O	O	B-T080
functional	O	O	B-T169
connectivity	O	O	I-T169
in	O	O	O
schizophrenia	O	O	O
.	O	O	O

Nineteen	O	O	O
patients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
and	O	O	O
18	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
underwent	O	O	O
high-resolution	O	O	B-T060
PET	O	O	I-T060
and	O	O	O
MRI	O	O	B-T060
.	O	O	O

The	O	O	O
binding	O	O	B-T067
potential	O	O	I-T067
(	O	O	O
BPND	O	O	B-T067
)	O	O	O
of	O	O	O
[(11)C]DASB	O	O	B-T109
and	O	O	O
standardized	O	O	B-T081
uptake	O	O	I-T081
value	O	O	I-T081
ratio	O	O	I-T081
(	O	O	O
SUVR	O	O	B-T081
)	O	O	O
of	O	O	O
[(18)F]FDG	O	O	B-T109
were	O	O	O
obtained	O	O	O
.	O	O	O

In	O	O	O
SERT	O	O	B-T116
availability	O	O	B-T169
,	O	O	O
the	O	O	O
region	O	O	B-T029
of	O	O	I-T082
interest	O	O	I-T082
(ROI)-based	O	O	O
analyses	O	O	B-T062
showed	O	O	O
no	O	O	O
significant	O	O	O
group	O	O	O
differences	O	O	O
in	O	O	O
any	O	O	O
region	O	O	O
,	O	O	O
except	O	O	O
for	O	O	O
the	O	O	O
anterior	O	O	B-T082
hippocampus	O	O	B-T023
where	O	O	O
the	O	O	O
SERT	O	O	O
availability	O	O	O
was	O	O	O
lower	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
than	O	O	O
in	O	O	O
controls	O	O	B-T096
.	O	O	O

The	O	O	O
ROI	O	O	B-T082
-	O	O	O
and	O	O	O
voxel	O	O	B-T077
-based	O	O	O
analyses	O	O	B-T062
revealed	O	O	O
that	O	O	O
the	O	O	O
[(18)F]FDG	O	O	B-T109
SUVR	O	O	B-T081
values	O	O	I-T081
were	O	O	O
significantly	O	O	O
lower	O	O	O
in	O	O	O
patients	O	O	B-T101
than	O	O	O
in	O	O	O
controls	O	O	B-T096
in	O	O	O
the	O	O	O
right	O	O	B-T023
superior	O	O	I-T023
frontal	O	O	I-T023
gyrus	O	O	I-T023
and	O	O	O
medial	O	O	B-T082
part	O	O	I-T082
of	O	O	O
the	O	O	O
left	O	O	B-T023
superior	O	O	I-T023
frontal	O	O	I-T023
gyrus	O	O	I-T023
.	O	O	O

Regarding	O	O	O
the	O	O	O
interregional	O	O	B-T029
correlations	O	O	B-T080
of	O	O	O
[(11)C]DASB	O	O	B-T109
BPND	O	O	B-T067
with	O	O	O
[(18)F]FDG	O	O	B-T109
SUVR	O	O	B-T081
,	O	O	O
more	O	O	O
widespread	O	O	O
positive	O	O	B-T033
correlations	O	O	O
across	O	O	O
the	O	O	O
brain	O	O	B-T029
regions	O	O	I-T029
were	O	O	O
observed	O	O	O
in	O	O	O
control	O	O	B-T096
subjects	O	O	I-T096
than	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

Notably	O	O	O
,	O	O	O
the	O	O	O
patients	O	O	B-T101
and	O	O	O
control	O	O	B-T096
subjects	O	O	I-T096
showed	O	O	O
statistically	O	O	O
significant	O	O	O
differences	O	O	O
in	O	O	O
correlations	O	O	B-T080
between	O	O	O
the	O	O	O
SERT	O	O	B-T116
availability	O	O	B-T169
in	O	O	O
the	O	O	O
parietal	O	O	B-T023
and	O	O	O
temporal	O	O	B-T023
cortices	O	O	I-T023
and	O	O	O
the	O	O	O
glucose	O	O	B-T044
metabolism	O	O	I-T044
in	O	O	O
the	O	O	O
posterior	O	O	B-T023
cingulate	O	O	I-T023
cortex	O	O	I-T023
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
abnormal	O	O	B-T033
functional	O	O	B-T169
connectivity	O	O	I-T169
between	O	O	O
the	O	O	O
higher-order	O	O	B-T029
cortical	O	O	I-T029
regions	O	O	I-T029
in	O	O	O
schizophrenia	O	O	B-T048
and	O	O	O
a	O	O	O
possible	O	O	O
important	O	O	O
role	O	O	B-T077
of	O	O	O
the	O	O	O
posterior	O	O	B-T023
cingulate	O	O	I-T023
gyrus	O	O	I-T023
and	O	O	O
its	O	O	O
related	O	O	O
circuitry	O	O	B-UnknownType
in	O	O	O
the	O	O	O
pathophysiology	O	O	B-T169
of	O	O	O
schizophrenia	O	O	O
.	O	O	O

-DOCSTART- (27761922)

Urticarial	O	O	B-T047
exanthema	O	O	B-T184
due	O	O	O
to	O	O	O
hepatitis	O	O	B-T047
B	O	O	I-T047
in	O	O	O
a	O	O	O
pregnant	O	O	B-T098
woman	O	O	I-T098
,	O	O	O
mimicking	O	O	O
a	O	O	O
polymorphic	O	O	B-T047
eruption	O	O	I-T047
of	O	O	O
pregnancy	O	O	O

Hepatitis	O	O	B-T047
B	O	O	I-T047
virus	O	O	I-T047
(	O	O	I-T047
HBV	O	O	I-T047
)	O	O	I-T047
infection	O	O	I-T047
in	O	O	I-T047
pregnant	O	O	I-T047
women	O	O	I-T047
is	O	O	O
very	O	O	O
rare	O	O	O
in	O	O	O
western	O	O	B-T083
countries	O	O	I-T083
,	O	O	O
thus	O	O	O
,	O	O	O
cutaneous	O	O	B-T082
manifestation	O	O	B-T080
of	O	O	I-T080
HBV	O	O	B-T047
infection	O	O	I-T047
may	O	O	O
be	O	O	O
confused	O	O	O
with	O	O	O
a	O	O	O
dermatosis	O	O	B-T047
specific	O	O	O
of	O	O	O
pregnancy	O	O	B-T040
.	O	O	O

We	O	O	O
report	O	O	O
a	O	O	O
39-year-old	O	O	O
woman	O	O	B-T098
who	O	O	O
presented	O	O	O
in	O	O	O
her	O	O	O
20th	O	O	O
week	O	O	O
of	O	O	O
pregnancy	O	O	B-T040
with	O	O	O
a	O	O	O
pruritic	O	O	B-T047
rash	O	O	I-T047
,	O	O	O
which	O	O	O
consisted	O	O	O
of	O	O	O
generalized	O	O	O
erythematous	O	O	B-T033
plaques	O	O	I-T033
,	O	O	O
some	O	O	O
of	O	O	O
them	O	O	O
with	O	O	O
a	O	O	O
purple	O	O	B-T033
centre	O	O	I-T033
.	O	O	O

Serology	O	O	B-T059
testing	O	O	I-T059
showed	O	O	O
acute	O	O	B-T047
HBV	O	O	I-T047
infection	O	O	I-T047
,	O	O	O
and	O	O	O
a	O	O	O
biopsy	O	O	B-T060
revealed	O	O	O
a	O	O	O
superficial	O	O	B-T082
and	O	O	O
interstitial	O	O	B-T033
perivascular	O	O	I-T033
inflammatory	O	O	I-T033
infiltrate	O	O	I-T033
of	O	O	O
lymphocytes	O	O	B-T025
and	O	O	O
eosinophils	O	O	B-T025
.	O	O	O

A	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
exanthema	O	O	B-T184
due	O	O	O
to	O	O	O
acute	O	O	B-T047
hepatitis	O	O	I-T047
B	O	O	I-T047
infection	O	O	I-T047
was	O	O	O
established	O	O	O
.	O	O	O

The	O	O	O
patient	O	O	B-T101
delivered	O	O	B-T033
a	O	O	O
clinically	O	O	B-T033
healthy	O	O	I-T033
boy	O	O	I-T033
,	O	O	O
who	O	O	O
was	O	O	O
given	O	O	O
the	O	O	O
first	O	O	B-T081
dose	O	O	I-T081
of	O	O	O
the	O	O	O
HBV	O	O	B-T005
vaccine	O	O	I-T061
and	O	O	O
intravenous	O	O	B-T116
specific	O	O	I-T116
immunoglobulin	O	O	I-T116
,	O	O	O
followed	O	O	O
by	O	O	O
the	O	O	O
second	O	O	B-T081
dose	O	O	I-T081
2	O	O	O
months	O	O	O
later	O	O	O
,	O	O	O
and	O	O	O
did	O	O	O
not	O	O	O
get	O	O	O
infected	O	O	B-T033
with	O	O	O
HBV	O	O	O
.	O	O	O

To	O	O	O
our	O	O	O
knowledge	O	O	O
,	O	O	O
this	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
case	O	O	O
describing	O	O	O
HBV	O	O	B-T047
exanthema	O	O	B-T184
in	O	O	O
a	O	O	O
pregnant	O	O	B-T098
woman	O	O	I-T098
,	O	O	O
which	O	O	O
led	O	O	O
to	O	O	O
early	O	O	O
action	O	O	O
for	O	O	O
the	O	O	O
newborn	O	O	B-T100
,	O	O	O
avoiding	O	O	O
vertical	O	O	B-T046
transmission	O	O	I-T046
and	O	O	O
its	O	O	O
high	O	O	O
prevalence	O	O	O
of	O	O	O
cirrhosis	O	O	B-T047
and	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
.	O	O	O

-DOCSTART- (27764829)

Determination	O	O	O
of	O	O	O
the	O	O	O
Mutant	O	O	B-T061
Prevention	O	O	I-T061
Concentration	O	O	I-T061
and	O	O	O
the	O	O	O
Mutant	O	O	B-T081
Selection	O	O	I-T081
Window	O	O	I-T081
of	O	O	O
Topical	O	O	B-T121
Antimicrobial	O	O	I-T121
Agents	O	O	I-T121
against	O	O	O
Propionibacterium	O	O	O
acnes	O	O	O

Determination	O	O	O
of	O	O	O
the	O	O	O
mutant	O	O	B-T061
prevention	O	O	I-T061
concentration	O	O	I-T061
(	O	O	O
MPC	O	O	B-T061
)	O	O	O
and	O	O	O
the	O	O	O
mutant	O	O	B-T081
selection	O	O	I-T081
window	O	O	I-T081
(	O	O	O
MSW	O	O	B-T081
)	O	O	O
of	O	O	O
antimicrobial	O	O	B-T121
agents	O	O	I-T121
used	O	O	O
to	O	O	O
treat	O	O	O
pathogenic	O	O	B-T001
bacteria	O	O	B-T007
is	O	O	O
important	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
apply	O	O	O
effective	O	O	O
antimicrobial	O	O	O
therapies	O	O	B-T061
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
determined	O	O	O
the	O	O	O
MPCs	O	O	B-T061
of	O	O	O
the	O	O	O
major	O	O	O
topical	O	O	B-T121
antimicrobial	O	O	I-T121
agents	O	O	I-T121
against	O	O	O
Propionibacterium	O	O	B-T007
acnes	O	O	I-T007
and	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
which	O	O	O
cause	O	O	O
skin	O	O	B-T047
infections	O	O	I-T047
and	O	O	O
compared	O	O	O
their	O	O	O
MSWs	O	O	B-T081
.	O	O	O

Among	O	O	O
the	O	O	O
MPCs	O	O	B-T061
of	O	O	O
nadifloxacin	O	O	B-T195
and	O	O	O
clindamycin	O	O	B-T195
,	O	O	O
the	O	O	O
clindamycin	O	O	O
MPC	O	O	B-T061
was	O	O	O
determined	O	O	O
to	O	O	O
be	O	O	O
the	O	O	O
lowest	O	O	B-T080
against	O	O	O
P.	O	O	B-T007
acnes	O	O	I-T007
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
nadifloxacin	O	O	B-T195
MPC	O	O	B-T061
was	O	O	O
the	O	O	O
lowest	O	O	B-T080
against	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
.	O	O	O

Calculations	O	O	B-T057
based	O	O	O
on	O	O	O
the	O	O	O
minimum	O	O	B-T034
inhibitory	O	O	I-T034
concentrations	O	O	I-T034
and	O	O	O
MPCs	O	O	B-T061
showed	O	O	O
that	O	O	O
clindamycin	O	O	B-T195
has	O	O	O
the	O	O	O
lowest	O	O	B-T080
MSW	O	O	B-T081
against	O	O	O
both	O	O	O
P.	O	O	B-T007
acnes	O	O	I-T007
and	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
.	O	O	O

Nadifloxacin	O	O	B-T195
MSWs	O	O	B-T081
were	O	O	O
4-fold	O	O	O
higher	O	O	B-T080
against	O	O	O
P.	O	O	B-T007
acnes	O	O	I-T007
than	O	O	O
against	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
.	O	O	O

It	O	O	O
is	O	O	O
more	O	O	O
likely	O	O	O
for	O	O	O
P.	O	O	B-T007
acnes	O	O	I-T007
to	O	O	O
acquire	O	O	O
resistance	O	O	B-T038
to	O	O	O
fluoroquinolones	O	O	B-T109
than	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
.	O	O	O

Therefore	O	O	O
,	O	O	O
topical	O	O	B-T061
application	O	O	I-T061
of	O	O	O
clindamycin	O	O	B-T195
contributes	O	O	O
very	O	O	O
little	O	O	O
to	O	O	O
the	O	O	O
emergence	O	O	O
of	O	O	O
resistant	O	O	B-T038
P.	O	O	B-T007
acnes	O	O	I-T007
and	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
strains	O	O	O
.	O	O	O

-DOCSTART- (27765805)

Total	O	O	O
colectomy	O	O	B-T061
for	O	O	O
colon	O	O	B-T037
perforation	O	O	I-T037
after	O	O	O
kayexalate	O	O	B-T109
administration	O	O	B-T061
:	O	O	O
a	O	O	O
case	O	O	O
report	O	O	O
and	O	O	O
literature	O	O	B-T170
review	O	O	I-T170
of	O	O	O
a	O	O	O
rare	O	O	B-T080
complication	O	O	O

Kayexalate	O	O	B-T109
is	O	O	O
an	O	O	O
ion	O	O	B-T121
exchange	O	O	I-T121
resin	O	O	I-T121
that	O	O	O
is	O	O	O
commonly	O	O	O
used	O	O	O
to	O	O	O
acutely	O	O	O
treat	O	O	B-T061
patients	O	O	B-T101
with	O	O	O
hyperkalemia	O	O	B-T033
.	O	O	O

Bowel	O	O	B-T047
ulceration	O	O	I-T047
and	O	O	O
necrosis	O	O	B-T042
is	O	O	O
a	O	O	O
rare	O	O	B-T080
and	O	O	O
uncommonly	O	O	O
recognized	O	O	O
complication	O	O	B-T046
of	O	O	O
kayexalate	O	O	B-T109
administration	O	O	B-T061
.	O	O	O

More	O	O	O
often	O	O	O
,	O	O	O
concomitant	O	O	B-T079
administration	O	O	B-T061
with	O	O	O
sorbitol	O	O	B-T109
is	O	O	O
reported	O	O	O
to	O	O	O
damage	O	O	B-T169
the	O	O	O
bowel	O	O	B-T023
;	O	O	O
however	O	O	O
,	O	O	O
there	O	O	O
are	O	O	O
reports	O	O	O
of	O	O	O
kayexalate	O	O	B-T109
administration	O	O	O
causing	O	O	O
bowel	O	O	B-T047
necrosis	O	O	I-T047
without	O	O	O
sorbitol	O	O	O
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
case	O	O	O
of	O	O	O
a	O	O	O
critically	O	O	B-T047
ill	O	O	I-T047
patient	O	O	B-T101
who	O	O	O
underwent	O	O	O
total	O	O	O
colectomy	O	O	B-T061
for	O	O	O
colonic	O	O	B-T047
necrosis	O	O	I-T047
secondary	O	O	O
to	O	O	O
oral	O	O	B-T082
kayexalate	O	O	B-T109
administration	O	O	B-T061
that	O	O	O
was	O	O	O
not	O	O	O
recognized	O	O	O
until	O	O	O
late	O	O	O
in	O	O	O
the	O	O	O
pathologic	O	O	B-T046
process	O	O	I-T046
.	O	O	O

We	O	O	O
also	O	O	O
review	O	O	B-T170
the	O	O	I-T170
literature	O	O	I-T170
to	O	O	O
further	O	O	O
investigate	O	O	O
this	O	O	O
progression	O	O	B-T046
.	O	O	O

-DOCSTART- (27766178)

Total	O	O	B-T080
Arsenic	O	O	B-T121
,	O	O	O
Cadmium	O	O	B-T131
,	O	O	O
and	O	O	O
Lead	O	O	B-T131
Determination	O	O	B-T059
in	O	O	O
Brazilian	O	O	B-T168
Rice	O	O	I-T168
Samples	O	O	B-T167
Using	O	O	O
ICP-MS	O	O	O

This	O	O	O
study	O	O	B-T062
is	O	O	O
aimed	O	O	O
at	O	O	O
investigating	O	O	B-T169
a	O	O	O
suitable	O	O	O
method	O	O	B-T170
for	O	O	O
rice	O	O	B-T168
sample	O	O	B-T167
preparation	O	O	B-T052
as	O	O	O
well	O	O	O
as	O	O	O
validating	O	O	B-T062
and	O	O	O
applying	O	O	B-T169
the	O	O	O
method	O	O	O
for	O	O	O
monitoring	O	O	B-T169
the	O	O	O
concentration	O	O	B-T081
of	O	O	O
total	O	O	B-T080
arsenic	O	O	B-T121
,	O	O	O
cadmium	O	O	B-T131
,	O	O	O
and	O	O	O
lead	O	O	B-T131
in	O	O	O
rice	O	O	O
by	O	O	O
using	O	O	O
Inductively	O	O	B-T059
Coupled	O	O	I-T059
Plasma	O	O	I-T059
Mass	O	O	I-T059
Spectrometry	O	O	I-T059
(	O	O	O
ICP-MS	O	O	B-T059
)	O	O	O
.	O	O	O

Various	O	O	O
rice	O	O	B-T168
sample	O	O	B-T167
preparation	O	O	B-T052
procedures	O	O	B-T169
were	O	O	O
evaluated	O	O	O
.	O	O	O

The	O	O	O
analytical	O	O	B-T170
method	O	O	I-T170
was	O	O	O
validated	O	O	B-T062
by	O	O	O
measuring	O	O	B-T169
several	O	O	O
parameters	O	O	B-T033
including	O	O	O
limit	O	O	B-T081
of	O	O	I-T081
detection	O	O	I-T081
(	O	O	O
LOD	O	O	B-T081
)	O	O	O
,	O	O	O
limit	O	O	B-T081
of	O	O	I-T081
quantification	O	O	I-T081
(	O	O	O
LOQ	O	O	B-T081
)	O	O	O
,	O	O	O
linearity	O	O	B-T081
,	O	O	O
relative	O	O	B-T078
bias	O	O	I-T078
,	O	O	O
and	O	O	O
repeatability	O	O	B-T080
.	O	O	O

Regarding	O	O	O
the	O	O	O
sample	O	O	B-T167
preparation	O	O	B-T052
,	O	O	O
recoveries	O	O	B-T033
of	O	O	O
spiked	O	O	B-T167
samples	O	O	I-T167
were	O	O	O
within	O	O	O
the	O	O	O
acceptable	O	O	B-T081
range	O	O	I-T081
from	O	O	O
89.3	O	O	O
to	O	O	O
98.2	O	O	O
%	O	O	O
for	O	O	O
muffle	O	O	B-T073
furnace	O	O	I-T073
,	O	O	O
94.2	O	O	O
to	O	O	O
103.3	O	O	O
%	O	O	O
for	O	O	O
heating	O	O	B-T074
block	O	O	I-T074
,	O	O	O
81.0	O	O	O
to	O	O	O
115.0	O	O	O
%	O	O	O
for	O	O	O
hot	O	O	B-T074
plate	O	O	I-T074
,	O	O	O
and	O	O	O
92.8	O	O	O
to	O	O	O
108.2	O	O	O
%	O	O	O
for	O	O	O
microwave	O	O	B-T073
.	O	O	O

Validation	O	O	B-T062
parameters	O	O	B-T033
showed	O	O	O
that	O	O	O
the	O	O	O
method	O	O	B-T170
fits	O	O	O
for	O	O	O
its	O	O	O
purpose	O	O	O
,	O	O	O
being	O	O	O
the	O	O	O
total	O	O	B-T080
arsenic	O	O	B-T121
,	O	O	O
cadmium	O	O	B-T131
,	O	O	O
and	O	O	O
lead	O	O	B-T131
within	O	O	O
the	O	O	O
Brazilian	O	O	O
Legislation	O	O	O
limits	O	O	O
.	O	O	O

The	O	O	O
method	O	O	B-T170
was	O	O	O
applied	O	O	O
for	O	O	O
analyzing	O	O	B-T062
37	O	O	O
rice	O	O	B-T168
samples	O	O	B-T167
(	O	O	O
including	O	O	O
polished	O	O	B-T168
,	O	O	O
brown	O	O	B-T168
,	O	O	O
and	O	O	O
parboiled	O	O	B-T168
)	O	O	O
,	O	O	O
consumed	O	O	O
by	O	O	O
the	O	O	O
Brazilian	O	O	B-T081
population	O	O	I-T081
.	O	O	O

The	O	O	O
total	O	O	B-T080
arsenic	O	O	B-T121
,	O	O	O
cadmium	O	O	B-T131
,	O	O	O
and	O	O	O
lead	O	O	B-T131
contents	O	O	B-T077
were	O	O	O
lower	O	O	O
than	O	O	O
the	O	O	O
established	O	O	O
legislative	O	O	B-T170
values	O	O	B-T080
,	O	O	O
except	O	O	O
for	O	O	O
total	O	O	O
arsenic	O	O	O
in	O	O	O
one	O	O	O
brown	O	O	B-T168
rice	O	O	I-T168
sample	O	O	B-T167
.	O	O	O

This	O	O	O
study	O	O	B-T062
indicated	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
establish	O	O	O
monitoring	O	O	B-T169
programs	O	O	B-T169
for	O	O	O
emphasizing	O	O	O
the	O	O	O
study	O	O	O
on	O	O	O
this	O	O	O
type	O	O	B-T080
of	O	O	O
cereal	O	O	B-T168
,	O	O	O
aiming	O	O	O
at	O	O	O
promoting	O	O	O
the	O	O	O
Public	O	O	B-T170
Health	O	O	I-T170
.	O	O	O

-DOCSTART- (27768063)

Safety	O	O	B-T058
Precautions	O	O	I-T058
and	O	O	O
Operating	O	O	B-T170
Procedures	O	O	I-T170
in	O	O	O
an	O	O	O
(	O	O	O
A	O	O	O
)	O	O	O
BSL-4	O	O	B-T170
Laboratory	O	O	B-T093
:	O	O	O
1	O	O	O
.	O	O	O
Biosafety	O	O	B-T170
Level	O	O	I-T170
4	O	O	I-T170
Suit	O	O	B-T093
Laboratory	O	O	I-T093
Suite	O	O	O
Entry	O	O	O
and	O	O	O
Exit	O	O	O
Procedures	O	O	O

Biosafety	O	O	B-T170
level	O	O	I-T170
4	O	O	I-T170
(	O	O	O
BSL-4	O	O	B-T170
)	O	O	O
suit	O	O	B-T093
laboratories	O	O	I-T093
are	O	O	O
specifically	O	O	O
designed	O	O	B-T052
to	O	O	O
study	O	O	B-T062
high-consequence	O	O	B-T001
pathogens	O	O	I-T001
for	O	O	O
which	O	O	O
neither	O	O	O
infection	O	O	B-T046
prophylaxes	O	O	B-T061
nor	O	O	O
treatment	O	O	B-T061
options	O	O	O
exist	O	O	O
.	O	O	O

The	O	O	O
hallmarks	O	O	O
of	O	O	O
these	O	O	O
laboratories	O	O	B-T093
are	O	O	O
:	O	O	O
custom-designed	O	O	B-T052
airtight	O	O	B-T073
doors	O	O	I-T073
,	O	O	O
dedicated	O	O	O
supply	O	O	B-T169
and	O	O	O
exhaust	O	O	B-T073
airflow	O	O	I-T073
systems	O	O	I-T073
,	O	O	O
a	O	O	O
negative-pressure	O	O	B-T074
environment	O	O	I-T074
,	O	O	O
and	O	O	O
mandatory	O	O	O
use	O	O	O
of	O	O	O
positive-pressure	O	O	B-T073
(	O	O	I-T073
"	O	O	I-T073
space	O	O	I-T073
"	O	O	I-T073
)	O	O	I-T073
suits	O	O	I-T073
.	O	O	O

The	O	O	O
risk	O	O	O
for	O	O	O
laboratory	O	O	B-T093
specialists	O	O	B-T097
working	O	O	O
with	O	O	O
highly	O	O	O
pathogenic	O	O	B-T001
agents	O	O	I-T001
is	O	O	O
minimized	O	O	O
through	O	O	O
rigorous	O	O	O
training	O	O	B-T065
and	O	O	O
adherence	O	O	O
to	O	O	O
stringent	O	O	O
safety	O	O	B-T170
protocols	O	O	I-T170
and	O	O	O
standard	O	O	B-T170
operating	O	O	I-T170
procedures	O	O	I-T170
.	O	O	O

Researchers	O	O	B-T097
perform	O	O	O
the	O	O	O
majority	O	O	B-T080
of	O	O	O
their	O	O	O
work	O	O	B-T057
in	O	O	O
BSL-2	O	O	B-T170
laboratories	O	O	B-T093
and	O	O	O
switch	O	O	O
to	O	O	O
BSL-4	O	O	B-T170
suit	O	O	B-T093
laboratories	O	O	I-T093
when	O	O	O
work	O	O	O
with	O	O	O
a	O	O	O
high-consequence	O	O	B-T001
pathogen	O	O	I-T001
is	O	O	O
required	O	O	O
.	O	O	O

Collaborators	O	O	B-T094
and	O	O	O
scientists	O	O	B-T097
considering	O	O	O
BSL-4	O	O	B-T170
projects	O	O	B-T062
should	O	O	O
be	O	O	O
aware	O	O	O
of	O	O	O
the	O	O	O
challenges	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
BSL-4	O	O	O
research	O	O	B-T062
both	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
experimental	O	O	B-T080
technical	O	O	B-T169
limitations	O	O	B-T169
in	O	O	O
BSL-4	O	O	O
laboratory	O	O	B-T093
space	O	O	B-T082
and	O	O	O
the	O	O	O
increased	O	O	B-T081
duration	O	O	B-T079
of	O	O	O
such	O	O	O
experiments	O	O	B-T062
.	O	O	O

Tasks	O	O	O
such	O	O	O
as	O	O	O
entering	O	O	B-T169
and	O	O	O
exiting	O	O	B-T169
the	O	O	O
BSL-4	O	O	B-T170
suit	O	O	B-T093
laboratories	O	O	B-T093
are	O	O	O
considerably	O	O	O
more	O	O	O
complex	O	O	B-T080
and	O	O	O
time-consuming	O	O	B-T080
compared	O	O	B-T052
to	O	O	O
BSL-2	O	O	B-T170
and	O	O	O
BSL-3	O	O	B-T170
laboratories	O	O	O
.	O	O	O

The	O	O	O
focus	O	O	O
of	O	O	O
this	O	O	O
particular	O	O	O
article	O	O	B-T170
is	O	O	O
to	O	O	O
address	O	O	B-T170
basic	O	O	O
biosafety	O	O	B-T068
concerns	O	O	B-T078
and	O	O	O
describe	O	O	O
the	O	O	O
entrance	O	O	B-T170
and	O	O	I-T170
exit	O	O	I-T170
procedures	O	O	I-T170
for	O	O	O
the	O	O	O
BSL-4	O	O	B-T170
laboratory	O	O	B-T093
at	O	O	O
the	O	O	O
NIH	O	O	B-T093
/	O	O	O
NIAID	O	O	B-T093
Integrated	O	O	B-T073
Research	O	O	I-T073
Facility	O	O	I-T073
at	O	O	O
Fort	O	O	O
Detrick	O	O	O
.	O	O	O

Such	O	O	O
procedures	O	O	B-T170
include	O	O	O
checking	O	O	O
external	O	O	O
systems	O	O	O
that	O	O	O
support	O	O	O
the	O	O	O
BSL-4	O	O	B-T170
laboratory	O	O	B-T093
,	O	O	O
and	O	O	O
inspecting	O	O	O
and	O	O	O
donning	O	O	O
positive-pressure	O	O	B-T073
suits	O	O	I-T073
,	O	O	O
entering	O	O	O
the	O	O	O
laboratory	O	O	O
,	O	O	O
moving	O	O	O
through	O	O	O
air	O	O	B-T070
pressure	O	O	I-T070
-	O	O	O
resistant	O	O	B-T169
doors	O	O	B-T073
,	O	O	O
and	O	O	O
connecting	O	O	O
to	O	O	O
air-supply	O	O	B-T074
hoses	O	O	I-T074
.	O	O	O

We	O	O	O
will	O	O	O
also	O	O	O
discuss	O	O	O
moving	O	O	B-T040
within	O	O	O
and	O	O	O
exiting	O	O	B-T169
the	O	O	O
BSL-4	O	O	B-T170
suit	O	O	B-T093
laboratories	O	O	I-T093
,	O	O	O
including	O	O	O
using	O	O	O
the	O	O	O
chemical	O	O	B-T103
shower	O	O	B-T073
and	O	O	O
removing	O	O	B-T052
and	O	O	O
storing	O	O	B-T169
positive-pressure	O	O	B-T073
suits	O	O	I-T073
.	O	O	O

-DOCSTART- (27768522)

Masters	O	O	B-T097
Athletes	O	O	I-T097
:	O	O	O
Exemplars	O	O	O
of	O	O	O
Successful	O	O	B-T040
Aging	O	O	I-T040
?	O	O	O

Global	O	O	B-T098
population	O	O	I-T098
aging	O	O	B-T040
has	O	O	O
raised	O	O	B-T033
academic	O	O	I-T033
interest	O	O	I-T033
in	O	O	O
successful	O	O	B-T040
aging	O	O	I-T040
to	O	O	O
a	O	O	O
public	O	O	B-T064
policy	O	O	I-T064
priority	O	O	O
.	O	O	O

Currently	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
consensus	O	O	B-T054
regarding	O	O	O
the	O	O	O
definition	O	O	O
of	O	O	O
successful	O	O	B-T040
aging	O	O	I-T040
.	O	O	O

However	O	O	O
,	O	O	O
a	O	O	O
synthesis	O	O	O
of	O	O	O
research	O	O	O
shows	O	O	O
successful	O	O	B-T040
aging	O	O	I-T040
can	O	O	O
be	O	O	O
defined	O	O	O
as	O	O	O
a	O	O	O
late-life	O	O	B-T048
process	O	O	I-T048
of	O	O	I-T048
change	O	O	I-T048
characterized	O	O	O
by	O	O	O
high	O	O	B-T033
physical	O	O	I-T033
,	O	O	O
psychological	O	O	B-T041
,	O	O	O
cognitive	O	O	B-T041
,	O	O	O
and	O	O	O
social	O	O	B-T054
functioning	O	O	I-T054
.	O	O	O

Masters	O	O	B-T097
athletes	O	O	I-T097
systematically	O	O	B-T080
train	O	O	I-T080
for	O	O	O
,	O	O	O
and	O	O	O
compete	O	O	B-T054
in	O	O	I-T054
,	O	O	O
organized	O	O	B-T096
forms	O	O	I-T096
of	O	O	I-T096
team	O	O	I-T096
and	O	O	O
individual	O	O	B-T056
sport	O	O	I-T056
specifically	O	O	O
designed	O	O	O
for	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
.	O	O	O

Masters	O	O	B-T097
athletes	O	O	I-T097
are	O	O	O
often	O	O	O
proposed	O	O	O
as	O	O	O
exemplars	O	O	O
of	O	O	O
successful	O	O	B-T040
aging	O	O	I-T040
.	O	O	O

However	O	O	O
,	O	O	O
their	O	O	O
aging	O	O	B-T033
status	O	O	I-T033
has	O	O	O
never	O	O	O
been	O	O	O
examined	O	O	O
using	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
multidimensional	O	O	B-T082
successful	O	O	B-T040
aging	O	O	I-T040
definition	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
examine	O	O	O
the	O	O	O
successful	O	O	B-T040
aging	O	O	I-T040
literature	O	O	B-T170
,	O	O	O
propose	O	O	O
a	O	O	O
successful	O	O	O
aging	O	O	O
definition	O	O	O
based	O	O	O
on	O	O	O
this	O	O	O
literature	O	O	O
,	O	O	O
present	O	O	O
evidence	O	O	O
which	O	O	O
suggests	O	O	O
masters	O	O	B-T097
athletes	O	O	I-T097
could	O	O	O
be	O	O	O
considered	O	O	O
exemplars	O	O	O
of	O	O	O
successful	O	O	O
aging	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
proposed	O	O	O
definition	O	O	O
,	O	O	O
and	O	O	O
list	O	O	O
future	O	O	O
experimental	O	O	B-T062
research	O	O	I-T062
directions	O	O	O
.	O	O	O

-DOCSTART- (27768814)

Non-specific	O	O	O
transient	O	O	O
mutualism	O	O	B-T070
between	O	O	O
the	O	O	O
plant	O	O	B-T204
parasitic	O	O	I-T204
nematode	O	O	I-T204
,	O	O	O
Bursaphelenchus	O	O	B-T204
xylophilus	O	O	I-T204
,	O	O	O
and	O	O	O
the	O	O	O
opportunistic	O	O	O
bacterium	O	O	B-T007
Serratia	O	O	B-T007
quinivorans	O	O	I-T007
BXF1	O	O	I-T007
,	O	O	O
a	O	O	O
plant-growth	O	O	B-T040
promoting	O	O	O
pine	O	O	B-T002
endophyte	O	O	B-T004
with	O	O	O
antagonistic	O	O	B-T120
effects	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
biological	O	O	O
role	O	O	O
of	O	O	O
Serratia	O	O	B-T007
quinivorans	O	O	I-T007
BXF1	O	O	I-T007
,	O	O	O
a	O	O	O
bacterium	O	O	B-T007
commonly	O	O	O
found	O	O	O
associated	O	O	O
with	O	O	O
Bursaphelenchus	O	O	B-T204
xylophilus	O	O	I-T204
,	O	O	O
the	O	O	O
plant	O	O	B-T204
parasitic	O	O	I-T204
nematode	O	O	I-T204
responsible	O	O	O
for	O	O	O
pine	O	O	B-T002
wilt	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
studied	O	O	O
strain	O	O	B-T007
BXF1	O	O	I-T007
effect	O	O	O
in	O	O	O
pine	O	O	B-T002
wilt	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
strain	O	O	B-T007
BXF1	O	O	I-T007
promoted	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
nematode	O	O	B-T204
reproduction	O	O	B-T040
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
bacteria	O	O	B-T007
led	O	O	O
to	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
nematode	O	O	B-T204
chitinase	O	O	B-T116
gene	O	O	I-T028
(	O	O	I-T028
Bxcht-1	O	O	I-T028
)	O	O	I-T028
expression	O	O	B-T045
,	O	O	O
suggesting	O	O	O
an	O	O	O
effect	O	O	O
for	O	O	O
bacterial	O	O	B-T007
chitinase	O	O	O
in	O	O	O
nematode	O	O	O
reproduction	O	O	B-T040
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
strain	O	O	B-T007
BXF1	O	O	I-T007
was	O	O	O
unable	O	O	O
to	O	O	O
colonize	O	O	B-T033
the	O	O	O
nematode	O	O	B-T204
interior	O	O	O
,	O	O	O
bind	O	O	O
to	O	O	O
its	O	O	O
cuticle	O	O	B-T023
with	O	O	O
high	O	O	O
affinity	O	O	O
or	O	O	O
protect	O	O	O
the	O	O	O
nematode	O	O	O
from	O	O	O
xenobiotic	O	O	B-T123
stress	O	O	B-T046
.	O	O	O

Interestingly	O	O	O
,	O	O	O
strain	O	O	B-T007
BXF1	O	O	I-T007
was	O	O	O
able	O	O	O
to	O	O	O
promote	O	O	O
tomato	O	O	B-T002
and	O	O	O
pine	O	O	B-T002
plant-growth	O	O	B-T040
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
to	O	O	O
colonize	O	O	B-T033
its	O	O	O
interior	O	O	O
,	O	O	O
thus	O	O	O
,	O	O	O
acting	O	O	O
like	O	O	O
a	O	O	O
plant-growth	O	O	O
promoting	O	O	O
endophyte	O	O	B-T004
.	O	O	O

Consequently	O	O	O
,	O	O	O
strain	O	O	B-T007
BXF1	O	O	I-T007
failed	O	O	O
to	O	O	O
induce	O	O	O
wilting	O	O	B-T184
symptoms	O	O	I-T184
when	O	O	O
inoculated	O	O	O
in	O	O	O
pine	O	O	B-T002
shoot	O	O	B-T002
artificial	O	O	B-T169
incisions	O	O	I-T169
.	O	O	O

This	O	O	O
bacterium	O	O	B-T007
also	O	O	O
presented	O	O	O
strong	O	O	O
antagonistic	O	O	B-T120
activities	O	O	B-T052
against	O	O	O
fungi	O	O	B-T004
and	O	O	O
bacteria	O	O	B-T007
isolated	O	O	O
from	O	O	O
Pinus	O	O	B-T002
pinaster	O	O	I-T002
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
B.	O	O	B-T204
xylophilus	O	O	I-T204
does	O	O	O
not	O	O	O
possess	O	O	O
a	O	O	O
strict	O	O	O
symbiotic	O	O	B-T001
community	O	O	I-T001
capable	O	O	O
of	O	O	O
inducing	O	O	O
pine	O	O	B-T002
wilt	O	O	B-T047
disease	O	O	I-T047
symptoms	O	O	B-T184
as	O	O	O
previously	O	O	O
hypothesized	O	O	O
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
bacteria	O	O	B-T007
like	O	O	O
BXF1	O	O	B-T007
,	O	O	O
which	O	O	O
possess	O	O	O
plant-growth	O	O	B-T040
promoting	O	O	O
and	O	O	O
antagonistic	O	O	B-T120
effects	O	O	B-T080
,	O	O	O
may	O	O	O
be	O	O	O
opportunistically	O	O	O
associated	O	O	O
with	O	O	O
B.	O	O	B-T204
xylophilus	O	O	I-T204
,	O	O	O
possibly	O	O	O
acquired	O	O	O
from	O	O	O
the	O	O	O
bacterial	O	O	B-T007
endophytic	O	O	B-T004
community	O	O	I-T004
of	O	O	O
the	O	O	O
host	O	O	B-T001
pine	O	O	B-T002
.	O	O	O

-DOCSTART- (27771865)

Habitual	O	O	B-UnknownType
physical	O	O	I-UnknownType
activity	O	O	I-UnknownType
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
improved	O	O	O
anthropometric	O	O	B-T081
and	O	O	O
androgenic	O	O	B-T125
profile	O	O	B-T059
in	O	O	O
PCOS	O	O	B-T047
:	O	O	O
a	O	O	O
cross-sectional	O	O	O
study	O	O	O

To	O	O	O
examine	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
habitual	O	O	B-UnknownType
physical	O	O	I-UnknownType
activity	O	O	I-UnknownType
(	O	O	O
PA	O	O	B-T056
)	O	O	O
on	O	O	O
the	O	O	O
metabolic	O	O	B-T039
and	O	O	O
hormonal	O	O	B-T060
profiles	O	O	I-T060
of	O	O	O
women	O	O	B-T098
with	O	O	O
polycystic	O	O	B-T047
ovary	O	O	I-T047
syndrome	O	O	I-T047
.	O	O	O

Anthropometric	O	O	B-T081
,	O	O	O
metabolic	O	O	B-T059
and	O	O	O
hormonal	O	O	B-T060
assessment	O	O	I-T060
and	O	O	O
determination	O	O	O
of	O	O	O
habitual	O	O	B-UnknownType
PA	O	O	I-UnknownType
levels	O	O	O
with	O	O	O
a	O	O	O
digital	O	O	B-T074
pedometer	O	O	I-T074
were	O	O	O
evaluated	O	O	O
in	O	O	O
84	O	O	O
women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
and	O	O	O
67	O	O	O
age-	O	O	O
and	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(BMI)-matched	O	O	O
controls	O	O	B-T096
.	O	O	O

PA	O	O	B-T056
status	O	O	O
was	O	O	O
defined	O	O	O
according	O	O	O
to	O	O	O
number	O	O	B-T081
of	O	O	I-T081
steps	O	O	I-T081
(	O	O	O
≥7500	O	O	O
steps	O	O	O
,	O	O	O
active	O	O	O
,	O	O	O
or	O	O	O
<	O	O	O
7500	O	O	O
steps	O	O	O
,	O	O	O
sedentary	O	O	B-T080
)	O	O	O
.	O	O	O

BMI	O	O	B-T201
was	O	O	O
lower	O	O	O
in	O	O	O
active	O	O	O
women	O	O	B-T098
from	O	O	O
both	O	O	O
groups	O	O	O
.	O	O	O

Active	O	O	O
PCOS	O	O	B-T047
women	O	O	B-T098
presented	O	O	O
lower	O	O	O
waist	O	O	B-T201
circumference	O	O	I-T201
(	O	O	O
WC	O	O	B-T201
)	O	O	O
and	O	O	O
lipid	O	O	B-T081
accumulation	O	O	I-T081
product	O	O	I-T081
(	O	O	O
LAP	O	O	B-T081
)	O	O	O
values	O	O	O
versus	O	O	O
sedentary	O	O	B-T080
PCOS	O	O	O
women	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
,	O	O	O
active	O	O	O
women	O	O	B-T098
also	O	O	O
had	O	O	O
lower	O	O	O
WC	O	O	B-T201
,	O	O	O
lower	O	O	O
values	O	O	O
for	O	O	O
fasting	O	O	O
and	O	O	O
120-min	O	O	O
insulin	O	O	B-T116
,	O	O	O
and	O	O	O
lower	O	O	O
LAP	O	O	B-T081
than	O	O	O
sedentary	O	O	B-T096
controls	O	O	I-T096
.	O	O	O

In	O	O	O
the	O	O	O
PCOS	O	O	B-T047
group	O	O	O
,	O	O	O
androgen	O	O	B-T125
levels	O	O	O
were	O	O	O
lower	O	O	O
in	O	O	O
active	O	O	O
versus	O	O	O
sedentary	O	O	B-T098
women	O	O	I-T098
(	O	O	O
p	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
,	O	O	O
free	O	O	B-T034
androgen	O	O	I-T034
index	O	O	I-T034
(	O	O	O
FAI	O	O	B-T034
)	O	O	O
was	O	O	O
also	O	O	O
lower	O	O	O
in	O	O	O
active	O	O	O
versus	O	O	O
sedentary	O	O	B-T098
women	O	O	I-T098
(	O	O	O
p	O	O	O
=	O	O	O
0.018	O	O	O
)	O	O	O
.	O	O	O

Homeostasis	O	O	B-T058
model	O	O	I-T058
assessment	O	O	I-T058
of	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
2000	O	O	O
daily	O	O	O
step	O	O	O
increments	O	O	O
were	O	O	O
independent	O	O	O
predictors	O	O	B-T078
of	O	O	O
FAI	O	O	B-T034
.	O	O	O

Each	O	O	O
2000	O	O	O
daily	O	O	O
step	O	O	O
increment	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
decrease	O	O	O
of	O	O	O
1.07	O	O	O
in	O	O	O
FAI	O	O	B-T034
.	O	O	O

Habitual	O	O	B-UnknownType
PA	O	O	I-UnknownType
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
better	O	O	O
anthropometric	O	O	B-T081
and	O	O	O
androgenic	O	O	B-T125
profile	O	O	B-T059
in	O	O	O
PCOS	O	O	B-T047
.	O	O	O

-DOCSTART- (27772674)

Geolocalization	O	O	B-T083
of	O	O	O
Influenza	O	O	B-T047
Outbreak	O	O	B-T067
Within	O	O	O
an	O	O	O
Acute	O	O	B-T058
Care	O	O	I-T058
Population	O	O	B-T098
:	O	O	O
A	O	O	O
Layered-Surveillance	O	O	B-T169
Approach	O	O	O

We	O	O	O
seek	O	O	O
to	O	O	O
use	O	O	O
a	O	O	O
novel	O	O	O
layered-surveillance	O	O	B-T169
approach	O	O	B-T082
to	O	O	O
localize	O	O	B-T082
influenza	O	O	B-T047
clusters	O	O	B-T081
within	O	O	O
an	O	O	O
acute	O	O	B-T058
care	O	O	I-T058
population	O	O	B-T098
.	O	O	O

The	O	O	O
first	O	O	O
layer	O	O	O
of	O	O	O
this	O	O	O
system	O	O	B-T169
is	O	O	O
a	O	O	O
syndromic	O	O	B-T047
surveillance	O	O	B-T058
screen	O	O	I-T058
to	O	O	O
guide	O	O	O
rapid	O	O	B-T059
polymerase	O	O	I-T059
chain	O	O	I-T059
reaction	O	O	I-T059
testing	O	O	I-T059
.	O	O	O

The	O	O	O
second	O	O	B-T081
layer	O	O	O
is	O	O	O
geolocalization	O	O	B-T083
and	O	O	O
cluster	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

We	O	O	O
posit	O	O	O
that	O	O	O
any	O	O	O
identified	O	O	B-T080
clusters	O	O	B-T081
could	O	O	O
represent	O	O	O
at-risk	O	O	B-T098
populations	O	O	I-T098
who	O	O	O
could	O	O	O
serve	O	O	O
as	O	O	O
high-yield	O	O	B-T081
targets	O	O	B-T169
for	O	O	O
preventive	O	O	B-T061
medical	O	O	I-T061
interventions	O	O	I-T061
.	O	O	O

This	O	O	O
was	O	O	O
a	O	O	O
prospective	O	O	B-T062
observational	O	O	I-T062
surveillance	O	O	I-T062
study	O	O	I-T062
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
screened	O	O	B-T058
with	O	O	O
a	O	O	O
previously	O	O	O
derived	O	O	O
clinical	O	O	B-T170
decision	O	O	I-T170
guideline	O	O	I-T170
that	O	O	O
has	O	O	O
a	O	O	O
90	O	O	O
%	O	O	O
sensitivity	O	O	B-T081
and	O	O	O
30	O	O	O
%	O	O	O
specificity	O	O	B-T081
for	O	O	O
influenza	O	O	B-T047
.	O	O	O

Patients	O	O	B-T101
received	O	O	O
points	O	O	B-T081
for	O	O	O
the	O	O	O
following	O	O	O
signs	O	O	B-T184
and	O	O	I-T184
symptoms	O	O	I-T184
within	O	O	O
the	O	O	O
past	O	O	B-T079
7	O	O	O
days	O	O	B-T079
:	O	O	O
cough	O	O	B-T184
(	O	O	O
2	O	O	O
points	O	O	O
)	O	O	O
,	O	O	O
headache	O	O	B-T184
(	O	O	O
1	O	O	O
point	O	O	O
)	O	O	O
,	O	O	O
subjective	O	O	B-UnknownType
fever	O	O	I-UnknownType
(	O	O	O
1	O	O	O
point	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
documented	O	O	B-T184
fever	O	O	I-T184
at	O	O	O
triage	O	O	B-T061
(	O	O	O
temperature	O	O	B-T081
>	O	O	O
38	O	O	O
°	O	O	O
C	O	O	O
[	O	O	O
100.4	O	O	O
°	O	O	O
F	O	O	O
]	O	O	O
)	O	O	O
(	O	O	O
1	O	O	O
point	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
scoring	O	O	B-T081
3	O	O	O
points	O	O	O
or	O	O	O
higher	O	O	O
were	O	O	O
indicated	O	O	B-T033
for	O	O	O
influenza	O	O	B-T047
testing	O	O	B-T169
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
tested	O	O	B-T169
with	O	O	O
Xpert	O	O	B-T059
Flu	O	O	I-T059
(	O	O	O
Cepheid	O	O	B-T073
,	O	O	O
Sunnyvale	O	O	B-T083
,	O	O	O
CA	O	O	B-T083
)	O	O	O
,	O	O	O
a	O	O	O
rapid	O	O	B-T059
polymerase	O	O	I-T059
chain	O	O	I-T059
reaction	O	O	I-T059
test	O	O	I-T059
.	O	O	O

Positive	O	O	B-T033
results	O	O	B-T169
were	O	O	O
mapped	O	O	B-T170
with	O	O	O
ArcGIS	O	O	B-T170
(	O	O	O
ESRI	O	O	B-T073
,	O	O	O
Redlands	O	O	B-T083
,	O	O	O
CA	O	O	B-T083
)	O	O	O
and	O	O	O
analyzed	O	O	B-T062
with	O	O	O
kernel	O	O	B-T062
density	O	O	I-T062
estimation	O	O	I-T062
to	O	O	O
create	O	O	O
heat	O	O	B-T073
maps	O	O	I-T073
.	O	O	O

There	O	O	O
were	O	O	O
1,360	O	O	O
patients	O	O	B-T101
tested	O	O	B-T169
with	O	O	O
Xpert	O	O	B-T059
Flu	O	O	I-T059
with	O	O	O
retrievable	O	O	B-T080
addresses	O	O	B-T170
within	O	O	O
the	O	O	O
greater	O	O	O
Phoenix	O	O	B-UnknownType
metro	O	O	I-UnknownType
area	O	O	I-UnknownType
.	O	O	O

One	O	O	O
hundred	O	O	O
sixty-seven	O	O	O
(	O	O	O
12	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
them	O	O	O
tested	O	O	B-T169
positive	O	O	B-T034
for	O	O	I-T034
influenza	O	O	I-T034
A	O	O	I-T034
and	O	O	O
23	O	O	O
(	O	O	O
2	O	O	O
%	O	O	O
)	O	O	O
tested	O	O	O
positive	O	O	O
for	O	O	O
influenza	O	O	O
B.	O	O	O
The	O	O	O
influenza	O	O	B-T005
A	O	O	I-T005
virus	O	O	I-T005
exhibited	O	O	O
a	O	O	O
clear	O	O	B-T081
cluster	O	O	I-T081
pattern	O	O	B-T082
within	O	O	O
this	O	O	O
patient	O	O	B-T101
population	O	O	B-T098
.	O	O	O

The	O	O	O
densest	O	O	B-T081
cluster	O	O	I-T081
was	O	O	O
located	O	O	B-T082
in	O	O	O
an	O	O	O
approximately	O	O	O
1-	O	O	O
square-mile	O	O	B-T081
region	O	O	B-T083
southeast	O	O	B-T082
of	O	O	O
our	O	O	O
hospital	O	O	B-T093
.	O	O	O

Our	O	O	O
layered-surveillance	O	O	B-T169
approach	O	O	B-T082
was	O	O	O
effective	O	O	B-T080
in	O	O	O
localizing	O	O	B-T082
a	O	O	O
cluster	O	O	B-T081
of	O	O	O
influenza	O	O	B-T047
A	O	O	I-T047
outbreak	O	O	B-T067
.	O	O	O

This	O	O	O
region	O	O	B-T083
may	O	O	O
house	O	O	B-T073
a	O	O	O
high-yield	O	O	B-T081
target	O	O	B-T169
population	O	O	B-T098
for	O	O	O
public	O	O	B-T058
health	O	O	I-T058
intervention	O	O	I-T058
.	O	O	O

Further	O	O	O
collaborative	O	O	B-T054
efforts	O	O	O
will	O	O	O
be	O	O	O
made	O	O	O
between	O	O	O
our	O	O	O
hospital	O	O	B-T093
and	O	O	O
the	O	O	O
Maricopa	O	O	B-T083
County	O	O	I-T083
Department	O	O	B-T093
of	O	O	I-T093
Public	O	O	I-T093
Health	O	O	I-T093
to	O	O	O
perform	O	O	B-T169
a	O	O	O
series	O	O	O
of	O	O	O
community	O	O	B-T096
vaccination	O	O	B-T061
events	O	O	B-T051
before	O	O	O
the	O	O	O
next	O	O	O
influenza	O	O	B-T047
season	O	O	B-T079
.	O	O	O

We	O	O	O
hope	O	O	O
these	O	O	O
efforts	O	O	O
will	O	O	O
ultimately	O	O	O
serve	O	O	O
to	O	O	O
reduce	O	O	B-T080
the	O	O	O
burden	O	O	B-T078
of	O	O	O
this	O	O	O
disease	O	O	B-T047
on	O	O	O
our	O	O	O
patient	O	O	B-T101
population	O	O	B-T098
,	O	O	O
and	O	O	O
that	O	O	O
this	O	O	O
system	O	O	B-T169
will	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
framework	O	O	O
for	O	O	O
future	O	O	B-T079
investigations	O	O	B-T058
locating	O	O	O
at-risk	O	O	B-T098
populations	O	O	I-T098
.	O	O	O

-DOCSTART- (27773678)

Heart	O	O	B-T201
rate	O	O	I-T201
variability	O	O	B-T077
:	O	O	O
Pre-deployment	O	O	B-T079
predictor	O	O	B-T078
of	O	O	O
post-deployment	O	O	B-T079
PTSD	O	O	B-T048
symptoms	O	O	O

Heart	O	O	B-T201
rate	O	O	I-T201
variability	O	O	B-T077
is	O	O	O
a	O	O	O
physiological	O	O	O
measure	O	O	O
associated	O	O	O
with	O	O	O
autonomic	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
activity	O	O	B-T052
.	O	O	O

This	O	O	O
study	O	O	B-T062
hypothesized	O	O	O
that	O	O	O
lower	O	O	O
pre-deployment	O	O	B-T079
HRV	O	O	B-T039
would	O	O	O
be	O	O	O
associated	O	O	O
with	O	O	O
higher	O	O	O
post-deployment	O	O	B-T079
post-traumatic	O	O	B-T048
stress	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
PTSD	O	O	B-T048
)	O	O	O
symptoms	O	O	B-T184
.	O	O	O

Three-hundred-forty-three	O	O	O
Army	O	O	B-T097
National	O	O	I-T097
Guard	O	O	I-T097
soldiers	O	O	I-T097
enrolled	O	O	O
in	O	O	O
the	O	O	O
Warriors	O	O	B-T062
Achieving	O	O	I-T062
Resilience	O	O	I-T062
(	O	O	I-T062
WAR	O	O	I-T062
)	O	O	I-T062
study	O	O	I-T062
were	O	O	O
analyzed	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	O
outcome	O	O	B-T169
was	O	O	O
PTSD	O	O	B-T048
symptom	O	O	B-T184
severity	O	O	B-T080
using	O	O	O
the	O	O	O
PTSD	O	O	O
Checklist	O	O	B-T170
-	O	O	O
Military	O	O	B-T097
version	O	O	B-T170
(	O	O	O
PCL	O	O	B-T170
)	O	O	O
measured	O	O	O
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
3-	O	O	O
and	O	O	O
12-	O	O	O
month	O	O	B-T079
post-deployment	O	O	B-T079
.	O	O	O

Heart	O	O	B-T201
rate	O	O	I-T201
variability	O	O	B-T077
predictor	O	O	B-T078
variables	O	O	B-T080
included	O	O	O
:	O	O	O
high	O	O	B-T081
frequency	O	O	I-T081
power	O	O	I-T081
(	O	O	O
HF	O	O	B-T081
)	O	O	O
and	O	O	O
standard	O	O	B-T081
deviation	O	O	I-T081
of	O	O	O
the	O	O	O
normal	O	O	O
cardiac	O	O	B-T042
inter-beat	O	O	I-T042
interval	O	O	B-T079
(	O	O	O
SDNN	O	O	B-T079
)	O	O	O
.	O	O	O

Generalized	O	O	O
linear	O	O	B-T170
mixed	O	O	I-T170
models	O	O	I-T170
revealed	O	O	O
that	O	O	O
the	O	O	O
pre-deployment	O	O	B-T079
PCL	O	O	B-T170
*	O	O	O
ln(HF	O	O	B-T081
)	O	O	I-T081
interaction	O	O	I-T081
term	O	O	O
was	O	O	O
significant	O	O	O
(	O	O	O
p<0.0001	O	O	O
)	O	O	O
.	O	O	O

Pre-deployment	O	O	B-T079
SDNN	O	O	B-T079
was	O	O	O
not	O	O	O
a	O	O	O
significant	O	O	O
predictor	O	O	B-T078
of	O	O	O
post-deployment	O	O	B-T079
PCL	O	O	B-T170
.	O	O	O

Covariates	O	O	B-T080
included	O	O	O
age	O	O	B-T032
,	O	O	O
pre-deployment	O	O	B-T079
PCL	O	O	B-T170
,	O	O	O
race	O	O	B-T098
/	O	O	O
ethnicity	O	O	B-T098
,	O	O	O
marital	O	O	B-T102
status	O	O	I-T102
,	O	O	O
tobacco	O	O	B-T055
use	O	O	I-T055
,	O	O	O
childhood	O	O	B-T048
abuse	O	O	I-T048
,	O	O	O
pre-deployment	O	O	O
traumatic	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
,	O	O	O
and	O	O	O
previous	O	O	O
combat	O	O	B-T082
zone	O	O	I-T082
deployment	O	O	B-T052
.	O	O	O

Pre-deployment	O	O	B-T079
heart	O	O	B-T201
rate	O	O	I-T201
variability	O	O	B-T077
predicts	O	O	O
post-deployment	O	O	B-T079
PTSD	O	O	B-T048
symptoms	O	O	B-T184
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
higher	O	O	O
pre-deployment	O	O	B-T079
PCL	O	O	B-T170
scores	O	O	B-T081
.	O	O	O

-DOCSTART- (27775720)

A	O	O	O
neuronal	O	O	B-T025
PI(3,4,5)P3	O	O	B-T109
-dependent	O	O	O
program	O	O	B-T169
of	O	O	O
oligodendrocyte	O	O	B-T025
precursor	O	O	B-T078
recruitment	O	O	B-T052
and	O	O	O
myelination	O	O	O

The	O	O	O
molecular	O	O	B-T044
trigger	O	O	I-T044
of	O	O	O
CNS	O	O	B-T022
myelination	O	O	B-T043
is	O	O	O
unknown	O	O	B-T080
.	O	O	O

By	O	O	O
targeting	O	O	B-T169
Pten	O	O	B-T116
in	O	O	O
cerebellar	O	O	B-T025
granule	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
activating	O	O	B-T052
the	O	O	O
AKT1	O	O	B-T116
-	O	O	O
mTOR	O	O	B-T116
pathway	O	O	B-T044
,	O	O	O
we	O	O	O
increased	O	O	B-T081
the	O	O	O
caliber	O	O	O
of	O	O	O
normally	O	O	B-T080
unmyelinated	O	O	B-T026
axons	O	O	I-T026
and	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
numerous	O	O	B-T081
genes	O	O	B-T028
encoding	O	O	B-T052
regulatory	O	O	B-T116
proteins	O	O	I-T116
.	O	O	O

This	O	O	O
led	O	O	O
to	O	O	O
the	O	O	O
expansion	O	O	B-T043
of	O	O	O
genetically	O	O	B-T028
wild-type	O	O	I-T028
oligodendrocyte	O	O	B-T025
progenitor	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
oligodendrocyte	O	O	O
differentiation	O	O	B-T043
and	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
myelination	O	O	B-T043
of	O	O	O
parallel	O	O	B-T026
fibers	O	O	I-T026
.	O	O	O

Thus	O	O	O
,	O	O	O
a	O	O	O
neuronal	O	O	B-T025
program	O	O	B-T169
dependent	O	O	O
on	O	O	O
the	O	O	O
phosphoinositide	O	O	B-T109
PI(3,4,5)P3	O	O	B-T109
is	O	O	O
sufficient	O	O	O
to	O	O	O
trigger	O	O	B-T044
all	O	O	O
steps	O	O	B-T077
of	O	O	O
myelination	O	O	B-T043
.	O	O	O

-DOCSTART- (27777102)

Atypical	O	O	O
microglial	O	O	B-T025
response	O	O	B-T032
to	O	O	O
biodiesel	O	O	B-T109
exhaust	O	O	I-T109
in	O	O	O
healthy	O	O	B-T080
and	O	O	O
hypertensive	O	O	B-T047
rats	O	O	O

Accumulating	O	O	O
evidence	O	O	B-T078
suggests	O	O	B-T078
a	O	O	O
deleterious	O	O	B-T169
role	O	O	B-T077
for	O	O	O
urban	O	O	B-T083
air	O	O	B-T069
pollution	O	O	I-T069
in	O	O	O
central	O	O	B-T047
nervous	O	O	I-T047
system	O	O	I-T047
(	O	O	I-T047
CNS	O	O	I-T047
)	O	O	I-T047
diseases	O	O	I-T047
and	O	O	O
neurodevelopmental	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Microglia	O	O	B-T025
,	O	O	O
the	O	O	O
resident	O	O	O
innate	O	O	B-T032
immune	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
sentinels	O	O	B-T109
in	O	O	O
the	O	O	O
brain	O	O	B-T023
,	O	O	O
are	O	O	O
a	O	O	O
common	O	O	B-T081
source	O	O	B-T033
of	O	O	O
neuroinflammation	O	O	B-UnknownType
and	O	O	O
are	O	O	O
implicated	O	O	O
in	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
-	O	O	O
induced	O	O	B-T169
CNS	O	O	B-T047
effects	O	O	I-T047
.	O	O	O

While	O	O	O
renewable	O	O	B-T169
energy	O	O	I-T169
,	O	O	O
such	O	O	O
as	O	O	O
soy-based	O	O	B-T109
biofuel	O	O	I-T109
,	O	O	O
is	O	O	O
of	O	O	O
increasing	O	O	B-T169
public	O	O	B-T098
interest	O	O	B-T041
,	O	O	O
there	O	O	O
is	O	O	O
little	O	O	B-T081
information	O	O	B-T078
on	O	O	O
how	O	O	O
soy	O	O	B-T109
biofuel	O	O	I-T109
may	O	O	O
affect	O	O	B-T080
the	O	O	O
brain	O	O	B-T023
,	O	O	O
especially	O	O	O
in	O	O	O
people	O	O	B-T098
with	O	O	O
preexisting	O	O	B-T033
disease	O	O	I-T033
conditions	O	O	I-T033
.	O	O	O

To	O	O	O
address	O	O	O
this	O	O	O
,	O	O	O
male	O	O	B-T032
spontaneously	O	O	B-T015
hypertensive	O	O	I-T015
rats	O	O	I-T015
(	O	O	O
SHR	O	O	B-T015
)	O	O	O
and	O	O	O
normotensive	O	O	B-T033
Wistar	O	O	B-T015
Kyoto	O	O	I-T015
(	O	O	I-T015
WKY	O	O	I-T015
)	O	O	I-T015
rats	O	O	I-T015
were	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
100	O	O	B-T109
%	O	O	I-T109
Soy-based	O	O	I-T109
Biodiesel	O	O	I-T109
Exhaust	O	O	I-T109
(	O	O	O
100SBDE	O	O	B-T109
;	O	O	O
0	O	O	O
,	O	O	O
50	O	O	O
,	O	O	O
150	O	O	O
and	O	O	O
500μg/m(3	O	O	O
)	O	O	O
)	O	O	O
by	O	O	O
inhalation	O	O	B-T040
,	O	O	O
4h/	O	O	O
day	O	O	B-T079
for	O	O	O
4	O	O	O
weeks	O	O	B-T079
(	O	O	O
5	O	O	O
days	O	O	B-T079
/	O	O	O
week	O	O	B-T079
)	O	O	O
.	O	O	O

Ionized	O	O	B-T116
calcium-binding	O	O	I-T116
adapter	O	O	I-T116
molecule-1	O	O	I-T116
(	O	O	O
IBA-1	O	O	B-T116
)	O	O	O
staining	O	O	B-T059
of	O	O	O
microglia	O	O	B-T025
in	O	O	O
the	O	O	O
substantia	O	O	B-T023
nigra	O	O	I-T023
revealed	O	O	B-T080
significant	O	O	B-T078
changes	O	O	B-T169
in	O	O	O
morphology	O	O	B-T080
with	O	O	O
100SBDE	O	O	B-T109
exposure	O	O	B-T080
in	O	O	O
rats	O	O	B-T015
from	O	O	O
both	O	O	B-T080
genotypes	O	O	B-T032
,	O	O	O
where	O	O	O
SHR	O	O	B-T015
were	O	O	O
less	O	O	B-T081
sensitive	O	O	B-T169
.	O	O	O

Aconitase	O	O	B-T044
activity	O	O	I-T044
was	O	O	O
inhibited	O	O	B-T080
in	O	O	O
the	O	O	O
frontal	O	O	B-T023
cortex	O	O	I-T023
and	O	O	O
cerebellum	O	O	B-T023
of	O	O	O
WKY	O	O	B-T015
rats	O	O	I-T015
exposed	O	O	B-T080
to	O	O	I-T080
100SBDE	O	O	B-T109
.	O	O	O

No	O	O	B-T169
consistent	O	O	B-T080
changes	O	O	B-T169
occurred	O	O	B-T079
in	O	O	O
pro-inflammatory	O	O	B-T169
cytokine	O	O	B-T116
expression	O	O	B-T045
,	O	O	O
nitrated	O	O	B-T116
protein	O	O	I-T116
,	O	O	O
or	O	O	O
arginase1	O	O	B-T116
expression	O	O	O
in	O	O	O
brain	O	O	B-T029
regions	O	O	I-T029
from	O	O	O
either	O	O	O
rat	O	O	B-T015
strain	O	O	I-T015
exposed	O	O	B-T080
to	O	O	I-T080
100SBDE	O	O	B-T109
.	O	O	O

However	O	O	O
,	O	O	O
while	O	O	O
IBA-1	O	O	B-T116
mRNA	O	O	B-T045
expression	O	O	I-T045
was	O	O	O
not	O	O	B-T169
modified	O	O	B-T169
,	O	O	O
CX3CR1	O	O	B-T116
mRNA	O	O	O
expression	O	O	O
was	O	O	O
lower	O	O	B-T080
in	O	O	O
the	O	O	O
striatum	O	O	B-T023
of	O	O	O
100SBDE	O	O	B-T109
exposed	O	O	B-T015
rats	O	O	I-T015
regardless	O	O	B-T080
of	O	O	O
genotype	O	O	B-T032
,	O	O	O
suggesting	O	O	B-T078
a	O	O	O
downregulation	O	O	B-T044
of	O	O	O
the	O	O	O
fractalkine	O	O	B-T116
receptor	O	O	I-T116
on	O	O	O
microglia	O	O	B-T025
in	O	O	O
this	O	O	O
brain	O	O	B-T029
region	O	O	I-T029
.	O	O	O

Together	O	O	O
,	O	O	O
these	O	O	O
data	O	O	B-T078
indicate	O	O	B-T078
that	O	O	O
while	O	O	O
microglia	O	O	B-T025
are	O	O	O
detecting	O	O	B-T033
and	O	O	O
responding	O	O	B-T032
to	O	O	O
100SBDE	O	O	B-T109
exposure	O	O	B-T080
with	O	O	O
changes	O	O	B-T169
in	O	O	O
morphology	O	O	B-T080
,	O	O	O
there	O	O	O
is	O	O	O
reduced	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
CX3CR1	O	O	B-T116
regardless	O	O	B-T080
of	O	O	O
genetic	O	O	B-T032
background	O	O	I-T032
and	O	O	O
the	O	O	O
activation	O	O	B-UnknownType
response	O	O	B-T032
is	O	O	O
atypical	O	O	B-T080
without	O	O	O
traditional	O	O	B-T169
inflammatory	O	O	B-T201
markers	O	O	I-T201
of	O	O	O
M1	O	O	B-T025
or	O	O	O
M2	O	O	B-T025
activation	O	O	O
in	O	O	O
the	O	O	O
brain	O	O	B-T023
.	O	O	O

-DOCSTART- (27777558)

Pre-Activation	O	O	B-T033
Negativity	O	O	I-T033
(	O	O	O
PrAN	O	O	B-T033
)	O	O	O
in	O	O	O
Brain	O	O	B-T023
Potentials	O	O	B-T080
to	O	O	O
Unfolding	O	O	O
Words	O	O	O

We	O	O	O
describe	O	O	O
an	O	O	O
event-related	O	O	B-T042
potential	O	O	I-T042
(	O	O	O
ERP	O	O	B-T042
)	O	O	O
effect	O	O	B-T080
termed	O	O	O
the	O	O	O
"	O	O	O
pre-activation	O	O	B-T033
negativity	O	O	I-T033
"	O	O	O
(	O	O	O
PrAN	O	O	B-T033
)	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
proposed	O	O	O
to	O	O	O
index	O	O	B-T170
the	O	O	O
degree	O	O	B-T081
of	O	O	I-T081
pre-activation	O	O	I-T081
of	O	O	O
upcoming	O	O	O
word	O	O	B-T078
-	O	O	O
internal	O	O	B-T082
morphemes	O	O	B-T170
in	O	O	O
speech	O	O	B-T040
processing	O	O	B-T052
.	O	O	O

Using	O	O	O
lexical	O	O	B-T078
competition	O	O	I-T067
measures	O	O	B-T081
based	O	O	O
on	O	O	O
word-initial	O	O	B-T068
speech	O	O	I-T068
fragments	O	O	I-T068
(	O	O	O
WIFs	O	O	B-T068
)	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
statistical	O	O	B-T062
analyses	O	O	I-T062
of	O	O	O
ERP	O	O	B-T042
data	O	O	B-T078
from	O	O	O
three	O	O	O
experiments	O	O	B-T062
,	O	O	O
it	O	O	O
is	O	O	O
shown	O	O	O
that	O	O	O
the	O	O	O
PrAN	O	O	B-T033
is	O	O	O
sensitive	O	O	O
to	O	O	O
lexical	O	O	O
competition	O	O	O
and	O	O	O
that	O	O	O
it	O	O	O
reflects	O	O	O
the	O	O	O
degree	O	O	B-T081
of	O	O	O
predictive	O	O	B-T080
certainty	O	O	B-T080
:	O	O	O
the	O	O	O
negativity	O	O	B-T033
is	O	O	O
larger	O	O	B-T081
when	O	O	O
there	O	O	O
are	O	O	O
fewer	O	O	B-T081
upcoming	O	O	O
lexical	O	O	O
competitors	O	O	B-T098
.	O	O	O

-DOCSTART- (27777603)

Angiotensin-converting	O	O	B-T033
enzyme	O	O	I-T033
insertion/deletion	O	O	I-T033
polymorphism	O	O	I-T033
association	O	O	B-T080
with	O	O	I-T080
obesity	O	O	B-T047
and	O	O	O
some	O	O	O
related	O	O	O
disorders	O	O	B-T047
in	O	O	O
Egyptian	O	O	B-T098
females	O	O	B-T032
:	O	O	O
a	O	O	O
case-control	O	O	O
observational	O	O	O
study	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
WHO	O	O	B-T093
report	O	O	B-T170
in	O	O	O
2015	O	O	O
,	O	O	O
obesity	O	O	B-T047
is	O	O	O
the	O	O	O
fifth	O	O	O
leading	O	O	O
cause	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
worldwide	O	O	B-T079
,	O	O	O
and	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
Egyptian	O	O	B-T098
female	O	O	B-T098
obesity	O	O	O
is	O	O	O
37.5	O	O	O
%	O	O	O
.	O	O	O

Since	O	O	O
obesity	O	O	B-T047
is	O	O	O
highly	O	O	O
influenced	O	O	B-T077
by	O	O	O
genetics	O	O	B-T169
,	O	O	O
and	O	O	O
adipose	O	O	B-T024
tissue	O	O	I-T024
renin-angiotensin	O	O	B-T022
system	O	O	I-T022
is	O	O	O
over-activated	O	O	B-T169
in	O	O	O
obesity	O	O	O
,	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
angiotensin-converting	O	O	B-T033
enzyme	O	O	I-T033
(	O	O	I-T033
ACE	O	O	I-T033
)	O	O	I-T033
insertion/deletion	O	O	I-T033
(	O	O	I-T033
I/D	O	O	I-T033
)	O	O	I-T033
polymorphism	O	O	I-T033
on	O	O	O
obesity	O	O	O
and	O	O	O
related	O	O	O
disorders	O	O	B-T047
was	O	O	O
studied	O	O	O
in	O	O	O
several	O	O	O
populations	O	O	B-T098
,	O	O	O
because	O	O	O
of	O	O	O
its	O	O	O
effect	O	O	O
on	O	O	O
ACE	O	O	B-T044
activity	O	O	I-T044
.	O	O	O

Our	O	O	O
objective	O	O	B-T170
was	O	O	O
to	O	O	O
study	O	O	B-T062
the	O	O	O
association	O	O	B-T080
of	O	O	O
ACE	O	O	B-T033
I/D	O	O	I-T033
polymorphism	O	O	I-T033
with	O	O	O
obesity	O	O	B-T047
and	O	O	O
certain	O	O	O
related	O	O	O
disorders	O	O	B-T047
,	O	O	O
namely	O	O	O
hypertension	O	O	B-T047
,	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
,	O	O	O
in	O	O	O
Egyptian	O	O	B-T098
females	O	O	B-T032
.	O	O	O

Eighty	O	O	B-T081
female	O	O	B-T098
volunteers	O	O	B-T098
were	O	O	O
recruited	O	O	O
,	O	O	O
blood	O	O	B-T058
pressure	O	O	I-T058
and	O	O	O
body	O	O	B-T060
measurements	O	O	I-T060
were	O	O	O
recorded	O	O	B-T169
and	O	O	O
a	O	O	O
fasting	O	O	B-T033
blood	O	O	B-T031
sample	O	O	I-T031
was	O	O	O
obtained	O	O	O
for	O	O	O
the	O	O	O
quantitation	O	O	B-T081
of	O	O	O
glucose	O	O	B-T109
,	O	O	O
lipid	O	O	B-T059
profile	O	O	I-T059
,	O	O	O
insulin	O	O	B-T116
,	O	O	I-T116
leptin	O	O	B-T116
and	O	O	O
identification	O	O	B-T080
of	O	O	O
ACE	O	O	B-T033
I/D	O	O	I-T033
polymorphs	O	O	I-T033
.	O	O	O

Subjects	O	O	B-T098
were	O	O	O
grouped	O	O	O
based	O	O	O
on	O	O	O
hypertension	O	O	B-T047
and	O	O	O
obesity	O	O	B-T033
states	O	O	I-T033
.	O	O	O

Comparisons	O	O	B-T052
of	O	O	O
continuous	O	O	B-T078
parameters	O	O	B-T033
were	O	O	O
made	O	O	O
with	O	O	O
independent	O	O	B-T078
sample	O	O	B-T170
t-test	O	O	I-T170
between	O	O	O
two	O	O	O
groups	O	O	B-T078
.	O	O	O

The	O	O	O
frequencies	O	O	B-T081
of	O	O	O
ACE	O	O	B-T116
genotypes	O	O	B-T032
and	O	O	O
alleles	O	O	B-T028
,	O	O	O
and	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
gene	O	O	B-T045
polymorphism	O	O	I-T045
and	O	O	O
metabolic	O	O	B-T169
parameters	O	O	B-T033
were	O	O	O
assessed	O	O	B-T052
using	O	O	O
chi-square	O	O	B-T170
or	O	O	O
Fisher	O	O	B-T170
's	O	O	I-T170
exact	O	O	I-T170
test	O	O	I-T170
.	O	O	O

Genotype	O	O	B-T032
frequencies	O	O	B-T081
were	O	O	O
in	O	O	O
Hardy-Weinberg	O	O	B-T081
equilibrium	O	O	I-T081
for	O	O	O
all	O	O	O
groups	O	O	B-T078
.	O	O	O

Genotype	O	O	B-T032
distribution	O	O	B-T169
did	O	O	O
not	O	O	O
differ	O	O	O
significantly	O	O	O
between	O	O	O
controls	O	O	B-T096
and	O	O	O
cases	O	O	B-T077
of	O	O	O
all	O	O	O
the	O	O	O
studied	O	O	O
disorders	O	O	B-T047
.	O	O	O

Although	O	O	O
DD	O	O	B-T033
carriers	O	O	I-T033
had	O	O	O
apparently	O	O	O
higher	O	O	B-T080
parameters	O	O	B-T033
of	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
,	O	O	O
lipid	O	O	B-T059
profile	O	O	I-T059
and	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
,	O	O	O
only	O	O	O
diastolic	O	O	B-T201
blood	O	O	I-T201
pressure	O	O	I-T201
was	O	O	O
almost	O	O	O
significant	O	O	B-T078
(	O	O	O
p	O	O	O
=	O	O	O
0.057	O	O	O
)	O	O	O
.	O	O	O

I-carriers	O	O	B-T033
were	O	O	O
significantly	O	O	O
less	O	O	O
susceptible	O	O	B-T169
to	O	O	O
hypertension	O	O	B-T047
than	O	O	O
DD	O	O	B-T033
carriers	O	O	I-T033
having	O	O	O
normal	O	O	B-T080
waist/hip	O	O	B-T032
ratio	O	O	I-T032
(	O	O	O
p	O	O	O
=	O	O	O
0.007	O	O	O
,	O	O	O
OR	O	O	B-T081
=	O	O	O
17.29	O	O	O
,	O	O	O
CI	O	O	B-T081
=	O	O	O
1.81	O	O	O
-	O	O	O
164.96	O	O	O
)	O	O	O
and	O	O	O
normal	O	O	O
conicity	O	O	B-T034
index	O	O	I-T034
(	O	O	O
p	O	O	O
=	O	O	O
0.024	O	O	O
,	O	O	O
OR	O	O	O
=	O	O	O
7.00	O	O	O
,	O	O	O
CI	O	O	O
=	O	O	O
1.36	O	O	O
-	O	O	O
35.93	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
DD	O	O	B-T033
genotype	O	O	I-T033
carriers	O	O	I-T033
,	O	O	O
a	O	O	O
significant	O	O	B-T078
association	O	O	B-T080
was	O	O	O
found	O	O	O
between	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
high	O	O	B-T033
body	O	O	I-T033
mass	O	O	I-T033
index	O	O	I-T033
(	O	O	O
p	O	O	O
=	O	O	O
0.004	O	O	O
,	O	O	O
OR	O	O	B-T081
=	O	O	O
8.89	O	O	O
,	O	O	O
CI	O	O	B-T081
=	O	O	O
1.94	O	O	O
-	O	O	O
40.71	O	O	O
)	O	O	O
,	O	O	O
waist	O	O	B-T201
circumference	O	O	I-T201
(	O	O	O
p	O	O	O
=	O	O	O
0.003	O	O	O
,	O	O	O
OR	O	O	O
=	O	O	O
9.63	O	O	O
,	O	O	O
CI	O	O	O
=	O	O	O
2.14	O	O	O
-	O	O	O
43.36	O	O	O
)	O	O	O
and	O	O	O
waist/height	O	O	B-T033
ratio	O	O	I-T033
(	O	O	O
p	O	O	O
=	O	O	O
0.034	O	O	O
,	O	O	O
OR	O	O	O
=	O	O	O
6.86	O	O	O
,	O	O	O
CI	O	O	O
=	O	O	O
1.25	O	O	O
-	O	O	O
37.61	O	O	O
)	O	O	O
,	O	O	O
although	O	O	O
the	O	O	O
variations	O	O	B-T070
in	O	O	O
percentages	O	O	B-T081
between	O	O	O
DD	O	O	O
and	O	O	O
I-carriers	O	O	B-T033
were	O	O	O
not	O	O	O
high	O	O	O
enough	O	O	O
to	O	O	O
conclude	O	O	O
an	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
ACE	O	O	B-T033
I/D	O	O	I-T033
on	O	O	O
such	O	O	O
an	O	O	O
association	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
sample	O	O	B-T167
of	O	O	O
Egyptian	O	O	B-T098
females	O	O	B-T032
,	O	O	O
ACE	O	O	B-T033
I/D	O	O	I-T033
polymorphism	O	O	I-T033
was	O	O	O
not	O	O	B-T033
significantly	O	O	I-T033
associated	O	O	B-T080
with	O	O	I-T080
obesity	O	O	B-T047
nor	O	O	O
with	O	O	O
any	O	O	O
of	O	O	O
its	O	O	O
related	O	O	O
disorders	O	O	B-T047
studied	O	O	O
.	O	O	O

The	O	O	O
I	O	O	B-T028
allele	O	O	I-T028
seemed	O	O	O
protective	O	O	O
against	O	O	O
hypertension	O	O	B-T047
in	O	O	O
subjects	O	O	B-T098
with	O	O	O
normal	O	O	B-T080
,	O	O	O
not	O	O	O
high	O	O	O
,	O	O	O
waist/hip	O	O	B-T032
ratio	O	O	I-T032
and	O	O	O
conicity	O	O	B-T034
index	O	O	I-T034
compared	O	O	O
to	O	O	O
DD	O	O	B-T033
genotype	O	O	I-T033
carriers	O	O	I-T033
.	O	O	O

-DOCSTART- (27781291)

Expressed	O	O	B-T045
microRNA	O	O	B-T114
associated	O	O	B-T080
with	O	O	I-T080
high	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
egg	O	O	B-T042
production	O	O	I-T042
in	O	O	O
chicken	O	O	B-T012
ovarian	O	O	O
follicles	O	O	O

MicroRNA	O	O	B-T114
(	O	O	O
miRNA	O	O	B-T114
)	O	O	O
is	O	O	O
a	O	O	O
highly	O	O	O
conserved	O	O	O
class	O	O	O
of	O	O	O
small	O	O	O
noncoding	O	O	B-T114
RNA	O	O	I-T114
about	O	O	O
19	O	O	O
-	O	O	O
24	O	O	O
nucleotides	O	O	B-T114
in	O	O	O
length	O	O	B-T081
that	O	O	O
function	O	O	B-T169
in	O	O	O
a	O	O	O
specific	O	O	O
manner	O	O	O
to	O	O	O
post-transcriptionally	O	O	B-T045
regulate	O	O	I-T045
gene	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
organisms	O	O	B-T001
.	O	O	O

Tissue	O	O	B-T024
miRNA	O	O	B-T114
expression	O	O	B-T045
studies	O	O	B-T062
have	O	O	O
discovered	O	O	O
a	O	O	O
myriad	O	O	O
of	O	O	O
functions	O	O	B-T169
for	O	O	O
miRNAs	O	O	B-T114
in	O	O	O
various	O	O	O
aspects	O	O	O
,	O	O	O
but	O	O	O
a	O	O	O
role	O	O	O
for	O	O	O
miRNAs	O	O	O
in	O	O	O
chicken	O	O	B-T012
ovarian	O	O	B-T024
tissue	O	O	I-T024
at	O	O	O
300	O	O	O
days	O	O	B-T079
of	O	O	O
age	O	O	B-T032
has	O	O	O
not	O	O	O
hitherto	O	O	O
been	O	O	O
reported	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
performed	O	O	O
the	O	O	O
first	O	O	O
miRNA	O	O	B-T114
analysis	O	O	B-T062
of	O	O	O
ovarian	O	O	B-T024
tissues	O	O	I-T024
in	O	O	O
chickens	O	O	B-T012
with	O	O	O
low	O	O	B-T080
and	O	O	O
high	O	O	B-T080
rates	O	O	B-T081
of	O	O	O
egg	O	O	B-T042
production	O	O	I-T042
using	O	O	O
high-throughput	O	O	B-T063
sequencing	O	O	I-T063
.	O	O	O

By	O	O	O
comparing	O	O	O
low	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
egg	O	O	B-T042
production	O	O	I-T042
chickens	O	O	B-T012
with	O	O	O
high	O	O	B-T080
rate	O	O	O
of	O	O	O
egg	O	O	O
production	O	O	O
chickens	O	O	O
,	O	O	O
17	O	O	O
significantly	O	O	O
differentially	O	O	O
expressed	O	O	B-T045
miRNAs	O	O	B-T114
were	O	O	O
found	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
,	O	O	O
including	O	O	O
11	O	O	O
known	O	O	O
and	O	O	O
six	O	O	O
novel	O	O	O
miRNAs	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
all	O	O	O
11	O	O	O
known	O	O	O
miRNAs	O	O	B-T114
were	O	O	O
involved	O	O	O
mainly	O	O	O
in	O	O	O
pathways	O	O	B-T044
of	O	O	O
reproduction	O	O	B-T040
regulation	O	O	B-T045
,	O	O	O
such	O	O	O
as	O	O	O
steroid	O	O	B-T044
hormone	O	O	I-T044
biosynthesis	O	O	I-T044
and	O	O	O
dopaminergic	O	O	B-T030
synapse	O	O	I-T030
.	O	O	O

Additionally	O	O	O
,	O	O	O
expression	O	O	B-T045
profiling	O	O	O
of	O	O	O
six	O	O	O
randomly	O	O	O
selected	O	O	O
differentially	O	O	O
regulated	O	O	B-T045
miRNAs	O	O	B-T114
were	O	O	O
validated	O	O	O
by	O	O	O
quantitative	O	O	B-T063
real-time	O	O	I-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(	O	O	O
RT-qPCR	O	O	B-T063
)	O	O	O
.	O	O	O

Some	O	O	O
miRNAs	O	O	B-T114
,	O	O	O
such	O	O	O
as	O	O	O
gga-miR-34b	O	O	B-T028
,	O	O	O
gga-miR-34c	O	O	B-T028
and	O	O	O
gga-miR-216b	O	O	B-T028
,	O	O	O
were	O	O	O
reported	O	O	O
to	O	O	O
regulate	O	O	B-T045
processes	O	O	O
such	O	O	O
as	O	O	O
proliferation	O	O	B-T043
,	O	O	O
cell	O	O	B-T043
cycle	O	O	I-T043
,	O	O	O
apoptosis	O	O	B-T043
and	O	O	O
metastasis	O	O	B-T046
and	O	O	O
were	O	O	O
expressed	O	O	B-T045
differentially	O	O	O
in	O	O	O
ovaries	O	O	B-T023
of	O	O	O
chickens	O	O	B-T012
with	O	O	O
high	O	O	B-T080
rates	O	O	B-T081
of	O	O	O
egg	O	O	B-T042
production	O	O	I-T042
,	O	O	O
suggesting	O	O	O
that	O	O	O
these	O	O	O
miRNAs	O	O	O
have	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
ovary	O	O	B-T023
development	O	O	B-T038
and	O	O	O
reproductive	O	O	B-T040
management	O	O	I-T040
of	O	O	O
chicken	O	O	B-T012
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
uncovered	O	O	O
that	O	O	O
a	O	O	O
significantly	O	O	O
up-regulated	O	O	B-T044
miRNA	O	O	B-T114
-	O	O	O
gga-miR-200a-3p	O	O	B-T028
-is	O	O	O
ubiquitous	O	O	O
in	O	O	O
reproduction	O	O	B-T040
-	O	O	O
regulation	O	O	B-T045
-related	O	O	O
pathways	O	O	B-T044
.	O	O	O

This	O	O	O
miRNA	O	O	B-T114
may	O	O	O
play	O	O	O
a	O	O	O
special	O	O	O
central	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
reproductive	O	O	B-T040
management	O	O	I-T040
of	O	O	O
chicken	O	O	B-T012
,	O	O	O
and	O	O	O
needs	O	O	O
to	O	O	O
be	O	O	O
further	O	O	O
studied	O	O	O
for	O	O	O
confirmation	O	O	O
.	O	O	O

-DOCSTART- (27784277)

Air	O	O	B-T069
pollution	O	O	I-T069
,	O	O	O
neighbourhood	O	O	B-T082
and	O	O	O
maternal	O	O	B-T033
-	O	O	O
level	O	O	B-T080
factors	O	O	B-T169
modify	O	O	B-T169
the	O	O	O
effect	O	O	B-T080
of	O	O	O
smoking	O	O	B-T055
on	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
:	O	O	O
a	O	O	O
multilevel	O	O	B-T062
analysis	O	O	I-T062
in	O	O	O
British	O	O	B-T083
Columbia	O	O	I-T083
,	O	O	O
Canada	O	O	O

Maternal	O	O	B-T033
smoking	O	O	B-T055
during	O	O	O
pregnancy	O	O	B-T040
negatively	O	O	B-T033
impacts	O	O	B-T080
fetal	O	O	B-T039
growth	O	O	I-T039
,	O	O	O
but	O	O	O
the	O	O	O
effect	O	O	B-T080
is	O	O	O
not	O	O	O
homogenous	O	O	B-T082
across	O	O	O
the	O	O	O
population	O	O	B-T081
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
determine	O	O	O
how	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
cigarette	O	O	B-T055
use	O	O	I-T055
and	O	O	O
fetal	O	O	B-T039
growth	O	O	I-T039
is	O	O	O
modified	O	O	B-T033
by	O	O	O
the	O	O	O
social	O	O	B-T078
and	O	O	O
physical	O	O	B-T082
environment	O	O	I-T082
.	O	O	O

Birth	O	O	B-T073
records	O	O	I-T073
with	O	O	O
covariates	O	O	O
were	O	O	O
obtained	O	O	O
from	O	O	O
the	O	O	O
BC	O	O	B-T170
Perinatal	O	O	I-T170
Database	O	O	I-T170
Registry	O	O	I-T170
(	O	O	O
N	O	O	O
=	O	O	O
232,291	O	O	O
)	O	O	O
.	O	O	O

Maternal	O	O	B-T033
smoking	O	O	B-T201
status	O	O	I-T201
was	O	O	O
self-reported	O	O	B-T062
as	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	O
cigarettes	O	O	B-T073
smoked	O	O	B-T055
per	O	O	B-T079
day	O	O	I-T079
usually	O	O	O
at	O	O	O
the	O	O	O
first	O	O	B-T061
prenatal	O	O	I-T061
care	O	O	I-T061
visit	O	O	I-T061
.	O	O	O

Census	O	O	B-T081
dissemination	O	O	B-T082
areas	O	O	B-T083
(	O	O	O
DAs	O	O	B-T083
)	O	O	O
were	O	O	O
used	O	O	O
as	O	O	O
neighbourhood	O	O	B-T082
-	O	O	O
level	O	O	B-T080
units	O	O	B-T081
and	O	O	O
linked	O	O	O
to	O	O	O
individual	O	O	B-T098
births	O	O	B-T040
using	O	O	O
residential	O	O	B-T078
postal	O	O	I-T078
codes	O	O	I-T078
to	O	O	O
assign	O	O	B-T169
exposure	O	O	B-T080
to	O	O	I-T080
particulate	O	O	B-T131
air	O	O	B-T069
pollution	O	O	I-T069
(	O	O	O
PM2.5	O	O	O
)	O	O	O
and	O	O	O
neighbourhood	O	O	O
-	O	O	O
level	O	O	O
attributes	O	O	B-T078
such	O	O	O
as	O	O	O
socioeconomic	O	O	B-T080
status	O	O	I-T080
(	O	O	O
SES	O	O	B-T080
)	O	O	O
,	O	O	O
proportion	O	O	B-T081
of	O	O	O
post-secondary	O	O	B-T170
education	O	O	I-T170
,	O	O	O
immigrant	O	O	B-T098
density	O	O	B-T081
and	O	O	O
living	O	O	B-UnknownType
in	O	O	O
a	O	O	O
rural	O	O	B-T082
place	O	O	I-T082
.	O	O	O

Random	O	O	B-T080
coefficient	O	O	B-T081
models	O	O	B-T170
were	O	O	O
used	O	O	O
with	O	O	O
cigarettes	O	O	B-T073
/day	O	O	B-T079
modeled	O	O	B-T170
with	O	O	O
a	O	O	O
random	O	O	B-T080
slope	O	O	B-T081
to	O	O	O
estimate	O	O	B-T081
its	O	O	O
between-	O	O	O
DA	O	O	B-T083
variability	O	O	B-T077
and	O	O	O
test	O	O	B-T169
cross-level	O	O	B-T080
interactions	O	O	B-T169
with	O	O	O
the	O	O	O
neighbourhood	O	O	B-T082
-	O	O	O
level	O	O	B-T080
variables	O	O	B-T080
on	O	O	O
continuous	O	O	B-T078
birth	O	O	B-T032
weight	O	O	I-T032
.	O	O	O

A	O	O	O
significant	O	O	B-T078
negative	O	O	B-T033
and	O	O	O
non-linear	O	O	O
association	O	O	B-T080
was	O	O	O
found	O	O	O
between	O	O	O
maternal	O	O	B-T033
smoking	O	O	B-T055
and	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
.	O	O	O

There	O	O	O
was	O	O	O
significant	O	O	B-T078
between-	O	O	O
DA	O	O	B-T083
intercept	O	O	B-T081
variability	O	O	B-T077
in	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
as	O	O	O
well	O	O	O
as	O	O	O
between-	O	O	O
DA	O	O	O
slope	O	O	B-T081
variability	O	O	O
of	O	O	O
maternal	O	O	B-T033
smoking	O	O	B-T055
on	O	O	O
birth	O	O	O
weight	O	O	O
of	O	O	O
which	O	O	O
68	O	O	O
and	O	O	O
30	O	O	O
%	O	O	O
respectively	O	O	O
was	O	O	O
explained	O	O	O
with	O	O	O
the	O	O	O
inclusion	O	O	B-T080
of	O	O	O
DA	O	O	O
-	O	O	O
level	O	O	B-T080
variables	O	O	B-T080
and	O	O	O
their	O	O	O
cross-level	O	O	B-T080
interactions	O	O	B-T169
.	O	O	O

High	O	O	B-T080
DA	O	O	B-T083
-	O	O	O
level	O	O	B-T080
SES	O	O	B-T080
had	O	O	O
a	O	O	O
strong	O	O	B-T080
positive	O	O	B-T033
association	O	O	B-T080
with	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
but	O	O	O
the	O	O	O
effect	O	O	B-T080
was	O	O	O
moderated	O	O	B-T080
with	O	O	O
increased	O	O	B-T169
cigarettes	O	O	B-T073
/day	O	O	B-T079
.	O	O	O

Conversely	O	O	O
,	O	O	O
heavy	O	O	B-T033
smokers	O	O	I-T033
showed	O	O	O
the	O	O	O
largest	O	O	B-T081
increases	O	O	B-T169
in	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
with	O	O	O
rising	O	O	B-T169
neighbourhood	O	O	B-T082
education	O	O	B-T033
levels	O	O	I-T033
.	O	O	O

Increased	O	O	B-T169
levels	O	O	B-T080
of	O	O	O
PM2.5	O	O	B-T131
and	O	O	O
immigrant	O	O	B-T098
density	O	O	B-T081
were	O	O	O
negatively	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
birth	O	O	B-T032
weight	O	O	I-T032
,	O	O	O
but	O	O	O
showed	O	O	O
positive	O	O	B-T033
interactions	O	O	B-T169
with	O	O	O
increased	O	O	B-T169
levels	O	O	O
of	O	O	O
smoking	O	O	B-T055
.	O	O	O

Older	O	O	O
maternal	O	O	B-T033
age	O	O	I-T079
and	O	O	O
suspected	O	O	B-T078
drug	O	O	B-T048
or	O	O	O
alcohol	O	O	B-T055
use	O	O	I-T055
both	O	O	O
had	O	O	O
negative	O	O	B-T033
interactions	O	O	B-T169
with	O	O	O
increased	O	O	B-T169
levels	O	O	B-T080
of	O	O	O
maternal	O	O	O
smoking	O	O	B-T055
.	O	O	O

Maternal	O	O	B-T033
smoking	O	O	B-T055
had	O	O	O
a	O	O	O
negative	O	O	B-T033
and	O	O	O
non-linear	O	O	O
dose-response	O	O	B-T038
association	O	O	I-T038
with	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
which	O	O	O
was	O	O	O
highly	O	O	B-T080
variable	O	O	B-T080
between	O	O	O
neighbourhood	O	O	B-T082
s	O	O	O
and	O	O	O
evidence	O	O	B-T078
of	O	O	O
effect	O	O	B-T080
modification	O	O	B-T033
with	O	O	O
neighbourhood	O	O	O
-	O	O	O
level	O	O	B-T080
factors	O	O	B-T169
.	O	O	O

These	O	O	O
results	O	O	B-T169
suggest	O	O	B-T078
that	O	O	O
focusing	O	O	O
exclusively	O	O	O
on	O	O	O
individual	O	O	B-T098
behaviours	O	O	B-T053
may	O	O	O
have	O	O	O
limited	O	O	B-T169
success	O	O	B-T054
in	O	O	O
improving	O	O	B-T080
outcomes	O	O	B-T169
without	O	O	B-T080
addressing	O	O	O
the	O	O	O
contextual	O	O	B-T041
influences	O	O	B-T077
at	O	O	O
the	O	O	O
neighbourhood	O	O	B-T082
-	O	O	O
level	O	O	B-T080
.	O	O	O

Further	O	O	O
studies	O	O	B-T062
are	O	O	O
needed	O	O	O
to	O	O	O
corroborate	O	O	B-T080
our	O	O	O
findings	O	O	B-T033
and	O	O	O
to	O	O	O
understand	O	O	B-T041
how	O	O	O
neighbourhood	O	O	B-T082
-	O	O	O
level	O	O	B-T080
attributes	O	O	B-T078
interact	O	O	B-T169
with	O	O	O
smoking	O	O	B-T055
to	O	O	O
affect	O	O	B-T041
birth	O	O	B-T201
outcomes	O	O	I-T201
.	O	O	O

-DOCSTART- (27786590)

Individual	O	O	B-T098
Leg	O	O	B-T023
Muscle	O	O	I-T023
Contributions	O	O	B-T052
to	O	O	O
the	O	O	O
Cost	O	O	O
of	O	O	O
Walking	O	O	B-T056
:	O	O	O
Effects	O	O	B-T080
of	O	O	O
Age	O	O	B-T032
and	O	O	O
Walking	O	O	O
Speed	O	O	O

This	O	O	O
study	O	O	B-T062
examined	O	O	B-T033
the	O	O	O
contributions	O	O	B-T052
of	O	O	O
individual	O	O	B-T098
muscles	O	O	B-T024
to	O	O	O
changes	O	O	O
in	O	O	O
energetic	O	O	O
cost	O	O	B-T169
of	O	O	I-T169
transport	O	O	I-T169
(	O	O	O
COT	O	O	B-T169
)	O	O	O
over	O	O	O
seven	O	O	O
walking	O	O	B-T032
speeds	O	O	I-T032
,	O	O	O
and	O	O	O
compared	O	O	O
results	O	O	O
between	O	O	O
healthy	O	O	B-T100
young	O	O	I-T100
and	O	O	O
elderly	O	O	B-T098
subjects	O	O	I-T098
.	O	O	O

Twenty	O	O	O
six	O	O	O
participants	O	O	B-T098
(	O	O	O
13	O	O	O
young	O	O	B-T100
aged	O	O	I-T100
18	O	O	O
-	O	O	O
30	O	O	O
;	O	O	O
13	O	O	O
old	O	O	B-T098
aged	O	O	I-T098
70	O	O	O
-	O	O	O
80	O	O	O
)	O	O	O
were	O	O	O
recruited	O	O	O
.	O	O	O

COT	O	O	B-T169
(	O	O	O
O2/kg	O	O	O
body	O	O	O
mass/km	O	O	O
)	O	O	O
was	O	O	O
calculated	O	O	O
by	O	O	O
standardizing	O	O	O
the	O	O	O
mean	O	O	B-T201
oxygen	O	O	I-T201
consumption	O	O	I-T201
recorded	O	O	O
during	O	O	O
steady	O	O	B-T056
state	O	O	I-T056
walking	O	O	I-T056
.	O	O	O

Electromyography	O	O	B-T060
signals	O	O	B-T067
from	O	O	O
10	O	O	O
leg	O	O	B-T023
muscles	O	O	I-T023
were	O	O	O
used	O	O	O
to	O	O	O
calculate	O	O	O
the	O	O	O
cumulative	O	O	B-T056
activity	O	O	I-T056
required	O	O	I-T056
to	O	O	I-T056
traverse	O	O	I-T056
a	O	O	I-T056
unit	O	O	I-T056
of	O	O	I-T056
distance	O	O	I-T056
(	O	O	O
CMAPD	O	O	B-T056
)	O	O	O
for	O	O	O
each	O	O	O
muscle	O	O	B-T024
at	O	O	O
each	O	O	O
speed	O	O	B-T081
.	O	O	O

In	O	O	O
the	O	O	O
old	O	O	B-T098
group	O	O	I-T098
CMAPD	O	O	B-T056
was	O	O	O
correlated	O	O	B-T080
with	O	O	O
COT	O	O	B-T169
,	O	O	O
presented	O	O	O
higher	O	O	O
and	O	O	O
more	O	O	O
variable	O	O	O
values	O	O	O
,	O	O	O
and	O	O	O
showed	O	O	O
greater	O	O	O
increases	O	O	O
around	O	O	O
optimal	O	O	B-T081
speed	O	O	I-T081
for	O	O	O
all	O	O	O
studied	O	O	O
muscles	O	O	B-T024
.	O	O	O

Soleus	O	O	B-T023
CMAPD	O	O	B-T056
was	O	O	O
independent	O	O	O
of	O	O	O
speed	O	O	B-T081
in	O	O	O
the	O	O	O
young	O	O	B-T100
group	O	O	I-T100
,	O	O	O
but	O	O	O
this	O	O	O
was	O	O	O
not	O	O	O
evident	O	O	O
with	O	O	O
aging	O	O	B-T040
.	O	O	O

Greater	O	O	B-T169
energy	O	O	B-T169
cost	O	O	I-T169
of	O	O	O
walking	O	O	B-T056
in	O	O	O
older	O	O	B-T098
individuals	O	O	B-T098
seems	O	O	O
to	O	O	O
be	O	O	O
attributable	O	O	O
to	O	O	O
increased	O	O	O
energy	O	O	O
cost	O	O	O
of	O	O	O
all	O	O	O
lower	O	O	B-T023
limb	O	O	I-T023
muscles	O	O	I-T023
.	O	O	O

-DOCSTART- (27790487)

Glycated	O	O	B-T116
Hemoglobin	O	O	I-T116
(	O	O	O
HbA1c	O	O	B-T116
)	O	O	O
Correlation	O	O	B-T080
with	O	O	O
Severity	O	O	B-T080
of	O	O	O
Coronary	O	O	B-T047
Artery	O	O	I-T047
Disease	O	O	I-T047
in	O	O	O
Non-diabetic	O	O	B-T033
Patients	O	O	B-T101
-	O	O	O
A	O	O	O
Hospital	O	O	B-T093
based	O	O	I-T093
Study	O	O	B-T062
from	O	O	O
North-Eastern	O	O	O
India	O	O	O

Glycated	O	O	B-T034
Hemoglobin	O	O	I-T034
(	O	O	I-T034
HbA1c	O	O	B-T116
)	O	O	I-T034
levels	O	O	I-T034
are	O	O	O
predictive	O	O	B-T080
of	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
mortality	O	O	B-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
,	O	O	O
however	O	O	O
,	O	O	O
association	O	O	O
of	O	O	O
HbA1c	O	O	O
with	O	O	O
Coronary	O	O	B-T047
Artery	O	O	I-T047
Disease	O	O	I-T047
(	O	O	O
CAD	O	O	B-T047
)	O	O	O
in	O	O	O
non-diabetics	O	O	B-T033
is	O	O	O
inconsistent	O	O	B-T080
.	O	O	O

To	O	O	O
evaluate	O	O	B-T058
the	O	O	O
correlation	O	O	B-T080
between	O	O	O
HbA1c	O	O	B-T034
level	O	O	I-T034
and	O	O	O
severity	O	O	B-T080
of	O	O	O
CAD	O	O	B-T047
in	O	O	O
non-diabetic	O	O	B-T101
patients	O	O	I-T101
using	O	O	O
SYNTAX	O	O	B-T081
score	O	O	I-T081
in	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
proven	O	O	O
CAD	O	O	O
on	O	O	O
angiography	O	O	B-T060
at	O	O	O
Gauhati	O	O	B-T093
Medical	O	O	I-T093
College	O	O	I-T093
,	O	O	O
Guwahati	O	O	B-T083
,	O	O	I-T083
Assam	O	O	I-T083
,	O	O	O
India	O	O	B-T083
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
major	O	O	O
tertiary	O	O	B-T093
care	O	O	I-T093
hospital	O	O	I-T093
of	O	O	O
North-Eastern	O	O	B-T083
India	O	O	I-T083
.	O	O	O

We	O	O	O
prospectively	O	O	O
collected	O	O	O
data	O	O	B-T078
of	O	O	O
non-diabetic	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
proven	O	O	O
CAD	O	O	B-T047
on	O	O	O
angiography	O	O	B-T060
from	O	O	O
June	O	O	O
2014	O	O	O
to	O	O	O
June	O	O	O
2015	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
divided	O	O	O
into	O	O	O
four	O	O	O
groups	O	O	B-T078
(	O	O	O
interquartiles	O	O	B-T080
)	O	O	O
according	O	O	O
to	O	O	O
HbA1c	O	O	B-T034
levels	O	O	I-T034
,	O	O	O
less	O	O	O
than	O	O	O
4.8	O	O	O
%	O	O	O
,	O	O	O
4.8	O	O	O
%	O	O	O
to	O	O	O
5.1	O	O	O
%	O	O	O
,	O	O	O
5.1	O	O	O
%	O	O	O
to	O	O	O
5.6	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
5.6	O	O	O
%	O	O	O
to	O	O	O
6.5	O	O	O
%	O	O	O
.	O	O	O

Severity	O	O	B-T080
of	O	O	O
CAD	O	O	B-T047
was	O	O	O
assessed	O	O	B-T052
using	O	O	O
SYNTAX	O	O	B-T081
score	O	O	I-T081
and	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	I-T081
coronary	O	O	I-T081
vessels	O	O	I-T081
diseased	O	O	I-T081
.	O	O	O

We	O	O	O
compared	O	O	O
different	O	O	O
quartiles	O	O	B-T080
of	O	O	O
HbA1c	O	O	B-T116
with	O	O	O
regard	O	O	O
to	O	O	O
SYNTAX	O	O	B-T081
score	O	O	I-T081
and	O	O	O
number	O	O	O
of	O	O	O
diseased	O	O	B-T081
vessels	O	O	I-T081
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
346	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

Mean	O	O	O
age	O	O	B-T032
was	O	O	O
58.1±10.4	O	O	O
years	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
total	O	O	O
91.9	O	O	O
%	O	O	O
(	O	O	O
318	O	O	O
)	O	O	O
were	O	O	O
males	O	O	B-T032
,	O	O	O
44.8	O	O	O
%	O	O	O
(	O	O	O
155	O	O	O
)	O	O	O
were	O	O	O
hypertensives	O	O	B-T033
,	O	O	O
29.2	O	O	O
%	O	O	O
(	O	O	O
101	O	O	O
)	O	O	O
were	O	O	O
smokers	O	O	B-T033
and	O	O	O
34.7	O	O	O
%	O	O	O
(	O	O	O
120	O	O	O
)	O	O	O
were	O	O	O
dyslipidemic	O	O	B-T033
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
CAD	O	O	B-T047
severity	O	O	B-T080
by	O	O	O
SYNTAX	O	O	B-T081
score	O	O	I-T081
as	O	O	O
well	O	O	O
as	O	O	O
number	O	O	O
of	O	O	O
vessels	O	O	B-T023
involved	O	O	O
was	O	O	O
significantly	O	O	O
different	O	O	O
among	O	O	O
quartiles	O	O	B-T080
(	O	O	O
p-values	O	O	B-T081
<	O	O	O
0.001	O	O	O
and	O	O	O
<	O	O	O
0.001	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Increase	O	O	B-T169
in	O	O	O
HbA1c	O	O	B-T034
level	O	O	I-T034
was	O	O	O
strongly	O	O	O
correlated	O	O	B-T080
with	O	O	O
disease	O	O	B-T080
severity	O	O	I-T080
and	O	O	O
higher	O	O	O
SYNTAX	O	O	B-T081
score	O	O	I-T081
.	O	O	O

A	O	O	O
significant	O	O	O
increase	O	O	B-T169
was	O	O	O
noted	O	O	O
in	O	O	O
the	O	O	O
mean	O	O	O
number	O	O	O
of	O	O	O
diseased	O	O	B-T081
vessels	O	O	I-T081
(	O	O	O
p-value	O	O	B-T081
<	O	O	O
0.001	O	O	O
)	O	O	O
as	O	O	O
HbA1c	O	O	B-T034
level	O	O	I-T034
increases	O	O	B-T169
.	O	O	O

Age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
hypertension	O	O	B-T047
and	O	O	O
dyslipidemia	O	O	B-T047
did	O	O	O
not	O	O	O
show	O	O	O
significant	O	O	O
difference	O	O	O
among	O	O	O
quartiles	O	O	B-T080
however	O	O	O
smoking	O	O	B-T055
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
independent	O	O	O
predictor	O	O	B-T078
of	O	O	O
severity	O	O	B-T080
of	O	O	O
CAD	O	O	B-T047
by	O	O	O
SYNTAX	O	O	B-T081
score	O	O	I-T081
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

From	O	O	O
this	O	O	O
clinical	O	O	B-T062
study	O	O	I-T062
,	O	O	O
we	O	O	O
can	O	O	O
conclude	O	O	O
that	O	O	O
a	O	O	O
significant	O	O	O
correlation	O	O	B-T080
exists	O	O	O
between	O	O	O
HbA1c	O	O	B-T116
and	O	O	O
severity	O	O	B-T080
of	O	O	O
CAD	O	O	B-T047
by	O	O	O
SYNTAX	O	O	B-T081
score	O	O	I-T081
as	O	O	O
well	O	O	O
as	O	O	O
number	O	O	O
of	O	O	O
vessels	O	O	B-T023
involved	O	O	O
in	O	O	O
non-	O	O	B-T033
diabetes	O	O	I-T033
.	O	O	O

-DOCSTART- (27792780)

On	O	O	O
the	O	O	O
Relation	O	O	B-T080
between	O	O	O
Face	O	O	B-T041
and	O	O	O
Object	O	O	B-T041
Recognition	O	O	I-T041
in	O	O	O
Developmental	O	O	B-T048
Prosopagnosia	O	O	I-T048
:	O	O	O
No	O	O	O
Dissociation	O	O	B-T048
but	O	O	O
a	O	O	O
Systematic	O	O	B-T169
Association	O	O	O

There	O	O	O
is	O	O	O
an	O	O	O
ongoing	O	O	O
debate	O	O	B-T052
about	O	O	O
whether	O	O	O
face	O	O	B-T041
recognition	O	O	I-T041
and	O	O	O
object	O	O	B-T041
recognition	O	O	I-T041
constitute	O	O	O
separate	O	O	B-T080
domains	O	O	B-T169
.	O	O	O

Clarification	O	O	B-T052
of	O	O	O
this	O	O	O
issue	O	O	B-T033
can	O	O	O
have	O	O	O
important	O	O	B-T080
theoretical	O	O	B-T078
implications	O	O	B-T080
as	O	O	O
face	O	O	B-T041
recognition	O	O	I-T041
is	O	O	O
often	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
prime	O	O	O
example	O	O	B-T077
of	O	O	O
domain	O	O	B-T169
-	O	O	O
specificity	O	O	B-T081
in	O	O	O
mind	O	O	B-T078
and	O	O	O
brain	O	O	B-T023
.	O	O	O

An	O	O	O
important	O	O	B-T080
source	O	O	B-T033
of	O	O	O
input	O	O	B-T077
to	O	O	O
this	O	O	O
debate	O	O	B-T052
comes	O	O	O
from	O	O	O
studies	O	O	O
of	O	O	O
individuals	O	O	B-T098
with	O	O	O
developmental	O	O	B-T048
prosopagnosia	O	O	I-T048
,	O	O	O
suggesting	O	O	B-T078
that	O	O	O
face	O	O	B-T041
recognition	O	O	I-T041
can	O	O	O
be	O	O	O
selectively	O	O	B-T169
impaired	O	O	I-T169
.	O	O	O

We	O	O	O
put	O	O	O
the	O	O	O
selectivity	O	O	B-T080
hypothesis	O	O	B-T078
to	O	O	O
test	O	O	B-T169
by	O	O	O
assessing	O	O	O
the	O	O	O
performance	O	O	B-T052
of	O	O	O
10	O	O	O
individuals	O	O	B-T098
with	O	O	O
developmental	O	O	B-T048
prosopagnosia	O	O	I-T048
on	O	O	O
demanding	O	O	O
tests	O	O	O
of	O	O	O
visual	O	O	B-T041
object	O	O	I-T041
processing	O	O	I-T041
involving	O	O	B-T169
both	O	O	O
regular	O	O	B-T080
and	O	O	O
degraded	O	O	B-T033
drawings	O	O	B-T170
.	O	O	O

None	O	O	O
of	O	O	O
the	O	O	O
individuals	O	O	B-T098
exhibited	O	O	O
a	O	O	O
clear	O	O	O
dissociation	O	O	B-T048
between	O	O	O
face	O	O	B-T041
and	O	O	O
object	O	O	B-T041
recognition	O	O	I-T041
,	O	O	O
and	O	O	O
as	O	O	O
a	O	O	O
group	O	O	B-UnknownType
they	O	O	O
were	O	O	O
significantly	O	O	B-T078
more	O	O	O
affected	O	O	B-T169
by	O	O	O
degradation	O	O	B-T033
of	O	O	O
objects	O	O	B-T072
than	O	O	O
control	O	O	B-T096
participants	O	O	B-T098
.	O	O	O

Importantly	O	O	O
,	O	O	O
we	O	O	O
also	O	O	O
find	O	O	O
positive	O	O	B-T033
correlations	O	O	B-T080
between	O	O	O
the	O	O	O
severity	O	O	B-T080
of	O	O	O
the	O	O	O
face	O	O	B-T041
recognition	O	O	I-T041
impairment	O	O	B-T169
and	O	O	O
the	O	O	O
degree	O	O	B-T081
of	O	O	O
impaired	O	O	B-T169
performance	O	O	B-T052
with	O	O	O
degraded	O	O	B-T033
objects	O	O	B-T072
.	O	O	O

This	O	O	O
suggests	O	O	O
that	O	O	O
the	O	O	O
face	O	O	B-T041
and	O	O	O
object	O	O	B-T041
deficits	O	O	B-T080
are	O	O	O
systematically	O	O	O
related	O	O	B-T080
rather	O	O	O
than	O	O	O
coincidental	O	O	B-T079
.	O	O	O

We	O	O	O
conclude	O	O	O
that	O	O	O
at	O	O	O
present	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
strong	O	O	O
evidence	O	O	B-T078
in	O	O	O
the	O	O	O
literature	O	O	B-T170
on	O	O	O
developmental	O	O	B-T048
prosopagnosia	O	O	I-T048
supporting	O	O	O
domain	O	O	B-T169
-	O	O	O
specific	O	O	B-T080
accounts	O	O	O
of	O	O	O
face	O	O	B-T041
recognition	O	O	I-T041
.	O	O	O

-DOCSTART- (27794081)

Reduced	O	O	B-T033
Chest	O	O	I-T033
and	O	O	O
Abdominal	O	O	B-T023
Wall	O	O	I-T023
Mobility	O	O	B-T080
and	O	O	O
Their	O	O	O
Relationship	O	O	B-T080
to	O	O	O
Lung	O	O	B-T039
Function	O	O	I-T039
,	O	O	O
Respiratory	O	O	B-T169
Muscle	O	O	B-T042
Strength	O	O	I-T042
,	O	O	O
and	O	O	O
Exercise	O	O	B-T201
Tolerance	O	O	I-T201
in	O	O	O
Subjects	O	O	B-T096
With	O	O	O
COPD	O	O	O

Advanced	O	O	O
air-flow	O	O	B-T039
limitation	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
COPD	O	O	B-T047
leads	O	O	O
to	O	O	O
a	O	O	O
reduction	O	O	B-T080
in	O	O	O
vital	O	O	B-T201
capacity	O	O	I-T201
,	O	O	O
respiratory	O	O	B-T169
muscle	O	O	B-T042
strength	O	O	I-T042
,	O	O	O
and	O	O	O
exercise	O	O	B-T201
capacity	O	O	I-T201
.	O	O	O

However	O	O	O
,	O	O	O
its	O	O	O
impact	O	O	O
on	O	O	O
chest	O	O	B-T029
and	O	O	O
abdominal	O	O	B-T023
wall	O	O	I-T023
mobility	O	O	B-T080
is	O	O	O
unknown	O	O	B-T080
.	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
ascertain	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
with	O	O	O
COPD	O	O	B-T047
with	O	O	O
reduced	O	O	B-T033
chest	O	O	I-T033
and	O	O	O
abdominal	O	O	B-T023
wall	O	O	I-T023
mobility	O	O	B-T080
and	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
effect	O	O	B-T080
of	O	O	O
reduced	O	O	O
chest	O	O	O
and	O	O	O
abdominal	O	O	O
wall	O	O	O
mobility	O	O	O
on	O	O	O
pulmonary	O	O	B-T039
function	O	O	I-T039
,	O	O	O
respiratory	O	O	B-T169
muscle	O	O	B-T042
strength	O	O	I-T042
,	O	O	O
and	O	O	O
exercise	O	O	B-T201
capacity	O	O	I-T201
.	O	O	O

In	O	O	O
51	O	O	O
elderly	O	O	B-T098
male	O	O	B-T032
subjects	O	O	B-T096
with	O	O	O
COPD	O	O	B-T047
,	O	O	O
chest	O	O	B-T029
and	O	O	O
abdominal	O	O	B-T023
wall	O	O	I-T023
mobility	O	O	B-T080
,	O	O	O
FVC	O	O	B-T034
,	O	O	O
FEV1	O	O	B-T060
,	O	O	O
FEV1/FVC	O	O	B-T059
,	O	O	O
maximal	O	O	B-T060
inspiratory	O	O	I-T060
pressure	O	O	I-T060
(	O	O	O
PImax	O	O	B-T060
)	O	O	O
,	O	O	O
maximal	O	O	B-T060
expiratory	O	O	I-T060
pressure	O	O	I-T060
(	O	O	O
PEmax	O	O	B-T060
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
6-min	O	O	B-T060
walk	O	O	I-T060
distance	O	O	I-T060
(	O	O	O
6MWD	O	O	B-T060
)	O	O	O
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

Chest	O	O	B-T023
and	O	O	O
abdominal	O	O	B-T023
wall	O	O	I-T023
mobility	O	O	B-T080
were	O	O	O
measured	O	O	B-T080
using	O	O	O
the	O	O	O
breathing	O	O	B-T040
movement	O	O	B-T059
scale	O	O	I-T059
(	O	O	O
0	O	O	O
-	O	O	O
8)	O	O	O
at	O	O	O
the	O	O	O
3	O	O	O
regions	O	O	B-T029
(	O	O	O
upper	O	O	B-T029
chest	O	O	I-T029
,	O	O	O
lower	O	O	B-T029
chest	O	O	I-T029
,	O	O	O
and	O	O	O
abdomen	O	O	B-T029
)	O	O	O
.	O	O	O

Reduced	O	O	B-T033
mobility	O	O	I-T033
was	O	O	O
defined	O	O	O
as	O	O	O
a	O	O	O
value	O	O	B-T081
lower	O	O	B-T052
than	O	O	O
the	O	O	O
lower	O	O	B-T081
limit	O	O	I-T081
of	O	O	I-T081
the	O	O	I-T081
normal	O	O	I-T081
scale	O	O	I-T081
.	O	O	O

The	O	O	O
unpaired	O	O	B-T170
t	O	O	I-T170
test	O	O	I-T170
,	O	O	O
Mann-Whitney	O	O	B-T170
test	O	O	I-T170
,	O	O	O
and	O	O	O
multiple	O	O	B-T080
regression	O	O	I-T080
analysis	O	O	I-T080
were	O	O	O
performed	O	O	B-T169
.	O	O	O

The	O	O	O
percentages	O	O	B-T081
of	O	O	O
subjects	O	O	B-T096
with	O	O	O
reduced	O	O	B-T033
mobility	O	O	I-T033
were	O	O	O
78	O	O	O
%	O	O	O
for	O	O	O
the	O	O	O
upper	O	O	B-T029
chest	O	O	I-T029
,	O	O	O
76	O	O	O
%	O	O	O
for	O	O	O
the	O	O	O
lower	O	O	B-T029
chest	O	O	I-T029
,	O	O	O
and	O	O	O
53	O	O	O
%	O	O	O
for	O	O	O
the	O	O	O
abdomen	O	O	B-T029
.	O	O	O

The	O	O	O
subjects	O	O	B-T096
with	O	O	O
reduced	O	O	B-T033
mobility	O	O	B-T080
had	O	O	O
significantly	O	O	B-T081
low	O	O	I-T081
FVC	O	O	B-T034
,	O	O	O
FEV1	O	O	B-T060
,	O	O	O
and	O	O	O
6MWD	O	O	B-T060
in	O	O	O
each	O	O	O
region	O	O	B-T029
and	O	O	O
significantly	O	O	O
low	O	O	O
FEV1/FVC	O	O	B-T059
,	O	O	O
PImax	O	O	B-T060
,	O	O	O
and	O	O	O
PEmax	O	O	B-T060
in	O	O	O
the	O	O	O
abdominal	O	O	B-T029
region	O	O	I-T029
compared	O	O	B-T052
with	O	O	O
those	O	O	O
with	O	O	O
nonreduced	O	O	O
mobility	O	O	O
.	O	O	O

FVC	O	O	B-T034
and	O	O	O
6MWD	O	O	B-T060
were	O	O	O
independently	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
scale	O	O	B-T080
values	O	O	I-T080
in	O	O	O
each	O	O	O
region	O	O	B-T029
and	O	O	O
with	O	O	O
the	O	O	O
abdominal	O	O	B-T029
scale	O	O	B-T080
value	O	O	I-T080
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
subjects	O	O	B-T096
with	O	O	O
COPD	O	O	B-T047
had	O	O	O
reduced	O	O	B-T033
chest	O	O	I-T033
and	O	O	O
abdominal	O	O	B-T023
wall	O	O	I-T023
mobility	O	O	B-T080
,	O	O	O
which	O	O	O
was	O	O	O
independently	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
FVC	O	O	B-T034
.	O	O	O

Even	O	O	O
though	O	O	O
abdominal	O	O	B-T023
wall	O	O	I-T023
mobility	O	O	B-T080
was	O	O	O
relatively	O	O	O
preserved	O	O	O
compared	O	O	B-T052
with	O	O	O
chest	O	O	B-T023
wall	O	O	I-T023
mobility	O	O	O
,	O	O	O
it	O	O	O
was	O	O	O
also	O	O	O
independently	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
6MWD	O	O	B-T060
.	O	O	O

-DOCSTART- (27794108)

FGF21	O	O	B-T116
is	O	O	O
a	O	O	O
biomarker	O	O	B-T201
for	O	O	O
mitochondrial	O	O	B-T045
translation	O	O	I-T045
and	O	O	O
mtDNA	O	O	B-T114
maintenance	O	O	B-T052
disorders	O	O	O

To	O	O	O
validate	O	O	O
new	O	O	O
mitochondrial	O	O	B-T047
myopathy	O	O	I-T047
serum	O	O	B-T031
biomarkers	O	O	B-T201
for	O	O	O
diagnostic	O	O	B-T060
use	O	O	I-T060
.	O	O	O

We	O	O	O
analyzed	O	O	B-T062
serum	O	O	B-T031
FGF21	O	O	B-T116
(	O	O	O
S-FGF21	O	O	B-T116
)	O	O	O
and	O	O	O
GDF15	O	O	B-T116
from	O	O	O
patients	O	O	B-T101
with	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
mitochondrial	O	O	B-T047
diseases	O	O	I-T047
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
nonmitochondrial	O	O	B-T047
disorders	O	O	I-T047
partially	O	O	B-T081
overlapping	O	O	B-T079
with	O	O	O
mitochondrial	O	O	B-T047
disorder	O	O	I-T047
phenotypes	O	O	B-T032
.	O	O	O

We	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
did	O	O	O
a	O	O	O
meta-analysis	O	O	B-T062
of	O	O	O
S-FGF21	O	O	B-T116
in	O	O	O
mitochondrial	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
analyzed	O	O	B-T062
S-Fgf21	O	O	B-T116
and	O	O	O
skeletal	O	O	B-T024
muscle	O	O	B-T024
Fgf21	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
6	O	O	O
mouse	O	O	B-T015
models	O	O	B-T008
with	O	O	O
different	O	O	B-T080
muscle	O	O	O
-	O	O	O
manifesting	O	O	B-T169
mitochondrial	O	O	B-T033
dysfunctions	O	O	I-T033
.	O	O	O

We	O	O	O
report	O	O	O
that	O	O	O
S-FGF21	O	O	B-T116
consistently	O	O	O
increases	O	O	B-T169
in	O	O	O
primary	O	O	B-T080
mitochondrial	O	O	B-T047
myopathy	O	O	I-T047
,	O	O	O
especially	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
mitochondrial	O	O	B-T045
translation	O	O	I-T045
defects	O	O	B-T019
or	O	O	O
mitochondrial	O	O	B-T033
DNA	O	O	I-T033
(	O	O	I-T033
mtDNA	O	O	I-T033
)	O	O	I-T033
deletions	O	O	I-T033
(	O	O	O
675	O	O	O
and	O	O	O
347	O	O	O
pg/mL	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
controls	O	O	B-T096
:	O	O	O
66	O	O	O
pg/mL	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
for	O	O	O
both	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
corroborated	O	O	O
in	O	O	O
mice	O	O	B-T015
(	O	O	O
mtDNA	O	O	B-T033
deletions	O	O	I-T033
1,163	O	O	O
vs	O	O	O
379	O	O	O
pg/mL	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
patients	O	O	B-T101
and	O	O	O
mice	O	O	B-T015
with	O	O	O
structural	O	O	B-T019
respiratory	O	O	I-T019
chain	O	O	I-T019
subunit	O	O	I-T019
or	O	O	I-T019
assembly	O	O	I-T019
factor	O	O	I-T019
defects	O	O	I-T019
showed	O	O	O
low	O	O	B-T080
induction	O	O	B-T169
(	O	O	O
human	O	O	B-T016
335	O	O	O
pg/mL	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
;	O	O	O
mice	O	O	O
335	O	O	O
pg/mL	O	O	O
,	O	O	O
not	O	O	B-T033
significant	O	O	I-T033
)	O	O	O
.	O	O	O

Overall	O	O	B-T080
specificities	O	O	B-T081
of	O	O	O
FGF21	O	O	B-T116
and	O	O	O
GDF15	O	O	B-T116
to	O	O	O
find	O	O	O
patients	O	O	B-T101
with	O	O	O
mitochondrial	O	O	B-T047
myopathy	O	O	I-T047
were	O	O	O
89.3	O	O	O
%	O	O	O
vs	O	O	O
86.4	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
sensitivities	O	O	B-T081
67.3	O	O	O
%	O	O	O
and	O	O	O
76.0	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
GDF15	O	O	B-T116
was	O	O	O
increased	O	O	B-T081
also	O	O	O
in	O	O	O
a	O	O	O
wide	O	O	O
range	O	O	O
of	O	O	O
nonmitochondrial	O	O	B-T080
conditions	O	O	I-T080
.	O	O	O

S-FGF21	O	O	B-T116
is	O	O	O
a	O	O	O
specific	O	O	B-T080
biomarker	O	O	B-T201
for	O	O	O
muscle	O	O	B-T024
-	O	O	O
manifesting	O	O	B-T169
defects	O	O	B-T019
of	O	O	O
mitochondrial	O	O	B-T026
translation	O	O	I-T045
,	O	O	O
including	O	O	O
mitochondrial	O	O	O
transfer-RNA	O	O	B-T114
mutations	O	O	B-T045
and	O	O	O
primary	O	O	B-T080
and	O	O	O
secondary	O	O	B-T080
mtDNA	O	O	B-T033
deletions	O	O	I-T033
,	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
causes	O	O	B-T169
of	O	O	O
mitochondrial	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
normal	O	O	B-T080
S-FGF21	O	O	B-T116
does	O	O	O
not	O	O	B-T033
exclude	O	O	B-T169
structural	O	O	B-T019
respiratory	O	O	I-T019
chain	O	O	I-T019
complex	O	O	I-T019
or	O	O	I-T019
assembly	O	O	I-T019
factor	O	O	I-T019
defects	O	O	I-T019
,	O	O	O
important	O	O	O
to	O	O	O
acknowledge	O	O	O
in	O	O	O
diagnostics	O	O	B-T060
.	O	O	O

This	O	O	O
study	O	O	B-T062
provides	O	O	O
Class	O	O	B-T170
III	O	O	I-T170
evidence	O	O	B-T078
that	O	O	O
elevated	O	O	B-T080
S-FGF21	O	O	B-T116
accurately	O	O	O
distinguishes	O	O	O
patients	O	O	B-T101
with	O	O	O
mitochondrial	O	O	B-T047
myopathies	O	O	B-T047
from	O	O	O
patients	O	O	O
with	O	O	O
other	O	O	O
conditions	O	O	B-T080
,	O	O	O
and	O	O	O
FGF21	O	O	B-T116
and	O	O	O
GDF15	O	O	B-T116
mitochondrial	O	O	B-T047
myopathy	O	O	I-T047
from	O	O	O
other	O	O	O
myopathies	O	O	O
.	O	O	O

-DOCSTART- (27794490)

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
captopril	O	O	B-T116
on	O	O	O
lipopolysaccharide	O	O	B-T109
induced	O	O	B-T169
learning	O	O	B-T048
and	O	O	O
memory	O	O	B-T048
impairments	O	O	I-T048
and	O	O	O
the	O	O	O
brain	O	O	B-T023
cytokine	O	O	B-T116
levels	O	O	B-T080
and	O	O	O
oxidative	O	O	B-T169
damage	O	O	B-T037
in	O	O	O
rats	O	O	O

Renin-angiotensin	O	O	B-T022
system	O	O	I-T022
has	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
inflammation	O	O	B-T046
and	O	O	O
also	O	O	O
involves	O	O	O
in	O	O	O
learning	O	O	B-T041
and	O	O	O
memory	O	O	B-T041
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
captopril	O	O	B-T116
on	O	O	O
lipopolysaccharide	O	O	B-T109
(	O	O	O
LPS	O	O	B-T109
)	O	O	O
induced	O	O	B-T169
learning	O	O	B-T048
and	O	O	O
memory	O	O	B-T048
impairments	O	O	I-T048
,	O	O	O
hippocampal	O	O	B-T023
cytokine	O	O	B-T116
levels	O	O	B-T080
and	O	O	O
brain	O	O	B-T023
tissues	O	O	I-T023
oxidative	O	O	B-T169
damage	O	O	B-T037
was	O	O	O
investigated	O	O	B-T169
.	O	O	O

The	O	O	O
rats	O	O	B-T015
were	O	O	O
divided	O	O	O
and	O	O	O
treated	O	O	O
:	O	O	O
[	O	O	O
1	O	O	O
]	O	O	O
saline	O	O	B-T167
(	O	O	O
Control	O	O	B-T096
)	O	O	O
,	O	O	O
[	O	O	O
2	O	O	O
]	O	O	O
LPS	O	O	B-T109
(	O	O	O
1mg/kg	O	O	O
)	O	O	O
,	O	O	O
[	O	O	O
3	O	O	O
-	O	O	O
5	O	O	O
]	O	O	O
10	O	O	O
,	O	O	O
50	O	O	O
or	O	O	O
100mg/kg	O	O	O
captopril	O	O	B-T116
30min	O	O	O
before	O	O	O
LPS	O	O	O
.	O	O	O

The	O	O	O
treatment	O	O	B-T061
was	O	O	O
started	O	O	O
since	O	O	O
six	O	O	O
days	O	O	B-T079
before	O	O	O
the	O	O	O
behavioral	O	O	B-T060
experiments	O	O	I-T060
and	O	O	O
continued	O	O	O
during	O	O	O
the	O	O	O
behavioral	O	O	B-T060
tests	O	O	I-T060
(	O	O	O
LPS	O	O	B-T109
injection	O	O	B-T061
two	O	O	O
h	O	O	O
before	O	O	O
each	O	O	O
behavioral	O	O	B-T060
experiment	O	O	I-T060
)	O	O	O
.	O	O	O

Administration	O	O	B-T061
of	O	O	O
LPS	O	O	B-T109
prolonged	O	O	B-T079
the	O	O	O
escape	O	O	O
latency	O	O	B-T080
and	O	O	O
traveled	O	O	O
path	O	O	O
to	O	O	O
find	O	O	O
the	O	O	O
platform	O	O	O
in	O	O	O
Morris	O	O	B-T060
water	O	O	I-T060
maze	O	O	I-T060
(	O	O	I-T060
MWM	O	O	I-T060
)	O	O	I-T060
test	O	O	B-T060
(	O	O	O
P<0.01-P<0.001	O	O	O
)	O	O	O
while	O	O	O
,	O	O	O
shortened	O	O	O
the	O	O	O
latency	O	O	O
to	O	O	O
enter	O	O	O
the	O	O	O
dark	O	O	B-T058
compartment	O	O	I-T058
in	O	O	O
passive	O	O	B-T041
avoidance	O	O	I-T041
(	O	O	O
PA	O	O	B-T041
)	O	O	O
test	O	O	O
(	O	O	O
P<0.001	O	O	O
)	O	O	O
.	O	O	O

Pretreatment	O	O	B-T052
by	O	O	O
all	O	O	O
doses	O	O	B-T081
of	O	O	O
captopril	O	O	B-T116
improved	O	O	B-T080
performances	O	O	B-T052
of	O	O	O
the	O	O	O
rats	O	O	B-T015
in	O	O	O
MWM	O	O	B-T060
(	O	O	O
P<0.05-P<0.001	O	O	O
)	O	O	O
and	O	O	O
also	O	O	O
prolonged	O	O	B-T079
the	O	O	O
latency	O	O	B-T080
to	O	O	O
enter	O	O	O
the	O	O	O
dark	O	O	B-T058
in	O	O	O
PA	O	O	B-T041
test	O	O	B-T060
(	O	O	O
P<0.001	O	O	O
)	O	O	O
.	O	O	O

LPS	O	O	B-T109
also	O	O	O
increased	O	O	B-T081
IL-6	O	O	B-T116
,	O	O	O
TNF-α	O	O	B-T116
,	O	O	O
malondialdehyde	O	O	B-T109
(	O	O	O
MDA	O	O	B-T109
)	O	O	O
and	O	O	O
nitric	O	O	B-T121
oxide	O	O	I-T121
(	O	O	O
NO	O	O	B-T121
)	O	O	O
metabolites	O	O	B-T123
in	O	O	O
the	O	O	O
hippocampal	O	O	B-T023
tissues	O	O	B-T023
(	O	O	O
P<0.05-P<0.001	O	O	O
)	O	O	O
which	O	O	O
were	O	O	O
prevented	O	O	B-T061
by	O	O	O
captopril	O	O	B-T116
(	O	O	O
P<0.05-P<0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
thiol	O	O	B-T123
,	O	O	O
superoxide	O	O	B-T116
dismutase	O	O	I-T116
(	O	O	O
SOD	O	O	B-T116
)	O	O	O
and	O	O	O
catalase	O	O	B-T116
(	O	O	O
CAT	O	O	B-T116
)	O	O	O
in	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
of	O	O	O
LPS	O	O	B-T109
group	O	O	B-T078
were	O	O	O
lower	O	O	O
than	O	O	O
the	O	O	O
control	O	O	B-T096
(	O	O	O
P<0.001	O	O	O
)	O	O	O
while	O	O	O
,	O	O	O
they	O	O	O
were	O	O	O
enhanced	O	O	B-T052
when	O	O	O
the	O	O	O
aniamls	O	O	B-T008
were	O	O	O
pretreated	O	O	B-T052
by	O	O	O
captopril	O	O	B-T116
(	O	O	O
P<0.01-P<0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
present	O	O	O
study	O	O	O
showed	O	O	O
that	O	O	O
captopril	O	O	B-T116
improved	O	O	B-T080
the	O	O	O
LPS	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
learning	O	O	B-T048
and	O	O	O
memory	O	O	B-T048
impairments	O	O	I-T048
in	O	O	O
rats	O	O	B-T015
which	O	O	O
were	O	O	O
accompanied	O	O	O
with	O	O	O
attenuating	O	O	B-T052
hippocampal	O	O	B-T023
cytokine	O	O	B-T116
levels	O	O	B-T080
and	O	O	O
improving	O	O	B-T080
the	O	O	O
brain	O	O	B-T023
tissues	O	O	I-T023
oxidative	O	O	B-T169
damage	O	O	B-T037
criteria	O	O	B-T078
.	O	O	O

-DOCSTART- (27795701)

Targeted	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
gastric	O	O	O
cancer	O	O	O

Gastric	O	O	B-T191
cancer	O	O	B-T191
is	O	O	O
the	O	O	O
fourth	O	O	O
most	O	O	O
common	O	O	O
cancer	O	O	O
worldwide	O	O	O
.	O	O	O

Surgery	O	O	B-T061
in	O	O	O
combination	O	O	O
with	O	O	O
multimodal	O	O	B-T061
therapy	O	O	I-T061
provides	O	O	O
the	O	O	O
only	O	O	O
curative	O	O	B-T033
therapy	O	O	I-T033
until	O	O	O
now	O	O	O
.	O	O	O

The	O	O	O
importance	O	O	O
of	O	O	O
targeted	O	O	B-T061
therapy	O	O	I-T061
became	O	O	O
clear	O	O	O
over	O	O	O
the	O	O	O
last	O	O	O
few	O	O	O
years	O	O	B-T079
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
implication	O	O	B-T169
of	O	O	O
HER2	O	O	B-T028
and	O	O	O
angiogenesis	O	O	B-T042
-directed	O	O	O
targeted	O	O	B-T061
therapies	O	O	I-T061
major	O	O	O
advances	O	O	O
in	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
could	O	O	O
be	O	O	O
reached	O	O	O
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
benefits	O	O	O
in	O	O	O
survival	O	O	O
remain	O	O	O
unsatisfactory	O	O	O
and	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
resistance	O	O	B-T169
to	O	O	O
monoclonal	O	O	B-T116
antibodies	O	O	I-T116
is	O	O	O
arising	O	O	O
.	O	O	O

A	O	O	O
comprehensive	O	O	B-T080
and	O	O	O
comparative	O	O	B-T062
literature	O	O	B-T170
research	O	O	B-T062
was	O	O	O
performed	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
status	O	O	O
of	O	O	O
HER2	O	O	B-T028
and	O	O	O
angiogenesis	O	O	B-T042
-directed	O	O	O
targeted	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Up	O	O	O
to	O	O	O
now	O	O	O
,	O	O	O
trastuzumab	O	O	B-T116
and	O	O	O
ramucirumab	O	O	B-T116
are	O	O	O
the	O	O	O
only	O	O	O
agents	O	O	B-T109
showing	O	O	O
remarkable	O	O	O
benefits	O	O	O
in	O	O	O
the	O	O	O
therapy	O	O	B-T061
for	O	O	O
the	O	O	O
patients	O	O	B-T101
suffering	O	O	O
from	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

The	O	O	O
limitations	O	O	O
of	O	O	O
targeted	O	O	B-T061
therapies	O	O	I-T061
in	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
are	O	O	O
mainly	O	O	O
associated	O	O	O
with	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
secondary	O	O	O
resistance	O	O	B-T169
.	O	O	O

Addition	O	O	O
of	O	O	O
targeted	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
second-line	O	O	B-T061
treatment	O	O	I-T061
is	O	O	O
beneficial	O	O	O
when	O	O	O
compared	O	O	O
with	O	O	O
chemotherapy	O	O	B-T061
alone	O	O	O
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
results	O	O	B-T033
in	O	O	O
first-line	O	O	B-T061
treatment	O	O	I-T061
remain	O	O	O
modest	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
new	O	O	O
therapeutic	O	O	B-T121
agents	O	O	I-T121
and	O	O	O
combinations	O	O	B-T121
in	O	O	O
the	O	O	O
first-line	O	O	B-T061
treatment	O	O	I-T061
of	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
are	O	O	O
urgently	O	O	O
needed	O	O	O
and	O	O	O
remain	O	O	O
to	O	O	O
be	O	O	O
validated	O	O	O
in	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
.	O	O	O

-DOCSTART- (27795726)

Serum	O	O	B-T059
C-Reactive	O	O	I-T059
Protein	O	O	I-T059
in	O	O	O
Children	O	O	B-T100
with	O	O	O
Liver	O	O	B-T047
Disease	O	O	I-T047
and	O	O	O
Ascites	O	O	O

The	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
peritonitis	O	O	B-T046
as	O	O	O
a	O	O	O
complication	O	O	B-T046
of	O	O	O
cirrhosis	O	O	B-T047
is	O	O	O
an	O	O	O
important	O	O	O
clinical	O	O	O
problem	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
serum	O	O	B-T059
C-reactive	O	O	I-T059
protein	O	O	I-T059
levels	O	O	I-T059
as	O	O	O
a	O	O	O
diagnostic	O	O	B-T201
factor	O	O	I-T201
for	O	O	O
spontaneous	O	O	B-T047
bacterial	O	O	I-T047
peritonitis	O	O	I-T047
(	O	O	O
SBP	O	O	B-T047
)	O	O	O
in	O	O	O
child	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
liver	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
150	O	O	O
children	O	O	B-T100
diagnosed	O	O	B-T062
with	O	O	O
liver	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
ascites	O	O	B-T033
upon	O	O	O
admission	O	O	B-T058
to	O	O	O
Nemazee	O	O	B-T093
Teaching	O	O	I-T093
Hospital	O	O	I-T093
(	O	O	O
Shiraz	O	O	B-T083
,	O	O	O
Iran	O	O	B-T083
)	O	O	O
were	O	O	O
examined	O	O	B-T033
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
divided	O	O	O
into	O	O	O
spontaneous	O	O	B-T047
bacterial	O	O	I-T047
peritonitis	O	O	I-T047
and	O	O	O
sterile	O	O	B-T031
ascetic	O	O	I-T031
fluid	O	O	I-T031
groups	O	O	I-T031
according	O	O	O
to	O	O	O
the	O	O	O
PMN	O	O	B-T059
count	O	O	I-T059
≥	O	O	O
250/mm(3	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
ascetic	O	O	B-T031
fluids	O	O	I-T031
.	O	O	O

Routine	O	O	B-T059
laboratory	O	O	I-T059
tests	O	O	I-T059
were	O	O	O
conducted	O	O	O
and	O	O	O
quantitative	O	O	O
C-reactive	O	O	B-T059
protein	O	O	I-T059
(	O	O	I-T059
CRP	O	O	I-T059
)	O	O	I-T059
levels	O	O	I-T059
were	O	O	O
measured	O	O	O
for	O	O	O
all	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
.	O	O	O

Accuracy	O	O	B-T080
,	O	O	O
sensitivity	O	O	B-T081
,	O	O	I-T081
and	O	O	I-T081
specificity	O	O	I-T081
of	O	O	O
CRP	O	O	B-T059
was	O	O	O
evaluated	O	O	O
for	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
SBP	O	O	B-T047
.	O	O	O

Of	O	O	O
150	O	O	O
cirrhotic	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
109	O	O	O
patients	O	O	O
presented	O	O	O
without	O	O	O
SBP	O	O	B-T047
(	O	O	O
52.29	O	O	O
%	O	O	O
male	O	O	B-T098
,	O	O	O
mean	O	O	B-T032
age	O	O	I-T032
:	O	O	O
5.02	O	O	O
±	O	O	O
4.49	O	O	O
years	O	O	B-T079
)	O	O	O
and	O	O	O
41	O	O	O
patients	O	O	O
presented	O	O	O
with	O	O	O
SBP	O	O	O
(	O	O	O
51.21	O	O	O
%	O	O	O
male	O	O	O
,	O	O	O
mean	O	O	O
age	O	O	O
:	O	O	O
4.71	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

Cell	O	O	B-T059
counts	O	O	I-T059
,	O	O	O
protein	O	O	B-T034
levels	O	O	I-T034
,	O	O	O
albumin	O	O	B-T034
levels	O	O	I-T034
,	O	O	O
and	O	O	O
lactate	O	O	B-T059
dehydrogenize	O	O	I-T059
(	O	O	I-T059
LDH	O	O	I-T059
)	O	O	I-T059
levels	O	O	I-T059
of	O	O	O
the	O	O	O
ascetic	O	O	B-T031
fluid	O	O	I-T031
and	O	O	O
serum	O	O	B-T031
samples	O	O	I-T031
in	O	O	O
the	O	O	O
SBP	O	O	B-T047
group	O	O	O
were	O	O	O
higher	O	O	O
than	O	O	O
the	O	O	O
rates	O	O	O
for	O	O	O
those	O	O	O
without	O	O	O
SBP	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
(	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	O
±	O	O	O
SD	O	O	O
of	O	O	O
CRP	O	O	B-T059
in	O	O	O
the	O	O	O
SBP	O	O	B-T047
group	O	O	O
(	O	O	O
36.89	O	O	O
±	O	O	O
23.43	O	O	O
)	O	O	O
increased	O	O	O
significantly	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
rate	O	O	O
among	O	O	O
those	O	O	O
without	O	O	O
SBP	O	O	O
(	O	O	O
21.59	O	O	O
±	O	O	O
15.43	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
percentages	O	O	O
for	O	O	O
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
of	O	O	O
CRP	O	O	B-T059
,	O	O	O
the	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
SBP	O	O	B-T047
based	O	O	O
on	O	O	O
the	O	O	O
PMN	O	O	B-T059
count	O	O	I-T059
≥	O	O	O
250/mm(3	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
cultured	O	O	B-T033
ascites	O	O	I-T033
were	O	O	O
69.23	O	O	O
%	O	O	O
,	O	O	O
90.25	O	O	O
%	O	O	O
,	O	O	O
88.43	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
84.32	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
areas	O	O	O
under	O	O	O
the	O	O	O
curve	O	O	O
of	O	O	O
CRP	O	O	B-T059
for	O	O	O
SBP	O	O	B-T047
based	O	O	O
on	O	O	O
the	O	O	O
PMN	O	O	B-T059
count	O	O	I-T059
≥	O	O	O
250/mm(3	O	O	O
)	O	O	O
and	O	O	O
cultured	O	O	B-T033
ascites	O	O	I-T033
was	O	O	O
0.94	O	O	O
(	O	O	O
CI	O	O	O
95	O	O	O
%	O	O	O
:	O	O	O
0.90	O	O	O
to	O	O	O
0.96	O	O	O
)	O	O	O
and	O	O	O
0.85	O	O	O
(	O	O	O
CI	O	O	O
95	O	O	O
%	O	O	O
:	O	O	O
0.84	O	O	O
to	O	O	O
0.92	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
study	O	O	B-T062
showed	O	O	O
that	O	O	O
CRP	O	O	B-T059
is	O	O	O
a	O	O	O
marker	O	O	O
with	O	O	O
high	O	O	O
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
for	O	O	O
the	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
SBP	O	O	B-T047
in	O	O	O
cirrhotic	O	O	B-T047
children	O	O	B-T100
.	O	O	O

-DOCSTART- (27796364)

Structure	O	O	O
of	O	O	O
the	O	O	O
bacterial	O	O	B-T080
plant	O	O	B-T002
-	O	O	O
ferredoxin	O	O	B-T116
receptor	O	O	B-T116
FusA	O	O	O

Iron	O	O	B-T121
is	O	O	O
a	O	O	O
limiting	O	O	O
nutrient	O	O	B-T168
in	O	O	O
bacterial	O	O	B-T047
infection	O	O	I-T047
putting	O	O	O
it	O	O	O
at	O	O	O
the	O	O	O
centre	O	O	O
of	O	O	O
an	O	O	O
evolutionary	O	O	O
arms	O	O	O
race	O	O	O
between	O	O	O
host	O	O	B-T001
and	O	O	O
pathogen	O	O	B-T001
.	O	O	O

Gram-negative	O	O	B-T007
bacteria	O	O	I-T007
utilize	O	O	O
TonB	O	O	B-T116
-dependent	O	O	O
outer	O	O	B-T026
membrane	O	O	I-T026
receptors	O	O	B-T116
to	O	O	O
obtain	O	O	O
iron	O	O	B-T121
during	O	O	O
infection	O	O	B-T046
.	O	O	O

These	O	O	O
receptors	O	O	B-T116
acquire	O	O	O
iron	O	O	B-T121
either	O	O	O
in	O	O	O
concert	O	O	O
with	O	O	O
soluble	O	O	O
iron-scavenging	O	O	B-T109
siderophores	O	O	I-T109
or	O	O	O
through	O	O	O
direct	O	O	B-T169
interaction	O	O	I-T169
and	O	O	O
extraction	O	O	B-T061
from	O	O	O
host	O	O	B-T001
proteins	O	O	B-T116
.	O	O	O

Characterization	O	O	B-T052
of	O	O	O
these	O	O	O
receptors	O	O	B-T116
provides	O	O	O
invaluable	O	O	O
insight	O	O	O
into	O	O	O
pathogenesis	O	O	B-T046
.	O	O	O

However	O	O	O
,	O	O	O
only	O	O	O
a	O	O	O
subset	O	O	O
of	O	O	O
virulence	O	O	B-T038
-related	O	O	O
TonB	O	O	B-T116
-dependent	O	O	O
receptors	O	O	B-T116
have	O	O	O
been	O	O	O
currently	O	O	O
described	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	O
the	O	O	O
discovery	O	O	B-T052
of	O	O	O
FusA	O	O	B-T116
,	O	O	O
a	O	O	O
new	O	O	O
class	O	O	O
of	O	O	O
TonB	O	O	B-T116
-dependent	O	O	O
receptor	O	O	B-T116
,	O	O	O
which	O	O	O
is	O	O	O
utilized	O	O	O
by	O	O	O
phytopathogenic	O	O	O
Pectobacterium	O	O	O
spp	O	O	O
.	O	O	O

to	O	O	O
obtain	O	O	O
iron	O	O	B-T121
from	O	O	O
plant	O	O	B-T002
ferredoxin	O	O	B-T116
.	O	O	O

Through	O	O	O
the	O	O	O
crystal	O	O	B-T104
structure	O	O	I-T104
of	O	O	O
FusA	O	O	B-T116
we	O	O	O
show	O	O	O
that	O	O	O
binding	O	O	B-T044
of	O	O	O
ferredoxin	O	O	B-T116
occurs	O	O	O
through	O	O	O
specialized	O	O	O
extracellular	O	O	B-T026
loops	O	O	I-T026
that	O	O	O
form	O	O	O
extensive	O	O	B-T080
interactions	O	O	B-T169
with	O	O	O
ferredoxin	O	O	O
.	O	O	O

The	O	O	O
function	O	O	B-T169
of	O	O	O
FusA	O	O	B-T116
and	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
homologues	O	O	B-T085
in	O	O	O
clinically	O	O	B-T080
important	O	O	I-T080
pathogens	O	O	B-T001
suggests	O	O	O
that	O	O	O
small	O	O	O
iron-containing	O	O	B-T116
proteins	O	O	I-T116
represent	O	O	O
an	O	O	O
iron	O	O	B-T121
source	O	O	B-T033
for	O	O	O
bacterial	O	O	B-T080
pathogens	O	O	O
.	O	O	O

-DOCSTART- (27798289)

Antigen	O	O	B-T129
Masking	O	O	B-T070
During	O	O	O
Fixation	O	O	B-T059
and	O	O	O
Embedding	O	O	B-T059
,	O	O	O
Dissected	O	O	O

Antigen	O	O	B-T129
masking	O	O	B-T070
in	O	O	O
routinely	O	O	O
processed	O	O	B-T067
tissue	O	O	B-T024
is	O	O	O
a	O	O	O
poorly	O	O	O
understood	O	O	O
process	O	O	O
caused	O	O	O
by	O	O	O
multiple	O	O	B-T081
factors	O	O	B-T169
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
dissect	O	O	B-T169
the	O	O	O
effect	O	O	O
on	O	O	O
antigenicity	O	O	B-T038
of	O	O	O
each	O	O	O
step	O	O	B-T077
of	O	O	O
processing	O	O	B-T052
by	O	O	O
using	O	O	O
frozen	O	O	B-T024
sections	O	O	I-T024
as	O	O	O
proxies	O	O	B-T096
of	O	O	O
the	O	O	O
whole	O	O	B-T024
tissue	O	O	I-T024
.	O	O	O

An	O	O	O
equivalent	O	O	O
extent	O	O	O
of	O	O	O
antigen	O	O	B-T129
masking	O	O	B-T070
occurs	O	O	O
across	O	O	O
variable	O	O	O
fixation	O	O	B-T059
times	O	O	B-T079
at	O	O	O
room	O	O	B-T080
temperature	O	O	I-T080
.	O	O	O

Most	O	O	O
antigens	O	O	B-T129
benefit	O	O	O
from	O	O	O
longer	O	O	O
fixation	O	O	B-T059
times	O	O	B-T079
(	O	O	O
>	O	O	O
24	O	O	O
hr	O	O	O
)	O	O	O
for	O	O	O
optimal	O	O	O
detection	O	O	B-T033
after	O	O	O
antigen	O	O	B-T129
retrieval	O	O	B-T058
(	O	O	O
AR	O	O	B-T058
;	O	O	O
for	O	O	O
example	O	O	O
,	O	O	O
Ki-67	O	O	B-T116
,	O	O	O
bcl-2	O	O	B-T129
,	O	O	O
ER	O	O	B-T116
)	O	O	O
.	O	O	O

The	O	O	O
transfer	O	O	B-T169
to	O	O	O
a	O	O	O
graded	O	O	B-T109
alcohol	O	O	I-T109
series	O	O	B-T081
results	O	O	O
in	O	O	O
an	O	O	O
enhanced	O	O	O
staining	O	O	B-T033
effect	O	O	I-T033
,	O	O	O
reproduced	O	O	O
by	O	O	O
treating	O	O	B-T169
the	O	O	O
sections	O	O	B-T024
with	O	O	O
detergents	O	O	B-T120
,	O	O	O
possibly	O	O	O
because	O	O	O
of	O	O	O
a	O	O	O
better	O	O	O
access	O	O	O
of	O	O	O
the	O	O	O
polymeric	O	O	B-T122
immunohistochemical	O	O	B-T059
detection	O	O	B-T033
system	O	O	B-T169
to	O	O	O
tissue	O	O	B-T024
structures	O	O	B-T082
.	O	O	O

A	O	O	O
second	O	O	O
round	O	O	O
of	O	O	O
masking	O	O	B-T070
occurs	O	O	O
upon	O	O	O
entering	O	O	O
the	O	O	O
clearing	O	O	B-T120
agent	O	O	I-T120
,	O	O	O
mostly	O	O	O
at	O	O	O
the	O	O	O
paraffin	O	O	B-T109
embedding	O	O	B-T059
step	O	O	B-T077
.	O	O	O

This	O	O	O
may	O	O	O
depend	O	O	O
on	O	O	O
the	O	O	O
non-freezable	O	O	B-T080
water	O	O	B-T121
removal	O	O	B-T052
.	O	O	O

AR	O	O	B-T058
fully	O	O	O
reverses	O	O	O
the	O	O	O
masking	O	O	B-T070
due	O	O	O
both	O	O	O
to	O	O	O
the	O	O	O
fixation	O	O	B-T059
time	O	O	B-T079
and	O	O	O
the	O	O	O
paraffin	O	O	B-T109
embedding	O	O	B-T059
.	O	O	O

AR	O	O	B-T058
itself	O	O	O
destroys	O	O	B-T052
some	O	O	O
epitopes	O	O	B-T129
which	O	O	O
do	O	O	O
not	O	O	O
survive	O	O	O
routine	O	O	B-T080
processing	O	O	B-T052
.	O	O	O

Processed	O	O	B-T067
frozen	O	O	B-T024
sections	O	O	I-T024
are	O	O	O
a	O	O	O
tool	O	O	O
to	O	O	O
investigate	O	O	B-T169
fixation	O	O	B-T059
and	O	O	O
processing	O	O	B-T052
requirements	O	O	B-T169
for	O	O	O
antigens	O	O	B-T129
in	O	O	O
routine	O	O	B-T080
specimens	O	O	B-T167
.	O	O	O

-DOCSTART- (27798823)

Synthesis	O	O	B-T052
of	O	O	O
1,2-Dioxetanes	O	O	B-T109
as	O	O	O
Thermochemiluminescent	O	O	B-T130
Labels	O	O	I-T130
for	O	O	O
Ultrasensitive	O	O	B-T059
Bioassays	O	O	I-T059
:	O	O	O
Rational	O	O	B-T078
Prediction	O	O	I-T078
of	O	O	O
Olefin	O	O	B-T109
Photooxygenation	O	O	B-T067
Outcome	O	O	B-T169
by	O	O	O
Using	O	O	O
a	O	O	O
Chemometric	O	O	O
Approach	O	O	O

Great	O	O	O
interest	O	O	O
in	O	O	O
new	O	O	O
thermochemiluminescent	O	O	B-T167
(	O	O	I-T167
TCL	O	O	I-T167
)	O	O	I-T167
molecules	O	O	I-T167
,	O	O	O
for	O	O	O
example	O	O	O
,	O	O	O
in	O	O	O
bioanalytical	O	O	B-T059
assays	O	O	I-T059
,	O	O	O
has	O	O	O
prompted	O	O	O
the	O	O	O
design	O	O	B-T052
and	O	O	O
synthesis	O	O	B-T052
of	O	O	O
a	O	O	O
small	O	O	O
library	O	O	B-T073
of	O	O	O
more	O	O	O
than	O	O	O
30	O	O	O
olefins	O	O	B-T109
to	O	O	O
be	O	O	O
subjected	O	O	O
to	O	O	O
photooxygenation	O	O	B-T067
,	O	O	O
with	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
obtaining	O	O	O
new	O	O	O
1,2-dioxetane-based	O	O	B-T109
TCL	O	O	B-T130
labels	O	O	I-T130
with	O	O	O
optimized	O	O	B-T080
properties	O	O	I-T080
.	O	O	O

Fluorine	O	O	B-T123
atoms	O	O	O
on	O	O	O
the	O	O	O
acridan	O	O	B-T109
system	O	O	O
remarkably	O	O	O
stabilize	O	O	O
1,2-dioxetanes	O	O	B-T109
when	O	O	O
they	O	O	O
are	O	O	O
located	O	O	O
in	O	O	O
the	O	O	O
3-	O	O	B-T082
and/or	O	O	I-T082
6-position	O	O	I-T082
(	O	O	O
4	O	O	O
h	O	O	O
and	O	O	O
4	O	O	O
i	O	O	O
)	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
2,7-difluorinated	O	O	B-T109
acridan	O	O	I-T109
dioxetane	O	O	I-T109
(	O	O	O
4	O	O	O
j	O	O	O
)	O	O	O
showed	O	O	O
a	O	O	O
significantly	O	O	O
enhanced	O	O	O
fluorescence	O	O	B-T081
quantum	O	O	I-T081
yield	O	O	I-T081
with	O	O	O
respect	O	O	O
to	O	O	O
the	O	O	O
unsubstituted	O	O	B-T109
dioxetane	O	O	I-T109
(	O	O	O
4	O	O	O
a	O	O	O
)	O	O	O
.	O	O	O

Some	O	O	O
of	O	O	O
the	O	O	O
synthesized	O	O	B-T052
olefins	O	O	B-T109
did	O	O	O
not	O	O	O
undergo	O	O	O
singlet	O	O	B-T067
oxygen	O	O	I-T067
addition	O	O	I-T067
and	O	O	O
a	O	O	O
rationale	O	O	B-T078
was	O	O	O
sought	O	O	O
to	O	O	O
ease	O	O	O
the	O	O	O
photooxygenation	O	O	B-T067
step	O	O	O
,	O	O	O
leading	O	O	O
to	O	O	O
the	O	O	O
TCL	O	O	B-T109
dioxetanes	O	O	I-T109
.	O	O	O

A	O	O	O
chemometric	O	O	B-T059
approach	O	O	I-T059
has	O	O	O
been	O	O	O
adopted	O	O	O
to	O	O	O
exploit	O	O	O
principal	O	O	B-T062
component	O	O	I-T062
analysis	O	O	I-T062
and	O	O	O
linear	O	O	B-T062
discriminant	O	O	I-T062
analysis	O	O	I-T062
of	O	O	O
the	O	O	O
structural	O	O	B-T082
and	O	O	O
electronic	O	O	B-T170
molecular	O	O	I-T170
descriptors	O	O	I-T170
obtained	O	O	O
by	O	O	O
DFT	O	O	B-T052
optimizations	O	O	I-T052
of	O	O	O
olefins	O	O	B-T109
3	O	O	O
.	O	O	O

This	O	O	O
approach	O	O	B-T082
allows	O	O	O
the	O	O	O
steric	O	O	B-T077
and	O	O	I-T077
electronic	O	O	I-T077
parameters	O	O	I-T077
that	O	O	O
govern	O	O	O
dioxetane	O	O	B-T109
formation	O	O	B-T169
to	O	O	O
be	O	O	O
revealed	O	O	B-T080
.	O	O	O

-DOCSTART- (27799048)

Prostate	O	O	B-T061
external	O	O	I-T061
beam	O	O	I-T061
radiotherapy	O	O	I-T061
combined	O	O	B-T080
with	O	O	O
high-dose-rate	O	O	B-T061
brachytherapy	O	O	I-T061
:	O	O	O
dose	O	O	B-T081
-	O	O	O
volume	O	O	B-T081
parameters	O	O	B-T033
from	O	O	O
deformably-registered	O	O	B-T170
plans	O	O	I-T170
correlate	O	O	B-T080
with	O	O	O
late	O	O	B-T079
gastrointestinal	O	O	O
complications	O	O	O

Derivation	O	O	B-T080
of	O	O	O
dose	O	O	B-T081
-	O	O	O
volume	O	O	B-T081
correlated	O	O	B-T080
with	O	O	O
toxicity	O	O	B-T080
for	O	O	O
multi-modal	O	O	B-T061
treatments	O	O	I-T061
can	O	O	O
be	O	O	O
difficult	O	O	B-T080
due	O	O	O
to	O	O	O
the	O	O	O
perceived	O	O	O
need	O	O	O
for	O	O	O
voxel-by-voxel	O	O	B-T059
dose	O	O	I-T059
accumulation	O	O	I-T059
.	O	O	O

With	O	O	O
data	O	O	B-T078
available	O	O	O
for	O	O	O
a	O	O	O
single	O	O	B-T081
-	O	O	O
institution	O	O	B-T093
cohort	O	O	B-T098
with	O	O	O
long	O	O	B-T080
follow-up	O	O	B-T058
,	O	O	O
an	O	O	O
investigation	O	O	B-T169
was	O	O	O
undertaken	O	O	O
into	O	O	O
rectal	O	O	B-T082
dose	O	O	B-T081
-	O	O	O
volume	O	O	B-T081
effects	O	O	B-T080
for	O	O	O
gastrointestinal	O	O	B-T033
toxicities	O	O	I-T033
after	O	O	O
deformably-registering	O	O	O
each	O	O	O
phase	O	O	B-T079
of	O	O	O
a	O	O	O
combined	O	O	B-T080
external	O	O	B-T061
beam	O	O	I-T061
radiotherapy	O	O	I-T061
(EBRT)/	O	O	O
high-dose-rate	O	O	B-T061
(	O	O	I-T061
HDR	O	O	I-T061
)	O	O	I-T061
brachytherapy	O	O	I-T061
prostate	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

One	O	O	O
hundred	O	O	O
and	O	O	O
eighteen	O	O	O
patients	O	O	B-T101
received	O	O	O
EBRT	O	O	B-T061
in	O	O	O
23	O	O	O
fractions	O	O	B-T081
of	O	O	O
2	O	O	O
Gy	O	O	B-T081
and	O	O	O
HDR	O	O	B-T061
(	O	O	O
TG43	O	O	B-T170
algorithm	O	O	I-T170
)	O	O	O
in	O	O	O
3	O	O	O
fractions	O	O	O
of	O	O	O
6.5	O	O	O
Gy	O	O	O
.	O	O	O

Results	O	O	B-T033
for	O	O	O
the	O	O	O
Late	O	O	B-T170
Effects	O	O	I-T170
of	O	O	I-T170
Normal	O	O	I-T170
Tissues	O	O	I-T170
-	O	O	I-T170
Subjective	O	O	I-T170
,	O	O	I-T170
Objective	O	O	I-T170
,	O	O	I-T170
Management	O	O	I-T170
and	O	O	I-T170
Analytic	O	O	I-T170
toxicity	O	O	I-T170
assessments	O	O	I-T170
were	O	O	O
available	O	O	O
with	O	O	O
a	O	O	O
median	O	O	B-T081
follow-up	O	O	B-T058
of	O	O	O
72	O	O	O
months	O	O	B-T079
.	O	O	O

The	O	O	O
HDR	O	O	B-T061
CT	O	O	B-T060
was	O	O	O
deformably-registered	O	O	O
to	O	O	O
the	O	O	O
EBRT	O	O	B-T061
CT	O	O	O
.	O	O	O

Doses	O	O	B-T081
were	O	O	O
corrected	O	O	B-T080
for	O	O	O
dose	O	O	B-T061
fractionation	O	O	I-T061
.	O	O	O

Rectum	O	O	B-T023
dose-volume	O	O	B-T170
histogram	O	O	I-T170
(	O	O	O
DVH	O	O	B-T170
)	O	O	O
parameters	O	O	B-T033
were	O	O	O
calculated	O	O	B-T052
in	O	O	O
two	O	O	O
ways	O	O	O
.	O	O	O

(	O	O	O
1	O	O	O
)	O	O	O
Distribution-adding	O	O	B-T170
:	O	O	O
parameters	O	O	B-T033
were	O	O	O
calculated	O	O	B-T052
after	O	O	O
the	O	O	O
EBRT	O	O	B-T061
dose	O	O	B-T081
distribution	O	O	B-T169
was	O	O	O
3D-summed	O	O	O
with	O	O	O
the	O	O	O
registered	O	O	O
HDR	O	O	B-T061
dose	O	O	O
distribution	O	O	O
.	O	O	O

(	O	O	O
2	O	O	O
)	O	O	O
Parameter-adding	O	O	B-T170
:	O	O	O
the	O	O	O
EBRT	O	O	B-T061
DVH	O	O	B-T170
parameters	O	O	B-T033
were	O	O	O
added	O	O	B-T169
to	O	O	O
HDR	O	O	B-T061
DVH	O	O	O
parameters	O	O	O
.	O	O	O

Logistic	O	O	B-T062
regressions	O	O	I-T062
and	O	O	O
Mann-Whitney	O	O	B-T081
U-tests	O	O	I-T081
were	O	O	O
used	O	O	O
to	O	O	O
correlate	O	O	B-T080
parameters	O	O	B-T033
with	O	O	O
late	O	O	B-T079
peak	O	O	B-T080
toxicity	O	O	B-T080
(	O	O	O
dichotomised	O	O	B-T169
at	O	O	O
grade	O	O	B-T185
1	O	O	O
or	O	O	O
2	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
48	O	O	O
-	O	O	O
80	O	O	O
,	O	O	O
40	O	O	O
-	O	O	O
63	O	O	O
and	O	O	O
49	O	O	O
-	O	O	O
55	O	O	O
Gy	O	O	B-T081
dose	O	O	B-T081
regions	O	O	B-T082
from	O	O	O
distribution-adding	O	O	B-T170
were	O	O	O
significantly	O	O	B-T078
correlated	O	O	B-T080
with	O	O	O
rectal	O	O	B-T046
bleeding	O	O	I-T046
,	O	O	O
urgency	O	O	B-T047
/	O	O	O
tenesmus	O	O	B-T184
and	O	O	O
stool	O	O	B-T033
frequency	O	O	I-T033
respectively	O	O	O
.	O	O	O

Additionally	O	O	B-T169
,	O	O	O
urgency	O	O	B-T047
/	O	O	O
tenesmus	O	O	B-T184
and	O	O	O
anorectal	O	O	B-T184
pain	O	O	I-T184
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
25	O	O	O
-	O	O	O
26	O	O	O
Gy	O	O	B-T081
and	O	O	O
44	O	O	O
-	O	O	O
48	O	O	O
Gy	O	O	O
dose	O	O	B-T081
regions	O	O	B-T082
from	O	O	O
distribution-adding	O	O	B-T170
respectively	O	O	O
.	O	O	O

Parameter-adding	O	O	B-T170
also	O	O	O
indicated	O	O	O
the	O	O	O
low	O	O	B-T080
-	O	O	O
mid	O	O	B-T082
dose	O	O	B-T081
region	O	O	B-T082
was	O	O	O
significantly	O	O	B-T078
correlated	O	O	B-T080
with	O	O	O
stool	O	O	B-T033
frequency	O	O	I-T033
and	O	O	O
proctitis	O	O	B-T047
.	O	O	O

This	O	O	O
study	O	O	B-T062
confirms	O	O	B-T033
significant	O	O	B-T078
dose-histogram	O	O	B-T170
effects	O	O	B-T080
for	O	O	O
gastrointestinal	O	O	B-T033
toxicities	O	O	I-T033
after	O	O	O
including	O	O	B-T169
deformable	O	O	B-T170
registration	O	O	I-T170
to	O	O	O
combine	O	O	B-T080
phases	O	O	B-T079
of	O	O	O
EBRT	O	O	B-T061
/	O	O	O
HDR	O	O	B-T061
prostate	O	O	B-T191
cancer	O	O	I-T191
treatment	O	O	B-T061
.	O	O	O

The	O	O	O
findings	O	O	B-T033
from	O	O	O
distribution-adding	O	O	B-T170
were	O	O	O
in	O	O	O
most	O	O	O
cases	O	O	B-T169
consistent	O	O	B-T078
with	O	O	I-T078
those	O	O	O
from	O	O	O
parameter-adding	O	O	B-T170
.	O	O	O

The	O	O	O
mid	O	O	B-T082
-	O	O	O
high	O	O	B-T080
dose	O	O	B-T081
range	O	O	B-T081
and	O	O	O
near	O	O	B-T080
maximum	O	O	B-T081
doses	O	O	B-T081
were	O	O	O
important	O	O	B-T080
for	O	O	O
rectal	O	O	B-T046
bleeding	O	O	I-T046
.	O	O	O

The	O	O	O
distribution-adding	O	O	B-T170
mid	O	O	B-T082
-	O	O	O
high	O	O	B-T080
dose	O	O	B-T081
range	O	O	B-T081
was	O	O	O
also	O	O	O
important	O	O	B-T080
for	O	O	O
stool	O	O	B-T033
frequency	O	O	I-T033
and	O	O	O
urgency	O	O	B-T047
/	O	O	O
tenesmus	O	O	B-T184
.	O	O	O

We	O	O	O
encourage	O	O	O
additional	O	O	B-T169
studies	O	O	B-T062
in	O	O	O
a	O	O	O
variety	O	O	B-T077
of	O	O	O
institutions	O	O	B-T078
using	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
dose	O	O	B-T059
accumulation	O	O	I-T059
methods	O	O	I-T059
with	O	O	O
appropriate	O	O	O
inter-fraction	O	O	B-T058
motion	O	O	I-T058
management	O	O	I-T058
.	O	O	O

NCT	O	O	O
NCT00193856	O	O	O
.	O	O	O

Retrospectively	O	O	O
registered	O	O	O
12	O	O	O
September	O	O	O
2005	O	O	O
.	O	O	O

-DOCSTART- (27799763)

Prescription	O	O	B-T170
of	O	O	O
opioids	O	O	B-T109
for	O	O	O
breathlessness	O	O	B-T184
in	O	O	O
end-stage	O	O	B-T080
COPD	O	O	B-T047
:	O	O	O
a	O	O	O
national	O	O	O
population-based	O	O	O
study	O	O	O

Low-dose	O	O	B-T081
opioids	O	O	B-T109
can	O	O	O
relieve	O	O	B-T169
breathlessness	O	O	B-T184
but	O	O	O
may	O	O	O
be	O	O	O
underused	O	O	O
in	O	O	O
late-stage	O	O	B-T079
COPD	O	O	B-T047
due	O	O	O
to	O	O	O
fear	O	O	B-T041
of	O	O	O
complications	O	O	B-T046
,	O	O	O
contributing	O	O	O
to	O	O	O
poor	O	O	O
symptom	O	O	B-T061
control	O	O	I-T061
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
study	O	O	B-T062
the	O	O	O
period	O	O	B-T079
prevalence	O	O	O
and	O	O	O
indications	O	O	B-T078
of	O	O	O
opioids	O	O	B-T109
actually	O	O	O
prescribed	O	O	B-T058
in	O	O	O
people	O	O	B-T098
with	O	O	O
end-stage	O	O	B-T080
COPD	O	O	B-T047
.	O	O	O

The	O	O	O
study	O	O	B-T062
was	O	O	O
a	O	O	O
longitudinal	O	O	B-T062
,	O	O	O
population-based	O	O	B-T062
study	O	O	I-T062
of	O	O	O
patients	O	O	B-T101
starting	O	O	O
long-term	O	O	B-T061
oxygen	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
LTOT	O	O	B-T061
)	O	O	O
for	O	O	O
COPD	O	O	B-T047
between	O	O	O
October	O	O	O
1	O	O	O
,	O	O	O
2005	O	O	O
and	O	O	O
June	O	O	O
30	O	O	O
,	O	O	O
2009	O	O	O
in	O	O	O
Sweden	O	O	B-T083
.	O	O	O

A	O	O	O
random	O	O	O
sample	O	O	O
(	O	O	O
n=2,000	O	O	O
)	O	O	O
of	O	O	O
their	O	O	O
dispensed	O	O	B-T058
opioid	O	O	B-T109
prescriptions	O	O	B-T170
was	O	O	O
obtained	O	O	O
from	O	O	O
the	O	O	O
national	O	O	B-T170
Prescribed	O	O	I-T170
Drugs	O	O	I-T170
Register	O	O	I-T170
from	O	O	O
91	O	O	O
days	O	O	B-T079
before	O	O	O
starting	O	O	O
LTOT	O	O	B-T061
until	O	O	O
the	O	O	O
first	O	O	O
of	O	O	O
LTOT	O	O	O
withdrawal	O	O	B-T052
,	O	O	O
death	O	O	B-T040
,	O	O	O
or	O	O	O
study	O	O	B-T079
end	O	O	I-T079
(	O	O	O
December	O	O	O
31	O	O	O
,	O	O	O
2009	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
analyzed	O	O	O
medication	O	O	O
type	O	O	O
,	O	O	O
dispensed	O	O	B-T081
quantity	O	O	I-T081
,	O	O	O
date	O	O	B-T033
of	O	O	I-T033
dispensing	O	O	I-T033
,	O	O	O
and	O	O	O
indications	O	O	B-T078
categorized	O	O	O
as	O	O	O
pain	O	O	B-T184
,	O	O	O
breathlessness	O	O	B-T184
,	O	O	O
other	O	O	O
,	O	O	O
or	O	O	O
unknown	O	O	O
.	O	O	O

In	O	O	O
total	O	O	O
,	O	O	O
2,249	O	O	O
COPD	O	O	B-T047
patients	O	O	B-T101
(	O	O	O
59	O	O	O
%	O	O	O
women	O	O	B-T098
)	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

During	O	O	O
a	O	O	O
median	O	O	O
follow-up	O	O	B-T058
of	O	O	O
1.1	O	O	O
(	O	O	O
interquartile	O	O	B-T081
range	O	O	I-T081
0.6	O	O	O
-	O	O	O
2.0	O	O	O
)	O	O	O
years	O	O	B-T079
,	O	O	O
1,034	O	O	O
patients	O	O	B-T101
(	O	O	O
46	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
dispensed	O	O	B-T058
≥1	O	O	O
opioid	O	O	B-T109
prescription	O	O	B-T058
(	O	O	O
N=13,722	O	O	O
prescriptions	O	O	B-T058
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
frequently	O	O	O
prescribed	O	O	B-T058
opioids	O	O	B-T109
were	O	O	O
tramadol	O	O	B-T109
(	O	O	O
23	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
oxycodone	O	O	B-T109
(	O	O	O
23	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
morphine	O	O	B-T109
(	O	O	O
16	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
codeine	O	O	B-T109
(	O	O	O
16	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Average	O	O	O
dispensed	O	O	B-T081
quantity	O	O	I-T081
was	O	O	O
9.3	O	O	O
(	O	O	O
interquartile	O	O	B-T081
range	O	O	I-T081
3.7	O	O	O
-	O	O	O
16.7	O	O	O
)	O	O	O
defined	O	O	O
daily	O	O	B-T081
doses	O	O	I-T081
per	O	O	O
prescription	O	O	B-T058
.	O	O	O

In	O	O	O
the	O	O	O
random	O	O	O
sample	O	O	B-T167
,	O	O	O
the	O	O	O
most	O	O	O
commonly	O	O	O
stated	O	O	O
indication	O	O	B-T078
was	O	O	O
pain	O	O	B-T184
(	O	O	O
97	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
only	O	O	O
2	O	O	O
%	O	O	O
for	O	O	O
breathlessness	O	O	B-T184
and	O	O	O
1	O	O	O
%	O	O	O
for	O	O	O
other	O	O	O
reasons	O	O	O
.	O	O	O

Despite	O	O	O
evidence	O	O	O
that	O	O	O
supported	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
opioids	O	O	B-T109
for	O	O	O
the	O	O	O
relief	O	O	B-T169
of	O	O	O
breathlessness	O	O	B-T184
predating	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
opioids	O	O	O
are	O	O	O
rarely	O	O	O
prescribed	O	O	B-T058
to	O	O	O
relieve	O	O	B-T169
breathlessness	O	O	O
in	O	O	O
oxygen-dependent	O	O	B-T042
COPD	O	O	B-T047
,	O	O	O
potentially	O	O	O
contributing	O	O	O
to	O	O	O
less-than-optimal	O	O	O
symptom	O	O	B-T061
control	O	O	I-T061
.	O	O	O

This	O	O	O
study	O	O	B-T062
creates	O	O	O
a	O	O	O
baseline	O	O	B-T081
against	O	O	O
which	O	O	O
to	O	O	O
compare	O	O	O
future	O	O	O
changes	O	O	O
in	O	O	O
morphine	O	O	B-T109
prescribing	O	O	O
in	O	O	O
this	O	O	O
setting	O	O	O
.	O	O	O

-DOCSTART- (27802488)

In	O	O	B-T082
Vivo	O	O	I-T082
3-Dimensional	O	O	B-T082
Strain	O	O	B-T052
Mapping	O	O	I-T052
Confirms	O	O	B-T080
Large	O	O	B-T081
Optic	O	O	B-T023
Nerve	O	O	I-T023
Head	O	O	I-T023
Deformations	O	O	B-T190
Following	O	O	B-T079
Horizontal	O	O	O
Eye	O	O	O
Movements	O	O	O

To	O	O	O
measure	O	O	B-T081
lamina	O	O	B-T023
cribrosa	O	O	I-T023
(	O	O	O
LC	O	O	B-T023
)	O	O	O
strains	O	O	B-T190
(	O	O	O
deformations	O	O	B-T190
)	O	O	O
following	O	O	B-T079
abduction	O	O	B-T039
and	O	O	O
adduction	O	O	B-T169
in	O	O	O
healthy	O	O	B-T098
subjects	O	O	I-T098
and	O	O	O
to	O	O	O
compare	O	O	B-T052
them	O	O	O
with	O	O	O
those	O	O	O
resulting	O	O	B-T169
from	O	O	O
a	O	O	O
relatively	O	O	B-T080
high	O	O	B-T080
acute	O	O	B-T079
intraocular	O	O	B-T042
pressure	O	O	I-T042
(	O	O	O
IOP	O	O	B-T042
)	O	O	O
elevation	O	O	B-T082
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
16	O	O	O
eyes	O	O	B-T023
from	O	O	O
8	O	O	O
healthy	O	O	B-T098
subjects	O	O	I-T098
were	O	O	O
included	O	O	B-T052
.	O	O	O

Among	O	O	O
the	O	O	O
16	O	O	O
eyes	O	O	B-T023
,	O	O	O
11	O	O	O
had	O	O	O
peripapillary	O	O	B-T033
atrophy	O	O	I-T033
(	O	O	O
PPA	O	O	B-T033
)	O	O	O
.	O	O	O

For	O	O	O
each	O	O	B-T081
subject	O	O	B-T096
,	O	O	O
both	O	O	O
optic	O	O	B-T023
nerve	O	O	I-T023
heads	O	O	I-T023
(	O	O	O
ONHs	O	O	B-T023
)	O	O	O
were	O	O	O
imaged	O	O	B-T170
using	O	O	O
optical	O	O	B-T060
coherence	O	O	I-T060
tomography	O	O	I-T060
(	O	O	O
OCT	O	O	B-T060
)	O	O	O
at	O	O	O
baseline	O	O	B-T081
(	O	O	O
twice	O	O	B-T081
)	O	O	O
,	O	O	O
in	O	O	O
different	O	O	B-T080
gaze	O	O	B-T074
positions	O	O	B-T082
(	O	O	O
adduction	O	O	B-T169
and	O	O	O
abduction	O	O	B-T039
of	O	O	O
20	O	O	O
°	O	O	O
)	O	O	O
and	O	O	O
following	O	O	B-T079
an	O	O	O
acute	O	O	B-T079
IOP	O	O	B-T042
elevation	O	O	B-T082
of	O	O	O
approximately	O	O	B-T080
20	O	O	O
mm	O	O	O
Hg	O	O	B-T131
from	O	O	O
baseline	O	O	O
(	O	O	O
via	O	O	O
ophthalmodynamometry	O	O	B-T060
)	O	O	O
.	O	O	O

Strains	O	O	B-T190
of	O	O	O
LC	O	O	B-T023
for	O	O	O
all	O	O	O
loading	O	O	B-T169
scenarios	O	O	I-T169
were	O	O	O
mapped	O	O	B-T170
using	O	O	O
a	O	O	O
three-dimensional	O	O	B-T082
tracking	O	O	B-T082
algorithm	O	O	B-T170
.	O	O	O

In	O	O	O
all	O	O	O
16	O	O	O
eyes	O	O	B-T023
,	O	O	O
LC	O	O	B-T023
strains	O	O	B-T190
induced	O	O	B-T169
by	O	O	O
adduction	O	O	B-T169
and	O	O	O
abduction	O	O	B-T039
were	O	O	O
5.83	O	O	O
%	O	O	O
±	O	O	O
3.78	O	O	O
%	O	O	O
and	O	O	O
3.93	O	O	O
%	O	O	O
±	O	O	O
2.57	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
and	O	O	O
both	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
than	O	O	O
the	O	O	O
control	O	O	B-T096
strains	O	O	O
measured	O	O	B-T080
from	O	O	O
the	O	O	O
repeated	O	O	B-T169
baseline	O	O	B-T081
acquisitions	O	O	B-T052
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Strains	O	O	B-T190
of	O	O	O
LC	O	O	B-T023
in	O	O	O
adduction	O	O	B-T169
were	O	O	O
on	O	O	O
average	O	O	B-T081
higher	O	O	B-T080
than	O	O	O
those	O	O	O
in	O	O	O
abduction	O	O	B-T039
,	O	O	O
but	O	O	O
the	O	O	O
difference	O	O	B-T080
was	O	O	O
not	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
(	O	O	O
P	O	O	O
=	O	O	O
0.07	O	O	O
)	O	O	O
.	O	O	O

Strains	O	O	B-T190
of	O	O	O
LC	O	O	B-T023
induced	O	O	B-T169
by	O	O	O
IOP	O	O	B-T042
elevations	O	O	B-T082
(	O	O	O
on	O	O	O
average	O	O	B-T081
21.13	O	O	O
±	O	O	O
7.61	O	O	O
mm	O	O	O
Hg	O	O	B-T131
)	O	O	O
were	O	O	O
6.41	O	O	O
%	O	O	O
±	O	O	O
3.21	O	O	O
%	O	O	O
and	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
than	O	O	O
the	O	O	O
control	O	O	B-T096
strains	O	O	B-T190
(	O	O	O
P	O	O	O
<	O	O	O
0.0005	O	O	O
)	O	O	O
.	O	O	O

Gaze	O	O	B-T074
-	O	O	O
induced	O	O	B-T169
LC	O	O	B-T023
strains	O	O	B-T190
in	O	O	O
the	O	O	O
PPA	O	O	B-T033
group	O	O	B-T101
were	O	O	O
on	O	O	O
average	O	O	B-T081
larger	O	O	B-T081
than	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
non-PPA	O	O	B-T101
group	O	O	I-T101
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
relationship	O	O	B-T080
was	O	O	O
not	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
.	O	O	O

Our	O	O	O
results	O	O	B-T033
confirm	O	O	B-T080
that	O	O	O
horizontal	O	O	B-T039
eye	O	O	I-T039
movements	O	O	I-T039
generate	O	O	B-T080
significant	O	O	B-T078
ONH	O	O	B-T023
strains	O	O	B-T190
,	O	O	O
which	O	O	O
is	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
our	O	O	O
previous	O	O	B-T079
estimations	O	O	B-T041
using	O	O	O
finite	O	O	B-T170
element	O	O	I-T170
analysis	O	O	I-T170
.	O	O	O

Further	O	O	B-T062
studies	O	O	I-T062
are	O	O	O
needed	O	O	O
to	O	O	O
explore	O	O	O
a	O	O	O
possible	O	O	B-T033
link	O	O	O
between	O	O	O
ONH	O	O	B-T023
strains	O	O	B-T190
induced	O	O	B-T169
by	O	O	O
eye	O	O	B-T039
movements	O	O	I-T039
and	O	O	O
axonal	O	O	B-T033
loss	O	O	I-T033
in	O	O	O
optic	O	O	B-T047
neuropathies	O	O	I-T047
.	O	O	O

-DOCSTART- (27804215)

Simultaneously	O	O	B-T079
Targeting	O	O	B-T169
Myofibroblast	O	O	B-T043
Contractility	O	O	I-T043
and	O	O	O
Extracellular	O	O	B-T024
Matrix	O	O	I-T024
Cross-Linking	O	O	B-T169
as	O	O	O
a	O	O	O
Therapeutic	O	O	B-T169
Concept	O	O	I-T169
in	O	O	O
Airway	O	O	B-T023
Fibrosis	O	O	O

Fibrosis	O	O	B-T046
after	O	O	O
solid	O	O	B-T061
organ	O	O	I-T061
transplantation	O	O	I-T061
is	O	O	O
considered	O	O	O
an	O	O	O
irreversible	O	O	B-T079
process	O	O	B-T067
and	O	O	O
remains	O	O	O
the	O	O	O
major	O	O	B-T080
cause	O	O	O
of	O	O	O
graft	O	O	B-T046
dysfunction	O	O	I-T046
and	O	O	O
death	O	O	B-T040
with	O	O	O
limited	O	O	B-T169
therapies	O	O	B-T061
.	O	O	O

This	O	O	O
remodeling	O	O	B-UnknownType
is	O	O	O
characterized	O	O	B-T052
by	O	O	O
aberrant	O	O	B-T080
accumulation	O	O	B-T033
of	O	O	O
contractile	O	O	B-T025
myofibroblasts	O	O	I-T025
that	O	O	O
deposit	O	O	B-T169
excessive	O	O	B-T080
extracellular	O	O	B-T024
matrix	O	O	I-T024
(	O	O	O
ECM	O	O	B-T024
)	O	O	O
and	O	O	O
increase	O	O	B-T169
tissue	O	O	B-T184
stiffness	O	O	I-T184
.	O	O	O

Studies	O	O	B-T062
demonstrate	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
that	O	O	O
a	O	O	O
stiff	O	O	B-T184
ECM	O	O	B-T024
itself	O	O	O
promotes	O	O	B-T052
fibroblast	O	O	B-T025
-to-	O	O	O
myofibroblast	O	O	B-T025
differentiation	O	O	B-T043
,	O	O	O
stimulating	O	O	B-T052
further	O	O	O
ECM	O	O	O
production	O	O	B-T052
.	O	O	O

This	O	O	O
creates	O	O	O
a	O	O	O
positive	O	O	B-UnknownType
feedback	O	O	I-UnknownType
loop	O	O	I-UnknownType
that	O	O	O
perpetuates	O	O	B-T080
fibrosis	O	O	B-T046
.	O	O	O

We	O	O	O
hypothesized	O	O	B-T078
that	O	O	O
simultaneously	O	O	B-T079
targeting	O	O	B-T169
myofibroblast	O	O	B-T043
contractility	O	O	I-T043
with	O	O	O
relaxin	O	O	B-T116
and	O	O	O
ECM	O	O	B-T024
stiffness	O	O	B-T184
with	O	O	O
lysyl	O	O	B-T116
oxidase	O	O	I-T116
inhibitors	O	O	B-T121
could	O	O	O
break	O	O	O
the	O	O	O
feedback	O	O	B-T039
loop	O	O	I-T039
,	O	O	O
reversing	O	O	B-T169
established	O	O	B-T080
fibrosis	O	O	B-T046
.	O	O	O

To	O	O	O
test	O	O	B-T169
this	O	O	O
,	O	O	O
we	O	O	O
used	O	O	O
the	O	O	O
orthotopic	O	O	B-T061
tracheal	O	O	I-T061
transplantation	O	O	I-T061
(	O	O	O
OTT	O	O	B-T061
)	O	O	O
mouse	O	O	B-T050
model	O	O	I-T050
,	O	O	O
which	O	O	O
develops	O	O	O
robust	O	O	B-T080
fibrotic	O	O	B-T169
airway	O	O	B-T023
remodeling	O	O	B-UnknownType
.	O	O	O

Mice	O	O	B-T015
with	O	O	O
established	O	O	B-T080
fibrosis	O	O	B-T046
were	O	O	O
treated	O	O	B-T169
with	O	O	O
saline	O	O	B-T167
,	O	O	O
mono-	O	O	B-T061
,	O	O	O
or	O	O	O
combination	O	O	B-T061
therapies	O	O	I-T061
.	O	O	O

Although	O	O	O
monotherapies	O	O	B-T061
had	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
,	O	O	O
combining	O	O	B-T121
these	O	O	I-T121
agents	O	O	I-T121
decreased	O	O	B-T081
collagen	O	O	B-T116
deposition	O	O	B-T169
and	O	O	O
promoted	O	O	B-T052
re-epithelialization	O	O	B-T042
of	O	O	O
remodeled	O	O	B-T033
airways	O	O	I-T033
.	O	O	O

Relaxin	O	O	B-T116
inhibited	O	O	B-T080
myofibroblast	O	O	B-T025
differentiation	O	O	B-T043
and	O	O	O
contraction	O	O	B-T046
in	O	O	O
a	O	O	O
matrix	O	O	B-T024
-	O	O	O
stiffness	O	O	B-T184
-	O	O	O
dependent	O	O	B-T169
manner	O	O	O
through	O	O	O
prostaglandin	O	O	B-T109
E2	O	O	I-T109
(	O	O	O
PGE2	O	O	B-T109
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
combination	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
lost	O	O	O
in	O	O	O
PGE2	O	O	B-T109
receptor	O	O	I-T116
knockout	O	O	B-T015
and	O	O	O
PGE2	O	O	O
-	O	O	O
inhibited	O	O	B-T080
OTT	O	O	B-T061
mice	O	O	B-T015
.	O	O	O

This	O	O	O
study	O	O	B-T062
revealed	O	O	B-T080
the	O	O	O
important	O	O	O
synergistic	O	O	B-T080
roles	O	O	B-T077
of	O	O	O
cellular	O	O	B-T046
contractility	O	O	I-T046
and	O	O	O
tissue	O	O	B-T024
stiffness	O	O	I-T184
in	O	O	O
the	O	O	O
maintenance	O	O	B-T052
of	O	O	O
fibrotic	O	O	B-T169
tissue	O	O	O
and	O	O	O
suggests	O	O	O
a	O	O	O
new	O	O	O
therapeutic	O	O	B-T169
principle	O	O	B-UnknownType
for	O	O	O
fibrosis	O	O	B-T046
.	O	O	O

-DOCSTART- (27804311)

Systemic	O	O	B-T116
matrix	O	O	I-T116
metalloproteinase-8	O	O	I-T116
response	O	O	B-T038
in	O	O	O
chronic	O	O	O
tonsillitis	O	O	O

The	O	O	O
development	O	O	B-T169
of	O	O	O
several	O	O	O
life-long	O	O	O
diseases	O	O	B-T047
,	O	O	O
such	O	O	O
as	O	O	O
coronary	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
is	O	O	O
affected	O	O	O
by	O	O	O
low-grade	O	O	B-T080
systemic	O	O	B-T169
inflammation	O	O	B-T046
.	O	O	O

Data	O	O	B-T078
on	O	O	O
the	O	O	O
potential	O	O	B-T080
long-term	O	O	B-T079
health	O	O	B-T078
effects	O	O	B-T080
of	O	O	O
chronic	O	O	B-T047
tonsillitis	O	O	I-T047
are	O	O	O
limited	O	O	O
.	O	O	O

Many	O	O	O
inflammatory	O	O	B-T046
conditions	O	O	B-T080
present	O	O	O
with	O	O	O
enhanced	O	O	O
systemic	O	O	B-T116
matrix	O	O	I-T116
metalloproteinase	O	O	I-T116
(MMP)-8	O	O	B-T116
response	O	O	B-T038
.	O	O	O

In	O	O	O
head	O	O	B-T191
and	O	O	I-T191
neck	O	O	I-T191
cancer	O	O	I-T191
,	O	O	O
high	O	O	B-T080
plasma	O	O	B-T031
level	O	O	B-T080
of	O	O	O
tissue	O	O	B-T116
inhibitor	O	O	I-T116
of	O	O	I-T116
metalloproteinase	O	O	I-T116
(TIMP)-1	O	O	B-T116
predicts	O	O	B-T078
poor	O	O	B-T033
prognosis	O	O	I-T033
.	O	O	O

We	O	O	O
analyzed	O	O	O
S-MMP-8	O	O	B-T116
with	O	O	O
immunofluorometric	O	O	B-T059
assay	O	O	I-T059
and	O	O	O
S-TIMP-1	O	O	B-T116
with	O	O	O
an	O	O	O
immunosorbent	O	O	B-T059
assay	O	O	I-T059
in	O	O	O
175	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
undergoing	O	O	O
tonsillectomy	O	O	B-T061
for	O	O	O
benign	O	O	B-T191
tonsillar	O	O	I-T191
disease	O	O	I-T191
,	O	O	O
and	O	O	O
in	O	O	O
33	O	O	O
control	O	O	B-T096
patients	O	O	O
with	O	O	O
tonsillar	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
.	O	O	O

Tonsillar	O	O	B-T023
human	O	O	B-T005
papillomavirus	O	O	I-T005
(	O	O	O
HPV	O	O	B-T005
)	O	O	O
status	O	O	O
was	O	O	O
determined	O	O	O
by	O	O	O
PCR	O	O	B-T063
.	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
benign	O	O	B-T191
tonsillar	O	O	I-T191
disease	O	O	I-T191
,	O	O	O
chronic	O	O	B-T047
tonsillitis	O	O	I-T047
without	O	O	O
hypertrophy	O	O	B-T046
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
enhanced	O	O	O
systemic	O	O	B-T116
MMP-8	O	O	I-T116
response	O	O	B-T038
.	O	O	O

Compared	O	O	O
to	O	O	O
patients	O	O	B-T101
with	O	O	O
benign	O	O	B-T191
tonsillar	O	O	I-T191
disease	O	O	I-T191
,	O	O	O
patients	O	O	O
with	O	O	O
tonsillar	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
had	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
concentrations	O	O	B-T081
of	O	O	O
S-MMP-8	O	O	B-T116
and	O	O	O
S-TIMP-1	O	O	B-T116
.	O	O	O

Neither	O	O	O
S-MMP-8	O	O	B-T116
nor	O	O	O
S-TIMP-1	O	O	B-T116
correlated	O	O	O
with	O	O	O
tonsillar	O	O	B-T023
HPV	O	O	B-T005
positivity	O	O	B-T033
.	O	O	O

-DOCSTART- (27805500)

Addressing	O	O	B-T170
holistic	O	O	B-T078
health	O	O	I-T078
and	O	O	O
work	O	O	B-T057
empowerment	O	O	B-T054
through	O	O	B-T169
a	O	O	O
body-mind-spirit	O	O	B-T058
intervention	O	O	I-T058
program	O	O	I-T058
among	O	O	O
helping	O	O	B-T054
professionals	O	O	B-T097
in	O	O	O
continuous	O	O	B-T078
education	O	O	B-T065
:	O	O	O
A	O	O	O
pilot	O	O	O
study	O	O	O

To	O	O	O
examine	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
a	O	O	O
body-mind-spirit	O	O	B-T058
(	O	O	I-T058
BMS	O	O	I-T058
)	O	O	I-T058
intervention	O	O	I-T058
program	O	O	I-T058
in	O	O	O
improving	O	O	B-T080
the	O	O	O
holistic	O	O	B-T078
well-being	O	O	I-T078
and	O	O	O
work	O	O	B-T057
empowerment	O	O	B-T054
among	O	O	O
helping	O	O	B-T054
professionals	O	O	B-T097
in	O	O	O
continuous	O	O	B-T078
education	O	O	B-T065
.	O	O	O

Forty-four	O	O	O
helping	O	O	B-T054
professionals	O	O	B-T097
,	O	O	O
who	O	O	O
were	O	O	O
in	O	O	O
their	O	O	O
first-year	O	O	O
part-time	O	O	O
postgraduate	O	O	B-T065
study	O	O	I-T065
,	O	O	O
participated	O	O	O
in	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
.	O	O	O

All	O	O	O
participants	O	O	B-T098
attended	O	O	B-T169
a	O	O	O
3-day	O	O	O
BMS	O	O	B-T058
intervention	O	O	I-T058
program	O	O	I-T058
which	O	O	O
emphasized	O	O	O
a	O	O	O
holistic	O	O	B-T078
approach	O	O	I-T078
to	O	O	O
health	O	O	B-T078
and	O	O	O
well-being	O	O	B-T078
.	O	O	O

Ratings	O	O	O
on	O	O	O
their	O	O	O
levels	O	O	B-T080
of	O	O	O
physical	O	O	B-T033
distress	O	O	I-T033
,	O	O	O
daily	O	O	B-T054
functioning	O	O	I-T054
,	O	O	O
affect	O	O	B-T041
,	O	O	O
spirituality	O	O	B-T078
,	O	O	O
and	O	O	O
psychologica	O	O	B-T169
l	O	O	O
empowerment	O	O	B-T054
at	O	O	O
work	O	O	B-T057
were	O	O	O
compared	O	O	O
before	O	O	O
and	O	O	O
immediately	O	O	O
after	O	O	O
the	O	O	O
intervention	O	O	B-T058
.	O	O	O

Participants	O	O	B-T098
reported	O	O	O
significantly	O	O	O
lower	O	O	O
levels	O	O	B-T080
of	O	O	O
negative	O	O	B-T033
affect	O	O	I-T033
and	O	O	O
physical	O	O	B-T033
distress	O	O	I-T033
,	O	O	O
and	O	O	O
were	O	O	O
less	O	O	O
spiritually	O	O	B-T033
disoriented	O	O	I-T033
after	O	O	O
the	O	O	O
intervention	O	O	B-T058
.	O	O	O

Enhanced	O	O	B-T052
levels	O	O	B-T080
of	O	O	O
daily	O	O	B-T054
functioning	O	O	I-T054
,	O	O	O
positive	O	O	B-T041
affect	O	O	I-T041
,	O	O	O
spiritual	O	O	B-UnknownType
resilience	O	O	I-UnknownType
,	O	O	O
and	O	O	O
tranquility	O	O	B-T041
were	O	O	O
also	O	O	O
reported	O	O	O
.	O	O	O

Results	O	O	O
also	O	O	O
suggested	O	O	O
that	O	O	O
participants	O	O	B-T098
were	O	O	O
empowered	O	O	B-T041
at	O	O	O
work	O	O	B-T057
,	O	O	O
and	O	O	O
specifically	O	O	O
felt	O	O	O
more	O	O	O
able	O	O	O
to	O	O	O
make	O	O	O
an	O	O	O
impact	O	O	O
on	O	O	O
work	O	O	O
outcomes	O	O	O
.	O	O	O

The	O	O	O
3-day	O	O	O
BMS	O	O	B-T058
intervention	O	O	I-T058
program	O	O	I-T058
produced	O	O	O
a	O	O	O
positive	O	O	B-T033
and	O	O	O
measurable	O	O	B-T169
effec	O	O	B-T080
t	O	O	O
on	O	O	O
participants	O	O	B-T098
'	O	O	O
holistic	O	O	B-T078
well-being	O	O	I-T078
and	O	O	O
empowerment	O	O	B-T054
at	O	O	O
work	O	O	B-T057
.	O	O	O

Educators	O	O	B-T097
in	O	O	O
related	O	O	O
fields	O	O	B-T077
could	O	O	O
incorporate	O	O	O
holistic	O	O	B-T078
practices	O	O	B-T041
into	O	O	O
the	O	O	O
curriculum	O	O	B-T170
to	O	O	O
better	O	O	O
prepare	O	O	O
the	O	O	O
future	O	O	O
practitioners	O	O	B-T097
,	O	O	O
leading	O	O	O
to	O	O	O
better	O	O	O
outcomes	O	O	O
both	O	O	O
to	O	O	O
the	O	O	O
professionals	O	O	B-T097
themselves	O	O	O
and	O	O	O
their	O	O	O
clients	O	O	B-T096
or	O	O	O
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27805887)

Successful	O	O	B-T061
Restoration	O	O	I-T061
of	O	O	O
Severely	O	O	O
Mutilated	O	O	B-T037
Primary	O	O	B-T023
Incisors	O	O	I-T023
Using	O	O	O
a	O	O	O
Novel	O	O	O
Method	O	O	O
to	O	O	O
Retain	O	O	O
Zirconia	O	O	B-T074
Crowns	O	O	B-T074
-	O	O	O
Two	O	O	B-T079
Year	O	O	I-T079
Results	O	O	O

This	O	O	O
manuscript	O	O	B-T073
describes	O	O	O
a	O	O	O
simple	O	O	O
reliable	O	O	B-T169
technique	O	O	I-T169
for	O	O	O
restoring	O	O	B-T061
severely	O	O	O
mutilated	O	O	B-T037
primary	O	O	B-T023
anterior	O	O	I-T023
teeth	O	O	I-T023
.	O	O	O

A	O	O	O
rigid	O	O	O
glass	O	O	B-T122
ionomer	O	O	I-T122
post	O	O	I-T122
is	O	O	O
created	O	O	O
over	O	O	O
which	O	O	O
zirconia	O	O	B-T074
crowns	O	O	B-T074
can	O	O	O
be	O	O	O
fitted	O	O	O
to	O	O	O
achieve	O	O	O
a	O	O	O
long-term	O	O	B-T079
stable	O	O	O
esthetic	O	O	B-T061
restoration	O	O	B-T061
for	O	O	O
primary	O	O	B-T023
anterior	O	O	I-T023
teeth	O	O	I-T023
.	O	O	O

Children	O	O	B-T100
aged	O	O	O
2	O	O	O
-	O	O	O
5	O	O	O
years	O	O	B-T079
with	O	O	O
two	O	O	O
up	O	O	O
to	O	O	O
six	O	O	O
extensively	O	O	O
decayed	O	O	B-T047
upper	O	O	B-T023
primary	O	O	I-T023
incisors	O	O	I-T023
were	O	O	O
included	O	O	O
.	O	O	O

Fuji	O	O	B-T122
IX	O	O	I-T122
was	O	O	O
condensed	O	O	O
into	O	O	O
an	O	O	O
intracanal	O	O	B-T061
space	O	O	I-T061
created	O	O	O
to	O	O	O
a	O	O	O
depth	O	O	B-T082
of	O	O	O
3	O	O	O
mm	O	O	O
,	O	O	O
to	O	O	O
provide	O	O	O
a	O	O	O
core	O	O	B-T082
which	O	O	O
also	O	O	O
extended	O	O	O
3	O	O	O
mm	O	O	O
supragingivally	O	O	B-T061
.	O	O	O

Crown	O	O	B-T061
preparations	O	O	I-T061
were	O	O	O
completed	O	O	O
upon	O	O	O
these	O	O	O
cores	O	O	B-T082
.	O	O	O

Zirconia	O	O	B-T074
crowns	O	O	B-T074
(	O	O	O
Nusmile	O	O	B-T170
,	O	O	O
Houston	O	O	B-T083
Texas	O	O	I-T083
USA	O	O	B-T083
)	O	O	O
were	O	O	O
fitted	O	O	B-T067
and	O	O	O
cemented	O	O	B-T031
over	O	O	O
the	O	O	O
prepared	O	O	O
cores	O	O	B-T082
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
recalled	O	O	B-T061
at	O	O	O
regular	O	O	B-T079
intervals	O	O	I-T079
.	O	O	O

Twenty-three	O	O	O
healthy	O	O	O
children	O	O	B-T100
with	O	O	O
86	O	O	O
restorations	O	O	B-T061
participated	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
of	O	O	O
the	O	O	O
restorations	O	O	B-T061
was	O	O	O
95.3	O	O	O
%	O	O	O
after	O	O	O
12	O	O	O
months	O	O	B-T079
and	O	O	O
80.2	O	O	O
%	O	O	O
after	O	O	O
24	O	O	O
months	O	O	O
.	O	O	O

According	O	O	O
to	O	O	O
Kaplan-Meier	O	O	B-T062
survival	O	O	I-T062
analysis	O	O	I-T062
,	O	O	O
the	O	O	O
median	O	O	B-T079
survival	O	O	I-T079
time	O	O	I-T079
was	O	O	O
not	O	O	O
reached	O	O	O
while	O	O	O
the	O	O	O
estimated	O	O	O
mean	O	O	B-T081
survival	O	O	I-T081
time	O	O	I-T081
was	O	O	O
22.9	O	O	O
months	O	O	B-T079
.	O	O	O

This	O	O	O
newly	O	O	O
described	O	O	O
clinical	O	O	B-T058
technique	O	O	I-T058
is	O	O	O
simple	O	O	O
and	O	O	O
reliable	O	O	B-T170
to	O	O	O
use	O	O	O
for	O	O	O
restoration	O	O	B-T061
of	O	O	O
extensively	O	O	O
decayed	O	O	B-T047
primary	O	O	B-T023
incisors	O	O	I-T023
.	O	O	O

Use	O	O	O
of	O	O	O
zirconia	O	O	B-T074
crowns	O	O	B-T074
retained	O	O	O
using	O	O	O
this	O	O	O
technique	O	O	B-T169
offers	O	O	O
superior	O	O	B-T080
esthetic	O	O	I-T080
,	O	O	O
durable	O	O	O
restorations	O	O	B-T061
with	O	O	O
remarkable	O	O	O
gingival	O	O	B-T033
response	O	O	I-T033
up	O	O	O
to	O	O	O
24	O	O	O
months	O	O	B-T079
.	O	O	O

-DOCSTART- (27806385)

Reimbursement	O	O	B-T170
Based	O	O	O
on	O	O	O
Value	O	O	O
in	O	O	O
Knee	O	O	B-T061
Surgery	O	O	I-T061
:	O	O	O
What	O	O	O
You	O	O	O
Need	O	O	O
to	O	O	O
Know	O	O	O
about	O	O	O
the	O	O	O
Medicare	O	O	O
Access	O	O	O
and	O	O	O
Children	O	O	O
's	O	O	O
Health	O	O	O
Insurance	O	O	O
Program	O	O	O
Reauthorization	O	O	O
Act	O	O	O
of	O	O	O
2015	O	O	O

Health	O	O	B-T081
care	O	O	I-T081
cost	O	O	I-T081
is	O	O	O
consuming	O	O	O
a	O	O	O
large	O	O	O
portion	O	O	O
of	O	O	O
the	O	O	O
nation	O	O	B-T092
's	O	O	I-T092
gross	O	O	B-T081
domestic	O	O	I-T081
product	O	O	I-T081
while	O	O	O
placing	O	O	O
added	O	O	O
economic	O	O	B-T081
burdens	O	O	I-T081
on	O	O	O
physicians	O	O	B-T097
and	O	O	O
their	O	O	O
patients	O	O	B-T101
.	O	O	O

With	O	O	O
total	O	O	B-T061
joint	O	O	I-T061
replacement	O	O	I-T061
being	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
early-targeted	O	O	O
procedures	O	O	B-T061
in	O	O	O
the	O	O	O
evolving	O	O	O
health	O	O	B-T093
care	O	O	I-T093
environment	O	O	I-T093
,	O	O	O
knee	O	O	B-T097
surgeons	O	O	I-T097
will	O	O	O
benefit	O	O	O
from	O	O	O
developing	O	O	O
a	O	O	O
critical	O	O	O
knowledge	O	O	O
on	O	O	O
health	O	O	B-T064
care	O	O	I-T064
reforms	O	O	I-T064
and	O	O	O
their	O	O	O
financial	O	O	O
implications	O	O	O
.	O	O	O

The	O	O	O
Medicare	O	O	B-T089
Access	O	O	I-T089
and	O	O	I-T089
Children	O	O	I-T089
's	O	O	I-T089
Health	O	O	I-T089
Insurance	O	O	I-T089
Program	O	O	I-T089
Reauthorization	O	O	I-T089
Act	O	O	I-T089
represents	O	O	O
a	O	O	O
cohesive	O	O	O
movement	O	O	O
toward	O	O	O
value-based	O	O	B-T064
payment	O	O	I-T064
reform	O	O	I-T064
and	O	O	O
contains	O	O	O
several	O	O	O
unchartered	O	O	O
rulings	O	O	O
that	O	O	O
require	O	O	O
detailed	O	O	O
attention	O	O	O
by	O	O	O
knee	O	O	B-T097
surgeons	O	O	I-T097
.	O	O	O

In	O	O	O
this	O	O	O
article	O	O	O
,	O	O	O
we	O	O	O
provide	O	O	O
a	O	O	O
contextual	O	O	B-T078
framework	O	O	I-T078
of	O	O	O
health	O	O	B-T089
care	O	O	I-T089
legislation	O	O	I-T089
that	O	O	O
has	O	O	O
led	O	O	O
to	O	O	O
the	O	O	O
formation	O	O	O
of	O	O	O
the	O	O	O
current	O	O	O
health	O	O	B-T089
policy	O	O	I-T089
,	O	O	O
and	O	O	O
present	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
summary	O	O	B-T170
and	O	O	O
update	O	O	O
on	O	O	O
the	O	O	O
Merit-Based	O	O	B-T170
Incentive	O	O	I-T170
Payment	O	O	I-T170
Systems	O	O	I-T170
and	O	O	O
Alternative	O	O	B-T170
Payment	O	O	I-T170
Models	O	O	I-T170
reimbursement	O	O	I-T170
models	O	O	I-T170
.	O	O	O

-DOCSTART- (27806641)

Empty	O	O	B-T080
Capsids	O	O	B-T017
and	O	O	O
Macrophage	O	O	B-T025
Inhibition	O	O	B-T052
/	O	O	O
Depletion	O	O	B-T169
Increase	O	O	B-T169
rAAV	O	O	B-T121
Transgene	O	O	B-T028
Expression	O	O	B-T045
in	O	O	O
Joints	O	O	B-T030
of	O	O	O
Both	O	O	O
Healthy	O	O	B-T080
and	O	O	O
Arthritic	O	O	B-T047
Mice	O	O	O

Gene	O	O	B-T061
therapy	O	O	I-T061
has	O	O	O
potential	O	O	B-T080
to	O	O	O
treat	O	O	B-T061
rheumatic	O	O	B-T047
diseases	O	O	I-T047
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
macrophages	O	O	B-T025
in	O	O	O
the	O	O	O
joint	O	O	B-T030
might	O	O	O
hamper	O	O	O
adeno-associated	O	O	B-T005
viral	O	O	I-T005
vector	O	O	B-T121
-mediated	O	O	O
gene	O	O	B-T077
delivery	O	O	I-T077
.	O	O	O

Here	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
in	O	O	O
arthritic	O	O	B-T047
,	O	O	O
but	O	O	O
also	O	O	O
in	O	O	O
healthy	O	O	B-T080
,	O	O	O
mice	O	O	B-T015
administration	O	O	B-T058
of	O	O	I-T058
agents	O	O	I-T058
that	O	O	O
influence	O	O	B-T077
macrophage	O	O	B-T025
activity	O	O	B-T052
/	O	O	O
number	O	O	B-T081
and/or	O	O	O
addition	O	O	B-T169
of	O	O	O
empty	O	O	B-T080
decoy	O	O	B-T017
capsids	O	O	I-T017
substantially	O	O	O
improve	O	O	B-T033
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
recombinant	O	O	B-T001
adeno-associated	O	O	B-T005
viral	O	O	I-T005
vector	O	O	B-T121
5	O	O	O
transgene	O	O	B-T028
expression	O	O	B-T045
in	O	O	O
the	O	O	O
joint	O	O	B-T030
.	O	O	O

Pretreatment	O	O	B-T052
with	O	O	O
triamcinolone	O	O	B-T109
or	O	O	O
clodronate	O	O	B-T109
liposomes	O	O	B-T109
improved	O	O	B-T033
luciferase	O	O	B-T116
expression	O	O	B-T045
over	O	O	O
a	O	O	O
period	O	O	B-T079
of	O	O	O
4	O	O	O
weeks	O	O	B-T079
.	O	O	O

Similar	O	O	B-T080
results	O	O	B-T033
were	O	O	O
seen	O	O	O
when	O	O	O
empty	O	O	B-T080
decoy	O	O	B-T017
capsids	O	O	B-T017
were	O	O	O
added	O	O	B-T169
to	O	O	O
full	O	O	B-T080
genome	O	O	B-T028
containing	O	O	O
capsids	O	O	O
in	O	O	O
a	O	O	O
5:1	O	O	O
ratio	O	O	B-T081
.	O	O	O

In	O	O	O
a	O	O	O
study	O	O	B-T062
to	O	O	O
assess	O	O	B-T052
the	O	O	O
duration	O	O	B-T079
of	O	O	O
expression	O	O	B-T045
as	O	O	O
well	O	O	O
as	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
combination	O	O	B-T080
of	O	O	O
these	O	O	O
two	O	O	O
approaches	O	O	B-T169
,	O	O	O
we	O	O	O
observed	O	O	B-T169
a	O	O	O
synergistic	O	O	B-T080
enhancement	O	O	B-T052
of	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
,	O	O	O
sustained	O	O	B-T169
for	O	O	O
at	O	O	O
least	O	O	O
12	O	O	O
weeks	O	O	B-T079
.	O	O	O

The	O	O	O
enhancement	O	O	B-T052
of	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
was	O	O	O
independent	O	O	O
of	O	O	O
the	O	O	O
route	O	O	B-T169
of	O	O	I-T169
administration	O	O	I-T169
of	O	O	O
triamcinolone	O	O	B-T109
(	O	O	O
intra-articular	O	O	B-T082
or	O	O	O
intramuscular	O	O	B-T082
)	O	O	O
.	O	O	O

In	O	O	O
healthy	O	O	B-T080
mice	O	O	B-T015
it	O	O	O
was	O	O	O
demonstrated	O	O	O
that	O	O	O
the	O	O	O
combination	O	O	B-T080
improved	O	O	B-T033
expression	O	O	B-T045
of	O	O	O
the	O	O	O
transgene	O	O	B-T028
significantly	O	O	O
,	O	O	O
in	O	O	O
a	O	O	O
serotype	O	O	B-T170
independent	O	O	O
manner	O	O	O
.	O	O	O

These	O	O	O
data	O	O	B-T078
have	O	O	O
implications	O	O	O
for	O	O	O
future	O	O	O
applications	O	O	O
of	O	O	O
gene	O	O	B-T061
therapy	O	O	I-T061
to	O	O	O
the	O	O	O
joint	O	O	B-T030
and	O	O	O
for	O	O	O
other	O	O	O
tissues	O	O	B-T024
with	O	O	O
an	O	O	O
abundance	O	O	B-T080
of	O	O	O
macrophages	O	O	B-T025
.	O	O	O

-DOCSTART- (27807162)

An	O	O	O
Inhibitory	O	O	B-T052
Septum	O	O	B-UnknownType
to	O	O	O
Lateral	O	O	B-T029
Hypothalamus	O	O	I-T029
Circuit	O	O	B-UnknownType
That	O	O	O
Suppresses	O	O	B-T169
Feeding	O	O	O

Feeding	O	O	B-T055
behavior	O	O	I-T055
is	O	O	O
orchestrated	O	O	B-T169
by	O	O	O
neural	O	O	B-UnknownType
circuits	O	O	I-UnknownType
primarily	O	O	O
residing	O	O	O
in	O	O	O
the	O	O	O
hypothalamus	O	O	B-T023
and	O	O	O
hindbrain	O	O	B-T023
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
relative	O	O	B-T080
influence	O	O	B-T077
of	O	O	O
cognitive	O	O	B-T169
and	O	O	O
emotional	O	O	B-T041
brain	O	O	B-UnknownType
circuits	O	O	I-UnknownType
to	O	O	O
the	O	O	O
feeding	O	O	B-T055
circuitry	O	O	B-UnknownType
in	O	O	O
the	O	O	O
hypothalamus	O	O	B-T023
and	O	O	O
hindbrain	O	O	B-T023
remains	O	O	O
unclear	O	O	B-T033
.	O	O	O

Here	O	O	O
,	O	O	O
using	O	O	B-T169
the	O	O	O
cell-type	O	O	B-T170
selectivity	O	O	O
of	O	O	O
genetic	O	O	B-T062
methods	O	O	I-T062
,	O	O	O
circuit	O	O	B-T060
mapping	O	O	I-T060
,	O	O	O
and	O	O	O
behavior	O	O	B-T053
assays	O	O	B-T059
,	O	O	O
we	O	O	O
sought	O	O	O
to	O	O	O
decipher	O	O	O
neural	O	O	B-UnknownType
circuits	O	O	I-UnknownType
emanating	O	O	O
from	O	O	O
the	O	O	O
septal	O	O	B-T023
nucleus	O	O	I-T023
to	O	O	O
the	O	O	O
lateral	O	O	B-T029
hypothalamus	O	O	I-T029
(	O	O	O
LH	O	O	B-T029
)	O	O	O
that	O	O	O
contribute	O	O	O
to	O	O	O
neural	O	O	B-T042
regulation	O	O	I-T042
of	O	O	O
food	O	O	B-T040
intake	O	O	I-T040
in	O	O	O
mice	O	O	B-T015
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
chemogenetic	O	O	B-T169
and	O	O	O
optogenetic	O	O	B-T169
activation	O	O	B-T052
of	O	O	O
septal	O	O	B-T082
vesicular	O	O	B-T116
GABA	O	O	I-T116
transporter	O	O	I-T116
(vGAT)-	O	O	O
containing	O	O	B-T169
neurons	O	O	B-T025
or	O	O	O
their	O	O	O
projections	O	O	O
in	O	O	O
the	O	O	O
LH	O	O	B-T029
reduced	O	O	B-T080
food	O	O	B-T040
intake	O	O	I-T040
in	O	O	O
mice	O	O	B-T015
.	O	O	O

Consistently	O	O	O
,	O	O	O
chemogenetic	O	O	B-T169
inhibition	O	O	B-T052
of	O	O	O
septal	O	O	B-T082
vGAT	O	O	B-T116
neurons	O	O	B-T025
increased	O	O	B-T081
food	O	O	B-T040
intake	O	O	I-T040
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
a	O	O	O
previously	O	O	O
unknown	O	O	B-T080
neural	O	O	B-UnknownType
circuit	O	O	I-UnknownType
originating	O	O	B-T079
from	O	O	O
septal	O	O	B-T082
vGAT	O	O	B-T116
neurons	O	O	B-T025
to	O	O	O
a	O	O	O
subset	O	O	B-T185
of	O	O	O
vGAT	O	O	O
neurons	O	O	O
in	O	O	O
the	O	O	O
LH	O	O	B-T029
,	O	O	O
an	O	O	O
area	O	O	B-T082
involved	O	O	B-T169
in	O	O	O
homeostatic	O	O	B-T038
and	O	O	O
hedonic	O	O	B-T038
control	O	O	B-T080
of	O	O	O
energy	O	O	B-T033
states	O	O	I-T033
.	O	O	O

Collectively	O	O	O
,	O	O	O
our	O	O	O
data	O	O	B-T078
reveal	O	O	B-T080
an	O	O	O
inhibitory	O	O	B-T052
septohypothalamic	O	O	B-T029
feeding	O	O	B-UnknownType
circuit	O	O	I-UnknownType
that	O	O	O
might	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
therapeutic	O	O	B-T169
target	O	O	B-T169
for	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
eating	O	O	B-T048
disorders	O	O	I-T048
such	O	O	O
as	O	O	O
anorexia	O	O	B-T048
nervosa	O	O	I-T048
.	O	O	O

Our	O	O	O
results	O	O	O
demonstrate	O	O	O
that	O	O	O
top-down	O	O	O
projections	O	O	O
from	O	O	O
the	O	O	O
septum	O	O	B-UnknownType
to	O	O	O
the	O	O	O
hypothalamus	O	O	B-T023
control	O	O	B-T080
food	O	O	B-T040
intake	O	O	I-T040
negatively	O	O	B-T033
.	O	O	O

Given	O	O	O
the	O	O	O
known	O	O	O
role	O	O	O
for	O	O	O
both	O	O	O
of	O	O	O
these	O	O	O
brain	O	O	B-T029
regions	O	O	I-T029
in	O	O	O
the	O	O	O
control	O	O	B-T080
of	O	O	O
feeding	O	O	B-T055
and	O	O	O
emotion	O	O	B-T041
-	O	O	O
related	O	O	B-T169
behaviors	O	O	B-T053
,	O	O	O
these	O	O	O
findings	O	O	B-T033
reveal	O	O	B-T080
previously	O	O	O
unknown	O	O	B-T080
neural	O	O	B-UnknownType
circuitry	O	O	I-UnknownType
that	O	O	O
is	O	O	O
likely	O	O	O
implicated	O	O	O
in	O	O	O
emotional	O	O	B-T078
aspects	O	O	I-T078
of	O	O	O
food	O	O	B-T040
intake	O	O	I-T040
and	O	O	O
provide	O	O	B-T052
new	O	O	O
insights	O	O	B-T041
into	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
therapeutic	O	O	B-T169
targets	O	O	B-T169
for	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
eating	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

-DOCSTART- (27807796)

Human	O	O	B-T016
Umbilical	O	O	B-T031
Cord	O	O	I-T031
Blood	O	O	I-T031
-	O	O	O
Derived	O	O	B-T078
Neural	O	O	B-T025
Stem	O	O	I-T025
Cell	O	O	I-T025
Line	O	O	I-T025
as	O	O	O
a	O	O	O
Screening	O	O	B-T058
Model	O	O	B-T075
for	O	O	O
Toxicity	O	O	O

The	O	O	O
aim	O	O	B-T078
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
a	O	O	O
human	O	O	B-T016
neural	O	O	B-T025
stem	O	O	I-T025
cell	O	O	I-T025
(	O	O	O
NSC	O	O	B-T025
)	O	O	O
line	O	O	B-T025
derived	O	O	B-T078
from	O	O	O
human	O	O	O
umbilical	O	O	B-T031
cord	O	O	I-T031
blood	O	O	I-T031
(	O	O	O
hUCB	O	O	B-T031
)	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
for	O	O	O
toxicity	O	O	B-T037
study	O	O	B-T062
.	O	O	O

Toxicity	O	O	B-T037
of	O	O	O
both	O	O	O
neurotoxic	O	O	B-T131
environmental	O	O	B-T082
xenobiotics	O	O	B-T123
,	O	O	O
methyl	O	O	B-T109
mercury	O	O	I-T109
chloride	O	O	I-T109
(	O	O	O
CH3HgCl	O	O	B-T109
)	O	O	O
,	O	O	O
lead	O	O	B-T121
acetate	O	O	I-T121
(	O	O	O
CH3COOPb	O	O	B-T121
)	O	O	O
,	O	O	O
and	O	O	O
chlorpyrifos	O	O	B-T109
(	O	O	O
CP	O	O	B-T109
)	O	O	O
,	O	O	O
and	O	O	O
non-neurotoxic	O	O	B-T033
insecticide	O	O	B-T131
,	O	O	O
dichlorvos	O	O	B-T109
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
non-neurotoxic	O	O	O
drugs	O	O	B-T121
,	O	O	O
theophylline	O	O	B-T109
and	O	O	O
acetaminophen	O	O	B-T109
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

Additionally	O	O	O
,	O	O	O
differentiation	O	O	B-T169
of	O	O	O
neuronal	O	O	B-T129
and	O	O	O
glial	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
derived	O	O	B-T078
from	O	O	O
hUCB	O	O	B-T031
was	O	O	O
elucidated	O	O	O
.	O	O	O

It	O	O	O
was	O	O	O
observed	O	O	B-T169
that	O	O	O
CH3HgCl	O	O	B-T109
was	O	O	O
more	O	O	O
toxic	O	O	B-T080
to	O	O	O
human	O	O	B-T016
NSCs	O	O	B-T025
in	O	O	O
comparison	O	O	B-T052
to	O	O	O
CH3COOPb	O	O	B-T121
and	O	O	O
CP	O	O	B-T109
.	O	O	O

The	O	O	O
minimum	O	O	B-T034
inhibitory	O	O	I-T034
concentration	O	O	I-T034
(	O	O	I-T034
MIC	O	O	I-T034
)	O	O	I-T034
value	O	O	I-T034
against	O	O	O
NSCs	O	O	B-T025
was	O	O	O
3	O	O	O
,	O	O	O
10	O	O	O
,	O	O	O
and	O	O	O
300	O	O	O
mg/L	O	O	O
,	O	O	O
in	O	O	O
each	O	O	O
staining	O	O	B-T059
process	O	O	I-T059
,	O	O	O
acridine	O	O	B-T109
orange	O	O	I-T109
/	O	O	O
ethidium	O	O	B-T109
bromide	O	O	I-T109
(	O	O	O
AO	O	O	B-T109
/	O	O	O
EB	O	O	B-T109
)	O	O	O
staining	O	O	O
,	O	O	O
3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl	O	O	B-T109
tetrazolium	O	O	I-T109
bromide	O	O	I-T109
(	O	O	O
MTT	O	O	B-T109
)	O	O	O
assay	O	O	B-T059
,	O	O	O
and	O	O	O
Hoechst	O	O	B-T059
staining	O	O	I-T059
,	O	O	O
for	O	O	O
CH3HgCl	O	O	B-T109
,	O	O	O
CP	O	O	B-T109
,	O	O	O
and	O	O	O
CH3COOPb	O	O	B-T121
,	O	O	O
respectively	O	O	O
.	O	O	O

CH3HgCl	O	O	B-T109
had	O	O	O
the	O	O	O
LC25	O	O	B-T081
value	O	O	B-T080
as	O	O	O
10.0	O	O	O
,	O	O	O
14.4	O	O	O
,	O	O	O
and	O	O	O
12.7	O	O	O
mg/L	O	O	O
,	O	O	O
by	O	O	O
staining	O	O	B-T059
method	O	O	I-T059
mentioned	O	O	O
in	O	O	O
succession	O	O	O
.	O	O	O

CP	O	O	B-T109
had	O	O	O
the	O	O	O
LC25	O	O	B-T081
value	O	O	B-T080
as	O	O	O
21.9	O	O	O
,	O	O	O
23.7	O	O	O
,	O	O	O
and	O	O	O
18.4	O	O	O
mg/L	O	O	O
;	O	O	O
similarly	O	O	O
,	O	O	O
CH3COOPb	O	O	B-T121
had	O	O	O
LC25	O	O	O
values	O	O	B-T080
,	O	O	O
successively	O	O	O
as	O	O	O
616.9	O	O	O
,	O	O	O
719.2	O	O	O
,	O	O	O
and	O	O	O
890.3	O	O	O
mg/L.	O	O	O
LC50	O	O	B-T081
values	O	O	O
ranged	O	O	B-T081
from	O	O	O
18.2	O	O	O
to	O	O	O
21.7	O	O	O
mg/L	O	O	O
for	O	O	O
CH3HgCl	O	O	B-T109
,	O	O	O
56.4	O	O	O
to	O	O	O
60.2	O	O	O
mg/L	O	O	O
for	O	O	O
CP	O	O	O
,	O	O	O
and	O	O	O
1000	O	O	O
to	O	O	O
1460.1	O	O	O
for	O	O	O
CH3COOPb	O	O	O
.	O	O	O

Theophylline	O	O	B-T109
,	O	O	O
acetaminophen	O	O	B-T109
,	O	O	O
and	O	O	O
dichlorvos	O	O	B-T109
had	O	O	O
no	O	O	O
impact	O	O	B-T080
on	O	O	O
the	O	O	O
viability	O	O	B-T080
of	O	O	O
NSCs	O	O	B-T025
.	O	O	O

This	O	O	O
work	O	O	O
justified	O	O	O
that	O	O	O
hUCB	O	O	B-T031
-	O	O	O
NSC	O	O	B-T025
model	O	O	B-T075
can	O	O	O
be	O	O	O
used	O	O	O
for	O	O	O
toxicity	O	O	B-T037
study	O	O	B-T062
.	O	O	O

-DOCSTART- (27809747)

MiR	O	O	B-T028
221	O	O	I-T028
/	O	O	O
222	O	O	B-T028
as	O	O	O
new	O	O	O
players	O	O	O
in	O	O	O
tamoxifen	O	O	B-T109
resistance	O	O	O

Breast	O	O	B-T191
cancer	O	O	B-T191
is	O	O	O
the	O	O	O
most	O	O	O
frequent	O	O	O
cancer	O	O	O
in	O	O	O
women	O	O	B-T098
.	O	O	O

Despite	O	O	O
advances	O	O	O
in	O	O	O
early	O	O	B-T060
detection	O	O	I-T060
and	O	O	O
treatment	O	O	B-T061
,	O	O	O
it	O	O	O
has	O	O	O
the	O	O	O
second	O	O	O
highest	O	O	O
mortality	O	O	B-T081
rate	O	O	I-T081
after	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Around	O	O	O
85	O	O	O
%	O	O	O
of	O	O	O
breast	O	O	B-T191
carcinomas	O	O	I-T191
are	O	O	O
ER+	O	O	B-T033
;	O	O	O
thus	O	O	O
,	O	O	O
antiestrogens	O	O	B-T121
like	O	O	O
tamoxifen	O	O	B-T109
are	O	O	O
beneficial	O	O	O
.	O	O	O

Although	O	O	O
,	O	O	O
tamoxifen	O	O	B-T109
is	O	O	O
useful	O	O	O
for	O	O	O
many	O	O	O
patients	O	O	B-T101
,	O	O	O
plenty	O	O	O
of	O	O	O
patients	O	O	O
respond	O	O	B-T033
poorly	O	O	I-T033
to	O	O	O
initial	O	O	O
therapy	O	O	B-T061
or	O	O	O
recurrence	O	O	B-T067
occurs	O	O	O
in	O	O	O
about	O	O	O
30	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	O
,	O	O	O
because	O	O	O
tamoxifen	O	O	O
resistance	O	O	B-T038
happens	O	O	O
.	O	O	O

Drug	O	O	B-T038
resistance	O	O	B-T038
remains	O	O	O
a	O	O	O
major	O	O	O
clinical	O	O	B-T080
obstacle	O	O	O
to	O	O	O
successful	O	O	B-T201
treatment	O	O	I-T201
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
more	O	O	O
than	O	O	O
90	O	O	O
%	O	O	O
of	O	O	O
unsuccessful	O	O	B-T033
treatments	O	O	I-T033
are	O	O	O
because	O	O	O
of	O	O	O
acquired	O	O	B-T080
resistance	O	O	O
and	O	O	O
MultiDrug	O	O	B-T032
Resistance	O	O	I-T032
(	O	O	B-T032
MDR	O	O	I-T032
)	O	O	I-T032
is	O	O	O
a	O	O	O
major	O	O	O
contributor	O	O	O
.	O	O	O

MicroRNAs	O	O	B-T114
are	O	O	O
members	O	O	O
of	O	O	O
a	O	O	O
novel	O	O	O
class	O	O	O
of	O	O	O
short	O	O	O
noncoding	O	O	B-T114
RNAs	O	O	I-T114
.	O	O	O

Besides	O	O	O
to	O	O	O
their	O	O	O
various	O	O	O
roles	O	O	O
in	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
,	O	O	O
miRNAs	O	O	B-T114
are	O	O	O
considered	O	O	O
as	O	O	O
important	O	O	O
cancer	O	O	B-T191
therapeutic	O	O	B-T104
targets	O	O	I-T104
and	O	O	O
biomarkers	O	O	B-T201
.	O	O	O

Since	O	O	O
2005	O	O	O
,	O	O	O
when	O	O	O
miRNA	O	O	B-T114
deregulation	O	O	B-T052
was	O	O	O
first	O	O	O
reported	O	O	O
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
more	O	O	O
than	O	O	O
1000	O	O	O
reports	O	O	B-T170
have	O	O	O
been	O	O	O
published	O	O	O
about	O	O	O
miRNAs	O	O	B-T114
.	O	O	O

Increasing	O	O	O
number	O	O	O
of	O	O	O
studies	O	O	B-T062
showed	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
miRNAs	O	O	B-T114
in	O	O	O
antiestrogen	O	O	B-T061
therapy	O	O	I-T061
,	O	O	O
especially	O	O	O
on	O	O	O
tamoxifen	O	O	B-T109
;	O	O	O
thus	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
not	O	O	O
surprising	O	O	O
that	O	O	O
these	O	O	O
tiny	O	O	O
molecules	O	O	B-T167
are	O	O	O
involved	O	O	O
in	O	O	O
drug	O	O	B-T038
resistance	O	O	I-T038
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
pivotal	O	O	O
role	O	O	O
of	O	O	O
these	O	O	O
known	O	O	O
RNA	O	O	B-T114
molecules	O	O	I-T114
,	O	O	O
in	O	O	O
this	O	O	O
review	O	O	O
,	O	O	O
we	O	O	O
tried	O	O	O
to	O	O	O
illustrate	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
the	O	O	O
miRNAs	O	O	B-T114
as	O	O	O
a	O	O	O
new	O	O	O
player	O	O	O
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
pathogenesis	O	O	B-T046
.	O	O	O

We	O	O	O
have	O	O	O
also	O	O	O
focused	O	O	O
on	O	O	O
cancer	O	O	B-T191
drug	O	O	B-T038
resistance	O	O	I-T038
mechanisms	O	O	B-T169
highlighting	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
important	O	O	O
oncomirs	O	O	B-T114
,	O	O	O
miR	O	O	B-T028
221	O	O	I-T028
/	O	O	O
222	O	O	B-T028
,	O	O	O
involved	O	O	O
in	O	O	O
cell	O	O	B-T049
cycle	O	O	I-T049
deregulation	O	O	I-T049
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

The	O	O	O
relationship	O	O	O
between	O	O	O
these	O	O	O
oncomiRs	O	O	B-T114
with	O	O	O
resistance	O	O	B-T038
to	O	O	O
tamoxifen	O	O	B-T109
is	O	O	O
also	O	O	O
emphasized	O	O	B-T080
.	O	O	O

-DOCSTART- (27812000)

Ultra-low	O	O	B-T052
activities	O	O	I-T052
of	O	O	O
a	O	O	O
common	O	O	O
radioisotope	O	O	B-T196
for	O	O	O
permission	O	O	B-T080
-free	O	O	O
tracking	O	O	B-T082
of	O	O	O
a	O	O	O
drosophilid	O	O	B-T204
fly	O	O	I-T204
in	O	O	O
its	O	O	O
natural	O	O	O
habitat	O	O	O

Knowledge	O	O	O
of	O	O	O
a	O	O	O
species	O	O	B-T185
'	O	O	O
ecology	O	O	B-T090
,	O	O	O
including	O	O	O
its	O	O	O
movement	O	O	B-T040
in	O	O	O
time	O	O	B-T079
and	O	O	O
space	O	O	B-T082
,	O	O	O
is	O	O	O
key	O	O	O
for	O	O	O
many	O	O	O
questions	O	O	O
in	O	O	O
biology	O	O	B-T091
and	O	O	O
conservation	O	O	B-T080
.	O	O	O

While	O	O	O
numerous	O	O	O
tools	O	O	B-T073
for	O	O	O
tracking	O	O	B-T082
larger	O	O	O
animals	O	O	B-T008
are	O	O	O
available	O	O	O
,	O	O	O
millimetre-sized	O	O	B-T204
insects	O	O	I-T204
are	O	O	O
averse	O	O	O
to	O	O	O
standard	O	O	O
tracking	O	O	O
and	O	O	O
labelling	O	O	B-T062
procedures	O	O	I-T062
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
evaluated	O	O	O
the	O	O	O
applicability	O	O	O
of	O	O	O
ultra-low	O	O	B-T052
,	O	O	O
permission	O	O	B-T080
-	O	O	O
exempt	O	O	B-T052
activities	O	O	I-T052
of	O	O	O
the	O	O	O
metastable	O	O	B-T070
isomer	O	O	I-T070
of	O	O	O
the	O	O	O
radionuclide	O	O	B-T196
Technetium-99	O	O	B-T130
for	O	O	O
labelling	O	O	B-T062
and	O	O	O
field	O	O	B-T033
detection	O	O	I-T033
of	O	O	O
the	O	O	O
mountain	O	O	B-T083
fly	O	O	B-T204
Drosophila	O	O	B-T204
nigrosparsa	O	O	I-T204
.	O	O	O

We	O	O	O
demonstrate	O	O	O
that	O	O	O
an	O	O	O
activity	O	O	B-T052
of	O	O	O
less	O	O	O
than	O	O	O
10	O	O	O
MBq	O	O	O
is	O	O	O
sufficient	O	O	O
to	O	O	O
label	O	O	B-T062
dozens	O	O	O
of	O	O	O
flies	O	O	B-T204
and	O	O	O
detect	O	O	B-T033
single	O	O	I-T033
individuals	O	O	I-T033
using	O	O	O
standard	O	O	O
radiation	O	O	B-T061
protection	O	O	I-T061
monitors	O	O	B-T059
.	O	O	O

The	O	O	O
methodology	O	O	B-T078
presented	O	O	O
here	O	O	O
is	O	O	O
applicable	O	O	O
to	O	O	O
many	O	O	O
small-sized	O	O	B-T033
,	O	O	O
low-mobility	O	O	B-T033
animals	O	O	B-T008
as	O	O	O
well	O	O	O
as	O	O	O
independent	O	O	O
from	O	O	O
light	O	O	B-T070
and	O	O	O
weather	O	O	B-T070
conditions	O	O	B-T080
and	O	O	O
visual	O	O	B-T033
contact	O	O	I-T033
with	O	O	O
the	O	O	O
target	O	O	B-T169
organism	O	O	B-T001
.	O	O	O

-DOCSTART- (27813390)

Injury	O	O	B-T057
surveillance	O	O	I-T057
of	O	O	O
female	O	O	B-T032
adult	O	O	B-T100
Zumba	O	O	B-T058
®	O	O	O
dancers	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
patterns	O	O	B-T082
of	O	O	O
injury	O	O	B-T037
and	O	O	O
to	O	O	O
establish	O	O	O
the	O	O	O
injury	O	O	O
incidence	O	O	B-T081
rates	O	O	I-T081
associated	O	O	B-T080
with	O	O	O
Zumba	O	O	B-T058
®	O	O	O
.	O	O	O

Zumba	O	O	B-T058
®	O	O	O
dancers	O	O	B-T097
were	O	O	O
invited	O	O	O
to	O	O	O
complete	O	O	O
an	O	O	O
anonymous	O	O	O
web-based	O	O	B-T073
survey	O	O	B-T170
containing	O	O	O
13	O	O	O
demographic	O	O	B-T078
background	O	O	B-T077
and	O	O	O
14	O	O	O
(	O	O	O
1	O	O	O
yr	O	O	B-T079
retrospective	O	O	B-T080
)	O	O	O
injury	O	O	B-T037
history	O	O	B-T169
questions	O	O	B-T170
.	O	O	O

Inclusion	O	O	B-T080
criteria	O	O	B-T078
stated	O	O	O
that	O	O	O
the	O	O	O
respondents	O	O	B-T098
had	O	O	O
to	O	O	O
be	O	O	O
aged	O	O	B-T032
18	O	O	O
-	O	O	O
64	O	O	O
yr	O	O	B-T079
and	O	O	O
currently	O	O	O
involved	O	O	O
in	O	O	O
group	O	O	B-T098
-based	O	O	O
classes	O	O	B-T170
of	O	O	O
Zumba	O	O	B-T058
®	O	O	O
,	O	O	O
either	O	O	O
as	O	O	O
a	O	O	O
registered	O	O	B-T097
instructor	O	O	I-T097
or	O	O	O
class	O	O	B-T170
participant	O	O	B-T098
.	O	O	O

Binomial	O	O	B-UnknownType
logistic	O	O	I-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
was	O	O	O
used	O	O	O
to	O	O	O
predict	O	O	O
the	O	O	O
odds	O	O	B-T081
of	O	O	O
injury	O	O	B-T037
during	O	O	O
Zumba	O	O	B-T058
®	O	O	O
and	O	O	O
Mann-Whitney	O	O	B-T170
tests	O	O	I-T170
were	O	O	O
employed	O	O	O
to	O	O	O
ascertain	O	O	O
differences	O	O	O
between	O	O	O
groups	O	O	B-T098
.	O	O	O

The	O	O	O
survey	O	O	B-T170
response	O	O	B-T081
rate	O	O	I-T081
was	O	O	O
74	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
final	O	O	O
sample	O	O	O
of	O	O	O
respondents	O	O	B-T098
(	O	O	O
N	O	O	O
=	O	O	O
138	O	O	O
;	O	O	O
female	O	O	B-T032
=	O	O	O
100	O	O	O
%	O	O	O
)	O	O	O
included	O	O	O
19	O	O	O
registered	O	O	B-T097
instructors	O	O	I-T097
and	O	O	O
119	O	O	O
class	O	O	B-T170
participants	O	O	B-T098
,	O	O	O
of	O	O	O
which	O	O	O
58	O	O	O
%	O	O	O
and	O	O	O
16	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
sustained	O	O	B-T169
≥	O	O	O
1	O	O	O
injury	O	O	B-T037
during	O	O	O
Zumba	O	O	B-T058
®	O	O	O
in	O	O	O
the	O	O	O
past	O	O	O
year	O	O	B-T079
.	O	O	O

The	O	O	O
odds	O	O	B-T081
of	O	O	O
injury	O	O	B-T037
was	O	O	O
7	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
2	O	O	O
-	O	O	O
19	O	O	O
)	O	O	O
times	O	O	O
greater	O	O	B-T081
(	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
for	O	O	O
registered	O	O	B-T097
instructors	O	O	I-T097
than	O	O	O
for	O	O	O
class	O	O	B-T170
participants	O	O	B-T098
.	O	O	O

Zumba	O	O	B-T058
®	O	O	O
dancers	O	O	B-T097
had	O	O	O
a	O	O	O
17	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
7	O	O	O
-	O	O	O
28	O	O	O
)	O	O	O
%	O	O	O
greater	O	O	B-T081
(	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
odds	O	O	B-T081
of	O	O	O
injury	O	O	B-T037
for	O	O	O
every	O	O	O
1	O	O	O
h	O	O	B-T079
of	O	O	O
non-	O	O	O
Zumba	O	O	O
®	O	O	O
-	O	O	O
related	O	O	O
moderate	O	O	B-T056
to	O	O	I-T056
vigorous	O	O	I-T056
physical	O	O	I-T056
activity	O	O	I-T056
(	O	O	O
MVPA	O	O	B-T056
)	O	O	O
engagement	O	O	O
per	O	O	O
week	O	O	B-T079
.	O	O	O

The	O	O	O
injury	O	O	B-T037
incidence	O	O	B-T081
rate	O	O	I-T081
for	O	O	O
registered	O	O	B-T097
instructors	O	O	I-T097
and	O	O	O
class	O	O	B-T170
participants	O	O	B-T098
was	O	O	O
5.7	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
3.1	O	O	O
-	O	O	O
8.2	O	O	O
)	O	O	O
and	O	O	O
3.9	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
2.5	O	O	O
-	O	O	O
5.3	O	O	O
)	O	O	O
injuries	O	O	B-T037
per	O	O	O
1000	O	O	O
h	O	O	B-T079
of	O	O	O
exposure	O	O	B-T080
,	O	O	O
respectively	O	O	O
.	O	O	O

Zumba	O	O	B-T058
®	O	O	O
presents	O	O	O
a	O	O	O
low	O	O	B-T081
risk	O	O	I-T081
of	O	O	O
injury	O	O	B-T037
;	O	O	O
for	O	O	O
registered	O	O	B-T097
instructors	O	O	I-T097
,	O	O	O
the	O	O	O
increased	O	O	B-T080
risk	O	O	I-T080
of	O	O	O
injury	O	O	O
is	O	O	O
likely	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
high	O	O	O
total	O	O	O
volume	O	O	O
of	O	O	O
MVPA	O	O	B-T056
participated	O	O	B-T169
in	O	O	O
weekly	O	O	B-T079
.	O	O	O

-DOCSTART- (27818328)

Clinical	O	O	B-T080
Features	O	O	B-T080
of	O	O	O
Smokers	O	O	B-T033
With	O	O	O
Radiological	O	O	B-T060
Emphysema	O	O	B-T047
But	O	O	O
Without	O	O	O
Airway	O	O	B-T023
Limitation	O	O	O

The	O	O	O
clinical	O	O	B-T201
characteristics	O	O	I-T201
of	O	O	O
patients	O	O	B-T101
with	O	O	O
emphysema	O	O	B-T047
but	O	O	O
without	O	O	O
airway	O	O	B-T023
limitations	O	O	B-T169
remain	O	O	O
unknown	O	O	B-T080
.	O	O	O

The	O	O	O
goal	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
clinical	O	O	B-T080
features	O	O	B-T080
of	O	O	O
current	O	O	B-T033
and	O	O	O
former	O	O	B-T033
smokers	O	O	I-T033
without	O	O	O
airflow	O	O	B-T039
limitation	O	O	B-T169
who	O	O	O
have	O	O	O
radiologic	O	O	B-T060
emphysema	O	O	B-T047
on	O	O	O
chest	O	O	B-T060
CT	O	O	I-T060
scans	O	O	I-T060
vs	O	O	O
a	O	O	O
control	O	O	B-T096
group	O	O	I-T096
of	O	O	O
current	O	O	O
and	O	O	O
ex-smokers	O	O	B-T033
without	O	O	O
emphysema	O	O	O
.	O	O	O

Subjects	O	O	B-T096
enrolled	O	O	O
had	O	O	O
anthropometric	O	O	B-T060
characteristics	O	O	I-T060
recorded	O	O	O
,	O	O	O
provided	O	O	B-T052
a	O	O	O
medical	O	O	B-T033
history	O	O	I-T033
,	O	O	O
and	O	O	O
underwent	O	O	O
low-dose	O	O	B-T081
chest	O	O	B-T060
CT	O	O	I-T060
scanning	O	O	I-T060
.	O	O	O

The	O	O	O
following	O	O	O
parameters	O	O	B-T033
were	O	O	O
also	O	O	O
evaluated	O	O	O
:	O	O	O
pulmonary	O	O	B-T060
function	O	O	I-T060
tests	O	O	I-T060
including	O	O	O
diffusion	O	O	B-T060
capacity	O	O	I-T060
for	O	O	I-T060
carbon	O	O	I-T060
monoxide	O	O	I-T060
(	O	O	O
Dlco	O	O	B-T060
)	O	O	O
,	O	O	O
the	O	O	O
modified	O	O	O
Medical	O	O	B-T170
Research	O	O	I-T170
Council	O	O	I-T170
dyspnea	O	O	I-T170
score	O	O	I-T170
,	O	O	O
COPD	O	O	B-T170
assessment	O	O	I-T170
test	O	O	I-T170
(	O	O	O
CAT	O	O	B-T170
)	O	O	O
,	O	O	O
and	O	O	O
6-min	O	O	B-T060
walk	O	O	I-T060
test	O	O	I-T060
(	O	O	O
6MWT	O	O	B-T060
)	O	O	O
.	O	O	O

A	O	O	O
comparison	O	O	B-T052
was	O	O	O
conducted	O	O	O
between	O	O	O
those	O	O	O
with	O	O	O
and	O	O	O
without	O	O	O
CT	O	O	B-T060
-	O	O	O
confirmed	O	O	B-T033
emphysema	O	O	B-T047
.	O	O	O

Of	O	O	O
the	O	O	O
203	O	O	O
subjects	O	O	B-T096
,	O	O	O
154	O	O	O
had	O	O	O
emphysema	O	O	B-T047
,	O	O	O
and	O	O	O
49	O	O	O
did	O	O	O
not	O	O	O
.	O	O	O

Adjusted	O	O	O
group	O	O	B-T098
comparisons	O	O	B-T052
revealed	O	O	B-T080
that	O	O	O
a	O	O	O
higher	O	O	O
proportion	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
with	O	O	O
emphysema	O	O	B-T047
according	O	O	O
to	O	O	O
low-dose	O	O	B-T081
chest	O	O	B-T060
CT	O	O	I-T060
scanning	O	O	I-T060
had	O	O	O
an	O	O	O
abnormal	O	O	B-T033
Dlco	O	O	I-T033
value	O	O	B-T081
(	O	O	O
<	O	O	O
80	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
46	O	O	O
%	O	O	O
vs	O	O	O
19	O	O	O
%	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.02	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
decrease	O	O	B-T081
in	O	O	O
percentage	O	O	B-T081
of	O	O	O
oxygen	O	O	B-T044
saturation	O	O	I-T044
>	O	O	O
4	O	O	O
%	O	O	O
during	O	O	O
the	O	O	O
6MWT	O	O	B-T060
(	O	O	O
8.5	O	O	O
%	O	O	O
vs	O	O	O
0	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.04	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
an	O	O	O
altered	O	O	B-T169
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
(	O	O	O
CAT	O	O	B-T170
score	O	O	B-T081
≥	O	O	O
10	O	O	O
)	O	O	O
(	O	O	O
32	O	O	O
%	O	O	O
vs	O	O	O
14	O	O	O
%	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.01	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
detailed	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
CAT	O	O	B-T170
questionnaire	O	O	I-T170
items	O	O	O
revealed	O	O	B-T080
that	O	O	O
more	O	O	O
patients	O	O	B-T101
with	O	O	O
emphysema	O	O	B-T047
had	O	O	O
a	O	O	O
score	O	O	B-T081
≥	O	O	O
1	O	O	O
in	O	O	O
the	O	O	O
"	O	O	O
chest	O	O	B-T184
tightness	O	O	I-T184
"	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
.05	O	O	O
)	O	O	O
and	O	O	O
"	O	O	O
limitation	O	O	B-T169
when	O	O	O
doing	O	O	O
activities	O	O	B-T052
at	O	O	O
home	O	O	B-T082
"	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
items	O	O	O
compared	O	O	B-T052
with	O	O	O
those	O	O	O
with	O	O	O
no	O	O	B-T033
emphysema	O	O	I-T033
.	O	O	O

They	O	O	O
also	O	O	O
experienced	O	O	O
significantly	O	O	O
more	O	O	O
exacerbations	O	O	B-T033
in	O	O	O
the	O	O	O
previous	O	O	O
year	O	O	B-T079
(	O	O	O
0.19	O	O	O
vs	O	O	O
0.04	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.02	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
significant	O	O	B-T078
proportion	O	O	B-T081
of	O	O	O
smokers	O	O	B-T033
with	O	O	O
emphysema	O	O	B-T047
according	O	O	O
to	O	O	O
low-dose	O	O	B-T081
chest	O	O	B-T060
CT	O	O	I-T060
scanning	O	O	I-T060
but	O	O	O
without	O	O	O
airway	O	O	B-T023
limitation	O	O	B-T169
had	O	O	O
alterations	O	O	B-T078
in	O	O	O
their	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
,	O	O	O
number	O	O	O
of	O	O	O
exacerbations	O	O	B-T033
,	O	O	O
Dlco	O	O	B-T060
values	O	O	B-T081
,	O	O	O
and	O	O	O
oxygen	O	O	B-T044
saturation	O	O	I-T044
during	O	O	O
the	O	O	O
6MWT	O	O	B-T060
test	O	O	I-T060
.	O	O	O

-DOCSTART- (27819344)

Anti-tumor	O	O	B-T042
activity	O	O	I-T042
of	O	O	O
SL4	O	O	B-T109
against	O	O	O
breast	O	O	B-T025
cancer	O	O	I-T025
cells	O	O	I-T025
:	O	O	O
induction	O	O	B-T169
of	O	O	O
G2/M	O	O	B-T044
arrest	O	O	I-T044
through	O	O	O
modulation	O	O	B-UnknownType
of	O	O	O
the	O	O	O
MAPK	O	O	B-T116
-dependent	O	O	O
p21	O	O	B-T116
signaling	O	O	O
pathway	O	O	O

SL4	O	O	B-T109
,	O	O	O
a	O	O	O
chalcone	O	O	B-T109
-based	O	O	O
compound	O	O	B-T103
,	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
retard	O	O	B-T080
tumor	O	O	B-T033
invasion	O	O	I-T033
and	O	O	O
angiogenesis	O	O	B-T191
by	O	O	O
suppressing	O	O	B-T169
HIF1	O	O	B-T116
activity	O	O	B-T052
and	O	O	O
to	O	O	O
induce	O	O	B-T169
apoptosis	O	O	B-T043
by	O	O	O
promoting	O	O	B-T052
ROS	O	O	B-T123
release	O	O	B-T169
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	B-T170
that	O	O	O
SL4	O	O	B-T109
is	O	O	O
able	O	O	O
to	O	O	O
inhibit	O	O	B-T052
the	O	O	O
proliferation	O	O	B-T043
of	O	O	O
different	O	O	B-T080
types	O	O	B-T080
of	O	O	O
breast	O	O	B-T025
cancer	O	O	I-T025
cell	O	O	I-T025
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
by	O	O	O
inducing	O	O	B-T169
G2/M	O	O	B-T044
cell	O	O	I-T044
cycle	O	O	I-T044
arrest	O	O	I-T044
.	O	O	O

Our	O	O	O
results	O	O	B-T033
showed	O	O	O
that	O	O	O
SL4	O	O	B-T109
exhibited	O	O	B-T169
strong	O	O	B-T080
anti-proliferative	O	O	B-T109
activity	O	O	B-T052
in	O	O	O
several	O	O	O
human	O	O	B-T016
breast	O	O	B-T191
cancer	O	O	I-T191
cell	O	O	B-T025
lines	O	O	I-T025
,	O	O	O
with	O	O	O
IC50	O	O	B-T081
values	O	O	I-T081
lower	O	O	B-T052
than	O	O	O
1.3	O	O	O
μM.	O	O	O
Further	O	O	O
studies	O	O	B-T062
indicated	O	O	B-T033
that	O	O	O
SL4	O	O	O
induced	O	O	B-T169
G2/M	O	O	B-T044
arrest	O	O	I-T044
in	O	O	O
these	O	O	O
cell	O	O	O
lines	O	O	O
.	O	O	O

Mechanistically	O	O	B-T022
,	O	O	O
SL4	O	O	B-T109
reduces	O	O	B-T080
the	O	O	O
expression	O	O	B-T045
of	O	O	O
cyclin	O	O	B-T116
A2	O	O	I-T116
and	O	O	O
cdc25C	O	O	B-T116
and	O	O	O
decreases	O	O	B-T081
the	O	O	O
activity	O	O	B-T044
of	O	O	O
the	O	O	O
cdc2	O	O	B-T116
/	O	O	O
cyclin	O	O	B-T116
B1	O	O	I-T116
complex	O	O	B-T104
.	O	O	O

Notably	O	O	O
,	O	O	O
SL4	O	O	B-T109
treatment	O	O	B-T061
resulted	O	O	B-T169
in	O	O	I-T169
an	O	O	O
obvious	O	O	O
increase	O	O	B-T169
in	O	O	O
p21	O	O	B-T028
mRNA	O	O	B-T114
and	O	O	O
protein	O	O	B-T116
levels	O	O	B-T080
through	O	O	O
activation	O	O	B-T043
of	O	O	O
MAPK	O	O	B-T043
signaling	O	O	I-T043
pathways	O	O	I-T043
,	O	O	O
but	O	O	O
not	O	O	O
the	O	O	O
TGF-β	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

SP600125	O	O	B-T109
and	O	O	O
PD98059	O	O	B-T109
,	O	O	O
specific	O	O	O
inhibitors	O	O	B-T120
of	O	O	O
JNK	O	O	B-T116
kinase	O	O	I-T116
and	O	O	O
ERK	O	O	B-T116
kinase	O	O	I-T116
,	O	O	O
significantly	O	O	B-T078
blocked	O	O	B-T169
the	O	O	O
SL4	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
G2/M	O	O	B-T044
phase	O	O	I-T044
arrest	O	O	I-T044
and	O	O	O
upregulation	O	O	B-T044
of	O	O	O
p21	O	O	B-T116
.	O	O	O

Furthermore	O	O	O
,	O	O	O
SL4	O	O	B-T109
suppressed	O	O	B-T169
the	O	O	O
growth	O	O	B-T043
of	O	O	O
established	O	O	B-T080
breast	O	O	B-T191
tumors	O	O	I-T191
in	O	O	O
nude	O	O	B-T015
mice	O	O	I-T015
through	O	O	O
upregulation	O	O	B-T044
of	O	O	O
p21	O	O	B-T116
and	O	O	O
downregulation	O	O	B-T044
of	O	O	O
cdc25C	O	O	B-T116
,	O	O	O
and	O	O	O
displayed	O	O	B-T169
a	O	O	O
good	O	O	O
safety	O	O	B-T068
profile	O	O	B-T169
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
these	O	O	O
findings	O	O	B-T033
demonstrate	O	O	B-T080
the	O	O	O
potential	O	O	B-T080
value	O	O	B-T080
of	O	O	O
SL4	O	O	B-T109
as	O	O	O
a	O	O	O
novel	O	O	O
multi-target	O	O	B-T109
anti-tumor	O	O	I-T109
drug	O	O	I-T109
candidate	O	O	I-T109
.	O	O	O

-DOCSTART- (27820857)

Identification	O	O	B-T080
of	O	O	O
In-Chain-Functionalized	O	O	B-T103
Compounds	O	O	I-T103
and	O	O	O
Methyl-Branched	O	O	B-T109
Alkanes	O	O	I-T109
in	O	O	O
Cuticular	O	O	B-T002
Waxes	O	O	B-T122
of	O	O	O
Triticum	O	O	O
aestivum	O	O	O
cv	O	O	O
.	O	O	O
Bethlehem	O	O	O

Bethlehem	O	O	O
In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
cuticular	O	O	B-T002
waxes	O	O	B-T122
from	O	O	O
flag	O	O	B-T002
leaf	O	O	I-T002
blades	O	O	B-T002
and	O	O	O
peduncles	O	O	B-T002
of	O	O	O
Triticum	O	O	O
aestivum	O	O	O
cv	O	O	O
.	O	O	O

Bethlehem	O	O	O
were	O	O	O
investigated	O	O	B-T169
in	O	O	O
search	O	O	O
for	O	O	O
novel	O	O	B-T080
wax	O	O	B-T122
compounds	O	O	I-T122
.	O	O	O

Seven	O	O	O
wax	O	O	B-T122
compound	O	O	I-T122
classes	O	O	B-T185
were	O	O	O
detected	O	O	B-T033
that	O	O	O
had	O	O	O
previously	O	O	O
not	O	O	O
been	O	O	O
reported	O	O	O
,	O	O	O
and	O	O	O
their	O	O	O
structures	O	O	B-T170
were	O	O	O
elucidated	O	O	O
using	O	O	O
gas	O	O	B-T059
chromatography-mass	O	O	I-T059
spectrometry	O	O	I-T059
of	O	O	O
various	O	O	O
derivatives	O	O	B-T104
.	O	O	O

Six	O	O	O
of	O	O	O
the	O	O	O
classes	O	O	O
were	O	O	O
identified	O	O	O
as	O	O	O
series	O	O	B-T081
of	O	O	I-T081
homologs	O	O	I-T081
differing	O	O	B-T080
by	O	O	O
two	O	O	B-T104
methylene	O	O	I-T104
units	O	O	I-T104
,	O	O	O
while	O	O	O
the	O	O	O
seventh	O	O	O
was	O	O	O
a	O	O	O
homologous	O	O	B-T081
series	O	O	I-T081
with	O	O	O
homologs	O	O	B-T104
with	O	O	I-T104
single	O	O	I-T104
methylene	O	O	I-T104
unit	O	O	I-T104
differences	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
waxes	O	O	B-T122
of	O	O	O
flag	O	O	B-T002
leaf	O	O	I-T002
blades	O	O	B-T002
,	O	O	O
secondary	O	O	B-UnknownType
alcohols	O	O	I-UnknownType
(	O	O	O
predominantly	O	O	B-T080
C27	O	O	B-UnknownType
and	O	O	O
C33	O	O	B-UnknownType
)	O	O	O
,	O	O	O
primary	O	O	B-T109
/	O	O	O
secondary	O	O	B-T109
diols	O	O	I-T109
(	O	O	O
predominantly	O	O	O
C28	O	O	B-T109
)	O	O	O
and	O	O	O
esters	O	O	B-T109
of	O	O	I-T109
primary	O	O	I-T109
/	O	O	O
secondary	O	O	O
diols	O	O	O
(	O	O	O
predominantly	O	O	O
C50	O	O	B-T109
,	O	O	O
combining	O	O	O
C28	O	O	B-T109
diol	O	O	I-T109
with	O	O	O
C22	O	O	B-T109
acid	O	O	I-T109
)	O	O	O
were	O	O	O
found	O	O	O
,	O	O	O
all	O	O	O
sharing	O	O	O
similar	O	O	O
secondary	O	O	B-T104
hydroxyl	O	O	I-T104
group	O	O	I-T104
positions	O	O	I-T104
at	O	O	O
and	O	O	O
around	O	O	O
C-12	O	O	O
or	O	O	O
ω-12	O	O	O
.	O	O	O

7-	O	O	B-T109
and	O	O	O
8-hydroxy-2-alkanol	O	O	B-T109
esters	O	O	I-T109
(	O	O	O
predominantly	O	O	B-T080
C35	O	O	B-T109
)	O	O	O
,	O	O	O
7-	O	O	O
and	O	O	O
8-oxo-2-alkanol	O	O	B-T109
esters	O	O	I-T109
(	O	O	O
predominantly	O	O	O
C35	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
4-alkylbutan-4-olides	O	O	B-T109
(	O	O	O
predominantly	O	O	O
C28	O	O	B-T109
)	O	O	O
were	O	O	O
found	O	O	O
both	O	O	O
in	O	O	O
flag	O	O	B-T002
leaf	O	O	I-T002
and	O	O	O
peduncle	O	O	B-T002
wax	O	O	B-T122
mixtures	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
a	O	O	O
series	O	O	B-T081
of	O	O	O
even	O	O	B-T104
-	O	O	O
and	O	O	O
odd-numbered	O	O	B-T104
alkane	O	O	I-T104
homologs	O	O	I-T104
was	O	O	O
identified	O	O	O
in	O	O	O
both	O	O	O
leaf	O	O	B-T002
and	O	O	O
peduncle	O	O	B-T002
waxes	O	O	B-T122
,	O	O	O
with	O	O	O
an	O	O	O
internal	O	O	B-T104
methyl	O	O	I-T104
branch	O	O	I-T104
preferentially	O	O	O
on	O	O	O
C-11	O	O	B-T109
and	O	O	O
C-13	O	O	B-T109
of	O	O	I-T109
homologs	O	O	I-T109
with	O	O	I-T109
even	O	O	I-T109
total	O	O	I-T109
carbon	O	O	I-T109
number	O	O	I-T109
and	O	O	O
on	O	O	O
C-12	O	O	B-T109
of	O	O	I-T109
odd-numbered	O	O	I-T109
homologs	O	O	I-T109
.	O	O	O

Biosynthetic	O	O	B-T044
pathways	O	O	I-T044
are	O	O	O
suggested	O	O	O
for	O	O	O
all	O	O	O
compounds	O	O	B-T080
,	O	O	O
based	O	O	O
on	O	O	O
common	O	O	O
structural	O	O	B-T170
features	O	O	B-T080
and	O	O	O
matching	O	O	O
chain	O	O	B-T081
length	O	O	I-T081
profiles	O	O	B-T169
with	O	O	O
other	O	O	O
wheat	O	O	B-T002
wax	O	O	B-T122
compound	O	O	I-T122
classes	O	O	O
.	O	O	O

-DOCSTART- (27821359)

Pupillary	O	O	B-T040
response	O	O	I-T040
abnormalities	O	O	B-T033
in	O	O	O
depressive	O	O	O
disorders	O	O	O

Depressive	O	O	B-T048
disorders	O	O	I-T048
lack	O	O	B-T080
objective	O	O	B-T080
physiological	O	O	B-T169
measurements	O	O	B-T169
to	O	O	O
characterize	O	O	B-T052
the	O	O	O
affected	O	O	B-T201
population	O	O	I-T201
and	O	O	O
facilitate	O	O	O
study	O	O	B-T062
of	O	O	O
relevant	O	O	B-T080
mechanisms	O	O	B-T169
.	O	O	O

The	O	O	O
melanopsin	O	O	B-T116
-	O	O	O
mediated	O	O	B-T041
light	O	O	B-T044
signaling	O	O	I-T044
pathway	O	O	I-T044
may	O	O	O
contribute	O	O	O
to	O	O	O
seasonal	O	O	B-T079
variation	O	O	I-T079
and	O	O	O
can	O	O	O
be	O	O	O
measured	O	O	B-T080
non-invasively	O	O	O
by	O	O	O
pupillometry	O	O	B-T060
.	O	O	O

We	O	O	O
prospectively	O	O	B-T062
studied	O	O	I-T062
changes	O	O	O
in	O	O	O
melanopsin	O	O	B-T116
-	O	O	O
mediated	O	O	B-T041
pupillary	O	O	B-T042
constriction	O	O	I-T042
in	O	O	O
19	O	O	O
participants	O	O	B-T101
with	O	O	O
major	O	O	B-T048
depressive	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
MDD	O	O	B-T048
)	O	O	O
and	O	O	O
10	O	O	O
control	O	O	B-T096
across	O	O	O
the	O	O	O
summer	O	O	B-T079
and	O	O	I-T079
winter	O	O	I-T079
solstices	O	O	I-T079
.	O	O	O

The	O	O	O
melanopsin	O	O	B-T116
-	O	O	O
mediated	O	O	B-T041
response	O	O	I-T041
,	O	O	O
as	O	O	O
measured	O	O	B-T080
by	O	O	O
the	O	O	O
pupil	O	O	B-T033
's	O	O	I-T033
sustained	O	O	I-T033
constriction	O	O	I-T033
six	O	O	O
s	O	O	O
after	O	O	O
a	O	O	O
high	O	O	B-UnknownType
intensity	O	O	I-UnknownType
blue	O	O	B-T070
light	O	O	I-T070
stimulus	O	O	B-T067
,	O	O	O
was	O	O	O
marginally	O	O	O
attenuated	O	O	B-T052
in	O	O	O
those	O	O	O
with	O	O	O
MDD	O	O	B-T048
relative	O	O	O
to	O	O	O
controls	O	O	B-T096
(	O	O	O
p	O	O	B-T081
=	O	O	O
0.071	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
participants	O	O	B-T101
with	O	O	O
MDD	O	O	B-T048
unexpectedly	O	O	O
showed	O	O	O
a	O	O	O
significantly	O	O	B-T078
reduced	O	O	B-T080
transient	O	O	B-T079
pupillary	O	O	B-T040
response	O	O	I-T040
to	O	O	O
low	O	O	B-UnknownType
intensity	O	O	I-UnknownType
red	O	O	B-T070
(	O	O	O
p	O	O	B-T081
=	O	O	O
0.011	O	O	O
)	O	O	O
and	O	O	O
blue	O	O	B-T070
light	O	O	I-T070
(	O	O	O
p	O	O	O
=	O	O	O
0.013	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
high	O	O	B-UnknownType
intensity	O	O	I-UnknownType
red	O	O	O
and	O	O	O
blue	O	O	O
light	O	O	O
.	O	O	O

Sustained	O	O	O
pupillary	O	O	B-T042
constriction	O	O	I-T042
in	O	O	O
response	O	O	B-T040
to	O	O	O
high	O	O	B-UnknownType
intensity	O	O	I-UnknownType
blue	O	O	B-T070
light	O	O	I-T070
was	O	O	O
more	O	O	O
pronounced	O	O	O
with	O	O	O
increasing	O	O	B-T169
daylight	O	O	B-T070
hours	O	O	B-T079
(	O	O	O
p	O	O	B-T081
=	O	O	O
0.037	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
more	O	O	O
strongly	O	O	O
related	O	O	O
to	O	O	O
objectively	O	O	B-T080
measured	O	O	B-T080
versus	O	O	O
estimated	O	O	B-T081
light	O	O	B-T051
exposure	O	O	I-T051
.	O	O	O

Melanopsin	O	O	B-T116
-	O	O	O
mediated	O	O	B-T041
impairments	O	O	B-T169
in	O	O	O
pupil	O	O	B-T040
response	O	O	I-T040
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
biological	O	O	B-T201
marker	O	O	I-T201
for	O	O	O
vulnerability	O	O	B-T033
to	O	O	O
depression	O	O	B-T048
in	O	O	O
low	O	O	B-UnknownType
light	O	O	I-UnknownType
conditions	O	O	B-T080
.	O	O	O

Assessment	O	O	B-T058
of	O	O	O
these	O	O	O
and	O	O	O
other	O	O	O
responses	O	O	B-T032
to	O	O	O
light	O	O	B-T070
stimuli	O	O	B-T067
,	O	O	O
such	O	O	O
as	O	O	O
response	O	O	B-T032
to	O	O	O
low	O	O	B-UnknownType
intensity	O	O	I-UnknownType
light	O	O	I-UnknownType
,	O	O	O
may	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
the	O	O	O
study	O	O	B-T062
of	O	O	O
the	O	O	O
neurobiology	O	O	B-T091
of	O	O	O
MDD	O	O	B-T048
and	O	O	O
related	O	O	O
mood	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

-DOCSTART- (27821419)

Long	O	O	B-T114
Noncoding	O	O	I-T114
RNAs	O	O	I-T114
in	O	O	O
Cardiovascular	O	O	B-T047
Pathology	O	O	I-T047
,	O	O	O
Diagnosis	O	O	B-T062
,	O	O	O
and	O	O	O
Therapy	O	O	O

Vast	O	O	O
parts	O	O	O
of	O	O	O
mammalian	O	O	B-T015
genomes	O	O	B-T028
encode	O	O	B-T052
for	O	O	O
transcripts	O	O	B-T114
that	O	O	O
are	O	O	O
not	O	O	O
further	O	O	O
translated	O	O	B-T045
into	O	O	I-T045
proteins	O	O	I-T045
.	O	O	O

The	O	O	O
purpose	O	O	B-T169
of	O	O	O
the	O	O	O
majority	O	O	B-T080
of	O	O	O
such	O	O	O
noncoding	O	O	B-T114
ribonucleic	O	O	I-T114
acids	O	O	I-T114
(	O	O	B-T114
RNAs	O	O	I-T114
)	O	O	I-T114
remained	O	O	O
paradoxical	O	O	B-T080
for	O	O	O
a	O	O	O
long	O	O	O
time	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
a	O	O	O
growing	O	O	B-T169
body	O	O	O
of	O	O	O
evidence	O	O	B-T078
demonstrates	O	O	B-T052
that	O	O	O
long	O	O	B-T114
noncoding	O	O	I-T114
RNAs	O	O	I-T114
are	O	O	O
dynamically	O	O	B-T169
expressed	O	O	B-T045
in	O	O	O
different	O	O	B-T080
cell	O	O	B-T025
types	O	O	I-T025
,	O	O	O
diseases	O	O	B-T047
,	O	O	O
or	O	O	O
developmental	O	O	B-T079
stages	O	O	I-T079
to	O	O	O
execute	O	O	B-T052
a	O	O	O
wide	O	O	B-T077
variety	O	O	I-T077
of	O	O	O
regulatory	O	O	B-T077
roles	O	O	I-T077
at	O	O	O
virtually	O	O	B-T080
every	O	O	O
step	O	O	B-T077
of	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
translation	O	O	B-T045
.	O	O	O

Indeed	O	O	O
,	O	O	O
long	O	O	B-T114
noncoding	O	O	I-T114
RNAs	O	O	I-T114
influence	O	O	B-T077
gene	O	O	B-T045
expression	O	O	I-T045
via	O	O	O
epigenetic	O	O	B-T045
modulations	O	O	I-T045
,	O	O	O
through	O	O	O
regulating	O	O	B-T045
alternative	O	O	B-T045
splicing	O	O	I-T045
,	O	O	O
or	O	O	O
by	O	O	O
acting	O	O	O
as	O	O	O
molecular	O	O	B-T080
sponges	O	O	I-T080
.	O	O	O

The	O	O	O
abundance	O	O	B-T080
of	O	O	O
long	O	O	B-T114
noncoding	O	O	I-T114
RNAs	O	O	I-T114
in	O	O	O
the	O	O	O
cardiovascular	O	O	B-T022
system	O	O	I-T022
indicates	O	O	O
that	O	O	O
they	O	O	O
may	O	O	O
be	O	O	O
part	O	O	O
of	O	O	O
a	O	O	O
complex	O	O	B-T080
regulatory	O	O	B-T044
network	O	O	I-T044
governing	O	O	B-T067
physiology	O	O	B-T039
and	O	O	O
pathology	O	O	B-T046
of	O	O	O
the	O	O	O
heart	O	O	B-T023
.	O	O	O

In	O	O	O
this	O	O	O
review	O	O	O
,	O	O	O
we	O	O	O
discuss	O	O	O
the	O	O	O
multifaceted	O	O	B-T082
functions	O	O	B-T169
of	O	O	O
long	O	O	B-T114
noncoding	O	O	I-T114
RNAs	O	O	I-T114
and	O	O	O
highlight	O	O	O
the	O	O	O
current	O	O	B-T170
literature	O	O	I-T170
with	O	O	O
an	O	O	O
emphasis	O	O	O
on	O	O	O
cardiac	O	O	B-T039
development	O	O	I-T039
and	O	O	O
disease	O	O	B-T047
.	O	O	O

Furthermore	O	O	B-T082
,	O	O	O
as	O	O	O
the	O	O	O
enormous	O	O	B-T080
spectrum	O	O	O
of	O	O	O
long	O	O	B-T114
noncoding	O	O	I-T114
RNAs	O	O	I-T114
potentially	O	O	B-T080
opens	O	O	O
up	O	O	O
new	O	O	O
avenues	O	O	B-T082
for	O	O	O
diagnosis	O	O	B-T062
and	O	O	O
prevention	O	O	B-T061
of	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
,	O	O	O
we	O	O	O
ultimately	O	O	O
evaluate	O	O	O
the	O	O	O
futuristic	O	O	B-T079
prospects	O	O	I-T079
of	O	O	O
long	O	O	O
noncoding	O	O	O
RNAs	O	O	O
as	O	O	O
biomarkers	O	O	B-T201
,	O	O	O
and	O	O	O
therapeutic	O	O	B-T169
targets	O	O	B-T114
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
cardiovascular	O	O	B-T047
disorders	O	O	I-T047
,	O	O	O
as	O	O	O
well	O	O	O
.	O	O	O

-DOCSTART- (27822189)

Flexible	O	O	B-T080
Coordination	O	O	B-T169
of	O	O	O
Stationary	O	O	B-T080
and	O	O	O
Mobile	O	O	B-T169
Conversations	O	O	B-T054
with	O	O	O
Gaze	O	O	B-T033
:	O	O	O
Resource	O	O	B-T081
Allocation	O	O	I-T081
among	O	O	O
Multiple	O	O	O
Joint	O	O	O
Activities	O	O	O

Gaze	O	O	B-T033
is	O	O	O
instrumental	O	O	O
in	O	O	O
coordinating	O	O	B-T169
face-to-face	O	O	B-T169
social	O	O	B-T033
interactions	O	O	I-T033
.	O	O	O

But	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
gaze	O	O	B-T033
use	O	O	O
when	O	O	O
social	O	O	B-T033
interactions	O	O	I-T033
co-occur	O	O	B-T052
with	O	O	O
other	O	O	O
joint	O	O	B-T056
activities	O	O	I-T056
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
the	O	O	O
case	O	O	O
of	O	O	O
walking	O	O	B-T056
while	O	O	O
talking	O	O	B-T056
.	O	O	O

We	O	O	O
assessed	O	O	B-T052
how	O	O	O
gaze	O	O	B-T033
gets	O	O	O
allocated	O	O	B-T052
among	O	O	O
various	O	O	O
targets	O	O	B-T098
in	O	O	O
mobile	O	O	B-T169
conversations	O	O	B-T054
,	O	O	O
whether	O	O	O
allocation	O	O	B-T052
of	O	O	O
gaze	O	O	O
to	O	O	O
other	O	O	O
targets	O	O	O
affects	O	O	B-T041
conversational	O	O	B-T054
coordination	O	O	B-T169
,	O	O	O
and	O	O	O
whether	O	O	O
reduced	O	O	B-T080
availability	O	O	B-T169
of	O	O	I-T169
gaze	O	O	O
for	O	O	O
conversational	O	O	O
coordination	O	O	O
affects	O	O	O
conversational	O	O	O
performance	O	O	B-T055
and	O	O	O
content	O	O	B-T077
.	O	O	O

In	O	O	O
an	O	O	O
experimental	O	O	B-T062
study	O	O	I-T062
,	O	O	O
pairs	O	O	O
were	O	O	O
videotaped	O	O	B-T073
in	O	O	O
four	O	O	O
conditions	O	O	B-T080
of	O	O	O
mobility	O	O	B-T033
(	O	O	O
standing	O	O	B-T082
still	O	O	I-T082
,	O	O	O
talking	O	O	B-T056
while	O	O	O
walking	O	O	B-T056
along	O	O	I-T060
a	O	O	I-T060
straight-line	O	O	I-T060
itinerary	O	O	I-T060
,	O	O	O
talking	O	O	O
while	O	O	O
walking	O	O	O
along	O	O	O
a	O	O	O
complex	O	O	B-T080
itinerary	O	O	I-T080
,	O	O	O
or	O	O	O
walking	O	O	O
along	O	O	O
a	O	O	O
complex	O	O	O
itinerary	O	O	O
with	O	O	O
no	O	O	B-T033
conversational	O	O	I-T033
task	O	O	B-T057
)	O	O	O
.	O	O	O

Gaze	O	O	B-T033
to	O	O	O
partners	O	O	B-T098
was	O	O	O
substantially	O	O	B-T080
reduced	O	O	I-T080
in	O	O	O
mobile	O	O	B-T169
conversations	O	O	B-T054
,	O	O	O
but	O	O	O
gaze	O	O	B-T033
was	O	O	O
still	O	O	O
used	O	O	O
to	O	O	O
coordinate	O	O	B-T169
conversation	O	O	B-T054
via	O	O	O
displays	O	O	B-T169
of	O	O	O
mutual	O	O	B-T080
orientation	O	O	B-T082
,	O	O	O
and	O	O	O
conversational	O	O	B-T054
performance	O	O	B-T055
and	O	O	O
content	O	O	B-T077
was	O	O	O
not	O	O	O
different	O	O	B-T080
between	O	O	O
stationary	O	O	B-T080
and	O	O	O
mobile	O	O	O
conditions	O	O	B-T080
.	O	O	O

Results	O	O	B-T034
expand	O	O	O
the	O	O	O
phenomena	O	O	B-T067
of	O	O	O
multitasking	O	O	O
to	O	O	O
joint	O	O	B-T056
activities	O	O	I-T056
.	O	O	O

-DOCSTART- (27823893)

Sepsis	O	O	B-T047
Clinical	O	O	B-T080
Criteria	O	O	I-T080
in	O	O	O
Emergency	O	O	B-T093
Department	O	O	I-T093
Patients	O	O	B-T101
Admitted	O	O	B-T058
to	O	O	O
an	O	O	O
Intensive	O	O	B-T093
Care	O	O	I-T093
Unit	O	O	I-T093
:	O	O	O
An	O	O	O
External	O	O	B-T062
Validation	O	O	I-T062
Study	O	O	I-T062
of	O	O	O
Quick	O	O	O
Sequential	O	O	O
Organ	O	O	O
Failure	O	O	O
Assessment	O	O	O

Quick	O	O	B-T033
Sequential	O	O	I-T033
Organ	O	O	I-T033
Failure	O	O	I-T033
Assessment	O	O	I-T033
(	O	O	O
qSOFA	O	O	B-T033
)	O	O	O
is	O	O	O
a	O	O	O
prognostic	O	O	B-T081
score	O	O	I-T081
for	O	O	O
patients	O	O	B-T101
with	O	O	O
sepsis	O	O	B-T047
.	O	O	O

Our	O	O	O
aim	O	O	B-T078
was	O	O	O
to	O	O	O
compare	O	O	O
the	O	O	O
area	O	O	B-T081
under	O	O	I-T081
the	O	O	I-T081
receiver	O	O	I-T081
operating	O	O	I-T081
curve	O	O	I-T081
(	O	O	O
AUROC	O	O	B-T081
)	O	O	O
,	O	O	O
sensitivity	O	O	B-T081
,	O	O	O
specificity	O	O	B-T081
,	O	O	O
and	O	O	O
likelihood	O	O	B-T081
ratios	O	O	I-T081
of	O	O	O
qSOFA	O	O	B-T033
vs.	O	O	O
systemic	O	O	B-T047
inflammation	O	O	I-T047
response	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
SIRS	O	O	B-T047
)	O	O	O
in	O	O	O
predicting	O	O	O
in-hospital	O	O	B-T080
mortality	O	O	I-T080
among	O	O	O
emergency	O	O	B-T093
department	O	O	I-T093
(	O	O	O
ED	O	O	B-T093
)	O	O	O
patients	O	O	B-T101
with	O	O	O
suspected	O	O	B-T046
infection	O	O	I-T046
admitted	O	O	B-T058
to	O	O	O
intensive	O	O	B-T093
care	O	O	I-T093
units	O	O	I-T093
(	O	O	O
ICUs	O	O	B-T093
)	O	O	O
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
retrospective	O	O	B-T062
cohort	O	O	I-T062
chart	O	O	I-T062
review	O	O	I-T062
study	O	O	I-T062
of	O	O	O
ED	O	O	B-T093
patients	O	O	B-T101
admitted	O	O	B-T058
to	O	O	O
an	O	O	O
ICU	O	O	B-T093
with	O	O	O
suspected	O	O	B-T046
infection	O	O	I-T046
from	O	O	O
August	O	O	B-T080
1	O	O	O
,	O	O	O
2012	O	O	O
to	O	O	O
February	O	O	B-T080
28	O	O	O
,	O	O	O
2015	O	O	O
.	O	O	O

We	O	O	O
included	O	O	O
all	O	O	O
patients	O	O	B-T101
with	O	O	O
body	O	O	B-T031
fluid	O	O	I-T031
cultures	O	O	I-T031
sampled	O	O	I-T031
either	O	O	O
during	O	O	O
their	O	O	O
ED	O	O	B-T093
stay	O	O	O
without	O	O	O
antibiotic	O	O	B-T061
administration	O	O	I-T061
or	O	O	O
within	O	O	O
24	O	O	O
h	O	O	O
of	O	O	O
antibiotics	O	O	B-T061
administered	O	O	I-T061
in	O	O	O
the	O	O	O
ED	O	O	O
.	O	O	O

Trained	O	O	B-T097
chart	O	O	I-T097
abstractors	O	O	I-T097
blinded	O	O	O
to	O	O	O
the	O	O	O
study	O	O	B-T062
hypothesis	O	O	O
double-entered	O	O	B-T078
data	O	O	I-T078
from	O	O	O
each	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
electronic	O	O	B-T170
medical	O	O	I-T170
record	O	O	I-T170
including	O	O	O
demographic	O	O	B-T102
characteristics	O	O	I-T102
,	O	O	O
vital	O	O	B-T201
signs	O	O	I-T201
,	O	O	O
laboratory	O	O	B-T059
study	O	O	I-T059
results	O	O	I-T059
,	O	O	O
physical	O	O	B-T058
examination	O	O	I-T058
findings	O	O	B-T033
,	O	O	O
and	O	O	O
in-hospital	O	O	B-T080
mortality	O	O	I-T080
.	O	O	O

We	O	O	O
then	O	O	O
calculated	O	O	O
the	O	O	O
AUROC	O	O	B-T081
,	O	O	O
sensitivity	O	O	B-T081
,	O	O	O
specificity	O	O	B-T081
,	O	O	O
and	O	O	O
likelihood	O	O	B-T081
ratios	O	O	I-T081
for	O	O	O
qSOFA	O	O	B-T033
and	O	O	O
SIRS	O	O	B-T047
for	O	O	O
predicting	O	O	O
in-hospital	O	O	B-T080
mortality	O	O	I-T080
.	O	O	O

Of	O	O	O
214	O	O	O
patients	O	O	B-T101
admitted	O	O	B-T058
to	O	O	O
an	O	O	O
ICU	O	O	B-T093
with	O	O	O
presumed	O	O	B-T047
sepsis	O	O	I-T047
,	O	O	O
39	O	O	O
(	O	O	O
18.2	O	O	O
%	O	O	O
)	O	O	O
died	O	O	B-T033
during	O	O	I-T033
hospitalization	O	O	I-T033
.	O	O	O

The	O	O	O
AUROC	O	O	B-T081
value	O	O	O
was	O	O	O
0.65	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
0.56	O	O	O
-	O	O	O
0.74	O	O	O
)	O	O	O
for	O	O	O
SIRS	O	O	B-T047
vs.	O	O	O
0.66	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.57	O	O	O
-	O	O	O
0.76	O	O	O
)	O	O	O
for	O	O	O
qSOFA	O	O	B-T033
;	O	O	O
2	O	O	O
+	O	O	O
qSOFA	O	O	O
criteria	O	O	O
predicted	O	O	O
in-hospital	O	O	B-T080
mortality	O	O	I-T080
with	O	O	O
89.7	O	O	O
%	O	O	O
sensitivity	O	O	B-T081
,	O	O	O
27.4	O	O	O
%	O	O	O
specificity	O	O	B-T081
,	O	O	O
1.2	O	O	O
positive	O	O	B-T081
likelihood	O	O	I-T081
ratio	O	O	I-T081
,	O	O	O
and	O	O	O
0.4	O	O	O
negative	O	O	B-T081
likelihood	O	O	I-T081
ratio	O	O	I-T081
.	O	O	O

Among	O	O	O
ED	O	O	B-T093
patients	O	O	B-T101
admitted	O	O	B-T058
to	O	O	O
an	O	O	O
ICU	O	O	B-T093
,	O	O	O
the	O	O	O
SIRS	O	O	B-T047
and	O	O	O
qSOFA	O	O	B-T033
criteria	O	O	O
had	O	O	O
comparable	O	O	O
prognostic	O	O	B-T081
value	O	O	I-T081
for	O	O	O
predicting	O	O	O
in-hospital	O	O	B-T080
mortality	O	O	I-T080
.	O	O	O

These	O	O	O
prognostic	O	O	B-T081
values	O	O	I-T081
are	O	O	O
similar	O	O	O
to	O	O	O
those	O	O	O
reported	O	O	O
by	O	O	O
the	O	O	O
Sepsis-3	O	O	B-T170
guidelines	O	O	I-T170
for	O	O	O
ICU	O	O	B-T093
encounters	O	O	B-T170
.	O	O	O

-DOCSTART- (27823981)

Repetitive	O	O	B-T061
transcranial	O	O	I-T061
magnetic	O	O	I-T061
stimulation	O	O	I-T061
improves	O	O	O
cognitive	O	O	B-T041
function	O	O	I-T041
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
patients	O	O	O

Repetitive	O	O	B-T061
transcranial	O	O	I-T061
magnetic	O	O	I-T061
stimulation	O	O	I-T061
(	O	O	O
rTMS	O	O	B-T061
)	O	O	O
acts	O	O	O
as	O	O	O
a	O	O	O
kind	O	O	O
of	O	O	O
widely-applied	O	O	O
and	O	O	O
non-invasive	O	O	O
method	O	O	O
in	O	O	O
the	O	O	O
intervention	O	O	B-T061
of	O	O	O
some	O	O	O
neurological	O	O	B-T047
disorders	O	O	I-T047
.	O	O	O

This	O	O	O
prospective	O	O	B-T062
,	O	O	O
randomized	O	O	B-T062
,	O	O	O
double-blind	O	O	B-T062
,	O	O	O
placebo-controlled	O	O	B-T062
trial	O	O	I-T062
investigates	O	O	B-T169
the	O	O	O
effect	O	O	O
of	O	O	O
rTMS	O	O	B-T061
on	O	O	O
30	O	O	O
cases	O	O	B-T169
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
participants	O	O	B-T098
,	O	O	O
who	O	O	O
were	O	O	O
classified	O	O	O
into	O	O	O
mild	O	O	B-T080
and	O	O	O
moderate	O	O	B-T080
groups	O	O	B-T098
.	O	O	O

Neuropsychological	O	O	B-T060
tests	O	O	I-T060
were	O	O	O
carried	O	O	O
out	O	O	O
using	O	O	O
the	O	O	O
AD	O	O	B-T170
Assessment	O	O	I-T170
Scale	O	O	I-T170
-	O	O	O
cognitive	O	O	B-T170
subscale	O	O	I-T170
(	O	O	O
ADAS	O	O	B-T170
-	O	O	O
cog	O	O	B-T170
)	O	O	O
,	O	O	O
Mini-Mental	O	O	B-T060
State	O	O	I-T060
Examination	O	O	I-T060
(	O	O	O
MMSE	O	O	B-T060
)	O	O	O
,	O	O	O
Montreal	O	O	B-T170
Cognitive	O	O	I-T170
Assessment	O	O	I-T170
(	O	O	O
MoCA	O	O	B-T170
)	O	O	O
,	O	O	O
and	O	O	O
World	O	O	B-T170
Health	O	O	I-T170
Organization	O	O	I-T170
University	O	O	I-T170
of	O	O	I-T170
California-Los	O	O	I-T170
Angeles	O	O	I-T170
,	O	O	I-T170
Auditory	O	O	I-T170
Verbal	O	O	I-T170
Learning	O	O	I-T170
Test	O	O	I-T170
(	O	O	O
WHO-UCLA	O	O	B-T170
AVLT	O	O	I-T170
)	O	O	O
before	O	O	O
,	O	O	O
immediately	O	O	O
after	O	O	O
,	O	O	O
and	O	O	O
6	O	O	O
weeks	O	O	B-T079
after	O	O	O
the	O	O	O
intervention	O	O	B-T061
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
data	O	O	B-T078
from	O	O	O
30	O	O	O
AD	O	O	B-T047
patients	O	O	B-T101
revealed	O	O	O
that	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
obvious	O	O	O
interaction	O	O	B-UnknownType
effect	O	O	I-UnknownType
of	O	O	O
time-by-group	O	O	O
.	O	O	O

The	O	O	O
ADAS	O	O	B-T170
-	O	O	O
cog	O	O	B-T170
,	O	O	O
MMSE	O	O	B-T060
and	O	O	O
WHO-UCLA	O	O	B-T170
AVLT	O	O	I-T170
score	O	O	B-T081
in	O	O	O
the	O	O	O
rTMS	O	O	B-T061
group	O	O	B-T098
was	O	O	O
significantly	O	O	O
improved	O	O	O
compared	O	O	B-T052
with	O	O	O
baselines	O	O	B-T081
at	O	O	O
6	O	O	O
weeks	O	O	B-T079
after	O	O	O
treatment	O	O	B-T061
(	O	O	O
all	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
MoCA	O	O	B-T170
scores	O	O	B-T081
were	O	O	O
also	O	O	O
obviously	O	O	O
ameliorated	O	O	B-T033
in	O	O	O
the	O	O	O
mild	O	O	B-T080
AD	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
rTMS	O	O	B-T061
.	O	O	O

Besides	O	O	O
,	O	O	O
subgroup	O	O	B-T062
analysis	O	O	I-T062
showed	O	O	O
that	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
rTMS	O	O	B-T061
on	O	O	O
the	O	O	O
memory	O	O	B-T041
and	O	O	O
language	O	O	B-T171
of	O	O	O
mild	O	O	B-T080
AD	O	O	B-T047
patients	O	O	B-T101
was	O	O	O
superior	O	O	O
to	O	O	O
those	O	O	O
of	O	O	O
moderate	O	O	B-T080
AD	O	O	O
patients	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	B-T033
suggested	O	O	O
that	O	O	O
repetitive	O	O	B-T061
transcranial	O	O	I-T061
magnetic	O	O	I-T061
stimulation	O	O	I-T061
improves	O	O	O
cognitive	O	O	B-T041
function	O	O	I-T041
,	O	O	O
memory	O	O	B-T041
and	O	O	O
language	O	O	B-T171
level	O	O	B-T080
of	O	O	O
AD	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
especially	O	O	O
in	O	O	O
the	O	O	O
mild	O	O	B-T080
stage	O	O	B-T079
of	O	O	O
AD	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
rTMS	O	O	B-T061
can	O	O	O
be	O	O	O
recommended	O	O	O
as	O	O	O
a	O	O	O
promising	O	O	O
adjuvant	O	O	B-T061
therapy	O	O	I-T061
combined	O	O	O
with	O	O	O
cholinesterase	O	O	B-T109
inhibitors	O	O	I-T109
at	O	O	O
the	O	O	O
mild	O	O	B-T080
stage	O	O	B-T079
of	O	O	O
AD	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27824066)

A	O	O	O
Novel	O	O	B-T080
Insulin/Glucose	O	O	B-T081
Model	O	O	B-T170
after	O	O	O
a	O	O	O
Mixed-Meal	O	O	B-T059
Test	O	O	I-T059
in	O	O	O
Patients	O	O	B-T101
with	O	O	O
Type	O	O	B-T047
1	O	O	I-T047
Diabetes	O	O	I-T047
on	O	O	O
Insulin	O	O	B-T074
Pump	O	O	I-T074
Therapy	O	O	O

Current	O	O	B-T079
closed-loop	O	O	B-T074
insulin	O	O	I-T074
delivery	O	O	I-T074
methods	O	O	I-T074
stem	O	O	O
from	O	O	O
sophisticated	O	O	O
models	O	O	O
of	O	O	O
the	O	O	O
glucose-insulin	O	O	B-T081
(	O	O	I-T081
G/I	O	O	I-T081
)	O	O	I-T081
system	O	O	I-T081
,	O	O	O
mostly	O	O	B-T078
based	O	O	O
on	O	O	O
complex	O	O	B-T080
studies	O	O	B-T062
employing	O	O	B-T033
glucose	O	O	B-T074
tracer	O	O	I-T074
technology	O	O	I-T074
.	O	O	O

We	O	O	O
tested	O	O	B-T169
the	O	O	O
performance	O	O	B-T052
of	O	O	O
a	O	O	O
new	O	O	O
minimal	O	O	B-T170
model	O	O	I-T170
(	O	O	O
GLUKINSLOOP	O	O	B-T170
2.0	O	O	I-T170
)	O	O	O
of	O	O	O
the	O	O	O
G/I	O	O	B-T081
system	O	O	I-T081
to	O	O	O
characterize	O	O	B-T052
the	O	O	O
glucose	O	O	B-T081
and	O	O	I-T081
insulin	O	O	I-T081
dynamics	O	O	B-T070
during	O	O	O
multiple	O	O	B-T081
mixed	O	O	B-T059
meal	O	O	I-T059
tests	O	O	I-T059
(	O	O	O
MMT	O	O	B-T059
)	O	O	O
of	O	O	O
different	O	O	B-T080
sizes	O	O	B-T082
in	O	O	O
patients	O	O	B-T101
with	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
(	O	O	O
T1D	O	O	B-T047
)	O	O	O
on	O	O	O
insulin	O	O	B-T074
pump	O	O	I-T074
therapy	O	O	B-T061
(	O	O	O
continuous	O	O	B-T061
subcutaneous	O	O	I-T061
insulin	O	O	I-T061
infusion	O	O	I-T061
,	O	O	O
CSII	O	O	B-T061
)	O	O	O
.	O	O	O

The	O	O	O
GLUKINSLOOP	O	O	B-T170
2.0	O	O	I-T170
identified	O	O	B-T080
the	O	O	O
G/I	O	O	B-T081
system	O	O	I-T081
,	O	O	O
provided	O	O	B-T052
a	O	O	O
close	O	O	O
fit	O	O	O
of	O	O	O
the	O	O	O
G/I	O	O	O
time-courses	O	O	B-T079
and	O	O	O
showed	O	O	O
acceptable	O	O	B-T080
reproducibility	O	O	B-T080
of	O	O	O
the	O	O	O
G/I	O	O	B-T081
system	O	O	I-T081
parameters	O	O	B-T033
in	O	O	O
repeated	O	O	B-T169
studies	O	O	B-T062
of	O	O	O
identical	O	O	B-T080
and	O	O	O
double-sized	O	O	B-T081
MMTs	O	O	B-T059
.	O	O	O

This	O	O	O
model	O	O	B-T170
can	O	O	O
provide	O	O	B-T052
a	O	O	O
fairly	O	O	O
good	O	O	O
and	O	O	O
reproducible	O	O	O
description	O	O	B-T170
of	O	O	O
the	O	O	O
G/I	O	O	B-T081
system	O	O	I-T081
in	O	O	O
T1D	O	O	B-T047
patients	O	O	B-T101
on	O	O	O
CSII	O	O	B-T061
,	O	O	O
and	O	O	O
it	O	O	O
may	O	O	O
be	O	O	O
applied	O	O	B-T169
to	O	O	O
create	O	O	O
a	O	O	O
bank	O	O	O
of	O	O	O
"	O	O	B-T058
virtual	O	O	I-T058
"	O	O	I-T058
patients	O	O	I-T058
.	O	O	O

Our	O	O	O
results	O	O	B-T034
might	O	O	O
be	O	O	O
relevant	O	O	B-T080
at	O	O	O
improving	O	O	B-T080
the	O	O	O
architecture	O	O	O
of	O	O	O
upcoming	O	O	O
closed-loop	O	O	B-T169
CSII	O	O	B-T061
systems	O	O	O
.	O	O	O

-DOCSTART- (27824925)

Impact	O	O	B-T080
of	O	O	O
Strategically	O	O	O
Located	O	O	O
White	O	O	B-T046
Matter	O	O	I-T046
Hyperintensities	O	O	I-T046
on	O	O	O
Cognition	O	O	B-T041
in	O	O	O
Memory	O	O	B-T093
Clinic	O	O	I-T093
Patients	O	O	B-T101
with	O	O	O
Small	O	O	O
Vessel	O	O	O
Disease	O	O	O

Studies	O	O	O
on	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
small	O	O	B-T047
vessel	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
SVD	O	O	B-T047
)	O	O	O
on	O	O	O
cognition	O	O	B-T041
generally	O	O	O
focus	O	O	B-T082
on	O	O	O
white	O	O	B-T046
matter	O	O	I-T046
hyperintensity	O	O	I-T046
(	O	O	O
WMH	O	O	B-T046
)	O	O	O
volume	O	O	B-T081
.	O	O	O

The	O	O	O
extent	O	O	B-T082
to	O	O	O
which	O	O	O
WMH	O	O	B-T046
location	O	O	B-T029
relates	O	O	B-T080
to	O	O	O
cognitive	O	O	B-T041
performance	O	O	I-T041
has	O	O	O
received	O	O	B-T080
less	O	O	B-T081
attention	O	O	B-T041
,	O	O	O
but	O	O	O
is	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
functionally	O	O	B-T169
important	O	O	B-T080
.	O	O	O

We	O	O	O
examined	O	O	O
the	O	O	O
relation	O	O	B-T080
between	O	O	O
WMH	O	O	B-T046
location	O	O	B-T029
and	O	O	O
cognition	O	O	B-T041
in	O	O	O
a	O	O	O
memory	O	O	B-T093
clinic	O	O	I-T093
cohort	O	O	B-T098
of	O	O	O
patients	O	O	B-T101
with	O	O	O
sporadic	O	O	B-T079
SVD	O	O	B-T047
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
167	O	O	O
patients	O	O	B-T101
with	O	O	O
SVD	O	O	B-T047
were	O	O	O
recruited	O	O	O
from	O	O	O
memory	O	O	B-T093
clinics	O	O	I-T093
.	O	O	O

Assumption-free	O	O	B-T062
region	O	O	I-T062
of	O	O	I-T062
interest-based	O	O	I-T062
analyses	O	O	B-T062
based	O	O	B-T169
on	O	O	O
major	O	O	O
white	O	O	B-T024
matter	O	O	I-T024
tracts	O	O	B-T023
and	O	O	O
voxel	O	O	B-T077
-	O	O	O
wise	O	O	B-T169
analyses	O	O	O
were	O	O	O
used	O	O	B-T169
to	O	O	O
determine	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
WMH	O	O	B-T046
location	O	O	B-T029
and	O	O	O
executive	O	O	B-T041
functioning	O	O	I-T041
,	O	O	O
visuomotor	O	O	B-T041
speed	O	O	I-T041
and	O	O	O
memory	O	O	B-T041
.	O	O	O

Region	O	O	B-T062
of	O	O	I-T062
interest-based	O	O	I-T062
analyses	O	O	I-T062
showed	O	O	O
that	O	O	O
WMHs	O	O	B-T046
located	O	O	B-T029
particularly	O	O	O
within	O	O	B-T082
the	O	O	O
anterior	O	O	B-T023
thalamic	O	O	I-T023
radiation	O	O	I-T023
and	O	O	O
forceps	O	O	B-T023
minor	O	O	I-T023
were	O	O	O
inversely	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
both	O	O	O
executive	O	O	B-T041
functioning	O	O	I-T041
and	O	O	O
visuomotor	O	O	B-T041
speed	O	O	I-T041
,	O	O	O
independent	O	O	B-T169
of	O	O	I-T169
total	O	O	B-T080
WMH	O	O	B-T046
volume	O	O	B-T081
.	O	O	O

Memory	O	O	B-T041
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
WMH	O	O	B-T046
volume	O	O	B-T081
in	O	O	O
the	O	O	O
forceps	O	O	B-T023
minor	O	O	I-T023
,	O	O	O
independent	O	O	B-T169
of	O	O	I-T169
total	O	O	B-T080
WMH	O	O	O
volume	O	O	O
.	O	O	O

An	O	O	O
independent	O	O	B-T062
assumption-free	O	O	I-T062
voxel-wise	O	O	I-T062
analysis	O	O	I-T062
identified	O	O	B-T080
strategic	O	O	O
voxels	O	O	B-T077
in	O	O	O
these	O	O	O
same	O	O	B-T080
tracts	O	O	B-T023
.	O	O	O

Region	O	O	B-T062
of	O	O	I-T062
interest-based	O	O	I-T062
analyses	O	O	I-T062
showed	O	O	O
that	O	O	O
WMH	O	O	B-T046
volume	O	O	B-T081
within	O	O	B-T082
the	O	O	O
anterior	O	O	B-T023
thalamic	O	O	I-T023
radiation	O	O	I-T023
explained	O	O	O
6.8	O	O	O
%	O	O	O
of	O	O	O
variance	O	O	B-T080
in	O	O	O
executive	O	O	B-T041
functioning	O	O	I-T041
,	O	O	O
compared	O	O	B-T052
to	O	O	O
3.9	O	O	O
%	O	O	O
for	O	O	O
total	O	O	B-T080
WMH	O	O	O
volume	O	O	O
;	O	O	O
WMH	O	O	O
volume	O	O	O
within	O	O	O
the	O	O	O
forceps	O	O	B-T023
minor	O	O	I-T023
explained	O	O	O
4.6	O	O	O
%	O	O	O
of	O	O	O
variance	O	O	O
in	O	O	O
visuomotor	O	O	B-T041
speed	O	O	I-T041
and	O	O	O
4.2	O	O	O
%	O	O	O
of	O	O	O
variance	O	O	O
in	O	O	O
memory	O	O	B-T041
,	O	O	O
compared	O	O	O
to	O	O	O
1.8	O	O	O
%	O	O	O
and	O	O	O
1.3	O	O	O
%	O	O	O
respectively	O	O	O
for	O	O	O
total	O	O	O
WMH	O	O	O
volume	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
identify	O	O	B-T080
the	O	O	O
anterior	O	O	B-T023
thalamic	O	O	I-T023
radiation	O	O	I-T023
and	O	O	O
forceps	O	O	B-T023
minor	O	O	I-T023
as	O	O	O
strategic	O	O	O
white	O	O	B-T024
matter	O	O	I-T024
tracts	O	O	B-T023
in	O	O	O
which	O	O	O
WMHs	O	O	B-T046
are	O	O	O
most	O	O	O
strongly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
cognitive	O	O	B-T048
impairment	O	O	I-T048
in	O	O	O
memory	O	O	B-T093
clinic	O	O	I-T093
patients	O	O	B-T101
with	O	O	O
SVD	O	O	B-T047
.	O	O	O

WMH	O	O	B-T046
volumes	O	O	B-T081
in	O	O	O
individual	O	O	O
tracts	O	O	B-T023
explained	O	O	O
more	O	O	O
variance	O	O	B-T080
in	O	O	O
cognition	O	O	B-T041
than	O	O	O
total	O	O	B-T080
WMH	O	O	O
burden	O	O	O
,	O	O	O
emphasizing	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
lesion	O	O	B-T033
location	O	O	I-T033
when	O	O	O
addressing	O	O	O
the	O	O	O
functional	O	O	B-T169
consequences	O	O	B-T169
of	O	O	I-T169
WMHs	O	O	B-T046
.	O	O	O

-DOCSTART- (27825443)

Natural	O	O	B-T169
competence	O	O	B-T080
for	O	O	O
transformation	O	O	O

While	O	O	O
most	O	O	O
molecular	O	O	B-T097
biologists	O	O	I-T097
are	O	O	O
familiar	O	O	O
with	O	O	O
the	O	O	O
artificial	O	O	B-T080
transformation	O	O	B-T045
of	O	O	I-T045
bacteria	O	O	I-T045
in	O	O	O
the	O	O	O
context	O	O	B-T078
of	O	O	O
laboratory	O	O	B-T093
cloning	O	O	B-T062
experiments	O	O	B-T062
,	O	O	O
natural	O	O	B-T169
competence	O	O	B-T080
for	O	O	O
transformation	O	O	O
refers	O	O	O
to	O	O	O
a	O	O	O
specific	O	O	B-T080
physiological	O	O	B-T169
state	O	O	B-T169
in	O	O	O
which	O	O	O
prokaryotes	O	O	B-T001
are	O	O	O
able	O	O	O
to	O	O	O
take	O	O	O
up	O	O	O
genetic	O	O	B-T028
material	O	O	I-T028
from	O	O	O
their	O	O	O
surroundings	O	O	B-T082
.	O	O	O

Occasionally	O	O	O
,	O	O	O
such	O	O	O
absorbed	O	O	B-T169
DNA	O	O	B-T114
is	O	O	O
recombined	O	O	B-T080
into	O	O	O
the	O	O	O
organism	O	O	B-T001
's	O	O	I-T001
own	O	O	O
genome	O	O	B-T028
,	O	O	O
resulting	O	O	O
in	O	O	O
natural	O	O	B-T169
transformation	O	O	B-T045
(	O	O	O
Figure	O	O	O
1	O	O	O
)	O	O	O
.	O	O	O

As	O	O	O
a	O	O	O
consequence	O	O	B-T169
,	O	O	O
natural	O	O	B-T169
competence	O	O	B-T080
for	O	O	O
transformation	O	O	B-T045
is	O	O	O
considered	O	O	O
a	O	O	O
primary	O	O	B-T080
mode	O	O	B-T169
of	O	O	O
horizontal	O	O	B-T045
gene	O	O	I-T045
transfer	O	O	B-T078
(	O	O	O
HGT	O	O	B-T045
)	O	O	O
in	O	O	O
prokaryotes	O	O	B-T001
,	O	O	O
together	O	O	O
with	O	O	O
conjugation	O	O	B-T045
(	O	O	O
direct	O	O	B-T080
cell	O	O	B-T025
to	O	O	O
cell	O	O	O
transfer	O	O	O
of	O	O	O
DNA	O	O	B-T114
via	O	O	O
a	O	O	O
specialized	O	O	B-T077
conjugal	O	O	B-T026
pilus	O	O	I-T026
)	O	O	O
and	O	O	O
phage	O	O	B-T005
transduction	O	O	B-T045
(	O	O	O
DNA	O	O	O
transfer	O	O	O
mediated	O	O	O
by	O	O	O
viruses	O	O	B-T005
)	O	O	O
.	O	O	O

HGT	O	O	B-T045
plays	O	O	O
a	O	O	O
major	O	O	O
role	O	O	O
in	O	O	O
bacterial	O	O	B-T080
evolution	O	O	B-T045
,	O	O	O
and	O	O	O
past	O	O	B-T079
research	O	O	B-T062
has	O	O	O
demonstrated	O	O	O
that	O	O	O
HGT	O	O	O
,	O	O	O
including	O	O	O
natural	O	O	B-T169
competence	O	O	B-T080
for	O	O	O
transformation	O	O	B-T045
,	O	O	O
contributes	O	O	B-T052
to	O	O	O
the	O	O	O
emergence	O	O	O
of	O	O	O
pathogens	O	O	B-T001
and	O	O	O
the	O	O	O
spread	O	O	B-T080
of	O	O	O
virulence	O	O	B-T109
factors	O	O	I-T109
.	O	O	O

Indeed	O	O	O
,	O	O	O
Frederick	O	O	O
Griffith	O	O	O
discovered	O	O	O
natural	O	O	B-T169
competence	O	O	B-T080
for	O	O	O
transformation	O	O	B-T045
in	O	O	O
1928	O	O	O
while	O	O	O
he	O	O	O
was	O	O	O
investigating	O	O	B-T169
the	O	O	O
exchange	O	O	B-T045
of	O	O	O
pathogenic	O	O	B-T033
traits	O	O	B-T032
in	O	O	O
pneumococci	O	O	B-T007
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
abundance	O	O	B-T080
and	O	O	O
spread	O	O	B-T080
of	O	O	O
multidrug-resistant	O	O	B-T007
microbes	O	O	I-T007
,	O	O	O
research	O	O	B-T062
on	O	O	O
HGT	O	O	B-T045
is	O	O	O
even	O	O	O
more	O	O	O
important	O	O	O
today	O	O	O
than	O	O	O
ever	O	O	O
before	O	O	O
.	O	O	O

-DOCSTART- (27826087)

Three-dimensional	O	O	B-T169
constructive	O	O	I-T169
interference	O	O	I-T169
in	O	O	I-T169
steady-state	O	O	I-T169
(	O	O	I-T169
3D-CISS	O	O	I-T169
)	O	O	I-T169
sequences	O	O	I-T169
and	O	O	O
Phase-contrast	O	O	B-T060
MRI	O	O	I-T060
of	O	O	O
arrested	O	O	O
hydrocephalus	O	O	O

to	O	O	O
evaluate	O	O	O
role	O	O	O
of	O	O	O
three-dimensional	O	O	B-T169
constructive	O	O	I-T169
interference	O	O	I-T169
in	O	O	I-T169
steady-state	O	O	I-T169
(	O	O	I-T169
3D-CISS	O	O	I-T169
)	O	O	I-T169
sequences	O	O	I-T169
and	O	O	O
phase-contrast	O	O	B-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
PC-MRI	O	O	B-T060
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
arrested	O	O	B-T047
hydrocephalus	O	O	I-T047
.	O	O	O

Prospective	O	O	B-T062
study	O	O	I-T062
was	O	O	O
conducted	O	O	O
on	O	O	O
20	O	O	O
patients	O	O	B-T101
with	O	O	O
arrested	O	O	B-T047
hydrocephalus	O	O	I-T047
.	O	O	O

All	O	O	O
patients	O	O	B-T101
underwent	O	O	O
PC-MRI	O	O	B-T060
and	O	O	O
3D-CISS	O	O	B-T169
for	O	O	O
assessment	O	O	B-T058
of	O	O	O
the	O	O	O
aqueduct	O	O	B-T030
.	O	O	O

Axial	O	O	B-T082
(	O	O	O
through-plane	O	O	B-T082
)	O	O	O
,	O	O	O
sagittal	O	O	B-T082
(	O	O	O
in-plane	O	O	B-T082
)	O	O	O
PC-MRI	O	O	B-T060
and	O	O	O
sagittal	O	O	O
3D-CISS	O	O	B-T169
were	O	O	O
applied	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
cerebral	O	O	B-T030
aqueduct	O	O	I-T030
and	O	O	O
the	O	O	O
spontaneous	O	O	B-T169
third	O	O	B-T061
ventriculostomy	O	O	I-T061
if	O	O	O
present	O	O	O
.	O	O	O

Aqueductal	O	O	B-T030
patency	O	O	B-T082
was	O	O	O
graded	O	O	B-T185
using	O	O	O
3D-CISS	O	O	B-T169
and	O	O	O
PC-MRI	O	O	B-T060
.	O	O	O

Quantitative	O	O	B-T059
analysis	O	O	I-T059
of	O	O	O
flow	O	O	O
through	O	O	O
the	O	O	O
aqueduct	O	O	B-T030
was	O	O	O
done	O	O	O
using	O	O	O
PC-MRI	O	O	B-T060
.	O	O	O

The	O	O	O
causes	O	O	O
of	O	O	O
obstruction	O	O	B-T046
were	O	O	O
aqueductal	O	O	B-T030
obstruction	O	O	O
in	O	O	O
75	O	O	O
%	O	O	O
(	O	O	O
n=15	O	O	O
)	O	O	O
,	O	O	O
3rd	O	O	O
ventricular	O	O	B-T047
obstruction	O	O	I-T047
in	O	O	O
5	O	O	O
%	O	O	O
(	O	O	O
n=1	O	O	O
)	O	O	O
and	O	O	O
4th	O	O	O
ventricular	O	O	O
obstruction	O	O	O
in	O	O	O
20	O	O	O
%	O	O	O
(	O	O	O
n=4	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
cause	O	O	O
of	O	O	O
arrest	O	O	B-T079
of	O	O	O
hydrocephalus	O	O	B-T047
was	O	O	O
spontaneous	O	O	B-T169
third	O	O	B-T061
ventriculostomy	O	O	I-T061
in	O	O	O
65	O	O	O
%	O	O	O
(	O	O	O
n=13	O	O	O
)	O	O	O
,	O	O	O
endoscopic	O	O	B-T061
third	O	O	I-T061
ventriculostomy	O	O	I-T061
in	O	O	O
10	O	O	O
%	O	O	O
(	O	O	O
n=2	O	O	O
)	O	O	O
,	O	O	O
ventriculo-peritoneal	O	O	B-T074
shunt	O	O	I-T074
in	O	O	O
5	O	O	O
%	O	O	O
(	O	O	O
n=1	O	O	O
)	O	O	O
and	O	O	O
no	O	O	O
cause	O	O	O
could	O	O	O
be	O	O	O
detected	O	O	B-T033
in	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
(	O	O	O
n=4	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
positive	O	O	B-T033
correlation	O	O	B-T080
(	O	O	O
r=	O	O	O
0.80	O	O	O
)	O	O	O
and	O	O	O
moderate	O	O	B-T080
agreement	O	O	B-T054
(	O	O	O
κ=	O	O	O
0.509	O	O	O
)	O	O	O
of	O	O	O
grading	O	O	B-T185
with	O	O	O
PC-MRI	O	O	B-T060
and	O	O	O
3D-CISS	O	O	B-T169
sequences	O	O	I-T169
.	O	O	O

The	O	O	O
mean	O	O	B-T081
peak	O	O	I-T081
systolic	O	O	I-T081
velocity	O	O	I-T081
of	O	O	O
CSF	O	O	B-T031
was	O	O	O
1.86	O	O	O
±	O	O	O
2.48	O	O	O
cm/sec	O	O	O
,	O	O	O
the	O	O	O
stroke	O	O	B-T201
volume	O	O	I-T201
was	O	O	O
6.43	O	O	O
±	O	O	O
13.81μl/cycle	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
mean	O	O	B-T081
flow	O	O	I-T081
was	O	O	O
0.21	O	O	O
±	O	O	O
0.32	O	O	O
ml/min	O	O	O
.	O	O	O

We	O	O	O
concluded	O	O	O
that	O	O	O
3D-CISS	O	O	B-T169
and	O	O	O
PC-MRI	O	O	B-T060
are	O	O	O
non-invasive	O	O	B-T169
sequences	O	O	O
for	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
the	O	O	O
level	O	O	O
and	O	O	O
cause	O	O	B-T169
of	O	O	O
arrested	O	O	B-T047
hydrocephalus	O	O	I-T047
.	O	O	O

-DOCSTART- (27828958)

Historical	O	O	B-T079
Environment	O	O	B-T082
Is	O	O	O
Reflected	O	O	O
in	O	O	O
Modern	O	O	B-T090
Population	O	O	I-T090
Genetics	O	O	I-T090
and	O	O	O
Biogeography	O	O	B-T090
of	O	O	O
an	O	O	O
Island	O	O	B-T083
Endemic	O	O	B-T169
Lizard	O	O	B-T014
(	O	O	O
Xantusia	O	O	B-T014
riversiana	O	O	I-T014
reticulata	O	O	I-T014
)	O	O	O

The	O	O	O
restricted	O	O	B-T169
distribution	O	O	I-T169
and	O	O	O
isolation	O	O	B-T169
of	O	O	O
island	O	O	B-T083
endemics	O	O	B-T169
often	O	O	O
produces	O	O	O
unique	O	O	O
genetic	O	O	B-T070
and	O	O	O
phenotypic	O	O	B-T032
diversity	O	O	B-T080
of	O	O	O
conservation	O	O	B-T080
interest	O	O	O
to	O	O	O
management	O	O	B-T090
agencies	O	O	B-T092
.	O	O	O

However	O	O	O
,	O	O	O
these	O	O	O
isolated	O	O	B-T169
species	O	O	B-T185
,	O	O	O
especially	O	O	O
those	O	O	O
with	O	O	O
sensitive	O	O	B-T169
life	O	O	B-T032
history	O	O	I-T032
traits	O	O	B-T032
,	O	O	O
are	O	O	O
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
for	O	O	O
the	O	O	O
adverse	O	O	B-T046
effects	O	O	I-T046
of	O	O	O
genetic	O	O	B-T045
drift	O	O	I-T045
and	O	O	O
habitat	O	O	B-T082
degradation	O	O	B-T169
by	O	O	O
non-native	O	O	B-T008
wildlife	O	O	I-T008
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
study	O	O	B-T062
the	O	O	O
population	O	O	B-T098
genetic	O	O	B-T070
diversity	O	O	I-T070
,	O	O	O
structure	O	O	B-T082
,	O	O	O
and	O	O	O
stability	O	O	B-T080
of	O	O	O
a	O	O	O
classic	O	O	O
"	O	O	O
island	O	O	B-T014
giant	O	O	I-T014
"	O	O	O
(	O	O	O
Xantusia	O	O	B-T014
riversiana	O	O	I-T014
,	O	O	O
the	O	O	O
Island	O	O	B-T014
Night	O	O	I-T014
Lizard	O	O	I-T014
)	O	O	O
on	O	O	O
San	O	O	B-T083
Clemente	O	O	I-T083
Island	O	O	I-T083
,	O	O	O
California	O	O	B-T083
following	O	O	O
the	O	O	O
removal	O	O	B-T052
of	O	O	O
feral	O	O	B-T015
goats	O	O	I-T015
.	O	O	O

Using	O	O	O
DNA	O	O	B-T114
microsatellites	O	O	B-T114
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
this	O	O	O
population	O	O	B-T098
is	O	O	O
reasonably	O	O	O
genetically	O	O	B-T169
robust	O	O	B-T080
despite	O	O	O
historical	O	O	B-T079
grazing	O	O	B-T040
,	O	O	O
with	O	O	O
similar	O	O	O
effective	O	O	O
population	O	O	B-T081
sizes	O	O	I-T081
and	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
metrics	O	O	O
across	O	O	O
all	O	O	O
sampling	O	O	B-T078
locations	O	O	B-T083
irrespective	O	O	O
of	O	O	O
habitat	O	O	B-T082
type	O	O	O
and	O	O	O
degree	O	O	B-T080
of	O	O	I-T080
degradation	O	O	I-T080
.	O	O	O

However	O	O	O
,	O	O	O
we	O	O	O
also	O	O	O
found	O	O	O
strong	O	O	O
site-specific	O	O	B-T082
patterns	O	O	B-T082
of	O	O	O
genetic	O	O	B-T070
variation	O	O	I-T070
and	O	O	O
low	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
compared	O	O	O
to	O	O	O
mainland	O	O	B-T014
congeners	O	O	I-T014
,	O	O	O
warranting	O	O	O
continued	O	O	O
special	O	O	O
management	O	O	B-T090
as	O	O	O
an	O	O	O
island	O	O	B-T083
endemic	O	O	B-T169
.	O	O	O

We	O	O	O
identify	O	O	O
both	O	O	O
high	O	O	B-T080
and	O	O	O
low	O	O	B-T080
elevation	O	O	B-T082
areas	O	O	I-T082
that	O	O	O
remain	O	O	O
valuable	O	O	O
repositories	O	O	B-T073
of	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
and	O	O	O
provide	O	O	O
a	O	O	O
case	O	O	B-T170
study	O	O	I-T170
for	O	O	O
other	O	O	O
low-dispersal	O	O	B-T070
coastal	O	O	B-T082
organisms	O	O	B-T001
in	O	O	O
the	O	O	O
face	O	O	O
of	O	O	O
future	O	O	B-T079
climate	O	O	B-T070
change	O	O	I-T070
.	O	O	O

-DOCSTART- (27829026)

Cross-Species	O	O	O
Rhesus	O	O	B-T015
Cytomegalovirus	O	O	B-T047
Infection	O	O	I-T047
of	O	O	O
Cynomolgus	O	O	O
Macaques	O	O	O

Cytomegaloviruses	O	O	B-T005
(	O	O	O
CMV	O	O	B-T005
)	O	O	O
are	O	O	O
highly	O	O	O
species-specific	O	O	O
due	O	O	O
to	O	O	O
millennia	O	O	O
of	O	O	O
co-evolution	O	O	B-T045
and	O	O	O
adaptation	O	O	B-T038
to	O	O	O
their	O	O	O
host	O	O	B-T001
,	O	O	O
with	O	O	O
no	O	O	O
successful	O	O	O
experimental	O	O	O
cross-	O	O	O
species	O	O	B-T185
infection	O	O	B-T046
in	O	O	O
primates	O	O	B-T015
reported	O	O	O
to	O	O	O
date	O	O	O
.	O	O	O

Accordingly	O	O	O
,	O	O	O
full	O	O	O
genome	O	O	B-T028
phylogenetic	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
multiple	O	O	O
new	O	O	O
CMV	O	O	B-T005
field	O	O	O
isolates	O	O	B-T123
derived	O	O	O
from	O	O	O
two	O	O	O
closely	O	O	O
related	O	O	O
nonhuman	O	O	B-T015
primate	O	O	B-T015
species	O	O	B-T185
,	O	O	O
Indian-origin	O	O	B-T033
rhesus	O	O	B-T015
macaques	O	O	I-T015
(	O	O	O
RM	O	O	B-T015
)	O	O	O
and	O	O	O
Mauritian	O	O	B-T083
-origin	O	O	O
cynomolgus	O	O	B-T015
macaques	O	O	I-T015
(	O	O	O
MCM	O	O	B-T015
)	O	O	O
,	O	O	O
revealed	O	O	O
distinct	O	O	O
and	O	O	O
tight	O	O	O
lineage	O	O	B-T077
clustering	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
species	O	O	B-T033
of	O	O	I-T033
origin	O	O	I-T033
,	O	O	O
with	O	O	O
MCM	O	O	O
CMV	O	O	O
isolates	O	O	O
mirroring	O	O	O
the	O	O	O
limited	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
of	O	O	O
their	O	O	O
primate	O	O	O
host	O	O	B-T001
that	O	O	O
underwent	O	O	O
a	O	O	O
population	O	O	O
bottleneck	O	O	O
400	O	O	O
years	O	O	O
ago	O	O	O
.	O	O	O

Despite	O	O	O
the	O	O	O
ability	O	O	B-T032
of	O	O	O
Rhesus	O	O	B-T015
CMV	O	O	B-T005
(	O	O	O
RhCMV	O	O	B-T005
)	O	O	O
laboratory	O	O	B-T025
strain	O	O	I-T025
68	O	O	O
-	O	O	O
1	O	O	O
to	O	O	O
replicate	O	O	B-T080
efficiently	O	O	O
in	O	O	O
MCM	O	O	B-T015
fibroblasts	O	O	B-T025
and	O	O	O
potently	O	O	O
inhibit	O	O	B-T039
antigen	O	O	I-T039
presentation	O	O	I-T039
to	O	O	O
MCM	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
in	O	O	B-T080
vitro	O	O	I-T080
,	O	O	O
RhCMV	O	O	O
68	O	O	O
-	O	O	O
1	O	O	O
failed	O	O	O
to	O	O	O
productively	O	O	O
infect	O	O	B-T046
MCM	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
,	O	O	O
even	O	O	O
in	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
host	O	O	B-T001
CD8	O	O	B-T025
+	O	O	I-T025
T	O	O	I-T025
and	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
RhCMV	O	O	B-T005
clone	O	O	B-T024
68	O	O	O
-	O	O	O
1.2	O	O	O
,	O	O	O
genetically	O	O	B-T169
repaired	O	O	B-T058
to	O	O	O
express	O	O	B-T045
the	O	O	O
homologues	O	O	B-T028
of	O	O	O
the	O	O	O
HCMV	O	O	B-T005
anti-apoptosis	O	O	B-T043
gene	O	O	B-T116
UL36	O	O	I-T116
and	O	O	O
epithelial	O	O	B-T039
cell	O	O	I-T039
tropism	O	O	I-T039
genes	O	O	B-T116
UL128	O	O	I-T116
and	O	O	O
UL130	O	O	B-T116
absent	O	O	O
in	O	O	O
68	O	O	O
-	O	O	O
1	O	O	O
,	O	O	O
efficiently	O	O	O
infected	O	O	B-T046
MCM	O	O	B-T098
as	O	O	O
evidenced	O	O	O
by	O	O	O
the	O	O	O
induction	O	O	B-T045
of	O	O	O
transgene	O	O	B-T028
-specific	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
virus	O	O	B-T046
shedding	O	O	I-T046
.	O	O	O

Recombinant	O	O	B-T116
variants	O	O	I-T116
of	O	O	O
RhCMV	O	O	B-T005
68	O	O	O
-	O	O	O
1	O	O	O
and	O	O	O
68	O	O	O
-	O	O	O
1.2	O	O	O
revealed	O	O	O
that	O	O	O
expression	O	O	B-T045
of	O	O	O
either	O	O	O
UL36	O	O	B-T116
or	O	O	O
UL128	O	O	B-T116
together	O	O	O
with	O	O	O
UL130	O	O	B-T116
enabled	O	O	O
productive	O	O	O
MCM	O	O	B-T098
infection	O	O	B-T046
,	O	O	O
indicating	O	O	O
that	O	O	O
multiple	O	O	O
layers	O	O	O
of	O	O	O
cross-	O	O	O
species	O	O	B-T185
restriction	O	O	B-T169
operate	O	O	O
even	O	O	O
between	O	O	O
closely	O	O	O
related	O	O	O
hosts	O	O	B-T001
.	O	O	O

Cumulatively	O	O	O
,	O	O	O
these	O	O	O
results	O	O	O
implicate	O	O	O
cell	O	O	B-T039
tropism	O	O	I-T039
and	O	O	O
evasion	O	O	O
of	O	O	O
apoptosis	O	O	B-T043
as	O	O	O
critical	O	O	O
determinants	O	O	B-T169
of	O	O	O
CMV	O	O	B-T005
transmission	O	O	B-T043
across	O	O	O
primate	O	O	B-T015
species	O	O	B-T185
barriers	O	O	O
,	O	O	O
and	O	O	O
extend	O	O	O
the	O	O	O
macaque	O	O	B-T015
model	O	O	B-T170
of	O	O	O
human	O	O	B-T016
CMV	O	O	O
infection	O	O	B-T046
and	O	O	O
immunology	O	O	B-T091
to	O	O	O
MCM	O	O	B-T098
,	O	O	O
a	O	O	O
nonhuman	O	O	B-T015
primate	O	O	I-T015
species	O	O	O
with	O	O	O
uniquely	O	O	O
simplified	O	O	O
host	O	O	B-T001
immunogenetics	O	O	B-T091
.	O	O	O

-DOCSTART- (27829875)

Mildly	O	O	B-T080
raised	O	O	B-T080
tricuspid	O	O	B-T033
regurgitant	O	O	I-T033
velocity	O	O	I-T033
2.5	O	O	O
-	O	O	O
3.0	O	O	O
m/s	O	O	O
in	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
with	O	O	O
sickle	O	O	B-T047
cell	O	O	I-T047
disease	O	O	I-T047
is	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
poor	O	O	B-T080
obstetric	O	O	B-T169
outcome	O	O	B-T169
-	O	O	O
An	O	O	O
observational	O	O	O
cross-sectional	O	O	O
study	O	O	O

Pulmonary	O	O	B-T046
hypertension	O	O	I-T046
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
36	O	O	O
%	O	O	O
mortality	O	O	B-T081
in	O	O	O
pregnancy	O	O	B-T040
,	O	O	O
and	O	O	O
6	O	O	O
-	O	O	O
10	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
sickle	O	O	B-T047
cell	O	O	I-T047
disease	O	O	I-T047
have	O	O	O
pulmonary	O	O	B-T046
hypertension	O	O	I-T046
.	O	O	O

Tricuspid	O	O	B-T033
regurgitant	O	O	I-T033
velocity	O	O	I-T033
≥2.5	O	O	O
m/s	O	O	O
on	O	O	O
echocardiography	O	O	B-T060
is	O	O	O
a	O	O	O
well	O	O	O
validated	O	O	O
means	O	O	O
of	O	O	O
screening	O	O	B-T058
for	O	O	O
pulmonary	O	O	B-T046
hypertension	O	O	I-T046
in	O	O	O
the	O	O	O
non-pregnant	O	O	B-T033
population	O	O	B-T098
.	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
to	O	O	O
determine	O	O	O
if	O	O	O
this	O	O	O
is	O	O	O
a	O	O	O
useful	O	O	O
non-invasive	O	O	B-T169
screening	O	O	B-T058
test	O	O	I-T058
for	O	O	O
pulmonary	O	O	B-T046
hypertension	O	O	I-T046
in	O	O	O
pregnancy	O	O	B-T040
,	O	O	O
and	O	O	O
whether	O	O	O
raised	O	O	O
tricuspid	O	O	B-T033
regurgitant	O	O	I-T033
velocity	O	O	I-T033
≥2.5	O	O	O
m/s	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
poor	O	O	B-T080
outcomes	O	O	B-T169
.	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
over	O	O	O
a	O	O	O
five-year	O	O	O
period	O	O	O
in	O	O	O
a	O	O	O
tertiary	O	O	B-T093
referral	O	O	I-T093
centre	O	O	I-T093
with	O	O	O
a	O	O	O
specialised	O	O	O
multidisciplinary	O	O	B-T093
clinic	O	O	I-T093
for	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
with	O	O	O
sickle	O	O	B-T047
cell	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

Women	O	O	B-T098
with	O	O	O
sickle	O	O	B-T047
cell	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
no	O	O	O
prior	O	O	O
pulmonary	O	O	B-T046
hypertension	O	O	I-T046
and	O	O	O
singleton	O	O	B-T099
pregnancies	O	O	B-T040
who	O	O	O
had	O	O	O
echocardiography	O	O	B-T060
with	O	O	O
a	O	O	O
measurable	O	O	O
tricuspid	O	O	B-T033
regurgitant	O	O	I-T033
velocity	O	O	I-T033
in	O	O	O
pregnancy	O	O	B-T040
were	O	O	O
included	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
34	O	O	O
pregnancies	O	O	B-T040
,	O	O	O
of	O	O	O
which	O	O	O
eight	O	O	O
had	O	O	O
tricuspid	O	O	B-T033
regurgitant	O	O	I-T033
velocity	O	O	I-T033
≥2.5	O	O	O
m/s	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
differences	O	O	O
in	O	O	O
their	O	O	O
characteristics	O	O	B-T080
,	O	O	O
sickle	O	O	B-T025
cell	O	O	I-T025
-related	O	O	O
complications	O	O	B-T046
or	O	O	O
medical	O	O	B-T169
co-morbidities	O	O	B-T081
.	O	O	O

The	O	O	O
women	O	O	B-T098
with	O	O	O
tricuspid	O	O	B-T033
regurgitant	O	O	I-T033
velocity	O	O	I-T033
≥2.5	O	O	O
m/s	O	O	O
had	O	O	O
similar	O	O	O
obstetric	O	O	B-T169
and	O	O	O
perinatal	O	O	B-T079
outcomes	O	O	B-T169
as	O	O	O
those	O	O	O
with	O	O	O
a	O	O	O
tricuspid	O	O	O
regurgitant	O	O	O
velocity	O	O	O
<	O	O	O
2.5	O	O	O
m/s	O	O	O
.	O	O	O

-DOCSTART- (27831503)

A	O	O	O
randomized	O	O	B-T062
trial	O	O	I-T062
of	O	O	O
TLR-2	O	O	B-T116
agonist	O	O	B-T121
CADI-05	O	O	B-T109
targeting	O	O	B-T169
desmocollin-3	O	O	B-T116
for	O	O	O
advanced	O	O	B-T080
non-small-cell	O	O	O
lung	O	O	O
cancer	O	O	O

Randomized	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
to	O	O	O
evaluate	O	O	B-T058
synergy	O	O	B-T044
between	O	O	O
taxane	O	O	B-T109
plus	O	O	O
platinum	O	O	B-T196
chemotherapy	O	O	B-T061
and	O	O	O
CADI-05	O	O	B-T109
,	O	O	O
a	O	O	O
Toll	O	O	B-T116
like	O	O	I-T116
receptor-2	O	O	I-T116
agonist	O	O	B-T121
targeting	O	O	B-T169
desmocollin-3	O	O	B-T116
as	O	O	O
a	O	O	O
first-line	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
advanced	O	O	B-T080
non-small-cell	O	O	B-T191
lung	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
NSCLC	O	O	B-T191
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
advanced	O	O	B-T080
NSCLC	O	O	B-T191
(	O	O	O
stage	O	O	O
IIIB	O	O	O
or	O	O	O
IV	O	O	O
)	O	O	O
were	O	O	O
randomized	O	O	B-T033
to	O	O	O
cisplatin-paclitaxel	O	O	B-T061
(	O	O	O
chemotherapy	O	O	B-T061
group	O	O	B-T078
,	O	O	O
N	O	O	O
=	O	O	O
112	O	O	O
)	O	O	O
or	O	O	O
cisplatin-paclitaxel	O	O	O
plus	O	O	O
CADI-05	O	O	B-T109
(	O	O	O
chemoimmunotherapy	O	O	B-T061
group	O	O	O
,	O	O	O
N	O	O	O
=	O	O	O
109	O	O	O
)	O	O	O
.	O	O	O

CADI-05	O	O	B-T109
was	O	O	O
administered	O	O	B-T169
a	O	O	O
week	O	O	B-T079
before	O	O	O
chemotherapy	O	O	B-T061
and	O	O	O
on	O	O	O
days	O	O	B-T079
8	O	O	O
and	O	O	O
15	O	O	O
of	O	O	O
each	O	O	O
cycle	O	O	B-T061
and	O	O	O
every	O	O	O
month	O	O	B-T079
subsequently	O	O	O
for	O	O	O
12	O	O	O
months	O	O	B-T079
or	O	O	O
disease	O	O	B-T046
progression	O	O	I-T046
.	O	O	O

Overall	O	O	B-T081
survival	O	O	I-T081
was	O	O	O
compared	O	O	O
using	O	O	O
a	O	O	O
log-rank	O	O	B-T170
test	O	O	I-T170
.	O	O	O

Computed	O	O	B-T060
tomography	O	O	I-T060
was	O	O	O
carried	O	O	O
out	O	O	O
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
end	O	O	O
of	O	O	O
two	O	O	O
cycles	O	O	B-T061
and	O	O	O
four	O	O	O
cycles	O	O	O
.	O	O	O

Response	O	O	B-T079
rate	O	O	I-T079
was	O	O	O
evaluated	O	O	B-T058
using	O	O	O
Response	O	O	B-T170
Evaluation	O	O	I-T170
Criteria	O	O	I-T170
in	O	O	I-T170
Solid	O	O	I-T170
Tumors	O	O	I-T170
criteria	O	O	B-T078
by	O	O	O
an	O	O	O
independent	O	O	B-T097
radiologist	O	O	I-T097
.	O	O	O

As	O	O	O
per	O	O	O
intention-to-treat	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
no	O	O	O
survival	O	O	B-T052
benefit	O	O	B-T081
was	O	O	O
observed	O	O	O
between	O	O	O
two	O	O	O
groups	O	O	B-T078
[	O	O	O
208	O	O	O
versus	O	O	O
196	O	O	O
days	O	O	B-T079
;	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
0.86	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	O
)	O	O	O
0.63	O	O	O
-	O	O	O
1.19	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.3804	O	O	O
]	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
subgroup	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
improvement	O	O	B-T077
in	O	O	O
median	O	O	B-T079
survival	O	O	I-T079
by	O	O	O
127	O	O	O
days	O	O	B-T079
was	O	O	O
observed	O	O	O
in	O	O	O
squamous	O	O	B-T191
NSCC	O	O	I-T191
with	O	O	O
chemoimmunotherapy	O	O	B-T061
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
0.55	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.32	O	O	O
-	O	O	O
0.95	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.046	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
patients	O	O	B-T101
receiving	O	O	O
planned	O	O	O
four	O	O	O
cycles	O	O	B-T061
of	O	O	O
chemotherapy	O	O	B-T061
,	O	O	O
there	O	O	O
was	O	O	O
improved	O	O	B-T077
median	O	O	B-T081
overall	O	O	B-T081
survival	O	O	I-T081
by	O	O	O
66	O	O	O
days	O	O	B-T079
(	O	O	O
299	O	O	O
versus	O	O	O
233	O	O	O
days	O	O	O
;	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
0.64	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.41	O	O	O
to	O	O	O
0.98	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.04	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
chemoimmunotherapy	O	O	B-T061
group	O	O	B-T078
compared	O	O	O
with	O	O	O
the	O	O	O
chemotherapy	O	O	O
group	O	O	O
.	O	O	O

This	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
improved	O	O	B-T077
survival	O	O	B-T052
by	O	O	O
17.48	O	O	O
%	O	O	O
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
1	O	O	O
year	O	O	B-T079
,	O	O	O
in	O	O	O
the	O	O	O
chemoimmunotherapy	O	O	B-T061
group	O	O	B-T078
.	O	O	O

Systemic	O	O	B-T046
adverse	O	O	I-T046
events	O	O	I-T046
were	O	O	O
identical	O	O	B-T080
in	O	O	O
both	O	O	O
the	O	O	O
group	O	O	B-T078
s.	O	O	O
There	O	O	O
was	O	O	O
no	O	O	O
survival	O	O	B-T052
benefit	O	O	B-T081
with	O	O	O
the	O	O	O
addition	O	O	B-T169
of	O	O	O
CADI-05	O	O	B-T109
to	O	O	O
the	O	O	O
combination	O	O	B-T080
of	O	O	O
cisplatin-paclitaxel	O	O	B-T061
in	O	O	O
patients	O	O	B-T101
with	O	O	O
advanced	O	O	B-T080
NSCLC	O	O	B-T191
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
squamous	O	O	B-T025
cell	O	O	I-T025
subset	O	O	I-T025
did	O	O	O
demonstrate	O	O	O
a	O	O	O
survival	O	O	O
advantage	O	O	O
.	O	O	O

-DOCSTART- (27831992)

Sex	O	O	B-T078
Life	O	O	I-T078
and	O	O	O
Impact	O	O	B-T080
of	O	O	O
Operative	O	O	B-T169
Intervention	O	O	B-T061
on	O	O	O
Sex	O	O	B-T184
Life-related	O	O	I-T184
Pain	O	O	I-T184
in	O	O	O
Degenerative	O	O	B-T046
Spinal	O	O	B-T023
Conditions	O	O	O
:	O	O	O
An	O	O	O
Analysis	O	O	B-T062
of	O	O	O
the	O	O	O
SPORT	O	O	O
Study	O	O	O

This	O	O	O
study	O	O	B-T062
is	O	O	O
a	O	O	O
therapeutic	O	O	B-T062
retrospective	O	O	I-T062
cohort	O	O	I-T062
study	O	O	I-T062
OBJECTIVES	O	O	O
.	O	O	O
:	O	O	O
This	O	O	O
study	O	O	O
aims	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
sexual	O	O	B-T040
function	O	O	I-T040
is	O	O	O
relevant	O	O	O
for	O	O	O
patients	O	O	B-T101
with	O	O	O
spinal	O	O	B-T020
stenosis	O	O	I-T020
(	O	O	O
SPS	O	O	B-T020
)	O	O	O
and	O	O	O
degenerative	O	O	B-T047
spondylolisthesis	O	O	I-T047
(	O	O	O
DS	O	O	B-T047
)	O	O	O
and	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
operative	O	O	B-T169
inter	O	O	O
vqAvention	O	O	O
on	O	O	O
sexual	O	O	O
function	O	O	O
for	O	O	O
these	O	O	O
patients	O	O	O
.	O	O	O

The	O	O	O
benefits	O	O	O
of	O	O	O
nonoperative	O	O	B-T169
versus	O	O	O
operative	O	O	B-T169
treatment	O	O	B-T169
for	O	O	O
patients	O	O	B-T101
with	O	O	O
SPS	O	O	B-T020
and	O	O	O
DS	O	O	B-T047
with	O	O	O
regards	O	O	O
to	O	O	O
sexual	O	O	B-T040
function	O	O	I-T040
are	O	O	O
unknown	O	O	O
.	O	O	O

Demographic	O	O	B-T090
,	O	O	O
treatment	O	O	B-T169
,	O	O	O
and	O	O	O
follow-up	O	O	B-T058
data	O	O	B-T078
,	O	O	O
including	O	O	O
the	O	O	O
Oswestry	O	O	O
Disability	O	O	O
Index	O	O	O
(	O	O	O
ODI	O	O	O
)	O	O	O
,	O	O	O
were	O	O	O
obtained	O	O	O
on	O	O	O
patients	O	O	B-T101
enrolled	O	O	O
in	O	O	O
the	O	O	O
SPORT	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
response	O	O	O
to	O	O	O
question	O	O	O
#	O	O	O
9	O	O	O
in	O	O	O
the	O	O	O
ODI	O	O	O
,	O	O	O
patients	O	O	B-T101
were	O	O	O
classified	O	O	O
into	O	O	O
a	O	O	O
sexual	O	O	B-T078
life	O	O	I-T078
relevant	O	O	I-T078
(	O	O	O
SLR	O	O	B-T078
)	O	O	O
or	O	O	O
sexual	O	O	B-T078
life	O	O	I-T078
not	O	O	I-T078
relevant	O	O	I-T078
(	O	O	I-T078
NR	O	O	I-T078
)	O	O	I-T078
group	O	O	I-T078
.	O	O	O

Univariate	O	O	B-T062
and	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
of	O	O	O
patient	O	O	B-T101
characteristics	O	O	B-T080
comparing	O	O	O
the	O	O	O
NR	O	O	B-T078
and	O	O	O
SLR	O	O	B-T078
group	O	O	I-T078
were	O	O	O
performed	O	O	O
.	O	O	O

Operative	O	O	B-T169
treatment	O	O	B-T169
groups	O	O	B-T078
were	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
nonoperative	O	O	B-T169
group	O	O	B-T078
with	O	O	O
regards	O	O	O
to	O	O	O
response	O	O	O
to	O	O	O
ODI	O	O	O
question	O	O	O
#	O	O	O
9	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
surgery	O	O	B-T061
on	O	O	O
sexual	O	O	B-T040
function	O	O	I-T040
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
1235	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
to	O	O	O
determine	O	O	O
relevance	O	O	O
of	O	O	O
sex	O	O	B-T078
life	O	O	I-T078
.	O	O	O

Three	O	O	O
hundred	O	O	O
sixty-six	O	O	O
patients	O	O	B-T101
(	O	O	O
29	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
NR	O	O	B-T078
group	O	O	I-T078
.	O	O	O

Eight	O	O	O
hundred	O	O	O
sixty-nine	O	O	O
patients	O	O	B-T101
(	O	O	O
71	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
SLR	O	O	B-T078
group	O	O	I-T078
.	O	O	O

Patients	O	O	B-T101
that	O	O	O
were	O	O	O
older	O	O	B-T098
,	O	O	O
female	O	O	B-T032
,	O	O	O
unmarried	O	O	B-T098
,	O	O	O
had	O	O	O
three	O	O	O
or	O	O	O
more	O	O	O
stenotic	O	O	B-T080
levels	O	O	I-T080
,	O	O	O
and	O	O	O
had	O	O	O
central	O	O	B-T169
stenosis	O	O	I-T169
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
in	O	O	O
the	O	O	O
NR	O	O	B-T078
group	O	O	I-T078
.	O	O	O

Eight	O	O	O
hundred	O	O	O
twenty-five	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
analysis	O	O	B-T062
comparing	O	O	O
operative	O	O	B-T169
versus	O	O	O
nonoperative	O	O	B-T169
treatment	O	O	B-T169
.	O	O	O

At	O	O	O
all	O	O	O
follow-up	O	O	B-T058
time	O	O	O
points	O	O	O
,	O	O	O
the	O	O	O
operative	O	O	B-T169
groups	O	O	B-T078
had	O	O	O
a	O	O	O
lower	O	O	O
percentage	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
reporting	O	O	O
pain	O	O	B-T184
with	O	O	O
their	O	O	O
sex	O	O	B-T078
life	O	O	I-T078
compared	O	O	O
to	O	O	O
the	O	O	O
nonoperative	O	O	B-T169
group	O	O	B-T078
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
at	O	O	O
all	O	O	O
time	O	O	O
points	O	O	O
except	O	O	O
between	O	O	O
more	O	O	O
than	O	O	O
one	O	O	O
level	O	O	O
fusion	O	O	O
and	O	O	O
nonoperative	O	O	O
at	O	O	O
4	O	O	O
years	O	O	B-T079
'	O	O	O
follow-up	O	O	O
)	O	O	O
.	O	O	O

Sex	O	O	B-T078
life	O	O	I-T078
is	O	O	O
a	O	O	O
relevant	O	O	O
consideration	O	O	O
for	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
DS	O	O	B-T047
and	O	O	O
SPS	O	O	B-T020
;	O	O	O
operative	O	O	B-T169
treatment	O	O	B-T169
leads	O	O	O
to	O	O	O
improved	O	O	B-T033
sex	O	O	B-T184
life-related	O	O	I-T184
pain	O	O	I-T184
.	O	O	O

3	O	O	O
.	O	O	O

-DOCSTART- (27835851)

Functional	O	O	B-T062
analyses	O	O	I-T062
of	O	O	O
OcRhS1	O	O	B-T116
and	O	O	O
OcUER1	O	O	B-T116
involved	O	O	O
in	O	O	O
UDP-L-rhamnose	O	O	B-T114
biosynthesis	O	O	B-T169
in	O	O	O
Ornithogalum	O	O	O
caudatum	O	O	O

UDP-L-rhamnose	O	O	B-T114
(	O	O	O
UDP-Rha	O	O	B-T114
)	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
sugar	O	O	B-T121
donor	O	O	I-T121
for	O	O	O
the	O	O	O
synthesis	O	O	B-T169
of	O	O	O
rhamnose	O	O	B-T109
-containing	O	O	O
compounds	O	O	B-T103
in	O	O	O
plants	O	O	B-T002
.	O	O	O

However	O	O	O
,	O	O	O
only	O	O	O
a	O	O	O
few	O	O	O
enzymes	O	O	B-T116
and	O	O	O
their	O	O	O
encoding	O	O	B-T052
genes	O	O	B-T028
involved	O	O	O
in	O	O	O
UDP-Rha	O	O	B-T114
biosynthesis	O	O	B-T169
are	O	O	O
available	O	O	O
in	O	O	O
plants	O	O	B-T002
.	O	O	O

Here	O	O	O
,	O	O	O
two	O	O	O
genes	O	O	B-T028
encoding	O	O	B-T052
rhamnose	O	O	B-T116
synthase	O	O	I-T116
(	O	O	O
RhS	O	O	B-T116
)	O	O	O
and	O	O	O
bi-functional	O	O	B-T116
UDP-4-keto-6-deoxy-D-glucose	O	O	B-T116
(	O	O	O
UDP-4K6DG	O	O	B-T116
)	O	O	O
3	O	O	B-T116
,	O	O	I-T116
5-epimerase/UDP-4-keto-L-rhamnose	O	O	I-T116
(	O	O	O
UDP-4KR	O	O	B-T116
)	O	O	O
4-keto-reductase	O	O	B-T116
(	O	O	O
UER	O	O	B-T116
)	O	O	O
were	O	O	O
isolated	O	O	O
from	O	O	O
Ornithogalum	O	O	B-T002
caudatum	O	O	I-T002
based	O	O	O
on	O	O	O
the	O	O	O
RNA	O	O	B-T114
-	O	O	O
Seq	O	O	B-T170
data	O	O	I-T170
.	O	O	O

The	O	O	O
OcRhS1	O	O	B-T028
gene	O	O	I-T028
has	O	O	O
an	O	O	O
ORF	O	O	B-T028
(	O	O	O
open	O	O	B-T028
reading	O	O	I-T028
frame	O	O	I-T028
)	O	O	O
of	O	O	O
2019	O	O	O
bp	O	O	O
encoding	O	O	B-T052
a	O	O	O
tri-functional	O	O	B-T026
RhS	O	O	I-T026
enzyme	O	O	I-T026
.	O	O	O

In	O	O	B-T080
vitro	O	O	I-T080
enzymatic	O	O	B-T059
assays	O	O	I-T059
revealed	O	O	B-T080
OcRhS1	O	O	B-T116
can	O	O	O
really	O	O	O
convert	O	O	O
UDP-D-glucose	O	O	B-T109
(	O	O	O
UDP-Glc	O	O	B-T109
)	O	O	O
into	O	O	O
UDP-Rha	O	O	B-T114
via	O	O	O
three	O	O	O
consecutive	O	O	B-T080
reactions	O	O	B-T169
.	O	O	O

Biochemical	O	O	B-T169
evidences	O	O	B-T169
indicated	O	O	O
that	O	O	O
the	O	O	O
recombinant	O	O	B-T116
OcRhS1	O	O	I-T116
was	O	O	O
active	O	O	O
in	O	O	O
the	O	O	O
pH	O	O	O
range	O	O	O
of	O	O	O
5	O	O	O
-	O	O	O
11	O	O	O
and	O	O	O
over	O	O	O
the	O	O	O
temperature	O	O	B-T081
range	O	O	I-T081
of	O	O	O
0	O	O	O
-	O	O	O
60	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

The	O	O	O
Km	O	O	B-T081
value	O	O	B-T081
of	O	O	O
OcRhS1	O	O	B-T116
for	O	O	O
UDP-Glc	O	O	B-T109
was	O	O	O
determined	O	O	O
to	O	O	O
be	O	O	O
1.52	O	O	O
×	O	O	O
10(-4	O	O	O
)	O	O	O
M.	O	O	O
OcRhS1	O	O	O
is	O	O	O
a	O	O	O
multi-domain	O	O	B-T116
protein	O	O	I-T116
with	O	O	O
two	O	O	O
sets	O	O	O
of	O	O	O
cofactor-binding	O	O	B-T044
motifs	O	O	I-T044
.	O	O	O

The	O	O	O
cofactors	O	O	B-T044
dependent	O	O	O
properties	O	O	O
of	O	O	O
OcRhS1	O	O	B-T116
were	O	O	O
thus	O	O	O
characterized	O	O	O
in	O	O	O
this	O	O	O
research	O	O	B-T062
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
N-terminal	O	O	B-T116
portion	O	O	I-T116
of	O	O	I-T116
OcRhS1	O	O	I-T116
(	O	O	O
OcRhS1-N	O	O	B-T116
)	O	O	O
was	O	O	O
observed	O	O	O
to	O	O	O
metabolize	O	O	B-T169
UDP-Glc	O	O	B-T109
to	O	O	O
form	O	O	O
intermediate	O	O	O
UDP-4K6DG	O	O	B-T114
.	O	O	O

OcUER1	O	O	B-T028
contains	O	O	O
an	O	O	O
ORF	O	O	B-T028
of	O	O	O
906	O	O	O
bp	O	O	O
encoding	O	O	B-T052
a	O	O	O
polypeptide	O	O	B-T116
of	O	O	O
301	O	O	O
aa	O	O	B-T116
.	O	O	O

OcUER1	O	O	B-T116
shared	O	O	O
high	O	O	O
similarity	O	O	O
with	O	O	O
the	O	O	O
carboxy-terminal	O	O	B-T116
domain	O	O	I-T116
of	O	O	I-T116
OcRhS1	O	O	I-T116
(	O	O	O
OcRhS1-C	O	O	B-T116
)	O	O	O
,	O	O	O
suggesting	O	O	O
its	O	O	O
intrinsic	O	O	O
ability	O	O	O
of	O	O	O
converting	O	O	O
UDP-4K6DG	O	O	B-T114
into	O	O	O
UDP-Rha	O	O	B-T114
.	O	O	O

It	O	O	O
was	O	O	O
thus	O	O	O
reasonably	O	O	O
inferred	O	O	O
that	O	O	O
UDP-Glc	O	O	B-T109
could	O	O	O
be	O	O	O
bio-transformed	O	O	B-T169
into	O	O	O
UDP-Rha	O	O	B-T114
under	O	O	O
the	O	O	O
collaborating	O	O	O
action	O	O	O
of	O	O	O
OcRhS1-N	O	O	B-T116
and	O	O	O
OcUER1	O	O	B-T116
.	O	O	O

The	O	O	O
subsequently	O	O	O
biochemical	O	O	B-T059
assay	O	O	I-T059
verified	O	O	O
this	O	O	O
notion	O	O	O
.	O	O	O

Importantly	O	O	O
,	O	O	O
expression	O	O	B-T034
profiles	O	O	I-T034
of	O	O	O
OcRhS1	O	O	B-T116
and	O	O	O
OcUER1	O	O	B-T116
revealed	O	O	B-T080
their	O	O	O
possible	O	O	O
involvement	O	O	O
in	O	O	O
the	O	O	O
biosynthesis	O	O	B-T169
of	O	O	O
rhamnose	O	O	B-T109
-containing	O	O	O
polysaccharides	O	O	B-T109
in	O	O	O
O.	O	O	B-T002
caudatum	O	O	I-T002
.	O	O	O

-DOCSTART- (27837017)

Differing	O	O	O
rates	O	O	O
of	O	O	O
antibody	O	O	B-T116
acquisition	O	O	B-T052
to	O	O	O
merozoite	O	O	B-T204
antigens	O	O	B-T129
in	O	O	O
malaria	O	O	B-T047
:	O	O	O
implications	O	O	O
for	O	O	O
immunity	O	O	B-T039
and	O	O	O
surveillance	O	O	O

Antibodies	O	O	B-T116
play	O	O	O
a	O	O	O
key	O	O	O
role	O	O	O
in	O	O	O
acquired	O	O	B-T039
human	O	O	I-T039
immunity	O	O	I-T039
to	O	O	O
Plasmodium	O	O	B-T047
falciparum	O	O	I-T047
(	O	O	I-T047
Pf	O	O	I-T047
)	O	O	I-T047
malaria	O	O	I-T047
and	O	O	O
target	O	O	O
merozoites	O	O	B-T204
to	O	O	O
reduce	O	O	O
or	O	O	O
prevent	O	O	O
blood	O	O	B-T031
-stage	O	O	O
replication	O	O	B-T043
and	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
disease	O	O	B-T047
.	O	O	O

Merozoites	O	O	B-T204
present	O	O	O
a	O	O	O
complex	O	O	O
array	O	O	O
of	O	O	O
antigens	O	O	B-T129
to	O	O	O
the	O	O	O
immune	O	O	B-T022
system	O	O	I-T022
,	O	O	O
and	O	O	O
currently	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
only	O	O	O
a	O	O	O
partial	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
targets	O	O	O
of	O	O	O
protective	O	O	O
antibodies	O	O	B-T116
and	O	O	O
how	O	O	O
responses	O	O	B-T039
to	O	O	O
different	O	O	O
antigens	O	O	O
are	O	O	O
acquired	O	O	B-T080
and	O	O	O
boosted	O	O	B-T169
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
there	O	O	O
would	O	O	O
be	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
acquisition	O	O	B-T052
of	O	O	O
antibodies	O	O	B-T116
to	O	O	O
different	O	O	O
antigens	O	O	B-T129
and	O	O	O
how	O	O	O
well	O	O	O
they	O	O	O
are	O	O	O
boosted	O	O	O
by	O	O	O
infection	O	O	B-T046
,	O	O	O
which	O	O	O
impacts	O	O	O
the	O	O	O
acquisition	O	O	O
of	O	O	O
immunity	O	O	B-T039
.	O	O	O

We	O	O	O
examined	O	O	O
responses	O	O	B-T039
to	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
merozoite	O	O	B-T204
antigens	O	O	B-T129
in	O	O	O
2	O	O	O
different	O	O	O
cohorts	O	O	O
of	O	O	O
children	O	O	B-T100
and	O	O	O
adults	O	O	B-T100
with	O	O	O
different	O	O	O
age	O	O	B-T032
structures	O	O	O
and	O	O	O
levels	O	O	O
of	O	O	O
malaria	O	O	B-T047
exposure	O	O	O
.	O	O	O

Overall	O	O	O
,	O	O	O
antibodies	O	O	B-T116
were	O	O	O
associated	O	O	O
with	O	O	O
age	O	O	B-T032
,	O	O	O
exposure	O	O	O
,	O	O	O
and	O	O	O
active	O	O	O
infection	O	O	B-T046
,	O	O	O
and	O	O	O
the	O	O	O
repertoire	O	O	O
of	O	O	O
responses	O	O	B-T039
increased	O	O	O
with	O	O	O
age	O	O	O
and	O	O	O
active	O	O	O
infection	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
rates	O	O	O
of	O	O	O
antibody	O	O	B-T116
acquisition	O	O	B-T052
varied	O	O	O
between	O	O	O
antigens	O	O	B-T129
and	O	O	O
different	O	O	O
regions	O	O	O
within	O	O	O
an	O	O	O
antigen	O	O	B-T129
following	O	O	O
exposure	O	O	O
to	O	O	O
malaria	O	O	B-T047
,	O	O	O
supporting	O	O	O
our	O	O	O
hypothesis	O	O	B-T078
.	O	O	O

Antigen	O	O	B-T129
-specific	O	O	O
responses	O	O	B-T039
could	O	O	O
be	O	O	O
broadly	O	O	O
classified	O	O	O
into	O	O	O
early	O	O	O
response	O	O	B-T039
types	O	O	O
in	O	O	O
which	O	O	O
antibodies	O	O	B-T116
were	O	O	O
acquired	O	O	B-T080
early	O	O	O
in	O	O	O
childhood	O	O	B-T079
exposure	O	O	O
and	O	O	O
late	O	O	B-T079
response	O	O	I-T079
types	O	O	O
that	O	O	O
appear	O	O	O
to	O	O	O
require	O	O	O
substantially	O	O	O
more	O	O	O
exposure	O	O	O
for	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
substantial	O	O	O
levels	O	O	O
.	O	O	O

We	O	O	O
identified	O	O	O
antigen	O	O	B-T129
-specific	O	O	O
responses	O	O	B-T039
that	O	O	O
were	O	O	O
effectively	O	O	O
boosted	O	O	O
after	O	O	O
recent	O	O	O
infection	O	O	B-T046
,	O	O	O
whereas	O	O	O
other	O	O	O
responses	O	O	O
were	O	O	O
not	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
advance	O	O	O
our	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
acquisition	O	O	B-T052
of	O	O	O
human	O	O	B-T016
immunity	O	O	B-T039
to	O	O	O
malaria	O	O	B-T047
and	O	O	O
are	O	O	O
relevant	O	O	O
to	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
malaria	O	O	B-T129
vaccines	O	O	I-T129
targeting	O	O	O
merozoite	O	O	B-T204
antigens	O	O	B-T129
and	O	O	O
the	O	O	O
selection	O	O	O
of	O	O	O
antigens	O	O	O
for	O	O	O
use	O	O	O
in	O	O	O
malaria	O	O	O
surveillance	O	O	B-T058
.	O	O	O

-DOCSTART- (27837093)

Variety	O	O	B-T077
of	O	O	O
DNA	O	O	B-T045
Replication	O	O	I-T045
Activity	O	O	I-T045
Among	O	O	O
Cyanobacteria	O	O	B-T007
Correlates	O	O	B-T039
with	O	O	O
Distinct	O	O	O
Respiration	O	O	B-T039
Activity	O	O	I-T039
in	O	O	O
the	O	O	O
Dark	O	O	O

Cyanobacteria	O	O	B-T007
exhibit	O	O	O
light	O	O	B-T070
-dependent	O	O	O
cell	O	O	B-T043
growth	O	O	I-T043
since	O	O	O
most	O	O	O
of	O	O	O
their	O	O	O
cellular	O	O	B-T025
energy	O	O	B-T081
is	O	O	O
obtained	O	O	O
by	O	O	O
photosynthesis	O	O	B-T070
.	O	O	O

In	O	O	O
Synechococcus	O	O	B-T007
elongatus	O	O	I-T007
PCC	O	O	I-T007
7942	O	O	I-T007
,	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
model	O	O	O
cyanobacteria	O	O	B-T007
,	O	O	O
DNA	O	O	B-T045
replication	O	O	I-T045
depends	O	O	O
on	O	O	O
photosynthetic	O	O	B-T044
electron	O	O	I-T044
transport	O	O	I-T044
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
critical	O	O	B-T067
signal	O	O	I-T067
for	O	O	O
the	O	O	O
regulatory	O	O	B-T038
mechanism	O	O	B-T169
of	O	O	O
DNA	O	O	B-T045
replication	O	O	I-T045
has	O	O	O
not	O	O	O
been	O	O	O
identified	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
conservation	O	O	B-T080
of	O	O	O
this	O	O	O
regulatory	O	O	B-T169
mechanism	O	O	I-T169
has	O	O	O
not	O	O	O
been	O	O	O
investigated	O	O	B-T169
among	O	O	O
cyanobacteria	O	O	B-T007
.	O	O	O

To	O	O	O
understand	O	O	O
this	O	O	O
regulatory	O	O	B-T038
signal	O	O	B-T067
and	O	O	O
its	O	O	O
dependence	O	O	O
on	O	O	O
light	O	O	B-T070
,	O	O	O
we	O	O	O
examined	O	O	O
the	O	O	O
regulation	O	O	B-T038
of	O	O	O
DNA	O	O	B-T045
replication	O	O	I-T045
under	O	O	O
both	O	O	O
light	O	O	O
and	O	O	O
dark	O	O	B-T070
conditions	O	O	O
among	O	O	O
three	O	O	O
model	O	O	B-T075
cyanobacteria	O	O	B-T007
,	O	O	O
S.	O	O	B-T007
elongatus	O	O	I-T007
PCC	O	O	I-T007
7942	O	O	I-T007
,	O	O	O
Synechocystis	O	O	B-T007
sp.	O	O	I-T007
PCC	O	O	I-T007
6803	O	O	I-T007
and	O	O	O
Anabaena	O	O	B-T007
sp.	O	O	I-T007
PCC	O	O	I-T007
7120	O	O	I-T007
.	O	O	O

Interestingly	O	O	O
,	O	O	O
DNA	O	O	B-T045
replication	O	O	I-T045
activity	O	O	I-T045
in	O	O	O
Synechocystis	O	O	B-T007
and	O	O	O
Anabaena	O	O	B-T007
was	O	O	O
retained	O	O	B-T169
when	O	O	O
cells	O	O	B-T025
were	O	O	O
transferred	O	O	B-T033
to	O	O	I-T033
the	O	O	O
dark	O	O	B-T070
,	O	O	O
although	O	O	O
it	O	O	O
was	O	O	O
drastically	O	O	O
decreased	O	O	B-T081
in	O	O	O
S.	O	O	B-T007
elongatus	O	O	I-T007
.	O	O	O

Glycogen	O	O	B-T044
metabolism	O	O	I-T044
and	O	O	O
respiration	O	O	B-T039
were	O	O	O
higher	O	O	O
in	O	O	O
Synechocystis	O	O	B-T007
and	O	O	O
Anabaena	O	O	B-T007
than	O	O	O
in	O	O	O
S.	O	O	B-T007
elongatus	O	O	I-T007
in	O	O	O
the	O	O	O
dark	O	O	B-T070
.	O	O	O

Moreover	O	O	O
,	O	O	O
DNA	O	O	B-T045
replication	O	O	I-T045
activity	O	O	I-T045
in	O	O	O
Synechocystis	O	O	B-T007
and	O	O	O
Anabaena	O	O	B-T007
was	O	O	O
reduced	O	O	B-T081
to	O	O	O
the	O	O	O
same	O	O	O
level	O	O	O
as	O	O	O
that	O	O	O
in	O	O	O
S.	O	O	B-T007
elongatus	O	O	I-T007
by	O	O	O
inhibition	O	O	B-T052
of	O	O	O
respiratory	O	O	B-T169
electron	O	O	B-T044
transport	O	O	I-T044
after	O	O	O
transfer	O	O	O
to	O	O	O
the	O	O	O
dark	O	O	B-T070
.	O	O	O

These	O	O	O
results	O	O	O
demonstrate	O	O	O
that	O	O	O
there	O	O	O
is	O	O	O
disparity	O	O	B-T033
in	O	O	O
DNA	O	O	B-T045
replication	O	O	I-T045
occurring	O	O	O
in	O	O	O
the	O	O	O
dark	O	O	B-T070
among	O	O	O
cyanobacteria	O	O	B-T007
,	O	O	O
which	O	O	O
is	O	O	O
caused	O	O	O
by	O	O	O
the	O	O	O
difference	O	O	B-T080
in	O	O	O
activity	O	O	B-T169
of	O	O	O
respiratory	O	O	B-T169
electron	O	O	B-T044
transport	O	O	I-T044
.	O	O	O

-DOCSTART- (27838149)

Radiosensitization	O	O	B-T061
of	O	O	O
non-small-cell	O	O	B-T191
lung	O	O	I-T191
cancer	O	O	I-T191
cells	O	O	B-T025
and	O	O	O
xenografts	O	O	B-T061
by	O	O	O
the	O	O	O
interactive	O	O	B-T169
effects	O	O	I-T169
of	O	O	O
pemetrexed	O	O	B-T109
and	O	O	O
methoxyamine	O	O	O

The	O	O	O
anti-folate	O	O	B-T121
pemetrexed	O	O	B-T109
is	O	O	O
a	O	O	O
radiosensitizer	O	O	B-T121
.	O	O	O

In	O	O	O
pre-clinical	O	O	B-T170
models	O	O	I-T170
,	O	O	O
pemetrexed	O	O	B-T109
is	O	O	O
more	O	O	O
effective	O	O	B-T080
along	O	O	O
with	O	O	O
the	O	O	O
base-excision-repair	O	O	B-T045
inhibitor	O	O	B-T080
methoxyamine	O	O	B-T109
.	O	O	O

We	O	O	O
tested	O	O	B-T169
whether	O	O	O
methoxyamine	O	O	B-T109
enhances	O	O	B-T052
pemetrexed	O	O	B-T109
-mediated	O	O	O
radiosensitization	O	O	B-T061
of	O	O	O
lung	O	O	B-T191
adenocarcinoma	O	O	I-T191
cells	O	O	O
and	O	O	O
xenografts	O	O	B-T061
.	O	O	O

A549	O	O	B-T025
and	O	O	O
H1299	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
evaluated	O	O	O
for	O	O	O
cell	O	O	B-T043
cycle	O	O	I-T043
distribution	O	O	B-T169
by	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
,	O	O	O
radiosensitization	O	O	B-T061
by	O	O	O
clonogenic	O	O	B-T059
assay	O	O	I-T059
,	O	O	O
and	O	O	O
DNA	O	O	B-T045
repair	O	O	I-T045
by	O	O	O
neutral	O	O	B-T063
comet	O	O	I-T063
assay	O	O	I-T063
and	O	O	O
repair	O	O	B-T044
protein	O	O	I-T044
activation	O	O	B-T045
.	O	O	O

H460	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
included	O	O	O
in	O	O	O
some	O	O	O
studies	O	O	O
.	O	O	O

Xenografts	O	O	B-T061
in	O	O	O
nude	O	O	B-T015
mice	O	O	I-T015
received	O	O	B-T033
drug	O	O	I-T033
(	O	O	O
s	O	O	O
)	O	O	O
and/or	O	O	O
radiation	O	O	B-T070
,	O	O	O
and	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
was	O	O	O
monitored	O	O	O
by	O	O	O
caliper	O	O	B-T074
and	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
toxicity	O	O	B-T037
by	O	O	O
animal	O	O	B-T032
weight	O	O	I-T032
.	O	O	O

Exposure	O	O	B-T080
to	O	O	I-T080
pemetrexed	O	O	B-T109
/	O	O	O
methoxyamine	O	O	B-T109
for	O	O	O
24	O	O	O
(	O	O	O
H1299	O	O	B-T025
,	O	O	O
H460	O	O	B-T025
)	O	O	O
or	O	O	O
48	O	O	O
(A549)hours	O	O	O
before	O	O	O
irradiation	O	O	B-T070
resulted	O	O	O
in	O	O	O
accumulation	O	O	B-T033
of	O	O	O
cells	O	O	B-T025
near	O	O	O
the	O	O	O
radiosensitive	O	O	B-T082
G1/S	O	O	I-T082
border	O	O	I-T082
;	O	O	O
dose	O	O	B-T081
-	O	O	O
enhancement	O	O	B-T052
factors	O	O	B-T169
of	O	O	O
1.62±0.19	O	O	O
,	O	O	O
1.97±0.25	O	O	O
,	O	O	O
and	O	O	O
1.67±0.30	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
reduction	O	O	O
of	O	O	O
mean	O	O	O
inactivation	O	O	B-T169
dose	O	O	O
by	O	O	O
32	O	O	O
%	O	O	O
,	O	O	O
30	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
46	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
and	O	O	O
significant	O	O	O
reductions	O	O	O
of	O	O	O
SF2	O	O	O
and	O	O	O
SF4	O	O	O
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

Radiosensitization	O	O	B-T061
was	O	O	O
associated	O	O	O
with	O	O	O
rapid	O	O	O
DNA	O	O	B-T045
double-strand-break	O	O	I-T045
rejoining	O	O	I-T045
and	O	O	O
increased	O	O	O
levels	O	O	O
of	O	O	O
DNA-PKcs	O	O	B-T116
.	O	O	O

Both	O	O	O
tumor-growth	O	O	B-T191
rate	O	O	B-T079
and	O	O	O
tumor-growth	O	O	O
delay	O	O	B-T079
were	O	O	O
significantly	O	O	O
improved	O	O	O
by	O	O	O
adding	O	O	O
methoxyamine	O	O	B-T109
to	O	O	O
pemetrexed	O	O	B-T109
pre-irradiation	O	O	B-T070
(	O	O	O
p<0.0001	O	O	O
)	O	O	O
;	O	O	O
no	O	O	O
mice	O	O	B-T015
lost	O	O	O
weight	O	O	O
during	O	O	O
treatment	O	O	B-T169
.	O	O	O

Addition	O	O	O
of	O	O	O
methoxyamine	O	O	B-T109
to	O	O	O
pemetrexed	O	O	B-T109
and	O	O	O
fractionated	O	O	O
radiotherapy	O	O	O
may	O	O	O
improve	O	O	O
outcome	O	O	O
for	O	O	O
patients	O	O	B-T101
with	O	O	O
locally	O	O	O
advanced	O	O	O
non-squamous	O	O	B-T191
non-small-cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

-DOCSTART- (27842269)

Using	O	O	O
language	O	O	B-T171
for	O	O	O
social	O	O	B-T033
interaction	O	O	I-T033
:	O	O	O
Communication	O	O	B-T054
mechanisms	O	O	O
promote	O	O	O
recovery	O	O	O
from	O	O	O
chronic	O	O	B-T079
non-fluent	O	O	O
aphasia	O	O	O

Clinical	O	O	B-T062
research	O	O	I-T062
highlights	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
massed	O	O	B-T170
practice	O	O	I-T170
in	O	O	O
the	O	O	O
rehabilitation	O	O	B-T061
of	O	O	O
chronic	O	O	B-T079
post-stroke	O	O	B-T079
aphasia	O	O	B-T048
.	O	O	O

However	O	O	O
,	O	O	O
while	O	O	O
necessary	O	O	O
,	O	O	O
massed	O	O	B-T170
practice	O	O	I-T170
may	O	O	O
not	O	O	O
be	O	O	O
sufficient	O	O	O
for	O	O	O
ensuring	O	O	O
progress	O	O	B-T169
in	O	O	O
speech-language	O	O	B-T058
therapy	O	O	I-T058
.	O	O	O

Motivated	O	O	O
by	O	O	O
recent	O	O	O
advances	O	O	O
in	O	O	O
neuroscience	O	O	B-T091
,	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
claimed	O	O	O
that	O	O	O
using	O	O	O
language	O	O	B-T171
as	O	O	O
a	O	O	O
tool	O	O	O
for	O	O	O
communication	O	O	B-T054
and	O	O	O
social	O	O	B-T033
interaction	O	O	I-T033
leads	O	O	O
to	O	O	O
synergistic	O	O	B-T080
effects	O	O	I-T080
in	O	O	O
left	O	O	B-T029
perisylvian	O	O	I-T029
eloquent	O	O	I-T029
areas	O	O	I-T029
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
conducted	O	O	O
a	O	O	O
crossover	O	O	O
randomized	O	O	O
controlled	O	O	O
trial	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
influence	O	O	O
of	O	O	O
communicative	O	O	B-T054
language	O	O	B-T041
function	O	O	I-T041
on	O	O	O
the	O	O	O
outcome	O	O	B-T169
of	O	O	O
intensive	O	O	B-T061
aphasia	O	O	I-T061
therapy	O	O	I-T061
.	O	O	O

Eighteen	O	O	O
individuals	O	O	B-T098
with	O	O	O
left-hemisphere	O	O	B-T033
lesions	O	O	I-T033
and	O	O	O
chronic	O	O	B-T079
non-fluent	O	O	B-T048
aphasia	O	O	I-T048
each	O	O	O
received	O	O	O
two	O	O	O
types	O	O	O
of	O	O	O
training	O	O	B-T065
in	O	O	O
counterbalanced	O	O	B-T080
order	O	O	I-T080
:	O	O	O
(	O	O	O
i	O	O	O
)	O	O	O
Intensive	O	O	B-T061
Language-Action	O	O	I-T061
Therapy	O	O	I-T061
(	O	O	O
ILAT	O	O	B-T061
,	O	O	O
an	O	O	O
extended	O	O	O
form	O	O	O
of	O	O	O
Constraint-Induced	O	O	B-T061
Aphasia	O	O	I-T061
Therapy	O	O	I-T061
)	O	O	O
embedding	O	O	O
verbal	O	O	B-T061
utterances	O	O	I-T061
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
communication	O	O	B-T054
and	O	O	O
social	O	O	B-T033
interaction	O	O	I-T033
,	O	O	O
and	O	O	O
(	O	O	O
ii	O	O	O
)	O	O	O
Naming	O	O	B-T073
Therapy	O	O	I-T073
focusing	O	O	O
on	O	O	O
speech	O	O	B-T060
production	O	O	I-T060
per	O	O	I-T060
se	O	O	I-T060
.	O	O	O

Both	O	O	O
types	O	O	O
of	O	O	O
training	O	O	B-T065
were	O	O	O
delivered	O	O	O
with	O	O	O
the	O	O	O
same	O	O	O
high	O	O	O
intensity	O	O	O
(	O	O	O
3.5	O	O	O
h	O	O	O
per	O	O	O
session	O	O	O
)	O	O	O
and	O	O	O
duration	O	O	B-T079
(	O	O	O
six	O	O	O
consecutive	O	O	O
working	O	O	O
days	O	O	B-T079
)	O	O	O
,	O	O	O
with	O	O	O
therapy	O	O	B-T061
materials	O	O	B-T167
and	O	O	O
number	O	O	B-T033
of	O	O	I-T033
utterances	O	O	I-T033
matched	O	O	O
between	O	O	O
treatment	O	O	B-T061
groups	O	O	I-T061
.	O	O	O

A	O	O	O
standardized	O	O	O
aphasia	O	O	B-T048
test	O	O	B-T060
battery	O	O	I-T060
revealed	O	O	O
significantly	O	O	O
improved	O	O	O
language	O	O	B-T171
performance	O	O	B-T055
with	O	O	O
ILAT	O	O	B-T061
,	O	O	O
independent	O	O	O
of	O	O	O
when	O	O	O
this	O	O	O
method	O	O	B-T170
was	O	O	O
administered	O	O	O
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
Naming	O	O	B-T073
Therapy	O	O	I-T073
tended	O	O	O
to	O	O	O
benefit	O	O	O
language	O	O	B-T171
performance	O	O	O
only	O	O	O
when	O	O	O
given	O	O	O
at	O	O	O
the	O	O	O
onset	O	O	O
of	O	O	O
the	O	O	O
treatment	O	O	B-T061
,	O	O	O
but	O	O	O
not	O	O	O
when	O	O	O
applied	O	O	O
after	O	O	O
previous	O	O	O
intensive	O	O	O
training	O	O	B-T065
.	O	O	O

The	O	O	O
current	O	O	O
results	O	O	O
challenge	O	O	O
the	O	O	O
notion	O	O	O
that	O	O	O
massed	O	O	B-T170
practice	O	O	I-T170
alone	O	O	O
promotes	O	O	O
recovery	O	O	O
from	O	O	O
chronic	O	O	B-T079
post-stroke	O	O	B-T079
aphasia	O	O	B-T048
.	O	O	O

Instead	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
demonstrate	O	O	O
that	O	O	O
using	O	O	O
language	O	O	B-T171
for	O	O	O
communication	O	O	B-T054
and	O	O	O
social	O	O	B-T033
interaction	O	O	I-T033
increases	O	O	O
the	O	O	O
efficacy	O	O	O
of	O	O	O
intensive	O	O	B-T061
aphasia	O	O	I-T061
therapy	O	O	I-T061
.	O	O	O

-DOCSTART- (27844448)

miR-27b	O	O	B-T028
inhibits	O	O	B-T052
gastric	O	O	B-T191
cancer	O	O	I-T191
metastasis	O	O	B-T191
by	O	O	O
targeting	O	O	B-T169
NR2F2	O	O	O

Increasing	O	O	B-T169
attention	O	O	B-T041
is	O	O	O
focused	O	O	O
on	O	O	O
the	O	O	O
down-regulation	O	O	B-T044
of	O	O	O
miRNAs	O	O	B-T114
in	O	O	O
cancer	O	O	B-T191
process	O	O	I-T191
.	O	O	O

Nuclear	O	O	B-T116
receptor	O	O	I-T116
subfamily	O	O	I-T116
2	O	O	I-T116
(	O	O	O
NR2F2	O	O	B-T116
,	O	O	O
also	O	O	O
known	O	O	O
as	O	O	O
COUP-TFII	O	O	B-T116
)	O	O	O
is	O	O	O
involved	O	O	B-T169
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
many	O	O	O
types	O	O	B-T080
of	O	O	O
cancers	O	O	B-T191
,	O	O	O
but	O	O	O
its	O	O	O
role	O	O	B-T077
in	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
remains	O	O	O
elusive	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
experiment	O	O	B-T062
,	O	O	O
oncomine	O	O	B-T170
and	O	O	O
Kaplan-meier	O	O	B-T170
database	O	O	I-T170
revealed	O	O	B-T080
that	O	O	O
NR2F2	O	O	B-T116
was	O	O	O
up-regulated	O	O	B-T044
in	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
that	O	O	O
the	O	O	O
high	O	O	B-T080
NR2F2	O	O	O
expression	O	O	B-T045
contributed	O	O	B-T052
to	O	O	O
poor	O	O	B-T080
survival	O	O	B-T081
.	O	O	O

MicroRNA-27b	O	O	B-T028
was	O	O	O
targeted	O	O	B-T169
and	O	O	O
down-regulated	O	O	B-T044
by	O	O	O
NR2F2	O	O	B-T116
in	O	O	O
human	O	O	B-T016
gastric	O	O	B-T191
cancer	O	O	I-T191
tissues	O	O	B-T024
and	O	O	O
cells	O	O	B-T025
.	O	O	O

The	O	O	O
ectopic	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
miR-27b	O	O	B-T028
inhibited	O	O	B-T080
gastric	O	O	B-T191
cancer	O	O	I-T191
cell	O	O	B-T043
proliferation	O	O	I-T043
and	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

Assays	O	O	B-T059
suggested	O	O	B-T078
that	O	O	O
the	O	O	O
overexpression	O	O	B-T045
of	O	O	O
miR-27b	O	O	B-T028
could	O	O	O
promote	O	O	B-T052
MGC-803	O	O	B-T025
cells	O	O	I-T025
'	O	O	O
migration	O	O	B-T043
and	O	O	O
invasion	O	O	B-T046
and	O	O	O
retard	O	O	B-T080
their	O	O	O
metastasis	O	O	B-T191
to	O	O	O
the	O	O	O
liver	O	O	B-T023
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
down-regulation	O	O	B-T044
of	O	O	O
miR-27b	O	O	B-T028
enhanced	O	O	O
GES-1	O	O	B-T025
cells	O	O	I-T025
'	O	O	O
proliferation	O	O	B-T043
and	O	O	O
metastasis	O	O	B-T191
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

These	O	O	O
findings	O	O	B-T033
reveal	O	O	B-T080
that	O	O	O
miR-27b	O	O	B-T028
is	O	O	O
a	O	O	O
tumor	O	O	B-T028
suppressor	O	O	I-T028
in	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
a	O	O	O
biomarker	O	O	B-T201
for	O	O	O
improving	O	O	B-T080
patients	O	O	B-T101
'	O	O	O
survival	O	O	B-T081
.	O	O	O

-DOCSTART- (27845744)

Promoting	O	O	B-T052
Healthy	O	O	B-T080
Growth	O	O	B-T040
or	O	O	O
Feeding	O	O	B-T052
Obesity	O	O	B-T047
?	O	O	O
The	O	O	O
Need	O	O	B-T080
for	O	O	O
Evidence	O	O	B-T078
-Based	O	O	O
Oversight	O	O	O
of	O	O	O
Infant	O	O	B-T100
Nutritional	O	O	B-T168
Supplement	O	O	I-T168
Claims	O	O	O

The	O	O	O
Need	O	O	B-T080
for	O	O	O
Evidence	O	O	B-T078
-Based	O	O	O
Oversight	O	O	O
of	O	O	O
Infant	O	O	B-T100
Nutritional	O	O	B-T168
Supplement	O	O	I-T168
Claims	O	O	O
The	O	O	O
Developmental	O	O	B-T170
Origins	O	O	I-T170
of	O	O	I-T170
Health	O	O	I-T170
and	O	O	I-T170
Disease	O	O	I-T170
(	O	O	O
DOHaD	O	O	B-T170
)	O	O	O
model	O	O	O
recognizes	O	O	O
growth	O	O	B-T040
in	O	O	O
infancy	O	O	B-T079
and	O	O	O
childhood	O	O	B-T079
as	O	O	O
a	O	O	O
fundamental	O	O	O
determinant	O	O	O
of	O	O	O
lifespan	O	O	B-T102
health	O	O	B-T078
.	O	O	O

Evidence	O	O	B-T169
of	O	O	I-T169
long-term	O	O	B-T079
health	O	O	B-T078
risks	O	O	B-T078
among	O	O	O
small	O	O	B-T081
neonates	O	O	B-T100
who	O	O	O
subsequently	O	O	O
grow	O	O	B-T067
rapidly	O	O	B-T080
poses	O	O	O
a	O	O	O
challenge	O	O	O
for	O	O	O
interventions	O	O	B-T058
aiming	O	O	O
to	O	O	O
support	O	O	O
healthy	O	O	B-T080
growth	O	O	B-T040
,	O	O	O
not	O	O	O
merely	O	O	O
drive	O	O	O
weight	O	O	B-T033
gain	O	O	I-T033
.	O	O	O

Defining	O	O	O
healthy	O	O	B-T080
growth	O	O	B-T040
beyond	O	O	O
"	O	O	O
getting	O	O	O
bigger	O	O	O
"	O	O	O
is	O	O	O
essential	O	O	B-T080
as	O	O	O
infant	O	O	B-T100
and	O	O	O
young	O	O	B-T079
child	O	O	B-T100
feeding	O	O	B-T052
industries	O	O	B-T057
expand	O	O	O
.	O	O	O

Liquid	O	O	B-T167
-based	O	O	O
nutritional	O	O	B-T168
supplements	O	O	I-T168
,	O	O	O
originally	O	O	O
formulated	O	O	B-T168
for	O	O	O
undernourished	O	O	B-T047
children	O	O	B-T100
,	O	O	O
are	O	O	O
increasingly	O	O	B-T169
marketed	O	O	B-T057
for	O	O	O
and	O	O	O
consumed	O	O	B-T052
by	O	O	O
children	O	O	O
generally	O	O	O
.	O	O	O

Clarifying	O	O	B-T052
the	O	O	O
nature	O	O	O
of	O	O	O
the	O	O	O
evidentiary	O	O	O
base	O	O	O
on	O	O	O
which	O	O	O
structure/function	O	O	O
claims	O	O	O
promoting	O	O	B-T052
"	O	O	O
healthy	O	O	B-T080
growth	O	O	B-T040
"	O	O	O
are	O	O	O
constructed	O	O	O
is	O	O	O
important	O	O	B-T080
to	O	O	O
curb	O	O	O
invalid	O	O	O
generalizations	O	O	O
.	O	O	O

Evidence	O	O	B-T078
points	O	O	O
to	O	O	O
changing	O	O	O
social	O	O	B-T169
beliefs	O	O	B-T078
and	O	O	O
cultural	O	O	B-T169
practices	O	O	B-T041
surrounding	O	O	O
supplementary	O	O	B-T061
feeding	O	O	B-T052
,	O	O	O
raising	O	O	O
specific	O	O	B-T080
concerns	O	O	B-T078
about	O	O	O
the	O	O	O
long-term	O	O	B-T079
health	O	O	B-T078
consequences	O	O	B-T169
of	O	O	I-T169
an	O	O	O
associated	O	O	B-T080
altered	O	O	B-T169
feeding	O	O	O
culture	O	O	B-T169
,	O	O	O
including	O	O	O
reduced	O	O	B-T080
dietary	O	O	B-T168
variety	O	O	B-T077
and	O	O	O
weight	O	O	B-T033
gain	O	O	I-T033
.	O	O	O

Reassessing	O	O	B-T052
the	O	O	O
evidence	O	O	B-T169
for	O	O	I-T169
and	O	O	O
relevance	O	O	B-T080
of	O	O	O
dietary	O	O	B-T168
supplements	O	O	I-T168
'	O	O	I-T168
"	O	O	O
promoting	O	O	B-T052
healthy	O	O	B-T080
growth	O	O	B-T040
"	O	O	O
claims	O	O	O
for	O	O	O
otherwise	O	O	O
healthy	O	O	O
children	O	O	B-T100
is	O	O	O
both	O	O	O
needed	O	O	B-T080
in	O	O	O
a	O	O	O
time	O	O	O
of	O	O	O
global	O	O	B-T080
obesity	O	O	B-T047
and	O	O	O
an	O	O	O
opportunity	O	O	B-T062
to	O	O	O
refine	O	O	O
intervention	O	O	B-T061
approaches	O	O	I-T061
among	O	O	O
small	O	O	B-T081
children	O	O	O
for	O	O	O
whom	O	O	O
rapid	O	O	B-T080
subsequent	O	O	O
growth	O	O	O
in	O	O	O
early	O	O	O
life	O	O	O
augments	O	O	O
risk	O	O	B-T078
for	O	O	O
chronic	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

Scientific	O	O	B-T090
and	O	O	O
health	O	O	B-T058
care	O	O	I-T058
partnerships	O	O	B-T092
are	O	O	O
needed	O	O	B-T080
to	O	O	O
consider	O	O	O
current	O	O	O
governmental	O	O	B-UnknownType
oversight	O	O	O
shortfalls	O	O	O
in	O	O	O
protecting	O	O	O
vulnerable	O	O	O
populations	O	O	B-T098
from	O	O	O
overconsumption	O	O	B-T052
.	O	O	O

This	O	O	O
is	O	O	O
important	O	O	B-T080
because	O	O	O
we	O	O	O
may	O	O	O
be	O	O	O
doing	O	O	O
more	O	O	O
harm	O	O	O
than	O	O	O
good	O	O	O
.	O	O	O

-DOCSTART- (27845854)

On-Site	O	O	B-T082
Fertility	O	O	B-T061
Preservation	O	O	I-T061
Services	O	O	I-T061
for	O	O	O
Adolescents	O	O	B-T100
and	O	O	O
Young	O	O	B-T100
Adults	O	O	I-T100
in	O	O	O
a	O	O	O
Comprehensive	O	O	O
Cancer	O	O	O
Center	O	O	O

Adolescents	O	O	B-T100
and	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
(	O	O	O
AYAs	O	O	B-T100
)	O	O	O
receiving	O	O	O
cancer	O	O	B-T061
treatments	O	O	I-T061
that	O	O	O
may	O	O	O
impair	O	O	B-T046
fertility	O	O	I-T046
should	O	O	O
receive	O	O	O
counseling	O	O	B-T058
about	O	O	O
risk	O	O	B-T033
of	O	O	I-T033
infertility	O	O	I-T033
and	O	O	O
options	O	O	O
for	O	O	O
fertility	O	O	B-T061
preservation	O	O	I-T061
(	O	O	O
FP	O	O	B-T061
)	O	O	O
before	O	O	O
treatment	O	O	B-T061
and/or	O	O	O
during	O	O	O
survivorship	O	O	B-T079
.	O	O	O

Our	O	O	O
objective	O	O	B-T170
was	O	O	O
to	O	O	O
define	O	O	O
the	O	O	O
AYA	O	O	B-T100
patient	O	O	B-T101
population	O	O	B-T098
referred	O	O	O
to	O	O	O
an	O	O	O
on-site	O	O	B-T058
fertility	O	O	I-T058
consultation	O	O	I-T058
service	O	O	I-T058
within	O	O	O
a	O	O	O
comprehensive	O	O	B-T093
cancer	O	O	I-T093
center	O	O	I-T093
and	O	O	O
determine	O	O	O
factors	O	O	B-T169
associated	O	O	O
with	O	O	O
patients	O	O	B-T101
proceeding	O	O	O
with	O	O	O
FP	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
retrospective	O	O	B-T062
chart	O	O	I-T062
review	O	O	I-T062
of	O	O	O
AYA	O	O	B-T100
women	O	O	B-T098
who	O	O	O
completed	O	O	O
a	O	O	O
consultation	O	O	B-T058
at	O	O	O
the	O	O	O
MD	O	O	B-T058
Anderson	O	O	I-T058
Fertility	O	O	I-T058
Preservation	O	O	I-T058
and	O	O	I-T058
Family	O	O	I-T058
Building	O	O	I-T058
Service	O	O	I-T058
during	O	O	O
the	O	O	O
first	O	O	O
year	O	O	O
of	O	O	O
service	O	O	B-T057
.	O	O	O

Records	O	O	B-T170
of	O	O	O
154	O	O	O
referred	O	O	O
AYA	O	O	B-T100
patients	O	O	B-T101
were	O	O	O
reviewed	O	O	B-T080
for	O	O	O
age	O	O	B-T032
,	O	O	O
ethnicity	O	O	B-T098
,	O	O	O
cancer	O	O	B-T033
type	O	O	I-T033
gravidity	O	O	B-T033
and	O	O	O
parity	O	O	B-T033
,	O	O	O
survivorship	O	O	B-T079
status	O	O	B-T080
,	O	O	O
and	O	O	O
decision	O	O	O
to	O	O	O
pursue	O	O	O
FP	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

Patients	O	O	B-T101
(	O	O	O
mean	O	O	O
age	O	O	O
29.7	O	O	O
)	O	O	O
were	O	O	O
Caucasian	O	O	B-T098
(	O	O	O
55	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
Hispanic	O	O	B-T098
(	O	O	O
23	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
African	O	O	B-T098
American	O	O	I-T098
(	O	O	O
10	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
women	O	O	B-T098
(	O	O	O
67	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
seen	O	O	O
for	O	O	O
FP	O	O	B-T061
before	O	O	O
cancer	O	O	B-T061
treatment	O	O	I-T061
and	O	O	O
the	O	O	O
remaining	O	O	O
sought	O	O	O
options	O	O	B-T169
for	O	O	O
family	O	O	B-T058
building	O	O	I-T058
while	O	O	O
in	O	O	O
survivorship	O	O	B-T079
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
cancer	O	O	B-T033
types	O	O	I-T033
were	O	O	O
hematologic	O	O	B-T191
(	O	O	O
29	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
breast	O	O	B-T191
(	O	O	O
25	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
gynecologic	O	O	B-T191
(	O	O	O
23	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
referred	O	O	O
to	O	O	O
an	O	O	O
on-site	O	O	B-T058
fertility	O	O	I-T058
consultation	O	O	I-T058
service	O	O	I-T058
were	O	O	O
medically	O	O	O
and	O	O	O
ethnically	O	O	B-T080
diverse	O	O	B-T080
.	O	O	O

Interest	O	O	O
in	O	O	O
fertility	O	O	B-T065
counseling	O	O	I-T065
and	O	O	O
treatment	O	O	B-T061
was	O	O	O
apparent	O	O	O
in	O	O	O
both	O	O	O
survivorship	O	O	B-T079
pre-	O	O	B-T061
and	O	O	I-T061
postcancer	O	O	I-T061
treatment	O	O	I-T061
.	O	O	O

Although	O	O	O
the	O	O	O
referral	O	O	B-T058
group	O	O	B-T078
was	O	O	O
ethnically	O	O	B-T080
diverse	O	O	B-T080
,	O	O	O
Caucasian	O	O	B-T098
women	O	O	B-T098
were	O	O	O
most	O	O	O
likely	O	O	O
to	O	O	O
pursue	O	O	O
FP	O	O	B-T061
treatment	O	O	I-T061
compared	O	O	O
to	O	O	O
women	O	O	O
of	O	O	O
other	O	O	O
ethnicities	O	O	B-T080
.	O	O	O

-DOCSTART- (27847549)

Results	O	O	B-T169
of	O	O	O
a	O	O	O
Multicenter	O	O	B-T062
,	O	O	O
Randomized	O	O	B-T062
,	O	O	O
Controlled	O	O	B-T170
Trial	O	O	I-T170
of	O	O	O
a	O	O	O
Hydrogen	O	O	B-T121
Peroxide	O	O	I-T121
-based	O	O	O
Kit	O	O	B-T074
versus	O	O	O
a	O	O	O
Benzoyl	O	O	B-T109
Peroxide	O	O	I-T109
-based	O	O	O
Kit	O	O	O
in	O	O	O
Mild-to-moderate	O	O	B-T080
Acne	O	O	O

Objective	O	O	O
:	O	O	O
To	O	O	O
evaluate	O	O	B-T058
the	O	O	O
efficacy	O	O	B-T080
and	O	O	O
tolerability	O	O	B-T062
of	O	O	O
a	O	O	O
novel	O	O	O
hydrogen	O	O	B-T121
peroxide	O	O	I-T121
-based	O	O	O
regimen	O	O	B-T061
versus	O	O	O
a	O	O	O
benzoyl	O	O	B-T109
peroxide	O	O	I-T109
-based	O	O	O
regimen	O	O	O
in	O	O	O
mild-to-moderate	O	O	B-T080
acne	O	O	B-T047
.	O	O	O

Methods	O	O	B-T170
:	O	O	O
In	O	O	O
this	O	O	O
eight-	O	O	O
week	O	O	B-T079
multicenter	O	O	B-T062
study	O	O	I-T062
,	O	O	O
patients	O	O	B-T101
were	O	O	O
randomized	O	O	B-T062
to	O	O	O
either	O	O	O
a	O	O	O
hydrogen	O	O	B-T121
peroxide	O	O	I-T121
-based	O	O	O
or	O	O	O
a	O	O	O
benzoyl	O	O	B-T109
peroxide	O	O	I-T109
-based	O	O	O
regimen	O	O	B-T061
.The	O	O	O
primary	O	O	B-T080
outcome	O	O	I-T080
measure	O	O	I-T080
of	O	O	O
clinical	O	O	B-T033
response	O	O	I-T033
was	O	O	O
assessed	O	O	B-T052
using	O	O	O
the	O	O	O
Global	O	O	B-T058
Acne	O	O	I-T058
Grading	O	O	I-T058
System	O	O	I-T058
(	O	O	O
GAGS	O	O	B-T058
)	O	O	O
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
four	O	O	O
weeks	O	O	B-T079
,	O	O	O
and	O	O	O
eight	O	O	O
weeks	O	O	O
.	O	O	O

At	O	O	O
Week	O	O	B-T079
8	O	O	O
,	O	O	O
a	O	O	O
patient	O	O	B-T101
self-satisfaction	O	O	B-T170
questionnaire	O	O	I-T170
was	O	O	O
administered	O	O	B-T169
.	O	O	O

Investigators	O	O	B-T097
were	O	O	O
also	O	O	O
queried	O	O	B-T170
at	O	O	O
that	O	O	O
time	O	O	O
regarding	O	O	O
assessment	O	O	B-T058
of	O	O	O
tolerability	O	O	B-T062
and	O	O	O
cosmetic	O	O	B-T073
acceptability	O	O	B-T080
.	O	O	O

Tolerability	O	O	B-T062
was	O	O	O
also	O	O	O
measured	O	O	B-T080
at	O	O	O
each	O	O	O
visit	O	O	B-T058
.	O	O	O

Results	O	O	O
:	O	O	O
Both	O	O	O
treatment	O	O	B-T061
regimens	O	O	I-T061
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
improvement	O	O	B-T077
of	O	O	O
GAGS	O	O	B-T081
score	O	O	I-T081
at	O	O	O
Week	O	O	B-T079
8	O	O	O
compared	O	O	B-T052
to	O	O	O
baseline	O	O	B-T081
(	O	O	O
p<0.0001	O	O	O
)	O	O	O
.	O	O	O

GAGS	O	O	B-T081
score	O	O	I-T081
did	O	O	O
not	O	O	O
differ	O	O	O
significantly	O	O	O
between	O	O	O
the	O	O	O
two	O	O	O
regimens	O	O	B-T061
over	O	O	O
the	O	O	O
same	O	O	O
period	O	O	B-T079
(	O	O	O
p=0.7765	O	O	O
)	O	O	O
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
adverse	O	O	I-T033
events	O	O	I-T033
were	O	O	O
reported	O	O	B-T058
or	O	O	O
observed	O	O	B-T169
in	O	O	O
either	O	O	O
treatment	O	O	B-T062
arm	O	O	I-T062
.	O	O	O

Both	O	O	O
patients	O	O	B-T101
and	O	O	O
investigators	O	O	B-T097
found	O	O	O
both	O	O	O
regimens	O	O	B-T061
to	O	O	O
be	O	O	O
similarly	O	O	O
effective	O	O	B-T080
and	O	O	O
cosmetically	O	O	B-T073
acceptable	O	O	B-T080
.	O	O	O

Conclusion	O	O	O
:	O	O	O
A	O	O	O
novel	O	O	O
hydrogen	O	O	B-T121
peroxide	O	O	I-T121
-based	O	O	O
regimen	O	O	B-T061
was	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
comparable	O	O	B-T052
in	O	O	O
efficacy	O	O	B-T080
,	O	O	O
safety	O	O	B-T068
,	O	O	O
and	O	O	O
cosmetic	O	O	B-T073
acceptability	O	O	B-T080
to	O	O	O
a	O	O	O
benzoyl	O	O	B-T109
peroxide	O	O	I-T109
-based	O	O	O
regimen	O	O	O
in	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
mild-to-moderate	O	O	B-T080
acne	O	O	B-T047
.	O	O	O

-DOCSTART- (27847822)

Multisensory	O	O	B-T040
Integration	O	O	I-T040
in	O	O	O
the	O	O	O
Virtual	O	O	B-T048
Hand	O	O	I-T048
Illusion	O	O	I-T048
with	O	O	O
Active	O	O	O
Movement	O	O	O

Improving	O	O	O
the	O	O	O
sense	O	O	B-T041
of	O	O	I-T041
immersion	O	O	O
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
core	O	O	O
issues	O	O	O
in	O	O	O
virtual	O	O	B-T066
reality	O	O	I-T066
.	O	O	O

Perceptual	O	O	B-T048
illusions	O	O	I-T048
of	O	O	O
ownership	O	O	O
can	O	O	O
be	O	O	O
perceived	O	O	B-T041
over	O	O	O
a	O	O	O
virtual	O	O	B-T066
body	O	O	I-T066
in	O	O	O
a	O	O	O
multisensory	O	O	B-T061
virtual	O	O	B-T066
reality	O	O	I-T066
environment	O	O	O
.	O	O	O

Rubber	O	O	B-T074
Hand	O	O	I-T074
and	O	O	O
Virtual	O	O	B-T048
Hand	O	O	I-T048
Illusions	O	O	I-T048
showed	O	O	O
that	O	O	O
body	O	O	O
ownership	O	O	O
can	O	O	O
be	O	O	O
manipulated	O	O	O
by	O	O	O
applying	O	O	O
suitable	O	O	O
visual	O	O	B-T061
and	O	O	O
tactile	O	O	B-T061
stimulation	O	O	I-T061
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
investigate	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
multisensory	O	O	B-T040
integration	O	O	I-T040
in	O	O	O
the	O	O	O
Virtual	O	O	B-T048
Hand	O	O	I-T048
Illusion	O	O	I-T048
with	O	O	O
active	O	O	B-T040
movement	O	O	I-T040
.	O	O	O

A	O	O	O
virtual	O	O	B-T066
xylophone	O	O	I-T066
playing	O	O	I-T066
system	O	O	O
which	O	O	O
can	O	O	O
interactively	O	O	O
provide	O	O	O
synchronous	O	O	B-T079
visual	O	O	B-T061
,	O	O	O
tactile	O	O	B-T061
,	O	O	O
and	O	O	O
auditory	O	O	B-T061
stimulation	O	O	I-T061
was	O	O	O
constructed	O	O	O
.	O	O	O

We	O	O	O
conducted	O	O	O
two	O	O	O
experiments	O	O	O
regarding	O	O	O
different	O	O	O
movement	O	O	O
conditions	O	O	O
and	O	O	O
different	O	O	O
sensory	O	O	B-T061
stimulations	O	O	I-T061
.	O	O	O

Our	O	O	O
results	O	O	O
demonstrate	O	O	O
that	O	O	O
multisensory	O	O	B-T040
integration	O	O	I-T040
with	O	O	O
free	O	O	O
active	O	O	B-T040
movement	O	O	I-T040
can	O	O	O
improve	O	O	O
the	O	O	O
sense	O	O	B-T041
of	O	O	I-T041
immersion	O	O	B-T066
in	O	O	I-T066
virtual	O	O	I-T066
reality	O	O	I-T066
.	O	O	O

-DOCSTART- (27847836)

Obstructive	O	O	B-T169
Acute	O	O	B-T047
Pancreatitis	O	O	I-T047
Secondary	O	O	O
to	O	O	O
PEG	O	O	B-T074
Tube	O	O	I-T074
Migration	O	O	O

Percutaneous	O	O	B-T061
gastrostomy	O	O	I-T061
is	O	O	O
a	O	O	O
well-established	O	O	O
method	O	O	B-T169
of	O	O	O
providing	O	O	O
enteral	O	O	B-T061
nutrition	O	O	I-T061
to	O	O	O
patients	O	O	B-T101
incapable	O	O	B-T033
of	O	O	O
oral	O	O	B-T033
intake	O	O	I-T033
,	O	O	O
or	O	O	O
for	O	O	O
whom	O	O	O
oral	O	O	O
intake	O	O	O
is	O	O	O
insufficient	O	O	B-T080
to	O	O	O
meet	O	O	O
metabolic	O	O	B-T169
needs	O	O	B-T080
.	O	O	O

In	O	O	O
comparison	O	O	O
to	O	O	O
total	O	O	B-T061
parenteral	O	O	I-T061
nutrition	O	O	I-T061
,	O	O	O
enteral	O	O	B-T058
feeding	O	O	I-T058
is	O	O	O
advantageous	O	O	O
in	O	O	O
that	O	O	O
it	O	O	O
helps	O	O	O
maintain	O	O	O
gut	O	O	B-T023
mucosal	O	O	B-T024
integrity	O	O	B-T080
,	O	O	O
which	O	O	O
decreases	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
bacterial	O	O	B-T043
translocation	O	O	I-T043
through	O	O	O
the	O	O	O
gastrointestinal	O	O	B-T022
tract	O	O	I-T022
.	O	O	O

Complications	O	O	B-T046
include	O	O	O
bleeding	O	O	B-T046
,	O	O	O
aspiration	O	O	B-T046
,	O	O	O
internal	O	O	B-T037
organ	O	O	I-T037
injury	O	O	I-T037
,	O	O	O
perforation	O	O	B-T047
,	O	O	O
periostomal	O	O	B-T047
leaks	O	O	I-T047
,	O	O	O
tube	O	O	B-T037
dislodgement	O	O	I-T037
,	O	O	O
and	O	O	O
occlusion	O	O	B-T046
.	O	O	O

Acute	O	O	B-T047
pancreatitis	O	O	I-T047
secondary	O	O	O
to	O	O	O
percutaneous	O	O	B-T074
gastrostomy	O	O	I-T074
tube	O	O	I-T074
migration	O	O	B-T033
is	O	O	O
rare	O	O	O
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
patient	O	O	B-T101
with	O	O	O
acute	O	O	B-T079
obstructive	O	O	B-T169
pancreatitis	O	O	B-T047
secondary	O	O	O
to	O	O	O
percutaneous	O	O	B-T074
gastrostomy	O	O	I-T074
tube	O	O	I-T074
migration	O	O	B-T033
.	O	O	O

-DOCSTART- (27848238)

A	O	O	O
Tractable	O	O	B-T080
Method	O	O	B-T170
for	O	O	O
Measuring	O	O	B-T080
Nanomaterial	O	O	B-T073
Risk	O	O	B-T078
Using	O	O	O
Bayesian	O	O	O
Networks	O	O	O

While	O	O	O
control	O	O	O
banding	O	O	B-T061
has	O	O	O
been	O	O	O
identified	O	O	O
as	O	O	O
a	O	O	O
suitable	O	O	O
framework	O	O	O
for	O	O	O
the	O	O	O
evaluation	O	O	B-T078
and	O	O	O
the	O	O	O
determination	O	O	O
of	O	O	O
potential	O	O	B-T080
human	O	O	B-T016
health	O	O	B-T061
risks	O	O	I-T061
associated	O	O	O
with	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
nanomaterials	O	O	B-T073
(	O	O	O
NMs	O	O	B-T073
)	O	O	O
,	O	O	O
the	O	O	O
approach	O	O	O
currently	O	O	O
lacks	O	O	O
any	O	O	O
implementation	O	O	B-T052
that	O	O	O
enjoys	O	O	O
widespread	O	O	O
support	O	O	O
.	O	O	O

Large	O	O	O
inconsistencies	O	O	O
in	O	O	O
characterisation	O	O	O
data	O	O	B-T078
,	O	O	O
toxicological	O	O	B-T038
measurements	O	O	B-T169
and	O	O	O
exposure	O	O	O
scenarios	O	O	O
make	O	O	O
it	O	O	O
difficult	O	O	O
to	O	O	O
map	O	O	O
and	O	O	O
compare	O	O	O
the	O	O	O
risk	O	O	B-T078
associated	O	O	O
with	O	O	O
NMs	O	O	B-T073
based	O	O	O
on	O	O	O
physicochemical	O	O	B-T070
data	O	O	O
,	O	O	O
concentration	O	O	B-T081
and	O	O	O
exposure	O	O	B-UnknownType
route	O	O	I-UnknownType
.	O	O	O

Here	O	O	O
we	O	O	O
demonstrate	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
Bayesian	O	O	B-T170
networks	O	O	I-T170
as	O	O	O
a	O	O	O
reliable	O	O	O
tool	O	O	B-T169
for	O	O	O
NM	O	O	B-T073
risk	O	O	B-T078
estimation	O	O	O
.	O	O	O

This	O	O	O
tool	O	O	B-T169
is	O	O	O
tractable	O	O	B-T080
,	O	O	O
accessible	O	O	B-T080
and	O	O	O
scalable	O	O	B-T081
.	O	O	O

Most	O	O	O
importantly	O	O	O
,	O	O	O
it	O	O	O
captures	O	O	O
a	O	O	O
broad	O	O	O
span	O	O	O
of	O	O	O
data	O	O	B-T078
types	O	O	O
,	O	O	O
from	O	O	O
complete	O	O	O
,	O	O	O
high	O	O	O
quality	O	O	B-T080
data	O	O	B-T170
sets	O	O	I-T170
through	O	O	O
to	O	O	O
data	O	O	O
sets	O	O	O
with	O	O	O
missing	O	O	O
data	O	O	O
and/or	O	O	O
values	O	O	B-T081
with	O	O	O
a	O	O	O
relatively	O	O	O
high	O	O	O
spread	O	O	O
of	O	O	O
probability	O	O	B-T081
distribution	O	O	I-T081
.	O	O	O

The	O	O	O
tool	O	O	B-T169
is	O	O	O
able	O	O	O
to	O	O	O
learn	O	O	O
iteratively	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
further	O	O	O
refine	O	O	O
forecasts	O	O	O
as	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
data	O	O	B-T078
available	O	O	O
improves	O	O	O
.	O	O	O

We	O	O	O
demonstrate	O	O	O
how	O	O	O
this	O	O	O
risk	O	O	B-T078
measurement	O	O	B-T169
approach	O	O	O
works	O	O	O
on	O	O	O
NMs	O	O	B-T073
with	O	O	O
varying	O	O	O
degrees	O	O	O
of	O	O	O
risk	O	O	O
potential	O	O	B-T080
,	O	O	O
namely	O	O	O
,	O	O	O
carbon	O	O	B-T104
nanotubes	O	O	I-T104
,	O	O	O
silver	O	O	B-T196
and	O	O	O
titanium	O	O	B-T121
dioxide	O	O	I-T121
.	O	O	O

The	O	O	O
results	O	O	O
afford	O	O	O
even	O	O	O
non-experts	O	O	B-T098
an	O	O	O
accurate	O	O	O
picture	O	O	O
of	O	O	O
the	O	O	O
occupational	O	O	O
risk	O	O	B-T078
probabilities	O	O	O
associated	O	O	O
with	O	O	O
these	O	O	O
NMs	O	O	B-T073
and	O	O	O
,	O	O	O
in	O	O	O
doing	O	O	O
so	O	O	O
,	O	O	O
demonstrated	O	O	O
how	O	O	O
NM	O	O	B-T073
risk	O	O	O
can	O	O	O
be	O	O	O
evaluated	O	O	B-T078
into	O	O	O
a	O	O	O
tractable	O	O	B-T080
,	O	O	O
quantitative	O	O	B-T081
risk	O	O	O
comparator	O	O	O
.	O	O	O

-DOCSTART- (27849409)

Gender	O	O	B-T032
and	O	O	O
Direction	O	O	B-T082
of	O	O	O
Effect	O	O	B-T080
of	O	O	O
Alcohol	O	O	B-T048
Problems	O	O	I-T048
and	O	O	O
Internalizing	O	O	B-T041
Symptoms	O	O	I-T041
in	O	O	O
a	O	O	O
Longitudinal	O	O	B-T062
Sample	O	O	I-T062
of	O	O	O
College	O	O	O
Students	O	O	O

Alcohol	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
internalizing	O	O	B-T041
symptoms	O	O	I-T041
are	O	O	O
consistently	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
associated	O	O	B-T080
but	O	O	O
how	O	O	O
they	O	O	O
relate	O	O	B-T080
to	O	O	O
each	O	O	O
other	O	O	O
is	O	O	O
unclear	O	O	B-T033
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
address	O	O	O
limitations	O	O	B-T169
in	O	O	O
the	O	O	O
literature	O	O	B-T170
of	O	O	O
comorbidity	O	O	B-T078
of	O	O	O
alcohol	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
internalizing	O	O	B-T041
symptoms	O	O	I-T041
by	O	O	O
investigating	O	O	B-T169
the	O	O	O
direction	O	O	B-T082
of	O	O	O
effect	O	O	B-T080
between	O	O	O
the	O	O	O
phenotypes	O	O	B-T032
and	O	O	O
possible	O	O	O
gender	O	O	B-T032
differences	O	O	I-T032
in	O	O	O
college	O	O	B-T098
students	O	O	I-T098
.	O	O	O

We	O	O	O
utilized	O	O	O
data	O	O	B-T078
from	O	O	O
a	O	O	O
large	O	O	O
longitudinal	O	O	B-T062
study	O	O	I-T062
of	O	O	O
college	O	O	B-T098
students	O	O	I-T098
from	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
(	O	O	O
N	O	O	O
=	O	O	O
2607	O	O	O
)	O	O	O
.	O	O	O

Three	O	O	O
waves	O	O	O
of	O	O	O
questionnaire-based	O	O	B-T170
data	O	O	B-T078
were	O	O	O
collected	O	O	O
over	O	O	O
the	O	O	O
first	O	O	O
two	O	O	O
years	O	O	B-T079
of	O	O	O
college	O	O	B-T073
(	O	O	O
in	O	O	O
2011	O	O	O
-	O	O	O
2013	O	O	O
)	O	O	O
.	O	O	O

Cross-lagged	O	O	B-T081
models	O	O	I-T081
were	O	O	O
applied	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
possible	O	O	O
direction	O	O	B-T082
of	O	O	O
effect	O	O	B-T080
of	O	O	O
internalizing	O	O	B-T041
symptoms	O	O	I-T041
and	O	O	O
alcohol	O	O	B-T048
problems	O	O	I-T048
.	O	O	O

Possible	O	O	O
effects	O	O	B-T080
of	O	O	O
gender	O	O	B-T032
were	O	O	O
investigated	O	O	B-T169
using	O	O	O
multigroup	O	O	B-T081
modeling	O	O	I-T081
.	O	O	O

There	O	O	O
were	O	O	O
significant	O	O	B-T078
correlations	O	O	B-T080
between	O	O	O
alcohol	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
internalizing	O	O	B-T041
symptoms	O	O	I-T041
.	O	O	O

A	O	O	O
direction	O	O	B-T082
of	O	O	O
effect	O	O	B-T080
was	O	O	O
found	O	O	O
between	O	O	O
alcohol	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
internalizing	O	O	B-T041
symptoms	O	O	I-T041
but	O	O	O
differed	O	O	O
between	O	O	O
genders	O	O	B-T032
.	O	O	O

A	O	O	O
unidirectional	O	O	O
relationship	O	O	B-T080
varying	O	O	O
with	O	O	O
age	O	O	B-T032
was	O	O	O
identified	O	O	O
for	O	O	O
males	O	O	B-T032
where	O	O	O
alcohol	O	O	B-T048
problems	O	O	I-T048
initially	O	O	O
predicted	O	O	B-T078
internalizing	O	O	B-T041
symptoms	O	O	I-T041
followed	O	O	O
by	O	O	O
internalizing	O	O	O
symptoms	O	O	O
predicting	O	O	O
alcohol	O	O	O
problems	O	O	O
.	O	O	O

For	O	O	O
females	O	O	B-T032
,	O	O	O
a	O	O	O
unidirectional	O	O	O
relationship	O	O	B-T080
existed	O	O	O
wherein	O	O	O
alcohol	O	O	B-T048
problems	O	O	I-T048
predicted	O	O	O
internalizing	O	O	B-T041
symptoms	O	O	I-T041
.	O	O	O

Conclusions/Importance	O	O	O
:	O	O	O
We	O	O	O
conclude	O	O	O
that	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
alcohol	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
internalizing	O	O	B-T041
symptoms	O	O	I-T041
is	O	O	O
complex	O	O	B-T080
and	O	O	O
differ	O	O	O
between	O	O	O
genders	O	O	B-T032
.	O	O	O

In	O	O	O
males	O	O	B-T032
,	O	O	O
both	O	O	O
phenotypes	O	O	B-T032
are	O	O	O
predictive	O	O	B-T080
of	O	O	O
each	O	O	O
other	O	O	O
,	O	O	O
while	O	O	O
in	O	O	O
females	O	O	B-T032
the	O	O	O
relationship	O	O	B-T080
is	O	O	O
driven	O	O	O
by	O	O	O
alcohol	O	O	B-T048
problems	O	O	I-T048
.	O	O	O

Importantly	O	O	O
,	O	O	O
our	O	O	O
study	O	O	B-T062
examines	O	O	O
a	O	O	O
population-based	O	O	B-T081
sample	O	O	I-T081
,	O	O	O
revealing	O	O	O
that	O	O	O
the	O	O	O
observed	O	O	O
relationships	O	O	B-T080
between	O	O	O
alcohol	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
internalizing	O	O	B-T041
symptoms	O	O	I-T041
are	O	O	O
not	O	O	O
limited	O	O	O
to	O	O	O
individuals	O	O	B-T098
with	O	O	O
clinically	O	O	B-T060
diagnosed	O	O	I-T060
mental	O	O	B-T041
health	O	O	I-T041
or	O	O	O
substance	O	O	B-T048
use	O	O	I-T048
problems	O	O	I-T048
.	O	O	O

-DOCSTART- (27853757)

Real-time	O	O	B-T079
monitoring	O	O	B-T058
of	O	O	O
vesicle	O	O	B-T026
pH	O	O	B-T081
in	O	O	O
an	O	O	O
endocytic	O	O	B-T043
pathway	O	O	B-T044
using	O	O	O
an	O	O	O
EGF	O	O	B-T116
-	O	O	O
conjugated	O	O	O
two-photon	O	O	O
probe	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
developed	O	O	O
a	O	O	O
ratiometric	O	O	B-T120
two-photon	O	O	I-T120
probe	O	O	I-T120
(	O	O	O
BHS3	O	O	B-T120
-	O	O	O
EGF	O	O	B-T116
)	O	O	O
,	O	O	O
derived	O	O	O
from	O	O	O
a	O	O	O
pH	O	O	B-T081
sensitive	O	O	B-T169
dye	O	O	O
and	O	O	O
epidermal	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
(	O	O	O
EGF	O	O	O
)	O	O	O
,	O	O	O
for	O	O	O
real-time	O	O	B-T079
monitoring	O	O	B-T058
and	O	O	O
quantitative	O	O	B-T081
analysis	O	O	B-T062
of	O	O	O
acidic	O	O	B-T030
luminal	O	O	I-T030
pH	O	O	O
values	O	O	B-T080
during	O	O	O
endocytic	O	O	B-T043
pathway	O	O	B-T044
activity	O	O	I-T044
.	O	O	O

Two-photon	O	O	B-T059
microscopy	O	O	I-T059
imaging	O	O	I-T059
with	O	O	O
BHS3	O	O	B-T120
-	O	O	O
EGF	O	O	B-T116
allows	O	O	O
the	O	O	O
quantitative	O	O	B-T081
analysis	O	O	B-T062
of	O	O	O
pH	O	O	B-T081
distributions	O	O	B-T169
of	O	O	O
single	O	O	O
vesicles	O	O	B-T026
and	O	O	O
their	O	O	O
dynamics	O	O	B-T070
in	O	O	O
receptor-mediated	O	O	B-T043
endocytosis	O	O	I-T043
in	O	O	O
real-time	O	O	B-T079
.	O	O	O

-DOCSTART- (27856018)

Body	O	O	B-T081
burden	O	O	I-T081
of	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
among	O	O	O
HIV	O	O	B-T033
high	O	O	B-T098
risk	O	O	I-T098
population	O	O	I-T098
in	O	O	O
USA	O	O	O

HIV	O	O	B-T033
high	O	O	B-T098
risk	O	O	I-T098
population	O	O	I-T098
may	O	O	O
face	O	O	O
not	O	O	O
only	O	O	O
the	O	O	O
threat	O	O	B-T078
of	O	O	O
HIV	O	O	B-T047
infection	O	O	I-T047
but	O	O	O
also	O	O	O
a	O	O	O
higher	O	O	B-T080
chance	O	O	B-T080
of	O	O	O
exposure	O	O	B-T037
to	O	O	I-T037
environmental	O	O	I-T037
contaminants	O	O	I-T037
.	O	O	O

However	O	O	O
,	O	O	O
no	O	O	O
previous	O	O	O
studies	O	O	B-T062
have	O	O	O
examined	O	O	B-T080
the	O	O	O
body	O	O	B-T081
burden	O	O	I-T081
of	O	O	O
environmental	O	O	B-T131
pollutants	O	O	I-T131
including	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
among	O	O	O
HIV	O	O	B-T033
high	O	O	B-T098
risk	O	O	I-T098
populations	O	O	I-T098
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	O
whether	O	O	O
adults	O	O	B-T100
aged	O	O	I-T100
20	O	O	O
-	O	O	O
59	O	O	O
years	O	O	O
old	O	O	O
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
HIV	O	O	B-T047
infection	O	O	I-T047
have	O	O	O
higher	O	O	B-T080
blood	O	O	B-T033
levels	O	O	I-T033
of	O	O	I-T033
heavy	O	O	I-T033
metals	O	O	I-T033
compared	O	O	B-T052
to	O	O	O
those	O	O	O
with	O	O	O
low	O	O	B-T081
risk	O	O	I-T081
of	O	O	O
HIV	O	O	O
infection	O	O	O
in	O	O	O
United	O	O	B-T083
States	O	O	I-T083
.	O	O	O

We	O	O	O
used	O	O	O
the	O	O	O
National	O	O	B-T062
Health	O	O	I-T062
and	O	O	I-T062
Nutrition	O	O	I-T062
Examination	O	O	I-T062
Survey	O	O	I-T062
(	O	O	O
NHANES	O	O	B-T062
)	O	O	O
1999	O	O	O
-	O	O	O
2010	O	O	O
to	O	O	O
compare	O	O	B-T052
exposures	O	O	B-T080
to	O	O	I-T080
heavy	O	O	B-T196
metals	O	O	I-T196
including	O	O	O
cadmium	O	O	B-T131
,	O	O	O
lead	O	O	B-T131
,	O	O	O
and	O	O	O
total	O	O	O
mercury	O	O	B-T131
by	O	O	O
HIV	O	O	B-T033
risk	O	O	B-T033
status	O	O	I-T033
.	O	O	O

The	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
people	O	O	B-T098
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
HIV	O	O	B-T033
had	O	O	O
higher	O	O	B-T080
blood	O	O	B-T034
concentrations	O	O	I-T034
of	O	O	O
all	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
compared	O	O	B-T052
to	O	O	O
their	O	O	O
counterparts	O	O	O
with	O	O	O
lower	O	O	B-T080
HIV	O	O	B-T033
risks	O	O	I-T033
.	O	O	O

In	O	O	O
multivariate	O	O	B-T081
linear	O	O	I-T081
regression	O	O	I-T081
models	O	O	B-T075
,	O	O	O
HIV	O	O	B-T033
risk	O	O	I-T033
status	O	O	O
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	B-T081
blood	O	O	B-T059
cadmium	O	O	I-T059
,	O	O	O
lead	O	O	B-T059
,	O	O	O
and	O	O	O
total	O	O	B-T059
mercury	O	O	I-T059
after	O	O	O
adjusting	O	O	B-T169
for	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
race	O	O	B-T098
,	O	O	O
education	O	O	B-UnknownType
,	O	O	O
and	O	O	O
poverty	O	O	B-T102
income	O	O	B-T081
ratio	O	O	B-T081
.	O	O	O

Our	O	O	O
study	O	O	B-T062
suggests	O	O	O
that	O	O	O
people	O	O	B-T098
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
HIV	O	O	B-T033
have	O	O	O
significantly	O	O	O
higher	O	O	B-T080
body	O	O	B-T081
burden	O	O	I-T081
of	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
including	O	O	O
cadmium	O	O	B-T131
,	O	O	O
lead	O	O	B-T131
,	O	O	O
and	O	O	O
mercury	O	O	B-T131
compared	O	O	B-T052
to	O	O	O
those	O	O	O
with	O	O	O
low	O	O	B-T081
risk	O	O	I-T081
of	O	O	O
HIV	O	O	O
.	O	O	O

Further	O	O	O
longitudinal	O	O	B-T062
study	O	O	I-T062
collecting	O	O	O
more	O	O	B-T081
pollutants	O	O	B-T131
are	O	O	O
warranted	O	O	B-T169
to	O	O	O
determine	O	O	O
the	O	O	O
potential	O	O	B-T080
health	O	O	B-T078
effects	O	O	B-T080
of	O	O	O
these	O	O	O
elevated	O	O	B-T080
pollutants	O	O	O
on	O	O	O
both	O	O	O
HIV-infected	O	O	B-T047
and	O	O	O
HIV	O	O	B-T033
high-risk	O	O	B-T098
populations	O	O	I-T098
.	O	O	O

-DOCSTART- (27857155)

Fluorescence-	O	O	B-T059
and	O	O	O
magnetic-activated	O	O	B-T059
cell	O	O	I-T059
sorting	O	O	I-T059
strategies	O	O	B-T169
to	O	O	O
separate	O	O	B-T080
spermatozoa	O	O	B-T025
involving	O	O	O
plural	O	O	B-T081
contributors	O	O	B-T098
from	O	O	O
biological	O	O	B-T077
mixtures	O	O	I-T077
for	O	O	O
human	O	O	O
identification	O	O	O

No	O	O	O
effective	O	O	O
method	O	O	B-T169
has	O	O	O
been	O	O	O
developed	O	O	O
to	O	O	O
distinguish	O	O	B-T080
sperm	O	O	B-T025
cells	O	O	I-T025
originating	O	O	O
from	O	O	O
different	O	O	O
men	O	O	B-T098
in	O	O	O
multi-suspect	O	O	B-T078
sexual	O	O	B-T048
assault	O	O	I-T048
cases	O	O	B-T169
.	O	O	O

Here	O	O	O
we	O	O	O
combined	O	O	O
MACS	O	O	B-T059
and	O	O	O
FACS	O	O	B-T059
to	O	O	O
isolate	O	O	B-T059
single	O	O	B-T081
donor	O	O	B-T098
sperm	O	O	B-T025
cells	O	O	I-T025
from	O	O	O
forensic	O	O	B-T167
mixture	O	O	I-T167
samples	O	O	I-T167
including	O	O	O
female	O	O	B-T098
vaginal	O	O	B-T023
epithelial	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
sperm	O	O	O
cells	O	O	O
from	O	O	O
multiple	O	O	B-T081
contributors	O	O	B-T098
.	O	O	O

Sperms	O	O	B-T025
from	O	O	O
vaginal	O	O	B-T167
swab	O	O	I-T167
were	O	O	O
isolated	O	O	B-T169
by	O	O	O
MACS	O	O	B-T059
using	O	O	O
FITC	O	O	B-T109
-conjugated	O	O	O
A	O	O	B-T116
kinase	O	O	I-T116
anchor	O	O	I-T116
protein	O	O	I-T116
3	O	O	I-T116
(	O	O	O
AKAP3	O	O	B-T116
)	O	O	O
antibody	O	O	B-T116
;	O	O	O
target	O	O	B-T098
individual	O	O	I-T098
sperm	O	O	B-T025
cells	O	O	I-T025
involving	O	O	O
two	O	O	O
or	O	O	O
three	O	O	O
donors	O	O	B-T098
were	O	O	O
separated	O	O	B-T080
by	O	O	O
FACS	O	O	B-T059
using	O	O	O
FITC	O	O	O
-labeled	O	O	O
blood	O	O	B-T116
group	O	O	I-T116
A/B	O	O	I-T116
antigen	O	O	I-T116
antibody	O	O	O
.	O	O	O

This	O	O	O
procedure	O	O	B-T169
was	O	O	O
further	O	O	O
tested	O	O	B-T169
in	O	O	O
two	O	O	O
mock	O	O	B-T033
multi-suspect	O	O	B-T078
sexual	O	O	B-T048
assault	O	O	I-T048
samples	O	O	B-T167
and	O	O	O
one	O	O	O
practical	O	O	B-T074
casework	O	O	I-T074
sample	O	O	B-T167
.	O	O	O

Our	O	O	O
results	O	O	O
showed	O	O	O
that	O	O	O
complete	O	O	B-T080
single	O	O	B-T081
donor	O	O	B-T098
STR	O	O	B-T114
profiles	O	O	I-T114
could	O	O	O
be	O	O	O
successfully	O	O	O
obtained	O	O	O
from	O	O	O
sperm	O	O	B-T025
/	O	O	O
epithelial	O	O	B-T025
cell	O	O	I-T025
and	O	O	O
sperm	O	O	O
mixtures	O	O	B-T167
from	O	O	O
two	O	O	O
contributors	O	O	B-T098
.	O	O	O

For	O	O	O
unbalanced	O	O	O
sperm	O	O	B-T025
/	O	O	O
epithelial	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
sperm	O	O	B-T025
cells	O	O	I-T025
mixtures	O	O	B-T167
,	O	O	O
sensitivity	O	O	B-T081
results	O	O	O
revealed	O	O	O
that	O	O	O
target	O	O	B-T034
cells	O	O	I-T034
could	O	O	O
be	O	O	O
detected	O	O	B-T033
at	O	O	O
as	O	O	O
low	O	O	O
as	O	O	O
1:32	O	O	O
and	O	O	O
1:8	O	O	O
mixed	O	O	O
ratios	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Although	O	O	O
highly	O	O	O
relies	O	O	O
on	O	O	O
cell	O	O	B-T059
number	O	O	I-T059
and	O	O	O
blood	O	O	B-T201
types	O	O	I-T201
or	O	O	O
secretor	O	O	O
status	O	O	O
of	O	O	O
the	O	O	O
individuals	O	O	B-T098
,	O	O	O
this	O	O	O
procedure	O	O	B-T169
would	O	O	O
still	O	O	O
be	O	O	O
useful	O	O	O
tools	O	O	O
for	O	O	O
forensic	O	O	B-T059
DNA	O	O	I-T059
analysis	O	O	I-T059
of	O	O	O
multi-suspect	O	O	B-T078
sexual	O	O	B-T048
assault	O	O	I-T048
cases	O	O	B-T169
by	O	O	O
the	O	O	O
combined	O	O	O
use	O	O	B-T169
of	O	O	I-T169
FACS	O	O	B-T059
and	O	O	O
MACS	O	O	B-T059
based	O	O	O
on	O	O	O
sperm	O	O	B-T025
-specific	O	O	O
AKAP3	O	O	B-T116
antigen	O	O	B-T129
and	O	O	O
human	O	O	B-T016
blood	O	O	B-T034
type	O	O	I-T034
antigen	O	O	I-T034
.	O	O	O

-DOCSTART- (27857815)

The	O	O	O
Role	O	O	O
of	O	O	O
the	O	O	O
Iron	O	O	B-T059
Stain	O	O	I-T059
in	O	O	O
Assessing	O	O	B-T052
Intracranial	O	O	O
Hemorrhage	O	O	O

The	O	O	O
timing	O	O	B-T079
of	O	O	O
the	O	O	O
breakdown	O	O	O
of	O	O	O
red	O	O	B-T025
blood	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
organization	O	O	B-T169
of	O	O	O
hemorrhage	O	O	B-T046
has	O	O	O
significance	O	O	B-T081
in	O	O	O
the	O	O	O
catabolism	O	O	B-T040
of	O	O	O
heme	O	O	B-T109
and	O	O	O
the	O	O	O
processing	O	O	B-T052
of	O	O	O
iron	O	O	B-T121
,	O	O	O
but	O	O	O
also	O	O	O
has	O	O	O
a	O	O	O
practical	O	O	O
application	O	O	B-T169
in	O	O	O
terms	O	O	O
of	O	O	O
assigning	O	O	B-T169
,	O	O	O
or	O	O	O
attempting	O	O	B-T051
to	O	O	O
assign	O	O	B-T169
,	O	O	O
a	O	O	O
time	O	O	B-T079
course	O	O	I-T079
with	O	O	O
respect	O	O	O
to	O	O	O
traumatic	O	O	B-T037
events	O	O	B-T051
(	O	O	O
e.g.	O	O	O
contusions	O	O	B-T037
and	O	O	O
hemorrhages	O	O	B-T046
)	O	O	O
.	O	O	O

Attempts	O	O	B-T051
to	O	O	O
date	O	O	B-T037
contusions	O	O	I-T037
,	O	O	O
however	O	O	O
,	O	O	O
have	O	O	O
generally	O	O	O
been	O	O	O
unsuccessful	O	O	B-T080
by	O	O	O
macroscopic	O	O	B-T059
observation	O	O	I-T059
,	O	O	O
whereas	O	O	O
the	O	O	O
microscopic	O	O	B-T059
observations	O	O	I-T059
provide	O	O	O
broad	O	O	O
data	O	O	B-T078
but	O	O	O
are	O	O	O
also	O	O	O
anatomically	O	O	B-T080
imprecise	O	O	B-T080
as	O	O	O
a	O	O	O
function	O	O	B-T169
of	O	O	O
time	O	O	B-T079
.	O	O	O

Intracranial	O	O	B-T033
lesions	O	O	I-T033
are	O	O	O
of	O	O	O
particular	O	O	O
significance	O	O	B-T081
with	O	O	O
respect	O	O	O
to	O	O	O
the	O	O	O
timing	O	O	B-T079
of	O	O	O
organizing	O	O	B-T169
hemorrhage	O	O	B-T046
given	O	O	O
the	O	O	O
acute	O	O	B-T079
,	O	O	O
and	O	O	O
often	O	O	O
life-threatening	O	O	B-T033
nature	O	O	B-T078
of	O	O	O
the	O	O	O
hemorrhages	O	O	B-T046
,	O	O	O
and	O	O	O
the	O	O	O
medicolegal	O	O	B-T060
investigation	O	O	I-T060
into	O	O	O
potential	O	O	B-T080
crimes	O	O	B-T068
.	O	O	O

Of	O	O	O
concern	O	O	O
is	O	O	O
that	O	O	O
the	O	O	O
Prussian	O	O	B-T059
Blue	O	O	I-T059
reaction	O	O	B-T169
for	O	O	O
iron	O	O	B-T121
,	O	O	O
a	O	O	O
relatively	O	O	O
straightforward	O	O	O
histochemical	O	O	B-T059
reaction	O	O	O
that	O	O	O
has	O	O	O
been	O	O	O
in	O	O	O
use	O	O	O
for	O	O	O
over	O	O	O
150	O	O	O
years	O	O	B-T079
,	O	O	O
is	O	O	O
sometimes	O	O	O
suggested	O	O	O
as	O	O	O
a	O	O	O
diagnostic	O	O	B-T060
test	O	O	I-T060
for	O	O	O
chronicity	O	O	B-T079
.	O	O	O

Therefore	O	O	O
,	O	O	O
this	O	O	O
study	O	O	B-T062
examined	O	O	B-T033
the	O	O	O
utility	O	O	O
of	O	O	O
the	O	O	O
Prussian	O	O	B-T121
Blue	O	O	I-T121
iron	O	O	I-T121
stain	O	O	I-T121
in	O	O	O
living	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
intracranial	O	O	B-T047
hemorrhages	O	O	I-T047
and	O	O	O
well-defined	O	O	O
symptom	O	O	B-T079
onset	O	O	I-T079
,	O	O	O
to	O	O	O
test	O	O	O
whether	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
Prussian	O	O	O
Blue	O	O	O
reactivity	O	O	B-UnknownType
could	O	O	O
be	O	O	O
correlated	O	O	B-T080
with	O	O	O
chronicity	O	O	B-T079
.	O	O	O

It	O	O	O
was	O	O	O
found	O	O	B-T033
that	O	O	O
out	O	O	O
of	O	O	O
12	O	O	O
cases	O	O	B-T169
with	O	O	O
intracranial	O	O	B-T047
hemorrhage	O	O	I-T047
,	O	O	O
eight	O	O	O
cases	O	O	O
showed	O	O	O
at	O	O	O
least	O	O	O
focal	O	O	B-T121
iron	O	O	I-T121
reactivity	O	O	B-UnknownType
.	O	O	O

The	O	O	O
duration	O	O	B-T079
from	O	O	O
symptom	O	O	B-T079
onset	O	O	I-T079
to	O	O	O
surgery	O	O	B-T061
in	O	O	O
those	O	O	O
eight	O	O	O
cases	O	O	B-T169
ranged	O	O	B-T081
from	O	O	O
<	O	O	O
24	O	O	O
hours	O	O	B-T079
to	O	O	O
more	O	O	O
than	O	O	O
3	O	O	O
days	O	O	B-T079
.	O	O	O

Of	O	O	O
those	O	O	O
cases	O	O	B-T169
with	O	O	O
no	O	O	B-T033
iron	O	O	I-T033
reactivity	O	O	I-T033
,	O	O	O
the	O	O	O
duration	O	O	B-T079
from	O	O	O
symptom	O	O	B-T079
onset	O	O	I-T079
to	O	O	O
surgery	O	O	B-T061
ranged	O	O	O
from	O	O	O
<	O	O	O
24	O	O	O
hours	O	O	B-T079
to	O	O	O
six	O	O	O
days	O	O	B-T079
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
the	O	O	O
Prussian	O	O	B-T059
Blue	O	O	I-T059
reaction	O	O	I-T059
was	O	O	O
unreliable	O	O	B-T078
as	O	O	O
an	O	O	O
indicator	O	O	B-T130
of	O	O	O
timing	O	O	B-T079
in	O	O	O
intracranial	O	O	B-T047
hemorrhage	O	O	I-T047
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
the	O	O	O
Prussian	O	O	B-T059
blue	O	O	I-T059
reaction	O	O	I-T059
as	O	O	O
an	O	O	O
independent	O	O	B-T130
indicator	O	O	I-T130
of	O	O	O
chronicity	O	O	B-T079
is	O	O	O
therefore	O	O	O
not	O	O	O
valid	O	O	B-T080
and	O	O	O
can	O	O	O
be	O	O	O
misleading	O	O	O
.	O	O	O

Caution	O	O	O
is	O	O	O
indicated	O	O	B-T033
when	O	O	O
employing	O	O	O
iron	O	O	B-T059
staining	O	O	I-T059
for	O	O	O
timing	O	O	B-T079
purposes	O	O	O
,	O	O	O
as	O	O	O
its	O	O	O
only	O	O	O
use	O	O	O
is	O	O	O
to	O	O	O
highlight	O	O	O
,	O	O	O
as	O	O	O
opposed	O	O	O
to	O	O	O
identify	O	O	O
,	O	O	O
pre-existing	O	O	B-T080
lesions	O	O	B-T033
.	O	O	O

With	O	O	O
respect	O	O	O
to	O	O	O
brain	O	O	B-T047
lesions	O	O	I-T047
,	O	O	O
the	O	O	O
Prussian	O	O	B-T059
blue	O	O	I-T059
reaction	O	O	I-T059
should	O	O	O
not	O	O	O
be	O	O	O
used	O	O	O
in	O	O	O
place	O	O	O
of	O	O	O
the	O	O	O
clinical	O	O	B-T080
timing	O	O	B-T079
of	O	O	O
the	O	O	O
neurologic	O	O	B-T033
decline	O	O	I-T033
,	O	O	O
or	O	O	O
clinical	O	O	B-T170
data	O	O	I-T170
that	O	O	O
is	O	O	O
otherwise	O	O	O
more	O	O	O
accurate	O	O	B-T080
and	O	O	O
less	O	O	O
susceptible	O	O	B-T169
to	O	O	O
false	O	O	B-T034
positive	O	O	I-T034
results	O	O	I-T034
.	O	O	O

-DOCSTART- (27860542)

Successful	O	O	B-T080
Fetal	O	O	B-T060
Tele-Echo	O	O	I-T060
at	O	O	O
a	O	O	O
Small	O	O	O
Regional	O	O	O
Hospital	O	O	O

Prenatal	O	O	B-T060
diagnosis	O	O	I-T060
of	O	O	O
complex	O	O	B-T080
congenital	O	O	B-T019
heart	O	O	I-T019
disease	O	O	I-T019
(	O	O	O
CHD	O	O	B-T019
)	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
improve	O	O	B-T033
newborn	O	O	B-T033
outcomes	O	O	B-T169
.	O	O	O

The	O	O	O
rate	O	O	O
of	O	O	O
prenatal	O	O	B-T060
diagnosis	O	O	I-T060
and	O	O	O
access	O	O	B-T082
to	O	O	O
fetal	O	O	B-T060
echocardiography	O	O	I-T060
vary	O	O	O
widely	O	O	O
across	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
.	O	O	O

A	O	O	O
clinical	O	O	B-T060
fetal	O	O	I-T060
tele-echo	O	O	I-T060
service	O	O	O
was	O	O	O
established	O	O	O
at	O	O	O
King	O	O	B-T093
's	O	O	I-T093
Daughters	O	O	I-T093
Medical	O	O	I-T093
Center	O	O	I-T093
(	O	O	O
KDMC	O	O	B-T093
)	O	O	O
in	O	O	O
Ashland	O	O	B-T083
,	O	O	O
KY	O	O	B-T083
,	O	O	O
a	O	O	O
region	O	O	O
in	O	O	O
eastern	O	O	B-T083
Kentucky	O	O	I-T083
that	O	O	O
is	O	O	O
3	O	O	O
h	O	O	O
from	O	O	O
the	O	O	O
nearest	O	O	O
congenital	O	O	B-T097
heart	O	O	I-T097
surgeon	O	O	I-T097
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
if	O	O	O
fetal	O	O	B-T060
tele-echo	O	O	I-T060
utilizing	O	O	O
local	O	O	B-T097
sonographers	O	O	I-T097
at	O	O	O
a	O	O	O
small	O	O	B-T093
regional	O	O	I-T093
hospital	O	O	I-T093
can	O	O	O
accurately	O	O	B-T080
and	O	O	O
efficiently	O	O	B-T080
identify	O	O	O
fetuses	O	O	B-T018
with	O	O	O
complex	O	O	B-T080
CHD	O	O	B-T019
.	O	O	O

Medical	O	O	B-T170
records	O	O	I-T170
were	O	O	O
reviewed	O	O	B-T080
for	O	O	O
all	O	O	O
mother-infant	O	O	B-T058
pairs	O	O	I-T058
who	O	O	O
had	O	O	O
fetal	O	O	B-T060
tele-echoes	O	O	I-T060
performed	O	O	B-T169
at	O	O	O
KDMC	O	O	B-T093
and	O	O	O
interpreted	O	O	B-T169
by	O	O	O
University	O	O	B-T093
of	O	O	I-T093
Louisville	O	O	I-T093
pediatric	O	O	I-T093
cardiology	O	O	I-T093
between	O	O	O
March	O	O	O
2011	O	O	O
and	O	O	O
December	O	O	O
2013	O	O	O
.	O	O	O

Findings	O	O	B-T033
on	O	O	O
fetal	O	O	B-T060
tele-echo	O	O	I-T060
were	O	O	O
compared	O	O	O
to	O	O	O
newborn	O	O	B-T100
echo	O	O	B-T060
and	O	O	O
clinical	O	O	B-T079
course	O	O	I-T079
,	O	O	O
and	O	O	O
divided	O	O	O
into	O	O	O
four	O	O	O
groups	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
Correct	O	O	B-T080
-	O	O	O
no	O	O	B-T033
difference	O	O	I-T033
between	O	O	O
fetal	O	O	O
tele-echo	O	O	O
and	O	O	O
newborn	O	O	O
echo	O	O	O
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
Likely	O	O	O
Correct-normal	O	O	O
fetal	O	O	O
tele-echo	O	O	O
and	O	O	O
benign	O	O	O
newborn	O	O	O
course	O	O	O
,	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
Major	O	O	B-T081
Difference	O	O	I-T081
-one	O	O	O
that	O	O	O
affected	O	O	B-T169
newborn	O	O	O
clinical	O	O	O
course	O	O	O
,	O	O	O
and	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
Minor	O	O	B-T081
Difference	O	O	I-T081
-did	O	O	O
not	O	O	O
affect	O	O	O
clinical	O	O	O
course	O	O	O
.	O	O	O

Seventy-five	O	O	O
mother-infant	O	O	B-T058
pairs	O	O	I-T058
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Fetal	O	O	B-T060
tele-echoes	O	O	I-T060
were	O	O	O
Correct	O	O	B-T080
in	O	O	O
21	O	O	O
%	O	O	O
,	O	O	O
Likely	O	O	O
Correct	O	O	O
in	O	O	O
56	O	O	O
%	O	O	O
,	O	O	O
showed	O	O	O
Major	O	O	B-T081
Differences	O	O	I-T081
in	O	O	O
0	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
showed	O	O	O
Minor	O	O	B-T081
Differences	O	O	I-T081
in	O	O	O
23	O	O	O
%	O	O	O
.	O	O	O

For	O	O	O
identifying	O	O	O
complex	O	O	B-T080
CHD	O	O	B-T019
,	O	O	O
fetal	O	O	B-T060
tele-echo	O	O	I-T060
had	O	O	O
a	O	O	O
sensitivity	O	O	B-T169
and	O	O	O
specificity	O	O	B-T081
of	O	O	O
100	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
average	O	O	O
number	O	O	O
of	O	O	O
fetal	O	O	B-T060
echocardiograms	O	O	I-T060
per	O	O	O
mother-infant	O	O	B-T058
pair	O	O	I-T058
was	O	O	O
1.1	O	O	O
.	O	O	O

Fetal	O	O	B-T060
tele-echocardiography	O	O	I-T060
performed	O	O	B-T169
by	O	O	O
local	O	O	B-T097
sonographers	O	O	I-T097
at	O	O	O
a	O	O	O
small	O	O	B-T093
regional	O	O	I-T093
hospital	O	O	I-T093
can	O	O	O
accurately	O	O	B-T080
and	O	O	O
efficiently	O	O	B-T080
identify	O	O	O
fetuses	O	O	B-T018
with	O	O	O
complex	O	O	B-T080
CHD	O	O	B-T019
.	O	O	O

-DOCSTART- (27861731)

Identification	O	O	B-T080
of	O	O	O
mineral	O	O	B-T197
-	O	O	O
binding	O	O	B-T052
peptides	O	O	B-T116
that	O	O	O
discriminate	O	O	B-T080
between	O	O	O
chalcopyrite	O	O	B-T197
and	O	O	O
enargite	O	O	O

Innovative	O	O	O
approaches	O	O	O
to	O	O	O
the	O	O	O
separation	O	O	B-T080
of	O	O	O
minerals	O	O	B-T197
and	O	O	O
subsequent	O	O	B-T079
extraction	O	O	B-T059
of	O	O	O
metals	O	O	B-T197
are	O	O	O
imperative	O	O	B-T080
owing	O	O	O
to	O	O	O
the	O	O	O
increasing	O	O	B-T169
mineralogical	O	O	B-T197
complexity	O	O	B-T080
of	O	O	O
ore	O	O	B-T197
deposits	O	O	I-T197
that	O	O	O
are	O	O	O
difficult	O	O	B-T080
or	O	O	O
even	O	O	O
impossible	O	O	B-T033
to	O	O	O
separate	O	O	B-T080
into	O	O	O
slurries	O	O	B-T167
or	O	O	O
solutions	O	O	B-T167
containing	O	O	B-T169
only	O	O	O
the	O	O	O
minerals	O	O	O
or	O	O	O
metals	O	O	O
of	O	O	O
interest	O	O	O
.	O	O	O

Low	O	O	B-T080
recovery	O	O	B-T052
of	O	O	O
metal	O	O	B-T197
is	O	O	O
typical	O	O	B-T080
for	O	O	O
these	O	O	O
complex	O	O	B-T080
deposits	O	O	B-T197
leading	O	O	O
to	O	O	O
significant	O	O	B-T078
losses	O	O	B-T081
to	O	O	O
tailings	O	O	B-T131
.	O	O	O

In	O	O	B-T169
addition	O	O	I-T169
,	O	O	O
the	O	O	O
minerals	O	O	B-T197
often	O	O	O
contain	O	O	O
impurities	O	O	B-T167
,	O	O	O
some	O	O	O
toxic	O	O	B-T080
,	O	O	O
which	O	O	O
are	O	O	O
difficult	O	O	B-T080
and	O	O	O
costly	O	O	B-T169
to	O	O	O
control	O	O	B-T169
or	O	O	O
manage	O	O	O
during	O	O	O
the	O	O	O
processing	O	O	B-T052
of	O	O	O
a	O	O	O
concentrate	O	O	B-T080
or	O	O	O
other	O	O	O
mineral	O	O	B-T197
product	O	O	B-T071
.	O	O	O

One	O	O	O
example	O	O	B-T077
of	O	O	O
this	O	O	O
complex	O	O	B-T080
situation	O	O	O
is	O	O	O
the	O	O	O
significant	O	O	B-T078
economic	O	O	B-T169
and	O	O	O
environmental	O	O	B-T082
costs	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
diluting	O	O	B-T169
and	O	O	O
processing	O	O	B-T052
copper	O	O	B-T121
concentrates	O	O	B-T080
containing	O	O	B-T169
arsenic	O	O	B-T121
(	O	O	O
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
the	O	O	O
mineral	O	O	B-T197
enargite	O	O	I-T197
,	O	O	O
Cu3	O	O	B-T197
AsS4	O	O	I-T197
)	O	O	O
in	O	O	O
the	O	O	O
production	O	O	B-T057
of	O	O	O
pure	O	O	B-T081
copper	O	O	O
.	O	O	O

To	O	O	O
overcome	O	O	O
these	O	O	O
separation	O	O	B-T080
problems	O	O	B-T033
,	O	O	O
we	O	O	O
have	O	O	O
utilized	O	O	O
phage	O	O	B-T063
display	O	O	I-T063
to	O	O	O
identify	O	O	B-T080
peptides	O	O	B-T116
that	O	O	O
demonstrate	O	O	O
selective	O	O	B-T080
recognition	O	O	B-T080
of	O	O	O
enargite	O	O	B-T197
and	O	O	O
the	O	O	O
arsenic	O	O	B-T121
-	O	O	O
free	O	O	B-T169
copper	O	O	B-T197
sulfide	O	O	I-T197
,	O	O	O
chalcopyrite	O	O	B-T197
.	O	O	O

Screening	O	O	O
of	O	O	O
two	O	O	O
random	O	O	B-T080
peptide	O	O	B-T116
phage	O	O	I-T116
display	O	O	I-T116
libraries	O	O	I-T116
resulted	O	O	O
in	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
an	O	O	O
enargite	O	O	B-T197
-	O	O	O
selective	O	O	B-T080
peptide	O	O	O
with	O	O	O
the	O	O	O
sequence	O	O	B-T087
MHKPTVHIKGPT	O	O	I-T087
and	O	O	O
a	O	O	O
chalcopyrite	O	O	B-T197
-	O	O	O
selective	O	O	O
peptide	O	O	O
with	O	O	O
the	O	O	O
sequence	O	O	B-T087
RKKKCKGNCCYTPQ	O	O	I-T087
.	O	O	O

Mineral	O	O	B-T197
-	O	O	O
binding	O	O	B-T052
selectivity	O	O	B-T080
was	O	O	O
demonstrated	O	O	O
by	O	O	O
binding	O	O	O
studies	O	O	B-T062
,	O	O	O
zeta	O	O	B-T067
potential	O	O	I-T067
determination	O	O	B-T059
and	O	O	O
immunochemistry	O	O	B-T091
.	O	O	O

Peptides	O	O	B-T116
that	O	O	O
have	O	O	O
the	O	O	O
ability	O	O	B-T033
to	O	O	O
discriminate	O	O	B-T080
between	O	O	O
enargite	O	O	B-T197
and	O	O	O
chalcopyrite	O	O	B-T197
provide	O	O	O
a	O	O	O
greener	O	O	O
option	O	O	B-T169
for	O	O	O
the	O	O	O
separation	O	O	B-T080
of	O	O	O
arsenic	O	O	B-T121
containing	O	O	B-T169
contaminants	O	O	B-T167
from	O	O	O
copper	O	O	B-T121
concentrates	O	O	B-T080
.	O	O	O

This	O	O	O
represents	O	O	O
the	O	O	O
first	O	O	O
step	O	O	O
towards	O	O	O
a	O	O	O
major	O	O	B-T080
advance	O	O	B-T079
in	O	O	O
the	O	O	O
replacement	O	O	B-T169
or	O	O	O
reduction	O	O	B-T080
of	O	O	O
toxic	O	O	B-T080
collectors	O	O	B-T169
as	O	O	O
well	O	O	O
as	O	O	O
reducing	O	O	B-T080
the	O	O	O
level	O	O	B-T080
of	O	O	O
arsenic	O	O	B-T121
-	O	O	O
bearing	O	O	B-T052
minerals	O	O	B-T197
in	O	O	O
the	O	O	O
early	O	O	B-T079
stages	O	O	B-T079
of	O	O	O
mineral	O	O	B-T197
processing	O	O	B-T052
.	O	O	O

Biotechnol	O	O	O
.	O	O	O

Bioeng	O	O	O
.	O	O	O

2016;9999	O	O	O
:	O	O	O
1	O	O	O
-	O	O	O
8	O	O	O
.	O	O	O

©	O	O	O
2016	O	O	O
Wiley	O	O	O
Periodicals	O	O	O
,	O	O	O
Inc.	O	O	O

-DOCSTART- (27861771)

High-density	O	O	B-T116
lipoprotein	O	O	I-T116
-associated	O	O	O
sphingosine-1-phosphate	O	O	B-T109
activity	O	O	O
in	O	O	O
heterozygous	O	O	O
familial	O	O	O
hypercholesterolaemia	O	O	O

Patients	O	O	B-T101
with	O	O	O
heterozygous	O	O	B-T047
familial	O	O	I-T047
hypercholesterolaemia	O	O	I-T047
(	O	O	O
FH	O	O	B-T047
)	O	O	O
suffer	O	O	B-T184
from	O	O	O
high	O	O	B-T033
plasma	O	O	I-T033
cholesterol	O	O	I-T033
and	O	O	O
an	O	O	O
environment	O	O	B-T082
of	O	O	O
increased	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
.	O	O	O

We	O	O	O
examined	O	O	O
its	O	O	O
potential	O	O	O
effects	O	O	O
on	O	O	O
high-density	O	O	B-T116
lipoprotein	O	O	I-T116
(HDL)-associated	O	O	O
sphingosine-1-phosphate	O	O	B-T109
(	O	O	O
S1P	O	O	B-T109
)	O	O	O
content	O	O	O
(	O	O	O
HDL	O	O	B-T116
-	O	O	O
S1P	O	O	O
)	O	O	O
and	O	O	O
HDL	O	O	O
-mediated	O	O	O
protection	O	O	B-T039
against	O	O	I-T039
oxidative	O	O	I-T039
stress	O	O	I-T039
,	O	O	O
both	O	O	O
with	O	O	O
and	O	O	O
without	O	O	O
statin	O	O	B-T058
treatment	O	O	I-T058
.	O	O	O

In	O	O	O
a	O	O	O
case-control	O	O	B-T062
study	O	O	I-T062
,	O	O	O
HDL	O	O	B-T116
was	O	O	O
isolated	O	O	B-T169
from	O	O	O
12	O	O	O
FH	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
and	O	O	O
without	O	O	O
statin	O	O	B-T058
treatment	O	O	I-T058
and	O	O	O
from	O	O	O
12	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

The	O	O	O
HDL	O	O	B-T116
-	O	O	O
S1P	O	O	B-T109
content	O	O	O
and	O	O	O
the	O	O	O
capacity	O	O	O
of	O	O	O
HDL	O	O	O
to	O	O	O
protect	O	O	B-T033
cardiomyocytes	O	O	B-T025
against	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
in	O	O	B-T062
vitro	O	O	I-T062
were	O	O	O
measured	O	O	O
.	O	O	O

HDL	O	O	B-T116
-associated	O	O	O
S1P	O	O	B-T109
was	O	O	O
significantly	O	O	O
correlated	O	O	O
with	O	O	O
cell	O	O	B-T039
protection	O	O	I-T039
,	O	O	O
but	O	O	O
not	O	O	O
with	O	O	O
HDL-cholesterol	O	O	B-T109
or	O	O	O
apolipoprotein	O	O	B-T116
AI	O	O	I-T116
.	O	O	O

The	O	O	O
latter	O	O	O
did	O	O	O
not	O	O	O
correlate	O	O	O
with	O	O	O
HDL	O	O	B-T116
-mediated	O	O	O
cell	O	O	B-T039
protection	O	O	I-T039
.	O	O	O

Neither	O	O	O
the	O	O	O
HDL	O	O	B-T116
-	O	O	O
S1P	O	O	B-T109
content	O	O	O
nor	O	O	O
HDL	O	O	O
protective	O	O	O
capacity	O	O	O
differed	O	O	O
between	O	O	O
nontreated	O	O	O
FH	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
controls	O	O	O
.	O	O	O

The	O	O	O
relative	O	O	O
amounts	O	O	O
of	O	O	O
apolipoprotein	O	O	B-T116
AI	O	O	I-T116
and	O	O	O
apolipoprotein	O	O	B-T116
M	O	O	I-T116
were	O	O	O
similar	O	O	O
between	O	O	O
controls	O	O	O
and	O	O	O
FH	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

Statin	O	O	B-T058
treatment	O	O	I-T058
had	O	O	O
no	O	O	O
effect	O	O	O
on	O	O	O
any	O	O	O
of	O	O	O
these	O	O	O
measures	O	O	O
.	O	O	O

The	O	O	O
FH	O	O	B-T047
environment	O	O	B-T082
is	O	O	O
not	O	O	O
detrimental	O	O	O
to	O	O	O
HDL	O	O	B-T116
-	O	O	O
S1P	O	O	B-T109
content	O	O	O
or	O	O	O
HDL	O	O	O
-	O	O	O
S1P	O	O	O
-mediated	O	O	O
cell	O	O	B-T039
protection	O	O	I-T039
.	O	O	O

Statin	O	O	B-T058
treatment	O	O	I-T058
does	O	O	O
not	O	O	O
modulate	O	O	O
HDL	O	O	B-T116
function	O	O	O
in	O	O	O
this	O	O	O
regard	O	O	O
.	O	O	O

-DOCSTART- (27863736)

Moberg	O	O	B-T059
Picking-Up	O	O	I-T059
Test	O	O	I-T059
in	O	O	O
patients	O	O	B-T101
with	O	O	O
hand	O	O	O
osteoarthritis	O	O	O

Clinical	O	O	B-T058
measurement	O	O	I-T058
.	O	O	O

The	O	O	O
Moberg	O	O	B-T059
Pick-up	O	O	I-T059
Test	O	O	I-T059
(	O	O	O
MPUT	O	O	B-T059
)	O	O	O
was	O	O	O
previously	O	O	O
used	O	O	O
to	O	O	O
evaluate	O	O	O
functional	O	O	B-T033
performance	O	O	I-T033
in	O	O	O
patients	O	O	B-T101
with	O	O	O
hand	O	O	B-T023
inflammatory	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
study	O	O	O
using	O	O	O
the	O	O	O
MPUT	O	O	B-T059
in	O	O	O
hand	O	O	B-T047
osteoarthritis	O	O	I-T047
(	O	O	O
OA	O	O	B-T047
)	O	O	O
.	O	O	O

Compare	O	O	O
the	O	O	O
functional	O	O	B-T033
performance	O	O	I-T033
(	O	O	O
MPUT	O	O	B-T059
)	O	O	O
in	O	O	O
hand	O	O	B-T047
OA	O	O	I-T047
patients	O	O	B-T101
and	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

Fifty	O	O	O
hand	O	O	B-T047
OA	O	O	I-T047
patients	O	O	B-T101
and	O	O	O
50	O	O	O
controls	O	O	B-T096
were	O	O	O
assessed	O	O	O
using	O	O	O
the	O	O	O
MPUT	O	O	B-T059
,	O	O	O
AUSCAN	O	O	B-T170
and	O	O	O
Cochin	O	O	B-T170
questionnaires	O	O	I-T170
,	O	O	O
grip	O	O	B-T033
and	O	O	O
pinch	O	O	B-T060
strength	O	O	I-T060
,	O	O	O
pain	O	O	B-T184
using	O	O	O
a	O	O	O
visual	O	O	B-T060
analog	O	O	I-T060
scale	O	O	I-T060
and	O	O	O
a	O	O	O
Likert	O	O	B-T170
scale	O	O	I-T170
regarding	O	O	O
difficulty	O	O	O
to	O	O	O
perform	O	O	O
MPUT	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
MPUT	O	O	B-T059
evaluation	O	O	B-T058
,	O	O	O
the	O	O	O
OA	O	O	B-T047
group	O	O	O
presented	O	O	O
a	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
difference	O	O	O
from	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

The	O	O	O
OA	O	O	B-T047
group	O	O	O
spent	O	O	O
more	O	O	B-T081
time	O	O	B-T079
executing	O	O	O
test	O	O	B-T170
.	O	O	O

The	O	O	O
grip	O	O	B-T033
and	O	O	O
pinch	O	O	B-T060
strength	O	O	I-T060
measurements	O	O	I-T060
showed	O	O	O
higher	O	O	O
values	O	O	O
for	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

The	O	O	O
OA	O	O	B-T047
group	O	O	O
reported	O	O	O
a	O	O	O
greater	O	O	O
difficulty	O	O	B-T080
than	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
in	O	O	O
performing	O	O	O
the	O	O	O
test	O	O	B-T170
.	O	O	O

The	O	O	O
MPUT	O	O	B-T059
is	O	O	O
a	O	O	O
short	O	O	O
and	O	O	O
easy	O	O	O
to	O	O	O
apply	O	O	O
test	O	O	B-T170
,	O	O	O
which	O	O	O
can	O	O	O
be	O	O	O
safely	O	O	O
used	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
functional	O	O	B-T033
performance	O	O	I-T033
of	O	O	O
the	O	O	O
hand	O	O	B-T047
OA	O	O	I-T047
.	O	O	O

II	O	O	O
.	O	O	O

-DOCSTART- (27867770)

Soymilk	O	O	B-T168
residue	O	O	B-T077
(	O	O	O
okara	O	O	B-T116
)	O	O	O
as	O	O	O
a	O	O	O
natural	O	O	B-T169
immobilization	O	O	B-T080
carrier	O	O	I-T080
for	O	O	O
Lactobacillus	O	O	B-T007
plantarum	O	O	I-T007
cells	O	O	B-T025
enhances	O	O	B-T052
soymilk	O	O	B-T168
fermentation	O	O	B-T044
,	O	O	O
glucosidic	O	O	B-T109
isoflavone	O	O	I-T109
bioconversion	O	O	B-T169
,	O	O	O
and	O	O	O
cell	O	O	B-T043
survival	O	O	I-T043
under	O	O	O
simulated	O	O	B-T080
gastric	O	O	I-T080
and	O	O	O
intestinal	O	O	B-T023
conditions	O	O	O

Cell	O	O	B-T025
immobilization	O	O	I-T025
is	O	O	O
an	O	O	O
alternative	O	O	B-T077
to	O	O	O
microencapsulation	O	O	B-T061
for	O	O	O
the	O	O	O
maintenance	O	O	O
of	O	O	O
cells	O	O	B-T025
in	O	O	O
a	O	O	O
liquid	O	O	B-T167
medium	O	O	B-T167
.	O	O	O

However	O	O	O
,	O	O	O
artificial	O	O	B-T080
immobilization	O	O	B-T080
carriers	O	O	I-T080
are	O	O	O
expensive	O	O	O
and	O	O	O
pose	O	O	O
a	O	O	O
high	O	O	O
safety	O	O	B-T068
risk	O	O	B-T078
.	O	O	O

Okara	O	O	B-T116
,	O	O	O
a	O	O	O
food-grade	O	O	B-T168
byproduct	O	O	B-T167
from	O	O	O
soymilk	O	O	B-T168
production	O	O	B-T057
,	O	O	O
is	O	O	O
rich	O	O	O
in	O	O	O
prebiotics	O	O	B-T109
.	O	O	O

Lactobacilli	O	O	B-T007
could	O	O	O
provide	O	O	O
health	O	O	B-T078
enhancing	O	O	B-T052
effects	O	O	B-T080
to	O	O	O
the	O	O	O
host	O	O	B-T001
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
potential	O	O	O
of	O	O	O
okara	O	O	B-T116
as	O	O	O
a	O	O	O
natural	O	O	O
immobilizer	O	O	O
for	O	O	O
L.	O	O	B-T025
plantarum	O	O	I-T025
70810	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
study	O	O	O
also	O	O	O
aimed	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
okara-immobilized	O	O	B-T116
L.	O	O	B-T025
plantarum	O	O	I-T025
70810	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
IL	O	O	B-T025
)	O	O	O
on	O	O	O
soymilk	O	O	B-T168
fermentation	O	O	B-T044
,	O	O	O
glucosidic	O	O	B-T109
isoflavone	O	O	I-T109
bioconversion	O	O	B-T169
,	O	O	O
and	O	O	O
cell	O	O	B-T025
resistance	O	O	B-T169
to	O	O	O
simulated	O	O	B-T080
gastric	O	O	I-T080
and	O	O	O
intestinal	O	O	B-T023
stresses	O	O	B-T046
.	O	O	O

Scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
(	O	O	O
SEM	O	O	B-T059
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
show	O	O	O
cells	O	O	B-T025
adherence	O	O	B-T169
to	O	O	O
the	O	O	O
surface	O	O	B-T082
of	O	O	O
okara	O	O	B-T116
.	O	O	O

Lactic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
acetic	O	O	B-T109
acid	O	O	I-T109
and	O	O	O
isoflavone	O	O	B-T109
analyses	O	O	B-T062
in	O	O	O
unfermented	O	O	O
and	O	O	O
fermented	O	O	B-T168
soymilk	O	O	B-T168
were	O	O	O
performed	O	O	B-T169
by	O	O	O
HPLC	O	O	B-T059
with	O	O	I-T059
UV	O	O	I-T059
detection	O	O	I-T059
.	O	O	O

Viability	O	O	B-T080
and	O	O	O
growth	O	O	O
kinetics	O	O	O
of	O	O	O
immobilized	O	O	B-T025
and	O	O	O
free	O	O	B-T025
L.	O	O	I-T025
plantarum	O	O	I-T025
70810	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
FL	O	O	B-T025
)	O	O	O
were	O	O	O
followed	O	O	O
during	O	O	O
soymilk	O	O	B-T168
fermentation	O	O	B-T044
.	O	O	O

Moreover	O	O	O
,	O	O	O
changes	O	O	B-T169
in	O	O	O
pH	O	O	B-T034
,	O	O	O
titrable	O	O	B-T034
acidity	O	O	I-T034
and	O	O	O
viscosity	O	O	B-T070
were	O	O	O
measured	O	O	B-T080
by	O	O	O
conventional	O	O	B-T170
methods	O	O	I-T170
.	O	O	O

For	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
testing	O	O	B-T169
of	O	O	O
simulated	O	O	O
gastrointestinal	O	O	B-T082
resistance	O	O	B-T169
,	O	O	O
fermented	O	O	B-T168
soymilk	O	O	B-T168
was	O	O	O
inoculated	O	O	B-T061
with	O	O	O
FL	O	O	B-T025
or	O	O	O
IL	O	O	B-T025
and	O	O	O
an	O	O	O
aliquot	O	O	B-T081
incubated	O	O	B-T059
into	O	O	O
acidic	O	O	B-T167
MRS	O	O	I-T167
broth	O	O	I-T167
which	O	O	O
was	O	O	O
conveniently	O	O	O
prepared	O	O	O
to	O	O	O
simulate	O	O	O
gastric	O	O	B-T080
,	O	O	O
pancreatic	O	O	B-T031
juices	O	O	I-T031
and	O	O	O
bile	O	O	B-T109
salts	O	O	I-T109
.	O	O	O

Survival	O	O	O
to	O	O	O
simulated	O	O	B-T080
gastric	O	O	I-T080
and	O	O	O
intestinal	O	O	B-T023
stresses	O	O	B-T046
was	O	O	O
evaluated	O	O	O
by	O	O	O
plate	O	O	B-T059
count	O	O	I-T059
of	O	O	I-T059
colony	O	O	I-T059
forming	O	O	I-T059
units	O	O	I-T059
on	O	O	O
MRS	O	O	B-T130
agar	O	O	I-T130
.	O	O	O

SEM	O	O	B-T059
revealed	O	O	O
that	O	O	O

the	O	O	O
lactobacilli	O	O	B-T007
cells	O	O	B-T025
attached	O	O	B-T067
and	O	O	O
bound	O	O	O
to	O	O	O
the	O	O	O
surface	O	O	B-T082
of	O	O	O
okara	O	O	B-T116
.	O	O	O

Compared	O	O	B-T052
with	O	O	O
FL	O	O	B-T025
,	O	O	O
IL	O	O	B-T025
exhibited	O	O	O
a	O	O	O
significantly	O	O	O
higher	O	O	B-T080
specific	O	O	B-T080
growth	O	O	B-T040
rate	O	O	I-T079
,	O	O	O
shorter	O	O	B-T081
lag	O	O	B-T079
phase	O	O	I-T079
of	O	O	O
growth	O	O	O
,	O	O	O
higher	O	O	O
productions	O	O	O
of	O	O	O
lactic	O	O	B-T109
and	O	O	O
acetic	O	O	B-T109
acids	O	O	I-T109
,	O	O	O
a	O	O	O
faster	O	O	B-T080
decrease	O	O	B-T081
in	O	O	O
pH	O	O	B-T034
and	O	O	O
increase	O	O	B-T169
in	O	O	O
titrable	O	O	B-T034
acidity	O	O	I-T034
,	O	O	O
and	O	O	O
a	O	O	O
higher	O	O	O
soymilk	O	O	B-T168
viscosity	O	O	B-T070
.	O	O	O

Similarly	O	O	O
,	O	O	O
IL	O	O	B-T025
in	O	O	O
soymilk	O	O	B-T168
showed	O	O	O
higher	O	O	O
productions	O	O	O
of	O	O	O
daizein	O	O	B-T109
and	O	O	O
genistein	O	O	B-T109
compared	O	O	B-T052
with	O	O	O
the	O	O	O
control	O	O	B-T167
.	O	O	O

Compared	O	O	B-T052
with	O	O	O
FL	O	O	B-T025
,	O	O	O
IL	O	O	B-T025
showed	O	O	O
reinforced	O	O	O
resistance	O	O	O
to	O	O	O
simulatedgastric	O	O	B-T080
and	O	O	O
intestinal	O	O	B-T023
stresses	O	O	B-T046
in	O	O	B-T080
vitro	O	O	I-T080
that	O	O	O
included	O	O	O
low	O	O	B-T033
pH	O	O	I-T033
,	O	O	O
low	O	O	B-T033
pH	O	O	I-T033
plus	O	O	I-T033
pepsin	O	O	B-T116
,	O	O	O
pancreatin	O	O	B-T116
,	O	O	O
and	O	O	O
bile	O	O	B-T109
salt	O	O	I-T109
.	O	O	O

Our	O	O	O
results	O	O	B-T169
indicate	O	O	O
that	O	O	O
okara	O	O	B-T116
is	O	O	O
a	O	O	O
new	O	O	O
potential	O	O	O
immobilization	O	O	B-T080
carrier	O	O	I-T080
to	O	O	O
enhance	O	O	B-T052
the	O	O	O
growth	O	O	B-T040
and	O	O	O
glucosidic	O	O	B-T109
isoflavone	O	O	I-T109
bioconversion	O	O	B-T169
activities	O	O	B-T052
of	O	O	O
L.	O	O	B-T007
plantarum	O	O	I-T007
in	O	O	O
soymilk	O	O	B-T168
and	O	O	O
improve	O	O	B-T033
cell	O	O	B-T043
survivability	O	O	I-T043
following	O	O	O
simulated	O	O	B-T080
gastric	O	O	I-T080
and	O	O	O
intestinal	O	O	B-T023
conditions	O	O	B-T080
.	O	O	O

-DOCSTART- (27871600)

Comparison	O	O	O
of	O	O	O
a	O	O	O
new	O	O	O
visual	O	O	B-T061
stylet	O	O	I-T061
(Discopo)-guided	O	O	I-T061
laryngeal	O	O	B-T061
mask	O	O	I-T061
airway	O	O	I-T061
placement	O	O	I-T061
vs	O	O	O
conventional	O	O	B-T061
blind	O	O	I-T061
technique	O	O	I-T061
:	O	O	O
a	O	O	O
prospective	O	O	O
randomized	O	O	B-T062
study	O	O	O

To	O	O	O
compare	O	O	O
the	O	O	O
ease	O	O	O
of	O	O	O
laryngeal	O	O	B-T061
mask	O	O	I-T061
airway	O	O	I-T061
(	O	O	I-T061
LMA	O	O	B-T074
)	O	O	I-T061
insertion	O	O	I-T061
and	O	O	O
fiberoptic	O	O	B-T082
view	O	O	I-T082
of	O	O	O
LMA	O	O	O
after	O	O	O
placement	O	O	B-T080
using	O	O	O
the	O	O	O
Discopo	O	O	B-T061
visual	O	O	I-T061
stylet-guided	O	O	I-T061
insertion	O	O	I-T061
and	O	O	O
conventional	O	O	B-T061
blind	O	O	I-T061
technique	O	O	I-T061
.	O	O	O

Prospective	O	O	O
,	O	O	O
randomized	O	O	B-T062
controlled	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Operating	O	O	B-T093
room	O	O	I-T093
in	O	O	O
a	O	O	O
university	O	O	B-T093
hospital	O	O	I-T093
.	O	O	O

One	O	O	O
hundred	O	O	O
adult	O	O	B-T100
patients	O	O	B-T101
scheduled	O	O	O
for	O	O	O
elective	O	O	B-T061
surgery	O	O	I-T061
under	O	O	O
LMA	O	O	B-T074
general	O	O	B-T061
anesthesia	O	O	I-T061
were	O	O	O
enrolled	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
randomly	O	O	B-T062
allocated	O	O	O
to	O	O	O
2	O	O	O
groups	O	O	B-UnknownType
:	O	O	O
GLMA	O	O	B-UnknownType
group	O	O	I-UnknownType
using	O	O	O
a	O	O	O
visual	O	O	B-T061
stylet-guided	O	O	I-T061
technique	O	O	I-T061
(	O	O	O
n=50	O	O	O
)	O	O	O
and	O	O	O
BLMA	O	O	B-UnknownType
group	O	O	I-UnknownType
using	O	O	O
standard	O	O	O
blind	O	O	B-T061
technique	O	O	I-T061
(	O	O	O
n=50	O	O	O
)	O	O	O
.	O	O	O

Correct	O	O	O
placement	O	O	B-T080
of	O	O	O
the	O	O	O
LMA	O	O	B-T074
was	O	O	O
confirmed	O	O	O
using	O	O	O
clinical	O	O	B-T201
test	O	O	I-T201
along	O	O	O
with	O	O	O
fiberoptic	O	O	B-T073
assessment	O	O	B-T058
.	O	O	O

Unblinded	O	O	B-T078
data	O	O	I-T078
were	O	O	O
collected	O	O	O
about	O	O	O
the	O	O	O
insertion	O	O	B-T061
time	O	O	O
,	O	O	O
the	O	O	O
first	O	O	O
attempt	O	O	O
success	O	O	B-T081
rate	O	O	I-T081
,	O	O	O
the	O	O	O
LMA	O	O	B-T074
position	O	O	B-T082
adjustment	O	O	O
rate	O	O	O
,	O	O	O
fiberoptic	O	O	B-T082
view	O	O	I-T082
of	O	O	O
LMA	O	O	O
anatomical	O	O	B-T029
position	O	O	I-T029
,	O	O	O
hemodynamic	O	O	B-T042
responses	O	O	B-T032
,	O	O	O
and	O	O	O
the	O	O	O
adverse	O	O	B-T169
insertion	O	O	O
responses	O	O	O
(	O	O	O
bucking	O	O	B-T037
,	O	O	O
breathholding	O	O	B-T033
,	O	O	O
and	O	O	O
laryngospasm	O	O	B-T037
)	O	O	O
.	O	O	O

Blinded	O	O	B-T078
data	O	O	I-T078
were	O	O	O
recorded	O	O	O
about	O	O	O
postoperative	O	O	B-T079
airway	O	O	B-T047
morbidity	O	O	I-T047
(	O	O	O
visible	O	O	O
blood	O	O	B-T031
staining	O	O	I-T031
on	O	O	O
LMA	O	O	B-T074
at	O	O	O
removal	O	O	O
,	O	O	O
sore	O	O	B-T184
throat	O	O	I-T184
,	O	O	O
and	O	O	O
hoarseness	O	O	B-T184
)	O	O	O
.	O	O	O

Insertion	O	O	B-T061
was	O	O	O
more	O	O	O
frequently	O	O	O
successful	O	O	O
at	O	O	O
the	O	O	O
first	O	O	O
attempt	O	O	O
in	O	O	O
GLMA	O	O	B-UnknownType
than	O	O	O
that	O	O	O
in	O	O	O
BLMA	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
100	O	O	O
%	O	O	O
vs	O	O	O
92	O	O	O
%	O	O	O
;	O	O	O
P=.041	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
time	O	O	O
taken	O	O	O
for	O	O	O
establishing	O	O	O
effective	O	O	O
airway	O	O	O
was	O	O	O
shorter	O	O	O
in	O	O	O
GLMA	O	O	B-UnknownType
than	O	O	O
that	O	O	O
in	O	O	O
BLMA	O	O	B-UnknownType
(	O	O	O
54.8	O	O	O
vs	O	O	O
62.9	O	O	O
seconds	O	O	O
;	O	O	O
P=.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
patients	O	O	B-T101
in	O	O	O
BLMA	O	O	B-UnknownType
group	O	O	I-UnknownType
required	O	O	O
more	O	O	O
readjustment	O	O	O
and	O	O	O
reinsertion	O	O	B-T061
than	O	O	O
those	O	O	O
in	O	O	O
GLMA	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
38	O	O	O
%	O	O	O
vs	O	O	O
0	O	O	O
%	O	O	O
;	O	O	O
P=.000	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
fiberoptic	O	O	B-T082
view	O	O	I-T082
was	O	O	O
significantly	O	O	O
better	O	O	O
in	O	O	O
GLMA	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
P<.001	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
difference	O	O	O
between	O	O	O
the	O	O	O
2	O	O	O
groups	O	O	B-UnknownType
existed	O	O	O
regarding	O	O	O
hemodynamic	O	O	B-T039
stress	O	O	I-T039
responses	O	O	I-T039
,	O	O	O
incidences	O	O	B-T081
of	O	O	O
adverse	O	O	B-T169
insertion	O	O	B-T061
responses	O	O	O
,	O	O	O
and	O	O	O
postoperative	O	O	B-T079
airway	O	O	B-T047
morbidity	O	O	I-T047
.	O	O	O

By	O	O	O
direct	O	O	O
visualizing	O	O	O
the	O	O	O
whole	O	O	O
process	O	O	O
of	O	O	O
LMA	O	O	B-T074
insertion	O	O	B-T061
,	O	O	O
the	O	O	O
Discopo	O	O	B-T061
visual	O	O	I-T061
stylet	O	O	I-T061
increases	O	O	O
the	O	O	O
success	O	O	B-T081
rate	O	O	I-T081
and	O	O	O
accuracy	O	O	B-T080
rate	O	O	I-T080
of	O	O	O
LMA	O	O	O
placement	O	O	B-T080
without	O	O	O
increasing	O	O	O
hemodynamic	O	O	B-T039
stress	O	O	I-T039
response	O	O	I-T039
or	O	O	O
incidences	O	O	B-T081
of	O	O	O
adverse	O	O	B-T046
events	O	O	I-T046
.	O	O	O

-DOCSTART- (27871881)

Targeting	O	O	B-T169
brain	O	O	B-T023
and	O	O	O
peripheral	O	O	B-T042
plasticity	O	O	I-T042
of	O	O	O
the	O	O	O
lipidome	O	O	B-T109
in	O	O	O
acute	O	O	B-T079
kainic	O	O	B-T109
acid	O	O	I-T109
-	O	O	O
induced	O	O	B-T169
epileptic	O	O	B-T047
seizures	O	O	I-T047
in	O	O	O
mice	O	O	B-T015
via	O	O	O
quantitative	O	O	O
mass	O	O	O
spectrometry	O	O	O

Epilepsy	O	O	B-T047
is	O	O	O
a	O	O	O
highly	O	O	O
common	O	O	O
chronic	O	O	B-T047
neurological	O	O	I-T047
disorder	O	O	I-T047
,	O	O	O
manifested	O	O	B-T169
in	O	O	O
many	O	O	O
different	O	O	O
types	O	O	B-T080
,	O	O	O
affecting	O	O	O
~1	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
worldwide	O	O	O
human	O	O	B-T016
population	O	O	B-T098
.	O	O	O

The	O	O	O
molecular	O	O	B-T044
mechanisms	O	O	I-T044
of	O	O	O
epileptogenesis	O	O	B-T047
have	O	O	O
not	O	O	O
yet	O	O	O
been	O	O	O
clarified	O	O	O
,	O	O	O
and	O	O	O
pharmacoresistance	O	O	B-T047
exhibited	O	O	O
by	O	O	O
30	O	O	O
-	O	O	O
40	O	O	O
%	O	O	O
of	O	O	O
epilepsy	O	O	B-T047
patients	O	O	B-T101
remains	O	O	O
a	O	O	O
major	O	O	O
obstacle	O	O	O
in	O	O	O
medical	O	O	B-T169
care	O	O	B-T058
.	O	O	O

Growing	O	O	O
evidence	O	O	B-T078
indicates	O	O	O
a	O	O	O
role	O	O	O
of	O	O	O
lipid	O	O	B-T109
signalling	O	O	B-T044
pathways	O	O	I-T044
in	O	O	O
epileptogenesis	O	O	B-T047
,	O	O	O
thus	O	O	O
lipid	O	O	O
signals	O	O	B-T044
emerge	O	O	O
as	O	O	O
potential	O	O	B-T080
biomarkers	O	O	B-T201
for	O	O	O
the	O	O	O
onset	O	O	O
and	O	O	O
evolving	O	O	O
course	O	O	O
of	O	O	O
the	O	O	O
epileptic	O	O	B-T047
disorder	O	O	I-T047
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
potential	O	O	O
therapeutic	O	O	B-T121
agents	O	O	I-T121
and	O	O	O
targets	O	O	B-T169
.	O	O	O

For	O	O	O
this	O	O	O
purpose	O	O	O
,	O	O	O
we	O	O	O
applied	O	O	O
a	O	O	O
lipidomic	O	O	B-T109
strategy	O	O	B-T062
to	O	O	O
unravel	O	O	O
lipid	O	O	B-T109
alterations	O	O	O
in	O	O	O
brain	O	O	B-T029
regions	O	O	I-T029
,	O	O	O
periphery	O	O	B-T024
tissues	O	O	I-T024
and	O	O	O
plasma	O	O	B-T031
that	O	O	O
are	O	O	O
specific	O	O	B-T080
for	O	O	O
acute	O	O	B-T079
epileptic	O	O	B-T047
seizures	O	O	I-T047
in	O	O	O
mice	O	O	B-T015
at	O	O	O
1h	O	O	O
after	O	O	O
seizure	O	O	B-T047
induction	O	O	B-T169
by	O	O	O
systemic	O	O	B-T062
kainic	O	O	B-T109
acid	O	O	I-T109
injection	O	O	B-T062
as	O	O	O
compared	O	O	B-T052
to	O	O	O
vehicle	O	O	B-T096
controls	O	O	I-T096
.	O	O	O

Specifically	O	O	O
,	O	O	O
levels	O	O	B-T080
of	O	O	O
(	O	O	O
i	O	O	O
)	O	O	O
selected	O	O	O
phospholipids	O	O	B-T109
and	O	O	O
sphingomyelins	O	O	B-T109
,	O	O	O
(	O	O	O
ii	O	O	O
)	O	O	O
the	O	O	O
endocannabinoids	O	O	B-T109
anandamide	O	O	B-T109
(	O	O	O
AEA	O	O	B-T109
)	O	O	O
and	O	O	O
2-arachidonoyl	O	O	B-T109
glycerol	O	O	I-T109
(	O	O	O
2-AG	O	O	B-T109
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
endocannabinoid	O	O	B-T109
-related	O	O	O
compounds	O	O	B-T103
oleoylethanolamide	O	O	B-T109
(	O	O	O
OEA	O	O	B-T109
)	O	O	O
and	O	O	O
palmitoylethanolamide	O	O	B-T109
(	O	O	O
PEA	O	O	B-T109
)	O	O	O
,	O	O	O
(	O	O	O
iii	O	O	O
)	O	O	O
arachidonic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
AA	O	O	B-T109
)	O	O	O
,	O	O	O
(	O	O	O
iv	O	O	O
)	O	O	O
selected	O	O	O
eicosanoids	O	O	B-T109
,	O	O	O
and	O	O	O
(	O	O	O
v	O	O	O
)	O	O	O
fatty	O	O	B-T123
acyl	O	O	I-T123
content	O	O	O
of	O	O	O
lipidome	O	O	B-T109
were	O	O	O
determined	O	O	O
in	O	O	O
pulverized	O	O	B-T062
tissues	O	O	B-T023
from	O	O	O
six	O	O	O
brain	O	O	B-T029
regions	O	O	I-T029
of	O	O	O
kainic	O	O	B-T109
acid	O	O	I-T109
induced	O	O	B-T169
epileptic	O	O	B-T047
seizure	O	O	I-T047
models	O	O	B-T075
and	O	O	O
vehicle	O	O	B-T096
controls	O	O	I-T096
:	O	O	O
hypothalamus	O	O	B-T023
,	O	O	O
hippocampus	O	O	B-T023
,	O	O	O
thalamus	O	O	B-T023
,	O	O	O
striatum	O	O	B-T023
,	O	O	O
cerebellum	O	O	B-T023
and	O	O	O
cerebral	O	O	B-T023
cortex	O	O	I-T023
,	O	O	O
and	O	O	O
from	O	O	O
peripheral	O	O	B-T082
organs	O	O	B-T023
,	O	O	O
such	O	O	O
as	O	O	O
heart	O	O	B-T023
and	O	O	O
lungs	O	O	B-T023
,	O	O	O
and	O	O	O
in	O	O	O
plasma	O	O	B-T031
.	O	O	O

Alterations	O	O	O
in	O	O	O
lipid	O	O	B-T109
levels	O	O	O
after	O	O	O
acute	O	O	B-T079
epileptic	O	O	B-T047
seizures	O	O	I-T047
as	O	O	O
compared	O	O	B-T052
to	O	O	O
non-seizure	O	O	B-T096
controls	O	O	I-T096
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
brain	O	O	B-T029
region	O	O	I-T029
-	O	O	O
and	O	O	O
periphery	O	O	B-T024
tissue	O	O	I-T024
-	O	O	O
specific	O	O	B-T080
,	O	O	O
including	O	O	O
specific	O	O	O
plasma	O	O	B-T031
lipid	O	O	O
correlates	O	O	O
,	O	O	O
highlighting	O	O	O
their	O	O	O
value	O	O	O
as	O	O	O
marker	O	O	B-T201
candidates	O	O	I-T201
in	O	O	O
translational	O	O	O
research	O	O	B-T062
studies	O	O	I-T062
,	O	O	O
and/or	O	O	O
drug	O	O	B-T062
discovery	O	O	I-T062
and	O	O	O
response	O	O	B-T058
monitoring	O	O	I-T058
.	O	O	O

-DOCSTART- (27872609)

Panitumumab	O	O	B-T116
-Associated	O	O	O
Encephalopathy	O	O	B-T047
after	O	O	O
Accidental	O	O	O
Intra-arterial	O	O	B-T169
Application	O	O	B-T058
through	O	O	O
Dislocated	O	O	O
Central	O	O	O
Venous	O	O	O
Access	O	O	O
Device	O	O	O

Acute	O	O	B-T079
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
(	O	O	O
CNS	O	O	B-T022
)	O	O	O
toxicity	O	O	B-T037
and	O	O	O
immune	O	O	B-T169
-related	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
are	O	O	O
increasingly	O	O	O
recognized	O	O	O
with	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
monoclonal	O	O	B-T116
antibodies	O	O	I-T116
for	O	O	O
cancer	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
a	O	O	O
patient	O	O	B-T101
who	O	O	O
developed	O	O	O
of	O	O	O
acute-onset	O	O	B-T033
encephalopathy	O	O	I-T033
and	O	O	O
coma	O	O	B-T047
,	O	O	O
which	O	O	O
began	O	O	O
shortly	O	O	O
after	O	O	O
administration	O	O	B-T169
of	O	O	O
panitumumab	O	O	B-T116
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
metastatic	O	O	B-T191
colorectal	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

Echocardiography	O	O	B-T060
revealed	O	O	O
that	O	O	O
the	O	O	O
drug	O	O	B-T121
had	O	O	O
been	O	O	O
infused	O	O	O
into	O	O	O
the	O	O	O
left	O	O	B-T023
cardiac	O	O	I-T023
ventricle	O	O	I-T023
via	O	O	O
a	O	O	O
dislocated	O	O	B-T074
central	O	O	I-T074
venous	O	O	I-T074
line	O	O	I-T074
.	O	O	O

Diffusion-weighted	O	O	B-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
disclosed	O	O	O
multiple	O	O	O
cortical	O	O	B-T033
hyperintensities	O	O	I-T033
,	O	O	O
which	O	O	O
were	O	O	O
preferentially	O	O	O
located	O	O	O
in	O	O	O
the	O	O	O
frontal	O	O	B-T023
lobes	O	O	I-T023
.	O	O	O

While	O	O	O
the	O	O	O
neurological	O	O	B-T047
condition	O	O	I-T047
improved	O	O	O
within	O	O	O
a	O	O	O
few	O	O	O
days	O	O	B-T079
,	O	O	O
the	O	O	O
patient	O	O	B-T101
died	O	O	B-T040
4	O	O	O
weeks	O	O	B-T079
later	O	O	O
.	O	O	O

It	O	O	O
seems	O	O	O
likely	O	O	O
that	O	O	O
the	O	O	O
administration	O	O	B-T169
of	O	O	O
the	O	O	O
antibody	O	O	B-T116
via	O	O	O
the	O	O	O
intra-arterial	O	O	B-T169
route	O	O	I-T169
contributed	O	O	O
to	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
this	O	O	O
condition	O	O	B-T047
.	O	O	O

Toxic	O	O	B-T037
encephalopathy	O	O	I-T037
may	O	O	O
be	O	O	O
a	O	O	O
hitherto	O	O	B-T079
unrecognized	O	O	O
complication	O	O	B-T046
of	O	O	O
panitumumab	O	O	B-T116
treatment	O	O	B-T061
and	O	O	O
should	O	O	O
be	O	O	O
taken	O	O	O
into	O	O	O
consideration	O	O	O
in	O	O	O
patients	O	O	B-T101
developing	O	O	O
CNS	O	O	B-T022
symptoms	O	O	B-T184
undergoing	O	O	O
this	O	O	O
therapy	O	O	B-T061
.	O	O	O

-DOCSTART- (27874309)

Abundance	O	O	B-T080
and	O	O	O
Characterization	O	O	B-T052
of	O	O	O
Perfect	O	O	O
Microsatellites	O	O	B-T114
on	O	O	O
the	O	O	O
Cattle	O	O	B-T015
Y	O	O	O
Chromosome	O	O	O

Microsatellites	O	O	B-T114
or	O	O	O
simple	O	O	B-T114
sequence	O	O	I-T114
repeats	O	O	I-T114
(	O	O	O
SSRs	O	O	B-T114
)	O	O	O
are	O	O	O
found	O	O	O
in	O	O	O
most	O	O	O
organisms	O	O	B-T001
and	O	O	O
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
genomic	O	O	B-T028
organization	O	O	I-T028
and	O	O	O
function	O	O	B-T045
.	O	O	O

To	O	O	O
characterize	O	O	B-T052
the	O	O	O
abundance	O	O	B-T080
of	O	O	O
SSRs	O	O	B-T114
(	O	O	O
1	O	O	O
-	O	O	O
6	O	O	O
base-pairs	O	O	B-T044
[	O	O	O
bp	O	O	B-T044
]	O	O	O
)	O	O	O
on	O	O	O
the	O	O	O
cattle	O	O	B-T015
Y	O	O	B-T026
chromsome	O	O	I-T026
,	O	O	O
the	O	O	O
relative	O	O	O
frequency	O	O	B-T079
and	O	O	O
density	O	O	B-T081
of	O	O	O
perfect	O	O	O
or	O	O	O
uninterrupted	O	O	O
SSRs	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
published	O	O	O
Y	O	O	B-T026
chromosome	O	O	I-T026
sequence	O	O	B-T086
were	O	O	O
examined	O	O	B-T033
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
17,273	O	O	O
perfect	O	O	O
SSRs	O	O	B-T114
were	O	O	O
found	O	O	O
,	O	O	O
with	O	O	O
total	O	O	O
length	O	O	B-T081
of	O	O	O
324.78	O	O	O
kb	O	O	O
,	O	O	O
indicating	O	O	O
that	O	O	O
approximately	O	O	O
0.75	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
cattle	O	O	B-T015
Y	O	O	B-T026
chromosome	O	O	I-T026
sequence	O	O	B-T086
(	O	O	O
43.30	O	O	O
Mb	O	O	O
)	O	O	O
comprises	O	O	O
perfect	O	O	O
SSRs	O	O	O
,	O	O	O
with	O	O	O
an	O	O	O
average	O	O	O
length	O	O	O
of	O	O	O
18.80	O	O	O
bp	O	O	B-T044
.	O	O	O

The	O	O	O
relative	O	O	O
frequency	O	O	B-T079
and	O	O	O
density	O	O	B-T081
were	O	O	O
398.92	O	O	O
loci/Mb	O	O	O
and	O	O	O
7500.62	O	O	O
bp	O	O	B-T044
/Mb	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
proportions	O	O	O
of	O	O	O
the	O	O	O
six	O	O	O
classes	O	O	O
of	O	O	O
perfect	O	O	O
SSRs	O	O	B-T114
were	O	O	O
highly	O	O	O
variable	O	O	O
on	O	O	O
the	O	O	O
cattle	O	O	B-T015
Y	O	O	B-T026
chromosome	O	O	I-T026
.	O	O	O

Mononucleotide	O	O	B-T114
repeats	O	O	I-T114
had	O	O	O
a	O	O	O
total	O	O	O
number	O	O	O
of	O	O	O
8073	O	O	O
(	O	O	O
46.74	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
an	O	O	O
average	O	O	O
length	O	O	B-T086
of	O	O	O
15.45	O	O	O
bp	O	O	B-T044
,	O	O	O
and	O	O	O
were	O	O	O
the	O	O	O
most	O	O	O
abundant	O	O	O
SSRs	O	O	B-T114
class	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
percentages	O	O	O
of	O	O	O
di-	O	O	B-T114
,	O	O	O
tetra-	O	O	B-T114
,	O	O	O
tri-	O	O	B-T114
,	O	O	O
penta-	O	O	B-T114
,	O	O	O
and	O	O	O
hexa-nucleotide	O	O	B-T114
repeats	O	O	I-T114
were	O	O	O
22.86	O	O	O
%	O	O	O
,	O	O	O
11.98	O	O	O
%	O	O	O
,	O	O	O
11.58	O	O	O
%	O	O	O
,	O	O	O
6.65	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
0.19	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Different	O	O	O
classes	O	O	O
of	O	O	O
SSRs	O	O	B-T114
varied	O	O	O
in	O	O	O
their	O	O	O
repeat	O	O	O
number	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
highest	O	O	O
being	O	O	O
42	O	O	O
for	O	O	O
dinucleotides	O	O	B-T114
.	O	O	O

Results	O	O	O
reveal	O	O	O
that	O	O	O
repeat	O	O	O
categories	O	O	O
A	O	O	B-T114
,	O	O	O
AC	O	O	B-T086
,	O	O	O
AT	O	O	B-T086
,	O	O	O
AAC	O	O	B-T086
,	O	O	O
AGC	O	O	B-T086
,	O	O	O
GTTT	O	O	B-T086
,	O	O	O
CTTT	O	O	B-T086
,	O	O	O
ATTT	O	O	B-T086
,	O	O	O
and	O	O	O
AACTG	O	O	B-T086
predominate	O	O	O
on	O	O	O
the	O	O	O
Y	O	O	B-T026
chromosome	O	O	I-T026
.	O	O	O

This	O	O	O
study	O	O	B-T062
provides	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
organization	O	O	O
of	O	O	O
cattle	O	O	B-T015
Y	O	O	B-T026
chromosome	O	O	I-T026
repetitive	O	O	O
DNA	O	O	B-T114
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
information	O	O	O
useful	O	O	O
for	O	O	O
developing	O	O	O
more	O	O	O
polymorphic	O	O	B-T080
cattle	O	O	O
Y-chromosome	O	O	B-T026
-specific	O	O	O
SSRs	O	O	B-T114
.	O	O	O

-DOCSTART- (27875058)

Antenatal	O	O	B-T079
Stressful	O	O	B-T051
Life	O	O	I-T051
Events	O	O	I-T051
and	O	O	O
Postpartum	O	O	B-T079
Depressive	O	O	B-T184
Symptoms	O	O	I-T184
in	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
:	O	O	O
The	O	O	O
Role	O	O	O
of	O	O	O
Women	O	O	B-T098
's	O	O	I-T098
Socioeconomic	O	O	B-T080
Status	O	O	I-T080
Indices	O	O	B-T170
at	O	O	O
the	O	O	O
State	O	O	O
Level	O	O	O

Approximately	O	O	O
10%-20	O	O	O
%	O	O	O
of	O	O	O
women	O	O	B-T098
suffer	O	O	B-T048
from	O	O	O
postpartum	O	O	B-T048
depression	O	O	I-T048
(	O	O	O
PPD	O	O	B-T048
)	O	O	O
,	O	O	O
important	O	O	O
predictors	O	O	B-T078
of	O	O	O
which	O	O	O
are	O	O	O
antenatal	O	O	B-T079
stressful	O	O	B-T051
life	O	O	I-T051
event	O	O	I-T051
(	O	O	O
SLE	O	O	B-T051
)	O	O	O
experiences	O	O	B-T067
.	O	O	O

The	O	O	O
association	O	O	B-T080
between	O	O	O
women	O	O	B-T098
's	O	O	I-T098
state-level	O	O	B-T081
socioeconomic	O	O	B-T080
status	O	O	I-T080
(	O	O	O
SES	O	O	B-T080
)	O	O	O
and	O	O	O
PPD	O	O	B-T048
has	O	O	O
not	O	O	O
been	O	O	O
explored	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
examine	O	O	O
whether	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
antenatal	O	O	B-T079
SLE	O	O	B-T051
and	O	O	O
PPD	O	O	B-T048
symptoms	O	O	B-T184
was	O	O	O
moderated	O	O	B-T080
by	O	O	O
women	O	O	B-T098
's	O	O	I-T098
state-level	O	O	B-T081
SES	O	O	B-T080
.	O	O	O

Data	O	O	B-T078
from	O	O	O
the	O	O	O
2009	O	O	O
-	O	O	O
2011	O	O	O
Pregnancy	O	O	B-T170
Risk	O	O	I-T170
Assessment	O	O	I-T170
Monitoring	O	O	I-T170
System	O	O	I-T170
(	O	O	O
PRAMS	O	O	B-T170
)	O	O	O
were	O	O	O
used	O	O	O
.	O	O	O

State-level	O	O	B-T081
women	O	O	B-T098
's	O	O	I-T098
employment	O	O	B-T080
/	O	O	O
earnings	O	O	B-T081
and	O	O	O
social	O	O	B-T169
/	O	O	O
economic	O	O	B-T169
autonomy	O	O	B-T078
indices	O	O	B-T170
were	O	O	O
computed	O	O	O
from	O	O	O
indicators	O	O	B-T130
published	O	O	O
by	O	O	O
the	O	O	O
Institute	O	O	B-T092
of	O	O	I-T092
Women	O	O	I-T092
's	O	O	I-T092
Policy	O	O	I-T092
Research	O	O	I-T092
(	O	O	O
IWPR	O	O	B-T092
)	O	O	O
.	O	O	O

Multilevel	O	O	B-UnknownType
multivariable	O	O	I-UnknownType
logistic	O	O	I-UnknownType
regression	O	O	I-UnknownType
analyses	O	O	I-UnknownType
were	O	O	O
performed	O	O	O
.	O	O	O

Among	O	O	O
91,253	O	O	O
women	O	O	B-T098
with	O	O	O
valid	O	O	B-T080
responses	O	O	B-T032
,	O	O	O
11.3	O	O	O
%	O	O	O
had	O	O	O
PPD	O	O	B-T048
symptoms	O	O	B-T184
,	O	O	O
prevalence	O	O	B-T081
ranging	O	O	O
from	O	O	O
7.1	O	O	O
%	O	O	O
in	O	O	O
Illinois	O	O	B-T083
to	O	O	O
17.1	O	O	O
%	O	O	O
in	O	O	O
Arkansas	O	O	B-T083
.	O	O	O

Women	O	O	B-T098
who	O	O	O
experienced	O	O	O
all	O	O	O
four	O	O	O
stressor	O	O	B-T078
categories	O	O	B-T170
,	O	O	O
including	O	O	O
partner	O	O	B-T098
related	O	O	B-T033
,	O	O	O
traumatic	O	O	B-T169
,	O	O	O
emotional	O	O	B-T033
,	O	O	O
and	O	O	O
financial	O	O	B-T081
,	O	O	O
had	O	O	O
the	O	O	O
highest	O	O	O
odds	O	O	B-T081
(	O	O	O
adjusted	O	O	B-T081
odds	O	O	I-T081
ratio	O	O	I-T081
[	O	O	O
aOR	O	O	B-T081
]	O	O	O
:	O	O	O
5.43	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
:	O	O	O
5.36	O	O	O
-	O	O	O
5.51	O	O	O
)	O	O	O
of	O	O	O
PPD	O	O	B-T048
symptoms	O	O	B-T184
.	O	O	O

The	O	O	O
odds	O	O	B-T081
of	O	O	O
experiencing	O	O	O
PPD	O	O	B-T048
symptoms	O	O	B-T184
decreased	O	O	B-T081
with	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
state-level	O	O	B-T081
social	O	O	B-T169
/	O	O	O
economic	O	O	B-T169
autonomy	O	O	B-T078
index	O	O	B-T170
(	O	O	O
aOR	O	O	B-T081
:	O	O	O
0.75	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.64	O	O	O
-	O	O	O
0.88	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
significant	O	O	O
cross-level	O	O	B-T080
interaction	O	O	I-T080
between	O	O	O
number	O	O	O
of	O	O	O
stressor	O	O	B-T078
categories	O	O	B-T170
experienced	O	O	O
and	O	O	O
state-level	O	O	B-T081
index	O	O	B-T170
.	O	O	O

Screening	O	O	B-T169
for	O	O	O
antenatal	O	O	B-T079
SLEs	O	O	B-T051
can	O	O	O
help	O	O	O
identify	O	O	O
women	O	O	B-T098
at	O	O	B-T080
risk	O	O	I-T080
for	O	O	O
PPD	O	O	B-T048
symptoms	O	O	B-T184
.	O	O	O

That	O	O	O
the	O	O	O
odds	O	O	B-T081
of	O	O	O
having	O	O	O
PPD	O	O	B-T048
symptoms	O	O	B-T184
decreased	O	O	B-T081
with	O	O	O
increasing	O	O	B-T169
state-level	O	O	B-T081
social	O	O	B-T169
/	O	O	O
economic	O	O	B-T169
autonomy	O	O	B-T078
and	O	O	O
women	O	O	B-T098
residing	O	O	O
in	O	O	O
states	O	O	B-T083
with	O	O	O
lower	O	O	O
indices	O	O	B-T170
were	O	O	O
more	O	O	B-T169
vulnerable	O	O	I-T169
to	O	O	O
the	O	O	O
impacts	O	O	O
of	O	O	O
antenatal	O	O	B-T079
stressors	O	O	B-T078
,	O	O	O
could	O	O	O
have	O	O	O
policy	O	O	B-UnknownType
implications	O	O	I-UnknownType
related	O	O	O
to	O	O	O
improving	O	O	O
the	O	O	O
SES	O	O	B-T080
of	O	O	O
women	O	O	O
in	O	O	O
these	O	O	O
states	O	O	O
.	O	O	O

-DOCSTART- (27876369)

Multi-component	O	O	B-T075
model	O	O	I-T075
of	O	O	O
intramural	O	O	O
hematoma	O	O	O

A	O	O	O
novel	O	O	O
multi-component	O	O	B-T075
model	O	O	I-T075
is	O	O	O
introduced	O	O	O
for	O	O	O
studying	O	O	B-T062
interaction	O	O	B-T169
between	O	O	O
blood	O	O	B-T039
flow	O	O	I-T039
and	O	O	O
deforming	O	O	B-T033
aortic	O	O	B-T023
wall	O	O	I-T023
with	O	O	O
intramural	O	O	B-T046
hematoma	O	O	I-T046
(	O	O	O
IMH	O	O	B-T046
)	O	O	O
.	O	O	O

The	O	O	O
aortic	O	O	B-T023
wall	O	O	I-T023
is	O	O	O
simulated	O	O	B-T062
by	O	O	O
a	O	O	O
composite	O	O	B-T075
structure	O	O	I-T075
submodel	O	O	I-T075
representing	O	O	O
material	O	O	B-T080
properties	O	O	I-T080
of	O	O	O
the	O	O	O
three	O	O	O
main	O	O	O
wall	O	O	B-T023
layers	O	O	I-T023
.	O	O	O

The	O	O	O
IMH	O	O	B-T046
is	O	O	O
described	O	O	O
by	O	O	O
a	O	O	O
poroelasticity	O	O	B-T075
submodel	O	O	I-T075
which	O	O	O
takes	O	O	O
into	O	O	O
account	O	O	O
both	O	O	O
the	O	O	O
pressure	O	O	B-T070
inside	O	O	O
hematoma	O	O	B-T046
and	O	O	O
its	O	O	O
deformation	O	O	B-T033
.	O	O	O

The	O	O	O
submodel	O	O	B-T075
of	O	O	O
the	O	O	O
hematoma	O	O	B-T046
is	O	O	O
fully	O	O	O
coupled	O	O	O
with	O	O	O
the	O	O	O
aortic	O	O	B-T075
submodel	O	O	I-T075
as	O	O	O
well	O	O	O
as	O	O	O
with	O	O	O
the	O	O	O
submodel	O	O	O
of	O	O	O
the	O	O	O
pulsatile	O	O	B-T067
blood	O	O	I-T067
flow	O	O	I-T067
.	O	O	O

Model	O	O	B-T062
simulations	O	O	I-T062
are	O	O	O
used	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
relation	O	O	O
between	O	O	O
the	O	O	O
peak	O	O	O
wall	O	O	O
stress	O	O	O
,	O	O	O
hematoma	O	O	B-T046
thickness	O	O	O
and	O	O	O
permeability	O	O	B-T070
in	O	O	O
patients	O	O	B-T101
of	O	O	O
different	O	O	O
age	O	O	B-T032
.	O	O	O

The	O	O	O
results	O	O	O
indicate	O	O	O
that	O	O	O
an	O	O	O
increase	O	O	O
in	O	O	O
hematoma	O	O	B-T046
thickness	O	O	O
leads	O	O	O
to	O	O	O
larger	O	O	O
wall	O	O	B-T033
stress	O	O	I-T033
,	O	O	O
which	O	O	O
is	O	O	O
in	O	O	O
agreement	O	O	O
with	O	O	O
clinical	O	O	B-T170
data	O	O	I-T170
.	O	O	O

Further	O	O	O
simulations	O	O	B-T062
demonstrate	O	O	O
that	O	O	O
a	O	O	O
hematoma	O	O	B-T046
with	O	O	O
smaller	O	O	O
permeability	O	O	B-T070
results	O	O	O
in	O	O	O
larger	O	O	O
wall	O	O	B-T033
stress	O	O	I-T033
,	O	O	O
suggesting	O	O	O
that	O	O	O
blood	O	O	B-T042
coagulation	O	O	I-T042
in	O	O	O
hematoma	O	O	O
might	O	O	O
increase	O	O	O
its	O	O	O
mechanical	O	O	B-T033
stability	O	O	I-T033
.	O	O	O

This	O	O	O
is	O	O	O
in	O	O	O
agreement	O	O	O
with	O	O	O
previous	O	O	O
experimental	O	O	B-T080
observations	O	O	B-T062
of	O	O	O
coagulation	O	O	B-T042
having	O	O	O
a	O	O	O
beneficial	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
the	O	O	O
condition	O	O	O
of	O	O	O
a	O	O	O
patient	O	O	B-T101
with	O	O	O
the	O	O	O
IMH	O	O	B-T046
.	O	O	O

-DOCSTART- (27877221)

The	O	O	O
Impact	O	O	B-T080
of	O	O	I-T080
Diabetes	O	O	B-T047
on	O	O	O
the	O	O	O
Risk	O	O	B-T078
of	O	O	O
Prostate	O	O	B-T191
Cancer	O	O	I-T191
Development	O	O	B-T169
according	O	O	O
to	O	O	O
Body	O	O	B-T201
Mass	O	O	I-T201
Index	O	O	I-T201
:	O	O	O
A	O	O	O
10-year	O	O	O
Nationwide	O	O	O
Cohort	O	O	O
Study	O	O	O

Purpose	O	O	O
:	O	O	O
We	O	O	O
examined	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
obesity	O	O	B-T047
and	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
both	O	O	O
with	O	O	O
and	O	O	O
without	O	O	B-T080
diabetic	O	O	B-T047
patients	O	O	B-T101
included	O	O	O
in	O	O	O
the	O	O	O
analysis	O	O	O
using	O	O	O
nationally	O	O	O
representative	O	O	O
data	O	O	B-T078
of	O	O	O
the	O	O	O
Korean	O	O	B-T098
population	O	O	I-T098
from	O	O	O
the	O	O	O
National	O	O	B-T058
Health	O	O	I-T058
Insurance	O	O	I-T058
System	O	O	I-T058
(	O	O	O
NHIS	O	O	B-T058
)	O	O	O
.	O	O	O

Materials	O	O	O
and	O	O	O
Methods	O	O	O
:	O	O	O
Of	O	O	O
the	O	O	O
424,712	O	O	O
participants	O	O	B-T098
who	O	O	O
underwent	O	O	O
health	O	O	B-T061
examinations	O	O	I-T061
in	O	O	O
2002	O	O	O
-	O	O	O
2008	O	O	O
,	O	O	O
139,519	O	O	O
men	O	O	B-T098
≥40	O	O	I-T098
years	O	O	I-T098
old	O	O	I-T098
and	O	O	O
without	O	O	B-T080
prostate	O	O	B-T191
cancer	O	O	I-T191
were	O	O	O
followed	O	O	O
from	O	O	O
the	O	O	O
beginning	O	O	O
of	O	O	O
2002	O	O	O
to	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
2012	O	O	O
.	O	O	O

Multivariate	O	O	B-T081
adjusted	O	O	I-T081
Cox	O	O	B-T081
regression	O	O	I-T081
analysis	O	O	I-T081
was	O	O	O
conducted	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
HR	O	O	B-T081
)	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
for	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
both	O	O	O
with	O	O	O
and	O	O	O
without	O	O	B-T080
diabetes	O	O	B-T047
.	O	O	O

Results	O	O	O
:	O	O	O
The	O	O	O
HR	O	O	B-T081
for	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
according	O	O	O
to	O	O	O
the	O	O	O
existence	O	O	O
of	O	O	O
diabetes	O	O	B-T047
was	O	O	O
stratified	O	O	B-T080
by	O	O	O
BMI	O	O	B-T201
in	O	O	O
both	O	O	O
age	O	O	B-T032
-	O	O	O
and	O	O	O
multivariable-adjusted	O	O	B-T081
models	O	O	I-T081
.	O	O	O

In	O	O	O
the	O	O	O
population	O	O	B-T098
without	O	O	B-T080
diabetes	O	O	B-T047
,	O	O	O
the	O	O	O
HR	O	O	B-T081
for	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
significantly	O	O	B-T081
increased	O	O	I-T081
as	O	O	O
BMI	O	O	B-T201
increased	O	O	O
beyond	O	O	O
the	O	O	O
reference	O	O	O
range	O	O	O
in	O	O	O
a	O	O	O
model	O	O	B-T081
adjusted	O	O	I-T081
for	O	O	I-T081
age	O	O	I-T081
and	O	O	I-T081
multiple	O	O	I-T081
variables	O	O	I-T081
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
increase	O	O	O
in	O	O	O
the	O	O	O
HR	O	O	O
was	O	O	O
small	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
population	O	O	B-T098
with	O	O	O
diabetes	O	O	B-T047
,	O	O	O
the	O	O	O
HR	O	O	B-T081
for	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
significantly	O	O	B-T081
increased	O	O	I-T081
as	O	O	O
BMI	O	O	B-T201
increased	O	O	O
from	O	O	O
<	O	O	O
18.5	O	O	O
kg/m(2	O	O	O
)	O	O	O
to	O	O	O
within	O	O	O
the	O	O	O
reference	O	O	O
range	O	O	O
(	O	O	O
18.5	O	O	O
to	O	O	O
22.9	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
multivariable-adjusted	O	O	B-T081
model	O	O	I-T081
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
a	O	O	O
marked	O	O	B-T081
decrease	O	O	I-T081
in	O	O	O
HR	O	O	B-T081
in	O	O	O
the	O	O	O
population	O	O	B-T098
with	O	O	O
BMI	O	O	B-T201
of	O	O	O
<	O	O	O
18.5	O	O	O
kg/m(2	O	O	O
)	O	O	O
was	O	O	O
seen	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
reference	O	O	O
or	O	O	O
higher	O	O	O
BMI	O	O	O
population	O	O	O
.	O	O	O

Conclusion	O	O	O
:	O	O	O
This	O	O	O
population	O	O	B-T098
-based	O	O	O
study	O	O	O
shows	O	O	O
the	O	O	O
evidence	O	O	O
of	O	O	O
association	O	O	O
between	O	O	O
obesity	O	O	B-T047
and	O	O	O
development	O	O	B-T169
of	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
and	O	O	O
the	O	O	O
risk	O	O	B-T033
increases	O	O	I-T033
vary	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
change	O	O	O
of	O	O	O
BMI	O	O	B-T201
category	O	O	O
and	O	O	O
the	O	O	O
existence	O	O	O
of	O	O	O
diabetes	O	O	B-T047
.	O	O	O

-DOCSTART- (27882066)

Bioinformatic	O	O	B-T091
Analysis	O	O	B-T062
of	O	O	O
Codon	O	O	B-T086
Usage	O	O	B-T169
and	O	O	O
Phylogenetic	O	O	B-T080
Relationships	O	O	I-T080
in	O	O	O
Different	O	O	O
Genotypes	O	O	B-T032
of	O	O	O
the	O	O	O
Hepatitis	O	O	O
C	O	O	O
Virus	O	O	O

The	O	O	O
hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
HCV	O	O	B-T005
)	O	O	O
has	O	O	O
six	O	O	O
major	O	O	O
genotypes	O	O	B-T032
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
phylogenetically	O	O	B-T062
investigate	O	O	I-T062
the	O	O	O
differences	O	O	O
between	O	O	O
the	O	O	O
genotypes	O	O	B-T032
of	O	O	O
HCV	O	O	B-T005
,	O	O	O
and	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
types	O	O	O
of	O	O	O
amino	O	O	B-T116
acid	O	O	I-T116
codon	O	O	B-T086
usage	O	O	B-T169
in	O	O	O
the	O	O	O
structure	O	O	B-T017
of	O	O	I-T017
the	O	O	I-T017
virus	O	O	I-T017
in	O	O	O
order	O	O	O
to	O	O	O
discover	O	O	O
new	O	O	O
methods	O	O	O
for	O	O	O
treatment	O	O	B-T058
regimes	O	O	I-T058
.	O	O	O

The	O	O	O
codon	O	O	B-T086
usage	O	O	B-T169
of	O	O	O
the	O	O	O
six	O	O	O
genotypes	O	O	B-T032
of	O	O	O
the	O	O	O
HCV	O	O	B-T005
nucleotide	O	O	B-T086
sequence	O	O	I-T086
was	O	O	O
investigated	O	O	B-T169
through	O	O	O
the	O	O	O
online	O	O	O
application	O	O	O
available	O	O	O
on	O	O	O
the	O	O	O
website	O	O	B-T170
Gene	O	O	I-T170
Infinity	O	O	I-T170
.	O	O	O

Also	O	O	O
,	O	O	O
phylogenetic	O	O	B-T062
analysis	O	O	I-T062
and	O	O	O
the	O	O	O
evolutionary	O	O	B-T080
relationship	O	O	I-T080
of	O	O	O
HCV	O	O	B-T005
genotypes	O	O	B-T032
were	O	O	O
analyzed	O	O	B-T062
with	O	O	O
MEGA	O	O	B-T073
7	O	O	I-T073
software	O	O	I-T073
.	O	O	O

The	O	O	O
six	O	O	O
genotypes	O	O	B-T032
of	O	O	O
HCV	O	O	B-T005
were	O	O	O
divided	O	O	O
into	O	O	O
two	O	O	O
groups	O	O	B-T078
based	O	O	O
on	O	O	O
their	O	O	O
codon	O	O	B-T086
usage	O	O	B-T169
properties	O	O	B-T080
.	O	O	O

In	O	O	O
the	O	O	O
first	O	O	O
group	O	O	B-T078
,	O	O	O
genotypes	O	O	B-T032
1	O	O	I-T032
and	O	O	I-T032
5	O	O	I-T032
(	O	O	O
74.02	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
in	O	O	O
the	O	O	O
second	O	O	O
group	O	O	O
,	O	O	O
genotypes	O	O	B-T032
2	O	O	I-T032
and	O	O	I-T032
6	O	O	I-T032
(	O	O	O
72.43	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
shown	O	O	O
to	O	O	O
have	O	O	O
the	O	O	O
most	O	O	O
similarity	O	O	B-T080
in	O	O	O
terms	O	O	O
of	O	O	O
codon	O	O	B-T086
usage	O	O	B-T169
.	O	O	O

Unlike	O	O	O
the	O	O	O
results	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
determining	O	O	O
the	O	O	O
similarity	O	O	B-T080
of	O	O	O
codon	O	O	B-T086
usage	O	O	B-T169
,	O	O	O
the	O	O	O
phylogenetic	O	O	B-T062
analysis	O	O	I-T062
showed	O	O	O
the	O	O	O
closest	O	O	O
resemblance	O	O	B-T080
and	O	O	O
correlation	O	O	B-T080
between	O	O	O
genotypes	O	O	B-T032
1	O	O	I-T032
and	O	O	I-T032
4	O	O	I-T032
.	O	O	O

The	O	O	O
results	O	O	O
also	O	O	O
showed	O	O	O
that	O	O	O
HCV	O	O	B-T005
has	O	O	O
a	O	O	O
GC	O	O	B-T114
(	O	O	O
guanine	O	O	B-T114
-	O	O	I-T114
cytosine	O	O	B-T109
)	O	O	O
abundant	O	O	O
genome	O	O	B-T028
structure	O	O	I-T028
and	O	O	O
prefers	O	O	O
codons	O	O	B-T086
with	O	O	O
GC	O	O	O
for	O	O	O
translation	O	O	B-UnknownType
.	O	O	O

Genotypes	O	O	B-T032
1	O	O	I-T032
and	O	O	I-T032
4	O	O	I-T032
demonstrated	O	O	O
remarkable	O	O	O
similarity	O	O	B-T080
in	O	O	O
terms	O	O	O
of	O	O	O
genome	O	O	B-T085
sequences	O	O	I-T085
and	O	O	O
proteins	O	O	B-T116
,	O	O	O
but	O	O	O
surprisingly	O	O	O
,	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
the	O	O	O
preferred	O	O	O
codons	O	O	B-T086
for	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
,	O	O	O
they	O	O	O
showed	O	O	O
the	O	O	O
greatest	O	O	O
difference	O	O	O
.	O	O	O

More	O	O	O
studies	O	O	B-T062
are	O	O	O
therefore	O	O	O
needed	O	O	O
to	O	O	O
confirm	O	O	O
the	O	O	O
results	O	O	O
and	O	O	O
select	O	O	O
the	O	O	O
best	O	O	O
approach	O	O	B-T082
for	O	O	O
treatment	O	O	B-T169
of	O	O	O
these	O	O	O
genotypes	O	O	B-T032
based	O	O	O
on	O	O	O
their	O	O	O
codon	O	O	B-T086
usage	O	O	B-T169
properties	O	O	B-T080
.	O	O	O

-DOCSTART- (27884163)

Chronic	O	O	B-T079
adiponectin	O	O	B-T047
deficiency	O	O	I-T047
leads	O	O	O
to	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
-like	O	O	O
cognitive	O	O	B-T048
impairments	O	O	I-T048
and	O	O	O
pathologies	O	O	B-T091
through	O	O	O
AMPK	O	O	B-T116
inactivation	O	O	O
and	O	O	O
cerebral	O	O	B-T023
insulin	O	O	B-T046
resistance	O	O	I-T046
in	O	O	O
aged	O	O	B-T032
mice	O	O	O

Insulin	O	O	B-T046
resistance	O	O	I-T046
is	O	O	O
the	O	O	O
major	O	O	O
pathogenesis	O	O	B-T046
underlying	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
mellitus	O	O	I-T047
(	O	O	O
T2DM	O	O	B-T047
)	O	O	O
and	O	O	O
these	O	O	O
patients	O	O	B-T101
have	O	O	O
doubled	O	O	O
risk	O	O	B-T078
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
.	O	O	O

Increasing	O	O	O
evidence	O	O	O
suggests	O	O	O
that	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
AD	O	O	O
pathogenesis	O	O	B-T046
,	O	O	O
possibly	O	O	O
due	O	O	O
to	O	O	O
abnormal	O	O	O
GSK3β	O	O	B-T116
activation	O	O	B-T044
,	O	O	O
causing	O	O	O
intra-	O	O	B-T026
and	O	O	O
extracellular	O	O	B-T026
amyloid-beta	O	O	B-T116
(	O	O	O
Aβ	O	O	B-T116
)	O	O	O
accumulation	O	O	O
.	O	O	O

Adiponectin	O	O	B-T116
(	O	O	O
APN	O	O	B-T116
)	O	O	O
is	O	O	O
an	O	O	O
adipokine	O	O	B-T116
with	O	O	O
insulin-sensitizing	O	O	O
and	O	O	O
anti-inflammatory	O	O	B-T080
effects	O	O	I-T080
.	O	O	O

Reduced	O	O	O
circulatory	O	O	O
APN	O	O	B-T116
level	O	O	O
is	O	O	O
associated	O	O	O
with	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
T2DM	O	O	B-T047
.	O	O	O

The	O	O	O
role	O	O	O
of	O	O	O
APN	O	O	B-T116
in	O	O	O
AD	O	O	B-T047
has	O	O	O
not	O	O	O
been	O	O	O
elucidated	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
aim	O	O	O
to	O	O	O
examine	O	O	O
if	O	O	O
adiponectin	O	O	B-T047
deficiency	O	O	I-T047
would	O	O	O
lead	O	O	O
to	O	O	O
cerebral	O	O	B-T023
insulin	O	O	B-T046
resistance	O	O	I-T046
,	O	O	O
cognitive	O	O	B-T048
decline	O	O	I-T048
and	O	O	O
Alzheimer's-like	O	O	B-T046
pathology	O	O	I-T046
in	O	O	O
mice	O	O	B-T015
.	O	O	O

To	O	O	O
study	O	O	B-T062
the	O	O	O
role	O	O	O
of	O	O	O
adiponectin	O	O	B-T116
in	O	O	O
cognitive	O	O	B-T041
functions	O	O	I-T041
,	O	O	O
we	O	O	O
employed	O	O	O
adiponectin-knockout	O	O	B-T050
(	O	O	B-T015
APN-KO	O	O	I-T015
)	O	O	I-T015
mice	O	O	I-T015
and	O	O	O
demonstrated	O	O	O
chronic	O	O	B-T079
APN	O	O	B-T047
deficiency	O	O	I-T047
in	O	O	O
their	O	O	O
CNS	O	O	B-T022
.	O	O	O

Behavioral	O	O	B-T060
tests	O	O	I-T060
were	O	O	O
performed	O	O	O
to	O	O	O
study	O	O	B-T062
the	O	O	O
cognitions	O	O	B-T041
of	O	O	O
male	O	O	B-T032
APN-KO	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Brains	O	O	B-T023
and	O	O	O
tissue	O	O	B-T024
lysates	O	O	B-T072
were	O	O	O
collected	O	O	O
to	O	O	O
study	O	O	B-T062
the	O	O	O
pathophysiological	O	O	O
and	O	O	O
molecular	O	O	B-T044
changes	O	O	I-T044
in	O	O	O
the	O	O	O
brain	O	O	B-T023
of	O	O	O
APN-KO	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

SH-SY5Y	O	O	B-T025
neuroblastoma	O	O	I-T025
cell	O	O	I-T025
line	O	O	I-T025
was	O	O	O
used	O	O	O
to	O	O	O
study	O	O	B-T062
the	O	O	O
molecular	O	O	B-T044
mechanism	O	O	I-T044
upon	O	O	O
APN	O	O	B-T116
and	O	O	O
insulin	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

Aged	O	O	B-T032
APN	O	O	B-T116
-deficient	O	O	O
mice	O	O	B-T015
displayed	O	O	O
spatial	O	O	B-T041
memory	O	O	I-T041
and	O	O	O
learning	O	O	B-T041
impairments	O	O	B-T046
,	O	O	O
fear-conditioned	O	O	B-T041
memory	O	O	B-T048
deficit	O	O	I-T048
as	O	O	O
well	O	O	O
as	O	O	O
anxiety	O	O	B-T033
.	O	O	O

These	O	O	O
mice	O	O	B-T015
also	O	O	O
developed	O	O	O
AD	O	O	B-T047
pathologies	O	O	B-T046
including	O	O	O
increased	O	O	O
cerebral	O	O	B-T023
Aβ42	O	O	B-T116
level	O	O	O
,	O	O	O
Aβ	O	O	B-T116
deposition	O	O	O
,	O	O	O
hyperphosphorylated	O	O	B-T116
Tau	O	O	I-T116
proteins	O	O	I-T116
,	O	O	O
microgliosis	O	O	B-T046
and	O	O	O
astrogliosis	O	O	B-T046
with	O	O	O
increased	O	O	O
cerebral	O	O	O
IL-1β	O	O	B-T116
and	O	O	O
TNFα	O	O	B-T116
levels	O	O	O
that	O	O	O
associated	O	O	O
with	O	O	O
increased	O	O	O
neuronal	O	O	B-T129
apoptosis	O	O	I-T043
and	O	O	O
reduced	O	O	O
synaptic	O	O	B-T030
proteins	O	O	B-T034
levels	O	O	I-T034
,	O	O	O
suggesting	O	O	O
APN	O	O	B-T047
deficiency	O	O	I-T047
may	O	O	O
lead	O	O	O
to	O	O	O
neuronal	O	O	O
and	O	O	O
synaptic	O	O	O
loss	O	O	O
in	O	O	O
the	O	O	O
brain	O	O	B-T023
.	O	O	O

AD	O	O	B-T047
pathologies	O	O	B-T169
-associated	O	O	O
APN	O	O	B-T116
-	O	O	O
KO	O	O	B-T015
mice	O	O	I-T015
displayed	O	O	O
attenuated	O	O	O
AMPK	O	O	B-T116
phosphorylation	O	O	B-T044
and	O	O	O
impaired	O	O	O
insulin	O	O	B-T044
signaling	O	O	I-T044
including	O	O	O
decreased	O	O	O
Akt	O	O	B-T116
induction	O	O	O
and	O	O	O
increased	O	O	O
GSK3β	O	O	B-T116
activation	O	O	B-T044
in	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
and	O	O	O
frontal	O	O	B-T023
cortex	O	O	I-T023
.	O	O	O

Aged	O	O	B-T032
APN	O	O	B-T116
-KO	O	O	O
mice	O	O	B-T015
developed	O	O	O
hippocampal	O	O	B-T023
insulin	O	O	B-T046
resistance	O	O	I-T046
with	O	O	O
reduced	O	O	O
pAkt	O	O	B-T116
induction	O	O	O
upon	O	O	O
intracerebral	O	O	O
insulin	O	O	B-T061
injection	O	O	I-T061
.	O	O	O

Consistently	O	O	O
,	O	O	O
APN	O	O	B-T116
treatment	O	O	B-T061
in	O	O	O
SH-SY5Y	O	O	B-UnknownType
cells	O	O	I-UnknownType
with	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
overexpressing	O	O	B-T045
Aβ	O	O	B-T116
induce	O	O	O
higher	O	O	O
pAkt	O	O	B-T116
levels	O	O	O
through	O	O	O
AdipoR1	O	O	B-T116
upon	O	O	O
insulin	O	O	B-T061
treatment	O	O	I-T061
whereas	O	O	O
the	O	O	O
induction	O	O	O
was	O	O	O
blocked	O	O	B-T046
by	O	O	O
compound	O	O	B-T103
C	O	O	I-T103
,	O	O	O
indicating	O	O	O
APN	O	O	O
can	O	O	O
enhance	O	O	O
neuronal	O	O	B-T129
insulin	O	O	B-T046
sensitivity	O	O	I-T046
through	O	O	O
AMPK	O	O	B-T116
activation	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	O
indicated	O	O	O
that	O	O	O
chronic	O	O	B-T079
APN	O	O	B-T047
deficiency	O	O	I-T047
inactivated	O	O	O
AMPK	O	O	B-T116
causing	O	O	O
insulin	O	O	O
desensitization	O	O	O
and	O	O	O
elicited	O	O	O
AD-like	O	O	B-T046
pathogenesis	O	O	I-T046
in	O	O	O
aged	O	O	B-T032
mice	O	O	B-T015
which	O	O	O
also	O	O	O
developed	O	O	O
significant	O	O	O
cognitive	O	O	B-T048
impairments	O	O	I-T048
and	O	O	O
psychiatric	O	O	B-T184
symptoms	O	O	I-T184
.	O	O	O

-DOCSTART- (27884960)

Can	O	O	O
inorganic	O	O	B-T121
phosphate	O	O	I-T121
explain	O	O	O
sag	O	O	B-T080
during	O	O	O
unfused	O	O	B-T080
tetanic	O	O	B-T039
contractions	O	O	I-T039
of	O	O	O
skeletal	O	O	B-T024
muscle	O	O	I-T024
?	O	O	O

We	O	O	O
test	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
cytosolic	O	O	B-T026
inorganic	O	O	B-T121
phosphate	O	O	I-T121
(	O	O	O
Pi	O	O	B-T121
)	O	O	O
can	O	O	O
account	O	O	O
for	O	O	O
the	O	O	O
contraction	O	O	B-T039
-	O	O	O
induced	O	O	B-T169
reductions	O	O	B-T070
in	O	O	O
twitch	O	O	B-T033
duration	O	O	B-T079
which	O	O	O
impair	O	O	B-T169
summation	O	O	O
and	O	O	O
cause	O	O	O
force	O	O	B-T067
to	O	O	O
decline	O	O	B-T080
(	O	O	O
sag	O	O	B-T080
)	O	O	O
during	O	O	O
unfused	O	O	B-T080
tetanic	O	O	B-T039
contractions	O	O	I-T039
of	O	O	O
fast-twitch	O	O	B-T025
muscle	O	O	I-T025
.	O	O	O

A	O	O	O
five-state	O	O	B-T075
model	O	O	I-T075
of	O	O	O
crossbridge	O	O	B-T042
cycling	O	O	I-T042
was	O	O	O
used	O	O	O
to	O	O	O
simulate	O	O	B-T169
twitch	O	O	B-T033
and	O	O	O
unfused	O	O	B-T080
tetanic	O	O	B-T039
contractions	O	O	I-T039
.	O	O	O

As	O	O	O
Pi	O	O	B-T121
concentration	O	O	B-T081
(	O	O	O
[	O	O	O
Pi	O	O	O
]	O	O	O
)	O	O	O
was	O	O	O
increased	O	O	B-T081
from	O	O	O
0	O	O	O
to	O	O	O
30	O	O	O
mmol·L(-1	O	O	O
)	O	O	O
,	O	O	O
twitch	O	O	B-T033
duration	O	O	B-T079
decreased	O	O	B-T081
,	O	O	O
with	O	O	O
progressive	O	O	B-T169
reductions	O	O	B-T061
in	O	O	O
sensitivity	O	O	B-T169
to	O	O	O
Pi	O	O	O
as	O	O	O
[	O	O	O
Pi	O	O	O
]	O	O	O
was	O	O	O
increased	O	O	O
.	O	O	O

When	O	O	O
unfused	O	O	B-T080
tetani	O	O	O
were	O	O	O
simulated	O	O	B-T062
with	O	O	O
rising	O	O	O
[	O	O	O
Pi	O	O	B-T121
]	O	O	O
,	O	O	O
sag	O	O	B-T080
was	O	O	O
most	O	O	O
pronounced	O	O	B-T080
when	O	O	O
initial	O	O	B-T079
[	O	O	O
Pi	O	O	O
]	O	O	O
was	O	O	O
low	O	O	B-T080
,	O	O	O
and	O	O	O
when	O	O	O
the	O	O	O
magnitude	O	O	B-T081
of	O	O	O
[	O	O	O
Pi	O	O	O
]	O	O	O
increase	O	O	B-T081
was	O	O	O
large	O	O	B-T081
.	O	O	O

Fast-twitch	O	O	B-T033
extensor	O	O	B-T023
digitorum	O	O	I-T023
longus	O	O	I-T023
(	O	O	I-T023
EDL	O	O	I-T023
)	O	O	I-T023
muscles	O	O	I-T023
(	O	O	O
sag-prone	O	O	B-T169
,	O	O	O
typically	O	O	O
low	O	O	O
basal	O	O	O
[	O	O	O
Pi	O	O	B-T121
]	O	O	O
)	O	O	O
and	O	O	O
slow-twitch	O	O	B-T033
soleus	O	O	B-T023
muscles	O	O	I-T023
(	O	O	O
sag	O	O	B-T080
-	O	O	O
resistant	O	O	B-T039
,	O	O	O
typically	O	O	O
high	O	O	O
basal	O	O	O
[	O	O	O
Pi	O	O	O
]	O	O	O
)	O	O	O
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
14	O	O	O
female	O	O	B-T032
C57BL/6	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Muscles	O	O	B-T024
were	O	O	O
sequentially	O	O	O
incubated	O	O	B-T059
in	O	O	O
solutions	O	O	B-T167
containing	O	O	O
either	O	O	O
glucose	O	O	B-T109
or	O	O	O
pyruvate	O	O	B-T109
to	O	O	O
create	O	O	O
typical	O	O	B-T080
and	O	O	O
low	O	O	B-T080
Pi	O	O	B-T121
environments	O	O	B-T082
,	O	O	O
respectively	O	O	O
.	O	O	O

Twitch	O	O	B-T033
duration	O	O	B-T079
was	O	O	O
greater	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
in	O	O	O
pyruvate	O	O	B-T109
than	O	O	O
glucose	O	O	B-T109
in	O	O	O
both	O	O	O
muscles	O	O	B-T024
.	O	O	O

Stimuli	O	O	B-T067
applied	O	O	B-T169
at	O	O	O
intervals	O	O	B-T079
approximately	O	O	O
three	O	O	O
times	O	O	O
the	O	O	O
time	O	O	O
to	O	O	O
peak	O	O	B-T080
twitch	O	O	B-T033
tension	O	O	B-T033
resulted	O	O	O
in	O	O	O
sag	O	O	B-T080
of	O	O	O
35.0	O	O	O
±	O	O	O
3.7	O	O	O
%	O	O	O
in	O	O	O
glucose	O	O	B-T109
and	O	O	O
50.5	O	O	O
±	O	O	O
1.4	O	O	O
%	O	O	O
in	O	O	O
pyruvate	O	O	B-T109
in	O	O	O
the	O	O	O
EDL	O	O	B-T023
(	O	O	O
pyruvate	O	O	O
>	O	O	O
glucose	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
3.9	O	O	O
±	O	O	O
0.3	O	O	O
%	O	O	O
in	O	O	O
glucose	O	O	O
and	O	O	O
37.8	O	O	O
±	O	O	O
2.7	O	O	O
%	O	O	O
in	O	O	O
pyruvate	O	O	O
in	O	O	O
the	O	O	O
soleus	O	O	B-T023
(	O	O	O
pyruvate	O	O	O
>	O	O	O
glucose	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
influence	O	O	O
of	O	O	O
Pi	O	O	B-T121
on	O	O	O
crossbridge	O	O	B-T042
cycling	O	O	I-T042
provides	O	O	O
a	O	O	O
tenable	O	O	B-T169
mechanism	O	O	I-T169
for	O	O	O
sag	O	O	B-T080
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
low	O	O	B-T033
basal	O	O	I-T033
[	O	O	O
Pi	O	O	B-T121
]	O	O	O
in	O	O	O
fast-twitch	O	O	B-T033
relative	O	O	O
to	O	O	O
slow-twitch	O	O	B-T033
muscle	O	O	I-T033
has	O	O	O
promise	O	O	O
as	O	O	O
an	O	O	O
explanation	O	O	B-T170
for	O	O	O
the	O	O	O
fiber-type	O	O	B-T025
dependency	O	O	O
of	O	O	O
sag	O	O	B-T080
.	O	O	O

-DOCSTART- (27885308)

Pancreatic	O	O	B-T191
Cancer	O	O	I-T191
:	O	O	O
A	O	O	O
Survival	O	O	B-T062
Analysis	O	O	I-T062
Study	O	O	B-T062
in	O	O	O
Oklahoma	O	O	O

Pancreatic	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
among	O	O	O
the	O	O	O
most	O	O	O
deadly	O	O	B-T191
cancers	O	O	I-T191
.	O	O	O

Risk	O	O	B-T033
factors	O	O	I-T033
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
disease	O	O	B-T047
include	O	O	O
age	O	O	B-T032
,	O	O	O
race	O	O	B-T098
,	O	O	O
sex	O	O	B-T032
,	O	O	O
smoking	O	O	B-T201
status	O	O	I-T201
,	O	O	O
and	O	O	O
diabetes	O	O	B-T033
status	O	O	I-T033
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
prospective	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
and	O	O	O
length	O	O	B-T079
of	O	O	I-T079
survival	O	O	I-T079
among	O	O	O
pancreatic	O	O	B-T101
cancer	O	O	I-T101
patients	O	O	I-T101
living	O	O	O
in	O	O	O
Oklahoma	O	O	B-T083
between	O	O	O
1997	O	O	O
and	O	O	O
2012	O	O	O
(	O	O	O
n=6,291	O	O	O
)	O	O	O
.	O	O	O

Kaplan-Meier	O	O	B-T081
survival	O	O	I-T081
curves	O	O	I-T081
were	O	O	O
created	O	O	B-T052
followed	O	O	O
by	O	O	O
the	O	O	O
log-rank	O	O	B-T169
test	O	O	I-T169
to	O	O	O
compare	O	O	O
difference	O	O	B-T080
in	O	O	O
the	O	O	O
survival	O	O	B-T201
time	O	O	I-T201
.	O	O	O

Cox	O	O	B-T081
proportional	O	O	I-T081
hazard	O	O	I-T081
regression	O	O	I-T081
models	O	O	I-T081
were	O	O	O
used	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
strength	O	O	B-T080
of	O	O	I-T080
association	O	O	I-T080
through	O	O	O
the	O	O	O
estimated	O	O	B-T081
hazard	O	O	B-T081
ratios	O	O	I-T081
.	O	O	O

The	O	O	O
median	O	O	B-T079
survival	O	O	I-T079
time	O	O	I-T079
of	O	O	O
the	O	O	O
cohort	O	O	B-T098
was	O	O	O
three	O	O	O
months	O	O	B-T079
.	O	O	O

Significant	O	O	B-T078
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
reduced	O	O	B-T080
survival	O	O	B-T201
times	O	O	I-T201
included	O	O	O
age	O	O	B-T032
,	O	O	O
stage	O	O	B-T185
at	O	O	I-T185
diagnosis	O	O	I-T185
,	O	O	O
and	O	O	O
year	O	O	B-T201
of	O	O	I-T201
diagnosis	O	O	I-T201
.	O	O	O

Results	O	O	B-T034
are	O	O	O
in	O	O	O
agreement	O	O	O
with	O	O	O
previous	O	O	O
research	O	O	B-T033
findings	O	O	I-T033
.	O	O	O

There	O	O	O
have	O	O	O
been	O	O	O
small	O	O	O
but	O	O	O
noteworthy	O	O	B-T077
improvements	O	O	I-T077
in	O	O	O
survival	O	O	B-T201
times	O	O	I-T201
for	O	O	O
pancreatic	O	O	B-T101
cancer	O	O	I-T101
patients	O	O	I-T101
in	O	O	O
Oklahoma	O	O	B-T083
.	O	O	O

Length	O	O	B-T079
of	O	O	I-T079
survival	O	O	I-T079
during	O	O	O
the	O	O	O
study	O	O	B-T062
period	O	O	I-T062
was	O	O	O
significantly	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
known	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
such	O	O	O
as	O	O	O
age	O	O	B-T032
and	O	O	O
stage	O	O	B-T185
of	O	O	I-T185
diagnosis	O	O	I-T185
.	O	O	O

-DOCSTART- (27887661)

Biochemical	O	O	B-T169
and	O	O	O
proteomic	O	O	B-T091
analyses	O	O	B-T062
of	O	O	O
the	O	O	O
physiological	O	O	B-T039
response	O	O	I-T039
induced	O	O	O
by	O	O	O
individual	O	O	O
housing	O	O	B-T073
in	O	O	O
gilts	O	O	B-T015
provide	O	O	O
new	O	O	O
potential	O	O	B-T080
stress	O	O	B-T046
markers	O	O	O

The	O	O	O
objective	O	O	B-T080
assessment	O	O	B-T058
of	O	O	O
animal	O	O	B-T008
stress	O	O	B-T046
and	O	O	O
welfare	O	O	O
requires	O	O	O
proper	O	O	O
laboratory	O	O	B-T093
biomarkers	O	O	B-T201
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
analyzed	O	O	O
the	O	O	O
changes	O	O	O
in	O	O	O
serum	O	O	B-T031
composition	O	O	B-T201
in	O	O	O
gilts	O	O	B-T015
after	O	O	O
switching	O	O	O
their	O	O	O
housing	O	O	B-T073
,	O	O	O
from	O	O	O
pen	O	O	O
to	O	O	O
individual	O	O	O
stalls	O	O	B-T073
,	O	O	O
which	O	O	O
is	O	O	O
generally	O	O	O
accepted	O	O	O
to	O	O	O
cause	O	O	O
animal	O	O	B-T008
discomfort	O	O	B-T184
.	O	O	O

Blood	O	O	B-T031
and	O	O	O
saliva	O	O	B-T031
samples	O	O	I-T031
were	O	O	O
collected	O	O	O
a	O	O	O
day	O	O	O
before	O	O	O
and	O	O	O
up	O	O	O
to	O	O	O
four	O	O	O
days	O	O	O
after	O	O	O
changing	O	O	O
the	O	O	O
housing	O	O	B-T073
system	O	O	O
.	O	O	O

Biochemical	O	O	B-T169
analyses	O	O	B-T062
showed	O	O	O
adaptive	O	O	B-T169
changes	O	O	O
in	O	O	O
lipid	O	O	B-T109
and	O	O	O
protein	O	O	B-T044
metabolism	O	O	I-T044
after	O	O	O
the	O	O	O
housing	O	O	B-T073
switch	O	O	O
,	O	O	O
whereas	O	O	O
cortisol	O	O	B-T125
and	O	O	O
muscular	O	O	B-T024
markers	O	O	B-T201
showed	O	O	O
a	O	O	O
large	O	O	O
variability	O	O	B-T077
between	O	O	O
animals	O	O	B-T008
.	O	O	O

2D-DIGE	O	O	B-T059
and	O	O	O
iTRAQ	O	O	B-T170
proteomic	O	O	B-T091
approaches	O	O	B-T057
revealed	O	O	O
variations	O	O	O
in	O	O	O
serum	O	O	B-T116
protein	O	O	I-T116
composition	O	O	B-T201
after	O	O	O
changing	O	O	O
housing	O	O	B-T073
and	O	O	O
diet	O	O	O
of	O	O	O
gilts	O	O	B-T015
.	O	O	O

Both	O	O	O
techniques	O	O	B-T169
showed	O	O	O
alterations	O	O	B-T078
in	O	O	O
two	O	O	O
main	O	O	O
homeostatic	O	O	B-T040
mechanisms	O	O	I-T040
:	O	O	O
the	O	O	O
innate	O	O	B-T032
immune	O	O	I-T032
and	O	O	O
redox	O	O	B-T044
systems	O	O	O
.	O	O	O

The	O	O	O
acute	O	O	B-T116
phase	O	O	I-T116
proteins	O	O	I-T116
haptoglobin	O	O	B-T116
,	O	O	O
apolipoprotein	O	O	B-T116
A-I	O	O	I-T116
and	O	O	O
α1-antichymotrypsin	O	O	O
3	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
antioxidant	O	O	B-T121
enzyme	O	O	O
peroxiredoxin	O	O	B-T116
2	O	O	I-T116
were	O	O	O
found	O	O	O
differentially	O	O	O
expressed	O	O	O
by	O	O	O
2D-DIGE	O	O	B-T059
.	O	O	O

Other	O	O	O
proteins	O	O	B-T116
related	O	O	O
to	O	O	O
the	O	O	O
innate	O	O	B-T032
immune	O	O	I-T032
system	O	O	I-T032
,	O	O	O
including	O	O	O
lactotransferrin	O	O	B-T116
,	O	O	O
protegrin	O	O	B-T116
3	O	O	I-T116
and	O	O	O
galectin	O	O	B-T116
1	O	O	I-T116
were	O	O	O
also	O	O	O
identified	O	O	O
by	O	O	O
iTRAQ	O	O	B-T170
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
enzymes	O	O	B-T116
such	O	O	O
as	O	O	O
peroxiredoxin	O	O	B-T116
2	O	O	I-T116
and	O	O	O
glutathione	O	O	B-T116
peroxidase	O	O	I-T116
3	O	O	I-T116
.	O	O	O

Proteomics	O	O	B-T091
also	O	O	O
revealed	O	O	O
the	O	O	O
decrease	O	O	B-T080
of	O	O	O
apolipoproteins	O	O	B-T116
,	O	O	O
and	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
intracellular	O	O	B-T082
proteins	O	O	B-T116
in	O	O	O
serum	O	O	B-T031
,	O	O	O
which	O	O	O
may	O	O	O
indicate	O	O	O
physical	O	O	B-T037
injury	O	O	I-T037
to	O	O	O
tissues	O	O	B-T024
.	O	O	O

Housing	O	O	B-T073
of	O	O	O
gilts	O	O	B-T015
in	O	O	O
individual	O	O	O
stalls	O	O	B-T073
and	O	O	O
diet	O	O	O
change	O	O	O
increase	O	O	O
lipid	O	O	B-T109
and	O	O	O
protein	O	O	B-T044
catabolism	O	O	I-T044
,	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
,	O	O	O
activate	O	O	O
the	O	O	O
innate	O	O	B-T032
immune	O	O	I-T032
system	O	O	I-T032
and	O	O	O
cause	O	O	O
a	O	O	O
certain	O	O	O
degree	O	O	O
of	O	O	O
tissue	O	O	B-T037
damage	O	O	I-T037
.	O	O	O

We	O	O	O
propose	O	O	O
that	O	O	O
valuable	O	O	O
assays	O	O	O
for	O	O	O
stress	O	O	B-T060
assessment	O	O	I-T060
in	O	O	O
gilts	O	O	B-T015
may	O	O	O
be	O	O	O
based	O	O	O
on	O	O	O
a	O	O	O
score	O	O	B-T081
composed	O	O	O
by	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
salivary	O	O	O
cortisol	O	O	O
,	O	O	O
lipid	O	O	B-T109
metabolites	O	O	B-T123
,	O	O	O
innate	O	O	B-T032
immunity	O	O	I-T032
and	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
markers	O	O	B-T201
and	O	O	O
intracellular	O	O	B-T082
proteins	O	O	B-T116
.	O	O	O

-DOCSTART- (27887778)

Cultivation	O	O	B-T059
of	O	O	O
four	O	O	O
microalgae	O	O	B-T204
species	O	O	B-T185
in	O	O	O
the	O	O	O
effluent	O	O	B-T167
of	O	O	O
anaerobic	O	O	B-T075
digester	O	O	I-T075
for	O	O	O
biodiesel	O	O	B-T109
production	O	O	O

This	O	O	O
study	O	O	B-T062
investigated	O	O	B-T169
if	O	O	O
an	O	O	O
effluent	O	O	B-T167
from	O	O	O
anaerobic	O	O	B-T075
digestion	O	O	I-T075
(	O	O	I-T075
AD	O	O	I-T075
)	O	O	I-T075
system	O	O	I-T075
can	O	O	O
be	O	O	O
used	O	O	B-T169
as	O	O	O
a	O	O	O
nutrients	O	O	B-T168
source	O	O	B-T033
for	O	O	O
the	O	O	O
microalgae	O	O	B-T204
cultivation	O	O	B-T059
,	O	O	O
and	O	O	O
in	O	O	O
so	O	O	O
doing	O	O	O
,	O	O	O
if	O	O	O
the	O	O	O
effluent	O	O	O
can	O	O	O
be	O	O	O
properly	O	O	O
treated	O	O	B-T169
.	O	O	O

Nitrogen	O	O	B-T123
and	O	O	O
phosphorus	O	O	B-T196
in	O	O	O
the	O	O	O
AD	O	O	B-T075
effluent	O	O	B-T167
well	O	O	O
supported	O	O	O
microalgal	O	O	B-T204
growth	O	O	B-T040
,	O	O	O
and	O	O	O
their	O	O	O
removal	O	O	B-T080
efficiency	O	O	B-T081
reached	O	O	O
>	O	O	O
97.9	O	O	O
%	O	O	O
and	O	O	O
99.2	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Among	O	O	O
four	O	O	O
different	O	O	B-T080
algal	O	O	B-T204
species	O	O	B-T185
tested	O	O	B-T169
,	O	O	O
Micractinium	O	O	B-T002
inermum	O	O	I-T002
particularly	O	O	O
stood	O	O	B-T169
out	O	O	I-T169
,	O	O	O
showing	O	O	O
the	O	O	O
highest	O	O	B-T080
biomass	O	O	B-T081
and	O	O	O
FAME	O	O	B-T109
productivity	O	O	B-T081
:	O	O	O
0.16gL(-1)d(-1	O	O	O
)	O	O	O
with	O	O	O
3.23gL(-1	O	O	O
)	O	O	O
of	O	O	O
dry	O	O	B-T080
cell	O	O	B-T025
weight	O	O	B-T032
,	O	O	O
and	O	O	O
0.04gL(-1)d(-1	O	O	O
)	O	O	O
with	O	O	O
27.54	O	O	O
%	O	O	O
(	O	O	O
w/w	O	O	O
)	O	O	O
of	O	O	O
FAME	O	O	O
contents	O	O	B-T077
,	O	O	O
respectively	O	O	O
.	O	O	O

As	O	O	O
the	O	O	O
concentrations	O	O	B-T081
of	O	O	O
the	O	O	O
nutrients	O	O	B-T168
decreased	O	O	B-T081
over	O	O	B-T079
time	O	O	B-T079
,	O	O	O
the	O	O	O
FAME	O	O	B-T109
contents	O	O	B-T077
were	O	O	O
increased	O	O	B-T081
and	O	O	O
its	O	O	O
quality	O	O	B-T080
as	O	O	O
well	O	O	B-T080
,	O	O	O
satisfying	O	O	O
several	O	O	B-T081
biodiesel	O	O	B-T109
quality	O	O	O
standards	O	O	B-T080
.	O	O	O

This	O	O	O
study	O	O	B-T062
supports	O	O	O
that	O	O	O
the	O	O	O
AD	O	O	B-T075
effluent	O	O	B-T167
can	O	O	O
indeed	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
cheap	O	O	B-T081
and	O	O	O
nutrient	O	O	B-T168
-	O	O	O
rich	O	O	B-T080
medium	O	O	B-T081
for	O	O	O
microalgae	O	O	B-T204
cultivation	O	O	B-T059
,	O	O	O
and	O	O	O
equally	O	O	B-T080
importantly	O	O	B-T080
,	O	O	O
microalgae	O	O	O
can	O	O	O
be	O	O	O
a	O	O	O
workable	O	O	O
treatment	O	O	B-T169
option	O	O	B-T169
for	O	O	O
it	O	O	O
.	O	O	O

-DOCSTART- (27889529)

Antiviral	O	O	B-T033
activities	O	O	I-T033
of	O	O	O
selected	O	O	O
antimalarials	O	O	B-T121
against	O	O	B-T080
dengue	O	O	B-T005
virus	O	O	I-T005
type	O	O	I-T005
2	O	O	I-T005
and	O	O	O
Zika	O	O	O
virus	O	O	O

In	O	O	O
a	O	O	O
previous	O	O	B-T079
study	O	O	B-T062
,	O	O	I-T062
twelve	O	O	O
antimalarial	O	O	B-T121
compounds	O	O	I-T121
,	O	O	O
amodiaquine	O	O	B-T109
(	O	O	O
AQ	O	O	B-T109
)	O	O	O
and	O	O	O
derivatives	O	O	B-T104
,	O	O	O
were	O	O	O
shown	O	O	O
to	O	O	O
have	O	O	O
potent	O	O	B-T080
anti-dengue	O	O	B-T033
viral	O	O	I-T033
(	O	O	I-T033
DENV	O	O	I-T033
)	O	O	I-T033
activity	O	O	I-T033
by	O	O	O
using	O	O	O
the	O	O	O
stable	O	O	B-T080
DENV2	O	O	B-T005
Renilla	O	O	B-T116
luciferase	O	O	I-T116
reporter	O	O	B-T028
replicon	O	O	B-T114
expressing	O	O	B-T045
BHK-21	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
infectivity	O	O	B-T080
(	O	O	O
plaque	O	O	B-T059
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
qRT-PCR	O	O	B-T063
assays	O	O	I-T063
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
performed	O	O	B-T169
molecular	O	O	B-T062
modeling	O	O	I-T062
on	O	O	O
these	O	O	O
compounds	O	O	B-T121
to	O	O	O
determine	O	O	O
their	O	O	O
stereo-electronic	O	O	B-T080
properties	O	O	I-T080
required	O	O	O
for	O	O	O
optimal	O	O	B-T080
antiviral	O	O	B-T033
activity	O	O	I-T033
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
similarity	O	O	B-T080
of	O	O	O
calculated	O	O	O
stereo-electronic	O	O	B-T080
profiles	O	O	I-T080
,	O	O	O
specifically	O	O	O
the	O	O	O
electrostatic	O	O	B-T081
potential	O	O	I-T081
profiles	O	O	I-T081
of	O	O	O
the	O	O	O
compounds	O	O	B-T121
,	O	O	O
and	O	O	O
in	O	O	B-T062
silico	O	O	I-T062
screening	O	O	I-T062
of	O	O	O
related	O	O	O
compounds	O	O	O
from	O	O	O
literature	O	O	B-T170
,	O	O	O
we	O	O	O
identified	O	O	B-T080
three	O	O	O
additional	O	O	B-T169
compounds	O	O	O
,	O	O	O
Quinacrine	O	O	B-T109
(	O	O	O
QC	O	O	B-T109
)	O	O	O
,	O	O	O
Mefloquine	O	O	B-T109
(	O	O	O
MQ	O	O	B-T109
)	O	O	O
,	O	O	O
and	O	O	O
GSK369796	O	O	B-T109
.	O	O	O

Analysis	O	O	O
of	O	O	O
their	O	O	O
antiviral	O	O	B-T033
activities	O	O	I-T033
indicated	O	O	O
that	O	O	O
all	O	O	O
three	O	O	B-T121
compounds	O	O	I-T121
have	O	O	O
high	O	O	B-T080
anti-DENV	O	O	B-T033
activity	O	O	I-T033
in	O	O	O
the	O	O	O
DENV2	O	O	B-T005
replicon	O	O	B-T114
expressing	O	O	B-T045
cells	O	O	B-T025
with	O	O	O
EC50	O	O	B-T081
values	O	O	I-T081
of	O	O	O
5.30	O	O	O
±	O	O	O
1.31	O	O	O
μM	O	O	O
(	O	O	O
QC	O	O	B-T109
)	O	O	O
,	O	O	O
3.22	O	O	O
±	O	O	O
0.37	O	O	O
μM	O	O	O
(	O	O	O
MQ	O	O	B-T109
)	O	O	O
,	O	O	O
and	O	O	O
5.06	O	O	O
±	O	O	O
0.86	O	O	O
μM	O	O	O
(	O	O	O
GSK369796	O	O	B-T109
)	O	O	O
.	O	O	O

The	O	O	O
infectivity	O	O	B-T059
assays	O	O	I-T059
revealed	O	O	B-T080
the	O	O	O
EC50	O	O	B-T081
values	O	O	I-T081
of	O	O	O
7.09	O	O	O
±	O	O	O
1.67	O	O	O
μM	O	O	O
(	O	O	O
QC	O	O	B-T109
)	O	O	O
,	O	O	O
4.36	O	O	O
±	O	O	O
0.31	O	O	O
μM	O	O	O
(	O	O	O
MQ	O	O	B-T109
)	O	O	O
and	O	O	O
3.03	O	O	O
±	O	O	O
0.35	O	O	O
μM	O	O	O
(	O	O	O
GSK369796	O	O	B-T109
)	O	O	O
.	O	O	O

The	O	O	O
mode	O	O	B-T169
of	O	O	I-T169
action	O	O	I-T169
of	O	O	O
these	O	O	O
compounds	O	O	B-T121
is	O	O	O
through	O	O	B-T169
inhibition	O	O	B-T052
of	O	O	O
autophagy	O	O	B-T043
,	O	O	O
thereby	O	O	O
affecting	O	O	B-T169
DENV2	O	O	B-T005
replication	O	O	B-T043
.	O	O	O

Moreover	O	O	O
,	O	O	O
these	O	O	O
compounds	O	O	B-T121
also	O	O	O
showed	O	O	O
antiviral	O	O	B-T033
activity	O	O	I-T033
against	O	O	B-T080
the	O	O	O
rapidly	O	O	O
emerging	O	O	O
Zika	O	O	B-T005
virus	O	O	I-T005
(	O	O	O
ZIKV	O	O	B-T005
)	O	O	O
with	O	O	O
EC50	O	O	B-T081
values	O	O	I-T081
of	O	O	O
2.27	O	O	O
±	O	O	O
0.14	O	O	O
μM	O	O	O
(	O	O	O
QC	O	O	B-T109
)	O	O	O
,	O	O	O
3.95	O	O	O
±	O	O	O
0.21	O	O	O
μM	O	O	O
(	O	O	O
MQ	O	O	B-T109
)	O	O	O
,	O	O	O
and	O	O	O
2.57	O	O	O
±	O	O	O
0.09	O	O	O
μM	O	O	O
(	O	O	O
GSK369796	O	O	B-T109
)	O	O	O
.	O	O	O

-DOCSTART- (27892236)

1	O	O	O
in	O	O	O
100	O	O	O
babies	O	O	B-T100
:	O	O	O
the	O	O	O
fetal	O	O	B-T047
alcohol	O	O	I-T047
spectrum	O	O	I-T047
disorder	O	O	I-T047
pathway	O	O	O

Alcohol	O	O	B-T168
consumed	O	O	B-T055
during	O	O	O
pregnancy	O	O	B-T040
is	O	O	O
the	O	O	O
nation	O	O	B-UnknownType
's	O	O	I-UnknownType
leading	O	O	O
preventable	O	O	B-T080
cause	O	O	B-T169
of	O	O	O
developmental	O	O	B-T048
disabilities	O	O	I-T048
and	O	O	O
birth	O	O	B-T019
defects	O	O	I-T019
.	O	O	O

One	O	O	O
in	O	O	O
100	O	O	O
babies	O	O	B-T100
is	O	O	O
estimated	O	O	O
to	O	O	O
be	O	O	O
born	O	O	B-T040
with	O	O	O
alcohol-related	O	O	B-T047
damage	O	O	I-T047
,	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
World	O	O	B-T093
Health	O	O	I-T093
Organization	O	O	I-T093
.	O	O	O

Fetal	O	O	B-T047
alcohol	O	O	I-T047
spectrum	O	O	I-T047
disorders	O	O	I-T047
(	O	O	O
FASDs	O	O	B-T047
)	O	O	O
are	O	O	O
more	O	O	O
common	O	O	O
than	O	O	O
autism	O	O	B-T048
but	O	O	O
are	O	O	O
under-	O	O	O
diagnosed	O	O	B-T033
.	O	O	O

-DOCSTART- (27892857)

Genotyping	O	O	B-T059
of	O	O	O
German	O	O	B-T098
and	O	O	O
Austrian	O	O	B-T098
Taylorella	O	O	B-T007
equigenitalis	O	O	I-T007
isolates	O	O	B-T123
using	O	O	O
repetitive	O	O	B-T063
extragenic	O	O	I-T063
palindromic	O	O	I-T063
(	O	O	I-T063
REP	O	O	I-T063
)	O	O	I-T063
PCR	O	O	I-T063
and	O	O	O
pulsed-field	O	O	B-T059
gel	O	O	I-T059
electrophoresis	O	O	I-T059
(	O	O	O
PFGE	O	O	B-T059
)	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
124	O	O	O
Taylorella	O	O	B-T007
(	O	O	I-T007
T.	O	O	I-T007
)	O	O	I-T007
equigenitalis	O	O	I-T007
and	O	O	O
five	O	O	O
T.	O	O	B-T007
asinigenitalis	O	O	I-T007
field	O	O	B-T077
isolates	O	O	B-T123
collected	O	O	B-T169
between	O	O	O
2002	O	O	O
and	O	O	O
2014	O	O	O
were	O	O	O
available	O	O	B-T169
for	O	O	O
genotyping	O	O	B-T059
using	O	O	O
REP-	O	O	B-T063
(	O	O	I-T063
repetitive	O	O	I-T063
extragenic	O	O	I-T063
palindromic	O	O	I-T063
)	O	O	I-T063
PCR	O	O	I-T063
and	O	O	O
PFGE	O	O	B-T059
(	O	O	O
pulsed-field	O	O	B-T059
gel	O	O	I-T059
electrophoresis	O	O	I-T059
)	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
comprised	O	O	O
79	O	O	O
T.	O	O	B-T007
equigenitalis	O	O	I-T007
field	O	O	B-T077
isolates	O	O	B-T123
originating	O	O	O
from	O	O	O
ten	O	O	O
defined	O	O	O
breeds	O	O	B-T040
of	O	O	O
German	O	O	B-T015
horses	O	O	I-T015
and	O	O	O
revealed	O	O	B-T080
a	O	O	O
spectrum	O	O	B-T077
of	O	O	O
five	O	O	O
REP	O	O	B-T086
(	O	O	O
rep-E1-E4	O	O	B-T032
,	O	O	O
rep-E3a	O	O	B-T032
)	O	O	O
and	O	O	O
15	O	O	O
PFGE	O	O	B-T059
(	O	O	O
TE-A1-A9	O	O	B-T032
,	O	O	O
TE-B1-B3	O	O	B-T032
,	O	O	O
TE-C	O	O	B-T032
,	O	O	O
TE-E1	O	O	B-T032
,	O	O	O
and	O	O	O
TE-E2	O	O	B-T032
)	O	O	O
genotypes	O	O	B-T032
.	O	O	O

T.	O	O	B-T007
equigenitalis	O	O	I-T007
field	O	O	B-T077
isolates	O	O	B-T123
(	O	O	O
n=40	O	O	O
)	O	O	O
obtained	O	O	B-T169
from	O	O	O
Austrian	O	O	B-T015
Lipizzaner	O	O	I-T015
horses	O	O	I-T015
were	O	O	O
differentiated	O	O	B-T080
into	O	O	O
three	O	O	O
REP	O	O	B-T086
(	O	O	O
rep-E1	O	O	B-T032
,	O	O	O
rep-E3a	O	O	B-T032
,	O	O	O
and	O	O	O
rep-E4	O	O	B-T032
)	O	O	O
and	O	O	O
three	O	O	O
PFGE	O	O	B-T059
genotypes	O	O	B-T032
(	O	O	O
TE-A2	O	O	B-T032
,	O	O	O
TE-A5	O	O	B-T032
,	O	O	O
and	O	O	O
TE-D	O	O	B-T032
)	O	O	O
;	O	O	O
those	O	O	O
isolated	O	O	B-T169
from	O	O	O
four	O	O	O
Austrian	O	O	B-T015
Trotters	O	O	I-T015
belonged	O	O	O
to	O	O	O
the	O	O	O
REP	O	O	O
/	O	O	O
PFGE	O	O	O
genotype	O	O	B-T032
rep-E2/TE-A1	O	O	B-T032
.	O	O	O

Interestingly	O	O	O
,	O	O	O
a	O	O	O
T.	O	O	B-T007
equigenitalis	O	O	I-T007
isolate	O	O	B-T123
recovered	O	O	B-T080
from	O	O	I-T080
a	O	O	O
Holsteiner	O	O	B-T015
stallion	O	O	I-T015
living	O	O	B-T078
in	O	O	O
South	O	O	B-T083
Africa	O	O	I-T083
revealed	O	O	B-T080
the	O	O	O
REP	O	O	B-T086
/	O	O	O
PFGE	O	O	B-T059
genotype	O	O	B-T032
rep-E1/TE-A5	O	O	B-T032
which	O	O	O
was	O	O	O
otherwise	O	O	O
exclusively	O	O	B-T078
present	O	O	B-T033
in	O	O	O
the	O	O	O
majority	O	O	B-T054
of	O	O	O
Austrian	O	O	B-T015
Lipizzaner	O	O	I-T015
horses	O	O	I-T015
in	O	O	O
our	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
type	O	O	O
strain	O	O	B-T001
included	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
revealed	O	O	B-T080
the	O	O	O
genotype	O	O	B-T032
REP	O	O	B-T086
/	O	O	O
PFGE	O	O	B-T059
rep-E1/TE-F.	O	O	O
Six	O	O	O
strains	O	O	B-T001
of	O	O	O
T.	O	O	B-T007
asinigenitalis	O	O	I-T007
including	O	O	O
the	O	O	O
type	O	O	O
strain	O	O	O
were	O	O	O
separated	O	O	B-T080
into	O	O	O
three	O	O	O
REP	O	O	O
(	O	O	O
rep-A1-A3	O	O	B-T032
)	O	O	O
and	O	O	O
six	O	O	O
PFGE	O	O	O
genotypes	O	O	B-T032
(	O	O	O
TA-A1	O	O	B-T032
,	O	O	O
TA-A2	O	O	B-T032
,	O	O	O
TA-A3	O	O	B-T032
,	O	O	O
TA-B	O	O	B-T032
,	O	O	O
TA-C	O	O	B-T032
,	O	O	O
TA-D	O	O	B-T032
)	O	O	O
.	O	O	O

Overall	O	O	B-T080
,	O	O	I-T080
the	O	O	O
generated	O	O	B-T052
REP	O	O	B-T086
and	O	O	O
PFGE	O	O	B-T059
genotypes	O	O	B-T032
showed	O	O	O
a	O	O	O
good	O	O	B-T080
correlation	O	O	B-T080
,	O	O	O
whereas	O	O	O
REP-PCR	O	O	B-T063
proved	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
suitable	O	O	B-T059
method	O	O	I-T059
for	O	O	O
molecular	O	O	B-T059
epidemiological	O	O	I-T059
screening	O	O	I-T059
of	O	O	O
T.	O	O	B-T007
equigenitalis	O	O	I-T007
and	O	O	O
T.	O	O	B-T007
asinigenitalis	O	O	I-T007
isolates	O	O	B-T123
that	O	O	O
should	O	O	O
be	O	O	O
differentiated	O	O	B-T080
in	O	O	O
detail	O	O	B-T080
by	O	O	O
genotyping	O	O	B-T059
using	O	O	O
PFGE	O	O	O
.	O	O	O

-DOCSTART- (27896225)

The	O	O	O
Urokinase	O	O	B-T116
/	O	O	O
Urokinase	O	O	B-T116
Receptor	O	O	I-T116
System	O	O	O
in	O	O	O
Mast	O	O	B-T025
Cells	O	O	I-T025
:	O	O	O
Effects	O	O	B-T080
of	O	O	O
its	O	O	O
Functional	O	O	B-T169
Interaction	O	O	B-T169
with	O	O	O
fMLF	O	O	O
Receptors	O	O	O

Mast	O	O	B-T025
cell	O	O	I-T025
and	O	O	O
basophils	O	O	B-T025
express	O	O	B-T045
the	O	O	O
high	O	O	B-T116
affinity	O	O	I-T116
receptor	O	O	I-T116
for	O	O	O
IgE	O	O	B-T116
(	O	O	O
FcɛRI	O	O	B-T116
)	O	O	O
and	O	O	O
are	O	O	O
primary	O	O	B-T025
effector	O	O	I-T025
cells	O	O	I-T025
of	O	O	O
allergic	O	O	B-T046
disorders	O	O	I-T046
.	O	O	O

The	O	O	O
urokinase	O	O	B-T116
(uPA)-mediated	O	O	O
plasminogen	O	O	B-T044
activation	O	O	I-T044
system	O	O	I-T044
is	O	O	O
involved	O	O	O
in	O	O	O
physiological	O	O	B-T039
and	O	O	O
pathological	O	O	B-T046
events	O	O	I-T046
based	O	O	O
on	O	O	O
cell	O	O	B-T043
migration	O	O	I-T043
and	O	O	O
tissue	O	O	B-T042
remodelling	O	O	I-T042
,	O	O	O
such	O	O	O
as	O	O	O
inflammation	O	O	B-T046
,	O	O	O
wound	O	O	B-T040
healing	O	O	I-T040
,	O	O	O
angiogenesis	O	O	B-T042
and	O	O	O
metastasis	O	O	B-T046
.	O	O	O

uPA	O	O	B-T116
is	O	O	O
a	O	O	O
serine	O	O	B-T116
protease	O	O	I-T116
that	O	O	O
binds	O	O	O
uPAR	O	O	B-T116
,	O	O	O
a	O	O	O
high	O	O	B-T109
affinity	O	O	I-T109
glycosyl-phosphatidyl-inositol	O	O	I-T109
(GPI)-anchored	O	O	I-T109
receptor	O	O	B-T116
.	O	O	O

uPAR	O	O	B-T116
focuses	O	O	O
uPA	O	O	B-T116
activity	O	O	B-T044
at	O	O	O
the	O	O	O
cell	O	O	B-T026
surface	O	O	I-T026
and	O	O	O
activates	O	O	B-T044
intracellular	O	O	I-T044
signaling	O	O	I-T044
through	O	O	O
lateral	O	O	O
interactions	O	O	B-T169
with	O	O	O
integrins	O	O	B-T116
,	O	O	O
receptor	O	O	B-T116
tyrosine	O	O	I-T116
kinases	O	O	I-T116
and	O	O	O
the	O	O	O
G-protein-coupled	O	O	B-T116
family	O	O	I-T116
of	O	O	O
fMLF	O	O	B-T116
chemotaxis	O	O	I-T116
receptors	O	O	I-T116
(	O	O	O
FPRs	O	O	B-T116
)	O	O	O
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
the	O	O	O
expression	O	O	B-T045
of	O	O	O
the	O	O	O
uPA	O	O	B-T116
-	O	O	O
uPAR	O	O	B-T116
system	O	O	O
and	O	O	O
its	O	O	O
functional	O	O	B-T169
interaction	O	O	B-T169
with	O	O	O
FPRs	O	O	B-T116
in	O	O	O
human	O	O	B-T016
mast	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
MCs	O	O	B-T025
)	O	O	O
.	O	O	O

Differently	O	O	O
from	O	O	O
basophils	O	O	B-T025
,	O	O	O
MCs	O	O	B-T025
produced	O	O	O
uPA	O	O	B-T116
that	O	O	O
was	O	O	O
able	O	O	O
to	O	O	O
induce	O	O	O
their	O	O	O
chemotaxis	O	O	B-T043
.	O	O	O

Indeed	O	O	O
,	O	O	O
MCs	O	O	B-T025
also	O	O	O
expressed	O	O	O
uPAR	O	O	B-T116
,	O	O	O
both	O	O	O
in	O	O	O
the	O	O	O
intact	O	O	O
and	O	O	O
in	O	O	O
a	O	O	O
cleaved	O	O	O
form	O	O	O
(	O	O	O
DII-DIII-uPAR	O	O	B-T116
)	O	O	O
that	O	O	O
can	O	O	O
expose	O	O	O
,	O	O	O
at	O	O	O
the	O	O	O
N-terminus	O	O	O
,	O	O	O
the	O	O	O
SRSRY	O	O	B-T087
sequence	O	O	I-T087
,	O	O	O
able	O	O	O
to	O	O	O
interact	O	O	O
with	O	O	O
FPRs	O	O	B-T116
and	O	O	O
to	O	O	O
mediate	O	O	O
cell	O	O	B-T043
chemotaxis	O	O	I-T043
.	O	O	O

MCs	O	O	B-T025
also	O	O	O
expressed	O	O	O
mRNAs	O	O	B-T114
for	O	O	O
FPRs	O	O	B-T116
that	O	O	O
were	O	O	O
functionally	O	O	O
active	O	O	O
;	O	O	O
indeed	O	O	O
,	O	O	O
uPA	O	O	B-T116
and	O	O	O
a	O	O	O
soluble	O	O	B-T116
peptide	O	O	I-T116
(	O	O	O
uPAR84	O	O	B-T116
-	O	O	I-T116
95	O	O	I-T116
)	O	O	O
,	O	O	O
containing	O	O	O
the	O	O	O
SRSRY	O	O	B-T087
chemotactic	O	O	I-T087
sequence	O	O	I-T087
of	O	O	O
uPAR	O	O	B-T116
and	O	O	O
able	O	O	O
to	O	O	O
interact	O	O	O
with	O	O	O
FPRs	O	O	O
,	O	O	O
were	O	O	O
able	O	O	O
to	O	O	O
induce	O	O	O
MCs	O	O	O
chemotaxis	O	O	B-T043
.	O	O	O

Thus	O	O	O
,	O	O	O
uPA	O	O	B-T116
is	O	O	O
a	O	O	O
potent	O	O	O
chemoattractant	O	O	B-T123
for	O	O	O
MCs	O	O	B-T025
acting	O	O	O
through	O	O	O
the	O	O	O
exposure	O	O	B-T080
of	O	O	O
the	O	O	O
chemotactic	O	O	B-T043
epitope	O	O	B-T129
of	O	O	O
uPAR	O	O	B-T116
,	O	O	O
that	O	O	O
is	O	O	O
an	O	O	O
endogenous	O	O	B-T169
ligand	O	O	B-T103
for	O	O	O
FPRs	O	O	B-T116
.	O	O	O

The	O	O	O
same	O	O	O
mechanism	O	O	B-T169
could	O	O	O
be	O	O	O
involved	O	O	O
in	O	O	O
VEGF-A	O	O	B-T116
secretion	O	O	B-T038
by	O	O	O
human	O	O	B-T016
MCs	O	O	B-T025
,	O	O	O
also	O	O	O
induced	O	O	B-T169
by	O	O	O
uPA	O	O	B-T116
and	O	O	O
uPAR84	O	O	B-T116
-	O	O	I-T116
95	O	O	I-T116
stimulation	O	O	O
.	O	O	O

-DOCSTART- (27898362)

Psychogenic	O	O	B-T048
non-epileptic	O	O	I-T048
seizure	O	O	I-T048
in	O	O	O
patients	O	O	B-T101
with	O	O	O
intellectual	O	O	B-T048
disability	O	O	I-T048
with	O	O	O
special	O	O	O
focus	O	O	O
on	O	O	O
choice	O	O	B-T052
of	O	O	O
therapeutic	O	O	O
intervention	O	O	O

There	O	O	O
have	O	O	O
been	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
studies	O	O	B-T062
exploring	O	O	O
treatments	O	O	B-T061
for	O	O	O
psychogenic	O	O	B-T048
non-epileptic	O	O	I-T048
seizure	O	O	I-T048
(	O	O	O
PNES	O	O	B-T048
)	O	O	O
but	O	O	O
largely	O	O	O
neglecting	O	O	B-T033
the	O	O	O
sizable	O	O	O
subgroup	O	O	B-T185
of	O	O	O
patients	O	O	B-T101
with	O	O	O
intellectual	O	O	B-T048
disability	O	O	I-T048
(	O	O	O
ID	O	O	B-T048
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	B-T079
study	O	O	B-T062
,	O	O	O
we	O	O	O
attempted	O	O	B-T051
to	O	O	O
demonstrate	O	O	B-T169
effects	O	O	B-T080
and	O	O	O
preferred	O	O	B-T078
modes	O	O	O
of	O	O	O
therapeutic	O	O	B-T061
intervention	O	O	I-T061
in	O	O	O
PNES	O	O	B-T048
patients	O	O	B-T101
with	O	O	O
ID	O	O	B-T048
being	O	O	O
treated	O	O	B-T169
at	O	O	O
a	O	O	O
Japanese	O	O	B-T093
municipal	O	O	I-T093
center	O	O	I-T093
with	O	O	O
a	O	O	O
short	O	O	B-T081
referral	O	O	B-T058
chain	O	O	I-T058
.	O	O	O

We	O	O	O
examined	O	O	B-T033
46	O	O	O
PNES	O	O	B-T048
patients	O	O	B-T101
with	O	O	O
ID	O	O	B-T048
(	O	O	O
ID	O	O	O
group	O	O	B-T078
)	O	O	O
and	O	O	O
106	O	O	O
PNES	O	O	O
patients	O	O	O
without	O	O	O
ID	O	O	O
(	O	O	O
non-ID	O	O	B-T033
group	O	O	O
)	O	O	O
retrospectively	O	O	B-T080
in	O	O	O
case	O	O	B-T170
charts	O	O	I-T170
.	O	O	O

In	O	O	B-T169
addition	O	O	I-T169
to	O	O	I-T169
examining	O	O	B-T033
basic	O	O	O
demographic	O	O	B-T090
and	O	O	O
clinical	O	O	B-T170
data	O	O	I-T170
,	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
different	O	O	B-T080
therapeutic	O	O	B-T061
intervention	O	O	I-T061
were	O	O	O
examined	O	O	B-T033
as	O	O	O
a	O	O	O
function	O	O	B-T169
of	O	O	O
decrease	O	O	B-T081
or	O	O	O
disappearance	O	O	B-T079
of	O	O	O
PNES	O	O	B-T048
attacks	O	O	O
in	O	O	O
the	O	O	O
ID	O	O	B-T048
group	O	O	B-T078
.	O	O	O

Age	O	O	B-T032
at	O	O	O
the	O	O	O
first	O	O	O
visit	O	O	B-T058
as	O	O	O
well	O	O	O
as	O	O	O
PNES	O	O	B-T048
onset	O	O	B-T080
was	O	O	O
younger	O	O	B-T079
in	O	O	O
the	O	O	O
ID	O	O	B-T048
than	O	O	O
in	O	O	O
the	O	O	O
non-ID	O	O	B-T033
group	O	O	B-T078
(	O	O	O
t=2.651	O	O	O
,	O	O	O
p=0.009	O	O	O
;	O	O	O
t=3.528	O	O	O
,	O	O	O
p=0.001	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

PNES	O	O	B-T048
-free	O	O	O
ratio	O	O	B-T081
at	O	O	O
the	O	O	O
last	O	O	O
visit	O	O	B-T058
tended	O	O	O
to	O	O	O
be	O	O	O
higher	O	O	B-T080
in	O	O	O
the	O	O	O
non-ID	O	O	B-T033
group	O	O	B-T078
(	O	O	O
chi	O	O	B-T081
square	O	O	I-T081
=	O	O	O
3.455	O	O	O
;	O	O	O
p=0.063	O	O	O
)	O	O	O
.	O	O	O

Psychosis	O	O	B-T048
was	O	O	O
more	O	O	O
often	O	O	O
encountered	O	O	O
in	O	O	O
the	O	O	O
ID	O	O	B-T048
group	O	O	B-T078
(	O	O	O
chi	O	O	B-T081
square	O	O	I-T081
=	O	O	O
13.443	O	O	O
;	O	O	O
p=0.001	O	O	O
)	O	O	O
.	O	O	O

Although	O	O	O
cognitive	O	O	B-T061
therapy	O	O	I-T061
and	O	O	O
pharmaco-therapeutic	O	O	B-T061
approaches	O	O	O
were	O	O	O
quite	O	O	O
similarly	O	O	B-T080
distributed	O	O	B-T169
in	O	O	O
both	O	O	O
groups	O	O	B-T078
,	O	O	O
environmental	O	O	B-T082
adjustment	O	O	B-T169
was	O	O	O
often	O	O	O
introduced	O	O	B-T169
in	O	O	O
the	O	O	O
ID	O	O	B-T048
group	O	O	B-T078
(	O	O	O
44	O	O	O
%	O	O	O
)	O	O	O
as	O	O	O
compared	O	O	B-T052
to	O	O	O
the	O	O	O
non-ID	O	O	B-T033
group	O	O	O
(	O	O	O
15	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
chi	O	O	B-T081
square	O	O	I-T081
=	O	O	O
14.299	O	O	O
;	O	O	O
p=0.001	O	O	O
)	O	O	O
.	O	O	O

Brief	O	O	B-T079
weekly	O	O	B-T079
visit	O	O	B-T058
service	O	O	I-T058
is	O	O	O
also	O	O	O
more	O	O	O
often	O	O	O
utilized	O	O	B-T169
by	O	O	O
the	O	O	O
patients	O	O	B-T101
with	O	O	O
ID	O	O	B-T048
(	O	O	O
54	O	O	O
%	O	O	O
)	O	O	O
than	O	O	O
by	O	O	O
those	O	O	O
without	O	O	O
ID	O	O	O
(	O	O	O
35	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
chi	O	O	B-T081
square	O	O	I-T081
=	O	O	O
5.021	O	O	O
,	O	O	O
p=0.025	O	O	O
)	O	O	O
.	O	O	O

Optimal	O	O	B-T080
treatment	O	O	B-T061
approaches	O	O	O
in	O	O	O
this	O	O	O
sizable	O	O	O
patient	O	O	B-T101
subgroup	O	O	B-T185
should	O	O	O
be	O	O	O
the	O	O	O
subject	O	O	B-T078
of	O	O	O
future	O	O	B-T079
prospective	O	O	B-T062
studies	O	O	I-T062
.	O	O	O

-DOCSTART- (27900080)

Effect	O	O	B-T080
of	O	O	I-T080
an	O	O	O
immunomodulatory	O	O	B-T061
regimen	O	O	I-T061
for	O	O	O
cancer	O	O	B-T061
prevention	O	O	I-T061
:	O	O	O
A	O	O	O
case	O	O	O
report	O	O	O

In	O	O	O
the	O	O	O
present	O	O	B-T033
case	O	O	B-T170
study	O	O	I-T170
,	O	O	O
an	O	O	O
immunomodulatory	O	O	B-T061
regimen	O	O	I-T061
for	O	O	O
cancer	O	O	B-T061
prevention	O	O	I-T061
is	O	O	O
reported	O	O	B-T058
.	O	O	O

A	O	O	O
patient	O	O	B-T101
with	O	O	O
an	O	O	O
abnormally	O	O	B-T080
high	O	O	I-T080
level	O	O	B-T080
of	O	O	O
the	O	O	O
tumor	O	O	B-T191
markers	O	O	I-T123
,	O	O	O
carbohydrate	O	O	B-T129
antigen-724	O	O	I-T129
(	O	O	O
CA724	O	O	B-T129
)	O	O	O
,	O	O	O
CA19	O	O	B-T129
-	O	O	I-T129
9	O	O	I-T129
and	O	O	O
carcinoembryonic	O	O	B-T116
antigen	O	O	I-T116
(	O	O	O
CEA	O	O	B-T116
)	O	O	O
,	O	O	O
although	O	O	O
without	O	O	B-T080
any	O	O	O
detectable	O	O	B-T201
tumor	O	O	O
,	O	O	O
was	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
an	O	O	O
immunomodulatory	O	O	B-T061
therapy	O	O	I-T061
featuring	O	O	O
an	O	O	O
infusion	O	O	B-T061
of	O	O	O
cytokine-induced	O	O	B-T025
autologous	O	O	I-T025
killer	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
CIKs	O	O	B-T025
)	O	O	O
at	O	O	O
the	O	O	O
request	O	O	B-T052
of	O	O	O
the	O	O	O
patient	O	O	O
.	O	O	O

Following	O	O	O
the	O	O	O
therapy	O	O	B-T061
,	O	O	O
the	O	O	O
three	O	O	O
tumor	O	O	B-T123
markers	O	O	I-T123
rapidly	O	O	B-T080
decreased	O	O	B-T081
to	O	O	O
below	O	O	O
the	O	O	O
normal	O	O	B-T081
reference	O	O	I-T081
level	O	O	I-T081
,	O	O	O
although	O	O	O
there	O	O	O
still	O	O	O
were	O	O	O
slight	O	O	B-T080
fluctuations	O	O	B-T079
within	O	O	O
a	O	O	O
narrow	O	O	B-T080
range	O	O	B-T081
frequently	O	O	B-T079
.	O	O	O

The	O	O	O
patient	O	O	B-T101
was	O	O	O
monitored	O	O	B-T058
for	O	O	O
21	O	O	O
months	O	O	B-T079
to	O	O	O
the	O	O	O
present	O	O	B-T033
day	O	O	B-T079
and	O	O	O
no	O	O	B-T033
abnormality	O	O	I-T033
was	O	O	O
observed	O	O	B-T169
.	O	O	O

The	O	O	O
results	O	O	B-T033
indicated	O	O	O
that	O	O	O
this	O	O	O
therapy	O	O	B-T061
may	O	O	O
be	O	O	O
applied	O	O	O
as	O	O	O
a	O	O	O
novel	O	O	B-T080
strategy	O	O	O
that	O	O	O
is	O	O	O
effective	O	O	B-T080
and	O	O	O
reliable	O	O	B-T080
for	O	O	O
cancer	O	O	B-T061
prevention	O	O	I-T061
.	O	O	O

As	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
promising	O	O	O
regimen	O	O	B-T061
for	O	O	O
the	O	O	O
prevention	O	O	B-T061
of	O	O	I-T061
malignancies	O	O	I-T061
to	O	O	O
date	O	O	O
,	O	O	O
such	O	O	O
a	O	O	O
treatment	O	O	B-T061
may	O	O	O
become	O	O	O
a	O	O	O
major	O	O	B-T080
cancer	O	O	B-T191
prophylactic	O	O	B-T061
regimen	O	O	I-T061
,	O	O	O
particularly	O	O	O
for	O	O	O
patients	O	O	B-T101
who	O	O	O
are	O	O	O
at	O	O	O
a	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
cancer	O	O	O
.	O	O	O

-DOCSTART- (27900133)

The	O	O	O
relationships	O	O	B-T080
between	O	O	O
rugby	O	O	B-T056
players	O	O	B-T098
'	O	O	I-T098
tackle	O	O	B-T053
training	O	O	B-T065
attitudes	O	O	B-T041
and	O	O	O
behaviour	O	O	B-T053
and	O	O	O
their	O	O	O
match	O	O	B-T041
tackle	O	O	I-T041
attitudes	O	O	I-T041
and	O	O	O
behaviour	O	O	O

The	O	O	O
tackle	O	O	B-T053
event	O	O	O
in	O	O	O
rugby	O	O	B-T056
is	O	O	O
a	O	O	O
technical	O	O	B-T080
and	O	O	O
physical	O	O	B-T169
contest	O	O	B-T056
between	O	O	O
opposing	O	O	O
players	O	O	B-T098
.	O	O	O

A	O	O	O
player	O	O	B-T098
's	O	O	I-T098
ability	O	O	O
to	O	O	O
tolerate	O	O	B-T054
and	O	O	O
contest	O	O	B-T056
during	O	O	O
a	O	O	O
tackle	O	O	B-T053
is	O	O	O
a	O	O	O
prerequisite	O	O	B-T078
for	O	O	O
safe	O	O	B-UnknownType
participation	O	O	B-T169
and	O	O	O
success	O	O	B-T054
in	O	O	O
rugby	O	O	B-T056
.	O	O	O

Little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
tackle	O	O	B-T065
training	O	O	I-T065
and	O	O	O
tackling	O	O	B-T053
in	O	O	O
matches	O	O	B-T056
in	O	O	O
rugby	O	O	B-T056
union	O	O	I-T056
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
relationships	O	O	B-T080
between	O	O	O
players	O	O	B-T098
'	O	O	I-T098
training	O	O	B-T041
attitudes	O	O	I-T041
and	O	O	O
behaviour	O	O	B-T053
and	O	O	O
their	O	O	O
match	O	O	B-T041
attitudes	O	O	I-T041
and	O	O	O
behaviour	O	O	O
for	O	O	O
tackling	O	O	B-T053
in	O	O	O
rugby	O	O	B-T056
union	O	O	I-T056
.	O	O	O

A	O	O	O
questionnaire	O	O	B-T170
was	O	O	O
designed	O	O	O
to	O	O	O
assess	O	O	B-T058
attitude	O	O	B-T041
(	O	O	O
importance	O	O	O
)	O	O	O
and	O	O	O
behaviours	O	O	B-T053
(	O	O	O
frequency	O	O	B-T080
and	O	O	O
quantity	O	O	B-T081
)	O	O	O
among	O	O	O
junior	O	O	B-T078
(	O	O	O
under	O	O	O
19	O	O	O
)	O	O	O
players	O	O	B-T098
on	O	O	O
a	O	O	O
5-point	O	O	B-T170
Likert	O	O	I-T170
Scale	O	O	I-T170
.	O	O	O

Questionnaires	O	O	B-T170
were	O	O	O
handed	O	O	O
out	O	O	O
to	O	O	O
220	O	O	O
players	O	O	B-T098
(	O	O	O
10	O	O	O
schools	O	O	B-T073
)	O	O	O
at	O	O	O
a	O	O	O
tournament	O	O	B-T056
and	O	O	O
75	O	O	O
%	O	O	O
(	O	O	O
9	O	O	O
schools	O	O	O
,	O	O	O
n=164	O	O	O
)	O	O	O
were	O	O	O
returned	O	O	O
for	O	O	O
analysis	O	O	B-T062
.	O	O	O

Associations	O	O	B-T041
between	O	O	O
training	O	O	B-T041
attitudes	O	O	I-T041
and	O	O	O
behaviours	O	O	B-T053
were	O	O	O
tested	O	O	B-T169
using	O	O	O
the	O	O	O
χ(2	O	O	B-T170
)	O	O	I-T170
test	O	O	I-T170
,	O	O	I-T170
Cramer	O	O	I-T170
's	O	O	I-T170
V	O	O	I-T170
and	O	O	I-T170
τ-b	O	O	I-T170
.	O	O	O

The	O	O	O
more	O	O	O
time	O	O	O
spent	O	O	O
on	O	O	O
emphasising	O	O	O
proper	O	O	O
technique	O	O	B-T169
to	O	O	O
prevent	O	O	B-T080
injuries	O	O	B-T037
in	O	O	O
training	O	O	B-T065
,	O	O	O
the	O	O	O
more	O	O	O
important	O	O	O
players	O	O	B-T098
rated	O	O	O
'	O	O	O
own	O	O	O
safety	O	O	O
'	O	O	O
(	O	O	O
τ-b=0.21	O	O	O
,	O	O	O
moderate	O	O	B-T080
,	O	O	O
z=3.1	O	O	O
,	O	O	O
p<0.01	O	O	O
)	O	O	O
,	O	O	O
'	O	O	O
going	O	O	O
for	O	O	O
the	O	O	O
ball	O	O	B-T073
only	O	O	O
'	O	O	O
(	O	O	O
τ-b=0.27	O	O	O
,	O	O	O
moderate	O	O	O
,	O	O	O
z=4.6	O	O	O
,	O	O	O
p<0.001	O	O	O
)	O	O	O
and	O	O	O
'	O	O	O
staying	O	O	O
on	O	O	O
feet	O	O	O
'	O	O	O
(	O	O	O
τ-b=0.23	O	O	O
,	O	O	O
moderate	O	O	O
,	O	O	O
z=3.6	O	O	O
,	O	O	O
p<0.001	O	O	O
)	O	O	O
in	O	O	O
match	O	O	B-T056
play	O	O	I-T056
.	O	O	O

The	O	O	O
more	O	O	O
time	O	O	O
spent	O	O	O
on	O	O	O
emphasising	O	O	O
proper	O	O	O
technique	O	O	B-T169
to	O	O	O
improve	O	O	B-T033
performance	O	O	B-T052
in	O	O	O
training	O	O	B-T065
,	O	O	O
the	O	O	O
more	O	O	O
important	O	O	O
players	O	O	B-T098
rated	O	O	O
actions	O	O	O
'	O	O	O
going	O	O	O
for	O	O	O
ball	O	O	B-T073
only	O	O	O
'	O	O	O
(	O	O	O
τ-b=0.23	O	O	O
,	O	O	O
moderate	O	O	B-T080
,	O	O	O
z=3.7	O	O	O
,	O	O	O
p<0.001	O	O	O
)	O	O	O
and	O	O	O
'	O	O	O
preventing	O	O	B-T080
the	O	O	O
ball	O	O	O
carrier	O	O	O
from	O	O	O
retaining	O	O	B-T169
position	O	O	B-T082
'	O	O	O
(	O	O	O
τ-b=0.20	O	O	O
,	O	O	O
moderate	O	O	O
,	O	O	O
z=3.1	O	O	O
,	O	O	O
p<0.01	O	O	O
)	O	O	O
in	O	O	O
match	O	O	B-T056
play	O	O	I-T056
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
study	O	O	B-T062
to	O	O	O
report	O	O	O
on	O	O	O
the	O	O	O
relationships	O	O	B-T080
between	O	O	O
players	O	O	B-T098
'	O	O	O
training	O	O	B-T041
attitudes	O	O	I-T041
and	O	O	O
behaviour	O	O	B-T053
and	O	O	O
their	O	O	O
match	O	O	B-T041
attitudes	O	O	I-T041
and	O	O	O
behaviour	O	O	O
s	O	O	O
for	O	O	O
tackling	O	O	B-T053
in	O	O	O
rugby	O	O	B-T056
union	O	O	I-T056
.	O	O	O

The	O	O	O
importance	O	O	O
of	O	O	O
tackle	O	O	B-T053
training	O	O	B-T065
to	O	O	O
prevent	O	O	B-T080
injury	O	O	B-T037
,	O	O	O
and	O	O	O
the	O	O	O
amount	O	O	O
of	O	O	O
time	O	O	O
spent	O	O	O
on	O	O	O
technique	O	O	B-T169
to	O	O	O
prevent	O	O	O
injuries	O	O	B-T037
,	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
behaviours	O	O	B-T053
that	O	O	O
reduce	O	O	B-T080
the	O	O	O
risk	O	O	B-T033
of	O	O	I-T033
injury	O	O	I-T033
in	O	O	O
matches	O	O	B-T056
.	O	O	O

-DOCSTART- (27903991)

Role	O	O	B-T077
of	O	O	O
Oxidative	O	O	B-T049
Stress	O	O	I-T049
and	O	O	O
Inflammatory	O	O	B-T169
Factors	O	O	B-T169
in	O	O	O
Diabetic	O	O	O
Kidney	O	O	O
Disease	O	O	O

Diabetic	O	O	B-T047
nephropathy	O	O	I-T047
(	O	O	O
DN	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
serious	O	O	B-T080
complication	O	O	B-T046
of	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
,	O	O	O
and	O	O	O
its	O	O	O
prevalence	O	O	B-T081
has	O	O	O
been	O	O	O
increasing	O	O	B-T169
in	O	O	O
developed	O	O	B-T080
countries	O	O	I-T080
.	O	O	O

Diabetic	O	O	B-T047
nephropathy	O	O	I-T047
has	O	O	O
become	O	O	O
the	O	O	O
most	O	O	O
common	O	O	B-T081
single	O	O	B-T081
cause	O	O	O
of	O	O	O
end-stage	O	O	B-T047
renal	O	O	I-T047
disease	O	O	I-T047
worldwide	O	O	B-T098
.	O	O	O

Oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
inflammation	O	O	B-T046
factors	O	O	B-T169
are	O	O	O
hypothesized	O	O	B-T078
to	O	O	O
play	O	O	B-T077
a	O	O	I-T077
role	O	O	I-T077
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
late	O	O	B-T079
diabetes	O	O	B-T047
complications	O	O	I-T047
.	O	O	O

Chronic	O	O	B-T046
hyperglycemia	O	O	I-T046
increases	O	O	B-T169
oxidative	O	O	B-T049
stress	O	O	I-T049
,	O	O	O
significantly	O	O	B-T169
modifies	O	O	I-T169
the	O	O	O
structure	O	O	B-T082
and	O	O	O
function	O	O	B-T039
of	O	O	O
proteins	O	O	B-T116
and	O	O	O
lipids	O	O	B-T109
,	O	O	O
and	O	O	O
induces	O	O	B-T169
glycoxidation	O	O	B-UnknownType
and	O	O	O
peroxidation	O	O	B-T067
.	O	O	O

Therefore	O	O	O
,	O	O	O
hyperglycemia	O	O	B-T047
causes	O	O	O
auto-oxidation	O	O	B-T070
of	O	O	O
glucose	O	O	B-T109
,	O	O	O
glycation	O	O	B-T067
of	O	O	O
proteins	O	O	B-T116
,	O	O	O
and	O	O	O
activation	O	O	B-T052
of	O	O	O
polyol	O	O	B-T169
mechanism	O	O	I-T169
.	O	O	O

Overproduction	O	O	B-T057
of	O	O	O
intracellular	O	O	B-T082
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
contributes	O	O	B-T052
to	O	O	O
several	O	O	B-T081
microvascular	O	O	B-T169
and	O	O	O
macrovascular	O	O	B-T169
complications	O	O	B-T046
of	O	O	O
DN	O	O	B-T047
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
modulates	O	O	B-T082
signaling	O	O	B-T043
cascade	O	O	I-T043
of	O	O	O
immune	O	O	B-T129
factors	O	O	I-T129
.	O	O	O

An	O	O	O
increase	O	O	B-T169
in	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
can	O	O	O
increase	O	O	O
the	O	O	O
production	O	O	B-T057
of	O	O	O
inflammatory	O	O	B-T169
cytokines	O	O	B-T116
,	O	O	O
and	O	O	O
likewise	O	O	O
,	O	O	O
an	O	O	O
increase	O	O	O
in	O	O	O
inflammatory	O	O	O
cytokines	O	O	O
can	O	O	O
stimulate	O	O	B-T070
the	O	O	O
production	O	O	O
of	O	O	O
free	O	O	B-T123
radicals	O	O	I-T123
.	O	O	O

Some	O	O	O
studies	O	O	B-T062
have	O	O	O
shown	O	O	O
that	O	O	O
kidney	O	O	B-T047
inflammation	O	O	I-T047
is	O	O	O
serious	O	O	B-T080
in	O	O	O
promoting	O	O	B-T052
the	O	O	O
development	O	O	B-T169
and	O	O	O
progression	O	O	B-T169
of	O	O	O
DN	O	O	B-T047
.	O	O	O

Inflammatory	O	O	B-T169
factors	O	O	B-T169
which	O	O	O
are	O	O	O
activated	O	O	B-T052
by	O	O	O
the	O	O	O
metabolic	O	O	B-T169
,	O	O	O
biochemical	O	O	B-T169
,	O	O	O
and	O	O	O
hemodynamic	O	O	B-T042
derangements	O	O	O
are	O	O	O
known	O	O	O
to	O	O	O
exist	O	O	B-T077
in	O	O	O
the	O	O	O
diabetic	O	O	B-T047
kidney	O	O	I-T047
.	O	O	O

This	O	O	O
review	O	O	B-T170
discusses	O	O	O
facts	O	O	O
for	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
inflammatory	O	O	B-T169
factors	O	O	B-T169
in	O	O	O
DN	O	O	B-T047
and	O	O	O
encompasses	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
immune	O	O	B-T025
and	O	O	O
inflammatory	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
inflammatory	O	O	O
cytokines	O	O	B-T116
,	O	O	O
and	O	O	O
stress	O	O	B-T049
oxidative	O	O	I-T049
factors	O	O	O
.	O	O	O

-DOCSTART- (27908503)

Cobalt-60	O	O	B-T074
Machines	O	O	I-T074
and	O	O	O
Medical	O	O	B-T074
Linear	O	O	I-T074
Accelerators	O	O	I-T074
:	O	O	O
Competing	O	O	B-T090
Technologies	O	O	I-T090
for	O	O	O
External	O	O	O
Beam	O	O	O
Radiotherapy	O	O	O

Medical	O	O	B-T074
linear	O	O	I-T074
accelerators	O	O	I-T074
(	O	O	O
linacs	O	O	B-T074
)	O	O	O
and	O	O	O
cobalt-60	O	O	B-T074
machines	O	O	I-T074
are	O	O	O
both	O	O	O
mature	O	O	O
technologies	O	O	B-T090
for	O	O	O
external	O	O	B-T061
beam	O	O	I-T061
radiotherapy	O	O	I-T061
.	O	O	O

A	O	O	O
comparison	O	O	B-T052
is	O	O	O
made	O	O	O
between	O	O	O
these	O	O	O
two	O	O	O
technologies	O	O	B-T090
in	O	O	O
terms	O	O	O
of	O	O	O
infrastructure	O	O	B-T185
and	O	O	O
maintenance	O	O	B-T052
,	O	O	O
dosimetry	O	O	B-T059
,	O	O	O
shielding	O	O	B-T033
requirements	O	O	B-T169
,	O	O	O
staffing	O	O	B-T057
,	O	O	O
costs	O	O	B-T081
,	O	O	O
security	O	O	B-T077
,	O	O	O
patient	O	O	B-T101
throughput	O	O	B-T081
and	O	O	O
clinical	O	O	B-T169
use	O	O	I-T169
.	O	O	O

Infrastructure	O	O	B-T185
and	O	O	O
maintenance	O	O	B-T052
are	O	O	O
more	O	O	O
demanding	O	O	B-T078
for	O	O	O
linacs	O	O	B-T074
due	O	O	O
to	O	O	O
the	O	O	O
complex	O	O	B-T073
electric	O	O	I-T073
componentry	O	O	I-T073
.	O	O	O

In	O	O	O
dosimetry	O	O	B-T059
,	O	O	O
a	O	O	O
higher	O	O	B-T080
beam	O	O	B-T081
energy	O	O	I-T081
,	O	O	O
modulated	O	O	B-T082
dose	O	O	B-T081
rate	O	O	I-T081
and	O	O	O
smaller	O	O	B-T080
focal	O	O	B-T080
spot	O	O	I-T080
size	O	O	I-T080
mean	O	O	O
that	O	O	O
it	O	O	O
is	O	O	O
easier	O	O	B-T033
to	O	O	O
create	O	O	B-T052
an	O	O	O
optimised	O	O	B-T052
treatment	O	O	B-T061
with	O	O	O
a	O	O	O
linac	O	O	B-T074
for	O	O	O
conformal	O	O	O
dose	O	O	O
coverage	O	O	B-T169
of	O	O	O
the	O	O	O
tumour	O	O	B-T191
while	O	O	O
sparing	O	O	O
healthy	O	O	B-T023
organs	O	O	I-T023
at	O	O	O
risk	O	O	B-T078
.	O	O	O

In	O	O	O
shielding	O	O	B-T033
,	O	O	O
the	O	O	O
requirements	O	O	B-T169
for	O	O	O
a	O	O	O
concrete	O	O	B-T073
bunker	O	O	I-T073
are	O	O	O
similar	O	O	O
for	O	O	O
cobalt-60	O	O	B-T074
machines	O	O	I-T074
and	O	O	O
linacs	O	O	B-T074
but	O	O	O
extra	O	O	O
shielding	O	O	O
and	O	O	O
protection	O	O	B-T033
from	O	O	O
neutrons	O	O	B-T167
are	O	O	O
required	O	O	O
for	O	O	O
linacs	O	O	O
.	O	O	O

Staffing	O	O	B-T033
levels	O	O	I-T033
can	O	O	O
be	O	O	O
higher	O	O	B-T080
for	O	O	O
linacs	O	O	B-T074
and	O	O	O
more	O	O	O
staff	O	O	B-T065
training	O	O	I-T065
is	O	O	O
required	O	O	O
for	O	O	O
linacs	O	O	O
.	O	O	O

Life	O	O	B-T169
cycle	O	O	I-T169
costs	O	O	I-T169
are	O	O	O
higher	O	O	B-T080
for	O	O	O
linacs	O	O	B-T074
,	O	O	O
especially	O	O	O
multi-energy	O	O	B-T074
linacs	O	O	I-T074
.	O	O	O

Security	O	O	B-T077
is	O	O	O
more	O	O	O
complex	O	O	B-T080
for	O	O	O
cobalt-60	O	O	B-T074
machines	O	O	I-T074
because	O	O	O
of	O	O	O
the	O	O	O
high	O	O	B-T080
activity	O	O	B-T052
radioactive	O	O	B-T122
source	O	O	I-T122
.	O	O	O

Patient	O	O	B-T101
throughput	O	O	B-T081
can	O	O	O
be	O	O	O
affected	O	O	B-T169
by	O	O	O
source	O	O	B-T033
decay	O	O	B-T067
for	O	O	O
cobalt-60	O	O	B-T074
machines	O	O	I-T074
but	O	O	O
poor	O	O	B-T080
maintenance	O	O	B-T052
and	O	O	O
breakdowns	O	O	B-T066
can	O	O	O
severely	O	O	O
affect	O	O	B-T169
patient	O	O	B-T101
throughput	O	O	O
for	O	O	O
linacs	O	O	B-T074
.	O	O	O

In	O	O	O
clinical	O	O	B-T169
use	O	O	I-T169
,	O	O	O
more	O	O	O
complex	O	O	B-T080
treatment	O	O	B-T061
techniques	O	O	B-T169
are	O	O	O
easier	O	O	B-T033
to	O	O	O
achieve	O	O	O
with	O	O	O
linacs	O	O	B-T074
,	O	O	O
and	O	O	O
the	O	O	O
availability	O	O	B-T169
of	O	O	I-T169
electron	O	O	B-T073
beams	O	O	I-T073
on	O	O	O
high	O	O	B-T080
-	O	O	O
energy	O	O	B-T081
linacs	O	O	O
can	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
certain	O	O	O
treatments	O	O	B-T061
.	O	O	O

In	O	O	O
summary	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
simple	O	O	O
answer	O	O	O
to	O	O	O
the	O	O	O
question	O	O	O
of	O	O	O
the	O	O	O
choice	O	O	O
of	O	O	O
either	O	O	O
cobalt-60	O	O	B-T074
machines	O	O	I-T074
or	O	O	O
linacs	O	O	B-T074
for	O	O	O
radiotherapy	O	O	B-T061
in	O	O	O
low-	O	O	B-T033
and	O	O	O
middle-income	O	O	B-T080
countries	O	O	B-T083
.	O	O	O

In	O	O	O
fact	O	O	O
a	O	O	O
radiotherapy	O	O	B-T093
department	O	O	I-T093
with	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
technologies	O	O	B-T090
,	O	O	O
including	O	O	O
orthovoltage	O	O	B-T092
X-ray	O	O	I-T092
units	O	O	I-T092
,	O	O	O
may	O	O	O
be	O	O	O
an	O	O	O
option	O	O	B-T169
.	O	O	O

Local	O	O	B-T082
needs	O	O	B-T080
,	O	O	O
conditions	O	O	B-T080
and	O	O	O
resources	O	O	B-T078
will	O	O	O
have	O	O	O
to	O	O	O
be	O	O	O
factored	O	O	O
into	O	O	O
any	O	O	O
decision	O	O	B-T041
on	O	O	O
technology	O	O	B-T090
taking	O	O	O
into	O	O	O
account	O	O	O
the	O	O	O
characteristics	O	O	B-T080
of	O	O	O
both	O	O	O
forms	O	O	O
of	O	O	O
teletherapy	O	O	B-T061
,	O	O	O
with	O	O	O
the	O	O	O
primary	O	O	O
goal	O	O	B-T170
being	O	O	O
the	O	O	O
sustainability	O	O	B-T169
of	O	O	O
the	O	O	O
radiotherapy	O	O	B-T093
service	O	O	I-T093
over	O	O	O
the	O	O	O
useful	O	O	O
lifetime	O	O	B-T079
of	O	O	O
the	O	O	O
equipment	O	O	B-T073
.	O	O	O

-DOCSTART- (27908539)

Design	O	O	B-T052
,	O	O	O
synthesis	O	O	B-T052
,	O	O	O
molecular	O	O	B-T170
docking	O	O	I-T170
,	O	O	O
anti-Proteus	O	O	B-T195
mirabilis	O	O	I-T195
and	O	O	O
urease	O	O	B-T116
inhibition	O	O	B-T039
of	O	O	O
new	O	O	O
fluoroquinolone	O	O	O
carboxylic	O	O	O
acid	O	O	O
derivatives	O	O	O

New	O	O	O
hydroxamic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
hydrazide	O	O	B-T109
and	O	O	O
amide	O	O	B-T109
derivatives	O	O	I-T109
of	O	O	O
ciprofloxacin	O	O	B-T109
in	O	O	O
addition	O	O	O
to	O	O	O
their	O	O	O
analogues	O	O	B-T104
of	O	O	O
levofloxacin	O	O	B-T195
were	O	O	O
prepared	O	O	O
and	O	O	O
identified	O	O	O
by	O	O	O
different	O	O	O
spectroscopic	O	O	B-T169
techniques	O	O	I-T169
.	O	O	O

Some	O	O	O
of	O	O	O
the	O	O	O
prepared	O	O	O
compounds	O	O	B-T121
revealed	O	O	O
good	O	O	O
activity	O	O	B-T040
against	O	O	O
the	O	O	O
urease	O	O	B-T116
splitting	O	O	O
bacteria	O	O	B-T007
,	O	O	O
Proteus	O	O	B-T007
mirabilis	O	O	I-T007
.	O	O	O

The	O	O	O
urease	O	O	B-T116
inhibitory	O	O	B-T040
activity	O	O	I-T040
was	O	O	O
investigated	O	O	O
using	O	O	O
indophenol	O	O	B-T059
method	O	O	I-T059
.	O	O	O

Most	O	O	O
of	O	O	O
the	O	O	O
tested	O	O	B-T170
compounds	O	O	B-T121
showed	O	O	O
better	O	O	O
activity	O	O	B-T040
than	O	O	O
the	O	O	O
reference	O	O	O
acetohydroxamic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
AHA	O	O	B-T109
)	O	O	O
.	O	O	O

The	O	O	O
ciprofloxacin	O	O	B-T121
hydrazide	O	O	I-T121
derivative	O	O	I-T121
3a	O	O	I-T121
and	O	O	O
levofloxacin	O	O	B-T121
hydroxamic	O	O	I-T121
acid	O	O	I-T121
7	O	O	I-T121
experienced	O	O	O
the	O	O	O
highest	O	O	O
activity	O	O	B-T040
(	O	O	O
IC50	O	O	B-T081
=	O	O	O
1.22μM	O	O	O
and	O	O	O
2.20μM	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Molecular	O	O	B-T170
docking	O	O	I-T170
study	O	O	I-T170
revealed	O	O	O
high	O	O	O
spontaneous	O	O	O
binding	O	O	B-T044
ability	O	O	I-T044
of	O	O	O
the	O	O	O
tested	O	O	B-T170
compounds	O	O	B-T121
to	O	O	O
the	O	O	O
active	O	O	B-T169
site	O	O	I-T169
of	O	O	O
urease	O	O	B-T116
.	O	O	O

-DOCSTART- (27909143)

Interobserver	O	O	B-T170
and	O	O	O
Intraobserver	O	O	B-T096
Reliability	O	O	B-T081
of	O	O	O
Clinical	O	O	B-T033
Assessments	O	O	I-T033
in	O	O	O
Knee	O	O	O
Osteoarthritis	O	O	O

Clinical	O	O	B-T033
examination	O	O	I-T033
of	O	O	O
the	O	O	O
knee	O	O	B-T023
is	O	O	O
subject	O	O	O
to	O	O	O
measurement	O	O	B-T081
error	O	O	I-T081
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
analysis	O	O	O
was	O	O	O
to	O	O	O
determine	O	O	O
interobserver	O	O	B-T170
and	O	O	O
intraobserver	O	O	B-T096
reliability	O	O	B-T081
of	O	O	O
commonly	O	O	O
used	O	O	O
clinical	O	O	O
tests	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
knee	O	O	B-T047
osteoarthritis	O	O	I-T047
(	O	O	O
OA	O	O	B-T047
)	O	O	O
.	O	O	O

We	O	O	O
studied	O	O	O
subjects	O	O	B-T096
with	O	O	O
symptomatic	O	O	B-T169
knee	O	O	B-T047
OA	O	O	I-T047
who	O	O	O
were	O	O	O
participants	O	O	B-T098
in	O	O	O
an	O	O	O
open-label	O	O	B-T062
clinical	O	O	I-T062
trial	O	O	I-T062
of	O	O	O
intraarticular	O	O	B-T061
steroid	O	O	I-T061
therapy	O	O	I-T061
.	O	O	O

Following	O	O	O
standardization	O	O	B-T062
of	O	O	O
the	O	O	O
clinical	O	O	B-T059
test	O	O	I-T059
procedures	O	O	I-T059
,	O	O	O
2	O	O	O
clinicians	O	O	B-T097
assessed	O	O	B-T058
25	O	O	O
subjects	O	O	B-T096
independently	O	O	O
at	O	O	O
the	O	O	O
same	O	O	O
visit	O	O	B-T058
,	O	O	O
and	O	O	O
the	O	O	O
same	O	O	O
clinician	O	O	B-T097
assessed	O	O	O
88	O	O	O
subjects	O	O	O
over	O	O	O
an	O	O	O
interval	O	O	B-T079
period	O	O	I-T079
of	O	O	O
2	O	O	O
-	O	O	O
10	O	O	O
weeks	O	O	O
;	O	O	O
in	O	O	O
both	O	O	O
cases	O	O	O
prior	O	O	O
to	O	O	O
the	O	O	O
steroid	O	O	B-T061
intervention	O	O	B-T061
.	O	O	O

Clinical	O	O	B-T033
examination	O	O	I-T033
included	O	O	B-T169
assessment	O	O	B-T058
of	O	O	O
bony	O	O	B-UnknownType
enlargement	O	O	I-UnknownType
,	O	O	O
crepitus	O	O	B-T046
,	O	O	O
quadriceps	O	O	B-T033
wasting	O	O	I-T033
,	O	O	O
knee	O	O	B-T033
effusion	O	O	I-T033
,	O	O	O
joint-line	O	O	B-T029
and	O	O	O
anserine	O	O	B-T023
tenderness	O	O	B-T184
,	O	O	O
and	O	O	O
knee	O	O	B-T033
range	O	O	I-T033
of	O	O	I-T033
movement	O	O	I-T033
(	O	O	O
ROM	O	O	B-T033
)	O	O	O
.	O	O	O

Intraclass	O	O	B-T081
correlation	O	O	I-T081
coefficients	O	O	I-T081
(	O	O	O
ICC	O	O	B-T081
)	O	O	O
,	O	O	O
estimated	O	O	B-T081
kappa	O	O	I-T081
(	O	O	O
κ	O	O	B-T081
)	O	O	O
,	O	O	O
weighted	O	O	B-T081
kappa	O	O	I-T081
(	O	O	O
κω	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
Bland-Altman	O	O	B-T081
plots	O	O	I-T081
were	O	O	O
used	O	O	O
to	O	O	O
determine	O	O	O
interobserver	O	O	B-T170
and	O	O	O
intraobserver	O	O	B-T096
levels	O	O	B-T080
of	O	O	O
agreement	O	O	B-T054
.	O	O	O

Using	O	O	O
Landis	O	O	B-T081
and	O	O	I-T081
Koch	O	O	I-T081
criteria	O	O	I-T081
,	O	O	O
interobserver	O	O	B-T080
κ	O	O	B-T081
scores	O	O	I-T080
were	O	O	O
moderate	O	O	B-T080
for	O	O	O
patellofemoral	O	O	B-T030
joint	O	O	I-T030
(	O	O	O
κ	O	O	O
=	O	O	O
0.53	O	O	O
)	O	O	O
and	O	O	O
anserine	O	O	B-T023
tenderness	O	O	B-T184
(	O	O	O
κ	O	O	O
=	O	O	O
0.48	O	O	O
)	O	O	O
;	O	O	O
good	O	O	B-T080
for	O	O	O
bony	O	O	B-UnknownType
enlargement	O	O	I-UnknownType
(	O	O	O
κ	O	O	O
=	O	O	O
0.66	O	O	O
)	O	O	O
,	O	O	O
quadriceps	O	O	B-T033
wasting	O	O	I-T033
(	O	O	O
κ	O	O	O
=	O	O	O
0.78	O	O	O
)	O	O	O
,	O	O	O
crepitus	O	O	B-T046
(	O	O	O
κ	O	O	O
=	O	O	O
0.78	O	O	O
)	O	O	O
,	O	O	O
medial	O	O	B-T082
tibiofemoral	O	O	B-T030
joint	O	O	I-T030
tenderness	O	O	O
(	O	O	O
κ	O	O	O
=	O	O	O
0.76	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
effusion	O	O	B-T033
assessed	O	O	O
by	O	O	O
ballottement	O	O	B-T184
(	O	O	O
κ	O	O	O
=	O	O	O
0.73	O	O	O
)	O	O	O
and	O	O	O
bulge	O	O	B-T060
sign	O	O	I-T060
(	O	O	O
κω	O	O	B-T081
=	O	O	O
0.78	O	O	O
)	O	O	O
;	O	O	O
and	O	O	O
excellent	O	O	B-T080
for	O	O	O
lateral	O	O	B-T082
tibiofemoral	O	O	O
joint	O	O	O
tenderness	O	O	O
(	O	O	O
κ	O	O	O
=	O	O	O
1.00	O	O	O
)	O	O	O
,	O	O	O
flexion	O	O	B-T042
(	O	O	O
ICC	O	O	B-T081
=	O	O	O
0.97	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
extension	O	O	B-T169
(	O	O	O
ICC	O	O	O
=	O	O	O
0.87	O	O	O
)	O	O	O
ROM	O	O	B-T033
.	O	O	O

Intraobserver	O	O	B-T080
κ	O	O	B-T081
scores	O	O	I-T080
were	O	O	O
moderate	O	O	B-T080
for	O	O	O
lateral	O	O	B-T082
tibiofemoral	O	O	B-T030
joint	O	O	I-T030
tenderness	O	O	B-T184
(	O	O	O
κ	O	O	O
=	O	O	O
0.60	O	O	O
)	O	O	O
;	O	O	O
good	O	O	O
for	O	O	O
crepitus	O	O	O
(	O	O	O
κ	O	O	O
=	O	O	O
0.78	O	O	O
)	O	O	O
,	O	O	O
effusion	O	O	B-T033
assessed	O	O	O
by	O	O	O
ballottement	O	O	B-T184
test	O	O	I-T184
(	O	O	O
κ	O	O	O
=	O	O	O
0.77	O	O	O
)	O	O	O
,	O	O	O
patellofemoral	O	O	B-T030
joint	O	O	I-T030
(	O	O	O
κ	O	O	O
=	O	O	O
0.66	O	O	O
)	O	O	O
,	O	O	O
medial	O	O	B-T082
tibiofemoral	O	O	O
joint	O	O	O
(	O	O	O
κ	O	O	O
=	O	O	O
0.64	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
anserine	O	O	B-T023
tenderness	O	O	O
(	O	O	O
κ	O	O	O
=	O	O	O
0.73	O	O	O
)	O	O	O
;	O	O	O
and	O	O	O
excellent	O	O	B-T080
for	O	O	O
effusion	O	O	O
assessed	O	O	O
by	O	O	O
bulge	O	O	B-T060
sign	O	O	I-T060
(	O	O	O
κω	O	O	B-T081
=	O	O	O
0.83	O	O	O
)	O	O	O
,	O	O	O
bony	O	O	B-UnknownType
enlargement	O	O	I-UnknownType
(	O	O	O
κ	O	O	O
=	O	O	O
0.98	O	O	O
)	O	O	O
,	O	O	O
quadriceps	O	O	B-T033
wasting	O	O	I-T033
(	O	O	O
κ	O	O	O
=	O	O	O
0.83	O	O	O
)	O	O	O
,	O	O	O
flexion	O	O	B-T042
(	O	O	O
ICC	O	O	B-T081
=	O	O	O
0.99	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
extension	O	O	B-T169
(	O	O	O
ICC	O	O	O
=	O	O	O
0.96	O	O	O
)	O	O	O
ROM	O	O	B-T033
.	O	O	O

Among	O	O	O
individuals	O	O	B-T098
with	O	O	O
symptomatic	O	O	B-T169
knee	O	O	B-T023
OA	O	O	I-T047
,	O	O	O
the	O	O	O
reliability	O	O	B-T081
of	O	O	O
clinical	O	O	B-T033
examination	O	O	I-T033
of	O	O	O
the	O	O	O
knee	O	O	O
was	O	O	O
at	O	O	O
least	O	O	O
good	O	O	O
for	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
clinical	O	O	B-T033
signs	O	O	I-T033
of	O	O	O
knee	O	O	B-T047
OA	O	O	I-T047
.	O	O	O

-DOCSTART- (27913319)

Assessing	O	O	O
the	O	O	O
benefits	O	O	B-T081
of	O	O	O
targeted	O	O	B-T169
drug	O	O	B-T074
delivery	O	O	I-T074
by	O	O	O
nanocarriers	O	O	B-T073
:	O	O	O
A	O	O	O
partico/pharmacokinetic	O	O	O
framework	O	O	O

An	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
kinetic	O	O	B-T169
framework	O	O	I-T169
is	O	O	O
introduced	O	O	O
to	O	O	O
analyze	O	O	B-T062
and	O	O	O
predict	O	O	O
the	O	O	O
quantitative	O	O	B-T081
advantage	O	O	O
of	O	O	O
using	O	O	O
nanocarriers	O	O	B-T073
to	O	O	O
deliver	O	O	B-T074
drugs	O	O	B-T121
,	O	O	O
especially	O	O	O
anticancer	O	O	B-T109
agents	O	O	I-T109
,	O	O	O
compared	O	O	B-T052
to	O	O	O
administering	O	O	B-T061
the	O	O	O
same	O	O	O
drugs	O	O	O
in	O	O	O
their	O	O	O
free	O	O	O
form	O	O	O
.	O	O	O

This	O	O	O
framework	O	O	B-T078
recognizes	O	O	O
three	O	O	O
levels	O	O	B-T080
of	O	O	O
kinetics	O	O	B-T039
.	O	O	O

First	O	O	O
is	O	O	O
the	O	O	O
particokinetics	O	O	B-T070
associated	O	O	B-T080
with	O	O	I-T080
deposition	O	O	B-T169
of	O	O	O
nanocarriers	O	O	B-T073
into	O	O	O
tissues	O	O	B-T024
associated	O	O	O
with	O	O	O
drug	O	O	B-T169
effect	O	O	I-T169
and	O	O	O
toxicity	O	O	B-T037
,	O	O	O
their	O	O	O
residence	O	O	B-T082
inside	O	O	O
those	O	O	O
tissues	O	O	O
,	O	O	O
and	O	O	O
elimination	O	O	B-T040
of	O	O	O
the	O	O	O
nanocarriers	O	O	O
from	O	O	O
the	O	O	O
body	O	O	B-T016
.	O	O	O

Second	O	O	O
is	O	O	O
the	O	O	O
release	O	O	B-T033
pattern	O	O	I-T033
in	O	O	O
time	O	O	O
of	O	O	O
free	O	O	B-T081
drug	O	O	I-T081
from	O	O	O
the	O	O	O
nanocarriers	O	O	B-T073
.	O	O	O

Third	O	O	O
is	O	O	O
the	O	O	O
pharmacokinetics	O	O	B-T039
of	O	O	O
free	O	O	B-T081
drug	O	O	I-T081
,	O	O	O
as	O	O	O
it	O	O	O
relates	O	O	O
to	O	O	O
deposition	O	O	B-T169
and	O	O	O
elimination	O	O	B-T040
processes	O	O	I-T040
in	O	O	O
the	O	O	O
target	O	O	B-T169
and	O	O	O
toxicity	O	O	B-T037
associated	O	O	B-T080
tissues	O	O	B-T024
,	O	O	O
and	O	O	O
total	O	O	B-T034
body	O	O	I-T034
clearance	O	O	I-T034
.	O	O	O

A	O	O	O
figure	O	O	O
of	O	O	O
merit	O	O	O
,	O	O	O
the	O	O	O
drug	O	O	B-T121
targeting	O	O	I-T081
index	O	O	I-T081
(	O	O	O
DTI	O	O	B-T081
)	O	O	O
,	O	O	O
is	O	O	O
used	O	O	O
to	O	O	O
quantitate	O	O	B-T081
the	O	O	O
benefit	O	O	O
of	O	O	O
nanocarrier	O	O	B-T073
based	O	O	O
drug	O	O	B-T074
delivery	O	O	I-T074
by	O	O	O
considering	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	O
preferential	O	O	O
deposition	O	O	B-T169
of	O	O	O
nanoparticles	O	O	B-T073
into	O	O	O
target	O	O	B-T169
tissues	O	O	B-T024
and	O	O	O
relative	O	O	O
avoidance	O	O	O
of	O	O	O
tissues	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
drug	O	O	B-T037
toxicity	O	O	I-T037
,	O	O	O
compared	O	O	B-T052
to	O	O	O
drug	O	O	O
that	O	O	O
is	O	O	O
administered	O	O	B-T061
in	O	O	O
its	O	O	O
free	O	O	O
form	O	O	O
.	O	O	O

General	O	O	O
methods	O	O	B-T170
are	O	O	O
derived	O	O	O
for	O	O	O
calculating	O	O	B-T052
DTI	O	O	B-T081
when	O	O	O
appropriate	O	O	O
particokinetic	O	O	B-T070
,	O	O	O
pharmacokinetic	O	O	B-T169
,	O	O	O
and	O	O	O
drug	O	O	B-T081
release	O	O	I-T081
rate	O	O	I-T081
information	O	O	O
is	O	O	O
available	O	O	O
,	O	O	O
and	O	O	O
it	O	O	O
is	O	O	O
shown	O	O	O
that	O	O	O
relatively	O	O	O
simple	O	O	O
algebraic	O	O	O
forms	O	O	O
result	O	O	B-T169
when	O	O	O
some	O	O	O
common	O	O	O
assumptions	O	O	O
are	O	O	O
made	O	O	O
.	O	O	O

This	O	O	O
approach	O	O	O
may	O	O	O
find	O	O	O
use	O	O	O
in	O	O	O
developing	O	O	B-T091
and	O	O	O
selecting	O	O	O
nanocarrier	O	O	B-T073
formulations	O	O	B-T077
,	O	O	O
either	O	O	O
for	O	O	O
populations	O	O	B-T098
or	O	O	O
for	O	O	O
individuals	O	O	B-T098
.	O	O	O

-DOCSTART- (27914462)

Recombinant	O	O	B-T001
MHC	O	O	B-T028
Tetramers	O	O	I-T028
for	O	O	O
Isolation	O	O	B-T061
of	O	O	O
Virus	O	O	B-T005
-	O	O	O
Specific	O	O	B-T080
CD8(+	O	O	B-T025
)	O	O	I-T025
Cells	O	O	I-T025
from	O	O	O
Healthy	O	O	B-T080
Donors	O	O	I-T080
:	O	O	O
Potential	O	O	B-T080
Approach	O	O	O
for	O	O	O
Cell	O	O	B-T061
Therapy	O	O	I-T061
of	O	O	O
Posttransplant	O	O	O
Cytomegalovirus	O	O	O
Infection	O	O	O

Patients	O	O	B-T101
undergoing	O	O	O
allogeneic	O	O	B-T080
hematopoietic	O	O	B-T061
stem	O	O	I-T061
cell	O	O	I-T061
transplantation	O	O	I-T061
have	O	O	O
a	O	O	O
high	O	O	O
risk	O	O	O
of	O	O	O
cytomegalovirus	O	O	B-T047
reactivation	O	O	I-T047
,	O	O	O
which	O	O	O
in	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
T-cell	O	O	B-T040
immunity	O	O	I-T040
can	O	O	O
result	O	O	O
in	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
an	O	O	O
acute	O	O	B-T033
inflammatory	O	O	I-T033
reaction	O	O	I-T033
and	O	O	O
damage	O	O	B-T037
of	O	O	I-T037
internal	O	O	I-T037
organs	O	O	I-T037
.	O	O	O

Transfusion	O	O	B-T061
of	O	O	O
the	O	O	O
virus-specific	O	O	B-T080
donor	O	O	B-T025
T-lymphocytes	O	O	I-T025
represents	O	O	O
an	O	O	O
alternative	O	O	O
to	O	O	O
a	O	O	O
highly	O	O	B-T080
toxic	O	O	I-T080
and	O	O	O
often	O	O	O
ineffective	O	O	B-T078
antiviral	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

Potentially	O	O	B-T080
promising	O	O	O
cell	O	O	B-T061
therapy	O	O	I-T061
approach	O	O	O
comprises	O	O	O
transfusion	O	O	B-T061
of	O	O	O
cytotoxic	O	O	B-T025
T-lymphocytes	O	O	I-T025
,	O	O	O
specific	O	O	B-T080
to	O	O	O
the	O	O	O
viral	O	O	B-T129
antigens	O	O	I-T129
,	O	O	O
immediately	O	O	O
after	O	O	O
their	O	O	O
isolation	O	O	B-T061
from	O	O	O
the	O	O	O
donor	O	O	B-T039
's	O	O	I-T039
blood	O	O	I-T039
circulation	O	O	I-T039
without	O	O	O
any	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
expansion	O	O	I-T080
.	O	O	O

Specific	O	O	B-T080
T-cells	O	O	B-T025
could	O	O	O
be	O	O	O
separated	O	O	O
from	O	O	O
potentially	O	O	B-T080
alloreactive	O	O	B-T025
lymphocytes	O	O	I-T025
using	O	O	O
recombinant	O	O	B-T001
major	O	O	B-T028
histocompatibility	O	O	I-T028
complex	O	O	I-T028
(	O	O	O
MHC	O	O	B-T028
)	O	O	O
multimers	O	O	B-T104
,	O	O	O
carrying	O	O	O
synthetic	O	O	B-T116
viral	O	O	I-T116
peptides	O	O	I-T116
.	O	O	O

Rapid	O	O	O
transfusion	O	O	B-T061
of	O	O	O
virus	O	O	B-T005
-	O	O	O
specific	O	O	B-T080
T-cells	O	O	B-T025
to	O	O	O
patients	O	O	B-T101
has	O	O	O
several	O	O	O
crucial	O	O	O
advantages	O	O	O
in	O	O	O
comparison	O	O	O
with	O	O	O
methods	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
expansion	O	O	I-T080
of	O	O	O
the	O	O	O
cells	O	O	B-T025
.	O	O	O

About	O	O	O
30	O	O	O
%	O	O	O
of	O	O	O
hematopoietic	O	O	B-T169
stem	O	O	B-T080
cell	O	O	I-T080
donors	O	O	I-T080
and	O	O	O
46	O	O	O
%	O	O	O
of	O	O	O
transplant	O	O	B-T101
recipients	O	O	I-T101
at	O	O	O
the	O	O	O
National	O	O	B-T093
Research	O	O	I-T093
Center	O	O	I-T093
for	O	O	I-T093
Hematology	O	O	I-T093
were	O	O	O
carriers	O	O	O
of	O	O	O
the	O	O	O
HLA-A*02	O	O	B-T028
allele	O	O	I-T028
.	O	O	O

Moreover	O	O	O
,	O	O	O
94	O	O	O
%	O	O	O
of	O	O	O
Russian	O	O	B-T098
donors	O	O	B-T080
have	O	O	O
an	O	O	O
immune	O	O	B-T042
response	O	O	I-T042
against	O	O	O
the	O	O	O
cytomegalovirus	O	O	B-T005
(	O	O	O
CMV	O	O	B-T005
)	O	O	O
.	O	O	O

Using	O	O	O
recombinant	O	O	B-T001
HLA-A*02	O	O	B-T028
multimers	O	O	B-T104
carrying	O	O	O
an	O	O	O
immunodominant	O	O	B-T080
cytomegalovirus	O	O	B-T116
peptide	O	O	I-T116
(	O	O	O
NLV	O	O	B-T116
)	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
shown	O	O	O
that	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
healthy	O	O	B-T080
donors	O	O	I-T080
have	O	O	O
pronounced	O	O	O
T-cell	O	O	B-T040
immunity	O	O	I-T040
against	O	O	O
this	O	O	O
antigen	O	O	B-T129
,	O	O	O
whereas	O	O	O
shortly	O	O	O
after	O	O	O
the	O	O	O
transplantation	O	O	B-T061
the	O	O	O
patients	O	O	B-T101
do	O	O	O
not	O	O	O
have	O	O	O
specific	O	O	B-T080
T-lymphocytes	O	O	B-T025
.	O	O	O

The	O	O	O
donor	O	O	B-T025
cells	O	O	I-T025
have	O	O	O
the	O	O	O
immune	O	O	B-T032
phenotype	O	O	I-T032
of	O	O	O
memory	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
can	O	O	O
be	O	O	O
activated	O	O	B-T043
and	O	O	O
proliferate	O	O	B-T043
after	O	O	O
stimulation	O	O	O
with	O	O	O
the	O	O	O
specific	O	O	B-T080
antigen	O	O	B-T129
.	O	O	O

Donor	O	O	B-T033
lymphocytes	O	O	I-T033
can	O	O	O
be	O	O	O
substantially	O	O	O
enriched	O	O	B-UnknownType
to	O	O	O
significant	O	O	O
purity	O	O	B-T081
by	O	O	O
magnetic	O	O	B-T059
separation	O	O	I-T059
with	O	O	O
recombinant	O	O	B-T001
MHC	O	O	B-T028
multimers	O	O	B-T104
and	O	O	O
are	O	O	O
not	O	O	O
activated	O	O	B-UnknownType
upon	O	O	O
cocultivation	O	O	B-T059
with	O	O	O
the	O	O	O
antigen	O	O	B-T129
-presenting	O	O	O
cells	O	O	B-T025
from	O	O	O
HLA	O	O	B-T116
-	O	O	O
incompatible	O	O	B-T098
donors	O	O	I-T098
without	O	O	O
addition	O	O	O
of	O	O	O
the	O	O	O
specific	O	O	B-T080
antigen	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
demonstrated	O	O	O
that	O	O	O
strong	O	O	O
immune	O	O	B-T042
response	O	O	I-T042
to	O	O	O
CMV	O	O	B-T005
of	O	O	O
healthy	O	O	B-T080
donors	O	O	I-T080
and	O	O	O
prevalence	O	O	O
of	O	O	O
HLA-A*02	O	O	B-T028
allele	O	O	I-T028
in	O	O	O
the	O	O	O
Russian	O	O	B-T098
population	O	O	I-T098
make	O	O	O
it	O	O	O
possible	O	O	O
to	O	O	O
isolate	O	O	O
a	O	O	O
significant	O	O	O
number	O	O	O
of	O	O	O
virus-specific	O	O	B-T080
cells	O	O	B-T025
using	O	O	O
HLA-A*02-NLV	O	O	B-T028
multimers	O	O	B-T104
.	O	O	O

After	O	O	O
the	O	O	O
transfusion	O	O	B-T061
,	O	O	O
these	O	O	O
cells	O	O	B-T025
should	O	O	O
protect	O	O	O
patients	O	O	B-T101
from	O	O	O
CMV	O	O	B-T005
without	O	O	O
development	O	O	O
of	O	O	O
allogeneic	O	O	B-T080
immune	O	O	B-T042
response	O	O	I-T042
.	O	O	O

-DOCSTART- (27914587)

Outcomes	O	O	B-T080
of	O	O	O
chest	O	O	B-T061
wall	O	O	I-T061
resections	O	O	I-T061
in	O	O	O
pediatric	O	O	B-T080
sarcoma	O	O	B-T191
patients	O	O	O

Chest	O	O	B-T191
wall	O	O	I-T191
tumors	O	O	I-T191
in	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
are	O	O	O
rare	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
evaluates	O	O	O
outcomes	O	O	B-T080
in	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
who	O	O	O
have	O	O	O
undergone	O	O	O
chest	O	O	B-T061
wall	O	O	I-T061
resections	O	O	I-T061
secondary	O	O	O
to	O	O	O
sarcomas	O	O	B-T191
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
review	O	O	I-T062
was	O	O	O
performed	O	O	O
for	O	O	O
patients	O	O	B-T101
<	O	O	O
19years	O	O	O
old	O	O	O
who	O	O	O
underwent	O	O	O
chest	O	O	B-T061
wall	O	O	I-T061
resections	O	O	I-T061
for	O	O	O
sarcoma	O	O	B-T191
1999	O	O	O
-	O	O	O
2014	O	O	O
at	O	O	O
the	O	O	O
University	O	O	B-T093
of	O	O	I-T093
Texas	O	O	I-T093
MD	O	O	I-T093
Anderson	O	O	I-T093
Cancer	O	O	I-T093
Center	O	O	I-T093
.	O	O	O

Of	O	O	O
44	O	O	O
patients	O	O	B-T101
,	O	O	O
Ewing	O	O	B-T191
's	O	O	I-T191
sarcoma	O	O	I-T191
(	O	O	O
n=18	O	O	O
)	O	O	O
and	O	O	O
osteosarcoma	O	O	B-T191
(	O	O	O
n=16	O	O	O
)	O	O	O
were	O	O	O
most	O	O	O
common	O	O	O
.	O	O	O

Other	O	O	O
sarcomas	O	O	B-T191
included	O	O	O
synovial	O	O	B-T191
sarcoma	O	O	I-T191
,	O	O	O
chondrosarcoma	O	O	B-T191
,	O	O	O
and	O	O	O
rhabdomyosarcoma	O	O	B-T191
.	O	O	O

Gore-Tex	O	O	B-T109
®	O	O	O
or	O	O	O
a	O	O	O
Marlex	O	O	B-T122
™	O	O	I-T122
mesh	O	O	I-T122
and	O	O	O
methyl	O	O	B-T122
methacrylate	O	O	I-T122
sandwich	O	O	I-T122
was	O	O	O
used	O	O	O
in	O	O	O
22	O	O	O
patients	O	O	B-T101
,	O	O	O
and	O	O	O
9	O	O	O
children	O	O	B-T100
did	O	O	O
not	O	O	B-T033
require	O	O	I-T033
reconstruction	O	O	I-T033
.	O	O	O

Twenty-four	O	O	O
(	O	O	O
54.5	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
had	O	O	O
normal	O	O	B-T080
activity	O	O	B-T052
,	O	O	O
3	O	O	O
(	O	O	O
6.8	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
occasional	O	O	B-T184
discomfort	O	O	I-T184
,	O	O	O
2	O	O	O
(	O	O	O
4.5	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
pain	O	O	B-T046
impairing	O	O	I-T046
function	O	O	I-T046
,	O	O	O
7	O	O	O
(	O	O	O
15.9	O	O	O
%	O	O	O
)	O	O	O
required	O	O	O
medication	O	O	B-T121
or	O	O	O
physical	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
impairment	O	O	B-T046
,	O	O	O
and	O	O	O
8	O	O	O
(	O	O	O
18.2	O	O	O
%	O	O	O
)	O	O	O
needed	O	O	O
additional	O	O	O
surgery	O	O	B-T091
.	O	O	O

Five	O	O	O
children	O	O	B-T100
(	O	O	O
11.4	O	O	O
%	O	O	O
)	O	O	O
developed	O	O	O
scoliosis	O	O	B-T190
,	O	O	O
and	O	O	O
all	O	O	O
of	O	O	O
these	O	O	O
patients	O	O	B-T101
had	O	O	O
posterior	O	O	B-T082
rib	O	O	B-T191
tumors	O	O	I-T191
.	O	O	O

Median	O	O	B-T081
overall	O	O	I-T081
survival	O	O	I-T081
for	O	O	O
the	O	O	O
entire	O	O	B-T098
cohort	O	O	I-T098
was	O	O	O
41.9±11.82	O	O	O
months	O	O	B-T079
.	O	O	O

Histology	O	O	B-T091
(	O	O	O
p=0.003	O	O	O
)	O	O	O
,	O	O	O
location	O	O	B-T082
of	O	O	O
tumor	O	O	B-T191
on	O	O	O
the	O	O	O
ribs	O	O	B-T023
(	O	O	O
p=0.007	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
surgical	O	O	B-T023
margins	O	O	I-T023
(	O	O	O
p=0.011	O	O	O
)	O	O	O
were	O	O	O
significantly	O	O	B-T080
associated	O	O	I-T080
with	O	O	I-T080
overall	O	O	B-T081
survival	O	O	I-T081
.	O	O	O

Tumors	O	O	B-T191
on	O	O	O
the	O	O	O
middle	O	O	O
and	O	O	O
posterior	O	O	B-T082
(	O	O	O
p=0.003	O	O	O
)	O	O	O
portions	O	O	O
of	O	O	O
the	O	O	O
ribs	O	O	B-T023
had	O	O	O
a	O	O	O
lower	O	O	O
chance	O	O	O
of	O	O	O
death	O	O	B-T040
.	O	O	O

Scoliosis	O	O	B-T190
is	O	O	O
more	O	O	O
common	O	O	O
in	O	O	O
posterior	O	O	B-T082
rib	O	O	B-T061
resections	O	O	I-T061
.	O	O	O

Histology	O	O	B-T091
,	O	O	O
location	O	O	B-T082
of	O	O	O
the	O	O	O
tumor	O	O	B-T191
,	O	O	O
and	O	O	O
surgical	O	O	B-T023
margins	O	O	I-T023
impact	O	O	O
survival	O	O	B-T052
,	O	O	O
but	O	O	O
,	O	O	O
type	O	O	O
of	O	O	O
reconstruction	O	O	O
does	O	O	O
not	O	O	O
.	O	O	O

III	O	O	O
.	O	O	O

Treatment	O	O	B-T062
Study	O	O	I-T062
.	O	O	O

-DOCSTART- (27914987)

Tetrabromobisphenol	O	O	B-T109
A	O	O	I-T109
activates	O	O	B-T052
the	O	O	O
hepatic	O	O	B-T023
interferon	O	O	B-T044
pathway	O	O	I-T044
in	O	O	O
rats	O	O	O

Tetrabromobisphenol	O	O	B-T109
A	O	O	I-T109
(	O	O	O
TBBPA	O	O	B-T109
)	O	O	O
is	O	O	O
a	O	O	O
widely	O	O	O
used	O	O	O
flame	O	O	B-T120
retardant	O	O	I-T120
in	O	O	O
printed	O	O	B-T073
circuit	O	O	I-T073
boards	O	O	I-T073
,	O	O	O
paper	O	O	B-T073
,	O	O	O
and	O	O	O
textiles	O	O	B-T073
.	O	O	O

In	O	O	O
a	O	O	O
two-year	O	O	B-T079
study	O	O	B-T062
,	O	O	O
TBBPA	O	O	B-T109
showed	O	O	O
evidence	O	O	O
of	O	O	O
uterine	O	O	B-T191
tumors	O	O	I-T191
in	O	O	O
female	O	O	B-T032
Wistar-Han	O	O	B-T015
rats	O	O	I-T015
and	O	O	O
liver	O	O	B-T191
and	O	O	O
colon	O	O	B-T191
tumors	O	O	I-T191
in	O	O	O
B6C3F1	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
gain	O	O	O
further	O	O	O
insight	O	O	O
into	O	O	O
early	O	O	O
gene	O	O	B-T028
and	O	O	O
pathway	O	O	B-T044
changes	O	O	O
leading	O	O	O
to	O	O	O
cancer	O	O	B-T191
,	O	O	O
we	O	O	O
exposed	O	O	O
female	O	O	B-T032
Wistar	O	O	B-T015
Han	O	O	I-T015
rats	O	O	I-T015
to	O	O	O
TBBPA	O	O	B-T109
at	O	O	O
0	O	O	O
,	O	O	O
25	O	O	O
,	O	O	O
250	O	O	O
,	O	O	O
or	O	O	O
1000mg/kg	O	O	O
(	O	O	O
oral	O	O	B-T169
gavage	O	O	I-T169
in	O	O	O
corn	O	O	B-T109
oil	O	O	I-T109
,	O	O	O
5	O	O	O
×	O	O	O
/	O	O	O
week	O	O	B-T079
)	O	O	O
for	O	O	O
13	O	O	O
weeks	O	O	B-T079
.	O	O	O

Because	O	O	O
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
TBBPA	O	O	B-T109
exposure	O	O	B-T080
period	O	O	O
,	O	O	O
there	O	O	O
were	O	O	O
no	O	O	O
treatment-related	O	O	O
effects	O	O	O
on	O	O	O
body	O	O	B-T032
weights	O	O	B-T081
,	O	O	O
liver	O	O	B-T033
or	O	O	O
uterus	O	O	B-T033
lesions	O	O	I-T033
,	O	O	O
and	O	O	O
liver	O	O	O
and	O	O	O
uterine	O	O	B-T023
organ	O	O	I-T023
weights	O	O	O
were	O	O	O
within	O	O	O
10	O	O	O
%	O	O	O
of	O	O	O
controls	O	O	B-T096
,	O	O	O
only	O	O	O
the	O	O	O
high	O	O	O
dose	O	O	B-T081
animals	O	O	B-T008
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
the	O	O	O
hepatic	O	O	B-T023
and	O	O	O
uterine	O	O	B-T023
transcriptomes	O	O	B-T086
showed	O	O	O
TBBPA	O	O	B-T109
-induced	O	O	O
changes	O	O	O
primarily	O	O	O
in	O	O	O
the	O	O	O
liver	O	O	B-T023
(	O	O	O
1000mg/kg	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
159	O	O	O
transcripts	O	O	B-T114
corresponding	O	O	O
to	O	O	O
132	O	O	O
genes	O	O	B-T028
differentially	O	O	O
expressed	O	O	B-T045
compared	O	O	O
to	O	O	O
controls	O	O	B-T096
(	O	O	O
FDR=0.05	O	O	O
)	O	O	O
.	O	O	O

Pathway	O	O	B-T170
analysis	O	O	I-T170
showed	O	O	O
activation	O	O	B-T052
of	O	O	O
interferon	O	O	B-T116
(	O	O	O
IFN	O	O	B-T116
)	O	O	O
and	O	O	O
metabolic	O	O	B-T044
networks	O	O	I-T044
.	O	O	O

TBBPA	O	O	B-T109
induced	O	O	O
few	O	O	O
molecular	O	O	O
changes	O	O	O
in	O	O	O
the	O	O	O
uterus	O	O	B-T023
.	O	O	O

Activation	O	O	B-T052
of	O	O	O
the	O	O	O
interferon	O	O	B-T044
pathway	O	O	I-T044
in	O	O	O
the	O	O	O
liver	O	O	B-T023
occurred	O	O	O
after	O	O	O
13-weeks	O	O	B-T079
of	O	O	O
TBBPA	O	O	B-T109
exposure	O	O	B-T080
,	O	O	O
and	O	O	O
with	O	O	O
longer	O	O	O
term	O	O	O
TBBPA	O	O	O
exposure	O	O	O
this	O	O	O
may	O	O	O
lead	O	O	O
to	O	O	O
immunomodulatory	O	O	B-T061
changes	O	O	B-T169
that	O	O	O
contribute	O	O	O
to	O	O	O
carcinogenic	O	O	B-T191
processes	O	O	I-T191
.	O	O	O

-DOCSTART- (27916672)

Famous	O	O	B-T041
faces	O	O	I-T041
and	O	O	O
voices	O	O	B-T041
:	O	O	O
Differential	O	O	B-T080
profiles	O	O	B-T082
in	O	O	O
early	O	O	B-T079
right	O	O	B-T023
and	O	O	O
left	O	O	B-T023
semantic	O	O	B-T048
dementia	O	O	I-T048
and	O	O	O
in	O	O	O
Alzheimer	O	O	O
's	O	O	O
disease	O	O	O

Famous	O	O	B-T041
face	O	O	I-T041
and	O	O	O
voice	O	O	B-T041
recognition	O	O	I-T041
is	O	O	O
reported	O	O	O
to	O	O	O
be	O	O	O
impaired	O	O	B-T169
both	O	O	O
in	O	O	O
semantic	O	O	B-T048
dementia	O	O	I-T048
(	O	O	O
SD	O	O	B-T048
)	O	O	O
and	O	O	O
in	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
,	O	O	O

although	O	O	O
more	O	O	O
severely	O	O	B-T080
in	O	O	O
the	O	O	O
former	O	O	O
.	O	O	O

In	O	O	O
AD	O	O	B-T047
a	O	O	O
coexistence	O	O	O
of	O	O	O
perceptual	O	O	B-T041
impairment	O	O	B-T169
in	O	O	O
face	O	O	B-T041
and	O	O	O
voice	O	O	B-T041
processing	O	O	B-T041
has	O	O	O
also	O	O	O
been	O	O	O
reported	O	O	O
and	O	O	O
this	O	O	O
could	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
altered	O	O	O
performance	O	O	B-T052
in	O	O	O
complex	O	O	B-T080
semantic	O	O	B-T078
tasks	O	O	B-T052
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
in	O	O	O
SD	O	O	B-T048
both	O	O	O
face	O	O	B-T041
and	O	O	O
voice	O	O	B-T041
recognition	O	O	I-T041
disorders	O	O	B-T047
could	O	O	O
be	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
atrophy	O	O	B-T046
in	O	O	O
the	O	O	O
right	O	O	B-T023
temporal	O	O	I-T023
lobe	O	O	I-T023
(	O	O	O
RTL	O	O	B-T023
)	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
twofold	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
to	O	O	O
investigate	O	O	B-T169
famous	O	O	B-T041
faces	O	O	I-T041
and	O	O	O
voices	O	O	B-T041
recognition	O	O	I-T041
in	O	O	O
SD	O	O	B-T048
and	O	O	O
AD	O	O	B-T047
to	O	O	O
verify	O	O	O
if	O	O	O
the	O	O	O
two	O	O	O
diseases	O	O	B-T047
show	O	O	O
a	O	O	O
differential	O	O	B-T080
pattern	O	O	B-T082
of	O	O	O
impairment	O	O	B-T169
,	O	O	O
resulting	O	O	O
from	O	O	O
disruption	O	O	B-T169
of	O	O	O
different	O	O	O
cognitive	O	O	B-T041
mechanisms	O	O	B-T169
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
to	O	O	O
check	O	O	O
if	O	O	O
face	O	O	B-T041
and	O	O	O
voice	O	O	B-T041
recognition	O	O	I-T041
disorders	O	O	B-T047
prevail	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
atrophy	O	O	B-T046
mainly	O	O	O
affecting	O	O	O
the	O	O	O
RTL	O	O	B-T023
.	O	O	O

To	O	O	O
avoid	O	O	O
the	O	O	O
potential	O	O	B-T080
influence	O	O	B-T077
of	O	O	O
primary	O	O	B-T080
perceptual	O	O	B-T041
problems	O	O	B-T033
in	O	O	O
face	O	O	B-T041
and	O	O	O
voice	O	O	B-T041
recognition	O	O	I-T041
,	O	O	O
a	O	O	O
pool	O	O	O
of	O	O	O
patients	O	O	B-T101
suffering	O	O	O
from	O	O	O
early	O	O	B-T079
SD	O	O	B-T048
and	O	O	O
AD	O	O	B-T047
were	O	O	O
administered	O	O	B-T169
a	O	O	O
detailed	O	O	O
set	O	O	O
of	O	O	O
tests	O	O	B-T058
exploring	O	O	O
face	O	O	O
and	O	O	O
voice	O	O	O
perception	O	O	B-T041
.	O	O	O

Thirteen	O	O	O
SD	O	O	B-T048
(	O	O	O
8	O	O	O
with	O	O	O
prevalence	O	O	B-T081
of	O	O	O
right	O	O	B-T023
and	O	O	O
5	O	O	O
with	O	O	O
prevalence	O	O	O
of	O	O	O
left	O	O	B-T023
temporal	O	O	I-T023
atrophy	O	O	B-T046
)	O	O	O
and	O	O	O
25	O	O	O
CE	O	O	O
patients	O	O	B-T101
,	O	O	O
who	O	O	O
did	O	O	O
not	O	O	O
show	O	O	O
visual	O	O	B-T169
and	O	O	O
auditory	O	O	B-T169
perceptual	O	O	B-T041
impairment	O	O	B-T169
,	O	O	O
were	O	O	O
finally	O	O	O
selected	O	O	O
and	O	O	O
were	O	O	O
administered	O	O	B-T169
an	O	O	O
experimental	O	O	B-T080
battery	O	O	B-T170
exploring	O	O	O
famous	O	O	B-T041
face	O	O	I-T041
and	O	O	O
voice	O	O	B-T041
recognition	O	O	I-T041
and	O	O	O
naming	O	O	B-T170
.	O	O	O

Twelve	O	O	O
SD	O	O	B-T048
patients	O	O	B-T101
underwent	O	O	O
cerebral	O	O	B-T023
PET	O	O	B-T060
imaging	O	O	I-T060
and	O	O	O
were	O	O	O
classified	O	O	O
in	O	O	O
right	O	O	B-T023
and	O	O	O
left	O	O	B-T023
SD	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
onset	O	O	O
modality	O	O	B-T078
and	O	O	O
to	O	O	O
the	O	O	O
prevalent	O	O	O
decrease	O	O	B-T081
in	O	O	O
FDG	O	O	B-T109
uptake	O	O	I-T109
in	O	O	O
right	O	O	O
or	O	O	O
left	O	O	B-T023
temporal	O	O	I-T023
lobe	O	O	I-T023
respectively	O	O	O
.	O	O	O

Correlation	O	O	B-T080
of	O	O	O
PET	O	O	B-T060
imaging	O	O	I-T060
and	O	O	O
famous	O	O	B-T041
face	O	O	I-T041
and	O	O	O
voice	O	O	B-T041
recognition	O	O	I-T041
was	O	O	O
performed	O	O	O
.	O	O	O

Results	O	O	B-T169
showed	O	O	O
a	O	O	O
differential	O	O	B-T080
performance	O	O	B-T052
profile	O	O	B-T082
in	O	O	O
the	O	O	O
two	O	O	O
diseases	O	O	B-T047
,	O	O	O
because	O	O	O
AD	O	O	B-T047
patients	O	O	B-T101
were	O	O	O
significantly	O	O	O
impaired	O	O	B-T169
in	O	O	O
the	O	O	O
naming	O	O	B-T170
tests	O	O	I-T170
,	O	O	O
but	O	O	O
showed	O	O	O
preserved	O	O	O
recognition	O	O	B-T041
,	O	O	O
whereas	O	O	O
SD	O	O	B-T048
patients	O	O	O
were	O	O	O
profoundly	O	O	O
impaired	O	O	O
both	O	O	O
in	O	O	O
naming	O	O	O
and	O	O	O
in	O	O	O
recognition	O	O	B-T041
of	O	O	I-T041
famous	O	O	I-T041
faces	O	O	I-T041
and	O	O	O
voices	O	O	B-T041
.	O	O	O

Furthermore	O	O	O
,	O	O	O
face	O	O	B-T041
and	O	O	O
voice	O	O	B-T041
recognition	O	O	I-T041
disorders	O	O	B-T047
prevailed	O	O	O
in	O	O	O
SD	O	O	B-T048
patients	O	O	B-T101
with	O	O	O
RTL	O	O	B-T023
atrophy	O	O	B-T046
,	O	O	O
who	O	O	O
also	O	O	O
showed	O	O	O
a	O	O	O
conceptual	O	O	B-T077
impairment	O	O	B-T169
on	O	O	O
the	O	O	O
Pyramids	O	O	B-T170
and	O	O	I-T170
Palm	O	O	I-T170
Trees	O	O	I-T170
test	O	O	I-T170
more	O	O	O
important	O	O	O
in	O	O	O
the	O	O	O
pictorial	O	O	O
than	O	O	O
in	O	O	O
the	O	O	O
verbal	O	O	B-T080
modality	O	O	B-T078
.	O	O	O

Finally	O	O	O
,	O	O	O
in	O	O	O
12	O	O	O
SD	O	O	B-T048
patients	O	O	B-T101
in	O	O	O
whom	O	O	O
PET	O	O	B-T060
was	O	O	O
available	O	O	O
,	O	O	O
a	O	O	O
strong	O	O	O
correlation	O	O	B-T080
between	O	O	O
FDG	O	O	B-T109
uptake	O	O	I-T109
and	O	O	O
face-to-name	O	O	B-T080
and	O	O	O
voice-to-name	O	O	B-T080
matching	O	O	I-T080
data	O	O	B-T078
was	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
right	O	O	B-T023
but	O	O	O
not	O	O	O
in	O	O	O
the	O	O	O
left	O	O	B-T023
temporal	O	O	I-T023
lobe	O	O	I-T023
.	O	O	O

The	O	O	O
data	O	O	B-T078
support	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
of	O	O	O
a	O	O	O
different	O	O	O
cognitive	O	O	B-T041
basis	O	O	O
for	O	O	O
impairment	O	O	B-T169
of	O	O	O
face	O	O	B-T041
and	O	O	O
voice	O	O	B-T041
recognition	O	O	I-T041
in	O	O	O
the	O	O	O
two	O	O	O
dementias	O	O	B-T048
and	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
pattern	O	O	B-T082
of	O	O	O
impairment	O	O	O
in	O	O	O
SD	O	O	B-T048
may	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
a	O	O	O
loss	O	O	O
of	O	O	O
semantic	O	O	B-T078
representations	O	O	B-T052
,	O	O	O
while	O	O	O
a	O	O	O
defect	O	O	O
of	O	O	O
semantic	O	O	O
control	O	O	B-T169
,	O	O	O
with	O	O	O
impaired	O	O	B-T169
naming	O	O	B-T170
and	O	O	O
preserved	O	O	B-T041
recognition	O	O	I-T041
might	O	O	O
be	O	O	O
hypothesized	O	O	O
in	O	O	O
AD	O	O	B-T047
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
correlation	O	O	B-T080
between	O	O	O
face	O	O	B-T041
and	O	O	O
voice	O	O	B-T041
recognition	O	O	I-T041
disorders	O	O	B-T047
and	O	O	O
RTL	O	O	B-T023
damage	O	O	B-T037
are	O	O	O
consistent	O	O	O
with	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
assuming	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
RTL	O	O	O
person	O	O	B-T098
-specific	O	O	O
knowledge	O	O	B-T170
may	O	O	O
be	O	O	O
mainly	O	O	O
based	O	O	O
upon	O	O	O
non-verbal	O	O	B-T041
representations	O	O	I-T041
.	O	O	O

-DOCSTART- (27917468)

Dry	O	O	B-T184
skin	O	O	I-T184
conditions	O	O	O
are	O	O	O
related	O	O	B-T080
to	O	O	O
the	O	O	O
recovery	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
skin	O	O	B-T032
temperature	O	O	I-T032
after	O	O	O
cold	O	O	B-T070
stress	O	O	B-T046
rather	O	O	O
than	O	O	O
to	O	O	O
blood	O	O	O
flow	O	O	O

Cutaneous	O	O	B-T082
blood	O	O	B-T039
flow	O	O	I-T039
plays	O	O	O
an	O	O	O
important	O	O	B-T080
role	O	O	O
in	O	O	O
the	O	O	O
thermoregulation	O	O	B-T042
,	O	O	O
oxygen	O	O	B-T201
supply	O	O	I-T201
,	O	O	O
and	O	O	O
nutritional	O	O	B-T061
support	O	O	I-T061
necessary	O	O	O
to	O	O	O
maintain	O	O	B-T052
the	O	O	O
skin	O	O	B-T022
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
little	O	O	O
evidence	O	O	B-T078
for	O	O	O
a	O	O	O
link	O	O	O
between	O	O	O
blood	O	O	B-T039
flow	O	O	I-T039
and	O	O	O
skin	O	O	B-T042
physiology	O	O	I-T042
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
conducted	O	O	O
surveys	O	O	B-T170
of	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
to	O	O	O
determine	O	O	O
the	O	O	O
relationship	O	O	B-T080
(	O	O	O
s	O	O	O
)	O	O	O
between	O	O	O
dry	O	O	B-T184
skin	O	O	I-T184
properties	O	O	O
and	O	O	O
cutaneous	O	O	B-T082
vascular	O	O	B-T201
function	O	O	I-T201
.	O	O	O

Water	O	O	O
content	O	O	O
of	O	O	O
the	O	O	O
stratum	O	O	B-T024
corneum	O	O	I-T024
,	O	O	O
transepidermal	O	O	B-T033
water	O	O	I-T033
loss	O	O	I-T033
,	O	O	O
and	O	O	O
visual	O	O	B-T080
dryness	O	O	I-T080
score	O	O	I-T080
were	O	O	O
investigated	O	O	B-T169
as	O	O	O
dry	O	O	B-T184
skin	O	O	I-T184
parameters	O	O	B-T033
.	O	O	O

Cutaneous	O	O	B-T082
blood	O	O	B-T039
flow	O	O	I-T039
in	O	O	O
the	O	O	O
resting	O	O	B-T033
state	O	O	I-T033
,	O	O	O
the	O	O	O
recovery	O	O	B-T081
rate	O	O	I-T081
(	O	O	O
RR	O	O	B-T081
)	O	O	O
of	O	O	O
skin	O	O	B-T032
temperature	O	O	I-T032
on	O	O	O
the	O	O	O
hand	O	O	B-T023
after	O	O	O
a	O	O	O
cold-stress	O	O	B-T059
test	O	O	I-T059
,	O	O	O
and	O	O	O
the	O	O	O
responsiveness	O	O	B-T169
of	O	O	O
facial	O	O	B-T023
skin	O	O	I-T023
blood	O	O	O
flow	O	O	O
to	O	O	O
local	O	O	B-T061
cooling	O	O	I-T061
were	O	O	O
examined	O	O	B-T033
as	O	O	O
indices	O	O	B-T170
of	O	O	O
cutaneous	O	O	B-T082
vascular	O	O	B-T201
functions	O	O	I-T201
.	O	O	O

The	O	O	O
relationships	O	O	B-T080
between	O	O	O
dry	O	O	B-T184
skin	O	O	I-T184
parameters	O	O	B-T033
and	O	O	O
cutaneous	O	O	B-T082
vascular	O	O	B-T201
functions	O	O	I-T201
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

The	O	O	O
RR	O	O	B-T081
correlated	O	O	B-T080
negatively	O	O	O
with	O	O	O
the	O	O	O
visual	O	O	B-T080
dryness	O	O	I-T080
score	O	O	I-T080
of	O	O	O
skin	O	O	B-T022
on	O	O	O
the	O	O	O
leg	O	O	B-T023
but	O	O	O
correlated	O	O	O
positively	O	O	O
with	O	O	O
water	O	O	O
content	O	O	O
of	O	O	O
the	O	O	O
stratum	O	O	B-T024
corneum	O	O	I-T024
on	O	O	O
the	O	O	O
arm	O	O	O
.	O	O	O

No	O	O	O
significant	O	O	O
correlation	O	O	B-T080
between	O	O	O
the	O	O	O
resting	O	O	B-T033
state	O	O	I-T033
of	O	O	O
blood	O	O	B-T039
flow	O	O	I-T039
and	O	O	O
dry	O	O	B-T184
skin	O	O	I-T184
parameters	O	O	B-T033
was	O	O	O
observed	O	O	B-T169
.	O	O	O

In	O	O	O
both	O	O	O
the	O	O	O
face	O	O	B-T029
and	O	O	O
the	O	O	O
body	O	O	B-T016
,	O	O	O
deterioration	O	O	B-T067
in	O	O	O
skin	O	O	B-T184
dryness	O	O	I-T184
from	O	O	O
summer	O	O	B-T079
to	O	O	O
winter	O	O	B-T079
was	O	O	O
significant	O	O	B-T078
in	O	O	O
subjects	O	O	O
with	O	O	O
low	O	O	O
RR	O	O	B-T081
.	O	O	O

The	O	O	O
RR	O	O	B-T081
correlated	O	O	B-T080
well	O	O	O
with	O	O	O
the	O	O	O
responsiveness	O	O	B-T169
of	O	O	O
facial	O	O	B-T023
skin	O	O	I-T023
blood	O	O	B-T039
flow	O	O	I-T039
to	O	O	O
local	O	O	B-T061
cooling	O	O	I-T061
,	O	O	O
indicating	O	O	B-T033
that	O	O	O
the	O	O	O
RR	O	O	O
affects	O	O	O
systemic	O	O	O
dry	O	O	B-T184
skin	O	O	I-T184
conditions	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
RR	O	O	B-T081
but	O	O	O
not	O	O	O
blood	O	O	B-T039
flow	O	O	I-T039
at	O	O	O
the	O	O	O
resting	O	O	B-T033
state	O	O	I-T033
is	O	O	O
associated	O	O	O
with	O	O	O
dry	O	O	B-T184
skin	O	O	I-T184
conditions	O	O	O
and	O	O	O
is	O	O	O
involved	O	O	O
in	O	O	O
skin	O	O	O
homeostasis	O	O	B-T038
during	O	O	O
seasonal	O	O	B-T079
environmental	O	O	B-T033
changes	O	O	I-T033
.	O	O	O

-DOCSTART- (27919226)

Molar	O	O	B-T020
loss	O	O	I-T020
and	O	O	O
powder	O	O	B-T061
diet	O	O	I-T061
leads	O	O	O
to	O	O	O
memory	O	O	B-T048
deficit	O	O	I-T048
and	O	O	O
modifies	O	O	O
the	O	O	O
mRNA	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
brain-derived	O	O	B-T116
neurotrophic	O	O	I-T116
factor	O	O	I-T116
in	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
of	O	O	O
adult	O	O	B-T100
mice	O	O	O

It	O	O	O
is	O	O	O
known	O	O	O
that	O	O	O
tooth	O	O	B-T020
loss	O	O	I-T020
is	O	O	O
known	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
soft	O	O	B-T061
diet	O	O	I-T061
feeding	O	O	B-T052
induces	O	O	O
memory	O	O	B-T048
impairment	O	O	I-T048
.	O	O	O

Recent	O	O	O
studies	O	O	O
have	O	O	O
shown	O	O	O
that	O	O	O
brain-derived	O	O	B-T116
neurotrophic	O	O	I-T116
factor	O	O	I-T116
(	O	O	O
BDNF	O	O	B-T116
)	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
tooth	O	O	B-T020
loss	O	O	I-T020
or	O	O	O
soft	O	O	B-T061
diet	O	O	I-T061
in	O	O	O
young	O	O	O
animal	O	O	B-T008
model	O	O	I-T008
,	O	O	O
and	O	O	O
that	O	O	O
BDNF	O	O	O
expression	O	O	B-T045
is	O	O	O
decreased	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
single	O	O	O
or	O	O	O
combined	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
tooth	O	O	B-T020
loss	O	O	I-T020
and/or	O	O	O
soft	O	O	B-T061
diet	O	O	I-T061
on	O	O	O
brain	O	O	B-T042
function	O	O	I-T042
has	O	O	O
not	O	O	O
fully	O	O	O
understood	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
examined	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
molar	O	O	B-T020
loss	O	O	I-T020
and	O	O	O
powder	O	O	B-T061
diet	O	O	I-T061
on	O	O	O
memory	O	O	B-T041
ability	O	O	I-T041
and	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
BDNF	O	O	B-T028
mRNA	O	O	I-T028
in	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
of	O	O	O
adult	O	O	B-T100
C57BL/6J	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Twenty	O	O	O
eight-weeks-old	O	O	O
C57BL/6J	O	O	B-T015
mice	O	O	I-T015
were	O	O	O
divided	O	O	O
into	O	O	O
intact	O	O	O
molar	O	O	O
group	O	O	O
and	O	O	O
extracted	O	O	O
molar	O	O	O
group	O	O	O
.	O	O	O

They	O	O	O
were	O	O	O
randomly	O	O	B-T062
divided	O	O	O
into	O	O	O
the	O	O	O
I/S	O	O	O
group	O	O	O
(	O	O	O
Intact	O	O	O
upper	O	O	B-T023
molar	O	O	I-T023
teeth	O	O	I-T023
/	O	O	O
Solid	O	O	B-T168
diet	O	O	I-T168
feeding	O	O	B-T052
)	O	O	O
,	O	O	O
the	O	O	O
E/S	O	O	O
group	O	O	O
(	O	O	O
Extracted	O	O	B-T061
upper	O	O	O
molar	O	O	O
teeth	O	O	O
/	O	O	O
Solid	O	O	O
diet	O	O	O
feeding	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
I/P	O	O	O
group	O	O	O
(	O	O	O
Intact	O	O	O
upper	O	O	O
molar	O	O	O
teeth	O	O	O
/	O	O	O
Powder	O	O	B-T061
diet	O	O	I-T061
feeding	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
E/P	O	O	O
group	O	O	O
(	O	O	O
Extracted	O	O	O
upper	O	O	O
molar	O	O	O
teeth	O	O	O
/	O	O	O
Powder	O	O	O
diet	O	O	O
feeding	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
observation	O	O	O
periods	O	O	O
were	O	O	O
4	O	O	O
and	O	O	O
16-week	O	O	O
.	O	O	O

To	O	O	O
analyze	O	O	B-T062
the	O	O	O
memory	O	O	B-T041
ability	O	O	I-T041
,	O	O	O
the	O	O	O
step-through	O	O	O
passive	O	O	B-T041
avoidance	O	O	I-T041
test	O	O	O
was	O	O	O
conducted	O	O	O
.	O	O	O

BDNF-related	O	O	B-T028
mRNA	O	O	I-T028
in	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
was	O	O	O
analyzed	O	O	B-T062
by	O	O	O
real-time	O	O	B-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(	O	O	O
RT-PCR	O	O	B-T063
)	O	O	O
.	O	O	O

At	O	O	O
4	O	O	O
weeks	O	O	O
later	O	O	O
,	O	O	O
we	O	O	O
performed	O	O	O
memory	O	O	B-T059
test	O	O	I-T059
and	O	O	O
isolated	O	O	O
brains	O	O	B-T023
to	O	O	O
analyze	O	O	B-T062
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
differences	O	O	I-T033
in	O	O	O
memory	O	O	B-T041
function	O	O	I-T041
and	O	O	O
BDNF	O	O	B-T028
mRNA	O	O	I-T028
level	O	O	O
between	O	O	O
these	O	O	O
four	O	O	O
groups	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
at	O	O	O
16	O	O	O
weeks	O	O	O
later	O	O	O
,	O	O	O
E/S	O	O	O
and	O	O	O
E/P	O	O	O
group	O	O	O
showed	O	O	O
memory	O	O	B-T048
impairment	O	O	I-T048
,	O	O	O
and	O	O	O
decreased	O	O	O
level	O	O	O
of	O	O	O
BDNF	O	O	B-T028
mRNA	O	O	I-T028
.	O	O	O

Whereas	O	O	O
,	O	O	O
the	O	O	O
powder	O	O	B-T061
diet	O	O	I-T061
had	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
memory	O	O	B-T041
function	O	O	I-T041
and	O	O	O
BDNF	O	O	B-T028
mRNA	O	O	I-T028
level	O	O	O
even	O	O	O
at	O	O	O
16	O	O	O
weeks	O	O	O
later	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
molar	O	O	B-T020
loss	O	O	I-T020
and	O	O	O
powder	O	O	B-T061
diet	O	O	I-T061
on	O	O	O
memory	O	O	B-T041
function	O	O	I-T041
and	O	O	O
BDNF	O	O	B-T028
mRNA	O	O	I-T028
levels	O	O	O
were	O	O	O
different	O	O	O
,	O	O	O
molar	O	O	O
loss	O	O	O
may	O	O	O
have	O	O	O
a	O	O	O
greater	O	O	O
long-term	O	O	B-T067
effect	O	O	I-T067
on	O	O	O
memory	O	O	B-T041
ability	O	O	I-T041
than	O	O	O
powder	O	O	O
diet	O	O	O
does	O	O	O
.	O	O	O

-DOCSTART- (27920607)

Description	O	O	O
of	O	O	O
the	O	O	O
first	O	O	O
species	O	O	B-T185
of	O	O	O
Fiorianteon	O	O	B-T204
Olmi	O	O	I-T204
(	O	O	O
Hymenoptera	O	O	B-T204
,	O	O	O
Dryinidae	O	O	B-T204
)	O	O	O
from	O	O	O
the	O	O	O
Afrotropical	O	O	O
region	O	O	O

Fiorianteon	O	O	B-T204
sulcatumsp	O	O	I-T204
.	O	O	O

n.	O	O	O
is	O	O	O
described	O	O	O
from	O	O	O
Fianarantsoa	O	O	B-T083
Province	O	O	I-T083
(	O	O	O
Madagascar	O	O	B-T083
)	O	O	O
.	O	O	O

It	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
species	O	O	B-T185
of	O	O	O
Fiorianteon	O	O	B-T204
found	O	O	O
in	O	O	O
the	O	O	O
Afrotropical	O	O	B-T083
region	O	O	I-T083
.	O	O	O

The	O	O	O
genus	O	O	B-T185
Fiorianteon	O	O	B-T204
can	O	O	O
be	O	O	O
distinguished	O	O	O
from	O	O	O
the	O	O	O
closely	O	O	O
related	O	O	O
genus	O	O	O
Conganteon	O	O	B-T204
by	O	O	O
the	O	O	O
distal	O	O	B-T082
part	O	O	O
of	O	O	O
the	O	O	O
stigmal	O	O	B-T023
vein	O	O	B-T023
,	O	O	O
which	O	O	O
is	O	O	O
as	O	O	O
long	O	O	B-T080
as	O	O	O
,	O	O	O
or	O	O	O
shorter	O	O	B-T033
than	O	O	O
the	O	O	O
proximal	O	O	B-T082
part	O	O	O
of	O	O	O
the	O	O	O
stigmal	O	O	O
vein	O	O	O
(	O	O	O
longer	O	O	O
than	O	O	O
the	O	O	O
proximal	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
vein	O	O	O
in	O	O	O
Conganteon	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27920947)

The	O	O	B-T170
Daniel	O	O	I-T170
K.	O	O	I-T170
Inouye	O	O	I-T170
College	O	O	I-T170
of	O	O	I-T170
Pharmacy	O	O	I-T170
Scripts	O	O	I-T170
:	O	O	O
Poha	O	O	B-T168
Berry	O	O	I-T168
(	O	O	O
Physalis	O	O	B-T002
peruviana	O	O	I-T002
)	O	O	O
with	O	O	O
Potential	O	O	B-T080
Anti-inflammatory	O	O	B-T080
and	O	O	O
Cancer	O	O	B-T061
Prevention	O	O	I-T061
Activities	O	O	O

The	O	O	B-T093
Daniel	O	O	I-T093
K.	O	O	I-T093
Inouye	O	O	I-T093
College	O	O	I-T093
of	O	O	I-T093
Pharmacy	O	O	I-T093
,	O	O	O
during	O	O	O
a	O	O	O
historic	O	O	B-T051
event	O	O	I-T051
in	O	O	O
Spring	O	O	B-T079
2016	O	O	O
,	O	O	O
graduated	O	O	B-T098
the	O	O	O
first	O	O	O
two	O	O	O
students	O	O	B-T098
in	O	O	O
the	O	O	O
Pacific	O	O	B-T083
region	O	O	I-T083
to	O	O	O
earn	O	O	O
a	O	O	O
PhD	O	O	B-T170
in	O	O	O
pharmaceutical	O	O	B-T091
sciences	O	O	I-T091
at	O	O	O
the	O	O	O
University	O	O	B-T073
of	O	O	I-T073
Hawai'i	O	O	I-T073
at	O	O	O
Hilo	O	O	B-T083
.	O	O	O

The	O	O	O
college	O	O	B-T093
offers	O	O	O
PhD	O	O	B-T170
programs	O	O	B-T169
in	O	O	O
these	O	O	O
five	O	O	O
disciplines	O	O	B-T090
:	O	O	O
Cancer	O	O	B-T091
Biology	O	O	I-T091
,	O	O	O
Medicinal	O	O	B-T091
Chemistry	O	O	I-T091
,	O	O	O
Pharmaceutics	O	O	B-T062
,	O	O	O
Pharmacognosy	O	O	B-T091
,	O	O	O
and	O	O	O
Pharmacology	O	O	B-T091
.	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
Pharmacognosy	O	O	B-T091
dissertations	O	O	B-T073
focused	O	O	O
on	O	O	O
plant-derived	O	O	B-T002
natural	O	O	B-T123
products	O	O	I-T123
with	O	O	O
potential	O	O	B-T080
anti-inflammatory	O	O	B-T080
and	O	O	O
cancer	O	O	B-T191
chemopreventive	O	O	B-T080
activities	O	O	B-T052
.	O	O	O

Physalis	O	O	B-T002
peruviana	O	O	I-T002
(	O	O	O
Pp	O	O	B-T002
)	O	O	O
L.	O	O	O
originated	O	O	O
in	O	O	O
tropical	O	O	O
South	O	O	B-T083
America	O	O	I-T083
.	O	O	O

It	O	O	O
has	O	O	O
become	O	O	O
naturalized	O	O	B-T169
and	O	O	O
is	O	O	O
found	O	O	O
readily	O	O	O
on	O	O	O
the	O	O	O
Island	O	O	B-T083
of	O	O	I-T083
Hawai'i	O	O	I-T083
.	O	O	O

The	O	O	O
edible	O	O	B-T168
fruits	O	O	B-T168
are	O	O	O
commonly	O	O	O
known	O	O	O
as	O	O	O
cape	O	O	B-T002
gooseberry	O	O	I-T002
or	O	O	O
poha	O	O	B-T002
in	O	O	O
Hawai'i	O	O	B-T083
.	O	O	O

In	O	O	O
part	O	O	O
of	O	O	O
our	O	O	O
study	O	O	O
,	O	O	O
three	O	O	O
new	O	O	O
withanolides	O	O	B-T109
,	O	O	O
physaperuvin	O	O	B-T121
G	O	O	I-T121
(	O	O	O
1	O	O	O
)	O	O	O
,	O	O	O
physaperuvins	O	O	B-T121
I-J	O	O	I-T121
(	O	O	O
2	O	O	O
-	O	O	O
3	O	O	O
)	O	O	O
,	O	O	O
along	O	O	O
with	O	O	O
four	O	O	O
known	O	O	O
withanolides	O	O	O
,	O	O	O
namely	O	O	O
,	O	O	O
4β-hydroxywithanolide	O	O	B-T121
E	O	O	I-T121
(	O	O	O
4	O	O	O
)	O	O	O
,	O	O	O
withaperuvin	O	O	B-T121
C	O	O	I-T121
(	O	O	O
5	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
physalactone	O	O	B-T121
(	O	O	O
6	O	O	O
)	O	O	O
,	O	O	O
coagulin	O	O	B-T121
(	O	O	O
7	O	O	O
)	O	O	O
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
aerial	O	O	B-T002
parts	O	O	I-T002
of	O	O	O
P.	O	O	B-T002
peruviana	O	O	I-T002
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
two	O	O	O
known	O	O	O
compounds	O	O	B-T103
,	O	O	O
phyperunolide	O	O	B-T121
F	O	O	I-T121
(	O	O	O
8)	O	O	O
,	O	O	O
and	O	O	O
withanolide	O	O	B-T121
S	O	O	I-T121
(	O	O	O
9	O	O	O
)	O	O	O
,	O	O	O
were	O	O	O
isolated	O	O	B-T169
and	O	O	O
identified	O	O	O
from	O	O	O
the	O	O	O
poha	O	O	B-T168
berry	O	O	I-T168
fruits	O	O	I-T168
.	O	O	O

The	O	O	O
structures	O	O	B-T082
and	O	O	O
absolute	O	O	B-T082
stereochemistry	O	O	I-T082
of	O	O	O
new	O	O	O
compounds	O	O	O
from	O	O	O
poha	O	O	B-T002
were	O	O	O
elucidated	O	O	O
by	O	O	O
several	O	O	O
spectroscopy	O	O	B-T169
methods	O	O	I-T169
:	O	O	O
Nuclear	O	O	B-T060
Magnetic	O	O	I-T060
Resonance	O	O	I-T060
(	O	O	I-T060
NMR	O	O	I-T060
)	O	O	I-T060
spectroscopy	O	O	I-T060
,	O	O	O
X-ray	O	O	B-T059
diffraction	O	O	I-T059
,	O	O	O
and	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
analyses	O	O	B-T062
.	O	O	O

All	O	O	O
isolated	O	O	B-T169
poha	O	O	B-T002
compounds	O	O	B-T103
(	O	O	O
aerial	O	O	B-T002
parts	O	O	I-T002
and	O	O	O
fruits	O	O	B-T168
)	O	O	O
were	O	O	O
evaluated	O	O	O
for	O	O	O
their	O	O	O
anti-inflammatory	O	O	B-T080
activity	O	O	I-T080
with	O	O	O
lipopolysaccharide	O	O	B-T109
(LPS)-activated	O	O	O
murine	O	O	B-T015
macrophage	O	O	B-T025
RAW	O	O	I-T025
264.7	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
tumor	O	O	B-T116
necrosis	O	O	I-T116
factor	O	O	I-T116
alpha	O	O	I-T116
(TNF-α)-activated	O	O	O
nuclear	O	O	B-T116
factor-kappa	O	O	I-T116
B	O	O	I-T116
(	O	O	O
NF-κB	O	O	B-T116
)	O	O	O
with	O	O	O
transfected	O	O	O
human	O	O	B-T025
embryonic	O	O	I-T025
kidney	O	O	I-T025
cells	O	O	I-T025
293	O	O	I-T025
.	O	O	O

Most	O	O	O
of	O	O	O
the	O	O	O
isolated	O	O	B-T169
natural	O	O	B-T123
compounds	O	O	I-T123
showed	O	O	O
activity	O	O	B-T169
with	O	O	O
these	O	O	O
assays	O	O	B-T059
.	O	O	O

Additional	O	O	O
studies	O	O	O
were	O	O	O
performed	O	O	O
with	O	O	O
models	O	O	B-T170
of	O	O	O
colon	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Specifically	O	O	O
,	O	O	O
4β-hydroxywithanolide	O	O	B-T121
E	O	O	I-T121
(	O	O	O
4HWE	O	O	B-T121
)	O	O	O
inhibited	O	O	B-T080
the	O	O	O
growth	O	O	B-T040
of	O	O	O
colon	O	O	B-T191
cancer	O	O	I-T191
monolayer	O	O	B-T059
and	O	O	O
spheroid	O	O	B-T025
cultures	O	O	B-T059
.	O	O	O

The	O	O	O
compound	O	O	B-T103
induced	O	O	B-T169
cell	O	O	B-T043
cycle	O	O	I-T043
arrest	O	O	I-T043
at	O	O	O
low	O	O	B-T081
concentrations	O	O	I-T081
and	O	O	O
apoptosis	O	O	B-T043
at	O	O	O
higher	O	O	B-T081
concentrations	O	O	I-T081
.	O	O	O

These	O	O	O
data	O	O	B-T078
suggest	O	O	O
the	O	O	O
ingestion	O	O	B-T038
of	O	O	O
poha	O	O	B-T168
berries	O	O	I-T168
may	O	O	O
have	O	O	O
some	O	O	O
effect	O	O	O
on	O	O	O
the	O	O	O
prevalence	O	O	O
of	O	O	O
colon	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Additionally	O	O	O
,	O	O	O
poha	O	O	B-T168
isolates	O	O	B-T103
compounds	O	O	I-T103
were	O	O	O
evaluated	O	O	O
for	O	O	O
their	O	O	O
growth	O	O	B-T039
inhibitory	O	O	I-T039
effects	O	O	I-T039
with	O	O	O
U251MG	O	O	B-T191
glioblastoma	O	O	I-T191
and	O	O	O
MDA-MB-231	O	O	B-T050
breast	O	O	I-T050
cancer	O	O	I-T050
cells	O	O	I-T050
that	O	O	O
harbor	O	O	O
aberrantly-active	O	O	O
signal	O	O	B-T116
transducer	O	O	I-T116
and	O	O	I-T116
activation	O	O	I-T116
of	O	O	I-T116
transcription	O	O	I-T116
3	O	O	I-T116
(	O	O	I-T116
STAT3	O	O	I-T116
)	O	O	I-T116
,	O	O	O
compared	O	O	O
to	O	O	O
normal	O	O	O
NIH-3T3	O	O	B-T025
mouse	O	O	I-T025
fibroblasts	O	O	I-T025
.	O	O	O

This	O	O	O
work	O	O	O
has	O	O	O
led	O	O	O
to	O	O	O
the	O	O	O
filing	O	O	O
of	O	O	O
three	O	O	O
provisional	O	O	B-T170
patents	O	O	I-T170
with	O	O	O
the	O	O	O
University	O	O	B-T073
of	O	O	I-T073
Hawai'i	O	O	I-T073
Office	O	O	I-T073
of	O	O	I-T073
Technology	O	O	I-T073
Transfer	O	O	I-T073
and	O	O	I-T073
Economic	O	O	I-T073
Development	O	O	I-T073
.	O	O	O

-DOCSTART- (27922526)

Air	O	O	B-T131
Pollutant	O	O	I-T131
Exposure	O	O	B-T080
Within	O	O	O
a	O	O	O
Few	O	O	O
Days	O	O	O
of	O	O	O
Delivery	O	O	B-T061
and	O	O	O
Placental	O	O	B-T046
Abruption	O	O	I-T046
in	O	O	O
Japan	O	O	O

Placental	O	O	B-T046
abruption	O	O	I-T046
is	O	O	O
an	O	O	O
emergency	O	O	B-T046
obstetric	O	O	I-T046
complication	O	O	I-T046
.	O	O	O

Although	O	O	O
the	O	O	O
etiology	O	O	B-T169
of	O	O	O
abruption	O	O	B-T046
is	O	O	O
not	O	O	O
fully	O	O	O
understood	O	O	O
,	O	O	O
acute	O	O	B-T079
stimuli	O	O	B-T067
,	O	O	O
such	O	O	O
as	O	O	O
ischemia	O	O	B-T046
and/or	O	O	O
inflammation	O	O	B-T046
,	O	O	O
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
rupture	O	O	B-T047
of	O	O	I-T047
the	O	O	I-T047
decidual	O	O	I-T047
artery	O	O	I-T047
,	O	O	O
resulting	O	O	O
in	O	O	O
placental	O	O	B-T042
separation	O	O	I-T042
.	O	O	O

Ischemia	O	O	B-T046
and	O	O	O
inflammation	O	O	B-T046
are	O	O	O
acute	O	O	B-T079
biologic	O	O	B-T080
effects	O	O	B-T080
of	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
.	O	O	O

Using	O	O	O
a	O	O	O
case-crossover	O	O	B-T062
design	O	O	I-T062
,	O	O	O
we	O	O	O
tested	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
a	O	O	O
short-term	O	O	B-T079
increase	O	O	B-T169
in	O	O	O
exposure	O	O	B-T080
to	O	O	O
air	O	O	B-T131
pollutants	O	O	I-T131
is	O	O	O
a	O	O	O
potential	O	O	B-T080
trigger	O	O	B-T201
of	O	O	O
placental	O	O	B-T046
abruption	O	O	I-T046
.	O	O	O

We	O	O	O
received	O	O	O
data	O	O	B-T078
for	O	O	O
western	O	O	B-T083
Japan	O	O	I-T083
(	O	O	O
Kyushu-Okinawa	O	O	B-T083
Districts	O	O	I-T083
)	O	O	O
from	O	O	O
the	O	O	O
Japan	O	O	B-T170
Perinatal	O	O	I-T170
Registry	O	O	I-T170
Network	O	O	I-T170
database	O	O	I-T170
.	O	O	O

From	O	O	O
2005	O	O	O
to	O	O	O
2010	O	O	O
,	O	O	O
821	O	O	O
singleton	O	O	B-T099
pregnant	O	O	B-T098
women	O	O	I-T098
with	O	O	O
placental	O	O	B-T046
abruption	O	O	I-T046
were	O	O	O
identified	O	O	O
.	O	O	O

We	O	O	O
assigned	O	O	O
daily	O	O	B-T079
concentrations	O	O	B-T081
of	O	O	O
air	O	O	B-T131
pollutants	O	O	I-T131
,	O	O	O
including	O	O	O
nitrogen	O	O	B-T131
dioxide	O	O	I-T131
(	O	O	O
NO2	O	O	B-T131
)	O	O	O
,	O	O	O
suspended	O	O	B-T131
particulate	O	O	I-T131
matter	O	O	I-T131
,	O	O	O
ozone	O	O	B-T103
,	O	O	O
and	O	O	O
sulfur	O	O	B-T131
dioxide	O	O	I-T131
(	O	O	O
SO2	O	O	B-T131
)	O	O	O
,	O	O	O
from	O	O	O
the	O	O	O
nearest	O	O	O
monitoring	O	O	B-T073
station	O	O	I-T073
to	O	O	O
the	O	O	O
respective	O	O	O
delivery	O	O	B-T061
hospital	O	O	B-T093
of	O	O	O
each	O	O	O
woman	O	O	B-T098
.	O	O	O

Because	O	O	O
information	O	O	B-T078
on	O	O	O
the	O	O	O
onset	O	O	B-T079
day	O	O	B-T079
of	O	O	O
abruption	O	O	B-T046
was	O	O	O
not	O	O	O
obtained	O	O	O
,	O	O	O
we	O	O	O
assumed	O	O	O
the	O	O	O
case	O	O	B-T169
day	O	O	O
to	O	O	O
be	O	O	O
1	O	O	O
day	O	O	O
before	O	O	O
the	O	O	O
day	O	O	O
of	O	O	O
delivery	O	O	B-T061
.	O	O	O

Exposure	O	O	B-T080
to	O	O	O
NO2	O	O	B-T131
at	O	O	O
2	O	O	O
days	O	O	O
'	O	O	O
lag	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
placental	O	O	B-T046
abruption	O	O	I-T046
(	O	O	O
temperature	O	O	B-T081
adjusted	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
per	O	O	O
10	O	O	O
ppb	O	O	O
increase	O	O	B-T169
=	O	O	O
1.4	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
=	O	O	O
1.1	O	O	O
,	O	O	O
1.8	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
association	O	O	B-T080
patterns	O	O	O
were	O	O	O
similar	O	O	O
,	O	O	O
when	O	O	O
we	O	O	O
restricted	O	O	O
to	O	O	O
participants	O	O	B-T098
who	O	O	O
delivered	O	O	B-T061
by	O	O	O
emergency	O	O	B-T061
cesarean	O	O	I-T061
(	O	O	O
1.4	O	O	O
,	O	O	O
1.1	O	O	O
,	O	O	O
1.9	O	O	O
)	O	O	O
,	O	O	O
or	O	O	O
who	O	O	O
delivered	O	O	O
after	O	O	O
35	O	O	B-T079
weeks	O	O	I-T079
of	O	O	I-T079
gestation	O	O	I-T079
(	O	O	O
1.4	O	O	O
,	O	O	O
1.0	O	O	O
,	O	O	O
2.0	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
association	O	O	I-T033
with	O	O	O
suspended	O	O	B-T131
particulate	O	O	I-T131
matter	O	O	I-T131
,	O	O	O
ozone	O	O	B-T103
,	O	O	O
or	O	O	O
SO2	O	O	B-T131
.	O	O	O

We	O	O	O
observed	O	O	O
an	O	O	O
association	O	O	B-T080
between	O	O	O
NO2	O	O	B-T131
exposure	O	O	B-T080
at	O	O	O
2	O	O	O
days	O	O	B-T079
before	O	O	O
the	O	O	O
day	O	O	B-T079
of	O	O	O
delivery	O	O	B-T061
and	O	O	O
placental	O	O	B-T046
abruption	O	O	I-T046
in	O	O	O
pregnant	O	O	B-T098
Japanese	O	O	I-T098
women	O	O	I-T098
.	O	O	O

-DOCSTART- (27922994)

The	O	O	O
2016	O	O	O
Infusion	O	O	B-T061
Therapy	O	O	I-T061
Standards	O	O	B-T081
of	O	O	O
Practice	O	O	O

Approximately	O	O	O
every	O	O	O
5	O	O	O
years	O	O	O
,	O	O	O
the	O	O	O
Infusion	O	O	B-T093
Nurses	O	O	I-T093
Society	O	O	I-T093
publishes	O	O	B-T057
evidence-based	O	O	B-T169
practice	O	O	I-T169
standards	O	O	B-T081
.	O	O	O

This	O	O	O
article	O	O	B-T170
provides	O	O	B-T052
an	O	O	O
overview	O	O	O
of	O	O	O
the	O	O	O
process	O	O	B-T067
used	O	O	B-T169
in	O	O	O
standards	O	O	B-T081
development	O	O	B-T169
,	O	O	O
describes	O	O	O
the	O	O	O
format	O	O	B-T170
of	O	O	O
the	O	O	O
standards	O	O	O
,	O	O	O
and	O	O	O
provides	O	O	O
a	O	O	O
short	O	O	O
summary	O	O	B-T170
of	O	O	O
selected	O	O	B-T052
standards	O	O	O
as	O	O	O
applied	O	O	B-T169
to	O	O	O
home	O	O	B-T058
care	O	O	I-T058
.	O	O	O

The	O	O	O
Standards	O	O	B-T081
are	O	O	O
an	O	O	O
important	O	O	B-T080
document	O	O	B-T170
that	O	O	O
should	O	O	O
be	O	O	O
available	O	O	B-T169
to	O	O	O
every	O	O	B-T080
home	O	O	B-T058
care	O	O	I-T058
organization	O	O	B-T093
that	O	O	O
provides	O	O	B-T052
home	O	O	B-T061
infusion	O	O	I-T061
therapy	O	O	I-T061
.	O	O	O

-DOCSTART- (27924297)

Datasets	O	O	B-T170
for	O	O	O
the	O	O	O
validation	O	O	B-T062
of	O	O	O
the	O	O	O
"	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
"	O	O	O
siRNA	O	O	B-T114
-	O	O	O
silencing	O	O	B-T045
of	O	O	O
CD40	O	O	B-T028
and	O	O	O
for	O	O	O
the	O	O	O
detection	O	O	B-T061
of	O	O	O
new	O	O	O
markers	O	O	B-T045
of	O	O	O
atherosclerosis	O	O	B-T047
progression	O	O	B-T046
in	O	O	O
ApoE	O	O	B-T028
-	O	O	O
deficient	O	O	B-T169
mice	O	O	O

Data	O	O	B-T078
presented	O	O	O
in	O	O	O
this	O	O	O
Data	O	O	O
in	O	O	O
Brief	O	O	O
article	O	O	O
correspond	O	O	O
to	O	O	O
the	O	O	O
article	O	O	O
"	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
"	O	O	O
silencing	O	O	B-T045
of	O	O	O
CD40	O	O	B-T028
reduces	O	O	O
progression	O	O	B-T046
of	O	O	O
experimental	O	O	B-T062
atherogenesis	O	O	B-T046
through	O	O	O
a	O	O	O
NFκB	O	O	B-T116
/	O	O	O
miR-125b	O	O	B-T114
axis	O	O	O
and	O	O	O
reveals	O	O	O
new	O	O	O
potential	O	O	B-T080
mediators	O	O	B-T116
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
atherosclerosis	O	O	B-T047
"	O	O	O
(	O	O	O
M.	O	O	B-T170
Hueso	O	O	I-T170
,	O	O	O
L.	O	O	B-T170
De	O	O	I-T170
Ramon	O	O	I-T170
,	O	O	O
E.	O	O	B-T170
Navarro	O	O	I-T170
,	O	O	O
E.	O	O	B-T170
Ripoll	O	O	I-T170
,	O	O	O
J.M.	O	O	B-T170
Cruzado	O	O	I-T170
,	O	O	O
J.M.	O	O	B-T170
Grinyo	O	O	I-T170
,	O	O	O
J.	O	O	B-T170
Torras	O	O	I-T170
,	O	O	O
2016	O	O	O
)	O	O	O
[	O	O	O
1	O	O	O
]	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
the	O	O	O
validation	O	O	B-T062
of	O	O	O
the	O	O	O
silencing	O	O	B-T045
of	O	O	O
CD40	O	O	B-T028
expression	O	O	B-T045
with	O	O	O
a	O	O	O
specific	O	O	O
siRNA	O	O	B-T114
in	O	O	O
ApoE(-/-	O	O	B-T028
)	O	O	I-T028
mouse	O	O	B-T015
aortas	O	O	B-T023
,	O	O	O
and	O	O	O
its	O	O	O
systemic	O	O	O
effects	O	O	O
on	O	O	O
splenic	O	O	B-T023
lymphocytic	O	O	B-T185
subpopulations	O	O	I-T185
as	O	O	O
well	O	O	O
as	O	O	O
on	O	O	O
the	O	O	O
infiltration	O	O	B-T046
of	O	O	O
aortic	O	O	B-T023
intima	O	O	I-T023
by	O	O	O
F4/80(+	O	O	B-T025
)	O	O	I-T025
,	O	O	O
galectin-3(+	O	O	B-T025
)	O	O	I-T025
macrophages	O	O	I-T025
or	O	O	O
by	O	O	O
NF-κB(+	O	O	B-T025
)	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

We	O	O	O
also	O	O	O
show	O	O	O
the	O	O	O
output	O	O	O
of	O	O	O
a	O	O	O
Gene	O	O	B-T170
Ontology	O	O	I-T170
and	O	O	O
TLDA	O	O	B-T062
analysis	O	O	I-T062
which	O	O	O
allowed	O	O	O
the	O	O	O
detection	O	O	B-T061
of	O	O	O
potential	O	O	B-T080
mediators	O	O	B-T116
of	O	O	O
atherosclerosis	O	O	B-T047
progression	O	O	B-T046
.	O	O	O

We	O	O	O
provide	O	O	O
the	O	O	O
scientific	O	O	O
community	O	O	O
with	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
genes	O	O	B-T028
whose	O	O	O
expression	O	O	B-T045
is	O	O	O
increased	O	O	B-T081
during	O	O	O
atherosclerosis	O	O	B-T047
progression	O	O	B-T046
but	O	O	O
downregulated	O	O	B-T044
upon	O	O	O
CD40	O	O	B-T028
silencing	O	O	B-T045
.	O	O	O

-DOCSTART- (27927071)

Investigation	O	O	B-T170
on	O	O	O
evaluation	O	O	B-T058
criteria	O	O	B-T078
of	O	O	O
backwashing	O	O	B-T067
effects	O	O	B-T080
for	O	O	O
a	O	O	O
pilot-scale	O	O	B-T062
BAF	O	O	B-T073
treating	O	O	B-T169
petrochemical	O	O	B-T103
wastewater	O	O	O

Parameters	O	O	B-T077
for	O	O	O
evaluation	O	O	B-T058
criteria	O	O	B-T078
of	O	O	O
air	O	O	B-T167
-	O	O	O
water	O	O	B-T121
backwashing	O	O	B-T067
effect	O	O	B-T080
s	O	O	O
of	O	O	O
a	O	O	O
pilot-scale	O	O	B-T062
biological	O	O	B-T073
aerated	O	O	I-T073
filter	O	O	I-T073
(	O	O	O
BAF	O	O	B-T073
)	O	O	O
treating	O	O	B-T169
petrochemical	O	O	B-T103
wastewater	O	O	B-T069
were	O	O	O
investigated	O	O	B-T169
.	O	O	O

The	O	O	O
parameters	O	O	B-T077
included	O	O	O
the	O	O	O
suspended	O	O	B-T169
solids	O	O	B-T167
(	O	O	O
SS	O	O	B-T167
)	O	O	O
and	O	O	O
specific	O	O	B-T033
oxygen	O	O	I-T033
uptake	O	O	I-T033
rate	O	O	I-T033
(	O	O	O
SOUR	O	O	B-T033
)	O	O	O
of	O	O	O
the	O	O	O
backwashing	O	O	B-T067
effluent	O	O	B-T170
,	O	O	O
recovery	O	O	B-T052
of	O	O	O
the	O	O	O
BAF	O	O	B-T073
after	O	O	O
backwashing	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
removal	O	O	B-T052
of	O	O	O
the	O	O	O
biomass	O	O	B-T081
/	O	O	O
bioactivity	O	O	B-T080
attached	O	O	B-T067
on	O	O	O
the	O	O	O
filter	O	O	B-T073
media	O	O	B-T167
after	O	O	O
backwashing	O	O	O
.	O	O	O

Results	O	O	B-T169
showed	O	O	O
that	O	O	O
the	O	O	O
weight	O	O	B-T081
of	O	O	O
the	O	O	O
total	O	O	B-T080
sludge	O	O	B-T069
produced	O	O	O
in	O	O	O
the	O	O	O
backwashing	O	O	B-T067
effluent	O	O	B-T170
increased	O	O	B-T081
with	O	O	O
the	O	O	O
increase	O	O	B-T169
in	O	O	O
water	O	O	B-T121
-	O	O	O
backwashing	O	O	O
intensity	O	O	B-T080
,	O	O	O
while	O	O	O
the	O	O	O
total	O	O	O
SOUR	O	O	B-T033
of	O	O	O
backwashing	O	O	O
effluent	O	O	O
rose	O	O	O
notably	O	O	B-T080
with	O	O	O
the	O	O	O
increase	O	O	O
of	O	O	O
air	O	O	B-T167
-	O	O	O
backwashing	O	O	O
intensity	O	O	O
.	O	O	O

The	O	O	O
optimal	O	O	B-T080
backwashing	O	O	B-T067
intensity	O	O	B-T080
of	O	O	O
14	O	O	O
L/(m(2)·s	O	O	O
)	O	O	O
for	O	O	O
air	O	O	B-T167
and	O	O	O
4	O	O	O
L/(m(2)·s	O	O	O
)	O	O	O
for	O	O	O
water	O	O	B-T121
were	O	O	O
obtained	O	O	B-T169
.	O	O	O

When	O	O	O
the	O	O	O
BAF	O	O	B-T073
was	O	O	O
backwashed	O	O	B-T067
on	O	O	O
this	O	O	O
condition	O	O	O
,	O	O	O
the	O	O	O
BAF	O	O	O
recovered	O	O	B-T080
with	O	O	O
high	O	O	B-T080
average	O	O	B-T081
removal	O	O	B-T052
of	O	O	O
chemical	O	O	B-T038
oxygen	O	O	I-T038
demand	O	O	I-T038
(	O	O	O
COD	O	O	B-T038
)	O	O	O
and	O	O	O
ammonia	O	O	B-T197
nitrogen	O	O	I-T197
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
of	O	O	O
14.3	O	O	O
%	O	O	O
and	O	O	O
50.3	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

High	O	O	B-T080
amount	O	O	B-T081
of	O	O	O
biomass	O	O	B-T081
removal	O	O	B-T052
at	O	O	O
15.8	O	O	O
%	O	O	O
and	O	O	O
low	O	O	B-T080
level	O	O	B-T080
of	O	O	O
bioactivity	O	O	B-T080
removal	O	O	O
at	O	O	O
8.8	O	O	O
%	O	O	O
attached	O	O	B-T067
on	O	O	O
the	O	O	O
filter	O	O	B-T073
media	O	O	B-T167
were	O	O	O
also	O	O	O
found	O	O	O
.	O	O	O

Concentrations	O	O	B-T081
of	O	O	O
the	O	O	O
benzene	O	O	B-T109
,	O	O	O
toluene	O	O	B-T109
,	O	O	O
ethylbenzene	O	O	B-T109
and	O	O	O
(	O	O	B-T109
o-	O	O	I-T109
,	O	O	I-T109
m-	O	O	I-T109
,	O	O	I-T109
p-	O	O	I-T109
)	O	O	I-T109
xylenes	O	O	I-T109
(	O	O	O
BTEX	O	O	B-T109
)	O	O	O
and	O	O	O
phenol	O	O	B-T109
in	O	O	O
the	O	O	O
backwashed	O	O	B-T067
sludge	O	O	B-T069
were	O	O	O
analyzed	O	O	B-T062
,	O	O	O
showing	O	O	O
that	O	O	O
the	O	O	O
backwashing	O	O	B-T067
was	O	O	O
essential	O	O	B-T080
to	O	O	O
remove	O	O	B-T052
some	O	O	O
aromatic	O	O	B-T109
compounds	O	O	I-T109
adsorbed	O	O	B-T059
in	O	O	O
the	O	O	O
microorganisms	O	O	B-T001
.	O	O	O

-DOCSTART- (27928742)

Implementation	O	O	B-T052
of	O	O	O
infrared	O	O	B-T059
and	O	O	O
Raman	O	O	B-T059
modalities	O	O	B-T078
for	O	O	O
glycosaminoglycan	O	O	B-T109
characterization	O	O	B-T185
in	O	O	O
complex	O	O	B-T080
systems	O	O	O

Glycosaminoglycans	O	O	B-T109
(	O	O	O
GAGs	O	O	B-T109
)	O	O	O
are	O	O	O
natural	O	O	B-T169
,	O	O	O
linear	O	O	B-T082
and	O	O	O
negatively	O	O	B-T196
charged	O	O	I-T196
heteropolysaccharides	O	O	B-T109
which	O	O	O
are	O	O	O
incident	O	O	B-T067
in	O	O	O
every	O	O	O
mammalian	O	O	B-T015
tissue	O	O	B-T024
.	O	O	O

They	O	O	O
consist	O	O	O
of	O	O	O
repeating	O	O	O
disaccharide	O	O	B-T109
units	O	O	B-T081
,	O	O	O
which	O	O	O
are	O	O	O
composed	O	O	O
of	O	O	O
either	O	O	O
sulfated	O	O	B-T109
or	O	O	O
non-sulfated	O	O	B-T109
monosaccharides	O	O	I-T109
.	O	O	O

Depending	O	O	O
on	O	O	O
tissue	O	O	B-T024
types	O	O	B-T080
,	O	O	O
GAGs	O	O	B-T109
exhibit	O	O	O
structural	O	O	B-T082
heterogeneity	O	O	B-T080
such	O	O	O
as	O	O	O
the	O	O	O
position	O	O	B-T082
and	O	O	O
degree	O	O	B-T081
of	O	O	O
sulfation	O	O	B-T067
or	O	O	O
within	O	O	O
their	O	O	O
disaccharide	O	O	B-T109
units	O	O	B-T081
composition	O	O	B-T080
being	O	O	O
heparin	O	O	B-T109
,	O	O	O
heparan	O	O	B-T109
sulfate	O	O	I-T109
,	O	O	O
chondroitine	O	O	B-T109
sulfate	O	O	I-T109
,	O	O	O
dermatan	O	O	B-T109
sulfate	O	O	I-T109
,	O	O	O
keratan	O	O	B-T109
sulfate	O	O	I-T109
,	O	O	O
and	O	O	O
hyaluronic	O	O	B-T109
acid	O	O	I-T109
.	O	O	O

They	O	O	O
are	O	O	O
covalently	O	O	B-T044
linked	O	O	I-T044
to	O	O	O
a	O	O	O
core	O	O	B-T082
protein	O	O	B-T116
(	O	O	O
proteoglycans	O	O	B-T116
)	O	O	O
or	O	O	O
as	O	O	O
free	O	O	B-T080
chains	O	O	B-T078
(	O	O	O
hyaluronan	O	O	B-T109
)	O	O	O
.	O	O	O

GAGs	O	O	B-T109
affect	O	O	O
cell	O	O	B-T025
properties	O	O	B-T080
and	O	O	O
functions	O	O	B-T043
either	O	O	O
by	O	O	O
direct	O	O	B-T080
interaction	O	O	B-T169
with	O	O	O
cell	O	O	B-T116
receptors	O	O	I-T116
or	O	O	O
by	O	O	O
sequestration	O	O	B-T169
of	O	O	O
growth	O	O	B-T116
factors	O	O	I-T116
.	O	O	O

These	O	O	O
evidences	O	O	B-T169
of	O	O	I-T169
divert	O	O	B-T080
biological	O	O	B-T080
roles	O	O	B-T077
of	O	O	O
GAGs	O	O	B-T109
make	O	O	O
their	O	O	O
characterization	O	O	B-T185
at	O	O	O
cell	O	O	B-T025
and	O	O	O
tissue	O	O	B-T024
levels	O	O	B-T080
of	O	O	O
importance	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
non-invasive	O	O	B-T169
techniques	O	O	B-T169
are	O	O	O
interesting	O	O	O
to	O	O	O
investigate	O	O	B-T169
,	O	O	O
to	O	O	O
qualitatively	O	O	B-T080
and	O	O	O
quantitatively	O	O	B-T081
characterize	O	O	O
GAGs	O	O	B-T109
in	O	O	B-T080
vitro	O	O	I-T080
in	O	O	O
order	O	O	O
to	O	O	O
use	O	O	O
them	O	O	O
as	O	O	O
diagnostic	O	O	B-T169
biomarkers	O	O	B-T201
and/or	O	O	O
as	O	O	O
therapeutic	O	O	B-T169
targets	O	O	B-T074
in	O	O	O
several	O	O	O
human	O	O	B-T016
diseases	O	O	B-T047
including	O	O	O
cancer	O	O	B-T191
.	O	O	O

Infrared	O	O	B-T059
and	O	O	O
Raman	O	O	B-T059
microspectroscopies	O	O	I-T059
and	O	O	O
imaging	O	O	B-T060
are	O	O	O
sensitive	O	O	B-T169
enough	O	O	O
to	O	O	O
differentiate	O	O	O
and	O	O	O
classify	O	O	B-T185
GAG	O	O	B-T109
types	O	O	B-T080
and	O	O	O
subtypes	O	O	B-T185
in	O	O	O
spite	O	O	O
of	O	O	O
their	O	O	O
close	O	O	O
molecular	O	O	B-T082
structures	O	O	I-T082
.	O	O	O

Spectroscopic	O	O	B-T059
markers	O	O	B-T080
characteristic	O	O	O
of	O	O	O
reference	O	O	O
GAG	O	O	B-T109
molecules	O	O	B-T167
were	O	O	O
identified	O	O	B-T080
.	O	O	O

Beyond	O	O	O
these	O	O	O
investigations	O	O	B-T058
of	O	O	O
the	O	O	O
standard	O	O	O
GAG	O	O	B-T109
spectral	O	O	O
signature	O	O	O
,	O	O	O
infrared	O	O	B-T059
and	O	O	O
Raman	O	O	B-T059
spectral	O	O	O
signatures	O	O	O
of	O	O	O
GAG	O	O	O
were	O	O	O
searched	O	O	O
in	O	O	O
complex	O	O	B-T080
biological	O	O	B-T080
systems	O	O	B-T169
like	O	O	O
cells	O	O	B-T025
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
review	O	O	O
is	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
implementation	O	O	B-T052
of	O	O	O
these	O	O	O
complementary	O	O	O
vibrational	O	O	B-T059
spectroscopy	O	O	I-T059
techniques	O	O	I-T059
,	O	O	O
and	O	O	O
to	O	O	O
discuss	O	O	O
their	O	O	O
potentials	O	O	O
,	O	O	O
advantages	O	O	O
and	O	O	O
disadvantages	O	O	O
for	O	O	O
GAG	O	O	B-T109
analysis	O	O	B-T059
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
this	O	O	O
review	O	O	O
presents	O	O	O
new	O	O	O
data	O	O	O
as	O	O	O
we	O	O	O
show	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
GAG	O	O	B-T109
infrared	O	O	B-T059
and	O	O	O
Raman	O	O	B-T059
spectral	O	O	O
signatures	O	O	O
from	O	O	O
conditioned	O	O	B-T130
media	O	O	I-T130
and	O	O	O
live	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
respectively	O	O	O
.	O	O	O

-DOCSTART- (27932568)

Targeting	O	O	B-T169
HIF2	O	O	B-T116
in	O	O	O
Clear	O	O	O
Cell	O	O	O
Renal	O	O	O
Cell	O	O	O
Carcinoma	O	O	O

Inactivation	O	O	O
of	O	O	O
the	O	O	O
von	O	O	B-T116
Hippel-Lindau	O	O	I-T116
tumor-suppressor	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
pVHL	O	O	B-T116
)	O	O	O
is	O	O	O
the	O	O	O
signature	O	O	B-T033
"	O	O	I-T033
truncal	O	O	I-T033
"	O	O	I-T033
event	O	O	I-T033
in	O	O	O
clear	O	O	B-T191
cell	O	O	I-T191
renal	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
,	O	O	O
which	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
form	O	O	O
of	O	O	O
kidney	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

pVHL	O	O	B-T116
is	O	O	O
part	O	O	O
of	O	O	O
a	O	O	O
ubiquitin	O	O	B-T116
ligase	O	O	I-T116
the	O	O	O
targets	O	O	B-T169
the	O	O	O
α	O	O	B-T116
subunit	O	O	I-T116
of	O	O	O
the	O	O	O
hypoxia-inducible	O	O	B-T116
factor	O	O	I-T116
(	O	O	I-T116
HIF	O	O	I-T116
)	O	O	I-T116
transcription	O	O	I-T116
factor	O	O	I-T116
for	O	O	O
destruction	O	O	B-T052
when	O	O	O
oxygen	O	O	O
is	O	O	O
available	O	O	O
.	O	O	O

Preclinical	O	O	B-T080
studies	O	O	B-T062
strongly	O	O	O
suggest	O	O	O
that	O	O	O
deregulation	O	O	B-T049
of	O	O	O
HIF	O	O	B-T116
,	O	O	O
and	O	O	O
particularly	O	O	O
HIF2	O	O	B-T116
,	O	O	O
drives	O	O	O
pVHL	O	O	B-T116
-defective	O	O	O
renal	O	O	B-T191
carcinogenesis	O	O	I-T191
.	O	O	O

Although	O	O	O
HIF2α	O	O	B-T116
was	O	O	O
classically	O	O	O
considered	O	O	O
undruggable	O	O	B-T080
,	O	O	O
structural	O	O	O
and	O	O	O
chemical	O	O	O
work	O	O	O
by	O	O	O
Rick	O	O	B-T170
Bruick	O	O	I-T170
and	O	O	O
Kevin	O	O	B-T170
Gardner	O	O	I-T170
at	O	O	O
University	O	O	B-T073
of	O	O	I-T073
Texas	O	O	I-T073
Southwestern	O	O	I-T073
laid	O	O	O
the	O	O	O
foundation	O	O	O
for	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
small	O	O	B-T109
molecule	O	O	I-T109
direct	O	O	O
HIF2α	O	O	B-T120
antagonists	O	O	I-T120
(	O	O	O
PT2385	O	O	B-T109
and	O	O	O
the	O	O	O
related	O	O	O
tool	O	O	O
compound	O	O	O
PT2399	O	O	B-T120
)	O	O	O
by	O	O	O
Peloton	O	O	B-T093
Therapeutics	O	O	I-T093
that	O	O	O
block	O	O	B-T169
the	O	O	O
dimerization	O	O	B-T044
of	O	O	O
HIF2α	O	O	O
with	O	O	O
its	O	O	O
partner	O	O	O
protein	O	O	B-T116
ARNT1	O	O	I-T116
.	O	O	O

These	O	O	O
compounds	O	O	O
inhibit	O	O	B-T043
clear	O	O	I-T043
cell	O	O	I-T043
renal	O	O	I-T043
cell	O	O	I-T043
carcinoma	O	O	I-T043
growth	O	O	I-T043
in	O	O	O
preclinical	O	O	B-T170
models	O	O	I-T170
,	O	O	O
and	O	O	O
PT2385	O	O	B-T109
has	O	O	O
now	O	O	O
entered	O	O	O
the	O	O	O
clinic	O	O	B-T093
.	O	O	O

Nonetheless	O	O	O
,	O	O	O
the	O	O	O
availability	O	O	O
of	O	O	O
such	O	O	B-T121
compounds	O	O	I-T121
,	O	O	O
together	O	O	O
with	O	O	O
clustered	O	O	B-T114
regularly	O	O	I-T114
interspaced	O	O	I-T114
short	O	O	I-T114
palindromic	O	O	I-T114
repeat	O	O	I-T114
(CRISPR)-based	O	O	O
gene	O	O	B-T063
editing	O	O	I-T063
approaches	O	O	I-T063
,	O	O	O
has	O	O	O
revealed	O	O	O
a	O	O	O
previously	O	O	O
unappreciated	O	O	B-T080
heterogeneity	O	O	I-T080
among	O	O	O
clear	O	O	B-T191
cell	O	O	I-T191
renal	O	O	I-T191
carcinomas	O	O	I-T191
and	O	O	O
patient	O	O	B-T101
-derived	O	O	O
xenografts	O	O	B-T061
with	O	O	O
respect	O	O	O
to	O	O	O
HIF2	O	O	B-T116
dependence	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
predictive	O	O	B-T123
biomarkers	O	O	I-T123
will	O	O	O
be	O	O	O
needed	O	O	O
to	O	O	O
optimize	O	O	B-T052
the	O	O	O
use	O	O	O
of	O	O	O
such	O	O	B-T121
agents	O	O	I-T121
in	O	O	O
the	O	O	O
clinic	O	O	B-T093
.	O	O	O

-DOCSTART- (27935120)

Prevalence	O	O	B-T081
of	O	O	O
high-risk	O	O	B-T033
human	O	O	B-T047
papillomavirus	O	O	I-T047
infection	O	O	I-T047
among	O	O	O
women	O	O	B-T032
in	O	O	O
Shaanxi	O	O	B-T083
province	O	O	B-T083
of	O	O	O
China	O	O	B-T083
:	O	O	O
A	O	O	O
hospital	O	O	B-T093
-based	O	O	O
investigation	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
characteristics	O	O	B-T080
of	O	O	O
female	O	O	B-T032
high-risk	O	O	B-T047
human	O	O	I-T047
papillomavirus	O	O	I-T047
(	O	O	I-T047
HR-HPV	O	O	I-T047
)	O	O	I-T047
infection	O	O	I-T047
in	O	O	O
Shaanxi	O	O	B-T083
province	O	O	B-T083
of	O	O	O
China	O	O	B-T083
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
14	O	O	O
111	O	O	O
women	O	O	B-T032
were	O	O	O
enrolled	O	O	O
for	O	O	O
HPV	O	O	B-T005
genotyping	O	O	B-T059
test	O	O	I-T059
,	O	O	O
and	O	O	O
a	O	O	O
cytology	O	O	B-T059
,	O	O	O
and/or	O	O	O
cervix	O	O	B-T060
biopsy	O	O	I-T060
were	O	O	O
performed	O	O	O
in	O	O	O
partial	O	O	O
women	O	O	O
.	O	O	O

Of	O	O	O
these	O	O	O
women	O	O	B-T032
,	O	O	O
the	O	O	O
HPV	O	O	B-T047
infection	O	O	I-T047
rate	O	O	B-T081
was	O	O	O
30.21	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
26.73	O	O	O
%	O	O	O
were	O	O	O
caused	O	O	O
by	O	O	O
HR-HPV	O	O	B-T005
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
HR-HPV	O	O	B-T005
genotypes	O	O	B-T032
were	O	O	O
HPV-16	O	O	B-T005
,	O	O	O
HPV-58	O	O	B-T005
,	O	O	O
HPV-52	O	O	B-T005
,	O	O	O
HPV-18	O	O	B-T005
,	O	O	O
and	O	O	O
HPV-31	O	O	B-T005
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
HR-HPV	O	O	B-T005
among	O	O	O
women	O	O	B-T032
older	O	O	O
than	O	O	O
50	O	O	O
years	O	O	O
was	O	O	O
significantly	O	O	O
higher	O	O	O
than	O	O	O
the	O	O	O
other	O	O	O
groups	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
main	O	O	O
carcinogenic	O	O	B-T131
genotypes	O	O	B-T032
were	O	O	O
HPV-16	O	O	B-T005
,	O	O	O
HPV-18	O	O	B-T005
,	O	O	O
HPV-58	O	O	B-T005
,	O	O	O
HPV-52	O	O	B-T005
,	O	O	O
and	O	O	O
HPV-31	O	O	B-T005
.	O	O	O

HPV-16	O	O	B-T005
and	O	O	O
HPV-18	O	O	B-T005
combined	O	O	O
caused	O	O	O
80.79	O	O	O
%	O	O	O
of	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
cases	O	O	O
.	O	O	O

The	O	O	O
infection	O	O	B-T046
with	O	O	O
multiple	O	O	O
HR-HPVs	O	O	B-T005
was	O	O	O
not	O	O	B-T033
a	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
cervical	O	O	B-T046
lesions	O	O	I-T046
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
HPV	O	O	B-T047
infection	O	O	I-T047
was	O	O	O
common	O	O	O
among	O	O	O
women	O	O	B-T032
in	O	O	O
Shaanxi	O	O	B-T083
province	O	O	B-T083
.	O	O	O

Women	O	O	B-T032
older	O	O	O
than	O	O	O
50	O	O	O
years	O	O	O
were	O	O	O
a	O	O	O
high-risk	O	O	B-T098
group	O	O	I-T098
for	O	O	O
HR-HPV	O	O	B-T047
infection	O	O	I-T047
and	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

HPV-16	O	O	B-T005
and	O	O	O
HPV-18	O	O	B-T005
were	O	O	O
the	O	O	O
main	O	O	O
carcinogenic	O	O	B-T131
genotypes	O	O	B-T032
in	O	O	O
this	O	O	O
region	O	O	B-T083
.	O	O	O

-DOCSTART- (27935944)

Novel	O	O	B-T080
and	O	O	O
Lost	O	O	B-T169
Forests	O	O	B-T070
in	O	O	O
the	O	O	O
Upper	O	O	B-T083
Midwestern	O	O	I-T083
United	O	O	I-T083
States	O	O	I-T083
,	O	O	O
from	O	O	O
New	O	O	B-T080
Estimates	O	O	B-T081
of	O	O	O
Settlement-Era	O	O	B-T079
Composition	O	O	O
,	O	O	O
Stem	O	O	B-T002
Density	O	O	B-T081
,	O	O	O
and	O	O	O
Biomass	O	O	O

EuroAmerican	O	O	B-T098
land-use	O	O	B-UnknownType
and	O	O	O
its	O	O	O
legacies	O	O	B-T081
have	O	O	O
transformed	O	O	B-T081
forest	O	O	B-T070
structure	O	O	I-T070
and	O	O	O
composition	O	O	O
across	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
(	O	O	O
US	O	O	B-T083
)	O	O	O
.	O	O	O

More	O	O	B-T081
accurate	O	O	B-T080
reconstructions	O	O	B-T052
of	O	O	O
historical	O	O	B-T083
states	O	O	I-T083
are	O	O	O
critical	O	O	B-T080
to	O	O	O
understanding	O	O	O
the	O	O	O
processes	O	O	B-T067
governing	O	O	B-T080
past	O	O	B-T079
,	O	O	O
current	O	O	B-T079
,	O	O	O
and	O	O	O
future	O	O	B-T079
forest	O	O	B-T070
dynamics	O	O	B-T070
.	O	O	O

Here	O	O	O
we	O	O	O
present	O	O	O
new	O	O	O
gridded	O	O	O
(	O	O	O
8x8	O	O	O
km	O	O	O
)	O	O	O
reconstructions	O	O	B-T052
of	O	O	O
pre-settlement	O	O	B-T079
(	O	O	O
1800s	O	O	O
)	O	O	O
forest	O	O	B-T070
composition	O	O	O
and	O	O	O
structure	O	O	O
from	O	O	O
the	O	O	O
upper	O	O	B-T083
Midwestern	O	O	I-T083
US	O	O	I-T083
(	O	O	O
Minnesota	O	O	B-T083
,	O	O	O
Wisconsin	O	O	B-T083
,	O	O	O
and	O	O	O
most	O	O	O
of	O	O	O
Michigan	O	O	B-T083
)	O	O	O
,	O	O	O
using	O	O	O
19th	O	O	O
Century	O	O	B-T170
Public	O	O	I-T170
Land	O	O	I-T170
Survey	O	O	I-T170
System	O	O	I-T170
(	O	O	O
PLSS	O	O	B-T170
)	O	O	O
,	O	O	O
with	O	O	O
estimates	O	O	B-T081
of	O	O	O
relative	O	O	B-T080
composition	O	O	O
,	O	O	O
above-ground	O	O	B-T082
biomass	O	O	B-T081
,	O	O	O
stem	O	O	B-T002
density	O	O	B-T081
,	O	O	O
and	O	O	O
basal	O	O	B-T082
area	O	O	I-T082
for	O	O	O
28	O	O	O
tree	O	O	B-T002
types	O	O	B-T080
.	O	O	O

This	O	O	O
mapping	O	O	B-T052
is	O	O	O
more	O	O	O
robust	O	O	B-T080
than	O	O	O
past	O	O	B-T079
efforts	O	O	B-T051
,	O	O	O
using	O	O	O
spatially	O	O	O
varying	O	O	O
correction	O	O	B-T081
factors	O	O	I-T081
to	O	O	O
accommodate	O	O	O
sampling	O	O	B-T170
design	O	O	I-T170
,	O	O	O
azimuthal	O	O	B-T080
censoring	O	O	I-T080
,	O	O	O
and	O	O	O
biases	O	O	B-T078
in	O	O	O
tree	O	O	B-T002
selection	O	O	B-T052
.	O	O	O

We	O	O	O
compare	O	O	O
pre-settlement	O	O	B-T079
to	O	O	O
modern	O	O	B-T079
forests	O	O	B-T070
using	O	O	O
US	O	O	B-T083
Forest	O	O	B-T070
Service	O	O	B-T057
Forest	O	O	B-T170
Inventory	O	O	I-T170
and	O	O	I-T170
Analysis	O	O	I-T170
(	O	O	I-T170
FIA	O	O	I-T170
)	O	O	I-T170
data	O	O	I-T170
to	O	O	O
show	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
lost	O	O	B-T169
forests	O	O	O
(	O	O	O
pre-settlement	O	O	O
forests	O	O	O
with	O	O	O
no	O	O	B-T169
current	O	O	B-T079
analog	O	O	B-T080
)	O	O	O
,	O	O	O
and	O	O	O
novel	O	O	B-T080
forests	O	O	O
(	O	O	O
modern	O	O	O
forests	O	O	O
with	O	O	O
no	O	O	O
past	O	O	B-T079
analogs	O	O	B-T080
)	O	O	O
.	O	O	O

Differences	O	O	O
between	O	O	O
pre-settlement	O	O	B-T079
and	O	O	O
modern	O	O	B-T079
forests	O	O	B-T070
are	O	O	O
spatially	O	O	O
structured	O	O	O
owing	O	O	O
to	O	O	O
differences	O	O	O
in	O	O	O
land-use	O	O	B-UnknownType
impacts	O	O	B-T080
and	O	O	O
accompanying	O	O	O
ecological	O	O	B-T055
responses	O	O	I-T055
.	O	O	O

Modern	O	O	B-T079
forests	O	O	B-T070
are	O	O	O
more	O	O	O
homogeneous	O	O	B-T080
,	O	O	O
and	O	O	O
ecotonal	O	O	B-T081
gradients	O	O	B-T081
are	O	O	O
more	O	O	O
diffuse	O	O	B-T082
today	O	O	O
than	O	O	O
in	O	O	B-T079
the	O	O	I-T079
past	O	O	I-T079
.	O	O	O

Novel	O	O	B-T080
forest	O	O	B-T070
assemblages	O	O	B-T169
represent	O	O	O
28	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
FIA	O	O	B-T170
cells	O	O	O
,	O	O	O
and	O	O	O
28	O	O	O
%	O	O	O
of	O	O	O
pre-settlement	O	O	B-T079
forests	O	O	B-T070
no	O	O	B-T033
longer	O	O	I-T033
exist	O	O	B-T077
in	O	O	O
a	O	O	O
modern	O	O	B-T079
context	O	O	B-T078
.	O	O	O

Lost	O	O	B-T169
forests	O	O	B-T070
include	O	O	O
tamarack	O	O	B-T002
forests	O	O	O
in	O	O	O
northeastern	O	O	B-T082
Minnesota	O	O	B-T083
,	O	O	O
hemlock	O	O	B-T002
and	O	O	O
cedar	O	O	B-T002
dominated	O	O	O
forests	O	O	O
in	O	O	O
north-central	O	O	B-T083
Wisconsin	O	O	B-T083
and	O	O	O
along	O	O	O
the	O	O	O
Upper	O	O	B-T083
Peninsula	O	O	I-T083
of	O	O	I-T083
Michigan	O	O	I-T083
,	O	O	O
and	O	O	O
elm	O	O	B-T002
,	O	O	O
oak	O	O	B-T002
,	O	O	O
basswood	O	O	B-T002
and	O	O	O
ironwood	O	O	B-T002
forests	O	O	O
along	O	O	O
the	O	O	O
forest	O	O	B-T070
-	O	O	O
prairie	O	O	B-T082
boundary	O	O	I-T082
in	O	O	O
south	O	O	B-T083
central	O	O	I-T083
Minnesota	O	O	I-T083
and	O	O	O
eastern	O	O	B-T082
Wisconsin	O	O	O
.	O	O	O

Novel	O	O	B-T080
FIA	O	O	B-T170
forest	O	O	B-T070
assemblages	O	O	B-T169
are	O	O	O
distributed	O	O	O
evenly	O	O	O
across	O	O	O
the	O	O	O
region	O	O	B-T083
,	O	O	O
but	O	O	O
novelty	O	O	B-T080
shows	O	O	O
a	O	O	O
strong	O	O	B-T080
relationship	O	O	B-T080
to	O	O	O
spatial	O	O	B-T081
distance	O	O	I-T081
from	O	O	O
remnant	O	O	B-T080
forests	O	O	B-T070
in	O	O	O
the	O	O	O
upper	O	O	B-T083
Midwest	O	O	I-T083
,	O	O	O
with	O	O	O
novelty	O	O	O
predicted	O	O	B-T078
at	O	O	O
between	O	O	O
20	O	O	O
to	O	O	O
60	O	O	O
km	O	O	O
from	O	O	O
remnants	O	O	B-T080
,	O	O	O
depending	O	O	O
on	O	O	O
historical	O	O	B-T079
forest	O	O	B-T070
type	O	O	I-T070
.	O	O	O

The	O	O	O
spatial	O	O	B-T082
relationships	O	O	B-T080
between	O	O	O
remnant	O	O	B-T080
and	O	O	O
novel	O	O	B-T080
forests	O	O	B-T070
,	O	O	O
shifts	O	O	B-T169
in	O	O	O
ecotone	O	O	B-T082
structure	O	O	I-T082
and	O	O	O
the	O	O	O
loss	O	O	B-T081
of	O	O	O
historic	O	O	B-T079
forest	O	O	B-T070
types	O	O	I-T070
point	O	O	O
to	O	O	O
significant	O	O	B-T078
challenges	O	O	O
for	O	O	O
land	O	O	B-T073
managers	O	O	B-T097
if	O	O	O
landscape	O	O	B-T082
restoration	O	O	O
is	O	O	O
a	O	O	O
priority	O	O	B-T079
.	O	O	O

The	O	O	O
spatial	O	O	O
signals	O	O	O
of	O	O	O
novelty	O	O	B-T080
and	O	O	O
ecological	O	O	B-T070
change	O	O	B-T169
also	O	O	O
point	O	O	O
to	O	O	O
potential	O	O	B-T080
challenges	O	O	O
in	O	O	O
using	O	O	O
modern	O	O	B-T079
spatial	O	O	B-T082
distributions	O	O	I-T082
of	O	O	O
species	O	O	B-T002
and	O	O	O
communities	O	O	B-T070
and	O	O	O
their	O	O	O
relationship	O	O	B-T080
to	O	O	O
underlying	O	O	O
geophysical	O	O	B-T070
and	O	O	O
climatic	O	O	B-T070
attributes	O	O	I-T070
in	O	O	O
understanding	O	O	O
potential	O	O	O
responses	O	O	O
to	O	O	O
changing	O	O	B-T169
climate	O	O	B-T070
.	O	O	O

The	O	O	O
signal	O	O	B-T067
of	O	O	O
human	O	O	B-T016
settlement	O	O	B-T052
on	O	O	O
modern	O	O	B-T079
forests	O	O	B-T070
is	O	O	O
broad	O	O	B-T082
,	O	O	O
spatially	O	O	O
varying	O	O	O
and	O	O	O
acts	O	O	O
to	O	O	O
homogenize	O	O	B-T080
modern	O	O	O
forests	O	O	O
relative	O	O	B-T080
to	O	O	O
their	O	O	O
historic	O	O	B-T079
counterparts	O	O	O
,	O	O	O
with	O	O	O
significant	O	O	B-T078
implications	O	O	O
for	O	O	O
future	O	O	B-T079
management	O	O	B-T057
.	O	O	O

-DOCSTART- (27936362)

Prevalence	O	O	B-T081
of	O	O	O
Self-Reported	O	O	B-T062
Prescription	O	O	B-T121
Drug	O	O	I-T121
Use	O	O	B-T169
in	O	O	O
a	O	O	O
National	O	O	B-T082
Sample	O	O	B-T167
of	O	O	O
U.S.	O	O	O
Drivers	O	O	O

Drug	O	O	B-T121
-involved	O	O	O
driving	O	O	B-T056
has	O	O	O
become	O	O	O
an	O	O	O
increasing	O	O	B-T169
concern	O	O	B-T078
.	O	O	O

Although	O	O	O
the	O	O	O
focus	O	O	O
has	O	O	O
been	O	O	O
on	O	O	O
illegal	O	O	B-T131
drugs	O	O	I-T131
,	O	O	O
there	O	O	O
is	O	O	O
evidence	O	O	B-T078
that	O	O	O
prescribed	O	O	B-T121
medications	O	O	I-T121
can	O	O	O
impair	O	O	B-T033
driving	O	O	I-T033
ability	O	O	I-T033
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
determine	O	O	B-T059
the	O	O	O
self-reported	O	O	B-T062
prevalence	O	O	B-T081
of	O	O	O
prescription	O	O	B-T121
drug	O	O	I-T121
use	O	O	B-T169
,	O	O	O
including	O	O	O
medical	O	O	B-T169
and	O	O	O
nonmedical	O	O	B-T033
use	O	O	O
,	O	O	O
among	O	O	O
a	O	O	O
nationally	O	O	B-T082
representative	O	O	B-T052
sample	O	O	B-T167
of	O	O	O
drivers	O	O	B-T098
and	O	O	O
to	O	O	O
report	O	O	O
related	O	O	O
driver	O	O	B-T098
characteristics	O	O	B-T080
.	O	O	O

As	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
2013	O	O	O
-	O	O	O
2014	O	O	O
National	O	O	B-T062
Roadside	O	O	I-T062
Survey	O	O	I-T062
,	O	O	O
drivers	O	O	B-T098
from	O	O	O
60	O	O	O
sites	O	O	O
were	O	O	O
randomly	O	O	B-T080
recruited	O	O	O
and	O	O	O
asked	O	O	O
to	O	O	O
complete	O	O	B-T080
a	O	O	O
survey	O	O	B-T062
on	O	O	O
prescription	O	O	B-T121
drug	O	O	I-T121
use	O	O	B-T169
.	O	O	O

Almost	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
drivers	O	O	B-T098
reported	O	O	O
using	O	O	O
a	O	O	O
prescription	O	O	B-T121
drug	O	O	I-T121
within	O	O	O
the	O	O	O
past	O	O	B-T079
2	O	O	O
days	O	O	B-T079
,	O	O	O
with	O	O	O
the	O	O	O
most	O	O	O
common	O	O	B-T121
drug	O	O	I-T121
class	O	O	I-T121
being	O	O	O
sedatives	O	O	B-T121
(	O	O	O
8.0	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
antidepressants	O	O	B-T121
(	O	O	O
7.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
narcotics	O	O	B-T121
(	O	O	O
7.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
stimulants	O	O	B-T121
(	O	O	O
3.9	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Drivers	O	O	B-T098
who	O	O	O
reported	O	O	O
prescription	O	O	B-T121
drug	O	O	I-T121
use	O	O	B-T169
were	O	O	O
significantly	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
female	O	O	B-T032
,	O	O	O
older	O	O	B-T098
,	O	O	O
non-Hispanic	O	O	B-T098
White	O	O	I-T098
,	O	O	O
and	O	O	O
report	O	O	O
disability	O	O	B-T033
.	O	O	O

Three	O	O	O
of	O	O	O
four	O	O	O
drivers	O	O	B-T098
who	O	O	O
reported	O	O	O
medication	O	O	B-T121
use	O	O	B-T169
(	O	O	O
78.2	O	O	O
%	O	O	O
)	O	O	O
said	O	O	O
the	O	O	O
drug	O	O	B-T121
was	O	O	O
prescribed	O	O	B-T058
for	O	O	O
their	O	O	O
use	O	O	O
;	O	O	O
the	O	O	O
odds	O	O	O
of	O	O	O
using	O	O	O
without	O	O	O
a	O	O	O
prescription	O	O	B-T170
were	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
for	O	O	O
males	O	O	B-T032
,	O	O	O
Black/African	O	O	B-T098
American	O	O	I-T098
,	O	O	O
and	O	O	O
Hispanic	O	O	B-T098
drivers	O	O	O
,	O	O	O
and	O	O	O
lower	O	O	O
for	O	O	O
older	O	O	B-T098
drivers	O	O	O
.	O	O	O

Among	O	O	O
those	O	O	O
with	O	O	O
a	O	O	O
prescription	O	O	B-T170
,	O	O	O
taking	O	O	O
more	O	O	O
than	O	O	O
prescribed	O	O	B-T058
was	O	O	O
most	O	O	O
common	O	O	O
for	O	O	O
narcotics	O	O	B-T121
(	O	O	O
6.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
sedatives	O	O	B-T121
(	O	O	O
4.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
stimulants	O	O	B-T121
(	O	O	O
3.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
antidepressants	O	O	B-T121
(	O	O	O
1.5	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	B-T169
help	O	O	O
to	O	O	O
identify	O	O	O
drivers	O	O	B-T098
using	O	O	O
potentially	O	O	B-T169
impairing	O	O	I-T169
prescription	O	O	B-T121
drugs	O	O	I-T121
,	O	O	O
both	O	O	O
medically	O	O	B-T169
and	O	O	O
nonmedically	O	O	B-T033
,	O	O	O
and	O	O	O
may	O	O	O
inform	O	O	O
the	O	O	O
targeting	O	O	B-T169
of	O	O	O
interventions	O	O	B-T058
to	O	O	O
reduce	O	O	O
impaired	O	O	B-T033
driving	O	O	I-T033
related	O	O	O
to	O	O	O
medications	O	O	B-T170
.	O	O	O

-DOCSTART- (27938482)

Repetitive	O	O	B-T079
and	O	O	O
Prolonged	O	O	B-T079
Omega-3	O	O	B-T109
Fatty	O	O	I-T109
Acid	O	O	I-T109
Treatment	O	O	B-T061
After	O	O	B-T079
Traumatic	O	O	B-T037
Brain	O	O	I-T037
Injury	O	O	I-T037
Enhances	O	O	B-T052
Long-Term	O	O	B-T079
Tissue	O	O	B-T024
Restoration	O	O	B-T061
and	O	O	O
Cognitive	O	O	O
Recovery	O	O	O

Traumatic	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
(	O	O	O
TBI	O	O	B-T037
)	O	O	O
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
disabling	O	O	B-T033
clinical	O	O	I-T033
conditions	O	O	I-T033
that	O	O	O
could	O	O	O
lead	O	O	B-T169
to	O	O	O
neurocognitive	O	O	B-T048
disorders	O	O	I-T048
in	O	O	O
survivors	O	O	B-T101
.	O	O	O

Our	O	O	O
group	O	O	B-T098
and	O	O	O
others	O	O	B-T098
previously	O	O	O
reported	O	O	B-T170
that	O	O	O
prophylactic	O	O	B-T061
enrichment	O	O	I-T061
of	O	O	O
dietary	O	O	B-T169
omega-3	O	O	B-T109
polyunsaturated	O	O	I-T109
fatty	O	O	I-T109
acids	O	O	I-T109
(	O	O	O
n-3	O	O	B-T109
PUFAs	O	O	I-T109
)	O	O	O
markedly	O	O	O
ameliorate	O	O	B-T169
cognitive	O	O	B-T048
deficits	O	O	I-T048
after	O	O	B-T079
TBI	O	O	B-T037
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
remains	O	O	O
unclear	O	O	B-T033
whether	O	O	O
a	O	O	O
clinically	O	O	B-T080
relevant	O	O	B-T080
therapeutic	O	O	B-T061
regimen	O	O	I-T061
with	O	O	O
n-3	O	O	B-T109
PUFAs	O	O	I-T109
administered	O	O	B-T169
after	O	O	B-T079
TBI	O	O	B-T037
would	O	O	O
still	O	O	O
offer	O	O	O
significant	O	O	O
improvement	O	O	B-T077
of	O	O	O
long-term	O	O	B-T079
cognitive	O	O	B-T061
recovery	O	O	I-T061
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
employed	O	O	O
the	O	O	O
decline	O	O	B-T080
of	O	O	O
spatial	O	O	O
cognitive	O	O	B-T048
function	O	O	I-T048
as	O	O	O
a	O	O	O
main	O	O	B-T080
outcome	O	O	B-T169
after	O	O	B-T079
TBI	O	O	B-T037
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
therapeutic	O	O	B-T080
efficacy	O	O	I-T080
of	O	O	O
post	O	O	B-T079
-	O	O	O
TBI	O	O	O
n-3	O	O	B-T109
PUFA	O	O	I-T109
treatment	O	O	B-T061
and	O	O	O
the	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
.	O	O	O

Mice	O	O	B-T015
were	O	O	O
subjected	O	O	O
to	O	O	O
sham	O	O	B-T061
operation	O	O	I-T061
or	O	O	O
controlled	O	O	B-T169
cortical	O	O	B-T023
impact	O	O	B-T080
,	O	O	O
followed	O	O	O
by	O	O	O
random	O	O	B-UnknownType
assignment	O	O	I-UnknownType
to	O	O	O
receive	O	O	B-T080
the	O	O	O
following	O	O	O
four	O	O	B-T081
treatments	O	O	B-T061
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
vehicle	O	O	B-T122
control	O	O	B-T169
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
daily	O	O	B-T079
intraperitoneal	O	O	B-T061
injections	O	O	I-T061
of	O	O	O
n-3	O	O	B-T109
PUFAs	O	O	I-T109
for	O	O	O
2	O	O	O
weeks	O	O	B-T079
,	O	O	O
beginning	O	O	B-T079
2	O	O	O
h	O	O	B-T079
after	O	O	B-T079
TBI	O	O	B-T037
;	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
fish	O	O	B-T168
oil	O	O	I-T168
dietary	O	O	I-T168
supplementation	O	O	B-T061
throughout	O	O	O
the	O	O	O
study	O	O	B-T062
,	O	O	O
beginning	O	O	O
1	O	O	O
day	O	O	B-T079
after	O	O	O
TBI	O	O	O
;	O	O	O
or	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
combination	O	O	B-T080
of	O	O	O
treatments	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
and	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
.	O	O	O

Spatial	O	O	O
cognitive	O	O	O
deficits	O	O	O
and	O	O	O
chronic	O	O	B-T079
brain	O	O	B-T023
tissue	O	O	I-T023
loss	O	O	B-T081
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
endogenous	O	O	B-T169
brain	O	O	B-T061
repair	O	O	I-T061
processes	O	O	I-T061
such	O	O	O
as	O	O	O
neurogenesis	O	O	B-T040
,	O	O	O
angiogenesis	O	O	B-T042
,	O	O	O
and	O	O	O
oligodendrogenesis	O	O	B-T038
,	O	O	O
were	O	O	O
evaluated	O	O	O
up	O	O	O
to	O	O	O
35	O	O	O
days	O	O	B-T079
after	O	O	B-T079
TBI	O	O	B-T037
.	O	O	O

The	O	O	O
results	O	O	B-T169
revealed	O	O	B-T080
prominent	O	O	O
spatial	O	O	O
cognitive	O	O	B-T048
deficits	O	O	I-T048
and	O	O	O
massive	O	O	B-T080
tissue	O	O	B-T023
loss	O	O	B-T081
caused	O	O	O
by	O	O	O
TBI	O	O	B-T037
.	O	O	O

Among	O	O	O
all	O	O	O
mice	O	O	B-T015
receiving	O	O	B-T080
post-TBI	O	O	B-T037
n-3	O	O	B-T109
PUFA	O	O	I-T109
treatments	O	O	B-T061
,	O	O	O
the	O	O	O
combined	O	O	B-T080
treatment	O	O	B-T061
of	O	O	O
fish	O	O	B-T168
oil	O	O	I-T168
dietary	O	O	I-T168
supplement	O	O	B-T168
and	O	O	O
n-3	O	O	O
PUFA	O	O	O
injections	O	O	B-T122
demonstrated	O	O	B-T052
a	O	O	O
reproducible	O	O	B-UnknownType
beneficial	O	O	I-UnknownType
effect	O	O	I-UnknownType
in	O	O	O
attenuating	O	O	O
cognitive	O	O	B-T048
deficits	O	O	I-T048
although	O	O	O
without	O	O	O
reducing	O	O	B-T080
gross	O	O	B-T080
tissue	O	O	B-T023
loss	O	O	B-T081
.	O	O	O

Mechanistically	O	O	O
,	O	O	O
the	O	O	O
combined	O	O	O
treatment	O	O	B-T061
promoted	O	O	B-T052
post-TBI	O	O	B-T037
restorative	O	O	B-T061
processes	O	O	I-T061
in	O	O	O
the	O	O	O
brain	O	O	B-T023
,	O	O	O
including	O	O	B-T169
generation	O	O	O
of	O	O	O
immature	O	O	B-T025
neurons	O	O	I-T025
,	O	O	O
microvessels	O	O	B-T023
,	O	O	O
and	O	O	O
oligodendrocytes	O	O	B-T025
,	O	O	O
each	O	O	O
of	O	O	O
which	O	O	O
was	O	O	O
significantly	O	O	O
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
improved	O	O	B-T033
cognitive	O	O	B-T169
recovery	O	O	I-T169
.	O	O	O

These	O	O	O
results	O	O	B-T169
indicated	O	O	B-T033
that	O	O	O
repetitive	O	O	B-T079
and	O	O	O
prolonged	O	O	B-T079
n-3	O	O	B-T109
PUFA	O	O	I-T109
treatments	O	O	B-T061
after	O	O	B-T079
TBI	O	O	B-T037
are	O	O	O
capable	O	O	O
of	O	O	O
enhancing	O	O	B-T052
brain	O	O	B-T023
remodeling	O	O	B-UnknownType
and	O	O	O
could	O	O	O
be	O	O	O
developed	O	O	O
as	O	O	O
a	O	O	O
potential	O	O	B-T080
therapy	O	O	B-T061
to	O	O	O
treat	O	O	O
TBI	O	O	O
victims	O	O	B-T098
in	O	O	O
the	O	O	O
clinic	O	O	B-T093
.	O	O	O

-DOCSTART- (27939139)

Influence	O	O	B-T077
of	O	O	O
yeast	O	O	B-T004
and	O	O	O
lactic	O	O	B-T007
acid	O	O	I-T007
bacterium	O	O	I-T007
on	O	O	O
the	O	O	O
constituent	O	O	B-T167
profile	O	O	B-T059
of	O	O	O
soy	O	O	B-T168
sauce	O	O	I-T168
during	O	O	B-T079
fermentation	O	O	O

Soy	O	O	B-T168
sauce	O	O	I-T168
is	O	O	O
a	O	O	O
Japanese	O	O	B-T083
traditional	O	O	B-T169
seasoning	O	O	B-T168
composed	O	O	B-T081
of	O	O	O
various	O	O	B-T081
constituents	O	O	B-T167
that	O	O	O
are	O	O	O
produced	O	O	B-T057
by	O	O	O
various	O	O	O
microbes	O	O	B-T001
during	O	O	B-T079
a	O	O	O
long-term	O	O	B-T079
fermentation	O	O	B-T044
process	O	O	I-T044
.	O	O	O

Due	O	O	B-T169
to	O	O	I-T169
the	O	O	O
complexity	O	O	B-T169
of	O	O	O
the	O	O	O
process	O	O	B-T067
,	O	O	O
the	O	O	O
investigation	O	O	B-T062
of	O	O	O
the	O	O	O
constituent	O	O	B-T167
profile	O	O	B-T059
during	O	O	B-T079
fermentation	O	O	B-T044
is	O	O	O
difficult	O	O	B-T033
.	O	O	O

Metabolomics	O	O	B-T091
,	O	O	O
the	O	O	O
comprehensive	O	O	B-T080
study	O	O	B-T062
of	O	O	O
low	O	O	B-T080
molecular	O	O	B-T081
weight	O	O	I-T081
compounds	O	O	B-T080
in	O	O	O
biological	O	O	B-T080
samples	O	O	B-T167
,	O	O	O
is	O	O	O
thought	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
promising	O	O	O
strategy	O	O	O
for	O	O	O
deep	O	O	O
understanding	O	O	B-T041
of	O	O	O
the	O	O	O
constituent	O	O	B-T167
contribution	O	O	B-T052
to	O	O	O
food	O	O	B-T080
flavor	O	O	I-T080
characteristics	O	O	B-T080
.	O	O	O

Therefore	O	O	O
,	O	O	O
metabolomics	O	O	B-T091
is	O	O	O
suitable	O	O	B-T080
for	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
soy	O	O	B-T168
sauce	O	O	I-T168
fermentation	O	O	B-T044
.	O	O	O

Unfortunately	O	O	O
,	O	O	O
only	O	O	O
few	O	O	O
and	O	O	O
unrefined	O	O	O
studies	O	O	B-T062
of	O	O	O
soy	O	O	B-T168
sauce	O	O	I-T168
fermentation	O	O	B-T044
using	O	O	B-T169
metabolomics	O	O	B-T091
approach	O	O	B-T082
have	O	O	O
been	O	O	O
reported	O	O	B-T170
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
changes	O	O	B-T169
in	O	O	O
low	O	O	B-T080
molecular	O	O	B-T081
weight	O	O	I-T081
hydrophilic	O	O	B-T081
and	O	O	O
volatile	O	O	B-T120
compounds	O	O	I-T120
of	O	O	O
soy	O	O	B-T168
sauce	O	O	I-T168
using	O	O	O
gas	O	O	B-T059
chromatography/mass	O	O	I-T059
spectrometry	O	O	I-T059
(GC/MS)-	O	O	O
based	O	O	B-T169
non-targeted	O	O	B-T169
metabolic	O	O	B-T091
profiling	O	O	I-T091
.	O	O	O

The	O	O	O
data	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
by	O	O	O
statistical	O	O	B-T062
analysis	O	O	I-T062
to	O	O	O
evaluate	O	O	O
influences	O	O	B-T077
of	O	O	O
yeast	O	O	B-T004
and	O	O	O
lactic	O	O	B-T007
acid	O	O	I-T007
bacterium	O	O	I-T007
on	O	O	O
the	O	O	O
constituent	O	O	B-T167
profile	O	O	B-T059
.	O	O	O

Consequently	O	O	O
,	O	O	O
our	O	O	O
results	O	O	B-T169
suggested	O	O	B-T078
a	O	O	O
novel	O	O	B-T080
finding	O	O	B-T033
that	O	O	O
lactic	O	O	B-T007
acid	O	O	I-T007
bacterium	O	O	I-T007
affected	O	O	B-T169
the	O	O	O
production	O	O	B-T057
of	O	O	O
several	O	O	B-T081
constituents	O	O	B-T167
such	O	O	O
as	O	O	O
cyclotene	O	O	B-T109
,	O	O	O
furfural	O	O	B-T109
,	O	O	O
furfuryl	O	O	B-T109
alcohol	O	O	I-T109
and	O	O	O
methional	O	O	B-T109
in	O	O	O
the	O	O	O
soy	O	O	B-T168
sauce	O	O	I-T168
fermentation	O	O	B-T044
process	O	O	I-T044
.	O	O	O

-DOCSTART- (27941491)

Low	O	O	B-T080
intensity	O	O	B-T080
sprint	O	O	B-T061
training	O	O	I-T061
with	O	O	O
blood	O	O	B-T065
flow	O	O	I-T065
restriction	O	O	I-T065
improves	O	O	O
100	O	O	O
m	O	O	O
dash	O	O	O

We	O	O	O
investigated	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
practical	O	O	B-T065
blood	O	O	I-T065
flow	O	O	I-T065
restriction	O	O	I-T065
(	O	O	O
pBFR	O	O	B-T065
)	O	O	O
of	O	O	O
leg	O	O	B-T023
muscles	O	O	I-T023
during	O	O	O
sprint	O	O	B-T061
training	O	O	I-T061
on	O	O	O
the	O	O	O
100	O	O	O
m	O	O	O
dash	O	O	O
time	O	O	B-T079
in	O	O	O
well-trained	O	O	B-T098
sport	O	O	I-T098
students	O	O	I-T098
.	O	O	O

Participants	O	O	B-T098
performed	O	O	O
6x100	O	O	O
m	O	O	O
sprints	O	O	B-T056
at	O	O	O
60	O	O	O
-	O	O	O
70	O	O	O
%	O	O	O
of	O	O	O
their	O	O	O
maximal	O	O	O
100	O	O	O
m	O	O	O
sprinting	O	O	B-T081
speed	O	O	I-T081
twice	O	O	B-T079
a	O	O	I-T079
week	O	O	I-T079
for	O	O	O
6	O	O	O
weeks	O	O	B-T079
,	O	O	O
either	O	O	O
with	O	O	O
(	O	O	O
IG	O	O	B-T098
;	O	O	O
n=12	O	O	O
)	O	O	O
or	O	O	O
without	O	O	O
pBFR	O	O	B-T065
(	O	O	O
CG	O	O	B-T096
;	O	O	O
n=12	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
100	O	O	O
m	O	O	O
dash	O	O	O
time	O	O	B-T079
significantly	O	O	O
decreased	O	O	B-T081
more	O	O	O
in	O	O	O
the	O	O	O
IG	O	O	B-T098
(	O	O	O
-0.38±0.24	O	O	O
s	O	O	O
)	O	O	O
than	O	O	O
in	O	O	O
the	O	O	O
CG	O	O	B-T096
(	O	O	O
-0.16±0.17	O	O	O
s	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
muscle	O	O	B-T024
thickness	O	O	B-T080
of	O	O	O
the	O	O	O
rectus	O	O	B-T023
femoris	O	O	I-T023
increased	O	O	B-T081
only	O	O	O
in	O	O	O
the	O	O	O
IG	O	O	B-T098
,	O	O	O
while	O	O	O
no	O	O	O
group	O	O	B-T078
by	O	O	O
time	O	O	B-T079
interactions	O	O	B-T169
were	O	O	O
found	O	O	O
for	O	O	O
the	O	O	O
muscle	O	O	O
thickness	O	O	O
of	O	O	O
the	O	O	O
biceps	O	O	B-T023
femoris	O	O	I-T023
and	O	O	O
the	O	O	O
biceps	O	O	B-T023
brachii	O	O	I-T023
.	O	O	O

The	O	O	O
maximal	O	O	B-T081
isometric	O	O	I-T081
force	O	O	I-T081
,	O	O	O
measured	O	O	O
using	O	O	O
a	O	O	O
leg	O	O	B-T056
press	O	O	I-T056
,	O	O	O
did	O	O	O
not	O	O	B-T033
change	O	O	I-T033
in	O	O	O
either	O	O	O
group	O	O	B-T078
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	I-T081
force	O	O	I-T081
development	O	O	I-T081
improved	O	O	O
in	O	O	O
the	O	O	O
IG	O	O	B-T098
.	O	O	O

Growth	O	O	B-T116
hormone	O	O	I-T116
,	O	O	O
testosterone	O	O	B-T125
,	O	O	O
insulin-like	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
1	O	O	I-T116
,	O	O	O
and	O	O	O
cortisol	O	O	B-T125
concentrations	O	O	B-T081
did	O	O	O
not	O	O	B-T033
significantly	O	O	I-T033
differ	O	O	I-T033
between	O	O	O
both	O	O	O
groups	O	O	B-T078
at	O	O	O
any	O	O	O
measurement	O	O	B-T169
time	O	O	B-T079
point	O	O	I-T079
(	O	O	O
pre	O	O	O
,	O	O	O
1	O	O	O
min	O	O	O
,	O	O	O
20	O	O	O
min	O	O	O
,	O	O	O
120	O	O	O
min	O	O	O
,	O	O	O
and	O	O	O
24	O	O	O
h	O	O	O
after	O	O	O
the	O	O	O
six	O	O	O
all-out	O	O	O
sprints	O	O	B-T056
of	O	O	O
the	O	O	O
first	O	O	O
training	O	O	B-T065
session	O	O	B-T051
)	O	O	O
.	O	O	O

The	O	O	O
muscle	O	O	B-T020
damage	O	O	I-T020
marker	O	O	B-T201
h-FABP	O	O	B-T116
increased	O	O	B-T081
significantly	O	O	O
more	O	O	O
in	O	O	O
the	O	O	O
CG	O	O	B-T096
than	O	O	O
in	O	O	O
the	O	O	O
IG	O	O	B-T098
.	O	O	O

The	O	O	O
pBFR	O	O	B-T065
improved	O	O	O
the	O	O	O
100	O	O	O
m	O	O	O
dash	O	O	O
time	O	O	B-T079
significantly	O	O	O
more	O	O	O
than	O	O	O
low	O	O	B-T080
-	O	O	O
intensity	O	O	B-T080
sprint	O	O	B-T061
interval	O	O	I-T061
training	O	O	I-T061
alone	O	O	O
.	O	O	O

Other	O	O	O
noted	O	O	O
benefits	O	O	B-T081
of	O	O	O
training	O	O	B-T065
with	O	O	O
pBFR	O	O	B-T065
were	O	O	O
a	O	O	O
decreased	O	O	B-T081
level	O	O	B-T080
of	O	O	O
muscle	O	O	B-T020
damage	O	O	I-T020
,	O	O	O
a	O	O	O
greater	O	O	O
increase	O	O	B-T169
of	O	O	O
the	O	O	O
rectus	O	O	B-T023
femoris	O	O	I-T023
muscle	O	O	I-T023
thickness	O	O	B-T080
,	O	O	O
and	O	O	O
a	O	O	O
higher	O	O	B-T080
rate	O	O	B-T081
of	O	O	I-T081
force	O	O	I-T081
development	O	O	I-T081
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
tested	O	O	B-T169
hormones	O	O	B-T125
were	O	O	O
unable	O	O	O
to	O	O	O
explain	O	O	O
the	O	O	O
additional	O	O	O
beneficial	O	O	B-T080
effects	O	O	I-T080
.	O	O	O

-DOCSTART- (27941576)

Sedation	O	O	B-T061
of	O	O	O
Patients	O	O	B-T101
With	O	O	O
Disorders	O	O	B-T048
of	O	O	I-T048
Consciousness	O	O	I-T048
During	O	O	O
Neuroimaging	O	O	B-T060
:	O	O	O
Effects	O	O	O
on	O	O	O
Resting	O	O	O
State	O	O	O
Functional	O	O	O
Brain	O	O	O
Connectivity	O	O	O

To	O	O	O
reduce	O	O	O
head	O	O	B-T040
movement	O	O	I-T040
during	O	O	O
resting	O	O	B-T060
state	O	O	I-T060
functional	O	O	I-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
,	O	O	O
post-coma	O	O	B-UnknownType
patients	O	O	B-T101
with	O	O	O
disorders	O	O	B-T048
of	O	O	I-T048
consciousness	O	O	I-T048
(	O	O	O
DOC	O	O	B-T048
)	O	O	O
are	O	O	O
frequently	O	O	O
sedated	O	O	B-T061
with	O	O	O
propofol	O	O	B-T109
.	O	O	O

However	O	O	O
,	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
this	O	O	O
sedation	O	O	B-T061
on	O	O	O
the	O	O	O
brain	O	O	B-T082
connectivity	O	O	I-T082
patterns	O	O	I-T082
in	O	O	O
the	O	O	O
damaged	O	O	B-T037
brain	O	O	I-T037
essential	O	O	O
for	O	O	O
differential	O	O	B-T060
diagnosis	O	O	I-T060
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
assess	O	O	B-T058
these	O	O	O
effects	O	O	O
.	O	O	O

Using	O	O	O
resting	O	O	B-T060
state	O	O	I-T060
functional	O	O	I-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
3	O	O	O
T	O	O	O
data	O	O	O
obtained	O	O	O
over	O	O	O
several	O	O	O
years	O	O	O
of	O	O	O
scanning	O	O	B-T060
patients	O	O	B-T101
for	O	O	O
diagnostic	O	O	B-T169
and	O	O	O
research	O	O	B-T062
purposes	O	O	B-T169
,	O	O	O
we	O	O	O
employed	O	O	O
a	O	O	O
seed-based	O	O	O
approach	O	O	O
to	O	O	O
examine	O	O	O
resting	O	O	B-T169
state	O	O	I-T169
connectivity	O	O	B-T169
in	O	O	O
higher-order	O	O	O
(	O	O	O
default	O	O	O
mode	O	O	O
,	O	O	O
bilateral	O	O	B-T082
external	O	O	B-UnknownType
control	O	O	I-UnknownType
,	O	O	O
and	O	O	O
salience	O	O	O
)	O	O	O
and	O	O	O
lower-order	O	O	O
(	O	O	O
auditory	O	O	B-T169
,	O	O	O
sensorimotor	O	O	B-T040
,	O	O	O
and	O	O	O
visual	O	O	B-T169
)	O	O	O
resting	O	O	B-T169
state	O	O	I-T169
networks	O	O	I-T169
and	O	O	O
connectivity	O	O	O
with	O	O	O
the	O	O	O
thalamus	O	O	B-T023
,	O	O	O
in	O	O	O
20	O	O	O
healthy	O	O	B-T080
unsedated	O	O	B-T033
controls	O	O	B-T096
,	O	O	O
8	O	O	O
unsedated	O	O	O
patients	O	O	O
with	O	O	O
DOC	O	O	B-T048
,	O	O	O
and	O	O	O
8	O	O	O
patients	O	O	O
with	O	O	O
DOC	O	O	O
sedated	O	O	B-T061
with	O	O	O
propofol	O	O	B-T109
.	O	O	O

The	O	O	O
DOC	O	O	B-T048
groups	O	O	O
were	O	O	O
matched	O	O	O
for	O	O	O
age	O	O	B-T081
at	O	O	I-T081
onset	O	O	I-T081
,	O	O	O
etiology	O	O	B-T169
,	O	O	O
time	O	O	B-T033
spent	O	O	I-T033
in	O	O	O
DOC	O	O	O
,	O	O	O
diagnosis	O	O	B-T033
,	O	O	O
standardized	O	O	B-T081
behavioral	O	O	I-T081
assessment	O	O	I-T081
scores	O	O	I-T081
,	O	O	O
movement	O	O	B-T040
intensities	O	O	B-T080
,	O	O	O
and	O	O	O
pattern	O	O	O
of	O	O	O
structural	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
(	O	O	O
as	O	O	O
assessed	O	O	O
with	O	O	O
T1-based	O	O	B-T059
voxel-based	O	O	I-T059
morphometry	O	O	I-T059
)	O	O	O
.	O	O	O

DOC	O	O	B-T048
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
severely	O	O	O
impaired	O	O	O
resting	O	O	B-T169
state	O	O	I-T169
network	O	O	B-T169
connectivity	O	O	I-T169
in	O	O	O
all	O	O	O
but	O	O	O
the	O	O	O
visual	O	O	B-T169
network	O	O	O
.	O	O	O

Thalamic	O	O	B-T023
connectivity	O	O	B-T169
to	O	O	O
higher-order	O	O	O
network	O	O	O
regions	O	O	O
was	O	O	O
also	O	O	O
reduced	O	O	B-T080
.	O	O	O

Propofol	O	O	B-T109
administration	O	O	B-T061
to	O	O	O
patients	O	O	B-T101
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
minor	O	O	O
further	O	O	O
decreases	O	O	B-T081
in	O	O	O
thalamic	O	O	B-T023
and	O	O	O
insular	O	O	B-T023
connectivity	O	O	B-T169
.	O	O	O

Our	O	O	O
findings	O	O	B-T169
indicate	O	O	O
that	O	O	O
connectivity	O	O	B-T169
decreases	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
propofol	O	O	B-T109
sedation	O	O	B-T061
,	O	O	O
involving	O	O	O
the	O	O	O
thalamus	O	O	B-T023
and	O	O	O
insula	O	O	B-T023
,	O	O	O
are	O	O	O
relatively	O	O	O
small	O	O	O
compared	O	O	O
with	O	O	O
those	O	O	O
already	O	O	O
caused	O	O	O
by	O	O	O
DOC	O	O	B-T048
-associated	O	O	O
structural	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
.	O	O	O

Nonetheless	O	O	O
,	O	O	O
given	O	O	O
the	O	O	O
known	O	O	O
importance	O	O	O
of	O	O	O
the	O	O	O
thalamus	O	O	B-T023
in	O	O	O
brain	O	O	B-T041
arousal	O	O	I-T041
,	O	O	O
its	O	O	O
disruption	O	O	B-T169
could	O	O	O
well	O	O	O
reflect	O	O	O
the	O	O	O
diminished	O	O	B-T081
movement	O	O	B-T040
obtained	O	O	O
in	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

However	O	O	O
,	O	O	O
more	O	O	O
research	O	O	B-T062
is	O	O	O
needed	O	O	O
on	O	O	O
this	O	O	O
topic	O	O	O
to	O	O	O
fully	O	O	O
address	O	O	O
the	O	O	O
research	O	O	B-T078
question	O	O	I-T078
.	O	O	O

-DOCSTART- (27942049)

Potassium	O	O	B-T047
depletion	O	O	I-T047
stimulates	O	O	B-T070
Na-Cl	O	O	B-T116
cotransporter	O	O	I-T116
via	O	O	O
phosphorylation	O	O	B-T044
and	O	O	O
inactivation	O	O	B-T169
of	O	O	O
the	O	O	O
ubiquitin	O	O	B-T116
ligase	O	O	I-T116
Kelch-like	O	O	O
3	O	O	O

Kelch-like	O	O	B-T116
3	O	O	I-T116
(	O	O	O
KLHL3	O	O	B-T116
)	O	O	O
is	O	O	O
a	O	O	O
component	O	O	B-T116
of	O	O	O
an	O	O	O
E3	O	O	B-T116
ubiquitin	O	O	I-T116
ligase	O	O	I-T116
complex	O	O	I-T116
that	O	O	O
regulates	O	O	B-T038
blood	O	O	B-T040
pressure	O	O	I-T040
by	O	O	O
targeting	O	O	B-T169
With-No-Lysine	O	O	B-T116
(	O	O	I-T116
WNK	O	O	I-T116
)	O	O	I-T116
kinases	O	O	I-T116
for	O	O	O
degradation	O	O	B-T169
.	O	O	O

Mutations	O	O	B-T045
in	O	O	O
KLHL3	O	O	B-T116
cause	O	O	O
constitutively	O	O	O
increased	O	O	B-T033
renal	O	O	I-T033
salt	O	O	I-T033
reabsorption	O	O	I-T033
and	O	O	O
impaired	O	O	B-T169
K(+	O	O	B-T123
)	O	O	I-T123
secretion	O	O	B-T038
,	O	O	O
resulting	O	O	O
in	O	O	O
hypertension	O	O	B-T047
and	O	O	O
hyperkalemia	O	O	B-T033
.	O	O	O

Although	O	O	O
clinical	O	O	B-T062
studies	O	O	I-T062
have	O	O	O
shown	O	O	O
that	O	O	O
dietary	O	O	B-T168
K(+	O	O	I-T168
)	O	O	I-T168
intake	O	O	B-T169
affects	O	O	B-T169
blood	O	O	B-T040
pressure	O	O	I-T040
,	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
have	O	O	O
been	O	O	O
obscure	O	O	B-T033
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
the	O	O	O
KLHL3	O	O	B-T116
ubiquitin	O	O	B-T116
ligase	O	O	I-T116
complex	O	O	B-T116
is	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
low-	O	O	O
K(+	O	O	B-T123
)	O	O	I-T123
-mediated	O	O	O
activation	O	O	B-T045
of	O	O	O
Na-Cl	O	O	B-T116
cotransporter	O	O	I-T116
(	O	O	O
NCC	O	O	B-T116
)	O	O	O
in	O	O	O
the	O	O	O
kidney	O	O	B-T023
.	O	O	O

In	O	O	O
the	O	O	O
distal	O	O	B-T023
convoluted	O	O	I-T023
tubules	O	O	I-T023
of	O	O	O
mice	O	O	B-T015
eating	O	O	B-T040
a	O	O	O
low-K(+	O	O	B-T061
)	O	O	I-T061
diet	O	O	I-T061
,	O	O	O
we	O	O	O
found	O	O	O
increased	O	O	O
KLHL3	O	O	B-T116
phosphorylation	O	O	B-T044
at	O	O	O
S433	O	O	B-T082
(	O	O	B-T116
KLHL3(S433-P	O	O	I-T116
)	O	O	I-T116
)	O	O	I-T116
,	O	O	O
a	O	O	O
modification	O	O	B-T033
that	O	O	O
impairs	O	O	B-T169
WNK	O	O	B-T116
binding	O	O	B-T052
,	O	O	O
and	O	O	O
also	O	O	O
reduced	O	O	O
total	O	O	O
KLHL3	O	O	O
levels	O	O	B-T080
.	O	O	O

These	O	O	O
changes	O	O	O
are	O	O	O
accompanied	O	O	O
by	O	O	O
the	O	O	O
accumulation	O	O	B-T033
of	O	O	O
the	O	O	O
target	O	O	B-T169
substrate	O	O	B-T167
WNK4	O	O	B-T116
,	O	O	O
and	O	O	O
activation	O	O	B-T045
of	O	O	O
the	O	O	O
downstream	O	O	B-T082
kinases	O	O	B-T116
SPAK	O	O	I-T116
(	O	O	O
STE20	O	O	B-T116
/	O	O	O
SPS1	O	O	B-T116
-related	O	O	O
proline-alanine-rich	O	O	B-T116
protein	O	O	I-T116
kinase	O	O	I-T116
)	O	O	O
and	O	O	O
OSR1	O	O	B-T116
(	O	O	O
oxidative	O	O	B-T116
stress-responsive	O	O	I-T116
1	O	O	I-T116
)	O	O	O
,	O	O	O
resulting	O	O	O
in	O	O	O
NCC	O	O	B-T116
phosphorylation	O	O	B-T044
and	O	O	O
its	O	O	O
accumulation	O	O	O
at	O	O	O
the	O	O	O
plasma	O	O	B-T026
membrane	O	O	I-T026
.	O	O	O

Increased	O	O	O
phosphorylation	O	O	B-T044
of	O	O	O
S433	O	O	B-T082
was	O	O	O
explained	O	O	O
by	O	O	O
increased	O	O	O
levels	O	O	B-T080
of	O	O	O
active	O	O	B-T169
,	O	O	O
phosphorylated	O	O	O
protein	O	O	B-T116
kinase	O	O	I-T116
C	O	O	I-T116
(	O	O	O
but	O	O	O
not	O	O	O
protein	O	O	B-T116
kinase	O	O	I-T116
A	O	O	I-T116
)	O	O	O
,	O	O	O
which	O	O	O
directly	O	O	O
phosphorylates	O	O	B-T044
S433	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
in	O	O	O
HEK	O	O	B-T025
cells	O	O	I-T025
expressing	O	O	B-T045
KLHL3	O	O	B-T116
and	O	O	O
WNK4	O	O	B-T116
,	O	O	O
we	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
activation	O	O	B-T045
of	O	O	O
protein	O	O	B-T116
kinase	O	O	I-T116
C	O	O	I-T116
by	O	O	O
phorbol	O	O	B-T109
12-myristate	O	O	I-T109
13-acetate	O	O	I-T109
induces	O	O	B-T169
KLHL3(S433-P	O	O	B-T116
)	O	O	I-T116
and	O	O	O
increases	O	O	O
WNK4	O	O	O
levels	O	O	B-T080
by	O	O	O
abrogating	O	O	O
its	O	O	O
ubiquitination	O	O	B-T044
.	O	O	O

These	O	O	O
data	O	O	B-T078
demonstrate	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
KLHL3	O	O	B-T116
in	O	O	O
low-	O	O	O
K(+	O	O	B-T123
)	O	O	I-T123
-mediated	O	O	O
induction	O	O	B-T169
of	O	O	O
NCC	O	O	B-T116
;	O	O	O
this	O	O	O
physiologic	O	O	B-T040
adaptation	O	O	I-T040
reduces	O	O	O
distal	O	O	B-T082
electrogenic	O	O	B-T042
Na(+	O	O	B-T039
)	O	O	I-T039
reabsorption	O	O	I-T039
,	O	O	O
preventing	O	O	B-T169
further	O	O	O
renal	O	O	B-T023
K(+	O	O	O
)	O	O	O
loss	O	O	B-T081
but	O	O	O
promoting	O	O	B-T052
increased	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
.	O	O	O

-DOCSTART- (27942150)

The	O	O	O
relationship	O	O	B-T080
between	O	O	O
thoracic	O	O	B-T029
configuration	O	O	B-T029
and	O	O	O
changes	O	O	B-T169
in	O	O	O
volumes	O	O	B-T081
of	O	O	O
hemithoraces	O	O	B-T029
in	O	O	O
upright	O	O	O
sitting	O	O	O

[	O	O	O
Purpose	O	O	O
]	O	O	O
Some	O	O	O
patients	O	O	B-T101
with	O	O	O
respiratory	O	O	B-T047
disease	O	O	I-T047
exhibit	O	O	O
asymmetrical	O	O	B-T033
movement	O	O	I-T033
of	O	O	I-T033
the	O	O	I-T033
thorax	O	O	I-T033
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
relationship	O	O	B-T080
of	O	O	O
thoracic	O	O	B-T029
configuration	O	O	B-T029
with	O	O	O
changes	O	O	B-T169
in	O	O	O
thoracic	O	O	B-T201
volume	O	O	I-T201
in	O	O	O
13	O	O	O
sedentary	O	O	B-T080
healthy	O	O	B-T080
men	O	O	B-T098
.	O	O	O

[	O	O	O
Subjects	O	O	O
and	O	O	O
Methods	O	O	O
]	O	O	O
In	O	O	O
upright	O	O	B-T033
sitting	O	O	I-T033
,	O	O	O
84	O	O	O
reflective	O	O	B-T080
markers	O	O	I-T080
were	O	O	O
placed	O	O	O
on	O	O	O
the	O	O	O
anterior	O	O	B-T082
and	O	O	O
posterior	O	O	B-T082
aspects	O	O	B-T080
of	O	O	O
the	O	O	O
trunk	O	O	B-T029
to	O	O	O
record	O	O	O
thoracic	O	O	B-T201
volume	O	O	I-T201
during	O	O	O
quiet	O	O	B-T080
and	O	O	O
volitional	O	O	B-T041
deep	O	O	B-T033
breathing	O	O	I-T033
.	O	O	O

Using	O	O	O
a	O	O	O
three-dimensional	O	O	B-T074
motion	O	O	I-T074
analyzer	O	O	I-T074
,	O	O	O
the	O	O	O
difference	O	O	B-T081
in	O	O	O
volume	O	O	B-T081
within	O	O	O
the	O	O	O
upper	O	O	B-T082
and	O	O	O
lower	O	O	B-T082
hemithoraces	O	O	B-T029
was	O	O	O
measured	O	O	B-T080
.	O	O	O

For	O	O	O
calculation	O	O	B-T052
of	O	O	O
the	O	O	O
thoracic	O	O	B-T201
volume	O	O	I-T201
six	O	O	O
imaginary	O	O	B-T082
hexahedra	O	O	I-T082
were	O	O	O
visualized	O	O	O
for	O	O	O
the	O	O	O
upper	O	O	B-T082
and	O	O	O
lower	O	O	B-T082
thorax	O	O	B-T029
using	O	O	O
four	O	O	O
reflective	O	O	B-T080
markers	O	O	I-T080
for	O	O	O
each	O	O	O
on	O	O	O
the	O	O	O
anterior	O	O	B-T082
and	O	O	O
posterior	O	O	B-T082
aspects	O	O	B-T080
of	O	O	O
the	O	O	O
thorax	O	O	O
.	O	O	O

Each	O	O	O
hexahedron	O	O	B-T082
was	O	O	O
then	O	O	O
divided	O	O	O
into	O	O	O
three	O	O	O
imaginary	O	O	B-T082
triangular	O	O	I-T082
pyramids	O	O	I-T082
to	O	O	O
calculate	O	O	B-T052
positional	O	O	B-T033
vectors	O	O	B-T082
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
volume	O	O	B-T081
for	O	O	O
both	O	O	O
the	O	O	O
hexahedra	O	O	B-T082
and	O	O	O
triangular	O	O	B-T082
pyramids	O	O	I-T082
was	O	O	O
calculated	O	O	B-T052
.	O	O	O

Four	O	O	O
thoracic	O	O	B-T201
volumes	O	O	I-T201
were	O	O	O
obtained	O	O	O
.	O	O	O

[	O	O	O
Results	O	O	O
]	O	O	O

The	O	O	O
findings	O	O	B-T169
showed	O	O	O
that	O	O	O
the	O	O	O
left	O	O	B-T082
upper	O	O	B-T082
and	O	O	O
right	O	O	B-T082
lower	O	O	B-T082
hemithorax	O	O	B-T029
yielded	O	O	O
significantly	O	O	O
larger	O	O	B-T081
thoracic	O	O	B-T201
volumes	O	O	I-T201
.	O	O	O

[	O	O	O
Conclusion	O	O	O
]	O	O	O
In	O	O	O
conclusion	O	O	B-T078
the	O	O	O
left	O	O	B-T082
upper	O	O	B-T082
and	O	O	O
right	O	O	B-T082
lower	O	O	B-T082
hemithoraces	O	O	B-T029
were	O	O	O
found	O	O	O
to	O	O	O
expand	O	O	B-T082
more	O	O	O
than	O	O	O
their	O	O	O
corresponding	O	O	O
sides	O	O	B-T082
.	O	O	O

Understanding	O	O	O
the	O	O	O
characteristics	O	O	B-T080
of	O	O	O
thoracic	O	O	B-T029
excursion	O	O	B-T184
during	O	O	O
quiet	O	O	B-T080
and	O	O	O
volitional	O	O	B-T041
deep	O	O	B-T033
breathing	O	O	I-T033
could	O	O	O
be	O	O	O
of	O	O	O
value	O	O	B-T080
in	O	O	O
assessment	O	O	B-T058
and	O	O	O
instruction	O	O	B-T170
of	O	O	O
breathing	O	O	B-T065
techniques	O	O	I-T065
to	O	O	O
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27951480)

Development	O	O	B-T169
of	O	O	O
the	O	O	O
four-item	O	O	B-UnknownType
Letter	O	O	I-UnknownType
and	O	O	I-UnknownType
Shape	O	O	I-UnknownType
Drawing	O	O	I-UnknownType
test	O	O	I-UnknownType
(	O	O	O
LSD-4	O	O	B-UnknownType
):	O	O	O
A	O	O	O
brief	O	O	O
bedside	O	O	B-T060
test	O	O	I-T060
of	O	O	O
visuospatial	O	O	O
function	O	O	O

Conventional	O	O	B-T080
bedside	O	O	B-T060
tests	O	O	I-T060
of	O	O	O
visuospatial	O	O	B-T041
function	O	O	I-T041
such	O	O	O
as	O	O	O
the	O	O	O
Clock	O	O	B-UnknownType
Drawing	O	O	I-UnknownType
(	O	O	O
CDT	O	O	B-UnknownType
)	O	O	O
and	O	O	O
Intersecting	O	O	B-UnknownType
Pentagons	O	O	I-UnknownType
(	O	O	O
IPT	O	O	B-UnknownType
)	O	O	O
lack	O	O	B-T080
consistency	O	O	B-T080
in	O	O	O
delivery	O	O	O
and	O	O	O
interpretation	O	O	B-T033
.	O	O	O

We	O	O	O
compared	O	O	B-T052
performance	O	O	B-T052
on	O	O	O
a	O	O	O
novel	O	O	O
test	O	O	O
of	O	O	O
visuospatial	O	O	B-T041
ability	O	O	I-T041
-	O	O	O
the	O	O	O
LSD	O	O	B-UnknownType
-	O	O	O
with	O	O	O
the	O	O	O
IPT	O	O	B-UnknownType
,	O	O	O
CDT	O	O	B-UnknownType
and	O	O	O
MMSE	O	O	B-T060
in	O	O	O
180	O	O	O
acute	O	O	B-T079
elderly	O	O	B-T098
medical	O	O	B-T169
inpatients	O	O	B-T101
[	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
79.7±7.1	O	O	O
(	O	O	O
range	O	O	B-T081
62	O	O	O
-	O	O	O
96	O	O	O
)	O	O	O
;	O	O	O
91	O	O	O
females	O	O	B-T032
(	O	O	O
50.6	O	O	O
%	O	O	O
)	O	O	O
]	O	O	O
.	O	O	O

124	O	O	O
(	O	O	O
69	O	O	O
%	O	O	O
)	O	O	O
scored	O	O	B-T081
≤23	O	O	O
on	O	O	O
the	O	O	O
MMSE	O	O	B-T060
;	O	O	O
60	O	O	O
with	O	O	O
mild	O	O	B-T080
(	O	O	O
score	O	O	B-T081
18	O	O	O
-	O	O	O
23	O	O	O
)	O	O	O
and	O	O	O
64	O	O	O
with	O	O	O
severe	O	O	B-T080
(	O	O	O
score	O	O	O
≤17	O	O	O
)	O	O	O
impairment	O	O	B-T169
.	O	O	O

78	O	O	O
(	O	O	O
43	O	O	O
%	O	O	O
)	O	O	O
scored	O	O	B-T081
≥6	O	O	O
on	O	O	O
the	O	O	O
CDT	O	O	B-UnknownType
,	O	O	O
while	O	O	O
for	O	O	O
the	O	O	O
IPT	O	O	B-UnknownType
,	O	O	O
87	O	O	O
(	O	O	O
47	O	O	O
%	O	O	O
)	O	O	O
scored	O	O	O
≥4	O	O	O
.	O	O	O

The	O	O	O
CDT	O	O	B-UnknownType
and	O	O	O
IPT	O	O	B-UnknownType
agreed	O	O	B-T033
on	O	O	O
the	O	O	O
classification	O	O	B-T185
of	O	O	O
138	O	O	O
patients	O	O	B-T101
(	O	O	O
77	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
modest-	O	O	O
strong	O	O	B-T080
agreement	O	O	O
with	O	O	O
the	O	O	O
MMSE	O	O	B-T060
categories	O	O	B-T170
.	O	O	O

Correlation	O	O	B-T080
between	O	O	O
the	O	O	O
LSD	O	O	B-UnknownType
and	O	O	O
visuospatial	O	O	B-UnknownType
tests	O	O	I-UnknownType
was	O	O	O
high	O	O	B-T080
.	O	O	O

A	O	O	O
four-item	O	O	B-T170
version	O	O	I-T170
of	O	O	O
the	O	O	O
LSD	O	O	B-UnknownType
incorporating	O	O	O
items	O	O	B-T071
1,10,12,15	O	O	O
had	O	O	O
high	O	O	B-T080
correlation	O	O	B-T080
with	O	O	O
the	O	O	O
LSD-15	O	O	B-UnknownType
and	O	O	O
strong	O	O	B-T080
association	O	O	B-T080
with	O	O	I-T080
MMSE	O	O	B-T060
categories	O	O	B-T170
.	O	O	O

The	O	O	O
LSD-4	O	O	B-UnknownType
provides	O	O	O
a	O	O	O
brief	O	O	O
and	O	O	O
easily	O	O	B-T033
interpreted	O	O	B-T169
bedside	O	O	B-T060
test	O	O	I-T060
of	O	O	O
visuospatial	O	O	B-T041
function	O	O	I-T041
that	O	O	O
has	O	O	O
high	O	O	B-T080
coverage	O	O	B-T169
of	O	O	O
elderly	O	O	B-T098
patients	O	O	B-T101
with	O	O	O
neurocognitive	O	O	B-T048
impairment	O	O	I-T048
,	O	O	O
good	O	O	O
agreement	O	O	O
with	O	O	O
conventional	O	O	B-T080
tests	O	O	O
of	O	O	O
visuospatial	O	O	B-T041
ability	O	O	I-T041
and	O	O	O
favourable	O	O	O
ability	O	O	O
to	O	O	O
identify	O	O	B-T080
significant	O	O	B-T078
cognitive	O	O	B-T048
impairment	O	O	I-T048
.	O	O	O

[	O	O	O
181	O	O	O
words	O	O	O
]	O	O	O
.	O	O	O

-DOCSTART- (27956431)

Salvage	O	O	B-T061
Therapy	O	O	I-T061
with	O	O	O
Ceftolozane-Tazobactam	O	O	B-T121
for	O	O	O
Multidrug-Resistant	O	O	B-T007
Pseudomonas	O	O	I-T007
aeruginosa	O	O	I-T007
Infections	O	O	O

Infections	O	O	B-T047
caused	O	O	O
by	O	O	O
multidrug-resistant	O	O	B-T007
Pseudomonas	O	O	I-T007
aeruginosa	O	O	I-T007
(	O	O	O
MDRPA	O	O	B-T007
)	O	O	O
present	O	O	O
a	O	O	O
major	O	O	O
problem	O	O	O
for	O	O	O
therapeutic	O	O	B-T058
management	O	O	I-T058
.	O	O	O

We	O	O	O
report	O	O	O
here	O	O	O
our	O	O	O
experience	O	O	O
with	O	O	O
12	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
severe	O	O	O
MDRPA	O	O	B-T007
infection	O	O	B-T047
(	O	O	O
6	O	O	O
of	O	O	O
which	O	O	O
were	O	O	O
pneumonia	O	O	B-T047
)	O	O	O
who	O	O	O
received	O	O	O
salvage	O	O	B-T061
therapy	O	O	I-T061
with	O	O	O
ceftolozane-tazobactam	O	O	B-T121
after	O	O	O
inappropriate	O	O	O
empirical	O	O	B-T061
treatment	O	O	B-T061
and/or	O	O	O
suboptimal	O	O	B-T080
targeted	O	O	O
treatment	O	O	O
.	O	O	O

Although	O	O	O
10	O	O	O
of	O	O	O
the	O	O	O
12	O	O	O
patients	O	O	B-T101
(	O	O	O
83.3	O	O	O
%	O	O	O
)	O	O	O
experienced	O	O	O
septic	O	O	B-T046
shock	O	O	I-T046
,	O	O	O
only	O	O	O
3	O	O	O
patients	O	O	O
(	O	O	O
25	O	O	O
%	O	O	O
)	O	O	O
died	O	O	B-T040
during	O	O	O
the	O	O	O
follow-up	O	O	B-T058
period	O	O	O
.	O	O	O

Microbiological	O	O	B-T059
cure	O	O	B-T077
in	O	O	O
7	O	O	O
patients	O	O	B-T101
(	O	O	O
58.3	O	O	O
%	O	O	O
)	O	O	O
was	O	O	O
observed	O	O	O
.	O	O	O

-DOCSTART- (27960292)

Ankaflavin	O	O	B-T109
and	O	O	O
Monascin	O	O	B-T109
Induce	O	O	B-T169
Apoptosis	O	O	B-T043
in	O	O	O
Activated	O	O	B-T052
Hepatic	O	O	B-T025
Stellate	O	O	I-T025
Cells	O	O	I-T025
through	O	O	O
Suppression	O	O	B-UnknownType
of	O	O	O
the	O	O	O
Akt	O	O	B-T116
/	O	O	O
NF-κB	O	O	B-T116
/	O	O	O
p38	O	O	B-T116
Signaling	O	O	O
Pathway	O	O	O

The	O	O	O
increased	O	O	B-T081
proliferation	O	O	B-T043
of	O	O	O
activated	O	O	B-T052
hepatic	O	O	B-T025
stellate	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
HSCs	O	O	B-T025
)	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
hepatic	O	O	B-T047
fibrosis	O	O	I-T047
and	O	O	O
excessive	O	O	B-T080
extracellular	O	O	B-T024
matrix	O	O	I-T024
(ECM)-	O	O	O
protein	O	O	B-T116
production	O	O	O
.	O	O	O

We	O	O	O
examined	O	O	O
the	O	O	O
inhibitory	O	O	B-T052
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
Monascus	O	O	B-T004
purpureus	O	O	I-T004
-fermented	O	O	O
metabolites	O	O	B-T123
,	O	O	O
ankaflavin	O	O	B-T109
and	O	O	O
monascin	O	O	B-T109
(	O	O	O
15	O	O	O
and	O	O	O
30	O	O	O
μM	O	O	O
)	O	O	O
,	O	O	O
on	O	O	O
the	O	O	O
Akt	O	O	B-T116
/	O	O	O
nuclear	O	O	B-T116
factor	O	O	I-T116
(NF)-κB	O	O	I-T116
and	O	O	O
p38	O	O	B-T116
mitogen-activated	O	O	I-T116
protein	O	O	I-T116
kinase	O	O	I-T116
(	O	O	O
MAPK	O	O	B-T116
)	O	O	O
signaling	O	O	B-T044
pathways	O	O	I-T044
in	O	O	O
HSC-T6	O	O	B-T025
(	O	O	O
activated	O	O	B-T025
hepatic	O	O	I-T025
stellate	O	O	I-T025
cell	O	O	I-T025
line	O	O	I-T025
)	O	O	O
.	O	O	O

Ankaflavin	O	O	B-T109
and	O	O	O
monascin	O	O	B-T109
(	O	O	O
30	O	O	O
μM	O	O	O
)	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
and	O	O	O
significantly	O	O	B-T078
inhibited	O	O	B-T080
cell	O	O	B-T043
growth	O	O	I-T043
(	O	O	O
cell	O	O	B-T043
viabilities	O	O	I-T043
:	O	O	O
80.2	O	O	O
±	O	O	O
5.43	O	O	O
%	O	O	O
and	O	O	O
62.8	O	O	O
±	O	O	O
8.20	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
versus	O	O	O
control	O	O	B-T025
cells	O	O	I-T025
;	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Apoptosis	O	O	B-T043
and	O	O	O
G1	O	O	B-T079
phase	O	O	I-T079
arrest	O	O	I-T043
(	O	O	O
G1	O	O	O
phase	O	O	O
percentages	O	O	B-T081
:	O	O	O
76.1	O	O	O
±	O	O	O
2.85	O	O	O
%	O	O	O
and	O	O	O
79.9	O	O	O
±	O	O	O
1.80	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
versus	O	O	O
control	O	O	B-T025
cells	O	O	I-T025
65.9	O	O	O
±	O	O	O
4.94	O	O	O
%	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
correlated	O	O	B-T080
with	O	O	O
increased	O	O	B-T081
p53	O	O	B-T116
and	O	O	O
p21	O	O	B-T116
levels	O	O	B-T034
and	O	O	O
caspase	O	O	B-T044
3	O	O	I-T044
activity	O	O	I-T044
and	O	O	O
decreased	O	O	B-T081
cyclin	O	O	B-T116
D1	O	O	I-T116
and	O	O	O
Bcl-2-family	O	O	B-T026
protein	O	O	I-T026
levels	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
,	O	O	O
all	O	O	O
cases	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
apoptotic	O	O	B-T080
effects	O	O	B-T080
of	O	O	I-T080
ankaflavin	O	O	B-T109
and	O	O	O
monascin	O	O	B-T109
were	O	O	O
HSC-T6	O	O	B-T025
-	O	O	O
specific	O	O	B-T080
,	O	O	O
suggesting	O	O	O
their	O	O	O
potential	O	O	B-T080
in	O	O	O
treating	O	O	B-T169
liver	O	O	B-T047
fibrosis	O	O	I-T047
.	O	O	O

-DOCSTART- (27965132)

Low-Volume	O	O	B-T093
vs	O	O	O
High-Volume	O	O	B-T093
Centers	O	O	I-T093
and	O	O	O
Management	O	O	B-T058
of	O	O	I-T058
Fournier	O	O	B-T047
's	O	O	I-T047
Gangrene	O	O	I-T047
in	O	O	O
Washington	O	O	O
State	O	O	O

Fournier	O	O	B-T047
's	O	O	I-T047
gangrene	O	O	I-T047
(	O	O	O
FG	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
life-threatening	O	O	B-T033
infection	O	O	I-T033
affecting	O	O	B-T169
the	O	O	O
perineum	O	O	B-T029
and	O	O	O
genitals	O	O	B-T023
.	O	O	O

Complex	O	O	B-T080
patient	O	O	B-T058
management	O	O	I-T058
often	O	O	O
necessitates	O	O	O
transfer	O	O	O
to	O	O	O
tertiary	O	O	B-T093
centers	O	O	I-T093
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
characterize	O	O	O
hospital	O	O	B-T058
transfer	O	O	I-T058
patterns	O	O	B-T082
and	O	O	O
assess	O	O	O
morbidity	O	O	B-T081
among	O	O	O
patients	O	O	B-T101
with	O	O	O
FG	O	O	B-T047
in	O	O	O
Washington	O	O	B-T083
State	O	O	I-T083
.	O	O	O

The	O	O	O
Washington	O	O	B-T083
State	O	O	I-T083
Comprehensive	O	O	B-T080
Hospital	O	O	O
Abstract	O	O	B-T057
Reporting	O	O	I-T057
System	O	O	O
includes	O	O	O
claims	O	O	O
from	O	O	O
all	O	O	O
hospital	O	O	B-UnknownType
discharges	O	O	I-UnknownType
in	O	O	O
Washington	O	O	O
.	O	O	O

We	O	O	O
identified	O	O	O
patients	O	O	B-T101
with	O	O	O
FG	O	O	B-T047
between	O	O	O
2007	O	O	O
and	O	O	O
2013	O	O	O
,	O	O	O
based	O	O	O
on	O	O	O
diagnosis	O	O	B-T170
and	O	O	I-T170
treatment	O	O	I-T170
codes	O	O	I-T170
.	O	O	O

Analyses	O	O	O
were	O	O	O
stratified	O	O	B-T080
by	O	O	O
center	O	O	O
volume	O	O	O
(	O	O	O
low-volume	O	O	B-T093
centers	O	O	I-T093
[	O	O	O
LVCs	O	O	B-T093
]	O	O	O
or	O	O	O
high-volume	O	O	B-T093
centers	O	O	I-T093
[	O	O	O
HVCs	O	O	B-T093
]	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
transfer	O	O	B-T033
status	O	O	I-T033
.	O	O	O

Variables	O	O	O
of	O	O	O
interest	O	O	O
included	O	O	O
number	O	O	O
of	O	O	O
debridements	O	O	B-T061
,	O	O	O
septic	O	O	B-T046
shock	O	O	I-T046
,	O	O	O
acute	O	O	B-T047
renal	O	O	I-T047
failure	O	O	I-T047
,	O	O	O
acute	O	O	B-T047
respiratory	O	O	I-T047
failure	O	O	I-T047
,	O	O	O
length	O	O	B-T058
of	O	O	I-T058
hospitalization	O	O	I-T058
,	O	O	O
and	O	O	O
death	O	O	B-T033
.	O	O	O

We	O	O	O
identified	O	O	O
165	O	O	O
FG	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

Only	O	O	O
1	O	O	O
HVC	O	O	B-T093
treated	O	O	B-T169
more	O	O	O
than	O	O	O
2	O	O	O
FG	O	O	B-T047
patients	O	O	B-T101
per	O	O	O
year	O	O	O
.	O	O	O

Overall	O	O	B-T081
mortality	O	O	I-T081
was	O	O	O
6.7	O	O	O
%	O	O	O
.	O	O	O

Most	O	O	O
patients	O	O	B-T101
(	O	O	O
57	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
treated	O	O	B-T169
entirely	O	O	O
at	O	O	O
LVCs	O	O	B-T093
;	O	O	O
87	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	O
treated	O	O	O
at	O	O	O
the	O	O	O
HVC	O	O	B-T093
were	O	O	O
transferred	O	O	O
from	O	O	O
an	O	O	O
LVC	O	O	B-T093
.	O	O	O

High-volume	O	O	B-T093
center	O	O	I-T093
-treated	O	O	O
patients	O	O	B-T101
had	O	O	O
similar	O	O	O
baseline	O	O	O
comorbidities	O	O	B-T078
(	O	O	O
p	O	O	O
=	O	O	O
0.77	O	O	O
)	O	O	O
and	O	O	O
similar	O	O	O
mortality	O	O	B-T081
(	O	O	O
p	O	O	O
=	O	O	O
0.87	O	O	O
)	O	O	O
,	O	O	O
despite	O	O	O
higher	O	O	O
rates	O	O	O
of	O	O	O
septic	O	O	B-T046
shock	O	O	I-T046
(	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
and	O	O	O
respiratory	O	O	B-T047
failure	O	O	I-T047
(	O	O	O
p	O	O	O
=	O	O	O
0.01	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
LVC	O	O	B-T093
patients	O	O	O
.	O	O	O

Among	O	O	O
HVC	O	O	B-T093
-	O	O	O
transferred	O	O	B-T058
patients	O	O	I-T058
,	O	O	O
immediate	O	O	B-T079
compared	O	O	O
with	O	O	O
delayed	O	O	B-T079
transfer	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
fewer	O	O	O
debridements	O	O	B-T061
(	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
,	O	O	O
lower	O	O	O
rates	O	O	O
of	O	O	O
septic	O	O	B-T046
shock	O	O	I-T046
(	O	O	O
p	O	O	O
=	O	O	O
0.05	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
acute	O	O	B-T047
renal	O	O	I-T047
failure	O	O	I-T047
(	O	O	O
p	O	O	O
=	O	O	O
0.04	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
treated	O	O	B-T169
at	O	O	O
the	O	O	O
HVC	O	O	B-T093
were	O	O	O
more	O	O	O
acutely	O	O	B-T033
ill	O	O	I-T033
,	O	O	O
yet	O	O	O
mortality	O	O	B-T081
was	O	O	O
similar	O	O	O
compared	O	O	O
with	O	O	O
patients	O	O	B-T101
treated	O	O	O
solely	O	O	O
at	O	O	O
LVCs	O	O	B-T093
,	O	O	O
suggesting	O	O	O
a	O	O	O
benefit	O	O	O
to	O	O	O
transfer	O	O	O
of	O	O	O
high	O	O	O
acuity	O	O	B-T080
patients	O	O	I-T080
.	O	O	O

Immediate	O	O	B-T079
vs	O	O	O
delayed	O	O	B-T079
transfer	O	O	O
may	O	O	O
benefit	O	O	O
FG	O	O	B-T047
health	O	O	B-T170
outcomes	O	O	I-T170
;	O	O	O
however	O	O	O
,	O	O	O
this	O	O	O
may	O	O	O
also	O	O	O
reflect	O	O	O
greater	O	O	O
disease	O	O	B-T047
acuity	O	O	B-T080
of	O	O	I-T080
patients	O	O	I-T080
with	O	O	O
delayed	O	O	O
transfer	O	O	B-T033
status	O	O	I-T033
.	O	O	O

-DOCSTART- (27965450)

Functional	O	O	O
Characterization	O	O	O
of	O	O	O
Pneumocystis	O	O	B-T004
carinii	O	O	I-T004
Inositol	O	O	O
Transporter	O	O	O
1	O	O	O

Fungi	O	O	B-T004
in	O	O	O
the	O	O	O
genus	O	O	B-T004
Pneumocystis	O	O	I-T004
live	O	O	O
in	O	O	O
the	O	O	O
lungs	O	O	B-T023
of	O	O	O
mammals	O	O	B-T015
,	O	O	O
where	O	O	O
they	O	O	O
can	O	O	O
cause	O	O	O
a	O	O	O
fatal	O	O	B-T080
pneumonia	O	O	B-T047
(	O	O	O
PCP	O	O	B-T047
[	O	O	O
Pneumocystis	O	O	B-T047
pneumonia	O	O	I-T047
]	O	O	O
)	O	O	O
in	O	O	O
hosts	O	O	B-T001
with	O	O	O
compromised	O	O	O
immune	O	O	B-T022
systems	O	O	I-T022
.	O	O	O

The	O	O	O
absence	O	O	O
of	O	O	O
a	O	O	O
continuous	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
culture	O	O	B-T059
system	O	O	I-T059
for	O	O	O
any	O	O	O
species	O	O	B-T185
of	O	O	O
Pneumocystis	O	O	B-T004
has	O	O	O
led	O	O	O
to	O	O	O
limited	O	O	O
understanding	O	O	O
of	O	O	O
these	O	O	O
fungi	O	O	B-T004
,	O	O	O
especially	O	O	O
for	O	O	O
the	O	O	O
discovery	O	O	B-T052
of	O	O	O
new	O	O	O
therapies	O	O	B-T061
.	O	O	O

We	O	O	O
recently	O	O	O
reported	O	O	O
that	O	O	O
Pneumocystis	O	O	B-T004
carinii	O	O	I-T004
,	O	O	O
Pneumocystis	O	O	B-T004
murina	O	O	I-T004
,	O	O	O
and	O	O	O
most	O	O	O
significantly	O	O	O
,	O	O	O
Pneumocystis	O	O	B-T004
jirovecii	O	O	I-T004
lack	O	O	O
both	O	O	O
enzymes	O	O	B-T116
necessary	O	O	O
for	O	O	O
myo-inositol	O	O	B-T127
biosynthesis	O	O	I-T044
but	O	O	O
contain	O	O	O
genes	O	O	B-T028
with	O	O	I-T028
homologies	O	O	I-T028
to	O	O	O
fungal	O	O	B-T004
myo-inositol	O	O	O
transporters	O	O	B-T116
.	O	O	O

Since	O	O	O
myo-inositol	O	O	B-T127
is	O	O	O
essential	O	O	O
for	O	O	O
eukaryotic	O	O	B-T025
viability	O	O	B-T043
,	O	O	O
the	O	O	O
primary	O	O	O
transporter	O	O	B-T116
,	O	O	O
ITR1	O	O	B-T116
,	O	O	O
was	O	O	O
functionally	O	O	B-T169
and	O	O	O
structurally	O	O	B-T082
characterized	O	O	O
in	O	O	O
P.	O	O	B-T004
carinii	O	O	I-T004
The	O	O	O
predicted	O	O	O
structure	O	O	B-T116
of	O	O	O
P.	O	O	O
carinii	O	O	O
ITR1	O	O	O
(	O	O	O
PcITR1	O	O	B-T116
)	O	O	O
contained	O	O	O
12	O	O	O
transmembrane	O	O	B-T026
alpha-helices	O	O	B-T082
with	O	O	O
intracellular	O	O	B-T082
C	O	O	B-T087
and	O	O	O
N	O	O	B-T087
termini	O	O	I-T087
,	O	O	O
consistent	O	O	O
with	O	O	O
other	O	O	O
inositol	O	O	B-T127
transporters	O	O	B-T116
.	O	O	O

The	O	O	O
apparent	O	O	O
Km	O	O	O
was	O	O	O
0.94	O	O	O
±	O	O	O
0.08	O	O	O
(	O	O	O
mean	O	O	O
±	O	O	O
standard	O	O	O
deviation	O	O	O
)	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
myo-inositol	O	O	B-T043
transport	O	O	I-T043
in	O	O	O
P.	O	O	B-T004
carinii	O	O	I-T004
is	O	O	O
likely	O	O	O
through	O	O	O
a	O	O	O
low-affinity	O	O	O
,	O	O	O
highly	O	O	O
selective	O	O	O
transport	O	O	B-T043
system	O	O	I-T043
,	O	O	O
as	O	O	O
no	O	O	O
other	O	O	O
sugars	O	O	B-T109
or	O	O	O
inositol	O	O	B-T127
stereoisomers	O	O	B-T104
were	O	O	O
significant	O	O	O
competitive	O	O	B-T044
inhibitors	O	O	B-T120
.	O	O	O

Glucose	O	O	B-T043
transport	O	O	B-T043
was	O	O	O
shown	O	O	O
to	O	O	O
use	O	O	O
a	O	O	O
different	O	O	O
transport	O	O	O
system	O	O	O
.	O	O	O

The	O	O	O
myo-inositol	O	O	B-T043
transport	O	O	I-T043
was	O	O	O
distinct	O	O	O
from	O	O	O
mammalian	O	O	B-T015
transporters	O	O	B-T116
,	O	O	O
as	O	O	O
it	O	O	O
was	O	O	O
not	O	O	O
sodium	O	O	B-T043
dependent	O	O	I-T043
and	O	O	O
was	O	O	O
cytochalasin	O	O	B-T121
B	O	O	I-T121
resistant	O	O	B-T169
.	O	O	O

Inositol	O	O	B-T043
transport	O	O	B-T043
in	O	O	O
these	O	O	O
fungi	O	O	B-T004
offers	O	O	O
an	O	O	O
attractive	O	O	B-T080
new	O	O	O
drug	O	O	B-T121
target	O	O	B-T169
because	O	O	O
of	O	O	O
the	O	O	O
reliance	O	O	O
of	O	O	O
the	O	O	O
fungi	O	O	O
on	O	O	O
its	O	O	O
transport	O	O	O
,	O	O	O
clear	O	O	O
differences	O	O	O
between	O	O	O
the	O	O	O
mammalian	O	O	B-T015
and	O	O	O
fungal	O	O	B-T004
transporters	O	O	B-T116
,	O	O	O
and	O	O	O
the	O	O	O
ability	O	O	O
of	O	O	O
the	O	O	O
host	O	O	B-T001
to	O	O	O
both	O	O	O
synthesize	O	O	O
and	O	O	O
transport	O	O	O
this	O	O	O
critical	O	O	B-T080
nutrient	O	O	B-T168
,	O	O	O
predicting	O	O	O
low	O	O	B-T080
toxicity	O	O	B-T037
of	O	O	O
potential	O	O	B-T080
inhibitors	O	O	B-T120
to	O	O	O
the	O	O	O
fungal	O	O	O
transporter	O	O	B-T116
.	O	O	O

myo-Inositol	O	O	B-T127
is	O	O	O
a	O	O	O
sugarlike	O	O	B-T109
nutrient	O	O	B-T168
that	O	O	O
is	O	O	O
essential	O	O	B-T080
for	O	O	O
life	O	O	B-T078
in	O	O	O
most	O	O	O
organisms	O	O	B-T001
.	O	O	O

Humans	O	O	B-T016
and	O	O	O
microbes	O	O	B-T001
alike	O	O	O
can	O	O	O
obtain	O	O	O
it	O	O	O
by	O	O	O
making	O	O	O
it	O	O	O
,	O	O	O
which	O	O	O
involves	O	O	O
only	O	O	O
2	O	O	O
enzymes	O	O	B-T116
,	O	O	O
by	O	O	O
taking	O	O	O
it	O	O	O
from	O	O	O
the	O	O	O
environment	O	O	B-T082
by	O	O	O
a	O	O	O
transport	O	O	B-T044
process	O	O	I-T044
,	O	O	O
or	O	O	O
by	O	O	O
recycling	O	O	O
it	O	O	O
from	O	O	O
other	O	O	O
cellular	O	O	B-T025
constituents	O	O	B-T167
.	O	O	O

Inspection	O	O	O
of	O	O	O
the	O	O	O
genomes	O	O	B-T028
of	O	O	O
the	O	O	O
pathogenic	O	O	B-T004
fungi	O	O	I-T004
of	O	O	O
the	O	O	O
genus	O	O	B-T004
Pneumocystis	O	O	I-T004
showed	O	O	O
that	O	O	O
these	O	O	O
pneumonia	O	O	B-T047
-	O	O	O
causing	O	O	B-T169
parasites	O	O	B-T204
could	O	O	O
not	O	O	O
make	O	O	O
myo-inositol	O	O	B-T127
,	O	O	O
as	O	O	O
they	O	O	O
lacked	O	O	O
the	O	O	O
2	O	O	O
enzymes	O	O	B-T116
.	O	O	O

Instead	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
evidence	O	O	O
of	O	O	O
inositol	O	O	B-T127
transporters	O	O	B-T116
,	O	O	O
which	O	O	O
would	O	O	O
import	O	O	O
the	O	O	O
sugar	O	O	B-T109
from	O	O	O
the	O	O	O
lungs	O	O	B-T023
where	O	O	O
the	O	O	O
fungi	O	O	B-T004
reside	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
report	O	O	O
,	O	O	O
we	O	O	O
characterized	O	O	O
the	O	O	O
transport	O	O	B-T043
of	O	O	O
myo-inositol	O	O	B-T127
in	O	O	O
the	O	O	O
fungus	O	O	B-T004
and	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
transporter	O	O	B-T116
was	O	O	O
highly	O	O	O
selective	O	O	O
for	O	O	O
myo-inositol	O	O	O
and	O	O	O
did	O	O	O
not	O	O	O
transport	O	O	O
any	O	O	O
other	O	O	O
molecules	O	O	B-T167
.	O	O	O

The	O	O	O
transport	O	O	B-T043
was	O	O	O
distinct	O	O	O
from	O	O	O
that	O	O	O
in	O	O	O
mammalian	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
since	O	O	O
mammals	O	O	B-T015
can	O	O	O
both	O	O	O
make	O	O	O
and	O	O	O
transport	O	O	O
myo-inositol	O	O	B-T127
,	O	O	O
while	O	O	O
Pneumocystis	O	O	B-T004
fungi	O	O	I-T004
must	O	O	O
transport	O	O	O
it	O	O	O
,	O	O	O
this	O	O	O
process	O	O	O
offers	O	O	O
a	O	O	O
potential	O	O	B-T080
new	O	O	O
drug	O	O	B-T121
target	O	O	B-T169
.	O	O	O

-DOCSTART- (27976878)

Worldwide	O	O	B-T082
Occurrence	O	O	B-T079
of	O	O	O
Mycotoxins	O	O	B-T109
in	O	O	O
Cereals	O	O	B-T168
and	O	O	O
Cereal	O	O	B-T168
-	O	O	O
Derived	O	O	B-T080
Food	O	O	B-T168
Products	O	O	I-T168
:	O	O	O
Public	O	O	B-T092
Health	O	O	B-T078
Perspectives	O	O	B-T078
of	O	O	O
Their	O	O	O
Co-occurrence	O	O	O

Cereal	O	O	B-T168
grains	O	O	I-T168
and	O	O	O
their	O	O	O
processed	O	O	B-T067
food	O	O	B-T168
products	O	O	I-T168
are	O	O	O
frequently	O	O	O
contaminated	O	O	B-T169
with	O	O	O
mycotoxins	O	O	B-T109
.	O	O	O

Among	O	O	O
many	O	O	O
,	O	O	O
five	O	O	B-T081
major	O	O	B-T080
mycotoxins	O	O	B-T109
of	O	O	O
aflatoxins	O	O	B-T109
,	O	O	O
ochratoxins	O	O	B-T109
,	O	O	O
fumonisins	O	O	B-T109
,	O	O	O
deoxynivalenol	O	O	B-T109
,	O	O	O
and	O	O	O
zearalenone	O	O	B-T109
are	O	O	O
of	O	O	O
significant	O	O	O
public	O	O	B-T092
health	O	O	B-T078
concern	O	O	B-T078
as	O	O	O
they	O	O	O
can	O	O	O
cause	O	O	B-T169
adverse	O	O	B-T046
effects	O	O	I-T046
in	O	O	O
humans	O	O	B-T016
.	O	O	O

Being	O	O	O
airborne	O	O	B-T169
or	O	O	O
soilborne	O	O	B-T169
,	O	O	O
the	O	O	O
cosmopolitan	O	O	O
nature	O	O	B-T080
of	O	O	O
mycotoxigenic	O	O	B-T004
fungi	O	O	I-T004
contribute	O	O	O
to	O	O	O
the	O	O	O
worldwide	O	O	B-T082
occurrence	O	O	B-T079
of	O	O	O
mycotoxins	O	O	B-T109
.	O	O	O

On	O	O	O
the	O	O	O
basis	O	O	B-T169
of	O	O	O
the	O	O	O
global	O	O	B-T080
occurrence	O	O	B-T079
data	O	O	B-T078
reported	O	O	B-T058
during	O	O	O
the	O	O	O
past	O	O	O
10	O	O	O
years	O	O	O
,	O	O	O
the	O	O	O
incidences	O	O	B-T081
and	O	O	O
maximum	O	O	B-T081
levels	O	O	B-T080
in	O	O	O
raw	O	O	B-T080
cereal	O	O	B-T168
grains	O	O	I-T168
were	O	O	O
55	O	O	O
%	O	O	O
and	O	O	O
1642	O	O	O
μg/kg	O	O	O
for	O	O	O
aflatoxins	O	O	B-T109
,	O	O	O
29	O	O	O
%	O	O	O
and	O	O	O
1164	O	O	O
μg/kg	O	O	O
for	O	O	O
ochratoxin	O	O	B-T109
A	O	O	I-T109
,	O	O	O
61	O	O	O
%	O	O	O
and	O	O	O
71,121	O	O	O
μg/kg	O	O	O
for	O	O	O
fumonisins	O	O	B-T109
,	O	O	O
58	O	O	O
%	O	O	O
and	O	O	O
41,157	O	O	O
μg/kg	O	O	O
,	O	O	O
for	O	O	O
deoxynivalenol	O	O	B-T109
,	O	O	O
and	O	O	O
46	O	O	O
%	O	O	O
and	O	O	O
3049	O	O	O
μg/kg	O	O	O
for	O	O	O
zearalenone	O	O	B-T109
.	O	O	O

The	O	O	O
concentrations	O	O	B-T081
of	O	O	O
mycotoxins	O	O	B-T109
tend	O	O	O
to	O	O	O
be	O	O	O
lower	O	O	B-T080
in	O	O	O
processed	O	O	B-T067
food	O	O	B-T168
products	O	O	I-T168
;	O	O	O
the	O	O	O
incidences	O	O	B-T081
varied	O	O	O
depending	O	O	O
on	O	O	O
the	O	O	O
individual	O	O	O
mycotoxins	O	O	O
,	O	O	O
possibly	O	O	O
due	O	O	B-T169
to	O	O	I-T169
the	O	O	O
varying	O	O	B-T169
stability	O	O	B-T080
during	O	O	B-T079
processing	O	O	B-T057
and	O	O	O
distribution	O	O	B-T169
of	O	O	O
mycotoxins	O	O	O
.	O	O	O

It	O	O	O
should	O	O	O
be	O	O	O
noted	O	O	O
that	O	O	O
more	O	O	O
than	O	O	O
one	O	O	O
mycotoxin	O	O	B-T109
,	O	O	O
produced	O	O	B-T169
by	O	O	O
a	O	O	O
single	O	O	B-T081
or	O	O	O
several	O	O	B-T081
fungal	O	O	B-T004
species	O	O	B-T185
,	O	O	O
may	O	O	O
occur	O	O	O
in	O	O	O
various	O	O	B-T081
combinations	O	O	B-T080
in	O	O	O
a	O	O	O
given	O	O	O
sample	O	O	B-T167
or	O	O	O
food	O	O	B-T168
.	O	O	O

Most	O	O	O
studies	O	O	B-T062
reported	O	O	B-T058
additive	O	O	B-T080
or	O	O	O
synergistic	O	O	B-T080
effects	O	O	B-T080
,	O	O	O
suggesting	O	O	B-T078
that	O	O	O
these	O	O	O
mixtures	O	O	B-T167
may	O	O	O
pose	O	O	O
a	O	O	O
significant	O	O	B-T078
threat	O	O	B-T078
to	O	O	O
public	O	O	B-T092
health	O	O	B-T078
,	O	O	O
particularly	O	O	O
to	O	O	O
infants	O	O	B-T100
and	O	O	O
young	O	O	B-T100
children	O	O	I-T100
.	O	O	O

Therefore	O	O	O
,	O	O	O
information	O	O	B-T078
on	O	O	O
the	O	O	O
co-occurrence	O	O	O
of	O	O	O
mycotoxins	O	O	B-T109
and	O	O	O
their	O	O	O
interactive	O	O	B-T169
toxicity	O	O	B-T037
is	O	O	O
summarized	O	O	B-T170
in	O	O	O
this	O	O	O
paper	O	O	O
.	O	O	O

-DOCSTART- (27979320)

Locating	O	O	O
the	O	O	O
Seventh	O	O	B-T023
Cervical	O	O	I-T023
Spinous	O	O	I-T023
Process	O	O	I-T023
:	O	O	O
Development	O	O	O
and	O	O	O
Validation	O	O	O
of	O	O	O
a	O	O	O
Multivariate	O	O	B-T081
Model	O	O	I-T081
Using	O	O	O
Palpation	O	O	B-T060
and	O	O	O
Personal	O	O	O
Information	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
develop	O	O	O
and	O	O	O
validate	O	O	O
a	O	O	O
multivariate	O	O	B-T081
prediction	O	O	I-T081
model	O	O	I-T081
,	O	O	O
guided	O	O	O
by	O	O	O
palpation	O	O	B-T060
and	O	O	O
personal	O	O	B-T077
information	O	O	I-T077
,	O	O	O
for	O	O	O
locating	O	O	O
the	O	O	O
seventh	O	O	B-T023
cervical	O	O	I-T023
spinous	O	O	I-T023
process	O	O	I-T023
(	O	O	O
C7SP	O	O	B-T023
)	O	O	O
.	O	O	O

A	O	O	O
single-blinded	O	O	B-T062
,	O	O	I-T062
cross-sectional	O	O	I-T062
study	O	O	I-T062
at	O	O	O
a	O	O	O
primary	O	O	B-T093
to	O	O	I-T093
tertiary	O	O	I-T093
health	O	O	I-T093
care	O	O	I-T093
center	O	O	I-T093
was	O	O	O
conducted	O	O	O
for	O	O	O
model	O	O	B-T170
development	O	O	I-T170
and	O	O	O
temporal	O	O	B-T062
validation	O	O	I-T062
.	O	O	O

One-hundred	O	O	O
sixty	O	O	O
participants	O	O	B-T098
were	O	O	O
prospectively	O	O	O
included	O	O	O
for	O	O	O
model	O	O	B-T170
development	O	O	I-T170
(	O	O	O
n	O	O	O
=	O	O	O
80	O	O	O
)	O	O	O
and	O	O	O
time-split	O	O	B-T081
validation	O	O	I-T081
stages	O	O	I-T081
(	O	O	O
n	O	O	O
=	O	O	O
80	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
C7SP	O	O	B-T023
was	O	O	O
located	O	O	O
using	O	O	O
the	O	O	O
thorax-rib	O	O	B-T060
static	O	O	I-T060
method	O	O	I-T060
(	O	O	O
TRSM	O	O	B-T060
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
underwent	O	O	O
chest	O	O	B-T060
radiography	O	O	I-T060
for	O	O	O
assessment	O	O	O
of	O	O	O
the	O	O	O
inner	O	O	B-T082
body	O	O	B-T017
structure	O	O	I-T017
located	O	O	O
with	O	O	O
TRSM	O	O	B-T060
and	O	O	O
using	O	O	O
radio-opaque	O	O	B-T074
markers	O	O	I-T074
placed	O	O	O
over	O	O	O
the	O	O	O
skin	O	O	B-T022
.	O	O	O

Age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
height	O	O	B-T032
,	O	O	O
body	O	O	B-T033
mass	O	O	I-T033
,	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
,	O	O	O
and	O	O	O
vertex-marker	O	O	B-T081
distanc	O	O	I-T081
e	O	O	O
(	O	O	O
DV-M	O	O	B-T081
)	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
predict	O	O	O
the	O	O	O
distance	O	O	B-T081
from	O	O	O
the	O	O	O
C7SP	O	O	B-T023
to	O	O	O
the	O	O	O
vertex	O	O	B-T029
(	O	O	O
DV-C7	O	O	B-T081
)	O	O	O
.	O	O	O

Multivariate	O	O	B-T170
linear	O	O	I-T170
regression	O	O	I-T170
modeling	O	O	I-T170
,	O	O	O
limits	O	O	O
of	O	O	O
agreement	O	O	O
plot	O	O	O
,	O	O	O
histogram	O	O	B-T170
of	O	O	I-T170
residues	O	O	I-T170
,	O	O	O
receiver	O	O	B-T081
operating	O	O	I-T081
characteristic	O	O	I-T081
curves	O	O	I-T081
,	O	O	O
and	O	O	O
confusion	O	O	B-T170
tables	O	O	I-T170
were	O	O	O
analyzed	O	O	O
.	O	O	O

The	O	O	O
multivariate	O	O	B-T081
linear	O	O	I-T081
prediction	O	O	I-T081
model	O	O	I-T081
for	O	O	O
DV-C7	O	O	B-T081
(	O	O	O
in	O	O	O
centimeters	O	O	O
)	O	O	O
was	O	O	O
DV-C7	O	O	O
=	O	O	O
0.986DV-M	O	O	O
+	O	O	O
0.018(mass	O	O	O
)	O	O	O
+	O	O	O
0.014(age	O	O	O
)	O	O	O
-	O	O	O
1.008	O	O	O
.	O	O	O

Receiver	O	O	B-T081
operating	O	O	I-T081
characteristic	O	O	I-T081
curves	O	O	I-T081
had	O	O	O
better	O	O	O
discrimination	O	O	O
of	O	O	O
DV-C7	O	O	B-T081
(	O	O	O
area	O	O	O
under	O	O	O
the	O	O	O
curve	O	O	O
=	O	O	O
0.661	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
=	O	O	O
0.541	O	O	O
-	O	O	O
0.782	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.015	O	O	O
)	O	O	O
than	O	O	O
DV-M	O	O	B-T081
(	O	O	O
area	O	O	O
under	O	O	O
the	O	O	O
curve	O	O	O
=	O	O	O
0.480	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	O
interval	O	O	O
=	O	O	O
0.345	O	O	O
-	O	O	O
0.614	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.761	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
respective	O	O	O
cutoff	O	O	O
points	O	O	O
at	O	O	O
23.40	O	O	O
cm	O	O	O
(	O	O	O
sensitivity	O	O	B-T081
=	O	O	O
41	O	O	O
%	O	O	O
,	O	O	O
specificity	O	O	B-T081
=	O	O	O
63	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
24.75	O	O	O
cm	O	O	O
(	O	O	O
sensitivity	O	O	O
=	O	O	O
69	O	O	O
%	O	O	O
,	O	O	O
specificity	O	O	O
=	O	O	O
52	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
C7SP	O	O	B-T023
was	O	O	O
correctly	O	O	O
located	O	O	O
more	O	O	O
often	O	O	O
when	O	O	O
using	O	O	O
predicted	O	O	O
DV-C7	O	O	B-T081
in	O	O	O
the	O	O	O
validation	O	O	O
sample	O	O	O
than	O	O	O
when	O	O	O
using	O	O	O
the	O	O	O
TRSM	O	O	B-T060
in	O	O	O
the	O	O	O
development	O	O	O
sample	O	O	O
:	O	O	O
n	O	O	O
=	O	O	O
53	O	O	O
(	O	O	O
66	O	O	O
%	O	O	O
)	O	O	O
vs	O	O	O
n	O	O	O
=	O	O	O
32	O	O	O
(	O	O	O
40	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
.	O	O	O

Better	O	O	O
accuracy	O	O	O
was	O	O	O
obtained	O	O	O
when	O	O	O
locating	O	O	O
the	O	O	O
C7SP	O	O	B-T023
by	O	O	O
use	O	O	O
of	O	O	O
a	O	O	O
multivariate	O	O	B-T081
model	O	O	I-T081
that	O	O	O
incorporates	O	O	O
palpation	O	O	B-T060
and	O	O	O
personal	O	O	B-T077
information	O	O	I-T077
.	O	O	O

-DOCSTART- (27983510)

Comparison	O	O	B-T052
of	O	O	O
Leishmania	O	O	B-T204
typing	O	O	B-T059
results	O	O	B-T034
obtained	O	O	B-T169
from	O	O	O
16	O	O	O
European	O	O	B-T083
clinical	O	O	B-T093
laboratories	O	O	I-T093
in	O	O	O
2014	O	O	O

Leishmaniasis	O	O	B-T047
is	O	O	O
endemic	O	O	B-UnknownType
in	O	O	O
southern	O	O	B-T083
Europe	O	O	I-T083
,	O	O	O
and	O	O	O
in	O	O	O
other	O	O	O
European	O	O	B-T083
countries	O	O	B-T083
cases	O	O	B-T081
are	O	O	O
diagnosed	O	O	B-T033
in	O	O	O
travellers	O	O	B-T097
who	O	O	O
have	O	O	O
visited	O	O	O
affected	O	O	B-T033
areas	O	O	I-T033
both	O	O	O
within	O	O	B-T082
the	O	O	O
continent	O	O	B-T083
and	O	O	O
beyond	O	O	O
.	O	O	O

Prompt	O	O	B-T080
and	O	O	O
accurate	O	O	B-T080
diagnosis	O	O	B-T033
poses	O	O	O
a	O	O	O
challenge	O	O	O
in	O	O	O
clinical	O	O	B-T170
practice	O	O	I-T170
in	O	O	O
Europe	O	O	B-T083
.	O	O	O

Different	O	O	B-T080
methods	O	O	B-T170
exist	O	O	B-T077
for	O	O	O
identification	O	O	B-T080
of	O	O	O
the	O	O	O
infecting	O	O	B-T033
Leishmania	O	O	B-T204
species	O	O	B-T185
.	O	O	O

Sixteen	O	O	O
clinical	O	O	B-T093
laboratories	O	O	I-T093
in	O	O	O
10	O	O	O
European	O	O	B-T083
countries	O	O	B-T083
,	O	O	O
plus	O	O	O
Israel	O	O	B-T083
and	O	O	O
Turkey	O	O	B-T083
,	O	O	O
conducted	O	O	O
a	O	O	O
study	O	O	B-T062
to	O	O	O
assess	O	O	O
their	O	O	O
genotyping	O	O	B-T059
performance	O	O	B-T052
.	O	O	O

DNA	O	O	B-T114
from	O	O	O
21	O	O	O
promastigote	O	O	B-T204
cultures	O	O	I-T204
of	O	O	O
13	O	O	O
species	O	O	B-T185
was	O	O	O
analysed	O	O	B-T062
blindly	O	O	B-T080
by	O	O	O
the	O	O	O
routinely	O	O	B-T080
used	O	O	O
typing	O	O	B-T059
method	O	O	B-T170
.	O	O	O

Five	O	O	O
different	O	O	B-T080
molecular	O	O	B-T104
targets	O	O	I-T104
were	O	O	O
used	O	O	O
,	O	O	O
which	O	O	O
were	O	O	O
analysed	O	O	B-T062
with	O	O	O
PCR-based	O	O	B-T063
methods	O	O	B-T170
.	O	O	O

Different	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
identification	O	O	B-T080
were	O	O	O
achieved	O	O	B-T033
,	O	O	O
and	O	O	O
either	O	O	O
the	O	O	O
Leishmania	O	O	B-T204
subgenus	O	O	B-T077
,	O	O	O
species	O	O	B-T185
complex	O	O	O
,	O	O	O
or	O	O	O
actual	O	O	O
species	O	O	O
were	O	O	O
reported	O	O	B-T170
.	O	O	O

The	O	O	O
overall	O	O	B-T080
error	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
strains	O	O	B-T001
placed	O	O	O
in	O	O	O
the	O	O	O
wrong	O	O	B-T080
complex	O	O	O
or	O	O	O
species	O	O	B-T185
was	O	O	O
8.5	O	O	O
%	O	O	O
.	O	O	O

Various	O	O	O
reasons	O	O	B-T078
for	O	O	O
incorrect	O	O	B-T080
typing	O	O	B-T059
were	O	O	O
identified	O	O	B-T080
.	O	O	O

The	O	O	O
study	O	O	B-T062
shows	O	O	O
there	O	O	O
is	O	O	O
considerable	O	O	B-T080
room	O	O	O
for	O	O	O
improvement	O	O	B-T077
and	O	O	O
standardisation	O	O	B-T062
of	O	O	O
Leishmania	O	O	B-T204
typing	O	O	B-T059
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
well	O	O	O
validated	O	O	B-T062
standard	O	O	B-T077
operating	O	O	I-T077
procedures	O	O	I-T077
is	O	O	O
recommended	O	O	B-T078
,	O	O	O
covering	O	O	O
testing	O	O	B-T169
,	O	O	O
interpretation	O	O	B-T170
,	O	O	O
and	O	O	O
reporting	O	O	B-T058
guidelines	O	O	B-T170
.	O	O	O

Application	O	O	O
of	O	O	O
the	O	O	O
internal	O	O	B-T082
transcribed	O	O	B-T080
spacer	O	O	B-T114
1	O	O	I-T114
of	O	O	O
the	O	O	O
rDNA	O	O	B-T114
array	O	O	B-T075
should	O	O	O
be	O	O	O
restricted	O	O	B-T169
to	O	O	O
Old	O	O	B-T080
World	O	O	I-T080
samples	O	O	B-T077
,	O	O	O
while	O	O	O
the	O	O	O
heat-shock	O	O	B-T028
protein	O	O	I-T028
70	O	O	I-T028
gene	O	O	I-T028
and	O	O	O
the	O	O	O
mini-exon	O	O	B-T114
can	O	O	O
be	O	O	O
applied	O	O	B-T169
globally	O	O	B-T080
.	O	O	O

-DOCSTART- (27983636)

Scoparone	O	O	B-T109
Inhibits	O	O	O
LPS	O	O	B-T109
-	O	O	O
Simulated	O	O	B-T169
Inflammatory	O	O	B-T046
Response	O	O	I-T046
by	O	O	O
Suppressing	O	O	B-T169
IRF3	O	O	B-T116
and	O	O	O
ERK	O	O	B-T116
in	O	O	O
BV-2	O	O	O
Microglial	O	O	O
Cells	O	O	O

Microglia	O	O	B-T025
activation	O	O	B-T043
and	O	O	O
the	O	O	O
release	O	O	O
of	O	O	O
various	O	O	O
inflammatory	O	O	B-T169
cytokines	O	O	B-T116
are	O	O	O
largely	O	O	O
related	O	O	O
to	O	O	O
neurological	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
including	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
,	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
,	O	O	O
and	O	O	O
other	O	O	B-T080
brain	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

The	O	O	O
suppression	O	O	O
of	O	O	O
microglial	O	O	B-T025
cells	O	O	I-T025
using	O	O	O
natural	O	O	B-T169
bioactive	O	O	B-T123
compounds	O	O	I-T123
has	O	O	O
become	O	O	O
increasingly	O	O	B-T169
important	O	O	B-T080
for	O	O	O
brain	O	O	B-T061
therapy	O	O	I-T061
owing	O	O	O
to	O	O	O
the	O	O	O
expected	O	O	O
beneficial	O	O	B-UnknownType
effect	O	O	I-UnknownType
of	O	O	O
lower	O	O	B-T080
toxicity	O	O	B-T080
.	O	O	O

Scoparone	O	O	B-T109
(	O	O	O
6,7-dimethoxycoumarin	O	O	B-T109
)	O	O	O
,	O	O	O
a	O	O	O
major	O	O	O
bioactive	O	O	B-T123
compound	O	O	I-T123
found	O	O	B-T033
in	O	O	O
various	O	O	O
plant	O	O	B-T185
parts	O	O	I-T185
,	O	O	O
including	O	O	O
the	O	O	O
inner	O	O	O
shell	O	O	B-T080
of	O	O	O
chestnut	O	O	B-T168
(	O	O	O
Castanea	O	O	B-T002
crenata	O	O	I-T002
)	O	O	O
,	O	O	O
was	O	O	O
evaluated	O	O	O
on	O	O	O
lipopolysaccharide	O	O	B-T109
(LPS)-	O	O	O
activated	O	O	B-T169
BV-2	O	O	B-T025
microglia	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
results	O	O	B-T169
indicated	O	O	B-T033
that	O	O	O
scoparone	O	O	B-T109
suppresses	O	O	B-T169
the	O	O	O
LPS	O	O	B-T109
-	O	O	O
stimulated	O	O	B-T169
increase	O	O	B-T169
of	O	O	O
neuroinflammatory	O	O	B-T046
responses	O	O	I-T046
and	O	O	O
inhibited	O	O	B-T080
the	O	O	O
pro-inflammatory	O	O	B-T169
cytokine	O	O	B-T116
production	O	O	O
in	O	O	O
the	O	O	O
BV-2	O	O	B-T025
microglial	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

A	O	O	O
mechanistic	O	O	B-T169
study	O	O	I-T169
showed	O	O	O
that	O	O	O
scoparone	O	O	B-T109
specifically	O	O	O
inhibited	O	O	B-T080
the	O	O	O
LPS	O	O	B-T109
-	O	O	O
stimulated	O	O	B-T169
activation	O	O	B-T043
via	O	O	O
a	O	O	O
major	O	O	O
regulation	O	O	B-T038
of	O	O	O
IRF-3	O	O	B-T116
and	O	O	O
a	O	O	O
regulation	O	O	O
of	O	O	O
ERK	O	O	B-T116
,	O	O	O
whereby	O	O	O
the	O	O	O
phosphorylation	O	O	B-T044
in	O	O	O
the	O	O	O
BV-2	O	O	B-T025
microglial	O	O	I-T025
cells	O	O	I-T025
is	O	O	O
blocked	O	O	B-T169
.	O	O	O

These	O	O	O
data	O	O	B-T078
suggest	O	O	B-T078
that	O	O	O
scoparone	O	O	B-T109
has	O	O	O
anti-neuroinflammatory	O	O	B-T080
effects	O	O	I-T080
in	O	O	O
LPS	O	O	B-T109
-	O	O	O
activated	O	O	B-T169
BV-2	O	O	B-T025
microglial	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
could	O	O	O
possibly	O	O	O
be	O	O	O
used	O	O	B-T169
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
novel	O	O	B-T080
drugs	O	O	B-T121
for	O	O	O
the	O	O	O
prevention	O	O	B-T080
and	O	O	O
treatment	O	O	B-T169
of	O	O	O
neuroinflammatory	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

-DOCSTART- (27987038)

Efficient	O	O	O
genome	O	O	B-T063
editing	O	O	I-T063
of	O	O	O
differentiated	O	O	B-T080
renal	O	O	B-T023
epithelial	O	O	O
cells	O	O	O

Recent	O	O	O
advances	O	O	O
in	O	O	O
genome	O	O	B-T063
editing	O	O	I-T063
technologies	O	O	I-T063
have	O	O	O
enabled	O	O	O
the	O	O	O
rapid	O	O	O
and	O	O	O
precise	O	O	O
manipulation	O	O	B-T063
of	O	O	I-T063
genomes	O	O	I-T063
,	O	O	O
including	O	O	O
the	O	O	O
targeted	O	O	B-T063
introduction	O	O	I-T063
,	O	O	O
alteration	O	O	B-T063
,	O	O	O
and	O	O	O
removal	O	O	B-T063
of	O	O	I-T063
genomic	O	O	I-T063
sequences	O	O	I-T063
.	O	O	O

However	O	O	O
,	O	O	O
respective	O	O	O
methods	O	O	B-T170
have	O	O	O
been	O	O	O
described	O	O	O
mainly	O	O	O
in	O	O	O
non-differentiated	O	O	B-T170
or	O	O	O
haploid	O	O	B-T025
cell	O	O	B-T170
types	O	O	I-T170
.	O	O	O

Genome	O	O	B-T063
editing	O	O	I-T063
of	O	O	O
well-differentiated	O	O	B-T080
renal	O	O	B-T023
epithelial	O	O	B-T025
cells	O	O	I-T025
has	O	O	O
been	O	O	O
hampered	O	O	O
by	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
technological	O	O	B-T033
issues	O	O	I-T033
,	O	O	O
including	O	O	O
optimal	O	O	B-T080
design	O	O	B-T052
,	O	O	O
efficient	O	O	B-T080
expression	O	O	B-T063
of	O	O	I-T063
multiple	O	O	I-T063
genome	O	O	I-T063
editing	O	O	I-T063
constructs	O	O	I-T063
,	O	O	O
attainable	O	O	B-T080
mutation	O	O	B-T080
rates	O	O	I-T080
,	O	O	O
and	O	O	O
best	O	O	O
screening	O	O	B-T170
strategies	O	O	I-T170
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
an	O	O	O
easily	O	O	O
implementable	O	O	O
workflow	O	O	B-T077
for	O	O	O
the	O	O	O
rapid	O	O	B-T080
generation	O	O	B-T063
of	O	O	I-T063
targeted	O	O	I-T063
heterozygous	O	O	I-T063
and	O	O	I-T063
homozygous	O	O	I-T063
genomic	O	O	I-T063
sequence	O	O	I-T063
alterations	O	O	I-T063
in	O	O	O
renal	O	O	B-T023
cells	O	O	B-T025
using	O	O	O
transcription	O	O	B-T116
activator-like	O	O	I-T116
effector	O	O	I-T116
nucleases	O	O	I-T116
(	O	O	O
TALENs	O	O	B-T116
)	O	O	O
and	O	O	O
the	O	O	O
clustered	O	O	B-T114
regularly	O	O	I-T114
interspaced	O	O	I-T114
short	O	O	I-T114
palindromic	O	O	I-T114
repeat	O	O	I-T114
(	O	O	I-T114
CRISPR	O	O	I-T114
)	O	O	I-T114
system	O	O	I-T114
.	O	O	O

We	O	O	O
demonstrate	O	O	O
the	O	O	O
versatility	O	O	O
of	O	O	O
established	O	O	O
protocols	O	O	B-T170
by	O	O	O
generating	O	O	B-T052
novel	O	O	B-T080
cellular	O	O	B-T075
models	O	O	I-T075
for	O	O	O
studying	O	O	B-T062
autosomal	O	O	B-T047
dominant	O	O	I-T047
polycystic	O	O	I-T047
kidney	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
ADPKD	O	O	B-T047
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
cell	O	O	B-T063
culture-validated	O	O	I-T063
genetic	O	O	I-T063
modifications	O	O	I-T063
can	O	O	O
be	O	O	O
readily	O	O	O
applied	O	O	O
to	O	O	O
mouse	O	O	B-T015
embryonic	O	O	I-T025
stem	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
mESCs	O	O	B-T025
)	O	O	O
for	O	O	O
the	O	O	O
generation	O	O	B-T052
of	O	O	O
corresponding	O	O	O
mouse	O	O	O
models	O	O	B-T008
.	O	O	O

The	O	O	O
described	O	O	O
procedure	O	O	B-T169
for	O	O	O
efficient	O	O	O
genome	O	O	B-T063
editing	O	O	I-T063
can	O	O	O
be	O	O	O
applied	O	O	O
to	O	O	O
any	O	O	O
cell	O	O	B-T170
type	O	O	I-T170
to	O	O	O
study	O	O	B-T062
physiological	O	O	B-T039
and	O	O	O
pathophysiological	O	O	B-T046
functions	O	O	I-T046
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
precisely	O	O	O
engineered	O	O	B-T028
genotypes	O	O	I-T028
.	O	O	O

-DOCSTART- (27988278)

Right	O	O	B-T023
Ventricular	O	O	I-T023
Response	O	O	B-T032
During	O	O	B-T079
Exercise	O	O	B-T056
in	O	O	O
Patients	O	O	B-T101
with	O	O	O
Chronic	O	O	O
Obstructive	O	O	O
Pulmonary	O	O	O
Disease	O	O	O

Right	O	O	B-T023
ventricular	O	O	I-T023
(	O	O	O
RV	O	O	B-T023
)	O	O	O
pump	O	O	B-T042
function	O	O	I-T042
is	O	O	O
of	O	O	O
essential	O	O	B-T080
clinical	O	O	B-T080
and	O	O	O
prognostic	O	O	B-T170
importance	O	O	B-T080
in	O	O	O
a	O	O	O
variety	O	O	B-T077
of	O	O	O
heart	O	O	B-T047
and	O	O	O
lung	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

While	O	O	O
the	O	O	O
evaluation	O	O	B-T058
of	O	O	O
RV	O	O	B-T023
performance	O	O	B-T052
at	O	O	O
rest	O	O	B-T056
has	O	O	O
been	O	O	O
implemented	O	O	O
in	O	O	O
the	O	O	O
clinical	O	O	B-T082
setting	O	O	I-T082
,	O	O	O
it	O	O	O
is	O	O	O
unknown	O	O	O
whether	O	O	O
this	O	O	O
assessment	O	O	B-T058
during	O	O	B-T079
exercise	O	O	B-T056
may	O	O	O
provide	O	O	O
additional	O	O	B-T169
benefit	O	O	B-T081
.	O	O	O

With	O	O	O
this	O	O	O
aim	O	O	B-T078
,	O	O	O
we	O	O	O
evaluated	O	O	B-T058
the	O	O	O
exercise	O	O	B-T056
-	O	O	O
induced	O	O	B-T169
pulmonary	O	O	B-T060
arterial	O	O	I-T060
systolic	O	O	I-T060
pressure	O	O	I-T060
(	O	O	O
PASP	O	O	B-T060
)	O	O	O
increase	O	O	B-T169
during	O	O	B-T079
exercise	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
severe	O	O	B-T080
chronic	O	O	B-T047
obstructive	O	O	I-T047
pulmonary	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
COPD	O	O	B-T047
)	O	O	O
as	O	O	O
an	O	O	O
expression	O	O	O
of	O	O	O
RV	O	O	B-T023
contractile	O	O	B-T081
reserve	O	O	I-T081
.	O	O	O

Cardiopulmonary	O	O	B-T060
exercise	O	O	I-T060
testing	O	O	I-T060
(	O	O	O
CPET	O	O	B-T060
)	O	O	O
with	O	O	O
synchronic	O	O	B-T060
echocardiography	O	O	I-T060
was	O	O	O
performed	O	O	B-T169
in	O	O	O
81	O	O	O
patients	O	O	B-T101
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
classified	O	O	B-T185
into	O	O	O
two	O	O	O
groups	O	O	B-T078
according	O	O	O
to	O	O	O
an	O	O	O
exercise	O	O	B-T056
-	O	O	O
induced	O	O	B-T169
PASP	O	O	B-T060
increase	O	O	B-T169
above	O	O	O
30mmHg	O	O	O
(	O	O	O
High	O	O	B-T080
PSAP	O	O	B-T060
)	O	O	O
or	O	O	O
below	O	O	O
30mmHg	O	O	O
(	O	O	O
Low	O	O	B-T080
PSAP	O	O	O
)	O	O	O
during	O	O	B-T079
maximal	O	O	B-T080
exercise	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
then	O	O	O
followed	O	O	B-T079
for	O	O	O
three	O	O	O
years	O	O	B-T079
.	O	O	O

Sixteen	O	O	O
patients	O	O	B-T101
(	O	O	O
20	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
low	O	O	B-T080
PSAP	O	O	B-T060
and	O	O	O
65	O	O	O
(	O	O	O
80	O	O	O
%	O	O	O
)	O	O	O
showed	O	O	O
high	O	O	B-T080
PSAP	O	O	O
.	O	O	O

These	O	O	O
were	O	O	O
not	O	O	B-T033
significant	O	O	I-T033
clinical	O	O	B-T080
and	O	O	O
functional	O	O	B-T169
differences	O	O	B-T081
.	O	O	O

Low	O	O	B-T080
PSAP	O	O	B-T060
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
peak	O	O	B-T080
VO2	O	O	B-T033
(	O	O	O
mean	O	O	B-T081
(	O	O	O
SD	O	O	B-T081
)	O	O	O
,	O	O	O
35	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
%	O	O	O
predicted	O	O	B-T078
)	O	O	O
compared	O	O	B-T052
to	O	O	O
high	O	O	B-T080
PSAP	O	O	O
response	O	O	B-T032
(	O	O	O
peak	O	O	O
VO2	O	O	O
45	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
%	O	O	O
predicted	O	O	O
)	O	O	O
,	O	O	O
p=0.045	O	O	O
.	O	O	O

Factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
mortality	O	O	B-T081
were	O	O	O
age	O	O	B-T032
and	O	O	O
exercise	O	O	B-T056
-	O	O	O
induced	O	O	B-T169
PASP	O	O	B-T060
.	O	O	O

Seventeen	O	O	O
patients	O	O	B-T101
died	O	O	O
during	O	O	B-T079
the	O	O	O
three	O	O	O
years	O	O	B-T079
of	O	O	O
follow-up	O	O	B-T058
(	O	O	O
7	O	O	O
(	O	O	O
39	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
low	O	O	B-T080
PSAP	O	O	B-T060
group	O	O	B-T078
and	O	O	O
only	O	O	O
10	O	O	O
(	O	O	O
1	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
high	O	O	B-T080
PSAP	O	O	O
group	O	O	O
,	O	O	O
p=0.041	O	O	O
)	O	O	O
.	O	O	O

Cardiopulmonary	O	O	B-T060
exercise	O	O	I-T060
testing	O	O	I-T060
with	O	O	O
a	O	O	O
synchronic	O	O	B-T060
echocardiography	O	O	I-T060
may	O	O	O
be	O	O	O
a	O	O	O
useful	O	O	O
tool	O	O	O
for	O	O	O
the	O	O	O
assessment	O	O	B-T058
of	O	O	O
RV	O	O	B-T023
contractile	O	O	B-T081
reserve	O	O	I-T081
in	O	O	O
severe	O	O	B-T080
COPD	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

Exercise	O	O	B-T056
-	O	O	O
induced	O	O	B-T169
PSAP	O	O	B-T060
emerges	O	O	O
as	O	O	O
a	O	O	O
possible	O	O	O
prognostic	O	O	B-T201
factor	O	O	I-T201
in	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27989992)

Adverse	O	O	B-T169
outcomes	O	O	I-T169
in	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
attending	O	O	B-T169
emergency	O	O	B-T093
departments	O	O	I-T093
:	O	O	O
a	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
and	O	O	O
meta-analysis	O	O	B-T062
of	O	O	O
the	O	O	O
Identification	O	O	O
of	O	O	O
Seniors	O	O	O
At	O	O	O
Risk	O	O	O
(	O	O	O
ISAR	O	O	O
)	O	O	O
screening	O	O	O
tool	O	O	O

older	O	O	B-T098
adults	O	O	I-T098
are	O	O	O
frequent	O	O	B-T079
users	O	O	O
of	O	O	O
emergency	O	O	B-T058
services	O	O	I-T058
and	O	O	O
demonstrate	O	O	O
high	O	O	B-T080
rates	O	O	B-T081
of	O	O	O
adverse	O	O	B-T169
outcomes	O	O	I-T169
following	O	O	O
emergency	O	O	B-T061
care	O	O	I-T061
.	O	O	O

to	O	O	O
perform	O	O	O
a	O	O	O
systematic	O	O	B-T169
review	O	O	I-T170
and	O	O	O
meta-analysis	O	O	B-T062
of	O	O	O
the	O	O	O
Identification	O	O	B-T170
of	O	O	I-T170
Seniors	O	O	I-T170
At	O	O	I-T170
Risk	O	O	I-T170
(	O	O	I-T170
ISAR	O	O	I-T170
)	O	O	I-T170
screening	O	O	I-T170
tool	O	O	I-T170
,	O	O	O
to	O	O	O
determine	O	O	O
its	O	O	O
predictive	O	O	B-T080
value	O	O	I-T080
in	O	O	O
identifying	O	O	O
adults	O	O	B-T100
≥65	O	O	O
years	O	O	B-T079
at	O	O	O
risk	O	O	B-T078
of	O	O	O
functional	O	O	B-T033
decline	O	O	I-T033
,	O	O	O
unplanned	O	O	O
emergency	O	O	B-T067
department	O	O	I-T058
(	O	O	I-T058
ED	O	O	I-T058
)	O	O	I-T058
readmission	O	O	I-T058
,	O	O	O
emergency	O	O	O
hospitalisation	O	O	B-T058
or	O	O	O
death	O	O	B-T033
within	O	O	O
180	O	O	O
days	O	O	B-T079
after	O	O	O
index	O	O	O
ED	O	O	B-T058
visit	O	O	I-T058
/	O	O	O
hospitalisation	O	O	O
.	O	O	O
a	O	O	O
systematic	O	O	O
literature	O	O	B-T170
search	O	O	B-T052
was	O	O	O
conducted	O	O	O
in	O	O	O
PubMed	O	O	B-T170
,	O	O	O
EMBASE	O	O	B-T170
,	O	O	O
CINAHL	O	O	B-T170
,	O	O	O
EBSCO	O	O	B-T170
and	O	O	O
the	O	O	O
Cochrane	O	O	B-T170
Library	O	O	I-T170
to	O	O	O
identify	O	O	O
validation	O	O	B-T062
and	O	O	O
impact	O	O	B-T080
analysis	O	O	B-T062
studies	O	O	O
of	O	O	O
the	O	O	O
ISAR	O	O	B-T170
tool	O	O	I-T170
.	O	O	O

A	O	O	O
pre-specified	O	O	B-T080
ISAR	O	O	B-T170
score	O	O	B-T081
of	O	O	O
≥2	O	O	O
(	O	O	O
maximum	O	O	O
score	O	O	O
6	O	O	O
points	O	O	O
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
identify	O	O	O
patients	O	O	B-T101
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
adverse	O	O	B-T169
outcomes	O	O	I-T169
.	O	O	O

A	O	O	O
bivariate	O	O	B-T170
random	O	O	I-T170
effects	O	O	I-T170
model	O	O	I-T170
generated	O	O	O
pooled	O	O	B-T169
estimates	O	O	B-T081
of	O	O	O
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
.	O	O	O

Statistical	O	O	B-T080
heterogeneity	O	O	I-T080
was	O	O	O
explored	O	O	O
and	O	O	O
methodological	O	O	B-UnknownType
quality	O	O	I-UnknownType
was	O	O	O
assessed	O	O	O
using	O	O	O
validated	O	O	B-T078
criteria	O	O	I-T078
.	O	O	O

thirty-two	O	O	O
validation	O	O	B-T062
studies	O	O	I-T062
(	O	O	O
n	O	O	O
=	O	O	O
12,939	O	O	O
)	O	O	O
are	O	O	O
included	O	O	B-T169
.	O	O	O

At	O	O	O
≥2	O	O	O
,	O	O	O
the	O	O	O
pooled	O	O	B-T169
sensitivity	O	O	B-T081
of	O	O	O
the	O	O	O
ISAR	O	O	B-T170
for	O	O	O
predicting	O	O	O
ED	O	O	B-T093
return	O	O	B-T080
,	O	O	O
emergency	O	O	B-T067
hospitalisation	O	O	B-T058
and	O	O	O
mortality	O	O	B-T081
at	O	O	O
6	O	O	O
months	O	O	B-T079
is	O	O	O
0.80	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
0.70	O	O	O
-	O	O	O
0.87	O	O	O
)	O	O	O
,	O	O	O
0.82	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.74	O	O	O
-	O	O	O
0.88	O	O	O
)	O	O	O
and	O	O	O
0.87	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.75	O	O	O
-	O	O	O
0.94	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
with	O	O	O
a	O	O	O
pooled	O	O	O
specificity	O	O	B-T081
of	O	O	O
0.31	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.24	O	O	O
-	O	O	O
0.38	O	O	O
)	O	O	O
,	O	O	O
0.32	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.24	O	O	O
-	O	O	O
0.41	O	O	O
)	O	O	O
and	O	O	O
0.35	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.26	O	O	O
-	O	O	O
0.44	O	O	O
)	O	O	O
.	O	O	O

Similar	O	O	O
values	O	O	B-T080
are	O	O	O
demonstrated	O	O	O
at	O	O	O
30	O	O	O
and	O	O	O
90	O	O	O
days	O	O	B-T079
.	O	O	O

Three	O	O	O
heterogeneous	O	O	B-T080
impact	O	O	B-T080
analysis	O	O	B-T062
studies	O	O	O
examined	O	O	B-T033
the	O	O	O
clinical	O	O	B-T080
implementation	O	O	B-T052
of	O	O	O
the	O	O	O
ISAR	O	O	B-T170
and	O	O	O
reported	O	O	O
mixed	O	O	B-T169
findings	O	O	I-T169
across	O	O	O
patient	O	O	B-T101
and	O	O	O
process	O	O	B-T067
outcomes	O	O	B-T169
.	O	O	O

the	O	O	O
ISAR	O	O	B-T170
has	O	O	O
modest	O	O	O
predictive	O	O	B-T080
accuracy	O	O	B-T080
and	O	O	O
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
decision-making	O	O	B-T041
adjunct	O	O	B-T169
when	O	O	O
determining	O	O	O
which	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
can	O	O	O
be	O	O	O
safely	O	O	O
discharged	O	O	B-T058
.	O	O	O

-DOCSTART- (27991947)

Ecohydrological	O	O	B-T062
modeling	O	O	I-T062
and	O	O	O
environmental	O	O	B-T082
flow	O	O	B-T070
regime	O	O	B-T080
in	O	O	O
the	O	O	O
Formoso	O	O	B-T070
River	O	O	I-T070
,	O	O	O
Minas	O	O	B-T083
Gerais	O	O	I-T083
State	O	O	I-T083
,	O	O	O
Brazil	O	O	O

This	O	O	O
paper	O	O	B-T170
aimed	O	O	O
at	O	O	O
determining	O	O	B-T080
the	O	O	O
environmental	O	O	B-T082
flow	O	O	B-T070
regime	O	O	O
in	O	O	O
a	O	O	O
1	O	O	B-T081
km	O	O	I-T081
stretch	O	O	B-T081
of	O	O	O
the	O	O	O
Formoso	O	O	B-T070
River	O	O	I-T070
,	O	O	O
MG	O	O	B-T083
,	O	O	O
using	O	O	O
River2D	O	O	B-T062
model	O	O	I-T062
.	O	O	O

To	O	O	O
carry	O	O	O
out	O	O	O
the	O	O	O
ecohydrological	O	O	B-T062
modeling	O	O	I-T062
,	O	O	O
the	O	O	O
following	O	O	B-T079
information	O	O	B-T078
was	O	O	O
used	O	O	O
:	O	O	O
bathymetry	O	O	B-T081
,	O	O	O
physical	O	O	B-T169
and	O	O	O
hydraulic	O	O	B-T169
features	O	O	B-T080
,	O	O	O
and	O	O	O
the	O	O	O
Habitat	O	O	B-T082
Suitability	O	O	B-T080
Index	O	O	I-T080
for	O	O	O
species	O	O	B-T185
of	O	O	O
the	O	O	O
Hypostomus	O	O	B-T013
auroguttatus	O	O	I-T013
.	O	O	O

In	O	O	O
the	O	O	O
River2D	O	O	B-T062
,	O	O	O
the	O	O	O
Weighted	O	O	B-T081
Usable	O	O	B-T080
Areas	O	O	B-T082
were	O	O	O
determined	O	O	B-T080
from	O	O	O
the	O	O	O
average	O	O	B-T081
long-term	O	O	B-T079
streamflows	O	O	B-T070
with	O	O	O
percentage	O	O	B-T081
from	O	O	O
10	O	O	O
%	O	O	O
to	O	O	O
100	O	O	O
%	O	O	O
.	O	O	O

Those	O	O	O
streamflows	O	O	B-T070
were	O	O	O
simulated	O	O	O
for	O	O	O
the	O	O	O
later	O	O	B-T079
construction	O	O	B-T169
of	O	O	O
optimization	O	O	B-T052
matrices	O	O	B-T082
that	O	O	O
maximize	O	O	B-T081
the	O	O	O
habitat	O	O	B-T082
area	O	O	B-T082
throughout	O	O	B-T169
the	O	O	O
year	O	O	B-T079
.	O	O	O

For	O	O	O
H.	O	O	B-T013
auroguttatus	O	O	I-T013
Juvenile	O	O	B-T100
,	O	O	O
higher	O	O	B-T080
values	O	O	B-T080
of	O	O	O
Weighted	O	O	B-T081
Usable	O	O	B-T080
Area	O	O	B-T082
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
percentage	O	O	B-T081
of	O	O	O
60	O	O	O
%	O	O	O
and	O	O	O
70	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
average	O	O	B-T081
long-term	O	O	B-T079
streamflows	O	O	B-T070
in	O	O	O
October	O	O	B-T079
and	O	O	O
September	O	O	B-T079
,	O	O	O
respectively	O	O	O
.	O	O	O

For	O	O	O
H.	O	O	B-T013
auroguttatus	O	O	I-T013
Adult	O	O	B-T100
,	O	O	O
the	O	O	O
highest	O	O	B-T080
value	O	O	B-T080
of	O	O	O
Weighted	O	O	B-T081
Usable	O	O	B-T080
Area	O	O	B-T082
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
percentage	O	O	B-T081
of	O	O	O
100	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
average	O	O	B-T081
long-term	O	O	B-T079
streamflow	O	O	B-T070
in	O	O	O
September	O	O	B-T079
.	O	O	O

The	O	O	O
environmental	O	O	B-T082
flows	O	O	B-T070
found	O	O	B-T033
for	O	O	O
this	O	O	O
stretch	O	O	B-T081
of	O	O	O
the	O	O	O
Formoso	O	O	B-T070
River	O	O	I-T070
varied	O	O	B-T169
over	O	O	B-T079
the	O	O	O
year	O	O	B-T079
.	O	O	O

The	O	O	O
lowest	O	O	B-T080
environmental	O	O	B-T082
flow	O	O	B-T070
was	O	O	O
observed	O	O	B-T169
in	O	O	O
December	O	O	B-T080
(	O	O	O
2.85	O	O	O
m3	O	O	O
s-1	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
highest	O	O	B-T080
was	O	O	O
observed	O	O	O
in	O	O	O
May	O	O	B-T079
(	O	O	O
4.13	O	O	O
m3	O	O	O
s-1	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
paper	O	O	B-T170
shows	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
ecohydrological	O	O	B-T062
studies	O	O	I-T062
in	O	O	O
forming	O	O	B-T169
a	O	O	O
basis	O	O	B-T169
for	O	O	O
water	O	O	B-T070
resources	O	O	I-T070
management	O	O	B-T080
actions	O	O	B-T052
.	O	O	O

-DOCSTART- (27992983)

Risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
hepatitis	O	O	B-T047
C	O	O	I-T047
virus	O	O	I-T047
infection	O	O	I-T047
in	O	O	O
the	O	O	O
Colombian	O	O	B-T098
Caribbean	O	O	B-T083
coast	O	O	I-T083
:	O	O	O
A	O	O	O
case-control	O	O	O
study	O	O	O

An	O	O	O
estimated	O	O	O
6.8	O	O	O
-	O	O	O
8.9	O	O	O
million	O	O	B-T081
people	O	O	B-T098
are	O	O	O
infected	O	O	B-T033
with	O	O	O
hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
in	O	O	O
Latin	O	O	B-T083
America	O	O	I-T083
,	O	O	O
of	O	O	O
which	O	O	O
less	O	O	B-T081
than	O	O	I-T081
1	O	O	O
%	O	O	O
receives	O	O	O
antiviral	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

Studies	O	O	B-T062
so	O	O	O
far	O	O	O
in	O	O	O
Colombia	O	O	B-T083
have	O	O	O
attempted	O	O	B-T051
to	O	O	O
determine	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
the	O	O	O
disease	O	O	B-T047
in	O	O	O
some	O	O	O
risk	O	O	B-T078
groups	O	O	B-T098
,	O	O	O
thus	O	O	O
preventing	O	O	B-T169
the	O	O	O
identification	O	O	B-T080
of	O	O	O
other	O	O	O
factors	O	O	B-T169
potentially	O	O	B-T080
involved	O	O	O
in	O	O	O
the	O	O	O
spread	O	O	O
of	O	O	O
the	O	O	O
infection	O	O	B-T046
.	O	O	O

To	O	O	O
identify	O	O	B-T080
traditional	O	O	O
and	O	O	O
non-traditional	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
chronic	O	O	B-T047
hepatitis	O	O	I-T047
C	O	O	I-T047
in	O	O	O
the	O	O	O
Colombian	O	O	B-T098
Caribbean	O	O	B-T083
coast	O	O	I-T083
.	O	O	O

This	O	O	O
was	O	O	O
a	O	O	O
case-control	O	O	B-T062
study	O	O	I-T062
(	O	O	O
1:3	O	O	O
)	O	O	O
matched	O	O	O
by	O	O	O
health	O	O	B-T097
care	O	O	I-T097
provider	O	O	I-T097
and	O	O	O
age	O	O	B-T032
(	O	O	O
±	O	O	O
10	O	O	O
years	O	O	B-T079
)	O	O	O
conducted	O	O	O
at	O	O	O
the	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
level	O	O	I-T058
of	O	O	O
gastroenterology	O	O	B-T091
and	O	O	O
hepatology	O	O	B-T091
outpatient	O	O	B-T058
services	O	O	I-T058
.	O	O	O

All	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
positive	O	O	B-T033
ELISA	O	O	B-T059
underwent	O	O	O
a	O	O	O
confirmatory	O	O	B-UnknownType
viral	O	O	B-T059
load	O	O	I-T059
test	O	O	I-T059
.	O	O	O

A	O	O	O
multivariate	O	O	B-UnknownType
logistic	O	O	I-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
identified	O	O	B-T080
the	O	O	O
independent	O	O	B-T078
predictors	O	O	I-T078
of	O	O	O
infection	O	O	B-T046
.	O	O	O

Blood	O	O	B-T061
transfusion	O	O	I-T061
(	O	O	O
OR	O	O	B-T081
=	O	O	O
159.2	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
35.4	O	O	O
-	O	O	O
715	O	O	O
;	O	O	O
p<0.001	O	O	O
)	O	O	O
and	O	O	O
history	O	O	B-T201
of	O	O	I-T201
hospitalization	O	O	I-T201
before	O	O	O
1994	O	O	O
(	O	O	O
OR	O	O	O
=	O	O	O
4.7	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.3	O	O	O
-	O	O	O
17.1	O	O	O
;	O	O	O
p=0.018	O	O	O
)	O	O	O
were	O	O	O
identified	O	O	B-T080
as	O	O	O
the	O	O	O
only	O	O	O
two	O	O	O
independent	O	O	B-T078
predictors	O	O	I-T078
of	O	O	O
infection	O	O	B-T046
.	O	O	O

It	O	O	O
is	O	O	O
necessary	O	O	O
to	O	O	O
check	O	O	O
the	O	O	O
reproducibility	O	O	B-T081
of	O	O	I-T081
these	O	O	I-T081
results	O	O	I-T081
and	O	O	O
to	O	O	O
conduct	O	O	O
cost-effectiveness	O	O	B-T081
studies	O	O	B-T062
before	O	O	O
recommending	O	O	B-T078
their	O	O	O
use	O	O	B-T169
in	O	O	O
the	O	O	O
design	O	O	B-T052
of	O	O	O
new	O	O	B-T062
screening	O	O	I-T062
strategies	O	O	I-T062
.	O	O	O

-DOCSTART- (27993519)

Quo	O	O	O
vadis	O	O	O
G	O	O	B-T044
protein-coupled	O	O	I-T044
receptor	O	O	I-T044
ligands	O	O	I-T044
?	O	O	O
A	O	O	O
tool	O	O	O
for	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
emergence	O	O	B-T078
of	O	O	O
new	O	O	O
groups	O	O	B-T078
of	O	O	O
compounds	O	O	B-T103
over	O	O	O
time	O	O	O

A	O	O	O
tool	O	O	O
for	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
emergence	O	O	B-T078
of	O	O	O
new	O	O	O
groups	O	O	B-T078
of	O	O	O
compounds	O	O	B-T103
over	O	O	B-T079
time	O	O	I-T079
Exponential	O	O	B-T081
growth	O	O	B-T067
in	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	O
compounds	O	O	O
with	O	O	O
experimentally	O	O	B-T080
verified	O	O	B-T169
activity	O	O	B-T052
towards	O	O	O
particular	O	O	O
target	O	O	B-T169
has	O	O	O
led	O	O	O
to	O	O	O
the	O	O	O
emergence	O	O	O
of	O	O	O
various	O	O	O
databases	O	O	B-T170
gathering	O	O	O
data	O	O	B-T078
on	O	O	O
biological	O	O	B-T080
activity	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
ligands	O	O	B-T103
of	O	O	O
family	O	O	B-T116
A	O	O	I-T116
of	O	O	I-T116
the	O	O	I-T116
G	O	O	I-T116
Protein-Coupled	O	O	I-T116
Receptors	O	O	I-T116
that	O	O	O
are	O	O	O
collected	O	O	B-T078
in	O	O	O
the	O	O	O
ChEMBL	O	O	B-T170
database	O	O	I-T170
were	O	O	O
examined	O	O	B-T033
,	O	O	O
and	O	O	O
special	O	O	O
attention	O	O	O
was	O	O	O
given	O	O	O
to	O	O	O
serotonin	O	O	B-T116
receptors	O	O	I-T116
.	O	O	O

Sets	O	O	B-T077
of	O	O	O
compounds	O	O	B-T103
were	O	O	O
examined	O	O	B-T033
in	O	O	O
terms	O	O	O
of	O	O	O
their	O	O	O
appearance	O	O	B-T080
over	O	O	B-T079
time	O	O	I-T079
,	O	O	O
they	O	O	O
were	O	O	O
mapped	O	O	B-T052
to	O	O	O
the	O	O	O
chemical	O	O	B-T104
space	O	O	I-T104
of	O	O	O
drugs	O	O	B-T121
deposited	O	O	O
in	O	O	O
DrugBank	O	O	B-T170
,	O	O	O
and	O	O	O
the	O	O	O
emergence	O	O	B-T078
of	O	O	O
structurally	O	O	B-T104
new	O	O	I-T104
clusters	O	O	I-T104
of	O	O	I-T104
compounds	O	O	I-T104
was	O	O	O
indicated	O	O	B-T033
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
a	O	O	O
tool	O	O	O
for	O	O	O
detailed	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
obtained	O	O	B-T169
visualizations	O	O	B-T170
was	O	O	O
prepared	O	O	B-T033
and	O	O	O
made	O	O	O
available	O	O	B-T169
online	O	O	B-UnknownType
at	O	O	O
http://chem.gmum.net/vischem	O	O	B-T170
,	O	O	O
which	O	O	O
enables	O	O	O
the	O	O	O
investigation	O	O	B-T080
of	O	O	O
chemical	O	O	B-T170
structures	O	O	I-T170
while	O	O	O
referring	O	O	B-T169
to	O	O	O
particular	O	O	O
data	O	O	B-T033
points	O	O	I-T033
depicted	O	O	O
in	O	O	O
the	O	O	O
figures	O	O	B-UnknownType
and	O	O	O
changes	O	O	B-T169
in	O	O	O
compounds	O	O	B-T103
datasets	O	O	B-T170
over	O	O	B-T079
time	O	O	I-T079
.	O	O	O

-DOCSTART- (27995352)

Diabetes	O	O	B-T047
and	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
mortality	O	O	B-T081
in	O	O	O
Black	O	O	O
women	O	O	O

Breast	O	O	B-T191
cancer	O	O	I-T191
mortality	O	O	B-T081
is	O	O	O
higher	O	O	O
in	O	O	O
Black	O	O	B-T098
women	O	O	I-T098
than	O	O	O
in	O	O	O
White	O	O	B-T098
women	O	O	I-T098
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	B-T047
mellitus	O	O	I-T047
is	O	O	O
also	O	O	O
higher	O	O	O
,	O	O	O
yet	O	O	O
data	O	O	B-T078
on	O	O	O
whether	O	O	O
diabetes	O	O	O
affects	O	O	B-T080
breast	O	O	B-T191
cancer	O	O	I-T191
mortality	O	O	B-T081
in	O	O	O
this	O	O	O
population	O	O	B-T098
are	O	O	O
lacking	O	O	B-T080
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
the	O	O	O
relation	O	O	O
of	O	O	O
diabetes	O	O	B-T047
at	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
diagnosis	O	O	B-T033
to	O	O	O
breast	O	O	O
cancer	O	O	O
mortality	O	O	B-T081
in	O	O	O
the	O	O	O
Black	O	O	B-T098
Women	O	O	I-T098
's	O	O	I-T098
Health	O	O	B-T058
Study	O	O	B-T062
,	O	O	O
a	O	O	O
prospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
.	O	O	O

1,621	O	O	O
Black	O	O	B-T098
women	O	O	I-T098
with	O	O	O
invasive	O	O	B-T080
breast	O	O	B-T191
cancer	O	O	I-T191
diagnosed	O	O	B-T033
in	O	O	O
1995	O	O	O
-	O	O	O
2013	O	O	O
were	O	O	O
followed	O	O	B-T079
by	O	O	I-T079
mailed	O	O	O
questionnaires	O	O	B-T170
and	O	O	O
searches	O	O	O
of	O	O	O
the	O	O	O
National	O	O	B-T170
Death	O	O	I-T170
Index	O	O	I-T170
.	O	O	O

Multivariable	O	O	B-T170
Cox	O	O	I-T170
regression	O	O	I-T170
analysis	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
compute	O	O	O
hazard	O	O	B-T081
ratios	O	O	I-T081
(	O	O	O
HRs	O	O	B-T081
)	O	O	O
for	O	O	O
diabetes	O	O	B-T047
in	O	O	O
relation	O	O	O
to	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
mortality	O	O	B-T081
and	O	O	O
all-cause	O	O	O
mortality	O	O	O
,	O	O	O
with	O	O	O
adjustment	O	O	O
for	O	O	O
age	O	O	B-T032
,	O	O	O
stage	O	O	B-T201
,	O	O	O
treatment	O	O	B-T061
modality	O	O	I-T061
,	O	O	O
estrogen	O	O	B-T116
receptor	O	O	I-T116
(	O	O	O
ER	O	O	B-T116
)	O	O	O
status	O	O	B-T080
,	O	O	O
and	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
.	O	O	O

There	O	O	O
were	O	O	O
368	O	O	O
deaths	O	O	B-T033
during	O	O	O
follow-up	O	O	B-T058
,	O	O	O
of	O	O	O
which	O	O	O
273	O	O	O
were	O	O	O
due	O	O	O
to	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Breast	O	O	B-T191
cancer	O	O	I-T191
mortality	O	O	B-T081
was	O	O	O
significantly	O	O	B-T081
increased	O	O	I-T081
in	O	O	O
women	O	O	B-T098
who	O	O	O
had	O	O	O
been	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
diabetes	O	O	B-T047
at	O	O	O
least	O	O	O
5	O	O	O
years	O	O	O
before	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
occurrence	O	O	B-T079
,	O	O	O
HR	O	O	B-T081
1.86	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.20	O	O	O
-	O	O	O
2.89	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
elevations	O	O	B-T082
observed	O	O	B-T169
for	O	O	O
both	O	O	O
ER+	O	O	B-T033
and	O	O	O
ER-	O	O	B-T033
breast	O	O	O
cancer	O	O	O
.	O	O	O

All-cause	O	O	O
mortality	O	O	B-T081
was	O	O	O
also	O	O	O
higher	O	O	O
in	O	O	O
diabetics	O	O	B-T033
,	O	O	O
with	O	O	O
HRs	O	O	B-T081
of	O	O	O
1.54	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.12	O	O	O
-	O	O	O
2.07	O	O	O
)	O	O	O
overall	O	O	B-T080
and	O	O	O
2.26	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.62	O	O	O
-	O	O	O
3.15	O	O	O
)	O	O	O
for	O	O	O
≥5-year	O	O	O
duration	O	O	O
of	O	O	O
diabetes	O	O	B-T047
relative	O	O	B-T080
to	O	O	O
non-diabetics	O	O	B-T033
.	O	O	O

Our	O	O	O
results	O	O	B-T034
present	O	O	B-T033
the	O	O	O
first	O	O	O
solid	O	O	O
evidence	O	O	B-T078
of	O	O	O
a	O	O	O
positive	O	O	B-T033
association	O	O	O
of	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
with	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
mortality	O	O	B-T081
in	O	O	O
Black	O	O	B-T098
women	O	O	I-T098
.	O	O	O

Given	O	O	O
the	O	O	O
higher	O	O	O
prevalence	O	O	B-T081
and	O	O	O
earlier	O	O	B-T033
onset	O	O	I-T033
of	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	B-T047
in	O	O	O
Black	O	O	B-T098
women	O	O	I-T098
,	O	O	O
it	O	O	O
is	O	O	O
likely	O	O	O
that	O	O	O
diabetes	O	O	O
contributes	O	O	B-T052
to	O	O	O
racial	O	O	B-T098
disparities	O	O	B-T033
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
mortality	O	O	B-T081
.	O	O	O

-DOCSTART- (27998307)

Neuro-Behcet	O	O	B-T047
disease	O	O	I-T047
presenting	O	O	B-T078
as	O	O	O
a	O	O	O
solitary	O	O	O
cerebellar	O	O	B-T046
hemorrhagic	O	O	I-T046
lesion	O	O	B-T033
:	O	O	O
a	O	O	O
case	O	O	B-T170
report	O	O	I-T170
and	O	O	O
review	O	O	O
of	O	O	O
the	O	O	O
literature	O	O	O

Behcet	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
is	O	O	O
a	O	O	O
heterogeneous	O	O	B-T033
,	O	O	O
multisystem	O	O	B-T047
,	O	O	O
inflammatory	O	O	B-T047
disorder	O	O	I-T047
of	O	O	O
unknown	O	O	B-T033
etiology	O	O	I-T033
.	O	O	O

The	O	O	O
classic	O	O	O
triad	O	O	O
of	O	O	O
oral	O	O	B-T047
and	O	O	O
genital	O	O	B-T047
ulcerations	O	O	I-T047
in	O	O	O
conjunction	O	O	B-T078
with	O	O	O
uveitis	O	O	B-T047
was	O	O	O
originally	O	O	O
described	O	O	B-T078
by	O	O	O
the	O	O	O
Turkish	O	O	B-T098
dermatologist	O	O	B-T097
Hulusi	O	O	O
Behcet	O	O	O
in	O	O	O
1937	O	O	O
,	O	O	O
but	O	O	O
associated	O	O	B-T184
symptoms	O	O	I-T184
of	O	O	O
the	O	O	O
cardiovascular	O	O	B-T022
,	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
,	O	O	O
pulmonary	O	O	B-T022
,	O	O	O
and	O	O	O
gastrointestinal	O	O	B-T022
systems	O	O	I-T022
were	O	O	O
later	O	O	O
identified	O	O	B-T080
.	O	O	O

In	O	O	O
fact	O	O	O
,	O	O	O
Behcet	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
with	O	O	O
neurological	O	O	B-T047
involvement	O	O	I-T047
(	O	O	O
neuro-Behcet	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
)	O	O	O
is	O	O	O
not	O	O	O
uncommon	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
neuro-Behcet	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
typically	O	O	O
exhibit	O	O	O
a	O	O	O
diverse	O	O	O
array	O	O	O
of	O	O	O
symptoms	O	O	B-T184
,	O	O	O
most	O	O	B-T081
commonly	O	O	B-T081
in	O	O	O
the	O	O	O
brainstem	O	O	B-T023
and	O	O	O
diencephalic	O	O	B-T023
regions	O	O	B-T082
.	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
report	O	O	B-T170
an	O	O	O
unusual	O	O	B-T080
case	O	O	B-T169
of	O	O	O
neuro-Behcet	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
a	O	O	O
patient	O	O	B-T101
who	O	O	O
presented	O	O	B-T078
with	O	O	O
a	O	O	O
solitary	O	O	O
cerebellar	O	O	B-T046
hemorrhage	O	O	I-T046
.	O	O	O

A	O	O	O
39-year-old	O	O	B-T100
Asian	O	O	B-T098
woman	O	O	B-T098
was	O	O	O
admitted	O	O	B-T058
to	O	O	O
our	O	O	O
hospital	O	O	B-T093
with	O	O	O
complaints	O	O	B-T033
of	O	O	O
a	O	O	O
sudden	O	O	B-T080
speech	O	O	B-T033
difficulty	O	O	I-T033
that	O	O	O
had	O	O	O
manifested	O	O	B-T169
the	O	O	O
same	O	O	B-T080
morning	O	O	B-T079
,	O	O	O
and	O	O	O
dizziness	O	O	B-T184
and	O	O	O
mild	O	O	B-T080
vomiting	O	O	B-T184
experienced	O	O	O
over	O	O	B-T079
the	O	O	O
previous	O	O	B-T079
3	O	O	O
days	O	O	B-T079
.	O	O	O

Magnetic	O	O	B-T170
resonance	O	O	I-T170
images	O	O	I-T170
revealed	O	O	B-T080
target-like	O	O	O
hemorrhagic	O	O	B-T046
lesions	O	O	B-T033
in	O	O	O
the	O	O	O
right	O	O	B-T023
hemisphere	O	O	I-T023
of	O	O	I-T023
the	O	O	I-T023
cerebellum	O	O	I-T023
.	O	O	O

Risk	O	O	B-T033
factors	O	O	I-T033
that	O	O	O
may	O	O	O
result	O	O	B-T169
in	O	O	O
cerebellar	O	O	B-T046
hemorrhage	O	O	I-T046
,	O	O	O
such	O	O	O
as	O	O	O
high	O	O	B-T047
blood	O	O	I-T047
pressure	O	O	I-T047
or	O	O	O
bleeding	O	O	B-T046
diathesis	O	O	I-T046
,	O	O	O
were	O	O	O
ruled	O	O	B-T033
out	O	O	I-T033
,	O	O	O
and	O	O	O
subsequent	O	O	B-T079
brain	O	O	B-T023
angiograms	O	O	B-T060
were	O	O	O
normal	O	O	B-T080
.	O	O	O

These	O	O	O
findings	O	O	B-T033
suggest	O	O	B-T078
that	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
cerebellar	O	O	B-T046
hemorrhage	O	O	I-T046
could	O	O	O
have	O	O	O
been	O	O	O
due	O	O	B-T169
to	O	O	I-T169
intracranial	O	O	B-T029
vasculitis	O	O	B-T047
in	O	O	O
a	O	O	O
rare	O	O	B-T080
,	O	O	O
if	O	O	O
not	O	O	O
unique	O	O	O
,	O	O	O
complication	O	O	B-T046
of	O	O	O
neuro-Behcet	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

-DOCSTART- (27999011)

Intrinsic	O	O	B-T082
rifamycin	O	O	B-T195
resistance	O	O	B-T032
of	O	O	O
Mycobacterium	O	O	B-T007
abscessus	O	O	I-T007
is	O	O	O
mediated	O	O	O
by	O	O	O
ADP-ribosyltransferase	O	O	B-T116
MAB_0591	O	O	O

Rifampicin	O	O	B-T195
,	O	O	O
a	O	O	O
potent	O	O	O
first-line	O	O	O
TB	O	O	B-T121
drug	O	O	I-T121
of	O	O	O
the	O	O	O
rifamycin	O	O	B-T195
group	O	O	I-T195
,	O	O	O
shows	O	O	O
only	O	O	O
little	O	O	O
activity	O	O	B-T169
against	O	O	O
the	O	O	O
emerging	O	O	O
pathogen	O	O	B-T001
Mycobacterium	O	O	B-T007
abscessus	O	O	I-T007
.	O	O	O

Reportedly	O	O	O
,	O	O	O
bacterial	O	O	B-T046
resistance	O	O	I-T046
to	O	O	O
rifampicin	O	O	B-T195
is	O	O	O
associated	O	O	O
with	O	O	O
polymorphisms	O	O	B-T045
in	O	O	O
the	O	O	O
target	O	O	O
gene	O	O	B-T028
rpoB	O	O	I-T028
or	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
enzymes	O	O	B-T116
that	O	O	O
modify	O	O	O
and	O	O	O
thereby	O	O	O
inactivate	O	O	O
rifampicin	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
MAB_0591	O	O	B-T028
(arrMab)-encoded	O	O	O
rifampicin	O	O	B-T195
ADP-ribosyltransferase	O	O	B-T116
(	O	O	O
Arr_Mab	O	O	B-T116
)	O	O	O
in	O	O	O
innate	O	O	O
high-level	O	O	O
rifampicin	O	O	O
resistance	O	O	B-T032
in	O	O	O
M.	O	O	B-T007
abscessus	O	O	I-T007
.	O	O	O

Recombinant	O	O	B-T001
Escherichia	O	O	B-T007
coli	O	O	I-T007
and	O	O	O
Mycobacterium	O	O	B-T007
tuberculosis	O	O	I-T007
strains	O	O	B-T001
expressing	O	O	B-T045
MAB_0591	O	O	B-T028
were	O	O	O
generated	O	O	O
,	O	O	O
as	O	O	O
was	O	O	O
an	O	O	O
M.	O	O	B-T007
abscessus	O	O	I-T007
deletion	O	O	B-T045
mutant	O	O	I-T045
deficient	O	O	B-T169
for	O	O	O
MAB_0591	O	O	O
.	O	O	O

MIC	O	O	B-T059
assays	O	O	I-T059
were	O	O	O
used	O	O	O
to	O	O	O
study	O	O	O
susceptibility	O	O	B-T169
to	O	O	O
rifampicin	O	O	B-T195
and	O	O	O
C25	O	O	B-T109
carbamate	O	O	I-T109
-modified	O	O	O
rifamycin	O	O	B-T195
derivatives	O	O	I-T195
.	O	O	O

Heterologous	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
MAB_0591	O	O	B-T028
conferred	O	O	O
rifampicin	O	O	B-T195
resistance	O	O	B-T032
to	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
and	O	O	O
M.	O	O	B-T007
tuberculosis	O	O	I-T007
Rifamycin	O	O	B-T195
MIC	O	O	B-T034
values	O	O	I-T034
were	O	O	O
consistently	O	O	O
lower	O	O	O
for	O	O	O
the	O	O	O
M.	O	O	B-T007
abscessus	O	O	I-T007
ΔarrMab	O	O	B-T028
mutant	O	O	I-T028
as	O	O	O
compared	O	O	B-T052
with	O	O	O
the	O	O	O
M.	O	O	B-T007
abscessus	O	O	I-T007
ATCC	O	O	I-T007
19977	O	O	I-T007
parental	O	O	B-T001
type	O	O	I-T001
strain	O	O	I-T001
.	O	O	O

The	O	O	O
rifamycin	O	O	B-T195
WT	O	O	B-T028
phenotype	O	O	B-T032
was	O	O	O
restored	O	O	O
after	O	O	O
complementation	O	O	B-T045
of	O	O	O
the	O	O	O
M.	O	O	B-T007
abscessus	O	O	I-T007
ΔarrMab	O	O	B-T028
mutant	O	O	I-T028
with	O	O	O
arrMab	O	O	B-T116
Further	O	O	O
MIC	O	O	B-T034
data	O	O	I-T034
demonstrated	O	O	O
that	O	O	O
a	O	O	O
C25	O	O	B-T109
modification	O	O	B-T033
increases	O	O	O
rifamycin	O	O	O
activity	O	O	B-T169
in	O	O	O
WT	O	O	O
M.	O	O	O
abscessus	O	O	O
However	O	O	O
,	O	O	O
MIC	O	O	B-T062
studies	O	O	I-T062
in	O	O	O
the	O	O	O
M.	O	O	O
abscessus	O	O	O
ΔarrMab	O	O	O
mutant	O	O	O
suggest	O	O	O
that	O	O	O
C25	O	O	O
modified	O	O	O
rifamycins	O	O	B-T195
are	O	O	O
still	O	O	O
subject	O	O	O
to	O	O	O
modification	O	O	O
by	O	O	O
Arr_Mab	O	O	B-T116
CONCLUSIONS	O	O	O
:	O	O	O
Our	O	O	O
findings	O	O	O
identify	O	O	O
Arr_Mab	O	O	O
as	O	O	O
the	O	O	O
major	O	O	O
innate	O	O	O
rifamycin	O	O	O
resistance	O	O	B-T032
determinant	O	O	O
of	O	O	O
M.	O	O	O
abscessus	O	O	O
.	O	O	O

Our	O	O	O
data	O	O	O
also	O	O	O
indicate	O	O	O
that	O	O	O
Arr_Mab	O	O	B-T116
-mediated	O	O	O
rifamycin	O	O	B-T195
resistance	O	O	B-T032
in	O	O	O
M.	O	O	B-T007
abscessus	O	O	I-T007
can	O	O	O
only	O	O	O
in	O	O	O
part	O	O	O
be	O	O	O
overcome	O	O	O
by	O	O	O
C25	O	O	B-T109
carbamate	O	O	I-T109
modification	O	O	B-T033
.	O	O	O

-DOCSTART- (28002691)

The	O	O	O
Silorane-based	O	O	B-T122
Resin	O	O	I-T122
Composites	O	O	I-T122
:	O	O	O
A	O	O	O
Review	O	O	O

This	O	O	O
article	O	O	B-T170
aims	O	O	O
to	O	O	O
review	O	O	B-T170
the	O	O	O
research	O	O	B-T062
done	O	O	O
on	O	O	O
the	O	O	O
silorane-based	O	O	B-T122
resin	O	O	I-T122
composites	O	O	I-T122
(	O	O	O
SBRC	O	O	B-T122
)	O	O	O
regarding	O	O	O
polymerization	O	O	B-T067
shrinkage	O	O	B-T169
and	O	O	O
contraction	O	O	B-T070
stresses	O	O	I-T070
and	O	O	O
their	O	O	O
ability	O	O	O
to	O	O	O
improve	O	O	O
the	O	O	O
shortcomings	O	O	O
of	O	O	O
the	O	O	O
methacrylate-based	O	O	B-T122
resin	O	O	I-T122
composites	O	O	I-T122
(	O	O	O
MRBC	O	O	B-T122
)	O	O	O
.	O	O	O

Special	O	O	O
attention	O	O	O
is	O	O	O
given	O	O	O
to	O	O	O
their	O	O	O
physical	O	O	B-T070
and	O	O	O
mechanical	O	O	B-T070
properties	O	O	I-T070
,	O	O	O
bond	O	O	B-T081
strength	O	O	I-T081
,	O	O	O
marginal	O	O	B-T061
adaptation	O	O	I-T061
,	O	O	O
and	O	O	O
cusp	O	O	B-T070
deflection	O	O	I-T070
.	O	O	O

The	O	O	O
clinical	O	O	B-T033
significance	O	O	I-T033
of	O	O	O
this	O	O	O
material	O	O	B-T167
is	O	O	O
critically	O	O	O
appraised	O	O	O
with	O	O	O
a	O	O	O
focus	O	O	O
on	O	O	O
the	O	O	O
ability	O	O	O
of	O	O	O
SBRC	O	O	B-T122
to	O	O	O
strengthen	O	O	O
the	O	O	O
tooth	O	O	B-T023
structure	O	O	I-T023
as	O	O	O
a	O	O	O
direct	O	O	B-T074
restorative	O	O	I-T074
material	O	O	I-T074
.	O	O	O

A	O	O	O
search	O	O	O
of	O	O	O
English	O	O	B-T171
peer-reviewed	O	O	B-T170
dental	O	O	I-T170
literature	O	O	I-T170
(	O	O	O
2003	O	O	O
-	O	O	O
2015	O	O	O
)	O	O	O
from	O	O	O
PubMed	O	O	B-T170
and	O	O	O
MEDLINE	O	O	B-T170
databases	O	O	B-T170
was	O	O	O
conducted	O	O	O
with	O	O	O
the	O	O	O
terms	O	O	O
"	O	O	O
low	O	O	B-T080
shrinkage	O	O	B-T169
"	O	O	O
and	O	O	O
"	O	O	O
silorane	O	O	B-T122
composites	O	O	I-T122
.	O	O	O
"	O	O	O
The	O	O	O
list	O	O	O
was	O	O	O
screened	O	O	O
,	O	O	O
and	O	O	O
70	O	O	O
articles	O	O	B-T170
that	O	O	O
were	O	O	O
relevant	O	O	O
to	O	O	O
the	O	O	O
objectives	O	O	B-T170
of	O	O	O
this	O	O	O
work	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

-DOCSTART- (28003168)

Endoscopic	O	O	B-T060
endonasal	O	O	B-T029
surgery	O	O	B-T061
for	O	O	O
remission	O	O	B-T033
of	O	O	O
Cushing	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
caused	O	O	O
by	O	O	O
ectopic	O	O	B-T082
intracavernous	O	O	B-T169
macroadenoma	O	O	B-T191
:	O	O	O
case	O	O	B-T170
report	O	O	I-T170
and	O	O	O
literature	O	O	O
review	O	O	O

Complete	O	O	O
surgical	O	O	B-T061
resection	O	O	I-T061
of	O	O	O
an	O	O	O
ACTH-secreting	O	O	B-T191
pituitary	O	O	I-T191
adenoma	O	O	I-T191
is	O	O	O
the	O	O	O
gold	O	O	B-T080
standard	O	O	I-T080
of	O	O	O
treatment	O	O	B-T061
of	O	O	O
Cushing	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
.	O	O	O

Ectopic	O	O	B-T082
location	O	O	B-T082
of	O	O	O
these	O	O	O
adenomas	O	O	B-T191
is	O	O	O
an	O	O	O
extremely	O	O	O
rare	O	O	B-T080
condition	O	O	O
that	O	O	O
may	O	O	O
compromise	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
surgical	O	O	B-T061
success	O	O	B-T054
.	O	O	O

We	O	O	O
present	O	O	O
the	O	O	O
first	O	O	O
case	O	O	O
of	O	O	O
an	O	O	O
ectopic	O	O	B-T082
intracavernous	O	O	B-T169
ACTH-secreting	O	O	B-T191
macroadenoma	O	O	I-T191
totally	O	O	O
resected	O	O	O
with	O	O	O
endoscopic	O	O	B-T060
endonasal	O	O	B-T029
surgery	O	O	B-T061
(	O	O	O
EES	O	O	B-T061
)	O	O	O
.	O	O	O

A	O	O	O
36	O	O	O
year	O	O	O
old	O	O	O
female	O	O	B-T032
presented	O	O	O
with	O	O	O
Cushing	O	O	B-T047
syndrome	O	O	I-T047
.	O	O	O

Increased	O	O	B-T081
ACTH	O	O	B-T116
,	O	O	O
serum	O	O	B-T125
cortisol	O	O	I-T125
and	O	O	O
free	O	O	B-T125
urine	O	O	I-T125
cortisol	O	O	I-T125
levels	O	O	B-T080
were	O	O	O
identified	O	O	O
,	O	O	O
however	O	O	O
the	O	O	O
pituitary	O	O	B-T060
MRI	O	O	I-T060
failed	O	O	O
to	O	O	O
reveal	O	O	O
a	O	O	O
pituitary	O	O	B-T191
tumor	O	O	I-T191
;	O	O	O
instead	O	O	O
,	O	O	O
a	O	O	O
parasellar	O	O	B-T033
lesion	O	O	I-T033
in	O	O	O
the	O	O	O
left	O	O	O
cavernous	O	O	B-T030
sinus	O	O	I-T030
(	O	O	O
CS	O	O	B-T030
)	O	O	O
was	O	O	O
noticed	O	O	O
.	O	O	O

Inferior	O	O	B-T060
petrosal	O	O	I-T060
sinus	O	O	I-T060
sampling	O	O	I-T060
demonstrated	O	O	O
a	O	O	O
significant	O	O	O
central	O	O	B-T082
-to-	O	O	O
peripheral	O	O	B-T082
and	O	O	O
lateralized	O	O	O
left-sided	O	O	O
ACTH	O	O	B-T116
gradient	O	O	O
.	O	O	O

The	O	O	O
patient	O	O	B-T101
underwent	O	O	O
EES	O	O	B-T061
.	O	O	O

No	O	O	B-T033
tumor	O	O	B-T191
was	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
sella	O	O	B-T023
,	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
left	O	O	O
CS	O	O	B-T030
was	O	O	O
widely	O	O	O
explored	O	O	O
and	O	O	O
a	O	O	O
tumor	O	O	O
was	O	O	O
found	O	O	O
lateral	O	O	B-T082
to	O	O	O
the	O	O	O
paraclival	O	O	O
segment	O	O	O
of	O	O	O
the	O	O	O
carotid	O	O	B-T023
artery	O	O	I-T023
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
complications	O	O	B-T046
following	O	O	O
EES	O	O	B-T061
.	O	O	O

Pathology	O	O	B-T091
confirmed	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
an	O	O	O
ACTH-secreting	O	O	B-T191
adenoma	O	O	I-T191
.	O	O	O

During	O	O	O
the	O	O	O
immediately	O	O	O
postoperative	O	O	B-T079
course	O	O	O
serum	O	O	B-T125
cortisol	O	O	I-T125
levels	O	O	B-T080
dropped	O	O	O
below	O	O	O
5	O	O	O
mcg/dl	O	O	O
.	O	O	O

Postoperative	O	O	B-T079
MRI	O	O	B-T060
demonstrated	O	O	O
complete	O	O	O
tumor	O	O	B-T061
resection	O	O	I-T061
.	O	O	O

At	O	O	O
20	O	O	O
months	O	O	O
follow-up	O	O	B-T058
,	O	O	O
the	O	O	O
patient	O	O	B-T101
remains	O	O	O
in	O	O	O
clinical	O	O	B-T080
and	O	O	O
biochemical	O	O	B-T169
remission	O	O	B-T033
of	O	O	O
Cushing	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
.	O	O	O

Only	O	O	O
12	O	O	O
cases	O	O	O
of	O	O	O
ectopic	O	O	B-T082
intracavernous	O	O	B-T169
ACTH-secreting	O	O	B-T191
adenomas	O	O	I-T191
have	O	O	O
been	O	O	O
reported	O	O	O
to	O	O	O
date	O	O	O
and	O	O	O
all	O	O	O
were	O	O	O
microadenomas	O	O	B-T191
.	O	O	O

The	O	O	O
presence	O	O	O
of	O	O	O
an	O	O	O
ectopic	O	O	B-T082
ACTH-secreting	O	O	B-T191
macroadenoma	O	O	I-T191
in	O	O	O
the	O	O	O
CS	O	O	B-T030
represents	O	O	O
a	O	O	O
surgical	O	O	B-T061
challenge	O	O	O
.	O	O	O

EES	O	O	B-T061
is	O	O	O
the	O	O	O
ideal	O	O	O
approach	O	O	O
for	O	O	O
complete	O	O	O
resection	O	O	B-T061
of	O	O	O
ectopic	O	O	B-T082
intracavernous	O	O	B-T169
adenomas	O	O	B-T191
allowing	O	O	O
for	O	O	O
a	O	O	O
wide	O	O	O
exploration	O	O	B-T061
of	O	O	O
the	O	O	O
CS	O	O	B-T030
with	O	O	O
no	O	O	B-T033
surgical	O	O	B-T061
complications	O	O	B-T046
.	O	O	O

-DOCSTART- (28005403)

Preliminary	O	O	O
Randomized	O	O	B-T062
Controlled	O	O	I-T062
Trial	O	O	I-T062
of	O	O	O
Habit	O	O	B-T061
Reversal	O	O	I-T061
Training	O	O	I-T061
for	O	O	O
Treatment	O	O	B-T061
of	O	O	O
Hair	O	O	B-T048
Pulling	O	O	I-T048
in	O	O	O
Youth	O	O	O

This	O	O	O
study	O	O	B-T062
evaluated	O	O	B-T058
the	O	O	O
treatment	O	O	B-T061
efficacy	O	O	B-T080
of	O	O	O
habit	O	O	B-T061
reversal	O	O	I-T061
training	O	O	I-T061
(	O	O	O
HRT	O	O	B-T061
)	O	O	O
relative	O	O	O
to	O	O	O
treatment	O	O	B-T077
as	O	O	I-T077
usual	O	O	I-T077
(	O	O	O
TAU	O	O	B-T077
)	O	O	O
for	O	O	O
children	O	O	B-T100
and	O	O	O
adolescents	O	O	B-T100
aged	O	O	B-T032
7	O	O	O
-	O	O	O
17	O	O	O
years	O	O	B-T079
with	O	O	O
a	O	O	O
primary	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
trichotillomania	O	O	B-T048
(	O	O	O
TTM	O	O	B-T048
)	O	O	O
.	O	O	O

An	O	O	O
initial	O	O	O
assessment	O	O	B-T058
consisting	O	O	O
of	O	O	O
semistructured	O	O	O
interviews	O	O	B-T052
and	O	O	O
rating	O	O	B-T081
scales	O	O	I-T081
was	O	O	O
conducted	O	O	O
.	O	O	O

Participants	O	O	B-T098
(	O	O	O
N	O	O	O
=	O	O	O
40	O	O	O
,	O	O	O
85	O	O	O
%	O	O	O
female	O	O	B-T032
)	O	O	O
meeting	O	O	O
diagnostic	O	O	B-T170
criteria	O	O	I-T170
for	O	O	O
TTM	O	O	B-T048
were	O	O	O
randomized	O	O	B-T062
to	O	O	O
either	O	O	O
8	O	O	O
weekly	O	O	B-T079
sessions	O	O	O
of	O	O	O
HRT	O	O	B-T061
by	O	O	O
trained	O	O	O
therapists	O	O	B-T097
or	O	O	O
8	O	O	O
weeks	O	O	B-T079
of	O	O	O
TAU	O	O	B-T077
.	O	O	O

One	O	O	O
week	O	O	B-T079
after	O	O	O
the	O	O	O
final	O	O	O
HRT	O	O	B-T061
session	O	O	O
or	O	O	O
final	O	O	O
TAU	O	O	B-T077
week	O	O	O
,	O	O	O
patients	O	O	B-T101
completed	O	O	O
a	O	O	O
posttreatment	O	O	B-T058
assessment	O	O	I-T058
,	O	O	O
followed	O	O	O
by	O	O	O
1-	O	O	O
and	O	O	O
3-	O	O	O
month	O	O	B-T079
follow-up	O	O	B-T058
assessments	O	O	B-T058
.	O	O	O

All	O	O	O
assessments	O	O	B-T058
were	O	O	O
conducted	O	O	O
by	O	O	O
a	O	O	O
trained	O	O	O
rater	O	O	B-T097
who	O	O	O
was	O	O	O
blinded	O	O	B-T062
to	O	O	O
treatment	O	O	B-T061
condition	O	O	B-T080
.	O	O	O

The	O	O	O
group	O	O	O
by	O	O	O
time	O	O	O
analysis	O	O	B-T081
of	O	O	I-T081
variance	O	O	I-T081
yielded	O	O	O
a	O	O	O
significant	O	O	B-T078
interaction	O	O	O
on	O	O	O
the	O	O	O
National	O	O	B-T093
Institute	O	O	I-T093
of	O	O	I-T093
Mental	O	O	I-T093
Health	O	O	I-T093
-	O	O	O
Trichotillomania	O	O	B-T081
Severity	O	O	I-T081
Scale	O	O	I-T081
Total	O	O	I-T081
Score	O	O	I-T081
(	O	O	O
F1,38	O	O	O
=	O	O	O
16.47	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
,	O	O	O
η(2)p	O	O	O
=	O	O	O
0.30	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T033
score	O	O	I-T033
decreased	O	O	O
from	O	O	O
12.67	O	O	O
±	O	O	O
4.60	O	O	O
at	O	O	O
baseline	O	O	B-T081
to	O	O	O
5.62	O	O	O
±	O	O	O
4.38	O	O	O
at	O	O	O
posttreatment	O	O	B-T058
in	O	O	O
the	O	O	O
HRT	O	O	B-T061
group	O	O	B-T098
(	O	O	O
t20	O	O	O
=	O	O	O
5.99	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
,	O	O	O
d	O	O	O
=	O	O	O
1.31	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
the	O	O	O
TAU	O	O	B-T077
group	O	O	O
changed	O	O	O
from	O	O	O
10.42	O	O	O
±	O	O	O
4.35	O	O	O
to	O	O	O
9.32	O	O	O
±	O	O	O
4.11	O	O	O
(	O	O	O
t18	O	O	O
=	O	O	O
1.34	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.20	O	O	O
,	O	O	O
d	O	O	O
=	O	O	O
0.31	O	O	O
)	O	O	O
.	O	O	O

The	O	O	B-T081
Massachusetts	O	O	I-T081
General	O	O	I-T081
Hospital-Hair	O	O	I-T081
Pulling	O	O	I-T081
Scale	O	O	I-T081
Total	O	O	I-T081
Score	O	O	I-T081
decreased	O	O	O
from	O	O	O
15.14	O	O	O
±	O	O	O
3.86	O	O	O
at	O	O	O
baseline	O	O	B-T081
to	O	O	O
7.14	O	O	O
±	O	O	O
5.54	O	O	O
at	O	O	O
posttreatment	O	O	B-T058
in	O	O	O
the	O	O	O
HRT	O	O	B-T061
group	O	O	B-T098
(	O	O	O
t20	O	O	O
=	O	O	O
6.16	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
,	O	O	O
d	O	O	O
=	O	O	O
1.34	O	O	O
)	O	O	O
;	O	O	O
the	O	O	O
TAU	O	O	B-T077
group	O	O	O
changed	O	O	O
from	O	O	O
14.16	O	O	O
±	O	O	O
4.51	O	O	O
to	O	O	O
12.26	O	O	O
±	O	O	O
4.34	O	O	O
(	O	O	O
t18	O	O	O
=	O	O	O
1.50	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.15	O	O	O
,	O	O	O
d	O	O	O
=	O	O	O
0.34	O	O	O
)	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
Clinical	O	O	B-T170
Global	O	O	I-T170
Impressions-Improvement	O	O	I-T170
,	O	O	O
16/21	O	O	O
participants	O	O	B-T098
(	O	O	O
76	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
rated	O	O	O
as	O	O	O
treatment	O	O	B-T061
responders	O	O	B-T098
in	O	O	O
the	O	O	O
HRT	O	O	B-T061
group	O	O	B-T098
versus	O	O	O
4/19	O	O	O
(	O	O	O
21	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
TAU	O	O	B-T077
group	O	O	O
(	O	O	O
χ(2	O	O	O
)	O	O	O
=	O	O	O
12.13	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
,	O	O	O
V	O	O	O
=	O	O	O
0.55	O	O	O
)	O	O	O
.	O	O	O

At	O	O	O
1-	O	O	O
month	O	O	B-T079
follow-up	O	O	B-T058
,	O	O	O
10	O	O	O
-	O	O	O
12	O	O	O
treatment	O	O	B-T061
responders	O	O	B-T098
who	O	O	O
completed	O	O	O
the	O	O	O
assessment	O	O	B-T058
maintained	O	O	O
improvement	O	O	B-T077
.	O	O	O

At	O	O	O
3-	O	O	O
month	O	O	B-T079
follow-up	O	O	B-T058
,	O	O	O
six	O	O	O
of	O	O	O
eight	O	O	O
maintained	O	O	O
improvement	O	O	B-T077
.	O	O	O

HRT	O	O	B-T061
can	O	O	O
be	O	O	O
an	O	O	O
effective	O	O	O
treatment	O	O	B-T061
for	O	O	O
TTM	O	O	B-T048
in	O	O	O
youth	O	O	B-T100
.	O	O	O

-DOCSTART- (28005775)

Fully	O	O	B-T080
Endoscope	O	O	B-T074
-	O	O	O
Controlled	O	O	B-T169
Clipping	O	O	B-T061
Bilateral	O	O	B-T047
Middle	O	O	I-T047
Cerebral	O	O	I-T047
Artery	O	O	I-T047
Aneurysm	O	O	I-T047
Via	O	O	O
Unilateral	O	O	O
Supraorbital	O	O	O
Keyhole	O	O	O
Approach	O	O	O

Clipping	O	O	B-T061
bilateral	O	O	B-T047
middle	O	O	I-T047
cerebral	O	O	I-T047
artery	O	O	I-T047
(	O	O	I-T047
bMCA	O	O	I-T047
)	O	O	I-T047
aneurysms	O	O	I-T047
via	O	O	O
unilateral	O	O	B-T061
approach	O	O	I-T061
in	O	O	O
a	O	O	O
single-stage	O	O	B-T061
operation	O	O	I-T061
is	O	O	O
considered	O	O	O
as	O	O	O
a	O	O	O
challenge	O	O	O
procedure	O	O	O
.	O	O	O

To	O	O	O
our	O	O	O
knowledge	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
study	O	O	O
in	O	O	O
surgical	O	O	B-T058
management	O	O	I-T058
of	O	O	O
patients	O	O	B-T101
with	O	O	O
bMCA	O	O	B-T047
aneurysms	O	O	I-T047
by	O	O	O
fully	O	O	O
endoscope	O	O	B-T074
-	O	O	O
controlled	O	O	B-T169
techniques	O	O	B-T169
.	O	O	O

The	O	O	O
author	O	O	O
reported	O	O	O
a	O	O	O
patient	O	O	B-T101
with	O	O	O
bMCA	O	O	B-T047
aneurysms	O	O	I-T047
who	O	O	O
underwent	O	O	O
aneurysms	O	O	B-T061
clipping	O	O	I-T061
via	O	O	O
a	O	O	O
unilateral	O	O	B-T061
supraorbital	O	O	I-T061
keyhole	O	O	I-T061
approach	O	O	I-T061
by	O	O	O
endoscope	O	O	B-T074
-	O	O	O
controlled	O	O	B-T169
microneurosurgery	O	O	B-T061
,	O	O	O
and	O	O	O
the	O	O	O
patient	O	O	O
had	O	O	O
an	O	O	O
uneventful	O	O	O
postoperative	O	O	B-T079
course	O	O	I-T079
without	O	O	B-T080
neurologic	O	O	B-T080
impairment	O	O	B-T046
and	O	O	O
complication	O	O	B-T046
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
author	O	O	O
discussed	O	O	O
the	O	O	O
advantages	O	O	O
and	O	O	O
adaptation	O	O	B-T170
of	O	O	O
endoscope	O	O	B-T074
-	O	O	O
controlled	O	O	B-T169
clipping	O	O	B-T061
bMCA	O	O	B-T047
aneurysms	O	O	I-T047
via	O	O	O
unilateral	O	O	B-T061
supraorbital	O	O	I-T061
keyhole	O	O	I-T061
approach	O	O	I-T061
.	O	O	O

-DOCSTART- (28007859)

Novel	O	O	B-T080
Observations	O	O	B-T062
in	O	O	O
11	O	O	O
Heteroresistant	O	O	B-T039
Vancomycin-Intermediate	O	O	B-T116
Methicillin-Resistant	O	O	B-T007
Staphylococcus	O	O	I-T007
aureus	O	O	I-T007
Strains	O	O	I-T007
from	O	O	O
South	O	O	O
India	O	O	O

We	O	O	O
report	O	O	O
here	O	O	O
the	O	O	O
draft	O	O	O
genome	O	O	B-T085
sequences	O	O	I-T085
of	O	O	O
11	O	O	O
heteroresistant	O	O	B-T039
vancomycin-intermediate	O	O	B-T007
Staphylococcus	O	O	I-T007
aureus	O	O	I-T007
(	O	O	I-T007
hVISA	O	O	I-T007
)	O	O	I-T007
strains	O	O	I-T007
from	O	O	O
bloodstream	O	O	B-T046
infection	O	O	I-T046
.	O	O	O

All	O	O	O
strains	O	O	B-T001
harbor	O	O	O
mutations	O	O	B-T045
in	O	O	O
vraSR	O	O	B-T028
,	O	O	O
graSR	O	O	B-T028
,	O	O	O
walKR	O	O	B-T028
,	O	O	O
and/or	O	O	O
tcaRAB	O	O	B-T028
and	O	O	O
are	O	O	O
often	O	O	O
implicated	O	O	O
as	O	O	O
the	O	O	O
frequently	O	O	O
mutated	O	O	B-T045
candidate	O	O	O
genes	O	O	B-T028
in	O	O	O
hVISA	O	O	B-T007
phenotypes	O	O	B-T032
.	O	O	O

-DOCSTART- (28008561)

Endpoints	O	O	B-T080
for	O	O	O
screening	O	O	B-T060
thyroid	O	O	B-T023
cancer	O	O	I-T191
in	O	O	O
the	O	O	O
Republic	O	O	B-T083
of	O	O	I-T083
Korea	O	O	I-T083
:	O	O	O
thyroid	O	O	O
specialists	O	O	B-T097
'	O	O	O
perspectives	O	O	O

Cancer	O	O	B-T060
screening	O	O	I-T060
is	O	O	O
aimed	O	O	O
primarily	O	O	O
at	O	O	O
reducing	O	O	B-T080
deaths	O	O	B-T033
from	O	O	O
the	O	O	O
specific	O	O	O
cancer	O	O	B-T191
.	O	O	O

Thyroid-specific	O	O	B-T191
cancer	O	O	I-T191
mortality	O	O	B-T081
may	O	O	O
be	O	O	O
the	O	O	O
most	O	O	O
ambitious	O	O	O
endpoint	O	O	B-T080
for	O	O	O
obtaining	O	O	O
estimates	O	O	B-T081
of	O	O	O
screening	O	O	B-T058
effect	O	O	B-T080
.	O	O	O

Numerous	O	O	B-T081
observations	O	O	B-T060
have	O	O	O
accumulated	O	O	B-T033
over	O	O	O
the	O	O	O
years	O	O	O
,	O	O	O
indicating	O	O	O
that	O	O	O
thyroid	O	O	B-T191
cancer	O	O	I-T191
mortality	O	O	B-T081
endpoint	O	O	B-T080
has	O	O	O
been	O	O	O
difficult	O	O	B-T080
to	O	O	O
study	O	O	O
and	O	O	O
is	O	O	O
confounded	O	O	O
by	O	O	O
population	O	O	B-T102
heterogeneity	O	O	I-T102
,	O	O	O
provision	O	O	B-T058
of	O	O	O
randomization	O	O	B-T062
,	O	O	O
and	O	O	O
requirement	O	O	B-T169
of	O	O	O
large	O	O	O
cohorts	O	O	B-T098
with	O	O	O
sufficiently	O	O	O
long	O	O	B-T058
follow-up	O	O	I-T058
due	O	O	O
to	O	O	O
the	O	O	O
excellent	O	O	B-T080
prognosis	O	O	B-T201
of	O	O	I-T201
the	O	O	I-T201
cancer	O	O	I-T201
.	O	O	O

Accordingly	O	O	O
,	O	O	O
it	O	O	O
may	O	O	O
be	O	O	O
important	O	O	B-T080
to	O	O	O
reconsider	O	O	O
how	O	O	O
to	O	O	O
best	O	O	O
measure	O	O	O
thyroid	O	O	B-T191
cancer	O	O	I-T191
screening	O	O	B-T060
efficacy	O	O	B-T080
.	O	O	O

Recommendations	O	O	B-T078
against	O	O	O
thyroid	O	O	B-T191
cancer	O	O	B-T191
screening	O	O	B-T060
should	O	O	O
be	O	O	O
based	O	O	O
upon	O	O	O
trials	O	O	O
designed	O	O	O
to	O	O	O
evaluate	O	O	O
its	O	O	O
effectiveness	O	O	B-T080
not	O	O	O
only	O	O	O
in	O	O	O
significant	O	O	B-T080
reduction	O	O	I-T080
in	O	O	O
cancer	O	O	O
mortality	O	O	B-T081
,	O	O	O
but	O	O	O
also	O	O	O
of	O	O	O
other	O	O	O
distinct	O	O	O
endpoint	O	O	B-T080
s.	O	O	O
It	O	O	O
is	O	O	O
desirable	O	O	O
to	O	O	O
evaluate	O	O	O
derivative	O	O	O
endpoints	O	O	B-T080
that	O	O	O
can	O	O	O
reliably	O	O	O
predict	O	O	O
reductions	O	O	B-T081
in	O	O	I-T081
mortality	O	O	I-T081
.	O	O	O

The	O	O	O
term	O	O	O
"	O	O	O
derivative	O	O	O
"	O	O	O
means	O	O	O
a	O	O	O
variable	O	O	O
that	O	O	O
is	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
true	O	O	O
endpoint	O	O	B-T080
and	O	O	O
is	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
observable	O	O	O
before	O	O	O
the	O	O	O
primary	O	O	O
endpoint	O	O	O
.	O	O	O

Derivative	O	O	O
endpoints	O	O	B-T080
may	O	O	O
include	O	O	O
thyroid	O	O	B-T191
cancer	O	O	I-T191
incidence	O	O	B-T081
,	O	O	O
the	O	O	O
proportion	O	O	B-T081
of	O	O	O
early-stage	O	O	B-T079
tumors	O	O	B-T191
detected	O	O	B-T033
,	O	O	O
more	O	O	O
treatable	O	O	B-T201
stage	O	O	I-T201
,	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
small	O	O	B-T080
tumors	O	O	I-T080
(	O	O	O
to	O	O	O
maintain	O	O	O
in	O	O	O
observation	O	O	O
)	O	O	O
,	O	O	O
decrease	O	O	B-T058
in	O	O	I-T058
the	O	O	I-T058
number	O	O	I-T058
of	O	O	I-T058
people	O	O	I-T058
who	O	O	O
develop	O	O	O
metastatic	O	O	B-T191
disease	O	O	I-T191
,	O	O	O
the	O	O	O
increased	O	O	B-T081
chance	O	O	O
of	O	O	O
lesser	O	O	O
extent	O	O	O
surgery	O	O	B-T061
,	O	O	O
and	O	O	O
the	O	O	O
application	O	O	O
of	O	O	O
minimally	O	O	B-T169
invasive	O	O	I-T169
approaches	O	O	I-T169
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
no	O	O	O
need	O	O	O
for	O	O	O
lifelong	O	O	B-T079
thyroid	O	O	B-T061
replacement	O	O	I-T061
therapy	O	O	I-T061
,	O	O	O
a	O	O	O
consistent	O	O	B-T078
follow-up	O	O	B-T058
,	O	O	O
low-dose	O	O	B-T081
or	O	O	O
no	O	O	O
RAI	O	O	B-T060
administration	O	O	I-T060
and	O	O	O
risk	O	O	B-T170
factor	O	O	I-T170
assessments	O	O	I-T170
where	O	O	O
case	O	O	B-T058
findings	O	O	I-T058
should	O	O	O
be	O	O	O
continuous	O	O	B-T078
.	O	O	O

The	O	O	O
Korean	O	O	B-T098
guidelines	O	O	O
for	O	O	O
thyroid	O	O	B-T191
cancer	O	O	I-T191
national-level	O	O	B-T082
screening	O	O	B-T058
were	O	O	O
published	O	O	O
by	O	O	O
a	O	O	O
relevant	O	O	O
group	O	O	O
of	O	O	O
multidisciplinary	O	O	B-T060
thyroid	O	O	I-T060
experts	O	O	I-T060
.	O	O	O

It	O	O	O
was	O	O	O
concluded	O	O	O
that	O	O	O
the	O	O	O
evidence	O	O	B-T169
is	O	O	I-T169
insufficient	O	O	I-T169
to	O	O	O
balance	O	O	O
the	O	O	O
benefits	O	O	B-T081
and	O	O	O
harms	O	O	O
of	O	O	O
thyroid	O	O	B-T191
cancer	O	O	I-T191
screening	O	O	B-T060
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
paper	O	O	O
seems	O	O	O
to	O	O	O
raise	O	O	O
the	O	O	O
necessary	O	O	O
investments	O	O	O
in	O	O	O
future	O	O	O
research	O	O	B-T062
and	O	O	O
demand	O	O	O
a	O	O	O
complete	O	O	B-T080
analysis	O	O	B-T062
for	O	O	O
derivative	O	O	O
endpoints	O	O	B-T080
,	O	O	O
and	O	O	O
offer	O	O	O
screening	O	O	B-T058
participants	O	O	B-T098
with	O	O	O
complete	O	O	O
information	O	O	B-T078
necessary	O	O	O
to	O	O	B-T041
make	O	O	I-T041
decisions	O	O	I-T041
that	O	O	O
will	O	O	O
provide	O	O	O
them	O	O	O
with	O	O	O
the	O	O	O
most	O	O	O
value	O	O	O
when	O	O	O
a	O	O	O
small	O	O	O
thyroid	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
screen-	O	O	O
identified	O	O	B-T080
.	O	O	O

-DOCSTART- (28009049)

Zebrafish	O	O	B-T013
adult	O	O	B-T025
pigment	O	O	I-T025
stem	O	O	I-T025
cells	O	O	I-T025
are	O	O	O
multipotent	O	O	B-T025
and	O	O	O
form	O	O	B-T025
pigment	O	O	I-T025
cells	O	O	I-T025
by	O	O	O
a	O	O	O
progressive	O	O	B-T169
fate	O	O	B-T043
restriction	O	O	I-T043
process	O	O	I-T043
:	O	O	O
Clonal	O	O	B-T060
analysis	O	O	I-T060
identifies	O	O	B-T080
shared	O	O	O
origin	O	O	O
of	O	O	O
all	O	O	O
pigment	O	O	O
cell	O	O	O
types	O	O	O

Skin	O	O	B-T033
pigment	O	O	I-T033
pattern	O	O	B-T040
formation	O	O	I-T040
is	O	O	O
a	O	O	O
paradigmatic	O	O	B-T061
example	O	O	O
of	O	O	O
pattern	O	O	O
formation	O	O	O
.	O	O	O

In	O	O	O
zebrafish	O	O	B-T013
,	O	O	O
the	O	O	O
adult	O	O	B-T100
body	O	O	B-T023
stripes	O	O	I-T023
are	O	O	O
generated	O	O	B-T052
by	O	O	O
coordinated	O	O	B-T169
rearrangement	O	O	B-T043
of	O	O	O
three	O	O	B-T081
distinct	O	O	O
pigment	O	O	B-T025
cell-types	O	O	I-T025
,	O	O	O
black	O	O	B-T080
melanocytes	O	O	B-T025
,	O	O	O
shiny	O	O	B-T080
iridophores	O	O	B-T025
and	O	O	O
yellow	O	O	B-T080
xanthophores	O	O	B-T025
.	O	O	O

A	O	O	O
stem	O	O	B-T025
cell	O	O	I-T025
origin	O	O	I-T025
of	O	O	O
melanocytes	O	O	B-T025
and	O	O	O
iridophores	O	O	B-T025
has	O	O	O
been	O	O	O
proposed	O	O	O
although	O	O	O
the	O	O	O
potency	O	O	B-T080
of	O	O	O
those	O	O	O
stem	O	O	B-T025
cells	O	O	I-T025
has	O	O	O
remained	O	O	B-T080
unclear	O	O	B-T033
.	O	O	O

Xanthophores	O	O	B-T025
,	O	O	O
however	O	O	O
,	O	O	O
seemed	O	O	O
to	O	O	O
originate	O	O	O
predominantly	O	O	B-T080
from	O	O	O
proliferation	O	O	B-T043
of	O	O	O
embryonic	O	O	B-T018
xanthophores	O	O	B-T025
.	O	O	O

Now	O	O	O
,	O	O	O
data	O	O	B-T078
from	O	O	O
Singh	O	O	O
et	O	O	O
al.	O	O	O
shows	O	O	O
that	O	O	O
all	O	O	O
three	O	O	B-T081
cell-types	O	O	B-T025
derive	O	O	B-T080
from	O	O	O
shared	O	O	O
stem	O	O	B-T025
cells	O	O	B-T025
,	O	O	O
and	O	O	O
that	O	O	O
these	O	O	O
cells	O	O	O
generate	O	O	B-T052
peripheral	O	O	B-T082
neural	O	O	B-T025
cell-types	O	O	I-T025
too	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
clonal	O	O	B-T024
compositions	O	O	B-T080
are	O	O	O
best	O	O	O
explained	O	O	O
by	O	O	O
a	O	O	O
progressive	O	O	B-T169
fate	O	O	B-T043
restriction	O	O	I-T043
model	O	O	I-T043
generating	O	O	B-T052
the	O	O	O
individual	O	O	B-T080
cell-types	O	O	B-T025
.	O	O	O

The	O	O	O
numbers	O	O	B-T081
of	O	O	O
adult	O	O	B-T025
pigment	O	O	I-T025
stem	O	O	I-T025
cells	O	O	I-T025
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
dorsal	O	O	B-T023
root	O	O	I-T023
ganglia	O	O	I-T023
remain	O	O	B-T033
low	O	O	B-T080
,	O	O	O
but	O	O	O
progenitor	O	O	B-T025
numbers	O	O	O
increase	O	O	B-T169
significantly	O	O	O
during	O	O	B-T079
larval	O	O	B-T040
development	O	O	I-T040
up	O	O	O
to	O	O	O
metamorphosis	O	O	B-T040
,	O	O	O
likely	O	O	O
via	O	O	O
production	O	O	O
of	O	O	O
partially	O	O	B-T081
restricted	O	O	B-T169
progenitors	O	O	B-T025
on	O	O	O
the	O	O	O
spinal	O	O	B-T023
nerves	O	O	I-T023
.	O	O	O

-DOCSTART- (28010062)

Covalent	O	O	B-T121
Modulators	O	O	I-T121
of	O	O	O
the	O	O	O
Vacuolar	O	O	O
ATPase	O	O	O

The	O	O	O
vacuolar	O	O	B-T116
H(+	O	O	I-T116
)	O	O	I-T116
ATPase	O	O	I-T116
(	O	O	O
V-ATPase	O	O	B-T116
)	O	O	O
is	O	O	O
a	O	O	O
complex	O	O	B-T104
multisubunit	O	O	O
machine	O	O	B-T169
that	O	O	O
regulates	O	O	B-T038
important	O	O	O
cellular	O	O	B-T043
processes	O	O	I-T043
through	O	O	O
controlling	O	O	B-T169
acidity	O	O	B-T081
of	O	O	O
intracellular	O	O	B-T082
compartments	O	O	B-T017
in	O	O	O
eukaryotes	O	O	B-T204
.	O	O	O

Existing	O	O	O
small-molecule	O	O	B-T109
modulators	O	O	B-T121
of	O	O	O
V-ATPase	O	O	B-T116
either	O	O	O
are	O	O	O
restricted	O	O	B-T169
to	O	O	O
targeting	O	O	B-T043
one	O	O	O
membranous	O	O	B-T080
subunit	O	O	B-T081
of	O	O	O
V-ATPase	O	O	O
or	O	O	O
have	O	O	O
poorly	O	O	O
understood	O	O	B-T041
mechanisms	O	O	B-T169
of	O	O	O
action	O	O	O
.	O	O	O

Small	O	O	B-T109
molecules	O	O	I-T109
with	O	O	O
novel	O	O	B-T080
and	O	O	O
defined	O	O	B-T080
mechanisms	O	O	B-T169
of	O	O	O
inhibition	O	O	B-T044
are	O	O	O
thus	O	O	O
needed	O	O	B-T080
to	O	O	O
functionally	O	O	B-T169
characterize	O	O	B-T052
V-ATPase	O	O	B-T116
and	O	O	O
to	O	O	O
fully	O	O	O
evaluate	O	O	O
the	O	O	O
therapeutic	O	O	B-T169
relevance	O	O	B-T080
of	O	O	O
V-ATPase	O	O	O
in	O	O	O
human	O	O	B-T016
diseases	O	O	B-T047
.	O	O	O

We	O	O	O
have	O	O	O
discovered	O	O	O
electrophilic	O	O	B-T080
quinazolines	O	O	B-T109
that	O	O	O
covalently	O	O	B-T044
modify	O	O	I-T044
a	O	O	O
soluble	O	O	B-T080
catalytic	O	O	B-T087
subunit	O	O	I-T087
of	O	O	O
V-ATPase	O	O	B-T116
with	O	O	O
high	O	O	B-T080
potency	O	O	B-T081
and	O	O	O
exquisite	O	O	O
proteomic	O	O	B-T080
selectivity	O	O	I-T080
as	O	O	O
revealed	O	O	B-T080
by	O	O	O
fluorescence	O	O	B-T060
imaging	O	O	I-T060
and	O	O	O
chemical	O	O	B-T059
proteomic	O	O	I-T059
activity-based	O	O	I-T059
profiling	O	O	I-T059
.	O	O	O

The	O	O	O
site	O	O	B-T082
of	O	O	O
covalent	O	O	O
modification	O	O	B-T169
was	O	O	O
mapped	O	O	B-T052
to	O	O	O
a	O	O	O
cysteine	O	O	B-T116
residue	O	O	B-T077
located	O	O	B-T082
in	O	O	I-T082
a	O	O	O
region	O	O	B-T087
of	O	O	O
V-ATPase	O	O	B-T116
subunit	O	O	B-T116
A	O	O	I-T116
that	O	O	O
is	O	O	O
thought	O	O	B-T041
to	O	O	O
regulate	O	O	B-T038
the	O	O	O
dissociation	O	O	B-T044
of	O	O	O
V-ATPase	O	O	O
.	O	O	O

We	O	O	O
further	O	O	O
demonstrate	O	O	O
that	O	O	O
a	O	O	O
previously	O	O	O
reported	O	O	O
V-ATPase	O	O	B-T116
inhibitor	O	O	I-T121
,	O	O	O
3-bromopyruvate	O	O	B-T109
,	O	O	O
also	O	O	O
targets	O	O	B-T169
the	O	O	O
same	O	O	B-T080
cysteine	O	O	B-T116
residue	O	O	B-T077
and	O	O	O
that	O	O	O
our	O	O	O
electrophilic	O	O	B-T080
quinazolines	O	O	B-T109
modulate	O	O	B-T082
the	O	O	O
function	O	O	B-T169
of	O	O	O
V-ATPase	O	O	O
in	O	O	O
cells	O	O	B-T025
.	O	O	O

With	O	O	O
their	O	O	O
well-defined	O	O	B-T080
mechanism	O	O	B-T169
of	O	O	O
action	O	O	B-T052
and	O	O	O
high	O	O	B-T080
proteomic	O	O	B-T081
specificity	O	O	I-T081
,	O	O	O
the	O	O	O
described	O	O	O
quinazolines	O	O	B-T109
offer	O	O	O
a	O	O	O
powerful	O	O	B-T081
set	O	O	B-T077
of	O	O	O
chemical	O	O	B-T120
probes	O	O	I-T120
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
physiological	O	O	B-T169
and	O	O	O
pathological	O	O	B-T169
roles	O	O	B-T077
of	O	O	O
V-ATPase	O	O	B-T116
.	O	O	O

-DOCSTART- (28011044)

Association	O	O	B-T080
of	O	O	O
Radiomics	O	O	O
and	O	O	O
Metabolic	O	O	B-T169
Tumor	O	O	B-T081
Volumes	O	O	I-T081
in	O	O	O
Radiation	O	O	B-T061
Treatment	O	O	I-T061
of	O	O	O
Glioblastoma	O	O	O
Multiforme	O	O	O

To	O	O	O
build	O	O	O
a	O	O	O
framework	O	O	O
for	O	O	O
investigation	O	O	B-T058
of	O	O	O
the	O	O	O
associations	O	O	B-T080
between	O	O	O
imaging	O	O	B-T060
,	O	O	O
clinical	O	O	B-T081
target	O	O	I-T081
volumes	O	O	B-T081
(	O	O	O
CTVs	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
metabolic	O	O	B-T169
tumor	O	O	B-T081
volumes	O	O	I-T081
(	O	O	O
MTVs	O	O	B-T081
)	O	O	O
features	O	O	B-T080
for	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
underlying	O	O	O
information	O	O	B-T078
in	O	O	O
the	O	O	O
CTVs	O	O	O
and	O	O	O
dependencies	O	O	O
between	O	O	O
these	O	O	O
volumes	O	O	O
.	O	O	O

High-throughput	O	O	B-T170
extraction	O	O	I-T170
of	O	O	O
imaging	O	O	B-T060
and	O	O	O
metabolomic	O	O	B-T091
quantitative	O	O	B-T081
features	O	O	B-T080
from	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
MRI	O	O	B-T060
)	O	O	O
and	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
spectroscopic	O	O	I-T060
imaging	O	O	I-T060
of	O	O	O
glioblastoma	O	O	B-T191
multiforme	O	O	I-T191
(	O	O	O
GBM	O	O	B-T191
)	O	O	O
results	O	O	O
in	O	O	O
tens	O	O	O
of	O	O	O
variables	O	O	O
per	O	O	O
patient	O	O	B-T101
.	O	O	O

In	O	O	O
radiation	O	O	B-T061
therapy	O	O	I-T061
of	O	O	O
GBM	O	O	B-T191
the	O	O	O
relevant	O	O	B-T080
metabolic	O	O	B-T169
tumor	O	O	B-T081
volumes	O	O	I-T081
(	O	O	O
MTVs	O	O	B-T081
)	O	O	O
are	O	O	O
related	O	O	O
to	O	O	O
aberrant	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
N-acetyl	O	O	B-T116
aspartate	O	O	I-T116
(	O	O	O
NAA	O	O	B-T116
)	O	O	O
and	O	O	O
choline	O	O	B-T109
(	O	O	O
Cho	O	O	B-T109
)	O	O	O
.	O	O	O

The	O	O	O
corresponding	O	O	O
clinical	O	O	B-T081
target	O	O	I-T081
volumes	O	O	I-T081
(	O	O	O
CTVs	O	O	B-T081
)	O	O	O
for	O	O	O
radiation	O	O	B-T061
therapy	O	O	I-T061
are	O	O	O
based	O	O	O
on	O	O	O
contrast-enhanced	O	O	B-T060
T1-weighted	O	O	I-T060
(	O	O	O
CE-T1w	O	O	B-T060
)	O	O	O
and	O	O	O
T2-weighted	O	O	B-T060
(T2w)/fluid-attenuated	O	O	I-T060
inversion	O	O	I-T060
recovery	O	O	I-T060
MRI	O	O	I-T060
.	O	O	O

Necrotic	O	O	B-T033
portions	O	O	I-T033
,	O	O	O
enhancing	O	O	B-T033
lesion	O	O	I-T033
,	O	O	O
and	O	O	O
edema	O	O	B-T184
were	O	O	O
manually	O	O	O
contoured	O	O	O
on	O	O	O
CE-T1w	O	O	B-T170
/	O	O	O
T2w	O	O	B-T170
images	O	O	I-T170
for	O	O	O
17	O	O	O
GBM	O	O	B-T191
patients	O	O	B-T101
.	O	O	O

Clinical	O	O	B-T081
target	O	O	I-T081
volumes	O	O	I-T081
and	O	O	O
MTVs	O	O	B-T081
for	O	O	O
NAA	O	O	B-T116
(	O	O	O
MTVNAA	O	O	B-T081
)	O	O	O
and	O	O	O
Cho	O	O	B-T109
(	O	O	O
MTVCho	O	O	B-T081
)	O	O	O
were	O	O	O
constructed	O	O	O
.	O	O	O

Imaging	O	O	B-T060
and	O	O	O
metabolic	O	O	B-T201
features	O	O	I-T201
related	O	O	O
to	O	O	O
size	O	O	B-T082
,	O	O	O
shape	O	O	B-T082
,	O	O	O
and	O	O	O
signal	O	O	B-T081
intensities	O	O	I-T081
of	O	O	O
the	O	O	O
volumes	O	O	B-T081
were	O	O	O
extracted	O	O	O
.	O	O	O

Tumors	O	O	B-T191
were	O	O	O
also	O	O	O
scored	O	O	O
categorically	O	O	O
for	O	O	O
10	O	O	O
semantic	O	O	B-T078
imaging	O	O	B-T080
traits	O	O	I-T080
by	O	O	O
a	O	O	O
neuroradiologist	O	O	B-T097
.	O	O	O

All	O	O	O
features	O	O	B-T080
were	O	O	O
investigated	O	O	B-T169
for	O	O	O
redundancy	O	O	B-T169
.	O	O	O

Two-way	O	O	B-T080
correlations	O	O	I-T080
between	O	O	O
imaging	O	O	B-T170
and	O	O	O
CTVs	O	O	B-T081
/	O	O	O
MTVs	O	O	B-T081
features	O	O	O
were	O	O	O
visualized	O	O	O
as	O	O	O
heatmaps	O	O	B-T073
.	O	O	O

Associations	O	O	B-T080
between	O	O	O
MTVNAA	O	O	B-T081
and	O	O	O
MTVCho	O	O	B-T081
and	O	O	O
imaging	O	O	B-T080
features	O	O	I-T080
were	O	O	O
studied	O	O	O
using	O	O	O
Spearman	O	O	B-T170
correlation	O	O	I-T170
.	O	O	O

Forty-eight	O	O	O
imaging	O	O	B-T080
features	O	O	I-T080
were	O	O	O
extracted	O	O	O
per	O	O	O
patient	O	O	B-T101
.	O	O	O

Half	O	O	B-T081
of	O	O	O
the	O	O	O
imaging	O	O	B-T080
traits	O	O	I-T080
were	O	O	O
replaced	O	O	B-T169
with	O	O	O
automatically	O	O	O
extracted	O	O	O
continuous	O	O	B-T080
variables	O	O	I-T080
.	O	O	O

Twenty	O	O	O
features	O	O	B-T080
were	O	O	O
extracted	O	O	O
from	O	O	O
CTVs	O	O	B-T081
and	O	O	O
MTVs	O	O	B-T081
.	O	O	O

A	O	O	O
series	O	O	O
of	O	O	O
semantic	O	O	B-T078
imaging	O	O	B-T080
traits	O	O	I-T080
were	O	O	O
replaced	O	O	B-T169
with	O	O	O
automatically	O	O	O
extracted	O	O	O
continuous	O	O	B-T080
variables	O	O	I-T080
.	O	O	O

There	O	O	O
were	O	O	O
multiple	O	O	O
(	O	O	O
22	O	O	O
)	O	O	O
significant	O	O	O
correlations	O	O	B-T080
of	O	O	O
imaging	O	O	B-T080
measures	O	O	I-T080
with	O	O	O
CTVs	O	O	B-T081
/	O	O	O
MTVNAA	O	O	B-T081
,	O	O	O
whereas	O	O	O
there	O	O	O
were	O	O	O
only	O	O	O
6	O	O	O
with	O	O	O
CTVs	O	O	O
/	O	O	O
MTVCho	O	O	B-T081
.	O	O	O

A	O	O	O
framework	O	O	O
for	O	O	O
investigation	O	O	O
of	O	O	O
codependencies	O	O	O
between	O	O	O
MRI	O	O	B-T060
and	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
spectroscopic	O	O	I-T060
imaging	O	O	I-T060
radiomic	O	O	O
features	O	O	B-T080
and	O	O	O
CTVs	O	O	B-T081
/	O	O	O
MTVs	O	O	B-T081
has	O	O	O
been	O	O	O
established	O	O	O
.	O	O	O

The	O	O	O
MTV	O	O	B-T081
for	O	O	O
NAA	O	O	B-T116
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
closely	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
MRI	O	O	B-T060
volumes	O	O	B-T081
,	O	O	O
whereas	O	O	O
very	O	O	O
few	O	O	O
imaging	O	O	B-T060
features	O	O	I-T080
were	O	O	O
related	O	O	O
to	O	O	O
MTVCho	O	O	B-T081
,	O	O	O
indicating	O	O	O
that	O	O	O
Cho	O	O	B-T109
provides	O	O	O
additional	O	O	B-T079
information	O	O	I-T079
to	O	O	O
imaging	O	O	O
.	O	O	O

-DOCSTART- (28011408)

Measurement	O	O	B-T169
of	O	O	O
fidgeting	O	O	B-T033
in	O	O	O
patients	O	O	B-T101
with	O	O	O
anorexia	O	O	B-T048
nervosa	O	O	I-T048
using	O	O	O
a	O	O	O
novel	O	O	O
shoe	O	O	B-T073
-based	O	O	O
monitor	O	O	O

To	O	O	O
objectively	O	O	O
assess	O	O	O
seated	O	O	B-T033
non-exercise	O	O	B-T056
physical	O	O	B-T056
activity	O	O	I-T056
in	O	O	O
patients	O	O	B-T101
with	O	O	O
anorexia	O	O	B-T048
nervosa	O	O	I-T048
(	O	O	O
AN	O	O	B-T048
)	O	O	O
relative	O	O	O
to	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
(	O	O	O
HCs	O	O	B-T080
)	O	O	O
and	O	O	O
examine	O	O	O
the	O	O	O
associations	O	O	B-T080
between	O	O	O
this	O	O	O
physical	O	O	O
activity	O	O	O
,	O	O	O
eating	O	O	B-T048
disorder	O	O	I-T048
pathology	O	O	B-T046
,	O	O	O
and	O	O	O
levels	O	O	B-T080
of	O	O	O
anxiety	O	O	B-T033
and	O	O	O
depression	O	O	B-T048
.	O	O	O

Eleven	O	O	O
inpatients	O	O	B-T101
with	O	O	O
AN	O	O	B-T048
and	O	O	O
10	O	O	O
HCs	O	O	B-T080
wore	O	O	O
a	O	O	O
shoe	O	O	B-T073
-based	O	O	O
accelerometer	O	O	B-T074
(	O	O	O
SmartShoe	O	O	B-T074
)	O	O	O
at	O	O	O
three	O	O	O
time	O	O	B-T079
points	O	O	I-T079
:	O	O	O
a	O	O	O
)	O	O	O
while	O	O	B-T079
eating	O	O	I-T079
lunch	O	O	I-T079
,	O	O	O
b	O	O	O
)	O	O	O
filling	O	O	B-T079
out	O	O	I-T079
questionnaires	O	O	I-T079
,	O	O	O
and	O	O	O
c	O	O	O
)	O	O	O
watching	O	O	B-T079
television	O	O	I-T079
for	O	O	I-T079
1h	O	O	I-T079
.	O	O	O

Across	O	O	O
all	O	O	O
three	O	O	O
tasks	O	O	B-T057
,	O	O	O
patients	O	O	B-T101
with	O	O	O
AN	O	O	B-T048
were	O	O	O
significantly	O	O	O
more	O	O	B-T169
active	O	O	I-T169
than	O	O	O
HCs	O	O	B-T080
,	O	O	O
thereby	O	O	O
engaging	O	O	O
in	O	O	O
a	O	O	O
greater	O	O	B-T081
degree	O	O	I-T081
of	O	O	O
restless	O	O	B-T184
or	O	O	O
fidgeting	O	O	B-T033
behavior	O	O	B-T053
.	O	O	O

Degree	O	O	B-T081
of	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
was	O	O	O
positively	O	O	B-T033
correlated	O	O	I-T033
with	O	O	O
eating	O	O	B-T048
disorder	O	O	I-T048
psychopathology	O	O	B-T091
in	O	O	O
the	O	O	O
sample	O	O	O
with	O	O	O
AN	O	O	B-T048
,	O	O	O
and	O	O	O
a	O	O	O
trend	O	O	O
towards	O	O	O
a	O	O	O
positive	O	O	B-T033
association	O	O	I-T033
between	O	O	O
physical	O	O	O
activity	O	O	O
and	O	O	O
levels	O	O	B-T080
of	O	O	O
depression	O	O	B-T048
and	O	O	O
anxiety	O	O	B-T033
was	O	O	O
also	O	O	O
found	O	O	O
in	O	O	O
this	O	O	O
sample	O	O	O
.	O	O	O

Among	O	O	O
individuals	O	O	B-T098
with	O	O	O
AN	O	O	B-T048
,	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
was	O	O	O
not	O	O	B-T033
significantly	O	O	O
correlated	O	O	B-T080
with	O	O	O
BMI	O	O	B-T201
,	O	O	O
duration	O	O	B-T079
of	O	O	I-T079
illness	O	O	I-T079
,	O	O	O
or	O	O	O
number	O	O	B-T081
of	O	O	I-T081
days	O	O	I-T081
since	O	O	O
hospital	O	O	B-T058
admission	O	O	I-T058
.	O	O	O

Use	O	O	O
of	O	O	O
a	O	O	O
minimally	O	O	B-T169
invasive	O	O	I-T169
,	O	O	O
shoe	O	O	B-T073
-based	O	O	O
monitor	O	O	B-T074
revealed	O	O	O
patients	O	O	B-T101
with	O	O	O
AN	O	O	B-T048
engaged	O	O	O
in	O	O	O
a	O	O	O
greater	O	O	B-T081
degree	O	O	I-T081
of	O	O	O
fidgeting	O	O	B-T033
relative	O	O	O
to	O	O	O
HCs	O	O	B-T080
during	O	O	O
quiet	O	O	O
,	O	O	O
seated	O	O	B-T033
tasks	O	O	B-T057
and	O	O	O
this	O	O	O
heightened	O	O	O
activity	O	O	B-T056
was	O	O	O
related	O	O	O
to	O	O	O
measures	O	O	B-T081
of	O	O	O
pathology	O	O	B-T046
.	O	O	O

Non-exercise	O	O	B-T056
physical	O	O	I-T056
activity	O	O	I-T056
,	O	O	O
including	O	O	O
fidgeting	O	O	B-T033
,	O	O	O
may	O	O	O
warrant	O	O	O
further	O	O	O
clinical	O	O	B-T080
attention	O	O	O
in	O	O	O
this	O	O	O
patient	O	O	B-T101
population	O	O	I-T101
.	O	O	O

-DOCSTART- (28013377)

Hospital	O	O	B-T093
clowning	O	O	I-T093
:	O	O	O
a	O	O	O
paediatrician	O	O	B-T097
's	O	O	I-T097
view	O	O	O

This	O	O	O
study	O	O	B-T062
investigates	O	O	B-T169
the	O	O	O
current	O	O	B-T079
position	O	O	O
of	O	O	O
hospital	O	O	B-T097
clowns	O	O	I-T097
from	O	O	O
the	O	O	O
perspective	O	O	B-T041
of	O	O	O
paediatricians	O	O	B-T097
and	O	O	O
paediatric	O	O	B-UnknownType
residents	O	O	I-UnknownType
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
14	O	O	O
attending	O	O	B-T097
paediatricians	O	O	I-T097
and	O	O	O
paediatric	O	O	B-UnknownType
residents	O	O	I-UnknownType
participated	O	O	B-T169
in	O	O	O
two	O	O	O
focus	O	O	B-T077
group	O	O	I-T077
sessions	O	O	I-T077
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analysed	O	O	B-T062
using	O	O	O
Atlas.ti	O	O	B-T073
5.0	O	O	I-T073
.	O	O	O

In	O	O	O
general	O	O	B-T082
,	O	O	O
physicians	O	O	B-T097
reported	O	O	B-T170
positive	O	O	B-T033
experiences	O	O	B-T041
regarding	O	O	O
the	O	O	O
interaction	O	O	B-T033
between	O	O	O
hospital	O	O	B-T097
clowns	O	O	I-T097
and	O	O	O
paediatric	O	O	B-T101
patients	O	O	I-T101
on	O	O	O
the	O	O	O
ward	O	O	B-T093
.	O	O	O

Physicians	O	O	B-T097
were	O	O	O
more	O	O	O
interested	O	O	B-T041
in	O	O	O
research	O	O	B-T062
on	O	O	O
children	O	O	B-T041
's	O	O	I-T041
perception	O	O	I-T041
of	O	O	O
hospital	O	O	B-T097
clowns	O	O	I-T097
than	O	O	O
in	O	O	O
research	O	O	O
on	O	O	O
the	O	O	O
clinical	O	O	B-T080
efficacy	O	O	I-T080
of	O	O	O
hospital	O	O	B-T093
clowning	O	O	I-T093
.	O	O	O

No	O	O	B-T080
direct	O	O	I-T080
collaboration	O	O	B-T054
between	O	O	O
physicians	O	O	B-T097
and	O	O	O
hospital	O	O	B-T097
clowns	O	O	I-T097
was	O	O	O
reported	O	O	B-T170
.	O	O	O

However	O	O	O
,	O	O	O
physicians	O	O	B-T097
proposed	O	O	B-T080
conditions	O	O	B-T080
which	O	O	O
may	O	O	O
streamline	O	O	B-T080
their	O	O	O
encounters	O	O	B-T053
with	O	O	O
hospital	O	O	B-T097
clowns	O	O	I-T097
such	O	O	O
as	O	O	O
clear	O	O	B-T054
communication	O	O	I-T054
prior	O	O	B-T079
to	O	O	O
hospital	O	O	B-T097
clown	O	O	I-T097
visits	O	O	B-T058
,	O	O	O
and	O	O	O
the	O	O	O
condition	O	O	B-T080
that	O	O	O
visits	O	O	O
do	O	O	O
not	O	O	O
impede	O	O	B-T080
medical	O	O	B-T061
interventions	O	O	I-T061
.	O	O	O

Overall	O	O	B-T080
,	O	O	O
paediatricians	O	O	B-T097
and	O	O	O
paediatric	O	O	B-UnknownType
residents	O	O	I-UnknownType
view	O	O	B-T041
the	O	O	O
positive	O	O	B-T033
impact	O	O	B-T080
on	O	O	O
paediatric	O	O	B-T101
patients	O	O	I-T101
as	O	O	O
the	O	O	O
most	O	O	O
important	O	O	B-T080
aspect	O	O	B-T080
of	O	O	O
hospital	O	O	B-T097
clown	O	O	I-T097
visits	O	O	B-T058
,	O	O	O
rather	O	O	O
than	O	O	O
the	O	O	O
clinical	O	O	B-T080
efficacy	O	O	I-T080
of	O	O	O
hospital	O	O	B-T093
clowning	O	O	I-T093
.	O	O	O

In	O	O	O
light	O	O	O
of	O	O	O
the	O	O	O
growing	O	O	O
number	O	O	O
of	O	O	O
hospital	O	O	B-T097
clowns	O	O	I-T097
worldwide	O	O	B-T098
,	O	O	O
this	O	O	O
article	O	O	B-T170
provides	O	O	O
recommendations	O	O	B-T078
for	O	O	O
arranging	O	O	O
their	O	O	O
encounters	O	O	B-T053
with	O	O	O
paediatricians	O	O	B-T097
and	O	O	O
paediatric	O	O	B-UnknownType
residents	O	O	I-UnknownType
to	O	O	O
maintain	O	O	B-T052
optimal	O	O	B-T080
health	O	O	B-T058
care	O	O	I-T058
.	O	O	O
What	O	O	O
is	O	O	O
known	O	O	O
:	O	O	O
•	O	O	O
Previous	O	O	B-T079
studies	O	O	B-T062
show	O	O	O
a	O	O	O
clinically	O	O	B-T078
significant	O	O	I-T078
pain	O	O	B-T184
-	O	O	O
and	O	O	O
anxiety	O	O	B-T033
-	O	O	O
reducing	O	O	B-T080
effect	O	O	I-T080
of	O	O	O
hospital	O	O	B-T093
clowning	O	O	I-T093
in	O	O	O
paediatric	O	O	B-T101
patients	O	O	I-T101
admitted	O	O	B-T058
to	O	O	I-T058
hospitals	O	O	I-T058
or	O	O	O
undergoing	O	O	B-T080
(	O	O	O
invasive	O	O	B-T080
)	O	O	O
medical	O	O	B-T058
procedures	O	O	I-T058
.	O	O	O

•	O	O	O
In	O	O	O
general	O	O	O
,	O	O	O
paediatricians	O	O	B-T097
have	O	O	O
positive	O	O	B-T033
ideas	O	O	B-T078
about	O	O	O
hospital	O	O	B-T097
clowns	O	O	I-T097
,	O	O	O
aside	O	O	O
from	O	O	O
personal	O	O	B-T055
prejudices	O	O	I-T055
.	O	O	O

What	O	O	O
is	O	O	O
new	O	O	O
:	O	O	O
•	O	O	O
This	O	O	O
novel	O	O	B-T080
study	O	O	B-T062
gives	O	O	O
deeper	O	O	O
insight	O	O	B-T041
into	O	O	O
day-to-day	O	O	B-T079
interaction	O	O	B-T033
between	O	O	O
paediatricians	O	O	B-T097
and	O	O	O
hospital	O	O	B-T097
clowns	O	O	I-T097
on	O	O	O
the	O	O	O
ward	O	O	B-T093
.	O	O	O

•	O	O	O
This	O	O	O
study	O	O	B-T062
provides	O	O	O
recommendations	O	O	B-T078
for	O	O	O
clinical	O	O	B-T170
practice	O	O	I-T170
to	O	O	O
arrange	O	O	O
encounters	O	O	B-T053
between	O	O	O
physicians	O	O	B-T097
and	O	O	O
hospital	O	O	B-T097
clowns	O	O	I-T097
during	O	O	O
hospital	O	O	B-T097
clown	O	O	I-T097
visits	O	O	B-T058
.	O	O	O

-DOCSTART- (28019021)

Multiparametric	O	O	B-T062
estimation	O	O	I-T062
of	O	O	O
brain	O	O	B-T042
hemodynamics	O	O	I-T042
with	O	O	O
MR	O	O	O
fingerprinting	O	O	O
ASL	O	O	O

Assessment	O	O	B-T058
of	O	O	O
brain	O	O	B-T042
hemodynamics	O	O	I-T042
without	O	O	O
exogenous	O	O	B-T169
contrast	O	O	B-T130
agents	O	O	I-T130
is	O	O	O
of	O	O	O
increasing	O	O	B-T169
importance	O	O	B-T080
in	O	O	O
clinical	O	O	B-UnknownType
applications	O	O	I-UnknownType
.	O	O	O

This	O	O	O
study	O	O	O
aims	O	O	O
to	O	O	O
develop	O	O	O
an	O	O	O
MR	O	O	B-T060
perfusion	O	O	I-T060
technique	O	O	I-T060
that	O	O	O
can	O	O	O
provide	O	O	O
noncontrast	O	O	B-T033
and	O	O	O
multiparametric	O	O	B-T062
estimation	O	O	I-T062
of	O	O	O
hemodynamic	O	O	B-T042
markers	O	O	B-T074
.	O	O	O

We	O	O	O
devised	O	O	O
an	O	O	O
arterial	O	O	B-T060
spin	O	O	I-T060
labeling	O	O	I-T060
(	O	O	O
ASL	O	O	B-T060
)	O	O	O
method	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
principle	O	O	O
of	O	O	O
MR	O	O	B-T060
fingerprinting	O	O	I-T060
(	O	O	O
MRF	O	O	B-T060
)	O	O	O
,	O	O	O
referred	O	O	B-T169
to	O	O	O
as	O	O	O
MRF-ASL	O	O	B-T060
.	O	O	O

By	O	O	O
taking	O	O	O
advantage	O	O	O
of	O	O	O
the	O	O	O
rich	O	O	O
information	O	O	B-T078
contained	O	O	O
in	O	O	O
MRF	O	O	B-T060
sequence	O	O	I-T060
,	O	O	O
up	O	O	O
to	O	O	O
seven	O	O	O
hemodynamic	O	O	B-T042
parameters	O	O	B-T033
can	O	O	O
be	O	O	O
estimated	O	O	B-T081
concomitantly	O	O	B-T079
.	O	O	O

Feasibility	O	O	B-T062
demonstration	O	O	I-T062
,	O	O	O
flip	O	O	B-T080
angle	O	O	I-T080
optimization	O	O	B-T052
,	O	O	O
comparison	O	O	B-T052
with	O	O	O
Look-Locker	O	O	B-T060
ASL	O	O	I-T060
,	O	O	O
reproducibility	O	O	B-T080
test	O	O	I-T080
,	O	O	O
sensitivity	O	O	B-T169
to	O	O	O
hypercapnia	O	O	B-T033
challenge	O	O	I-T033
,	O	O	O
and	O	O	O
initial	O	O	O
clinical	O	O	B-UnknownType
application	O	O	I-UnknownType
in	O	O	O
an	O	O	O
intracranial	O	O	B-T061
steno-occlusive	O	O	I-T061
process	O	O	I-T061
,	O	O	O
Moyamoya	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
were	O	O	O
performed	O	O	B-T169
to	O	O	O
evaluate	O	O	O
this	O	O	O
technique	O	O	B-T169
.	O	O	O

Magnetic	O	O	B-T060
resonance	O	O	I-T060
fingerprinting	O	O	I-T060
ASL	O	O	I-T060
provided	O	O	B-T052
estimation	O	O	O
of	O	O	O
up	O	O	O
to	O	O	O
seven	O	O	O
parameters	O	O	B-T033
,	O	O	O
including	O	O	O
B1	O	O	B-T081
+	O	O	I-T081
,	O	O	O
tissue	O	O	B-T023
T1	O	O	B-T081
,	O	O	O
cerebral	O	O	B-T033
blood	O	O	I-T033
flow	O	O	I-T033
(	O	O	O
CBF	O	O	B-T033
)	O	O	O
,	O	O	O
tissue	O	O	O
bolus	O	O	B-T033
arrival	O	O	I-T033
time	O	O	I-T033
(	O	O	O
BAT	O	O	B-T033
)	O	O	O
,	O	O	O
pass-through	O	O	O
arterial	O	O	B-T023
BAT	O	O	O
,	O	O	O
pass-through	O	O	O
blood	O	O	B-T201
volume	O	O	I-T201
,	O	O	O
and	O	O	O
pass-through	O	O	O
blood	O	O	B-T060
travel	O	O	I-T060
time	O	O	I-T060
.	O	O	O

Coefficients	O	O	B-T081
of	O	O	O
variation	O	O	B-T080
of	O	O	O
the	O	O	O
estimated	O	O	B-T081
parameters	O	O	B-T033
ranged	O	O	O
from	O	O	O
0.2	O	O	O
to	O	O	O
9.6	O	O	O
%	O	O	O
.	O	O	O

Hypercapnia	O	O	B-T033
resulted	O	O	O
in	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
CBF	O	O	B-T033
by	O	O	O
57.7	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
decrease	O	O	B-T081
in	O	O	O
BAT	O	O	B-T033
by	O	O	O
13.7	O	O	O
and	O	O	O
24.8	O	O	O
%	O	O	O
in	O	O	O
tissue	O	O	B-T024
and	O	O	O
vessels	O	O	B-T023
,	O	O	O
respectively	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
Moyamoya	O	O	B-T047
disease	O	O	I-T047
showed	O	O	O
diminished	O	O	B-T081
CBF	O	O	B-T033
and	O	O	O
lengthened	O	O	B-T169
BAT	O	O	B-T033
that	O	O	O
could	O	O	B-T033
not	O	O	I-T033
be	O	O	I-T033
detected	O	O	I-T033
with	O	O	O
regular	O	O	B-T080
ASL	O	O	B-T060
.	O	O	O

Magnetic	O	O	B-T060
resonance	O	O	I-T060
fingerprinting	O	O	I-T060
ASL	O	O	I-T060
is	O	O	O
a	O	O	O
promising	O	O	O
technique	O	O	B-T169
for	O	O	O
noncontrast	O	O	B-T033
,	O	O	O
multiparametric	O	O	B-T062
perfusion	O	O	B-T058
assessment	O	O	I-T058
.	O	O	O

Magn	O	O	O
Reson	O	O	O
Med	O	O	O
,	O	O	O
2016	O	O	O
.	O	O	O

©	O	O	O
2016	O	O	O
International	O	O	B-T093
Society	O	O	I-T093
for	O	O	I-T093
Magnetic	O	O	I-T093
Resonance	O	O	I-T093
in	O	O	I-T093
Medicine	O	O	I-T093
.	O	O	O

-DOCSTART- (28019706)

Acute	O	O	B-T079
sensitivity	O	O	B-T169
of	O	O	O
the	O	O	O
vernal	O	O	B-T204
pool	O	O	I-T204
fairy	O	O	I-T204
shrimp	O	O	I-T204
,	O	O	O
Branchinecta	O	O	B-T204
lynchi	O	O	I-T204
(	O	O	O
Anostraca	O	O	B-T204
;	O	O	O
Branchinectidae	O	O	B-T204
)	O	O	O
,	O	O	O
and	O	O	O
surrogate	O	O	B-T099
species	O	O	B-T185
to	O	O	O
10	O	O	O
chemicals	O	O	O

Vernal	O	O	B-T204
pool	O	O	I-T204
fairy	O	O	B-T204
shrimp	O	O	I-T204
,	O	O	O
Branchinecta	O	O	B-T204
lynchi	O	O	I-T204
,	O	O	O
(	O	O	O
Branchiopoda	O	O	B-T204
;	O	O	O
Anostraca	O	O	B-T204
)	O	O	O
and	O	O	O
other	O	O	O
fairy	O	O	O
shrimp	O	O	O
species	O	O	B-T185
have	O	O	O
been	O	O	O
listed	O	O	O
as	O	O	O
threatened	O	O	B-T098
or	O	O	O
endangered	O	O	B-T098
under	O	O	O
the	O	O	O
US	O	O	O
Endangered	O	O	O
Species	O	O	O
Act	O	O	O
.	O	O	O

Because	O	O	O
few	O	O	O
data	O	O	B-T078
exist	O	O	O
about	O	O	O
the	O	O	O
sensitivity	O	O	B-T169
of	O	O	O
Branchinecta	O	O	B-T204
spp	O	O	O
.	O	O	O

to	O	O	O
toxic	O	O	B-T037
effects	O	O	I-T037
of	O	O	O
contaminants	O	O	B-T167
,	O	O	O
it	O	O	O
is	O	O	O
difficult	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
they	O	O	O
are	O	O	O
adequately	O	O	B-T204
protected	O	O	I-T204
by	O	O	O
water	O	O	B-T080
quality	O	O	I-T080
criteria	O	O	B-T078
.	O	O	O

A	O	O	O
series	O	O	O
of	O	O	O
acute	O	O	B-T059
(	O	O	I-T059
24-h	O	O	I-T059
)	O	O	I-T059
lethality/immobilization	O	O	I-T059
tests	O	O	I-T059
was	O	O	O
conducted	O	O	O
with	O	O	O
3	O	O	O
species	O	O	B-T185
of	O	O	O
fairy	O	O	B-T204
shrimp	O	O	I-T204
(	O	O	O
B.	O	O	B-T204
lynchi	O	O	I-T204
,	O	O	O
Branchinecta	O	O	B-T204
lindahli	O	O	I-T204
,	O	O	O
and	O	O	O
Thamnocephalus	O	O	B-T204
platyurus	O	O	I-T204
)	O	O	O
and	O	O	O
10	O	O	O
chemicals	O	O	B-T103
with	O	O	O
varying	O	O	O
modes	O	O	O
of	O	O	O
toxic	O	O	B-T131
action	O	O	I-T131
:	O	O	O
ammonia	O	O	B-T121
,	O	O	O
potassium	O	O	B-T123
,	O	O	O
chloride	O	O	B-T197
,	O	O	O
sulfate	O	O	B-T197
,	O	O	O
chromium(VI	O	O	B-T131
)	O	O	I-T131
,	O	O	O
copper	O	O	B-T121
,	O	O	O
nickel	O	O	B-T123
,	O	O	O
zinc	O	O	B-T121
,	O	O	O
alachlor	O	O	B-T109
,	O	O	O
and	O	O	O
metolachlor	O	O	B-T109
.	O	O	O

The	O	O	O
same	O	O	O
chemicals	O	O	B-T103
were	O	O	O
tested	O	O	O
in	O	O	O
48-	O	O	O
h	O	O	B-T079
tests	O	O	B-T059
with	O	O	O
other	O	O	O
branchiopods	O	O	B-T204
(	O	O	O
the	O	O	O
cladocerans	O	O	B-T204
Daphnia	O	O	B-T204
magna	O	O	I-T204
and	O	O	O
Ceriodaphnia	O	O	B-T204
dubia	O	O	I-T204
)	O	O	O
and	O	O	O
an	O	O	O
amphipod	O	O	B-T204
(	O	O	O
Hyalella	O	O	B-T011
azteca	O	O	I-T011
)	O	O	O
,	O	O	O
and	O	O	O
in	O	O	O
96-	O	O	O
h	O	O	O
tests	O	O	O
with	O	O	O
snails	O	O	B-T204
(	O	O	O
Physa	O	O	B-T204
gyrina	O	O	I-T204
and	O	O	O
Lymnaea	O	O	B-T204
stagnalis	O	O	I-T204
)	O	O	O
.	O	O	O

Median	O	O	O
effect	O	O	B-T081
concentrations	O	O	I-T081
(	O	O	O
EC50s	O	O	B-T081
)	O	O	O
for	O	O	O
B.	O	O	B-T204
lynchi	O	O	I-T204
were	O	O	O
strongly	O	O	O
correlated	O	O	B-T080
(	O	O	O
r(2	O	O	O
)	O	O	O
=	O	O	O
0.975	O	O	O
)	O	O	O
with	O	O	O
EC50s	O	O	O
for	O	O	O
the	O	O	O
commercially	O	O	O
available	O	O	O
fairy	O	O	B-T204
shrimp	O	O	I-T204
species	O	O	B-T185
T.	O	O	B-T204
platyurus	O	O	I-T204
for	O	O	O
most	O	O	O
chemicals	O	O	B-T103
tested	O	O	O
.	O	O	O

Comparison	O	O	B-T052
of	O	O	O
EC50s	O	O	B-T081
for	O	O	O
fairy	O	O	B-T204
shrimp	O	O	I-T204
and	O	O	O
EC50s	O	O	O
for	O	O	O
invertebrate	O	O	B-T204
taxa	O	O	I-T204
tested	O	O	O
concurrently	O	O	O
and	O	O	O
with	O	O	O
other	O	O	O
published	O	O	O
toxicity	O	O	B-T037
data	O	O	B-T078
indicated	O	O	O
that	O	O	O
fairy	O	O	O
shrimp	O	O	O
were	O	O	O
relatively	O	O	O
sensitive	O	O	B-T169
to	O	O	O
potassium	O	O	B-T123
and	O	O	O
several	O	O	O
trace	O	O	B-T121
metals	O	O	I-T121
compared	O	O	B-T052
with	O	O	O
other	O	O	O
invertebrate	O	O	O
taxa	O	O	O
,	O	O	O
although	O	O	O
cladocerans	O	O	B-T204
,	O	O	O
amphipods	O	O	B-T204
,	O	O	O
and	O	O	O
mussels	O	O	B-T204
had	O	O	O
similar	O	O	O
broad	O	O	O
toxicant	O	O	B-T131
sensitivity	O	O	B-T169
.	O	O	O

Interspecies	O	O	B-T170
correlation	O	O	I-T170
estimation	O	O	I-T170
models	O	O	B-T170
for	O	O	O
predicting	O	O	O
toxicity	O	O	B-T037
to	O	O	O
fairy	O	O	B-T204
shrimp	O	O	I-T204
from	O	O	O
surrogate	O	O	B-T099
species	O	O	B-T185
indicated	O	O	O
that	O	O	O
models	O	O	O
with	O	O	O
cladocerans	O	O	B-T204
and	O	O	O
freshwater	O	O	B-T204
mussels	O	O	I-T204
as	O	O	O
surrogates	O	O	B-T099
produced	O	O	O
the	O	O	O
best	O	O	O
predictions	O	O	O
of	O	O	O
the	O	O	O
sensitivity	O	O	B-T169
of	O	O	O
fairy	O	O	O
shrimp	O	O	O
to	O	O	O
contaminants	O	O	B-T167
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
these	O	O	O
studies	O	O	B-T062
indicate	O	O	O
that	O	O	O
fairy	O	O	B-T204
shrimp	O	O	I-T204
are	O	O	O
relatively	O	O	O
sensitive	O	O	B-T169
to	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
toxicants	O	O	B-T131
,	O	O	O
but	O	O	O
Endangered	O	O	O
Species	O	O	O
Act	O	O	O
-listed	O	O	O
fairy	O	O	O
shrimp	O	O	O
of	O	O	O
the	O	O	O
genus	O	O	B-T204
Branchinecta	O	O	I-T204
were	O	O	O
not	O	O	O
consistently	O	O	O
more	O	O	O
sensitive	O	O	O
than	O	O	O
other	O	O	O
fairy	O	O	B-T204
shrimp	O	O	I-T204
taxa	O	O	I-T204
.	O	O	O

Environ	O	O	O
Toxicol	O	O	O
Chem	O	O	O
2016;9999:1	O	O	O
-	O	O	O
10	O	O	O
.	O	O	O

Published	O	O	O
2016	O	O	O
Wiley	O	O	O
Periodicals	O	O	O
Inc.	O	O	O
on	O	O	O
behalf	O	O	O
of	O	O	O
SETAC	O	O	O
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
a	O	O	O
US	O	O	O
government	O	O	O
work	O	O	O
and	O	O	O
,	O	O	O
as	O	O	O
such	O	O	O
,	O	O	O
is	O	O	O
in	O	O	O
the	O	O	O
public	O	O	O
domain	O	O	O
in	O	O	O
the	O	O	O
United	O	O	O
States	O	O	O
of	O	O	O
America	O	O	O
.	O	O	O

-DOCSTART- (28024592)

Bi-layered	O	O	B-T122
constructs	O	O	I-T122
of	O	O	O
poly(glycerol-sebacate	O	O	B-T109
)	O	O	I-T109
-	O	O	O
β-tricalcium	O	O	B-T122
phosphate	O	O	I-T122
for	O	O	O
bone-soft	O	O	B-UnknownType
tissue	O	O	I-UnknownType
interface	O	O	O
applications	O	O	O

This	O	O	O
study	O	O	B-T062
aims	O	O	O
to	O	O	O
establish	O	O	O
a	O	O	O
facile	O	O	O
protocol	O	O	B-T170
for	O	O	O
the	O	O	O
preparation	O	O	B-T052
of	O	O	O
a	O	O	O
bi-layered	O	O	B-T080
poly(glycerol-sebacate	O	O	B-T109
)	O	O	I-T109
(PGS)/	O	O	O
β-tricalcium	O	O	B-T122
phosphate	O	O	I-T122
(	O	O	O
β-TCP	O	O	B-T122
)	O	O	O
construct	O	O	B-T122
and	O	O	O
to	O	O	O
investigate	O	O	B-T169
its	O	O	O
potential	O	O	O
for	O	O	O
bone-soft	O	O	B-UnknownType
tissue	O	O	I-UnknownType
engineering	O	O	B-T061
applications	O	O	B-T169
.	O	O	O

The	O	O	O
layered	O	O	B-T082
structure	O	O	I-T082
was	O	O	O
prepared	O	O	O
by	O	O	O
distributing	O	O	B-T169
the	O	O	O
ceramic	O	O	B-T073
particles	O	O	B-T104
within	O	O	O
a	O	O	O
prepolymer	O	O	B-T104
synthesized	O	O	B-T052
in	O	O	O
a	O	O	O
microwave	O	O	B-T073
reactor	O	O	I-T073
followed	O	O	O
by	O	O	O
a	O	O	O
cross-linking	O	O	B-T070
of	O	O	O
the	O	O	O
final	O	O	O
construct	O	O	B-T122
in	O	O	O
vacuum	O	O	B-T070
(	O	O	O
<	O	O	O
10	O	O	O
mbar	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
vacuum	O	O	B-T070
stage	O	O	B-T079
led	O	O	O
to	O	O	O
the	O	O	O
separation	O	O	B-UnknownType
of	O	O	O
cross-linked	O	O	B-T070
elastomer	O	O	B-T109
(	O	O	O
top	O	O	B-T082
)	O	O	O
and	O	O	O
ceramic	O	O	B-T073
(	O	O	O
bottom	O	O	B-T082
)	O	O	O
phases	O	O	B-T079
.	O	O	O

Results	O	O	O
showed	O	O	O
that	O	O	O
addition	O	O	O
of	O	O	O
β-TCP	O	O	B-T122
particles	O	O	B-T104
to	O	O	O
the	O	O	O
elastomer	O	O	B-T109
matrix	O	O	I-T109
after	O	O	O
the	O	O	O
polymerization	O	O	B-T067
led	O	O	O
to	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
compression	O	O	B-T081
strength	O	O	I-T081
(	O	O	O
up	O	O	O
to	O	O	O
14±2.3MPa	O	O	O
)	O	O	O
.	O	O	O

Tensile	O	O	B-T081
strength	O	O	I-T081
(	O	O	O
σ	O	O	O
)	O	O	O
,	O	O	O
Young	O	O	B-T081
's	O	O	I-T081
modulus	O	O	I-T081
(	O	O	O
E	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
elongation	O	O	B-T081
at	O	O	I-T081
break	O	O	I-T081
(	O	O	O
%	O	O	O
)	O	O	O
values	O	O	O
were	O	O	O
calculated	O	O	O
as	O	O	O
0.29±0.03MPa	O	O	O
and	O	O	O
0.21±0.03	O	O	O
;	O	O	O
0.38±0.02	O	O	O
and	O	O	O
1.95±0.4	O	O	O
;	O	O	O
and	O	O	O
240±50	O	O	O
%	O	O	O
and	O	O	O
24±2	O	O	O
%	O	O	O
for	O	O	O
PGS	O	O	B-T109
and	O	O	O
PGS	O	O	O
/	O	O	O
β-TCP	O	O	B-T122
bi-layered	O	O	B-T122
constructs	O	O	I-T122
,	O	O	O
respectively	O	O	O
.	O	O	O

Morphology	O	O	B-T082
was	O	O	O
characterized	O	O	O
by	O	O	O
using	O	O	O
Scanning	O	O	B-T059
Electron	O	O	I-T059
Microscopy	O	O	I-T059
(	O	O	O
SEM	O	O	B-T059
)	O	O	O
and	O	O	O
micro-computed	O	O	B-T060
tomography	O	O	I-T060
(	O	O	O
μ-CT	O	O	B-T060
)	O	O	O
.	O	O	O

Tomography	O	O	B-T060
data	O	O	B-T078
revealed	O	O	O
an	O	O	O
open	O	O	B-T080
porosity	O	O	I-T080
of	O	O	O
35	O	O	O
%	O	O	O
for	O	O	O
the	O	O	O
construct	O	O	B-T122
,	O	O	O
mostly	O	O	O
contributed	O	O	O
from	O	O	O
the	O	O	O
ceramic	O	O	B-T079
phase	O	O	I-T079
since	O	O	O
the	O	O	O
elastomer	O	O	B-T109
side	O	O	B-T082
has	O	O	O
no	O	O	O
pore	O	O	B-T082
.	O	O	O

Homogeneous	O	O	B-T080
β-TCP	O	O	B-T122
distribution	O	O	B-T169
within	O	O	O
the	O	O	O
elastomeric	O	O	B-T082
structure	O	O	I-T082
was	O	O	O
observed	O	O	O
.	O	O	O

Cell	O	O	B-UnknownType
culture	O	O	I-UnknownType
studies	O	O	I-UnknownType
confirmed	O	O	O
biocompatibility	O	O	B-T044
with	O	O	O
poor	O	O	O
elastomer	O	O	B-T109
-	O	O	O
side	O	O	B-T082
and	O	O	O
good	O	O	O
bone	O	O	B-T024
-	O	O	O
side	O	O	O
cell	O	O	B-T026
attachment	O	O	I-T026
.	O	O	O

In	O	O	O
a	O	O	O
further	O	O	O
study	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
osteogenic	O	O	B-T024
properties	O	O	B-T080
,	O	O	O
the	O	O	O
construct	O	O	B-T122
were	O	O	O
loaded	O	O	O
with	O	O	O
BMP-2	O	O	B-T116
and/or	O	O	O
TGF-β1	O	O	B-T116
.	O	O	O

The	O	O	O
PGS	O	O	B-T109
/	O	O	O
β-TCP	O	O	B-T122
bi-layered	O	O	B-T122
constructs	O	O	I-T122
with	O	O	O
improved	O	O	O
mechanical	O	O	B-T080
and	O	O	O
biological	O	O	B-T080
properties	O	O	B-T080
have	O	O	O
the	O	O	O
potential	O	O	O
to	O	O	O
be	O	O	O
used	O	O	O
in	O	O	O
bone-soft	O	O	B-UnknownType
tissue	O	O	I-UnknownType
interface	O	O	B-T169
applications	O	O	I-T169
where	O	O	O
soft	O	O	B-T024
tissue	O	O	I-T024
penetration	O	O	B-T169
is	O	O	O
a	O	O	O
problem	O	O	B-T033
.	O	O	O

-DOCSTART- (28024987)

Effects	O	O	B-T080
of	O	O	I-T080
high-intensity	O	O	B-T056
training	O	O	I-T056
on	O	O	O
cardiovascular	O	O	B-T047
risk	O	O	I-T047
factors	O	O	I-T047
in	O	O	O
premenopausal	O	O	B-T033
and	O	O	O
postmenopausal	O	O	B-T033
women	O	O	O

Menopause	O	O	B-T039
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	B-T081
risk	O	O	O
of	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
the	O	O	O
causal	O	O	O
factors	O	O	B-T169
have	O	O	O
been	O	O	O
proposed	O	O	O
to	O	O	O
be	O	O	O
the	O	O	O
loss	O	O	B-T081
of	O	O	O
estrogen	O	O	B-T125
and	O	O	O
the	O	O	O
subsequent	O	O	O
alterations	O	O	O
of	O	O	O
the	O	O	O
hormonal	O	O	B-T125
milieu	O	O	I-T125
.	O	O	O

However	O	O	O
,	O	O	O
which	O	O	O
factors	O	O	B-T169
contribute	O	O	B-T052
to	O	O	O
the	O	O	O
deterioration	O	O	B-T067
of	O	O	O
cardiometabolic	O	O	B-T042
health	O	O	I-T042
in	O	O	O
postmenopausal	O	O	B-T033
women	O	O	B-T098
is	O	O	O
debated	O	O	O
as	O	O	O
the	O	O	O
menopausal	O	O	B-T039
transition	O	O	B-T052
is	O	O	O
also	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	B-T081
age	O	O	B-T032
and	O	O	O
fat	O	O	B-T032
mass	O	O	I-T032
.	O	O	O

Furthermore	O	O	O
,	O	O	O
indications	O	O	B-T078
of	O	O	O
reduced	O	O	B-T080
cardiometabolic	O	O	B-T042
adaptations	O	O	B-T038
to	O	O	O
exercise	O	O	B-T056
in	O	O	O
postmenopausal	O	O	B-T033
women	O	O	B-T098
add	O	O	O
to	O	O	O
the	O	O	O
adverse	O	O	B-T046
health	O	O	B-T080
profile	O	O	I-T080
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
evaluate	O	O	B-T058
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
and	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
late	O	O	B-T079
premenopausal	O	O	B-T033
and	O	O	O
early	O	O	B-T079
postmenopausal	O	O	B-T033
women	O	O	B-T098
,	O	O	O
matched	O	O	O
by	O	O	O
age	O	O	B-T032
and	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
,	O	O	O
and	O	O	O
investigate	O	O	B-T169
the	O	O	O
effect	O	O	O
of	O	O	O
high-intensity	O	O	B-T056
training	O	O	I-T056
.	O	O	O

A	O	O	O
3-month	O	O	O
high-intensity	O	O	B-T056
aerobic	O	O	I-T056
training	O	O	I-T056
intervention	O	O	B-T061
,	O	O	O
involving	O	O	O
healthy	O	O	B-T080
,	O	O	O
nonobese	O	O	B-T033
,	O	O	O
late	O	O	B-T079
premenopausal	O	O	B-T033
(	O	O	O
n	O	O	O
=	O	O	O
40	O	O	O
)	O	O	O
and	O	O	O
early	O	O	B-T079
postmenopausal	O	O	B-T033
(	O	O	O
n	O	O	O
=	O	O	O
39	O	O	O
)	O	O	O
women	O	O	B-T098
was	O	O	O
conducted	O	O	O
and	O	O	O
anthropometrics	O	O	B-T201
,	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
,	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
,	O	O	O
lipid	O	O	B-T059
profile	O	O	I-T059
,	O	O	O
glucose	O	O	B-T039
tolerance	O	O	I-T039
,	O	O	O
and	O	O	O
maximal	O	O	B-T201
oxygen	O	O	I-T201
consumption	O	O	I-T201
were	O	O	O
determined	O	O	O
at	O	O	O
baseline	O	O	B-T081
and	O	O	O
after	O	O	O
the	O	O	O
intervention	O	O	O
.	O	O	O

At	O	O	O
baseline	O	O	B-T081
,	O	O	O
the	O	O	O
groups	O	O	B-T098
matched	O	O	O
in	O	O	O
anthropometrics	O	O	B-T201
and	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
,	O	O	O
and	O	O	O
only	O	O	O
differed	O	O	O
by	O	O	O
4.2	O	O	O
years	O	O	O
in	O	O	O
age	O	O	B-T032
(	O	O	O
mean	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
limits	O	O	I-T081
]	O	O	O
49.2	O	O	O
[	O	O	O
48.5	O	O	O
-	O	O	O
49.9	O	O	O
]	O	O	O
vs	O	O	O
53.4	O	O	O
[	O	O	O
52.4	O	O	O
-	O	O	O
54.4	O	O	O
]	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

Time	O	O	O
since	O	O	O
last	O	O	O
menstrual	O	O	B-T040
period	O	O	I-T040
for	O	O	O
the	O	O	O
postmenopausal	O	O	B-T033
women	O	O	B-T098
was	O	O	O
(	O	O	O
mean	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
confidecnce	O	O	B-T081
limits	O	O	I-T081
]	O	O	O
3.1	O	O	O
[	O	O	O
2.6	O	O	O
-	O	O	O
3.7	O	O	O
]	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

Hormonal	O	O	B-T034
levels	O	O	I-T034
(	O	O	O
estrogen	O	O	B-T125
,	O	O	O
follicle	O	O	B-T116
stimulation	O	O	I-T116
hormone	O	O	I-T116
,	O	O	O
luteinizing	O	O	B-T116
hormone	O	O	I-T116
)	O	O	O
confirmed	O	O	O
menopausal	O	O	B-T201
status	O	O	I-T201
.	O	O	O

At	O	O	O
baseline	O	O	B-T081
the	O	O	O
postmenopausal	O	O	B-T033
women	O	O	B-T098
had	O	O	O
higher	O	O	O
total	O	O	B-T109
cholesterol	O	O	I-T109
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
,	O	O	O
low-density	O	O	B-T109
lipoprotein-cholesterol	O	O	I-T109
(	O	O	O
P	O	O	O
<	O	O	O
.05	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
high-density	O	O	B-T109
lipoprotein-cholesterol	O	O	I-T109
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
than	O	O	O
the	O	O	O
premenopausal	O	O	B-T033
women	O	O	O
.	O	O	O

The	O	O	O
training	O	O	O
intervention	O	O	B-T061
reduced	O	O	B-T080
body	O	O	B-T032
weight	O	O	I-T032
(	O	O	O
P	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
,	O	O	O
waist	O	O	B-T201
circumference	O	O	I-T201
(	O	O	O
P	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
improved	O	O	B-T033
body	O	O	B-T032
composition	O	O	I-T032
by	O	O	O
increasing	O	O	B-T169
lean	O	O	B-T201
body	O	O	I-T201
mass	O	O	I-T201
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
and	O	O	O
decreasing	O	O	B-T033
fat	O	O	B-T032
mass	O	O	I-T032
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
similarly	O	O	O
in	O	O	O
both	O	O	O
groups	O	O	B-T098
.	O	O	O

Moreover	O	O	O
,	O	O	O
training	O	O	O
resulted	O	O	O
in	O	O	O
lower	O	O	B-T033
diastolic	O	O	I-T033
blood	O	O	I-T033
pressure	O	O	I-T033
(	O	O	O
P	O	O	O
<	O	O	O
.05	O	O	O
)	O	O	O
,	O	O	O
resting	O	O	B-T033
heart	O	O	I-T033
rate	O	O	I-T033
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
,	O	O	O
total	O	O	B-T109
cholesterol	O	O	I-T109
(	O	O	O
P	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
,	O	O	O
low-density	O	O	B-T109
lipoprotein-cholesterol	O	O	I-T109
(	O	O	O
P	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
,	O	O	O
total	O	O	O
cholesterol	O	O	O
/	O	O	O
high-density	O	O	B-T109
lipoprotein-cholesterol	O	O	I-T109
index	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
improved	O	O	B-T033
plasma	O	O	B-T059
insulin	O	O	I-T059
concentration	O	O	I-T059
during	O	O	O
the	O	O	O
oral	O	O	B-T060
glucose	O	O	I-T060
tolerance	O	O	I-T060
test	O	O	I-T060
(	O	O	O
P	O	O	O
<	O	O	O
.05	O	O	O
)	O	O	O
in	O	O	O
both	O	O	O
groups	O	O	B-T098
.	O	O	O

Cardiovascular	O	O	B-T047
risk	O	O	I-T047
factors	O	O	I-T047
are	O	O	O
similar	O	O	O
in	O	O	O
late	O	O	B-T079
premenopausal	O	O	B-T033
and	O	O	O
early	O	O	B-T079
postmenopausal	O	O	B-T033
women	O	O	B-T098
,	O	O	O
matched	O	O	O
by	O	O	O
age	O	O	B-T032
and	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
,	O	O	O
with	O	O	O
the	O	O	O
exception	O	O	O
that	O	O	O
postmenopausal	O	O	O
women	O	O	O
have	O	O	O
higher	O	O	O
high-	O	O	B-T059
and	O	O	O
low-density	O	O	B-T059
lipoprotein-cholesterol	O	O	I-T059
levels	O	O	I-T059
.	O	O	O

A	O	O	O
3-month	O	O	O
intervention	O	O	B-T061
of	O	O	O
high-intensity	O	O	B-T056
aerobic	O	O	I-T056
training	O	O	I-T056
reduces	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
type	O	O	B-T047
2	O	O	I-T047
.diabetes	O	O	I-T047
and	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
to	O	O	O
a	O	O	O
similar	O	O	O
extent	O	O	O
in	O	O	O
late	O	O	B-T079
premenopausal	O	O	B-T033
and	O	O	O
early	O	O	B-T079
postmenopausal	O	O	B-T033
women	O	O	B-T098
.	O	O	O

-DOCSTART- (28025023)

Correlation	O	O	B-T080
between	O	O	O
preoperative	O	O	B-T079
physical	O	O	B-T033
signs	O	O	I-T033
and	O	O	O
functional	O	O	B-T169
outcomes	O	O	B-T169
after	O	O	O
laminoplasty	O	O	B-T061
for	O	O	O
ossification	O	O	O
of	O	O	O
the	O	O	O
posterior	O	O	O
longitudinal	O	O	O
ligament	O	O	O

Ossification	O	O	B-T046
of	O	O	I-T046
the	O	O	I-T046
posterior	O	O	I-T046
longitudinal	O	O	I-T046
ligament	O	O	I-T046
(	O	O	O
OPLL	O	O	B-T046
)	O	O	O
can	O	O	O
cause	O	O	O
myelopathy	O	O	B-T047
that	O	O	O
is	O	O	O
often	O	O	B-T079
managed	O	O	B-T058
surgically	O	O	B-T061
.	O	O	O

Knowledge	O	O	B-T041
of	O	O	O
predictors	O	O	B-T078
of	O	O	O
surgical	O	O	B-T061
outcomes	O	O	B-T080
can	O	O	O
provide	O	O	B-T052
decision	O	O	B-T170
support	O	O	I-T170
to	O	O	O
surgeons	O	O	B-T097
.	O	O	O

The	O	O	O
aims	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
were	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
relationships	O	O	B-T080
between	O	O	O
preoperative	O	O	B-T079
physical	O	O	B-T033
signs	O	O	I-T033
and	O	O	O
postoperative	O	O	B-T079
functional	O	O	B-T169
outcomes	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
OPLL	O	O	B-T046
and	O	O	O
to	O	O	O
clarify	O	O	B-T052
whether	O	O	O
physical	O	O	O
signs	O	O	O
could	O	O	O
predict	O	O	B-T078
functional	O	O	O
outcomes	O	O	O
.	O	O	O

Fifty-five	O	O	O
patients	O	O	B-T101
with	O	O	O
OPLL	O	O	B-T046
who	O	O	O
had	O	O	O
undergone	O	O	O
cervical	O	O	B-T061
laminoplasty	O	O	I-T061
were	O	O	O
included	O	O	B-T169
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

Six	O	O	O
physical	O	O	B-T033
signs	O	O	I-T033
including	O	O	O
hyperreflexia	O	O	B-T033
,	O	O	O
Babinski	O	O	B-T033
sign	O	O	I-T033
,	O	O	O
sensory	O	O	B-T047
disturbance	O	O	I-T047
,	O	O	O
grip	O	O	B-T081
strength	O	O	I-T081
,	O	O	O
10-s	O	O	B-T060
grip	O	O	I-T060
and	O	O	I-T060
release	O	O	I-T060
test	O	O	I-T060
,	O	O	O
and	O	O	O
bladder	O	O	B-T046
dysfunction	O	O	I-T046
,	O	O	O
and	O	O	O
four	O	O	O
other	O	O	O
factors	O	O	B-T169
including	O	O	O
age	O	O	B-T032
,	O	O	O
duration	O	O	B-T079
of	O	O	I-T079
symptoms	O	O	I-T079
,	O	O	O
history	O	O	O
of	O	O	O
minor	O	O	B-T037
trauma	O	O	I-T037
and	O	O	O
preoperative	O	O	B-T079
Japanese	O	O	B-T081
Orthopaedic	O	O	I-T081
Association	O	O	I-T081
(	O	O	I-T081
JOA	O	O	I-T081
)	O	O	I-T081
score	O	O	I-T081
were	O	O	O
investigated	O	O	B-T169
as	O	O	O
potential	O	O	B-T080
predictive	O	O	B-T080
prognostic	O	O	B-T201
factors	O	O	I-T201
using	O	O	O
both	O	O	O
univariate	O	O	B-T062
and	O	O	O
multivariate	O	O	B-T081
analyses	O	O	I-T081
.	O	O	O

The	O	O	O
mean	O	O	B-T081
recovery	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
JOA	O	O	B-T081
score	O	O	I-T081
was	O	O	O
62.5	O	O	O
±	O	O	O
32.5	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
neurological	O	O	B-T080
recovery	O	O	B-T081
rate	O	O	I-T081
was	O	O	O
negatively	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
age	O	O	B-T032
(	O	O	O
P	O	O	O
=	O	O	O
0.002	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
duration	O	O	B-T079
of	O	O	I-T079
symptoms	O	O	I-T079
(	O	O	O
P	O	O	O
=	O	O	O
0.002	O	O	O
)	O	O	O
and	O	O	O
Babinski	O	O	B-T033
sign	O	O	I-T033
(	O	O	O
P	O	O	O
=	O	O	O
0.007	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
it	O	O	O
was	O	O	O
positively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
grip	O	O	B-T081
strength	O	O	I-T081
(	O	O	O
P	O	O	O
=	O	O	O
0.011	O	O	O
)	O	O	O
.	O	O	O

Multiple	O	O	B-T170
logistic	O	O	I-T170
regression	O	O	I-T170
analyses	O	O	I-T170
revealed	O	O	B-T080
that	O	O	O
age	O	O	B-T032
(	O	O	O
Odds	O	O	B-T081
ratio	O	O	I-T081
:	O	O	O
0.89	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.81	O	O	O
-	O	O	O
0.99	O	O	O
)	O	O	O
and	O	O	O
Babinski	O	O	B-T033
sign	O	O	I-T033
(	O	O	O
Odds	O	O	O
ratio	O	O	O
:	O	O	O
0.18	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.04	O	O	O
-	O	O	O
0.89	O	O	O
)	O	O	O
were	O	O	O
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
functional	O	O	B-T169
outcomes	O	O	B-T169
.	O	O	O

Satisfactory	O	O	B-T080
functional	O	O	B-T169
outcomes	O	O	B-T169
could	O	O	O
be	O	O	O
expected	O	O	B-T170
for	O	O	O
patients	O	O	B-T101
who	O	O	O
are	O	O	O
young	O	O	B-T079
and	O	O	O
do	O	O	O
not	O	O	O
exhibit	O	O	O
the	O	O	O
Babinski	O	O	B-T033
sign	O	O	I-T033
,	O	O	O
showing	O	O	O
that	O	O	O
the	O	O	O
Babinski	O	O	O
sign	O	O	O
could	O	O	O
be	O	O	O
useful	O	O	B-T080
as	O	O	O
an	O	O	O
indicator	O	O	B-T169
of	O	O	O
the	O	O	O
window	O	O	B-T080
of	O	O	I-T080
opportunity	O	O	I-T080
for	O	O	O
achieving	O	O	B-T080
satisfactory	O	O	B-T080
functional	O	O	O
outcomes	O	O	O
.	O	O	O

-DOCSTART- (28025224)

Bacteria	O	O	B-T007
and	O	O	O
Hoverflies	O	O	B-T204
(	O	O	O
Diptera	O	O	B-T204
:	O	O	O
Syrphidae	O	O	B-T204
)	O	O	O
in	O	O	O
Tree	O	O	B-T023
Hollows	O	O	I-T023
From	O	O	O
the	O	O	O
Iberian	O	O	O
Mediterranean	O	O	O
Forest	O	O	O

Saproxylic	O	O	B-T204
insect	O	O	I-T204
communities	O	O	I-T204
inhabiting	O	O	B-T082
tree	O	O	B-T023
hollows	O	O	I-T023
in	O	O	O
Mediterranean	O	O	B-T070
forests	O	O	I-T070
depend	O	O	O
on	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
physical	O	O	B-T080
characteristics	O	O	I-T080
and	O	O	O
interactions	O	O	B-T169
occurring	O	O	O
between	O	O	O
community	O	O	B-T185
member	O	O	I-T185
species	O	O	I-T185
.	O	O	O

Despite	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
preserve	O	O	O
these	O	O	O
organisms	O	O	B-T001
,	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
their	O	O	O
interrelationships	O	O	B-T080
,	O	O	O
in	O	O	O
particular	O	O	O
those	O	O	O
relationships	O	O	B-T080
between	O	O	O
saproxylic	O	O	B-T204
insects	O	O	I-T204
and	O	O	O
microbiota	O	O	B-T001
occurring	O	O	O
in	O	O	O
these	O	O	O
microhabitats	O	O	B-T082
.	O	O	O

In	O	O	O
tree	O	O	B-T023
hollows	O	O	I-T023
of	O	O	O
Quercus	O	O	B-T002
rotundifolia	O	O	I-T002
Lamark	O	O	I-T002
that	O	O	O
hold	O	O	B-T169
water	O	O	I-T169
and	O	O	O
contain	O	O	O
dead	O	O	B-T002
leaves	O	O	I-T002
,	O	O	O
abundant	O	O	B-T001
microbial	O	O	I-T001
populations	O	O	I-T001
can	O	O	O
be	O	O	O
found	O	O	O
.	O	O	O

Developing	O	O	O
on	O	O	O
them	O	O	O
are	O	O	O
the	O	O	O
larvae	O	O	B-T204
of	O	O	O
Mallota	O	O	B-T204
dusmeti	O	O	I-T204
Andréu	O	O	O
,	O	O	O
1926	O	O	O
(	O	O	O
Diptera	O	O	B-T204
:	O	O	O
Syrphidae	O	O	B-T204
)	O	O	O
,	O	O	O
a	O	O	O
vulnerable	O	O	B-T185
species	O	O	I-T185
(	O	O	O
IUCN	O	O	B-T170
category	O	O	I-T170
:	O	O	O
Marcos-García	O	O	B-T098
and	O	O	O
Quinto	O	O	B-T098
2011	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
provides	O	O	O
the	O	O	O
first	O	O	O
data	O	O	O
on	O	O	O
the	O	O	O
microbiota	O	O	B-T001
living	O	O	B-T082
inside	O	O	I-T082
the	O	O	O
gut	O	O	B-T023
of	O	O	O
the	O	O	O
larvae	O	O	B-T204
of	O	O	O
M.	O	O	B-T204
dusmeti	O	O	I-T204
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
microbiota	O	O	O
in	O	O	O
the	O	O	O
hollow	O	O	B-T082
where	O	O	O
these	O	O	O
larvae	O	O	O
develop	O	O	B-T039
.	O	O	O

Bacteria	O	O	B-T007
were	O	O	O
identified	O	O	O
by	O	O	O
amplification	O	O	B-T059
and	O	O	I-T059
partial	O	O	I-T059
sequencing	O	O	I-T059
of	O	O	O
the	O	O	O
V1-V3	O	O	B-T028
regions	O	O	I-T028
and	O	O	O
the	O	O	O
complete	O	O	O
nucleotide	O	O	B-T086
sequence	O	O	I-T086
of	O	O	O
16S	O	O	B-T114
rRNA	O	O	I-T114
genes	O	O	I-T114
.	O	O	O

We	O	O	O
found	O	O	O
eight	O	O	O
species	O	O	B-T185
of	O	O	I-T007
bacteria	O	O	B-T007
living	O	O	B-T082
in	O	O	I-T082
tree	O	O	B-T023
hollows	O	O	I-T023
and	O	O	O
three	O	O	O
species	O	O	O
in	O	O	B-T023
the	O	O	I-T023
gut	O	O	I-T023
of	O	O	O
M.	O	O	B-T204
dusmeti	O	O	I-T204
larvae	O	O	B-T204
:	O	O	O
Bacillus	O	O	B-T007
cereus	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
toyonensis	O	O	I-T007
,	O	O	O
and	O	O	O
Lysinibacillus	O	O	B-T007
sphaericus	O	O	I-T007
The	O	O	O
filter-feeding	O	O	B-T033
mechanism	O	O	I-T033
characteristic	O	O	I-T033
of	O	O	O
M.	O	O	O
dusmeti	O	O	O
larvae	O	O	O
is	O	O	O
selective	O	O	O
in	O	O	O
enabling	O	O	O
ingestion	O	O	B-T038
of	O	O	O
bacteria	O	O	O
only	O	O	O
above	O	O	O
2.1	O	O	O
µm	O	O	O
in	O	O	O
diameter	O	O	O
.	O	O	O

-DOCSTART- (28026207)

Impact	O	O	B-T056
sports	O	O	I-T056
and	O	O	O
bone	O	O	B-T037
fractures	O	O	I-T037
among	O	O	O
adolescents	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
different	O	O	B-T080
sports	O	O	B-T056
on	O	O	O
stress	O	O	B-T037
fractures	O	O	I-T037
among	O	O	O
adolescents	O	O	B-T100
during	O	O	O
a	O	O	O
9-	O	O	O
month	O	O	B-T079
follow-up	O	O	B-T058
period	O	O	B-T079
.	O	O	O

The	O	O	O
sample	O	O	B-T098
was	O	O	O
composed	O	O	O
of	O	O	O
184	O	O	O
adolescents	O	O	B-T100
divided	O	O	O
into	O	O	O
three	O	O	O
groups	O	O	B-T098
(	O	O	O
impact	O	O	B-T056
sports	O	O	I-T056
[	O	O	O
n	O	O	O
=	O	O	O
102	O	O	O
]	O	O	O
;	O	O	O
swimming	O	O	B-T056
[	O	O	O
n	O	O	O
=	O	O	O
35	O	O	O
]	O	O	O
;	O	O	O
non-sports	O	O	B-T056
[	O	O	O
n	O	O	O
=	O	O	O
47	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
occurrence	O	O	B-T079
of	O	O	O
stress	O	O	B-T037
fracture	O	O	I-T037
was	O	O	O
reported	O	O	O
by	O	O	O
participants	O	O	B-T098
and	O	O	O
coaches	O	O	B-T097
.	O	O	O

As	O	O	O
potential	O	O	O
confounders	O	O	B-T169
we	O	O	O
considered	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
resistance	O	O	B-T061
training	O	O	I-T061
,	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
variables	O	O	B-T080
and	O	O	O
age	O	O	O
at	O	O	O
peak	O	O	B-T080
of	O	O	O
height	O	O	B-T081
velocity	O	O	I-T081
.	O	O	O

There	O	O	O
were	O	O	O
13	O	O	O
adolescents	O	O	B-T100
who	O	O	O
reported	O	O	O
fractures	O	O	B-T037
during	O	O	O
the	O	O	O
9-	O	O	O
month	O	O	B-T079
period	O	O	B-T079
.	O	O	O

Bone	O	O	B-T201
mineral	O	O	I-T201
density	O	O	I-T201
values	O	O	B-T080
were	O	O	O
higher	O	O	O
in	O	O	O
adolescents	O	O	B-T100
engaged	O	O	O
in	O	O	O
impact	O	O	B-T056
sports	O	O	I-T056
(	O	O	O
P-value	O	O	B-T081
=	O	O	O
0.002	O	O	O
)	O	O	O
.	O	O	O

Independently	O	O	O
of	O	O	O
confounders	O	O	B-T169
,	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
stress	O	O	B-T037
fracture	O	O	B-T037
was	O	O	O
lower	O	O	O
in	O	O	O
adolescents	O	O	B-T100
engaged	O	O	O
in	O	O	O
impact	O	O	B-T056
sports	O	O	I-T056
than	O	O	O
in	O	O	O
non-active	O	O	B-T100
adolescents	O	O	I-T100
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
HR	O	O	B-T081
]	O	O	O
=	O	O	O
0.23	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
=	O	O	O
0.05	O	O	O
to	O	O	O
0.98	O	O	O
]	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
swimming	O	O	B-T056
practice	O	O	B-T041
was	O	O	O
not	O	O	O
associated	O	O	O
to	O	O	O
lower	O	O	O
risk	O	O	O
of	O	O	O
fracture	O	O	O
(	O	O	O
HR	O	O	O
=	O	O	O
0.49	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
0.09	O	O	O
to	O	O	O
2.55	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
the	O	O	O
findings	O	O	B-T033
from	O	O	O
this	O	O	O
study	O	O	B-T062
indicate	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
sports	O	O	B-T056
participation	O	O	B-T169
among	O	O	O
adolescents	O	O	B-T100
in	O	O	O
the	O	O	O
reduction	O	O	B-T080
of	O	O	O
stress	O	O	B-T037
fracture	O	O	I-T037
risk	O	O	B-T078
,	O	O	O
especially	O	O	O
with	O	O	O
impact	O	O	B-T056
sports	O	O	I-T056
.	O	O	O

More	O	O	O
importantly	O	O	O
,	O	O	O
these	O	O	O
results	O	O	B-T169
could	O	O	O
be	O	O	O
relevant	O	O	B-T080
for	O	O	O
recognising	O	O	O
adolescents	O	O	B-T100
in	O	O	O
danger	O	O	O
of	O	O	O
not	O	O	O
reaching	O	O	O
their	O	O	O
potential	O	O	O
for	O	O	O
peak	O	O	B-T080
bone	O	O	B-T201
mass	O	O	I-T201
and	O	O	O
later	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
fractures	O	O	B-T037
.	O	O	O

-DOCSTART- (28027163)

The	O	O	O
Business	O	O	B-UnknownType
of	O	O	O
Health	O	O	B-T091
Physics	O	O	I-T091
-	O	O	O
Jobs	O	O	B-T090
In	O	O	O
A	O	O	O
Changing	O	O	O
Market	O	O	O

The	O	O	O
health	O	O	B-T091
physics	O	O	I-T091
profession	O	O	B-T090
was	O	O	O
born	O	O	O
abruptly	O	O	O
when	O	O	O
once	O	O	O
rare	O	O	O
and	O	O	O
precious	O	O	O
radioactive	O	O	B-T122
materials	O	O	I-T122
became	O	O	O
commonplace	O	O	B-T081
.	O	O	O

The	O	O	O
technological	O	O	B-UnknownType
advancements	O	O	I-UnknownType
that	O	O	O
triggered	O	O	O
an	O	O	O
industrial	O	O	B-T080
complex	O	O	I-T080
and	O	O	O
ended	O	O	O
World	O	O	B-T051
War	O	O	I-T051
II	O	O	I-T051
demanded	O	O	O
radiation	O	O	B-T067
safety	O	O	I-T067
on	O	O	O
an	O	O	O
unprecedented	O	O	B-T170
scale	O	O	I-T170
.	O	O	O

Until	O	O	O
then	O	O	O
,	O	O	O
protective	O	O	B-T068
measures	O	O	I-T068
against	O	O	I-T068
radiation	O	O	I-T068
were	O	O	O
largely	O	O	O
absent	O	O	O
in	O	O	O
laboratories	O	O	B-T093
.	O	O	O

Over	O	O	O
the	O	O	O
subsequent	O	O	O
decades	O	O	O
,	O	O	O
health	O	O	B-T097
physicists	O	O	I-T097
began	O	O	O
protecting	O	O	B-T061
people	O	O	I-T061
and	O	O	O
the	O	O	O
environment	O	O	B-T064
in	O	O	O
a	O	O	O
wide	O	O	O
range	O	O	O
of	O	O	O
settings	O	O	O
including	O	O	O
medical	O	O	B-T058
,	O	O	O
research	O	O	B-T062
,	O	O	O
and	O	O	O
industrial	O	O	B-T057
.	O	O	O

The	O	O	O
use	O	O	B-T033
of	O	O	I-T033
radioactive	O	O	I-T033
materials	O	O	I-T033
and	O	O	O
radiation-generating	O	O	B-T074
devices	O	O	I-T074
is	O	O	O
prevalent	O	O	B-T082
today	O	O	I-T082
.	O	O	O

Radiation	O	O	B-T081
doses	O	O	I-T081
occur	O	O	O
continuously	O	O	O
including	O	O	O
during	O	O	O
airline	O	O	B-T073
flights	O	O	I-T073
,	O	O	O
in	O	O	O
our	O	O	O
homes	O	O	O
,	O	O	O
during	O	O	O
medical	O	O	B-T058
procedures	O	O	I-T058
,	O	O	O
and	O	O	O
in	O	O	O
energy	O	O	O
production	O	O	O
.	O	O	O

Radiation	O	O	B-T070
is	O	O	O
integral	O	O	B-T169
to	O	O	I-T169
numerous	O	O	I-T169
applications	O	O	I-T169
including	O	O	O
those	O	O	O
in	O	O	O
medicine	O	O	B-T091
,	O	O	O
dentistry	O	O	B-T091
,	O	O	O
manufacturing	O	O	B-T090
,	O	O	O
construction	O	O	O
,	O	O	O
scientific	O	O	B-T062
research	O	O	I-T062
,	O	O	O
nuclear	O	O	B-T073
electric	O	O	I-T073
power	O	O	I-T073
generation	O	O	I-T073
,	O	O	O
and	O	O	O
oil	O	O	B-T070
and	O	O	I-T070
gas	O	O	I-T070
exploration	O	O	I-T070
.	O	O	O

Activities	O	O	O
that	O	O	O
were	O	O	O
once	O	O	O
groundbreaking	O	O	O
have	O	O	O
now	O	O	O
become	O	O	O
routine	O	O	B-T080
and	O	O	O
scripted	O	O	B-T170
.	O	O	O

At	O	O	O
higher	O	O	B-T081
doses	O	O	I-T081
,	O	O	O
health	O	O	B-T033
effects	O	O	I-T033
are	O	O	O
understood	O	O	B-T169
and	O	O	I-T169
avoided	O	O	I-T169
.	O	O	O

Instruments	O	O	B-T074
for	O	O	I-T074
the	O	O	I-T074
detection	O	O	I-T074
and	O	O	I-T074
measurement	O	O	I-T074
of	O	O	I-T074
radiation	O	O	I-T074
are	O	O	O
at	O	O	O
times	O	O	O
smarter	O	O	O
than	O	O	O
their	O	O	O
users	O	O	O
.	O	O	O

Ironically	O	O	O
,	O	O	O
the	O	O	O
same	O	O	O
health	O	O	B-T091
physics	O	O	I-T091
community	O	O	O
that	O	O	O
has	O	O	O
been	O	O	O
successful	O	O	O
in	O	O	O
demonstrating	O	O	O
that	O	O	O
exposures	O	O	B-T037
to	O	O	I-T037
radiation	O	O	I-T037
and	O	O	O
to	O	O	O
radioactive	O	O	B-T122
materials	O	O	I-T122
can	O	O	O
be	O	O	O
effectively	O	O	B-T058
managed	O	O	I-T058
is	O	O	O
shrinking	O	O	O
at	O	O	O
an	O	O	O
increasingly	O	O	O
rapid	O	O	B-T081
rate	O	O	I-T081
.	O	O	O

This	O	O	O
paper	O	O	O
highlights	O	O	O
the	O	O	O
creation	O	O	B-T052
of	O	O	O
past	O	O	O
and	O	O	O
current	O	O	O
jobs	O	O	B-T090
,	O	O	O
predicts	O	O	O
the	O	O	O
future	O	O	O
opportunities	O	O	B-T078
in	O	O	I-T078
the	O	O	I-T078
profession	O	O	I-T078
,	O	O	O
and	O	O	O
makes	O	O	O
recommendations	O	O	B-T078
necessary	O	O	O
to	O	O	O
protect	O	O	O
the	O	O	O
disappearing	O	O	B-T091
specialties	O	O	I-T091
.	O	O	O

-DOCSTART- (28032366)

Permanence	O	O	B-T079
can	O	O	O
be	O	O	O
Defended	O	O	O

In	O	O	O
donation	O	O	B-T055
after	O	O	O
the	O	O	O
circulatory-respiratory	O	O	B-T060
determination	O	O	I-T060
of	O	O	I-T060
death	O	O	I-T060
(	O	O	O
DCDD	O	O	B-T060
)	O	O	O
,	O	O	O
the	O	O	O
dead	O	O	B-T040
donor	O	O	B-T098
rule	O	O	B-T170
requires	O	O	B-T080
that	O	O	O
the	O	O	O
donor	O	O	O
be	O	O	O
dead	O	O	O
before	O	O	B-T079
organ	O	O	B-T058
procurement	O	O	I-T058
can	O	O	O
proceed	O	O	O
.	O	O	O

Under	O	O	O
the	O	O	O
relevant	O	O	B-T080
limb	O	O	I-T080
of	O	O	O
the	O	O	O
Uniform	O	O	B-T170
Determination	O	O	I-T170
of	O	O	I-T170
Death	O	O	I-T170
Act	O	O	I-T170
1981	O	O	I-T170
(	O	O	I-T170
USA	O	O	I-T170
)	O	O	I-T170
,	O	O	O
a	O	O	O
person	O	O	B-T098
is	O	O	O
dead	O	O	B-T040
when	O	O	O
the	O	O	O
cessation	O	O	B-T052
of	O	O	O
circulatory-respiratory	O	O	B-T169
function	O	O	I-T169
is	O	O	O
'	O	O	O
irreversible	O	O	B-T033
'	O	O	O
.	O	O	O

Critics	O	O	B-T097
of	O	O	O
current	O	O	B-T079
practice	O	O	B-T041
in	O	O	O
DCDD	O	O	B-T060
have	O	O	O
argued	O	O	B-T054
that	O	O	O
the	O	O	O
donor	O	O	B-T098
is	O	O	O
not	O	O	O
dead	O	O	B-T040
at	O	O	O
the	O	O	O
time	O	O	B-T079
organs	O	O	B-T023
are	O	O	O
procured	O	O	B-T058
,	O	O	O
and	O	O	O
so	O	O	O
the	O	O	O
procurement	O	O	B-T058
of	O	O	I-T058
organs	O	O	I-T058
from	O	O	O
these	O	O	O
donors	O	O	B-T098
violates	O	O	O
the	O	O	O
dead	O	O	O
donor	O	O	O
rule	O	O	B-T170
.	O	O	O

We	O	O	O
offer	O	O	B-T033
a	O	O	O
new	O	O	B-T080
argument	O	O	B-T054
here	O	O	O
in	O	O	O
defence	O	O	B-T054
of	O	O	O
current	O	O	B-T079
DCDD	O	O	B-T060
practice	O	O	B-T041
,	O	O	O
and	O	O	O
,	O	O	O
in	O	O	O
particular	O	O	O
,	O	O	O
of	O	O	O
the	O	O	O
interpretation	O	O	B-T170
of	O	O	O
the	O	O	O
requirement	O	O	B-T169
of	O	O	O
'	O	O	O
irreversibility	O	O	B-T033
'	O	O	O
as	O	O	O
permanence	O	O	B-T079
.	O	O	O

-DOCSTART- (28033725)

Untypeable	O	O	B-T080
hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
subtypes	O	O	B-T185
in	O	O	O
Pakistan	O	O	B-T083
:	O	O	O
A	O	O	O
neglected	O	O	O
section	O	O	O

Diagnostically	O	O	B-T169
untypeable	O	O	B-T080
subtypes	O	O	B-T185
contribute	O	O	O
a	O	O	O
considerable	O	O	O
percent	O	O	O
of	O	O	O
hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
HCV	O	O	B-T005
)	O	O	O
subtypes	O	O	O
in	O	O	O
Pakistan	O	O	B-T083
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
chronically	O	O	B-T047
infected	O	O	I-T047
HCV	O	O	B-T005
patients	O	O	B-T101
with	O	O	O
known	O	O	O
viremia	O	O	B-T047
were	O	O	O
subjected	O	O	O
to	O	O	O
HCV	O	O	O
genotyping	O	O	B-T059
.	O	O	O

Among	O	O	O
the	O	O	O
total	O	O	O
retrieved	O	O	O
samples	O	O	B-T077
,	O	O	O
92.7	O	O	O
%	O	O	O
(	O	O	O
64/69	O	O	O
)	O	O	O
were	O	O	O
found	O	O	O
typeable	O	O	B-T080
while	O	O	O
7.24	O	O	O
%	O	O	O
(	O	O	O
5/69	O	O	O
)	O	O	O
were	O	O	O
diagnostically	O	O	B-T169
untypeable	O	O	B-T080
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
,	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
large	O	O	O
number	O	O	O
of	O	O	O
untypeable	O	O	B-T080
HCV	O	O	B-T005
subtypes	O	O	B-T185
emphasizes	O	O	O
the	O	O	O
need	O	O	O
of	O	O	O
an	O	O	O
updated	O	O	O
type	O	O	B-T080
-	O	O	O
specific	O	O	B-T080
genotyping	O	O	B-T059
assay	O	O	B-T059
and	O	O	O
consideration	O	O	O
of	O	O	O
primers	O	O	B-T114
for	O	O	O
proportionally	O	O	O
rare	O	O	B-T080
subtypes	O	O	O
to	O	O	O
minimize	O	O	B-T080
the	O	O	O
number	O	O	O
of	O	O	O
untypeable	O	O	O
HCV	O	O	O
subtypes	O	O	O
.	O	O	O

-DOCSTART- (28036301)

ITPR3	O	O	B-T028
gene	O	O	I-T028
haplotype	O	O	B-T032
is	O	O	O
associated	O	O	O
with	O	O	O
cervical	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
risk	O	O	B-T078
in	O	O	O
Taiwanese	O	O	B-T098
women	O	O	O

Host	O	O	B-T091
immunogenetic	O	O	I-T091
background	O	O	O
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
human	O	O	B-T047
papillomavirus	O	O	I-T047
(	O	O	I-T047
HPV	O	O	I-T047
)	O	O	I-T047
infection	O	O	I-T047
and	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
development	O	O	I-T191
.	O	O	O

Inositol	O	O	B-T028
1,4,5-triphosphate	O	O	I-T028
receptor	O	O	I-T028
type	O	O	I-T028
3	O	O	I-T028
(	O	O	O
ITPR3	O	O	B-T028
)	O	O	O
is	O	O	O
essential	O	O	O
for	O	O	O
both	O	O	O
immune	O	O	B-T043
activation	O	O	I-T043
and	O	O	O
cancer	O	O	B-T191
pathogenesis	O	O	B-T046
.	O	O	O

We	O	O	O
aim	O	O	O
to	O	O	O
investigate	O	O	O
if	O	O	O
ITPR3	O	O	B-T028
genetic	O	O	B-T045
polymorphisms	O	O	I-T045
are	O	O	O
associated	O	O	O
with	O	O	O
the	O	O	O
risk	O	O	B-T081
of	O	O	I-T081
cervical	O	O	I-T081
cancer	O	O	I-T081
in	O	O	O
Taiwanese	O	O	B-T098
women	O	O	B-T098
.	O	O	O

ITPR3	O	O	B-T028
rs3748079	O	O	B-T086
A/G	O	O	I-T086
and	O	O	O
rs2229634	O	O	B-T086
C/T	O	O	I-T086
polymorphisms	O	O	I-T086
were	O	O	O
genotyped	O	O	B-T032
in	O	O	O
a	O	O	O
hospital-based	O	O	B-T062
study	O	O	I-T062
of	O	O	O
462	O	O	O
women	O	O	B-T098
with	O	O	O
cervical	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
CSCC	O	O	B-T191
)	O	O	O
and	O	O	O
921	O	O	O
age-matched	O	O	O
healthy	O	O	B-T080
control	O	O	I-T080
women	O	O	O
.	O	O	O

The	O	O	O
presence	O	O	O
and	O	O	O
genotypes	O	O	B-T032
of	O	O	O
HPV	O	O	B-T005
in	O	O	O
CSCC	O	O	B-T191
was	O	O	O
determined	O	O	O
.	O	O	O

No	O	O	O
significant	O	O	O
association	O	O	O
of	O	O	O
individual	O	O	O
ITPR3	O	O	B-T028
variants	O	O	B-T028
were	O	O	O
found	O	O	O
among	O	O	O
controls	O	O	O
,	O	O	O
CSCC	O	O	B-T191
,	O	O	O
and	O	O	O
HPV-16	O	O	B-T034
positive	O	O	I-T034
CSCC	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
a	O	O	O
significant	O	O	O
association	O	O	O
of	O	O	O
haplotype	O	O	B-T032
AT	O	O	I-T032
between	O	O	O
CSCC	O	O	B-T191
and	O	O	O
controls	O	O	O
(	O	O	O
OR	O	O	B-T081
=	O	O	O
2.28	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
1.31	O	O	O
-	O	O	O
3.97	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
2.83	O	O	O
×	O	O	O
10	O	O	O
-	O	O	O
3	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
OR	O	O	O
increased	O	O	O
further	O	O	O
in	O	O	O
CSCC	O	O	O
patients	O	O	B-T101
infected	O	O	I-T101
with	O	O	O
HPV-16	O	O	B-T005
(	O	O	O
OR	O	O	O
=	O	O	O
2.89	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.55	O	O	O
-	O	O	O
5.37	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
4.54	O	O	O
×	O	O	O
10	O	O	O
-	O	O	O
4	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
linkage	O	O	B-T063
disequilibrium	O	O	I-T063
analysis	O	O	I-T063
demonstrated	O	O	O
that	O	O	O
ITPR3	O	O	B-T028
association	O	O	B-T063
with	O	O	O
CSCC	O	O	B-T191
was	O	O	O
independent	O	O	O
of	O	O	O
HLA-DRB1	O	O	B-T028
alleles	O	O	B-T028
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
these	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
AT	O	O	B-T032
haplotype	O	O	I-T032
in	O	O	O
the	O	O	O
ITPR3	O	O	B-T028
gene	O	O	I-T028
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
potential	O	O	B-T045
marker	O	O	I-T045
for	O	O	O
genetic	O	O	B-T032
susceptibility	O	O	I-T032
to	O	O	O
CSCC	O	O	B-T191
.	O	O	O

-DOCSTART- (28039284)

Defining	O	O	O
categories	O	O	B-T170
of	O	O	O
actionability	O	O	B-T052
for	O	O	O
secondary	O	O	B-T080
findings	O	O	B-T033
in	O	O	O
next-generation	O	O	O
sequencing	O	O	O

Next-generation	O	O	B-T059
sequencing	O	O	I-T059
is	O	O	O
increasingly	O	O	O
used	O	O	O
in	O	O	O
clinical	O	O	B-T057
practice	O	O	I-T057
for	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
Mendelian	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

Because	O	O	O
of	O	O	O
the	O	O	O
high	O	O	O
likelihood	O	O	O
of	O	O	O
secondary	O	O	B-T080
findings	O	O	B-T033
associated	O	O	O
with	O	O	O
this	O	O	O
technique	O	O	B-T169
,	O	O	O
the	O	O	O
process	O	O	O
of	O	O	O
informing	O	O	B-T058
patients	O	O	I-T058
is	O	O	O
beset	O	O	O
with	O	O	O
new	O	O	O
challenges	O	O	O
.	O	O	O

One	O	O	O
of	O	O	O
them	O	O	O
is	O	O	O
regarding	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
secondary	O	O	B-T080
findings	O	O	B-T033
that	O	O	O
ought	O	O	O
to	O	O	O
be	O	O	O
disclosed	O	O	O
to	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
research	O	O	B-T062
is	O	O	O
to	O	O	O
propose	O	O	O
a	O	O	O
practical	O	O	O
implementation	O	O	B-T052
of	O	O	O
the	O	O	O
notion	O	O	O
of	O	O	O
actionability	O	O	B-T052
,	O	O	O
a	O	O	O
common	O	O	O
criteria	O	O	O
justifying	O	O	O
the	O	O	O
disclosure	O	O	B-T055
of	O	O	O
secondary	O	O	B-T080
findings	O	O	B-T033
but	O	O	O
whose	O	O	O
interpretation	O	O	B-T170
varies	O	O	O
greatly	O	O	O
among	O	O	O
professionals	O	O	B-T097
.	O	O	O

We	O	O	O
distinguish	O	O	O
three	O	O	O
types	O	O	O
of	O	O	O
actionability	O	O	B-T052
corresponding	O	O	O
to	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
well-established	O	O	O
medical	O	O	B-T169
actions	O	O	B-T052
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
patient	O	O	B-T101
-initiated	O	O	O
health-related	O	O	B-T055
actions	O	O	I-T055
and	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
life-plan	O	O	B-T041
decisions	O	O	I-T041
.	O	O	O

We	O	O	O
argue	O	O	O
that	O	O	O
actionability	O	O	B-T052
depends	O	O	O
on	O	O	O
the	O	O	O
characteristics	O	O	O
of	O	O	O
the	O	O	O
mutation	O	O	B-T045
or	O	O	O
gene	O	O	B-T028
and	O	O	O
on	O	O	O
the	O	O	O
values	O	O	O
of	O	O	O
patients	O	O	B-T101
.	O	O	O

In	O	O	O
discussing	O	O	O
the	O	O	O
return	O	O	O
of	O	O	O
secondary	O	O	B-T080
findings	O	O	B-T033
,	O	O	O
it	O	O	O
is	O	O	O
important	O	O	O
that	O	O	O
the	O	O	O
physician	O	O	B-T097
tries	O	O	O
to	O	O	O
get	O	O	O
an	O	O	O
impression	O	O	B-T080
of	O	O	O
the	O	O	O
specific	O	O	O
situation	O	O	O
and	O	O	O
values	O	O	O
of	O	O	O
patients	O	O	B-T101
.	O	O	O

Regarding	O	O	O
variants	O	O	B-T028
of	O	O	O
uncertain	O	O	O
clinical	O	O	B-T033
significance	O	O	I-T033
in	O	O	O
actionable	O	O	O
genes	O	O	B-T028
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
different	O	O	O
understandings	O	O	O
of	O	O	O
autonomy	O	O	B-T078
lead	O	O	O
to	O	O	O
different	O	O	O
conclusions	O	O	B-T078
and	O	O	O
that	O	O	O
,	O	O	O
for	O	O	O
some	O	O	O
of	O	O	O
them	O	O	O
,	O	O	O
it	O	O	O
may	O	O	O
be	O	O	O
legitimate	O	O	O
to	O	O	O
refrain	O	O	O
from	O	O	O
returning	O	O	O
uncertain	O	O	O
information	O	O	B-T078
.	O	O	O

-DOCSTART- (28039304)

Allergen	O	O	B-T129
Valency	O	O	B-T081
,	O	O	O
Dose	O	O	B-T081
,	O	O	O
and	O	O	O
FcεRI	O	O	B-T116
Occupancy	O	O	B-T080
Set	O	O	O
Thresholds	O	O	B-T080
for	O	O	O
Secretory	O	O	B-T043
Responses	O	O	I-T043
to	O	O	O
Pen	O	O	B-T116
a	O	O	I-T116
1	O	O	I-T116
and	O	O	O
Motivate	O	O	O
Design	O	O	B-T052
of	O	O	O
Hypoallergens	O	O	O

Ag	O	O	B-T196
-mediated	O	O	O
crosslinking	O	O	B-T070
of	O	O	O
IgE	O	O	B-T116
-	O	O	O
FcεRI	O	O	B-T116
complexes	O	O	B-T116
activates	O	O	O
mast	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
basophils	O	O	B-T025
,	O	O	O
initiating	O	O	O
the	O	O	O
allergic	O	O	B-T046
response	O	O	I-T046
.	O	O	O

Of	O	O	O
34	O	O	O
donors	O	O	O
recruited	O	O	O
having	O	O	O
self-reported	O	O	B-T062
shrimp	O	O	B-T204
allergy	O	O	I-T046
,	O	O	O
only	O	O	O
35	O	O	O
%	O	O	O
had	O	O	O
significant	O	O	O
levels	O	O	O
of	O	O	O
shrimp-specific	O	O	B-T116
IgE	O	O	I-T116
in	O	O	O
serum	O	O	B-T031
and	O	O	O
measurable	O	O	O
basophil	O	O	B-T025
secretory	O	O	B-T043
responses	O	O	B-T038
to	O	O	O
rPen	O	O	B-T129
a	O	O	I-T129
1	O	O	I-T129
(	O	O	O
shrimp	O	O	O
tropomyosin	O	O	B-T116
)	O	O	O
.	O	O	O

We	O	O	O
report	O	O	O
that	O	O	O
degranulation	O	O	O
is	O	O	O
linked	O	O	O
to	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
FcεRI	O	O	B-T116
occupied	O	O	O
with	O	O	O
allergen-specific	O	O	B-T116
IgE	O	O	I-T116
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
dose	O	O	B-T081
and	O	O	O
valency	O	O	B-T081
of	O	O	O
Pen	O	O	B-T116
a	O	O	I-T116
1	O	O	I-T116
.	O	O	O

Using	O	O	O
clustered	O	O	B-T063
regularly	O	O	I-T063
interspaced	O	O	I-T063
palindromic	O	O	I-T063
repeat-based	O	O	I-T063
gene	O	O	I-T063
editing	O	O	I-T063
,	O	O	O
human	O	O	O
RBL(rαKO	O	O	O
)	O	O	O
cells	O	O	O
were	O	O	O
created	O	O	O
that	O	O	O
exclusively	O	O	O
express	O	O	O
the	O	O	O
human	O	O	O
FcεRIα	O	O	B-T116
subunit	O	O	O
.	O	O	O

Pen	O	O	B-T116
a	O	O	I-T116
1	O	O	I-T116
-	O	O	O
specific	O	O	B-T116
IgE	O	O	I-T116
was	O	O	O
affinity	O	O	O
purified	O	O	O
from	O	O	O
shrimp	O	O	B-T204
-	O	O	O
positive	O	O	B-T033
plasma	O	O	B-T031
.	O	O	O

Cells	O	O	O
primed	O	O	O
with	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
Pen	O	O	B-T116
a	O	O	I-T116
1	O	O	I-T116
-	O	O	O
specific	O	O	B-T116
IgE	O	O	I-T116
and	O	O	O
challenged	O	O	O
with	O	O	O
Pen	O	O	O
a	O	O	O
1	O	O	O
showed	O	O	O
a	O	O	O
bell-shaped	O	O	O
dose	O	O	B-T081
response	O	O	B-T043
for	O	O	I-T043
secretion	O	O	I-T043
,	O	O	O
with	O	O	O
optimal	O	O	O
Pen	O	O	O
a	O	O	O
1	O	O	O
doses	O	O	B-T081
of	O	O	O
0.1	O	O	O
-	O	O	O
10	O	O	O
ng/ml	O	O	O
.	O	O	O

Mathematical	O	O	B-T170
modeling	O	O	I-T170
provided	O	O	O
estimates	O	O	O
of	O	O	O
receptor	O	O	B-T044
aggregation	O	O	I-T044
kinetics	O	O	B-T070
based	O	O	O
on	O	O	O
FcεRI	O	O	B-T116
occupancy	O	O	O
with	O	O	O
IgE	O	O	B-T116
and	O	O	O
allergen	O	O	B-T129
dose	O	O	B-T081
.	O	O	O

Maximal	O	O	O
degranulation	O	O	O
was	O	O	O
elicited	O	O	O
when	O	O	O
∼2700	O	O	O
I	O	O	O
gE	O	O	B-T116
-	O	O	O
FcεRI	O	O	B-T116
complexes	O	O	B-T116
were	O	O	O
occupied	O	O	O
with	O	O	O
specific	O	O	B-T116
IgE	O	O	B-T116
and	O	O	O
challenged	O	O	O
with	O	O	O
Pen	O	O	B-T116
a	O	O	I-T116
1	O	O	I-T116
(	O	O	O
IgE	O	O	O
epitope	O	O	B-T129
valency	O	O	B-T081
of	O	O	O
≥8	O	O	O
)	O	O	O
,	O	O	O
although	O	O	O
measurable	O	O	O
responses	O	O	O
were	O	O	O
achieved	O	O	O
when	O	O	O
only	O	O	O
a	O	O	O
few	O	O	O
hundred	O	O	O
FcεRI	O	O	O
were	O	O	O
occupied	O	O	O
.	O	O	O

Prolonged	O	O	O
periods	O	O	O
of	O	O	O
pepsin	O	O	B-T116
-mediated	O	O	O
Pen	O	O	B-T116
a	O	O	I-T116
1	O	O	I-T116
proteolysis	O	O	B-T044
,	O	O	O
which	O	O	O
simulates	O	O	O
gastric	O	O	B-T080
digestion	O	O	B-T040
,	O	O	O
were	O	O	O
required	O	O	O
to	O	O	O
diminish	O	O	O
secretory	O	O	B-T043
responses	O	O	I-T043
.	O	O	O

Recombinant	O	O	B-T116
fragments	O	O	I-T116
(	O	O	O
60	O	O	O
-	O	O	O
79	O	O	O
aa	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
together	O	O	O
span	O	O	O
the	O	O	O
entire	O	O	O
length	O	O	O
of	O	O	O
tropomyosin	O	O	B-T116
,	O	O	O
were	O	O	O
weak	O	O	O
secretagogues	O	O	O
.	O	O	O

These	O	O	O
fragments	O	O	O
have	O	O	O
reduced	O	O	O
dimerization	O	O	B-T044
capacity	O	O	B-T081
,	O	O	O
compete	O	O	O
with	O	O	O
intact	O	O	O
Pen	O	O	B-T116
a	O	O	I-T116
1	O	O	I-T116
for	O	O	O
binding	O	O	O
to	O	O	O
IgE	O	O	B-T116
-	O	O	O
FcεRI	O	O	B-T116
complexes	O	O	B-T116
,	O	O	O
and	O	O	O
represent	O	O	O
a	O	O	O
starting	O	O	O
point	O	O	O
for	O	O	O
the	O	O	O
design	O	O	O
of	O	O	O
promising	O	O	O
hypoallergens	O	O	B-T129
for	O	O	O
immunotherapy	O	O	B-T061
.	O	O	O

-DOCSTART- (28043654)

Selected	O	O	B-T052
flavonoid	O	O	B-T109
compounds	O	O	I-T109
as	O	O	O
promising	O	O	O
inhibitors	O	O	B-T120
of	O	O	O
protein	O	O	B-T116
kinase	O	O	I-T116
CK2α	O	O	B-T116
and	O	O	O
CK2α	O	O	B-T116
'	O	O	I-T116
,	O	O	O
the	O	O	O
catalytic	O	O	B-T087
subunits	O	O	I-T087
of	O	O	O
CK2	O	O	O

CK2	O	O	B-T116
is	O	O	O
a	O	O	O
ubiquitous	O	O	O
protein	O	O	B-T116
kinase	O	O	I-T116
involved	O	O	O
in	O	O	O
many	O	O	O
cell	O	O	B-T043
functions	O	O	I-T043
.	O	O	O

During	O	O	O
the	O	O	O
last	O	O	O
years	O	O	B-T079
it	O	O	O
became	O	O	O
an	O	O	O
interesting	O	O	O
target	O	O	B-T169
in	O	O	O
cancer	O	O	B-T062
research	O	O	I-T062
.	O	O	O

A	O	O	O
series	O	O	O
of	O	O	O
flavonoid	O	O	B-T109
compounds	O	O	I-T109
was	O	O	O
tested	O	O	B-T169
as	O	O	O
inhibitors	O	O	B-T120
of	O	O	O
protein	O	O	B-T116
kinase	O	O	I-T116
CK2	O	O	B-T116
.	O	O	O

Several	O	O	O
substances	O	O	B-T167
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
highly	O	O	B-T080
active	O	O	B-T078
against	O	O	I-T078
both	O	O	O
catalytic	O	O	B-T087
subunits	O	O	I-T087
with	O	O	O
IC50	O	O	B-T081
values	O	O	B-T080
below	O	O	O
1	O	O	O
μM	O	O	O
in	O	O	O
case	O	O	O
of	O	O	O
CK2α	O	O	B-T116
'	O	O	I-T116
.	O	O	O

The	O	O	O
most	O	O	O
promising	O	O	O
inhibitor	O	O	B-T120
we	O	O	O
identified	O	O	B-T080
is	O	O	O
chrysoeriol	O	O	B-T109
with	O	O	O
IC50	O	O	B-T081
values	O	O	B-T080
of	O	O	O
250	O	O	O
and	O	O	O
34	O	O	O
nM	O	O	O
for	O	O	O
CK2α	O	O	B-T116
and	O	O	O
CK2α	O	O	B-T116
'	O	O	I-T116
,	O	O	O
respectively	O	O	O
.	O	O	O

-DOCSTART- (28044140)

Fibrinogen	O	O	B-T116
:	O	O	O
A	O	O	O
Marker	O	O	B-T201
in	O	O	O
Predicting	O	O	O
Diabetic	O	O	B-T047
Foot	O	O	I-T047
Ulcer	O	O	I-T047
Severity	O	O	O

Aims	O	O	O
.	O	O	O

To	O	O	O
examine	O	O	B-T058
whether	O	O	O
fibrinogen	O	O	B-T034
levels	O	O	I-T034
are	O	O	O
a	O	O	O
valuable	O	O	O
biomarker	O	O	B-T201
for	O	O	O
assessing	O	O	B-T058
disease	O	O	B-T080
severity	O	O	I-T080
and	O	O	O
monitoring	O	O	B-T058
disease	O	O	B-T046
progression	O	O	I-T046
in	O	O	O
patients	O	O	B-T101
with	O	O	O
diabetic	O	O	B-T047
foot	O	O	I-T047
ulcer	O	O	I-T047
(	O	O	O
DFU	O	O	B-T047
)	O	O	O
.	O	O	O

Methods	O	O	O
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
was	O	O	O
designed	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
utility	O	O	B-T169
of	O	O	O
fibrinogen	O	O	B-T116
in	O	O	O
estimating	O	O	O
disease	O	O	B-T080
severity	O	O	I-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
DFU	O	O	B-T047
admitted	O	O	B-T058
to	O	O	O
our	O	O	O
hospital	O	O	B-T093
between	O	O	O
January	O	O	B-T080
2015	O	O	O
and	O	O	O
January	O	O	O
2016	O	O	O
.	O	O	O

In	O	O	O
total	O	O	O
,	O	O	O
152	O	O	O
patients	O	O	B-T101
with	O	O	O
DFU	O	O	B-T047
were	O	O	O
enrolled	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-UnknownType
group	O	O	I-UnknownType
,	O	O	O
and	O	O	O
52	O	O	O
age	O	O	O
and	O	O	O
gender	O	O	B-T032
matched	O	O	O
people	O	O	B-T101
with	O	O	O
diabetes	O	O	B-T047
but	O	O	O
no	O	O	O
DFU	O	O	O
were	O	O	O
included	O	O	O
as	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

DFU	O	O	B-T047
severity	O	O	B-T080
was	O	O	O
assessed	O	O	O
using	O	O	O
Wagner	O	O	O
criteria	O	O	O
.	O	O	O

Results	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
DFU	O	O	B-T047
were	O	O	O
divided	O	O	O
into	O	O	O
2	O	O	O
subgroups	O	O	B-T185
based	O	O	O
on	O	O	O
the	O	O	O
Wagner	O	O	O
criteria	O	O	O
.	O	O	O

Mean	O	O	O
fibrinogen	O	O	B-T034
values	O	O	I-T034
were	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
DFU	O	O	B-T047
grade	O	O	B-T185
≧	O	O	O
3	O	O	O
compared	O	O	O
to	O	O	O
those	O	O	O
with	O	O	O
DFU	O	O	O
grades	O	O	B-T185
1	O	O	O
-	O	O	O
2	O	O	O
(	O	O	O
5.23	O	O	O
±	O	O	O
1.37	O	O	O
g/L	O	O	O
versus	O	O	O
3.61	O	O	O
±	O	O	O
1.04	O	O	O
g/L	O	O	O
)	O	O	O
.	O	O	O

Using	O	O	O
ROC	O	O	B-T081
statistic	O	O	I-T081
,	O	O	O
a	O	O	O
cut-off	O	O	B-T081
value	O	O	I-T081
of	O	O	O
5.13	O	O	O
g/L	O	O	O
indicated	O	O	O
the	O	O	O
possible	O	O	O
amputation	O	O	B-T061
with	O	O	O
a	O	O	O
sensitivity	O	O	B-T081
of	O	O	O
81.8	O	O	O
%	O	O	O
and	O	O	O
a	O	O	O
specificity	O	O	B-T081
of	O	O	O
78.9	O	O	O
%	O	O	O
(	O	O	O
positive	O	O	B-T081
predictive	O	O	I-T081
value	O	O	I-T081
[	O	O	O
PPV	O	O	B-T081
]	O	O	O
78.6	O	O	O
%	O	O	O
,	O	O	O
negative	O	O	B-T081
predictive	O	O	I-T081
value	O	O	I-T081
[	O	O	O
89.0	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

Fibrinogen	O	O	B-T034
values	O	O	I-T034
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
correlated	O	O	O
with	O	O	O
CRP	O	O	B-T034
levels	O	O	I-T034
,	O	O	O
neutrophil	O	O	B-T059
,	O	O	O
and	O	O	O
WBC	O	O	B-T059
count	O	O	I-T059
.	O	O	O

Conclusions	O	O	O
.	O	O	O

Fibrinogen	O	O	B-T034
levels	O	O	I-T034
might	O	O	O
be	O	O	O
a	O	O	O
valuable	O	O	O
tool	O	O	O
for	O	O	O
assessing	O	O	B-T058
the	O	O	O
disease	O	O	B-T080
severity	O	O	I-T080
and	O	O	O
monitoring	O	O	B-T058
the	O	O	O
disease	O	O	B-T046
progression	O	O	I-T046
in	O	O	O
patients	O	O	B-T101
with	O	O	O
DFU	O	O	B-T047
.	O	O	O

-DOCSTART- (28046142)

Nitrogen	O	O	B-T044
utilization	O	O	I-T044
efficiency	O	O	B-T081
and	O	O	O
prediction	O	O	B-T078
of	O	O	O
nitrogen	O	O	B-T123
excretion	O	O	B-T039
in	O	O	O
sheep	O	O	B-T015
offered	O	O	B-T033
fresh	O	O	B-T002
perennial	O	O	I-T002
ryegrass	O	O	I-T002
(	O	O	O
)	O	O	O

Nitrogen	O	O	B-T123
excretion	O	O	B-T039
from	O	O	O
sheep	O	O	B-T015
production	O	O	B-T082
systems	O	O	I-T082
is	O	O	O
an	O	O	O
important	O	O	O
source	O	O	O
of	O	O	O
nitrate	O	O	B-T197
,	O	O	O
ammonia	O	O	B-T121
,	O	O	O
and	O	O	O
nitrous	O	O	B-T121
oxide	O	O	I-T121
responsible	O	O	O
for	O	O	O
groundwater	O	O	B-T082
pollution	O	O	B-T069
and	O	O	O
global	O	O	B-T069
warming	O	O	I-T069
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
identify	O	O	B-T080
key	O	O	B-T077
parameters	O	O	I-T077
influencing	O	O	O
N	O	O	B-T123
utilization	O	O	I-T044
efficiency	O	O	B-T081
and	O	O	O
develop	O	O	O
prediction	O	O	B-T078
equations	O	O	B-T077
for	O	O	O
manure	O	O	B-T167
N	O	O	O
,	O	O	O
feces	O	O	B-T031
N	O	O	O
,	O	O	O
and	O	O	O
urine	O	O	B-T031
N	O	O	O
outputs	O	O	B-T077
in	O	O	O
sheep	O	O	B-T015
.	O	O	O

Data	O	O	B-T078
used	O	O	O
were	O	O	O
collected	O	O	O
from	O	O	O
82	O	O	O
sheep	O	O	B-T015
offered	O	O	B-T033
fresh	O	O	B-T002
perennial	O	O	I-T002
ryegrass	O	O	I-T002
(	O	O	O
)	O	O	O
as	O	O	O
the	O	O	O
sole	O	O	B-T168
diet	O	O	I-T168
in	O	O	O
6	O	O	O
metabolism	O	O	B-T040
experiments	O	O	B-T062
(	O	O	O
data	O	O	B-T078
from	O	O	O
non-grass-only	O	O	B-T168
diets	O	O	I-T168
were	O	O	O
not	O	O	B-T169
used	O	O	I-T169
)	O	O	O
.	O	O	O

Sheep	O	O	B-T015
were	O	O	O
from	O	O	O
breeds	O	O	B-T185
of	O	O	O
Highlander	O	O	B-T098
,	O	O	O
Texel	O	O	B-T015
,	O	O	O
Scottish	O	O	B-T015
Blackface	O	O	I-T015
,	O	O	O
and	O	O	O
Swaledale	O	O	B-T015
at	O	O	O
the	O	O	O
age	O	O	B-T032
of	O	O	O
5	O	O	O
to	O	O	O
18	O	O	O
mo	O	O	B-T079
and	O	O	O
weighing	O	O	O
from	O	O	O
24.5	O	O	O
to	O	O	O
62.7	O	O	O
kg	O	O	O
.	O	O	O

Herbage	O	O	B-T002
was	O	O	O
harvested	O	O	B-T067
daily	O	O	B-T079
from	O	O	O
6	O	O	O
swards	O	O	B-T002
of	O	O	O
contrasting	O	O	O
harvest	O	O	B-T067
dates	O	O	B-T079
(	O	O	O
May	O	O	O
to	O	O	O
December	O	O	O
)	O	O	O
,	O	O	O
offering	O	O	B-T033
wide	O	O	O
variation	O	O	B-T080
in	O	O	O
feed	O	O	O
value	O	O	O
to	O	O	O
cover	O	O	O
the	O	O	O
range	O	O	B-T081
that	O	O	O
would	O	O	O
be	O	O	O
offered	O	O	B-T033
in	O	O	O
most	O	O	O
practical	O	O	O
farm	O	O	B-T082
situations	O	O	I-T082
.	O	O	O

Before	O	O	O
the	O	O	O
commencement	O	O	O
of	O	O	O
each	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
experimental	O	O	B-T080
sward	O	O	B-T002
was	O	O	O
harvested	O	O	B-T067
at	O	O	O
a	O	O	O
residual	O	O	B-T032
height	O	O	B-T032
of	O	O	O
4	O	O	O
cm	O	O	O
and	O	O	O
allowed	O	O	O
to	O	O	O
grow	O	O	B-T040
for	O	O	O
2	O	O	O
to	O	O	O
4	O	O	O
wk	O	O	B-T079
to	O	O	O
target	O	O	B-T169
an	O	O	O
average	O	O	O
pregrazing	O	O	O
sward	O	O	O
height	O	O	O
in	O	O	O
a	O	O	O
range	O	O	B-T081
of	O	O	O
8	O	O	O
to	O	O	O
15	O	O	O
cm	O	O	O
depending	O	O	B-T169
on	O	O	O
the	O	O	O
time	O	O	B-T081
of	O	O	I-T081
year	O	O	I-T081
.	O	O	O

Sheep	O	O	B-T015
were	O	O	O
housed	O	O	B-T082
in	O	O	O
individual	O	O	O
pens	O	O	O
for	O	O	O
14	O	O	O
d	O	O	B-T079
and	O	O	O
then	O	O	O
transferred	O	O	B-T033
to	O	O	I-T033
individual	O	O	O
metabolism	O	O	B-T040
crates	O	O	O
for	O	O	O
4	O	O	O
d	O	O	O
with	O	O	O
feed	O	O	B-T052
intake	O	O	B-T169
and	O	O	O
feces	O	O	B-T031
and	O	O	O
urine	O	O	B-T031
outputs	O	O	B-T077
measured	O	O	O
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
the	O	O	O
linear	O	O	B-T081
mixed	O	O	I-T081
model	O	O	I-T081
procedure	O	O	I-T081
to	O	O	O
develop	O	O	O
prediction	O	O	B-T078
equations	O	O	B-T077
for	O	O	O
feces	O	O	B-T031
N	O	O	B-T123
,	O	O	O
urine	O	O	B-T031
N	O	O	O
,	O	O	O
and	O	O	O
manure	O	O	B-T167
N	O	O	O
outputs	O	O	B-T077
using	O	O	O
N	O	O	B-T033
intake	O	O	I-T033
,	O	O	O
herbage	O	O	B-T002
chemical	O	O	B-T070
composition	O	O	I-T070
,	O	O	O
and	O	O	O
digestibility	O	O	B-T067
with	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
sex	O	O	B-T032
,	O	O	O
breed	O	O	B-T185
,	O	O	O
and	O	O	O
experimental	O	O	O
periods	O	O	B-T079
removed	O	O	B-T080
.	O	O	O

Nitrogen	O	O	B-T123
intake	O	O	B-T169
was	O	O	O
the	O	O	O
best	O	O	B-T080
single	O	O	B-T078
predictor	O	O	I-T078
for	O	O	O
N	O	O	B-T123
output	O	O	B-T077
in	O	O	O
feces	O	O	B-T031
,	O	O	O
urine	O	O	B-T031
,	O	O	O
and	O	O	O
manure	O	O	B-T167
,	O	O	O
and	O	O	O
the	O	O	O
value	O	O	O
for	O	O	O
prediction	O	O	B-T078
of	O	O	O
manure	O	O	O
N	O	O	O
output	O	O	O
was	O	O	O
greater	O	O	B-T081
than	O	O	O
those	O	O	O
for	O	O	O
feces	O	O	O
N	O	O	O
and	O	O	O
urine	O	O	O
N	O	O	O
(	O	O	O
0.86	O	O	O
vs.	O	O	O
0.70	O	O	O
and	O	O	O
0.77	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Animal	O	O	B-T008
BW	O	O	B-T032
and	O	O	O
herbage	O	O	B-T002
DM	O	O	B-T167
,	O	O	O
ether	O	O	B-T081
extract	O	O	I-T081
,	O	O	O
NDF	O	O	B-T168
,	O	O	O
ADF	O	O	B-T168
,	O	O	O
water	O	O	B-T059
soluble	O	O	I-T059
carbohydrate	O	O	I-T059
,	O	O	O
and	O	O	O
DE	O	O	O
concentrations	O	O	O
and	O	O	O
N	O	O	B-T123
digestibility	O	O	B-T067
were	O	O	O
also	O	O	O
used	O	O	O
to	O	O	O
predict	O	O	B-T078
N	O	O	O
outputs	O	O	B-T077
because	O	O	O
N	O	O	O
intake	O	O	B-T169
may	O	O	O
not	O	O	B-T080
be	O	O	I-T080
available	O	O	I-T080
in	O	O	O
commercial	O	O	B-T078
practice	O	O	I-T078
.	O	O	O

The	O	O	O
prediction	O	O	B-T078
equations	O	O	B-T077
for	O	O	O
N	O	O	B-T123
utilizatio	O	O	I-T044
n	O	O	O
efficiency	O	O	B-T081
indicated	O	O	O
that	O	O	O
increasing	O	O	B-T169
feeding	O	O	B-T052
level	O	O	B-T080
and	O	O	O
ME	O	O	B-T081
concentration	O	O	B-T081
and	O	O	O
reducing	O	O	B-T080
N	O	O	B-T033
concentration	O	O	I-T033
could	O	O	O
improve	O	O	B-T033
N	O	O	B-T044
utilization	O	O	I-T044
efficiency	O	O	O
and	O	O	O
shift	O	O	O
N	O	O	O
excretion	O	O	B-T039
into	O	O	O
feces	O	O	B-T031
rather	O	O	B-T033
than	O	O	I-T033
urine	O	O	B-T031
(	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
equations	O	O	B-T077
developed	O	O	O
in	O	O	O
the	O	O	O
current	O	O	O
study	O	O	B-T062
provide	O	O	O
an	O	O	O
approach	O	O	B-T082
for	O	O	O
sheep	O	O	B-T015
producers	O	O	B-T098
to	O	O	O
quantify	O	O	B-T081
N	O	O	B-T123
excretion	O	O	B-T039
against	O	O	O
production	O	O	B-T057
and	O	O	O
,	O	O	O
consequently	O	O	O
,	O	O	O
to	O	O	O
develop	O	O	O
their	O	O	O
own	O	O	O
mitigation	O	O	B-T062
strategies	O	O	I-T062
to	O	O	O
reduce	O	O	B-T080
the	O	O	O
environmental	O	O	B-T067
impact	O	O	I-T067
of	O	O	O
sheep	O	O	O
production	O	O	B-T082
systems	O	O	I-T082
.	O	O	O

-DOCSTART- (28049415)

Improving	O	O	B-T080
protein	O	O	B-T116
complex	O	O	I-T116
prediction	O	O	B-T078
by	O	O	O
reconstructing	O	O	B-T170
a	O	O	O
high-confidence	O	O	B-T080
protein-protein	O	O	B-T169
interaction	O	O	I-T169
network	O	O	I-T169
of	O	O	O
Escherichia	O	O	B-T007
coli	O	O	I-T007
from	O	O	O
different	O	O	O
physical	O	O	B-T169
interaction	O	O	I-T169
data	O	O	O
sources	O	O	O

Although	O	O	O
different	O	O	O
protein-protein	O	O	B-T044
physical	O	O	I-T044
interaction	O	O	I-T044
(	O	O	O
PPI	O	O	B-T044
)	O	O	O
datasets	O	O	B-T170
exist	O	O	O
for	O	O	O
Escherichia	O	O	B-T007
coli	O	O	I-T007
,	O	O	O
no	O	O	O
common	O	O	O
methodology	O	O	B-T078
exists	O	O	O
to	O	O	O
integrate	O	O	B-T066
these	O	O	O
datasets	O	O	O
and	O	O	O
extract	O	O	O
reliable	O	O	O
modules	O	O	B-T077
reflecting	O	O	O
the	O	O	O
existing	O	O	O
biological	O	O	B-T038
process	O	O	I-T038
and	O	O	O
protein	O	O	B-T116
complexes	O	O	I-T116
.	O	O	O

Naïve	O	O	B-T170
Bayesian	O	O	I-T170
formula	O	O	I-T170
is	O	O	O
the	O	O	O
highly	O	O	O
accepted	O	O	O
method	O	O	O
to	O	O	O
integrate	O	O	B-T066
different	O	O	O
PPI	O	O	B-T044
datasets	O	O	B-T170
into	O	O	O
a	O	O	O
single	O	O	O
weighted	O	O	B-T081
PPI	O	O	B-T169
network	O	O	B-T169
,	O	O	O
but	O	O	O
detecting	O	O	O
proper	O	O	O
weights	O	O	B-T081
in	O	O	O
such	O	O	O
network	O	O	O
is	O	O	O
still	O	O	O
a	O	O	O
major	O	O	O
problem	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
proposed	O	O	O
a	O	O	O
new	O	O	O
methodology	O	O	B-T078
to	O	O	O
integrate	O	O	B-T066
various	O	O	O
physical	O	O	B-T044
PPI	O	O	I-T044
datasets	O	O	B-T170
into	O	O	O
a	O	O	O
single	O	O	O
weighted	O	O	B-T081
PPI	O	O	B-T169
network	O	O	I-T169
in	O	O	O
a	O	O	O
way	O	O	O
that	O	O	O
the	O	O	O
detected	O	O	B-T033
modules	O	O	B-T077
in	O	O	O
PPI	O	O	O
network	O	O	O
exhibit	O	O	O
the	O	O	O
highest	O	O	O
similarity	O	O	O
to	O	O	O
available	O	O	O
functional	O	O	B-T169
modules	O	O	O
.	O	O	O

We	O	O	O
used	O	O	O
the	O	O	O
co-expression	O	O	B-T061
modules	O	O	B-T077
as	O	O	O
functional	O	O	B-T169
modules	O	O	O
,	O	O	O
and	O	O	O
we	O	O	O
shown	O	O	O
that	O	O	O
direct	O	O	O
functional	O	O	O
modules	O	O	O
detected	O	O	B-T033
from	O	O	O
Gene	O	O	B-T170
Ontology	O	O	I-T170
terms	O	O	B-T078
could	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
an	O	O	O
alternative	O	O	O
dataset	O	O	B-T170
.	O	O	O

After	O	O	O
running	O	O	O
this	O	O	O
integrating	O	O	B-T066
methodology	O	O	B-T078
over	O	O	O
six	O	O	O
different	O	O	O
physical	O	O	B-T044
PPI	O	O	B-T044
datasets	O	O	B-T170
,	O	O	O
orthologous	O	O	B-T080
high-confidence	O	O	B-T080
interactions	O	O	B-T169
from	O	O	O
a	O	O	O
related	O	O	O
organism	O	O	B-T001
and	O	O	O
two	O	O	O
AP-MS	O	O	B-T059
PPI	O	O	O
datasets	O	O	O
gained	O	O	B-T033
high	O	O	I-T033
weights	O	O	B-T081
in	O	O	O
the	O	O	O
integrated	O	O	B-T066
networks	O	O	B-T169
,	O	O	O
while	O	O	O
the	O	O	O
weights	O	O	O
for	O	O	O
one	O	O	O
AP-MS	O	O	O
PPI	O	O	O
dataset	O	O	B-T170
and	O	O	O
two	O	O	O
other	O	O	O
datasets	O	O	O
derived	O	O	O
from	O	O	O
public	O	O	B-T170
databases	O	O	I-T170
have	O	O	O
converged	O	O	O
to	O	O	O
zero	O	O	O
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
detected	O	O	B-T033
modules	O	O	B-T077
shaped	O	O	O
around	O	O	O
one	O	O	O
or	O	O	O
few	O	O	O
hub	O	O	B-T116
protein(s	O	O	I-T116
)	O	O	I-T116
.	O	O	O

Still	O	O	O
,	O	O	O
a	O	O	O
large	O	O	O
number	O	O	O
of	O	O	O
highly	O	O	O
interacting	O	O	O
protein	O	O	B-T116
modules	O	O	B-T077
were	O	O	O
detected	O	O	B-T033
which	O	O	O
are	O	O	O
functionally	O	O	B-T169
relevant	O	O	B-T080
and	O	O	O
are	O	O	O
likely	O	O	O
to	O	O	O
construct	O	O	B-T185
protein	O	O	B-T116
complexes	O	O	I-T116
.	O	O	O

We	O	O	O
provided	O	O	O
a	O	O	O
new	O	O	O
high	O	O	B-T080
confidence	O	O	I-T080
protein	O	O	B-T116
complex	O	O	I-T116
prediction	O	O	B-T078
method	O	O	O
supported	O	O	O
by	O	O	O
functional	O	O	B-T169
studies	O	O	O
and	O	O	O
literature	O	O	B-T170
mining	O	O	O
.	O	O	O

-DOCSTART- (28053186)

AAV9	O	O	B-T005
-	O	O	O
NPC1	O	O	B-T028
significantly	O	O	B-T078
ameliorates	O	O	B-T033
Purkinje	O	O	B-T025
cell	O	O	I-T025
death	O	O	B-T043
and	O	O	O
behavioral	O	O	B-T048
abnormalities	O	O	I-T048
in	O	O	O
mouse	O	O	B-T015
NPC	O	O	O
disease	O	O	O

Niemann-Pick	O	O	B-T047
type	O	O	I-T047
C	O	O	I-T047
(	O	O	I-T047
NPC	O	O	I-T047
)	O	O	I-T047
disease	O	O	I-T047
is	O	O	O
a	O	O	O
fatal	O	O	B-T080
inherited	O	O	B-T169
neurodegenerative	O	O	B-T047
disorder	O	O	I-T047
caused	O	O	O
by	O	O	O
loss-of-function	O	O	B-T033
mutations	O	O	B-T045
in	O	O	O
the	O	O	O
NPC1	O	O	B-T028
or	O	O	O
NPC2	O	O	B-T028
gene	O	O	I-T028
.	O	O	O

There	O	O	O
is	O	O	O
no	O	O	O
effective	O	O	O
way	O	O	O
to	O	O	O
treat	O	O	B-T169
NPC	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
used	O	O	O
adeno-associated	O	O	B-T005
virus	O	O	I-T005
(	O	O	O
AAV	O	O	B-T005
)	O	O	O
serotype	O	O	B-T170
9	O	O	I-T170
(	O	O	O
AAV9	O	O	B-T005
)	O	O	O
to	O	O	O
deliver	O	O	O
a	O	O	O
functional	O	O	B-T169
NPC1	O	O	B-T028
gene	O	O	I-T028
systemically	O	O	B-T169
into	O	O	O
NPC1(-/-	O	O	B-T028
)	O	O	I-T028
mice	O	O	B-T015
at	O	O	O
postnatal	O	O	B-T061
day	O	O	I-T061
4	O	O	I-T061
.	O	O	O

One	O	O	O
single	O	O	B-T081
AAV9-NPC1	O	O	B-T061
injection	O	O	I-T061
resulted	O	O	O
in	O	O	O
robust	O	O	B-T080
NPC1	O	O	B-T028
expression	O	O	B-T045
in	O	O	O
various	O	O	O
tissues	O	O	B-T024
,	O	O	O
including	O	O	O
brain	O	O	B-T023
,	O	O	O
heart	O	O	B-T023
,	O	O	O
and	O	O	O
lung	O	O	B-T023
.	O	O	O

Strikingly	O	O	O
,	O	O	O
AAV9-mediated	O	O	B-T054
NPC1	O	O	B-T077
delivery	O	O	I-T077
significantly	O	O	B-T078
promoted	O	O	B-T052
Purkinje	O	O	B-T025
cell	O	O	I-T025
survival	O	O	B-T052
,	O	O	O
restored	O	O	O
locomotor	O	O	B-T040
activity	O	O	I-T040
and	O	O	O
coordination	O	O	B-T042
,	O	O	O
and	O	O	O
increased	O	O	B-T081
the	O	O	O
lifespan	O	O	B-T079
of	O	O	O
NPC1(-/-	O	O	B-T028
)	O	O	I-T028
mice	O	O	B-T015
.	O	O	O

Our	O	O	O
work	O	O	O
suggests	O	O	O
that	O	O	O
AAV-based	O	O	B-T061
gene	O	O	I-T061
therapy	O	O	I-T061
is	O	O	O
a	O	O	O
promising	O	O	O
means	O	O	O
to	O	O	O
treat	O	O	B-T169
NPC	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

-DOCSTART- (28055142)

Executive	O	O	B-T041
functions	O	O	I-T041
deficits	O	O	B-T080
impair	O	O	B-T169
extinction	O	O	B-T041
of	O	O	O
generalization	O	O	B-T041
of	O	O	O
fear	O	O	B-T041
of	O	O	O
movement-related	O	O	O
pain	O	O	O

Generalization	O	O	B-T041
of	O	O	O
fear	O	O	B-T041
of	O	O	O
movement-related	O	O	B-T033
pain	O	O	B-T184
across	O	O	O
novel	O	O	O
but	O	O	O
similar	O	O	O
movements	O	O	B-T040
can	O	O	O
lead	O	O	O
to	O	O	O
fear	O	O	B-T039
responses	O	O	I-T039
to	O	O	O
movements	O	O	O
that	O	O	O
are	O	O	O
actually	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
pain	O	O	O
.	O	O	O

The	O	O	O
peak-shift	O	O	B-T080
effect	O	O	I-T080
describes	O	O	O
a	O	O	O
phenomenon	O	O	B-T067
whereby	O	O	O
particular	O	O	O
novel	O	O	O
movements	O	O	B-T040
elicit	O	O	B-T080
even	O	O	O
greater	O	O	O
fear	O	O	B-T039
responses	O	O	I-T039
than	O	O	O
the	O	O	O
original	O	O	O
pain-provoking	O	O	B-T184
movement	O	O	B-T040
(	O	O	O
CS+	O	O	B-T041
)	O	O	O
,	O	O	O
because	O	O	O
they	O	O	O
represent	O	O	O
a	O	O	O
more	O	O	O
extreme	O	O	O
version	O	O	O
of	O	O	O
the	O	O	O
CS+	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
great	O	O	O
variance	O	O	B-T080
in	O	O	O
the	O	O	O
propensity	O	O	O
to	O	O	O
generalize	O	O	B-T041
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
speed	O	O	O
of	O	O	O
extinction	O	O	B-T041
learning	O	O	I-T041
when	O	O	O
these	O	O	O
novel	O	O	O
movements	O	O	B-T040
are	O	O	O
not	O	O	O
followed	O	O	O
by	O	O	O
pain	O	O	B-T184
.	O	O	O

It	O	O	O
can	O	O	O
be	O	O	O
argued	O	O	O
that	O	O	O
this	O	O	O
variance	O	O	B-T080
may	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
executive	O	O	B-T041
function	O	O	I-T041
capacity	O	O	I-T041
,	O	O	O
as	O	O	O
individuals	O	O	B-T098
may	O	O	O
be	O	O	O
unable	O	O	O
to	O	O	O
intentionally	O	O	O
inhibit	O	O	B-T039
fear	O	O	I-T039
responses	O	O	I-T039
.	O	O	O

This	O	O	O
study	O	O	O
examined	O	O	B-T033
whether	O	O	O
executive	O	O	B-T041
function	O	O	I-T041
capacity	O	O	I-T041
contributes	O	O	O
to	O	O	O
generalization	O	O	B-T041
and	O	O	O
extinction	O	O	B-T041
of	O	O	O
generalization	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
peak-shift	O	O	B-T169
of	O	O	O
conditioned	O	O	B-T041
fear	O	O	I-T041
of	O	O	O
movement-related	O	O	B-T033
pain	O	O	I-T033
and	O	O	O
expectancy	O	O	B-T078
.	O	O	O

Healthy	O	O	B-T098
participants	O	O	I-T098
performed	O	O	O
a	O	O	O
proprioceptive	O	O	B-T039
fear	O	O	B-T041
conditioning	O	O	I-T041
task	O	O	I-T041
.	O	O	O

Executive	O	O	B-T041
function	O	O	I-T041
tests	O	O	I-T041
assessing	O	O	O
updating	O	O	B-T079
,	O	O	O
switching	O	O	O
,	O	O	O
and	O	O	O
inhibition	O	O	B-T041
were	O	O	O
used	O	O	O
to	O	O	O
predict	O	O	O
changes	O	O	O
in	O	O	O
(	O	O	O
extinction	O	O	B-T041
of	O	O	O
)	O	O	O
fear	O	O	B-T041
of	O	O	O
movement-related	O	O	B-T033
pain	O	O	B-T184
and	O	O	O
pain	O	O	O
expectancy	O	O	B-T078
generalization	O	O	B-T041
.	O	O	O

Low	O	O	B-T041
inhibitory	O	O	I-T041
capacity	O	O	I-T041
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
slower	O	O	O
extinction	O	O	B-T041
of	O	O	O
generalized	O	O	B-T041
fear	O	O	I-T041
of	O	O	O
movement-related	O	O	B-T033
pain	O	O	B-T184
and	O	O	O
pain	O	O	O
expectancy	O	O	B-T078
.	O	O	O

Evidence	O	O	O
was	O	O	O
found	O	O	O
in	O	O	O
favor	O	O	O
of	O	O	O
an	O	O	O
area-shift	O	O	B-T169
,	O	O	O
rather	O	O	O
than	O	O	O
a	O	O	O
peak-shift	O	O	B-T080
effect	O	O	I-T080
,	O	O	O
which	O	O	O
implies	O	O	O
that	O	O	O
the	O	O	O
peak	O	O	B-T080
conditioned	O	O	B-T039
fear	O	O	I-T039
response	O	O	I-T039
extended	O	O	O
to	O	O	O
,	O	O	O
but	O	O	O
did	O	O	O
not	O	O	O
shift	O	O	O
to	O	O	O
a	O	O	O
novel	O	O	O
stimulus	O	O	B-T067
.	O	O	O

Participants	O	O	B-T098
with	O	O	O
low	O	O	O
inhibitory	O	O	B-T041
capacity	O	O	I-T041
may	O	O	O
have	O	O	O
difficulties	O	O	O
withholding	O	O	O
fear	O	O	B-T039
responses	O	O	I-T039
,	O	O	O
leading	O	O	O
to	O	O	O
a	O	O	O
slower	O	O	O
decrease	O	O	O
of	O	O	O
generalized	O	O	B-T041
fear	O	O	I-T041
over	O	O	O
time	O	O	B-T079
.	O	O	O

The	O	O	O
findings	O	O	B-T033
may	O	O	O
be	O	O	O
relevant	O	O	O
to	O	O	O
inform	O	O	O
treatments	O	O	B-T169
.	O	O	O

Low	O	O	B-T041
inhibitory	O	O	I-T041
capacity	O	O	I-T041
is	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
slower	O	O	O
generalization	O	O	B-T041
,	O	O	O
but	O	O	O
extinction	O	O	B-T041
of	O	O	O
fear	O	O	B-T041
generalization	O	O	O
.	O	O	O

Fear	O	O	B-T041
elicited	O	O	B-T080
by	O	O	I-T080
a	O	O	O
novel	O	O	O
safe	O	O	O
movement	O	O	B-T040
,	O	O	O
situated	O	O	O
outside	O	O	O
the	O	O	O
CS+/-	O	O	B-T041
continuum	O	O	O
on	O	O	O
the	O	O	O
CS+	O	O	B-T041
side	O	O	O
,	O	O	O
can	O	O	O
be	O	O	O
as	O	O	O
strong	O	O	O
as	O	O	O
to	O	O	O
the	O	O	O
original	O	O	O
stimulus	O	O	B-T067
predicting	O	O	O
the	O	O	O
pain-onset	O	O	B-T033
.	O	O	O

-DOCSTART- (28055920)

Robust	O	O	B-T080
DLPP	O	O	B-T081
With	O	O	O
Nongreedy	O	O	B-T080
ℓ₁$-Norm	O	O	I-T080
Minimization	O	O	I-T080
and	O	O	O
Maximization	O	O	O

Recently	O	O	O
,	O	O	O
discriminant	O	O	B-T081
locality	O	O	I-T081
preserving	O	O	I-T081
projection	O	O	I-T081
based	O	O	I-T081
on	O	O	I-T081
L1-norm	O	O	I-T081
(	O	O	O
DLPP-L1	O	O	B-T081
)	O	O	O
was	O	O	O
developed	O	O	O
for	O	O	O
robust	O	O	B-T080
subspace	O	O	B-T041
learning	O	O	I-T041
and	O	O	O
image	O	O	B-T170
classification	O	O	B-T185
.	O	O	O

It	O	O	O
obtains	O	O	O
projection	O	O	B-T082
vectors	O	O	B-T082
by	O	O	O
greedy	O	O	B-T062
strategy	O	O	I-T062
,	O	O	O
i.e.	O	O	O
,	O	O	O
all	O	O	O
projection	O	O	O
vectors	O	O	O
are	O	O	O
optimized	O	O	O
individually	O	O	O
through	O	O	O
maximizing	O	O	B-T080
the	O	O	O
objective	O	O	B-T080
function	O	O	B-T169
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
obtained	O	O	O
solution	O	O	B-T170
does	O	O	O
not	O	O	O
necessarily	O	O	O
best	O	O	O
optimize	O	O	O
the	O	O	O
corresponding	O	O	O
trace	O	O	B-T170
ratio	O	O	I-T170
optimization	O	O	I-T170
algorithm	O	O	I-T170
,	O	O	O
which	O	O	O
is	O	O	O
the	O	O	O
essential	O	O	O
objective	O	O	B-T080
function	O	O	B-T169
for	O	O	O
general	O	O	O
dimensionality	O	O	B-T170
reduction	O	O	I-T170
.	O	O	O

It	O	O	O
results	O	O	O
in	O	O	O
insufficient	O	O	O
recognition	O	O	B-T041
accuracy	O	O	B-T080
.	O	O	O

To	O	O	O
tackle	O	O	O
this	O	O	O
problem	O	O	O
,	O	O	O
we	O	O	O
propose	O	O	O
a	O	O	O
nongreedy	O	O	B-T170
algorithm	O	O	I-T170
to	O	O	O
solve	O	O	O
the	O	O	O
trace	O	O	B-T170
ratio	O	O	I-T170
formula	O	O	I-T170
of	O	O	O
DLPP-L1	O	O	B-T081
,	O	O	O
and	O	O	O
analyze	O	O	O
its	O	O	O
convergence	O	O	B-T052
.	O	O	O

Experimental	O	O	O
results	O	O	O
on	O	O	O
three	O	O	O
databases	O	O	B-T170
illustrate	O	O	O
the	O	O	O
effectiveness	O	O	O
of	O	O	O
our	O	O	O
proposed	O	O	O
algorithm	O	O	B-T170
.	O	O	O

-DOCSTART- (28056024)

A	O	O	O
Double-Blind	O	O	B-T062
Randomized	O	O	B-T062
Controlled	O	O	I-T062
Trial	O	O	I-T062
of	O	O	O
Maternal	O	O	B-T047
Postpartum	O	O	I-T047
Deworming	O	O	B-T061
to	O	O	O
Improve	O	O	O
Infant	O	O	B-T100
Weight	O	O	B-T033
Gain	O	O	I-T033
in	O	O	O
the	O	O	O
Peruvian	O	O	B-T098
Amazon	O	O	O

Nutritional	O	O	B-T061
interventions	O	O	I-T061
targeting	O	O	O
the	O	O	O
critical	O	O	B-T080
growth	O	O	B-T033
and	O	O	I-T033
development	O	O	I-T033
period	O	O	I-T033
before	O	O	O
two	O	O	O
years	O	O	O
of	O	O	O
age	O	O	B-T032
can	O	O	O
have	O	O	O
the	O	O	O
greatest	O	O	O
impact	O	O	O
on	O	O	O
health	O	O	B-T078
trajectories	O	O	B-T079
over	O	O	O
the	O	O	O
life	O	O	B-T079
course	O	O	I-T079
.	O	O	O

Compelling	O	O	O
evidence	O	O	B-T078
has	O	O	O
demonstrated	O	O	O
that	O	O	O
interventions	O	O	B-T061
investing	O	O	O
in	O	O	O
maternal	O	O	B-T081
health	O	O	I-T081
in	O	O	O
the	O	O	O
first	O	O	O
1000	O	O	O
days	O	O	B-T079
of	O	O	O
life	O	O	B-T078
are	O	O	O
beneficial	O	O	O
for	O	O	O
both	O	O	O
mothers	O	O	B-T099
and	O	O	O
their	O	O	O
children	O	O	B-T099
.	O	O	O

One	O	O	O
such	O	O	O
potential	O	O	O
intervention	O	O	B-T061
is	O	O	O
deworming	O	O	B-T061
integrated	O	O	O
into	O	O	O
maternal	O	O	B-UnknownType
postpartum	O	O	I-UnknownType
care	O	O	I-UnknownType
in	O	O	O
areas	O	O	B-T082
where	O	O	O
soil	O	O	B-T167
-	O	O	O
transmitted	O	O	B-T169
helminth	O	O	B-T204
(	O	O	O
STH	O	O	B-T204
)	O	O	O
infections	O	O	B-T047
are	O	O	O
endemic	O	O	B-T047
.	O	O	O

From	O	O	O
February	O	O	B-T080
to	O	O	O
August	O	O	B-T080
2014	O	O	O
,	O	O	O
1010	O	O	O
mother	O	O	B-T099
-	O	O	O
infant	O	O	B-T100
pairs	O	O	O
were	O	O	O
recruited	O	O	O
into	O	O	O
a	O	O	O
trial	O	O	B-T062
aimed	O	O	O
at	O	O	O
assessing	O	O	B-T058
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
maternal	O	O	B-T047
postpartum	O	O	I-T047
deworming	O	O	B-T061
on	O	O	O
infant	O	O	O
and	O	O	O
maternal	O	O	B-T081
health	O	O	I-T081
outcomes	O	O	B-T080
.	O	O	O

Following	O	O	B-T079
delivery	O	O	B-T040
,	O	O	O
mothers	O	O	B-T099
were	O	O	O
randomly	O	O	O
assigned	O	O	O
to	O	O	O
receive	O	O	O
either	O	O	O
single-	O	O	O
dose	O	O	B-T081
400	O	O	O
mg	O	O	O
albendazole	O	O	B-T109
or	O	O	O
placebo	O	O	B-T122
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
followed-up	O	O	B-T058
at	O	O	O
1	O	O	B-T079
and	O	O	O
6	O	O	B-T079
months	O	O	I-T079
postpartum	O	O	B-T079
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
statistically	O	O	I-T033
significant	O	O	I-T033
difference	O	O	B-T081
in	O	O	O
mean	O	O	O
weight	O	O	B-T033
gain	O	O	I-T033
between	O	O	O
infants	O	O	B-T100
in	O	O	O
the	O	O	O
experimental	O	O	B-T101
and	O	O	O
control	O	O	B-T096
groups	O	O	I-T096
(	O	O	O
mean	O	O	B-T081
difference	O	O	I-T081
:	O	O	O
-0.02	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
-0.1	O	O	O
,	O	O	O
0.08	O	O	O
)	O	O	O
at	O	O	O
6	O	O	B-T079
months	O	O	I-T079
of	O	O	O
age	O	O	B-T032
.	O	O	O

Further	O	O	O
,	O	O	O
deworming	O	O	B-T061
had	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
measured	O	O	O
infant	O	O	B-T046
morbidity	O	O	I-T046
indicators	O	O	B-T081
.	O	O	O

However	O	O	O
,	O	O	O
ad	O	O	B-T081
hoc	O	O	I-T081
analyses	O	O	I-T081
restricted	O	O	O
to	O	O	O
mothers	O	O	B-T099
who	O	O	O
tested	O	O	O
positive	O	O	B-T033
for	O	O	O
STHs	O	O	B-T204
at	O	O	O
baseline	O	O	B-T081
suggest	O	O	O
that	O	O	O
infants	O	O	B-T100
of	O	O	O
mothers	O	O	O
in	O	O	O
the	O	O	O
experimental	O	O	O
group	O	O	O
had	O	O	O
greater	O	O	O
mean	O	O	O
length	O	O	B-T032
gain	O	O	B-T081
in	O	O	O
cm	O	O	O
(	O	O	O
mean	O	O	B-T081
difference	O	O	I-T081
:	O	O	O
0.8	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.1	O	O	O
,	O	O	O
1.4	O	O	O
)	O	O	O
and	O	O	O
length-for-age	O	O	B-T081
z-score	O	O	I-T081
(	O	O	O
mean	O	O	O
difference	O	O	O
:	O	O	O
0.5	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.2	O	O	O
,	O	O	O
0.8	O	O	O
)	O	O	O
at	O	O	O
6	O	O	B-T079
months	O	O	I-T079
of	O	O	O
age	O	O	B-T032
.	O	O	O

In	O	O	O
a	O	O	O
study	O	O	B-T098
population	O	O	I-T098
composed	O	O	O
of	O	O	O
both	O	O	O
STH-infected	O	O	B-T047
and	O	O	O
uninfected	O	O	B-T080
mothers	O	O	B-T099
,	O	O	O
maternal	O	O	B-T047
postpartum	O	O	B-T079
deworming	O	O	B-T061
was	O	O	O
insufficient	O	O	B-T080
to	O	O	O
impact	O	O	O
infant	O	O	B-T100
growth	O	O	B-T040
and	O	O	O
morbidity	O	O	B-T046
indicators	O	O	B-T081
up	O	O	O
to	O	O	O
6	O	O	B-T079
months	O	O	I-T079
postpartum	O	O	O
.	O	O	O

Among	O	O	O
STH-infected	O	O	B-T047
mothers	O	O	B-T099
,	O	O	O
however	O	O	O
,	O	O	O
important	O	O	O
improvements	O	O	O
in	O	O	O
infant	O	O	B-T100
length	O	O	O
gain	O	O	O
and	O	O	O
length-for-age	O	O	B-T033
were	O	O	O
observed	O	O	O
.	O	O	O

The	O	O	O
benefits	O	O	O
of	O	O	O
maternal	O	O	B-T047
postpartum	O	O	I-T047
deworming	O	O	B-T061
should	O	O	O
be	O	O	O
further	O	O	O
investigated	O	O	O
in	O	O	O
study	O	O	B-T098
populations	O	O	I-T098
having	O	O	O
higher	O	O	O
overall	O	O	O
prevalences	O	O	B-T081
and	O	O	O
intensities	O	O	B-T185
of	O	O	O
STH	O	O	B-T047
infections	O	O	I-T047
and	O	O	O
,	O	O	O
in	O	O	O
particular	O	O	O
,	O	O	O
where	O	O	O
whipworm	O	O	B-T047
and	O	O	O
hookworm	O	O	B-T047
infections	O	O	I-T047
are	O	O	O
of	O	O	O
public	O	O	B-T058
health	O	O	I-T058
concern	O	O	I-T058
.	O	O	O

ClinicalTrials.gov	O	O	O
(	O	O	O
NCT01748929	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (28056376)

Technical	O	O	O
note	O	O	O
:	O	O	O
A	O	O	O
preliminary	O	O	B-T079
comparative	O	O	B-T062
study	O	O	I-T062
between	O	O	O
classical	O	O	B-T169
and	O	O	O
interventional	O	O	B-T091
radiological	O	O	I-T091
approaches	O	O	I-T091
for	O	O	O
multi-phase	O	O	B-T079
post-mortem	O	O	B-T060
CT	O	O	I-T060
angiography	O	O	O

Multi-phase	O	O	B-T079
post-mortem	O	O	B-T060
computed	O	O	I-T060
tomography	O	O	I-T060
angiography	O	O	I-T060
(	O	O	O
MPMCTA	O	O	B-T060
)	O	O	O
is	O	O	O
a	O	O	O
new	O	O	B-T080
diagnostic	O	O	B-T060
tool	O	O	I-T060
,	O	O	O
used	O	O	O
in	O	O	O
forensic	O	O	B-T091
pathology	O	O	I-T091
.	O	O	O

On	O	O	O
the	O	O	O
one	O	O	O
hand	O	O	O
,	O	O	O
this	O	O	O
technique	O	O	B-T169
allows	O	O	O
a	O	O	O
better	O	O	O
and	O	O	O
direct	O	O	B-T033
visualization	O	O	I-T033
of	O	O	O
vascular	O	O	B-T047
and	O	O	O
solid	O	O	B-T023
organ	O	O	I-T023
lesions	O	O	B-T033
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
the	O	O	O
invasiveness	O	O	B-T080
of	O	O	O
the	O	O	O
procedure	O	O	B-T169
-which	O	O	O
requires	O	O	O
surgical	O	O	B-T033
denudation	O	O	I-T033
(	O	O	O
inguinal	O	O	B-T029
and/or	O	O	O
cervical	O	O	B-T082
)	O	O	O
and	O	O	O
the	O	O	O
insertion	O	O	B-T061
of	O	O	O
surgical	O	O	B-T074
cannulas	O	O	I-T074
-leads	O	O	O
to	O	O	O
many	O	O	O
relatives	O	O	B-T099
refusing	O	O	B-T052
scientific	O	O	B-T060
autopsies	O	O	I-T060
.	O	O	O

Our	O	O	O
hypothesis	O	O	B-T078
states	O	O	O
that	O	O	O
a	O	O	O
minimally-invasive	O	O	B-T169
procedure	O	O	I-T169
combining	O	O	O
interventional	O	O	B-T061
radiological	O	O	I-T061
techniques	O	O	I-T061
with	O	O	O
MPMCTA	O	O	B-T060
(	O	O	O
replacement	O	O	B-T169
of	O	O	O
surgical	O	O	B-T074
cannulas	O	O	I-T074
by	O	O	O
radiological	O	O	B-T074
catheters	O	O	I-T074
)	O	O	O
will	O	O	O
improve	O	O	B-T033
the	O	O	O
approval	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
scientific	O	O	B-T060
autopsies	O	O	I-T060
by	O	O	O
families	O	O	B-T099
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
feasibility	O	O	B-T062
of	O	O	O
the	O	O	O
minimally-invasive	O	O	B-T169
MPMCTA	O	O	B-T060
approach	O	O	O
and	O	O	O
to	O	O	O
compare	O	O	B-T052
its	O	O	O
performance	O	O	B-T052
to	O	O	O
the	O	O	O
current	O	O	B-T079
reference-standard	O	O	B-T081
(	O	O	O
the	O	O	O
conventional	O	O	O
approach	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
included	O	O	O
consecutively	O	O	B-T080
16	O	O	O
corpses	O	O	B-T017
divided	O	O	O
in	O	O	O
two	O	O	O
groups	O	O	B-T078
according	O	O	O
to	O	O	O
the	O	O	O
contrast	O	O	B-T080
enhancement	O	O	B-T052
approach	O	O	O
:	O	O	O
radiological	O	O	B-T074
catheters	O	O	I-T074
(	O	O	O
n=8	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
surgical	O	O	B-T074
cannulas	O	O	I-T074
(	O	O	O
n=8	O	O	O
)	O	O	O
.	O	O	O

Corpses	O	O	B-T017
were	O	O	O
chosen	O	O	O
and	O	O	O
assigned	O	O	O
randomly	O	O	O
from	O	O	O
our	O	O	O
local	O	O	O
data	O	O	B-T078
.	O	O	O

The	O	O	O
quality	O	O	B-T080
of	O	O	O
the	O	O	O
imaging	O	O	B-T060
procedure	O	O	I-T060
was	O	O	O
compared	O	O	B-T052
according	O	O	O
to	O	O	O
four	O	O	O
items	O	O	O
:	O	O	O
global	O	O	B-T023
vascular	O	O	I-T023
opacification	O	O	B-T080
,	O	O	O
cerebral	O	O	B-T080
venous	O	O	B-T082
opacification	O	O	I-T080
,	O	O	O
and	O	O	O
lower	O	O	B-T023
limbs	O	O	I-T023
opacification	O	O	O
(	O	O	O
arterial	O	O	B-T082
and	O	O	O
venous	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
minimally-invasive	O	O	B-T169
approach	O	O	I-T169
for	O	O	O
scientific	O	O	B-T060
autopsies	O	O	I-T060
is	O	O	O
feasible	O	O	O
through	O	O	O
a	O	O	O
radiological	O	O	B-T074
catheter	O	O	I-T074
.	O	O	O

Vascular	O	O	B-T023
opacification	O	O	B-T080
was	O	O	O
optimal	O	O	B-T080
in	O	O	O
8	O	O	O
out	O	O	O
of	O	O	O
8	O	O	O
cases	O	O	O
and	O	O	O
was	O	O	O
no	O	O	O
less	O	O	O
effective	O	O	B-T080
than	O	O	O
the	O	O	O
control	O	O	B-T096
reference	O	O	I-T096
group	O	O	I-T096
using	O	O	O
surgical	O	O	B-T074
cannula	O	O	I-T074
incision	O	O	B-T061
associated	O	O	B-T080
with	O	O	I-T080
their	O	O	O
non-occlusive	O	O	B-T080
aspects	O	O	I-T080
.	O	O	O

-DOCSTART- (28056892)

Correlations	O	O	B-T080
between	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
and	O	O	O
neurocognitive	O	O	B-T041
domain	O	O	I-T041
functions	O	O	I-T041
in	O	O	O
patients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
:	O	O	O
a	O	O	O
cross-sectional	O	O	O
study	O	O	O

Neurocognitive	O	O	B-T048
dysfunction	O	O	I-T048
is	O	O	O
a	O	O	O
critical	O	O	O
target	O	O	O
symptom	O	O	B-T184
of	O	O	O
schizophrenia	O	O	B-T048
treatment	O	O	B-T061
.	O	O	O

A	O	O	O
positive	O	O	O
correlation	O	O	B-T080
between	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
level	O	O	O
and	O	O	O
neurocognitive	O	O	B-T041
function	O	O	I-T041
has	O	O	O
been	O	O	O
reported	O	O	O
in	O	O	O
healthy	O	O	B-T098
individuals	O	O	I-T098
,	O	O	O
but	O	O	O
it	O	O	O
is	O	O	O
unclear	O	O	O
whether	O	O	O
such	O	O	O
a	O	O	O
correlation	O	O	O
exists	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
and	O	O	O
whether	O	O	O
the	O	O	O
relationship	O	O	B-T080
is	O	O	O
different	O	O	O
according	O	O	O
to	O	O	O
inpatients	O	O	B-T101
or	O	O	O
outpatients	O	O	B-T101
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
examine	O	O	B-T058
the	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
correlations	O	O	B-T080
between	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
and	O	O	O
multiple	O	O	O
neurocognitive	O	O	B-T041
domains	O	O	I-T041
in	O	O	O
inpatients	O	O	B-T101
and	O	O	O
outpatients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
and	O	O	O
obtain	O	O	O
suggestions	O	O	B-T078
for	O	O	O
further	O	O	O
study	O	O	O
to	O	O	O
facilitate	O	O	O
this	O	O	O
field	O	O	O
.	O	O	O

Twenty-nine	O	O	O
patients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
were	O	O	O
examined	O	O	B-T058
(	O	O	O
16	O	O	O
inpatients	O	O	B-T101
and	O	O	O
13	O	O	O
outpatients	O	O	B-T101
,	O	O	O
56.0	O	O	O
±	O	O	O
11.4	O	O	O
years	O	O	B-T079
of	O	O	O
age	O	O	B-T032
)	O	O	O
.	O	O	O

Current	O	O	O
symptoms	O	O	B-T184
were	O	O	O
assessed	O	O	B-T052
using	O	O	O
the	O	O	O
Positive	O	O	B-T033
and	O	O	O
Negative	O	O	B-T033
Symptom	O	O	B-T170
Scale	O	O	I-T170
and	O	O	O
neurocognitive	O	O	B-T041
functions	O	O	I-T041
using	O	O	O
Cognitrax	O	O	B-T170
,	O	O	O
which	O	O	O
yields	O	O	O
a	O	O	O
composite	O	O	O
neurocognitive	O	O	B-T060
index	O	O	I-T060
(	O	O	O
NCI	O	O	B-T060
)	O	O	O
and	O	O	O
11	O	O	O
domain	O	O	O
scores	O	O	B-T081
.	O	O	O

After	O	O	O
testing	O	O	O
,	O	O	O
participants	O	O	B-T098
wore	O	O	O
an	O	O	O
HJA-750C	O	O	B-T074
accelerometer	O	O	I-T074
for	O	O	O
one	O	O	B-T079
week	O	O	I-T079
to	O	O	O
measure	O	O	B-T081
physical	O	O	B-T056
activity	O	O	I-T056
levels	O	O	O
and	O	O	O
durations	O	O	B-T079
.	O	O	O

Partial	O	O	B-T062
correlation	O	O	I-T062
analyses	O	O	I-T062
were	O	O	O
performed	O	O	O
between	O	O	O
exercise	O	O	B-T056
and	O	O	O
cognitive	O	O	B-T041
parameters	O	O	B-T033
.	O	O	O

In	O	O	O
the	O	O	O
outpatient	O	O	B-T101
group	O	O	O
,	O	O	O
higher	O	O	B-T080
physical	O	O	B-T056
activity	O	O	I-T056
was	O	O	O
associated	O	O	O
with	O	O	O
faster	O	O	O
Motor	O	O	B-T169
and	O	O	O
Psychomotor	O	O	B-T041
Speeds	O	O	B-T081
in	O	O	O
outpatients	O	O	B-T101
.	O	O	O

However	O	O	O
,	O	O	O
higher	O	O	B-T080
physical	O	O	B-T056
activity	O	O	I-T056
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
lower	O	O	B-T080
overall	O	O	O
NCI	O	O	B-T060
,	O	O	O
Attention	O	O	B-T041
score	O	O	B-T081
,	O	O	O
and	O	O	O
Memory	O	O	B-T041
scores	O	O	B-T081
in	O	O	O
inpatients	O	O	B-T101
.	O	O	O

Although	O	O	O
higher	O	O	B-T080
physical	O	O	B-T056
activity	O	O	I-T056
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
better	O	O	O
neurocognitive	O	O	B-T041
functions	O	O	I-T041
of	O	O	O
outpatients	O	O	B-T101
,	O	O	O
in	O	O	O
inpatients	O	O	B-T101
with	O	O	O
non-remitted	O	O	O
schizophrenia	O	O	B-T048
,	O	O	O
higher	O	O	O
physical	O	O	O
activity	O	O	O
was	O	O	O
associated	O	O	O
with	O	O	O
worsening	O	O	O
of	O	O	O
several	O	O	O
cognitive	O	O	B-T041
domains	O	O	I-T041
.	O	O	O

In	O	O	O
a	O	O	O
future	O	O	O
study	O	O	B-T062
examining	O	O	B-T058
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
and	O	O	O
neurocognitive	O	O	B-T041
function	O	O	I-T041
for	O	O	O
facilitating	O	O	O
this	O	O	O
research	O	O	O
field	O	O	O
,	O	O	O
separation	O	O	O
between	O	O	O
inpatients	O	O	B-T101
and	O	O	O
outpatients	O	O	B-T101
are	O	O	O
needed	O	O	O
because	O	O	O
the	O	O	O
relationship	O	O	O
is	O	O	O
different	O	O	O
between	O	O	O
inpatients	O	O	O
and	O	O	O
outpatients	O	O	O
.	O	O	O

-DOCSTART- (28057994)

A	O	O	O
completely	O	O	B-T080
calcified	O	O	B-T080
prostate	O	O	O

Prostatic	O	O	B-T047
calcification	O	O	I-T047
and	O	O	O
prostatic	O	O	B-T047
calculus	O	O	I-T047
formation	O	O	B-T169
is	O	O	O
commonly	O	O	O
seen	O	O	O
in	O	O	O
adult	O	O	B-T100
population	O	O	B-T098
with	O	O	O
chronic	O	O	B-T047
prostatitis	O	O	I-T047
,	O	O	O
however	O	O	O
,	O	O	O
gross	O	O	O
prostatic	O	O	B-T047
calcification	O	O	I-T047
which	O	O	O
involves	O	O	O
more	O	O	O
than	O	O	O
3	O	O	O
cm(2	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
gland	O	O	B-T023
is	O	O	O
quite	O	O	O
rare	O	O	B-T080
.	O	O	O

We	O	O	O
are	O	O	O
presenting	O	O	B-T078
here	O	O	O
one	O	O	O
such	O	O	O
case	O	O	B-T169
in	O	O	O
which	O	O	O
almost	O	O	O
whole	O	O	O
glandular	O	O	B-T023
prostate	O	O	I-T023
was	O	O	O
converted	O	O	B-T169
into	O	O	O
stone	O	O	B-T031
which	O	O	O
is	O	O	O
never	O	O	O
reported	O	O	O
so	O	O	O
far	O	O	O
.	O	O	O

-DOCSTART- (28058375)

A	O	O	O
rare	O	O	B-T080
cause	O	O	B-T169
of	O	O	O
gastric	O	O	B-T047
obstruction	O	O	I-T047
:	O	O	O
Lighters	O	O	B-T073
swallowing	O	O	O

The	O	O	O
majority	O	O	B-T080
of	O	O	O
swallowed	O	O	B-T033
foreign	O	O	I-T033
bodies	O	O	I-T033
are	O	O	O
thrown	O	O	B-T080
spontaneously	O	O	B-T169
without	O	O	B-T080
causing	O	O	B-T169
complications	O	O	B-T046
in	O	O	O
the	O	O	O
digestive	O	O	B-T022
system	O	O	I-T022
.	O	O	O

Multiple	O	O	B-T081
number	O	O	B-T081
of	O	O	O
foreign	O	O	B-T037
bodies	O	O	I-T037
may	O	O	O
be	O	O	O
swallowed	O	O	B-T040
by	O	O	O
psychiatric	O	O	B-T101
patients	O	O	I-T101
which	O	O	O
delay	O	O	B-T080
diagnosis	O	O	I-T080
and	O	O	O
increase	O	O	B-T169
the	O	O	O
complication	O	O	B-T046
rate	O	O	B-T081
.	O	O	O

Long	O	O	B-T080
and	O	O	O
hard	O	O	B-T080
objects	O	O	B-T037
can	O	O	O
not	O	O	O
pass	O	O	O
through	O	O	O
the	O	O	O
pylorus	O	O	B-T023
,	O	O	O
and	O	O	O
may	O	O	O
cause	O	O	B-T169
obstruction	O	O	B-T046
,	O	O	O
ulceration	O	O	B-T046
,	O	O	O
bleeding	O	O	B-T046
and	O	O	O
perforation	O	O	B-T033
.	O	O	O

Endoscopy	O	O	B-T060
is	O	O	O
used	O	O	B-T169
as	O	O	O
an	O	O	O
effective	O	O	B-T080
method	O	O	B-T169
in	O	O	O
such	O	O	O
cases	O	O	B-T169
.	O	O	O

An	O	O	O
exploratory	O	O	B-T060
laparatomy	O	O	I-T060
was	O	O	O
performed	O	O	B-T169
after	O	O	O
unsuccessful	O	O	B-T080
endoscopic	O	O	B-T082
foreign	O	O	B-T037
object	O	O	I-T037
removal	O	O	B-T061
in	O	O	O
a	O	O	O
28-year-old	O	O	O
schizophrenic	O	O	B-T048
patient	O	O	B-T101
with	O	O	O
gastric	O	O	B-T047
outlet	O	O	I-T047
obstruction	O	O	I-T047
due	O	O	B-T169
to	O	O	I-T169
multiple	O	O	B-T081
cigarette	O	O	B-T073
lighter	O	O	I-T073
swallowing	O	O	B-T040
.	O	O	O

Ten	O	O	O
lighters	O	O	B-T073
were	O	O	O
removed	O	O	B-T080
from	O	O	O
the	O	O	O
stomach	O	O	B-T023
through	O	O	B-T169
gastrotomy	O	O	B-T061
and	O	O	O
one	O	O	O
more	O	O	O
lighter	O	O	B-T073
was	O	O	O
removed	O	O	O
from	O	O	O
the	O	O	O
descending	O	O	B-T023
colon	O	O	I-T023
by	O	O	O
milking	O	O	B-T061
through	O	O	O
the	O	O	O
anus	O	O	B-T023
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
paper	O	O	O
is	O	O	O
to	O	O	O
discuss	O	O	O
encountered	O	O	O
difficulties	O	O	B-T033
in	O	O	O
psychiatric	O	O	B-T101
patients	O	O	I-T101
who	O	O	O
underwent	O	O	O
surgery	O	O	B-T061
due	O	O	B-T169
to	O	O	I-T169
intake	O	O	B-T169
of	O	O	O
foreign	O	O	B-T037
bodies	O	O	I-T037
.	O	O	O

-DOCSTART- (28058593)

Ceftaroline	O	O	B-T195
fosamil	O	O	I-T195
for	O	O	O
community-acquired	O	O	B-T047
pneumonia	O	O	I-T047
and	O	O	O
skin	O	O	B-T022
and	O	O	O
skin	O	O	B-T046
structure	O	O	I-T046
infections	O	O	I-T046
:	O	O	O
a	O	O	O
systematic	O	O	O
review	O	O	O

Background	O	O	O
Ceftaroline	O	O	B-T195
is	O	O	O
a	O	O	O
parentally	O	O	O
administered	O	O	B-T169
cephalosporin	O	O	B-T195
that	O	O	O
has	O	O	O
an	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
expanded	O	O	B-T082
spectrum	O	O	O
of	O	O	O
activity	O	O	B-T044
compared	O	O	B-T052
with	O	O	O
other	O	O	O
cephalosporins	O	O	B-T195
yet	O	O	O
data	O	O	B-T078
is	O	O	O
conflicting	O	O	O
regarding	O	O	O
its	O	O	O
place	O	O	O
in	O	O	O
therapy	O	O	B-T061
.	O	O	O

Aim	O	O	O
of	O	O	O
the	O	O	O
Review	O	O	B-T170
To	O	O	O
compare	O	O	B-T052
the	O	O	O
efficacy	O	O	B-T080
and	O	O	O
safety	O	O	B-T068
of	O	O	O
ceftaroline	O	O	B-T195
against	O	O	O
standard	O	O	O
antibiotic	O	O	B-T195
regimens	O	O	B-T061
for	O	O	O
community-acquired	O	O	B-T047
pneumonia	O	O	I-T047
(	O	O	O
CAP	O	O	B-T047
)	O	O	O
and	O	O	O
complicated	O	O	B-T046
skin	O	O	I-T046
and	O	O	I-T046
skin	O	O	I-T046
structure	O	O	I-T046
infections	O	O	I-T046
(	O	O	O
cSSSIs	O	O	B-T046
)	O	O	O
.	O	O	O

Method	O	O	O
The	O	O	O
databases	O	O	B-T170
of	O	O	O
MEDLINE	O	O	B-T170
,	O	O	O
EBSCO	O	O	B-T170
,	O	O	O
and	O	O	O
Embase	O	O	B-T170
were	O	O	O
searched	O	O	O
up	O	O	O
to	O	O	O
June	O	O	O
2016	O	O	O
.	O	O	O

Manual	O	O	B-T170
review	O	O	I-T170
of	O	O	I-T170
references	O	O	I-T170
was	O	O	I-T170
completed	O	O	I-T170
and	O	O	O
experts	O	O	B-T097
in	O	O	O
the	O	O	O
field	O	O	O
were	O	O	O
contacted	O	O	O
for	O	O	O
unpublished	O	O	B-T170
data	O	O	I-T170
.	O	O	O

Randomized	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
of	O	O	O
ceftaroline	O	O	B-T195
in	O	O	O
CAP	O	O	B-T047
or	O	O	O
cSSSI	O	O	B-T046
populations	O	O	B-T098
were	O	O	O
included	O	O	O
.	O	O	O

Outcomes	O	O	B-T169
included	O	O	O
clinical	O	O	B-T033
cure	O	O	I-T033
,	O	O	O
mortality	O	O	B-T081
,	O	O	O
adverse	O	O	B-T046
events	O	O	I-T046
,	O	O	O
serious	O	O	B-T033
adverse	O	O	I-T033
events	O	O	I-T033
,	O	O	O
and	O	O	O
discontinuation	O	O	B-T061
due	O	O	O
to	O	O	O
adverse	O	O	O
events	O	O	O
.	O	O	O

Meta-analysis	O	O	B-T170
was	O	O	O
used	O	O	O
to	O	O	O
pool	O	O	O
results	O	O	O
for	O	O	O
these	O	O	O
outcomes	O	O	B-T169
.	O	O	O

We	O	O	O
performed	O	O	O
subgroup	O	O	B-T185
analyses	O	O	B-T062
for	O	O	O
gram	O	O	B-T047
positive	O	O	I-T047
infections	O	O	B-T046
in	O	O	O
CAP	O	O	B-T047
and	O	O	O
infections	O	O	O
caused	O	O	O
by	O	O	O
methicillin-resistant	O	O	B-T007
Staphylococcus	O	O	I-T007
aureus	O	O	I-T007
in	O	O	O
cSSSIs	O	O	B-T046
.	O	O	O

Risk	O	O	B-T078
of	O	O	O
bias	O	O	B-T078
was	O	O	O
assessed	O	O	O
for	O	O	O
all	O	O	O
studies	O	O	B-T062
.	O	O	O

Results	O	O	O
Six	O	O	O
trials	O	O	B-T062
(	O	O	O
three	O	O	O
for	O	O	O
each	O	O	O
indication	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
,	O	O	O
each	O	O	O
of	O	O	O
which	O	O	O
had	O	O	O
an	O	O	O
unclear	O	O	O
or	O	O	O
high	O	O	O
risk	O	O	B-T078
of	O	O	O
bias	O	O	B-T078
in	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
domain	O	O	O
.	O	O	O

For	O	O	O
CAP	O	O	B-T047
,	O	O	O
ceftaroline	O	O	B-T195
was	O	O	O
significantly	O	O	O
more	O	O	O
efficacious	O	O	B-T080
in	O	O	O
achieving	O	O	O
clinical	O	O	B-T033
cure	O	O	I-T033
than	O	O	O
ceftriaxone	O	O	B-T195
[	O	O	O
risk	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
RR	O	O	B-T081
)	O	O	O
1.11	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
1.04	O	O	O
-	O	O	O
1.19	O	O	O
;	O	O	O
I(2	O	O	O
)	O	O	O
=	O	O	O
47	O	O	O
%	O	O	O
]	O	O	O
.	O	O	O

For	O	O	O
cSSSIs	O	O	B-T046
,	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	O
difference	O	O	O
in	O	O	O
clinical	O	O	B-T033
cure	O	O	I-T033
between	O	O	O
ceftaroline	O	O	B-T195
and	O	O	O
vancomycin	O	O	B-T116
plus	O	O	O
aztreonam	O	O	B-T195
(	O	O	O
RR	O	O	B-T081
1.01	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
0.97	O	O	O
-	O	O	O
1.05	O	O	O
;	O	O	O
I(2	O	O	O
)	O	O	O
=	O	O	O
0	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
differences	O	O	O
were	O	O	O
found	O	O	O
for	O	O	O
overall	O	O	O
mortality	O	O	B-T081
,	O	O	O
serious	O	O	B-T033
adverse	O	O	B-T046
events	O	O	I-T046
,	O	O	O
discontinuation	O	O	B-T061
due	O	O	O
to	O	O	O
adverse	O	O	O
events	O	O	O
,	O	O	O
and	O	O	O
overall	O	O	O
adverse	O	O	O
events	O	O	O
.	O	O	O

Conclusion	O	O	O
Ceftaroline	O	O	B-T195
is	O	O	O
a	O	O	O
viable	O	O	O
therapeutic	O	O	B-T061
alternative	O	O	I-T061
for	O	O	O
patients	O	O	B-T101
with	O	O	O
CAP	O	O	B-T047
and	O	O	O
cSSSIs	O	O	B-T046
,	O	O	O
yet	O	O	O
identified	O	O	O
risks	O	O	B-T078
of	O	O	O
bias	O	O	B-T078
and	O	O	O
poor	O	O	B-T033
external	O	O	I-T033
validity	O	O	I-T033
preclude	O	O	O
it	O	O	O
from	O	O	O
being	O	O	O
recommended	O	O	O
as	O	O	O
a	O	O	O
first-line	O	O	B-T195
agent	O	O	I-T195
.	O	O	O

-DOCSTART- (28062192)

Direct	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
glucose	O	O	B-T109
,	O	O	O
insulin	O	O	B-T116
,	O	O	O
GLP-1	O	O	B-T116
,	O	O	O
and	O	O	O
GIP	O	O	B-T116
on	O	O	O
bulbospinal	O	O	B-T029
neurons	O	O	B-T025
in	O	O	O
the	O	O	O
rostral	O	O	B-T023
ventrolateral	O	O	I-T023
medulla	O	O	I-T023
in	O	O	O
neonatal	O	O	B-T100
wistar	O	O	O
rats	O	O	O

Although	O	O	O
patients	O	O	B-T101
with	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
(	O	O	O
DM	O	O	B-T047
)	O	O	O
often	O	O	O
exhibit	O	O	O
hypertension	O	O	B-T047
,	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
responsible	O	O	O
for	O	O	O
this	O	O	O
correlation	O	O	B-T080
are	O	O	O
not	O	O	O
well	O	O	O
known	O	O	O
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
the	O	O	O
bulbospinal	O	O	B-T029
neurons	O	O	B-T025
in	O	O	O
the	O	O	O
rostral	O	O	B-T023
ventrolateral	O	O	I-T023
medulla	O	O	I-T023
(	O	O	O
RVLM	O	O	B-T023
)	O	O	O
are	O	O	O
affected	O	O	B-T169
by	O	O	O
the	O	O	O
levels	O	O	B-T080
of	O	O	O
glucose	O	O	B-T109
,	O	O	O
insulin	O	O	B-T116
,	O	O	O
or	O	O	O
incretins	O	O	B-T116
(	O	O	O
glucagon	O	O	B-T116
like	O	O	I-T116
peptide-1	O	O	I-T116
[	O	O	O
GLP-1	O	O	B-T116
]	O	O	O
or	O	O	O
glucose-dependent	O	O	B-T116
insulinotropic	O	O	I-T116
peptide	O	O	I-T116
[	O	O	O
GIP	O	O	B-T116
]	O	O	O
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
DM	O	O	B-T047
.	O	O	O

To	O	O	O
investigate	O	O	B-T169
whether	O	O	O
RVLM	O	O	B-T023
neurons	O	O	B-T025
are	O	O	O
activated	O	O	B-T052
by	O	O	O
glucose	O	O	B-T109
,	O	O	O
insulin	O	O	B-T116
,	O	O	O
GLP-1	O	O	B-T116
,	O	O	O
or	O	O	O
GIP	O	O	B-T116
,	O	O	O
we	O	O	O
examined	O	O	O
changes	O	O	B-T169
in	O	O	O
the	O	O	O
membrane	O	O	B-T043
potentials	O	O	I-T043
of	O	O	O
bulbospinal	O	O	B-T029
RVLM	O	O	O
neurons	O	O	O
using	O	O	O
whole-cell	O	O	B-T025
patch-clamp	O	O	B-T062
technique	O	O	I-T062
during	O	O	O
superfusion	O	O	B-T067
with	O	O	O
various	O	O	O
levels	O	O	B-T080
of	O	O	O
glucose	O	O	O
or	O	O	O
these	O	O	O
hormones	O	O	B-T125
in	O	O	O
neonatal	O	O	B-T100
Wistar	O	O	B-T015
rats	O	O	I-T015
.	O	O	O

A	O	O	O
brainstem	O	O	B-T023
-	O	O	O
spinal	O	O	B-T023
cord	O	O	I-T023
preparation	O	O	B-T052
was	O	O	O
used	O	O	O
for	O	O	O
the	O	O	O
experiments	O	O	B-T062
.	O	O	O

A	O	O	O
low	O	O	B-T080
level	O	O	B-T080
of	O	O	O
glucose	O	O	B-T109
stimulated	O	O	O
bulbospinal	O	O	B-T029
RVLM	O	O	B-T023
neurons	O	O	B-T025
.	O	O	O

During	O	O	O
insulin	O	O	B-T116
superfusion	O	O	B-T067
,	O	O	O
almost	O	O	O
all	O	O	O
the	O	O	O
RVLM	O	O	B-T023
neurons	O	O	B-T025
were	O	O	O
depolarized	O	O	B-T043
,	O	O	O
while	O	O	O
during	O	O	O
GLP-1	O	O	B-T116
or	O	O	O
GIP	O	O	B-T116
superfusion	O	O	O
,	O	O	O
almost	O	O	O
all	O	O	O
the	O	O	O
RVLM	O	O	O
neurons	O	O	O
were	O	O	O
hyperpolarized	O	O	B-T043
.	O	O	O

Next	O	O	O
,	O	O	O
histological	O	O	B-T059
examinations	O	O	I-T059
were	O	O	O
performed	O	O	O
to	O	O	O
examine	O	O	O
transporters	O	O	B-T116
for	O	O	I-T116
glucose	O	O	I-T116
and	O	O	O
receptors	O	O	B-T116
for	O	O	O
insulin	O	O	B-T116
,	O	O	O
GLP-1	O	O	B-T116
,	O	O	O
and	O	O	O
GIP	O	O	B-T116
on	O	O	O
RVLM	O	O	B-T023
neurons	O	O	B-T025
.	O	O	O

Low	O	O	B-T080
-	O	O	O
level	O	O	B-T080
glucose	O	O	B-T109
-	O	O	O
depolarized	O	O	B-T043
RVLM	O	O	B-T023
neurons	O	O	B-T025
exhibited	O	O	O
the	O	O	O
presence	O	O	B-T080
of	O	O	O
glucose	O	O	B-T116
transporter	O	O	I-T116
3	O	O	I-T116
(	O	O	O
GLUT3	O	O	B-T116
)	O	O	O
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
insulin	O	O	B-T116
-	O	O	O
depolarized	O	O	B-T043
,	O	O	O
GLP-1	O	O	B-T116
-	O	O	O
hyperpolarized	O	O	B-T043
,	O	O	O
and	O	O	O
GIP	O	O	B-T116
-	O	O	O
hyperpolarized	O	O	O
RVLM	O	O	B-T023
neurons	O	O	B-T025
showed	O	O	O
each	O	O	O
of	O	O	O
the	O	O	O
respective	O	O	O
specific	O	O	B-T080
receptor	O	O	B-T116
.	O	O	O

These	O	O	O
results	O	O	O
indicate	O	O	O
that	O	O	O
a	O	O	O
low	O	O	B-T080
level	O	O	B-T080
of	O	O	O
glucose	O	O	B-T109
stimulates	O	O	B-T070
bulbospinal	O	O	B-T029
RVLM	O	O	B-T023
neurons	O	O	B-T025
via	O	O	O
specific	O	O	B-T080
transporters	O	O	B-T116
on	O	O	O
these	O	O	O
neurons	O	O	O
,	O	O	O
inducing	O	O	B-T169
hypertension	O	O	B-T047
.	O	O	O

Furthermore	O	O	O
,	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
insulin	O	O	B-T116
or	O	O	O
a	O	O	O
reduction	O	O	B-T080
in	O	O	O
incretins	O	O	B-T116
may	O	O	O
also	O	O	O
activate	O	O	B-T052
the	O	O	O
sympathetic	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
and	O	O	O
induce	O	O	B-T169
hypertension	O	O	B-T047
by	O	O	O
activating	O	O	B-T052
RVLM	O	O	B-T023
neurons	O	O	B-T025
via	O	O	O
their	O	O	O
own	O	O	O
receptors	O	O	B-T116
.	O	O	O

-DOCSTART- (28063273)

Mechanisms	O	O	B-T169
of	O	O	O
compensation	O	O	B-T058
in	O	O	O
the	O	O	O
gait	O	O	B-T033
of	O	O	O
patients	O	O	B-T101
with	O	O	O
drop	O	O	O
foot	O	O	O

Drop	O	O	B-T047
foot	O	O	I-T047
is	O	O	O
a	O	O	O
complex	O	O	O
syndrome	O	O	B-T047
,	O	O	O
with	O	O	O
multiple	O	O	B-T081
interactions	O	O	B-T169
between	O	O	O
joints	O	O	B-T030
and	O	O	O
muscles	O	O	B-T024
.	O	O	O

Abnormalities	O	O	B-T033
in	O	O	O
movement	O	O	B-T033
patterns	O	O	I-T033
can	O	O	O
be	O	O	O
measured	O	O	O
using	O	O	O
motion	O	O	B-T058
capture	O	O	I-T058
techniques	O	O	I-T058
,	O	O	O
but	O	O	O
identifying	O	O	O
compensation	O	O	B-T058
mechanisms	O	O	B-T169
remains	O	O	O
challenging	O	O	O
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
identify	O	O	O
compensatory	O	O	B-T169
mechanisms	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
drop	O	O	B-T047
foot	O	O	I-T047
,	O	O	O
this	O	O	O
study	O	O	B-T062
evaluated	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
15	O	O	O
such	O	O	O
patients	O	O	O
using	O	O	O
a	O	O	O
computerized	O	O	B-T066
gait	O	O	B-T074
analysis	O	O	I-T074
system	O	O	I-T074
,	O	O	O
as	O	O	O
compared	O	O	O
to	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
15	O	O	O
healthy	O	O	B-T098
subjects	O	O	I-T098
.	O	O	O

Four	O	O	O
classes	O	O	O
of	O	O	O
parameters	O	O	O
were	O	O	O
distinguished	O	O	O
,	O	O	O
falling	O	O	B-T033
in	O	O	O
differing	O	O	O
intervals	O	O	B-T079
of	O	O	O
percentage	O	O	B-T081
differences	O	O	B-T081
between	O	O	O
the	O	O	O
groups	O	O	B-T098
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
first	O	O	O
class	O	O	O
comprised	O	O	O
two	O	O	O
kinematic	O	O	B-T091
parameters	O	O	I-T091
for	O	O	O
which	O	O	O
the	O	O	O
values	O	O	O
of	O	O	O
percentage	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
were	O	O	O
more	O	O	O
than	O	O	O
100	O	O	O
%	O	O	O
greater	O	O	O
than	O	O	O
for	O	O	O
the	O	O	O
patient	O	O	B-T101
group	O	O	I-T101
.	O	O	O

The	O	O	O
second	O	O	O
class	O	O	O
comprised	O	O	O
two	O	O	O
kinetic	O	O	B-T070
parameters	O	O	I-T070
falling	O	O	B-T033
in	O	O	O
the	O	O	O
interval	O	O	B-T079
of	O	O	O
100	O	O	O
-	O	O	O
49	O	O	O
%	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
third	O	O	O
class	O	O	O
,	O	O	O
in	O	O	O
the	O	O	O
49	O	O	O
-	O	O	O
20	O	O	O
%	O	O	O
interval	O	O	B-T079
the	O	O	O
main	O	O	O
differences	O	O	O
were	O	O	O
observed	O	O	O
for	O	O	O
spatiotemporal	O	O	B-T062
parameters	O	O	I-T062
,	O	O	O
whereas	O	O	O
in	O	O	O
the	O	O	O
20	O	O	O
-	O	O	O
4	O	O	O
%	O	O	O
interval	O	O	O
the	O	O	O
differences	O	O	O
were	O	O	O
distributed	O	O	O
similarly	O	O	O
for	O	O	O
kinematic	O	O	B-T091
,	O	O	O
kinetic	O	O	B-T070
and	O	O	O
spatiotemporal	O	O	O
parameters	O	O	O
.	O	O	O

These	O	O	O
differences	O	O	O
in	O	O	O
gait	O	O	B-T033
pattern	O	O	I-T033
between	O	O	O
the	O	O	O
groups	O	O	B-T098
may	O	O	O
be	O	O	O
related	O	O	O
to	O	O	O
both	O	O	O
primary	O	O	O
motor	O	O	B-T033
deficits	O	O	I-T033
and	O	O	O
secondary	O	O	O
compensatory	O	O	B-T169
mechanisms	O	O	B-T169
.	O	O	O

Generally	O	O	O
,	O	O	O
we	O	O	O
conclude	O	O	O
that	O	O	O
drop	O	O	B-T047
foot	O	O	I-T047
affects	O	O	O
the	O	O	O
patients	O	O	B-T101
'	O	O	O
overall	O	O	O
kinematic	O	O	B-T091
and	O	O	O
kinetic	O	O	B-T070
gait	O	O	B-T033
parameters	O	O	O
,	O	O	O
with	O	O	O
compensation	O	O	B-T058
seen	O	O	O
as	O	O	O
a	O	O	O
chain	O	O	O
originating	O	O	O
from	O	O	O
a	O	O	O
change	O	O	B-T169
of	O	O	O
movement	O	O	B-T040
within	O	O	O
the	O	O	O
ankle	O	O	B-T030
joint	O	O	I-T030
.	O	O	O

-DOCSTART- (28063305)

Inhibitory	O	O	B-T052
effects	O	O	B-T080
of	O	O	I-T080
Lactobacillus	O	O	B-T007
rhamnosus	O	O	I-T007
and	O	O	O
Lactobacillus	O	O	B-T007
casei	O	O	I-T007
on	O	O	O
Candida	O	O	B-T004
biofilm	O	O	B-T007
of	O	O	O
denture	O	O	O
surface	O	O	O

Candida	O	O	B-T004
albicans	O	O	I-T004
biofilm	O	O	B-T007
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
denture-related	O	O	B-T047
stomatitis	O	O	I-T047
and	O	O	O
oral	O	O	B-T047
candidiasis	O	O	I-T047
of	O	O	O
elderly	O	O	B-T098
.	O	O	O

Probiotics	O	O	B-T007
are	O	O	O
beneficial	O	O	O
bacteria	O	O	B-T007
and	O	O	O
have	O	O	O
antibacterial	O	O	B-T033
activity	O	O	I-T033
against	O	O	O
pathogenic	O	O	B-T007
bacteria	O	O	I-T007
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
antifungal	O	O	B-T033
activity	O	O	I-T033
of	O	O	O
various	O	O	O
probiotics	O	O	B-T007
against	O	O	O
C.	O	O	B-T004
albicans	O	O	I-T004
and	O	O	O
the	O	O	O
inhibitory	O	O	B-T052
effects	O	O	B-T080
of	O	O	I-T080
probiotics	O	O	O
on	O	O	O
Candida	O	O	B-T004
biofilm	O	O	B-T007
on	O	O	O
the	O	O	O
denture	O	O	B-T033
surface	O	O	I-T033
.	O	O	O

The	O	O	O
spent	O	O	B-T130
culture	O	O	I-T130
media	O	O	I-T130
of	O	O	O
various	O	O	O
probiotics	O	O	B-T007
were	O	O	O
investigated	O	O	O
the	O	O	O
antifungal	O	O	B-T080
efficacy	O	O	I-T080
against	O	O	O
C.	O	O	B-T004
albicans	O	O	I-T004
.	O	O	O

Candida	O	O	B-T004
biofilm	O	O	B-T007
was	O	O	O
formed	O	O	O
on	O	O	O
a	O	O	O
denture	O	O	B-T074
base	O	O	I-T074
resin	O	O	I-T074
and	O	O	O
was	O	O	O
then	O	O	O
treated	O	O	B-T169
with	O	O	O
Lactobacillus	O	O	B-T007
rhamnosus	O	O	I-T007
and	O	O	O
Lactobacillus	O	O	B-T007
casei	O	O	I-T007
.	O	O	O

Also	O	O	O
,	O	O	O
the	O	O	O
biofilm	O	O	B-T007
s	O	O	O
of	O	O	O
L.	O	O	B-T007
rhamnosus	O	O	I-T007
and	O	O	O
L.	O	O	B-T007
casei	O	O	I-T007
were	O	O	O
formed	O	O	O
and	O	O	O
were	O	O	O
sequentially	O	O	O
treated	O	O	B-T169
with	O	O	O
C.	O	O	B-T004
albicans	O	O	I-T004
.	O	O	O

Colony-forming	O	O	B-T081
units	O	O	I-T081
of	O	O	O
C.	O	O	B-T004
albicans	O	O	I-T004
on	O	O	O
the	O	O	O
denture	O	O	B-T033
surface	O	O	I-T033
were	O	O	O
counted	O	O	O
after	O	O	O
spreading	O	O	B-T080
on	O	O	O
agar	O	O	B-T109
plate	O	O	B-T074
.	O	O	O

The	O	O	O
denture	O	O	B-T074
base	O	O	I-T074
resin	O	O	I-T074
was	O	O	O
treated	O	O	B-T169
with	O	O	O
the	O	O	O
spent	O	O	B-T130
culture	O	O	I-T130
media	O	O	I-T130
for	O	O	O
30	O	O	O
days	O	O	B-T079
,	O	O	O
after	O	O	O
which	O	O	O
the	O	O	O
denture	O	O	B-T033
surface	O	O	I-T033
roughness	O	O	B-T033
was	O	O	O
analyzed	O	O	O
with	O	O	O
an	O	O	O
atomic	O	O	B-T059
force	O	O	I-T059
microscope	O	O	I-T059
.	O	O	O

L.	O	O	B-T007
rhamnosus	O	O	I-T007
and	O	O	O
L.	O	O	B-T007
casei	O	O	I-T007
exhibited	O	O	O
stronger	O	O	O
antifungal	O	O	B-T033
activity	O	O	I-T033
than	O	O	O
other	O	O	O
probiotics	O	O	B-T007
.	O	O	O

The	O	O	O
spent	O	O	B-T130
culture	O	O	I-T130
medium	O	O	I-T130
of	O	O	O
L.	O	O	B-T007
rhamnosus	O	O	I-T007
and	O	O	O
L.	O	O	B-T007
casei	O	O	I-T007
exhibited	O	O	O
the	O	O	O
antifungal	O	O	B-T033
activity	O	O	I-T033
against	O	O	O
blastoconidia	O	O	B-T004
and	O	O	O
biofilm	O	O	B-T007
of	O	O	O
C.	O	O	B-T004
albicans	O	O	I-T004
.	O	O	O

L.	O	O	B-T007
rhamnosus	O	O	I-T007
and	O	O	O
L.	O	O	B-T007
casei	O	O	I-T007
showed	O	O	O
the	O	O	O
antifungal	O	O	B-T033
activity	O	O	I-T033
against	O	O	O
Candida	O	O	B-T004
biofilm	O	O	B-T007
,	O	O	O
and	O	O	O
the	O	O	O
biofilm	O	O	O
of	O	O	O
L.	O	O	O
rhamnosus	O	O	O
and	O	O	O
L.	O	O	O
casei	O	O	O
inhibited	O	O	B-T052
formation	O	O	B-T169
of	O	O	O
Candida	O	O	O
biofilm	O	O	O
on	O	O	O
denture	O	O	B-T033
surface	O	O	I-T033
.	O	O	O

Neither	O	O	O
of	O	O	O
the	O	O	O
probiotics	O	O	B-T007
affected	O	O	O
the	O	O	O
surface	O	O	B-T033
roughness	O	O	I-T033
of	O	O	O
the	O	O	O
denture	O	O	B-T074
base	O	O	I-T074
resin	O	O	I-T074
.	O	O	O

L.	O	O	B-T007
rhamnosus	O	O	I-T007
and	O	O	O
L.	O	O	B-T007
casei	O	O	I-T007
may	O	O	O
be	O	O	O
the	O	O	O
ideal	O	O	O
probiotics	O	O	B-T007
for	O	O	O
the	O	O	O
prevention	O	O	B-T080
and	O	O	O
treatment	O	O	B-T169
of	O	O	O
denture-related	O	O	B-T047
stomatitis	O	O	I-T047
.	O	O	O

-DOCSTART- (28063657)

Persistent	O	O	B-T131
Organic	O	O	I-T131
Pollutants	O	O	I-T131
(	O	O	O
POPs	O	O	B-T131
)	O	O	O
in	O	O	O
the	O	O	O
atmosphere	O	O	B-T070
of	O	O	O
three	O	O	O
Chilean	O	O	B-T098
cities	O	O	B-T083
using	O	O	O
passive	O	O	B-T080
air	O	O	O
samplers	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
passive	O	O	B-T080
air	O	O	B-T074
samplers	O	O	I-T074
containing	O	O	O
polyurethane	O	O	B-T109
foam	O	O	I-T109
(	O	O	O
PUF	O	O	B-T109
)	O	O	O
disks	O	O	B-T074
were	O	O	O
deployed	O	O	B-T052
in	O	O	O
three	O	O	O
cities	O	O	B-T083
across	O	O	O
Chile	O	O	B-T083
;	O	O	O
Santiago	O	O	B-T083
(	O	O	O
STG	O	O	B-T083
)	O	O	O
(	O	O	O
n=5	O	O	O
,	O	O	O
sampling	O	O	B-T082
sites	O	O	I-T082
)	O	O	O
,	O	O	O
Concepciόn	O	O	B-T083
(	O	O	O
CON	O	O	B-T083
)	O	O	O
(	O	O	O
n=6	O	O	O
)	O	O	O
and	O	O	O
Temuco	O	O	B-T083
(	O	O	O
TEM	O	O	B-T083
)	O	O	O
(	O	O	O
n=6	O	O	O
)	O	O	O
from	O	O	O
2008	O	O	O
to	O	O	O
2009	O	O	O
.	O	O	O

Polychlorinated	O	O	B-T109
biphenyls	O	O	I-T109
(	O	O	O
PCBs	O	O	B-T109
)	O	O	O
(	O	O	O
7	O	O	O
indicator	O	O	B-T169
congeners	O	O	B-T104
)	O	O	O
,	O	O	O
chlorinated	O	O	B-T131
pesticides	O	O	I-T131
hexachlorocyclohexanes	O	O	B-T109
(	O	O	O
HCHs	O	O	B-T109
)	O	O	O
,	O	O	O
dichlorodiphenyl	O	O	B-T109
trichloroethanes	O	O	I-T109
(	O	O	O
DDTs	O	O	B-T109
)	O	O	O
and	O	O	O
flame	O	O	B-T120
retardants	O	O	I-T120
such	O	O	O
as	O	O	O
polybrominated	O	O	B-T109
diphenyl	O	O	I-T109
ethers	O	O	I-T109
(	O	O	O
PBDEs	O	O	B-T109
)	O	O	O
were	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
gas	O	O	B-T059
chromatography	O	O	I-T059
coupled	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	O
GC/MS	O	O	B-T059
)	O	O	O
.	O	O	O

A	O	O	O
sampling	O	O	B-T078
rate	O	O	B-T081
(	O	O	O
R	O	O	B-T081
)	O	O	O
typical	O	O	O
of	O	O	O
urban	O	O	B-T082
sites	O	O	I-T082
(	O	O	O
4m(3)/day	O	O	O
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
estimate	O	O	B-T081
the	O	O	O
atmospheric	O	O	B-T070
concentrations	O	O	B-T081
of	O	O	O
individual	O	O	B-T081
compounds	O	O	B-T080
.	O	O	O

PCB	O	O	B-T109
concentrations	O	O	B-T081
in	O	O	O
the	O	O	O
air	O	O	B-T167
(	O	O	O
pg/m(3	O	O	O
)	O	O	O
)	O	O	O
ranged	O	O	B-T081
from	O	O	O
~1	O	O	O
-	O	O	O
10	O	O	O
(	O	O	O
TEM	O	O	B-T083
)	O	O	O
,	O	O	O
~1	O	O	O
-	O	O	O
40	O	O	O
(	O	O	O
STG	O	O	B-T083
)	O	O	O
and	O	O	O
4	O	O	O
-	O	O	O
30	O	O	O
(	O	O	O
CON	O	O	B-T083
)	O	O	O
.	O	O	O

Higher	O	O	B-T080
molecular	O	O	I-T080
weight	O	O	I-T080
PCBs	O	O	B-T109
(	O	O	O
PCB	O	O	B-T109
-153	O	O	O
,	O	O	O
-180	O	O	O
)	O	O	O
were	O	O	O
detected	O	O	B-T033
at	O	O	O
industrial	O	O	B-T082
sites	O	O	I-T082
(	O	O	O
in	O	O	O
Concepción	O	O	B-T083
)	O	O	O
.	O	O	O

The	O	O	O
HCHs	O	O	B-T109
showed	O	O	O
a	O	O	O
prevalence	O	O	B-T081
of	O	O	O
γ-HCH	O	O	B-T109
across	O	O	O
all	O	O	O
sites	O	O	B-T082
,	O	O	O
indicative	O	O	B-T169
of	O	O	O
inputs	O	O	B-T077
from	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
lindane	O	O	B-T109
but	O	O	O
a	O	O	O
limited	O	O	B-T169
use	O	O	O
of	O	O	O
technical	O	O	B-T081
HCHs	O	O	O
in	O	O	O
Chile	O	O	B-T083
.	O	O	O

DDTs	O	O	B-T109
were	O	O	O
detected	O	O	B-T033
with	O	O	O
a	O	O	O
prevalence	O	O	B-T081
of	O	O	O
p	O	O	B-T109
,	O	O	I-T109
p'-DDE	O	O	I-T109
accounting	O	O	B-UnknownType
for	O	O	O
~50	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
total	O	O	O
DDTs	O	O	O
.	O	O	O

PBDE	O	O	B-T109
concentrations	O	O	B-T081
in	O	O	O
air	O	O	B-T167
(	O	O	O
pg/m(3	O	O	O
)	O	O	O
)	O	O	O
ranged	O	O	B-T081
from	O	O	O
1	O	O	O
to	O	O	O
55	O	O	O
(	O	O	O
STG	O	O	B-T083
)	O	O	O
,	O	O	O
0.5	O	O	O
to	O	O	O
20	O	O	O
(	O	O	O
CON	O	O	B-T083
)	O	O	O
and	O	O	O
from	O	O	O
0.4	O	O	O
to	O	O	O
10	O	O	O
(	O	O	O
TEM	O	O	B-T083
)	O	O	O
,	O	O	O
and	O	O	O
were	O	O	O
generally	O	O	O
similar	O	O	B-T080
to	O	O	O
those	O	O	O
reported	O	O	B-T170
for	O	O	O
many	O	O	O
other	O	O	O
urban	O	O	B-T082
areas	O	O	I-T082
globally	O	O	B-T080
.	O	O	O

The	O	O	O
pattern	O	O	B-T082
of	O	O	O
PBDEs	O	O	B-T109
was	O	O	O
different	O	O	O
among	O	O	O
the	O	O	O
three	O	O	O
cities	O	O	B-T083
;	O	O	O
however	O	O	O
,	O	O	O
PBDE	O	O	B-T109
-209	O	O	O
was	O	O	O
dominant	O	O	B-T169
at	O	O	O
most	O	O	O
of	O	O	O
the	O	O	O
sites	O	O	B-T082
.	O	O	O

These	O	O	O
results	O	O	B-T033
represent	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
few	O	O	O
assessments	O	O	B-T058
of	O	O	O
air	O	O	B-T167
concentrations	O	O	B-T081
of	O	O	O
POPs	O	O	B-T131
across	O	O	O
different	O	O	O
urban	O	O	B-T082
areas	O	O	I-T082
within	O	O	O
the	O	O	O
same	O	O	O
country	O	O	B-T083
.	O	O	O

These	O	O	O
data	O	O	B-T078
will	O	O	O
support	O	O	B-T077
Chilean	O	O	B-T098
commitments	O	O	B-T041
as	O	O	O
a	O	O	O
signatory	O	O	B-T169
to	O	O	O
the	O	O	O
Stockholm	O	O	B-T064
Convention	O	O	I-T064
on	O	O	O
POPs	O	O	B-T131
and	O	O	O
for	O	O	O
reporting	O	O	B-T062
as	O	O	O
a	O	O	O
member	O	O	B-T097
country	O	O	B-T083
of	O	O	O
the	O	O	O
Group	O	O	B-T083
of	O	O	I-T083
Latin	O	O	I-T083
America	O	O	I-T083
and	O	O	I-T083
Caribbean	O	O	I-T083
Countries	O	O	I-T083
(	O	O	I-T083
GRULAC	O	O	I-T083
)	O	O	I-T083
region	O	O	I-T083
.	O	O	O

-DOCSTART- (28067693)

Intraoperative	O	O	B-T079
ketamine	O	O	B-T109
reduces	O	O	B-T080
immediate	O	O	B-T079
postoperative	O	O	B-T079
opioid	O	O	B-T109
consumption	O	O	B-T169
after	O	O	O
spinal	O	O	B-T061
fusion	O	O	I-T061
surgery	O	O	I-T061
in	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
patients	O	O	B-T101
with	O	O	O
opioid	O	O	O
dependency	O	O	B-T080
:	O	O	O
a	O	O	O
randomized	O	O	B-T062
,	O	O	O
blinded	O	O	O
trial	O	O	O

Perioperative	O	O	B-T079
handling	O	O	B-T033
of	O	O	O
surgical	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
opioid	O	O	B-T109
dependency	O	O	B-T080
represents	O	O	O
an	O	O	O
important	O	O	B-T080
clinical	O	O	B-T080
problem	O	O	B-T033
.	O	O	O

Animal	O	O	B-T008
studies	O	O	I-T008
suggest	O	O	O
that	O	O	O
ketamine	O	O	B-T109
attenuates	O	O	B-T052
central	O	O	B-T047
sensitization	O	O	I-T047
and	O	O	O
hyperalgesia	O	O	B-T184
and	O	O	O
thereby	O	O	O
reduces	O	O	B-T080
postoperative	O	O	B-T079
opioid	O	O	B-T109
tolerance	O	O	O
.	O	O	O

We	O	O	O
hypothesized	O	O	B-T078
that	O	O	O
intraoperative	O	O	B-T079
ketamine	O	O	B-T109
would	O	O	O
reduce	O	O	B-T080
immediate	O	O	B-T079
postoperative	O	O	B-T079
opioid	O	O	B-T109
consumption	O	O	B-T169
compared	O	O	O
with	O	O	O
placebo	O	O	B-T122
in	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
patients	O	O	B-T101
with	O	O	O
opioid	O	O	O
dependency	O	O	B-T080
undergoing	O	O	O
lumbar	O	O	B-T061
spinal	O	O	I-T061
fusion	O	O	I-T061
surgery	O	O	I-T061
.	O	O	O

Primary	O	O	B-T080
outcome	O	O	I-T080
was	O	O	O
morphine	O	O	B-T109
consumption	O	O	B-T169
0	O	O	B-T079
to	O	O	I-T079
24	O	O	I-T079
hours	O	O	I-T079
postoperatively	O	O	B-T079
.	O	O	O

Secondary	O	O	B-T080
outcomes	O	O	I-T080
were	O	O	O
acute	O	O	B-T184
pain	O	O	B-T184
at	O	O	I-T184
rest	O	O	I-T184
and	O	O	O
during	O	O	O
mobilization	O	O	B-T061
2	O	O	B-T079
to	O	O	I-T079
24	O	O	I-T079
hours	O	O	I-T079
postoperatively	O	O	B-T079
(	O	O	O
visual	O	O	B-T060
analogue	O	O	I-T060
scale	O	O	I-T060
)	O	O	O
,	O	O	O
adverse	O	O	B-T046
events	O	O	I-T046
,	O	O	O
and	O	O	O
persistent	O	O	B-T079
pain	O	O	O
6	O	O	O
months	O	O	O
postoperatively	O	O	O
.	O	O	O

One	O	O	O
hundred	O	O	O
fifty	O	O	O
patients	O	O	B-T101
were	O	O	O
randomly	O	O	B-T062
assigned	O	O	I-T062
to	O	O	O
intraoperative	O	O	B-T079
S-ketamine	O	O	B-T109
bolus	O	O	B-T061
0.5	O	O	I-T061
mg/kg	O	O	I-T061
and	O	O	I-T061
infusion	O	O	I-T061
0.25	O	O	O
mg·kg·h	O	O	O
or	O	O	O
placebo	O	O	B-T122
.	O	O	O

Postoperatively	O	O	B-T079
,	O	O	O
patients	O	O	B-T101
received	O	O	O
their	O	O	O
usual	O	O	O
opioids	O	O	B-T109
,	O	O	O
paracetamol	O	O	B-T109
and	O	O	O
IV	O	O	O
patient-controlled	O	O	B-T061
analgesia	O	O	I-T061
with	O	O	O
morphine	O	O	B-T109
.	O	O	O

In	O	O	O
the	O	O	O
final	O	O	B-T170
analyses	O	O	I-T170
,	O	O	O
147	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
.	O	O	O

Patient-controlled	O	O	B-T061
analgesia	O	O	I-T061
IV	O	O	O
morphine	O	O	B-T109
consumption	O	O	B-T169
0	O	O	O
to	O	O	O
24	O	O	O
hours	O	O	O
postoperatively	O	O	B-T079
was	O	O	O
significantly	O	O	B-T078
reduced	O	O	B-T080
in	O	O	O
the	O	O	O
ketamine	O	O	B-T109
group	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
placebo	O	O	B-T122
group	O	O	O
:	O	O	O
79	O	O	O
(	O	O	O
47	O	O	O
)	O	O	O
vs	O	O	O
121	O	O	O
(	O	O	O
53	O	O	O
)	O	O	O
mg	O	O	O
IV	O	O	O
,	O	O	O
mean	O	O	B-T081
difference	O	O	B-T080
42	O	O	O
mg	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
-59	O	O	O
to	O	O	O
-25	O	O	O
)	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
.	O	O	O

Sedation	O	O	B-T033
was	O	O	O
significantly	O	O	B-T078
reduced	O	O	B-T080
in	O	O	O
the	O	O	O
ketamine	O	O	B-T109
group	O	O	O
6	O	O	O
and	O	O	O
24	O	O	O
hours	O	O	O
postoperatively	O	O	B-T079
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
differences	O	O	I-T033
regarding	O	O	O
acute	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
nausea	O	O	B-T184
,	O	O	O
vomiting	O	O	B-T184
,	O	O	O
hallucinations	O	O	B-T048
,	O	O	O
or	O	O	O
nightmares	O	O	B-T184
.	O	O	O

Back	O	O	B-T184
pain	O	O	B-T184
at	O	O	O
6	O	O	O
months	O	O	O
postoperatively	O	O	B-T079
compared	O	O	O
with	O	O	O
preoperative	O	O	B-T079
pain	O	O	O
was	O	O	O
significantly	O	O	B-T078
more	O	O	O
improved	O	O	B-T033
in	O	O	O
the	O	O	O
ketamine	O	O	B-T109
group	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
placebo	O	O	B-T122
group	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.005	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
intraoperative	O	O	B-T079
ketamine	O	O	B-T109
significantly	O	O	B-T078
reduced	O	O	B-T080
morphine	O	O	B-T109
consumption	O	O	B-T169
0	O	O	B-T079
to	O	O	I-T079
24	O	O	I-T079
hours	O	O	I-T079
after	O	O	O
lumbar	O	O	B-T061
fusion	O	O	I-T061
surgery	O	O	I-T061
in	O	O	O
opioid	O	O	B-T109
-	O	O	O
dependent	O	O	B-T080
patients	O	O	B-T101
.	O	O	O

The	O	O	O
trend	O	O	B-T079
regarding	O	O	O
less	O	O	O
persistent	O	O	B-T079
pain	O	O	B-T184
6	O	O	O
months	O	O	O
postoperatively	O	O	B-T079
needs	O	O	O
further	O	O	B-T082
investigation	O	O	B-T169
.	O	O	O

-DOCSTART- (28068639)

Effects	O	O	B-T080
of	O	O	I-T080
argan	O	O	B-T109
oil	O	O	I-T109
on	O	O	O
the	O	O	O
mitochondrial	O	O	B-T043
function	O	O	I-T043
,	O	O	O
antioxidant	O	O	B-T022
system	O	O	I-T022
and	O	O	O
the	O	O	O
activity	O	O	B-T044
of	O	O	O
NADPH	O	O	B-T114
-	O	O	O
generating	O	O	B-T052
enzymes	O	O	B-T116
in	O	O	O
acrylamide	O	O	B-T109
treated	O	O	B-T061
rat	O	O	B-T015
brain	O	O	O

Argan	O	O	B-T109
oil	O	O	I-T109
(	O	O	O
AO	O	O	B-T109
)	O	O	O
is	O	O	O
rich	O	O	O
in	O	O	O
minor	O	O	O
compounds	O	O	B-T103
such	O	O	O
as	O	O	O
polyphenols	O	O	B-T109
and	O	O	O
tocopherols	O	O	B-T127
which	O	O	O
are	O	O	O
powerful	O	O	O
antioxidants	O	O	B-T121
.	O	O	O

Acrylamide	O	O	B-T109
(	O	O	O
ACR	O	O	B-T109
)	O	O	O
has	O	O	O
been	O	O	O
classified	O	O	B-T185
as	O	O	O
a	O	O	O
neurotoxic	O	O	B-T131
agent	O	O	I-T131
in	O	O	O
animals	O	O	B-T008
and	O	O	O
humans	O	O	B-T016
.	O	O	O

Mitochondrial	O	O	B-T026
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
dysfunction	O	O	B-T033
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
probable	O	O	B-T081
molecular	O	O	B-T044
mechanisms	O	O	I-T044
of	O	O	O
neurodegenerative	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

Female	O	O	B-T032
Sprague	O	O	B-T015
Dawley	O	O	I-T015
rats	O	O	I-T015
were	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
ACR	O	O	B-T109
(	O	O	O
50mg/kg	O	O	O
i.p	O	O	O
.	O	O	O

three	O	O	O
times	O	O	O
a	O	O	O
week	O	O	O
)	O	O	O
,	O	O	O
AO	O	O	B-T109
(	O	O	O
6ml/kg	O	O	O
,	O	O	O
o.p	O	O	O
,	O	O	O
per	O	O	O
day	O	O	O
)	O	O	O
or	O	O	O
together	O	O	O
for	O	O	O
30days	O	O	O
.	O	O	O

The	O	O	O
activities	O	O	B-T052
of	O	O	O
cytosolic	O	O	B-T026
enzymes	O	O	B-T116
such	O	O	O
as	O	O	O
xanthine	O	O	B-T116
oxidase	O	O	I-T116
(	O	O	O
XO	O	O	B-T116
)	O	O	O
,	O	O	O
glucose	O	O	B-T116
6-phosphate	O	O	I-T116
dehydrogenase	O	O	I-T116
(	O	O	O
G6PDH	O	O	B-T116
)	O	O	O
,	O	O	O
glutathione-S-transferase	O	O	B-T116
(	O	O	O
GST	O	O	B-T116
)	O	O	O
,	O	O	O
mitochondrial	O	O	B-T026
oxidative	O	O	B-T049
stress	O	O	I-T049
,	O	O	O
oxidative	O	O	B-T044
phosphorylation	O	O	I-T044
(	O	O	O
OXPHOS	O	O	B-T044
)	O	O	O
and	O	O	O
tricarboxylic	O	O	B-T044
acid	O	O	I-T044
cycle	O	O	I-T044
(	O	O	O
TCA	O	O	B-T044
)	O	O	O
enzymes	O	O	O
,	O	O	O
mitochondrial	O	O	O
metabolic	O	O	B-T040
function	O	O	I-T040
,	O	O	O
adenosine	O	O	B-T114
triphosphate	O	O	I-T114
(	O	O	O
ATP	O	O	B-T114
)	O	O	O
level	O	O	B-T080
and	O	O	O
acetylcholinesterase	O	O	B-T044
(	O	O	I-T044
AChE	O	O	I-T044
)	O	O	I-T044
activity	O	O	I-T044
were	O	O	O
assessed	O	O	B-T052
in	O	O	O
rat	O	O	B-T015
brain	O	O	B-T023
.	O	O	O

Cytosolic	O	O	B-T026
and	O	O	O
mitochondrial	O	O	B-T026
antioxidant	O	O	B-T116
enzymes	O	O	I-T116
were	O	O	O
significantly	O	O	B-T078
diminished	O	O	B-T081
in	O	O	O
the	O	O	O
brains	O	O	B-T023
of	O	O	O
rats	O	O	B-T015
treated	O	O	B-T061
with	O	O	I-T061
ACR	O	O	B-T109
compared	O	O	B-T052
to	O	O	O
those	O	O	O
in	O	O	O
control	O	O	B-T096
.	O	O	O

Besides	O	O	O
,	O	O	O
ACR	O	O	B-T109
treatment	O	O	B-T061
resulted	O	O	B-T169
in	O	O	O
a	O	O	O
significant	O	O	B-T078
reduction	O	O	B-T080
in	O	O	O
brain	O	O	B-T023
ATP	O	O	B-T114
level	O	O	B-T080
,	O	O	O
mitochondrial	O	O	B-T026
metabolic	O	O	B-T040
function	O	O	I-T040
,	O	O	O
OXPHOS	O	O	B-T044
and	O	O	O
TCA	O	O	B-T044
enzymes	O	O	B-T116
.	O	O	O

Administration	O	O	B-T061
of	O	O	O
AO	O	O	B-T109
restored	O	O	O
both	O	O	O
the	O	O	O
cytosolic	O	O	B-T026
and	O	O	O
mitochondrial	O	O	B-T026
oxidative	O	O	B-T049
stress	O	O	I-T049
by	O	O	O
normalizing	O	O	B-T062
nicotinamide	O	O	B-T114
adenine	O	O	I-T114
dinucleotide	O	O	I-T114
phosphate	O	O	I-T114
(	O	O	O
NADPH	O	O	B-T114
)	O	O	O
generating	O	O	B-T052
enzymes	O	O	B-T116
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
improved	O	O	B-T033
mitochondrial	O	O	B-T043
function	O	O	I-T043
primarily	O	O	O
enhancing	O	O	B-T052
nicotinamide	O	O	B-T114
adenine	O	O	I-T114
dinucleotide	O	O	I-T114
(	O	O	O
NADH	O	O	B-T114
)	O	O	O
generated	O	O	B-T052
enzymes	O	O	B-T044
activities	O	O	I-T044
and	O	O	O
ATP	O	O	B-T114
level	O	O	B-T080
in	O	O	O
the	O	O	O
mitochondria	O	O	B-T026
.	O	O	O

The	O	O	O
reason	O	O	B-T078
for	O	O	O
AO	O	O	B-T109
's	O	O	I-T109
obvious	O	O	O
beneficial	O	O	B-UnknownType
effects	O	O	I-UnknownType
in	O	O	O
this	O	O	O
study	O	O	B-T062
may	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
synergistic	O	O	B-UnknownType
effects	O	O	I-UnknownType
of	O	O	O
its	O	O	O
different	O	O	B-T080
bioactive	O	O	B-T167
compounds	O	O	I-T167
which	O	O	O
is	O	O	O
especially	O	O	O
effective	O	O	B-T080
on	O	O	O
mitochondria	O	O	B-T026
.	O	O	O

Modulation	O	O	B-T082
of	O	O	O
the	O	O	O
brain	O	O	B-T023
mitochondrial	O	O	B-T043
functions	O	O	I-T043
and	O	O	O
antioxidant	O	O	B-T022
systems	O	O	I-T022
by	O	O	O
AO	O	O	B-T109
may	O	O	O
lead	O	O	O
to	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
new	O	O	O
mitochondria	O	O	B-T026
-	O	O	O
targeted	O	O	B-T043
antioxidants	O	O	B-T121
in	O	O	O
the	O	O	O
future	O	O	B-T079
.	O	O	O

-DOCSTART- (28070811)

Encaged	O	O	B-T073
Chironomus	O	O	B-T204
riparius	O	O	I-T204
larvae	O	O	B-T204
in	O	O	O
assessment	O	O	B-T052
of	O	O	O
trace	O	O	B-T121
metal	O	O	I-T121
bioavailability	O	O	B-T169
and	O	O	O
transfer	O	O	B-T169
in	O	O	O
a	O	O	O
landfill	O	O	B-T131
leachate	O	O	I-T131
collection	O	O	B-T169
pond	O	O	O

Household	O	O	B-T056
wastes	O	O	B-T131
may	O	O	O
constitute	O	O	B-T167
a	O	O	O
vector	O	O	B-T080
of	O	O	O
environmental	O	O	B-T069
contamination	O	O	I-T069
when	O	O	O
buried	O	O	B-T082
,	O	O	O
in	O	O	O
particular	O	O	O
through	O	O	O
degradation	O	O	B-T169
and	O	O	O
production	O	O	O
of	O	O	O
leachates	O	O	B-T131
containing	O	O	B-T169
significant	O	O	B-T078
trace	O	O	B-T121
metal	O	O	I-T121
(	O	O	O
TM	O	O	B-T121
)	O	O	O
concentrations	O	O	B-T081
that	O	O	O
may	O	O	O
constitute	O	O	O
a	O	O	O
serious	O	O	O
risk	O	O	B-T078
to	O	O	O
biota	O	O	B-T070
.	O	O	O

The	O	O	O
objectives	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
were	O	O	O
to	O	O	O
assess	O	O	B-T052
the	O	O	O
bioavailability	O	O	B-T169
and	O	O	O
transfer	O	O	B-T169
potential	O	O	B-T080
of	O	O	O
various	O	O	O
TMs	O	O	B-T121
present	O	O	B-T033
in	O	O	O
water	O	O	B-T121
and	O	O	O
sediments	O	O	B-T070
in	O	O	O
a	O	O	O
reservoir	O	O	B-T083
receiving	O	O	B-T080
landfill	O	O	B-T131
leachates	O	O	I-T131
.	O	O	O

An	O	O	O
active	O	O	B-T169
biomonitoring	O	O	B-T057
approach	O	O	O
was	O	O	O
adopted	O	O	O
consisting	O	O	O
of	O	O	O
exposing	O	O	B-T080
naive	O	O	O
laboratory	O	O	B-T001
organisms	O	O	I-T001
in	O	O	O
cages	O	O	B-T073
deployed	O	O	B-T052
in	O	O	B-T082
the	O	O	I-T082
field	O	O	I-T082
.	O	O	O

Aquatic	O	O	B-T001
insects	O	O	I-T001
such	O	O	O
as	O	O	O
Chironomus	O	O	B-T204
riparius	O	O	I-T204
larvae	O	O	B-T204
are	O	O	O
good	O	O	O
candidates	O	O	O
since	O	O	O
they	O	O	O
represent	O	O	B-T052
key	O	O	O
organisms	O	O	B-T001
in	O	O	O
the	O	O	O
trophic	O	O	B-T070
functioning	O	O	B-T169
of	O	O	O
aquatic	O	O	B-T067
ecosystems	O	O	I-T067
.	O	O	O

The	O	O	O
results	O	O	B-T033
show	O	O	O
that	O	O	O
water	O	O	B-T121
,	O	O	O
suspended	O	O	B-T169
particles	O	O	B-T104
,	O	O	O
and	O	O	O
sediments	O	O	B-T070
were	O	O	O
significant	O	O	B-T078
ly	O	O	O
contaminated	O	O	B-T169
by	O	O	O
various	O	O	O
TMs	O	O	B-T121
(	O	O	O
As	O	O	B-T121
,	O	O	O
Cd	O	O	B-T131
,	O	O	O
Cu	O	O	B-T121
,	O	O	O
Ni	O	O	B-T123
,	O	O	O
Pb	O	O	B-T131
,	O	O	O
and	O	O	O
Zn	O	O	B-T121
)	O	O	O
.	O	O	O

Their	O	O	O
contribution	O	O	B-T052
to	O	O	O
the	O	O	O
transfer	O	O	B-T169
of	O	O	O
TMs	O	O	B-T121
depends	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
on	O	O	O
the	O	O	O
specific	O	O	B-T080
element	O	O	B-T196
considered	O	O	B-T078
,	O	O	O
e.g.	O	O	O
,	O	O	O
Cd	O	O	B-T131
in	O	O	O
sediments	O	O	B-T070
or	O	O	O
Pb	O	O	B-T131
in	O	O	O
both	O	O	O
suspended	O	O	B-T169
particles	O	O	B-T104
and	O	O	O
sediments	O	O	O
.	O	O	O

The	O	O	O
internal	O	O	O
fate	O	O	O
of	O	O	O
TMs	O	O	B-T121
was	O	O	O
investigated	O	O	B-T169
according	O	O	O
to	O	O	O
their	O	O	O
fractionation	O	O	B-T059
between	O	O	O
an	O	O	O
insoluble	O	O	B-T080
and	O	O	O
a	O	O	O
cytosolic	O	O	B-T026
fraction	O	O	B-T081
.	O	O	O

This	O	O	O
approach	O	O	O
revealed	O	O	B-T080
different	O	O	O
detoxification	O	O	B-T061
strategies	O	O	B-T041
capable	O	O	O
of	O	O	O
preventing	O	O	B-T169
the	O	O	O
induction	O	O	B-T169
of	O	O	O
deleterious	O	O	B-T046
effects	O	O	I-T046
at	O	O	O
the	O	O	O
individual	O	O	B-T098
scale	O	O	B-T077
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
accumulation	O	O	B-T033
of	O	O	O
several	O	O	O
TMs	O	O	B-T121
in	O	O	O
C.	O	O	B-T204
riparius	O	O	I-T204
larvae	O	O	B-T204
tissues	O	O	B-T024
may	O	O	O
also	O	O	O
represent	O	O	B-T052
a	O	O	O
significant	O	O	B-T078
load	O	O	O
potentially	O	O	B-T080
transferable	O	O	B-T169
to	O	O	O
higher	O	O	B-T080
trophic	O	O	B-T070
levels	O	O	B-T080
.	O	O	O

-DOCSTART- (28072457)

Effects	O	O	O
of	O	O	O
Binge-Like	O	O	B-T055
Ethanol	O	O	B-UnknownType
Exposure	O	O	I-UnknownType
During	O	O	O
Adolescence	O	O	B-T079
on	O	O	O
the	O	O	O
Febrile	O	O	B-T184
Response	O	O	B-T032
in	O	O	O
Rats	O	O	O

Ethanol	O	O	B-UnknownType
(	O	O	I-UnknownType
EtOH	O	O	I-UnknownType
)	O	O	I-UnknownType
exposure	O	O	I-UnknownType
during	O	O	O
different	O	O	O
phases	O	O	B-T079
of	O	O	O
life	O	O	B-T078
may	O	O	O
increase	O	O	O
the	O	O	O
risk	O	O	B-T033
of	O	O	I-T033
infections	O	O	I-T033
and	O	O	O
cause	O	O	O
alterations	O	O	B-T078
in	O	O	O
the	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
investigated	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
binge-like	O	O	B-T055
EtOH	O	O	B-UnknownType
exposure	O	O	I-UnknownType
in	O	O	O
adolescent	O	O	B-T079
rats	O	O	B-T015
on	O	O	O
the	O	O	O
febrile	O	O	B-T184
response	O	O	B-T032
that	O	O	O
was	O	O	O
induced	O	O	O
by	O	O	O
lipopolysaccharide	O	O	B-T109
(	O	O	O
LPS	O	O	B-T109
)	O	O	O
and	O	O	O
interleukin-1β	O	O	B-T116
(	O	O	O
IL-1β	O	O	B-T116
)	O	O	O
.	O	O	O

Male	O	O	O
rats	O	O	B-T015
were	O	O	O
exposed	O	O	B-UnknownType
to	O	O	I-UnknownType
EtOH	O	O	I-UnknownType
from	O	O	O
postnatal	O	O	B-T079
days	O	O	I-T079
25	O	O	O
to	O	O	O
38	O	O	O
in	O	O	O
a	O	O	O
binge-like	O	O	B-T055
pattern	O	O	O
.	O	O	O

Fever	O	O	B-T184
was	O	O	O
induced	O	O	O
by	O	O	O
LPS	O	O	B-T109
(	O	O	O
5	O	O	O
and	O	O	O
50	O	O	O
μg/kg	O	O	O
,	O	O	O
intraperitoneally	O	O	B-T082
)	O	O	O
and	O	O	O
evaluated	O	O	O
on	O	O	O
postnatal	O	O	B-T079
days	O	O	I-T079
51	O	O	O
and	O	O	O
63	O	O	O
,	O	O	O
or	O	O	O
by	O	O	O
IL-β	O	O	B-T116
(	O	O	O
3	O	O	O
ng	O	O	O
)	O	O	O
and	O	O	O
evaluated	O	O	O
on	O	O	O
postnatal	O	O	B-T079
day	O	O	I-T079
51	O	O	O
.	O	O	O

Hematological	O	O	B-T091
parameters	O	O	O
,	O	O	O
the	O	O	O
status	O	O	O
of	O	O	O
peritoneal	O	O	B-T025
macrophages	O	O	I-T025
,	O	O	O
and	O	O	O
plasma	O	O	B-T031
and	O	O	O
cerebrospinal	O	O	B-T169
IL-1β	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
also	O	O	O
evaluated	O	O	O
on	O	O	O
postnatal	O	O	B-T079
day	O	O	I-T079
51	O	O	O
.	O	O	O

EtOH	O	O	B-UnknownType
exposure	O	O	I-UnknownType
during	O	O	O
adolescence	O	O	B-T079
did	O	O	O
not	O	O	O
alter	O	O	O
normal	O	O	B-T033
body	O	O	I-T033
temperature	O	O	I-T033
.	O	O	O

However	O	O	O
,	O	O	O
a	O	O	O
significant	O	O	O
reduction	O	O	O
in	O	O	O
the	O	O	O
febrile	O	O	B-T184
response	O	O	B-T032
that	O	O	O
was	O	O	O
induced	O	O	O
by	O	O	O
LPS	O	O	B-T109
at	O	O	O
both	O	O	O
doses	O	O	O
was	O	O	O
observed	O	O	O
on	O	O	O
postnatal	O	O	B-T079
day	O	O	O
51	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
no	O	O	O
changes	O	O	O
in	O	O	O
the	O	O	O
febrile	O	O	B-T184
response	O	O	B-T032
were	O	O	O
observed	O	O	O
on	O	O	O
postnatal	O	O	B-T079
day	O	O	I-T079
63	O	O	O
in	O	O	O
EtOH-exposed	O	O	B-UnknownType
animals	O	O	B-T015
.	O	O	O

The	O	O	O
febrile	O	O	B-T184
response	O	O	B-T032
that	O	O	O
was	O	O	O
induced	O	O	O
by	O	O	O
intracerebroventricular	O	O	B-T082
IL-1β	O	O	B-T116
also	O	O	O
significantly	O	O	O
decreased	O	O	O
in	O	O	O
animals	O	O	B-T015
that	O	O	O
received	O	O	O
binge-like	O	O	B-T055
EtOH	O	O	B-UnknownType
exposure	O	O	I-UnknownType
during	O	O	O
adolescence	O	O	B-T079
.	O	O	O

Acute	O	O	B-T169
oral	O	O	I-T169
treatment	O	O	I-T169
with	O	O	O
EtOH	O	O	B-T109
24	O	O	O
h	O	O	O
prior	O	O	O
to	O	O	O
LPS	O	O	B-T109
administration	O	O	B-T061
did	O	O	O
not	O	O	O
alter	O	O	O
the	O	O	O
febrile	O	O	B-T184
response	O	O	B-T032
that	O	O	O
was	O	O	O
induced	O	O	O
by	O	O	O
LPS	O	O	O
.	O	O	O

Binge-like	O	O	B-T055
EtOH	O	O	B-UnknownType
exposure	O	O	I-UnknownType
during	O	O	O
adolescence	O	O	B-T079
did	O	O	O
not	O	O	O
alter	O	O	O
hematological	O	O	B-T091
parameters	O	O	O
or	O	O	O
the	O	O	O
number	O	O	O
or	O	O	O
viability	O	O	B-T043
of	O	O	O
peritoneal	O	O	B-T025
macrophages	O	O	I-T025
.	O	O	O

Binge-like	O	O	B-T055
EtOH	O	O	B-UnknownType
exposure	O	O	I-UnknownType
did	O	O	O
not	O	O	O
alter	O	O	O
plasma	O	O	B-T031
IL-1β	O	O	B-T116
levels	O	O	B-T080
but	O	O	O
reduced	O	O	O
the	O	O	O
cerebrospinal	O	O	B-T031
fluid	O	O	I-T031
levels	O	O	O
of	O	O	O
this	O	O	O
cytokine	O	O	B-T116
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
binge-like	O	O	B-T055
EtOH	O	O	B-UnknownType
exposure	O	O	I-UnknownType
during	O	O	O
adolescence	O	O	B-T079
causes	O	O	O
changes	O	O	O
in	O	O	O
the	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
that	O	O	O
can	O	O	O
impair	O	O	O
the	O	O	O
febrile	O	O	B-T184
response	O	O	B-T032
that	O	O	O
can	O	O	O
be	O	O	O
observed	O	O	O
after	O	O	O
the	O	O	O
cessation	O	O	B-T052
of	O	O	O
EtOH	O	O	O
exposure	O	O	O
.	O	O	O

These	O	O	O
changes	O	O	O
were	O	O	O
reversible	O	O	O
and	O	O	O
appeared	O	O	O
to	O	O	O
involve	O	O	O
the	O	O	O
LPS	O	O	B-T109
/	O	O	O
IL-1β	O	O	B-T116
system	O	O	O
.	O	O	O

-DOCSTART- (28072668)

Genital	O	O	B-T047
and	O	O	O
Extragenital	O	O	B-T047
Gonorrhea	O	O	I-T047
and	O	O	O
Chlamydia	O	O	B-T047
in	O	O	O
Children	O	O	B-T100
and	O	O	O
Adolescents	O	O	B-T100
Evaluated	O	O	B-T058
for	O	O	O
Sexual	O	O	O
Abuse	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
a	O	O	O
nucleic	O	O	B-T059
acid	O	O	I-T059
amplification	O	O	I-T059
test	O	O	I-T059
in	O	O	O
detecting	O	O	B-T061
genital	O	O	B-T007
and	O	O	O
extragenital	O	O	B-T007
Neisseria	O	O	I-T007
gonorrhoeae	O	O	I-T007
(	O	O	O
NG	O	O	B-T007
)	O	O	O
and	O	O	O
Chlamydia	O	O	B-T007
trachomatis	O	O	I-T007
(	O	O	O
CT	O	O	B-T007
)	O	O	O
in	O	O	O
children	O	O	B-T100
and	O	O	O
adolescents	O	O	B-T100
assessed	O	O	B-T058
for	O	O	O
sexual	O	O	B-T037
abuse	O	O	I-T037
/	O	O	O
assault	O	O	B-T048
.	O	O	O

The	O	O	O
charts	O	O	O
of	O	O	O
children	O	O	B-T100
aged	O	O	B-T032
0	O	O	O
to	O	O	O
17	O	O	O
years	O	O	B-T079
,	O	O	O
consecutively	O	O	O
evaluated	O	O	B-T058
for	O	O	O
sexual	O	O	B-T068
victimization	O	O	I-T068
,	O	O	O
in	O	O	O
emergency	O	O	B-T093
department	O	O	I-T093
and	O	O	O
outpatient	O	O	B-T093
settings	O	O	I-T093
were	O	O	O
reviewed	O	O	O
.	O	O	O

Data	O	O	B-T078
extracted	O	O	O
included	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
type	O	O	O
of	O	O	O
sexual	O	O	B-T033
contact	O	O	I-T033
,	O	O	O
anogenital	O	O	B-T029
findings	O	O	B-T033
,	O	O	O
previous	O	O	B-T079
sexual	O	O	O
contact	O	O	O
,	O	O	O
toxicology	O	O	B-T033
results	O	O	I-T033
,	O	O	O
and	O	O	O
sites	O	O	B-T082
tested	O	O	B-T059
for	O	O	O
NG	O	O	B-T007
and	O	O	O
CT	O	O	B-T007
.	O	O	O

Of	O	O	O
the	O	O	O
1319	O	O	O
patients	O	O	B-T101
who	O	O	O
were	O	O	O
tested	O	O	B-T059
,	O	O	O
579	O	O	O
were	O	O	O
tested	O	O	O
at	O	O	O
more	O	O	O
than	O	O	O
1	O	O	O
site	O	O	B-T082
,	O	O	O
and	O	O	O
120	O	O	O
had	O	O	O
at	O	O	O
least	O	O	O
1	O	O	O
infected	O	O	B-T033
site	O	O	O
.	O	O	O

Chlamydia	O	O	B-T007
trachomatis	O	O	I-T007
was	O	O	O
identified	O	O	O
in	O	O	O
104	O	O	O
patients	O	O	B-T101
,	O	O	O
and	O	O	O
NG	O	O	B-T007
was	O	O	O
found	O	O	O
in	O	O	O
33	O	O	O
.	O	O	O

In	O	O	O
bivariate	O	O	B-UnknownType
analysis	O	O	I-UnknownType
,	O	O	O
a	O	O	O
positive	O	O	O
test	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
female	O	O	B-T032
sex	O	O	I-T032
,	O	O	O
age	O	O	B-T032
older	O	O	O
than	O	O	O
11	O	O	O
years	O	O	B-T079
,	O	O	O
previous	O	O	B-T079
sexual	O	O	B-T033
contact	O	O	I-T033
,	O	O	O
acute	O	O	O
or	O	O	O
healed	O	O	B-T169
genital	O	O	B-T037
injury	O	O	I-T037
,	O	O	O
drug/alcohol	O	O	B-T033
intoxication	O	O	I-T033
,	O	O	O
and	O	O	O
examination	O	O	B-T058
within	O	O	O
72	O	O	O
hours	O	O	B-T079
of	O	O	O
sexual	O	O	O
contact	O	O	O
.	O	O	O

Fifty-one	O	O	O
patients	O	O	B-T101
had	O	O	O
positive	O	O	B-T033
anal	O	O	B-T023
tests	O	O	B-T059
,	O	O	O
and	O	O	O
24	O	O	O
had	O	O	O
positive	O	O	O
oral	O	O	B-T082
tests	O	O	O
.	O	O	O

More	O	O	O
than	O	O	O
75	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
positive	O	O	B-T033
extragenital	O	O	B-T059
tests	O	O	B-T059
had	O	O	O
additional	O	O	O
positive	O	O	O
tests	O	O	O
or	O	O	O
anogenital	O	O	B-T029
injury	O	O	B-T037
.	O	O	O

Most	O	O	O
with	O	O	O
a	O	O	O
positive	O	O	B-T033
anal	O	O	B-T023
(	O	O	O
59	O	O	O
%	O	O	O
)	O	O	O
or	O	O	O
oral	O	O	B-T082
(	O	O	O
77	O	O	O
%	O	O	O
)	O	O	O
test	O	O	B-T059
did	O	O	O
not	O	O	O
report	O	O	O
that	O	O	O
the	O	O	O
assailant	O	O	O
's	O	O	O
genitals	O	O	B-T023
came	O	O	O
into	O	O	O
contact	O	O	O
with	O	O	O
that	O	O	O
site	O	O	B-T082
.	O	O	O

Positive	O	O	B-T033
tests	O	O	B-T059
for	O	O	O
NG	O	O	B-T007
and	O	O	O
CT	O	O	B-T007
in	O	O	O
patients	O	O	B-T101
evaluated	O	O	B-T058
for	O	O	O
sexual	O	O	B-T068
victimization	O	O	I-T068
may	O	O	O
represent	O	O	O
infection	O	O	B-T046
from	O	O	O
sexual	O	O	B-T033
contact	O	O	I-T033
,	O	O	O
contiguous	O	O	B-T080
spread	O	O	I-T080
of	O	O	O
infection	O	O	O
,	O	O	O
or	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
infected	O	O	B-T031
assailant	O	O	I-T031
secretions	O	O	I-T031
.	O	O	O

Relying	O	O	O
on	O	O	O
patient	O	O	B-T101
reports	O	O	O
of	O	O	O
symptoms	O	O	B-T184
,	O	O	O
or	O	O	O
types	O	O	O
of	O	O	O
sexual	O	O	B-T033
contact	O	O	I-T033
,	O	O	O
to	O	O	O
determine	O	O	O
need	O	O	O
for	O	O	O
testing	O	O	O
may	O	O	O
miss	O	O	O
NG	O	O	B-T047
and	O	O	O
CT	O	O	B-T047
infections	O	O	I-T047
in	O	O	O
patients	O	O	B-T101
evaluated	O	O	B-T058
for	O	O	O
sexual	O	O	B-T068
victimization	O	O	I-T068
.	O	O	O

-DOCSTART- (28074357)

The	O	O	O
Longitudinal	O	O	B-T082
Effects	O	O	B-T080
of	O	O	I-T080
Parenting	O	O	B-T055
on	O	O	O
Adaptive	O	O	B-T055
Behavior	O	O	I-T055
in	O	O	O
Children	O	O	B-T100
with	O	O	O
Fragile	O	O	O
X	O	O	O
Syndrome	O	O	O

Several	O	O	O
studies	O	O	B-T062
have	O	O	O
reported	O	O	O
declines	O	O	B-T080
in	O	O	O
adaptive	O	O	B-T055
behavior	O	O	I-T055
amongst	O	O	O
children	O	O	B-T100
with	O	O	O
fragile	O	O	B-T047
X	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
FXS	O	O	B-T047
)	O	O	O
starting	O	O	O
in	O	O	O
middle	O	O	B-T079
childhood	O	O	B-T079
.	O	O	O

We	O	O	O
examined	O	O	B-T033
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
maternal	O	O	B-T099
responsivity	O	O	B-T041
on	O	O	O
adaptive	O	O	B-T055
behavior	O	O	I-T055
in	O	O	O
55	O	O	O
children	O	O	B-T100
with	O	O	O
FXS	O	O	B-T047
visited	O	O	O
5	O	O	O
-	O	O	O
6	O	O	O
times	O	O	O
in	O	O	O
their	O	O	O
homes	O	O	B-T073
from	O	O	O
early	O	O	O
through	O	O	O
middle	O	O	B-T079
childhood	O	O	B-T079
.	O	O	O

Our	O	O	O
analyses	O	O	B-T062
indicated	O	O	O
that	O	O	O
sustained	O	O	B-T169
maternal	O	O	B-T099
responsivity	O	O	B-T041
had	O	O	O
a	O	O	O
significant	O	O	B-T078
positive	O	O	B-T080
impact	O	O	I-T080
on	O	O	O
the	O	O	O
trajectories	O	O	B-T082
of	O	O	O
communication	O	O	B-T054
and	O	O	O
to	O	O	O
a	O	O	O
lesser	O	O	O
extent	O	O	O
other	O	O	O
adaptive	O	O	B-T055
behavior	O	O	I-T055
domains	O	O	B-T077
through	O	O	O
middle	O	O	B-T079
childhood	O	O	B-T079
with	O	O	O
many	O	O	O
effects	O	O	B-T080
remaining	O	O	O
significant	O	O	O
after	O	O	O
controlling	O	O	B-T067
for	O	O	O
autism	O	O	B-T033
symptoms	O	O	I-T033
and	O	O	O
developmental	O	O	B-T040
level	O	O	I-T040
.	O	O	O

For	O	O	O
children	O	O	B-T100
who	O	O	O
showed	O	O	O
declines	O	O	B-T080
in	O	O	O
adaptive	O	O	B-T055
behavior	O	O	I-T055
during	O	O	O
middle	O	O	B-T079
childhood	O	O	B-T079
,	O	O	O
sustained	O	O	B-T169
high	O	O	B-T080
levels	O	O	I-T080
of	O	O	O
maternal	O	O	B-T099
responsivity	O	O	B-T041
minimized	O	O	B-T080
the	O	O	O
amount	O	O	O
of	O	O	O
decline	O	O	B-T080
observed	O	O	B-T169
in	O	O	O
the	O	O	O
communication	O	O	B-T054
,	O	O	O
socialization	O	O	B-T065
,	O	O	O
and	O	O	O
daily	O	O	B-UnknownType
living	O	O	I-UnknownType
domains	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (28076405)

Development	O	O	B-T169
and	O	O	O
Validation	O	O	B-T062
of	O	O	O
a	O	O	O
New	O	O	O
Reliable	O	O	O
Method	O	O	B-T059
for	O	O	O
the	O	O	O
Diagnosis	O	O	B-T033
of	O	O	O
Avian	O	O	B-T012
Botulism	O	O	O

Liver	O	O	B-T023
is	O	O	O
a	O	O	O
reliable	O	O	O
matrix	O	O	B-T031
for	O	O	O
laboratory	O	O	B-T059
confirmation	O	O	B-T080
of	O	O	I-T080
avian	O	O	B-T012
botulism	O	O	B-T037
using	O	O	O
real-time	O	O	B-T063
PCR	O	O	I-T063
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
developed	O	O	B-T169
,	O	O	O
optimized	O	O	B-T052
,	O	O	O
and	O	O	O
validated	O	O	B-T062
the	O	O	O
analytical	O	O	B-T062
steps	O	O	B-T077
preceding	O	O	B-T079
PCR	O	O	B-T063
to	O	O	O
maximize	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
Clostridium	O	O	B-T007
botulinum	O	O	I-T007
group	O	O	I-T007
III	O	O	I-T007
in	O	O	O
avian	O	O	B-T012
liver	O	O	B-T023
.	O	O	O

These	O	O	O
pre	O	O	B-T079
-	O	O	O
PCR	O	O	B-T063
steps	O	O	B-T077
included	O	O	O
enrichment	O	O	B-T130
incubation	O	O	B-T059
of	O	O	O
the	O	O	O
whole	O	O	O
liver	O	O	B-T023
(	O	O	O
maximum	O	O	O
25	O	O	O
g	O	O	O
)	O	O	O
at	O	O	O
37	O	O	B-T059
°	O	O	I-T059
C	O	O	I-T059
for	O	O	O
at	O	O	O
least	O	O	O
24	O	O	O
h	O	O	B-T079
in	O	O	O
an	O	O	O
anaerobic	O	O	B-T074
chamber	O	O	I-T074
and	O	O	O
DNA	O	O	B-T063
extraction	O	O	I-T063
using	O	O	O
an	O	O	O
enzymatic	O	O	B-T059
digestion	O	O	I-T059
step	O	O	O
followed	O	O	O
by	O	O	O
a	O	O	O
DNA	O	O	B-T059
purification	O	O	I-T059
step	O	O	O
.	O	O	O

Conditions	O	O	O
of	O	O	O
sample	O	O	B-T077
storage	O	O	B-T169
before	O	O	O
analysis	O	O	B-T062
appear	O	O	O
to	O	O	O
have	O	O	O
a	O	O	O
strong	O	O	O
effect	O	O	B-T080
on	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
group	O	O	B-T007
III	O	O	I-T007
C.	O	O	I-T007
botulinum	O	O	I-T007
strains	O	O	I-T007
and	O	O	O
our	O	O	O
results	O	O	B-T169
recommend	O	O	O
storage	O	O	O
at	O	O	O
temperatures	O	O	B-T081
below	O	O	O
-18	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

Short-term	O	O	B-T079
storage	O	O	B-T169
at	O	O	O
5	O	O	O
°	O	O	O
C	O	O	O
is	O	O	O
possible	O	O	O
for	O	O	O
up	O	O	O
to	O	O	O
24	O	O	O
h	O	O	B-T079
,	O	O	O
but	O	O	O
a	O	O	O
decrease	O	O	B-T081
in	O	O	O
sensitivity	O	O	B-T169
was	O	O	O
observed	O	O	O
at	O	O	O
48	O	O	O
h	O	O	O
of	O	O	O
storage	O	O	O
at	O	O	O
this	O	O	O
temperature	O	O	B-T081
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
whole	O	O	O
livers	O	O	B-T023
(	O	O	O
maximum	O	O	O
25	O	O	O
g	O	O	O
)	O	O	O
is	O	O	O
required	O	O	O
and	O	O	O
pooling	O	O	B-T169
samples	O	O	B-T077
before	O	O	O
enrichment	O	O	B-T059
culturing	O	O	I-T059
must	O	O	O
be	O	O	O
avoided	O	O	O
.	O	O	O

Pooling	O	O	B-T169
is	O	O	O
however	O	O	O
possible	O	O	O
before	O	O	O
or	O	O	O
after	O	O	O
DNA	O	O	B-T063
extraction	O	O	I-T063
under	O	O	O
certain	O	O	O
conditions	O	O	O
.	O	O	O

Whole	O	O	O
livers	O	O	B-T023
should	O	O	O
be	O	O	O
10-fold	O	O	O
diluted	O	O	O
in	O	O	O
enrichment	O	O	B-T130
medium	O	O	I-T130
and	O	O	O
homogenized	O	O	O
using	O	O	O
a	O	O	O
Pulsifier	O	O	B-T074
®	O	O	I-T074
blender	O	O	I-T074
(	O	O	O
Microgen	O	O	O
,	O	O	O
Surrey	O	O	B-T083
,	O	O	O
UK	O	O	B-T083
)	O	O	O
instead	O	O	O
of	O	O	O
a	O	O	O
conventional	O	O	O
paddle	O	O	B-T074
blender	O	O	I-T074
.	O	O	O

Spiked	O	O	B-T023
liver	O	O	B-T023
samples	O	O	B-T077
showed	O	O	O
a	O	O	O
limit	O	O	O
of	O	O	O
detection	O	O	B-T033
of	O	O	O
5	O	O	O
spores	O	O	B-T007
/g	O	O	O
liver	O	O	O
for	O	O	O
types	O	O	B-T007
C	O	O	I-T007
and	O	O	O
D	O	O	B-T007
and	O	O	O
250	O	O	O
spores	O	O	O
/g	O	O	O
for	O	O	O
type	O	O	O
E.	O	O	O
Using	O	O	O
the	O	O	O
method	O	O	B-T059
developed	O	O	B-T169
here	O	O	O
,	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
268	O	O	O
samples	O	O	O
from	O	O	O
73	O	O	O
suspected	O	O	O
outbreaks	O	O	B-T081
showed	O	O	O
100	O	O	O
%	O	O	O
specificity	O	O	B-T081
and	O	O	O
95.35	O	O	O
%	O	O	O
sensitivity	O	O	B-T169
compared	O	O	B-T052
with	O	O	O
other	O	O	O
PCR	O	O	B-T063
-based	O	O	O
methods	O	O	B-T059
considered	O	O	O
as	O	O	O
reference	O	O	O
.	O	O	O

The	O	O	O
mosaic	O	O	B-T007
type	O	O	I-T007
C	O	O	I-T007
/	O	O	O
D	O	O	B-T007
was	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
neurotoxin	O	O	B-T131
type	O	O	O
found	O	O	O
in	O	O	O
examined	O	O	O
samples	O	O	B-T077
,	O	O	O
which	O	O	O
included	O	O	O
both	O	O	O
wild	O	O	B-T012
and	O	O	O
domestic	O	O	B-T012
birds	O	O	I-T012
.	O	O	O

-DOCSTART- (28077898)

Quality	O	O	B-T057
Improvement	O	O	I-T057
of	O	O	O
Liver	O	O	B-T023
Ultrasound	O	O	B-T060
Images	O	O	B-T170
Using	O	O	O
Fuzzy	O	O	B-T170
Techniques	O	O	O

Liver	O	O	B-T023
ultrasound	O	O	B-T060
images	O	O	B-T170
are	O	O	O
so	O	O	O
common	O	O	O
and	O	O	O
are	O	O	O
applied	O	O	O
so	O	O	O
often	O	O	O
to	O	O	O
diagnose	O	O	B-T033
diffuse	O	O	B-T047
liver	O	O	I-T047
diseases	O	O	I-T047
like	O	O	O
fatty	O	O	B-T047
liver	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
low	O	O	B-T080
quality	O	O	B-T080
of	O	O	O
such	O	O	O
images	O	O	B-T170
makes	O	O	O
it	O	O	O
difficult	O	O	O
to	O	O	O
analyze	O	O	B-T062
them	O	O	O
and	O	O	O
diagnose	O	O	B-T033
diseases	O	O	B-T047
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
therefore	O	O	O
,	O	O	O
is	O	O	O
to	O	O	O
improve	O	O	O
the	O	O	O
contrast	O	O	B-T080
and	O	O	O
quality	O	O	B-T080
of	O	O	O
liver	O	O	B-T023
ultrasound	O	O	B-T060
images	O	O	B-T170
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
image	O	O	B-T170
contrast	O	O	B-T080
enhancement	O	O	B-T170
algorithms	O	O	B-T170
which	O	O	O
are	O	O	O
based	O	O	O
on	O	O	O
fuzzy	O	O	B-T170
logic	O	O	I-T170
were	O	O	O
applied	O	O	O
to	O	O	O
liver	O	O	B-T023
ultrasound	O	O	B-T060
images	O	O	B-T170
-	O	O	O
in	O	O	O
which	O	O	O
the	O	O	O
view	O	O	O
of	O	O	O
kidney	O	O	B-T023
is	O	O	O
observable	O	O	O
-	O	O	O
using	O	O	O
Matlab2013b	O	O	B-T073
to	O	O	O
improve	O	O	O
the	O	O	O
image	O	O	O
contrast	O	O	O
and	O	O	O
quality	O	O	B-T080
which	O	O	O
has	O	O	O
a	O	O	O
fuzzy	O	O	O
definition	O	O	B-T170
;	O	O	O
just	O	O	O
like	O	O	O
image	O	O	O
contrast	O	O	O
improvement	O	O	B-T077
algorithms	O	O	O
using	O	O	O
a	O	O	O
fuzzy	O	O	O
intensification	O	O	B-T074
operator	O	O	I-T074
,	O	O	O
contrast	O	O	O
improvement	O	O	O
algorithms	O	O	O
applying	O	O	O
fuzzy	O	O	O
image	O	O	O
histogram	O	O	B-T170
hyperbolization	O	O	I-T170
,	O	O	O
and	O	O	O
contrast	O	O	O
improvement	O	O	O
algorithms	O	O	O
by	O	O	O
fuzzy	O	O	O
IF-THEN	O	O	B-T170
rules	O	O	I-T170
.	O	O	O

With	O	O	O
the	O	O	O
measurement	O	O	B-T169
of	O	O	O
Mean	O	O	B-T080
Squared	O	O	I-T080
Error	O	O	I-T080
and	O	O	O
Peak	O	O	B-T080
Signal	O	O	B-T081
to	O	O	I-T081
Noise	O	O	I-T081
Ratio	O	O	I-T081
obtained	O	O	O
from	O	O	O
different	O	O	O
images	O	O	B-T170
,	O	O	O
fuzzy	O	O	B-T170
methods	O	O	B-T170
provided	O	O	O
better	O	O	O
results	O	O	B-T169
,	O	O	O
and	O	O	O
their	O	O	O
implementation	O	O	B-T052
-	O	O	O
compared	O	O	B-T052
with	O	O	O
histogram	O	O	B-T170
equalization	O	O	I-T170
method	O	O	I-T170
-	O	O	O
led	O	O	O
both	O	O	O
to	O	O	O
the	O	O	O
improvement	O	O	B-T077
of	O	O	O
contrast	O	O	B-T080
and	O	O	O
visual	O	O	B-T033
quality	O	O	I-T033
of	O	O	O
images	O	O	O
and	O	O	O
to	O	O	O
the	O	O	O
improvement	O	O	O
of	O	O	O
liver	O	O	B-T023
segmentation	O	O	B-T170
algorithms	O	O	I-T170
results	O	O	O
in	O	O	O
images	O	O	O
.	O	O	O

Comparison	O	O	B-T052
of	O	O	O
the	O	O	O
four	O	O	O
algorithms	O	O	B-T170
revealed	O	O	O
the	O	O	O
power	O	O	O
of	O	O	O
fuzzy	O	O	B-T170
logic	O	O	I-T170
in	O	O	O
improving	O	O	O
image	O	O	B-T170
contrast	O	O	B-T080
compared	O	O	B-T052
with	O	O	O
traditional	O	O	O
image	O	O	B-T066
processing	O	O	I-T066
algorithms	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
contrast	O	O	B-T080
improvement	O	O	B-T077
algorithm	O	O	B-T170
based	O	O	O
on	O	O	O
a	O	O	O
fuzzy	O	O	B-T170
intensification	O	O	B-T074
operator	O	O	I-T074
was	O	O	O
selected	O	O	O
as	O	O	O
the	O	O	O
strongest	O	O	O
algorithm	O	O	O
considering	O	O	O
the	O	O	O
measured	O	O	O
indicators	O	O	O
.	O	O	O

This	O	O	O
method	O	O	B-T170
can	O	O	O
also	O	O	O
be	O	O	O
used	O	O	O
in	O	O	O
future	O	O	O
studies	O	O	B-T062
on	O	O	O
other	O	O	O
ultrasound	O	O	B-T060
images	O	O	B-T170
for	O	O	O
quality	O	O	B-T057
improvement	O	O	I-T057
and	O	O	O
other	O	O	O
image	O	O	B-T066
processing	O	O	I-T066
and	O	O	O
analysis	O	O	B-T062
applications	O	O	B-T169
.	O	O	O

-DOCSTART- (28078640)

Development	O	O	B-T169
of	O	O	O
the	O	O	O
pediatric	O	O	B-T170
quality	O	O	I-T170
of	O	O	I-T170
life	O	O	I-T170
inventory	O	O	I-T170
neurofibromatosis	O	O	B-T191
type	O	O	I-T191
1	O	O	I-T191
module	O	O	B-T170
items	O	O	B-T062
for	O	O	O
children	O	O	B-T100
,	O	O	O
adolescents	O	O	B-T100
and	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
:	O	O	O
qualitative	O	O	O
methods	O	O	O

Health-related	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
(	O	O	O
HRQOL	O	O	B-T078
)	O	O	O
is	O	O	O
arguably	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
important	O	O	B-T080
measures	O	O	B-T081
in	O	O	O
evaluating	O	O	B-T058
effectiveness	O	O	B-T080
of	O	O	O
clinical	O	O	B-T061
treatments	O	O	I-T061
.	O	O	O

At	O	O	O
present	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
disease	O	O	B-T047
-	O	O	O
specific	O	O	B-T080
outcome	O	O	B-T081
measure	O	O	I-T081
to	O	O	O
assess	O	O	B-T058
the	O	O	O
HRQOL	O	O	B-T078
of	O	O	O
children	O	O	B-T100
,	O	O	O
adolescents	O	O	B-T100
and	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
with	O	O	O
Neurofibromatosis	O	O	B-T191
Type	O	O	I-T191
1	O	O	I-T191
(	O	O	O
NF1	O	O	B-T191
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
develop	O	O	O
the	O	O	O
items	O	O	B-T062
and	O	O	O
support	O	O	O
the	O	O	O
content	O	O	B-T080
validity	O	O	I-T080
for	O	O	O
the	O	O	O
Pediatric	O	O	B-T170
Quality	O	O	I-T170
of	O	O	I-T170
Life	O	O	I-T170
Inventory	O	O	I-T170
™	O	O	I-T170
(	O	O	O
PedsQL	O	O	B-T170
™	O	O	I-T170
)	O	O	O
NF1	O	O	B-T191
Module	O	O	B-T170
for	O	O	O
children	O	O	B-T100
,	O	O	O
adolescents	O	O	B-T100
and	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
.	O	O	O

The	O	O	O
iterative	O	O	B-T033
process	O	O	B-T067
included	O	O	O
multiphase	O	O	B-T062
qualitative	O	O	I-T062
methods	O	O	I-T062
including	O	O	O
a	O	O	O
literature	O	O	B-T170
review	O	O	I-T170
,	O	O	O
survey	O	O	B-T170
of	O	O	O
expert	O	O	B-T077
opinions	O	O	I-T077
,	O	O	O
semi-structured	O	O	B-T052
interviews	O	O	B-T052
,	O	O	O
cognitive	O	O	B-T169
interviews	O	O	O
and	O	O	O
pilot	O	O	B-T062
testing	O	O	I-T062
.	O	O	O

Fifteen	O	O	O
domains	O	O	B-T169
were	O	O	O
derived	O	O	O
from	O	O	O
the	O	O	O
qualitative	O	O	B-T062
methods	O	O	I-T062
,	O	O	O
with	O	O	O
content	O	O	B-T077
saturation	O	O	O
achieved	O	O	O
,	O	O	O
resulting	O	O	O
in	O	O	O
115	O	O	O
items	O	O	B-T062
.	O	O	O

The	O	O	O
domains	O	O	B-T169
include	O	O	O
skin	O	O	B-T022
,	O	O	O
pain	O	O	B-T184
,	O	O	O
pain	O	O	O
impact	O	O	B-T080
,	O	O	O
pain	O	O	B-T061
management	O	O	I-T061
,	O	O	O
cognitive	O	O	B-T041
functioning	O	O	I-T041
,	O	O	O
speech	O	O	B-T040
,	O	O	O
fine	O	O	B-T042
motor	O	O	I-T042
,	O	O	O
balance	O	O	B-T169
,	O	O	O
vision	O	O	B-T040
,	O	O	O
perceived	O	O	B-T041
physical	O	O	B-T184
appearance	O	O	I-T184
,	O	O	O
communication	O	O	B-T054
,	O	O	O
worry	O	O	B-T033
,	O	O	O
treatment	O	O	B-T061
,	O	O	O
medicines	O	O	B-T121
and	O	O	O
gastrointestinal	O	O	B-T184
symptoms	O	O	I-T184
.	O	O	O

This	O	O	O
study	O	O	O
is	O	O	O
limited	O	O	B-T169
because	O	O	O
all	O	O	O
participants	O	O	B-T098
are	O	O	O
recruited	O	O	O
from	O	O	O
a	O	O	O
single	O	O	B-T081
-	O	O	O
site	O	O	B-T082
.	O	O	O

Qualitative	O	O	B-T062
methods	O	O	I-T062
support	O	O	O
the	O	O	O
content	O	O	B-T080
validity	O	O	I-T080
for	O	O	O
the	O	O	O
PedsQL	O	O	B-T170
™	O	O	I-T170
NF1	O	O	B-T191
Module	O	O	B-T170
for	O	O	O
children	O	O	B-T100
,	O	O	O
adolescents	O	O	B-T100
and	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
.	O	O	O

The	O	O	O
PedsQL	O	O	B-T170
™	O	O	I-T170
NF1	O	O	B-T191
Module	O	O	B-T170
is	O	O	O
now	O	O	O
undergoing	O	O	O
national	O	O	B-T169
multisite	O	O	I-T169
field	O	O	I-T169
testing	O	O	I-T169
for	O	O	O
the	O	O	O
psychometric	O	O	B-T060
validation	O	O	B-T062
of	O	O	O
the	O	O	O
instrument	O	O	B-T170
development	O	O	B-T169
.	O	O	O

-DOCSTART- (28079476)

Mimiviruses	O	O	B-T005
and	O	O	O
the	O	O	O
Human	O	O	B-T016
Interferon	O	O	B-T116
System	O	O	B-T022
:	O	O	O
Viral	O	O	B-T043
Evasion	O	O	I-T043
of	O	O	O
Classical	O	O	B-T169
Antiviral	O	O	B-T040
Activities	O	O	I-T040
,	O	O	O
But	O	O	O
Inhibition	O	O	B-T052
By	O	O	O
a	O	O	O
Novel	O	O	O
Interferon-β	O	O	B-T116
Regulated	O	O	B-T038
Immunomodulatory	O	O	B-T061
Pathway	O	O	O

In	O	O	O
this	O	O	O
review	O	O	B-T170
we	O	O	O
discuss	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
mimiviruses	O	O	B-T005
as	O	O	O
potential	O	O	B-T080
human	O	O	B-T016
pathogens	O	O	B-T001
focusing	O	O	O
on	O	O	O
clinical	O	O	B-T080
and	O	O	O
evolutionary	O	O	B-T045
evidence	O	O	B-T078
.	O	O	O

We	O	O	O
also	O	O	O
propose	O	O	B-T080
a	O	O	O
novel	O	O	O
antiviral	O	O	B-T040
immunomodulatory	O	O	B-T129
pathway	O	O	B-T077
controlled	O	O	B-T169
by	O	O	O
interferon-β	O	O	B-T116
(	O	O	O
IFN-β	O	O	B-T116
)	O	O	O
and	O	O	O
mediated	O	O	O
by	O	O	O
immune-responsive	O	O	B-T116
gene	O	O	I-T116
1	O	O	I-T116
(	O	O	O
IRG1	O	O	B-T116
)	O	O	O
and	O	O	O
itaconic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
its	O	O	O
product	O	O	B-T071
.	O	O	O

Acanthamoeba	O	O	B-T005
polyphaga	O	O	I-T005
Mimivirus	O	O	I-T005
(	O	O	O
APMV	O	O	B-T005
)	O	O	O
was	O	O	O
isolated	O	O	B-T169
from	O	O	O
amoebae	O	O	B-T204
in	O	O	O
a	O	O	O
hospital	O	O	B-T093
while	O	O	O
investigating	O	O	B-T169
a	O	O	O
pneumonia	O	O	B-T047
outbreak	O	O	B-T067
.	O	O	O

Mimivirus	O	O	B-T005
ubiquity	O	O	B-T080
and	O	O	O
role	O	O	B-T077
as	O	O	O
protist	O	O	B-T001
pathogens	O	O	B-T001
are	O	O	O
well	O	O	O
understood	O	O	O
,	O	O	O
and	O	O	O
its	O	O	O
putative	O	O	B-T082
status	O	O	B-T169
as	O	O	O
a	O	O	O
human	O	O	B-T016
pathogen	O	O	B-T001
has	O	O	O
been	O	O	O
gaining	O	O	B-T081
strength	O	O	B-T078
as	O	O	O
more	O	O	O
evidence	O	O	B-T078
is	O	O	O
being	O	O	O
found	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
of	O	O	O
APMV	O	O	B-T005
and	O	O	O
human	O	O	B-T016
cells	O	O	B-T025
interaction	O	O	B-T040
revealed	O	O	O
that	O	O	O
the	O	O	O
virus	O	O	B-T005
is	O	O	O
able	O	O	O
to	O	O	O
evade	O	O	B-T040
the	O	O	O
IFN	O	O	B-T116
system	O	O	B-T022
by	O	O	O
inhibiting	O	O	B-T052
the	O	O	O
regulation	O	O	B-T045
of	O	O	O
interferon	O	O	B-T116
-stimulated	O	O	O
genes	O	O	B-T028
,	O	O	O
suggesting	O	O	O
that	O	O	O
the	O	O	O
virus	O	O	O
and	O	O	O
humans	O	O	B-T016
have	O	O	O
had	O	O	O
host-pathogen	O	O	B-T040
interactions	O	O	I-T040
.	O	O	O

It	O	O	O
also	O	O	O
has	O	O	O
shown	O	O	O
that	O	O	O
the	O	O	O
virus	O	O	B-T005
is	O	O	O
capable	O	O	B-T080
of	O	O	O
growing	O	O	O
on	O	O	O
IFN-α2	O	O	B-T116
,	O	O	O
but	O	O	O
not	O	O	O
on	O	O	O
IFN-β	O	O	B-T116
-	O	O	O
treated	O	O	B-T169
cells	O	O	B-T025
,	O	O	O
hinting	O	O	O
at	O	O	O
an	O	O	O
exclusive	O	O	B-T078
IFN-β	O	O	O
antiviral	O	O	B-T040
pathway	O	O	B-T077
.	O	O	O

Our	O	O	O
hypothesis	O	O	B-T078
based	O	O	B-T078
on	O	O	O
preliminary	O	O	B-T078
data	O	O	I-T078
and	O	O	O
published	O	O	B-T170
articles	O	O	I-T170
is	O	O	O
that	O	O	O
IFN-β	O	O	B-T116
preferentially	O	O	B-T078
upregulates	O	O	B-T044
IRG1	O	O	B-T116
in	O	O	I-T116
human	O	O	I-T116
macrophagic	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
which	O	O	O
in	O	O	O
turn	O	O	O
produces	O	O	O
itaconic	O	O	B-T109
acid	O	O	I-T109
.	O	O	O

This	O	O	O
metabolite	O	O	B-T123
links	O	O	O
metabolism	O	O	B-T040
to	O	O	O
antiviral	O	O	B-T040
activity	O	O	I-T040
by	O	O	O
inactivating	O	O	B-T169
the	O	O	O
virus	O	O	B-T005
,	O	O	O
in	O	O	O
a	O	O	O
novel	O	O	O
immunomodulatory	O	O	B-T061
pathway	O	O	B-T077
relevant	O	O	B-T080
for	O	O	O
APMV	O	O	B-T005
infections	O	O	B-T046
and	O	O	O
probably	O	O	O
to	O	O	O
other	O	O	O
infectious	O	O	B-T047
diseases	O	O	I-T047
as	O	O	O
well	O	O	O
.	O	O	O

-DOCSTART- (28080032)

Heteroprotein	O	O	B-T116
Complex	O	O	B-T104
Formation	O	O	O
of	O	O	O
Bovine	O	O	B-T116
Lactoferrin	O	O	I-T116
and	O	O	O
Pea	O	O	B-T116
Protein	O	O	I-T116
Isolate	O	O	B-T121
:	O	O	O
A	O	O	O
Multiscale	O	O	O
Structural	O	O	O
Analysis	O	O	O

Associative	O	O	B-T080
electrostatic	O	O	B-UnknownType
interactions	O	O	I-UnknownType
between	O	O	O
two	O	O	O
oppositely	O	O	B-T080
charged	O	O	B-T032
globular	O	O	B-T116
proteins	O	O	I-T116
,	O	O	O
lactoferrin	O	O	B-T116
(	O	O	O
LF	O	O	B-T116
)	O	O	O
and	O	O	O
pea	O	O	B-T116
protein	O	O	I-T116
isolate	O	O	B-T121
(	O	O	O
PPI	O	O	B-T116
)	O	O	O
,	O	O	O
the	O	O	O
latter	O	O	O
being	O	O	O
a	O	O	O
mixture	O	O	B-T167
of	O	O	O
vicilin	O	O	B-T116
,	O	O	O
legumin	O	O	B-T116
,	O	O	O
and	O	O	O
convicilin	O	O	B-T116
,	O	O	O
was	O	O	O
studied	O	O	B-T062
with	O	O	O
a	O	O	O
specific	O	O	B-T080
PPI	O	O	O
/	O	O	O
LF	O	O	O
molar	O	O	B-T081
ratio	O	O	I-T081
at	O	O	O
room	O	O	B-T033
temperature	O	O	I-T033
.	O	O	O

Structural	O	O	B-T082
aspects	O	O	B-T080
of	O	O	O
the	O	O	O
electrostatic	O	O	B-T070
complexes	O	O	B-T104
probed	O	O	O
at	O	O	O
different	O	O	B-T080
length	O	O	B-T081
scales	O	O	B-T081
were	O	O	O
investigated	O	O	B-T169
as	O	O	O
a	O	O	O
function	O	O	B-T169
of	O	O	O
pH	O	O	B-T081
by	O	O	O
means	O	O	O
of	O	O	O
different	O	O	O
complementary	O	O	B-T169
techniques	O	O	I-T169
,	O	O	O
namely	O	O	O
,	O	O	O
with	O	O	O
dynamic	O	O	B-T059
light	O	O	I-T059
scattering	O	O	I-T059
,	O	O	O
small-angle	O	O	B-T059
X-ray	O	O	I-T059
scattering	O	O	I-T059
(	O	O	O
SAXS	O	O	B-T059
)	O	O	O
,	O	O	O
turbidity	O	O	B-T059
measurements	O	O	I-T059
,	O	O	O
and	O	O	O
atomic	O	O	B-T059
force	O	O	I-T059
microscopy	O	O	I-T059
(	O	O	O
AFM	O	O	B-T059
)	O	O	O
.	O	O	O

Irrespective	O	O	O
of	O	O	O
the	O	O	O
applied	O	O	O
techniques	O	O	B-T169
,	O	O	O
the	O	O	O
results	O	O	B-T034
consistently	O	O	B-T078
displayed	O	O	B-T169
that	O	O	O
complexation	O	O	B-T104
between	O	O	O
LF	O	O	B-T116
and	O	O	O
PPI	O	O	B-T116
did	O	O	O
occur	O	O	B-T052
.	O	O	O

In	O	O	O
an	O	O	O
optimum	O	O	B-T080
narrow	O	O	B-T080
range	O	O	B-T081
of	O	O	O
pH	O	O	B-T081
5.0	O	O	O
-	O	O	O
5.8	O	O	O
,	O	O	O
a	O	O	O
viscous	O	O	B-T080
liquid	O	O	B-T033
phase	O	O	B-T079
of	O	O	O
complex	O	O	B-T104
coacervate	O	O	B-T167
was	O	O	O
obtained	O	O	B-T169
upon	O	O	O
mild	O	O	O
centrifugation	O	O	B-T059
of	O	O	O
the	O	O	O
turbid	O	O	B-T080
LF	O	O	B-T116
-	O	O	O
PPI	O	O	B-T116
mixture	O	O	B-T167
with	O	O	O
a	O	O	O
maximum	O	O	B-T081
Rh	O	O	O
,	O	O	O
turbidity	O	O	B-T080
and	O	O	O
the	O	O	O
ζ-potential	O	O	B-T067
being	O	O	O
close	O	O	O
to	O	O	O
zero	O	O	O
observed	O	O	B-T169
at	O	O	O
pH	O	O	O
5.4	O	O	O
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
the	O	O	O
SAXS	O	O	B-T059
data	O	O	B-T078
demonstrated	O	O	O
that	O	O	O
the	O	O	O
coacervates	O	O	B-T167
were	O	O	O
densely	O	O	B-T080
assembled	O	O	B-T052
with	O	O	O
a	O	O	O
roughly	O	O	B-T080
spherical	O	O	B-T082
size	O	O	B-T082
distribution	O	O	B-T082
exhibiting	O	O	O
a	O	O	O
maximum	O	O	B-T081
extension	O	O	B-T169
of	O	O	O
∼80	O	O	O
nm	O	O	O
at	O	O	O
pH	O	O	B-T081
5.4	O	O	O
.	O	O	O

Equally	O	O	O
,	O	O	O
AFM	O	O	B-T059
image	O	O	B-T059
analysis	O	O	I-T059
showed	O	O	O
size	O	O	B-T082
distributions	O	O	B-T082
containing	O	O	B-T169
most	O	O	O
frequent	O	O	B-T079
cluster	O	O	B-T081
sizes	O	O	B-T082
around	O	O	O
40	O	O	O
-	O	O	O
80	O	O	O
nm	O	O	O
with	O	O	O
spherical	O	O	B-T082
to	O	O	O
elliptical	O	O	B-T082
shapes	O	O	I-T082
(	O	O	O
axis	O	O	O
aspect	O	O	O
ratio	O	O	O
≤	O	O	O
2	O	O	O
)	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
less	O	O	O
frequent	O	O	O
elongated	O	O	O
to	O	O	O
chainlike	O	O	B-T080
structures	O	O	B-T082
.	O	O	O

The	O	O	O
most	O	O	O
frequently	O	O	B-T079
observed	O	O	B-T169
compact	O	O	O
complexes	O	O	B-T104
,	O	O	O
we	O	O	O
identify	O	O	O
as	O	O	O
mainly	O	O	O
leading	O	O	O
to	O	O	O
LF	O	O	B-T116
-	O	O	O
PPI	O	O	B-T116
coacervation	O	O	B-T067
,	O	O	O
whereas	O	O	O
for	O	O	O
the	O	O	O
less	O	O	O
frequent	O	O	B-T079
chain-like	O	O	B-T080
aggregates	O	O	I-T080
,	O	O	O
we	O	O	O
hypothesize	O	O	O
that	O	O	O
additionally	O	O	O
PPI	O	O	O
-	O	O	O
PPI	O	O	O
facilitated	O	O	O
complexes	O	O	O
exist	O	O	O
.	O	O	O

-DOCSTART- (28084862)

Visual	O	O	B-T169
outcome	O	O	B-T169
,	O	O	O
endocrine	O	O	B-T039
function	O	O	I-T039
and	O	O	O
tumor	O	O	B-T191
control	O	O	B-T169
after	O	O	O
fractionated	O	O	B-T061
stereotactic	O	O	I-T061
radiation	O	O	I-T061
therapy	O	O	I-T061
of	O	O	O
craniopharyngiomas	O	O	B-T191
in	O	O	I-T191
adults	O	O	I-T191
:	O	O	O
findings	O	O	O
in	O	O	O
a	O	O	O
prospective	O	O	O
cohort	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
examine	O	O	B-T058
visual	O	O	B-T169
outcome	O	O	B-T169
,	O	O	O
endocrine	O	O	B-T039
function	O	O	I-T039
and	O	O	O
tumor	O	O	B-T191
control	O	O	B-T169
in	O	O	O
a	O	O	O
prospective	O	O	B-T062
cohort	O	O	I-T062
of	O	O	O
craniopharyngioma	O	O	B-T191
patients	O	O	B-T101
,	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
fractionated	O	O	B-T061
stereotactic	O	O	I-T061
radiation	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
FSRT	O	O	B-T061
)	O	O	O
.	O	O	O

Sixteen	O	O	O
adult	O	O	B-T100
patients	O	O	B-T101
with	O	O	O
craniopharyngiomas	O	O	B-T191
were	O	O	O
eligible	O	O	B-T080
for	O	O	O
analysis	O	O	B-T062
.	O	O	O

They	O	O	O
were	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
linear	O	O	B-T074
accelerator-based	O	O	I-T074
FSRT	O	O	B-T061
during	O	O	O
1999	O	O	O
-	O	O	O
2015	O	O	O
.	O	O	O

In	O	O	O
all	O	O	O
cases	O	O	B-T077
,	O	O	O
diagnosis	O	O	B-T062
was	O	O	O
confirmed	O	O	O
by	O	O	O
histological	O	O	B-T169
analysis	O	O	B-T062
.	O	O	O

The	O	O	O
prescription	O	O	B-T058
dose	O	O	B-T081
to	O	O	O
the	O	O	O
tumor	O	O	B-T191
was	O	O	O
54	O	O	O
Gy	O	O	B-T081
(	O	O	O
median	O	O	B-T081
,	O	O	O
range	O	O	B-T081
48	O	O	O
-	O	O	O
54	O	O	O
)	O	O	O
in	O	O	O
1.8	O	O	O
or	O	O	O
2.0	O	O	O
Gy	O	O	O
per	O	O	O
fraction	O	O	B-T081
,	O	O	O
and	O	O	O
the	O	O	O
maximum	O	O	O
radiation	O	O	B-T081
dose	O	O	I-T081
to	O	O	O
the	O	O	O
optic	O	O	B-T023
nerves	O	O	I-T023
and	O	O	O
chiasm	O	O	B-T023
was	O	O	O
54.2	O	O	O
Gy	O	O	O
(	O	O	O
median	O	O	O
,	O	O	O
range	O	O	O
48.6	O	O	O
-	O	O	O
60.0	O	O	O
)	O	O	O
for	O	O	O
the	O	O	O
cohort	O	O	B-T098
.	O	O	O

Serial	O	O	O
ophthalmological	O	O	B-T061
and	O	O	O
endocrine	O	O	B-T058
evaluations	O	O	I-T058
and	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
MRI	O	O	B-T060
)	O	O	O
scans	O	O	B-T060
were	O	O	O
performed	O	O	O
at	O	O	O
regular	O	O	O
intervals	O	O	O
.	O	O	O

Median	O	O	B-T081
follow-up	O	O	B-T058
was	O	O	O
3.3	O	O	O
years	O	O	B-T079
(	O	O	O
range	O	O	B-T081
1.1	O	O	O
-	O	O	O
14.1	O	O	O
)	O	O	O
,	O	O	O
3.7	O	O	O
years	O	O	O
(	O	O	O
range	O	O	O
0.8	O	O	O
-	O	O	O
15.2	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
3.6	O	O	O
years	O	O	O
(	O	O	O
range	O	O	O
0.7	O	O	O
-	O	O	O
13.1	O	O	O
)	O	O	O
for	O	O	O
visual	O	O	B-T169
outcome	O	O	B-T169
,	O	O	O
endocrine	O	O	B-T039
function	O	O	I-T039
,	O	O	O
and	O	O	O
tumor	O	O	B-T191
control	O	O	B-T169
,	O	O	O
respectively	O	O	O
.	O	O	O

Visual	O	O	B-T201
acuity	O	O	I-T201
impairment	O	O	B-T169
was	O	O	O
present	O	O	O
in	O	O	O
10	O	O	O
patients	O	O	B-T101
(	O	O	O
62.5	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
visual	O	O	B-T033
field	O	O	I-T033
defects	O	O	I-T033
were	O	O	O
present	O	O	O
in	O	O	O
12	O	O	O
patients	O	O	O
(	O	O	O
75	O	O	O
%	O	O	O
)	O	O	O
before	O	O	O
FSRT	O	O	B-T061
.	O	O	O

One	O	O	O
patient	O	O	B-T101
developed	O	O	O
radiation-induced	O	O	B-T047
optic	O	O	I-T047
neuropathy	O	O	I-T047
at	O	O	O
seven	O	O	O
years	O	O	B-T079
after	O	O	O
FSRT	O	O	B-T061
.	O	O	O

Thirteen	O	O	O
of	O	O	O
16	O	O	O
patients	O	O	B-T101
(	O	O	O
81.3	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
pituitary	O	O	B-T047
deficiency	O	O	I-T047
before	O	O	O
FSRT	O	O	B-T061
,	O	O	O
and	O	O	O
did	O	O	O
not	O	O	O
develop	O	O	O
further	O	O	O
pituitary	O	O	O
deficiency	O	O	O
after	O	O	O
FSRT	O	O	O
.	O	O	O

Mean	O	O	B-T081
tumor	O	O	B-T081
volume	O	O	I-T081
pre-	O	O	O
FSRT	O	O	B-T061
was	O	O	O
2.72	O	O	O
cm(3	O	O	O
)	O	O	O
(	O	O	O
range	O	O	B-T081
0.20	O	O	O
-	O	O	O
9.90	O	O	O
)	O	O	O
and	O	O	O
post-	O	O	O
FSRT	O	O	O
1.2	O	O	O
cm(3	O	O	O
)	O	O	O
(	O	O	O
range	O	O	O
0.00	O	O	O
-	O	O	O
13.10	O	O	O
)	O	O	O
.	O	O	O

Tumor	O	O	B-T191
control	O	O	B-T169
rate	O	O	B-T081
was	O	O	O
81.3	O	O	O
%	O	O	O
at	O	O	O
two	O	O	O
,	O	O	O
five	O	O	O
,	O	O	O
and	O	O	O
10	O	O	O
years	O	O	B-T079
after	O	O	O
FSRT	O	O	B-T061
.	O	O	O

FSRT	O	O	B-T061
was	O	O	O
relatively	O	O	O
safe	O	O	O
in	O	O	O
this	O	O	O
prospective	O	O	O
cohort	O	O	B-T098
of	O	O	O
craniopharyngiomas	O	O	B-T191
,	O	O	O
with	O	O	O
only	O	O	O
one	O	O	O
case	O	O	B-T077
of	O	O	O
radiation-induced	O	O	B-T047
optic	O	O	I-T047
neuropathy	O	O	I-T047
and	O	O	O
no	O	O	O
case	O	O	O
of	O	O	O
new	O	O	O
endocrinopathy	O	O	B-T047
.	O	O	O

Tumor	O	O	B-T191
control	O	O	B-T169
rate	O	O	B-T081
was	O	O	O
acceptable	O	O	O
.	O	O	O

-DOCSTART- (28086772)

Scutellaria	O	O	B-T123
barbata	O	O	I-T123
D.	O	O	I-T123
Don	O	O	I-T123
extract	O	O	I-T123
inhibits	O	O	B-T052
the	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
through	O	O	O
down-regulating	O	O	B-T044
of	O	O	O
Treg	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
manipulating	O	O	B-T040
Th1	O	O	B-T043
/	O	O	O
Th17	O	O	B-T040
immune	O	O	I-T040
response	O	O	I-T040
in	O	O	O
hepatoma	O	O	B-T025
H22	O	O	I-T025
-bearing	O	O	O
mice	O	O	O

Previous	O	O	O
studies	O	O	O
showed	O	O	O
Scutellaria	O	O	B-T123
barbata	O	O	I-T123
D.	O	O	I-T123
Don	O	O	I-T123
extract	O	O	I-T123
(	O	O	O
SBE	O	O	B-T123
)	O	O	O
is	O	O	O
a	O	O	O
potent	O	O	O
inhibitor	O	O	B-T121
in	O	O	O
hepatoma	O	O	B-T191
and	O	O	O
could	O	O	O
improve	O	O	O
immune	O	O	B-T042
function	O	O	I-T042
of	O	O	O
hepatoma	O	O	B-T025
H22	O	O	I-T025
-bearing	O	O	O
mice	O	O	B-T015
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
immunomodulatory	O	O	B-T044
function	O	O	I-T044
of	O	O	O
SBE	O	O	B-T123
on	O	O	O
the	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
of	O	O	O
hepatoma	O	O	B-T191
remains	O	O	O
unclear	O	O	B-T033
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
anti-tumor	O	O	B-T080
effects	O	O	B-T080
of	O	O	O
SBE	O	O	B-T123
on	O	O	O
hepatoma	O	O	B-T025
H22	O	O	I-T025
-bearing	O	O	O
mice	O	O	B-T015
and	O	O	O
explore	O	O	O
the	O	O	O
underlying	O	O	O
immunomodulatory	O	O	B-T044
function	O	O	I-T044
.	O	O	O

The	O	O	O
hepatoma	O	O	B-T025
H22	O	O	I-T025
-bearing	O	O	O
mice	O	O	B-T015
were	O	O	O
treated	O	O	B-T169
by	O	O	O
SBE	O	O	B-T123
for	O	O	O
30	O	O	O
days	O	O	B-T079
.	O	O	O

The	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
SBE	O	O	B-T123
on	O	O	O
the	O	O	O
proliferation	O	O	B-T043
of	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
in	O	O	B-T080
vitro	O	O	I-T080
,	O	O	O
the	O	O	O
growth	O	O	B-T191
of	O	O	I-T191
transplanted	O	O	I-T191
tumor	O	O	I-T191
,	O	O	O
the	O	O	O
cytotoxicity	O	O	B-T043
of	O	O	I-T043
natural	O	O	I-T043
killer	O	O	I-T043
(	O	O	I-T043
NK	O	O	I-T043
)	O	O	I-T043
cells	O	O	I-T043
in	O	O	O
spleen	O	O	B-T023
,	O	O	O
the	O	O	O
amount	O	O	B-T081
of	O	O	O
CD4(+)CD25(+)Foxp3(+	O	O	B-T121
)	O	O	I-T121
Treg	O	O	I-T121
cells	O	O	I-T121
and	O	O	O
Th17	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
tumor	O	O	B-T024
tissue	O	O	I-T024
,	O	O	O
and	O	O	O
the	O	O	O
levels	O	O	B-T080
of	O	O	O
IL-10	O	O	B-T116
,	O	O	O
TGF-β	O	O	B-T116
,	O	O	O
IL-17A	O	O	B-T116
,	O	O	O
IL-2	O	O	B-T116
,	O	O	O
and	O	O	O
IFN-γ	O	O	B-T116
in	O	O	O
serum	O	O	B-T031
of	O	O	O
the	O	O	O
hepatoma	O	O	B-T025
H22	O	O	I-T025
-bearing	O	O	O
mice	O	O	B-T015
was	O	O	O
observered	O	O	O
.	O	O	O

IL-17A	O	O	B-T116
was	O	O	O
injected	O	O	B-T169
to	O	O	O
the	O	O	O
SBE	O	O	B-T123
treated	O	O	B-T169
mice	O	O	B-T015
from	O	O	O
day	O	O	B-T079
9	O	O	O
post	O	O	B-T079
H22	O	O	B-T025
inoculation	O	O	B-T061
to	O	O	O
examine	O	O	O
its	O	O	O
effect	O	O	B-T080
on	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
.	O	O	O

SBE	O	O	B-T123
treatment	O	O	B-T169
inhibited	O	O	B-T080
the	O	O	O
proliferation	O	O	B-T043
of	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
in	O	O	B-T080
vitro	O	O	I-T080
with	O	O	O
a	O	O	O
dose-dependent	O	O	B-T169
manner	O	O	I-T169
and	O	O	O
significantly	O	O	O
suppressed	O	O	B-T169
the	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
of	O	O	O
hepatoma	O	O	B-T025
H22	O	O	I-T025
-bearing	O	O	O
mice	O	O	B-T015
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
it	O	O	O
increased	O	O	B-T081
NK	O	O	B-T043
cells	O	O	I-T043
'	O	O	I-T043
cytotoxicity	O	O	I-T043
in	O	O	O
spleen	O	O	B-T023
,	O	O	O
down-regulated	O	O	B-T044
the	O	O	O
amount	O	O	B-T081
of	O	O	O
CD4(+)CD25(+)Foxp3(+	O	O	B-T121
)	O	O	I-T121
Treg	O	O	I-T121
cells	O	O	I-T121
and	O	O	O
Th17	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
tumor	O	O	B-T024
tissue	O	O	I-T024
,	O	O	O
and	O	O	O
decreased	O	O	B-T081
IL-10	O	O	B-T116
,	O	O	O
TGF-β	O	O	B-T116
,	O	O	O
and	O	O	O
IL-17A	O	O	B-T116
levels	O	O	B-T080
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
whereas	O	O	O
increased	O	O	O
IL-2	O	O	B-T116
and	O	O	O
IFN-γ	O	O	B-T116
levels	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
serum	O	O	B-T031
of	O	O	O
hepatoma	O	O	B-T025
H22	O	O	I-T025
-bearing	O	O	O
mice	O	O	B-T015
.	O	O	O

Moreover	O	O	O
,	O	O	O
administration	O	O	B-T081
of	O	O	O
recombinant	O	O	B-T015
mouse	O	O	I-T015
IL-17A	O	O	B-T116
reversed	O	O	B-T169
the	O	O	O
anti-tumor	O	O	B-T080
effects	O	O	B-T080
of	O	O	O
SBE	O	O	B-T123
.	O	O	O

SBE	O	O	B-T123
could	O	O	O
inhibit	O	O	B-T052
the	O	O	O
proliferation	O	O	B-T043
of	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
SBE	O	O	B-T123
also	O	O	O
could	O	O	O
inhibit	O	O	B-T052
the	O	O	O
growth	O	O	B-T043
of	O	O	O
H22	O	O	B-T025
implanted	O	O	B-T191
tumor	O	O	I-T191
in	O	O	O
hepatoma	O	O	B-T025
H22	O	O	I-T025
-bearing	O	O	O
mice	O	O	B-T015
,	O	O	O
and	O	O	O
this	O	O	O
function	O	O	B-T169
might	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
immunomodulatory	O	O	B-T044
activity	O	O	I-T044
through	O	O	O
down-regulating	O	O	B-T044
of	O	O	O
Treg	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
manipulating	O	O	B-T040
Th1	O	O	B-T043
/	O	O	O
Th17	O	O	B-T040
immune	O	O	I-T040
response	O	O	I-T040
.	O	O	O

-DOCSTART- (28086838)

Clinical	O	O	B-T201
characteristics	O	O	I-T201
of	O	O	O
genital	O	O	B-T047
chlamydia	O	O	I-T047
infection	O	O	I-T047
in	O	O	O
pelvic	O	O	O
inflammatory	O	O	O
disease	O	O	O

Chlamydia	O	O	B-T047
infection	O	O	I-T047
in	O	O	O
acute	O	O	B-T047
pelvic	O	O	I-T047
inflammatory	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PID	O	O	B-T047
)	O	O	O
is	O	O	O
associated	O	O	O
with	O	O	O
serious	O	O	O
complications	O	O	B-T046
including	O	O	O
ectopic	O	O	B-T046
pregnancy	O	O	I-T046
,	O	O	O
tubal	O	O	B-T047
infertility	O	O	I-T047
,	O	O	O
Fitz-Hugh-Curtis	O	O	B-T047
syndrome	O	O	I-T047
and	O	O	O
tubo-ovarian	O	O	B-T047
abscess	O	O	I-T047
(	O	O	O
TOA	O	O	B-T047
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
compared	O	O	O
clinical	O	O	B-T170
and	O	O	O
laboratory	O	O	B-T170
data	O	O	I-T170
between	O	O	O
PID	O	O	B-T047
with	O	O	O
and	O	O	O
without	O	O	O
chlamydia	O	O	B-T047
infection	O	O	I-T047
.	O	O	O

The	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
of	O	O	O
497	O	O	O
women	O	O	B-T098
who	O	O	O
were	O	O	O
admitted	O	O	O
with	O	O	O
PID	O	O	B-T047
between	O	O	O
2002	O	O	O
and	O	O	O
2011	O	O	O
were	O	O	O
reviewed	O	O	O
.	O	O	O

The	O	O	O
patients	O	O	B-T101
were	O	O	O
divided	O	O	O
into	O	O	O
two	O	O	O
groups	O	O	B-T098
(	O	O	O
PID	O	O	B-T047
with	O	O	O
and	O	O	O
without	O	O	O
chlamydia	O	O	B-T047
infection	O	O	I-T047
)	O	O	O
,	O	O	O
which	O	O	O
were	O	O	O
compared	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T201
'	O	O	I-T201
characteristics	O	O	I-T201
,	O	O	O
clinical	O	O	B-T170
presentation	O	O	I-T170
,	O	O	O
and	O	O	O
laboratory	O	O	B-T034
findings	O	O	I-T034
,	O	O	O
including	O	O	O
inflammatory	O	O	B-T169
markers	O	O	B-T201
.	O	O	O

The	O	O	O
chlamydia	O	O	B-T098
and	O	O	O
non-chlamydia	O	O	B-T098
groups	O	O	I-T098
comprised	O	O	O
175	O	O	O
and	O	O	O
322	O	O	O
women	O	O	B-T098
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
chlamydia	O	O	B-T098
group	O	O	I-T098
were	O	O	O
younger	O	O	B-T079
and	O	O	O
had	O	O	O
a	O	O	O
higher	O	O	O
rate	O	O	O
of	O	O	O
TOA	O	O	B-T047
,	O	O	O
a	O	O	O
longer	O	O	O
mean	O	O	B-T081
hospital	O	O	B-T079
stay	O	O	I-T079
,	O	O	O
and	O	O	O
had	O	O	O
undergone	O	O	O
more	O	O	O
surgeries	O	O	B-T061
than	O	O	O
the	O	O	O
patients	O	O	O
in	O	O	O
the	O	O	O
non-	O	O	B-T098
chlamydia	O	O	I-T098
group	O	O	I-T098
.	O	O	O

The	O	O	O
erythrocyte	O	O	B-T034
sedimentation	O	O	I-T034
rate	O	O	I-T034
(	O	O	O
ESR	O	O	B-T034
)	O	O	O
,	O	O	O
C-reactive	O	O	B-T116
protein	O	O	I-T116
(	O	O	O
CRP	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
CA-125	O	O	B-T129
level	O	O	B-T080
were	O	O	O
higher	O	O	O
in	O	O	O
the	O	O	O
chlamydia	O	O	B-T098
group	O	O	I-T098
than	O	O	O
in	O	O	O
the	O	O	O
non-chlamydia	O	O	B-T098
group	O	O	I-T098
,	O	O	O
but	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	B-T078
difference	O	O	O
in	O	O	O
the	O	O	O
white	O	O	B-T033
blood	O	O	I-T033
cell	O	O	I-T033
count	O	O	I-T033
between	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T098
.	O	O	O

The	O	O	O
CA-125	O	O	B-T129
level	O	O	B-T080
was	O	O	O
the	O	O	O
strongest	O	O	O
predictor	O	O	B-T078
of	O	O	O
chlamydia	O	O	B-T047
infection	O	O	I-T047
,	O	O	O
followed	O	O	O
by	O	O	O
the	O	O	O
ESR	O	O	B-T034
and	O	O	O
CRP	O	O	B-T116
level	O	O	O
.	O	O	O

The	O	O	O
area	O	O	B-T082
under	O	O	O
the	O	O	O
receiving	O	O	B-T081
operating	O	O	I-T081
curve	O	O	I-T081
for	O	O	O
CA-125	O	O	B-T129
,	O	O	O
ESR	O	O	B-T034
,	O	O	O
and	O	O	O
CRP	O	O	B-T116
was	O	O	O
0.804	O	O	O
,	O	O	O
0.755	O	O	O
,	O	O	O
and	O	O	O
0.663	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Chlamydia	O	O	B-T047
infection	O	O	I-T047
in	O	O	O
acute	O	O	B-T047
PID	O	O	I-T047
is	O	O	O
associated	O	O	O
with	O	O	O
increased	O	O	O
level	O	O	B-T080
of	O	O	O
inflammatory	O	O	B-T169
markers	O	O	B-T201
,	O	O	O
such	O	O	O
as	O	O	O
CA-125	O	O	B-T129
,	O	O	O
ESR	O	O	B-T034
and	O	O	O
CRP	O	O	B-T116
,	O	O	O
incidence	O	O	O
of	O	O	O
TOA	O	O	B-T047
,	O	O	O
operation	O	O	B-T061
risk	O	O	B-T078
,	O	O	O
and	O	O	O
longer	O	O	O
hospitalization	O	O	B-T058
.	O	O	O

-DOCSTART- (28087131)

Incidence	O	O	B-T081
and	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
variant	O	O	B-T080
histology	O	O	B-T091
on	O	O	O
oncological	O	O	B-T080
outcomes	O	O	I-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
bladder	O	O	B-T191
cancer	O	O	I-T191
treated	O	O	B-T169
with	O	O	O
radical	O	O	O
cystectomy	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
describe	O	O	O
incidence	O	O	B-T081
of	O	O	O
histological	O	O	B-T169
variants	O	O	B-T080
after	O	O	O
radical	O	O	B-T061
cystectomy	O	O	I-T061
(	O	O	O
RC	O	O	B-T061
)	O	O	O
due	O	O	O
to	O	O	O
bladder	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
BCa	O	O	B-T191
)	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	O
survival	O	O	B-T169
outcomes	O	O	B-T080
accounting	O	O	O
for	O	O	O
this	O	O	O
parameter	O	O	O
.	O	O	O

We	O	O	O
retrospectively	O	O	B-T080
evaluated	O	O	B-T058
data	O	O	B-T078
from	O	O	O
1,067	O	O	O
patients	O	O	B-T101
with	O	O	O
BCa	O	O	B-T191
treated	O	O	B-T169
with	O	O	O
RC	O	O	B-T061
between	O	O	O
1990	O	O	O
and	O	O	O
2013	O	O	O
at	O	O	O
a	O	O	O
single	O	O	B-T093
tertiary	O	O	I-T093
care	O	O	I-T093
referral	O	O	I-T093
center	O	O	I-T093
.	O	O	O

All	O	O	O
specimen	O	O	B-T167
were	O	O	O
evaluated	O	O	B-T058
by	O	O	O
dedicated	O	O	O
uropathologists	O	O	B-T097
.	O	O	O

Univariable	O	O	B-T170
and	O	O	I-T170
multivariable	O	O	I-T170
Cox	O	O	I-T170
regression	O	O	I-T170
analyses	O	O	I-T170
tested	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
different	O	O	O
histopathological	O	O	B-T169
variant	O	O	B-T080
on	O	O	O
recurrence	O	O	B-T067
,	O	O	O
cancer-specific	O	O	B-T081
mortality	O	O	I-T081
(	O	O	O
CSM	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
overall	O	O	B-T081
mortality	O	O	I-T081
(	O	O	O
OM	O	O	B-T081
)	O	O	O
after	O	O	O
accounting	O	O	O
for	O	O	O
all	O	O	O
available	O	O	O
confounders	O	O	B-T169
.	O	O	O

Of	O	O	O
1,067	O	O	O
patients	O	O	B-T101
,	O	O	O
729	O	O	O
(	O	O	O
68.3	O	O	O
%	O	O	O
)	O	O	O
harbored	O	O	O
pure	O	O	B-T191
urothelial	O	O	I-T191
BCa	O	O	I-T191
while	O	O	O
338	O	O	O
(	O	O	O
31.7	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
a	O	O	O
variant	O	O	B-T080
.	O	O	O

Considering	O	O	O
uncommon	O	O	O
variants	O	O	B-T080
,	O	O	O
21	O	O	O
(	O	O	O
2.0	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
sarcomatoid	O	O	B-T191
,	O	O	O
10	O	O	O
(	O	O	O
0.9	O	O	O
%	O	O	O
)	O	O	O
lymphoepitelial	O	O	B-T191
,	O	O	O
19	O	O	O
(	O	O	O
1.8	O	O	O
%	O	O	O
)	O	O	O
small	O	O	B-T191
cell	O	O	I-T191
,	O	O	O
109	O	O	O
(	O	O	O
10.2	O	O	O
%	O	O	O
)	O	O	O
squamous	O	O	B-T191
,	O	O	O
89	O	O	O
(	O	O	O
8.3	O	O	O
%	O	O	O
)	O	O	O
micropapillary	O	O	B-T191
,	O	O	O
23	O	O	O
(	O	O	O
2.2	O	O	O
%	O	O	O
)	O	O	O
glandular	O	O	B-T191
,	O	O	O
34	O	O	O
(	O	O	O
3.2	O	O	O
%	O	O	O
)	O	O	O
mixed	O	O	O
variants	O	O	O
,	O	O	O
and	O	O	O
33	O	O	O
(	O	O	O
3.1	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
found	O	O	O
with	O	O	O
other	O	O	O
types	O	O	O
of	O	O	O
variants	O	O	O
.	O	O	O

With	O	O	O
a	O	O	O
median	O	O	B-T081
follow-up	O	O	B-T058
of	O	O	O
6.2	O	O	O
years	O	O	B-T079
,	O	O	O
343	O	O	O
recurrence	O	O	B-T067
,	O	O	O
365	O	O	O
CSM	O	O	B-T081
,	O	O	O
and	O	O	O
451	O	O	O
OM	O	O	B-T081
were	O	O	O
recorded	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

At	O	O	O
multivariable	O	O	B-T170
Cox	O	O	I-T170
regression	O	O	I-T170
analyses	O	O	I-T170
,	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
small	O	O	B-T191
cell	O	O	I-T191
variant	O	O	I-T191
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
higher	O	O	O
recurrence	O	O	B-T067
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
HR	O	O	B-T081
]	O	O	O
=	O	O	O
3.47	O	O	O
,	O	O	O
P<0.001	O	O	O
)	O	O	O
,	O	O	O
CSM	O	O	B-T081
(	O	O	O
HR	O	O	O
=	O	O	O
3.30	O	O	O
,	O	O	O
P<0.04	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
OM	O	O	B-T081
(	O	O	O
HR	O	O	O
=	O	O	O
2.97	O	O	O
,	O	O	O
P<0.003	O	O	O
)	O	O	O
as	O	O	O
compared	O	O	O
with	O	O	O
pure	O	O	O
urothelial	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Conversely	O	O	O
,	O	O	O
no	O	O	B-T033
survival	O	O	I-T033
differences	O	O	I-T033
were	O	O	O
recorded	O	O	O
considering	O	O	O
other	O	O	O
histological	O	O	B-T169
variants	O	O	B-T080
(	O	O	O
all	O	O	O
P	O	O	O
>	O	O	O
0.1	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
study	O	O	B-T077
confirms	O	O	O
that	O	O	O
histological	O	O	B-T169
variant	O	O	B-T080
is	O	O	O
not	O	O	O
an	O	O	O
infrequent	O	O	O
event	O	O	O
at	O	O	O
RC	O	O	B-T061
specimen	O	O	B-T167
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
our	O	O	O
single-center	O	O	B-T093
series	O	O	I-T093
,	O	O	O
only	O	O	O
patients	O	O	B-T101
found	O	O	O
with	O	O	O
small	O	O	B-T191
cell	O	O	I-T191
variant	O	O	I-T191
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
negative	O	O	B-T033
effect	O	O	B-T080
on	O	O	O
survival	O	O	B-T169
after	O	O	O
RC	O	O	B-T061
.	O	O	O

-DOCSTART- (28087217)

Psychometric	O	O	B-T060
properties	O	O	B-T080
of	O	O	O
the	O	O	O
Japanese	O	O	B-T171
version	O	O	B-T170
of	O	O	O
short	O	O	B-T170
forms	O	O	I-T170
of	O	O	O
the	O	O	O
Pain	O	O	B-T170
Catastrophizing	O	O	I-T170
Scale	O	O	I-T170
in	O	O	O
participants	O	O	B-T098
with	O	O	O
musculoskeletal	O	O	B-T033
pain	O	O	I-T033
:	O	O	O
A	O	O	O
cross-sectional	O	O	O
study	O	O	O

The	O	O	O
Pain	O	O	B-T170
Catastrophizing	O	O	I-T170
Scale	O	O	I-T170
(	O	O	O
PCS	O	O	B-T170
)	O	O	O
is	O	O	O
a	O	O	O
commonly	O	O	O
used	O	O	O
as	O	O	O
measure	O	O	B-T081
of	O	O	O
pain	O	O	B-T041
catastrophizing	O	O	I-T041
.	O	O	O

The	O	O	O
scale	O	O	B-T170
comprises	O	O	O
13	O	O	O
items	O	O	B-T062
related	O	O	O
to	O	O	O
magnification	O	O	B-T060
,	O	O	O
rumination	O	O	B-T038
,	O	O	O
and	O	O	O
helplessness	O	O	B-T048
.	O	O	O

To	O	O	O
facilitate	O	O	O
quick	O	O	O
screening	O	O	B-T058
and	O	O	O
to	O	O	O
reduce	O	O	B-T080
participant	O	O	B-T098
's	O	O	I-T098
burden	O	O	B-T078
,	O	O	O
the	O	O	O
four-	O	O	O
item	O	O	B-T062
and	O	O	O
six-	O	O	O
item	O	O	O
short	O	O	B-T170
forms	O	O	I-T170
of	O	O	O
the	O	O	O
English	O	O	B-T171
version	O	O	B-T170
of	O	O	O
the	O	O	O
PCS	O	O	B-T170
were	O	O	O
developed	O	O	O
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
psychometric	O	O	B-T060
properties	O	O	B-T080
of	O	O	O
a	O	O	O
Japanese	O	O	B-T171
version	O	O	B-T170
of	O	O	O
the	O	O	O
short	O	O	B-T170
forms	O	O	I-T170
of	O	O	O
PCS	O	O	B-T170
using	O	O	O
a	O	O	O
contemporary	O	O	O
approach	O	O	B-T169
called	O	O	O
Rasch	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
216	O	O	O
patients	O	O	B-T101
with	O	O	O
musculoskeletal	O	O	B-T047
disorders	O	O	I-T047
were	O	O	O
recruited	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

Participants	O	O	B-T098
completed	O	O	O
study	O	O	B-T062
measures	O	O	B-T081
,	O	O	O
which	O	O	O
included	O	O	O
the	O	O	O
pain	O	O	B-T201
intensity	O	O	I-T201
,	O	O	O
the	O	O	O
Pain	O	O	B-T170
Catastrophizing	O	O	I-T170
Scale	O	O	I-T170
(	O	O	O
PCS	O	O	B-T170
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
Tampa	O	O	B-T170
Scale	O	O	I-T170
of	O	O	I-T170
Kinesiophobia	O	O	I-T170
(	O	O	O
TSK	O	O	B-T170
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
four-	O	O	O
item	O	O	B-T062
(	O	O	O
items	O	O	B-T062
3	O	O	O
,	O	O	O
6	O	O	O
,	O	O	O
8	O	O	O
,	O	O	O
and	O	O	O
11	O	O	O
)	O	O	O
and	O	O	O
six-	O	O	O
item	O	O	O
(	O	O	O
items	O	O	O
4	O	O	O
,	O	O	O
5	O	O	O
,	O	O	O
6	O	O	O
,	O	O	O
10	O	O	O
,	O	O	O
11	O	O	O
,	O	O	O
and	O	O	O
13	O	O	O
)	O	O	O
short	O	O	B-T170
forms	O	O	I-T170
of	O	O	O
the	O	O	O
Japanese	O	O	B-T171
version	O	O	B-T170
of	O	O	O
PCS	O	O	B-T170
were	O	O	O
measured	O	O	O
.	O	O	O

We	O	O	O
used	O	O	O
Rasch	O	O	B-T062
analysis	O	O	I-T062
to	O	O	O
analyze	O	O	B-T169
the	O	O	O
psychometric	O	O	B-T060
properties	O	O	B-T080
of	O	O	O
the	O	O	O
original	O	O	O
,	O	O	O
four-	O	O	O
item	O	O	B-T062
,	O	O	O
and	O	O	O
six-	O	O	O
item	O	O	O
short	O	O	B-T170
forms	O	O	I-T170
of	O	O	O
PCS	O	O	B-T170
.	O	O	O

Rasch	O	O	B-T062
analysis	O	O	I-T062
showed	O	O	O
that	O	O	O
both	O	O	O
short	O	O	B-T170
forms	O	O	I-T170
of	O	O	O
PCS	O	O	B-T170
had	O	O	O
acceptable	O	O	O
internal	O	O	O
consistency	O	O	B-T080
,	O	O	O
unidimensionality	O	O	B-T082
,	O	O	O
and	O	O	O
no	O	O	O
notable	O	O	O
DIF	O	O	O
and	O	O	O
were	O	O	O
functional	O	O	B-T169
on	O	O	O
the	O	O	O
category	O	O	B-T170
rating	O	O	I-T170
scale	O	O	I-T170
.	O	O	O

However	O	O	O
,	O	O	O
four-	O	O	O
item	O	O	B-T062
short	O	O	B-T170
form	O	O	I-T170
of	O	O	O
PCS	O	O	B-T170
had	O	O	O
two	O	O	O
misfit	O	O	O
items	O	O	B-T062
.	O	O	O

Six-	O	O	O
item	O	O	B-T062
short	O	O	B-T170
form	O	O	I-T170
of	O	O	O
PCS	O	O	B-T170
has	O	O	O
acceptable	O	O	O
psychometric	O	O	B-T060
properties	O	O	B-T080
and	O	O	O
is	O	O	O
suitable	O	O	O
for	O	O	O
use	O	O	O
in	O	O	O
participants	O	O	B-T098
with	O	O	O
musculoskeletal	O	O	B-T033
pain	O	O	I-T033
.	O	O	O

Thus	O	O	O
,	O	O	O
six-	O	O	O
item	O	O	B-T062
can	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
brief	O	O	O
instruments	O	O	B-T074
to	O	O	O
evaluate	O	O	B-T058
pain	O	O	B-T041
catastrophizing	O	O	I-T041
.	O	O	O

-DOCSTART- (28088177)

A	O	O	O
novel	O	O	O
quantitative	O	O	B-T063
PCR	O	O	I-T063
detects	O	O	O
Babesia	O	O	B-T204
infection	O	O	B-T046
in	O	O	O
patients	O	O	B-T101
not	O	O	O
identified	O	O	O
by	O	O	O
currently	O	O	O
available	O	O	O
non-nucleic	O	O	O
acid	O	O	O
amplification	O	O	O
tests	O	O	O

Ticks	O	O	B-T204
transmit	O	O	B-T169
Babesia	O	O	B-T204
microti	O	O	I-T204
,	O	O	O
the	O	O	O
causative	O	O	B-T033
agents	O	O	I-T033
of	O	O	O
babesiosis	O	O	B-T047
in	O	O	O
North	O	O	B-T083
America	O	O	I-T083
and	O	O	O
Europe	O	O	B-T083
.	O	O	O

Babesiosis	O	O	B-T047
is	O	O	O
now	O	O	O
endemic	O	O	B-T047
in	O	O	O
Northeastern	O	O	B-T083
USA	O	O	B-T083
and	O	O	O
affects	O	O	O
people	O	O	B-T098
of	O	O	O
all	O	O	O
ages	O	O	B-T032
.	O	O	O

Babesia	O	O	B-T204
species	O	O	I-T204
infect	O	O	O
erythrocytes	O	O	B-T025
and	O	O	O
can	O	O	O
be	O	O	O
transmitted	O	O	B-T046
through	O	O	O
blood	O	O	B-T061
transfusion	O	O	I-T061
.	O	O	O

Whole	O	O	B-T031
blood	O	O	I-T031
and	O	O	O
blood	O	O	B-T121
products	O	O	I-T121
,	O	O	O
which	O	O	O
are	O	O	O
not	O	O	O
tested	O	O	O
for	O	O	O
Babesia	O	O	B-T204
,	O	O	O
can	O	O	O
cause	O	O	O
transfusion	O	O	B-T061
-	O	O	O
transmitted	O	O	B-T046
babesiosis	O	O	B-T047
(	O	O	O
TTB	O	O	B-T047
)	O	O	O
resulting	O	O	O
in	O	O	O
severe	O	O	B-T080
consequences	O	O	B-T169
in	O	O	O
the	O	O	O
immuno-compromised	O	O	B-T033
patients	O	O	B-T101
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
epidemiological	O	O	B-T062
evaluation	O	O	I-T062
of	O	O	O
babesiosis	O	O	B-T047
in	O	O	O
a	O	O	O
tick-infested	O	O	B-T047
state	O	O	I-T047
.	O	O	O

We	O	O	O
examined	O	O	B-T033
blood	O	O	B-T031
samples	O	O	I-T031
from	O	O	O
192	O	O	O
patients	O	O	B-T101
who	O	O	O
visited	O	O	O
clinics	O	O	B-T093
during	O	O	O
the	O	O	O
active	O	O	O
tick-borne	O	O	B-T047
diseases	O	O	I-T047
season	O	O	B-T079
,	O	O	O
using	O	O	O
a	O	O	O
newly	O	O	O
developed	O	O	O
qPCR	O	O	B-T063
assay	O	O	I-T063
that	O	O	O
uses	O	O	O
the	O	O	O
specific	O	O	O
molecular	O	O	B-T114
beacon	O	O	I-T114
probe	O	O	I-T114
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
clear	O	O	O
symptomology	O	O	B-T184
,	O	O	O
clinical	O	O	B-T073
laboratories	O	O	I-T073
did	O	O	O
not	O	O	O
test	O	O	O
131	O	O	O
samples	O	O	B-T031
by	O	O	O
IFA	O	O	B-T059
,	O	O	O
FISH	O	O	B-T063
or	O	O	O
microscopic	O	O	B-T059
examination	O	O	I-T059
of	O	O	O
Giemsa-stained	O	O	B-T109
blood	O	O	B-T059
smears	O	O	I-T059
.	O	O	O

Babesia	O	O	B-T204
infection	O	O	B-T046
was	O	O	O
detected	O	O	O
in	O	O	O
all	O	O	O
age	O	O	B-T032
groups	O	O	I-T100
by	O	O	O
FISH	O	O	B-T063
and	O	O	O
microscopy	O	O	B-T059
;	O	O	O
notably	O	O	O
patients	O	O	B-T101
>	O	O	O
40	O	O	O
years	O	O	B-T079
of	O	O	O
age	O	O	O
represented	O	O	O
64	O	O	O
%	O	O	O
of	O	O	O
tested	O	O	O
samples	O	O	B-T031
and	O	O	O
13	O	O	O
%	O	O	O
were	O	O	O
younger	O	O	B-T079
patients	O	O	O
.	O	O	O

We	O	O	O
tested	O	O	O
all	O	O	O
samples	O	O	B-T031
using	O	O	O
qPCR	O	O	B-T063
and	O	O	O
found	O	O	O
that	O	O	O
38	O	O	O
%	O	O	O
were	O	O	O
positive	O	O	B-T033
for	O	O	O
Babesia	O	O	B-T204
.	O	O	O

Of	O	O	O
28	O	O	O
samples	O	O	B-T031
that	O	O	O
were	O	O	O
positive	O	O	B-T033
by	O	O	O
FISH	O	O	B-T063
,	O	O	O
27	O	O	O
(	O	O	O
96	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
also	O	O	O
positive	O	O	O
by	O	O	O
qPCR	O	O	B-T063
indicating	O	O	O
high	O	O	O
congruency	O	O	O
between	O	O	O
nucleic	O	O	B-T059
acid	O	O	I-T059
based	O	O	I-T059
tests	O	O	I-T059
.	O	O	O

Interestingly	O	O	O
,	O	O	O
of	O	O	O
78	O	O	O
asymptomatic	O	O	B-T033
samples	O	O	B-T031
not	O	O	O
tested	O	O	O
by	O	O	O
FISH	O	O	B-T063
,	O	O	O
22	O	O	O
were	O	O	O
positive	O	O	B-T033
by	O	O	O
our	O	O	O
qPCR	O	O	B-T063
.	O	O	O

Direct	O	O	O
detection	O	O	B-T061
of	O	O	O
Babesia	O	O	B-T204
relies	O	O	O
upon	O	O	O
microscopic	O	O	B-T059
examination	O	O	I-T059
of	O	O	O
patient	O	O	B-T101
blood	O	O	B-T059
smears	O	O	I-T059
,	O	O	O
which	O	O	O
is	O	O	O
labor	O	O	O
intensive	O	O	O
,	O	O	O
difficult	O	O	O
to	O	O	O
scale	O	O	O
up	O	O	O
,	O	O	O
requires	O	O	O
specific	O	O	O
expertise	O	O	O
and	O	O	O
is	O	O	O
hence	O	O	O
,	O	O	O
often	O	O	O
not	O	O	O
performed	O	O	O
.	O	O	O

In	O	O	O
fact	O	O	O
,	O	O	O
a	O	O	O
clinical	O	O	B-T073
laboratory	O	O	I-T073
examined	O	O	B-T033
only	O	O	O
23	O	O	O
of	O	O	O
86	O	O	O
blood	O	O	B-T031
samples	O	O	I-T031
obtained	O	O	O
from	O	O	O
two	O	O	O
different	O	O	O
counties	O	O	B-T083
by	O	O	O
microscopy	O	O	B-T059
.	O	O	O

By	O	O	O
considering	O	O	O
individuals	O	O	B-T098
positive	O	O	B-T033
for	O	O	O
Babesia	O	O	B-T204
infection	O	O	B-T046
when	O	O	O
results	O	O	O
from	O	O	O
currently	O	O	O
available	O	O	O
microscopy	O	O	B-T059
,	O	O	O
FISH	O	O	B-T063
or	O	O	O
serological	O	O	B-T059
tests	O	O	I-T059
were	O	O	O
positive	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
our	O	O	O
qPCR	O	O	B-T063
is	O	O	O
highly	O	O	O
sensitive	O	O	B-T169
(	O	O	O
96.2	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
showed	O	O	O
a	O	O	O
specificity	O	O	B-T081
of	O	O	O
70.5	O	O	O
%	O	O	O
for	O	O	O
Babesia	O	O	O
.	O	O	O

Robust	O	O	O
qPCR	O	O	B-T063
using	O	O	O
specific	O	O	O
probes	O	O	B-T130
can	O	O	O
be	O	O	O
highly	O	O	O
useful	O	O	O
for	O	O	O
efficient	O	O	O
and	O	O	O
appropriate	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
babesiosis	O	O	B-T047
in	O	O	O
patients	O	O	B-T101
in	O	O	O
conjunction	O	O	O
with	O	O	O
conventional	O	O	O
diagnostics	O	O	B-T062
,	O	O	O
or	O	O	O
as	O	O	O
a	O	O	O
stand-alone	O	O	O
test	O	O	O
,	O	O	O
especially	O	O	O
for	O	O	O
donated	O	O	O
blood	O	O	B-T059
screening	O	O	I-T059
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
a	O	O	O
nucleic	O	O	B-T059
acid	O	O	I-T059
amplification	O	O	I-T059
test	O	O	I-T059
based	O	O	O
screening	O	O	B-T059
of	O	O	I-T059
blood	O	O	I-T059
and	O	O	O
blood	O	O	B-T121
products	O	O	I-T121
could	O	O	O
prevent	O	O	O
TTB	O	O	B-T047
.	O	O	O

-DOCSTART- (28088402)

Historical	O	O	B-T079
relationships	O	O	I-T079
of	O	O	O
three	O	O	O
enigmatic	O	O	B-T080
phasianid	O	O	B-T012
genera	O	O	I-T012
(	O	O	O
Aves	O	O	B-T012
:	O	O	O
Galliformes	O	O	B-T012
)	O	O	O
inferred	O	O	O
using	O	O	O
phylogenomic	O	O	O
and	O	O	O
mitogenomic	O	O	O
data	O	O	O

The	O	O	O
phylogeny	O	O	B-T078
of	O	O	O
the	O	O	O
Phasianidae	O	O	B-T012
(	O	O	O
pheasants	O	O	B-T012
,	O	O	O
partridges	O	O	B-T012
,	O	O	O
and	O	O	O
allies	O	O	B-T012
)	O	O	O
has	O	O	O
been	O	O	O
studied	O	O	O
extensively	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
these	O	O	O
studies	O	O	O
have	O	O	O
largely	O	O	O
ignored	O	O	O
three	O	O	O
enigmatic	O	O	B-T080
genera	O	O	I-T080
because	O	O	O
of	O	O	O
scarce	O	O	B-T080
DNA	O	O	B-T114
source	O	O	B-T033
material	O	O	I-T033
and	O	O	O
limited	O	O	O
overlapping	O	O	O
phylogenetic	O	O	B-T170
data	O	O	I-T170
:	O	O	O
blood	O	O	B-T012
pheasants	O	O	I-T012
(	O	O	O
Ithaginis	O	O	B-T012
)	O	O	O
,	O	O	O
snow	O	O	B-T012
partridges	O	O	I-T012
(	O	O	O
Lerwa	O	O	B-T012
)	O	O	O
,	O	O	O
and	O	O	O
long-billed	O	O	B-T012
partridges	O	O	I-T012
(	O	O	O
Rhizothera	O	O	B-T012
)	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
phylogenetic	O	O	B-T032
positions	O	O	I-T032
of	O	O	O
these	O	O	O
three	O	O	O
genera	O	O	O
remain	O	O	O
uncertain	O	O	O
in	O	O	O
what	O	O	O
is	O	O	O
otherwise	O	O	O
a	O	O	O
well-resolved	O	O	O
phylogeny	O	O	B-T078
.	O	O	O

Previous	O	O	O
studies	O	O	O
using	O	O	O
different	O	O	O
data	O	O	B-T078
types	O	O	O
place	O	O	O
Lerwa	O	O	B-T012
and	O	O	O
Ithaginis	O	O	B-T012
in	O	O	O
similar	O	O	O
positions	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
overlapping	O	O	B-T079
data	O	O	I-T079
means	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
them	O	O	O
could	O	O	O
not	O	O	O
be	O	O	O
inferred	O	O	O
.	O	O	O

Rhizothera	O	O	B-T012
was	O	O	O
originally	O	O	O
described	O	O	O
in	O	O	O
the	O	O	O
genus	O	O	O
Perdix	O	O	B-T012
(	O	O	O
true	O	O	B-T012
partridges	O	O	I-T012
)	O	O	O
,	O	O	O
although	O	O	O
a	O	O	O
partial	O	O	O
cytochrome	O	O	B-T116
b	O	O	I-T116
(	O	O	O
CYB	O	O	B-T116
)	O	O	O
sequence	O	O	O
suggests	O	O	O
it	O	O	O
is	O	O	O
sister	O	O	B-T077
to	O	O	O
Pucrasia	O	O	B-T012
(	O	O	O
koklass	O	O	B-T012
pheasant	O	O	I-T012
)	O	O	O
.	O	O	O

To	O	O	O
identify	O	O	O
robust	O	O	O
relationships	O	O	B-T080
among	O	O	O
Ithaginis	O	O	B-T012
,	O	O	O
Lerwa	O	O	B-T012
,	O	O	O
Rhizothera	O	O	B-T012
,	O	O	O
and	O	O	O
their	O	O	O
phasianid	O	O	B-T012
relatives	O	O	B-T080
,	O	O	O
we	O	O	O
used	O	O	O
3692	O	O	O
ultra-conserved	O	O	B-T028
element	O	O	I-T028
(	O	O	I-T028
UCE	O	O	I-T028
)	O	O	I-T028
loci	O	O	I-T028
and	O	O	O
complete	O	O	O
mitogenomes	O	O	B-T028
from	O	O	O
19	O	O	O
species	O	O	B-T185
including	O	O	O
previously	O	O	O
hypothesized	O	O	B-T078
relatives	O	O	O
of	O	O	O
the	O	O	O
three	O	O	O
focal	O	O	O
genera	O	O	O
and	O	O	O
representatives	O	O	O
from	O	O	O
all	O	O	O
major	O	O	O
phasianid	O	O	B-T012
clades	O	O	I-T012
.	O	O	O

We	O	O	O
used	O	O	O
DNA	O	O	B-T114
extracted	O	O	I-T114
from	O	O	O
historical	O	O	O
specimen	O	O	B-T033
toepads	O	O	I-T033
for	O	O	O
species	O	O	O
that	O	O	O
lacked	O	O	B-T024
fresh	O	O	I-T024
tissue	O	O	I-T024
in	O	O	O
museum	O	O	B-T059
collections	O	O	I-T059
.	O	O	O

Maximum	O	O	O
likelihood	O	O	O
and	O	O	O
multispecies	O	O	B-T081
coalescent	O	O	I-T081
UCE	O	O	I-T081
analyses	O	O	I-T081
strongly	O	O	O
supported	O	O	O
Lerwa	O	O	B-T012
sister	O	O	B-T077
to	O	O	O
a	O	O	O
large	O	O	B-T012
clade	O	O	I-T012
which	O	O	O
included	O	O	O
Ithaginis	O	O	B-T012
at	O	O	O
its	O	O	O
base	O	O	O
,	O	O	O
and	O	O	O
also	O	O	O
including	O	O	O
turkey	O	O	B-T012
,	O	O	O
grouse	O	O	B-T012
,	O	O	O
typical	O	O	O
pheasants	O	O	B-T012
,	O	O	O
tragopans	O	O	B-T012
,	O	O	O
Pucrasia	O	O	B-T012
,	O	O	O
and	O	O	O
Perdix	O	O	B-T012
.	O	O	O

Rhizothera	O	O	B-T012
was	O	O	O
also	O	O	O
in	O	O	O
this	O	O	O
clade	O	O	B-T012
,	O	O	O
sister	O	O	B-T077
to	O	O	O
a	O	O	O
diverse	O	O	O
group	O	O	O
comprising	O	O	O
Perdix	O	O	B-T012
,	O	O	O
typical	O	O	O
pheasants	O	O	B-T012
,	O	O	O
Pucrasia	O	O	B-T012
,	O	O	O
turkey	O	O	B-T012
and	O	O	O
grouse	O	O	B-T012
.	O	O	O

Mitogenomic	O	O	B-T170
genealogies	O	O	I-T170
differed	O	O	O
from	O	O	O
UCEs	O	O	B-T169
topologies	O	O	I-T169
,	O	O	O
supporting	O	O	O
a	O	O	O
sister	O	O	B-T077
relationship	O	O	I-T077
between	O	O	O
Ithaginis	O	O	B-T012
and	O	O	O
Lerwa	O	O	B-T012
rather	O	O	O
than	O	O	O
a	O	O	O
grade	O	O	O
.	O	O	O

The	O	O	O
position	O	O	O
of	O	O	O
Rhizothera	O	O	B-T012
using	O	O	O
mitogenomes	O	O	B-T028
depended	O	O	O
on	O	O	O
analytical	O	O	B-T062
choices	O	O	I-T062
.	O	O	O

Unpartitioned	O	O	O
and	O	O	O
codon-based	O	O	B-T059
analyses	O	O	I-T059
placed	O	O	O
Rhizothera	O	O	B-T012
sister	O	O	B-T077
to	O	O	O
a	O	O	O
tragopan	O	O	B-T012
clade	O	O	I-T012
,	O	O	O
whereas	O	O	O
a	O	O	O
partitioned	O	O	O
DNA	O	O	B-T170
model	O	O	I-T170
of	O	O	O
the	O	O	O
mitogenome	O	O	B-T028
was	O	O	O
congruent	O	O	B-T080
with	O	O	O
UCE	O	O	B-T033
results	O	O	I-T033
.	O	O	O

In	O	O	O
all	O	O	O
mitogenome	O	O	B-T059
analyses	O	O	I-T059
,	O	O	O
Pucrasia	O	O	B-T012
was	O	O	O
sister	O	O	B-T077
to	O	O	O
a	O	O	O
clade	O	O	B-T012
including	O	O	O
Perdix	O	O	B-T012
and	O	O	O
the	O	O	O
typical	O	O	O
pheasants	O	O	B-T012
with	O	O	O
high	O	O	O
support	O	O	O
,	O	O	O
in	O	O	O
contrast	O	O	O
to	O	O	O
UCEs	O	O	O
and	O	O	O
published	O	O	B-T170
nuclear	O	O	I-T170
intron	O	O	I-T170
data	O	O	I-T170
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
strong	O	O	O
support	O	O	O
and	O	O	O
consistent	O	O	O
topology	O	O	B-T170
provided	O	O	O
by	O	O	O
all	O	O	O
UCE	O	O	B-T170
analyses	O	O	I-T170
,	O	O	O
we	O	O	O
have	O	O	O
identified	O	O	O
phylogenetic	O	O	B-T078
relationships	O	O	B-T080
of	O	O	O
these	O	O	O
three	O	O	O
enigmatic	O	O	B-T080
,	O	O	O
poorly-studied	O	O	O
,	O	O	O
phasianid	O	O	B-T012
taxa	O	O	I-T012
.	O	O	O

-DOCSTART- (28091848)

A	O	O	O
novel	O	O	B-T080
combination	O	O	O
treatment	O	O	B-T169
to	O	O	O
stimulate	O	O	B-T061
bone	O	O	B-T033
healing	O	O	I-T033
and	O	O	O
regeneration	O	O	B-T042
under	O	O	O
hypoxic	O	O	B-T046
conditions	O	O	I-T046
:	O	O	O
photobiomodulation	O	O	B-T061
and	O	O	O
melatonin	O	O	O

Melatonin	O	O	B-T125
has	O	O	O
anabolic	O	O	B-T039
effects	O	O	I-T039
on	O	O	O
the	O	O	O
bone	O	O	B-T024
,	O	O	O
even	O	O	O
under	O	O	O
hypoxia	O	O	B-T046
,	O	O	O
and	O	O	O
laser	O	O	B-T061
irradiation	O	O	I-T061
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
improve	O	O	O
osteoblastic	O	O	B-T043
differentiation	O	O	I-T043
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
laser	O	O	B-T061
irradiation	O	O	I-T061
and	O	O	O
melatonin	O	O	B-T125
would	O	O	O
have	O	O	O
synergistic	O	O	B-T080
effects	O	O	B-T080
on	O	O	O
osteoblastic	O	O	B-T043
differentiation	O	O	I-T043
and	O	O	O
mineralization	O	O	B-T042
under	O	O	O
hypoxic	O	O	B-T046
conditions	O	O	I-T046
.	O	O	O

MC3T3-E1	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
exposed	O	O	O
to	O	O	O
1	O	O	O
%	O	O	O
oxygen	O	O	B-T033
tension	O	O	I-T033
for	O	O	O
the	O	O	O
hypoxia	O	O	B-T046
condition	O	O	I-T046
.	O	O	O

The	O	O	O
cells	O	O	B-T025
were	O	O	O
divided	O	O	O
into	O	O	O
four	O	O	O
groups	O	O	B-T078
:	O	O	O
G1	O	O	B-T078
-	O	O	O
osteoblast	O	O	B-T043
differentiation	O	O	I-T043
medium	O	O	B-T130
only	O	O	O
(	O	O	O
as	O	O	O
the	O	O	O
hypoxic	O	O	B-T046
condition	O	O	I-T046
)	O	O	O
,	O	O	O
G2	O	O	B-T078
-	O	O	O
treatment	O	O	B-T169
with	O	O	O
50	O	O	O
μM	O	O	O
melatonin	O	O	B-T125
only	O	O	O
,	O	O	O
G3	O	O	B-T078
-	O	O	O
laser	O	O	B-T061
irradiation	O	O	I-T061
(	O	O	O
808	O	O	O
nm	O	O	O
,	O	O	O
80	O	O	O
mW	O	O	O
,	O	O	O
GaAlAs	O	O	B-T074
diode	O	O	I-T074
)	O	O	O
only	O	O	O
,	O	O	O
and	O	O	O
G4	O	O	B-T078
-	O	O	O
treatment	O	O	O
with	O	O	O
50	O	O	O
μM	O	O	O
melatonin	O	O	O
and	O	O	O
laser	O	O	O
irradiation	O	O	O
(	O	O	O
808	O	O	O
nm	O	O	O
,	O	O	O
80	O	O	O
mW	O	O	O
,	O	O	O
GaAlAs	O	O	O
diode	O	O	O
)	O	O	O
.	O	O	O

Immunoblotting	O	O	B-T059
showed	O	O	O
that	O	O	O
osterix	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
markedly	O	O	O
increased	O	O	B-T081
in	O	O	O
the	O	O	O
melatonin	O	O	B-T125
-	O	O	O
treated	O	O	B-T169
and	O	O	O
laser-irradiated	O	O	B-T061
cells	O	O	B-T025
at	O	O	O
48	O	O	O
and	O	O	O
72	O	O	O
h.	O	O	O
In	O	O	O
addition	O	O	O
,	O	O	O
alkaline	O	O	B-T116
phosphatase	O	O	I-T116
activity	O	O	B-T052
significantly	O	O	O
increased	O	O	O
and	O	O	O
continued	O	O	B-T078
to	O	O	O
rise	O	O	O
throughout	O	O	O
the	O	O	O
experiment	O	O	B-T062
.	O	O	O

Alizarin	O	O	B-T059
Red	O	O	I-T059
staining	O	O	I-T059
showed	O	O	O
markedly	O	O	O
increased	O	O	B-T081
mineralized	O	O	B-T042
nodules	O	O	B-T046
as	O	O	O
compared	O	O	O
with	O	O	O
only	O	O	O
melatonin	O	O	B-T125
-	O	O	O
treated	O	O	B-T169
or	O	O	O
laser-irradiated	O	O	B-T061
cells	O	O	B-T025
at	O	O	O
day	O	O	O
7	O	O	O
,	O	O	O
which	O	O	O
significantly	O	O	O
increased	O	O	O
by	O	O	O
day	O	O	O
14	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
when	O	O	O
melatonin	O	O	B-T125
-	O	O	O
treated	O	O	B-T169
cells	O	O	B-T025
were	O	O	O
laser-irradiated	O	O	B-T061
,	O	O	O
the	O	O	O
differentiation	O	O	B-T043
and	O	O	O
mineralization	O	O	B-T042
of	O	O	O
cells	O	O	O
were	O	O	O
found	O	O	O
to	O	O	O
involve	O	O	O
p38	O	O	B-T116
MAPK	O	O	I-T116
and	O	O	O
PRKD1	O	O	B-T116
signaling	O	O	B-T043
mechanisms	O	O	I-T043
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
enhanced	O	O	B-T052
effects	O	O	B-T080
of	O	O	I-T080
laser	O	O	B-T061
irradiation	O	O	I-T061
with	O	O	O
melatonin	O	O	B-T125
were	O	O	O
markedly	O	O	O
inhibited	O	O	B-T080
when	O	O	O
the	O	O	O
cells	O	O	B-T025
were	O	O	O
treated	O	O	B-T169
with	O	O	O
luzindole	O	O	B-T109
,	O	O	O
a	O	O	O
selective	O	O	O
melatonin	O	O	B-T121
receptor	O	O	I-T121
antagonist	O	O	I-T121
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
concluded	O	O	O
that	O	O	O
laser	O	O	B-T061
irradiation	O	O	I-T061
could	O	O	O
promote	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
melatonin	O	O	B-T125
on	O	O	O
the	O	O	O
differentiation	O	O	B-T043
and	O	O	O
mineralization	O	O	B-T042
of	O	O	O
MC3T3-E1	O	O	B-T025
cells	O	O	I-T025
under	O	O	O
hypoxic	O	O	B-T046
conditions	O	O	I-T046
,	O	O	O
and	O	O	O
that	O	O	O
this	O	O	O
process	O	O	O
is	O	O	O
mediated	O	O	O
through	O	O	O
melatonin	O	O	B-T116
1/2	O	O	I-T116
receptors	O	O	I-T116
and	O	O	O
PKRD	O	O	B-T116
/	O	O	O
p38	O	O	B-T116
signaling	O	O	B-T044
pathways	O	O	I-T044
.	O	O	O

-DOCSTART- (28092112)

Aquaporin-2	O	O	B-T116
excretion	O	O	B-T042
in	O	O	O
hospitalized	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
cirrhosis	O	O	B-T047
:	O	O	O
Relation	O	O	O
to	O	O	O
development	O	O	B-T169
of	O	O	O
renal	O	O	B-T047
insufficiency	O	O	I-T047
and	O	O	O
mortality	O	O	O

Urinary	O	O	B-T080
aquaporin-2	O	O	B-T116
(	O	O	O
AQP2	O	O	B-T116
)	O	O	O
is	O	O	O
a	O	O	O
parameter	O	O	O
of	O	O	O
water	O	O	B-T043
transport	O	O	I-T043
in	O	O	O
the	O	O	O
principal	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
the	O	O	O
distal	O	O	B-T029
part	O	O	I-T029
of	O	O	O
the	O	O	O
nephron	O	O	B-T023
and	O	O	O
involved	O	O	O
in	O	O	O
water	O	O	B-T040
retention	O	O	I-T040
in	O	O	O
cirrhosis	O	O	B-T047
and	O	O	O
may	O	O	O
be	O	O	O
a	O	O	O
marker	O	O	B-T201
of	O	O	O
renal	O	O	B-T042
function	O	O	I-T042
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
the	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
AQP2	O	O	B-T116
as	O	O	O
a	O	O	O
predictor	O	O	B-T170
of	O	O	O
renal	O	O	B-T047
insufficiency	O	O	I-T047
and	O	O	O
death	O	O	B-T040
in	O	O	O
patients	O	O	B-T101
with	O	O	O
cirrhosis	O	O	B-T047
.	O	O	O

Urine	O	O	B-T031
samples	O	O	I-T031
from	O	O	O
199	O	O	O
patients	O	O	B-T101
(	O	O	O
90	O	O	O
patients	O	O	O
without	O	O	O
organ	O	O	B-T184
failure	O	O	I-T184
[	O	O	O
Group	O	O	B-UnknownType
1	O	O	I-UnknownType
]	O	O	O
,	O	O	O
58	O	O	O
patients	O	O	O
with	O	O	O
organ	O	O	O
failure	O	O	O
excluding	O	O	O
renal	O	O	B-T047
failure	O	O	I-T047
[	O	O	O
Group	O	O	B-UnknownType
2	O	O	I-UnknownType
]	O	O	O
,	O	O	O
and	O	O	O
51	O	O	O
patients	O	O	O
with	O	O	O
organ	O	O	O
failure	O	O	O
including	O	O	O
renal	O	O	O
failure	O	O	O
[	O	O	O
Group	O	O	B-UnknownType
3	O	O	I-UnknownType
]	O	O	O
)	O	O	O
from	O	O	O
the	O	O	O
CANONIC	O	O	B-T062
study	O	O	I-T062
were	O	O	O
analyzed	O	O	O
for	O	O	O
urine	O	O	B-T031
AQP2	O	O	B-T116
and	O	O	O
urine	O	O	B-T201
osmolality	O	O	I-T201
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
difference	O	O	I-T033
in	O	O	O
AQP2	O	O	B-T116
between	O	O	O
the	O	O	O
three	O	O	O
groups	O	O	B-UnknownType
.	O	O	O

Urine	O	O	B-T201
osmolality	O	O	I-T201
was	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
in	O	O	O
patients	O	O	B-T101
in	O	O	O
Group	O	O	B-UnknownType
3	O	O	I-UnknownType
versus	O	O	O
Group	O	O	B-UnknownType
1	O	O	I-UnknownType
and	O	O	O
Group	O	O	B-UnknownType
2	O	O	I-UnknownType
(	O	O	O
P	O	O	O
=	O	O	O
0.0004	O	O	O
)	O	O	O
.	O	O	O

No	O	O	B-T033
relation	O	O	I-T033
was	O	O	O
found	O	O	O
between	O	O	O
AQP2	O	O	B-T116
and	O	O	O
glomerular	O	O	B-T060
filtration	O	O	I-T060
rate	O	O	I-T060
or	O	O	O
creatinine	O	O	B-T109
;	O	O	O
however	O	O	O
,	O	O	O
AQP2	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	O
predictor	O	O	B-T170
of	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
renal	O	O	B-T047
insufficiency	O	O	I-T047
(	O	O	O
P	O	O	O
=	O	O	O
0.0485	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
univariate	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
AQP2	O	O	B-T116
was	O	O	O
a	O	O	O
significant	O	O	O
predictor	O	O	B-T170
of	O	O	O
14	O	O	O
and	O	O	O
28-day	O	O	O
survival	O	O	B-T169
,	O	O	O
but	O	O	O
this	O	O	O
was	O	O	O
not	O	O	O
confirmed	O	O	O
in	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
.	O	O	O

Aquaporin-2	O	O	B-T116
was	O	O	O
not	O	O	O
associated	O	O	O
with	O	O	O
disease	O	O	B-T080
severity	O	O	I-T080
or	O	O	O
markers	O	O	B-T080
of	O	O	O
renal	O	O	B-T042
function	O	O	I-T042
but	O	O	O
was	O	O	O
a	O	O	O
predictor	O	O	B-T170
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
renal	O	O	B-T047
insufficiency	O	O	I-T047
and	O	O	O
death	O	O	B-T040
.	O	O	O

Therefore	O	O	O
,	O	O	O
its	O	O	O
future	O	O	O
use	O	O	O
as	O	O	O
marker	O	O	B-T201
of	O	O	O
renal	O	O	B-T047
insufficiency	O	O	I-T047
could	O	O	O
be	O	O	O
promising	O	O	O
,	O	O	O
but	O	O	O
further	O	O	O
research	O	O	B-T062
is	O	O	O
needed	O	O	O
before	O	O	O
it	O	O	O
can	O	O	O
be	O	O	O
considered	O	O	O
a	O	O	O
clinical	O	O	B-T080
useful	O	O	O
tool	O	O	O
.	O	O	O

-DOCSTART- (28092340)

Decompression	O	O	B-T061
Surgery	O	O	I-T061
Alone	O	O	O
Versus	O	O	O
Decompression	O	O	O
Plus	O	O	O
Fusion	O	O	B-T061
in	O	O	O
Symptomatic	O	O	B-T169
Lumbar	O	O	B-T047
Spinal	O	O	I-T047
Stenosis	O	O	I-T047
:	O	O	O
A	O	O	O
Swiss	O	O	B-T098
Prospective	O	O	B-T062
Multi-center	O	O	I-T062
Cohort	O	O	I-T062
Study	O	O	I-T062
with	O	O	O
3	O	O	O
Years	O	O	B-T079
of	O	O	O
Follow-up	O	O	O

Retrospective	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
a	O	O	O
prospective	O	O	B-T062
,	O	O	I-T062
multicenter	O	O	I-T062
cohort	O	O	I-T062
study	O	O	I-T062
.	O	O	O

To	O	O	O
estimate	O	O	O
the	O	O	O
added	O	O	O
effect	O	O	B-T080
of	O	O	O
surgical	O	O	B-T061
fusion	O	O	I-T061
as	O	O	O
compared	O	O	O
to	O	O	O
decompression	O	O	B-T061
surgery	O	O	I-T061
alone	O	O	O
in	O	O	O
symptomatic	O	O	B-T169
lumbar	O	O	B-T047
spinal	O	O	I-T047
stenosis	O	O	I-T047
patients	O	O	B-T101
with	O	O	O
spondylolisthesis	O	O	B-T047
.	O	O	O

The	O	O	O
optimal	O	O	B-T058
surgical	O	O	I-T058
management	O	O	I-T058
of	O	O	O
lumbar	O	O	B-T047
spinal	O	O	I-T047
stenosis	O	O	I-T047
patients	O	O	B-T101
with	O	O	O
spondylolisthesis	O	O	B-T047
remains	O	O	O
controversial	O	O	O
.	O	O	O

Patients	O	O	B-T101
of	O	O	O
the	O	O	O
LSOS	O	O	B-T062
with	O	O	O
confirmed	O	O	O
DLSS	O	O	B-T047
and	O	O	O
spondylolisthesis	O	O	B-T047
were	O	O	O
enrolled	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T077
.	O	O	O

The	O	O	O
outcomes	O	O	B-T062
of	O	O	O
this	O	O	O
study	O	O	B-T077
were	O	O	O
Spinal	O	O	B-T020
Stenosis	O	O	I-T020
Measure	O	O	O
(	O	O	O
SSM	O	O	B-T081
)	O	O	O
symptoms	O	O	B-T184
(	O	O	O
score	O	O	B-T081
range	O	O	I-T081
1	O	O	O
-	O	O	O
5	O	O	O
,	O	O	O
best-worst	O	O	O
)	O	O	O
and	O	O	O
function	O	O	B-T169
(	O	O	O
1	O	O	O
-	O	O	O
4	O	O	O
)	O	O	O
over	O	O	B-T079
time	O	O	I-T079
,	O	O	O
measured	O	O	B-T080
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
6	O	O	O
,	O	O	O
12	O	O	O
,	O	O	O
24	O	O	O
and	O	O	O
36	O	O	O
months	O	O	B-T079
follow-up	O	O	B-T062
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
quantify	O	O	B-T081
the	O	O	O
effect	O	O	B-T080
of	O	O	O
fusion	O	O	B-T061
surgery	O	O	I-T061
as	O	O	O
compared	O	O	O
to	O	O	O
decompression	O	O	B-T061
alone	O	O	O
and	O	O	O
number	O	O	B-T033
of	O	O	I-T033
decompressed	O	O	I-T033
levels	O	O	I-T033
,	O	O	O
we	O	O	O
used	O	O	O
mixed	O	O	O
effects	O	O	B-T080
models	O	O	B-T075
and	O	O	O
accounted	O	O	O
for	O	O	O
the	O	O	O
repeated	O	O	B-T062
observations	O	O	I-T062
in	O	O	O
main	O	O	O
outcomes	O	O	B-T062
(	O	O	O
SSM	O	O	B-T081
symptoms	O	O	B-T184
and	O	O	O
SSM	O	O	O
function	O	O	B-T169
)	O	O	O
over	O	O	B-T079
time	O	O	I-T079
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
individual	O	O	O
patients	O	O	B-T101
'	O	O	O
random	O	O	B-T080
effects	O	O	I-T080
,	O	O	O
we	O	O	O
also	O	O	O
fitted	O	O	B-T081
random	O	O	I-T081
slopes	O	O	I-T081
for	O	O	O
follow-up	O	O	B-T033
time	O	O	B-T079
points	O	O	I-T079
and	O	O	O
compared	O	O	O
these	O	O	O
two	O	O	O
approaches	O	O	B-T169
with	O	O	O
Akaike	O	O	B-T170
's	O	O	I-T170
Information	O	O	I-T170
Criterion	O	O	I-T170
(	O	O	O
AIC	O	O	B-T170
)	O	O	O
and	O	O	O
the	O	O	O
chi-squared	O	O	B-T170
test	O	O	I-T170
.	O	O	O

Confounders	O	O	B-T169
were	O	O	O
adjusted	O	O	O
with	O	O	O
fixed	O	O	B-T080
effects	O	O	I-T080
for	O	O	O
age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
BMI	O	O	B-T201
,	O	O	O
diabetes	O	O	B-T047
,	O	O	O
CIRS	O	O	B-T081
musculoskeletal	O	O	B-T047
disorders	O	O	I-T047
and	O	O	O
duration	O	O	B-T109
of	O	O	O
symptoms	O	O	B-T184
.	O	O	O

One	O	O	O
hundred	O	O	O
and	O	O	O
thirty-one	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
decompression	O	O	B-T061
surgery	O	O	I-T061
alone	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
85	O	O	O
)	O	O	O
or	O	O	O
decompression	O	O	O
plus	O	O	O
fusion	O	O	B-T061
surgery	O	O	I-T061
(	O	O	O
n	O	O	O
=	O	O	O
46	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T077
.	O	O	O

In	O	O	O
the	O	O	O
multiple	O	O	B-T080
mixed	O	O	I-T080
effects	O	O	I-T080
model	O	O	B-T075
the	O	O	O
adjusted	O	O	O
effect	O	O	B-T080
of	O	O	O
fusion	O	O	B-T061
versus	O	O	O
decompression	O	O	B-T061
alone	O	O	I-T061
surgery	O	O	I-T061
on	O	O	O
SSM	O	O	B-T081
symptoms	O	O	B-T184
was	O	O	O
0.06	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
,	O	O	O
CI	O	O	B-T081
:	O	O	O
-0.16	O	O	O
to	O	O	O
0.27	O	O	O
)	O	O	O
and	O	O	O
-0.07	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
-0.25	O	O	O
to	O	O	O
0.10	O	O	O
)	O	O	O
on	O	O	O
SSM	O	O	O
function	O	O	B-T169
,	O	O	O
respectively	O	O	O
.	O	O	O

Among	O	O	O
the	O	O	O
patients	O	O	B-T101
with	O	O	O
degenerative	O	O	B-T047
lumbar	O	O	I-T047
spinal	O	O	I-T047
stenosis	O	O	I-T047
and	O	O	O
spondylolisthesis	O	O	B-T047
our	O	O	O
study	O	O	B-T077
confirms	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T078
,	O	O	O
decompression	O	O	B-T061
alone	O	O	O
and	O	O	O
decompression	O	O	O
plus	O	O	O
fusion	O	O	B-T061
,	O	O	O
patients	O	O	O
distinctively	O	O	O
benefited	O	O	O
from	O	O	O
surgical	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

When	O	O	O
adjusted	O	O	O
for	O	O	O
confounders	O	O	B-T169
,	O	O	O
fusion	O	O	B-T061
surgery	O	O	I-T061
was	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
more	O	O	O
favorable	O	O	O
outcome	O	O	B-T062
in	O	O	O
both	O	O	O
SSM	O	O	B-T081
scores	O	O	I-T081
as	O	O	O
compared	O	O	O
to	O	O	O
decompression	O	O	B-T061
alone	O	O	I-T061
surgery	O	O	I-T061
.	O	O	O

3	O	O	O
.	O	O	O

-DOCSTART- (28097208)

Muscle	O	O	B-T024
synergies	O	O	B-T169
after	O	O	O
stroke	O	O	B-T047
are	O	O	O
correlated	O	O	O
with	O	O	O
perilesional	O	O	B-T082
high	O	O	O
gamma	O	O	O

Movements	O	O	B-T033
can	O	O	O
be	O	O	O
factored	O	O	O
into	O	O	O
modules	O	O	B-T077
termed	O	O	O
"	O	O	O
muscle	O	O	B-T024
synergies	O	O	B-T169
"	O	O	O
.	O	O	O

After	O	O	O
stroke	O	O	B-T047
,	O	O	O
abnormal	O	O	B-T033
synergies	O	O	B-T169
are	O	O	O
linked	O	O	O
to	O	O	O
impaired	O	O	B-T169
movements	O	O	B-T033
;	O	O	O
however	O	O	O
,	O	O	O
their	O	O	O
neural	O	O	B-T025
basis	O	O	B-T169
is	O	O	O
not	O	O	O
understood	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
single	O	O	O
subject	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	O
how	O	O	O
electrocorticography	O	O	B-T060
signals	O	O	I-T060
from	O	O	O
the	O	O	O
perilesional	O	O	B-T082
cortex	O	O	B-T023
were	O	O	O
associated	O	O	O
with	O	O	O
synergies	O	O	B-T169
.	O	O	O

The	O	O	O
measured	O	O	O
synergies	O	O	B-T169
contained	O	O	B-T169
a	O	O	O
mix	O	O	O
of	O	O	O
both	O	O	O
normal	O	O	B-T080
and	O	O	O
abnormal	O	O	B-T033
patterns	O	O	B-T082
and	O	O	O
were	O	O	O
remarkably	O	O	O
similar	O	O	O
to	O	O	O
those	O	O	O
described	O	O	O
in	O	O	O
past	O	O	O
work	O	O	O
.	O	O	O

Interestingly	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
both	O	O	O
normal	O	O	B-T080
and	O	O	O
abnormal	O	O	B-T033
synergies	O	O	B-T169
were	O	O	O
correlated	O	O	O
with	O	O	O
perilesional	O	O	B-T082
high	O	O	B-T081
gamma	O	O	I-T081
.	O	O	O

Given	O	O	O
the	O	O	O
link	O	O	O
between	O	O	O
high	O	O	B-T081
gamma	O	O	I-T081
and	O	O	O
cortical	O	O	B-T033
spiking	O	O	I-T033
,	O	O	O
our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
perilesional	O	O	B-T033
spiking	O	O	I-T033
may	O	O	O
organize	O	O	O
synergies	O	O	B-T169
after	O	O	O
stroke	O	O	B-T047
.	O	O	O

-DOCSTART- (28097611)

Assessing	O	O	B-T058
nitrous	O	O	B-T121
oxide	O	O	I-T121
effect	O	O	B-T080
using	O	O	O
electroencephalographically	O	O	B-T060
-based	O	O	O
depth	O	O	B-T033
of	O	O	I-T033
anesthesia	O	O	I-T033
measures	O	O	B-T081
cortical	O	O	B-T023
state	O	O	B-T170
and	O	O	O
cortical	O	O	O
input	O	O	O

Existing	O	O	O
electroencephalography	O	O	B-T060
(	O	O	O
EEG	O	O	B-T060
)	O	O	O
based	O	O	O
depth	O	O	B-T033
of	O	O	I-T033
anesthesia	O	O	B-T061
monitors	O	O	B-T058
can	O	O	O
not	O	O	O
reliably	O	O	O
track	O	O	O
sedative	O	O	B-T121
or	O	O	O
anesthetic	O	O	B-T121
states	O	O	B-T080
during	O	O	O
n-methyl-D-aspartate	O	O	B-T121
(	O	O	I-T121
NMDA	O	O	I-T121
)	O	O	I-T121
receptor	O	O	I-T121
antagonist	O	O	I-T121
based	O	O	O
anesthesia	O	O	O
with	O	O	O
ketamine	O	O	B-T109
or	O	O	O
nitrous	O	O	B-T121
oxide	O	O	I-T121
(	O	O	O
N2O	O	O	B-T121
)	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
a	O	O	O
physiologically	O	O	B-T169
-motivated	O	O	O
depth	O	O	B-T033
of	O	O	I-T033
anesthesia	O	O	I-T033
monitoring	O	O	B-T058
algorithm	O	O	B-T170
based	O	O	O
on	O	O	O
autoregressive-moving-average	O	O	B-T170
(	O	O	I-T170
ARMA	O	O	I-T170
)	O	O	I-T170
modeling	O	O	I-T170
and	O	O	O
derivative	O	O	O
measures	O	O	O
of	O	O	O
interest	O	O	O
,	O	O	O
Cortical	O	O	B-T023
State	O	O	B-T170
(	O	O	O
CS	O	O	B-T170
)	O	O	O
and	O	O	O
Cortical	O	O	O
Input	O	O	B-T170
(	O	O	O
CI	O	O	B-T170
)	O	O	O
,	O	O	O
is	O	O	O
retrospectively	O	O	B-T062
applied	O	O	O
in	O	O	O
an	O	O	O
exploratory	O	O	B-T169
manner	O	O	O
to	O	O	O
the	O	O	O
NMDA	O	O	B-T121
receptor	O	O	I-T121
antagonist	O	O	I-T121
N2O	O	O	B-T121
,	O	O	O
an	O	O	O
adjuvant	O	O	B-T121
anesthetic	O	O	I-T121
gas	O	O	I-T121
used	O	O	O
in	O	O	O
clinical	O	O	B-T169
practice	O	O	I-T169
.	O	O	O

Composite	O	O	B-T170
Cortical	O	O	I-T170
State	O	O	I-T170
(	O	O	O
CCS	O	O	B-T170
)	O	O	O
and	O	O	O
Composite	O	O	B-T170
Cortical	O	O	I-T170
State	O	O	I-T170
distance	O	O	I-T170
(	O	O	O
CCSd	O	O	B-T170
)	O	O	O
,	O	O	O
two	O	O	O
new	O	O	O
modifications	O	O	B-T033
of	O	O	O
CS	O	O	B-T170
,	O	O	O
along	O	O	O
with	O	O	O
CS	O	O	O
and	O	O	O
CI	O	O	B-T170
were	O	O	O
evaluated	O	O	B-T058
on	O	O	O
electroencephalographic	O	O	B-T060
(	O	O	O
EEG	O	O	B-T060
)	O	O	O
data	O	O	B-T078
of	O	O	O
healthy	O	O	B-T080
control	O	O	I-T080
individuals	O	O	I-T080
undergoing	O	O	O
N2O	O	O	B-T121
inhalation	O	O	B-T040
up	O	O	O
to	O	O	O
equilibrated	O	O	B-T081
peak	O	O	B-T081
gas	O	O	I-T081
concentrations	O	O	I-T081
of	O	O	O
20	O	O	O
,	O	O	O
40	O	O	O
or	O	O	O
60	O	O	O
%	O	O	O
N2O	O	O	O
/	O	O	O
O2	O	O	B-T121
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
CCSd	O	O	B-T170
has	O	O	O
been	O	O	O
devised	O	O	O
to	O	O	O
vary	O	O	O
consistently	O	O	O
for	O	O	O
increasing	O	O	B-T081
levels	O	O	B-T080
of	O	O	O
anesthetic	O	O	B-T033
concentration	O	O	I-T033
independent	O	O	B-T169
of	O	O	I-T169
the	O	O	O
anesthetic	O	O	B-T121
's	O	O	I-T121
microscopic	O	O	B-T080
mode	O	O	B-T169
of	O	O	I-T169
action	O	O	I-T169
for	O	O	O
both	O	O	O
N2O	O	O	B-T121
and	O	O	O
propofol	O	O	B-T109
.	O	O	O

The	O	O	O
strongest	O	O	O
effects	O	O	B-T080
were	O	O	O
observed	O	O	O
for	O	O	O
the	O	O	O
60	O	O	O
%	O	O	O
peak	O	O	B-T081
gas	O	O	I-T081
concentration	O	O	I-T081
group	O	O	B-T098
.	O	O	O

For	O	O	O
the	O	O	O
50	O	O	O
-	O	O	O
60	O	O	O
%	O	O	O
peak	O	O	B-T080
gas	O	O	I-T080
levels	O	O	I-T080
,	O	O	O
individuals	O	O	B-T098
showed	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
reductions	O	O	B-T061
in	O	O	O
responsiveness	O	O	B-T033
compared	O	O	B-T052
to	O	O	O
rest	O	O	B-T056
,	O	O	O
and	O	O	O
across	O	O	O
the	O	O	O
group	O	O	B-T098
CS	O	O	B-T170
and	O	O	O
CCS	O	O	B-T170
increased	O	O	B-T081
by	O	O	O
39	O	O	O
and	O	O	O
42	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
while	O	O	O
CCSd	O	O	B-T170
was	O	O	O
found	O	O	O
to	O	O	O
decrease	O	O	B-T081
by	O	O	O
398	O	O	O
%	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
a	O	O	O
clear	O	O	O
conclusion	O	O	B-T078
regarding	O	O	O
the	O	O	O
changes	O	O	O
in	O	O	O
CI	O	O	B-T170
could	O	O	O
not	O	O	O
be	O	O	O
reached	O	O	O
.	O	O	O

These	O	O	O
results	O	O	B-T169
indicate	O	O	O
that	O	O	O
,	O	O	O
contrary	O	O	B-T082
to	O	O	O
previous	O	O	O
depth	O	O	B-T033
of	O	O	I-T033
anesthesia	O	O	I-T033
monitoring	O	O	B-T058
measures	O	O	B-T081
,	O	O	O
the	O	O	O
CS	O	O	B-T170
,	O	O	O
CCS	O	O	B-T170
,	O	O	O
and	O	O	O
especially	O	O	O
CCSd	O	O	B-T170
measures	O	O	O
derived	O	O	B-T080
from	O	O	O
frontal	O	O	B-T082
EEG	O	O	B-T060
are	O	O	O
potentially	O	O	B-T080
useful	O	O	O
for	O	O	O
differentiating	O	O	O
gas	O	O	B-T081
concentration	O	O	I-T081
and	O	O	O
responsiveness	O	O	B-T033
levels	O	O	I-T033
in	O	O	O
people	O	O	B-T098
under	O	O	O
N2O	O	O	B-T121
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
determining	O	O	O
the	O	O	O
utility	O	O	B-T169
of	O	O	O
CI	O	O	B-T170
in	O	O	O
this	O	O	O
regard	O	O	O
will	O	O	O
require	O	O	O
larger	O	O	B-T081
sample	O	O	B-T081
sizes	O	O	I-T081
and	O	O	O
potentially	O	O	B-T080
higher	O	O	B-T080
gas	O	O	B-T081
concentrations	O	O	I-T081
.	O	O	O

Future	O	O	O
work	O	O	O
will	O	O	O
assess	O	O	B-T058
the	O	O	O
sensitivity	O	O	B-T081
of	O	O	O
CS	O	O	B-T170
-based	O	O	O
and	O	O	O
CI	O	O	B-T170
measures	O	O	B-T081
to	O	O	O
other	O	O	O
anesthetics	O	O	B-T121
and	O	O	O
their	O	O	O
utility	O	O	B-T169
in	O	O	O
a	O	O	O
clinical	O	O	B-T093
environment	O	O	B-T082
.	O	O	O

-DOCSTART- (28098510)

DT	O	O	B-T060
MRI	O	O	I-T060
microstructural	O	O	B-T080
cortical	O	O	B-T023
lesion	O	O	B-T047
damage	O	O	B-T169
does	O	O	O
not	O	O	O
explain	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
in	O	O	O
MS	O	O	O

We	O	O	O
combined	O	O	O
double	O	O	B-T060
inversion	O	O	I-T060
recovery	O	O	I-T060
(	O	O	O
DIR	O	O	B-T060
)	O	O	O
and	O	O	O
diffusion	O	O	B-T060
tensor	O	O	I-T060
(	O	O	I-T060
DT	O	O	I-T060
)	O	O	I-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	I-T060
MRI	O	O	I-T060
)	O	O	I-T060
to	O	O	O
quantify	O	O	B-T081
the	O	O	O
severity	O	O	B-T080
of	O	O	O
cortical	O	O	B-T023
lesion	O	O	B-T047
(	O	O	O
CL	O	O	B-T047
)	O	O	O
microstructural	O	O	B-T080
tissue	O	O	B-T024
abnormalities	O	O	B-T020
in	O	O	O
a	O	O	O
large	O	O	B-T081
cohort	O	O	B-T098
of	O	O	O
relapse	O	O	B-T067
-	O	O	O
onset	O	O	B-T080
multiple	O	O	B-T047
sclerosis	O	O	I-T047
(	O	O	O
MS	O	O	B-T047
)	O	O	O
patients	O	O	B-T101
and	O	O	O
its	O	O	O
contribution	O	O	B-T052
to	O	O	O
cognitive	O	O	B-T048
dysfunction	O	O	I-T048
.	O	O	O

DIR	O	O	B-T060
,	O	O	O
DT	O	O	B-T060
,	O	O	O
dual-echo	O	O	B-T060
,	O	O	O
and	O	O	O
three-dimensional	O	O	B-T082
(	O	O	O
3D	O	O	B-T082
)	O	O	O
T1-weighted	O	O	B-T060
scans	O	O	I-T060
were	O	O	O
acquired	O	O	O
from	O	O	O
149	O	O	O
MS	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
40	O	O	O
controls	O	O	B-T096
.	O	O	O

Cognitively	O	O	B-T048
impaired	O	O	I-T048
(	O	O	O
CI	O	O	B-T048
)	O	O	O
patients	O	O	B-T101
had	O	O	O
⩾2	O	O	O
abnormal	O	O	B-T033
neuropsychological	O	O	B-T060
tests	O	O	I-T060
.	O	O	O

Diffusivity	O	O	B-T077
values	O	O	I-T077
in	O	O	O
CLs	O	O	B-T047
,	O	O	O
cortex	O	O	B-T023
,	O	O	O
white	O	O	B-T033
matter	O	O	I-T033
(	O	O	I-T033
WM	O	O	I-T033
)	O	O	I-T033
lesions	O	O	I-T033
,	O	O	O
and	O	O	O
normal-appearing	O	O	B-T024
(	O	O	I-T024
NA	O	O	I-T024
)	O	O	I-T024
WM	O	O	I-T024
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

Predictors	O	O	B-T078
of	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
were	O	O	O
identified	O	O	B-T080
using	O	O	O
a	O	O	O
random	O	O	B-T062
forest	O	O	I-T062
analysis	O	O	I-T062
.	O	O	O

Compared	O	O	O
to	O	O	O
controls	O	O	B-T096
,	O	O	O
MS	O	O	B-T047
patients	O	O	B-T101
had	O	O	O
lower	O	O	B-T080
normalized	O	O	B-T081
brain	O	O	I-T081
volume	O	O	I-T081
(	O	O	O
NBV	O	O	B-T081
)	O	O	O
,	O	O	O
gray	O	O	B-T081
matter	O	O	I-T081
volume	O	O	I-T081
(	O	O	O
GMV	O	O	B-T081
)	O	O	O
,	O	O	O
WM	O	O	B-T033
volume	O	O	I-T033
,	O	O	O
lower	O	O	O
fractional	O	O	B-T081
anisotropy	O	O	I-T081
(	O	O	O
FA	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
higher	O	O	B-T080
mean	O	O	B-T077
diffusivity	O	O	I-T077
in	O	O	O
cortex	O	O	B-T023
and	O	O	O
normal-appearing	O	O	B-T024
white	O	O	I-T024
matter	O	O	I-T024
(	O	O	O
NAWM	O	O	B-T024
)	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
44	O	O	O
(	O	O	O
29.5	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
were	O	O	O
CI	O	O	B-T048
.	O	O	O

Compared	O	O	O
to	O	O	O
cognitively	O	O	B-T101
preserved	O	O	I-T101
(	O	O	O
CP	O	O	B-T101
)	O	O	O
,	O	O	O
CI	O	O	B-T048
patients	O	O	B-T101
had	O	O	O
higher	O	O	B-T080
T2	O	O	B-T081
WM	O	O	I-T081
lesion	O	O	I-T081
volume	O	O	I-T081
(	O	O	O
LV	O	O	B-T081
)	O	O	O
,	O	O	O
lower	O	O	B-T080
NBV	O	O	B-T081
and	O	O	O
GMV	O	O	B-T081
,	O	O	O
and	O	O	O
more	O	O	O
severe	O	O	B-T080
diffusivity	O	O	B-T077
abnormalities	O	O	B-T020
in	O	O	O
WM	O	O	B-T033
lesions	O	O	I-T033
,	O	O	O
cortex	O	O	B-T023
,	O	O	O
and	O	O	O
NAWM	O	O	B-T024
.	O	O	O

CL	O	O	B-T047
measures	O	O	B-T081
did	O	O	O
not	O	O	B-T033
differ	O	O	I-T033
between	O	O	O
CI	O	O	B-T101
and	O	O	O
CP	O	O	B-T101
patients	O	O	I-T101
.	O	O	O

Cortex	O	O	B-T023
FA	O	O	B-T081
,	O	O	O
age	O	O	B-T032
,	O	O	O
disease	O	O	B-T079
duration	O	O	I-T079
,	O	O	O
T2	O	O	B-T081
WM	O	O	I-T081
LV	O	O	I-T081
,	O	O	O
and	O	O	O
GMV	O	O	B-T081
best	O	O	O
predicted	O	O	O
MS	O	O	B-T047
-related	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
(	O	O	O
C-statistic	O	O	O
=	O	O	O
0.88	O	O	O
)	O	O	O
.	O	O	O

"	O	O	O
Diffuse	O	O	B-T082
"	O	O	O
GM	O	O	B-T024
and	O	O	O
NAWM	O	O	B-T024
damage	O	O	B-T169
and	O	O	O
WM	O	O	B-T033
lesions	O	O	I-T033
,	O	O	O
rather	O	O	O
than	O	O	O
intrinsic	O	O	B-T082
CL	O	O	B-T047
damage	O	O	O
,	O	O	O
contribute	O	O	O
to	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
in	O	O	O
MS	O	O	B-T047
.	O	O	O

-DOCSTART- (28099597)

Correlation	O	O	B-T080
between	O	O	O
the	O	O	O
histopathology	O	O	B-T169
of	O	O	O
chronic	O	O	B-T047
urticaria	O	O	I-T047
and	O	O	O
its	O	O	O
clinical	O	O	O
picture	O	O	O

Chronic	O	O	B-T047
urticaria	O	O	I-T047
is	O	O	O
characterized	O	O	O
by	O	O	O
transient	O	O	B-T079
,	O	O	O
pruritic	O	O	B-UnknownType
lesions	O	O	I-UnknownType
of	O	O	O
varying	O	O	O
sizes	O	O	B-T082
,	O	O	O
with	O	O	O
central	O	O	B-T082
pallor	O	O	B-T033
and	O	O	O
well-defined	O	O	O
edges	O	O	O
,	O	O	O
with	O	O	O
disease	O	O	B-T047
duration	O	O	O
longer	O	O	O
than	O	O	O
six	O	O	O
weeks	O	O	B-T079
.	O	O	O

Its	O	O	O
cellular	O	O	B-T046
infiltrate	O	O	I-T046
consists	O	O	O
of	O	O	O
neutrophils	O	O	B-T025
,	O	O	O
lymphocytes	O	O	B-T025
and	O	O	O
eosinophils	O	O	B-T025
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
subgroup	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
eosinophilic	O	O	B-T025
or	O	O	O
neutrophilic	O	O	B-T047
urticaria	O	O	I-T047
,	O	O	O
resistant	O	O	O
to	O	O	O
the	O	O	O
treatment	O	O	B-T061
with	O	O	O
antihistamines	O	O	B-T109
,	O	O	O
but	O	O	O
that	O	O	O
respond	O	O	O
to	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
antihistamine	O	O	B-T109
with	O	O	O
other	O	O	O
drugs	O	O	B-T121
.	O	O	O

To	O	O	O
evaluate	O	O	O
the	O	O	O
present	O	O	O
infiltration	O	O	B-T046
in	O	O	O
chronic	O	O	B-T047
urticaria	O	O	I-T047
biopsies	O	O	B-T060
and	O	O	O
correlate	O	O	O
it	O	O	O
with	O	O	O
the	O	O	O
clinical	O	O	B-UnknownType
disease	O	O	I-UnknownType
activity	O	O	I-UnknownType
and	O	O	O
response	O	O	B-T201
to	O	O	I-T201
treatment	O	O	I-T201
.	O	O	O

Forty-one	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T047
urticaria	O	O	I-T047
were	O	O	O
classified	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
score	O	O	B-T081
of	O	O	I-T081
severity	O	O	I-T081
of	O	O	O
the	O	O	O
disease	O	O	B-T047
,	O	O	O
response	O	O	B-T201
to	O	O	I-T201
treatment	O	O	I-T201
and	O	O	O
type	O	O	O
of	O	O	O
perivascular	O	O	B-T046
infiltrate	O	O	I-T046
.	O	O	O

Inflammatory	O	O	B-T031
infiltrates	O	O	I-T031
were	O	O	O
divided	O	O	O
in	O	O	O
eosinophilic	O	O	B-T025
(	O	O	O
46.30	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
neutrophilic	O	O	B-T025
and	O	O	O
mixed	O	O	O
.	O	O	O

An	O	O	O
association	O	O	B-T080
was	O	O	O
found	O	O	O
between	O	O	O
the	O	O	O
eosinophilic	O	O	B-T031
infiltrate	O	O	I-T031
and	O	O	O
clinical	O	O	B-T081
scores	O	O	I-T081
of	O	O	O
greater	O	O	O
severity	O	O	B-T080
(	O	O	O
p	O	O	O
=	O	O	O
0.002	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
association	O	O	B-T080
shows	O	O	O
that	O	O	O
the	O	O	O
eosinophilic	O	O	B-T031
inflammatory	O	O	I-T031
infiltrates	O	O	I-T031
denote	O	O	O
high	O	O	O
clinical	O	O	B-T184
activity	O	O	I-T184
,	O	O	O
which	O	O	O
means	O	O	O
more	O	O	O
severe	O	O	B-T080
and	O	O	O
exuberant	O	O	O
clinical	O	O	B-T201
pictures	O	O	I-T201
of	O	O	O
the	O	O	O
disease	O	O	B-T047
.	O	O	O

-DOCSTART- (28100136)

Barriers	O	O	B-T080
to	O	O	O
access	O	O	B-T080
and	O	O	I-T080
uptake	O	O	I-T080
of	O	O	O
antiretroviral	O	O	B-T061
therapy	O	O	I-T061
among	O	O	O
HIV-positive	O	O	B-T034
men	O	O	B-T098
who	O	O	I-T098
have	O	O	I-T098
sex	O	O	I-T098
with	O	O	I-T098
men	O	O	I-T098
in	O	O	O
Hanoi	O	O	B-UnknownType
,	O	O	O
Vietnam	O	O	B-T083
:	O	O	O
from	O	O	O
HIV	O	O	B-T059
testing	O	O	I-T059
to	O	O	O
treatment	O	O	O

Little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
experiences	O	O	B-T041
of	O	O	O
Vietnamese	O	O	B-T098
men	O	O	B-T098
who	O	O	I-T098
have	O	O	I-T098
sex	O	O	I-T098
with	O	O	I-T098
men	O	O	I-T098
in	O	O	O
accessing	O	O	B-T082
HIV	O	O	B-T059
testing	O	O	I-T059
and	O	O	O
treatment	O	O	B-T061
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
explore	O	O	O
barriers	O	O	B-T080
to	O	O	O
access	O	O	B-T080
and	O	O	I-T080
uptake	O	O	I-T080
of	O	O	O
antiretroviral	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
ART	O	O	B-T061
)	O	O	O
among	O	O	O
HIV-positive	O	O	B-T034
men	O	O	B-T098
who	O	O	I-T098
have	O	O	I-T098
sex	O	O	I-T098
with	O	O	I-T098
men	O	O	I-T098
in	O	O	O
Hanoi	O	O	B-UnknownType
.	O	O	O

During	O	O	O
2015	O	O	O
,	O	O	O
we	O	O	O
conducted	O	O	O
qualitative	O	O	B-T080
interviews	O	O	B-T052
with	O	O	O
35	O	O	O
participants	O	O	B-T098
recruited	O	O	O
using	O	O	O
snowball	O	O	B-T062
sampling	O	O	I-T062
based	O	O	O
on	O	O	O
previous	O	O	O
research	O	O	B-T062
and	O	O	O
social	O	O	B-T098
networks	O	O	I-T098
.	O	O	O

Key	O	O	O
individual	O	O	O
impediments	O	O	O
to	O	O	O
ART	O	O	B-T061
uptake	O	O	O
included	O	O	O
inadequate	O	O	B-T080
preparation	O	O	B-T052
for	O	O	O
a	O	O	O
positive	O	O	B-T033
diagnosis	O	O	B-T033
and	O	O	O
the	O	O	O
dual	O	O	O
stigmatisation	O	O	B-T078
of	O	O	O
homosexuality	O	O	B-T054
and	O	O	O
HIV	O	O	B-T005
and	O	O	O
its	O	O	O
consequences	O	O	B-T062
,	O	O	O
leading	O	O	O
to	O	O	O
fear	O	O	B-T041
of	O	O	O
disclosure	O	O	B-T055
of	O	O	O
HIV	O	O	B-T033
status	O	O	I-T033
.	O	O	O

Health	O	O	B-T093
system	O	O	I-T093
barriers	O	O	B-T080
included	O	O	O
lack	O	O	O
of	O	O	O
clarity	O	O	O
and	O	O	O
consistency	O	O	B-T080
about	O	O	O
how	O	O	O
to	O	O	O
register	O	O	O
for	O	O	O
and	O	O	O
access	O	O	B-T080
ART	O	O	B-T061
,	O	O	O
failure	O	O	O
to	O	O	O
protect	O	O	O
patient	O	O	B-T101
confidentiality	O	O	B-T078
and	O	O	O
a	O	O	O
reticence	O	O	O
by	O	O	O
providers	O	O	B-T169
to	O	O	O
discuss	O	O	O
sexual	O	O	B-T041
identity	O	O	I-T041
and	O	O	O
same-sex	O	O	B-T054
issues	O	O	I-T054
.	O	O	O

Results	O	O	O
suggest	O	O	O
fundamental	O	O	O
problems	O	O	O
in	O	O	O
the	O	O	O
way	O	O	O
HIV	O	O	B-T059
testing	O	O	I-T059
is	O	O	O
currently	O	O	O
delivered	O	O	O
in	O	O	O
Hanoi	O	O	B-UnknownType
,	O	O	O
including	O	O	O
a	O	O	O
lack	O	O	O
of	O	O	O
client-centred	O	O	O
counselling	O	O	B-T058
,	O	O	O
peer	O	O	B-T061
support	O	O	I-T061
and	O	O	O
clear	O	O	B-T058
referral	O	O	I-T058
pathways	O	O	O
.	O	O	O

Overcoming	O	O	O
these	O	O	O
barriers	O	O	B-T080
will	O	O	O
require	O	O	O
educating	O	O	O
men	O	O	B-T098
who	O	O	I-T098
have	O	O	I-T098
sex	O	O	I-T098
with	O	O	I-T098
men	O	O	I-T098
about	O	O	O
the	O	O	O
benefits	O	O	B-T081
of	O	O	O
routine	O	O	B-T060
testing	O	O	I-T060
,	O	O	O
improving	O	O	B-T080
access	O	O	B-T080
to	O	O	O
quality	O	O	O
diagnostic	O	O	B-T058
services	O	O	I-T058
and	O	O	O
building	O	O	O
a	O	O	O
safe	O	O	O
,	O	O	O
confidential	O	O	B-T033
treatment	O	O	B-T061
environment	O	O	B-T082
for	O	O	O
HIV-positive	O	O	B-T034
men	O	O	O
to	O	O	O
access	O	O	O
,	O	O	O
receive	O	O	B-T052
and	O	O	I-T052
remain	O	O	I-T052
in	O	O	I-T052
care	O	O	I-T052
.	O	O	O

-DOCSTART- (28100698)

Cdc45	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
loading	O	O	B-T052
of	O	O	O
human	O	O	B-T116
RPA	O	O	I-T116
onto	O	O	O
single-stranded	O	O	O
DNA	O	O	O

Cell	O	O	B-T116
division	O	O	I-T116
cycle	O	O	I-T116
protein	O	O	I-T116
45	O	O	I-T116
(	O	O	O
Cdc45	O	O	B-T116
)	O	O	O
is	O	O	O
an	O	O	O
essential	O	O	O
component	O	O	O
of	O	O	O
the	O	O	O
eukaryotic	O	O	B-T204
replicative	O	O	B-T080
DNA	O	O	B-T116
helicase	O	O	I-T116
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
human	O	O	B-T116
Cdc45	O	O	I-T116
forms	O	O	O
a	O	O	O
complex	O	O	B-T104
with	O	O	O
the	O	O	O
single-stranded	O	O	B-T116
DNA	O	O	I-T116
(	O	O	I-T116
ssDNA	O	O	I-T116
)	O	O	I-T116
binding	O	O	I-T116
protein	O	O	I-T116
RPA	O	O	I-T116
.	O	O	O

Moreover	O	O	O
,	O	O	O
it	O	O	O
actively	O	O	O
loads	O	O	B-T052
RPA	O	O	B-T116
onto	O	O	O
nascent	O	O	O
ssDNA	O	O	B-T114
.	O	O	O

Pull-down	O	O	B-T059
assays	O	O	I-T059
and	O	O	O
surface	O	O	B-T063
plasmon	O	O	I-T063
resonance	O	O	I-T063
studies	O	O	I-T063
revealed	O	O	O
that	O	O	O
Cdc45	O	O	B-T116
-	O	O	O
bound	O	O	B-T044
RPA	O	O	B-T116
complexed	O	O	B-T104
with	O	O	O
ssDNA	O	O	B-T114
in	O	O	O
the	O	O	O
8	O	O	O
-	O	O	O
10	O	O	O
nucleotide	O	O	B-T044
binding	O	O	I-T044
mode	O	O	O
,	O	O	O
but	O	O	O
dissociated	O	O	B-T044
when	O	O	O
RPA	O	O	O
covered	O	O	O
a	O	O	O
30-mer	O	O	B-T086
.	O	O	O

Real-time	O	O	B-T059
analysis	O	O	I-T059
of	O	O	O
RPA	O	O	B-T116
-	O	O	O
ssDNA	O	O	B-T114
binding	O	O	B-T044
demonstrated	O	O	O
that	O	O	O
Cdc45	O	O	B-T116
catalytically	O	O	O
loaded	O	O	B-T052
RPA	O	O	O
onto	O	O	O
ssDNA	O	O	O
.	O	O	O

This	O	O	O
placement	O	O	B-T080
reaction	O	O	B-T169
required	O	O	O
physical	O	O	B-T067
contacts	O	O	I-T067
of	O	O	O
Cdc45	O	O	B-T116
with	O	O	O
the	O	O	O
RPA70A	O	O	B-T087
subdomain	O	O	I-T087
.	O	O	O

Our	O	O	O
results	O	O	O
imply	O	O	O
that	O	O	O
Cdc45	O	O	B-T116
controlled	O	O	O
stabilization	O	O	B-T061
of	O	O	O
the	O	O	O
8-	O	O	O
nt	O	O	B-T114
RPA	O	O	B-T116
binding	O	O	B-T044
mode	O	O	B-T169
,	O	O	O
the	O	O	O
subsequent	O	O	O
RPA	O	O	O
transition	O	O	O
into	O	O	O
30-mer	O	O	B-T086
mode	O	O	O
and	O	O	O
facilitated	O	O	O
an	O	O	O
ordered	O	O	O
binding	O	O	O
to	O	O	O
ssDNA	O	O	B-T114
.	O	O	O

We	O	O	O
propose	O	O	O
that	O	O	O
a	O	O	O
Cdc45	O	O	B-T116
-mediated	O	O	O
loading	O	O	B-T052
guarantees	O	O	O
a	O	O	O
seamless	O	O	O
deposition	O	O	B-T169
of	O	O	O
RPA	O	O	B-T116
on	O	O	O
newly	O	O	O
emerging	O	O	O
ssDNA	O	O	B-T114
at	O	O	O
the	O	O	O
nascent	O	O	O
replication	O	O	B-T026
fork	O	O	I-T026
.	O	O	O

-DOCSTART- (28101782)

The	O	O	O
antineoplastic	O	O	B-T109
drug	O	O	I-T109
,	O	O	O
trastuzumab	O	O	B-T116
,	O	O	O
dysregulates	O	O	B-T033
metabolism	O	O	B-T040
in	O	O	O
iPSC	O	O	B-T025
-derived	O	O	O
cardiomyocytes	O	O	O

The	O	O	O
targeted	O	O	B-T061
ERBB2	O	O	I-T061
therapy	O	O	I-T061
,	O	O	O
trastuzumab	O	O	B-T116
,	O	O	O
has	O	O	O
had	O	O	O
a	O	O	O
tremendous	O	O	O
impact	O	O	B-T080
on	O	O	O
management	O	O	B-T058
of	O	O	O
patients	O	O	B-T101
with	O	O	O
HER2	O	O	B-T116
+	O	O	I-T191
breast	O	O	I-T191
cancer	O	O	I-T191
,	O	O	O
leading	O	O	O
to	O	O	O
development	O	O	B-T169
and	O	O	O
increased	O	O	B-T081
use	O	O	O
of	O	O	O
further	O	O	O
HER2	O	O	O
targeted	O	O	B-T061
therapies	O	O	I-T061
.	O	O	O

The	O	O	O
major	O	O	O
clinical	O	O	B-T080
side	O	O	B-T046
effect	O	O	I-T046
is	O	O	O
cardiotoxicity	O	O	B-T037
but	O	O	O
the	O	O	O
mechanism	O	O	B-T169
is	O	O	O
largely	O	O	O
unknown	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
basis	O	O	O
that	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
is	O	O	O
known	O	O	O
to	O	O	O
be	O	O	O
altered	O	O	B-T169
in	O	O	O
multiple	O	O	B-T081
models	O	O	B-T170
of	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
,	O	O	O
we	O	O	O
examined	O	O	O
differential	O	O	B-T045
gene	O	O	I-T045
expression	O	O	I-T045
of	O	O	O
iPSC	O	O	B-T025
-derived	O	O	O
cardiomyocytes	O	O	B-T025
treated	O	O	B-T169
at	O	O	O
day	O	O	B-T079
11	O	O	O
with	O	O	O
the	O	O	O
ERBB2	O	O	B-T116
targeted	O	O	O
monoclonal	O	O	B-T116
antibody	O	O	I-T116
,	O	O	O
trastuzumab	O	O	B-T116
for	O	O	O
48	O	O	O
h	O	O	O
and	O	O	O
the	O	O	O
small	O	O	B-T121
molecule	O	O	I-T121
tyrosine	O	O	I-T121
kinase	O	O	I-T121
inhibitor	O	O	I-T121
of	O	O	O
EGFR	O	O	B-T116
and	O	O	O
ERBB2	O	O	O
.	O	O	O

Transcriptome	O	O	B-T059
sequencing	O	O	I-T059
was	O	O	O
performed	O	O	B-T169
on	O	O	O
four	O	O	O
replicates	O	O	B-T080
from	O	O	O
each	O	O	O
group	O	O	B-T078
(	O	O	O
48	O	O	O
h	O	O	O
untreated	O	O	O
,	O	O	O
48	O	O	O
h	O	O	O
trastuzumab	O	O	B-T116
and	O	O	O
48	O	O	O
h	O	O	O
lapatinib	O	O	B-T109
)	O	O	O
and	O	O	O
differential	O	O	B-T045
gene	O	O	I-T045
expression	O	O	I-T045
analyses	O	O	B-T062
were	O	O	O
performed	O	O	O
on	O	O	O
each	O	O	O
treatment	O	O	B-T169
group	O	O	O
relative	O	O	O
to	O	O	O
untreated	O	O	O
cardiomyocytes	O	O	B-T025
.	O	O	O

517	O	O	O
and	O	O	O
1358	O	O	O
genes	O	O	B-T028
were	O	O	O
differentially	O	O	B-T045
expressed	O	O	I-T045
,	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
,	O	O	O
respectively	O	O	O
in	O	O	O
cardiomyocytes	O	O	B-T025
treated	O	O	B-T169
with	O	O	O
trastuzumab	O	O	B-T116
and	O	O	O
lapatinib	O	O	B-T109
.	O	O	O

Gene	O	O	B-T170
ontology	O	O	I-T170
analyses	O	O	B-T062
revealed	O	O	O
in	O	O	O
cardiomyocytes	O	O	B-T025
treated	O	O	B-T169
with	O	O	O
trastuzumab	O	O	B-T116
,	O	O	O
significant	O	O	B-T078
down-regulation	O	O	B-T044
of	O	O	O
genes	O	O	B-T028
involved	O	O	O
in	O	O	O
small	O	O	B-T040
molecule	O	O	I-T040
metabolism	O	O	I-T040
(	O	O	O
p	O	O	O
=	O	O	O
3.22	O	O	O
�	O	O	O
—	O	O	O
10(-9	O	O	O
)	O	O	O
)	O	O	O
and	O	O	O
cholesterol	O	O	B-T109
(	O	O	O
p	O	O	O
=	O	O	O
0.01	O	O	O
)	O	O	O
and	O	O	O
sterol	O	O	B-T109
(	O	O	O
p	O	O	O
=	O	O	O
0.03	O	O	O
)	O	O	O
processing	O	O	O
.	O	O	O

We	O	O	O
next	O	O	O
measured	O	O	B-T080
glucose	O	O	B-T043
uptake	O	O	I-T043
and	O	O	O
lactate	O	O	B-T109
production	O	O	B-T169
in	O	O	O
iPSC	O	O	B-T025
-derived	O	O	O
cardiomyocytes	O	O	B-T025
13	O	O	O
days	O	O	B-T079
post-plating	O	O	O
,	O	O	O
treated	O	O	B-T169
with	O	O	O
trastuzumab	O	O	B-T116
up	O	O	O
to	O	O	O
96	O	O	O
h.	O	O	O
We	O	O	O
observed	O	O	B-T169
significantly	O	O	B-T081
decreased	O	O	B-T081
glucose	O	O	O
uptake	O	O	O
from	O	O	O
the	O	O	O
media	O	O	B-T130
of	O	O	O
iPSC	O	O	O
-derived	O	O	O
cardiomyocytes	O	O	O
treated	O	O	O
with	O	O	O
trastuzumab	O	O	O
as	O	O	O
early	O	O	O
as	O	O	O
24	O	O	O
h	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
consistently	O	O	B-T080
up	O	O	O
to	O	O	O
96	O	O	O
h	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.03	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
study	O	O	B-T062
suggests	O	O	O
dysregulation	O	O	B-T033
of	O	O	O
cardiac	O	O	B-T023
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
metabolism	O	O	B-T040
as	O	O	O
key	O	O	O
elements	O	O	O
of	O	O	O
ERBB2	O	O	B-T028
signaling	O	O	B-T044
that	O	O	O
could	O	O	O
potentially	O	O	B-T080
be	O	O	O
early	O	O	O
biomarkers	O	O	B-T201
of	O	O	O
cardiotoxicity	O	O	B-T037
.	O	O	O

-DOCSTART- (28102508)

Simvastatin	O	O	B-T109
Promotes	O	O	O
Hematoma	O	O	B-T046
Absorption	O	O	B-T070
and	O	O	O
Reduces	O	O	O
Hydrocephalus	O	O	B-T047
Following	O	O	O
Intraventricular	O	O	B-T046
Hemorrhage	O	O	I-T046
in	O	O	O
Part	O	O	O
by	O	O	O
Upregulating	O	O	B-T044
CD36	O	O	O

We	O	O	O
previously	O	O	O
found	O	O	O
that	O	O	O
hematoma	O	O	B-T046
worsens	O	O	B-T033
hydrocephalus	O	O	B-T047
after	O	O	O
intraventricular	O	O	B-T046
hemorrhage	O	O	I-T046
(	O	O	O
IVH	O	O	B-T046
)	O	O	O
via	O	O	O
increasing	O	O	B-T169
iron	O	O	B-T046
deposition	O	O	I-T046
and	O	O	O
aggravating	O	O	O
ependymal	O	O	B-T024
cilia	O	O	B-T026
injury	O	O	B-T037
;	O	O	O
therefore	O	O	O
,	O	O	O
promoting	O	O	O
hematoma	O	O	O
absorption	O	O	B-T070
may	O	O	O
be	O	O	O
a	O	O	O
promising	O	O	O
strategy	O	O	O
for	O	O	O
IVH	O	O	O
.	O	O	O

Recently	O	O	O
,	O	O	O
some	O	O	O
investigations	O	O	O
imply	O	O	O
that	O	O	O
simvastatin	O	O	B-T109
has	O	O	O
the	O	O	O
ability	O	O	O
of	O	O	O
accelerating	O	O	O
hematoma	O	O	B-T046
absorption	O	O	B-T070
.	O	O	O

Thus	O	O	O
,	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
designed	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
simvastatin	O	O	B-T109
for	O	O	O
IVH	O	O	B-T046
in	O	O	O
rats	O	O	B-T015
.	O	O	O

Intracerebral	O	O	B-T046
hemorrhage	O	O	I-T046
with	O	O	O
ventricular	O	O	O
extension	O	O	O
was	O	O	O
induced	O	O	O
in	O	O	O
adult	O	O	B-T032
male	O	O	I-T032
Sprague-Dawley	O	O	B-T015
rats	O	O	I-T015
after	O	O	O
autologous	O	O	B-T061
blood	O	O	I-T061
injection	O	O	I-T061
.	O	O	O

Simvastatin	O	O	B-T109
or	O	O	O
vehicle	O	O	B-T122
was	O	O	O
administered	O	O	B-T061
orally	O	O	I-T061
at	O	O	O
1	O	O	O
day	O	O	O
after	O	O	O
IVH	O	O	B-T046
and	O	O	O
then	O	O	O
daily	O	O	O
for	O	O	O
1	O	O	O
week	O	O	O
.	O	O	O

MRI	O	O	B-T060
studies	O	O	I-T060
were	O	O	O
performed	O	O	O
to	O	O	O
measure	O	O	B-T169
the	O	O	O
volumes	O	O	B-T059
of	O	O	O
intracranial	O	O	B-T029
hematoma	O	O	B-T046
and	O	O	O
lateral	O	O	B-T030
ventricle	O	O	I-T030
at	O	O	O
days	O	O	O
1	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
7	O	O	O
,	O	O	O
14	O	O	O
,	O	O	O
and	O	O	O
28	O	O	O
after	O	O	O
IVH	O	O	B-T046
.	O	O	O

Motor	O	O	B-T038
and	O	O	O
neurocognitive	O	O	B-T038
functions	O	O	I-T038
were	O	O	O
assessed	O	O	B-T052
at	O	O	O
days	O	O	O
1	O	O	O
to	O	O	O
7	O	O	O
and	O	O	O
23	O	O	O
to	O	O	O
28	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Iron	O	O	B-T046
deposition	O	O	I-T046
,	O	O	O
iron	O	O	B-T121
-related	O	O	O
protein	O	O	B-T045
expression	O	O	I-T045
,	O	O	O
ependymal	O	O	B-T033
damage	O	O	I-T033
,	O	O	O
and	O	O	O
histology	O	O	B-T169
were	O	O	O
detected	O	O	B-T033
at	O	O	O
day	O	O	O
28	O	O	O
.	O	O	O

Expression	O	O	B-T045
of	O	O	O
CD36	O	O	B-T028
scavenger	O	O	B-T116
receptor	O	O	I-T116
(	O	O	O
facilitating	O	O	O
phagocytosis	O	O	B-T043
)	O	O	O
was	O	O	O
examined	O	O	B-T033
at	O	O	O
day	O	O	O
3	O	O	O
after	O	O	O
IVH	O	O	B-T046
using	O	O	O
western	O	O	B-T059
blotting	O	O	I-T059
and	O	O	O
immunofluorescence	O	O	B-T059
.	O	O	O

Simvastatin	O	O	B-T109
significantly	O	O	O
increased	O	O	B-T081
hematoma	O	O	B-T046
absorption	O	O	B-T070
ratio	O	O	B-T081
,	O	O	O
reduced	O	O	B-T080
ventricular	O	O	B-T078
volume	O	O	I-T078
,	O	O	O
and	O	O	O
attenuated	O	O	B-T033
neurological	O	O	I-T033
dysfunction	O	O	I-T033
post-	O	O	O
IVH	O	O	B-T046
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
less	O	O	B-T033
iron	O	O	I-T033
accumulation	O	O	I-T033
and	O	O	O
more	O	O	O
cilia	O	O	B-T026
survival	O	O	B-T081
was	O	O	O
observed	O	O	O
in	O	O	O
the	O	O	O
simvastatin	O	O	B-T109
group	O	O	O
when	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
control	O	O	B-T096
.	O	O	O

What	O	O	O
's	O	O	O
more	O	O	O
,	O	O	O
higher	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
CD36	O	O	B-T028
was	O	O	O
detected	O	O	B-T033
around	O	O	O
the	O	O	O
hematoma	O	O	B-T046
after	O	O	O
simvastatin	O	O	B-T109
administration	O	O	B-T061
.	O	O	O

Simvastatin	O	O	B-T109
significantly	O	O	O
enhanced	O	O	O
brain	O	O	B-T023
hematoma	O	O	B-T046
absorption	O	O	B-T070
,	O	O	O
alleviated	O	O	B-T047
hydrocephalus	O	O	I-T047
,	O	O	O
and	O	O	O
improved	O	O	B-T033
neurological	O	O	B-T080
recovery	O	O	B-T040
after	O	O	O
experimental	O	O	B-T080
IVH	O	O	B-T046
,	O	O	O
which	O	O	O
may	O	O	O
in	O	O	O
part	O	O	O
by	O	O	O
upregulating	O	O	B-T044
CD36	O	O	B-T028
expression	O	O	B-T045
.	O	O	O

Our	O	O	O
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
early	O	O	O
simvastatin	O	O	B-T109
use	O	O	O
may	O	O	O
be	O	O	O
a	O	O	O
novel	O	O	B-T080
therapy	O	O	B-T061
for	O	O	O
IVH	O	O	B-T046
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28103582)

AMPK	O	O	B-T116
-	O	O	O
autophagy	O	O	B-T043
inhibition	O	O	B-T052
sensitizes	O	O	O
icaritin	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
anti-colorectal	O	O	B-T033
cancer	O	O	I-T033
cell	O	O	O
activity	O	O	O

The	O	O	O
current	O	O	B-T079
research	O	O	B-T062
studied	O	O	O
the	O	O	O
potential	O	O	B-T080
effect	O	O	I-T080
of	O	O	O
autophagy	O	O	B-T043
on	O	O	O
icaritin	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
anti-colorectal	O	O	B-T033
cancer	O	O	I-T033
(	O	O	O
CRC	O	O	B-T191
)	O	O	O
cell	O	O	B-T043
activity	O	O	I-T043
.	O	O	O

Treatment	O	O	B-T169
of	O	O	O
icaritin	O	O	B-T109
in	O	O	O
both	O	O	O
primary	O	O	B-T080
and	O	O	O
established	O	O	B-T080
(	O	O	O
HT-29	O	O	B-T025
)	O	O	O
CRC	O	O	B-T191
cells	O	O	B-T025
induced	O	O	B-T169
feedback	O	O	B-T052
activation	O	O	I-T052
of	O	O	O
autophagy	O	O	B-T043
,	O	O	O
evidenced	O	O	O
by	O	O	O
p62	O	O	B-T028
degradation	O	O	B-T044
,	O	O	O
Beclin-1	O	O	B-T028
and	O	O	O
autophagy-related	O	O	B-T028
gene-5	O	O	I-T028
(	O	O	O
ATG-5	O	O	B-T028
)	O	O	O
upregulation	O	O	B-T044
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
light	O	O	B-T116
chain	O	O	I-T116
3B	O	O	I-T116
(LC3B)-	O	O	O
GFP	O	O	B-T116
puncta	O	O	O
formation	O	O	B-T169
.	O	O	O

Pharmacological	O	O	B-T169
inhibiting	O	O	B-T052
of	O	O	O
autophagy	O	O	B-T043
dramatically	O	O	O
potentiated	O	O	O
icaritin	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
CRC	O	O	B-T191
cell	O	O	B-T043
death	O	O	I-T043
and	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
shRNA	O	O	B-T114
-mediated	O	O	O
knockdown	O	O	B-T063
of	O	O	O
Beclin-1	O	O	B-T028
or	O	O	O
ATG-5	O	O	B-T028
also	O	O	O
sensitized	O	O	O
icaritin	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
CRC	O	O	B-T191
cell	O	O	B-T043
death	O	O	I-T043
and	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

Icaritin	O	O	B-T109
activated	O	O	B-T052
AMP-activated	O	O	B-T116
protein	O	O	I-T116
kinase	O	O	I-T116
(	O	O	O
AMPK	O	O	B-T116
)	O	O	O
signaling	O	O	B-T043
in	O	O	O
CRC	O	O	B-T191
cells	O	O	B-T025
,	O	O	O
functioning	O	O	B-T169
as	O	O	O
the	O	O	O
upstream	O	O	O
signaling	O	O	O
for	O	O	O
autophagy	O	O	B-T043
activation	O	O	B-T052
.	O	O	O

shRNA	O	O	B-T114
/	O	O	O
siRNA	O	O	B-T114
-mediated	O	O	O
knockdown	O	O	B-T063
of	O	O	O
AMPKα1	O	O	B-T028
inhibited	O	O	B-T080
icaritin	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
autophagy	O	O	B-T043
activation	O	O	B-T052
,	O	O	O
but	O	O	O
exacerbated	O	O	B-T080
CRC	O	O	B-T191
cell	O	O	B-T043
death	O	O	I-T043
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
the	O	O	O
AMPK	O	O	B-T116
activator	O	O	O
compound	O	O	B-T121
13	O	O	I-T121
(	O	O	O
C13	O	O	B-T121
)	O	O	O
or	O	O	O
the	O	O	O
autophagy	O	O	B-T043
activator	O	O	O
MHY1485	O	O	B-T109
attenuated	O	O	B-T052
icaritin	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
cytotoxicity	O	O	B-T049
.	O	O	O

In	O	O	O
nude	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
icaritin	O	O	B-T109
(	O	O	O
oral	O	O	O
administration)-	O	O	O
induced	O	O	B-T169
HT-29	O	O	B-T025
tumor	O	O	B-T191
growth	O	O	I-T191
inhibition	O	O	B-T052
was	O	O	O
potentiated	O	O	O
when	O	O	O
combined	O	O	O
with	O	O	O
AMPKα1	O	O	B-T028
shRNA	O	O	B-T114
knockdown	O	O	B-T063
in	O	O	O
tumors	O	O	B-T191
.	O	O	O

We	O	O	O
conclude	O	O	O
that	O	O	O
feedback	O	O	B-T052
activation	O	O	I-T052
of	O	O	O
AMPK	O	O	B-T116
-	O	O	O
autophagy	O	O	B-T043
pathway	O	O	B-T044
could	O	O	O
be	O	O	O
a	O	O	O
primary	O	O	O
resistance	O	O	B-T169
factor	O	O	B-T169
of	O	O	O
icaritin	O	O	B-T109
.	O	O	O

-DOCSTART- (28105970)

Classification	O	O	B-T185
of	O	O	O
Edible	O	O	B-T168
Oils	O	O	I-T168
Based	O	O	O
on	O	O	O
ATR-FTIR	O	O	B-T062
Spectral	O	O	B-T078
Information	O	O	I-T078
During	O	O	O
a	O	O	O
Long	O	O	O
Heating	O	O	O
Treatment	O	O	O

Identification	O	O	B-T080
of	O	O	O
oil	O	O	B-T168
type	O	O	B-T080
and	O	O	O
its	O	O	O
QC	O	O	B-T169
are	O	O	O
important	O	O	O
concerns	O	O	O
in	O	O	O
food	O	O	B-T093
control	O	O	I-T093
laboratories	O	O	I-T093
.	O	O	O

Classifying	O	O	B-T185
edible	O	O	B-T168
oils	O	O	I-T168
that	O	O	O
have	O	O	O
not	O	O	O
been	O	O	O
used	O	O	O
(	O	O	O
i.e.	O	O	O
,	O	O	O
unheated	O	O	B-T169
)	O	O	O
with	O	O	O
the	O	O	O
aid	O	O	O
of	O	O	O
vibrational	O	O	B-T059
spectroscopy	O	O	I-T059
has	O	O	O
previously	O	O	O
been	O	O	O
reported	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
classification	O	O	B-T185
of	O	O	O
used	O	O	O
(	O	O	O
i.e.	O	O	O
,	O	O	O
heat-treated	O	O	B-T169
)	O	O	O
oils	O	O	B-T168
needs	O	O	O
special	O	O	O
attention	O	O	O
.	O	O	O

The	O	O	O
effect	O	O	B-T080
of	O	O	O
long	O	O	B-T079
heating	O	O	I-T079
times	O	O	I-T079
on	O	O	O
the	O	O	O
classification	O	O	B-T185
of	O	O	O
four	O	O	O
kinds	O	O	O
of	O	O	O
edible	O	O	B-T168
oils	O	O	I-T168
(	O	O	O
canola	O	O	B-T109
,	O	O	O
corn	O	O	B-T109
,	O	O	O
frying	O	O	B-T168
,	O	O	O
and	O	O	O
sunflower	O	O	B-T109
)	O	O	O
based	O	O	O
on	O	O	O
attenuated	O	O	B-T062
total	O	O	I-T062
reflectance	O	O	I-T062
(ATR)-FTIR	O	O	I-T062
spectra	O	O	I-T062
was	O	O	O
surveyed	O	O	B-T062
.	O	O	O

The	O	O	O
sampling	O	O	B-T078
was	O	O	O
done	O	O	O
on	O	O	O
the	O	O	O
oils	O	O	B-T168
during	O	O	O
a	O	O	O
36	O	O	O
h	O	O	O
heating	O	O	B-T067
process	O	O	I-T067
(	O	O	O
at	O	O	O
170	O	O	O
°	O	O	O
C	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
ATR-FTIR	O	O	B-T062
spectra	O	O	I-T062
of	O	O	O
the	O	O	O
samples	O	O	B-T167
were	O	O	O
collected	O	O	B-T169
in	O	O	O
the	O	O	O
range	O	O	O
of	O	O	O
4000	O	O	O
-	O	O	O
550	O	O	O
cm-1	O	O	O
.	O	O	O

Interval	O	O	B-T081
extended	O	O	I-T081
canonical	O	O	I-T081
variates	O	O	I-T081
analysis	O	O	I-T081
(	O	O	O
ECVA	O	O	B-T081
)	O	O	O
,	O	O	O
as	O	O	O
a	O	O	O
variable	O	O	B-T080
selection	O	O	I-T080
and	O	O	O
classification	O	O	B-T185
tool	O	O	O
,	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
best	O	O	O
intervals	O	O	B-T079
during	O	O	O
the	O	O	O
heating	O	O	B-T067
procedure	O	O	I-T067
for	O	O	O
classification	O	O	O
.	O	O	O

Principal	O	O	B-T081
component	O	O	I-T081
analysis	O	O	I-T081
discriminate	O	O	B-T081
analysis	O	O	I-T081
,	O	O	O
partial	O	O	B-T081
least-squares	O	O	I-T081
discriminate	O	O	I-T081
analysis	O	O	I-T081
,	O	O	O
and	O	O	O
ECVA	O	O	B-T081
were	O	O	O
performed	O	O	O
on	O	O	O
the	O	O	O
selected	O	O	O
intervals	O	O	B-T079
and	O	O	O
on	O	O	O
the	O	O	O
total	O	O	B-T079
heating	O	O	I-T079
time	O	O	I-T079
.	O	O	O

The	O	O	O
effect	O	O	O
of	O	O	O
autoscaling	O	O	B-T033
and	O	O	O
mean-centering	O	O	B-T033
,	O	O	O
as	O	O	O
data	O	O	B-T170
preprocessing	O	O	I-T170
methods	O	O	I-T170
,	O	O	O
was	O	O	O
also	O	O	O
investigated	O	O	B-T169
.	O	O	O

The	O	O	O
ECVA	O	O	B-T081
method	O	O	I-T081
resulted	O	O	O
in	O	O	O
the	O	O	O
best	O	O	O
performances	O	O	O
for	O	O	O
classification	O	O	B-T185
,	O	O	O
with	O	O	O
a	O	O	O
94	O	O	O
%	O	O	O
cross-validated	O	O	B-T081
nonerror	O	O	I-T081
rate	O	O	I-T081
(	O	O	O
one	O	O	O
misclassification	O	O	O
)	O	O	O
for	O	O	O
the	O	O	O
heating	O	O	B-T067
process	O	O	I-T067
times	O	O	B-T079
of	O	O	O
24	O	O	O
-	O	O	O
27	O	O	O
and	O	O	O
33	O	O	O
-	O	O	O
36	O	O	O
h.	O	O	O

-DOCSTART- (28106239)

Intravitreal	O	O	B-T169
chemotherapy	O	O	B-T061
in	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
vitreous	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
retinoblastoma	O	O	O

To	O	O	O
evaluate	O	O	O
the	O	O	O
therapeutic	O	O	B-T080
outcome	O	O	I-T080
of	O	O	O
intravitreal	O	O	B-T169
melphalan	O	O	B-T116
injection	O	O	B-T122
in	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
vitreous	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
patients	O	O	B-T101
with	O	O	O
retinoblastoma	O	O	B-T191
.	O	O	O

We	O	O	O
particularly	O	O	O
aimed	O	O	O
to	O	O	O
assess	O	O	O
whether	O	O	O
higher	O	O	B-T080
melphalan	O	O	B-T116
dose	O	O	B-T081
with	O	O	O
lower	O	O	B-T080
number	O	O	B-T081
of	O	O	O
injections	O	O	B-T122
was	O	O	O
more	O	O	O
effective	O	O	B-T080
and	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
fewer	O	O	B-T081
side	O	O	B-T046
effects	O	O	I-T046
.	O	O	O

This	O	O	O
retrospective	O	O	B-T062
,	O	O	O
interventional	O	O	B-T062
,	O	O	O
noncomparative	O	O	B-T062
,	O	O	O
and	O	O	O
nonrandomized	O	O	B-T062
study	O	O	I-T062
included	O	O	O
39	O	O	O
eyes	O	O	B-T023
of	O	O	O
37	O	O	O
patients	O	O	B-T101
.	O	O	O

Vitreous	O	O	B-T033
seeds	O	O	I-T033
were	O	O	O
classified	O	O	B-T185
as	O	O	O
dust	O	O	B-T191
,	O	O	O
sphere	O	O	B-T191
,	O	O	O
and	O	O	O
cloud	O	O	B-T191
types	O	O	I-T191
.	O	O	O

Intravitreal	O	O	B-T169
injections	O	O	B-T122
were	O	O	O
performed	O	O	B-T169
through	O	O	B-T169
pars	O	O	B-T023
plana	O	O	I-T023
free	O	O	O
of	O	O	O
any	O	O	O
visible	O	O	B-T080
tumor	O	O	B-T191
using	O	O	B-T169
30-G	O	O	B-T074
needle	O	O	I-T074
.	O	O	O

Response	O	O	B-T040
of	O	O	I-T040
the	O	O	I-T040
seeds	O	O	I-T040
(	O	O	O
disappearance	O	O	B-T033
,	O	O	O
conversion	O	O	B-T169
into	O	O	O
inactive	O	O	B-T033
debris	O	O	I-T033
,	O	O	O
or	O	O	O
progression	O	O	B-T191
)	O	O	O
and	O	O	O
enucleation	O	O	B-T061
rate	O	O	B-T081
were	O	O	O
determined	O	O	O
as	O	O	O
outcome	O	O	B-T080
measures	O	O	B-T081
.	O	O	O

All	O	O	O
patients	O	O	B-T101
previously	O	O	O
received	O	O	B-T080
systemic	O	O	B-T061
or	O	O	O
intra-arterial	O	O	B-T061
chemotherapy	O	O	I-T061
.	O	O	O

Vitreous	O	O	B-T033
seeding	O	O	I-T033
was	O	O	O
primary	O	O	B-T080
in	O	O	O
54	O	O	O
%	O	O	O
of	O	O	O
eyes	O	O	B-T023
and	O	O	O
secondary	O	O	B-T080
in	O	O	O
46	O	O	O
%	O	O	O
of	O	O	O
eyes	O	O	O
.	O	O	O

Vitreous	O	O	B-T033
seeds	O	O	I-T033
were	O	O	O
classified	O	O	B-T185
as	O	O	O
dust	O	O	B-T191
in	O	O	O
9	O	O	O
(	O	O	O
23.1	O	O	O
%	O	O	O
)	O	O	O
eyes	O	O	B-T023
,	O	O	O
sphere	O	O	B-T191
in	O	O	O
24	O	O	O
(	O	O	O
61.5	O	O	O
%	O	O	O
)	O	O	O
eyes	O	O	O
,	O	O	O
and	O	O	O
cloud	O	O	B-T191
in	O	O	O
6	O	O	O
(	O	O	O
15.4	O	O	O
%	O	O	O
)	O	O	O
eyes	O	O	O
.	O	O	O

Melphalan	O	O	B-T116
dose	O	O	B-T081
varied	O	O	O
between	O	O	O
20	O	O	O
and	O	O	O
40	O	O	O
µg	O	O	O
and	O	O	O
20	O	O	O
(	O	O	O
51.3	O	O	O
%	O	O	O
)	O	O	O
eyes	O	O	B-T023
received	O	O	B-T080
>	O	O	O
30	O	O	O
µg	O	O	O
.	O	O	O

The	O	O	O
total	O	O	B-T081
number	O	O	I-T081
of	O	O	O
injections	O	O	B-T122
was	O	O	O
70	O	O	O
(	O	O	O
range	O	O	O
1	O	O	O
-	O	O	O
5	O	O	O
,	O	O	O
mean	O	O	B-T081
1.8	O	O	O
per	O	O	O
eye	O	O	B-T023
)	O	O	O
.	O	O	O

Various	O	O	B-T081
types	O	O	B-T080
of	O	O	O
regression	O	O	B-T046
were	O	O	O
obtained	O	O	B-T169
in	O	O	O
27	O	O	O
(	O	O	O
69.2	O	O	O
%	O	O	O
)	O	O	O
eyes	O	O	B-T023
.	O	O	O

Sphere-type	O	O	B-T191
seeds	O	O	I-T191
were	O	O	O
the	O	O	O
most	O	O	B-T081
responsive	O	O	B-T169
to	O	O	O
melphalan	O	O	B-T116
.	O	O	O

Nonresponse	O	O	B-T033
and	O	O	O
disease	O	O	B-T046
progression	O	O	I-T046
were	O	O	O
noted	O	O	B-T080
in	O	O	O
12	O	O	O
(	O	O	O
30.8	O	O	O
%	O	O	O
)	O	O	O
eyes	O	O	B-T023
.	O	O	O

After	O	O	O
a	O	O	O
mean	O	O	B-T081
follow-up	O	O	B-T058
of	O	O	O
11.8	O	O	O
months	O	O	B-T079
,	O	O	O
17	O	O	O
(	O	O	O
44	O	O	O
%	O	O	O
)	O	O	O
eyes	O	O	B-T023
were	O	O	O
enucleated	O	O	B-T037
.	O	O	O

Vitreous	O	O	B-T046
hemorrhage	O	O	I-T046
(	O	O	O
18	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
retinal	O	O	B-T023
pigment	O	O	I-T023
epithelial	O	O	I-T023
alterations	O	O	B-T078
(	O	O	O
8	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
the	O	O	O
most	O	O	B-T081
common	O	O	B-T081
side	O	O	B-T046
effects	O	O	I-T046
.	O	O	O

Intravitreal	O	O	B-T169
melphalan	O	O	B-T116
at	O	O	O
30	O	O	O
-	O	O	O
40	O	O	O
µg	O	O	O
in	O	O	O
1	O	O	O
or	O	O	O
2	O	O	O
injections	O	O	B-T122
proved	O	O	O
effective	O	O	B-T080
in	O	O	O
69.2	O	O	O
%	O	O	O
of	O	O	O
eyes	O	O	B-T023
with	O	O	O
vitreous	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

-DOCSTART- (28108399)

Fine	O	O	B-T082
structure	O	O	I-T082
of	O	O	O
the	O	O	O
anterior	O	O	B-T023
median	O	O	I-T023
eyes	O	O	I-T023
of	O	O	O
the	O	O	O
funnel	O	O	B-T082
-	O	O	O
web	O	O	B-T204
spider	O	O	I-T204
Agelena	O	O	B-T204
labyrinthica	O	O	I-T204
(	O	O	O
Araneae	O	O	B-T204
:	O	O	O
Agelenidae	O	O	B-T204
)	O	O	O

Only	O	O	O
few	O	O	O
electron	O	O	B-T059
microscopic	O	O	I-T059
studies	O	O	I-T059
exist	O	O	O
on	O	O	O
the	O	O	O
structure	O	O	B-T082
of	O	O	O
the	O	O	O
main	O	O	O
eyes	O	O	B-T023
(	O	O	O
anterior	O	O	B-T023
median	O	O	I-T023
eyes	O	O	I-T023
,	O	O	O
AME	O	O	B-T023
)	O	O	O
of	O	O	O
web	O	O	B-T204
spiders	O	O	I-T204
.	O	O	O

The	O	O	O
present	O	O	O
paper	O	O	O
provides	O	O	O
details	O	O	O
on	O	O	O
the	O	O	O
anatomy	O	O	B-T017
of	O	O	O
the	O	O	O
AME	O	O	B-T023
in	O	O	O
the	O	O	O
funnel-web	O	O	O
spider	O	O	B-T204
Agelena	O	O	B-T204
labyrinthica	O	O	I-T204
.	O	O	O

The	O	O	O
retina	O	O	B-T023
consists	O	O	O
of	O	O	O
two	O	O	O
separate	O	O	O
regions	O	O	B-T082
with	O	O	O
differently	O	O	O
arranged	O	O	O
photoreceptor	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Its	O	O	O
central	O	O	B-T082
part	O	O	I-T082
has	O	O	O
sensory	O	O	B-T026
cells	O	O	I-T026
with	O	O	O
rhabdomeres	O	O	B-T026
on	O	O	O
2	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
or	O	O	O
4	O	O	O
sides	O	O	O
,	O	O	O
whereas	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
ventral	O	O	B-T082
retina	O	O	B-T023
have	O	O	O
only	O	O	O
two	O	O	O
rhabdomeres	O	O	O
on	O	O	O
opposite	O	O	O
sides	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
rhabdomeres	O	O	B-T026
of	O	O	O
the	O	O	O
ventral	O	O	B-T082
retina	O	O	B-T023
are	O	O	O
arranged	O	O	O
in	O	O	O
a	O	O	O
specific	O	O	O
way	O	O	O
:	O	O	O
Whereas	O	O	O
in	O	O	O
the	O	O	O
most	O	O	O
ventral	O	O	O
part	O	O	O
they	O	O	O
form	O	O	O
long	O	O	B-T082
tangential	O	O	I-T082
rows	O	O	I-T082
,	O	O	O
those	O	O	O
towards	O	O	O
the	O	O	O
center	O	O	B-T082
are	O	O	O
detached	O	O	O
and	O	O	O
are	O	O	O
arranged	O	O	O
radially	O	O	O
.	O	O	O

All	O	O	O
sensory	O	O	B-T026
cells	O	O	I-T026
are	O	O	O
wrapped	O	O	O
by	O	O	O
unpigmented	O	O	B-T033
pigment	O	O	B-T025
cell	O	O	I-T025
processes	O	O	B-T043
.	O	O	O

In	O	O	O
agelenid	O	O	B-T204
spiders	O	O	B-T204
the	O	O	O
axons	O	O	B-T026
of	O	O	O
the	O	O	O
sensory	O	O	B-T026
cells	O	O	I-T026
exit	O	O	O
from	O	O	O
the	O	O	O
middle	O	O	O
of	O	O	O
the	O	O	O
cell	O	O	B-T026
body	O	O	I-T026
;	O	O	O
their	O	O	O
fine	O	O	B-T082
structure	O	O	I-T082
and	O	O	O
course	O	O	O
through	O	O	O
the	O	O	O
eye	O	O	B-T074
cup	O	O	I-T074
is	O	O	O
described	O	O	O
in	O	O	O
detail	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
central	O	O	B-T082
part	O	O	I-T082
of	O	O	O
the	O	O	O
retina	O	O	B-T023
efferent	O	O	O
nerve	O	O	B-T026
fibres	O	O	I-T026
were	O	O	O
found	O	O	O
forming	O	O	O
synapses	O	O	B-T030
along	O	O	O
the	O	O	O
distal	O	O	B-T082
region	O	O	I-T082
of	O	O	O
the	O	O	O
receptor	O	O	B-T026
cells	O	O	I-T026
.	O	O	O

A	O	O	O
muscle	O	O	B-T024
is	O	O	O
attached	O	O	O
laterally	O	O	O
to	O	O	O
each	O	O	O
eye	O	O	B-T074
cup	O	O	I-T074
that	O	O	O
allows	O	O	O
mainly	O	O	O
rotational	O	O	B-T082
movements	O	O	B-T039
of	O	O	O
the	O	O	O
eyes	O	O	B-T023
.	O	O	O

The	O	O	O
optical	O	O	B-T070
performance	O	O	I-T070
(	O	O	O
image	O	O	B-T077
resolution	O	O	I-T077
)	O	O	O
of	O	O	O
these	O	O	O
main	O	O	O
eyes	O	O	B-T023
with	O	O	O
relatively	O	O	O
few	O	O	O
visual	O	O	B-T025
cells	O	O	I-T025
is	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (28111379)

Knocking	O	O	B-T063
down	O	O	I-T063
TCF8	O	O	B-T028
inhibits	O	O	O
high	O	O	B-T033
glucose	O	O	I-T033
-	O	O	O
and	O	O	O
angiotensin	O	O	B-T116
II	O	O	I-T116
-	O	O	O
induced	O	O	B-T169
epithelial	O	O	B-T043
to	O	O	I-T043
mesenchymal	O	O	I-T043
transition	O	O	I-T043
in	O	O	O
podocytes	O	O	O

Epithelial	O	O	B-T043
to	O	O	I-T043
mesenchymal	O	O	I-T043
transition	O	O	I-T043
(	O	O	O
EMT	O	O	B-T043
)	O	O	O
is	O	O	O
a	O	O	O
physiological	O	O	B-T039
phenomenon	O	O	I-T039
in	O	O	O
mammalian	O	O	B-T015
embryogenesis	O	O	B-T042
by	O	O	O
which	O	O	O
epithelial	O	O	B-T025
cells	O	O	I-T025
become	O	O	O
mesenchymal	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

Studies	O	O	O
have	O	O	O
indicated	O	O	O
that	O	O	O
an	O	O	O
inappropriate	O	O	O
EMT	O	O	B-T043
plays	O	O	O
a	O	O	O
key	O	O	O
role	O	O	O
in	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
pathogenic	O	O	B-T033
processes	O	O	B-T067
such	O	O	O
as	O	O	O
embryonic	O	O	B-T042
development	O	O	I-T042
and	O	O	O
tumor	O	O	B-T191
metastasis	O	O	I-T191
.	O	O	O

Moreover	O	O	O
,	O	O	O
recent	O	O	O
studies	O	O	O
have	O	O	O
indicated	O	O	O
EMT	O	O	B-T043
also	O	O	O
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
renal	O	O	B-T047
fibrosis	O	O	I-T047
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	O
study	O	O	O
,	O	O	O
glucose	O	O	B-T109
and	O	O	O
angiotensin	O	O	B-T116
II	O	O	I-T116
promoted	O	O	O
EMT	O	O	B-T043
in	O	O	O
podocytes	O	O	B-T025
as	O	O	O
well	O	O	O
as	O	O	O
changes	O	O	O
in	O	O	O
the	O	O	O
cellular	O	O	B-T201
morphology	O	O	I-T201
of	O	O	O
podocytes	O	O	O
.	O	O	O

A	O	O	O
high	O	O	B-T080
concentration	O	O	B-T081
of	O	O	O
glucose	O	O	B-T109
and	O	O	O
angiotensin	O	O	B-T116
II	O	O	I-T116
also	O	O	O
promoted	O	O	O
podocyte	O	O	B-T025
movement	O	O	B-T040
and	O	O	O
migration	O	O	B-T043
.	O	O	O

Moreover	O	O	O
,	O	O	O
a	O	O	O
high	O	O	B-T080
concentration	O	O	B-T081
of	O	O	O
glucose	O	O	B-T109
and	O	O	O
angiotensin	O	O	B-T116
II	O	O	I-T116
promoted	O	O	O
TCF8	O	O	B-T028
expression	O	O	B-T045
.	O	O	O

Inhibiting	O	O	B-T052
TCF8	O	O	B-T028
expression	O	O	B-T045
with	O	O	O
siRNA	O	O	B-T114
reversed	O	O	O
EMT	O	O	B-T043
in	O	O	O
podocytes	O	O	B-T025
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
a	O	O	O
high	O	O	B-T080
concentration	O	O	B-T081
of	O	O	O
glucose	O	O	B-T109
and	O	O	O
angiotensin	O	O	B-T116
.	O	O	O

Inhibiting	O	O	B-T052
TCF8	O	O	B-T028
expression	O	O	B-T045
also	O	O	O
reversed	O	O	O
changes	O	O	O
in	O	O	O
cellular	O	O	B-T201
morphology	O	O	I-T201
and	O	O	O
podocyte	O	O	B-T025
movement	O	O	B-T040
and	O	O	O
migration	O	O	B-T043
.	O	O	O

Therefore	O	O	O
,	O	O	O
glucose	O	O	B-T109
and	O	O	O
angiotensin	O	O	B-T116
II	O	O	I-T116
may	O	O	O
promote	O	O	O
EMT	O	O	B-T043
in	O	O	O
podocytes	O	O	B-T025
via	O	O	O
TCF8	O	O	B-T028
.	O	O	O

-DOCSTART- (28113047)

Temporal	O	O	O
upregulation	O	O	B-T044
of	O	O	O
host	O	O	B-T116
surface	O	O	I-T116
receptors	O	O	I-T116
provides	O	O	O
a	O	O	O
window	O	O	O
of	O	O	O
opportunity	O	O	O
for	O	O	O
bacterial	O	O	B-T040
adhesion	O	O	I-T040
and	O	O	O
disease	O	O	O

Host	O	O	B-T116
surface	O	O	I-T116
receptors	O	O	I-T116
provide	O	O	O
bacteria	O	O	B-T007
with	O	O	O
a	O	O	O
foothold	O	O	O
from	O	O	O
which	O	O	O
to	O	O	O
attach	O	O	B-T067
,	O	O	O
colonize	O	O	O
and	O	O	O
,	O	O	O
in	O	O	O
some	O	O	O
cases	O	O	O
,	O	O	O
invade	O	O	O
tissue	O	O	B-T024
and	O	O	O
elicit	O	O	O
human	O	O	B-T016
disease	O	O	B-T047
.	O	O	O

In	O	O	O
this	O	O	O
review	O	O	O
,	O	O	O
we	O	O	O
discuss	O	O	O
several	O	O	O
key	O	O	O
host	O	O	B-T116
receptors	O	O	I-T116
and	O	O	O
cognate	O	O	B-T026
adhesins	O	O	I-T026
that	O	O	O
function	O	O	O
in	O	O	O
bacterial	O	O	B-T007
pathogenesis	O	O	B-T046
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
we	O	O	O
examine	O	O	O
the	O	O	O
elevated	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
host	O	O	B-T116
surface	O	O	I-T116
receptors	O	O	I-T116
such	O	O	O
as	O	O	O
CEACAM-1	O	O	B-T116
,	O	O	O
CEACAM-6	O	O	B-T116
,	O	O	O
ICAM-1	O	O	B-T116
and	O	O	O
PAFR	O	O	B-T116
in	O	O	O
response	O	O	B-T039
to	O	O	I-T039
specific	O	O	I-T039
stimuli	O	O	I-T039
.	O	O	O

We	O	O	O
explore	O	O	O
how	O	O	O
upregulated	O	O	B-T044
receptors	O	O	I-T044
,	O	O	O
in	O	O	O
turn	O	O	O
,	O	O	O
expose	O	O	O
the	O	O	O
host	O	O	B-T001
to	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
bacterial	O	O	B-T047
infections	O	O	I-T047
in	O	O	O
the	O	O	O
respiratory	O	O	B-T022
tract	O	O	I-T022
.	O	O	O

It	O	O	O
is	O	O	O
apparent	O	O	O
that	O	O	O
exploitation	O	O	O
of	O	O	O
receptor	O	O	B-T116
induction	O	O	B-T169
for	O	O	O
bacterial	O	O	B-T040
adherence	O	O	I-T040
is	O	O	O
not	O	O	O
unique	O	O	O
to	O	O	O
one	O	O	O
body	O	O	B-T022
system	O	O	I-T022
,	O	O	O
but	O	O	O
is	O	O	O
also	O	O	O
observed	O	O	O
in	O	O	O
the	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
,	O	O	O
gastrointestinal	O	O	B-T022
and	O	O	O
urogenital	O	O	B-T022
systems	O	O	I-T022
.	O	O	O

Prokaryotic	O	O	B-T001
pathogens	O	O	B-T046
which	O	O	O
utilize	O	O	O
this	O	O	O
mechanism	O	O	O
for	O	O	O
their	O	O	O
infectivity	O	O	B-T046
include	O	O	O
Streptococcus	O	O	B-T007
pneumoniae	O	O	I-T007
,	O	O	O
Haemophilus	O	O	B-T007
influenzae	O	O	I-T007
,	O	O	O
Neisseria	O	O	B-T007
meningitidis	O	O	I-T007
and	O	O	O
Escherichia	O	O	B-T007
coli	O	O	I-T007
.	O	O	O

A	O	O	O
number	O	O	O
of	O	O	O
approaches	O	O	O
have	O	O	O
been	O	O	O
used	O	O	O
,	O	O	O
in	O	O	O
both	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
and	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
experimental	O	O	I-T062
models	O	O	I-T062
,	O	O	O
to	O	O	O
inhibit	O	O	O
bacterial	O	O	B-T040
attachment	O	O	I-T040
to	O	O	O
temporally	O	O	O
expressed	O	O	B-T045
host	O	O	B-T116
receptors	O	O	I-T116
.	O	O	O

Some	O	O	O
of	O	O	O
these	O	O	O
novel	O	O	O
strategies	O	O	O
may	O	O	O
advance	O	O	O
future	O	O	O
targeted	O	O	B-T169
interventions	O	O	B-T058
for	O	O	O
the	O	O	O
prevention	O	O	B-T061
and	O	O	O
treatment	O	O	B-T061
of	O	O	O
bacterial	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

-DOCSTART- (28115057)

Optogenetic	O	O	B-T063
Demonstration	O	O	B-T052
of	O	O	O
Functional	O	O	B-T169
Innervation	O	O	B-T042
of	O	O	O
Mouse	O	O	B-T015
Colon	O	O	B-T023
by	O	O	O
Neurons	O	O	B-T025
Derived	O	O	O
From	O	O	O
Transplanted	O	O	B-T169
Neural	O	O	O
Cells	O	O	O

Cell	O	O	B-T061
therapy	O	O	I-T061
offers	O	O	O
the	O	O	O
potential	O	O	O
to	O	O	O
treat	O	O	B-T169
gastrointestinal	O	O	B-T047
motility	O	O	I-T047
disorders	O	O	I-T047
caused	O	O	O
by	O	O	O
diseased	O	O	B-T025
or	O	O	O
absent	O	O	B-T169
enteric	O	O	B-T082
neurons	O	O	B-T025
.	O	O	O

We	O	O	O
examined	O	O	O
whether	O	O	O
neurons	O	O	B-T025
generated	O	O	O
from	O	O	O
transplanted	O	O	B-T169
enteric	O	O	B-T082
neural	O	O	B-T025
cells	O	O	I-T025
provide	O	O	O
a	O	O	O
functional	O	O	B-T169
innervation	O	O	B-T042
of	O	O	O
bowel	O	O	B-T023
smooth	O	O	B-T024
muscle	O	O	I-T024
in	O	O	O
mice	O	O	B-T015
.	O	O	O

Enteric	O	O	B-T082
neural	O	O	B-T025
cells	O	O	I-T025
expressing	O	O	O
the	O	O	O
light-sensitive	O	O	B-T116
ion	O	O	I-T116
channel	O	O	I-T116
,	O	O	O
channelrhodopsin	O	O	B-T116
,	O	O	O
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
fetal	O	O	B-T169
or	O	O	O
postnatal	O	O	B-T079
mouse	O	O	B-T015
bowel	O	O	B-T023
and	O	O	O
transplanted	O	O	B-T169
into	O	O	O
the	O	O	O
distal	O	O	B-T024
colon	O	O	I-T024
of	O	O	O
3-	O	O	O
to	O	O	O
4-	O	O	O
week	O	O	B-T079
-old	O	O	O
wild-type	O	O	B-T028
recipient	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Intracellular	O	O	B-T082
electrophysiological	O	O	B-T059
recordings	O	O	I-T059
of	O	O	O
responses	O	O	B-T169
to	O	O	O
light	O	O	B-UnknownType
stimulation	O	O	I-UnknownType
of	O	O	O
the	O	O	O
transplanted	O	O	B-T169
cells	O	O	B-T025
were	O	O	O
made	O	O	O
from	O	O	O
colonic	O	O	B-T023
smooth	O	O	B-T025
muscle	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
recipient	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Electrical	O	O	B-T067
stimulation	O	O	I-T067
of	O	O	O
endogenous	O	O	B-T169
enteric	O	O	B-T082
neurons	O	O	B-T025
was	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
control	O	O	B-T096
.	O	O	O

The	O	O	O
axons	O	O	B-T026
of	O	O	O
graft	O	O	B-T024
-derived	O	O	O
neurons	O	O	B-T025
formed	O	O	O
a	O	O	O
plexus	O	O	B-T023
in	O	O	O
the	O	O	O
circular	O	O	B-T023
muscle	O	O	I-T023
layer	O	O	I-T023
.	O	O	O

Selective	O	O	B-T067
stimulation	O	O	I-T067
of	O	O	O
graft	O	O	B-T024
-derived	O	O	O
cells	O	O	B-T025
by	O	O	O
light	O	O	B-T070
resulted	O	O	O
in	O	O	O
excitatory	O	O	B-T042
and	O	O	O
inhibitory	O	O	B-T042
junction	O	O	I-T042
potentials	O	O	I-T042
,	O	O	O
the	O	O	O
electrical	O	O	B-T169
events	O	O	B-T051
underlying	O	O	O
contraction	O	O	B-T039
and	O	O	O
relaxation	O	O	B-T042
,	O	O	O
respectively	O	O	O
,	O	O	O
in	O	O	O
colonic	O	O	B-T023
muscle	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Graft	O	O	B-T024
-derived	O	O	O
excitatory	O	O	B-T025
and	O	O	O
inhibitory	O	O	B-T025
motor	O	O	B-T025
neurons	O	O	I-T025
released	O	O	O
the	O	O	O
same	O	O	O
neurotransmitters	O	O	B-T123
as	O	O	O
endogenous	O	O	B-T169
motor	O	O	O
neurons	O	O	O
-	O	O	O
acetylcholine	O	O	B-T109
and	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
adenosine	O	O	B-T114
triphosphate	O	O	I-T114
and	O	O	O
nitric	O	O	B-T121
oxide	O	O	I-T121
,	O	O	O
respectively	O	O	O
.	O	O	O

Graft	O	O	B-T024
-derived	O	O	O
neurons	O	O	B-T025
also	O	O	O
included	O	O	O
interneurons	O	O	B-T025
that	O	O	O
provided	O	O	O
synaptic	O	O	O
inputs	O	O	O
to	O	O	O
motor	O	O	O
neurons	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
pharmacologic	O	O	B-T080
properties	O	O	I-T080
of	O	O	O
interneurons	O	O	O
varied	O	O	O
with	O	O	O
the	O	O	O
age	O	O	B-T032
of	O	O	O
the	O	O	O
donors	O	O	B-T098
from	O	O	O
which	O	O	O
enteric	O	O	B-T082
neural	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
obtained	O	O	O
.	O	O	O

Enteric	O	O	B-T082
neural	O	O	B-T025
cells	O	O	I-T025
transplanted	O	O	B-T169
into	O	O	O
the	O	O	O
bowel	O	O	B-T023
give	O	O	O
rise	O	O	O
to	O	O	O
multiple	O	O	B-T081
functional	O	O	B-T169
types	O	O	B-T080
of	O	O	O
neurons	O	O	B-T025
that	O	O	O
integrate	O	O	O
and	O	O	O
provide	O	O	O
a	O	O	O
functional	O	O	O
innervation	O	O	B-T042
of	O	O	O
the	O	O	O
smooth	O	O	B-T024
muscle	O	O	I-T024
of	O	O	O
the	O	O	O
bowel	O	O	B-T023
wall	O	O	I-T023
.	O	O	O

Circuits	O	O	B-UnknownType
composed	O	O	O
of	O	O	O
both	O	O	O
motor	O	O	B-T025
neurons	O	O	I-T025
and	O	O	O
interneurons	O	O	B-T025
were	O	O	O
established	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
age	O	O	B-T032
at	O	O	O
which	O	O	O
cells	O	O	B-T025
are	O	O	O
isolated	O	O	O
influences	O	O	O
the	O	O	O
neurotransmitter	O	O	B-T123
phenotype	O	O	B-T032
of	O	O	O
interneurons	O	O	O
that	O	O	O
are	O	O	O
generated	O	O	O
.	O	O	O

-DOCSTART- (28117211)

Assessment	O	O	B-T058
of	O	O	O
Vascular	O	O	B-T074
Stent	O	O	I-T074
Heating	O	O	B-T070
with	O	O	O
Repetitive	O	O	O
Transcranial	O	O	O
Magnetic	O	O	O
Stimulation	O	O	O

A	O	O	O
high	O	O	O
proportion	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
stroke	O	O	B-T047
do	O	O	O
not	O	O	O
qualify	O	O	O
for	O	O	O
repetitive	O	O	B-T061
transcranial	O	O	I-T061
magnetic	O	O	I-T061
stimulation	O	O	I-T061
(	O	O	O
rTMS	O	O	B-T061
)	O	O	O
clinical	O	O	B-T062
studies	O	O	I-T062
due	O	O	O
to	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
metallic	O	O	B-T074
stents	O	O	I-T074
.	O	O	O

The	O	O	O
ultimate	O	O	O
concern	O	O	O
is	O	O	O
that	O	O	O
any	O	O	O
metal	O	O	B-T197
could	O	O	O
become	O	O	O
heated	O	O	B-T070
due	O	O	O
to	O	O	O
eddy	O	O	B-T070
currents	O	O	I-T070
.	O	O	O

However	O	O	O
,	O	O	O
to	O	O	O
date	O	O	O
,	O	O	O
no	O	O	O
clinical	O	O	B-T170
safety	O	O	I-T170
data	O	O	I-T170
are	O	O	O
available	O	O	O
regarding	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
metallic	O	O	B-T074
stents	O	O	I-T074
heating	O	O	B-T070
with	O	O	O
rTMS	O	O	B-T061
.	O	O	O

We	O	O	O
tested	O	O	B-T169
the	O	O	O
safety	O	O	B-T062
of	O	O	O
common	O	O	O
rTMS	O	O	B-T061
protocols	O	O	B-T170
(	O	O	O
1	O	O	O
Hz	O	O	O
and	O	O	O
10	O	O	O
Hz	O	O	O
)	O	O	O
with	O	O	O
stents	O	O	B-T074
used	O	O	O
commonly	O	O	O
in	O	O	O
stroke	O	O	B-T047
,	O	O	O
nitinol	O	O	B-T122
and	O	O	O
elgiloy	O	O	B-T122
.	O	O	O

In	O	O	O
our	O	O	O
method	O	O	O
,	O	O	O
stents	O	O	B-T074
were	O	O	O
tested	O	O	B-T170
in	O	O	O
gelled	O	O	B-T167
saline	O	O	B-T167
at	O	O	O
2	O	O	O
different	O	O	O
locations	O	O	B-T082
:	O	O	O
at	O	O	B-T082
the	O	O	I-T082
center	O	O	I-T082
and	O	O	O
at	O	O	O
the	O	O	O
lobe	O	O	B-T023
of	O	O	O
the	O	O	O
coil	O	O	B-T074
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
at	O	O	O
each	O	O	O
location	O	O	B-T082
,	O	O	O
stent	O	O	B-T074
heating	O	O	B-T070
was	O	O	O
evaluated	O	O	B-T058
in	O	O	O
3	O	O	O
different	O	O	O
orientations	O	O	B-T082
:	O	O	O
parallel	O	O	B-T082
to	O	O	O
the	O	O	O
long	O	O	B-T082
axis	O	O	I-T082
of	O	O	O
coil	O	O	B-T074
,	O	O	O
parallel	O	O	O
to	O	O	O
the	O	O	O
short	O	O	B-T082
axis	O	O	I-T082
of	O	O	O
the	O	O	O
coil	O	O	O
,	O	O	O
and	O	O	O
perpendicular	O	O	B-T082
to	O	O	O
the	O	O	O
plane	O	O	O
of	O	O	O
the	O	O	O
coil	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
stents	O	O	B-T074
did	O	O	O
not	O	O	O
heat	O	O	B-T070
to	O	O	O
more	O	O	O
than	O	O	O
1	O	O	O
°	O	O	O
C	O	O	O
with	O	O	O
either	O	O	O
1	O	O	O
Hz	O	O	O
rTMS	O	O	B-T061
or	O	O	O
10	O	O	O
Hz	O	O	O
rTMS	O	O	O
in	O	O	O
any	O	O	O
configuration	O	O	O
or	O	O	O
orientation	O	O	B-T082
.	O	O	O

Heating	O	O	B-T070
in	O	O	O
general	O	O	O
was	O	O	O
greater	O	O	B-T081
at	O	O	O
the	O	O	O
lobe	O	O	B-T023
when	O	O	O
the	O	O	O
stent	O	O	B-T074
was	O	O	O
oriented	O	O	B-T082
perpendicularly	O	O	B-T082
.	O	O	O

Our	O	O	O
study	O	O	O
represents	O	O	O
a	O	O	O
new	O	O	O
method	O	O	O
for	O	O	O
ex	O	O	B-T169
vivo	O	O	I-T169
quantification	O	O	B-T081
of	O	O	O
stent	O	O	B-T074
heating	O	O	B-T070
.	O	O	O

We	O	O	O
have	O	O	O
found	O	O	O
that	O	O	O
heating	O	O	B-T070
of	O	O	O
stents	O	O	B-T074
was	O	O	O
well	O	O	O
below	O	O	O
the	O	O	O
Food	O	O	B-T093
and	O	O	I-T093
Drug	O	O	I-T093
Administration	O	O	I-T093
standards	O	O	B-T170
of	O	O	O
2	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
our	O	O	O
study	O	O	O
paves	O	O	O
the	O	O	O
way	O	O	O
for	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
testing	O	O	B-T169
of	O	O	O
rTMS	O	O	B-T061
(	O	O	O
≤10	O	O	O
Hz	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
implanted	O	O	B-T074
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
-	O	O	O
compatible	O	O	B-T080
stents	O	O	B-T074
in	O	O	O
animal	O	O	B-T008
studies	O	O	I-T008
.	O	O	O

When	O	O	O
planning	O	O	O
human	O	O	B-T016
safety	O	O	B-T062
studies	O	O	I-T062
though	O	O	O
,	O	O	O
geometry	O	O	B-T090
,	O	O	O
orientation	O	O	B-T082
,	O	O	O
and	O	O	O
location	O	O	B-T082
relative	O	O	O
to	O	O	O
the	O	O	O
coil	O	O	B-T074
would	O	O	O
be	O	O	O
important	O	O	O
to	O	O	O
consider	O	O	O
as	O	O	O
well	O	O	O
.	O	O	O

-DOCSTART- (28118200)

Clinical	O	O	B-T058
Observation	O	O	I-T058
of	O	O	O
Treatment	O	O	B-T169
of	O	O	O
Chronic	O	O	B-T046
Subdural	O	O	I-T046
Hematoma	O	O	I-T046
With	O	O	O
Novel	O	O	O
Double	O	O	O
Needle	O	O	O
Minimally	O	O	O
Invasive	O	O	O
Aspiration	O	O	O
Technology	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
explore	O	O	O
the	O	O	O
clinical	O	O	B-T080
effects	O	O	I-T080
,	O	O	O
including	O	O	O
the	O	O	O
prevention	O	O	O
of	O	O	O
complications	O	O	B-T046
,	O	O	O
of	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
chronic	O	O	B-T046
subdural	O	O	I-T046
hematoma	O	O	I-T046
with	O	O	O
double	O	O	B-T074
needle	O	O	I-T074
aspiration	O	O	I-T074
.	O	O	O

The	O	O	O
clinical	O	O	B-T170
data	O	O	I-T170
of	O	O	O
31	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T046
subdural	O	O	I-T046
hematoma	O	O	I-T046
treated	O	O	B-T169
by	O	O	O
double	O	O	B-T074
YL-1	O	O	I-T074
needle	O	O	I-T074
double	O	O	O
skull	O	O	B-T061
drilling	O	O	B-T061
and	O	O	O
31	O	O	O
controls	O	O	O
treated	O	O	O
by	O	O	O
traditional	O	O	O
drilling	O	O	O
and	O	O	O
drainage	O	O	B-T061
were	O	O	O
analyzed	O	O	O
retrospectively	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
YL-1	O	O	B-T074
needle	O	O	I-T074
group	O	O	B-T078
,	O	O	O
only	O	O	O
1	O	O	O
patient	O	O	B-T101
was	O	O	O
with	O	O	O
hematoma	O	O	B-T046
recurrence	O	O	B-T046
,	O	O	O
1	O	O	O
patient	O	O	O
was	O	O	O
with	O	O	O
intracranial	O	O	B-T047
pneumocephalus	O	O	I-T047
,	O	O	O
and	O	O	O
the	O	O	O
remaining	O	O	O
patients	O	O	B-T101
who	O	O	O
were	O	O	O
followed	O	O	O
up	O	O	O
for	O	O	O
3	O	O	O
months	O	O	B-T079
achieved	O	O	O
a	O	O	O
clinical	O	O	B-T033
cure	O	O	I-T033
.	O	O	O

In	O	O	O
the	O	O	O
traditional	O	O	B-T061
drilling	O	O	I-T061
and	O	O	O
drainage	O	O	B-T061
group	O	O	B-T078
,	O	O	O
13	O	O	O
patients	O	O	B-T101
were	O	O	O
with	O	O	O
hematoma	O	O	B-T046
recurrence	O	O	B-T046
within	O	O	O
3	O	O	O
months	O	O	B-T079
after	O	O	O
the	O	O	O
operation	O	O	B-T061
and	O	O	O
7	O	O	O
patients	O	O	O
were	O	O	O
with	O	O	O
postoperative	O	O	B-T079
intracranial	O	O	B-T047
pneumocephalus	O	O	I-T047
.	O	O	O

The	O	O	O
method	O	O	B-T170
of	O	O	O
double	O	O	B-T074
YL-1	O	O	I-T074
needle	O	O	I-T074
is	O	O	O
better	O	O	O
than	O	O	O
the	O	O	O
traditional	O	O	B-T061
drilling	O	O	I-T061
and	O	O	O
drainage	O	O	B-T061
method	O	O	I-T061
for	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
chronic	O	O	B-T046
subdural	O	O	I-T046
hematoma	O	O	I-T046
because	O	O	O
it	O	O	O
reduces	O	O	O
the	O	O	O
postoperative	O	O	B-T079
recurrence	O	O	B-T046
rate	O	O	O
and	O	O	O
complications	O	O	B-T046
.	O	O	O

-DOCSTART- (28118752)

The	O	O	O
impact	O	O	B-T080
of	O	O	O
adjunctive	O	O	B-T061
guanfacine	O	O	B-T109
extended	O	O	B-T122
release	O	O	I-T122
on	O	O	O
stimulant	O	O	B-T121
adherence	O	O	B-T169
in	O	O	O
children	O	O	B-T100
/	O	O	O
adolescents	O	O	B-T100
with	O	O	O
attention-deficit	O	O	B-T048
/	O	O	O
hyperactivity	O	O	O
disorder	O	O	O

To	O	O	O
assess	O	O	O
stimulant	O	O	B-T121
adherence	O	O	B-T169
among	O	O	O
children	O	O	B-T100
/	O	O	O
adolescents	O	O	B-T100
with	O	O	O
attention-deficit	O	O	B-T048
/	O	O	O
hyperactivity	O	O	B-T048
disorder	O	O	I-T048
(	O	O	O
ADHD	O	O	B-T048
)	O	O	O
augmenting	O	O	B-T120
stimulants	O	O	B-T121
with	O	O	O
guanfacine	O	O	B-T122
extended-release	O	O	I-T122
(	O	O	O
GXR	O	O	B-T122
)	O	O	O
.	O	O	O

Inclusion	O	O	B-T078
criteria	O	O	I-T078
:	O	O	O
6	O	O	O
-	O	O	O
17	O	O	O
years	O	O	B-T079
,	O	O	O
≥1	O	O	O
ADHD	O	O	B-T048
diagnosis	O	O	B-T033
,	O	O	O
≥1	O	O	O
long-acting	O	O	B-T121
and/or	O	O	O
short-acting	O	O	B-T121
stimulant	O	O	I-T121
with	O	O	O
GXR	O	O	B-T122
augmentation	O	O	B-T061
.	O	O	O

Modified	O	O	B-T081
medication	O	O	B-T058
possession	O	O	I-T081
ratio	O	O	I-T081
(	O	O	O
mMPR	O	O	B-T081
;	O	O	O
days	O	O	B-T079
medication	O	O	O
available	O	O	B-T169
/	O	O	O
days	O	O	O
in	O	O	O
period	O	O	B-T079
,	O	O	O
excluding	O	O	B-T169
medication	O	O	O
holidays	O	O	B-T052
)	O	O	O
was	O	O	O
assessed	O	O	O
;	O	O	O
mMPR	O	O	O
<	O	O	O
0.80	O	O	O
nonadherent	O	O	B-T033
.	O	O	O

Regression	O	O	B-T170
models	O	O	B-T170
assessed	O	O	B-T058
change	O	O	B-T169
in	O	O	O
mMPR	O	O	B-T081
adjusting	O	O	B-T169
for	O	O	O
demographic	O	O	B-T102
and	O	O	O
clinical	O	O	B-T201
characteristics	O	O	I-T201
.	O	O	O

Among	O	O	O
patients	O	O	B-T101
nonadherent	O	O	B-T033
to	O	O	O
stimulants	O	O	B-T121
pre	O	O	B-T079
-	O	O	O
augmentation	O	O	B-T061
(	O	O	O
n	O	O	O
=	O	O	O
165	O	O	O
)	O	O	O
,	O	O	O
unadjusted	O	O	B-T169
mean	O	O	O
(	O	O	O
SD	O	O	B-T081
)	O	O	O
pre	O	O	O
-	O	O	O
and	O	O	O
post	O	O	B-T079
-	O	O	O
stimulant	O	O	B-T121
mMPRs	O	O	B-T081
were	O	O	O
0.68	O	O	O
(	O	O	O
0.11	O	O	O
)	O	O	O
and	O	O	O
0.87	O	O	O
(	O	O	O
0.16	O	O	O
)	O	O	O
.	O	O	O

Adjusted	O	O	B-T169
mean	O	O	O
change	O	O	B-T169
in	O	O	O
mMPR	O	O	B-T081
was	O	O	O
0.20	O	O	O
for	O	O	O
long-acting	O	O	B-T121
versus	O	O	O
0.18	O	O	O
for	O	O	O
short-acting	O	O	B-T121
stimulants	O	O	I-T121
(	O	O	O
p	O	O	O
=	O	O	O
0.34	O	O	O
)	O	O	O
.	O	O	O

Among	O	O	O
patients	O	O	B-T101
nonadherent	O	O	B-T033
to	O	O	O
stimulants	O	O	B-T121
,	O	O	O
GXR	O	O	B-T122
augmentation	O	O	B-T061
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	B-T081
stimulant	O	O	B-T121
adherence	O	O	B-T169
.	O	O	O

-DOCSTART- (28118814)

Bxb1	O	O	B-T005
phage	O	O	I-T005
recombinase	O	O	B-T116
assists	O	O	O
genome	O	O	B-T063
engineering	O	O	I-T063
in	O	O	O
Drosophila	O	O	O
melanogaster	O	O	O

Rapid	O	O	B-T080
and	O	O	O
reliable	O	O	B-T080
genome	O	O	B-T063
modifications	O	O	I-T063
provide	O	O	O
the	O	O	O
basis	O	O	O
for	O	O	O
detailed	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
functional	O	O	B-T058
analysis	O	O	I-T058
of	O	O	O
any	O	O	O
genomic	O	O	B-T169
entity	O	O	I-T169
(	O	O	O
gene	O	O	B-T028
,	O	O	O
regulatory	O	O	B-T086
DNA	O	O	I-T086
,	O	O	O
non-coding	O	O	B-T114
RNA	O	O	I-T114
,	O	O	O
etc	O	O	O
)	O	O	O
.	O	O	O

With	O	O	O
the	O	O	O
advent	O	O	O
of	O	O	O
CRISPR	O	O	B-T114
/	O	O	O
Cas9	O	O	B-T063
genome	O	O	I-T063
editing	O	O	I-T063
technology	O	O	I-T063
,	O	O	O
manipulation	O	O	B-T063
of	O	O	O
a	O	O	O
particular	O	O	O
genomic	O	O	B-T028
locus	O	O	I-T028
has	O	O	O
become	O	O	O
a	O	O	O
routine	O	O	O
undertaking	O	O	O
in	O	O	O
variety	O	O	O
of	O	O	O
model	O	O	B-T001
organisms	O	O	I-T001
,	O	O	O
including	O	O	O
the	O	O	O
fruit	O	O	B-T204
fly	O	O	I-T204
Drosophila	O	O	I-T204
melanogaster	O	O	I-T204
.	O	O	O

To	O	O	O
further	O	O	O
diversify	O	O	O
the	O	O	O
available	O	O	O
tools	O	O	O
for	O	O	O
genome	O	O	B-T063
engineering	O	O	I-T063
,	O	O	O
we	O	O	O
successfully	O	O	O
harnessed	O	O	O
the	O	O	O
phage	O	O	B-T005
recombinase	O	O	B-T116
Bxb1	O	O	I-T116
to	O	O	O
perform	O	O	O
recombinase-mediated	O	O	O
cassette	O	O	O
exchange	O	O	O
(	O	O	O
RMCE	O	O	O
)	O	O	O
in	O	O	O
D.	O	O	B-T204
melanogaster	O	O	I-T204
.	O	O	O

We	O	O	O
demonstrate	O	O	O
that	O	O	O
Bxb1	O	O	B-T005
possesses	O	O	O
highly	O	O	O
efficient	O	O	O
recombinase	O	O	B-T045
activity	O	O	I-T045
and	O	O	O
could	O	O	O
be	O	O	O
used	O	O	O
alone	O	O	O
or	O	O	O
in	O	O	O
conjunction	O	O	O
with	O	O	O
other	O	O	O
currently	O	O	O
available	O	O	O
recombinases	O	O	B-T116
for	O	O	O
creating	O	O	O
platforms	O	O	O
for	O	O	O
cassette	O	O	O
exchange	O	O	O
of	O	O	O
targeted	O	O	B-T028
loci	O	O	I-T028
.	O	O	O

-DOCSTART- (28119222)

Tailor-made	O	O	B-T122
drug	O	O	I-T122
carrier	O	O	I-T122
:	O	O	O
Comparison	O	O	B-T052
of	O	O	O
formation-dependent	O	O	O
physicochemical	O	O	B-T080
properties	O	O	I-T080
within	O	O	O
self-assembled	O	O	B-T044
aggregates	O	O	B-T080
for	O	O	O
an	O	O	O
optimal	O	O	B-T080
drug	O	O	O
carrier	O	O	O

Self-assembled	O	O	B-T044
surfactant	O	O	B-T122
aggregates	O	O	B-T080
,	O	O	O
such	O	O	O
as	O	O	O
micelles	O	O	B-T109
and	O	O	O
vesicles	O	O	B-T104
,	O	O	O
have	O	O	O
been	O	O	O
investigated	O	O	O
for	O	O	O
their	O	O	O
application	O	O	B-T169
as	O	O	O
drug	O	O	B-T122
carriers	O	O	I-T122
in	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
various	O	O	O
diseases	O	O	B-T047
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
characteristics	O	O	B-T080
that	O	O	O
decide	O	O	O
which	O	O	O
aggregate	O	O	B-T080
is	O	O	O
the	O	O	O
best	O	O	B-T080
drug	O	O	B-T122
carrier	O	O	I-T122
for	O	O	O
each	O	O	O
disease	O	O	B-T047
have	O	O	O
not	O	O	O
yet	O	O	O
been	O	O	O
clarified	O	O	O
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
design	O	O	B-T052
an	O	O	O
optimal	O	O	B-T080
drug	O	O	B-T122
carrier	O	O	I-T122
for	O	O	O
each	O	O	O
disease	O	O	B-T047
,	O	O	O
various	O	O	O
kinds	O	O	O
of	O	O	O
self-assembled	O	O	B-T044
aggregates	O	O	B-T080
,	O	O	O
such	O	O	O
as	O	O	O
spherical	O	O	B-T109
micelles	O	O	I-T109
,	O	O	O
lens-like	O	O	B-T104
vesicles	O	O	I-T104
,	O	O	O
and	O	O	O
tube-like	O	O	B-T104
vesicles	O	O	I-T104
,	O	O	O
were	O	O	O
evaluated	O	O	O
by	O	O	O
"	O	O	O
multiple	O	O	B-T169
techniques	O	O	I-T169
"	O	O	O
including	O	O	O
dynamic	O	O	B-T059
light	O	O	I-T059
scattering	O	O	I-T059
,	O	O	O
differential	O	O	B-T059
scanning	O	O	I-T059
calorimetry	O	O	I-T059
,	O	O	O
nuclear	O	O	B-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
spectroscopy	O	O	I-T060
,	O	O	O
and	O	O	O
fluorescence	O	O	B-T059
measurement	O	O	I-T059
using	O	O	O
the	O	O	O
Laurdan	O	O	B-T109
probe	O	O	B-T074
.	O	O	O

These	O	O	O
studies	O	O	B-T062
led	O	O	O
to	O	O	O
the	O	O	O
compilation	O	O	O
of	O	O	O
a	O	O	O
database	O	O	B-T170
on	O	O	O
the	O	O	O
formation-dependent	O	O	O
properties	O	O	O
of	O	O	O
self-assembled	O	O	B-T044
aggregates	O	O	B-T080
.	O	O	O

As	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
physicochemical	O	O	B-T080
properties	O	O	I-T080
of	O	O	O
self-assembled	O	O	B-T044
aggregates	O	O	B-T080
and	O	O	O
their	O	O	O
functions	O	O	B-T169
as	O	O	O
drug	O	O	B-T122
carriers	O	O	I-T122
have	O	O	O
been	O	O	O
extensively	O	O	O
reported	O	O	O
,	O	O	O
this	O	O	O
database	O	O	B-T170
can	O	O	O
be	O	O	O
utilized	O	O	O
for	O	O	O
designing	O	O	O
an	O	O	O
optimal	O	O	B-T080
drug	O	O	B-T122
carrier	O	O	I-T122
,	O	O	O
i.e.	O	O	O
,	O	O	O
a	O	O	O
tailor-made	O	O	B-T122
drug	O	O	I-T122
carrier	O	O	I-T122
.	O	O	O

-DOCSTART- (28122499)

Uridine	O	O	B-T114
stimulate	O	O	O
laxative	O	O	B-T121
effect	O	O	B-T080
in	O	O	O
the	O	O	O
loperamide	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
constipation	O	O	B-T184
of	O	O	O
SD	O	O	B-T015
rats	O	O	I-T015
through	O	O	O
regulation	O	O	B-T044
of	O	O	O
the	O	O	O
mAChRs	O	O	B-T116
signaling	O	O	B-T044
pathway	O	O	I-T044
and	O	O	O
mucin	O	O	B-T116
secretion	O	O	O

Uridine	O	O	B-T114
(	O	O	O
Urd	O	O	B-T114
)	O	O	O
,	O	O	O
which	O	O	O
has	O	O	O
been	O	O	O
reported	O	O	B-T058
as	O	O	O
a	O	O	O
major	O	O	B-T080
component	O	O	O
of	O	O	O
RNA	O	O	B-T114
,	O	O	O
plays	O	O	O
an	O	O	O
important	O	O	B-T080
role	O	O	B-T077
in	O	O	O
various	O	O	O
biological	O	O	B-T038
process	O	O	I-T038
including	O	O	O
neuroprotection	O	O	B-T043
,	O	O	O
biochemical	O	O	B-UnknownType
modulation	O	O	I-UnknownType
and	O	O	O
glycolysis	O	O	B-T044
,	O	O	O
although	O	O	O
its	O	O	O
role	O	O	O
in	O	O	O
constipation	O	O	B-T184
has	O	O	O
yet	O	O	O
to	O	O	O
be	O	O	O
established	O	O	B-T080
.	O	O	O

Therefore	O	O	O
,	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
laxative	O	O	B-T121
effects	O	O	B-T080
of	O	O	O
Urd	O	O	B-T114
on	O	O	O
chronic	O	O	B-T079
constipation	O	O	B-T184
.	O	O	O

The	O	O	O
constipation	O	O	B-T184
phenotypes	O	O	B-T032
and	O	O	O
their	O	O	O
related	O	O	O
mechanisms	O	O	B-T169
were	O	O	O
investigated	O	O	B-T169
in	O	O	O
the	O	O	O
transverse	O	O	B-T023
colons	O	O	I-T023
of	O	O	O
SD	O	O	B-T015
rats	O	O	I-T015
with	O	O	O
loperamide	O	O	B-T109
(Lop)-	O	O	O
induced	O	O	B-T169
constipation	O	O	O
after	O	O	O
treatment	O	O	B-T061
with	O	O	O
100	O	O	O
mg/kg	O	O	O
of	O	O	O
Urd	O	O	B-T114
.	O	O	O

The	O	O	O
number	O	O	B-T081
,	O	O	O
weight	O	O	B-T081
and	O	O	O
water	O	O	B-T121
contents	O	O	B-T077
of	O	O	O
stools	O	O	B-T031
were	O	O	O
significantly	O	O	B-T078
higher	O	O	B-T080
in	O	O	O
the	O	O	O
Lop	O	O	B-T109
+	O	O	O
Urd	O	O	B-T114
treated	O	O	B-T033
group	O	O	B-T078
than	O	O	O
the	O	O	O
Lop	O	O	O
+	O	O	O
Vehicle	O	O	B-T122
treated	O	O	O
group	O	O	O
,	O	O	O
while	O	O	O
food	O	O	B-T040
intake	O	O	I-T040
and	O	O	O
water	O	O	B-T040
consumption	O	O	I-T040
of	O	O	O
the	O	O	O
same	O	O	O
group	O	O	O
were	O	O	O
maintained	O	O	O
at	O	O	O
a	O	O	O
constant	O	O	B-T080
level	O	O	B-T080
.	O	O	O

The	O	O	O
thickness	O	O	B-T080
of	O	O	O
the	O	O	O
mucosa	O	O	B-T024
layer	O	O	I-T024
,	O	O	O
muscle	O	O	B-T024
and	O	O	O
flat	O	O	B-T029
luminal	O	O	I-T029
surface	O	O	I-T029
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	O
goblet	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
paneth	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
lipid	O	O	B-T026
droplets	O	O	I-T026
were	O	O	O
enhanced	O	O	B-T052
in	O	O	O
the	O	O	O
Lop	O	O	B-T109
+	O	O	O
Urd	O	O	B-T114
treated	O	O	B-T033
group	O	O	B-T078
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
the	O	O	O
muscarinic	O	O	B-T116
acetylcholine	O	O	I-T116
receptors	O	O	I-T116
M2	O	O	I-T116
and	O	O	O
M3	O	O	B-T116
(	O	O	O
mAChR	O	O	B-T116
M2	O	O	I-T116
and	O	O	O
M3	O	O	O
)	O	O	O
at	O	O	O
the	O	O	O
transcriptional	O	O	B-T045
and	O	O	O
translational	O	O	B-T045
level	O	O	B-T080
was	O	O	O
recovered	O	O	B-T080
in	O	O	O
the	O	O	O
Lop	O	O	B-T109
+	O	O	O
Urd	O	O	B-T114
treated	O	O	B-T033
group	O	O	B-T078
,	O	O	O
while	O	O	O
some	O	O	O
markers	O	O	B-T201
such	O	O	O
as	O	O	O
Gα	O	O	B-T116
and	O	O	O
inositol	O	O	B-UnknownType
triphosphate	O	O	I-UnknownType
(	O	O	O
IP3	O	O	B-UnknownType
)	O	O	O
in	O	O	O
their	O	O	O
downstream	O	O	B-T082
signaling	O	O	B-T044
pathway	O	O	I-T044
were	O	O	O
completely	O	O	O
recovered	O	O	O
by	O	O	O
Urd	O	O	O
treatment	O	O	B-T061
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
ability	O	O	O
for	O	O	O
mucin	O	O	B-T116
secretion	O	O	B-T038
and	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
membrane	O	O	B-T116
water	O	O	I-T116
channel	O	O	I-T116
(	O	O	O
aquaporine	O	O	B-T116
8	O	O	I-T116
,	O	O	O
AQP8	O	O	B-T116
)	O	O	O
were	O	O	O
increased	O	O	B-T081
significantly	O	O	B-T078
in	O	O	O
the	O	O	O
Lop	O	O	B-T109
+	O	O	O
Urd	O	O	B-T114
treated	O	O	B-T033
group	O	O	B-T078
compared	O	O	B-T052
with	O	O	O
Lop	O	O	O
+	O	O	O
Vehicle	O	O	B-T122
treated	O	O	O
group	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
activity	O	O	B-T052
of	O	O	O
Urd	O	O	B-T114
was	O	O	O
confirmed	O	O	O
in	O	O	O
primary	O	O	B-T024
smooth	O	O	I-T024
muscle	O	O	I-T024
of	O	O	O
rat	O	O	B-T015
intestine	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
pRISMC	O	O	B-T025
)	O	O	O
based	O	O	O
on	O	O	O
Gα	O	O	B-T116
expression	O	O	B-T045
and	O	O	O
IP3	O	O	B-UnknownType
concentration	O	O	B-T081
.	O	O	O

The	O	O	O
results	O	O	B-T033
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
provide	O	O	O
the	O	O	O
first	O	O	O
strong	O	O	B-T080
evidence	O	O	B-T078
that	O	O	O
Urd	O	O	B-T114
can	O	O	O
be	O	O	O
considered	O	O	O
an	O	O	O
important	O	O	B-T080
candidate	O	O	O
for	O	O	O
improving	O	O	B-T080
chronic	O	O	B-T079
constipation	O	O	B-T184
induced	O	O	B-T169
by	O	O	O
Lop	O	O	B-T109
treatment	O	O	B-T061
in	O	O	O
animal	O	O	B-T008
models	O	O	I-T008
.	O	O	O

-DOCSTART- (28123107)

Characterization	O	O	B-T052
of	O	O	O
Phytochrome	O	O	B-T123
Interacting	O	O	I-T123
Factors	O	O	I-T123
from	O	O	O
the	O	O	O
Moss	O	O	B-T002
Physcomitrella	O	O	B-T002
patens	O	O	I-T002
Illustrates	O	O	O
Conservation	O	O	B-T080
of	O	O	O
Phytochrome	O	O	B-T123
Signaling	O	O	I-T123
Modules	O	O	I-T123
in	O	O	O
Land	O	O	O
Plants	O	O	O

Across	O	O	O
the	O	O	O
plant	O	O	B-T002
kingdom	O	O	I-T002
,	O	O	O
phytochrome	O	O	B-T116
(	O	O	O
PHY	O	O	B-T116
)	O	O	O
photoreceptors	O	O	B-T025
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
during	O	O	O
adaptive	O	O	B-T169
and	O	O	O
developmental	O	O	O
responses	O	O	B-T040
to	O	O	I-T040
light	O	O	I-T040
.	O	O	O

In	O	O	O
Arabidopsis	O	O	B-T002
thaliana	O	O	I-T002
,	O	O	O
light-activated	O	O	O
PHYs	O	O	B-T116
accumulate	O	O	O
in	O	O	O
the	O	O	O
nucleus	O	O	B-T026
,	O	O	O
where	O	O	O
they	O	O	O
regulate	O	O	O
downstream	O	O	B-T123
signaling	O	O	I-T123
components	O	O	I-T123
,	O	O	O
such	O	O	O
as	O	O	O
phytochrome	O	O	B-T123
interacting	O	O	I-T123
factors	O	O	I-T123
(	O	O	O
PIFs	O	O	B-T123
)	O	O	O
.	O	O	O

PIFs	O	O	B-T123
are	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
that	O	O	O
act	O	O	O
as	O	O	O
repressors	O	O	B-T116
of	O	O	O
photomorphogenesis	O	O	B-T039
;	O	O	O
their	O	O	O
inhibition	O	O	B-T040
by	O	O	O
PHYs	O	O	B-T116
leads	O	O	O
to	O	O	O
substantial	O	O	O
changes	O	O	O
in	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
.	O	O	O

The	O	O	O
nuclear	O	O	B-T043
function	O	O	I-T043
of	O	O	O
PHYs	O	O	B-T116
,	O	O	O
however	O	O	O
,	O	O	O
has	O	O	O
so	O	O	O
far	O	O	O
been	O	O	O
investigated	O	O	O
in	O	O	O
only	O	O	O
a	O	O	O
few	O	O	O
non-seed	O	O	B-T002
plants	O	O	I-T002
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
identified	O	O	O
putative	O	O	O
target	O	O	O
genes	O	O	B-T028
of	O	O	O
PHY	O	O	B-T116
signaling	O	O	B-T038
in	O	O	O
the	O	O	O
moss	O	O	B-T002
Physcomitrella	O	O	B-T002
patens	O	O	I-T002
and	O	O	O
found	O	O	O
light-regulated	O	O	B-T028
genes	O	O	I-T028
that	O	O	O
are	O	O	O
putative	O	O	O
orthologs	O	O	B-T028
of	O	O	O
PIF-controlled	O	O	B-T028
genes	O	O	I-T028
in	O	O	O
Arabidopsis	O	O	B-T002
.	O	O	O

Phylogenetic	O	O	B-T062
analyses	O	O	I-T062
revealed	O	O	O
that	O	O	O
an	O	O	O
ancestral	O	O	O
PIF-like	O	O	B-T028
gene	O	O	I-T028
was	O	O	O
already	O	O	O
present	O	O	O
in	O	O	O
streptophyte	O	O	B-T204
algae	O	O	I-T204
,	O	O	O
i.e.	O	O	O
,	O	O	O
before	O	O	O
the	O	O	O
water-to-land	O	O	B-T052
transition	O	O	I-T052
of	O	O	O
plants	O	O	B-T002
.	O	O	O

The	O	O	O
PIF	O	O	B-T123
homologs	O	O	I-T123
in	O	O	O
the	O	O	O
genome	O	O	B-T028
of	O	O	O
P.	O	O	B-T002
patens	O	O	I-T002
resemble	O	O	O
Arabidopsis	O	O	B-T002
PIFs	O	O	B-T123
in	O	O	O
their	O	O	O
protein	O	O	B-T116
domain	O	O	I-T116
structure	O	O	I-T116
,	O	O	O
molecular	O	O	B-T080
properties	O	O	I-T080
,	O	O	O
and	O	O	O
physiological	O	O	B-T039
effects	O	O	I-T039
,	O	O	O
albeit	O	O	O
with	O	O	O
notable	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
motif-dependent	O	O	O
PHY	O	O	B-T116
interaction	O	O	B-T082
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
P.	O	O	B-T002
patens	O	O	I-T002
PIFs	O	O	B-T123
are	O	O	O
involved	O	O	O
in	O	O	O
PHY	O	O	B-T116
signaling	O	O	B-T038
.	O	O	O

The	O	O	O
PHY-PIF	O	O	B-T044
signaling	O	O	I-T044
node	O	O	I-T044
that	O	O	O
relays	O	O	O
light	O	O	B-T067
signals	O	O	I-T067
to	O	O	O
target	O	O	O
genes	O	O	B-T028
has	O	O	O
been	O	O	O
largely	O	O	O
conserved	O	O	O
during	O	O	O
land	O	O	B-T002
plant	O	O	I-T002
evolution	O	O	B-T045
,	O	O	O
with	O	O	O
evidence	O	O	O
of	O	O	O
lineage-specific	O	O	B-T077
diversification	O	O	I-T077
.	O	O	O

-DOCSTART- (28125105)

Conditional	O	O	B-T059
reprogramming	O	O	I-T059
and	O	O	O
long-term	O	O	B-T079
expansion	O	O	B-T043
of	O	O	O
normal	O	O	B-T025
and	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
from	O	O	O
human	O	O	B-T016
biospecimens	O	O	O

Historically	O	O	O
,	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
difficult	O	O	O
to	O	O	O
propagate	O	O	B-T052
cells	O	O	B-T025
in	O	O	B-T080
vitro	O	O	I-T080
that	O	O	O
are	O	O	O
derived	O	O	O
directly	O	O	O
from	O	O	O
human	O	O	B-T016
tumors	O	O	B-T191
or	O	O	O
healthy	O	O	B-T024
tissue	O	O	I-T024
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
preclinical	O	O	B-T170
models	O	O	I-T170
are	O	O	O
essential	O	O	O
tools	O	O	O
for	O	O	O
both	O	O	O
the	O	O	O
study	O	O	B-T091
of	O	O	I-T091
basic	O	O	I-T091
cancer	O	O	I-T091
biology	O	O	I-T091
and	O	O	O
the	O	O	O
promotion	O	O	O
of	O	O	O
translational	O	O	B-T062
research	O	O	I-T062
,	O	O	O
including	O	O	O
drug	O	O	B-T062
discovery	O	O	I-T062
and	O	O	O
drug	O	O	B-T074
target	O	O	I-T074
identification	O	O	I-T074
.	O	O	O

This	O	O	O
protocol	O	O	B-T059
describes	O	O	O
conditional	O	O	B-T043
reprogramming	O	O	I-T043
(	O	O	O
CR	O	O	B-T043
)	O	O	O
,	O	O	O
which	O	O	O
involves	O	O	O
coculture	O	O	B-T059
of	O	O	O
irradiated	O	O	O
mouse	O	O	B-T015
fibroblast	O	O	B-T025
feeder	O	O	I-T025
cells	O	O	I-T025
with	O	O	O
normal	O	O	B-T025
and	O	O	O
tumor	O	O	B-T191
human	O	O	B-T016
epithelial	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
a	O	O	O
Rho	O	O	B-T116
kinase	O	O	I-T116
inhibitor	O	O	B-T121
(	O	O	O
Y-27632	O	O	B-T109
)	O	O	O
.	O	O	O

CR	O	O	B-T059
cells	O	O	B-T025
can	O	O	O
be	O	O	O
used	O	O	O
for	O	O	O
various	O	O	O
applications	O	O	O
,	O	O	O
including	O	O	O
regenerative	O	O	B-T091
medicine	O	O	I-T091
,	O	O	O
drug	O	O	B-T059
sensitivity	O	O	I-T059
testing	O	O	I-T059
,	O	O	O
gene	O	O	B-T059
expression	O	O	I-T059
profiling	O	O	I-T059
and	O	O	O
xenograft	O	O	B-T061
studies	O	O	I-T061
.	O	O	O

The	O	O	O
method	O	O	B-T059
requires	O	O	O
a	O	O	O
pathologist	O	O	B-T097
to	O	O	O
differentiate	O	O	O
healthy	O	O	B-T024
tissue	O	O	I-T024
from	O	O	O
tumor	O	O	B-T024
tissue	O	O	I-T024
,	O	O	O
and	O	O	O
basic	O	O	B-T059
tissue	O	O	I-T059
culture	O	O	I-T059
skills	O	O	O
.	O	O	O

The	O	O	O
protocol	O	O	B-T059
can	O	O	O
be	O	O	O
used	O	O	O
with	O	O	O
cells	O	O	B-T025
derived	O	O	O
from	O	O	O
both	O	O	O
fresh	O	O	B-T024
and	O	O	O
cryopreserved	O	O	B-T024
tissue	O	O	I-T024
samples	O	O	I-T024
.	O	O	O

As	O	O	O
approximately	O	O	O
1	O	O	O
million	O	O	O
cells	O	O	B-T025
can	O	O	O
be	O	O	O
generated	O	O	B-T052
in	O	O	O
7	O	O	O
d	O	O	O
,	O	O	O
the	O	O	O
technique	O	O	B-T059
is	O	O	O
directly	O	O	O
applicable	O	O	O
to	O	O	O
diagnostic	O	O	B-T130
and	O	O	O
predictive	O	O	B-T080
medicine	O	O	B-T121
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
epithelial	O	O	B-T025
cells	O	O	I-T025
can	O	O	O
be	O	O	O
propagated	O	O	B-T052
indefinitely	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
,	O	O	O
yet	O	O	O
retain	O	O	O
the	O	O	O
capacity	O	O	B-T081
to	O	O	O
become	O	O	O
fully	O	O	O
differentiated	O	O	B-T043
when	O	O	O
placed	O	O	O
into	O	O	O
conditions	O	O	B-T082
that	O	O	O
mimic	O	O	O
their	O	O	O
natural	O	O	B-T082
environment	O	O	I-T082
.	O	O	O

-DOCSTART- (28125454)

Types	O	O	O
of	O	O	O
internal	O	O	B-T093
facilitation	O	O	I-T093
activities	O	O	B-T052
in	O	O	O
hospitals	O	O	B-T093
implementing	O	O	O
evidence-based	O	O	O
interventions	O	O	O

Implementation	O	O	B-T052
models	O	O	B-T170
,	O	O	O
frameworks	O	O	B-T077
,	O	O	O
and	O	O	O
theories	O	O	B-T078
recognize	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
activities	O	O	B-T052
that	O	O	O
facilitate	O	O	O
implementation	O	O	B-T052
success	O	O	B-T054
.	O	O	O

However	O	O	O
,	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
internal	O	O	B-T093
facilitation	O	O	I-T093
activities	O	O	B-T052
that	O	O	O
hospital	O	O	B-T097
personnel	O	O	I-T097
engage	O	O	B-T169
in	O	O	O
during	O	O	O
implementation	O	O	B-T052
efforts	O	O	I-T052
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
examine	O	O	O
internal	O	O	B-T093
facilitation	O	O	B-T093
activities	O	O	B-T052
at	O	O	O
10	O	O	O
critical	O	O	B-T093
access	O	O	I-T093
hospitals	O	O	I-T093
in	O	O	O
rural	O	O	B-T083
Iowa	O	O	I-T083
during	O	O	O
their	O	O	O
implementation	O	O	B-T052
of	O	O	O
TeamSTEPPS	O	O	B-T093
,	O	O	O
a	O	O	O
patient	O	O	B-T058
safety	O	O	I-T058
intervention	O	O	B-T061
,	O	O	O
and	O	O	O
to	O	O	O
identify	O	O	O
characteristics	O	O	B-T080
that	O	O	O
distinguish	O	O	O
different	O	O	O
types	O	O	O
of	O	O	O
facilitation	O	O	O
activities	O	O	O
.	O	O	O

We	O	O	O
followed	O	O	O
10	O	O	O
critical	O	O	B-T093
access	O	O	I-T093
hospitals	O	O	I-T093
for	O	O	O
2	O	O	O
years	O	O	B-T079
after	O	O	O
the	O	O	O
onset	O	O	B-T080
of	O	O	I-T080
implementation	O	O	B-T052
,	O	O	O
conducting	O	O	O
quarterly	O	O	B-T079
interviews	O	O	B-T052
with	O	O	O
key	O	O	B-T098
informants	O	O	I-T098
.	O	O	O

On	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
the	O	O	O
transcripts	O	O	B-T170
from	O	O	O
the	O	O	O
first	O	O	O
two	O	O	O
quarters	O	O	B-T081
,	O	O	O
a	O	O	O
coding	O	O	B-T078
template	O	O	I-T078
was	O	O	O
developed	O	O	O
using	O	O	O
inductive	O	O	B-T062
analyses	O	O	I-T062
.	O	O	O

The	O	O	O
template	O	O	B-T078
was	O	O	O
then	O	O	O
applied	O	O	O
deductively	O	O	B-T080
to	O	O	O
code	O	O	O
all	O	O	O
interview	O	O	B-T052
transcripts	O	O	B-T170
.	O	O	O

Using	O	O	O
comparative	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
we	O	O	O
examined	O	O	O
the	O	O	O
characteristics	O	O	B-T080
that	O	O	O
distinguish	O	O	O
between	O	O	O
the	O	O	O
facilitation	O	O	B-T093
types	O	O	O
.	O	O	O

We	O	O	O
identified	O	O	O
four	O	O	O
types	O	O	O
of	O	O	O
facilitation	O	O	B-T093
activities	O	O	B-T052
-	O	O	O
Leadership	O	O	B-T054
,	O	O	O
Buy-in	O	O	O
,	O	O	O
Customization	O	O	B-T052
,	O	O	O
and	O	O	O
Accountability	O	O	B-T078
.	O	O	O

Individuals	O	O	B-T098
and	O	O	O
teams	O	O	B-T096
engaged	O	O	B-T169
in	O	O	O
different	O	O	O
types	O	O	O
of	O	O	O
facilitation	O	O	B-T093
activities	O	O	B-T052
,	O	O	O
both	O	O	O
in	O	O	O
a	O	O	O
planned	O	O	O
and	O	O	O
an	O	O	O
ad	O	O	B-T033
hoc	O	O	I-T033
manner	O	O	I-T033
.	O	O	O

These	O	O	O
activities	O	O	B-T052
targeted	O	O	O
at	O	O	O
both	O	O	O
people	O	O	B-T098
and	O	O	O
practices	O	O	B-T041
and	O	O	O
exhibited	O	O	O
varying	O	O	O
temporal	O	O	B-T079
patterns	O	O	I-T079
(	O	O	O
start	O	O	B-T079
and	O	O	O
peak	O	O	B-T079
time	O	O	I-T079
)	O	O	O
.	O	O	O

There	O	O	O
are	O	O	O
four	O	O	O
types	O	O	O
of	O	O	O
facilitation	O	O	B-T093
activities	O	O	B-T052
that	O	O	O
hospitals	O	O	B-T093
engage	O	O	B-T169
in	O	O	O
while	O	O	O
implementing	O	O	B-T052
evidence-based	O	O	B-T091
practices	O	O	I-T091
,	O	O	O
offering	O	O	O
a	O	O	O
parsimonious	O	O	B-T080
way	O	O	O
to	O	O	O
characterize	O	O	O
facilitation	O	O	O
activities	O	O	O
.	O	O	O

New	O	O	O
theoretical	O	O	B-T078
and	O	O	O
empirical	O	O	B-T062
research	O	O	B-T062
opportunities	O	O	I-T062
are	O	O	O
discussed	O	O	O
.	O	O	O

Understanding	O	O	O
the	O	O	O
types	O	O	O
of	O	O	O
facilitation	O	O	B-T093
activities	O	O	B-T052
and	O	O	O
their	O	O	O
distinguishing	O	O	O
characteristics	O	O	B-T080
can	O	O	O
assist	O	O	O
managers	O	O	B-T097
in	O	O	O
planning	O	O	B-T169
and	O	O	O
executing	O	O	B-T052
implementations	O	O	B-T052
of	O	O	O
evidence-based	O	O	B-T091
interventions	O	O	I-T091
.	O	O	O

-DOCSTART- (28129043)

Directing	O	O	B-T045
traffic	O	O	I-T045
on	O	O	I-T045
DNA	O	O	I-T045
-How	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
relieve	O	O	B-T169
or	O	O	O
induce	O	O	B-T169
transcriptional	O	O	O
interference	O	O	O

Transcriptional	O	O	B-T045
interference	O	O	I-T045
(	O	O	O
TI	O	O	B-T045
)	O	O	O
is	O	O	O
increasingly	O	O	O
recognized	O	O	O
as	O	O	O
a	O	O	O
widespread	O	O	B-T082
mechanism	O	O	O
of	O	O	O
gene	O	O	B-T045
control	O	O	I-T045
,	O	O	O
particularly	O	O	O
given	O	O	O
the	O	O	O
pervasive	O	O	B-T081
nature	O	O	I-T081
of	O	O	O
transcription	O	O	B-T045
,	O	O	O
both	O	O	O
sense	O	O	B-T169
and	O	O	O
antisense	O	O	B-T114
,	O	O	O
across	O	O	O
all	O	O	O
kingdoms	O	O	B-T185
of	O	O	O
life	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
discuss	O	O	O
how	O	O	O
transcription	O	O	B-T116
factor	O	O	I-T116
binding	O	O	B-T090
kinetics	O	O	I-T090
strongly	O	O	O
influence	O	O	B-T077
the	O	O	O
ability	O	O	B-T032
of	O	O	O
a	O	O	O
transcription	O	O	O
factor	O	O	O
to	O	O	O
relieve	O	O	B-T169
or	O	O	O
induce	O	O	B-T169
TI	O	O	B-T045
.	O	O	O

-DOCSTART- (28131759)

Acoustic	O	O	B-T040
startle	O	O	I-T040
response	O	O	I-T040
in	O	O	O
rats	O	O	B-T015
predicts	O	O	O
inter-individual	O	O	B-T098
variation	O	O	B-T080
in	O	O	O
fear	O	O	B-T041
extinction	O	O	O

Although	O	O	O
a	O	O	O
large	O	O	O
portion	O	O	O
of	O	O	O
the	O	O	O
population	O	O	B-T098
is	O	O	O
exposed	O	O	O
to	O	O	O
a	O	O	O
traumatic	O	O	B-T169
event	O	O	B-T051
at	O	O	O
some	O	O	O
point	O	O	O
,	O	O	O
only	O	O	O
a	O	O	O
small	O	O	O
percentage	O	O	B-T081
of	O	O	O
the	O	O	O
population	O	O	O
develops	O	O	O
post-traumatic	O	O	B-T048
stress	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
PTSD	O	O	B-T048
)	O	O	O
,	O	O	O
suggesting	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
predisposing	O	O	B-T079
factors	O	O	I-T079
.	O	O	O

Abnormal	O	O	B-T033
acoustic	O	O	B-T040
startle	O	O	I-T040
response	O	O	I-T040
(	O	O	O
ASR	O	O	B-T040
)	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
associated	O	O	O
with	O	O	O
PTSD	O	O	B-T048
,	O	O	O
implicating	O	O	O
it	O	O	O
as	O	O	O
a	O	O	O
potential	O	O	B-T080
predictor	O	O	B-T078
of	O	O	O
the	O	O	O
development	O	O	B-T039
of	O	O	O
PTSD	O	O	O
-like	O	O	O
behavior	O	O	B-T053
.	O	O	O

Since	O	O	O
poor	O	O	O
extinction	O	O	B-T041
and	O	O	O
retention	O	O	O
of	O	O	O
extinction	O	O	B-T041
learning	O	O	I-T041
are	O	O	O
characteristic	O	O	O
of	O	O	O
PTSD	O	O	B-T048
patients	O	O	B-T101
,	O	O	O
it	O	O	O
is	O	O	O
of	O	O	O
interest	O	O	O
to	O	O	O
determine	O	O	O
if	O	O	O
abnormal	O	O	B-T033
ASR	O	O	B-T040
is	O	O	O
predictive	O	O	O
of	O	O	O
development	O	O	B-T039
of	O	O	O
such	O	O	O
deficits	O	O	B-T080
.	O	O	O

To	O	O	O
determine	O	O	O
whether	O	O	O
baseline	O	O	B-T081
ASR	O	O	B-T040
has	O	O	O
utility	O	O	O
in	O	O	O
predicting	O	O	O
the	O	O	O
development	O	O	B-T039
of	O	O	O
PTSD	O	O	B-T048
-like	O	O	O
behavior	O	O	B-T053
,	O	O	O
the	O	O	O
relationship	O	O	O
between	O	O	O
baseline	O	O	O
ASR	O	O	O
and	O	O	O
freezing	O	O	B-T053
behavior	O	O	I-T053
following	O	O	O
Pavlovian	O	O	B-T062
fear	O	O	I-T062
conditioning	O	O	I-T062
was	O	O	O
examined	O	O	O
in	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
adult	O	O	B-T100
,	O	O	O
male	O	O	B-T032
Sprague-Dawley	O	O	B-T015
rats	O	O	I-T015
.	O	O	O

Baseline	O	O	B-T081
acoustic	O	O	B-T040
startle	O	O	I-T040
response	O	O	I-T040
(	O	O	O
ASR	O	O	B-T040
)	O	O	O
was	O	O	O
assessed	O	O	O
preceding	O	O	O
exposure	O	O	O
to	O	O	O
a	O	O	O
Pavlovian	O	O	B-T062
fear	O	O	B-T062
conditioning	O	O	I-T062
paradigm	O	O	I-T062
where	O	O	O
freezing	O	O	B-T053
behavior	O	O	I-T053
was	O	O	O
measured	O	O	O
during	O	O	O
fear	O	O	O
conditioning	O	O	O
,	O	O	O
extinction	O	O	B-T041
training	O	O	B-T065
,	O	O	O
and	O	O	O
extinction	O	O	O
testing	O	O	B-T169
.	O	O	O

Although	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
relationship	O	O	O
between	O	O	O
baseline	O	O	B-T081
ASR	O	O	B-T040
and	O	O	O
fear	O	O	B-T041
memory	O	O	B-T041
following	O	O	O
conditioning	O	O	B-T062
,	O	O	O
rats	O	O	B-T015
with	O	O	O
low	O	O	O
baseline	O	O	O
ASR	O	O	O
had	O	O	O
significantly	O	O	O
lower	O	O	O
magnitude	O	O	O
of	O	O	O
retention	O	O	B-T041
of	O	O	O
the	O	O	O
extinction	O	O	B-T041
memory	O	O	O
than	O	O	O
rats	O	O	O
with	O	O	O
high	O	O	O
baseline	O	O	O
ASR	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
baseline	O	O	B-T081
ASR	O	O	B-T040
has	O	O	O
value	O	O	O
as	O	O	O
a	O	O	O
predictive	O	O	B-T080
index	O	O	B-T170
of	O	O	O
the	O	O	O
development	O	O	B-T039
of	O	O	O
a	O	O	O
PTSD	O	O	B-T048
-like	O	O	O
phenotype	O	O	B-T032
.	O	O	O

-DOCSTART- (28132082)

High	O	O	O
tacrolimus	O	O	B-T109
blood	O	O	B-T081
concentrations	O	O	I-T081
early	O	O	O
after	O	O	O
lung	O	O	B-T061
transplantation	O	O	I-T061
and	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
kidney	O	O	O
injury	O	O	O

Lung	O	O	B-T023
transplant	O	O	B-T101
recipients	O	O	I-T101
often	O	O	O
develop	O	O	O
acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
(	O	O	O
AKI	O	O	B-T037
)	O	O	O
evolving	O	O	O
into	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CKD	O	O	B-T047
)	O	O	O
.	O	O	O

The	O	O	O
immunosuppressant	O	O	B-T129
tacrolimus	O	O	B-T109
might	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
emergence	O	O	O
of	O	O	O
AKI	O	O	B-T037
.	O	O	O

We	O	O	O
analyzed	O	O	O
the	O	O	O
development	O	O	B-T169
and	O	O	O
recovery	O	O	B-T040
of	O	O	O
kidney	O	O	B-T037
injury	O	O	I-T037
after	O	O	O
lung	O	O	B-T061
transplantation	O	O	I-T061
and	O	O	O
related	O	O	O
AKI	O	O	B-T037
to	O	O	O
whole-blood	O	O	B-T031
tacrolimus	O	O	B-T109
trough	O	O	B-T081
concentrations	O	O	I-T081
and	O	O	O
other	O	O	O
factors	O	O	O
causing	O	O	O
kidney	O	O	O
injury	O	O	O
.	O	O	O

We	O	O	O
retrospectively	O	O	B-T062
studied	O	O	I-T062
kidney	O	O	B-T037
injury	O	O	I-T037
in	O	O	O
186	O	O	O
lung-transplantation	O	O	B-T061
patients	O	O	B-T101
at	O	O	O
the	O	O	O
UMC	O	O	B-T093
Utrecht	O	O	I-T093
between	O	O	O
2001	O	O	O
and	O	O	O
2011	O	O	O
.	O	O	O

Kidney	O	O	B-T042
function	O	O	I-T042
and	O	O	O
whole-blood	O	O	B-T031
tacrolimus	O	O	B-T109
trough	O	O	B-T081
concentrations	O	O	I-T081
were	O	O	O
determined	O	O	O
from	O	O	O
day	O	O	B-T079
1	O	O	O
to	O	O	O
14	O	O	O
and	O	O	O
at	O	O	O
1	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
6	O	O	O
,	O	O	O
and	O	O	O
12	O	O	O
months	O	O	B-T079
postoperative	O	O	B-T079
.	O	O	O

Systemic	O	O	B-T047
inflammatory	O	O	I-T047
response	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
SIRS	O	O	B-T047
)	O	O	O
,	O	O	O
septic	O	O	B-T046
shock	O	O	I-T046
,	O	O	O
and	O	O	O
nephrotoxic	O	O	B-T080
medications	O	O	B-T170
were	O	O	O
evaluated	O	O	O
as	O	O	O
covariates	O	O	B-UnknownType
for	O	O	O
AKI	O	O	B-T037
.	O	O	O

We	O	O	O
analyzed	O	O	O
liver	O	O	B-T037
injury	O	O	I-T037
and	O	O	O
drug-drug	O	O	B-T044
interactions	O	O	I-T044
.	O	O	O

AKI	O	O	B-T037
was	O	O	O
present	O	O	B-T033
in	O	O	O
85	O	O	O
(	O	O	O
46	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
.	O	O	O

Tacrolimus	O	O	B-T109
concentrations	O	O	B-T081
were	O	O	O
supra-therapeutic	O	O	B-T034
in	O	O	O
135	O	O	O
of	O	O	O
186	O	O	O
patients	O	O	B-T101
(	O	O	O
73	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

AKI	O	O	B-T037
in	O	O	O
the	O	O	O
first	O	O	O
week	O	O	B-T079
after	O	O	O
transplantation	O	O	B-T061
was	O	O	O
related	O	O	O
to	O	O	O
supra-therapeutic	O	O	B-T034
tacrolimus	O	O	B-T109
concentrations	O	O	B-T081
(	O	O	O
OR	O	O	B-T081
1.55	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
1.06	O	O	O
-	O	O	O
2.27	O	O	O
)	O	O	O
,	O	O	O
≥3	O	O	O
other	O	O	O
nephrotoxic	O	O	B-T061
drugs	O	O	I-T061
(	O	O	O
OR	O	O	O
1.96	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.02	O	O	O
-	O	O	O
3.77	O	O	O
)	O	O	O
,	O	O	O
infection	O	O	B-T046
(	O	O	O
OR	O	O	O
2.48	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.31	O	O	O
-	O	O	O
4.70	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
cystic	O	O	B-T047
fibrosis	O	O	I-T047
(	O	O	O
OR	O	O	O
2.17	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.16	O	O	O
-	O	O	O
4.06	O	O	O
)	O	O	O
.	O	O	O

Recovery	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
AKI	O	O	B-T037
was	O	O	O
lower	O	O	O
than	O	O	O
expected	O	O	O
(	O	O	O
19	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
cumulative	O	O	O
incidence	O	O	B-T169
of	O	O	O
severe	O	O	O
CKD	O	O	B-T047
at	O	O	O
1	O	O	O
year	O	O	B-T079
was	O	O	O
15	O	O	O
%	O	O	O
.	O	O	O

After	O	O	O
lung	O	O	B-T061
transplantation	O	O	I-T061
,	O	O	O
AKI	O	O	B-T037
is	O	O	O
common	O	O	O
and	O	O	O
often	O	O	O
evolves	O	O	O
into	O	O	O
severe	O	O	B-T080
CKD	O	O	B-T047
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
known	O	O	O
cause	O	O	O
of	O	O	O
morbidity	O	O	B-T081
and	O	O	O
mortality	O	O	B-T081
.	O	O	O

Supra-therapeutic	O	O	B-T034
whole-blood	O	O	B-T031
tacrolimus	O	O	B-T109
trough	O	O	B-T081
concentrations	O	O	I-T081
are	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
early	O	O	O
onset	O	O	O
of	O	O	O
AKI	O	O	B-T037
.	O	O	O

Conscientious	O	O	B-T033
targeting	O	O	B-T169
tacrolimus	O	O	B-T109
blood	O	O	B-T081
concentrations	O	O	I-T081
might	O	O	O
be	O	O	O
vital	O	O	B-T080
in	O	O	O
the	O	O	O
early	O	O	B-UnknownType
phase	O	O	I-UnknownType
after	O	O	O
lung	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

What	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
this	O	O	O
subject	O	O	O
?	O	O	O

•	O	O	O
Lung	O	O	B-T023
transplant	O	O	B-T101
recipients	O	O	I-T101
often	O	O	O
develop	O	O	O
acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
evolving	O	O	O
into	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
increasing	O	O	O
both	O	O	O
morbidity	O	O	B-T081
and	O	O	O
mortality	O	O	B-T081
.	O	O	O

•	O	O	O
To	O	O	O
date	O	O	O
,	O	O	O
the	O	O	O
pathophysiology	O	O	B-T169
of	O	O	O
kidney	O	O	B-T037
injury	O	O	I-T037
after	O	O	O
lung	O	O	B-T061
transplantation	O	O	I-T061
has	O	O	O
not	O	O	O
been	O	O	O
fully	O	O	O
elucidated	O	O	O
.	O	O	O

•	O	O	O
The	O	O	O
immunosuppressant	O	O	B-T129
tacrolimus	O	O	B-T109
is	O	O	O
difficult	O	O	O
to	O	O	O
dose	O	O	B-T081
,	O	O	O
especially	O	O	O
in	O	O	O
the	O	O	O
unstable	O	O	B-T033
clinical	O	O	B-T082
setting	O	O	I-T082
,	O	O	O
and	O	O	O
is	O	O	O
nephrotoxic	O	O	B-T080
.	O	O	O

•	O	O	O
For	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
,	O	O	O
supra-therapeutic	O	O	B-T034
whole-blood	O	O	B-T031
tacrolimus	O	O	B-T109
trough	O	O	B-T081
concentrations	O	O	I-T081
are	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
emergence	O	O	O
of	O	O	O
acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
in	O	O	O
the	O	O	O
first	O	O	O
days	O	O	B-T079
after	O	O	O
lung	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

•	O	O	O
Supra-therapeutic	O	O	B-T034
whole-blood	O	O	B-T031
tacrolimus	O	O	B-T109
trough	O	O	B-T081
concentrations	O	O	I-T081
often	O	O	O
occur	O	O	O
early	O	O	O
after	O	O	O
lung	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

•	O	O	O
AKI	O	O	B-T037
after	O	O	O
lung	O	O	B-T061
transplantation	O	O	I-T061
shows	O	O	O
low	O	O	B-T080
recovery	O	O	B-T040
rates	O	O	B-T081
.	O	O	O

-DOCSTART- (28132765)

Zebrafish	O	O	B-T013
akt2	O	O	B-T028
is	O	O	O
essential	O	O	B-T080
for	O	O	O
survival	O	O	B-T052
,	O	O	O
growth	O	O	B-T040
,	O	O	O
bone	O	O	B-T042
development	O	O	I-T042
,	O	O	O
and	O	O	O
glucose	O	O	O
homeostasis	O	O	O

As	O	O	O
one	O	O	O
of	O	O	O
three	O	O	O
akt	O	O	B-T116
isoforms	O	O	B-T116
,	O	O	O
akt2	O	O	B-T116
plays	O	O	O
a	O	O	O
key	O	O	O
role	O	O	B-T077
in	O	O	O
the	O	O	O
regulation	O	O	B-T038
of	O	O	O
widely	O	O	O
divergent	O	O	O
cellular	O	O	B-T043
processes	O	O	I-T043
in	O	O	O
mammals	O	O	B-T015
.	O	O	O

However	O	O	O
,	O	O	O
its	O	O	O
role	O	O	B-T077
and	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
in	O	O	O
zebrafish	O	O	B-T013
remain	O	O	O
largely	O	O	O
unknown	O	O	B-T080
.	O	O	O

To	O	O	O
elucidate	O	O	O
the	O	O	O
function	O	O	B-T169
of	O	O	O
akt2	O	O	B-T028
in	O	O	O
zebrafish	O	O	B-T013
,	O	O	O
we	O	O	O
generated	O	O	B-T080
zebrafish	O	O	O
lacking	O	O	B-T080
akt2	O	O	B-T028
gene	O	O	I-T028
via	O	O	O
CRISPR/Cas9	O	O	B-T044
technology	O	O	B-T090
.	O	O	O

Akt2	O	O	B-T028
-	O	O	O
null	O	O	B-T081
zebrafish	O	O	B-T013
exhibit	O	O	O
partial	O	O	O
lethality	O	O	B-T033
and	O	O	O
severe	O	O	B-T080
growth	O	O	B-T040
deficiency	O	O	B-T169
,	O	O	O
which	O	O	O
is	O	O	O
different	O	O	O
from	O	O	O
those	O	O	O
observed	O	O	O
in	O	O	O
akt2	O	O	B-T028
-	O	O	O
null	O	O	O
mice	O	O	B-T015
.	O	O	O

Furthermore	O	O	O
,	O	O	O
akt2	O	O	B-T028
-	O	O	O
null	O	O	B-T081
zebrafish	O	O	B-T013
display	O	O	B-T169
deficiency	O	O	B-T169
in	O	O	O
fin	O	O	B-T040
ray	O	O	I-T040
development	O	O	I-T040
,	O	O	O
but	O	O	O
their	O	O	O
cartilage	O	O	B-T024
is	O	O	O
not	O	O	B-T077
affected	O	O	I-T077
.	O	O	O

Similar	O	O	O
to	O	O	O
observations	O	O	B-T062
in	O	O	O
akt2	O	O	B-T028
-	O	O	O
null	O	O	B-T081
mice	O	O	B-T015
,	O	O	O
akt2	O	O	O
-	O	O	O
null	O	O	O
zebrafish	O	O	B-T013
display	O	O	B-T169
impaired	O	O	B-T169
glucose	O	O	B-T039
homeostasis	O	O	I-T039
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
contrast	O	O	O
to	O	O	O
that	O	O	O
in	O	O	O
akt2	O	O	B-T028
-	O	O	O
null	O	O	B-T081
mice	O	O	B-T015
,	O	O	O
insulin	O	O	B-T059
level	O	O	I-T059
is	O	O	O
lower	O	O	B-T080
in	O	O	O
akt2	O	O	O
-	O	O	O
null	O	O	O
zebrafish	O	O	B-T013
,	O	O	O
implicating	O	O	O
the	O	O	O
symptoms	O	O	B-T184
of	O	O	O
type	O	O	B-T047
I	O	O	I-T047
diabetes	O	O	I-T047
exhibited	O	O	O
in	O	O	O
akt2	O	O	O
-	O	O	O
null	O	O	O
zebrafish	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
transcriptome	O	O	B-T059
analysis	O	O	I-T059
reveals	O	O	B-T080
that	O	O	O
the	O	O	O
genes	O	O	B-T028
involved	O	O	O
in	O	O	O
metabolism	O	O	B-T040
and	O	O	O
osteogenesis	O	O	B-T042
are	O	O	O
disturbed	O	O	O
in	O	O	O
akt2	O	O	B-T028
-	O	O	O
null	O	O	B-T081
zebrafish	O	O	B-T013
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
these	O	O	O
data	O	O	B-T078
not	O	O	O
only	O	O	O
support	O	O	O
an	O	O	O
important	O	O	O
role	O	O	B-T077
of	O	O	O
akt2	O	O	B-T028
in	O	O	O
zebrafish	O	O	B-T013
survival	O	O	B-T052
,	O	O	O
growth	O	O	B-T040
,	O	O	O
bone	O	O	B-T042
development	O	O	I-T042
and	O	O	O
glucose	O	O	B-T039
homeostasis	O	O	I-T039
,	O	O	O
but	O	O	O
also	O	O	O
suggest	O	O	O
that	O	O	O
akt2	O	O	O
has	O	O	O
divergent	O	O	O
functions	O	O	B-T169
between	O	O	O
mice	O	O	B-T015
and	O	O	O
zebrafish	O	O	O
,	O	O	O
even	O	O	O
though	O	O	O
they	O	O	O
are	O	O	O
evolutionarily	O	O	B-T045
conserved	O	O	B-T044
.	O	O	O

-DOCSTART- (28132824)

Physiological	O	O	B-T169
Properties	O	O	B-T080
and	O	O	O
Behavioral	O	O	B-T053
Correlates	O	O	B-T080
of	O	O	O
Hippocampal	O	O	B-T023
Granule	O	O	B-T025
Cells	O	O	I-T025
and	O	O	O
Mossy	O	O	O
Cells	O	O	O

The	O	O	O
hippocampal	O	O	B-T023
dentate	O	O	B-T023
gyrus	O	O	I-T023
is	O	O	O
often	O	O	O
viewed	O	O	O
as	O	O	O
a	O	O	O
segregator	O	O	B-T169
of	O	O	O
upstream	O	O	B-T042
information	O	O	I-T042
.	O	O	O

Physiological	O	O	B-T039
support	O	O	I-T039
for	O	O	O
such	O	O	O
function	O	O	B-T169
has	O	O	O
been	O	O	O
hampered	O	O	O
by	O	O	O
a	O	O	O
lack	O	O	B-T080
of	O	O	O
well-defined	O	O	B-T080
characteristics	O	O	B-T080
that	O	O	O
can	O	O	O
identify	O	O	O
granule	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
mossy	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

We	O	O	O
developed	O	O	O
an	O	O	O
electrophysiology	O	O	B-UnknownType
-based	O	O	O
classification	O	O	B-T185
of	O	O	O
dentate	O	O	B-T023
granule	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
mossy	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
mice	O	O	B-T015
that	O	O	O
we	O	O	O
validated	O	O	O
by	O	O	O
optogenetic	O	O	B-T063
tagging	O	O	I-T063
of	O	O	O
mossy	O	O	O
cells	O	O	O
.	O	O	O

Granule	O	O	B-T025
cells	O	O	I-T025
exhibited	O	O	O
sparse	O	O	O
firing	O	O	B-T043
,	O	O	O
had	O	O	O
a	O	O	O
single	O	O	B-T081
place	O	O	B-T082
field	O	O	I-T082
,	O	O	O
and	O	O	O
showed	O	O	O
only	O	O	O
modest	O	O	O
changes	O	O	B-T169
when	O	O	O
the	O	O	O
mouse	O	O	B-T015
was	O	O	O
tested	O	O	B-T169
in	O	O	O
different	O	O	O
mazes	O	O	B-T073
in	O	O	O
the	O	O	O
same	O	O	O
room	O	O	B-T082
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
mossy	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
more	O	O	O
active	O	O	B-T169
,	O	O	O
had	O	O	O
multiple	O	O	B-T081
place	O	O	B-T082
fields	O	O	I-T082
and	O	O	O
showed	O	O	O
stronger	O	O	O
remapping	O	O	O
of	O	O	O
place	O	O	O
fields	O	O	O
under	O	O	O
the	O	O	O
same	O	O	O
conditions	O	O	B-T080
.	O	O	O

Although	O	O	O
the	O	O	O
granule	O	O	B-T025
cell	O	O	I-T025
-	O	O	O
mossy	O	O	B-T025
cell	O	O	I-T025
synapse	O	O	B-T030
was	O	O	O
strong	O	O	O
and	O	O	O
facilitating	O	O	O
,	O	O	O
mossy	O	O	B-T025
cells	O	O	I-T025
rarely	O	O	O
"	O	O	O
inherited	O	O	O
"	O	O	O
place	O	O	B-T082
fields	O	O	I-T082
from	O	O	O
single	O	O	B-T081
granule	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Our	O	O	O
findings	O	O	B-T169
suggest	O	O	O
that	O	O	O
the	O	O	O
granule	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
mossy	O	O	B-T025
cells	O	O	I-T025
could	O	O	O
be	O	O	O
modulated	O	O	B-T082
separately	O	O	O
and	O	O	O
their	O	O	O
joint	O	O	O
action	O	O	B-T052
may	O	O	O
be	O	O	O
critical	O	O	O
for	O	O	O
pattern	O	O	B-T169
separation	O	O	I-T169
.	O	O	O

-DOCSTART- (28134415)

A	O	O	O
primer	O	O	O
on	O	O	O
intraosseous	O	O	B-T169
access	O	O	I-T169
:	O	O	O
History	O	O	B-T033
,	O	O	O
clinical	O	O	B-T033
considerations	O	O	I-T033
,	O	O	O
and	O	O	O
current	O	O	O
devices	O	O	O

Intraosseous	O	O	B-T169
(	O	O	I-T169
IO	O	O	I-T169
)	O	O	I-T169
access	O	O	I-T169
is	O	O	O
a	O	O	O
method	O	O	B-T170
recommended	O	O	O
by	O	O	O
the	O	O	O
American	O	O	B-T093
Heart	O	O	I-T093
Association	O	O	I-T093
and	O	O	O
the	O	O	O
European	O	O	B-T093
Resuscitation	O	O	I-T093
Council	O	O	I-T093
to	O	O	O
administer	O	O	B-T169
resuscitative	O	O	B-T121
drugs	O	O	I-T121
and	O	O	O
fluids	O	O	B-T167
when	O	O	O
intravenous	O	O	B-T082
(	O	O	I-T082
IV	O	O	I-T082
)	O	O	I-T082
access	O	O	I-T082
can	O	O	O
not	O	O	O
be	O	O	O
rapidly	O	O	O
or	O	O	O
easily	O	O	O
obtained	O	O	O
.	O	O	O

Many	O	O	O
clinicians	O	O	B-T097
have	O	O	O
limited	O	O	B-T170
knowledge	O	O	I-T170
or	O	O	O
experience	O	O	B-T041
with	O	O	O
the	O	O	O
IO	O	O	B-T169
route	O	O	I-T169
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
review	O	O	B-T170
was	O	O	O
to	O	O	O
provide	O	O	O
the	O	O	O
reader	O	O	O
with	O	O	O
a	O	O	O
succinct	O	O	B-T170
review	O	O	I-T170
of	O	O	O
the	O	O	O
history	O	O	B-T033
,	O	O	O
clinical	O	O	B-T033
considerations	O	O	I-T033
,	O	O	O
and	O	O	O
devices	O	O	B-T074
associated	O	O	B-T080
with	O	O	I-T080
IO	O	O	B-T169
access	O	O	I-T169
.	O	O	O

Narrative	O	O	O
review	O	O	O
.	O	O	O

University-based	O	O	O
academic	O	O	O
research	O	O	O
cell	O	O	O
.	O	O	O

Not	O	O	O
applicable	O	O	O
.	O	O	O

Not	O	O	O
applicable	O	O	O
.	O	O	O

IO	O	O	B-T169
access	O	O	I-T169
is	O	O	O
a	O	O	O
lifesaving	O	O	B-T078
bridge	O	O	I-T078
to	O	O	O
definitive	O	O	B-T074
vascular	O	O	I-T074
access	O	O	I-T074
that	O	O	O
may	O	O	O
be	O	O	O
considered	O	O	O
when	O	O	O
an	O	O	O
IV	O	O	B-T082
can	O	O	O
not	O	O	O
be	O	O	O
rapidly	O	O	O
attained	O	O	O
and	O	O	O
the	O	O	O
patient	O	O	B-T078
's	O	O	I-T078
outcome	O	O	I-T078
may	O	O	O
be	O	O	O
negatively	O	O	B-T033
affected	O	O	I-T033
without	O	O	O
prompt	O	O	B-T082
circulatory	O	O	I-T082
access	O	O	I-T082
.	O	O	O

The	O	O	O
IO	O	O	B-T169
route	O	O	I-T169
has	O	O	O
few	O	O	O
contraindications	O	O	B-T080
for	O	O	O
use	O	O	O
and	O	O	O
a	O	O	O
low	O	O	O
rate	O	O	O
of	O	O	O
serious	O	O	B-T046
complications	O	O	I-T046
.	O	O	O

Multiple	O	O	O
manual	O	O	B-T169
and	O	O	O
powered	O	O	B-T074
devices	O	O	I-T074
that	O	O	O
may	O	O	O
be	O	O	O
placed	O	O	O
in	O	O	O
several	O	O	B-T082
anatomic	O	O	I-T082
sites	O	O	I-T082
are	O	O	O
commercially	O	O	O
available	O	O	O
.	O	O	O

All	O	O	O
clinicians	O	O	B-T097
who	O	O	O
provide	O	O	O
acute	O	O	B-T058
care	O	O	I-T058
or	O	O	O
respond	O	O	O
to	O	O	O
cardiovascular	O	O	B-T029
emergencies	O	O	B-T046
should	O	O	O
obtain	O	O	O
training	O	O	B-T065
and	O	O	O
maintain	O	O	O
proficiency	O	O	B-T080
in	O	O	O
placing	O	O	O
and	O	O	O
using	O	O	O
IO	O	O	B-T169
devices	O	O	B-T074
as	O	O	O
the	O	O	O
IO	O	O	B-T169
route	O	O	I-T169
is	O	O	O
recommended	O	O	O
by	O	O	O
the	O	O	O
major	O	O	O
resuscitation	O	O	B-T093
organizations	O	O	I-T093
as	O	O	O
the	O	O	O
preferred	O	O	B-T169
route	O	O	I-T169
of	O	O	I-T169
infusion	O	O	I-T169
when	O	O	O
rapid	O	O	O
,	O	O	O
reliable	O	O	O
IV	O	O	B-T082
access	O	O	I-T082
is	O	O	O
unavailable	O	O	O
.	O	O	O

-DOCSTART- (28135569)

C-5a-substituted	O	O	B-T109
validamine	O	O	I-T109
type	O	O	I-T109
glycosidase	O	O	O
inhibitors	O	O	O

A	O	O	O
series	O	O	O
of	O	O	O
N-alkyl	O	O	B-T121
derivatives	O	O	I-T121
of	O	O	O
the	O	O	O
D-galactosidase	O	O	B-T116
inhibitor	O	O	B-T121
1,4-di-epi-validamine	O	O	B-T121
featuring	O	O	O
lipophilic	O	O	B-T081
substituents	O	O	B-T104
at	O	O	I-T104
position	O	O	I-T104
C-5a	O	O	I-T104
was	O	O	O
prepared	O	O	O
and	O	O	O
screened	O	O	B-T059
for	O	O	O
their	O	O	O
glycosidase	O	O	B-T116
inhibitory	O	O	B-T039
properties	O	O	I-T039
.	O	O	O

Products	O	O	B-T071
turned	O	O	O
out	O	O	O
selective	O	O	O
for	O	O	O
β-galactosidases	O	O	B-T116
as	O	O	O
well	O	O	O
as	O	O	O
β-glucosidases	O	O	B-T116
.	O	O	O

-DOCSTART- (28135997)

Exposure	O	O	B-T033
to	O	O	I-T033
suicidal	O	O	I-T033
behaviors	O	O	I-T033
:	O	O	O
A	O	O	O
common	O	O	O
suicide	O	O	B-T033
risk	O	O	B-T033
factor	O	O	I-T033
or	O	O	O
a	O	O	O
personal	O	O	B-T032
negative	O	O	B-T033
life	O	O	I-T033
event	O	O	I-T033
?	O	O	O

Numerous	O	O	B-T081
suicide	O	O	B-T033
risk	O	O	B-T033
factors	O	O	I-T033
have	O	O	O
been	O	O	O
proposed	O	O	O
but	O	O	O
not	O	O	O
adequately	O	O	O
validated	O	O	B-T080
for	O	O	I-T080
epidemiology	O	O	I-T080
,	O	O	O
treatment	O	O	B-T061
and	O	O	O
prevention	O	O	B-T080
efforts	O	O	I-T080
.	O	O	O

Exposures	O	O	B-T033
to	O	O	I-T033
suicidal	O	O	B-T033
behaviors	O	O	I-T033
(	O	O	O
ESB	O	O	B-T033
)	O	O	O
,	O	O	O
from	O	O	O
family	O	O	B-T099
and	O	O	O
friend	O	O	B-T098
suicide	O	O	B-T033
attempts	O	O	I-T033
and	O	O	O
completions	O	O	B-T033
,	O	O	O
were	O	O	O
tested	O	O	O
for	O	O	O
validity	O	O	B-T080
as	O	O	O
a	O	O	O
suicidal	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
and	O	O	O
also	O	O	O
for	O	O	O
measurement	O	O	B-T169
and	O	O	O
construct	O	O	O
adequacy	O	O	B-T080
.	O	O	O

An	O	O	O
anonymous	O	O	B-T080
online	O	O	B-T073
survey	O	O	B-T170
yielded	O	O	O
713	O	O	O
participants	O	O	B-T098
(	O	O	O
aged	O	O	B-T032
18	O	O	O
-	O	O	O
71	O	O	O
)	O	O	O
,	O	O	O
who	O	O	O
reported	O	O	O
ESB	O	O	B-T033
,	O	O	O
completed	O	O	O
the	O	O	O
Suicidal	O	O	B-T170
Affect-Behavior-Cognition	O	O	I-T170
Scale	O	O	I-T170
(	O	O	O
SABCS	O	O	B-T170
)	O	O	O
,	O	O	O
and	O	O	O
comprised	O	O	O
a	O	O	O
broad	O	O	O
spectrum	O	O	O
on	O	O	O
those	O	O	O
variables	O	O	B-T080
.	O	O	O

Tests	O	O	B-T170
of	O	O	O
dimensionality	O	O	B-T082
and	O	O	O
internal	O	O	B-T081
consistency	O	O	I-T081
showed	O	O	O
the	O	O	O
four	O	O	O
ESB	O	O	B-T033
variables	O	O	B-T080
(	O	O	O
attempts	O	O	B-T033
/	O	O	O
completions	O	O	B-T033
through	O	O	O
family	O	O	B-T099
/	O	O	O
friends	O	O	B-T098
)	O	O	O
were	O	O	O
independent	O	O	B-T169
and	O	O	O
did	O	O	O
not	O	O	O
form	O	O	O
a	O	O	O
common	O	O	O
factor	O	O	O
or	O	O	O
an	O	O	O
identifiable	O	O	O
ESB	O	O	O
latent	O	O	B-T080
trait	O	O	B-T032
.	O	O	O

ESB	O	O	B-T033
variables	O	O	B-T080
were	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
associated	O	O	O
with	O	O	O
demographic	O	O	B-T033
and	O	O	O
psychiatric	O	O	B-T033
histories	O	O	I-T033
.	O	O	O

A	O	O	O
battery	O	O	O
of	O	O	O
tests	O	O	B-T170
revealed	O	O	O
no	O	O	O
meaningful	O	O	O
associations	O	O	B-T080
between	O	O	O
ESB	O	O	B-T033
and	O	O	O
total	O	O	O
suicidality	O	O	B-T201
or	O	O	O
suicide	O	O	B-T033
risk	O	O	B-T033
factors	O	O	I-T033
(	O	O	O
social	O	O	B-T054
support	O	O	I-T054
,	O	O	O
depression	O	O	B-T048
,	O	O	O
anxiety	O	O	B-T033
,	O	O	O
stress	O	O	B-T033
,	O	O	O
satisfaction	O	O	B-T080
with	O	O	I-T080
life	O	O	I-T080
and	O	O	O
emotional	O	O	B-T041
stability	O	O	I-T041
)	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
in	O	O	O
contrast	O	O	O
to	O	O	O
previous	O	O	O
reports	O	O	B-T170
,	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
(	O	O	O
n	O	O	O
=	O	O	O
200	O	O	O
;	O	O	O
aged	O	O	B-T032
18	O	O	O
-	O	O	O
20	O	O	O
)	O	O	O
showed	O	O	O
no	O	O	O
increased	O	O	B-T081
suicidality	O	O	B-T201
due	O	O	O
to	O	O	O
ESB	O	O	B-T033
.	O	O	O

Results	O	O	B-T169
showed	O	O	O
no	O	O	O
validity	O	O	B-T080
for	O	O	O
ESB	O	O	B-T033
as	O	O	O
a	O	O	O
common	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
suicidality	O	O	B-T201
or	O	O	O
other	O	O	O
psychopathology	O	O	B-UnknownType
,	O	O	O
or	O	O	O
as	O	O	O
a	O	O	O
latent	O	O	B-T080
trait	O	O	B-T032
.	O	O	O

ESB	O	O	B-T033
showed	O	O	O
evidence	O	O	B-T078
as	O	O	O
a	O	O	O
personal	O	O	B-T032
negative	O	O	B-T033
life	O	O	I-T033
event	O	O	I-T033
with	O	O	O
individual	O	O	B-T098
effects	O	O	B-T080
and	O	O	O
interpretations	O	O	B-T170
.	O	O	O

-DOCSTART- (28137262)

Direct	O	O	B-T082
anterior	O	O	I-T082
approach	O	O	I-T082
for	O	O	O
total	O	O	B-T061
hip	O	O	I-T061
arthroplasty	O	O	I-T061
with	O	O	O
a	O	O	O
novel	O	O	O
mobile	O	O	B-T074
traction	O	O	I-T074
table	O	O	I-T074
-a	O	O	O
prospective	O	O	O
cohort	O	O	O
study	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
prospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
was	O	O	O
to	O	O	O
clarify	O	O	O
the	O	O	O
safety	O	O	O
and	O	O	O
efficacy	O	O	O
of	O	O	O
total	O	O	B-T061
hip	O	O	I-T061
arthroplasty	O	O	I-T061
via	O	O	O
the	O	O	O
direct	O	O	B-T082
anterior	O	O	I-T082
approach	O	O	I-T082
in	O	O	O
the	O	O	O
supine	O	O	B-T082
position	O	O	I-T082
with	O	O	O
a	O	O	O
novel	O	O	O
mobile	O	O	B-T074
traction	O	O	I-T074
table	O	O	I-T074
.	O	O	O

The	O	O	O
first	O	O	O
experience	O	O	O
of	O	O	O
consecutive	O	O	B-T061
surgeries	O	O	I-T061
by	O	O	O
a	O	O	O
single	O	O	B-T097
surgeon	O	O	I-T097
using	O	O	O
the	O	O	O
direct	O	O	B-T082
anterior	O	O	I-T082
approach	O	O	I-T082
with	O	O	O
a	O	O	O
traction	O	O	B-T074
table	O	O	I-T074
is	O	O	O
described	O	O	O
with	O	O	O
a	O	O	O
two-year	O	O	O
follow-up	O	O	B-T058
period	O	O	O
.	O	O	O

Of	O	O	O
121	O	O	O
patients	O	O	B-T101
,	O	O	O
100	O	O	O
patients	O	O	O
without	O	O	O
previous	O	O	B-T033
hip	O	O	I-T033
surgeries	O	O	I-T033
,	O	O	O
severe	O	O	B-T190
deformity	O	O	I-T190
,	O	O	O
or	O	O	O
cemented	O	O	B-T061
implants	O	O	I-T061
were	O	O	O
divided	O	O	O
into	O	O	O
two	O	O	O
groups	O	O	B-T078
comprising	O	O	O
the	O	O	O
first	O	O	O
50	O	O	O
patients	O	O	O
and	O	O	O
the	O	O	O
second	O	O	O
50	O	O	O
patients	O	O	O
.	O	O	O

The	O	O	O
implant	O	O	B-T081
survival	O	O	I-T081
rate	O	O	I-T081
was	O	O	O
99	O	O	O
%	O	O	O
at	O	O	O
the	O	O	O
two-year	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Revision	O	O	B-T061
surgery	O	O	I-T061
was	O	O	O
required	O	O	O
for	O	O	O
periprosthetic	O	O	B-T037
femoral	O	O	B-T037
fracture	O	O	I-T037
in	O	O	O
one	O	O	O
patient	O	O	B-T101
.	O	O	O

The	O	O	O
complication	O	O	B-T046
rate	O	O	B-T081
possibly	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
traction	O	O	B-T074
table	O	O	I-T074
was	O	O	O
5	O	O	O
%	O	O	O
(	O	O	O
5	O	O	O
patients	O	O	B-T101
):	O	O	O
three	O	O	O
anterior	O	O	B-T037
dislocations	O	O	I-T037
,	O	O	O
one	O	O	O
periprosthetic	O	O	B-T037
femoral	O	O	B-T037
fracture	O	O	I-T037
,	O	O	O
and	O	O	O
one	O	O	O
intraoperative	O	O	B-T058
perforation	O	O	I-T058
caused	O	O	O
by	O	O	O
femoral	O	O	B-T037
rasping	O	O	I-T037
.	O	O	O

The	O	O	O
complication	O	O	B-T046
rate	O	O	B-T081
tended	O	O	O
to	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
second	O	O	O
group	O	O	B-T078
compared	O	O	O
to	O	O	O
the	O	O	O
first	O	O	O
group	O	O	O
(	O	O	O
4	O	O	O
%	O	O	O
versus	O	O	O
6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Mean	O	O	B-T079
surgical	O	O	I-T079
time	O	O	I-T079
(	O	O	O
72.0	O	O	O
minutes	O	O	O
versus	O	O	O
82.5	O	O	O
min	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.027	O	O	O
)	O	O	O
,	O	O	O
rate	O	O	B-T081
of	O	O	O
allogeneic	O	O	B-T061
blood	O	O	I-T061
transfusion	O	O	I-T061
(	O	O	O
2	O	O	O
%	O	O	O
versus	O	O	O
24	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
cup	O	O	B-T033
alignment	O	O	I-T033
in	O	O	O
the	O	O	O
safe	O	O	B-T082
zone	O	O	I-T082
(	O	O	O
100	O	O	O
%	O	O	O
versus	O	O	O
88	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.027	O	O	O
)	O	O	O
were	O	O	O
significantly	O	O	O
improved	O	O	O
in	O	O	O
the	O	O	O
second	O	O	O
group	O	O	B-T078
compared	O	O	O
to	O	O	O
the	O	O	O
first	O	O	O
group	O	O	O
.	O	O	O

The	O	O	O
direct	O	O	B-T082
anterior	O	O	I-T082
approach	O	O	I-T082
with	O	O	O
a	O	O	O
novel	O	O	O
mobile	O	O	B-T074
traction	O	O	I-T074
table	O	O	I-T074
showed	O	O	O
a	O	O	O
positive	O	O	B-T033
learning	O	O	I-T033
curve	O	O	I-T033
for	O	O	O
surgical	O	O	B-T079
time	O	O	I-T079
,	O	O	O
rate	O	O	B-T081
of	O	O	O
allogeneic	O	O	B-T061
blood	O	O	I-T061
transfusion	O	O	I-T061
,	O	O	O
and	O	O	O
cup	O	O	B-T033
alignment	O	O	I-T033
in	O	O	O
the	O	O	O
safe	O	O	B-T082
zone	O	O	I-T082
.	O	O	O

-DOCSTART- (28137449)

The	O	O	O
binding	O	O	B-T044
orientations	O	O	B-T082
of	O	O	O
structurally	O	O	B-T082
-related	O	O	O
ligands	O	O	B-T103
can	O	O	O
differ	O	O	B-T080
;	O	O	O
A	O	O	O
cautionary	O	O	O
note	O	O	O

Crystal	O	O	B-T104
structures	O	O	I-T104
can	O	O	O
identify	O	O	O
ligand-receptor	O	O	B-T044
interactions	O	O	I-T044
and	O	O	O
assist	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
novel	O	O	O
therapeutics	O	O	B-T061
,	O	O	O
but	O	O	O
experimental	O	O	B-T080
challenges	O	O	O
sometimes	O	O	O
necessitate	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
homologous	O	O	B-T116
proteins	O	O	I-T116
.	O	O	O

Tropisetron	O	O	B-T109
is	O	O	O
an	O	O	O
orthosteric	O	O	B-T103
ligand	O	O	I-T103
at	O	O	O
both	O	O	O
5-HT3	O	O	B-T116
and	O	O	O
α7	O	O	B-T116
nACh	O	O	I-T116
receptors	O	O	I-T116
and	O	O	O
its	O	O	O
binding	O	O	B-T044
orientation	O	O	B-T082
has	O	O	O
been	O	O	O
determined	O	O	O
in	O	O	O
the	O	O	O
structural	O	O	B-T087
homologue	O	O	I-T087
AChBP	O	O	B-T116
(	O	O	O
pdbid	O	O	O
:	O	O	O
2WNC	O	O	O
)	O	O	O
.	O	O	O

Co-crystallisation	O	O	B-T070
with	O	O	O
a	O	O	O
structurally	O	O	B-T082
-related	O	O	O
ligand	O	O	B-T103
,	O	O	O
granisetron	O	O	B-T109
,	O	O	O
reveals	O	O	O
an	O	O	O
almost	O	O	O
identical	O	O	B-T080
orientation	O	O	B-T082
(	O	O	O
pdbid	O	O	O
;	O	O	O
2YME	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
>	O	O	O
1000-fold	O	O	O
difference	O	O	B-T080
in	O	O	O
the	O	O	O
affinity	O	O	B-T070
of	O	O	O
tropisetron	O	O	B-T109
at	O	O	O
5-HT3	O	O	B-T116
versus	O	O	O
α7	O	O	B-T116
nACh	O	O	I-T116
receptors	O	O	I-T116
,	O	O	O
and	O	O	O
α7	O	O	O
nACh	O	O	O
receptors	O	O	O
do	O	O	O
not	O	O	B-T169
bind	O	O	B-T044
granisetron	O	O	B-T109
.	O	O	O

These	O	O	O
striking	O	O	O
pharmacological	O	O	B-T169
differences	O	O	B-T080
prompt	O	O	O
questions	O	O	O
about	O	O	O
which	O	O	O
receptor	O	O	B-T116
the	O	O	O
crystal	O	O	B-T104
structures	O	O	I-T104
most	O	O	O
closely	O	O	O
represent	O	O	O
and	O	O	O
whether	O	O	O
the	O	O	O
ligand	O	O	B-T103
orientations	O	O	B-T082
are	O	O	O
correct	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
probe	O	O	O
the	O	O	O
binding	O	O	B-T044
orientation	O	O	B-T082
of	O	O	O
tropisetron	O	O	B-T109
and	O	O	O
granisetron	O	O	B-T109
at	O	O	O
5-HT3	O	O	B-T116
receptors	O	O	I-T116
by	O	O	O
in	O	O	B-T066
silico	O	O	I-T066
modelling	O	O	B-T090
and	O	O	O
docking	O	O	B-T044
,	O	O	O
radioligand	O	O	B-T044
binding	O	O	I-T044
on	O	O	O
cysteine	O	O	B-T116
-	O	O	O
substituted	O	O	B-T045
5-HT3	O	O	B-T116
receptor	O	O	I-T116
mutants	O	O	B-T049
transiently	O	O	O
expressed	O	O	B-T045
in	O	O	O
HEK	O	O	B-T025
293	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
synthetic	O	O	B-T091
modification	O	O	I-T091
of	O	O	O
the	O	O	O
ligands	O	O	B-T103
.	O	O	O

For	O	O	O
15	O	O	O
of	O	O	O
the	O	O	O
23	O	O	O
cysteine	O	O	B-T116
substitutions	O	O	B-T045
,	O	O	O
the	O	O	O
effects	O	O	B-T080
on	O	O	O
tropisetron	O	O	B-T109
and	O	O	O
granisetron	O	O	B-T109
were	O	O	O
different	O	O	O
.	O	O	O

Structure-activity	O	O	B-T080
relationships	O	O	I-T080
on	O	O	O
synthesised	O	O	O
derivatives	O	O	O
of	O	O	O
both	O	O	O
ligands	O	O	B-T103
were	O	O	O
also	O	O	O
consistent	O	O	O
with	O	O	O
different	O	O	B-T080
orientations	O	O	B-T082
,	O	O	O
revealing	O	O	B-T080
that	O	O	O
contrary	O	O	O
to	O	O	O
the	O	O	O
crystallographic	O	O	B-T059
evidence	O	O	B-T078
from	O	O	O
AChBP	O	O	B-T116
,	O	O	O
the	O	O	O
two	O	O	O
ligands	O	O	O
adopt	O	O	O
different	O	O	O
orientations	O	O	O
in	O	O	O
the	O	O	O
5-HT3	O	O	B-T116
receptor	O	O	I-T116
binding	O	O	B-T192
site	O	O	I-T192
.	O	O	O

Our	O	O	O
results	O	O	O
show	O	O	O
that	O	O	O
even	O	O	O
quite	O	O	O
structurally	O	O	B-T082
similar	O	O	O
molecules	O	O	B-T167
can	O	O	O
adopt	O	O	O
different	O	O	O
orientations	O	O	B-T082
in	O	O	O
the	O	O	O
same	O	O	O
binding	O	O	B-T192
site	O	O	I-T192
,	O	O	O
and	O	O	O
that	O	O	O
caution	O	O	O
may	O	O	O
be	O	O	O
needed	O	O	O
when	O	O	O
using	O	O	O
homologous	O	O	B-T116
proteins	O	O	I-T116
to	O	O	O
predict	O	O	O
ligand	O	O	B-T044
binding	O	O	I-T044
.	O	O	O

-DOCSTART- (28138631)

Pancreatic	O	O	B-T023
neuroendocrine	O	O	B-T191
cancer	O	O	I-T191
with	O	O	O
liver	O	O	B-T191
metastases	O	O	I-T191
and	O	O	O
multiple	O	O	B-T191
peritoneal	O	O	I-T191
metastases	O	O	I-T191
:	O	O	O
report	O	O	O
of	O	O	O
one	O	O	O
case	O	O	O

Pancreatic	O	O	B-T023
neuroendocrine	O	O	B-T191
tumor	O	O	I-T191
(	O	O	O
pNET	O	O	B-T191
)	O	O	O
is	O	O	O
a	O	O	O
rare	O	O	O
pancreatic	O	O	B-T191
tumor	O	O	I-T191
,	O	O	O
with	O	O	O
its	O	O	O
incidence	O	O	O
showing	O	O	O
a	O	O	O
rising	O	O	O
trend	O	O	O
in	O	O	O
recent	O	O	O
years	O	O	O
.	O	O	O

Most	O	O	O
of	O	O	O
its	O	O	O
distant	O	O	B-T201
metastases	O	O	I-T201
are	O	O	O
found	O	O	B-T033
in	O	O	O
the	O	O	O
liver	O	O	B-T023
.	O	O	O

This	O	O	O
article	O	O	O
describes	O	O	O
a	O	O	O
59-year-old	O	O	O
male	O	O	B-T032
patient	O	O	I-T032
with	O	O	O
pNET	O	O	B-T191
with	O	O	O
liver	O	O	B-T191
metastasis	O	O	I-T191
and	O	O	O
multiple	O	O	B-T191
abdominal	O	O	I-T191
metastases	O	O	I-T191
,	O	O	O
focusing	O	O	O
on	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
this	O	O	O
tumor	O	O	B-T191
in	O	O	O
its	O	O	O
advanced	O	O	B-T079
stage	O	O	I-T079
.	O	O	O

-DOCSTART- (28139296)

Lignans	O	O	B-T109
from	O	O	O
the	O	O	O
fruits	O	O	B-T168
of	O	O	O
Schisandra	O	O	B-T002
chinensis	O	O	I-T002
(	O	O	I-T002
Turcz	O	O	I-T002
.	O	O	I-T002
)	O	O	I-T002
Baill	O	O	I-T002
inhibit	O	O	B-T052
proprotein	O	O	B-T028
convertase	O	O	I-T028
subtilisin/kexin	O	O	I-T028
type	O	O	I-T028
9	O	O	I-T028
expression	O	O	O

Bioactivity-guided	O	O	B-T059
fractionation	O	O	I-T059
of	O	O	O
the	O	O	O
fruits	O	O	B-T168
of	O	O	O
Schisandra	O	O	B-T002
chinensis	O	O	I-T002
,	O	O	O
using	O	O	O
the	O	O	O
proprotein	O	O	B-T028
convertase	O	O	I-T028
subtilisin-kexin	O	O	I-T028
type	O	O	I-T028
9	O	O	I-T028
(	O	O	O
PCSK9	O	O	B-T028
)	O	O	O
mRNA	O	O	B-T045
expression	O	O	I-T045
screening	O	O	B-T059
assay	O	O	I-T059
,	O	O	O
led	O	O	O
to	O	O	O
isolation	O	O	B-T169
of	O	O	O
two	O	O	B-T081
previously	O	O	B-T080
unknown	O	O	I-T080
lignans	O	O	B-T109
,	O	O	O
14-tigloylschinlignan	O	O	B-T109
D	O	O	I-T109
and	O	O	O
rel-(7R	O	O	B-T109
,	O	O	I-T109
8R	O	O	I-T109
,	O	O	I-T109
7'R	O	O	I-T109
,	O	O	I-T109
8'R)-manglisin	O	O	I-T109
E	O	O	I-T109
,	O	O	O
along	O	O	O
with	O	O	O
28	O	O	O
known	O	O	O
compounds	O	O	O
.	O	O	O

All	O	O	O
structures	O	O	B-T170
were	O	O	O
established	O	O	B-T080
by	O	O	O
NMR	O	O	B-T060
spectroscopic	O	O	I-T060
data	O	O	B-T078
as	O	O	O
well	O	O	O
as	O	O	O
CD	O	O	B-T059
and	O	O	O
MS	O	O	B-T059
analysis	O	O	B-T062
.	O	O	O

All	O	O	O
isolates	O	O	O
were	O	O	O
tested	O	O	B-T169
for	O	O	O
their	O	O	O
inhibitory	O	O	B-T052
activities	O	O	B-T052
on	O	O	O
the	O	O	O
mRNA	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
PCSK9	O	O	B-T028
.	O	O	O

Of	O	O	O
the	O	O	O
tested	O	O	B-T169
compounds	O	O	O
,	O	O	O
four	O	O	B-T081
of	O	O	O
the	O	O	O
compounds	O	O	O
rel-(7R	O	O	B-T109
,	O	O	I-T109
8R	O	O	I-T109
,	O	O	I-T109
7'R	O	O	I-T109
,	O	O	I-T109
8'R)-manglisin	O	O	I-T109
E	O	O	I-T109
,	O	O	O
(-)-schisandrin	O	O	B-T109
C	O	O	I-T109
,	O	O	O
schinlignan	O	O	B-T109
D	O	O	I-T109
,	O	O	O
and	O	O	O
(+)-schisandrol	O	O	B-T109
B	O	O	I-T109
potently	O	O	O
inhibited	O	O	B-T080
PCSK9	O	O	B-T028
mRNA	O	O	B-T045
expression	O	O	I-T045
with	O	O	O
IC50	O	O	B-T081
values	O	O	O
of	O	O	O
3.15	O	O	O
,	O	O	O
3.85	O	O	O
,	O	O	O
0.36	O	O	O
,	O	O	O
and	O	O	O
1.10	O	O	O
μM	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
schinlignan	O	O	B-T109
D	O	O	I-T109
and	O	O	O
(+)-schisandrol	O	O	B-T109
B	O	O	I-T109
were	O	O	O
found	O	O	O
to	O	O	O
suppress	O	O	B-T169
PCSK9	O	O	B-T116
protein	O	O	B-T045
expressions	O	O	I-T045
and	O	O	O
schinlignan	O	O	O
D	O	O	O
deemed	O	O	O
to	O	O	O
increase	O	O	O
low	O	O	B-T116
density	O	O	I-T116
lipoprotein	O	O	I-T116
receptor	O	O	I-T116
expression	O	O	B-T045
.	O	O	O

-DOCSTART- (28139371)

A	O	O	O
comparison	O	O	O
of	O	O	O
outcomes	O	O	B-T080
in	O	O	O
morbidly	O	O	B-T047
obese	O	O	B-T047
,	O	O	O
obese	O	O	O
and	O	O	O
non-obese	O	O	B-T032
patients	O	O	B-T101
undergoing	O	O	O
primary	O	O	B-T061
total	O	O	I-T061
knee	O	O	I-T061
and	O	O	O
total	O	O	O
hip	O	O	O
arthroplasty	O	O	O

Obesity	O	O	B-T047
is	O	O	O
a	O	O	O
growing	O	O	O
public	O	O	B-T092
health	O	O	B-T033
issue	O	O	I-T033
with	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
morbid	O	O	B-T033
obesity	O	O	I-T033
,	O	O	I-T033
(	O	O	I-T033
Body	O	O	I-T033
Mass	O	O	I-T033
Index	O	O	I-T033
(	O	O	I-T033
BMI	O	O	I-T033
)	O	O	I-T033
≥	O	O	I-T033
40	O	O	I-T033
kg/m(2	O	O	I-T033
)	O	O	I-T033
)	O	O	I-T033
increasing	O	O	B-T169
.	O	O	O

There	O	O	O
is	O	O	O
some	O	O	O
evidence	O	O	B-T078
these	O	O	O
patients	O	O	B-T101
have	O	O	O
more	O	O	O
peri-	O	O	B-T047
and	O	O	I-T047
post-operative	O	O	I-T047
complications	O	O	I-T047
and	O	O	O
poorer	O	O	B-T080
outcomes	O	O	I-T080
when	O	O	O
undergoing	O	O	O
arthroplasty	O	O	B-T061
procedures	O	O	I-T061
.	O	O	O

This	O	O	O
audit	O	O	O
aimed	O	O	O
to	O	O	O
determine	O	O	O
and	O	O	O
compare	O	O	O
the	O	O	O
outcomes	O	O	B-T080
of	O	O	O
non-obese	O	O	B-T032
,	O	O	O
obese	O	O	B-T047
and	O	O	O
morbidly	O	O	B-T047
obese	O	O	I-T047
patients	O	O	B-T101
undergoing	O	O	O
arthroplasty	O	O	B-T061
at	O	O	O
our	O	O	O
institution	O	O	B-T093
.	O	O	O

This	O	O	O
was	O	O	O
a	O	O	O
retrospective	O	O	B-T058
audit	O	O	I-T058
of	O	O	O
patients	O	O	B-T101
from	O	O	O
our	O	O	O
institution	O	O	B-T093
who	O	O	O
had	O	O	O
undergone	O	O	O
total	O	O	B-T061
knee	O	O	I-T061
(	O	O	O
TKA	O	O	B-T061
)	O	O	O
or	O	O	O
total	O	O	B-T061
hip	O	O	I-T061
arthroplasty	O	O	I-T061
(	O	O	O
THA	O	O	B-T061
)	O	O	O
in	O	O	O
2009	O	O	O
.	O	O	O

Data	O	O	B-T078
collected	O	O	B-T078
were	O	O	O
:	O	O	O
age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
BMI	O	O	B-T201
,	O	O	O
length	O	O	B-T079
of	O	O	I-T079
stay	O	O	I-T079
(	O	O	O
LOS	O	O	B-T079
)	O	O	O
,	O	O	O
Oxford	O	O	B-T201
knee	O	O	I-T201
or	O	O	O
hip	O	O	B-T201
score	O	O	I-T201
(	O	O	O
OKS	O	O	B-T201
/	O	O	O
OHS	O	O	B-T201
)	O	O	O
,	O	O	O
satisfaction	O	O	B-T033
and	O	O	O
complications	O	O	B-T046
up	O	O	O
to	O	O	O
two	O	O	O
years	O	O	B-T079
post	O	O	B-T061
operation	O	O	I-T061
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
divided	O	O	O
into	O	O	O
three	O	O	O
groups	O	O	B-T078
:	O	O	O
BMI	O	O	B-T033
<	O	O	I-T033
30	O	O	I-T033
,	O	O	O
BMI	O	O	B-T201
30	O	O	I-T201
-	O	O	I-T201
40	O	O	I-T201
and	O	O	O
BMI	O	O	B-T033
>	O	O	I-T033
40	O	O	I-T033
.	O	O	O

Outcomes	O	O	B-T080
for	O	O	O
each	O	O	O
BMI	O	O	B-T201
group	O	O	B-T078
were	O	O	O
compared	O	O	O
.	O	O	O

1014	O	O	O
TKA	O	O	B-T061
and	O	O	O
906	O	O	O
THA	O	O	B-T061
operations	O	O	B-T061
were	O	O	O
included	O	O	O
.	O	O	O

When	O	O	O
compared	O	O	O
to	O	O	O
obese	O	O	B-T047
and	O	O	O
non-obese	O	O	B-T032
patients	O	O	B-T101
,	O	O	O
morbidly	O	O	B-T047
obese	O	O	I-T047
patients	O	O	O
undergoing	O	O	O
TKA	O	O	B-T061
had	O	O	O
a	O	O	O
mean	O	O	O
LOS	O	O	B-T079
one	O	O	O
day	O	O	B-T079
longer	O	O	O
,	O	O	O
a	O	O	O
mean	O	O	B-T201
OKS	O	O	I-T201
four	O	O	O
points	O	O	O
lower	O	O	O
and	O	O	O
higher	O	O	O
rates	O	O	O
of	O	O	O
postoperative	O	O	B-T046
problems	O	O	I-T046
,	O	O	O
37	O	O	O
%	O	O	O
vs.	O	O	O
21	O	O	O
%	O	O	O
.	O	O	O

For	O	O	O
THA	O	O	B-T061
patients	O	O	B-T101
there	O	O	O
was	O	O	O
no	O	O	B-T033
difference	O	O	I-T033
in	O	O	O
LOS	O	O	B-T079
,	O	O	O
OHS	O	O	B-T201
score	O	O	I-T201
was	O	O	O
two	O	O	O
points	O	O	O
lower	O	O	O
for	O	O	O
each	O	O	O
increasing	O	O	B-T169
BMI	O	O	B-T201
category	O	O	B-T170
and	O	O	O
postoperative	O	O	B-T046
problems	O	O	I-T046
increase	O	O	B-T169
from	O	O	O
25	O	O	O
%	O	O	O
for	O	O	O
non-obese	O	O	B-T032
to	O	O	O
31	O	O	O
%	O	O	O
for	O	O	O
obese	O	O	B-T047
and	O	O	O
38	O	O	O
%	O	O	O
for	O	O	O
morbidly	O	O	B-T047
obese	O	O	I-T047
patients	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
will	O	O	O
be	O	O	O
useful	O	O	O
in	O	O	O
informing	O	O	O
obese	O	O	B-T047
patients	O	O	B-T101
of	O	O	O
their	O	O	O
potential	O	O	O
outcomes	O	O	B-T080
following	O	O	O
TKA	O	O	B-T061
or	O	O	O
THA	O	O	B-T061
.	O	O	O

These	O	O	O
patients	O	O	B-T101
can	O	O	O
then	O	O	O
make	O	O	O
a	O	O	O
more	O	O	O
informed	O	O	O
choice	O	O	O
before	O	O	O
proceeding	O	O	O
with	O	O	O
arthroplasty	O	O	B-T061
.	O	O	O

-DOCSTART- (28139665)

Vitamin	O	O	B-T123
D	O	O	I-T123
Receptor	O	O	I-T123
Activator	O	O	I-T123
Use	O	O	O
and	O	O	O
Cause-specific	O	O	B-T081
Death	O	O	I-T081
among	O	O	O
dialysis	O	O	B-T061
Patients	O	O	B-T101
:	O	O	O
a	O	O	O
Nationwide	O	O	B-T081
Cohort	O	O	I-T081
Study	O	O	I-T081
using	O	O	O
Coarsened	O	O	O
Exact	O	O	O
Matching	O	O	O

Vitamin	O	O	B-T123
D	O	O	I-T123
receptor	O	O	I-T123
activators	O	O	I-T123
(	O	O	O
VDRA	O	O	B-T123
)	O	O	O
may	O	O	O
exert	O	O	O
pleiotropic	O	O	B-T045
effects	O	O	I-T045
on	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
malignancy	O	O	B-T191
,	O	O	O
and	O	O	O
infections	O	O	B-T046
among	O	O	O
dialysis	O	O	B-T061
patients	O	O	B-T101
,	O	O	O
but	O	O	O
recent	O	O	O
studies	O	O	O
have	O	O	O
mainly	O	O	O
focused	O	O	O
on	O	O	O
cardiovascular	O	O	B-T033
outcomes	O	O	I-T033
.	O	O	O

Among	O	O	O
8,675	O	O	O
patients	O	O	B-T101
who	O	O	O
started	O	O	O
dialysis	O	O	B-T061
in	O	O	O
2007	O	O	O
and	O	O	O
who	O	O	B-T081
survived	O	O	I-T081
until	O	O	O
January	O	O	O
1	O	O	O
,	O	O	O
2010	O	O	O
,	O	O	O
listed	O	O	O
in	O	O	O
the	O	O	O
Renal	O	O	B-T062
Data	O	O	I-T062
Registry	O	O	I-T062
of	O	O	O
the	O	O	O
Japanese	O	O	B-T093
Society	O	O	I-T093
for	O	O	O
Dialysis	O	O	B-T061
Therapy	O	O	I-T061
,	O	O	O
5,365	O	O	O
VDRA	O	O	B-T123
users	O	O	O
were	O	O	O
matched	O	O	O
to	O	O	O
3,203	O	O	O
non-users	O	O	O
based	O	O	O
on	O	O	O
clinically	O	O	B-T079
relevant	O	O	I-T079
variables	O	O	I-T079
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
2009	O	O	O
using	O	O	O
the	O	O	O
coarsened	O	O	B-T081
exact	O	O	I-T081
matching	O	O	I-T081
procedure	O	O	I-T081
.	O	O	O

Until	O	O	O
December	O	O	O
31	O	O	O
,	O	O	O
2011	O	O	O
,	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
1,128	O	O	O
deaths	O	O	B-T081
occurred	O	O	O
,	O	O	O
of	O	O	O
which	O	O	O
468	O	O	O
(	O	O	O
42	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
cardiovascular	O	O	B-T046
deaths	O	O	I-T046
,	O	O	O
229	O	O	O
(	O	O	O
20	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
infection-related	O	O	B-T033
deaths	O	O	I-T033
,	O	O	O
and	O	O	O
141	O	O	O
(	O	O	O
12	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
malignancy-related	O	O	B-T081
deaths	O	O	I-T081
.	O	O	O

Multivariable	O	O	B-T062
survival	O	O	I-T062
analyses	O	O	I-T062
accounting	O	O	O
for	O	O	O
intra-region	O	O	B-T080
correlation	O	O	I-T080
revealed	O	O	O
that	O	O	O
VDRA	O	O	B-T123
use	O	O	O
was	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
lower	O	O	B-T081
rates	O	O	I-T081
of	O	O	O
infection	O	O	B-T046
-	O	O	O
and	O	O	O
malignancy	O	O	B-T191
-related	O	O	O
deaths	O	O	B-T081
[	O	O	O
subhazard	O	O	B-T081
ratio	O	O	I-T081
0.62	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0.52	O	O	O
-	O	O	O
0.73	O	O	O
)	O	O	O
and	O	O	O
0.70	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.50	O	O	O
-	O	O	O
0.97	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
]	O	O	O
but	O	O	O
not	O	O	O
with	O	O	O
cardiovascular	O	O	B-T046
death	O	O	I-T046
[	O	O	O
subhazard	O	O	O
ratio	O	O	O
0.86	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.72	O	O	O
-	O	O	O
1.04	O	O	O
)	O	O	O
]	O	O	O
.	O	O	O

Future	O	O	O
randomized	O	O	B-T062
clinical	O	O	I-T062
trials	O	O	I-T062
with	O	O	O
a	O	O	O
sufficient	O	O	O
sample	O	O	B-T081
size	O	O	I-T081
and	O	O	O
an	O	O	O
adequate	O	O	O
follow-up	O	O	B-T058
period	O	O	O
are	O	O	O
warranted	O	O	O
to	O	O	O
test	O	O	O
the	O	O	O
clinical	O	O	B-T080
effectiveness	O	O	I-T080
of	O	O	O
VDRA	O	O	B-T123
on	O	O	O
infection	O	O	B-T046
and	O	O	O
malignancy	O	O	B-T191
,	O	O	O
rather	O	O	O
than	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
among	O	O	O
dialysis	O	O	B-T061
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28144096)

Burden	O	O	B-T078
of	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
role	O	O	O
of	O	O	O
screening	O	O	B-T058
in	O	O	O
India	O	O	O

Cervical	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
a	O	O	O
major	O	O	O
cause	O	O	O
of	O	O	O
cancer	O	O	B-T081
mortality	O	O	I-T081
in	O	O	O
women	O	O	B-T098
and	O	O	O
more	O	O	O
than	O	O	O
a	O	O	O
quarter	O	O	B-T081
of	O	O	O
its	O	O	O
global	O	O	B-T080
burden	O	O	B-T078
is	O	O	O
contributed	O	O	B-T052
by	O	O	O
developing	O	O	B-T080
countries	O	O	I-T080
.	O	O	O

In	O	O	O
India	O	O	B-T083
,	O	O	O
in	O	O	O
spite	O	O	O
of	O	O	O
alarmingly	O	O	O
high	O	O	O
figures	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
nationwide	O	O	O
government-sponsored	O	O	B-T064
screening	O	O	I-T064
program	O	O	I-T064
.	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
conducted	O	O	B-T169
to	O	O	O
assess	O	O	B-T052
the	O	O	O
burden	O	O	B-T078
of	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
in	O	O	O
India	O	O	B-T083
and	O	O	O
review	O	O	B-T169
the	O	O	O
performance	O	O	B-T052
characteristics	O	O	B-T080
of	O	O	O
available	O	O	O
cervical	O	O	O
cancer	O	O	O
screening	O	O	B-T058
tools	O	O	O
,	O	O	O
so	O	O	O
as	O	O	O
to	O	O	O
provide	O	O	B-T052
evidence	O	O	B-T078
-based	O	O	O
recommendations	O	O	B-T078
for	O	O	O
application	O	O	O
of	O	O	O
most	O	O	O
practically	O	O	O
suited	O	O	O
screening	O	O	B-T060
test	O	O	I-T060
to	O	O	O
be	O	O	O
used	O	O	O
in	O	O	O
resource	O	O	B-T078
-poor	O	O	O
field	O	O	O
settings	O	O	O
.	O	O	O

MEDLINE	O	O	B-T170
and	O	O	O
Web	O	O	B-T170
of	O	O	I-T170
Science	O	O	I-T170
electronic	O	O	I-T170
database	O	O	I-T170
were	O	O	O
searched	O	O	B-T052
from	O	O	O
January	O	O	B-T080
1990	O	O	O
to	O	O	O
December	O	O	B-T080
2015	O	O	O
,	O	O	O
using	O	O	O
the	O	O	O
keywords	O	O	B-T170
such	O	O	O
as	O	O	O
"	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
"	O	O	O
,	O	O	O
"	O	O	O
screening	O	O	B-T060
"	O	O	O
,	O	O	O
"	O	O	O
early	O	O	B-T060
detection	O	O	I-T060
"	O	O	O
,	O	O	O
"	O	O	O
cervical	O	O	B-T059
cytology	O	O	I-T059
"	O	O	O
and	O	O	O
"	O	O	O
visual	O	O	B-T058
inspection	O	O	I-T058
"	O	O	O
,	O	O	O
and	O	O	O
their	O	O	O
corresponding	O	O	O
MeSH	O	O	B-T170
terms	O	O	I-T170
in	O	O	O
combination	O	O	B-T080
with	O	O	O
Boolean	O	O	B-T169
operators	O	O	I-T169
"	O	O	O
OR	O	O	O
,	O	O	O
AND	O	O	O
.	O	O	O
"	O	O	O
Two	O	O	O
authors	O	O	B-T097
independently	O	O	O
selected	O	O	B-T052
studies	O	O	B-T062
that	O	O	O
are	O	O	O
published	O	O	B-T170
in	O	O	O
English	O	O	B-T171
and	O	O	O
conducted	O	O	B-T169
in	O	O	O
India	O	O	B-T083
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
11	O	O	O
studies	O	O	B-T062
were	O	O	O
found	O	O	B-T033
to	O	O	O
be	O	O	O
relevant	O	O	B-T080
and	O	O	O
eligible	O	O	B-T080
to	O	O	O
be	O	O	O
included	O	O	B-T169
in	O	O	O
the	O	O	O
present	O	O	B-T033
study	O	O	B-T062
.	O	O	O

In	O	O	O
India	O	O	B-T083
,	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
contributes	O	O	B-T052
to	O	O	O
approximately	O	O	B-T080
6	O	O	O
-	O	O	O
29	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
cancers	O	O	B-T191
in	O	O	O
women	O	O	B-T098
.	O	O	O

The	O	O	O
age-adjusted	O	O	B-T081
incidence	O	O	I-T081
rate	O	O	I-T081
of	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
varies	O	O	O
widely	O	O	O
among	O	O	O
registries	O	O	B-T170
;	O	O	O
highest	O	O	B-T080
is	O	O	O
23.07/100,000	O	O	O
in	O	O	O
Mizoram	O	O	B-UnknownType
state	O	O	I-UnknownType
and	O	O	O
the	O	O	O
lowest	O	O	B-T080
is	O	O	O
4.91/100,000	O	O	O
in	O	O	O
Dibrugarh	O	O	B-UnknownType
district	O	O	I-UnknownType
.	O	O	O

The	O	O	O
pooled	O	O	O
estimates	O	O	B-T081
of	O	O	O
sensitivity	O	O	B-T081
and	O	O	O
specificity	O	O	B-T081
of	O	O	O
visual	O	O	B-T060
inspection	O	O	I-T060
with	O	O	I-T060
acetic	O	O	I-T060
acid	O	O	I-T060
(	O	O	O
VIA	O	O	B-T060
)	O	O	O
,	O	O	O
magnified	O	O	B-T060
VIA	O	O	I-T060
,	O	O	O
visual	O	O	B-T060
inspection	O	O	I-T060
with	O	O	I-T060
Lugol	O	O	I-T060
's	O	O	I-T060
iodine	O	O	I-T060
(	O	O	O
VILI	O	O	B-T060
)	O	O	O
,	O	O	O
cytology	O	O	B-T059
(	O	O	O
Pap	O	O	B-T060
smear	O	O	I-T060
)	O	O	O
,	O	O	O
and	O	O	O
human	O	O	B-T059
papillomavirus	O	O	I-T059
DNA	O	O	I-T059
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
67.65	O	O	O
%	O	O	O
and	O	O	O
84.32	O	O	O
%	O	O	O
,	O	O	O
65.36	O	O	O
%	O	O	O
and	O	O	O
85.76	O	O	O
%	O	O	O
,	O	O	O
78.27	O	O	O
%	O	O	O
and	O	O	O
87.10	O	O	O
%	O	O	O
,	O	O	O
62.11	O	O	O
%	O	O	O
and	O	O	O
93.51	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
77.81	O	O	O
%	O	O	O
and	O	O	O
91.54	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
developing	O	O	B-T080
countries	O	O	I-T080
because	O	O	O
of	O	O	O
lack	O	O	B-T080
of	O	O	O
necessary	O	O	O
infrastructure	O	O	B-T185
and	O	O	O
quality	O	O	B-T169
control	O	O	I-T169
,	O	O	O
high-quality	O	O	B-T080
cytology	O	O	B-T060
screening	O	O	I-T060
may	O	O	O
not	O	O	O
be	O	O	O
feasible	O	O	O
for	O	O	O
wide-scale	O	O	O
implementation	O	O	B-T052
.	O	O	O

Hence	O	O	O
,	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
screening	O	O	B-T058
program	O	O	B-T169
based	O	O	O
on	O	O	O
visual	O	O	B-T060
screening	O	O	I-T060
test	O	O	I-T060
such	O	O	O
as	O	O	O
VIA	O	O	B-T060
/	O	O	O
VILI	O	O	B-T060
should	O	O	O
be	O	O	O
adopted	O	O	O
as	O	O	O
an	O	O	O
integral	O	O	O
part	O	O	O
of	O	O	O
primary	O	O	O
health-care	O	O	B-T058
setup	O	O	I-T058
in	O	O	O
resource	O	O	B-T078
-	O	O	O
poor	O	O	B-T080
countries	O	O	B-T083
like	O	O	O
India	O	O	B-T083
.	O	O	O

-DOCSTART- (28144564)

Structural	O	O	B-T052
and	O	O	I-T052
tribometric	O	O	I-T052
characterization	O	O	I-T052
of	O	O	O
biomimetically	O	O	O
inspired	O	O	O
synthetic	O	O	O
"	O	O	O
insect	O	O	B-T204
adhesives	O	O	B-T073
"	O	O	O

Background	O	O	O
:	O	O	O
Based	O	O	O
on	O	O	O
previous	O	O	O
chemical	O	O	B-T059
analyses	O	O	I-T059
of	O	O	O
insect	O	O	B-T204
tarsal	O	O	B-T023
adhesives	O	O	B-T073
,	O	O	O
we	O	O	O
prepared	O	O	O
12	O	O	O
heterogeneous	O	O	B-T080
synthetic	O	O	B-T052
emulsions	O	O	B-T104
mimicking	O	O	O
the	O	O	O
polar/non-polar	O	O	B-T033
principle	O	O	I-T033
,	O	O	O
analysed	O	O	O
their	O	O	O
microscopical	O	O	B-T082
structure	O	O	I-T082
and	O	O	O
tested	O	O	O
their	O	O	O
adhesive	O	O	B-T080
,	O	O	O
frictional	O	O	B-T080
,	O	O	O
and	O	O	O
rheological	O	O	B-T080
properties	O	O	I-T080
.	O	O	O

Results	O	O	O
:	O	O	O
The	O	O	O
prepared	O	O	B-T033
emulsions	O	O	B-T104
varied	O	O	O
in	O	O	O
their	O	O	O
consistency	O	O	B-T080
from	O	O	O
solid	O	O	B-T080
rubber-like	O	O	B-T109
,	O	O	O
over	O	O	O
soft	O	O	B-T080
elastic	O	O	B-T073
,	O	O	O
to	O	O	O
fluid	O	O	B-T167
(	O	O	O
watery	O	O	B-T080
or	O	O	O
oily	O	O	B-T080
)	O	O	O
.	O	O	O

With	O	O	O
droplet	O	O	B-T082
sizes	O	O	I-T082
>	O	O	O
100	O	O	O
nm	O	O	O
,	O	O	O
all	O	O	O
the	O	O	O
emulsions	O	O	B-T104
belonged	O	O	O
to	O	O	O
the	O	O	O
common	O	O	O
type	O	O	O
of	O	O	O
macroemulsions	O	O	B-T104
.	O	O	O

The	O	O	O
emulsions	O	O	B-T104
of	O	O	O
the	O	O	O
first	O	O	B-T079
generation	O	O	I-T079
generally	O	O	O
showed	O	O	O
broader	O	O	O
droplet-size	O	O	B-T082
ranges	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
second	O	O	B-T079
generation	O	O	I-T079
,	O	O	O
especially	O	O	O
when	O	O	O
less	O	O	O
defined	O	O	O
components	O	O	B-T078
such	O	O	O
as	O	O	O
petrolatum	O	O	B-T109
or	O	O	O
waxes	O	O	B-T122
were	O	O	O
present	O	O	O
in	O	O	O
the	O	O	O
lipophilic	O	O	B-T081
fraction	O	O	B-T081
of	O	O	O
the	O	O	O
first	O	O	O
generation	O	O	O
of	O	O	O
emulsions	O	O	O
.	O	O	O

Some	O	O	O
of	O	O	O
the	O	O	O
prepared	O	O	B-T033
emulsions	O	O	B-T104
showed	O	O	O
a	O	O	O
yield	O	O	B-T033
point	O	O	I-T033
and	O	O	O
were	O	O	O
Bingham	O	O	B-T120
fluids	O	O	I-T120
.	O	O	O

Tribometric	O	O	B-T059
adhesion	O	O	I-T059
was	O	O	O
tested	O	O	O
via	O	O	O
probe	O	O	B-T059
tack	O	O	I-T059
tests	O	O	I-T059
.	O	O	O

Compared	O	O	O
with	O	O	O
the	O	O	O
"	O	O	O
second	O	O	B-T079
generation	O	O	I-T079
"	O	O	O
(	O	O	O
containing	O	O	O
less	O	O	O
viscous	O	O	B-T080
components	O	O	B-T167
)	O	O	O
,	O	O	O
the	O	O	O
"	O	O	O
first	O	O	B-T079
generation	O	O	I-T079
"	O	O	O
emulsions	O	O	B-T104
were	O	O	O
much	O	O	O
more	O	O	B-T033
adhesive	O	O	I-T033
(	O	O	O
31	O	O	O
-	O	O	O
93	O	O	O
mN	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
finding	O	O	O
attributable	O	O	O
to	O	O	O
their	O	O	O
highly	O	O	O
viscous	O	O	O
components	O	O	O
,	O	O	O
i.e.	O	O	O
,	O	O	O
wax	O	O	B-T122
,	O	O	O
petrolatum	O	O	B-T109
,	O	O	O
gelatin	O	O	B-T116
and	O	O	O
poly(vinyl	O	O	B-T109
alcohol	O	O	I-T109
)	O	O	I-T109
.	O	O	O

In	O	O	O
the	O	O	O
second	O	O	B-T079
generation	O	O	I-T079
emulsions	O	O	B-T104
,	O	O	O
we	O	O	O
attained	O	O	O
much	O	O	O
lower	O	O	O
adhesivenesses	O	O	B-T070
,	O	O	O
ranging	O	O	O
between	O	O	O
1	O	O	O
-	O	O	O
18	O	O	O
mN.	O	O	O
The	O	O	O
adhesive	O	O	B-T073
performance	O	O	B-T052
was	O	O	O
drastically	O	O	O
reduced	O	O	B-T080
in	O	O	O
the	O	O	O
emulsions	O	O	O
that	O	O	O
contained	O	O	O
albumin	O	O	B-T116
as	O	O	O
the	O	O	O
protein	O	O	B-T116
component	O	O	I-T116
or	O	O	O
that	O	O	O
lacked	O	O	O
protein	O	O	O
.	O	O	O

Tribometric	O	O	B-T059
shear	O	O	I-T059
tests	O	O	I-T059
were	O	O	O
performed	O	O	O
at	O	O	O
moderate	O	O	O
normal	O	O	B-T080
loads	O	O	I-T080
.	O	O	O

Our	O	O	O
measured	O	O	O
friction	O	O	B-T070
forces	O	O	I-T070
(	O	O	O
4	O	O	O
-	O	O	O
93	O	O	O
mN	O	O	O
in	O	O	O
the	O	O	O
first	O	O	O
and	O	O	O
0.1	O	O	O
-	O	O	O
5.8	O	O	O
mN	O	O	O
in	O	O	O
the	O	O	O
second	O	O	B-T079
generation	O	O	I-T079
emulsions	O	O	B-T104
)	O	O	O
were	O	O	O
comparatively	O	O	O
low	O	O	O
.	O	O	O

Differences	O	O	B-T081
in	O	O	O
shear	O	O	B-T070
performance	O	O	B-T052
were	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
chemical	O	O	B-T070
composition	O	O	I-T070
and	O	O	O
emulsion	O	O	B-T104
structure	O	O	B-T082
.	O	O	O

Conclusion	O	O	O
:	O	O	O
By	O	O	O
varying	O	O	O
their	O	O	O
chemical	O	O	B-T070
composition	O	O	I-T070
,	O	O	O
synthetic	O	O	O
heterogeneous	O	O	B-T080
adhesive	O	O	B-T073
emulsions	O	O	B-T104
can	O	O	O
be	O	O	O
adjusted	O	O	O
to	O	O	O
have	O	O	O
diverse	O	O	O
consistencies	O	O	B-T080
and	O	O	O
are	O	O	O
able	O	O	O
to	O	O	O
mimic	O	O	O
certain	O	O	O
rheological	O	O	B-T080
and	O	O	O
tribological	O	O	B-T080
properties	O	O	I-T080
of	O	O	O
natural	O	O	B-T169
tarsal	O	O	B-T023
insect	O	O	B-T204
adhesives	O	O	B-T073
.	O	O	O

-DOCSTART- (28149973)

Opioids	O	O	B-T109
for	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
:	O	O	O
The	O	O	O
CDC	O	O	B-T093
's	O	O	I-T093
12	O	O	O
recommendations	O	O	O

The	O	O	O
Centers	O	O	B-T093
for	O	O	I-T093
Disease	O	O	I-T093
Control	O	O	I-T093
and	O	O	I-T093
Prevention	O	O	I-T093
has	O	O	O
issued	O	O	O
12	O	O	O
recommendations	O	O	B-T078
to	O	O	O
help	O	O	O
clinicians	O	O	B-T097
prescribe	O	O	B-T058
an	O	O	O
optimal	O	O	B-T080
and	O	O	O
safe	O	O	O
course	O	O	O
of	O	O	O
treatment	O	O	B-T061
for	O	O	O
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28150322)

Three-Dimensional	O	O	B-T082
HyCoSy	O	O	B-T060
With	O	O	O
Perfluoropropane-Albumin	O	O	B-T109
Microspheres	O	O	I-T109
as	O	O	O
Contrast	O	O	B-T130
Agents	O	O	I-T130
and	O	O	O
Normal	O	O	O
Saline	O	O	B-T167
Injections	O	O	B-T061
Into	O	O	O
the	O	O	O
Pelvic	O	O	B-T030
Cavity	O	O	I-T030
for	O	O	O
Morphological	O	O	B-T080
Assessment	O	O	B-T058
of	O	O	O
the	O	O	O
Fallopian	O	O	B-T023
Tube	O	O	I-T023
in	O	O	O
Infertile	O	O	B-T046
Women	O	O	O

To	O	O	O
apply	O	O	O
the	O	O	O
three-dimensional	O	O	B-T082
(	O	O	O
3D	O	O	B-T082
)	O	O	O
hysterosalpingo-contrast	O	O	B-T060
sonography	O	O	I-T060
(	O	O	O
HyCoSy	O	O	B-T060
)	O	O	O
with	O	O	O
perfluoropropane-albumin	O	O	B-T109
microspheres	O	O	I-T109
as	O	O	O
contrast	O	O	B-T130
agents	O	O	I-T130
and	O	O	O
normal	O	O	O
saline	O	O	B-T167
injections	O	O	B-T061
into	O	O	O
the	O	O	O
pelvic	O	O	B-T030
cavity	O	O	I-T030
for	O	O	O
assessment	O	O	B-T060
of	O	O	I-T060
the	O	O	I-T060
tubal	O	O	I-T060
patency	O	O	I-T060
and	O	O	O
adhesions	O	O	B-T047
of	O	O	I-T047
fimbrial	O	O	I-T047
parts	O	O	I-T047
.	O	O	O

Fifty-five	O	O	O
infertile	O	O	B-T046
female	O	O	B-T032
patients	O	O	B-T101
were	O	O	O
recruited	O	O	O
to	O	O	O
undergo	O	O	O
3D	O	O	B-T082
HyCoSy	O	O	B-T060
with	O	O	O
normal	O	O	O
saline	O	O	B-T167
injected	O	O	B-T061
into	O	O	O
the	O	O	O
pelvic	O	O	B-T030
cavity	O	O	I-T030
,	O	O	O
in	O	O	O
which	O	O	O
the	O	O	O
tubal	O	O	O
patency	O	O	O
was	O	O	O
observed	O	O	O
by	O	O	O
visualizing	O	O	O
the	O	O	O
spillage	O	O	O
of	O	O	O
contrast	O	O	B-T130
agents	O	O	I-T130
from	O	O	O
the	O	O	O
fimbriae	O	O	B-T023
,	O	O	O
and	O	O	O
the	O	O	O
fimbrial	O	O	B-T047
adhesion	O	O	I-T047
was	O	O	O
confirmed	O	O	O
by	O	O	O
the	O	O	O
finger-like	O	O	B-T082
projections	O	O	I-T082
of	O	O	O
the	O	O	O
fimbriae	O	O	O
and	O	O	O
their	O	O	O
floating	O	O	B-T080
and	O	O	O
moving	O	O	B-T078
status	O	O	I-T078
.	O	O	O

Of	O	O	O
the	O	O	O
55	O	O	O
patients	O	O	B-T101
,	O	O	O
bilateral	O	O	B-T082
tubal	O	O	I-T033
patency	O	O	I-T033
was	O	O	O
observed	O	O	O
in	O	O	O
44	O	O	O
(	O	O	O
80.0	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
unilateral	O	O	B-T082
tubal	O	O	I-T033
patency	O	O	I-T033
and	O	O	O
the	O	O	O
other	O	O	O
partial	O	O	B-T047
occlusion	O	O	I-T047
in	O	O	O
7	O	O	O
(	O	O	O
12.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
unilateral	O	O	O
partial	O	O	O
occlusion	O	O	O
and	O	O	O
the	O	O	O
other	O	O	O
complete	O	O	B-T046
occlusion	O	O	I-T046
in	O	O	O
3	O	O	O
(	O	O	O
5.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
bilateral	O	O	O
complete	O	O	O
occlusion	O	O	O
in	O	O	O
1	O	O	O
(	O	O	O
1.8	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
fimbrial	O	O	B-T023
parts	O	O	I-T023
were	O	O	O
observed	O	O	O
in	O	O	O
105	O	O	O
fallopian	O	O	B-T023
tubes	O	O	I-T023
,	O	O	O
among	O	O	O
which	O	O	O
101	O	O	O
were	O	O	O
seen	O	O	O
with	O	O	O
the	O	O	O
finger-like	O	O	B-T082
fimbriae	O	O	B-T023
floated	O	O	B-T080
and	O	O	O
moved	O	O	B-T078
in	O	O	O
the	O	O	O
pelvic	O	O	B-T030
cavity	O	O	I-T030
,	O	O	O
whereas	O	O	O
4	O	O	O
tubes	O	O	O
were	O	O	O
not	O	O	O
because	O	O	O
of	O	O	O
adhesion	O	O	B-T047
to	O	O	O
the	O	O	O
pelvic	O	O	O
cavity	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
3	O	O	O
)	O	O	O
or	O	O	O
the	O	O	O
ovary	O	O	B-T023
and	O	O	O
intestine	O	O	B-T023
(	O	O	O
n	O	O	O
=	O	O	O
1	O	O	O
)	O	O	O
.	O	O	O

More	O	O	O
than	O	O	O
three	O	O	O
visible	O	O	O
,	O	O	O
quite	O	O	O
long	O	O	O
,	O	O	O
and	O	O	O
distributed	O	O	O
evenly	O	O	O
finger-like	O	O	B-T082
projection	O	O	I-T082
s	O	O	O
were	O	O	O
present	O	O	O
for	O	O	O
the	O	O	O
patent	O	O	B-T082
fimbrial	O	O	B-T023
parts	O	O	I-T023
;	O	O	O
however	O	O	O
,	O	O	O
fewer	O	O	B-T081
,	O	O	O
flat	O	O	B-T082
,	O	O	O
and	O	O	O
not	O	O	O
evenly	O	O	O
distributed	O	O	O
finger-like	O	O	O
projection	O	O	O
s	O	O	O
were	O	O	O
present	O	O	O
for	O	O	O
the	O	O	O
adhesive	O	O	B-T047
tubes	O	O	I-T047
.	O	O	O

No	O	O	O
serious	O	O	O
complications	O	O	B-T046
occurred	O	O	O
during	O	O	O
or	O	O	O
after	O	O	O
this	O	O	O
procedure	O	O	B-T060
.	O	O	O

Combination	O	O	B-T080
of	O	O	O
3D	O	O	B-T082
HyCoSy	O	O	B-T060
with	O	O	O
normal	O	O	O
saline	O	O	B-T167
injected	O	O	B-T061
into	O	O	O
the	O	O	O
pelvic	O	O	B-T030
cavity	O	O	I-T030
may	O	O	O
be	O	O	O
a	O	O	O
feasible	O	O	O
and	O	O	O
safe	O	O	O
procedure	O	O	B-T060
to	O	O	O
assess	O	O	O
tubal	O	O	O
patency	O	O	O
and	O	O	O
adhesions	O	O	B-T047
of	O	O	I-T047
the	O	O	I-T047
fimbrial	O	O	I-T047
parts	O	O	I-T047
.	O	O	O

-DOCSTART- (28150378)

Challenging	O	O	B-T058
some	O	O	O
assumptions	O	O	O
about	O	O	O
empathy	O	O	O

In	O	O	O
New	O	O	B-T083
Zealand	O	O	I-T083
little	O	O	O
nursing	O	O	B-T065
or	O	O	O
medical	O	O	B-T065
curricula	O	O	I-T065
time	O	O	B-T079
,	O	O	O
if	O	O	O
any	O	O	O
,	O	O	O
is	O	O	O
specifically	O	O	O
devoted	O	O	O
to	O	O	O
the	O	O	O
enhancement	O	O	B-T052
of	O	O	O
empathy	O	O	B-T055
.	O	O	O

If	O	O	O
being	O	O	O
empathic	O	O	B-T033
is	O	O	O
important	O	O	B-T080
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
patient	O	O	B-T058
care	O	O	I-T058
,	O	O	O
it	O	O	O
is	O	O	O
a	O	O	O
quality	O	O	O
that	O	O	O
is	O	O	O
already	O	O	O
present	O	O	O
in	O	O	O
students	O	O	B-T098
or	O	O	O
is	O	O	O
learned	O	O	O
by	O	O	O
students	O	O	O
during	O	O	O
their	O	O	O
practicum	O	O	B-T065
in	O	O	O
the	O	O	O
company	O	O	O
of	O	O	O
experienced	O	O	B-T041
clinicians	O	O	B-T097
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
compare	O	O	B-T052
self-reported	O	O	B-T062
empathy	O	O	B-T055
ratings	O	O	O
between	O	O	O
different	O	O	O
groups	O	O	B-T098
of	O	O	O
medical	O	O	B-T097
students	O	O	I-T097
and	O	O	O
one	O	O	O
cohort	O	O	B-T098
of	O	O	O
nursing	O	O	B-T097
students	O	O	I-T097
who	O	O	O
were	O	O	O
either	O	O	O
exposed	O	O	O
or	O	O	O
not	O	O	O
exposed	O	O	O
to	O	O	O
explicit	O	O	O
empathy	O	O	O
training	O	O	B-T065
or	O	O	O
learning	O	O	B-T041
in	O	O	O
clinical	O	O	B-T082
settings	O	O	I-T082
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
Jefferson	O	O	B-T080
Scale	O	O	I-T080
of	O	O	I-T080
Physician	O	O	I-T080
Empathy	O	O	I-T080
(	O	O	O
JSPE	O	O	B-T080
)	O	O	O
was	O	O	O
completed	O	O	O
before	O	O	O
and	O	O	O
after	O	O	O
groups	O	O	O
of	O	O	O
medical	O	O	B-T097
and	O	O	O
nursing	O	O	B-T097
students	O	O	I-T097
had	O	O	O
been	O	O	O
exposed	O	O	O
to	O	O	O
various	O	O	O
extended	O	O	B-T079
periods	O	O	B-T079
of	O	O	O
practicum	O	O	B-T065
.	O	O	O

Some	O	O	O
medical	O	O	B-T097
student	O	O	I-T097
cohorts	O	O	B-T098
undertook	O	O	O
brief	O	O	B-T079
empathy	O	O	B-T055
training	O	O	B-T065
,	O	O	O
whereas	O	O	O
others	O	O	O
had	O	O	O
no	O	O	O
exposure	O	O	O
.	O	O	O

The	O	O	O
nursing	O	O	B-T097
student	O	O	I-T097
cohort	O	O	B-T098
had	O	O	O
no	O	O	B-T033
formal	O	O	I-T033
,	O	O	O
explicit	O	O	O
empathy	O	O	B-T055
training	O	O	B-T065
.	O	O	O

Irrespective	O	O	O
of	O	O	O
profession	O	O	B-T090
,	O	O	O
length	O	O	B-T079
of	O	O	O
practicum	O	O	B-T065
or	O	O	O
exposure	O	O	O
to	O	O	O
specific	O	O	O
empathy	O	O	B-T055
training	O	O	B-T065
,	O	O	O
there	O	O	O
were	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
differences	O	O	I-T033
in	O	O	O
the	O	O	O
self-reported	O	O	B-T062
JSPE	O	O	B-T080
scores	O	O	I-T080
across	O	O	O
the	O	O	O
seven	O	O	O
different	O	O	O
cohorts	O	O	B-T098
of	O	O	O
students	O	O	B-T098
.	O	O	O

Empathy	O	O	B-T055
is	O	O	O
a	O	O	O
quality	O	O	B-T080
that	O	O	O
is	O	O	O
already	O	O	O
present	O	O	B-T033
in	O	O	O
students	O	O	B-T098
or	O	O	O
is	O	O	O
learned	O	O	B-T041
by	O	O	I-T041
students	O	O	O
during	O	O	O
their	O	O	O
practicum	O	O	B-T065
DISCUSSION	O	O	B-T054
:	O	O	O
If	O	O	O
empathy	O	O	B-T055
is	O	O	O
caught	O	O	B-T055
rather	O	O	O
than	O	O	O
taught	O	O	B-T080
,	O	O	O
then	O	O	O
brief	O	O	O
efforts	O	O	O
to	O	O	O
enhance	O	O	B-T052
empathy	O	O	O
may	O	O	O
be	O	O	O
futile	O	O	B-T033
.	O	O	O

To	O	O	O
optimise	O	O	O
the	O	O	O
inherent	O	O	B-T033
empathic	O	O	I-T033
qualities	O	O	I-T033
of	O	O	O
aspirant	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
,	O	O	O
explicit	O	O	O
consideration	O	O	B-T033
should	O	O	O
be	O	O	O
given	O	O	O
to	O	O	O
how	O	O	O
empathy	O	O	B-T055
is	O	O	O
influenced	O	O	B-T077
by	O	O	O
the	O	O	O
practicum	O	O	B-T065
experience	O	O	B-T041
.	O	O	O

-DOCSTART- (28155918)

Surface	O	O	B-T082
mediated	O	O	O
cooperative	O	O	O
interactions	O	O	B-T044
of	O	O	I-T044
drugs	O	O	I-T044
enhance	O	O	B-T052
mechanical	O	O	B-T067
forces	O	O	I-T067
for	O	O	O
antibiotic	O	O	B-T195
action	O	O	O

The	O	O	O
alarming	O	O	B-T169
increase	O	O	I-T169
of	O	O	O
pathogenic	O	O	B-T001
bacteria	O	O	I-T001
that	O	O	O
are	O	O	O
resistant	O	O	B-T046
to	O	O	I-T046
multiple	O	O	I-T046
antibiotics	O	O	I-T046
is	O	O	O
now	O	O	O
recognized	O	O	O
as	O	O	O
a	O	O	O
major	O	O	B-T033
health	O	O	I-T033
issue	O	O	I-T033
fuelling	O	O	O
demand	O	O	B-T061
for	O	O	O
new	O	O	O
drugs	O	O	B-T121
.	O	O	O

Bacterial	O	O	B-T046
resistance	O	O	I-T046
is	O	O	O
often	O	O	O
caused	O	O	O
by	O	O	O
molecular	O	O	B-T033
changes	O	O	I-T033
at	O	O	O
the	O	O	O
bacterial	O	O	B-T034
surface	O	O	I-T034
,	O	O	O
which	O	O	O
alter	O	O	O
the	O	O	O
nature	O	O	O
of	O	O	O
specific	O	O	O
drug-target	O	O	B-T044
interactions	O	O	I-T044
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
identify	O	O	O
a	O	O	O
novel	O	O	O
mechanism	O	O	B-T169
by	O	O	O
which	O	O	O
drug-target	O	O	B-T044
interactions	O	O	I-T044
in	O	O	O
resistant	O	O	B-T007
bacteria	O	O	I-T007
can	O	O	O
be	O	O	O
enhanced	O	O	B-T052
.	O	O	O

We	O	O	O
examined	O	O	O
the	O	O	O
surface	O	O	B-T082
forces	O	O	B-T067
generated	O	O	O
by	O	O	O
four	O	O	O
antibiotics	O	O	B-T195
;	O	O	O
vancomycin	O	O	B-T116
,	O	O	O
ristomycin	O	O	B-T116
,	O	O	O
chloroeremomycin	O	O	B-T116
and	O	O	O
oritavancin	O	O	B-T116
against	O	O	O
drug-susceptible	O	O	B-T169
and	O	O	O
drug-resistant	O	O	B-T007
targets	O	O	I-T007
on	O	O	O
a	O	O	O
cantilever	O	O	O
and	O	O	O
demonstrated	O	O	O
significant	O	O	B-T078
differences	O	O	O
in	O	O	O
mechanical	O	O	B-T169
response	O	O	B-T032
when	O	O	O
drug-resistant	O	O	O
targets	O	O	O
are	O	O	O
challenged	O	O	O
with	O	O	O
different	O	O	O
antibiotics	O	O	O
although	O	O	O
no	O	O	O
significant	O	O	O
differences	O	O	O
were	O	O	O
observed	O	O	B-T169
when	O	O	O
using	O	O	O
susceptible	O	O	B-T169
targets	O	O	I-T169
.	O	O	O

Remarkably	O	O	O
,	O	O	O
the	O	O	O
binding	O	O	B-T039
affinity	O	O	I-T039
for	O	O	O
oritavancin	O	O	B-T116
against	O	O	O
drug-resistant	O	O	B-T007
targets	O	O	I-T007
(	O	O	O
70	O	O	O
nM	O	O	O
)	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
11,000	O	O	O
times	O	O	O
stronger	O	O	O
than	O	O	O
for	O	O	O
vancomycin	O	O	B-T116
(	O	O	O
800	O	O	O
μM	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
powerful	O	O	O
antibiotic	O	O	B-T195
used	O	O	O
as	O	O	O
the	O	O	O
last	O	O	O
resort	O	O	B-T061
treatment	O	O	I-T061
for	O	O	O
streptococcal	O	O	B-T007
and	O	O	O
staphylococcal	O	O	B-T007
bacteria	O	O	I-T007
including	O	O	O
methicillin-resistant	O	O	B-T007
Staphylococcus	O	O	I-T007
aureus	O	O	I-T007
(	O	O	O
MRSA	O	O	B-T007
)	O	O	O
.	O	O	O

Using	O	O	O
an	O	O	O
exactly	O	O	B-T170
solvable	O	O	I-T170
model	O	O	I-T170
,	O	O	O
which	O	O	O
takes	O	O	O
into	O	O	O
account	O	O	O
the	O	O	O
solvent	O	O	B-T130
and	O	O	O
membrane	O	O	B-T026
effects	O	O	B-T080
,	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
drug-target	O	O	B-T044
interactions	O	O	I-T044
are	O	O	O
strengthened	O	O	O
by	O	O	O
pronounced	O	O	B-T044
polyvalent	O	O	I-T044
interactions	O	O	I-T044
catalyzed	O	O	B-T070
by	O	O	O
the	O	O	O
surface	O	O	B-T082
itself	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
further	O	O	O
enhance	O	O	B-T052
our	O	O	O
understanding	O	O	B-T041
of	O	O	O
antibiotic	O	O	B-T169
mode	O	O	I-T169
of	O	O	I-T169
action	O	O	I-T169
and	O	O	O
will	O	O	O
enable	O	O	O
development	O	O	B-T169
of	O	O	O
more	O	O	O
effective	O	O	O
therapies	O	O	B-T061
.	O	O	O

-DOCSTART- (28162781)

Intra-articular	O	O	B-T082
corticosteroids	O	O	B-T121
versus	O	O	O
intra-articular	O	O	B-T082
corticosteroids	O	O	O
plus	O	O	B-T169
methotrexate	O	O	B-T109
in	O	O	O
oligoarticular	O	O	B-T047
juvenile	O	O	I-T047
idiopathic	O	O	I-T047
arthritis	O	O	I-T047
:	O	O	O
a	O	O	O
multicentre	O	O	B-T062
,	O	O	O
prospective	O	O	B-T062
,	O	O	O
randomised	O	O	B-T062
,	O	O	O
open-label	O	O	O
trial	O	O	O

Little	O	O	O
evidence-based	O	O	O
information	O	O	O
is	O	O	O
available	O	O	O
to	O	O	O
guide	O	O	B-T170
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
oligoarticular	O	O	B-T047
juvenile	O	O	I-T047
idiopathic	O	O	I-T047
arthritis	O	O	I-T047
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
oral	O	O	B-T200
methotrexate	O	O	I-T200
increases	O	O	B-T169
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
intra-articular	O	O	B-T061
corticosteroid	O	O	I-T061
therapy	O	O	I-T061
.	O	O	O

We	O	O	O
did	O	O	O
this	O	O	O
prospective	O	O	B-T062
,	O	O	O
open-label	O	O	B-T062
,	O	O	O
randomised	O	O	B-T062
trial	O	O	I-T062
at	O	O	O
ten	O	O	O
hospitals	O	O	B-T093
in	O	O	O
Italy	O	O	B-T083
.	O	O	O

Using	O	O	O
a	O	O	O
concealed	O	O	B-T080
computer-generated	O	O	B-T170
list	O	O	I-T170
,	O	O	O
children	O	O	B-T100
younger	O	O	B-T033
than	O	O	I-T033
18	O	O	O
years	O	O	B-T079
with	O	O	O
oligoarticular	O	O	B-T082
-	O	O	O
onset	O	O	B-T079
disease	O	O	I-T079
were	O	O	O
randomly	O	O	B-T080
assigned	O	O	B-T169
(	O	O	O
1:1	O	O	O
)	O	O	O
to	O	O	O
intra-articular	O	O	B-T082
corticosteroids	O	O	B-T121
alone	O	O	B-T081
or	O	O	O
in	O	O	B-T080
combination	O	O	I-T080
with	O	O	I-T080
oral	O	O	B-T200
methotrexate	O	O	I-T200
(	O	O	O
15	O	O	O
mg/m(2	O	O	O
)	O	O	O
;	O	O	O
maximum	O	O	B-T081
20	O	O	O
mg	O	O	O
)	O	O	O
.	O	O	O

Corticosteroids	O	O	B-T121
used	O	O	O
were	O	O	O
triamcinolone	O	O	B-T109
hexacetonide	O	O	I-T109
(	O	O	O
shoulder	O	O	B-T030
,	O	O	O
elbow	O	O	B-T030
,	O	O	O
wrist	O	O	B-T030
,	O	O	O
knee	O	O	B-T030
,	O	O	O
and	O	O	O
tibiotalar	O	O	B-T030
joints	O	O	I-T030
)	O	O	O
or	O	O	O
methylprednisolone	O	O	B-T109
acetate	O	O	I-T109
(	O	O	O
ie	O	O	O
,	O	O	O
subtalar	O	O	B-T030
and	O	O	O
tarsal	O	O	B-T030
joints	O	O	I-T030
)	O	O	O
.	O	O	O

We	O	O	O
did	O	O	O
not	O	O	O
mask	O	O	O
patients	O	O	B-T101
or	O	O	O
investigators	O	O	B-T097
to	O	O	O
treatment	O	O	B-T061
assignments	O	O	B-T169
.	O	O	O

Our	O	O	O
primary	O	O	B-T169
outcome	O	O	I-T169
was	O	O	O
the	O	O	O
proportion	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
intention-to-treat	O	O	B-T062
population	O	O	B-T098
who	O	O	O
had	O	O	O
remission	O	O	B-T033
of	O	O	O
arthritis	O	O	B-T047
in	O	O	O
all	O	O	O
injected	O	O	B-T061
joints	O	O	B-T030
at	O	O	O
12	O	O	O
months	O	O	B-T079
.	O	O	O

This	O	O	O
trial	O	O	B-T062
is	O	O	O
registered	O	O	B-T058
with	O	O	O
European	O	O	B-T058
Union	O	O	I-T058
Clinical	O	O	I-T058
Trials	O	O	I-T058
Register	O	O	I-T058
,	O	O	O
EudraCT	O	O	B-T170
number	O	O	I-T170
2008	O	O	O
-	O	O	O
006741	O	O	O
-	O	O	O
70	O	O	O
.	O	O	O

Between	O	O	O
July	O	O	B-T080
7	O	O	O
,	O	O	O
2009	O	O	O
,	O	O	O
and	O	O	O
March	O	O	B-T079
31	O	O	O
,	O	O	O
2013	O	O	O
,	O	O	O
we	O	O	O
screened	O	O	B-T169
226	O	O	O
participants	O	O	B-T098
and	O	O	O
randomly	O	O	B-T080
assigned	O	O	B-T169
102	O	O	O
to	O	O	O
intra-articular	O	O	B-T082
corticosteroids	O	O	B-T121
alone	O	O	B-T081
and	O	O	O
105	O	O	O
to	O	O	O
intra-articular	O	O	O
corticosteroids	O	O	O
plus	O	O	B-T169
methotrexate	O	O	B-T109
.	O	O	O

33	O	O	O
(	O	O	O
32	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
assigned	O	O	B-T169
to	O	O	O
intra-articular	O	O	B-T082
corticosteroids	O	O	B-T121
alone	O	O	B-T081
and	O	O	O
39	O	O	O
(	O	O	O
37	O	O	O
%	O	O	O
)	O	O	O
assigned	O	O	O
to	O	O	O
intra-articular	O	O	O
corticosteroids	O	O	O
and	O	O	O
methotrexate	O	O	B-T109
therapy	O	O	B-T061
had	O	O	O
remission	O	O	B-T033
of	O	O	O
arthritis	O	O	B-T047
in	O	O	O
all	O	O	O
injected	O	O	B-T061
joints	O	O	B-T030
(	O	O	O
p=0·48	O	O	O
)	O	O	O
.	O	O	O

Adverse	O	O	B-T046
events	O	O	I-T046
were	O	O	O
recorded	O	O	O
for	O	O	O
20	O	O	O
(	O	O	O
17	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
who	O	O	O
received	O	O	O
methotrexate	O	O	B-T109
,	O	O	O
which	O	O	O
led	O	O	O
to	O	O	O
permanent	O	O	B-T079
treatment	O	O	B-T061
discontinuation	O	O	B-T033
in	O	O	O
two	O	O	O
patients	O	O	O
(	O	O	O
one	O	O	O
due	O	O	O
to	O	O	O
increased	O	O	B-T033
liver	O	O	I-T033
transaminases	O	O	I-T033
and	O	O	O
one	O	O	O
due	O	O	O
to	O	O	O
gastrointestinal	O	O	B-T184
discomfort	O	O	I-T184
)	O	O	O
.	O	O	O

No	O	O	B-T033
patient	O	O	B-T101
had	O	O	O
a	O	O	O
serious	O	O	B-T080
adverse	O	O	B-T046
event	O	O	I-T046
.	O	O	O

Concomitant	O	O	B-T169
administration	O	O	I-T169
of	O	O	O
methotrexate	O	O	B-T109
did	O	O	O
not	O	O	O
augment	O	O	B-T169
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
intra-articular	O	O	B-T061
corticosteroid	O	O	I-T061
therapy	O	O	I-T061
.	O	O	O

Future	O	O	B-T062
studies	O	O	I-T062
are	O	O	O
needed	O	O	O
to	O	O	O
define	O	O	O
the	O	O	O
optimal	O	O	B-T080
therapeutic	O	O	B-T061
strategies	O	O	I-T061
for	O	O	O
oligoarticular	O	O	B-T047
juvenile	O	O	I-T047
idiopathic	O	O	I-T047
arthritis	O	O	I-T047
.	O	O	O

Italian	O	O	B-T092
Agency	O	O	I-T092
of	O	O	I-T092
Drug	O	O	I-T092
Evaluation	O	O	I-T092
.	O	O	O

-DOCSTART- (28164568)

Methylation	O	O	B-T063
Analysis	O	O	I-T063
of	O	O	O
BRCA1	O	O	B-T028
and	O	O	O
APC	O	O	B-T028
in	O	O	O
Breast	O	O	B-T191
Cancer	O	O	I-T191
and	O	O	O
It	O	O	O
's	O	O	O
Relationship	O	O	B-T080
to	O	O	O
Clinicopathological	O	O	B-T169
Features	O	O	O

Promoter	O	O	B-T044
methylation	O	O	I-T044
of	O	O	O
tumor	O	O	B-T028
suppressor	O	O	I-T028
genes	O	O	I-T028
is	O	O	O
an	O	O	O
important	O	O	O
epigenetic	O	O	B-T045
alteration	O	O	I-T045
that	O	O	O
occurs	O	O	O
in	O	O	O
the	O	O	O
primary	O	O	B-T080
stages	O	O	B-T079
of	O	O	O
human	O	O	B-T016
tumors	O	O	B-T191
,	O	O	O
including	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Identification	O	O	O
of	O	O	O
methylated	O	O	B-T028
genes	O	O	I-T028
and	O	O	O
their	O	O	O
relationship	O	O	B-T080
to	O	O	O
clinical	O	O	B-T080
features	O	O	B-T080
can	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
prognosis	O	O	B-T058
and	O	O	O
early	O	O	B-T060
detection	O	O	I-T060
of	O	O	O
tumors	O	O	B-T191
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
explored	O	O	O
the	O	O	O
methylation	O	O	B-T044
status	O	O	B-T080
of	O	O	O
APC	O	O	B-T028
and	O	O	O
BRCA1	O	O	B-T028
genes	O	O	I-T028
and	O	O	O
their	O	O	O
relationship	O	O	B-T080
to	O	O	O
clinical	O	O	B-T080
factors	O	O	B-T169
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

BRCA1	O	O	B-T028
and	O	O	O
APC	O	O	B-T028
promoter	O	O	B-T044
methylation	O	O	B-T044
was	O	O	O
examined	O	O	O
by	O	O	O
methylation	O	O	O
-	O	O	O
specific	O	O	B-T063
multiplex	O	O	I-T063
ligation-dependent	O	O	I-T063
probe	O	O	I-T063
amplification	O	O	I-T063
(	O	O	O
MS-MLPA	O	O	B-T063
)	O	O	O
assay	O	O	B-T059
in	O	O	O
formalin-fixed	O	O	B-T024
paraffin	O	O	I-T024
embedded	O	O	I-T024
(	O	O	I-T024
FFPE	O	O	I-T024
)	O	O	I-T024
breast	O	O	I-T024
tissue	O	O	I-T024
from	O	O	O
75	O	O	O
patients	O	O	B-T101
.	O	O	O

APC	O	O	B-T028
promoter	O	O	B-T044
methylation	O	O	I-T044
was	O	O	O
detected	O	O	B-T033
in	O	O	O
30.67	O	O	O
%	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
tissues	O	O	B-T024
and	O	O	O
BRCA1	O	O	B-T028
was	O	O	O
methylated	O	O	B-T044
in	O	O	O
9.33	O	O	O
%	O	O	O
of	O	O	O
breast	O	O	B-T191
tumors	O	O	I-T191
.	O	O	O

Methylation	O	O	B-T044
of	O	O	O
APC	O	O	B-T028
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
low	O	O	O
histological	O	O	B-T185
grade	O	O	I-T185
(	O	O	O
p	O	O	O
=	O	O	O
0.006	O	O	O
)	O	O	O
and	O	O	O
methylation	O	O	B-T044
of	O	O	O
BRCA1	O	O	B-T028
was	O	O	O
related	O	O	O
with	O	O	O
lymph	O	O	B-T023
node	O	O	I-T023
metastasis	O	O	B-T046
(	O	O	O
p	O	O	O
=	O	O	O
0.017	O	O	O
)	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	B-T033
suggest	O	O	O
that	O	O	O
the	O	O	O
methylation	O	O	B-T044
status	O	O	B-T080
of	O	O	O
APC	O	O	B-T028
and	O	O	O
BRCA1	O	O	B-T028
can	O	O	O
be	O	O	O
a	O	O	O
predictive	O	O	B-T201
marker	O	O	I-T201
for	O	O	O
early	O	O	B-T060
detection	O	O	I-T060
and	O	O	O
better	O	O	O
management	O	O	B-T058
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28166607)

Recombinant	O	O	B-T116
fibrinogen	O	O	B-T116
reveals	O	O	O
the	O	O	O
differential	O	O	B-T080
roles	O	O	O
of	O	O	O
α-	O	O	B-T116
and	O	O	O
γ-chain	O	O	B-T116
cross-linking	O	O	B-T044
and	O	O	O
molecular	O	O	B-T080
heterogeneity	O	O	B-T080
in	O	O	O
fibrin	O	O	B-T044
clot	O	O	I-T044
strain-stiffening	O	O	O

Essentials	O	O	O
Fibrinogen	O	O	B-T116
circulates	O	O	B-T169
in	O	O	O
human	O	O	B-T016
plasma	O	O	B-T031
as	O	O	O
a	O	O	O
complex	O	O	B-T104
mixture	O	O	B-T167
of	O	O	O
heterogeneous	O	O	B-T080
molecular	O	O	B-T080
variants	O	O	B-T080
.	O	O	O

We	O	O	O
measured	O	O	B-T080
strain-stiffening	O	O	B-T070
of	O	O	O
recombinantly	O	O	B-T045
produced	O	O	O
fibrinogen	O	O	B-T116
upon	O	O	O
clotting	O	O	B-T042
.	O	O	O

Factor	O	O	B-T116
XIII	O	O	I-T116
and	O	O	O
molecular	O	O	B-T080
heterogeneity	O	O	B-T080
alter	O	O	O
clot	O	O	B-T044
elasticity	O	O	B-T070
at	O	O	O
the	O	O	O
protofibril	O	O	B-T116
and	O	O	O
fiber	O	O	B-T024
level	O	O	O
.	O	O	O

This	O	O	O
highlights	O	O	O
the	O	O	O
hitherto	O	O	O
unknown	O	O	O
role	O	O	O
of	O	O	O
molecular	O	O	B-T080
composition	O	O	B-T080
in	O	O	O
fibrin	O	O	B-T044
clot	O	O	I-T044
mechanics	O	O	B-T070
.	O	O	O

Background	O	O	O
Fibrin	O	O	B-T116
plays	O	O	O
a	O	O	O
crucial	O	O	O
role	O	O	O
in	O	O	O
haemostasis	O	O	B-T042
and	O	O	O
wound	O	O	B-T040
healing	O	O	I-T040
by	O	O	O
forming	O	O	O
strain-stiffening	O	O	B-T070
fibrous	O	O	B-T026
networks	O	O	I-T026
that	O	O	O
reinforce	O	O	O
blood	O	O	B-T046
clots	O	O	I-T046
.	O	O	O

The	O	O	O
molecular	O	O	B-T080
origin	O	O	O
of	O	O	O
fibrin	O	O	B-T116
's	O	O	I-T116
strain-stiffening	O	O	B-T070
behavior	O	O	O
remains	O	O	O
poorly	O	O	O
understood	O	O	O
,	O	O	O
primarily	O	O	O
because	O	O	O
plasma	O	O	B-T031
fibrinogen	O	O	B-T116
is	O	O	O
a	O	O	O
complex	O	O	B-T104
mixture	O	O	B-T167
of	O	O	O
heterogeneous	O	O	B-T080
molecular	O	O	O
variants	O	O	B-T080
and	O	O	O
is	O	O	O
often	O	O	O
contaminated	O	O	O
by	O	O	O
plasma	O	O	B-T116
factors	O	O	I-T116
that	O	O	O
affect	O	O	O
clot	O	O	B-T044
properties	O	O	B-T080
.	O	O	O

Objectives	O	O	O
and	O	O	O
methods	O	O	O
To	O	O	O
facilitate	O	O	O
mechanistic	O	O	B-T169
dissection	O	O	I-T169
of	O	O	O
fibrin	O	O	B-T116
nonlinear	O	O	B-T070
elasticity	O	O	I-T070
,	O	O	O
we	O	O	O
produced	O	O	O
a	O	O	O
homogeneous	O	O	B-T080
recombinant	O	O	B-T116
fibrinogen	O	O	B-T116
corresponding	O	O	O
to	O	O	O
the	O	O	O
main	O	O	O
variant	O	O	B-T080
in	O	O	O
human	O	O	B-T016
plasma	O	O	B-T031
,	O	O	O
termed	O	O	O
rFib610	O	O	B-T116
.	O	O	O

We	O	O	O
characterized	O	O	O
the	O	O	O
structure	O	O	B-T082
of	O	O	O
rFib610	O	O	B-T116
clots	O	O	B-T044
using	O	O	O
turbidimetry	O	O	B-T059
,	O	O	O
microscopy	O	O	B-T059
and	O	O	O
X-ray	O	O	B-T059
scattering	O	O	I-T059
.	O	O	O

We	O	O	O
used	O	O	O
rheology	O	O	B-T059
to	O	O	O
measure	O	O	B-T081
the	O	O	O
strain-stiffening	O	O	B-T070
behavior	O	O	O
of	O	O	O
the	O	O	O
clots	O	O	B-T044
and	O	O	O
determined	O	O	O
the	O	O	O
fiber	O	O	B-T024
properties	O	O	B-T080
by	O	O	O
modeling	O	O	B-T062
the	O	O	O
clots	O	O	O
as	O	O	O
semi-flexible	O	O	B-T169
polymer	O	O	I-T169
networks	O	O	I-T169
.	O	O	O

Results	O	O	O
We	O	O	O
show	O	O	O
that	O	O	O
addition	O	O	O
of	O	O	O
FXIII	O	O	B-T116
to	O	O	O
rFib610	O	O	B-T116
clots	O	O	B-T044
causes	O	O	O
a	O	O	O
dose-dependent	O	O	B-T080
stiffness	O	O	I-T080
increase	O	O	O
at	O	O	O
small	O	O	O
deformations	O	O	B-T169
and	O	O	O
renders	O	O	O
the	O	O	O
strain-stiffening	O	O	B-T070
response	O	O	O
reversible	O	O	O
.	O	O	O

We	O	O	O
find	O	O	O
that	O	O	O
γ-chain	O	O	B-T116
cross-linking	O	O	B-T044
contributes	O	O	O
to	O	O	O
clot	O	O	B-T044
elasticity	O	O	B-T070
by	O	O	O
changing	O	O	O
the	O	O	O
force-extension	O	O	B-T169
behavior	O	O	I-T169
of	O	O	O
the	O	O	O
protofibrils	O	O	B-T116
,	O	O	O
whereas	O	O	O
α-chain	O	O	B-T116
cross-linking	O	O	O
stiffens	O	O	O
the	O	O	O
fibers	O	O	B-T024
,	O	O	O
as	O	O	O
a	O	O	O
consequence	O	O	O
of	O	O	O
tighter	O	O	B-T169
coupling	O	O	I-T169
between	O	O	O
the	O	O	O
constituent	O	O	O
protofibrils	O	O	O
.	O	O	O

Interestingly	O	O	O
,	O	O	O
rFib610	O	O	B-T116
protofibrils	O	O	B-T116
have	O	O	O
a	O	O	O
25	O	O	O
%	O	O	O
larger	O	O	O
bending	O	O	B-T080
rigidity	O	O	I-T080
than	O	O	O
plasma	O	O	B-T031
-purified	O	O	O
fibrin	O	O	B-T116
protofibrils	O	O	O
and	O	O	O
a	O	O	O
delayed	O	O	O
strain-stiffening	O	O	B-T070
,	O	O	O
indicating	O	O	O
that	O	O	O
molecular	O	O	B-T080
heterogeneity	O	O	B-T080
influences	O	O	B-T077
clot	O	O	B-T044
mechanics	O	O	B-T070
at	O	O	O
the	O	O	O
protofibril	O	O	B-T116
scale	O	O	I-T116
.	O	O	O

Conclusions	O	O	O
Fibrinogen	O	O	B-T116
molecular	O	O	B-T080
heterogeneity	O	O	B-T080
and	O	O	O
FXIII	O	O	B-T116
affect	O	O	O
the	O	O	O
mechanical	O	O	B-T169
function	O	O	I-T169
of	O	O	O
fibrin	O	O	B-T044
clots	O	O	I-T044
by	O	O	O
altering	O	O	O
the	O	O	O
nonlinear	O	O	B-T080
viscoelastic	O	O	I-T080
properties	O	O	I-T080
at	O	O	O
the	O	O	O
protofibril	O	O	B-T026
and	O	O	O
fiber	O	O	B-T024
scale	O	O	I-T024
.	O	O	O

This	O	O	O
work	O	O	O
provides	O	O	O
a	O	O	O
starting	O	O	O
point	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
role	O	O	O
of	O	O	O
molecular	O	O	B-T080
heterogeneity	O	O	B-T080
of	O	O	O
plasma	O	O	B-T031
fibrinogen	O	O	B-T116
in	O	O	O
fibrin	O	O	B-T044
clot	O	O	I-T044
mechanics	O	O	B-T070
and	O	O	O
haemostasis	O	O	B-T042
.	O	O	O

-DOCSTART- (28166877)

Effects	O	O	O
of	O	O	O
display	O	O	B-T169
curvature	O	O	B-T082
,	O	O	O
display	O	O	O
zone	O	O	B-T082
,	O	O	O
and	O	O	O
task	O	O	B-UnknownType
duration	O	O	B-T079
on	O	O	O
legibility	O	O	B-T033
and	O	O	O
visual	O	O	B-T047
fatigue	O	O	I-T047
during	O	O	O
visual	O	O	O
search	O	O	O
task	O	O	O

This	O	O	O
study	O	O	O
examined	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
display	O	O	B-T169
curvature	O	O	B-T082
(	O	O	O
400	O	O	O
,	O	O	O
600	O	O	O
,	O	O	O
1200	O	O	O
mm	O	O	O
,	O	O	O
and	O	O	O
flat	O	O	B-T082
)	O	O	O
,	O	O	O
display	O	O	O
zone	O	O	B-T082
(	O	O	O
5	O	O	O
zones	O	O	B-T082
)	O	O	O
,	O	O	O
and	O	O	O
task	O	O	B-UnknownType
duration	O	O	B-T079
(	O	O	O
15	O	O	O
and	O	O	O
30	O	O	O
min	O	O	O
)	O	O	O
on	O	O	O
legibility	O	O	B-T033
and	O	O	O
visual	O	O	B-T047
fatigue	O	O	I-T047
.	O	O	O

Each	O	O	O
participant	O	O	B-T098
completed	O	O	O
two	O	O	O
15-min	O	O	O
visual	O	O	B-UnknownType
search	O	O	I-UnknownType
task	O	O	I-UnknownType
sets	O	O	O
at	O	O	O
each	O	O	O
curvature	O	O	B-T082
setting	O	O	B-T082
.	O	O	O

The	O	O	O
600-mm	O	O	O
and	O	O	O
1200-mm	O	O	O
settings	O	O	B-T082
yielded	O	O	O
better	O	O	O
results	O	O	O
than	O	O	O
the	O	O	O
flat	O	O	B-T082
setting	O	O	B-T082
in	O	O	O
terms	O	O	O
of	O	O	O
legibility	O	O	B-T033
and	O	O	O
perceived	O	O	O
visual	O	O	B-T047
fatigue	O	O	I-T047
.	O	O	O

Relative	O	O	O
to	O	O	O
the	O	O	O
corresponding	O	O	O
centre	O	O	B-T082
zone	O	O	B-T082
,	O	O	O
the	O	O	O
outermost	O	O	O
zones	O	O	B-T082
of	O	O	O
the	O	O	O
1200-mm	O	O	O
and	O	O	O
flat	O	O	B-T082
settings	O	O	B-T082
showed	O	O	O
a	O	O	O
decrease	O	O	O
of	O	O	O
8%-37	O	O	O
%	O	O	O
in	O	O	O
legibility	O	O	B-T033
,	O	O	O
whereas	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
flat	O	O	O
setting	O	O	B-T082
showed	O	O	O
an	O	O	O
increase	O	O	B-T169
of	O	O	O
26%-45	O	O	O
%	O	O	O
in	O	O	O
perceived	O	O	B-T041
visual	O	O	B-T047
fatigue	O	O	I-T047
.	O	O	O

Across	O	O	O
curvature	O	O	B-T082
s	O	O	O
,	O	O	O
legibility	O	O	B-T033
decreased	O	O	B-T081
by	O	O	O
2%-8	O	O	O
%	O	O	O
,	O	O	O
whereas	O	O	O
perceived	O	O	B-T041
visual	O	O	B-T047
fatigue	O	O	I-T047
increased	O	O	B-T169
by	O	O	O
22	O	O	O
%	O	O	O
during	O	O	O
the	O	O	O
second	O	O	O
task	O	O	B-UnknownType
set	O	O	I-UnknownType
.	O	O	O

The	O	O	O
two	O	O	O
task	O	O	B-UnknownType
sets	O	O	I-UnknownType
induced	O	O	O
an	O	O	O
increase	O	O	B-T169
of	O	O	O
102	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
eye	O	O	B-T081
complaint	O	O	I-T081
score	O	O	I-T081
and	O	O	O
a	O	O	O
decrease	O	O	O
of	O	O	O
0.3	O	O	O
Hz	O	O	O
in	O	O	O
the	O	O	O
critical	O	O	B-T034
fusion	O	O	I-T034
frequency	O	O	I-T034
,	O	O	O
both	O	O	O
of	O	O	O
which	O	O	O
indicated	O	O	O
an	O	O	O
increase	O	O	O
in	O	O	O
visual	O	O	B-T047
fatigue	O	O	I-T047
.	O	O	O

In	O	O	O
summary	O	O	O
,	O	O	O
a	O	O	O
curvature	O	O	B-T082
of	O	O	O
around	O	O	O
600	O	O	O
mm	O	O	O
,	O	O	O
central	O	O	B-T082
display	O	O	B-T169
zones	O	O	B-T082
,	O	O	O
and	O	O	O
frequent	O	O	O
breaks	O	O	B-T082
are	O	O	O
recommended	O	O	O
to	O	O	O
improve	O	O	B-T033
legibility	O	O	B-T033
and	O	O	O
reduce	O	O	O
visual	O	O	B-T047
fatigue	O	O	I-T047
.	O	O	O

-DOCSTART- (28171696)

Predicting	O	O	O
changes	O	O	O
in	O	O	O
adaptive	O	O	B-T169
functioning	O	O	B-T169
and	O	O	O
behavioral	O	O	B-T053
adjustment	O	O	B-T169
following	O	O	O
treatment	O	O	B-T061
for	O	O	O
a	O	O	O
pediatric	O	O	B-T191
brain	O	O	I-T191
tumor	O	O	I-T191
:	O	O	O
A	O	O	O
report	O	O	B-T201
from	O	O	O
the	O	O	O
Brain	O	O	B-T023
Radiation	O	O	O
Investigative	O	O	O
Study	O	O	O
Consortium	O	O	O

Children	O	O	B-T100
are	O	O	O
at	O	O	O
risk	O	O	B-T078
for	O	O	O
behavioral	O	O	B-T053
and	O	O	O
adaptive	O	O	B-T169
difficulties	O	O	B-T080
following	O	O	O
pediatric	O	O	B-T191
brain	O	O	I-T191
tumor	O	O	I-T191
.	O	O	O

This	O	O	O
study	O	O	B-T062
explored	O	O	O
whether	O	O	O
familial	O	O	B-T169
/	O	O	O
demographic	O	O	B-T090
,	O	O	O
developmental	O	O	B-T080
,	O	O	O
diagnostic	O	O	B-T169
,	O	O	O
or	O	O	O
treatment	O	O	B-T061
-related	O	O	O
variables	O	O	B-T080
best	O	O	O
predict	O	O	O
posttreatment	O	O	B-T079
behavioral	O	O	B-T053
and	O	O	O
adaptive	O	O	B-T169
functioning	O	O	B-T169
.	O	O	O

Participants	O	O	B-T098
included	O	O	O
40	O	O	O
children	O	O	B-T100
(	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
=	O	O	O
12.76	O	O	O
years	O	O	O
,	O	O	O
SD	O	O	B-T081
=	O	O	O
4.01	O	O	O
)	O	O	O
posttreatment	O	O	B-T079
(	O	O	O
mean	O	O	O
time	O	O	B-T079
since	O	O	O
diagnosis	O	O	B-T033
=	O	O	O
1.99	O	O	O
years	O	O	O
,	O	O	O
SD	O	O	O
=	O	O	O
0.21	O	O	O
)	O	O	O
for	O	O	O
pediatric	O	O	B-T191
brain	O	O	I-T191
tumor	O	O	I-T191
.	O	O	O

Parents	O	O	B-T099
rated	O	O	O
children	O	O	B-T100
's	O	O	O
behavioral	O	O	B-T053
adjustment	O	O	B-T169
and	O	O	O
adaptive	O	O	B-T169
functioning	O	O	B-T169
and	O	O	O
provided	O	O	O
demographic	O	O	B-T090
and	O	O	O
developmental	O	O	B-T080
histories	O	O	B-T033
.	O	O	O

Diagnostic	O	O	B-T033
and	O	O	O
treatment	O	O	B-T061
-related	O	O	O
information	O	O	B-T078
was	O	O	O
abstracted	O	O	O
from	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
.	O	O	O

Ratings	O	O	B-T052
of	O	O	O
adaptive	O	O	B-T169
and	O	O	O
behavioral	O	O	B-T053
functioning	O	O	B-T169
approximately	O	O	O
2	O	O	O
years	O	O	O
postdiagnosis	O	O	B-T033
were	O	O	O
within	O	O	O
the	O	O	O
average	O	O	B-T081
range	O	O	B-T081
,	O	O	O
although	O	O	O
the	O	O	O
percentage	O	O	B-T081
of	O	O	O
children	O	O	B-T100
exceeding	O	O	O
clinical	O	O	B-T080
cutoffs	O	O	B-T169
for	O	O	O
impairment	O	O	B-T169
in	O	O	O
adaptive	O	O	O
skills	O	O	B-T055
exceeded	O	O	O
expectation	O	O	B-T078
,	O	O	O
particularly	O	O	O
practical	O	O	O
skills	O	O	O
.	O	O	O

Premorbid	O	O	B-T053
behavior	O	O	I-T053
problems	O	O	B-T078
and	O	O	O
tumor	O	O	B-T082
size	O	O	I-T082
predicted	O	O	O
posttreatment	O	O	B-T079
adaptive	O	O	B-T169
functioning	O	O	B-T169
.	O	O	O

After	O	O	O
accounting	O	O	O
for	O	O	O
adaptive	O	O	B-T169
functioning	O	O	B-T169
near	O	O	O
diagnosis	O	O	B-T033
,	O	O	O
premorbid	O	O	B-T053
behavior	O	O	I-T053
problems	O	O	B-T078
predicted	O	O	O
declines	O	O	O
in	O	O	O
adaptive	O	O	O
functioning	O	O	O
2	O	O	O
years	O	O	O
postdiagnosis	O	O	B-T033
.	O	O	O

After	O	O	O
accounting	O	O	O
for	O	O	O
adjustment	O	O	B-T169
near	O	O	O
diagnosis	O	O	B-T033
,	O	O	O
no	O	O	O
variables	O	O	B-T080
predicted	O	O	O
declines	O	O	O
in	O	O	O
behavioral	O	O	B-T053
adjustment	O	O	O
.	O	O	O

Children	O	O	B-T100
may	O	O	O
be	O	O	O
vulnerable	O	O	B-T169
to	O	O	O
reduced	O	O	O
adaptive	O	O	B-T169
functioning	O	O	B-T169
following	O	O	O
pediatric	O	O	B-T191
brain	O	O	I-T191
tumor	O	O	I-T191
treatment	O	O	B-T061
,	O	O	O
especially	O	O	O
in	O	O	O
practical	O	O	O
skills	O	O	O
.	O	O	O

Assessing	O	O	O
prediagnosis	O	O	B-T033
functioning	O	O	B-T169
and	O	O	O
diagnostic	O	O	B-T033
and	O	O	O
treatment	O	O	B-T061
-related	O	O	O
variables	O	O	B-T080
may	O	O	O
improve	O	O	B-T033
our	O	O	O
ability	O	O	B-T032
to	O	O	O
predict	O	O	O
those	O	O	O
at	O	O	O
greatest	O	O	O
risk	O	O	B-T078
,	O	O	O
although	O	O	O
those	O	O	O
factors	O	O	B-T169
may	O	O	O
be	O	O	O
less	O	O	O
helpful	O	O	B-T080
in	O	O	O
identifying	O	O	B-T080
children	O	O	B-T100
likely	O	O	O
to	O	O	O
develop	O	O	O
behavioral	O	O	B-T053
difficulties	O	O	B-T080
.	O	O	O

Screening	O	O	B-T058
of	O	O	O
these	O	O	O
factors	O	O	B-T169
in	O	O	O
tertiary	O	O	B-T058
care	O	O	I-T058
and	O	O	O
long-term	O	O	B-T079
follow-up	O	O	B-T058
settings	O	O	O
may	O	O	O
improve	O	O	B-T033
identification	O	O	B-T080
of	O	O	O
those	O	O	O
at	O	O	O
greatest	O	O	O
need	O	O	B-T080
for	O	O	O
support	O	O	B-UnknownType
services	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (28175980)

Spine	O	O	B-T037
fracture	O	O	I-T037
prevalence	O	O	B-T081
in	O	O	O
a	O	O	O
nationally	O	O	B-T082
representative	O	O	I-T082
sample	O	O	O
of	O	O	O
US	O	O	B-T083
women	O	O	B-T098
and	O	O	O
men	O	O	B-T098
aged	O	O	B-T032
≥40	O	O	O
years	O	O	O
:	O	O	O
results	O	O	O
from	O	O	O
the	O	O	O
National	O	O	B-T062
Health	O	O	I-T062
and	O	O	I-T062
Nutrition	O	O	I-T062
Examination	O	O	I-T062
Survey	O	O	I-T062
(	O	O	O
NHANES	O	O	B-T062
)	O	O	O
2013	O	O	O
-	O	O	O
2014	O	O	O

Spine	O	O	B-T037
fracture	O	O	I-T037
prevalence	O	O	B-T081
is	O	O	O
similar	O	O	O
in	O	O	O
men	O	O	B-T098
and	O	O	O
women	O	O	B-T098
,	O	O	O
increasing	O	O	O
from	O	O	O
<	O	O	O
5	O	O	O
%	O	O	O
in	O	O	O
those	O	O	O
<	O	O	O
60	O	O	O
to	O	O	O
11	O	O	O
%	O	O	O
in	O	O	O
those	O	O	O
70	O	O	O
-	O	O	O
79	O	O	O
and	O	O	O
18	O	O	O
%	O	O	O
in	O	O	O
those	O	O	O
≥80	O	O	O
years	O	O	O
.	O	O	O

Prevalence	O	O	B-T081
was	O	O	O
higher	O	O	B-T080
with	O	O	O
age	O	O	B-T032
,	O	O	O
lower	O	O	B-T080
bone	O	O	B-T201
mineral	O	O	I-T201
density	O	O	I-T201
(	O	O	O
BMD	O	O	B-T201
)	O	O	O
,	O	O	O
and	O	O	O
in	O	O	O
those	O	O	O
meeting	O	O	O
criteria	O	O	B-T080
for	O	O	O
spine	O	O	B-T060
imaging	O	O	I-T060
.	O	O	O

Most	O	O	O
subjects	O	O	B-T062
with	O	O	O
spine	O	O	B-T037
fractures	O	O	I-T037
were	O	O	O
unaware	O	O	B-T033
of	O	O	O
them	O	O	O
.	O	O	O

Spine	O	O	B-T037
fractures	O	O	I-T037
have	O	O	O
substantial	O	O	O
medical	O	O	B-T169
significance	O	O	O
but	O	O	O
are	O	O	O
seldom	O	O	B-T080
recognized	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
collected	O	O	O
contemporary	O	O	O
nationally	O	O	B-T082
representative	O	O	I-T082
spine	O	O	B-T037
fracture	O	O	I-T037
prevalence	O	O	B-T081
data	O	O	O
.	O	O	O

Cross-sectional	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
3330	O	O	O
US	O	O	B-T083
adults	O	O	B-T100
aged	O	O	B-T032
≥40	O	O	O
years	O	O	O
participating	O	O	O
in	O	O	O
NHANES	O	O	B-T062
2013	O	O	O
-	O	O	O
2014	O	O	O
with	O	O	O
evaluable	O	O	O
Vertebral	O	O	B-T037
Fracture	O	O	I-T037
Assessment	O	O	O
(	O	O	O
VFA	O	O	B-T060
)	O	O	O
.	O	O	O

VFA	O	O	B-T060
was	O	O	O
graded	O	O	O
by	O	O	O
semiquantitative	O	O	O
measurement	O	O	O
.	O	O	O

BMD	O	O	B-T201
and	O	O	O
an	O	O	O
osteoporosis	O	O	B-T047
questionnaire	O	O	B-T170
were	O	O	O
collected	O	O	O
.	O	O	O

Overall	O	O	O
spine	O	O	B-T037
fracture	O	O	I-T037
prevalence	O	O	B-T081
was	O	O	O
5.4	O	O	O
%	O	O	O
and	O	O	O
similar	O	O	O
in	O	O	O
men	O	O	B-T098
and	O	O	O
women	O	O	B-T098
.	O	O	O

Prevalence	O	O	B-T081
increased	O	O	O
with	O	O	O
age	O	O	B-T032
from	O	O	O
<	O	O	O
5	O	O	O
%	O	O	O
in	O	O	O
those	O	O	O
<	O	O	O
60	O	O	O
to	O	O	O
11	O	O	O
%	O	O	O
in	O	O	O
those	O	O	O
70	O	O	O
-	O	O	O
79	O	O	O
and	O	O	O
18	O	O	O
%	O	O	O
in	O	O	O
those	O	O	O
≥80	O	O	O
years	O	O	O
.	O	O	O

Fractures	O	O	B-T037
were	O	O	O
more	O	O	O
common	O	O	O
in	O	O	O
non-Hispanic	O	O	B-T098
whites	O	O	I-T098
and	O	O	O
in	O	O	O
people	O	O	O
with	O	O	O
lower	O	O	B-T080
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
and	O	O	O
BMD	O	O	B-T201
.	O	O	O

Among	O	O	O
subjects	O	O	B-T062
with	O	O	O
spine	O	O	B-T037
fracture	O	O	I-T037
,	O	O	O
26	O	O	O
%	O	O	O
met	O	O	O
BMD	O	O	B-T201
criteria	O	O	B-T080
for	O	O	O
osteoporosis	O	O	B-T047
.	O	O	O

Prevalence	O	O	B-T081
was	O	O	O
higher	O	O	B-T080
in	O	O	O
subjects	O	O	B-T062
who	O	O	O
met	O	O	O
National	O	O	B-UnknownType
Osteoporosis	O	O	I-UnknownType
Foundation	O	O	I-UnknownType
(	O	O	O
NOF	O	O	B-UnknownType
)	O	O	O
criteria	O	O	B-T080
for	O	O	O
spine	O	O	B-T060
imaging	O	O	I-T060
(	O	O	O
14	O	O	O
vs	O	O	O
4.7	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Only	O	O	O
8	O	O	O
%	O	O	O
of	O	O	O
people	O	O	O
with	O	O	O
a	O	O	O
spine	O	O	B-T037
fracture	O	O	B-T037
diagnosed	O	O	B-T033
by	O	O	O
VFA	O	O	B-T060
had	O	O	O
a	O	O	O
self-reported	O	O	B-T062
fracture	O	O	O
,	O	O	O
and	O	O	O
among	O	O	O
those	O	O	O
who	O	O	O
self-reported	O	O	O
a	O	O	O
spine	O	O	O
fracture	O	O	O
,	O	O	O
only	O	O	O
21	O	O	O
%	O	O	O
were	O	O	O
diagnosed	O	O	O
with	O	O	O
fracture	O	O	O
by	O	O	O
VFA	O	O	O
.	O	O	O

Spine	O	O	B-T037
fracture	O	O	I-T037
prevalence	O	O	B-T081
is	O	O	O
similar	O	O	O
in	O	O	O
women	O	O	B-T098
and	O	O	O
men	O	O	B-T098
and	O	O	O
increases	O	O	O
with	O	O	O
age	O	O	B-T032
and	O	O	O
lower	O	O	B-T080
BMD	O	O	B-T201
,	O	O	O
although	O	O	O
most	O	O	O
subjects	O	O	B-T062
with	O	O	O
spine	O	O	B-T037
fracture	O	O	I-T037
do	O	O	O
not	O	O	O
meet	O	O	O
BMD	O	O	O
criteria	O	O	O
for	O	O	O
osteoporosis	O	O	B-T047
.	O	O	O

Since	O	O	O
most	O	O	O
(	O	O	O
>	O	O	O
90	O	O	O
%	O	O	O
)	O	O	O
individuals	O	O	B-T098
were	O	O	O
unaware	O	O	B-T033
of	O	O	O
their	O	O	O
spine	O	O	B-T037
fractures	O	O	I-T037
,	O	O	O
lateral	O	O	B-T082
spine	O	O	B-T060
imaging	O	O	I-T060
is	O	O	O
needed	O	O	O
to	O	O	O
identify	O	O	O
these	O	O	O
women	O	O	B-T098
and	O	O	O
men	O	O	B-T098
.	O	O	O

Spine	O	O	B-T037
fracture	O	O	I-T037
prevalence	O	O	B-T081
was	O	O	O
threefold	O	O	O
higher	O	O	B-T080
in	O	O	O
individuals	O	O	B-T098
meeting	O	O	O
NOF	O	O	B-UnknownType
criteria	O	O	B-T080
for	O	O	O
spine	O	O	B-T060
imaging	O	O	I-T060
(	O	O	O
∼1	O	O	O
in	O	O	O
7	O	O	O
undergoing	O	O	O
VFA	O	O	B-T060
)	O	O	O
.	O	O	O

Identifying	O	O	O
spine	O	O	B-T037
fractures	O	O	I-T037
as	O	O	O
part	O	O	O
of	O	O	O
comprehensive	O	O	B-T080
risk	O	O	B-T058
assessment	O	O	I-T058
may	O	O	O
improve	O	O	B-T033
clinical	O	O	B-T060
decision	O	O	I-T060
making	O	O	I-T060
.	O	O	O

-DOCSTART- (28179308)

Renieramycin	O	O	B-T109
M	O	O	I-T109
Attenuates	O	O	O
Cancer	O	O	B-T025
Stem	O	O	I-T025
Cell	O	O	I-T025
-like	O	O	O
Phenotypes	O	O	B-T032
in	O	O	O
H460	O	O	B-T025
Lung	O	O	B-T023
Cancer	O	O	O
Cells	O	O	O

Cancer	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
CSCs	O	O	B-T025
)	O	O	O
are	O	O	O
a	O	O	O
subpopulation	O	O	O
of	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
that	O	O	O
possess	O	O	O
self-renewal	O	O	B-T043
and	O	O	O
differentiation	O	O	B-T043
capacities	O	O	O
.	O	O	O

CSCs	O	O	B-T025
contribute	O	O	O
to	O	O	O
drug-resistance	O	O	B-T038
,	O	O	O
cancer	O	O	B-T191
recurrence	O	O	I-T191
and	O	O	O
metastasis	O	O	B-T046
,	O	O	O
thus	O	O	O
development	O	O	B-T169
of	O	O	O
CSC	O	O	B-T025
-targeted	O	O	O
therapeutic	O	O	B-T061
strategies	O	O	I-T061
has	O	O	O
recently	O	O	O
received	O	O	O
significant	O	O	O
attention	O	O	O
in	O	O	O
cancer	O	O	B-T062
research	O	O	I-T062
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
potential	O	O	O
efficacy	O	O	B-T080
of	O	O	O
renieramycin	O	O	B-T109
M	O	O	I-T109
(	O	O	O
RM	O	O	B-T109
)	O	O	O
isolated	O	O	O
from	O	O	O
the	O	O	O
sponge	O	O	B-T204
Xestospongia	O	O	B-T204
species	O	O	I-T204
,	O	O	O
was	O	O	O
examined	O	O	B-T033
against	O	O	O
lung	O	O	B-T023
CSCs	O	O	B-T025
.	O	O	O

Colony	O	O	B-T059
and	O	O	I-T059
spheroid	O	O	I-T059
formation	O	O	I-T059
assays	O	O	I-T059
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
western	O	O	B-T059
blotting	O	O	I-T059
analysis	O	O	I-T059
of	O	O	O
lung	O	O	B-T023
CSC	O	O	B-T025
protein	O	O	B-T116
markers	O	O	B-T123
were	O	O	O
employed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
CSC	O	O	O
-like	O	O	O
phenotypes	O	O	B-T032
of	O	O	O
H460	O	O	B-T025
lung	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
after	O	O	O
treatment	O	O	B-T061
with	O	O	O
RM	O	O	B-T109
at	O	O	O
non-toxic	O	O	B-UnknownType
concentrations	O	O	I-UnknownType
.	O	O	O

RM	O	O	B-T109
treatment	O	O	B-T061
reduced	O	O	O
significantly	O	O	O
colony	O	O	B-T059
and	O	O	I-T059
spheroid	O	O	I-T059
formation	O	O	I-T059
of	O	O	O
H460	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
CSC	O	O	B-T025
markers	O	O	B-T123
CD133	O	O	B-T116
,	O	O	O
CD44	O	O	B-T116
and	O	O	O
ALDH1A1	O	O	B-T116
of	O	O	O
CSC	O	O	O
-enriched	O	O	O
H460	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
reduced	O	O	O
significantly	O	O	O
following	O	O	O
RM	O	O	B-T109
treatment	O	O	B-T061
.	O	O	O

RM	O	O	B-T109
could	O	O	O
be	O	O	O
a	O	O	O
potent	O	O	O
anti-metastatic	O	O	B-T121
agent	O	O	I-T121
by	O	O	O
suppressing	O	O	O
lung	O	O	B-T023
CSC	O	O	B-T025
-like	O	O	O
phenotypes	O	O	B-T032
in	O	O	O
H460	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (28181464)

Physicochemical	O	O	O
characterization	O	O	O
of	O	O	O
chitosan	O	O	B-T109
-	O	O	O
hyaluronan	O	O	B-T109
-coated	O	O	O
solid	O	O	O
lipid	O	O	B-T203
nanoparticles	O	O	I-T203
for	O	O	O
the	O	O	O
targeted	O	O	O
delivery	O	O	B-T061
of	O	O	O
paclitaxel	O	O	B-T109
:	O	O	O
a	O	O	O
proof-of-concept	O	O	B-T062
study	O	O	I-T062
in	O	O	O
breast	O	O	O
cancer	O	O	O
cells	O	O	O

To	O	O	O
investigate	O	O	O
the	O	O	O
potential	O	O	O
of	O	O	O
modified	O	O	O
solid	O	O	B-T203
lipid	O	O	I-T203
nanoparticles	O	O	I-T203
(	O	O	O
SLN	O	O	B-T203
)	O	O	O
for	O	O	O
the	O	O	O
delivery	O	O	O
of	O	O	O
paclitaxel	O	O	B-T109
(	O	O	O
PAX	O	O	B-T109
)	O	O	O
.	O	O	O

SLN	O	O	B-T109
loaded	O	O	I-T109
with	O	O	I-T109
PAX	O	O	I-T109
were	O	O	O
prepared	O	O	O
via	O	O	O
modified	O	O	O
high-pressure	O	O	B-T059
hot	O	O	I-T059
homogenization	O	O	I-T059
.	O	O	O

Formulation	O	O	B-T062
parameters	O	O	I-T062
were	O	O	O
optimized	O	O	O
to	O	O	O
obtain	O	O	O
a	O	O	O
high-quality	O	O	B-T074
delivery	O	O	I-T074
system	O	O	I-T074
.	O	O	O

SLN	O	O	B-T203
cores	O	O	O
were	O	O	O
coated	O	O	B-T080
,	O	O	I-T080
layer-by-layer	O	O	I-T080
,	O	O	O
with	O	O	O
a	O	O	O
chitosan	O	O	B-T109
and	O	O	O
hyaluronan	O	O	B-T109
(	O	O	O
HA	O	O	B-T109
)	O	O	O
shell	O	O	O
.	O	O	O

Selectivity	O	O	O
toward	O	O	O
HA	O	O	B-T109
receptors	O	O	B-T116
was	O	O	O
tested	O	O	O
in	O	O	O
a	O	O	O
breast	O	O	B-T025
cancer	O	O	I-T025
cell	O	O	I-T025
line	O	O	I-T025
,	O	O	O
MCF-7	O	O	B-T025
.	O	O	O

Stable	O	O	B-T080
and	O	O	I-T080
reproducible	O	O	I-T080
nano-sized	O	O	B-T080
and	O	O	O
negatively	O	O	B-T073
charged	O	O	I-T073
nanoparticles	O	O	I-T073
resulted	O	O	O
.	O	O	O

Findings	O	O	O
reveal	O	O	O
that	O	O	O
chitosan	O	O	B-T109
-	O	O	O
HA	O	O	B-T109
-coated	O	O	O
SLN	O	O	B-T203
facilitated	O	O	O
the	O	O	O
targeting	O	O	B-T169
,	O	O	O
cellular	O	O	B-T043
uptake	O	O	I-T043
and	O	O	O
the	O	O	O
time-/dose-controlled	O	O	B-T203
delivery	O	O	I-T203
and	O	O	I-T203
release	O	O	I-T203
of	O	O	O
PAX	O	O	B-T109
,	O	O	O
enhancing	O	O	O
intrinsic	O	O	B-T061
chemotherapeutic	O	O	I-T061
activities	O	O	I-T061
.	O	O	O

SLN	O	O	B-T203
are	O	O	O
suitable	O	O	O
carrier	O	O	B-T074
candidates	O	O	I-T074
for	O	O	O
nano-oncology	O	O	B-T091
given	O	O	O
their	O	O	O
localized	O	O	O
,	O	O	O
and	O	O	O
potent	O	O	O
cytotoxic	O	O	B-T121
potential	O	O	I-T121
overcoming	O	O	B-T033
multidrug-resistant	O	O	B-T038
cancer	O	O	I-T038
cells	O	O	I-T038
.	O	O	O

-DOCSTART- (28181538)

Epigenetic	O	O	B-T063
Editing	O	O	I-T063
of	O	O	O
Ascl1	O	O	B-T028
Gene	O	O	I-T028
in	O	O	O
Neural	O	O	B-T025
Stem	O	O	I-T025
Cells	O	O	I-T025
by	O	O	O
Optogenetics	O	O	O

Enzymes	O	O	B-T116
involved	O	O	O
in	O	O	O
epigenetic	O	O	B-T045
processes	O	O	I-T045
such	O	O	O
as	O	O	O
methyltransferases	O	O	B-T116
or	O	O	O
demethylases	O	O	B-T116
are	O	O	O
becoming	O	O	O
highly	O	O	B-T080
utilized	O	O	B-T169
for	O	O	O
their	O	O	O
persistent	O	O	B-T114
DNA	O	O	I-T114
or	O	O	O
histone	O	O	B-T044
modifying	O	O	I-T044
efficacy	O	O	B-T080
.	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
developed	O	O	O
an	O	O	O
optogenetic	O	O	B-T063
toolbox	O	O	B-T170
fused	O	O	O
to	O	O	O
the	O	O	O
catalytic	O	O	B-T087
domain	O	O	I-T087
(	O	O	O
CD	O	O	B-T087
)	O	O	O
of	O	O	O
DNA-methyltransferase3A	O	O	B-T116
(	O	O	O
DNMT3A	O	O	B-T116
-	O	O	O
CD	O	O	O
)	O	O	O
or	O	O	O
Ten-Eleven	O	O	B-T116
Dioxygenase-1	O	O	I-T116
(	O	O	O
TET1	O	O	B-T116
-	O	O	O
CD	O	O	O
)	O	O	O
for	O	O	O
loci	O	O	B-T082
-	O	O	O
specific	O	O	B-T080
alteration	O	O	B-T045
of	O	O	O
the	O	O	O
methylation	O	O	B-T044
state	O	O	B-T169
at	O	O	O
the	O	O	O
promoter	O	O	B-T114
of	O	O	O
Ascl1	O	O	B-T028
(	O	O	O
Mash1	O	O	B-T028
)	O	O	O
,	O	O	O
a	O	O	O
candidate	O	O	B-T028
proneuron	O	O	I-T028
gene	O	O	I-T028
.	O	O	O

Optogenetical	O	O	B-T116
protein	O	O	I-T116
pairs	O	O	I-T116
,	O	O	O
CRY2	O	O	B-T116
linked	O	O	O
to	O	O	O
DNMT3A	O	O	B-T116
-	O	O	O
CD	O	O	B-T087
or	O	O	O
TET1	O	O	B-T116
-	O	O	O
CD	O	O	O
and	O	O	O
CIB1	O	O	B-T116
fused	O	O	B-T169
to	O	O	O
a	O	O	O
Transcription	O	O	B-T116
Activator-Like	O	O	I-T116
Element	O	O	I-T116
(	O	O	O
TALE	O	O	B-T116
)	O	O	O
locating	O	O	O
an	O	O	O
Ascl1	O	O	B-T028
promoter	O	O	B-T114
region	O	O	I-T114
,	O	O	O
were	O	O	O
designed	O	O	O
for	O	O	O
site	O	O	B-T082
specific	O	O	I-T082
epigenetic	O	O	B-T063
editing	O	O	I-T063
.	O	O	O

A	O	O	O
differentially	O	O	B-T080
methylated	O	O	B-T082
region	O	O	I-T082
at	O	O	O
the	O	O	O
Ascl1	O	O	B-T028
promoter	O	O	B-T114
,	O	O	O
isolated	O	O	B-T169
from	O	O	O
murine	O	O	B-T015
dorsal	O	O	B-T023
root	O	O	I-T023
ganglion	O	O	I-T023
(	O	O	O
hypermethylated	O	O	B-T044
)	O	O	O
and	O	O	O
striated	O	O	B-T080
cells	O	O	B-T025
(	O	O	O
hypomethylated	O	O	B-T044
)	O	O	O
,	O	O	O
was	O	O	O
targeted	O	O	B-T169
with	O	O	O
these	O	O	O
optogenetic-epigenetic	O	O	B-T116
constructs	O	O	I-T116
.	O	O	O

Optimized	O	O	O
blue-light	O	O	B-T070
illumination	O	O	B-T059
triggered	O	O	B-T080
the	O	O	O
co-localization	O	O	B-T067
of	O	O	O
TALE	O	O	B-T116
constructs	O	O	I-T116
with	O	O	O
DNMT3A	O	O	B-T116
-	O	O	O
CD	O	O	B-T087
or	O	O	O
TET1	O	O	B-T116
-	O	O	O
CD	O	O	O
fusion	O	O	B-T116
proteins	O	O	I-T116
at	O	O	O
the	O	O	O
targeted	O	O	B-T082
site	O	O	I-T082
of	O	O	O
the	O	O	O
Ascl1	O	O	B-T028
promoter	O	O	B-T114
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
this	O	O	O
spatiotemporal	O	O	B-T080
association	O	O	O
of	O	O	O
the	O	O	O
fusion	O	O	B-T116
proteins	O	O	I-T116
selectively	O	O	O
alters	O	O	B-T169
the	O	O	O
methylation	O	O	B-T044
state	O	O	B-T169
and	O	O	O
also	O	O	O
regulates	O	O	B-T045
gene	O	O	B-T045
activity	O	O	I-T045
.	O	O	O

This	O	O	O
proof	O	O	O
of	O	O	O
concept	O	O	B-T078
developed	O	O	O
herein	O	O	O
holds	O	O	O
immense	O	O	B-T081
promise	O	O	B-T078
for	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
regulate	O	O	B-T044
gene	O	O	B-T045
activity	O	O	I-T045
via	O	O	O
epigenetic	O	O	B-T063
modulation	O	O	I-T063
with	O	O	O
spatiotemporal	O	O	B-T080
precision	O	O	B-T080
.	O	O	O

-DOCSTART- (28182076)

Vaginal	O	O	B-T047
Infections	O	O	I-T047
of	O	O	O
Albanian	O	O	B-T083
women	O	O	B-T098
Infected	O	O	B-T046
with	O	O	O
HPV	O	O	B-T005
and	O	O	O
their	O	O	O
impact	O	O	O
in	O	O	O
intraepithelial	O	O	B-T191
cervical	O	O	I-T191
lesions	O	O	I-T191
evidenced	O	O	O
by	O	O	O
Pap	O	O	O
test	O	O	O

Cervical	O	O	B-T059
cytology	O	O	I-T059
is	O	O	O
the	O	O	O
best	O	O	O
single	O	O	O
method	O	O	O
for	O	O	O
large	O	O	O
screening	O	O	B-T060
of	O	O	O
the	O	O	O
population	O	O	O
in	O	O	O
identifying	O	O	O
precancerous	O	O	B-T191
lesions	O	O	I-T191
of	O	O	O
the	O	O	O
uterine	O	O	B-T023
cervix	O	O	I-T023
.	O	O	O

To	O	O	O
estimate	O	O	O
the	O	O	O
frequency	O	O	O
of	O	O	O
human	O	O	B-T034
papillomavirus	O	O	I-T034
(	O	O	I-T034
HPV	O	O	B-T005
)	O	O	I-T034
positivity	O	O	I-T034
in	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
Albanian	O	O	B-T083
women	O	O	B-T098
,	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
vaginal	O	O	B-T047
coinfections	O	O	B-T047
,	O	O	O
and	O	O	O
the	O	O	O
relationship	O	O	O
of	O	O	O
coinfections	O	O	O
with	O	O	O
HPV	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
their	O	O	O
role	O	O	O
in	O	O	O
metaplasia	O	O	B-T049
or	O	O	O
cervical	O	O	B-T191
intraepithelial	O	O	I-T191
lesions	O	O	I-T191
(	O	O	O
CIN	O	O	B-T191
)	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
,	O	O	O
2075	O	O	O
vaginal	O	O	B-T060
smears	O	O	I-T060
were	O	O	O
examined	O	O	O
.	O	O	O

The	O	O	O
Papanicolaou	O	O	B-T060
stain	O	O	I-T060
was	O	O	O
used	O	O	O
for	O	O	O
all	O	O	O
slides	O	O	O
.	O	O	O

The	O	O	O
New	O	O	B-T059
Bethesda	O	O	I-T059
System	O	O	I-T059
2001	O	O	O
was	O	O	O
used	O	O	O
for	O	O	O
the	O	O	O
interpretations	O	O	B-T059
of	O	O	I-T059
the	O	O	I-T059
smears	O	O	I-T059
.	O	O	O

Data	O	O	O
analysis	O	O	O
was	O	O	O
completed	O	O	O
using	O	O	O
the	O	O	O
Statistical	O	O	B-T081
Package	O	O	I-T081
for	O	O	I-T081
the	O	O	I-T081
Social	O	O	I-T081
Sciences	O	O	I-T081
version	O	O	I-T081
19.0	O	O	O
.	O	O	O

Prevalence	O	O	B-T081
of	O	O	O
HPV	O	O	B-T034
positivity	O	O	I-T034
was	O	O	O
43.9	O	O	O
%	O	O	O
with	O	O	O
an	O	O	O
average	O	O	O
age	O	O	O
of	O	O	O
35.48	O	O	O
±	O	O	O
9.27	O	O	O
years	O	O	O
.	O	O	O

Candida	O	O	B-T047
coinfection	O	O	I-T047
resulted	O	O	O
in	O	O	O
57.8	O	O	O
%	O	O	O
of	O	O	O
HPV	O	O	B-T034
positive	O	O	I-T034
women	O	O	B-T098
with	O	O	O
a	O	O	O
significant	O	O	O
relationship	O	O	O
between	O	O	O
them	O	O	O
.	O	O	O

Gardnerella	O	O	B-T047
coinfection	O	O	I-T047
resulted	O	O	O
in	O	O	O
36	O	O	O
(	O	O	O
23	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
mixed	O	O	B-T047
flora	O	O	I-T047
in	O	O	O
34	O	O	O
(	O	O	O
8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
Trichomonas	O	O	B-T047
vaginalis	O	O	I-T047
in	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
HPV	O	O	B-T034
positive	O	O	I-T034
woman	O	O	B-T098
.	O	O	O

Among	O	O	O
the	O	O	O
women	O	O	B-T098
with	O	O	O
positive	O	O	B-T034
HPV	O	O	B-T005
,	O	O	O
19	O	O	O
%	O	O	O
had	O	O	O
CIN	O	O	B-T191
,	O	O	O
8	O	O	O
%	O	O	O
had	O	O	O
metaplasia	O	O	B-T049
,	O	O	O
and	O	O	O
1	O	O	O
%	O	O	O
had	O	O	O
metaplasia	O	O	O
and	O	O	O
CIN	O	O	O
;	O	O	O
9	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
women	O	O	O
with	O	O	O
HPV	O	O	O
had	O	O	O
CIN1	O	O	B-T191
and	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
coinfections	O	O	B-T047
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
strong	O	O	O
relationship	O	O	O
between	O	O	O
CIN1	O	O	B-T191
and	O	O	O
HPV	O	O	B-T034
positivity	O	O	I-T034
as	O	O	O
well	O	O	O
as	O	O	O
between	O	O	O
CIN1	O	O	O
and	O	O	O
coinfections	O	O	B-T047
.	O	O	O

HPV	O	O	B-T047
infection	O	O	I-T047
is	O	O	O
a	O	O	O
major	O	O	O
factor	O	O	O
contributing	O	O	O
to	O	O	O
metaplasia	O	O	B-T049
,	O	O	O
and	O	O	O
bacterial	O	O	B-T047
coinfections	O	O	I-T047
in	O	O	O
HPV	O	O	B-T034
positive	O	O	I-T034
women	O	O	B-T098
have	O	O	O
a	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
impact	O	O	O
in	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
metaplasia	O	O	O
.	O	O	O

-DOCSTART- (28182129)

A	O	O	O
Case	O	O	O
of	O	O	O
Acute	O	O	B-T079
Hepatitis	O	O	B-T047
E	O	O	I-T047
Infection	O	O	I-T047
in	O	O	O
a	O	O	O
Patient	O	O	B-T101
with	O	O	O
Non-Hodgkin	O	O	B-T191
Lymphoma	O	O	I-T191
Treated	O	O	B-T061
Successfully	O	O	O
with	O	O	O
Ribavirin	O	O	O

We	O	O	O
present	O	O	O
the	O	O	O
case	O	O	O
of	O	O	O
a	O	O	O
man	O	O	B-T098
who	O	O	O
,	O	O	O
following	O	O	O
immunosuppressive	O	O	B-T061
treatment	O	O	I-T061
for	O	O	O
non-Hodgkin	O	O	B-T191
lymphoma	O	O	I-T191
,	O	O	O
became	O	O	O
infected	O	O	B-T033
with	O	O	O
viral	O	O	O
hepatitis	O	O	O
E.	O	O	O
Acute	O	O	B-T079
hepatitis	O	O	B-T047
E	O	O	I-T047
virus	O	O	I-T047
infection	O	O	I-T047
should	O	O	O
be	O	O	O
considered	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
deranged	O	O	B-T080
liver	O	O	B-T042
function	O	O	I-T042
on	O	O	O
a	O	O	O
background	O	O	O
of	O	O	O
haematological	O	O	B-T191
malignancies	O	O	I-T191
or	O	O	O
immunosuppression	O	O	B-T047
,	O	O	O
even	O	O	O
without	O	O	O
travel	O	O	O
to	O	O	O
endemic	O	O	B-T083
regions	O	O	I-T083
.	O	O	O

Whilst	O	O	O
clearance	O	O	O
is	O	O	O
usually	O	O	O
spontaneous	O	O	O
in	O	O	O
immune	O	O	B-T169
-	O	O	O
competent	O	O	B-T080
individuals	O	O	B-T098
,	O	O	O
these	O	O	O
at-risk	O	O	B-T098
groups	O	O	I-T098
may	O	O	O
develop	O	O	O
a	O	O	O
more	O	O	O
complicated	O	O	O
and	O	O	O
protracted	O	O	B-T033
disease	O	O	I-T033
course	O	O	I-T033
.	O	O	O

Thus	O	O	O
awareness	O	O	O
is	O	O	O
important	O	O	O
as	O	O	O
additional	O	O	O
treatment	O	O	B-T061
with	O	O	O
ribavirin	O	O	B-T114
or	O	O	O
pegylated	O	O	B-T129
interferon	O	O	I-T129
may	O	O	O
be	O	O	O
required	O	O	O
,	O	O	O
as	O	O	O
in	O	O	O
this	O	O	O
case	O	O	O
,	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
help	O	O	O
achieve	O	O	O
eradication	O	O	B-T058
.	O	O	O

-DOCSTART- (28183806)

Commissioning	O	O	B-T097
through	O	O	O
competition	O	O	B-T054
and	O	O	O
cooperation	O	O	B-T054
in	O	O	O
the	O	O	O
English	O	O	B-T098
NHS	O	O	B-T058
under	O	O	O
the	O	O	O
Health	O	O	B-T058
and	O	O	I-T058
Social	O	O	I-T058
Care	O	O	I-T058
Act	O	O	I-T058
2012	O	O	I-T058
:	O	O	O
evidence	O	O	O
from	O	O	O
a	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
of	O	O	O
four	O	O	O
clinical	O	O	O
commissioning	O	O	O
groups	O	O	O

The	O	O	O
Health	O	O	B-T058
and	O	O	I-T058
Social	O	O	I-T058
Care	O	O	I-T058
Act	O	O	I-T058
2012	O	O	I-T058
(	O	O	O
'	O	O	O
HSCA	O	O	B-T058
2012	O	O	I-T058
'	O	O	O
)	O	O	O
introduced	O	O	O
a	O	O	O
new	O	O	O
,	O	O	O
statutory	O	O	O
,	O	O	O
form	O	O	O
of	O	O	O
regulation	O	O	B-T064
of	O	O	O
competition	O	O	B-T054
into	O	O	O
the	O	O	O
National	O	O	B-T058
Health	O	O	I-T058
Service	O	O	I-T058
(	O	O	O
NHS	O	O	B-T058
)	O	O	O
,	O	O	O
while	O	O	O
at	O	O	O
the	O	O	O
same	O	O	O
time	O	O	O
recognising	O	O	O
that	O	O	O
cooperation	O	O	B-T054
was	O	O	O
necessary	O	O	O
.	O	O	O

NHS	O	O	B-T058
England	O	O	B-T170
's	O	O	I-T170
policy	O	O	I-T170
document	O	O	I-T170
,	O	O	O
The	O	O	O
Five	O	O	B-T170
Year	O	O	I-T170
Forward	O	O	I-T170
View	O	O	I-T170
(	O	O	O
'	O	O	O
5YFV	O	O	B-T170
'	O	O	O
)	O	O	O
of	O	O	O
2014	O	O	O
placed	O	O	O
less	O	O	O
emphasis	O	O	O
on	O	O	O
competition	O	O	B-T054
without	O	O	O
altering	O	O	O
the	O	O	O
legislation	O	O	B-T170
.	O	O	O

We	O	O	O
explored	O	O	O
how	O	O	O
commissioners	O	O	B-T062
and	O	O	O
providers	O	O	B-T169
understand	O	O	O
the	O	O	O
complex	O	O	B-T080
regulatory	O	O	B-T089
framework	O	O	I-T089
,	O	O	O
and	O	O	O
how	O	O	O
they	O	O	O
behave	O	O	O
in	O	O	O
relation	O	O	O
to	O	O	O
competition	O	O	B-T054
and	O	O	O
cooperation	O	O	B-T054
.	O	O	O

We	O	O	O
carried	O	O	O
out	O	O	O
detailed	O	O	O
case	O	O	B-T170
studies	O	O	I-T170
in	O	O	O
four	O	O	O
clinical	O	O	B-T097
commissioning	O	O	I-T097
groups	O	O	I-T097
,	O	O	O
using	O	O	O
interviews	O	O	B-T052
and	O	O	O
documentary	O	O	B-T062
analysis	O	O	I-T062
to	O	O	O
explore	O	O	O
the	O	O	O
commissioners	O	O	B-T062
'	O	O	O
and	O	O	O
providers	O	O	B-T169
'	O	O	O
understanding	O	O	O
and	O	O	O
experience	O	O	O
of	O	O	O
competition	O	O	B-T054
and	O	O	O
cooperation	O	O	B-T054
.	O	O	O

We	O	O	O
conducted	O	O	O
42	O	O	O
interviews	O	O	B-T052
with	O	O	O
senior	O	O	B-T097
managers	O	O	I-T097
in	O	O	O
commissioning	O	O	B-T097
organisations	O	O	B-T094
and	O	O	O
senior	O	O	O
managers	O	O	O
in	O	O	O
NHS	O	O	B-T058
and	O	O	O
independent	O	O	B-T093
provider	O	O	I-T093
organisations	O	O	I-T093
(	O	O	O
acute	O	O	B-T095
and	O	O	I-T095
community	O	O	I-T095
services	O	O	I-T095
)	O	O	O
.	O	O	O

Neither	O	O	O
commissioners	O	O	B-T062
nor	O	O	O
providers	O	O	B-T169
fully	O	O	O
understand	O	O	O
the	O	O	O
regulatory	O	O	B-T089
regime	O	O	I-T089
in	O	O	O
respect	O	O	O
of	O	O	O
competition	O	O	B-T054
in	O	O	O
the	O	O	O
NHS	O	O	B-T058
,	O	O	O
and	O	O	O
have	O	O	O
not	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
regulatory	O	O	B-T089
authorities	O	O	I-T089
have	O	O	O
provided	O	O	O
adequate	O	O	O
guidance	O	O	B-T065
.	O	O	O

Despite	O	O	O
the	O	O	O
HSCA	O	O	B-T058
2012	O	O	I-T058
promoting	O	O	B-T052
competition	O	O	B-T054
,	O	O	O
commissioners	O	O	B-T062
chose	O	O	O
mainly	O	O	O
to	O	O	O
use	O	O	O
collaborative	O	O	B-T062
strategies	O	O	I-T062
to	O	O	O
effect	O	O	O
major	O	O	O
service	O	O	B-T057
reconfigurations	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
endorsed	O	O	O
as	O	O	O
a	O	O	O
suitable	O	O	O
approach	O	O	O
by	O	O	O
providers	O	O	B-T169
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
commissioners	O	O	B-T062
are	O	O	O
using	O	O	O
competitive	O	O	B-T054
tendering	O	O	O
in	O	O	O
respect	O	O	O
of	O	O	O
more	O	O	O
peripheral	O	O	B-T057
services	O	O	I-T057
in	O	O	O
order	O	O	O
to	O	O	O
improve	O	O	O
quality	O	O	B-T058
of	O	O	I-T058
care	O	O	I-T058
and	O	O	O
value	O	O	B-T078
for	O	O	I-T078
money	O	O	I-T078
.	O	O	O

Commissioners	O	O	B-T062
regard	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
competition	O	O	B-T054
and	O	O	O
cooperation	O	O	B-T054
as	O	O	O
appropriate	O	O	O
in	O	O	O
the	O	O	O
NHS	O	O	B-T058
currently	O	O	O
,	O	O	O
although	O	O	O
collaborative	O	O	B-T062
strategies	O	O	I-T062
appear	O	O	O
more	O	O	O
helpful	O	O	O
in	O	O	O
respect	O	O	O
of	O	O	O
large-scale	O	O	B-UnknownType
changes	O	O	I-UnknownType
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
current	O	O	O
regulatory	O	O	B-T089
framework	O	O	I-T089
contained	O	O	O
in	O	O	O
the	O	O	O
HSCA	O	O	B-T058
2012	O	O	I-T058
,	O	O	O
particularly	O	O	O
since	O	O	O
the	O	O	O
publication	O	O	B-T073
of	O	O	O
the	O	O	O
5YFV	O	O	B-T170
,	O	O	O
is	O	O	O
not	O	O	O
clear	O	O	O
.	O	O	O

Better	O	O	O
guidance	O	O	B-T065
should	O	O	O
be	O	O	O
issued	O	O	O
by	O	O	O
the	O	O	O
regulatory	O	O	B-T089
authorities	O	O	I-T089
.	O	O	O

-DOCSTART- (28187247)

Prevalence	O	O	B-T081
and	O	O	O
correlates	O	O	B-T080
of	O	O	O
antibiotic	O	O	B-T195
sharing	O	O	B-T054
in	O	O	O
the	O	O	O
Philippines	O	O	B-T083
:	O	O	O
antibiotic	O	O	O
misconceptions	O	O	B-T041
and	O	O	O
community	O	O	B-T096
-	O	O	O
level	O	O	B-T080
access	O	O	O
to	O	O	O
non-medical	O	O	B-T056
sources	O	O	B-T033
of	O	O	O
antibiotics	O	O	O

To	O	O	O
identify	O	O	O
sociodemographic	O	O	B-T078
,	O	O	O
knowledge	O	O	B-T170
and	O	O	O
attitudinal	O	O	B-T041
correlates	O	O	B-T080
to	O	O	O
antibiotic	O	O	B-T195
sharing	O	O	B-T054
among	O	O	O
a	O	O	O
community-based	O	O	B-T081
sample	O	O	I-T081
of	O	O	O
adults	O	O	B-T100
(	O	O	O
age	O	O	O
18	O	O	O
and	O	O	O
older	O	O	O
)	O	O	O
in	O	O	O
a	O	O	O
low-income	O	O	B-T033
setting	O	O	I-T033
of	O	O	O
the	O	O	O
Philippines	O	O	B-T083
and	O	O	O
to	O	O	O
explore	O	O	O
community	O	O	B-T096
-	O	O	O
level	O	O	B-T080
data	O	O	B-T078
on	O	O	O
informal	O	O	B-T033
antibiotic	O	O	O
distribution	O	O	B-T057
in	O	O	O
roadside	O	O	B-T082
stands	O	O	I-T082
(	O	O	O
i.e.	O	O	O
,	O	O	O
sari-sari	O	O	B-T082
stands	O	O	I-T082
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
(	O	O	O
n	O	O	O
=	O	O	O
307	O	O	O
)	O	O	O
completed	O	O	B-T080
self-administered	O	O	B-T169
surveys	O	O	B-T170
.	O	O	O

Correlates	O	O	B-T080
to	O	O	O
antibiotic	O	O	B-T195
sharing	O	O	B-T054
were	O	O	O
assessed	O	O	B-T052
using	O	O	O
logistic	O	O	B-T062
regression	O	O	I-T062
with	O	O	O
Firth	O	O	B-T170
's	O	O	I-T170
bias-adjusted	O	O	I-T170
estimate	O	O	I-T170
s.	O	O	O
Study	O	O	O
staff	O	O	B-T097
also	O	O	O
visited	O	O	O
106	O	O	O
roadside	O	O	B-T082
stands	O	O	B-T082
and	O	O	O
collected	O	O	B-T033
data	O	O	I-T033
on	O	O	O
availability	O	O	B-T169
and	O	O	O
characteristics	O	O	O
of	O	O	O
antibiotics	O	O	B-T195
in	O	O	O
the	O	O	O
stands	O	O	O
.	O	O	O

78	O	O	O
%	O	O	O
had	O	O	O
shared	O	O	B-T054
antibiotics	O	O	B-T195
in	O	O	O
their	O	O	O
lifetime	O	O	B-T079
,	O	O	O
most	O	O	O
often	O	O	B-T079
with	O	O	O
family	O	O	B-T099
members	O	O	I-T099
.	O	O	O

In	O	O	O
multivariable	O	O	B-T081
analysis	O	O	I-T081
,	O	O	O
agreement	O	O	B-T054
with	O	O	O
the	O	O	O
belief	O	O	B-T078
that	O	O	O
it	O	O	O
is	O	O	O
safe	O	O	O
to	O	O	O
prematurely	O	O	B-T079
stop	O	O	B-T052
an	O	O	O
antibiotic	O	O	B-T195
course	O	O	B-T079
(	O	O	O
OR	O	O	B-T081
:	O	O	O
2.8	O	O	O
,	O	O	O
CI	O	O	O
:	O	O	O
1.3	O	O	O
-	O	O	O
5.8	O	O	O
)	O	O	O
and	O	O	O
concerns	O	O	B-T078
about	O	O	O
antibiotic	O	O	B-T037
side	O	O	I-T037
effects	O	O	I-T037
(	O	O	O
OR	O	O	O
:	O	O	O
2.1	O	O	O
,	O	O	O
CI	O	O	O
:	O	O	O
1.1	O	O	O
-	O	O	O
4.4	O	O	O
)	O	O	O
were	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	B-T081
odds	O	O	O
of	O	O	O
reported	O	O	O
antibiotic	O	O	O
sharing	O	O	B-T054
.	O	O	O

Antibiotic	O	O	B-T195
sharing	O	O	B-T054
was	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
sociodemographic	O	O	B-T102
characteristics	O	O	I-T102
or	O	O	O
antibiotic	O	O	B-T195
knowledge	O	O	B-T170
.	O	O	O

Antibiotics	O	O	B-T195
were	O	O	O
widely	O	O	O
available	O	O	B-T169
in	O	O	O
60	O	O	O
%	O	O	O
of	O	O	O
sampled	O	O	O
sari-sari	O	O	B-T082
stands	O	O	I-T082
,	O	O	O
in	O	O	O
which	O	O	O
59	O	O	O
%	O	O	O
of	O	O	O
antibiotics	O	O	B-T195
were	O	O	O
missing	O	O	B-T033
expiration	O	O	I-T033
dates	O	O	I-T033
.	O	O	O

Amoxicillin	O	O	B-T195
and	O	O	O
cephalexin	O	O	B-T195
were	O	O	O
the	O	O	O
most	O	O	O
commonly	O	O	B-T081
available	O	O	B-T169
antibiotics	O	O	B-T195
for	O	O	O
sale	O	O	O
at	O	O	O
the	O	O	O
stands	O	O	B-T082
(	O	O	O
60	O	O	O
%	O	O	O
and	O	O	O
21	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Antibiotic	O	O	B-T195
sharing	O	O	B-T054
was	O	O	O
common	O	O	B-T081
and	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
misconceptions	O	O	B-T041
about	O	O	O
proper	O	O	O
antibiotic	O	O	B-T195
use	O	O	O
.	O	O	O

Antibiotics	O	O	B-T195
were	O	O	O
widely	O	O	O
available	O	O	B-T169
in	O	O	O
sari-sari	O	O	B-T082
stands	O	O	I-T082
,	O	O	O
and	O	O	O
usually	O	O	O
without	O	O	B-T080
expiration	O	O	B-T170
information	O	O	I-T170
.	O	O	O

This	O	O	O
study	O	O	O
suggests	O	O	O
that	O	O	O
multipronged	O	O	O
and	O	O	O
locally	O	O	O
tailored	O	O	O
approaches	O	O	O
to	O	O	O
curbing	O	O	B-T169
informal	O	O	B-T033
antibiotic	O	O	B-T195
access	O	O	O
are	O	O	O
needed	O	O	O
in	O	O	O
the	O	O	O
Philippines	O	O	B-T083
and	O	O	O
similar	O	O	O
Southeast-Asian	O	O	B-T083
countries	O	O	I-T083
.	O	O	O

-DOCSTART- (28187885)

Automated	O	O	B-T169
characterization	O	O	B-T052
and	O	O	O
counting	O	O	B-T081
of	O	O	O
Ki-67	O	O	B-T116
protein	O	O	I-T116
for	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
prognosis	O	O	B-T058
:	O	O	O
A	O	O	O
quantitative	O	O	B-T081
immunohistochemistry	O	O	B-T060
approach	O	O	O

Ki-67	O	O	B-T116
protein	O	O	I-T116
expression	O	O	B-T045
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
predicting	O	O	O
the	O	O	O
proliferative	O	O	B-T081
status	O	O	I-T081
of	O	O	O
tumour	O	O	B-T025
cell	O	O	I-T025
s	O	O	O
and	O	O	O
deciding	O	O	O
the	O	O	O
future	O	O	B-T079
course	O	O	B-T079
of	O	O	O
therapy	O	O	B-T061
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Immunohistochemical	O	O	B-T060
(	O	O	I-T060
IHC	O	O	I-T060
)	O	O	I-T060
determination	O	O	I-T060
of	O	O	O
Ki-67	O	O	B-T059
score	O	O	I-T059
or	O	O	O
labelling	O	O	B-T059
index	O	O	I-T059
,	O	O	O
by	O	O	O
estimating	O	O	O
the	O	O	O
fraction	O	O	B-T081
of	O	O	I-T081
Ki67	O	O	B-T116
positively	O	O	B-T033
stained	O	O	B-T080
tumour	O	O	B-T191
cells	O	O	I-T025
,	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
widely	O	O	O
practiced	O	O	O
method	O	O	B-T060
to	O	O	O
assess	O	O	B-T058
tumour	O	O	O
proliferation	O	O	B-T169
(	O	O	O
Dowsett	O	O	O
et	O	O	O
al.	O	O	O
2011	O	O	O
)	O	O	O
.	O	O	O

Accurate	O	O	B-T080
manual	O	O	B-T059
counting	O	O	I-T059
of	O	O	O
these	O	O	O
cells	O	O	B-T025
(	O	O	O
specifically	O	O	B-T080
nuclei	O	O	B-T026
)	O	O	O
due	O	O	O
to	O	O	O
complex	O	O	B-T080
and	O	O	O
dense	O	O	B-T080
distribution	O	O	B-T169
of	O	O	O
cells	O	O	O
,	O	O	O
therefore	O	O	O
,	O	O	O
becomes	O	O	O
critical	O	O	B-T080
and	O	O	O
presents	O	O	B-T078
a	O	O	O
major	O	O	B-T080
challenge	O	O	O
to	O	O	O
pathologists	O	O	B-T097
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
suggest	O	O	O
a	O	O	O
hybrid	O	O	B-T170
clustering	O	O	I-T170
algorithm	O	O	I-T170
to	O	O	O
quantify	O	O	B-T081
the	O	O	O
proliferative	O	O	B-T081
index	O	O	I-T081
of	O	O	O
breast	O	O	B-T025
cancer	O	O	I-T025
cells	O	O	I-T025
based	O	O	O
on	O	O	O
automated	O	O	B-T059
counting	O	O	I-T059
of	O	O	O
Ki-67	O	O	B-T116
nuclei	O	O	B-T026
.	O	O	O

The	O	O	O
proposed	O	O	O
methodology	O	O	B-T060
initially	O	O	B-T079
pre-processes	O	O	B-T067
the	O	O	O
IHC	O	O	B-T060
images	O	O	B-T170
of	O	O	O
Ki-67	O	O	B-T116
stained	O	O	B-T080
slides	O	O	B-T075
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

The	O	O	O
RGB	O	O	O
images	O	O	O
are	O	O	O
converted	O	O	O
to	O	O	O
grey	O	O	B-T080
,	O	O	O
L*a*b	O	O	O
*	O	O	O
,	O	O	O
HSI	O	O	O
,	O	O	O
YCbCr	O	O	O
,	O	O	O
YIQ	O	O	O
and	O	O	O
XYZ	O	O	O
colour	O	O	B-T170
space	O	O	I-T170
.	O	O	O

All	O	O	O
the	O	O	O
stained	O	O	B-T080
cells	O	O	B-T025
are	O	O	O
then	O	O	O
characterized	O	O	B-T052
by	O	O	O
two	O	O	B-T059
stage	O	O	I-T059
segmentation	O	O	I-T059
process	O	O	I-T059
.	O	O	O

Fuzzy	O	O	B-T170
C-means	O	O	I-T170
quantifies	O	O	B-T081
all	O	O	O
the	O	O	O
stained	O	O	B-T080
cells	O	O	B-T025
as	O	O	O
one	O	O	O
cluster	O	O	B-T081
.	O	O	O

The	O	O	O
blue	O	O	B-T080
channel	O	O	B-T077
of	O	O	O
the	O	O	O
first	O	O	B-T185
stage	O	O	I-T185
output	O	O	B-T077
is	O	O	O
given	O	O	O
as	O	O	O
input	O	O	O
to	O	O	O
k-means	O	O	B-T062
algorithm	O	O	I-T062
,	O	O	O
which	O	O	O
provides	O	O	O
separate	O	O	B-T080
cluster	O	O	B-T081
for	O	O	O
Ki-67	O	O	B-T116
positive	O	O	B-T033
and	O	O	I-T033
negative	O	O	I-T033
cells	O	O	B-T025
.	O	O	O

The	O	O	O
count	O	O	B-T081
of	O	O	O
positive	O	O	B-T033
and	O	O	I-T033
negative	O	O	I-T033
nuclei	O	O	B-T026
is	O	O	O
used	O	O	O
to	O	O	O
calculate	O	O	B-T059
the	O	O	O
F-measure	O	O	B-T081
for	O	O	O
each	O	O	O
colour	O	O	B-T170
space	O	O	I-T170
.	O	O	O

A	O	O	O
comparative	O	O	B-T062
study	O	O	I-T062
of	O	O	O
our	O	O	O
work	O	O	O
with	O	O	O
the	O	O	O
expert	O	O	B-T077
opinion	O	O	I-T077
is	O	O	O
studied	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
error	O	O	B-T080
rate	O	O	B-T081
.	O	O	O

The	O	O	O
positive	O	O	B-T033
and	O	O	I-T033
negative	O	O	I-T033
nuclei	O	O	B-T026
detection	O	O	B-T033
results	O	O	B-T169
for	O	O	O
all	O	O	O
colour	O	O	B-T170
space	O	O	I-T170
s	O	O	O
are	O	O	O
compared	O	O	B-T052
with	O	O	O
the	O	O	O
ground	O	O	O
truth	O	O	O
for	O	O	O
validation	O	O	O
and	O	O	O
F-measure	O	O	B-T081
is	O	O	O
calculated	O	O	B-T059
.	O	O	O

The	O	O	O
F-measure	O	O	B-T081
for	O	O	O
L*a*b	O	O	O
*	O	O	O
colour	O	O	B-T170
space	O	O	I-T170
(	O	O	O
0.8847	O	O	O
)	O	O	O
provides	O	O	O
the	O	O	O
best	O	O	O
statistical	O	O	B-T081
result	O	O	B-T169
as	O	O	O
compared	O	O	B-T052
to	O	O	O
grey	O	O	B-T080
,	O	O	O
HSI	O	O	O
,	O	O	O
YCbCr	O	O	O
,	O	O	O
YIQ	O	O	O
and	O	O	O
XYZ	O	O	O
colour	O	O	O
space	O	O	O
.	O	O	O

Further	O	O	O
,	O	O	O
a	O	O	O
study	O	O	B-T062
is	O	O	O
carried	O	O	O
out	O	O	O
to	O	O	O
count	O	O	B-T081
nuclei	O	O	B-T026
manually	O	O	B-T059
and	O	O	O
automatically	O	O	B-T059
from	O	O	O
the	O	O	O
proposed	O	O	O
algorithm	O	O	B-T170
with	O	O	O
an	O	O	O
average	O	O	B-T081
error	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
6.84	O	O	O
%	O	O	O
which	O	O	O
is	O	O	O
significant	O	O	B-T078
.	O	O	O

The	O	O	O
study	O	O	B-T062
provides	O	O	O
an	O	O	O
automated	O	O	B-T169
count	O	O	B-T081
of	O	O	O
positive	O	O	B-T033
and	O	O	I-T033
negative	O	O	I-T033
nuclei	O	O	B-T026
using	O	O	O
L*a*b	O	O	O
*	O	O	O
colour	O	O	B-T170
space	O	O	I-T170
and	O	O	O
hybrid	O	O	B-T066
segmentation	O	O	I-T066
technique	O	O	I-T066
.	O	O	O

Computerized	O	O	B-T059
evaluation	O	O	I-T059
of	O	O	O
proliferation	O	O	B-T081
index	O	O	I-T081
can	O	O	O
aid	O	O	O
pathologist	O	O	B-T097
in	O	O	O
assessing	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
severity	O	O	B-T080
.	O	O	O

The	O	O	O
proposed	O	O	O
methodology	O	O	B-T060
,	O	O	O
further	O	O	O
,	O	O	O
has	O	O	O
the	O	O	O
potential	O	O	B-T080
advantage	O	O	O
of	O	O	O
saving	O	O	O
time	O	O	O
and	O	O	O
assisting	O	O	B-T058
in	O	O	O
decision	O	O	O
making	O	O	O
over	O	O	O
the	O	O	O
present	O	O	O
manual	O	O	B-T059
procedure	O	O	I-T059
and	O	O	O
could	O	O	O
evolve	O	O	O
as	O	O	O
an	O	O	O
assistive	O	O	O
pathological	O	O	B-T169
decision	O	O	B-T068
support	O	O	I-T068
system	O	O	I-T068
.	O	O	O

-DOCSTART- (28189069)

Multitarget	O	O	B-T169
sensing	O	O	B-T059
of	O	O	I-T059
glucose	O	O	I-T059
and	O	O	O
cholesterol	O	O	B-T059
based	O	O	O
on	O	O	O
Janus	O	O	O
hydrogel	O	O	O
microparticles	O	O	O

A	O	O	O
visualized	O	O	B-T169
sensing	O	O	B-T059
method	O	O	I-T059
for	O	O	I-T059
glucose	O	O	I-T059
and	O	O	O
cholesterol	O	O	B-T059
was	O	O	O
developed	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
hemispheres	O	O	O
of	O	O	O
the	O	O	O
same	O	O	O
Janus	O	O	B-T109
hydrogel	O	O	I-T109
microparticles	O	O	I-T109
.	O	O	O

Single-phase	O	O	O
and	O	O	O
Janus	O	O	B-T109
hydrogel	O	O	I-T109
microparticles	O	O	I-T109
were	O	O	O
both	O	O	O
generated	O	O	O
using	O	O	O
a	O	O	O
centrifugal	O	O	B-T080
microfluidic	O	O	B-T075
chip	O	O	I-T075
.	O	O	O

For	O	O	O
glucose	O	O	B-T109
sensing	O	O	I-T059
,	O	O	O
concanavalin	O	O	B-T116
A	O	O	I-T116
and	O	O	O
fluorescein	O	O	B-T109
labeled	O	O	I-T109
dextran	O	O	I-T109
used	O	O	O
for	O	O	O
competitive	O	O	B-T059
binding	O	O	I-T059
assay	O	O	I-T059
were	O	O	O
encapsulated	O	O	B-T080
in	O	O	O
alginate	O	O	B-T109
microparticles	O	O	B-T104
,	O	O	O
and	O	O	O
the	O	O	O
fluorescence	O	O	B-T070
of	O	O	O
the	O	O	O
microparticles	O	O	O
was	O	O	O
positively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
glucose	O	O	O
concentration	O	O	B-T081
.	O	O	O

For	O	O	O
cholesterol	O	O	B-T109
sensing	O	O	I-T059
,	O	O	O
the	O	O	O
microparticles	O	O	B-T104
embedded	O	O	O
with	O	O	O
γ-Fe2O3	O	O	B-T130
nanoparticles	O	O	I-T130
were	O	O	O
used	O	O	O
as	O	O	O
catalyst	O	O	B-T067
for	O	O	O
the	O	O	O
oxidation	O	O	B-T044
of	O	O	O
3,3',5,5'-Tetramethylbenzidine	O	O	B-T109
by	O	O	O
H2O2	O	O	B-T121
,	O	O	O
an	O	O	O
enzymatic	O	O	B-T116
hydrolysis	O	O	B-T070
product	O	O	B-T071
of	O	O	O
cholesterol	O	O	O
.	O	O	O

And	O	O	O
the	O	O	O
color	O	O	B-T080
transition	O	O	B-T052
was	O	O	O
more	O	O	O
sensitive	O	O	B-T169
in	O	O	O
the	O	O	O
microparticles	O	O	B-T104
than	O	O	O
in	O	O	O
solutions	O	O	B-T167
,	O	O	O
indicating	O	O	O
the	O	O	O
microparticles	O	O	O
are	O	O	O
more	O	O	O
applicable	O	O	B-T080
for	O	O	O
visualized	O	O	B-T169
determination	O	O	B-T059
.	O	O	O

Furthermore	O	O	O
,	O	O	O
Janus	O	O	B-T104
microparticles	O	O	B-T104
were	O	O	O
employed	O	O	B-T033
for	O	O	O
multitarget	O	O	B-T169
sensing	O	O	B-T080
in	O	O	O
the	O	O	O
two	O	O	O
hemespheres	O	O	O
,	O	O	O
and	O	O	O
glucose	O	O	B-T109
and	O	O	O
cholesterol	O	O	B-T109
were	O	O	O
detected	O	O	B-T033
within	O	O	O
the	O	O	O
same	O	O	O
microparticles	O	O	O
without	O	O	O
obvious	O	O	O
interference	O	O	B-T169
.	O	O	O

Besides	O	O	O
,	O	O	O
the	O	O	O
particles	O	O	B-T104
could	O	O	O
be	O	O	O
manipulated	O	O	O
by	O	O	O
an	O	O	O
external	O	O	B-T082
magnetic	O	O	B-T070
field	O	O	I-T070
.	O	O	O

The	O	O	O
glucose	O	O	B-T034
and	O	O	O
cholesterol	O	O	B-T034
levels	O	O	I-T034
were	O	O	O
measured	O	O	B-T080
in	O	O	O
human	O	O	B-T016
serum	O	O	B-T031
utilizing	O	O	O
the	O	O	O
microparticles	O	O	B-T104
,	O	O	O
which	O	O	O
confirmed	O	O	B-T033
the	O	O	O
potential	O	O	B-T080
application	O	O	O
of	O	O	O
the	O	O	O
microparticles	O	O	O
in	O	O	O
real	O	O	O
sample	O	O	B-T167
detection	O	O	B-T061
.	O	O	O

-DOCSTART- (28190392)

PI3	O	O	B-T116
K	O	O	I-T116
/	O	O	O
Akt	O	O	B-T116
pathway	O	O	B-T044
:	O	O	O
a	O	O	O
potential	O	O	O
therapeutic	O	O	B-T169
target	O	O	B-T169
for	O	O	O
chronic	O	O	O
pain	O	O	O

Chronic	O	O	B-T184
pain	O	O	I-T184
is	O	O	O
among	O	O	O
the	O	O	O
most	O	O	O
disabling	O	O	B-T047
and	O	O	O
costly	O	O	O
disorders	O	O	B-T047
,	O	O	O
with	O	O	O
prevalence	O	O	B-T081
ranging	O	O	B-T081
from	O	O	O
10	O	O	O
%	O	O	O
to	O	O	O
55	O	O	O
%	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
current	O	O	O
therapeutic	O	O	B-T169
strategies	O	O	O
for	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
are	O	O	O
unsatisfactory	O	O	B-T080
due	O	O	O
to	O	O	O
our	O	O	O
poor	O	O	B-T080
understanding	O	O	B-T041
of	O	O	O
its	O	O	O
mechanisms	O	O	B-T169
.	O	O	O

Thus	O	O	O
,	O	O	O
novel	O	O	O
therapeutic	O	O	B-T169
targets	O	O	B-T169
need	O	O	O
to	O	O	O
be	O	O	O
found	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
improve	O	O	B-T033
these	O	O	O
patients	O	O	B-T101
'	O	O	I-T101
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
.	O	O	O

PI3	O	O	B-T116
K	O	O	I-T116
and	O	O	O
its	O	O	O
downstream	O	O	B-T082
Akt	O	O	B-T116
are	O	O	O
widely	O	O	O
expressed	O	O	B-T045
in	O	O	O
the	O	O	O
spinal	O	O	B-T023
cord	O	O	I-T023
,	O	O	O
particularly	O	O	O
in	O	O	O
the	O	O	O
laminae	O	O	B-T023
I-IV	O	O	I-T023
of	O	O	O
the	O	O	O
dorsal	O	O	B-T023
horn	O	O	I-T023
,	O	O	O
where	O	O	O
nociceptive	O	O	B-T026
C	O	O	I-T026
and	O	O	O
Aδ	O	O	B-T026
fibers	O	O	I-T026
of	O	O	O
primary	O	O	B-T080
afferents	O	O	B-T023
principally	O	O	O
terminate	O	O	B-T079
.	O	O	O

Recent	O	O	O
studies	O	O	B-T062
have	O	O	O
demonstrated	O	O	O
their	O	O	O
critical	O	O	B-T080
roles	O	O	B-T077
in	O	O	O
the	O	O	O
development	O	O	B-T169
and	O	O	O
maintenance	O	O	B-T052
of	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
.	O	O	O

In	O	O	O
this	O	O	O
review	O	O	B-T170
,	O	O	O
we	O	O	O
summarized	O	O	O
the	O	O	O
roles	O	O	B-T077
and	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
/	O	O	O
Akt	O	O	B-T116
pathway	O	O	B-T044
in	O	O	O
the	O	O	O
progression	O	O	B-T046
of	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
through	O	O	O
sciatic	O	O	B-T037
nerve	O	O	I-T037
injury	O	O	I-T037
,	O	O	O
diabetic	O	O	B-T047
neuropathy	O	O	I-T047
,	O	O	O
spinal	O	O	B-T037
cord	O	O	I-T037
injury	O	O	I-T037
,	O	O	O
bone	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
opioid	O	O	B-T109
tolerance	O	O	I-UnknownType
,	O	O	O
or	O	O	O
opioid	O	O	O
-	O	O	O
induced	O	O	B-T169
hyperalgesia	O	O	B-T184
.	O	O	O

-DOCSTART- (28190791)

No	O	O	O
free	O	O	B-T073
bed	O	O	I-T073
with	O	O	O
ventilator	O	O	B-T074
:	O	O	O
experience	O	O	O
of	O	O	O
a	O	O	O
public	O	O	O
health	O	O	O
specialist	O	O	O

While	O	O	O
the	O	O	O
author	O	O	B-T097
was	O	O	O
dealing	O	O	O
with	O	O	O
a	O	O	O
poor	O	O	B-T102
elderly	O	O	B-T099
father	O	O	I-T099
struggling	O	O	O
to	O	O	O
shift	O	O	O
his	O	O	O
gravely	O	O	B-T169
injured	O	O	I-T169
young	O	O	B-T079
son	O	O	B-T099
to	O	O	O
a	O	O	O
government	O	O	B-T093
hospital	O	O	I-T093
due	O	O	O
to	O	O	O
the	O	O	O
high	O	O	O
cost	O	O	O
of	O	O	O
intensive	O	O	B-T058
care	O	O	I-T058
,	O	O	O
her	O	O	O
friends	O	O	B-T098
across	O	O	O
the	O	O	O
globe	O	O	B-T082
were	O	O	O
discussing	O	O	O
euthanasia	O	O	B-T058
in	O	O	O
the	O	O	O
social	O	O	B-T170
media	O	O	I-T170
.	O	O	O

While	O	O	O
marginalised	O	O	B-T054
groups	O	O	B-T098
of	O	O	I-T098
people	O	O	B-T098
are	O	O	O
struggling	O	O	O
to	O	O	O
access	O	O	B-T078
care	O	O	B-T052
in	O	O	O
India	O	O	B-T083
,	O	O	O
friends	O	O	B-T098
who	O	O	O
have	O	O	O
moved	O	O	O
to	O	O	O
developed	O	O	B-T080
parts	O	O	I-T080
of	O	O	I-T080
the	O	O	I-T080
world	O	O	I-T080
were	O	O	O
discussing	O	O	O
one	O	O	O
's	O	O	O
choice	O	O	B-T052
to	O	O	O
live	O	O	B-T080
or	O	O	O
die	O	O	B-T040
!	O	O	O
The	O	O	O
poor	O	O	B-T102
father	O	O	B-T099
,	O	O	O
after	O	O	O
battling	O	O	B-T048
to	O	O	O
save	O	O	B-T078
his	O	O	O
son	O	O	B-T099
and	O	O	O
reaching	O	O	O
out	O	O	O
to	O	O	O
many	O	O	O
people	O	O	O
for	O	O	O
help	O	O	B-T080
,	O	O	O
could	O	O	O
not	O	O	O
save	O	O	O
him	O	O	O
.	O	O	O

Early	O	O	B-UnknownType
treatment	O	O	I-UnknownType
might	O	O	O
have	O	O	O
helped	O	O	B-T080
the	O	O	O
young	O	O	B-T079
boy	O	O	B-T100
.	O	O	O

The	O	O	O
incident	O	O	B-T067
left	O	O	O
the	O	O	O
author	O	O	B-T097
thinking	O	O	O
about	O	O	O
how	O	O	O
the	O	O	O
poor	O	O	B-T102
are	O	O	O
denied	O	O	B-T052
care	O	O	B-T052
simply	O	O	O
because	O	O	O
they	O	O	O
can	O	O	O
not	O	O	O
afford	O	O	O
it	O	O	O
.	O	O	O

Others	O	O	O
debate	O	O	B-T052
when	O	O	O
to	O	O	O
pull	O	O	B-T078
the	O	O	I-T078
plug	O	O	I-T078
on	O	O	O
the	O	O	O
patient	O	O	B-T101
.	O	O	O

…	O	O	O
How	O	O	O
many	O	O	O
families	O	O	B-T099
can	O	O	O
afford	O	O	O
such	O	O	O
care	O	O	B-T052
in	O	O	O
India	O	O	B-T083
?	O	O	O
When	O	O	O
nearly	O	O	O
71	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
people	O	O	B-T098
are	O	O	O
paying	O	O	B-T081
out	O	O	I-T081
of	O	O	I-T081
pocket	O	O	I-T081
for	O	O	O
healthcare	O	O	B-T058
and	O	O	O
16	O	O	O
%	O	O	O
are	O	O	O
pushed	O	O	O
below	O	O	B-T102
the	O	O	I-T102
poverty	O	O	I-T102
line	O	O	I-T102
every	O	O	B-T079
year	O	O	I-T079
,	O	O	O
can	O	O	O
we	O	O	O
even	O	O	O
think	O	O	B-T041
of	O	O	O
universal	O	O	B-T078
health	O	O	B-T078
coverage	O	O	I-T078
?	O	O	O

It	O	O	O
just	O	O	O
sounds	O	O	O
like	O	O	O
a	O	O	O
fancy	O	O	B-T078
term	O	O	I-T078
to	O	O	O
be	O	O	O
used	O	O	O
at	O	O	O
conferences	O	O	B-T058
and	O	O	I-T058
meetings	O	O	I-T058
because	O	O	O
the	O	O	O
ground	O	O	B-T078
reality	O	O	I-T078
is	O	O	O
completely	O	O	B-T080
different	O	O	I-T080
.	O	O	O

-DOCSTART- (28192718)

Quantitative	O	O	B-T081
determination	O	O	B-T059
of	O	O	O
five	O	O	O
metabolites	O	O	B-T123
of	O	O	O
aspirin	O	O	B-T109
by	O	O	O
UHPLC-MS	O	O	B-T059
/	O	O	O
MS	O	O	B-T059
coupled	O	O	B-T169
with	O	O	O
enzymatic	O	O	B-T044
reaction	O	O	I-T044
and	O	O	O
its	O	O	O
application	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	O
aspirin	O	O	O
dosage	O	O	B-T081
on	O	O	O
the	O	O	O
metabolic	O	O	O
profile	O	O	O

Acetylsalicylic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
Aspirin	O	O	B-T109
,	O	O	O
ASA	O	O	B-T109
)	O	O	O
is	O	O	O
a	O	O	O
famous	O	O	O
drug	O	O	B-T121
for	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
in	O	O	O
recent	O	O	O
years	O	O	B-T079
.	O	O	O

Effects	O	O	O
of	O	O	O
ASA	O	O	B-T109
dosage	O	O	B-T081
on	O	O	O
the	O	O	O
metabolic	O	O	B-T039
profile	O	O	I-T039
have	O	O	O
not	O	O	O
been	O	O	O
fully	O	O	O
understood	O	O	O
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
our	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
establish	O	O	O
a	O	O	O
rapid	O	O	B-T080
and	O	O	O
reliable	O	O	B-T170
method	O	O	B-T059
to	O	O	O
quantify	O	O	B-T081
ASA	O	O	B-T109
metabolites	O	O	B-T123
in	O	O	O
biological	O	O	B-T031
matrices	O	O	I-T031
,	O	O	O
especially	O	O	O
for	O	O	O
glucuronide	O	O	B-T109
metabolites	O	O	O
whose	O	O	O
standards	O	O	O
are	O	O	O
not	O	O	O
commercially	O	O	O
available	O	O	O
.	O	O	O

Then	O	O	O
we	O	O	O
applied	O	O	O
this	O	O	O
method	O	O	B-T059
to	O	O	O
evaluate	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
ASA	O	O	B-T109
dosage	O	O	B-T081
on	O	O	O
the	O	O	O
metabolic	O	O	B-T039
and	O	O	O
excretion	O	O	B-T039
profile	O	O	B-T081
of	O	O	O
ASA	O	O	O
metabolites	O	O	B-T123
in	O	O	O
rat	O	O	B-T015
urine	O	O	B-T031
.	O	O	O

Salicylic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
SA	O	O	B-T109
)	O	O	O
,	O	O	O
gentisic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
GA	O	O	B-T109
)	O	O	O
and	O	O	O
salicyluric	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
SUA	O	O	B-T109
)	O	O	O
were	O	O	O
determined	O	O	O
directly	O	O	O
by	O	O	O
UHPLC-MS	O	O	B-T059
/	O	O	O
MS	O	O	B-T059
,	O	O	O
while	O	O	O
salicyl	O	O	B-T109
phenolic	O	O	I-T109
glucuronide	O	O	I-T109
(	O	O	O
SAPG	O	O	B-T109
)	O	O	O
and	O	O	O
salicyluric	O	O	B-T109
acid	O	O	I-T109
phenolic	O	O	I-T109
glucuronide	O	O	I-T109
(	O	O	O
SUAPG	O	O	B-T109
)	O	O	O
were	O	O	O
quantified	O	O	B-T081
indirectly	O	O	O
by	O	O	O
measuring	O	O	O
the	O	O	O
released	O	O	O
SA	O	O	O
and	O	O	O
SUA	O	O	O
from	O	O	O
SAPG	O	O	O
and	O	O	O
SUAPG	O	O	O
after	O	O	O
β-glucuronidase	O	O	B-T116
digestion	O	O	B-T040
.	O	O	O

SUA	O	O	B-T109
and	O	O	O
SUAPG	O	O	B-T109
were	O	O	O
the	O	O	O
major	O	O	O
metabolites	O	O	B-T123
of	O	O	O
ASA	O	O	B-T109
in	O	O	O
rat	O	O	B-T015
urine	O	O	B-T031
24	O	O	O
h	O	O	B-T079
after	O	O	O
ASA	O	O	O
administration	O	O	B-T081
,	O	O	O
which	O	O	O
accounted	O	O	O
for	O	O	O
50	O	O	O
%	O	O	O
(	O	O	O
SUA	O	O	O
)	O	O	O
and	O	O	O
26	O	O	O
%	O	O	O
(	O	O	O
SUAPG	O	O	O
)	O	O	O
.	O	O	O

When	O	O	O
ASA	O	O	B-T109
dosage	O	O	B-T081
was	O	O	O
increased	O	O	B-T081
,	O	O	O
the	O	O	O
contributions	O	O	O
dropped	O	O	O
to	O	O	O
32	O	O	O
%	O	O	O
and	O	O	O
18	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
excretion	O	O	B-T039
of	O	O	O
other	O	O	O
three	O	O	O
metabolites	O	O	B-T123
(	O	O	O
GA	O	O	B-T109
,	O	O	O
SA	O	O	B-T109
and	O	O	O
SAPG	O	O	B-T109
)	O	O	O
however	O	O	O
showed	O	O	O
remarkable	O	O	O
increases	O	O	O
by	O	O	O
16	O	O	O
%	O	O	O
,	O	O	O
6	O	O	O
%	O	O	O
and	O	O	O
4	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
SUA	O	O	B-T109
and	O	O	O
SUAPG	O	O	B-T109
were	O	O	O
mainly	O	O	O
excreted	O	O	B-T039
in	O	O	O
the	O	O	O
time	O	O	B-T079
period	O	O	I-T079
of	O	O	O
12	O	O	O
-	O	O	O
24	O	O	O
h	O	O	B-T079
,	O	O	O
while	O	O	O
GA	O	O	B-T109
was	O	O	O
excreted	O	O	O
in	O	O	O
the	O	O	O
earlier	O	O	O
time	O	O	B-T079
periods	O	O	I-T079
(	O	O	O
0	O	O	O
-	O	O	O
4	O	O	O
h	O	O	O
and	O	O	O
4	O	O	O
-	O	O	O
8	O	O	O
h	O	O	O
)	O	O	O
.	O	O	O

SA	O	O	B-T109
was	O	O	O
mainly	O	O	O
excreted	O	O	B-T039
in	O	O	O
the	O	O	O
time	O	O	B-T079
period	O	O	I-T079
of	O	O	O
0	O	O	O
-	O	O	O
4	O	O	O
h	O	O	B-T079
and	O	O	O
12	O	O	O
-	O	O	O
24	O	O	O
h.	O	O	O
And	O	O	O
the	O	O	O
excretion	O	O	B-T039
of	O	O	O
SAPG	O	O	B-T109
was	O	O	O
equally	O	O	O
distributed	O	O	O
in	O	O	O
the	O	O	O
four	O	O	O
time	O	O	B-T079
periods	O	O	I-T079
.	O	O	O

We	O	O	O
went	O	O	O
further	O	O	O
to	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
excretion	O	O	B-T039
of	O	O	O
five	O	O	O
metabolites	O	O	B-T123
in	O	O	O
rat	O	O	B-T015
urine	O	O	B-T031
was	O	O	O
delayed	O	O	O
when	O	O	O
ASA	O	O	B-T109
dosage	O	O	B-T081
was	O	O	O
increased	O	O	B-T081
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
developed	O	O	O
a	O	O	O
rapid	O	O	B-T080
and	O	O	O
sensitive	O	O	B-T169
method	O	O	B-T059
to	O	O	O
determine	O	O	O
the	O	O	O
five	O	O	O
ASA	O	O	B-T109
metabolites	O	O	B-T123
(	O	O	O
SA	O	O	B-T109
,	O	O	O
GA	O	O	B-T109
,	O	O	O
SUA	O	O	B-T109
,	O	O	O
SAPG	O	O	B-T109
and	O	O	O
SUAPG	O	O	B-T109
)	O	O	O
in	O	O	O
rat	O	O	B-T015
urine	O	O	B-T031
.	O	O	O

We	O	O	O
showed	O	O	O
that	O	O	O
ASA	O	O	B-T109
dosage	O	O	B-T081
could	O	O	O
significantly	O	O	O
influence	O	O	B-T077
the	O	O	O
metabolic	O	O	B-T039
and	O	O	O
excretion	O	O	B-T039
profile	O	O	B-T081
of	O	O	O
ASA	O	O	O
metabolites	O	O	B-T123
in	O	O	O
rat	O	O	B-T015
urine	O	O	B-T031
.	O	O	O

-DOCSTART- (28193730)

Mismatch	O	O	B-T045
Repair	O	O	I-T045
Incompatibilities	O	O	B-T054
in	O	O	O
Diverse	O	O	B-T080
Yeast	O	O	B-T004
Populations	O	O	O

An	O	O	O
elevated	O	O	B-T080
mutation	O	O	B-T080
rate	O	O	I-T080
can	O	O	O
provide	O	O	O
cells	O	O	B-T025
with	O	O	O
a	O	O	O
source	O	O	B-T033
of	O	O	O
mutations	O	O	B-T045
to	O	O	O
adapt	O	O	O
to	O	O	O
changing	O	O	B-T169
environments	O	O	B-T082
.	O	O	O

We	O	O	O
identified	O	O	B-T080
a	O	O	O
negative	O	O	B-T033
epistatic	O	O	B-T045
interaction	O	O	I-T045
involving	O	O	B-T169
naturally	O	O	O
occurring	O	O	O
variants	O	O	B-T080
in	O	O	O
the	O	O	O
MLH1	O	O	B-T028
and	O	O	O
PMS1	O	O	B-T028
mismatch	O	O	B-T045
repair	O	O	I-T045
(	O	O	O
MMR	O	O	B-T045
)	O	O	O
genes	O	O	B-T028
of	O	O	O
Saccharomyces	O	O	B-T004
cerevisiae	O	O	I-T004
We	O	O	O
hypothesized	O	O	O
that	O	O	O
this	O	O	O
MMR	O	O	O
incompatibility	O	O	B-T054
,	O	O	O
created	O	O	O
through	O	O	O
mating	O	O	B-T040
between	O	O	O
divergent	O	O	O
S.	O	O	B-T004
cerevisiae	O	O	I-T004
,	O	O	O
yields	O	O	O
mutator	O	O	O
progeny	O	O	B-T099
that	O	O	O
can	O	O	O
rapidly	O	O	B-T080
but	O	O	O
transiently	O	O	O
adapt	O	O	O
to	O	O	O
an	O	O	O
environmental	O	O	B-T067
stress	O	O	I-T067
.	O	O	O

Here	O	O	O
we	O	O	O
analyzed	O	O	B-T062
the	O	O	O
MLH1	O	O	B-T028
and	O	O	O
PMS1	O	O	B-T028
genes	O	O	I-T028
across	O	O	O
1010	O	O	O
S.	O	O	B-T004
cerevisiae	O	O	I-T004
natural	O	O	B-T169
isolates	O	O	B-T123
spanning	O	O	O
a	O	O	O
wide	O	O	O
range	O	O	B-T081
of	O	O	O
ecological	O	O	B-T070
sources	O	O	B-T033
(	O	O	O
tree	O	O	B-T002
exudates	O	O	B-T031
,	O	O	O
Drosophila	O	O	B-T204
,	O	O	O
fruits	O	O	B-T168
,	O	O	O
and	O	O	O
various	O	O	O
fermentation	O	O	B-T044
and	O	O	O
clinical	O	O	B-T080
isolates	O	O	O
)	O	O	O
and	O	O	O
geographical	O	O	B-T082
sources	O	O	O
(	O	O	O
Europe	O	O	B-T083
,	O	O	O
America	O	O	B-T083
,	O	O	O
Africa	O	O	B-T083
,	O	O	O
and	O	O	O
Asia	O	O	B-T083
)	O	O	O
.	O	O	O

We	O	O	O
identified	O	O	B-T080
one	O	O	O
homozygous	O	O	B-T032
clinical	O	O	B-T080
isolate	O	O	B-T123
and	O	O	O
18	O	O	O
heterozygous	O	O	B-T032
isolates	O	O	B-T123
containing	O	O	B-T169
the	O	O	O
incompatible	O	O	O
MMR	O	O	B-T045
genotype	O	O	B-T032
.	O	O	O

The	O	O	O
MLH1	O	O	B-T028
-	O	O	O
PMS1	O	O	B-T028
gene	O	O	I-T028
combination	O	O	B-T080
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
homozygous	O	O	B-T032
clinical	O	O	B-T080
isolate	O	O	B-T123
conferred	O	O	O
a	O	O	O
mutator	O	O	O
phenotype	O	O	B-T032
when	O	O	O
expressed	O	O	B-T045
in	O	O	O
the	O	O	O
S288c	O	O	O
laboratory	O	O	B-T093
background	O	O	B-T077
.	O	O	O

Using	O	O	O
a	O	O	O
novel	O	O	O
reporter	O	O	B-T130
to	O	O	O
measure	O	O	B-T081
mutation	O	O	B-T080
rates	O	O	I-T080
,	O	O	O
we	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
overall	O	O	B-T080
mutation	O	O	B-T080
rate	O	O	I-T080
in	O	O	O
the	O	O	O
homozygous	O	O	B-T032
incompatible	O	O	O
background	O	O	B-T077
was	O	O	O
similar	O	O	O
to	O	O	O
that	O	O	O
seen	O	O	O
in	O	O	O
compatible	O	O	B-T080
strains	O	O	B-T001
,	O	O	O
indicating	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
suppressor	O	O	B-T049
mutations	O	O	I-T049
in	O	O	O
the	O	O	O
clinical	O	O	B-T080
isolate	O	O	B-T123
that	O	O	O
lowered	O	O	O
its	O	O	O
mutation	O	O	O
rate	O	O	O
.	O	O	O

This	O	O	O
observation	O	O	B-T062
and	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
18	O	O	O
heterozygous	O	O	B-T032
isolates	O	O	B-T123
,	O	O	O
which	O	O	O
can	O	O	O
lead	O	O	O
to	O	O	O
MMR	O	O	B-T045
incompatible	O	O	O
genotypes	O	O	B-T032
in	O	O	O
the	O	O	O
offspring	O	O	B-T099
,	O	O	O
are	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
an	O	O	O
elevated	O	O	B-T080
mutation	O	O	B-T080
rate	O	O	I-T080
rapidly	O	O	O
but	O	O	O
transiently	O	O	O
facilitating	O	O	O
adaptation	O	O	B-T038
.	O	O	O

To	O	O	O
avoid	O	O	O
long-term	O	O	B-T079
fitness	O	O	B-T045
costs	O	O	B-T081
,	O	O	O
the	O	O	O
incompatibility	O	O	B-T054
is	O	O	O
apparently	O	O	O
buffered	O	O	B-T121
by	O	O	O
mating	O	O	B-T040
or	O	O	O
by	O	O	O
acquiring	O	O	O
suppressors	O	O	B-T049
.	O	O	O

These	O	O	O
observations	O	O	B-T062
highlight	O	O	O
effective	O	O	B-T080
strategies	O	O	O
in	O	O	O
eukaryotes	O	O	B-T204
to	O	O	O
avoid	O	O	O
long-term	O	O	B-T079
fitness	O	O	B-T045
costs	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
elevated	O	O	B-T080
mutation	O	O	B-T080
rates	O	O	I-T080
.	O	O	O

-DOCSTART- (28203094)

Mapping	O	O	B-T052
circulating	O	O	B-T169
serum	O	O	B-T031
miRNAs	O	O	B-T114
to	O	O	O
their	O	O	O
immune	O	O	B-T169
-	O	O	O
related	O	O	B-T080
target	O	O	B-T169
mRNAs	O	O	O

Evidence	O	O	B-T078
suggests	O	O	B-T078
that	O	O	O
circulating	O	O	B-T169
serum	O	O	B-T031
microRNAs	O	O	B-T114
(	O	O	O
miRNAs	O	O	B-T114
)	O	O	O
might	O	O	O
preferentially	O	O	O
target	O	O	B-T169
immune	O	O	B-T169
-	O	O	O
related	O	O	B-T080
mRNAs	O	O	B-T114
.	O	O	O

If	O	O	O
this	O	O	O
were	O	O	O
the	O	O	O
case	O	O	O
,	O	O	O
we	O	O	O
hypothesized	O	O	O
that	O	O	O
immune	O	O	B-T169
-	O	O	O
related	O	O	B-T080
mRNAs	O	O	B-T114
would	O	O	O
have	O	O	O
more	O	O	O
predicted	O	O	B-T078
serum	O	O	B-T031
miRNA	O	O	B-T045
binding	O	O	I-T045
sites	O	O	B-T082
than	O	O	O
other	O	O	O
mRNAs	O	O	O
and	O	O	O
,	O	O	O
reciprocally	O	O	B-T080
,	O	O	O
that	O	O	O
serum	O	O	O
miRNAs	O	O	B-T114
would	O	O	O
have	O	O	O
more	O	O	O
immune	O	O	O
-	O	O	O
related	O	O	O
mRNA	O	O	B-T114
targets	O	O	B-T169
than	O	O	O
non	O	O	B-T169
-	O	O	O
serum	O	O	O
miRNAs	O	O	O
.	O	O	O

We	O	O	O
developed	O	O	B-T169
a	O	O	O
consensus	O	O	O
target	O	O	B-T169
predictor	O	O	O
using	O	O	O
the	O	O	O
random	O	O	B-T169
forest	O	O	I-T169
framework	O	O	I-T169
and	O	O	O
calculated	O	O	B-T169
the	O	O	O
number	O	O	O
of	O	O	O
predicted	O	O	B-T078
miRNA	O	O	B-T114
-	O	O	O
mRNA	O	O	B-T114
interactions	O	O	B-T045
in	O	O	O
various	O	O	O
subsets	O	O	B-T185
of	O	O	O
miRNAs	O	O	B-T114
(	O	O	O
serum	O	O	B-T031
,	O	O	O
non	O	O	B-T169
-	O	O	O
serum	O	O	O
)	O	O	O
and	O	O	O
mRNAs	O	O	B-T114
(	O	O	O
immune	O	O	B-T169
related	O	O	B-T080
,	O	O	O
nonimmune	O	O	B-T080
related	O	O	I-T080
)	O	O	O
.	O	O	O

Immune	O	O	B-T169
-	O	O	O
related	O	O	B-T080
mRNAs	O	O	B-T114
were	O	O	O
predicted	O	O	B-T078
to	O	O	O
be	O	O	O
targeted	O	O	B-T169
by	O	O	O
serum	O	O	B-T031
miRNA	O	O	B-T114
more	O	O	O
than	O	O	O
other	O	O	O
mRNAs	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
serum	O	O	B-T031
miRNAs	O	O	B-T114
were	O	O	O
predicted	O	O	B-T078
to	O	O	O
target	O	O	B-T169
many	O	O	O
more	O	O	O
immune	O	O	B-T169
-	O	O	O
related	O	O	B-T080
mRNA	O	O	B-T114
targets	O	O	B-T169
than	O	O	O
non	O	O	B-T169
-	O	O	O
serum	O	O	O
miRNAs	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
these	O	O	O
two	O	O	O
biases	O	O	B-T078
in	O	O	O
immune	O	O	O
-	O	O	O
related	O	O	O
mRNAs	O	O	B-T114
and	O	O	O
serum	O	O	O
miRNAs	O	O	O
appear	O	O	O
to	O	O	O
be	O	O	O
completely	O	O	B-T080
independent	O	O	B-T078
.	O	O	O

Immune	O	O	B-T169
-	O	O	O
related	O	O	B-T080
mRNAs	O	O	B-T114
have	O	O	O
more	O	O	O
miRNA	O	O	B-T045
binding	O	O	I-T045
sites	O	O	B-T082
in	O	O	O
general	O	O	O
,	O	O	O
not	O	O	O
just	O	O	O
for	O	O	O
serum	O	O	B-T031
miRNAs	O	O	B-T114
;	O	O	O
likewise	O	O	O
,	O	O	O
serum	O	O	O
miRNAs	O	O	O
target	O	O	B-T169
many	O	O	O
more	O	O	O
mRNAs	O	O	O
than	O	O	O
non	O	O	B-T169
-	O	O	O
serum	O	O	O
miRNAs	O	O	O
overall	O	O	O
,	O	O	O
regardless	O	O	B-T080
of	O	O	O
whether	O	O	O
they	O	O	O
are	O	O	O
immune	O	O	B-T169
related	O	O	O
or	O	O	O
not	O	O	O
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
these	O	O	O
two	O	O	O
independent	O	O	B-T078
phenomena	O	O	B-T067
result	O	O	B-T169
in	O	O	O
a	O	O	O
significantly	O	O	O
larger	O	O	O
number	O	O	O
of	O	O	O
predicted	O	O	B-T078
serum	O	O	B-T031
miRNA	O	O	B-T114
-	O	O	O
immune	O	O	B-T169
mRNA	O	O	B-T114
interactions	O	O	B-T045
than	O	O	O
would	O	O	O
be	O	O	O
expected	O	O	O
by	O	O	O
chance	O	O	O
.	O	O	O

-DOCSTART- (28205317)

Oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
immunosenescence	O	O	B-T039
in	O	O	O
spleen	O	O	B-T023
of	O	O	O
obese	O	O	B-T015
mice	O	O	I-T015
can	O	O	O
be	O	O	O
reversed	O	O	O
by	O	O	O
2-hydroxyoleic	O	O	O
acid	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
obesity	O	O	B-T047
on	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
leukocyte	O	O	B-T025
function	O	O	B-T043
in	O	O	O
spleen	O	O	B-T023
of	O	O	O
mice	O	O	B-T015
,	O	O	O
and	O	O	O
to	O	O	O
assess	O	O	O
whether	O	O	O
supplementation	O	O	B-T061
with	O	O	O
2-hydroxyoleic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
2-OHOA	O	O	B-T109
)	O	O	O
or	O	O	O
n-3	O	O	B-T109
polyunsaturated	O	O	I-T109
fatty	O	O	I-T109
acids	O	O	I-T109
(	O	O	O
PUFA	O	O	B-T109
)	O	O	O
could	O	O	O
reverse	O	O	O
those	O	O	O
effects	O	O	O
.	O	O	O

Female	O	O	B-T032
ICR/CD1	O	O	B-T015
mice	O	O	I-T015
(	O	O	O
8	O	O	O
weeks	O	O	B-T079
old	O	O	O
,	O	O	O
n	O	O	O
=	O	O	O
24	O	O	O
)	O	O	O
received	O	O	O
an	O	O	O
obesogenic	O	O	B-T168
diet	O	O	I-T168
(	O	O	O
22	O	O	O
%	O	O	O
fat	O	O	B-T109
for	O	O	O
4	O	O	O
weeks	O	O	O
and	O	O	O
60	O	O	O
%	O	O	O
fat	O	O	O
for	O	O	O
14	O	O	O
weeks	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
6	O	O	O
weeks	O	O	B-T079
,	O	O	O
mice	O	O	B-T015
were	O	O	O
split	O	O	O
in	O	O	O
three	O	O	O
groups	O	O	B-UnknownType
(	O	O	O
n	O	O	O
=	O	O	O
8/	O	O	O
group	O	O	B-UnknownType
):	O	O	O
no	O	O	B-UnknownType
supplementation	O	O	I-UnknownType
,	O	O	O
2-OHOA	O	O	B-UnknownType
supplementation	O	O	I-UnknownType
(	O	O	O
1500	O	O	O
mg	O	O	O
kg(-1	O	O	O
)	O	O	O
)	O	O	O
and	O	O	O
n-3	O	O	B-UnknownType
PUFA	O	O	I-UnknownType
supplementation	O	O	I-UnknownType
(	O	O	O
EPA	O	O	B-T109
+	O	O	O
DHA	O	O	B-T109
,	O	O	O
3000	O	O	O
mg	O	O	O
kg(-1	O	O	O
)	O	O	O
diet	O	O	O
)	O	O	O
.	O	O	O

Eight	O	O	O
mice	O	O	B-T015
were	O	O	O
fed	O	O	O
standard	O	O	O
diet	O	O	B-T168
for	O	O	O
the	O	O	O
whole	O	O	O
duration	O	O	B-T079
of	O	O	O
the	O	O	O
study	O	O	B-T062
(	O	O	O
control	O	O	B-T096
group	O	O	I-T096
)	O	O	O
.	O	O	O

At	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
experiment	O	O	B-T062
,	O	O	O
the	O	O	O
following	O	O	O
variables	O	O	B-T080
were	O	O	O
assessed	O	O	B-T052
in	O	O	O
spleens	O	O	B-T023
:	O	O	O
levels	O	O	B-T080
of	O	O	O
reduced	O	O	B-T116
(	O	O	O
GSH	O	O	B-T116
)	O	O	O
and	O	O	O
oxidized	O	O	B-T116
(	O	O	I-T116
GSSG	O	O	B-T116
)	O	O	I-T116
glutathione	O	O	I-T116
,	O	O	O
GSH	O	O	O
/	O	O	O
GSSG	O	O	O
,	O	O	O
xanthine	O	O	B-T044
oxidase	O	O	I-T044
(	O	O	I-T044
XO	O	O	I-T044
)	O	O	I-T044
activity	O	O	I-T044
,	O	O	O
lipid	O	O	B-T044
peroxidation	O	O	I-T044
,	O	O	O
lymphocyte	O	O	B-T043
chemotaxis	O	O	I-T043
,	O	O	O
natural	O	O	B-T043
killer	O	O	I-T043
(	O	O	I-T043
NK	O	O	I-T043
)	O	O	I-T043
activity	O	O	I-T043
and	O	O	O
mitogen	O	O	B-T121
(	O	O	O
ConA	O	O	B-T116
and	O	O	O
LPS)-induced	O	O	O
lymphocyte	O	O	B-T043
proliferation	O	O	I-T043
.	O	O	O

Obese	O	O	B-T032
animals	O	O	B-T008
presented	O	O	O
higher	O	O	B-T080
GSSG	O	O	B-T116
levels	O	O	B-T080
(	O	O	O
P	O	O	O
=	O	O	O
0.003	O	O	O
)	O	O	O
,	O	O	O
GSSG	O	O	O
/	O	O	O
GSH	O	O	B-T116
ratio	O	O	B-T081
(	O	O	O
P	O	O	O
=	O	O	O
0.013	O	O	O
)	O	O	O
,	O	O	O
lipid	O	O	B-T044
peroxidation	O	O	I-T044
(	O	O	O
P	O	O	O
=	O	O	O
0.004	O	O	O
)	O	O	O
,	O	O	O
XO	O	O	B-T044
activity	O	O	I-T044
(	O	O	O
P	O	O	O
=	O	O	O
0.015	O	O	O
)	O	O	O
and	O	O	O
lymphocyte	O	O	B-T043
chemotaxis	O	O	I-T043
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
lower	O	O	O
NK	O	O	B-T043
activity	O	O	I-T043
(	O	O	O
P	O	O	O
=	O	O	O
0.003	O	O	O
)	O	O	O
and	O	O	O
proliferation	O	O	B-T169
in	O	O	O
response	O	O	O
to	O	O	O
ConA	O	O	B-T116
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
than	O	O	O
controls	O	O	B-T096
.	O	O	O

2-OHOA	O	O	B-T109
reversed	O	O	O
totally	O	O	O
or	O	O	O
partially	O	O	O
most	O	O	O
of	O	O	O
the	O	O	O
changes	O	O	B-T081
(	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
,	O	O	O
fat	O	O	O
content	O	O	O
,	O	O	O
GSSG	O	O	B-T116
levels	O	O	B-T080
,	O	O	O
GSH	O	O	B-T116
/	O	O	O
GSSG	O	O	O
,	O	O	O
lipid	O	O	B-T044
peroxidation	O	O	I-T044
,	O	O	O
chemotaxis	O	O	B-T043
and	O	O	O
proliferation	O	O	B-T043
,	O	O	O
all	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
n-3	O	O	B-T109
PUFA	O	O	I-T109
reversed	O	O	O
the	O	O	O
increase	O	O	B-T169
in	O	O	O
XO	O	O	B-T044
activity	O	O	I-T044
(	O	O	O
P	O	O	O
=	O	O	O
0.032	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
2-OHOA	O	O	B-T109
,	O	O	O
and	O	O	O
to	O	O	O
a	O	O	O
lesser	O	O	O
extent	O	O	O
n-3	O	O	B-T109
PUFA	O	O	I-T109
,	O	O	O
could	O	O	O
ameliorate	O	O	O
the	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
alteration	O	O	B-T078
of	O	O	O
leukocyte	O	O	B-T025
function	O	O	B-T043
in	O	O	O
spleen	O	O	B-T023
of	O	O	O
obese	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
support	O	O	O
a	O	O	O
link	O	O	O
between	O	O	O
obesity	O	O	B-T047
and	O	O	O
immunosenescence	O	O	B-T039
and	O	O	O
suggest	O	O	O
a	O	O	O
potential	O	O	O
therapeutic	O	O	B-T169
tool	O	O	I-T169
for	O	O	O
obesity	O	O	O
-related	O	O	O
immune	O	O	B-T047
dysfunction	O	O	I-T047
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
protected	O	O	O
by	O	O	O
copyright	O	O	O
.	O	O	O

All	O	O	O
rights	O	O	O
reserved	O	O	O
.	O	O	O

-DOCSTART- (28207180)

Assembly	O	O	B-T043
of	O	O	I-T043
the	O	O	I-T043
outermost	O	O	I-T043
spore	O	O	I-T043
layer	O	O	I-T043
:	O	O	O
pieces	O	O	O
of	O	O	O
the	O	O	O
puzzle	O	O	O
are	O	O	O
coming	O	O	O
together	O	O	O

Certain	O	O	O
endospore-forming	O	O	B-T007
soil	O	O	I-T007
dwelling	O	O	I-T007
bacteria	O	O	I-T007
are	O	O	O
important	O	O	O
human	O	O	B-T016
,	O	O	O
animal	O	O	B-T008
or	O	O	O
insect	O	O	B-T204
pathogens	O	O	B-T001
.	O	O	O

These	O	O	O
organisms	O	O	B-T001
produce	O	O	O
spores	O	O	B-T001
containing	O	O	O
an	O	O	O
outer	O	O	B-T026
layer	O	O	I-T026
,	O	O	O
the	O	O	O
exosporium	O	O	B-T026
.	O	O	O

The	O	O	O
exosporium	O	O	B-T026
is	O	O	O
the	O	O	O
site	O	O	B-T080
of	O	O	I-T080
interactions	O	O	B-T169
between	O	O	O
the	O	O	O
spore	O	O	B-T001
and	O	O	O
the	O	O	O
soil	O	O	B-T167
environment	O	O	B-T082
and	O	O	O
between	O	O	O
the	O	O	O
spore	O	O	O
and	O	O	O
the	O	O	O
infected	O	O	B-T033
host	O	O	B-T001
during	O	O	O
the	O	O	O
initial	O	O	B-T079
stages	O	O	B-T079
of	O	O	O
infection	O	O	B-T046
.	O	O	O

The	O	O	O
composition	O	O	B-T201
and	O	O	O
assembly	O	O	B-T043
process	O	O	I-T043
of	O	O	I-T043
the	O	O	I-T043
exosporium	O	O	I-T043
are	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
partly	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
extreme	O	O	O
stability	O	O	B-T080
of	O	O	O
the	O	O	O
exosporium	O	O	B-T026
that	O	O	O
has	O	O	O
proven	O	O	O
to	O	O	O
be	O	O	O
refractive	O	O	O
to	O	O	O
existing	O	O	O
methods	O	O	B-T169
to	O	O	O
deconstruct	O	O	O
the	O	O	O
intact	O	O	B-T080
structure	O	O	B-T082
into	O	O	O
its	O	O	O
component	O	O	B-T077
parts	O	O	B-T082
.	O	O	O

Although	O	O	O
more	O	O	O
than	O	O	O
20	O	O	O
proteins	O	O	B-T116
have	O	O	O
been	O	O	O
identified	O	O	B-T080
as	O	O	O
exosporium	O	O	B-T026
-	O	O	O
associated	O	O	B-T080
,	O	O	O
their	O	O	O
abundance	O	O	B-T080
,	O	O	O
relationship	O	O	B-T080
to	O	O	O
other	O	O	O
proteins	O	O	O
and	O	O	O
the	O	O	O
processes	O	O	B-T067
by	O	O	O
which	O	O	O
they	O	O	O
are	O	O	O
assembled	O	O	B-T043
to	O	O	I-T043
create	O	O	I-T043
the	O	O	I-T043
exosporium	O	O	I-T043
are	O	O	O
largely	O	O	O
unknown	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
issue	O	O	O
of	O	O	O
Molecular	O	O	B-T091
Microbiology	O	O	I-T091
,	O	O	O
Terry	O	O	O
,	O	O	O
Jiang	O	O	O
,	O	O	O
and	O	O	O
colleagues	O	O	O
in	O	O	O
Per	O	O	O
Bullough	O	O	O
's	O	O	O
laboratory	O	O	B-T093
show	O	O	O
that	O	O	O
the	O	O	O
ExsY	O	O	B-T116
protein	O	O	I-T116
is	O	O	O
a	O	O	O
major	O	O	O
structural	O	O	B-T082
protein	O	O	I-T116
of	O	O	O
the	O	O	O
exosporium	O	O	B-T026
basal	O	O	I-T026
layer	O	O	I-T026
of	O	O	O
B.	O	O	B-T007
cereus	O	O	I-T007
family	O	O	I-T007
spores	O	O	B-T001
and	O	O	O
that	O	O	O
it	O	O	O
can	O	O	O
self-assemble	O	O	B-T052
into	O	O	O
complex	O	O	B-T080
structures	O	O	B-T082
that	O	O	O
possess	O	O	O
many	O	O	O
of	O	O	O
the	O	O	O
structural	O	O	O
features	O	O	B-T080
characteristic	O	O	B-T080
of	O	O	O
the	O	O	O
exosporium	O	O	O
basal	O	O	O
layer	O	O	O
.	O	O	O

The	O	O	O
authors	O	O	B-T097
refined	O	O	O
a	O	O	O
model	O	O	B-T170
for	O	O	O
exosporium	O	O	B-T043
assembly	O	O	I-T043
.	O	O	O

Their	O	O	O
findings	O	O	B-T033
may	O	O	O
have	O	O	O
implications	O	O	O
for	O	O	O
exosporium	O	O	B-T026
formation	O	O	B-T169
in	O	O	O
other	O	O	O
spore	O	O	B-T007
forming	O	O	I-T007
bacteria	O	O	I-T007
,	O	O	O
including	O	O	O
Clostridium	O	O	B-T007
species	O	O	I-T007
.	O	O	O

-DOCSTART- (28207880)

Skeletal	O	O	B-T024
muscle	O	O	I-T024
metabolic	O	O	O
adaptations	O	O	B-T038
to	O	O	O
endurance	O	O	B-T079
exercise	O	O	B-T056
training	O	O	I-T056
are	O	O	O
attainable	O	O	B-T052
in	O	O	O
mice	O	O	B-T015
with	O	O	O
simvastatin	O	O	B-T109
treatment	O	O	O

We	O	O	O
tested	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
a	O	O	O
6-week	O	O	O
regimen	O	O	B-T061
of	O	O	O
simvastatin	O	O	B-T109
would	O	O	O
attenuate	O	O	B-T052
skeletal	O	O	B-T024
muscle	O	O	I-T024
adaptation	O	O	B-T038
to	O	O	O
low-intensity	O	O	B-T056
exercise	O	O	I-T056
.	O	O	O

Male	O	O	B-T032
C57BL/6J	O	O	B-T015
wildtype	O	O	I-T015
mice	O	O	I-T015
were	O	O	O
subjected	O	O	O
to	O	O	O
6-weeks	O	O	O
of	O	O	O
voluntary	O	O	B-T056
wheel	O	O	I-T056
running	O	O	I-T056
or	O	O	O
normal	O	O	O
cage	O	O	B-T073
activities	O	O	B-T052
with	O	O	O
or	O	O	O
without	O	O	O
simvastatin	O	O	B-T109
treatment	O	O	B-T061
(	O	O	O
20	O	O	O
mg/kg/d	O	O	O
,	O	O	O
n	O	O	O
=	O	O	O
7	O	O	O
-	O	O	O
8	O	O	O
per	O	O	O
group	O	O	O
)	O	O	O
.	O	O	O

Adaptations	O	O	B-T038
in	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
fatigue	O	O	B-T184
resistance	O	O	B-T169
were	O	O	O
determined	O	O	O
by	O	O	O
a	O	O	O
treadmill	O	O	B-T060
running	O	O	I-T060
test	O	O	I-T060
,	O	O	O
and	O	O	O
by	O	O	O
ankle	O	O	B-T023
plantarflexor	O	O	I-T023
contractile	O	O	B-T039
assessment	O	O	O
.	O	O	O

The	O	O	O
tibialis	O	O	B-T023
anterior	O	O	I-T023
,	O	O	O
gastrocnemius	O	O	B-T023
,	O	O	O
and	O	O	O
plantaris	O	O	B-T023
muscles	O	O	I-T023
were	O	O	O
evaluated	O	O	B-T058
for	O	O	O
exercised	O	O	B-T056
-induced	O	O	O
mitochondrial	O	O	B-T026
adaptations	O	O	B-T038
(	O	O	O
i.e.	O	O	O
,	O	O	O
biogenesis	O	O	B-T070
,	O	O	O
function	O	O	B-T169
,	O	O	O
autophagy	O	O	B-T043
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
difference	O	O	I-T033
in	O	O	O
weekly	O	O	O
wheel	O	O	B-T052
running	O	O	I-T052
distance	O	O	I-T052
between	O	O	O
control	O	O	O
and	O	O	O
simvastatin	O	O	B-T109
-	O	O	O
treated	O	O	B-T169
mice	O	O	B-T015
(	O	O	O
P	O	O	O
=	O	O	O
0.51	O	O	O
)	O	O	O
.	O	O	O

Trained	O	O	B-T065
mice	O	O	B-T015
had	O	O	O
greater	O	O	O
treadmill	O	O	B-T056
running	O	O	I-T056
distance	O	O	B-T081
(	O	O	O
296	O	O	O
%	O	O	O
,	O	O	O
P<0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
ankle	O	O	B-T023
plantarflexor	O	O	I-T023
contractile	O	O	B-T039
fatigue	O	O	B-T184
resistance	O	O	B-T169
(	O	O	O
9	O	O	O
%	O	O	O
,	O	O	O
P<0.05	O	O	O
)	O	O	O
compared	O	O	O
to	O	O	O
sedentary	O	O	O
mice	O	O	O
,	O	O	O
independent	O	O	O
of	O	O	O
simvastatin	O	O	B-T109
treatment	O	O	B-T061
.	O	O	O

At	O	O	O
the	O	O	O
cellular	O	O	B-T025
level	O	O	I-T025
,	O	O	O
trained	O	O	B-T065
mice	O	O	B-T015
had	O	O	O
greater	O	O	O
mitochondrial	O	O	B-T026
biogenesis	O	O	I-T043
(	O	O	O
e.g.	O	O	O
,	O	O	O
~2-fold	O	O	O
greater	O	O	O
PGC1α	O	O	B-T116
expression	O	O	B-T045
,	O	O	O
P<0.05	O	O	O
)	O	O	O
and	O	O	O
mitochondrial	O	O	O
content	O	O	O
(	O	O	O
e.g.	O	O	O
,	O	O	O
25	O	O	O
%	O	O	O
greater	O	O	O
citrate	O	O	B-T116
synthase	O	O	I-T116
activity	O	O	B-T044
,	O	O	O
P<0.05	O	O	O
)	O	O	O
,	O	O	O
independent	O	O	O
of	O	O	O
simvastatin	O	O	B-T109
treatment	O	O	B-T061
.	O	O	O

Mitochondrial	O	O	B-T026
autophagy	O	O	B-T043
-related	O	O	O
protein	O	O	B-T116
contents	O	O	O
were	O	O	O
greater	O	O	O
in	O	O	O
trained	O	O	B-T065
mice	O	O	B-T015
(	O	O	O
e.g.	O	O	O
,	O	O	O
40	O	O	O
%	O	O	O
greater	O	O	O
Bnip3	O	O	B-T116
,	O	O	O
P<0.05	O	O	O
)	O	O	O
,	O	O	O
independent	O	O	O
of	O	O	O
simvastatin	O	O	B-T109
treatment	O	O	B-T061
.	O	O	O

However	O	O	O
,	O	O	O
Drp1	O	O	B-T116
,	O	O	O
a	O	O	O
marker	O	O	B-T201
of	O	O	O
mitochondrial	O	O	B-T043
fission	O	O	I-T043
,	O	O	O
was	O	O	O
less	O	O	O
in	O	O	O
simvastatin	O	O	B-T109
treated	O	O	B-T169
mice	O	O	B-T015
,	O	O	O
independent	O	O	O
of	O	O	O
exercise	O	O	B-T056
training	O	O	B-T065
,	O	O	O
and	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	O
interaction	O	O	B-T169
between	O	O	O
training	O	O	O
and	O	O	O
statin	O	O	O
treatment	O	O	B-T061
(	O	O	O
P<0.022	O	O	O
)	O	O	O
for	O	O	O
LC3-II	O	O	B-T116
protein	O	O	I-T116
content	O	O	B-T081
,	O	O	O
a	O	O	O
marker	O	O	O
of	O	O	O
autophagy	O	O	B-T043
flux	O	O	O
.	O	O	O

These	O	O	O
data	O	O	O
indicate	O	O	O
that	O	O	O
whole	O	O	B-T017
body	O	O	I-T017
and	O	O	O
skeletal	O	O	B-T024
muscle	O	O	B-T024
adaptations	O	O	B-T038
to	O	O	O
endurance	O	O	B-T079
exercise	O	O	B-T056
training	O	O	I-T056
are	O	O	O
attainable	O	O	B-T052
with	O	O	O
simvastatin	O	O	B-T109
treatment	O	O	B-T061
,	O	O	O
but	O	O	O
simvastatin	O	O	O
may	O	O	O
have	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
on	O	O	O
muscle	O	O	O
mitochondrial	O	O	B-T026
maintenance	O	O	O
via	O	O	O
autophagy	O	O	B-T043
,	O	O	O
which	O	O	O
could	O	O	O
have	O	O	O
long-term	O	O	B-T079
implications	O	O	O
on	O	O	O
muscle	O	O	O
health	O	O	B-T078
.	O	O	O

-DOCSTART- (28210010)

Evaluation	O	O	B-T058
and	O	O	O
Treatment	O	O	B-T169
of	O	O	O
Anemia	O	O	B-T047
in	O	O	O
Premature	O	O	O
Infants	O	O	O

Anemia	O	O	B-T047
in	O	O	O
preterm	O	O	B-T100
infants	O	O	B-T100
is	O	O	O
the	O	O	O
pathophysiological	O	O	B-T169
process	O	O	B-T067
with	O	O	O
greater	O	O	O
and	O	O	O
more	O	O	O
rapid	O	O	O
decline	O	O	B-T081
in	O	O	O
hemoglobin	O	O	B-T116
compared	O	O	B-T052
to	O	O	O
the	O	O	O
physiological	O	O	B-T169
anemia	O	O	B-T047
in	O	O	O
infants	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
transfusions	O	O	B-T061
and	O	O	O
administration	O	O	B-T061
of	O	O	O
human	O	O	B-T116
recombinant	O	O	I-T116
erythropoietin	O	O	I-T116
.	O	O	O

To	O	O	O
determine	O	O	B-T078
the	O	O	O
frequency	O	O	B-T079
of	O	O	O
anemia	O	O	B-T047
in	O	O	O
premature	O	O	B-T047
infants	O	O	I-T047
at	O	O	O
the	O	O	O
Pediatric	O	O	B-T093
Clinic	O	O	I-T093
,	O	O	I-T093
University	O	O	I-T093
Clinical	O	O	I-T093
Center	O	O	I-T093
Sarajevo	O	O	I-T093
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
parameter	O	O	B-T077
values	O	O	I-T077
in	O	O	O
the	O	O	O
blood	O	O	B-T059
count	O	O	I-T059
of	O	O	O
premature	O	O	O
infants	O	O	O
and	O	O	O
to	O	O	O
explore	O	O	O
a	O	O	O
relationship	O	O	B-T080
between	O	O	O
blood	O	O	B-T061
transfusions	O	O	I-T061
with	O	O	O
the	O	O	O
advent	O	O	O
of	O	O	O
intraventricular	O	O	B-T046
hemorrhage	O	O	I-T046
(	O	O	O
determine	O	O	O
treatment	O	O	B-T169
outcome	O	O	O
in	O	O	O
preterm	O	O	B-T100
infants	O	O	I-T100
)	O	O	O
.	O	O	O

Research	O	O	B-T062
is	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
and	O	O	O
it	O	O	O
included	O	O	O
the	O	O	O
period	O	O	B-T079
of	O	O	O
six	O	O	O
months	O	O	B-T079
in	O	O	O
year	O	O	B-T079
2014	O	O	O
.	O	O	O

Research	O	O	B-T062
included	O	O	O
100	O	O	O
patients	O	O	B-T101
,	O	O	O
gestational	O	O	B-T032
age	O	O	I-T032
<	O	O	O
37	O	O	O
weeks	O	O	B-T079
(	O	O	O
premature	O	O	B-T047
infants	O	O	I-T047
)	O	O	O
.	O	O	O

Data	O	O	B-T078
were	O	O	O
collected	O	O	B-T078
by	O	O	O
examining	O	O	B-T033
the	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
of	O	O	O
patients	O	O	B-T101
at	O	O	O
the	O	O	O
Pediatric	O	O	B-T093
Clinic	O	O	I-T093
,	O	O	I-T093
UCCS	O	O	I-T093
.	O	O	O

The	O	O	O
first	O	O	B-T081
group	O	O	B-T078
of	O	O	O
patients	O	O	B-T101
were	O	O	O
premature	O	O	B-T047
infants	O	O	I-T047
of	O	O	O
gestational	O	O	B-T032
age	O	O	I-T032
≤	O	O	O
32	O	O	O
weeks	O	O	B-T079
(	O	O	O
62/100	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
second	O	O	B-T081
group	O	O	O
were	O	O	O
premature	O	O	O
infants	O	O	O
of	O	O	O
gestational	O	O	O
age	O	O	O
33	O	O	O
-	O	O	O
37	O	O	O
weeks	O	O	O
(	O	O	O
38/100	O	O	O
)	O	O	O
.	O	O	O

Among	O	O	O
the	O	O	O
patients	O	O	B-T101
,	O	O	O
5	O	O	O
%	O	O	O
were	O	O	O
boys	O	O	B-T100
and	O	O	O
46	O	O	O
%	O	O	O
girls	O	O	B-T100
.	O	O	O

There	O	O	O
was	O	O	O
significant	O	O	B-T081
difference	O	O	I-T081
in	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
APGAR	O	O	B-T032
score	O	O	I-T032
among	O	O	O
the	O	O	O
groups	O	O	B-T078
.	O	O	O

In	O	O	O
the	O	O	O
first	O	O	B-T081
group	O	O	B-T078
,	O	O	O
there	O	O	O
were	O	O	O
27.42	O	O	O
%	O	O	O
of	O	O	O
deaths	O	O	B-T033
,	O	O	O
while	O	O	O
in	O	O	O
the	O	O	O
second	O	O	B-T081
group	O	O	O
,	O	O	O
there	O	O	O
were	O	O	O
only	O	O	O
10.53	O	O	O
%	O	O	O
of	O	O	O
deaths	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	B-T081
difference	O	O	I-T081
in	O	O	O
the	O	O	O
length	O	O	O
of	O	O	O
treatment	O	O	B-T169
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
difference	O	O	B-T081
in	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
transfusion	O	O	B-T061
among	O	O	O
the	O	O	O
groups	O	O	B-T078
.	O	O	O

18	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
first	O	O	B-T081
group	O	O	B-T078
required	O	O	O
a	O	O	O
transfusion	O	O	B-T061
,	O	O	O
while	O	O	O
in	O	O	O
the	O	O	O
second	O	O	B-T081
group	O	O	O
only	O	O	O
3	O	O	O
patients	O	O	O
.	O	O	O

Preterm	O	O	B-T100
infants	O	O	I-T100
of	O	O	O
gestational	O	O	B-T032
age	O	O	I-T032
≤	O	O	O
32	O	O	O
weeks	O	O	B-T079
are	O	O	O
likely	O	O	O
candidates	O	O	B-T101
for	O	O	O
blood	O	O	B-T061
transfusion	O	O	I-T061
during	O	O	O
treatment	O	O	B-T169
.	O	O	O

Preterm	O	O	B-T100
infants	O	O	I-T100
of	O	O	O
gestational	O	O	B-T032
age	O	O	I-T032
≤	O	O	O
32	O	O	O
weeks	O	O	B-T079
have	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
intracranial	O	O	B-T047
bleeding	O	O	I-T047
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
application	O	O	B-T058
of	O	O	O
blood	O	O	B-T061
transfusion	O	O	I-T061
in	O	O	O
the	O	O	O
first	O	O	O
week	O	O	B-T079
of	O	O	O
life	O	O	B-T078
.	O	O	O

-DOCSTART- (28210659)

Medial	O	O	B-T023
Patellofemoral	O	O	I-T023
Ligament	O	O	I-T023
Reconstruction	O	O	B-T061
Femoral	O	O	B-T023
Tunnel	O	O	B-T082
Accuracy	O	O	B-T080
:	O	O	O
Relationship	O	O	O
to	O	O	O
Disease	O	O	B-T047
-	O	O	O
Specific	O	O	B-T080
Quality	O	O	O
of	O	O	O
Life	O	O	O

Medial	O	O	B-T023
patellofemoral	O	O	I-T023
ligament	O	O	I-T023
(	O	O	O
MPFL	O	O	B-T023
)	O	O	O
reconstruction	O	O	B-T061
is	O	O	O
a	O	O	O
procedure	O	O	O
aimed	O	O	O
to	O	O	O
reestablish	O	O	O
the	O	O	O
checkrein	O	O	O
to	O	O	O
lateral	O	O	B-T037
patellar	O	O	I-T037
translation	O	O	I-T037
in	O	O	O
patients	O	O	B-T101
with	O	O	O
symptomatic	O	O	B-T037
patellofemoral	O	O	I-T037
instability	O	O	I-T037
.	O	O	O

Correct	O	O	O
femoral	O	O	B-T023
tunnel	O	O	B-T082
position	O	O	B-T082
is	O	O	O
thought	O	O	O
to	O	O	O
be	O	O	O
crucial	O	O	O
to	O	O	O
successful	O	O	O
MPFL	O	O	B-T023
reconstruction	O	O	B-T061
,	O	O	O
but	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
this	O	O	O
statement	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
patient	O	O	B-T058
outcomes	O	O	I-T058
has	O	O	O
not	O	O	O
been	O	O	O
tested	O	O	O
.	O	O	O

To	O	O	O
assess	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
femoral	O	O	B-T023
tunnel	O	O	B-T082
placement	O	O	B-T058
in	O	O	O
an	O	O	O
MPFL	O	O	B-T023
reconstruction	O	O	B-T061
cohort	O	O	B-T098
and	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
correlation	O	O	B-T080
between	O	O	O
tunnel	O	O	O
accuracy	O	O	O
and	O	O	O
a	O	O	O
validated	O	O	B-T062
disease	O	O	B-T047
-	O	O	O
specific	O	O	B-T080
,	O	O	O
patient	O	O	B-T101
-reported	O	O	O
quality-of-life	O	O	B-T078
outcome	O	O	B-T081
measure	O	O	I-T081
.	O	O	O

Case	O	O	O
series	O	O	O
;	O	O	O
Level	O	O	O
of	O	O	O
evidence	O	O	O
,	O	O	O
4	O	O	O
.	O	O	O

Between	O	O	O
June	O	O	B-T079
2008	O	O	O
and	O	O	O
February	O	O	B-T080
2014	O	O	O
,	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
206	O	O	O
subjects	O	O	B-T098
underwent	O	O	O
an	O	O	O
MPFL	O	O	B-T023
reconstruction	O	O	B-T061
.	O	O	O

Lateral	O	O	B-T082
radiographs	O	O	B-T060
were	O	O	O
measured	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
the	O	O	O
femoral	O	O	B-T023
tunnel	O	O	B-T082
by	O	O	O
measuring	O	O	O
the	O	O	O
distance	O	O	O
from	O	O	O
the	O	O	O
center	O	O	O
of	O	O	O
the	O	O	O
femoral	O	O	O
tunnel	O	O	O
to	O	O	O
the	O	O	O
Schöttle	O	O	B-T082
point	O	O	I-T082
.	O	O	O

Banff	O	O	B-T081
Patella	O	O	I-T081
Instability	O	O	I-T081
Instrument	O	O	I-T081
(	O	O	I-T081
BPII	O	O	I-T081
)	O	O	I-T081
scores	O	O	I-T081
were	O	O	O
collected	O	O	O
a	O	O	O
mean	O	O	B-T081
24	O	O	O
months	O	O	B-T079
postoperatively	O	O	B-T079
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
155	O	O	O
(	O	O	O
79.5	O	O	O
%	O	O	O
)	O	O	O
subjects	O	O	O
had	O	O	O
adequate	O	O	O
postoperative	O	O	B-T079
lateral	O	O	B-T082
radiographs	O	O	B-T060
and	O	O	O
complete	O	O	O
BPII	O	O	B-T081
scores	O	O	I-T081
.	O	O	O

The	O	O	O
mean	O	O	B-T081
duration	O	O	B-T079
of	O	O	O
follow-up	O	O	B-T058
(	O	O	O
±	O	O	O
SD	O	O	B-T081
)	O	O	O
was	O	O	O
24.4	O	O	O
±	O	O	O
8.2	O	O	O
months	O	O	B-T079
(	O	O	O
range	O	O	O
,	O	O	O
12	O	O	O
-	O	O	O
74	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

Measurement	O	O	B-T169
from	O	O	O
the	O	O	O
center	O	O	B-T082
of	O	O	O
the	O	O	O
femoral	O	O	B-T023
tunnel	O	O	B-T082
to	O	O	O
the	O	O	O
Schöttle	O	O	B-T082
point	O	O	I-T082
resulted	O	O	O
in	O	O	O
143	O	O	O
(	O	O	O
92.3	O	O	O
%	O	O	O
)	O	O	O
tunnel	O	O	O
s	O	O	O
being	O	O	O
categorized	O	O	O
as	O	O	O
"	O	O	O
good	O	O	B-T080
"	O	O	O
or	O	O	O
"	O	O	O
ideal	O	O	B-T080
.	O	O	O
"	O	O	O
There	O	O	O
were	O	O	O
8	O	O	O
failures	O	O	B-T046
in	O	O	O
the	O	O	O
cohort	O	O	B-T098
,	O	O	O
none	O	O	O
of	O	O	O
which	O	O	O
occurred	O	O	O
in	O	O	O
malpositioned	O	O	B-T082
tunnels	O	O	B-T082
.	O	O	O

The	O	O	O
mean	O	O	B-T081
distance	O	O	O
from	O	O	O
the	O	O	O
center	O	O	B-T082
of	O	O	O
the	O	O	O
MPFL	O	O	B-T023
tunnel	O	O	B-T082
to	O	O	O
the	O	O	O
center	O	O	O
of	O	O	O
the	O	O	O
Schöttle	O	O	B-T082
point	O	O	I-T082
was	O	O	O
5.9	O	O	O
±	O	O	O
4.2	O	O	O
mm	O	O	O
(	O	O	O
range	O	O	O
,	O	O	O
0.5	O	O	O
-	O	O	O
25.9	O	O	O
mm	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
postoperative	O	O	B-T079
BPII	O	O	B-T081
score	O	O	I-T081
was	O	O	O
65.2	O	O	O
±	O	O	O
22.5	O	O	O
(	O	O	O
range	O	O	O
,	O	O	O
9.2	O	O	O
-	O	O	O
100	O	O	O
)	O	O	O
.	O	O	O

Pearson	O	O	B-T170
r	O	O	I-T170
correlation	O	O	I-T170
demonstrated	O	O	O
no	O	O	B-T033
statistically	O	O	I-T033
significant	O	O	I-T033
relationship	O	O	B-T080
between	O	O	O
accuracy	O	O	B-T080
of	O	O	O
femoral	O	O	B-T023
tunnel	O	O	B-T082
position	O	O	B-T082
and	O	O	O
BPII	O	O	B-T081
score	O	O	I-T081
(	O	O	O
r	O	O	O
=	O	O	O
-0.08	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
-0.24	O	O	O
to	O	O	O
0.08	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T080
evidence	O	O	I-T080
of	O	O	I-T080
a	O	O	O
correlation	O	O	B-T080
between	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
MPFL	O	O	B-T023
reconstruction	O	O	B-T061
femoral	O	O	B-T023
tunnel	O	O	B-T082
in	O	O	O
relation	O	O	O
to	O	O	O
the	O	O	O
Schöttle	O	O	B-T082
point	O	O	I-T082
and	O	O	O
disease	O	O	B-T047
-	O	O	O
specific	O	O	B-T080
quality-of-life	O	O	B-T080
scores	O	O	I-T080
.	O	O	O

Graft	O	O	B-T046
failure	O	O	I-T046
was	O	O	O
not	O	O	O
related	O	O	O
to	O	O	O
femoral	O	O	B-T023
tunnel	O	O	B-T082
placement	O	O	B-T058
.	O	O	O

The	O	O	O
patellofemoral	O	O	B-T037
instability	O	O	I-T037
population	O	O	O
is	O	O	O
complex	O	O	O
,	O	O	O
and	O	O	O
patients	O	O	B-T101
present	O	O	O
with	O	O	O
multiple	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
that	O	O	O
,	O	O	O
in	O	O	O
addition	O	O	O
to	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
femoral	O	O	O
tunnel	O	O	B-T082
position	O	O	B-T082
,	O	O	O
contribute	O	O	O
to	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
and	O	O	O
warrant	O	O	O
further	O	O	O
investigation	O	O	B-T058
.	O	O	O

-DOCSTART- (28210819)

Evidence	O	O	O
for	O	O	O
instructions	O	O	B-T065
-based	O	O	O
updating	O	O	O
of	O	O	O
task-set	O	O	B-T061
representations	O	O	I-T061
:	O	O	O
the	O	O	O
informed	O	O	B-T080
fadeout	O	O	O
effect	O	O	O

The	O	O	O
cognitive	O	O	B-T041
system	O	O	I-T041
can	O	O	O
be	O	O	O
updated	O	O	O
rapidly	O	O	O
and	O	O	O
efficiently	O	O	O
to	O	O	O
maximize	O	O	O
performance	O	O	B-T061
in	O	O	O
cognitive	O	O	B-T041
tasks	O	O	I-T041
.	O	O	O

This	O	O	O
paper	O	O	O
used	O	O	O
a	O	O	O
task	O	O	B-T057
-	O	O	O
switching	O	O	B-T169
task	O	O	O
to	O	O	O
explore	O	O	O
updating	O	O	O
at	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
the	O	O	O
plausible	O	O	O
task	O	O	O
-sets	O	O	O
held	O	O	O
for	O	O	O
future	O	O	O
performance	O	O	B-T061
.	O	O	O

Previous	O	O	O
research	O	O	B-T062
suggested	O	O	O
a	O	O	O
"	O	O	O
fadeout	O	O	B-T041
effect	O	O	I-T041
"	O	O	O
,	O	O	O
performance	O	O	B-T061
improvement	O	O	B-T061
when	O	O	O
moving	O	O	O
from	O	O	O
task	O	O	B-T057
-	O	O	O
switching	O	O	B-T169
context	O	O	O
to	O	O	O
single-task	O	O	B-T169
context	O	O	O
,	O	O	O
yet	O	O	O
this	O	O	O
effect	O	O	O
could	O	O	O
reflect	O	O	O
passive	O	O	B-T080
learning	O	O	B-T041
rather	O	O	O
than	O	O	O
intentional	O	O	B-T080
control	O	O	B-T080
.	O	O	O

In	O	O	O
a	O	O	O
novel	O	O	O
"	O	O	O
informed	O	O	B-T080
fadeout	O	O	B-T078
paradigm	O	O	B-T062
"	O	O	O
,	O	O	O
one	O	O	O
of	O	O	O
two	O	O	O
tasks	O	O	B-T057
was	O	O	O
canceled	O	O	O
for	O	O	O
a	O	O	O
certain	O	O	O
number	O	O	O
of	O	O	O
trials	O	O	B-T062
and	O	O	O
participants	O	O	B-T098
were	O	O	O
informed	O	O	O
or	O	O	O
uninformed	O	O	B-T033
regarding	O	O	O
task	O	O	B-T057
cancelation	O	O	B-T080
.	O	O	O

The	O	O	O
"	O	O	O
informed	O	O	B-T080
fadeout	O	O	B-T041
effect	O	O	I-T041
"	O	O	O
indicates	O	O	O
better	O	O	O
performance	O	O	B-T061
in	O	O	O
the	O	O	O
informed	O	O	O
than	O	O	O
uninformed	O	O	B-T033
fadeout	O	O	O
after	O	O	O
one	O	O	O
informed	O	O	O
trial	O	O	B-T062
had	O	O	O
been	O	O	O
executed	O	O	B-T052
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
results	O	O	O
regarding	O	O	O
the	O	O	O
first	O	O	O
trial	O	O	B-T062
were	O	O	O
inconclusive	O	O	O
.	O	O	O

Possible	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
are	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (28217198)

Metacarpophalangeal	O	O	B-T061
Joint	O	O	I-T061
Arthrodesis	O	O	I-T061
of	O	O	O
the	O	O	O
Thumb	O	O	B-T023
-	O	O	O
Minimum	O	O	O
of	O	O	O
Eight	O	O	O
Months	O	O	B-T079
Follow-up	O	O	O

Disorders	O	O	B-T047
of	O	O	O
the	O	O	O
thumb	O	O	B-T030
metacarpophalangeal	O	O	I-T030
(	O	O	I-T030
MCP	O	O	I-T030
)	O	O	I-T030
joint	O	O	I-T030
can	O	O	O
lead	O	O	O
to	O	O	O
significant	O	O	O
loss	O	O	B-T081
of	O	O	O
function	O	O	B-T039
and	O	O	O
pain	O	O	B-T184
.	O	O	O

Thumb	O	O	B-T030
MCP	O	O	I-T030
arthrodesis	O	O	B-T061
following	O	O	O
traumatic	O	O	B-T037
injuries	O	O	I-T037
is	O	O	O
inadequately	O	O	O
described	O	O	B-T078
and	O	O	O
recent	O	O	O
studies	O	O	B-T062
have	O	O	O
questioned	O	O	O
the	O	O	O
outcome	O	O	B-T169
of	O	O	O
this	O	O	O
treatment	O	O	B-T061
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
report	O	O	B-T058
outcome	O	O	B-T169
and	O	O	O
disability	O	O	B-T033
following	O	O	O
thumb	O	O	B-T030
MCP	O	O	I-T030
joint	O	O	I-T030
arthrodesis	O	O	B-T061
in	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
chronic	O	O	B-T046
instability	O	O	I-T046
after	O	O	O
traumatic	O	O	B-T037
injuries	O	O	I-T037
.	O	O	O

A	O	O	O
retrospective	O	O	B-T080
review	O	O	B-T061
of	O	O	O
26	O	O	O
patients	O	O	B-T101
operated	O	O	B-T061
on	O	O	O
with	O	O	O
MCP	O	O	B-T030
joint	O	O	I-T030
arthrodesis	O	O	B-T061
,	O	O	O
median	O	O	O
follow-up	O	O	B-T058
42	O	O	O
months	O	O	B-T079
(	O	O	O
8	O	O	O
-	O	O	O
104	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

Subjective	O	O	O
outcome	O	O	B-T169
was	O	O	O
assessed	O	O	B-T052
using	O	O	O
the	O	O	O
disabilities	O	O	B-T170
of	O	O	I-T170
the	O	O	I-T170
Arm	O	O	I-T170
,	O	O	I-T170
Shoulder	O	O	I-T170
,	O	O	I-T170
and	O	O	I-T170
Hand-questionnaire	O	O	I-T170
(	O	O	O
DASH	O	O	B-T170
)	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
patient	O	O	B-T080
satisfaction	O	O	I-T080
,	O	O	O
pain	O	O	B-T184
,	O	O	O
stiffness	O	O	B-T184
,	O	O	O
and	O	O	O
impairment	O	O	B-T169
of	O	O	O
activities	O	O	B-T056
of	O	O	I-T056
daily	O	O	I-T056
living	O	O	I-T056
were	O	O	O
assessed	O	O	B-T052
on	O	O	O
a	O	O	O
Visual	O	O	B-T060
Analogue	O	O	I-T060
Scale	O	O	I-T060
(	O	O	O
VAS	O	O	B-T060
)	O	O	O
followed	O	O	O
by	O	O	O
a	O	O	O
question	O	O	O
stating	O	O	O
whether	O	O	O
they	O	O	O
would	O	O	O
undergo	O	O	O
the	O	O	O
same	O	O	O
procedure	O	O	B-T169
again	O	O	O
.	O	O	O

Two	O	O	O
patients	O	O	B-T101
(	O	O	O
7.7	O	O	O
%	O	O	O
)	O	O	O
needed	O	O	O
re-operation	O	O	B-T061
due	O	O	O
to	O	O	O
nonunion	O	O	B-T033
.	O	O	O

Four	O	O	O
patients	O	O	B-T101
(	O	O	O
15.4	O	O	O
%	O	O	O
)	O	O	O
needed	O	O	O
hardware	O	O	B-T061
removal	O	O	I-T061
.	O	O	O

Median	O	O	B-T081
DASH	O	O	B-T170
-	O	O	O
score	O	O	B-T081
was	O	O	O
18	O	O	O
(	O	O	O
25	O	O	O
-	O	O	O
75	O	O	O
%	O	O	O
range	O	O	B-T081
6	O	O	O
-	O	O	O
47	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
lower	O	O	O
DASH	O	O	O
score	O	O	B-T081
s	O	O	I-T081
being	O	O	O
better	O	O	O
.	O	O	O

Score	O	O	B-T081
s	O	O	I-T081
were	O	O	O
significantly	O	O	O
worse	O	O	O
in	O	O	O
gender	O	O	B-T032
and	O	O	O
age	O	O	B-T032
matched	O	O	O
individuals	O	O	B-T098
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

Median	O	O	B-T081
VAS	O	O	B-T060
for	O	O	O
pain	O	O	B-T184
was	O	O	O
3.7	O	O	O
(	O	O	O
range	O	O	B-T081
0	O	O	O
-	O	O	O
8)	O	O	O
.	O	O	O

More	O	O	O
than	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
reported	O	O	O
mild	O	O	B-T033
,	O	O	O
moderate	O	O	B-T184
or	O	O	O
severe	O	O	B-T033
pain	O	O	I-T033
,	O	O	O
but	O	O	O
all	O	O	O
patients	O	O	O
reported	O	O	O
that	O	O	O
they	O	O	O
were	O	O	O
willing	O	O	O
to	O	O	O
undergo	O	O	O
the	O	O	O
same	O	O	O
procedure	O	O	B-T169
again	O	O	O
.	O	O	O

Our	O	O	O
data	O	O	B-T078
suggest	O	O	O
,	O	O	O
that	O	O	O
patients	O	O	B-T101
with	O	O	O
post-traumatic	O	O	B-T079
thumb	O	O	B-T037
injuries	O	O	I-T037
managed	O	O	O
with	O	O	O
thumb	O	O	B-T030
MCP	O	O	I-T030
joint	O	O	I-T030
arthrodesis	O	O	B-T061
perform	O	O	O
worse	O	O	O
than	O	O	O
gender	O	O	B-T032
and	O	O	O
age	O	O	B-T032
matched	O	O	O
individuals	O	O	B-T098
.	O	O	O

Many	O	O	O
lived	O	O	O
with	O	O	O
pain	O	O	B-T184
,	O	O	O
but	O	O	O
all	O	O	O
reported	O	O	O
that	O	O	O
they	O	O	O
were	O	O	O
willing	O	O	O
to	O	O	O
undergo	O	O	O
the	O	O	O
same	O	O	O
procedure	O	O	B-T169
again	O	O	O
.	O	O	O

We	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
disability	O	O	B-T170
scale	O	O	I-T170
by	O	O	O
the	O	O	O
National	O	O	B-T092
Board	O	O	I-T092
of	O	O	I-T092
Industrial	O	O	I-T092
Injuries	O	O	I-T092
should	O	O	O
be	O	O	O
reconsidered	O	O	O
for	O	O	O
patients	O	O	B-T101
operated	O	O	B-T061
on	O	O	O
with	O	O	O
thumb	O	O	B-T030
MCP	O	O	I-T030
arthrodesis	O	O	B-T061
.	O	O	O

-DOCSTART- (28217611)

Pyoderma	O	O	B-T047
gangrenosum	O	O	I-T047
:	O	O	O
A	O	O	O
clinician	O	O	B-T097
's	O	O	I-T097
nightmare	O	O	O

Pyoderma	O	O	B-T047
gangrenosum	O	O	I-T047
(	O	O	O
PG	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
rare	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
that	O	O	O
affecting	O	O	O
specifically	O	O	O
the	O	O	O
sole	O	O	B-T029
of	O	O	I-T029
the	O	O	I-T029
foot	O	O	I-T029
,	O	O	O
is	O	O	O
even	O	O	O
rarer	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	B-T170
the	O	O	O
case	O	O	O
of	O	O	O
a	O	O	O
54-year-	O	O	O
old	O	O	B-T079
female	O	O	B-T032
admitted	O	O	B-T058
with	O	O	O
a	O	O	O
painful	O	O	B-T184
ulcer	O	O	B-T047
on	O	O	O
the	O	O	O
sole	O	O	B-T029
of	O	O	I-T029
the	O	O	I-T029
right	O	O	I-T029
foot	O	O	I-T029
which	O	O	O
was	O	O	O
initially	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
empirical	O	O	O
antibiotics	O	O	B-T195
and	O	O	O
debridement	O	O	B-T061
.	O	O	O

The	O	O	O
disease	O	O	B-T047
was	O	O	O
found	O	O	O
to	O	O	O
spread	O	O	O
rapidly	O	O	B-T080
after	O	O	O
each	O	O	O
debridement	O	O	B-T061
.	O	O	O

The	O	O	O
culture	O	O	B-T034
reports	O	O	I-T034
were	O	O	O
negative	O	O	B-T033
;	O	O	O
rheumatology	O	O	B-T091
workup	O	O	B-T060
and	O	O	O
Doppler	O	O	B-T060
study	O	O	I-T060
were	O	O	O
within	O	O	O
normal	O	O	B-T033
limits	O	O	I-T033
.	O	O	O

A	O	O	O
clinical	O	O	B-T080
suspicion	O	O	B-T078
of	O	O	O
PG	O	O	B-T047
was	O	O	O
made	O	O	O
and	O	O	O
was	O	O	O
confirmed	O	O	O
with	O	O	O
tissue	O	O	B-T060
biopsy	O	O	I-T060
.	O	O	O

She	O	O	O
was	O	O	O
started	O	O	B-T061
on	O	O	I-T061
oral	O	O	I-T061
steroids	O	O	I-T061
following	O	O	O
which	O	O	O
she	O	O	O
dramatically	O	O	O
improved	O	O	B-T033
.	O	O	O

Thus	O	O	O
,	O	O	O
when	O	O	O
a	O	O	O
patient	O	O	B-T101
presents	O	O	O
with	O	O	O
a	O	O	O
rapidly	O	O	B-T080
expanding	O	O	O
painful	O	O	B-T184
ulcer	O	O	B-T047
in	O	O	O
a	O	O	O
vascular	O	O	B-T023
limb	O	O	I-T023
that	O	O	O
is	O	O	O
refractory	O	O	B-T169
to	O	O	O
antibiotic	O	O	B-T061
treatment	O	O	I-T061
and	O	O	O
exacerbating	O	O	B-T080
on	O	O	O
debridement	O	O	B-T061
,	O	O	O
it	O	O	O
is	O	O	O
imperative	O	O	O
to	O	O	O
consider	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
PG	O	O	B-T047
.	O	O	O

-DOCSTART- (28217766)

Visualization	O	O	B-T060
for	O	O	O
Understanding	O	O	O
Uncertainty	O	O	B-T033
in	O	O	O
Activation	O	O	B-T052
Volumes	O	O	B-T081
for	O	O	O
Deep	O	O	O
Brain	O	O	O
Stimulation	O	O	O

We	O	O	O
have	O	O	O
created	O	O	O
the	O	O	O
Neurostimulation	O	O	B-T170
Uncertainty	O	O	I-T170
Viewer	O	O	I-T170
(	O	O	I-T170
nuView	O	O	I-T170
or	O	O	I-T170
νView	O	O	I-T170
)	O	O	I-T170
tool	O	O	I-T170
for	O	O	O
exploring	O	O	O
data	O	O	B-T078
arising	O	O	O
from	O	O	O
deep	O	O	B-T061
brain	O	O	I-T061
stimulation	O	O	I-T061
(	O	O	O
DBS	O	O	B-T061
)	O	O	O
.	O	O	O

Simulated	O	O	B-T062
volume	O	O	B-T081
of	O	O	I-T081
tissue	O	O	I-T081
activated	O	O	I-T081
(	O	O	O
VTA	O	O	B-T081
)	O	O	O
,	O	O	O
using	O	O	O
clinical	O	O	B-T060
electrode	O	O	I-T060
placements	O	O	I-T060
,	O	O	O
are	O	O	O
recorded	O	O	B-T052
along	O	O	O
with	O	O	O
patient	O	O	B-T101
outcomes	O	O	B-T080
in	O	O	O
the	O	O	O
Unified	O	O	B-T170
Parkinson	O	O	I-T170
's	O	O	I-T170
disease	O	O	I-T170
rating	O	O	I-T170
scale	O	O	I-T170
(	O	O	O
UPDRS	O	O	B-T170
)	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T078
is	O	O	O
volumetric	O	O	B-T080
and	O	O	O
sparse	O	O	B-T080
,	O	O	O
with	O	O	O
multi-value	O	O	B-T080
patient	O	O	B-T101
results	O	O	B-T169
for	O	O	O
each	O	O	O
activated	O	O	B-T052
voxel	O	O	B-T077
in	O	O	O
the	O	O	O
simulation	O	O	B-T062
.	O	O	O

νView	O	O	B-T077
provides	O	O	O
a	O	O	O
collection	O	O	B-T169
of	O	O	O
visual	O	O	B-T170
methods	O	O	I-T170
to	O	O	O
explore	O	O	O
the	O	O	O
activated	O	O	B-T052
tissue	O	O	B-T024
to	O	O	O
enhance	O	O	O
understanding	O	O	O
of	O	O	O
electrode	O	O	B-T074
usage	O	O	B-T169
for	O	O	O
improved	O	O	O
therapy	O	O	B-T061
with	O	O	O
DBS	O	O	B-T061
.	O	O	O

-DOCSTART- (28217770)

Post-synthetic	O	O	O
conversion	O	O	B-T169
of	O	O	O
5-pivaloyloxymethyluridine	O	O	B-T114
present	O	O	B-T033
in	O	O	O
a	O	O	O
support-bound	O	O	O
RNA	O	O	B-T114
oligomer	O	O	B-T087
into	O	O	O
biologically	O	O	B-T080
relevant	O	O	B-T080
derivatives	O	O	B-T104
of	O	O	O
5-methyluridine	O	O	O

A	O	O	O
post-synthetic	O	O	O
reaction	O	O	B-T169
of	O	O	O
5-pivaloyloxymethyluridine	O	O	B-T114
(	O	O	O
present	O	O	B-T033
in	O	O	O
a	O	O	O
support-bound	O	O	O
RNA	O	O	B-T114
oligomer	O	O	B-T087
)	O	O	O
with	O	O	O
various	O	O	O
nucleophilic	O	O	B-T130
reagents	O	O	I-T130
furnished	O	O	O
efficiently	O	O	O
the	O	O	O
corresponding	O	O	O
products	O	O	B-T071
bearing	O	O	O
one	O	O	O
aof	O	O	O
the	O	O	O
tRNA	O	O	B-T045
wobble	O	O	I-T045
5-methyluridines	O	O	B-T114
(	O	O	O
mnm(5)U	O	O	B-T114
,	O	O	O
cmnm(5)U	O	O	B-T114
,	O	O	O
τm(5)U	O	O	B-T114
,	O	O	O
nm(5)U	O	O	B-T114
,	O	O	O
inm(5)U	O	O	B-T114
or	O	O	O
cnm(5)U	O	O	B-T114
)	O	O	O
.	O	O	O

The	O	O	O
syntheses	O	O	B-T052
of	O	O	O
oligoribonucleotides	O	O	B-T114
modified	O	O	B-T169
with	O	O	O
inm(5)U	O	O	B-T114
and	O	O	O
cnm(5)U	O	O	B-T114
are	O	O	O
reported	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
.	O	O	O

-DOCSTART- (28219657)

Non-pharmacological	O	O	B-T169
treatments	O	O	B-T061
for	O	O	O
pain	O	O	B-T061
relief	O	O	I-T061
:	O	O	O
TENS	O	O	B-T061
and	O	O	O
acupuncture	O	O	O

Acupuncture	O	O	B-T061
and	O	O	O
transcutaneous	O	O	B-T061
electrical	O	O	I-T061
nerve	O	O	I-T061
stimulation	O	O	I-T061
(	O	O	O
TENS	O	O	B-T061
)	O	O	O
are	O	O	O
non-pharmacological	O	O	B-T169
methods	O	O	B-T169
that	O	O	O
have	O	O	O
been	O	O	O
used	O	O	O
for	O	O	O
millennia	O	O	B-T079
to	O	O	O
relieve	O	O	B-T061
pain	O	O	I-T061
.	O	O	O

As	O	O	O
with	O	O	O
all	O	O	O
complementary	O	O	B-T061
treatments	O	O	I-T061
,	O	O	O
efficacy	O	O	B-T080
evaluations	O	O	B-T058
face	O	O	O
two	O	O	O
hurdles	O	O	O
:	O	O	O
the	O	O	O
non-feasibility	O	O	O
of	O	O	O
double-blinding	O	O	B-T062
and	O	O	O
the	O	O	O
difficulty	O	O	O
in	O	O	O
identifying	O	O	O
the	O	O	O
optimal	O	O	B-T081
control	O	O	I-T081
population	O	O	I-T081
or	O	O	O
treatment	O	O	B-T061
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
recent	O	O	O
studies	O	O	O
of	O	O	O
good	O	O	B-T080
methodological	O	O	B-UnknownType
quality	O	O	I-UnknownType
have	O	O	O
demonstrated	O	O	O
benefits	O	O	B-T081
in	O	O	O
many	O	O	O
types	O	O	O
of	O	O	O
pain	O	O	B-T184
compared	O	O	O
to	O	O	O
conventional	O	O	B-T080
treatment	O	O	B-T061
.	O	O	O

The	O	O	O
mechanisms	O	O	B-T169
of	O	O	I-T169
action	O	O	I-T169
of	O	O	O
acupuncture	O	O	B-T061
and	O	O	O
TENS	O	O	B-T061
,	O	O	O
which	O	O	O
are	O	O	O
increasingly	O	O	B-T169
well	O	O	O
understood	O	O	O
,	O	O	O
involve	O	O	O
endogenous	O	O	B-T169
pain	O	O	B-T061
control	O	O	I-T061
systems	O	O	I-T061
,	O	O	O
cerebral	O	O	B-T042
plasticity	O	O	I-T042
,	O	O	O
and	O	O	O
nonspecific	O	O	O
effects	O	O	B-T080
(	O	O	O
e.g.	O	O	O
,	O	O	O
expectations	O	O	B-T078
and	O	O	O
placebo	O	O	B-T078
effect	O	O	I-T078
)	O	O	O
.	O	O	O

No	O	O	O
serious	O	O	O
adverse	O	O	B-T046
effects	O	O	I-T046
have	O	O	O
been	O	O	O
reported	O	O	O
.	O	O	O

These	O	O	O
data	O	O	B-T078
support	O	O	O
the	O	O	O
more	O	O	O
widespread	O	O	O
use	O	O	O
of	O	O	O
non-pharmacological	O	O	B-T169
pain	O	O	B-T061
management	O	O	I-T061
,	O	O	O
most	O	O	O
notably	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
inadequately	O	O	O
relieved	O	O	B-T169
by	O	O	I-T169
medications	O	O	B-T121
alone	O	O	O
.	O	O	O

-DOCSTART- (28220082)

Synaptic	O	O	B-T030
and	O	O	O
Neuronal	O	O	B-T025
Autoantibody	O	O	B-T116
-	O	O	O
Associated	O	O	B-T080
Psychiatric	O	O	B-T048
Syndromes	O	O	I-T048
:	O	O	O
Controversies	O	O	B-T054
and	O	O	O
Hypotheses	O	O	O

Autoimmune	O	O	B-T047
encephalitis	O	O	I-T047
(	O	O	O
AE	O	O	B-T047
)	O	O	O
mediated	O	O	O
by	O	O	O
antibodies	O	O	B-T116
against	O	O	O
synaptic	O	O	B-T030
and	O	O	O
neuronal	O	O	B-T025
surface	O	O	B-T082
targets	O	O	B-T169
frequently	O	O	B-T079
presents	O	O	B-T033
with	O	O	O
a	O	O	O
psychiatric	O	O	B-T048
syndrome	O	O	I-T048
.	O	O	O

In	O	O	O
these	O	O	O
patients	O	O	B-T101
,	O	O	O
removal	O	O	B-T061
of	O	O	I-T061
autoantibodies	O	O	B-T116
treats	O	O	B-T169
the	O	O	O
disease	O	O	B-T047
and	O	O	O
outcomes	O	O	B-T080
are	O	O	O
closely	O	O	O
linked	O	O	O
to	O	O	O
early	O	O	O
intervention	O	O	B-T061
.	O	O	O

The	O	O	O
discovery	O	O	B-T052
of	O	O	O
these	O	O	O
autoantibodies	O	O	B-T116
in	O	O	O
isolated	O	O	B-T169
psychiatric	O	O	B-T048
syndromes	O	O	I-T048
has	O	O	O
raised	O	O	B-T080
the	O	O	O
possibility	O	O	O
that	O	O	O
these	O	O	O
patients	O	O	B-T101
may	O	O	O
derive	O	O	O
similar	O	O	O
benefits	O	O	B-T081
from	O	O	O
immunotherapy	O	O	B-T061
,	O	O	O
a	O	O	O
potentially	O	O	B-T080
transformational	O	O	O
approach	O	O	B-T082
to	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
mental	O	O	B-T048
illness	O	O	I-T048
.	O	O	O

Although	O	O	O
open-label	O	O	B-T062
case	O	O	I-T062
series	O	O	I-T062
suggest	O	O	O
impressive	O	O	O
therapeutic	O	O	B-T080
outcomes	O	O	I-T080
,	O	O	O
the	O	O	O
pathological	O	O	B-T169
relevance	O	O	B-T080
of	O	O	O
these	O	O	O
autoantibodies	O	O	B-T116
outside	O	O	O
of	O	O	O
canonical	O	O	B-T081
presentations	O	O	I-T081
is	O	O	O
debated	O	O	O
.	O	O	O

The	O	O	O
advent	O	O	O
of	O	O	O
diagnostic	O	O	B-T170
criteria	O	O	I-T170
for	O	O	O
AE	O	O	B-T047
attempts	O	O	B-T051
to	O	O	O
facilitate	O	O	O
its	O	O	O
prompt	O	O	O
identification	O	O	B-T080
but	O	O	O
risks	O	O	B-T078
prematurely	O	O	O
neglecting	O	O	O
the	O	O	O
potential	O	O	B-T080
scientific	O	O	B-T090
and	O	O	O
clinical	O	O	B-T033
significance	O	O	I-T033
of	O	O	O
isolated	O	O	B-T169
syndromes	O	O	B-T047
that	O	O	O
do	O	O	O
not	O	O	O
satisfy	O	O	O
these	O	O	O
criteria	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
propose	O	O	O
using	O	O	O
a	O	O	O
syndrome	O	O	B-T047
-	O	O	O
level	O	O	B-T080
taxonomy	O	O	B-T090
that	O	O	O
has	O	O	O
occasional	O	O	B-T079
,	O	O	O
but	O	O	O
not	O	O	O
necessary	O	O	O
,	O	O	O
overlap	O	O	B-T079
with	O	O	O
AE	O	O	B-T047
:	O	O	O
synaptic	O	O	B-T030
and	O	O	O
neuronal	O	O	B-T025
autoantibody	O	O	B-T116
-	O	O	O
associated	O	O	B-T080
psychiatric	O	O	B-T048
syndromes	O	O	I-T048
or	O	O	O
"	O	O	O
SNAps	O	O	B-T048
"	O	O	O
.	O	O	O

This	O	O	O
will	O	O	O
prevent	O	O	B-T169
confusion	O	O	O
with	O	O	O
AE	O	O	B-T047
and	O	O	O
act	O	O	B-T170
heuristically	O	O	I-T170
to	O	O	O
promote	O	O	B-T052
active	O	O	B-T169
investigation	O	O	B-T058
into	O	O	O
this	O	O	O
rare	O	O	B-T080
example	O	O	B-T077
of	O	O	O
psychopathology	O	O	B-T091
defined	O	O	B-T170
on	O	O	O
a	O	O	O
molecular	O	O	B-T081
level	O	O	I-T081
.	O	O	O

We	O	O	O
suggest	O	O	O
that	O	O	O
this	O	O	O
concept	O	O	B-T078
would	O	O	O
have	O	O	O
application	O	O	O
in	O	O	O
other	O	O	O
autoantibody	O	O	B-T116
-	O	O	O
associated	O	O	B-T080
syndromes	O	O	B-T047
including	O	O	B-T169
seizure	O	O	B-T184
,	O	O	O
cognitive	O	O	B-T169
,	O	O	O
and	O	O	O
movement	O	O	B-T047
disorders	O	O	I-T047
,	O	O	O
in	O	O	O
which	O	O	O
similar	O	O	B-T080
issues	O	O	B-T033
arise	O	O	O
.	O	O	O

We	O	O	O
review	O	O	B-T169
putative	O	O	O
direct	O	O	B-T080
and	O	O	O
indirect	O	O	B-T080
mechanisms	O	O	B-T169
and	O	O	O
outline	O	O	O
experimentally	O	O	B-T080
testable	O	O	O
hypotheses	O	O	B-T078
that	O	O	O
would	O	O	O
help	O	O	O
to	O	O	O
determine	O	O	O
prospectively	O	O	B-T062
in	O	O	O
whom	O	O	O
autoantibody	O	O	B-T116
detection	O	O	B-T061
is	O	O	O
relevant	O	O	B-T080
,	O	O	O
and	O	O	O
as	O	O	O
important	O	O	B-T080
,	O	O	O
in	O	O	O
whom	O	O	O
it	O	O	O
is	O	O	O
not	O	O	O
.	O	O	O

We	O	O	O
summarize	O	O	O
a	O	O	O
pragmatic	O	O	B-T054
approach	O	O	O
to	O	O	O
autoantibody	O	O	B-T116
testing	O	O	B-T169
and	O	O	O
management	O	O	B-T058
in	O	O	O
severe	O	O	B-T080
mental	O	O	B-T048
illness	O	O	I-T048
in	O	O	O
order	O	O	O
to	O	O	O
promptly	O	O	O
diagnose	O	O	B-T033
AE	O	O	B-T047
and	O	O	O
advocate	O	O	O
a	O	O	O
research	O	O	B-T062
-	O	O	O
orientated	O	O	B-T033
experimental	O	O	B-T080
medicine	O	O	B-T121
paradigm	O	O	B-T062
for	O	O	O
SNAps	O	O	B-T048
,	O	O	O
where	O	O	O
there	O	O	O
is	O	O	O
greater	O	O	B-T081
equipoise	O	O	B-T109
.	O	O	O

We	O	O	O
conclude	O	O	O
that	O	O	O
SNAps	O	O	B-T048
remains	O	O	O
a	O	O	O
nascent	O	O	O
area	O	O	O
of	O	O	O
clinical	O	O	B-T080
neuroscience	O	O	B-T091
with	O	O	O
great	O	O	O
potential	O	O	B-T080
and	O	O	O
in	O	O	O
ongoing	O	O	B-T078
need	O	O	B-T080
of	O	O	O
psychiatry	O	O	B-T091
-led	O	O	O
basic	O	O	O
and	O	O	O
clinical	O	O	B-T062
research	O	O	I-T062
.	O	O	O

-DOCSTART- (28220122)

NF-κB	O	O	B-T116
Links	O	O	O
TLR2	O	O	B-T116
and	O	O	O
PAR1	O	O	B-T116
to	O	O	O
Soluble	O	O	B-T080
Immunomodulator	O	O	B-T129
Factor	O	O	I-T129
Secretion	O	O	B-T038
in	O	O	O
Human	O	O	B-T016
Platelets	O	O	O

The	O	O	O
primary	O	O	B-T080
toll-like	O	O	B-T116
receptor	O	O	I-T116
(TLR)-mediated	O	O	O
immune	O	O	B-T043
cell	O	O	I-T043
response	O	O	I-T043
pathway	O	O	I-T043
common	O	O	O
for	O	O	O
all	O	O	O
TLRs	O	O	B-T116
is	O	O	O
MyD88	O	O	B-T116
-dependent	O	O	O
activation	O	O	B-T045
of	O	O	O
NF-κB	O	O	B-T116
,	O	O	O
a	O	O	O
seminal	O	O	B-T023
transcription	O	O	B-T116
factor	O	O	I-T116
for	O	O	O
many	O	O	O
chemokines	O	O	B-T116
and	O	O	O
cytokines	O	O	B-T116
.	O	O	O

Remarkably	O	O	O
,	O	O	O
anucleate	O	O	B-T025
platelets	O	O	B-T025
express	O	O	O
the	O	O	O
NF-κB	O	O	B-T116
machinery	O	O	O
,	O	O	O
whose	O	O	O
role	O	O	O
in	O	O	O
platelets	O	O	O
remains	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
contribution	O	O	B-T052
of	O	O	O
NF-κB	O	O	B-T116
in	O	O	O
the	O	O	O
release	O	O	B-T169
of	O	O	O
cytokines	O	O	B-T116
and	O	O	O
serotonin	O	O	B-T109
by	O	O	O
human	O	O	B-T016
platelets	O	O	B-T025
,	O	O	O
following	O	O	B-T079
selective	O	O	O
stimulation	O	O	O
of	O	O	O
TLR2	O	O	B-T116
and	O	O	O
protease	O	O	B-T116
activated	O	O	I-T116
receptor	O	O	I-T116
1	O	O	I-T116
(	O	O	O
PAR1	O	O	B-T116
)	O	O	O
,	O	O	O
a	O	O	O
classical	O	O	O
and	O	O	O
non-classical	O	O	O
pattern-recognition	O	O	B-T116
receptor	O	O	I-T116
,	O	O	O
respectively	O	O	O
,	O	O	O
able	O	O	O
to	O	O	O
participate	O	O	O
to	O	O	O
the	O	O	O
innate	O	O	B-T032
immune	O	O	I-T032
system	O	O	I-T032
.	O	O	O

We	O	O	O
discovered	O	O	O
that	O	O	O
platelet	O	O	B-T025
PAR1	O	O	B-T116
activation	O	O	B-T045
drives	O	O	O
the	O	O	O
process	O	O	O
of	O	O	O
NF-κB	O	O	B-T116
phosphorylation	O	O	B-T044
,	O	O	O
in	O	O	O
contrast	O	O	O
to	O	O	O
TLR2	O	O	B-T116
activation	O	O	O
,	O	O	O
which	O	O	O
induces	O	O	B-T169
a	O	O	O
slower	O	O	O
phosphorylation	O	O	B-T044
process	O	O	I-T044
.	O	O	O

Conversely	O	O	O
,	O	O	O
platelet	O	O	B-T025
PAR1	O	O	B-T116
and	O	O	O
TLR2	O	O	B-T116
activation	O	O	B-T052
induces	O	O	B-T169
similar	O	O	O
ERK1/2	O	O	B-T044
,	O	O	O
p38	O	O	B-T116
,	O	O	O
and	O	O	O
AKT	O	O	B-T116
phosphorylation	O	O	B-T044
.	O	O	O

Moreover	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
engagement	O	O	O
of	O	O	O
platelet	O	O	B-T025
TLR2	O	O	B-T116
with	O	O	O
its	O	O	O
ligand	O	O	B-T103
,	O	O	O
Pam3CSK4	O	O	B-T116
,	O	O	O
significantly	O	O	B-T081
increases	O	O	I-T081
the	O	O	O
release	O	O	B-T169
of	O	O	O
sCD62P	O	O	B-T116
,	O	O	O
RANTES	O	O	B-T116
,	O	O	O
and	O	O	O
sCD40L	O	O	B-T116
;	O	O	O
this	O	O	O
effect	O	O	B-T080
was	O	O	O
attenuated	O	O	B-T080
by	O	O	I-T080
incubating	O	O	B-T059
platelets	O	O	B-T025
with	O	O	O
a	O	O	O
blocking	O	O	B-T169
anti-TLR2	O	O	B-T116
antibody	O	O	I-T116
.	O	O	O

This	O	O	O
effect	O	O	B-T080
appeared	O	O	I-T080
selective	O	O	O
since	O	O	O
no	O	O	O
modulation	O	O	B-T082
of	O	O	O
serotonin	O	O	B-T043
secretion	O	O	I-T043
was	O	O	O
observed	O	O	B-T169
following	O	O	B-T079
platelet	O	O	B-T025
TLR2	O	O	B-T116
activation	O	O	B-T043
.	O	O	O

Platelet	O	O	B-T025
release	O	O	B-T169
of	O	O	O
sCD62P	O	O	B-T116
,	O	O	O
RANTES	O	O	B-T116
,	O	O	O
and	O	O	O
sCD40L	O	O	B-T116
following	O	O	B-T079
TLR2	O	O	B-T116
or	O	O	O
PAR1	O	O	B-T116
triggering	O	O	O
was	O	O	O
abolished	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
the	O	O	O
NF-κB	O	O	B-T116
inhibitor	O	O	B-T120
Bay11	O	O	B-T109
-	O	O	I-T109
7082	O	O	I-T109
,	O	O	O
while	O	O	O
serotonin	O	O	B-T043
release	O	O	I-T043
following	O	O	O
PAR1	O	O	O
activation	O	O	B-T043
was	O	O	O
significantly	O	O	B-T081
decreased	O	O	I-T081
.	O	O	O

These	O	O	O
new	O	O	B-T080
findings	O	O	B-T169
support	O	O	O
the	O	O	O
concept	O	O	O
that	O	O	O
NF-κB	O	O	B-T116
is	O	O	O
an	O	O	O
important	O	O	O
player	O	O	O
in	O	O	O
platelet	O	O	B-T025
immunoregulations	O	O	B-T040
and	O	O	O
functions	O	O	B-T042
.	O	O	O

-DOCSTART- (28222010)

Optical	O	O	B-T062
tweezers	O	O	I-T062
studies	O	O	B-T062
of	O	O	O
transcription	O	O	B-T045
by	O	O	O
eukaryotic	O	O	B-T025
RNA	O	O	O
polymerases	O	O	O

Transcription	O	O	B-T045
is	O	O	O
the	O	O	O
first	O	O	B-T077
step	O	O	I-T077
in	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
genetic	O	O	B-T169
information	O	O	B-T078
and	O	O	O
it	O	O	O
is	O	O	O
carried	O	O	B-T052
out	O	O	O
by	O	O	O
large	O	O	O
macromolecular	O	O	B-T104
enzymes	O	O	B-T116
called	O	O	O
RNA	O	O	B-T116
polymerases	O	O	I-T116
.	O	O	O

Transcription	O	O	B-T045
has	O	O	O
been	O	O	O
studied	O	O	B-T062
for	O	O	O
many	O	O	O
years	O	O	O
and	O	O	O
with	O	O	O
a	O	O	O
myriad	O	O	B-T170
of	O	O	O
experimental	O	O	B-T080
techniques	O	O	B-T169
,	O	O	O
ranging	O	O	B-T081
from	O	O	O
bulk	O	O	O
studies	O	O	B-T062
to	O	O	O
high-resolution	O	O	B-T059
transcript	O	O	I-T059
sequencing	O	O	I-T059
.	O	O	O

In	O	O	O
this	O	O	O
review	O	O	B-T170
,	O	O	O
we	O	O	O
emphasise	O	O	O
the	O	O	O
advantages	O	O	O
of	O	O	O
using	O	O	O
single-molecule	O	O	B-T167
techniques	O	O	B-T169
,	O	O	O
particularly	O	O	O
optical	O	O	B-T062
tweezers	O	O	I-T062
,	O	O	O
to	O	O	O
study	O	O	B-T062
transcription	O	O	B-T045
dynamics	O	O	B-T070
.	O	O	O

We	O	O	O
give	O	O	O
an	O	O	O
overview	O	O	B-T170
of	O	O	O
the	O	O	O
latest	O	O	O
results	O	O	B-T169
in	O	O	O
the	O	O	O
single-molecule	O	O	B-T167
transcription	O	O	B-T045
field	O	O	B-T077
,	O	O	O
focusing	O	O	O
on	O	O	O
transcription	O	O	O
by	O	O	O
eukaryotic	O	O	B-T025
RNA	O	O	B-T116
polymerases	O	O	I-T116
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
evaluate	O	O	O
recent	O	O	O
quantitative	O	O	B-T081
models	O	O	B-T075
that	O	O	O
describe	O	O	B-T078
the	O	O	O
biophysics	O	O	B-T091
of	O	O	O
RNA	O	O	B-T116
polymerase	O	O	I-T116
translocation	O	O	B-T043
and	O	O	O
backtracking	O	O	O
dynamics	O	O	B-T070
.	O	O	O

-DOCSTART- (28222462)

Decreased	O	O	B-T080
Frequencies	O	O	I-T080
of	O	O	O
Peripheral	O	O	B-T031
Blood	O	O	I-T031
CD4+CD25+CD127-Foxp3	O	O	B-T025
+	O	O	I-T025
in	O	O	O
Patients	O	O	B-T101
with	O	O	O
Graves	O	O	B-T047
'	O	O	I-T047
Disease	O	O	I-T047
and	O	O	O
Graves	O	O	B-T047
'	O	O	I-T047
Orbitopathy	O	O	I-T047
:	O	O	O
Enhancing	O	O	B-T080
Effect	O	O	I-T080
of	O	O	O
Insulin	O	O	B-T116
Growth	O	O	I-T116
Factor-1	O	O	I-T116
on	O	O	O
Treg	O	O	O
Cells	O	O	O

Graves	O	O	B-T047
'	O	O	I-T047
orbitopathy	O	O	I-T047
(	O	O	O
GO	O	O	B-T047
)	O	O	O
is	O	O	O
characterized	O	O	B-T052
by	O	O	O
orbital	O	O	B-T025
T	O	O	I-T025
cell	O	O	I-T025
infiltration	O	O	B-T046
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
the	O	O	O
regulatory	O	O	B-T025
T	O	O	I-T025
(	O	O	I-T025
Treg	O	O	I-T025
)	O	O	I-T025
cell	O	O	I-T025
fractions	O	O	B-T081
induced	O	O	B-T169
with	O	O	O
IGF-1	O	O	B-T116
in	O	O	O
Graves	O	O	B-T047
'	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
GD	O	O	B-T047
)	O	O	O
with	O	O	O
and	O	O	O
without	O	O	O
GO	O	O	B-T047
.	O	O	O

Peripheral	O	O	B-T025
blood	O	O	I-T025
mononuclear	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
PBMCs	O	O	B-T025
)	O	O	O
were	O	O	O
obtained	O	O	O
from	O	O	O
13	O	O	O
patients	O	O	B-T101
with	O	O	O
GD	O	O	B-T047
without	O	O	O
eye	O	O	B-T184
manifestations	O	O	I-T184
;	O	O	O
10	O	O	O
patients	O	O	O
with	O	O	O
active	O	O	B-T169
GO	O	O	B-T047
;	O	O	O
and	O	O	O
12	O	O	O
patients	O	O	O
with	O	O	O
nodular	O	O	B-T047
goiter	O	O	I-T047
(	O	O	O
NG	O	O	B-T047
)	O	O	O
.	O	O	O

All	O	O	O
the	O	O	O
patients	O	O	B-T101
from	O	O	O
GD	O	O	B-T047
,	O	O	O
GO	O	O	B-T047
,	O	O	O
and	O	O	O
NG	O	O	B-T047
were	O	O	O
subclinical	O	O	B-UnknownType
hyperthyroid	O	O	I-UnknownType
.	O	O	O

We	O	O	O
analyzed	O	O	B-T062
the	O	O	O
expression	O	O	B-T059
of	O	O	I-T059
Treg	O	O	I-T059
cell	O	O	I-T059
markers	O	O	I-T059
(	O	O	O
CD4	O	O	B-T116
,	O	O	O
CD25	O	O	B-T116
,	O	O	O
CD127(-	O	O	B-T116
)	O	O	I-T116
,	O	O	O
Foxp3	O	O	B-T116
)	O	O	O
on	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
their	O	O	O
ability	O	O	O
to	O	O	O
respond	O	O	B-T170
to	O	O	I-T170
IGF-1	O	O	B-T116
stimulation	O	O	B-T070
.	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
GD	O	O	B-T047
without	O	O	O
GO	O	O	B-T047
,	O	O	O
we	O	O	O
found	O	O	O
lowered	O	O	B-T081
percentages	O	O	I-T081
of	O	O	O
CD4(+	O	O	B-T025
)	O	O	I-T025
Foxp3(+	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
as	O	O	O
compared	O	O	O
to	O	O	O
nodular	O	O	B-T047
goiter	O	O	I-T047
1.77	O	O	O
vs.	O	O	O
5.42	O	O	O
%	O	O	O
(	O	O	O
p=0.0276	O	O	O
)	O	O	O
.	O	O	O

Similarly	O	O	O
,	O	O	O
significantly	O	O	B-T080
reduced	O	O	I-T080
frequencies	O	O	I-T080
of	O	O	O
CD4(+)CD25(+)CD127(-)Foxp3(+	O	O	B-T025
)	O	O	I-T025
and	O	O	O
CD4(+)CD25(+)CD127(-	O	O	B-T025
)	O	O	I-T025
cells	O	O	I-T025
were	O	O	O
observed	O	O	B-T169
in	O	O	O
GD	O	O	B-T047
patients	O	O	B-T101
as	O	O	O
compared	O	O	O
to	O	O	O
nodular	O	O	B-T047
goiter	O	O	I-T047
patients	O	O	O
with	O	O	O
hyperthyreosis	O	O	B-T047
,	O	O	O
(	O	O	O
0.7	O	O	O
vs.	O	O	O
1.48	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
p=0.0071	O	O	O
)	O	O	O
and	O	O	O
(	O	O	O
14.5	O	O	O
vs.	O	O	O
37.2	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
p=0.0051	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
GO	O	O	B-T047
with	O	O	O
active	O	O	B-T169
GO	O	O	O
,	O	O	O
only	O	O	O
the	O	O	O
percentage	O	O	B-T081
of	O	O	O
CD4(+)CD25(+)CD127(-	O	O	B-T025
)	O	O	I-T025
cells	O	O	I-T025
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
decreased	O	O	B-T081
versus	O	O	O
nodular	O	O	B-T047
goiter	O	O	I-T047
(	O	O	O
9.35	O	O	O
vs.	O	O	O
37.2	O	O	O
)	O	O	O
(	O	O	O
p=0.0275	O	O	O
)	O	O	O
.	O	O	O

Stimulation	O	O	B-T070
of	O	O	O
PBMC	O	O	B-T025
derived	O	O	O
from	O	O	O
GO	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
IGF-1	O	O	B-T116
resulted	O	O	O
in	O	O	O
significant	O	O	B-T080
increase	O	O	I-T080
of	O	O	I-T080
frequency	O	O	I-T080
of	O	O	O
both	O	O	O
CD4(+	O	O	B-T025
)	O	O	I-T025
Foxp3(+	O	O	I-T025
)	O	O	I-T025
and	O	O	O
CD4(+)CD25(+)CD127(-	O	O	B-T025
)	O	O	I-T025
Foxp3	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

Decreased	O	O	B-T080
frequencies	O	O	I-T080
of	O	O	O
peripheral	O	O	B-T031
blood	O	O	I-T031
CD4(+)CD25(+)CD127(-)Foxp3(+	O	O	B-T025
)	O	O	I-T025
in	O	O	O
patients	O	O	B-T101
with	O	O	O
GD	O	O	B-T047
and	O	O	O
GO	O	O	B-T047
could	O	O	O
be	O	O	O
an	O	O	O
useful	O	O	B-T201
marker	O	O	I-T201
of	O	O	O
autoimmune	O	O	B-T046
process	O	O	I-T046
and	O	O	O
perhaps	O	O	O
a	O	O	O
possible	O	O	O
target	O	O	O
for	O	O	O
future	O	O	B-T169
therapies	O	O	I-T169
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
study	O	O	B-T062
demonstrating	O	O	O
Treg	O	O	B-T025
-	O	O	O
enhancing	O	O	B-T080
effects	O	O	I-T080
of	O	O	O
IGF-1	O	O	B-T116
.	O	O	O

Thus	O	O	O
IGF-1	O	O	B-T116
can	O	O	O
be	O	O	O
accounted	O	O	O
for	O	O	O
modulating	O	O	B-T082
Treg	O	O	B-T025
cell	O	O	I-T025
-related	O	O	O
action	O	O	B-T052
in	O	O	O
GO	O	O	B-T047
.	O	O	O

-DOCSTART- (28228227)

γ-Butenolide	O	O	B-T123
and	O	O	O
furanone	O	O	B-T123
derivatives	O	O	I-T123
from	O	O	O
the	O	O	O
soil	O	O	B-T167
-derived	O	O	O
fungus	O	O	B-T004
Aspergillus	O	O	B-T004
sclerotiorum	O	O	I-T004
PSU-RSPG178	O	O	O

Chromatographic	O	O	B-T059
separation	O	O	I-T059
of	O	O	O
the	O	O	O
broth	O	O	B-T130
extract	O	O	B-T167
of	O	O	O
the	O	O	O
soil	O	O	B-T167
-derived	O	O	O
fungus	O	O	B-T004
Aspergillus	O	O	B-T004
sclerotiorum	O	O	I-T004
PSU-RSPG178	O	O	B-T004
resulted	O	O	O
in	O	O	O
isolation	O	O	B-T169
of	O	O	O
four	O	O	O
γ-butenolide-furanone	O	O	B-T123
dimers	O	O	I-T123
,	O	O	O
aspersclerotiorones	O	O	B-T123
A-D	O	O	I-T123
,	O	O	O
a	O	O	O
furanone	O	O	B-T123
derivative	O	O	I-T123
,	O	O	O
aspersclerotiorone	O	O	B-T123
E	O	O	I-T123
,	O	O	O
and	O	O	O
two	O	O	O
γ-butenolide	O	O	B-T123
derivatives	O	O	I-T123
,	O	O	O
aspersclerotiorones	O	O	B-T123
F	O	O	I-T123
and	O	O	O
G	O	O	B-T123
,	O	O	O
together	O	O	O
with	O	O	O
six	O	O	O
known	O	O	O
compounds	O	O	O
,	O	O	O
penicillic	O	O	B-T195
acid	O	O	I-T195
,	O	O	O
dihydropenicillic	O	O	B-T123
acid	O	O	I-T123
,	O	O	O
5,6-dihydro-6-hydroxypenicillic	O	O	B-T123
acid	O	O	I-T123
,	O	O	O
6-methoxy-5,6-dihydropenicillic	O	O	B-T123
acid	O	O	I-T123
,	O	O	O
coculnol	O	O	B-T123
and	O	O	O
(4R,5R)-4,5-dihydroxy-3-methoxy-5-methylcyclohex-2-en-1-one	O	O	B-T123
.	O	O	O

Their	O	O	O
structures	O	O	B-T170
were	O	O	O
determined	O	O	O
by	O	O	O
spectroscopic	O	O	B-T059
evidence	O	O	I-T059
.	O	O	O

For	O	O	O
aspersclerotiorones	O	O	B-T123
A	O	O	I-T123
and	O	O	O
B	O	O	B-T123
,	O	O	O
the	O	O	O
structures	O	O	B-T170
were	O	O	O
confirmed	O	O	O
by	O	O	O
single-crystal	O	O	B-T059
X-ray	O	O	I-T059
diffraction	O	O	I-T059
crystallography	O	O	I-T059
.	O	O	O

Penicillic	O	O	O
acid	O	O	O
displayed	O	O	O
weak	O	O	O
antibacterial	O	O	B-T034
activity	O	O	I-T034
against	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
and	O	O	O
Escherichia	O	O	B-T007
coli	O	O	I-T007
with	O	O	O
equal	O	O	O
MIC	O	O	B-T034
values	O	O	I-T034
of	O	O	O
128	O	O	O
μg/mL	O	O	O
,	O	O	O
and	O	O	O
it	O	O	O
was	O	O	O
noncytotoxic	O	O	B-T080
towards	O	O	O
African	O	O	B-T015
green	O	O	I-T015
monkey	O	O	I-T015
kidney	O	O	B-T023
fibroblast	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (28228265)

E3	O	O	B-T116
Ligase	O	O	I-T116
RNF126	O	O	B-T116
Directly	O	O	O
Ubiquitinates	O	O	B-T044
Frataxin	O	O	B-T116
,	O	O	O
Promoting	O	O	B-T052
Its	O	O	O
Degradation	O	O	B-T169
:	O	O	O
Identification	O	O	B-T080
of	O	O	O
a	O	O	O
Potential	O	O	O
Therapeutic	O	O	B-T169
Target	O	O	B-T169
for	O	O	O
Friedreich	O	O	O
Ataxia	O	O	O

Friedreich	O	O	B-T047
ataxia	O	O	I-T047
(	O	O	O
FRDA	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
severe	O	O	O
genetic	O	O	B-T169
neurodegenerative	O	O	B-T047
disease	O	O	I-T047
caused	O	O	O
by	O	O	O
reduced	O	O	O
expression	O	O	B-T045
of	O	O	O
the	O	O	O
mitochondrial	O	O	B-T116
protein	O	O	I-T116
frataxin	O	O	B-T116
.	O	O	O

To	O	O	O
date	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
therapy	O	O	B-T169
to	O	O	O
treat	O	O	B-T061
this	O	O	O
condition	O	O	B-T080
.	O	O	O

The	O	O	O
amount	O	O	O
of	O	O	O
residual	O	O	B-T080
frataxin	O	O	B-T116
critically	O	O	O
affects	O	O	O
the	O	O	O
severity	O	O	B-T080
of	O	O	O
the	O	O	O
disease	O	O	B-T047
;	O	O	O
thus	O	O	O
,	O	O	O
attempts	O	O	O
to	O	O	O
restore	O	O	O
physiological	O	O	B-T169
frataxin	O	O	O
levels	O	O	B-T080
are	O	O	O
considered	O	O	O
therapeutically	O	O	B-T169
relevant	O	O	B-T080
.	O	O	O

Frataxin	O	O	B-T116
levels	O	O	B-T080
are	O	O	O
controlled	O	O	B-T169
by	O	O	I-T169
the	O	O	O
ubiquitin-proteasome	O	O	B-T044
system	O	O	I-T044
;	O	O	O
therefore	O	O	O
,	O	O	O
inhibition	O	O	B-T052
of	O	O	O
the	O	O	O
frataxin	O	O	B-T116
E3	O	O	B-T116
ligase	O	O	I-T116
may	O	O	O
represent	O	O	O
a	O	O	O
strategy	O	O	B-T062
to	O	O	O
achieve	O	O	O
an	O	O	O
increase	O	O	O
in	O	O	O
frataxin	O	O	O
levels	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
the	O	O	O
RING	O	O	B-T116
E3	O	O	I-T116
ligase	O	O	I-T116
RNF126	O	O	B-T116
as	O	O	O
the	O	O	O
enzyme	O	O	B-T116
that	O	O	O
specifically	O	O	O
mediates	O	O	O
frataxin	O	O	B-T116
ubiquitination	O	O	B-T044
and	O	O	O
targets	O	O	O
it	O	O	O
for	O	O	O
degradation	O	O	B-T169
.	O	O	O

RNF126	O	O	B-T116
interacts	O	O	B-T169
with	O	O	O
frataxin	O	O	B-T116
and	O	O	O
promotes	O	O	B-T052
its	O	O	O
ubiquitination	O	O	B-T044
in	O	O	O
a	O	O	O
catalytic	O	O	B-T169
activity	O	O	I-T169
-	O	O	O
dependent	O	O	B-T080
manner	O	O	O
,	O	O	O
both	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

Most	O	O	O
importantly	O	O	O
,	O	O	O
RNF126	O	O	B-T116
depletion	O	O	B-T169
results	O	O	O
in	O	O	O
frataxin	O	O	B-T116
accumulation	O	O	B-T033
in	O	O	O
cells	O	O	B-T025
derived	O	O	O
from	O	O	O
FRDA	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
highlighting	O	O	O
the	O	O	O
relevance	O	O	B-T080
of	O	O	O
RNF126	O	O	O
as	O	O	O
a	O	O	O
new	O	O	O
therapeutic	O	O	B-T169
target	O	O	B-T169
for	O	O	O
Friedreich	O	O	B-T047
ataxia	O	O	I-T047
.	O	O	O

-DOCSTART- (28228370)

Enhancing	O	O	O
Doctors	O	O	B-T097
'	O	O	I-T097
Competencies	O	O	B-T080
in	O	O	O
Communication	O	O	B-T054
With	O	O	O
and	O	O	O
Activation	O	O	B-T052
of	O	O	O
Older	O	O	B-T098
Patients	O	O	B-T101
:	O	O	O
The	O	O	O
Promoting	O	O	B-T052
Active	O	O	B-T169
Aging	O	O	B-T040
(	O	O	O
PRACTA	O	O	B-T058
)	O	O	O
Computer-Based	O	O	O
Intervention	O	O	O
Study	O	O	O

Demographic	O	O	B-T090
changes	O	O	B-T169
over	O	O	O
the	O	O	O
past	O	O	O
decades	O	O	B-T081
call	O	O	O
for	O	O	O
the	O	O	O
promotion	O	O	B-UnknownType
of	O	O	I-UnknownType
health	O	O	I-UnknownType
and	O	O	I-UnknownType
disease	O	O	I-UnknownType
prevention	O	O	I-UnknownType
for	O	O	O
older	O	O	B-T098
patients	O	O	B-T101
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
strategies	O	O	O
to	O	O	O
enhance	O	O	O
their	O	O	O
independence	O	O	B-T078
,	O	O	O
productivity	O	O	B-T081
,	O	O	O
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
.	O	O	O

Our	O	O	O
objective	O	O	O
was	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
a	O	O	O
computer-based	O	O	B-T061
educational	O	O	I-T061
intervention	O	O	I-T061
designed	O	O	O
for	O	O	O
general	O	O	B-T097
practitioners	O	O	I-T097
(	O	O	O
GPs	O	O	B-T097
)	O	O	O
to	O	O	O
promote	O	O	O
active	O	O	B-T169
aging	O	O	B-T040
.	O	O	O

The	O	O	O
Promoting	O	O	B-T052
Active	O	O	O
Aging	O	O	B-T040
(	O	O	O
PRACTA	O	O	B-T058
)	O	O	O
study	O	O	O
consisted	O	O	O
of	O	O	O
a	O	O	O
baseline	O	O	B-T170
questionnaire	O	O	I-T170
,	O	O	O
implementation	O	O	B-T052
of	O	O	O
an	O	O	O
intervention	O	O	B-T061
,	O	O	O
and	O	O	O
a	O	O	O
follow-up	O	O	B-T170
questionnaire	O	O	I-T170
that	O	O	O
was	O	O	O
administered	O	O	B-T169
1	O	O	O
month	O	O	O
after	O	O	O
the	O	O	O
intervention	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
151	O	O	O
primary	O	O	B-T093
care	O	O	I-T093
facilities	O	O	I-T093
(	O	O	O
response	O	O	B-T079
rate	O	O	I-T079
151/767	O	O	O
,	O	O	O
19.7	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
503	O	O	O
GPs	O	O	B-T097
(	O	O	O
response	O	O	O
rate	O	O	O
503/996	O	O	O
,	O	O	O
50.5	O	O	O
%	O	O	O
)	O	O	O
agreed	O	O	O
to	O	O	O
participate	O	O	B-T169
in	O	O	O
the	O	O	O
baseline	O	O	B-T062
assessment	O	O	I-T062
.	O	O	O

At	O	O	O
the	O	O	O
follow-up	O	O	B-T062
,	O	O	O
393	O	O	O
GPs	O	O	B-T097
filled	O	O	O
in	O	O	O
the	O	O	O
questionnaires	O	O	B-T170
(	O	O	O
response	O	O	B-T079
rate	O	O	I-T079
,	O	O	O
393/503	O	O	O
,	O	O	O
78.1	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
all	O	O	O
of	O	O	O
them	O	O	O
took	O	O	O
part	O	O	O
in	O	O	O
the	O	O	O
intervention	O	O	B-T061
.	O	O	O

The	O	O	O
final	O	O	O
study	O	O	B-UnknownType
group	O	O	I-UnknownType
of	O	O	O
225	O	O	O
GPs	O	O	B-T097
participated	O	O	O
in	O	O	O
3	O	O	O
study	O	O	O
conditions	O	O	O
:	O	O	O
e-learning	O	O	B-T065
(	O	O	O
knowledge	O	O	B-T041
plus	O	O	O
skills	O	O	B-T055
modelling	O	O	B-T170
,	O	O	O
n=42	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
pdf	O	O	B-T170
article	O	O	I-T170
(	O	O	O
knowledge	O	O	O
only	O	O	O
,	O	O	O
n=89	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
control	O	O	B-T096
(	O	O	O
no	O	O	B-T080
intervention	O	O	B-T058
,	O	O	O
n=94	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
measured	O	O	O
the	O	O	O
outcome	O	O	O
as	O	O	O
scores	O	O	B-T081
on	O	O	O
the	O	O	O
Patients	O	O	B-T101
Expectations	O	O	B-T170
Scale	O	O	I-T170
,	O	O	O
Communication	O	O	B-T170
Scale	O	O	I-T170
,	O	O	O
Attitude	O	O	B-T170
Toward	O	O	I-T170
Treatment	O	O	I-T170
and	O	O	I-T170
Health	O	O	I-T170
Scale	O	O	I-T170
,	O	O	O
and	O	O	O
Self-Efficacy	O	O	B-T170
Scale	O	O	I-T170
.	O	O	O

GPs	O	O	B-T097
participating	O	O	O
in	O	O	O
e-learning	O	O	B-T065
demonstrated	O	O	O
a	O	O	O
significant	O	O	B-T078
rise	O	O	O
in	O	O	O
their	O	O	O
perception	O	O	B-T041
of	O	O	O
older	O	O	B-T098
patients	O	O	B-T101
'	O	O	O
expectations	O	O	B-T078
for	O	O	O
disease	O	O	B-T170
explanation	O	O	I-T170
(	O	O	O
Wald	O	O	O
χ(2)=19.7	O	O	O
,	O	O	O
P<.001	O	O	O
)	O	O	O
and	O	O	O
in	O	O	O
perception	O	O	O
of	O	O	O
motivational	O	O	B-T041
aspect	O	O	O
of	O	O	O
older	O	O	O
patients	O	O	O
'	O	O	O
attitude	O	O	O
toward	O	O	O
treatment	O	O	B-T169
and	O	O	O
health	O	O	B-T078
(	O	O	O
Wald	O	O	O
χ(2)=8.9	O	O	O
,	O	O	O
P=.03	O	O	O
)	O	O	O
in	O	O	O
comparison	O	O	O
with	O	O	O
both	O	O	O
the	O	O	O
control	O	O	B-T096
and	O	O	O
pdf	O	O	B-UnknownType
article	O	O	I-UnknownType
groups	O	O	I-UnknownType
.	O	O	O

We	O	O	O
observed	O	O	O
additional	O	O	O
between-	O	O	O
group	O	O	B-UnknownType
differences	O	O	O
at	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
statistical	O	O	B-T090
trend	O	O	O
.	O	O	O

GPs	O	O	B-T097
participating	O	O	O
in	O	O	O
the	O	O	O
pdf	O	O	B-T170
article	O	O	I-T170
intervention	O	O	B-T061
demonstrated	O	O	O
a	O	O	O
decline	O	O	O
in	O	O	O
self-assessed	O	O	O
communication	O	O	B-T054
,	O	O	O
both	O	O	O
at	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
global	O	O	B-T081
scoring	O	O	I-T081
(	O	O	O
Wald	O	O	O
χ(2)=34.5	O	O	O
,	O	O	O
P<.001	O	O	O
)	O	O	O
and	O	O	O
at	O	O	O
the	O	O	O
level	O	O	O
of	O	O	O
20	O	O	O
of	O	O	O
26	O	O	O
specific	O	O	B-UnknownType
behaviors	O	O	I-UnknownType
(	O	O	O
all	O	O	O
P<.05	O	O	O
)	O	O	O
.	O	O	O

Factors	O	O	O
moderating	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
intervention	O	O	B-T061
were	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
patients	O	O	B-T101
per	O	O	O
GP	O	O	B-T097
and	O	O	O
the	O	O	O
facility	O	O	O
's	O	O	O
organizational	O	O	B-T170
structure	O	O	I-T170
.	O	O	O

Both	O	O	O
methods	O	O	O
were	O	O	O
suitable	O	O	O
,	O	O	O
but	O	O	O
in	O	O	O
different	O	O	O
areas	O	O	B-T082
and	O	O	O
under	O	O	O
different	O	O	O
conditions	O	O	B-T080
.	O	O	O

The	O	O	O
key	O	O	O
benefit	O	O	O
of	O	O	O
the	O	O	O
pdf	O	O	B-T170
article	O	O	I-T170
intervention	O	O	B-T061
was	O	O	O
raising	O	O	O
doctors	O	O	B-T097
'	O	O	O
reflection	O	O	O
on	O	O	O
limitations	O	O	B-T169
in	O	O	O
their	O	O	O
communication	O	O	B-T032
skills	O	O	I-T032
,	O	O	O
whereas	O	O	O
e-learning	O	O	B-T065
was	O	O	O
more	O	O	O
effective	O	O	B-T080
in	O	O	O
changing	O	O	O
their	O	O	O
perception	O	O	O
of	O	O	O
older	O	O	B-T098
patients	O	O	B-T101
'	O	O	O
proactive	O	O	O
attitude	O	O	O
,	O	O	O
especially	O	O	O
among	O	O	O
GPs	O	O	B-T097
working	O	O	O
in	O	O	O
privately	O	O	B-T093
owned	O	O	I-T093
facilities	O	O	I-T093
and	O	O	O
having	O	O	O
a	O	O	O
greater	O	O	O
number	O	O	O
of	O	O	O
assigned	O	O	B-T169
patients	O	O	O
.	O	O	O

Although	O	O	O
we	O	O	O
did	O	O	O
not	O	O	O
achieve	O	O	O
all	O	O	O
expected	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
PRACTA	O	O	B-T058
intervention	O	O	I-T058
,	O	O	O
both	O	O	O
its	O	O	O
forms	O	O	O
seem	O	O	O
promising	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
enhancing	O	O	O
the	O	O	O
competencies	O	O	B-T080
of	O	O	O
doctors	O	O	B-T097
in	O	O	O
communication	O	O	B-T054
with	O	O	O
and	O	O	O
activation	O	O	O
of	O	O	O
older	O	O	B-T098
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28229178)

The	O	O	O
consummatory	O	O	B-T054
and	O	O	O
motivational	O	O	B-T041
behaviors	O	O	B-T053
for	O	O	O
natural	O	O	B-T169
rewards	O	O	B-T041
following	O	O	O
long-term	O	O	O
withdrawal	O	O	B-T061
from	O	O	O
morphine	O	O	B-T109
:	O	O	O
no	O	O	O
anhedonia	O	O	B-T048
but	O	O	O
persistent	O	O	O
maladaptive	O	O	B-T033
behaviors	O	O	I-T033
for	O	O	O
high-value	O	O	O
rewards	O	O	O

The	O	O	O
negative	O	O	O
affective	O	O	O
state	O	O	O
,	O	O	O
e.g.	O	O	O
,	O	O	O
anhedonia	O	O	B-T048
,	O	O	O
emerges	O	O	O
after	O	O	O
abstinence	O	O	B-T061
from	O	O	O
abused	O	O	B-T131
drugs	O	O	I-T131
may	O	O	O
be	O	O	O
linked	O	O	O
to	O	O	O
the	O	O	O
motivational	O	O	B-T041
processes	O	O	B-T067
of	O	O	O
drug	O	O	B-T033
craving	O	O	I-T033
and	O	O	O
relapse	O	O	B-T067
.	O	O	O

Although	O	O	O
anhedonia	O	O	B-T048
diminishes	O	O	O
over	O	O	O
time	O	O	O
with	O	O	O
drug	O	O	B-T055
abstinence	O	O	I-T055
,	O	O	O
it	O	O	O
is	O	O	O
not	O	O	O
yet	O	O	O
rather	O	O	O
explicit	O	O	O
whether	O	O	O
anhedonia	O	O	O
exists	O	O	O
or	O	O	O
not	O	O	O
following	O	O	O
protracted	O	O	O
withdrawal	O	O	B-T061
.	O	O	O

The	O	O	O
behavioral	O	O	B-T053
responses	O	O	B-T032
to	O	O	O
natural	O	O	B-T169
rewards	O	O	B-T041
were	O	O	O
examined	O	O	O
after	O	O	O
2	O	O	O
to	O	O	O
3	O	O	O
weeks	O	O	B-T079
withdrawal	O	O	B-T061
from	O	O	O
morphine	O	O	B-T109
.	O	O	O

Male	O	O	B-T032
rats	O	O	B-T015
were	O	O	O
pretreated	O	O	O
with	O	O	O
either	O	O	O
a	O	O	O
binge-like	O	O	O
morphine	O	O	B-T109
paradigm	O	O	B-T062
or	O	O	O
daily	O	O	B-T079
saline	O	O	B-T061
injection	O	O	I-T061
for	O	O	O
5	O	O	O
days	O	O	B-T079
.	O	O	O

The	O	O	O
consummatory	O	O	B-T054
and	O	O	O
motivational	O	O	B-T041
behaviors	O	O	B-T053
for	O	O	O
three	O	O	O
natural	O	O	B-T169
rewards	O	O	B-T041
(	O	O	O
sucrose	O	O	B-T109
solutions	O	O	I-T109
4	O	O	O
,	O	O	O
15	O	O	O
,	O	O	O
and	O	O	O
60	O	O	O
%	O	O	O
,	O	O	O
social	O	O	B-T169
stimulus	O	O	B-T067
:	O	O	O
male	O	O	B-T032
rat	O	O	B-T015
,	O	O	O
and	O	O	O
sexual	O	O	B-T054
stimulus	O	O	O
:	O	O	O
estrous	O	O	B-T040
female	O	O	B-T032
rat	O	O	O
)	O	O	O
were	O	O	O
examined	O	O	O
under	O	O	O
varied	O	O	O
testing	O	O	B-T080
conditions	O	O	I-T080
.	O	O	O

The	O	O	O
morphine	O	O	B-T109
-	O	O	O
withdrawn	O	O	B-T061
rats	O	O	B-T015
significantly	O	O	O
increased	O	O	O
their	O	O	O
intake	O	O	O
of	O	O	O
15	O	O	O
%	O	O	O
sucrose	O	O	B-T109
solution	O	O	I-T109
during	O	O	O
the	O	O	O
1-h	O	O	O
consumption	O	O	B-T060
test	O	O	I-T060
and	O	O	O
their	O	O	O
operant	O	O	B-T041
responding	O	O	I-T041
for	O	O	O
15	O	O	O
%	O	O	O
sucrose	O	O	O
solution	O	O	O
under	O	O	O
a	O	O	O
progressive	O	O	B-T062
ratio	O	O	I-T062
(	O	O	I-T062
PR	O	O	I-T062
)	O	O	I-T062
schedule	O	O	I-T062
of	O	O	I-T062
reinforcement	O	O	I-T062
.	O	O	O

When	O	O	O
obtaining	O	O	O
a	O	O	O
reinforcer	O	O	B-T078
was	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
0.5	O	O	O
mA	O	O	O
foot	O	O	B-T023
shock	O	O	B-T061
under	O	O	O
a	O	O	O
PR-punishment	O	O	B-T062
schedule	O	O	I-T062
,	O	O	O
the	O	O	O
morphine	O	O	B-T109
-	O	O	O
withdrawn	O	O	B-T061
rats	O	O	B-T015
showed	O	O	O
a	O	O	O
higher	O	O	O
performance	O	O	O
for	O	O	O
60	O	O	O
%	O	O	O
sucrose	O	O	B-T109
solution	O	O	I-T109
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
the	O	O	O
morphine	O	O	B-T109
-	O	O	O
withdrawn	O	O	B-T061
rats	O	O	B-T015
displayed	O	O	O
a	O	O	O
higher	O	O	O
motivation	O	O	B-T041
to	O	O	O
sexual	O	O	B-T054
stimulus	O	O	B-T067
during	O	O	O
the	O	O	O
free-approach	O	O	B-T060
test	O	O	I-T060
and	O	O	O
more	O	O	O
approaching	O	O	O
behaviors	O	O	B-T053
towards	O	O	O
sexual	O	O	O
stimulus	O	O	O
in	O	O	O
a	O	O	O
conflict-based	O	O	B-T060
approach	O	O	I-T060
test	O	O	I-T060
(	O	O	O
concurrent	O	O	O
presence	O	O	O
of	O	O	O
reward	O	O	B-T041
and	O	O	O
aversive	O	O	B-T169
stimulus	O	O	I-T169
)	O	O	O
.	O	O	O

No	O	O	B-T033
anhedonia	O	O	B-T048
-like	O	O	O
behavior	O	O	B-T053
but	O	O	O
sensitized	O	O	B-T169
behaviors	O	O	B-T053
for	O	O	O
natural	O	O	B-T169
rewards	O	O	B-T041
were	O	O	O
found	O	O	O
after	O	O	O
long-term	O	O	O
morphine	O	O	B-T109
withdrawal	O	O	B-T061
.	O	O	O

Notably	O	O	O
,	O	O	O
the	O	O	O
morphine	O	O	B-T109
-	O	O	O
withdrawn	O	O	B-T061
rats	O	O	B-T015
displayed	O	O	O
persistent	O	O	O
motivated	O	O	B-T041
behaviors	O	O	B-T053
for	O	O	O
high-value	O	O	O
rewards	O	O	B-T041
(	O	O	O
60	O	O	O
%	O	O	O
sucrose	O	O	B-T109
and	O	O	O
sexual	O	O	B-T054
stimulus	O	O	B-T067
)	O	O	O
in	O	O	O
the	O	O	O
conflict	O	O	B-T060
tests	O	O	I-T060
suggesting	O	O	O
impairments	O	O	O
in	O	O	O
inhibitory	O	O	O
control	O	O	O
in	O	O	O
morphine	O	O	O
-	O	O	O
treated	O	O	B-T169
rats	O	O	O
.	O	O	O

-DOCSTART- (28230977)

Extracellular	O	O	B-T026
Self-Assembly	O	O	B-T044
of	O	O	O
Functional	O	O	B-T169
and	O	O	O
Tunable	O	O	B-T116
Protein	O	O	I-T116
Conjugates	O	O	I-T116
from	O	O	O
Bacillus	O	O	O
subtilis	O	O	O

The	O	O	O
ability	O	O	O
to	O	O	O
stably	O	O	B-T080
and	O	O	O
specifically	O	O	O
conjugate	O	O	B-T043
recombinant	O	O	B-T116
proteins	O	O	I-T116
to	O	O	O
one	O	O	O
another	O	O	O
is	O	O	O
a	O	O	O
powerful	O	O	O
approach	O	O	O
for	O	O	O
engineering	O	O	B-T063
multifunctional	O	O	B-T169
enzymes	O	O	B-T116
,	O	O	O
protein	O	O	B-T121
therapeutics	O	O	I-T121
,	O	O	O
and	O	O	O
novel	O	O	B-T080
biological	O	O	B-T122
materials	O	O	I-T122
.	O	O	O

While	O	O	O
many	O	O	O
of	O	O	O
these	O	O	O
applications	O	O	B-UnknownType
have	O	O	O
been	O	O	O
illustrated	O	O	O
through	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
intracellular	O	O	B-T082
protein	O	O	B-T043
conjugation	O	O	I-T043
methods	O	O	O
,	O	O	O
extracellular	O	O	B-T026
self-assembly	O	O	B-T044
of	O	O	O
protein	O	O	B-T116
conjugates	O	O	I-T116
offers	O	O	O
unique	O	O	O
advantages	O	O	O
:	O	O	O
simplifying	O	O	O
purification	O	O	B-T059
,	O	O	O
reducing	O	O	B-T080
toxicity	O	O	B-T037
and	O	O	O
burden	O	O	B-T078
,	O	O	O
and	O	O	O
enabling	O	O	O
tunability	O	O	B-T080
.	O	O	O

Exploiting	O	O	O
the	O	O	O
recently	O	O	O
described	O	O	O
SpyTag-SpyCatcher	O	O	B-T059
system	O	O	I-T059
,	O	O	O
we	O	O	O
describe	O	O	O
here	O	O	O
how	O	O	O
enzymes	O	O	B-T116
and	O	O	O
structural	O	O	B-T116
proteins	O	O	I-T116
can	O	O	O
be	O	O	O
genetically	O	O	B-T045
encoded	O	O	I-T045
to	O	O	O
covalently	O	O	B-T044
conjugate	O	O	B-T043
in	O	O	O
culture	O	O	B-T130
media	O	O	I-T130
following	O	O	O
programmable	O	O	B-T043
secretion	O	O	I-T043
from	O	O	O
Bacillus	O	O	B-T007
subtilis	O	O	I-T007
.	O	O	O

Using	O	O	O
this	O	O	O
approach	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
how	O	O	O
self-conjugation	O	O	B-T043
of	O	O	O
a	O	O	O
secreted	O	O	B-T043
industrial	O	O	O
enzyme	O	O	B-T116
,	O	O	O
XynA	O	O	B-T116
,	O	O	O
dramatically	O	O	O
increases	O	O	B-T081
its	O	O	O
resilience	O	O	B-T033
to	O	O	O
boiling	O	O	B-T069
,	O	O	O
and	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
cellular	O	O	B-T025
consortia	O	O	I-T025
can	O	O	O
be	O	O	O
engineered	O	O	B-T063
to	O	O	O
self-assemble	O	O	B-T044
functional	O	O	B-T169
protein-protein	O	O	B-T116
conjugates	O	O	I-T116
with	O	O	O
tunable	O	O	O
composition	O	O	O
.	O	O	O

This	O	O	O
novel	O	O	B-T080
genetically	O	O	B-T045
encoded	O	O	I-T045
modular	O	O	B-T169
system	O	O	I-T169
provides	O	O	O
a	O	O	O
flexible	O	O	B-T080
strategy	O	O	I-T080
for	O	O	O
protein	O	O	B-T043
conjugation	O	O	I-T043
harnessing	O	O	O
the	O	O	O
substantial	O	O	O
advantages	O	O	O
of	O	O	O
extracellular	O	O	B-T026
self-assembly	O	O	B-T044
.	O	O	O

-DOCSTART- (28234672)

Vascular	O	O	B-T025
smooth	O	O	I-T025
muscle	O	O	I-T025
cell	O	O	I-T025
peroxisome	O	O	B-T116
proliferator-activated	O	O	I-T116
receptor	O	O	I-T116
γ	O	O	I-T116
protects	O	O	O
against	O	O	O
endothelin-1	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
inflammation	O	O	O

Peroxisome	O	O	B-T116
proliferator-activated	O	O	I-T116
receptor	O	O	I-T116
γ	O	O	I-T116
(	O	O	O
PPARγ	O	O	B-T116
)	O	O	O
agonists	O	O	B-T121
reduce	O	O	B-T080
blood	O	O	B-T040
pressure	O	O	I-T040
and	O	O	O
vascular	O	O	B-T037
injury	O	O	I-T037
in	O	O	O
hypertensive	O	O	B-T033
rodents	O	O	B-T015
.	O	O	O

Pparγ	O	O	B-T116
inactivation	O	O	B-T044
in	O	O	O
vascular	O	O	B-T025
smooth	O	O	I-T025
muscle	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
VSMC	O	O	B-T025
)	O	O	O
enhances	O	O	B-T052
vascular	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

Transgenic	O	O	B-T015
mice	O	O	I-T015
overexpressing	O	O	B-T045
endothelin	O	O	B-T116
(ET)-1	O	O	I-T116
selectively	O	O	O
in	O	O	O
the	O	O	O
endothelium	O	O	B-T024
(	O	O	B-T116
eET-1	O	O	I-T116
)	O	O	I-T116
exhibit	O	O	O
endothelial	O	O	B-T047
dysfunction	O	O	I-T047
,	O	O	O
increased	O	O	B-T081
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
inflammation	O	O	B-T046
.	O	O	O

We	O	O	O
hypothesized	O	O	B-T078
that	O	O	O
inactivation	O	O	B-T044
of	O	O	O
the	O	O	O
Pparγ	O	O	B-T028
gene	O	O	I-T028
in	O	O	O
VSMC	O	O	B-T025
(	O	O	O
smPparγ	O	O	B-T028
)	O	O	O
would	O	O	O
exaggerate	O	O	B-T080
ET-1	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
vascular	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

eET-1	O	O	B-T116
,	O	O	O
smPparγ	O	O	B-T116
and	O	O	O
eET-1	O	O	O
/	O	O	O
smPparγ	O	O	O
mice	O	O	B-T015
were	O	O	O
treated	O	O	B-T033
with	O	O	O
tamoxifen	O	O	B-T109
for	O	O	O
5	O	O	O
days	O	O	O
and	O	O	O
studied	O	O	B-T062
4	O	O	O
weeks	O	O	O
later	O	O	O
.	O	O	O

SBP	O	O	B-T201
was	O	O	O
higher	O	O	B-T080
in	O	O	O
eET-1	O	O	B-T116
and	O	O	O
unaffected	O	O	B-T077
by	O	O	O
smPparγ	O	O	B-T116
inactivation	O	O	B-T044
.	O	O	O

Mesenteric	O	O	B-T023
artery	O	O	I-T023
vasodilatory	O	O	B-T042
responses	O	O	B-T032
to	O	O	O
acetylcholine	O	O	B-T109
were	O	O	O
impaired	O	O	B-T169
only	O	O	O
in	O	O	O
smPparγ	O	O	B-T116
.	O	O	O

N-Nitro-L-arginine	O	O	B-T116
methyl	O	O	I-T116
ester	O	O	I-T116
abrogated	O	O	B-T169
relaxation	O	O	B-T052
responses	O	O	B-T032
,	O	O	O
and	O	O	O
the	O	O	O
Ednra	O	O	B-T028
/	O	O	O
Ednrb	O	O	B-T028
mRNA	O	O	B-T114
ratio	O	O	B-T081
was	O	O	O
decreased	O	O	B-T081
in	O	O	O
eET-1	O	O	B-T116
/	O	O	O
smPparγ	O	O	B-T116
,	O	O	O
which	O	O	O
could	O	O	O
indicate	O	O	B-T078
that	O	O	O
nitric	O	O	B-T121
oxide	O	O	I-T121
production	O	O	B-T052
was	O	O	O
enhanced	O	O	B-T052
by	O	O	O
ET-1	O	O	B-T116
stimulation	O	O	B-T045
of	O	O	O
endothelin	O	O	B-T116
type	O	O	I-T116
B	O	O	I-T116
receptors	O	O	I-T116
.	O	O	O

Mesenteric	O	O	B-T023
artery	O	O	I-T023
media	O	O	B-T167
/	O	O	O
lumen	O	O	B-T080
was	O	O	O
greater	O	O	B-T081
only	O	O	O
in	O	O	O
eET-1	O	O	B-T116
/	O	O	O
smPparγ	O	O	B-T116
.	O	O	O

Mesenteric	O	O	B-T023
artery	O	O	I-T023
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
increased	O	O	B-T081
in	O	O	O
smPparγ	O	O	B-T116
and	O	O	O
were	O	O	O
further	O	O	O
enhanced	O	O	B-T052
in	O	O	O
eET-1	O	O	B-T116
/	O	O	O
smPparγ	O	O	O
.	O	O	O

Perivascular	O	O	B-T082
fat	O	O	B-T025
monocyte	O	O	I-T025
/	O	O	O
macrophage	O	O	B-T025
infiltration	O	O	B-T046
was	O	O	O
higher	O	O	B-T080
in	O	O	O
eET-1	O	O	B-T116
and	O	O	O
smPparγ	O	O	B-T116
and	O	O	O
increased	O	O	B-T081
further	O	O	O
in	O	O	O
eET-1	O	O	O
/	O	O	O
smPparγ	O	O	O
.	O	O	O

Spleen	O	O	B-T023
CD11b	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
increased	O	O	B-T081
in	O	O	O
smPparγ	O	O	B-T116
and	O	O	O
further	O	O	O
enhance	O	O	B-T052
d	O	O	O
in	O	O	O
eET-1	O	O	B-T116
/	O	O	O
smPparγ	O	O	O
,	O	O	O
whereas	O	O	O
Ly-6C	O	O	B-T025
monocytes	O	O	I-T025
increased	O	O	O
in	O	O	O
eET-1	O	O	O
and	O	O	O
smPparγ	O	O	O
but	O	O	O
not	O	O	O
in	O	O	O
eET-1	O	O	O
/	O	O	O
smPparγ	O	O	O
.	O	O	O

Spleen	O	O	B-T023
T	O	O	B-T025
regulatory	O	O	I-T025
lymphocytes	O	O	I-T025
increased	O	O	B-T081
in	O	O	O
smPparγ	O	O	B-T116
and	O	O	O
decreased	O	O	B-T081
in	O	O	O
eET-1	O	O	B-T116
,	O	O	O
and	O	O	O
decreased	O	O	O
further	O	O	O
in	O	O	O
eET-1	O	O	O
/	O	O	O
smPparγ	O	O	O
.	O	O	O

VSMC	O	O	B-T025
Pparγ	O	O	B-T116
inactivation	O	O	B-T044
exaggerates	O	O	B-T080
ET-1	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
vascular	O	O	B-T037
injury	O	O	I-T037
,	O	O	O
supporting	O	O	O
a	O	O	O
protective	O	O	O
role	O	O	B-T077
for	O	O	O
PPARγ	O	O	B-T116
in	O	O	O
hypertension	O	O	B-T047
through	O	O	O
modulation	O	O	B-T082
of	O	O	O
pro-oxidant	O	O	B-T123
and	O	O	O
proinflammatory	O	O	B-T169
pathways	O	O	B-T044
.	O	O	O

Paradoxically	O	O	O
,	O	O	O
ET-1	O	O	B-T116
overexpression	O	O	B-T045
preserved	O	O	O
endothelial	O	O	B-T024
function	O	O	B-T169
in	O	O	O
smPparγ	O	O	B-T116
mice	O	O	B-T015
,	O	O	O
presumably	O	O	O
by	O	O	O
enhancing	O	O	B-T052
nitric	O	O	B-T121
oxide	O	O	I-T121
through	O	O	O
stimulation	O	O	B-T045
of	O	O	O
endothelin	O	O	B-T116
type	O	O	I-T116
B	O	O	I-T116
receptors	O	O	I-T116
.	O	O	O

-DOCSTART- (28235120)

Prospective	O	O	O
Evaluation	O	O	B-T058
of	O	O	O
Opioid	O	O	B-T048
Consumption	O	O	I-T048
After	O	O	O
Distal	O	O	B-T037
Radius	O	O	I-T037
Fracture	O	O	I-T037
Repair	O	O	O
Surgery	O	O	O

Pain	O	O	B-T061
management	O	O	I-T061
and	O	O	O
opioid	O	O	B-T048
consumption	O	O	I-T048
after	O	O	O
distal	O	O	B-T037
radius	O	O	I-T037
fracture	O	O	I-T037
(	O	O	O
DRF	O	O	B-T037
)	O	O	O
open	O	O	B-T061
reduction	O	O	I-T061
and	O	O	I-T061
internal	O	O	I-T061
fixation	O	O	I-T061
(	O	O	I-T061
ORIF	O	O	I-T061
)	O	O	I-T061
are	O	O	O
highly	O	O	O
variable	O	O	O
and	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

To	O	O	O
optimize	O	O	B-T061
postoperative	O	O	B-T079
opioid	O	O	B-T109
dosage	O	O	B-T081
and	O	O	O
better	O	O	O
understand	O	O	O
opioid	O	O	B-T048
consumption	O	O	I-T048
patterns	O	O	O
after	O	O	O
DRF	O	O	B-T037
-	O	O	O
ORIF	O	O	B-T061
,	O	O	O
we	O	O	O
conducted	O	O	O
a	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
with	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
opioid	O	O	O
consumption	O	O	O
would	O	O	O
increase	O	O	B-T169
with	O	O	O
worsening	O	O	B-T080
fracture	O	O	B-T037
classification	O	O	B-T185
and	O	O	O
various	O	O	O
patient	O	O	B-T078
demographics	O	O	I-T078
.	O	O	O

All	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
DRF	O	O	B-T037
-	O	O	O
ORIF	O	O	B-T061
were	O	O	O
consecutively	O	O	O
enrolled	O	O	O
over	O	O	O
a	O	O	O
6-month	O	O	B-T079
period	O	O	I-T079
.	O	O	O

Information	O	O	O
collected	O	O	O
included	O	O	O
patient	O	O	B-T078
demographics	O	O	I-T078
,	O	O	O
fracture	O	O	B-T080
type	O	O	B-T080
,	O	O	O
anesthesia	O	O	B-T185
type	O	O	I-T185
,	O	O	O
amount	O	O	B-T081
and	O	O	O
type	O	O	O
of	O	O	O
opioid	O	O	B-T109
prescribed	O	O	B-T058
,	O	O	O
number	O	O	B-T081
of	O	O	O
pills	O	O	B-T109
taken	O	O	B-T077
,	O	O	O
reason	O	O	B-T078
for	O	O	O
stopping	O	O	B-T061
,	O	O	O
and	O	O	O
adverse	O	O	B-T046
events	O	O	I-T046
.	O	O	O

Statistical	O	O	B-T062
analysis	O	O	I-T062
was	O	O	O
performed	O	O	O
.	O	O	O

Ninety-eight	O	O	O
patients	O	O	B-T101
(	O	O	O
79	O	O	O
female	O	O	B-T098
,	O	O	O
19	O	O	O
male	O	O	B-T098
)	O	O	O
were	O	O	O
eligible	O	O	O
for	O	O	O
the	O	O	O
study	O	O	O
.	O	O	O

Mean	O	O	O
age	O	O	O
was	O	O	O
58	O	O	O
years	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
98	O	O	O
patients	O	O	B-T101
,	O	O	O
45	O	O	O
received	O	O	O
general	O	O	B-T061
anesthesia	O	O	I-T061
,	O	O	O
and	O	O	O
53	O	O	O
received	O	O	O
regional	O	O	B-T061
anesthesia	O	O	I-T061
with	O	O	O
a	O	O	O
single-shot	O	O	O
peripheral	O	O	B-T061
nerve	O	O	I-T061
block	O	O	I-T061
.	O	O	O

Mean	O	O	O
opioid	O	O	B-T048
consumption	O	O	I-T048
(	O	O	O
morphine	O	O	B-T109
equivalence	O	O	B-T080
)	O	O	O
over	O	O	O
a	O	O	O
mean	O	O	O
of	O	O	O
4.8	O	O	O
postoperative	O	O	B-T079
days	O	O	I-T079
(	O	O	O
range	O	O	O
,	O	O	O
0	O	O	O
-	O	O	O
16	O	O	O
days	O	O	O
)	O	O	O
was	O	O	O
58.5	O	O	O
mg	O	O	O
(	O	O	O
range	O	O	O
,	O	O	O
0	O	O	O
-	O	O	O
280	O	O	O
mg	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
differences	O	O	O
in	O	O	O
opioid	O	O	B-T048
consumption	O	O	I-T048
between	O	O	O
the	O	O	O
general	O	O	B-T061
and	O	O	O
regional	O	O	B-T061
anesthesia	O	O	I-T061
groups	O	O	O
.	O	O	O

Mean	O	O	O
opioid	O	O	B-T048
consumption	O	O	I-T048
for	O	O	O
the	O	O	O
3	O	O	O
fracture-type	O	O	B-T080
groups	O	O	O
(	O	O	O
AO/OTA	O	O	B-T170
[	O	O	I-T170
Arbeitsgemeinschaft	O	O	I-T170
für	O	O	I-T170
Osteosynthesefragen/Orthopaedic	O	O	I-T170
Trauma	O	O	I-T170
Association	O	O	I-T170
]	O	O	I-T170
classification	O	O	I-T170
)	O	O	O
was	O	O	O
57.7	O	O	O
mg	O	O	O
(	O	O	O
class	O	O	B-T185
A	O	O	I-T185
)	O	O	O
,	O	O	O
60.3	O	O	O
mg	O	O	O
(	O	O	O
class	O	O	B-T185
B	O	O	I-T185
)	O	O	O
,	O	O	O
and	O	O	O
62.0	O	O	O
mg	O	O	O
(	O	O	O
class	O	O	B-T185
C	O	O	I-T185
)	O	O	O
.	O	O	O

Demographic	O	O	B-T062
analysis	O	O	I-T062
revealed	O	O	O
an	O	O	O
inverse	O	O	B-T080
relationship	O	O	B-T080
between	O	O	O
age	O	O	B-T032
and	O	O	O
opioid	O	O	B-T048
use	O	O	I-T048
.	O	O	O

Similarly	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
trend	O	O	O
toward	O	O	O
more	O	O	O
opioid	O	O	B-T048
consumption	O	O	I-T048
among	O	O	O
self-pay	O	O	B-T033
and	O	O	O
Medicaid	O	O	B-T064
patients	O	O	B-T101
.	O	O	O

Opioid	O	O	B-T048
consumption	O	O	I-T048
after	O	O	O
DRF	O	O	B-T037
-	O	O	O
ORIF	O	O	B-T061
was	O	O	O
equivalent	O	O	B-T080
for	O	O	O
general	O	O	B-T061
and	O	O	O
regional	O	O	B-T061
anesthesia	O	O	I-T061
.	O	O	O

A	O	O	O
significant	O	O	O
relationship	O	O	B-T080
was	O	O	O
found	O	O	O
between	O	O	O
increasing	O	O	B-T033
age	O	O	I-T033
and	O	O	O
decreasing	O	O	B-T033
opioid	O	O	B-T048
consumption	O	O	I-T048
.	O	O	O

Worsening	O	O	B-T080
fracture	O	O	B-T170
classification	O	O	I-T170
and	O	O	O
self-payment	O	O	B-T033
/	O	O	O
Medicaid	O	O	B-T064
payment	O	O	I-T064
trended	O	O	O
toward	O	O	O
increasing	O	O	B-T169
opioid	O	O	B-T048
consumption	O	O	I-T048
.	O	O	O

Mean	O	O	O
overall	O	O	O
opioid	O	O	B-T048
consumption	O	O	I-T048
(	O	O	O
morphine	O	O	B-T109
equivalence	O	O	B-T080
)	O	O	O
was	O	O	O
58.5	O	O	O
mg	O	O	O
,	O	O	O
or	O	O	O
14.6	O	O	O
pills	O	O	B-T122
of	O	O	O
oxycodone/acetaminophen	O	O	B-T121
5/325	O	O	O
mg	O	O	O
.	O	O	O

Surgeons	O	O	B-T097
should	O	O	O
take	O	O	O
these	O	O	O
findings	O	O	O
into	O	O	O
account	O	O	O
when	O	O	O
optimizing	O	O	B-T061
opioid	O	O	B-T109
prescribing	O	O	O
after	O	O	O
DRF	O	O	B-T037
repair	O	O	B-T061
.	O	O	O

-DOCSTART- (28236130)

Entrapment	O	O	B-T047
of	O	O	O
the	O	O	O
posterior	O	O	B-T023
femoral	O	O	I-T023
cutaneous	O	O	I-T023
nerve	O	O	I-T023
and	O	O	O
its	O	O	O
inferior	O	O	B-T023
cluneal	O	O	I-T023
branches	O	O	I-T023
:	O	O	O
anatomical	O	O	B-T029
basis	O	O	I-T029
of	O	O	O
surgery	O	O	B-T091
for	O	O	O
inferior	O	O	O
cluneal	O	O	O
neuralgia	O	O	O

The	O	O	O
apparent	O	O	O
failure	O	O	O
of	O	O	O
pudendal	O	O	B-T023
nerve	O	O	I-T023
surgery	O	O	B-T091
in	O	O	O
some	O	O	O
patients	O	O	B-T101
has	O	O	O
led	O	O	O
us	O	O	O
to	O	O	O
suggest	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
entrapment	O	O	B-T047
of	O	O	O
other	O	O	O
adjacent	O	O	B-T024
nerve	O	O	I-T024
structures	O	O	I-T024
,	O	O	O
leading	O	O	O
to	O	O	O
the	O	O	O
concept	O	O	O
of	O	O	O
inferior	O	O	B-T184
cluneal	O	O	I-T184
neuralgia	O	O	I-T184
.	O	O	O

Via	O	O	O
its	O	O	O
numerous	O	O	O
collateral	O	O	B-T023
branches	O	O	I-T023
,	O	O	O
the	O	O	O
posterior	O	O	B-T023
femoral	O	O	I-T023
cutaneous	O	O	I-T023
nerve	O	O	I-T023
innervates	O	O	O
a	O	O	O
very	O	O	O
extensive	O	O	O
territory	O	O	O
including	O	O	O
the	O	O	O
posterior	O	O	B-T029
surface	O	O	I-T029
of	O	O	I-T029
the	O	O	I-T029
thigh	O	O	I-T029
,	O	O	O
the	O	O	O
infragluteal	O	O	B-T023
fold	O	O	I-T023
,	O	O	O
the	O	O	O
skin	O	O	B-T022
over	O	O	O
the	O	O	O
ischial	O	O	B-T023
tuberosity	O	O	I-T023
,	O	O	O
but	O	O	O
also	O	O	O
the	O	O	O
lateral	O	O	B-T029
anal	O	O	I-T029
region	O	O	I-T029
,	O	O	O
scrotum	O	O	B-T023
or	O	O	O
labium	O	O	B-T023
majus	O	O	I-T023
via	O	O	O
its	O	O	O
perineal	O	O	B-T023
branch	O	O	I-T023
.	O	O	O

We	O	O	O
described	O	O	O
the	O	O	O
pathophysiological	O	O	B-T169
features	O	O	B-T080
of	O	O	O
cluneal	O	O	B-T184
neuralgia	O	O	I-T184
,	O	O	O
the	O	O	O
surgical	O	O	B-T060
technique	O	O	I-T060
and	O	O	O
our	O	O	O
preliminary	O	O	B-T078
results	O	O	I-T078
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
transmuscular	O	O	B-T061
approach	O	O	I-T061
leading	O	O	O
to	O	O	O
the	O	O	O
fat	O	O	B-T023
of	O	O	O
the	O	O	O
deep	O	O	O
gluteal	O	O	B-T029
region	O	O	I-T029
.	O	O	O

Exploration	O	O	B-T061
was	O	O	O
continued	O	O	O
cranially	O	O	O
underneath	O	O	O
the	O	O	O
piriformis	O	O	B-T023
,	O	O	O
looking	O	O	O
for	O	O	O
potential	O	O	O
entrapments	O	O	B-T047
affecting	O	O	O
the	O	O	O
posterior	O	O	B-T023
femoral	O	O	I-T023
cutaneous	O	O	I-T023
nerve	O	O	I-T023
and	O	O	O
the	O	O	O
sciatic	O	O	B-T023
nerve	O	O	I-T023
.	O	O	O

Nerve	O	O	B-T061
decompression	O	O	I-T061
on	O	O	O
the	O	O	O
lateral	O	O	B-T029
surface	O	O	I-T029
of	O	O	O
the	O	O	O
ischial	O	O	B-T023
tuberosity	O	O	I-T023
was	O	O	O
then	O	O	O
performed	O	O	O
.	O	O	O

A	O	O	O
constant	O	O	O
anatomical	O	O	B-T029
finding	O	O	I-T029
must	O	O	O
be	O	O	O
highlighted	O	O	O
:	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
a	O	O	O
lateral	O	O	B-T024
fibrous	O	O	I-T024
expansion	O	O	B-T061
from	O	O	O
the	O	O	O
ischium	O	O	B-T023
passing	O	O	O
behind	O	O	O
the	O	O	O
nerves	O	O	B-T024
and	O	O	O
vessels	O	O	B-T023
,	O	O	O
especially	O	O	O
the	O	O	O
posterior	O	O	B-T023
femoral	O	O	I-T023
cutaneous	O	O	I-T023
nerve	O	O	I-T023
and	O	O	O
its	O	O	O
perineal	O	O	B-T023
branches	O	O	I-T023
.	O	O	O

In	O	O	O
our	O	O	O
patients	O	O	B-T101
,	O	O	O
release	O	O	O
of	O	O	O
this	O	O	O
expansion	O	O	B-T061
allowed	O	O	O
decompression	O	O	B-T061
of	O	O	O
the	O	O	O
nerve	O	O	B-T047
trapped	O	O	I-T047
by	O	O	O
this	O	O	O
expansion	O	O	O
.	O	O	O

Cluneal	O	O	B-T184
neuralgia	O	O	I-T184
constitutes	O	O	O
a	O	O	O
distinct	O	O	O
entity	O	O	O
of	O	O	O
perineal	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
which	O	O	O
must	O	O	O
be	O	O	O
identified	O	O	O
and	O	O	O
distinguished	O	O	O
from	O	O	O
pudendal	O	O	B-T047
neuralgia	O	O	I-T047
.	O	O	O

Surgery	O	O	B-T091
should	O	O	O
be	O	O	O
performed	O	O	O
via	O	O	O
a	O	O	O
transgluteal	O	O	B-T082
approach	O	O	I-T082
.	O	O	O

A	O	O	O
lateral	O	O	B-T023
ischial	O	O	I-T023
obstacle	O	O	O
must	O	O	O
be	O	O	O
investigated	O	O	B-T169
,	O	O	O
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
a	O	O	O
constant	O	O	O
fibrous	O	O	B-T024
expansion	O	O	B-T061
,	O	O	O
which	O	O	O
,	O	O	O
like	O	O	O
a	O	O	O
retinaculum	O	O	B-T023
,	O	O	O
can	O	O	O
cause	O	O	O
nerve	O	O	B-T047
entrapment	O	O	I-T047
.	O	O	O

-DOCSTART- (28237116)

Methods	O	O	B-T170
to	O	O	O
Study	O	O	B-T062
Autophagy	O	O	B-T043
in	O	O	O
Zebrafish	O	O	O

Autophagy	O	O	B-T043
(	O	O	O
cellular	O	O	B-T043
self-eating	O	O	I-T043
)	O	O	O
is	O	O	O
a	O	O	O
highly	O	O	O
regulated	O	O	O
degradation	O	O	B-T044
process	O	O	I-T044
of	O	O	O
the	O	O	O
eukaryotic	O	O	B-T025
cell	O	O	I-T025
during	O	O	O
which	O	O	O
parts	O	O	O
of	O	O	O
the	O	O	O
cytoplasm	O	O	B-T026
are	O	O	O
delivered	O	O	B-T169
into	O	O	O
,	O	O	O
and	O	O	O
broken	O	O	B-T080
down	O	O	I-T080
within	O	O	O
,	O	O	O
the	O	O	O
lysosomal	O	O	B-T029
compartment	O	O	I-T029
.	O	O	O

The	O	O	O
process	O	O	O
serves	O	O	O
as	O	O	O
a	O	O	O
main	O	O	O
route	O	O	O
for	O	O	O
the	O	O	O
elimination	O	O	B-T039
of	O	O	O
superfluous	O	O	O
and	O	O	O
damaged	O	O	O
cellular	O	O	B-T026
constituents	O	O	I-T026
,	O	O	O
thereby	O	O	O
mediating	O	O	O
macromolecular	O	O	B-T044
and	O	O	O
organellar	O	O	B-T042
turnover	O	O	I-T042
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
maintaining	O	O	O
cellular	O	O	B-T043
homeostasis	O	O	I-T043
,	O	O	O
autophagy	O	O	B-T043
is	O	O	O
involved	O	O	O
in	O	O	O
various	O	O	O
other	O	O	O
cellular	O	O	O
and	O	O	O
developmental	O	O	B-T040
processes	O	O	I-T040
by	O	O	O
degrading	O	O	B-T044
specific	O	O	O
regulatory	O	O	B-T116
proteins	O	O	I-T116
,	O	O	O
and	O	O	O
contributing	O	O	O
to	O	O	O
the	O	O	O
clearance	O	O	O
of	O	O	O
intracellular	O	O	B-T082
pathogens	O	O	B-T001
.	O	O	O

The	O	O	O
physiological	O	O	B-T169
roles	O	O	I-T169
and	O	O	O
pathological	O	O	B-T169
involvement	O	O	O
of	O	O	O
autophagy	O	O	B-T043
can	O	O	O
be	O	O	O
effectively	O	O	O
studied	O	O	O
in	O	O	O
divergent	O	O	O
eukaryotic	O	O	B-T204
model	O	O	B-T075
systems	O	O	I-T075
ranging	O	O	O
from	O	O	O
yeast	O	O	B-T004
to	O	O	O
mice	O	O	B-T015
.	O	O	O

Such	O	O	O
a	O	O	O
tractable	O	O	O
animal	O	O	B-T008
model	O	O	I-T008
applied	O	O	O
only	O	O	O
recently	O	O	O
for	O	O	O
autophagy	O	O	B-T043
researchis	O	O	O
the	O	O	O
zebrafish	O	O	B-T013
Danio	O	O	B-T013
rerio	O	O	I-T013
,	O	O	O
which	O	O	O
also	O	O	O
facilitates	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
more	O	O	O
specific	O	O	O
biological	O	O	B-T038
processes	O	O	I-T038
such	O	O	O
as	O	O	O
tissue	O	O	B-T042
regeneration	O	O	I-T042
.	O	O	O

In	O	O	O
this	O	O	O
chapter	O	O	O
,	O	O	O
we	O	O	O
overview	O	O	O
the	O	O	O
main	O	O	O
methods	O	O	B-T169
and	O	O	I-T169
tools	O	O	I-T169
that	O	O	O
are	O	O	O
used	O	O	O
to	O	O	O
monitor	O	O	O
autophagic	O	O	B-T026
structures	O	O	I-T026
and	O	O	O
to	O	O	O
assay	O	O	B-T059
autophagic	O	O	B-T043
responses	O	O	I-T043
in	O	O	O
this	O	O	O
vertebrate	O	O	B-T010
organism	O	O	I-T010
.	O	O	O

We	O	O	O
place	O	O	O
emphasis	O	O	O
on	O	O	O
genetic	O	O	B-T062
(	O	O	I-T062
functional	O	O	I-T062
)	O	O	I-T062
approaches	O	O	I-T062
applied	O	O	O
for	O	O	O
exploring	O	O	O
novel	O	O	O
cellular	O	O	B-T043
and	O	O	O
developmental	O	O	B-T040
roles	O	O	I-T040
of	O	O	O
the	O	O	O
autophagic	O	O	B-T043
process	O	O	I-T043
.	O	O	O

-DOCSTART- (28237961)

Healthcare	O	O	B-T058
usage	O	O	B-T169
and	O	O	O
economic	O	O	B-T081
impact	O	O	I-T081
of	O	O	O
non-treated	O	O	B-T033
obesity	O	O	B-T047
in	O	O	O
Italy	O	O	B-T083
:	O	O	O
findings	O	O	B-T169
from	O	O	O
a	O	O	O
retrospective	O	O	B-T080
administrative	O	O	B-T033
and	O	O	O
clinical	O	O	B-T170
database	O	O	I-T170
analysis	O	O	O

Investigate	O	O	B-T169
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
obesity	O	O	B-T047
in	O	O	O
Italy	O	O	B-T083
and	O	O	O
examine	O	O	O
its	O	O	O
resource	O	O	B-T078
consumption	O	O	B-T033
and	O	O	O
economic	O	O	B-T081
impact	O	O	I-T081
on	O	O	O
the	O	O	O
Italian	O	O	B-T083
national	O	O	B-T170
healthcare	O	O	I-T170
system	O	O	I-T170
(	O	O	O
NHS	O	O	B-T170
)	O	O	O
.	O	O	O

Retrospective	O	O	B-T080
,	O	O	O
observational	O	O	B-T062
and	O	O	O
real-life	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Data	O	O	B-T078
from	O	O	O
three	O	O	O
health	O	O	B-T093
units	O	O	I-T093
from	O	O	O
Northern	O	O	B-T082
(	O	O	O
Bergamo	O	O	B-T083
,	O	O	O
Lombardy	O	O	B-T083
)	O	O	O
,	O	O	O
Central	O	O	B-T082
(	O	O	O
Grosseto	O	O	B-T083
,	O	O	O
Tuscany	O	O	B-T083
)	O	O	O
and	O	O	O
Southern	O	O	B-T082
(	O	O	O
Naples	O	O	B-T083
,	O	O	O
Campania	O	O	B-T083
)	O	O	O
Italy	O	O	B-T083
.	O	O	O

All	O	O	O
patients	O	O	B-T101
aged	O	O	B-T032
≥18	O	O	B-T079
years	O	O	I-T079
with	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
recorded	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
measurement	O	O	B-T169
between	O	O	O
1	O	O	O
January	O	O	O
2009	O	O	O
and	O	O	O
31	O	O	O
December	O	O	O
2012	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

Information	O	O	B-T078
retrieved	O	O	O
from	O	O	O
the	O	O	O
databases	O	O	B-T170
included	O	O	O
primary	O	O	B-T078
care	O	O	I-T078
data	O	O	I-T078
,	O	O	O
medical	O	O	B-T170
prescriptions	O	O	I-T170
,	O	O	O
specialist	O	O	B-T058
consultations	O	O	I-T058
and	O	O	O
hospital	O	O	B-T170
discharge	O	O	I-T170
records	O	O	I-T170
from	O	O	O
2009	O	O	O
-	O	O	O
2013	O	O	O
.	O	O	O

Costs	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
these	O	O	O
data	O	O	B-T078
were	O	O	O
also	O	O	O
calculated	O	O	B-T052
.	O	O	O

Data	O	O	B-T078
are	O	O	O
presented	O	O	O
for	O	O	O
two	O	O	O
time	O	O	B-T079
periods	O	O	I-T079
(	O	O	O
1	O	O	B-T079
year	O	O	I-T079
after	O	O	O
BMI	O	O	B-T201
measurement	O	O	B-T169
and	O	O	O
study	O	O	O
end	O	O	O
)	O	O	O
.	O	O	O

Primary	O	O	B-T080
-to	O	O	O
estimate	O	O	B-T081
health	O	O	B-T078
resources	O	O	I-T078
consumption	O	O	B-T033
and	O	O	O
the	O	O	O
associated	O	O	O
economic	O	O	B-T081
impact	O	O	I-T081
on	O	O	O
the	O	O	O
Italian	O	O	B-T083
NHS	O	O	B-T170
.	O	O	O

Secondary	O	O	B-T081
-the	O	O	O
prevalence	O	O	B-T081
and	O	O	O
characteristics	O	O	B-T080
of	O	O	O
subjects	O	O	B-T098
by	O	O	O
BMI	O	O	B-T201
category	O	O	B-T170
.	O	O	O

20	O	O	O
159	O	O	O
adult	O	O	B-T100
subjects	O	O	B-T098
with	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
documented	O	O	B-T033
BMI	O	O	I-T033
measurement	O	O	B-T169
.	O	O	O

Subjects	O	O	B-T098
with	O	O	O
BMI	O	O	B-T201
≥30	O	O	O
kg/m(2	O	O	O
)	O	O	O
were	O	O	O
defined	O	O	O
as	O	O	O
obese	O	O	B-T047
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
obesity	O	O	B-T047
was	O	O	O
22.2	O	O	O
%	O	O	O
(	O	O	O
N=4471	O	O	O
)	O	O	O
and	O	O	O
increased	O	O	B-T081
with	O	O	O
age	O	O	B-T032
.	O	O	O

At	O	O	O
the	O	O	O
1-year	O	O	B-T079
observation	O	O	B-T062
period	O	O	B-T079
,	O	O	O
obese	O	O	B-T047
subjects	O	O	B-T098
who	O	O	O
did	O	O	O
not	O	O	O
receive	O	O	O
treatment	O	O	B-T061
for	O	O	O
their	O	O	O
obesity	O	O	B-T047
experienced	O	O	O
longer	O	O	B-T079
durations	O	O	I-T079
of	O	O	O
hospitalisation	O	O	B-T058
(	O	O	O
median	O	O	O
length	O	O	O
:	O	O	O
5	O	O	B-T079
days	O	O	I-T079
vs	O	O	O
3	O	O	B-T079
days	O	O	I-T079
)	O	O	O
,	O	O	O
used	O	O	O
more	O	O	O
prescription	O	O	B-T121
drugs	O	O	I-T121
(	O	O	O
75.0	O	O	O
%	O	O	O
vs	O	O	O
57.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
required	O	O	O
more	O	O	O
specialised	O	O	B-T077
outpatient	O	O	B-T101
healthcare	O	O	B-T058
(	O	O	O
mean	O	O	B-T081
number	O	O	I-T081
:	O	O	O
5.3	O	O	O
vs	O	O	O
4.4	O	O	O
)	O	O	O
and	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
greater	O	O	B-T081
costs	O	O	I-T081
,	O	O	O
primarily	O	O	O
owing	O	O	O
to	O	O	O
prescription	O	O	O
drugs	O	O	O
and	O	O	O
hospital	O	O	B-T058
admissions	O	O	I-T058
(	O	O	O
mean	O	O	B-T081
annual	O	O	I-T081
cost	O	O	I-T081
per	O	O	O
year	O	O	B-T079
per	O	O	O
patient	O	O	B-T101
:	O	O	O
€	O	O	O
460.6	O	O	O
vs	O	O	O
€	O	O	O
288.0	O	O	O
for	O	O	O
drug	O	O	B-T170
prescriptions	O	O	I-T170
,	O	O	O
€	O	O	O
422.7	O	O	O
vs	O	O	O
€	O	O	O
279.2	O	O	O
for	O	O	O
hospitalisations	O	O	B-T058
and	O	O	O
€	O	O	O
283.2	O	O	O
vs	O	O	O
€	O	O	O
251.7	O	O	O
for	O	O	O
outpatient	O	O	B-T058
care	O	O	I-T058
)	O	O	O
,	O	O	O
compared	O	O	O
with	O	O	O
normal	O	O	B-T033
weight	O	O	I-T033
subjects	O	O	O
.	O	O	O

Similar	O	O	O
findings	O	O	B-T169
were	O	O	O
observed	O	O	O
for	O	O	O
the	O	O	O
period	O	O	B-T079
up	O	O	O
to	O	O	O
data	O	O	B-T078
cut-off	O	O	O
(	O	O	O
mean	O	O	O
follow-up	O	O	B-T058
of	O	O	O
2.7	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

Untreated	O	O	B-T033
obesity	O	O	B-T047
has	O	O	O
a	O	O	O
significant	O	O	O
economic	O	O	B-T081
impact	O	O	I-T081
on	O	O	O
the	O	O	O
Italian	O	O	B-T083
healthcare	O	O	B-T170
system	O	O	I-T170
,	O	O	O
highlighting	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
raise	O	O	O
awareness	O	O	B-T041
and	O	O	O
proactively	O	O	O
treat	O	O	B-T061
obese	O	O	O
subjects	O	O	B-T098
.	O	O	O

-DOCSTART- (28239032)

Effects	O	O	B-T080
of	O	O	I-T080
heat	O	O	B-T070
treatment	O	O	B-T169
on	O	O	O
conformation	O	O	B-T082
and	O	O	O
cell	O	O	B-T043
growth	O	O	I-T043
activity	O	O	O
of	O	O	O
alpha-	O	O	B-T116
lactalbumin	O	O	I-T116
and	O	O	O
beta-lactoglobulin	O	O	B-T116
from	O	O	O
market	O	O	B-T083
milk	O	O	O

Heat	O	O	B-T070
processes	O	O	B-T067
,	O	O	O
low	O	O	B-T080
temperature	O	O	B-T081
for	O	O	O
long	O	O	B-T080
time	O	O	B-T079
(	O	O	O
LTLT	O	O	B-T068
)	O	O	O
pasteurization	O	O	B-T068
and	O	O	O
ultra-heat	O	O	B-T061
treatment	O	O	I-T061
(	O	O	I-T061
UHT	O	O	I-T061
)	O	O	I-T061
sterilization	O	O	I-T061
,	O	O	O
are	O	O	O
essential	O	O	O
for	O	O	O
commercial	O	O	O
market	O	O	B-T083
milk	O	O	B-T168
to	O	O	O
improve	O	O	O
the	O	O	O
shelf	O	O	B-T070
life	O	O	I-T070
of	O	O	O
raw	O	O	B-T167
milk	O	O	I-T167
and	O	O	O
ensure	O	O	O
microbial	O	O	B-T001
safety	O	O	B-T068
.	O	O	O

We	O	O	O
evaluated	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
heat	O	O	B-T070
experience	O	O	O
on	O	O	O
the	O	O	O
molecular	O	O	B-T080
properties	O	O	B-T080
of	O	O	O
α-lactalbumin	O	O	B-T116
(	O	O	O
α-LA	O	O	B-T116
)	O	O	O
and	O	O	O
β-lactoglobulin	O	O	B-T116
(	O	O	O
β-LG	O	O	B-T116
)	O	O	O
isolated	O	O	O
from	O	O	O
four	O	O	O
types	O	O	O
of	O	O	O
market	O	O	B-T083
milk	O	O	B-T168
such	O	O	O
as	O	O	O
LTLT-A	O	O	B-T068
(	O	O	O
66	O	O	O
°	O	O	O
C	O	O	O
for	O	O	O
30	O	O	O
min	O	O	O
)	O	O	O
,	O	O	O
LTLT-B	O	O	B-T068
(	O	O	O
65	O	O	O
°	O	O	O
C	O	O	O
for	O	O	O
30	O	O	O
min	O	O	O
)	O	O	O
,	O	O	O
UHT-I	O	O	B-T061
(	O	O	O
130	O	O	O
°	O	O	O
C	O	O	O
for	O	O	O
2	O	O	O
s	O	O	O
,	O	O	O
indirect	O	O	B-T080
heating	O	O	B-T070
)	O	O	O
and	O	O	O
UHT-D	O	O	B-T061
(	O	O	O
135	O	O	O
°	O	O	O
C	O	O	O
for	O	O	O
2	O	O	O
s	O	O	O
,	O	O	O
direct	O	O	B-T080
heating	O	O	O
)	O	O	O
samples	O	O	O
.	O	O	O

We	O	O	O
examined	O	O	O
molecular	O	O	B-T082
conformations	O	O	I-T082
using	O	O	O
circular	O	O	B-T059
dichroism	O	O	I-T059
spectrum	O	O	I-T059
measurement	O	O	I-T059
and	O	O	O
cell	O	O	B-T043
growth	O	O	I-T043
activity	O	O	O
using	O	O	O
the	O	O	O
WST-1	O	O	B-T062
method	O	O	I-T062
for	O	O	O
the	O	O	O
proteins	O	O	B-T116
.	O	O	O

α-LA	O	O	B-T116
isolated	O	O	O
from	O	O	O
each	O	O	O
of	O	O	O
these	O	O	O
four	O	O	O
types	O	O	O
of	O	O	O
market	O	O	B-T083
milk	O	O	B-T168
displayed	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
structural	O	O	B-T116
difference	O	O	B-T080
as	O	O	O
compared	O	O	O
to	O	O	O
raw	O	O	B-T167
milk	O	O	I-T167
α-LA	O	O	O
,	O	O	O
while	O	O	O
α-LA	O	O	O
of	O	O	O
UHT-I	O	O	B-T061
only	O	O	O
inhibited	O	O	B-T080
cell	O	O	B-T043
growth	O	O	I-T043
of	O	O	O
an	O	O	O
intestinal	O	O	B-T023
epithelial	O	O	B-T025
cell	O	O	I-T025
line	O	O	I-T025
more	O	O	O
potently	O	O	O
than	O	O	O
raw	O	O	O
milk	O	O	O
α-LA	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
case	O	O	O
of	O	O	O
β-LG	O	O	B-T116
,	O	O	O
only	O	O	O
the	O	O	O
UHT-I	O	O	B-T061
sample	O	O	O
demonstrated	O	O	O
a	O	O	O
drastic	O	O	O
change	O	O	B-T169
in	O	O	O
structure	O	O	B-T116
,	O	O	O
while	O	O	O
it	O	O	O
did	O	O	B-T033
not	O	O	I-T033
exhibit	O	O	I-T033
any	O	O	O
cytotoxicity	O	O	B-T049
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
cell	O	O	B-T043
viability	O	O	I-T043
effects	O	O	B-T080
of	O	O	I-T080
α-LA	O	O	B-T116
and	O	O	O
β-LG	O	O	B-T116
are	O	O	O
attributable	O	O	O
to	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
UHT	O	O	B-T061
;	O	O	O
indirect	O	O	B-T080
and	O	O	O
direct	O	O	B-T080
.	O	O	O

These	O	O	O
findings	O	O	B-T033
indicate	O	O	O
that	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
heat	O	O	B-T070
treatment	O	O	B-T169
on	O	O	O
whey	O	O	B-T168
proteins	O	O	I-T168
should	O	O	O
carefully	O	O	O
be	O	O	O
investigated	O	O	B-T169
further	O	O	O
.	O	O	O

-DOCSTART- (28240640)

Comparison	O	O	B-T052
of	O	O	O
270	O	O	B-T200
Versus	O	O	O
320	O	O	B-T200
mg	O	O	I-T200
I/mL	O	O	I-T200
of	O	O	I-T200
Iodixanol	O	O	I-T200
in	O	O	O
1	O	O	O
Image	O	O	B-T058
Assessment	O	O	I-T058
of	O	O	O
Both	O	O	O
Renal	O	O	B-T023
Arteries	O	O	I-T023
and	O	O	O
Veins	O	O	B-T023
With	O	O	O
Dual-Energy	O	O	B-T060
Spectral	O	O	I-T060
CT	O	O	I-T060
Imaging	O	O	I-T060
in	O	O	O
Late	O	O	B-T079
Arterial	O	O	I-T079
Phase	O	O	I-T079
and	O	O	O
Their	O	O	O
Influence	O	O	B-T077
on	O	O	O
Renal	O	O	O
Function	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
image	O	O	B-T080
quality	O	O	I-T080
of	O	O	O
renal	O	O	B-T023
arteries	O	O	I-T023
and	O	O	O
veins	O	O	B-T023
with	O	O	O
dual-energy	O	O	B-T060
spectral	O	O	I-T060
computed	O	O	I-T060
tomography	O	O	I-T060
(	O	O	I-T060
CT	O	O	I-T060
)	O	O	I-T060
imaging	O	O	I-T060
in	O	O	O
late	O	O	B-T079
arterial	O	O	I-T079
phase	O	O	I-T079
using	O	O	O
270	O	O	B-T200
and	O	O	O
320	O	O	B-T200
mg	O	O	I-T200
I/mL	O	O	I-T200
of	O	O	I-T200
iodixanol	O	O	I-T200
and	O	O	O
their	O	O	O
influence	O	O	B-T077
on	O	O	O
renal	O	O	B-T042
function	O	O	I-T042
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
1062	O	O	O
patients	O	O	B-T101
underwent	O	O	O
renal	O	O	B-T060
CT	O	O	I-T060
angiography	O	O	I-T060
with	O	O	O
270	O	O	B-T200
or	O	O	O
320	O	O	B-T200
mg	O	O	I-T200
I/mL	O	O	I-T200
of	O	O	I-T200
iodixanol	O	O	I-T200
with	O	O	O
dual-energy	O	O	B-T060
spectral	O	O	I-T060
CT	O	O	I-T060
imaging	O	O	I-T060
in	O	O	O
late	O	O	B-T079
arterial	O	O	I-T079
phase	O	O	I-T079
.	O	O	O

Image	O	O	B-T080
quality	O	O	I-T080
and	O	O	O
their	O	O	O
influence	O	O	B-T077
on	O	O	O
renal	O	O	B-T042
function	O	O	I-T042
were	O	O	O
compared	O	O	B-T052
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
significant	O	O	O
differences	O	O	O
of	O	O	O
CT	O	O	B-T081
value	O	O	I-T081
,	O	O	O
signal-to-noise	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
contrast-to-noise	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
and	O	O	O
subjective	O	O	O
score	O	O	B-T081
of	O	O	O
renal	O	O	B-T023
vessels	O	O	I-T023
between	O	O	O
2	O	O	O
groups	O	O	O
(	O	O	O
all	O	O	O
P	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
of	O	O	O
contrast-induced	O	O	B-T047
nephropathy	O	O	I-T047
in	O	O	O
patients	O	O	B-T101
with	O	O	O
abnormal	O	O	B-T046
renal	O	O	I-T046
function	O	O	I-T046
using	O	O	O
320	O	O	B-T200
mg	O	O	I-T200
I/mL	O	O	I-T200
of	O	O	I-T200
iodixanol	O	O	I-T200
was	O	O	O
significantly	O	O	O
higher	O	O	O
than	O	O	O
using	O	O	O
270	O	O	B-T200
mg	O	O	I-T200
I/mL	O	O	I-T200
of	O	O	I-T200
iodixanol	O	O	I-T200
(	O	O	O
P	O	O	O
=	O	O	O
0.043	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
renal	O	O	B-T023
arteries	O	O	I-T023
and	O	O	O
veins	O	O	B-T023
can	O	O	O
be	O	O	O
fully	O	O	O
assessed	O	O	O
in	O	O	O
late	O	O	B-T079
arterial	O	O	I-T079
phase	O	O	I-T079
with	O	O	O
270	O	O	B-T200
mg	O	O	I-T200
I/mL	O	O	I-T200
of	O	O	I-T200
iodixanol	O	O	I-T200
using	O	O	O
dual-energy	O	O	B-T060
spectral	O	O	I-T060
CT	O	O	I-T060
scan	O	O	I-T060
with	O	O	O
better	O	O	O
preserved	O	O	O
renal	O	O	B-T042
function	O	O	I-T042
.	O	O	O

-DOCSTART- (28241991)

Effect	O	O	O
of	O	O	O
magnesium	O	O	B-T061
supplementation	O	O	I-T061
on	O	O	O
depression	O	O	B-T048
status	O	O	B-T033
in	O	O	O
depressed	O	O	B-T048
patients	O	O	B-T101
with	O	O	O
magnesium	O	O	B-T047
deficiency	O	O	I-T047
:	O	O	O
A	O	O	O
randomized	O	O	B-T062
,	O	O	O
double-blind	O	O	B-T062
,	O	O	O
placebo-controlled	O	O	O
trial	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
effect	O	O	B-T169
of	O	O	O
magnesium	O	O	B-T061
supplementation	O	O	I-T061
on	O	O	O
the	O	O	O
depression	O	O	B-T048
status	O	O	B-T033
of	O	O	O
depressed	O	O	B-T048
patients	O	O	B-T101
suffering	O	O	B-T033
from	O	O	O
magnesium	O	O	B-T047
deficiency	O	O	I-T047
.	O	O	O

Sixty	O	O	B-T033
depressed	O	O	I-T033
people	O	O	I-T033
suffering	O	O	B-T033
from	O	O	O
hypomagnesemia	O	O	B-T033
participated	O	O	O
in	O	O	O
this	O	O	B-T062
trial	O	O	I-T062
.	O	O	O

The	O	O	O
individuals	O	O	B-T098
were	O	O	O
randomly	O	O	B-T062
categorized	O	O	I-T062
into	O	O	O
two	O	O	O
groups	O	O	B-T078
of	O	O	O
30	O	O	O
members	O	O	O
;	O	O	O
one	O	O	O
receiving	O	O	O
two	O	O	O
250-mg	O	O	O
tablets	O	O	B-T121
of	O	O	I-T121
magnesium	O	O	I-T121
oxide	O	O	I-T121
(	O	O	O
MG	O	O	B-T121
)	O	O	O
daily	O	O	O
and	O	O	O
the	O	O	O
other	O	O	O
receiving	O	O	O
placebo	O	O	B-T122
(	O	O	O
PG	O	O	B-T122
)	O	O	O
for	O	O	O
8	O	O	O
wk	O	O	O
.	O	O	O

The	O	O	O
Beck	O	O	B-T060
Depression	O	O	I-T060
Inventory-II	O	O	I-T060
was	O	O	O
conducted	O	O	O
and	O	O	O
the	O	O	O
concentration	O	O	O
of	O	O	O
serum	O	O	B-T059
magnesium	O	O	I-T059
was	O	O	I-T059
measured	O	O	I-T059
.	O	O	O

At	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
intervention	O	O	O
,	O	O	O
88.5	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
MG	O	O	B-T121
and	O	O	O
48.1	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
PG	O	O	B-T122
(	O	O	O
P	O	O	O
=	O	O	O
0.002	O	O	O
)	O	O	O
had	O	O	O
a	O	O	O
normal	O	O	B-T034
level	O	O	I-T034
of	O	O	I-T034
magnesium	O	O	I-T034
.	O	O	O

The	O	O	O
mean	O	O	O
changes	O	O	B-T033
of	O	O	I-T033
serum	O	O	I-T033
magnesium	O	O	I-T033
were	O	O	O
significantly	O	O	O
different	O	O	O
across	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T078
.	O	O	O

After	O	O	O
the	O	O	O
intervention	O	O	O
,	O	O	O
the	O	O	O
mean	O	O	B-T201
Beck	O	O	I-T201
score	O	O	I-T201
significantly	O	O	B-T081
declined	O	O	I-T081
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
the	O	O	O
MG	O	O	B-T121
,	O	O	O
this	O	O	O
reduction	O	O	O
was	O	O	O
more	O	O	B-T080
significant	O	O	I-T080
than	O	O	O
in	O	O	O
the	O	O	O
PG	O	O	B-T122
(	O	O	O
P	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
,	O	O	O
so	O	O	O
that	O	O	O
the	O	O	O
mean	O	O	O
changes	O	O	O
in	O	O	O
this	O	O	O
group	O	O	B-T078
experienced	O	O	O
15.65	O	O	O
±	O	O	O
8.9	O	O	O
reduction	O	O	O
,	O	O	O
but	O	O	O
in	O	O	O
the	O	O	O
PG	O	O	O
,	O	O	O
it	O	O	O
declined	O	O	O
by	O	O	O
10.40	O	O	O
±	O	O	O
7.9	O	O	O
.	O	O	O

Daily	O	O	B-UnknownType
consumption	O	O	I-UnknownType
of	O	O	O
500	O	O	O
mg	O	O	O
magnesium	O	O	B-T121
oxide	O	O	I-T121
tablets	O	O	I-T121
for	O	O	O
≥8	O	O	O
wk	O	O	O
by	O	O	O
depressed	O	O	B-T048
patients	O	O	B-T101
suffering	O	O	B-T033
from	O	O	O
magnesium	O	O	B-T047
deficiency	O	O	I-T047
leads	O	O	O
to	O	O	O
improvements	O	O	O
in	O	O	O
depression	O	O	B-T048
status	O	O	B-T033
and	O	O	O
magnesium	O	O	B-T034
levels	O	O	I-T034
.	O	O	O

Therefore	O	O	O
,	O	O	O
assessment	O	O	B-T059
of	O	O	I-T059
the	O	O	I-T059
magnesium	O	O	I-T059
serum	O	O	I-T059
and	O	O	O
resolving	O	O	O
this	O	O	O
deficiency	O	O	B-T047
positively	O	O	O
influence	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
depressed	O	O	B-T048
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28243780)

The	O	O	O
influence	O	O	B-T077
of	O	O	O
cognitive	O	O	B-T081
load	O	O	I-T081
on	O	O	O
metabolic	O	O	B-T040
cost	O	O	B-T081
of	O	O	O
transport	O	O	B-T078
during	O	O	O
overground	O	O	B-T056
walking	O	O	I-T056
in	O	O	O
healthy	O	O	B-T080
,	O	O	O
young	O	O	O
adults	O	O	O

Our	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
examine	O	O	O
whether	O	O	O
cognitive	O	O	B-T041
processing	O	O	I-T041
during	O	O	O
walking	O	O	B-T056
increases	O	O	B-T169
the	O	O	O
metabolic	O	O	B-T040
cost	O	O	B-T081
of	O	O	O
transport	O	O	B-T078
in	O	O	O
healthy	O	O	B-T080
young	O	O	B-T100
adults	O	O	I-T100
.	O	O	O

Twenty	O	O	O
healthy	O	O	B-T080
,	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
completed	O	O	O
five	O	O	O
conditions	O	O	B-T080
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
walking	O	O	B-T056
at	O	O	O
a	O	O	O
self	O	O	B-T078
-	O	O	O
selected	O	O	B-T052
speed	O	O	B-T081
(	O	O	O
spontaneous	O	O	B-T169
single-task	O	O	B-T052
)	O	O	O
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
seated	O	O	B-T033
resting	O	O	B-T056
(	O	O	O
baseline	O	O	B-T081
)	O	O	O
,	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
performing	O	O	B-T169
cognitive	O	O	B-T041
task	O	O	B-T052
while	O	O	O
seated	O	O	O
(	O	O	O
cognitive	O	O	O
single-task	O	O	O
)	O	O	O
,	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
walking	O	O	O
while	O	O	O
simultaneously	O	O	B-T079
performing	O	O	O
the	O	O	O
cognitive	O	O	O
task	O	O	O
(	O	O	O
dual-task	O	O	B-T052
)	O	O	O
,	O	O	O
and	O	O	O
(	O	O	O
5	O	O	O
)	O	O	O
single-task	O	O	O
walking	O	O	O
at	O	O	O
a	O	O	O
speed	O	O	O
that	O	O	O
matched	O	O	B-T080
the	O	O	O
participant	O	O	B-T098
's	O	O	I-T098
dual-task	O	O	O
gait	O	O	B-T032
speed	O	O	I-T032
(	O	O	O
matched	O	O	O
single-task	O	O	O
)	O	O	O
.	O	O	O

Rate	O	O	B-T081
of	O	O	I-T081
oxygen	O	O	I-T081
consumption	O	O	I-T081
(	O	O	O
V̇O2	O	O	B-T081
)	O	O	O
was	O	O	O
recorded	O	O	O
during	O	O	O
all	O	O	O
conditions	O	O	B-T080
.	O	O	O

Gait	O	O	B-T032
speed	O	O	I-T032
and	O	O	O
cost	O	O	B-T081
of	O	O	O
walking	O	O	B-T056
(	O	O	O
Cw	O	O	B-T081
;	O	O	O
oxygen	O	O	B-T201
consumed	O	O	I-T201
per	O	O	I-T201
distance	O	O	I-T201
traveled	O	O	I-T201
)	O	O	O
were	O	O	O
recorded	O	O	O
during	O	O	O
all	O	O	O
walking	O	O	O
conditions	O	O	B-T080
.	O	O	O

Reaction	O	O	B-T079
time	O	O	I-T079
and	O	O	O
accuracy	O	O	B-T080
of	O	O	O
responses	O	O	B-T032
in	O	O	O
the	O	O	O
cognitive	O	O	B-T041
task	O	O	B-T052
were	O	O	O
recorded	O	O	O
during	O	O	O
all	O	O	O
cognitive	O	O	O
task	O	O	O
conditions	O	O	B-T080
.	O	O	O

Data	O	O	B-T078
from	O	O	O
the	O	O	O
fifth	O	O	O
minute	O	O	B-T079
of	O	O	O
each	O	O	O
5-	O	O	O
min	O	O	B-T079
condition	O	O	B-T080
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
difference	O	O	O
in	O	O	O
V̇O2	O	O	B-T081
between	O	O	O
the	O	O	O
dual-task	O	O	B-T052
and	O	O	O
matched	O	O	B-T080
single-task	O	O	B-T052
walking	O	O	B-T056
conditions	O	O	B-T080
.	O	O	O

V̇O2	O	O	B-T081
in	O	O	O
the	O	O	O
seated	O	O	B-T033
cognitive	O	O	B-T041
condition	O	O	B-T080
was	O	O	O
significantly	O	O	O
smaller	O	O	O
than	O	O	O
both	O	O	O
walking	O	O	B-T056
conditions	O	O	B-T080
,	O	O	O
but	O	O	O
was	O	O	O
not	O	O	O
significantly	O	O	O
different	O	O	O
than	O	O	O
zero	O	O	O
.	O	O	O

Cw	O	O	B-T081
was	O	O	O
significantly	O	O	O
greater	O	O	O
during	O	O	O
the	O	O	O
matched	O	O	B-T080
single-task	O	O	B-T052
walking	O	O	B-T056
condition	O	O	B-T080
than	O	O	O
during	O	O	O
the	O	O	O
dual-task	O	O	B-T052
walking	O	O	O
condition	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
difference	O	O	O
in	O	O	O
Cw	O	O	B-T081
was	O	O	O
so	O	O	O
small	O	O	O
that	O	O	O
it	O	O	O
is	O	O	O
unlikely	O	O	O
to	O	O	O
be	O	O	O
clinically	O	O	B-T080
significant	O	O	B-T078
(	O	O	O
0.008	O	O	O
mLO2/kg/m	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.002	O	O	O
-	O	O	O
0.014	O	O	O
)	O	O	O
.	O	O	O

Cognitive	O	O	B-T041
processing	O	O	I-T041
while	O	O	O
walking	O	O	B-T056
may	O	O	O
not	O	O	O
increase	O	O	B-T169
energy	O	O	B-T081
demands	O	O	O
of	O	O	O
walking	O	O	O
in	O	O	O
healthy	O	O	B-T080
young	O	O	B-T100
adults	O	O	I-T100
.	O	O	O

Maintaining	O	O	O
non-preferred	O	O	O
gait	O	O	B-T032
speed	O	O	B-T081
(	O	O	O
matched	O	O	B-T080
speed	O	O	O
)	O	O	O
overground	O	O	O
continuously	O	O	O
for	O	O	O
5	O	O	O
min	O	O	B-T079
may	O	O	O
require	O	O	O
attentional	O	O	B-T041
resources	O	O	B-T078
,	O	O	O
and	O	O	O
thereby	O	O	O
increase	O	O	B-T169
metabolic	O	O	B-T040
costs	O	O	B-T081
relative	O	O	O
to	O	O	O
walking	O	O	B-T056
at	O	O	O
habitual	O	O	B-T079
speed	O	O	O
.	O	O	O

-DOCSTART- (28245193)

Problem-based	O	O	B-T065
learning	O	O	I-T065
using	O	O	O
patient	O	O	B-T170
-simulated	O	O	I-T170
videos	O	O	I-T170
showing	O	O	O
daily	O	O	B-T079
life	O	O	B-T078
for	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
clinical	O	O	B-T080
approach	O	O	O

We	O	O	O
examined	O	O	O
whether	O	O	O
problem-based	O	O	B-T065
learning	O	O	B-T041
tutorials	O	O	B-T170
using	O	O	O
patient	O	O	B-T170
-simulated	O	O	I-T170
videos	O	O	I-T170
showing	O	O	O
daily	O	O	B-T079
life	O	O	B-T078
are	O	O	O
more	O	O	O
practical	O	O	O
for	O	O	O
clinical	O	O	B-T080
learning	O	O	O
,	O	O	O
compared	O	O	O
with	O	O	O
traditional	O	O	O
paper-based	O	O	B-T065
problem-based	O	O	I-T065
learning	O	O	I-T065
,	O	O	O
for	O	O	O
the	O	O	O
consideration	O	O	O
rate	O	O	B-T033
of	O	O	I-T033
psychosocial	O	O	I-T033
issues	O	O	I-T033
and	O	O	O
the	O	O	O
recall	O	O	B-T033
rate	O	O	I-T033
for	O	O	O
experienced	O	O	B-T041
learning	O	O	I-T041
.	O	O	O

Twenty-two	O	O	O
groups	O	O	B-T078
with	O	O	O
120	O	O	O
fifth-	O	O	O
year	O	O	B-T079
students	O	O	B-T098
were	O	O	O
each	O	O	O
assigned	O	O	O
paper-based	O	O	B-T065
problem-based	O	O	I-T065
learning	O	O	I-T065
and	O	O	O
video	O	O	B-T065
-based	O	O	I-T065
problem-based	O	O	I-T065
learning	O	O	I-T065
using	O	O	O
patient	O	O	B-T170
-simulated	O	O	I-T170
videos	O	O	I-T170
.	O	O	O

We	O	O	O
compared	O	O	O
target	O	O	B-T169
achievement	O	O	B-T033
rates	O	O	I-T033
in	O	O	O
questionnaires	O	O	B-T170
using	O	O	O
the	O	O	O
Wilcoxon	O	O	B-T170
signed-rank	O	O	I-T170
test	O	O	I-T170
and	O	O	O
discussion	O	O	B-T054
contents	O	O	B-T077
diversity	O	O	B-T080
using	O	O	O
the	O	O	O
Mann-Whitney	O	O	B-T081
U	O	O	I-T081
test	O	O	I-T081
.	O	O	O

A	O	O	O
follow-up	O	O	B-T062
survey	O	O	B-T170
used	O	O	O
a	O	O	O
chi-square	O	O	B-T170
test	O	O	I-T170
to	O	O	O
measure	O	O	O
students	O	O	B-T098
'	O	O	O
recall	O	O	O
of	O	O	O
cases	O	O	O
in	O	O	O
three	O	O	O
categories	O	O	B-T170
:	O	O	O
video	O	O	B-T170
,	O	O	O
paper	O	O	B-T073
,	O	O	O
and	O	O	O
non-experienced	O	O	B-T078
.	O	O	O

Video	O	O	B-T065
-based	O	O	I-T065
problem-based	O	O	I-T065
learning	O	O	I-T065
displayed	O	O	O
significantly	O	O	O
higher	O	O	O
achievement	O	O	B-T033
rates	O	O	I-T033
for	O	O	O
imagining	O	O	O
authentic	O	O	B-T101
patients	O	O	I-T101
(	O	O	O
p=0.001	O	O	O
)	O	O	O
,	O	O	O
incorporating	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
approach	O	O	B-T169
including	O	O	O
psychosocial	O	O	B-T078
aspects	O	O	I-T078
(	O	O	O
p<0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
satisfaction	O	O	O
with	O	O	O
sessions	O	O	B-T077
(	O	O	O
p=0.001	O	O	O
)	O	O	O
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
differences	O	O	I-T033
existed	O	O	O
in	O	O	O
the	O	O	O
discussion	O	O	B-T054
contents	O	O	B-T077
diversity	O	O	B-T080
regarding	O	O	O
the	O	O	O
International	O	O	B-T170
Classification	O	O	I-T170
of	O	O	I-T170
Primary	O	O	I-T170
Care	O	O	I-T170
Second	O	O	I-T170
Edition	O	O	I-T170
codes	O	O	I-T170
and	O	O	I-T170
chapter	O	O	I-T170
types	O	O	I-T170
or	O	O	O
in	O	O	O
the	O	O	O
rate	O	O	B-T033
of	O	O	I-T033
psychological	O	O	I-T033
codes	O	O	I-T033
.	O	O	O

In	O	O	O
a	O	O	O
follow-up	O	O	B-T062
survey	O	O	B-T170
comparing	O	O	O
video	O	O	B-T170
and	O	O	O
paper	O	O	B-T073
groups	O	O	B-T078
to	O	O	O
non-experienced	O	O	B-T078
groups	O	O	I-T078
,	O	O	O
the	O	O	O
rates	O	O	B-T081
were	O	O	O
higher	O	O	O
for	O	O	O
video	O	O	O
(	O	O	O
χ(2)=24.319	O	O	O
,	O	O	O
p<0.001	O	O	O
)	O	O	O
and	O	O	O
paper	O	O	O
(	O	O	O
χ(2)=11.134	O	O	O
,	O	O	O
p=0.001	O	O	O
)	O	O	O
.	O	O	O

Although	O	O	O
the	O	O	O
video	O	O	B-T170
rate	O	O	B-T081
tended	O	O	O
to	O	O	O
be	O	O	O
higher	O	O	O
than	O	O	O
the	O	O	O
paper	O	O	B-T073
rate	O	O	O
,	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
was	O	O	O
found	O	O	O
between	O	O	O
the	O	O	O
two	O	O	O
.	O	O	O

Patient	O	O	B-T170
-simulated	O	O	I-T170
videos	O	O	I-T170
showing	O	O	O
daily	O	O	B-T079
life	O	O	B-T078
facilitate	O	O	O
imagining	O	O	O
true	O	O	O
patients	O	O	B-T101
and	O	O	O
support	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
approach	O	O	B-T169
that	O	O	O
fosters	O	O	B-T056
better	O	O	O
memory	O	O	B-T041
.	O	O	O

The	O	O	O
clinical	O	O	B-T080
patient	O	O	B-T170
-simulated	O	O	I-T170
video	O	O	I-T170
method	O	O	B-T169
is	O	O	O
more	O	O	O
practical	O	O	O
and	O	O	O
clinical	O	O	O
problem-based	O	O	B-T170
tutorials	O	O	I-T170
can	O	O	O
be	O	O	O
implemented	O	O	O
if	O	O	O
we	O	O	O
create	O	O	O
patient	O	O	B-T170
-simulated	O	O	I-T170
videos	O	O	I-T170
for	O	O	O
each	O	O	O
symptom	O	O	B-T184
as	O	O	O
teaching	O	O	B-T073
materials	O	O	I-T073
.	O	O	O

-DOCSTART- (28246934)

Forensic	O	O	B-UnknownType
characteristics	O	O	I-UnknownType
and	O	O	O
phylogenetic	O	O	B-T062
analyses	O	O	I-T062
of	O	O	O
the	O	O	O
Chinese	O	O	B-T098
Yi	O	O	B-T098
population	O	O	I-T098
via	O	O	O
19	O	O	O
X-chromosomal	O	O	B-T026
STR	O	O	B-T086
loci	O	O	O

The	O	O	O
demographic	O	O	B-T102
characteristics	O	O	I-T102
and	O	O	O
genetic	O	O	B-T045
polymorphism	O	O	I-T045
data	O	O	B-T078
of	O	O	O
56	O	O	O
Chinese	O	O	B-T098
nationalities	O	O	B-T102
or	O	O	O
31	O	O	O
administrative	O	O	B-T092
divisions	O	O	I-T092
in	O	O	O
Chinese	O	O	B-T083
mainland	O	O	I-T083
have	O	O	O
repeatedly	O	O	O
been	O	O	O
the	O	O	O
genetic	O	O	B-T062
research	O	O	I-T062
hotspots	O	O	B-T082
.	O	O	O

While	O	O	O
most	O	O	O
genetic	O	O	B-T062
studies	O	O	I-T062
focused	O	O	O
on	O	O	O
some	O	O	O
particular	O	O	O
Chinese	O	O	B-T098
populations	O	O	B-T098
based	O	O	O
on	O	O	O
autosomal	O	O	B-T026
or	O	O	O
Y-chromosomal	O	O	B-T026
genetic	O	O	B-T045
markers	O	O	I-T045
,	O	O	O
the	O	O	O
forensic	O	O	B-UnknownType
characteristics	O	O	I-UnknownType
and	O	O	O
phylogenetic	O	O	B-T062
analyses	O	O	I-T062
of	O	O	O
the	O	O	O
seventh	O	O	O
largest	O	O	O
Chinese	O	O	O
population	O	O	B-T098
(	O	O	O
Yi	O	O	B-T098
ethnicity	O	O	I-T098
)	O	O	O
on	O	O	O
the	O	O	O
X-chromosomal	O	O	B-T026
genetic	O	O	O
markers	O	O	O
are	O	O	O
scarce	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
allele	O	O	B-T081
frequencies	O	O	I-T081
and	O	O	O
forensic	O	O	B-T033
statistical	O	O	I-T033
parameters	O	O	I-T033
for	O	O	O
19	O	O	O
X-chromosomal	O	O	B-T026
short	O	O	B-T086
tandem	O	O	I-T086
repeat	O	O	I-T086
loci	O	O	B-T028
(	O	O	O
DXS7424-DXS101	O	O	B-T028
,	O	O	O
DXS6789-DXS6809	O	O	B-T028
,	O	O	O
DXS7423-DXS10134	O	O	B-T028
,	O	O	O
DXS10103-HPRTB-DXS10101	O	O	B-T028
,	O	O	O
DXS10159-DXS10162-DXS10164	O	O	B-T028
,	O	O	O
DXS10148-DXS10135-DXS8378	O	O	B-T028
,	O	O	O
and	O	O	O
DXS7132-DXS10079-DXS10074-DXS10075	O	O	B-T028
)	O	O	O
of	O	O	O
331	O	O	O
Chinese	O	O	B-T098
Yi	O	O	B-T098
individuals	O	O	I-T098
were	O	O	O
obtained	O	O	O
.	O	O	O

All	O	O	O
19	O	O	O
X-chromosomal	O	O	B-T026
short	O	O	B-T086
tandem	O	O	I-T086
repeat	O	O	I-T086
(	O	O	O
STR	O	O	B-T086
)	O	O	O
loci	O	O	B-T028
in	O	O	O
females	O	O	B-T098
were	O	O	O
consistent	O	O	O
with	O	O	O
the	O	O	O
Hardy-Weinberg	O	O	O
equilibrium	O	O	O
test	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
214	O	O	O
alleles	O	O	B-T028
were	O	O	O
identified	O	O	B-T080
with	O	O	O
the	O	O	O
corresponding	O	O	O
allele	O	O	B-T081
frequencies	O	O	I-T081
spanned	O	O	O
from	O	O	O
0.0019	O	O	O
to	O	O	O
0.6106	O	O	O
.	O	O	O

The	O	O	O
combined	O	O	O
PE	O	O	B-T081
,	O	O	O
PDF	O	O	B-T081
,	O	O	O
and	O	O	O
PDM	O	O	B-T081
were	O	O	O
0.9999999214	O	O	O
,	O	O	O
0.9999999999999999999993	O	O	O
,	O	O	O
and	O	O	O
0.9999999999998	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
high	O	O	O
combined	O	O	O
MECKrüger	O	O	B-T081
,	O	O	O
MECKishida	O	O	B-T081
,	O	O	O
MECDesmarais	O	O	B-T081
,	O	O	O
and	O	O	O
MECDesmarais	O	O	B-T081
Duo	O	O	I-T081
were	O	O	O
achieved	O	O	O
as	O	O	O
0.9999999617638	O	O	O
,	O	O	O
0.9999999999971	O	O	O
,	O	O	O
0.9999999999971	O	O	O
,	O	O	O
and	O	O	O
0.9999999931538	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
findings	O	O	B-T033
suggested	O	O	O
that	O	O	O
the	O	O	O
panel	O	O	B-T078
of	O	O	O
19	O	O	O
X-STR	O	O	B-T086
loci	O	O	B-T028
is	O	O	O
highly	O	O	O
polymorphic	O	O	B-T080
and	O	O	O
informative	O	O	B-T080
in	O	O	O
the	O	O	O
Yi	O	O	B-T098
ethnic	O	O	I-T098
population	O	O	I-T098
and	O	O	O
can	O	O	O
be	O	O	O
considered	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
powerful	O	O	O
tool	O	O	B-T073
in	O	O	O
forensic	O	O	B-T078
complex	O	O	I-T078
kinship	O	O	I-T078
identification	O	O	I-T078
.	O	O	O

Population	O	O	B-T062
differentiation	O	O	I-T062
analyses	O	O	I-T062
among	O	O	O
12	O	O	O
populations	O	O	B-T098
indicated	O	O	O
that	O	O	O
significant	O	O	O
differences	O	O	B-T080
in	O	O	O
genetic	O	O	B-T028
structure	O	O	I-T028
were	O	O	O
observed	O	O	O
in	O	O	O
between	O	O	O
the	O	O	O
Yi	O	O	B-T098
ethnicity	O	O	I-T098
and	O	O	O
the	O	O	O
Chinese	O	O	B-T098
Uyghur	O	O	B-T098
as	O	O	O
well	O	O	O
as	O	O	O
Kazakh	O	O	B-T098
,	O	O	O
and	O	O	O
genetic	O	O	B-T080
homogeneity	O	O	I-T080
existed	O	O	O
in	O	O	O
similar	O	O	O
ethno-origin	O	O	B-T098
or	O	O	O
geographic	O	O	B-T081
origin	O	O	I-T081
populations	O	O	I-T081
.	O	O	O

-DOCSTART- (28249160)

Loss	O	O	B-T081
of	O	O	O
Snf5	O	O	B-T028
Induces	O	O	B-T169
Formation	O	O	B-T169
of	O	O	O
an	O	O	O
Aberrant	O	O	B-T080
SWI/SNF	O	O	O
Complex	O	O	O

The	O	O	O
SWI/SNF	O	O	B-T026
chromatin	O	O	B-T026
remodeling	O	O	I-T026
complex	O	O	I-T026
is	O	O	O
highly	O	O	O
conserved	O	O	O
from	O	O	O
yeast	O	O	B-T004
to	O	O	O
human	O	O	B-T016
,	O	O	O
and	O	O	O
aberrant	O	O	B-T080
SWI/SNF	O	O	B-T026
complexes	O	O	I-T026
contribute	O	O	O
to	O	O	O
human	O	O	O
disease	O	O	B-T047
.	O	O	O

The	O	O	O
Snf5/SMARCB1/INI1	O	O	B-T028
subunit	O	O	B-T081
of	O	O	O
SWI/SNF	O	O	B-T026
is	O	O	O
a	O	O	O
tumor	O	O	B-T028
suppressor	O	O	I-T028
frequently	O	O	O
lost	O	O	B-T169
in	O	O	O
pediatric	O	O	B-T080
rhabdoid	O	O	B-T191
cancers	O	O	I-T191
.	O	O	O

We	O	O	O
examined	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
Snf5	O	O	B-T028
loss	O	O	B-T081
on	O	O	O
the	O	O	O
composition	O	O	B-T033
,	O	O	O
nucleosome	O	O	B-T045
binding	O	O	I-T045
,	O	O	O
recruitment	O	O	O
,	O	O	O
and	O	O	O
remodeling	O	O	O
activities	O	O	O
of	O	O	O
yeast	O	O	B-T004
SWI/SNF	O	O	B-T026
.	O	O	O

The	O	O	O
Snf5	O	O	B-T028
subunit	O	O	B-T081
is	O	O	O
shown	O	O	O
by	O	O	O
crosslinking-mass	O	O	B-T059
spectrometry	O	O	I-T059
(	O	O	O
CX-MS	O	O	B-T059
)	O	O	O
and	O	O	O
subunit	O	O	O
deletion	O	O	B-T059
analysis	O	O	I-T059
to	O	O	O
interact	O	O	O
with	O	O	O
the	O	O	O
ATPase	O	O	B-T087
domain	O	O	I-T087
of	O	O	O
Snf2	O	O	B-T116
and	O	O	O
to	O	O	O
form	O	O	O
a	O	O	O
submodule	O	O	B-T044
consisting	O	O	O
of	O	O	O
Snf5	O	O	O
,	O	O	O
Swp82	O	O	B-T028
,	O	O	O
and	O	O	O
Taf14	O	O	B-T028
.	O	O	O

Snf5	O	O	B-T028
promotes	O	O	O
binding	O	O	B-T045
of	O	O	O
the	O	O	O
Snf2	O	O	B-T116
ATPase	O	O	B-T087
domain	O	O	I-T087
to	O	O	O
nucleosomal	O	O	B-T045
DNA	O	O	I-T045
and	O	O	O
enhances	O	O	O
the	O	O	O
catalytic	O	O	O
and	O	O	O
nucleosome	O	O	O
remodeling	O	O	O
activities	O	O	O
of	O	O	O
SWI/SNF	O	O	B-T026
.	O	O	O

Snf5	O	O	B-T028
is	O	O	O
also	O	O	O
required	O	O	O
for	O	O	O
SWI/SNF	O	O	B-T026
recruitment	O	O	O
by	O	O	O
acidic	O	O	B-T116
transcription	O	O	I-T116
factors	O	O	I-T116
.	O	O	O

RNA-seq	O	O	B-T059
analysis	O	O	I-T059
suggests	O	O	O
that	O	O	O
both	O	O	O
the	O	O	O
recruitment	O	O	O
and	O	O	O
remodeling	O	O	O
functions	O	O	O
of	O	O	O
Snf5	O	O	B-T028
are	O	O	O
required	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
for	O	O	O
SWI/SNF	O	O	B-T026
regulation	O	O	B-T045
of	O	O	I-T045
gene	O	O	I-T045
expression	O	O	I-T045
.	O	O	O

Thus	O	O	O
,	O	O	O
loss	O	O	B-T081
of	O	O	O
SNF5	O	O	B-T028
alters	O	O	O
the	O	O	O
structure	O	O	B-T082
and	O	O	O
function	O	O	B-T169
of	O	O	O
SWI/SNF	O	O	B-T026
.	O	O	O

-DOCSTART- (28249785)

Identifying	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
using	O	O	O
low-frequency	O	O	B-T079
fluctuations	O	O	B-T184
in	O	O	O
BOLD	O	O	O
signals	O	O	O

Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PD	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
chronic	O	O	B-T079
,	O	O	O
progressive	O	O	B-T169
,	O	O	O
and	O	O	O
degenerative	O	O	B-T169
neurological	O	O	B-T047
disorder	O	O	I-T047
that	O	O	O
is	O	O	O
characterized	O	O	B-T052
by	O	O	O
the	O	O	O
degeneration	O	O	B-T169
of	O	O	O
dopamine	O	O	B-T025
neurons	O	O	I-T025
in	O	O	O
the	O	O	O
substantia	O	O	B-T023
nigra	O	O	I-T023
and	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
intracellular	O	O	B-T082
Lewy	O	O	B-T026
inclusion	O	O	I-T026
bodies	O	O	I-T026
.	O	O	O

Resting-state	O	O	B-T060
functional	O	O	I-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
RS-fMRI	O	O	B-T060
)	O	O	O
has	O	O	O
demonstrated	O	O	O
evidence	O	O	B-T078
of	O	O	O
changes	O	O	O
in	O	O	O
metabolic	O	O	B-T169
patterns	O	O	B-T082
in	O	O	O
individuals	O	O	B-T098
with	O	O	O
PD	O	O	B-T047
.	O	O	O

The	O	O	O
purpose	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
PD	O	O	B-T047
could	O	O	O
be	O	O	O
"	O	O	O
predicted	O	O	B-T078
"	O	O	O
based	O	O	O
on	O	O	O
resting	O	O	O
fluctuations	O	O	B-T184
in	O	O	O
the	O	O	O
blood	O	O	B-T042
oxygenation	O	O	I-T042
level	O	O	I-T042
dependent	O	O	I-T042
signal	O	O	I-T042
.	O	O	O

We	O	O	O
utilized	O	O	O
RS-fMRI	O	O	B-T060
to	O	O	O
measure	O	O	O
the	O	O	O
amplitude	O	O	B-T082
of	O	O	O
low-frequency	O	O	B-T079
fluctuation	O	O	B-T184
(	O	O	O
ALFF	O	O	B-T184
)	O	O	O
and	O	O	O
the	O	O	O
fractional	O	O	O
ALFF	O	O	O
(	O	O	O
fALFF	O	O	B-T184
)	O	O	O
in	O	O	O
51	O	O	O
patients	O	O	B-T101
with	O	O	O
PD	O	O	B-T047
and	O	O	O
50	O	O	O
age	O	O	B-T032
-	O	O	O
and	O	O	O
sex	O	O	B-T032
-matched	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

Compared	O	O	O
with	O	O	O
the	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
,	O	O	O
the	O	O	O
individuals	O	O	B-T098
with	O	O	O
PD	O	O	B-T047
exhibited	O	O	O
altered	O	O	O
ALFFs	O	O	B-T184
in	O	O	O
the	O	O	O
bilateral	O	O	B-T082
lingual	O	O	B-T023
gyrus	O	O	I-T023
and	O	O	O
left	O	O	B-T023
putamen	O	O	I-T023
and	O	O	O
an	O	O	O
altered	O	O	O
fALFF	O	O	B-T184
in	O	O	O
the	O	O	O
right	O	O	B-T029
cerebellum	O	O	I-T029
posterior	O	O	I-T029
lobe	O	O	I-T029
.	O	O	O

Support	O	O	B-T081
vector	O	O	I-T081
machines	O	O	I-T081
(	O	O	O
SVMs	O	O	B-T081
)	O	O	O
,	O	O	O
which	O	O	O
comprise	O	O	O
a	O	O	O
supervised	O	O	O
pattern	O	O	B-T041
recognition	O	O	I-T041
method	O	O	B-T170
that	O	O	O
enables	O	O	O
predictions	O	O	B-T078
at	O	O	O
the	O	O	O
individual	O	O	B-T098
level	O	O	B-T080
,	O	O	O
were	O	O	O
trained	O	O	O
to	O	O	O
separate	O	O	O
individuals	O	O	B-T098
with	O	O	O
PD	O	O	B-T047
from	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
based	O	O	O
on	O	O	O
the	O	O	O
ALFF	O	O	B-T184
and	O	O	O
fALFF	O	O	B-T184
.	O	O	O

Using	O	O	O
the	O	O	O
leave-one-out	O	O	O
cross-validation	O	O	B-T062
method	O	O	I-T062
to	O	O	O
analyze	O	O	B-T062
our	O	O	O
sample	O	O	B-T167
,	O	O	O
we	O	O	O
reliably	O	O	O
distinguished	O	O	O
the	O	O	O
participants	O	O	B-T098
with	O	O	O
PD	O	O	B-T047
from	O	O	O
the	O	O	O
controls	O	O	B-T096
with	O	O	O
92	O	O	O
%	O	O	O
sensitivity	O	O	B-T080
and	O	O	O
87	O	O	O
%	O	O	O
specificity	O	O	B-T081
.	O	O	O

Overall	O	O	O
,	O	O	O
these	O	O	O
findings	O	O	B-T169
suggest	O	O	O
that	O	O	O
the	O	O	O
SVM	O	O	B-T081
-	O	O	O
neuroimaging	O	O	B-T060
approach	O	O	O
may	O	O	O
be	O	O	O
of	O	O	O
particular	O	O	O
clinical	O	O	B-T080
value	O	O	O
because	O	O	O
it	O	O	O
enables	O	O	O
the	O	O	O
accurate	O	O	O
identification	O	O	O
of	O	O	O
PD	O	O	B-T047
at	O	O	O
the	O	O	O
individual	O	O	B-T098
level	O	O	B-T080
.	O	O	O

RS-fMRI	O	O	B-T060
should	O	O	O
be	O	O	O
considered	O	O	O
for	O	O	O
development	O	O	B-T169
as	O	O	O
a	O	O	O
biomarker	O	O	B-T201
and	O	O	O
an	O	O	O
analytical	O	O	O
tool	O	O	O
for	O	O	O
the	O	O	O
evaluation	O	O	B-T058
of	O	O	O
PD	O	O	B-T047
.	O	O	O

-DOCSTART- (28250235)

Methylation	O	O	B-T044
dynamics	O	O	B-T070
during	O	O	O
folliculogenesis	O	O	B-T042
and	O	O	O
early	O	O	B-T079
embryo	O	O	B-T042
development	O	O	I-T042
in	O	O	O
sheep	O	O	O

Genome	O	O	B-T028
-wide	O	O	O
DNA	O	O	B-T044
methylation	O	O	I-T044
reprogramming	O	O	O
occurs	O	O	O
during	O	O	O
mammalian	O	O	B-T015
gametogenesis	O	O	B-T042
and	O	O	O
early	O	O	B-T079
embryogenesis	O	O	B-T042
.	O	O	O

Post	O	O	B-T079
-	O	O	O
fertilization	O	O	B-T040
demethylation	O	O	B-T045
of	O	O	O
paternal	O	O	B-T080
and	O	O	O
maternal	O	O	B-T033
genomes	O	O	B-T028
is	O	O	O
considered	O	O	O
to	O	O	O
occur	O	O	O
by	O	O	O
an	O	O	O
active	O	O	O
and	O	O	O
passive	O	O	O
mechanism	O	O	O
respectively	O	O	O
,	O	O	O
in	O	O	O
most	O	O	O
mammals	O	O	B-T015
but	O	O	O
sheep	O	O	B-T015
;	O	O	O
in	O	O	O
this	O	O	O
species	O	O	O
no	O	O	O
loss	O	O	O
of	O	O	O
methylation	O	O	B-T044
was	O	O	O
observed	O	O	O
in	O	O	O
either	O	O	O
pronucleus	O	O	B-T026
.	O	O	O

Post	O	O	B-T079
-	O	O	O
fertilization	O	O	B-T040
reprogramming	O	O	O
relies	O	O	O
on	O	O	O
methylating	O	O	B-T116
and	O	O	O
demethylating	O	O	B-T116
enzymes	O	O	I-T116
and	O	O	O
co-factors	O	O	O
that	O	O	O
are	O	O	O
stored	O	O	O
during	O	O	O
oocyte	O	O	B-T025
growth	O	O	I-T043
,	O	O	O
concurrently	O	O	O
with	O	O	O
the	O	O	O
re-methylation	O	O	B-T044
of	O	O	O
the	O	O	O
oocyte	O	O	O
itself	O	O	O
.	O	O	O

The	O	O	O
crucial	O	O	O
remodelling	O	O	O
of	O	O	O
the	O	O	O
oocyte	O	O	B-T025
epigenetic	O	O	O
baggage	O	O	O
often	O	O	O
overlaps	O	O	O
with	O	O	O
potential	O	O	O
interfering	O	O	O
events	O	O	O
such	O	O	O
as	O	O	O
exposure	O	O	O
to	O	O	O
assisted	O	O	O
reproduction	O	O	B-T061
technologies	O	O	I-T061
or	O	O	O
environmental	O	O	B-T033
changes	O	O	I-T033
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
a	O	O	O
temporal	O	O	O
analysis	O	O	O
of	O	O	O
methylation	O	O	B-T044
dynamics	O	O	B-T070
during	O	O	O
folliculogenesis	O	O	B-T042
and	O	O	O
early	O	O	B-T079
embryo	O	O	B-T042
development	O	O	I-T042
in	O	O	O
sheep	O	O	B-T015
.	O	O	O

We	O	O	O
characterized	O	O	O
global	O	O	O
DNA	O	O	B-T044
methylation	O	O	I-T044
and	O	O	O
hydroxymethylation	O	O	B-T045
by	O	O	O
immunofluorescence	O	O	B-T059
and	O	O	O
relatively	O	O	O
quantified	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
the	O	O	O
enzymes	O	O	B-T116
and	O	O	O
co-factors	O	O	O
mainly	O	O	O
responsible	O	O	O
for	O	O	O
their	O	O	O
remodelling	O	O	O
(	O	O	O
DNA	O	O	B-T116
methyltransferases	O	O	I-T116
(	O	O	O
DNMTs	O	O	B-T116
)	O	O	O
,	O	O	O
ten-eleven	O	O	B-T116
translocation	O	O	I-T116
(	O	O	I-T116
TET	O	O	I-T116
)	O	O	I-T116
proteins	O	O	B-T116
and	O	O	O
methyl-CpG-binding	O	O	B-T087
domain	O	O	I-T087
(	O	O	O
MBD	O	O	B-T087
)	O	O	O
proteins	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	O
illustrate	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
the	O	O	O
patterns	O	O	O
of	O	O	O
hydroxymethylation	O	O	B-T045
during	O	O	O
oocyte	O	O	B-T043
growth	O	O	I-T043
.	O	O	O

We	O	O	O
observed	O	O	O
different	O	O	O
patterns	O	O	O
of	O	O	O
methylation	O	O	B-T044
and	O	O	O
hydroxymethylation	O	O	B-T045
between	O	O	O
the	O	O	O
two	O	O	O
parental	O	O	B-T026
pronuclei	O	O	I-T026
,	O	O	O
suggesting	O	O	O
that	O	O	O
male	O	O	B-T026
pronucleus	O	O	I-T026
undergoes	O	O	O
active	O	O	O
demethylation	O	O	B-T045
also	O	O	O
in	O	O	O
sheep	O	O	B-T015
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
gene	O	O	B-T028
-specific	O	O	O
accumulation	O	O	O
dynamics	O	O	B-T070
for	O	O	O
methylating	O	O	B-T116
and	O	O	O
demethylating	O	O	B-T116
enzymes	O	O	I-T116
during	O	O	O
oocyte	O	O	B-T025
growth	O	O	I-T043
and	O	O	O
observe	O	O	O
patterns	O	O	O
of	O	O	O
expression	O	O	B-T045
associated	O	O	O
with	O	O	O
developmental	O	O	B-T080
competence	O	O	B-T080
in	O	O	O
a	O	O	O
differential	O	O	O
model	O	O	O
of	O	O	O
oocyte	O	O	O
potential	O	O	O
.	O	O	O

Our	O	O	O
work	O	O	O
contributes	O	O	O
to	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
methylation	O	O	B-T044
dynamics	O	O	B-T070
during	O	O	O
folliculogenesis	O	O	B-T042
and	O	O	O
early	O	O	B-T079
embryo	O	O	B-T018
development	O	O	I-T042
and	O	O	O
improves	O	O	O
the	O	O	O
overall	O	O	O
picture	O	O	O
of	O	O	O
early	O	O	O
rearrangements	O	O	O
that	O	O	O
will	O	O	O
originate	O	O	O
the	O	O	O
embryo	O	O	O
epigenome	O	O	B-T028
.	O	O	O

-DOCSTART- (28250430)

Network	O	O	B-T169
analysis	O	O	B-T062
reveals	O	O	B-T080
why	O	O	O
Xylella	O	O	B-T007
fastidiosa	O	O	I-T007
will	O	O	O
persist	O	O	O
in	O	O	O
Europe	O	O	O

The	O	O	O
insect	O	O	B-T204
vector	O	O	I-T204
borne	O	O	O
bacterium	O	O	B-T007
Xylella	O	O	B-T007
fastidiosa	O	O	I-T007
was	O	O	O
first	O	O	O
detected	O	O	O
in	O	O	O
olive	O	O	B-T002
trees	O	O	I-T002
in	O	O	O
Southern	O	O	B-T083
Italy	O	O	I-T083
in	O	O	O
2013	O	O	O
,	O	O	O
and	O	O	O
identified	O	O	O
as	O	O	O
the	O	O	O
main	O	O	O
culprit	O	O	O
behind	O	O	O
the	O	O	O
'	O	O	O
olive	O	O	B-T047
quick	O	O	I-T047
decline	O	O	I-T047
syndrome	O	O	I-T047
'	O	O	O
.	O	O	O

Since	O	O	O
then	O	O	O
,	O	O	O
the	O	O	O
disease	O	O	B-T047
has	O	O	O
spread	O	O	O
rapidly	O	O	O
through	O	O	O
Italy	O	O	B-T083
's	O	O	I-T083
main	O	O	O
olive	O	O	B-T109
oil	O	O	I-T109
producing	O	O	O
region	O	O	B-T083
.	O	O	O

The	O	O	O
epidemiology	O	O	B-T062
of	O	O	O
the	O	O	O
outbreak	O	O	B-T067
is	O	O	O
largely	O	O	O
unstudied	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
list	O	O	O
of	O	O	O
X.	O	O	B-T007
fastidiosa	O	O	I-T007
hosts	O	O	B-T001
and	O	O	O
vectors	O	O	B-T204
in	O	O	O
Europe	O	O	B-T083
likely	O	O	O
incomplete	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
role	O	O	O
humans	O	O	B-T016
play	O	O	O
in	O	O	O
dispersal	O	O	B-T080
unknown	O	O	B-T080
.	O	O	O

These	O	O	O
knowledge	O	O	B-T170
gaps	O	O	B-T082
have	O	O	O
led	O	O	O
to	O	O	O
management	O	O	B-T057
strategies	O	O	I-T057
based	O	O	O
on	O	O	O
general	O	O	O
assumptions	O	O	O
that	O	O	O
require	O	O	O
,	O	O	O
among	O	O	O
others	O	O	O
,	O	O	O
local	O	O	O
vector	O	O	B-T057
control	O	O	I-T057
and	O	O	O
,	O	O	O
in	O	O	O
certain	O	O	O
areas	O	O	B-UnknownType
,	O	O	O
the	O	O	O
destruction	O	O	B-T052
of	O	O	O
infected	O	O	B-T002
plants	O	O	I-T002
and	O	O	O
healthy	O	O	B-T080
ones	O	O	O
around	O	O	O
them	O	O	O
in	O	O	O
an	O	O	O
attempt	O	O	O
to	O	O	O
eradicate	O	O	B-T052
or	O	O	O
halt	O	O	B-T079
the	O	O	O
spreading	O	O	B-T080
pest	O	O	B-T047
.	O	O	O

Here	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
,	O	O	O
regardless	O	O	O
of	O	O	O
epidemiological	O	O	B-T169
uncertainties	O	O	B-T033
,	O	O	O
the	O	O	O
mere	O	O	O
distribution	O	O	O
of	O	O	O
olive	O	O	B-T002
orchards	O	O	O
in	O	O	O
Southern	O	O	B-T083
Italy	O	O	I-T083
makes	O	O	O
the	O	O	O
chances	O	O	O
of	O	O	O
eradicating	O	O	B-T052
X.	O	O	B-T007
fastidiosa	O	O	I-T007
from	O	O	O
the	O	O	O
region	O	O	B-T083
extremely	O	O	O
slim	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	B-T169
imply	O	O	O
that	O	O	O
Southern	O	O	B-T083
Italy	O	O	I-T083
is	O	O	O
becoming	O	O	O
a	O	O	O
reservoir	O	O	B-T083
for	O	O	O
X.	O	O	B-T007
fastidiosa	O	O	I-T007
.	O	O	O

As	O	O	O
a	O	O	O
consequence	O	O	O
,	O	O	O
management	O	O	B-T057
strategies	O	O	I-T057
should	O	O	O
keep	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
X.	O	O	B-T007
fastidiosa	O	O	I-T007
in	O	O	O
the	O	O	O
region	O	O	B-T083
as	O	O	O
low	O	O	O
as	O	O	O
possible	O	O	O
,	O	O	O
primarily	O	O	O
through	O	O	O
vector	O	O	B-T057
control	O	O	I-T057
,	O	O	O
lest	O	O	B-T169
the	O	O	O
pathogen	O	O	B-T001
,	O	O	O
that	O	O	O
has	O	O	O
also	O	O	O
been	O	O	O
detected	O	O	O
in	O	O	O
southern	O	O	B-T083
France	O	O	I-T083
and	O	O	O
the	O	O	O
island	O	O	B-T083
of	O	O	I-T083
Mallorca	O	O	I-T083
(	O	O	O
Spain	O	O	B-T083
)	O	O	O
,	O	O	O
continues	O	O	O
spreading	O	O	B-T080
through	O	O	O
Italy	O	O	B-T083
and	O	O	O
Europe	O	O	B-T083
.	O	O	O

-DOCSTART- (28251086)

Novel	O	O	O
biomarkers	O	O	B-T201
for	O	O	O
patients	O	O	B-T101
with	O	O	O
idiopathic	O	O	B-T169
acute	O	O	B-T047
anterior	O	O	I-T047
uveitis	O	O	I-T047
:	O	O	O
neutrophil	O	O	B-T025
to	O	O	O
lymphocyte	O	O	B-T025
ratio	O	O	B-T081
and	O	O	O
platelet	O	O	B-T025
to	O	O	O
lymphocyte	O	O	O
ratio	O	O	O

To	O	O	O
assess	O	O	B-T052
the	O	O	O
levels	O	O	B-T080
of	O	O	O
the	O	O	O
neutrophil	O	O	B-T025
to	O	O	O
lymphocyte	O	O	B-T025
ratio	O	O	B-T081
(	O	O	O
N	O	O	B-T025
/	O	O	O
L	O	O	B-T025
)	O	O	O
and	O	O	O
the	O	O	O
platelet	O	O	B-T025
to	O	O	O
lymphocyte	O	O	O
ratio	O	O	O
(	O	O	O
P	O	O	B-T025
/	O	O	O
L	O	O	O
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
idiopathic	O	O	B-T169
acute	O	O	B-T047
anterior	O	O	I-T047
uveitis	O	O	I-T047
(	O	O	O
AAU	O	O	B-T047
)	O	O	O
and	O	O	O
to	O	O	O
compare	O	O	B-T052
with	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

Thirty-six	O	O	O
male	O	O	B-T098
patients	O	O	B-T101
with	O	O	O
idiopathic	O	O	B-T169
AAU	O	O	B-T047
and	O	O	O
36	O	O	O
male	O	O	O
healthy	O	O	B-T080
subjects	O	O	B-T098
were	O	O	O
enrolled	O	O	O
in	O	O	O
this	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Complete	O	O	B-T080
ophthalmological	O	O	B-T061
examination	O	O	I-T061
and	O	O	O
complete	O	O	O
blood	O	O	B-T059
count	O	O	I-T059
measurements	O	O	I-T059
results	O	O	B-T033
of	O	O	O
all	O	O	O
subjects	O	O	B-T098
were	O	O	O
evaluated	O	O	B-T058
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	B-T078
difference	O	O	O
in	O	O	O
N	O	O	B-T025
/	O	O	O
L	O	O	B-T025
and	O	O	O
P	O	O	B-T025
/	O	O	O
L	O	O	O
between	O	O	O
idiopathic	O	O	B-T169
AAU	O	O	B-T047
and	O	O	O
control	O	O	B-T096
groups	O	O	I-T096
(	O	O	O
P=0.006	O	O	O
,	O	O	O
P=0.022	O	O	O
)	O	O	O
.	O	O	O

Also	O	O	O
,	O	O	O
correlation	O	O	B-T080
analysis	O	O	I-T062
revealed	O	O	O
a	O	O	O
significant	O	O	B-T078
correlation	O	O	O
between	O	O	O
C-reactive	O	O	B-T116
protein	O	O	I-T116
(	O	O	O
CRP	O	O	B-T116
)	O	O	O
and	O	O	O
N	O	O	B-T025
/	O	O	O
L	O	O	B-T025
(	O	O	O
P=0.002	O	O	O
;	O	O	O
r=0.461	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
study	O	O	B-T062
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
provides	O	O	O
evidence	O	O	B-T169
of	O	O	I-T169
N	O	O	B-T025
/	O	O	O
L	O	O	B-T025
and	O	O	O
P	O	O	B-T025
/	O	O	O
L	O	O	O
may	O	O	O
be	O	O	O
useful	O	O	B-T080
biomarkers	O	O	B-T201
in	O	O	O
patients	O	O	B-T101
with	O	O	O
idiopathic	O	O	B-T169
AAU	O	O	B-T047
.	O	O	O

N	O	O	B-T025
/	O	O	O
L	O	O	B-T025
is	O	O	O
correlated	O	O	B-T080
with	O	O	O
CRP	O	O	B-T116
,	O	O	O
so	O	O	O
it	O	O	O
can	O	O	O
be	O	O	O
a	O	O	O
useful	O	O	B-T080
biomarker	O	O	B-T201
to	O	O	O
predict	O	O	O
the	O	O	O
prognosis	O	O	B-T058
in	O	O	O
idiopathic	O	O	B-T169
AAU	O	O	B-T047
.	O	O	O

-DOCSTART- (28251780)

Comparison	O	O	B-T052
between	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
and	O	O	O
B-mode	O	O	B-T060
ultrasound	O	O	I-T060
in	O	O	O
detecting	O	O	B-T033
and	O	O	O
estimating	O	O	B-T081
the	O	O	O
extent	O	O	B-T082
of	O	O	O
human	O	O	B-T016
carotid	O	O	O
atherosclerosis	O	O	O

In	O	O	O
MRI	O	O	B-T060
studies	O	O	I-T060
of	O	O	O
carotid	O	O	B-T020
plaques	O	O	B-T033
,	O	O	O
ultrasound	O	O	B-T060
is	O	O	O
used	O	O	O
to	O	O	O
find	O	O	B-T033
plaques	O	O	O
,	O	O	O
which	O	O	O
are	O	O	O
later	O	O	O
imaged	O	O	B-T170
using	O	O	O
MRI	O	O	O
.	O	O	O

The	O	O	O
performance	O	O	B-T052
in	O	O	O
plaque	O	O	B-T033
detection	O	O	B-T033
has	O	O	O
not	O	O	O
been	O	O	O
compared	O	O	B-T052
between	O	O	O
the	O	O	O
modalities	O	O	B-T169
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
current	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
performance	O	O	B-T052
of	O	O	O
MRI	O	O	B-T060
and	O	O	O
ultrasound	O	O	B-T060
in	O	O	O
detecting	O	O	B-T033
carotid	O	O	B-T020
artery	O	O	I-T020
plaques	O	O	I-T020
and	O	O	O
measuring	O	O	B-T080
extent	O	O	B-T082
of	O	O	O
atherosclerosis	O	O	B-T047
.	O	O	O

Subjects	O	O	B-T096
with	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
plaque	O	O	B-T033
(	O	O	O
height	O	O	B-T081
≥2·5	O	O	O
mm	O	O	O
)	O	O	O
on	O	O	O
ultrasound	O	O	B-T060
were	O	O	O
imaged	O	O	B-T170
using	O	O	O
MRI	O	O	B-T060
.	O	O	O

The	O	O	O
number	O	O	B-T081
of	O	O	O
plaques	O	O	B-T033
and	O	O	O
their	O	O	O
height	O	O	B-T081
was	O	O	O
measured	O	O	B-T080
in	O	O	O
both	O	O	O
modalities	O	O	B-T169
;	O	O	O
plaque	O	O	B-T033
area	O	O	B-T082
and	O	O	O
volume	O	O	B-T081
were	O	O	O
analysed	O	O	B-T062
on	O	O	O
ultrasound	O	O	B-T060
and	O	O	O
MRI	O	O	B-T060
,	O	O	O
respectively	O	O	O
.	O	O	O

Thirty-eight	O	O	B-T081
subjects	O	O	B-T096
were	O	O	O
included	O	O	B-T169
.	O	O	O

MRI	O	O	B-T060
detected	O	O	B-T033
plaques	O	O	B-T033
in	O	O	O
95	O	O	O
%	O	O	O
of	O	O	O
carotid	O	O	B-T023
arteries	O	O	I-T023
with	O	O	O
a	O	O	O
plaque	O	O	B-T033
height	O	O	B-T081
of	O	O	O
≥2·5	O	O	O
mm	O	O	O
on	O	O	O
ultrasound	O	O	B-T060
and	O	O	O
in	O	O	O
all	O	O	O
carotid	O	O	O
arteries	O	O	O
with	O	O	O
a	O	O	O
plaque	O	O	O
exceeding	O	O	O
2·5	O	O	O
mm	O	O	O
.	O	O	O

MRI	O	O	B-T060
detected	O	O	B-T033
53	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
plaques	O	O	B-T033
with	O	O	O
a	O	O	O
height	O	O	B-T081
below	O	O	O
2·5	O	O	O
mm	O	O	O
.	O	O	O

The	O	O	O
plaque	O	O	B-T033
height	O	O	B-T081
measured	O	O	B-T080
with	O	O	O
both	O	O	O
techniques	O	O	B-T169
correlated	O	O	B-T080
significantly	O	O	O
,	O	O	O
0·59	O	O	O
,	O	O	O
P<0·0001	O	O	O
.	O	O	O

Ultrasound	O	O	B-T060
-derived	O	O	O
plaque	O	O	B-T033
height	O	O	B-T081
and	O	O	O
plaque	O	O	O
area	O	O	B-T082
correlated	O	O	B-T080
similarly	O	O	B-T080
to	O	O	O
MRI	O	O	B-T060
-derived	O	O	O
plaque	O	O	O
volume	O	O	B-T081
,	O	O	O
r	O	O	O
=	O	O	O
0·52	O	O	O
;	O	O	O
P<0·0001	O	O	O
and	O	O	O
r	O	O	O
=	O	O	O
0·47	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0·001	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

We	O	O	O
conclude	O	O	O
that	O	O	O
MRI	O	O	B-T060
has	O	O	O
a	O	O	O
similar	O	O	B-T080
sensitivity	O	O	B-T081
to	O	O	O
ultrasound	O	O	B-T060
in	O	O	O
finding	O	O	B-T033
carotid	O	O	B-T020
artery	O	O	I-T020
plaques	O	O	I-T020
that	O	O	O
are	O	O	O
2·5	O	O	O
mm	O	O	O
or	O	O	O
higher	O	O	B-T080
.	O	O	O

In	O	O	O
smaller	O	O	B-T080
plaques	O	O	B-T033
,	O	O	O
MRI	O	O	B-T060
detects	O	O	B-T033
fewer	O	O	B-T081
plaques	O	O	O
.	O	O	O

Multiple	O	O	B-T020
carotid	O	O	I-T020
plaques	O	O	I-T020
seen	O	O	O
on	O	O	O
ultrasound	O	O	B-T060
most	O	O	O
often	O	O	O
are	O	O	O
a	O	O	O
misinterpretation	O	O	O
of	O	O	O
the	O	O	O
anatomy	O	O	B-T080
and	O	O	O
correspond	O	O	O
to	O	O	O
a	O	O	O
single	O	O	B-T033
plaque	O	O	I-T033
.	O	O	O

Plaque	O	O	B-T033
height	O	O	B-T081
on	O	O	O
ultrasound	O	O	B-T060
is	O	O	O
comparable	O	O	O
to	O	O	O
plaque	O	O	B-T033
height	O	O	O
on	O	O	O
MRI	O	O	B-T060
and	O	O	O
correlates	O	O	B-T080
fairly	O	O	O
well	O	O	O
with	O	O	O
plaque	O	O	O
volume	O	O	B-T081
on	O	O	O
MRI	O	O	O
making	O	O	O
it	O	O	O
an	O	O	O
interesting	O	O	O
proxy	O	O	O
for	O	O	O
plaque	O	O	O
burden	O	O	B-T078
.	O	O	O

-DOCSTART- (28252933)

Lightweight	O	O	O
Open-Cell	O	O	B-T026
Scaffolds	O	O	I-T026
from	O	O	O
Sea	O	O	B-T204
Urchin	O	O	I-T204
Spines	O	O	B-T122
with	O	O	O
Superior	O	O	O
Material	O	O	B-T167
Properties	O	O	B-T080
for	O	O	O
Bone	O	O	O
Defect	O	O	O
Repair	O	O	O

Sea	O	O	B-T204
urchin	O	O	I-T204
spines	O	O	B-T122
(	O	O	O
Heterocentrotus	O	O	B-T204
mammillatus	O	O	I-T204
)	O	O	O
,	O	O	O
with	O	O	O
a	O	O	O
hierarchical	O	O	O
open-cell	O	O	B-T026
structure	O	O	I-T026
similar	O	O	O
to	O	O	O
that	O	O	O
of	O	O	O
human	O	O	B-T016
trabecular	O	O	B-T024
bone	O	O	I-T024
and	O	O	O
superior	O	O	O
mechanical	O	O	B-T080
property	O	O	I-T080
(	O	O	O
compressive	O	O	B-T081
strength	O	O	I-T081
∼43.4	O	O	O
MPa	O	O	O
)	O	O	O
suitable	O	O	B-T080
for	O	O	O
machining	O	O	B-T052
to	O	O	O
shape	O	O	B-T080
,	O	O	O
were	O	O	O
explored	O	O	O
for	O	O	O
potential	O	O	B-T080
applications	O	O	B-T169
of	O	O	O
bone	O	O	B-T061
defect	O	O	I-T061
repair	O	O	I-T061
.	O	O	O

Finite	O	O	B-T170
element	O	O	I-T170
analyses	O	O	I-T170
reveal	O	O	O
that	O	O	O
the	O	O	O
compressive	O	O	O
stress	O	O	B-T033
concentrates	O	O	B-T052
along	O	O	O
the	O	O	O
dense	O	O	B-T080
growth	O	O	B-T042
rings	O	O	I-T042
and	O	O	O
dissipates	O	O	B-T082
through	O	O	O
strut	O	O	O
structures	O	O	B-T017
of	O	O	I-T017
the	O	O	I-T017
stereoms	O	O	I-T017
,	O	O	O
indicating	O	O	O
that	O	O	O
the	O	O	O
exquisite	O	O	O
mesostructures	O	O	B-T082
play	O	O	O
an	O	O	O
important	O	O	B-T080
role	O	O	O
in	O	O	O
high	O	O	O
strength	O	O	B-T080
-to-	O	O	O
weight	O	O	B-T081
ratios	O	O	B-T081
.	O	O	O

The	O	O	O
fracture	O	O	B-T037
strength	O	O	B-T080
of	O	O	O
magnesium	O	O	B-T123
-	O	O	O
substituted	O	O	B-T122
tricalcium	O	O	I-T122
phosphate	O	O	I-T122
(	O	O	B-T122
β-TCMP	O	O	I-T122
)	O	O	I-T122
scaffolds	O	O	I-T122
produced	O	O	O
by	O	O	O
hydrothermal	O	O	B-T067
conversion	O	O	B-T169
of	O	O	O
urchin	O	O	B-T204
spines	O	O	B-T122
is	O	O	O
about	O	O	O
9.3	O	O	O
MPa	O	O	O
,	O	O	O
comparable	O	O	B-T052
to	O	O	O
that	O	O	O
of	O	O	O
human	O	O	B-T016
trabecular	O	O	B-T024
bone	O	O	I-T024
.	O	O	O

New	O	O	O
bone	O	O	B-T023
forms	O	O	B-T169
along	O	O	O
outer	O	O	O
surfaces	O	O	B-T082
of	O	O	O
β-TCMP	O	O	B-T122
scaffolds	O	O	I-T122
after	O	O	O
implantation	O	O	B-T061
in	O	O	O
rabbit	O	O	B-T015
femoral	O	O	B-T037
defects	O	O	I-T037
for	O	O	O
one	O	O	O
month	O	O	B-T079
and	O	O	O
grows	O	O	B-T042
into	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
the	O	O	O
inner	O	O	O
open-cell	O	O	B-T030
spaces	O	O	I-T030
postoperation	O	O	B-T079
in	O	O	O
three	O	O	O
month	O	O	O
s	O	O	O
,	O	O	O
showing	O	O	O
tight	O	O	B-T044
interface	O	O	I-T044
between	O	O	O
the	O	O	O
scaffold	O	O	B-T122
and	O	O	O
regenerative	O	O	B-T042
bone	O	O	I-T042
tissue	O	O	I-T042
.	O	O	O

Fusion	O	O	B-T061
of	O	O	O
beagle	O	O	B-T015
lumbar	O	O	B-T030
facet	O	O	I-T030
joints	O	O	I-T030
using	O	O	O
a	O	O	O
Ti-6Al-4V	O	O	B-T197
cage	O	O	I-T197
and	O	O	O
β-TCMP	O	O	B-T122
scaffold	O	O	I-T122
can	O	O	O
be	O	O	O
completed	O	O	B-T080
within	O	O	O
seven	O	O	O
months	O	O	B-T079
with	O	O	O
obvious	O	O	O
biodegradation	O	O	B-T070
of	O	O	O
the	O	O	O
β-TCMP	O	O	O
scaffold	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
nearly	O	O	O
completely	O	O	B-T080
degraded	O	O	B-T070
and	O	O	O
replaced	O	O	B-T169
by	O	O	I-T169
newly	O	O	O
formed	O	O	B-T169
bone	O	O	B-T023
ten	O	O	O
months	O	O	O
after	O	O	O
implantation	O	O	B-T061
.	O	O	O

Thus	O	O	O
,	O	O	O
sea	O	O	B-T204
urchin	O	O	I-T204
spines	O	O	B-T122
suitable	O	O	O
for	O	O	O
machining	O	O	B-T052
to	O	O	O
shape	O	O	B-T080
have	O	O	O
advantages	O	O	O
for	O	O	O
production	O	O	O
of	O	O	O
biodegradable	O	O	B-T070
artificial	O	O	B-T122
grafts	O	O	I-T122
for	O	O	O
bone	O	O	B-T061
defect	O	O	I-T061
repair	O	O	I-T061
.	O	O	O

-DOCSTART- (28254544)

Melatonin	O	O	B-T125
and	O	O	O
nitric	O	O	B-T121
oxide	O	O	I-T121
regulate	O	O	B-T040
sunflower	O	O	B-T002
seedling	O	O	B-T040
growth	O	O	I-T040
under	O	O	O
salt	O	O	B-T043
stress	O	O	I-T043
accompanying	O	O	O
differential	O	O	O
expression	O	O	B-T045
of	O	O	O
Cu/Zn	O	O	B-T116
SOD	O	O	I-T116
and	O	O	O
Mn	O	O	O
SOD	O	O	O

Salinity	O	O	B-T043
results	O	O	I-T043
in	O	O	O
significant	O	O	B-T080
reduction	O	O	I-T080
in	O	O	O
sunflower	O	O	B-T002
(	O	O	O
Helianthus	O	O	B-T002
annuus	O	O	I-T002
L.	O	O	I-T002
)	O	O	O
seedling	O	O	B-T040
growth	O	O	I-T040
and	O	O	O
excessive	O	O	O
generation	O	O	O
of	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
.	O	O	O

Present	O	O	O
work	O	O	O
highlights	O	O	O
the	O	O	O
possible	O	O	O
role	O	O	O
of	O	O	O
melatonin	O	O	B-T125
as	O	O	O
an	O	O	O
antioxidant	O	O	B-T121
through	O	O	O
its	O	O	O
interaction	O	O	O
with	O	O	O
nitric	O	O	B-T121
oxide	O	O	I-T121
(	O	O	O
NO	O	O	B-T121
)	O	O	O
,	O	O	O
and	O	O	O
as	O	O	O
an	O	O	O
early	O	O	O
and	O	O	O
long	O	O	O
distance	O	O	O
NaCl-stress	O	O	B-T043
sensing	O	O	O
signaling	O	O	B-T123
molecule	O	O	I-T123
in	O	O	O
seedling	O	O	B-T002
cotyledons	O	O	B-T002
.	O	O	O

Exogenous	O	O	B-T169
melatonin	O	O	B-T125
(15µM)±	O	O	O
NaCl	O	O	B-T121
(	O	O	O
120mM	O	O	O
)	O	O	O
inhibit	O	O	B-T052
seedling	O	O	B-T040
growth	O	O	I-T040
,	O	O	O
which	O	O	O
is	O	O	O
also	O	O	O
correlated	O	O	O
with	O	O	O
NO	O	O	B-T121
availability	O	O	O
,	O	O	O
accumulation	O	O	O
of	O	O	O
potential	O	O	B-T196
superoxide	O	O	I-T196
anion	O	O	I-T196
(	O	O	O
O2(•-	O	O	B-T196
)	O	O	I-T196
)	O	O	O
and	O	O	O
peroxynitrite	O	O	B-T123
anion	O	O	I-T123
(	O	O	O
ONOO(-	O	O	B-T123
)	O	O	I-T123
)	O	O	O
,	O	O	O
extent	O	O	O
of	O	O	O
tyrosine-nitration	O	O	B-T044
of	O	O	O
proteins	O	O	B-T116
,	O	O	O
spatial	O	O	B-T169
localization	O	O	I-T169
and	O	O	O
activity	O	O	B-T044
of	O	O	I-T044
superoxide	O	O	I-T044
dismutase	O	O	I-T044
(	O	O	O
SOD	O	O	B-T116
)	O	O	O
isoforms	O	O	B-T116
.	O	O	O

NO	O	O	B-T121
acts	O	O	O
as	O	O	O
a	O	O	O
positive	O	O	O
modulator	O	O	O
of	O	O	O
melatonin	O	O	B-T125
accumulation	O	O	O
in	O	O	O
seedling	O	O	B-T002
cotyledons	O	O	B-T002
as	O	O	O
a	O	O	O
long-distance	O	O	B-T044
signaling	O	O	I-T044
response	O	O	I-T044
.	O	O	O

Modulation	O	O	B-T040
of	O	O	I-T040
superoxide	O	O	I-T040
anion	O	O	I-T040
and	O	O	O
peroxynitrite	O	O	B-T123
anion	O	O	I-T123
content	O	O	O
by	O	O	O
melatonin	O	O	B-T125
highlights	O	O	O
its	O	O	O
crucial	O	O	O
role	O	O	O
in	O	O	O
combating	O	O	O
deleterious	O	O	O
effects	O	O	O
of	O	O	O
ROS	O	O	B-T123
and	O	O	O
reactive	O	O	B-T123
nitrogen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
RNS	O	O	O
)	O	O	O
.	O	O	O

Present	O	O	O
findings	O	O	O
provide	O	O	O
evidence	O	O	O
for	O	O	O
an	O	O	O
interaction	O	O	O
between	O	O	O
melatonin	O	O	B-T125
and	O	O	O
NO	O	O	B-T121
in	O	O	O
their	O	O	O
effect	O	O	O
on	O	O	O
seedling	O	O	B-T040
growth	O	O	I-T040
under	O	O	O
salt	O	O	B-T043
stress	O	O	I-T043
accompanying	O	O	I-T043
differential	O	O	O
modulation	O	O	O
of	O	O	O
two	O	O	O
SOD	O	O	B-T116
isoforms	O	O	B-T116
,	O	O	O
i.e.	O	O	O
Cu/Zn	O	O	B-T116
SOD	O	O	I-T116
and	O	O	O
Mn	O	O	B-T116
SOD	O	O	I-T116
.	O	O	O

-DOCSTART- (28258572)

The	O	O	O
Physiological	O	O	B-T169
Role	O	O	O
and	O	O	O
Regulation	O	O	B-T038
of	O	O	O
Aquaporins	O	O	B-T116
in	O	O	O
Teleost	O	O	B-T013
Germ	O	O	O
Cells	O	O	O

The	O	O	O
unicellular	O	O	O
germ	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
gametes	O	O	B-T025
of	O	O	O
oviparous	O	O	B-T042
teleosts	O	O	B-T013
lack	O	O	O
the	O	O	O
osmoregulatory	O	O	B-T043
organs	O	O	B-T023
present	O	O	O
in	O	O	O
juveniles	O	O	B-T100
and	O	O	O
adults	O	O	B-T100
,	O	O	O
yet	O	O	O
during	O	O	O
development	O	O	B-T039
and	O	O	O
particularly	O	O	O
at	O	O	O
spawning	O	O	B-T032
,	O	O	O
they	O	O	O
face	O	O	O
tremendous	O	O	O
osmotic	O	O	B-T169
challenges	O	O	B-T033
when	O	O	O
released	O	O	O
into	O	O	O
the	O	O	O
external	O	O	B-T082
aquatic	O	O	B-T067
environment	O	O	I-T067
.	O	O	O

Increasing	O	O	O
evidence	O	O	O
suggests	O	O	O
that	O	O	O
transmembrane	O	O	B-T116
water	O	O	I-T116
channels	O	O	I-T116
(	O	O	O
aquaporins	O	O	B-T116
)	O	O	O
evolved	O	O	O
to	O	O	O
play	O	O	O
vital	O	O	O
adaptive	O	O	O
roles	O	O	O
that	O	O	O
mitigate	O	O	B-T067
the	O	O	O
osmotic	O	O	B-T070
and	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
problems	O	O	B-T033
of	O	O	O
the	O	O	O
developing	O	O	B-T039
oocytes	O	O	B-T025
,	O	O	O
embryos	O	O	B-T018
and	O	O	O
spermatozoa	O	O	B-T025
.	O	O	O

In	O	O	O
this	O	O	O
chapter	O	O	O
,	O	O	O
we	O	O	O
provide	O	O	O
a	O	O	O
short	O	O	O
overview	O	O	O
of	O	O	O
the	O	O	O
diversity	O	O	B-T080
of	O	O	O
the	O	O	O
aquaporin	O	O	B-T116
superfamily	O	O	O
in	O	O	O
teleosts	O	O	B-T013
,	O	O	O
and	O	O	O
summarize	O	O	O
the	O	O	O
findings	O	O	O
that	O	O	O
uncovered	O	O	O
a	O	O	O
highly	O	O	O
specific	O	O	O
molecular	O	O	B-T044
regulation	O	O	I-T044
of	O	O	O
aquaporins	O	O	B-T116
during	O	O	O
oogenesis	O	O	B-T042
and	O	O	O
spermatogenesis	O	O	B-T043
.	O	O	O

We	O	O	O
further	O	O	O
review	O	O	O
the	O	O	O
multiple	O	O	O
functions	O	O	O
that	O	O	O
these	O	O	O
channels	O	O	B-T116
play	O	O	O
during	O	O	O
the	O	O	O
establishment	O	O	O
of	O	O	O
egg	O	O	B-T025
buoyancy	O	O	B-T039
and	O	O	O
the	O	O	O
activation	O	O	B-T052
and	O	O	O
detoxification	O	O	B-T061
of	O	O	O
spermatozoa	O	O	B-T025
in	O	O	O
the	O	O	O
marine	O	O	B-T083
environment	O	O	B-T082
.	O	O	O

-DOCSTART- (28261447)

Caribbean	O	O	B-T083
massive	O	O	B-T204
corals	O	O	I-T204
not	O	O	B-T080
recovering	O	O	I-T080
from	O	O	I-T080
repeated	O	O	O
thermal	O	O	B-T067
stress	O	O	I-T067
events	O	O	B-T051
during	O	O	O
2005	O	O	O
-	O	O	O
2013	O	O	O

Massive	O	O	B-T204
coral	O	O	I-T204
bleaching	O	O	B-T070
events	O	O	B-T051
associated	O	O	O
with	O	O	O
high	O	O	O
sea	O	O	B-T083
surface	O	O	B-T082
temperatures	O	O	B-T081
are	O	O	O
forecast	O	O	O
to	O	O	O
become	O	O	O
more	O	O	O
frequent	O	O	B-T079
and	O	O	O
severe	O	O	B-T080
in	O	O	O
the	O	O	O
future	O	O	O
due	O	O	O
to	O	O	O
climate	O	O	B-T070
change	O	O	I-T070
.	O	O	O

Monitoring	O	O	B-T062
colony	O	O	B-T096
recovery	O	O	B-T052
from	O	O	O
bleaching	O	O	B-T070
disturbances	O	O	O
over	O	O	O
multiyear	O	O	B-T079
time	O	O	I-T079
frames	O	O	I-T079
is	O	O	O
important	O	O	O
for	O	O	O
improving	O	O	O
predictions	O	O	O
of	O	O	O
future	O	O	O
coral	O	O	B-T204
community	O	O	B-T096
changes	O	O	B-T169
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
are	O	O	O
currently	O	O	O
few	O	O	O
multiyear	O	O	B-T062
studies	O	O	I-T062
describing	O	O	O
long-term	O	O	B-T079
outcomes	O	O	B-T169
for	O	O	O
coral	O	O	B-T204
colonies	O	O	B-T096
following	O	O	O
acute	O	O	B-T070
bleaching	O	O	I-T070
events	O	O	B-T051
.	O	O	O

We	O	O	O
recorded	O	O	O
colony	O	O	B-T096
pigmentation	O	O	B-T032
and	O	O	O
size	O	O	B-T082
for	O	O	O
bleached	O	O	B-T078
and	O	O	O
unbleached	O	O	B-T078
groups	O	O	I-T078
of	O	O	O
co-located	O	O	O
conspecifics	O	O	O
of	O	O	O
three	O	O	O
major	O	O	O
reef-building	O	O	B-T204
scleractinian	O	O	I-T204
corals	O	O	B-T204
(	O	O	O
Orbicella	O	O	B-T204
franksi	O	O	I-T204
,	O	O	O
Siderastrea	O	O	B-T204
siderea	O	O	I-T204
,	O	O	O
and	O	O	O
Stephanocoenia	O	O	B-T204
michelini	O	O	I-T204
;	O	O	O
n	O	O	O
=	O	O	O
198	O	O	O
total	O	O	O
)	O	O	O
in	O	O	O
Bocas	O	O	B-UnknownType
del	O	O	I-UnknownType
Toro	O	O	I-UnknownType
,	O	O	O
Panama	O	O	B-T083
,	O	O	O
during	O	O	O
the	O	O	O
major	O	O	O
2005	O	O	O
bleaching	O	O	B-T070
event	O	O	B-T051
and	O	O	O
then	O	O	O
monitored	O	O	B-T062
pigmentation	O	O	O
status	O	O	B-T080
and	O	O	O
changes	O	O	O
live	O	O	B-T024
tissue	O	O	I-T024
colony	O	O	O
size	O	O	O
for	O	O	O
8	O	O	O
years	O	O	B-T079
(	O	O	O
2005	O	O	O
-	O	O	O
2013	O	O	O
)	O	O	O
.	O	O	O

Corals	O	O	B-T204
that	O	O	O
were	O	O	O
bleached	O	O	B-T070
in	O	O	O
2005	O	O	O
demonstrated	O	O	O
markedly	O	O	O
different	O	O	O
response	O	O	O
trajectories	O	O	O
compared	O	O	O
to	O	O	O
unbleached	O	O	O
colony	O	O	B-T096
groups	O	O	B-T078
,	O	O	O
with	O	O	O
extensive	O	O	O
live	O	O	B-T024
tissue	O	O	I-T024
loss	O	O	B-T081
for	O	O	O
bleached	O	O	O
corals	O	O	B-T204
of	O	O	O
all	O	O	O
species	O	O	B-T185
following	O	O	O
bleaching	O	O	B-T070
,	O	O	O
with	O	O	O
mean	O	O	O
live	O	O	O
tissue	O	O	O
losses	O	O	B-T081
per	O	O	O
colony	O	O	O
9	O	O	O
months	O	O	B-T079
postbleaching	O	O	B-T079
of	O	O	O
26.2	O	O	O
%	O	O	O
(	O	O	O
±5.4	O	O	O
SE	O	O	O
)	O	O	O
for	O	O	O
O.	O	O	B-T204
franksi	O	O	I-T204
,	O	O	O
35.7	O	O	O
%	O	O	O
(	O	O	O
±4.7	O	O	O
SE	O	O	O
)	O	O	O
for	O	O	O
S.	O	O	B-T204
michelini	O	O	I-T204
,	O	O	O
and	O	O	O
11.2	O	O	O
%	O	O	O
(	O	O	O
±3.9	O	O	O
SE	O	O	O
)	O	O	O
for	O	O	O
S.	O	O	B-T204
siderea	O	O	I-T204
.	O	O	O

Two	O	O	O
species	O	O	B-T185
,	O	O	O
O.	O	O	B-T204
franksi	O	O	I-T204
and	O	O	O
S.	O	O	B-T204
michelini	O	O	I-T204
,	O	O	O
later	O	O	O
recovered	O	O	O
to	O	O	O
net	O	O	O
positive	O	O	B-T033
growth	O	O	B-T040
,	O	O	O
which	O	O	O
continued	O	O	O
until	O	O	O
a	O	O	O
second	O	O	O
thermal	O	O	B-T067
stress	O	O	I-T067
event	O	O	B-T051
in	O	O	O
2010	O	O	O
.	O	O	O

Following	O	O	O
this	O	O	O
event	O	O	B-T051
,	O	O	O
all	O	O	O
species	O	O	B-T185
again	O	O	O
lost	O	O	B-T169
tissue	O	O	B-T024
,	O	O	O
with	O	O	O
previously	O	O	O
unbleached	O	O	O
colony	O	O	B-T096
species	O	O	O
groups	O	O	B-T078
experiencing	O	O	O
greater	O	O	O
declines	O	O	O
than	O	O	O
conspecific	O	O	O
sample	O	O	O
groups	O	O	O
,	O	O	O
which	O	O	O
were	O	O	O
previously	O	O	O
bleached	O	O	B-T070
,	O	O	O
indicating	O	O	O
a	O	O	O
possible	O	O	O
positive	O	O	O
acclimative	O	O	B-T040
response	O	O	I-T040
.	O	O	O

However	O	O	O
,	O	O	O
despite	O	O	O
this	O	O	O
beneficial	O	O	O
effect	O	O	O
for	O	O	O
previously	O	O	O
bleached	O	O	B-T070
corals	O	O	B-T204
,	O	O	O
all	O	O	O
groups	O	O	B-T078
experienced	O	O	O
substantial	O	O	O
net	O	O	O
tissue	O	O	B-T024
loss	O	O	B-T081
between	O	O	O
2005	O	O	O
and	O	O	O
2013	O	O	O
,	O	O	O
indicating	O	O	O
that	O	O	O
many	O	O	O
important	O	O	O
Caribbean	O	O	B-T083
reef-building	O	O	B-T204
corals	O	O	I-T204
will	O	O	O
likely	O	O	O
suffer	O	O	O
continued	O	O	O
tissue	O	O	O
loss	O	O	O
and	O	O	O
may	O	O	O
be	O	O	O
unable	O	O	O
to	O	O	O
maintain	O	O	O
current	O	O	O
benthic	O	O	B-T082
coverage	O	O	I-T082
when	O	O	O
faced	O	O	O
with	O	O	O
future	O	O	O
thermal	O	O	B-T067
stress	O	O	I-T067
forecast	O	O	O
for	O	O	O
the	O	O	O
region	O	O	B-T083
,	O	O	O
even	O	O	O
with	O	O	O
potential	O	O	O
benefits	O	O	O
from	O	O	O
bleaching	O	O	B-T070
-related	O	O	O
acclimation	O	O	B-T040
.	O	O	O

-DOCSTART- (28263833)

Preparation	O	O	B-T052
and	O	O	O
characterization	O	O	B-T052
of	O	O	O
gastrointestinal	O	O	B-T082
wafer	O	O	B-T122
formulations	O	O	O

Many	O	O	O
active	O	O	B-T121
pharmaceutical	O	O	I-T121
ingredients	O	O	I-T121
(	O	O	O
API	O	O	B-T121
)	O	O	O
have	O	O	O
a	O	O	O
very	O	O	O
poor	O	O	O
or	O	O	O
highly	O	O	O
variable	O	O	B-T080
bioavailability	O	O	B-T081
after	O	O	O
oral	O	O	B-T061
administration	O	O	I-T061
.	O	O	O

One	O	O	O
possibility	O	O	O
to	O	O	O
overcome	O	O	B-T052
this	O	O	O
problem	O	O	O
might	O	O	O
be	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
application	O	O	O
of	O	O	O
mucoadhesive	O	O	B-T122
dosage	O	O	I-T122
forms	O	O	I-T122
like	O	O	O
gastrointestinal	O	O	B-T082
wafers	O	O	B-T122
.	O	O	O

However	O	O	O
,	O	O	O
a	O	O	O
currently	O	O	B-T079
unsolved	O	O	B-T077
challenge	O	O	O
is	O	O	O
the	O	O	O
control	O	O	B-T080
of	O	O	O
the	O	O	O
adhesion	O	O	B-T070
of	O	O	O
the	O	O	O
wafer	O	O	B-T122
to	O	O	O
the	O	O	O
intestinal	O	O	B-T031
mucus	O	O	I-T031
.	O	O	O

One	O	O	O
suggested	O	O	O
solution	O	O	O
might	O	O	O
be	O	O	O
the	O	O	O
combination	O	O	B-T080
of	O	O	O
gastrointestinal	O	O	B-T082
wafers	O	O	B-T122
and	O	O	O
expanding	O	O	B-T169
systems	O	O	I-T169
.	O	O	O

Such	O	O	O
a	O	O	O
combination	O	O	B-T080
requires	O	O	O
thin	O	O	B-T122
and	O	O	I-T122
elastic	O	O	I-T122
wafers	O	O	I-T122
which	O	O	O
are	O	O	O
further	O	O	O
characterized	O	O	B-T052
by	O	O	O
an	O	O	O
unidirectional	O	O	B-T070
drug	O	O	I-T070
release	O	O	I-T070
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
gastrointestinal	O	O	B-T082
,	O	O	O
twolayered	O	O	B-T122
wafers	O	O	I-T122
containing	O	O	O
a	O	O	O
water-insoluble	O	O	B-T080
backing	O	O	I-T080
layer	O	O	I-T080
and	O	O	O
a	O	O	O
drug-loaded	O	O	B-T081
,	O	O	O
mucoadhesive	O	O	B-T080
layer	O	O	I-T080
were	O	O	O
fabricated	O	O	O
by	O	O	O
casting	O	O	B-T169
solvent	O	O	I-T169
technique	O	O	I-T169
.	O	O	O

The	O	O	O
backing	O	O	B-T080
layer	O	O	I-T080
consists	O	O	O
of	O	O	O
Ethocel	O	O	B-T121
™	O	O	I-T121
Standard	O	O	I-T121
10	O	O	I-T121
Premium	O	O	I-T121
and	O	O	O
the	O	O	O
mucoadhesive	O	O	B-T080
layer	O	O	I-T080
was	O	O	O
prepared	O	O	O
using	O	O	O
a	O	O	O
mixture	O	O	B-T167
of	O	O	O
Methocel	O	O	B-T109
™	O	O	I-T109
E15	O	O	I-T109
Premium	O	O	I-T109
LV	O	O	I-T109
,	O	O	O
polyvinyl	O	O	B-T122
alcohol	O	O	I-T122
and	O	O	O
Macrogol	O	O	B-T109
400	O	O	I-T109
.	O	O	O

The	O	O	O
wafers	O	O	B-T122
were	O	O	O
characterized	O	O	B-T052
regarding	O	O	O
their	O	O	O
appearance	O	O	B-T080
,	O	O	O
mechanical	O	O	B-T080
properties	O	O	I-T080
and	O	O	O
dissolution	O	O	B-T070
profiles	O	O	I-T070
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
backing	O	O	B-T080
layer	O	O	I-T080
thickness	O	O	B-T080
on	O	O	O
drug	O	O	B-T052
transfer	O	O	I-T052
and	O	O	O
their	O	O	O
ability	O	O	O
of	O	O	O
unidirectional	O	O	B-T070
drug	O	O	I-T070
release	O	O	I-T070
.	O	O	O

The	O	O	O
wafers	O	O	B-T122
with	O	O	O
backing	O	O	B-T080
layer	O	O	I-T080
thickness	O	O	B-T080
of	O	O	O
500μg	O	O	B-T109
Ethocel	O	O	I-T109
™	O	O	O
/cm(2	O	O	O
)	O	O	O
presented	O	O	O
adequate	O	O	B-T080
mechanical	O	O	B-T080
properties	O	O	I-T080
,	O	O	O
a	O	O	O
drug	O	O	B-T052
transfer	O	O	I-T052
about	O	O	O
73	O	O	O
%	O	O	O
and	O	O	O
unidirectional	O	O	B-T070
drug	O	O	I-T070
release	O	O	I-T070
.	O	O	O

-DOCSTART- (28264394)

Discovery	O	O	B-T052
of	O	O	O
<	O	O	B-T204
i	O	O	I-T204
>	O	O	I-T204
Neopanorpa	O	O	I-T204
chillcotti</i	O	O	I-T204
>	O	O	I-T204
Byers	O	O	I-T204
(	O	O	O
Mecoptera	O	O	B-T204
:	O	O	O
Panorpidae	O	O	B-T204
)	O	O	O
from	O	O	O
Tibet	O	O	B-T083
,	O	O	O
China	O	O	B-T083
,	O	O	O
with	O	O	O
discussion	O	O	O
of	O	O	O
its	O	O	O
generic	O	O	O
status	O	O	O

Neopanorpa	O	O	B-T204
chillcotti	O	O	I-T204
Byers	O	O	I-T204
,	O	O	O
1971	O	O	O
was	O	O	O
originally	O	O	O
described	O	O	O
from	O	O	O
Kathmandu	O	O	B-UnknownType
in	O	O	O
Nepal	O	O	B-T083
and	O	O	O
is	O	O	O
now	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
distributed	O	O	O
in	O	O	O
Gyirong	O	O	B-UnknownType
,	O	O	O
Tibet	O	O	B-T083
in	O	O	O
China	O	O	B-T083
.	O	O	O

The	O	O	O
species	O	O	O
is	O	O	O
redescribed	O	O	O
and	O	O	O
illustrated	O	O	O
based	O	O	O
on	O	O	O
new	O	O	B-T167
material	O	O	I-T167
from	O	O	O
China	O	O	B-T083
and	O	O	O
Nepal	O	O	B-T083
.	O	O	O

The	O	O	O
generic	O	O	B-T078
status	O	O	I-T078
of	O	O	O
this	O	O	O
species	O	O	B-T185
is	O	O	O
briefly	O	O	O
discussed	O	O	B-T054
.	O	O	O

-DOCSTART- (28264678)

Passive	O	O	B-T062
case	O	O	I-T062
detection	O	O	I-T062
of	O	O	O
malaria	O	O	B-T047
in	O	O	O
Ratanakiri	O	O	B-UnknownType
Province	O	O	I-UnknownType
(	O	O	O
Cambodia	O	O	B-UnknownType
)	O	O	O
to	O	O	O
detect	O	O	B-T033
villages	O	O	B-T083
at	O	O	B-T033
higher	O	O	I-T033
risk	O	O	I-T033
for	O	O	O
malaria	O	O	O

Cambodia	O	O	B-UnknownType
reduced	O	O	B-T080
malaria	O	O	B-T047
incidence	O	O	B-T081
by	O	O	O
more	O	O	O
than	O	O	O
75	O	O	O
%	O	O	O
between	O	O	O
2000	O	O	O
and	O	O	O
2015	O	O	O
,	O	O	O
a	O	O	O
target	O	O	B-T169
of	O	O	O
the	O	O	O
Millennium	O	O	B-T170
Development	O	O	I-T170
Goal	O	O	I-T170
6	O	O	I-T170
.	O	O	O

The	O	O	O
Cambodian	O	O	B-UnknownType
Government	O	O	B-T092
aims	O	O	B-T078
to	O	O	O
eliminate	O	O	B-T080
all	O	O	O
forms	O	O	O
of	O	O	O
malaria	O	O	B-T047
by	O	O	O
2025	O	O	O
.	O	O	O

The	O	O	O
country	O	O	B-T083
's	O	O	I-T083
malaria	O	O	B-T047
incidence	O	O	B-T081
is	O	O	O
highly	O	O	B-T080
variable	O	O	B-T080
at	O	O	O
provincial	O	O	B-UnknownType
level	O	O	B-T080
,	O	O	O
but	O	O	O
less	O	O	O
is	O	O	O
known	O	O	O
at	O	O	O
village	O	O	B-T083
level	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
used	O	O	O
passive	O	O	B-T062
case	O	O	I-T062
detection	O	O	I-T062
(	O	O	O
PCD	O	O	B-T062
)	O	O	O
data	O	O	O
at	O	O	O
village	O	O	B-T083
level	O	O	B-T080
in	O	O	O
Ratanakiri	O	O	B-UnknownType
Province	O	O	I-UnknownType
from	O	O	O
2010	O	O	O
to	O	O	O
2014	O	O	O
to	O	O	O
describe	O	O	O
incidence	O	O	B-T081
trends	O	O	B-T079
and	O	O	O
identify	O	O	B-T080
high-risk	O	O	B-T033
areas	O	O	I-T033
of	O	O	I-T033
malaria	O	O	B-T047
to	O	O	O
be	O	O	O
primarily	O	O	B-T080
targeted	O	O	B-T169
towards	O	O	O
malaria	O	O	O
elimination	O	O	B-T080
.	O	O	O

In	O	O	O
2010	O	O	O
,	O	O	O
the	O	O	O
Cambodian	O	O	B-UnknownType
malaria	O	O	B-T047
programme	O	O	B-T170
created	O	O	O
a	O	O	O
Malaria	O	O	B-T170
Information	O	O	I-T170
System	O	O	I-T170
(	O	O	O
MIS	O	O	B-T170
)	O	O	O
to	O	O	O
capture	O	O	O
malaria	O	O	O
information	O	O	B-T078
at	O	O	O
village	O	O	B-T083
level	O	O	B-T080
through	O	O	O
PCD	O	O	B-T062
by	O	O	O
village	O	O	O
malaria	O	O	B-T097
workers	O	O	I-T097
and	O	O	O
health	O	O	B-T093
facilities	O	O	I-T093
.	O	O	O

The	O	O	O
MIS	O	O	B-T170
data	O	O	B-T078
of	O	O	O
Ratanakiri	O	O	B-UnknownType
Province	O	O	I-UnknownType
2010	O	O	O
-	O	O	O
2014	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
calculate	O	O	B-T052
annual	O	O	B-T079
incidence	O	O	B-T081
rates	O	O	I-T081
by	O	O	O
Plasmodium	O	O	B-T204
species	O	O	I-T204
at	O	O	O
province	O	O	B-UnknownType
and	O	O	O
commune	O	O	B-T098
levels	O	O	B-T080
.	O	O	O

For	O	O	O
estimating	O	O	B-T081
the	O	O	O
trend	O	O	B-T079
at	O	O	O
provincial	O	O	B-UnknownType
level	O	O	B-T080
only	O	O	O
villages	O	O	B-T083
reporting	O	O	B-T058
each	O	O	O
year	O	O	B-T079
were	O	O	O
selected	O	O	O
.	O	O	O

The	O	O	O
communal	O	O	B-T096
incidences	O	O	B-T081
and	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
cases	O	O	B-T169
per	O	O	B-T080
village	O	O	B-T083
were	O	O	O
visualized	O	O	O
on	O	O	O
a	O	O	O
map	O	O	B-T073
per	O	O	O
Plasmodium	O	O	B-T204
species	O	O	I-T204
and	O	O	O
per	O	O	B-T079
year	O	O	I-T079
.	O	O	O

Analysis	O	O	B-UnknownType
of	O	O	I-UnknownType
spatial	O	O	I-UnknownType
clustering	O	O	I-UnknownType
of	O	O	O
village	O	O	B-T083
malaria	O	O	B-T047
cases	O	O	B-T169
by	O	O	O
Plasmodium	O	O	B-T204
species	O	O	I-T204
was	O	O	O
performed	O	O	B-T169
by	O	O	O
year	O	O	B-T079
.	O	O	O

Overall	O	O	O
,	O	O	O
malaria	O	O	B-T047
annual	O	O	B-T079
incidence	O	O	B-T081
rates	O	O	I-T081
per	O	O	O
1000	O	O	O
inhabitants	O	O	B-T101
decreased	O	O	B-T080
from	O	O	O
86	O	O	O
(	O	O	O
2010	O	O	O
)	O	O	O
to	O	O	O
30	O	O	O
(	O	O	O
2014	O	O	O
)	O	O	O
.	O	O	O

Falciparum	O	O	B-T204
incidence	O	O	B-T081
decreased	O	O	B-T080
(	O	O	O
by	O	O	O
79	O	O	O
%	O	O	O
in	O	O	O
2014	O	O	O
compared	O	O	B-T052
to	O	O	O
2010	O	O	O
;	O	O	O
CI	O	O	B-T081
95	O	O	O
%	O	O	O
76	O	O	O
-	O	O	O
82	O	O	O
%	O	O	O
)	O	O	O
more	O	O	O
rapidly	O	O	B-T080
than	O	O	O
vivax	O	O	B-T204
incidence	O	O	O
(	O	O	O
by	O	O	O
19	O	O	O
%	O	O	O
in	O	O	O
2014	O	O	O
compared	O	O	O
to	O	O	O
2010	O	O	O
;	O	O	O
CI	O	O	O
95	O	O	O
%	O	O	O
5	O	O	O
-	O	O	O
32	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
ten	O	O	O
to	O	O	O
16	O	O	O
significant	O	O	B-T078
spatial	O	O	B-T081
clusters	O	O	I-T081
each	O	O	O
year	O	O	B-T079
.	O	O	O

Big	O	O	B-T081
clusters	O	O	I-T081
tended	O	O	O
to	O	O	O
extend	O	O	B-T082
along	O	O	O
the	O	O	O
Cambodian-Vietnamese	O	O	B-UnknownType
border	O	O	I-UnknownType
and	O	O	O
along	O	O	O
the	O	O	O
Sesan	O	O	B-T070
River	O	O	I-T070
.	O	O	O

Three	O	O	O
clusters	O	O	B-T081
appeared	O	O	O
throughout	O	O	O
all	O	O	O
years	O	O	B-T079
(	O	O	O
2010	O	O	O
-	O	O	O
2014	O	O	O
):	O	O	O
one	O	O	O
with	O	O	O
21	O	O	O
villages	O	O	B-T083
appeared	O	O	O
each	O	O	O
year	O	O	B-T079
,	O	O	O
the	O	O	O
second	O	O	O
shrunk	O	O	B-T081
progressively	O	O	B-T169
from	O	O	O
2012	O	O	O
to	O	O	O
2014	O	O	O
and	O	O	O
the	O	O	O
third	O	O	O
was	O	O	O
split	O	O	B-T169
into	O	O	O
two	O	O	O
smaller	O	O	O
clusters	O	O	O
in	O	O	O
2013	O	O	O
and	O	O	O
2014	O	O	O
.	O	O	O

The	O	O	O
decline	O	O	B-T067
of	O	O	O
malaria	O	O	B-T047
burden	O	O	B-T078
can	O	O	O
be	O	O	O
attributed	O	O	O
to	O	O	O
intensive	O	O	B-T169
malaria	O	O	B-T052
control	O	O	I-T052
activities	O	O	I-T052
implemented	O	O	B-T052
in	O	O	O
the	O	O	O
areas	O	O	B-T082
:	O	O	O
distribution	O	O	B-T078
of	O	O	O
a	O	O	O
long-lasting	O	O	B-T078
insecticidal	O	O	B-T074
net	O	O	I-T074
per	O	O	O
person	O	O	B-T098
and	O	O	O
early	O	O	B-T060
diagnosis	O	O	I-T060
and	O	O	O
prompt	O	O	B-T169
treatment	O	O	B-T169
.	O	O	O

Dihydro-artemisinin	O	O	B-T109
piperaquine	O	O	B-T109
was	O	O	O
the	O	O	O
only	O	O	O
first-line	O	O	B-T061
treatment	O	O	I-T061
for	O	O	O
all	O	O	O
malaria	O	O	B-T047
cases	O	O	B-T169
.	O	O	O

No	O	O	O
radical	O	O	B-T080
treatment	O	O	B-T169
with	O	O	O
primaquine	O	O	B-T109
was	O	O	O
provided	O	O	O
for	O	O	O
Plasmodium	O	O	B-T204
vivax	O	O	I-T204
cases	O	O	B-T169
,	O	O	O
which	O	O	O
could	O	O	O
explain	O	O	O
the	O	O	O
slow	O	O	B-T080
decrease	O	O	B-T081
of	O	O	O
P.	O	O	B-T204
vivax	O	O	I-T204
due	O	O	O
to	O	O	O
relapses	O	O	B-T067
.	O	O	O

To	O	O	O
achieve	O	O	B-T080
malaria	O	O	B-T047
elimination	O	O	B-T080
by	O	O	O
2025	O	O	O
,	O	O	O
priority	O	O	B-T079
should	O	O	O
be	O	O	O
given	O	O	O
to	O	O	O
the	O	O	O
control	O	O	O
of	O	O	O
stable	O	O	B-T080
malaria	O	O	B-T081
clusters	O	O	I-T081
appearing	O	O	O
over	O	O	O
time	O	O	O
.	O	O	O

-DOCSTART- (28266114)

Interaction	O	O	B-T054
of	O	O	I-T054
lifestyle	O	O	I-T054
,	O	O	O
behaviour	O	O	B-T053
or	O	O	O
systemic	O	O	B-T047
diseases	O	O	I-T047
with	O	O	O
dental	O	O	B-T047
caries	O	O	B-T047
and	O	O	O
periodontal	O	O	B-T047
diseases	O	O	I-T047
:	O	O	O
consensus	O	O	B-T097
report	O	O	I-T097
of	O	O	I-T097
group	O	O	I-T097
2	O	O	I-T097
of	O	O	I-T097
the	O	O	I-T097
joint	O	O	I-T097
EFP/ORCA	O	O	I-T097
workshop	O	O	I-T097
on	O	O	O
the	O	O	O
boundaries	O	O	O
between	O	O	O
caries	O	O	O
and	O	O	O
periodontal	O	O	O
diseases	O	O	O

Periodontal	O	O	B-T047
diseases	O	O	I-T047
and	O	O	O
dental	O	O	B-T047
caries	O	O	I-T047
are	O	O	O
the	O	O	O
most	O	O	O
common	O	O	B-T047
diseases	O	O	I-T047
of	O	O	O
humans	O	O	O
and	O	O	O
the	O	O	O
main	O	O	O
cause	O	O	O
of	O	O	O
tooth	O	O	B-T020
loss	O	O	I-T020
.	O	O	O

Both	O	O	O
diseases	O	O	B-T047
can	O	O	O
lead	O	O	O
to	O	O	O
nutritional	O	O	B-T169
compromise	O	O	I-T169
and	O	O	O
negative	O	O	O
impacts	O	O	O
upon	O	O	O
self-esteem	O	O	B-T041
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
.	O	O	O

As	O	O	O
complex	O	O	B-T047
chronic	O	O	I-T047
diseases	O	O	I-T047
,	O	O	O
they	O	O	O
share	O	O	O
common	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
,	O	O	O
such	O	O	O
as	O	O	O
a	O	O	O
requirement	O	O	O
for	O	O	O
a	O	O	O
pathogenic	O	O	B-T001
plaque	O	O	I-T001
biofilm	O	O	I-T001
,	O	O	O
yet	O	O	O
they	O	O	O
exhibit	O	O	O
distinct	O	O	B-T046
pathophysiologies	O	O	I-T046
.	O	O	O

Multiple	O	O	B-T080
exposures	O	O	I-T080
contribute	O	O	O
to	O	O	O
their	O	O	O
causal	O	O	O
pathways	O	O	O
,	O	O	O
and	O	O	O
susceptibility	O	O	B-T201
involves	O	O	I-T201
risk	O	O	B-T033
factors	O	O	I-T033
that	O	O	O
are	O	O	O
inherited	O	O	B-T169
(	O	O	O
e.g.	O	O	O
genetic	O	O	B-T070
variants	O	O	I-T070
)	O	O	O
,	O	O	O
and	O	O	O
those	O	O	O
that	O	O	O
are	O	O	O
acquired	O	O	O
(	O	O	O
e.g.	O	O	O
socio-economic	O	O	B-T080
factors	O	O	I-T080
,	O	O	O
biofilm	O	O	B-T007
load	O	O	O
or	O	O	O
composition	O	O	O
,	O	O	O
smoking	O	O	B-T055
,	O	O	O
carbohydrate	O	O	B-T201
intake	O	O	I-T201
)	O	O	O
.	O	O	O

Identification	O	O	O
of	O	O	O
these	O	O	O
factors	O	O	O
is	O	O	O
crucial	O	O	O
in	O	O	O
the	O	O	O
prevention	O	O	B-T061
of	O	O	I-T061
both	O	O	I-T061
diseases	O	O	I-T061
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
their	O	O	B-T058
management	O	O	I-T058
.	O	O	O

To	O	O	O
systematically	O	O	O
appraise	O	O	O
the	O	O	O
scientific	O	O	B-T170
literature	O	O	I-T170
to	O	O	O
identify	O	O	O
potential	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
for	O	O	O
caries	O	O	B-T047
and	O	O	O
periodontal	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

One	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
(	O	O	O
genetic	O	O	B-T080
risk	O	O	I-T080
factors	O	O	I-T080
)	O	O	O
,	O	O	O
one	O	O	O
narrative	O	O	B-UnknownType
review	O	O	I-UnknownType
(	O	O	O
role	O	O	B-T062
of	O	O	I-T062
diet	O	O	I-T062
and	O	O	I-T062
nutrition	O	O	I-T062
)	O	O	O
and	O	O	O
reference	O	O	B-T170
documentation	O	O	I-T170
for	O	O	O
modifiable	O	O	B-T033
acquired	O	O	I-T033
risk	O	O	I-T033
factors	O	O	I-T033
common	O	O	O
to	O	O	O
both	O	O	O
disease	O	O	O
groups	O	O	O
,	O	O	O
formed	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
the	O	O	O
report	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
moderately	O	O	O
strong	O	O	O
evidence	O	O	O
for	O	O	O
a	O	O	O
genetic	O	O	B-T033
contribution	O	O	I-T033
to	O	O	O
periodontal	O	O	B-T047
diseases	O	O	I-T047
and	O	O	O
caries	O	O	B-T032
susceptibility	O	O	I-T032
,	O	O	O
with	O	O	O
an	O	O	O
attributable	O	O	B-T080
risk	O	O	I-T080
estimated	O	O	O
to	O	O	O
be	O	O	O
up	O	O	O
to	O	O	O
50	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
genetics	O	O	B-T169
literature	O	O	I-T169
for	O	O	O
periodontal	O	O	B-T047
disease	O	O	I-T047
is	O	O	O
more	O	O	O
substantial	O	O	O
than	O	O	O
for	O	O	O
caries	O	O	B-T047
and	O	O	O
genes	O	O	B-T028
associated	O	O	B-T080
with	O	O	I-T080
chronic	O	O	B-T047
periodontitis	O	O	I-T047
are	O	O	O
the	O	O	O
vitamin	O	O	B-T028
D	O	O	I-T028
receptor	O	O	I-T028
(	O	O	O
VDR	O	O	B-T028
)	O	O	O
,	O	O	O
Fc	O	O	B-T028
gamma	O	O	I-T028
receptor	O	O	I-T028
IIA	O	O	I-T028
(	O	O	O
Fc-γRIIA	O	O	B-T028
)	O	O	O
and	O	O	O
Interleukin	O	O	B-T028
10	O	O	I-T028
(	O	O	I-T028
IL10	O	O	B-T028
)	O	O	I-T028
genes	O	O	I-T028
.	O	O	O

For	O	O	O
caries	O	O	B-T047
,	O	O	O
genes	O	O	B-T028
involved	O	O	O
in	O	O	O
enamel	O	O	B-T033
formation	O	O	I-T033
(	O	O	O
AMELX	O	O	B-T028
,	O	O	O
AMBN	O	O	B-T028
,	O	O	O
ENAM	O	O	B-T028
,	O	O	O
TUFT	O	O	B-T116
,	O	O	O
MMP20	O	O	B-T028
,	O	O	O
and	O	O	O
KLK4	O	O	B-T028
)	O	O	O
,	O	O	O
salivary	O	O	B-T033
characteristics	O	O	I-T033
(	O	O	O
AQP5	O	O	B-T028
)	O	O	O
,	O	O	O
immune	O	O	B-T040
regulation	O	O	I-T040
and	O	O	O
dietary	O	O	B-T080
preferences	O	O	I-T080
had	O	O	O
the	O	O	O
largest	O	O	B-T080
impact	O	O	I-T080
.	O	O	O

No	O	O	O
common	O	O	O
genetic	O	O	O
variants	O	O	O
were	O	O	O
found	O	O	O
.	O	O	O

Fermentable	O	O	B-T109
carbohydrates	O	O	I-T109
(	O	O	O
sugars	O	O	B-UnknownType
and	O	O	I-UnknownType
starches	O	O	I-UnknownType
)	O	O	O
were	O	O	O
the	O	O	O
most	O	O	O
relevant	O	O	O
common	O	O	O
dietary	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	I-T033
both	O	O	I-T033
diseases	O	O	I-T033
,	O	O	O
but	O	O	O
associated	O	O	O
mechanisms	O	O	O
differed	O	O	O
.	O	O	O

In	O	O	O
caries	O	O	B-T047
,	O	O	O
the	O	O	O
fermentation	O	O	B-T044
process	O	O	I-T044
leads	O	O	O
to	O	O	O
acid	O	O	O
production	O	O	O
and	O	O	O
the	O	O	O
generation	O	O	B-T043
of	O	O	I-T043
biofilm	O	O	I-T043
components	O	O	O
such	O	O	O
as	O	O	O
Glucans	O	O	B-T109
.	O	O	O

In	O	O	O
periodontitis	O	O	B-T047
,	O	O	O
glycaemia	O	O	B-T033
drives	O	O	I-T033
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
advanced	O	O	B-T067
glycation	O	O	I-T067
end-products	O	O	O
may	O	O	O
also	O	O	O
trigger	O	O	O
a	O	O	O
hyper	O	O	B-T046
inflammatory	O	O	I-T046
state	O	O	O
.	O	O	O

Micronutrient	O	O	B-T046
deficiencies	O	O	I-T046
,	O	O	O
such	O	O	O
as	O	O	O
for	O	O	O
vitamin	O	O	B-T127
C	O	O	I-T127
,	O	O	O
vitamin	O	O	B-T127
D	O	O	I-T127
or	O	O	O
vitamin	O	O	B-T127
B12	O	O	I-T127
,	O	O	O
may	O	O	O
be	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
onset	O	O	B-T079
and	O	O	O
progression	O	O	B-T046
of	O	O	I-T046
both	O	O	I-T046
diseases	O	O	I-T046
.	O	O	O

Functional	O	O	B-T168
foods	O	O	I-T168
or	O	O	O
probiotics	O	O	B-T007
could	O	O	O
be	O	O	O
helpful	O	O	O
in	O	O	O
caries	O	O	B-T058
prevention	O	O	I-T058
and	O	O	O
periodontal	O	O	B-T047
disease	O	O	I-T047
management	O	O	B-T058
,	O	O	O
although	O	O	O
evidence	O	O	O
is	O	O	O
limited	O	O	O
and	O	O	O
biological	O	O	B-T044
mechanisms	O	O	I-T044
not	O	O	O
fully	O	O	O
elucidated	O	O	O
.	O	O	O

Hyposalivation	O	O	B-T033
,	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
,	O	O	O
smoking/tobacco	O	O	B-T033
use	O	O	I-T033
,	O	O	O
undiagnosed	O	O	B-T033
or	O	O	O
sub-optimally	O	O	B-T033
controlled	O	O	I-T033
diabetes	O	O	B-T047
and	O	O	O
obesity	O	O	B-T047
are	O	O	O
common	O	O	O
acquired	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
both	O	O	O
caries	O	O	B-T047
and	O	O	O
periodontal	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

-DOCSTART- (28266884)

Intestinal	O	O	B-T023
micropatches	O	O	B-T074
for	O	O	O
oral	O	O	B-T082
insulin	O	O	O
delivery	O	O	O

Diabetes	O	O	B-T047
mellitus	O	O	I-T047
has	O	O	O
become	O	O	O
a	O	O	O
major	O	O	O
public	O	O	B-T078
health	O	O	I-T078
issue	O	O	I-T078
that	O	O	O
has	O	O	O
almost	O	O	O
reached	O	O	O
epidemic	O	O	B-T169
proportions	O	O	I-T169
worldwide	O	O	O
.	O	O	O

Injectable	O	O	B-UnknownType
insulin	O	O	I-UnknownType
has	O	O	O
been	O	O	O
typically	O	O	O
utilized	O	O	O
for	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
this	O	O	O
chronic	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
lack	O	O	B-T033
of	O	O	I-T033
patient	O	O	I-T033
compliance	O	O	I-T033
with	O	O	O
injectable	O	O	B-T121
formulations	O	O	B-T077
has	O	O	O
spurred	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
oral	O	O	B-T082
insulin	O	O	B-T116
formulations	O	O	O
,	O	O	O
which	O	O	O
although	O	O	O
appealing	O	O	O
,	O	O	O
face	O	O	O
several	O	O	O
delivery	O	O	B-T061
challenges	O	O	B-T058
.	O	O	O

We	O	O	O
have	O	O	O
developed	O	O	O
novel	O	O	O
mucoadhesive	O	O	B-T073
intestinal	O	O	B-T023
patches	O	O	B-T074
,	O	O	O
several	O	O	O
hundred	O	O	O
micrometers	O	O	B-T081
in	O	O	O
dimension	O	O	B-T081
(	O	O	O
micropatches	O	O	B-T074
)	O	O	O
that	O	O	O
address	O	O	O
the	O	O	O
challenges	O	O	B-T058
of	O	O	O
oral	O	O	B-T082
insulin	O	O	B-T061
delivery	O	O	I-T061
.	O	O	O

The	O	O	O
micropatches	O	O	B-T074
adhere	O	O	B-T067
to	O	O	O
the	O	O	O
intestinal	O	O	B-T024
mucosa	O	O	I-T024
,	O	O	O
release	O	O	O
their	O	O	O
drug	O	O	B-T121
load	O	O	O
rapidly	O	O	B-T080
within	O	O	O
30	O	O	O
min	O	O	O
and	O	O	O
are	O	O	O
effective	O	O	B-T080
in	O	O	O
lowering	O	O	B-T033
blood	O	O	I-T033
glucose	O	O	I-T033
levels	O	O	I-T033
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

When	O	O	O
insulin	O	O	B-T116
-loaded	O	O	O
micropatches	O	O	B-T074
were	O	O	O
administered	O	O	B-T061
with	O	O	O
a	O	O	O
permeation	O	O	B-T121
enhancer	O	O	I-T121
and	O	O	O
protease	O	O	B-T121
inhibitor	O	O	I-T121
,	O	O	O
a	O	O	O
peak	O	O	B-T080
efficacy	O	O	B-T080
of	O	O	O
34	O	O	O
%	O	O	O
drop	O	O	B-T033
in	O	O	I-T033
blood	O	O	I-T033
glucose	O	O	I-T033
levels	O	O	I-T033
was	O	O	O
observed	O	O	O
within	O	O	O
3	O	O	O
h.	O	O	O
Efficacy	O	O	B-T080
further	O	O	O
improved	O	O	O
to	O	O	O
41	O	O	O
%	O	O	O
when	O	O	O
micropatches	O	O	O
were	O	O	O
administered	O	O	O
in	O	O	O
multiple	O	O	B-T201
doses	O	O	I-T201
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
the	O	O	O
design	O	O	O
of	O	O	O
micropatches	O	O	B-T074
as	O	O	O
an	O	O	O
oral	O	O	B-T082
insulin	O	O	B-T116
formulation	O	O	B-T077
and	O	O	O
report	O	O	O
their	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
efficacy	O	O	B-T080
.	O	O	O

-DOCSTART- (28269523)

Hybrid	O	O	B-T075
automata	O	O	I-T075
models	O	O	I-T075
of	O	O	O
cardiac	O	O	B-T023
ventricular	O	O	I-T023
electrophysiology	O	O	B-T060
for	O	O	O
real-time	O	O	B-T079
computational	O	O	O
applications	O	O	O

Virtual	O	O	O
heart	O	O	B-T075
models	O	O	I-T075
have	O	O	O
been	O	O	O
proposed	O	O	O
for	O	O	O
closed	O	O	B-T169
loop	O	O	I-T169
validation	O	O	B-T062
of	O	O	O
safety	O	O	B-T068
-	O	O	O
critical	O	O	B-T080
embedded	O	O	O
medical	O	O	B-T074
devices	O	O	I-T074
,	O	O	O
such	O	O	O
as	O	O	O
pacemakers	O	O	B-T074
.	O	O	O

These	O	O	O
models	O	O	B-T075
must	O	O	O
react	O	O	O
in	O	O	O
real-time	O	O	B-T079
to	O	O	O
off-the-shelf	O	O	O
medical	O	O	B-T074
devices	O	O	I-T074
.	O	O	O

Real-time	O	O	B-T079
performance	O	O	B-T052
can	O	O	O
be	O	O	O
obtained	O	O	B-T169
by	O	O	O
implementing	O	O	O
models	O	O	B-T075
in	O	O	O
computer	O	O	B-T073
hardware	O	O	I-T073
,	O	O	O
and	O	O	O
methods	O	O	B-T169
of	O	O	O
compiling	O	O	O
classes	O	O	O
of	O	O	O
Hybrid	O	O	B-T075
Automata	O	O	I-T075
(	O	O	O
HA	O	O	B-T075
)	O	O	O
onto	O	O	O
FPGA	O	O	B-T074
have	O	O	O
been	O	O	O
developed	O	O	O
.	O	O	O

Models	O	O	B-T075
of	O	O	O
ventricular	O	O	B-T025
cardiac	O	O	I-T025
cell	O	O	I-T025
electrophysiology	O	O	B-T060
have	O	O	O
been	O	O	O
described	O	O	B-T078
using	O	O	O
HA	O	O	B-T075
which	O	O	O
capture	O	O	B-T067
the	O	O	O
complex	O	O	O
nonlinear	O	O	O
behavior	O	O	B-T080
of	O	O	O
biological	O	O	B-T169
systems	O	O	I-T169
.	O	O	O

However	O	O	O
,	O	O	O
many	O	O	O
models	O	O	B-T075
that	O	O	O
have	O	O	O
been	O	O	O
used	O	O	O
for	O	O	O
closed-loop	O	O	B-T169
validation	O	O	B-T062
of	O	O	O
pacemakers	O	O	B-T074
are	O	O	O
highly	O	O	O
abstract	O	O	B-T078
and	O	O	O
do	O	O	O
not	O	O	O
capture	O	O	B-T067
important	O	O	B-T080
characteristics	O	O	B-T080
of	O	O	O
the	O	O	O
dynamic	O	O	B-T169
rate	O	O	B-T079
response	O	O	I-T079
.	O	O	O

We	O	O	O
developed	O	O	O
a	O	O	O
new	O	O	O
HA	O	O	B-T075
model	O	O	B-T075
of	O	O	O
cardiac	O	O	B-T025
cells	O	O	I-T025
which	O	O	O
captures	O	O	B-T067
dynamic	O	O	B-T169
behavior	O	O	B-T080
and	O	O	O
we	O	O	O
implemented	O	O	O
the	O	O	O
model	O	O	O
in	O	O	O
hardware	O	O	B-T073
.	O	O	O

This	O	O	O
potentially	O	O	B-T080
enables	O	O	O
modeling	O	O	B-T062
the	O	O	O
heart	O	O	B-T023
with	O	O	O
over	O	O	O
1	O	O	O
million	O	O	B-T081
dynamic	O	O	B-T169
cells	O	O	B-T025
,	O	O	O
making	O	O	O
the	O	O	O
approach	O	O	O
ideal	O	O	B-T080
for	O	O	O
closed	O	O	B-T169
loop	O	O	I-T169
testing	O	O	B-T169
of	O	O	O
medical	O	O	B-T074
devices	O	O	I-T074
.	O	O	O

-DOCSTART- (28269731)

Comparison	O	O	B-T052
of	O	O	O
pulse	O	O	B-T081
wave	O	O	I-T081
velocity	O	O	I-T081
derived	O	O	O
from	O	O	O
accelerometer	O	O	B-T074
and	O	O	O
reflective	O	O	B-T060
photo-plethysmography	O	O	I-T060
signals	O	O	I-T060
placed	O	O	O
at	O	O	O
the	O	O	O
carotid	O	O	B-T023
and	O	O	O
femoral	O	O	O
artery	O	O	O

Carotid	O	O	B-T023
-	O	O	O
femoral	O	O	B-T023
pulse	O	O	B-T081
wave	O	O	I-T081
velocity	O	O	I-T081
is	O	O	O
an	O	O	O
established	O	O	B-T081
measure	O	O	I-T081
to	O	O	O
assess	O	O	B-T058
cardiovascular	O	O	B-T033
risk	O	O	I-T033
and	O	O	O
an	O	O	O
interesting	O	O	O
surrogate	O	O	B-T077
parameter	O	O	I-T077
towards	O	O	O
non-invasive	O	O	B-T201
continuous	O	O	I-T201
blood	O	O	I-T201
pressure	O	O	I-T201
inference	O	O	I-T201
.	O	O	O

Due	O	O	O
to	O	O	O
progress	O	O	B-T169
in	O	O	O
sensing	O	O	O
technologies	O	O	O
for	O	O	O
wearable	O	O	B-T073
wrist	O	O	I-T073
worn	O	O	I-T073
sensors	O	O	I-T073
,	O	O	O
there	O	O	O
are	O	O	O
low	O	O	O
cost	O	O	O
sensor	O	O	O
combinations	O	O	O
of	O	O	O
photo-plethysmography	O	O	B-T060
and	O	O	O
high	O	O	B-T074
fidelity	O	O	I-T074
accelerometer	O	O	I-T074
s	O	O	I-T074
available	O	O	O
offering	O	O	O
access	O	O	O
to	O	O	O
pulse	O	O	B-T058
information	O	O	I-T058
from	O	O	O
larger	O	O	B-T023
arteries	O	O	I-T023
complemented	O	O	O
by	O	O	O
blood	O	O	B-T201
volume	O	O	I-T201
changes	O	O	O
in	O	O	O
the	O	O	O
superficial	O	O	B-T024
tissue	O	O	I-T024
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
we	O	O	O
compare	O	O	O
pulse	O	O	B-T081
wave	O	O	I-T081
velocities	O	O	I-T081
derived	O	O	O
from	O	O	O
accelerometer	O	O	B-T074
and	O	O	O
reflective	O	O	B-T060
photo-plethysmography	O	O	I-T060
signals	O	O	I-T060
placed	O	O	O
at	O	O	O
the	O	O	O
carotid	O	O	B-T023
and	O	O	O
femoral	O	O	B-T023
artery	O	O	I-T023
.	O	O	O

We	O	O	O
discuss	O	O	O
the	O	O	O
different	O	O	O
underlying	O	O	O
physiological	O	O	B-T039
processes	O	O	I-T039
for	O	O	O
the	O	O	O
two	O	O	O
sensing	O	O	B-T078
principles	O	O	I-T078
and	O	O	O
present	O	O	O
experimental	O	O	B-T033
results	O	O	I-T033
obtained	O	O	O
in	O	O	O
a	O	O	O
study	O	O	B-T062
with	O	O	O
healthy	O	O	B-T098
subjects	O	O	I-T098
.	O	O	O

-DOCSTART- (28270328)

Constructive	O	O	B-T033
and	O	O	I-T033
Unproductive	O	O	I-T033
Processing	O	O	I-T033
of	O	O	O
Traumatic	O	O	B-T048
Experiences	O	O	I-T048
in	O	O	O
Trauma-Focused	O	O	B-T061
Cognitive-Behavioral	O	O	I-T061
Therapy	O	O	I-T061
for	O	O	O
Youth	O	O	O

Although	O	O	O
there	O	O	O
is	O	O	O
substantial	O	O	O
evidence	O	O	B-T078
to	O	O	O
support	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
cognitive-behavioral	O	O	B-T061
treatments	O	O	B-T061
(	O	O	O
CBT	O	O	B-T061
)	O	O	O
for	O	O	O
posttraumatic	O	O	B-T048
stress	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
PTSD	O	O	B-T048
)	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
some	O	O	O
debate	O	O	O
about	O	O	O
how	O	O	O
these	O	O	O
treatments	O	O	O
have	O	O	O
their	O	O	O
effects	O	O	O
.	O	O	O

Modern	O	O	O
learning	O	O	B-T170
theory	O	O	I-T170
and	O	O	O
cognitive	O	O	B-T170
and	O	O	I-T170
emotional	O	O	I-T170
processing	O	O	I-T170
theories	O	O	I-T170
highlight	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
reducing	O	O	O
avoidance	O	O	B-T041
,	O	O	O
facilitating	O	O	O
the	O	O	O
constructive	O	O	B-T033
processing	O	O	I-T033
of	O	O	I-T033
feared	O	O	I-T033
experiences	O	O	I-T033
,	O	O	O
and	O	O	O
strengthening	O	O	O
new	O	O	O
inhibitory	O	O	B-T041
learning	O	O	I-T041
.	O	O	O

We	O	O	O
examined	O	O	O
variables	O	O	O
thought	O	O	O
to	O	O	O
be	O	O	O
associated	O	O	O
with	O	O	O
unproductive	O	O	B-T033
and	O	O	I-T033
constructive	O	O	I-T033
processing	O	O	I-T033
of	O	O	O
traumatic	O	O	B-T048
experiences	O	O	I-T048
in	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
81	O	O	O
youth	O	O	O
with	O	O	O
elevated	O	O	O
PTSD	O	O	B-T048
symptoms	O	O	B-T184
,	O	O	O
who	O	O	O
received	O	O	O
Trauma-Focused	O	O	B-T061
Cognitive	O	O	I-T061
Behavioral	O	O	I-T061
Therapy	O	O	I-T061
(	O	O	O
TF-CBT	O	O	B-T061
)	O	O	O
for	O	O	O
abuse	O	O	B-T033
or	O	O	O
traumatic	O	O	O
interpersonal	O	O	B-UnknownType
loss	O	O	I-UnknownType
.	O	O	O

Sessions	O	O	B-T077
during	O	O	O
the	O	O	O
trauma	O	O	B-T061
narrative	O	O	I-T061
phase	O	O	I-T061
of	O	O	O
TF-CBT	O	O	B-T061
were	O	O	O
coded	O	O	O
for	O	O	O
indicators	O	O	O
of	O	O	O
unproductive	O	O	B-T033
processing	O	O	I-T033
(	O	O	O
overgeneralization	O	O	B-T033
,	O	O	O
rumination	O	O	B-T048
,	O	O	O
avoidance	O	O	B-T041
)	O	O	O
and	O	O	O
constructive	O	O	B-T033
processing	O	O	I-T033
(	O	O	O
decentering	O	O	B-T033
,	O	O	O
accommodation	O	O	B-T033
of	O	O	I-T033
corrective	O	O	I-T033
information	O	O	I-T033
)	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
levels	O	O	B-T058
of	O	O	I-T058
negative	O	O	I-T058
emotion	O	O	I-T058
.	O	O	O

In	O	O	O
previous	O	O	B-T079
analyses	O	O	O
of	O	O	O
this	O	O	O
trial	O	O	O
(	O	O	O
Ready	O	O	O
et	O	O	O
al.	O	O	O
,	O	O	O
2015	O	O	O
)	O	O	O
,	O	O	O
more	O	O	O
overgeneralization	O	O	B-T033
during	O	O	O
the	O	O	O
narrative	O	O	B-T061
phase	O	O	I-T061
predicted	O	O	O
less	O	O	O
improvement	O	O	O
in	O	O	O
internalizing	O	O	B-T184
symptoms	O	O	I-T184
at	O	O	O
posttreatment	O	O	B-UnknownType
and	O	O	O
a	O	O	O
worsening	O	O	B-T080
of	O	O	O
externalizing	O	O	B-T184
symptoms	O	O	I-T184
over	O	O	O
the	O	O	O
12-month	O	O	O
follow-up	O	O	B-T058
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
more	O	O	O
accommodation	O	O	B-T033
predicted	O	O	I-T033
improvement	O	O	I-T033
in	O	O	O
internalizing	O	O	B-T184
symptoms	O	O	I-T184
and	O	O	O
also	O	O	O
moderated	O	O	B-T080
the	O	O	O
negative	O	O	B-T033
effects	O	O	B-T080
of	O	O	I-T080
overgeneralization	O	O	B-T033
on	O	O	O
internalizing	O	O	B-T184
and	O	O	I-T184
externalizing	O	O	I-T184
symptoms	O	O	I-T184
.	O	O	O

The	O	O	O
current	O	O	O
study	O	O	O
examined	O	O	O
correlates	O	O	O
of	O	O	O
overgeneralization	O	O	B-T033
and	O	O	O
accommodation	O	O	B-T033
.	O	O	O

Overgeneralization	O	O	B-T033
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
more	O	O	O
rumination	O	O	B-T048
,	O	O	O
less	O	O	O
decentering	O	O	O
,	O	O	O
and	O	O	O
more	O	O	O
negative	O	O	B-T058
emotion	O	O	I-T058
,	O	O	O
suggesting	O	O	B-T078
immersion	O	O	B-T058
in	O	O	O
trauma	O	O	B-T048
-related	O	O	O
material	O	O	O
.	O	O	O

Accommodation	O	O	B-T033
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
less	O	O	O
avoidance	O	O	B-T041
and	O	O	O
more	O	O	O
decentering	O	O	B-T033
,	O	O	O
suggesting	O	O	O
a	O	O	O
healthy	O	O	B-T080
distance	O	O	O
from	O	O	O
trauma	O	O	B-T048
-related	O	O	O
material	O	O	O
that	O	O	O
might	O	O	O
allow	O	O	O
for	O	O	O
processing	O	O	O
and	O	O	O
cognitive	O	O	B-T048
change	O	O	I-T048
.	O	O	O

Decentering	O	O	O
also	O	O	O
predicted	O	O	B-T078
improvement	O	O	B-T077
in	O	O	O
externalizing	O	O	B-T184
symptoms	O	O	I-T184
at	O	O	O
posttreatment	O	O	B-UnknownType
.	O	O	O

Rumination	O	O	B-T048
and	O	O	O
avoidance	O	O	B-T041
showed	O	O	O
important	O	O	O
associations	O	O	O
with	O	O	O
overgeneralization	O	O	B-T033
and	O	O	O
accommodation	O	O	B-T033
,	O	O	O
respectively	O	O	O
,	O	O	O
but	O	O	O
did	O	O	O
not	O	O	O
predict	O	O	O
treatment	O	O	B-T080
outcomes	O	O	I-T080
.	O	O	O

This	O	O	O
study	O	O	O
identifies	O	O	O
correlates	O	O	O
of	O	O	O
overgeneralization	O	O	B-T033
and	O	O	O
accommodation	O	O	B-T033
that	O	O	O
might	O	O	O
shed	O	O	O
light	O	O	O
on	O	O	O
how	O	O	O
these	O	O	O
variables	O	O	O
relate	O	O	O
to	O	O	O
unproductive	O	O	B-T033
and	O	O	I-T033
constructive	O	O	I-T033
processing	O	O	I-T033
of	O	O	O
traumatic	O	O	B-T048
experiences	O	O	I-T048
.	O	O	O

-DOCSTART- (28273985)

Giant	O	O	B-T025
Antrochoanal	O	O	B-T191
Polyp	O	O	I-T191
-A	O	O	O
Rare	O	O	B-T080
Presentation	O	O	O

Antrochoanal	O	O	B-T191
polyp	O	O	I-T191
(	O	O	O
ACP	O	O	B-T191
)	O	O	O
,	O	O	O
also	O	O	O
called	O	O	O
as	O	O	O
Killian	O	O	B-T191
polyp	O	O	I-T191
,	O	O	O
is	O	O	O
an	O	O	O
infrequent	O	O	O
,	O	O	O
benign	O	O	B-T033
lesion	O	O	I-T033
of	O	O	O
maxillary	O	O	B-T023
origin	O	O	O
in	O	O	O
non-atopic	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
antrochoanal	O	O	B-T191
polyp	O	O	I-T191
is	O	O	O
shaped	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
anatomical	O	O	B-T080
constraints	O	O	O
of	O	O	O
the	O	O	O
lateral	O	O	B-T029
nasal	O	O	I-T029
wall	O	O	I-T029
,	O	O	O
particularly	O	O	O
the	O	O	O
middle	O	O	B-T023
meatus	O	O	I-T023
and	O	O	O
antrum	O	O	B-T023
,	O	O	O
resembling	O	O	O
typically	O	O	O
a	O	O	O
dumbbell	O	O	B-T082
.	O	O	O

Here	O	O	O
presenting	O	O	O
a	O	O	O
common	O	O	O
problem	O	O	B-T033
with	O	O	O
unusual	O	O	B-T080
presentation	O	O	B-T078
.	O	O	O

-DOCSTART- (28274612)

Effects	O	O	B-T080
of	O	O	O
obesity	O	O	B-T047
on	O	O	O
IL-33	O	O	B-T116
/	O	O	O
ST2	O	O	B-T116
system	O	O	B-T169
in	O	O	O
heart	O	O	B-T023
,	O	O	O
adipose	O	O	B-T024
tissue	O	O	I-T024
and	O	O	O
liver	O	O	B-T023
:	O	O	O
study	O	O	B-T062
in	O	O	O
the	O	O	O
experimental	O	O	B-T170
model	O	O	I-T170
of	O	O	O
Zucker	O	O	O
rats	O	O	O

Suppression	O	O	B-T116
of	O	O	I-T116
tumorigenicity	O	O	I-T116
2	O	O	I-T116
(	O	O	O
ST2	O	O	B-T116
)	O	O	O
mediates	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
Interleukin-33	O	O	B-T116
(	O	O	O
IL-33	O	O	B-T116
)	O	O	O
.	O	O	O

Few	O	O	O
data	O	O	O
are	O	O	O
reported	O	O	O
on	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
IL-33	O	O	B-T116
/	O	O	O
ST2	O	O	B-T116
and	O	O	O
obesity	O	O	B-T047
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	O
effects	O	O	B-T080
of	O	O	O
obesity	O	O	B-T047
on	O	O	O
IL-33	O	O	B-T116
/	O	O	O
ST2	O	O	B-T116
system	O	O	B-T169
in	O	O	O
heart	O	O	B-T023
,	O	O	O
adipose	O	O	B-T024
tissue	O	O	I-T024
and	O	O	O
liver	O	O	B-T023
in	O	O	O
a	O	O	O
rodent	O	O	B-T050
model	O	O	I-T050
of	O	O	O
obesity	O	O	O
.	O	O	O

The	O	O	O
relationship	O	O	B-T080
of	O	O	O
cardiac	O	O	B-T024
expression	O	O	B-T045
of	O	O	O
IL-33	O	O	B-T116
/	O	O	O
ST2	O	O	B-T116
system	O	O	B-T169
with	O	O	O
natriuretic	O	O	B-T116
peptides	O	O	I-T116
(	O	O	O
NPs	O	O	B-T116
)	O	O	O
system	O	O	O
and	O	O	O
inflammatory	O	O	B-T038
mediators	O	O	I-T038
was	O	O	O
also	O	O	O
studied	O	O	O
.	O	O	O

mRNA	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
IL-33	O	O	B-T028
/	O	O	O
ST2	O	O	B-T028
system	O	O	B-T169
was	O	O	O
evaluated	O	O	O
in	O	O	O
cardiac	O	O	B-T060
,	O	O	O
adipose	O	O	B-T024
and	O	O	O
hepatic	O	O	B-T060
biopsies	O	O	I-T060
from	O	O	O
obese	O	O	B-T015
Zucker	O	O	I-T015
rats	O	O	I-T015
(	O	O	O
O	O	O	B-T015
)	O	O	O
and	O	O	O
controls	O	O	B-T096
(	O	O	O
CO	O	O	B-T096
)	O	O	O
.	O	O	O

Expression	O	O	B-T045
levels	O	O	O
of	O	O	O
sST2	O	O	B-T116
was	O	O	O
significantly	O	O	O
lower	O	O	O
in	O	O	O
O	O	O	B-T015
rats	O	O	I-T015
compared	O	O	O
with	O	O	O
CO	O	O	B-T096
(	O	O	O
p<0.05	O	O	O
)	O	O	O
in	O	O	O
all	O	O	O
tissues	O	O	B-T024
.	O	O	O

Besides	O	O	O
,	O	O	O
the	O	O	O
mRNA	O	O	B-T114
levels	O	O	O
of	O	O	O
IL-33	O	O	B-T028
decreased	O	O	O
significant	O	O	O
in	O	O	O
fat	O	O	O
of	O	O	O
O	O	O	B-T015
respect	O	O	O
to	O	O	O
CO	O	O	B-T096
,	O	O	O
while	O	O	O
,	O	O	O
expression	O	O	B-T045
levels	O	O	O
of	O	O	O
ST2L	O	O	B-T028
was	O	O	O
significantly	O	O	O
higher	O	O	O
in	O	O	O
liver	O	O	B-T023
of	O	O	O
CO	O	O	O
than	O	O	O
in	O	O	O
O.	O	O	O
A	O	O	O
strong	O	O	O
relationship	O	O	B-T080
of	O	O	O
IL-33	O	O	O
/	O	O	O
ST2	O	O	B-T116
with	O	O	O
NPs	O	O	B-T116
and	O	O	O
classical	O	O	O
inflammatory	O	O	B-T038
mediators	O	O	I-T038
was	O	O	O
observed	O	O	O
in	O	O	O
cardiac	O	O	B-T024
tissue	O	O	I-T024
.	O	O	O

Expression	O	O	B-T045
of	O	O	O
sST2	O	O	B-T116
in	O	O	O
cardiac	O	O	B-T024
,	O	O	O
adipose	O	O	B-T024
and	O	O	O
liver	O	O	B-T023
tissue	O	O	I-T023
decreased	O	O	O
in	O	O	O
O	O	O	B-T015
compared	O	O	O
with	O	O	O
controls	O	O	B-T096
,	O	O	O
suggesting	O	O	O
an	O	O	O
involvement	O	O	O
for	O	O	O
IL-33	O	O	B-T116
/	O	O	O
ST2	O	O	B-T116
system	O	O	B-T169
in	O	O	O
molecular	O	O	B-T044
mechanisms	O	O	I-T044
of	O	O	O
obesity	O	O	B-T047
.	O	O	O

The	O	O	O
strong	O	O	O
relationships	O	O	B-T080
with	O	O	O
NP	O	O	B-T116
systems	O	O	B-T169
and	O	O	O
inflammatory	O	O	B-T038
mediators	O	O	I-T038
could	O	O	O
suggest	O	O	O
an	O	O	O
involvement	O	O	O
for	O	O	O
IL-33	O	O	B-T116
/	O	O	O
ST2	O	O	B-T116
in	O	O	O
molecular	O	O	B-T044
pathways	O	O	I-T044
leading	O	O	O
to	O	O	O
cardiac	O	O	B-T033
dysfunction	O	O	I-T033
and	O	O	O
inflammation	O	O	B-T046
associated	O	O	O
with	O	O	O
obesity	O	O	B-T047
.	O	O	O

-DOCSTART- (28277316)

CXCL14	O	O	B-T116
-	O	O	O
CXCR4	O	O	B-T116
and	O	O	O
CXCL12	O	O	B-T116
-	O	O	O
CXCR4	O	O	O
Axes	O	O	O
May	O	O	O
Play	O	O	O
Important	O	O	O
Roles	O	O	O
in	O	O	O
the	O	O	O
Unique	O	O	O
Invasion	O	O	B-T033
Process	O	O	B-T067
of	O	O	O
Endometrioid	O	O	B-T191
Carcinoma	O	O	I-T191
With	O	O	O
MELF-Pattern	O	O	B-T082
Myoinvasion	O	O	O

The	O	O	O
term	O	O	O
"	O	O	O
MELF-pattern	O	O	B-T082
myometrial	O	O	B-T029
invasion	O	O	B-T033
"	O	O	O
(	O	O	O
MELF	O	O	B-T082
pattern	O	O	I-T082
)	O	O	O
denotes	O	O	O
an	O	O	O
unusual	O	O	B-T080
morphology	O	O	B-T080
of	O	O	O
myometrial	O	O	O
invasion	O	O	O
in	O	O	O
endometrioid	O	O	B-T191
carcinomas	O	O	I-T191
,	O	O	O
and	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
frequent	O	O	O
lymphovascular	O	O	B-T033
invasion	O	O	I-T033
and	O	O	O
lymph	O	O	B-T191
node	O	O	I-T191
metastasis	O	O	I-T191
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
directly	O	O	O
collected	O	O	B-T078
from	O	O	O
a	O	O	O
MELF	O	O	B-T082
pattern	O	O	I-T082
site	O	O	O
,	O	O	O
using	O	O	O
laser	O	O	B-T059
microdissection	O	O	I-T059
.	O	O	O

Comprehensive	O	O	B-T080
microarray	O	O	B-T059
analysis	O	O	I-T059
of	O	O	O
the	O	O	O
genes	O	O	B-T028
was	O	O	O
conducted	O	O	O
,	O	O	O
and	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
results	O	O	O
,	O	O	O
expression	O	O	B-T045
of	O	O	O
a	O	O	O
metastasis	O	O	B-T116
progression	O	O	I-T116
gene	O	O	I-T116
,	O	O	I-T116
CXCR4	O	O	I-T116
,	O	O	O
and	O	O	O
its	O	O	O
ligands	O	O	B-T044
CXCL14	O	O	B-T116
and	O	O	O
CXCL12	O	O	B-T116
,	O	O	O
was	O	O	O
further	O	O	O
investigated	O	O	B-T169
.	O	O	O

In	O	O	B-T062
vitro	O	O	I-T062
studies	O	O	I-T062
of	O	O	O
endometrioid	O	O	B-T191
carcinoma	O	O	I-T191
cell	O	O	B-T025
lines	O	O	I-T025
revealed	O	O	O
elevated	O	O	B-T080
invasion	O	O	B-T033
activity	O	O	B-T052
in	O	O	O
a	O	O	O
manner	O	O	O
dependent	O	O	O
on	O	O	O
the	O	O	O
CXCL14	O	O	B-T116
-	O	O	O
CXCR4	O	O	B-T116
or	O	O	O
CXCL12	O	O	B-T116
-	O	O	O
CXCR4	O	O	O
axis	O	O	O
.	O	O	O

Immunohistochemical	O	O	B-T059
analysis	O	O	I-T059
of	O	O	O
93	O	O	O
(	O	O	O
MELF	O	O	B-T078
group	O	O	I-T078
,	O	O	O
46	O	O	O
;	O	O	O
non-MELF	O	O	B-T078
group	O	O	I-T078
,	O	O	O
47	O	O	O
)	O	O	O
cases	O	O	O
illustrated	O	O	O
CXCR4	O	O	B-T116
was	O	O	O
expressed	O	O	B-T045
in	O	O	O
all	O	O	O
endometrioid	O	O	B-T191
carcinomas	O	O	I-T191
,	O	O	O
while	O	O	O
based	O	O	O
on	O	O	O
CXCL14	O	O	B-T116
and	O	O	O
CXCL12	O	O	B-T116
expression	O	O	B-T045
score	O	O	B-T081
,	O	O	O
high	O	O	B-T081
proportions	O	O	I-T081
of	O	O	O
cells	O	O	B-T025
were	O	O	O
positive	O	O	B-T033
at	O	O	O
the	O	O	O
sites	O	O	B-T082
of	O	O	O
the	O	O	O
MELF	O	O	B-T082
pattern	O	O	I-T082
(	O	O	O
P<0.01	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
in	O	O	O
progression-free	O	O	B-T081
survival	O	O	I-T081
or	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
between	O	O	O
MELF	O	O	B-T078
group	O	O	I-T078
and	O	O	O
non-MELF	O	O	B-T078
group	O	O	I-T078
by	O	O	O
Kaplan-Meier	O	O	B-T081
analysis	O	O	I-T081
.	O	O	O

These	O	O	O
findings	O	O	O
suggest	O	O	O
a	O	O	O
possibility	O	O	O
that	O	O	O
cells	O	O	B-T025
at	O	O	O
the	O	O	O
sites	O	O	B-T082
of	O	O	O
MELF	O	O	B-T082
pattern	O	O	I-T082
had	O	O	O
acquired	O	O	O
increased	O	O	B-T081
invasiveness	O	O	B-T046
through	O	O	O
the	O	O	O
function	O	O	B-T039
of	O	O	O
the	O	O	O
CXCL14	O	O	B-T116
-	O	O	O
CXCR4	O	O	B-T116
and	O	O	O
CXCL12	O	O	B-T116
-	O	O	O
CXCR4	O	O	O
axes	O	O	O
.	O	O	O

-DOCSTART- (28277879)

Crude	O	O	B-T080
4-methylcyclohexanemethanol	O	O	B-T109
(	O	O	O
MCHM	O	O	B-T109
)	O	O	O
did	O	O	O
not	O	O	O
cause	O	O	B-T169
skin	O	O	B-T033
irritation	O	O	I-T033
in	O	O	O
humans	O	O	B-T016
in	O	O	O
48-h	O	O	B-T079
patch	O	O	O
test	O	O	O

Crude	O	O	B-T080
4-methylcyclohexanemethanol	O	O	B-T109
(	O	O	O
MCHM	O	O	B-T109
)	O	O	O
is	O	O	O
an	O	O	O
industrial	O	O	B-T057
chemical	O	O	B-T103
used	O	O	O
to	O	O	O
wash	O	O	B-T052
and	O	O	O
clean	O	O	B-T052
coal	O	O	B-T109
.	O	O	O

On	O	O	O
January	O	O	O
9th	O	O	O
,	O	O	O
2014	O	O	O
approximately	O	O	O
10,000	O	O	B-T081
gallons	O	O	I-T081
of	O	O	O
a	O	O	O
mixture	O	O	B-T167
containing	O	O	O
crude	O	O	B-T080
MCHM	O	O	B-T109
were	O	O	O
released	O	O	O
into	O	O	O
the	O	O	O
Elk	O	O	B-T070
River	O	O	I-T070
near	O	O	O
Charleston	O	O	B-T083
,	O	O	O
West	O	O	B-T083
Virginia	O	O	I-T083
,	O	O	O
contaminating	O	O	B-T169
the	O	O	O
local	O	O	B-T082
water	O	O	B-T081
supply	O	O	I-T081
.	O	O	O

Following	O	O	O
the	O	O	O
spill	O	O	B-T069
,	O	O	O
residents	O	O	B-T098
reported	O	O	B-T058
numerous	O	O	B-T081
health	O	O	B-T184
complaints	O	O	I-T184
,	O	O	O
and	O	O	O
sought	O	O	O
medical	O	O	B-T033
attention	O	O	I-T033
for	O	O	O
ailments	O	O	B-T184
including	O	O	O
rashes	O	O	B-T184
and	O	O	O
itching	O	O	B-T184
.	O	O	O

The	O	O	O
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
complaints	O	O	B-T184
and	O	O	O
the	O	O	O
spill	O	O	B-T069
were	O	O	O
unknown	O	O	O
,	O	O	O
as	O	O	O
such	O	O	O
symptoms	O	O	B-T184
are	O	O	O
reported	O	O	B-T058
frequently	O	O	B-T079
in	O	O	O
the	O	O	O
background	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
primary	O	O	B-T080
irritation	O	O	B-T033
potential	O	O	B-T080
of	O	O	O
crude	O	O	B-T080
MCHM	O	O	B-T109
was	O	O	O
evaluated	O	O	B-T169
in	O	O	O
206	O	O	O
individuals	O	O	B-T098
who	O	O	O
underwent	O	O	O
48	O	O	B-T079
hour	O	O	I-T079
semi-occluded	O	O	B-T169
patch	O	O	B-T060
testing	O	O	I-T060
.	O	O	O

MCHM	O	O	B-T109
concentrations	O	O	B-T081
assessed	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
were	O	O	O
1	O	O	O
,	O	O	O
5	O	O	O
,	O	O	O
15	O	O	O
,	O	O	O
and	O	O	O
100	O	O	O
ppm	O	O	O
.	O	O	O

No	O	O	O
appreciable	O	O	O
skin	O	O	B-T201
reactions	O	O	I-T201
were	O	O	O
observed	O	O	O
in	O	O	O
individuals	O	O	B-T098
at	O	O	O
any	O	O	O
concentration	O	O	B-T081
.	O	O	O

Three	O	O	O
of	O	O	O
the	O	O	O
five	O	O	O
concentrations	O	O	B-T081
evaluated	O	O	B-T169
were	O	O	O
above	O	O	O
the	O	O	O
highest	O	O	O
measured	O	O	B-T081
concentration	O	O	I-T081
of	O	O	O
MCHM	O	O	B-T109
in	O	O	O
the	O	O	O
tap	O	O	B-T121
water	O	O	I-T121
of	O	O	O
residents	O	O	B-T098
in	O	O	O
West	O	O	B-T083
Virginia	O	O	I-T083
(	O	O	O
3.7	O	O	O
ppm	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
results	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
suggest	O	O	O
that	O	O	O
crude	O	O	B-T080
MCHM	O	O	B-T109
would	O	O	O
not	O	O	O
be	O	O	O
a	O	O	O
dermal	O	O	B-T080
irritant	O	O	B-T131
for	O	O	O
the	O	O	O
vast	O	O	O
majority	O	O	O
,	O	O	O
if	O	O	O
not	O	O	O
all	O	O	O
,	O	O	O
potentially	O	O	O
exposed	O	O	O
persons	O	O	B-T098
at	O	O	O
the	O	O	O
concentrations	O	O	B-T081
in	O	O	O
the	O	O	O
water	O	O	B-T121
reported	O	O	B-T058
after	O	O	O
the	O	O	O
spill	O	O	B-T069
.	O	O	O

-DOCSTART- (28278674)

New	O	O	B-T080
metabolites	O	O	B-T123
from	O	O	O
the	O	O	O
sponge	O	O	B-T204
-derived	O	O	O
fungus	O	O	B-T004
Aspergillus	O	O	O
sydowii	O	O	O
J05B-7F-4	O	O	O

Two	O	O	O
new	O	O	B-T080
metabolites	O	O	B-T123
,	O	O	O
diorcinolic	O	O	B-T123
acid	O	O	I-T123
(	O	O	O
1	O	O	O
)	O	O	O
and	O	O	O
β-d-glucopyranosyl	O	O	B-T109
aspergillusene	O	O	I-T109
A	O	O	I-T109
(	O	O	O
8)	O	O	O
,	O	O	O
together	O	O	O
with	O	O	O
six	O	O	O
diphenylethers	O	O	B-T123
(	O	O	O
2	O	O	O
-	O	O	O
7	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
diketopiperazine	O	O	B-T109
(	O	O	O
9	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
chromone	O	O	B-T109
(	O	O	O
10	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
xanthone	O	O	B-T109
(	O	O	O
11	O	O	O
)	O	O	O
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
fungus	O	O	B-T004
Aspergillus	O	O	B-T004
sydowii	O	O	I-T004
derived	O	O	O
from	O	O	O
the	O	O	O
marine	O	O	B-T204
sponge	O	O	I-T204
Stelletta	O	O	O
sp.	O	O	O
The	O	O	O
planar	O	O	O
structures	O	O	O
and	O	O	O
their	O	O	O
relative	O	O	O
configurations	O	O	B-T082
were	O	O	O
elucidated	O	O	O
by	O	O	O
analysing	O	O	O
1D	O	O	B-T070
,	O	O	I-T070
2D	O	O	I-T070
NMR	O	O	I-T070
and	O	O	O
HRESIMS	O	O	B-T059
data	O	O	B-T078
.	O	O	O

Compound	O	O	B-T103
8	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
glycoside	O	O	B-T109
of	O	O	O
phenolic	O	O	B-T109
bisabolane	O	O	B-T109
sesquiterpenes	O	O	I-T109
.	O	O	O

Compounds	O	O	B-T121
1	O	O	I-T121
and	O	O	I-T121
8	O	O	I-T121
exhibited	O	O	O
mild	O	O	B-T080
cytotoxicity	O	O	B-T049
against	O	O	O
KB	O	O	B-T025
(	O	O	O
human	O	O	B-T025
nasopharyngeal	O	O	I-T025
carcinoma	O	O	I-T025
cells	O	O	I-T025
)	O	O	O
,	O	O	O
HepG2	O	O	B-T025
(	O	O	O
human	O	O	B-T025
liver	O	O	I-T025
cancer	O	O	I-T025
cells	O	O	I-T025
)	O	O	O
and	O	O	O
HCT	O	O	B-T025
116	O	O	I-T025
(	O	O	O
human	O	O	B-T025
colon	O	O	I-T025
cancer	O	O	I-T025
cells	O	O	I-T025
)	O	O	O
.	O	O	O

All	O	O	O
compounds	O	O	B-T121
were	O	O	O
evaluated	O	O	B-T058
for	O	O	O
antibacterial	O	O	B-T052
activity	O	O	I-T052
and	O	O	O
their	O	O	O
abilities	O	O	O
to	O	O	O
suppress	O	O	B-T169
LPS	O	O	B-T109
-induced	O	O	O
nitric	O	O	B-T121
oxide	O	O	I-T121
(	O	O	O
NO	O	O	B-T121
)	O	O	O
production	O	O	O
.	O	O	O

Compounds	O	O	B-T121
2	O	O	I-T121
and	O	O	I-T121
4	O	O	I-T121
-	O	O	I-T121
7	O	O	I-T121
showed	O	O	O
mild	O	O	B-T080
antibacterial	O	O	B-T033
activity	O	O	I-T033
against	O	O	O
human	O	O	B-T016
pathogen	O	O	B-T001
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
and	O	O	O
fish	O	O	B-T013
pathogens	O	O	B-T001
Streptococcus	O	O	B-T007
iniae	O	O	I-T007
and	O	O	O
Vibrio	O	O	B-T007
ichthyoenteri	O	O	I-T007
,	O	O	O
and	O	O	O
compounds	O	O	B-T103
4	O	O	I-T103
and	O	O	I-T103
7	O	O	I-T103
weakly	O	O	O
suppressed	O	O	B-T169
NO	O	O	B-T121
production	O	O	O
.	O	O	O

-DOCSTART- (28279706)

The	O	O	O
neural	O	O	B-T169
legacy	O	O	B-T081
of	O	O	O
a	O	O	O
single	O	O	O
concussion	O	O	O

It	O	O	O
has	O	O	O
been	O	O	O
hypothesized	O	O	B-T078
that	O	O	O
concussions	O	O	B-T037
impart	O	O	B-T080
lasting	O	O	B-T079
brain	O	O	B-T037
damage	O	O	I-T037
,	O	O	O
even	O	O	O
after	O	O	O
a	O	O	O
patient	O	O	B-T101
has	O	O	O
ostensibly	O	O	O
recovered	O	O	B-T080
.	O	O	O

This	O	O	O
hypothesis	O	O	B-T078
is	O	O	O
based	O	O	O
largely	O	O	B-T081
upon	O	O	O
neuropathological	O	O	B-T169
studies	O	O	B-T062
in	O	O	O
deceased	O	O	B-T040
athletes	O	O	B-T097
,	O	O	O
however	O	O	O
,	O	O	O
leaving	O	O	O
open	O	O	O
the	O	O	O
question	O	O	O
of	O	O	O
whether	O	O	O
it	O	O	O
can	O	O	O
be	O	O	O
detected	O	O	B-T061
in	O	O	B-T062
vivo	O	O	I-T062
.	O	O	O

We	O	O	O
measured	O	O	B-T080
neural	O	O	B-T169
responses	O	O	B-T032
to	O	O	O
speech	O	O	B-T040
in	O	O	O
collegiate	O	O	B-T098
student	O	O	I-T098
-	O	O	O
athletes	O	O	B-T097
with	O	O	O
a	O	O	O
history	O	O	B-T033
of	O	O	O
a	O	O	O
single	O	O	O
concussion	O	O	B-T037
from	O	O	O
which	O	O	O
they	O	O	O
had	O	O	O
recovered	O	O	B-T080
.	O	O	O

These	O	O	O
student	O	O	B-T098
-	O	O	O
athletes	O	O	B-T097
had	O	O	O
weaker	O	O	B-T080
responses	O	O	B-T032
to	O	O	O
speech	O	O	B-T040
than	O	O	O
age	O	O	B-T032
-	O	O	O
and	O	O	O
position	O	O	B-T082
-	O	O	O
matched	O	O	B-T080
peers	O	O	B-T098
.	O	O	O

This	O	O	O
group	O	O	B-UnknownType
difference	O	O	B-T080
suggests	O	O	B-T078
that	O	O	O
concussions	O	O	B-T037
engender	O	O	B-T169
small	O	O	B-T081
,	O	O	O
but	O	O	O
detectable	O	O	B-T201
,	O	O	O
changes	O	O	B-T169
in	O	O	O
brain	O	O	B-T042
function	O	O	I-T042
prior	O	O	B-T079
to	O	O	O
the	O	O	O
emergence	O	O	B-T079
of	O	O	O
frank	O	O	B-T080
behavioral	O	O	B-T184
indications	O	O	I-T184
.	O	O	O

-DOCSTART- (28281265)

Enhanced	O	O	O
Performance	O	O	B-T052
of	O	O	O
Colorimetric	O	O	B-T059
Biosensing	O	O	B-T059
on	O	O	O
Paper	O	O	B-T073
Microfluidic	O	O	B-T059
Platforms	O	O	I-T059
Through	O	O	O
Chemical	O	O	B-T169
Modification	O	O	I-T169
and	O	O	O
Incorporation	O	O	B-T169
of	O	O	O
Nanoparticles	O	O	O

This	O	O	O
chapter	O	O	O
describes	O	O	O
two	O	O	O
different	O	O	O
methodologies	O	O	B-T062
used	O	O	O
to	O	O	O
improve	O	O	O
the	O	O	O
analytical	O	O	B-T052
performance	O	O	I-T052
of	O	O	O
colorimetric	O	O	B-T059
paper	O	O	B-T073
-based	O	O	O
biosensors	O	O	B-T075
.	O	O	O

Microfluidic	O	O	B-T075
paper-based	O	O	I-T075
analytical	O	O	I-T075
devices	O	O	I-T075
(	O	O	O
μPADs	O	O	B-T075
)	O	O	O
have	O	O	O
been	O	O	O
produced	O	O	O
by	O	O	O
a	O	O	O
stamping	O	O	B-T067
process	O	O	I-T067
and	O	O	O
CO2	O	O	B-T123
laser	O	O	B-T061
ablation	O	O	I-T061
and	O	O	O
modified	O	O	B-T080
,	O	O	O
respectively	O	O	O
,	O	O	O
through	O	O	O
an	O	O	O
oxidation	O	O	B-T067
step	O	O	B-T077
and	O	O	O
incorporation	O	O	O
of	O	O	O
silica	O	O	B-T122
nanoparticles	O	O	B-T073
on	O	O	O
the	O	O	O
paper	O	O	B-T073
structure	O	O	I-T073
.	O	O	O

Both	O	O	O
methods	O	O	B-T170
are	O	O	O
employed	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
overcome	O	O	O
the	O	O	O
largest	O	O	O
problem	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
colorimetric	O	O	B-T059
detection	O	O	I-T059
,	O	O	O
the	O	O	O
heterogeneity	O	O	B-T080
of	O	O	O
the	O	O	O
color	O	O	B-T080
distribution	O	O	B-T169
in	O	O	O
the	O	O	O
detection	O	O	B-T082
zones	O	O	I-T082
.	O	O	O

The	O	O	O
modification	O	O	B-T169
steps	O	O	B-T077
are	O	O	O
necessary	O	O	O
to	O	O	O
improve	O	O	O
the	O	O	O
interaction	O	O	B-T169
between	O	O	O
the	O	O	O
paper	O	O	B-T073
surface	O	O	B-T082
and	O	O	O
the	O	O	O
selected	O	O	O
enzymes	O	O	B-T116
.	O	O	O

The	O	O	O
enhanced	O	O	O
performance	O	O	B-T052
has	O	O	O
ensured	O	O	O
reliability	O	O	B-T081
for	O	O	O
quantitative	O	O	B-T081
analysis	O	O	B-T062
of	O	O	O
clinically	O	O	B-T080
relevant	O	O	O
compounds	O	O	B-T103
.	O	O	O

-DOCSTART- (28282510)

CXCR4	O	O	B-T116
(	O	O	O
CD184	O	O	B-T116
)	O	O	O
expression	O	O	B-T045
on	O	O	O
stem	O	O	B-T061
cell	O	O	I-T061
harvest	O	O	I-T061
and	O	O	O
CD34(+	O	O	B-T116
)	O	O	I-T116
cells	O	O	B-T025
post-transplant	O	O	O

CXCR4	O	O	B-T116
is	O	O	O
a	O	O	O
receptor	O	O	B-T116
for	O	O	O
stromal-derived	O	O	B-T116
factor-1	O	O	I-T116
(	O	O	O
SDF-1	O	O	B-T116
)	O	O	O
,	O	O	O
a	O	O	O
molecule	O	O	B-T167
that	O	O	O
has	O	O	O
a	O	O	O
chemotactic	O	O	B-T043
activity	O	O	B-T052
for	O	O	O
lymphocytes	O	O	B-T025
and	O	O	O
is	O	O	O
important	O	O	O
in	O	O	O
homing	O	O	B-T043
of	O	O	O
hematopoietic	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
to	O	O	O
their	O	O	O
adult	O	O	B-T024
marrow	O	O	I-T024
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
the	O	O	O
CXCR4	O	O	B-T116
(	O	O	O
CD184	O	O	B-T116
)	O	O	O
expression	O	O	B-T045
in	O	O	O
the	O	O	O
harvest	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
in	O	O	O
the	O	O	O
post-transplant	O	O	B-T079
bone	O	O	B-T024
marrow	O	O	I-T024
(	O	O	O
BM	O	O	B-T024
)	O	O	O
and	O	O	O
its	O	O	O
relation	O	O	B-T080
to	O	O	O
engraftment	O	O	B-T039
,	O	O	O
as	O	O	O
determined	O	O	O
by	O	O	O
the	O	O	O
consensus	O	O	B-T170
criteria	O	O	I-T170
and	O	O	O
chimerism	O	O	B-T032
.	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
which	O	O	O
included	O	O	O
30	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
hematopoietic	O	O	B-T061
stem	O	O	I-T061
cell	O	O	I-T061
transplantation	O	O	I-T061
;	O	O	O
15	O	O	O
patients	O	O	O
received	O	O	B-T080
autograft	O	O	B-T061
and	O	O	O
15	O	O	O
patients	O	O	O
received	O	O	O
allograft	O	O	B-T061
on	O	O	O
dates	O	O	O
between	O	O	O
January	O	O	O
2012	O	O	O
and	O	O	O
May	O	O	O
2014	O	O	O
.	O	O	O

We	O	O	O
assessed	O	O	B-T052
CD184	O	O	B-T116
(	O	O	O
CXCR4	O	O	B-T116
)	O	O	O
using	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
in	O	O	O
the	O	O	O
harvest	O	O	B-T025
cells	O	O	B-T025
together	O	O	O
with	O	O	O
post-transplant	O	O	B-T079
BM	O	O	B-T024
assessment	O	O	B-T058
on	O	O	O
Day	O	O	O
28	O	O	O
and	O	O	O
Day	O	O	O
90	O	O	O
for	O	O	O
complete	O	O	B-T080
morphologic	O	O	B-T082
,	O	O	O
molecular	O	O	B-T059
studies	O	O	I-T059
,	O	O	O
and	O	O	O
detection	O	O	B-T061
of	O	O	O
CD184	O	O	O
expression	O	O	B-T045
on	O	O	O
CD34(+	O	O	B-T116
)	O	O	I-T116
cells	O	O	O
with	O	O	O
chimerism	O	O	B-T032
studies	O	O	O
on	O	O	O
total	O	O	B-T080
peripheral	O	O	B-T025
blood	O	O	I-T025
mononuclear	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

Diagnoses	O	O	B-T033
of	O	O	O
the	O	O	O
enrolled	O	O	O
patients	O	O	B-T101
were	O	O	O
as	O	O	O
follows	O	O	O
:	O	O	O
seven	O	O	O
(	O	O	O
24.1	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
acute	O	O	B-T191
myeloid	O	O	I-T191
leukemia	O	O	I-T191
,	O	O	O
eight	O	O	O
(	O	O	O
27.6	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
multiple	O	O	B-T191
myeloma	O	O	I-T191
,	O	O	O
four	O	O	O
(	O	O	O
13.8	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
acute	O	O	B-T191
lymphoblastic	O	O	I-T191
leukemia	O	O	I-T191
,	O	O	O
three	O	O	O
(	O	O	O
10.3	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
non-Hodgkin	O	O	B-T191
lymphoma	O	O	I-T191
,	O	O	O
two	O	O	O
(	O	O	O
6.9	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
myelodysplastic	O	O	B-T191
syndromes	O	O	I-T191
,	O	O	O
two	O	O	O
(	O	O	O
6.9	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
aplastic	O	O	B-T047
anemia	O	O	I-T047
,	O	O	O
two	O	O	O
(	O	O	O
6.9	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
chronic	O	O	B-T191
myeloid	O	O	I-T191
leukemia	O	O	I-T191
,	O	O	O
one	O	O	O
(	O	O	O
3.4	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
Hodgkin	O	O	B-T191
lymphoma	O	O	I-T191
,	O	O	O
and	O	O	O
one	O	O	O
(	O	O	O
3.4	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
plasmacytomas	O	O	B-T191
.	O	O	O

One	O	O	O
patient	O	O	B-T101
died	O	O	B-T033
and	O	O	O
was	O	O	O
excluded	O	O	B-T052
from	O	O	O
the	O	O	O
study	O	O	B-T062
because	O	O	O
there	O	O	O
were	O	O	O
not	O	O	O
enough	O	O	O
data	O	O	O
about	O	O	O
engraftment	O	O	B-T039
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
statistical	O	O	B-T081
significance	O	O	I-T081
between	O	O	O
the	O	O	O
level	O	O	B-T034
of	O	O	O
CD184	O	O	B-T116
in	O	O	O
stem	O	O	B-T061
cell	O	O	I-T061
harvest	O	O	I-T061
and	O	O	O
the	O	O	O
prediction	O	O	B-T078
of	O	O	O
successful	O	O	B-T080
engraftment	O	O	B-T039
(	O	O	O
p>0.05	O	O	O
)	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
Day	O	O	O
28	O	O	O
BM	O	O	B-T031
sample	O	O	I-T031
(	O	O	O
p>0.05	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
statistical	O	O	O
significance	O	O	O
between	O	O	O
the	O	O	O
level	O	O	O
of	O	O	O
CD184	O	O	O
in	O	O	O
Day	O	O	O
90	O	O	O
BM	O	O	O
sample	O	O	O
and	O	O	O
the	O	O	O
occurrence	O	O	B-T079
of	O	O	O
successful	O	O	O
engraftment	O	O	O
(	O	O	O
p=0.002	O	O	O
)	O	O	O
.	O	O	O

SDF-1	O	O	B-T116
/	O	O	O
CXCR4	O	O	B-T116
axis	O	O	O
plays	O	O	O
a	O	O	O
crucial	O	O	O
role	O	O	O
in	O	O	O
engraftment	O	O	B-T039
;	O	O	O
however	O	O	O
,	O	O	O
more	O	O	O
studies	O	O	O
are	O	O	O
warranted	O	O	O
to	O	O	O
assess	O	O	B-T052
their	O	O	O
expression	O	O	B-T045
post-transplant	O	O	B-T079
.	O	O	O

Evaluating	O	O	O
the	O	O	O
ligand	O	O	O
(	O	O	O
chemokine	O	O	B-T116
,	O	O	O
SDF-1	O	O	B-T116
)	O	O	O
or	O	O	O
its	O	O	O
receptor	O	O	B-T116
(	O	O	O
CXCR4	O	O	B-T116
)	O	O	O
may	O	O	O
serve	O	O	O
as	O	O	O
potential	O	O	B-T080
surrogate	O	O	B-T080
markers	O	O	I-T080
for	O	O	O
assessment	O	O	B-T058
of	O	O	O
engraftment	O	O	B-T039
.	O	O	O

-DOCSTART- (28284223)

Genetic	O	O	B-T070
diversity	O	O	I-T070
of	O	O	O
Taenia	O	O	B-T204
saginata	O	O	I-T204
(	O	O	O
Cestoda	O	O	B-T204
:	O	O	O
Cyclophyllidea	O	O	B-T204
)	O	O	O
from	O	O	O
Lao	O	O	B-T083
People	O	O	I-T083
's	O	O	I-T083
Democratic	O	O	I-T083
Republic	O	O	I-T083
and	O	O	O
northeastern	O	O	B-T083
Thailand	O	O	B-T083
based	O	O	O
on	O	O	O
mitochondrial	O	O	O
DNA	O	O	O

Taenia	O	O	B-T204
saginata	O	O	I-T204
is	O	O	O
a	O	O	O
tapeworm	O	O	B-T204
found	O	O	O
in	O	O	O
cattle	O	O	B-T015
worldwide	O	O	O
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
in	O	O	O
different	O	O	O
geographical	O	O	B-T081
populations	O	O	I-T081
of	O	O	O
T.	O	O	B-T204
saginata	O	O	I-T204
not	O	O	O
only	O	O	O
helps	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
origin	O	O	B-T079
,	O	O	O
transmission	O	O	B-T070
and	O	O	O
spread	O	O	B-T080
of	O	O	O
this	O	O	O
organism	O	O	B-T001
,	O	O	O
but	O	O	O
also	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
selection	O	O	O
pressures	O	O	O
acting	O	O	O
on	O	O	O
T.	O	O	O
saginata	O	O	O
and	O	O	O
how	O	O	O
it	O	O	O
is	O	O	O
responding	O	O	O
to	O	O	O
them	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
are	O	O	O
few	O	O	O
reports	O	O	O
of	O	O	O
the	O	O	O
genetic	O	O	B-T070
variability	O	O	I-T070
of	O	O	O
T.	O	O	B-T204
saginata	O	O	I-T204
populations	O	O	I-T204
in	O	O	O
different	O	O	O
regions	O	O	B-T083
of	O	O	O
the	O	O	O
world	O	O	B-T098
,	O	O	O
including	O	O	O
Lao	O	O	B-T083
PDR	O	O	I-T083
and	O	O	O
Thailand	O	O	B-T083
.	O	O	O

We	O	O	O
report	O	O	O
the	O	O	O
genetic	O	O	B-T114
diversity	O	O	I-T114
of	O	O	O
T.	O	O	B-T204
saginata	O	O	I-T204
populations	O	O	I-T204
in	O	O	O
Lao	O	O	B-T083
PDR	O	O	I-T083
and	O	O	O
northeastern	O	O	B-T083
Thailand	O	O	B-T083
together	O	O	O
with	O	O	O
sequences	O	O	B-T086
of	O	O	O
T.	O	O	O
saginata	O	O	O
from	O	O	O
other	O	O	O
countries	O	O	B-T083
deposited	O	O	O
in	O	O	O
GenBank	O	O	B-T170
.	O	O	O

Mitochondrial	O	O	B-T028
cox1	O	O	I-T028
sequence	O	O	B-T059
analysis	O	O	I-T059
revealed	O	O	O
that	O	O	O
15	O	O	O
and	O	O	O
8	O	O	O
haplotypes	O	O	B-T032
were	O	O	O
identified	O	O	O
in	O	O	O
30	O	O	O
and	O	O	O
21	O	O	O
T.	O	O	B-T204
saginata	O	O	I-T204
isolates	O	O	O
from	O	O	O
Lao	O	O	B-T083
PDR	O	O	I-T083
and	O	O	O
northeastern	O	O	B-T083
Thailand	O	O	B-T083
,	O	O	O
respectively	O	O	O
.	O	O	O

Fifty-three	O	O	O
haplotypes	O	O	B-T032
were	O	O	O
identified	O	O	O
from	O	O	O
98	O	O	O
sequences	O	O	B-T086
.	O	O	O

Phylogenetic	O	O	B-T062
tree	O	O	I-T062
and	O	O	O
haplotype	O	O	B-T062
network	O	O	I-T062
analyses	O	O	I-T062
revealed	O	O	O
that	O	O	O
global	O	O	B-T080
isolates	O	O	O
of	O	O	O
T.	O	O	B-T204
saginata	O	O	I-T204
were	O	O	O
genetically	O	O	O
divided	O	O	O
into	O	O	O
five	O	O	O
groups	O	O	B-T078
(	O	O	O
A	O	O	B-T078
,	O	O	O
B	O	O	B-T078
,	O	O	O
C1	O	O	B-T078
,	O	O	O
C2	O	O	B-T078
and	O	O	O
D	O	O	B-T078
)	O	O	O
.	O	O	O

Taenia	O	O	B-T204
saginata	O	O	I-T204
isolates	O	O	O
from	O	O	O
Lao	O	O	B-T083
PDR	O	O	I-T083
and	O	O	O
northeastern	O	O	B-T083
Thailand	O	O	B-T083
belonged	O	O	O
to	O	O	O
either	O	O	O
Group	O	O	B-T078
A	O	O	I-T078
or	O	O	O
B.	O	O	O
Taenia	O	O	O
saginata	O	O	O
from	O	O	O
western	O	O	B-T083
Thailand	O	O	O
clustered	O	O	O
in	O	O	O
groups	O	O	B-T078
C1	O	O	I-T078
,	O	O	O
C2	O	O	B-T078
and	O	O	O
D	O	O	B-T078
,	O	O	O
and	O	O	O
populations	O	O	B-T204
from	O	O	O
the	O	O	O
northeast	O	O	B-T083
and	O	O	O
western	O	O	O
Thailand	O	O	O
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
genetically	O	O	O
distinct	O	O	O
.	O	O	O

Taenia	O	O	B-T204
saginata	O	O	I-T204
isolates	O	O	O
in	O	O	O
Lao	O	O	B-T083
PDR	O	O	I-T083
and	O	O	O
Thailand	O	O	B-T083
were	O	O	O
also	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
genetically	O	O	B-T070
diverse	O	O	I-T070
but	O	O	O
the	O	O	O
degree	O	O	O
of	O	O	O
genetic	O	O	B-T045
differentiation	O	O	I-T045
was	O	O	O
low	O	O	O
.	O	O	O

Taenia	O	O	B-T204
saginata	O	O	I-T204
populations	O	O	I-T204
from	O	O	O
Lao	O	O	B-T083
PDR	O	O	I-T083
and	O	O	O
northeastern	O	O	B-T083
Thailand	O	O	B-T083
are	O	O	O
genetically	O	O	O
distinct	O	O	O
from	O	O	O
the	O	O	O
population	O	O	B-T204
in	O	O	O
western	O	O	B-T083
Thailand	O	O	O
and	O	O	O
it	O	O	O
is	O	O	O
proposed	O	O	O
that	O	O	O
T.	O	O	B-T204
saginata	O	O	I-T204
has	O	O	O
been	O	O	O
dispersed	O	O	O
by	O	O	O
different	O	O	O
transmission	O	O	B-T070
routes	O	O	I-T070
in	O	O	O
Southeast	O	O	B-T083
Asia	O	O	I-T083
.	O	O	O

-DOCSTART- (28284864)

Development	O	O	O
of	O	O	O
a	O	O	O
novel	O	O	B-T080
near-infrared	O	O	B-T070
fluorescent	O	O	B-T070
theranostic	O	O	B-T091
combretastain	O	O	B-T109
A-4	O	O	I-T109
analogue	O	O	B-T104
,	O	O	O
YK-5	O	O	B-T121
-	O	O	I-T121
252	O	O	I-T121
,	O	O	O
to	O	O	O
target	O	O	O
triple	O	O	O
negative	O	O	O
breast	O	O	O
cancer	O	O	O

The	O	O	O
treatment	O	O	B-T061
of	O	O	O
triple	O	O	B-T191
negative	O	O	I-T191
breast	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
TNBC	O	O	B-T191
)	O	O	O
is	O	O	O
a	O	O	O
significant	O	O	O
challenge	O	O	O
to	O	O	O
cancer	O	O	B-T062
research	O	O	I-T062
.	O	O	O

The	O	O	O
lack	O	O	O
of	O	O	O
hormone	O	O	B-T116
receptors	O	O	I-T116
limits	O	O	O
the	O	O	O
treatment	O	O	B-T061
options	O	O	O
available	O	O	O
to	O	O	O
patients	O	O	B-T101
with	O	O	O
this	O	O	O
diagnosis	O	O	B-T033
,	O	O	O
forcing	O	O	O
them	O	O	O
to	O	O	O
endure	O	O	O
prolonged	O	O	O
radiation	O	O	B-T061
and	O	O	O
chemotherapy	O	O	B-T061
.	O	O	O

Anti-angiogenesis	O	O	B-T061
is	O	O	O
a	O	O	O
chemotherapeutic	O	O	O
strategy	O	O	O
that	O	O	O
targets	O	O	O
the	O	O	O
vasculature	O	O	B-T017
of	O	O	O
tumors	O	O	B-T191
.	O	O	O

Combretastatin	O	O	B-T109
A-4	O	O	I-T109
(	O	O	O
CA-4	O	O	B-T109
)	O	O	O
is	O	O	O
a	O	O	O
well-known	O	O	O
vasculature	O	O	B-T017
-	O	O	O
disrupting	O	O	O
agent	O	O	O
,	O	O	O
which	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
effectively	O	O	O
kill	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
cancers	O	O	B-T191
through	O	O	O
inhibition	O	O	B-T052
of	O	O	O
tubulin	O	O	B-T116
polymerization	O	O	B-T067
.	O	O	O

Due	O	O	O
to	O	O	O
its	O	O	O
toxicity	O	O	B-T037
,	O	O	O
small	O	O	O
molecule	O	O	O
analogues	O	O	B-T104
of	O	O	O
CA-4	O	O	B-T109
have	O	O	O
been	O	O	O
sought	O	O	O
out	O	O	O
.	O	O	O

We	O	O	O
have	O	O	O
designed	O	O	O
a	O	O	O
novel	O	O	B-T080
dual	O	O	O
action	O	O	O
CA-4	O	O	B-T109
prodrug	O	O	B-T120
,	O	O	O
YK-5	O	O	B-T121
-	O	O	I-T121
252	O	O	I-T121
,	O	O	O
which	O	O	O
releases	O	O	O
the	O	O	O
drug	O	O	B-T121
through	O	O	O
a	O	O	O
disulfide	O	O	B-T044
bond	O	O	I-T044
cleavage	O	O	B-T067
mechanism	O	O	B-T169
and	O	O	O
contains	O	O	O
a	O	O	O
near-infrared	O	O	B-T070
(	O	O	O
NIR	O	O	B-T070
)	O	O	O
fluorophore	O	O	B-T121
,	O	O	O
which	O	O	O
allows	O	O	O
fluorescence	O	O	B-T070
monitoring	O	O	O
of	O	O	O
cleavage	O	O	O
.	O	O	O

This	O	O	O
disulfide	O	O	B-T044
linkage	O	O	I-T044
causes	O	O	O
CA-4	O	O	B-T109
to	O	O	O
become	O	O	O
effective	O	O	O
only	O	O	O
when	O	O	O
released	O	O	O
by	O	O	O
glutathione	O	O	B-T116
(	O	O	O
GSH	O	O	B-T116
)	O	O	O
reducing	O	O	O
the	O	O	O
toxicity	O	O	B-T037
of	O	O	O
the	O	O	O
drug	O	O	B-T121
while	O	O	O
simultaneously	O	O	O
releasing	O	O	O
the	O	O	O
NIR	O	O	B-T070
fluorophore	O	O	B-T121
.	O	O	O

Therefore	O	O	O
the	O	O	O
prodrug	O	O	B-T120
,	O	O	O
YK-5	O	O	B-T121
-	O	O	I-T121
252	O	O	I-T121
,	O	O	O
represents	O	O	O
a	O	O	O
novel	O	O	B-T080
CA-4	O	O	B-T109
analogue	O	O	B-T104
which	O	O	O
has	O	O	O
reduced	O	O	O
toxicity	O	O	B-T037
and	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
for	O	O	O
theranostics	O	O	B-T091
imaging	O	O	B-T060
.	O	O	O

-DOCSTART- (28288758)

Epidemiological	O	O	B-T169
patterns	O	O	B-T082
of	O	O	O
bovine	O	O	B-T015
besnoitiosis	O	O	B-T047
in	O	O	O
an	O	O	O
endemic	O	O	B-T169
beef	O	O	B-T015
cattle	O	O	I-T015
herd	O	O	B-T054
reared	O	O	B-T082
under	O	O	O
extensive	O	O	O
conditions	O	O	O

Bovine	O	O	B-T015
besnoitiosis	O	O	B-T047
is	O	O	O
a	O	O	O
parasitic	O	O	B-T047
disease	O	O	I-T047
caused	O	O	O
by	O	O	O
the	O	O	O
protozoan	O	O	B-T204
Besnoitia	O	O	B-T204
besnoiti	O	O	I-T204
.	O	O	O

Described	O	O	O
many	O	O	O
decades	O	O	O
ago	O	O	O
,	O	O	O
recent	O	O	O
epidemiological	O	O	B-T062
studies	O	O	I-T062
reveal	O	O	O
its	O	O	O
important	O	O	O
spread	O	O	O
within	O	O	O
Europe	O	O	B-T083
in	O	O	O
the	O	O	O
last	O	O	O
years	O	O	B-T079
.	O	O	O

To	O	O	O
date	O	O	O
,	O	O	O
many	O	O	O
epidemiological	O	O	B-T169
aspects	O	O	B-T080
related	O	O	O
to	O	O	O
life	O	O	O
cycle	O	O	O
,	O	O	O
routes	O	O	O
of	O	O	O
transmission	O	O	B-T046
,	O	O	O
incidence	O	O	B-T081
rates	O	O	I-T081
and	O	O	O
associated	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
are	O	O	O
lacking	O	O	B-T080
;	O	O	O
hence	O	O	O
,	O	O	O
the	O	O	O
establishment	O	O	O
of	O	O	O
appropriate	O	O	B-T058
disease	O	O	I-T058
control	O	O	I-T058
programmes	O	O	B-T170
poses	O	O	O
an	O	O	O
important	O	O	O
challenge	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
epidemiological	O	O	B-T169
pattern	O	O	B-T082
of	O	O	O
the	O	O	O
disease	O	O	B-T047
in	O	O	O
an	O	O	O
endemic	O	O	B-T169
herd	O	O	B-T054
reared	O	O	B-T082
under	O	O	O
extensive	O	O	O
conditions	O	O	O
(	O	O	O
Spanish	O	O	B-T083
Pyrenees	O	O	B-T083
)	O	O	O
by	O	O	O
identifying	O	O	O
main	O	O	O
factors	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
infection	O	O	B-T046
and	O	O	O
clinical	O	O	B-T047
disease	O	O	I-T047
dynamics	O	O	B-T070
.	O	O	O

The	O	O	O
study	O	O	B-T062
population	O	O	I-T062
consisted	O	O	O
of	O	O	O
276	O	O	O
Brown	O	O	B-T015
Swiss	O	O	I-T015
and	O	O	O
Pirenaica	O	O	B-T015
adult	O	O	B-T008
animals	O	O	I-T008
and	O	O	O
145	O	O	O
calves	O	O	B-T015
born	O	O	B-T040
and	O	O	O
weaned	O	O	B-T033
at	O	O	O
the	O	O	O
farm	O	O	B-T082
during	O	O	O
the	O	O	O
study	O	O	O
.	O	O	O

Three	O	O	O
sampling	O	O	B-T078
time	O	O	B-T079
frames	O	O	I-T079
were	O	O	O
used	O	O	O
:	O	O	O
January	O	O	O
2010	O	O	O
,	O	O	O
September	O	O	O
2010	O	O	O
and	O	O	O
February	O	O	O
2011	O	O	O
,	O	O	O
which	O	O	O
allowed	O	O	O
us	O	O	O
to	O	O	O
differentiate	O	O	O
two	O	O	O
periods	O	O	B-T079
designated	O	O	O
as	O	O	O
mountain	O	O	B-T083
and	O	O	O
valley	O	O	B-T082
periods	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T078
related	O	O	O
to	O	O	O
animals	O	O	B-T008
(	O	O	O
breed	O	O	B-T185
,	O	O	O
sex	O	O	B-T032
and	O	O	O
age	O	O	B-T032
)	O	O	O
and	O	O	O
herd	O	O	B-T054
management	O	O	B-T057
(	O	O	O
animal	O	O	B-T096
grouping	O	O	I-T096
and	O	O	O
time	O	O	B-T079
in	O	O	O
housing	O	O	B-T073
)	O	O	O
were	O	O	O
recorded	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T062
collection	O	O	I-T062
methodology	O	O	B-T078
was	O	O	O
mainly	O	O	O
based	O	O	O
on	O	O	O
clinical	O	O	B-T033
examinations	O	O	I-T033
and	O	O	O
defining	O	O	O
the	O	O	O
serological	O	O	B-T169
status	O	O	B-T080
against	O	O	O
bovine	O	O	B-T015
besnoitiosis	O	O	B-T047
by	O	O	O
the	O	O	O
immunofluorescent	O	O	B-T059
antibody	O	O	I-T059
testing	O	O	I-T059
of	O	O	O
blood	O	O	B-T031
samples	O	O	I-T031
.	O	O	O

The	O	O	O
total	O	O	O
prevalence	O	O	B-T081
among	O	O	O
adult	O	O	B-T008
animals	O	O	B-T008
was	O	O	O
38.34	O	O	O
%	O	O	O
(	O	O	O
CI	O	O	B-T081
95	O	O	O
%	O	O	O
:	O	O	O
34.53	O	O	O
-	O	O	O
42.07	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
18.54	O	O	O
%	O	O	O
of	O	O	O
seropositive	O	O	B-T080
animals	O	O	O
showing	O	O	O
clinical	O	O	O
signs	O	O	O
.	O	O	O

In	O	O	O
regard	O	O	O
to	O	O	O
the	O	O	O
cumulative	O	O	B-T081
incidence	O	O	I-T081
,	O	O	O
34.57	O	O	O
%	O	O	O
of	O	O	O
new	O	O	B-T080
infections	O	O	B-T046
were	O	O	O
detected	O	O	B-T033
during	O	O	O
the	O	O	O
mountain	O	O	B-T083
period	O	O	B-T079
,	O	O	O
in	O	O	O
contrast	O	O	O
to	O	O	O
the	O	O	O
24.59	O	O	O
%	O	O	O
observed	O	O	O
in	O	O	O
the	O	O	O
valley	O	O	B-T082
period	O	O	O
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
density	O	O	I-T081
was	O	O	O
0.058	O	O	O
and	O	O	O
0.061	O	O	O
new	O	O	B-T080
infections	O	O	B-T046
per	O	O	O
animal	O	O	B-T008
-	O	O	O
month	O	O	B-T079
for	O	O	O
the	O	O	O
mountain	O	O	B-T083
and	O	O	O
valley	O	O	B-T082
periods	O	O	B-T079
,	O	O	O
respectively	O	O	O
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
seroepidemiological	O	O	B-T062
study	O	O	I-T062
,	O	O	O
the	O	O	O
seroconversion	O	O	B-T070
probability	O	O	B-T081
of	O	O	O
B.	O	O	B-T204
besnoiti	O	O	I-T204
infection	O	O	B-T046
was	O	O	O
directly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
number	O	O	B-T081
of	O	O	O
seropositive	O	O	B-T080
cows	O	O	B-T015
with	O	O	O
whom	O	O	O
an	O	O	O
animal	O	O	B-T008
had	O	O	O
been	O	O	O
stabled	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
housing	O	O	B-T073
period	O	O	B-T079
duration	O	O	B-T079
,	O	O	O
supporting	O	O	O
horizontal	O	O	B-T046
transmission	O	O	I-T046
by	O	O	O
close	O	O	O
contact	O	O	O
as	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
methods	O	O	O
of	O	O	O
disease	O	O	B-T047
spread	O	O	B-T080
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
developing	O	O	O
the	O	O	O
clinical	O	O	B-T079
course	O	O	I-T079
increased	O	O	B-T081
with	O	O	O
age	O	O	B-T032
,	O	O	O
and	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
clinical	O	O	B-T033
signs	O	O	I-T033
was	O	O	O
related	O	O	O
to	O	O	O
higher	O	O	B-T080
antibody	O	O	B-T038
responses	O	O	I-T038
.	O	O	O

Among	O	O	O
calves	O	O	B-T015
(	O	O	O
from	O	O	O
3.1	O	O	O
to	O	O	O
7.1	O	O	O
months	O	O	B-T079
old	O	O	B-T079
)	O	O	O
sampled	O	O	O
once	O	O	O
at	O	O	O
weaning	O	O	B-T033
,	O	O	O
the	O	O	O
total	O	O	O
seroprevalence	O	O	B-T062
was	O	O	O
15.17	O	O	O
%	O	O	O
(	O	O	O
CI	O	O	B-T081
95	O	O	O
%	O	O	O
:	O	O	O
9.36	O	O	O
-	O	O	O
21.04	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
chronic	O	O	B-T079
stage	O	O	B-T079
was	O	O	O
observed	O	O	O
in	O	O	O
three	O	O	O
animals	O	O	B-T008
,	O	O	O
supporting	O	O	O
the	O	O	O
ability	O	O	O
of	O	O	O
B.	O	O	B-T204
besnoiti	O	O	I-T204
to	O	O	O
infect	O	O	B-T046
and	O	O	O
even	O	O	O
cause	O	O	B-T169
disease	O	O	B-T047
in	O	O	O
animals	O	O	O
less	O	O	O
than	O	O	O
6	O	O	O
months	O	O	O
old	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
calf	O	O	B-T015
seroconversion	O	O	B-T070
was	O	O	O
positively	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
serological	O	O	B-T169
status	O	O	B-T080
of	O	O	O
the	O	O	O
cows	O	O	B-T015
,	O	O	O
suggesting	O	O	O
postnatal	O	O	B-T079
transmission	O	O	B-T046
between	O	O	O
dams	O	O	B-T015
and	O	O	O
offspring	O	O	B-T015
by	O	O	O
contact	O	O	O
during	O	O	O
the	O	O	O
suckling	O	O	B-T015
period	O	O	B-T079
.	O	O	O

-DOCSTART- (28295177)

A	O	O	O
fast	O	O	B-T170
small-sample	O	O	I-T170
kernel	O	O	I-T170
independence	O	O	I-T170
test	O	O	I-T170
for	O	O	O
microbiome	O	O	B-T001
community	O	O	B-T096
-	O	O	O
level	O	O	O
association	O	O	O
analysis	O	O	O

To	O	O	O
fully	O	O	O
understand	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
microbiome	O	O	B-T001
in	O	O	O
human	O	O	B-T016
health	O	O	B-T078
and	O	O	O
diseases	O	O	B-T047
,	O	O	O
researchers	O	O	B-T097
are	O	O	O
increasingly	O	O	O
interested	O	O	O
in	O	O	O
assessing	O	O	B-T052
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
microbiome	O	O	B-T001
composition	O	O	I-T001
and	O	O	O
host	O	O	B-T001
genomic	O	O	B-T028
data	O	O	B-T078
.	O	O	O

The	O	O	O
dimensionality	O	O	B-T082
of	O	O	O
the	O	O	O
data	O	O	B-T078
as	O	O	O
well	O	O	O
as	O	O	O
complex	O	O	B-T080
relationships	O	O	B-T080
between	O	O	O
microbiota	O	O	B-T001
and	O	O	O
host	O	O	B-T001
genomics	O	O	B-T028
pose	O	O	O
considerable	O	O	O
challenges	O	O	B-T058
for	O	O	O
analysis	O	O	B-T062
.	O	O	O

In	O	O	O
this	O	O	O
article	O	O	O
,	O	O	O
we	O	O	O
apply	O	O	O
a	O	O	O
kernel	O	O	B-T170
RV	O	O	I-T170
coefficient	O	O	I-T170
(	O	O	I-T170
KRV	O	O	I-T170
)	O	O	I-T170
test	O	O	I-T170
to	O	O	O
evaluate	O	O	O
the	O	O	O
overall	O	O	B-T080
association	O	O	B-T080
between	O	O	O
host	O	O	B-T001
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
microbiome	O	O	B-T001
composition	O	O	I-T001
.	O	O	O

The	O	O	O
KRV	O	O	B-T170
statistic	O	O	I-T170
can	O	O	O
capture	O	O	O
nonlinear	O	O	B-T080
correlations	O	O	I-T080
and	O	O	O
complex	O	O	B-T080
relationships	O	O	B-T080
among	O	O	O
the	O	O	O
individual	O	O	O
data	O	O	B-T078
types	O	O	I-T078
and	O	O	O
between	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
microbiome	O	O	B-T001
composition	O	O	I-T001
through	O	O	O
measuring	O	O	O
general	O	O	O
dependency	O	O	B-T078
.	O	O	O

Testing	O	O	B-T169
proceeds	O	O	O
via	O	O	O
a	O	O	O
similar	O	O	O
route	O	O	O
as	O	O	O
existing	O	O	O
tests	O	O	B-T170
of	O	O	O
the	O	O	O
generalized	O	O	O
RV	O	O	B-T081
coefficients	O	O	I-T081
and	O	O	O
allows	O	O	O
for	O	O	O
rapid	O	O	O
p-value	O	O	B-T081
calculation	O	O	B-T052
.	O	O	O

Strategies	O	O	B-T169
to	O	O	O
allow	O	O	O
adjustment	O	O	O
for	O	O	O
confounding	O	O	B-T169
effects	O	O	I-T169
,	O	O	O
which	O	O	O
is	O	O	O
crucial	O	O	O
for	O	O	O
avoiding	O	O	O
misleading	O	O	O
results	O	O	B-T169
,	O	O	O
and	O	O	O
to	O	O	O
alleviate	O	O	O
the	O	O	O
problem	O	O	B-T033
of	O	O	O
selecting	O	O	O
the	O	O	O
most	O	O	O
favorable	O	O	O
kernel	O	O	B-T170
are	O	O	O
considered	O	O	O
.	O	O	O

Simulation	O	O	B-T062
studies	O	O	I-T062
show	O	O	O
that	O	O	O
KRV	O	O	B-T081
is	O	O	O
useful	O	O	O
in	O	O	O
testing	O	O	B-T169
statistical	O	O	B-T078
independence	O	O	I-T078
with	O	O	O
finite	O	O	O
samples	O	O	O
given	O	O	O
the	O	O	O
kernels	O	O	B-T170
are	O	O	O
appropriately	O	O	O
chosen	O	O	O
,	O	O	O
and	O	O	O
can	O	O	O
powerfully	O	O	O
identify	O	O	O
existing	O	O	O
associations	O	O	B-T080
between	O	O	O
microbiome	O	O	B-T001
composition	O	O	I-T001
and	O	O	O
host	O	O	B-T001
genomic	O	O	B-T028
data	O	O	B-T078
while	O	O	O
protecting	O	O	O
type	O	O	B-T185
I	O	O	I-T185
error	O	O	B-T080
.	O	O	O

We	O	O	O
apply	O	O	O
the	O	O	O
KRV	O	O	B-T081
to	O	O	O
a	O	O	O
microbiome	O	O	B-T001
study	O	O	B-T062
examining	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
host	O	O	B-T001
transcriptome	O	O	B-T086
and	O	O	O
microbiome	O	O	B-T001
composition	O	O	I-T001
within	O	O	O
the	O	O	O
context	O	O	B-T078
of	O	O	O
inflammatory	O	O	B-T047
bowel	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
are	O	O	O
able	O	O	O
to	O	O	O
derive	O	O	O
new	O	O	O
biological	O	O	O
insights	O	O	O
and	O	O	O
provide	O	O	O
formal	O	O	O
inference	O	O	O
on	O	O	O
prior	O	O	O
qualitative	O	O	B-T080
observations	O	O	I-T080
.	O	O	O

-DOCSTART- (28295357)

An	O	O	O
Analysis	O	O	B-T062
of	O	O	O
Systematic	O	O	B-T169
Elemental	O	O	B-T196
Changes	O	O	B-T081
in	O	O	O
Decomposing	O	O	O
Bone	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
compositional	O	O	B-T201
changes	O	O	B-T081
in	O	O	O
bone	O	O	B-T023
during	O	O	O
decomposition	O	O	B-T067
.	O	O	O

Elemental	O	O	B-T196
concentrations	O	O	B-T081
of	O	O	O
barium	O	O	B-T196
,	O	O	O
calcium	O	O	B-T121
,	O	O	O
iron	O	O	B-T121
,	O	O	O
potassium	O	O	B-T123
,	O	O	O
magnesium	O	O	B-T123
,	O	O	O
zinc	O	O	B-T121
and	O	O	O
phosphorus	O	O	B-T196
in	O	O	O
porcine	O	O	B-T015
bone	O	O	B-T023
(	O	O	O
as	O	O	O
an	O	O	O
experimental	O	O	B-T080
analog	O	O	B-T104
for	O	O	O
human	O	O	B-T016
bone	O	O	O
)	O	O	O
were	O	O	O
analyzed	O	O	B-T062
by	O	O	O
inductively	O	O	B-T059
coupled	O	O	I-T059
plasma	O	O	I-T059
optical	O	O	I-T059
emission	O	O	I-T059
spectroscopy	O	O	I-T059
(	O	O	O
ICP-OES	O	O	B-T059
)	O	O	O
.	O	O	O

The	O	O	O
samples	O	O	B-UnknownType
were	O	O	O
taken	O	O	O
from	O	O	O
porcine	O	O	B-T015
bone	O	O	B-T023
subjected	O	O	B-T169
to	O	O	O
shallow	O	O	B-T052
burial	O	O	I-T052
and	O	O	O
surface	O	O	B-T029
depositions	O	O	B-T169
at	O	O	O
28-	O	O	O
day	O	O	B-T079
intervals	O	O	B-T079
for	O	O	O
a	O	O	O
period	O	O	B-T079
of	O	O	O
140	O	O	O
days	O	O	B-T079
.	O	O	O

Results	O	O	B-T033
indicated	O	O	B-T033
that	O	O	O
ICP-OES	O	O	B-T059
elemental	O	O	B-T196
profiling	O	O	B-T169
has	O	O	O
potential	O	O	B-T080
to	O	O	O
be	O	O	O
developed	O	O	B-T080
as	O	O	O
a	O	O	O
forensic	O	O	B-T059
test	O	O	I-T059
for	O	O	O
determining	O	O	B-T080
whether	O	O	O
a	O	O	O
bone	O	O	B-UnknownType
sample	O	O	I-UnknownType
originates	O	O	O
from	O	O	O
the	O	O	O
early	O	O	B-T079
stages	O	O	B-T079
of	O	O	O
soft	O	O	B-T024
tissue	O	O	I-T024
putrefaction	O	O	B-T046
.	O	O	O

Significant	O	O	B-T081
changes	O	O	I-T081
in	O	O	O
iron	O	O	B-T121
,	O	O	O
sodium	O	O	B-T123
and	O	O	O
potassium	O	O	B-T123
concentrations	O	O	B-T081
were	O	O	O
found	O	O	B-T033
over	O	O	B-T079
140	O	O	O
days	O	O	B-T079
.	O	O	O

These	O	O	O
elements	O	O	B-T196
are	O	O	O
known	O	O	B-T080
to	O	O	O
be	O	O	O
primarily	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
proteins	O	O	B-T116
and/or	O	O	O
tissue	O	O	B-T031
fluids	O	O	I-T031
within	O	O	O
the	O	O	O
bone	O	O	B-T023
.	O	O	O

Changes	O	O	B-T081
in	O	O	O
their	O	O	O
respective	O	O	O
concentrations	O	O	B-T081
may	O	O	O
therefore	O	O	O
be	O	O	O
linked	O	O	O
to	O	O	O
dehydration	O	O	B-T033
over	O	O	O
time	O	O	B-T079
and	O	O	O
in	O	O	O
turn	O	O	O
may	O	O	O
be	O	O	O
indicative	O	O	O
of	O	O	O
time	O	O	O
since	O	O	B-T079
deposition	O	O	B-T169
.	O	O	O

-DOCSTART- (28295838)

Chasing	O	O	O
ghosts	O	O	O
:	O	O	O
allopolyploid	O	O	O
origin	O	O	O
of	O	O	O
Oxyria	O	O	B-T002
sinensis	O	O	I-T002
(	O	O	O
Polygonaceae	O	O	B-T002
)	O	O	O
from	O	O	O
its	O	O	O
only	O	O	O
diploid	O	O	B-T032
congener	O	O	B-T104
and	O	O	O
an	O	O	O
unknown	O	O	O
ancestor	O	O	O

Reconstructing	O	O	O
the	O	O	O
origin	O	O	B-T070
of	O	O	O
a	O	O	O
polyploid	O	O	B-T049
species	O	O	B-T185
is	O	O	O
particularly	O	O	O
challenging	O	O	O
when	O	O	O
an	O	O	O
ancestor	O	O	B-T099
has	O	O	O
become	O	O	O
extinct	O	O	B-T070
.	O	O	O

Under	O	O	O
such	O	O	O
circumstances	O	O	O
,	O	O	O
the	O	O	O
extinct	O	O	B-T070
donor	O	O	O
of	O	O	O
a	O	O	O
genome	O	O	B-T028
found	O	O	O
in	O	O	O
the	O	O	O
polyploid	O	O	B-T049
may	O	O	O
be	O	O	O
treated	O	O	O
as	O	O	O
a	O	O	O
'	O	O	O
ghost	O	O	O
'	O	O	O
species	O	O	B-T185
in	O	O	O
that	O	O	O
its	O	O	O
prior	O	O	O
existence	O	O	B-T081
is	O	O	O
recognized	O	O	O
through	O	O	O
the	O	O	O
presence	O	O	B-T080
of	O	O	O
its	O	O	O
genome	O	O	O
in	O	O	O
the	O	O	O
polyploid	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
polyploid	O	O	B-T049
origin	O	O	B-T070
of	O	O	O
Oxyria	O	O	B-T002
sinensis	O	O	I-T002
(	O	O	O
2n	O	O	O
=	O	O	O
40	O	O	O
)	O	O	O
for	O	O	O
which	O	O	O
only	O	O	O
one	O	O	O
congeneric	O	O	B-T104
species	O	O	B-T185
is	O	O	O
known	O	O	O
,	O	O	O
that	O	O	O
is	O	O	O
diploid	O	O	B-T032
O.	O	O	B-T002
digyna	O	O	I-T002
(	O	O	O
2n	O	O	O
=	O	O	O
14	O	O	O
)	O	O	O
.	O	O	O

Genomic	O	O	B-T063
in	O	O	I-T063
situ	O	O	I-T063
hybridization	O	O	I-T063
(	O	O	O
GISH	O	O	B-T063
)	O	O	O
,	O	O	O
transcriptome	O	O	B-T059
,	O	O	O
phylogenetic	O	O	B-T062
and	O	O	O
demographic	O	O	B-T062
analyses	O	O	I-T062
,	O	O	O
and	O	O	O
ecological	O	O	B-T170
niche	O	O	I-T170
modelling	O	O	I-T170
were	O	O	O
conducted	O	O	O
for	O	O	O
this	O	O	O
purpose	O	O	O
.	O	O	O

GISH	O	O	B-T063
revealed	O	O	O
that	O	O	O
O.	O	O	B-T002
sinensis	O	O	I-T002
comprised	O	O	O
14	O	O	O
chromosomes	O	O	B-T026
from	O	O	O
O.	O	O	B-T002
digyna	O	O	I-T002
and	O	O	O
26	O	O	O
chromosomes	O	O	O
from	O	O	O
an	O	O	O
unknown	O	O	O
ancestor	O	O	B-T099
.	O	O	O

Transcriptome	O	O	B-T059
analysis	O	O	I-T059
indicated	O	O	O
that	O	O	O
following	O	O	O
divergence	O	O	B-T082
from	O	O	O
O.	O	O	B-T002
digyna	O	O	I-T002
,	O	O	O
involving	O	O	O
genome	O	O	B-T045
duplication	O	O	I-T045
around	O	O	O
12	O	O	O
million	O	O	O
years	O	O	O
ago	O	O	O
(	O	O	O
Ma	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
second	O	O	O
genome	O	O	O
duplication	O	O	O
occurred	O	O	O
approximately	O	O	O
6	O	O	O
Ma	O	O	O
to	O	O	O
give	O	O	O
rise	O	O	O
to	O	O	O
O.	O	O	B-T002
sinensis	O	O	I-T002
.	O	O	O

Oxyria	O	O	B-T002
sinensis	O	O	I-T002
was	O	O	O
shown	O	O	O
to	O	O	O
contain	O	O	O
homologous	O	O	B-T085
gene	O	O	I-T085
sequences	O	O	I-T085
divergent	O	O	B-T082
from	O	O	O
those	O	O	O
present	O	O	O
in	O	O	O
O.	O	O	B-T002
digyna	O	O	I-T002
in	O	O	O
addition	O	O	O
to	O	O	O
a	O	O	O
set	O	O	O
that	O	O	O
clustered	O	O	B-T028
with	O	O	O
those	O	O	O
in	O	O	O
O.	O	O	O
digyna	O	O	O
.	O	O	O

Coalescent	O	O	B-T170
simulations	O	O	I-T170
indicated	O	O	O
that	O	O	O
O.	O	O	B-T002
sinensis	O	O	I-T002
expanded	O	O	O
its	O	O	O
distribution	O	O	B-T067
approximately	O	O	O
6	O	O	O
-	O	O	O
7	O	O	O
Ma	O	O	O
,	O	O	O
possibly	O	O	O
following	O	O	O
the	O	O	O
second	O	O	O
polyploidization	O	O	B-T049
event	O	O	I-T049
,	O	O	O
whereas	O	O	O
O.	O	O	B-T002
digyna	O	O	I-T002
expanded	O	O	O
its	O	O	O
range	O	O	O
much	O	O	O
later	O	O	O
.	O	O	O

It	O	O	O
was	O	O	O
also	O	O	O
indicated	O	O	O
that	O	O	O
the	O	O	O
distributions	O	O	B-T067
of	O	O	O
both	O	O	O
species	O	O	B-T185
contracted	O	O	B-T169
and	O	O	I-T169
re-expanded	O	O	I-T169
during	O	O	O
the	O	O	O
Pleistocene	O	O	B-T070
climatic	O	O	I-T070
oscillations	O	O	I-T070
.	O	O	O

Ecological	O	O	B-T170
niche	O	O	I-T170
modelling	O	O	I-T170
similarly	O	O	O
suggested	O	O	O
that	O	O	O
both	O	O	O
species	O	O	B-T185
experienced	O	O	O
changes	O	O	O
in	O	O	O
their	O	O	O
distributional	O	O	B-T067
ranges	O	O	O
in	O	O	O
response	O	O	O
to	O	O	O
Quaternary	O	O	B-T070
climatic	O	O	I-T070
changes	O	O	I-T070
.	O	O	O

The	O	O	O
extinction	O	O	B-T070
of	O	O	O
the	O	O	O
unknown	O	O	O
'	O	O	O
ghost	O	O	O
'	O	O	O
tetraploid	O	O	B-T049
species	O	O	B-T185
implicated	O	O	O
in	O	O	O
the	O	O	O
origin	O	O	B-T070
of	O	O	O
O.	O	O	B-T002
sinensis	O	O	I-T002
could	O	O	O
have	O	O	O
resulted	O	O	O
from	O	O	O
superior	O	O	O
adaptation	O	O	B-T040
of	O	O	O
O.	O	O	O
sinensis	O	O	O
to	O	O	O
repeated	O	O	B-T070
climatic	O	O	I-T070
changes	O	O	I-T070
in	O	O	O
the	O	O	O
region	O	O	O
where	O	O	O
it	O	O	O
now	O	O	O
occurs	O	O	O
.	O	O	O

-DOCSTART- (28296680)

Primitive	O	O	B-T191
Neuroectodermal	O	O	I-T191
Tumors	O	O	I-T191
of	O	O	O
the	O	O	O
Female	O	O	B-T023
Genital	O	O	I-T023
Tract	O	O	I-T023
:	O	O	O
A	O	O	O
Morphologic	O	O	B-T080
,	O	O	O
Immunohistochemical	O	O	B-T059
,	O	O	O
and	O	O	O
Molecular	O	O	B-T080
Study	O	O	B-T062
of	O	O	O
19	O	O	O
Cases	O	O	O

Primary	O	O	B-T191
primitive	O	O	I-T191
neuroectodermal	O	O	I-T191
tumor	O	O	I-T191
(	O	O	O
PNET	O	O	B-T191
)	O	O	O
of	O	O	O
the	O	O	O
female	O	O	B-T023
genital	O	O	I-T023
tract	O	O	I-T023
is	O	O	O
rare	O	O	O
,	O	O	O
and	O	O	O
its	O	O	O
proper	O	O	O
classification	O	O	B-T185
remains	O	O	O
unclear	O	O	O
.	O	O	O

The	O	O	O
clinical	O	O	B-T080
,	O	O	O
histologic	O	O	B-T169
,	O	O	O
and	O	O	O
immunophenotypic	O	O	B-T059
features	O	O	B-T080
as	O	O	O
well	O	O	O
as	O	O	O
EWSR1	O	O	B-T028
rearrangement	O	O	B-T045
status	O	O	O
of	O	O	O
19	O	O	O
gynecologic	O	O	B-T082
PNETs	O	O	B-T191
,	O	O	O
including	O	O	O
10	O	O	O
ovarian	O	O	B-T023
,	O	O	O
8	O	O	O
uterine	O	O	B-T023
,	O	O	O
and	O	O	O
1	O	O	O
vulvar	O	O	B-T023
tumors	O	O	B-T191
,	O	O	O
are	O	O	O
herein	O	O	O
reported	O	O	B-T170
.	O	O	O

Patient	O	O	B-T101
age	O	O	B-T032
ranged	O	O	B-T081
from	O	O	O
12	O	O	O
to	O	O	O
68	O	O	O
years	O	O	B-T079
,	O	O	O
with	O	O	O
a	O	O	O
median	O	O	O
age	O	O	O
of	O	O	O
20	O	O	O
and	O	O	O
51	O	O	O
years	O	O	O
among	O	O	O
those	O	O	O
with	O	O	O
ovarian	O	O	B-T023
and	O	O	O
uterine	O	O	B-T023
PNETs	O	O	B-T191
,	O	O	O
respectively	O	O	O
.	O	O	O

Morphologic	O	O	B-T080
features	O	O	B-T080
of	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
(	O	O	O
CNS	O	O	B-T022
)	O	O	O
tumors	O	O	B-T191
were	O	O	O
seen	O	O	O
in	O	O	O
15	O	O	O
PNETs	O	O	B-T191
,	O	O	O
including	O	O	O
9	O	O	O
medulloblastomas	O	O	B-T191
,	O	O	O
3	O	O	O
ependymomas	O	O	B-T191
,	O	O	O
2	O	O	O
medulloepitheliomas	O	O	B-T191
,	O	O	O
and	O	O	O
1	O	O	O
glioblastoma	O	O	B-T191
,	O	O	O
consistent	O	O	O
with	O	O	O
central	O	O	B-T191
PNET	O	O	I-T191
.	O	O	O

The	O	O	O
remaining	O	O	O
4	O	O	O
PNETs	O	O	B-T191
were	O	O	O
composed	O	O	O
entirely	O	O	O
of	O	O	O
undifferentiated	O	O	B-T080
small	O	O	B-T025
round	O	O	I-T025
blue	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
were	O	O	O
classified	O	O	O
as	O	O	O
Ewing	O	O	B-T191
sarcoma/peripheral	O	O	I-T191
PNET	O	O	I-T191
.	O	O	O

Eight	O	O	O
PNETs	O	O	B-T191
were	O	O	O
associated	O	O	O
with	O	O	O
another	O	O	O
tumor	O	O	B-T191
type	O	O	O
,	O	O	O
including	O	O	O
5	O	O	O
ovarian	O	O	B-T023
mature	O	O	B-T191
cystic	O	O	I-T191
teratomas	O	O	I-T191
,	O	O	O
2	O	O	O
endometrial	O	O	B-T080
low-grade	O	O	I-T080
endometrioid	O	O	B-T191
carcinomas	O	O	I-T191
,	O	O	O
and	O	O	O
a	O	O	O
uterine	O	O	B-T191
carcinosarcoma	O	O	I-T191
.	O	O	O

By	O	O	O
immunohistochemistry	O	O	B-T060
,	O	O	O
17	O	O	O
PNETs	O	O	B-T191
expressed	O	O	O
at	O	O	O
least	O	O	O
1	O	O	O
marker	O	O	B-T123
of	O	O	O
neuronal	O	O	B-T033
differentiation	O	O	I-T033
,	O	O	O
including	O	O	O
synaptophysin	O	O	B-T116
,	O	O	O
NSE	O	O	B-T116
,	O	O	O
CD56	O	O	B-T116
,	O	O	O
S100	O	O	B-T116
,	O	O	O
and	O	O	O
chromogranin	O	O	B-T116
in	O	O	O
10	O	O	O
,	O	O	O
8	O	O	O
,	O	O	O
14	O	O	O
,	O	O	O
8	O	O	O
,	O	O	O
and	O	O	O
1	O	O	O
tumors	O	O	B-T191
,	O	O	O
respectively	O	O	O
.	O	O	O

GFAP	O	O	B-T116
was	O	O	O
positive	O	O	O
in	O	O	O
4	O	O	O
PNETs	O	O	B-T191
,	O	O	O
all	O	O	O
of	O	O	O
which	O	O	O
were	O	O	O
of	O	O	O
central	O	O	O
type	O	O	O
.	O	O	O

Membranous	O	O	B-T024
CD99	O	O	B-T116
and	O	O	O
nuclear	O	O	B-T082
Fli-1	O	O	B-T116
staining	O	O	B-T059
was	O	O	O
seen	O	O	O
in	O	O	O
10	O	O	O
and	O	O	O
16	O	O	O
tumors	O	O	B-T191
,	O	O	O
respectively	O	O	O
,	O	O	O
and	O	O	O
concurrent	O	O	O
expression	O	O	B-T045
of	O	O	O
both	O	O	O
markers	O	O	B-T123
was	O	O	O
seen	O	O	O
in	O	O	O
both	O	O	O
central	O	O	B-T191
and	O	O	O
Ewing	O	O	B-T191
sarcoma/peripheral	O	O	I-T191
PNET	O	O	I-T191
s.	O	O	O
All	O	O	O
tumors	O	O	O
expressed	O	O	B-T045
vimentin	O	O	B-T116
,	O	O	O
whereas	O	O	O
keratin	O	O	B-T116
cocktail	O	O	O
(	O	O	O
CAM5.2	O	O	B-T116
,	O	O	O
AE1/AE3	O	O	B-T116
)	O	O	O
staining	O	O	O
was	O	O	O
only	O	O	O
focally	O	O	O
present	O	O	O
in	O	O	O
4	O	O	O
PNETs	O	O	B-T191
.	O	O	O

Fluorescence	O	O	B-T063
in	O	O	I-T063
situ	O	O	I-T063
hybridization	O	O	I-T063
was	O	O	O
successful	O	O	O
in	O	O	O
all	O	O	O
cases	O	O	B-T077
and	O	O	O
confirmed	O	O	O
EWSR1	O	O	B-T028
rearrangement	O	O	B-T045
in	O	O	O
2	O	O	O
of	O	O	O
4	O	O	O
tumors	O	O	B-T191
demonstrating	O	O	O
morphologic	O	O	B-T080
features	O	O	B-T080
of	O	O	O
Ewing	O	O	B-T191
sarcoma/peripheral	O	O	I-T191
PNET	O	O	I-T191
and	O	O	O
concurrent	O	O	O
CD99	O	O	B-T116
and	O	O	O
Fli-1	O	O	B-T116
expression	O	O	B-T045
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
central	O	O	B-T191
and	O	O	O
Ewing	O	O	B-T191
sarcoma/peripheral	O	O	I-T191
PNETs	O	O	I-T191
may	O	O	O
be	O	O	O
encountered	O	O	O
in	O	O	O
the	O	O	O
female	O	O	B-T023
genital	O	O	I-T023
tract	O	O	I-T023
with	O	O	O
central	O	O	B-T191
PNETs	O	O	I-T191
being	O	O	O
more	O	O	O
common	O	O	O
.	O	O	O

Central	O	O	B-T191
PNETs	O	O	I-T191
show	O	O	O
a	O	O	O
spectrum	O	O	B-T077
of	O	O	O
morphologic	O	O	B-T080
features	O	O	B-T080
that	O	O	O
overlaps	O	O	O
with	O	O	O
CNS	O	O	B-T022
tumors	O	O	B-T191
but	O	O	O
lack	O	O	O
EWSR1	O	O	B-T028
rearrangement	O	O	B-T045
s.	O	O	O
GFAP	O	O	B-T116
expression	O	O	B-T045
supports	O	O	O
a	O	O	O
morphologic	O	O	O
impression	O	O	O
of	O	O	O
central	O	O	B-T191
PNET	O	O	I-T191
and	O	O	O
is	O	O	O
absent	O	O	O
in	O	O	O
Ewing	O	O	O
sarcoma/peripheral	O	O	B-T191
PNET	O	O	I-T191
.	O	O	O

Ewing	O	O	B-T191
sarcoma/peripheral	O	O	I-T191
PNETs	O	O	I-T191
lack	O	O	O
morphologic	O	O	B-T080
features	O	O	B-T080
of	O	O	O
CNS	O	O	B-T022
tumors	O	O	B-T191
.	O	O	O

-DOCSTART- (28297577)

Surgical	O	O	B-T061
Excision	O	O	I-T061
of	O	O	O
Heterotopic	O	O	B-T046
Ossification	O	O	I-T046
Leads	O	O	O
to	O	O	O
Re-Emergence	O	O	B-T079
of	O	O	O
Mesenchymal	O	O	B-T025
Stem	O	O	I-T025
Cell	O	O	I-T025
Populations	O	O	I-T025
Responsible	O	O	O
for	O	O	O
Recurrence	O	O	O

Trauma-induced	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
(	O	O	O
HO	O	O	B-T046
)	O	O	O
occurs	O	O	O
after	O	O	O
severe	O	O	B-T080
musculoskeletal	O	O	B-T037
injuries	O	O	I-T037
and	O	O	O
burns	O	O	B-T037
,	O	O	O
and	O	O	O
presents	O	O	O
a	O	O	O
significant	O	O	B-T078
barrier	O	O	O
to	O	O	O
patient	O	O	B-T101
rehabilitation	O	O	B-T061
.	O	O	O

Interestingly	O	O	O
,	O	O	O
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
HO	O	O	B-T046
significantly	O	O	O
increases	O	O	B-T081
with	O	O	O
repeated	O	O	B-T061
operations	O	O	I-T061
and	O	O	O
after	O	O	O
resection	O	O	B-T061
of	O	O	O
previous	O	O	O
HO	O	O	O
.	O	O	O

Treatment	O	O	B-T061
of	O	O	O
established	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
is	O	O	O
challenging	O	O	O
because	O	O	O
surgical	O	O	B-T061
excision	O	O	I-T061
is	O	O	O
often	O	O	O
incomplete	O	O	B-T080
,	O	O	O
with	O	O	O
evidence	O	O	B-T169
of	O	O	I-T169
persistent	O	O	B-T079
heterotopic	O	O	B-T033
bone	O	O	I-T033
.	O	O	O

As	O	O	O
a	O	O	O
result	O	O	O
,	O	O	O
patients	O	O	B-T101
may	O	O	O
continue	O	O	B-T078
to	O	O	O
report	O	O	O
the	O	O	O
signs	O	O	B-T033
or	O	O	I-T033
symptoms	O	O	I-T033
of	O	O	O
HO	O	O	B-T046
,	O	O	O
including	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
nonhealing	O	O	B-T033
wounds	O	O	B-T037
,	O	O	O
and	O	O	O
joint	O	O	B-T033
restriction	O	O	I-T033
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
designed	O	O	O
a	O	O	O
model	O	O	B-T050
of	O	O	O
recurrent	O	O	B-T079
HO	O	O	B-T046
that	O	O	O
occurs	O	O	O
after	O	O	O
surgical	O	O	B-T061
excision	O	O	I-T061
of	O	O	O
mature	O	O	B-T079
HO	O	O	O
in	O	O	O
a	O	O	O
mouse	O	O	B-T050
model	O	O	I-T050
of	O	O	O
hind-limb	O	O	B-T023
Achilles	O	O	I-T023
'	O	O	I-T023
tendon	O	O	I-T023
transection	O	O	B-T061
with	O	O	O
dorsal	O	O	B-T082
burn	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

We	O	O	O
first	O	O	O
demonstrated	O	O	O
that	O	O	O
key	O	O	B-T080
signaling	O	O	B-T044
mediators	O	O	B-T116
of	O	O	O
HO	O	O	B-T046
,	O	O	O
including	O	O	O
bone	O	O	B-T044
morphogenetic	O	O	I-T044
protein	O	O	I-T044
signaling	O	O	I-T044
,	O	O	O
are	O	O	O
diminished	O	O	O
in	O	O	O
mature	O	O	B-T024
bone	O	O	I-T024
.	O	O	O

However	O	O	O
,	O	O	O
upon	O	O	O
surgical	O	O	B-T061
excision	O	O	I-T061
,	O	O	O
we	O	O	O
have	O	O	O
noted	O	O	O
upregulation	O	O	B-T044
of	O	O	O
downstream	O	O	B-T082
mediators	O	O	B-T116
of	O	O	O
osteogenic	O	O	B-T116
differentiation	O	O	B-T169
,	O	O	O
including	O	O	O
pSMAD	O	O	B-T116
1	O	O	I-T116
/	O	O	O
5	O	O	B-T116
.	O	O	O

Additionally	O	O	O
,	O	O	O
surgical	O	O	B-T061
excision	O	O	I-T061
resulted	O	O	O
in	O	O	O
re-emergence	O	O	B-T079
of	O	O	O
a	O	O	O
mesenchymal	O	O	B-T025
cell	O	O	I-T025
population	O	O	I-T025
marked	O	O	O
by	O	O	O
expression	O	O	B-T045
of	O	O	O
platelet-derived	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
receptor-α	O	O	I-T116
(	O	O	O
PDGFRα	O	O	B-T116
)	O	O	O
and	O	O	O
present	O	O	B-T033
in	O	O	O
the	O	O	O
initial	O	O	B-T079
developing	O	O	O
HO	O	O	B-T046
lesion	O	O	B-T033
but	O	O	O
absent	O	O	B-T169
in	O	O	O
mature	O	O	B-T079
HO	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
recurrent	O	O	B-T079
lesion	O	O	B-T033
,	O	O	O
these	O	O	O
PDGFRα	O	O	B-T116
+	O	O	O
mesenchymal	O	O	B-T025
cells	O	O	I-T025
are	O	O	O
also	O	O	O
highly	O	O	O
proliferative	O	O	B-T046
,	O	O	O
similar	O	O	O
to	O	O	O
the	O	O	O
initial	O	O	B-T079
developing	O	O	O
HO	O	O	B-T046
lesion	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
indicate	O	O	O
that	O	O	O
surgical	O	O	B-T061
excision	O	O	I-T061
of	O	O	O
HO	O	O	B-T046
results	O	O	B-T033
in	O	O	O
recurrence	O	O	B-T067
through	O	O	O
similar	O	O	O
mesenchymal	O	O	B-T025
cell	O	O	I-T025
populations	O	O	I-T025
and	O	O	O
signaling	O	O	B-T044
mechanisms	O	O	B-T169
that	O	O	O
are	O	O	O
present	O	O	B-T033
in	O	O	O
the	O	O	O
initial	O	O	B-T079
developing	O	O	O
HO	O	O	O
lesion	O	O	B-T033
.	O	O	O

These	O	O	O
results	O	O	B-T033
are	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
findings	O	O	B-T033
in	O	O	O
patients	O	O	B-T101
that	O	O	O
new	O	O	O
foci	O	O	B-T082
of	O	O	O
ectopic	O	O	B-T024
bone	O	O	B-T024
can	O	O	O
develop	O	O	O
in	O	O	O
excision	O	O	B-T061
sites	O	O	B-T029
and	O	O	O
are	O	O	O
likely	O	O	O
related	O	O	O
to	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
formation	O	O	B-T169
rather	O	O	O
than	O	O	O
extension	O	O	B-T169
of	O	O	O
unresected	O	O	B-T185
bone	O	O	O
.	O	O	O

Stem	O	O	O
Cells	O	O	O
Translational	O	O	O
Medicine	O	O	O
2017;6:799	O	O	O
-	O	O	O
806	O	O	O
.	O	O	O

-DOCSTART- (28298171)

Extended	O	O	B-T079
release	O	O	I-T079
of	O	O	O
flurbiprofen	O	O	B-T109
from	O	O	O
tromethamine	O	O	B-T109
-	O	O	O
buffered	O	O	B-T121
HPMC	O	O	B-T109
hydrophilic	O	O	B-T080
matrix	O	O	O
tablets	O	O	O

The	O	O	O
pH	O	O	B-T081
-	O	O	O
dependent	O	O	B-T169
solubility	O	O	B-T080
of	O	O	O
a	O	O	O
drug	O	O	B-T121
can	O	O	O
lead	O	O	O
to	O	O	O
pH	O	O	O
-	O	O	O
dependent	O	O	O
drug	O	O	B-T070
release	O	O	I-T070
from	O	O	O
hydrophilic	O	O	B-T080
matrix	O	O	B-T122
tablets	O	O	I-T122
.	O	O	O

Adding	O	O	O
buffer	O	O	B-T121
salts	O	O	I-T121
to	O	O	O
the	O	O	O
formulation	O	O	B-T122
to	O	O	O
attempt	O	O	B-T051
to	O	O	O
mitigate	O	O	B-T067
this	O	O	O
can	O	O	O
impair	O	O	B-T169
matrix	O	O	B-T067
hydration	O	O	I-T067
and	O	O	O
negatively	O	O	B-T033
impact	O	O	B-T080
drug	O	O	B-T070
release	O	O	I-T070
.	O	O	O

An	O	O	O
evaluation	O	O	B-T058
of	O	O	O
the	O	O	O
buffering	O	O	B-T121
of	O	O	O
hydrophilic	O	O	B-T080
matrix	O	O	B-T122
tablets	O	O	I-T122
containing	O	O	O
a	O	O	O
pH	O	O	B-T081
-	O	O	O
dependent	O	O	B-T169
solubility	O	O	B-T080
weak	O	O	B-T121
acid	O	O	I-T121
drug	O	O	I-T121
(	O	O	O
flurbiprofen	O	O	B-T109
)	O	O	O
,	O	O	O
identified	O	O	B-T080
as	O	O	O
possessing	O	O	B-T078
a	O	O	O
deleterious	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
hydroxypropyl	O	O	B-T109
methylcellulose	O	O	I-T109
(	O	O	O
HPMC	O	O	B-T109
)	O	O	O
solubility	O	O	O
,	O	O	O
swelling	O	O	B-T067
and	O	O	O
gelation	O	O	B-T067
,	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
drug	O	O	B-T070
dissolution	O	O	I-T070
and	O	O	O
the	O	O	O
characteristics	O	O	B-T080
of	O	O	O
the	O	O	O
hydrophilic	O	O	O
matrix	O	O	B-T122
gel	O	O	I-T122
layer	O	O	I-T122
in	O	O	O
the	O	O	O
presence	O	O	B-UnknownType
of	O	O	O
tromethamine	O	O	B-T109
as	O	O	O
a	O	O	O
buffer	O	O	B-T121
was	O	O	O
undertaken	O	O	O
.	O	O	O

The	O	O	O
inclusion	O	O	B-T080
of	O	O	O
tromethamine	O	O	B-T109
as	O	O	O
an	O	O	O
alkalizing	O	O	B-T121
agent	O	O	I-T121
afforded	O	O	O
pH	O	O	B-T081
-	O	O	O
independent	O	O	B-T169
flurbiprofen	O	O	B-T109
release	O	O	B-T079
from	O	O	O
matrices	O	O	B-T167
based	O	O	O
on	O	O	O
both	O	O	O
HPMC	O	O	B-T109
2910	O	O	I-T109
(	O	O	I-T109
E	O	O	I-T109
series	O	O	I-T109
)	O	O	I-T109
and	O	O	O
2208	O	O	B-T109
(	O	O	I-T109
K	O	O	I-T109
series	O	O	I-T109
)	O	O	I-T109
,	O	O	O
while	O	O	O
concomitantly	O	O	B-T079
decreasing	O	O	B-T033
the	O	O	O
apparent	O	O	O
critical	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
dissolution	O	O	B-T070
mediated	O	O	B-T054
by	O	O	O
this	O	O	O
drug	O	O	B-T121
with	O	O	O
respect	O	O	O
to	O	O	O
the	O	O	O
early	O	O	O
pseudo-gel	O	O	B-T169
layer	O	O	I-T169
formation	O	O	I-T169
and	O	O	O
functionality	O	O	B-T169
.	O	O	O

Drug	O	O	B-T073
release	O	O	I-T073
profiles	O	O	I-T073
were	O	O	O
unaffected	O	O	B-T077
by	O	O	O
matrix	O	O	B-T167
pH-changes	O	O	B-T033
resulting	O	O	O
from	O	O	O
loss	O	O	B-T081
of	O	O	O
tromethamine	O	O	B-T109
over	O	O	B-T079
time	O	O	I-T079
,	O	O	O
suggesting	O	O	O
that	O	O	O
HPMC	O	O	B-T109
inhibited	O	O	B-T080
precipitation	O	O	B-T070
of	O	O	O
drug	O	O	B-T121
from	O	O	O
supersaturated	O	O	B-T167
solution	O	O	I-T167
in	O	O	O
the	O	O	O
hydrated	O	O	B-T067
matrix	O	O	I-T067
.	O	O	O

We	O	O	O
propose	O	O	O
that	O	O	O
facilitation	O	O	B-T042
of	O	O	O
diffusion-based	O	O	B-T070
release	O	O	B-T079
of	O	O	O
potentially	O	O	O
deleterious	O	O	B-T121
drugs	O	O	I-T121
in	O	O	O
hydrophilic	O	O	B-T080
matrices	O	O	B-T167
may	O	O	O
be	O	O	O
achieved	O	O	O
through	O	O	O
judicious	O	O	O
selection	O	O	O
of	O	O	O
a	O	O	O
buffering	O	O	B-T121
species	O	O	I-T121
.	O	O	O

-DOCSTART- (28299515)

The	O	O	O
influence	O	O	B-T077
of	O	O	O
slope	O	O	B-T082
on	O	O	O
Spartium	O	O	B-T002
junceum	O	O	I-T002
root	O	O	B-T002
system	O	O	I-T002
:	O	O	O
morphological	O	O	B-T080
,	O	O	O
anatomical	O	O	B-T080
and	O	O	O
biomechanical	O	O	B-T080
adaptation	O	O	O

Root	O	O	B-T002
systems	O	O	I-T002
have	O	O	O
a	O	O	O
pivotal	O	O	O
role	O	O	B-T077
in	O	O	O
plant	O	O	B-T002
anchorage	O	O	B-T052
and	O	O	O
their	O	O	O
mechanical	O	O	B-T169
interactions	O	O	I-T169
with	O	O	O
the	O	O	O
soil	O	O	B-T167
may	O	O	O
contribute	O	O	O
to	O	O	O
soil	O	O	O
reinforcement	O	O	B-T169
and	O	O	O
stabilization	O	O	B-T080
of	O	O	O
slide-prone	O	O	B-T082
slopes	O	O	I-T082
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
responses	O	O	B-T032
of	O	O	O
root	O	O	B-T002
system	O	O	I-T002
to	O	O	O
mechanical	O	O	B-T070
stress	O	O	I-T070
induced	O	O	B-T169
by	O	O	O
slope	O	O	B-T082
,	O	O	O
samples	O	O	B-T167
of	O	O	O
Spartium	O	O	B-T002
junceum	O	O	I-T002
L.	O	O	I-T002
,	O	O	O
growing	O	O	B-T169
in	O	O	O
slope	O	O	O
and	O	O	O
in	O	O	O
plane	O	O	B-T082
natural	O	O	B-T169
conditions	O	O	I-T169
,	O	O	O
were	O	O	O
compared	O	O	O
in	O	O	O
their	O	O	O
morphology	O	O	B-T080
,	O	O	O
biomechanical	O	O	B-T080
properties	O	O	I-T080
and	O	O	O
anatomical	O	O	B-T082
features	O	O	I-T082
.	O	O	O

Soils	O	O	B-T167
sampled	O	O	B-T078
in	O	O	O
slope	O	O	B-T082
and	O	O	O
plane	O	O	B-T082
revealed	O	O	O
similar	O	O	O
characteristics	O	O	B-T080
,	O	O	O
with	O	O	O
the	O	O	O
exception	O	O	B-T077
of	O	O	O
organic	O	O	B-T167
matter	O	O	I-T167
content	O	O	B-T077
and	O	O	O
penetrometer	O	O	B-T169
resistance	O	O	I-T169
,	O	O	O
both	O	O	O
higher	O	O	O
in	O	O	O
slope	O	O	O
.	O	O	O

Slope	O	O	B-T082
significantly	O	O	O
influenced	O	O	B-T077
root	O	O	B-T002
morphology	O	O	B-T080
and	O	O	O
in	O	O	O
particular	O	O	O
the	O	O	O
distribution	O	O	B-T169
of	O	O	O
lateral	O	O	B-T082
roots	O	O	B-T002
along	O	O	O
the	O	O	O
soil	O	O	B-T167
depth	O	O	B-T082
.	O	O	O

Indeed	O	O	O
,	O	O	O
first-order	O	O	B-T169
lateral	O	O	B-T082
roots	O	O	B-T002
of	O	O	O
plants	O	O	B-T002
growing	O	O	B-T169
on	O	O	O
slope	O	O	B-T082
condition	O	O	B-T080
showed	O	O	O
an	O	O	O
asymmetric	O	O	B-T082
distribution	O	O	B-T169
between	O	O	O
up-	O	O	B-T082
and	O	O	O
down-slope	O	O	B-T082
.	O	O	O

Contrarily	O	O	O
,	O	O	O
this	O	O	O
asymmetric	O	O	B-T082
distribution	O	O	B-T169
was	O	O	O
not	O	O	O
observed	O	O	O
in	O	O	O
plants	O	O	B-T002
growing	O	O	B-T169
in	O	O	O
plane	O	O	B-T082
.	O	O	O

The	O	O	O
tensile	O	O	B-T081
strength	O	O	I-T081
was	O	O	O
higher	O	O	O
in	O	O	O
lateral	O	O	B-T082
roots	O	O	B-T002
growing	O	O	B-T169
up-slope	O	O	B-T082
and	O	O	O
in	O	O	O
plane	O	O	B-T082
conditions	O	O	B-T080
than	O	O	O
in	O	O	O
those	O	O	O
growing	O	O	O
down-slope	O	O	B-T082
.	O	O	O

Anatomical	O	O	B-T062
investigations	O	O	I-T062
revealed	O	O	O
that	O	O	O
,	O	O	O
while	O	O	O
roots	O	O	B-T002
grown	O	O	O
up-slope	O	O	B-T082
had	O	O	O
higher	O	O	O
area	O	O	B-T082
covered	O	O	O
by	O	O	O
xylem	O	O	B-T002
fibers	O	O	I-T002
,	O	O	O
the	O	O	O
ratio	O	O	B-T081
of	O	O	O
xylem	O	O	O
and	O	O	O
phloem	O	O	B-T002
fibers	O	O	I-T002
to	O	O	O
root	O	O	B-T002
diameter	O	O	B-T081
did	O	O	O
not	O	O	O
differ	O	O	O
among	O	O	O
the	O	O	O
three	O	O	O
conditions	O	O	B-T080
,	O	O	O
as	O	O	O
also	O	O	O
,	O	O	O
no	O	O	B-T033
differences	O	O	I-T033
were	O	O	O
found	O	O	O
for	O	O	O
xylem	O	O	B-T002
fiber	O	O	I-T002
cell	O	O	B-T026
wall	O	O	I-T026
thickness	O	O	B-T080
.	O	O	O

Roots	O	O	B-T002
growing	O	O	B-T169
up-slope	O	O	B-T082
were	O	O	O
the	O	O	O
main	O	O	O
contributors	O	O	O
to	O	O	O
anchorage	O	O	B-T052
properties	O	O	B-T080
,	O	O	O
which	O	O	O
included	O	O	O
higher	O	O	O
strength	O	O	B-T081
and	O	O	O
higher	O	O	O
number	O	O	O
of	O	O	O
fibers	O	O	B-T002
in	O	O	O
the	O	O	O
xylematic	O	O	B-T002
tissues	O	O	B-T025
.	O	O	O

Results	O	O	O
suggested	O	O	O
that	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
root	O	O	B-T002
-	O	O	O
specific	O	O	B-T080
morphological	O	O	B-T080
,	O	O	O
anatomical	O	O	B-T080
and	O	O	O
biomechanical	O	O	B-T080
traits	O	O	B-T032
,	O	O	O
determines	O	O	O
anchorage	O	O	B-T052
functions	O	O	B-T169
in	O	O	O
slope	O	O	B-T082
conditions	O	O	B-T080
.	O	O	O

-DOCSTART- (28299817)

Altered	O	O	O
expression	O	O	B-T045
of	O	O	O
the	O	O	O
Olr59	O	O	B-T028
,	O	O	O
Ethe1	O	O	B-T028
,	O	O	O
and	O	O	O
Slc10a2	O	O	B-T028
genes	O	O	I-T028
in	O	O	O
the	O	O	O
liver	O	O	B-T023
of	O	O	O
F344	O	O	B-T015
rats	O	O	I-T015
by	O	O	O
neonatal	O	O	B-T100
thyroid	O	O	O
hormone	O	O	O
disruption	O	O	O

Many	O	O	O
concerns	O	O	O
have	O	O	O
been	O	O	O
expressed	O	O	O
regarding	O	O	O
the	O	O	O
possible	O	O	O
adverse	O	O	O
effects	O	O	O
of	O	O	O
thyroid	O	O	B-T037
hormone-disrupting	O	O	I-T037
chemicals	O	O	B-T131
in	O	O	O
the	O	O	O
environment	O	O	B-T082
.	O	O	O

The	O	O	O
disruption	O	O	B-T037
of	O	O	I-T037
thyroid	O	O	B-T116
hormones	O	O	I-T116
in	O	O	O
the	O	O	O
neonatal	O	O	B-T079
period	O	O	I-T079
may	O	O	O
lead	O	O	O
to	O	O	O
permanent	O	O	B-T080
effects	O	O	I-T080
on	O	O	O
thyroid	O	O	B-T116
hormone	O	O	I-T116
homeostasis	O	O	B-T038
as	O	O	O
well	O	O	O
as	O	O	O
related	O	O	O
developmental	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
as	O	O	O
thyroid	O	O	O
hormones	O	O	O
are	O	O	O
essential	O	O	O
for	O	O	O
regulating	O	O	B-T040
the	O	O	I-T040
growth	O	O	I-T040
and	O	O	O
differentiation	O	O	B-T033
of	O	O	I-T033
many	O	O	I-T033
tissues	O	O	I-T033
.	O	O	O

To	O	O	O
understand	O	O	O
the	O	O	O
long-term	O	O	O
alteration	O	O	O
in	O	O	O
gene	O	O	B-T045
expressions	O	O	I-T045
by	O	O	O
neonatal	O	O	B-T100
administration	O	O	B-T061
of	O	O	I-T061
thyroid	O	O	B-T116
hormone	O	O	I-T116
-like	O	O	O
chemicals	O	O	O
in	O	O	O
general	O	O	O
,	O	O	O
we	O	O	O
identified	O	O	O
genes	O	O	B-T045
whose	O	O	I-T045
expression	O	O	I-T045
was	O	O	O
altered	O	O	B-T169
in	O	O	O
the	O	O	O
liver	O	O	B-T023
,	O	O	O
an	O	O	O
important	O	O	O
component	O	O	O
of	O	O	O
the	O	O	O
thyroid	O	O	O
hormone	O	O	O
axis	O	O	O
,	O	O	O
by	O	O	O
neonatal	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
triiodothyronine	O	O	B-T116
(	O	O	O
T3	O	O	B-T116
)	O	O	O
.	O	O	O

T3	O	O	B-T116
was	O	O	O
administered	O	O	B-T061
to	O	O	O
male	O	O	B-T015
F344	O	O	I-T015
rats	O	O	I-T015
on	O	O	O
postnatal	O	O	B-T079
days	O	O	I-T079
1	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
and	O	O	O
5	O	O	O
(	O	O	O
week	O	O	O
0	O	O	O
)	O	O	O
.	O	O	O

At	O	O	O
8	O	O	O
weeks	O	O	O
of	O	O	O
age	O	O	O
,	O	O	O
cDNA	O	O	B-T062
microarray	O	O	I-T062
analysis	O	O	I-T062
was	O	O	O
used	O	O	O
to	O	O	O
identify	O	O	O
hepatic	O	O	B-T029
genes	O	O	B-T028
whose	O	O	O
expression	O	O	B-T045
was	O	O	O
altered	O	O	O
by	O	O	O
neonatal	O	O	B-T100
exposure	O	O	B-T080
to	O	O	I-T080
T3	O	O	B-T116
.	O	O	O

Among	O	O	O
the	O	O	O
up-regulated	O	O	B-T044
genes	O	O	I-T044
that	O	O	O
were	O	O	O
identified	O	O	O
,	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
Olr59	O	O	B-T028
,	O	O	O
Ethe1	O	O	B-T028
,	O	O	O
and	O	O	O
Slc10a2	O	O	B-T028
increased	O	O	O
specifically	O	O	O
in	O	O	O
rats	O	O	B-T015
neonatally	O	O	B-T100
exposed	O	O	B-T080
to	O	O	I-T080
T3	O	O	B-T116
.	O	O	O

Interestingly	O	O	O
,	O	O	O
altered	O	O	O
hepatic	O	O	B-T029
expression	O	O	B-T045
of	O	O	I-T045
these	O	O	I-T045
genes	O	O	I-T045
indeed	O	O	O
increased	O	O	O
when	O	O	O
a	O	O	O
hydroxylated	O	O	B-T109
polybrominated	O	O	I-T109
diphenyl	O	O	I-T109
ether	O	O	I-T109
(	O	O	O
PBDE	O	O	B-T109
)	O	O	O
,	O	O	O
OH-BDE42	O	O	B-T109
,	O	O	O
which	O	O	O
is	O	O	O
capable	O	O	O
of	O	O	O
binding	O	O	B-T044
to	O	O	I-T044
the	O	O	I-T044
TR	O	O	I-T044
,	O	O	O
was	O	O	O
given	O	O	O
neonatally	O	O	B-T100
.	O	O	O

Our	O	O	O
data	O	O	O
demonstrated	O	O	O
that	O	O	O
neonatal	O	O	B-T100
exposure	O	O	O
to	O	O	O
thyroid	O	O	B-T116
hormones	O	O	I-T116
could	O	O	O
affect	O	O	O
the	O	O	O
long-term	O	O	O
expression	O	O	B-T045
of	O	O	I-T045
the	O	O	I-T045
genes	O	O	I-T045
,	O	O	O
which	O	O	O
could	O	O	O
be	O	O	O
useful	O	O	O
markers	O	O	O
for	O	O	O
neonatal	O	O	B-T047
effects	O	O	I-T047
by	O	O	O
thyroid	O	O	B-T116
hormone	O	O	I-T116
-	O	O	O
disrupting	O	O	B-T131
chemicals	O	O	I-T131
.	O	O	O

Copyright	O	O	O
©	O	O	O
2017	O	O	O
John	O	O	O
Wiley	O	O	O
&	O	O	O
Sons	O	O	O
,	O	O	O
Ltd.	O	O	O

-DOCSTART- (28300431)

The	O	O	O
Psychometric	O	O	B-T060
Costs	O	O	I-T060
of	O	O	O
Applicants	O	O	B-T098
'	O	O	O
Faking	O	O	B-T055
:	O	O	O
Examining	O	O	O
Measurement	O	O	B-T169
Invariance	O	O	O
and	O	O	O
Retest	O	O	B-T062
Correlations	O	O	I-T062
Across	O	O	O
Response	O	O	O
Conditions	O	O	O

This	O	O	O
study	O	O	O
examines	O	O	B-T080
the	O	O	I-T080
stability	O	O	I-T080
of	O	O	O
the	O	O	O
response	O	O	B-T041
process	O	O	I-T041
and	O	O	O
the	O	O	O
rank-order	O	O	B-T062
of	O	O	O
respondents	O	O	B-T098
responding	O	O	B-T041
to	O	O	O
3	O	O	O
personality	O	O	B-T170
scales	O	O	I-T170
in	O	O	O
4	O	O	O
different	O	O	O
response	O	O	B-T041
conditions	O	O	I-T041
.	O	O	O

Applicants	O	O	B-T098
to	O	O	O
the	O	O	O
University	O	O	B-T073
College	O	O	I-T073
of	O	O	I-T073
Teacher	O	O	I-T073
Education	O	O	I-T073
Styria	O	O	B-T083
(	O	O	O
N	O	O	O
=	O	O	O
243	O	O	O
)	O	O	O
completed	O	O	O
personality	O	O	B-T170
scales	O	O	I-T170
as	O	O	O
part	O	O	O
of	O	O	O
their	O	O	O
college	O	O	B-T170
admission	O	O	I-T170
process	O	O	I-T170
.	O	O	O

Half	O	O	O
a	O	O	O
year	O	O	O
later	O	O	O
,	O	O	O
they	O	O	O
retook	O	O	O
the	O	O	O
same	O	O	O
personality	O	O	B-T170
scales	O	O	I-T170
in	O	O	O
1	O	O	O
of	O	O	O
3	O	O	O
randomly	O	O	B-UnknownType
assigned	O	O	I-UnknownType
experimental	O	O	O
response	O	O	B-T041
conditions	O	O	I-T041
:	O	O	O
honest	O	O	B-T055
,	O	O	O
faking-good	O	O	B-T055
,	O	O	O
or	O	O	O
reproduce	O	O	O
.	O	O	O

Longitudinal	O	O	B-T062
means	O	O	I-T062
and	O	O	O
covariance	O	O	B-T081
structure	O	O	I-T081
analyses	O	O	I-T081
showed	O	O	O
that	O	O	O
applicants	O	O	B-T098
'	O	O	O
response	O	O	B-T041
processes	O	O	I-T041
could	O	O	O
be	O	O	O
partially	O	O	O
reproduced	O	O	O
after	O	O	O
half	O	O	O
a	O	O	O
year	O	O	O
,	O	O	O
and	O	O	O
respondents	O	O	B-T098
seemed	O	O	O
to	O	O	O
rely	O	O	O
on	O	O	O
an	O	O	O
honest	O	O	B-T055
response	O	O	B-T041
behavior	O	O	I-T041
as	O	O	O
a	O	O	O
frame	O	O	B-T077
of	O	O	I-T077
reference	O	O	I-T077
.	O	O	O

Additionally	O	O	O
,	O	O	O
applicants	O	O	B-T098
'	O	O	O
faking	O	O	B-T055
behavior	O	O	I-T055
and	O	O	O
instructed	O	O	O
faking	O	O	O
(	O	O	O
faking-good	O	O	B-T055
)	O	O	O
caused	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
latent	O	O	B-T080
retest	O	O	B-T062
correlations	O	O	I-T062
and	O	O	O
consistently	O	O	O
affected	O	O	O
measurement	O	O	B-T169
properties	O	O	O
.	O	O	O

The	O	O	O
varying	O	O	O
latent	O	O	B-T080
retest	O	O	B-T062
correlations	O	O	I-T062
indicated	O	O	B-T033
that	O	O	O
faking	O	O	B-T055
can	O	O	O
distort	O	O	B-T169
respondents	O	O	B-T098
'	O	O	O
rank-order	O	O	B-T062
and	O	O	O
thus	O	O	O
the	O	O	O
fairness	O	O	B-T080
of	O	O	O
subsequent	O	O	O
selection	O	O	B-T041
decisions	O	O	I-T041
,	O	O	O
depending	O	O	O
on	O	O	O
the	O	O	O
kind	O	O	O
of	O	O	O
faking	O	O	B-T055
behavior	O	O	I-T055
.	O	O	O

Instructed	O	O	O
faking	O	O	B-T055
(	O	O	O
faking-good	O	O	B-T055
)	O	O	O
even	O	O	O
affected	O	O	O
weak	O	O	O
measurement	O	O	B-T169
invariance	O	O	O
,	O	O	O
whereas	O	O	O
applicants	O	O	B-T098
'	O	O	O
faking	O	O	B-T055
behavior	O	O	I-T055
did	O	O	O
not	O	O	O
.	O	O	O

Consequently	O	O	O
,	O	O	O
correlations	O	O	B-T080
with	O	O	O
personality	O	O	B-T170
scales	O	O	I-T170
-which	O	O	O
can	O	O	O
be	O	O	O
utilized	O	O	O
for	O	O	O
predictive	O	O	B-T080
validity	O	O	I-T080
-may	O	O	O
be	O	O	O
readily	O	O	O
interpreted	O	O	B-T169
for	O	O	O
applicants	O	O	B-T098
.	O	O	O

Faking	O	O	B-T055
behavior	O	O	I-T055
also	O	O	O
introduced	O	O	O
a	O	O	O
uniform	O	O	B-T078
bias	O	O	I-T078
,	O	O	O
implying	O	O	O
that	O	O	O
the	O	O	O
classically	O	O	O
observed	O	O	O
mean	O	O	B-T081
raw	O	O	I-T081
score	O	O	I-T081
differences	O	O	O
may	O	O	O
not	O	O	O
be	O	O	O
readily	O	O	O
interpreted	O	O	B-T169
.	O	O	O

-DOCSTART- (28303067)

Intraspinal	O	O	B-T191
meningioma	O	O	I-T191
with	O	O	O
malignant	O	O	B-T191
transformation	O	O	I-T191
and	O	O	O
distant	O	O	O
metastasis	O	O	O

Meningioma	O	O	B-T191
is	O	O	O
typically	O	O	O
considered	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
benign	O	O	B-T191
tumor	O	O	I-T191
.	O	O	O

Malignant	O	O	B-T191
transformation	O	O	I-T191
and	O	O	O
metastasis	O	O	B-T191
of	O	O	O
meningiomas	O	O	B-T191
are	O	O	O
rare	O	O	B-T080
.	O	O	O

Moreover	O	O	O
,	O	O	O
most	O	O	O
meningiomas	O	O	B-T191
are	O	O	O
intracranial	O	O	B-T029
,	O	O	O
and	O	O	O
there	O	O	O
are	O	O	O
few	O	O	O
reports	O	O	B-T170
on	O	O	O
intraspinal	O	O	B-T191
meningiomas	O	O	I-T191
.	O	O	O

This	O	O	O
report	O	O	B-T170
aimed	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
clinical	O	O	B-T201
features	O	O	I-T201
and	O	O	O
pathological	O	O	B-T169
findings	O	O	B-T033
of	O	O	O
a	O	O	O
case	O	O	B-T077
of	O	O	O
malignant	O	O	B-T191
transformation	O	O	I-T191
and	O	O	O
distant	O	O	B-T185
metastasis	O	O	I-T185
of	O	O	O
intraspinal	O	O	B-T191
meningioma	O	O	I-T191
,	O	O	O
with	O	O	O
a	O	O	O
review	O	O	B-T169
of	O	O	I-T169
the	O	O	O
literature	O	O	B-T170
.	O	O	O

A	O	O	O
44-year-old	O	O	O
man	O	O	B-T098
with	O	O	O
a	O	O	O
bilateral	O	O	B-T082
lower	O	O	B-T184
limb	O	O	I-T184
paresis	O	O	I-T184
was	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
an	O	O	O
intradural	O	O	B-T191
extramedullary	O	O	I-T191
tumor	O	O	I-T191
of	O	O	I-T191
the	O	O	I-T191
thoracic	O	O	I-T191
spine	O	O	I-T191
.	O	O	O

Primary	O	O	B-T080
tumor	O	O	B-T061
resection	O	O	I-T061
was	O	O	O
performed	O	O	B-T169
,	O	O	O
and	O	O	O
the	O	O	O
histological	O	O	B-T033
findings	O	O	I-T033
revealed	O	O	O
atypical	O	O	B-T191
meningioma	O	O	I-T191
.	O	O	O

The	O	O	O
meningioma	O	O	B-T191
recurred	O	O	B-T067
2	O	O	O
years	O	O	B-T079
after	O	O	O
the	O	O	O
primary	O	O	B-T080
surgery	O	O	B-T061
,	O	O	O
and	O	O	O
a	O	O	O
second	O	O	B-T081
resection	O	O	B-T061
was	O	O	O
performed	O	O	B-T169
,	O	O	O
but	O	O	O
only	O	O	O
partial	O	O	B-T081
resection	O	O	O
was	O	O	O
possible	O	O	O
because	O	O	O
of	O	O	O
decreased	O	O	B-T081
motor	O	O	B-T042
evoked	O	O	I-T042
potential	O	O	I-T042
.	O	O	O

At	O	O	O
age	O	O	B-T032
48	O	O	O
,	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
lower	O	O	B-T184
limb	O	O	I-T184
weakness	O	O	I-T184
returned	O	O	B-T067
,	O	O	O
and	O	O	O
a	O	O	O
third	O	O	B-T081
resection	O	O	B-T061
was	O	O	O
performed	O	O	B-T169
,	O	O	O
and	O	O	O
the	O	O	O
histological	O	O	B-T033
finding	O	O	I-T033
remained	O	O	O
atypical	O	O	B-T191
meningioma	O	O	I-T191
.	O	O	O

At	O	O	O
age	O	O	B-T032
54	O	O	O
,	O	O	O
the	O	O	O
tumor	O	O	B-T191
increased	O	O	B-T081
and	O	O	O
stereotactic	O	O	B-T061
irradiation	O	O	I-T061
was	O	O	O
performed	O	O	B-T169
.	O	O	O

At	O	O	O
age	O	O	B-T032
60	O	O	O
,	O	O	O
the	O	O	O
patient	O	O	B-T101
was	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
metastatic	O	O	B-T191
tumors	O	O	I-T191
of	O	O	O
the	O	O	O
rib	O	O	B-T023
,	O	O	O
lumbar	O	O	B-T023
vertebra	O	O	I-T023
,	O	O	O
cervical	O	O	B-T023
spine	O	O	I-T023
,	O	O	O
and	O	O	O
sacrum	O	O	B-T023
.	O	O	O

Biopsy	O	O	B-T060
of	O	O	O
the	O	O	O
rib	O	O	B-T023
metastatic	O	O	B-T191
tumor	O	O	I-T191
was	O	O	O
performed	O	O	B-T169
,	O	O	O
and	O	O	O
the	O	O	O
histological	O	O	B-T033
findings	O	O	I-T033
revealed	O	O	O
anaplastic	O	O	B-T191
meningioma	O	O	I-T191
.	O	O	O

This	O	O	O
case	O	O	B-T077
is	O	O	O
the	O	O	O
first	O	O	O
report	O	O	B-T170
of	O	O	O
an	O	O	O
intraspinal	O	O	B-T191
meningioma	O	O	I-T191
that	O	O	O
transformed	O	O	B-T191
from	O	O	O
atypical	O	O	B-T191
to	O	O	O
anaplastic	O	O	B-T191
meningioma	O	O	I-T191
with	O	O	O
distant	O	O	B-T185
hematogenous	O	O	B-T033
metastasis	O	O	I-T185
.	O	O	O

-DOCSTART- (28303341)

Epidemiology	O	O	B-T091
and	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
associated	O	O	B-T080
with	O	O	I-T080
surgical	O	O	B-T046
site	O	O	I-T046
infection	O	O	I-T046
after	O	O	O
different	O	O	O
types	O	O	B-T080
of	O	O	O
hepatobiliary	O	O	O
and	O	O	O
pancreatic	O	O	O
surgery	O	O	O

Surgical	O	O	B-T046
site	O	O	I-T046
infection	O	O	I-T046
(	O	O	O
SSI	O	O	B-T046
)	O	O	O
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
healthcare-associated	O	O	B-T046
infections	O	O	I-T046
(	O	O	O
HAIs	O	O	B-T046
)	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
SSI	O	O	O
after	O	O	O
hepatobiliary	O	O	B-T091
and	O	O	I-T091
pancreatic	O	O	I-T091
surgery	O	O	I-T091
(	O	O	O
HBPS	O	O	B-T091
)	O	O	O
has	O	O	O
not	O	O	O
been	O	O	O
well	O	O	O
investigated	O	O	B-T169
in	O	O	O
a	O	O	O
large	O	O	B-T081
cohort	O	O	B-T098
of	O	O	O
patients	O	O	B-T101
.	O	O	O

This	O	O	O
study	O	O	O
analyzed	O	O	O
the	O	O	O
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
SSI	O	O	B-T046
following	O	O	O
HBPS	O	O	B-T091
in	O	O	O
Japan	O	O	B-T083
,	O	O	O
using	O	O	O
a	O	O	O
Japanese	O	O	B-T170
national	O	O	I-T170
database	O	O	I-T170
.	O	O	O

Data	O	O	B-T078
on	O	O	O
HBPS	O	O	B-T091
performed	O	O	B-T169
between	O	O	O
2012	O	O	O
and	O	O	O
2014	O	O	O
were	O	O	O
extracted	O	O	B-T062
from	O	O	O
a	O	O	O
national	O	O	B-T170
monitoring	O	O	I-T170
system	O	O	I-T170
for	O	O	O
HAI	O	O	B-T046
:	O	O	O
The	O	O	O
Japan	O	O	B-T061
Nosocomial	O	O	I-T061
Infections	O	O	I-T061
Surveillance	O	O	I-T061
.	O	O	O

Using	O	O	O
multivariate	O	O	B-T062
logistic	O	O	I-T062
regression	O	O	I-T062
,	O	O	O
I	O	O	O
assessed	O	O	B-T052
the	O	O	O
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
SSI	O	O	B-T046
.	O	O	O

The	O	O	O
cumulative	O	O	B-T080
incidence	O	O	B-T081
of	O	O	O
SSI	O	O	B-T046
following	O	O	O
HBPS	O	O	B-T091
was	O	O	O
15.6	O	O	O
%	O	O	O
(	O	O	O
2873/18,398	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
of	O	O	O
SSI	O	O	B-T046
after	O	O	O
pancreatoduodenectomy	O	O	B-T061
was	O	O	O
28.0	O	O	O
%	O	O	O
,	O	O	O
which	O	O	O
was	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
than	O	O	O
that	O	O	O
after	O	O	O
liver	O	O	B-T061
resection	O	O	I-T061
and	O	O	O
other	O	O	O
types	O	O	B-T080
of	O	O	O
HBPS	O	O	B-T091
(	O	O	O
8.8	O	O	O
and	O	O	O
15.5	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Among	O	O	O
the	O	O	O
four	O	O	O
traditional	O	O	B-T169
risk	O	O	B-T033
factors	O	O	I-T033
,	O	O	O
the	O	O	O
American	O	O	B-T094
Society	O	O	I-T094
of	O	O	I-T094
Anesthesiologists	O	O	I-T094
score	O	O	B-T081
was	O	O	O
ineffective	O	O	B-T078
for	O	O	O
predicting	O	O	B-T078
SSI	O	O	B-T046
in	O	O	O
the	O	O	O
final	O	O	O
model	O	O	B-T170
of	O	O	O
all	O	O	O
three	O	O	O
types	O	O	B-T080
of	O	O	O
surgery	O	O	B-T061
.	O	O	O

Additional	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
were	O	O	O
identified	O	O	B-T080
,	O	O	O
including	O	O	O
age	O	O	B-T032
and	O	O	O
male	O	O	B-T032
gender	O	O	I-T032
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
of	O	O	O
and	O	O	O
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
SSI	O	O	B-T046
after	O	O	O
the	O	O	O
three	O	O	O
types	O	O	B-T080
of	O	O	O
HBPS	O	O	B-T091
analyzed	O	O	O
differed	O	O	O
significantly	O	O	O
.	O	O	O

To	O	O	O
accurately	O	O	B-T080
compare	O	O	B-T052
hospital	O	O	B-T093
performance	O	O	B-T080
in	O	O	O
relation	O	O	B-T080
to	O	O	O
SSI	O	O	B-T046
following	O	O	O
HBPS	O	O	B-T091
,	O	O	O
the	O	O	O
operative	O	O	B-T061
procedure	O	O	I-T061
category	O	O	B-T170
in	O	O	O
the	O	O	O
surveillance	O	O	B-T058
system	O	O	I-T058
must	O	O	O
be	O	O	O
divided	O	O	B-T169
into	O	O	O
three	O	O	O
types	O	O	B-T080
.	O	O	O

-DOCSTART- (28303942)

Signature	O	O	B-T087
of	O	O	O
an	O	O	O
aggregation	O	O	B-T169
-	O	O	O
prone	O	O	B-T082
conformation	O	O	O
of	O	O	O
tau	O	O	O

The	O	O	O
self-assembly	O	O	B-T044
of	O	O	O
the	O	O	O
microtubule	O	O	B-T026
associated	O	O	B-T080
tau	O	O	B-T116
protein	O	O	I-T116
into	O	O	O
fibrillar	O	O	B-T026
cell	O	O	I-T026
inclusions	O	O	I-T026
is	O	O	O
linked	O	O	B-T082
to	O	O	O
a	O	O	O
number	O	O	B-T081
of	O	O	O
devastating	O	O	O
neurodegenerative	O	O	B-T047
disorders	O	O	I-T047
collectively	O	O	O
known	O	O	O
as	O	O	O
tauopathies	O	O	B-T047
.	O	O	O

The	O	O	O
mechanism	O	O	B-T169
by	O	O	O
which	O	O	O
tau	O	O	B-T116
self-assembles	O	O	B-T044
into	O	O	O
pathological	O	O	B-T169
entities	O	O	B-T071
is	O	O	O
a	O	O	O
matter	O	O	O
of	O	O	O
much	O	O	O
debate	O	O	B-T052
,	O	O	O
largely	O	O	B-T081
due	O	O	B-T169
to	O	O	I-T169
the	O	O	O
lack	O	O	O
of	O	O	O
direct	O	O	B-T080
experimental	O	O	B-T080
insights	O	O	B-T041
into	O	O	O
the	O	O	O
earliest	O	O	B-T079
stages	O	O	I-T079
of	O	O	O
aggregation	O	O	B-T169
.	O	O	O

We	O	O	O
present	O	O	O
pulsed	O	O	B-T059
double	O	O	I-T059
electron-electron	O	O	I-T059
resonance	O	O	I-T059
measurements	O	O	B-T169
of	O	O	O
two	O	O	O
key	O	O	O
fibril	O	O	B-T026
-	O	O	O
forming	O	O	B-T169
regions	O	O	B-T082
of	O	O	O
tau	O	O	B-T116
,	O	O	O
PHF6	O	O	B-T116
and	O	O	O
PHF6	O	O	B-T116
*	O	O	I-T116
,	O	O	O
in	O	O	O
transient	O	O	B-T079
as	O	O	O
aggregation	O	O	B-T169
happens	O	O	O
.	O	O	O

By	O	O	O
monitoring	O	O	O
the	O	O	O
end-to-end	O	O	B-T081
distance	O	O	I-T081
distribution	O	O	B-T169
of	O	O	O
these	O	O	O
segments	O	O	O
as	O	O	O
a	O	O	O
function	O	O	B-T169
of	O	O	O
aggregation	O	O	B-T169
time	O	O	B-T079
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
PHF6	O	O	B-T116
(	O	O	I-T116
(	O	O	I-T116
*	O	O	I-T116
)	O	O	I-T116
)	O	O	I-T116
regions	O	O	B-T082
dramatically	O	O	O
extend	O	O	B-T169
to	O	O	O
distances	O	O	B-T081
commensurate	O	O	B-T080
with	O	O	O
extended	O	O	B-T082
β-strand	O	O	B-T082
structures	O	O	I-T082
within	O	O	O
the	O	O	O
earliest	O	O	B-T079
stages	O	O	I-T079
of	O	O	O
aggregation	O	O	O
,	O	O	O
well	O	O	O
before	O	O	O
fibril	O	O	B-T026
formation	O	O	B-T169
.	O	O	O

Combined	O	O	B-T080
with	O	O	O
simulations	O	O	B-T062
,	O	O	O
our	O	O	O
experiments	O	O	B-T062
show	O	O	O
that	O	O	O
the	O	O	O
extended	O	O	B-T082
β-strand	O	O	B-T082
conformational	O	O	I-T082
state	O	O	B-T169
of	O	O	O
PHF6	O	O	B-T116
(	O	O	I-T116
(	O	O	I-T116
*	O	O	I-T116
)	O	O	I-T116
)	O	O	I-T116
is	O	O	O
readily	O	O	O
populated	O	O	O
under	O	O	O
aggregating	O	O	B-T169
conditions	O	O	B-T080
,	O	O	O
constituting	O	O	O
a	O	O	O
defining	O	O	O
signature	O	O	B-T087
of	O	O	O
aggregation	O	O	B-T169
-	O	O	O
prone	O	O	B-T082
tau	O	O	B-T116
,	O	O	O
and	O	O	O
as	O	O	O
such	O	O	O
,	O	O	O
a	O	O	O
possible	O	O	O
target	O	O	B-T169
for	O	O	O
therapeutic	O	O	B-T061
interventions	O	O	I-T061
.	O	O	O

-DOCSTART- (28304102)

Design	O	O	B-T052
,	O	O	O
Synthesis	O	O	B-T070
,	O	O	O
and	O	O	O
Cytotoxic	O	O	B-T049
Evaluation	O	O	B-T058
of	O	O	O
Certain	O	O	O
7-Chloro-4-(piperazin-1-yl)quinoline	O	O	B-T109
Derivatives	O	O	B-T104
as	O	O	O
VEGFR-II	O	O	B-T116
Inhibitors	O	O	O

Signaling	O	O	B-T044
pathway	O	O	I-T044
inhibition	O	O	B-T052
of	O	O	O
VEGFR-II	O	O	B-T116
is	O	O	O
visualized	O	O	O
as	O	O	O
valuable	O	O	O
tool	O	O	O
in	O	O	O
cancer	O	O	B-T191
management	O	O	B-T058
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	B-T062
study	O	O	I-T062
,	O	O	O
the	O	O	O
synthesis	O	O	B-T070
of	O	O	O
novel	O	O	B-T080
1	O	O	B-T109
-	O	O	I-T109
4-(7-chloroquinolin-4-yl)piperazin-1-yl)-2-(N-substituted-amino)-ethanone	O	O	I-T109
derivatives	O	O	B-T104
(	O	O	O
4a-t	O	O	B-T109
)	O	O	O
was	O	O	O
achieved	O	O	O
through	O	O	O
the	O	O	O
amination	O	O	B-T070
of	O	O	O
2-chloro-1-(4-(7-chloroquinolin-4-yl)piperazin-1-yl)ethanone	O	O	B-T109
(	O	O	I-T109
3	O	O	I-T109
)	O	O	I-T109
with	O	O	O
different	O	O	O
secondary	O	O	O
amines	O	O	O
.	O	O	O

The	O	O	O
structures	O	O	B-T085
of	O	O	O
the	O	O	O
target	O	O	B-T169
compounds	O	O	B-T103
were	O	O	O
confirmed	O	O	B-T080
by	O	O	I-T080
IR	O	O	B-T059
,	O	O	O
(	O	O	B-T060
1	O	O	I-T060
)	O	O	I-T060
H-NMR	O	O	I-T060
,	O	O	O
(	O	O	B-T060
13	O	O	I-T060
)	O	O	I-T060
C-NMR	O	O	I-T060
,	O	O	O
HRMS	O	O	B-T059
,	O	O	O
and	O	O	O
microanalysis	O	O	B-T059
.	O	O	O

Compounds	O	O	B-T103
4a-t	O	O	B-T109
were	O	O	O
subjected	O	O	O
to	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
anticancer	O	O	B-T061
screening	O	O	B-T058
against	O	O	O
human	O	O	B-T191
breast	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
MCF-7	O	O	B-T025
)	O	O	O
and	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
PC3	O	O	B-T025
)	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
.	O	O	O

The	O	O	O
highest	O	O	O
cytotoxicty	O	O	B-T049
against	O	O	O
both	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
was	O	O	O
displayed	O	O	O
by	O	O	O
2-(4-(4-bromobenzyl)piperazin-1-yl)-1-(4-(7-chloroquinolin-4-yl)piperazin-1-yl)ethanone	O	O	B-T109
(	O	O	I-T109
4q	O	O	I-T109
)	O	O	I-T109
,	O	O	O
with	O	O	O
IC50	O	O	B-T081
values	O	O	I-T081
of	O	O	O
6.502	O	O	O
and	O	O	O
11.751	O	O	O
μM	O	O	O
against	O	O	O
MCF-7	O	O	B-T025
and	O	O	O
PC3	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
respectively	O	O	O
,	O	O	O
compared	O	O	B-T052
with	O	O	O
the	O	O	O
standard	O	O	B-T170
drug	O	O	I-T170
doxorubicin	O	O	B-T195
(	O	O	O
MCF-7	O	O	O
:	O	O	O
6.774	O	O	O
μM	O	O	O
,	O	O	O
PC3	O	O	O
:	O	O	O
7.7316	O	O	O
μM	O	O	O
)	O	O	O
.	O	O	O

Due	O	O	O
to	O	O	O
its	O	O	O
notable	O	O	O
activity	O	O	B-T052
toward	O	O	O
MCF-7	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
4q	O	O	B-T109
was	O	O	O
further	O	O	O
evaluated	O	O	O
as	O	O	O
VEGFR-II	O	O	B-T116
inhibitor	O	O	B-T120
,	O	O	O
showing	O	O	O
an	O	O	O
IC50	O	O	B-T081
of	O	O	O
1.38	O	O	O
μM	O	O	O
compared	O	O	O
to	O	O	O
sorafenib	O	O	B-T109
(	O	O	O
0.33	O	O	O
μM	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
docking	O	O	B-T044
study	O	O	O
proved	O	O	O
that	O	O	O
4q	O	O	B-T109
has	O	O	O
a	O	O	O
binding	O	O	B-T044
mode	O	O	I-T044
akin	O	O	O
to	O	O	O
that	O	O	O
of	O	O	O
VEGFR-II	O	O	B-T116
inhibitors	O	O	B-T120
.	O	O	O

-DOCSTART- (28304405)

The	O	O	O
ErbB3	O	O	B-T116
receptor	O	O	I-T116
tyrosine	O	O	I-T116
kinase	O	O	I-T116
negatively	O	O	O
regulates	O	O	B-T038
Paneth	O	O	B-T025
cells	O	O	I-T025
by	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
-	O	O	O
dependent	O	O	B-T169
suppression	O	O	B-T045
of	O	O	O
Atoh1	O	O	O

Paneth	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
PCs	O	O	B-T025
)	O	O	O
,	O	O	O
a	O	O	O
secretory	O	O	B-T025
population	O	O	I-T025
located	O	O	O
at	O	O	O
the	O	O	O
base	O	O	O
of	O	O	O
the	O	O	O
intestinal	O	O	B-T023
crypt	O	O	I-T023
,	O	O	O
support	O	O	O
the	O	O	O
intestinal	O	O	O
stem	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
ISC	O	O	B-T025
)	O	O	O
with	O	O	O
growth	O	O	B-T116
factors	O	O	I-T116
and	O	O	O
participate	O	O	O
in	O	O	O
innate	O	O	B-T032
immunity	O	O	I-T032
by	O	O	O
releasing	O	O	O
antimicrobial	O	O	B-T116
peptides	O	O	I-T116
,	O	O	O
including	O	O	O
lysozyme	O	O	B-T116
and	O	O	O
defensins	O	O	B-T116
.	O	O	O

PC	O	O	B-T025
dysfunction	O	O	B-T077
is	O	O	O
associated	O	O	O
with	O	O	O
disorders	O	O	B-T047
such	O	O	O
as	O	O	O
Crohn	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
necrotizing	O	O	B-T047
enterocolitis	O	O	I-T047
,	O	O	O
but	O	O	O
the	O	O	O
specific	O	O	O
pathways	O	O	B-T044
regulating	O	O	B-T038
PC	O	O	O
development	O	O	B-T043
and	O	O	O
function	O	O	B-T043
are	O	O	O
not	O	O	O
fully	O	O	O
understood	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
tested	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
neuregulin	O	O	B-T116
receptor	O	O	I-T116
ErbB3	O	O	I-T116
in	O	O	O
control	O	O	O
of	O	O	O
PC	O	O	B-T025
differentiation	O	O	B-T043
and	O	O	O
the	O	O	O
ISC	O	O	B-T022
niche	O	O	I-T022
.	O	O	O

Intestinal	O	O	B-T023
epithelial	O	O	B-T080
ErbB3	O	O	B-T028
knockout	O	O	B-T063
caused	O	O	O
precocious	O	O	B-T079
appearance	O	O	B-T080
of	O	O	O
PCs	O	O	B-T025
as	O	O	O
early	O	O	O
as	O	O	O
postnatal	O	O	B-T079
day	O	O	B-T033
7	O	O	I-T033
,	O	O	O
and	O	O	O
substantially	O	O	O
increased	O	O	B-T081
the	O	O	O
number	O	O	O
of	O	O	O
mature	O	O	B-T079
PCs	O	O	O
in	O	O	O
adult	O	O	B-T015
mouse	O	O	I-T015
ileum	O	O	B-T023
.	O	O	O

ErbB3	O	O	B-T116
loss	O	O	O
had	O	O	O
no	O	O	O
effect	O	O	O
on	O	O	O
other	O	O	O
secretory	O	O	B-T078
lineages	O	O	I-T078
,	O	O	O
but	O	O	O
increased	O	O	B-T081
expression	O	O	B-T045
of	O	O	O
the	O	O	O
ISC	O	O	B-T025
marker	O	O	O
Lgr5	O	O	B-T116
.	O	O	O

ErbB3	O	O	B-T116
-null	O	O	O
intestines	O	O	B-T023
had	O	O	O
elevated	O	O	O
levels	O	O	O
of	O	O	O
the	O	O	O
Atoh1	O	O	B-T028
transcription	O	O	B-T116
factor	O	O	I-T116
,	O	O	O
which	O	O	O
is	O	O	O
required	O	O	O
for	O	O	O
secretory	O	O	O
fate	O	O	O
determination	O	O	O
,	O	O	O
while	O	O	O
Atoh1(+	O	O	B-T116
)	O	O	I-T116
cells	O	O	B-T025
had	O	O	O
reduced	O	O	O
ErbB3	O	O	O
,	O	O	O
suggesting	O	O	O
reciprocal	O	O	B-T080
negative	O	O	B-T033
regulation	O	O	B-T038
.	O	O	O

ErbB3	O	O	B-T116
-null	O	O	O
intestinal	O	O	B-T025
progenitor	O	O	I-T025
cells	O	O	I-T025
showed	O	O	O
reduced	O	O	B-T080
activation	O	O	B-T052
of	O	O	O
the	O	O	O
PI3K-Akt	O	O	B-T169
and	O	O	O
ERK	O	O	B-T044
MAPK	O	O	I-T044
pathways	O	O	I-T044
.	O	O	O

Inhibiting	O	O	O
these	O	O	O
pathways	O	O	B-T044
in	O	O	O
HT29	O	O	B-T025
cells	O	O	I-T025
increased	O	O	B-T081
levels	O	O	O
of	O	O	O
ATOH1	O	O	B-T028
and	O	O	O
the	O	O	O
PC	O	O	B-T025
marker	O	O	O
LYZ	O	O	B-T028
.	O	O	O

Conversely	O	O	O
,	O	O	O
ErbB3	O	O	B-T116
activation	O	O	O
suppressed	O	O	B-T045
LYZ	O	O	B-T028
and	O	O	O
ATOH1	O	O	B-T028
in	O	O	O
a	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
-	O	O	O
dependent	O	O	B-T169
manner	O	O	O
.	O	O	O

Expansion	O	O	O
of	O	O	O
the	O	O	O
PC	O	O	B-T025
compartment	O	O	O
in	O	O	O
ErbB3	O	O	B-T116
-null	O	O	O
intestines	O	O	B-T023
was	O	O	O
accompanied	O	O	O
with	O	O	O
elevated	O	O	O
ER	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
inflammation	O	O	B-T046
markers	O	O	B-T201
,	O	O	O
raising	O	O	O
the	O	O	O
possibility	O	O	O
that	O	O	O
negative	O	O	B-T033
regulation	O	O	B-T038
of	O	O	O
PCs	O	O	B-T025
by	O	O	O
ErbB3	O	O	O
is	O	O	O
necessary	O	O	O
to	O	O	O
maintain	O	O	O
homeostasis	O	O	B-T038
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
our	O	O	O
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
ErbB3	O	O	B-T116
restricts	O	O	O
PC	O	O	B-T025
numbers	O	O	O
through	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
-mediated	O	O	O
suppression	O	O	B-T045
of	O	O	O
Atoh1	O	O	B-T028
levels	O	O	O
leading	O	O	O
to	O	O	O
inhibition	O	O	O
of	O	O	O
PC	O	O	O
differentiation	O	O	B-T043
,	O	O	O
with	O	O	O
important	O	O	O
implications	O	O	O
for	O	O	O
regulation	O	O	B-T043
of	O	O	O
the	O	O	O
ISC	O	O	B-T022
niche	O	O	I-T022
.	O	O	O

-DOCSTART- (28306155)

CDF	O	O	B-T081
-	O	O	O
quantile	O	O	B-T081
distributions	O	O	B-T081
for	O	O	O
modelling	O	O	B-T170
random	O	O	B-T081
variables	O	O	I-T081
on	O	O	O
the	O	O	O
unit	O	O	O
interval	O	O	O

This	O	O	O
paper	O	O	O
introduces	O	O	O
a	O	O	O
two-parameter	O	O	B-T077
family	O	O	O
of	O	O	O
distributions	O	O	B-T081
for	O	O	O
modelling	O	O	B-T170
random	O	O	B-T081
variables	O	O	I-T081
on	O	O	O
the	O	O	O
(	O	O	O
0,1	O	O	O
)	O	O	O
interval	O	O	B-T170
by	O	O	O
applying	O	O	O
the	O	O	O
cumulative	O	O	B-T081
distribution	O	O	I-T081
function	O	O	B-T170
of	O	O	O
one	O	O	O
'	O	O	O
parent	O	O	B-T081
'	O	O	I-T081
distribution	O	O	I-T081
to	O	O	O
the	O	O	O
quantile	O	O	B-T081
function	O	O	O
of	O	O	O
another	O	O	O
.	O	O	O

Family	O	O	O
members	O	O	O
have	O	O	O
explicit	O	O	O
probability	O	O	B-T081
density	O	O	I-T081
functions	O	O	B-T170
,	O	O	O
cumulative	O	O	B-T081
distribution	O	O	I-T081
functions	O	O	I-T081
and	O	O	O
quantile	O	O	B-T081
s	O	O	O
in	O	O	O
a	O	O	O
location	O	O	B-T082
parameter	O	O	B-T077
and	O	O	O
a	O	O	O
dispersion	O	O	B-T082
parameter	O	O	O
.	O	O	O

They	O	O	O
capture	O	O	O
a	O	O	O
wide	O	O	O
variety	O	O	B-T077
of	O	O	O
shapes	O	O	B-T082
that	O	O	O
the	O	O	O
beta	O	O	B-T081
and	O	O	O
Kumaraswamy	O	O	B-T081
distributions	O	O	I-T081
can	O	O	B-T033
not	O	O	I-T033
.	O	O	O

They	O	O	O
are	O	O	O
amenable	O	O	B-T080
to	O	O	O
likelihood	O	O	B-T081
inference	O	O	I-T081
,	O	O	O
and	O	O	O
enable	O	O	O
a	O	O	O
wide	O	O	O
variety	O	O	B-T077
of	O	O	O
quantile	O	O	B-T081
regression	O	O	B-T170
models	O	O	I-T170
,	O	O	O
with	O	O	O
predictors	O	O	B-T078
for	O	O	O
both	O	O	O
the	O	O	O
location	O	O	B-T082
and	O	O	O
dispersion	O	O	B-T082
parameters	O	O	B-T077
.	O	O	O

We	O	O	O
demonstrate	O	O	O
their	O	O	O
applicability	O	O	O
to	O	O	O
psychological	O	O	B-T091
research	O	O	B-T062
problems	O	O	I-T062
and	O	O	O
their	O	O	O
utility	O	O	B-T169
in	O	O	O
modelling	O	O	B-T170
real	O	O	B-T170
data	O	O	I-T170
.	O	O	O

-DOCSTART- (28314676)

First	O	O	B-T081
and	O	O	O
second	O	O	B-T081
generation	O	O	B-T079
DESs	O	O	B-T074
reduce	O	O	B-T080
diabetes	O	O	B-T047
adverse	O	O	B-T046
effect	O	O	I-T046
on	O	O	O
mortality	O	O	B-T081
and	O	O	O
re-intervention	O	O	B-T061
in	O	O	O
multivessel	O	O	B-T023
coronary	O	O	B-T047
disease	O	O	I-T047
:	O	O	O
9-	O	O	O
Year	O	O	B-T079
analysis	O	O	O

Diabetes	O	O	B-T047
portends	O	O	B-T169
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
adverse	O	O	B-T046
early	O	O	B-T079
and	O	O	O
late	O	O	B-T079
outcomes	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
PCI	O	O	B-T061
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
if	O	O	O
the	O	O	O
adverse	O	O	B-T046
effect	O	O	I-T046
of	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
(	O	O	O
DM	O	O	B-T047
)	O	O	O
on	O	O	O
early	O	O	B-T079
and	O	O	O
late	O	O	B-T079
PCI	O	O	B-T061
outcomes	O	O	B-T169
is	O	O	O
reduced	O	O	B-T080
with	O	O	O
drug-eluting	O	O	B-T074
(	O	O	O
DES	O	O	B-T074
)	O	O	O
compared	O	O	O
to	O	O	O
bare-metal	O	O	B-T074
(	O	O	I-T074
BMS	O	O	I-T074
)	O	O	I-T074
stents	O	O	I-T074
.	O	O	O

We	O	O	O
reviewed	O	O	B-T078
the	O	O	O
Mount	O	O	B-T093
Sinai	O	O	I-T093
Beth	O	O	I-T093
Israel	O	O	I-T093
Hospital	O	O	I-T093
first	O	O	B-T081
PCI	O	O	B-T061
experience	O	O	O
for	O	O	O
multivessel	O	O	B-T023
coronary	O	O	B-T047
artery	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CAD	O	O	B-T047
,	O	O	O
1998	O	O	O
-	O	O	O
2009	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
excluded	O	O	B-T052
if	O	O	O
they	O	O	O
had	O	O	O
single-vessel	O	O	B-T047
CAD	O	O	I-T047
,	O	O	O
emergency	O	O	B-T078
,	O	O	O
no	O	O	B-T033
stent	O	O	B-T074
,	O	O	O
prior	O	O	B-T079
bypass	O	O	B-T061
graft	O	O	I-T061
or	O	O	O
myocardial	O	O	B-T047
infarction	O	O	I-T047
<	O	O	O
24h	O	O	O
.	O	O	O

Diabetes	O	O	B-T047
-	O	O	O
effect	O	O	B-T080
was	O	O	O
derived	O	O	O
from	O	O	O
9-	O	O	O
year	O	O	B-T079
all-cause	O	O	O
mortality	O	O	B-T081
and	O	O	O
re-intervention	O	O	B-T061
risk-adjusted	O	O	B-T081
hazard	O	O	I-T081
ratios	O	O	I-T081
[	O	O	O
AHR	O	O	B-T081
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
)	O	O	O
]	O	O	O
for	O	O	O
DES	O	O	B-T074
(	O	O	O
N=2679	O	O	O
;	O	O	O
48	O	O	O
%	O	O	O
three-vessel	O	O	B-T047
;	O	O	O
39	O	O	O
%	O	O	O
DM	O	O	B-T047
)	O	O	O
and	O	O	O
BMS	O	O	B-T074
(	O	O	O
N=2651	O	O	O
;	O	O	O
40	O	O	O
%	O	O	O
three-vessel	O	O	O
;	O	O	O
33	O	O	O
%	O	O	O
DM	O	O	O
)	O	O	O
and	O	O	O
then	O	O	O
stratified	O	O	O
based	O	O	O
on	O	O	O
stent	O	O	B-T074
(	O	O	O
DES	O	O	O
/	O	O	O
BMS	O	O	O
)	O	O	O
and	O	O	O
vessel	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
two	O	O	B-T047
/	O	O	O
three	O	O	B-T047
)	O	O	O
.	O	O	O

Diabetes	O	O	B-T047
-	O	O	O
effect	O	O	B-T080
on	O	O	O
mortality	O	O	B-T081
was	O	O	O
lower	O	O	B-T080
for	O	O	O
DES	O	O	B-T074
(	O	O	O
AHRDM/NoDM	O	O	B-T081
=	O	O	O
1.41	O	O	O
[	O	O	O
1.14	O	O	O
-	O	O	O
1.74	O	O	O
]	O	O	O
)	O	O	O
versus	O	O	O
BMS	O	O	B-T074
(	O	O	O
AHRDM/NoDM	O	O	O
=	O	O	O
1.71	O	O	O
[	O	O	O
1.50	O	O	O
-	O	O	O
2.01	O	O	O
]	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
this	O	O	O
was	O	O	O
predominantly	O	O	B-T080
driven	O	O	O
by	O	O	O
two-vessel	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

This	O	O	O
diabetes	O	O	B-T047
effect	O	O	B-T080
was	O	O	O
similar	O	O	O
for	O	O	O
first	O	O	B-T081
(	O	O	O
DES1	O	O	B-T074
:	O	O	O
AHRDM/NoDM	O	O	B-T081
=	O	O	O
1.43	O	O	O
[	O	O	O
1.14	O	O	O
-	O	O	O
1.79	O	O	O
]	O	O	O
)	O	O	O
and	O	O	O
second	O	O	B-T081
(	O	O	O
DES2	O	O	B-T074
:	O	O	O
AHRDM/NoDM	O	O	O
=	O	O	O
1.53	O	O	O
[	O	O	O
0.77	O	O	O
-	O	O	O
3.07	O	O	O
]	O	O	O
)	O	O	O
generation	O	O	B-T079
DES	O	O	B-T074
.	O	O	O

Re-intervention	O	O	B-T061
comparisons	O	O	B-T052
were	O	O	O
similarly	O	O	O
increased	O	O	B-T081
by	O	O	O
diabetes	O	O	B-T047
in	O	O	O
all	O	O	O
sub-cohorts	O	O	B-T098
.	O	O	O

Our	O	O	O
analysis	O	O	B-T062
of	O	O	O
a	O	O	O
large	O	O	O
real-world	O	O	O
PCI	O	O	B-T061
series	O	O	O
indicates	O	O	O
that	O	O	O
diabetes	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
worse	O	O	B-T033
9-	O	O	O
year	O	O	B-T079
mortality	O	O	B-T081
irrespective	O	O	B-T077
of	O	O	O
stent	O	O	B-T074
type	O	O	B-T080
,	O	O	O
albeit	O	O	O
this	O	O	O
is	O	O	O
mitigated	O	O	O
to	O	O	O
varying	O	O	O
degrees	O	O	O
with	O	O	O
DES	O	O	B-T074
,	O	O	O
particularly	O	O	O
in	O	O	O
DES2	O	O	B-T074
and	O	O	O
in	O	O	O
case	O	O	O
of	O	O	O
2-vessel	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

A	O	O	O
complementary	O	O	B-T077
stent	O	O	B-T074
-	O	O	O
effect	O	O	B-T080
analysis	O	O	B-T062
confirmed	O	O	B-T033
DES	O	O	B-T074
-to-	O	O	O
BMS	O	O	B-T074
and	O	O	O
DES2	O	O	B-T074
-to-	O	O	O
DES1	O	O	B-T074
superiority	O	O	B-T080
in	O	O	O
both	O	O	O
diabetics	O	O	B-T033
and	O	O	O
non-diabetics	O	O	B-T033
.	O	O	O

-DOCSTART- (28318092)

Lycopene	O	O	B-T109
and	O	O	O
risk	O	O	B-T078
of	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
:	O	O	O
A	O	O	O
meta-analysis	O	O	B-T062
of	O	O	O
observational	O	O	O
studies	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
current	O	O	O
meta-analysis	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
relation	O	O	O
between	O	O	O
lycopene	O	O	B-T109
and	O	O	O
risk	O	O	B-T078
of	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
(	O	O	O
CVD	O	O	B-T047
)	O	O	O
.	O	O	O

Studies	O	O	B-T062
concerning	O	O	O
about	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
lycopene	O	O	B-T109
and	O	O	O
risk	O	O	B-T078
of	O	O	O
CVD	O	O	B-T047
were	O	O	O
searched	O	O	O
on	O	O	O
Pubmed	O	O	B-T170
,	O	O	O
Embase	O	O	B-T170
,	O	O	O
and	O	O	O
Web	O	O	B-T170
of	O	O	I-T170
Science	O	O	I-T170
from	O	O	O
inception	O	O	O
to	O	O	O
October	O	O	O
2016	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
14	O	O	O
eligible	O	O	B-T062
studies	O	O	I-T062
were	O	O	O
identified	O	O	B-T080
.	O	O	O

A	O	O	O
significantly	O	O	O
inverse	O	O	B-T077
association	O	O	I-T077
with	O	O	O
a	O	O	O
pooled	O	O	O
risk	O	O	B-T078
ratio	O	O	I-T081
(	O	O	O
RR	O	O	B-T081
)	O	O	O
of	O	O	O
0.83	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.76	O	O	O
-	O	O	O
0.90	O	O	O
)	O	O	O
was	O	O	O
shown	O	O	O
between	O	O	O
lycopene	O	O	B-T109
exposure	O	O	B-T080
and	O	O	O
risk	O	O	O
of	O	O	O
CVD	O	O	B-T047
.	O	O	O

Findings	O	O	B-T033
were	O	O	O
similar	O	O	O
restricting	O	O	O
to	O	O	O
dietary	O	O	B-T168
studies	O	O	B-T062
(	O	O	O
RR	O	O	B-T081
=	O	O	O
0.87	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
0.79	O	O	O
-	O	O	O
0.96	O	O	O
)	O	O	O
and	O	O	O
biomarker	O	O	B-T201
studies	O	O	O
(	O	O	O
RR	O	O	O
=	O	O	O
0.74	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
0	O	O	O
.	O	O	O
62	O	O	O
-	O	O	O
0.87	O	O	O
)	O	O	O
.	O	O	O

Dietary	O	O	B-T168
lycopene	O	O	B-T109
intake	O	O	B-T169
was	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
for	O	O	O
coronary	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CHD	O	O	B-T047
)	O	O	O
(	O	O	O
RR	O	O	B-T081
:	O	O	O
0.87	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.76	O	O	O
-	O	O	O
0.98	O	O	O
)	O	O	O
and	O	O	O
stroke	O	O	B-T047
(	O	O	O
RR	O	O	O
:	O	O	O
0.83	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.69	O	O	O
-	O	O	O
0.96).The	O	O	O
pooled	O	O	O
risk	O	O	B-T081
estimate	O	O	I-T081
was	O	O	O
generally	O	O	O
similar	O	O	O
for	O	O	O
lycopene	O	O	O
biomarker	O	O	B-T201
concentrations	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
association	O	O	O
was	O	O	O
only	O	O	O
statistically	O	O	O
significant	O	O	O
for	O	O	O
stroke	O	O	O
(	O	O	O
RR	O	O	O
:	O	O	O
0.65	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.42	O	O	O
-	O	O	O
0.87	O	O	O
)	O	O	O
.	O	O	O

Subgroup	O	O	B-T185
analyses	O	O	B-T062
showed	O	O	O
that	O	O	O
retrospective	O	O	B-T062
and	O	O	O
low	O	O	O
quality	O	O	O
studies	O	O	B-T062
were	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
sources	O	O	O
of	O	O	O
heterogeneity	O	O	B-T080
.	O	O	O

Higher	O	O	O
lycopene	O	O	B-T109
exposure	O	O	B-T080
is	O	O	O
inversely	O	O	B-T077
associated	O	O	I-T077
with	O	O	O
a	O	O	O
lower	O	O	O
risk	O	O	B-T078
of	O	O	O
CVD	O	O	B-T047
.	O	O	O

Further	O	O	O
well-designed	O	O	O
randomized	O	O	B-T062
clinical	O	O	I-T062
trials	O	O	I-T062
are	O	O	O
required	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
lycopene	O	O	B-T109
on	O	O	O
CVD	O	O	B-T047
.	O	O	O

-DOCSTART- (28318300)

Bacteria	O	O	B-T007
from	O	O	O
Wheat	O	O	B-T002
and	O	O	O
Cucurbit	O	O	B-T002
Plant	O	O	B-T002
Roots	O	O	I-T002
Metabolize	O	O	B-T040
PAHs	O	O	B-T109
and	O	O	O
Aromatic	O	O	B-T109
Root	O	O	B-T002
Exudates	O	O	B-T167
:	O	O	O
Implications	O	O	B-T078
for	O	O	O
Rhizodegradation	O	O	O

The	O	O	O
chemical	O	O	B-T070
interaction	O	O	I-T070
between	O	O	O
plants	O	O	B-T002
and	O	O	O
bacteria	O	O	B-T007
in	O	O	O
the	O	O	O
root	O	O	B-T002
zone	O	O	B-T082
can	O	O	O
lead	O	O	O
to	O	O	O
soil	O	O	B-T167
decontamination	O	O	B-T169
.	O	O	O

Bacteria	O	O	B-T007
which	O	O	O
degrade	O	O	B-T169
PAHs	O	O	B-T109
have	O	O	O
been	O	O	O
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
rhizospheres	O	O	B-T070
of	O	O	O
plant	O	O	B-T002
species	O	O	B-T185
with	O	O	O
varied	O	O	O
biological	O	O	B-T080
traits	O	O	B-T032
,	O	O	O
however	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
not	O	O	O
known	O	O	O
what	O	O	O
phytochemicals	O	O	B-T109
promote	O	O	O
contaminant	O	O	B-T167
degradation	O	O	B-T169
.	O	O	O

One	O	O	O
monocot	O	O	B-T002
and	O	O	O
two	O	O	O
dicotyledon	O	O	B-T002
plants	O	O	I-T002
were	O	O	O
grown	O	O	B-T040
in	O	O	O
PAH	O	O	B-T109
-	O	O	O
contaminated	O	O	B-T169
soil	O	O	B-T167
from	O	O	O
a	O	O	O
manufactured	O	O	B-T073
gas	O	O	I-T073
plant	O	O	I-T073
(	O	O	O
MGP	O	O	B-T073
)	O	O	O
site	O	O	B-T082
.	O	O	O

A	O	O	O
phytotoxicity	O	O	B-T059
assay	O	O	I-T059
confirmed	O	O	O
greater	O	O	O
soil	O	O	B-T167
decontamination	O	O	B-T169
in	O	O	O
rhizospheres	O	O	B-T070
when	O	O	O
compared	O	O	B-T052
to	O	O	O
bulk	O	O	O
soil	O	O	O
controls	O	O	B-T169
.	O	O	O

Bacteria	O	O	B-T007
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
plant	O	O	B-T002
roots	O	O	I-T002
(	O	O	O
rhizobacteria	O	O	B-T007
)	O	O	O
and	O	O	O
selected	O	O	B-T052
for	O	O	O
growth	O	O	B-T040
on	O	O	O
anthracene	O	O	B-T109
and	O	O	O
chrysene	O	O	B-T109
on	O	O	O
PAH	O	O	B-T109
-	O	O	O
amended	O	O	B-T080
plates	O	O	B-T074
.	O	O	O

Rhizosphere	O	O	B-T070
isolates	O	O	B-T123
metabolized	O	O	B-T040
3-	O	O	O
and	O	O	O
4-ring	O	O	O
PAHs	O	O	B-T109
and	O	O	O
PAH	O	O	B-T109
catabolic	O	O	B-T169
intermediates	O	O	O
in	O	O	O
liquid	O	O	B-T059
incubations	O	O	I-T059
.	O	O	O

Aromatic	O	O	B-T109
root	O	O	B-T002
exudate	O	O	B-T167
compounds	O	O	I-T167
,	O	O	O
namely	O	O	O
flavonoids	O	O	B-T109
and	O	O	O
simple	O	O	B-T109
phenols	O	O	I-T109
,	O	O	O
were	O	O	O
also	O	O	O
substrates	O	O	B-T167
for	O	O	O
isolated	O	O	B-T169
rhizobacteria	O	O	B-T007
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
the	O	O	O
phenolic	O	O	B-T109
compounds	O	O	I-T109
-	O	O	O
morin	O	O	B-T109
,	O	O	O
caffeic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
and	O	O	O
protocatechuic	O	O	B-T109
acid	O	O	I-T109
-	O	O	O
appear	O	O	O
to	O	O	O
be	O	O	O
linked	O	O	O
to	O	O	O
bacterial	O	O	B-T007
degradation	O	O	B-T169
of	O	O	O
3-	O	O	O
and	O	O	O
4-	O	O	O
ring	O	O	O
PAHs	O	O	B-T109
in	O	O	O
the	O	O	O
rhizosphere	O	O	B-T070
.	O	O	O

-DOCSTART- (28319455)

Joint	O	O	B-T081
model	O	O	I-T081
imputation	O	O	I-T081
to	O	O	O
estimate	O	O	B-T081
the	O	O	O
treatment	O	O	B-T033
effect	O	O	I-T033
on	O	O	O
long-term	O	O	B-T079
survival	O	O	B-T052
using	O	O	O
auxiliary	O	O	O
events	O	O	O

Clinical	O	O	B-T062
trial	O	O	I-T062
duration	O	O	B-T079
may	O	O	O
be	O	O	O
a	O	O	O
concern	O	O	O
in	O	O	O
clinical	O	O	B-T062
research	O	O	I-T062
,	O	O	O
especially	O	O	O
in	O	O	O
cancer	O	O	B-T062
trials	O	O	I-T062
where	O	O	O
the	O	O	O
endpoint	O	O	B-T201
is	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
.	O	O	O

A	O	O	O
surrogate	O	O	B-T080
endpoint	O	O	I-T080
can	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
an	O	O	O
auxiliary	O	O	B-T080
variable	O	O	I-T080
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
treatment	O	O	B-T033
effect	O	O	I-T033
earlier	O	O	O
.	O	O	O

At	O	O	O
an	O	O	O
early	O	O	O
time	O	O	O
point	O	O	O
,	O	O	O
the	O	O	O
high	O	O	O
number	O	O	O
of	O	O	O
censored	O	O	B-T052
observations	O	O	B-T062
can	O	O	O
be	O	O	O
compensated	O	O	B-T080
by	O	O	O
the	O	O	O
imputation	O	O	B-T081
of	O	O	O
the	O	O	O
unobserved	O	O	B-T033
deaths	O	O	B-T033
times	O	O	O
.	O	O	O

We	O	O	O
propose	O	O	O
to	O	O	O
use	O	O	O
predictions	O	O	B-T078
of	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
death	O	O	B-T040
from	O	O	O
a	O	O	O
joint	O	O	B-T081
model	O	O	I-T081
for	O	O	O
a	O	O	O
recurrent	O	O	B-T079
event	O	O	B-T051
and	O	O	O
a	O	O	O
terminal	O	O	B-T080
event	O	O	O
,	O	O	O
which	O	O	O
account	O	O	O
for	O	O	O
disease	O	O	B-T047
relapse	O	O	I-T047
information	O	O	B-T078
.	O	O	O

Two	O	O	O
imputation	O	O	B-T081
methods	O	O	I-T081
were	O	O	O
compared	O	O	B-T052
:	O	O	O
sampling	O	O	B-T062
from	O	O	O
the	O	O	O
estimated	O	O	B-T081
parametric	O	O	I-T081
distribution	O	O	I-T081
of	O	O	O
the	O	O	O
survival	O	O	B-T201
time	O	O	I-T201
and	O	O	O
sampling	O	O	O
using	O	O	O
its	O	O	O
nonparametric	O	O	B-T081
estimation	O	O	I-T081
.	O	O	O

The	O	O	O
treatment	O	O	B-T033
effect	O	O	I-T033
and	O	O	O
its	O	O	O
standard	O	O	B-T081
error	O	O	I-T081
were	O	O	O
estimated	O	O	B-T081
via	O	O	O
multiple	O	O	B-T081
imputations	O	O	I-T081
.	O	O	O

The	O	O	O
performances	O	O	B-T052
of	O	O	O
the	O	O	O
two	O	O	O
methods	O	O	B-T170
were	O	O	O
compared	O	O	B-T052
in	O	O	O
terms	O	O	O
of	O	O	O
bias	O	O	B-T078
in	O	O	O
the	O	O	O
estimates	O	O	B-T081
,	O	O	O
standard	O	O	B-T081
errors	O	O	I-T081
,	O	O	O
and	O	O	O
coverage	O	O	B-T052
probability	O	O	B-T081
.	O	O	O

Both	O	O	O
methods	O	O	B-T170
were	O	O	O
then	O	O	O
retrospectively	O	O	B-T080
applied	O	O	B-T169
to	O	O	O
two	O	O	O
randomized	O	O	B-T062
clinical	O	O	I-T062
trials	O	O	I-T062
studying	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
adjuvant	O	O	B-T169
chemotherapy	O	O	B-T061
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28319640)

The	O	O	O
Corneal	O	O	B-T025
Epithelial	O	O	I-T025
Barrier	O	O	B-T033
and	O	O	O
Its	O	O	O
Developmental	O	O	B-T080
Role	O	O	O
in	O	O	O
Isolating	O	O	B-T169
Corneal	O	O	O
Epithelial	O	O	O
and	O	O	O
Conjunctival	O	O	B-T025
Cells	O	O	I-T025
From	O	O	O
One	O	O	O
Another	O	O	O

During	O	O	O
development	O	O	B-T169
,	O	O	O
the	O	O	O
corneal	O	O	B-T024
epithelium	O	O	I-T024
(	O	O	O
CE	O	O	B-T024
)	O	O	O
and	O	O	O
the	O	O	O
conjunctiva	O	O	B-T023
are	O	O	O
derived	O	O	O
from	O	O	O
the	O	O	O
surface	O	O	B-T018
ectoderm	O	O	I-T018
.	O	O	O

Here	O	O	O
we	O	O	O
have	O	O	O
examined	O	O	B-T033
how	O	O	O
,	O	O	O
during	O	O	O
development	O	O	B-T169
,	O	O	O
the	O	O	O
cells	O	O	B-T025
of	O	O	O
these	O	O	O
two	O	O	O
issues	O	O	O
become	O	O	O
isolated	O	O	B-T169
from	O	O	O
each	O	O	O
other	O	O	O
.	O	O	O

Epithelia	O	O	B-T024
from	O	O	O
the	O	O	O
anterior	O	O	B-T023
eyes	O	O	I-T023
of	O	O	O
chicken	O	O	B-T018
embryos	O	O	I-T018
were	O	O	O
labeled	O	O	B-T130
with	O	O	O
the	O	O	O
fluorescent	O	O	B-T130
,	O	O	O
lipophilic	O	O	B-T130
dye	O	O	I-T130
,	O	O	O
1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine	O	O	B-T109
perchlorate	O	O	I-T109
(	O	O	O
DiI	O	O	B-T109
)	O	O	O
.	O	O	O

DiI	O	O	B-T109
was	O	O	O
placed	O	O	O
on	O	O	O
the	O	O	O
epithelial	O	O	B-T026
surface	O	O	I-T026
of	O	O	O
the	O	O	O
developing	O	O	O
anterior	O	O	B-T023
eye	O	O	I-T023
and	O	O	O
its	O	O	O
diffusion	O	O	B-T070
was	O	O	O
monitored	O	O	O
by	O	O	O
fluorescence	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

Concomitant	O	O	O
morphologic	O	O	B-T080
changes	O	O	B-T169
in	O	O	O
the	O	O	O
surface	O	O	B-T026
cells	O	O	I-T026
of	O	O	I-T026
these	O	O	I-T026
epithelial	O	O	I-T026
were	O	O	O
examined	O	O	B-T033
by	O	O	O
scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
.	O	O	O

Immunofluorescence	O	O	B-T059
was	O	O	O
used	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
cytokeratin	O	O	B-T116
K3	O	O	I-T116
,	O	O	O
ZO-1	O	O	B-T116
,	O	O	O
N-cadherin	O	O	B-T116
and	O	O	O
Connexin-43	O	O	B-T116
and	O	O	O
the	O	O	O
function	O	O	B-T039
of	O	O	O
gap	O	O	B-T030
junctions	O	O	I-T030
was	O	O	O
analyzed	O	O	B-T062
using	O	O	O
a	O	O	O
cut-loading	O	O	B-T081
with	O	O	O
the	O	O	O
fluorescent	O	O	B-T130
dye	O	O	I-T130
rhodamine-dextran	O	O	B-T109
.	O	O	O

Prior	O	O	O
to	O	O	O
embryonic	O	O	B-T042
day	O	O	B-T079
8	O	O	O
(	O	O	O
E	O	O	B-T042
8)	O	O	O
,	O	O	O
DiI	O	O	B-T109
placed	O	O	O
on	O	O	O
the	O	O	O
surface	O	O	B-T082
of	O	O	O
the	O	O	O
CE	O	O	B-T024
spreads	O	O	B-T080
throughout	O	O	O
all	O	O	O
the	O	O	O
epithelial	O	O	B-T025
cells	O	O	I-T025
of	O	O	O
the	O	O	O
anterior	O	O	B-T023
eye	O	O	I-T023
.	O	O	O

When	O	O	O
older	O	O	B-T023
eyes	O	O	I-T023
were	O	O	O
similarly	O	O	O
labeled	O	O	B-T130
,	O	O	O
dye	O	O	B-T130
diffusion	O	O	B-T070
was	O	O	O
restricted	O	O	B-T169
to	O	O	O
the	O	O	O
CE	O	O	B-T024
.	O	O	O

Similarly	O	O	O
,	O	O	O
diffusion	O	O	B-T070
of	O	O	O
DiI	O	O	B-T109
placed	O	O	O
on	O	O	O
the	O	O	O
conjunctival	O	O	B-T023
surface	O	O	B-T082
after	O	O	O
E	O	O	B-T042
8	O	O	O
was	O	O	O
restricted	O	O	B-T169
to	O	O	O
the	O	O	O
conjunctiva	O	O	B-T023
.	O	O	O

Scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
showed	O	O	O
that	O	O	O
developmentally	O	O	B-T169
(	O	O	O
1	O	O	O
)	O	O	O
physical	O	O	B-T033
separations	O	O	B-T169
progressively	O	O	B-T169
form	O	O	O
between	O	O	O
the	O	O	O
cells	O	O	B-T025
of	O	O	O
the	O	O	O
CE	O	O	B-T024
and	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
conjunctiva	O	O	B-T023
,	O	O	O
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
by	O	O	O
E	O	O	B-T042
8	O	O	O
these	O	O	O
separations	O	O	O
form	O	O	O
a	O	O	O
ring	O	O	B-T023
that	O	O	O
completely	O	O	O
encompasses	O	O	O
the	O	O	O
cornea	O	O	B-T023
.	O	O	O

The	O	O	O
functional	O	O	B-T169
restriction	O	O	B-T169
of	O	O	O
gap	O	O	B-T030
junctions	O	O	I-T030
between	O	O	O
these	O	O	O
tissues	O	O	B-T024
did	O	O	O
not	O	O	O
occur	O	O	B-T052
until	O	O	O
E	O	O	B-T042
14	O	O	O
.	O	O	O

During	O	O	O
ocular	O	O	B-T042
development	O	O	I-T042
,	O	O	O
a	O	O	O
barrier	O	O	B-T033
to	O	O	O
the	O	O	O
diffusion	O	O	B-T070
of	O	O	O
DiI	O	O	B-T109
forms	O	O	O
between	O	O	O
the	O	O	O
contiguous	O	O	B-T082
CE	O	O	B-T024
and	O	O	O
conjunctiva	O	O	B-T023
prior	O	O	O
to	O	O	O
the	O	O	O
differential	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
gap	O	O	B-T030
junctions	O	O	I-T030
within	O	O	O
these	O	O	O
tissues	O	O	B-T024
.	O	O	O

-DOCSTART- (28321789)

Longitudinal	O	O	B-T062
study	O	O	I-T062
of	O	O	O
bovine	O	O	B-T015
rotavirus	O	O	B-T005
group	O	O	I-T005
A	O	O	I-T005
in	O	O	O
newborn	O	O	B-T008
calves	O	O	B-T015
from	O	O	O
vaccinated	O	O	B-T033
and	O	O	O
unvaccinated	O	O	B-T033
dairy	O	O	O
herds	O	O	O

Reports	O	O	O
of	O	O	O
rotavirus	O	O	B-T005
excretion	O	O	B-T031
in	O	O	O
calves	O	O	B-T015
usually	O	O	O
result	O	O	O
from	O	O	O
cross-sectional	O	O	B-T062
studies	O	O	I-T062
,	O	O	O
and	O	O	O
in	O	O	O
face	O	O	O
of	O	O	O
the	O	O	O
conflicting	O	O	O
results	O	O	O
regarding	O	O	O
protection	O	O	B-T061
of	O	O	O
calves	O	O	O
born	O	O	B-T040
to	O	O	O
vaccinated	O	O	B-T033
dams	O	O	B-T015
against	O	O	O
diarrhea	O	O	B-T184
,	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
evaluate	O	O	O
rotavirus	O	O	O
excretion	O	O	O
in	O	O	O
dairy	O	O	B-T015
calves	O	O	I-T015
born	O	O	O
to	O	O	O
vaccinated	O	O	O
or	O	O	O
unvaccinated	O	O	B-T033
dams	O	O	O
,	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
genotypes	O	O	B-T032
of	O	O	O
bovine	O	O	B-T015
rotavirus	O	O	B-T005
group	O	O	I-T005
A	O	O	I-T005
(	O	O	O
RVA	O	O	B-T005
)	O	O	O
strains	O	O	B-T001
isolated	O	O	O
from	O	O	O
these	O	O	O
animals	O	O	B-T015
as	O	O	O
well	O	O	O
as	O	O	O
to	O	O	O
investigate	O	O	O
characteristics	O	O	O
of	O	O	O
the	O	O	O
disease	O	O	B-T047
in	O	O	O
naturally	O	O	B-T169
occurring	O	O	B-T052
circumstances	O	O	O
throughout	O	O	O
the	O	O	O
first	O	O	B-T033
month	O	O	I-T033
of	O	O	I-T033
life	O	O	I-T033
.	O	O	O

Five	O	O	O
hundred	O	O	O
fifty-two	O	O	O
fecal	O	O	B-T031
samples	O	O	B-T031
were	O	O	O
taken	O	O	O
from	O	O	O
56	O	O	O
calves	O	O	B-T015
,	O	O	O
28	O	O	O
from	O	O	O
each	O	O	O
farm	O	O	B-T082
and	O	O	O
,	O	O	O
in	O	O	O
the	O	O	O
vaccinated	O	O	B-T033
herd	O	O	B-T015
,	O	O	O
11/281	O	O	O
samples	O	O	O
(	O	O	O
3.91	O	O	O
%	O	O	O
)	O	O	O
taken	O	O	O
from	O	O	O
six	O	O	O
different	O	O	O
calves	O	O	O
tested	O	O	B-T033
positive	O	O	I-T033
for	O	O	O
RVA	O	O	B-T005
while	O	O	O
in	O	O	O
the	O	O	O
unvaccinated	O	O	B-T033
herd	O	O	O
,	O	O	O
3/271	O	O	O
samples	O	O	O
(	O	O	O
1.11	O	O	O
%	O	O	O
)	O	O	O
taken	O	O	O
from	O	O	O
3	O	O	O
different	O	O	O
calves	O	O	O
tested	O	O	O
positive	O	O	O
.	O	O	O

The	O	O	O
genotyping	O	O	B-T059
of	O	O	O
the	O	O	O
VP7	O	O	B-T028
genes	O	O	I-T028
showed	O	O	O
91.2	O	O	O
%	O	O	O
nucleotide	O	O	B-T086
sequence	O	O	I-T086
identity	O	O	O
to	O	O	O
G6	O	O	B-T032
genotype	O	O	I-T032
(	O	O	O
NCDV	O	O	B-T001
strain	O	O	I-T001
)	O	O	O
,	O	O	O
and	O	O	O
for	O	O	O
the	O	O	O
VP4	O	O	B-T028
gene	O	O	I-T028
,	O	O	O
strains	O	O	B-T001
from	O	O	O
the	O	O	O
vaccinated	O	O	B-T033
herd	O	O	B-T015
were	O	O	O
96.6	O	O	O
%	O	O	O
related	O	O	O
to	O	O	O
B223	O	O	B-T001
strain	O	O	I-T001
,	O	O	O
while	O	O	O
strains	O	O	O
from	O	O	O
the	O	O	O
unvaccinated	O	O	B-T033
herd	O	O	O
were	O	O	O
88	O	O	O
%	O	O	O
related	O	O	O
to	O	O	O
P[5	O	O	B-T032
]	O	O	I-T032
genotype	O	O	I-T032
(	O	O	O
UK	O	O	B-T001
strain	O	O	I-T001
)	O	O	O
.	O	O	O

Genotypes	O	O	B-T032
found	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
were	O	O	O
G6P[11	O	O	B-T032
]	O	O	I-T032
in	O	O	O
the	O	O	O
vaccinated	O	O	B-T033
herd	O	O	B-T015
and	O	O	O
G6P[5	O	O	B-T032
]	O	O	I-T032
in	O	O	O
the	O	O	O
unvaccinated	O	O	B-T033
herd	O	O	O
.	O	O	O

All	O	O	O
calves	O	O	B-T015
infected	O	O	B-T033
with	O	O	O
rotavirus	O	O	B-T005
presented	O	O	O
an	O	O	O
episode	O	O	O
of	O	O	O
diarrhea	O	O	B-T184
in	O	O	O
the	O	O	O
first	O	O	O
month	O	O	O
of	O	O	O
life	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
discrepancy	O	O	O
between	O	O	O
the	O	O	O
genotypes	O	O	B-T032
found	O	O	O
in	O	O	O
the	O	O	O
commercial	O	O	B-T129
vaccine	O	O	I-T129
(	O	O	O
G6P[1	O	O	B-T032
]	O	O	I-T032
and	O	O	O
G10P[11	O	O	B-T032
]	O	O	I-T032
)	O	O	O
and	O	O	O
the	O	O	O
rotavirus	O	O	O
strains	O	O	B-T001
circulating	O	O	O
in	O	O	O
both	O	O	O
vaccinated	O	O	B-T033
and	O	O	O
unvaccinated	O	O	B-T033
herds	O	O	B-T015
show	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
keeping	O	O	O
constant	O	O	B-T080
surveillance	O	O	B-T061
in	O	O	O
order	O	O	O
to	O	O	O
avoid	O	O	O
potential	O	O	B-T080
causes	O	O	B-T169
of	O	O	O
vaccination	O	O	B-T061
failure	O	O	B-T033
.	O	O	O

-DOCSTART- (28322352)

Gene	O	O	B-T028
-based	O	O	O
genome-wide	O	O	B-T063
association	O	O	I-T063
study	O	O	I-T063
identified	O	O	B-T080
19p13.3	O	O	B-T026
for	O	O	O
lean	O	O	O
body	O	O	O
mass	O	O	O

Lean	O	O	B-T201
body	O	O	I-T201
mass	O	O	I-T201
(	O	O	O
LBM	O	O	B-T201
)	O	O	O
is	O	O	O
a	O	O	O
complex	O	O	O
trait	O	O	B-T032
for	O	O	O
human	O	O	B-T016
health	O	O	B-T078
.	O	O	O

To	O	O	O
identify	O	O	O
genomic	O	O	B-T028
loci	O	O	I-T028
underlying	O	O	O
LBM	O	O	B-T201
,	O	O	O
we	O	O	O
performed	O	O	O
a	O	O	O
gene	O	O	B-T028
-based	O	O	O
genome-wide	O	O	B-T063
association	O	O	I-T063
study	O	O	I-T063
of	O	O	O
lean	O	O	B-T081
mass	O	O	I-T081
index	O	O	I-T081
(	O	O	O
LMI	O	O	B-T081
)	O	O	O
in	O	O	O
1000	O	O	O
unrelated	O	O	B-T033
Caucasian	O	O	B-T098
subjects	O	O	B-T098
,	O	O	O
and	O	O	O
replicated	O	O	B-T169
in	O	O	O
2283	O	O	O
unrelated	O	O	O
Caucasians	O	O	B-T098
subjects	O	O	O
.	O	O	O

Gene	O	O	B-T028
-based	O	O	O
association	O	O	B-T063
analyses	O	O	I-T063
highlighted	O	O	O
the	O	O	O
significant	O	O	O
associations	O	O	B-T080
of	O	O	O
three	O	O	O
genes	O	O	B-T028
UQCR	O	O	B-T028
,	O	O	O
TCF3	O	O	B-T028
and	O	O	O
MBD3	O	O	B-T028
in	O	O	O
one	O	O	O
single	O	O	B-T081
locus	O	O	B-T028
19p13.3	O	O	B-T026
(	O	O	O
discovery	O	O	B-T080
p	O	O	O
=	O	O	O
6.10	O	O	O
×	O	O	O
10(-5	O	O	O
)	O	O	O
,	O	O	O
1.65	O	O	O
×	O	O	O
10(-4	O	O	O
)	O	O	O
and	O	O	O
1.10	O	O	O
×	O	O	O
10(-4	O	O	O
)	O	O	O
;	O	O	O
replication	O	O	B-T080
p	O	O	O
=	O	O	O
2.21	O	O	O
×	O	O	O
10(-3	O	O	O
)	O	O	O
,	O	O	O
1.84	O	O	O
×	O	O	O
10(-3	O	O	O
)	O	O	O
and	O	O	O
6.95	O	O	O
×	O	O	O
10(-3	O	O	O
)	O	O	O
;	O	O	O
combined	O	O	O
p	O	O	O
=	O	O	O
2.26	O	O	O
×	O	O	O
10(-6	O	O	O
)	O	O	O
,	O	O	O
4.86	O	O	O
×	O	O	O
10(-6	O	O	O
)	O	O	O
and	O	O	O
1.15	O	O	O
×	O	O	O
10(-5	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
,	O	O	O
together	O	O	O
with	O	O	O
the	O	O	O
known	O	O	O
functional	O	O	B-T169
relevance	O	O	B-T080
of	O	O	O
the	O	O	O
three	O	O	O
genes	O	O	B-T028
to	O	O	O
LMI	O	O	B-T081
,	O	O	O
suggested	O	O	O
that	O	O	O
the	O	O	O
19p13.3	O	O	B-T026
region	O	O	B-T082
containing	O	O	O
UQCR	O	O	B-T028
,	O	O	O
TCF3	O	O	B-T028
and	O	O	O
MBD3	O	O	B-T028
genes	O	O	I-T028
was	O	O	O
a	O	O	O
novel	O	O	O
locus	O	O	B-T028
underlying	O	O	O
lean	O	O	B-T201
mass	O	O	I-T201
variation	O	O	B-T070
.	O	O	O

-DOCSTART- (28322744)

Basal	O	O	B-T082
ryanodine	O	O	B-T044
receptor	O	O	I-T044
activity	O	O	I-T044
suppresses	O	O	B-T169
autophagic	O	O	B-T026
flux	O	O	O

The	O	O	O
inositol	O	O	B-T116
1,4,5-trisphosphate	O	O	I-T116
receptors	O	O	I-T116
(	O	O	O
IP3Rs	O	O	B-T116
)	O	O	O
and	O	O	O
intracellular	O	O	B-T043
Ca(2	O	O	I-T043
+	O	O	I-T043
)	O	O	I-T043
signaling	O	O	I-T043
are	O	O	O
critically	O	O	B-T080
involved	O	O	B-T169
in	O	O	O
regulating	O	O	B-T038
different	O	O	B-T080
steps	O	O	B-T077
of	O	O	O
autophagy	O	O	B-T043
,	O	O	O
a	O	O	O
lysosomal	O	O	B-T026
degradation	O	O	B-T077
pathway	O	O	I-T077
.	O	O	O

The	O	O	O
ryanodine	O	O	B-T116
receptors	O	O	I-T116
(	O	O	O
RyR	O	O	B-T116
)	O	O	O
,	O	O	O
intracellular	O	O	B-T044
Ca(2+)-release	O	O	I-T044
channels	O	O	I-T044
mainly	O	O	O
expressed	O	O	B-T045
in	O	O	O
excitable	O	O	B-T033
cell	O	O	B-T170
types	O	O	I-T170
including	O	O	B-T169
muscle	O	O	B-T024
and	O	O	O
neurons	O	O	B-T025
,	O	O	O
have	O	O	O
however	O	O	O
not	O	O	O
yet	O	O	O
been	O	O	O
extensively	O	O	B-T080
studied	O	O	B-T062
in	O	O	O
relation	O	O	O
to	O	O	O
autophagy	O	O	B-T043
.	O	O	O

Yet	O	O	O
,	O	O	O
aberrant	O	O	B-T080
expression	O	O	B-T045
and	O	O	O
excessive	O	O	B-T080
activity	O	O	B-T044
of	O	O	O
RyRs	O	O	B-T116
in	O	O	O
these	O	O	O
tissues	O	O	B-T024
has	O	O	O
been	O	O	O
implicated	O	O	B-T033
in	O	O	O
the	O	O	O
onset	O	O	B-T080
of	O	O	I-T080
several	O	O	B-T081
diseases	O	O	B-T047
including	O	O	B-T169
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
where	O	O	O
impaired	O	O	B-T169
autophagy	O	O	B-T043
regulation	O	O	B-T038
contributes	O	O	B-T052
to	O	O	O
the	O	O	O
pathology	O	O	B-T169
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
determined	O	O	B-T059
whether	O	O	O
pharmacological	O	O	B-T038
RyR	O	O	B-T116
inhibition	O	O	B-T052
could	O	O	O
modulate	O	O	B-T082
autophagic	O	O	B-T026
flux	O	O	B-T070
in	O	O	O
ectopic	O	O	B-T082
RyR	O	O	O
-	O	O	O
expressing	O	O	B-T045
models	O	O	B-T170
,	O	O	O
like	O	O	O
HEK293	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
in	O	O	O
cell	O	O	B-T170
types	O	O	I-T170
that	O	O	O
endogenously	O	O	B-T169
express	O	O	B-T045
RyR	O	O	O
s	O	O	O
,	O	O	O
like	O	O	O
C2C12	O	O	B-T025
myoblasts	O	O	I-T025
and	O	O	O
primary	O	O	B-T080
hippocampal	O	O	B-T023
neurons	O	O	B-T025
.	O	O	O

Importantly	O	O	B-T080
,	O	O	O
RyR3	O	O	B-T116
overexpression	O	O	B-T045
in	O	O	O
HEK293	O	O	B-T025
cells	O	O	I-T025
impaired	O	O	B-T169
the	O	O	O
autophagic	O	O	B-T026
flux	O	O	B-T070
.	O	O	O

Conversely	O	O	O
,	O	O	O
in	O	O	O
all	O	O	O
cell	O	O	B-T025
models	O	O	B-T170
tested	O	O	B-T169
,	O	O	O
pharmacological	O	O	B-T038
inhibition	O	O	B-T052
of	O	O	O
endogenous	O	O	B-T169
or	O	O	O
ectopically	O	O	B-T082
expressed	O	O	B-T045
RyRs	O	O	B-T116
,	O	O	O
using	O	O	O
dantrolene	O	O	B-T109
or	O	O	O
ryanodine	O	O	B-T109
,	O	O	O
augmented	O	O	B-T081
autophagic	O	O	B-T026
flux	O	O	B-T070
by	O	O	O
increasing	O	O	B-T169
lysosomal	O	O	B-T026
turn-over	O	O	B-T044
(	O	O	O
number	O	O	B-T081
of	O	O	O
autophagosomes	O	O	B-T026
and	O	O	O
autolysosomes	O	O	B-T026
measured	O	O	B-T080
as	O	O	O
mCherry	O	O	B-T116
-	O	O	O
LC3	O	O	B-T116
punctae	O	O	I-T116
/	O	O	O
cell	O	O	O
increased	O	O	B-T081
from	O	O	O
70.37±7.81	O	O	O
in	O	O	O
control	O	O	B-T096
HEK	O	O	B-T025
RyR3	O	O	I-T025
cells	O	O	I-T025
to	O	O	O
111.18±7.72	O	O	O
and	O	O	O
98.14±7.31	O	O	O
after	O	O	O
dantrolene	O	O	O
and	O	O	O
ryanodine	O	O	O
treatments	O	O	B-T061
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
in	O	O	O
differentiated	O	O	B-T043
C2C12	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
transmission	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
demonstrated	O	O	B-T080
that	O	O	O
dantrolene	O	O	B-T109
treatment	O	O	B-T061
decreased	O	O	B-T081
the	O	O	O
number	O	O	B-T081
of	O	O	O
early	O	O	O
autophagic	O	O	B-T026
vacuoles	O	O	B-T026
from	O	O	O
5.9±2.97	O	O	O
to	O	O	O
1.8±1.03	O	O	O
per	O	O	O
cellular	O	O	B-T025
cross	O	O	B-T082
section	O	O	I-T082
.	O	O	O

The	O	O	O
modulation	O	O	B-UnknownType
of	O	O	O
the	O	O	O
autophagic	O	O	B-T026
flux	O	O	B-T070
could	O	O	O
be	O	O	O
linked	O	O	O
to	O	O	O
the	O	O	O
functional	O	O	B-T169
inhibition	O	O	B-T052
of	O	O	O
RyR	O	O	B-T116
channels	O	O	I-T116
as	O	O	O
both	O	O	O
RyR	O	O	O
inhibitors	O	O	B-T120
efficiently	O	O	B-T080
diminished	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	O
cells	O	O	B-T025
showing	O	O	O
spontaneous	O	O	B-T169
RyR3	O	O	B-T116
activity	O	O	B-T044
in	O	O	O
the	O	O	O
HEK293	O	O	B-T025
cell	O	O	I-T025
model	O	O	B-T170
(	O	O	O
from	O	O	O
41.14%±2.12	O	O	O
in	O	O	O
control	O	O	B-T096
cells	O	O	O
to	O	O	O
18.70%±2.25	O	O	O
and	O	O	O
9.74%±2.67	O	O	O
after	O	O	O
dantrolene	O	O	B-T109
and	O	O	O
ryanodine	O	O	B-T109
treatments	O	O	B-T061
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
,	O	O	O
basal	O	O	B-T082
RyR	O	O	B-T116
-mediated	O	O	O
Ca(2+)-release	O	O	B-T044
events	O	O	I-T044
suppress	O	O	B-T169
autophagic	O	O	B-T026
flux	O	O	B-T070
at	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
the	O	O	O
lysosomes	O	O	B-T026
.	O	O	O

-DOCSTART- (28322885)

Fluoride	O	O	B-T121
concentration	O	O	B-T081
in	O	O	O
saliva	O	O	B-T031
and	O	O	O
biofilm	O	O	B-T007
fluid	O	O	I-T007
following	O	O	O
the	O	O	O
application	O	O	B-T058
of	O	O	O
three	O	O	O
fluoride	O	O	O
varnishes	O	O	O

Most	O	O	O
of	O	O	O
the	O	O	O
commercially	O	O	O
available	O	O	O
fluoride	O	O	B-T122
varnishes	O	O	I-T122
(	O	O	O
FV	O	O	B-T122
)	O	O	O
have	O	O	O
not	O	O	O
been	O	O	O
evaluated	O	O	B-T058
for	O	O	O
their	O	O	O
cariostatic	O	O	B-T039
properties	O	O	I-T039
.	O	O	O

Consequently	O	O	B-T033
,	O	O	O
the	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T058
intra	O	O	B-T082
-	O	O	O
oral	O	O	B-T082
fluoride	O	O	B-T121
retention	O	O	B-T169
and	O	O	O
clearance	O	O	B-T033
patterns	O	O	I-T033
from	O	O	O
three	O	O	O
different	O	O	O
FV	O	O	B-T122
.	O	O	O

Eighteen	O	O	O
subjects	O	O	B-T098
(	O	O	O
7	O	O	O
-	O	O	O
11	O	O	O
years	O	O	B-T079
)	O	O	O
participated	O	O	O
in	O	O	O
a	O	O	O
laboratory	O	O	B-T093
analyst	O	O	B-T097
-	O	O	O
blinded	O	O	B-T062
,	O	O	O
randomized	O	O	B-T062
,	O	O	O
crossover	O	O	B-T062
study	O	O	I-T062
comparing	O	O	B-T052
the	O	O	O
ability	O	O	B-T032
of	O	O	O
5	O	O	O
%	O	O	O
sodium	O	O	B-T122
fluoride	O	O	B-T121
varnishes	O	O	I-T122
(	O	O	O
CavityShield-CS	O	O	B-T122
,	O	O	O
Enamel	O	O	B-T122
Pro-EP	O	O	I-T122
,	O	O	O
Vanish-V	O	O	B-T122
)	O	O	O
to	O	O	O
enhance	O	O	B-T052
fluoride	O	O	O
concentrations	O	O	B-T081
in	O	O	O
biofilm	O	O	B-T007
fluid	O	O	I-T007
,	O	O	O
centrifuged	O	O	B-T031
and	O	O	O
whole	O	O	B-T081
saliva	O	O	B-T031
over	O	O	O
a	O	O	O
period	O	O	B-T079
of	O	O	O
48h	O	O	O
after	O	O	O
a	O	O	O
single	O	O	O
FV	O	O	B-T122
application	O	O	O
.	O	O	O

Similar	O	O	O
fluoride	O	O	B-T121
concentration	O	O	B-T081
×	O	O	O
time	O	O	B-T079
patterns	O	O	I-T079
were	O	O	O
noted	O	O	B-T170
for	O	O	O
all	O	O	O
investigated	O	O	B-T080
FV	O	O	B-T122
and	O	O	O
studied	O	O	B-T062
variables	O	O	B-T080
,	O	O	O
with	O	O	O
the	O	O	O
highest	O	O	B-T080
fluoride	O	O	O
concentrations	O	O	B-T081
observed	O	O	B-T169
for	O	O	O
the	O	O	O
first	O	O	O
biological	O	O	B-T077
sample	O	O	I-T077
collected	O	O	B-T169
after	O	O	O
FV	O	O	O
application	O	O	O
(	O	O	O
30min	O	O	O
)	O	O	O
.	O	O	O

Mean±SE	O	O	B-T081
(	O	O	O
area	O	O	B-T081
under	O	O	I-T081
fluoride	O	O	I-T081
clearance	O	O	I-T081
curve	O	O	I-T081
)	O	O	O
values	O	O	B-T080
were	O	O	O
(	O	O	O
μg	O	O	O
F/g	O	O	O
or	O	O	O
ml	O	O	O
×	O	O	O
min	O	O	O
):	O	O	O
biofilm	O	O	B-T007
fluid	O	O	I-T007
-	O	O	O
CS	O	O	B-T122
(	O	O	O
472±191	O	O	O
)	O	O	O
,	O	O	O
EP	O	O	B-T122
(	O	O	O
423±75	O	O	O
)	O	O	O
,	O	O	O
V	O	O	B-T122
(	O	O	O
1264±279	O	O	O
)	O	O	O
;	O	O	O
centrifuged	O	O	B-T031
saliva	O	O	B-T031
-	O	O	O
CS	O	O	O
(	O	O	O
42±7	O	O	O
)	O	O	O
,	O	O	O
EP	O	O	O
(	O	O	O
19±3	O	O	O
)	O	O	O
,	O	O	O
V	O	O	O
(	O	O	O
41±8	O	O	O
)	O	O	O
;	O	O	O
whole	O	O	B-T081
saliva	O	O	O
-	O	O	O
CS	O	O	O
(	O	O	O
68±11	O	O	O
)	O	O	O
,	O	O	O
EP	O	O	O
(	O	O	O
64±10	O	O	O
)	O	O	O
,	O	O	O
V	O	O	O
(	O	O	O
60±7	O	O	O
)	O	O	O
.	O	O	O

V	O	O	B-T122
delivered	O	O	O
more	O	O	O
fluoride	O	O	B-T121
to	O	O	O
biofilm	O	O	B-T007
fluid	O	O	I-T007
than	O	O	O
CS	O	O	B-T122
(	O	O	O
p=0.0116	O	O	O
)	O	O	O
and	O	O	O
EP	O	O	B-T122
(	O	O	O
p=0.0065	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
did	O	O	O
not	O	O	O
differ	O	O	O
(	O	O	O
p=0.27	O	O	O
)	O	O	O
.	O	O	O

For	O	O	O
centrifuged	O	O	B-T031
saliva	O	O	B-T031
,	O	O	O
CS	O	O	B-T122
and	O	O	O
V	O	O	B-T122
were	O	O	O
not	O	O	O
significantly	O	O	B-T078
different	O	O	O
(	O	O	O
p=0.86	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
resulted	O	O	B-T169
in	O	O	O
higher	O	O	B-T080
fluoride	O	O	B-T121
retention	O	O	B-T169
than	O	O	O
EP	O	O	B-T122
(	O	O	O
p<0.0008	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
significant	O	O	B-T078
differences	O	O	O
among	O	O	O
FV	O	O	B-T122
were	O	O	O
observed	O	O	B-T169
for	O	O	O
whole	O	O	B-T081
saliva	O	O	B-T031
(	O	O	O
p=0.79	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
present	O	O	B-T033
study	O	O	B-T062
has	O	O	O
shown	O	O	O
that	O	O	O
FV	O	O	B-T122
vary	O	O	O
in	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
deliver	O	O	O
fluoride	O	O	B-T121
intra	O	O	B-T082
-	O	O	O
orally	O	O	B-T082
potentially	O	O	B-T080
related	O	O	B-T080
to	O	O	O
formulation	O	O	O
differences	O	O	B-T080
.	O	O	O

To	O	O	O
what	O	O	O
extent	O	O	B-T082
the	O	O	O
present	O	O	B-T033
findings	O	O	B-T033
relate	O	O	B-T080
to	O	O	O
clinical	O	O	B-T080
efficacy	O	O	I-T080
remains	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
to	O	O	O
be	O	O	O
determined	O	O	B-T059
.	O	O	O

Clinical	O	O	B-T062
research	O	O	I-T062
that	O	O	O
investigates	O	O	B-T058
fluoride	O	O	B-T121
release	O	O	B-T080
patterns	O	O	B-T082
into	O	O	O
saliva	O	O	B-T031
and	O	O	O
biofilm	O	O	B-T007
fluid	O	O	I-T007
from	O	O	O
different	O	O	O
FV	O	O	B-T122
products	O	O	I-T122
is	O	O	O
insufficient	O	O	B-T080
.	O	O	O

More	O	O	O
research	O	O	B-T062
is	O	O	O
needed	O	O	O
to	O	O	O
investigate	O	O	B-T058
different	O	O	O
FV	O	O	B-T122
formulations	O	O	I-T122
for	O	O	O
their	O	O	O
efficacy	O	O	B-T080
in	O	O	O
order	O	O	O
to	O	O	O
help	O	O	O
clinicians	O	O	B-T097
make	O	O	O
better	O	O	B-T080
evidence	O	O	B-T078
based	O	O	O
treatment	O	O	B-T169
choices	O	O	O
.	O	O	O

-DOCSTART- (28323338)

The	O	O	O
prognostic	O	O	B-T201
value	O	O	I-T201
of	O	O	O
extranodal	O	O	B-T033
extension	O	O	I-T033
in	O	O	O
human	O	O	B-T005
papillomavirus	O	O	I-T005
-associated	O	O	O
oropharyngeal	O	O	O
squamous	O	O	O
cell	O	O	O
carcinoma	O	O	O

Extranodal	O	O	B-T033
(	O	O	I-T033
or	O	O	I-T033
extracapsular	O	O	I-T033
)	O	O	I-T033
extension	O	O	I-T033
(	O	O	O
ENE	O	O	B-T033
)	O	O	O
is	O	O	O
an	O	O	O
adverse	O	O	B-T201
prognostic	O	O	I-T201
factor	O	O	I-T201
in	O	O	O
patients	O	O	B-T101
with	O	O	O
head	O	O	B-T191
and	O	O	I-T191
neck	O	O	I-T191
cancers	O	O	I-T191
who	O	O	O
undergo	O	O	O
primary	O	O	B-T058
surgery	O	O	I-T058
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
significance	O	O	O
of	O	O	O
ENE	O	O	B-T033
in	O	O	O
human	O	O	B-T191
papillomavirus	O	O	I-T191
(HPV)-positive	O	O	I-T191
oropharyngeal	O	O	I-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	I-T191
OPSCC	O	O	I-T191
)	O	O	I-T191
is	O	O	O
not	O	O	O
well	O	O	O
established	O	O	O
,	O	O	O
and	O	O	O
single-institution	O	O	B-T093
studies	O	O	B-T062
have	O	O	O
not	O	O	B-T080
established	O	O	I-T080
that	O	O	O
ENE	O	O	O
predicts	O	O	B-T078
inferior	O	O	B-T082
outcome	O	O	B-T169
.	O	O	O

The	O	O	O
authors	O	O	O
investigated	O	O	O
the	O	O	O
prognostic	O	O	B-T201
value	O	O	I-T201
of	O	O	O
ENE	O	O	B-T033
in	O	O	O
HPV	O	O	B-T005
-	O	O	O
positive	O	O	B-T033
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
primary	O	O	B-T058
surgery	O	O	I-T058
and	O	O	O
whether	O	O	O
adjuvant	O	O	B-T061
chemoradiation	O	O	I-T061
improved	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
OS	O	O	B-T081
)	O	O	O
compared	O	O	B-T052
with	O	O	O
radiation	O	O	B-T070
alone	O	O	I-T070
in	O	O	O
ENE	O	O	O
-	O	O	O
positive	O	O	O
patients	O	O	O
.	O	O	O

Patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
primary	O	O	B-T058
surgery	O	O	I-T058
for	O	O	O
pathologic	O	O	B-T169
T1	O	O	I-T169
(	O	O	O
pT1	O	O	B-T169
)	O	O	O
through	O	O	O
pT4	O	O	B-T191
tumors	O	O	I-T191
,	O	O	O
pathologic	O	O	B-T169
N1	O	O	I-T169
(	O	O	O
pN1	O	O	B-T169
)	O	O	O
through	O	O	O
pN3	O	O	B-T023
lymph	O	O	I-T023
node	O	O	I-T023
status	O	O	B-T080
,	O	O	O
HPV-positive	O	O	B-T191
OPSCC	O	O	I-T191
were	O	O	O
identified	O	O	B-T080
in	O	O	O
the	O	O	O
National	O	O	B-T170
Cancer	O	O	I-T170
Data	O	O	I-T170
Base	O	O	I-T170
from	O	O	O
2010	O	O	O
through	O	O	O
2012	O	O	O
.	O	O	O

Features	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
ENE	O	O	B-T033
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Univariable	O	O	B-T170
and	O	O	I-T170
multivariable	O	O	I-T170
Cox	O	O	I-T170
regression	O	O	I-T170
analyses	O	O	I-T170
identified	O	O	B-T080
predictors	O	O	B-T078
of	O	O	O
OS	O	O	B-T081
.	O	O	O

The	O	O	O
effect	O	O	B-T080
of	O	O	O
adjuvant	O	O	B-T061
treatment	O	O	I-T061
on	O	O	O
OS	O	O	B-T081
in	O	O	O
ENE	O	O	B-T033
-	O	O	O
positive	O	O	B-T033
cohort	O	O	B-T081
was	O	O	O
also	O	O	O
evaluated	O	O	B-T058
.	O	O	O

In	O	O	O
total	O	O	O
,	O	O	O
1043	O	O	O
patients	O	O	B-T101
met	O	O	O
inclusion	O	O	B-T080
criteria	O	O	I-T080
,	O	O	O
among	O	O	O
whom	O	O	O
43.5	O	O	O
%	O	O	O
were	O	O	O
ENE	O	O	B-T033
-	O	O	O
positive	O	O	B-T033
.	O	O	O

Of	O	O	O
the	O	O	O
ENE	O	O	B-T033
-	O	O	O
positive	O	O	B-T033
patients	O	O	B-T101
who	O	O	O
had	O	O	O
treatment	O	O	B-T061
details	O	O	O
available	O	O	O
,	O	O	O
72	O	O	O
%	O	O	O
received	O	O	B-T080
concurrent	O	O	B-T061
chemoradiotherapy	O	O	I-T061
,	O	O	O
16	O	O	O
%	O	O	O
received	O	O	O
radiotherapy	O	O	B-T061
,	O	O	O
and	O	O	O
12	O	O	O
%	O	O	O
received	O	O	O
no	O	O	B-T080
adjuvant	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

After	O	O	O
a	O	O	O
median	O	O	B-T081
follow-up	O	O	B-T058
of	O	O	O
28.4	O	O	O
months	O	O	B-T079
,	O	O	O
ENE	O	O	B-T033
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
worse	O	O	B-T033
3-	O	O	O
year	O	O	B-T079
OS	O	O	B-T081
(	O	O	O
89.3	O	O	O
%	O	O	O
vs	O	O	O
93.6	O	O	O
%	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.01	O	O	O
)	O	O	O
.	O	O	O

On	O	O	O
multivariable	O	O	B-T170
analysis	O	O	I-T170
that	O	O	O
included	O	O	B-T169
involved	O	O	O
lymph	O	O	B-T023
nodes	O	O	I-T023
,	O	O	O
only	O	O	O
ENE	O	O	B-T033
,	O	O	O
lymphovascular	O	O	B-T033
invasion	O	O	I-T033
,	O	O	O
pT3/pT4	O	O	B-T191
tumors	O	O	I-T191
,	O	O	O
and	O	O	O
Charlson-Deyo	O	O	B-T081
score	O	O	I-T081
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
worse	O	O	B-T033
OS	O	O	B-T081
.	O	O	O

Among	O	O	O
ENE	O	O	B-T033
-	O	O	O
positive	O	O	B-T033
patients	O	O	B-T101
,	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
difference	O	O	I-T033
in	O	O	O
3-	O	O	O
year	O	O	B-T079
OS	O	O	B-T081
between	O	O	O
those	O	O	O
who	O	O	O
received	O	O	B-T080
adjuvant	O	O	B-T061
concurrent	O	O	I-T061
chemoradiotherapy	O	O	I-T061
versus	O	O	O
radiotherapy	O	O	B-T061
alone	O	O	I-T061
(	O	O	O
89.6	O	O	O
%	O	O	O
vs	O	O	O
89.3	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.55	O	O	O
)	O	O	O
.	O	O	O

Propensity	O	O	B-T081
score	O	O	I-T081
-	O	O	O
matched	O	O	B-T081
comparison	O	O	I-T081
revealed	O	O	B-T080
similar	O	O	O
results	O	O	B-T169
.	O	O	O

ENE	O	O	B-T033
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
inferior	O	O	B-T082
OS	O	O	B-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
HPV-positive	O	O	B-T191
OPSCC	O	O	I-T191
.	O	O	O

However	O	O	O
,	O	O	O
OS	O	O	B-T081
was	O	O	O
not	O	O	B-T033
better	O	O	I-T033
with	O	O	O
adjuvant	O	O	B-T061
chemoradiotherapy	O	O	I-T061
compared	O	O	B-T052
with	O	O	O
radiotherapy	O	O	B-T061
alone	O	O	I-T061
in	O	O	O
ENE	O	O	B-T033
-	O	O	O
positive	O	O	B-T033
patients	O	O	B-T101
.	O	O	O

The	O	O	O
current	O	O	B-T081
findings	O	O	I-T081
support	O	O	I-T081
the	O	O	O
need	O	O	O
for	O	O	O
prospective	O	O	B-T062
studies	O	O	I-T062
of	O	O	O
adjuvant	O	O	B-T061
chemoradiation	O	O	I-T061
in	O	O	O
HPV	O	O	B-T005
-	O	O	O
positive	O	O	B-T033
patients	O	O	B-T101
with	O	O	O
ENE	O	O	B-T033
.	O	O	O

Cancer	O	O	O
2017	O	O	O
.	O	O	O

©	O	O	O
2017	O	O	O
American	O	O	O
Cancer	O	O	O
Society	O	O	O
.	O	O	O

-DOCSTART- (28323926)

Psychological	O	O	B-T048
Distress	O	O	I-T048
Is	O	O	O
More	O	O	O
Prevalent	O	O	O
in	O	O	O
Fertile	O	O	B-T040
Age	O	O	B-T032
and	O	O	O
Premenopausal	O	O	B-T039
Women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
Symptoms	O	O	B-T184
-15-yr	O	O	O
Follow-up	O	O	O

Polycystic	O	O	B-T047
ovary	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
PCOS	O	O	B-T047
)	O	O	O
is	O	O	O
associated	O	O	O
with	O	O	O
increased	O	O	O
psychological	O	O	B-T048
distress	O	O	I-T048
;	O	O	O
obesity	O	O	B-T047
and	O	O	O
hyperandrogenism	O	O	B-T047
being	O	O	O
suggested	O	O	O
as	O	O	O
key	O	O	O
promoters	O	O	B-T052
.	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
anxiety	O	O	B-T048
/	O	O	O
depression	O	O	B-T048
and	O	O	O
their	O	O	O
coexistence	O	O	O
in	O	O	O
women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
/	O	O	O
PCOS	O	O	O
symptoms	O	O	B-T184
at	O	O	O
age	O	O	B-T032
s	O	O	O
31	O	O	O
and	O	O	O
46	O	O	O
.	O	O	O

The	O	O	O
roles	O	O	O
of	O	O	O
obesity	O	O	B-T047
,	O	O	O
hyperandrogenism	O	O	B-T047
and	O	O	O
awareness	O	O	B-T041
of	O	O	O
PCOS	O	O	B-T047
on	O	O	O
psychological	O	O	B-T048
distress	O	O	I-T048
were	O	O	O
also	O	O	O
assessed	O	O	B-T052
.	O	O	O

Population	O	O	B-T062
based	O	O	I-T062
follow-up	O	O	I-T062
.	O	O	O

Northern	O	O	B-T083
Finland	O	O	I-T083
Birth	O	O	B-T081
Cohort	O	O	I-T081
1966	O	O	O
with	O	O	O
15-	O	O	O
year	O	O	B-T079
follow-up	O	O	B-T058
.	O	O	O

At	O	O	O
age	O	O	B-T032
31	O	O	O
a	O	O	O
questionnaire-based	O	O	B-T062
screening	O	O	I-T062
for	O	O	O
oligoamenorrhea	O	O	B-T046
(	O	O	O
OA	O	O	B-T046
)	O	O	O
and	O	O	O
hirsutism	O	O	B-T047
(	O	O	O
H	O	O	B-T047
):	O	O	O
2188	O	O	O
asymptomatic	O	O	B-T033
(	O	O	O
controls	O	O	B-T096
)	O	O	O
,	O	O	O
331	O	O	O
OA	O	O	O
,	O	O	O
323	O	O	O
H	O	O	O
,	O	O	O
125	O	O	O
OA	O	O	O
+	O	O	O
H	O	O	O
(	O	O	O
PCOS	O	O	B-T047
)	O	O	O
.	O	O	O

46	O	O	O
year	O	O	B-T079
old	O	O	O
follow-up	O	O	B-T058
:	O	O	O
1576	O	O	O
controls	O	O	B-T096
,	O	O	O
239	O	O	O
OA	O	O	B-T046
,	O	O	O
231	O	O	O
H	O	O	B-T047
and	O	O	O
85	O	O	O
PCOS	O	O	B-T047
.	O	O	O

Questionnaire-based	O	O	B-T062
screening	O	O	I-T062
for	O	O	O
anxiety	O	O	B-T048
and	O	O	O
depression	O	O	B-T048
symptoms	O	O	I-T184
(	O	O	O
Hopkins	O	O	B-T170
Symptom	O	O	I-T170
Checklist-25	O	O	I-T170
)	O	O	O
and	O	O	O
previously	O	O	O
diagnosed	O	O	B-T033
/	O	O	O
treated	O	O	B-T033
depression	O	O	O
at	O	O	O
age	O	O	B-T032
31	O	O	O
and	O	O	O
46	O	O	O
.	O	O	O

BMI	O	O	B-T201
,	O	O	O
serum	O	O	B-T059
testosterone	O	O	I-T059
/	O	O	O
free	O	O	B-T059
androgen	O	O	I-T059
index	O	O	I-T059
(	O	O	O
FAI	O	O	B-T059
)	O	O	O
and	O	O	O
awareness	O	O	B-T041
of	O	O	O
polycystic	O	O	B-T047
ovaries	O	O	I-T047
/	O	O	O
PCOS	O	O	B-T047
on	O	O	O
psychological	O	O	B-T048
distress	O	O	I-T048
were	O	O	O
also	O	O	O
assessed	O	O	B-T052
.	O	O	O

Population-based	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
anxiety	O	O	B-T048
and/or	O	O	O
depression	O	O	B-T048
in	O	O	O
women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
/	O	O	O
PCOS	O	O	O
symptoms	O	O	B-T184
at	O	O	O
age	O	O	B-T032
s	O	O	O
31	O	O	O
and	O	O	O
46	O	O	O
.	O	O	O

Anxiety	O	O	B-T048
and/or	O	O	O
depression	O	O	B-T048
symptoms	O	O	I-T184
,	O	O	O
their	O	O	O
coexistence	O	O	O
and	O	O	O
rate	O	O	O
of	O	O	O
depression	O	O	O
were	O	O	O
increased	O	O	O
at	O	O	O
age	O	O	B-T032
31	O	O	O
and	O	O	O
46	O	O	O
in	O	O	O
women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
or	O	O	O
isolated	O	O	O
H	O	O	B-T047
compared	O	O	O
with	O	O	O
controls	O	O	B-T096
.	O	O	O

High	O	O	O
BMI	O	O	B-T201
or	O	O	O
hyperandrogenism	O	O	B-T047
did	O	O	O
not	O	O	O
associate	O	O	O
with	O	O	O
increased	O	O	O
anxiety	O	O	B-T048
or	O	O	O
depression	O	O	B-T184
symptoms	O	O	I-T184
.	O	O	O

The	O	O	O
awareness	O	O	B-T041
of	O	O	O
PCOS	O	O	B-T047
was	O	O	O
associated	O	O	O
with	O	O	O
increased	O	O	O
anxiety	O	O	B-T048
.	O	O	O

Women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
or	O	O	O
isolated	O	O	O
H	O	O	B-T047
present	O	O	O
more	O	O	O
often	O	O	O
with	O	O	O
anxiety	O	O	B-T048
and/or	O	O	O
depression	O	O	B-T184
symptoms	O	O	I-T184
and	O	O	O
their	O	O	O
coexistence	O	O	O
compared	O	O	O
with	O	O	O
controls	O	O	B-T096
.	O	O	O

High	O	O	O
BMI	O	O	B-T201
or	O	O	O
hyperandrogenism	O	O	B-T047
did	O	O	O
not	O	O	O
provoke	O	O	O
psychological	O	O	B-T048
distress	O	O	I-T048
in	O	O	O
PCOS	O	O	B-T047
.	O	O	O

The	O	O	O
awareness	O	O	B-T041
of	O	O	O
PCOS	O	O	B-T047
increased	O	O	O
anxiety	O	O	B-T048
but	O	O	O
did	O	O	O
not	O	O	O
associate	O	O	O
with	O	O	O
severe	O	O	O
anxiety	O	O	O
or	O	O	O
depression	O	O	B-T048
.	O	O	O

-DOCSTART- (28327913)

The	O	O	O
use	O	O	B-T169
of	O	O	I-T169
Oxford	O	O	B-T092
Nanopore	O	O	I-T092
native	O	O	B-T169
barcoding	O	O	B-T062
for	O	O	O
complete	O	O	B-T080
genome	O	O	O
assembly	O	O	O

The	O	O	O
Oxford	O	O	B-T092
Nanopore	O	O	I-T092
Technologies	O	O	I-T092
MinION(TM	O	O	B-T074
)	O	O	I-T074
is	O	O	O
a	O	O	O
mobile	O	O	B-T169
DNA	O	O	O
sequencer	O	O	O
that	O	O	O
can	O	O	O
produce	O	O	O
long	O	O	B-T086
read	O	O	I-T086
sequences	O	O	I-T086
with	O	O	O
a	O	O	O
short	O	O	O
turn-around	O	O	B-T079
time	O	O	I-T079
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	B-T170
the	O	O	O
first	O	O	O
demonstration	O	O	O
of	O	O	O
single	O	O	B-T085
contig	O	O	I-T085
genome	O	O	I-T085
assembly	O	O	I-T085
using	O	O	B-T169
Oxford	O	O	B-T092
Nanopore	O	O	I-T092
native	O	O	B-T169
barcoding	O	O	B-T062
when	O	O	O
applied	O	O	B-T169
to	O	O	O
a	O	O	O
multiplexed	O	O	B-T114
library	O	O	I-T114
of	O	O	O
12	O	O	O
samples	O	O	B-T077
and	O	O	O
combined	O	O	B-T080
with	O	O	O
existing	O	O	B-T077
Illumina	O	O	O
short-read	O	O	B-T170
data	O	O	I-T170
.	O	O	O

This	O	O	O
paves	O	O	O
the	O	O	O
way	O	O	O
for	O	O	O
the	O	O	O
closure	O	O	B-T062
of	O	O	O
multiple	O	O	B-T081
bacterial	O	O	B-T028
genomes	O	O	I-T028
from	O	O	O
a	O	O	O
single	O	O	B-T081
MinION(TM	O	O	B-T074
)	O	O	I-T074
sequencing	O	O	B-T063
run	O	O	B-T169
,	O	O	O
given	O	O	O
the	O	O	O
availability	O	O	B-T169
of	O	O	I-T169
existing	O	O	B-T077
short-read	O	O	B-T170
data	O	O	I-T170
.	O	O	O

The	O	O	O
strain	O	O	B-T001
we	O	O	O
used	O	O	B-T169
,	O	O	O
MHO_001	O	O	B-T001
,	O	O	O
represents	O	O	O
the	O	O	O
important	O	O	O
community-acquired	O	O	O
methicillin	O	O	B-T032
resistant	O	O	I-T032
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
lineage	O	O	O
USA300	O	O	B-T001
.	O	O	O

Using	O	O	B-T169
a	O	O	O
hybrid	O	O	O
assembly	O	O	B-T085
of	O	O	O
existing	O	O	B-T077
short	O	O	B-T080
read	O	O	I-T080
and	O	O	O
barcoded	O	O	B-T086
long	O	O	I-T086
read	O	O	I-T086
sequences	O	O	I-T086
from	O	O	O
multiplexed	O	O	B-T078
data	O	O	I-T078
,	O	O	O
we	O	O	O
completed	O	O	O
a	O	O	O
genome	O	O	B-T028
of	O	O	O
the	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
USA300	O	O	B-T001
strain	O	O	I-T001
MHO_001	O	O	I-T001
.	O	O	O

The	O	O	O
long-read	O	O	B-T170
data	O	O	I-T170
represented	O	O	O
only	O	O	O
~5	O	O	O
-	O	O	O
10	O	O	O
%	O	O	O
of	O	O	O
an	O	O	O
average	O	O	B-T081
MinION(TM	O	O	B-T074
)	O	O	I-T074
run	O	O	B-T169
(	O	O	O
~7x	O	O	O
genomic	O	O	B-T028
coverage	O	O	B-T169
)	O	O	O
,	O	O	O
but	O	O	O
,	O	O	O
using	O	O	B-T169
standard	O	O	B-T081
tools	O	O	B-T170
,	O	O	O
this	O	O	O
was	O	O	O
sufficient	O	O	B-T080
to	O	O	O
complete	O	O	B-T080
the	O	O	O
circular	O	O	B-T026
chromosome	O	O	I-T026
of	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
strain	O	O	B-T001
MHO_001	O	O	I-T001
(	O	O	O
2.86	O	O	O
Mb	O	O	O
)	O	O	O
and	O	O	O
two	O	O	O
complete	O	O	O
plasmids	O	O	B-T114
(	O	O	O
27	O	O	O
Kb	O	O	O
and	O	O	O
3	O	O	O
Kb	O	O	O
)	O	O	O
.	O	O	O

Minor	O	O	B-T080
differences	O	O	B-T080
were	O	O	O
noted	O	O	B-T080
when	O	O	O
compared	O	O	B-T052
to	O	O	O
USA300	O	O	B-T001
reference	O	O	O
genome	O	O	B-T028
,	O	O	O
USA300_FPR3757	O	O	B-T028
,	O	O	O
including	O	O	B-T169
the	O	O	O
translocation	O	O	B-T043
,	O	O	O
loss	O	O	B-T081
and	O	O	O
gain	O	O	B-T081
of	O	O	O
mobile	O	O	B-T114
genetic	O	O	I-T114
elements	O	O	I-T114
.	O	O	O

Here	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
MinION(TM	O	O	B-T074
)	O	O	I-T074
reads	O	O	B-T169
,	O	O	O
multiplexed	O	O	B-T169
using	O	O	B-T169
native	O	O	B-T169
barcoding	O	O	B-T062
,	O	O	O
can	O	O	O
be	O	O	O
used	O	O	B-T169
in	O	O	O
combination	O	O	B-T080
with	O	O	O
short-read	O	O	B-T170
data	O	O	I-T170
,	O	O	O
to	O	O	O
fully	O	O	O
complete	O	O	B-T080
a	O	O	O
bacterial	O	O	B-T028
genome	O	O	I-T028
.	O	O	O

The	O	O	O
ability	O	O	O
to	O	O	O
complete	O	O	B-T080
multiple	O	O	B-T081
genomes	O	O	B-T028
,	O	O	O
for	O	O	O
which	O	O	O
short-read	O	O	B-T170
data	O	O	I-T170
is	O	O	O
already	O	O	O
available	O	O	B-T033
,	O	O	O
from	O	O	O
a	O	O	O
single	O	O	B-T081
MinION(TM	O	O	B-T074
)	O	O	I-T074
run	O	O	B-T169
is	O	O	O
set	O	O	O
to	O	O	O
impact	O	O	B-T080
on	O	O	O
our	O	O	O
understanding	O	O	B-T041
of	O	O	O
accessory	O	O	B-T081
genome	O	O	B-T028
content	O	O	I-T028
,	O	O	O
plasmid	O	O	B-T114
diversity	O	O	B-T080
and	O	O	O
genome	O	O	O
rearrangements	O	O	B-T045
.	O	O	O

-DOCSTART- (28329872)

Doxorubicin	O	O	B-T195
Has	O	O	O
Dose-Dependent	O	O	B-T081
Toxicity	O	O	B-T037
on	O	O	O
Mouse	O	O	B-T015
Ovarian	O	O	B-T023
Follicle	O	O	I-T023
Development	O	O	B-T039
,	O	O	O
Hormone	O	O	B-T042
Secretion	O	O	I-T042
,	O	O	O
and	O	O	O
Oocyte	O	O	O
Maturation	O	O	O

Doxorubicin	O	O	B-T195
(	O	O	O
DOX	O	O	B-T195
)	O	O	O
,	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
commonly	O	O	B-T081
used	O	O	O
anticancer	O	O	B-T109
medications	O	O	I-T109
,	O	O	O
has	O	O	O
been	O	O	O
reported	O	O	O
to	O	O	O
affect	O	O	O
fertility	O	O	B-T040
by	O	O	O
damaging	O	O	B-T169
ovarian	O	O	B-T023
follicles	O	O	I-T023
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
dose-dependent	O	O	B-T081
toxicity	O	O	B-T037
of	O	O	O
DOX	O	O	O
on	O	O	O
the	O	O	O
dynamic	O	O	B-T169
follicle	O	O	B-T023
development	O	O	B-T039
and	O	O	O
oocyte	O	O	B-T043
maturation	O	O	I-T043
has	O	O	O
not	O	O	O
been	O	O	O
well-defined	O	O	O
.	O	O	O

Our	O	O	O
objective	O	O	B-T170
is	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
human	O	O	B-T016
-	O	O	O
relevant	O	O	B-T080
exposure	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
DOX	O	O	B-T195
on	O	O	O
follicular	O	O	B-T023
functions	O	O	B-T169
across	O	O	O
developmental	O	O	B-T039
time	O	O	B-T079
.	O	O	O

In	O	O	B-T080
vitro	O	O	I-T080
cultured	O	O	B-T059
multilayered	O	O	B-T023
secondary	O	O	I-T023
mouse	O	O	I-T023
follicles	O	O	I-T023
were	O	O	O
treated	O	O	B-T169
with	O	O	O
DOX	O	O	B-T195
at	O	O	O
0	O	O	O
,	O	O	O
2	O	O	O
,	O	O	O
20	O	O	O
,	O	O	O
100	O	O	O
,	O	O	O
and	O	O	O
200	O	O	O
nM	O	O	O
for	O	O	O
24	O	O	O
h	O	O	O
,	O	O	O
and	O	O	O
follicle	O	O	B-T023
development	O	O	B-T039
,	O	O	O
hormone	O	O	B-T042
secretion	O	O	I-T042
,	O	O	O
and	O	O	O
oocyte	O	O	B-T043
maturation	O	O	I-T043
were	O	O	O
analyzed	O	O	O
.	O	O	O

DOX	O	O	B-T195
caused	O	O	O
dose-dependent	O	O	B-T081
toxicity	O	O	B-T037
on	O	O	O
follicle	O	O	B-T042
growth	O	O	I-T042
,	O	O	O
survival	O	O	B-T169
,	O	O	O
and	O	O	O
secretion	O	O	B-T042
of	O	O	O
17β-estradiol	O	O	B-T125
(	O	O	O
E2	O	O	B-T125
)	O	O	O
.	O	O	O

At	O	O	O
200	O	O	O
nM	O	O	O
,	O	O	O
DOX	O	O	B-T195
induced	O	O	B-T169
DNA	O	O	B-T049
damage	O	O	I-T049
and	O	O	O
apoptosis	O	O	B-T043
in	O	O	O
follicle	O	O	B-T023
somatic	O	O	B-T025
cells	O	O	I-T025
first	O	O	O
and	O	O	O
then	O	O	O
in	O	O	O
oocytes	O	O	B-T025
,	O	O	O
which	O	O	O
was	O	O	O
correlated	O	O	O
with	O	O	O
the	O	O	O
uptake	O	O	B-T039
of	O	O	O
DOX	O	O	O
first	O	O	O
to	O	O	O
the	O	O	O
somatic	O	O	O
cells	O	O	O
followed	O	O	O
by	O	O	O
germ	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Follicles	O	O	B-T023
treated	O	O	B-T169
with	O	O	O
DOX	O	O	B-T195
at	O	O	O
0	O	O	O
,	O	O	O
2	O	O	O
,	O	O	O
and	O	O	O
20	O	O	O
nM	O	O	O
showed	O	O	O
similar	O	O	O
oocyte	O	O	B-T025
metaphase	O	O	B-T043
II	O	O	I-T043
(	O	O	O
MII	O	O	B-T043
)	O	O	O
percentages	O	O	B-T081
after	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
oocyte	O	O	B-T043
maturation	O	O	I-T043
;	O	O	O
however	O	O	O
,	O	O	O
20	O	O	O
nM	O	O	O
DOX	O	O	O
significantly	O	O	O
increased	O	O	B-T081
the	O	O	O
number	O	O	O
of	O	O	O
MII	O	O	O
oocytes	O	O	B-T025
with	O	O	O
abnormal	O	O	B-T033
spindle	O	O	B-T026
morphology	O	O	B-T080
and	O	O	O
chromosome	O	O	B-T026
misalignment	O	O	B-T080
.	O	O	O

In	O	O	O
an	O	O	O
effort	O	O	O
to	O	O	O
harmonize	O	O	O
the	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
study	O	O	I-T062
to	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
treatment	O	O	B-T169
,	O	O	O
dose-dependent	O	O	B-T081
toxicity	O	O	B-T037
on	O	O	O
oocyte	O	O	B-T043
meiotic	O	O	I-T043
maturation	O	O	I-T043
was	O	O	O
found	O	O	O
in	O	O	O
16-day-old	O	O	O
CD-1	O	O	B-T015
mice	O	O	I-T015
treated	O	O	B-T169
with	O	O	O
DOX	O	O	B-T195
at	O	O	O
0	O	O	O
,	O	O	O
0.4	O	O	O
,	O	O	O
2	O	O	O
,	O	O	O
and	O	O	O
10	O	O	O
mg/kg	O	O	O
,	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
the	O	O	O
in	O	O	O
vitro	O	O	O
oocyte	O	O	B-T043
maturation	O	O	I-T043
outcomes	O	O	B-T169
.	O	O	O

Our	O	O	O
study	O	O	B-T062
demonstrates	O	O	O
that	O	O	O
DOX	O	O	B-T195
has	O	O	O
dose-dependent	O	O	B-T081
toxicity	O	O	B-T037
on	O	O	O
ovarian	O	O	B-T023
follicle	O	O	I-T023
development	O	O	B-T039
,	O	O	O
hormone	O	O	B-T042
secretion	O	O	I-T042
,	O	O	O
and	O	O	O
oocyte	O	O	B-T043
maturation	O	O	I-T043
,	O	O	O
which	O	O	O
are	O	O	O
three	O	O	O
key	O	O	O
factors	O	O	B-T169
to	O	O	O
support	O	O	O
the	O	O	O
female	O	O	B-T040
reproductive	O	O	I-T040
and	O	O	O
endocrine	O	O	B-T039
functions	O	O	I-T039
.	O	O	O

-DOCSTART- (28330470)

Involvement	O	O	O
of	O	O	O
apoptotic	O	O	B-T043
pathways	O	O	I-T043
in	O	O	O
docosahexaenoic	O	O	B-T109
acid	O	O	I-T109
-induced	O	O	O
benefit	O	O	O
in	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
:	O	O	O
Pathway-focused	O	O	O
gene	O	O	B-T063
expression	O	O	I-T063
analysis	O	O	I-T063
using	O	O	O
RT(2	O	O	O
)	O	O	O
Profile	O	O	O
PCR	O	O	O
Array	O	O	O
System	O	O	O

Present	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
better	O	O	O
understand	O	O	O
the	O	O	O
potential	O	O	O
apoptotic	O	O	B-T043
pathways	O	O	I-T043
that	O	O	O
involved	O	O	O
in	O	O	O
docosahexaenoic	O	O	B-T109
acid	O	O	I-T109
(DHA)-induced	O	O	O
apoptosis	O	O	B-T043
of	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
cells	O	O	B-T025
.	O	O	O

Human	O	O	B-T016
prostate	O	O	B-T191
cancer	O	O	I-T191
DU145	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
treated	O	O	O
with	O	O	O
different	O	O	O
concentrations	O	O	O
of	O	O	O
fish	O	O	B-T109
oil	O	O	I-T109
,	O	O	O
omega-3	O	O	B-T109
PUFA	O	O	I-T109
(	O	O	O
DHA	O	O	B-T109
,	O	O	O
and	O	O	O
Eicosapentaenoic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
EPA	O	O	B-T109
)	O	O	O
,	O	O	O
or	O	O	O
omega-6	O	O	B-T109
PUFA	O	O	I-T109
(	O	O	O
Arachidonic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
AA	O	O	B-T109
)	O	O	O
.	O	O	O

Cell	O	O	B-T043
viability	O	O	I-T043
and	O	O	O
apoptosis	O	O	B-T043
were	O	O	O
evaluated	O	O	O
by	O	O	O
MTT	O	O	B-T062
assay	O	O	I-T062
and	O	O	O
Hoechst	O	O	B-T059
staining	O	O	I-T059
.	O	O	O

Pathway-focused	O	O	O
gene	O	O	B-T059
expression	O	O	I-T059
profiling	O	O	I-T059
of	O	O	O
DU145	O	O	B-T025
cells	O	O	I-T025
was	O	O	O
analyzed	O	O	O
with	O	O	O
the	O	O	O
RT(2	O	O	O
)	O	O	O
Profile	O	O	O
PCR	O	O	O
Array	O	O	O
System	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
were	O	O	O
verified	O	O	O
by	O	O	O
real	O	O	B-T063
time	O	O	I-T063
quantitative	O	O	I-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(	O	O	O
RT-qPCR	O	O	B-T063
)	O	O	O
.	O	O	O

AA	O	O	B-T109
exposure	O	O	O
showed	O	O	O
no	O	O	O
obvious	O	O	O
effect	O	O	O
on	O	O	O
viability	O	O	B-T043
of	O	O	O
DU145	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

However	O	O	O
,	O	O	O
exposure	O	O	O
with	O	O	O
fish	O	O	B-T109
oil	O	O	I-T109
,	O	O	O
EPA	O	O	B-T109
,	O	O	O
or	O	O	O
DHA	O	O	B-T109
for	O	O	O
24	O	O	O
h	O	O	O
significantly	O	O	O
affected	O	O	O
cell	O	O	B-T043
viability	O	O	I-T043
.	O	O	O

The	O	O	O
growth	O	O	B-T043
inhibition	O	O	I-T043
of	O	O	O
DHA	O	O	B-T109
was	O	O	O
more	O	O	O
pronounced	O	O	O
than	O	O	O
that	O	O	O
of	O	O	O
EPA	O	O	B-T109
and	O	O	O
showed	O	O	O
a	O	O	O
time-dependent	O	O	O
increase	O	O	O
.	O	O	O

DHA	O	O	B-T109
exposure	O	O	O
caused	O	O	O
typical	O	O	O
apoptotic	O	O	B-T080
characteristics	O	O	O
.	O	O	O

Ten	O	O	O
genes	O	O	B-T028
were	O	O	O
more	O	O	O
expressed	O	O	O
,	O	O	O
while	O	O	O
5	O	O	O
genes	O	O	O
were	O	O	O
less	O	O	O
expressed	O	O	O
following	O	O	O
DHA	O	O	B-T109
exposure	O	O	O
.	O	O	O

RT-qPCR	O	O	B-T063
confirmed	O	O	O
the	O	O	O
time	O	O	O
dependent	O	O	O
effect	O	O	O
of	O	O	O
DHA	O	O	B-T109
on	O	O	O
the	O	O	O
expression	O	O	O
of	O	O	O
these	O	O	O
differentially	O	O	O
expressed	O	O	O
genes	O	O	B-T028
.	O	O	O

KEGG	O	O	O
pathway	O	O	O
analysis	O	O	O
showed	O	O	O
that	O	O	O
DHA	O	O	B-T109
may	O	O	O
induce	O	O	O
the	O	O	O
apoptosis	O	O	B-T043
of	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
preferentially	O	O	O
through	O	O	O
mediating	O	O	O
P53	O	O	B-T044
,	O	O	O
MAPK	O	O	B-T044
,	O	O	O
TNF	O	O	B-T039
,	O	O	O
PI3K/AKT	O	O	B-T169
,	O	O	O
and	O	O	O
NF-κB	O	O	B-T045
signaling	O	O	I-T045
pathways	O	O	I-T045
.	O	O	O

Our	O	O	O
study	O	O	O
demonstrated	O	O	O
the	O	O	O
beneficial	O	O	O
action	O	O	O
of	O	O	O
DHA	O	O	B-T109
on	O	O	O
human	O	O	B-T016
prostate	O	O	B-T191
carcinoma	O	O	I-T191
cell	O	O	B-T025
line	O	O	I-T025
DU145	O	O	I-T025
.	O	O	O

The	O	O	O
pro-apoptotic	O	O	O
effect	O	O	O
of	O	O	O
DHA	O	O	B-T109
on	O	O	O
DU145	O	O	B-T025
cells	O	O	I-T025
may	O	O	O
involve	O	O	O
mediation	O	O	O
various	O	O	O
pathways	O	O	B-T044
,	O	O	O
especially	O	O	O
P53	O	O	B-T044
,	O	O	O
MAPK	O	O	B-T044
,	O	O	O
TNF	O	O	B-T039
,	O	O	O
PI3K/AKT	O	O	B-T169
,	O	O	O
and	O	O	O
NF-κB	O	O	B-T045
signaling	O	O	I-T045
pathways	O	O	I-T045
.	O	O	O

Molecular	O	O	B-T044
mechanisms	O	O	I-T044
of	O	O	O
DHA	O	O	B-T109
on	O	O	O
apoptosis	O	O	B-T043
of	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
still	O	O	O
need	O	O	O
to	O	O	O
be	O	O	O
further	O	O	O
clarified	O	O	O
.	O	O	O

-DOCSTART- (28333697)

Medication	O	O	B-T058
Reconciliation	O	O	I-T058
During	O	O	O
Hospitalization	O	O	B-T058
and	O	O	O
in	O	O	O
Hospital-Home	O	O	B-T058
Interface	O	O	I-T058
:	O	O	O
An	O	O	O
Observational	O	O	O
Retrospective	O	O	O
Study	O	O	O

Medication	O	O	B-T080
errors	O	O	I-T080
are	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
leading	O	O	O
causes	O	O	O
of	O	O	O
patient	O	O	B-T080
harms	O	O	I-T080
.	O	O	O

Medication	O	O	B-T058
reconciliation	O	O	I-T058
is	O	O	O
a	O	O	O
fundamental	O	O	O
process	O	O	O
that	O	O	O
to	O	O	O
be	O	O	O
effective	O	O	O
,	O	O	O
it	O	O	O
should	O	O	O
be	O	O	O
embraced	O	O	O
during	O	O	O
each	O	O	O
single	O	O	O
care	O	O	B-T058
transition	O	O	I-T058
.	O	O	O

Our	O	O	O
objectives	O	O	O
were	O	O	O
to	O	O	O
investigate	O	O	B-T169
current	O	O	O
medication	O	O	B-T058
reconciliation	O	O	I-T058
practices	O	O	O
in	O	O	O
the	O	O	O
2	O	O	O
Fondazione	O	O	B-T093
Toscana	O	O	I-T093
Gabriele	O	O	I-T093
Monasterio	O	O	I-T093
hospitals	O	O	I-T093
and	O	O	O
comprehensively	O	O	O
assess	O	O	B-T080
the	O	O	I-T080
quality	O	O	I-T080
of	O	O	O
medication	O	O	O
reconciliation	O	O	O
practices	O	O	O
between	O	O	O
inpatient	O	O	B-T101
and	O	O	O
outpatient	O	O	B-T101
care	O	O	B-T052
by	O	O	O
analyzing	O	O	B-T062
the	O	O	O
medication	O	O	B-T058
patterns	O	O	I-T058
6	O	O	O
months	O	O	B-T079
before	O	O	O
admission	O	O	B-T058
,	O	O	O
during	O	O	O
hospitalization	O	O	B-T058
,	O	O	O
and	O	O	O
9	O	O	O
months	O	O	O
after	O	O	O
discharge	O	O	B-T058
for	O	O	O
a	O	O	O
selected	O	O	O
group	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
observational	O	O	I-T062
study	O	O	I-T062
was	O	O	O
conducted	O	O	O
in	O	O	O
the	O	O	O
Cardiothoracic	O	O	B-T093
Department	O	O	I-T093
of	O	O	O
the	O	O	O
Fondazione	O	O	B-T093
Toscana	O	O	I-T093
Gabriele	O	O	I-T093
Monasterio	O	O	I-T093
hospitals	O	O	I-T093
.	O	O	O

Medication	O	O	B-T170
history	O	O	I-T170
was	O	O	O
reviewed	O	O	B-T080
for	O	O	O
all	O	O	O
the	O	O	O
patients	O	O	B-T101
admitted	O	O	B-T058
from	O	O	O
and	O	O	O
discharged	O	O	B-T058
to	O	O	O
the	O	O	O
community	O	O	B-T096
,	O	O	O
from	O	O	O
January	O	O	O
to	O	O	O
March	O	O	O
2013	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
excluded	O	O	O
if	O	O	O
they	O	O	O
had	O	O	O
less	O	O	O
than	O	O	O
4	O	O	O
drugs	O	O	B-T061
or	O	O	O
less	O	O	O
than	O	O	O
2	O	O	O
drugs	O	O	O
for	O	O	O
cardiovascular	O	O	B-T022
system	O	O	I-T022
in	O	O	O
their	O	O	O
prescription	O	O	B-T170
list	O	O	I-T170
at	O	O	O
admission	O	O	B-T058
or	O	O	O
if	O	O	O
they	O	O	O
died	O	O	B-T033
during	O	O	O
follow-up	O	O	B-T058
.	O	O	O

We	O	O	O
selected	O	O	O
714	O	O	O
patients	O	O	B-T101
,	O	O	O
and	O	O	O
we	O	O	O
obtained	O	O	O
the	O	O	O
clinical	O	O	B-T170
charts	O	O	I-T170
and	O	O	O
all	O	O	O
drug	O	O	B-T170
prescriptions	O	O	I-T170
collected	O	O	O
during	O	O	O
patients	O	O	O
'	O	O	O
hospitalization	O	O	B-T058
by	O	O	O
the	O	O	O
electronic	O	O	B-T170
clinical	O	O	I-T170
recording	O	O	I-T170
system	O	O	I-T170
.	O	O	O

We	O	O	O
also	O	O	O
analyzed	O	O	B-T062
the	O	O	O
list	O	O	B-T170
of	O	O	I-T170
prescriptions	O	O	I-T170
of	O	O	O
this	O	O	O
sample	O	O	O
of	O	O	O
patients	O	O	B-T101
,	O	O	O
from	O	O	O
6	O	O	O
months	O	O	B-T079
before	O	O	O
admission	O	O	B-T058
to	O	O	O
9	O	O	O
months	O	O	O
after	O	O	O
discharge	O	O	B-T058
,	O	O	O
extracted	O	O	O
from	O	O	O
the	O	O	O
regional	O	O	B-T170
prescription	O	O	I-T170
registry	O	O	I-T170
.	O	O	O

In	O	O	O
the	O	O	O
resulting	O	O	O
sample	O	O	O
,	O	O	O
prescriptions	O	O	B-T170
were	O	O	O
analyzed	O	O	B-T062
to	O	O	O
assess	O	O	O
unintentional	O	O	B-T169
discrepancies	O	O	B-T033
.	O	O	O

The	O	O	O
study	O	O	B-T062
included	O	O	O
298	O	O	O
patients	O	O	B-T101
(	O	O	O
mean	O	O	O
age	O	O	B-T032
,	O	O	O
71.2	O	O	O
years	O	O	B-T079
)	O	O	O
,	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
inclusion	O	O	B-T078
and	O	O	I-T078
exclusion	O	O	I-T078
criteria	O	O	I-T078
.	O	O	O

Among	O	O	O
14,573	O	O	O
prescriptions	O	O	B-T170
analyzed	O	O	B-T062
,	O	O	O
we	O	O	O
found	O	O	O
4363	O	O	O
discrepancies	O	O	B-T033
(	O	O	O
14.6	O	O	O
discrepancies	O	O	O
per	O	O	O
patient	O	O	B-T101
)	O	O	O
.	O	O	O

Among	O	O	O
these	O	O	O
discrepancies	O	O	B-T033
,	O	O	O
1310	O	O	O
were	O	O	O
classified	O	O	O
as	O	O	O
unintentional	O	O	B-T169
(	O	O	O
4.4	O	O	O
discrepancies	O	O	O
per	O	O	O
patient	O	O	B-T101
)	O	O	O
.	O	O	O

Among	O	O	O
unintentional	O	O	B-T169
discrepancies	O	O	B-T033
,	O	O	O
only	O	O	O
63	O	O	O
(	O	O	O
4.8	O	O	O
%	O	O	O
)	O	O	O
took	O	O	O
place	O	O	O
during	O	O	O
hospitalization	O	O	B-T058
.	O	O	O

Although	O	O	O
at	O	O	O
the	O	O	O
hospital-home	O	O	B-T058
interface	O	O	I-T058
,	O	O	O
33.1	O	O	O
%	O	O	O
of	O	O	O
unintentional	O	O	B-T169
discrepancies	O	O	B-T033
were	O	O	O
detected	O	O	O
through	O	O	O
the	O	O	O
comparison	O	O	B-T052
between	O	O	O
the	O	O	O
patients	O	O	B-T101
'	O	O	O
declared	O	O	O
therapy	O	O	B-T169
and	O	O	O
the	O	O	O
previous	O	O	O
medication	O	O	B-T058
consumption	O	O	I-T058
and	O	O	O
62.1	O	O	O
%	O	O	O
were	O	O	O
identified	O	O	O
in	O	O	O
the	O	O	O
comparison	O	O	O
between	O	O	O
the	O	O	O
prescription	O	O	B-T170
at	O	O	O
the	O	O	O
discharge	O	O	B-T058
and	O	O	O
the	O	O	O
following	O	O	O
medication	O	O	B-T058
pattern	O	O	I-T058
at	O	O	O
home	O	O	B-T082
.	O	O	O

Medication	O	O	B-T080
errors	O	O	I-T080
have	O	O	O
important	O	O	O
implications	O	O	O
for	O	O	O
patient	O	O	B-T058
safety	O	O	I-T058
,	O	O	O
and	O	O	O
their	O	O	O
identification	O	O	O
is	O	O	O
a	O	O	O
main	O	O	O
target	O	O	O
for	O	O	O
improving	O	O	O
clinical	O	O	B-T058
practice	O	O	I-T058
.	O	O	O

The	O	O	O
comparison	O	O	B-T052
between	O	O	O
the	O	O	O
medication	O	O	B-T058
patterns	O	O	I-T058
acquired	O	O	O
through	O	O	O
the	O	O	O
regional	O	O	B-T170
prescription	O	O	I-T170
registry	O	O	I-T170
before	O	O	O
and	O	O	O
after	O	O	O
hospitalization	O	O	B-T058
outlined	O	O	O
critical	O	O	O
touchpoint	O	O	O
in	O	O	O
the	O	O	O
current	O	O	O
medication	O	O	B-T058
reconciliation	O	O	I-T058
process	O	O	O
,	O	O	O
calling	O	O	O
for	O	O	O
the	O	O	O
definition	O	O	O
of	O	O	O
shared	O	O	O
medication	O	O	O
reconciliation	O	O	O
standards	O	O	O
between	O	O	O
hospitals	O	O	B-T093
and	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
services	O	O	I-T058
to	O	O	O
minimize	O	O	O
medication	O	O	B-T080
discrepancies	O	O	I-T080
and	O	O	O
enhance	O	O	O
patient	O	O	B-T058
safety	O	O	I-T058
.	O	O	O

-DOCSTART- (28334327)

Autologous	O	O	B-T122
vs	O	O	O
Irradiated	O	O	B-T122
Homologous	O	O	I-T122
Costal	O	O	I-T122
Cartilage	O	O	I-T122
as	O	O	O
Graft	O	O	B-T122
Material	O	O	I-T122
in	O	O	O
Rhinoplasty	O	O	O

Studies	O	O	O
comparing	O	O	O
surgical	O	O	O
results	O	O	O
of	O	O	O
rhinoplasty	O	O	B-T061
using	O	O	O
autologous	O	O	B-T122
costal	O	O	I-T122
cartilage	O	O	I-T122
(	O	O	O
ACC	O	O	B-T122
)	O	O	O
and	O	O	O
irradiated	O	O	B-T122
homologous	O	O	I-T122
costal	O	O	I-T122
cartilage	O	O	I-T122
(	O	O	O
IHCC	O	O	B-T122
)	O	O	O
are	O	O	O
rare	O	O	O
.	O	O	O

To	O	O	O
compare	O	O	O
the	O	O	O
clinical	O	O	B-T034
results	O	O	I-T034
of	O	O	O
major	O	O	O
augmentation	O	O	B-T061
rhinoplasty	O	O	I-T061
using	O	O	O
ACC	O	O	B-T122
vs	O	O	O
IHCC	O	O	B-T122
and	O	O	O
analyze	O	O	O
the	O	O	O
histologic	O	O	B-T169
properties	O	O	I-T169
of	O	O	O
both	O	O	O
types	O	O	O
of	O	O	O
cartilage	O	O	B-T024
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
clinical	O	O	I-T062
study	O	O	I-T062
was	O	O	O
conducted	O	O	O
among	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
undergone	O	O	O
rhinoseptoplasty	O	O	B-T061
using	O	O	O
ACC	O	O	B-T122
or	O	O	O
IHCC	O	O	B-T122
from	O	O	O
January	O	O	O
1	O	O	O
,	O	O	O
2009	O	O	O
,	O	O	O
to	O	O	O
December	O	O	O
31	O	O	O
,	O	O	O
2014	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
followed	O	O	B-T058
up	O	O	I-T058
for	O	O	O
more	O	O	O
than	O	O	O
1	O	O	O
year	O	O	O
after	O	O	O
surgery	O	O	B-T061
and	O	O	O
the	O	O	O
histologic	O	O	B-T169
characteristics	O	O	I-T169
of	O	O	O
ACC	O	O	B-T122
and	O	O	O
IHCC	O	O	B-T122
were	O	O	O
compared	O	O	B-T052
.	O	O	O

The	O	O	O
details	O	O	O
of	O	O	O
the	O	O	O
surgical	O	O	B-T061
procedures	O	O	I-T061
and	O	O	O
complications	O	O	B-T033
,	O	O	O
including	O	O	O
warping	O	O	B-T033
,	O	O	O
infection	O	O	B-T046
,	O	O	O
resorption	O	O	B-T040
,	O	O	O
and/or	O	O	O
donor-site	O	O	B-T029
morbidity	O	O	B-T081
,	O	O	O
were	O	O	O
evaluated	O	O	B-T058
by	O	O	O
reviewing	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
and	O	O	O
facial	O	O	B-T073
photographs	O	O	I-T073
.	O	O	O

Patients	O	O	B-T101
'	O	O	O
subjective	O	O	B-T080
satisfaction	O	O	B-T041
with	O	O	O
aesthetic	O	O	B-T055
and	O	O	O
functional	O	O	B-T169
results	O	O	B-T169
was	O	O	O
evaluated	O	O	B-T058
using	O	O	O
a	O	O	O
questionnaire	O	O	B-T170
.	O	O	O

The	O	O	O
details	O	O	O
of	O	O	O
the	O	O	O
surgical	O	O	B-T061
procedures	O	O	I-T061
and	O	O	O
complications	O	O	B-T033
,	O	O	O
including	O	O	O
warping	O	O	B-T033
,	O	O	O
infection	O	O	B-T046
,	O	O	O
resorption	O	O	B-T040
,	O	O	O
and/or	O	O	O
donor-site	O	O	B-T029
morbidity	O	O	B-T081
;	O	O	O
patients	O	O	B-T101
'	O	O	O
subjective	O	O	B-T080
satisfaction	O	O	B-T041
with	O	O	O
aesthetic	O	O	B-T055
and	O	O	O
functional	O	O	B-T169
results	O	O	B-T169
'	O	O	O
objective	O	O	B-T080
evaluation	O	O	B-T058
of	O	O	O
surgical	O	O	O
outcomes	O	O	B-T169
,	O	O	O
including	O	O	O
symmetry	O	O	B-T067
,	O	O	O
dorsal	O	O	B-T082
height	O	O	B-T032
,	O	O	O
dorsal	O	O	O
length	O	O	B-T081
,	O	O	O
dorsal	O	O	O
width	O	O	B-T081
,	O	O	O
tip	O	O	B-T033
projection	O	O	I-T033
,	O	O	O
tip	O	O	B-T033
rotation	O	O	I-T033
,	O	O	O
tip	O	O	B-T033
width	O	O	I-T033
,	O	O	O
and	O	O	O
overall	O	O	B-T080
result	O	O	B-T169
;	O	O	O
and	O	O	O
histologic	O	O	B-T169
structures	O	O	B-T082
.	O	O	O

Objective	O	O	B-T080
evaluation	O	O	B-T058
of	O	O	O
surgical	O	O	B-T061
outcomes	O	O	B-T169
was	O	O	O
graded	O	O	O
using	O	O	O
the	O	O	O
Objective	O	O	O
Rhinoplasty	O	O	B-T061
Outcome	O	O	B-T033
Score	O	O	I-T033
,	O	O	O
which	O	O	O
assessed	O	O	O
symmetry	O	O	B-T067
,	O	O	O
dorsal	O	O	B-T082
height	O	O	B-T032
,	O	O	O
dorsal	O	O	O
length	O	O	B-T081
,	O	O	O
dorsal	O	O	O
width	O	O	B-T081
,	O	O	O
tip	O	O	B-T033
projection	O	O	I-T033
,	O	O	O
tip	O	O	B-T033
rotation	O	O	I-T033
,	O	O	O
tip	O	O	B-T033
width	O	O	I-T033
,	O	O	O
and	O	O	O
overall	O	O	B-T080
result	O	O	B-T169
.	O	O	O

Histologic	O	O	B-T169
structures	O	O	I-T169
were	O	O	O
evaluated	O	O	B-T058
using	O	O	O
hematoxylin	O	O	B-T059
and	O	O	I-T059
eosin	O	O	I-T059
,	O	O	O
Masson	O	O	B-T059
trichrome	O	O	I-T059
,	O	O	O
Alcian	O	O	B-T059
blue	O	O	I-T059
,	O	O	O
and	O	O	O
Verhoeff	O	O	B-T059
elastic	O	O	I-T059
stains	O	O	I-T059
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
63	O	O	O
patients	O	O	B-T101
(	O	O	O
27	O	O	O
males	O	O	B-T032
and	O	O	O
36	O	O	O
females	O	O	B-T032
;	O	O	O
mean	O	O	O
[	O	O	O
SD	O	O	O
]	O	O	O
age	O	O	O
,	O	O	O
30.6	O	O	O
[	O	O	O
9.5	O	O	O
]	O	O	O
years	O	O	O
)	O	O	O
had	O	O	O
rhinoseptoplasty	O	O	B-T061
using	O	O	O
ACC	O	O	B-T122
and	O	O	O
20	O	O	O
(	O	O	O
9	O	O	O
males	O	O	O
and	O	O	O
11	O	O	O
females	O	O	O
;	O	O	O
mean	O	O	O
[	O	O	O
SD	O	O	O
]	O	O	O
age	O	O	O
,	O	O	O
35.4	O	O	O
[	O	O	O
15.4	O	O	O
]	O	O	O
years	O	O	O
)	O	O	O
had	O	O	O
rhinoseptoplasty	O	O	O
using	O	O	O
IHCC	O	O	B-T122
.	O	O	O

Among	O	O	O
observed	O	O	B-T169
complications	O	O	B-T033
,	O	O	O
only	O	O	O
notable	O	O	B-T080
resorption	O	O	B-T040
occurred	O	O	B-T052
more	O	O	O
frequently	O	O	B-T079
in	O	O	O
patients	O	O	B-T101
using	O	O	O
IHCC	O	O	B-T122
(	O	O	O
6	O	O	O
[	O	O	O
30	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
than	O	O	O
with	O	O	O
ACC	O	O	B-T122
(	O	O	O
2	O	O	O
[	O	O	O
3	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
.002	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
subjective	O	O	B-T080
evaluations	O	O	B-T058
of	O	O	O
aesthetic	O	O	B-T055
satisfaction	O	O	B-T041
,	O	O	O
patients	O	O	B-T101
who	O	O	O
received	O	O	B-T080
ACC	O	O	B-T122
showed	O	O	O
significantly	O	O	B-T078
greater	O	O	B-T081
satisfaction	O	O	O
(	O	O	O
37	O	O	O
of	O	O	O
51	O	O	O
patients	O	O	O
[	O	O	O
73	O	O	O
%	O	O	O
]	O	O	O
were	O	O	O
very	O	O	B-T033
satisfied	O	O	I-T033
)	O	O	O
than	O	O	O
did	O	O	O
those	O	O	O
who	O	O	O
received	O	O	O
IHCC	O	O	B-T122
(	O	O	O
6	O	O	O
of	O	O	O
20	O	O	O
[	O	O	O
30	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
.001	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
between-group	O	O	O
difference	O	O	O
in	O	O	O
subjective	O	O	B-T080
functional	O	O	B-T169
outcomes	O	O	B-T169
:	O	O	O
4	O	O	O
of	O	O	O
51	O	O	O
patients	O	O	B-T101
receiving	O	O	B-T080
ACC	O	O	B-T122
(	O	O	O
8	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
5	O	O	O
of	O	O	O
20	O	O	O
receiving	O	O	O
IHCC	O	O	B-T122
(	O	O	O
25	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
satisfied	O	O	B-T041
(	O	O	O
P	O	O	O
=	O	O	O
.50	O	O	O
)	O	O	O
and	O	O	O
45	O	O	O
of	O	O	O
51	O	O	O
receiving	O	O	O
ACC	O	O	O
(	O	O	O
88	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
15	O	O	O
of	O	O	O
20	O	O	O
receiving	O	O	O
IHCC	O	O	O
(	O	O	O
75	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
very	O	O	B-T033
satisfied	O	O	I-T033
(	O	O	O
P	O	O	O
=	O	O	O
.15	O	O	O
)	O	O	O
.	O	O	O

Regarding	O	O	O
objective	O	O	B-T080
aesthetic	O	O	B-T055
outcomes	O	O	B-T169
,	O	O	O
all	O	O	O
scores	O	O	B-T081
for	O	O	O
both	O	O	O
ACC	O	O	B-T122
and	O	O	O
IHCC	O	O	B-T122
were	O	O	O
more	O	O	O
than	O	O	O
3.1	O	O	O
(	O	O	O
between	O	O	O
good	O	O	B-T080
and	O	O	O
excellent	O	O	B-T080
)	O	O	O
.	O	O	O

Histologic	O	O	B-T059
analyses	O	O	I-T059
showed	O	O	O
larger	O	O	B-T081
,	O	O	O
more	O	O	O
evenly	O	O	O
distributed	O	O	O
,	O	O	O
uniform	O	O	B-T080
chondrocytes	O	O	B-T025
and	O	O	O
more	O	O	O
collagens	O	O	B-T116
and	O	O	O
proteoglycan	O	O	B-T116
contents	O	O	B-T078
in	O	O	O
ACC	O	O	B-T122
than	O	O	O
in	O	O	O
IHCC	O	O	B-T122
.	O	O	O

Compared	O	O	B-T052
with	O	O	O
patients	O	O	B-T101
receiving	O	O	B-T080
IHCC	O	O	B-T122
,	O	O	O
those	O	O	O
receiving	O	O	O
ACC	O	O	B-T122
for	O	O	O
rhinoseptoplasty	O	O	B-T061
showed	O	O	O
superior	O	O	B-T080
aesthetic	O	O	B-T055
satisfaction	O	O	B-T041
;	O	O	O
ACC	O	O	O
also	O	O	O
had	O	O	O
less	O	O	B-T080
frequent	O	O	B-T079
notable	O	O	B-T080
resorption	O	O	B-T040
.	O	O	O

Autologous	O	O	B-T122
costal	O	O	I-T122
cartilage	O	O	I-T122
also	O	O	O
had	O	O	O
better	O	O	B-T080
histologic	O	O	B-T169
properties	O	O	I-T169
than	O	O	O
IHCC	O	O	B-T122
did	O	O	O
,	O	O	O
suggesting	O	O	O
it	O	O	O
as	O	O	O
an	O	O	O
ideal	O	O	B-T080
graft	O	O	B-T122
material	O	O	I-T122
with	O	O	O
less	O	O	B-T080
chance	O	O	B-T080
of	O	O	O
long-term	O	O	B-T079
resorption	O	O	B-T040
.	O	O	O

3	O	O	O
.	O	O	O

-DOCSTART- (28334784)

Testing	O	O	O
the	O	O	O
Ret	O	O	B-T028
and	O	O	O
Sema3d	O	O	B-T028
genetic	O	O	B-T045
interaction	O	O	I-T045
in	O	O	O
mouse	O	O	B-T015
enteric	O	O	O
nervous	O	O	O
system	O	O	O
development	O	O	O

For	O	O	O
most	O	O	O
multigenic	O	O	B-T047
disorders	O	O	I-T047
,	O	O	O
clinical	O	O	B-T080
manifestation	O	O	I-T080
(	O	O	O
penetrance	O	O	B-T081
)	O	O	O
and	O	O	O
presentation	O	O	B-T078
(	O	O	O
expressivity	O	O	B-T078
)	O	O	O
are	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
outcome	O	O	B-T169
of	O	O	O
genetic	O	O	B-T045
interaction	O	O	I-T045
between	O	O	O
multiple	O	O	O
susceptibility	O	O	B-T028
genes	O	O	I-T028
.	O	O	O

Here	O	O	O
,	O	O	O
using	O	O	O
gene	O	O	B-UnknownType
knockouts	O	O	I-UnknownType
in	O	O	O
mice	O	O	B-T015
we	O	O	O
evaluated	O	O	O
genetic	O	O	B-T045
interaction	O	O	I-T045
between	O	O	O
loss	O	O	O
of	O	O	O
Ret	O	O	B-T028
and	O	O	O
loss	O	O	O
of	O	O	O
Sema3d	O	O	B-T028
,	O	O	O
two	O	O	O
Hirschsprung	O	O	B-T047
disease	O	O	I-T047
susceptibility	O	O	B-T028
genes	O	O	I-T028
.	O	O	O

We	O	O	O
intercrossed	O	O	O
Ret	O	O	B-T028
and	O	O	O
Sema3d	O	O	B-T028
double	O	O	O
null	O	O	O
heterozygotes	O	O	O
to	O	O	O
generate	O	O	B-T169
mice	O	O	I-T169
with	O	O	O
the	O	O	O
nine	O	O	O
possible	O	O	O
genotypes	O	O	B-T032
and	O	O	O
assessed	O	O	B-T052
survival	O	O	I-T052
by	O	O	O
counting	O	O	B-T059
various	O	O	I-T059
genotypes	O	O	I-T059
,	O	O	O
myenteric	O	O	B-T023
plexus	O	O	I-T023
presence	O	O	O
by	O	O	O
acetylcholinesterase	O	O	B-T059
staining	O	O	I-T059
and	O	O	O
embryonic	O	O	B-UnknownType
day	O	O	I-UnknownType
12.5	O	O	I-UnknownType
(	O	O	O
E12.5	O	O	B-UnknownType
)	O	O	O
intestine	O	O	B-T086
transcriptome	O	O	I-T086
by	O	O	O
RNA-sequencing	O	O	B-T086
.	O	O	O

Survival	O	O	B-T081
rates	O	O	I-T081
of	O	O	O
Ret	O	O	B-T028
wildtype	O	O	B-T028
,	O	O	O
null	O	O	O
heterozygote	O	O	O
and	O	O	O
null	O	O	O
homozygote	O	O	O
mice	O	O	B-T015
at	O	O	O
E12.5	O	O	B-UnknownType
,	O	O	O
birth	O	O	B-T040
and	O	O	O
weaning	O	O	B-T033
were	O	O	O
not	O	O	O
influenced	O	O	O
by	O	O	O
the	O	O	O
genotypes	O	O	B-T032
at	O	O	O
Sema3d	O	O	B-T028
locus	O	O	B-T082
and	O	O	O
vice-versa	O	O	O
.	O	O	O

Loss	O	O	O
of	O	O	O
myenteric	O	O	B-T023
plexus	O	O	I-T023
was	O	O	O
observed	O	O	O
only	O	O	O
in	O	O	O
all	O	O	O
Ret	O	O	B-T028
null	O	O	O
homozygotes	O	O	O
,	O	O	O
irrespective	O	O	O
of	O	O	O
the	O	O	O
genotypes	O	O	B-T032
at	O	O	O
Sema3d	O	O	B-T028
locus	O	O	B-T082
,	O	O	O
and	O	O	O
Sema3d	O	O	O
null	O	O	O
heterozygote	O	O	B-T032
and	O	O	O
homozygote	O	O	B-T032
mice	O	O	I-T032
had	O	O	O
normal	O	O	O
intestinal	O	O	B-T080
innervation	O	O	I-T080
.	O	O	O

As	O	O	O
compared	O	O	O
to	O	O	O
wildtype	O	O	B-T028
mice	O	O	I-T028
intestinal	O	O	I-T028
gene	O	O	B-T045
expression	O	O	I-T045
,	O	O	O
loss	O	O	O
of	O	O	O
Ret	O	O	B-T028
in	O	O	O
null	O	O	O
homozygotes	O	O	O
led	O	O	O
to	O	O	O
differential	O	O	O
expression	O	O	B-T045
of	O	O	I-T045
∼300	O	O	I-T045
genes	O	O	I-T045
,	O	O	I-T045
whereas	O	O	O
loss	O	O	O
of	O	O	O
Sema3d	O	O	B-T028
in	O	O	O
null	O	O	O
homozygotes	O	O	O
had	O	O	O
no	O	O	O
major	O	O	O
consequence	O	O	O
and	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T080
evidence	O	O	I-T080
supporting	O	O	O
major	O	O	O
interaction	O	O	B-T045
between	O	O	I-T045
the	O	O	I-T045
two	O	O	I-T045
genes	O	O	I-T045
influencing	O	O	O
intestine	O	O	B-T086
transcriptome	O	O	I-T086
.	O	O	O

Overall	O	O	O
,	O	O	O
given	O	O	O
the	O	O	O
null	O	O	B-T049
alleles	O	O	I-T049
and	O	O	O
phenotypic	O	O	B-T059
assays	O	O	I-T059
used	O	O	O
,	O	O	O
we	O	O	O
did	O	O	O
not	O	O	B-T080
find	O	O	I-T080
evidence	O	O	I-T080
for	O	O	O
genetic	O	O	B-T045
interaction	O	O	I-T045
between	O	O	O
Ret	O	O	B-T028
and	O	O	O
Sema3d	O	O	B-T028
affecting	O	O	O
survival	O	O	O
,	O	O	O
presence	O	O	O
of	O	O	O
myenteric	O	O	B-T023
plexus	O	O	I-T023
or	O	O	O
intestine	O	O	B-T086
transcriptome	O	O	I-T086
.	O	O	O

-DOCSTART- (28338376)

Pembrolizumab	O	O	B-T116
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
non-small	O	O	O
cell	O	O	O
lung	O	O	O
cancer	O	O	O

In	O	O	O
the	O	O	O
last	O	O	O
years	O	O	O
,	O	O	O
a	O	O	O
spectacular	O	O	O
development	O	O	B-T169
of	O	O	O
immunotherapeutic	O	O	B-T129
agents	O	O	I-T129
aimed	O	O	O
at	O	O	O
the	O	O	O
PD-1	O	O	B-T116
/	O	O	O
PD-L1	O	O	B-T129
axis	O	O	O
has	O	O	O
taken	O	O	O
place	O	O	O
.	O	O	O

This	O	O	O
development	O	O	B-T169
of	O	O	O
these	O	O	O
checkpoint	O	O	B-T120
inhibitors	O	O	I-T120
has	O	O	O
greatly	O	O	O
influenced	O	O	O
our	O	O	O
approach	O	O	O
to	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
in	O	O	O
first	O	O	B-T061
and	O	O	O
second	O	O	B-T061
line	O	O	I-T061
.	O	O	O

The	O	O	O
limited	O	O	B-T169
toxicity	O	O	B-T037
profile	O	O	O
and	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
treat	O	O	B-T061
for	O	O	O
prolonged	O	O	B-T079
periods	O	O	B-T079
,	O	O	O
even	O	O	O
in	O	O	O
smokers	O	O	B-T033
,	O	O	O
is	O	O	O
a	O	O	O
welcome	O	O	O
expansion	O	O	O
of	O	O	O
the	O	O	O
therapeutic	O	O	O
arsenal	O	O	O
of	O	O	O
the	O	O	O
oncologist	O	O	B-T097
.	O	O	O

Areas	O	O	O
covered	O	O	O
:	O	O	O
This	O	O	O
review	O	O	B-T170
highlights	O	O	O
the	O	O	O
results	O	O	B-T169
of	O	O	O
recent	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
on	O	O	O
pembrolizumab	O	O	B-T116
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
non-small	O	O	B-T191
cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

The	O	O	O
authors	O	O	B-T097
discuss	O	O	O
both	O	O	O
first	O	O	B-T061
and	O	O	O
second	O	O	B-T061
line	O	O	I-T061
treatment	O	O	I-T061
with	O	O	O
pembrolizumab	O	O	B-T116
as	O	O	O
monotherapy	O	O	B-T061
and	O	O	O
in	O	O	O
combination	O	O	B-T061
therapies	O	O	I-T061
.	O	O	O

Additionally	O	O	O
,	O	O	O
implications	O	O	O
of	O	O	O
the	O	O	O
PD-L1	O	O	B-T129
immunohistochemistry	O	O	B-T059
assay	O	O	I-T059
with	O	O	O
the	O	O	O
22C3	O	O	B-T116
antibody	O	O	I-T116
and	O	O	O
its	O	O	O
use	O	O	B-T169
in	O	O	O
clinical	O	O	B-T062
practice	O	O	I-T062
and	O	O	O
trials	O	O	B-T062
is	O	O	O
discussed	O	O	O
.	O	O	O

Expert	O	O	O
commentary	O	O	O
:	O	O	O
A	O	O	O
higher	O	O	B-T080
overall	O	O	B-T033
response	O	O	I-T033
,	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
and	O	O	O
a	O	O	O
moderate	O	O	B-T080
toxicity	O	O	B-T037
profile	O	O	O
is	O	O	O
observed	O	O	O
with	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	O
pembrolizumab	O	O	B-T116
,	O	O	O
compared	O	O	O
to	O	O	O
chemotherapy	O	O	B-T061
,	O	O	O
in	O	O	O
both	O	O	O
first	O	O	B-T061
and	O	O	O
second	O	O	B-T061
line	O	O	I-T061
.	O	O	O

These	O	O	O
promising	O	O	O
results	O	O	B-T169
have	O	O	O
already	O	O	O
translated	O	O	O
into	O	O	O
the	O	O	O
registration	O	O	B-T058
of	O	O	O
pembrolizumab	O	O	B-T116
in	O	O	O
first	O	O	B-T061
and	O	O	O
second	O	O	B-T061
line	O	O	I-T061
in	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
high	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
PD-L1	O	O	B-T129
.	O	O	O

However	O	O	O
,	O	O	O
as	O	O	O
PD-L1	O	O	B-T129
staining	O	O	B-T059
does	O	O	O
not	O	O	O
sufficiently	O	O	O
discriminate	O	O	O
responders	O	O	B-T033
from	O	O	O
non-responders	O	O	B-T033
for	O	O	O
all	O	O	O
checkpoint	O	O	B-T120
inhibitors	O	O	I-T120
,	O	O	O
there	O	O	O
still	O	O	O
is	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
a	O	O	O
better	O	O	O
predictive	O	O	B-T080
biomarker	O	O	B-T201
.	O	O	O

-DOCSTART- (28338976)

Synchronisms	O	O	B-T079
between	O	O	O
bud	O	O	B-T002
and	O	O	O
cambium	O	O	B-T023
phenology	O	O	B-T080
in	O	O	O
black	O	O	B-T002
spruce	O	O	I-T002
:	O	O	O
early	O	O	B-T079
-	O	O	O
flushing	O	O	B-T052
provenances	O	O	B-T077
exhibit	O	O	O
early	O	O	O
xylem	O	O	B-T002
formation	O	O	O

Bud	O	O	B-T002
and	O	O	O
cambial	O	O	B-T023
phenology	O	O	B-T080
represent	O	O	B-T052
the	O	O	O
adaptation	O	O	B-T038
of	O	O	O
species	O	O	B-T185
to	O	O	O
the	O	O	O
local	O	O	B-T082
environment	O	O	B-T082
that	O	O	O
allows	O	O	O
the	O	O	O
growing	O	O	B-T079
season	O	O	I-T079
to	O	O	O
be	O	O	O
maximized	O	O	B-T169
while	O	O	O
minimizing	O	O	B-T080
the	O	O	O
risk	O	O	B-T078
of	O	O	O
frost	O	O	B-T197
for	O	O	O
the	O	O	O
developing	O	O	B-T169
tissues	O	O	B-T025
.	O	O	O

The	O	O	O
temporal	O	O	B-T079
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
apical	O	O	B-T082
and	O	O	O
radial	O	O	B-T077
meristems	O	O	B-T002
can	O	O	O
help	O	O	O
in	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
tree	O	O	B-T002
growth	O	O	B-T040
as	O	O	O
a	O	O	O
whole	O	O	B-T081
process	O	O	B-T067
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
compare	O	O	B-T052
cambial	O	O	B-T023
phenology	O	O	B-T080
in	O	O	O
black	O	O	B-T002
spruce	O	O	I-T002
(	O	O	O
Picea	O	O	B-T002
mariana	O	O	I-T002
(	O	O	O
Mill	O	O	O
.	O	O	O
)	O	O	O
B.S.P.	O	O	O
)	O	O	O
provenances	O	O	B-T077
classified	O	O	B-T185
as	O	O	O
early	O	O	B-T079
and	O	O	O
late	O	O	B-T079
bud	O	O	B-T002
flushing	O	O	B-T052
.	O	O	O

The	O	O	O
different	O	O	B-T080
phases	O	O	B-T079
of	O	O	O
cambial	O	O	B-T023
phenology	O	O	B-T080
were	O	O	O
assessed	O	O	B-T052
on	O	O	O
wood	O	O	B-T167
microcores	O	O	B-T082
sampled	O	O	B-T078
weekly	O	O	B-T079
from	O	O	O
April	O	O	O
to	O	O	O
October	O	O	O
in	O	O	O
2014	O	O	O
and	O	O	O
2015	O	O	O
from	O	O	O
61	O	O	O
trees	O	O	B-T002
growing	O	O	B-T040
in	O	O	O
a	O	O	O
provenance	O	O	B-T062
trial	O	O	I-T062
in	O	O	O
Quebec	O	O	B-T083
,	O	O	O
Canada	O	O	B-T083
.	O	O	O

Trees	O	O	B-T002
showing	O	O	O
an	O	O	O
early	O	O	B-T079
bud	O	O	B-T002
flush	O	O	B-T052
also	O	O	O
exhibited	O	O	O
early	O	O	O
reactivation	O	O	B-T052
of	O	O	O
xylem	O	O	B-T002
differentiation	O	O	B-T043
,	O	O	O
although	O	O	O
an	O	O	O
average	O	O	B-T081
difference	O	O	B-T081
of	O	O	O
12	O	O	O
days	O	O	B-T079
for	O	O	O
buds	O	O	B-T002
corresponded	O	O	O
to	O	O	O
small	O	O	B-T081
although	O	O	O
significant	O	O	B-T081
differences	O	O	B-T081
of	O	O	O
4	O	O	O
days	O	O	O
for	O	O	O
xylem	O	O	O
.	O	O	O

Provenances	O	O	B-T077
with	O	O	O
early	O	O	B-T079
bud	O	O	B-T002
flush	O	O	B-T052
had	O	O	O
an	O	O	O
early	O	O	O
bud	O	O	O
set	O	O	O
and	O	O	O
completed	O	O	B-T080
xylem	O	O	B-T002
formation	O	O	B-T169
earlier	O	O	B-T079
than	O	O	O
late	O	O	B-T079
bud	O	O	O
flush	O	O	O
provenances	O	O	B-T077
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
difference	O	O	B-T081
in	O	O	O
the	O	O	O
period	O	O	B-T079
of	O	O	O
xylem	O	O	B-T002
formation	O	O	B-T169
and	O	O	O
total	O	O	B-T080
growth	O	O	B-T040
was	O	O	O
observed	O	O	B-T169
between	O	O	O
the	O	O	O
flushing	O	O	B-T052
classes	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	B-T033
demonstrate	O	O	O
that	O	O	O
the	O	O	O
ecotype	O	O	B-T032
differentiation	O	O	B-T043
of	O	O	O
black	O	O	B-T002
spruce	O	O	I-T002
provenances	O	O	B-T077
represented	O	O	O
by	O	O	O
the	O	O	O
phenological	O	O	B-T080
adaptation	O	O	B-T038
of	O	O	O
buds	O	O	B-T002
to	O	O	O
the	O	O	O
local	O	O	B-T082
climate	O	O	B-T070
corresponds	O	O	O
to	O	O	O
specific	O	O	B-T080
growth	O	O	B-T040
dynamics	O	O	B-T070
of	O	O	O
the	O	O	O
xylem	O	O	B-T002
.	O	O	O

-DOCSTART- (28340485)

An	O	O	O
approach	O	O	O
for	O	O	O
liposome	O	O	B-T109
immobilization	O	O	B-T061
using	O	O	O
sterically	O	O	B-T080
stabilized	O	O	I-T080
micelles	O	O	B-T109
(	O	O	O
SSMs	O	O	B-T109
)	O	O	O
as	O	O	O
a	O	O	O
precursor	O	O	B-T078
for	O	O	O
bio-layer	O	O	B-T059
interferometry	O	O	I-T059
-	O	O	O
based	O	O	B-T169
interaction	O	O	B-T169
studies	O	O	O

Non-fluidic	O	O	B-T080
bio-layer	O	O	B-T059
interferometry	O	O	I-T059
(	O	O	O
BLI	O	O	B-T059
)	O	O	O
has	O	O	O
rapidly	O	O	B-T080
become	O	O	O
a	O	O	O
standard	O	O	B-T080
tool	O	O	O
for	O	O	O
monitoring	O	O	B-T057
almost	O	O	O
all	O	O	O
biomolecular	O	O	B-T080
interactions	O	O	B-T169
in	O	O	O
a	O	O	O
label-free	O	O	B-T080
,	O	O	O
real-time	O	O	B-T079
and	O	O	O
high-throughput	O	O	B-T080
manner	O	O	O
.	O	O	O

High	O	O	B-T080
-	O	O	O
efficiency	O	O	B-T081
screening	O	O	B-T059
methods	O	O	I-T059
which	O	O	O
measure	O	O	B-T081
the	O	O	O
kinetics	O	O	B-T070
of	O	O	O
liposomes	O	O	B-T109
with	O	O	O
a	O	O	O
variety	O	O	B-T077
of	O	O	O
compounds	O	O	B-T103
require	O	O	O
the	O	O	O
immobilization	O	O	B-T061
of	O	O	O
liposomes	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
a	O	O	O
method	O	O	B-T169
is	O	O	O
described	O	O	B-T078
for	O	O	O
immobilizing	O	O	B-T061
liposomes	O	O	B-T109
for	O	O	O
interaction	O	O	B-T169
studies	O	O	B-T062
,	O	O	O
based	O	O	B-T169
on	O	O	O
the	O	O	O
biophysical	O	O	B-T070
principles	O	O	I-T070
of	O	O	O
this	O	O	O
biosensor	O	O	B-T075
platform	O	O	B-T075
.	O	O	O

The	O	O	O
immobilization	O	O	B-T061
approach	O	O	O
includes	O	O	B-T169
the	O	O	O
loading	O	O	B-T052
of	O	O	O
DSPE-PEG(2000	O	O	B-T109
)	O	O	I-T109
-	O	O	O
biotin	O	O	B-T127
containing	O	O	O
sterically	O	O	B-T080
stabilized	O	O	I-T080
micelles	O	O	B-T109
(	O	O	O
SSMs	O	O	B-T109
)	O	O	O
which	O	O	O
are	O	O	O
restructured	O	O	B-T080
in	O	O	O
a	O	O	O
buffer	O	O	B-T080
change	O	O	I-T080
step	O	O	O
,	O	O	O
resulting	O	O	B-T169
in	O	O	I-T169
an	O	O	O
accessible	O	O	O
substrate	O	O	B-T167
for	O	O	O
liposome	O	O	B-T109
immobilization	O	O	O
.	O	O	O

Liposomes	O	O	B-T109
in	O	O	O
a	O	O	O
concentration	O	O	B-T081
of	O	O	O
5mM	O	O	O
of	O	O	O
varying	O	O	O
composition	O	O	B-T201
and	O	O	O
fluidity	O	O	B-T081
were	O	O	O
immobilized	O	O	B-T061
on	O	O	O
the	O	O	O
sensor	O	O	B-T075
surface	O	O	B-T082
by	O	O	O
inserting	O	O	O
the	O	O	O
hydrophobic	O	O	B-T080
residues	O	O	B-T077
of	O	O	O
the	O	O	O
former	O	O	B-T079
loaded	O	O	O
SSMs	O	O	B-T109
.	O	O	O

This	O	O	O
proof	O	O	O
of	O	O	O
principle	O	O	O
was	O	O	O
carried	O	O	O
out	O	O	O
using	O	O	O
Cytochrome	O	O	B-T116
C	O	O	I-T116
as	O	O	O
a	O	O	O
membrane-interacting	O	O	B-T080
model	O	O	O
protein	O	O	B-T116
.	O	O	O

The	O	O	O
binding	O	O	B-T044
of	O	O	O
Cytochrome	O	O	B-T116
C	O	O	I-T116
to	O	O	O
the	O	O	O
immobilized	O	O	B-T061
liposomes	O	O	B-T109
was	O	O	O
demonstrated	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
derived	O	O	O
kinetic	O	O	B-T070
and	O	O	O
affinity	O	O	B-T070
constants	O	O	B-T081
were	O	O	O
similar	O	O	B-T080
to	O	O	O
values	O	O	B-T080
given	O	O	O
in	O	O	O
the	O	O	O
literature	O	O	B-T170
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
obtain	O	O	O
a	O	O	O
detailed	O	O	B-T080
understanding	O	O	B-T041
of	O	O	O
this	O	O	O
surface	O	O	B-T082
,	O	O	O
and	O	O	O
to	O	O	O
show	O	O	O
the	O	O	O
integrity	O	O	B-T080
of	O	O	O
the	O	O	O
liposomes	O	O	B-T109
,	O	O	O
confocal	O	O	B-T059
fluorescence	O	O	I-T059
microscopy	O	O	I-T059
was	O	O	O
used	O	O	O
.	O	O	O

Images	O	O	O
of	O	O	O
immobilized	O	O	B-T061
liposomes	O	O	B-T109
containing	O	O	B-T169
calcein	O	O	B-T109
in	O	O	O
the	O	O	O
aqueous	O	O	B-T080
core	O	O	B-T082
indicated	O	O	B-T033
intact	O	O	B-T080
vesicles	O	O	B-T026
.	O	O	O

A	O	O	O
combination	O	O	B-T080
of	O	O	O
this	O	O	O
simple	O	O	O
liposome	O	O	B-T109
immobilization	O	O	B-T061
approach	O	O	O
,	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
automation	O	O	B-T066
on	O	O	O
BLI	O	O	B-T059
systems	O	O	B-T169
with	O	O	O
high	O	O	B-T080
throughput	O	O	I-T080
within	O	O	O
an	O	O	O
acceptable	O	O	B-T080
timescale	O	O	O
and	O	O	O
excellent	O	O	B-T080
reproducibility	O	O	B-T080
makes	O	O	O
this	O	O	O
assay	O	O	B-T059
suitable	O	O	B-T080
for	O	O	O
basic	O	O	O
research	O	O	B-T062
as	O	O	O
well	O	O	O
as	O	O	O
for	O	O	O
industrial	O	O	B-T169
and	O	O	O
regulatory	O	O	B-T170
applications	O	O	I-T170
.	O	O	O

-DOCSTART- (28341903)

Exercise	O	O	B-T056
increases	O	O	B-T081
lactoferrin	O	O	B-T116
,	O	O	O
but	O	O	O
decreases	O	O	B-T081
lysozyme	O	O	B-T116
in	O	O	O
salivary	O	O	B-T082
granulocytes	O	O	O

Intracellular	O	O	B-T116
lactoferrin	O	O	I-T116
(	O	O	O
Lac	O	O	B-T116
)	O	O	O
and	O	O	O
lysozyme	O	O	B-T116
(	O	O	O
Lys	O	O	B-T116
)	O	O	O
content	O	O	O
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
regulating	O	O	O
inflammation	O	O	B-T046
and	O	O	O
promoting	O	O	B-T052
host	O	O	B-T039
protection	O	O	I-T039
.	O	O	O

While	O	O	O
exercise	O	O	B-T056
has	O	O	O
demonstrated	O	O	O
an	O	O	O
increase	O	O	B-T081
in	O	O	O
Lac	O	O	B-T116
and	O	O	O
Lys	O	O	B-T116
concentration	O	O	B-T081
in	O	O	O
exocrine	O	O	B-T031
solutions	O	O	I-T031
,	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
regarding	O	O	O
intracellular	O	O	B-T081
concentration	O	O	I-T081
changes	O	O	I-T081
in	O	O	O
response	O	O	O
to	O	O	O
exercise	O	O	O
.	O	O	O

To	O	O	O
quantify	O	O	B-T081
intracellular	O	O	O
Lac	O	O	B-T116
and	O	O	O
Lys	O	O	B-T116
concentration	O	O	B-T081
before	O	O	O
and	O	O	O
after	O	O	O
exercise	O	O	B-T056
in	O	O	O
salivary	O	O	B-T082
CD45(+)CD15(+	O	O	B-T025
)	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

11	O	O	O
males	O	O	B-T032
(	O	O	O
20.3	O	O	O
±	O	O	O
0.8	O	O	O
years	O	O	B-T079
,	O	O	O
57.2	O	O	O
±	O	O	O
7.6	O	O	O
mL/kg/min	O	O	O
V̇O2pk	O	O	B-T081
,	O	O	O
11.1	O	O	O
±	O	O	O
3.9	O	O	O
%	O	O	O
body	O	O	B-T201
fat	O	O	I-T201
)	O	O	O
ran	O	O	B-T056
for	O	O	O
45	O	O	O
min	O	O	B-T079
at	O	O	O
75	O	O	O
%	O	O	O
of	O	O	O
VO2pk	O	O	B-T081
.	O	O	O

12	O	O	O
mL	O	O	O
of	O	O	O
stimulated	O	O	B-T031
saliva	O	O	I-T031
were	O	O	O
collected	O	O	B-T169
pre	O	O	B-T079
and	O	O	O
immediately	O	O	O
post	O	O	B-T079
exercise	O	O	I-T079
.	O	O	O

Saliva	O	O	B-T031
was	O	O	O
filtered	O	O	O
through	O	O	O
a	O	O	O
30-µm	O	O	O
filter	O	O	O
before	O	O	O
analysis	O	O	O
of	O	O	O
leukocytes	O	O	B-T025
(	O	O	O
CD45(+	O	O	B-T025
)	O	O	I-T025
)	O	O	O
and	O	O	O
granulocytes	O	O	B-T025
(	O	O	O
CD45(+)CD15(+	O	O	B-T025
)	O	O	I-T025
)	O	O	O
using	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
.	O	O	O

Median	O	O	B-T081
fluorescent	O	O	I-T081
intensity	O	O	I-T081
(	O	O	O
MFI	O	O	B-T081
)	O	O	O
of	O	O	O
Lac	O	O	B-T116
increased	O	O	B-T081
from	O	O	O
pre	O	O	B-T079
(	O	O	O
64,268	O	O	O
±	O	O	O
46,036	O	O	O
MFI	O	O	O
)	O	O	O
to	O	O	O
post	O	O	B-T079
(	O	O	O
117,134	O	O	O
±	O	O	O
88,115	O	O	O
MFI	O	O	O
)	O	O	O
exercise	O	O	B-T056
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Lys	O	O	B-T116
MFI	O	O	B-T081
decreased	O	O	B-T081
with	O	O	O
exercise	O	O	B-T056
(	O	O	O
pre	O	O	B-T079
:	O	O	O
16,933	O	O	O
±	O	O	O
8249	O	O	O
;	O	O	O
post	O	O	B-T079
:	O	O	O
11,616	O	O	O
±	O	O	O
6875	O	O	O
)	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Acute	O	O	B-T056
running	O	O	I-T056
resulted	O	O	O
in	O	O	O
an	O	O	O
increased	O	O	B-T081
Lac	O	O	B-T116
concentration	O	O	B-T081
which	O	O	O
could	O	O	O
lead	O	O	O
to	O	O	O
a	O	O	O
decrease	O	O	B-T081
in	O	O	O
inflammation	O	O	B-T046
,	O	O	O
adding	O	O	O
further	O	O	O
evidence	O	O	O
of	O	O	O
the	O	O	O
anti-inflammatory	O	O	B-T080
effects	O	O	I-T080
of	O	O	O
exercise	O	O	B-T056
.	O	O	O

Conversely	O	O	O
,	O	O	O
the	O	O	O
exercise	O	O	B-T056
-associated	O	O	O
decrease	O	O	B-T081
of	O	O	O
intracellular	O	O	B-T116
Lys	O	O	B-T116
content	O	O	O
could	O	O	O
be	O	O	O
the	O	O	O
cause	O	O	B-T169
of	O	O	O
increased	O	O	B-T081
Lys	O	O	O
in	O	O	O
exocrine	O	O	B-T031
solutions	O	O	I-T031
.	O	O	O

-DOCSTART- (28345005)

Chronic	O	O	B-T061
Enzyme	O	O	I-T061
Replacement	O	O	I-T061
to	O	O	O
the	O	O	O
Brain	O	O	B-T023
of	O	O	O
a	O	O	O
Late	O	O	B-T047
Infantile	O	O	I-T047
Neuronal	O	O	I-T047
Ceroid	O	O	I-T047
Lipofuscinosis	O	O	I-T047
Mouse	O	O	B-T015
Has	O	O	O
Differential	O	O	O
Effects	O	O	B-T080
on	O	O	O
Phenotypes	O	O	B-T032
of	O	O	O
Disease	O	O	O

Late	O	O	B-T047
infantile	O	O	I-T047
neuronal	O	O	I-T047
ceroid	O	O	I-T047
lipofuscinosis	O	O	I-T047
(	O	O	O
LINCL	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
fatal	O	O	B-T080
inherited	O	O	O
neurodegenerative	O	O	B-T047
disease	O	O	I-T047
caused	O	O	O
by	O	O	O
loss	O	O	O
of	O	O	O
lysosomal	O	O	B-T116
protease	O	O	I-T116
tripeptidyl	O	O	I-T116
peptidase	O	O	I-T116
1	O	O	I-T116
(	O	O	O
TPP1	O	O	B-T116
)	O	O	O
.	O	O	O

We	O	O	O
have	O	O	O
investigated	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	O
chronic	O	O	B-T169
intrathecal	O	O	I-T169
(	O	O	I-T169
IT	O	O	I-T169
)	O	O	I-T169
administration	O	O	I-T169
using	O	O	O
enzyme	O	O	B-T061
replacement	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
ERT	O	O	B-T061
)	O	O	O
to	O	O	O
the	O	O	O
brain	O	O	B-T023
of	O	O	O
an	O	O	O
LINCL	O	O	B-T047
mouse	O	O	B-T050
model	O	O	I-T050
,	O	O	O
in	O	O	O
which	O	O	O
locomotor	O	O	B-T038
function	O	O	I-T038
declines	O	O	O
dramatically	O	O	O
prior	O	O	O
to	O	O	O
early	O	O	B-T033
death	O	O	I-T033
.	O	O	O

Median	O	O	O
lifespan	O	O	B-T102
was	O	O	O
significantly	O	O	O
extended	O	O	O
from	O	O	O
126	O	O	O
days	O	O	B-T079
to	O	O	O
>	O	O	O
259	O	O	O
days	O	O	O
when	O	O	O
chronic	O	O	B-T061
IT	O	O	I-T061
treatment	O	O	I-T061
was	O	O	O
initiated	O	O	O
before	O	O	O
the	O	O	O
onset	O	O	B-T079
of	O	O	O
disease	O	O	B-T047
.	O	O	O

While	O	O	O
treated	O	O	O
animals	O	O	B-T008
lived	O	O	O
longer	O	O	O
and	O	O	O
showed	O	O	O
little	O	O	O
sign	O	O	O
of	O	O	O
locomotor	O	O	B-T033
dysfunction	O	O	I-T033
as	O	O	O
measured	O	O	O
by	O	O	O
stride	O	O	O
length	O	O	O
,	O	O	O
some	O	O	O
or	O	O	O
all	O	O	O
(	O	O	O
depending	O	O	O
on	O	O	O
regimen	O	O	O
)	O	O	O
still	O	O	O
died	O	O	B-T040
prematurely	O	O	O
.	O	O	O

One	O	O	O
explanation	O	O	O
is	O	O	O
that	O	O	O
cerebrospinal	O	O	B-T031
fluid	O	O	I-T031
(CSF)-mediated	O	O	O
delivery	O	O	B-T169
may	O	O	O
not	O	O	O
deliver	O	O	B-T169
TPP1	O	O	B-T116
to	O	O	O
all	O	O	O
brain	O	O	B-T029
regions	O	O	I-T029
.	O	O	O

Morphological	O	O	B-T082
studies	O	O	B-T062
support	O	O	O
this	O	O	O
,	O	O	O
showing	O	O	O
delivery	O	O	B-T169
of	O	O	O
TPP1	O	O	B-T116
to	O	O	O
ventral	O	O	B-T029
,	O	O	O
but	O	O	O
not	O	O	O
deeper	O	O	O
and	O	O	O
dorsal	O	O	B-T029
regions	O	O	I-T029
.	O	O	O

When	O	O	O
IT	O	O	B-T061
treatment	O	O	I-T061
is	O	O	O
initiated	O	O	O
in	O	O	O
severely	O	O	B-T080
affected	O	O	B-T169
LINCL	O	O	B-T047
mice	O	O	B-T015
,	O	O	O
lifespan	O	O	B-T102
was	O	O	O
extended	O	O	O
modestly	O	O	O
in	O	O	O
most	O	O	O
but	O	O	O
dramatically	O	O	O
extended	O	O	O
in	O	O	O
approximately	O	O	O
one-third	O	O	O
of	O	O	O
the	O	O	O
cohort	O	O	B-T098
.	O	O	O

Treatment	O	O	B-T169
improved	O	O	O
locomotor	O	O	B-T038
function	O	O	I-T038
in	O	O	O
these	O	O	O
severely	O	O	O
compromised	O	O	O
animals	O	O	B-T008
after	O	O	O
it	O	O	O
had	O	O	O
declined	O	O	O
to	O	O	O
the	O	O	O
point	O	O	O
at	O	O	O
which	O	O	O
animals	O	O	O
normally	O	O	O
die	O	O	B-T040
.	O	O	O

This	O	O	O
indicates	O	O	O
that	O	O	O
some	O	O	O
pathology	O	O	B-T046
in	O	O	O
LINCL	O	O	B-T047
is	O	O	O
reversible	O	O	B-T169
and	O	O	O
does	O	O	O
not	O	O	O
simply	O	O	O
reflect	O	O	O
neuronal	O	O	B-T043
death	O	O	I-T043
.	O	O	O

-DOCSTART- (28346872)

5-Bromo-2-aryl	O	O	B-T109
benzimidazole	O	O	I-T109
derivatives	O	O	I-T109
as	O	O	O
non-cytotoxic	O	O	B-T121
potential	O	O	B-T080
dual	O	O	O
inhibitors	O	O	B-T121
of	O	O	O
α-glucosidase	O	O	B-T116
and	O	O	O
urease	O	O	O
enzymes	O	O	O

On	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
previous	O	O	O
report	O	O	B-T170
on	O	O	O
promising	O	O	O
α-glucosidase	O	O	B-T116
inhibitory	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
5-bromo-2-aryl	O	O	B-T109
benzimidazole	O	O	I-T109
derivatives	O	O	I-T109
,	O	O	O
these	O	O	O
derivatives	O	O	O
were	O	O	O
further	O	O	O
screened	O	O	B-T059
for	O	O	O
urease	O	O	B-T116
inhibitory	O	O	O
and	O	O	O
cytotoxicity	O	O	B-T059
activity	O	O	I-T059
in	O	O	O
order	O	O	O
to	O	O	O
get	O	O	O
more	O	O	B-T080
potent	O	O	I-T080
and	O	O	O
non-cytotoxic	O	O	B-T121
potential	O	O	B-T080
dual	O	O	O
inhibitor	O	O	B-T121
for	O	O	O
the	O	O	O
patients	O	O	B-T101
suffering	O	O	O
from	O	O	O
diabetes	O	O	B-T047
as	O	O	O
well	O	O	O
as	O	O	O
peptic	O	O	B-T047
ulcer	O	O	I-T047
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
all	O	O	O
compounds	O	O	B-T121
showed	O	O	O
varying	O	O	O
degree	O	O	B-T038
of	O	O	I-T038
potency	O	O	I-T038
in	O	O	O
the	O	O	O
range	O	O	O
of	O	O	O
(	O	O	O
IC50	O	O	B-T081
=	O	O	O
8.15±0.03	O	O	O
-	O	O	O
354.67±0.19μM	O	O	O
)	O	O	O
as	O	O	O
compared	O	O	O
to	O	O	O
standard	O	O	B-T081
thiourea	O	O	B-T109
(	O	O	O
IC50	O	O	O
=	O	O	O
21.25±0.15μM	O	O	O
)	O	O	O
.	O	O	O

It	O	O	O
is	O	O	O
worth	O	O	O
mentioning	O	O	O
that	O	O	O
derivatives	O	O	B-T121
7	O	O	I-T121
(	O	O	O
IC50	O	O	B-T081
=	O	O	O
12.07±0.05μM	O	O	O
)	O	O	O
,	O	O	O
8	O	O	B-T121
(	O	O	O
IC50	O	O	O
=	O	O	O
10.57±0.12μM	O	O	O
)	O	O	O
,	O	O	O
11	O	O	B-T121
(	O	O	O
IC50	O	O	O
=	O	O	O
13.76±0.02μM	O	O	O
)	O	O	O
,	O	O	O
14	O	O	B-T121
(	O	O	O
IC50	O	O	O
=	O	O	O
15.70±0.12μM	O	O	O
)	O	O	O
and	O	O	O
22	O	O	B-T121
(	O	O	O
IC50	O	O	O
=	O	O	O
8.15±0.03μM	O	O	O
)	O	O	O
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
more	O	O	O
potent	O	O	B-T121
inhibitors	O	O	I-T121
than	O	O	O
standard	O	O	B-T081
.	O	O	O

All	O	O	O
compounds	O	O	B-T121
were	O	O	O
also	O	O	O
evaluated	O	O	O
for	O	O	O
cytotoxicity	O	O	B-T059
towards	O	O	O
3T3	O	O	B-T025
mouse	O	O	B-T025
fibroblast	O	O	I-T025
cell	O	O	I-T025
line	O	O	I-T025
and	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
completely	O	O	O
non-toxic	O	O	B-T033
.	O	O	O

Previously	O	O	O
benzimidazole	O	O	B-T109
1	O	O	I-T109
-	O	O	I-T109
25	O	O	I-T109
were	O	O	O
also	O	O	O
showed	O	O	O
α-glucosidase	O	O	B-T116
inhibitory	O	O	B-T044
potential	O	O	I-T044
.	O	O	O

In	O	O	B-T066
silico	O	O	I-T066
studies	O	O	B-T062
were	O	O	O
performed	O	O	O
on	O	O	O
the	O	O	O
lead	O	O	B-T121
molecules	O	O	I-T121
i.e.	O	O	O
2	O	O	B-T121
,	O	O	O
7	O	O	B-T121
,	O	O	O
8	O	O	B-T121
,	O	O	O
11	O	O	B-T121
,	O	O	O
14	O	O	B-T121
,	O	O	O
and	O	O	O
22	O	O	B-T121
,	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
rationalize	O	O	O
the	O	O	O
binding	O	O	B-T044
interaction	O	O	I-T044
of	O	O	O
compounds	O	O	B-T121
with	O	O	O
the	O	O	O
active	O	O	B-T169
site	O	O	I-T169
of	O	O	O
urease	O	O	B-T116
enzyme	O	O	I-T116
.	O	O	O

-DOCSTART- (28347978)

Intra-articular	O	O	B-T082
implantation	O	O	B-T061
of	O	O	O
collagen	O	O	B-T116
scaffold	O	O	B-T073
carriers	O	O	B-T074
is	O	O	O
safe	O	O	B-T082
in	O	O	O
both	O	O	O
native	O	O	B-T169
and	O	O	O
arthrofibrotic	O	O	B-T047
rabbit	O	O	B-T015
knee	O	O	O
joints	O	O	O

Sustained	O	O	B-T169
intra-articular	O	O	B-T082
delivery	O	O	B-T070
of	O	O	I-T070
pharmacological	O	O	I-T070
agents	O	O	I-T070
is	O	O	O
an	O	O	O
attractive	O	O	B-T080
modality	O	O	B-T078
but	O	O	O
requires	O	O	O
use	O	O	B-T169
of	O	O	O
a	O	O	O
safe	O	O	B-T082
carrier	O	O	B-T074
that	O	O	O
would	O	O	O
not	O	O	O
induce	O	O	B-T169
cartilage	O	O	B-T037
damage	O	O	I-T037
or	O	O	O
fibrosis	O	O	B-T046
.	O	O	O

Collagen	O	O	B-T116
scaffolds	O	O	B-T073
are	O	O	O
widely	O	O	O
available	O	O	B-T169
and	O	O	O
could	O	O	O
be	O	O	O
used	O	O	O
intra-articularly	O	O	B-T082
,	O	O	O
but	O	O	O
no	O	O	O
investigation	O	O	B-T058
has	O	O	O
looked	O	O	O
at	O	O	O
the	O	O	O
safety	O	O	B-T068
of	O	O	O
collagen	O	O	B-T116
scaffolds	O	O	O
within	O	O	O
synovial	O	O	B-T030
joints	O	O	I-T030
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	B-T078
the	O	O	O
safety	O	O	B-T068
of	O	O	O
collagen	O	O	B-T116
scaffold	O	O	B-T073
implantation	O	O	B-T061
in	O	O	O
a	O	O	O
validated	O	O	B-T062
in	O	O	B-T082
vivo	O	O	I-T082
animal	O	O	B-T008
model	O	O	O
of	O	O	O
knee	O	O	B-T047
arthrofibrosis	O	O	I-T047
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
96	O	O	O
rabbits	O	O	B-T015
were	O	O	O
randomly	O	O	B-T080
and	O	O	O
equally	O	O	B-T080
assigned	O	O	B-T169
to	O	O	O
four	O	O	O
different	O	O	B-T080
groups	O	O	B-T078
:	O	O	O
arthrotomy	O	O	B-T061
alone	O	O	O
;	O	O	O
arthrotomy	O	O	O
and	O	O	O
collagen	O	O	B-T116
scaffold	O	O	B-T073
placement	O	O	B-T058
;	O	O	O
contracture	O	O	B-T190
surgery	O	O	B-T061
;	O	O	O
and	O	O	O
contracture	O	O	O
surgery	O	O	O
and	O	O	O
collagen	O	O	O
scaffold	O	O	O
placement	O	O	O
.	O	O	O

Animals	O	O	B-T008
were	O	O	O
killed	O	O	B-T054
in	O	O	O
equal	O	O	B-T080
numbers	O	O	O
at	O	O	O
72	O	O	O
hours	O	O	B-T079
,	O	O	O
two	O	O	O
weeks	O	O	B-T079
,	O	O	O
eight	O	O	O
weeks	O	O	O
,	O	O	O
and	O	O	O
24	O	O	O
weeks	O	O	O
.	O	O	O

Joint	O	O	B-T190
contracture	O	O	I-T190
was	O	O	O
measured	O	O	B-T080
,	O	O	O
and	O	O	O
cartilage	O	O	B-T024
and	O	O	O
synovial	O	O	B-T023
samples	O	O	B-T167
underwent	O	O	O
histological	O	O	B-T059
analysis	O	O	I-T059
.	O	O	O

Animals	O	O	B-T008
that	O	O	O
underwent	O	O	O
arthrotomy	O	O	B-T061
had	O	O	O
equivalent	O	O	B-T080
joint	O	O	B-T190
contractures	O	O	I-T190
regardless	O	O	O
of	O	O	O
scaffold	O	O	B-T073
implantation	O	O	B-T061
(	O	O	O
-13.9	O	O	O
°	O	O	O
versus	O	O	O
-10.9	O	O	O
°	O	O	O
,	O	O	O
equivalence	O	O	O
limit	O	O	O
15	O	O	O
°	O	O	O
)	O	O	O
.	O	O	O

Animals	O	O	B-T008
that	O	O	O
underwent	O	O	O
surgery	O	O	B-T061
to	O	O	O
induce	O	O	B-T169
contracture	O	O	B-T190
did	O	O	O
not	O	O	O
demonstrate	O	O	O
equivalent	O	O	B-T080
joint	O	O	B-T190
contracture	O	O	I-T190
s	O	O	O
with	O	O	O
(	O	O	O
41.8	O	O	O
°	O	O	O
)	O	O	O
or	O	O	O
without	O	O	O
(	O	O	O
53.9	O	O	O
°	O	O	O
)	O	O	O
collagen	O	O	B-T116
scaffold	O	O	B-T073
implantation	O	O	B-T061
.	O	O	O

Chondral	O	O	B-T082
damage	O	O	B-T169
occurred	O	O	B-T052
in	O	O	O
similar	O	O	O
rates	O	O	B-T081
with	O	O	O
(	O	O	O
11	O	O	O
of	O	O	O
48	O	O	O
)	O	O	O
and	O	O	O
without	O	O	O
(	O	O	O
nine	O	O	O
of	O	O	O
48	O	O	O
)	O	O	O
scaffold	O	O	B-T073
implantation	O	O	B-T061
.	O	O	O

No	O	O	O
significant	O	O	B-T081
difference	O	O	I-T081
in	O	O	O
synovitis	O	O	B-T047
was	O	O	O
noted	O	O	O
between	O	O	O
groups	O	O	B-T078
.	O	O	O

Absorption	O	O	B-T070
of	O	O	O
the	O	O	O
collagen	O	O	B-T116
scaffold	O	O	B-T073
occurred	O	O	B-T052
within	O	O	O
eight	O	O	O
weeks	O	O	B-T079
in	O	O	O
all	O	O	O
animals	O	O	B-T008
CONCLUSION	O	O	O
:	O	O	O
Our	O	O	O
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
intra-articular	O	O	B-T082
implantation	O	O	B-T061
of	O	O	O
a	O	O	O
collagen	O	O	O
sponge	O	O	B-T073
does	O	O	O
not	O	O	O
induce	O	O	B-T169
synovitis	O	O	B-T047
or	O	O	O
cartilage	O	O	B-T037
damage	O	O	I-T037
.	O	O	O

Implantation	O	O	B-T061
in	O	O	O
a	O	O	O
native	O	O	B-T169
joint	O	O	B-T030
does	O	O	O
not	O	O	O
seem	O	O	O
to	O	O	O
induce	O	O	B-T169
contracture	O	O	B-T190
.	O	O	O

Implantation	O	O	B-T061
of	O	O	O
the	O	O	O
collagen	O	O	B-T116
sponge	O	O	B-T073
in	O	O	O
a	O	O	O
rabbit	O	O	B-T015
knee	O	O	O
model	O	O	O
of	O	O	O
contracture	O	O	B-T190
may	O	O	O
decrease	O	O	B-T081
the	O	O	O
severity	O	O	B-T080
of	O	O	O
the	O	O	O
contracture	O	O	O
.Cite	O	O	O
this	O	O	O
article	O	O	O
:	O	O	O
J.	O	O	O
A.	O	O	O
Walker	O	O	O
,	O	O	O
T.	O	O	O
J.	O	O	O
Ewald	O	O	O
,	O	O	O
E.	O	O	O
Lewallen	O	O	O
,	O	O	O
A.	O	O	O
Van	O	O	O
Wijnen	O	O	O
,	O	O	O
A.	O	O	O
D.	O	O	O
Hanssen	O	O	O
,	O	O	O
B.	O	O	O
F.	O	O	O
Morrey	O	O	O
,	O	O	O
M.	O	O	O
E.	O	O	O
Morrey	O	O	O
,	O	O	O
M.	O	O	O
P.	O	O	O
Abdel	O	O	O
,	O	O	O
J.	O	O	O
Sanchez-Sotelo	O	O	O
.	O	O	O

Intra-articular	O	O	O
implantation	O	O	O
of	O	O	O
collagen	O	O	O
scaffold	O	O	O
carriers	O	O	O
is	O	O	O
safe	O	O	O
in	O	O	O
both	O	O	O
native	O	O	O
and	O	O	O
arthrofibrotic	O	O	O
rabbit	O	O	O
knee	O	O	O
joints	O	O	O
.	O	O	O

Bone	O	O	O
Joint	O	O	O
Res	O	O	O
2016;6:162	O	O	O
-	O	O	O
171	O	O	O
.	O	O	O

DOI	O	O	O
:	O	O	O
10.1302/2046	O	O	O
-	O	O	O
3758.63.BJR-2016	O	O	O
-	O	O	O
0193	O	O	O
.	O	O	O

-DOCSTART- (28348057)

HOST	O	O	B-T001
IMMUNE	O	O	B-T042
RECOGNITION	O	O	I-T042
OF	O	O	O
THE	O	O	O
EPIDEMIC	O	O	B-T067
CYSTIC	O	O	B-T047
FIBROSIS	O	O	I-T047
PATHOGEN	O	O	B-T001
BURKHOLDERIA	O	O	O
DOLOSA	O	O	O

Burkholderia	O	O	B-T007
dolosa	O	O	I-T007
caused	O	O	O
an	O	O	O
outbreak	O	O	O
in	O	O	O
the	O	O	O
cystic	O	O	B-T047
fibrosis	O	O	I-T047
(	O	O	O
CF	O	O	B-T047
)	O	O	O
clinic	O	O	O
at	O	O	O
Boston	O	O	B-T093
Children	O	O	I-T093
's	O	O	I-T093
Hospital	O	O	I-T093
from	O	O	O
1998	O	O	O
to	O	O	O
2005	O	O	O
and	O	O	O
led	O	O	O
to	O	O	O
the	O	O	O
infection	O	O	B-T046
of	O	O	O
over	O	O	O
40	O	O	O
patients	O	O	B-T101
,	O	O	O
many	O	O	O
of	O	O	O
whom	O	O	O
died	O	O	B-T040
due	O	O	O
to	O	O	O
complications	O	O	B-T046
from	O	O	O
infection	O	O	O
by	O	O	O
this	O	O	O
organism	O	O	B-T007
.	O	O	O

To	O	O	O
assess	O	O	O
whether	O	O	O
B.	O	O	B-T007
dolosa	O	O	I-T007
significantly	O	O	O
contributes	O	O	O
to	O	O	O
disease	O	O	B-T047
or	O	O	O
is	O	O	O
recognized	O	O	O
by	O	O	O
the	O	O	O
host	O	O	B-T001
immune	O	O	B-T042
response	O	O	I-T042
,	O	O	O
mice	O	O	B-T015
were	O	O	O
infected	O	O	B-T033
with	O	O	O
a	O	O	O
sequenced	O	O	O
outbreak	O	O	O
B.	O	O	B-T007
dolosa	O	O	I-T007
strain	O	O	I-T007
,	O	O	O
AU0158	O	O	B-T007
,	O	O	O
and	O	O	O
responses	O	O	B-T032
compared	O	O	O
to	O	O	O
the	O	O	O
well-studied	O	O	O
CF	O	O	B-T047
pathogen	O	O	B-T001
,	O	O	O
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
In	O	O	O
parallel	O	O	O
,	O	O	O
mice	O	O	O
were	O	O	O
also	O	O	O
infected	O	O	O
with	O	O	O
a	O	O	O
polar	O	O	O
flagellin	O	O	B-T026
mutant	O	O	B-T049
of	O	O	O
B.	O	O	O
dolosa	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
flagella	O	O	B-T026
in	O	O	O
B.	O	O	O
dolosa	O	O	O
lung	O	O	B-T023
colonization	O	O	B-T033
.	O	O	O

The	O	O	O
results	O	O	O
showed	O	O	O
a	O	O	O
higher	O	O	B-T080
persistence	O	O	B-T041
in	O	O	O
the	O	O	O
host	O	O	B-T001
by	O	O	O
B.	O	O	B-T007
dolosa	O	O	I-T007
strains	O	O	I-T007
and	O	O	O
yet	O	O	O
neutrophil	O	O	B-T025
recruitment	O	O	O
and	O	O	O
cytokine	O	O	B-T116
production	O	O	B-T169
were	O	O	O
lower	O	O	O
compared	O	O	O
to	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
The	O	O	O
ability	O	O	O
of	O	O	O
host	O	O	O
immune	O	O	B-T025
cells	O	O	I-T025
to	O	O	O
recognize	O	O	O
B.	O	O	O
dolosa	O	O	O
was	O	O	O
then	O	O	O
assessed	O	O	O
and	O	O	O
B.	O	O	O
dolosa	O	O	O
induced	O	O	O
a	O	O	O
robust	O	O	O
cytokine	O	O	O
response	O	O	O
in	O	O	O
cultured	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
this	O	O	O
effect	O	O	O
was	O	O	O
dependent	O	O	O
on	O	O	O
the	O	O	O
flagella	O	O	B-T026
only	O	O	O
when	O	O	O
bacteria	O	O	B-T007
were	O	O	O
dead	O	O	B-T040
.	O	O	O

Together	O	O	O
,	O	O	O
these	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
B.	O	O	B-T007
dolosa	O	O	I-T007
can	O	O	O
be	O	O	O
recognized	O	O	O
by	O	O	O
host	O	O	B-T001
cells	O	O	I-T026
in	O	O	B-T080
vitro	O	O	I-T080
but	O	O	O
may	O	O	O
avoid	O	O	O
or	O	O	O
suppress	O	O	B-T169
the	O	O	O
host	O	O	O
immune	O	O	B-T042
response	O	O	I-T042
in	O	O	B-T082
vivo	O	O	I-T082
through	O	O	O
unknown	O	O	O
mechanisms	O	O	O
.	O	O	O

B.	O	O	B-T007
dolosa	O	O	I-T007
was	O	O	O
then	O	O	O
compared	O	O	O
to	O	O	O
other	O	O	O
Burkholderia	O	O	B-T007
species	O	O	I-T007
and	O	O	O
found	O	O	O
to	O	O	O
induce	O	O	O
similar	O	O	O
levels	O	O	O
of	O	O	O
cytokine	O	O	B-T116
production	O	O	B-T169
despite	O	O	O
being	O	O	O
internalized	O	O	O
by	O	O	O
macrophages	O	O	B-T025
more	O	O	O
than	O	O	O
B.	O	O	B-T007
cenocepacia	O	O	I-T007
strains	O	O	I-T007
.	O	O	O

These	O	O	O
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
B.	O	O	B-T007
dolosa	O	O	I-T007
AU0158	O	O	I-T007
may	O	O	O
act	O	O	O
differently	O	O	O
with	O	O	O
host	O	O	B-T026
cells	O	O	I-T026
and	O	O	O
is	O	O	O
it	O	O	O
recognized	O	O	O
differently	O	O	O
by	O	O	O
immune	O	O	B-T022
systems	O	O	I-T022
compared	O	O	O
other	O	O	O
Burkholderia	O	O	B-T007
strains	O	O	I-T007
or	O	O	O
species	O	O	B-T185
.	O	O	O

-DOCSTART- (28355176)

Visualization	O	O	B-T033
and	O	O	O
targeting	O	O	B-T169
of	O	O	O
LGR5(+	O	O	B-T028
)	O	O	I-T028
human	O	O	B-T016
colon	O	O	B-T023
cancer	O	O	O
stem	O	O	O
cells	O	O	O

The	O	O	O
cancer	O	O	B-T025
stem	O	O	I-T025
cell	O	O	I-T025
(	O	O	O
CSC	O	O	B-T025
)	O	O	O
theory	O	O	B-T078
highlights	O	O	O
a	O	O	O
self-renewing	O	O	B-T043
subpopulation	O	O	B-T185
of	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
that	O	O	O
fuels	O	O	O
tumour	O	O	O
growth	O	O	O
.	O	O	O

The	O	O	O
existence	O	O	B-T081
of	O	O	O
human	O	O	B-T016
CSCs	O	O	B-T025
is	O	O	O
mainly	O	O	O
supported	O	O	O
by	O	O	O
xenotransplantation	O	O	B-T061
of	O	O	O
prospectively	O	O	O
isolated	O	O	B-T033
cells	O	O	I-T033
,	O	O	O
but	O	O	O
their	O	O	O
clonal	O	O	B-T024
dynamics	O	O	B-T070
and	O	O	O
plasticity	O	O	B-T070
remain	O	O	O
unclear	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
human	O	O	B-T016
LGR5(+	O	O	B-T028
)	O	O	I-T028
colorectal	O	O	B-T025
cancer	O	O	B-T191
cells	O	O	I-T025
serve	O	O	O
as	O	O	O
CSCs	O	O	B-T025
in	O	O	O
growing	O	O	O
cancer	O	O	O
tissues	O	O	B-T024
.	O	O	O

Lineage	O	O	B-T077
-	O	O	O
tracing	O	O	B-T059
experiments	O	O	I-T059
with	O	O	O
a	O	O	O
tamoxifen	O	O	B-T109
-inducible	O	O	O
Cre	O	O	B-T116
knock-in	O	O	B-T063
allele	O	O	B-T028
of	O	O	O
LGR5	O	O	B-T116
reveal	O	O	O
the	O	O	O
self-renewal	O	O	B-T043
and	O	O	O
differentiation	O	O	B-T043
capacity	O	O	B-T081
of	O	O	O
LGR5(+	O	O	B-T028
)	O	O	I-T028
tumour	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Selective	O	O	O
ablation	O	O	B-T061
of	O	O	O
LGR5(+	O	O	B-T028
)	O	O	I-T028
CSCs	O	O	B-T025
in	O	O	O
LGR5	O	O	B-T028
-i	O	O	O
Caspase9	O	O	B-T028
knock-in	O	O	B-T063
organoids	O	O	B-T024
leads	O	O	O
to	O	O	O
tumour	O	O	B-T201
regression	O	O	I-T201
,	O	O	O
followed	O	O	O
by	O	O	O
tumour	O	O	B-T191
regrowth	O	O	I-T191
driven	O	O	O
by	O	O	O
re-emerging	O	O	O
LGR5(+	O	O	O
)	O	O	O
CSCs	O	O	O
.	O	O	O

KRT20	O	O	B-T028
knock-in	O	O	B-T063
reporter	O	O	B-T028
marks	O	O	O
differentiated	O	O	B-T043
cancer	O	O	B-T025
cells	O	O	I-T025
that	O	O	O
constantly	O	O	O
diminish	O	O	O
in	O	O	O
tumour	O	O	B-T024
tissues	O	O	I-T024
,	O	O	O
while	O	O	O
reverting	O	O	O
to	O	O	O
LGR5(+	O	O	B-T028
)	O	O	I-T028
CSCs	O	O	B-T025
and	O	O	O
contributing	O	O	O
to	O	O	O
tumour	O	O	B-T191
regrowth	O	O	I-T191
after	O	O	O
LGR5(+	O	O	O
)	O	O	O
CSC	O	O	B-T025
ablation	O	O	B-T061
.	O	O	O

We	O	O	O
also	O	O	O
show	O	O	O
that	O	O	O
combined	O	O	O
chemotherapy	O	O	B-T061
potentiates	O	O	O
targeting	O	O	B-T169
of	O	O	O
LGR5(+	O	O	B-T028
)	O	O	I-T028
CSCs	O	O	B-T025
.	O	O	O

These	O	O	O
data	O	O	B-T078
provide	O	O	O
insights	O	O	O
into	O	O	O
the	O	O	O
plasticity	O	O	B-T070
of	O	O	O
CSCs	O	O	B-T025
and	O	O	O
their	O	O	O
potential	O	O	B-T080
as	O	O	O
a	O	O	O
therapeutic	O	O	B-T169
target	O	O	B-T169
in	O	O	O
human	O	O	B-T016
colorectal	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

-DOCSTART- (28355605)

The	O	O	O
Use	O	O	O
of	O	O	O
a	O	O	O
Software	O	O	B-T073
-	O	O	O
Assisted	O	O	B-T080
Method	O	O	B-T170
to	O	O	O
Estimate	O	O	B-T081
Fetal	O	O	B-T032
Weight	O	O	I-T032
at	O	O	O
and	O	O	O
Near	O	O	O
Term	O	O	B-T040
Using	O	O	O
Magnetic	O	O	O
Resonance	O	O	O
Imaging	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
apply	O	O	O
a	O	O	O
semi-automated	O	O	B-T169
calculation	O	O	B-T052
method	O	O	B-T170
of	O	O	O
fetal	O	O	B-T018
body	O	O	B-T032
volume	O	O	I-T032
and	O	O	O
,	O	O	O
thus	O	O	O
,	O	O	O
of	O	O	O
magnetic	O	O	B-T032
resonance-estimated	O	O	I-T032
fetal	O	O	I-T032
weight	O	O	I-T032
(	O	O	O
MR-EFW	O	O	B-T032
)	O	O	O
prior	O	O	O
to	O	O	O
planned	O	O	B-T169
delivery	O	O	B-T040
and	O	O	O
to	O	O	O
evaluate	O	O	B-T058
whether	O	O	O
the	O	O	O
technique	O	O	B-T169
of	O	O	O
measurement	O	O	B-T169
could	O	O	O
be	O	O	O
simplified	O	O	B-T080
while	O	O	O
remaining	O	O	B-T080
accurate	O	O	B-T080
.	O	O	O

MR-EFW	O	O	B-T032
was	O	O	O
calculated	O	O	B-T169
using	O	O	O
a	O	O	O
semi-automated	O	O	B-T169
method	O	O	B-T170
at	O	O	O
38.6	O	O	O
weeks	O	O	B-T079
of	O	O	O
gestation	O	O	B-T040
in	O	O	O
36	O	O	O
patients	O	O	B-T101
and	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
picture	O	O	B-T074
archiving	O	O	I-T074
and	O	O	I-T074
communication	O	O	I-T074
system	O	O	I-T074
(	O	O	O
PACS	O	O	B-T074
)	O	O	O
.	O	O	O

Per	O	O	O
patient	O	O	B-T101
,	O	O	O
8	O	O	O
sequences	O	O	B-T169
were	O	O	O
acquired	O	O	B-T080
with	O	O	O
a	O	O	O
slice	O	O	B-T081
thickness	O	O	I-T081
of	O	O	O
4	O	O	O
-	O	O	O
8	O	O	O
mm	O	O	O
and	O	O	O
an	O	O	O
intersection	O	O	B-T082
gap	O	O	I-T082
of	O	O	O
0	O	O	O
,	O	O	O
4	O	O	O
,	O	O	O
8	O	O	O
,	O	O	O
12	O	O	O
,	O	O	O
16	O	O	O
,	O	O	O
or	O	O	O
20	O	O	O
mm	O	O	O
.	O	O	O

The	O	O	O
median	O	O	B-T082
absolute	O	O	B-T080
relative	O	O	B-T080
errors	O	O	I-T080
for	O	O	O
MR-EFW	O	O	B-T032
and	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	O
planimetric	O	O	B-T169
measurements	O	O	I-T169
were	O	O	O
calculated	O	O	B-T169
for	O	O	O
all	O	O	O
8	O	O	O
sequences	O	O	B-T169
and	O	O	O
for	O	O	O
each	O	O	O
method	O	O	B-T170
(	O	O	O
assisted	O	O	B-T170
vs.	O	O	O
PACS	O	O	B-T074
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
difference	O	O	O
between	O	O	O
the	O	O	O
methods	O	O	B-T170
was	O	O	O
calculated	O	O	O
.	O	O	O

The	O	O	O
median	O	O	B-T082
delivery	O	O	O
weight	O	O	O
was	O	O	O
3,280	O	O	O
g.	O	O	O
The	O	O	O
overall	O	O	O
median	O	O	O
relative	O	O	B-T080
error	O	O	I-T080
for	O	O	O
all	O	O	O
288	O	O	O
MR-EFW	O	O	B-T032
calculations	O	O	B-T052
was	O	O	O
2.4	O	O	O
%	O	O	O
using	O	O	O
the	O	O	O
semi-automated	O	O	B-T169
method	O	O	B-T170
and	O	O	O
2.2	O	O	O
%	O	O	O
for	O	O	O
the	O	O	O
PACS	O	O	B-T074
method	O	O	O
.	O	O	O

Measurements	O	O	B-T169
did	O	O	O
not	O	O	O
differ	O	O	O
between	O	O	O
the	O	O	O
8	O	O	O
sequences	O	O	B-T169
using	O	O	O
the	O	O	O
assisted	O	O	B-T170
method	O	O	B-T170
(	O	O	O
p	O	O	O
=	O	O	O
0.313	O	O	O
)	O	O	O
or	O	O	O
the	O	O	O
PACS	O	O	B-T074
(	O	O	O
p	O	O	O
=	O	O	O
0.118	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	O
planimetric	O	O	B-T169
measurement	O	O	I-T169
decreased	O	O	B-T081
significantly	O	O	O
with	O	O	O
a	O	O	O
larger	O	O	O
gap	O	O	B-T082
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
in	O	O	O
the	O	O	O
assisted	O	O	O
method	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
PACS	O	O	O
method	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
simplified	O	O	B-T080
MR-EFW	O	O	B-T032
measurement	O	O	B-T169
showed	O	O	O
a	O	O	O
dramatic	O	O	B-T081
decrease	O	O	B-T081
in	O	O	O
time	O	O	B-T079
of	O	O	O
planimetric	O	O	B-T169
measurement	O	O	I-T169
without	O	O	O
a	O	O	O
decrease	O	O	O
in	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
weight	O	O	B-T032
estimates	O	O	B-T081
.	O	O	O

-DOCSTART- (28355968)

Abiraterone	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
rhabdomyolysis	O	O	B-T046
resulting	O	O	O
in	O	O	O
acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
:	O	O	O
A	O	O	O
case	O	O	B-T170
report	O	O	I-T170
and	O	O	O
review	O	O	O
of	O	O	O
the	O	O	O
literature	O	O	O

Abiraterone	O	O	B-T109
,	O	O	O
a	O	O	O
CYP17	O	O	B-T121
inhibitor	O	O	I-T121
,	O	O	O
blocks	O	O	O
androgen	O	O	B-T044
biosynthesis	O	O	I-T044
in	O	O	O
multiple	O	O	O
tissue	O	O	B-T024
types	O	O	O
.	O	O	O

In	O	O	O
combination	O	O	O
with	O	O	O
prednisone	O	O	B-T125
,	O	O	O
it	O	O	O
is	O	O	O
approved	O	O	O
as	O	O	O
a	O	O	O
first-line	O	O	B-T061
treatment	O	O	I-T061
for	O	O	O
metastatic	O	O	B-T191
castration-resistant	O	O	B-T191
prostate	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
case	O	O	B-T077
of	O	O	O
rhabdomyolysis	O	O	B-T046
associated	O	O	O
with	O	O	O
abiraterone	O	O	B-T109
therapy	O	O	B-T061
resulting	O	O	O
in	O	O	O
acute	O	O	B-T037
on	O	O	O
chronic	O	O	B-T079
kidney	O	O	B-T037
injury	O	O	I-T037
in	O	O	O
a	O	O	O
patient	O	O	B-T101
with	O	O	O
metastatic	O	O	B-T191
castration-resistant	O	O	B-T191
prostate	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

Strict	O	O	O
monitoring	O	O	B-T062
should	O	O	O
be	O	O	O
employed	O	O	O
in	O	O	O
patients	O	O	B-T101
started	O	O	O
on	O	O	O
abiraterone	O	O	B-T109
who	O	O	O
have	O	O	O
additional	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
developing	O	O	O
rhabdomyolysis	O	O	B-T046
.	O	O	O

-DOCSTART- (28356949)

Association	O	O	B-T080
between	O	O	O
XRCC1	O	O	B-T028
and	O	O	O
ERCC1	O	O	B-T028
single-nucleotide	O	O	B-T086
polymorphisms	O	O	I-T086
and	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
concurrent	O	O	B-T061
radiochemotherapy	O	O	I-T061
in	O	O	O
patients	O	O	B-T101
with	O	O	O
esophageal	O	O	O
squamous	O	O	O
cell	O	O	O
carcinoma	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
association	O	O	B-T080
between	O	O	O
single-nucleotide	O	O	B-T086
polymorphisms	O	O	I-T086
(	O	O	O
SNPs	O	O	B-T086
)	O	O	O
in	O	O	O
X-ray	O	O	B-T028
repair	O	O	I-T028
cross-complementing	O	O	I-T028
1	O	O	I-T028
-	O	O	I-T028
399	O	O	I-T028
(	O	O	O
XRCC1	O	O	B-T028
-	O	O	I-T028
399	O	O	I-T028
)	O	O	O
or	O	O	O
excision	O	O	B-T028
repair	O	O	I-T028
cross-complementation	O	O	I-T028
group	O	O	I-T028
1	O	O	I-T028
-	O	O	I-T028
118	O	O	I-T028
(	O	O	O
ERCC1	O	O	B-T028
-	O	O	I-T028
118	O	O	I-T028
)	O	O	O
and	O	O	O
the	O	O	O
short-term	O	O	B-T079
efficacy	O	O	B-T080
of	O	O	O
radiochemotherapy	O	O	B-T061
,	O	O	O
tumor	O	O	B-T191
metastasis	O	O	I-T191
and	O	O	O
relapse	O	O	B-T067
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
survival	O	O	B-T201
time	O	O	I-T201
in	O	O	O
patients	O	O	B-T101
with	O	O	O
esophageal	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
ESCC	O	O	B-T191
)	O	O	O
.	O	O	O

TaqMan	O	O	B-T063
probe-based	O	O	I-T063
quantitative	O	O	I-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(	O	O	O
qPCR	O	O	B-T063
)	O	O	O
was	O	O	O
conducted	O	O	O
to	O	O	O
examine	O	O	B-T033
the	O	O	O
levels	O	O	B-T080
of	O	O	O
XRCC1	O	O	B-T028
-	O	O	I-T028
399	O	O	I-T028
and	O	O	O
ERCC1	O	O	B-T028
-	O	O	I-T028
118	O	O	I-T028
SNPs	O	O	B-T086
in	O	O	O
the	O	O	O
peripheral	O	O	B-T031
blood	O	O	I-T031
of	O	O	O
50	O	O	O
patients	O	O	B-T101
with	O	O	O
pathologically	O	O	B-T169
confirmed	O	O	B-T033
ESCC	O	O	B-T191
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
associations	O	O	B-T080
between	O	O	O
different	O	O	B-T080
genotypes	O	O	B-T032
and	O	O	O
short-term	O	O	B-T079
therapeutic	O	O	B-T080
efficacy	O	O	I-T080
[	O	O	O
the	O	O	O
complete	O	O	B-T033
remission	O	O	I-T033
(	O	O	O
CR	O	O	B-T033
)	O	O	O
rate	O	O	B-T081
]	O	O	O
,	O	O	O
tumor	O	O	B-T191
metastasis	O	O	I-T191
and	O	O	O
relapse	O	O	B-T067
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
survival	O	O	B-T201
time	O	O	I-T201
following	O	O	O
concurrent	O	O	B-T061
radiochemotherapy	O	O	I-T061
,	O	O	O
were	O	O	O
determined	O	O	B-T080
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
50	O	O	O
ESCC	O	O	B-T191
patients	O	O	B-T101
who	O	O	O
received	O	O	O
concurrent	O	O	B-T061
radiochemotherapy	O	O	I-T061
were	O	O	O
enrolled	O	O	O
.	O	O	O

It	O	O	O
was	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
short-term	O	O	B-T079
therapeutic	O	O	B-T080
efficacy	O	O	I-T080
(	O	O	O
CR	O	O	B-T033
rate	O	O	B-T081
)	O	O	O
was	O	O	O
higher	O	O	O
in	O	O	O
the	O	O	O
group	O	O	B-T078
of	O	O	O
patients	O	O	B-T101
carrying	O	O	O
the	O	O	O
homozygous	O	O	B-T045
mutation	O	O	B-T045
of	O	O	O
XRCC1	O	O	B-T028
-	O	O	I-T028
399	O	O	I-T028
(	O	O	O
A	O	O	B-T114
/	O	O	O
A	O	O	O
genotype	O	O	B-T032
)	O	O	O
than	O	O	O
in	O	O	O
the	O	O	O
group	O	O	O
of	O	O	O
patients	O	O	O
without	O	O	O
the	O	O	O
XRCC1	O	O	O
-	O	O	O
399	O	O	O
mutation	O	O	O
(	O	O	O
G	O	O	B-T114
/	O	O	O
G	O	O	O
genotype	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
CR	O	O	B-T033
rate	O	O	B-T081
was	O	O	O
significantly	O	O	B-T081
increased	O	O	I-T081
in	O	O	O
patients	O	O	B-T101
carrying	O	O	O
one	O	O	O
or	O	O	O
two	O	O	O
ERCC1	O	O	B-T028
-	O	O	I-T028
118	O	O	I-T028
C	O	O	B-T114
alleles	O	O	B-T028
(	O	O	O
C	O	O	O
/	O	O	O
C	O	O	O
or	O	O	O
C	O	O	O
/	O	O	O
T	O	O	B-T114
genotype	O	O	B-T032
)	O	O	O
compared	O	O	B-T052
with	O	O	O
patients	O	O	O
lacking	O	O	O
the	O	O	O
C	O	O	O
allele	O	O	B-T028
(	O	O	O
T	O	O	O
/	O	O	O
T	O	O	O
genotype	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
differences	O	O	O
were	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
(	O	O	O
A	O	O	B-T114
/	O	O	O
A	O	O	O
vs.	O	O	O
G	O	O	B-T114
/	O	O	O
G	O	O	O
,	O	O	O
P=0.014	O	O	O
;	O	O	O
T	O	O	B-T114
T	O	O	O
vs.	O	O	O
C	O	O	B-T114
/	O	O	O
T	O	O	O
+	O	O	O
C	O	O	O
/	O	O	O
C	O	O	O
,	O	O	O
P=0.040	O	O	O
)	O	O	O
.	O	O	O

During	O	O	O
the	O	O	O
follow-up	O	O	B-T033
period	O	O	I-T033
,	O	O	O
the	O	O	O
group	O	O	B-T078
of	O	O	O
patients	O	O	B-T101
carrying	O	O	O
the	O	O	O
homozygous	O	O	B-T045
mutation	O	O	I-T045
of	O	O	O
XRCC1	O	O	B-T028
-	O	O	I-T028
399	O	O	I-T028
(	O	O	O
A	O	O	B-T114
/	O	O	O
A	O	O	O
genotype	O	O	B-T032
)	O	O	O
exhibited	O	O	O
a	O	O	O
markedly	O	O	B-T080
reduced	O	O	I-T080
risk	O	O	B-T078
of	O	O	O
metastasis	O	O	B-T046
and	O	O	O
relapse	O	O	B-T067
compared	O	O	B-T052
with	O	O	O
the	O	O	O
group	O	O	O
of	O	O	O
patients	O	O	O
carrying	O	O	O
non-mutated	O	O	O
XRCC1	O	O	O
-	O	O	O
399	O	O	O
(	O	O	O
G	O	O	B-T114
/	O	O	O
G	O	O	O
genotype	O	O	O
;	O	O	O
P=0.031	O	O	O
)	O	O	O
.	O	O	O

By	O	O	O
contrast	O	O	O
,	O	O	O
ERCC1	O	O	B-T028
-	O	O	I-T028
118	O	O	I-T028
SNP	O	O	B-T086
was	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
risk	O	O	B-T078
of	O	O	O
metastasis	O	O	B-T046
and	O	O	O
recurrence	O	O	B-T067
(	O	O	O
P>0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
combined	O	O	O
results	O	O	O
of	O	O	O
univariate	O	O	B-T062
and	O	O	O
multivariate	O	O	B-T170
Cox	O	O	I-T170
regression	O	O	I-T170
analysis	O	O	I-T170
showed	O	O	O
that	O	O	O
the	O	O	O
SNP	O	O	B-T086
in	O	O	O
ERCC1	O	O	B-T028
-	O	O	I-T028
118	O	O	I-T028
was	O	O	O
closely	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
survival	O	O	B-T201
time	O	O	I-T201
.	O	O	O

The	O	O	O
mean	O	O	B-T081
survival	O	O	I-T081
time	O	O	I-T081
was	O	O	O
significantly	O	O	B-T078
prolonged	O	O	B-T079
in	O	O	O
patients	O	O	B-T101
carrying	O	O	O
1	O	O	O
or	O	O	O
2	O	O	O
C	O	O	B-T114
alleles	O	O	B-T028
(	O	O	O
C	O	O	O
/	O	O	O
C	O	O	O
or	O	O	O
C	O	O	O
/	O	O	O
T	O	O	B-T114
genotype	O	O	B-T032
)	O	O	O
compared	O	O	B-T052
with	O	O	O
patients	O	O	O
lacking	O	O	O
the	O	O	O
C	O	O	O
allele	O	O	B-T028
(	O	O	O
T	O	O	O
/	O	O	O
T	O	O	O
genotype	O	O	O
)	O	O	O
[	O	O	O
T	O	O	O
/	O	O	O
T	O	O	O
vs.	O	O	O
C	O	O	O
/	O	O	O
C	O	O	O
,	O	O	O
HR	O	O	B-T081
=	O	O	O
12.96	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(CI)=3.08	O	O	O
-	O	O	O
54.61	O	O	O
,	O	O	O
P<0.001	O	O	O
;	O	O	O
T	O	O	O
T	O	O	O
vs.	O	O	O
C	O	O	O
/	O	O	O
T	O	O	O
+	O	O	O
C	O	O	O
/	O	O	O
C	O	O	O
,	O	O	O
HR	O	O	O
=	O	O	O
11.71	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
3.06	O	O	O
-	O	O	O
44.83	O	O	O
,	O	O	O
P<0.001	O	O	O
]	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
XRCC1	O	O	B-T028
-	O	O	I-T028
399	O	O	I-T028
SNP	O	O	B-T086
had	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
survival	O	O	B-T201
time	O	O	I-T201
(	O	O	O
P>0.05	O	O	O
)	O	O	O
.	O	O	O

XRCCl-399	O	O	B-T028
SNP	O	O	B-T086
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
short-term	O	O	B-T079
therapeutic	O	O	B-T080
efficacy	O	O	I-T080
(	O	O	O
the	O	O	O
CR	O	O	B-T033
rate	O	O	B-T081
)	O	O	O
and	O	O	O
tumor	O	O	B-T191
metastasis	O	O	I-T191
/	O	O	O
relapse	O	O	B-T067
in	O	O	O
ESCC	O	O	B-T191
patients	O	O	B-T101
who	O	O	O
received	O	O	O
the	O	O	O
docetaxel	O	O	B-T061
plus	O	O	I-T061
cisplatin	O	O	I-T061
(	O	O	I-T061
TP	O	O	I-T061
)	O	O	I-T061
regimen	O	O	I-T061
-based	O	O	O
concurrent	O	O	B-T061
radiochemotherapy	O	O	I-T061
.	O	O	O

By	O	O	O
contrast	O	O	O
,	O	O	O
ERCC1	O	O	B-T028
-	O	O	I-T028
118	O	O	I-T028
SNP	O	O	B-T086
was	O	O	O
significantly	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
short-term	O	O	B-T079
therapeutic	O	O	B-T080
efficacy	O	O	I-T080
(	O	O	O
the	O	O	O
CR	O	O	B-T033
rate	O	O	B-T081
)	O	O	O
and	O	O	O
survival	O	O	B-T201
time	O	O	I-T201
in	O	O	O
ESCC	O	O	B-T191
patients	O	O	B-T101
who	O	O	O
received	O	O	O
TP	O	O	B-T061
regimen	O	O	I-T061
-based	O	O	O
concurrent	O	O	B-T061
radiochemotherapy	O	O	I-T061
.	O	O	O

-DOCSTART- (28357725)

Ventricular	O	O	B-T061
pacing	O	O	I-T061
site	O	O	B-T082
separation	O	O	I-T082
by	O	O	O
cardiac	O	O	B-T082
computed	O	O	B-T060
tomography	O	O	I-T060
:	O	O	O
validation	O	O	B-T062
for	O	O	O
the	O	O	O
prediction	O	O	B-T078
of	O	O	O
clinical	O	O	B-T033
response	O	O	I-T033
to	O	O	O
cardiac	O	O	O
resynchronization	O	O	O
therapy	O	O	O

Cardiac	O	O	B-T061
Resynchronization	O	O	I-T061
Therapy	O	O	I-T061
(	O	O	O
CRT	O	O	B-T061
)	O	O	O
fails	O	O	O
to	O	O	O
provide	O	O	B-T052
benefit	O	O	B-T081
in	O	O	O
up	O	O	O
to	O	O	O
one-third	O	O	O
of	O	O	O
patients	O	O	B-T101
.	O	O	O

Maximizing	O	O	O
the	O	O	O
geographic	O	O	B-T082
separation	O	O	I-T082
of	O	O	O
right	O	O	B-T082
and	O	O	O
left	O	O	B-T082
ventricular	O	O	B-T061
pacing	O	O	I-T061
lead	O	O	B-T029
sites	O	O	I-T029
has	O	O	O
been	O	O	O
suggested	O	O	B-T078
as	O	O	O
one	O	O	O
way	O	O	O
to	O	O	O
improve	O	O	B-T033
response	O	O	B-T032
.	O	O	O

Cardiac	O	O	B-T060
CT	O	O	I-T060
provides	O	O	B-T052
an	O	O	O
opportunity	O	O	B-T062
to	O	O	O
explore	O	O	O
3-dimensional	O	O	B-T082
inter-lead	O	O	B-T082
distance	O	O	I-T082
(	O	O	O
ILD	O	O	B-T082
)	O	O	O
measures	O	O	B-T081
for	O	O	O
the	O	O	O
prediction	O	O	B-T078
of	O	O	O
CRT	O	O	B-T061
response	O	O	B-T032
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
associations	O	O	B-T080
between	O	O	O
standardized	O	O	B-T080
measures	O	O	B-T081
of	O	O	O
ILD	O	O	B-T082
by	O	O	O
cardiac	O	O	B-T060
CT	O	O	I-T060
and	O	O	O
echocardiographic	O	O	B-T060
response	O	O	B-T032
to	O	O	O
CRT	O	O	B-T061
.	O	O	O

Forty-two	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
undergoing	O	O	O
CRT	O	O	B-T061
had	O	O	O
serial	O	O	O
clinical	O	O	B-T058
and	O	O	O
echocardiographic	O	O	B-T060
evaluations	O	O	B-T058
performed	O	O	B-T169
in	O	O	B-T169
addition	O	O	I-T169
to	O	O	I-T169
a	O	O	O
post-procedural	O	O	B-T079
cardiac	O	O	B-T082
-gated	O	O	O
CT	O	O	B-T060
with	O	O	O
blinded	O	O	B-T062
measurement	O	O	B-T169
of	O	O	O
direct	O	O	B-T080
and	O	O	O
circumferential	O	O	B-T082
(	O	O	O
via	O	O	O
the	O	O	O
myocardium	O	O	B-T024
)	O	O	O
ILD	O	O	B-T082
measures	O	O	B-T081
.	O	O	O

Clinical	O	O	B-T033
response	O	O	I-T033
to	O	O	O
CRT	O	O	B-T061
,	O	O	O
the	O	O	O
primary	O	O	B-T034
clinical	O	O	I-T034
outcome	O	O	I-T034
,	O	O	O
was	O	O	O
defined	O	O	O
as	O	O	O
a	O	O	O
≥15	O	O	O
%	O	O	O
reduction	O	O	B-T080
in	O	O	O
LVESV	O	O	B-T033
using	O	O	O
echocardiography	O	O	B-T060
at	O	O	O
6-months	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T032
age	O	O	I-T032
and	O	O	O
ejection	O	O	B-T033
fraction	O	O	I-T033
was	O	O	O
63.6	O	O	O
±	O	O	O
8.9	O	O	O
years	O	O	O
and	O	O	O
25.2	O	O	O
±	O	O	O
7.8	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	B-T080
outcome	O	O	I-T080
occurred	O	O	B-T052
in	O	O	O
35	O	O	O
of	O	O	O
42	O	O	O
patients	O	O	B-T101
(	O	O	O
83	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Both	O	O	O
direct	O	O	B-T080
and	O	O	O
circumferential	O	O	B-T082
CT	O	O	B-T060
-based	O	O	O
ILD	O	O	B-T082
measures	O	O	B-T081
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
primary	O	O	B-T080
outcome	O	O	I-T080
by	O	O	O
univariate	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

Receiver	O	O	B-T081
Operator	O	O	I-T081
Characteristic	O	O	I-T081
analysis	O	O	B-T062
identified	O	O	O
Circumferential	O	O	B-T082
ILD	O	O	B-T082
to	O	O	O
have	O	O	O
the	O	O	O
strongest	O	O	O
predictive	O	O	B-T080
accuracy	O	O	B-T080
(	O	O	O
AUC	O	O	O
0.78	O	O	O
)	O	O	O
.	O	O	O

Inter-	O	O	B-T081
and	O	O	O
intra-observer	O	O	B-T081
reproducibility	O	O	B-T080
of	O	O	O
CT	O	O	B-T060
-derived	O	O	O
ILD	O	O	B-T082
measures	O	O	B-T081
was	O	O	O
excellent	O	O	B-T080
.	O	O	O

Circumferential	O	O	B-T082
ILD	O	O	B-T082
measures	O	O	B-T081
on	O	O	O
cardiac	O	O	B-T060
CT	O	O	I-T060
are	O	O	O
predictive	O	O	B-T080
of	O	O	O
clinical	O	O	B-T033
response	O	O	I-T033
to	O	O	O
CRT	O	O	B-T061
.	O	O	O

Incorporation	O	O	B-T169
of	O	O	O
these	O	O	O
measures	O	O	B-T081
into	O	O	O
the	O	O	O
selection	O	O	B-T052
of	O	O	O
optimal	O	O	B-T080
pacing	O	O	B-T061
targets	O	O	B-T169
,	O	O	O
particularly	O	O	O
from	O	O	O
pre-procedural	O	O	B-T079
CT	O	O	B-T060
coronary	O	O	B-T023
vein	O	O	I-T023
imaging	O	O	B-T060
may	O	O	O
be	O	O	O
of	O	O	O
therapeutic	O	O	B-T169
benefit	O	O	B-T081
and	O	O	O
warrants	O	O	O
further	O	O	O
investigation	O	O	B-T058
.	O	O	O

-DOCSTART- (28358234)

Iodine	O	O	B-T196
Storage	O	O	I-T196
and	O	O	O
Metabolism	O	O	B-T040
of	O	O	O
Mild	O	O	B-T080
to	O	O	I-T080
Moderate	O	O	I-T080
Iodine-Deficient	O	O	B-T046
Pregnant	O	O	B-T040
Rats	O	O	O

Severe	O	O	B-T046
iodine	O	O	I-T046
deficiency	O	O	I-T046
during	O	O	B-T079
pregnancy	O	O	I-T079
results	O	O	I-T079
in	O	O	O
neurodevelopmental	O	O	B-T048
disorders	O	O	I-T048
in	O	O	O
children	O	O	B-T100
,	O	O	O
while	O	O	O
the	O	O	O
consequences	O	O	B-T169
of	O	O	I-T169
mild	O	O	B-T046
to	O	O	I-T046
moderate	O	O	I-T046
iodine	O	O	I-T046
deficiency	O	O	I-T046
(	O	O	O
MMID	O	O	B-T046
)	O	O	O
are	O	O	O
uncertain	O	O	B-T033
.	O	O	O

The	O	O	O
concentration	O	O	B-T059
of	O	O	I-T059
iodine	O	O	I-T059
in	O	O	O
the	O	O	O
thyroid	O	O	B-T023
is	O	O	O
the	O	O	O
most	O	O	O
accurate	O	O	O
indicator	O	O	O
of	O	O	O
iodine	O	O	B-T196
nutrition	O	O	I-T196
.	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
evaluate	O	O	O
whether	O	O	O
the	O	O	O
iodine	O	O	B-T121
stores	O	O	I-T196
in	O	O	O
the	O	O	O
thyroid	O	O	B-T023
cover	O	O	I-T023
the	O	O	O
needs	O	O	O
of	O	O	O
the	O	O	O
mother	O	O	B-T029
and	O	O	I-T029
the	O	O	I-T029
fetus	O	O	I-T029
in	O	O	O
iodine	O	O	O
-	O	O	O
sufficient	O	O	B-T080
and	O	O	O
MMID	O	O	B-T046
conditions	O	O	O
by	O	O	O
inductively	O	O	B-T059
coupled	O	O	I-T059
plasma-mass	O	O	I-T059
spectrometry	O	O	I-T059
.	O	O	O

One	O	O	O
hundred	O	O	O
four-week-old	O	O	O
female	O	O	B-T015
Wistar	O	O	I-T015
rats	O	O	I-T015
were	O	O	O
randomly	O	O	O
divided	O	O	O
into	O	O	O
MMID	O	O	B-T046
(	O	O	O
low	O	O	B-T033
iodine	O	O	I-T033
intake	O	O	I-T033
[	O	O	O
L	O	O	O
]	O	O	O
)	O	O	O
and	O	O	O
normal	O	O	B-T033
(	O	O	O
normal	O	O	B-T033
iodine	O	O	I-T033
intake	O	O	I-T033
[	O	O	O
N	O	O	O
]	O	O	O
)	O	O	O
groups	O	O	B-T078
.	O	O	O

The	O	O	O
rats	O	O	B-T015
were	O	O	O
fed	O	O	B-T052
for	O	O	I-T052
the	O	O	I-T052
next	O	O	I-T052
three	O	O	I-T052
months	O	O	I-T052
,	O	O	O
and	O	O	O
after	O	O	B-T079
pregnancy	O	O	B-T040
they	O	O	O
were	O	O	O
further	O	O	O
divided	O	O	B-T185
into	O	O	I-T185
two	O	O	I-T185
subgroups	O	O	I-T185
,	O	O	O
respectively	O	O	O
:	O	O	O
low	O	O	B-T033
iodine	O	O	I-T033
pregnancy	O	O	O
(	O	O	O
LP	O	O	B-T033
)	O	O	O
and	O	O	O
low	O	O	O
iodine	O	O	O
pregnancy	O	O	O
with	O	O	O
iodine	O	O	B-T168
supplement	O	O	I-T168
(	O	O	O
LP+	O	O	B-T168
)	O	O	O
,	O	O	O
and	O	O	O
normal	O	O	B-T033
iodine	O	O	I-T033
intake	O	O	I-T033
pregnancy	O	O	O
(	O	O	O
NP	O	O	B-T040
)	O	O	O
and	O	O	O
normal	O	O	O
iodine	O	O	O
intake	O	O	O
pregnancy	O	O	O
with	O	O	O
iodine	O	O	O
supplement	O	O	O
(	O	O	O
NP+	O	O	B-T168
)	O	O	O
.	O	O	O

The	O	O	O
iodine	O	O	B-T033
intake	O	O	I-T033
of	O	O	O
pregnant	O	O	B-T040
rats	O	O	B-T015
in	O	O	O
the	O	O	O
NP+	O	O	B-T168
and	O	O	O
LP+	O	O	B-T168
groups	O	O	I-T168
was	O	O	O
twice	O	O	O
as	O	O	O
much	O	O	O
as	O	O	O
in	O	O	O
the	O	O	O
NP	O	O	B-T033
and	O	O	O
LP	O	O	B-T033
groups	O	O	I-T033
.	O	O	O

The	O	O	O
rats	O	O	B-T015
were	O	O	O
sacrificed	O	O	O
on	O	O	O
gestational	O	O	B-T079
day	O	O	I-T079
15	O	O	O
and	O	O	O
postnatal	O	O	B-T079
day	O	O	I-T079
7	O	O	O
.	O	O	O

The	O	O	O
iodine	O	O	B-T059
concentration	O	O	I-T059
in	O	O	O
the	O	O	O
thyroid	O	O	B-T023
of	O	O	O
the	O	O	O
maternal	O	O	B-T033
and	O	O	O
newborn	O	O	B-T033
rats	O	O	B-T015
,	O	O	O
maternal	O	O	B-T059
serum	O	O	I-T059
,	O	O	O
placenta	O	O	B-T018
,	O	O	O
and	O	O	O
amniotic	O	O	B-T031
fluid	O	O	I-T031
were	O	O	O
determined	O	O	O
by	O	O	O
inductively	O	O	B-T059
coupled	O	O	I-T059
plasma-mass	O	O	I-T059
spectrometry	O	O	I-T059
.	O	O	O

The	O	O	O
concentration	O	O	B-T059
of	O	O	I-T059
iodine	O	O	I-T059
in	O	O	O
the	O	O	O
thyroid	O	O	B-T023
of	O	O	O
the	O	O	O
N	O	O	B-T033
group	O	O	I-T033
was	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
than	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
L	O	O	B-T033
group	O	O	I-T033
before	O	O	B-T033
pregnancy	O	O	I-T033
.	O	O	O

The	O	O	O
concentration	O	O	B-T059
of	O	O	I-T059
iodine	O	O	I-T059
in	O	O	O
the	O	O	O
maternal	O	O	B-T058
thyroids	O	O	I-T058
of	O	O	O
the	O	O	O
LP	O	O	B-T033
group	O	O	I-T033
decreased	O	O	O
during	O	O	B-T079
pregnancy	O	O	I-T079
,	O	O	O
whereas	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
NP	O	O	B-T033
group	O	O	I-T033
did	O	O	O
not	O	O	O
change	O	O	O
significantly	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	O
difference	O	O	O
in	O	O	O
the	O	O	O
iodine	O	O	B-T059
concentration	O	O	I-T059
in	O	O	O
the	O	O	O
thyroid	O	O	B-T023
of	O	O	O
mothers	O	O	B-T099
and	O	O	O
offspring	O	O	B-T099
between	O	O	O
the	O	O	O
NP	O	O	B-T033
and	O	O	O
NP+	O	O	B-T168
groups	O	O	I-T168
,	O	O	O
but	O	O	O
it	O	O	O
was	O	O	O
significant	O	O	O
between	O	O	O
LP	O	O	B-T040
and	O	O	O
LP+	O	O	B-T168
groups	O	O	I-T168
.	O	O	O

The	O	O	O
concentration	O	O	B-T059
of	O	O	I-T059
iodine	O	O	I-T059
in	O	O	O
amniotic	O	O	B-T031
fluid	O	O	I-T031
was	O	O	O
significantly	O	O	O
different	O	O	O
between	O	O	O
the	O	O	O
four	O	O	O
groups	O	O	B-T078
.	O	O	O

There	O	O	O
is	O	O	O
sufficient	O	O	O
iodine	O	O	B-T196
storage	O	O	I-T196
in	O	O	O
the	O	O	O
thyroid	O	O	B-T023
of	O	O	O
maternal	O	O	B-T033
rats	O	O	B-T015
with	O	O	O
normal	O	O	B-T033
iodine	O	O	I-T033
intake	O	O	I-T033
during	O	O	B-T079
pregnancy	O	O	I-T079
,	O	O	O
and	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
need	O	O	O
for	O	O	O
iodine	O	O	B-T058
supplementation	O	O	I-T058
.	O	O	O

However	O	O	O
,	O	O	O
iodine	O	O	B-T196
stores	O	O	I-T196
are	O	O	O
insufficient	O	O	O
in	O	O	O
rats	O	O	B-T015
with	O	O	O
MMID	O	O	B-T046
.	O	O	O

Iodine	O	O	B-T058
supplementation	O	O	I-T058
can	O	O	O
increase	O	O	O
the	O	O	O
iodine	O	O	B-T059
concentration	O	O	I-T059
in	O	O	O
the	O	O	O
thyroid	O	O	B-T023
of	O	O	O
maternal	O	O	B-T033
rats	O	O	B-T015
with	O	O	O
MMID	O	O	B-T046
and	O	O	O
their	O	O	O
offspring	O	O	B-T099
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
the	O	O	O
amniotic	O	O	B-T031
fluid	O	O	I-T031
during	O	O	B-T079
pregnancy	O	O	I-T079
.	O	O	O

-DOCSTART- (28359664)

Omega	O	O	B-T109
3	O	O	I-T109
Fatty	O	O	I-T109
Acids	O	O	I-T109
Reduce	O	O	B-T080
Bone	O	O	B-T042
Resorption	O	O	I-T042
While	O	O	O
Promoting	O	O	B-T042
Bone	O	O	I-T042
Generation	O	O	I-T042
in	O	O	O
Rat	O	O	B-T015
Apical	O	O	O
Periodontitis	O	O	O

This	O	O	O
study	O	O	O
evaluated	O	O	B-T058
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
dietary	O	O	B-T168
supplement	O	O	I-T168
omega	O	O	B-T109
3	O	O	I-T109
polyunsaturated	O	O	I-T109
fatty	O	O	I-T109
acids	O	O	I-T109
(	O	O	O
ω-3	O	O	B-T109
PUFAs	O	O	I-T109
)	O	O	O
on	O	O	O
pulp	O	O	B-T047
exposure	O	O	I-T047
-induced	O	O	O
apical	O	O	B-T047
periodontitis	O	O	I-T047
(	O	O	O
AP	O	O	B-T047
)	O	O	O
in	O	O	O
rats	O	O	B-T015
.	O	O	O

Twenty-eight	O	O	O
male	O	O	B-T032
rats	O	O	B-T015
were	O	O	O
divided	O	O	O
into	O	O	O
groups	O	O	B-T098
:	O	O	O
control	O	O	O
untreated	O	O	B-T033
rats	O	O	O
(	O	O	O
C	O	O	O
)	O	O	O
,	O	O	O
control	O	O	O
rats	O	O	O
treated	O	O	B-T169
with	O	O	I-T169
ω-3	O	O	B-T109
PUFAs	O	O	I-T109
alone	O	O	O
(	O	O	O
C-O	O	O	O
)	O	O	O
,	O	O	O
rats	O	O	O
with	O	O	O
pulp	O	O	B-T047
exposure	O	O	I-T047
-induced	O	O	O
AP	O	O	B-T047
,	O	O	O
and	O	O	O
rats	O	O	O
with	O	O	O
pulp	O	O	O
exposure	O	O	O
-induced	O	O	O
AP	O	O	O
treated	O	O	O
with	O	O	O
ω-3	O	O	O
PUFAs	O	O	O
(	O	O	O
AP	O	O	O
-O	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
ω-3	O	O	B-T109
PUFAs	O	O	I-T109
were	O	O	O
administered	O	O	B-T061
orally	O	O	I-T061
,	O	O	O
once	O	O	O
a	O	O	O
day	O	O	O
,	O	O	O
for	O	O	O
15	O	O	O
days	O	O	O
before	O	O	O
pulp	O	O	B-T047
exposure	O	O	I-T047
and	O	O	O
,	O	O	O
subsequently	O	O	O
,	O	O	O
30	O	O	O
days	O	O	O
after	O	O	O
pulp	O	O	O
exposure	O	O	O
.	O	O	O

Rats	O	O	B-T015
were	O	O	O
killed	O	O	B-T054
30	O	O	O
days	O	O	O
after	O	O	O
pulp	O	O	B-T047
exposure	O	O	I-T047
,	O	O	O
and	O	O	O
jaws	O	O	B-T023
were	O	O	O
subjected	O	O	O
to	O	O	O
histologic	O	O	B-UnknownType
and	O	O	O
immunohistochemical	O	O	B-T059
analyses	O	O	B-T062
.	O	O	O

Immunohistochemical	O	O	B-T059
analyses	O	O	B-T062
were	O	O	O
performed	O	O	O
to	O	O	O
detect	O	O	O
tartrate-resistant	O	O	B-T116
acid	O	O	I-T116
phosphatase	O	O	I-T116
-	O	O	O
positive	O	O	B-T033
osteoclasts	O	O	B-T025
and	O	O	O
osteocalcin	O	O	B-T116
-	O	O	O
positive	O	O	O
osteoblasts	O	O	B-T025
on	O	O	O
the	O	O	O
bone	O	O	B-T029
surface	O	O	I-T029
of	O	O	O
periapical	O	O	B-T082
area	O	O	I-T082
.	O	O	O

Results	O	O	O
were	O	O	O
statistically	O	O	O
evaluated	O	O	B-T058
by	O	O	O
using	O	O	O
analysis	O	O	B-T081
of	O	O	I-T081
variance	O	O	I-T081
and	O	O	O
Tukey	O	O	B-T081
honestly	O	O	I-T081
significant	O	O	I-T081
difference	O	O	I-T081
,	O	O	O
and	O	O	O
P	O	O	O
<	O	O	O
.05	O	O	O
was	O	O	O
considered	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
.	O	O	O

The	O	O	O
bone	O	O	B-T042
resorption	O	O	I-T042
lesion	O	O	B-T033
was	O	O	O
significantly	O	O	B-T081
larger	O	O	I-T081
in	O	O	O
the	O	O	O
AP	O	O	B-T047
group	O	O	O
compared	O	O	O
with	O	O	O
AP	O	O	O
-O	O	O	O
,	O	O	O
C	O	O	O
,	O	O	O
and	O	O	O
C-O	O	O	O
groups	O	O	B-T098
(	O	O	O
P	O	O	O
<	O	O	O
.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
level	O	O	B-T080
of	O	O	O
inflammatory	O	O	B-T046
cell	O	O	I-T046
infiltration	O	O	I-T046
was	O	O	O
significantly	O	O	O
elevated	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
tartrate-resistant	O	O	B-T116
acid	O	O	I-T116
phosphatase	O	O	I-T116
-	O	O	O
positive	O	O	B-T033
osteoclasts	O	O	B-T025
was	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
in	O	O	O
the	O	O	O
periapical	O	O	B-T082
lesions	O	O	B-T033
of	O	O	O
the	O	O	O
AP	O	O	B-T047
group	O	O	O
compared	O	O	O
with	O	O	O
AP	O	O	O
-O	O	O	O
,	O	O	O
C	O	O	O
,	O	O	O
and	O	O	O
C-O	O	O	O
groups	O	O	B-T098
(	O	O	O
P	O	O	O
<	O	O	O
.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
osteocalcin	O	O	B-T116
-	O	O	O
positive	O	O	B-T033
osteoblasts	O	O	B-T025
was	O	O	O
significantly	O	O	O
increased	O	O	B-T081
in	O	O	O
the	O	O	O
AP	O	O	B-T047
-O	O	O	O
group	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
AP	O	O	O
group	O	O	O
(	O	O	O
P	O	O	O
>	O	O	O
.05	O	O	O
)	O	O	O
.	O	O	O

Supplementation	O	O	B-T061
with	O	O	O
ω-3	O	O	B-T109
PUFAs	O	O	I-T109
not	O	O	O
only	O	O	O
suppresses	O	O	B-T169
bone	O	O	B-T042
resorption	O	O	I-T042
but	O	O	O
also	O	O	O
promotes	O	O	B-T042
new	O	O	I-T042
bone	O	O	I-T042
formation	O	O	I-T042
in	O	O	O
the	O	O	O
periapical	O	O	B-T082
area	O	O	I-T082
of	O	O	O
rats	O	O	B-T015
with	O	O	O
AP	O	O	B-T047
in	O	O	O
conjunction	O	O	B-T078
with	O	O	O
downregulation	O	O	B-T044
of	O	O	O
inflammatory	O	O	B-T046
cell	O	O	I-T046
infiltration	O	O	I-T046
into	O	O	O
the	O	O	O
lesion	O	O	B-T033
.	O	O	O

-DOCSTART- (28360843)

MagR	O	O	B-T116
Alone	O	O	O
Is	O	O	O
Insufficient	O	O	B-T080
to	O	O	O
Confer	O	O	O
Cellular	O	O	B-T043
Calcium	O	O	I-T043
Responses	O	O	I-T043
to	O	O	O
Magnetic	O	O	B-T070
Stimulation	O	O	O

Magnetic	O	O	B-T070
manipulation	O	O	B-T061
of	O	O	O
cell	O	O	B-T043
activity	O	O	I-T043
offers	O	O	O
advantages	O	O	B-T081
over	O	O	O
optical	O	O	B-T061
manipulation	O	O	I-T061
but	O	O	O
an	O	O	O
ideal	O	O	O
tool	O	O	O
remains	O	O	O
elusive	O	O	O
.	O	O	O

The	O	O	O
MagR	O	O	B-T116
protein	O	O	B-T116
was	O	O	O
found	O	O	O
through	O	O	O
its	O	O	O
interaction	O	O	B-T044
with	O	O	O
cryptochrome	O	O	B-T116
(	O	O	O
Cry	O	O	B-T116
)	O	O	O
and	O	O	O
the	O	O	O
protein	O	O	O
in	O	O	O
solution	O	O	B-T167
appeared	O	O	O
to	O	O	O
respond	O	O	B-T032
to	O	O	O
magnetic	O	O	B-T070
stimulation	O	O	B-T061
(	O	O	O
MS	O	O	B-T061
)	O	O	O
.	O	O	O

After	O	O	O
we	O	O	O
initiated	O	O	O
an	O	O	O
investigation	O	O	B-T058
on	O	O	O
the	O	O	O
specific	O	O	O
role	O	O	B-T077
of	O	O	O
MagR	O	O	B-T116
in	O	O	O
cellular	O	O	B-T043
response	O	O	I-T043
to	O	O	O
MS	O	O	B-T061
,	O	O	O
a	O	O	O
subsequent	O	O	O
study	O	O	B-T062
claimed	O	O	O
that	O	O	O
MagR	O	O	O
expression	O	O	B-T045
alone	O	O	O
could	O	O	O
achieve	O	O	O
cellular	O	O	B-T043
activation	O	O	I-T043
by	O	O	O
MS	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	O
that	O	O	O
despite	O	O	O
systematically	O	O	B-T169
testing	O	O	B-T169
different	O	O	O
ways	O	O	O
of	O	O	O
measuring	O	O	B-T080
intracellular	O	O	B-T082
calcium	O	O	B-T121
and	O	O	O
different	O	O	O
MS	O	O	B-T061
protocols	O	O	B-T170
,	O	O	O
it	O	O	O
was	O	O	O
not	O	O	O
possible	O	O	O
to	O	O	O
detect	O	O	B-T033
any	O	O	O
cellular	O	O	B-T025
or	O	O	O
neuronal	O	O	B-T025
responses	O	O	B-T032
to	O	O	O
MS	O	O	O
in	O	O	O
MagR	O	O	B-T116
-	O	O	O
expressing	O	O	B-T045
HEK	O	O	B-T025
cells	O	O	I-T025
or	O	O	O
primary	O	O	B-T080
neurons	O	O	B-T025
from	O	O	O
the	O	O	O
dorsal	O	O	B-T082
root	O	O	B-T023
ganglion	O	O	I-T023
and	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
.	O	O	O

By	O	O	O
contrast	O	O	O
,	O	O	O
in	O	O	O
neurons	O	O	B-T025
co-expressing	O	O	B-T045
MagR	O	O	B-T116
and	O	O	O
channelrhodopin	O	O	B-T116
,	O	O	O
optical	O	O	B-T061
but	O	O	O
not	O	O	O
MS	O	O	B-T061
increased	O	O	B-T081
calcium	O	O	B-T043
influx	O	O	I-T043
in	O	O	O
hippocampal	O	O	B-T023
neurons	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	O
indicate	O	O	O
that	O	O	O
MagR	O	O	B-T116
alone	O	O	O
is	O	O	O
not	O	O	B-T080
sufficient	O	O	I-T080
to	O	O	O
confer	O	O	O
cellular	O	O	B-T025
magnetic	O	O	B-T040
responses	O	O	I-T040
.	O	O	O

-DOCSTART- (28361230)

Acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
and	O	O	O
fluid	O	O	B-T047
overload	O	O	I-T047
in	O	O	O
infants	O	O	B-T100
and	O	O	O
children	O	O	B-T100
after	O	O	O
cardiac	O	O	O
surgery	O	O	O

Acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
is	O	O	O
a	O	O	O
common	O	O	O
and	O	O	O
serious	O	O	B-T080
complication	O	O	B-T046
after	O	O	O
congenital	O	O	B-T061
heart	O	O	I-T061
surgery	O	O	I-T061
,	O	O	O
particularly	O	O	O
among	O	O	O
infants	O	O	B-T100
.	O	O	O

This	O	O	O
comorbidity	O	O	B-T078
has	O	O	O
been	O	O	O
independently	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
adverse	O	O	B-T046
outcomes	O	O	I-T046
including	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
mortality	O	O	B-T081
.	O	O	O

Postoperative	O	O	B-T079
acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
has	O	O	O
a	O	O	O
complex	O	O	O
pathophysiology	O	O	B-T169
with	O	O	O
many	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
,	O	O	O
and	O	O	O
therefore	O	O	O
no	O	O	B-T033
single	O	O	I-T033
medication	O	O	I-T033
or	O	O	O
therapy	O	O	B-T033
has	O	O	O
been	O	O	O
demonstrated	O	O	O
to	O	O	O
be	O	O	O
effective	O	O	B-T080
for	O	O	O
treatment	O	O	B-T061
or	O	O	O
prevention	O	O	B-T080
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
established	O	O	O
that	O	O	O
the	O	O	O
associated	O	O	O
fluid	O	O	B-T047
overload	O	O	I-T047
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
major	O	O	O
determinants	O	O	B-T169
of	O	O	O
morbidity	O	O	B-T081
,	O	O	O
particularly	O	O	O
in	O	O	O
infants	O	O	B-T100
after	O	O	O
cardiac	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

Therefore	O	O	O
,	O	O	O
in	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
an	O	O	O
intervention	O	O	B-T061
to	O	O	O
prevent	O	O	O
acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
,	O	O	O
much	O	O	O
of	O	O	O
the	O	O	O
effort	O	O	O
to	O	O	O
improve	O	O	B-T080
outcomes	O	O	B-T080
has	O	O	O
focused	O	O	O
on	O	O	O
treating	O	O	B-T169
and	O	O	O
preventing	O	O	B-T080
fluid	O	O	B-T047
overload	O	O	I-T047
.	O	O	O

Early	O	O	B-T079
renal	O	O	B-T061
replacement	O	O	I-T061
therapy	O	O	I-T061
,	O	O	O
often	O	O	O
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
peritoneal	O	O	B-T061
dialysis	O	O	I-T061
,	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
safe	O	O	B-T068
and	O	O	O
beneficial	O	O	B-T081
in	O	O	O
infants	O	O	B-T100
with	O	O	O
oliguria	O	O	B-T047
after	O	O	O
heart	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

As	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
pathophysiology	O	O	B-T169
of	O	O	O
acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
and	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
confidently	O	O	O
diagnose	O	O	B-T033
it	O	O	O
earlier	O	O	O
continues	O	O	O
to	O	O	O
evolve	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
likely	O	O	O
that	O	O	O
novel	O	O	O
preventative	O	O	B-T080
and	O	O	O
therapeutic	O	O	B-T061
interventions	O	O	I-T061
will	O	O	O
be	O	O	O
available	O	O	O
in	O	O	O
the	O	O	O
future	O	O	O
.	O	O	O

-DOCSTART- (28362102)

Systems	O	O	B-T169
Toxicology	O	O	B-T091
:	O	O	O
Real	O	O	O
World	O	O	B-T098
Applications	O	O	B-T169
and	O	O	O
Opportunities	O	O	O

Systems	O	O	B-T169
Toxicology	O	O	B-T091
aims	O	O	O
to	O	O	O
change	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
how	O	O	O
adverse	O	O	B-T169
biological	O	O	I-T169
effects	O	O	I-T169
of	O	O	O
xenobiotics	O	O	B-T123
are	O	O	O
characterized	O	O	B-T052
from	O	O	O
empirical	O	O	B-T080
end	O	O	B-T080
points	O	O	I-T080
to	O	O	O
describing	O	O	O
modes	O	O	B-T169
of	O	O	O
action	O	O	B-T052
as	O	O	O
adverse	O	O	O
outcome	O	O	B-T169
pathways	O	O	B-T077
and	O	O	O
perturbed	O	O	B-T169
networks	O	O	I-T169
.	O	O	O

Toward	O	O	O
this	O	O	O
aim	O	O	O
,	O	O	O
Systems	O	O	B-T169
Toxicology	O	O	B-T091
entails	O	O	O
the	O	O	O
integration	O	O	B-T066
of	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
toxicity	O	O	B-T037
data	O	O	B-T078
with	O	O	O
computational	O	O	B-T066
modeling	O	O	I-T066
.	O	O	O

This	O	O	O
evolving	O	O	O
approach	O	O	B-T169
depends	O	O	O
critically	O	O	O
on	O	O	O
data	O	O	B-T078
reliability	O	O	B-T081
and	O	O	O
relevance	O	O	B-T080
,	O	O	O
which	O	O	O
in	O	O	O
turn	O	O	O
depends	O	O	O
on	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
experimental	O	O	B-T170
models	O	O	I-T170
and	O	O	O
bioanalysis	O	O	B-T062
techniques	O	O	I-T062
used	O	O	O
to	O	O	O
generate	O	O	O
toxicological	O	O	B-T169
data	O	O	O
.	O	O	O

Systems	O	O	B-T169
Toxicology	O	O	B-T091
involves	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
large-scale	O	O	O
data	O	O	B-T078
streams	O	O	I-T170
(	O	O	O
"	O	O	O
big	O	O	O
data	O	O	O
"	O	O	O
)	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
those	O	O	O
derived	O	O	O
from	O	O	O
omics	O	O	B-T062
measurements	O	O	I-T062
that	O	O	O
require	O	O	O
computational	O	O	B-T052
means	O	O	O
for	O	O	O
obtaining	O	O	O
informative	O	O	B-T080
results	O	O	B-T169
.	O	O	O

Thus	O	O	O
,	O	O	O
integrative	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
multiple	O	O	B-T081
molecular	O	O	B-T169
measurements	O	O	I-T169
,	O	O	O
particularly	O	O	O
acquired	O	O	O
by	O	O	O
omics	O	O	B-T059
strategies	O	O	I-T059
,	O	O	O
is	O	O	O
a	O	O	O
key	O	O	O
approach	O	O	B-T169
in	O	O	O
Systems	O	O	B-T169
Toxicology	O	O	B-T091
.	O	O	O

In	O	O	O
recent	O	O	O
years	O	O	O
,	O	O	O
there	O	O	O
have	O	O	O
been	O	O	O
significant	O	O	O
advances	O	O	O
centered	O	O	O
on	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
test	O	O	O
systems	O	O	O
and	O	O	O
bioanalytical	O	O	B-T059
strategies	O	O	I-T059
,	O	O	O
yet	O	O	O
a	O	O	O
frontier	O	O	O
challenge	O	O	O
concerns	O	O	O
linking	O	O	B-T169
observed	O	O	O
network	O	O	B-T169
perturbations	O	O	B-T169
to	O	O	O
phenotypes	O	O	B-T032
,	O	O	O
which	O	O	O
will	O	O	O
require	O	O	O
understanding	O	O	O
pathways	O	O	B-T077
and	O	O	O
networks	O	O	B-T169
that	O	O	O
give	O	O	O
rise	O	O	O
to	O	O	O
adverse	O	O	B-T169
responses	O	O	I-T169
.	O	O	O

This	O	O	O
summary	O	O	B-T170
perspective	O	O	O
from	O	O	O
a	O	O	O
2016	O	O	O
Systems	O	O	B-T169
Toxicology	O	O	B-T091
meeting	O	O	B-T052
,	O	O	O
an	O	O	O
international	O	O	B-T068
conference	O	O	I-T068
held	O	O	O
in	O	O	O
the	O	O	O
Alps	O	O	B-T083
of	O	O	O
Switzerland	O	O	B-T083
,	O	O	O
describes	O	O	O
the	O	O	O
limitations	O	O	B-T169
and	O	O	O
opportunities	O	O	B-T078
of	O	O	O
selected	O	O	O
emerging	O	O	O
applications	O	O	B-T169
in	O	O	O
this	O	O	O
rapidly	O	O	O
advancing	O	O	O
field	O	O	O
.	O	O	O

Systems	O	O	B-T169
Toxicology	O	O	B-T091
aims	O	O	O
to	O	O	O
change	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
how	O	O	O
adverse	O	O	B-T169
biological	O	O	I-T169
effects	O	O	I-T169
of	O	O	O
xenobiotics	O	O	B-T123
are	O	O	O
characterized	O	O	B-T052
,	O	O	O
from	O	O	O
empirical	O	O	B-T080
end	O	O	B-T080
points	O	O	I-T080
to	O	O	O
pathways	O	O	B-T077
of	O	O	O
toxicity	O	O	B-T037
.	O	O	O

This	O	O	O
requires	O	O	O
the	O	O	O
integration	O	O	B-T066
of	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
data	O	O	B-T078
with	O	O	O
computational	O	O	B-T066
modeling	O	O	I-T066
.	O	O	O

Test	O	O	O
systems	O	O	O
and	O	O	O
bioanalytical	O	O	B-T059
technologies	O	O	I-T059
have	O	O	O
made	O	O	O
significant	O	O	O
advances	O	O	O
,	O	O	O
but	O	O	O
ensuring	O	O	O
data	O	O	B-T078
reliability	O	O	B-T081
and	O	O	O
relevance	O	O	B-T080
is	O	O	O
an	O	O	O
ongoing	O	O	O
concern	O	O	O
.	O	O	O

The	O	O	O
major	O	O	O
challenge	O	O	O
facing	O	O	O
the	O	O	O
new	O	O	O
pathway	O	O	B-T077
approach	O	O	B-T169
is	O	O	O
determining	O	O	O
how	O	O	O
to	O	O	O
link	O	O	B-T169
observed	O	O	O
network	O	O	B-T169
perturbations	O	O	B-T169
to	O	O	O
phenotypic	O	O	B-T032
toxicity	O	O	B-T037
.	O	O	O

-DOCSTART- (28363626)

Validating	O	O	B-T062
Signs	O	O	B-T184
and	O	O	I-T184
Symptoms	O	O	I-T184
From	O	O	O
An	O	O	O
Actual	O	O	O
Mass	O	O	B-T051
Casualty	O	O	I-T051
Incident	O	O	I-T051
to	O	O	O
Characterize	O	O	B-T052
An	O	O	O
Irritant	O	O	B-T131
Gas	O	O	I-T131
Syndrome	O	O	I-T131
Agent	O	O	I-T131
(	O	O	O
IGSA	O	O	B-T131
)	O	O	O
Exposure	O	O	O
:	O	O	O
A	O	O	O
First	O	O	O
Step	O	O	O
in	O	O	O
The	O	O	O
Development	O	O	B-T169
of	O	O	O
a	O	O	O
Novel	O	O	B-T080
IGSA	O	O	O
Triage	O	O	B-T061
Algorithm	O	O	O

Chemical	O	O	B-T033
exposures	O	O	I-T033
can	O	O	O
pose	O	O	O
a	O	O	O
significant	O	O	B-T078
threat	O	O	B-T078
to	O	O	O
life	O	O	B-T078
.	O	O	O

Rapid	O	O	O
assessment	O	O	B-T058
by	O	O	O
first	O	O	B-T097
responders	O	O	I-T097
/	O	O	O
emergency	O	O	B-T097
nurses	O	O	I-T097
is	O	O	O
required	O	O	B-T169
to	O	O	O
reduce	O	O	B-T080
death	O	O	B-T040
and	O	O	O
disability	O	O	B-T033
.	O	O	O

Currently	O	O	O
,	O	O	O
no	O	O	B-T169
informatics	O	O	B-T170
tools	O	O	I-T170
for	O	O	O
irritant	O	O	B-T131
gas	O	O	I-T131
syndrome	O	O	I-T131
agent	O	O	I-T131
s	O	O	O
(	O	O	O
IGSA	O	O	B-T131
)	O	O	O
exposures	O	O	B-T080
exist	O	O	B-T077
to	O	O	O
process	O	O	B-T067
victims	O	O	B-T098
efficiently	O	O	B-T080
,	O	O	O
continuously	O	O	B-T078
monitor	O	O	B-T058
for	O	O	O
latent	O	O	B-T080
signs/symptoms	O	O	B-T184
,	O	O	O
or	O	O	O
make	O	O	O
triage	O	O	B-T061
recommendations	O	O	B-T078
.	O	O	O

This	O	O	O
study	O	O	B-T062
describes	O	O	O
the	O	O	O
first	O	O	O
step	O	O	O
in	O	O	O
developing	O	O	O
ED	O	O	B-T093
informatics	O	O	B-T170
tools	O	O	I-T170
for	O	O	O
chemical	O	O	B-T068
incidents	O	O	I-T068
:	O	O	O
validation	O	O	B-T062
of	O	O	O
signs/symptoms	O	O	B-T184
that	O	O	O
characterize	O	O	B-T052
an	O	O	O
IGSA	O	O	B-T131
syndrome	O	O	B-T047
.	O	O	O

Data	O	O	B-T079
abstracted	O	O	I-T079
from	O	O	O
146	O	O	O
patients	O	O	B-T101
treated	O	O	B-T061
for	O	O	O
chlorine	O	O	B-T033
exposure	O	O	I-T033
in	O	O	O
one	O	O	O
emergency	O	O	B-T093
department	O	O	I-T093
during	O	O	B-T079
a	O	O	O
2005	O	O	O
train	O	O	B-T067
derailment	O	O	I-T067
and	O	O	O
152	O	O	O
patients	O	O	O
not	O	O	B-T169
exposed	O	O	B-T033
to	O	O	I-T033
chlorine	O	O	I-T033
(	O	O	O
a	O	O	O
comparison	O	O	B-T096
group	O	O	I-T096
)	O	O	O
were	O	O	O
mapped	O	O	B-T170
to	O	O	O
93	O	O	O
possible	O	O	O
signs/symptoms	O	O	B-T184
within	O	O	O
2	O	O	O
tools	O	O	B-T170
(	O	O	O
WISER	O	O	B-T170
and	O	O	O
CHEMM-IST	O	O	B-T170
)	O	O	O
designed	O	O	B-T052
to	O	O	O
assist	O	O	B-T080
emergency	O	O	B-T097
responders	O	O	I-T097
/	O	O	O
emergency	O	O	B-T097
nurses	O	O	I-T097
with	O	O	O
managing	O	O	O
hazardous	O	O	B-T131
material	O	O	I-T131
exposures	O	O	B-T080
.	O	O	O

Inferential	O	O	B-T081
statistics	O	O	I-T081
(	O	O	O
χ(2)/	O	O	O
Fisher	O	O	B-T170
's	O	O	I-T170
exact	O	O	I-T170
test	O	O	I-T170
)	O	O	O
and	O	O	O
diagnostics	O	O	B-T060
tests	O	O	I-T060
were	O	O	O
used	O	O	B-T169
to	O	O	O
examine	O	O	O
mapped	O	O	B-T170
signs/symptoms	O	O	B-T184
of	O	O	O
persons	O	O	B-T098
who	O	O	O
were	O	O	O
and	O	O	O
were	O	O	O
not	O	O	O
exposed	O	O	B-T033
to	O	O	I-T033
chlorine	O	O	I-T033
.	O	O	O

Three	O	O	O
clusters	O	O	B-T081
of	O	O	O
signs/symptoms	O	O	B-T184
are	O	O	O
statistically	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
IGSA	O	O	B-T131
syndrome	O	O	B-T047
(	O	O	O
P	O	O	O
<	O	O	O
.01	O	O	O
):	O	O	O
respiratory	O	O	B-T169
(	O	O	O
shortness	O	O	B-T184
of	O	O	I-T184
breath	O	O	I-T184
,	O	O	O
wheezing	O	O	B-T184
,	O	O	O
coughing	O	O	B-T184
,	O	O	O
and	O	O	O
choking	O	O	B-T046
)	O	O	O
;	O	O	O
chest	O	O	B-T184
discomfort	O	O	I-T184
(	O	O	O
tightness	O	O	B-T184
,	O	O	O
pain	O	O	B-T184
,	O	O	O
and	O	O	O
burning	O	O	B-T184
)	O	O	O
,	O	O	O
and	O	O	O
eye	O	O	B-T023
,	O	O	O
nose	O	O	B-T023
and/or	O	O	O
throat	O	O	B-T023
(	O	O	O
pain	O	O	O
,	O	O	O
irritation	O	O	B-T067
,	O	O	O
and	O	O	O
burning	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
syndrome	O	O	B-T047
requires	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
signs/symptoms	O	O	B-T184
from	O	O	O
at	O	O	O
least	O	O	O
2	O	O	O
of	O	O	O
these	O	O	O
clusters	O	O	B-T081
.	O	O	O

The	O	O	O
latency	O	O	B-T079
period	O	O	I-T079
must	O	O	O
also	O	O	O
be	O	O	O
considered	O	O	B-T078
for	O	O	O
exposed	O	O	B-T098
/	O	O	O
potentially	O	O	B-T080
exposed	O	O	B-T098
persons	O	O	I-T098
.	O	O	O

This	O	O	O
study	O	O	B-T062
uses	O	O	B-T169
actual	O	O	O
patient	O	O	B-T170
data	O	O	I-T170
from	O	O	O
a	O	O	O
chemical	O	O	B-T068
incident	O	O	I-T068
to	O	O	O
characterize	O	O	B-T052
and	O	O	O
validate	O	O	B-T062
signs/symptoms	O	O	B-T184
of	O	O	O
an	O	O	O
IGSA	O	O	B-T131
syndrome	O	O	B-T047
.	O	O	O

Validating	O	O	B-T062
signs/symptoms	O	O	B-T184
is	O	O	O
the	O	O	O
first	O	O	O
step	O	O	O
in	O	O	O
developing	O	O	O
new	O	O	B-T080
ED	O	O	B-T093
informatics	O	O	B-T170
tools	O	O	I-T170
with	O	O	O
the	O	O	O
potential	O	O	B-T080
to	O	O	O
revolutionize	O	O	O
the	O	O	O
process	O	O	B-T067
by	O	O	O
which	O	O	O
emergency	O	O	B-T097
nurses	O	O	I-T097
manage	O	O	O
triage	O	O	B-T061
victims	O	O	B-T098
of	O	O	O
chemical	O	O	B-T068
incidents	O	O	I-T068
.	O	O	O

-DOCSTART- (28363782)

Fyn	O	O	B-T116
regulates	O	O	O
multipolar	O	O	B-T082
-	O	O	O
bipolar	O	O	B-T082
transition	O	O	B-T052
and	O	O	O
neurite	O	O	B-T043
morphogenesis	O	O	I-T043
of	O	O	O
migrating	O	O	B-T043
neurons	O	O	I-T043
in	O	O	O
the	O	O	O
developing	O	O	O
neocortex	O	O	O

Fyn	O	O	B-T116
is	O	O	O
a	O	O	O
non-receptor	O	O	B-T033
protein	O	O	B-T116
tyrosine	O	O	I-T116
kinase	O	O	I-T116
that	O	O	O
belongs	O	O	O
to	O	O	O
Src	O	O	B-T116
family	O	O	I-T116
kinases	O	O	I-T116
.	O	O	O

Fyn	O	O	B-T116
plays	O	O	O
a	O	O	O
critical	O	O	O
role	O	O	O
in	O	O	O
neuronal	O	O	B-T043
migration	O	O	I-T043
,	O	O	O
but	O	O	O
the	O	O	O
mechanism	O	O	B-T169
remains	O	O	O
unclear	O	O	B-T033
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
reported	O	O	O
that	O	O	O
suppression	O	O	B-T045
of	O	O	O
Fyn	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
mouse	O	O	B-T024
cerebral	O	O	I-T024
cortex	O	O	I-T024
led	O	O	O
to	O	O	O
migration	O	O	B-T033
defects	O	O	I-T033
of	O	O	O
both	O	O	O
early-born	O	O	B-T079
and	O	O	O
late-born	O	O	B-T079
neurons	O	O	B-T025
.	O	O	O

Morphological	O	O	B-T082
analysis	O	O	B-T062
showed	O	O	O
that	O	O	O
loss	O	O	O
of	O	O	O
Fyn	O	O	B-T116
function	O	O	O
impaired	O	O	O
multipolar	O	O	B-T082
-	O	O	O
bipolar	O	O	B-T082
transition	O	O	B-T052
of	O	O	O
newly	O	O	O
generated	O	O	B-T052
neurons	O	O	B-T025
and	O	O	O
neurite	O	O	B-T043
formation	O	O	I-T043
in	O	O	O
the	O	O	O
early	O	O	O
phase	O	O	B-T079
of	O	O	O
migration	O	O	B-T043
.	O	O	O

Moreover	O	O	O
,	O	O	O
Fyn	O	O	B-T116
inhibition	O	O	B-T045
increased	O	O	O
the	O	O	O
length	O	O	O
of	O	O	O
leading	O	O	B-T043
process	O	O	I-T043
and	O	O	O
decreased	O	O	O
the	O	O	O
branching	O	O	B-T082
number	O	O	O
of	O	O	O
the	O	O	O
migrating	O	O	B-T043
cortical	O	O	I-T043
neurons	O	O	I-T043
.	O	O	O

Together	O	O	O
,	O	O	O
these	O	O	O
results	O	O	O
indicate	O	O	O
that	O	O	O
Fyn	O	O	B-T116
controls	O	O	B-T169
neuronal	O	O	B-T043
migration	O	O	I-T043
by	O	O	O
regulating	O	O	B-T038
the	O	O	O
cytoskeletal	O	O	B-T026
dynamics	O	O	B-T070
and	O	O	O
multipolar	O	O	B-T082
-	O	O	O
bipolar	O	O	B-T082
transition	O	O	B-T052
of	O	O	O
newly	O	O	B-T078
generated	O	O	B-T052
neurons	O	O	B-T025
during	O	O	O
cortical	O	O	B-T042
development	O	O	I-T042
.	O	O	O

-DOCSTART- (28367636)

Closing	O	O	B-T169
the	O	O	I-T169
Loop	O	O	I-T169
in	O	O	O
Adults	O	O	B-T100
,	O	O	O
Children	O	O	B-T100
and	O	O	O
Adolescents	O	O	B-T100
With	O	O	O
Suboptimally	O	O	B-T033
Controlled	O	O	I-T033
Type	O	O	I-T033
1	O	O	I-T033
Diabetes	O	O	I-T033
Under	O	O	O
Free	O	O	B-T078
Living	O	O	B-T080
Conditions	O	O	I-T080
:	O	O	O
A	O	O	O
Psychosocial	O	O	B-T169
Substudy	O	O	O

The	O	O	O
objective	O	O	O
was	O	O	O
to	O	O	O
explore	O	O	O
psychosocial	O	O	B-T033
experiences	O	O	I-T033
of	O	O	O
closed	O	O	B-T074
loop	O	O	I-T074
technology	O	O	I-T074
for	O	O	O
adults	O	O	B-T100
,	O	O	O
children	O	O	B-T100
,	O	O	O
and	O	O	O
adolescents	O	O	B-T100
with	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
and	O	O	O
their	O	O	O
parents	O	O	B-T099
taking	O	O	O
part	O	O	O
in	O	O	O
two	O	O	O
multicenter	O	O	B-T062
,	O	O	O
free	O	O	B-T078
-	O	O	O
living	O	O	B-T080
,	O	O	O
randomized	O	O	B-T062
crossover	O	O	B-T062
home	O	O	I-T062
studies	O	O	I-T062
.	O	O	O

Participants	O	O	B-T098
using	O	O	O
insulin	O	O	B-T074
pump	O	O	I-T074
therapy	O	O	B-T061
were	O	O	O
randomized	O	O	B-T062
to	O	O	O
either	O	O	O
12	O	O	O
weeks	O	O	B-T079
of	O	O	O
automated	O	O	B-T169
closed-loop	O	O	B-T169
glucose	O	O	B-T130
control	O	O	I-T130
,	O	O	O
then	O	O	O
12	O	O	O
weeks	O	O	O
of	O	O	O
sensor	O	O	B-T073
augmented	O	O	B-T081
insulin	O	O	O
pump	O	O	O
therapy	O	O	O
(	O	O	O
open	O	O	B-T169
loop	O	O	I-T169
)	O	O	O
,	O	O	O
or	O	O	O
vice	O	O	O
versa	O	O	O
.	O	O	O

Closed	O	O	B-T169
loop	O	O	I-T169
was	O	O	O
used	O	O	O
for	O	O	O
24	O	O	O
hours	O	O	B-T079
by	O	O	O
adults	O	O	B-T100
and	O	O	O
overnight	O	O	B-T079
only	O	O	O
by	O	O	O
children	O	O	B-T100
and	O	O	O
adolescents	O	O	B-T100
.	O	O	O

Participants	O	O	B-T098
completed	O	O	O
the	O	O	O
Diabetes	O	O	B-T170
Technology	O	O	I-T170
Questionnaire	O	O	I-T170
(	O	O	O
DTQ	O	O	B-T170
)	O	O	O
periodically	O	O	B-T079
and	O	O	O
shared	O	O	O
their	O	O	O
views	O	O	B-T082
in	O	O	O
semistructured	O	O	B-UnknownType
interviews	O	O	I-UnknownType
.	O	O	O

This	O	O	O
analysis	O	O	B-T062
characterizes	O	O	B-T078
the	O	O	O
impact	O	O	B-T080
of	O	O	O
the	O	O	O
technology	O	O	B-T090
,	O	O	O
positive	O	O	B-T033
and	O	O	O
negative	O	O	B-T080
aspects	O	O	O
of	O	O	O
living	O	O	B-T080
with	O	O	O
the	O	O	O
device	O	O	B-T074
,	O	O	O
alongside	O	O	O
participants	O	O	B-T098
'	O	O	O
expectations	O	O	B-T078
,	O	O	O
hopes	O	O	B-T041
,	O	O	O
and	O	O	O
anxieties	O	O	B-T033
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
32	O	O	O
adults	O	O	B-T100
,	O	O	O
age	O	O	B-T032
38.6	O	O	O
±	O	O	O
9.6	O	O	O
years	O	O	B-T079
,	O	O	O
55	O	O	O
%	O	O	O
male	O	O	B-T032
,	O	O	O
and	O	O	O
26	O	O	O
children	O	O	B-T100
,	O	O	O
mean	O	O	O
age	O	O	O
12	O	O	O
years	O	O	O
(	O	O	O
range	O	O	O
6	O	O	O
-	O	O	O
18	O	O	O
years	O	O	O
)	O	O	O
,	O	O	O
54	O	O	O
%	O	O	O
male	O	O	O
.	O	O	O

DTQ	O	O	B-T170
results	O	O	B-T169
indicated	O	O	O
moderately	O	O	B-T080
favorable	O	O	I-T080
impact	O	O	I-T080
of	O	O	O
,	O	O	O
and	O	O	O
satisfaction	O	O	O
with	O	O	O
,	O	O	O
both	O	O	O
open	O	O	B-T169
and	O	O	O
closed	O	O	B-T169
loop	O	O	I-T169
interventions	O	O	B-T061
,	O	O	O
but	O	O	O
little	O	O	O
evidence	O	O	B-T078
of	O	O	O
a	O	O	O
comparative	O	O	B-UnknownType
advantage	O	O	I-UnknownType
of	O	O	O
either	O	O	O
.	O	O	O

Key	O	O	O
positive	O	O	B-T033
themes	O	O	I-T033
included	O	O	O
perceived	O	O	O
improved	O	O	B-T130
blood	O	O	I-T130
glucose	O	O	I-T130
control	O	O	I-T130
,	O	O	O
improved	O	O	B-T033
general	O	O	I-T033
well-being	O	O	I-T033
,	O	O	O
particularly	O	O	O
on	O	O	O
waking	O	O	B-T039
,	O	O	O
improved	O	O	B-T040
sleep	O	O	I-T040
,	O	O	O
reduced	O	O	B-T080
burden	O	O	B-T078
of	O	O	O
diabetes	O	O	B-T047
,	O	O	O
and	O	O	O
visibility	O	O	B-T080
of	O	O	O
data	O	O	B-T078
.	O	O	O

Key	O	O	O
negative	O	O	B-T080
themes	O	O	I-T080
included	O	O	O
having	O	O	O
to	O	O	O
carry	O	O	O
around	O	O	O
the	O	O	O
equipment	O	O	B-T073
and	O	O	O
dislike	O	O	B-T041
of	O	O	O
the	O	O	O
pump	O	O	B-T074
and	O	O	O
second	O	O	O
cannula	O	O	B-T074
(	O	O	O
ie	O	O	O
,	O	O	O
sensor	O	O	B-T073
)	O	O	O
inserted	O	O	O
.	O	O	O

Overall	O	O	O
,	O	O	O
participants	O	O	B-T098
reported	O	O	O
a	O	O	O
positive	O	O	B-T033
experience	O	O	B-T055
of	O	O	O
the	O	O	O
closed	O	O	B-T074
loop	O	O	I-T074
technology	O	O	I-T074
.	O	O	O

Results	O	O	B-T169
are	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
previous	O	O	O
research	O	O	O
with	O	O	O
size	O	O	B-T082
of	O	O	O
equipment	O	O	B-T073
continuing	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
problem	O	O	B-T033
.	O	O	O

Progress	O	O	O
is	O	O	O
being	O	O	O
made	O	O	O
in	O	O	O
the	O	O	O
usability	O	O	B-T169
of	O	O	O
the	O	O	O
closed-loop	O	O	B-T074
system	O	O	I-T074
.	O	O	O

-DOCSTART- (28370352)

Serum	O	O	B-T031
levels	O	O	B-T080
of	O	O	O
genomic	O	O	B-T114
DNA	O	O	I-T114
of	O	O	O
α1(I	O	O	B-T028
)	O	O	I-T028
collagen	O	O	I-T028
are	O	O	O
elevated	O	O	B-T080
in	O	O	O
scleroderma	O	O	B-T047
patients	O	O	O

Recent	O	O	O
studies	O	O	O
have	O	O	O
indicated	O	O	O
that	O	O	O
various	O	O	O
nucleic	O	O	B-T114
acids	O	O	I-T114
are	O	O	O
present	O	O	O
in	O	O	O
human	O	O	B-T016
sera	O	O	B-T031
,	O	O	O
and	O	O	O
attracted	O	O	O
attention	O	O	O
for	O	O	O
their	O	O	O
potential	O	O	O
as	O	O	O
novel	O	O	O
disease	O	O	B-T078
markers	O	O	I-T078
in	O	O	O
many	O	O	O
human	O	O	O
diseases	O	O	B-T047
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
tried	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
possibility	O	O	O
that	O	O	O
DNA	O	O	B-T114
and	O	O	O
RNA	O	O	B-T114
of	O	O	O
collagens	O	O	B-T028
exist	O	O	O
in	O	O	O
human	O	O	B-T016
sera	O	O	B-T031
,	O	O	O
and	O	O	O
determined	O	O	O
whether	O	O	O
their	O	O	O
serum	O	O	B-T031
levels	O	O	B-T080
can	O	O	O
be	O	O	O
useful	O	O	O
biomarkers	O	O	B-T201
in	O	O	O
scleroderma	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

The	O	O	O
RNA	O	O	B-T114
or	O	O	O
DNA	O	O	B-T114
of	O	O	O
collagens	O	O	B-T028
were	O	O	O
purified	O	O	B-T169
from	O	O	O
sera	O	O	B-T031
,	O	O	O
and	O	O	O
detected	O	O	B-T033
by	O	O	O
polymerase	O	O	B-T063
chain	O	O	I-T063
reaction	O	O	I-T063
or	O	O	O
quantitated	O	O	B-T081
by	O	O	O
real-time	O	O	B-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
.	O	O	O

Among	O	O	O
approximately	O	O	O
18	O	O	O
360	O	O	B-T028
bases	O	O	I-T028
of	O	O	I-T028
full-length	O	O	I-T028
α1(I	O	O	I-T028
)	O	O	I-T028
collagen	O	O	I-T028
DNA	O	O	B-T114
,	O	O	O
various	O	O	O
regions	O	O	B-T028
were	O	O	O
detected	O	O	B-T033
by	O	O	O
polymerase	O	O	B-T063
chain	O	O	I-T063
reaction	O	O	I-T063
in	O	O	O
human	O	O	B-T016
sera	O	O	B-T031
.	O	O	O

However	O	O	O
,	O	O	O
α2(I	O	O	B-T028
)	O	O	I-T028
collagen	O	O	I-T028
DNA	O	O	B-T114
,	O	O	O
α1(I	O	O	B-T028
)	O	O	I-T028
collagen	O	O	I-T028
RNA	O	O	B-T114
or	O	O	O
α2(I	O	O	O
)	O	O	O
collagen	O	O	O
RNA	O	O	O
were	O	O	O
not	O	O	B-T033
detectable	O	O	I-T033
.	O	O	O

α1(I	O	O	B-T028
)	O	O	I-T028
Collagen	O	O	I-T028
DNA	O	O	B-T114
in	O	O	O
sera	O	O	B-T031
was	O	O	O
quantitative	O	O	B-T081
using	O	O	O
our	O	O	O
method	O	O	O
.	O	O	O

The	O	O	O
levels	O	O	B-T080
of	O	O	O
serum	O	O	B-T031
α1(I	O	O	B-T028
)	O	O	I-T028
collagen	O	O	I-T028
DNA	O	O	B-T114
were	O	O	O
significantly	O	O	O
increased	O	O	B-T081
in	O	O	O
scleroderma	O	O	B-T047
patients	O	O	B-T101
compared	O	O	O
with	O	O	O
healthy	O	O	B-T080
control	O	O	I-T080
subjects	O	O	B-T098
or	O	O	O
systemic	O	O	B-T047
lupus	O	O	I-T047
erythematosus	O	O	I-T047
patients	O	O	O
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
receiver-operator	O	O	B-T081
curve	O	O	I-T081
analysis	O	O	I-T081
,	O	O	O
serum	O	O	B-T031
α1(I	O	O	B-T028
)	O	O	I-T028
collagen	O	O	I-T028
DNA	O	O	B-T114
levels	O	O	B-T080
were	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
effective	O	O	O
as	O	O	O
a	O	O	O
diagnostic	O	O	B-T201
marker	O	O	I-T201
of	O	O	O
scleroderma	O	O	B-T047
.	O	O	O

Furthermore	O	O	O
,	O	O	O
when	O	O	O
we	O	O	O
determined	O	O	O
the	O	O	O
association	O	O	B-T080
of	O	O	O
serum	O	O	B-T031
α1(I	O	O	B-T028
)	O	O	I-T028
collagen	O	O	I-T028
DNA	O	O	B-T114
levels	O	O	B-T080
with	O	O	O
clinical	O	O	B-T080
/	O	O	O
laboratory	O	O	B-T093
features	O	O	B-T080
in	O	O	O
scleroderma	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
those	O	O	O
with	O	O	O
elevated	O	O	B-T080
α1(I	O	O	O
)	O	O	O
collagen	O	O	O
DNA	O	O	O
levels	O	O	O
showed	O	O	O
significantly	O	O	O
higher	O	O	O
prevalence	O	O	B-T081
of	O	O	O
pitting	O	O	B-T047
scars	O	O	I-T047
/	O	O	O
ulcers	O	O	B-T047
.	O	O	O

In	O	O	O
summary	O	O	O
,	O	O	O
elevation	O	O	B-T080
of	O	O	O
serum	O	O	B-T031
α1(I	O	O	B-T028
)	O	O	I-T028
collagen	O	O	I-T028
DNA	O	O	B-T114
levels	O	O	B-T080
in	O	O	O
scleroderma	O	O	B-T047
patients	O	O	B-T101
may	O	O	O
be	O	O	O
useful	O	O	O
as	O	O	O
the	O	O	O
diagnostic	O	O	B-T201
marker	O	O	I-T201
,	O	O	O
reflecting	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
vasculopathy	O	O	B-T047
.	O	O	O

Jou	O	O	O
rna	O	O	O

-DOCSTART- (28370605)

Metabolite	O	O	B-T123
mapping	O	O	B-T052
by	O	O	O
consecutive	O	O	O
nanostructure	O	O	B-T073
and	O	O	O
silver-assisted	O	O	B-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
imaging	O	O	I-T059
on	O	O	O
tissue	O	O	O
sections	O	O	O

Nanostructure-based	O	O	B-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
imaging	O	O	I-T059
(	O	O	O
MSI	O	O	B-T059
)	O	O	O
is	O	O	O
a	O	O	O
promising	O	O	O
technology	O	O	O
for	O	O	O
molecular	O	O	B-T060
imaging	O	O	I-T060
of	O	O	O
small	O	O	B-T109
molecules	O	O	I-T109
,	O	O	O
without	O	O	O
the	O	O	O
complex	O	O	O
chemical	O	O	O
background	O	O	O
typically	O	O	O
encountered	O	O	O
in	O	O	O
matrix-assisted	O	O	B-T060
molecular	O	O	I-T060
imaging	O	O	I-T060
approaches	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
enhanced	O	O	O
these	O	O	O
surfaces	O	O	B-T082
with	O	O	O
silver	O	O	B-T196
(	O	O	O
Ag	O	O	B-T196
)	O	O	O
to	O	O	O
provide	O	O	O
a	O	O	O
second	O	O	O
tier	O	O	O
of	O	O	O
MSI	O	O	B-T170
data	O	O	I-T170
from	O	O	O
a	O	O	O
single	O	O	O
sample	O	O	O
.	O	O	O

MSI	O	O	B-T170
data	O	O	I-T170
was	O	O	O
acquired	O	O	O
through	O	O	O
the	O	O	O
application	O	O	B-T169
of	O	O	O
laser	O	O	B-T059
desorption/ionization	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
to	O	O	O
biological	O	O	B-UnknownType
samples	O	O	I-UnknownType
imprinted	O	O	O
onto	O	O	O
desorption/ionization	O	O	B-T067
on	O	O	I-T067
silicon	O	O	I-T067
(	O	O	O
DIOS	O	O	B-T067
)	O	O	O
substrates	O	O	B-T167
.	O	O	O

Following	O	O	O
initial	O	O	O
analysis	O	O	B-T062
,	O	O	O
ultra-thin	O	O	B-T080
Ag	O	O	I-T080
layers	O	O	I-T080
were	O	O	O
overlaid	O	O	O
onto	O	O	O
the	O	O	O
followed	O	O	O
by	O	O	O
MSI	O	O	B-T059
analysis	O	O	I-T059
(	O	O	O
Ag-DIOS	O	O	B-T059
MSI	O	O	I-T059
)	O	O	O
.	O	O	O

This	O	O	O
approach	O	O	O
was	O	O	O
first	O	O	O
demonstrated	O	O	O
for	O	O	O
fingermark	O	O	O
small	O	O	B-T109
molecules	O	O	I-T109
including	O	O	O
environmental	O	O	B-T082
contaminants	O	O	B-T167
and	O	O	O
sebum	O	O	B-T031
components	O	O	O
.	O	O	O

Subsequently	O	O	O
,	O	O	O
this	O	O	O
bimodal	O	O	O
method	O	O	O
was	O	O	O
translated	O	O	O
to	O	O	O
lipids	O	O	B-T109
and	O	O	O
metabolites	O	O	B-T123
in	O	O	O
fore-stomach	O	O	B-T024
sections	O	O	I-T024
from	O	O	O
a	O	O	O
6-bromoisatin	O	O	B-T109
chemopreventative	O	O	B-T080
murine	O	O	B-T050
mouse	O	O	I-T050
model	O	O	I-T050
.	O	O	O

DIOS	O	O	B-T059
MSI	O	O	I-T059
allowed	O	O	O
mapping	O	O	B-T052
of	O	O	O
common	O	O	O
ions	O	O	B-T196
in	O	O	O
fingermarks	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
6-bromoisatin	O	O	B-T109
metabolites	O	O	B-T123
and	O	O	O
lipids	O	O	B-T109
in	O	O	O
murine	O	O	B-T024
fore-stomach	O	O	I-T024
.	O	O	O

Furthermore	O	O	O
,	O	O	O
DIOS	O	O	B-T059
MSI	O	O	I-T059
was	O	O	O
complemented	O	O	O
by	O	O	O
the	O	O	O
Ag-DIOS	O	O	B-T059
MSI	O	O	I-T059
of	O	O	O
Ag-adductable	O	O	B-T109
lipids	O	O	I-T109
such	O	O	O
as	O	O	O
wax	O	O	B-T109
esters	O	O	I-T109
in	O	O	O
fingermarks	O	O	O
and	O	O	O
cholesterol	O	O	B-T109
in	O	O	O
murine	O	O	B-T024
fore-stomach	O	O	I-T024
.	O	O	O

Gastrointestinal	O	O	B-T031
acid	O	O	I-T031
condensation	O	O	B-T067
products	O	O	B-T123
of	O	O	O
6-bromoisatin	O	O	B-T109
,	O	O	O
such	O	O	O
as	O	O	O
the	O	O	O
6,6'-dibromoindirubin	O	O	B-T123
mapped	O	O	O
herein	O	O	O
,	O	O	O
are	O	O	O
very	O	O	O
challenging	O	O	O
to	O	O	O
isolate	O	O	B-T059
and	O	O	O
characterize	O	O	B-T052
.	O	O	O

By	O	O	O
re-analyzing	O	O	O
the	O	O	O
same	O	O	O
tissue	O	O	B-T024
imprints	O	O	O
,	O	O	O
this	O	O	O
metabolite	O	O	B-T123
was	O	O	O
readily	O	O	O
detected	O	O	O
by	O	O	O
DIOS	O	O	B-T067
,	O	O	O
placed	O	O	O
in	O	O	O
a	O	O	O
tissue-specific	O	O	B-T024
spatial	O	O	I-T024
context	O	O	I-T024
,	O	O	O
and	O	O	O
subsequently	O	O	O
overlaid	O	O	O
with	O	O	O
additional	O	O	O
lipid	O	O	B-T043
distributions	O	O	I-T043
acquired	O	O	O
using	O	O	O
Ag-DIOS	O	O	B-T059
MSI	O	O	I-T059
.	O	O	O

The	O	O	O
ability	O	O	O
to	O	O	O
place	O	O	O
metabolite	O	O	B-T123
and	O	O	O
lipid	O	O	B-T109
classes	O	O	O
in	O	O	O
a	O	O	O
tissue-specific	O	O	B-T024
context	O	O	O
makes	O	O	O
this	O	O	O
novel	O	O	O
method	O	O	O
suited	O	O	O
to	O	O	O
MSI	O	O	B-T059
analyses	O	O	I-T059
where	O	O	O
the	O	O	O
collection	O	O	O
of	O	O	O
additional	O	O	O
information	O	O	O
from	O	O	O
the	O	O	O
same	O	O	O
sample	O	O	O
maximises	O	O	O
resource	O	O	O
use	O	O	O
,	O	O	O
and	O	O	O
also	O	O	O
maximises	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
annotated	O	O	O
small	O	O	B-T109
molecules	O	O	I-T109
,	O	O	O
in	O	O	O
particular	O	O	O
for	O	O	O
metabolites	O	O	B-T123
that	O	O	O
are	O	O	O
typically	O	O	O
undetectable	O	O	B-T201
with	O	O	O
traditional	O	O	O
platforms	O	O	O
.	O	O	O

Copyright	O	O	O
©	O	O	O
2017	O	O	O
John	O	O	O
Wiley	O	O	O
&	O	O	O
Sons	O	O	O
,	O	O	O
Ltd.	O	O	O

-DOCSTART- (28370728)

Towards	O	O	O
culturally	O	O	B-T058
competent	O	O	I-T058
paediatric	O	O	I-T058
oncology	O	O	I-T058
care	O	O	I-T058
.	O	O	O
A	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
from	O	O	O
the	O	O	O
perspective	O	O	B-T077
of	O	O	O
care	O	O	O
providers	O	O	O

A	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
from	O	O	O
the	O	O	O
perspective	O	O	B-T077
of	O	O	O
care	O	O	B-T097
providers	O	O	I-T097
In	O	O	O
order	O	O	O
to	O	O	O
gain	O	O	O
more	O	O	O
insight	O	O	O
on	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
ethnic	O	O	B-T033
diversity	O	O	B-T080
in	O	O	O
paediatric	O	O	B-T091
cancer	O	O	B-T061
care	O	O	I-T061
,	O	O	O
the	O	O	O
perspectives	O	O	B-T077
of	O	O	O
care	O	O	O
providers	O	O	O
were	O	O	O
explored	O	O	O
.	O	O	O

Semi-structured	O	O	B-T058
interviews	O	O	I-T058
were	O	O	O
conducted	O	O	O
among	O	O	O
12	O	O	O
paediatric	O	O	B-T097
oncologists	O	O	I-T097
and	O	O	O
13	O	O	O
nurses	O	O	B-T097
of	O	O	O
two	O	O	O
different	O	O	O
paediatric	O	O	B-T093
oncology	O	O	I-T093
wards	O	O	I-T093
and	O	O	O
were	O	O	O
analysed	O	O	B-T062
using	O	O	O
a	O	O	O
framework	O	O	B-T170
method	O	O	I-T170
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
care	O	O	B-T097
providers	O	O	I-T097
described	O	O	O
the	O	O	O
contact	O	O	O
with	O	O	O
Turkish	O	O	B-T098
and	O	O	O
Moroccan	O	O	B-T098
parents	O	O	B-T099
as	O	O	O
more	O	O	O
difficult	O	O	O
.	O	O	O

They	O	O	O
offered	O	O	O
two	O	O	O
reasons	O	O	O
for	O	O	O
this	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
language	O	O	B-T033
barriers	O	O	I-T033
between	O	O	O
care	O	O	B-T097
provider	O	O	I-T097
and	O	O	O
parents	O	O	B-T099
hindered	O	O	B-T169
the	O	O	O
exchange	O	O	B-T170
of	O	O	I-T170
information	O	O	I-T170
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
cultural	O	O	B-T058
barriers	O	O	I-T058
between	O	O	O
care	O	O	O
provider	O	O	O
and	O	O	O
parents	O	O	O
about	O	O	O
sharing	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
palliative	O	O	B-T080
perspective	O	O	B-T077
hindered	O	O	O
communication	O	O	B-T054
.	O	O	O

Care	O	O	B-T097
providers	O	O	I-T097
reported	O	O	O
different	O	O	O
solutions	O	O	B-T077
to	O	O	O
deal	O	O	O
with	O	O	O
these	O	O	O
barriers	O	O	B-T078
,	O	O	O
such	O	O	O
as	O	O	O
using	O	O	O
an	O	O	O
interpreter	O	O	B-T097
and	O	O	O
improving	O	O	O
their	O	O	O
cultural	O	O	B-T170
knowledge	O	O	I-T170
about	O	O	O
their	O	O	O
patients	O	O	B-T101
.	O	O	O

They	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
were	O	O	O
not	O	O	O
using	O	O	O
interpreters	O	O	B-T097
sufficiently	O	O	O
and	O	O	O
were	O	O	O
unaware	O	O	O
of	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
eliciting	O	O	B-T048
parents	O	O	B-T099
'	O	O	O
perspectives	O	O	B-T077
.	O	O	O

Communication	O	O	B-T054
techniques	O	O	B-T169
to	O	O	O
overcome	O	O	O
dilemmas	O	O	B-T068
between	O	O	O
parents	O	O	B-T099
and	O	O	O
care	O	O	B-T097
providers	O	O	I-T097
were	O	O	O
not	O	O	O
used	O	O	O
and	O	O	O
care	O	O	O
providers	O	O	O
were	O	O	O
unaware	O	O	O
of	O	O	O
stereotypes	O	O	B-T041
and	O	O	O
prejudice	O	O	B-T055
.	O	O	O

Care	O	O	B-T097
providers	O	O	I-T097
should	O	O	O
be	O	O	O
offered	O	O	O
insight	O	O	O
in	O	O	O
cultural	O	O	B-T058
barriers	O	O	I-T058
they	O	O	O
are	O	O	O
unaware	O	O	O
of	O	O	O
.	O	O	O

Training	O	O	B-T065
in	O	O	O
cultural	O	O	B-T054
competence	O	O	I-T054
might	O	O	O
be	O	O	O
a	O	O	O
possibility	O	O	O
to	O	O	O
overcome	O	O	O
manifest	O	O	B-T169
barriers	O	O	B-T078
.	O	O	O

-DOCSTART- (28371313)

Obesogenic	O	O	B-T047
eating	O	O	B-T055
behaviors	O	O	I-T055
mediate	O	O	O
the	O	O	O
relationships	O	O	B-T080
between	O	O	O
psychological	O	O	B-T033
problems	O	O	I-T033
and	O	O	O
BMI	O	O	B-T201
in	O	O	O
children	O	O	O

To	O	O	O
examine	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
psychological	O	O	B-T033
problems	O	O	I-T033
and	O	O	O
weight	O	O	B-T032
status	O	O	B-T080
in	O	O	O
children	O	O	B-T100
aged	O	O	B-T032
3.5	O	O	O
to	O	O	O
4	O	O	O
years	O	O	B-T079
and	O	O	O
test	O	O	O
whether	O	O	O
obesogenic	O	O	B-T047
eating	O	O	B-T055
behaviors	O	O	I-T055
mediate	O	O	O
this	O	O	O
relationship	O	O	B-T080
.	O	O	O

This	O	O	O
study	O	O	O
is	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
secondary	O	O	I-T062
analysis	O	O	I-T062
of	O	O	O
data	O	O	B-T078
from	O	O	O
first-time	O	O	B-T099
mothers	O	O	I-T099
(	O	O	O
N	O	O	O
=	O	O	O
194	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
control	O	O	O
arm	O	O	O
of	O	O	O
the	O	O	O
NOURISH	O	O	B-T062
randomized	O	O	I-T062
controlled	O	O	I-T062
trial	O	O	I-T062
.	O	O	O

At	O	O	O
child	O	O	B-T100
age	O	O	O
3.5	O	O	O
to	O	O	O
4	O	O	O
years	O	O	O
,	O	O	O
maternal	O	O	B-T099
-reported	O	O	O
child	O	O	O
eating	O	O	B-T055
behaviors	O	O	I-T055
and	O	O	O
psychological	O	O	B-T033
problems	O	O	I-T033
were	O	O	O
collected	O	O	O
via	O	O	O
valid	O	O	O
tools	O	O	O
,	O	O	O
and	O	O	O
child	O	O	O
weight	O	O	B-T032
and	O	O	O
height	O	O	B-T032
data	O	O	B-T062
were	O	O	I-T062
collected	O	O	I-T062
by	O	O	O
trained	O	O	O
study	O	O	O
staff	O	O	B-T080
.	O	O	O

Pearson	O	O	B-T170
's	O	O	I-T170
correlations	O	O	I-T170
and	O	O	O
linear	O	O	B-T081
regressions	O	O	I-T081
examined	O	O	O
associations	O	O	B-T080
between	O	O	O
eating	O	O	B-T055
behaviors	O	O	I-T055
,	O	O	O
psychological	O	O	B-T033
problems	O	O	I-T033
,	O	O	O
and	O	O	O
BMI	O	O	B-T201
z	O	O	B-T081
score	O	O	I-T081
.	O	O	O

Multiple	O	O	B-UnknownType
mediation	O	O	I-UnknownType
models	O	O	I-UnknownType
were	O	O	O
tested	O	O	B-T169
by	O	O	O
assessing	O	O	O
indirect	O	O	B-T080
effects	O	O	B-T080
of	O	O	O
psychological	O	O	B-T033
problems	O	O	I-T033
on	O	O	O
BMI	O	O	B-T201
z	O	O	B-T081
score	O	O	I-T081
via	O	O	O
obesogenic	O	O	B-T047
eating	O	O	B-T055
behaviors	O	O	I-T055
.	O	O	O

Peer	O	O	B-T098
problems	O	O	B-T033
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
both	O	O	O
higher	O	O	B-T080
food	O	O	B-T168
responsiveness	O	O	B-T169
and	O	O	O
emotional	O	O	B-T048
overeating	O	O	I-T048
and	O	O	O
directly	O	O	B-T080
with	O	O	O
higher	O	O	O
BMI	O	O	B-T201
z	O	O	B-T081
score	O	O	I-T081
.	O	O	O

This	O	O	O
relationship	O	O	B-T080
was	O	O	O
partially	O	O	O
mediated	O	O	O
by	O	O	O
emotional	O	O	B-T048
overeating	O	O	I-T048
.	O	O	O

Both	O	O	O
emotional	O	O	B-T048
overeating	O	O	I-T048
and	O	O	O
food	O	O	B-T168
responsiveness	O	O	B-T169
fully	O	O	O
mediated	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
emotional	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
BMI	O	O	B-T201
z	O	O	B-T081
score	O	O	I-T081
,	O	O	O
and	O	O	O
food	O	O	O
responsiveness	O	O	O
fully	O	O	O
mediated	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
conduct	O	O	B-T048
problems	O	O	I-T048
and	O	O	O
BMI	O	O	O
z	O	O	O
score	O	O	O
.	O	O	O

The	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
children	O	O	B-T100
with	O	O	O
psychological	O	O	B-T033
problems	O	O	I-T033
may	O	O	O
also	O	O	O
display	O	O	O
obesogenic	O	O	B-T047
eating	O	O	B-T055
behaviors	O	O	I-T055
,	O	O	O
which	O	O	O
may	O	O	O
result	O	O	O
in	O	O	O
higher	O	O	B-T080
BMI	O	O	B-T201
.	O	O	O

This	O	O	O
needs	O	O	O
to	O	O	O
be	O	O	O
considered	O	O	O
in	O	O	O
the	O	O	O
clinical	O	O	B-T058
management	O	O	I-T058
of	O	O	O
both	O	O	O
pediatric	O	O	B-T080
overweight	O	O	B-T184
/	O	O	O
obesity	O	O	B-T047
and	O	O	O
psychological	O	O	B-T033
problems	O	O	I-T033
.	O	O	O

-DOCSTART- (28371745)

Homocysteine	O	O	B-T116
as	O	O	O
a	O	O	O
peripheral	O	O	B-T082
biomarker	O	O	B-T201
in	O	O	O
bipolar	O	O	B-T048
disorder	O	O	I-T048
:	O	O	O
A	O	O	O
meta-analysis	O	O	O

Bipolar	O	O	B-T048
disorder	O	O	I-T048
(	O	O	O
BD	O	O	B-T048
)	O	O	O
is	O	O	O
a	O	O	O
psychiatric	O	O	B-T048
disorder	O	O	I-T048
with	O	O	O
an	O	O	O
uncertain	O	O	B-T033
aetiology	O	O	B-T169
.	O	O	O

Recently	O	O	O
,	O	O	O
special	O	O	O
attention	O	O	O
has	O	O	O
been	O	O	O
given	O	O	O
to	O	O	O
homocysteine	O	O	B-T116
(	O	O	O
Hcy	O	O	B-T116
)	O	O	O
,	O	O	O
as	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
suggested	O	O	O
that	O	O	O
alterations	O	O	B-T078
in	O	O	O
1-carbon	O	O	B-T044
metabolism	O	O	I-T044
might	O	O	O
be	O	O	O
implicated	O	O	O
in	O	O	O
diverse	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
uncertainty	O	O	B-T033
regarding	O	O	O
possible	O	O	O
alterations	O	O	B-T078
in	O	O	O
peripheral	O	O	B-T082
Hcy	O	O	B-T116
levels	O	O	O
in	O	O	O
BD	O	O	B-T048
.	O	O	O

This	O	O	O
study	O	O	O
comprises	O	O	O
a	O	O	O
meta-analysis	O	O	B-T062
comparing	O	O	O
serum	O	O	B-T059
and	O	O	O
plasma	O	O	B-T059
Hcy	O	O	I-T059
levels	O	O	I-T059
in	O	O	O
persons	O	O	B-T098
with	O	O	O
BD	O	O	B-T048
and	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
systematic	O	O	B-T169
search	O	O	B-T052
for	O	O	O
all	O	O	O
eligible	O	O	B-T080
English	O	O	O
and	O	O	O
non-English	O	O	O
peer-reviewed	O	O	B-T170
articles	O	O	I-T170
.	O	O	O

Nine	O	O	O
cross-sectional	O	O	B-T062
studies	O	O	I-T062
were	O	O	O
included	O	O	B-T169
in	O	O	O
the	O	O	O
meta-analyses	O	O	B-T062
,	O	O	O
providing	O	O	B-T052
data	O	O	B-T078
on	O	O	O
1547	O	O	O
participants	O	O	B-T098
.	O	O	O

Random-effects	O	O	B-T080
meta-analysis	O	O	B-T062
showed	O	O	O
that	O	O	O
serum	O	O	B-T059
and	O	O	O
plasma	O	O	B-T059
levels	O	O	I-T059
of	O	O	I-T059
Hcy	O	O	I-T059
were	O	O	O
increased	O	O	B-T081
in	O	O	O
subjects	O	O	B-T096
with	O	O	O
BD	O	O	B-T048
in	O	O	O
either	O	O	O
mania	O	O	B-T048
or	O	O	O
euthymia	O	O	B-T048
when	O	O	O
compared	O	O	B-T052
to	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
,	O	O	O
with	O	O	O
a	O	O	O
large	O	O	O
effect	O	O	B-T080
size	O	O	I-T081
in	O	O	O
the	O	O	O
mania	O	O	O
group	O	O	B-T098
(	O	O	O
g=0.98	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.8	O	O	O
-	O	O	O
1.17	O	O	O
,	O	O	O
P<0.001	O	O	O
,	O	O	O
n=495	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
small	O	O	O
effect	O	O	O
in	O	O	O
the	O	O	O
euthymia	O	O	O
group	O	O	O
(	O	O	O
g=0.3	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.11	O	O	O
-	O	O	O
0.48	O	O	O
,	O	O	O
P=0.002	O	O	O
,	O	O	O
n=1052	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
meta-analysis	O	O	B-T062
provides	O	O	O
evidence	O	O	O
that	O	O	O
Hcy	O	O	B-T033
levels	O	O	I-T033
are	O	O	I-T033
elevated	O	O	I-T033
in	O	O	O
persons	O	O	B-T098
with	O	O	O
BD	O	O	B-T048
during	O	O	O
mania	O	O	B-T048
and	O	O	O
euthymia	O	O	B-T048
.	O	O	O

Peripheral	O	O	B-T082
Hcy	O	O	B-T116
could	O	O	O
be	O	O	O
considered	O	O	B-T078
as	O	O	O
a	O	O	O
potential	O	O	B-T080
biomarker	O	O	B-T201
in	O	O	O
BD	O	O	B-T048
,	O	O	O
both	O	O	O
of	O	O	O
trait	O	O	B-T032
(	O	O	O
since	O	O	O
it	O	O	O
is	O	O	O
increased	O	O	B-T081
in	O	O	O
euthymia	O	O	B-T048
)	O	O	O
,	O	O	O
and	O	O	O
also	O	O	O
of	O	O	O
state	O	O	B-T169
(	O	O	O
since	O	O	O
its	O	O	O
increase	O	O	B-T169
is	O	O	O
more	O	O	O
accentuated	O	O	B-T080
in	O	O	O
mania	O	O	B-T048
)	O	O	O
.	O	O	O

Longitudinal	O	O	B-T062
studies	O	O	I-T062
are	O	O	O
needed	O	O	O
to	O	O	O
clarify	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
bipolar	O	O	B-T048
disorder	O	O	I-T048
and	O	O	O
Hcy	O	O	B-T116
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
usefulness	O	O	B-T080
of	O	O	O
peripheral	O	O	B-T082
Hcy	O	O	O
as	O	O	O
both	O	O	O
a	O	O	O
trait	O	O	B-T032
and	O	O	O
state	O	O	B-T169
biomarker	O	O	B-T201
in	O	O	O
BD	O	O	B-T048
.	O	O	O

-DOCSTART- (28373195)

Structural	O	O	B-T061
Modification	O	O	I-T061
of	O	O	O
Lipopolysaccharide	O	O	B-T109
Conferred	O	O	O
by	O	O	O
mcr-1	O	O	B-T028
in	O	O	O
Gram-Negative	O	O	B-T007
ESKAPE	O	O	I-T007
Pathogens	O	O	O

mcr-1	O	O	B-T028
was	O	O	O
initially	O	O	O
reported	O	O	O
as	O	O	O
the	O	O	O
first	O	O	O
plasmid	O	O	B-T114
-mediated	O	O	O
colistin	O	O	B-T116
resistance	O	O	B-T028
gene	O	O	I-T028
in	O	O	O
clinical	O	O	B-T080
isolates	O	O	I-T123
of	O	O	O
Escherichia	O	O	B-T007
coli	O	O	I-T007
and	O	O	O
Klebsiella	O	O	B-T007
pneumoniae	O	O	I-T007
in	O	O	O
China	O	O	B-T083
and	O	O	O
has	O	O	O
subsequently	O	O	O
been	O	O	O
identified	O	O	O
worldwide	O	O	O
in	O	O	O
various	O	O	O
species	O	O	B-T185
of	O	O	O
the	O	O	O
family	O	O	B-T007
Enterobacteriaceae	O	O	I-T007
mcr-1	O	O	O
encodes	O	O	O
a	O	O	O
phosphoethanolamine	O	O	B-T109
transferase	O	O	I-T044
,	O	O	O
and	O	O	O
its	O	O	O
expression	O	O	B-T045
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
generate	O	O	O
phosphoethanolamine	O	O	O
-modified	O	O	O
bis-phosphorylated	O	O	B-T129
hexa-acylated	O	O	I-T129
lipid	O	O	I-T129
A	O	O	I-T129
in	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
Here	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
mcr-1	O	O	O
on	O	O	O
colistin	O	O	O
susceptibility	O	O	B-T033
and	O	O	O
on	O	O	O
lipopolysaccharide	O	O	B-T109
structures	O	O	B-T082
in	O	O	O
laboratory	O	O	B-T093
and	O	O	O
clinical	O	O	O
strains	O	O	B-T080
of	O	O	O
the	O	O	O
Gram-negative	O	O	B-T007
ESKAPE	O	O	I-T007
(	O	O	O
Enterococcus	O	O	B-T007
faecium	O	O	I-T007
,	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
,	O	O	O
K.	O	O	B-T007
pneumoniae	O	O	I-T007
,	O	O	O
Acinetobacter	O	O	B-T007
baumannii	O	O	I-T007
,	O	O	O
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
,	O	O	O
and	O	O	O
Enterobacter	O	O	B-T007
species	O	O	I-T007
)	O	O	O
pathogens	O	O	B-T001
,	O	O	O
which	O	O	O
are	O	O	O
often	O	O	O
treated	O	O	B-T169
clinically	O	O	B-T080
by	O	O	O
colistin	O	O	O
.	O	O	O

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
mcr-1	O	O	B-T028
on	O	O	O
colistin	O	O	B-T116
resistance	O	O	B-T032
were	O	O	O
determined	O	O	O
using	O	O	O
MIC	O	O	B-T059
assays	O	O	I-T059
of	O	O	O
laboratory	O	O	B-T093
and	O	O	O
clinical	O	O	B-T080
strains	O	O	B-T080
of	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
,	O	O	O
K.	O	O	B-T007
pneumoniae	O	O	I-T007
,	O	O	O
A.	O	O	B-T007
baumannii	O	O	I-T007
,	O	O	O
and	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
Lipid	O	O	B-T129
A	O	O	I-T129
structural	O	O	B-T082
changes	O	O	O
resulting	O	O	O
from	O	O	O
MCR-1	O	O	B-T116
were	O	O	O
analyzed	O	O	O
by	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
.	O	O	O

The	O	O	O
introduction	O	O	O
of	O	O	O
mcr-1	O	O	B-T028
led	O	O	O
to	O	O	O
colistin	O	O	B-T116
resistance	O	O	B-T032
in	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
,	O	O	O
K.	O	O	B-T007
pneumoniae	O	O	I-T007
,	O	O	O
and	O	O	O
A.	O	O	B-T007
baumannii	O	O	I-T007
but	O	O	O
only	O	O	O
moderately	O	O	O
reduced	O	O	B-T080
susceptibility	O	O	B-T033
in	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
Phosphoethanolamine	O	O	B-T109
modification	O	O	B-T033
of	O	O	O
lipid	O	O	B-T129
A	O	O	I-T129
was	O	O	O
observed	O	O	O
consistently	O	O	O
for	O	O	O
all	O	O	O
four	O	O	O
species	O	O	B-T185
.	O	O	O

These	O	O	O
findings	O	O	B-T169
highlight	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
colistin	O	O	B-T116
resistance	O	O	B-T032
as	O	O	O
a	O	O	O
consequence	O	O	B-T169
of	O	O	I-T169
mcr-1	O	O	B-T028
expression	O	O	B-T045
among	O	O	O
ESKAPE	O	O	B-T007
pathogens	O	O	B-T001
,	O	O	O
especially	O	O	O
in	O	O	O
K.	O	O	B-T007
pneumoniae	O	O	I-T007
and	O	O	O
A.	O	O	B-T007
baumannii	O	O	I-T007
Furthermore	O	O	O
,	O	O	O
the	O	O	O
observation	O	O	O
that	O	O	O
lipid	O	O	B-T129
A	O	O	I-T129
structures	O	O	B-T082
were	O	O	O
modified	O	O	O
despite	O	O	O
only	O	O	O
modest	O	O	O
increases	O	O	B-T169
in	O	O	O
colistin	O	O	O
MICs	O	O	B-T059
in	O	O	O
some	O	O	O
instances	O	O	O
suggests	O	O	O
more	O	O	O
sophisticated	O	O	O
surveillance	O	O	B-T062
methods	O	O	I-T062
may	O	O	O
need	O	O	O
to	O	O	O
be	O	O	O
developed	O	O	O
to	O	O	O
track	O	O	O
the	O	O	O
dissemination	O	O	B-T082
of	O	O	O
mcr-1	O	O	O
or	O	O	O
plasmid	O	O	B-T114
-mediated	O	O	O
phosphoethanolamine	O	O	B-T044
transferases	O	O	I-T044
in	O	O	O
general	O	O	O
.	O	O	O

-DOCSTART- (28373627)

Effects	O	O	B-T080
of	O	O	O
Transplanted	O	O	B-T061
Human	O	O	B-T016
Cord	O	O	B-T031
Blood	O	O	I-T031
-	O	O	O
Mononuclear	O	O	B-T025
Cells	O	O	I-T025
on	O	O	O
Pulmonary	O	O	B-T046
Hypertension	O	O	I-T046
in	O	O	O
Immunodeficient	O	O	B-T015
Mice	O	O	I-T015
and	O	O	O
Their	O	O	O
Distribution	O	O	O

To	O	O	O
investigate	O	O	B-T058
the	O	O	O
effects	O	O	B-T080
of	O	O	O
human	O	O	B-T016
umbilical	O	O	B-T031
cord	O	O	I-T031
blood	O	O	I-T031
-derived	O	O	O
mononuclear	O	O	B-T025
cell	O	O	I-T025
(	O	O	O
hUCB	O	O	B-T031
-	O	O	O
MNC	O	O	B-T025
)	O	O	O
transplantation	O	O	B-T061
on	O	O	O
pulmonary	O	O	B-T046
hypertension	O	O	I-T046
(	O	O	O
PH	O	O	B-T046
)	O	O	O
induced	O	O	B-T169
by	O	O	O
monocrotaline	O	O	B-T109
(	O	O	O
MCT	O	O	B-T109
)	O	O	O
in	O	O	O
immunodeficient	O	O	B-T015
mice	O	O	I-T015
and	O	O	O
their	O	O	O
distribution	O	O	B-T169
.	O	O	O

MCT	O	O	B-T109
was	O	O	O
administered	O	O	B-T169
to	O	O	O
BALB/c	O	O	B-T015
Slc-nu/nu	O	O	I-T015
mice	O	O	B-T015
,	O	O	O
and	O	O	O
PH	O	O	B-T046
was	O	O	O
induced	O	O	B-T169
in	O	O	O
mice	O	O	O
4	O	O	O
weeks	O	O	O
later	O	O	O
.	O	O	O

Fresh	O	O	B-T080
hUCB	O	O	B-T031
-	O	O	O
MNCs	O	O	B-T025
harvested	O	O	B-T061
from	O	O	O
a	O	O	O
human	O	O	B-T016
donor	O	O	B-T098
after	O	O	O
her	O	O	O
delivery	O	O	B-T169
were	O	O	O
injected	O	O	B-T169
intravenously	O	O	I-T169
into	O	O	O
those	O	O	O
PH	O	O	B-T046
mice	O	O	B-T015
.	O	O	O

The	O	O	O
medial	O	O	B-T082
thickness	O	O	B-T080
of	O	O	O
pulmonary	O	O	B-T023
arterioles	O	O	I-T023
,	O	O	O
ratio	O	O	B-T081
of	O	O	O
right	O	O	B-T023
ventricular	O	O	I-T023
to	O	O	O
septum	O	O	B-T023
plus	O	O	B-T169
left	O	O	B-T023
ventricular	O	O	I-T023
weight	O	O	B-T081
(	O	O	O
RV	O	O	B-T023
/	O	O	O
S	O	O	B-T023
+	O	O	O
LV	O	O	B-T023
)	O	O	O
,	O	O	O
and	O	O	O
ratio	O	O	O
of	O	O	O
acceleration	O	O	B-T081
time	O	O	I-T081
to	O	O	O
ejection	O	O	B-T201
time	O	O	I-T201
of	O	O	O
pulmonary	O	O	B-T201
blood	O	O	I-T201
flow	O	O	I-T201
waveform	O	O	B-T070
(	O	O	O
AT	O	O	B-T081
/	O	O	O
ET	O	O	B-T201
)	O	O	O
were	O	O	O
determined	O	O	B-T080
4	O	O	O
weeks	O	O	O
after	O	O	O
hUCB	O	O	B-T031
-	O	O	O
MNC	O	O	B-T025
transplantation	O	O	B-T061
.	O	O	O

To	O	O	O
reveal	O	O	B-T080
the	O	O	O
incorporation	O	O	B-T169
into	O	O	O
the	O	O	O
lung	O	O	B-T023
,	O	O	O
CMTMR	O	O	B-T109
-	O	O	O
labeled	O	O	B-T130
hUCB	O	O	B-T031
-	O	O	O
MNCs	O	O	B-T025
were	O	O	O
observed	O	O	B-T169
in	O	O	O
the	O	O	O
lung	O	O	O
by	O	O	O
fluorescent	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

DiR-labeled	O	O	B-T130
hUCB	O	O	B-T031
-	O	O	O
MNCs	O	O	B-T025
were	O	O	O
detected	O	O	B-T033
in	O	O	O
the	O	O	O
lung	O	O	B-T023
and	O	O	O
other	O	O	O
organs	O	O	B-T023
by	O	O	O
bioluminescence	O	O	B-T074
images	O	O	I-T074
.	O	O	O

Medial	O	O	B-T082
thickness	O	O	B-T080
,	O	O	O
RV	O	O	B-T023
/	O	O	O
S	O	O	B-T023
+	O	O	O
LV	O	O	B-T023
and	O	O	O
AT	O	O	B-T081
/	O	O	O
ET	O	O	B-T201
were	O	O	O
significantly	O	O	B-T078
improved	O	O	B-T033
4	O	O	O
weeks	O	O	O
after	O	O	O
hUCB	O	O	B-T031
-	O	O	O
MNC	O	O	B-T025
transplantation	O	O	B-T061
compared	O	O	B-T052
with	O	O	O
those	O	O	O
in	O	O	O
mice	O	O	B-T015
without	O	O	O
hUCB	O	O	O
-	O	O	O
MNC	O	O	O
transplantation	O	O	O
.	O	O	O

CMTMR	O	O	B-T109
-	O	O	O
positive	O	O	B-T033
hUCB	O	O	B-T031
-	O	O	O
MNCs	O	O	B-T025
were	O	O	O
observed	O	O	B-T169
in	O	O	O
the	O	O	O
lung	O	O	B-T023
3	O	O	O
hours	O	O	O
after	O	O	O
transplantation	O	O	B-T061
.	O	O	O

Bioluminescence	O	O	B-T038
signals	O	O	B-T067
were	O	O	O
detected	O	O	B-T033
more	O	O	O
strongly	O	O	B-T080
in	O	O	O
the	O	O	O
lung	O	O	B-T023
than	O	O	O
in	O	O	O
other	O	O	O
organs	O	O	B-T023
for	O	O	O
24	O	O	O
hours	O	O	O
after	O	O	O
transplantation	O	O	B-T061
.	O	O	O

The	O	O	O
results	O	O	B-T033
indicate	O	O	B-T033
that	O	O	O
hUCB	O	O	B-T031
-	O	O	O
MNCs	O	O	B-T025
are	O	O	O
incorporated	O	O	B-T169
into	O	O	O
the	O	O	O
lung	O	O	B-T023
early	O	O	B-T079
after	O	O	O
hUCB	O	O	O
-	O	O	O
MNC	O	O	B-T025
transplantation	O	O	B-T061
and	O	O	O
improve	O	O	B-T033
MCT	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
PH	O	O	B-T046
.	O	O	O

J.	O	O	O
Med	O	O	O
.	O	O	O

Invest	O	O	O
.	O	O	O

64	O	O	O
:	O	O	O
43	O	O	O
-	O	O	O
49	O	O	O
,	O	O	O
February	O	O	O
,	O	O	O
2017	O	O	O
.	O	O	O

-DOCSTART- (28375952)

Interprofessional	O	O	B-T033
Barriers	O	O	I-T033
:	O	O	O
A	O	O	O
Study	O	O	O
of	O	O	O
Quality	O	O	B-T057
Improvement	O	O	I-T057
Work	O	O	I-T057
Among	O	O	O
Nurses	O	O	B-T097
and	O	O	O
Physicians	O	O	O

This	O	O	O
article	O	O	O
studies	O	O	O
interprofessional	O	O	B-T033
barriers	O	O	I-T033
between	O	O	O
nurses	O	O	B-T097
and	O	O	O
physicians	O	O	B-T097
in	O	O	O
the	O	O	O
context	O	O	B-T078
of	O	O	O
quality	O	O	B-T057
improvement	O	O	I-T057
work	O	O	I-T057
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
17	O	O	O
nurses	O	O	B-T097
and	O	O	O
10	O	O	O
physicians	O	O	B-T097
were	O	O	O
interviewed	O	O	B-T062
at	O	O	O
2	O	O	O
hospitals	O	O	B-T093
in	O	O	O
Sweden	O	O	B-T083
.	O	O	O

The	O	O	O
study	O	O	B-T169
uncovered	O	O	I-T169
a	O	O	O
number	O	O	B-T033
of	O	O	I-T033
barriers	O	O	I-T033
relating	O	O	O
to	O	O	O
both	O	O	O
the	O	O	O
relative	O	O	O
status	O	O	O
of	O	O	O
each	O	O	B-T078
group	O	O	I-T078
and	O	O	O
their	O	O	O
defined	O	O	O
areas	O	O	B-T055
of	O	O	I-T055
responsibility	O	O	I-T055
.	O	O	O

-DOCSTART- (28376287)

Recovery	O	O	B-T052
from	O	O	O
alcohol	O	O	B-T048
dependence	O	O	I-T048
:	O	O	O
Do	O	O	O
smoking	O	O	B-T055
indicators	O	O	B-T169
predict	O	O	O
abstinence	O	O	B-T061
?	O	O	O

There	O	O	O
is	O	O	O
inconsistent	O	O	B-T080
evidence	O	O	B-T078
about	O	O	O
the	O	O	O
potential	O	O	B-T080
influence	O	O	B-T077
of	O	O	O
smoking	O	O	B-T055
on	O	O	O
recovery	O	O	B-T052
from	O	O	O
alcohol	O	O	B-T048
dependence	O	O	I-T048
.	O	O	O

Our	O	O	O
study	O	O	B-T059
aimed	O	O	O
at	O	O	O
assessing	O	O	B-T058
the	O	O	O
impact	O	O	B-T080
of	O	O	O
smoking-behavior	O	O	B-T055
on	O	O	O
relapse	O	O	B-T067
during	O	O	O
a	O	O	O
12	O	O	O
months	O	O	B-T079
follow-up	O	O	B-T058
period	O	O	B-T079
following	O	O	O
a	O	O	O
detoxification	O	O	B-T061
in	O	O	O
patients	O	O	B-T101
with	O	O	O
Alcohol	O	O	B-T048
Use	O	O	I-T048
Disorder	O	O	I-T048
(	O	O	O
AUD	O	O	B-T048
)	O	O	O
.	O	O	O

Three	O	O	O
hundred	O	O	O
Patients	O	O	B-T101
with	O	O	O
AUD	O	O	B-T048
(	O	O	O
74.9	O	O	O
%	O	O	O
smoking	O	O	B-T055
)	O	O	O
were	O	O	O
recruited	O	O	O
from	O	O	O
two	O	O	O
inpatient	O	O	B-T101
detoxification	O	O	B-T093
units	O	O	I-T093
in	O	O	O
psychiatric	O	O	B-T093
hospitals	O	O	I-T093
in	O	O	O
Germany	O	O	B-T083
and	O	O	O
their	O	O	O
alcohol	O	O	B-T055
consumption	O	O	I-T055
was	O	O	O
prospectively	O	O	O
followed	O	O	O
for	O	O	O
1	O	O	O
year	O	O	B-T079
.	O	O	O

Data	O	O	B-T078
on	O	O	O
different	O	O	O
indicators	O	O	B-T169
of	O	O	O
smoking	O	O	B-T055
behavior	O	O	I-T055
was	O	O	O
gathered	O	O	O
.	O	O	O

Cox	O	O	B-T081
regression	O	O	I-T081
model	O	O	I-T081
was	O	O	O
used	O	O	O
to	O	O	O
evaluate	O	O	B-T058
potential	O	O	B-T080
risk	O	O	B-T033
factors	O	O	I-T033
on	O	O	O
time	O	O	O
to	O	O	O
relapse	O	O	B-T067
of	O	O	O
alcohol	O	O	B-T055
consumption	O	O	I-T055
.	O	O	O

Two	O	O	O
hundred	O	O	O
seventy-nine	O	O	O
participants	O	O	B-T098
(	O	O	O
n	O	O	O
=	O	O	O
279	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
final	O	O	B-T079
analysis	O	O	B-T062
.	O	O	O

Smoking	O	O	B-T055
increased	O	O	B-T081
the	O	O	O
risk	O	O	B-T078
for	O	O	O
alcohol	O	O	B-T067
relapse	O	O	I-T067
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
=	O	O	O
3.962	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
1.582	O	O	O
-	O	O	O
9.921	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
this	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
is	O	O	O
slightly	O	O	O
reduced	O	O	B-T080
with	O	O	O
higher	O	O	O
numbers	O	O	O
of	O	O	O
daily	O	O	B-T079
consumed	O	O	B-T033
cigarettes	O	O	I-T033
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
per	O	O	B-T080
cigarette	O	O	B-T033
=	O	O	O
.986	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
.976-.995	O	O	O
)	O	O	O
.	O	O	O

Smoking	O	O	B-T033
reduced	O	O	I-T033
the	O	O	O
probability	O	O	B-T081
of	O	O	O
maintaining	O	O	B-T052
alcohol	O	O	B-T061
abstinence	O	O	I-T061
significantly	O	O	B-T078
,	O	O	O
whereas	O	O	O
higher	O	O	B-T080
number	O	O	O
of	O	O	O
cigarettes	O	O	B-T033
smoked	O	O	I-T033
daily	O	O	B-T079
diminished	O	O	B-T081
the	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
alcohol	O	O	B-T067
relapse	O	O	I-T067
in	O	O	O
alcohol-dependent	O	O	B-T048
patients	O	O	B-T101
.	O	O	O

Coordinated	O	O	B-T169
psychiatric	O	O	B-T169
and	O	O	O
substance	O	O	B-T048
abuse	O	O	I-T048
interventions	O	O	B-T061
for	O	O	O
different	O	O	O
subgroups	O	O	B-T185
of	O	O	O
patients	O	O	B-T101
with	O	O	O
AUD	O	O	B-T048
in	O	O	O
the	O	O	O
post-acute	O	O	B-UnknownType
treatment	O	O	I-UnknownType
phase	O	O	I-UnknownType
are	O	O	O
necessary	O	O	O
.	O	O	O

Individualized	O	O	B-T080
treatment	O	O	B-T169
planning	O	O	O
is	O	O	O
especially	O	O	O
important	O	O	O
in	O	O	O
smoking	O	O	B-T055
patients	O	O	B-T101
with	O	O	O
AUD	O	O	B-T048
who	O	O	O
are	O	O	O
vulnerable	O	O	O
for	O	O	O
a	O	O	O
relapse	O	O	B-T067
to	O	O	I-T067
alcohol	O	O	I-T067
drinking	O	O	I-T067
and	O	O	O
for	O	O	O
somatic	O	O	B-T080
complications	O	O	B-T046
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
might	O	O	O
support	O	O	O
individualized	O	O	B-T080
treatment	O	O	B-T170
plans	O	O	I-T170
.(Am	O	O	O
J	O	O	O
Addict	O	O	O
2017;XX:1	O	O	O
-	O	O	O
8)	O	O	O
.	O	O	O

-DOCSTART- (28377210)

Similar	O	O	O
patterns	O	O	B-T082
of	O	O	O
neural	O	O	B-T042
activity	O	O	I-T042
predict	O	O	O
memory	O	O	B-T041
function	O	O	I-T041
during	O	O	O
encoding	O	O	B-T041
and	O	O	O
retrieval	O	O	O

Neural	O	O	B-T023
networks	O	O	I-T023
that	O	O	O
span	O	O	B-T081
the	O	O	O
medial	O	O	B-T023
temporal	O	O	I-T023
lobe	O	O	I-T023
(	O	O	O
MTL	O	O	B-T023
)	O	O	O
,	O	O	O
prefrontal	O	O	B-T023
cortex	O	O	I-T023
,	O	O	O
and	O	O	O
posterior	O	O	B-T023
cortical	O	O	I-T023
regions	O	O	I-T023
are	O	O	O
essential	O	O	O
to	O	O	O
episodic	O	O	B-T041
memory	O	O	I-T041
function	O	O	I-T041
in	O	O	O
humans	O	O	B-T016
.	O	O	O

Encoding	O	O	B-T041
and	O	O	O
retrieval	O	O	B-T041
are	O	O	O
supported	O	O	O
by	O	O	O
the	O	O	O
engagement	O	O	O
of	O	O	O
both	O	O	O
distinct	O	O	O
neural	O	O	B-T023
pathways	O	O	I-T023
across	O	O	O
the	O	O	O
cortex	O	O	B-T023
and	O	O	O
common	O	O	O
structures	O	O	B-T082
within	O	O	O
the	O	O	O
medial	O	O	B-T023
temporal	O	O	I-T023
lobes	O	O	I-T023
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
degree	O	O	O
to	O	O	O
which	O	O	O
memory	O	O	B-T041
performance	O	O	I-T041
can	O	O	O
be	O	O	O
determined	O	O	O
by	O	O	O
neural	O	O	B-T040
processing	O	O	I-T040
that	O	O	O
is	O	O	O
common	O	O	O
to	O	O	O
encoding	O	O	B-T041
and	O	O	O
retrieval	O	O	B-T041
remains	O	O	O
to	O	O	O
be	O	O	O
determined	O	O	O
.	O	O	O

To	O	O	O
identify	O	O	O
neural	O	O	B-T169
signatures	O	O	I-T169
of	O	O	O
successful	O	O	O
memory	O	O	B-T041
function	O	O	I-T041
,	O	O	O
we	O	O	O
administered	O	O	O
a	O	O	O
delayed	O	O	O
free-recall	O	O	B-T057
task	O	O	I-T057
to	O	O	O
187	O	O	O
neurosurgical	O	O	B-T061
patients	O	O	B-T101
implanted	O	O	B-T061
with	O	O	O
subdural	O	O	B-T030
or	O	O	O
intraparenchymal	O	O	B-T023
depth	O	O	B-T074
electrodes	O	O	I-T074
.	O	O	O

We	O	O	O
developed	O	O	O
multivariate	O	O	B-T170
classifiers	O	O	I-T170
to	O	O	O
identify	O	O	O
patterns	O	O	B-T082
of	O	O	O
spectral	O	O	O
power	O	O	O
across	O	O	O
the	O	O	O
brain	O	O	B-T023
that	O	O	O
independently	O	O	O
predicted	O	O	O
successful	O	O	O
episodic	O	O	B-T041
encoding	O	O	I-T041
and	O	O	O
retrieval	O	O	B-T041
.	O	O	O

During	O	O	O
encoding	O	O	B-T041
and	O	O	O
retrieval	O	O	B-T041
,	O	O	O
patterns	O	O	B-T082
of	O	O	O
increased	O	O	O
high	O	O	B-T079
frequency	O	O	I-T079
activity	O	O	B-T042
in	O	O	O
prefrontal	O	O	B-T023
,	O	O	O
MTL	O	O	B-T023
,	O	O	O
and	O	O	O
inferior	O	O	B-T023
parietal	O	O	I-T023
cortices	O	O	I-T023
,	O	O	O
accompanied	O	O	O
by	O	O	O
widespread	O	O	O
decreases	O	O	O
in	O	O	O
low	O	O	B-T079
frequency	O	O	I-T079
power	O	O	O
across	O	O	O
the	O	O	O
brain	O	O	B-T023
predicted	O	O	O
successful	O	O	O
memory	O	O	B-T041
function	O	O	I-T041
.	O	O	O

Using	O	O	O
a	O	O	O
cross-decoding	O	O	B-T081
approach	O	O	I-T081
,	O	O	O
we	O	O	O
demonstrate	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
predict	O	O	O
memory	O	O	B-T041
function	O	O	I-T041
across	O	O	O
distinct	O	O	O
phases	O	O	O
of	O	O	O
the	O	O	O
free-recall	O	O	B-T057
task	O	O	I-T057
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
classifiers	O	O	B-T170
that	O	O	O
combine	O	O	O
information	O	O	O
from	O	O	O
both	O	O	O
encoding	O	O	B-T041
and	O	O	O
retrieval	O	O	B-T041
states	O	O	I-T041
can	O	O	O
outperform	O	O	O
task-independent	O	O	B-T170
models	O	O	I-T170
.	O	O	O

These	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
engagement	O	O	O
of	O	O	O
a	O	O	O
core	O	O	O
memory	O	O	B-T041
network	O	O	I-T041
during	O	O	O
either	O	O	O
encoding	O	O	B-T041
or	O	O	O
retrieval	O	O	B-T041
shapes	O	O	B-T082
the	O	O	O
ability	O	O	B-T033
to	O	O	I-T033
remember	O	O	I-T033
the	O	O	I-T033
past	O	O	I-T033
,	O	O	O
despite	O	O	O
distinct	O	O	O
neural	O	O	B-T042
interactions	O	O	I-T042
that	O	O	O
facilitate	O	O	O
encoding	O	O	O
and	O	O	O
retrieval	O	O	O
.	O	O	O

-DOCSTART- (28378668)

Trump	O	O	B-T016
's	O	O	I-T016
got	O	O	O
the	O	O	O
right	O	O	O
idea	O	O	O

I	O	O	O
am	O	O	O
a	O	O	O
US	O	O	B-T083
nursing	O	O	B-T097
student	O	O	I-T097
and	O	O	O
feel	O	O	B-T041
that	O	O	O
Obamacare	O	O	B-T089
is	O	O	O
a	O	O	O
bad	O	O	B-T078
idea	O	O	I-T078
.	O	O	O
I	O	O	O
'm	O	O	O
disappointed	O	O	B-T041
that	O	O	O
President	O	O	B-T090
Trump	O	O	B-T016
was	O	O	O
not	O	O	B-T033
able	O	O	I-T033
to	O	O	I-T033
get	O	O	I-T033
rid	O	O	I-T033
of	O	O	I-T033
it	O	O	O
last	O	O	B-T079
month	O	O	I-T079
.	O	O	O

-DOCSTART- (28379026)

Bilirubin	O	O	B-T109
and	O	O	O
atherosclerotic	O	O	B-T047
diseases	O	O	O

Bilirubin	O	O	B-T109
is	O	O	O
the	O	O	O
final	O	O	O
product	O	O	B-T071
of	O	O	O
heme	O	O	B-T044
catabolism	O	O	I-T044
in	O	O	O
the	O	O	O
systemic	O	O	B-UnknownType
circulation	O	O	I-UnknownType
.	O	O	O

For	O	O	O
decades	O	O	B-T081
,	O	O	O
increased	O	O	B-T081
serum	O	O	B-T031
/	O	O	O
plasma	O	O	B-T031
bilirubin	O	O	B-T109
levels	O	O	B-T080
were	O	O	O
considered	O	O	O
an	O	O	O
ominous	O	O	O
sign	O	O	B-T033
of	O	O	O
an	O	O	O
underlying	O	O	O
liver	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
data	O	O	B-T078
from	O	O	O
recent	O	O	O
years	O	O	B-T079
convincingly	O	O	O
suggest	O	O	O
that	O	O	O
mildly	O	O	O
elevated	O	O	B-T080
bilirubin	O	O	B-T109
concentrations	O	O	B-T081
are	O	O	O
associated	O	O	B-T080
with	O	O	O
protection	O	O	B-T033
against	O	O	O
various	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
-mediated	O	O	O
diseases	O	O	B-T047
,	O	O	O
atherosclerotic	O	O	B-T047
conditions	O	O	O
being	O	O	O
the	O	O	O
most	O	O	O
clinically	O	O	B-T080
relevant	O	O	B-T080
.	O	O	O

Although	O	O	O
scarce	O	O	O
data	O	O	B-T078
on	O	O	O
beneficial	O	O	B-T081
effects	O	O	B-T080
of	O	O	O
bilirubin	O	O	B-T109
had	O	O	O
been	O	O	O
published	O	O	B-T057
also	O	O	O
in	O	O	O
the	O	O	O
past	O	O	O
,	O	O	O
it	O	O	O
took	O	O	O
until	O	O	O
1994	O	O	O
when	O	O	O
the	O	O	O
first	O	O	O
clinical	O	O	B-T062
study	O	O	I-T062
demonstrated	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
coronary	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
subjects	O	O	O
with	O	O	O
low	O	O	B-T080
serum	O	O	B-T031
bilirubin	O	O	O
levels	O	O	B-T080
,	O	O	O
and	O	O	O
bilirubin	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
atherosclerotic	O	O	B-T047
diseases	O	O	B-T047
independent	O	O	O
of	O	O	O
standard	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
.	O	O	O

Consistent	O	O	O
with	O	O	O
these	O	O	O
results	O	O	B-T169
,	O	O	O
we	O	O	O
proved	O	O	O
in	O	O	O
our	O	O	O
own	O	O	O
studies	O	O	B-T062
,	O	O	O
that	O	O	O
subjects	O	O	O
with	O	O	O
mild	O	O	B-UnknownType
elevation	O	O	I-UnknownType
of	O	O	I-UnknownType
serum	O	O	I-UnknownType
levels	O	O	I-UnknownType
of	O	O	I-UnknownType
unconjugated	O	O	I-UnknownType
bilirubin	O	O	I-UnknownType
(	O	O	O
benign	O	O	B-T080
hyperbilirubinemia	O	O	B-T047
,	O	O	O
Gilbert	O	O	B-T047
syndrome	O	O	I-T047
)	O	O	O
have	O	O	O
much	O	O	O
lower	O	O	O
prevalence	O	O	B-T081
/	O	O	O
incidence	O	O	B-T081
of	O	O	O
coronary	O	O	B-T047
heart	O	O	I-T047
as	O	O	O
well	O	O	O
as	O	O	O
peripheral	O	O	B-T047
vascular	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

We	O	O	O
have	O	O	O
also	O	O	O
demonstrated	O	O	O
that	O	O	O
this	O	O	O
association	O	O	B-T080
is	O	O	O
even	O	O	O
more	O	O	O
general	O	O	O
,	O	O	O
with	O	O	O
serum	O	O	B-T031
bilirubin	O	O	B-T109
being	O	O	O
a	O	O	O
biomarker	O	O	B-T201
of	O	O	O
numerous	O	O	O
other	O	O	O
diseases	O	O	B-T047
,	O	O	O
often	O	O	O
associated	O	O	B-T080
with	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
atherosclerosis	O	O	B-T047
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
very	O	O	O
recent	O	O	O
data	O	O	B-T078
have	O	O	O
demonstrated	O	O	O
biological	O	O	B-T044
pathways	O	O	I-T044
modulated	O	O	O
by	O	O	O
bilirubin	O	O	B-T109
,	O	O	O
which	O	O	O
are	O	O	O
responsible	O	O	O
for	O	O	O
observed	O	O	O
strong	O	O	O
clinical	O	O	B-T080
associations	O	O	B-T080
.	O	O	O

-DOCSTART- (28379326)

An	O	O	O
Automated	O	O	B-T169
,	O	O	O
Pharmacist	O	O	B-T097
-Driven	O	O	O
Initiative	O	O	B-T041
Improves	O	O	B-T033
Quality	O	O	B-T058
of	O	O	I-T058
Care	O	O	I-T058
for	O	O	O
Staphylococcus	O	O	O
aureus	O	O	O
Bacteremia	O	O	O

Infectious	O	O	B-T047
diseases	O	O	I-T047
(	O	O	O
ID	O	O	B-T047
)	O	O	O
consultation	O	O	B-T058
and	O	O	O
antimicrobial	O	O	B-T058
stewardship	O	O	I-T058
intervention	O	O	I-T058
have	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
improve	O	O	B-T033
the	O	O	O
management	O	O	B-T058
of	O	O	O
Staphylococcus	O	O	B-T047
aureus	O	O	I-T047
bacteremia	O	O	I-T047
(	O	O	O
SAB	O	O	B-T047
)	O	O	O
.	O	O	O

As	O	O	O
the	O	O	O
workload	O	O	B-T081
of	O	O	O
antimicrobial	O	O	B-T058
stewardship	O	O	I-T058
programs	O	O	I-T058
(	O	O	O
ASPs	O	O	B-T058
)	O	O	O
continues	O	O	O
to	O	O	O
increase	O	O	O
,	O	O	O
ASPs	O	O	O
must	O	O	O
find	O	O	O
a	O	O	O
way	O	O	O
to	O	O	O
maximize	O	O	O
the	O	O	O
efficiency	O	O	B-T078
of	O	O	I-T078
the	O	O	I-T078
program	O	O	I-T078
while	O	O	O
optimizing	O	O	O
patient	O	O	B-T101
outcomes	O	O	B-T169
.	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
impact	O	O	B-T080
of	O	O	O
incorporating	O	O	O
health	O	O	B-T091
informatics	O	O	I-T091
into	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
SAB	O	O	B-T047
via	O	O	O
a	O	O	O
pharmacist	O	O	B-T097
-driven	O	O	O
initiative	O	O	B-T041
.	O	O	O

Retrospective	O	O	B-T080
,	O	O	O
single-center	O	O	O
quasi-experimental	O	O	B-T062
study	O	O	B-T062
of	O	O	O
hospitalized	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
SAB	O	O	B-T047
.	O	O	O

During	O	O	O
the	O	O	O
intervention	O	O	B-T061
period	O	O	B-T079
,	O	O	O
pharmacists	O	O	B-T097
were	O	O	O
alerted	O	O	O
to	O	O	O
patients	O	O	B-T101
with	O	O	O
SAB	O	O	B-T047
via	O	O	O
a	O	O	O
patient	O	O	B-T101
scoring	O	O	B-T074
tool	O	O	I-T074
integrated	O	O	O
into	O	O	O
the	O	O	O
electronic	O	O	B-T170
medical	O	O	I-T170
record	O	O	I-T170
.	O	O	O

Pharmacists	O	O	B-T097
utilized	O	O	O
the	O	O	O
scoring	O	O	B-T074
tool	O	O	I-T074
and	O	O	O
the	O	O	O
institution	O	O	B-T093
's	O	O	I-T093
evidence-based	O	O	B-T169
practice	O	O	I-T169
guideline	O	O	B-T170
to	O	O	O
make	O	O	O
standardized	O	O	B-T078
recommendations	O	O	I-T078
to	O	O	O
promote	O	O	O
adherence	O	O	B-T169
to	O	O	O
SAB	O	O	B-T047
quality-of-care	O	O	B-T058
measures	O	O	B-T081
and	O	O	O
encourage	O	O	O
ID	O	O	B-T047
consultation	O	O	B-T058
.	O	O	O

The	O	O	O
primary	O	O	B-T080
outcome	O	O	B-T169
was	O	O	O
overall	O	O	O
compliance	O	O	B-T033
along	O	O	O
with	O	O	O
adherence	O	O	B-T169
to	O	O	O
individual	O	O	B-T098
quality-of-care	O	O	B-T058
components	O	O	B-T077
.	O	O	O

Secondary	O	O	B-T080
clinical	O	O	O
outcomes	O	O	B-T169
were	O	O	O
also	O	O	O
analyzed	O	O	B-T062
.	O	O	O

84	O	O	O
patients	O	O	B-T101
were	O	O	O
identified	O	O	O
for	O	O	O
study	O	O	B-T062
inclusion	O	O	B-T080
,	O	O	O
45	O	O	O
in	O	O	O
the	O	O	O
pre-	O	O	O
intervention	O	O	B-T061
and	O	O	O
39	O	O	O
in	O	O	O
the	O	O	O
intervention	O	O	O
group	O	O	B-T078
.	O	O	O

As	O	O	O
a	O	O	O
whole	O	O	O
,	O	O	O
all	O	O	O
four	O	O	O
quality-of-care	O	O	B-T058
components	O	O	B-T077
for	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
SAB	O	O	B-T047
were	O	O	O
significantly	O	O	B-T078
more	O	O	O
frequently	O	O	O
adhered	O	O	O
to	O	O	O
in	O	O	O
the	O	O	O
intervention	O	O	B-T061
group	O	O	B-T078
(	O	O	O
68.9	O	O	O
%	O	O	O
vs.	O	O	O
92.3	O	O	O
%	O	O	O
;	O	O	O
P=0.008	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
of	O	O	O
ID	O	O	B-T047
consult	O	O	B-T058
improved	O	O	B-T033
significantly	O	O	B-T078
by	O	O	O
almost	O	O	O
20	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
intervention	O	O	B-T061
group	O	O	B-T078
(	O	O	O
75.6	O	O	O
%	O	O	O
vs.	O	O	O
94.9	O	O	O
%	O	O	O
,	O	O	O
P=0.015	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
differences	O	O	B-T080
in	O	O	O
duration	O	O	O
of	O	O	O
bacteremia	O	O	B-T047
,	O	O	O
length-of-stay	O	O	B-T079
,	O	O	O
infection	O	O	B-T046
-related	O	O	O
length-of-stay	O	O	O
,	O	O	O
or	O	O	O
readmission	O	O	B-T058
were	O	O	O
observed	O	O	O
between	O	O	O
the	O	O	O
groups	O	O	B-T078
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
of	O	O	O
all-cause	O	O	O
mortality	O	O	B-T081
was	O	O	O
6-fold	O	O	O
higher	O	O	O
in	O	O	O
the	O	O	O
pre-	O	O	O
intervention	O	O	B-T061
group	O	O	B-T078
compared	O	O	O
to	O	O	O
the	O	O	O
intervention	O	O	O
group	O	O	O
(	O	O	O
15.6	O	O	O
%	O	O	O
vs.	O	O	O
2.6	O	O	O
%	O	O	O
,	O	O	O
P=0.063	O	O	O
)	O	O	O
.	O	O	O

An	O	O	O
automated	O	O	B-T169
,	O	O	O
pharmacist	O	O	B-T097
-driven	O	O	O
intervention	O	O	B-T061
for	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
patients	O	O	B-T101
with	O	O	O
SAB	O	O	B-T047
demonstrated	O	O	O
a	O	O	O
significant	O	O	B-T078
improvement	O	O	B-T077
in	O	O	O
patients	O	O	O
receiving	O	O	O
an	O	O	O
ID	O	O	B-T047
consult	O	O	B-T058
,	O	O	O
targeted	O	O	B-T169
antimicrobial	O	O	B-T121
therapy	O	O	I-T121
,	O	O	O
and	O	O	O
adherence	O	O	B-T169
to	O	O	O
all	O	O	O
SAB	O	O	O
quality-of-care	O	O	B-T058
measures	O	O	B-T081
.	O	O	O

As	O	O	O
antimicrobial	O	O	B-T058
stewardship	O	O	I-T058
becomes	O	O	O
a	O	O	O
mandatory	O	O	B-T169
aspect	O	O	O
of	O	O	O
healthcare	O	O	B-T058
in	O	O	O
all	O	O	O
hospitals	O	O	B-T093
in	O	O	O
the	O	O	O
U.S.	O	O	B-T083
,	O	O	O
ASPs	O	O	B-T058
will	O	O	O
be	O	O	O
forced	O	O	B-T169
to	O	O	O
find	O	O	B-T033
ways	O	O	O
to	O	O	O
provide	O	O	O
more	O	O	O
efficient	O	O	B-T080
,	O	O	O
impactful	O	O	B-T080
,	O	O	O
disease	O	O	B-T047
state-based	O	O	O
patient	O	O	B-T058
care	O	O	I-T058
.	O	O	O

Our	O	O	O
study	O	O	B-T062
provides	O	O	O
the	O	O	O
framework	O	O	O
for	O	O	O
and	O	O	O
data	O	O	B-T078
to	O	O	O
support	O	O	O
this	O	O	O
intervention	O	O	B-T061
in	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
clinically	O	O	B-T080
important	O	O	I-T080
infectious	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

-DOCSTART- (28380662)

Involvement	O	O	O
of	O	O	O
intracellular	O	O	B-T026
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
signaling	O	O	B-T043
in	O	O	O
LTP	O	O	B-T042
at	O	O	O
perforant	O	O	B-T023
pathway	O	O	I-T023
-	O	O	O
CA1	O	O	O
pyramidal	O	O	O
cell	O	O	O
synapse	O	O	O

Physiological	O	O	B-T169
significance	O	O	O
of	O	O	O
synaptic	O	O	B-T043
Zn(2	O	O	I-T043
+	O	O	I-T043
)	O	O	I-T043
signaling	O	O	I-T043
was	O	O	O
examined	O	O	O
at	O	O	O
perforant	O	O	B-T023
pathway	O	O	I-T023
-	O	O	O
CA1	O	O	B-T023
pyramidal	O	O	I-T023
cell	O	O	I-T023
synapses	O	O	I-T023
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
long-term	O	O	B-T042
potentiation	O	O	I-T042
(	O	O	O
LTP	O	O	B-T042
)	O	O	O
at	O	O	O
perforant	O	O	B-T023
pathway	O	O	I-T023
-	O	O	O
CA1	O	O	B-T023
pyramidal	O	O	I-T023
cell	O	O	I-T023
synapses	O	O	I-T023
was	O	O	O
induced	O	O	O
using	O	O	O
a	O	O	O
recording	O	O	O
electrode	O	O	B-T074
attached	O	O	O
to	O	O	O
a	O	O	O
microdialysis	O	O	B-T058
probe	O	O	B-T074
and	O	O	O
the	O	O	O
recording	O	O	O
region	O	O	O
was	O	O	O
locally	O	O	O
perfused	O	O	B-T061
with	O	O	O
artificial	O	O	B-T103
cerebrospinal	O	O	I-T103
fluid	O	O	I-T103
(	O	O	O
ACSF	O	O	B-T103
)	O	O	O
via	O	O	O
the	O	O	O
microdialysis	O	O	O
probe	O	O	O
.	O	O	O

Perforant	O	O	B-T023
pathway	O	O	I-T023
LTP	O	O	B-T042
was	O	O	O
not	O	O	O
attenuated	O	O	O
under	O	O	O
perfusion	O	O	B-T061
with	O	O	O
CaEDTA	O	O	B-T130
(	O	O	O
10	O	O	O
mM	O	O	O
)	O	O	O
,	O	O	O
an	O	O	O
extracellular	O	O	B-T026
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
chelator	O	O	O
,	O	O	O
but	O	O	O
attenuated	O	O	O
under	O	O	O
perfusion	O	O	O
with	O	O	O
ZnAF-2DA	O	O	B-T130
(	O	O	O
50	O	O	O
μM	O	O	O
)	O	O	O
,	O	O	O
an	O	O	O
intracellular	O	O	B-T026
Zn(2	O	O	O
+	O	O	O
)	O	O	O
chelator	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
intracellular	O	O	O
Zn(2	O	O	O
+	O	O	O
)	O	O	O
signaling	O	O	B-T043
is	O	O	O
required	O	O	O
for	O	O	O
perforant	O	O	B-T023
pathway	O	O	I-T023
LTP	O	O	O
.	O	O	O

Even	O	O	O
in	O	O	O
rat	O	O	B-T023
brain	O	O	I-T023
slices	O	O	I-T023
bathed	O	O	O
in	O	O	O
CaEDTA	O	O	B-T130
in	O	O	O
ACSF	O	O	B-T103
,	O	O	O
intracellular	O	O	B-T026
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
level	O	O	O
,	O	O	O
which	O	O	O
was	O	O	O
measured	O	O	O
with	O	O	O
intracellular	O	O	O
ZnAF-2	O	O	B-T130
,	O	O	O
was	O	O	O
increased	O	O	O
in	O	O	O
the	O	O	O
stratum	O	O	B-T023
lacunosum-moleculare	O	O	I-T023
where	O	O	O
perforant	O	O	B-T023
pathway	O	O	I-T023
-	O	O	O
CA1	O	O	B-T023
pyramidal	O	O	I-T023
cell	O	O	I-T023
synapses	O	O	I-T023
were	O	O	O
contained	O	O	O
after	O	O	O
tetanic	O	O	B-T061
stimulation	O	O	I-T061
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
intracellular	O	O	B-T026
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
signaling	O	O	B-T043
,	O	O	O
which	O	O	O
originates	O	O	O
in	O	O	O
internal	O	O	O
stores/	O	O	O
proteins	O	O	B-T116
,	O	O	O
is	O	O	O
involved	O	O	O
in	O	O	O
LTP	O	O	B-T042
at	O	O	O
perforant	O	O	B-T023
pathway	O	O	I-T023
-	O	O	O
CA1	O	O	B-T023
pyramidal	O	O	I-T023
cell	O	O	I-T023
synapses	O	O	I-T023
.	O	O	O

Because	O	O	O
the	O	O	O
influx	O	O	B-T043
of	O	O	O
extracellular	O	O	B-T026
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
,	O	O	O
which	O	O	O
originates	O	O	O
in	O	O	O
presynaptic	O	O	B-T043
Zn(2	O	O	I-T043
+	O	O	I-T043
)	O	O	I-T043
release	O	O	I-T043
,	O	O	O
is	O	O	O
involved	O	O	O
in	O	O	O
LTP	O	O	B-T042
at	O	O	O
Schaffer	O	O	B-T026
collateral	O	O	I-T026
-	O	O	O
CA1	O	O	B-T023
pyramidal	O	O	I-T023
cell	O	O	I-T023
synapses	O	O	I-T023
,	O	O	O
synapse	O	O	B-T030
-dependent	O	O	O
Zn(2	O	O	O
+	O	O	O
)	O	O	O
dynamics	O	O	O
may	O	O	O
be	O	O	O
involved	O	O	O
in	O	O	O
plasticity	O	O	B-T043
of	O	O	O
postsynaptic	O	O	B-UnknownType
CA1	O	O	B-T025
pyramidal	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (28381880)

20S	O	O	B-T116
immunoproteasomes	O	O	I-T116
remove	O	O	O
formaldehyde	O	O	B-T109
-	O	O	O
damaged	O	O	B-T169
cytoplasmic	O	O	B-T116
proteins	O	O	I-T116
suppressing	O	O	B-T169
caspase-independent	O	O	O
cell	O	O	O
death	O	O	O

Immunoproteasomes	O	O	B-T116
are	O	O	O
known	O	O	O
for	O	O	O
their	O	O	O
involvement	O	O	B-T169
in	O	O	O
antigen	O	O	B-T043
presentation	O	O	I-T043
.	O	O	O

However	O	O	O
,	O	O	O
their	O	O	O
broad	O	O	B-T082
tissue	O	O	B-T024
presence	O	O	B-T033
and	O	O	O
other	O	O	O
evidence	O	O	B-T169
are	O	O	O
indicative	O	O	B-T078
of	O	O	I-T078
nonimmune	O	O	B-T039
functions	O	O	I-T039
.	O	O	O

We	O	O	O
examined	O	O	O
a	O	O	O
role	O	O	O
for	O	O	O
immunoproteasomes	O	O	B-T116
in	O	O	O
cellular	O	O	B-T043
responses	O	O	I-T043
to	O	O	O
the	O	O	O
endogenous	O	O	B-T169
and	O	O	O
environmental	O	O	B-T131
carcinogen	O	O	I-T131
formaldehyde	O	O	B-T109
(	O	O	O
FA	O	O	B-T109
)	O	O	O
that	O	O	O
binds	O	O	O
to	O	O	O
cytosolic	O	O	B-T026
and	O	O	O
nuclear	O	O	B-T116
proteins	O	O	I-T116
producing	O	O	O
proteotoxic	O	O	B-T046
stress	O	O	I-T046
and	O	O	O
genotoxic	O	O	B-T049
DNA	O	O	B-T114
-	O	O	O
histone	O	O	B-T116
crosslinks	O	O	B-T070
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
immunoproteasomes	O	O	B-T116
were	O	O	O
important	O	O	B-T080
for	O	O	O
suppression	O	O	B-T169
of	O	O	O
a	O	O	O
caspase-independent	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
and	O	O	O
the	O	O	O
long-term	O	O	B-T079
survival	O	O	B-T169
of	O	O	O
FA-treated	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

All	O	O	O
major	O	O	O
genotoxic	O	O	B-T049
responses	O	O	B-T032
to	O	O	O
FA	O	O	B-T109
,	O	O	O
including	O	O	O
replication	O	O	B-T045
inhibition	O	O	I-T045
and	O	O	O
activation	O	O	B-T052
of	O	O	O
the	O	O	O
transcription	O	O	B-T116
factor	O	O	I-T116
p53	O	O	I-T116
and	O	O	O
the	O	O	O
apical	O	O	B-T082
ATM	O	O	B-T116
and	O	O	O
ATR	O	O	B-T116
kinases	O	O	I-T116
,	O	O	O
were	O	O	O
unaffected	O	O	B-T077
by	O	O	O
immunoproteasome	O	O	B-T116
inactivity	O	O	B-T080
.	O	O	O

Immunoproteasome	O	O	O
inhibition	O	O	B-T052
enhanced	O	O	B-T052
activation	O	O	B-T052
of	O	O	O
the	O	O	O
cytosolic	O	O	B-T026
protein	O	O	B-T116
damage	O	O	B-T169
sensor	O	O	B-T116
HSF1	O	O	I-T116
,	O	O	O
elevated	O	O	B-T080
levels	O	O	I-T080
of	O	O	O
K48-polyubiquitinated	O	O	B-T044
cytoplasmic	O	O	B-T116
proteins	O	O	I-T116
and	O	O	O
increased	O	O	B-T081
depletion	O	O	B-T169
of	O	O	O
unconjugated	O	O	B-T080
ubiquitin	O	O	B-T116
.	O	O	O

We	O	O	O
further	O	O	O
found	O	O	O
that	O	O	O
FA	O	O	B-T109
induced	O	O	B-T169
the	O	O	O
disassembly	O	O	B-T052
of	O	O	O
26S	O	O	B-T116
immunoproteasomes	O	O	I-T116
,	O	O	O
but	O	O	O
not	O	O	O
standard	O	O	O
26S	O	O	B-T116
proteasomes	O	O	I-T116
,	O	O	O
releasing	O	O	O
the	O	O	O
20S	O	O	B-T116
catalytic	O	O	I-T116
immunoproteasome	O	O	I-T116
.	O	O	O

FA-treated	O	O	B-T025
cells	O	O	I-T025
also	O	O	O
had	O	O	O
higher	O	O	B-T081
amounts	O	O	I-T081
of	O	O	O
small	O	O	O
activators	O	O	B-T116
PA28αβ	O	O	I-T116
and	O	O	O
PA28γ	O	O	B-T116
bound	O	O	O
to	O	O	O
20S	O	O	B-T116
particles	O	O	I-T116
.	O	O	O

Our	O	O	O
findings	O	O	O
highlight	O	O	O
the	O	O	O
significance	O	O	B-T078
of	O	O	O
nonnuclear	O	O	B-T169
damage	O	O	I-T169
in	O	O	O
FA	O	O	B-T109
injury	O	O	O
and	O	O	O
reveal	O	O	O
a	O	O	O
major	O	O	O
role	O	O	O
for	O	O	O
immunoproteasomes	O	O	B-T116
in	O	O	O
elimination	O	O	O
of	O	O	O
FA-damaged	O	O	B-T169
cytoplasmic	O	O	B-T116
proteins	O	O	I-T116
through	O	O	O
ubiquitin	O	O	B-T116
-	O	O	O
independent	O	O	B-T078
proteolysis	O	O	B-T044
.	O	O	O

-DOCSTART- (28383311)

Musculoskeletal	O	O	B-T033
pain	O	O	I-T033
profile	O	O	B-T170
of	O	O	O
obese	O	O	B-T047
individuals	O	O	B-T098
attending	O	O	B-T169
a	O	O	O
multidisciplinary	O	O	O
weight	O	O	O
management	O	O	O
service	O	O	O

Obesity	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
numerous	O	O	B-T081
chronic	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
including	O	O	B-T169
musculoskeletal	O	O	B-T033
(	O	O	I-T033
MSK	O	O	I-T033
)	O	O	I-T033
pain	O	O	I-T033
,	O	O	O
which	O	O	O
impacts	O	O	B-T080
on	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
(	O	O	O
QoL	O	O	B-T078
)	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
limited	O	O	O
research	O	O	O
providing	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
MSK	O	O	B-T033
pain	O	O	I-T033
profile	O	O	B-T170
of	O	O	O
an	O	O	O
obese	O	O	B-T047
cohort	O	O	B-T098
.	O	O	O

This	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
utilized	O	O	O
a	O	O	O
patient	O	O	B-T101
database	O	O	B-T170
at	O	O	O
a	O	O	O
national	O	O	B-T093
weight	O	O	I-T093
management	O	O	I-T093
service	O	O	I-T093
(	O	O	O
WMS	O	O	B-T093
)	O	O	O
.	O	O	O

Following	O	O	O
ethical	O	O	B-T078
approval	O	O	B-T170
,	O	O	O
anonymized	O	O	B-T170
patient	O	O	B-T170
data	O	O	I-T170
were	O	O	O
statistically	O	O	B-T062
analyzed	O	O	I-T062
to	O	O	O
develop	O	O	O
a	O	O	O
pain	O	O	B-T184
profile	O	O	B-T170
,	O	O	O
investigate	O	O	B-T169
relationships	O	O	B-T080
between	O	O	O
pain	O	O	O
,	O	O	O
sleep	O	O	B-T040
,	O	O	O
and	O	O	O
function	O	O	B-T033
,	O	O	O
and	O	O	O
explore	O	O	O
variables	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
having	O	O	O
low	O	O	B-T184
back	O	O	I-T184
pain	O	O	I-T184
(	O	O	O
LBP	O	O	B-T184
)	O	O	O
and	O	O	O
knee	O	O	B-T033
pain	O	O	I-T033
.	O	O	O

Overall	O	O	O
,	O	O	O
915	O	O	O
individuals	O	O	B-T098
attended	O	O	O
the	O	O	O
WMS	O	O	B-T093
from	O	O	O
January	O	O	O
2011	O	O	O
to	O	O	O
September	O	O	O
2015	O	O	O
[	O	O	O
male	O	O	B-T098
,	O	O	O
35	O	O	O
%	O	O	O
(	O	O	O
n=318	O	O	O
;	O	O	O
CI	O	O	B-T081
=	O	O	O
32	O	O	O
-	O	O	O
38	O	O	O
)	O	O	O
;	O	O	O
female	O	O	B-T098
,	O	O	O
65	O	O	O
%	O	O	O
(	O	O	O
n=597	O	O	O
;	O	O	O
CI	O	O	O
=	O	O	O
62	O	O	O
-	O	O	O
68	O	O	O
)	O	O	O
;	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
44.6	O	O	O
]	O	O	O
.	O	O	O

Mean	O	O	B-T081
BMI	O	O	B-T201
was	O	O	O
50.7	O	O	O
kg/m2	O	O	O
[	O	O	O
Class	O	O	O
III	O	O	O
obese	O	O	B-T047
(	O	O	O
BMI	O	O	O
≥40	O	O	O
kg/m2	O	O	O
)	O	O	O
,	O	O	O
92	O	O	O
%	O	O	O
(	O	O	O
n=835	O	O	O
;	O	O	O
CI	O	O	B-T081
=	O	O	O
91	O	O	O
-	O	O	O
94	O	O	O
)	O	O	O
]	O	O	O
.	O	O	O

Approximately	O	O	B-T080
91	O	O	O
%	O	O	O
reported	O	O	O
MSK	O	O	B-T033
pain	O	O	I-T033
:	O	O	O
LBP	O	O	B-T184
,	O	O	O
69	O	O	O
%	O	O	O
(	O	O	O
n=539	O	O	O
;	O	O	O
CI	O	O	B-T081
=	O	O	O
65-	O	O	O
72	O	O	O
)	O	O	O
[	O	O	O
mean	O	O	B-T081
NRS	O	O	O
7.4	O	O	O
]	O	O	O
;	O	O	O
knee	O	O	B-T033
pain	O	O	I-T033
,	O	O	O
58	O	O	O
%	O	O	O
(	O	O	O
n=447	O	O	O
;	O	O	O
CI	O	O	O
=	O	O	O
55	O	O	O
-	O	O	O
61	O	O	O
)	O	O	O
[	O	O	O
mean	O	O	O
NRS	O	O	O
6.8	O	O	O
]	O	O	O
.	O	O	O

Class	O	O	O
III	O	O	O
obese	O	O	B-T047
and	O	O	O
multi-site	O	O	B-T082
pain	O	O	B-T184
patients	O	O	B-T101
had	O	O	O
lower	O	O	B-T052
QoL	O	O	B-T078
and	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
levels	O	O	B-T080
,	O	O	O
reduced	O	O	B-T080
sleep	O	O	B-T040
,	O	O	O
and	O	O	O
poorer	O	O	B-T080
physical	O	O	B-T033
function	O	O	I-T033
than	O	O	O
less	O	O	B-T080
obese	O	O	O
patients	O	O	O
and	O	O	O
those	O	O	O
without	O	O	B-T080
pain	O	O	O
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

Relationships	O	O	B-T080
were	O	O	O
found	O	O	O
between	O	O	O
demographic	O	O	B-T090
,	O	O	O
pain	O	O	B-T184
,	O	O	O
self-report	O	O	B-T062
,	O	O	O
psychological	O	O	B-T169
,	O	O	O
and	O	O	O
functional	O	O	B-T169
measures	O	O	B-T081
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
who	O	O	O
slept	O	O	B-T033
fewer	O	O	I-T033
hours	O	O	I-T033
and	O	O	O
had	O	O	O
poorer	O	O	B-T080
functional	O	O	B-T033
outcomes	O	O	I-T033
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
LBP	O	O	B-T184
;	O	O	O
patients	O	O	B-T101
who	O	O	O
were	O	O	O
divorced	O	O	B-T033
,	O	O	O
had	O	O	O
lower	O	O	B-T052
QoL	O	O	B-T078
,	O	O	O
and	O	O	O
more	O	O	O
frequent	O	O	B-T079
nocturia	O	O	B-T047
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
knee	O	O	B-T033
pain	O	O	I-T033
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

Multi-site	O	O	B-T082
MSK	O	O	B-T033
pain	O	O	I-T033
is	O	O	O
prevalent	O	O	B-T081
and	O	O	O
severe	O	O	B-T080
in	O	O	O
obese	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
is	O	O	O
negatively	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
most	O	O	O
self-report	O	O	O
and	O	O	O
functional	O	O	B-T033
outcomes	O	O	I-T033
.	O	O	O

This	O	O	O
high	O	O	O
prevalence	O	O	B-T081
suggests	O	O	O
pain	O	O	B-T061
management	O	O	I-T061
strategies	O	O	O
must	O	O	O
be	O	O	O
considered	O	O	O
when	O	O	O
treating	O	O	B-T061
obesity	O	O	B-T047
.	O	O	O

-DOCSTART- (28384898)

Primary	O	O	B-T080
Management	O	O	B-T058
and	O	O	O
Outcome	O	O	B-T169
-	O	O	O
Open	O	O	O
Laryngotracheal	O	O	O
Trauma	O	O	O

Acute	O	O	B-T079
external	O	O	B-T080
injury	O	O	I-T080
to	O	O	O
the	O	O	O
larynx	O	O	B-T023
is	O	O	O
both	O	O	O
life	O	O	B-T033
threatening	O	O	I-T033
and	O	O	O
a	O	O	O
potential	O	O	O
long	O	O	B-T079
term	O	O	I-T079
management	O	O	B-T170
challenge	O	O	O
.	O	O	O

As	O	O	O
Otorhinolaryngologist	O	O	B-T097
we	O	O	O
must	O	O	O
be	O	O	O
prepared	O	O	O
and	O	O	O
well	O	O	O
versed	O	O	O
to	O	O	O
manage	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

In	O	O	O
our	O	O	O
study	O	O	O
seven	O	O	O
patients	O	O	B-T101
of	O	O	O
open	O	O	B-T037
laryngeal	O	O	I-T037
traumas	O	O	I-T037
were	O	O	O
managed	O	O	O
by	O	O	O
primary	O	O	B-T061
closure	O	O	I-T061
.	O	O	O

In	O	O	O
five	O	O	O
patients	O	O	B-T101
nature	O	O	B-T037
of	O	O	I-T037
injury	O	O	I-T037
was	O	O	O
known	O	O	O
in	O	O	O
other	O	O	O
two	O	O	O
patients	O	O	O
exact	O	O	O
nature	O	O	O
of	O	O	O
injury	O	O	O
was	O	O	O
not	O	O	O
known	O	O	O
.	O	O	O

After	O	O	O
primary	O	O	B-T061
closure	O	O	I-T061
five	O	O	O
patients	O	O	B-T101
with	O	O	O
known	O	O	O
injury	O	O	B-T037
survived	O	O	B-T052
and	O	O	O
two	O	O	O
patients	O	O	O
with	O	O	O
unknown	O	O	O
injury	O	O	O
died	O	O	B-T040
.	O	O	O

As	O	O	O
per	O	O	O
our	O	O	O
experience	O	O	B-T033
,	O	O	O
we	O	O	O
recommend	O	O	O
primary	O	O	B-T061
closure	O	O	I-T061
,	O	O	O
if	O	O	O
the	O	O	O
exact	O	O	O
nature	O	O	B-T037
of	O	O	I-T037
injury	O	O	I-T037
is	O	O	O
known	O	O	O
as	O	O	O
the	O	O	O
outcome	O	O	B-T169
is	O	O	O
definitely	O	O	O
favourable	O	O	B-T033
.	O	O	O

-DOCSTART- (28385001)

Comparative	O	O	O
kinematic	O	O	B-T060
gait	O	O	I-T060
analysis	O	O	I-T060
in	O	O	O
young	O	O	B-T079
and	O	O	O
old	O	O	B-T079
Beagle	O	O	O
dogs	O	O	O

Age-related	O	O	B-T079
involution	O	O	B-T040
in	O	O	O
dogs	O	O	B-T015
involves	O	O	O
loss	O	O	B-T033
of	O	O	I-T033
muscle	O	O	I-T033
mass	O	O	I-T033
and	O	O	O
changes	O	O	O
in	O	O	O
connective	O	O	B-T024
tissue	O	O	I-T024
and	O	O	O
articular	O	O	B-T024
cartilage	O	O	I-T024
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
examine	O	O	B-T033
whether	O	O	O
an	O	O	O
age-related	O	O	B-T079
influence	O	O	O
on	O	O	O
joint	O	O	B-T033
mobility	O	O	I-T033
can	O	O	O
be	O	O	O
detected	O	O	B-T033
in	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
diseases	O	O	B-T047
.	O	O	O

Five	O	O	O
young	O	O	B-T079
(	O	O	O
Ø	O	O	O
2.0	O	O	O
years	O	O	B-T079
)	O	O	O
and	O	O	O
five	O	O	O
old	O	O	B-T079
(	O	O	O
Ø	O	O	O
10.4	O	O	O
years	O	O	O
)	O	O	O
healthy	O	O	B-T080
and	O	O	O
sound	O	O	B-T015
Beagle	O	O	I-T015
dogs	O	O	I-T015
were	O	O	O
measured	O	O	B-T080
during	O	O	O
locomotion	O	O	B-T040
on	O	O	O
a	O	O	O
treadmill	O	O	B-T073
by	O	O	O
computer-assisted	O	O	B-T059
gait	O	O	B-T060
analysis	O	O	I-T060
.	O	O	O

Angles	O	O	B-T082
of	O	O	O
the	O	O	O
shoulder	O	O	B-T030
,	O	O	O
elbow	O	O	B-T030
,	O	O	O
carpal	O	O	B-T030
,	O	O	O
hip	O	O	B-T030
,	O	O	O
stifle	O	O	B-T030
and	O	O	O
tarsal	O	O	B-T030
joints	O	O	I-T030
were	O	O	O
analyzed	O	O	B-T062
,	O	O	O
including	O	O	O
joint	O	O	B-T030
angle	O	O	I-T081
progression	O	O	I-T081
curves	O	O	I-T081
,	O	O	O
minimum	O	O	B-T080
and	O	O	O
maximum	O	O	B-T081
joint	O	O	O
angles	O	O	B-T082
and	O	O	O
range	O	O	B-T201
of	O	O	I-T201
motion	O	O	I-T201
(	O	O	O
ROM	O	O	B-T201
)	O	O	O
.	O	O	O

The	O	O	O
old	O	O	B-T079
group	O	O	B-T096
showed	O	O	O
a	O	O	O
smaller	O	O	O
maximum	O	O	O
joint	O	O	B-T030
angle	O	O	B-T082
(	O	O	O
p	O	O	O
=	O	O	O
0.037	O	O	O
)	O	O	O
and	O	O	O
ROM	O	O	B-T201
(	O	O	O
p	O	O	O
=	O	O	O
0.037	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
carpal	O	O	B-T030
joint	O	O	I-T030
and	O	O	O
similar	O	O	O
tendencies	O	O	O
in	O	O	O
the	O	O	O
shoulder	O	O	B-T030
,	O	O	O
elbow	O	O	B-T030
and	O	O	O
carpal	O	O	O
joint	O	O	O
.	O	O	O

The	O	O	O
descriptive	O	O	B-T170
analysis	O	O	I-T170
of	O	O	O
the	O	O	O
progression	O	O	B-T081
curves	O	O	I-T081
revealed	O	O	O
less	O	O	B-T033
flexion	O	O	I-T033
and	O	O	O
extension	O	O	B-T169
of	O	O	O
the	O	O	O
joints	O	O	B-T030
of	O	O	O
the	O	O	O
forelimb	O	O	B-T029
.	O	O	O

This	O	O	O
indicates	O	O	O
restricted	O	O	B-T169
joint	O	O	B-T033
mobility	O	O	I-T033
of	O	O	O
the	O	O	O
forelimb	O	O	B-T029
but	O	O	O
primarily	O	O	O
of	O	O	O
the	O	O	O
carpal	O	O	B-T030
joint	O	O	I-T030
.	O	O	O

Findings	O	O	B-T169
in	O	O	O
the	O	O	O
joints	O	O	B-T030
of	O	O	O
the	O	O	O
hindlimb	O	O	B-T023
were	O	O	O
not	O	O	O
consistent	O	O	B-T078
;	O	O	O
contrasting	O	O	O
alterations	O	O	B-T078
may	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
a	O	O	O
compensatory	O	O	B-T169
mechanism	O	O	B-T169
.	O	O	O

As	O	O	O
most	O	O	O
alterations	O	O	B-T078
were	O	O	O
found	O	O	B-T033
in	O	O	O
the	O	O	O
distal	O	O	B-T030
joints	O	O	I-T030
,	O	O	O
these	O	O	O
should	O	O	O
receive	O	O	O
particular	O	O	B-T041
attention	O	O	I-T041
when	O	O	O
examining	O	O	O
elderly	O	O	B-T015
dogs	O	O	I-T015
.	O	O	O

-DOCSTART- (28385075)

Propensity	O	O	B-T081
Score	O	O	I-T081
Matched	O	O	O
Comparison	O	O	B-T052
of	O	O	O
Partial	O	O	B-T081
to	O	O	O
Whole	O	O	B-T081
Gland	O	O	B-T023
Cryotherapy	O	O	B-T061
for	O	O	O
Intermediate-Risk	O	O	B-T033
Prostate	O	O	B-T191
Cancer	O	O	I-T191
:	O	O	O
An	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
COLD	O	O	O
registry	O	O	O
data	O	O	O

To	O	O	O
compare	O	O	O
the	O	O	O
oncological	O	O	B-T191
and	O	O	O
functional	O	O	B-T169
outcomes	O	O	B-T080
of	O	O	O
partial	O	O	B-T081
versus	O	O	O
whole	O	O	B-T081
-	O	O	O
gland	O	O	B-T023
cryotherapy	O	O	B-T061
for	O	O	O
men	O	O	B-T098
with	O	O	O
intermediate-risk	O	O	B-T033
prostate	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Men	O	O	B-T098
with	O	O	O
intermediate-risk	O	O	B-T033
prostate	O	O	B-T191
cancer	O	O	I-T191
treated	O	O	B-T061
with	O	O	I-T061
primary	O	O	B-T080
prostate	O	O	B-T061
cryotherapy	O	O	I-T061
from	O	O	O
1993	O	O	O
-	O	O	O
2013	O	O	O
were	O	O	O
selected	O	O	O
from	O	O	O
the	O	O	O
Cryo	O	O	B-T170
On-Line	O	O	I-T170
Data	O	O	I-T170
Registry	O	O	I-T170
for	O	O	O
a	O	O	O
1:1	O	O	O
matched	O	O	B-T062
comparison	O	O	B-T052
between	O	O	O
those	O	O	O
undergoing	O	O	O
whole	O	O	B-T081
-	O	O	O
gland	O	O	B-T023
and	O	O	O
partial	O	O	B-T081
prostate	O	O	O
cryotherapy	O	O	O
(	O	O	O
targeted-ablation	O	O	B-T061
,	O	O	O
unilateral/bilateral	O	O	B-T061
nerve-sparing	O	O	I-T061
ablations	O	O	I-T061
)	O	O	O
.	O	O	O

A	O	O	O
propensity	O	O	B-T081
score	O	O	I-T081
was	O	O	O
developed	O	O	O
based	O	O	O
on	O	O	O
age	O	O	B-T032
,	O	O	O
pre-biopsy	O	O	B-T031
serum	O	O	I-T031
PSA	O	O	B-T116
,	O	O	O
biopsy	O	O	B-T033
Gleason	O	O	I-T033
score	O	O	I-T033
,	O	O	O
clinical	O	O	B-T079
stage	O	O	I-T079
,	O	O	O
prostate	O	O	B-T081
volume	O	O	I-T081
,	O	O	O
neoadjuvant	O	O	B-T061
androgen	O	O	I-T061
deprivation	O	O	I-T061
status	O	O	B-T080
,	O	O	O
year	O	O	B-T079
of	O	O	O
surgery	O	O	B-T061
and	O	O	O
pre-treatment	O	O	B-T079
potency	O	O	O
.	O	O	O

Outcomes	O	O	B-T080
were	O	O	O
biochemical	O	O	B-T170
progression-free	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
BPFS	O	O	B-T081
)	O	O	O
using	O	O	O
ASTRO	O	O	B-T170
and	O	O	O
Phoenix	O	O	B-T170
criteria	O	O	I-T170
,	O	O	O
12-month	O	O	O
continence	O	O	B-T040
(	O	O	O
strictly	O	O	O
pad-free	O	O	O
)	O	O	O
and	O	O	O
sexual	O	O	B-T040
function	O	O	I-T040
(	O	O	O
potency	O	O	O
sufficient	O	O	B-T080
for	O	O	O
sexual	O	O	B-T040
intercourse	O	O	I-T040
)	O	O	O
.	O	O	O

After	O	O	O
propensity	O	O	B-T081
score	O	O	I-T081
-	O	O	O
matching	O	O	B-T062
,	O	O	O
BPFS	O	O	B-T081
was	O	O	O
compared	O	O	B-T052
using	O	O	O
Kaplan-Meier	O	O	B-T081
analysis	O	O	I-T081
and	O	O	O
functional	O	O	B-T169
outcomes	O	O	B-T080
using	O	O	O
chi-square	O	O	B-T170
tests	O	O	I-T170
.	O	O	O

In	O	O	O
all	O	O	O
,	O	O	O
897	O	O	O
men	O	O	B-T098
were	O	O	O
identified	O	O	B-T080
(	O	O	O
731	O	O	O
whole	O	O	B-T081
-	O	O	O
gland	O	O	B-T023
and	O	O	O
166	O	O	O
partial	O	O	B-T081
)	O	O	O
.	O	O	O

Post-matching	O	O	B-T079
,	O	O	O
166	O	O	O
pairs	O	O	O
of	O	O	O
men	O	O	B-T098
were	O	O	O
analysed	O	O	B-T062
(	O	O	O
mean	O	O	O
follow-up	O	O	B-T058
31	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
2/5	O	O	O
year	O	O	O
BPFS	O	O	B-T081
rate	O	O	B-T081
was	O	O	O
87.2%/76.4	O	O	O
%	O	O	O
for	O	O	O
whole	O	O	B-T081
-	O	O	O
gland	O	O	B-T023
vs.	O	O	O
80.7%/70.0	O	O	O
%	O	O	O
for	O	O	O
partial	O	O	B-T081
ablation	O	O	B-T061
using	O	O	O
Phoenix	O	O	B-T170
(	O	O	O
p=0.26	O	O	O
)	O	O	O
and	O	O	O
72.3%/69.6	O	O	O
%	O	O	O
for	O	O	O
whole	O	O	O
gland	O	O	O
vs.	O	O	O
82.1%/75.0	O	O	O
%	O	O	O
for	O	O	O
partial	O	O	O
ablation	O	O	O
using	O	O	O
ASTRO	O	O	B-T170
criteria	O	O	O
(	O	O	O
p=0.10	O	O	O
)	O	O	O
.	O	O	O

Of	O	O	O
164	O	O	O
pairs	O	O	O
,	O	O	O
the	O	O	O
12-month	O	O	O
continence	O	O	B-T040
rate	O	O	B-T081
was	O	O	O
similar	O	O	B-T080
94.1	O	O	O
%	O	O	O
vs.	O	O	O
95.1	O	O	O
%	O	O	O
(	O	O	O
p=0.803	O	O	O
)	O	O	O
.	O	O	O

Of	O	O	O
139	O	O	O
pairs	O	O	O
,	O	O	O
the	O	O	O
12-month	O	O	O
rate	O	O	O
of	O	O	O
successful	O	O	B-T080
intercourse	O	O	B-T040
was	O	O	O
29.5	O	O	O
%	O	O	O
for	O	O	O
whole	O	O	B-T081
-	O	O	O
gland	O	O	B-T023
and	O	O	O
46.8	O	O	O
%	O	O	O
for	O	O	O
partial	O	O	B-T081
ablation	O	O	B-T061
(	O	O	O
OR	O	O	O
2.1	O	O	O
,	O	O	O
p=0.003	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
of	O	O	O
post-treatment	O	O	B-T079
urinary	O	O	B-T033
retention	O	O	I-T033
was	O	O	O
6.0	O	O	O
%	O	O	O
and	O	O	O
6.6	O	O	O
%	O	O	O
(	O	O	O
p=0.88	O	O	O
)	O	O	O
following	O	O	O
whole	O	O	B-T081
-	O	O	O
gland	O	O	B-T023
and	O	O	O
partial	O	O	B-T081
ablation	O	O	B-T061
respectively	O	O	O
and	O	O	O
that	O	O	O
of	O	O	O
rectourethral	O	O	B-T047
fistula	O	O	I-T047
was	O	O	O
1.2	O	O	O
%	O	O	O
and	O	O	O
0	O	O	O
%	O	O	O
(	O	O	O
p=0.50	O	O	O
)	O	O	O
Conclusion	O	O	O
:	O	O	O
Partial	O	O	B-T081
ablation	O	O	O
results	O	O	B-T033
in	O	O	O
better	O	O	B-T080
post-treatment	O	O	O
sexual	O	O	B-T040
function	O	O	I-T040
compared	O	O	B-T052
to	O	O	O
whole	O	O	O
-	O	O	O
gland	O	O	O
ablation	O	O	O
in	O	O	O
men	O	O	B-T098
with	O	O	O
intermediate-risk	O	O	B-T033
prostate	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

We	O	O	O
did	O	O	O
not	O	O	O
observe	O	O	O
a	O	O	O
difference	O	O	O
in	O	O	O
early	O	O	B-T079
BPFS	O	O	B-T081
between	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T078
.	O	O	O

-DOCSTART- (28386687)

Abnormal	O	O	B-T033
metabolic	O	O	B-T169
brain	O	O	B-T023
network	O	O	B-T040
associated	O	O	O
with	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
:	O	O	O
replication	O	O	B-T080
on	O	O	O
a	O	O	O
new	O	O	O
European	O	O	B-T098
sample	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
identify	O	O	B-T080
the	O	O	O
specific	O	O	O
metabolic	O	O	B-T169
brain	O	O	B-T023
pattern	O	O	B-T082
characteristic	O	O	B-T080
for	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PD	O	O	B-T047
):	O	O	O
Parkinson	O	O	B-T081
's	O	O	I-T081
disease-related	O	O	I-T081
pattern	O	O	I-T081
(	O	O	O
PDRP	O	O	B-T081
)	O	O	O
,	O	O	O
using	O	O	O
network	O	O	B-T040
analysis	O	O	O
of	O	O	O
[18F]-fluorodeoxyglucose	O	O	B-T060
positron	O	O	I-T060
emission	O	O	I-T060
tomography	O	O	I-T060
(	O	O	O
FDG-PET	O	O	B-T060
)	O	O	O
brain	O	O	O
images	O	O	B-T170
in	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
Slovenian	O	O	B-T083
PD	O	O	O
patients	O	O	B-T101
.	O	O	O

Twenty	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
(	O	O	O
age	O	O	B-T032
70.1	O	O	O
±	O	O	O
7.8	O	O	O
years	O	O	B-T079
,	O	O	O
Movement	O	O	B-T170
Disorder	O	O	I-T170
Society	O	O	I-T170
Unified	O	O	I-T170
Parkinson	O	O	I-T170
's	O	O	I-T170
Disease	O	O	I-T170
Motor	O	O	I-T170
Rating	O	O	I-T170
Scale	O	O	I-T170
(	O	O	O
MDS-UPDRS-III	O	O	B-T170
)	O	O	O
38.3	O	O	O
±	O	O	O
12.2	O	O	O
;	O	O	O
disease	O	O	B-T079
duration	O	O	I-T079
4.3	O	O	O
±	O	O	O
4.1	O	O	O
years	O	O	O
)	O	O	O
and	O	O	O
20	O	O	O
age	O	O	O
-	O	O	O
matched	O	O	B-T080
normal	O	O	B-T096
controls	O	O	I-T096
(	O	O	O
NCs	O	O	B-T096
)	O	O	O
underwent	O	O	O
FDG-PET	O	O	B-T060
brain	O	O	B-T060
imaging	O	O	I-T060
.	O	O	O

An	O	O	O
automatic	O	O	B-T075
voxel-based	O	O	I-T075
scaled	O	O	I-T075
subprofile	O	O	I-T075
model	O	O	I-T075
/	O	O	O
principal	O	O	B-T081
component	O	O	I-T081
analysis	O	O	I-T081
(	O	O	O
SSM	O	O	B-T075
/	O	O	O
PCA	O	O	B-T081
)	O	O	O
was	O	O	O
applied	O	O	O
to	O	O	O
these	O	O	O
scans	O	O	B-T060
for	O	O	O
PDRP	O	O	B-T081
-	O	O	O
Slovenia	O	O	B-T083
identification	O	O	B-T080
.	O	O	O

The	O	O	O
pattern	O	O	B-T081
was	O	O	O
characterized	O	O	B-T052
by	O	O	O
relative	O	O	O
hypermetabolism	O	O	B-T033
in	O	O	O
pallidum	O	O	B-T023
,	O	O	O
putamen	O	O	B-T023
,	O	O	O
thalamus	O	O	B-T023
,	O	O	O
brain	O	O	B-T023
stem	O	O	I-T023
,	O	O	O
and	O	O	O
cerebellum	O	O	B-T023
associated	O	O	O
with	O	O	O
hypometabolism	O	O	B-T033
in	O	O	O
sensorimotor	O	O	B-T023
cortex	O	O	I-T023
,	O	O	O
posterior	O	O	B-T023
parietal	O	O	I-T023
,	O	O	O
occipital	O	O	B-T029
,	O	O	O
and	O	O	O
frontal	O	O	B-T023
cortices	O	O	I-T023
.	O	O	O

The	O	O	O
expression	O	O	B-T078
of	O	O	O
PDRP	O	O	B-T081
-	O	O	O
Slovenia	O	O	B-T083
discriminated	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
from	O	O	O
NCs	O	O	B-T096
(	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
and	O	O	O
correlated	O	O	B-T080
positively	O	O	O
with	O	O	O
patients	O	O	O
'	O	O	O
clinical	O	O	B-T080
score	O	O	B-T081
(	O	O	O
MDS-UPDRS-III	O	O	B-T170
,	O	O	O
p	O	O	O
=	O	O	O
0.03	O	O	O
)	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
its	O	O	O
topography	O	O	B-T185
agrees	O	O	O
well	O	O	O
with	O	O	O
the	O	O	O
original	O	O	O
PDRP	O	O	B-T081
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
identified	O	O	B-T080
in	O	O	O
American	O	O	B-T098
cohort	O	O	B-T098
of	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

We	O	O	O
validated	O	O	O
the	O	O	O
PDRP	O	O	B-T081
-	O	O	O
Slovenia	O	O	B-T083
expression	O	O	B-T078
on	O	O	O
additional	O	O	O
FDG-PET	O	O	B-T060
scans	O	O	B-T060
of	O	O	O
20	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
20	O	O	O
NCs	O	O	B-T096
,	O	O	O
and	O	O	O
25	O	O	O
patients	O	O	O
with	O	O	O
atypical	O	O	B-T047
parkinsonism	O	O	I-T047
(	O	O	O
AP	O	O	B-T047
)	O	O	O
.	O	O	O

We	O	O	O
confirmed	O	O	O
that	O	O	O
the	O	O	O
expression	O	O	B-T078
of	O	O	O
PDRP	O	O	B-T081
-	O	O	O
Slovenia	O	O	B-T083
manifests	O	O	O
good	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
with	O	O	O
specificity	O	O	B-T081
and	O	O	O
sensitivity	O	O	B-T081
of	O	O	O
85	O	O	O
-	O	O	O
90	O	O	O
%	O	O	O
at	O	O	O
optimal	O	O	O
pattern	O	O	B-T081
expression	O	O	O
cutoff	O	O	O
for	O	O	O
discrimination	O	O	O
of	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
NCs	O	O	B-T096
and	O	O	O
is	O	O	O
not	O	O	O
expressed	O	O	O
in	O	O	O
AP	O	O	B-T047
.	O	O	O

PDRP	O	O	B-T081
-	O	O	O
Slovenia	O	O	B-T083
proves	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
robust	O	O	O
and	O	O	O
reproducible	O	O	O
functional	O	O	B-T060
imaging	O	O	I-T060
biomarker	O	O	B-T201
independent	O	O	O
of	O	O	O
patient	O	O	B-T101
population	O	O	B-T098
.	O	O	O

It	O	O	O
accurately	O	O	O
differentiates	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
from	O	O	O
NCs	O	O	B-T096
and	O	O	O
AP	O	O	B-T047
and	O	O	O
correlates	O	O	O
well	O	O	O
with	O	O	O
the	O	O	O
clinical	O	O	B-T080
measure	O	O	B-T081
of	O	O	O
PD	O	O	O
progression	O	O	B-T046
.	O	O	O

-DOCSTART- (28386942)

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
gestational	O	O	B-T079
use	O	O	B-T169
of	O	O	I-T169
antidepressants	O	O	B-T121
and	O	O	O
antipsychotics	O	O	B-T121
on	O	O	O
neonatal	O	O	B-T100
outcomes	O	O	B-T169
for	O	O	O
women	O	O	B-T098
with	O	O	O
severe	O	O	B-T080
mental	O	O	O
illness	O	O	O

Psychotropic	O	O	B-T121
medication	O	O	I-T121
use	O	O	B-T169
occurs	O	O	B-T079
in	O	O	O
8	O	O	O
%	O	O	O
of	O	O	O
pregnancies	O	O	B-T040
,	O	O	O
with	O	O	O
rates	O	O	B-T033
increasing	O	O	B-T169
,	O	O	O
and	O	O	O
often	O	O	B-T079
multiple	O	O	B-T081
medications	O	O	B-T121
prescribed	O	O	B-T058
.	O	O	O

This	O	O	O
study	O	O	B-T062
aims	O	O	O
to	O	O	O
determine	O	O	O
if	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
psychotropic	O	O	B-T121
medication	O	O	I-T121
,	O	O	O
in	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
women	O	O	B-T098
with	O	O	O
severe	O	O	B-T080
mental	O	O	B-T048
illness	O	O	I-T048
,	O	O	O
increases	O	O	B-T169
rates	O	O	B-T081
of	O	O	O
special	O	O	B-T061
care	O	O	I-T061
nursery	O	O	I-T061
admission	O	O	B-T058
and	O	O	O
reports	O	O	B-T170
differences	O	O	B-T080
between	O	O	O
antidepressant	O	O	B-T121
and	O	O	O
antipsychotic	O	O	B-T121
medication	O	O	I-T121
use	O	O	O
either	O	O	O
alone	O	O	B-T081
or	O	O	O
in	O	O	O
combination	O	O	B-T121
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
database	O	O	I-T062
analysis	O	O	I-T062
from	O	O	I-T062
a	O	O	I-T062
cohort	O	O	I-T062
with	O	O	O
severe	O	O	B-T080
mental	O	O	B-T048
illness	O	O	I-T048
in	O	O	O
pregnancy	O	O	B-T040
identified	O	O	B-T080
268	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
who	O	O	O
were	O	O	O
grouped	O	O	B-T185
according	O	O	O
to	O	O	O
medication	O	O	B-T121
type	O	O	B-T080
.	O	O	O

Demographic	O	O	B-T080
,	O	O	O
obstetric	O	O	B-T169
and	O	O	O
neonatal	O	O	B-T100
variables	O	O	B-T080
were	O	O	O
analysed	O	O	B-T062
using	O	O	B-T169
t-tests	O	O	B-T170
,	O	O	O
χ(2	O	O	O
)	O	O	O
,	O	O	O
analysis	O	O	B-T062
of	O	O	O
variance	O	O	B-T080
and	O	O	O
logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
for	O	O	O
special	O	O	B-T061
care	O	O	I-T061
nursery	O	O	I-T061
admission	O	O	B-T058
.	O	O	O

The	O	O	O
medication	O	O	B-T101
groups	O	O	I-T101
consisted	O	O	O
of	O	O	O
:	O	O	O
women	O	O	B-T098
taking	O	O	B-T101
no	O	O	I-T101
psychotropic	O	O	I-T101
medications	O	O	I-T101
(	O	O	O
n	O	O	O
=	O	O	O
67	O	O	O
)	O	O	O
;	O	O	O
those	O	O	B-T101
taking	O	O	I-T101
antipsychotics	O	O	I-T101
(	O	O	O
n	O	O	O
=	O	O	O
87	O	O	O
)	O	O	O
;	O	O	O
those	O	O	B-T101
taking	O	O	I-T101
antidepressants	O	O	I-T101
(	O	O	O
n	O	O	O
=	O	O	O
55	O	O	O
)	O	O	O
;	O	O	O
those	O	O	B-T101
taking	O	O	I-T101
and	O	O	I-T101
a	O	O	I-T101
combination	O	O	I-T101
of	O	O	I-T101
antidepressants/antipsychotics	O	O	I-T101
(	O	O	O
n	O	O	O
=	O	O	O
59	O	O	O
)	O	O	O
.	O	O	O

Rates	O	O	B-T033
of	O	O	O
special	O	O	B-T061
care	O	O	I-T061
nursery	O	O	I-T061
admission	O	O	B-T058
in	O	O	O
women	O	O	B-T098
who	O	O	O
took	O	O	O
psychotropic	O	O	B-T121
medication	O	O	I-T121
(	O	O	O
41.3	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
elevated	O	O	O
compared	O	O	B-T052
to	O	O	O
those	O	O	B-T101
who	O	O	I-T101
did	O	O	I-T101
not	O	O	I-T101
(	O	O	O
26.9	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.035	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
were	O	O	O
significantly	O	O	B-T078
raised	O	O	B-T080
when	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
(	O	O	O
P	O	O	O
<	O	O	O
0.000	O	O	O
)	O	O	O
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
occurred	O	O	O
between	O	O	O
the	O	O	O
medication	O	O	B-T101
groups	O	O	I-T101
.	O	O	O

A	O	O	O
significant	O	O	B-T078
adjusted	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
of	O	O	O
2.79	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.286	O	O	O
-	O	O	O
6.049	O	O	O
)	O	O	O
was	O	O	O
found	O	O	B-T033
for	O	O	O
special	O	O	B-T061
care	O	O	I-T061
nursery	O	O	I-T061
and	O	O	O
psychiatric	O	O	B-T058
admission	O	O	I-T058
during	O	O	B-T079
pregnancy	O	O	B-T040
but	O	O	O
not	O	O	O
for	O	O	O
psychotropic	O	O	B-T121
medication	O	O	I-T121
.	O	O	O

Rates	O	O	B-T081
of	O	O	O
special	O	O	B-T061
care	O	O	I-T061
nursery	O	O	I-T061
admission	O	O	B-T058
are	O	O	O
elevated	O	O	O
in	O	O	O
neonates	O	O	B-T100
of	O	O	O
women	O	O	B-T098
with	O	O	O
severe	O	O	B-T080
mental	O	O	B-T048
illness	O	O	I-T048
taking	O	O	O
psychotropic	O	O	B-T121
medication	O	O	I-T121
,	O	O	O
but	O	O	O
were	O	O	O
not	O	O	O
different	O	O	O
for	O	O	O
monotherapy	O	O	B-T061
or	O	O	O
polytherapy	O	O	B-T061
when	O	O	O
prescribing	O	O	B-T058
antidepressants	O	O	B-T121
or	O	O	O
antipsychotic	O	O	B-T121
medication	O	O	I-T121
.	O	O	O

Additional	O	O	O
vulnerability	O	O	B-T033
occurs	O	O	B-T079
in	O	O	O
the	O	O	O
neonates	O	O	B-T100
of	O	O	O
women	O	O	B-T098
with	O	O	O
a	O	O	O
mental	O	O	B-T048
illness	O	O	I-T048
and	O	O	O
paediatric	O	O	B-T097
presence	O	O	O
at	O	O	O
delivery	O	O	B-T040
is	O	O	O
recommended	O	O	B-T078
.	O	O	O

-DOCSTART- (28387851)

Does	O	O	O
Intrawound	O	O	B-T116
Vancomycin	O	O	I-T116
Application	O	O	B-T169
During	O	O	O
Spine	O	O	B-T061
Surgery	O	O	I-T061
Create	O	O	O
Vancomycin-Resistant	O	O	B-T032
Organism	O	O	B-T001
?	O	O	O

Surgical	O	O	B-T046
site	O	O	I-T046
infection	O	O	I-T046
(	O	O	O
SSI	O	O	B-T046
)	O	O	O
following	O	O	O
spine	O	O	B-T061
surgery	O	O	I-T061
is	O	O	O
a	O	O	O
morbid	O	O	B-T080
and	O	O	O
expensive	O	O	B-T169
complication	O	O	I-T169
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
intrawound	O	O	B-T116
vancomycin	O	O	I-T116
is	O	O	O
emerging	O	O	O
as	O	O	O
a	O	O	O
solution	O	O	O
to	O	O	O
reduce	O	O	O
SSI	O	O	B-T046
.	O	O	O

The	O	O	O
development	O	O	O
of	O	O	O
vancomycin-resistant	O	O	B-T032
pathogens	O	O	B-T001
is	O	O	O
an	O	O	O
understandable	O	O	O
concern	O	O	O
.	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
occurrence	O	O	B-T079
of	O	O	O
vancomycin-resistant	O	O	B-T032
SSI	O	O	B-T046
in	O	O	O
patients	O	O	B-T101
with	O	O	O
and	O	O	O
without	O	O	O
use	O	O	O
of	O	O	O
intrawound	O	O	B-T116
vancomycin	O	O	I-T116
.	O	O	O

Patients	O	O	B-T101
undergoing	O	O	O
elective	O	O	O
spine	O	O	B-T061
surgery	O	O	I-T061
were	O	O	O
dichotomized	O	O	B-T080
based	O	O	O
on	O	O	O
whether	O	O	O
intrawound	O	O	B-T116
vancomycin	O	O	I-T116
was	O	O	O
applied	O	O	O
.	O	O	O

Outcome	O	O	O
was	O	O	O
occurrence	O	O	B-T079
of	O	O	O
SSI	O	O	B-T046
requiring	O	O	O
return	O	O	O
to	O	O	O
the	O	O	O
operating	O	O	B-T093
room	O	O	I-T093
within	O	O	O
postoperative	O	O	B-T079
90	O	O	I-T079
days	O	O	I-T079
.	O	O	O

The	O	O	O
intrawound	O	O	B-T059
culture	O	O	I-T059
and	O	O	O
vancomycin	O	O	B-T116
minimal	O	O	B-T059
inhibitory	O	O	I-T059
concentrations	O	O	I-T059
(	O	O	O
MIC	O	O	B-T059
)	O	O	O
were	O	O	O
reviewed	O	O	O
.	O	O	O

Analyses	O	O	O
were	O	O	O
conducted	O	O	O
to	O	O	O
compare	O	O	O
the	O	O	O
pathogen	O	O	B-T001
profile	O	O	I-T001
and	O	O	O
MIC	O	O	B-T059
for	O	O	O
vancomycin	O	O	B-T116
in	O	O	O
patients	O	O	B-T101
who	O	O	O
received	O	O	O
vancomycin	O	O	O
and	O	O	O
those	O	O	O
who	O	O	O
did	O	O	O
not	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
total	O	O	O
2802	O	O	O
patients	O	O	B-T101
,	O	O	O
43	O	O	O
%	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
1215	O	O	O
)	O	O	O
had	O	O	O
intrawound	O	O	B-T116
vancomycin	O	O	I-T116
application	O	O	O
during	O	O	B-T079
the	O	O	I-T079
index	O	O	I-T079
surgery	O	O	I-T079
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
vancomycin	O	O	B-T116
was	O	O	O
associated	O	O	O
with	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
deep	O	O	O
SSI	O	O	B-T046
rates	O	O	B-T023
(	O	O	O
1.6	O	O	O
%	O	O	O
[	O	O	O
n	O	O	O
=	O	O	O
20	O	O	O
]	O	O	O
vs	O	O	O
2.5	O	O	O
%	O	O	O
[	O	O	O
n	O	O	O
=	O	O	O
40	O	O	O
]	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.02	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
occurrence	O	O	B-T079
of	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
SSI	O	O	B-T046
was	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
in	O	O	O
the	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
application	O	O	B-T169
of	O	O	O
intrawound	O	O	B-T116
vancomycin	O	O	I-T116
(	O	O	O
32	O	O	O
%	O	O	O
vs	O	O	O
65	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.003	O	O	O
)	O	O	O
.	O	O	O

None	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
application	O	O	B-T169
of	O	O	O
intrawound	O	O	B-T116
vancomycin	O	O	I-T116
powder	O	O	I-T116
,	O	O	O
and	O	O	O
subsequently	O	O	O
developed	O	O	O
an	O	O	O
S	O	O	B-T007
aureus	O	O	I-T007
SSI	O	O	B-T046
,	O	O	O
demonstrated	O	O	O
pathogens	O	O	B-T001
with	O	O	O
resistance	O	O	B-T033
to	O	O	I-T033
vancomycin	O	O	I-T033
.	O	O	O

All	O	O	O
patients	O	O	B-T101
had	O	O	O
MIC	O	O	B-T059
<	O	O	O
2	O	O	O
μg/mL	O	O	O
,	O	O	O
the	O	O	O
vancomycin	O	O	B-T116
susceptibility	O	O	O
threshold	O	O	O
.	O	O	O

The	O	O	O
occurrence	O	O	B-T079
of	O	O	O
gram-negative	O	O	B-T047
SSI	O	O	B-T046
(	O	O	O
28	O	O	O
%	O	O	O
vs	O	O	O
7	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
culture	O	O	B-T033
negative	O	O	I-T033
fluid	O	O	I-T033
collection	O	O	I-T033
(	O	O	O
16	O	O	O
%	O	O	O
vs	O	O	O
5	O	O	O
%	O	O	O
)	O	O	O
was	O	O	O
higher	O	O	B-T080
in	O	O	O
the	O	O	O
vancomycin	O	O	B-T116
cohort	O	O	B-T098
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
intrawound	O	O	B-T116
vancomycin	O	O	I-T116
during	O	O	O
the	O	O	O
index	O	O	O
spine	O	O	B-T061
surgery	O	O	I-T061
was	O	O	O
protective	O	O	O
against	O	O	O
SSI	O	O	B-T046
following	O	O	O
spine	O	O	O
surgery	O	O	O
.	O	O	O

The	O	O	O
application	O	O	B-T169
of	O	O	O
intrawound	O	O	B-T116
vancomycin	O	O	I-T116
during	O	O	B-T079
index	O	O	I-T079
surgery	O	O	I-T079
does	O	O	O
not	O	O	O
appear	O	O	O
to	O	O	O
create	O	O	O
vancomycin-resistant	O	O	B-T032
organisms	O	O	B-T001
in	O	O	O
the	O	O	O
event	O	O	O
of	O	O	O
an	O	O	O
SSI	O	O	B-T046
.	O	O	O

-DOCSTART- (28388017)

Adequacy	O	O	B-T170
criteria	O	O	B-T078
for	O	O	O
thyroid	O	O	B-T060
FNA	O	O	I-T060
evaluated	O	O	B-T058
by	O	O	O
ThinPrep	O	O	B-T060
slides	O	O	I-T060
only	O	O	O

Adequacy	O	O	B-T170
criteria	O	O	B-T078
for	O	O	O
thyroid	O	O	B-T060
fine-needle	O	O	I-T060
aspiration	O	O	I-T060
(	O	O	O
FNA	O	O	B-T060
)	O	O	O
recommended	O	O	B-T078
by	O	O	O
The	O	O	O
Bethesda	O	O	B-T059
System	O	O	I-T059
for	O	O	I-T059
Reporting	O	O	I-T059
Thyroid	O	O	I-T059
Cytopathology	O	O	I-T059
(	O	O	O
TBS	O	O	B-T059
)	O	O	O
were	O	O	O
developed	O	O	O
with	O	O	O
smears	O	O	B-T060
,	O	O	O
but	O	O	O
they	O	O	O
are	O	O	O
commonly	O	O	O
applied	O	O	B-T169
to	O	O	O
ThinPreps	O	O	B-T060
(	O	O	O
TPs	O	O	B-T060
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
evaluated	O	O	B-T058
adequacy	O	O	B-T170
in	O	O	O
TPs	O	O	B-T060
at	O	O	O
different	O	O	O
diagnostic	O	O	B-T169
thresholds	O	O	B-T080
.	O	O	O

All	O	O	O
FNA	O	O	B-T060
procedures	O	O	I-T060
performed	O	O	B-T169
between	O	O	O
2010	O	O	O
and	O	O	O
2015	O	O	O
with	O	O	O
matched	O	O	B-T080
surgical	O	O	B-T167
specimens	O	O	I-T167
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Cell	O	O	B-T059
counts	O	O	I-T059
and	O	O	O
cytological	O	O	B-T169
features	O	O	B-T080
were	O	O	O
evaluated	O	O	B-T058
in	O	O	O
all	O	O	O
initially	O	O	O
nondiagnostic	O	O	B-T033
(	O	O	O
ND	O	O	B-T033
)	O	O	O
cases	O	O	B-T096
.	O	O	O

ND	O	O	B-T033
cases	O	O	B-T096
were	O	O	O
reclassified	O	O	B-T080
into	O	O	O
TBS	O	O	B-T059
categories	O	O	B-T170
by	O	O	O
2	O	O	O
pathologists	O	O	B-T097
,	O	O	O
and	O	O	O
the	O	O	O
results	O	O	B-T169
were	O	O	O
compared	O	O	B-T052
with	O	O	O
surgical	O	O	B-T169
outcomes	O	O	I-T169
.	O	O	O

One	O	O	O
hundred	O	O	B-T081
forty-six	O	O	I-T081
of	O	O	O
the	O	O	O
151	O	O	O
cases	O	O	B-T096
initially	O	O	O
classified	O	O	B-T185
as	O	O	O
ND	O	O	B-T033
were	O	O	O
available	O	O	B-T169
for	O	O	O
review	O	O	B-T169
,	O	O	O
and	O	O	O
they	O	O	O
had	O	O	O
a	O	O	O
mean	O	O	B-T081
cell	O	O	B-T059
count	O	O	I-T059
of	O	O	O
60.5	O	O	O
(	O	O	O
standard	O	O	B-T081
deviation	O	O	I-T081
,	O	O	O
71.4	O	O	O
)	O	O	O
.	O	O	O

Interobserver	O	O	B-T054
agreement	O	O	I-T054
on	O	O	O
the	O	O	O
reclassification	O	O	B-T185
of	O	O	O
ND	O	O	B-T033
cases	O	O	B-T096
was	O	O	O
moderate	O	O	B-T080
(	O	O	O
k	O	O	O
=	O	O	O
0.57	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
consensus	O	O	B-T054
yielded	O	O	B-T081
48	O	O	O
ND	O	O	O
cases	O	O	O
(	O	O	O
33	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
72	O	O	O
benign	O	O	B-T080
cases	O	O	O
(	O	O	O
49	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
24	O	O	O
cases	O	O	O
of	O	O	O
atypia	O	O	B-T033
of	O	O	O
undetermined	O	O	B-T033
significance	O	O	I-T033
(	O	O	O
16	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
2	O	O	O
cases	O	O	O
suspicious	O	O	B-T033
for	O	O	I-T033
malignancy	O	O	I-T033
(	O	O	O
1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Lowering	O	O	B-T052
the	O	O	O
diagnostic	O	O	B-T169
threshold	O	O	B-T080
to	O	O	O
any	O	O	O
follicular	O	O	B-T023
cells	O	O	B-T025
yielded	O	O	B-T081
a	O	O	O
sensitivity	O	O	B-T081
of	O	O	O
92	O	O	O
%	O	O	O
,	O	O	O
a	O	O	O
specificity	O	O	B-T081
of	O	O	O
60	O	O	O
%	O	O	O
,	O	O	O
a	O	O	O
positive	O	O	B-T081
predictive	O	O	I-T081
value	O	O	I-T081
of	O	O	O
59	O	O	O
%	O	O	O
,	O	O	O
a	O	O	O
negative	O	O	B-T081
predictive	O	O	I-T081
value	O	O	I-T081
of	O	O	O
92	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
false-negative	O	O	B-T034
rate	O	O	B-T081
of	O	O	O
7.7	O	O	O
%	O	O	O
,	O	O	O
whereas	O	O	O
the	O	O	O
values	O	O	O
for	O	O	O
the	O	O	O
initially	O	O	O
diagnostic	O	O	O
cases	O	O	B-T096
were	O	O	O
93	O	O	O
%	O	O	O
,	O	O	O
58	O	O	O
%	O	O	O
,	O	O	O
59	O	O	O
%	O	O	O
,	O	O	O
93	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
7.7	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Including	O	O	O
cases	O	O	B-T096
with	O	O	O
>	O	O	O
60	O	O	O
cells	O	O	B-T025
but	O	O	O
lacking	O	O	B-T080
6	O	O	O
groups	O	O	B-UnknownType
containing	O	O	B-T052
at	O	O	O
least	O	O	O
10	O	O	O
cells	O	O	O
did	O	O	O
not	O	O	O
affect	O	O	O
test	O	O	B-T060
performance	O	O	I-T060
.	O	O	O

Nuclear	O	O	B-T049
enlargement	O	O	I-T049
,	O	O	O
pallor	O	O	B-T033
,	O	O	O
grooves	O	O	B-T030
,	O	O	O
and	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
histiocytoid	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
initially	O	O	O
ND	O	O	B-T033
FNA	O	O	B-T060
correlated	O	O	B-T080
with	O	O	O
malignancy	O	O	B-T191
.	O	O	O

In	O	O	O
thyroid	O	O	B-T060
FNA	O	O	I-T060
examined	O	O	B-T033
with	O	O	O
TP	O	O	B-T060
only	O	O	O
,	O	O	O
lowering	O	O	B-T052
the	O	O	O
adequacy	O	O	B-T170
threshold	O	O	B-T080
and	O	O	O
eliminating	O	O	O
the	O	O	O
requirement	O	O	B-T169
of	O	O	O
6	O	O	O
groups	O	O	B-UnknownType
of	O	O	O
at	O	O	O
least	O	O	O
10	O	O	O
cells	O	O	B-T025
did	O	O	O
not	O	O	O
significantly	O	O	B-T078
affect	O	O	O
test	O	O	B-T060
performance	O	O	I-T060
if	O	O	O
cytological	O	O	B-T169
features	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
malignancy	O	O	B-T191
were	O	O	O
absent	O	O	B-T169
.	O	O	O

Cancer	O	O	O
Cytopathol	O	O	O
2017	O	O	O
.	O	O	O

©	O	O	O
2017	O	O	O
American	O	O	O
Cancer	O	O	O
Society	O	O	O
.	O	O	O

-DOCSTART- (28389368)

Silk	O	O	B-T116
I	O	O	I-T116
and	O	O	O
Silk	O	O	B-T116
II	O	O	I-T116
studied	O	O	B-T062
by	O	O	O
fast	O	O	O
scanning	O	O	O
calorimetry	O	O	O

Using	O	O	O
fast	O	O	B-T059
scanning	O	O	I-T059
calorimetry	O	O	I-T059
(	O	O	O
FSC	O	O	B-T059
)	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
glass	O	O	B-T052
transition	O	O	I-T052
and	O	O	O
crystal	O	O	B-T104
melting	O	O	B-T070
of	O	O	O
samples	O	O	B-T167
of	O	O	O
B.	O	O	B-T204
mori	O	O	I-T204
silk	O	O	B-T116
fibroin	O	O	I-T116
containing	O	O	O
Silk	O	O	B-T116
I	O	O	I-T116
and/or	O	O	O
Silk	O	O	B-T116
II	O	O	I-T116
crystal	O	O	O
s.	O	O	O
Due	O	O	O
to	O	O	O
the	O	O	O
very	O	O	O
short	O	O	B-T081
residence	O	O	B-T082
times	O	O	B-T079
at	O	O	O
high	O	O	B-T080
temperatures	O	O	B-T081
during	O	O	O
such	O	O	O
measurements	O	O	B-T169
,	O	O	O
thermal	O	O	B-T070
decomposition	O	O	B-T067
of	O	O	O
silk	O	O	B-T116
protein	O	O	I-T116
can	O	O	O
be	O	O	O
significantly	O	O	B-T078
suppressed	O	O	B-T080
.	O	O	O

FSC	O	O	B-T059
was	O	O	O
performed	O	O	B-T169
at	O	O	O
2000K/s	O	O	O
using	O	O	O
the	O	O	O
Mettler	O	O	B-T059
Flash	O	O	I-T059
DSC1	O	O	I-T059
on	O	O	O
fibroin	O	O	B-T116
films	O	O	B-T167
with	O	O	O
masses	O	O	B-T081
around	O	O	O
130	O	O	O
-	O	O	O
270ng	O	O	O
.	O	O	O

Films	O	O	B-T167
were	O	O	O
prepared	O	O	O
with	O	O	O
different	O	O	B-T080
crystalline	O	O	B-T104
fractions	O	O	B-T081
(	O	O	O
ranging	O	O	O
from	O	O	O
0.26	O	O	O
to	O	O	O
0.50	O	O	O
)	O	O	O
and	O	O	O
with	O	O	O
different	O	O	O
crystal	O	O	B-T104
structures	O	O	I-T104
(	O	O	O
Silk	O	O	B-T116
I	O	O	I-T116
,	O	O	O
Silk	O	O	B-T116
II	O	O	I-T116
,	O	O	O
or	O	O	O
mixed	O	O	O
)	O	O	O
by	O	O	O
varying	O	O	O
the	O	O	O
processing	O	O	B-T052
conditions	O	O	B-T080
.	O	O	O

These	O	O	O
included	O	O	O
water	O	O	B-T121
annealing	O	O	B-T061
at	O	O	O
different	O	O	B-T080
temperatures	O	O	B-T081
,	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
50	O	O	O
%	O	O	O
MeOH	O	O	B-T109
in	O	O	O
water	O	O	O
,	O	O	O
or	O	O	O
autoclaving	O	O	B-T074
.	O	O	O

The	O	O	O
resulting	O	O	B-T169
crystal	O	O	B-T104
structure	O	O	I-T104
was	O	O	O
examined	O	O	O
using	O	O	O
wide	O	O	B-T082
angle	O	O	I-T082
X-ray	O	O	B-T060
scattering	O	O	I-T060
.	O	O	O

Degree	O	O	B-T081
of	O	O	O
crystallinity	O	O	B-T104
was	O	O	O
evaluated	O	O	B-T033
from	O	O	O
Fourier	O	O	B-T062
transform	O	O	I-T062
infrared	O	O	I-T062
(	O	O	I-T062
FTIR	O	O	I-T062
)	O	O	I-T062
spectroscopy	O	O	I-T062
and	O	O	O
from	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
heat	O	O	B-T081
capacity	O	O	I-T081
increment	O	O	B-T081
at	O	O	O
the	O	O	O
glass	O	O	B-T080
transition	O	O	I-T080
temperature	O	O	I-T080
.	O	O	O

Silk	O	O	B-T116
fibroin	O	O	I-T116
films	O	O	B-T167
prepared	O	O	O
by	O	O	O
water	O	O	B-T121
annealing	O	O	B-T061
at	O	O	O
25	O	O	O
°	O	O	O
C	O	O	O
were	O	O	O
the	O	O	O
least	O	O	O
crystalline	O	O	B-T104
and	O	O	O
had	O	O	O
Silk	O	O	B-T116
I	O	O	I-T116
structure	O	O	B-T116
.	O	O	O

FTIR	O	O	B-T062
and	O	O	O
FSC	O	O	B-T059
studies	O	O	B-T062
showed	O	O	O
that	O	O	O
films	O	O	B-T167
prepared	O	O	O
by	O	O	O
autoclaving	O	O	B-T074
or	O	O	O
50	O	O	O
%	O	O	O
MeOH	O	O	B-T109
exposure	O	O	B-T080
were	O	O	O
the	O	O	O
most	O	O	O
crystalline	O	O	B-T104
and	O	O	O
had	O	O	O
Silk	O	O	B-T116
II	O	O	I-T116
structure	O	O	B-T116
.	O	O	O

Intermediate	O	O	B-T082
crystalline	O	O	B-T104
fraction	O	O	B-T081
and	O	O	O
mixed	O	O	O
Silk	O	O	B-T116
I	O	O	I-T116
/	O	O	O
Silk	O	O	B-T116
II	O	O	I-T116
structure	O	O	B-T116
s	O	O	O
were	O	O	O
found	O	O	O
in	O	O	O
films	O	O	B-T167
prepared	O	O	O
by	O	O	O
water	O	O	B-T121
annealing	O	O	B-T061
at	O	O	O
37	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

FSC	O	O	B-T059
results	O	O	B-T033
indicate	O	O	O
that	O	O	O
Silk	O	O	B-T116
I	O	O	I-T116
I	O	O	O
crystals	O	O	B-T104
exhibit	O	O	O
endotherms	O	O	B-T080
of	O	O	O
narrower	O	O	B-T080
width	O	O	I-T080
and	O	O	O
have	O	O	O
higher	O	O	B-T080
mean	O	O	B-T081
melting	O	O	B-T081
temperature	O	O	I-T081
Tm(II)=351±2.6	O	O	O
°	O	O	O
C	O	O	O
,	O	O	O
compared	O	O	B-T052
to	O	O	O
Silk	O	O	O
I	O	O	O
crystals	O	O	O
which	O	O	O
melt	O	O	B-T070
at	O	O	O
Tm(I)=292±3.8	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

Films	O	O	B-T167
containing	O	O	O
mixed	O	O	O
Silk	O	O	B-T116
I	O	O	I-T116
/	O	O	O
Silk	O	O	B-T116
II	O	O	I-T116
structure	O	O	B-T116
showed	O	O	O
two	O	O	O
clearly	O	O	B-T080
separated	O	O	B-T080
endothermic	O	O	B-T080
peaks	O	O	B-T080
.	O	O	O

Evidence	O	O	B-T078
suggests	O	O	O
that	O	O	O
the	O	O	O
two	O	O	O
types	O	O	O
of	O	O	O
crystal	O	O	B-T104
s	O	O	O
melt	O	O	B-T070
separately	O	O	B-T080
and	O	O	O
do	O	O	O
not	O	O	O
thermal	O	O	B-T070
ly	O	O	O
interconvert	O	O	B-T169
on	O	O	O
the	O	O	O
extremely	O	O	B-T080
short	O	O	B-T081
time	O	O	B-T079
scale	O	O	I-T079
(	O	O	O
0.065s	O	O	O
between	O	O	O
onset	O	O	O
and	O	O	O
end	O	O	O
of	O	O	O
melting	O	O	B-T070
)	O	O	O
of	O	O	O
the	O	O	O
FSC	O	O	B-T059
experiment	O	O	I-T059
.	O	O	O

Silkworm	O	O	B-T204
silk	O	O	B-T116
is	O	O	O
a	O	O	O
naturally	O	O	B-T169
occurring	O	O	O
biomaterial	O	O	B-T169
.	O	O	O

The	O	O	O
fibroin	O	O	B-T116
component	O	O	I-T116
of	O	O	O
silk	O	O	B-T116
forms	O	O	I-T116
two	O	O	O
types	O	O	O
of	O	O	O
crystals	O	O	B-T104
.	O	O	O

Silk	O	O	B-T116
properties	O	O	B-T080
depend	O	O	O
upon	O	O	O
the	O	O	O
amount	O	O	B-T081
and	O	O	O
type	O	O	O
of	O	O	O
crystals	O	O	B-T104
,	O	O	O
and	O	O	O
their	O	O	O
stability	O	O	B-T080
.	O	O	O

One	O	O	O
measure	O	O	B-T081
of	O	O	O
stability	O	O	B-T080
is	O	O	O
crystal	O	O	B-T104
melting	O	O	B-T081
temperature	O	O	I-T081
.	O	O	O

Crystal	O	O	B-T104
s	O	O	O
which	O	O	O
are	O	O	O
more	O	O	O
stable	O	O	B-T080
have	O	O	O
a	O	O	O
higher	O	O	B-T080
melting	O	O	B-T081
temperature	O	O	I-T081
.	O	O	O

Until	O	O	O
now	O	O	O
,	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
challenging	O	O	O
to	O	O	O
study	O	O	B-T062
thermal	O	O	B-T070
behavior	O	O	B-T053
of	O	O	O
silk	O	O	B-T116
crystal	O	O	B-T104
s	O	O	O
because	O	O	O
they	O	O	O
degrade	O	O	B-T169
at	O	O	O
high	O	O	B-T080
temperature	O	O	B-T081
.	O	O	O

To	O	O	O
avoid	O	O	O
degradation	O	O	B-T169
,	O	O	O
and	O	O	O
study	O	O	B-T062
the	O	O	O
melting	O	O	B-T070
properties	O	O	B-T080
of	O	O	O
silk	O	O	B-T116
biomaterial	O	O	B-T169
,	O	O	O
we	O	O	O
heated	O	O	B-T067
silk	O	O	O
at	O	O	O
a	O	O	O
very	O	O	O
fast	O	O	O
rate	O	O	O
of	O	O	O
2000K/s	O	O	O
using	O	O	O
a	O	O	O
special	O	O	B-UnknownType
calorimeter	O	O	I-UnknownType
.	O	O	O

We	O	O	O
have	O	O	O
shown	O	O	O
that	O	O	O
the	O	O	O
two	O	O	O
crystal	O	O	B-T104
types	O	O	O
have	O	O	O
very	O	O	O
different	O	O	B-T080
melting	O	O	B-T081
temperature	O	O	I-T081
s	O	O	O
,	O	O	O
indicating	O	O	O
that	O	O	O
one	O	O	O
crystal	O	O	O
type	O	O	B-T080
is	O	O	O
much	O	O	O
more	O	O	O
stable	O	O	B-T080
than	O	O	O
the	O	O	O
other	O	O	O
.	O	O	O

-DOCSTART- (28389633)

Leonurine	O	O	B-T109
Attenuates	O	O	B-T052
Hyperalgesia	O	O	B-T184
in	O	O	O
Mice	O	O	B-T015
with	O	O	O
Induced	O	O	B-T169
Adenomyosis	O	O	O

BACKGROUND	O	O	O
Adenomyosis	O	O	B-T047
,	O	O	O
defined	O	O	O
as	O	O	O
the	O	O	O
invasion	O	O	B-T046
of	O	O	O
endometrial	O	O	B-T023
glands	O	O	I-T023
and	O	O	O
stroma	O	O	B-T023
into	O	O	O
the	O	O	O
myometrium	O	O	B-T023
,	O	O	O
is	O	O	O
a	O	O	O
common	O	O	B-T081
gynecological	O	O	B-T047
disorder	O	O	I-T047
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
we	O	O	O
report	O	O	B-T170
on	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
leonurine	O	O	B-T109
on	O	O	O
ICR	O	O	B-T015
mice	O	O	I-T015
with	O	O	O
adenomyosis	O	O	B-T047
induced	O	O	B-T169
by	O	O	O
neonatal	O	O	B-T079
tamoxifen	O	O	B-T109
.	O	O	O

MATERIAL	O	O	O
AND	O	O	O
METHODS	O	O	O
After	O	O	O
being	O	O	O
treated	O	O	B-T169
with	O	O	O
tamoxifen	O	O	B-T109
for	O	O	O
4	O	O	O
,	O	O	O
8	O	O	O
,	O	O	O
and	O	O	O
12	O	O	O
weeks	O	O	O
,	O	O	O
we	O	O	O
assessed	O	O	B-T052
body	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
pain	O	O	B-T184
modulation	O	O	O
in	O	O	O
mice	O	O	B-T015
in	O	O	O
hotplate	O	O	B-T074
tests	O	O	B-T059
.	O	O	O

The	O	O	O
mice	O	O	B-T015
were	O	O	O
divided	O	O	B-T169
into	O	O	O
5	O	O	O
groups	O	O	B-T078
:	O	O	O
a	O	O	O
low-dose	O	O	B-T081
leonurine	O	O	B-T109
treatment	O	O	B-T061
group	O	O	B-T078
,	O	O	O
a	O	O	O
high-dose	O	O	B-T081
leonurine	O	O	O
treatment	O	O	O
group	O	O	O
,	O	O	O
a	O	O	O
valproic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
VPA	O	O	B-T109
)	O	O	O
treatment	O	O	O
group	O	O	O
,	O	O	O
a	O	O	O
vehicle	O	O	B-T122
only	O	O	B-T081
treatment	O	O	O
group	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
blank	O	O	B-T033
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
body	O	O	B-T032
weight	O	O	I-T032
,	O	O	O
pain	O	O	O
modulation	O	O	O
in	O	O	O
hotplate	O	O	B-T074
tests	O	O	B-T059
,	O	O	O
and	O	O	O
the	O	O	O
depth	O	O	B-T082
of	O	O	O
myometrial	O	O	B-T029
infiltration	O	O	B-T046
.	O	O	O

Immunoreactivity	O	O	B-T044
staining	O	O	B-T059
of	O	O	O
progesterone	O	O	B-T116
receptor	O	O	I-T116
(	O	O	O
PR	O	O	B-T116
)	O	O	O
,	O	O	O
nuclear	O	O	B-T116
factor-κB	O	O	I-T116
phosphorylated-p65	O	O	I-T116
(	O	O	O
p-p65	O	O	B-T116
)	O	O	O
,	O	O	O
cyclooxygenase-2	O	O	B-T116
(	O	O	O
COX-2	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
oxytocin	O	O	B-T116
receptor	O	O	I-T116
(	O	O	O
OTR	O	O	B-T116
)	O	O	O
was	O	O	O
evaluated	O	O	B-T058
by	O	O	O
immunohistochemistry	O	O	B-T060
.	O	O	O

RESULTS	O	O	O
The	O	O	O
measurement	O	O	B-T169
of	O	O	O
the	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
,	O	O	O
myometrial	O	O	B-T029
infiltration	O	O	B-T046
,	O	O	O
and	O	O	O
pain	O	O	O
modulation	O	O	O
showed	O	O	O
that	O	O	O
neonatal	O	O	B-T079
tamoxifen	O	O	B-T109
treatment	O	O	B-T061
led	O	O	O
to	O	O	O
adenomyosis	O	O	B-T047
.	O	O	O

Leonurine	O	O	B-T109
treatment	O	O	B-T061
appeared	O	O	O
to	O	O	O
decrease	O	O	B-T081
hyperalgesia	O	O	B-T184
and	O	O	O
myometrial	O	O	B-T029
infiltration	O	O	B-T046
.	O	O	O

Immunoreactivity	O	O	B-T044
staining	O	O	B-T059
showed	O	O	O
decreased	O	O	B-T081
p-p65	O	O	B-T116
,	O	O	O
COX-2	O	O	B-T116
,	O	O	O
and	O	O	O
OTR	O	O	B-T116
protein	O	O	B-T045
expressions	O	O	I-T045
.	O	O	O

CONCLUSIONS	O	O	O
Our	O	O	O
results	O	O	O
indicate	O	O	O
that	O	O	O
leonurine	O	O	B-T109
attenuates	O	O	B-T052
hyperalgesia	O	O	B-T184
in	O	O	O
mice	O	O	B-T015
with	O	O	O
induced	O	O	B-T169
adenomyosis	O	O	B-T047
via	O	O	O
down-regulating	O	O	B-T044
expressions	O	O	B-T045
of	O	O	O
p-P65	O	O	B-T116
,	O	O	O
COX-2	O	O	B-T116
,	O	O	O
and	O	O	O
OTR	O	O	B-T116
,	O	O	O
and	O	O	O
could	O	O	O
be	O	O	O
beneficial	O	O	O
for	O	O	O
treating	O	O	B-T169
adenomyosis	O	O	O
.	O	O	O

-DOCSTART- (28394217)

A	O	O	O
Randomized	O	O	B-T062
,	O	O	O
Head-to-Head	O	O	B-T080
Study	O	O	B-T062
of	O	O	O
Virtual	O	O	B-T061
Reality	O	O	I-T061
Exposure	O	O	I-T061
Therapy	O	O	I-T061
for	O	O	O
Posttraumatic	O	O	O
Stress	O	O	O
Disorder	O	O	O

Virtual	O	O	B-T061
reality	O	O	I-T061
exposure	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
VRET	O	O	B-T061
)	O	O	O
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
few	O	O	O
interventions	O	O	B-T058
supported	O	O	B-T077
by	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
combat-related	O	O	B-T048
posttraumatic	O	O	I-T048
stress	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
PTSD	O	O	B-T048
)	O	O	O
in	O	O	O
active	O	O	B-T033
duty	O	O	I-T033
service	O	O	I-T033
members	O	O	B-T098
.	O	O	O

A	O	O	O
comparative	O	O	B-T062
effectiveness	O	O	I-T062
study	O	O	I-T062
was	O	O	O
conducted	O	O	O
to	O	O	O
determine	O	O	O
if	O	O	O
virtual	O	O	B-T066
reality	O	O	I-T066
technology	O	O	B-T090
itself	O	O	O
improved	O	O	B-T033
outcomes	O	O	B-T080
,	O	O	O
or	O	O	O
if	O	O	O
similar	O	O	B-T080
results	O	O	B-T169
could	O	O	O
be	O	O	O
achieved	O	O	B-T053
with	O	O	O
a	O	O	O
control	O	O	B-T061
exposure	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
CET	O	O	B-T061
)	O	O	O
condition	O	O	B-T080
.	O	O	O

Service	O	O	B-T057
members	O	O	B-T098
with	O	O	O
combat-related	O	O	B-T048
PTSD	O	O	I-T048
were	O	O	O
randomly	O	O	B-T080
selected	O	O	B-T052
to	O	O	O
receive	O	O	B-T080
nine	O	O	O
weeks	O	O	B-T079
of	O	O	O
VRET	O	O	B-T061
or	O	O	O
CET	O	O	B-T061
.	O	O	O

Assessors	O	O	B-T097
,	O	O	O
but	O	O	O
not	O	O	O
therapists	O	O	B-T097
,	O	O	O
were	O	O	O
blinded	O	O	B-T062
.	O	O	O

PTSD	O	O	B-T048
symptom	O	O	B-T184
improvement	O	O	B-T077
was	O	O	O
assessed	O	O	B-T052
one	O	O	O
week	O	O	B-T079
and	O	O	O
3	O	O	O
months	O	O	B-T079
after	O	O	O
the	O	O	O
conclusion	O	O	B-T078
of	O	O	O
treatment	O	O	B-T061
using	O	O	O
the	O	O	O
clinician-administered	O	O	B-T170
PTSD	O	O	I-T170
scale	O	O	I-T170
(	O	O	O
CAPS	O	O	B-T170
)	O	O	O
.	O	O	O

A	O	O	O
small	O	O	B-T081
crossover	O	O	O
component	O	O	O
was	O	O	O
included	O	O	B-T169
.	O	O	O

Results	O	O	B-T169
demonstrated	O	O	O
that	O	O	O
PTSD	O	O	B-T048
symptoms	O	O	B-T184
improved	O	O	B-T033
with	O	O	O
both	O	O	O
treatments	O	O	B-T061
,	O	O	O
but	O	O	O
there	O	O	O
were	O	O	O
no	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
differences	O	O	B-T033
between	O	O	O
groups	O	O	B-T078
.	O	O	O

Dropout	O	O	B-T098
rates	O	O	B-T081
were	O	O	O
higher	O	O	B-T080
in	O	O	O
VRET	O	O	B-T061
.	O	O	O

Of	O	O	O
those	O	O	O
who	O	O	O
received	O	O	B-T080
VRET	O	O	B-T061
,	O	O	O
13/42	O	O	O
(	O	O	O
31	O	O	O
%	O	O	O
)	O	O	O
showed	O	O	O
>	O	O	O
30	O	O	O
%	O	O	O
improvement	O	O	B-T077
on	O	O	O
the	O	O	O
CAPS	O	O	B-T170
,	O	O	O
versus	O	O	O
16/43	O	O	O
(	O	O	O
37	O	O	O
%	O	O	O
)	O	O	O
who	O	O	O
received	O	O	O
CET	O	O	B-T061
.	O	O	O

Three	O	O	O
months	O	O	B-T079
after	O	O	O
treatment	O	O	B-T061
,	O	O	O
>	O	O	O
30	O	O	O
%	O	O	O
improvement	O	O	B-T077
was	O	O	O
seen	O	O	O
in	O	O	O
10/33	O	O	O
(	O	O	O
30	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
VRET	O	O	B-T061
participants	O	O	B-T098
and	O	O	O
12/33	O	O	O
(	O	O	O
36	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
CET	O	O	B-T061
.	O	O	O

Participants	O	O	B-T098
who	O	O	O
crossed	O	O	B-T033
over	O	O	I-T033
(	O	O	O
n	O	O	O
=	O	O	O
11	O	O	O
)	O	O	O
showed	O	O	O
no	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
improvements	O	O	B-T077
in	O	O	O
a	O	O	O
second	O	O	B-T081
round	O	O	O
of	O	O	O
treatment	O	O	B-T061
,	O	O	O
regardless	O	O	B-T080
of	O	O	O
condition	O	O	B-T080
.	O	O	O

This	O	O	O
study	O	O	B-T062
supported	O	O	B-T077
the	O	O	O
utility	O	O	B-T169
of	O	O	O
exposure	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
PTSD	O	O	B-T048
,	O	O	O
but	O	O	O
did	O	O	O
not	O	O	O
support	O	O	B-T077
additional	O	O	B-T169
benefit	O	O	B-T081
by	O	O	O
the	O	O	O
inclusion	O	O	B-T080
of	O	O	O
virtual	O	O	B-T066
reality	O	O	I-T066
.	O	O	O

-DOCSTART- (28394503)

Accounting	O	O	B-UnknownType
for	O	O	O
linkage	O	O	B-T081
disequilibrium	O	O	I-T081
in	O	O	O
genome	O	O	B-T061
scans	O	O	I-T061
for	O	O	O
selection	O	O	B-T045
without	O	O	B-T080
individual	O	O	B-T080
genotypes	O	O	B-T032
:	O	O	O
The	O	O	O
local	O	O	O
score	O	O	O
approach	O	O	O

Detecting	O	O	B-T063
genomic	O	O	I-T063
footprints	O	O	I-T063
of	O	O	O
selection	O	O	B-T045
is	O	O	O
an	O	O	O
important	O	O	O
step	O	O	O
in	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
evolution	O	O	B-T045
.	O	O	O

Accounting	O	O	O
for	O	O	O
linkage	O	O	B-T081
disequilibrium	O	O	I-T081
in	O	O	O
genome	O	O	B-T061
scans	O	O	I-T061
increases	O	O	O
detection	O	O	B-T061
power	O	O	B-T081
,	O	O	O
but	O	O	O
haplotype	O	O	B-T032
-based	O	O	O
methods	O	O	O
require	O	O	O
individual	O	O	B-T080
genotypes	O	O	B-T032
and	O	O	O
are	O	O	O
not	O	O	O
applicable	O	O	O
on	O	O	O
pool-sequenced	O	O	B-T201
samples	O	O	I-T201
.	O	O	O

We	O	O	O
propose	O	O	O
to	O	O	O
take	O	O	O
advantage	O	O	O
of	O	O	O
the	O	O	O
local	O	O	B-T062
score	O	O	I-T062
approach	O	O	I-T062
to	O	O	O
account	O	O	O
for	O	O	O
linkage	O	O	B-T081
disequilibrium	O	O	I-T081
in	O	O	O
genome	O	O	B-T061
scans	O	O	I-T061
for	O	O	O
selection	O	O	B-T045
,	O	O	O
cumulating	O	O	B-T169
(	O	O	O
possibly	O	O	O
small	O	O	O
)	O	O	O
signals	O	O	B-T044
from	O	O	O
single	O	O	O
markers	O	O	B-T045
over	O	O	O
a	O	O	O
genomic	O	O	B-T077
segment	O	O	I-T077
,	O	O	O
to	O	O	O
clearly	O	O	O
pinpoint	O	O	O
a	O	O	O
selection	O	O	O
signal	O	O	B-T044
.	O	O	O

Using	O	O	O
computer	O	O	B-T066
simulations	O	O	I-T066
,	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
this	O	O	O
approach	O	O	O
detects	O	O	B-T033
selection	O	O	B-T045
with	O	O	O
higher	O	O	O
power	O	O	O
than	O	O	O
several	O	O	O
state-of-the-art	O	O	B-UnknownType
single-marker	O	O	B-T045
,	O	O	O
windowing	O	O	O
or	O	O	O
haplotype	O	O	B-T032
-based	O	O	O
approaches	O	O	O
.	O	O	O

We	O	O	O
illustrate	O	O	O
this	O	O	O
on	O	O	O
two	O	O	O
benchmark	O	O	B-T081
data	O	O	B-T170
sets	O	O	I-T170
including	O	O	O
individual	O	O	B-T080
genotypes	O	O	B-T032
,	O	O	O
for	O	O	O
which	O	O	O
we	O	O	O
obtain	O	O	O
similar	O	O	O
results	O	O	O
with	O	O	O
the	O	O	O
local	O	O	B-T062
score	O	O	I-T062
and	O	O	O
one	O	O	O
haplotype	O	O	B-T032
-based	O	O	O
approach	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
apply	O	O	O
the	O	O	O
local	O	O	B-T062
score	O	O	I-T062
approach	O	O	I-T062
to	O	O	O
Pool-Seq	O	O	B-T170
data	O	O	I-T170
obtained	O	O	O
from	O	O	O
a	O	O	O
divergent	O	O	B-T080
selection	O	O	B-T045
experiment	O	O	B-T062
on	O	O	O
behaviour	O	O	B-T053
in	O	O	O
quail	O	O	B-T012
and	O	O	O
obtain	O	O	O
precise	O	O	O
and	O	O	O
biologically	O	O	B-T080
coherent	O	O	B-T033
selection	O	O	O
signals	O	O	B-T044
:	O	O	O
while	O	O	O
competing	O	O	O
methods	O	O	O
fail	O	O	O
to	O	O	O
highlight	O	O	O
any	O	O	O
clear	O	O	O
selection	O	O	O
signature	O	O	O
,	O	O	O
our	O	O	O
method	O	O	O
detects	O	O	B-T033
several	O	O	O
regions	O	O	O
involving	O	O	O
genes	O	O	B-T028
known	O	O	O
to	O	O	O
act	O	O	O
on	O	O	O
social	O	O	B-T169
responsiveness	O	O	B-T169
or	O	O	O
autistic	O	O	B-T033
traits	O	O	I-T033
.	O	O	O

Although	O	O	O
we	O	O	O
focus	O	O	O
here	O	O	O
on	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
positive	O	O	B-T033
selection	O	O	B-T045
from	O	O	O
multiple	O	O	B-T170
population	O	O	I-T170
data	O	O	I-T170
,	O	O	O
the	O	O	O
local	O	O	B-T062
score	O	O	I-T062
approach	O	O	I-T062
is	O	O	O
general	O	O	O
and	O	O	O
can	O	O	O
be	O	O	O
applied	O	O	O
to	O	O	O
other	O	O	O
genome	O	O	B-T061
scans	O	O	I-T061
for	O	O	O
selection	O	O	O
or	O	O	O
other	O	O	O
genomewide	O	O	B-T063
analyses	O	O	I-T063
such	O	O	O
as	O	O	O
GWAS	O	O	B-T063
.	O	O	O

-DOCSTART- (28394602)

Is	O	O	O
UV	O	O	B-T070
-	O	O	O
Induced	O	O	B-T169
Electron-Driven	O	O	B-T070
Proton	O	O	I-T070
Transfer	O	O	I-T070
Active	O	O	B-T169
in	O	O	O
a	O	O	O
Chemically	O	O	B-T080
Modified	O	O	I-T080
A	O	O	B-T114
·	O	O	O
T	O	O	B-T114
DNA	O	O	B-T114
Base	O	O	B-T044
Pair	O	O	I-T044
?	O	O	O

Transient	O	O	B-T059
electronic	O	O	I-T059
and	O	O	I-T059
vibrational	O	O	I-T059
absorption	O	O	I-T059
spectroscopies	O	O	I-T059
have	O	O	O
been	O	O	O
used	O	O	O
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
UV	O	O	B-T070
-	O	O	O
induced	O	O	B-T169
electron-driven	O	O	B-T070
proton	O	O	I-T070
transfer	O	O	I-T070
(	O	O	O
EDPT	O	O	B-T070
)	O	O	O
mechanisms	O	O	B-T169
are	O	O	O
active	O	O	B-T169
in	O	O	O
a	O	O	O
chemically	O	O	B-T080
modified	O	O	I-T080
adenine	O	O	B-T114
-	O	O	O
thymine	O	O	B-T114
(	O	O	O
A	O	O	B-T114
·	O	O	O
T	O	O	B-T114
)	O	O	O
DNA	O	O	B-T114
base	O	O	B-T044
pair	O	O	I-T044
.	O	O	O

To	O	O	O
enhance	O	O	O
the	O	O	O
fraction	O	O	B-T081
of	O	O	I-T081
biologically	O	O	B-T080
relevant	O	O	I-T080
Watson-Crick	O	O	B-T070
(	O	O	I-T070
WC	O	O	I-T070
)	O	O	I-T070
hydrogen-bonding	O	O	I-T070
motifs	O	O	B-T086
and	O	O	O
eliminate	O	O	O
undesired	O	O	O
Hoogsteen	O	O	B-T104
structures	O	O	I-T104
,	O	O	O
a	O	O	O
chemically	O	O	B-T080
modified	O	O	I-T080
derivative	O	O	B-T169
of	O	O	I-T169
A	O	O	B-T114
was	O	O	O
synthesized	O	O	B-T052
,	O	O	O
8-(tert-butyl)-9-ethyladenine	O	O	B-T109
(	O	O	O
8tBA	O	O	B-T109
)	O	O	O
.	O	O	O

Equimolar	O	O	B-T167
solutions	O	O	I-T167
of	O	O	O
8tBA	O	O	B-T109
and	O	O	O
silyl-protected	O	O	B-T114
T	O	O	I-T114
nucleosides	O	O	B-T114
in	O	O	O
chloroform	O	O	B-T109
yield	O	O	B-T081
a	O	O	O
mixture	O	O	B-T167
of	O	O	O
WC	O	O	B-T044
pairs	O	O	I-T044
,	O	O	O
reverse	O	O	B-T044
WC	O	O	I-T044
pairs	O	O	I-T044
,	O	O	O
and	O	O	O
residual	O	O	B-T104
monomers	O	O	I-T104
.	O	O	O

Unlike	O	O	O
previous	O	O	O
transient	O	O	B-T059
absorption	O	O	I-T059
studies	O	O	I-T059
of	O	O	O
WC	O	O	O
guanine	O	O	B-T114
-	O	O	O
cytosin	O	O	B-T109
e	O	O	O
(	O	O	O
G	O	O	B-T114
·	O	O	O
C	O	O	B-T109
)	O	O	O
pairs	O	O	B-T044
,	O	O	O
no	O	O	O
clear	O	O	O
spectroscopic	O	O	B-T078
or	O	O	I-T078
kinetic	O	O	I-T078
evidence	O	O	I-T078
was	O	O	O
identified	O	O	B-T080
for	O	O	O
the	O	O	O
participation	O	O	B-T169
of	O	O	O
EDPT	O	O	B-T070
in	O	O	O
the	O	O	O
excited-state	O	O	B-T070
relaxation	O	O	I-T070
dynamics	O	O	I-T070
of	O	O	O
8tBA	O	O	B-T109
·	O	O	O
T	O	O	B-T114
pairs	O	O	O
,	O	O	O
although	O	O	O
ultrafast	O	O	B-T080
(	O	O	O
sub-100	O	O	O
fs	O	O	O
)	O	O	O
EDPT	O	O	O
can	O	O	O
not	O	O	O
be	O	O	O
discounted	O	O	O
.	O	O	O

Monomer-like	O	O	B-T070
dynamics	O	O	I-T070
are	O	O	O
proposed	O	O	O
to	O	O	O
dominate	O	O	O
in	O	O	O
8tBA	O	O	B-T109
·	O	O	O
T.	O	O	O

-DOCSTART- (28395554)

Monitoring	O	O	B-T058
proteolytic	O	O	B-T044
processing	O	O	I-T044
events	O	O	B-T051
by	O	O	O
quantitative	O	O	O
mass	O	O	O
spectrometry	O	O	O

Protease	O	O	B-T044
activity	O	O	I-T044
plays	O	O	O
a	O	O	O
key	O	O	O
role	O	O	B-T170
in	O	O	O
a	O	O	O
wide	O	O	O
variety	O	O	O
of	O	O	O
biological	O	O	B-T038
processes	O	O	I-T038
including	O	O	B-T169
gene	O	O	B-T045
expression	O	O	I-T045
,	O	O	O
protein	O	O	B-T044
turnover	O	O	I-T044
and	O	O	O
development	O	O	B-T040
.	O	O	O

misregulation	O	O	B-T033
of	O	O	O
these	O	O	O
proteins	O	O	B-T116
has	O	O	O
been	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
many	O	O	O
cancer	O	O	B-T033
types	O	O	I-T033
such	O	O	O
as	O	O	O
prostate	O	O	B-T191
,	O	O	O
breast	O	O	B-T191
,	O	O	O
and	O	O	O
skin	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

thus	O	O	O
,	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
protease	O	O	B-T116
substrates	O	O	B-T167
will	O	O	O
provide	O	O	B-T052
key	O	O	O
information	O	O	B-T078
to	O	O	O
understand	O	O	B-T041
proteolysis	O	O	B-T044
-related	O	O	O
pathologies	O	O	B-T091
.	O	O	O

Areas	O	O	O
covered	O	O	B-T169
:	O	O	O
Proteomics	O	O	B-T091
-based	O	O	O
methods	O	O	B-T170
to	O	O	O
investigate	O	O	B-T169
proteolysis	O	O	B-T044
activity	O	O	I-T044
,	O	O	I-T044
focusing	O	O	O
on	O	O	O
substrate	O	O	B-T167
identification	O	O	B-T080
,	O	O	O
protease	O	O	B-T116
specificity	O	O	B-UnknownType
and	O	O	O
their	O	O	O
applications	O	O	B-T061
in	O	O	O
systems	O	O	B-T091
biology	O	O	I-T091
are	O	O	O
reviewed	O	O	B-T080
.	O	O	O

Their	O	O	O
quantification	O	O	B-T081
strategies	O	O	O
,	O	O	O
challenges	O	O	B-T058
and	O	O	O
pitfalls	O	O	B-T080
are	O	O	O
underlined	O	O	O
and	O	O	O
the	O	O	O
biological	O	O	B-T080
implications	O	O	O
of	O	O	O
protease	O	O	B-T116
malfunction	O	O	B-T169
are	O	O	O
highlighted	O	O	O
.	O	O	O

Expert	O	O	B-T077
commentary	O	O	I-T077
:	O	O	O
Dysregulated	O	O	B-T033
protease	O	O	B-T044
activity	O	O	I-T044
is	O	O	O
a	O	O	O
hallmark	O	O	B-T080
for	O	O	O
some	O	O	O
disease	O	O	B-T047
pathologies	O	O	B-T091
such	O	O	O
as	O	O	O
cancer	O	O	B-T191
.	O	O	O

Current	O	O	B-T079
biochemical	O	O	B-T169
approaches	O	O	B-T169
are	O	O	O
low	O	O	B-T080
throughput	O	O	B-T081
and	O	O	O
some	O	O	O
are	O	O	O
limited	O	O	B-T169
by	O	O	O
the	O	O	O
amount	O	O	B-T081
of	O	O	O
sample	O	O	B-T077
required	O	O	B-T169
to	O	O	O
obtain	O	O	B-T169
reliable	O	O	O
results	O	O	B-T034
.	O	O	O

Mass	O	O	B-T059
spectrometry	O	O	I-T059
based	O	O	O
proteomics	O	O	B-T091
provides	O	O	B-T052
a	O	O	O
suitable	O	O	B-T080
platform	O	O	B-T075
to	O	O	O
investigate	O	O	B-T169
protease	O	O	B-T044
activity	O	O	I-T044
,	O	O	O
providing	O	O	B-T052
information	O	O	B-T078
about	O	O	O
substrate	O	O	B-T081
specificity	O	O	I-T081
and	O	O	O
mapping	O	O	B-T059
cleavage	O	O	B-T087
sites	O	O	I-T087
.	O	O	O

-DOCSTART- (28396744)

Diabetic	O	O	B-T047
nephropathy	O	O	I-T047
as	O	O	O
the	O	O	O
cause	O	O	B-T169
of	O	O	O
end-stage	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
reported	O	O	O
on	O	O	O
the	O	O	O
medical	O	O	B-T170
evidence	O	O	I-T170
form	O	O	I-T170
CMS2728	O	O	B-T170
at	O	O	O
a	O	O	O
single	O	O	O
center	O	O	O

Background	O	O	O
:	O	O	O
End-stage	O	O	B-T047
renal	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
ESRD	O	O	B-T047
)	O	O	O
incidence	O	O	B-T081
due	O	O	O
to	O	O	O
Type	O	O	B-T185
2	O	O	I-T185
diabetic	O	O	B-T047
nephropathy	O	O	I-T047
(	O	O	O
DN	O	O	B-T047
)	O	O	O
is	O	O	O
35	O	O	O
-	O	O	O
50	O	O	O
%	O	O	O
,	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
United	O	O	B-T073
States	O	O	I-T073
Renal	O	O	I-T073
Data	O	O	I-T073
System	O	O	I-T073
.	O	O	O

Methods	O	O	O
:	O	O	O
A	O	O	O
single-	O	O	O
center	O	O	B-T093
,	O	O	O
retrospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
to	O	O	O
determine	O	O	O
incidence	O	O	B-T081
and	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
for	O	O	O
Type	O	O	B-T185
2	O	O	I-T185
DN	O	O	B-T047
as	O	O	O
the	O	O	O
primary	O	O	B-T080
cause	O	O	B-T169
of	O	O	O
ESRD	O	O	B-T047
(	O	O	O
Code	O	O	O
250.40	O	O	O
)	O	O	O
on	O	O	O
the	O	O	O
Center	O	O	B-T093
for	O	O	I-T093
Medicare	O	O	I-T093
&	O	O	I-T093
Medicaid	O	O	I-T093
(	O	O	O
CMS	O	O	B-T093
)	O	O	O
Medical	O	O	B-T170
Evidence	O	O	I-T170
Report	O	O	I-T170
form	O	O	I-T170
(	O	O	O
CMS2728	O	O	B-T170
)	O	O	O
submitted	O	O	B-T169
at	O	O	O
renal	O	O	B-T061
replacement	O	O	I-T061
therapy	O	O	I-T061
initiation	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
≥18	O	O	O
years	O	O	B-T079
of	O	O	O
age	O	O	B-T032
with	O	O	O
a	O	O	O
CMS2728	O	O	B-T170
submitted	O	O	B-T169
between	O	O	O
1	O	O	O
March	O	O	O
2006	O	O	O
and	O	O	O
31	O	O	O
March	O	O	O
2015	O	O	O
at	O	O	O
a	O	O	O
single	O	O	O
academic	O	O	B-T093
military	O	O	I-T093
medical	O	O	I-T093
center	O	O	I-T093
(	O	O	O
ESRD	O	O	B-T047
Network	O	O	O
5	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

Medical	O	O	B-T170
records	O	O	I-T170
of	O	O	O
those	O	O	O
with	O	O	O
a	O	O	O
Code	O	O	O
250.40	O	O	O
diagnosis	O	O	B-T033
were	O	O	O
reviewed	O	O	B-T080
to	O	O	O
determine	O	O	O
whether	O	O	O
they	O	O	O
met	O	O	O
the	O	O	O
Kidney	O	O	B-T093
Disease	O	O	I-T093
Outcomes	O	O	I-T093
Quality	O	O	I-T093
Initiative	O	O	I-T093
(	O	O	O
KDOQI	O	O	B-T093
)	O	O	O
2007	O	O	O
criteria	O	O	B-T170
for	O	O	O
DN	O	O	B-T047
.	O	O	O

Results	O	O	O
:	O	O	O
ESRD	O	O	B-T047
incidence	O	O	B-T081
secondary	O	O	O
to	O	O	O
Type	O	O	B-T185
2	O	O	I-T185
DN	O	O	B-T047
was	O	O	O
18.7	O	O	O
%	O	O	O
(	O	O	O
56/299	O	O	O
individual	O	O	B-T098
CMS2728	O	O	B-T170
submissions	O	O	B-T169
over	O	O	O
9.09	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
all	O	O	O
,	O	O	O
12/56	O	O	O
(	O	O	O
21.4	O	O	O
%	O	O	O
)	O	O	O
did	O	O	O
not	O	O	O
meet	O	O	O
KDOQI	O	O	B-T170
criteria	O	O	I-T170
for	O	O	O
Type	O	O	B-T185
2	O	O	I-T185
DN	O	O	B-T047
.	O	O	O

Although	O	O	O
all	O	O	O
had	O	O	O
diabetes	O	O	B-T047
,	O	O	O
those	O	O	O
not	O	O	B-T077
meeting	O	O	I-T077
criteria	O	O	I-T077
had	O	O	O
shorter	O	O	O
disease	O	O	B-T079
duration	O	O	I-T079
(	O	O	O
P	O	O	O
=	O	O	O
0.007	O	O	O
)	O	O	O
,	O	O	O
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
active	O	O	B-T169
urine	O	O	B-T031
sediment	O	O	I-T031
(	O	O	O
P	O	O	O
=	O	O	O
0.006	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
were	O	O	O
less	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
macroalbuminuria	O	O	B-T033
(	O	O	O
P	O	O	O
=	O	O	O
0.037	O	O	O
)	O	O	O
or	O	O	O
retinopathy	O	O	B-T047
(	O	O	O
P	O	O	O
=	O	O	O
0.002	O	O	O
)	O	O	O
prior	O	O	O
to	O	O	O
ESRD	O	O	B-T047
.	O	O	O

On	O	O	O
exact	O	O	O
logistic	O	O	B-T062
regression	O	O	I-T062
,	O	O	O
retinopathy	O	O	B-T047
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
KDOQI	O	O	B-T093
-predicted	O	O	O
DN	O	O	B-T047
[	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
=	O	O	O
19.16	O	O	O
(	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
2.76	O	O	O
-	O	O	O
223.7	O	O	O
)	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.0009	O	O	O
]	O	O	O
.	O	O	O

Conclusions	O	O	B-T078
:	O	O	O
In	O	O	O
this	O	O	O
single-	O	O	O
center	O	O	B-T093
cohort	O	O	B-T062
,	O	O	O
21.4	O	O	O
%	O	O	O
identified	O	O	B-T080
as	O	O	O
having	O	O	O
Type	O	O	B-T185
2	O	O	I-T185
DN	O	O	B-T047
as	O	O	O
the	O	O	O
primary	O	O	B-T080
cause	O	O	B-T169
of	O	O	O
ESRD	O	O	B-T047
were	O	O	O
incorrectly	O	O	O
assigned	O	O	B-T169
per	O	O	O
KDOQI	O	O	B-T093
2007	O	O	O
clinical	O	O	B-T080
criteria	O	O	B-T170
.	O	O	O

If	O	O	O
replicated	O	O	B-T169
in	O	O	O
larger	O	O	B-T081
populations	O	O	B-T098
,	O	O	O
this	O	O	O
could	O	O	O
have	O	O	O
substantial	O	O	O
implications	O	O	O
regarding	O	O	O
the	O	O	O
epidemiology	O	O	B-T091
of	O	O	O
ESRD	O	O	B-T047
in	O	O	O
the	O	O	O
USA	O	O	B-T083
.	O	O	O

-DOCSTART- (28397533)

Socioeconomic	O	O	B-T077
Predictors	O	O	B-T078
of	O	O	O
Adherence	O	O	B-T033
Behavior	O	O	I-T033
Among	O	O	O
HIV-Positive	O	O	B-T034
Patients	O	O	B-T101
Receiving	O	O	B-T080
Antiretroviral	O	O	B-T061
Therapy	O	O	I-T061
in	O	O	O
Selangor	O	O	B-T083
,	O	O	O
Malaysia	O	O	O

Medication	O	O	B-T033
adherence	O	O	I-T033
remains	O	O	O
a	O	O	O
critical	O	O	B-T080
link	O	O	O
between	O	O	O
the	O	O	O
prescribed	O	O	B-T058
ART	O	O	B-T061
regimen	O	O	B-T061
and	O	O	O
treatment	O	O	B-T080
outcome	O	O	I-T080
.	O	O	O

Several	O	O	B-T081
factors	O	O	B-T169
may	O	O	O
influence	O	O	B-T077
adherence	O	O	B-T033
behavior	O	O	I-T033
.	O	O	O

This	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
aimed	O	O	B-T078
to	O	O	O
highlight	O	O	O
socioeconomic	O	O	B-T077
predictors	O	O	B-T078
of	O	O	O
adherence	O	O	B-T033
behavior	O	O	I-T033
among	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
242	O	O	O
adult	O	O	B-T100
Malaysian	O	O	B-T098
patients	O	O	B-T101
receiving	O	O	B-T080
antiretroviral	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
Hospital	O	O	B-T093
Sungai	O	O	I-T093
Buloh	O	O	I-T093
,	O	O	O
Malaysia	O	O	B-T083
,	O	O	O
where	O	O	O
they	O	O	O
were	O	O	O
enrolled	O	O	O
in	O	O	O
a	O	O	O
parent	O	O	O
study	O	O	O
(	O	O	O
single-blinded	O	O	B-T062
randomized	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
)	O	O	O
between	O	O	O
January	O	O	B-T080
and	O	O	O
December	O	O	B-T080
2014	O	O	O
.	O	O	O

Statistical	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
secondary	O	O	B-UnknownType
data	O	O	I-UnknownType
on	O	O	O
adherence	O	O	B-T033
behavior	O	O	I-T033
and	O	O	O
sociodemographic	O	O	B-T102
characteristics	O	O	I-T102
of	O	O	O
the	O	O	O
patients	O	O	B-T101
revealed	O	O	B-T080
mean	O	O	B-T033
age	O	O	I-T033
of	O	O	O
33.4	O	O	O
years	O	O	B-T079
and	O	O	O
ranged	O	O	B-T081
from	O	O	O
18	O	O	O
to	O	O	O
64	O	O	O
years	O	O	O
;	O	O	O
88.8	O	O	O
%	O	O	O
were	O	O	O
males	O	O	B-T032
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
224	O	O	O
(	O	O	O
93	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
who	O	O	O
completed	O	O	O
6	O	O	O
months	O	O	O
'	O	O	O
adherence	O	O	B-T058
assessment	O	O	I-T058
were	O	O	O
included	O	O	B-T169
in	O	O	O
the	O	O	O
model	O	O	O
.	O	O	O

Of	O	O	O
these	O	O	O
,	O	O	O
135	O	O	O
(	O	O	O
60.3	O	O	O
%	O	O	O
)	O	O	O
achieved	O	O	B-T033
optimal	O	O	B-T080
adherence	O	O	B-T169
.	O	O	O

Multivariate	O	O	B-T170
binary	O	O	I-T170
logistic	O	O	I-T170
regression	O	O	I-T170
analysis	O	O	I-T170
revealed	O	O	B-T080
that	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
income	O	O	B-T081
and	O	O	O
ethnicity	O	O	B-T080
were	O	O	O
significant	O	O	B-T078
predictors	O	O	B-T078
of	O	O	O
adherence	O	O	B-T033
behavior	O	O	I-T033
.	O	O	O

This	O	O	O
may	O	O	O
be	O	O	O
valuable	O	O	O
for	O	O	O
targeted	O	O	B-T169
programmatic	O	O	B-T061
interventions	O	O	I-T061
to	O	O	O
further	O	O	O
enhance	O	O	B-T052
successful	O	O	B-T201
treatment	O	O	I-T201
outcomes	O	O	B-T169
among	O	O	O
the	O	O	O
target	O	O	B-T098
population	O	O	I-T098
.	O	O	O

-DOCSTART- (28399372)

A	O	O	O
Tobramycin	O	O	B-T195
Vector	O	O	I-T195
Enhances	O	O	B-T052
Synergy	O	O	B-T034
and	O	O	O
Efficacy	O	O	B-T080
of	O	O	O
Efflux	O	O	B-T121
Pump	O	O	I-T121
Inhibitors	O	O	I-T121
against	O	O	B-T080
Multidrug-Resistant	O	O	B-T032
Gram-Negative	O	O	O
Bacteria	O	O	O

Drug	O	O	B-T044
efflux	O	O	I-T044
mechanisms	O	O	B-T169
interact	O	O	B-T044
synergistically	O	O	B-T080
with	O	O	O
the	O	O	O
outer	O	O	B-T026
membrane	O	O	I-T026
permeability	O	O	B-T043
barrier	O	O	B-T046
of	O	O	O
Gram-negative	O	O	B-T007
bacteria	O	O	I-T007
,	O	O	O
leading	O	O	B-T169
to	O	O	O
intrinsic	O	O	B-T082
resistance	O	O	B-T169
that	O	O	O
presents	O	O	O
a	O	O	O
major	O	O	B-T080
challenge	O	O	B-T058
for	O	O	O
antibiotic	O	O	B-T195
drug	O	O	B-T062
development	O	O	I-T062
.	O	O	O

Efflux	O	O	B-T121
pump	O	O	I-T121
inhibitors	O	O	I-T121
(	O	O	O
EPIs	O	O	B-T121
)	O	O	O
which	O	O	O
block	O	O	B-T169
the	O	O	O
efflux	O	O	B-T044
of	O	O	O
antibiotics	O	O	B-T195
synergize	O	O	B-T080
antibiotics	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
clinical	O	O	B-T062
development	O	O	I-T062
of	O	O	O
EPI	O	O	B-T121
/	O	O	O
antibiotic	O	O	B-T195
combination	O	O	B-T061
therapy	O	O	I-T061
to	O	O	O
treat	O	O	B-T061
multidrug-resistant	O	O	B-T032
(	O	O	O
MDR	O	O	B-T032
)	O	O	O
Gram-negative	O	O	B-T047
infections	O	O	I-T047
has	O	O	O
been	O	O	O
challenging	O	O	B-T058
.	O	O	O

This	O	O	O
is	O	O	O
in	O	O	O
part	O	O	O
caused	O	O	B-T169
by	O	O	O
the	O	O	O
inefficiency	O	O	B-T033
of	O	O	O
current	O	O	B-T079
EPIs	O	O	B-T121
to	O	O	O
penetrate	O	O	B-T169
the	O	O	O
outer	O	O	B-T026
membrane	O	O	I-T026
and	O	O	O
resist	O	O	B-T169
efflux	O	O	B-T044
.	O	O	O

We	O	O	O
demonstrate	O	O	O
that	O	O	O
conjugation	O	O	B-T043
of	O	O	O
a	O	O	O
tobramycin	O	O	B-T195
(	O	O	O
TOB	O	O	B-T195
)	O	O	O
vector	O	O	O
to	O	O	O
EPIs	O	O	B-T121
like	O	O	O
NMP	O	O	B-T109
,	O	O	O
paroxetine	O	O	B-T109
,	O	O	O
or	O	O	O
DBP	O	O	B-T201
enhances	O	O	B-T052
synergy	O	O	B-T034
and	O	O	O
efficacy	O	O	B-T080
of	O	O	O
EPIs	O	O	O
in	O	O	O
combination	O	O	B-T080
with	O	O	O
tetracycline	O	O	B-T195
antibiotics	O	O	I-T195
against	O	O	O
MDR	O	O	B-T032
Gram-negative	O	O	B-T007
bacteria	O	O	I-T007
including	O	O	O
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
.	O	O	O

Besides	O	O	O
potentiating	O	O	B-T044
tetracycline	O	O	B-T195
antibiotics	O	O	I-T195
,	O	O	O
TOB	O	O	B-T195
-	O	O	O
EPI	O	O	B-T121
conjugates	O	O	B-T104
can	O	O	O
also	O	O	O
suppress	O	O	B-T169
resistance	O	O	B-T169
development	O	O	B-T169
to	O	O	O
the	O	O	O
tetracycline	O	O	B-T195
antibiotic	O	O	I-T195
minocycline	O	O	B-T195
,	O	O	O
thereby	O	O	O
providing	O	O	B-T052
a	O	O	O
strategy	O	O	B-T041
to	O	O	O
develop	O	O	B-T169
more	O	O	O
effective	O	O	B-T080
adjuvants	O	O	B-T120
to	O	O	O
rescue	O	O	O
tetracycline	O	O	O
antibiotics	O	O	O
from	O	O	O
resistance	O	O	O
in	O	O	O
MDR	O	O	B-T032
Gram-negative	O	O	B-T007
bacteria	O	O	I-T007
.	O	O	O

-DOCSTART- (28400582)

Detection	O	O	B-T061
of	O	O	O
AMA-M2	O	O	B-T116
in	O	O	O
human	O	O	B-T016
saliva	O	O	B-T031
:	O	O	O
Potentials	O	O	B-T080
in	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
monitoring	O	O	B-T058
of	O	O	O
primary	O	O	O
biliary	O	O	O
cholangitis	O	O	O

Serum	O	O	B-T031
anti-mitochondrial	O	O	B-T116
antibody	O	O	I-T116
type	O	O	I-T116
2	O	O	I-T116
(	O	O	O
AMA-M2	O	O	B-T116
)	O	O	O
is	O	O	O
considered	O	O	O
as	O	O	O
a	O	O	O
pivotal	O	O	O
biomarker	O	O	B-T201
for	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
primary	O	O	B-T047
biliary	O	O	I-T047
cholangitis	O	O	I-T047
(	O	O	O
PBC	O	O	B-T047
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
serological	O	O	B-T059
tests	O	O	I-T059
have	O	O	O
many	O	O	O
limitations	O	O	B-T169
,	O	O	O
including	O	O	O
inconvenience	O	O	B-T033
,	O	O	O
invasiveness	O	O	B-T080
,	O	O	O
and	O	O	O
infection	O	O	B-T033
risks	O	O	I-T033
.	O	O	O

Thus	O	O	O
,	O	O	O
a	O	O	O
less	O	O	B-T080
invasive	O	O	B-T080
approach	O	O	B-T082
to	O	O	O
detect	O	O	B-T033
AMA-M2	O	O	B-T059
titer	O	O	I-T059
is	O	O	O
desirable	O	O	O
.	O	O	O

We	O	O	O
examined	O	O	O
salivary	O	O	B-T031
AMA-M2	O	O	B-T116
of	O	O	O
potential	O	O	B-T080
PBC	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
found	O	O	O
that	O	O	O
AMA-M2	O	O	O
could	O	O	O
be	O	O	O
detected	O	O	B-T033
only	O	O	O
in	O	O	O
saliva	O	O	B-T031
of	O	O	O
serum	O	O	B-T031
AMA-M2-positive	O	O	B-T033
PBC	O	O	O
patients	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
in	O	O	O
saliva	O	O	O
of	O	O	O
serum	O	O	O
AMA-M2-negative	O	O	B-T033
PBC	O	O	O
patients	O	O	O
,	O	O	O
oral	O	O	B-T047
lichen	O	O	I-T047
planus	O	O	I-T047
patients	O	O	O
(	O	O	O
OLP	O	O	B-T047
)	O	O	O
patients	O	O	O
,	O	O	O
or	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
concentration	O	O	B-T081
of	O	O	O
salivary	O	O	B-T031
AMA-M2	O	O	B-T116
was	O	O	O
positively	O	O	B-T080
correlated	O	O	I-T080
with	O	O	O
the	O	O	O
amount	O	O	B-T081
of	O	O	O
serum	O	O	B-T031
AMA-M2	O	O	O
in	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
salivary	O	O	B-T031
inflammatory	O	O	B-T116
cytokines	O	O	I-T116
were	O	O	O
increased	O	O	B-T081
in	O	O	O
the	O	O	O
PBC	O	O	B-T047
,	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
the	O	O	O
results	O	O	B-T169
of	O	O	O
serum	O	O	B-T031
test	O	O	B-T059
.	O	O	O

These	O	O	O
findings	O	O	O
indicated	O	O	O
that	O	O	O
saliva	O	O	B-T031
might	O	O	O
be	O	O	O
a	O	O	O
less	O	O	B-T080
invasive	O	O	B-T080
and	O	O	O
cost-effective	O	O	B-T057
medium	O	O	B-T167
to	O	O	O
accurately	O	O	O
test	O	O	B-T169
for	O	O	O
AMA-M2	O	O	B-T059
levels	O	O	I-T059
and	O	O	O
this	O	O	O
is	O	O	O
a	O	O	O
promising	O	O	O
development	O	O	B-T169
for	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
monitoring	O	O	B-T058
of	O	O	O
PBC	O	O	B-T047
.	O	O	O

-DOCSTART- (28402002)

Mental	O	O	B-T041
health	O	O	I-T041
and	O	O	O
associated	O	O	B-T080
factors	O	O	B-T169
among	O	O	O
young	O	O	B-T079
offenders	O	O	B-T098
in	O	O	O
Chile	O	O	B-T083
:	O	O	O
a	O	O	O
cross-sectional	O	O	O
study	O	O	O

Few	O	O	O
studies	O	O	O
in	O	O	O
Latin	O	O	B-T083
America	O	O	I-T083
have	O	O	O
explored	O	O	O
mental	O	O	B-T048
disorder	O	O	I-T048
among	O	O	O
young	O	O	B-T079
offenders	O	O	B-T098
,	O	O	O
or	O	O	O
variables	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
it	O	O	O
.	O	O	O

Our	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
test	O	O	O
for	O	O	O
associations	O	O	B-T080
between	O	O	O
childhood	O	O	B-T079
adversity	O	O	B-T077
or	O	O	O
substance	O	O	B-T033
misuse	O	O	I-T033
and	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
among	O	O	O
young	O	O	B-T079
offenders	O	O	B-T098
.	O	O	O

Sentenced	O	O	B-T064
adolescent	O	O	B-T100
offenders	O	O	B-T098
were	O	O	O
recruited	O	O	B-T052
from	O	O	O
young	O	O	B-T079
offenders	O	O	B-T098
'	O	O	I-T098
institutions	O	O	B-T073
or	O	O	O
community	O	O	B-T058
centres	O	O	I-T058
provided	O	O	O
by	O	O	O
the	O	O	O
Chilean	O	O	B-UnknownType
National	O	O	I-UnknownType
Service	O	O	I-UnknownType
for	O	O	I-UnknownType
Minors	O	O	I-UnknownType
.	O	O	O

Psychiatric	O	O	B-T048
disorders	O	O	I-T048
were	O	O	O
assessed	O	O	B-T052
using	O	O	O
the	O	O	O
Mini	O	O	B-T060
International	O	O	I-T060
Neuropsychiatric	O	O	I-T060
Interview	O	O	I-T060
,	O	O	O
conducted	O	O	O
by	O	O	O
trained	O	O	B-T097
psychologists	O	O	I-T097
.	O	O	O

A	O	O	O
trained	O	O	B-T097
sociologist	O	O	I-T097
used	O	O	O
an	O	O	O
ad	O	O	B-T052
hoc	O	O	I-T052
interview	O	O	I-T052
to	O	O	O
collect	O	O	O
information	O	O	B-T078
about	O	O	O
childhood	O	O	B-T201
experiences	O	O	I-T201
,	O	O	O
including	O	O	O
parenting	O	O	B-T033
,	O	O	O
trauma	O	O	B-T037
,	O	O	O
education	O	O	B-T185
and	O	O	O
substance	O	O	B-T033
misuse	O	O	I-T033
.	O	O	O

Multivariable	O	O	B-T062
logistic	O	O	I-T062
regressions	O	O	I-T062
were	O	O	O
used	O	O	O
to	O	O	O
analyse	O	O	B-T081
data	O	O	I-T081
.	O	O	O

The	O	O	O
most	O	O	O
prevalent	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
among	O	O	O
the	O	O	O
935	O	O	O
participants	O	O	B-T098
were	O	O	O
marijuana	O	O	B-T048
dependence	O	O	I-T048
disorder	O	O	I-T048
,	O	O	O
major	O	O	B-T048
depressive	O	O	I-T048
disorder	O	O	I-T048
,	O	O	O
and	O	O	O
anxiety	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Substance	O	O	B-T048
use	O	O	I-T048
disorders	O	O	I-T048
were	O	O	O
less	O	O	O
frequent	O	O	B-T079
among	O	O	O
young	O	O	B-T079
offenders	O	O	B-T098
who	O	O	O
were	O	O	O
serving	O	O	O
their	O	O	O
sentence	O	O	B-T033
in	O	O	O
young	O	O	O
offenders	O	O	B-T098
'	O	O	I-T098
institutions	O	O	B-T073
than	O	O	O
among	O	O	O
those	O	O	O
serving	O	O	O
in	O	O	O
community	O	O	B-T058
centres	O	O	I-T058
and	O	O	O
more	O	O	O
frequent	O	O	O
among	O	O	O
those	O	O	O
who	O	O	O
started	O	O	B-T080
to	O	O	O
use	O	O	B-T048
marijuana	O	O	I-T048
at	O	O	O
an	O	O	O
earlier	O	O	B-T032
age	O	O	I-T032
.	O	O	O

Among	O	O	O
other	O	O	O
variables	O	O	B-T081
,	O	O	O
childhood	O	O	B-T048
maltreatment	O	O	I-T048
was	O	O	O
related	O	O	O
to	O	O	O
major	O	O	B-T048
depressive	O	O	I-T048
disorder	O	O	I-T048
,	O	O	O
and	O	O	O
maternal	O	O	B-T040
death	O	O	I-T040
to	O	O	O
anxiety	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Higher	O	O	O
educational	O	O	B-T033
status	O	O	I-T033
was	O	O	O
related	O	O	O
to	O	O	O
a	O	O	O
lower	O	O	B-T079
frequency	O	O	I-T079
of	O	O	O
depressive	O	O	B-T048
and	O	O	O
anxiety	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
suggest	O	O	B-T078
that	O	O	O
greater	O	O	O
efforts	O	O	O
must	O	O	O
be	O	O	O
made	O	O	O
to	O	O	O
identify	O	O	B-T080
vulnerable	O	O	B-T169
young	O	O	B-T079
people	O	O	B-T098
much	O	O	O
earlier	O	O	B-T079
.	O	O	O

Few	O	O	B-T081
of	O	O	O
these	O	O	O
young	O	O	B-T079
offenders	O	O	B-T098
with	O	O	O
mental	O	O	B-T041
health	O	O	B-T078
problems	O	O	B-T033
had	O	O	O
been	O	O	O
well	O	O	O
adjusted	O	O	B-T169
in	O	O	O
health	O	O	O
,	O	O	O
education	O	O	B-T185
or	O	O	O
socially	O	O	B-T054
before	O	O	O
this	O	O	O
period	O	O	B-T079
of	O	O	O
detention	O	O	B-T064
.	O	O	O

©	O	O	O
2017	O	O	O
The	O	O	O
Authors	O	O	O
.	O	O	O

Criminal	O	O	O
Behaviour	O	O	O
and	O	O	O
Mental	O	O	O
Health	O	O	O
Published	O	O	O
by	O	O	O
John	O	O	O
Wiley	O	O	O
&	O	O	O
Sons	O	O	O
Ltd.	O	O	O

-DOCSTART- (28402055)

Effects	O	O	B-T080
of	O	O	I-T080
regular	O	O	B-T080
water	O	O	B-T056
-	O	O	O
and	O	O	O
land-based	O	O	B-T056
exercise	O	O	I-T056
on	O	O	O
physical	O	O	B-T033
function	O	O	I-T033
after	O	O	O
5	O	O	O
years	O	O	B-T079
:	O	O	O
A	O	O	O
long-term	O	O	B-T062
study	O	O	I-T062
on	O	O	O
the	O	O	O
well-being	O	O	O
of	O	O	O
older	O	O	B-T098
Japanese	O	O	I-T098
adults	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	O
5	O	O	O
years	O	O	B-T079
of	O	O	O
physical	O	O	B-T056
exercise	O	O	I-T056
on	O	O	O
functional	O	O	B-T169
parameters	O	O	B-T077
among	O	O	O
older	O	O	B-T098
Japanese	O	O	I-T098
adults	O	O	B-T098
who	O	O	O
carried	O	O	O
out	O	O	O
water	O	O	B-T056
-	O	O	O
or	O	O	O
land-based	O	O	B-T056
exercise	O	O	I-T056
.	O	O	O

We	O	O	O
retrospectively	O	O	B-T080
investigated	O	O	B-T169
data	O	O	B-T078
from	O	O	O
5707	O	O	O
medical	O	O	B-T058
examinations	O	O	I-T058
and	O	O	O
enrolled	O	O	B-T058
77	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
into	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

Eligible	O	O	O
participants	O	O	B-T098
had	O	O	O
to	O	O	O
be	O	O	O
aged	O	O	B-T032
≥60	O	O	O
years	O	O	B-T079
,	O	O	O
and	O	O	O
engaged	O	O	O
in	O	O	O
water-based	O	O	B-T056
exercise	O	O	I-T056
(	O	O	O
n	O	O	O
=	O	O	O
38	O	O	O
)	O	O	O
or	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
water	O	O	B-T056
-	O	O	O
and	O	O	O
land-based	O	O	B-T056
exercise	O	O	I-T056
(	O	O	O
n	O	O	O
=	O	O	O
39	O	O	O
)	O	O	O
for	O	O	O
at	O	O	O
least	O	O	O
80	O	O	O
%	O	O	O
of	O	O	O
their	O	O	O
total	O	O	B-T079
exercise	O	O	I-T079
time	O	O	I-T079
for	O	O	O
over	O	O	O
5	O	O	O
years	O	O	O
at	O	O	O
our	O	O	O
fitness	O	O	B-T093
center	O	O	I-T093
.	O	O	O

In	O	O	O
statistical	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
a	O	O	O
two-way	O	O	B-T081
repeated-measures	O	O	I-T081
analysis	O	O	I-T081
of	O	O	I-T081
variance	O	O	I-T081
was	O	O	O
carried	O	O	O
out	O	O	O
to	O	O	O
examine	O	O	B-T033
the	O	O	O
effects	O	O	B-T080
over	O	O	O
time	O	O	B-T079
and	O	O	O
by	O	O	O
exercise	O	O	B-T033
type	O	O	I-T033
,	O	O	O
and	O	O	O
the	O	O	O
changes	O	O	B-T169
in	O	O	O
each	O	O	O
parameter	O	O	B-T077
over	O	O	O
5	O	O	O
years	O	O	B-T079
were	O	O	O
also	O	O	O
compared	O	O	B-T052
between	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T078
.	O	O	O

We	O	O	O
found	O	O	B-T033
significant	O	O	B-T078
main	O	O	B-T080
effects	O	O	B-T080
and	O	O	O
an	O	O	O
interaction	O	O	B-T169
between	O	O	O
time	O	O	B-T079
and	O	O	O
exercise	O	O	B-T033
type	O	O	I-T033
for	O	O	O
gait	O	O	B-T032
speed	O	O	I-T032
,	O	O	O
with	O	O	O
an	O	O	O
early	O	O	B-T081
decline	O	O	I-T081
in	O	O	O
the	O	O	O
combined	O	O	B-T080
exercise	O	O	B-T078
group	O	O	I-T078
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
significant	O	O	O
main	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
time	O	O	O
,	O	O	O
showing	O	O	O
a	O	O	O
functional	O	O	B-T033
decline	O	O	I-T033
in	O	O	O
grip	O	O	B-T081
strength	O	O	I-T081
,	O	O	O
one-leg	O	O	B-T082
standing	O	O	I-T082
time	O	O	O
and	O	O	O
step/height	O	O	B-T033
ratio	O	O	B-T081
in	O	O	O
both	O	O	O
exercise	O	O	B-T033
types	O	O	I-T033
at	O	O	O
the	O	O	O
5-	O	O	O
year	O	O	B-T079
follow	O	O	B-T058
up	O	O	I-T058
.	O	O	O

The	O	O	O
5-	O	O	O
year	O	O	B-T079
changes	O	O	B-T169
in	O	O	O
each	O	O	O
parameter	O	O	B-T077
did	O	O	O
not	O	O	O
differ	O	O	O
between	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T078
despite	O	O	O
the	O	O	O
frequency	O	O	B-T033
of	O	O	I-T033
exercise	O	O	I-T033
,	O	O	O
even	O	O	O
though	O	O	O
we	O	O	O
found	O	O	B-T033
a	O	O	O
negative	O	O	B-T033
correlation	O	O	B-T080
between	O	O	O
changes	O	O	O
in	O	O	O
one-leg	O	O	B-T082
standing	O	O	I-T082
time	O	O	B-T079
and	O	O	O
total	O	O	B-T080
amount	O	O	B-T081
of	O	O	O
water-based	O	O	B-T056
exercise	O	O	I-T056
.	O	O	O

Contrary	O	O	O
to	O	O	O
expectations	O	O	B-T078
,	O	O	O
these	O	O	O
results	O	O	B-T169
suggest	O	O	B-T078
that	O	O	O
regular	O	O	B-T080
engagement	O	O	O
in	O	O	O
water-based	O	O	B-T056
exercise	O	O	I-T056
,	O	O	O
even	O	O	O
combined	O	O	B-T080
with	O	O	O
land-based	O	O	B-T056
exercise	O	O	I-T056
,	O	O	O
might	O	O	O
have	O	O	O
poor	O	O	O
long-term	O	O	B-T079
benefits	O	O	B-T081
for	O	O	O
maintaining	O	O	B-T169
physical	O	O	B-T032
performance	O	O	I-T032
in	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
.	O	O	O

Geriatr	O	O	O
Gerontol	O	O	O
Int	O	O	O
2017	O	O	O
;	O	O	O
••	O	O	O
:	O	O	O
••-••.	O	O	O

-DOCSTART- (28402232)

Combined	O	O	B-T080
exposures	O	O	B-T037
of	O	O	O
whole-body	O	O	B-T033
vibration	O	O	I-T033
and	O	O	O
awkward	O	O	B-T033
posture	O	O	I-T033
:	O	O	O
a	O	O	O
cross	O	O	B-T062
sectional	O	O	I-T062
investigation	O	O	I-T062
among	O	O	O
occupational	O	O	B-T090
drivers	O	O	B-T098
by	O	O	O
means	O	O	O
of	O	O	O
simultaneous	O	O	B-T079
field	O	O	O
measurements	O	O	O

Multifactorial	O	O	B-T033
workloads	O	O	B-T081
such	O	O	O
as	O	O	O
whole-body	O	O	B-T033
vibration	O	O	I-T033
(	O	O	O
WBV	O	O	B-T033
)	O	O	O
,	O	O	O
awkward	O	O	B-T033
posture	O	O	I-T033
and	O	O	O
heavy	O	O	O
lifting	O	O	B-T052
are	O	O	O
potential	O	O	B-T080
predictors	O	O	B-T033
for	O	O	O
low	O	O	B-T184
back	O	O	I-T184
pain	O	O	I-T184
(	O	O	O
LBP	O	O	B-T184
)	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
investigate	O	O	B-T169
the	O	O	O
association	O	O	B-T080
between	O	O	O
LBP	O	O	B-T184
and	O	O	O
these	O	O	O
exposures	O	O	B-T037
among	O	O	O
102	O	O	O
professional	O	O	B-T090
drivers	O	O	B-T098
.	O	O	O

The	O	O	O
combined	O	O	B-T080
exposures	O	O	B-T037
of	O	O	O
WBV	O	O	B-T033
and	O	O	O
posture	O	O	O
are	O	O	O
measured	O	O	B-T080
at	O	O	O
different	O	O	B-T080
workplaces	O	O	B-T082
.	O	O	O

Health	O	O	B-T078
and	O	O	O
personal	O	O	O
data	O	O	B-T078
as	O	O	O
well	O	O	O
as	O	O	O
information	O	O	B-T078
about	O	O	O
lifting	O	O	B-T052
tasks	O	O	B-T057
are	O	O	O
collected	O	O	B-T169
by	O	O	O
a	O	O	O
questionnaire	O	O	B-T170
.	O	O	O

The	O	O	O
daily	O	O	B-T079
vibration	O	O	B-T037
exposure	O	O	I-T037
value	O	O	B-T081
(	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
1.69	O	O	O
)	O	O	O
and	O	O	O
an	O	O	O
index	O	O	B-T081
for	O	O	O
awkward	O	O	B-T033
posture	O	O	I-T033
(	O	O	O
odds	O	O	O
ratio	O	O	O
1.63	O	O	O
)	O	O	O
show	O	O	O
significant	O	O	B-T078
association	O	O	B-T080
with	O	O	O
the	O	O	O
occurence	O	O	B-T079
of	O	O	O
LBP	O	O	B-T184
.	O	O	O

Awkward	O	O	B-T033
posture	O	O	I-T033
and	O	O	O
heavy	O	O	O
lifting	O	O	B-T052
appear	O	O	B-T080
to	O	O	O
be	O	O	O
more	O	O	O
strongly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
sick	O	O	B-T078
leave	O	O	I-T078
than	O	O	O
WBV	O	O	B-T033
exposure	O	O	B-T037
.	O	O	O

Furthermore	O	O	O
,	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
the	O	O	O
measurement	O	O	B-T169
results	O	O	B-T169
of	O	O	O
WBV	O	O	B-T033
and	O	O	O
awkward	O	O	B-T033
posture	O	O	I-T033
into	O	O	O
one	O	O	O
quantity	O	O	B-T081
also	O	O	O
shows	O	O	O
significant	O	O	B-T078
correlation	O	O	B-T080
to	O	O	O
LBP	O	O	B-T184
.	O	O	O

The	O	O	O
combined	O	O	B-T080
exposure	O	O	B-T037
of	O	O	O
WBV	O	O	B-T033
and	O	O	O
awkward	O	O	B-T033
posture	O	O	I-T033
can	O	O	O
be	O	O	O
described	O	O	B-T078
in	O	O	O
terms	O	O	O
of	O	O	O
the	O	O	O
daily	O	O	B-T079
vibration	O	O	B-T037
exposure	O	O	I-T037
and	O	O	O
the	O	O	O
index	O	O	B-T081
for	O	O	O
awkward	O	O	O
posture	O	O	O
.	O	O	O

This	O	O	O
facilitates	O	O	O
work	O	O	B-T082
place	O	O	I-T082
assessments	O	O	B-T052
and	O	O	O
future	O	O	B-T079
research	O	O	B-T062
in	O	O	O
this	O	O	O
area	O	O	B-T082
.	O	O	O

Practitioner	O	O	O
Summary	O	O	O
:	O	O	O
For	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
,	O	O	O
quantitative	O	O	B-T081
measures	O	O	B-T081
combining	O	O	O
whole-body	O	O	B-T033
vibration	O	O	I-T033
and	O	O	O
awkward	O	O	B-T033
posture	O	O	I-T033
exposures	O	O	B-T037
have	O	O	O
shown	O	O	O
to	O	O	O
correlate	O	O	B-T080
with	O	O	O
the	O	O	O
occurrence	O	O	B-T079
of	O	O	O
low	O	O	B-T184
back	O	O	I-T184
pain	O	O	I-T184
significantly	O	O	O
.	O	O	O

This	O	O	O
validates	O	O	O
the	O	O	O
proposed	O	O	O
quantities	O	O	B-T081
and	O	O	O
measurement	O	O	B-T169
methods	O	O	B-T169
,	O	O	O
which	O	O	O
facilitate	O	O	O
workplace	O	O	B-T082
assessments	O	O	B-T052
and	O	O	O
assist	O	O	B-T080
in	O	O	O
the	O	O	O
design	O	O	B-T052
of	O	O	O
further	O	O	B-T079
studies	O	O	B-T062
which	O	O	O
are	O	O	O
necessary	O	O	O
to	O	O	O
establish	O	O	B-T080
a	O	O	O
causal	O	O	B-T037
exposure	O	O	I-T037
-	O	O	O
response	O	O	B-T032
relationship	O	O	B-T080
.	O	O	O

-DOCSTART- (28402261)

Association	O	O	B-T080
of	O	O	O
CKIP-1	O	O	B-T028
P21A	O	O	I-T028
polymorphism	O	O	B-T086
with	O	O	O
risk	O	O	B-T078
of	O	O	O
chronic	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
in	O	O	O
a	O	O	O
Chinese	O	O	O
population	O	O	O

Pathological	O	O	B-T169
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
is	O	O	O
an	O	O	O
independent	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
chronic	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
.	O	O	O

Casein	O	O	B-T116
kinase-2	O	O	I-T116
interacting	O	O	I-T116
protein-1	O	O	I-T116
(	O	O	O
CKIP-1	O	O	B-T116
)	O	O	O
can	O	O	O
inhibit	O	O	O
pathological	O	O	B-T169
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
whether	O	O	O
CKIP-1	O	O	B-T028
nonsynonymous	O	O	B-T086
polymorphism	O	O	I-T086
rs2306235	O	O	I-T086
(	O	O	O
Pro21Ala	O	O	B-T045
)	O	O	O
contributes	O	O	O
to	O	O	O
risk	O	O	B-T078
and	O	O	O
prognosis	O	O	B-T058
of	O	O	O
chronic	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
in	O	O	O
a	O	O	O
Chinese	O	O	B-T098
population	O	O	I-T098
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
923	O	O	O
adult	O	O	B-T100
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
and	O	O	O
1020	O	O	O
age	O	O	B-T032
-	O	O	O
and	O	O	O
gender	O	O	B-T032
-matched	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
were	O	O	O
recruited	O	O	O
.	O	O	O

CKIP-1	O	O	B-T028
rs2306235	O	O	I-T028
polymorphism	O	O	B-T086
was	O	O	O
genotyped	O	O	B-T059
using	O	O	O
PCR	O	O	B-T063
-	O	O	O
restriction	O	O	B-T059
fragment	O	O	I-T059
length	O	O	I-T059
polymorphism	O	O	I-T059
.	O	O	O

Additional	O	O	O
follow-up	O	O	B-T058
data	O	O	B-T078
for	O	O	O
140	O	O	O
chronic	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
patients	O	O	B-T101
was	O	O	O
evaluated	O	O	B-T058
.	O	O	O

The	O	O	O
rs2306235	O	O	B-T028
G	O	O	B-T028
allele	O	O	I-T028
was	O	O	O
associated	O	O	O
with	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
chronic	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
(	O	O	O
OR	O	O	B-T081
=	O	O	O
1.38	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
1.09	O	O	O
-	O	O	O
1.75	O	O	O
,	O	O	O
p	O	O	B-T081
=	O	O	O
0.007	O	O	O
)	O	O	O
,	O	O	O
especially	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
hypertension	O	O	B-T047
(	O	O	O
OR	O	O	O
=	O	O	O
1.45	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
1.09	O	O	O
-	O	O	O
1.75	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.006	O	O	O
)	O	O	O
and	O	O	O
coronary	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
OR	O	O	O
=	O	O	O
1.41	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
1.09	O	O	O
-	O	O	O
1.83	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.010	O	O	O
)	O	O	O
after	O	O	O
adjustment	O	O	O
for	O	O	O
multiple	O	O	B-T033
cardiovascular	O	O	I-T033
risk	O	O	B-T033
factors	O	O	I-T033
.	O	O	O

However	O	O	O
,	O	O	O
rs2306235	O	O	B-T028
polymorphism	O	O	B-T086
was	O	O	O
not	O	O	O
associated	O	O	O
with	O	O	O
cardiovascular	O	O	B-T081
mortality	O	O	I-T081
in	O	O	O
chronic	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
(	O	O	O
p	O	O	O
=	O	O	O
0.875	O	O	O
)	O	O	O
.	O	O	O

CKIP-1	O	O	B-T028
rs2306235	O	O	I-T028
polymorphism	O	O	B-T086
may	O	O	O
be	O	O	O
a	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
chronic	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
in	O	O	O
a	O	O	O
Chinese	O	O	B-UnknownType
Han	O	O	I-UnknownType
population	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (28403152)

Linking	O	O	O
phenological	O	O	B-T079
events	O	O	I-T079
in	O	O	O
migratory	O	O	B-T012
passerines	O	O	I-T012
with	O	O	O
a	O	O	O
changing	O	O	B-T070
climate	O	O	I-T070
:	O	O	O
50	O	O	O
years	O	O	B-T079
in	O	O	O
the	O	O	O
Laurel	O	O	O
Highlands	O	O	O
of	O	O	O
Pennsylvania	O	O	O

Advanced	O	O	B-T079
timing	O	O	I-T079
of	O	O	O
both	O	O	O
seasonal	O	O	B-T079
migration	O	O	O
and	O	O	O
reproduction	O	O	B-T039
in	O	O	O
birds	O	O	B-T012
has	O	O	O
been	O	O	O
strongly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
warming	O	O	B-T070
climate	O	O	I-T070
for	O	O	O
many	O	O	O
bird	O	O	B-T012
species	O	O	B-T185
.	O	O	O

Phenological	O	O	B-T079
responses	O	O	I-T079
to	O	O	O
climate	O	O	B-T070
linking	O	O	O
these	O	O	O
stages	O	O	B-T079
may	O	O	O
ultimately	O	O	O
impact	O	O	B-T080
fitness	O	O	B-T052
.	O	O	O

We	O	O	O
analyzed	O	O	B-T062
five	O	O	O
decades	O	O	B-T081
of	O	O	O
banding	O	O	B-T078
data	O	O	I-T078
from	O	O	O
17	O	O	O
migratory	O	O	B-T012
bird	O	O	I-T012
species	O	O	B-T185
to	O	O	O
investigate	O	O	O
1	O	O	O
)	O	O	O
how	O	O	O
spring	O	O	B-T079
arrival	O	O	B-T052
related	O	O	O
to	O	O	O
timing	O	O	B-T079
of	O	O	O
breeding	O	O	B-T040
,	O	O	O
2	O	O	O
)	O	O	O
if	O	O	O
the	O	O	O
interval	O	O	B-T079
between	O	O	O
arrival	O	O	O
and	O	O	O
breeding	O	O	O
has	O	O	O
changed	O	O	O
with	O	O	O
increasing	O	O	B-T169
spring	O	O	O
temperatures	O	O	B-T081
,	O	O	O
and	O	O	O
3	O	O	O
)	O	O	O
whether	O	O	O
arrival	O	O	O
timing	O	O	O
or	O	O	O
breeding	O	O	O
timing	O	O	O
best	O	O	O
predicted	O	O	O
local	O	O	B-T033
productivity	O	O	I-T033
.	O	O	O

Four	O	O	O
of	O	O	O
17	O	O	O
species	O	O	B-T185
,	O	O	O
all	O	O	O
mid-	O	O	B-T012
to	O	O	I-T012
long-distance	O	O	I-T012
migrants	O	O	B-T098
,	O	O	O
hatched	O	O	B-T040
young	O	O	O
earlier	O	O	B-T079
in	O	O	O
years	O	O	B-T079
when	O	O	O
migrants	O	O	O
arrived	O	O	B-T052
earlier	O	O	O
to	O	O	O
the	O	O	O
breeding	O	O	B-T082
grounds	O	O	I-T082
(	O	O	O
~1:1	O	O	O
day	O	O	B-T079
advancement	O	O	I-T079
)	O	O	O
.	O	O	O

The	O	O	O
interval	O	O	B-T079
between	O	O	O
arrival	O	O	B-T052
on	O	O	O
breeding	O	O	B-T082
grounds	O	O	I-T082
and	O	O	O
appearance	O	O	B-T080
of	O	O	O
juveniles	O	O	B-T100
shortened	O	O	B-T080
with	O	O	O
warmer	O	O	O
spring	O	O	B-T079
temperatures	O	O	B-T081
for	O	O	O
12	O	O	O
species	O	O	B-T185
(	O	O	O
1	O	O	O
-	O	O	O
6	O	O	O
days	O	O	B-T079
for	O	O	O
every	O	O	O
1	O	O	O
°	O	O	O
C	O	O	O
increase	O	O	B-T169
)	O	O	O
and	O	O	O
over	O	O	O
time	O	O	B-T079
for	O	O	O
seven	O	O	O
species	O	O	O
(	O	O	O
1	O	O	O
-	O	O	O
8	O	O	O
days	O	O	O
per	O	O	O
decade	O	O	B-T081
)	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
some	O	O	O
migratory	O	O	B-T012
passerines	O	O	I-T012
adapt	O	O	O
to	O	O	O
climate	O	O	B-T070
change	O	O	I-T070
by	O	O	O
laying	O	O	B-T040
more	O	O	B-T033
quickly	O	O	I-T033
after	O	O	O
arrival	O	O	O
or	O	O	O
reducing	O	O	B-T080
the	O	O	O
time	O	O	O
from	O	O	O
laying	O	O	O
to	O	O	O
fledging	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
more	O	O	O
support	O	O	O
for	O	O	O
the	O	O	O
former	O	O	B-T078
,	O	O	O
that	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
reproductive	O	O	B-T040
advancement	O	O	I-T040
was	O	O	O
higher	O	O	B-T080
than	O	O	O
that	O	O	O
for	O	O	O
arrival	O	O	B-T033
in	O	O	O
warm	O	O	B-T070
years	O	O	I-T070
.	O	O	O

Timing	O	O	B-T079
of	O	O	O
spring	O	O	B-T079
arrival	O	O	B-T052
and	O	O	O
breeding	O	O	B-T040
were	O	O	O
both	O	O	O
poor	O	O	B-T080
predictors	O	O	B-T078
of	O	O	O
avian	O	O	B-T012
productivity	O	O	B-T081
for	O	O	O
most	O	O	O
migrants	O	O	B-T012
analyzed	O	O	B-T062
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
evidence	O	O	B-T078
that	O	O	O
fitness	O	O	B-T045
benefits	O	O	O
may	O	O	O
occur	O	O	O
from	O	O	O
shifts	O	O	B-T067
to	O	O	O
earlier	O	O	O
spring	O	O	B-T079
arrival	O	O	B-T052
for	O	O	O
the	O	O	O
multi-brooded	O	O	B-T012
Song	O	O	I-T012
Sparrow	O	O	I-T012
.	O	O	O

Our	O	O	O
results	O	O	B-T169
uniquely	O	O	O
demonstrate	O	O	O
that	O	O	O
co-occurring	O	O	O
avian	O	O	B-T012
species	O	O	B-T185
are	O	O	O
phenologically	O	O	B-T079
plastic	O	O	I-T079
in	O	O	O
their	O	O	O
response	O	O	B-T032
to	O	O	O
climate	O	O	B-T070
change	O	O	I-T070
on	O	O	O
their	O	O	O
breeding	O	O	B-T082
grounds	O	O	I-T082
.	O	O	O

If	O	O	O
migrants	O	O	B-T098
continue	O	O	O
to	O	O	O
show	O	O	O
a	O	O	O
weaker	O	O	B-T080
response	O	O	B-T032
to	O	O	O
temperatures	O	O	B-T081
during	O	O	O
migration	O	O	O
than	O	O	O
breeding	O	O	B-T040
,	O	O	O
and	O	O	O
the	O	O	O
window	O	O	B-T079
between	O	O	O
arrival	O	O	B-T052
and	O	O	O
optimal	O	O	B-T040
breeding	O	O	I-T040
shortens	O	O	B-T080
further	O	O	O
,	O	O	O
biological	O	O	O
constraints	O	O	O
to	O	O	O
plasticity	O	O	B-T070
may	O	O	O
limit	O	O	O
the	O	O	O
ability	O	O	B-T032
of	O	O	O
species	O	O	B-T185
to	O	O	O
adapt	O	O	O
successfully	O	O	O
to	O	O	O
future	O	O	B-T070
warming	O	O	I-T070
.	O	O	O

-DOCSTART- (28404634)

Mucosal	O	O	B-T024
IgM	O	O	B-T116
Antibody	O	O	I-T116
with	O	O	O
d-Mannose	O	O	B-T109
Affinity	O	O	B-T070
in	O	O	O
Fugu	O	O	B-T013
Takifugu	O	O	I-T013
rubripes	O	O	I-T013
Is	O	O	O
Utilized	O	O	O
by	O	O	O
a	O	O	O
Monogenean	O	O	B-T204
Parasite	O	O	B-T204
Heterobothrium	O	O	B-T204
okamotoi	O	O	I-T204
for	O	O	O
Host	O	O	O
Recognition	O	O	O

How	O	O	O
parasites	O	O	B-T204
recognize	O	O	B-T041
their	O	O	O
definitive	O	O	B-T079
hosts	O	O	B-T001
is	O	O	O
a	O	O	O
mystery	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
parasitism	O	O	B-T070
is	O	O	O
reportedly	O	O	O
initiated	O	O	O
by	O	O	O
recognition	O	O	B-T041
of	O	O	O
certain	O	O	O
molecules	O	O	B-T167
on	O	O	O
host	O	O	B-T026
surfaces	O	O	I-T026
.	O	O	O

Fish	O	O	B-T013
ectoparasites	O	O	B-T204
make	O	O	O
initial	O	O	B-T033
contact	O	O	I-T033
with	O	O	O
their	O	O	O
hosts	O	O	B-T001
at	O	O	O
body	O	O	B-T032
surfaces	O	O	I-T032
,	O	O	O
such	O	O	O
as	O	O	O
skin	O	O	B-T022
and	O	O	O
gills	O	O	B-T023
,	O	O	O
which	O	O	O
are	O	O	O
covered	O	O	B-T169
with	O	O	O
mucosa	O	O	B-T024
that	O	O	O
are	O	O	O
similar	O	O	O
to	O	O	O
those	O	O	O
of	O	O	O
mammalian	O	O	B-T023
guts	O	O	I-T023
.	O	O	O

Fish	O	O	B-T013
are	O	O	O
among	O	O	O
the	O	O	O
most	O	O	O
primitive	O	O	B-T010
vertebrates	O	O	I-T010
with	O	O	O
immune	O	O	B-T022
systems	O	O	I-T022
that	O	O	O
are	O	O	O
equivalent	O	O	O
to	O	O	O
those	O	O	O
in	O	O	O
mammals	O	O	B-T015
,	O	O	O
and	O	O	O
they	O	O	O
produce	O	O	O
and	O	O	O
secrete	O	O	B-T038
IgM	O	O	B-T116
into	O	O	O
mucus	O	O	B-T031
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
monogenean	O	O	B-T204
parasite	O	O	B-T204
Heterobothrium	O	O	B-T204
okamotoi	O	O	I-T204
utilizes	O	O	O
IgM	O	O	B-T116
to	O	O	O
recognize	O	O	B-UnknownType
its	O	O	O
host	O	O	B-T001
,	O	O	O
fugu	O	O	B-T013
Takifugu	O	O	I-T013
rubripes	O	O	I-T013
Oncomiracidia	O	O	I-T013
are	O	O	O
infective	O	O	B-T204
larvae	O	O	I-T204
of	O	O	O
H.	O	O	B-T204
okamotoi	O	O	I-T204
that	O	O	O
shed	O	O	O
their	O	O	O
cilia	O	O	B-T026
and	O	O	O
metamorphose	O	O	B-T040
into	O	O	O
juveniles	O	O	B-T100
when	O	O	O
exposed	O	O	O
to	O	O	O
purified	O	O	B-T169
d-mannose	O	O	B-T109
-	O	O	O
binding	O	O	B-T052
fractions	O	O	B-T081
from	O	O	O
fugu	O	O	O
mucus	O	O	B-T031
.	O	O	O

Using	O	O	O
liquid	O	O	B-T059
chromatography-tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
analysis	O	O	I-T059
,	O	O	O
proteins	O	O	B-T116
contained	O	O	O
in	O	O	O
the	O	O	O
fraction	O	O	B-T081
were	O	O	O
identified	O	O	B-T080
as	O	O	O
d-mannose	O	O	B-T109
-specific	O	O	O
IgM	O	O	B-T116
with	O	O	O
two	O	O	O
d-mannose	O	O	B-T052
-binding	O	O	I-T052
lectins	O	O	B-T116
.	O	O	O

However	O	O	O
,	O	O	O
although	O	O	O
deciliation	O	O	B-T039
was	O	O	O
significantly	O	O	O
induced	O	O	B-T169
by	O	O	O
IgM	O	O	B-T116
and	O	O	O
was	O	O	O
inhibited	O	O	B-T080
by	O	O	O
d-mannose	O	O	B-T109
or	O	O	O
a	O	O	O
specific	O	O	O
Ab	O	O	B-T116
against	O	O	O
fugu	O	O	B-T013
IgM	O	O	O
,	O	O	O
other	O	O	O
lectins	O	O	B-T116
had	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
,	O	O	O
and	O	O	O
IgM	O	O	O
without	O	O	O
d-mannose	O	O	O
affinity	O	O	B-T070
induced	O	O	O
deciliation	O	O	O
to	O	O	O
a	O	O	O
limited	O	O	O
degree	O	O	O
.	O	O	O

Subsequent	O	O	O
immunofluorescent	O	O	B-T059
staining	O	O	I-T059
experiments	O	O	I-T059
showed	O	O	O
that	O	O	O
fugu	O	O	B-T013
d-mannose	O	O	B-T109
-specific	O	O	O
IgM	O	O	B-T116
binds	O	O	B-T052
ciliated	O	O	B-T025
epidermal	O	O	I-T025
cells	O	O	I-T025
of	O	O	O
oncomiracidium	O	O	B-T013
.	O	O	O

These	O	O	O
observations	O	O	B-T078
suggest	O	O	O
that	O	O	O
deciliation	O	O	B-T039
is	O	O	O
triggered	O	O	B-T080
by	O	O	I-T080
binding	O	O	B-T052
of	O	O	O
fugu	O	O	B-T013
IgM	O	O	B-T116
to	O	O	O
cell	O	O	B-T129
surface	O	O	I-T129
Ags	O	O	I-T129
via	O	O	O
Ag	O	O	B-T129
binding	O	O	I-T129
sites	O	O	I-T129
.	O	O	O

Moreover	O	O	O
,	O	O	O
concentrations	O	O	B-T081
of	O	O	O
d-mannose	O	O	B-T109
-	O	O	O
binding	O	O	B-T052
IgM	O	O	B-T116
in	O	O	O
gill	O	O	B-T031
mucus	O	O	I-T031
were	O	O	O
sufficient	O	O	O
to	O	O	O
induce	O	O	B-T169
deciliation	O	O	B-T039
in	O	O	B-T080
vitro	O	O	I-T080
,	O	O	O
indicating	O	O	B-T078
that	O	O	O
H.	O	O	B-T204
okamotoi	O	O	I-T204
parasites	O	O	I-T204
initially	O	O	O
use	O	O	B-T169
host	O	O	B-T001
Abs	O	O	B-T116
to	O	O	O
colonize	O	O	B-T033
host	O	O	O
gills	O	O	B-T023
.	O	O	O

-DOCSTART- (28404899)

BALB/c	O	O	B-T015
mice	O	O	I-T015
immunized	O	O	B-T061
with	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
virus-like	O	O	B-T026
particles	O	O	I-T026
incorporating	O	O	O
Kaposi	O	O	B-T005
sarcoma-associated	O	O	I-T005
herpesvirus	O	O	I-T005
(	O	O	O
KSHV	O	O	B-T005
)	O	O	O
envelope	O	O	O
glycoproteins	O	O	B-T116
gpK8.1	O	O	I-T116
,	O	O	O
gB	O	O	B-T116
,	O	O	O
and	O	O	O
gH	O	O	B-T116
/	O	O	O
gL	O	O	B-T116
induced	O	O	O
comparable	O	O	O
serum	O	O	B-T031
neutralizing	O	O	B-T116
antibody	O	O	I-T116
activity	O	O	B-T044
to	O	O	O
UV	O	O	B-T070
-	O	O	O
inactivated	O	O	B-T169
KSHV	O	O	O

Infection	O	O	O
with	O	O	O
Kaposi	O	O	B-T005
sarcoma-associated	O	O	I-T005
herpesvirus	O	O	I-T005
(	O	O	O
KSHV	O	O	B-T005
)	O	O	O
is	O	O	O
estimated	O	O	O
to	O	O	O
account	O	O	O
for	O	O	O
over	O	O	O
44,000	O	O	O
new	O	O	O
cases	O	O	O
of	O	O	O
Kaposi	O	O	B-T191
sarcoma	O	O	I-T191
annually	O	O	O
,	O	O	O
with	O	O	O
84	O	O	O
%	O	O	O
occurring	O	O	O
in	O	O	O
Africa	O	O	B-T083
,	O	O	O
where	O	O	O
the	O	O	O
virus	O	O	B-T005
is	O	O	O
endemic	O	O	O
.	O	O	O

To	O	O	O
date	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
prophylactic	O	O	B-T129
vaccine	O	O	I-T129
against	O	O	O
KSHV	O	O	B-T005
.	O	O	O

KSHV	O	O	B-T005
gpK8.1	O	O	B-T116
,	O	O	O
gB	O	O	B-T116
,	O	O	O
and	O	O	O
gH	O	O	B-T116
/	O	O	O
gL	O	O	B-T116
glycoproteins	O	O	I-T116
,	O	O	O
implicated	O	O	O
in	O	O	O
the	O	O	O
virus	O	O	B-T005
entry	O	O	O
into	O	O	O
host	O	O	B-T026
cells	O	O	I-T026
,	O	O	O
are	O	O	O
attractive	O	O	O
vaccine	O	O	B-T129
targets	O	O	B-T169
for	O	O	O
eliciting	O	O	O
potent	O	O	O
neutralizing	O	O	B-T116
antibodies	O	O	I-T116
(	O	O	O
nAbs	O	O	B-T116
)	O	O	O
against	O	O	O
virus	O	O	B-T047
infection	O	O	I-T047
.	O	O	O

We	O	O	O
incorporated	O	O	O
gpK8.1	O	O	B-T116
,	O	O	O
gB	O	O	B-T116
,	O	O	O
or	O	O	O
gH	O	O	B-T116
/	O	O	O
gL	O	O	B-T116
on	O	O	O
the	O	O	O
surface	O	O	O
of	O	O	O
virus-like	O	O	B-T026
particles	O	O	I-T026
(	O	O	O
VLPs	O	O	B-T026
)	O	O	O
and	O	O	O
characterized	O	O	O
these	O	O	O
VLPs	O	O	O
for	O	O	O
their	O	O	O
composition	O	O	O
,	O	O	O
size	O	O	O
,	O	O	O
and	O	O	O
functionality	O	O	O
.	O	O	O

To	O	O	O
determine	O	O	O
which	O	O	O
viral	O	O	B-T026
glycoprotein(s	O	O	I-T026
)	O	O	I-T026
elicit	O	O	O
the	O	O	O
most	O	O	O
effective	O	O	O
serum	O	O	B-T031
-	O	O	O
nAbs	O	O	B-T116
,	O	O	O
we	O	O	O
immunized	O	O	B-T061
BALB/c	O	O	B-T015
mice	O	O	I-T015
with	O	O	O
gpK8.1	O	O	B-T116
,	O	O	O
gB	O	O	B-T116
,	O	O	O
or	O	O	O
gH	O	O	B-T116
/	O	O	O
gL	O	O	B-T116
VLPs	O	O	B-T026
individually	O	O	O
or	O	O	O
in	O	O	O
combination	O	O	O
.	O	O	O

Neutralizing	O	O	B-T116
antibody	O	O	I-T116
assay	O	O	O
revealed	O	O	O
that	O	O	O
sera	O	O	O
from	O	O	O
mice	O	O	B-T015
immunized	O	O	B-T061
with	O	O	O
the	O	O	O
VLPs	O	O	B-T026
inhibited	O	O	O
KSHV	O	O	B-T005
infection	O	O	B-T047
of	O	O	O
HEK-293	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
a	O	O	O
dose-dependent	O	O	B-T081
manner	O	O	O
.	O	O	O

As	O	O	O
a	O	O	O
single	O	O	O
immunogen	O	O	B-T129
,	O	O	O
gpK8.1	O	O	B-T116
VLPs	O	O	B-T026
stimulated	O	O	O
comparable	O	O	O
nAb	O	O	B-T116
activity	O	O	O
to	O	O	O
that	O	O	O
of	O	O	O
UV	O	O	B-T070
-	O	O	O
inactivated	O	O	B-T169
KSHV	O	O	B-T005
(	O	O	O
UV-KSHV	O	O	B-T005
)	O	O	O
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
UV-KSHV	O	O	B-T005
stimulated	O	O	O
higher	O	O	O
titers	O	O	O
of	O	O	O
nAb	O	O	O
compared	O	O	O
to	O	O	O
gB	O	O	B-T116
(	O	O	O
p	O	O	O
=	O	O	O
0.0316	O	O	O
)	O	O	O
or	O	O	O
gH	O	O	B-T116
/	O	O	O
gL	O	O	B-T116
(	O	O	O
p	O	O	O
=	O	O	O
0.0486	O	O	O
)	O	O	O
.	O	O	O

Mice	O	O	B-T015
immunized	O	O	B-T061
with	O	O	O
the	O	O	O
combination	O	O	O
of	O	O	O
gB	O	O	B-T116
and	O	O	O
gH	O	O	B-T116
/	O	O	O
gL	O	O	B-T116
VLPs	O	O	B-T026
had	O	O	O
a	O	O	O
better	O	O	O
nAb	O	O	O
response	O	O	O
than	O	O	O
those	O	O	O
immunized	O	O	O
with	O	O	O
either	O	O	O
gB	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.0268	O	O	O
)	O	O	O
,	O	O	O
or	O	O	O
gH	O	O	O
/gL	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.0397	O	O	O
)	O	O	O
as	O	O	O
single	O	O	O
VLP	O	O	B-T026
immunogens	O	O	B-T129
.	O	O	O

Immunization	O	O	B-T061
with	O	O	O
any	O	O	O
VLP	O	O	B-T026
combination	O	O	O
stimulated	O	O	O
comparable	O	O	O
nAb	O	O	B-T116
activity	O	O	O
to	O	O	O
UV-KSHV	O	O	B-T005
serum	O	O	B-T031
.	O	O	O

Our	O	O	O
data	O	O	O
provide	O	O	O
the	O	O	O
first	O	O	O
evidence	O	O	O
that	O	O	O
KSHV	O	O	B-T005
gpK8.1	O	O	B-T116
,	O	O	O
gB	O	O	B-T116
,	O	O	O
and	O	O	O
gH	O	O	B-T116
/	O	O	O
gL	O	O	B-T116
glycoproteins	O	O	I-T116
can	O	O	O
be	O	O	O
incorporated	O	O	O
onto	O	O	O
the	O	O	O
surface	O	O	O
of	O	O	O
VLPs	O	O	B-T026
and	O	O	O
used	O	O	O
as	O	O	O
prophylactic	O	O	B-T129
vaccine	O	O	I-T129
candidates	O	O	O
,	O	O	O
with	O	O	O
potential	O	O	O
to	O	O	O
prevent	O	O	O
KSHV	O	O	O
infection	O	O	B-T047
.	O	O	O

-DOCSTART- (28405013)

A	O	O	O
missense	O	O	B-T045
variant	O	O	B-T080
,	O	O	O
rs373863828-A	O	O	B-T028
(	O	O	I-T028
p.	O	O	I-T028
Arg457Gln	O	O	I-T028
)	O	O	I-T028
,	O	O	I-T028
of	O	O	I-T028
CREBRF	O	O	I-T028
and	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
in	O	O	O
Oceanic	O	O	O
populations	O	O	O

It	O	O	O
has	O	O	O
been	O	O	O
suggested	O	O	O
that	O	O	O
a	O	O	O
'	O	O	O
thrifty	O	O	O
'	O	O	O
genotype	O	O	B-T032
hypothesis	O	O	B-T078
can	O	O	O
account	O	O	O
for	O	O	O
high	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
obesity	O	O	B-T047
in	O	O	O
the	O	O	O
island	O	O	B-T083
populations	O	O	B-T098
of	O	O	O
Oceania	O	O	B-T083
.	O	O	O

A	O	O	O
recent	O	O	O
genome-wide	O	O	B-T063
association	O	O	I-T063
study	O	O	I-T063
revealed	O	O	O
that	O	O	O
a	O	O	O
missense	O	O	B-T045
variant	O	O	B-T080
,	O	O	O
rs373863828-A	O	O	B-T028
(	O	O	I-T028
p.	O	O	I-T028
Arg457Gln	O	O	I-T028
)	O	O	I-T028
,	O	O	I-T028
of	O	O	I-T028
the	O	O	I-T028
CREBRF	O	O	I-T028
gene	O	O	I-T028
(	O	O	O
encoding	O	O	O
CREB3	O	O	B-T116
regulatory	O	O	I-T116
factor	O	O	I-T116
)	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
excessive	O	O	B-T080
increase	O	O	B-T169
in	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
in	O	O	O
Samoans	O	O	B-T098
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
the	O	O	O
association	O	O	O
of	O	O	O
rs373863828-A	O	O	B-T028
with	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
BMI	O	O	B-T201
was	O	O	O
examined	O	O	B-T033
in	O	O	O
four	O	O	O
Austronesian	O	O	B-UnknownType
(AN)-	O	O	O
speaking	O	O	B-T056
populations	O	O	B-T098
in	O	O	O
Oceania	O	O	B-T083
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
rs373863828-A	O	O	B-T028
was	O	O	O
frequently	O	O	O
observed	O	O	O
(	O	O	O
frequency	O	O	O
of	O	O	O
0.15	O	O	O
)	O	O	O
in	O	O	O
Tongans	O	O	B-T098
(	O	O	O
Polynesians	O	O	B-T098
)	O	O	O
,	O	O	O
and	O	O	O
was	O	O	O
strongly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
higher	O	O	O
BMI	O	O	B-T201
(	O	O	O
P=6.1	O	O	O
×	O	O	O
10(-4	O	O	O
)	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
single	O	O	O
copy	O	O	O
of	O	O	O
the	O	O	O
rs373863828-A	O	O	B-T028
allele	O	O	B-T028
increased	O	O	B-T081
BMI	O	O	B-T201
by	O	O	O
3.09	O	O	O
kg	O	O	O
m(-2	O	O	O
)	O	O	O
after	O	O	O
adjustment	O	O	O
of	O	O	O
age	O	O	B-T032
and	O	O	O
sex	O	O	B-T032
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
association	O	O	B-T080
was	O	O	O
detected	O	O	B-T061
in	O	O	O
the	O	O	O
other	O	O	O
three	O	O	O
AN	O	O	B-UnknownType
-	O	O	O
speaking	O	O	B-T056
populations	O	O	B-T098
(	O	O	O
Melanesians	O	O	B-T098
and	O	O	O
Micronesians	O	O	B-T098
)	O	O	O
living	O	O	B-T078
in	O	O	O
Solomon	O	O	B-T083
Islands	O	O	I-T083
.	O	O	O

This	O	O	O
was	O	O	O
probably	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
low	O	O	B-T080
allele	O	O	B-T081
frequency	O	O	I-T081
(	O	O	O
0.02	O	O	O
-	O	O	O
0.06	O	O	O
)	O	O	O
of	O	O	O
rs373863828-A	O	O	B-T028
as	O	O	O
well	O	O	O
as	O	O	O
small	O	O	O
sample	O	O	B-T081
size	O	O	I-T081
.	O	O	O

The	O	O	O
rs373863828-A	O	O	B-T028
allele	O	O	B-T028
was	O	O	O
not	O	O	O
found	O	O	O
in	O	O	O
both	O	O	O
AN	O	O	B-UnknownType
-	O	O	O
speaking	O	O	B-T056
and	O	O	O
non-	O	O	O
AN	O	O	O
-	O	O	O
speaking	O	O	O
Melanesians	O	O	B-T098
living	O	O	O
in	O	O	O
Papua	O	O	B-T083
New	O	O	I-T083
Guinea	O	O	I-T083
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
rs373863828-A	O	O	B-T028
of	O	O	I-T028
CREBRF	O	O	I-T028
,	O	O	O
a	O	O	O
promising	O	O	O
thrifty	O	O	O
variant	O	O	B-T080
,	O	O	O
arose	O	O	O
in	O	O	O
recent	O	O	O
ancestors	O	O	B-T099
of	O	O	O
AN	O	O	B-UnknownType
-	O	O	O
speaking	O	O	B-T056
Polynesians	O	O	B-T098
.Journal	O	O	O
of	O	O	O
Human	O	O	O
Genetics	O	O	O
advance	O	O	O
online	O	O	O
publication	O	O	O
,	O	O	O
13	O	O	O
April	O	O	O
2017	O	O	O
;	O	O	O
doi:10.1038/jhg.2017.44	O	O	O
.	O	O	O

-DOCSTART- (28405450)

Vaccination	O	O	B-T061
of	O	O	O
piglets	O	O	B-T015
at	O	O	O
2	O	O	O
and	O	O	O
3	O	O	O
weeks	O	O	O
of	O	O	O
age	O	O	O
with	O	O	O
Ingelvac	O	O	B-T129
PRRSFLEX	O	O	I-T129
®	O	O	I-T129
EU	O	O	I-T129
provides	O	O	O
protection	O	O	B-T033
against	O	O	O
heterologous	O	O	B-T080
field	O	O	O
challenge	O	O	O
in	O	O	O
the	O	O	O
face	O	O	O
of	O	O	O
homologous	O	O	B-T032
maternally	O	O	O
derived	O	O	O
antibodies	O	O	O

Due	O	O	O
to	O	O	O
difficulties	O	O	O
in	O	O	O
eradicating	O	O	B-T058
porcine	O	O	B-T047
reproductive	O	O	I-T047
and	O	O	I-T047
respiratory	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
PRRS	O	O	B-T047
)	O	O	O
linked	O	O	O
to	O	O	O
biosecurity	O	O	O
challenges	O	O	O
,	O	O	O
transmission	O	O	B-T043
of	O	O	I-T043
the	O	O	I-T043
virus	O	O	I-T043
and	O	O	O
the	O	O	O
lack	O	O	O
of	O	O	O
efficient	O	O	B-T080
DIVA	O	O	B-T129
vaccines	O	O	I-T129
,	O	O	O
successful	O	O	B-T080
control	O	O	B-T080
of	O	O	O
PRRS	O	O	O
requires	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
strict	O	O	O
management	O	O	B-T058
measures	O	O	I-T058
and	O	O	O
vaccination	O	O	B-T061
of	O	O	O
both	O	O	O
sows	O	O	B-T015
and	O	O	O
piglets	O	O	B-T015
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
a	O	O	O
recently	O	O	O
developed	O	O	O
MLV	O	O	B-T129
vaccine	O	O	I-T129
(	O	O	O
Ingelvac	O	O	B-T129
PRRSFLEX	O	O	I-T129
®	O	O	I-T129
EU	O	O	I-T129
)	O	O	O
in	O	O	O
piglets	O	O	B-T015
at	O	O	O
2	O	O	O
and	O	O	O
3-weeks	O	O	O
of	O	O	O
age	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
homologous	O	O	B-T032
maternally	O	O	B-T116
derived	O	O	I-T116
antibodies	O	O	I-T116
as	O	O	O
the	O	O	O
dams	O	O	O
were	O	O	O
vaccinated	O	O	B-T061
with	O	O	O
the	O	O	O
same	O	O	O
vaccine	O	O	B-T129
strain	O	O	I-T129
(	O	O	O
ReproCyc	O	O	B-T129
®	O	O	I-T129
PRRS	O	O	I-T129
EU	O	O	I-T129
)	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
was	O	O	O
carried	O	O	O
out	O	O	O
on	O	O	O
a	O	O	O
Hungarian	O	O	B-T015
farrow	O	O	I-T015
to	O	O	O
finish	O	O	O
farm	O	O	B-T082
naturally	O	O	B-T033
infected	O	O	I-T033
with	O	O	O
PRRSv	O	O	B-T005
.	O	O	O

The	O	O	O
study	O	O	B-T062
was	O	O	O
designed	O	O	O
as	O	O	O
a	O	O	O
blind	O	O	B-T062
,	O	O	O
placebo	O	O	B-T062
controlled	O	O	I-T062
side	O	O	O
by	O	O	O
side	O	O	O
trial	O	O	O
.	O	O	O

ORF5	O	O	B-T116
sequence	O	O	B-T081
similarity	O	O	I-T081
of	O	O	O
the	O	O	O
vaccine	O	O	B-T129
strain	O	O	I-T129
and	O	O	O
the	O	O	O
resident	O	O	B-T098
field	O	O	I-T098
strain	O	O	I-T098
was	O	O	O
87.8	O	O	O
%	O	O	O
.	O	O	O

PRRS	O	O	B-T047
specific	O	O	O
real-time	O	O	B-T063
quantitative	O	O	I-T063
PCR	O	O	I-T063
was	O	O	O
performed	O	O	O
from	O	O	O
serum	O	O	B-T031
samples	O	O	I-T031
to	O	O	O
measure	O	O	B-T081
both	O	O	O
the	O	O	O
viral	O	O	B-T059
load	O	O	I-T059
and	O	O	O
the	O	O	O
frequency	O	O	O
of	O	O	O
virus	O	O	B-T034
positive	O	O	I-T034
animals	O	O	B-T008
.	O	O	O

At	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
the	O	O	O
natural	O	O	B-T046
infection	O	O	I-T046
observed	O	O	B-T169
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
at	O	O	O
10	O	O	O
-	O	O	O
12	O	O	O
weeks	O	O	O
of	O	O	O
age	O	O	O
,	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
viraemic	O	O	B-T033
animals	O	O	B-T008
did	O	O	O
not	O	O	O
increase	O	O	O
significantly	O	O	O
in	O	O	O
the	O	O	O
vaccinated	O	O	B-T061
group	O	O	O
.	O	O	O

To	O	O	O
understand	O	O	O
the	O	O	O
infection	O	O	B-T046
dynamics	O	O	B-T070
,	O	O	O
positive	O	O	B-T033
PCR	O	O	B-T063
samples	O	O	B-T167
with	O	O	O
low	O	O	O
Ct	O	O	O
values	O	O	O
were	O	O	O
sequenced	O	O	O
(	O	O	O
ORF5	O	O	B-T116
)	O	O	O
and	O	O	O
the	O	O	O
data	O	O	B-T057
analysis	O	O	I-T057
indicated	O	O	B-T033
the	O	O	O
circulation	O	O	B-T033
of	O	O	O
wild	O	O	O
type	O	O	O
virus	O	O	B-T005
in	O	O	O
both	O	O	O
groups	O	O	O
,	O	O	O
however	O	O	O
wild	O	O	O
type	O	O	O
virus	O	O	O
was	O	O	O
only	O	O	O
found	O	O	O
in	O	O	O
non-vaccinated	O	O	O
animals	O	O	O
.	O	O	O

Our	O	O	O
data	O	O	B-T078
indicate	O	O	O
that	O	O	O
piglets	O	O	B-T015
vaccinated	O	O	B-T061
at	O	O	O
as	O	O	O
early	O	O	O
as	O	O	O
2	O	O	O
weeks	O	O	O
of	O	O	O
age	O	O	O
with	O	O	O
Ingelvac	O	O	B-T129
PRRSFLEX	O	O	I-T129
®	O	O	I-T129
EU	O	O	I-T129
were	O	O	O
protected	O	O	O
both	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
proportion	O	O	B-T081
of	O	O	O
viraemic	O	O	B-T033
animals	O	O	B-T008
and	O	O	O
viraemia	O	O	B-T047
levels	O	O	O
.	O	O	O

It	O	O	O
has	O	O	O
to	O	O	O
be	O	O	O
highlighted	O	O	O
that	O	O	O
these	O	O	O
results	O	O	O
were	O	O	O
achieved	O	O	O
in	O	O	O
piglets	O	O	B-T015
with	O	O	O
high	O	O	O
levels	O	O	O
of	O	O	O
homologous	O	O	B-T032
maternally	O	O	B-T116
derived	O	O	I-T116
antibodies	O	O	I-T116
(	O	O	O
MDA	O	O	B-T116
)	O	O	O
at	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
vaccination	O	O	B-T061
.	O	O	O

-DOCSTART- (28406413)

Lung	O	O	B-T033
nodule	O	O	I-T033
in	O	O	O
French	O	O	B-T083
Guiana	O	O	I-T083
in	O	O	O
a	O	O	O
immunocompetent	O	O	B-T201
patient	O	O	O

We	O	O	O
report	O	O	O
the	O	O	O
case	O	O	B-T077
of	O	O	O
an	O	O	O
immunocompetent	O	O	B-T201
French	O	O	B-T098
soldier	O	O	B-T097
stationed	O	O	O
in	O	O	O
French	O	O	B-T083
Guiana	O	O	I-T083
,	O	O	O
who	O	O	O
developed	O	O	O
symptomatic	O	O	B-T169
pulmonary	O	O	B-T047
histoplasmosis	O	O	I-T047
.	O	O	O

-DOCSTART- (28407625)

Comparison	O	O	B-T052
of	O	O	O
Occlusive	O	O	B-T169
and	O	O	O
Open	O	O	B-T082
Application	O	O	B-T169
in	O	O	O
a	O	O	O
Psoriasis	O	O	B-T062
Plaque	O	O	I-T062
Test	O	O	I-T062
Design	O	O	I-T062
,	O	O	O
Exemplarily	O	O	O
Using	O	O	O
Investigations	O	O	B-T169
of	O	O	O
Mapracorat	O	O	B-T109
0.1	O	O	O
%	O	O	O
Ointment	O	O	B-T122
versus	O	O	O
Vehicle	O	O	B-T122
and	O	O	O
Reference	O	O	B-T077
Drugs	O	O	O

Psoriasis	O	O	B-T062
plaque	O	O	I-T062
tests	O	O	I-T062
(	O	O	O
PPTs	O	O	B-T062
)	O	O	O
are	O	O	O
important	O	O	O
tools	O	O	O
in	O	O	O
the	O	O	O
early	O	O	O
phases	O	O	O
of	O	O	O
antipsoriatic	O	O	B-T121
drug	O	O	B-T091
development	O	O	I-T091
.	O	O	O

Two	O	O	O
distinct	O	O	O
PPT	O	O	B-T062
design	O	O	I-T062
variants	O	O	O
(	O	O	O
open	O	O	B-T169
vs.	O	O	O
occluded	O	O	B-T169
drug	O	O	I-T169
application	O	O	I-T169
)	O	O	O
are	O	O	O
commonly	O	O	O
used	O	O	O
,	O	O	O
but	O	O	O
no	O	O	O
previous	O	O	O
work	O	O	O
has	O	O	O
aimed	O	O	O
to	O	O	O
directly	O	O	O
compare	O	O	O
and	O	O	O
contrast	O	O	O
their	O	O	O
performance	O	O	O
.	O	O	O

We	O	O	O
compared	O	O	O
the	O	O	O
antipsoriatic	O	O	B-T121
efficacy	O	O	O
of	O	O	O
mapracorat	O	O	B-T109
0.1	O	O	O
%	O	O	O
ointment	O	O	B-T122
and	O	O	O
reference	O	O	B-T077
drugs	O	O	B-T121
reported	O	O	O
in	O	O	O
2	O	O	O
separate	O	O	O
studies	O	O	B-T062
,	O	O	O
representing	O	O	O
open	O	O	B-T062
and	O	O	O
occluded	O	O	B-T062
PPT	O	O	I-T062
designs	O	O	I-T062
.	O	O	O

The	O	O	O
drug	O	O	B-T169
effect	O	O	I-T169
size	O	O	O
was	O	O	O
measured	O	O	O
by	O	O	O
sonography	O	O	B-T060
(	O	O	O
mean	O	O	O
change	O	O	O
in	O	O	O
echo-poor	O	O	O
band	O	O	O
thickness	O	O	B-T080
)	O	O	O
,	O	O	O
chromametry	O	O	B-T059
,	O	O	O
and	O	O	O
standardized	O	O	O
clinical	O	O	B-T033
assessment	O	O	I-T033
.	O	O	O

Antipsoriatic	O	O	B-T121
effects	O	O	B-T169
were	O	O	O
detectable	O	O	O
for	O	O	O
the	O	O	O
study	O	O	B-T062
drugs	O	O	B-T121
in	O	O	O
both	O	O	O
occluded	O	O	B-T062
and	O	O	O
open	O	O	B-T062
PPTs	O	O	I-T062
.	O	O	O

Differences	O	O	O
between	O	O	O
the	O	O	O
potency	O	O	B-T038
of	O	O	O
antipsoriatic	O	O	B-T121
drugs	O	O	I-T121
and	O	O	O
vehicle	O	O	B-T122
were	O	O	O
observable	O	O	O
.	O	O	O

The	O	O	O
total	O	O	O
antipsoriatic	O	O	B-T121
effect	O	O	B-T169
size	O	O	O
appeared	O	O	O
to	O	O	O
be	O	O	O
higher	O	O	O
in	O	O	O
the	O	O	O
occluded	O	O	B-T062
PPT	O	O	I-T062
than	O	O	O
the	O	O	O
open	O	O	B-T062
PPT	O	O	I-T062
,	O	O	O
despite	O	O	O
the	O	O	O
shorter	O	O	O
treatment	O	O	B-T079
duration	O	O	I-T079
(	O	O	O
2	O	O	O
vs.	O	O	O
4	O	O	O
weeks	O	O	B-T079
)	O	O	O
.	O	O	O

Effect	O	O	B-T169
dynamics	O	O	B-T070
over	O	O	O
time	O	O	B-T079
revealed	O	O	O
greater	O	O	O
differences	O	O	O
between	O	O	O
some	O	O	O
study	O	O	B-T062
drugs	O	O	B-T121
in	O	O	O
the	O	O	O
open	O	O	B-T062
PPT	O	O	I-T062
compared	O	O	O
to	O	O	O
the	O	O	O
occluded	O	O	B-T062
PPT	O	O	I-T062
.	O	O	O

Taking	O	O	O
the	O	O	O
higher	O	O	O
technical	O	O	B-T067
challenges	O	O	I-T067
for	O	O	O
the	O	O	O
open	O	O	B-T062
PPT	O	O	I-T062
into	O	O	O
account	O	O	O
,	O	O	O
we	O	O	O
recommend	O	O	O
the	O	O	O
occluded	O	O	B-T062
PPT	O	O	I-T062
as	O	O	O
a	O	O	O
standard	O	O	O
screening	O	O	B-T062
setting	O	O	O
in	O	O	O
early	O	O	B-T079
drug	O	O	B-T091
development	O	O	I-T091
.	O	O	O

In	O	O	O
special	O	O	O
cases	O	O	O
,	O	O	O
considering	O	O	O
certain	O	O	O
drug	O	O	B-T121
aspects	O	O	B-T080
or	O	O	O
study	O	O	B-T062
objectives	O	O	O
that	O	O	O
would	O	O	O
require	O	O	O
procedural	O	O	O
adaptations	O	O	O
,	O	O	O
an	O	O	O
open	O	O	B-T062
PPT	O	O	I-T062
could	O	O	O
be	O	O	O
the	O	O	O
better-suited	O	O	O
design	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
both	O	O	O
PPT	O	O	B-T062
models	O	O	O
show	O	O	O
clear	O	O	O
advantages	O	O	O
:	O	O	O
classification	O	O	B-T185
as	O	O	O
phase	O	O	B-T062
I	O	O	I-T062
studies	O	O	I-T062
,	O	O	O
small	O	O	O
number	O	O	O
of	O	O	O
psoriatic	O	O	O
subjects	O	O	O
,	O	O	O
relatively	O	O	O
short	O	O	O
study	O	O	B-T062
duration	O	O	B-T079
,	O	O	O
excellent	O	O	O
discrimination	O	O	O
between	O	O	O
compounds	O	O	B-T103
and	O	O	O
concentrations	O	O	B-T081
,	O	O	O
parallel	O	O	O
measurement	O	O	B-T169
of	O	O	O
treatment	O	O	B-T201
response	O	O	I-T201
,	O	O	O
and	O	O	O
go/no	O	O	O
go	O	O	O
decisions	O	O	O
very	O	O	O
early	O	O	B-T079
in	O	O	O
clinical	O	O	B-T062
development	O	O	I-T062
.	O	O	O

-DOCSTART- (28407650)

Insurance	O	O	B-T078
Coverage	O	O	I-T078
and	O	O	O
Utilization	O	O	B-T169
at	O	O	O
a	O	O	O
Sexually	O	O	B-T093
Transmitted	O	O	I-T093
Disease	O	O	I-T093
Clinic	O	O	I-T093
in	O	O	O
a	O	O	O
Medicaid	O	O	B-T064
Expansion	O	O	O
State	O	O	O

In	O	O	O
Rhode	O	O	B-T083
Island	O	O	I-T083
,	O	O	O
the	O	O	O
Patient	O	O	B-T089
Protection	O	O	I-T089
and	O	O	I-T089
Affordable	O	O	I-T089
Care	O	O	I-T089
Act	O	O	I-T089
has	O	O	O
led	O	O	O
to	O	O	O
over	O	O	O
95	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
state	O	O	B-T083
's	O	O	I-T083
population	O	O	B-T081
being	O	O	O
insured	O	O	B-T170
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
insurance	O	O	B-T058
coverage	O	O	I-T078
and	O	O	O
barriers	O	O	B-T033
to	O	O	O
insurance	O	O	O
use	O	O	O
among	O	O	O
patients	O	O	B-T101
presenting	O	O	O
for	O	O	O
services	O	O	B-T058
at	O	O	O
the	O	O	O
Rhode	O	O	B-T083
Island	O	O	I-T083
sexually	O	O	B-T093
transmitted	O	O	I-T093
disease	O	O	I-T093
(	O	O	I-T093
STD	O	O	I-T093
)	O	O	I-T093
clinic	O	O	I-T093
.	O	O	O

We	O	O	O
analyzed	O	O	B-T062
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
insurance	O	O	B-T078
coverage	O	O	I-T078
and	O	O	O
utilization	O	O	B-T169
among	O	O	O
patients	O	O	B-T101
presenting	O	O	O
for	O	O	O
STD	O	O	B-T047
services	O	O	B-T058
between	O	O	O
July	O	O	B-T080
and	O	O	O
December	O	O	B-T080
2015	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
692	O	O	O
patients	O	O	B-T101
had	O	O	O
insurance	O	O	B-T078
information	O	O	I-T078
available	O	O	B-T077
;	O	O	O
of	O	O	O
those	O	O	O
,	O	O	O
40	O	O	O
%	O	O	O
were	O	O	O
uninsured	O	O	B-T098
.	O	O	O

Patients	O	O	B-T101
without	O	O	B-T098
insurance	O	O	B-T058
were	O	O	O
more	O	O	O
likely	O	O	O
than	O	O	O
those	O	O	O
with	O	O	O
insurance	O	O	O
to	O	O	O
be	O	O	O
nonwhite	O	O	O
(	O	O	O
50	O	O	O
%	O	O	O
among	O	O	O
uninsured	O	O	B-T098
,	O	O	O
compared	O	O	O
with	O	O	O
40	O	O	O
%	O	O	O
among	O	O	O
insured	O	O	B-T170
;	O	O	O
P	O	O	O
=	O	O	O
0.014	O	O	O
)	O	O	O
and	O	O	O
Hispanic	O	O	B-T098
or	O	O	O
Latino/a	O	O	B-T098
(	O	O	O
25	O	O	O
%	O	O	O
,	O	O	O
compared	O	O	O
with	O	O	O
16	O	O	O
%	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.006	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
less	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
men	O	O	B-T098
who	O	O	O
have	O	O	O
sex	O	O	B-T040
with	O	O	O
men	O	O	O
(	O	O	O
27	O	O	O
%	O	O	O
,	O	O	O
compared	O	O	O
with	O	O	O
39	O	O	O
%	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Of	O	O	O
those	O	O	O
with	O	O	O
health	O	O	B-T058
insurance	O	O	I-T058
,	O	O	O
26	O	O	O
%	O	O	O
obtained	O	O	O
coverage	O	O	B-T078
as	O	O	O
a	O	O	O
result	O	O	B-T169
of	O	O	O
the	O	O	O
Affordable	O	O	B-T089
Care	O	O	I-T089
Act	O	O	I-T089
,	O	O	O
and	O	O	O
56	O	O	O
%	O	O	O
of	O	O	O
those	O	O	O
were	O	O	O
previously	O	O	O
uninsured	O	O	B-T098
.	O	O	O

Among	O	O	O
uninsured	O	O	B-T098
individuals	O	O	I-T098
,	O	O	O
barriers	O	O	B-T033
to	O	O	O
obtaining	O	O	O
health	O	O	B-T058
insurance	O	O	I-T058
included	O	O	O
cost	O	O	B-T081
and	O	O	O
unemployment	O	O	B-T033
.	O	O	O

Among	O	O	O
those	O	O	O
with	O	O	B-T170
insurance	O	O	B-T058
,	O	O	O
43	O	O	O
%	O	O	O
reported	O	O	O
willingness	O	O	B-T033
to	O	O	O
use	O	O	O
insurance	O	O	O
for	O	O	O
STD	O	O	B-T047
services	O	O	B-T058
.	O	O	O

Barriers	O	O	B-T033
to	O	O	O
insurance	O	O	B-T058
use	O	O	O
included	O	O	O
concerns	O	O	O
about	O	O	O
anonymity	O	O	B-T078
and	O	O	O
out-of-pocket	O	O	B-T081
costs	O	O	I-T081
.	O	O	O

Despite	O	O	O
expanded	O	O	O
insurance	O	O	B-T058
access	O	O	B-T078
,	O	O	O
many	O	O	O
individuals	O	O	B-T098
presenting	O	O	O
to	O	O	O
the	O	O	O
Rhode	O	O	B-T083
Island	O	O	I-T083
STD	O	O	B-T093
Clinic	O	O	I-T093
were	O	O	O
uninsured	O	O	B-T098
.	O	O	O

Among	O	O	O
those	O	O	O
who	O	O	O
were	O	O	O
insured	O	O	B-T170
,	O	O	O
significant	O	O	O
barriers	O	O	B-T033
still	O	O	O
existed	O	O	O
to	O	O	O
using	O	O	O
insurance	O	O	B-T058
.	O	O	O

STD	O	O	B-T047
clinics	O	O	I-T093
continue	O	O	O
to	O	O	O
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
providing	O	O	O
safety-net	O	O	B-T058
STD	O	O	O
services	O	O	B-T058
in	O	O	O
states	O	O	B-T083
with	O	O	O
low	O	O	O
uninsured	O	O	B-T098
rates	O	O	B-T081
.	O	O	O

Both	O	O	O
public	O	O	B-T092
and	O	O	O
private	O	O	B-T092
insurers	O	O	B-T092
are	O	O	O
needed	O	O	O
to	O	O	O
address	O	O	O
financial	O	O	B-T033
barriers	O	O	I-T033
and	O	O	O
optimize	O	O	B-T052
payment	O	O	B-T081
structures	O	O	B-T082
for	O	O	O
services	O	O	B-T058
.	O	O	O

-DOCSTART- (28410389)

Molecular	O	O	B-T059
subtyping	O	O	I-T059
of	O	O	O
Treponema	O	O	B-T007
pallidum	O	O	I-T007
and	O	O	O
associated	O	O	B-T169
factors	O	O	I-T169
of	O	O	O
serofast	O	O	B-T033
status	O	O	B-T080
in	O	O	O
early	O	O	B-T047
syphilis	O	O	I-T047
patients	O	O	B-T101
:	O	O	O
Identified	O	O	B-T080
novel	O	O	O
genotype	O	O	B-T032
and	O	O	O
cytokine	O	O	B-T116
marker	O	O	O

Serofast	O	O	B-T033
,	O	O	O
a	O	O	O
persistent	O	O	B-T079
nontreponemal	O	O	B-T169
serological	O	O	I-T169
response	O	O	B-T201
observed	O	O	B-T169
in	O	O	O
early	O	O	B-T047
syphilis	O	O	B-T047
patients	O	O	B-T101
after	O	O	O
conventional	O	O	B-T061
treatment	O	O	I-T061
,	O	O	O
remains	O	O	O
a	O	O	O
concern	O	O	B-T078
of	O	O	O
clinicians	O	O	B-T097
and	O	O	O
syphilis	O	O	O
patients	O	O	O
.	O	O	O

No	O	O	O
consensus	O	O	O
has	O	O	O
been	O	O	O
established	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
that	O	O	O
defines	O	O	O
an	O	O	O
effective	O	O	B-T080
treatment	O	O	B-T061
strategy	O	O	I-T061
and	O	O	O
clarifies	O	O	B-T052
the	O	O	O
pathogenesis	O	O	B-T046
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
517	O	O	O
patients	O	O	B-T101
with	O	O	O
early	O	O	B-T047
syphilis	O	O	I-T047
were	O	O	O
enrolled	O	O	B-T058
and	O	O	O
treated	O	O	B-T169
.	O	O	O

Twelve	O	O	O
months	O	O	B-T079
after	O	O	O
treatment	O	O	B-T061
,	O	O	O
79.3	O	O	O
%	O	O	O
(	O	O	O
410/517	O	O	O
)	O	O	O
of	O	O	O
patients	O	O	B-T101
achieved	O	O	O
serological	O	O	B-T169
cure	O	O	B-T077
,	O	O	O
20.1	O	O	O
%	O	O	O
(	O	O	O
104/517	O	O	O
)	O	O	O
were	O	O	O
serofast	O	O	B-T033
,	O	O	O
and	O	O	O
0.6	O	O	O
%	O	O	O
(	O	O	O
3/517	O	O	O
)	O	O	O
were	O	O	O
serological	O	O	O
failures	O	O	B-T169
.	O	O	O

Multivariate	O	O	B-T081
analysis	O	O	I-T081
demonstrated	O	O	O
that	O	O	O
older	O	O	B-T098
age	O	O	I-T098
(	O	O	O
>	O	O	O
40	O	O	O
years	O	O	B-T079
)	O	O	O
and	O	O	O
lower	O	O	O
baseline	O	O	B-T081
RPR	O	O	B-T059
titer	O	O	I-T059
(	O	O	O
≤	O	O	O
1:8	O	O	O
)	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
serofast	O	O	B-T033
status	O	O	B-T080
.	O	O	O

We	O	O	O
also	O	O	O
identified	O	O	O
21	O	O	O
T.	O	O	B-T007
pallidum	O	O	I-T007
molecular	O	O	B-T185
subtypes	O	O	I-T185
among	O	O	O
early	O	O	B-T047
syphilis	O	O	I-T047
patients	O	O	B-T101
and	O	O	O
detected	O	O	O
a	O	O	O
new	O	O	O
subtype	O	O	B-T185
,	O	O	I-T185
14i/a	O	O	I-T185
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
proportion	O	O	O
of	O	O	O
14i/a	O	O	B-T185
type	O	O	I-T185
in	O	O	O
serofast	O	O	B-T033
patients	O	O	B-T101
was	O	O	O
significantly	O	O	O
higher	O	O	O
than	O	O	O
that	O	O	O
in	O	O	O
patients	O	O	O
with	O	O	O
serological	O	O	B-T169
cure	O	O	B-T077
,	O	O	O
predicting	O	O	O
an	O	O	O
increasing	O	O	B-T169
risk	O	O	B-T078
of	O	O	O
serofast	O	O	O
status	O	O	B-T080
.	O	O	O

Levels	O	O	B-T080
of	O	O	O
chemerin	O	O	B-T116
were	O	O	O
higher	O	O	B-T080
in	O	O	O
the	O	O	O
serum	O	O	B-T031
of	O	O	O
serofast	O	O	B-T033
cases	O	O	O
than	O	O	O
serological	O	O	B-T169
cure	O	O	B-T077
cases	O	O	O
,	O	O	O
potentially	O	O	O
indicating	O	O	O
a	O	O	O
novel	O	O	O
cytokine	O	O	B-T116
marker	O	O	B-T201
for	O	O	O
serofast	O	O	O
in	O	O	O
early	O	O	B-T047
syphilis	O	O	I-T047
patients	O	O	B-T101
after	O	O	O
therapy	O	O	B-T061
.	O	O	O

We	O	O	O
hope	O	O	O
that	O	O	O
these	O	O	O
results	O	O	B-T169
contribute	O	O	B-T052
to	O	O	O
improve	O	O	B-T033
guidelines	O	O	B-T170
for	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
syphilis	O	O	B-T047
patients	O	O	B-T101
who	O	O	O
experience	O	O	O
serofast	O	O	B-T033
.	O	O	O

-DOCSTART- (28411311)

Total	O	O	O
Fluorescence	O	O	B-T070
Fingerprinting	O	O	B-T073
of	O	O	O
Pesticides	O	O	B-T131
:	O	O	O
A	O	O	O
Reliable	O	O	O
Approach	O	O	O
for	O	O	O
Continuous	O	O	B-T078
Monitoring	O	O	O
of	O	O	O
Soils	O	O	O
and	O	O	O
Waters	O	O	O

The	O	O	O
present	O	O	O
work	O	O	O
relates	O	O	O
to	O	O	O
the	O	O	O
creation	O	O	B-T052
/	O	O	O
extension	O	O	B-T169
of	O	O	O
a	O	O	O
database	O	O	B-T170
of	O	O	O
Total	O	O	B-T059
Excitation-Emission	O	O	I-T059
and	O	O	I-T059
Total	O	O	I-T059
Synchronous	O	O	I-T059
Fluorescence	O	O	I-T059
Matrices	O	O	I-T059
(	O	O	O
TEEMs	O	O	B-T059
and	O	O	I-T059
TSFMs	O	O	I-T059
)	O	O	O
along	O	O	O
with	O	O	O
optimal	O	O	B-T059
Synchronous	O	O	I-T059
Fluorescence	O	O	I-T059
Spectra	O	O	I-T059
(	O	O	O
SFS	O	O	B-T059
)	O	O	O
to	O	O	O
fingerprint	O	O	B-T073
pesticides	O	O	B-T131
widely	O	O	O
used	O	O	O
in	O	O	O
Morocco	O	O	B-T083
.	O	O	O

This	O	O	O
spectrometric	O	O	B-T059
multi-component	O	O	I-T059
fingerprinting	O	O	I-T059
may	O	O	O
permit	O	O	O
the	O	O	O
direct	O	O	O
detection	O	O	B-T059
of	O	O	I-T059
pesticides	O	O	I-T059
persisting	O	O	B-T131
in	O	O	I-T131
soil	O	O	I-T131
or	O	O	O
water	O	O	B-T131
.	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
the	O	O	O
current	O	O	O
investigation	O	O	O
is	O	O	O
to	O	O	O
detect	O	O	B-T059
four	O	O	I-T059
pesticide	O	O	I-T059
remains	O	O	O
in	O	O	O
agricultural	O	O	B-T082
soils	O	O	I-T082
by	O	O	O
applying	O	O	O
the	O	O	O
spectrometric	O	O	B-T059
fingerprinting	O	O	I-T059
results	O	O	O
.	O	O	O

They	O	O	O
are	O	O	O
the	O	O	O
commercial	O	O	O
:	O	O	O
i	O	O	O
)	O	O	O
insecticide	O	O	B-T131
Axlera	O	O	I-T131
5	O	O	I-T131
G	O	O	I-T131
(	O	O	O
carbamate	O	O	B-T131
)	O	O	O
,	O	O	O
ii	O	O	O
)	O	O	O
fungicide	O	O	B-T131
Orsalis	O	O	I-T131
5	O	O	I-T131
%	O	O	I-T131
SC	O	O	I-T131
(	O	O	O
triazole	O	O	B-T131
)	O	O	O
,	O	O	O
iii	O	O	O
)	O	O	O
insecticide	O	O	B-T109
Force	O	O	I-T109
0,5	O	O	I-T109
G	O	O	I-T109
(	O	O	O
pyrethrinoid	O	O	B-T109
)	O	O	O
and	O	O	O
iv	O	O	O
)	O	O	O
insecticide	O	O	B-T131
Proclaim	O	O	I-T131
05	O	O	I-T131
SG	O	O	I-T131
(	O	O	O
non-assigned	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
agricultural	O	O	B-T090
plantations	O	O	I-T090
monitored	O	O	I-T090
are	O	O	O
located	O	O	O
in	O	O	O
the	O	O	O
great	O	O	B-T083
agricultural	O	O	I-T083
Doukkala	O	O	I-T083
region	O	O	I-T083
at	O	O	O
the	O	O	O
western	O	O	B-T083
Atlantic	O	O	I-T083
side	O	O	I-T083
of	O	O	O
Morocco	O	O	B-T083
,	O	O	O
where	O	O	O
these	O	O	O
chemicals	O	O	B-T103
are	O	O	O
in	O	O	O
large	O	O	O
sale	O	O	O
and	O	O	O
use	O	O	O
.	O	O	O

-DOCSTART- (28412969)

Engagement	O	O	O
of	O	O	O
cellular	O	O	B-T116
prion	O	O	I-T116
protein	O	O	I-T116
with	O	O	O
the	O	O	O
co-chaperone	O	O	B-T116
Hsp70	O	O	B-T116
/	O	O	I-T116
90	O	O	B-T116
organizing	O	O	I-T116
protein	O	O	I-T116
regulates	O	O	O
the	O	O	O
proliferation	O	O	B-T043
of	O	O	O
glioblastoma	O	O	B-T191
stem-like	O	O	O
cells	O	O	O

Glioblastoma	O	O	B-T191
(	O	O	O
GBM	O	O	B-T191
)	O	O	O
,	O	O	O
a	O	O	O
highly	O	O	O
aggressive	O	O	O
brain	O	O	B-T191
tumor	O	O	B-T191
,	O	O	O
contains	O	O	O
a	O	O	O
subpopulation	O	O	O
of	O	O	O
glioblastoma	O	O	B-T025
stem-like	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
GSCs	O	O	B-T025
)	O	O	O
that	O	O	O
play	O	O	O
roles	O	O	O
in	O	O	O
tumor	O	O	O
maintenance	O	O	B-T052
,	O	O	O
invasion	O	O	B-T046
,	O	O	O
and	O	O	O
therapeutic	O	O	B-T038
resistance	O	O	I-T038
.	O	O	O

GSCs	O	O	B-T025
are	O	O	O
therefore	O	O	O
a	O	O	O
promising	O	O	O
target	O	O	B-T169
for	O	O	O
GBM	O	O	B-T191
treatment	O	O	B-T169
.	O	O	O

Our	O	O	O
group	O	O	O
identified	O	O	O
the	O	O	O
cellular	O	O	B-T116
prion	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
)	O	O	O
and	O	O	O
its	O	O	O
partner	O	O	O
,	O	O	O
the	O	O	O
co-chaperone	O	O	B-T116
Hsp70	O	O	B-T116
/	O	O	I-T116
90	O	O	B-T116
organizing	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
HOP	O	O	B-T116
)	O	O	O
,	O	O	O
as	O	O	O
potential	O	O	O
target	O	O	B-T169
candidates	O	O	O
due	O	O	O
to	O	O	O
their	O	O	O
role	O	O	O
in	O	O	O
GBM	O	O	B-T191
tumorigenesis	O	O	B-T191
and	O	O	O
in	O	O	O
neural	O	O	B-T025
stem	O	O	I-T025
cell	O	O	I-T025
maintenance	O	O	O
.	O	O	O

GSCs	O	O	B-T025
expressing	O	O	O
different	O	O	O
levels	O	O	O
of	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
were	O	O	O
cultured	O	O	B-T059
as	O	O	O
neurospheres	O	O	B-T025
with	O	O	O
growth	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
and	O	O	O
characterized	O	O	O
with	O	O	O
stem	O	O	B-T025
cells	O	O	I-T025
markers	O	O	B-T086
and	O	O	O
adhesion	O	O	B-T086
molecules	O	O	I-T086
markers	O	O	I-T086
through	O	O	O
immunofluorescence	O	O	B-T059
and	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
.	O	O	O

We	O	O	O
than	O	O	O
evaluated	O	O	O
GSC	O	O	B-T025
self-renewal	O	O	B-T043
and	O	O	O
proliferation	O	O	B-T043
by	O	O	O
clonal	O	O	B-T059
density	O	O	I-T059
assays	O	O	I-T059
and	O	O	O
BrdU	O	O	B-T114
incorporation	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
in	O	O	O
front	O	O	O
of	O	O	O
recombinant	O	O	O
HOP	O	O	B-T116
treatment	O	O	B-T169
,	O	O	O
combined	O	O	O
or	O	O	O
not	O	O	O
with	O	O	O
a	O	O	O
HOP	O	O	O
peptide	O	O	B-T116
which	O	O	O
mimics	O	O	O
the	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
binding	O	O	B-T192
site	O	O	I-T192
.	O	O	O

Stable	O	O	O
silencing	O	O	B-T045
of	O	O	O
HOP	O	O	B-T116
was	O	O	O
also	O	O	O
performed	O	O	O
in	O	O	O
parental	O	O	O
and/or	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
-depleted	O	O	O
cell	O	O	B-T025
populations	O	O	I-T025
,	O	O	O
and	O	O	O
proliferation	O	O	B-T043
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
in	O	O	B-T082
vivo	O	O	I-T082
were	O	O	O
evaluated	O	O	O
.	O	O	O

Migration	O	O	B-T059
assays	O	O	I-T059
were	O	O	O
performed	O	O	O
on	O	O	O
laminin-1	O	O	B-T073
pre-coated	O	O	I-T073
glass	O	O	I-T073
.	O	O	O

We	O	O	O
observed	O	O	O
that	O	O	O
,	O	O	O
when	O	O	O
GBM	O	O	B-T191
cells	O	O	B-T025
are	O	O	O
cultured	O	O	B-T059
as	O	O	O
neurospheres	O	O	B-T025
,	O	O	O
they	O	O	O
express	O	O	O
specific	O	O	O
stemness	O	O	B-T086
markers	O	O	I-T086
such	O	O	O
as	O	O	O
CD133	O	O	B-T116
,	O	O	O
CD15	O	O	B-T129
,	O	O	O
Oct4	O	O	B-T116
,	O	O	O
and	O	O	O
SOX2	O	O	B-T116
;	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
is	O	O	O
upregulated	O	O	O
compared	O	O	O
to	O	O	O
monolayer	O	O	B-T059
culture	O	O	I-T059
and	O	O	O
co-localizes	O	O	O
with	O	O	O
CD133	O	O	O
.	O	O	O

PrP(C	O	O	B-T116
)	O	O	I-T116
silencing	O	O	B-T045
downregulates	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	I-T045
molecules	O	O	I-T045
associated	O	O	O
with	O	O	O
cancer	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
upregulates	O	O	O
markers	O	O	B-T086
of	O	O	O
cell	O	O	B-T043
differentiation	O	O	I-T043
and	O	O	O
affects	O	O	O
GSC	O	O	B-T025
self-renewal	O	O	B-T043
,	O	O	O
pointing	O	O	O
to	O	O	O
a	O	O	O
pivotal	O	O	O
role	O	O	O
for	O	O	O
PrP(C	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
maintenance	O	O	O
of	O	O	O
GSCs	O	O	B-T025
.	O	O	O

Exogenous	O	O	O
HOP	O	O	B-T116
treatment	O	O	B-T169
increases	O	O	O
proliferation	O	O	B-T043
and	O	O	O
self-renewal	O	O	B-T043
of	O	O	O
GSCs	O	O	B-T025
in	O	O	O
a	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
-dependent	O	O	O
manner	O	O	O
while	O	O	O
HOP	O	O	O
knockdown	O	O	O
disturbs	O	O	O
the	O	O	O
proliferation	O	O	B-T043
process	O	O	I-T043
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
,	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
and/or	O	O	O
HOP	O	O	B-T116
knockdown	O	O	O
potently	O	O	O
inhibits	O	O	B-T052
the	O	O	O
growth	O	O	B-T043
of	O	O	O
subcutaneously	O	O	O
implanted	O	O	O
glioblastoma	O	O	B-T191
cells	O	O	B-T025
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
disruption	O	O	O
of	O	O	O
the	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
-	O	O	I-T116
HOP	O	O	B-T116
complex	O	O	I-T116
by	O	O	O
a	O	O	O
HOP	O	O	O
peptide	O	O	B-T116
,	O	O	O
which	O	O	O
mimics	O	O	O
the	O	O	O
PrP(C	O	O	O
)	O	O	O
binding	O	O	B-T192
site	O	O	I-T192
,	O	O	O
affects	O	O	O
GSC	O	O	B-T025
self-renewal	O	O	B-T043
and	O	O	O
proliferation	O	O	B-T043
indicating	O	O	O
that	O	O	O
the	O	O	O
HOP	O	O	B-T116
-	O	O	I-T116
PrP(C	O	O	I-T116
)	O	O	I-T116
complex	O	O	I-T116
is	O	O	O
required	O	O	O
for	O	O	O
GSC	O	O	O
stemness	O	O	B-T080
.	O	O	O

Furthermore	O	O	O
,	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
-depleted	O	O	O
GSCs	O	O	B-T025
downregulate	O	O	O
cell	O	O	B-T025
adhesion-related	O	O	B-T116
proteins	O	O	I-T116
and	O	O	O
impair	O	O	O
cell	O	O	B-T043
migration	O	O	I-T043
indicating	O	O	O
a	O	O	O
putative	O	O	O
role	O	O	O
for	O	O	O
PrP(C	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
cell	O	O	B-T033
surface	O	O	I-T033
stability	O	O	I-T033
of	O	O	O
cell	O	O	B-T116
adhesion	O	O	I-T116
molecules	O	O	I-T116
and	O	O	O
GBM	O	O	B-T191
cell	O	O	O
invasiveness	O	O	B-T046
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
modulation	O	O	O
of	O	O	O
HOP	O	O	B-T116
-	O	O	O
PrP(C	O	O	B-T116
)	O	O	I-T116
engagement	O	O	O
or	O	O	O
the	O	O	O
decrease	O	O	O
of	O	O	O
PrP(C	O	O	O
)	O	O	O
and	O	O	O
HOP	O	O	O
expression	O	O	B-T045
may	O	O	O
represent	O	O	O
a	O	O	O
potential	O	O	O
therapeutic	O	O	B-T061
intervention	O	O	I-T061
in	O	O	O
GBM	O	O	B-T191
,	O	O	O
regulating	O	O	O
glioblastoma	O	O	B-T025
stem-like	O	O	I-T025
cell	O	O	I-T025
self-renewal	O	O	B-T043
,	O	O	O
proliferation	O	O	B-T043
,	O	O	O
and	O	O	O
migration	O	O	B-T043
.	O	O	O

-DOCSTART- (28413179)

Cyclic	O	O	B-T047
thrombocytopenia	O	O	B-T047
synchronizing	O	O	B-T079
with	O	O	O
the	O	O	O
menstrual	O	O	B-T040
cycle	O	O	I-T040
showing	O	O	O
periodic	O	O	B-T079
phases	O	O	B-T079
of	O	O	O
thrombocytopenia	O	O	O
and	O	O	O
rebound	O	O	B-T067
thrombocytosis	O	O	O

A	O	O	O
37-	O	O	O
year	O	O	B-T079
-old	O	O	O
woman	O	O	B-T098
was	O	O	O
admitted	O	O	B-T058
to	O	O	O
our	O	O	O
hospital	O	O	B-T093
for	O	O	O
purpura	O	O	B-T047
involving	O	O	O
the	O	O	O
extremities	O	O	B-T023
and	O	O	O
thrombocytopenia	O	O	B-T047
.	O	O	O

Prednisolone	O	O	B-T109
(	O	O	O
PSL	O	O	B-T109
)	O	O	O
was	O	O	O
administered	O	O	B-T169
based	O	O	O
on	O	O	O
a	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
idiopathic	O	O	B-T047
thrombocytopenic	O	O	I-T047
purpura	O	O	I-T047
(	O	O	O
ITP	O	O	B-T047
)	O	O	O
,	O	O	O
but	O	O	O
was	O	O	O
not	O	O	B-T080
effective	O	O	I-T080
for	O	O	O
maintaining	O	O	B-T052
her	O	O	O
platelet	O	O	B-T059
count	O	O	I-T059
within	O	O	O
the	O	O	O
normal	O	O	B-T081
range	O	O	I-T081
,	O	O	O
which	O	O	O
showed	O	O	O
cyclic	O	O	B-UnknownType
fluctuation	O	O	I-UnknownType
corresponding	O	O	O
to	O	O	O
the	O	O	O
menstrual	O	O	B-T040
cycle	O	O	I-T040
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
discontinued	O	O	B-T033
PSL	O	O	B-T109
,	O	O	O
and	O	O	O
cyclic	O	O	B-T047
thrombocytopenia	O	O	I-T047
(	O	O	O
CTP	O	O	B-T047
)	O	O	O
was	O	O	O
diagnosed	O	O	B-T033
.	O	O	O

CTP	O	O	B-T047
is	O	O	O
a	O	O	O
rare	O	O	B-T047
disease	O	O	I-T047
which	O	O	O
is	O	O	O
usually	O	O	O
treated	O	O	B-T169
as	O	O	O
ITP	O	O	B-T047
but	O	O	O
with	O	O	O
no	O	O	B-T033
response	O	O	I-T033
.	O	O	O

Although	O	O	O
the	O	O	O
exact	O	O	O
cause	O	O	B-T078
of	O	O	O
CTP	O	O	B-T047
is	O	O	O
uncertain	O	O	B-T033
,	O	O	O
in	O	O	O
our	O	O	O
case	O	O	B-T077
,	O	O	O
a	O	O	O
hormonal	O	O	B-T040
mechanism	O	O	I-T040
may	O	O	O
be	O	O	O
responsible	O	O	O
for	O	O	O
fluctuating	O	O	B-T079
platelet	O	O	B-T059
count	O	O	I-T059
.	O	O	O

-DOCSTART- (28413794)

Comparative	O	O	B-T058
evaluation	O	O	I-T058
of	O	O	O
iodine-131	O	O	B-T109
metaiodobenzylguanidine	O	O	I-T109
and	O	O	O
18-fluorodeoxyglucose	O	O	B-T109
positron	O	O	B-T060
emission	O	O	I-T060
tomography	O	O	I-T060
in	O	O	O
assessing	O	O	O
neural	O	O	B-T047
crest	O	O	I-T047
tumors	O	O	I-T047
:	O	O	O
Will	O	O	O
they	O	O	O
play	O	O	O
a	O	O	O
complementary	O	O	O
role	O	O	O
?	O	O	O

18-Fluorodeoxyglucose	O	O	B-T109
positron	O	O	B-T060
emission	O	O	I-T060
tomography	O	O	I-T060
(	O	O	O
FDG-PET	O	O	B-T060
)	O	O	O
has	O	O	O
established	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
evaluation	O	O	O
of	O	O	O
several	O	O	O
malignancies	O	O	B-T191
.	O	O	O

However	O	O	O
,	O	O	O
its	O	O	O
precise	O	O	O
clinical	O	O	B-T078
role	O	O	I-T078
in	O	O	O
the	O	O	O
neural	O	O	B-T047
crest	O	O	I-T047
cell	O	O	I-T047
tumors	O	O	I-T047
continues	O	O	O
to	O	O	O
evolve	O	O	O
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
compare	O	O	O
iodine-131	O	O	B-T109
metaiodobenzylguanidine	O	O	I-T109
(	O	O	O
(131)I-MIBG	O	O	B-T109
)	O	O	O
and	O	O	O
FDG-PET	O	O	B-T060
of	O	O	O
head	O	O	O
to	O	O	O
head	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
neural	O	O	B-T047
crest	O	O	I-T047
tumors	O	O	I-T047
both	O	O	O
qualitatively	O	O	B-T080
and	O	O	O
semiquantitatively	O	O	B-T057
and	O	O	O
to	O	O	O
determine	O	O	O
their	O	O	O
clinical	O	O	B-T033
utility	O	O	I-T033
in	O	O	O
disease	O	O	B-T033
status	O	O	I-T033
evaluation	O	O	I-T033
and	O	O	O
further	O	O	B-T058
management	O	O	I-T058
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
32	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
undergone	O	O	O
(131)I-MIBG	O	O	B-T109
and	O	O	O
FDG-PET	O	O	B-T060
prospectively	O	O	O
were	O	O	O
evaluated	O	O	O
and	O	O	O
clinicopathologically	O	O	B-T169
grouped	O	O	O
into	O	O	O
three	O	O	O
categories	O	O	O
:	O	O	O
neuroblastoma	O	O	B-T191
,	O	O	O
pheochromocytoma	O	O	B-T191
,	O	O	O
and	O	O	O
medullary	O	O	B-T191
carcinoma	O	O	I-T191
thyroid	O	O	I-T191
.	O	O	O

In	O	O	O
18	O	O	O
patients	O	O	B-T101
of	O	O	O
neuroblastoma	O	O	B-T191
,	O	O	O
FDG	O	O	B-T060
PET	O	O	I-T060
and	O	O	O
(131)I-MIBG	O	O	B-T109
showed	O	O	O
patient-specific	O	O	B-T033
sensitivity	O	O	I-T033
of	O	O	O
84	O	O	O
%	O	O	O
and	O	O	O
72	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	O
maximum	O	O	B-T081
standardized	O	O	I-T081
uptake	O	O	I-T081
value	O	O	I-T081
(	O	O	O
SUVmax	O	O	B-T081
)	O	O	O
of	O	O	O
primary	O	O	B-T047
lesions	O	O	I-T047
in	O	O	O
patients	O	O	B-T101
with	O	O	O
unfavorable	O	O	B-T169
histology	O	O	I-T169
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
relatively	O	O	O
higher	O	O	O
than	O	O	O
those	O	O	O
with	O	O	O
favorable	O	O	B-T169
histology	O	O	I-T169
(	O	O	O
5.18	O	O	O
±	O	O	O
2.38	O	O	O
vs.	O	O	O
3.21	O	O	O
±	O	O	O
1.69	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	O
SUVmax	O	O	B-T081
of	O	O	O
two	O	O	O
common	O	O	O
sites	O	O	O
(	O	O	O
posterior	O	O	B-T023
superior	O	O	I-T023
iliac	O	O	I-T023
spine	O	O	I-T023
[	O	O	O
PSIS	O	O	B-T023
]	O	O	O
and	O	O	O
greater	O	O	B-T023
trochanter	O	O	I-T023
)	O	O	O
was	O	O	O
higher	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
involved	O	O	O
marrow	O	O	B-T023
than	O	O	O
those	O	O	O
with	O	O	O
uninvolved	O	O	O
one	O	O	O
(	O	O	O
2.36	O	O	O
and	O	O	O
2.75	O	O	O
vs.	O	O	O
1.26	O	O	O
and	O	O	O
1.34	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
ratio	O	O	O
of	O	O	O
SUVmax	O	O	B-T081
of	O	O	O
the	O	O	O
involved/	O	O	O
contralateral	O	O	B-T082
normal	O	O	I-T082
sites	O	O	I-T082
was	O	O	O
2.16	O	O	O
±	O	O	O
1.9	O	O	O
.	O	O	O

In	O	O	O
equivocal	O	O	B-T080
bone	O	O	B-T034
marrow	O	O	I-T034
results	O	O	I-T034
,	O	O	O
the	O	O	O
uptake	O	O	O
pattern	O	O	O
with	O	O	O
SUV	O	O	B-T081
estimation	O	O	O
can	O	O	O
depict	O	O	O
metastatic	O	O	B-T169
involvement	O	O	I-T169
and	O	O	O
help	O	O	O
in	O	O	O
redirecting	O	O	O
the	O	O	O
biopsy	O	O	B-T201
site	O	O	I-T201
.	O	O	O

Among	O	O	O
seven	O	O	O
patients	O	O	B-T101
of	O	O	O
pheochromocytoma	O	O	B-T191
,	O	O	O
FDG-PET	O	O	B-T060
revealed	O	O	O
100	O	O	O
%	O	O	O
patient-specific	O	O	B-T033
sensitivity	O	O	I-T033
.	O	O	O

FDG-PET	O	O	B-T060
detected	O	O	O
more	O	O	O
metastatic	O	O	B-T082
foci	O	O	I-T082
than	O	O	O
(131)I-MIBG	O	O	B-T109
(	O	O	O
18	O	O	O
vs.	O	O	O
13	O	O	O
sites	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
seven	O	O	O
patients	O	O	B-T101
of	O	O	O
medullary	O	O	B-T191
carcinoma	O	O	I-T191
thyroid	O	O	I-T191
,	O	O	O
FDG-PET	O	O	B-T060
localized	O	O	O
residual	O	O	O
,	O	O	O
recurrent	O	O	B-T047
,	O	O	O
or	O	O	O
metastatic	O	O	B-T191
disease	O	O	I-T191
with	O	O	O
much	O	O	O
higher	O	O	O
sensitivity	O	O	O
(	O	O	O
32	O	O	O
metastatic	O	O	B-T082
foci	O	O	I-T082
with	O	O	O
72	O	O	O
%	O	O	O
patient	O	O	B-T033
specific	O	O	I-T033
sensitivity	O	O	I-T033
)	O	O	O
than	O	O	O
(131)I-MIBG	O	O	B-T109
,	O	O	O
trending	O	O	O
along	O	O	O
the	O	O	O
higher	O	O	B-T059
serum	O	O	I-T059
calcitonin	O	O	I-T059
levels	O	O	I-T059
.	O	O	O

FDG-PET	O	O	B-T060
is	O	O	O
not	O	O	O
only	O	O	O
a	O	O	O
good	O	O	O
complementary	O	O	B-T078
modality	O	O	I-T078
in	O	O	O
the	O	O	O
management	O	O	O
of	O	O	O
neural	O	O	B-T047
crest	O	O	I-T047
cell	O	O	I-T047
tumors	O	O	I-T047
but	O	O	O
also	O	O	O
it	O	O	O
can	O	O	O
even	O	O	O
be	O	O	O
superior	O	O	O
,	O	O	O
especially	O	O	O
in	O	O	O
cases	O	O	O
of	O	O	O
(131)I-MIBG	O	O	B-T109
nonavid	O	O	B-T191
tumors	O	O	I-T191
.	O	O	O

-DOCSTART- (28416410)

Progressive	O	O	B-T169
Occlusion	O	O	I-T169
and	O	O	O
Recanalization	O	O	B-T061
after	O	O	O
Endovascular	O	O	B-T061
Treatment	O	O	I-T061
for	O	O	O
287	O	O	O
Unruptured	O	O	B-T047
Small	O	O	I-T047
Aneurysms	O	O	I-T047
(	O	O	O
<	O	O	O
5	O	O	O
mm	O	O	O
):	O	O	O
A	O	O	O
Single-Center	O	O	B-T093
6-Year	O	O	B-T079
Experience	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
coiling	O	O	B-T082
for	O	O	O
small	O	O	O
unruptured	O	O	B-T047
intracranial	O	O	I-T047
aneurysms	O	O	I-T047
(UIAs)﹤5	O	O	O
mm	O	O	O
)	O	O	O
on	O	O	O
progressive	O	O	B-T169
occlusio	O	O	I-T169
n	O	O	O
and	O	O	O
recanalization	O	O	B-T061
,	O	O	O
and	O	O	O
the	O	O	O
dubious	O	O	O
factors	O	O	O
related	O	O	O
to	O	O	O
progressive	O	O	B-T169
occlusion	O	O	B-T169
and	O	O	O
recanalization	O	O	O
among	O	O	O
UIAs	O	O	B-T047
without	O	O	O
complete	O	O	O
occlusion	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
264	O	O	O
patients	O	O	B-T101
with	O	O	O
287	O	O	O
small	O	O	O
UIAs	O	O	B-T047
were	O	O	O
coiled	O	O	O
in	O	O	O
our	O	O	O
institute	O	O	B-T092
between	O	O	O
June	O	O	O
2009	O	O	O
and	O	O	O
December	O	O	O
2014	O	O	O
.	O	O	O

All	O	O	O
UIAs	O	O	B-T047
enrolled	O	O	O
were	O	O	O
divided	O	O	O
into	O	O	O
small	O	O	O
(	O	O	O
3	O	O	O
-	O	O	O
5	O	O	O
mm	O	O	O
)	O	O	O
and	O	O	O
very	O	O	O
small	O	O	O
(	O	O	O
<3	O	O	O
mm	O	O	O
)	O	O	O
group	O	O	B-T078
s	O	O	O
,	O	O	O
and	O	O	O
UIAs	O	O	O
without	O	O	O
initial	O	O	O
complete	O	O	O
occlusion	O	O	B-T169
were	O	O	O
divided	O	O	O
into	O	O	O
progressive	O	O	B-T169
,	O	O	O
stable	O	O	B-T080
and	O	O	O
recanalization	O	O	B-T061
groups	O	O	B-T078
.	O	O	O

Baseline	O	O	B-T081
characteristics	O	O	B-T080
,	O	O	O
procedure	O	O	B-T061
-related	O	O	O
complications	O	O	B-T046
,	O	O	O
angiographic	O	O	B-T060
follow-up	O	O	B-T058
results	O	O	I-T058
,	O	O	O
and	O	O	O
clinical	O	O	B-T080
outcomes	O	O	I-T080
were	O	O	O
statistically	O	O	B-T062
analyzed	O	O	I-T062
.	O	O	O

Among	O	O	O
287	O	O	O
aneurysms	O	O	B-T047
,	O	O	O
211	O	O	O
aneurysms	O	O	O
(	O	O	O
73.5	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
completely	O	O	O
coiled	O	O	O
,	O	O	O
three	O	O	O
(	O	O	O
1.2	O	O	O
%	O	O	O
)	O	O	O
intraoperative	O	O	B-T079
ruptures	O	O	B-T037
and	O	O	O
12	O	O	O
(	O	O	O
4.2	O	O	O
%	O	O	O
)	O	O	O
perioperative	O	O	B-T079
thromboembolic	O	O	B-T046
events	O	O	I-T046
occurred	O	O	O
.	O	O	O

Angiographic	O	O	B-T060
follow-up	O	O	B-T058
was	O	O	O
available	O	O	O
for	O	O	O
174	O	O	O
patients	O	O	B-T101
(	O	O	O
65.9	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
recanalization	O	O	B-T061
was	O	O	O
5.7	O	O	O
%	O	O	O
.	O	O	O

Among	O	O	O
56	O	O	O
aneurysms	O	O	B-T047
without	O	O	O
complete	O	O	O
occlusion	O	O	B-T169
,	O	O	O
43	O	O	O
(	O	O	O
76.8	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
progressive	O	O	B-T169
occlusion	O	O	I-T169
and	O	O	O
6(10.7	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
recanalization	O	O	B-T061
.	O	O	O

Anatomic	O	O	B-T033
results	O	O	I-T033
of	O	O	O
initial	O	O	O
and	O	O	O
follow-up	O	O	B-T058
between	O	O	O
small	O	O	O
and	O	O	O
very	O	O	O
small	O	O	O
groups	O	O	B-T078
were	O	O	O
similar	O	O	O
in	O	O	O
both	O	O	O
groups	O	O	O
.	O	O	O

On	O	O	O
logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
,	O	O	O
smaller	O	O	O
size	O	O	B-T082
(	O	O	O
<3	O	O	O
mm	O	O	O
)	O	O	O
without	O	O	O
complete	O	O	O
occlusion	O	O	B-T169
related	O	O	O
to	O	O	O
recanalization	O	O	B-T061
(	O	O	O
OR	O	O	O
,	O	O	O
8.0	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.3	O	O	O
-	O	O	O
50.0	O	O	O
,	O	O	O
P=0.026	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
study	O	O	B-T062
suggested	O	O	O
that	O	O	O
coil	O	O	B-T061
embolization	O	O	I-T061
of	O	O	O
small	O	O	O
UIAs	O	O	B-T047
can	O	O	O
achieve	O	O	O
a	O	O	O
high	O	O	O
rate	O	O	O
of	O	O	O
progressive	O	O	B-T169
occlusion	O	O	I-T169
and	O	O	O
low	O	O	O
rate	O	O	O
of	O	O	O
recanalization	O	O	B-T061
during	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Anatomic	O	O	B-T033
results	O	O	I-T033
of	O	O	O
initial	O	O	O
and	O	O	O
follow-up	O	O	B-T058
between	O	O	O
small	O	O	O
(	O	O	O
3	O	O	O
-	O	O	O
5	O	O	O
mm	O	O	O
)	O	O	O
and	O	O	O
very	O	O	O
small	O	O	O
(	O	O	O
<3	O	O	O
mm	O	O	O
)	O	O	O
groups	O	O	B-T078
were	O	O	O
similar	O	O	O
in	O	O	O
both	O	O	O
groups	O	O	O
.	O	O	O

What	O	O	O
's	O	O	O
more	O	O	O
,	O	O	O
smaller	O	O	O
size	O	O	O
(	O	O	O
<3	O	O	O
mm	O	O	O
)	O	O	O
without	O	O	O
complete	O	O	O
occlusion	O	O	B-T169
may	O	O	O
relate	O	O	O
to	O	O	O
recanalization	O	O	B-T061
.	O	O	O

-DOCSTART- (28417422)

Selection	O	O	B-T052
of	O	O	O
an	O	O	O
Artificial	O	O	B-T080
Diet	O	O	B-T168
for	O	O	O
Laboratory	O	O	B-T093
Rearing	O	O	B-T059
of	O	O	O
Opogona	O	O	B-T204
sacchari	O	O	I-T204
(	O	O	O
Lepidoptera	O	O	B-T204
:	O	O	O
Tineidae	O	O	B-T204
)	O	O	O
(	O	O	O
Bojer	O	O	O
,	O	O	O
1856	O	O	O
)	O	O	O

The	O	O	O
banana	O	O	B-T168
moth	O	O	I-T204
Opogona	O	O	I-T204
sacchari	O	O	I-T204
(	O	O	O
Bojer	O	O	B-T204
)	O	O	O
(	O	O	O
Lepidoptera	O	O	B-T204
:	O	O	O
Tineidae	O	O	B-T204
)	O	O	O
is	O	O	O
a	O	O	O
polyphagous	O	O	B-T204
pest	O	O	I-T204
that	O	O	O
can	O	O	O
cause	O	O	O
serious	O	O	B-T080
damage	O	O	B-T169
,	O	O	O
in	O	O	O
particular	O	O	O
to	O	O	O
banana	O	O	O
crops	O	O	B-T002
in	O	O	O
southern	O	O	B-T082
Brazil	O	O	B-T083
.	O	O	O

The	O	O	O
insect	O	O	B-T204
is	O	O	O
a	O	O	O
quarantine	O	O	O
pest	O	O	B-T204
in	O	O	O
several	O	O	O
countries	O	O	B-T083
,	O	O	O
including	O	O	O
Argentina	O	O	B-T083
,	O	O	O
the	O	O	O
main	O	O	O
consumer	O	O	B-T098
market	O	O	B-T083
for	O	O	O
bananas	O	O	B-T168
from	O	O	O
southern	O	O	B-T082
Brazil	O	O	B-T083
.	O	O	O

Little	O	O	O
information	O	O	B-T078
is	O	O	O
available	O	O	O
about	O	O	O
the	O	O	O
biology	O	O	B-T091
and	O	O	O
ecology	O	O	B-T090
of	O	O	O
this	O	O	O
moth	O	O	B-T204
,	O	O	O
such	O	O	O
as	O	O	O
a	O	O	O
suitable	O	O	O
diet	O	O	B-T168
for	O	O	O
laboratory	O	O	B-T093
rearing	O	O	B-T059
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
provide	O	O	O
support	O	O	O
for	O	O	O
integrated	O	O	O
pest	O	O	B-T204
management	O	O	I-T057
of	O	O	O
the	O	O	O
pest	O	O	O
,	O	O	O
this	O	O	O
study	O	O	B-T062
furnished	O	O	O
data	O	O	B-T078
for	O	O	O
selecting	O	O	O
two	O	O	O
diets	O	O	B-T168
suitable	O	O	O
for	O	O	O
continuous	O	O	O
laboratory	O	O	B-T093
rearing	O	O	B-T059
of	O	O	O
O.	O	O	B-T204
sacchari	O	O	I-T204
,	O	O	O
one	O	O	O
based	O	O	O
on	O	O	O
dried	O	O	B-T080
beans	O	O	B-T168
,	O	O	O
wheat	O	O	B-T168
germ	O	O	I-T168
,	O	O	O
soy	O	O	B-T168
bran	O	O	I-T168
,	O	O	O
brewer	O	O	B-T004
's	O	O	I-T004
yeast	O	O	I-T004
,	O	O	O
and	O	O	O
casein	O	O	B-T116
and	O	O	O
another	O	O	O
diet	O	O	B-T168
with	O	O	O
wheat	O	O	O
germ	O	O	O
and	O	O	O
casein	O	O	O
as	O	O	O
protein	O	O	B-T116
sources	O	O	B-T033
.	O	O	O

With	O	O	O
both	O	O	O
diets	O	O	B-T168
,	O	O	O
the	O	O	O
viability	O	O	B-T080
of	O	O	O
the	O	O	O
egg	O	O	B-T025
-	O	O	O
adult	O	O	B-T100
period	O	O	B-T079
exceeded	O	O	O
68	O	O	O
%	O	O	O
,	O	O	O
with	O	O	O
fertility	O	O	B-T040
over	O	O	O
338	O	O	O
eggs	O	O	B-T025
per	O	O	O
female	O	O	B-T098
.	O	O	O

A	O	O	O
corrected	O	O	O
biotic	O	O	B-T070
potential	O	O	B-T080
analysis	O	O	B-T062
gave	O	O	O
similar	O	O	O
values	O	O	B-T080
for	O	O	O
the	O	O	O
two	O	O	O
diets	O	O	B-T168
.	O	O	O

-DOCSTART- (28420538)

The	O	O	O
impact	O	O	B-T080
on	O	O	O
productivity	O	O	B-T081
of	O	O	O
a	O	O	O
hypothetical	O	O	B-T081
tax	O	O	I-T081
on	O	O	O
sugar-sweetened	O	O	O
beverages	O	O	O

To	O	O	O
quantify	O	O	O
the	O	O	O
potential	O	O	B-T080
impact	O	O	B-T080
of	O	O	O
an	O	O	O
additional	O	O	B-T169
20	O	O	O
%	O	O	O
tax	O	O	B-T081
on	O	O	O
sugar-sweetened	O	O	B-T168
beverages	O	O	I-T168
(	O	O	O
SSBs	O	O	B-T168
)	O	O	O
on	O	O	O
productivity	O	O	B-T081
in	O	O	O
Australia	O	O	B-T083
.	O	O	O

We	O	O	O
used	O	O	O
a	O	O	O
multi-state	O	O	B-T081
lifetable	O	O	I-T081
Markov	O	O	I-T081
model	O	O	I-T081
to	O	O	O
examine	O	O	B-T033
the	O	O	O
potential	O	O	B-T080
impact	O	O	B-T080
of	O	O	O
an	O	O	O
additional	O	O	B-T169
20	O	O	O
%	O	O	O
tax	O	O	B-T081
on	O	O	O
SSBs	O	O	B-T168
on	O	O	O
total	O	O	B-T079
lifetime	O	O	I-T079
productivity	O	O	B-T081
in	O	O	O
the	O	O	O
paid	O	O	B-T078
and	O	O	I-T078
unpaid	O	O	I-T078
sectors	O	O	I-T078
of	O	O	O
the	O	O	O
economy	O	O	B-T081
.	O	O	O

The	O	O	O
study	O	O	B-T098
population	O	O	I-T098
consisted	O	O	O
of	O	O	O
Australians	O	O	B-T098
aged	O	O	B-T032
20	O	O	O
years	O	O	B-T079
or	O	O	O
older	O	O	B-T098
in	O	O	O
2010	O	O	O
,	O	O	O
whose	O	O	O
health	O	O	B-T170
and	O	O	O
other	O	O	O
relevant	O	O	B-T080
outcomes	O	O	B-T169
were	O	O	O
modelled	O	O	B-T062
over	O	O	O
their	O	O	O
remaining	O	O	B-T080
lifetime	O	O	B-T079
.	O	O	O

The	O	O	O
SSBs	O	O	B-T168
tax	O	O	B-T081
was	O	O	O
estimated	O	O	B-T081
to	O	O	O
reduce	O	O	B-T080
the	O	O	O
number	O	O	B-T081
of	O	O	O
people	O	O	B-T098
with	O	O	O
obesity	O	O	B-T047
by	O	O	O
1.96	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
entire	O	O	O
population	O	O	B-T098
(	O	O	O
437,000	O	O	O
fewer	O	O	O
persons	O	O	B-T098
with	O	O	O
obesity	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
reduce	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
employees	O	O	B-T097
with	O	O	O
obesity	O	O	O
by	O	O	O
317,000	O	O	O
persons	O	O	O
.	O	O	O

These	O	O	O
effects	O	O	B-T080
translated	O	O	O
into	O	O	O
productivity	O	O	B-T081
gains	O	O	B-T081
in	O	O	O
the	O	O	O
paid	O	O	B-T078
sector	O	O	I-T078
of	O	O	O
AU$751	O	O	O
million	O	O	B-T081
for	O	O	O
the	O	O	O
working	O	O	B-T057
-	O	O	O
age	O	O	B-T032
population	O	O	B-T098
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
:	O	O	O
AU$565	O	O	O
million	O	O	O
to	O	O	O
AU$954	O	O	O
million	O	O	O
)	O	O	O
,	O	O	O
using	O	O	O
the	O	O	O
human	O	O	B-T081
capital	O	O	I-T081
approach	O	O	B-T082
.	O	O	O

In	O	O	O
the	O	O	O
unpaid	O	O	B-T078
sector	O	O	I-T078
,	O	O	O
the	O	O	O
potential	O	O	B-T080
productivity	O	O	B-T081
gains	O	O	B-T081
amounted	O	O	B-T081
to	O	O	O
AU$1172	O	O	O
million	O	O	B-T081
(	O	O	O
AU$929	O	O	O
million	O	O	O
to	O	O	O
AU$1435	O	O	O
million	O	O	O
)	O	O	O
using	O	O	O
the	O	O	O
replacement	O	O	B-T170
cost	O	O	I-T170
method	O	O	I-T170
.	O	O	O

These	O	O	O
productivity	O	O	B-T081
benefits	O	O	B-T081
are	O	O	O
in	O	O	O
addition	O	O	O
to	O	O	O
the	O	O	O
health	O	O	B-T081
benefits	O	O	I-T081
of	O	O	O
35,000	O	O	O
life	O	O	B-T079
years	O	O	I-T079
gained	O	O	B-T081
and	O	O	O
a	O	O	O
reduction	O	O	B-T080
in	O	O	O
healthcare	O	O	B-T081
costs	O	O	I-T081
of	O	O	O
AU$425	O	O	O
million	O	O	B-T081
.	O	O	O

An	O	O	O
additional	O	O	B-T169
20	O	O	O
%	O	O	O
tax	O	O	B-T081
on	O	O	O
SSBs	O	O	B-T168
not	O	O	O
only	O	O	O
improves	O	O	B-T033
health	O	O	B-T170
outcomes	O	O	I-T170
and	O	O	O
reduces	O	O	B-T080
healthcare	O	O	B-T081
costs	O	O	I-T081
,	O	O	O
but	O	O	O
provides	O	O	O
productivity	O	O	B-T081
gains	O	O	B-T081
in	O	O	O
both	O	O	O
the	O	O	O
paid	O	O	B-T078
and	O	O	I-T078
unpaid	O	O	I-T078
sectors	O	O	I-T078
of	O	O	O
the	O	O	O
economy	O	O	B-T081
.	O	O	O

-DOCSTART- (28421026)

Keeping	O	O	O
the	O	O	O
Spirits	O	O	O
Up	O	O	O
:	O	O	O
The	O	O	O
Effect	O	O	B-T080
of	O	O	O
Teachers	O	O	B-T097
'	O	O	I-T097
and	O	O	O
Parents	O	O	B-T099
'	O	O	I-T099
Emotional	O	O	B-T058
Support	O	O	I-T058
on	O	O	O
Children	O	O	B-T100
's	O	O	I-T100
Working	O	O	B-T041
Memory	O	O	I-T041
Performance	O	O	O

Working	O	O	B-T041
memory	O	O	I-T041
,	O	O	O
used	O	O	O
to	O	O	O
temporarily	O	O	B-T041
store	O	O	I-T041
and	O	O	O
mentally	O	O	O
manipulate	O	O	O
information	O	O	B-T078
,	O	O	O
is	O	O	O
important	O	O	O
for	O	O	O
children	O	O	B-T100
's	O	O	I-T100
learning	O	O	B-T041
.	O	O	O

It	O	O	O
is	O	O	O
therefore	O	O	O
valuable	O	O	O
to	O	O	O
understand	O	O	O
which	O	O	O
(	O	O	O
contextual	O	O	O
)	O	O	O
factors	O	O	B-T169
promote	O	O	B-T052
or	O	O	O
hinder	O	O	B-T052
working	O	O	B-T041
memory	O	O	I-T041
performance	O	O	B-T041
.	O	O	O

Recent	O	O	O
research	O	O	B-T062
shows	O	O	O
positive	O	O	B-T033
associations	O	O	B-T080
between	O	O	O
positive	O	O	O
parent-child	O	O	B-T054
and	O	O	O
teacher-student	O	O	B-T054
interactions	O	O	I-T054
and	O	O	O
working	O	O	B-T041
memory	O	O	I-T041
performance	O	O	B-T041
and	O	O	O
development	O	O	B-T169
.	O	O	O

However	O	O	O
,	O	O	O
no	O	O	O
study	O	O	B-T062
has	O	O	O
yet	O	O	O
experimentally	O	O	B-T169
investigated	O	O	I-T169
how	O	O	O
parents	O	O	B-T099
and	O	O	O
teachers	O	O	B-T097
affect	O	O	O
working	O	O	B-T041
memory	O	O	I-T041
performance	O	O	B-T041
.	O	O	O

Based	O	O	O
on	O	O	O
attachment	O	O	B-T078
theory	O	O	I-T078
,	O	O	O
the	O	O	O
current	O	O	O
study	O	O	B-T062
investigated	O	O	B-T169
the	O	O	O
role	O	O	O
of	O	O	O
parent	O	O	B-T099
and	O	O	O
teacher	O	O	B-T097
emotional	O	O	B-T058
support	O	O	I-T058
in	O	O	O
promoting	O	O	B-T052
working	O	O	B-T041
memory	O	O	I-T041
performance	O	O	B-T041
by	O	O	O
buffering	O	O	O
the	O	O	O
negative	O	O	B-T033
effect	O	O	B-T080
of	O	O	O
social	O	O	B-T048
stress	O	O	I-T048
.	O	O	O

Questionnaires	O	O	B-T170
and	O	O	O
an	O	O	O
experimental	O	O	B-T062
session	O	O	I-T062
were	O	O	O
completed	O	O	O
by	O	O	O
170	O	O	O
children	O	O	B-T100
from	O	O	O
grade	O	O	O
1	O	O	O
to	O	O	O
2	O	O	O
(	O	O	O
Mage	O	O	O
=	O	O	O
7	O	O	O
years	O	O	B-T079
6	O	O	O
months	O	O	B-T079
,	O	O	O
SD	O	O	O
=	O	O	O
7	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

Questionnaires	O	O	B-T170
were	O	O	O
used	O	O	O
to	O	O	O
assess	O	O	O
children	O	O	B-T100
's	O	O	I-T100
perceptions	O	O	B-T041
of	O	O	O
the	O	O	O
teacher-student	O	O	B-T054
and	O	O	O
parent-child	O	O	B-T054
relationship	O	O	I-T054
.	O	O	O

During	O	O	O
an	O	O	O
experimental	O	O	B-T062
session	O	O	I-T062
,	O	O	O
working	O	O	B-T041
memory	O	O	I-T041
was	O	O	O
measured	O	O	O
with	O	O	O
the	O	O	O
Corsi	O	O	B-UnknownType
task	O	O	I-UnknownType
backward	O	O	I-UnknownType
(	O	O	O
Milner	O	O	O
,	O	O	O
1971	O	O	O
)	O	O	O
in	O	O	O
a	O	O	O
pre-	O	O	B-T052
and	O	O	O
post-test	O	O	B-T052
design	O	O	I-T052
.	O	O	O

In-between	O	O	O
the	O	O	O
tests	O	O	B-T170
stress	O	O	B-T033
was	O	O	O
induced	O	O	B-T169
in	O	O	O
the	O	O	O
children	O	O	B-T100
using	O	O	O
the	O	O	O
Cyberball	O	O	B-T062
paradigm	O	O	I-T062
(	O	O	O
Williams	O	O	O
et	O	O	O
al.	O	O	O
,	O	O	O
2000	O	O	O
)	O	O	O
.	O	O	O

Emotional	O	O	B-T058
support	O	O	I-T058
was	O	O	O
manipulated	O	O	B-T053
(	O	O	O
between-subjects	O	O	O
)	O	O	O
through	O	O	O
an	O	O	O
audio	O	O	B-T073
message	O	O	B-T170
(	O	O	O
either	O	O	O
a	O	O	O
weather	O	O	B-T070
report	O	O	B-T170
,	O	O	O
a	O	O	O
supportive	O	O	B-T058
message	O	O	O
of	O	O	O
a	O	O	O
stranger	O	O	B-T098
,	O	O	O
a	O	O	O
supportive	O	O	O
message	O	O	O
of	O	O	O
a	O	O	O
parent	O	O	B-T099
,	O	O	O
or	O	O	O
a	O	O	O
supportive	O	O	O
message	O	O	O
of	O	O	O
a	O	O	O
teacher	O	O	B-T097
)	O	O	O
.	O	O	O

Results	O	O	B-T169
of	O	O	O
repeated	O	O	B-T062
measures	O	O	I-T062
ANOVA	O	O	B-T081
showed	O	O	O
no	O	O	O
clear	O	O	O
effect	O	O	B-T080
of	O	O	O
the	O	O	O
stress	O	O	B-T033
induction	O	O	B-T169
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
an	O	O	O
effect	O	O	B-T080
of	O	O	O
parent	O	O	B-T099
and	O	O	O
teacher	O	O	B-T097
support	O	O	B-T058
was	O	O	O
found	O	O	O
and	O	O	O
depended	O	O	O
on	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
the	O	O	O
parent-child	O	O	B-T054
relationship	O	O	I-T054
.	O	O	O

When	O	O	O
children	O	O	B-T100
had	O	O	O
a	O	O	O
positive	O	O	B-T033
relationship	O	O	B-T080
with	O	O	O
their	O	O	O
parent	O	O	B-T099
,	O	O	O
support	O	O	B-T058
of	O	O	O
parents	O	O	B-T099
and	O	O	O
teachers	O	O	B-T097
had	O	O	O
little	O	O	O
effect	O	O	B-T080
on	O	O	O
working	O	O	B-T041
memory	O	O	I-T041
performance	O	O	B-T041
.	O	O	O

When	O	O	O
children	O	O	B-T100
had	O	O	O
a	O	O	O
negative	O	O	B-T033
relationship	O	O	B-T080
with	O	O	O
their	O	O	O
parent	O	O	B-T099
,	O	O	O
a	O	O	O
supportive	O	O	B-T058
message	O	O	B-T170
of	O	O	O
that	O	O	O
parent	O	O	O
decreased	O	O	O
working	O	O	B-T041
memory	O	O	I-T041
performance	O	O	B-T041
,	O	O	O
while	O	O	O
a	O	O	O
supportive	O	O	O
message	O	O	O
from	O	O	O
the	O	O	O
teacher	O	O	B-T097
increased	O	O	O
performance	O	O	O
.	O	O	O

In	O	O	O
sum	O	O	O
,	O	O	O
the	O	O	O
current	O	O	O
study	O	O	B-T062
suggests	O	O	O
that	O	O	O
parents	O	O	B-T099
and	O	O	O
teachers	O	O	B-T097
can	O	O	O
support	O	O	B-T058
working	O	O	B-T041
memory	O	O	I-T041
performance	O	O	B-T041
by	O	O	O
being	O	O	O
supportive	O	O	B-T058
for	O	O	O
the	O	O	O
child	O	O	B-T100
.	O	O	O

Teacher	O	O	B-T097
support	O	O	B-T058
is	O	O	O
most	O	O	O
effective	O	O	B-T080
when	O	O	O
the	O	O	O
child	O	O	B-T100
has	O	O	O
a	O	O	O
negative	O	O	B-T033
relationship	O	O	B-T080
with	O	O	O
the	O	O	O
parent	O	O	B-T099
.	O	O	O

These	O	O	O
insights	O	O	O
can	O	O	O
give	O	O	O
direction	O	O	O
to	O	O	O
specific	O	O	O
measures	O	O	O
aimed	O	O	O
at	O	O	O
preventing	O	O	B-T169
and	O	O	O
resolving	O	O	B-T033
working	O	O	B-T041
memory	O	O	I-T041
problems	O	O	B-T033
and	O	O	O
related	O	O	O
issues	O	O	B-T033
.	O	O	O

-DOCSTART- (28424445)

Management	O	O	B-T057
of	O	O	O
tachyarrhythmia	O	O	B-T033
during	O	O	O
pregnancy	O	O	O

Maternal	O	O	B-T033
tachyarrhythmia	O	O	B-T033
is	O	O	O
a	O	O	O
common	O	O	B-T081
complication	O	O	B-T046
during	O	O	O
pregnancy	O	O	B-T040
due	O	O	O
to	O	O	O
hormonal	O	O	B-T033
changes	O	O	I-T033
that	O	O	O
enhance	O	O	B-T052
pre-existing	O	O	B-T080
arrhythmias	O	O	B-T033
or	O	O	O
induce	O	O	B-T169
new	O	O	O
arrhythmias	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
congenital	O	O	B-T019
heart	O	O	I-T019
defects	O	O	I-T019
in	O	O	O
pregnant	O	O	B-T098
females	O	O	I-T098
.	O	O	O

Presence	O	O	B-T033
of	O	O	O
tachyarrhythmia	O	O	B-T033
during	O	O	O
pregnancy	O	O	B-T040
poses	O	O	O
risk	O	O	B-T078
to	O	O	O
the	O	O	O
mother	O	O	B-T099
and	O	O	O
fetus	O	O	B-T018
,	O	O	O
calling	O	O	B-T041
for	O	O	O
proper	O	O	B-T061
treatment	O	O	I-T061
with	O	O	O
medications	O	O	B-T121
.	O	O	O

Use	O	O	O
of	O	O	O
antiarrhythmic	O	O	B-T121
drugs	O	O	I-T121
in	O	O	O
cases	O	O	O
of	O	O	O
maternal	O	O	B-T033
tachyarrhythmia	O	O	B-T033
must	O	O	O
give	O	O	O
due	O	O	O
consideration	O	O	B-T078
of	O	O	O
potential	O	O	B-T080
teratogenic	O	O	B-T046
side	O	O	I-T046
effects	O	O	I-T046
.	O	O	O

Utilization	O	O	B-T169
of	O	O	O
antiarrhythmic	O	O	B-T121
drugs	O	O	I-T121
during	O	O	O
pregnancy	O	O	B-T040
has	O	O	O
been	O	O	O
well	O	O	O
studied	O	O	B-T062
;	O	O	O
some	O	O	O
result	O	O	B-T169
in	O	O	O
minimal	O	O	B-T080
fetal	O	O	B-T018
harm	O	O	B-T037
or	O	O	O
none	O	O	O
at	O	O	O
all	O	O	O
.	O	O	O

New	O	O	O
techniques	O	O	B-T169
,	O	O	O
such	O	O	O
as	O	O	O
cardiac	O	O	B-T061
ablation	O	O	I-T061
,	O	O	O
have	O	O	O
also	O	O	O
been	O	O	O
implemented	O	O	B-T052
with	O	O	O
minimal	O	O	B-T080
or	O	O	O
no	O	O	O
radiation	O	O	B-T037
exposure	O	O	I-T037
to	O	O	O
the	O	O	O
fetus	O	O	B-T018
or	O	O	O
mother	O	O	B-T099
.	O	O	O

Pregnant	O	O	B-T098
women	O	O	I-T098
with	O	O	O
tachyarrhythmia	O	O	B-T033
have	O	O	O
been	O	O	O
successfully	O	O	B-T080
treated	O	O	B-T033
with	O	O	O
little	O	O	B-T081
to	O	O	O
no	O	O	O
impact	O	O	B-T080
on	O	O	O
the	O	O	O
developing	O	O	B-T039
fetus	O	O	I-T039
as	O	O	O
result	O	O	B-T169
of	O	O	O
increasing	O	O	B-T169
experience	O	O	B-T041
with	O	O	O
antiarrhythmic	O	O	B-T121
drugs	O	O	I-T121
and	O	O	O
progress	O	O	B-T169
of	O	O	O
new	O	O	O
procedural	O	O	B-T169
techniques	O	O	B-T169
.	O	O	O

-DOCSTART- (28424584)

Hif-1α	O	O	B-T116
Overexpression	O	O	B-T045
Improves	O	O	B-T033
Transplanted	O	O	B-T061
Bone	O	O	I-T061
Mesenchymal	O	O	I-T061
Stem	O	O	I-T061
Cells	O	O	I-T061
Survival	O	O	B-T043
in	O	O	O
Rat	O	O	O
MCAO	O	O	O
Stroke	O	O	O
Model	O	O	O

Bone	O	O	B-T025
mesenchymal	O	O	I-T025
stem	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
BMSCs	O	O	B-T025
)	O	O	O
death	O	O	B-T043
after	O	O	O
transplantation	O	O	B-T061
is	O	O	O
a	O	O	O
serious	O	O	O
obstacle	O	O	O
impacting	O	O	O
on	O	O	O
the	O	O	O
outcome	O	O	O
of	O	O	O
cell	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
cerebral	O	O	B-T047
infarction	O	O	I-T047
.	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
aimed	O	O	B-T078
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
modification	O	O	B-T169
of	O	O	O
BMSCs	O	O	B-T025
with	O	O	O
hypoxia-inducible	O	O	B-T116
factor	O	O	I-T116
1α	O	O	I-T116
(	O	O	O
Hif-1α	O	O	B-T116
)	O	O	O
could	O	O	O
enhance	O	O	B-T052
the	O	O	O
survival	O	O	B-T043
of	O	O	O
the	O	O	O
implanted	O	O	B-T061
BMSCs	O	O	I-T061
.	O	O	O

BMSCs	O	O	B-T025
were	O	O	O
isolated	O	O	B-T059
from	O	O	O
Wistar	O	O	B-T015
rats	O	O	I-T015
,	O	O	O
and	O	O	O
were	O	O	O
infected	O	O	B-T046
with	O	O	O
Hif-1α-GFP	O	O	B-T121
lentiviral	O	O	I-T121
vector	O	O	I-T121
or	O	O	O
Hif-1α	O	O	B-T114
siRNA	O	O	I-T114
.	O	O	O

The	O	O	O
modified	O	O	B-T169
BMSCs	O	O	B-T025
were	O	O	O
exposed	O	O	O
to	O	O	O
oxygen-glucose	O	O	B-T039
deprivation	O	O	I-T039
(	O	O	I-T039
OGD	O	O	I-T039
)	O	O	I-T039
condition	O	O	I-T039
,	O	O	O
cellular	O	O	B-T043
viability	O	O	I-T043
and	O	O	O
apoptosis	O	O	B-T043
were	O	O	O
then	O	O	O
assessed	O	O	B-T052
.	O	O	O

An	O	O	O
inhibitor	O	O	B-T121
of	O	O	O
AMPK	O	O	B-T116
(	O	O	O
compound	O	O	B-T121
C	O	O	I-T121
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
detect	O	O	B-T061
whether	O	O	O
AMPK	O	O	O
and	O	O	O
mTOR	O	O	B-T116
were	O	O	O
implicated	O	O	O
in	O	O	O
the	O	O	O
functions	O	O	O
of	O	O	O
Hif-1α	O	O	B-T116
on	O	O	O
BMSCs	O	O	B-T043
survival	O	O	I-T043
.	O	O	O

Besides	O	O	O
,	O	O	O
ultrastructure	O	O	O
of	O	O	O
BMSCs	O	O	B-T025
was	O	O	O
observed	O	O	O
and	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	I-T045
autophagy	O	O	I-T045
markers	O	O	I-T045
was	O	O	O
measured	O	O	O
.	O	O	O

The	O	O	O
modified	O	O	B-T169
BMSCs	O	O	B-T025
were	O	O	O
transplanted	O	O	B-T061
into	O	O	O
middle	O	O	B-T020
cerebral	O	O	I-T020
artery	O	O	I-T020
occlusion	O	O	I-T020
(	O	O	O
MCAO	O	O	B-T020
)	O	O	O
model	O	O	B-T050
of	O	O	I-T050
rats	O	O	I-T050
,	O	O	O
and	O	O	O
the	O	O	O
cerebral	O	O	B-T047
infarction	O	O	I-T047
volume	O	O	B-T081
and	O	O	O
neurological	O	O	B-T042
function	O	O	I-T042
was	O	O	O
assessed	O	O	B-T052
.	O	O	O

The	O	O	O
results	O	O	O
indicated	O	O	O
that	O	O	O
Hif-1α	O	O	B-T045
overexpression	O	O	I-T045
protected	O	O	O
OGD	O	O	B-T039
induced	O	O	B-T169
injury	O	O	B-T037
by	O	O	O
promoting	O	O	O
cellular	O	O	B-T043
viability	O	O	I-T043
and	O	O	O
inhibiting	O	O	B-T044
apoptosis	O	O	B-T043
.	O	O	O

AMPK	O	O	B-T116
was	O	O	O
activated	O	O	O
while	O	O	O
mTOR	O	O	B-T116
was	O	O	O
inactivated	O	O	B-T169
by	O	O	O
Hif-1α	O	O	B-T116
overexpression	O	O	I-T045
,	O	O	O
and	O	O	O
that	O	O	O
might	O	O	O
be	O	O	O
through	O	O	O
which	O	O	O
Hif-1α	O	O	O
functioned	O	O	O
BMSCs	O	O	B-T043
survival	O	O	I-T043
.	O	O	O

Hif-1α	O	O	B-T045
overexpression	O	O	I-T045
promoted	O	O	O
autophagy	O	O	B-T043
;	O	O	O
more	O	O	O
important	O	O	O
,	O	O	O
compound	O	O	B-T121
C	O	O	I-T121
abolished	O	O	O
the	O	O	O
induction	O	O	B-T045
of	O	O	I-T045
Hif-1α	O	O	I-T045
on	O	O	O
autophagy	O	O	O
.	O	O	O

Transplantation	O	O	B-T061
of	O	O	I-T061
the	O	O	I-T061
overexpressed	O	O	I-T061
Hif-1α	O	O	I-T061
of	O	O	I-T061
BMSCs	O	O	I-T061
into	O	O	O
the	O	O	O
MCAO	O	O	B-T050
rats	O	O	I-T050
reduced	O	O	O
brain	O	O	B-T047
infarct	O	O	I-T047
volume	O	O	B-T081
and	O	O	O
improved	O	O	B-T033
neurobehavioral	O	O	B-T080
outcome	O	O	I-T080
;	O	O	O
besides	O	O	O
,	O	O	O
it	O	O	O
inhibited	O	O	O
pro-inflammatory	O	O	B-T116
cytokines	O	O	I-T116
generation	O	O	O
while	O	O	O
promoted	O	O	O
neurotrophin	O	O	B-T116
secretion	O	O	B-T043
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
Hif-1α	O	O	B-T116
might	O	O	O
be	O	O	O
contributed	O	O	O
in	O	O	O
the	O	O	O
survival	O	O	B-T043
of	O	O	I-T043
BMSCs	O	O	I-T043
by	O	O	O
regulating	O	O	O
the	O	O	O
activation	O	O	B-T044
of	O	O	I-T044
AMPK	O	O	I-T044
and	O	O	I-T044
mTOR	O	O	I-T044
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
by	O	O	O
promoting	O	O	O
autophagy	O	O	B-T043
.	O	O	O

-DOCSTART- (28425183)

Associations	O	O	B-T080
between	O	O	O
major	O	O	B-T032
life	O	O	I-T032
events	O	O	I-T032
and	O	O	O
adherence	O	O	B-T169
,	O	O	O
glycemic	O	O	B-T061
control	O	O	I-T061
,	O	O	I-T061
and	O	O	O
psychosocial	O	O	B-T080
characteristics	O	O	I-T080
in	O	O	O
teens	O	O	B-T098
with	O	O	O
type	O	O	O
1	O	O	O
diabetes	O	O	O

This	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
assessed	O	O	B-T052
the	O	O	O
type	O	O	O
of	O	O	O
major	O	O	B-T032
life	O	O	I-T032
events	O	O	I-T032
occurring	O	O	O
in	O	O	O
a	O	O	O
contemporary	O	O	O
sample	O	O	O
of	O	O	O
teens	O	O	B-T098
with	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
and	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
event	O	O	B-T051
frequency	O	O	I-T051
and	O	O	O
demographic	O	O	B-T078
,	O	O	O
diabetes	O	O	B-T061
management	O	O	I-T061
,	O	O	O
and	O	O	O
psychosocial	O	O	B-T080
characteristics	O	O	I-T080
.	O	O	O

Parents	O	O	B-T099
of	O	O	O
178	O	O	O
teens	O	O	B-T098
completed	O	O	O
the	O	O	O
Life	O	O	B-T032
Events	O	O	I-T032
Checklist	O	O	B-T170
to	O	O	O
report	O	O	O
major	O	O	O
events	O	O	B-T051
teens	O	O	O
had	O	O	O
experienced	O	O	B-T067
in	O	O	O
the	O	O	O
last	O	O	O
year	O	O	B-T079
:	O	O	O
42	O	O	O
%	O	O	O
experienced	O	O	O
0	O	O	O
to	O	O	O
1	O	O	O
event	O	O	B-T051
(	O	O	O
n	O	O	O
=	O	O	O
75	O	O	O
)	O	O	O
,	O	O	O
32	O	O	O
%	O	O	O
experienced	O	O	O
2	O	O	O
to	O	O	O
3	O	O	O
events	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
57	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
26	O	O	O
%	O	O	O
experienced	O	O	O
4	O	O	O
+	O	O	O
events	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
46	O	O	O
)	O	O	O
.	O	O	O

Teens	O	O	B-T098
and	O	O	O
parents	O	O	B-T099
completed	O	O	O
validated	O	O	O
measures	O	O	B-T081
of	O	O	O
treatment	O	O	B-T033
adherence	O	O	I-T033
,	O	O	O
diabetes	O	O	B-T047
-specific	O	O	O
self-efficacy	O	O	B-T041
,	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
,	O	O	O
and	O	O	O
diabetes	O	O	O
-specific	O	O	O
family	O	O	B-T033
conflict	O	O	I-T033
.	O	O	O

Parent-youth	O	O	B-T052
interview	O	O	I-T052
and	O	O	O
chart	O	O	B-T058
review	O	O	I-T058
provided	O	O	O
demographics	O	O	B-T062
and	O	O	O
diabetes	O	O	B-T061
management	O	O	I-T061
data	O	O	O
.	O	O	O

Mean	O	O	O
number	O	O	O
of	O	O	O
events	O	O	B-T051
/	O	O	O
teen	O	O	B-T098
was	O	O	O
2.6	O	O	O
±	O	O	O
2.7	O	O	O
(	O	O	O
range	O	O	O
=	O	O	O
0	O	O	O
-	O	O	O
15	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
events	O	O	B-T051
were	O	O	O
"	O	O	O
Hospitalization	O	O	B-T058
of	O	O	O
a	O	O	O
family	O	O	B-T099
member	O	O	I-T099
"	O	O	O
(	O	O	O
24	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
"	O	O	O
Getting	O	O	B-T033
a	O	O	I-T033
bad	O	O	I-T033
report	O	O	I-T033
card	O	O	I-T033
"	O	O	O
(	O	O	O
20	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
"	O	O	O
Serious	O	O	O
arguments	O	O	B-T054
between	O	O	O
parents	O	O	B-T099
"	O	O	O
(	O	O	O
19	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
"	O	O	O
Serious	O	O	B-T184
illness	O	O	I-T184
/	O	O	O
injury	O	O	B-T037
in	O	O	O
a	O	O	O
family	O	O	O
member	O	O	O
"	O	O	O
(	O	O	O
19	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Compared	O	O	O
with	O	O	O
teens	O	O	B-T098
experiencing	O	O	O
0	O	O	O
to	O	O	O
1	O	O	O
event	O	O	B-T051
,	O	O	O
teens	O	O	O
experiencing	O	O	O
4	O	O	O
+	O	O	O
events	O	O	B-T051
were	O	O	O
less	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
married	O	O	O
parents	O	O	B-T099
(	O	O	O
P	O	O	O
=	O	O	O
.01	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
parent	O	O	B-T099
with	O	O	O
a	O	O	O
college	O	O	B-T170
degree	O	O	I-T170
(	O	O	O
P	O	O	O
=	O	O	O
.006	O	O	O
)	O	O	O
.	O	O	O

Teen	O	O	B-T098
s	O	O	O
with	O	O	O
4	O	O	O
+	O	O	O
events	O	O	B-T051
had	O	O	O
significantly	O	O	O
poorer	O	O	O
adherence	O	O	B-T169
(	O	O	O
P	O	O	O
=	O	O	O
.002	O	O	O
teen	O	O	B-T098
,	O	O	O
P	O	O	O
=	O	O	O
.02	O	O	O
parent	O	O	B-T099
)	O	O	O
,	O	O	O
lower	O	O	O
self-efficacy	O	O	B-T041
(	O	O	O
P	O	O	O
=	O	O	O
.03	O	O	O
teen	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
parent	O	O	O
)	O	O	O
,	O	O	O
poorer	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
(	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
teen	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
parent	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
more	O	O	O
conflict	O	O	B-T033
(	O	O	O
P	O	O	O
=	O	O	O
.006	O	O	O
teen	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.02	O	O	O
parent	O	O	O
)	O	O	O
than	O	O	O
teens	O	O	B-T098
with	O	O	O
fewer	O	O	O
events	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
multivariate	O	O	B-T170
model	O	O	I-T170
(	O	O	O
R	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
=	O	O	O
0.21	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
)	O	O	O
controlling	O	O	O
for	O	O	O
demographic	O	O	B-T078
and	O	O	O
diabetes	O	O	B-T061
management	O	O	I-T061
characteristics	O	O	O
,	O	O	O
fewer	O	O	O
events	O	O	B-T051
was	O	O	O
associated	O	O	O
with	O	O	O
lower	O	O	O
A1c	O	O	B-T116
(	O	O	O
P	O	O	O
=	O	O	O
.0009	O	O	O
)	O	O	O
.	O	O	O

Occurrence	O	O	O
of	O	O	O
more	O	O	O
major	O	O	B-T032
life	O	O	I-T032
events	O	O	I-T032
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
poorer	O	O	O
diabetes	O	O	B-T061
care	O	O	I-T061
and	O	O	O
A1c	O	O	B-T116
and	O	O	O
more	O	O	O
negative	O	O	O
psychosocial	O	O	B-T078
qualities	O	O	I-T078
in	O	O	O
teens	O	O	B-T098
with	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
.	O	O	O

-DOCSTART- (28427537)

Metabolomics	O	O	B-T091
,	O	O	O
Nutrition	O	O	B-T033
,	O	O	O
and	O	O	O
Potential	O	O	B-T080
Biomarkers	O	O	B-T201
of	O	O	O
Food	O	O	B-T080
Quality	O	O	I-T080
,	O	O	O
Intake	O	O	B-T169
,	O	O	O
and	O	O	O
Health	O	O	O
Status	O	O	O

Diet	O	O	B-T168
,	O	O	O
dietary	O	O	B-T062
patterns	O	O	I-T062
,	O	O	O
and	O	O	O
other	O	O	O
environmental	O	O	B-T080
factors	O	O	I-T080
such	O	O	O
as	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
toxins	O	O	B-T123
are	O	O	O
playing	O	O	O
an	O	O	O
important	O	O	O
role	O	O	B-T077
in	O	O	O
the	O	O	O
prevention	O	O	B-T080
/	O	O	O
development	O	O	B-T169
of	O	O	O
many	O	O	O
diseases	O	O	B-T047
,	O	O	O
like	O	O	O
obesity	O	O	B-T047
,	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
,	O	O	O
and	O	O	O
consequently	O	O	O
on	O	O	O
the	O	O	O
health	O	O	B-T080
status	O	O	I-T080
of	O	O	O
individuals	O	O	B-T098
.	O	O	O

A	O	O	O
major	O	O	O
challenge	O	O	O
nowadays	O	O	O
is	O	O	O
to	O	O	O
identify	O	O	B-T080
novel	O	O	B-T080
biomarkers	O	O	B-T201
to	O	O	O
detect	O	O	B-T033
as	O	O	O
early	O	O	B-T079
as	O	O	O
possible	O	O	O
metabolic	O	O	B-T169
dysfunction	O	O	B-T077
and	O	O	O
to	O	O	O
predict	O	O	B-T078
evolution	O	O	B-T169
of	O	O	O
health	O	O	B-T080
status	O	O	I-T080
in	O	O	O
order	O	O	O
to	O	O	O
refine	O	O	O
nutritional	O	O	B-T061
advices	O	O	I-T061
to	O	O	O
specific	O	O	O
population	O	O	B-T098
groups	O	O	I-T098
.	O	O	O

Omics	O	O	B-T090
technologies	O	O	I-T090
such	O	O	O
as	O	O	O
genomics	O	O	B-T091
,	O	O	O
transcriptomics	O	O	O
,	O	O	O
proteomics	O	O	B-T091
,	O	O	O
and	O	O	O
metabolomics	O	O	B-T091
coupled	O	O	B-T169
with	O	O	O
statistical	O	O	B-T170
and	O	O	O
bioinformatics	O	O	B-T170
tools	O	O	I-T170
have	O	O	O
already	O	O	O
shown	O	O	O
great	O	O	O
potential	O	O	B-T080
in	O	O	O
this	O	O	O
research	O	O	B-UnknownType
field	O	O	I-UnknownType
even	O	O	O
if	O	O	O
so	O	O	O
far	O	O	O
only	O	O	O
few	O	O	O
biomarkers	O	O	B-T201
have	O	O	O
been	O	O	O
validated	O	O	O
.	O	O	O

For	O	O	O
the	O	O	O
past	O	O	O
two	O	O	O
decades	O	O	B-T081
,	O	O	O
important	O	O	O
analytical	O	O	B-T059
techniques	O	O	I-T059
have	O	O	O
been	O	O	O
developed	O	O	B-T169
to	O	O	O
detect	O	O	B-T033
as	O	O	O
many	O	O	O
metabolites	O	O	B-T123
as	O	O	O
possible	O	O	O
in	O	O	O
human	O	O	B-T016
biofluids	O	O	B-T031
such	O	O	O
as	O	O	O
urine	O	O	B-T031
,	O	O	O
blood	O	O	B-T031
,	O	O	O
and	O	O	O
saliva	O	O	B-T031
.	O	O	O

In	O	O	O
the	O	O	O
field	O	O	O
of	O	O	O
food	O	O	B-T168
science	O	O	I-T090
and	O	O	O
nutrition	O	O	B-T091
,	O	O	O
many	O	O	O
studies	O	O	B-T062
have	O	O	O
been	O	O	O
carried	O	O	O
out	O	O	O
for	O	O	O
food	O	O	O
authenticity	O	O	B-T080
,	O	O	O
quality	O	O	B-T080
,	O	O	O
and	O	O	O
safety	O	O	B-T068
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
for	O	O	O
food	O	O	B-T057
processing	O	O	I-T057
.	O	O	O

Furthermore	O	O	O
,	O	O	O
metabolomic	O	O	B-T091
investigations	O	O	B-T169
have	O	O	O
been	O	O	O
carried	O	O	O
out	O	O	O
to	O	O	O
discover	O	O	B-T052
new	O	O	O
early	O	O	B-T079
biomarkers	O	O	B-T201
of	O	O	O
metabolic	O	O	B-T169
dysfunction	O	O	B-T077
and	O	O	O
predictive	O	O	B-T080
biomarkers	O	O	O
of	O	O	O
developing	O	O	O
pathologies	O	O	B-T091
(	O	O	O
obesity	O	O	B-T047
,	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
,	O	O	O
type-2	O	O	B-T047
diabetes	O	O	I-T047
,	O	O	O
etc	O	O	O
.	O	O	O
)	O	O	O
.	O	O	O

Great	O	O	O
emphasis	O	O	O
is	O	O	O
also	O	O	O
placed	O	O	O
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
methodologies	O	O	B-T062
to	O	O	O
identify	O	O	B-T080
and	O	O	O
validate	O	O	O
biomarkers	O	O	B-T201
of	O	O	O
nutrients	O	O	B-T168
exposure	O	O	B-T080
.	O	O	O

-DOCSTART- (28428293)

Draft	O	O	B-T086
Genome	O	O	I-T086
Sequence	O	O	I-T086
of	O	O	O
Bacillus	O	O	B-T007
cereus	O	O	I-T007
LA2007	O	O	I-T007
,	O	O	O
a	O	O	O
Human-Pathogenic	O	O	B-T123
Isolate	O	O	I-T123
Harboring	O	O	O
Anthrax	O	O	B-T204
-Like	O	O	O
Plasmids	O	O	O

We	O	O	O
present	O	O	O
the	O	O	O
genome	O	O	B-T086
sequence	O	O	I-T086
of	O	O	O
Bacillus	O	O	B-T007
cereus	O	O	I-T007
LA2007	O	O	I-T007
,	O	O	O
a	O	O	O
strain	O	O	B-T001
isolated	O	O	B-T169
in	O	O	O
2007	O	O	O
from	O	O	O
a	O	O	O
fatal	O	O	B-T047
pneumonia	O	O	I-T047
case	O	O	B-T170
in	O	O	O
Louisiana	O	O	B-T083
.	O	O	O

Sequence-based	O	O	B-T059
genome	O	O	I-T059
analysis	O	O	I-T059
revealed	O	O	B-T080
that	O	O	O
LA2007	O	O	B-T007
carries	O	O	B-T033
a	O	O	O
plasmid	O	O	B-T114
highly	O	O	O
similar	O	O	O
to	O	O	O
Bacillus	O	O	B-T007
anthracis	O	O	I-T007
pXO1	O	O	I-T007
,	O	O	O
including	O	O	O
the	O	O	O
genes	O	O	B-T028
responsible	O	O	O
for	O	O	O
the	O	O	O
production	O	O	B-T131
and	O	O	O
regulation	O	O	B-T038
of	O	O	O
anthrax	O	O	B-T116
toxin	O	O	I-T116
.	O	O	O

-DOCSTART- (28429154)

Developing	O	O	O
elite	O	O	B-T080
Neurospora	O	O	B-T004
crassa	O	O	I-T004
strains	O	O	B-T001
for	O	O	O
cellulosic	O	O	B-T109
ethanol	O	O	B-T040
production	O	O	I-T040
using	O	O	O
fungal	O	O	B-T169
breeding	O	O	O

The	O	O	O
demand	O	O	O
for	O	O	O
renewable	O	O	B-T169
and	O	O	O
sustainable	O	O	B-T169
energy	O	O	I-T169
has	O	O	O
generated	O	O	B-T052
considerable	O	O	O
interest	O	O	B-T041
in	O	O	O
the	O	O	O
conversion	O	O	B-T169
of	O	O	O
cellulosic	O	O	B-T109
biomass	O	O	B-T081
into	O	O	O
liquid	O	O	B-T167
fuels	O	O	B-T073
such	O	O	O
as	O	O	O
ethanol	O	O	B-T109
using	O	O	O
a	O	O	O
filamentous	O	O	B-T004
fungus	O	O	I-T004
.	O	O	O

While	O	O	O
attempts	O	O	B-T051
have	O	O	O
been	O	O	O
made	O	O	O
to	O	O	O
study	O	O	B-T062
cellulose	O	O	B-T044
metabolism	O	O	I-T044
through	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
knock-out	O	O	B-T050
mutants	O	O	B-T049
,	O	O	O
there	O	O	O
have	O	O	O
been	O	O	O
no	O	O	O
systematic	O	O	B-T169
effort	O	O	O
to	O	O	O
characterize	O	O	B-T052
natural	O	O	B-T169
variation	O	O	B-T070
for	O	O	O
cellulose	O	O	O
metabolism	O	O	O
in	O	O	O
ecotypes	O	O	B-T032
adapted	O	O	B-T070
to	O	O	O
different	O	O	B-T080
habitats	O	O	B-T082
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
characterized	O	O	B-T052
natural	O	O	B-T169
variation	O	O	B-T070
in	O	O	O
saccharification	O	O	B-T067
of	O	O	O
cellulose	O	O	B-T109
and	O	O	O
fermentation	O	O	B-T044
in	O	O	O
73	O	O	O
ecotypes	O	O	B-T032
and	O	O	O
89	O	O	O
laboratory	O	O	B-T093
strains	O	O	B-T001
of	O	O	O
the	O	O	O
model	O	O	B-T170
fungus	O	O	B-T004
Neurospora	O	O	B-T004
crassa	O	O	I-T004
.	O	O	O

We	O	O	O
observed	O	O	B-T169
significant	O	O	B-T078
variation	O	O	B-T070
in	O	O	O
both	O	O	O
traits	O	O	B-T032
among	O	O	O
natural	O	O	B-T169
and	O	O	O
laboratory	O	O	B-T080
generated	O	O	I-T080
populations	O	O	B-T004
,	O	O	O
with	O	O	O
some	O	O	O
elite	O	O	B-T080
strains	O	O	B-T001
performing	O	O	B-T169
better	O	O	B-T080
than	O	O	O
the	O	O	O
reference	O	O	B-T081
strain	O	O	B-T001
.	O	O	O

In	O	O	O
the	O	O	O
F1	O	O	B-T099
population	O	O	B-T004
N345	O	O	I-T099
,	O	O	O
15	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
population	O	O	O
outperformed	O	O	O
both	O	O	O
parents	O	O	B-T004
with	O	O	O
the	O	O	O
top	O	O	O
performing	O	O	B-T169
strain	O	O	B-T001
having	O	O	O
10	O	O	O
%	O	O	O
improvement	O	O	B-T077
in	O	O	O
ethanol	O	O	B-T040
production	O	O	I-T040
.	O	O	O

These	O	O	O
results	O	O	B-T034
suggest	O	O	O
that	O	O	O
natural	O	O	B-T169
alleles	O	O	B-T028
can	O	O	O
be	O	O	O
exploited	O	O	O
through	O	O	O
fungal	O	O	B-T169
breeding	O	O	B-T040
for	O	O	O
developing	O	O	O
elite	O	O	B-T080
industrial	O	O	B-T057
strains	O	O	B-T001
for	O	O	O
bioethanol	O	O	B-T040
production	O	O	I-T040
.	O	O	O

-DOCSTART- (28429354)

The	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
and	O	O	O
the	O	O	O
function	O	O	O
of	O	O	O
calcitonin	O	O	B-T116
gene-related	O	O	I-T116
peptide	O	O	I-T116
in	O	O	O
the	O	O	O
mechanism	O	O	O
of	O	O	O
traumatic	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
accelerating	O	O	O
fracture-healing	O	O	O

This	O	O	O
research	O	O	O
attempts	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
part	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
plays	O	O	O
in	O	O	O
accelerated	O	O	O
fracture-healing	O	O	B-T042
after	O	O	O
traumatic	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
as	O	O	O
well	O	O	O
as	O	O	O
to	O	O	O
test	O	O	O
functions	O	O	O
of	O	O	O
calcitonin	O	O	B-T116
gene-related	O	O	I-T116
peptide	O	O	I-T116
(	O	O	O
CGRP	O	O	B-T116
)	O	O	O
during	O	O	O
this	O	O	O
process	O	O	O
.	O	O	O

Experiments	O	O	O
were	O	O	O
carried	O	O	O
out	O	O	O
on	O	O	O
Male	O	O	O
Sprague-Dawley	O	O	B-T015
rats	O	O	I-T015
that	O	O	O
were	O	O	O
split	O	O	O
into	O	O	O
four	O	O	O
groups	O	O	B-T078
at	O	O	O
random	O	O	O
:	O	O	O
TBI	O	O	B-T037
-	O	O	O
fracture	O	O	B-T037
group	O	O	B-T078
,	O	O	O
fracture	O	O	O
-	O	O	O
only	O	O	B-T081
group	O	O	O
,	O	O	O
TBI	O	O	O
-	O	O	O
only	O	O	O
group	O	O	O
,	O	O	O
and	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

In	O	O	O
the	O	O	O
first	O	O	O
week	O	O	O
,	O	O	O
blood	O	O	B-T031
specimen	O	O	I-T031
would	O	O	O
be	O	O	O
drawn	O	O	O
from	O	O	O
rats	O	O	B-T015
among	O	O	O
the	O	O	O
groups	O	O	B-T078
except	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
at	O	O	O
three-time	O	O	O
points	O	O	O
(	O	O	O
24	O	O	O
,	O	O	O
72	O	O	O
and	O	O	O
168	O	O	O
hours	O	O	O
)	O	O	O
post	O	O	B-T079
-	O	O	O
damage	O	O	B-T037
.	O	O	O

These	O	O	O
rats	O	O	B-T015
would	O	O	O
be	O	O	O
assessed	O	O	O
from	O	O	O
the	O	O	O
neurological	O	O	B-T080
perspective	O	O	O
based	O	O	O
on	O	O	O
their	O	O	O
grades	O	O	O
of	O	O	O
performance	O	O	O
in	O	O	O
a	O	O	O
sequence	O	O	O
of	O	O	O
tests	O	O	O
24	O	O	O
hours	O	O	O
before	O	O	O
and	O	O	O
12	O	O	O
hours	O	O	O
after	O	O	O
brain	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

Blood	O	O	B-T059
samples	O	O	I-T059
were	O	O	O
also	O	O	O
taken	O	O	O
from	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
24	O	O	O
hours	O	O	O
before	O	O	O
the	O	O	O
injury	O	O	B-T037
,	O	O	O
and	O	O	O
whole	O	O	O
brain	O	O	B-T023
tissues	O	O	I-T023
in	O	O	O
the	O	O	O
injured	O	O	B-T169
groups	O	O	B-T078
were	O	O	O
harvested	O	O	B-T061
at	O	O	O
72	O	O	O
and	O	O	O
168	O	O	O
hours	O	O	O
post	O	O	B-T079
-	O	O	O
injury	O	O	O
.	O	O	O

We	O	O	O
compared	O	O	O
the	O	O	O
serum	O	O	B-T031
CGRP	O	O	B-T116
concentration	O	O	B-T081
,	O	O	O
the	O	O	O
distribution	O	O	O
of	O	O	O
CGRP	O	O	O
,	O	O	O
the	O	O	O
CGRP	O	O	O
expression	O	O	B-T045
,	O	O	O
and	O	O	O
the	O	O	O
expression	O	O	O
of	O	O	O
CGRP	O	O	O
in	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
,	O	O	O
the	O	O	O
expression	O	O	O
of	O	O	O
CGRP	O	O	O
in	O	O	O
the	O	O	O
hippocampus	O	O	O
,	O	O	O
the	O	O	O
expression	O	O	O
of	O	O	O
CGRP	O	O	O
in	O	O	O
the	O	O	O
hippocampus	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
expression	O	O	O
of	O	O	O
CGRP	O	O	O
in	O	O	O
the	O	O	O
brain	O	O	B-T023
by	O	O	O
immunohistochemistry	O	O	B-T060
,	O	O	O
Western	O	O	B-T059
blotting	O	O	I-T059
,	O	O	O
RT	O	O	B-T045
-	O	O	O
Of	O	O	O
CGRP	O	O	O
RNA	O	O	B-T045
expression	O	O	I-T045
levels	O	O	O
.	O	O	O

Neurological	O	O	B-T060
examinations	O	O	I-T060
suggested	O	O	O
that	O	O	O
the	O	O	O
functions	O	O	O
of	O	O	O
the	O	O	O
cerebral	O	O	B-T023
cortex	O	O	I-T023
,	O	O	O
cerebellum	O	O	B-T023
,	O	O	O
and	O	O	O
brain	O	O	B-T023
stem	O	O	I-T023
showed	O	O	O
significant	O	O	O
differences	O	O	O
pre	O	O	B-T079
-	O	O	O
and	O	O	O
post	O	O	B-T079
-	O	O	O
injury	O	O	B-T037
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

ELISA	O	O	B-T059
analysis	O	O	I-T059
indicated	O	O	O
a	O	O	O
great	O	O	O
density	O	O	O
of	O	O	O
CGRP	O	O	B-T116
in	O	O	O
TBI	O	O	B-T037
-	O	O	O
fracture	O	O	B-T037
group	O	O	B-T078
at	O	O	O
different	O	O	O
time	O	O	O
points	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
in	O	O	O
the	O	O	O
TBI	O	O	B-T037
-	O	O	O
fracture	O	O	B-T037
group	O	O	B-T078
,	O	O	O
CGRP	O	O	B-T116
in	O	O	O
both	O	O	O
hippocampus	O	O	B-T023
and	O	O	O
the	O	O	O
whole	O	O	B-T023
brain	O	O	I-T023
showed	O	O	O
a	O	O	O
noticeable	O	O	O
augment	O	O	O
in	O	O	O
RT-PCR	O	O	B-T063
and	O	O	O
western	O	O	B-T059
blot	O	O	I-T059
analysis	O	O	I-T059
at	O	O	O
72	O	O	O
and	O	O	O
168	O	O	O
h	O	O	O
post	O	O	B-T079
-	O	O	O
injury	O	O	B-T037
,	O	O	O
and	O	O	O
only	O	O	B-T081
in	O	O	O
this	O	O	O
group	O	O	O
,	O	O	O
immunohistochemistry	O	O	B-T060
analysis	O	O	I-T060
indicated	O	O	O
that	O	O	O
CGRP	O	O	O
was	O	O	O
present	O	O	O
in	O	O	O
the	O	O	O
hippocampus	O	O	O
at	O	O	O
168	O	O	O
hours	O	O	O
post	O	O	O
-	O	O	O
injury	O	O	O
.	O	O	O

We	O	O	O
observed	O	O	O
that	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
and	O	O	O
CGRP	O	O	B-T116
were	O	O	O
responsible	O	O	O
for	O	O	O
quick	O	O	O
bone-healing	O	O	B-T047
mechanisms	O	O	O
.	O	O	O

We	O	O	O
suggest	O	O	O
a	O	O	O
role	O	O	O
for	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
in	O	O	O
accelerated	O	O	O
fracture	O	O	B-T042
healing	O	O	I-T042
.	O	O	O

CGRP	O	O	B-T116
expression	O	O	B-T045
,	O	O	O
as	O	O	O
determined	O	O	O
by	O	O	O
IHC	O	O	B-T060
,	O	O	O
can	O	O	O
not	O	O	O
be	O	O	O
observed	O	O	O
in	O	O	O
other	O	O	O
groups	O	O	B-T078
,	O	O	O
indicating	O	O	O
that	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
may	O	O	O
be	O	O	O
the	O	O	O
specific	O	O	O
component	O	O	O
of	O	O	O
the	O	O	O
brain	O	O	B-T023
that	O	O	O
responds	O	O	O
to	O	O	O
"	O	O	O
big	O	O	B-T046
stress	O	O	I-T046
"	O	O	O
.	O	O	O

-DOCSTART- (28429412)

Bone	O	O	B-T024
extracellular	O	O	B-T024
matrix	O	O	I-T024
hydrogel	O	O	B-T122
enhances	O	O	O
osteogenic	O	O	B-T043
differentiation	O	O	I-T043
of	O	O	O
C2C12	O	O	B-T025
myoblasts	O	O	I-T025
and	O	O	O
mouse	O	O	B-T015
primary	O	O	O
calvarial	O	O	B-T023
cells	O	O	O

Hydrogel	O	O	B-T122
scaffolds	O	O	I-T122
derived	O	O	O
from	O	O	O
the	O	O	O
extracellular	O	O	B-T024
matrix	O	O	I-T024
(	O	O	O
ECM	O	O	B-T024
)	O	O	O
of	O	O	O
mammalian	O	O	B-T024
tissues	O	O	I-T024
have	O	O	O
been	O	O	O
successfully	O	O	O
used	O	O	O
to	O	O	O
promote	O	O	O
tissue	O	O	B-T040
repair	O	O	I-T040
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
osteogenic	O	O	B-T042
potential	O	O	I-T042
of	O	O	O
ECM	O	O	B-T024
hydrogels	O	O	B-T122
prepared	O	O	O
from	O	O	O
demineralized	O	O	B-T122
and	O	O	O
decellularized	O	O	B-T122
bovine	O	O	I-T122
bone	O	O	I-T122
in	O	O	O
the	O	O	O
presence	O	O	O
and	O	O	O
absence	O	O	O
of	O	O	O
osteogenic	O	O	B-T130
medium	O	O	I-T130
.	O	O	O

Culture	O	O	B-T059
of	O	O	O
C2C12	O	O	B-T025
and	O	O	O
mouse	O	O	B-T015
primary	O	O	O
calvarial	O	O	B-T023
cells	O	O	B-T025
(	O	O	O
mPCs	O	O	B-T025
)	O	O	O
on	O	O	O
decellularized	O	O	B-T122
bone	O	O	I-T122
ECM	O	O	I-T122
(	O	O	O
bECM	O	O	B-T122
)	O	O	O
and	O	O	O
demineralized	O	O	B-T122
bone	O	O	I-T122
matrix	O	O	I-T122
(	O	O	O
DBM	O	O	B-T122
)	O	O	O
gels	O	O	B-T122
resulted	O	O	O
in	O	O	O
increased	O	O	O
expression	O	O	B-T059
of	O	O	O
osteogenic	O	O	B-T045
gene	O	O	I-T045
markers	O	O	I-T045
,	O	O	O
including	O	O	O
a	O	O	O
3.6-	O	O	O
and	O	O	O
13.4-fold	O	O	O
increase	O	O	O
in	O	O	O
osteopontin	O	O	B-T116
and	O	O	O
15.7-	O	O	O
and	O	O	O
27.1-fold	O	O	O
increase	O	O	O
in	O	O	O
osteocalcin	O	O	B-T116
when	O	O	O
mPCs	O	O	O
were	O	O	O
cultured	O	O	B-T059
upon	O	O	O
bECM	O	O	O
with	O	O	O
basal	O	O	B-T130
and	O	O	O
osteogenic	O	O	B-T130
media	O	O	I-T130
,	O	O	O
respectively	O	O	O
.	O	O	O

bECM	O	O	B-T122
hydrogels	O	O	B-T122
stimulated	O	O	O
the	O	O	O
osteogenic	O	O	B-T043
differentiation	O	O	I-T043
of	O	O	O
C2C12	O	O	B-T025
and	O	O	O
mPCs	O	O	B-T025
even	O	O	O
in	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
osteogenic	O	O	B-T130
medium	O	O	I-T130
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
bECM	O	O	B-T122
hydrogel	O	O	B-T122
scaffolds	O	O	I-T122
may	O	O	O
have	O	O	O
great	O	O	O
utility	O	O	O
in	O	O	O
future	O	O	O
clinical	O	O	B-T080
applications	O	O	B-T169
for	O	O	O
bone	O	O	B-T024
tissue	O	O	B-T061
engineering	O	O	I-T061
.	O	O	O

©	O	O	O
2017	O	O	O
Wiley	O	O	O
Periodicals	O	O	O
,	O	O	O
Inc.	O	O	O
J	O	O	O
Biomed	O	O	O
Mater	O	O	O
Res	O	O	O
Part	O	O	O
B	O	O	O
:	O	O	O
Appl	O	O	O
Biomater	O	O	O
,	O	O	O
2017	O	O	O
.	O	O	O

-DOCSTART- (28430341)

Prostate-specific	O	O	B-T116
antigen	O	O	I-T116
increase	O	O	B-T169
during	O	O	O
dutasteride	O	O	B-T109
to	O	O	O
indicate	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
prostate	O	O	B-T060
biopsy	O	O	I-T060
:	O	O	O
influence	O	O	O
of	O	O	O
prostatic	O	O	O
inflammation	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
significance	O	O	O
of	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
total	O	O	B-T059
prostate-specific	O	O	I-T059
antigen	O	O	I-T059
(	O	O	I-T059
PSA	O	O	I-T059
)	O	O	I-T059
serum	O	O	I-T059
levels	O	O	I-T059
despite	O	O	O
dutasteride	O	O	B-T109
treatment	O	O	B-T061
as	O	O	O
a	O	O	O
predictor	O	O	B-T078
of	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
PC	O	O	B-T191
)	O	O	O
at	O	O	O
biopsy	O	O	B-T060
.	O	O	O

We	O	O	O
focused	O	O	O
our	O	O	O
attention	O	O	O
on	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
the	O	O	O
first	O	O	O
PSA	O	O	B-T116
increase	O	O	B-T169
and	O	O	O
on	O	O	O
the	O	O	O
influence	O	O	O
of	O	O	O
prostatic	O	O	B-T047
inflammation	O	O	I-T047
.	O	O	O

From	O	O	O
2011	O	O	O
to	O	O	O
2016	O	O	O
,	O	O	O
365	O	O	O
men	O	O	B-T098
with	O	O	O
a	O	O	O
previous	O	O	O
negative	O	O	O
prostate	O	O	B-T060
biopsy	O	O	I-T060
and	O	O	O
persistent	O	O	O
elevated	O	O	B-T080
PSA	O	O	B-T116
levels	O	O	O
received	O	O	O
dutasteride	O	O	B-T109
treatment	O	O	B-T061
.	O	O	O

The	O	O	O
population	O	O	B-T098
was	O	O	O
followed	O	O	O
for	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
12	O	O	O
-	O	O	O
48	O	O	O
months	O	O	O
.	O	O	O

One	O	O	O
hundred	O	O	O
twelve	O	O	O
cases	O	O	O
with	O	O	O
a	O	O	O
confirmed	O	O	O
PSA	O	O	B-T116
increase	O	O	B-T169
>	O	O	O
0.5	O	O	O
ng/ml	O	O	O
over	O	O	O
the	O	O	O
nadir	O	O	O
value	O	O	O
during	O	O	O
the	O	O	O
follow-up	O	O	B-T058
were	O	O	O
included	O	O	O
in	O	O	O
Group	O	O	O
A	O	O	O
and	O	O	O
underwent	O	O	O
a	O	O	O
new	O	O	O
prostate	O	O	B-T060
biopsy	O	O	I-T060
.	O	O	O

In	O	O	O
Group	O	O	O
A	O	O	O
,	O	O	O
the	O	O	O
PSA	O	O	B-T116
increase	O	O	B-T169
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
PC	O	O	B-T191
at	O	O	O
the	O	O	O
re-biopsy	O	O	B-T060
in	O	O	O
66	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	O
.	O	O	O

The	O	O	O
percentage	O	O	O
of	O	O	O
PSA	O	O	B-T033
reduction	O	O	I-T033
after	O	O	O
6	O	O	O
months	O	O	O
of	O	O	O
treatment	O	O	B-T061
was	O	O	O
not	O	O	O
a	O	O	O
significant	O	O	O
indicator	O	O	B-T201
of	O	O	O
the	O	O	O
risk	O	O	O
for	O	O	O
PC	O	O	B-T191
.	O	O	O

The	O	O	O
distribution	O	O	O
of	O	O	O
inflammatory	O	O	B-T033
infiltrates	O	O	I-T033
significantly	O	O	O
(	O	O	O
p<00.01	O	O	O
)	O	O	O
varied	O	O	O
from	O	O	O
positive	O	O	O
to	O	O	O
negative	O	O	O
prostate	O	O	B-T060
biopsies	O	O	I-T060
.	O	O	O

The	O	O	O
relative	O	O	O
risk	O	O	O
for	O	O	O
PC	O	O	B-T191
at	O	O	O
biopsy	O	O	B-T060
significantly	O	O	O
increase	O	O	B-T169
d	O	O	O
according	O	O	O
to	O	O	O
PSA	O	O	B-T116
level	O	O	O
during	O	O	O
dutasteride	O	O	B-T109
.	O	O	O

Treatment	O	O	B-T061
with	O	O	O
dutasteride	O	O	B-T109
can	O	O	O
help	O	O	O
to	O	O	O
analyze	O	O	B-T062
PSA	O	O	B-T116
kinetic	O	O	B-T070
.	O	O	O

A	O	O	O
persistent	O	O	O
prostatic	O	O	B-T047
inflammation	O	O	I-T047
is	O	O	O
a	O	O	O
factor	O	O	O
able	O	O	O
to	O	O	O
reduce	O	O	O
the	O	O	O
performance	O	O	O
of	O	O	O
PSA	O	O	B-T116
kinetic	O	O	B-T070
during	O	O	O
dutasteride	O	O	B-T109
treatment	O	O	B-T061
.	O	O	O

-DOCSTART- (28433844)

Neurological	O	O	B-T033
Decline	O	O	I-T033
in	O	O	O
an	O	O	O
Elderly	O	O	B-T098
with	O	O	O
Repaired	O	O	B-T169
Myelomeningocele	O	O	B-T019
Complicated	O	O	B-T169
with	O	O	O
Lumbar	O	O	B-T047
Canal	O	O	I-T047
Stenosis	O	O	I-T047
:	O	O	O
a	O	O	O
case	O	O	O
report	O	O	O

Tethered	O	O	B-T047
cord	O	O	I-T047
syndrome	O	O	I-T047
is	O	O	O
a	O	O	O
well-known	O	O	O
complication	O	O	B-T046
after	O	O	O
myelomeningocele	O	O	B-T019
(	O	O	O
MMC	O	O	B-T019
)	O	O	O
repair	O	O	B-T058
in	O	O	O
childhood	O	O	B-T079
.	O	O	O

However	O	O	O
,	O	O	O
late	O	O	O
complications	O	O	B-T046
in	O	O	O
adults	O	O	B-T100
with	O	O	O
a	O	O	O
repaired	O	O	B-T169
MMC	O	O	B-T019
are	O	O	O
not	O	O	O
well	O	O	O
understood	O	O	O
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
a	O	O	O
degenerative	O	O	B-T190
spinal	O	O	I-T190
deformity	O	O	I-T190
on	O	O	O
a	O	O	O
sustained	O	O	B-T169
tethered	O	O	B-T033
cord	O	O	I-T033
is	O	O	O
still	O	O	O
unclear	O	O	O
.	O	O	O

A	O	O	O
63-year-old	O	O	B-T100
man	O	O	B-T032
with	O	O	O
a	O	O	O
repaired	O	O	B-T169
MMC	O	O	B-T019
presented	O	O	O
with	O	O	O
a	O	O	O
progressive	O	O	B-T033
gait	O	O	I-T033
disturbance	O	O	I-T033
and	O	O	O
numbness	O	O	B-T184
in	O	O	O
both	O	O	O
lower	O	O	B-T023
limbs	O	O	I-T023
.	O	O	O

Magnetic	O	O	B-T170
resonance	O	O	I-T170
images	O	O	I-T170
demonstrated	O	O	O
that	O	O	O
the	O	O	O
tethered	O	O	B-T033
spinal	O	O	I-T033
cord	O	O	I-T033
was	O	O	O
compressed	O	O	B-T169
by	O	O	O
severe	O	O	B-T080
canal	O	O	B-T047
stenosis	O	O	I-T047
along	O	O	O
the	O	O	O
entire	O	O	B-T029
lumbar	O	O	I-T029
spine	O	O	I-T029
.	O	O	O

After	O	O	O
a	O	O	O
multi-level	O	O	B-T061
lumbar	O	O	I-T061
decompression	O	O	I-T061
surgery	O	O	B-T061
,	O	O	O
the	O	O	O
patient	O	O	B-T032
recovered	O	O	I-T032
to	O	O	O
baseline	O	O	B-T081
neurological	O	O	B-T080
status	O	O	O
.	O	O	O

In	O	O	O
adults	O	O	B-T100
with	O	O	O
a	O	O	O
repaired	O	O	B-T169
MMC	O	O	B-T019
,	O	O	O
lumbar	O	O	B-T047
canal	O	O	I-T047
stenosis	O	O	I-T047
should	O	O	O
be	O	O	O
investigated	O	O	B-T169
as	O	O	O
a	O	O	O
possible	O	O	O
cause	O	O	O
of	O	O	O
late	O	O	O
neurological	O	O	B-T033
decline	O	O	I-T033
.	O	O	O

Clinical	O	O	O
manifestations	O	O	O
may	O	O	O
be	O	O	O
complicated	O	O	B-T169
by	O	O	O
the	O	O	O
coexistence	O	O	O
of	O	O	O
both	O	O	O
the	O	O	O
original	O	O	O
and	O	O	O
subsequent	O	O	O
neurological	O	O	B-T047
disorders	O	O	I-T047
.	O	O	O

Because	O	O	O
these	O	O	O
additional	O	O	O
disorders	O	O	B-T047
result	O	O	O
from	O	O	O
compressive	O	O	B-T047
myelopathy	O	O	I-T047
,	O	O	O
early	O	O	O
surgical	O	O	B-T061
decompression	O	O	I-T061
is	O	O	O
indicated	O	O	O
to	O	O	O
avoid	O	O	O
irreversible	O	O	O
spinal	O	O	B-T047
cord	O	O	I-T047
dysfunction	O	O	I-T047
.	O	O	O

-DOCSTART- (28434897)

Epidemiology	O	O	B-T091
of	O	O	O
polyomavirus	O	O	B-T005
BK	O	O	I-T005
(	O	O	O
BKV	O	O	B-T005
)	O	O	O
and	O	O	O
the	O	O	O
emergent	O	O	B-T078
African	O	O	B-T083
variant	O	O	B-T080
in	O	O	O
kidney	O	O	B-T023
and	O	O	O
bone	O	O	B-T024
marrow	O	O	I-T024
transplant	O	O	B-T101
recipients	O	O	I-T101
in	O	O	O
the	O	O	O
Fundacion	O	O	B-T093
Valle	O	O	I-T093
del	O	O	I-T093
Lili	O	O	I-T093
in	O	O	I-T093
Cali	O	O	I-T093
,	O	O	O
Colombia	O	O	O

To	O	O	O
describe	O	O	O
the	O	O	O
epidemiology	O	O	B-T091
of	O	O	O
BKV	O	O	B-T005
and	O	O	O
to	O	O	O
assess	O	O	B-T052
the	O	O	O
presence	O	O	B-T033
of	O	O	O
the	O	O	O
African	O	O	B-T083
variant	O	O	B-T080
in	O	O	O
bone	O	O	B-T024
marrow	O	O	I-T024
and	O	O	O
kidney	O	O	B-T033
transplant	O	O	I-T033
patients	O	O	I-T033
who	O	O	O
have	O	O	O
suspected	O	O	B-T080
BKV	O	O	O
reactivation	O	O	B-T052
.	O	O	O

A	O	O	O
descriptive	O	O	B-T062
study	O	O	I-T062
was	O	O	O
conducted	O	O	B-T033
,	O	O	O
using	O	O	O
institutional	O	O	B-T170
records	O	O	I-T170
,	O	O	O
at	O	O	O
the	O	O	O
Fundación	O	O	B-T093
Valle	O	O	I-T093
del	O	O	I-T093
Lili	O	O	I-T093
,	O	O	I-T093
Cali	O	O	I-T093
-	O	O	O
Colombia	O	O	B-T083
.	O	O	O

The	O	O	O
overall	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
BKV	O	O	B-T005
during	O	O	O
the	O	O	O
study	O	O	O
period	O	O	O
was	O	O	O
51	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
African	O	O	B-T083
variant	O	O	B-T080
was	O	O	O
identified	O	O	B-T080
in	O	O	O
49.4	O	O	O
%	O	O	O
of	O	O	O
samples	O	O	B-T167
that	O	O	O
were	O	O	O
positive	O	O	B-T033
for	O	O	O
BKV	O	O	B-T005
.	O	O	O

50.6	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
samples	O	O	B-T167
were	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
the	O	O	O
wild	O	O	B-T028
strain	O	O	B-T080
of	O	O	O
BKV	O	O	B-T005
.	O	O	O

Among	O	O	O
BKV	O	O	B-T005
positive	O	O	B-T033
patients	O	O	B-T101
,	O	O	O
57	O	O	O
%	O	O	O
were	O	O	O
kidney	O	O	B-T033
transplant	O	O	B-T101
recipients	O	O	I-T101
and	O	O	O
43	O	O	O
%	O	O	O
were	O	O	O
bone	O	O	B-T024
marrow	O	O	I-T024
transplant	O	O	O
recipients	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
epidemiological	O	O	B-T062
study	O	O	I-T062
describing	O	O	O
the	O	O	O
African	O	O	B-T083
variant	O	O	B-T080
of	O	O	O
BKV	O	O	B-T005
in	O	O	O
Colombia	O	O	B-T083
.	O	O	O

-DOCSTART- (28434980)

Thaw	O	O	B-T059
-and-use	O	O	O
target	O	O	B-T025
cells	O	O	I-T025
pre-labeled	O	O	B-T080
with	O	O	O
calcein	O	O	B-T130
AM	O	O	I-T130
for	O	O	O
antibody-dependent	O	O	O
cell-mediated	O	O	O
cytotoxicity	O	O	O
assays	O	O	O

In	O	O	B-T080
vitro	O	O	I-T080
antibody-dependent	O	O	B-T059
cell-mediated	O	O	I-T059
cytotoxicity	O	O	I-T059
(	O	O	I-T059
ADCC	O	O	I-T059
)	O	O	I-T059
assays	O	O	I-T059
are	O	O	O
routinely	O	O	O
performed	O	O	O
to	O	O	O
support	O	O	O
the	O	O	O
research	O	O	O
and	O	O	O
development	O	O	O
of	O	O	O
therapeutic	O	O	B-T116
antibodies	O	O	I-T116
.	O	O	O

In	O	O	O
ADCC	O	O	B-T059
assays	O	O	I-T059
,	O	O	O
target	O	O	B-T025
cells	O	O	I-T025
bound	O	O	O
by	O	O	O
the	O	O	O
antibodies	O	O	B-T116
are	O	O	O
lysed	O	O	B-T046
by	O	O	O
activated	O	O	B-T052
effector	O	O	B-T025
cells	O	O	I-T025
following	O	O	O
interactions	O	O	O
between	O	O	O
the	O	O	O
Fc	O	O	B-T116
region	O	O	I-T116
of	O	O	O
the	O	O	O
bound	O	O	O
antibody	O	O	B-T116
and	O	O	O
Fcγ	O	O	B-T116
receptors	O	O	I-T116
on	O	O	O
effector	O	O	O
cells	O	O	O
.	O	O	O

Target	O	O	B-T025
cell	O	O	I-T025
lysis	O	O	B-T046
is	O	O	O
typically	O	O	O
measured	O	O	O
by	O	O	O
quantification	O	O	B-T081
of	O	O	O
released	O	O	O
endogenous	O	O	B-T169
enzymes	O	O	B-T116
,	O	O	O
e.g.	O	O	O
,	O	O	O
lactate	O	O	B-T116
dehydrogenase	O	O	I-T116
,	O	O	O
or	O	O	O
measurement	O	O	O
of	O	O	O
released	O	O	O
exogenous	O	O	B-T169
labels	O	O	B-T130
,	O	O	O
e.g.	O	O	O
,	O	O	O
(51)Cr	O	O	B-T121
,	O	O	O
europium	O	O	B-T196
or	O	O	O
calcein	O	O	B-T109
.	O	O	O

ADCC	O	O	B-T059
assays	O	O	I-T059
based	O	O	O
on	O	O	O
the	O	O	O
detection	O	O	O
of	O	O	O
exogenous	O	O	B-T169
labels	O	O	B-T130
released	O	O	O
from	O	O	O
lysed	O	O	B-T046
target	O	O	B-T025
cells	O	O	I-T025
generally	O	O	O
show	O	O	O
higher	O	O	O
sensitivity	O	O	O
and	O	O	O
require	O	O	O
shorter	O	O	O
incubation	O	O	B-T033
times	O	O	I-T033
.	O	O	O

However	O	O	O
,	O	O	O
target	O	O	B-T025
cells	O	O	I-T025
are	O	O	O
usually	O	O	O
labeled	O	O	B-T080
immediately	O	O	O
prior	O	O	O
to	O	O	O
assay	O	O	B-T059
,	O	O	O
which	O	O	O
inadvertently	O	O	O
introduces	O	O	O
additional	O	O	O
assay	O	O	O
variations	O	O	B-T080
due	O	O	O
to	O	O	O
differences	O	O	O
in	O	O	O
target	O	O	B-T025
cell	O	O	I-T025
conditions	O	O	O
and	O	O	O
labeling	O	O	B-T059
/	O	O	O
handling	O	O	B-T059
processes	O	O	I-T059
.	O	O	O

In	O	O	O
this	O	O	O
report	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
thaw	O	O	B-T059
-and-use	O	O	O
pre-labeled	O	O	B-T080
target	O	O	B-T025
cells	O	O	I-T025
for	O	O	O
ADCC	O	O	B-T059
assays	O	O	I-T059
.	O	O	O

Thaw	O	O	B-T059
-and-use	O	O	O
target	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
our	O	O	O
experiments	O	O	O
were	O	O	O
pre-labeled	O	O	B-T080
with	O	O	O
the	O	O	O
fluorescent	O	O	B-T130
dye	O	O	I-T130
calcein	O	O	I-T130
AM	O	O	I-T130
,	O	O	O
cryopreserved	O	O	B-T059
in	O	O	O
single-use	O	O	O
aliquots	O	O	O
and	O	O	O
used	O	O	O
directly	O	O	O
in	O	O	O
assays	O	O	B-T059
after	O	O	O
thawing	O	O	B-T059
.	O	O	O

Upon	O	O	O
thaw	O	O	B-T059
,	O	O	O
the	O	O	O
pre-labeled	O	O	B-T080
cells	O	O	B-T025
displayed	O	O	O
viability	O	O	B-T043
and	O	O	O
label	O	O	B-T130
retention	O	O	B-T169
comparable	O	O	O
to	O	O	O
freshly	O	O	O
labeled	O	O	B-T080
cells	O	O	O
,	O	O	O
responded	O	O	O
to	O	O	O
ADCC	O	O	B-T043
mediated	O	O	O
by	O	O	O
both	O	O	O
peripheral	O	O	B-T025
blood	O	O	I-T025
mononuclear	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
engineered	O	O	B-T025
natural	O	O	I-T025
killer	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
performed	O	O	O
stably	O	O	O
for	O	O	O
at	O	O	O
least	O	O	O
3	O	O	O
years	O	O	O
and	O	O	O
provided	O	O	O
favorable	O	O	O
precision	O	O	O
and	O	O	O
accuracy	O	O	O
to	O	O	O
ADCC	O	O	B-T059
assays	O	O	I-T059
.	O	O	O

Implementation	O	O	O
of	O	O	O
thaw	O	O	B-T059
-and-use	O	O	O
pre-labeled	O	O	B-T080
target	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
ADCC	O	O	B-T059
assays	O	O	I-T059
can	O	O	O
help	O	O	O
to	O	O	O
alleviate	O	O	O
both	O	O	O
cell	O	O	B-T059
culture	O	O	I-T059
and	O	O	O
dye	O	O	B-T059
labeling	O	O	I-T059
derived	O	O	O
variability	O	O	O
,	O	O	O
increase	O	O	O
the	O	O	O
flexibility	O	O	O
of	O	O	O
assay	O	O	B-T059
scheduling	O	O	O
and	O	O	O
improve	O	O	O
assay	O	O	B-T080
consistency	O	O	I-T080
and	O	O	O
robustness	O	O	B-T080
.	O	O	O

-DOCSTART- (28436433)

Pathways	O	O	B-T044
and	O	O	O
Genes	O	O	B-T028
Associated	O	O	B-T080
with	O	O	I-T080
Immune	O	O	B-T022
Dysfunction	O	O	B-T046
in	O	O	O
Sheep	O	O	B-T015
Paratuberculosis	O	O	O

Multibacillary	O	O	B-T033
and	O	O	O
paucibacillary	O	O	B-T033
paratuberculosis	O	O	B-T047
are	O	O	O
both	O	O	O
caused	O	O	O
by	O	O	O
Mycobacterium	O	O	B-T007
avium	O	O	I-T007
subspecies	O	O	I-T007
paratuberculosis	O	O	I-T007
.	O	O	O

Multibacillary	O	O	B-T033
lesions	O	O	B-T033
are	O	O	O
composed	O	O	O
largely	O	O	O
of	O	O	O
infected	O	O	B-T033
epithelioid	O	O	B-T025
macrophages	O	O	I-T025
and	O	O	O
paucibacillary	O	O	B-T033
lesions	O	O	O
contain	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
but	O	O	O
few	O	O	O
bacteria	O	O	B-T007
.	O	O	O

Multibacillary	O	O	B-T033
disease	O	O	B-T047
is	O	O	O
similar	O	O	O
to	O	O	O
human	O	O	O
lepromatous	O	O	B-T047
leprosy	O	O	I-T047
,	O	O	O
with	O	O	O
variable/high	O	O	O
levels	O	O	O
of	O	O	O
antibody	O	O	B-T116
and	O	O	O
a	O	O	O
dysfunctional	O	O	B-T169
immune	O	O	B-T042
response	O	O	I-T042
.	O	O	O

Animals	O	O	B-T008
with	O	O	O
paucibacillary	O	O	B-T033
disease	O	O	B-T047
have	O	O	O
high	O	O	O
cell-mediated	O	O	B-T040
immunity	O	O	I-T040
and	O	O	O
variable	O	O	B-T080
levels	O	O	I-T080
of	O	O	O
antibody	O	O	B-T116
.	O	O	O

This	O	O	O
study	O	O	O
aims	O	O	O
to	O	O	O
characterize	O	O	O
the	O	O	O
immunological	O	O	B-T047
dysfunction	O	O	I-T047
using	O	O	O
TruSeq	O	O	B-T170
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
ileocaecal	O	O	B-T082
lymph	O	O	B-T023
node	O	O	I-T023
that	O	O	O
drains	O	O	O
disease	O	O	B-T047
lesions	O	O	B-T033
.	O	O	O

Immune	O	O	B-T022
dysfunction	O	O	B-T046
is	O	O	O
highlighted	O	O	O
by	O	O	O
repression	O	O	B-T045
of	O	O	O
TCR	O	O	B-T028
/	O	O	O
CD3	O	O	B-T028
genes	O	O	B-T028
,	O	O	O
T	O	O	B-T116
cell	O	O	I-T116
co-receptors	O	O	I-T116
/	O	O	O
co-stimulators	O	O	B-T116
,	O	O	O
T	O	O	B-T043
cell	O	O	I-T043
activation	O	O	I-T043
and	O	O	O
signal-transduction	O	O	B-T043
genes	O	O	O
.	O	O	O

Inflammation	O	O	B-T046
was	O	O	O
an	O	O	O
acute	O	O	B-T046
phase	O	O	I-T046
response	O	O	I-T046
and	O	O	O
chronic	O	O	B-T046
inflammation	O	O	I-T046
,	O	O	O
with	O	O	O
little	O	O	O
evidence	O	O	O
of	O	O	O
acute	O	O	B-T033
inflammation	O	O	I-T033
.	O	O	O

The	O	O	O
high	O	O	O
levels	O	O	O
of	O	O	O
immunoglobulin	O	O	B-T116
and	O	O	O
plasma	O	O	B-T025
cell	O	O	I-T025
transcripts	O	O	B-T114
is	O	O	O
consistent	O	O	O
with	O	O	O
the	O	O	O
anti-MAP	O	O	B-T038
antibody	O	O	I-T038
responses	O	O	I-T038
in	O	O	O
paratuberculosis	O	O	B-T047
sheep	O	O	B-T015
.	O	O	O

Also	O	O	O
notable	O	O	O
was	O	O	O
the	O	O	O
overwhelming	O	O	O
reduction	O	O	B-T080
in	O	O	O
mast	O	O	B-T025
cell	O	O	I-T025
transcripts	O	O	B-T114
,	O	O	O
potentially	O	O	O
affecting	O	O	B-T169
DC	O	O	B-T043
activation	O	O	I-T043
of	O	O	I-T043
the	O	O	I-T043
immune	O	O	I-T043
response	O	O	I-T043
.	O	O	O

This	O	O	O
study	O	O	O
also	O	O	O
shows	O	O	O
that	O	O	O
there	O	O	O
were	O	O	O
no	O	O	O
fundamental	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
patterns	O	O	O
in	O	O	O
multibacillary	O	O	B-T033
and	O	O	O
paucibacillary	O	O	B-T033
disease	O	O	B-T047
,	O	O	O
no	O	O	O
shift	O	O	O
in	O	O	O
T	O	O	B-T025
cell	O	O	I-T025
genes	O	O	B-T028
from	O	O	O
Th1	O	O	B-T025
to	O	O	O
Th2	O	O	B-T025
pattern	O	O	O
but	O	O	O
rather	O	O	O
an	O	O	O
incremental	O	O	B-T081
decline	O	O	O
into	O	O	O
immune	O	O	B-T022
dysfunction	O	O	B-T046
leading	O	O	O
to	O	O	O
multibacillary	O	O	O
pathology	O	O	B-T047
.	O	O	O

-DOCSTART- (28437582)

Modified	O	O	B-T169
frailty	O	O	B-T170
index	O	O	I-T170
predicts	O	O	B-T078
postoperative	O	O	B-T033
outcomes	O	O	B-T081
in	O	O	O
older	O	O	B-T098
gastrointestinal	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	O

Frailty	O	O	B-T033
disproportionately	O	O	B-T080
impacts	O	O	B-T080
older	O	O	B-T098
patients	O	O	B-T101
with	O	O	O
gastrointestinal	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
rendering	O	O	B-T169
them	O	O	O
at	O	O	O
increased	O	O	B-T033
risk	O	O	I-T033
for	O	O	I-T033
poor	O	O	I-T033
outcomes	O	O	I-T033
.	O	O	O

A	O	O	O
frailty	O	O	B-T170
index	O	O	I-T170
may	O	O	O
aid	O	O	O
in	O	O	O
preoperative	O	O	B-T079
risk	O	O	B-T078
stratification	O	O	B-T062
.	O	O	O

We	O	O	O
hypothesized	O	O	B-T078
that	O	O	O
high	O	O	O
modified	O	O	B-T033
frailty	O	O	I-T033
index	O	O	I-T033
(	O	O	I-T033
mFI	O	O	I-T033
)	O	O	I-T033
scores	O	O	I-T033
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
adverse	O	O	B-T033
outcomes	O	O	I-T033
after	O	O	O
tumor	O	O	B-T191
resection	O	O	B-T061
in	O	O	O
older	O	O	B-T098
,	O	O	O
gastrointestinal	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

Patients	O	O	B-T101
(	O	O	O
60	O	O	B-T098
-	O	O	I-T098
90	O	O	I-T098
years	O	O	I-T098
old	O	O	I-T098
)	O	O	O
who	O	O	O
underwent	O	O	B-T169
gastrointestinal	O	O	B-UnknownType
tumor	O	O	I-UnknownType
resection	O	O	I-UnknownType
were	O	O	O
identified	O	O	B-T080
in	O	O	O
the	O	O	O
2005	O	O	O
-	O	O	O
2012	O	O	O
NSQIP	O	O	B-T033
Participant	O	O	B-T098
Use	O	O	O
File	O	O	O
.	O	O	O

mFI	O	O	B-T033
was	O	O	O
defined	O	O	O
by	O	O	O
11	O	O	O
previously	O	O	B-T079
described	O	O	B-T078
,	O	O	O
preoperative	O	O	B-T079
variables	O	O	B-T080
.	O	O	O

Frailty	O	O	B-T033
was	O	O	O
defined	O	O	O
by	O	O	O
an	O	O	O
mFI	O	O	B-T033
score	O	O	I-T033
>	O	O	O
0.27	O	O	O
.	O	O	O

The	O	O	O
postoperative	O	O	B-T058
course	O	O	I-T058
was	O	O	O
evaluated	O	O	B-T058
using	O	O	O
univariate	O	O	B-T062
and	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
.	O	O	O

41	O	O	O
455	O	O	O
patients	O	O	B-T101
(	O	O	O
mean	O	O	O
age	O	O	O
72.4	O	O	O
years	O	O	O
,	O	O	O
47.4	O	O	O
%	O	O	O
female	O	O	B-T032
)	O	O	O
were	O	O	O
identified	O	O	B-T080
.	O	O	O

The	O	O	O
most	O	O	O
prevalent	O	O	B-T082
form	O	O	I-T082
of	O	O	O
cancer	O	O	B-T191
was	O	O	O
colorectal	O	O	B-T191
(	O	O	O
69.3	O	O	O
%	O	O	O
,	O	O	O
n	O	O	O
=	O	O	O
28	O	O	O
708	O	O	O
)	O	O	O
and	O	O	O
2.8	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
were	O	O	O
frail	O	O	B-T033
(	O	O	O
n	O	O	O
=	O	O	O
1,164	O	O	O
)	O	O	O
.	O	O	O

Frail	O	O	B-T033
patients	O	O	B-T101
were	O	O	O
significantly	O	O	B-T078
more	O	O	B-T078
likely	O	O	I-T078
to	O	O	O
have	O	O	O
increased	O	O	B-T079
length	O	O	I-T079
of	O	O	I-T079
stay	O	O	I-T079
(	O	O	O
11.7	O	O	O
vs	O	O	O
9.0	O	O	O
days	O	O	O
)	O	O	O
,	O	O	O
major	O	O	B-T080
complications	O	O	B-T046
(	O	O	O
29.1	O	O	O
%	O	O	O
vs	O	O	O
17.9	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
30-day	O	O	O
mortality	O	O	B-T081
(	O	O	O
5.6	O	O	O
%	O	O	O
vs	O	O	O
2.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
(	O	O	O
all	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Multivariate	O	O	B-T081
analysis	O	O	I-T081
identified	O	O	B-T080
mFI	O	O	B-T033
as	O	O	O
an	O	O	O
independent	O	O	B-T078
predictor	O	O	B-T078
of	O	O	O
major	O	O	B-T080
complications	O	O	B-T046
(	O	O	O
OR	O	O	O
1.52	O	O	O
,	O	O	O
95%CI	O	O	O
1.39	O	O	O
-	O	O	O
1.65	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
30-day	O	O	O
mortality	O	O	B-T081
(	O	O	O
OR	O	O	O
1.48	O	O	O
,	O	O	O
95%CI	O	O	O
1.24	O	O	O
-	O	O	O
1.75	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

mFI	O	O	B-T033
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
postoperative	O	O	B-T033
complications	O	O	B-T046
and	O	O	O
mortality	O	O	B-T081
in	O	O	O
older	O	O	B-T098
surgical	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
gastrointestinal	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

-DOCSTART- (28440090)

Spermatocytic	O	O	B-T191
Tumor	O	O	I-T191
With	O	O	O
Sarcoma	O	O	B-T191
:	O	O	O
A	O	O	O
Rare	O	O	B-T080
Testicular	O	O	O
Neoplasm	O	O	O

Spermatocytic	O	O	B-T191
tumor	O	O	I-T191
,	O	O	O
formerly	O	O	O
known	O	O	O
as	O	O	O
spermatocytic	O	O	B-T191
seminoma	O	O	B-T191
,	O	O	O
is	O	O	O
an	O	O	O
uncommon	O	O	B-T080
testicular	O	O	B-T191
neoplasm	O	O	I-T191
which	O	O	O
is	O	O	O
a	O	O	O
distinct	O	O	O
clinicopathologic	O	O	B-T169
entity	O	O	I-T169
from	O	O	O
classic	O	O	O
seminoma	O	O	O
.	O	O	O

These	O	O	O
tumors	O	O	B-T191
are	O	O	O
not	O	O	O
associated	O	O	O
with	O	O	O
germ	O	O	B-T191
cell	O	O	I-T191
neoplasia	O	O	I-T191
in	O	O	O
situ	O	O	O
,	O	O	O
other	O	O	O
germ	O	O	B-T191
cell	O	O	I-T191
tumors	O	O	I-T191
,	O	O	O
or	O	O	O
isochromosome	O	O	B-T049
12p	O	O	I-T049
.	O	O	O

Although	O	O	O
typically	O	O	O
,	O	O	O
these	O	O	O
tumors	O	O	B-T191
have	O	O	O
an	O	O	O
excellent	O	O	B-T080
prognosis	O	O	B-T058
occasional	O	O	B-T169
cases	O	O	I-T169
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
sarcoma	O	O	B-T191
and	O	O	O
have	O	O	O
a	O	O	O
very	O	O	B-T033
poor	O	O	I-T033
prognosis	O	O	I-T033
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
case	O	O	B-T077
of	O	O	O
spermatocytic	O	O	B-T191
tumor	O	O	I-T191
with	O	O	O
sarcoma	O	O	B-T191
showing	O	O	O
a	O	O	O
chondrosarcomatous	O	O	B-T191
component	O	O	I-T191
,	O	O	O
discuss	O	O	O
the	O	O	O
pathologic	O	O	B-T033
findings	O	O	I-T033
and	O	O	O
differential	O	O	B-T060
diagnosis	O	O	I-T060
and	O	O	O
provide	O	O	O
follow-up	O	O	B-T058
information	O	O	B-T078
.	O	O	O

-DOCSTART- (28443376)

Remote	O	O	B-T082
Ischemic	O	O	B-T061
Conditioning	O	O	I-T061
and	O	O	O
Renal	O	O	B-T023
Protection	O	O	O

Over	O	O	O
the	O	O	O
course	O	O	O
of	O	O	O
the	O	O	O
last	O	O	O
2	O	O	O
decades	O	O	O
,	O	O	O
the	O	O	O
concept	O	O	O
of	O	O	O
remote	O	O	B-T082
ischemic	O	O	B-T169
conditioning	O	O	I-T061
(	O	O	O
RIC	O	O	B-T061
)	O	O	O
has	O	O	O
attracted	O	O	O
considerable	O	O	O
research	O	O	B-T062
interest	O	O	B-T041
,	O	O	O
because	O	O	O
RIC	O	O	O
,	O	O	O
in	O	O	O
most	O	O	O
of	O	O	O
its	O	O	O
embodiments	O	O	O
offers	O	O	O
an	O	O	O
inexpensive	O	O	O
way	O	O	O
of	O	O	O
protecting	O	O	B-T033
tissues	O	O	B-T024
against	O	O	O
ischemic	O	O	O
damage	O	O	B-T037
inflicted	O	O	O
by	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
medical	O	O	B-T169
conditions	O	O	B-T080
or	O	O	O
procedures	O	O	B-T058
.	O	O	O

Acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
(	O	O	O
AKI	O	O	B-T037
)	O	O	O
is	O	O	O
a	O	O	O
common	O	O	O
side	O	O	B-T169
effect	O	O	I-T169
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
various	O	O	O
medical	O	O	B-T058
procedures	O	O	I-T058
,	O	O	O
and	O	O	O
RIC	O	O	B-T061
has	O	O	O
been	O	O	O
suggested	O	O	O
as	O	O	O
a	O	O	O
means	O	O	O
of	O	O	O
reducing	O	O	O
its	O	O	O
incidence	O	O	O
.	O	O	O

Outcomes	O	O	B-T169
regarding	O	O	O
kidney	O	O	B-T042
function	O	O	I-T042
have	O	O	O
been	O	O	O
reported	O	O	O
in	O	O	O
numerous	O	O	O
studies	O	O	B-T062
that	O	O	O
evaluated	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
RIC	O	O	B-T061
in	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
settings	O	O	O
(	O	O	O
eg	O	O	O
,	O	O	O
cardiac	O	O	B-T061
surgery	O	O	I-T061
,	O	O	O
interventions	O	O	B-T061
requiring	O	O	O
intravenous	O	O	B-T082
administration	O	O	I-T082
of	O	O	O
contrast	O	O	B-T130
media	O	O	I-T130
)	O	O	O
.	O	O	O

Although	O	O	O
several	O	O	O
individual	O	O	O
studies	O	O	B-T062
have	O	O	O
implied	O	O	O
a	O	O	O
beneficial	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
RIC	O	O	B-T061
in	O	O	O
preserving	O	O	O
kidney	O	O	B-T042
function	O	O	I-T042
,	O	O	O
3	O	O	O
recently	O	O	O
published	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
evaluating	O	O	O
more	O	O	O
than	O	O	O
1000	O	O	O
patients	O	O	B-T101
each	O	O	O
(	O	O	O
Effect	O	O	B-T080
of	O	O	I-T080
Remote	O	O	B-T061
Ischemic	O	O	I-T061
Preconditioning	O	O	I-T061
in	O	O	O
the	O	O	O
Cardiac	O	O	B-T061
Surgery	O	O	I-T061
,	O	O	O
Remote	O	O	B-T061
Ischaemic	O	O	I-T061
Preconditioning	O	O	I-T061
for	O	O	O
Heart	O	O	B-T061
Surgery	O	O	I-T061
,	O	O	O
and	O	O	O
E	O	O	B-T061
RIC	O	O	I-T061
CA	O	O	I-T061
)	O	O	O

were	O	O	O
negative	O	O	B-T033
.	O	O	O

However	O	O	O
,	O	O	O
AKI	O	O	B-T037
or	O	O	O
any	O	O	O
other	O	O	O
index	O	O	O
of	O	O	O
renal	O	O	B-T042
function	O	O	I-T042
was	O	O	O
not	O	O	O
a	O	O	O
stand-alone	O	O	O
primary	O	O	O
end	O	O	O
point	O	O	O
in	O	O	O
any	O	O	O
of	O	O	O
these	O	O	O
trials	O	O	B-T062
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
meta-analyses	O	O	B-T062
(	O	O	O
each	O	O	O
including	O	O	O
thousands	O	O	O
of	O	O	O
participants	O	O	B-T098
)	O	O	O
have	O	O	O
reported	O	O	O
mixed	O	O	O
results	O	O	B-T169
,	O	O	O
with	O	O	O
the	O	O	O
most	O	O	O
recent	O	O	O
among	O	O	O
them	O	O	O
showing	O	O	O
benefit	O	O	O
from	O	O	O
RIC	O	O	B-T061
,	O	O	O
pinpointing	O	O	O
at	O	O	O
the	O	O	O
same	O	O	O
time	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
shortcomings	O	O	O
in	O	O	O
published	O	O	B-T170
studies	O	O	B-T062
,	O	O	O
adversely	O	O	B-T169
affecting	O	O	I-T169
the	O	O	O
quality	O	O	B-T080
of	O	O	O
available	O	O	B-T170
data	O	O	I-T170
.	O	O	O

The	O	O	O
present	O	O	O
review	O	O	B-T170
provides	O	O	O
a	O	O	O
critical	O	O	O
appraisal	O	O	O
of	O	O	O
the	O	O	O
current	O	O	O
state	O	O	O
of	O	O	O
this	O	O	O
field	O	O	O
of	O	O	O
research	O	O	B-T062
.	O	O	O

It	O	O	O
is	O	O	O
the	O	O	O
opinion	O	O	O
of	O	O	O
the	O	O	O
authors	O	O	B-T097
of	O	O	O
this	O	O	O
review	O	O	B-T170
that	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
clear	O	O	O
need	O	O	O
for	O	O	O
a	O	O	O
common	O	O	O
clinical	O	O	B-T062
trial	O	O	I-T062
framework	O	O	O
for	O	O	O
ischemic	O	O	B-T061
conditioning	O	O	I-T061
studies	O	O	B-T062
.	O	O	O

If	O	O	O
the	O	O	O
current	O	O	O
babel	O	O	O
of	O	O	O
definitions	O	O	B-T170
,	O	O	O
procedures	O	O	B-T169
,	O	O	O
outcomes	O	O	B-T169
,	O	O	O
and	O	O	O
goals	O	O	B-T170
persists	O	O	I-T170
,	O	O	O
it	O	O	O
is	O	O	O
most	O	O	O
likely	O	O	O
that	O	O	O
soon	O	O	O
ischemic	O	O	B-T061
conditioning	O	O	I-T061
will	O	O	O
be	O	O	O
"	O	O	O
yesterday	O	O	O
's	O	O	O
news	O	O	O
"	O	O	O
with	O	O	O
no	O	O	O
definitive	O	O	O
conclusions	O	O	O
having	O	O	O
been	O	O	O
reached	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
its	O	O	O
real	O	O	O
clinical	O	O	B-T061
utility	O	O	I-T061
.	O	O	O

-DOCSTART- (28446912)

Temporal	O	O	B-T079
and	O	O	O
Spatial	O	O	B-T082
Variability	O	O	B-T077
of	O	O	O
Fungal	O	O	B-T017
Structures	O	O	I-T017
and	O	O	O
Host	O	O	B-T042
Responses	O	O	I-T042
in	O	O	O
an	O	O	O
Incompatible	O	O	O
Rust-Wheat	O	O	O
Interaction	O	O	O

Information	O	O	B-T078
about	O	O	O
temporal	O	O	B-T079
and	O	O	O
spatial	O	O	B-T082
variability	O	O	B-T077
of	O	O	O
fungal	O	O	B-T017
structures	O	O	I-T017
and	O	O	O
host	O	O	B-T042
responses	O	O	I-T042
is	O	O	O
scarce	O	O	B-T080
in	O	O	O
comparison	O	O	B-T052
to	O	O	O
the	O	O	O
vast	O	O	O
amount	O	O	B-T081
of	O	O	O
genetic	O	O	B-T169
,	O	O	O
biochemical	O	O	B-T169
,	O	O	O
and	O	O	O
physiological	O	O	B-T169
studies	O	O	B-T062
of	O	O	O
host-pathogen	O	O	B-T040
interactions	O	O	I-T040
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
used	O	O	B-T169
avirulent	O	O	B-T080
wild	O	O	B-T028
type	O	O	I-T028
and	O	O	O
virulent	O	O	B-T080
mutant	O	O	B-T028
isolates	O	O	B-T123
of	O	O	O
Puccinia	O	O	B-T004
striiformis	O	O	I-T004
to	O	O	O
characterize	O	O	B-T052
the	O	O	O
interactions	O	O	B-T169
in	O	O	O
wheat	O	O	B-T168
carrying	O	O	B-T052
yellow	O	O	B-T004
rust	O	O	I-T004
Yr2	O	O	B-T004
resistance	O	O	B-T046
.	O	O	O

Both	O	O	O
conventional	O	O	B-T080
and	O	O	O
advanced	O	O	B-T080
microscopic	O	O	B-T080
techniques	O	O	B-T169
were	O	O	O
used	O	O	B-T169
for	O	O	O
a	O	O	O
detailed	O	O	B-T080
study	O	O	B-T062
of	O	O	O
morphology	O	O	B-T080
and	O	O	O
growth	O	O	B-T040
of	O	O	O
fungal	O	O	B-T169
colonies	O	O	B-T025
and	O	O	O
associated	O	O	B-T080
host	O	O	B-T042
cell	O	O	I-T042
responses	O	O	I-T042
.	O	O	O

The	O	O	O
growth	O	O	B-T040
of	O	O	O
the	O	O	O
wild	O	O	B-T028
type	O	O	I-T028
isolates	O	O	B-T123
was	O	O	O
highly	O	O	B-T080
restricted	O	O	B-T169
due	O	O	O
to	O	O	O
hypersensitive	O	O	B-T046
response	O	O	I-T046
(	O	O	O
HR	O	O	B-T046
,	O	O	O
plant	O	O	B-T002
cell	O	O	B-T043
death	O	O	I-T043
)	O	O	O
indicated	O	O	B-T033
by	O	O	O
autofluorescence	O	O	B-T059
and	O	O	O
change	O	O	B-T169
in	O	O	O
the	O	O	O
shape	O	O	B-T082
of	O	O	O
the	O	O	O
affected	O	O	B-T169
plant	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
host	O	O	B-T042
response	O	O	B-T032
appeared	O	O	B-T080
post	O	O	B-T079
-	O	O	O
haustorial	O	O	B-T017
,	O	O	O
but	O	O	O
large	O	O	B-T081
variation	O	O	B-T080
in	O	O	O
the	O	O	O
time	O	O	B-T079
and	O	O	O
stage	O	O	B-T079
of	O	O	O
arrest	O	O	B-T046
was	O	O	O
observed	O	O	B-T169
for	O	O	O
individual	O	O	B-T098
fungal	O	O	B-T169
colonies	O	O	B-T025
,	O	O	O
probably	O	O	B-T078
due	O	O	O
to	O	O	O
a	O	O	O
delay	O	O	B-T079
between	O	O	B-T082
detection	O	O	B-T061
and	O	O	O
response	O	O	O
.	O	O	O

Some	O	O	O
colonies	O	O	B-T025
were	O	O	O
stopped	O	O	B-T079
right	O	O	B-T079
after	O	O	I-T079
the	O	O	O
formation	O	O	B-T169
of	O	O	O
the	O	O	O
primary	O	O	B-T047
infection	O	O	I-T047
hyphae	O	O	B-T004
whereas	O	O	O
others	O	O	O
formed	O	O	B-T169
highly	O	O	B-T080
branched	O	O	B-T082
mycelia	O	O	B-T004
.	O	O	O

HR	O	O	B-T046
was	O	O	O
first	O	O	O
observed	O	O	B-T169
in	O	O	O
host	O	O	B-T026
cells	O	O	I-T026
in	O	O	O
direct	O	O	B-T080
contact	O	O	B-T067
with	O	O	O
fungal	O	O	B-T169
structures	O	O	I-T017
,	O	O	O
after	O	O	O
which	O	O	O
the	O	O	O
defense	O	O	B-T040
responses	O	O	I-T040
spread	O	O	B-T080
to	O	O	O
adjacent	O	O	B-T082
host	O	O	O
cells	O	O	O
,	O	O	O
and	O	O	O
eventually	O	O	O
led	O	O	O
to	O	O	O
encasement	O	O	B-T082
of	O	O	O
the	O	O	O
fungal	O	O	O
colony	O	O	B-T025
.	O	O	O

Several	O	O	B-T081
cells	O	O	B-T025
with	O	O	O
HR	O	O	B-T046
contained	O	O	B-T052
haustoria	O	O	B-T017
,	O	O	O
which	O	O	O
were	O	O	O
small	O	O	B-T081
and	O	O	O
underdeveloped	O	O	B-T080
,	O	O	O
but	O	O	O
some	O	O	B-T081
cells	O	O	O
contained	O	O	O
normal	O	O	B-T080
sized	O	O	B-T082
haustoria	O	O	O
without	O	O	O
signs	O	O	B-T184
of	O	O	O
hypersensitivity	O	O	B-T046
.	O	O	O

The	O	O	O
growth	O	O	B-T040
of	O	O	O
the	O	O	O
virulent	O	O	B-T080
mutants	O	O	B-T028
in	O	O	O
the	O	O	O
resistant	O	O	B-T169
plants	O	O	B-T002
was	O	O	O
similar	O	O	B-T080
to	O	O	O
the	O	O	O
growth	O	O	O
in	O	O	O
plants	O	O	O
without	O	O	O
Yr2	O	O	B-T004
resistance	O	O	B-T046
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
strong	O	O	B-T080
indication	O	O	B-T078
that	O	O	O
the	O	O	O
incompatible	O	O	B-T080
phenotype	O	O	B-T032
was	O	O	O
associated	O	O	B-T080
with	O	O	O
Yr2	O	O	O
.	O	O	O

The	O	O	O
interaction	O	O	B-T169
between	O	O	B-T082
P.	O	O	B-T004
striiformis	O	O	I-T004
and	O	O	O
wheat	O	O	B-T168
with	O	O	O
Yr2	O	O	B-T004
resistance	O	O	B-T046
was	O	O	O
highly	O	O	B-T080
variable	O	O	B-T080
in	O	O	O
time	O	O	B-T079
and	O	O	O
space	O	O	B-T082
,	O	O	O
which	O	O	O
demonstrate	O	O	B-T080
that	O	O	O
histological	O	O	B-T091
studies	O	O	B-T062
are	O	O	O
important	O	O	B-T080
for	O	O	O
a	O	O	O
deeper	O	O	B-T041
understanding	O	O	I-T041
of	O	O	O
host-pathogen	O	O	B-T040
interactions	O	O	I-T040
and	O	O	O
plant	O	O	B-T002
defense	O	O	B-T042
mechanisms	O	O	B-T169
in	O	O	O
general	O	O	B-T082
.	O	O	O

-DOCSTART- (28447924)

The	O	O	O
Effects	O	O	B-T080
of	O	O	I-T080
Messages	O	O	B-T170
about	O	O	O
the	O	O	O
Causes	O	O	B-T169
of	O	O	O
Obesity	O	O	B-T047
on	O	O	O
Disciplinary	O	O	B-T057
Action	O	O	I-T057
Decisions	O	O	B-T041
for	O	O	O
Overweight	O	O	B-T047
Employees	O	O	O

We	O	O	O
investigated	O	O	B-T169
the	O	O	O
impact	O	O	B-T080
of	O	O	O
messages	O	O	B-T170
about	O	O	O
the	O	O	O
causes	O	O	B-T169
of	O	O	O
obesity	O	O	B-T047
(	O	O	O
controllable	O	O	B-T033
or	O	O	O
uncontrollable	O	O	B-T080
)	O	O	O
on	O	O	O
the	O	O	O
disciplinary	O	O	B-T057
action	O	O	I-T057
consequences	O	O	B-T169
selected	O	O	O
for	O	O	O
obese	O	O	B-T047
employees	O	O	B-T097
in	O	O	O
response	O	O	B-T032
to	O	O	O
a	O	O	O
work-related	O	O	B-T033
mistake	O	O	B-T080
.	O	O	O

Participants	O	O	B-T098
read	O	O	O
about	O	O	O
either	O	O	O
the	O	O	O
controllable	O	O	B-T033
or	O	O	O
uncontrollable	O	O	B-T080
causes	O	O	B-T169
of	O	O	O
obesity	O	O	B-T047
before	O	O	O
reviewing	O	O	B-T080
an	O	O	O
ostensible	O	O	B-T078
employee	O	O	B-T097
file	O	O	B-T057
that	O	O	O
included	O	O	O
a	O	O	O
description	O	O	O
of	O	O	O
an	O	O	O
employee	O	O	O
mistake	O	O	B-T080
.	O	O	O

Depending	O	O	O
on	O	O	O
condition	O	O	O
,	O	O	O
the	O	O	O
file	O	O	B-T057
contained	O	O	O
a	O	O	O
photo	O	O	B-T073
of	O	O	O
the	O	O	O
employee	O	O	B-T097
that	O	O	O
either	O	O	O
depicted	O	O	O
them	O	O	O
as	O	O	O
obese	O	O	B-T047
or	O	O	O
average	O	O	B-T081
weight	O	O	B-T032
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
more	O	O	O
willing	O	O	O
to	O	O	O
withhold	O	O	B-T052
a	O	O	O
raise	O	O	O
or	O	O	O
promotion	O	O	B-T057
from	O	O	O
an	O	O	O
obese	O	O	B-T047
employee	O	O	B-T097
than	O	O	O
from	O	O	O
an	O	O	O
average	O	O	B-T081
-	O	O	O
weight	O	O	B-T032
employee	O	O	O
.	O	O	O

Further	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
little	O	O	O
evidence	O	O	B-T078
that	O	O	O
the	O	O	O
messages	O	O	B-T170
about	O	O	O
the	O	O	O
causes	O	O	B-T169
of	O	O	O
obesity	O	O	B-T047
affected	O	O	B-T169
participants	O	O	B-T098
'	O	O	O
perceived	O	O	B-T033
control	O	O	I-T033
and	O	O	O
self-efficacy	O	O	B-T041
for	O	O	O
healthy	O	O	B-T080
behaviors	O	O	B-T053
.	O	O	O

-DOCSTART- (28447984)

Experience	O	O	B-T041
is	O	O	O
Instrumental	O	O	B-T081
in	O	O	O
Tuning	O	O	B-T081
a	O	O	O
Link	O	O	B-T052
Between	O	O	O
Language	O	O	B-T171
and	O	O	O
Cognition	O	O	B-T041
:	O	O	O
Evidence	O	O	B-T078
from	O	O	O
6-	O	O	B-T032
to	O	O	I-T032
7-	O	O	I-T032
Month-Old	O	O	I-T032
Infants	O	O	B-T100
'	O	O	O
Object	O	O	O
Categorization	O	O	O

At	O	O	B-T080
birth	O	O	I-T080
,	O	O	O
infants	O	O	B-T100
not	O	O	O
only	O	O	O
prefer	O	O	O
listening	O	O	B-T041
to	O	O	O
human	O	O	B-T016
vocalizations	O	O	B-T054
,	O	O	O
but	O	O	O
also	O	O	O
have	O	O	O
begun	O	O	B-T079
to	O	O	O
link	O	O	B-T052
these	O	O	O
vocalizations	O	O	O
to	O	O	O
cognition	O	O	B-T041
:	O	O	O
For	O	O	O
infants	O	O	O
as	O	O	O
young	O	O	B-T079
as	O	O	O
three	O	O	B-T079
months	O	O	I-T079
of	O	O	O
age	O	O	B-T032
,	O	O	O
listening	O	O	O
to	O	O	O
human	O	O	O
language	O	O	B-T171
supports	O	O	O
object	O	O	O
categorization	O	O	B-T185
,	O	O	O
a	O	O	O
core	O	O	B-T082
cognitive	O	O	B-T169
capacity	O	O	B-T081
.	O	O	O

This	O	O	O
precocious	O	O	B-T079
link	O	O	B-T082
is	O	O	O
initially	O	O	B-T079
broad	O	O	B-T082
:	O	O	O
At	O	O	O
3	O	O	O
and	O	O	O
4	O	O	O
months	O	O	O
,	O	O	O
vocalizations	O	O	B-T054
of	O	O	O
both	O	O	B-T080
humans	O	O	B-T016
and	O	O	O
nonhuman	O	O	B-T015
primates	O	O	I-T015
support	O	O	O
categorization	O	O	B-T185
.	O	O	O

But	O	O	O
by	O	O	O
6	O	O	B-T079
months	O	O	I-T079
,	O	O	O
infants	O	O	B-T100
have	O	O	O
narrowed	O	O	B-T080
the	O	O	O
link	O	O	B-T052
:	O	O	O
Only	O	O	O
human	O	O	B-T016
vocalizations	O	O	B-T054
support	O	O	O
object	O	O	O
categorization	O	O	B-T185
.	O	O	O

Here	O	O	O
we	O	O	O
ask	O	O	O
what	O	O	O
guides	O	O	O
infants	O	O	B-T100
as	O	O	O
they	O	O	O
tune	O	O	B-T081
their	O	O	O
initially	O	O	B-T079
broad	O	O	B-T082
link	O	O	B-T052
to	O	O	O
a	O	O	O
more	O	O	O
precise	O	O	B-T080
one	O	O	O
,	O	O	O
engaged	O	O	O
only	O	O	O
by	O	O	O
the	O	O	O
vocalizations	O	O	B-T054
of	O	O	O
our	O	O	O
species	O	O	B-T185
.	O	O	O

Across	O	O	O
three	O	O	O
studies	O	O	B-T062
,	O	O	O
we	O	O	O
use	O	O	O
a	O	O	O
novel	O	O	B-T080
exposure	O	O	B-T080
paradigm	O	O	B-T062
to	O	O	O
examine	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	O
experience	O	O	B-T041
.	O	O	O

We	O	O	O
document	O	O	O
that	O	O	O
merely	O	O	O
exposing	O	O	B-T080
infants	O	O	B-T100
to	O	O	O
nonhuman	O	O	B-T015
primate	O	O	I-T015
vocalizations	O	O	B-T054
enables	O	O	B-T041
infants	O	O	O
to	O	O	O
preserve	O	O	O
the	O	O	O
early	O	O	B-T079
-	O	O	O
established	O	O	B-T080
link	O	O	B-T052
between	O	O	O
this	O	O	O
signal	O	O	B-T067
and	O	O	O
categorization	O	O	B-T185
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
exposing	O	O	B-T080
infants	O	O	B-T100
to	O	O	O
backward	O	O	B-T169
speech	O	O	B-T040
-	O	O	O
a	O	O	O
signal	O	O	B-T067
that	O	O	O
fails	O	O	B-T169
to	O	O	O
support	O	O	B-T077
categorization	O	O	B-T185
at	O	O	O
any	O	O	O
age	O	O	B-T032
-	O	O	O
offers	O	O	O
no	O	O	O
such	O	O	O
advantage	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
reveal	O	O	B-T080
the	O	O	O
power	O	O	B-T081
of	O	O	O
early	O	O	B-T079
experience	O	O	B-T041
as	O	O	O
infants	O	O	B-T100
specify	O	O	O
which	O	O	O
signals	O	O	B-T067
,	O	O	O
from	O	O	O
an	O	O	O
initially	O	O	B-T079
broad	O	O	B-T082
set	O	O	O
,	O	O	O
they	O	O	O
will	O	O	O
continue	O	O	B-T078
to	O	O	O
link	O	O	B-T052
to	O	O	O
cognition	O	O	B-T041
.	O	O	O

-DOCSTART- (28448089)

Bone	O	O	B-T047
Degeneration	O	O	I-T047
and	O	O	O
Its	O	O	O
Recovery	O	O	O
in	O	O	O
SMP30/GNL	O	O	B-T028
-	O	O	O
Knockout	O	O	O
Mice	O	O	O

Senescence	O	O	B-T116
marker	O	O	I-T116
protein-30	O	O	I-T116
(	O	O	O
SMP30	O	O	B-T116
)	O	O	O
decreases	O	O	O
androgen	O	O	B-T125
-independently	O	O	O
with	O	O	O
aging	O	O	B-T040
and	O	O	O
is	O	O	O
a	O	O	O
lactone	O	O	B-T109
-	O	O	O
hydrolyzing	O	O	B-T116
enzyme	O	O	I-T116
gluconolactonase	O	O	B-T116
(	O	O	O
GNL	O	O	B-T116
)	O	O	O
that	O	O	O
is	O	O	O
involved	O	O	O
in	O	O	O
vitamin	O	O	B-T127
C	O	O	I-T127
biosynthesis	O	O	B-T169
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
bone	O	O	B-T023
properties	O	O	O
of	O	O	O
SMP30/GNL	O	O	B-T028
knockout	O	O	B-T015
(	O	O	I-T015
KO	O	O	I-T015
)	O	O	I-T015
mice	O	O	I-T015
with	O	O	O
deficiency	O	O	B-T169
in	O	O	O
vitamin	O	O	B-T127
C	O	O	I-T127
synthesis	O	O	B-T169
were	O	O	O
investigated	O	O	O
to	O	O	O
reveal	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
SMP30/GNL	O	O	O
and	O	O	O
exogenous	O	O	B-T169
vitamin	O	O	O
C	O	O	O
supplementation	O	O	B-T121
on	O	O	O
bone	O	O	B-T042
formation	O	O	I-T042
.	O	O	O

Mineral	O	O	B-T081
content	O	O	I-T081
(	O	O	O
BMC	O	O	B-T081
)	O	O	O
and	O	O	O
mineral	O	O	B-T201
density	O	O	I-T201
(	O	O	O
BMD	O	O	B-T201
)	O	O	O
of	O	O	O
the	O	O	O
mandible	O	O	B-T023
and	O	O	O
femur	O	O	B-T023
of	O	O	O
SMP30/GNL	O	O	B-T028
KO	O	O	B-T015
and	O	O	O
wild-type	O	O	B-T015
mice	O	O	I-T015
at	O	O	O
2	O	O	O
and	O	O	O
3	O	O	O
months	O	O	B-T079
of	O	O	O
age	O	O	B-T032
with	O	O	O
or	O	O	O
without	O	O	O
vitamin	O	O	B-T127
C	O	O	I-T127
supplementation	O	O	B-T121
were	O	O	O
measured	O	O	O
by	O	O	O
dual-energy	O	O	B-T060
X-ray	O	O	I-T060
absorptiometry	O	O	I-T060
.	O	O	O

Body	O	O	B-T032
and	O	O	O
bone	O	O	B-T023
weight	O	O	B-T081
of	O	O	O
both	O	O	O
age	O	O	B-T100
groups	O	O	I-T100
decreased	O	O	O
and	O	O	O
became	O	O	O
significantly	O	O	O
lower	O	O	O
than	O	O	O
those	O	O	O
of	O	O	O
wild-type	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

The	O	O	O
bones	O	O	B-T023
of	O	O	O
SMP30/GNL	O	O	B-T028
KO	O	O	B-T015
mice	O	O	I-T015
were	O	O	O
rough	O	O	O
and	O	O	O
porous	O	O	O
,	O	O	O
with	O	O	O
BMC	O	O	B-T081
and	O	O	O
BMD	O	O	B-T201
significantly	O	O	O
below	O	O	O
wild-type	O	O	B-T015
.	O	O	O

Oral	O	O	B-T030
supplementation	O	O	B-T121
with	O	O	O
vitamin	O	O	B-T127
C	O	O	I-T127
eliminated	O	O	O
differences	O	O	O
in	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
,	O	O	O
bone	O	O	B-T023
weight	O	O	O
,	O	O	O
BMC	O	O	B-T081
,	O	O	O
and	O	O	O
BMD	O	O	B-T201
between	O	O	O
SMP30/GNL	O	O	B-T028
KO	O	O	B-T015
and	O	O	O
wild-type	O	O	B-T015
mice	O	O	I-T015
at	O	O	O
each	O	O	O
age	O	O	B-T032
.	O	O	O

These	O	O	O
results	O	O	O
indicate	O	O	O
that	O	O	O
bone	O	O	B-T047
degeneration	O	O	I-T047
in	O	O	O
SMP30/GNL	O	O	B-T028
KO	O	O	B-T015
mice	O	O	I-T015
was	O	O	O
caused	O	O	O
by	O	O	O
lack	O	O	O
of	O	O	O
vitamin	O	O	B-T127
C	O	O	I-T127
,	O	O	O
and	O	O	O
that	O	O	O
this	O	O	O
mouse	O	O	B-T015
strain	O	O	I-T015
is	O	O	O
an	O	O	O
appropriate	O	O	O
model	O	O	B-T008
for	O	O	O
bone	O	O	B-T042
metabolism	O	O	I-T042
in	O	O	O
humans	O	O	B-T016
,	O	O	O
which	O	O	O
have	O	O	O
no	O	O	O
ability	O	O	O
to	O	O	O
synthesize	O	O	B-T169
vitamin	O	O	O
C.	O	O	O

-DOCSTART- (28449774)

Utility	O	O	O
of	O	O	O
Post-Mortem	O	O	B-T060
Genetic	O	O	B-T062
Testing	O	O	I-T062
in	O	O	O
Cases	O	O	O
of	O	O	O
Sudden	O	O	O
Arrhythmic	O	O	O
Death	O	O	O
Syndrome	O	O	O

Sudden	O	O	B-T047
arrhythmic	O	O	I-T047
death	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
SADS	O	O	B-T047
)	O	O	O
describes	O	O	O
a	O	O	O
sudden	O	O	B-T046
death	O	O	I-T046
with	O	O	O
negative	O	O	O
autopsy	O	O	B-T060
and	O	O	O
toxicological	O	O	B-T169
analysis	O	O	B-T062
.	O	O	O

Cardiac	O	O	B-T047
genetic	O	O	I-T047
disease	O	O	I-T047
is	O	O	O
a	O	O	O
likely	O	O	O
etiology	O	O	B-T169
.	O	O	O

This	O	O	O
study	O	O	B-T062
investigated	O	O	B-T169
the	O	O	O
clinical	O	O	B-T080
utility	O	O	I-T080
and	O	O	O
combined	O	O	O
yield	O	O	O
of	O	O	O
post-mortem	O	O	B-T060
genetic	O	O	B-T062
testing	O	O	I-T062
(	O	O	O
molecular	O	O	B-T060
autopsy	O	O	I-T060
)	O	O	O
in	O	O	O
cases	O	O	O
of	O	O	O
SADS	O	O	B-T047
and	O	O	O
comprehensive	O	O	B-T080
clinical	O	O	B-T058
evaluation	O	O	I-T058
of	O	O	O
surviving	O	O	B-T052
relatives	O	O	B-T099
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
302	O	O	O
expertly	O	O	O
validated	O	O	O
SADS	O	O	B-T047
cases	O	O	O
with	O	O	O
suitable	O	O	O
DNA	O	O	B-T114
(	O	O	O
median	O	O	O
age	O	O	B-T032
:	O	O	O
24	O	O	O
years	O	O	O
;	O	O	O
65	O	O	O
%	O	O	O
males	O	O	B-T032
)	O	O	O
who	O	O	O
underwent	O	O	O
next-generation	O	O	B-T090
sequencing	O	O	B-T059
using	O	O	O
an	O	O	O
extended	O	O	O
panel	O	O	B-T078
of	O	O	O
77	O	O	O
primary	O	O	B-T028
electrical	O	O	I-T028
disorder	O	O	I-T028
and	O	O	O
cardiomyopathy	O	O	B-T028
genes	O	O	I-T028
.	O	O	O

Pathogenic	O	O	B-T033
and	O	O	O
likely	O	O	O
pathogenic	O	O	B-T080
variants	O	O	I-T080
were	O	O	O
classified	O	O	O
using	O	O	O
American	O	O	B-T093
College	O	O	I-T093
of	O	O	I-T093
Medical	O	O	I-T093
Genetics	O	O	I-T093
(	O	O	O
ACMG	O	O	B-T093
)	O	O	O
consensus	O	O	B-T170
guidelines	O	O	I-T170
.	O	O	O

The	O	O	O
yield	O	O	O
of	O	O	O
combined	O	O	O
molecular	O	O	B-T060
autopsy	O	O	I-T060
and	O	O	O
clinical	O	O	B-T058
evaluation	O	O	I-T058
in	O	O	O
82	O	O	O
surviving	O	O	B-T099
families	O	O	I-T099
was	O	O	O
evaluated	O	O	B-T058
.	O	O	O

A	O	O	O
gene-level	O	O	B-T063
rare	O	O	I-T063
variant	O	O	I-T063
association	O	O	I-T063
analysis	O	O	I-T063
was	O	O	O
conducted	O	O	O
in	O	O	O
SADS	O	O	B-T047
cases	O	O	O
versus	O	O	O
controls	O	O	B-T096
.	O	O	O

A	O	O	O
clinically	O	O	B-T080
actionable	O	O	I-T080
pathogenic	O	O	B-T033
or	O	O	O
likely	O	O	O
pathogenic	O	O	B-T080
variant	O	O	I-T080
was	O	O	O
identified	O	O	O
in	O	O	O
40	O	O	O
of	O	O	O
302	O	O	O
cases	O	O	O
(	O	O	O
13	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
main	O	O	O
etiologies	O	O	B-T169
established	O	O	O
were	O	O	O
catecholaminergic	O	O	B-T047
polymorphic	O	O	I-T047
ventricular	O	O	I-T047
tachycardia	O	O	I-T047
and	O	O	O
long	O	O	B-T047
QT	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
17	O	O	O
[	O	O	O
6	O	O	O
%	O	O	O
]	O	O	O
and	O	O	O
11	O	O	O
[	O	O	O
4	O	O	O
%	O	O	O
]	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Gene-based	O	O	B-T063
rare	O	O	I-T063
variants	O	O	I-T063
association	O	O	I-T063
analysis	O	O	I-T063
showed	O	O	O
enrichment	O	O	O
of	O	O	O
rare	O	O	O
predicted	O	O	O
deleterious	O	O	B-T080
variants	O	O	I-T080
in	O	O	O
RYR2	O	O	B-T028
(	O	O	O
p	O	O	O
=	O	O	O
5	O	O	O
×	O	O	O
10(-5	O	O	O
)	O	O	O
)	O	O	O
.	O	O	O

Combining	O	O	O
molecular	O	O	B-T060
autopsy	O	O	I-T060
with	O	O	O
clinical	O	O	B-T058
evaluation	O	O	I-T058
in	O	O	O
surviving	O	O	B-T099
families	O	O	I-T099
increased	O	O	O
diagnostic	O	O	B-T080
yield	O	O	I-T080
from	O	O	O
26	O	O	O
%	O	O	O
to	O	O	O
39	O	O	O
%	O	O	O
.	O	O	O

Molecular	O	O	B-T060
autopsy	O	O	I-T060
for	O	O	O
electrical	O	O	B-T028
disorder	O	O	I-T028
and	O	O	O
cardiomyopathy	O	O	B-T028
genes	O	O	I-T028
,	O	O	O
using	O	O	O
ACMG	O	O	B-T093
guidelines	O	O	B-T170
for	O	O	O
variant	O	O	B-T185
classification	O	O	I-T185
,	O	O	O
identified	O	O	O
a	O	O	O
modest	O	O	O
but	O	O	O
realistic	O	O	O
yield	O	O	O
in	O	O	O
SADS	O	O	B-T047
.	O	O	O

Our	O	O	O
data	O	O	O
highlighted	O	O	O
the	O	O	O
predominant	O	O	O
role	O	O	O
of	O	O	O
catecholaminergic	O	O	B-T047
polymorphic	O	O	I-T047
ventricular	O	O	I-T047
tachycardia	O	O	I-T047
and	O	O	O
long	O	O	B-T047
QT	O	O	I-T047
syndrome	O	O	I-T047
,	O	O	O
especially	O	O	O
the	O	O	O
RYR2	O	O	B-T028
gene	O	O	I-T028
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
minimal	O	O	O
yield	O	O	O
from	O	O	O
other	O	O	O
genes	O	O	B-T028
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
showed	O	O	O
the	O	O	O
enhanced	O	O	O
utility	O	O	O
of	O	O	O
combined	O	O	O
clinical	O	O	B-T058
and	O	O	O
genetic	O	O	B-T058
evaluation	O	O	I-T058
.	O	O	O

-DOCSTART- (28450395)

Binding	O	O	B-T052
of	O	O	O
DEAD-box	O	O	B-T116
helicase	O	O	I-T116
Dhh1	O	O	B-T116
to	O	O	O
the	O	O	O
5'UTR	O	O	B-T114
of	O	O	O
ASH1	O	O	B-T028
mRNA	O	O	B-T114
represses	O	O	B-T045
localized	O	O	O
translation	O	O	B-T045
of	O	O	O
ASH1	O	O	O
in	O	O	O
yeast	O	O	B-T004
cells	O	O	O

Local	O	O	B-T045
translation	O	O	I-T045
of	O	O	O
specific	O	O	B-T080
mRNAs	O	O	B-T114
is	O	O	O
regulated	O	O	B-T043
by	O	O	O
dynamic	O	O	O
changes	O	O	B-T169
in	O	O	O
their	O	O	O
subcellular	O	O	B-T026
localization	O	O	B-T169
,	O	O	O
and	O	O	O
these	O	O	O
changes	O	O	O
are	O	O	O
due	O	O	O
to	O	O	O
complex	O	O	B-T080
mechanisms	O	O	B-T169
controlling	O	O	B-T067
cytoplasmic	O	O	B-T026
mRNA	O	O	B-T043
transport	O	O	I-T043
.	O	O	O

The	O	O	O
budding	O	O	B-T043
yeast	O	O	I-T004
Saccharomyces	O	O	B-T004
cerevisiae	O	O	I-T004
is	O	O	O
well	O	O	O
suited	O	O	O
to	O	O	O
studying	O	O	O
these	O	O	O
mechanisms	O	O	B-T169
because	O	O	O
many	O	O	O
of	O	O	O
its	O	O	O
transcripts	O	O	B-T114
are	O	O	O
transported	O	O	B-T044
from	O	O	O
the	O	O	O
mother	O	O	B-T025
cell	O	O	I-T025
to	O	O	O
the	O	O	O
budding	O	O	O
daughter	O	O	B-T025
cell	O	O	I-T025
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
translational	O	O	B-T043
control	O	O	I-T043
of	O	O	O
ASH1	O	O	B-T028
mRNA	O	O	B-T114
after	O	O	O
transport	O	O	B-T044
and	O	O	O
localization	O	O	B-T169
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
although	O	O	O
ASH1	O	O	B-T028
transcripts	O	O	B-T114
were	O	O	O
translated	O	O	B-T045
after	O	O	O
they	O	O	O
reached	O	O	O
the	O	O	O
bud-tip	O	O	B-T026
,	O	O	O
some	O	O	O
mRNAs	O	O	B-T114
were	O	O	O
bound	O	O	O
by	O	O	O
the	O	O	O
RNA-binding	O	O	B-T116
protein	O	O	I-T116
Puf6	O	O	B-T116
and	O	O	O
were	O	O	O
non-polysomal	O	O	B-T033
.	O	O	O

We	O	O	O
also	O	O	O
found	O	O	O
that	O	O	O

the	O	O	O
DEAD-box	O	O	B-T116
helicase	O	O	I-T116
Dhh1	O	O	B-T116
complexed	O	O	B-T080
with	O	O	O
the	O	O	O
untranslated	O	O	B-T114
ASH1	O	O	B-T028
mRNA	O	O	B-T114
and	O	O	O
Puf6	O	O	B-T116
.	O	O	O

Loss	O	O	O
of	O	O	O
Dhh1	O	O	B-T116
affected	O	O	O
local	O	O	B-T045
translation	O	O	I-T045
of	O	O	O
ASH1	O	O	B-T028
mRNA	O	O	B-T114
and	O	O	O
resulted	O	O	O
in	O	O	O
delocalization	O	O	B-T169
of	O	O	O
ASH1	O	O	O
transcript	O	O	B-T114
in	O	O	O
the	O	O	O
bud	O	O	B-T002
.	O	O	O

Forcibly	O	O	O
shifting	O	O	O
the	O	O	O
non-polysomal	O	O	B-T033
ASH1	O	O	B-T028
mRNA	O	O	B-T114
into	O	O	O
polysomes	O	O	B-T026
was	O	O	O
associated	O	O	O
with	O	O	O
Dhh1	O	O	B-T116
dissociation	O	O	B-T048
.	O	O	O

We	O	O	O
further	O	O	O
demonstrated	O	O	O
that	O	O	O
Dhh1	O	O	B-T116
is	O	O	O
not	O	O	O
recruited	O	O	O
to	O	O	O
ASH1	O	O	B-T028
mRNA	O	O	B-T114
co-transcriptionally	O	O	B-T045
,	O	O	O
suggesting	O	O	B-T078
that	O	O	O
it	O	O	O
could	O	O	O
bind	O	O	O
to	O	O	O
ASH1	O	O	O
mRNA	O	O	O
within	O	O	O
the	O	O	O
cytoplasm	O	O	B-T026
.	O	O	O

Of	O	O	O
note	O	O	O
,	O	O	O
Dhh1	O	O	B-T116
bound	O	O	O
to	O	O	O
the	O	O	O
5	O	O	B-T114
UTR	O	O	I-T114
of	O	O	O
ASH1	O	O	B-T028
mRNA	O	O	B-T114
and	O	O	O
inhibited	O	O	B-T080
its	O	O	O
translation	O	O	B-T045
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	B-T078
that	O	O	O
after	O	O	O
localization	O	O	B-T169
to	O	O	O
the	O	O	O
bud	O	O	B-T026
tip	O	O	I-T026
,	O	O	I-T026
a	O	O	O
portion	O	O	B-T082
of	O	O	O
the	O	O	O
localized	O	O	B-T082
ASH1	O	O	B-T028
mRNA	O	O	B-T114
becomes	O	O	O
translationally	O	O	B-T045
inactive	O	O	B-T080
,	O	O	O
because	O	O	O
of	O	O	O
binding	O	O	B-T052
of	O	O	O
Dhh1	O	O	B-T116
and	O	O	O
Puf6	O	O	B-T116
to	O	O	O
the	O	O	O
5	O	O	B-T114
'	O	O	I-T114
and	O	O	I-T114
3	O	O	I-T114
'	O	O	I-T114
UTRs	O	O	I-T114
of	O	O	O
ASH1	O	O	O
mRNA	O	O	O
.	O	O	O

-DOCSTART- (28450855)

The	O	O	O
Abundance	O	O	B-T080
of	O	O	O
Endofungal	O	O	B-T007
Bacterium	O	O	I-T007
Rhizobium	O	O	B-T007
radiobacter	O	O	I-T007
(	O	O	O
syn	O	O	O
.	O	O	O
Agrobacterium	O	O	B-T007
tumefaciens	O	O	I-T007
)	O	O	O
Increases	O	O	B-T169
in	O	O	O
Its	O	O	O
Fungal	O	O	B-T169
Host	O	O	B-T001
Piriformospora	O	O	B-T004
indica	O	O	I-T004
during	O	O	O
the	O	O	O
Tripartite	O	O	O
Sebacinalean	O	O	B-T004
Symbiosis	O	O	B-T070
with	O	O	O
Higher	O	O	O
Plants	O	O	O

Agrobacterium	O	O	B-T007
tumefaciens	O	O	I-T007
)	O	O	O
Increases	O	O	B-T169
in	O	O	O
Its	O	O	O
Fungal	O	O	B-T169
Host	O	O	B-T001
Piriformospora	O	O	B-T004
indica	O	O	I-T004
during	O	O	O
the	O	O	O
Tripartite	O	O	O
Sebacinalean	O	O	B-T004
Symbiosis	O	O	B-T070
with	O	O	O
Higher	O	O	B-T002
Plants	O	O	I-T002
Rhizobium	O	O	B-T007
radiobacter	O	O	I-T007
(	O	O	O
syn	O	O	O
.	O	O	O

Agrobacterium	O	O	B-T007
tumefaciens	O	O	I-T007
,	O	O	O
syn	O	O	O
.	O	O	O
"	O	O	O
Agrobacterium	O	O	B-T007
fabrum	O	O	I-T007
"	O	O	O
)	O	O	O
is	O	O	O
an	O	O	O
endofungal	O	O	B-T007
bacterium	O	O	I-T007
of	O	O	O
the	O	O	O
fungal	O	O	B-T169
mutualist	O	O	B-T070
Piriformospora	O	O	B-T004
(	O	O	O
syn	O	O	O
.	O	O	O

Serendipita	O	O	B-T004
)	O	O	O
indica	O	O	B-T004
(	O	O	O
Basidiomycota	O	O	B-T004
)	O	O	O
,	O	O	O
which	O	O	O
together	O	O	O
form	O	O	O
a	O	O	O
tripartite	O	O	O
Sebacinalean	O	O	B-T004
symbiosis	O	O	B-T070
with	O	O	O
a	O	O	O
broad	O	O	O
range	O	O	O
of	O	O	O
plants	O	O	B-T002
.	O	O	O

R.	O	O	B-T007
radiobacter	O	O	I-T007
strain	O	O	B-T001
F4	O	O	I-T001
(	O	O	O
RrF4	O	O	B-T001
)	O	O	O
,	O	O	O
isolated	O	O	O
from	O	O	O
P.	O	O	B-T004
indica	O	O	I-T004
DSM	O	O	I-T004
11827	O	O	I-T004
,	O	O	O
induces	O	O	B-T169
growth	O	O	B-T040
promotion	O	O	B-T052
and	O	O	O
systemic	O	O	B-T043
resistance	O	O	I-T043
in	O	O	O
cereal	O	O	B-T168
crops	O	O	B-T002
,	O	O	O
including	O	O	O
barley	O	O	B-T002
and	O	O	O
wheat	O	O	B-T002
,	O	O	O
suggesting	O	O	O
that	O	O	O
R.	O	O	O
radiobacter	O	O	O
contributes	O	O	O
to	O	O	O
a	O	O	O
successful	O	O	O
symbiosis	O	O	B-T070
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
studied	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
endobacteria	O	O	B-T007
on	O	O	O
the	O	O	O
morphology	O	O	B-T080
and	O	O	O
the	O	O	O
beneficial	O	O	O
activity	O	O	O
of	O	O	O
P.	O	O	B-T004
indica	O	O	I-T004
during	O	O	O
interactions	O	O	B-T169
with	O	O	O
plants	O	O	B-T002
.	O	O	O

Low	O	O	O
numbers	O	O	O
of	O	O	O
endobacteria	O	O	B-T007
were	O	O	O
detected	O	O	B-T033
in	O	O	O
the	O	O	O
axenically	O	O	B-T059
grown	O	O	I-T059
P.	O	O	B-T004
indica	O	O	I-T004
(	O	O	O
long	O	O	B-T079
term	O	O	I-T079
lab-cultured	O	O	B-T059
,	O	O	O
lcPiri	O	O	B-T004
)	O	O	O
whereas	O	O	O
mycelia	O	O	B-T004
colonizing	O	O	B-T033
the	O	O	O
plant	O	O	B-T002
root	O	O	I-T002
contained	O	O	O
increased	O	O	B-T081
numbers	O	O	O
of	O	O	O
bacteria	O	O	B-T007
.	O	O	O

Higher	O	O	O
numbers	O	O	O
of	O	O	O
endobacteria	O	O	B-T007
were	O	O	O
also	O	O	O
found	O	O	O
in	O	O	O
axenic	O	O	B-T059
cultures	O	O	I-T059
of	O	O	O
P.	O	O	B-T004
indica	O	O	I-T004
that	O	O	O
was	O	O	O
freshly	O	O	O
re-isolated	O	O	B-T169
(	O	O	O
riPiri	O	O	B-T004
)	O	O	O
from	O	O	O
plant	O	O	B-T002
roots	O	O	I-T002
,	O	O	O
though	O	O	O
numbers	O	O	O
dropped	O	O	O
during	O	O	O
repeated	O	O	O
axenic	O	O	B-T059
re-cultivation	O	O	I-T059
.	O	O	O

Prolonged	O	O	B-T079
treatments	O	O	B-T061
of	O	O	O
P.	O	O	B-T004
indica	O	O	I-T004
cultures	O	O	B-T059
with	O	O	O
various	O	O	O
antibiotics	O	O	B-T195
could	O	O	O
not	O	O	O
completely	O	O	O
eliminate	O	O	O
the	O	O	O
bacterium	O	O	B-T007
,	O	O	O
though	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
detectable	O	O	B-T201
endobacteria	O	O	B-T007
decreased	O	O	B-T081
significantly	O	O	B-T078
,	O	O	O
resulting	O	O	O
in	O	O	O
partial-cured	O	O	B-T033
P.	O	O	O
indica	O	O	O
(	O	O	O
pcPiri	O	O	B-T004
)	O	O	O
.	O	O	O

pcPiri	O	O	B-T004
showed	O	O	O
reduced	O	O	B-T080
growth	O	O	B-T040
in	O	O	O
axenic	O	O	B-T059
cultures	O	O	I-T059
and	O	O	O
poor	O	O	B-T080
sporulation	O	O	B-T043
.	O	O	O

Consistent	O	O	B-T078
with	O	O	I-T078
this	O	O	O
,	O	O	O
pcPiri	O	O	B-T004
also	O	O	O
showed	O	O	O
reduced	O	O	B-T080
plant	O	O	B-T040
growth	O	O	I-T040
promotion	O	O	B-T052
and	O	O	O
reduced	O	O	O
systemic	O	O	B-T043
resistanc	O	O	I-T043
e	O	O	O
against	O	O	O
powdery	O	O	B-T004
mildew	O	O	I-T004
infection	O	O	B-T046
as	O	O	O
compared	O	O	O
with	O	O	O
riPiri	O	O	B-T004
and	O	O	O
lcPiri	O	O	B-T004
.	O	O	O

These	O	O	O
results	O	O	B-T169
are	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
the	O	O	O
assumption	O	O	O
that	O	O	O
the	O	O	O
endobacterium	O	O	B-T007
R.	O	O	B-T007
radiobacter	O	O	I-T007
improves	O	O	B-T033
P.	O	O	B-T004
indica	O	O	I-T004
's	O	O	I-T004
fitness	O	O	B-T032
and	O	O	O
thus	O	O	O
contributes	O	O	O
to	O	O	O
the	O	O	O
success	O	O	O
of	O	O	O
the	O	O	O
tripartite	O	O	O
Sebacinalean	O	O	B-T004
symbiosis	O	O	B-T070
.	O	O	O

-DOCSTART- (28451446)

Stem	O	O	B-T025
cell	O	O	I-T025
registry	O	O	B-T170
programme	O	O	B-T169
for	O	O	O
patients	O	O	B-T101
with	O	O	O
ischemic	O	O	B-T047
cardiomyopathy	O	O	I-T047
undergoing	O	O	O
coronary	O	O	B-T061
artery	O	O	I-T061
bypass	O	O	I-T061
grafting	O	O	I-T061
:	O	O	O
what	O	O	O
benefits	O	O	B-T081
does	O	O	O
it	O	O	O
derive	O	O	O
?	O	O	O

Standardization	O	O	B-T062
of	O	O	O
stem	O	O	B-T061
cell	O	O	I-T061
therapy	O	O	I-T061
requires	O	O	O
application	O	O	O
of	O	O	O
appropriate	O	O	O
methods	O	O	B-T062
to	O	O	O
evaluate	O	O	B-T058
safety	O	O	B-T058
and	O	O	I-T058
efficac	O	O	I-T058
y	O	O	O
,	O	O	O
including	O	O	O
long-term	O	O	B-T079
pharmacovigilance	O	O	B-T062
.	O	O	O

To	O	O	O
accomplish	O	O	O
this	O	O	O
objective	O	O	B-T170
,	O	O	O
a	O	O	O
long-term	O	O	B-T079
registry	O	O	B-T073
programme	O	O	I-T073
was	O	O	O
installed	O	O	O
.	O	O	O

We	O	O	O
analysed	O	O	O
150	O	O	O
patients	O	O	B-T101
with	O	O	O
ischemic	O	O	B-T047
cardiomyopathy	O	O	I-T047
,	O	O	O
who	O	O	O
received	O	O	B-T080
intramyocardial	O	O	B-T024
CD133	O	O	B-T025
+	O	O	I-T025
bone	O	O	I-T025
marrow	O	O	I-T025
mononuclear	O	O	I-T025
stem	O	O	I-T025
cell	O	O	I-T025
treatment	O	O	B-T061
combined	O	O	B-T080
with	O	O	O
coronary	O	O	B-T061
artery	O	O	I-T061
bypass	O	O	I-T061
grafting	O	O	I-T061
(	O	O	O
CABG	O	O	B-T061
)	O	O	O
or	O	O	O
CABG	O	O	O
alone	O	O	B-T081
.	O	O	O

The	O	O	O
mortality	O	O	B-T081
rate	O	O	I-T081
,	O	O	O
major	O	O	B-T080
adverse	O	O	B-T033
cerebral	O	O	I-T033
and	O	O	O
cardiac	O	O	B-T033
events	O	O	I-T033
,	O	O	O
and	O	O	O
functional	O	O	O
outcome	O	O	O
parameters	O	O	O
were	O	O	O
evaluated	O	O	B-T058
for	O	O	O
the	O	O	O
time	O	O	B-T079
period	O	O	I-T079
up	O	O	O
to	O	O	O
14	O	O	O
years	O	O	O
follow-up	O	O	B-T058
.	O	O	O

As	O	O	O
a	O	O	O
result	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
stratified	O	O	B-T080
the	O	O	O
patient	O	O	B-T101
population	O	O	B-T098
(	O	O	O
96	O	O	O
patients	O	O	B-T101
)	O	O	O
into	O	O	O
responders	O	O	B-T033
and	O	O	O
non-responders	O	O	B-T033
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
relevant	O	O	B-T080
predictors	O	O	B-T078
of	O	O	O
good	O	O	B-T033
response	O	O	I-T033
to	O	O	O
CD133	O	O	B-T025
+	O	O	I-T025
bone	O	O	I-T025
marrow	O	O	I-T025
mononuclear	O	O	I-T025
stem	O	O	I-T025
cell	O	O	I-T025
treatment	O	O	B-T061
was	O	O	O
performed	O	O	B-T169
.	O	O	O

Several	O	O	B-T081
positive	O	O	O
tendencies	O	O	O
related	O	O	O
to	O	O	O
stem	O	O	B-T061
cells	O	O	I-T061
transplantation	O	O	I-T061
were	O	O	O
demonstrated	O	O	O
.	O	O	O

First	O	O	O
,	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	B-T080
in	O	O	O
major	O	O	B-T080
adverse	O	O	B-T033
cardiovascular	O	O	I-T033
and	O	O	O
cerebral	O	O	B-T033
events	O	O	I-T033
was	O	O	O
observed	O	O	B-T169
between	O	O	O
stem	O	O	B-T025
cell	O	O	I-T025
and	O	O	O
control	O	O	B-T096
group	O	O	I-T096
up	O	O	O
to	O	O	O
14	O	O	O
years	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Second	O	O	O
,	O	O	O
an	O	O	O
improvement	O	O	B-T077
of	O	O	O
left	O	O	B-T201
ventricle	O	O	I-T201
ejection	O	O	I-T201
fraction	O	O	I-T201
(	O	O	O
LVEF	O	O	B-T201
)	O	O	O
in	O	O	O
stem	O	O	B-T025
cell	O	O	I-T025
group	O	O	B-T078
retained	O	O	B-T169
for	O	O	O
5	O	O	O
years	O	O	O
in	O	O	O
contrast	O	O	B-T080
with	O	O	O
CABG	O	O	B-T061
-	O	O	O
only	O	O	B-T081
group	O	O	O
,	O	O	O
where	O	O	O
no	O	O	O
significant	O	O	O
changes	O	O	O
in	O	O	O
LVEF	O	O	O
after	O	O	O
2	O	O	O
years	O	O	O
were	O	O	O
observed	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
LVEF	O	O	B-T201
under	O	O	O
30	O	O	O
%	O	O	O
and	O	O	O
left	O	O	B-T060
ventricle	O	O	I-T060
end	O	O	I-T060
diastolic	O	O	I-T060
diameter	O	O	I-T060
above	O	O	O
60	O	O	O
mm	O	O	O
were	O	O	O
independent	O	O	O
predictors	O	O	B-T078
of	O	O	O
functional	O	O	B-T169
response	O	O	O
to	O	O	O
CD133	O	O	B-T025
+	O	O	I-T025
cell	O	O	I-T025
therapy	O	O	B-T061
.	O	O	O

Participants	O	O	B-T098
with	O	O	O
overt	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
benefit	O	O	B-T081
most	O	O	B-T081
from	O	O	O
CABG	O	O	B-T061
combined	O	O	B-T080
with	O	O	O
intramyocardial	O	O	B-T024
injection	O	O	B-T061
of	O	O	O
CD133	O	O	B-T025
+	O	O	I-T025
bone	O	O	I-T025
marrow	O	O	I-T025
mononuclear	O	O	I-T025
cell	O	O	I-T025
within	O	O	O
the	O	O	O
group	O	O	B-T078
.	O	O	O

An	O	O	O
improvement	O	O	B-T077
LVEF	O	O	B-T201
in	O	O	O
stem	O	O	B-T025
cell	O	O	I-T025
group	O	O	B-T078
remained	O	O	O
for	O	O	O
5	O	O	O
years	O	O	O
in	O	O	O
contrast	O	O	B-T080
with	O	O	O
the	O	O	O
CABG	O	O	B-T061
-	O	O	O
only	O	O	B-T081
group	O	O	O
.	O	O	O

The	O	O	O
patients	O	O	B-T101
,	O	O	O
in	O	O	O
whom	O	O	O
the	O	O	O
improvement	O	O	B-T077
of	O	O	O
both	O	O	O
LVEF	O	O	B-T201
and	O	O	O
LVED	O	O	B-T060
was	O	O	O
observed	O	O	B-T169
,	O	O	O
have	O	O	O
benefited	O	O	O
by	O	O	O
increased	O	O	B-T081
life	O	O	B-T102
expectancy	O	O	I-T102
.	O	O	O

-DOCSTART- (28454482)

Effects	O	O	B-T080
of	O	O	O
Environmental	O	O	B-T082
Factors	O	O	B-T169
and	O	O	O
Metallic	O	O	B-T197
Electrodes	O	O	B-T074
on	O	O	O
AC	O	O	B-T070
Electrical	O	O	B-T081
Conduction	O	O	I-T081
Through	O	O	O
DNA	O	O	O
Molecule	O	O	O

Deoxyribonucleic	O	O	B-T114
acid	O	O	I-T114
(	O	O	I-T114
DNA	O	O	I-T114
)	O	O	I-T114
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
best	O	O	O
candidate	O	O	O
materials	O	O	O
for	O	O	O
various	O	O	O
device	O	O	B-T073
applications	O	O	B-T169
such	O	O	O
as	O	O	O
in	O	O	O
electrodes	O	O	B-T074
for	O	O	O
rechargeable	O	O	B-T073
batteries	O	O	I-T073
,	O	O	O
biosensors	O	O	B-T075
,	O	O	O
molecular	O	O	B-T074
electronics	O	O	I-T074
,	O	O	O
medical	O	O	B-T074
-	O	O	O
and	O	O	O
biomedical	O	O	B-T074
-	O	O	O
applications	O	O	O
etc	O	O	O
.	O	O	O

Hence	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
worthwhile	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
mechanism	O	O	O
of	O	O	O
charge	O	O	B-T070
transport	O	O	I-T070
in	O	O	O
the	O	O	O
DNA	O	O	B-T114
molecule	O	O	I-T114
,	O	O	O
however	O	O	O
,	O	O	O
still	O	O	O
a	O	O	O
question	O	O	O
without	O	O	O
a	O	O	O
clear	O	O	O
answer	O	O	O
is	O	O	O
DNA	O	O	O
a	O	O	O
molecular	O	O	B-T080
conducting	O	O	B-T070
material	O	O	B-T167
(	O	O	O
wire	O	O	B-T073
)	O	O	O
,	O	O	O
semiconductor	O	O	B-T073
,	O	O	O
or	O	O	O
insulator	O	O	B-T073
?	O	O	O

The	O	O	O
answer	O	O	O
,	O	O	O
after	O	O	O
the	O	O	O
published	O	O	O
data	O	O	O
,	O	O	O
is	O	O	O
still	O	O	O
ambiguous	O	O	O
without	O	O	O
any	O	O	O
confirmed	O	O	O
and	O	O	O
clear	O	O	O
scientific	O	O	O
answer	O	O	O
.	O	O	O

DNA	O	O	B-T114
is	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
always	O	O	O
surrounded	O	O	O
with	O	O	O
different	O	O	O
electric	O	O	B-T070
charges	O	O	I-T070
,	O	O	O
ions	O	O	B-T196
,	O	O	O
and	O	O	O
dipoles	O	O	B-UnknownType
.	O	O	O

These	O	O	O
surrounding	O	O	O
charges	O	O	B-T070
and	O	O	O
electric	O	O	B-T073
barrier(s	O	O	I-T073
)	O	O	I-T073
due	O	O	O
to	O	O	O
metallic	O	O	B-T197
electrodes	O	O	B-T074
(	O	O	O
as	O	O	O
environmental	O	O	B-T082
factors	O	O	B-T169
(	O	O	O
EFs	O	O	B-T169
)	O	O	O
)	O	O	O
play	O	O	O
a	O	O	O
substantial	O	O	O
role	O	O	O
when	O	O	O
measuring	O	O	B-T080
the	O	O	O
electrical	O	O	B-T081
conductivity	O	O	I-T081
through	O	O	O
λ-double	O	O	B-T114
helix	O	O	I-T114
(	O	O	I-T114
DNA	O	O	I-T114
)	O	O	I-T114
molecule	O	O	I-T114
suspended	O	O	O
between	O	O	O
metallic	O	O	O
electrodes	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
strong	O	O	B-T080
frequency	O	O	B-T079
dependence	O	O	O
of	O	O	O
AC	O	O	B-T070
-	O	O	O
complex	O	O	B-T080
conductivity	O	O	B-T081
comes	O	O	O
from	O	O	O
the	O	O	O
electrical	O	O	B-T067
conduction	O	O	I-T067
of	O	O	O
EFs	O	O	B-T169
.	O	O	O

This	O	O	O
leads	O	O	O
to	O	O	O
superimposing	O	O	O
serious	O	O	O
incorrect	O	O	O
experimental	O	O	B-T062
data	O	O	O
to	O	O	O
measured	O	O	B-T080
ones	O	O	O
.	O	O	O

At	O	O	O
1	O	O	O
MHz	O	O	O
,	O	O	O
we	O	O	O
carried	O	O	O
out	O	O	O
a	O	O	O
first	O	O	O
control	O	O	O
experiment	O	O	B-T062
on	O	O	O
electrical	O	O	B-T081
conductivity	O	O	I-T081
with	O	O	O
and	O	O	O
without	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
DNA	O	O	B-T114
molecule	O	O	I-T114
.	O	O	O

If	O	O	O
there	O	O	O
are	O	O	O
possible	O	O	O
electrical	O	O	B-T081
conduction	O	O	I-T081
due	O	O	O
to	O	O	O
stray	O	O	O
ions	O	O	B-T196
and	O	O	O
contribution	O	O	O
of	O	O	O
substrate	O	O	O
,	O	O	O
we	O	O	O
will	O	O	O
detected	O	O	O
them	O	O	O
.	O	O	O

This	O	O	O
control	O	O	O
experiment	O	O	B-T062
revealed	O	O	O
that	O	O	O
there	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
played	O	O	O
by	O	O	O
the	O	O	O
environmental	O	O	B-T082
-	O	O	O
charges	O	O	B-T070
around	O	O	O
DNA	O	O	B-T114
molecule	O	O	I-T114
and	O	O	O
any	O	O	O
experiment	O	O	O
should	O	O	O
consider	O	O	O
this	O	O	O
role	O	O	O
.	O	O	O

We	O	O	O
have	O	O	O
succeeded	O	O	O
to	O	O	O
measure	O	O	B-T081
both	O	O	O
electrical	O	O	B-T081
conductivity	O	O	I-T081
due	O	O	O
to	O	O	O
EFs	O	O	B-T169
(	O	O	O
σ	O	O	O
ENV	O	O	O
)	O	O	O
and	O	O	O
electrical	O	O	O
conductivity	O	O	O
due	O	O	O
to	O	O	O
DNA	O	O	B-T114
molecule	O	O	I-T114
(	O	O	O
σ	O	O	B-T114
DNA	O	O	I-T114
)	O	O	O
independently	O	O	O
by	O	O	O
carrying	O	O	O
the	O	O	O
measurements	O	O	B-T169
at	O	O	O
different	O	O	O
DNA	O	O	O
-	O	O	O
lengths	O	O	B-T081
and	O	O	O
subtracting	O	O	O
the	O	O	O
data	O	O	O
.	O	O	O

We	O	O	O
carried	O	O	O
out	O	O	O
measurements	O	O	B-T169
as	O	O	O
a	O	O	O
function	O	O	O
of	O	O	O
frequency	O	O	B-T079
(	O	O	I-T079
f	O	O	I-T079
)	O	O	I-T079
and	O	O	O
temperature	O	O	B-T081
(	O	O	I-T081
T	O	O	I-T081
)	O	O	I-T081
in	O	O	O
the	O	O	O
ranges	O	O	O
0.1	O	O	O
Hz	O	O	O
<	O	O	O
f	O	O	O
<	O	O	O
1	O	O	O
MHz	O	O	O
and	O	O	O
288	O	O	O
K	O	O	O
<	O	O	O
T	O	O	O
<	O	O	O
343	O	O	O
K.	O	O	O
The	O	O	O
measured	O	O	B-T080
conductivity	O	O	B-T081
(	O	O	O
σ	O	O	O
MES	O	O	O
)	O	O	O
portrays	O	O	O
a	O	O	O
metal	O	O	B-T197
-like	O	O	O
behavior	O	O	O
at	O	O	O
high	O	O	B-T079
frequencies	O	O	I-T079
near	O	O	O
1	O	O	O
MHz	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
σ	O	O	B-T114
DNA	O	O	I-T114
was	O	O	O
far	O	O	O
from	O	O	O
this	O	O	O
behavior	O	O	O
because	O	O	O
the	O	O	O
conduction	O	O	B-T070
due	O	O	O
to	O	O	O
EFs	O	O	B-T169
superimposes	O	O	O
σ	O	O	O
DNA	O	O	O
,	O	O	O
in	O	O	O
particular	O	O	O
at	O	O	O
low	O	O	B-T079
frequencies	O	O	I-T079
.	O	O	O

By	O	O	O
measuring	O	O	B-T080
the	O	O	O
electrical	O	O	B-T081
conductivity	O	O	I-T081
at	O	O	O
different	O	O	O
lengths	O	O	B-T081
:	O	O	O
40	O	O	O
,	O	O	O
60	O	O	O
,	O	O	O
80	O	O	O
,	O	O	O
and	O	O	O
100	O	O	O
nm	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
succeeded	O	O	O
not	O	O	O
only	O	O	O
to	O	O	O
separate	O	O	O
the	O	O	O
electrical	O	O	B-T067
conduction	O	O	I-T067
of	O	O	O
the	O	O	O
DNA	O	O	B-T114
molecule	O	O	B-T114
from	O	O	O
all	O	O	O
EFs	O	O	B-T169
effects	O	O	O
that	O	O	O
surround	O	O	O
the	O	O	O
molecule	O	O	O
,	O	O	O
but	O	O	O
also	O	O	O
to	O	O	O
present	O	O	O
accurate	O	O	O
values	O	O	O
of	O	O	O
σ	O	O	B-T114
DNA	O	O	I-T114
and	O	O	O
the	O	O	O
dielectric	O	O	B-UnknownType
constant	O	O	I-UnknownType
of	O	O	O
the	O	O	O
molecule	O	O	O
ε'DNA	O	O	B-T114
as	O	O	O
a	O	O	O
function	O	O	O
of	O	O	O
temperature	O	O	O
and	O	O	O
frequency	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
explain	O	O	O
these	O	O	O
data	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
a	O	O	O
model	O	O	O
describing	O	O	O
the	O	O	O
electrical	O	O	B-T067
conduction	O	O	I-T067
through	O	O	O
DNA	O	O	B-T114
molecule	O	O	I-T114
:	O	O	O
DNA	O	O	O
is	O	O	O
a	O	O	O
classical	O	O	O
semiconductor	O	O	B-T073
with	O	O	O
charges	O	O	B-T070
,	O	O	O
dipoles	O	O	B-UnknownType
and	O	O	O
ions	O	O	B-T196
that	O	O	O
result	O	O	O
in	O	O	O
creation	O	O	O
of	O	O	O
localized	O	O	B-T169
energy	O	O	B-T081
-	O	O	O
states	O	O	B-T169
(	O	O	O
LESs	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
extended	O	O	O
bands	O	O	O
and	O	O	O
in	O	O	O
the	O	O	O
energy	O	O	B-T070
gap	O	O	I-T070
of	O	O	O
the	O	O	O
DNA	O	O	B-T114
molecule	O	O	I-T114
.	O	O	O

This	O	O	O
model	O	O	O
explains	O	O	O
clearly	O	O	O
the	O	O	O
mechanism	O	O	O
of	O	O	O
charge	O	O	B-T070
transfer	O	O	I-T070
mechanism	O	O	I-T070
in	O	O	O
the	O	O	O
DNA	O	O	B-T114
,	O	O	O
and	O	O	O
it	O	O	O
sheds	O	O	O
light	O	O	O
on	O	O	O
why	O	O	O
the	O	O	O
charge	O	O	O
transfer	O	O	O
through	O	O	O
the	O	O	O
DNA	O	O	O
can	O	O	O
lead	O	O	O
to	O	O	O
insulating	O	O	B-T070
,	O	O	O
semiconducting	O	O	B-T070
,	O	O	O
or	O	O	O
metallic	O	O	B-T197
behavior	O	O	O
on	O	O	O
the	O	O	O
same	O	O	O
time	O	O	O
.	O	O	O

The	O	O	O
model	O	O	O
considers	O	O	O
charges	O	O	B-T070
on	O	O	O
DNA	O	O	B-T114
,	O	O	O
in	O	O	O
the	O	O	O
extended	O	O	O
bands	O	O	O
,	O	O	O
either	O	O	O
could	O	O	O
be	O	O	O
free	O	O	O
to	O	O	O
move	O	O	O
under	O	O	O
electric	O	O	B-T070
field	O	O	I-T070
or	O	O	O
localized	O	O	O
in	O	O	O
potential	O	O	B-T082
wells/hills	O	O	I-T082
.	O	O	O

Localization	O	O	B-T169
of	O	O	O
charges	O	O	B-T070
in	O	O	O
DNA	O	O	B-T114
is	O	O	O
an	O	O	O
intrinsic	O	O	B-T169
structural	O	O	B-T082
-	O	O	O
property	O	O	B-T080
of	O	O	O
this	O	O	O
solitaire	O	O	O
molecule	O	O	O
.	O	O	O

At	O	O	O
all	O	O	O
temperatures	O	O	O
,	O	O	O
the	O	O	O
expected	O	O	O
increase	O	O	O
in	O	O	O
thermal	O	O	B-T070
-	O	O	O
induced	O	O	B-T169
charge	O	O	B-T070
is	O	O	O
attributed	O	O	O
to	O	O	O
the	O	O	O
delocalization	O	O	B-T070
of	O	O	I-T070
holes	O	O	I-T070
(	O	O	O
or/and	O	O	O
electrons	O	O	B-T196
)	O	O	O
in	O	O	O
potential	O	O	B-T082
hills	O	O	I-T082
(	O	O	O
or/and	O	O	O
potential	O	O	B-T082
wells	O	O	I-T082
)	O	O	I-T082
which	O	O	O
accurately	O	O	O
accounts	O	O	O
for	O	O	O
the	O	O	O
total	O	O	O
electric	O	O	B-T081
and	O	O	O
dielectric	O	O	B-T081
behavior	O	O	I-T081
through	O	O	O
DNA	O	O	B-T114
molecule	O	O	I-T114
.	O	O	O

We	O	O	O
succeeded	O	O	O
to	O	O	O
fit	O	O	O
the	O	O	O
experiment	O	O	B-T062
al	O	O	O
data	O	O	O
to	O	O	O
the	O	O	O
proposed	O	O	O
model	O	O	O
with	O	O	O
reasonable	O	O	O
magnitudes	O	O	O
of	O	O	O
potential	O	O	B-T082
hills/wells	O	O	I-T082
that	O	O	O
are	O	O	O
in	O	O	O
the	O	O	O
energy	O	O	B-T081
range	O	O	O
from	O	O	O
0.068	O	O	O
eV.	O	O	O

-DOCSTART- (28456987)

Next-Generation	O	O	B-T063
Sequencing	O	O	I-T063
Approaches	O	O	B-T169
to	O	O	O
Define	O	O	O
the	O	O	O
Role	O	O	B-T077
of	O	O	O
the	O	O	O
Autophagy	O	O	B-T043
Lysosomal	O	O	I-T043
Pathway	O	O	I-T043
in	O	O	O
Human	O	O	B-T016
Disease	O	O	B-T047
:	O	O	O
The	O	O	O
Example	O	O	B-T077
of	O	O	O
LysoPlex	O	O	O

Next-Generation	O	O	B-T063
Sequencing	O	O	I-T063
(	O	O	I-T063
NGS	O	O	I-T063
)	O	O	I-T063
technologies	O	O	I-T063
have	O	O	O
deeply	O	O	O
changed	O	O	O
the	O	O	O
throughput	O	O	B-T081
of	O	O	O
genetic	O	O	B-T059
testing	O	O	I-T059
allowing	O	O	O
analyzing	O	O	O
millions	O	O	O
of	O	O	O
DNA	O	O	B-UnknownType
fragments	O	O	I-UnknownType
in	O	O	O
parallel	O	O	B-T080
.	O	O	O

One	O	O	O
key	O	O	O
application	O	O	B-T169
is	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
genetically	O	O	B-T169
heterogeneous	O	O	B-T033
and	O	O	O
complex	O	O	B-T047
diseases	O	O	I-T047
where	O	O	O
50	O	O	O
-	O	O	O
100	O	O	O
different	O	O	O
genes	O	O	B-T028
may	O	O	O
converge	O	O	O
to	O	O	O
control	O	O	B-T080
the	O	O	O
same	O	O	O
pathways	O	O	B-T044
.	O	O	O

These	O	O	O
disorders	O	O	B-T047
can	O	O	O
not	O	O	O
be	O	O	O
studied	O	O	O
using	O	O	O
traditional	O	O	B-T169
approaches	O	O	B-T169
,	O	O	O
based	O	O	O
on	O	O	O
gene-by-gene	O	O	B-T063
Sanger	O	O	I-T063
sequencing	O	O	I-T063
.	O	O	O

We	O	O	O
have	O	O	O
set	O	O	O
up	O	O	O
an	O	O	O
NGS	O	O	B-T063
protocol	O	O	B-T170
based	O	O	O
on	O	O	O
a	O	O	O
specific	O	O	O
selection	O	O	B-T052
of	O	O	O
DNA	O	O	B-T114
regions	O	O	I-T114
belonging	O	O	O
to	O	O	O
about	O	O	O
900	O	O	O
genes	O	O	B-T028
of	O	O	O
the	O	O	O
autophagy-lysosomal	O	O	B-T043
(	O	O	I-T043
ALP	O	O	I-T043
)	O	O	I-T043
pathway	O	O	I-T043
.	O	O	O

We	O	O	O
here	O	O	O
specify	O	O	O
all	O	O	O
the	O	O	O
technical	O	O	B-T077
steps	O	O	I-T077
and	O	O	O
challenges	O	O	B-T058
of	O	O	O
our	O	O	O
protocol	O	O	B-T170
,	O	O	O
named	O	O	O
LysoPlex	O	O	B-T170
.	O	O	O

This	O	O	O
is	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
Haloplex	O	O	O
technology	O	O	O
and	O	O	O
together	O	O	O
with	O	O	O
high-coverage	O	O	B-UnknownType
sequencing	O	O	I-UnknownType
empowers	O	O	O
a	O	O	O
high	O	O	O
and	O	O	O
uniform	O	O	O
coverage	O	O	O
of	O	O	O
ALP	O	O	B-T028
genes	O	O	I-T028
.	O	O	O

LysoPlex	O	O	B-T170
outplays	O	O	O
other	O	O	O
NGS	O	O	B-T063
applications	O	O	B-T169
in	O	O	O
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
,	O	O	O
providing	O	O	O
an	O	O	O
accurate	O	O	O
picture	O	O	O
of	O	O	O
all	O	O	O
variations	O	O	B-T070
in	O	O	O
ALP	O	O	B-T028
genes	O	O	I-T028
.	O	O	O

-DOCSTART- (28457143)

Typical	O	O	O
Skin	O	O	B-T037
Injuries	O	O	I-T037
in	O	O	O
Children	O	O	B-T100
With	O	O	O
Autism	O	O	O
Spectrum	O	O	O
Disorder	O	O	O

Pediatric	O	O	B-T080
skin	O	O	B-T037
injuries	O	O	I-T037
have	O	O	O
primarily	O	O	O
been	O	O	O
described	O	O	O
in	O	O	O
typically	O	O	O
developing	O	O	B-T100
children	O	O	I-T100
.	O	O	O

Our	O	O	O
objectives	O	O	B-T170
were	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
prevalence	O	O	B-T081
and	O	O	O
pattern	O	O	B-T082
of	O	O	O
skin	O	O	B-T037
injuries	O	O	I-T037
of	O	O	O
children	O	O	B-T100
with	O	O	O
autism	O	O	B-T048
spectrum	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
ASD	O	O	B-T048
)	O	O	O
,	O	O	O
to	O	O	O
describe	O	O	O
how	O	O	O
this	O	O	O
compared	O	O	O
with	O	O	O
previously	O	O	O
demonstrated	O	O	O
skin	O	O	B-T037
injury	O	O	I-T037
locations	O	O	B-T033
in	O	O	O
typically	O	O	O
developing	O	O	B-T100
children	O	O	I-T100
,	O	O	O
and	O	O	O
to	O	O	O
identify	O	O	O
differences	O	O	B-T080
in	O	O	O
skin	O	O	O
injury	O	O	O
frequency	O	O	B-T079
and	O	O	O
locations	O	O	O
between	O	O	O
autistic	O	O	B-T101
children	O	O	I-T101
with	O	O	O
and	O	O	O
without	O	O	O
self-injurious	O	O	B-T055
behaviors	O	O	I-T055
(	O	O	O
SIBs	O	O	B-T055
)	O	O	O
.	O	O	O

Children	O	O	B-T100
with	O	O	O
ASD	O	O	B-T048
were	O	O	O
recruited	O	O	O
between	O	O	O
September	O	O	B-T079
of	O	O	O
2011	O	O	O
and	O	O	O
September	O	O	O
of	O	O	O
2014	O	O	O
.	O	O	O

Demographic	O	O	B-T078
information	O	O	I-T078
was	O	O	O
obtained	O	O	O
from	O	O	O
the	O	O	O
caregiver	O	O	B-T097
.	O	O	O

All	O	O	O
skin	O	O	B-T037
injuries	O	O	I-T037
and	O	O	O
their	O	O	O
locations	O	O	B-T033
were	O	O	O
documented	O	O	B-T058
.	O	O	O

Of	O	O	O
the	O	O	O
41	O	O	O
children	O	O	B-T100
enrolled	O	O	O
,	O	O	O
half	O	O	O
were	O	O	O
reported	O	O	O
to	O	O	O
have	O	O	O
SIBs	O	O	B-T055
.	O	O	O

The	O	O	O
most	O	O	O
identified	O	O	O
skin	O	O	B-T037
injury	O	O	I-T037
locations	O	O	B-T033
were	O	O	O
the	O	O	O
legs	O	O	B-T023
,	O	O	O
knees	O	O	B-T023
,	O	O	O
and	O	O	O
back	O	O	B-T029
.	O	O	O

Children	O	O	B-T100
with	O	O	O
autism	O	O	B-T048
(	O	O	O
1	O	O	O
)	O	O	O
obtain	O	O	O
skin	O	O	B-T037
injuries	O	O	I-T037
frequently	O	O	O
and	O	O	O
in	O	O	O
similar	O	O	O
locations	O	O	B-T033
as	O	O	O
typically	O	O	O
developing	O	O	B-T100
children	O	O	I-T100
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
rarely	O	O	O
obtain	O	O	O
skin	O	O	O
injuries	O	O	O
to	O	O	O
locations	O	O	O
that	O	O	O
are	O	O	O
considered	O	O	O
uncommon	O	O	O
for	O	O	O
accidental	O	O	B-T037
injuries	O	O	I-T037
despite	O	O	O
reports	O	O	O
of	O	O	O
SIBs	O	O	B-T055
.	O	O	O

-DOCSTART- (28459420)

Is	O	O	O
Total	O	O	B-T061
Elbow	O	O	I-T061
Arthroplasty	O	O	I-T061
Safe	O	O	B-T068
as	O	O	O
an	O	O	O
Outpatient	O	O	B-T061
Procedure	O	O	I-T061
?	O	O	O

Ambulatory	O	O	B-T093
surgery	O	O	I-T093
centers	O	O	I-T093
are	O	O	O
the	O	O	O
preferred	O	O	B-T093
setting	O	O	B-T093
for	O	O	O
many	O	O	O
procedures	O	O	B-T169
formerly	O	O	O
performed	O	O	B-T169
in	O	O	O
a	O	O	O
hospital	O	O	B-T093
setting	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
sought	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
outpatient	O	O	B-T101
total	O	O	B-T061
elbow	O	O	I-T061
arthroplasty	O	O	I-T061
(	O	O	O
TEA	O	O	B-T061
)	O	O	O
is	O	O	O
as	O	O	O
safe	O	O	B-T068
as	O	O	O
inpatient	O	O	B-T101
TEA	O	O	O
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
analysis	O	O	I-T062
was	O	O	O
performed	O	O	B-T169
of	O	O	O
inpatient	O	O	B-T101
(	O	O	O
IP	O	O	B-T101
)	O	O	O
versus	O	O	O
outpatient	O	O	B-T101
(	O	O	O
OP	O	O	B-T101
)	O	O	O
TEA	O	O	B-T061
by	O	O	O
a	O	O	O
single	O	O	B-T081
surgeon	O	O	B-T097
over	O	O	O
a	O	O	O
period	O	O	O
of	O	O	O
18	O	O	O
years	O	O	B-T079
.	O	O	O

Demographic	O	O	B-T062
,	O	O	O
social	O	O	B-T080
,	O	O	O
and	O	O	O
comorbidity	O	O	B-T081
measures	O	O	I-T081
as	O	O	O
well	O	O	O
as	O	O	O
complication	O	O	B-T046
rates	O	O	B-T081
were	O	O	O
analyzed	O	O	B-T062
and	O	O	O
stratified	O	O	B-T080
by	O	O	O
IP	O	O	B-T101
or	O	O	O
OP	O	O	B-T101
status	O	O	B-T080
.	O	O	O

Bivariate	O	O	B-UnknownType
comparison	O	O	I-UnknownType
showed	O	O	O
increased	O	O	B-T081
prevalence	O	O	B-T081
of	O	O	O
coronary	O	O	B-T047
artery	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
the	O	O	O
OP	O	O	B-T101
group	O	O	B-T098
(	O	O	O
32	O	O	O
%	O	O	O
vs.	O	O	O
7	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
increased	O	O	O
age	O	O	B-T032
in	O	O	O
the	O	O	O
IP	O	O	B-T101
group	O	O	O
(	O	O	O
68	O	O	O
years	O	O	B-T079
vs.	O	O	O
58	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

All	O	O	O
other	O	O	O
demographic	O	O	B-T062
,	O	O	O
social	O	O	B-T080
,	O	O	O
and	O	O	O
comorbidity	O	O	B-T081
factors	O	O	I-T081
were	O	O	O
comparable	O	O	B-T052
between	O	O	O
the	O	O	O
IP	O	O	B-T101
and	O	O	O
OP	O	O	B-T101
groups	O	O	B-T098
,	O	O	O
although	O	O	O
more	O	O	B-T081
infections	O	O	B-T046
were	O	O	O
seen	O	O	B-T080
in	O	O	O
the	O	O	O
IP	O	O	O
group	O	O	B-T098
.	O	O	O

The	O	O	O
surgeons	O	O	B-T097
'	O	O	I-T097
initial	O	O	B-T041
learning	O	O	I-T041
curve	O	O	I-T041
occurred	O	O	B-T052
mostly	O	O	O
within	O	O	O
the	O	O	O
IP	O	O	B-T101
group	O	O	B-T098
.	O	O	O

Most	O	O	O
important	O	O	O
,	O	O	O
no	O	O	B-T033
difference	O	O	I-T033
in	O	O	O
complication	O	O	B-T046
rate	O	O	B-T081
was	O	O	O
observed	O	O	B-T169
between	O	O	O
the	O	O	O
IP	O	O	B-T101
and	O	O	O
OP	O	O	B-T101
groups	O	O	B-T098
.	O	O	O

-DOCSTART- (28459654)

Developmental	O	O	B-T080
Hypoxia	O	O	B-T046
Has	O	O	O
Negligible	O	O	B-T080
Effects	O	O	B-T080
on	O	O	O
Long-Term	O	O	B-T079
Hypoxia	O	O	O
Tolerance	O	O	B-T080
and	O	O	O
Aerobic	O	O	B-T043
Metabolism	O	O	I-T043
of	O	O	O
Atlantic	O	O	B-T013
Salmon	O	O	I-T013
(	O	O	O
Salmo	O	O	B-T013
salar	O	O	I-T013
)	O	O	O

Exposure	O	O	B-T080
to	O	O	I-T080
developmental	O	O	B-T080
hypoxia	O	O	B-T046
can	O	O	O
have	O	O	O
long-term	O	O	B-T079
impacts	O	O	B-T080
on	O	O	O
the	O	O	O
physiological	O	O	B-T039
performance	O	O	B-T052
of	O	O	O
fish	O	O	B-T013
because	O	O	O
of	O	O	O
irreversible	O	O	B-T169
plasticity	O	O	B-T070
.	O	O	O

Wild	O	O	B-T170
and	O	O	O
captive-reared	O	O	B-T033
Atlantic	O	O	B-T013
salmon	O	O	I-T013
(	O	O	O
Salmo	O	O	B-T013
salar	O	O	I-T013
)	O	O	O
can	O	O	O
be	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
hypoxic	O	O	B-T046
conditions	O	O	B-T080
during	O	O	O
development	O	O	B-T169
and	O	O	O
continue	O	O	B-T078
to	O	O	O
experience	O	O	O
fluctuating	O	O	B-T079
oxygen	O	O	B-T121
levels	O	O	B-T080
as	O	O	O
juveniles	O	O	B-T100
and	O	O	O
adults	O	O	B-T100
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
examine	O	O	B-T033
whether	O	O	O
developmental	O	O	B-T080
hypoxia	O	O	B-T046
impacts	O	O	B-T080
subsequent	O	O	B-T079
hypoxia	O	O	O
tolerance	O	O	B-T080
and	O	O	O
aerobic	O	O	B-T080
performance	O	O	B-T052
of	O	O	O
Atlantic	O	O	B-T013
salmon	O	O	I-T013
.	O	O	O

Individuals	O	O	B-T013
at	O	O	O
8	O	O	O
°	O	O	O
C	O	O	O
were	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
50	O	O	O
%	O	O	O
(	O	O	O
hypoxia	O	O	B-T046
)	O	O	O
or	O	O	O
100	O	O	O
%	O	O	O
(	O	O	O
normoxia	O	O	B-T070
)	O	O	O
dissolved	O	O	B-T044
oxygen	O	O	I-T044
(	O	O	I-T044
DO	O	O	I-T044
)	O	O	I-T044
saturation	O	O	I-T044
(	O	O	O
as	O	O	O
percent	O	O	O
of	O	O	O
air	O	O	B-T070
saturation	O	O	I-T070
)	O	O	O
from	O	O	O
fertilization	O	O	B-T040
for	O	O	O
∼100	O	O	O
d	O	O	O
(	O	O	O
800	O	O	O
degree	O	O	O
days	O	O	O
)	O	O	O
and	O	O	O
then	O	O	O
raised	O	O	B-T080
in	O	O	O
normoxic	O	O	B-T070
conditions	O	O	B-T080
for	O	O	O
a	O	O	O
further	O	O	O
15	O	O	O
mo	O	O	O
.	O	O	O

At	O	O	O
18	O	O	O
mo	O	O	O
after	O	O	O
fertilization	O	O	B-T040
,	O	O	O
aerobic	O	O	B-T080
scope	O	O	B-T077
was	O	O	O
calculated	O	O	B-T052
in	O	O	O
normoxia	O	O	B-T070
(	O	O	O
100	O	O	O
%	O	O	O
DO	O	O	B-T121
)	O	O	O
and	O	O	O
acute	O	O	B-T079
(	O	O	O
18	O	O	O
h	O	O	O
)	O	O	O
hypoxia	O	O	B-T046
(	O	O	O
50	O	O	O
%	O	O	O
DO	O	O	O
)	O	O	O
from	O	O	O
the	O	O	O
difference	O	O	B-T080
between	O	O	O
the	O	O	O
minimum	O	O	B-T080
and	O	O	O
maximum	O	O	B-T081
oxygen	O	O	B-T201
consumption	O	O	I-T201
rates	O	O	B-T081
(	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
and	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
at	O	O	O
10	O	O	O
°	O	O	O
C	O	O	O
.	O	O	O

Hypoxia	O	O	B-T046
tolerance	O	O	B-T080
was	O	O	O
determined	O	O	B-T080
as	O	O	O
the	O	O	O
DO	O	O	B-T121
at	O	O	O
which	O	O	O
loss	O	O	B-T184
of	O	O	I-T184
equilibrium	O	O	I-T184
(	O	O	O
LOE	O	O	B-T184
)	O	O	O
occurred	O	O	B-T052
in	O	O	O
a	O	O	O
constantly	O	O	O
decreasing	O	O	B-T033
DO	O	O	O
environment	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
difference	O	O	I-T033
in	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
,	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
,	O	O	O
or	O	O	O
aerobic	O	O	B-T080
scope	O	O	B-T077
between	O	O	O
fish	O	O	B-T013
raised	O	O	B-T080
in	O	O	O
hypoxia	O	O	B-T046
or	O	O	O
normoxia	O	O	B-T070
.	O	O	O

There	O	O	O
was	O	O	O
some	O	O	O
evidence	O	O	B-T078
that	O	O	O
hypoxia	O	O	B-T046
tolerance	O	O	B-T080
was	O	O	O
lower	O	O	B-T052
(	O	O	O
higher	O	O	O
DO	O	O	B-T121
at	O	O	O
LOE	O	O	B-T184
)	O	O	O
in	O	O	O
hypoxia	O	O	O
-	O	O	O
raised	O	O	B-T080
fish	O	O	B-T013
compared	O	O	O
with	O	O	O
those	O	O	O
raised	O	O	O
in	O	O	O
normoxia	O	O	B-T070
,	O	O	O
but	O	O	O
the	O	O	O
magnitude	O	O	B-T081
of	O	O	O
the	O	O	O
effect	O	O	B-T080
was	O	O	O
small	O	O	B-T081
(	O	O	O
12.52	O	O	O
%	O	O	O
DO	O	O	O
vs.	O	O	O
11.73	O	O	O
%	O	O	O
DO	O	O	O
at	O	O	O
LOE	O	O	O
)	O	O	O
.	O	O	O

Acute	O	O	B-T079
hypoxia	O	O	B-T046
significantly	O	O	O
reduced	O	O	B-T080
aerobic	O	O	B-T080
scope	O	O	B-T077
by	O	O	O
reducing	O	O	B-T080
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
,	O	O	O
while	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
remained	O	O	O
unchanged	O	O	B-T033
.	O	O	O

Interestingly	O	O	O
,	O	O	O
acute	O	O	B-T079
hypoxia	O	O	B-T046
uncovered	O	O	O
individual	O	O	B-T013
-level	O	O	O
relationships	O	O	B-T080
between	O	O	O
DO	O	O	B-T121
at	O	O	O
LOE	O	O	B-T184
and	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
,	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
,	O	O	O
and	O	O	O
aerobic	O	O	B-T080
scope	O	O	B-T077
.	O	O	O

We	O	O	O
discuss	O	O	O
our	O	O	O
findings	O	O	B-T169
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
developmental	O	O	B-T080
trajectories	O	O	O
and	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
aerobic	O	O	B-T080
performance	O	O	B-T052
in	O	O	O
hypoxia	O	O	B-T046
tolerance	O	O	B-T080
.	O	O	O

-DOCSTART- (28460374)

LDL	O	O	B-T109
particle	O	O	B-T081
number	O	O	I-T081
and	O	O	O
size	O	O	B-T081
and	O	O	O
cardiovascular	O	O	B-T029
risk	O	O	B-T078
:	O	O	O
anything	O	O	O
new	O	O	O
under	O	O	O
the	O	O	O
sun	O	O	O
?	O	O	O

We	O	O	O
provide	O	O	O
here	O	O	O
an	O	O	O
up-to-date	O	O	O
perspective	O	O	O
on	O	O	O
the	O	O	O
potential	O	O	B-T080
use	O	O	B-T169
of	O	O	O
LDL	O	O	B-T109
particle	O	O	B-T081
number	O	O	I-T081
and	O	O	O
size	O	O	B-T081
as	O	O	O
complementary	O	O	O
risk	O	O	B-T078
factors	O	O	I-T033
to	O	O	O
predict	O	O	O
and	O	O	O
manage	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
CVD	O	O	B-T047
)	O	O	O
risk	O	O	O
in	O	O	O
the	O	O	O
clinical	O	O	B-T080
realm	O	O	O
.	O	O	O

Studies	O	O	B-T062
show	O	O	O
that	O	O	O
a	O	O	O
significant	O	O	B-T078
proportion	O	O	B-T081
of	O	O	O
the	O	O	O
population	O	O	B-T098
has	O	O	O
discordant	O	O	B-T077
LDL	O	O	B-T109
particle	O	O	B-T081
number	O	O	I-T081
and	O	O	O
cholesterol	O	O	B-T109
indices	O	O	B-T170
[	O	O	O
non-HDL	O	O	B-T109
cholesterol	O	O	I-T109
(	O	O	O
HDL-C	O	O	B-T109
)	O	O	O
]	O	O	O
.	O	O	O

Data	O	O	O
also	O	O	O
show	O	O	O
that	O	O	O
risk	O	O	O
prediction	O	O	O
may	O	O	O
be	O	O	O
improved	O	O	O
when	O	O	O
using	O	O	O
information	O	O	B-T078
on	O	O	O
LDL	O	O	B-T109
particle	O	O	B-T081
number	O	O	I-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
discordant	O	O	B-T077
particle	O	O	O
number	O	O	O
and	O	O	O
cholesterol	O	O	B-T109
data	O	O	O
.	O	O	O

Yet	O	O	O
,	O	O	O
most	O	O	O
of	O	O	O
the	O	O	O
current	O	O	O
CVD	O	O	B-T047
guidelines	O	O	B-T170
conclude	O	O	O
that	O	O	O
LDL	O	O	B-T109
particle	O	O	B-T081
number	O	O	I-T081
is	O	O	O
not	O	O	O
superior	O	O	O
to	O	O	O
cholesterol	O	O	B-T109
indices	O	O	B-T170
,	O	O	O
including	O	O	O
non-HDL-C	O	O	B-T109
concentrations	O	O	B-T081
,	O	O	O
in	O	O	O
predicting	O	O	O
CVD	O	O	O
risk	O	O	B-T078
.	O	O	O

LDL	O	O	B-T109
particle	O	O	B-T081
size	O	O	I-T081
,	O	O	O
on	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
has	O	O	O
not	O	O	O
been	O	O	O
independently	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
CVD	O	O	B-T047
risk	O	O	B-T078
after	O	O	O
adjustment	O	O	B-T169
for	O	O	O
other	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
such	O	O	O
as	O	O	O
LDL	O	O	B-T109
cholesterol	O	O	I-T109
,	O	O	O
triglycerides	O	O	B-T109
,	O	O	O
and	O	O	O
HDL-C	O	O	B-T109
and	O	O	O
that	O	O	O
routine	O	O	O
use	O	O	O
of	O	O	O
information	O	O	B-T078
pertaining	O	O	O
to	O	O	O
particle	O	O	O
size	O	O	O
to	O	O	O
determine	O	O	O
and	O	O	O
manage	O	O	O
patients	O	O	B-T101
'	O	O	I-T101
risk	O	O	O
is	O	O	O
not	O	O	O
yet	O	O	O
justified	O	O	O
.	O	O	O

Additional	O	O	B-T169
studies	O	O	B-T062
are	O	O	O
required	O	O	O
to	O	O	O
settle	O	O	O
the	O	O	O
debate	O	O	B-T052
on	O	O	O
which	O	O	O
of	O	O	O
cholesterol	O	O	B-T109
indices	O	O	B-T170
and	O	O	O
LDL	O	O	B-T109
particle	O	O	B-T081
number	O	O	I-T081
is	O	O	O
the	O	O	O
best	O	O	O
predictor	O	O	O
of	O	O	O
CVD	O	O	B-T047
risk	O	O	B-T078
,	O	O	O
and	O	O	O
if	O	O	O
such	O	O	O
measures	O	O	B-T081
should	O	O	O
be	O	O	O
integrated	O	O	O
in	O	O	O
clinical	O	O	B-T061
practice	O	O	I-T061
.	O	O	O

-DOCSTART- (28462032)

The	O	O	O
emerging	O	O	B-T052
contribution	O	O	I-T052
of	O	O	O
social	O	O	B-T204
wasps	O	O	I-T204
to	O	O	O
grape	O	O	B-T047
rot	O	O	I-T047
disease	O	O	I-T047
ecology	O	O	O

Grape	O	O	B-T047
sour	O	O	I-T047
(	O	O	I-T047
bunch	O	O	I-T047
)	O	O	I-T047
rot	O	O	I-T047
is	O	O	O
a	O	O	O
polymicrobial	O	O	B-T047
disease	O	O	I-T047
of	O	O	O
vineyards	O	O	B-T083
that	O	O	O
causes	O	O	O
millions	O	O	B-T081
of	O	O	O
dollars	O	O	B-T081
in	O	O	O
lost	O	O	B-T081
revenue	O	O	I-T081
per	O	O	B-T079
year	O	O	I-T079
due	O	O	O
to	O	O	O
decreased	O	O	B-T081
quality	O	O	B-T080
of	O	O	O
grapes	O	O	B-T168
and	O	O	O
resultant	O	O	B-T168
wine	O	O	I-T168
.	O	O	O

The	O	O	O
disease	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
damaged	O	O	B-T169
berries	O	O	B-T168
infected	O	O	B-T033
with	O	O	O
a	O	O	O
community	O	O	B-T096
of	O	O	O
acetic	O	O	B-T007
acid	O	O	I-T007
bacteria	O	O	I-T007
,	O	O	O
yeasts	O	O	B-T004
,	O	O	O
and	O	O	O
filamentous	O	O	B-T004
fungi	O	O	I-T004
that	O	O	O
results	O	O	O
in	O	O	O
rotting	O	O	B-T067
berries	O	O	O
with	O	O	O
high	O	O	B-T080
amounts	O	O	B-T081
of	O	O	O
undesirable	O	O	O
volatile	O	O	B-T080
acidity	O	O	B-T103
.	O	O	O

Many	O	O	O
insect	O	O	B-T204
species	O	O	B-T185
cause	O	O	O
the	O	O	O
initial	O	O	B-T079
grape	O	O	B-T168
berry	O	O	B-T168
damage	O	O	B-T169
that	O	O	O
can	O	O	O
lead	O	O	O
to	O	O	O
this	O	O	O
disease	O	O	B-T047
,	O	O	O
but	O	O	O
most	O	O	O
studies	O	O	B-T062
have	O	O	O
focused	O	O	B-T169
on	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
fruit	O	O	B-T204
flies	O	O	I-T204
in	O	O	O
facilitating	O	O	O
symptoms	O	O	B-T184
and	O	O	O
vectoring	O	O	B-T204
the	O	O	O
microorganisms	O	O	B-T001
of	O	O	O
this	O	O	O
disease	O	O	O
complex	O	O	B-T080
.	O	O	O

Like	O	O	O
fruit	O	O	B-T204
flies	O	O	I-T204
,	O	O	O
social	O	O	B-T204
wasps	O	O	I-T204
are	O	O	O
abundant	O	O	B-T080
in	O	O	O
vineyards	O	O	B-T083
where	O	O	O
they	O	O	O
feed	O	O	O
on	O	O	O
ripe	O	O	B-T168
berries	O	O	I-T168
and	O	O	O
cause	O	O	O
significant	O	O	B-T078
damage	O	O	B-T169
,	O	O	O
while	O	O	O
also	O	O	O
dispersing	O	O	B-T082
yeasts	O	O	B-T004
involved	O	O	B-T169
in	O	O	O
wine	O	O	B-T168
fermentation	O	O	B-T044
.	O	O	O

Despite	O	O	O
this	O	O	O
,	O	O	O
their	O	O	O
possible	O	O	O
role	O	O	B-T077
in	O	O	O
disease	O	O	B-T047
facilitation	O	O	O
and	O	O	O
dispersal	O	O	B-T047
of	O	O	I-T047
grape	O	O	I-T047
rots	O	O	I-T047
has	O	O	O
not	O	O	O
been	O	O	O
explored	O	O	O
.	O	O	O

We	O	O	O
tested	O	O	B-T169
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
the	O	O	O
paper	O	O	B-T204
wasp	O	O	I-T204
Polistes	O	O	B-T129
dominulus	O	O	I-T129
could	O	O	O
facilitate	O	O	O
grape	O	O	B-T047
sour	O	O	I-T047
rot	O	O	I-T047
in	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
other	O	O	O
insect	O	O	B-T204
vectors	O	O	I-T204
.	O	O	O

Using	O	O	O
marker	O	O	B-T059
gene	O	O	I-T059
sequencing	O	O	I-T059
we	O	O	O
characterized	O	O	B-T052
the	O	O	O
bacterial	O	O	B-T007
and	O	O	O
fungal	O	O	B-T004
community	O	O	B-T096
of	O	O	O
wild-caught	O	O	B-T100
adults	O	O	I-T100
.	O	O	O

We	O	O	O
used	O	O	O
a	O	O	O
sterilized	O	O	O
foraging	O	O	B-T055
arena	O	O	I-T082
to	O	O	O
determine	O	O	O
if	O	O	O
these	O	O	O
wasps	O	O	B-T204
transfer	O	O	O
viable	O	O	B-T080
microorganisms	O	O	B-T001
when	O	O	O
foraging	O	O	O
.	O	O	O

We	O	O	O
then	O	O	O
tested	O	O	B-T169
if	O	O	O
wasps	O	O	B-T204
harboring	O	O	O
their	O	O	O
native	O	O	B-T098
microbial	O	O	B-T001
community	O	O	B-T096
,	O	O	O
or	O	O	O
those	O	O	O
inoculated	O	O	B-T061
with	O	O	O
sour	O	O	B-T047
rot	O	O	I-T047
,	O	O	O
had	O	O	O
an	O	O	O
effect	O	O	B-T080
on	O	O	O
grape	O	O	B-T047
sour	O	O	I-T047
rot	O	O	I-T047
incidence	O	O	B-T081
and	O	O	O
severity	O	O	B-T080
using	O	O	O
a	O	O	O
laboratory	O	O	B-T083
foraging	O	O	I-T083
arena	O	O	I-T083
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
all	O	O	O
wasps	O	O	B-T204
harbor	O	O	O
some	O	O	O
portion	O	O	O
of	O	O	O
the	O	O	O
sour	O	O	B-T047
rot	O	O	I-T047
microbial	O	O	B-T001
community	O	O	B-T096
and	O	O	O
that	O	O	O
they	O	O	O
have	O	O	O
the	O	O	O
ability	O	O	B-T032
to	O	O	O
transfer	O	O	O
viable	O	O	B-T080
microorganisms	O	O	B-T001
when	O	O	O
foraging	O	O	B-T055
.	O	O	O

Foraging	O	O	B-T055
by	O	O	O
inoculated	O	O	B-T061
and	O	O	O
uninoculated	O	O	B-T204
wasps	O	O	I-T204
led	O	O	O
to	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
berry	O	O	B-T047
rot	O	O	I-T047
disease	O	O	I-T047
symptom	O	O	B-T184
severity	O	O	B-T080
and	O	O	O
incidence	O	O	B-T081
.	O	O	O

Our	O	O	O
results	O	O	B-T033
indicate	O	O	O
that	O	O	O
paper	O	O	B-T204
wasps	O	O	I-T204
can	O	O	O
facilitate	O	O	O
sour	O	O	B-T047
rot	O	O	I-T047
diseases	O	O	I-T047
in	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
other	O	O	B-T204
vectors	O	O	I-T204
and	O	O	O
that	O	O	O
the	O	O	O
mechanism	O	O	B-T169
of	O	O	O
this	O	O	O
facilitation	O	O	O
may	O	O	O
include	O	O	O
both	O	O	O
increasing	O	O	B-T169
host	O	O	B-T001
susceptibility	O	O	B-T201
and	O	O	O
transmitting	O	O	B-T169
these	O	O	O
microbial	O	O	B-T001
communities	O	O	B-T096
to	O	O	O
the	O	O	O
grapes	O	O	B-T168
.	O	O	O

Social	O	O	B-T204
wasps	O	O	I-T204
are	O	O	O
understudied	O	O	O
but	O	O	O
relevant	O	O	B-T080
players	O	O	I-T080
in	O	O	O
the	O	O	O
sour	O	O	B-T047
rot	O	O	I-T047
ecology	O	O	B-T090
of	O	O	O
vineyards	O	O	B-T083
.	O	O	O

-DOCSTART- (28463085)

Low-intensity	O	O	B-T070
pulsed	O	O	I-T070
ultrasound	O	O	I-T070
reduces	O	O	O
periodontal	O	O	B-T047
atrophy	O	O	I-T047
in	O	O	O
occlusal	O	O	B-T042
hypofunctional	O	O	B-T046
teeth	O	O	O

To	O	O	O
clarify	O	O	O
whether	O	O	O
low-intensity	O	O	B-T070
pulsed	O	O	I-T070
ultrasound	O	O	I-T070
(	O	O	O
LIPUS	O	O	B-T070
)	O	O	O
exposure	O	O	O
has	O	O	O
recovery	O	O	O
effects	O	O	O
on	O	O	O
the	O	O	O
hypofunctional	O	O	B-T046
periodontal	O	O	B-T023
ligament	O	O	I-T023
(	O	O	O
PDL	O	O	B-T023
)	O	O	O
and	O	O	O
interradicular	O	O	B-T023
alveolar	O	O	I-T023
bone	O	O	I-T023
(	O	O	O
IRAB	O	O	B-T023
)	O	O	O
.	O	O	O

Twelve-	O	O	O
week	O	O	B-T079
-old	O	O	O
male	O	O	B-T032
Sprague-Dawley	O	O	B-T015
rats	O	O	I-T015
were	O	O	O
divided	O	O	O
into	O	O	O
three	O	O	O
groups	O	O	B-T098
(	O	O	O
n	O	O	O
=	O	O	O
5	O	O	O
each	O	O	O
):	O	O	O
a	O	O	O
normal	O	O	B-T042
occlusion	O	O	I-T042
(	O	O	O
C	O	O	O
)	O	O	O
group	O	O	B-T098
,	O	O	O
an	O	O	O
occlusal	O	O	B-T042
hypofunction	O	O	B-T046
(	O	O	O
H	O	O	O
)	O	O	O
group	O	O	O
,	O	O	O
and	O	O	O
an	O	O	O
occlusal	O	O	B-T098
hypofunction	O	O	I-T098
group	O	O	I-T098
subjected	O	O	O
to	O	O	O
LIPUS	O	O	B-T070
(	O	O	O
HL	O	O	O
)	O	O	O
treatment	O	O	B-T061
.	O	O	O

Hypofunctional	O	O	B-T046
occlusion	O	O	B-T042
of	O	O	O
the	O	O	O
maxillary	O	O	B-T023
first	O	O	I-T023
molar	O	O	I-T023
(	O	O	O
M1	O	O	B-T023
)	O	O	O
of	O	O	O
the	O	O	O
H	O	O	B-T098
and	O	O	O
HL	O	O	B-T098
groups	O	O	I-T098
was	O	O	O
induced	O	O	O
by	O	O	O
the	O	O	O
bite-raising	O	O	B-T058
technique	O	O	I-T058
.	O	O	O

Only	O	O	O
the	O	O	O
HL	O	O	B-T098
group	O	O	I-T098
was	O	O	O
irradiated	O	O	O
with	O	O	O
LIPUS	O	O	B-T070
for	O	O	O
5	O	O	O
days	O	O	B-T079
.	O	O	O

The	O	O	O
IRAB	O	O	B-T023
and	O	O	O
PDL	O	O	B-T023
of	O	O	O
M1	O	O	B-T023
were	O	O	O
examined	O	O	O
by	O	O	O
microcomputed	O	O	B-T060
tomography	O	O	I-T060
(	O	O	O
micro-CT	O	O	B-T060
)	O	O	O
analysis	O	O	B-T062
.	O	O	O

To	O	O	O
quantify	O	O	O
mRNA	O	O	B-T114
expression	O	O	B-T045
of	O	O	O
cytokines	O	O	B-T116
involved	O	O	O
in	O	O	O
PDL	O	O	B-T023
proliferation	O	O	B-T169
and	O	O	O
development	O	O	B-T169
,	O	O	O
real-time	O	O	B-T063
reverse	O	O	I-T063
transcription	O	O	I-T063
quantitative	O	O	I-T063
PCR	O	O	I-T063
(	O	O	O
qRT-PCR	O	O	B-T063
)	O	O	O
was	O	O	O
performed	O	O	O
for	O	O	O
twist	O	O	B-T028
family	O	O	I-T028
bHLH	O	O	I-T028
transcription	O	O	I-T028
factor	O	O	I-T028
1	O	O	I-T028
(	O	O	O
Twist1	O	O	B-T028
)	O	O	O
,	O	O	O
periostin	O	O	B-T028
,	O	O	O
and	O	O	O
connective	O	O	B-T028
tissue	O	O	I-T028
growth	O	O	I-T028
factor	O	O	I-T028
(	O	O	O
CTGF	O	O	B-T028
)	O	O	O
in	O	O	O
the	O	O	O
PDL	O	O	O
samples	O	O	B-T167
.	O	O	O

Micro-CT	O	O	B-T060
analysis	O	O	B-T062
showed	O	O	O
that	O	O	O
the	O	O	O
PDL	O	O	B-T023
volume	O	O	B-T081
was	O	O	O
decreased	O	O	O
in	O	O	O
the	O	O	O
H	O	O	B-T098
group	O	O	I-T098
compared	O	O	O
with	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
C	O	O	B-T098
and	O	O	O
HL	O	O	B-T098
groups	O	O	I-T098
.	O	O	O

Both	O	O	O
bone	O	O	B-T032
volume	O	O	I-T032
per	O	O	O
tissue	O	O	B-T081
volume	O	O	I-T081
(	O	O	O
BV	O	O	B-T032
/	O	O	O
TV	O	O	B-T081
)	O	O	O
of	O	O	O
IRAB	O	O	B-T023
was	O	O	O
decreased	O	O	O
in	O	O	O
the	O	O	O
H	O	O	B-T098
group	O	O	I-T098
compared	O	O	O
with	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
C	O	O	B-T098
group	O	O	I-T098
.	O	O	O

LIPUS	O	O	B-T070
exposure	O	O	O
restored	O	O	O
BV	O	O	B-T032
/	O	O	O
TV	O	O	B-T081
in	O	O	O
the	O	O	O
IRAB	O	O	B-T023
of	O	O	O
the	O	O	O
HL	O	O	B-T098
group	O	O	I-T098
.	O	O	O

qRT-PCR	O	O	B-T063
analysis	O	O	B-T062
showed	O	O	O
that	O	O	O
Twist1	O	O	B-T028
,	O	O	O
periostin	O	O	B-T028
,	O	O	O
and	O	O	O
CTGF	O	O	B-T028
mRNA	O	O	B-T114
levels	O	O	B-T080
were	O	O	O
decreased	O	O	O
in	O	O	O
the	O	O	O
H	O	O	B-T098
group	O	O	I-T098
and	O	O	O
increased	O	O	O
in	O	O	O
the	O	O	O
HL	O	O	B-T098
group	O	O	I-T098
.	O	O	O

LIPUS	O	O	B-T070
exposure	O	O	O
reduced	O	O	O
the	O	O	O
atrophic	O	O	B-T046
changes	O	O	B-T169
of	O	O	O
alveolar	O	O	B-T023
bone	O	O	I-T023
by	O	O	O
inducing	O	O	B-T169
the	O	O	O
upregulation	O	O	B-T044
of	O	O	O
periostin	O	O	B-T028
and	O	O	O
CTGF	O	O	B-T028
expression	O	O	B-T045
to	O	O	O
promote	O	O	O
PDL	O	O	B-T023
healing	O	O	B-T040
after	O	O	O
induction	O	O	B-T061
of	O	O	O
occlusal	O	O	B-T042
hypofunction	O	O	B-T046
.	O	O	O

-DOCSTART- (28464019)

Radiologic	O	O	B-T060
assessment	O	O	I-T060
of	O	O	O
quality	O	O	O
of	O	O	O
root	O	O	B-T061
canal	O	O	I-T061
fillings	O	O	I-T061
and	O	O	O
periapical	O	O	B-T082
status	O	O	I-T082
in	O	O	O
an	O	O	O
Austrian	O	O	B-T098
subpopulation	O	O	B-T098
-	O	O	O
An	O	O	O
observational	O	O	O
study	O	O	O

Progress	O	O	B-T169
in	O	O	O
endodontic	O	O	B-T061
techniques	O	O	I-T061
and	O	O	O
methodological	O	O	O
advances	O	O	O
have	O	O	O
altered	O	O	O
root	O	O	B-T061
canal	O	O	I-T061
therapy	O	O	I-T061
over	O	O	O
the	O	O	O
last	O	O	O
decades	O	O	O
.	O	O	O

These	O	O	O
techniques	O	O	O
and	O	O	O
methods	O	O	O
need	O	O	O
periodical	O	O	B-T170
documentation	O	O	B-T170
.	O	O	O

This	O	O	O
observational	O	O	B-T062
study	O	O	I-T062
determined	O	O	O
the	O	O	O
current	O	O	O
prevalence	O	O	B-T081
of	O	O	O
endodontic	O	O	B-T061
treatments	O	O	I-T061
,	O	O	I-T061
and	O	O	O
investigated	O	O	B-T169
the	O	O	O
relationship	O	O	O
of	O	O	O
various	O	O	O
factors	O	O	O
with	O	O	O
the	O	O	O
periapical	O	O	B-T082
status	O	O	I-T082
in	O	O	O
a	O	O	O
Lower	O	O	O
Austrian	O	O	B-T098
subpopulation	O	O	B-T098
.	O	O	O

One	O	O	O
thousand	O	O	O
orthopantomograms	O	O	B-T060
of	O	O	O
first-time	O	O	O
university	O	O	B-T093
adult	O	O	O
patients	O	O	B-T101
radiographed	O	O	B-T060
at	O	O	O
an	O	O	O
outpatient	O	O	B-T093
clinic	O	O	I-T093
were	O	O	O
evaluated	O	O	B-T058
.	O	O	O

For	O	O	O
each	O	O	O
tooth	O	O	B-T023
,	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
periradicular	O	O	B-T047
pathosis	O	O	I-T047
and/or	O	O	O
endodontic	O	O	B-T061
treatment	O	O	I-T061
was	O	O	O
recorded	O	O	O
,	O	O	O
as	O	O	O
was	O	O	O
the	O	O	O
quality	O	O	O
of	O	O	O
(	O	O	O
post-	O	O	O
)	O	O	O
endodontic	O	O	O
treatment	O	O	O
(	O	O	O
homogeneity	O	O	B-T080
and	O	O	O
length	O	O	O
of	O	O	O
root	O	O	B-T061
canal	O	O	I-T061
fillings	O	O	I-T061
;	O	O	O
preparation	O	O	B-T033
failures	O	O	I-T033
;	O	O	O
posts	O	O	B-T074
/	O	O	O
screws	O	O	B-T074
;	O	O	O
apicoectomies	O	O	B-T061
;	O	O	O
coronal	O	O	B-T061
restorations	O	O	I-T061
)	O	O	O
.	O	O	O

Two	O	O	O
evaluators	O	O	B-T097
,	O	O	O
blinded	O	O	B-T062
to	O	O	O
each	O	O	O
other	O	O	O
,	O	O	O
scored	O	O	B-T081
all	O	O	O
teeth	O	O	B-T023
.	O	O	O

In	O	O	O
cases	O	O	O
of	O	O	O
disagreement	O	O	O
,	O	O	O
they	O	O	O
joined	O	O	O
for	O	O	O
a	O	O	O
consensus	O	O	O
score	O	O	B-T081
.	O	O	O

In	O	O	O
all	O	O	O
,	O	O	O
22,586	O	O	O
teeth	O	O	B-T081
were	O	O	I-T081
counted	O	O	I-T081
.	O	O	O

Of	O	O	O
these	O	O	O
,	O	O	O
2,907	O	O	O
teeth	O	O	B-T023
(	O	O	O
12.9	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
periapical	O	O	B-T047
pathosis	O	O	I-T047
,	O	O	O
while	O	O	O
2,504	O	O	O
teeth	O	O	O
had	O	O	O
undergone	O	O	O
root	O	O	B-T061
canal	O	O	I-T061
treatment	O	O	I-T061
.	O	O	O

Of	O	O	O
the	O	O	O
endodontically	O	O	B-T047
treated	O	O	I-T047
teeth	O	O	I-T047
,	O	O	O
52	O	O	O
%	O	O	O
showed	O	O	O
no	O	O	O
radiographic	O	O	B-T070
signs	O	O	O
of	O	O	O
apical	O	O	B-T047
periodontitis	O	O	I-T047
,	O	O	O
while	O	O	O
44.9	O	O	O
%	O	O	O
had	O	O	O
overt	O	O	O
apical	O	O	B-T047
lesions	O	O	I-T047
,	O	O	O
and	O	O	O
3,1	O	O	O
%	O	O	O
revealed	O	O	O
widened	O	O	B-T047
periodontal	O	O	I-T047
ligament	O	O	I-T047
space	O	O	I-T047
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
the	O	O	O
root	O	O	B-T061
canal	O	O	I-T061
fillings	O	O	I-T061
was	O	O	O
inhomogeneous	O	O	O
(	O	O	O
70.4	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
75.4	O	O	O
%	O	O	O
were	O	O	O
rated	O	O	O
too	O	O	O
short	O	O	O
,	O	O	O
and	O	O	O
3.8	O	O	O
%	O	O	O
too	O	O	O
long	O	O	O
.	O	O	O

The	O	O	O
presence	O	O	B-T033
of	O	O	O
apical	O	O	B-T023
pathosis	O	O	B-T047
was	O	O	O
significantly	O	O	B-T080
correlated	O	O	I-T080
(	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
OR	O	O	B-T081
)	O	O	O
2.556	O	O	O
[	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
2.076	O	O	O
-	O	O	O
3.146	O	O	O
]	O	O	O
;	O	O	O
P<0.0001	O	O	O
)	O	O	O
with	O	O	O
poor	O	O	O
root	O	O	B-T061
canal	O	O	I-T061
fillings	O	O	I-T061
(	O	O	O
length	O	O	O
and	O	O	O
homogeneity	O	O	B-T080
)	O	O	O
.	O	O	O

Posts	O	O	B-T074
or	O	O	O
screws	O	O	B-T074
positively	O	O	O
affected	O	O	O
periapical	O	O	B-T082
status	O	O	I-T082
(	O	O	O
OR	O	O	B-T081
1.853	O	O	O
[	O	O	O
CI	O	O	O
1.219	O	O	O
-	O	O	O
2.819	O	O	O
]	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.004	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
endodontically	O	O	B-T047
treated	O	O	I-T047
posterior	O	O	I-T047
teeth	O	O	I-T047
were	O	O	O
infrequently	O	O	O
restored	O	O	B-T061
(	O	O	O
posts	O	O	B-T074
,	O	O	O
7.5	O	O	O
%	O	O	O
;	O	O	O
screws	O	O	O
,	O	O	O
2.7	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Best	O	O	O
results	O	O	O
were	O	O	O
found	O	O	O
for	O	O	O
teeth	O	O	B-T023
with	O	O	O
both	O	O	O
appropriate	O	O	O
endodontic	O	O	B-T061
treatment	O	O	I-T061
and	O	O	O
adequate	O	O	O
coronal	O	O	B-T061
restoration	O	O	I-T061
.	O	O	O

A	O	O	O
high	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
periradicular	O	O	B-T033
radiolucencies	O	O	I-T033
was	O	O	O
observed	O	O	O
with	O	O	O
root	O	O	B-T023
canal	O	O	I-T023
filled	O	O	I-T023
teeth	O	O	I-T023
,	O	O	O
along	O	O	O
with	O	O	O
high	O	O	O
numbers	O	O	O
of	O	O	O
unmet	O	O	O
treatment	O	O	B-T061
needs	O	O	O
.	O	O	O

Periapical	O	O	B-T082
health	O	O	B-T078
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
adequate	O	O	O
root	O	O	B-T061
canal	O	O	I-T061
obturation	O	O	I-T061
and	O	O	O
high-grade	O	O	O
postendodontic	O	O	B-T061
restorations	O	O	I-T061
,	O	O	O
and	O	O	O
quality	O	O	O
regarding	O	O	O
these	O	O	O
latter	O	O	O
aspects	O	O	O
is	O	O	O
considered	O	O	O
mandatory	O	O	O
to	O	O	O
promote	O	O	O
periapical	O	O	B-T082
health	O	O	O
.	O	O	O

-DOCSTART- (28464071)

Chemical	O	O	B-T070
composition	O	O	I-T070
and	O	O	O
amino	O	O	B-T116
acid	O	O	I-T116
digestibility	O	O	B-T081
of	O	O	O
soybean	O	O	B-T168
meal	O	O	I-T168
produced	O	O	O
in	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
,	O	O	O
China	O	O	B-T083
,	O	O	O
Argentina	O	O	B-T083
,	O	O	O
Brazil	O	O	B-T083
,	O	O	O
or	O	O	O
India	O	O	O

An	O	O	O
experiment	O	O	O
was	O	O	O
conducted	O	O	O
to	O	O	O
compare	O	O	O
nutritional	O	O	B-T080
composition	O	O	B-T070
of	O	O	O
soybean	O	O	B-T168
meal	O	O	I-T168
(	O	O	O
SBM	O	O	B-T168
)	O	O	O
produced	O	O	O
in	O	O	O
China	O	O	B-T083
,	O	O	O
Argentina	O	O	B-T083
,	O	O	O
Brazil	O	O	B-T083
,	O	O	O
the	O	O	O
U.S	O	O	B-T083
.	O	O	O
,	O	O	O
or	O	O	O
India	O	O	B-T083
and	O	O	O
the	O	O	O
apparent	O	O	B-T081
ileal	O	O	I-T081
digestibility	O	O	I-T081
(	O	O	O
AID	O	O	B-T081
)	O	O	O
and	O	O	O
the	O	O	O
standardized	O	O	B-T081
ileal	O	O	I-T081
digestibility	O	O	I-T081
(	O	O	O
SID	O	O	B-T081
)	O	O	O
of	O	O	O
CP	O	O	B-T116
and	O	O	O
AA	O	O	B-T116
in	O	O	O
these	O	O	O
SBM	O	O	O
when	O	O	O
fed	O	O	O
to	O	O	O
growing	O	O	O
pigs	O	O	B-T015
.	O	O	O

Five	O	O	O
sources	O	O	O
of	O	O	O
SBM	O	O	B-T168
from	O	O	O
China	O	O	B-T083
,	O	O	O
Argentina	O	O	B-T083
,	O	O	O
Brazil	O	O	B-T083
,	O	O	O
and	O	O	O
the	O	O	O
U.S	O	O	B-T083
.	O	O	O
,	O	O	O
and	O	O	O
4	O	O	O
sources	O	O	O
from	O	O	O
India	O	O	B-T083
were	O	O	O
collected	O	O	O
for	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
24	O	O	O
sources	O	O	O
of	O	O	O
SBM	O	O	O
.	O	O	O

All	O	O	O
samples	O	O	O
were	O	O	O
analyzed	O	O	O
for	O	O	O
energy	O	O	B-T081
,	O	O	O
DM	O	O	B-T167
,	O	O	O
and	O	O	O
nutrients	O	O	B-T168
,	O	O	O
and	O	O	O
each	O	O	O
source	O	O	O
was	O	O	O
included	O	O	O
in	O	O	O
a	O	O	O
cornstarch	O	O	B-T109
based	O	O	I-T109
diet	O	O	I-T109
in	O	O	O
which	O	O	O
SBM	O	O	B-T168
was	O	O	O
the	O	O	O
only	O	O	O
AA	O	O	B-T116
contributing	O	O	O
ingredient	O	O	B-T120
.	O	O	O

An	O	O	O
N-free	O	O	B-T168
diet	O	O	I-T168
was	O	O	O
also	O	O	O
formulated	O	O	O
.	O	O	O

Twenty-five	O	O	O
barrows	O	O	O
(	O	O	O
initial	O	O	O
BW	O	O	O
:	O	O	O
30.53	O	O	O
±	O	O	O
1.73	O	O	O
kg	O	O	O
)	O	O	O
were	O	O	O
equipped	O	O	O
with	O	O	O
a	O	O	O
T-cannula	O	O	O
in	O	O	O
the	O	O	O
distal	O	O	B-T029
ileum	O	O	I-T029
and	O	O	O
randomly	O	O	O
allotted	O	O	O
to	O	O	O
a	O	O	O
25	O	O	O
×	O	O	O
8	O	O	O
Youden	O	O	B-T062
square	O	O	I-T062
design	O	O	I-T062
with	O	O	O
25	O	O	O
diets	O	O	B-T168
and	O	O	O
8	O	O	O
periods	O	O	B-T079
.	O	O	O

Results	O	O	O
indicate	O	O	O
that	O	O	O
the	O	O	O
concentration	O	O	B-T081
of	O	O	O
CP	O	O	B-T116
was	O	O	O
greater	O	O	O
(	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
in	O	O	O
SBM	O	O	B-T168
from	O	O	O
Brazil	O	O	B-T083
and	O	O	O
India	O	O	B-T083
(	O	O	O
49.3	O	O	O
and	O	O	O
49.5	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
than	O	O	O
in	O	O	O
SBM	O	O	O
from	O	O	O
China	O	O	B-T083
,	O	O	O
Argentina	O	O	B-T083
,	O	O	O
or	O	O	O
the	O	O	O
U.S.	O	O	O
(	O	O	O
45.1	O	O	O
,	O	O	O
46.7	O	O	O
,	O	O	O
and	O	O	O
47.3	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
as-fed	O	O	O
basis	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
concentration	O	O	B-T081
of	O	O	O
most	O	O	O
indispensable	O	O	O
AA	O	O	B-T116
followed	O	O	O
the	O	O	O
same	O	O	O
pattern	O	O	O
as	O	O	O
CP	O	O	B-T116
with	O	O	O
the	O	O	O
exception	O	O	O
that	O	O	O
SBM	O	O	B-T168
from	O	O	O
the	O	O	O
U.S.	O	O	O
contained	O	O	O
more	O	O	O
(	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
indispensable	O	O	O
AA	O	O	O
than	O	O	O
SBM	O	O	O
from	O	O	O
China	O	O	B-T083
or	O	O	O
Argentina	O	O	B-T083
.	O	O	O

However	O	O	O
,	O	O	O
SBM	O	O	B-T168
from	O	O	O
India	O	O	B-T083
contained	O	O	O
more	O	O	O
(	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
trypsin	O	O	B-T116
inhibitors	O	O	I-T116
than	O	O	O
SBM	O	O	O
from	O	O	O
the	O	O	O
other	O	O	O
countries	O	O	B-T083
.	O	O	O

A	O	O	O
greater	O	O	O
(	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
AID	O	O	B-T081
and	O	O	O
SID	O	O	B-T081
of	O	O	O
CP	O	O	B-T116
and	O	O	O
most	O	O	O
AA	O	O	B-T116
was	O	O	O
observed	O	O	O
in	O	O	O
SBM	O	O	B-T168
from	O	O	O
the	O	O	O
U.S.	O	O	O
compared	O	O	O
with	O	O	O
SBM	O	O	O
from	O	O	O
Brazil	O	O	B-T083
,	O	O	O
Argentina	O	O	B-T083
,	O	O	O
and	O	O	O
India	O	O	B-T083
,	O	O	O
but	O	O	O
there	O	O	O
were	O	O	O
no	O	O	O
differences	O	O	O
between	O	O	O
SBM	O	O	O
from	O	O	O
the	O	O	O
U.S.	O	O	O
and	O	O	O
SBM	O	O	O
from	O	O	O
China	O	O	B-T083
.	O	O	O

However	O	O	O
,	O	O	O
because	O	O	O
of	O	O	O
the	O	O	O
lower	O	O	O
concentration	O	O	B-T081
of	O	O	O
AA	O	O	B-T116
in	O	O	O
SBM	O	O	B-T168
from	O	O	O
China	O	O	B-T083
,	O	O	O
the	O	O	O
concentration	O	O	O
of	O	O	O
standardized	O	O	B-T081
ileal	O	O	I-T081
digestible	O	O	I-T081
AA	O	O	O
in	O	O	O
SBM	O	O	O
from	O	O	O
China	O	O	O
was	O	O	O
less	O	O	O
(	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
than	O	O	O
in	O	O	O
SBM	O	O	O
from	O	O	O
the	O	O	O
U.S.	O	O	O
Soybean	O	O	O
meal	O	O	O
from	O	O	O
the	O	O	O
U.S.	O	O	O
or	O	O	O
Brazil	O	O	B-T083
had	O	O	O
less	O	O	O
(	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
variability	O	O	O
in	O	O	O
SID	O	O	B-T081
values	O	O	O
than	O	O	O
SBM	O	O	O
from	O	O	O
Argentina	O	O	B-T083
,	O	O	O
China	O	O	O
,	O	O	O
or	O	O	O
India	O	O	B-T083
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
the	O	O	O
SID	O	O	B-T081
of	O	O	O
CP	O	O	B-T116
and	O	O	O
AA	O	O	B-T116
is	O	O	O
dependent	O	O	O
on	O	O	O
the	O	O	O
country	O	O	B-T083
where	O	O	O
the	O	O	O
SBM	O	O	B-T168
is	O	O	O
produced	O	O	O
.	O	O	O

This	O	O	O
difference	O	O	O
and	O	O	O
the	O	O	O
variability	O	O	O
within	O	O	O
each	O	O	O
country	O	O	B-T083
should	O	O	O
be	O	O	O
evaluated	O	O	O
when	O	O	O
formulating	O	O	B-T061
diets	O	O	I-T061
for	O	O	O
pigs	O	O	B-T015
.	O	O	O

-DOCSTART- (28464291)

Developing	O	O	B-T169
understanding	O	O	B-T041
of	O	O	O
object	O	O	B-T072
fall	O	O	B-T033
:	O	O	O
Going	O	O	O
beyond	O	O	O
inhibitory	O	O	B-T052
processes	O	O	O

A	O	O	O
study	O	O	B-T062
is	O	O	O
reported	O	O	B-T170
where	O	O	O
118	O	O	O
participants	O	O	B-T098
aged	O	O	B-T032
between	O	O	O
10	O	O	O
years	O	O	O
and	O	O	O
early	O	O	B-T079
20s	O	O	O
drew	O	O	O
the	O	O	O
trajectories	O	O	B-T079
they	O	O	O
expected	O	O	B-T170
objects	O	O	B-T072
to	O	O	O
follow	O	O	B-T169
as	O	O	O
they	O	O	O
fell	O	O	B-T033
.	O	O	O

The	O	O	O
younger	O	O	B-T079
participants	O	O	B-T098
typically	O	O	B-T080
anticipated	O	O	B-T033
backward	O	O	B-T082
trajectories	O	O	B-T079
during	O	O	O
fall	O	O	B-T033
from	O	O	O
moving	O	O	B-T040
carriers	O	O	B-T073
while	O	O	O
forward	O	O	B-T082
but	O	O	O
non-parabolic	O	O	B-T079
trajectories	O	O	I-T079
were	O	O	O
relatively	O	O	B-T080
more	O	O	B-T081
frequent	O	O	B-T079
amongst	O	O	O
the	O	O	O
older	O	O	B-T098
participants	O	O	I-T098
.	O	O	O

Both	O	O	O
patterns	O	O	B-T082
suggest	O	O	B-T078
strong	O	O	B-T080
sociocultural	O	O	B-UnknownType
influences	O	O	B-T077
,	O	O	O
with	O	O	O
implications	O	O	B-T078
for	O	O	O
models	O	O	B-T170
that	O	O	O
regard	O	O	O
development	O	O	B-T169
in	O	O	O
this	O	O	O
area	O	O	B-T078
as	O	O	O
purely	O	O	B-T080
the	O	O	O
inhibition	O	O	B-T052
of	O	O	O
principles	O	O	B-UnknownType
established	O	O	B-T080
in	O	O	O
infancy	O	O	B-T079
.	O	O	O

Statement	O	O	B-T078
of	O	O	O
contribution	O	O	B-T052
What	O	O	O
is	O	O	O
already	O	O	O
known	O	O	B-T080
on	O	O	O
this	O	O	O
subject	O	O	B-T096
?	O	O	O

Research	O	O	B-T062
with	O	O	O
infants	O	O	B-T100
demonstrates	O	O	B-T080
an	O	O	O
early	O	O	B-T079
-	O	O	O
established	O	O	B-T080
belief	O	O	B-T078
that	O	O	O
dropped	O	O	B-T052
objects	O	O	B-T072
fall	O	O	B-T033
straight	O	O	B-T082
down	O	O	B-T082
.	O	O	O

The	O	O	O
erroneous	O	O	B-T078
expectations	O	O	B-T078
that	O	O	O
pre-schoolers	O	O	B-T100
hold	O	O	B-T052
about	O	O	O
object	O	O	B-T072
fall	O	O	B-T033
are	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
failure	O	O	B-T055
to	O	O	O
inhibit	O	O	B-T052
the	O	O	O
presumption	O	O	B-T078
of	O	O	O
straight	O	O	B-T082
-	O	O	O
down	O	O	B-T082
fall	O	O	O
,	O	O	O
in	O	O	O
contexts	O	O	B-T078
where	O	O	O
it	O	O	O
is	O	O	O
inappropriate	O	O	B-T080
.	O	O	O

What	O	O	O
does	O	O	O
this	O	O	O
study	O	O	B-T062
add	O	O	O
?	O	O	O

The	O	O	O
research	O	O	B-T062
replicates	O	O	B-T169
and	O	O	O
extends	O	O	B-T169
research	O	O	O
with	O	O	O
older	O	O	B-T098
participants	O	O	I-T098
,	O	O	O
which	O	O	O
indicates	O	O	B-T078
errors	O	O	B-T080
that	O	O	O
can	O	O	O
not	O	O	O
be	O	O	O
explained	O	O	B-T058
via	O	O	O
failed	O	O	B-T169
inhibition	O	O	B-T052
of	O	O	O
straight	O	O	B-T082
-	O	O	O
down	O	O	B-T082
fall	O	O	B-T033
.	O	O	O

It	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
study	O	O	B-T062
to	O	O	O
trace	O	O	O
patterns	O	O	B-T082
of	O	O	O
errors	O	O	B-T080
across	O	O	O
late	O	O	B-T079
childhood	O	O	B-T079
,	O	O	O
adolescence	O	O	B-T079
and	O	O	O
early	O	O	B-T079
adulthood	O	O	B-T079
.	O	O	O

A	O	O	O
consequence	O	O	B-T169
of	O	O	I-T169
the	O	O	O
findings	O	O	B-T033
is	O	O	O
that	O	O	O
adequate	O	O	B-T080
modelling	O	O	B-T077
in	O	O	O
developmental	O	O	B-T091
psychology	O	O	I-T091
must	O	O	O
consider	O	O	B-T078
multilayered	O	O	B-T077
interactions	O	O	B-T169
between	O	O	O
prior	O	O	B-T079
representations	O	O	B-T052
and	O	O	O
sociocultural	O	O	B-UnknownType
experiences	O	O	B-T041
.	O	O	O

-DOCSTART- (28464602)

Attenuation	O	O	B-T052
of	O	O	O
High	O	O	B-T109
Glucose	O	O	I-T109
-	O	O	O
Induced	O	O	B-T169
Rat	O	O	B-T015
Cardiomyocyte	O	O	B-T025
Apoptosis	O	O	B-T043
by	O	O	O
Exendin-4	O	O	B-T116
via	O	O	O
Intervention	O	O	B-T061
of	O	O	O
HO-1	O	O	B-T116
/	O	O	O
Nrf-2	O	O	B-T116
and	O	O	O
the	O	O	O
PI3K/AKT	O	O	O
Signaling	O	O	O
Pathway	O	O	O

Exendin-4	O	O	B-T116
,	O	O	O
a	O	O	O
glucagon-like	O	O	B-T121
peptide-1	O	O	I-T121
receptor	O	O	I-T121
agonist	O	O	I-T121
,	O	O	O
demonstrated	O	O	O
cytoprotective	O	O	B-T039
actions	O	O	I-T039
beyond	O	O	O
glycemic	O	O	B-T033
control	O	O	I-T033
in	O	O	O
recent	O	O	O
studies	O	O	O
.	O	O	O

The	O	O	O
aims	O	O	B-T078
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
were	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
exendin-4	O	O	B-T116
on	O	O	O
high	O	O	B-T109
glucose	O	O	I-T109
(HG)-	O	O	O
induced	O	O	B-T169
cardiomyocyte	O	O	B-T025
apoptosis	O	O	B-T043
and	O	O	O
the	O	O	O
possible	O	O	O
mechanisms	O	O	B-T169
.	O	O	O

Rat	O	O	B-T015
cardiomyocytes	O	O	B-T025
were	O	O	O
divided	O	O	O
into	O	O	O
3	O	O	O
groups	O	O	B-UnknownType
:	O	O	O
normal	O	O	B-T109
glucose	O	O	I-T109
group	O	O	B-UnknownType
(	O	O	O
NG	O	O	B-T109
group	O	O	O
)	O	O	O
,	O	O	O
HG	O	O	B-T109
group	O	O	O
and	O	O	O
HG	O	O	O
+	O	O	O
exendin-4	O	O	B-T116
group	O	O	O
(	O	O	O
HG	O	O	O
+	O	O	O
Ex	O	O	B-T116
Group	O	O	B-UnknownType
)	O	O	O
.	O	O	O

Cardiomyocyte	O	O	B-T025
apoptosis	O	O	B-T043
was	O	O	O
evaluated	O	O	O
by	O	O	O
double-staining	O	O	B-T059
with	O	O	O
annexin	O	O	B-T109
V-fluorescein	O	O	I-T109
isothiocyanate	O	O	I-T109
(FITC)/	O	O	O
propidium	O	O	B-T109
iodide	O	O	I-T109
(	O	O	O
PI	O	O	B-T109
)	O	O	O
and	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
.	O	O	O

Intracellular	O	O	B-T082
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	I-T123
ROS	O	O	I-T123
)	O	O	I-T123
production	O	O	B-T169
was	O	O	O
detected	O	O	B-T033
by	O	O	O
2’,7’-dichlorodihydrofluorescein	O	O	B-T109
diacetate	O	O	I-T109
(	O	O	O
DCHF-DA	O	O	B-T109
)	O	O	O
incubation	O	O	B-T059
and	O	O	O
fluorescence	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

LY294002	O	O	B-T109
(	O	O	O
LY	O	O	B-T109
)	O	O	O
,	O	O	O
a	O	O	O
phosphoinositide	O	O	B-T116
3-kinase	O	O	I-T116
(	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
)	O	O	O
pathway	O	O	B-T044
inhibitor	O	O	B-T080
,	O	O	O
was	O	O	O
added	O	O	O
to	O	O	O
the	O	O	O
medium	O	O	B-T130
of	O	O	O
the	O	O	O
HG	O	O	B-T109
+	O	O	O
Ex	O	O	B-T116
+	O	O	O
LY	O	O	O
Group	O	O	B-UnknownType
for	O	O	O
further	O	O	O
western	O	O	B-T059
blot	O	O	I-T059
analysis	O	O	I-T059
.	O	O	O

The	O	O	O
proteins	O	O	B-T116
analyzed	O	O	B-T062
involved	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
-	O	O	O
associated	O	O	B-T116
proteins	O	O	I-T116
,	O	O	O
heme	O	O	B-T116
oxygenase-1	O	O	I-T116
(	O	O	O
HO-1	O	O	B-T116
)	O	O	O
and	O	O	O
nuclear	O	O	B-T116
factor	O	O	I-T116
E2-related	O	O	I-T116
factor	O	O	I-T116
2	O	O	I-T116
(	O	O	O
Nrf-2	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
apoptosis	O	O	B-T043
-	O	O	O
associated	O	O	O
proteins	O	O	O
,	O	O	O
caspase-3	O	O	B-T116
,	O	O	O
Bax/B-cell	O	O	B-T116
lymphoma	O	O	I-T116
2	O	O	I-T116
(	O	O	O
Bcl-2	O	O	B-T116
)	O	O	O
and	O	O	O
p-AKT	O	O	B-T116
/	O	O	O
AKT	O	O	B-T116
.	O	O	O

HG	O	O	B-T109
treatment	O	O	B-T169
induced	O	O	B-T169
cardiomyocyte	O	O	B-T025
apoptosis	O	O	B-T043
(	O	O	O
P	O	O	O
=	O	O	O
0.00	O	O	O
)	O	O	O
and	O	O	O
clearly	O	O	O
upregulated	O	O	B-T044
ROS	O	O	B-T123
production	O	O	B-T169
(	O	O	O
P	O	O	O
=	O	O	O
0.00	O	O	O
)	O	O	O
;	O	O	O
exendin-4	O	O	B-T116
co-incubation	O	O	B-T059
also	O	O	O
ameliorated	O	O	O
cardiomyocyte	O	O	O
apoptosis	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.004	O	O	O
)	O	O	O
and	O	O	O
decreased	O	O	B-T081
ROS	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.00	O	O	O
)	O	O	O
level	O	O	B-T080
significantly	O	O	B-T078
.	O	O	O

HO-1	O	O	B-T116
and	O	O	O
Nrf-2	O	O	B-T116
protein	O	O	B-T045
expression	O	O	I-T045
levels	O	O	B-T080
decreased	O	O	B-T081
significantly	O	O	B-T078
in	O	O	O
the	O	O	O
HG	O	O	B-T109
group	O	O	B-UnknownType
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
levels	O	O	O
were	O	O	O
elevated	O	O	B-T080
by	O	O	O
exendin-4	O	O	B-T116
intervention	O	O	B-T061
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
exendin-4	O	O	B-T116
attenuated	O	O	B-T052
HG	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
higher	O	O	O
protein	O	O	B-T045
expression	O	O	B-T045
,	O	O	O
including	O	O	O
cleaved	O	O	O
caspase-3	O	O	B-T116
and	O	O	O
Bax	O	O	B-T116
,	O	O	O
increased	O	O	B-T081
the	O	O	O
expression	O	O	O
of	O	O	O
Bcl-2	O	O	B-T116
protein	O	O	I-T116
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
these	O	O	O
impacts	O	O	B-T080
of	O	O	O
exendin-4	O	O	B-T116
were	O	O	O
counteracted	O	O	O
significantly	O	O	B-T078
by	O	O	O
co-incubation	O	O	B-T059
with	O	O	O
LY294002	O	O	B-T109
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
exendin-4	O	O	B-T116
ameliorated	O	O	O
HG	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
p-AKT	O	O	B-T116
/	O	O	O
AKT	O	O	B-T116
lower	O	O	B-T045
expression	O	O	I-T045
,	O	O	O
and	O	O	O
this	O	O	O
impact	O	O	B-T080
was	O	O	O
also	O	O	O
suppressed	O	O	B-T169
by	O	O	O
LY294002	O	O	B-T109
.	O	O	O

Exendin-4	O	O	B-T116
ameliorates	O	O	O
HG	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
cardiomyocyte	O	O	B-T025
apoptosis	O	O	B-T043
,	O	O	O
and	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
may	O	O	O
involve	O	O	O
anti-oxidative	O	O	B-T044
stress	O	O	I-T044
via	O	O	O
the	O	O	O
HO-1	O	O	B-T116
/	O	O	O
Nrf-2	O	O	B-T116
system	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
intervention	O	O	B-T061
of	O	O	O
the	O	O	O
PI3K/AKT	O	O	B-T169
signaling	O	O	I-T169
pathway	O	O	I-T169
.	O	O	O

-DOCSTART- (28465793)

KMAP-O	O	O	B-T058
framework	O	O	I-T058
for	O	O	O
care	O	O	B-T058
management	O	O	I-T058
research	O	O	B-T062
of	O	O	O
patients	O	O	B-T101
with	O	O	O
type	O	O	O
2	O	O	O
diabetes	O	O	O

To	O	O	O
review	O	O	B-T080
impacts	O	O	B-T080
of	O	O	O
interventions	O	O	B-T058
involving	O	O	O
self-management	O	O	B-T058
education	O	O	I-T058
,	O	O	O
health	O	O	B-T065
coaching	O	O	I-T065
,	O	O	O
and	O	O	O
motivational	O	O	B-T061
interviewing	O	O	I-T061
for	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
.	O	O	O

A	O	O	O
thorough	O	O	O
review	O	O	B-T078
of	O	O	O
the	O	O	O
scientific	O	O	B-T170
literature	O	O	I-T170
on	O	O	O
diabetes	O	O	B-T047
care	O	O	B-T058
and	O	O	I-T058
management	O	O	I-T058
was	O	O	O
executed	O	O	O
by	O	O	O
a	O	O	O
research	O	O	B-T062
team	O	O	B-T096
.	O	O	O

This	O	O	O
article	O	O	B-T170
summarizes	O	O	O
important	O	O	O
findings	O	O	B-T169
in	O	O	O
regard	O	O	O
to	O	O	O
the	O	O	O
validity	O	O	B-T081
of	O	O	O
developing	O	O	B-T169
a	O	O	O
comprehensive	O	O	B-T080
behavioral	O	O	B-T078
system	O	O	I-T078
as	O	O	O
a	O	O	O
framework	O	O	B-T058
for	O	O	O
empirical	O	O	B-T080
investigation	O	O	B-T058
.	O	O	O

The	O	O	O
behavioral	O	O	B-T078
system	O	O	I-T078
framework	O	O	B-T058
consists	O	O	O
of	O	O	O
patients	O	O	B-T101
'	O	O	O
knowledge	O	O	B-T033
(	O	O	O
K	O	O	B-T033
)	O	O	O
,	O	O	O
motivation	O	O	B-T041
(	O	O	O
M	O	O	B-T041
)	O	O	O
,	O	O	O
attitude	O	O	B-T041
(	O	O	O
A	O	O	B-T041
)	O	O	O
,	O	O	O
and	O	O	O
practice	O	O	B-T041
(	O	O	O
P	O	O	B-T041
)	O	O	O
as	O	O	O
predictor	O	O	B-T078
variables	O	O	B-T080
for	O	O	O
diabetes	O	O	B-T047
care	O	O	B-T170
outcomes	O	O	I-T170
(	O	O	O
O	O	O	B-T170
)	O	O	O
.	O	O	O

Care	O	O	B-T058
management	O	O	I-T058
strategies	O	O	O
or	O	O	O
health	O	O	B-T058
education	O	O	I-T058
programs	O	O	I-T058
serve	O	O	O
as	O	O	O
the	O	O	O
intervention	O	O	B-T058
variable	O	O	B-T080
that	O	O	O
directly	O	O	O
influences	O	O	B-T077
K	O	O	B-T033
,	O	O	O
M	O	O	B-T041
,	O	O	O
A	O	O	B-T041
,	O	O	O
and	O	O	O
P	O	O	B-T041
and	O	O	O
then	O	O	O
indirectly	O	O	O
affects	O	O	O
the	O	O	O
variability	O	O	B-T077
in	O	O	O
patient	O	O	B-T101
care	O	O	B-T170
outcomes	O	O	I-T170
of	O	O	O
patients	O	O	B-T101
with	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
.	O	O	O

This	O	O	O
review	O	O	B-T170
contributes	O	O	O
to	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
KMAP-O	O	O	B-T058
framework	O	O	I-T058
and	O	O	O
how	O	O	O
it	O	O	O
can	O	O	O
guide	O	O	B-T170
the	O	O	O
care	O	O	B-T058
management	O	O	I-T058
of	O	O	O
patients	O	O	B-T101
with	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
.	O	O	O

It	O	O	O
will	O	O	O
allow	O	O	O
the	O	O	O
tailoring	O	O	O
of	O	O	O
interventions	O	O	B-T058
to	O	O	O
be	O	O	O
more	O	O	O
effective	O	O	O
through	O	O	O
knowledge	O	O	B-T033
enhancement	O	O	B-T052
,	O	O	O
increased	O	O	B-T041
motivation	O	O	I-T041
,	O	O	O
attitudinal	O	O	B-T041
changes	O	O	B-T169
,	O	O	O
and	O	O	O
improved	O	O	B-T033
preventive	O	O	B-T058
practice	O	O	I-T058
to	O	O	O
reduce	O	O	B-T080
the	O	O	O
progression	O	O	B-T046
of	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
and	O	O	O
comorbidities	O	O	B-T078
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
health	O	O	B-T066
information	O	O	I-T066
technology	O	O	I-T066
for	O	O	O
enhancing	O	O	B-T052
changes	O	O	B-T169
in	O	O	O
KMAP	O	O	B-T058
and	O	O	O
communications	O	O	B-T054
is	O	O	O
advocated	O	O	O
in	O	O	O
health	O	O	B-T058
promotion	O	O	I-T058
and	O	O	O
development	O	O	B-T169
.	O	O	O

-DOCSTART- (28466379)

Bayesian	O	O	B-T081
and	O	O	O
Phylogenic	O	O	B-T062
Approaches	O	O	I-T062
for	O	O	O
Studying	O	O	O
Relationships	O	O	B-T080
among	O	O	O
Table	O	O	O
Olive	O	O	O
Cultivars	O	O	O

To	O	O	O
enhance	O	O	O
table	O	O	B-T002
olive	O	O	I-T002
tree	O	O	I-T002
authentication	O	O	B-T080
,	O	O	O
relationship	O	O	B-T080
,	O	O	O
and	O	O	O
productivity	O	O	B-T081
,	O	O	O
we	O	O	O
consider	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
18	O	O	O
worldwide	O	O	O
table	O	O	B-T002
olive	O	O	I-T002
cultivars	O	O	I-T002
(	O	O	O
Olea	O	O	B-T002
europaea	O	O	I-T002
L.	O	O	I-T002
)	O	O	O
based	O	O	O
on	O	O	O
morphological	O	O	B-T080
,	O	O	O
biological	O	O	B-T080
,	O	O	O
and	O	O	O
physicochemical	O	O	B-T045
markers	O	O	I-T045
analyzed	O	O	O
by	O	O	O
bioinformatic	O	O	B-T170
and	O	O	O
biostatistic	O	O	B-T170
tools	O	O	I-T170
.	O	O	O

Accordingly	O	O	O
,	O	O	O
we	O	O	O
assess	O	O	O
the	O	O	O
relationships	O	O	B-T080
between	O	O	O
the	O	O	O
studied	O	O	O
varieties	O	O	B-T080
,	O	O	O
on	O	O	O
the	O	O	O
one	O	O	O
hand	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
potential	O	O	O
productivity	O	O	B-T081
-	O	O	O
quantitative	O	O	B-T081
parameter	O	O	B-T077
links	O	O	O
on	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
.	O	O	O

The	O	O	O
bioinformatic	O	O	B-T170
analysis	O	O	B-T062
based	O	O	O
on	O	O	O
the	O	O	O
graphical	O	O	B-T170
representation	O	O	I-T170
of	O	O	O
the	O	O	O
matrix	O	O	B-T062
of	O	O	I-T062
Euclidean	O	O	I-T062
distances	O	O	I-T062
,	O	O	O
the	O	O	O
principal	O	O	B-T081
components	O	O	I-T081
analysis	O	O	I-T081
,	O	O	O
unweighted	O	O	B-T062
pair	O	O	I-T062
group	O	O	I-T062
method	O	O	I-T062
with	O	O	O
arithmetic	O	O	B-T081
mean	O	O	I-T081
,	O	O	O
and	O	O	O
principal	O	O	B-T062
coordinate	O	O	I-T062
analysis	O	O	I-T062
(	O	O	O
PCoA	O	O	B-T062
)	O	O	O
revealed	O	O	O
three	O	O	O
major	O	O	O
clusters	O	O	B-T081
which	O	O	O
were	O	O	O
not	O	O	O
correlated	O	O	O
with	O	O	O
the	O	O	O
geographic	O	O	B-T082
origin	O	O	B-T033
.	O	O	O

The	O	O	O
statistical	O	O	B-T062
analysis	O	O	I-T062
based	O	O	O
on	O	O	O
Kendall	O	O	O
's	O	O	O
and	O	O	O
Spearman	O	O	B-T081
correlation	O	O	I-T081
coefficients	O	O	I-T081
suggests	O	O	O
two	O	O	O
highly	O	O	O
significant	O	O	O
associations	O	O	B-T080
with	O	O	O
both	O	O	O
fruit	O	O	B-T168
color	O	O	B-T080
and	O	O	O
pollinization	O	O	B-T040
and	O	O	O
the	O	O	O
productivity	O	O	B-T081
character	O	O	O
.	O	O	O

These	O	O	O
results	O	O	B-T169
are	O	O	O
confirmed	O	O	O
by	O	O	O
the	O	O	O
multiple	O	O	B-T081
linear	O	O	I-T081
regression	O	O	I-T081
prediction	O	O	I-T081
models	O	O	I-T081
.	O	O	O

In	O	O	O
fact	O	O	O
,	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
coefficient	O	O	B-T081
of	O	O	I-T081
determination	O	O	I-T081
(	O	O	O
R	O	O	B-T081
(	O	O	I-T081
2	O	O	I-T081
)	O	O	I-T081
)	O	O	O
value	O	O	O
,	O	O	O
the	O	O	O
best	O	O	O
model	O	O	B-T170
demonstrated	O	O	O
the	O	O	O
power	O	O	B-T081
of	O	O	O
the	O	O	O
pollinization	O	O	B-T040
on	O	O	O
the	O	O	O
tree	O	O	O
productivity	O	O	B-T081
(	O	O	O
R	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
=	O	O	O
0.846	O	O	O
)	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
derived	O	O	O
directed	O	O	B-T170
acyclic	O	O	I-T170
graph	O	O	I-T170
showed	O	O	O
that	O	O	O
only	O	O	O
two	O	O	O
direct	O	O	O
influences	O	O	B-T077
are	O	O	O
detected	O	O	B-T033
:	O	O	O
effect	O	O	B-T080
of	O	O	O
tolerance	O	O	B-T080
on	O	O	O
fruit	O	O	B-T168
and	O	O	O
stone	O	O	B-T080
symmetry	O	O	I-T080
on	O	O	O
side	O	O	O
and	O	O	O
effect	O	O	O
of	O	O	O
tolerance	O	O	O
on	O	O	O
stone	O	O	B-T080
form	O	O	I-T080
and	O	O	O
oil	O	O	B-T109
content	O	O	B-T077
on	O	O	O
the	O	O	O
other	O	O	O
side	O	O	O
.	O	O	O

This	O	O	O
work	O	O	O
provides	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
diversity	O	O	B-T080
available	O	O	O
in	O	O	O
worldwide	O	O	O
table	O	O	B-T002
olive	O	O	B-T002
cultivars	O	O	I-T002
and	O	O	O
supplies	O	O	O
an	O	O	O
important	O	O	O
contribution	O	O	O
for	O	O	O
olive	O	O	O
breeding	O	O	B-T040
and	O	O	O
authenticity	O	O	B-T080
.	O	O	O

-DOCSTART- (28468175)

Wiedemann-Rautenstrauch	O	O	B-T047
Syndrome	O	O	I-T047
With	O	O	O
Bilateral	O	O	B-T082
Tarsal	O	O	B-T019
Kink	O	O	I-T019
:	O	O	O
Three	O	O	O
Sutures	O	O	B-T061
for	O	O	O
Correction	O	O	O

The	O	O	O
authors	O	O	O
describe	O	O	O
a	O	O	O
5-	O	O	O
month-old	O	O	B-T079
male	O	O	B-T032
infant	O	O	B-T100
with	O	O	O
Wiedemann-Rautenstrauch	O	O	B-T047
syndrome	O	O	I-T047
,	O	O	O
which	O	O	O
is	O	O	O
an	O	O	O
extremely	O	O	O
rare	O	O	B-T080
condition	O	O	B-T047
.	O	O	O

He	O	O	O
had	O	O	O
tarsal	O	O	B-T019
kink	O	O	I-T019
in	O	O	O
upper	O	O	B-T023
eyelids	O	O	I-T023
in	O	O	O
both	O	O	B-T023
eyes	O	O	I-T023
.	O	O	O

The	O	O	O
authors	O	O	O
treated	O	O	B-T169
bilateral	O	O	B-T082
tarsal	O	O	B-T019
kink	O	O	I-T019
with	O	O	O
an	O	O	O
everting	O	O	B-T058
suture	O	O	B-T061
via	O	O	O
a	O	O	O
transconjunctival	O	O	B-T082
approach	O	O	I-T082
under	O	O	O
local	O	O	B-T061
anesthesia	O	O	I-T061
.	O	O	O

-DOCSTART- (28468714)

The	O	O	O
Indications	O	O	B-T078
for	O	O	O
Laparoscopic	O	O	O
Pancreatectomy	O	O	O

Laparoscopic	O	O	B-T061
pancreatectomy	O	O	I-T061
is	O	O	O
not	O	O	O
yet	O	O	O
established	O	O	O
as	O	O	O
a	O	O	O
routine	O	O	B-T061
procedure	O	O	I-T061
everywhere	O	O	O
in	O	O	O
Germany	O	O	B-T083
or	O	O	O
in	O	O	O
other	O	O	O
countries	O	O	B-T083
.	O	O	O

Few	O	O	O
data	O	O	B-T078
are	O	O	O
available	O	O	O
on	O	O	O
its	O	O	O
short-	O	O	B-T080
and	O	O	I-T080
long-term	O	O	I-T080
outcomes	O	O	I-T080
.	O	O	O

From	O	O	O
2008	O	O	O
onward	O	O	O
,	O	O	O
a	O	O	O
working	O	O	B-T098
group	O	O	I-T098
initiated	O	O	O
by	O	O	O
10	O	O	O
centers	O	O	B-T093
and	O	O	O
currently	O	O	O
comprising	O	O	O
34	O	O	O
centers	O	O	O
has	O	O	O
gathered	O	O	O
data	O	O	B-T078
on	O	O	O
all	O	O	O
cases	O	O	B-T169
of	O	O	O
laparoscopic	O	O	B-T061
pancreatectomy	O	O	I-T061
.	O	O	O

Procedures	O	O	B-T061
in	O	O	O
which	O	O	O
laparoscopy	O	O	B-T061
was	O	O	O
converted	O	O	O
to	O	O	O
open	O	O	B-T061
surgery	O	O	I-T061
are	O	O	O
also	O	O	O
included	O	O	O
.	O	O	O

The	O	O	O
registry	O	O	B-T170
now	O	O	O
contains	O	O	O
550	O	O	O
data	O	O	B-T078
sets	O	O	O
representing	O	O	O
267	O	O	O
cases	O	O	B-T169
of	O	O	O
benign	O	O	B-T191
disease	O	O	I-T191
,	O	O	O
244	O	O	O
malignancies	O	O	B-T191
,	O	O	O
and	O	O	O
39	O	O	O
borderline	O	O	B-T191
tumors	O	O	I-T191
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
procedure	O	O	B-T061
was	O	O	O
laparoscopic	O	O	B-T061
left	O	O	I-T061
pancreatectomy	O	O	I-T061
,	O	O	O
followed	O	O	O
by	O	O	O
resection	O	O	B-T061
of	O	O	O
the	O	O	O
head	O	O	B-T023
of	O	O	I-T023
the	O	O	I-T023
pancreas	O	O	I-T023
and	O	O	O
tumor	O	O	B-T191
enucleation	O	O	B-T061
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
intraoperative	O	O	B-T046
complication	O	O	I-T046
was	O	O	O
hemorrhage	O	O	B-T046
,	O	O	O
with	O	O	O
a	O	O	O
frequency	O	O	O
of	O	O	O
3	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
rate	O	O	B-T081
of	O	O	O
conversion	O	O	B-T169
to	O	O	O
open	O	O	B-T061
surgery	O	O	I-T061
was	O	O	O
35	O	O	O
%	O	O	O
;	O	O	O
if	O	O	O
minilaparotomies	O	O	B-T058
are	O	O	O
excluded	O	O	O
,	O	O	O
the	O	O	O
conversion	O	O	O
rate	O	O	O
was	O	O	O
only	O	O	O
16	O	O	O
%	O	O	O
.	O	O	O

39	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
developed	O	O	O
a	O	O	O
pancreatic	O	O	B-T047
fistula	O	O	I-T047
after	O	O	O
surgery	O	O	B-T061
(	O	O	O
usually	O	O	O
grade	O	O	O
A	O	O	O
or	O	O	O
B	O	O	O
,	O	O	O
with	O	O	O
1.5	O	O	O
%	O	O	O
grade	O	O	O
C	O	O	O
)	O	O	O
and	O	O	O
3	O	O	O
%	O	O	O
underwent	O	O	O
reoperation	O	O	B-T061
because	O	O	O
of	O	O	O
postoperative	O	O	B-T046
hemorrhage	O	O	I-T046
.	O	O	O

The	O	O	O
procedure-related	O	O	B-T033
mortality	O	O	I-T033
was	O	O	O
1.3	O	O	O
%	O	O	O
.	O	O	O

91	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
reported	O	O	O
only	O	O	O
very	O	O	O
mild	O	O	O
postoperative	O	O	B-T184
pain	O	O	I-T184
.	O	O	O

6.7	O	O	O
%	O	O	O
newly	O	O	O
developed	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
after	O	O	O
the	O	O	O
procedure	O	O	B-T061
.	O	O	O

The	O	O	O
patient	O	O	B-T101
cohort	O	O	B-T098
in	O	O	O
the	O	O	O
registry	O	O	B-T170
consists	O	O	O
of	O	O	O
persons	O	O	B-T098
who	O	O	O
were	O	O	O
selected	O	O	O
to	O	O	O
undergo	O	O	O
laparoscopic	O	O	B-T061
pancreatectomy	O	O	I-T061
by	O	O	O
the	O	O	O
participating	O	O	O
hospital	O	O	B-T093
teams	O	O	B-T096
,	O	O	O
and	O	O	O
the	O	O	O
data	O	O	B-T078
are	O	O	O
thus	O	O	O
inherently	O	O	O
affected	O	O	O
by	O	O	O
selection	O	O	B-T081
bias	O	O	I-T081
.	O	O	O

The	O	O	O
operative	O	O	B-T061
procedures	O	O	I-T061
that	O	O	O
they	O	O	O
underwent	O	O	O
reflect	O	O	O
the	O	O	O
current	O	O	O
practice	O	O	O
of	O	O	O
laparoscopic	O	O	B-T061
pancreatectomy	O	O	I-T061
in	O	O	O
Germany	O	O	B-T083
.	O	O	O

The	O	O	O
complication	O	O	B-T046
rates	O	O	B-T081
are	O	O	O
similar	O	O	O
to	O	O	O
those	O	O	O
of	O	O	O
open	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

Selection	O	O	B-T081
bias	O	O	I-T081
can	O	O	O
be	O	O	O
avoided	O	O	O
only	O	O	O
by	O	O	O
a	O	O	O
randomized	O	O	B-T062
trial	O	O	I-T062
.	O	O	O

-DOCSTART- (28470106)

Associations	O	O	O
of	O	O	O
NEUROD2	O	O	B-T028
polymorphisms	O	O	B-T045
and	O	O	O
change	O	O	B-T169
of	O	O	O
cognitive	O	O	B-T048
dysfunctions	O	O	I-T048
in	O	O	O
schizophrenia	O	O	B-T048
and	O	O	O
schizoaffective	O	O	B-T048
disorder	O	O	I-T048
after	O	O	O
eight	O	O	O
weeks	O	O	B-T079
of	O	O	O
antipsychotic	O	O	B-T121
treatment	O	O	O

NEUROD2	O	O	B-T028
is	O	O	O
a	O	O	O
neurospecific	O	O	B-T082
helix-loop-helix	O	O	I-T082
transcription	O	O	B-T116
factor	O	O	I-T116
which	O	O	O
has	O	O	O
an	O	O	O
impact	O	O	B-T080
on	O	O	O
the	O	O	O
regulation	O	O	B-T045
of	O	O	O
glutamatergic	O	O	B-T116
and	O	O	O
GABAergic	O	O	B-T116
genes	O	O	B-T028
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
an	O	O	O
association	O	O	O
of	O	O	O
NEUROD2	O	O	B-T028
with	O	O	O
neurocognitive	O	O	B-T048
dysfunctions	O	O	I-T048
in	O	O	O
schizophrenia	O	O	B-T048
and	O	O	O
schizoaffective	O	O	B-T048
disorder	O	O	I-T048
patients	O	O	B-T101
before	O	O	O
and	O	O	O
during	O	O	O
treatment	O	O	B-T061
with	O	O	O
different	O	O	O
second-generation	O	O	B-T121
antipsychotics	O	O	I-T121
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
genotyped	O	O	B-T032
for	O	O	O
four	O	O	O
different	O	O	O
polymorphisms	O	O	B-T045
of	O	O	O
the	O	O	O
NEUROD2	O	O	B-T028
gene	O	O	B-T028
(	O	O	O
(	O	O	O
rs9889354(A/G	O	O	B-T045
)	O	O	O
,	O	O	O
rs1877032(C/T	O	O	B-T045
)	O	O	I-T045
,	O	O	O
rs12453682(C/T	O	O	B-T045
)	O	O	I-T045
and	O	O	O
rs11078918(C/G	O	O	B-T045
)	O	O	I-T045
)	O	O	O
.	O	O	O

Cognitive	O	O	B-T041
function	O	O	I-T041
was	O	O	O
assessed	O	O	B-T052
at	O	O	O
baseline	O	O	B-T081
and	O	O	O
week	O	O	B-T079
8	O	O	O
.	O	O	O

Results	O	O	B-T169
of	O	O	O
individual	O	O	O
neuropsychological	O	O	B-T060
tests	O	O	I-T060
were	O	O	O
assigned	O	O	O
to	O	O	O
six	O	O	O
cognitive	O	O	B-T169
domains	O	O	I-T170
(	O	O	B-T079
reaction	O	O	I-T079
time	O	O	I-T079
and	O	O	O
quality	O	O	B-T080
;	O	O	O
executive	O	O	B-T041
function	O	O	I-T041
;	O	O	O
working	O	O	B-T078
,	O	O	O
verbal	O	O	B-T041
and	O	O	O
visual	O	O	B-T041
memory	O	O	I-T041
)	O	O	O
and	O	O	O
a	O	O	O
general	O	O	O
cognitive	O	O	O
index	O	O	B-T170
.	O	O	O

167	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
NEUROD2	O	O	B-T028
exonic	O	O	B-T045
polymorphism	O	O	I-T045
rs11078918	O	O	I-T045
showed	O	O	O
significant	O	O	O
associations	O	O	O
with	O	O	O
verbal	O	O	B-T041
memory	O	O	I-T041
and	O	O	O
executive	O	O	B-T041
functions	O	O	I-T041
,	O	O	O
whereas	O	O	O
the	O	O	O
NEUROD2	O	O	O
polymorphism	O	O	B-T045
rs12453682	O	O	I-T045
was	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
working	O	O	B-T078
and	O	O	O
verbal	O	O	O
memory	O	O	O
,	O	O	O
executive	O	O	O
functions	O	O	O
and	O	O	O
with	O	O	O
a	O	O	O
cognitive	O	O	B-T169
index	O	O	B-T170
.	O	O	O

Significant	O	O	O
associations	O	O	O
were	O	O	O
found	O	O	O
at	O	O	O
baseline	O	O	B-T081
and	O	O	O
after	O	O	O
eight	O	O	O
weeks	O	O	B-T079
.	O	O	O

Moreover	O	O	O
,	O	O	O
significant	O	O	O
associations	O	O	O
between	O	O	O
the	O	O	O
change	O	O	B-T169
in	O	O	O
neuropsychological	O	O	B-T060
test	O	O	I-T060
results	O	O	B-T169
during	O	O	O
antipsychotic	O	O	B-T121
treatment	O	O	B-T061
and	O	O	O
the	O	O	O
NEUROD2	O	O	B-T028
polymorphisms	O	O	B-T045
rs11078918	O	O	B-T045
and	O	O	O
rs12453682	O	O	B-T045
were	O	O	O
observed	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
NEUROD2	O	O	B-T028
gene	O	O	I-T028
could	O	O	O
play	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
pathophysiology	O	O	B-T169
of	O	O	O
neurocognitive	O	O	B-T048
dysfunctions	O	O	I-T048
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
the	O	O	O
change	O	O	B-T169
of	O	O	O
cognitive	O	O	B-T184
symptoms	O	O	I-T184
under	O	O	O
antipsychotic	O	O	B-T121
treatment	O	O	B-T061
in	O	O	O
schizophrenia	O	O	B-T048
and	O	O	O
schizoaffective	O	O	B-T048
disorder	O	O	I-T048
.	O	O	O

-DOCSTART- (28470482)

New	O	O	B-T080
Diterpenoids	O	O	B-T109
from	O	O	O
Clerodendranthus	O	O	O
spicatus	O	O	O

Two	O	O	O
new	O	O	B-T080
diterpenoids	O	O	B-T109
,	O	O	O
neoorthosiphonones	O	O	B-T109
B	O	O	I-T109
and	O	O	O
C	O	O	B-T109
(	O	O	O
1	O	O	B-T109
and	O	O	O
2	O	O	B-T109
)	O	O	O
,	O	O	O
and	O	O	O
one	O	O	O
known	O	O	O
diterpenoid	O	O	B-T109
,	O	O	O
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
aerial	O	O	B-T002
parts	O	O	I-T002
of	O	O	O
Clerodendranthus	O	O	B-T002
spicatus	O	O	I-T002
.	O	O	O

Their	O	O	O
structures	O	O	B-T082
including	O	O	O
absolute	O	O	B-T080
configurations	O	O	B-T082
were	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
comprehensive	O	O	O
spectroscopic	O	O	B-T059
analyses	O	O	I-T059
and	O	O	O
X-ray	O	O	B-T059
crystallographic	O	O	I-T059
methods	O	O	I-T059
.	O	O	O

No	O	O	O
compound	O	O	B-T080
was	O	O	O
found	O	O	O
to	O	O	O
inhibit	O	O	B-T080
fibronectin	O	O	B-T116
production	O	O	B-T057
at	O	O	O
the	O	O	O
concentration	O	O	B-T081
of	O	O	O
20	O	O	O
μM.	O	O	O

-DOCSTART- (28470753)

Stalk	O	O	B-T017
versus	O	O	O
base	O	O	B-T017
invasion	O	O	B-T033
in	O	O	O
pT1	O	O	B-T033
papillary	O	O	B-T191
cancers	O	O	I-T191
of	O	O	I-T191
the	O	O	I-T191
bladder	O	O	I-T191
:	O	O	O
improved	O	O	O
substaging	O	O	O
system	O	O	O
predicting	O	O	O
risk	O	O	B-T078
of	O	O	O
progression	O	O	O

Pathologic	O	O	B-T033
stage	O	O	I-T033
T1	O	O	I-T033
(	O	O	O
pT1	O	O	B-T033
)	O	O	O
bladder	O	O	B-T191
cancers	O	O	I-T191
are	O	O	O
a	O	O	O
clinically	O	O	B-T080
heterogeneous	O	O	B-T080
group	O	O	I-T080
.	O	O	O

However	O	O	O
,	O	O	O
current	O	O	O
staging	O	O	B-T185
guidelines	O	O	O
for	O	O	O
superficially	O	O	B-T082
invasive	O	O	B-T191
cancers	O	O	I-T191
do	O	O	O
not	O	O	O
acknowledge	O	O	O
the	O	O	O
variability	O	O	B-T077
in	O	O	O
type	O	O	O
and	O	O	O
extent	O	O	O
of	O	O	O
lamina	O	O	B-T033
propria	O	O	I-T033
invasion	O	O	I-T033
in	O	O	O
papillary	O	O	B-T191
urothelial	O	O	I-T191
carcinomas	O	O	I-T191
(	O	O	O
PUC	O	O	B-T191
)	O	O	O
,	O	O	O
and	O	O	O
historically	O	O	O
proposed	O	O	O
substaging	O	O	O
systems	O	O	O
showed	O	O	O
either	O	O	O
high	O	O	O
inter-observer	O	O	B-T081
variation	O	O	I-T081
or	O	O	O
limited	O	O	B-T169
value	O	O	I-T169
in	O	O	O
predicting	O	O	O
patient	O	O	B-T058
outcomes	O	O	I-T058
.	O	O	O

Herein	O	O	O
we	O	O	O
reappraise	O	O	B-T058
pT1	O	O	B-T033
PUC	O	O	B-T191
substaging	O	O	O
,	O	O	O
aiming	O	O	B-T078
to	O	O	O
identify	O	O	B-T080
a	O	O	O
novel	O	O	B-T080
scheme	O	O	B-T170
which	O	O	O
is	O	O	O
reproducible	O	O	B-T080
and	O	O	O
prognostically	O	O	B-T170
meaningful	O	O	O
.	O	O	O

Stage	O	O	B-T033
pT1	O	O	I-T033
PUC	O	O	B-T191
diagnosed	O	O	B-T033
during	O	O	O
years	O	O	B-T079
1999	O	O	O
-	O	O	O
2015	O	O	O
were	O	O	O
retrospectively	O	O	B-T062
reviewed	O	O	I-T062
and	O	O	O
characterized	O	O	B-T052
as	O	O	O
focal	O	O	B-T082
invasion	O	O	B-T046
confined	O	O	O
to	O	O	O
papillary	O	O	B-T017
stalk	O	O	I-T017
,	O	O	O
focal	O	O	O
invasion	O	O	O
of	O	O	O
tumor	O	O	B-T191
base	O	O	B-T017
,	O	O	O
or	O	O	O
extensive	O	O	O
invasion	O	O	O
of	O	O	O
tumor	O	O	O
base	O	O	O
.	O	O	O

Cases	O	O	B-T169
with	O	O	O
concurrent	O	O	B-T079
flat	O	O	B-T033
carcinoma	O	O	I-T033
in-situ	O	O	I-T033
,	O	O	O
angiolymphatic	O	O	B-T033
invasion	O	O	I-T033
,	O	O	O
absent	O	O	B-T169
muscularis	O	O	B-T024
propria	O	O	I-T024
,	O	O	O
or	O	O	O
clinically	O	O	B-T080
advanced	O	O	B-UnknownType
disease	O	O	I-UnknownType
were	O	O	O
excluded	O	O	B-T169
.	O	O	O

We	O	O	O
calculated	O	O	O
cumulative	O	O	B-T080
incidence	O	O	B-T081
of	O	O	O
recurrence	O	O	B-T033
,	O	O	O
progression	O	O	B-T046
,	O	O	O
and	O	O	O
death	O	O	B-T040
by	O	O	O
tumor	O	O	B-T185
subtype	O	O	I-T185
and	O	O	O
evaluated	O	O	B-T058
differential	O	O	B-T033
risks	O	O	I-T033
using	O	O	O
log-rank	O	O	B-T170
tests	O	O	I-T170
and	O	O	O
Kaplan-Meier	O	O	B-T081
curves	O	O	I-T081
stratified	O	O	B-T080
by	O	O	O
type	O	O	B-T080
and	O	O	O
extent	O	O	B-T201
of	O	O	I-T201
invasion	O	O	I-T201
.	O	O	O

Among	O	O	O
62	O	O	O
patients	O	O	B-T101
satisfying	O	O	O
inclusion	O	O	B-T080
criteria	O	O	B-T078
,	O	O	O
22	O	O	O
of	O	O	O
29	O	O	O
patients	O	O	O
with	O	O	O
base	O	O	B-T017
extensive	O	O	B-T080
invasion	O	O	B-T033
progressed	O	O	B-T169
while	O	O	O
4	O	O	O
of	O	O	O
13	O	O	O
with	O	O	O
base	O	O	O
focal	O	O	B-T082
and	O	O	O
0	O	O	O
of	O	O	O
20	O	O	O
with	O	O	O
stalk	O	O	B-T017
only	O	O	O
invasion	O	O	O
progressed	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
strong	O	O	O
evidence	O	O	O
that	O	O	O
base	O	O	B-T017
extensive	O	O	O
patients	O	O	B-T101
had	O	O	O
higher	O	O	O
risk	O	O	B-T078
of	O	O	O
progression	O	O	B-T046
and	O	O	O
death	O	O	B-T040
due	O	O	O
to	O	O	O
bladder	O	O	B-T191
cancer	O	O	I-T191
than	O	O	O
base	O	O	O
focal	O	O	B-T082
or	O	O	O
stalk	O	O	B-T017
only	O	O	O
counterparts	O	O	O
(	O	O	O
P<0.0001	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
tumor	O	O	B-T185
subtype	O	O	I-T185
was	O	O	O
not	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
risk	O	O	B-T078
of	O	O	O
recurrence	O	O	B-T033
(	O	O	O
P=0.21	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
propose	O	O	O
an	O	O	O
innovative	O	O	O
substaging	O	O	O
approach	O	O	O
for	O	O	O
reporting	O	O	O
site	O	O	O
and	O	O	O
extent	O	O	O
of	O	O	O
lamina	O	O	B-T033
propria	O	O	I-T033
invasion	O	O	I-T033
in	O	O	O
patients	O	O	B-T101
with	O	O	O
pT1	O	O	B-T033
PUC	O	O	B-T191
allowing	O	O	O
patient	O	O	B-T101
stratification	O	O	B-T080
for	O	O	O
risk	O	O	B-T078
of	O	O	O
progression	O	O	B-T046
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
protected	O	O	O
by	O	O	O
copyright	O	O	O
.	O	O	O

All	O	O	O
rights	O	O	O
reserved	O	O	O
.	O	O	O

-DOCSTART- (28471941)

Basic	O	O	B-T062
science	O	O	I-T062
and	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
ageing	O	O	B-T040
with	O	O	O
HIV	O	O	B-T047
:	O	O	O
potential	O	O	O
mechanisms	O	O	B-T169
and	O	O	O
biomarkers	O	O	O

:	O	O	O
The	O	O	O
increased	O	O	O
prevalence	O	O	B-T081
of	O	O	O
age	O	O	B-T032
-related	O	O	O
comorbidities	O	O	B-T078
and	O	O	O
mortality	O	O	B-T081
is	O	O	O
worrisome	O	O	B-T033
in	O	O	O
ageing	O	O	B-T040
HIV-infected	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
aim	O	O	B-T078
to	O	O	O
analyse	O	O	B-T062
the	O	O	O
different	O	O	O
ageing	O	O	B-T040
mechanisms	O	O	B-T169
with	O	O	O
regard	O	O	O
to	O	O	O
HIV	O	O	B-T047
infection	O	O	I-T047
.	O	O	O

Ageing	O	O	B-T040
results	O	O	O
from	O	O	O
the	O	O	O
time	O	O	B-T079
-	O	O	O
dependent	O	O	B-T169
accumulation	O	O	B-T033
of	O	O	O
random	O	O	O
cellular	O	O	B-T049
damage	O	O	I-T049
.	O	O	O

Epigenetic	O	O	B-T045
modifications	O	O	I-T045
and	O	O	O
mitochondrial	O	O	B-T114
DNA	O	O	I-T114
haplogroups	O	O	B-T032
modulate	O	O	B-T082
ageing	O	O	B-T040
.	O	O	O

In	O	O	O
antiretroviral	O	O	B-T061
treatment	O	O	I-T061
-controlled	O	O	O
patients	O	O	B-T101
,	O	O	O
epigenetic	O	O	B-T040
clock	O	O	I-T040
appears	O	O	O
to	O	O	O
be	O	O	O
advanced	O	O	O
,	O	O	O
and	O	O	O
some	O	O	O
haplogroups	O	O	B-T032
are	O	O	O
associated	O	O	O
with	O	O	O
HIV	O	O	B-T047
infection	O	O	I-T047
severity	O	O	B-T080
.	O	O	O

Telomere	O	O	B-T049
shortening	O	O	I-T049
is	O	O	O
enhanced	O	O	O
in	O	O	O
HIV-infected	O	O	B-T047
patients	O	O	B-T101
because	O	O	O
of	O	O	O
HIV	O	O	B-T005
and	O	O	O
some	O	O	O
nucleoside	O	O	B-T114
analogue	O	O	I-T114
reverse	O	O	B-T121
transcriptase	O	O	I-T121
inhibitors	O	O	I-T121
.	O	O	O

Mitochondria	O	O	B-T026
-related	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
mitochondrial	O	O	B-T114
DNA	O	O	I-T114
mutations	O	O	B-T045
are	O	O	O
increased	O	O	O
during	O	O	O
ageing	O	O	B-T040
and	O	O	O
also	O	O	O
by	O	O	O
some	O	O	O
nucleoside	O	O	B-T114
analogue	O	O	I-T114
reverse	O	O	B-T121
transcriptase	O	O	I-T121
inhibitors	O	O	I-T121
.	O	O	O

Overall	O	O	O
,	O	O	O
increased	O	O	O
inflammation	O	O	B-T046
or	O	O	O
'	O	O	O
inflammageing	O	O	B-T046
'	O	O	O
is	O	O	O
a	O	O	O
major	O	O	O
driver	O	O	O
of	O	O	O
ageing	O	O	B-T040
and	O	O	O
could	O	O	O
result	O	O	O
from	O	O	O
cell	O	O	B-T043
senescence	O	O	I-T043
with	O	O	O
secreted	O	O	O
proinflammatory	O	O	B-T121
mediators	O	O	I-T121
,	O	O	O
altered	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
,	O	O	O
and	O	O	O
coinfections	O	O	B-T047
.	O	O	O

In	O	O	O
HIV-infected	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
inflammation	O	O	B-T046
and	O	O	O
innate	O	O	B-T032
immunity	O	O	I-T032
activation	O	O	B-T052
is	O	O	O
enhanced	O	O	O
and	O	O	O
related	O	O	O
to	O	O	O
most	O	O	O
comorbidities	O	O	B-T078
and	O	O	O
to	O	O	O
mortality	O	O	B-T081
.	O	O	O

This	O	O	O
status	O	O	O
could	O	O	O
result	O	O	O
,	O	O	O
in	O	O	O
addition	O	O	O
to	O	O	O
age	O	O	B-T032
,	O	O	O
from	O	O	O
the	O	O	O
virus	O	O	B-T005
itself	O	O	O
or	O	O	O
viral	O	O	B-T116
protein	O	O	I-T116
released	O	O	O
from	O	O	O
reservoirs	O	O	B-T078
,	O	O	O
from	O	O	O
HIV	O	O	B-T005
-enhanced	O	O	O
gut	O	O	B-T023
permeability	O	O	B-T070
and	O	O	O
dysbiosis	O	O	B-T046
,	O	O	O
from	O	O	O
antiretroviral	O	O	B-T061
treatment	O	O	I-T061
,	O	O	O
from	O	O	O
frequent	O	O	O
cytomegalovirus	O	O	B-T005
and	O	O	O
hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
coinfections	O	O	B-T047
,	O	O	O
and	O	O	O
also	O	O	O
from	O	O	O
personal	O	O	O
and	O	O	O
environmental	O	O	B-T169
factors	O	O	I-T169
,	O	O	O
as	O	O	O
central	O	O	O
fat	O	O	B-T033
accumulation	O	O	I-T033
or	O	O	O
smoking	O	O	B-T055
.	O	O	O

Adaptive	O	O	B-T039
immune	O	O	I-T039
activation	O	O	B-T052
and	O	O	O
immunosenescence	O	O	B-T039
are	O	O	O
associated	O	O	O
with	O	O	O
comorbidities	O	O	B-T078
and	O	O	O
mortality	O	O	B-T081
in	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
but	O	O	O
are	O	O	O
less	O	O	O
predictive	O	O	B-T080
in	O	O	O
HIV-infected	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

Biomarkers	O	O	B-T201
to	O	O	O
evaluate	O	O	B-T058
ageing	O	O	B-T040
in	O	O	O
HIV-infected	O	O	B-T047
patients	O	O	B-T101
are	O	O	O
required	O	O	O
.	O	O	O

Numerous	O	O	O
systemic	O	O	B-T169
or	O	O	O
cellular	O	O	B-T025
inflammatory	O	O	I-T025
,	O	O	O
immune	O	O	B-T169
activation	O	O	B-T052
,	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
,	O	O	O
or	O	O	O
senescence	O	O	O
markers	O	O	B-T201
can	O	O	O
be	O	O	O
tested	O	O	B-T169
in	O	O	O
serum	O	O	B-T031
or	O	O	O
peripheral	O	O	B-T025
blood	O	O	I-T025
mononuclear	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
novel	O	O	O
European	O	O	B-T083
Study	O	O	B-T062
to	O	O	O
Establish	O	O	O
Biomarkers	O	O	B-T201
of	O	O	O
Human	O	O	B-T170
Ageing	O	O	I-T170
MARK-AGE	O	O	I-T170
algorithm	O	O	I-T170
,	O	O	O
evaluating	O	O	B-T058
the	O	O	O
biological	O	O	B-T080
age	O	O	B-T032
,	O	O	O
is	O	O	O
currently	O	O	O
assessed	O	O	O
in	O	O	O
HIV-infected	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
reveals	O	O	O
an	O	O	O
advanced	O	O	O
biological	O	O	O
age	O	O	O
.	O	O	O

Some	O	O	O
enhanced	O	O	O
inflammatory	O	O	B-T169
or	O	O	O
innate	O	O	B-T032
immune	O	O	I-T032
activation	O	O	B-T052
markers	O	O	B-T201
are	O	O	O
interesting	O	O	O
but	O	O	O
still	O	O	O
not	O	O	O
validated	O	O	O
for	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
follow-up	O	O	B-T058
.	O	O	O

To	O	O	O
be	O	O	O
able	O	O	O
to	O	O	O
assess	O	O	O
patients	O	O	B-T101
'	O	O	O
biological	O	O	B-T080
age	O	O	B-T032
is	O	O	O
an	O	O	O
important	O	O	O
objective	O	O	O
to	O	O	O
improve	O	O	O
their	O	O	O
healthspan	O	O	B-T078
.	O	O	O

-DOCSTART- (28473015)

MESOTHELIAL	O	O	B-T025
CELL	O	O	I-T025
ADHERENCE	O	O	B-T169
TO	O	O	O
VASCULAR	O	O	B-T074
PROSTHESES	O	O	I-T074
AND	O	O	O
THEIR	O	O	O
SUBSEQUENT	O	O	B-T079
GROWTH	O	O	B-T040
IN	O	O	O
VITRO	O	O	O

Cell	O	O	B-T025
seeding	O	O	B-T059
may	O	O	O
decrease	O	O	B-T081
the	O	O	O
thrombogenicity	O	O	B-T046
of	O	O	O
implanted	O	O	B-T074
vascular	O	O	B-T074
grafts	O	O	I-T074
,	O	O	O
but	O	O	O
its	O	O	O
application	O	O	O
is	O	O	O
hampered	O	O	O
by	O	O	O
the	O	O	O
limited	O	O	O
availability	O	O	B-T169
of	O	O	I-T169
autologous	O	O	B-T080
endothelial	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Human	O	O	B-T016
peritoneal	O	O	B-T029
mesothelial	O	O	B-T025
cells	O	O	I-T025
have	O	O	O
blood	O	O	B-T039
flow	O	O	I-T039
supporting	O	O	B-T080
qualities	O	O	I-T080
and	O	O	O
are	O	O	O
readily	O	O	B-T169
available	O	O	I-T169
.	O	O	O

This	O	O	O
study	O	O	O
investigated	O	O	B-T169
the	O	O	O
adherence	O	O	B-T169
of	O	O	O
mesothelial	O	O	B-T025
cells	O	O	I-T025
to	O	O	O
vascular	O	O	B-T074
prostheses	O	O	I-T074
and	O	O	O
their	O	O	O
subsequent	O	O	B-T079
growth	O	O	B-T040
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

Circular	O	O	B-T082
pieces	O	O	B-T081
of	O	O	O
various	O	O	O
vascular	O	O	B-T080
prosthetic	O	O	B-T122
materials	O	O	I-T122
were	O	O	O
seeded	O	O	B-T059
with	O	O	O
51Chromium-labeled	O	O	B-T121
mesothelial	O	O	B-T025
and	O	O	O
endothelial	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
left	O	O	O
for	O	O	O
either	O	O	O
5	O	O	O
,	O	O	O
15	O	O	O
,	O	O	O
30	O	O	O
,	O	O	O
60	O	O	O
,	O	O	O
and	O	O	O
120	O	O	O
minutes	O	O	B-T079
.	O	O	O

The	O	O	O
unattached	O	O	B-T033
cells	O	O	B-T025
were	O	O	O
removed	O	O	B-T080
and	O	O	O
the	O	O	O
degree	O	O	B-T081
of	O	O	O
cell	O	O	B-T025
attachment	O	O	B-T052
was	O	O	O
measured	O	O	B-T080
.	O	O	O

The	O	O	O
number	O	O	B-T081
of	O	O	O
mesothelial	O	O	B-T025
cells	O	O	I-T025
to	O	O	O
Dacron	O	O	B-T109
increased	O	O	B-T081
during	O	O	O
the	O	O	O
first	O	O	O
60	O	O	O
min	O	O	B-T079
up	O	O	O
to	O	O	O
35.2	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
seeded	O	O	B-T059
inoculum	O	O	B-T167
where	O	O	O
after	O	O	O
a	O	O	O
plateau	O	O	B-T081
was	O	O	O
reached	O	O	B-T033
.	O	O	O

Scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
showed	O	O	O
spreaded	O	O	B-T080
mesothelial	O	O	B-T025
cells	O	O	I-T025
adherent	O	O	B-T169
to	O	O	O
the	O	O	O
Dacron	O	O	B-T109
fibers	O	O	I-T109
.	O	O	O

A	O	O	O
significant	O	O	B-T078
increase	O	O	B-T169
in	O	O	O
adherence	O	O	B-T169
was	O	O	O
observed	O	O	B-T169
after	O	O	O
preincubation	O	O	B-T059
of	O	O	O
Dacron	O	O	B-T109
with	O	O	O
10	O	O	O
μg/mL	O	O	O
fibronectin	O	O	B-T116
,	O	O	O
but	O	O	O
no	O	O	B-T033
improvement	O	O	I-T033
was	O	O	O
found	O	O	B-T033
after	O	O	O
preincubation	O	O	O
with	O	O	O
human	O	O	B-T016
serum	O	O	B-T116
albumin	O	O	I-T116
or	O	O	O
gelatin	O	O	B-T116
.	O	O	O

Mesothelial	O	O	B-T025
cells	O	O	I-T025
adhered	O	O	B-T067
better	O	O	O
to	O	O	O
Gelcoated	O	O	B-T080
than	O	O	O
to	O	O	O
Gelsealed	O	O	B-T080
or	O	O	O
plain	O	O	B-T109
Dacron	O	O	I-T109
.	O	O	O

The	O	O	O
adherence	O	O	B-T169
of	O	O	O
mesothelial	O	O	B-T025
cells	O	O	I-T025
to	O	O	O
ePTFE	O	O	B-T109
(	O	O	O
Teflon	O	O	B-T109
)	O	O	O
was	O	O	O
significantly	O	O	B-T078
poorer	O	O	B-T080
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
differences	O	O	B-T080
in	O	O	O
adherence	O	O	B-T169
were	O	O	O
found	O	O	B-T033
between	O	O	O
mesothelial	O	O	B-T025
and	O	O	O
endothelial	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Mesothelial	O	O	B-T025
cell	O	O	I-T025
growth	O	O	B-T040
on	O	O	O
Dacron	O	O	B-T109
resulted	O	O	B-T169
in	O	O	O
a	O	O	O
modest	O	O	B-T169
increase	O	O	I-T169
in	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	O
viable	O	O	B-T025
cells	O	O	I-T025
during	O	O	O
27	O	O	O
days	O	O	B-T079
,	O	O	O
which	O	O	O
implies	O	O	O
biocompatibility	O	O	B-T044
of	O	O	O
Dacron	O	O	O
and	O	O	O
mesothelial	O	O	B-T025
cells	O	O	I-T025
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

-DOCSTART- (28473640)

Anterolateral	O	O	B-T082
entorhinal	O	O	B-T023
cortex	O	O	I-T023
volume	O	O	B-T081
predicted	O	O	O
by	O	O	O
altered	O	O	O
intra-item	O	O	O
configural	O	O	O
processing	O	O	O

Recent	O	O	O
functional	O	O	O
imaging	O	O	B-T060
studies	O	O	I-T060
have	O	O	O
proposed	O	O	O
that	O	O	O
the	O	O	O
human	O	O	B-T016
entorhinal	O	O	B-T023
cortex	O	O	I-T023
is	O	O	O
subdivided	O	O	O
into	O	O	O
functionally	O	O	O
distinct	O	O	O
anterolateral	O	O	B-T082
(	O	O	O
alERC	O	O	B-T023
)	O	O	O
and	O	O	O
posteromedial	O	O	B-T082
(	O	O	O
pmERC	O	O	B-T023
)	O	O	O
subregions	O	O	B-T029
.	O	O	O

The	O	O	O
alERC	O	O	B-T023
overlaps	O	O	O
with	O	O	O
regions	O	O	O
that	O	O	O
are	O	O	O
affected	O	O	O
earliest	O	O	O
by	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
pathology	O	O	B-T046
,	O	O	O
yet	O	O	O
its	O	O	O
cognitive	O	O	B-T041
function	O	O	I-T041
remains	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

Previous	O	O	O
human	O	O	B-T016
fMRI	O	O	B-T060
studies	O	O	B-T008
have	O	O	O
focused	O	O	O
on	O	O	O
its	O	O	O
role	O	O	O
in	O	O	O
object	O	O	B-T072
memory	O	O	B-T041
,	O	O	O
but	O	O	O
rodent	O	O	B-T015
studies	O	O	O
on	O	O	O
the	O	O	O
putatively	O	O	O
homologous	O	O	O
lateral	O	O	O
entorhinal	O	O	B-T023
cortex	O	O	I-T023
suggest	O	O	O
that	O	O	O
it	O	O	O
also	O	O	O
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
representing	O	O	O
spatial	O	O	B-T082
properties	O	O	I-T082
of	O	O	O
objects	O	O	B-T072
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
cognitive	O	O	B-T033
effects	O	O	I-T033
of	O	O	O
human	O	O	B-T016
alERC	O	O	B-T023
volume	O	O	B-T081
differences	O	O	O
,	O	O	O
we	O	O	O
developed	O	O	O
an	O	O	O
eyetracking-based	O	O	O
task	O	O	O
to	O	O	O
evaluate	O	O	B-T058
intra-item	O	O	B-T170
configural	O	O	I-T170
processing	O	O	B-T052
(	O	O	O
i.e.	O	O	O
,	O	O	O
processing	O	O	O
the	O	O	O
arrangement	O	O	B-T082
of	O	O	O
an	O	O	O
object	O	O	B-T072
's	O	O	I-T072
features	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
used	O	O	O
manual	O	O	B-T058
segmentation	O	O	I-T058
based	O	O	O
on	O	O	O
a	O	O	O
recently-	O	O	O
developed	O	O	B-T170
protocol	O	O	I-T170
to	O	O	O
delineate	O	O	O
the	O	O	O
alERC	O	O	O
/	O	O	O
pmERC	O	O	B-T023
as	O	O	O
well	O	O	O
as	O	O	O
other	O	O	O
medial	O	O	B-T023
temporal	O	O	I-T023
lobe	O	O	I-T023
(	O	O	O
MTL	O	O	B-T023
)	O	O	O
subregions	O	O	B-T029
.	O	O	O

In	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
older	O	O	O
adult	O	O	B-T100
men	O	O	B-T098
and	O	O	O
women	O	O	B-T098
at	O	O	O
varying	O	O	O
stages	O	O	B-T079
of	O	O	O
brain	O	O	B-T047
atrophy	O	O	I-T047
and	O	O	O
cognitive	O	O	B-T046
decline	O	O	I-T046
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
intra-item	O	O	B-T170
configural	O	O	I-T170
processing	O	O	I-T170
-	O	O	O
regardless	O	O	O
of	O	O	O
an	O	O	O
object	O	O	B-T072
's	O	O	I-T072
novelty	O	O	O
-	O	O	O
was	O	O	O
strongly	O	O	O
predicted	O	O	O
by	O	O	O
alERC	O	O	B-T023
volume	O	O	B-T081
,	O	O	O
but	O	O	O
not	O	O	O
by	O	O	O
the	O	O	O
volume	O	O	O
of	O	O	O
any	O	O	O
other	O	O	O
MTL	O	O	B-T023
subregion	O	O	I-T023
.	O	O	O

These	O	O	O
results	O	O	O
provide	O	O	O
the	O	O	O
first	O	O	O
evidence	O	O	O
that	O	O	O
the	O	O	O
human	O	O	B-T016
alERC	O	O	B-T023
plays	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
supporting	O	O	O
a	O	O	O
distinct	O	O	O
aspect	O	O	O
of	O	O	O
object	O	O	B-T072
processing	O	O	B-T052
,	O	O	O
namely	O	O	O
attending	O	O	O
to	O	O	O
the	O	O	O
arrangement	O	O	B-T082
of	O	O	O
an	O	O	O
object	O	O	B-T072
's	O	O	I-T072
component	O	O	O
features	O	O	O
.	O	O	O

SIGNIFICANCE	O	O	O
STATEMENT	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
pathology	O	O	B-T046
appears	O	O	O
earliest	O	O	O
in	O	O	O
brain	O	O	B-T029
regions	O	O	I-T029
that	O	O	O
overlap	O	O	O
with	O	O	O
the	O	O	O
anterolateral	O	O	B-T082
entorhinal	O	O	B-T023
cortex	O	O	I-T023
(	O	O	O
alERC	O	O	B-T023
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
cognitive	O	O	B-T041
role	O	O	I-T041
of	O	O	O
the	O	O	O
alERC	O	O	B-T023
is	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

Previous	O	O	O
human	O	O	B-T062
studies	O	O	I-T062
treat	O	O	B-T061
the	O	O	O
alERC	O	O	B-T023
as	O	O	O
an	O	O	O
extension	O	O	O
of	O	O	O
the	O	O	O
neighboring	O	O	O
perirhinal	O	O	B-T029
cortex	O	O	I-T029
,	O	O	O
supporting	O	O	O
object	O	O	B-T072
memory	O	O	B-T041
.	O	O	O

Animal	O	O	B-T008
studies	O	O	I-T008
suggest	O	O	O
that	O	O	O
the	O	O	O
alERC	O	O	B-T023
may	O	O	O
support	O	O	O
the	O	O	O
spatial	O	O	B-T082
properties	O	O	I-T082
of	O	O	O
objects	O	O	B-T072
.	O	O	O

In	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
older	O	O	O
adult	O	O	B-T100
humans	O	O	B-T016
at	O	O	O
the	O	O	O
earliest	O	O	B-T079
stages	O	O	I-T079
of	O	O	O
cognitive	O	O	B-T046
decline	O	O	I-T046
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
alERC	O	O	B-T023
volume	O	O	B-T081
selectively	O	O	O
predicted	O	O	O
configural	O	O	B-T170
processing	O	O	I-T170
(	O	O	O
attention	O	O	B-T041
to	O	O	O
the	O	O	O
spatial	O	O	B-T082
arrangement	O	O	I-T082
of	O	O	O
an	O	O	O
object	O	O	B-T072
's	O	O	I-T072
parts	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
study	O	O	O
to	O	O	O
demonstrate	O	O	O
a	O	O	O
cognitive	O	O	B-T041
role	O	O	I-T041
related	O	O	O
to	O	O	O
alERC	O	O	B-T023
volume	O	O	B-T081
in	O	O	O
humans	O	O	B-T016
.	O	O	O

This	O	O	O
task	O	O	O
can	O	O	O
be	O	O	O
adapted	O	O	O
to	O	O	O
serve	O	O	O
as	O	O	O
an	O	O	O
early	O	O	B-T170
detection	O	O	I-T170
method	O	O	I-T170
for	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
pathology	O	O	B-T046
.	O	O	O

-DOCSTART- (28476271)

Alcohol	O	O	B-T058
brief	O	O	I-T058
intervention	O	O	I-T058
in	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
:	O	O	O
Blood	O	O	B-T040
pressure	O	O	I-T040
outcomes	O	O	B-T033
in	O	O	O
hypertensive	O	O	B-T047
patients	O	O	O

In	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
alcohol	O	O	B-T058
brief	O	O	I-T058
intervention	O	O	I-T058
(	O	O	O
BI	O	O	B-T058
)	O	O	O
in	O	O	O
adult	O	O	B-T100
primary	O	O	B-T058
care	O	O	I-T058
has	O	O	O
been	O	O	O
efficacious	O	O	B-T080
in	O	O	O
reducing	O	O	B-T080
alcohol	O	O	B-T055
consumption	O	O	I-T055
,	O	O	O
but	O	O	O
we	O	O	O
know	O	O	O
little	O	O	O
about	O	O	O
its	O	O	O
impact	O	O	B-T080
on	O	O	O
health	O	O	B-T080
outcomes	O	O	I-T080
.	O	O	O

Hypertension	O	O	B-T047
is	O	O	O
a	O	O	O
prevalent	O	O	O
and	O	O	O
costly	O	O	O
chronic	O	O	B-T033
condition	O	O	I-T033
in	O	O	O
the	O	O	O
U.S.	O	O	B-T083
and	O	O	O
worldwide	O	O	B-T080
,	O	O	O
and	O	O	O
alcohol	O	O	B-T055
use	O	O	I-T055
is	O	O	O
a	O	O	O
modifiable	O	O	O
hypertension	O	O	B-T047
risk	O	O	B-T033
factor	O	O	I-T033
.	O	O	O

To	O	O	O
evaluate	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
receiving	O	O	O
BI	O	O	B-T058
for	O	O	O
unhealthy	O	O	B-T055
drinking	O	O	I-T055
on	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
(	O	O	I-T040
BP	O	O	I-T040
)	O	O	I-T040
control	O	O	I-T040
among	O	O	O
adult	O	O	B-T100
hypertensive	O	O	B-T047
patients	O	O	B-T101
by	O	O	O
analyzing	O	O	B-UnknownType
secondary	O	O	I-UnknownType
data	O	O	I-UnknownType
from	O	O	O
a	O	O	O
clustered	O	O	B-T062
,	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
on	O	O	O
alcohol	O	O	B-T058
screening	O	O	I-T058
,	O	O	O
brief	O	O	B-T058
intervention	O	O	I-T058
and	O	O	O
referral	O	O	B-UnknownType
to	O	O	I-UnknownType
treatment	O	O	I-UnknownType
(	O	O	O
SBIRT	O	O	B-T058
)	O	O	O
implementation	O	O	B-T052
by	O	O	O
primary	O	O	B-T097
care	O	O	I-T097
physicians	O	O	I-T097
(	O	O	O
PCP	O	O	B-T097
intervention	O	O	I-T097
arm	O	O	I-T097
)	O	O	O
and	O	O	O
non-physician	O	O	B-T097
providers	O	O	I-T097
and	O	O	O
medical	O	O	B-T097
assistants	O	O	I-T097
(	O	O	O
NPP	O	O	B-T097
&	O	O	O
MA	O	O	B-T097
intervention	O	O	I-T097
arm	O	O	I-T097
)	O	O	O
in	O	O	O
a	O	O	O
large	O	O	O
,	O	O	O
integrated	O	O	B-T093
health	O	O	I-T093
care	O	O	I-T093
delivery	O	O	I-T093
system	O	O	I-T093
.	O	O	O

Observational	O	O	B-T062
,	O	O	O
prospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
.	O	O	O

3811	O	O	O
adult	O	O	B-T100
hypertensive	O	O	B-T047
primary	O	O	B-T101
care	O	O	I-T101
patients	O	O	I-T101
screening	O	O	B-T058
positive	O	O	O
for	O	O	O
past-year	O	O	B-T079
heavy	O	O	B-T048
drinking	O	O	I-T048
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
of	O	O	O
which	O	O	O
1422	O	O	O
(	O	O	O
37	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
an	O	O	O
electronic	O	O	B-T170
health	O	O	I-T170
record	O	O	I-T170
BP	O	O	B-T040
measure	O	O	O
at	O	O	O
baseline	O	O	O
and	O	O	O
18-month	O	O	B-T079
follow-up	O	O	B-T058
.	O	O	O

Change	O	O	B-T033
in	O	O	I-T033
BP	O	O	I-T033
and	O	O	O
controlled	O	O	B-T040
BP	O	O	I-T040
(	O	O	O
systolic/diastolic	O	O	B-T032
BP	O	O	I-T032
<	O	O	O
140/90	O	O	O
mmHg	O	O	B-T081
)	O	O	O
.	O	O	O

Overall	O	O	O
no	O	O	O
significant	O	O	O
associations	O	O	B-T080
were	O	O	O
found	O	O	O
between	O	O	O
alcohol	O	O	B-T058
BI	O	O	I-T058
and	O	O	O
BP	O	O	B-T033
change	O	O	I-T033
at	O	O	O
18-month	O	O	B-T079
follow-up	O	O	B-T058
when	O	O	O
analyzing	O	O	O
the	O	O	O
combined	O	O	O
sample	O	O	O
of	O	O	O
subjects	O	O	B-T098
in	O	O	O
both	O	O	O
intervention	O	O	B-T097
arms	O	O	I-T097
.	O	O	O

However	O	O	O
,	O	O	O
moderation	O	O	O
analyses	O	O	O
found	O	O	O
that	O	O	O
receiving	O	O	O
BI	O	O	B-T058
for	O	O	O
positive	O	O	O
past-year	O	O	B-T079
unhealthy	O	O	B-T055
drinking	O	O	I-T055
was	O	O	O
positively	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
better	O	O	O
BP	O	O	B-T040
control	O	O	I-T040
at	O	O	O
18months	O	O	B-T079
in	O	O	O
the	O	O	O
PCP	O	O	B-T097
intervention	O	O	I-T097
arm	O	O	I-T097
,	O	O	O
and	O	O	O
for	O	O	O
those	O	O	O
with	O	O	O
lower	O	O	O
heavy	O	O	B-T048
drinking	O	O	I-T048
frequency	O	O	B-T079
and	O	O	O
poor	O	O	O
BP	O	O	O
control	O	O	O
at	O	O	O
the	O	O	O
index	O	O	B-T058
screening	O	O	I-T058
.	O	O	O

Our	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
hypertensive	O	O	B-T047
patients	O	O	B-T101
may	O	O	O
benefit	O	O	B-T081
from	O	O	O
receiving	O	O	O
physician	O	O	B-T097
brief	O	O	B-T058
intervention	O	O	I-T058
for	O	O	O
unhealthy	O	O	B-T055
alcohol	O	O	I-T055
use	O	O	I-T055
in	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
.	O	O	O

Findings	O	O	O
also	O	O	O
highlight	O	O	O
potential	O	O	O
population-level	O	O	B-T081
benefits	O	O	I-T081
of	O	O	O
alcohol	O	O	B-T058
BI	O	O	I-T058
if	O	O	O
widely	O	O	O
applied	O	O	O
,	O	O	O
suggesting	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
innovative	O	O	O
strategies	O	O	O
to	O	O	O
facilitate	O	O	O
SBIRT	O	O	B-T058
delivery	O	O	I-T058
in	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
settings	O	O	O
.	O	O	O

-DOCSTART- (28476381)

Unusual	O	O	B-T080
asymptomatic	O	O	B-T047
presentation	O	O	I-T047
of	O	O	O
bladder	O	O	B-T191
cancer	O	O	I-T191
metastatic	O	O	O
to	O	O	O
the	O	O	O
penis	O	O	O

Penile	O	O	B-T191
metastasis	O	O	I-T191
is	O	O	O
an	O	O	O
extremely	O	O	B-T047
rare	O	O	I-T047
event	O	O	I-T047
and	O	O	O
mainly	O	O	O
originate	O	O	O
from	O	O	O
primary	O	O	O
pelvic	O	O	B-T023
tumor	O	O	B-T082
sites	O	O	I-T082
such	O	O	O
us	O	O	O
urinary	O	O	B-T023
bladder	O	O	I-T023
,	O	O	O
gastro-intestinal	O	O	B-T022
tract	O	O	I-T022
and	O	O	O
prostate	O	O	B-T023
and	O	O	O
more	O	O	O
rarely	O	O	O
from	O	O	O
respiratory	O	O	B-T022
system	O	O	I-T022
,	O	O	O
bone	O	O	B-T191
tumors	O	O	I-T191
and	O	O	O
melanoma	O	O	B-T191
.	O	O	O

Here	O	O	O
we	O	O	O
describe	O	O	O
the	O	O	O
unusual	O	O	B-T080
presentation	O	O	B-T078
of	O	O	O
two	O	O	O
bladder	O	O	B-T191
urothelial	O	O	I-T191
cancer	O	O	I-T191
metastatic	O	O	B-T169
to	O	O	I-T169
the	O	O	O
penis	O	O	B-T023
with	O	O	O
no	O	O	B-T033
relevant	O	O	I-T033
clinical	O	O	I-T033
symptoms	O	O	I-T033
.	O	O	O

Namely	O	O	O
,	O	O	O
a	O	O	O
69	O	O	O
years-old	O	O	O
man	O	O	O
with	O	O	O
a	O	O	O
warthy	O	O	O
lesions	O	O	B-T033
of	O	O	O
the	O	O	O
foreskin	O	O	B-UnknownType
and	O	O	I-UnknownType
the	O	O	I-UnknownType
glans	O	O	I-UnknownType
misunderstood	O	O	O
for	O	O	O
a	O	O	O
condylomata	O	O	B-T047
that	O	O	O
at	O	O	O
histological	O	O	B-T059
and	O	O	O
immunohistochemical	O	O	B-T059
analysis	O	O	I-T059
showed	O	O	O
a	O	O	O
bladder	O	O	B-T191
urothelial	O	O	I-T191
carcinoma	O	O	I-T191
;	O	O	O
and	O	O	O
a	O	O	O
71	O	O	O
years-old	O	O	O
man	O	O	O
with	O	O	O
reddish	O	O	B-T080
skin	O	O	B-T033
lesion	O	O	I-T033
of	O	O	I-T033
the	O	O	I-T033
glans	O	O	I-T033
,	O	O	O
a	O	O	O
previous	O	O	O
history	O	O	B-T033
of	O	O	I-T033
bladder	O	O	I-T033
and	O	O	O
urethral	O	O	B-T191
carcinoma	O	O	I-T191
and	O	O	O
histological	O	O	B-T033
pagetoid	O	O	I-T033
spread	O	O	I-T033
of	O	O	O
urothelial	O	O	B-T191
cancer	O	O	I-T191
to	O	O	B-T023
the	O	O	I-T023
glans	O	O	I-T023
.	O	O	O

Recurrent	O	O	B-T191
bladder	O	O	I-T191
urothelial	O	O	I-T191
carcinoma	O	O	I-T191
is	O	O	O
usually	O	O	O
a	O	O	O
visceral	O	O	B-T023
disease	O	O	B-T047
that	O	O	O
rarely	O	O	O
presents	O	O	O
as	O	O	O
a	O	O	O
superficial	O	O	O
asymptomatic	O	O	B-T033
skin	O	O	B-T047
lesion	O	O	I-T047
.	O	O	O

The	O	O	O
two	O	O	O
reported	O	O	O
cases	O	O	B-T033
were	O	O	I-T033
asymptomatic	O	O	I-T033
superficial	O	O	B-T191
penis	O	O	I-T191
metastases	O	O	I-T191
with	O	O	O
a	O	O	O
relatively	O	O	O
slow	O	O	O
growth	O	O	O
and	O	O	O
a	O	O	O
fairy	O	O	B-T033
good	O	O	I-T033
prognosis	O	O	I-T033
after	O	O	O
conservative	O	O	B-T169
surgical	O	O	I-T169
approach	O	O	I-T169
.	O	O	O

Accurate	O	O	O
clinical	O	O	B-T064
examination	O	O	I-T064
of	O	O	I-T064
the	O	O	I-T064
penis	O	O	I-T064
is	O	O	I-T064
mandatory	O	O	I-T064
for	O	O	I-T064
males	O	O	I-T064
with	O	O	O
history	O	O	B-T033
of	O	O	I-T033
bladder	O	O	I-T033
cancer	O	O	I-T033
.	O	O	O

-DOCSTART- (28478321)

The	O	O	O
bachelorette	O	O	O
:	O	O	O
Female	O	O	B-T032
Siamese	O	O	B-T013
fighting	O	O	I-T013
fish	O	O	I-T013
avoid	O	O	B-T169
males	O	O	B-T032
exposed	O	O	B-T080
to	O	O	I-T080
an	O	O	O
estrogen	O	O	B-T125
mimic	O	O	O

Due	O	O	O
to	O	O	O
improper	O	O	B-T080
disposal	O	O	B-T052
and	O	O	O
a	O	O	O
lack	O	O	B-T080
of	O	O	O
removal	O	O	B-T052
during	O	O	O
the	O	O	O
wastewater	O	O	B-T069
treatment	O	O	B-T169
process	O	O	I-T169
,	O	O	O
endocrine	O	O	B-T169
disrupting	O	O	B-T080
chemicals	O	O	B-T103
enter	O	O	O
aquatic	O	O	B-T067
ecosystems	O	O	I-T067
where	O	O	O
they	O	O	O
exert	O	O	O
detrimental	O	O	O
effects	O	O	B-T080
on	O	O	O
fish	O	O	B-T013
behavior	O	O	B-T053
and	O	O	O
physiology	O	O	B-T039
.	O	O	O

Perhaps	O	O	O
the	O	O	O
most	O	O	O
well-studied	O	O	O
and	O	O	O
prevalent	O	O	B-T081
EDC	O	O	B-T103
is	O	O	O
17α-ethinylestradiol	O	O	B-T125
(	O	O	O
EE2	O	O	B-T125
)	O	O	O
,	O	O	O
an	O	O	O
active	O	O	O
ingredient	O	O	B-T120
in	O	O	O
oral	O	O	B-T121
contraceptives	O	O	I-T121
,	O	O	O
which	O	O	O
is	O	O	O
known	O	O	O
to	O	O	O
cause	O	O	O
dramatic	O	O	O
reductions	O	O	B-T080
in	O	O	O
male	O	O	B-T032
-typical	O	O	O
behaviors	O	O	B-T053
.	O	O	O

While	O	O	O
it	O	O	O
is	O	O	O
likely	O	O	O
that	O	O	O
alterations	O	O	B-T078
in	O	O	O
male	O	O	B-T032
courtship	O	O	B-T054
behavior	O	O	B-T053
decrease	O	O	B-T081
reproductive	O	O	B-T045
fitness	O	O	I-T045
,	O	O	O
this	O	O	O
is	O	O	O
rarely	O	O	O
explicitly	O	O	O
examined	O	O	O
.	O	O	O

To	O	O	O
this	O	O	O
end	O	O	O
,	O	O	O
whether	O	O	O
EE2	O	O	B-T125
exposure	O	O	B-T080
reduces	O	O	B-T080
male	O	O	B-T032
attractiveness	O	O	B-T032
to	O	O	O
female	O	O	B-T032
Siamese	O	O	B-T013
fighting	O	O	I-T013
fish	O	O	I-T013
,	O	O	O
Betta	O	O	B-T013
splendens	O	O	I-T013
,	O	O	O
was	O	O	O
investigated	O	O	B-T169
by	O	O	O
showing	O	O	O
females	O	O	B-T032
video	O	O	B-T170
images	O	O	B-T170
of	O	O	O
exposed	O	O	B-T098
and	O	O	O
unexposed	O	O	B-T098
males	O	O	B-T032
.	O	O	O

Females	O	O	B-T032
were	O	O	O
randomly	O	O	O
assigned	O	O	O
to	O	O	O
one	O	O	O
of	O	O	O
two	O	O	O
exposure	O	O	B-T080
conditions	O	O	B-T080
(	O	O	O
exposed	O	O	B-T098
to	O	O	I-T080
EE2	O	O	B-T125
,	O	O	O
control	O	O	B-T096
)	O	O	O
and	O	O	O
each	O	O	O
subject	O	O	B-T096
then	O	O	O
viewed	O	O	O
four	O	O	B-T081
different	O	O	B-T080
video	O	O	B-T170
combinations	O	O	B-T080
of	O	O	O
male	O	O	B-T032
conspecifics	O	O	B-T078
(	O	O	O
courting	O	O	B-T054
exposed	O	O	O
+	O	O	O
exposed	O	O	O
;	O	O	O
courting	O	O	O
unexposed	O	O	B-T098
+	O	O	O
unexposed	O	O	O
;	O	O	O
courting	O	O	O
unexposed	O	O	O
+	O	O	O
exposed	O	O	O
;	O	O	O
swimming	O	O	B-T056
unexposed	O	O	O
+	O	O	O
exposed	O	O	O
)	O	O	O
.	O	O	O

Females	O	O	B-T032
,	O	O	O
regardless	O	O	O
of	O	O	O
whether	O	O	O
or	O	O	O
not	O	O	O
they	O	O	O
were	O	O	O
exposed	O	O	B-T098
to	O	O	I-T080
EE2	O	O	B-T125
,	O	O	O
directed	O	O	O
markedly	O	O	O
less	O	O	O
behavior	O	O	B-T053
towards	O	O	O
exposed	O	O	O
males	O	O	B-T032
,	O	O	O
especially	O	O	O
when	O	O	O
they	O	O	O
viewed	O	O	O
an	O	O	O
exposed	O	O	O
male	O	O	B-T032
and	O	O	O
an	O	O	O
unexposed	O	O	B-T098
male	O	O	O
simultaneously	O	O	B-T079
.	O	O	O

These	O	O	O
findings	O	O	O
demonstrate	O	O	O
that	O	O	O
EE2	O	O	B-T125
can	O	O	O
have	O	O	O
significant	O	O	B-T078
individual	O	O	B-T081
-	O	O	O
and	O	O	O
population-level	O	O	B-T098
consequences	O	O	B-T169
on	O	O	O
fitness	O	O	B-T078
by	O	O	O
disrupting	O	O	B-T080
sexual	O	O	B-T054
selection	O	O	I-T054
and	O	O	O
,	O	O	O
ultimately	O	O	O
,	O	O	O
the	O	O	O
success	O	O	B-T054
of	O	O	O
exposed	O	O	B-T098
males	O	O	B-T032
.	O	O	O

-DOCSTART- (28478867)

Targeting	O	O	B-T169
accuracy	O	O	B-T080
of	O	O	O
single-isocenter	O	O	B-T082
intensity-modulated	O	O	B-T061
radiosurgery	O	O	B-T061
for	O	O	O
multiple	O	O	O
lesions	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
targeting	O	O	B-T169
accuracy	O	O	B-T080
of	O	O	O
intensity-modulated	O	O	B-T061
SRS	O	O	B-T061
(	O	O	O
IMRS	O	O	B-T061
)	O	O	O
plans	O	O	B-T170
designed	O	O	O
to	O	O	O
simultaneously	O	O	O
treat	O	O	O
multiple	O	O	O
brain	O	O	B-T023
metastases	O	O	B-T046
with	O	O	O
a	O	O	O
single	O	O	B-T082
isocenter	O	O	I-T082
.	O	O	O

A	O	O	O
home-made	O	O	B-T122
acrylic	O	O	I-T122
phantom	O	O	B-T073
able	O	O	O
to	O	O	O
support	O	O	O
a	O	O	O
film	O	O	B-T167
(	O	O	O
EBT3	O	O	B-T167
)	O	O	O
in	O	O	O
its	O	O	O
coronal	O	O	B-T082
plane	O	O	I-T082
was	O	O	O
used	O	O	O
.	O	O	O

The	O	O	O
phantom	O	O	B-T073
was	O	O	O
CT	O	O	B-T060
scanned	O	O	I-T060
and	O	O	O
three	O	O	O
coplanar	O	O	O
small	O	O	O
targets	O	O	B-T169
(	O	O	O
a	O	O	O
central	O	O	B-T082
and	O	O	O
two	O	O	O
peripheral	O	O	B-T082
)	O	O	O
were	O	O	O
outlined	O	O	O
in	O	O	O
the	O	O	O
Eclipse	O	O	B-T061
system	O	O	I-T061
.	O	O	O

Peripheral	O	O	B-T082
targets	O	O	B-T169
were	O	O	O
6	O	O	O
cm	O	O	O
apart	O	O	O
from	O	O	O
the	O	O	O
central	O	O	B-T082
one	O	O	O
.	O	O	O

A	O	O	O
reference	O	O	O
IMRS	O	O	B-T061
plan	O	O	B-T170
was	O	O	O
designed	O	O	O
to	O	O	O
simultaneously	O	O	O
treat	O	O	O
the	O	O	O
three	O	O	O
targets	O	O	B-T169
,	O	O	O
but	O	O	O
only	O	O	O
a	O	O	O
single	O	O	B-T082
isocenter	O	O	I-T082
located	O	O	O
at	O	O	O
the	O	O	O
center	O	O	O
of	O	O	O
the	O	O	O
central	O	O	B-T082
target	O	O	B-T169
was	O	O	O
used	O	O	O
.	O	O	O

After	O	O	O
positioning	O	O	B-T082
the	O	O	O
phantom	O	O	B-T073
on	O	O	O
the	O	O	O
linac	O	O	B-T074
using	O	O	O
the	O	O	O
room	O	O	B-T082
lasers	O	O	B-T073
,	O	O	O
a	O	O	O
CBCT	O	O	B-T060
scan	O	O	I-T060
was	O	O	O
acquired	O	O	O
and	O	O	O
the	O	O	O
reference	O	O	O
plan	O	O	B-T170
were	O	O	O
mapped	O	O	B-T052
on	O	O	O
it	O	O	O
,	O	O	O
by	O	O	O
placing	O	O	O
the	O	O	O
planned	O	O	O
isocenter	O	O	B-T082
at	O	O	O
the	O	O	O
intersection	O	O	B-T078
of	O	O	O
the	O	O	O
landmarks	O	O	O
used	O	O	O
in	O	O	O
the	O	O	O
film	O	O	B-T167
showing	O	O	O
the	O	O	O
linac	O	O	O
isocenter	O	O	O
.	O	O	O

The	O	O	O
mapped	O	O	B-T052
plan	O	O	B-T170
was	O	O	O
then	O	O	O
recalculated	O	O	B-T052
and	O	O	O
delivered	O	O	B-T169
.	O	O	O

The	O	O	O
film	O	O	B-T167
dose	O	O	B-T061
distribution	O	O	I-T061
was	O	O	O
derived	O	O	O
using	O	O	O
a	O	O	O
cloud	O	O	B-T170
computing	O	O	I-T170
application	O	O	I-T170
(	O	O	O
www.radiochromic.com	O	O	B-T170
)	O	O	O
that	O	O	O
uses	O	O	O
a	O	O	O
triple-channel	O	O	O
dosimetry	O	O	B-T059
algorithm	O	O	B-T170
.	O	O	O

Comparison	O	O	O
of	O	O	O
dose	O	O	B-T061
distributions	O	O	I-T061
using	O	O	O
the	O	O	O
gamma	O	O	B-T081
index	O	O	I-T081
(	O	O	O
5%/1	O	O	O
mm	O	O	O
)	O	O	O
were	O	O	O
performed	O	O	O
over	O	O	O
a	O	O	O
5	O	O	O
×	O	O	O
5	O	O	O
cm(2	O	O	O
)	O	O	O
region	O	O	O
centered	O	O	O
over	O	O	O
each	O	O	O
target	O	O	B-T169
.	O	O	O

2D	O	O	B-T169
shifts	O	O	I-T169
required	O	O	O
to	O	O	O
get	O	O	O
the	O	O	O
best	O	O	O
gamma	O	O	B-T070
passing	O	O	O
rates	O	O	O
on	O	O	O
the	O	O	O
peripheral	O	O	B-T082
target	O	O	B-T169
regions	O	O	O
were	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
reported	O	O	O
ones	O	O	O
for	O	O	O
the	O	O	O
central	O	O	B-T082
target	O	O	O
.	O	O	O

The	O	O	O
experiment	O	O	B-T062
was	O	O	O
repeated	O	O	O
ten	O	O	O
times	O	O	O
in	O	O	O
different	O	O	O
sessions	O	O	B-T061
.	O	O	O

Average	O	O	O
2D	O	O	B-T169
shifts	O	O	I-T169
required	O	O	O
to	O	O	O
achieve	O	O	O
optimal	O	O	O
gamma	O	O	B-T070
passing	O	O	O
rates	O	O	O
(	O	O	O
99	O	O	O
%	O	O	O
,	O	O	O
97	O	O	O
%	O	O	O
,	O	O	O
99	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
0.7	O	O	O
mm	O	O	O
(	O	O	O
SD	O	O	O
:	O	O	O
0.3	O	O	O
mm	O	O	O
)	O	O	O
,	O	O	O
0.8	O	O	O
mm	O	O	O
(	O	O	O
SD	O	O	O
:	O	O	O
0.4	O	O	O
mm	O	O	O
)	O	O	O
and	O	O	O
0.8	O	O	O
mm	O	O	O
(	O	O	O
SD	O	O	O
:	O	O	O
0.3	O	O	O
mm	O	O	O
)	O	O	O
,	O	O	O
for	O	O	O
the	O	O	O
central	O	O	B-T082
and	O	O	O
the	O	O	O
two	O	O	O
peripheral	O	O	B-T082
targets	O	O	B-T169
,	O	O	O
respectively	O	O	O
.	O	O	O

No	O	O	O
statistical	O	O	O
differences	O	O	O
(	O	O	O
p	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
were	O	O	O
found	O	O	O
for	O	O	O
targeting	O	O	B-T169
accuracy	O	O	B-T080
between	O	O	O
the	O	O	O
central	O	O	B-T082
and	O	O	O
the	O	O	O
two	O	O	O
peripheral	O	O	B-T082
targets	O	O	B-T169
.	O	O	O

The	O	O	O
study	O	O	B-T062
revealed	O	O	O
a	O	O	O
targeting	O	O	B-T169
accuracy	O	O	B-T080
within	O	O	O
1	O	O	O
mm	O	O	O
for	O	O	O
off-	O	O	O
isocenter	O	O	B-T082
targets	O	O	B-T169
within	O	O	O
6	O	O	O
cm	O	O	O
of	O	O	O
the	O	O	O
linac	O	O	B-T074
isocenter	O	O	O
,	O	O	O
when	O	O	O
a	O	O	O
single-isocenter	O	O	B-T082
IMRS	O	O	B-T061
plan	O	O	B-T170
is	O	O	O
designed	O	O	O
.	O	O	O

-DOCSTART- (28479259)

Physical	O	O	B-T056
activity	O	O	I-T056
limits	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
age	O	O	B-T032
and	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
on	O	O	O
postural	O	O	O
control	O	O	O

The	O	O	O
aim	O	O	B-T078
was	O	O	O
to	O	O	O
study	O	O	O
the	O	O	O
possible	O	O	O
influence	O	O	B-T077
of	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
on	O	O	O
the	O	O	O
postural	O	O	B-T169
performance	O	O	B-T052
of	O	O	O
subjects	O	O	B-T098
with	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
.	O	O	O

The	O	O	O
postural	O	O	B-T169
performance	O	O	B-T052
(	O	O	O
i.e.	O	O	O
surface	O	O	B-T081
area	O	O	I-T081
of	O	O	O
the	O	O	O
center	O	O	B-T082
of	O	O	I-T082
foot	O	O	I-T082
pressure	O	O	I-T082
displacement	O	O	I-T082
)	O	O	O
of	O	O	O
3	O	O	O
groups	O	O	B-T078
was	O	O	O
compared	O	O	B-T052
:	O	O	O
Alzheimer	O	O	B-T078
active	O	O	I-T078
group	O	O	I-T078
(	O	O	O
AA	O	O	B-T078
)	O	O	O
,	O	O	O
Alzheimer	O	O	B-T078
non-active	O	O	I-T078
group	O	O	I-T078
(	O	O	O
ANA	O	O	B-T078
)	O	O	O
and	O	O	O
healthy	O	O	B-T078
non-active	O	O	I-T078
group	O	O	I-T078
(	O	O	O
HNA	O	O	B-T078
)	O	O	O
.	O	O	O

The	O	O	O
AA	O	O	B-T098
group	O	O	I-T098
's	O	O	I-T098
postural	O	O	B-T169
performance	O	O	B-T052
was	O	O	O
superior	O	O	B-T082
to	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
ANA	O	O	B-T078
and	O	O	O
HNA	O	O	B-T078
groups	O	O	I-T078
.	O	O	O

AD	O	O	B-T047
disturbed	O	O	O
postural	O	O	B-T169
performance	O	O	B-T052
but	O	O	O
participation	O	O	B-T169
in	O	O	O
regular	O	O	B-T080
physical	O	O	B-T056
activity	O	O	I-T056
made	O	O	O
it	O	O	O
possible	O	O	O
to	O	O	O
limit	O	O	B-T169
the	O	O	O
disturbing	O	O	B-T080
effects	O	O	I-T080
of	O	O	O
AD	O	O	O
to	O	O	O
a	O	O	O
surprising	O	O	O
extent	O	O	O
,	O	O	O
since	O	O	O
the	O	O	O
postural	O	O	O
performance	O	O	O
of	O	O	O
active	O	O	B-T098
AD	O	O	I-T098
subjects	O	O	I-T098
was	O	O	O
also	O	O	O
superior	O	O	B-T082
to	O	O	O
that	O	O	O
of	O	O	O
healthy	O	O	B-T098
subjects	O	O	I-T098
.	O	O	O

-DOCSTART- (28483530)

LAMP-2	O	O	B-T116
mediates	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
-dependent	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
in	O	O	O
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
-	O	O	O
treated	O	O	B-T061
lung	O	O	B-T023
epithelium	O	O	O
cells	O	O	O

Zinc	O	O	B-T121
is	O	O	O
an	O	O	O
essential	O	O	O
element	O	O	B-T196
for	O	O	O
the	O	O	O
biological	O	O	B-T022
system	O	O	I-T022
.	O	O	O

However	O	O	O
,	O	O	O
excessive	O	O	O
exogenous	O	O	B-T169
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
would	O	O	O
disrupt	O	O	O
cellular	O	O	B-T043
Zn(2	O	O	I-T043
+	O	O	I-T043
)	O	O	I-T043
homeostasis	O	O	I-T043
and	O	O	O
cause	O	O	B-T037
toxicity	O	O	I-T037
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
Zinc	O	O	B-T121
salts	O	O	I-T121
or	O	O	O
ZnO	O	O	B-T121
nanoparticles	O	O	B-T073
exposure	O	O	O
could	O	O	O
induce	O	O	O
respiratory	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

Although	O	O	O
previous	O	O	O
studies	O	O	O
have	O	O	O
indicated	O	O	O
that	O	O	O
organelle	O	O	B-T026
damage	O	O	B-T049
(	O	O	O
including	O	O	O
mitochondria	O	O	B-T026
or	O	O	O
lysosomes	O	O	B-T026
)	O	O	O
and	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
production	O	O	O
are	O	O	O
involved	O	O	O
in	O	O	O
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
-induced	O	O	O
toxicity	O	O	B-T037
,	O	O	O
the	O	O	O
interplay	O	O	O
between	O	O	O
mitochondria	O	O	O
/	O	O	O
lysosomes	O	O	O
damage	O	O	O
and	O	O	O
ROS	O	O	O
production	O	O	O
is	O	O	O
obscure	O	O	O
.	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
demonstrated	O	O	O
that	O	O	O
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
could	O	O	O
induce	O	O	O
deglycosylation	O	O	B-T044
of	O	O	O
lysosome-associated	O	O	B-T116
membrane	O	O	I-T116
protein	O	O	I-T116
1	O	O	I-T116
and	O	O	O
2	O	O	B-T116
(	O	O	O
LAMP-1	O	O	B-T116
and	O	O	O
LAMP-2	O	O	B-T116
)	O	O	O
,	O	O	O
which	O	O	O
primarily	O	O	O
locate	O	O	O
in	O	O	O
late	O	O	O
endosomes	O	O	B-T026
/	O	O	O
lysosomes	O	O	B-T026
,	O	O	O
in	O	O	O
A549	O	O	B-T025
lung	O	O	I-T025
epithelium	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

Intriguingly	O	O	O
,	O	O	O
LAMP-2	O	O	B-T028
knockdown	O	O	B-T063
further	O	O	O
aggravated	O	O	B-T080
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
-mediated	O	O	O
ROS	O	O	B-T123
production	O	O	O
and	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
,	O	O	O
indicating	O	O	O
LAMP-2	O	O	O
(	O	O	O
not	O	O	O
LAMP-1	O	O	B-T116
)	O	O	O
was	O	O	O
involved	O	O	O
in	O	O	O
Zn(2	O	O	O
+	O	O	O
)	O	O	O
-induced	O	O	O
toxicity	O	O	B-T037
.	O	O	O

Our	O	O	O
results	O	O	O
provide	O	O	O
a	O	O	O
new	O	O	O
insight	O	O	O
that	O	O	O
LAMP-2	O	O	B-T116
contributes	O	O	O
to	O	O	O
the	O	O	O
ROS	O	O	B-T123
clearance	O	O	O
and	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
induced	O	O	O
by	O	O	O
Zn(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
treatment	O	O	B-T061
,	O	O	O
which	O	O	O
would	O	O	O
help	O	O	O
us	O	O	O
to	O	O	O
get	O	O	O
a	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
Zn(2	O	O	O
+	O	O	O
)	O	O	O
-induced	O	O	O
toxicity	O	O	B-T037
in	O	O	O
respiratory	O	O	B-T022
system	O	O	I-T022
.	O	O	O

-DOCSTART- (28485130)

Fluorescence	O	O	B-T060
hyperspectral	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
fHSI	O	O	B-T060
)	O	O	O
using	O	O	O
a	O	O	O
spectrally	O	O	B-T080
resolved	O	O	B-T033
detector	O	O	O
array	O	O	O

The	O	O	O
ability	O	O	O
to	O	O	O
resolve	O	O	B-T077
multiple	O	O	B-T081
fluorescent	O	O	B-T067
emissions	O	O	I-T067
from	O	O	O
different	O	O	B-T080
biological	O	O	B-T080
targets	O	O	B-T169
in	O	O	O
video	O	O	B-UnknownType
rate	O	O	I-UnknownType
applications	O	O	I-UnknownType
,	O	O	O
such	O	O	O
as	O	O	O
endoscopy	O	O	B-T060
and	O	O	O
intraoperative	O	O	B-T060
imaging	O	O	I-T060
,	O	O	O
has	O	O	O
traditionally	O	O	O
been	O	O	O
limited	O	O	B-T169
by	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
filter-based	O	O	B-T080
imaging	O	O	O
systems	O	O	O
.	O	O	O

Hyperspectral	O	O	B-T060
imaging	O	O	I-T060
(	O	O	O
HSI	O	O	B-T060
)	O	O	O
facilitates	O	O	O
the	O	O	O
detection	O	O	B-T061
of	O	O	O
both	O	O	O
spatial	O	O	B-T082
and	O	O	O
spectral	O	O	B-T081
information	O	O	B-T078
in	O	O	O
a	O	O	O
single	O	O	B-T052
data	O	O	I-T052
acquisition	O	O	I-T052
,	O	O	O
however	O	O	O
,	O	O	O
instrumentation	O	O	B-T080
for	O	O	O
HSI	O	O	O
is	O	O	O
typically	O	O	O
complex	O	O	B-T080
,	O	O	O
bulky	O	O	B-T081
and	O	O	O
expensive	O	O	B-T080
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
overcome	O	O	B-T052
these	O	O	O
limitations	O	O	B-T169
using	O	O	O
a	O	O	O
novel	O	O	B-T080
robust	O	O	B-T080
and	O	O	O
low	O	O	B-T081
cost	O	O	I-T081
HSI	O	O	B-T060
camera	O	O	B-T074
based	O	O	O
on	O	O	O
a	O	O	O
spectrally	O	O	B-T074
resolved	O	O	I-T074
detector	O	O	I-T074
array	O	O	I-T074
(	O	O	O
SRDA	O	O	B-T074
)	O	O	O
.	O	O	O

We	O	O	O
integrated	O	O	B-T066
this	O	O	O
HSI	O	O	B-T060
camera	O	O	B-T074
into	O	O	O
a	O	O	O
wide-field	O	O	B-T033
reflectance-based	O	O	B-T059
imaging	O	O	B-T073
system	O	O	I-T073
operating	O	O	B-T169
in	O	O	O
the	O	O	O
near-infrared	O	O	B-T080
range	O	O	B-T081
to	O	O	O
assess	O	O	B-T058
the	O	O	O
suitability	O	O	O
for	O	O	O
in	O	O	B-T059
vivo	O	O	I-T059
imaging	O	O	I-T059
of	O	O	O
exogenous	O	O	B-T169
fluorescent	O	O	B-T130
contrast	O	O	I-T130
agents	O	O	I-T130
.	O	O	O

Using	O	O	O
this	O	O	O
fluorescence	O	O	B-T060
HSI	O	O	I-T060
(	O	O	O
fHSI	O	O	B-T060
)	O	O	O
system	O	O	B-T169
,	O	O	O
we	O	O	O
were	O	O	O
able	O	O	O
to	O	O	O
accurately	O	O	B-T080
resolve	O	O	B-T077
the	O	O	O
presence	O	O	B-T080
and	O	O	O
concentration	O	O	B-T081
of	O	O	O
at	O	O	O
least	O	O	O
7	O	O	O
fluorescent	O	O	B-T130
dyes	O	O	I-T130
in	O	O	O
solution	O	O	B-T167
.	O	O	O

We	O	O	O
also	O	O	O
demonstrate	O	O	O
high	O	O	B-T080
spectral	O	O	B-T066
unmixing	O	O	I-T066
precision	O	O	B-T080
,	O	O	O
signal	O	O	B-T067
linearity	O	O	B-T080
with	O	O	O
dye	O	O	B-T130
concentration	O	O	B-T081
and	O	O	O
at	O	O	O
depth	O	O	B-T082
in	O	O	O
tissue	O	O	B-T024
mimicking	O	O	B-T070
phantoms	O	O	B-T073
,	O	O	O
and	O	O	O
delineate	O	O	B-T033
4	O	O	O
fluorescent	O	O	B-T130
dyes	O	O	I-T130
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

Our	O	O	O
approach	O	O	O
,	O	O	O
including	O	O	B-T169
statistical	O	O	B-T080
background	O	O	B-T077
removal	O	O	O
,	O	O	O
could	O	O	O
be	O	O	O
directly	O	O	B-T080
generalised	O	O	B-T082
to	O	O	O
broader	O	O	B-T074
spectral	O	O	I-T074
ranges	O	O	B-T081
,	O	O	O
for	O	O	O
example	O	O	O
,	O	O	O
to	O	O	O
resolve	O	O	B-T077
tissue	O	O	B-T024
reflectance	O	O	B-T059
or	O	O	O
autofluorescence	O	O	B-T059
and	O	O	O
in	O	O	O
future	O	O	B-T079
be	O	O	O
tailored	O	O	O
to	O	O	O
video	O	O	B-UnknownType
rate	O	O	I-UnknownType
applications	O	O	I-UnknownType
requiring	O	O	O
snapshot	O	O	O
HSI	O	O	B-T060
data	O	O	B-T052
acquisition	O	O	I-T052
.	O	O	O

-DOCSTART- (28485268)

Biochemical	O	O	B-T169
studies	O	O	B-T062
of	O	O	O
amylase	O	O	B-T116
,	O	O	O
lipase	O	O	B-T116
and	O	O	O
protease	O	O	B-T116
in	O	O	O
Callosobruchus	O	O	B-T204
maculatus	O	O	I-T204
(	O	O	O
Coleoptera	O	O	B-T204
:	O	O	O
Chrysomelidae	O	O	B-T204
)	O	O	O
populations	O	O	B-T098
fed	O	O	O
with	O	O	O
Vigna	O	O	B-T002
unguiculata	O	O	I-T002
grain	O	O	B-T168
cultivated	O	O	B-T062
with	O	O	O
diazotrophic	O	O	O
bacteria	O	O	O
strains	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
enzymatic	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
homogenates	O	O	B-T072
of	O	O	O
insects	O	O	B-T204
fed	O	O	O
on	O	O	O
grain	O	O	B-T168
of	O	O	O
cowpea	O	O	B-T002
,	O	O	O
Vigna	O	O	B-T002
unguiculata	O	O	I-T002
(	O	O	I-T002
L.	O	O	I-T002
)	O	O	I-T002
,	O	O	O
cultivars	O	O	B-T002
grown	O	O	O
with	O	O	O
different	O	O	O
nitrogen	O	O	B-T123
sources	O	O	O
.	O	O	O

For	O	O	O
the	O	O	O
experiment	O	O	O
we	O	O	O
used	O	O	O
aliquots	O	O	O
of	O	O	O
the	O	O	O
homogenate	O	O	B-T072
of	O	O	O
100	O	O	O
unsexed	O	O	O
adult	O	O	B-T100
insects	O	O	B-T204
,	O	O	O
emerged	O	O	O
from	O	O	O
10	O	O	O
g	O	O	O
of	O	O	O
grain	O	O	B-T168
obtained	O	O	O
from	O	O	O
four	O	O	O
cowpea	O	O	B-T002
cultivars	O	O	B-T002
:	O	O	O
'	O	O	O
BRS	O	O	B-T002
Acauã	O	O	I-T002
'	O	O	O
,	O	O	O
'	O	O	O
BRS	O	O	B-T002
Carijó	O	O	I-T002
'	O	O	O
,	O	O	O
'	O	O	O
BRS	O	O	B-T002
Pujante	O	O	I-T002
'	O	O	O
,	O	O	O
and	O	O	O
'	O	O	O
BRS	O	O	B-T002
Tapaihum	O	O	I-T002
'	O	O	O
grown	O	O	O
under	O	O	O
different	O	O	O
regimes	O	O	O
of	O	O	O
nitrogen	O	O	B-T123
sources	O	O	O
:	O	O	O
mineral	O	O	B-T197
fertilizer	O	O	B-T131
,	O	O	O
inoculation	O	O	B-T059
with	O	O	O
strains	O	O	B-T007
of	O	O	I-T007
diazotrophs	O	O	I-T007
(	O	O	O
BR	O	O	B-T007
3267	O	O	I-T007
,	O	O	O
BR	O	O	B-T007
3262	O	O	I-T007
,	O	O	O
BR	O	O	B-T007
3299	O	O	I-T007
;	O	O	O
INPA	O	O	B-T007
03	O	O	I-T007
-	O	O	I-T007
11B	O	O	I-T007
,	O	O	O
03	O	O	B-T007
-	O	O	I-T007
84	O	O	I-T007
UFLA	O	O	I-T007
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
control	O	O	B-T096
(	O	O	O
with	O	O	O
soil	O	O	B-T167
nitrogen	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
parameters	O	O	O
evaluated	O	O	O
were	O	O	O
enzymatic	O	O	B-T044
activities	O	O	I-T044
of	O	O	O
insect	O	O	B-T204
protease	O	O	B-T116
,	O	O	O
amylase	O	O	B-T116
and	O	O	O
lipase	O	O	B-T116
and	O	O	O
the	O	O	O
starch	O	O	B-T109
content	O	O	O
of	O	O	O
the	O	O	O
grains	O	O	B-T168
.	O	O	O

There	O	O	O
were	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
enzymatic	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
amylase	O	O	B-T116
,	O	O	O
lipase	O	O	B-T116
and	O	O	O
protease	O	O	B-T116
of	O	O	O
insect	O	O	B-T204
homogenate	O	O	B-T072
according	O	O	O
to	O	O	O
the	O	O	O
food	O	O	B-T168
source	O	O	O
.	O	O	O

A	O	O	O
lower	O	O	O
activity	O	O	B-T044
of	O	O	I-T044
the	O	O	I-T044
enzyme	O	O	I-T044
amylase	O	O	B-T116
from	O	O	O
C.	O	O	B-T204
maculatus	O	O	I-T204
homogenate	O	O	B-T072
was	O	O	O
observed	O	O	O
when	O	O	O
insects	O	O	B-T204
were	O	O	O
fed	O	O	O
grain	O	O	B-T168
of	O	O	O
the	O	O	O
cultivar	O	O	B-T002
BRS	O	O	I-T002
Carijó	O	O	I-T002
.	O	O	O

A	O	O	O
lower	O	O	O
activity	O	O	B-T044
of	O	O	I-T044
lipase	O	O	I-T044
enzyme	O	O	I-T044
from	O	O	O
C.	O	O	B-T204
maculatus	O	O	I-T204
homogenate	O	O	B-T072
was	O	O	O
observed	O	O	O
when	O	O	O
the	O	O	O
insects	O	O	B-T204
fed	O	O	O
on	O	O	O
grain	O	O	B-T168
from	O	O	O
the	O	O	O
interaction	O	O	O
of	O	O	O
the	O	O	O
cultivar	O	O	B-T002
Tapaihum	O	O	I-T002
inoculated	O	O	O
with	O	O	O
BR	O	O	B-T007
3262	O	O	I-T007
diazotrophs	O	O	I-T007
.	O	O	O

The	O	O	O
lowest	O	O	O
proteolytic	O	O	B-T044
activity	O	O	I-T044
was	O	O	O
observed	O	O	O
in	O	O	O
homogenate	O	O	B-T072
of	O	O	O
insects	O	O	B-T204
fed	O	O	O
on	O	O	O
interaction	O	O	O
of	O	O	O
'	O	O	O
BRS	O	O	B-T002
Carijó	O	O	I-T002
'	O	O	O
inoculated	O	O	O
with	O	O	O
BR	O	O	B-T007
3262	O	O	I-T007
diazotroph	O	O	I-T007
s.	O	O	O
Starch	O	O	B-T109
content	O	O	O
correlated	O	O	O
positively	O	O	O
with	O	O	O
the	O	O	O
amylase	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
C.	O	O	B-T204
maculatus	O	O	I-T204
homogenate	O	O	O
.	O	O	O

The	O	O	O
cultivar	O	O	B-T002
BRS	O	O	I-T002
Carijó	O	O	I-T002
had	O	O	O
a	O	O	O
different	O	O	O
behavior	O	O	O
from	O	O	O
the	O	O	O
other	O	O	O
cultivars	O	O	B-T002
,	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
cluster	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

-DOCSTART- (28485296)

The	O	O	O
correlation	O	O	B-T081
of	O	O	I-T081
the	O	O	I-T081
results	O	O	I-T081
of	O	O	O
the	O	O	O
survey	O	O	B-T170
SNOT-20	O	O	I-T170
of	O	O	O
objective	O	O	B-T078
studies	O	O	I-T078
of	O	O	O
nasal	O	O	B-T033
obstruction	O	O	I-T033
and	O	O	O
the	O	O	O
geometry	O	O	O
of	O	O	O
the	O	O	O
nasal	O	O	O
cavities	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
were	O	O	O
verified	O	O	O
the	O	O	O
correlation	O	O	B-T081
between	O	O	I-T081
the	O	O	I-T081
results	O	O	I-T081
of	O	O	O
the	O	O	O
survey	O	O	B-T170
SNOT-20	O	O	I-T170
and	O	O	O
the	O	O	O
results	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
objective	O	O	I-T033
tests	O	O	I-T033
of	O	O	O
nasal	O	O	B-T033
obstruction	O	O	I-T033
which	O	O	O
are	O	O	O
rhinomanometry	O	O	B-T060
and	O	O	O
acoustic	O	O	B-T060
rhinometry	O	O	I-T060
before	O	O	O
and	O	O	O
after	O	O	O
surgical	O	O	B-T061
treatment	O	O	I-T061
,	O	O	O
such	O	O	O
as	O	O	O
septoplasty	O	O	B-T061
,	O	O	O
septoconchoplasty	O	O	B-T060
,	O	O	O
ethmoidectomy	O	O	B-T061
and	O	O	O
septoethmoidectomy	O	O	B-T060
.	O	O	O

The	O	O	O
material	O	O	O
used	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
233	O	O	O
patients	O	O	B-T101
diagnosed	O	O	B-T033
routinely	O	O	O
in	O	O	O
the	O	O	O
Rhinomanometry	O	O	B-T060
Laboratory	O	O	B-T093
of	O	O	O
the	O	O	O
Department	O	O	B-T093
of	O	O	I-T093
Otolaryngology	O	O	I-T093
at	O	O	O
the	O	O	O
Medical	O	O	B-T093
University	O	O	I-T093
of	O	O	O
Warsaw	O	O	B-UnknownType
,	O	O	O
reporting	O	O	O
rhinological	O	O	B-T047
problems	O	O	I-T047
.	O	O	O

Data	O	O	B-T078
were	O	O	O
obtained	O	O	O
from	O	O	O
70	O	O	O
women	O	O	B-T098
(	O	O	O
31,4	O	O	O
%	O	O	O
)	O	O	O
ranging	O	O	O
in	O	O	O
ages	O	O	O
from	O	O	O
18	O	O	O
to	O	O	O
81	O	O	O
years	O	O	O
of	O	O	O
age	O	O	O
and	O	O	O
153	O	O	O
men	O	O	B-T098
(	O	O	O
68,6	O	O	O
%	O	O	O
)	O	O	O
ranging	O	O	O
in	O	O	O
ages	O	O	O
from	O	O	O
16	O	O	O
to	O	O	O
81	O	O	O
years	O	O	O
of	O	O	O
age	O	O	O
.	O	O	O

The	O	O	O
researches	O	O	O
presented	O	O	O
in	O	O	O
the	O	O	O
study	O	O	O
were	O	O	O
made	O	O	O
using	O	O	O
the	O	O	O
device	O	O	O
RhinoMetrics	O	O	B-T074
SRE	O	O	I-T074
2100	O	O	I-T074
which	O	O	O
combines	O	O	O
the	O	O	O
Rhinomanometer	O	O	B-T074
(	O	O	O
RhinoStream	O	O	B-T074
)	O	O	O
and	O	O	O
Acoustic	O	O	B-T074
Rhinometer	O	O	I-T074
(	O	O	O
RhinoScan	O	O	B-T074
)	O	O	O
Interacoustics	O	O	B-T074
AS	O	O	I-T074
(	O	O	O
Denmark	O	O	B-T083
)	O	O	O
.	O	O	O

Survey	O	O	B-T170
SNOT-20	O	O	I-T170
(	O	O	O
Sino-Nasal	O	O	B-T170
Outcome	O	O	I-T170
Test-20	O	O	I-T170
)	O	O	O
in	O	O	O
Polish	O	O	B-UnknownType
was	O	O	O
completed	O	O	O
by	O	O	O
patients	O	O	B-T101
before	O	O	B-T079
surgery	O	O	I-T079
and	O	O	O
during	O	O	B-T079
the	O	O	I-T079
postoperative	O	O	I-T079
control	O	O	I-T079
visits	O	O	I-T079
.	O	O	O

The	O	O	O
calculated	O	O	O
correlations	O	O	O
between	O	O	O
the	O	O	O
objective	O	O	B-T033
parameter	O	O	I-T033
,	O	O	O
which	O	O	O
was	O	O	O
the	O	O	O
resistance	O	O	B-T169
to	O	O	O
the	O	O	O
flow	O	O	B-T033
of	O	O	I-T033
air	O	O	I-T033
through	O	O	I-T033
the	O	O	I-T033
nasal	O	O	I-T033
cavity	O	O	I-T033
,	O	O	O
and	O	O	O
the	O	O	O
subjective	O	O	B-T033
feelings	O	O	I-T033
of	O	O	I-T033
respondents	O	O	I-T033
expressed	O	O	O
in	O	O	O
the	O	O	O
survey	O	O	B-T170
SNOT-20	O	O	I-T170
were	O	O	O
generally	O	O	B-T080
weak	O	O	I-T080
,	O	O	O
and	O	O	O
statistical	O	O	B-T081
significance	O	O	I-T081
was	O	O	O
achieved	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
the	O	O	O
first	O	O	B-T062
question	O	O	I-T062
survey	O	O	I-T062
(	O	O	O
the	O	O	O
severity	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
nose	O	O	I-T033
obstruction	O	O	I-T033
)	O	O	O
for	O	O	O
all	O	O	O
components	O	O	O
of	O	O	O
resistance	O	O	B-T169
flow	O	O	I-T169
.	O	O	O

The	O	O	O
feeling	O	O	O
of	O	O	O
nasal	O	O	B-T033
obstruction	O	O	I-T033
is	O	O	O
the	O	O	O
most	O	O	O
reproducible	O	O	O
and	O	O	O
reliable	O	O	O
complaint	O	O	O
reported	O	O	O
by	O	O	O
the	O	O	O
patient	O	O	B-T101
with	O	O	O
rhinological	O	O	B-T047
problems	O	O	I-T047
.	O	O	O

-DOCSTART- (28486935)

Emergency	O	O	B-T093
department	O	O	I-T093
use	O	O	B-T169
and	O	O	O
barriers	O	O	B-T080
to	O	O	O
wellness	O	O	B-T078
:	O	O	O
a	O	O	O
survey	O	O	B-T170
of	O	O	O
emergency	O	O	B-T093
department	O	O	I-T093
frequent	O	O	B-T079
users	O	O	O

There	O	O	O
is	O	O	O
no	O	O	O
common	O	O	O
understanding	O	O	O
of	O	O	O
how	O	O	O
needs	O	O	B-T080
of	O	O	O
emergency	O	O	B-T093
department	O	O	I-T093
(	O	O	O
ED	O	O	B-T093
)	O	O	O
frequent	O	O	B-T079
users	O	O	B-T098
differ	O	O	O
from	O	O	O
other	O	O	O
patients	O	O	B-T101
.	O	O	O

This	O	O	O
study	O	O	B-T062
sought	O	O	O
to	O	O	O
examine	O	O	O
how	O	O	O
to	O	O	O
best	O	O	O
serve	O	O	O
this	O	O	O
population	O	O	B-T098
.	O	O	O

Examinations	O	O	B-T058
of	O	O	O
why	O	O	O
ED	O	O	B-T093
frequent	O	O	B-T079
users	O	O	B-T098
present	O	O	B-T033
to	O	O	O
the	O	O	O
ED	O	O	O
,	O	O	O
what	O	O	O
barriers	O	O	B-T080
to	O	O	O
care	O	O	B-T058
exist	O	O	B-T077
,	O	O	O
and	O	O	O
what	O	O	O
service	O	O	B-T057
offerings	O	O	O
may	O	O	O
help	O	O	O
these	O	O	O
patients	O	O	B-T101
achieve	O	O	O
an	O	O	O
optimal	O	O	B-T080
level	O	O	B-T080
of	O	O	O
health	O	O	B-T078
were	O	O	O
conducted	O	O	O
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
of	O	O	O
frequent	O	O	B-T079
ED	O	O	B-T093
users	O	O	B-T098
in	O	O	O
an	O	O	O
adult	O	O	B-T100
only	O	O	O
,	O	O	O
level	O	O	B-T093
1	O	O	I-T093
trauma	O	O	I-T093
center	O	O	I-T093
with	O	O	O
approximately	O	O	B-T080
90,000	O	O	O
visits	O	O	B-T058
per	O	O	B-T079
year	O	O	I-T079
.	O	O	O

Frequent	O	O	B-T079
ED	O	O	B-T093
users	O	O	B-T098
were	O	O	O
defined	O	O	O
as	O	O	O
those	O	O	O
who	O	O	O
make	O	O	O
four	O	O	O
or	O	O	O
more	O	O	O
ED	O	O	B-T058
visits	O	O	I-T058
in	O	O	O
a	O	O	O
12	O	O	O
month	O	O	B-T079
period	O	O	B-T079
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
administered	O	O	B-T169
a	O	O	O
piloted	O	O	B-UnknownType
structured	O	O	I-UnknownType
interview	O	O	I-UnknownType
by	O	O	O
a	O	O	O
trained	O	O	B-T097
researcher	O	O	I-T097
querying	O	O	B-T170
demographics	O	O	B-T090
,	O	O	O
ED	O	O	B-T093
usage	O	O	B-T169
,	O	O	O
perceived	O	O	B-T080
barriers	O	O	I-T080
to	O	O	O
care	O	O	B-T058
,	O	O	O
and	O	O	O
potential	O	O	O
aids	O	O	B-T080
to	O	O	O
maintaining	O	O	B-T055
health	O	O	I-T055
.	O	O	O

Of	O	O	O
1,523	O	O	O
screened	O	O	B-T058
patients	O	O	B-T101
,	O	O	O
297	O	O	O
were	O	O	O
identified	O	O	B-T080
as	O	O	O
frequent	O	O	B-T079
ED	O	O	B-T093
users	O	O	B-T098
.	O	O	O

One	O	O	O
hundred	O	O	O
frequent	O	O	B-T079
ED	O	O	B-T093
users	O	O	B-T098
were	O	O	O
enrolled	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T032
age	O	O	I-T032
was	O	O	O
48	O	O	O
years	O	O	B-T079
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
45	O	O	O
-	O	O	O
51	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
subjects	O	O	B-T098
were	O	O	O
female	O	O	B-T098
(	O	O	O
64	O	O	O
%	O	O	O
,	O	O	O
64/100	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
55	O	O	O
-	O	O	O
73	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
white	O	O	B-T098
(	O	O	O
61	O	O	O
%	O	O	O
,	O	O	O
60/98	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
52	O	O	O
-	O	O	O
71	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
insured	O	O	B-T170
by	O	O	O
Medicaid	O	O	B-T064
(	O	O	O
55	O	O	O
%	O	O	O
,	O	O	O
47/86	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
44	O	O	O
-	O	O	O
65	O	O	O
%	O	O	O
)	O	O	O
or	O	O	O
Medicare	O	O	B-T064
(	O	O	O
23	O	O	O
%	O	O	O
,	O	O	O
20/86	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
14	O	O	O
-	O	O	O
32	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Subjects	O	O	B-T098
had	O	O	O
a	O	O	O
median	O	O	B-T081
of	O	O	O
6	O	O	O
ED	O	O	B-T058
visits	O	O	I-T058
,	O	O	O
and	O	O	O
2	O	O	O
inpatient	O	O	B-T169
admissions	O	O	I-T169
in	O	O	O
the	O	O	O
past	O	O	B-T079
12	O	O	O
months	O	O	B-T079
at	O	O	O
this	O	O	O
hospital	O	O	B-T093
.	O	O	O

Most	O	O	O
frequent	O	O	B-T079
ED	O	O	B-T093
users	O	O	B-T098
(	O	O	O
61	O	O	O
%	O	O	O
,	O	O	O
59/96	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
52	O	O	O
-	O	O	O
71	O	O	O
%	O	O	O
)	O	O	O
stated	O	O	O
the	O	O	O
primary	O	O	B-T078
reason	O	O	I-T078
for	O	O	O
their	O	O	O
visit	O	O	B-T058
was	O	O	O
that	O	O	O
they	O	O	O
felt	O	O	O
that	O	O	O
their	O	O	O
health	O	O	B-T033
problem	O	O	I-T033
could	O	O	O
only	O	O	O
be	O	O	O
treated	O	O	B-T169
in	O	O	O
an	O	O	O
ED	O	O	O
.	O	O	O

Transportation	O	O	B-T078
presented	O	O	O
as	O	O	O
a	O	O	O
major	O	O	B-T080
barrier	O	O	B-T080
to	O	O	O
few	O	O	B-T081
patients	O	O	B-T101
(	O	O	O
7	O	O	O
%	O	O	O
,	O	O	O
7/95	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
3	O	O	O
-	O	O	O
14	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Subjects	O	O	B-T098
stated	O	O	O
that	O	O	O
"	O	O	O
after-hours	O	O	B-T058
options	O	O	I-T058
,	O	O	O
besides	O	O	O
the	O	O	O
ED	O	O	B-T093
for	O	O	O
minor	O	O	B-T080
health	O	O	B-T078
issues	O	O	I-T078
"	O	O	O
(	O	O	O
63	O	O	O
%	O	O	O
,	O	O	O
60/95	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
53	O	O	O
-	O	O	O
73	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
having	O	O	O
"	O	O	O
a	O	O	O
nurse	O	O	B-T097
to	O	O	O
work	O	O	B-T057
with	O	O	O
you	O	O	O
one-on-one	O	O	B-T061
to	O	O	O
help	O	O	O
manage	O	O	B-T058
health	O	O	B-T058
care	O	O	I-T058
needs	O	O	B-T080
"	O	O	O
(	O	O	O
53	O	O	O
%	O	O	O
,	O	O	O
50/95	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
43	O	O	O
-	O	O	O
63	O	O	O
%	O	O	O
)	O	O	O
would	O	O	O
be	O	O	O
most	O	O	O
helpful	O	O	O
in	O	O	O
achieving	O	O	O
optimal	O	O	B-T080
health	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
characterized	O	O	B-T052
ED	O	O	B-T093
frequent	O	O	B-T079
users	O	O	B-T098
and	O	O	O
identified	O	O	B-T080
several	O	O	B-T081
opportunities	O	O	B-T062
to	O	O	O
better	O	O	O
serve	O	O	O
this	O	O	O
population	O	O	B-T098
.	O	O	O

By	O	O	O
understanding	O	O	O
barriers	O	O	B-T080
to	O	O	O
care	O	O	B-T058
from	O	O	O
the	O	O	O
patient	O	O	B-T101
perspective	O	O	O
,	O	O	O
health	O	O	B-T064
systems	O	O	I-T064
can	O	O	O
potentially	O	O	O
address	O	O	O
unmet	O	O	O
needs	O	O	B-T080
that	O	O	O
prevent	O	O	B-T080
wellness	O	O	B-T078
in	O	O	O
this	O	O	O
population	O	O	B-T098
.	O	O	O

-DOCSTART- (28490164)

Contralateral	O	O	B-T082
Superior	O	O	B-T046
Cerebellar	O	O	I-T046
Artery	O	O	I-T046
Syndrome	O	O	I-T046
:	O	O	O
A	O	O	O
Consequence	O	O	B-T169
of	O	O	I-T169
Brain	O	O	O
Herniation	O	O	O

Vascular	O	O	B-T023
compromise	O	O	B-T033
is	O	O	O
a	O	O	O
well-known	O	O	O
consequence	O	O	B-T169
of	O	O	I-T169
brain	O	O	B-T190
herniation	O	O	I-T190
syndromes	O	O	B-T047
.	O	O	O

Transtentorial	O	O	B-T082
brain	O	O	B-T190
herniation	O	O	I-T190
most	O	O	O
often	O	O	O
involves	O	O	O
posterior	O	O	B-T023
cerebral	O	O	I-T023
arteries	O	O	I-T023
.	O	O	O

However	O	O	O
,	O	O	O
isolated	O	O	B-T169
involvement	O	O	B-T169
of	O	O	O
contralateral	O	O	B-T082
superior	O	O	B-T023
cerebellar	O	O	I-T023
artery	O	O	I-T023
(	O	O	O
SCA	O	O	B-T023
)	O	O	O
during	O	O	O
unilateral	O	O	B-T082
impending	O	O	B-T079
brain	O	O	B-T190
herniation	O	O	I-T190
is	O	O	O
reported	O	O	B-T058
only	O	O	O
once	O	O	O
and	O	O	O
we	O	O	O
present	O	O	O
another	O	O	O
case	O	O	O
of	O	O	O
this	O	O	O
exceedingly	O	O	O
rare	O	O	B-T080
entity	O	O	B-T071
.	O	O	O

A	O	O	O
24-year-old	O	O	O
man	O	O	B-T098
was	O	O	O
referred	O	O	O
to	O	O	O
us	O	O	O
with	O	O	O
impending	O	O	B-T079
herniation	O	O	B-T190
due	O	O	O
to	O	O	O
a	O	O	O
multiloculated	O	O	B-T082
hydrocephalus	O	O	B-T047
,	O	O	O
and	O	O	O
during	O	O	O
the	O	O	O
course	O	O	B-T046
of	O	O	I-T046
illness	O	O	I-T046
,	O	O	O
he	O	O	O
developed	O	O	O
an	O	O	O
isolated	O	O	B-T169
SCA	O	O	B-T023
ischemia	O	O	B-T046
in	O	O	O
the	O	O	O
opposite	O	O	O
side	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
dilated	O	O	B-T033
entrapped	O	O	O
horn	O	O	B-T023
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	O
article	O	O	B-T170
we	O	O	O
discuss	O	O	O
the	O	O	O
probable	O	O	O
pathophysiologic	O	O	B-T169
mechanisms	O	O	B-T169
of	O	O	O
this	O	O	O
phenomenon	O	O	B-T067
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
recommending	O	O	O
more	O	O	O
inclusive	O	O	B-T169
brain	O	O	B-T023
studies	O	O	O
in	O	O	O
cases	O	O	O
suspected	O	O	B-T078
of	O	O	O
Kernohan-Woltman	O	O	B-T046
notch	O	O	I-T046
phenomenon	O	O	I-T046
in	O	O	O
unilateral	O	O	B-T082
brain	O	O	B-T190
herniation	O	O	I-T190
.	O	O	O

The	O	O	O
rationale	O	O	B-T078
for	O	O	O
this	O	O	O
commentary	O	O	B-T170
is	O	O	O
that	O	O	O
contralateral	O	O	B-T082
SCA	O	O	B-T023
transient	O	O	B-T047
ischemia	O	O	I-T047
or	O	O	O
infarct	O	O	B-T046
might	O	O	O
be	O	O	O
the	O	O	O
underdiagnosed	O	O	B-T033
underlying	O	O	O
pathomechanism	O	O	B-T046
of	O	O	O
ipsilateral	O	O	B-T082
hemiparesis	O	O	B-T184
occurring	O	O	O
in	O	O	O
many	O	O	O
cases	O	O	O
of	O	O	O
this	O	O	O
somehow	O	O	O
vague	O	O	B-T080
phenomenon	O	O	B-T067
.	O	O	O

-DOCSTART- (28490376)

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
clinical	O	O	B-T057
supervision	O	O	I-T057
on	O	O	O
supervisees	O	O	B-T098
and	O	O	O
patients	O	O	B-T101
in	O	O	O
cognitive-behavioral	O	O	B-T061
therapy	O	O	I-T061
:	O	O	O
a	O	O	O
study	O	O	B-T170
protocol	O	O	I-T170
for	O	O	O
a	O	O	O
systematic	O	O	O
review	O	O	O

Clinical	O	O	B-T057
supervision	O	O	I-T057
by	O	O	O
a	O	O	O
senior	O	O	B-T097
therapist	O	O	I-T097
is	O	O	O
a	O	O	O
very	O	O	O
common	O	O	O
practice	O	O	B-T041
in	O	O	O
psychotherapist	O	O	B-T097
training	O	O	B-T065
and	O	O	O
psychiatric	O	O	B-T061
care	O	O	I-T061
settings	O	O	O
.	O	O	O

Though	O	O	O
clinical	O	O	B-T057
supervision	O	O	I-T057
is	O	O	O
advocated	O	O	O
by	O	O	O
most	O	O	O
educational	O	O	B-UnknownType
and	O	O	I-UnknownType
governing	O	O	I-UnknownType
institutions	O	O	I-UnknownType
,	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
clinical	O	O	O
supervision	O	O	O
on	O	O	O
the	O	O	O
supervisees	O	O	B-T098
'	O	O	O
competence	O	O	B-T080
,	O	O	O
e.g.	O	O	O
,	O	O	O
attitudes	O	O	B-T041
,	O	O	O
behaviors	O	O	B-T053
,	O	O	O
and	O	O	O
skills	O	O	B-T055
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
on	O	O	O
treatment	O	O	B-T080
outcomes	O	O	I-T080
and	O	O	O
other	O	O	O
patient	O	O	B-T101
variables	O	O	O
are	O	O	O
debated	O	O	O
and	O	O	O
largely	O	O	O
unknown	O	O	O
.	O	O	O

Evidence-based	O	O	B-T169
practice	O	O	I-T169
is	O	O	O
advocated	O	O	O
in	O	O	O
clinical	O	O	B-T082
settings	O	O	I-T082
but	O	O	O
has	O	O	O
not	O	O	O
yet	O	O	O
been	O	O	O
fully	O	O	O
implemented	O	O	O
in	O	O	O
educational	O	O	O
or	O	O	O
clinical	O	O	O
training	O	O	O
settings	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
is	O	O	O
to	O	O	O
synthesize	O	O	O
and	O	O	O
present	O	O	O
the	O	O	O
empirical	O	O	B-T170
literature	O	O	I-T170
regarding	O	O	O
effects	O	O	O
of	O	O	O
clinical	O	O	B-T057
supervision	O	O	I-T057
in	O	O	O
cognitive-behavioral	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

This	O	O	O
study	O	O	O
will	O	O	O
include	O	O	O
a	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
of	O	O	O
the	O	O	O
literature	O	O	B-T170
to	O	O	O
identify	O	O	O
studies	O	O	O
that	O	O	O
have	O	O	O
empirically	O	O	O
investigated	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
supervision	O	O	O
on	O	O	O
supervised	O	O	B-T097
psychotherapists	O	O	I-T097
and/or	O	O	O
the	O	O	O
supervisees	O	O	O
'	O	O	O
patients	O	O	B-T101
.	O	O	O

A	O	O	O
comprehensive	O	O	O
search	O	O	O
strategy	O	O	O
will	O	O	O
be	O	O	O
conducted	O	O	O
to	O	O	O
identify	O	O	O
published	O	O	O
controlled	O	O	O
studies	O	O	O
indexed	O	O	B-T170
in	O	O	O
the	O	O	O
MEDLINE	O	O	B-T170
,	O	O	O
EMBASE	O	O	B-T170
,	O	O	O
PsycINFO	O	O	B-T170
,	O	O	O
and	O	O	O
Cochrane	O	O	B-T170
Library	O	O	I-T170
databases	O	O	I-T170
.	O	O	O

Data	O	O	B-T078
on	O	O	O
supervision	O	O	O
outcomes	O	O	O
in	O	O	O
both	O	O	O
psychotherapists	O	O	B-T097
and	O	O	O
their	O	O	O
patients	O	O	B-T101
will	O	O	O
be	O	O	O
extracted	O	O	O
,	O	O	O
synthesized	O	O	O
,	O	O	O
and	O	O	O
reported	O	O	B-T170
.	O	O	O

Risk	O	O	O
of	O	O	O
bias	O	O	O
and	O	O	O
quality	O	O	O
of	O	O	O
the	O	O	O
included	O	O	O
studies	O	O	O
will	O	O	O
be	O	O	O
assessed	O	O	O
systematically	O	O	O
.	O	O	O

This	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
will	O	O	O
rigorously	O	O	O
follow	O	O	O
established	O	O	O
guidelines	O	O	B-T170
for	O	O	O
systematic	O	O	B-T170
reviews	O	O	I-T170
in	O	O	O
order	O	O	O
to	O	O	O
summarize	O	O	O
and	O	O	O
present	O	O	O
the	O	O	O
evidence	O	O	O
base	O	O	O
for	O	O	O
clinical	O	O	B-T057
supervision	O	O	I-T057
in	O	O	O
cognitive-behavioral	O	O	B-T061
therapy	O	O	I-T061
and	O	O	O
may	O	O	O
aid	O	O	O
further	O	O	O
research	O	O	B-T062
and	O	O	O
discussion	O	O	O
in	O	O	O
this	O	O	O
area	O	O	O
.	O	O	O

PROSPERO	O	O	O
CRD42016046834	O	O	O
.	O	O	O

-DOCSTART- (28492106)

Higher	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
revision	O	O	B-T079
for	O	O	O
infection	O	O	B-T046
using	O	O	O
systemic	O	O	B-T169
clindamycin	O	O	B-T195
prophylaxis	O	O	B-T061
than	O	O	O
with	O	O	O
cloxacillin	O	O	O

Background	O	O	O
and	O	O	O
purpose	O	O	O
-	O	O	O
Clindamycin	O	O	B-T195
has	O	O	O
not	O	O	O
been	O	O	O
compared	O	O	O
with	O	O	O
other	O	O	O
antibiotics	O	O	B-T195
for	O	O	O
prophylaxis	O	O	B-T061
in	O	O	O
arthroplasty	O	O	B-T061
.	O	O	O

Since	O	O	O
2009	O	O	O
,	O	O	O
the	O	O	O
Swedish	O	O	B-T170
Knee	O	O	B-T061
Arthroplasty	O	O	I-T061
Register	O	O	I-T170
(	O	O	O
SKAR	O	O	B-T170
)	O	O	O
has	O	O	O
been	O	O	O
collecting	O	O	B-T169
information	O	O	B-T078
on	O	O	O
the	O	O	O
prophylactic	O	O	B-T061
antibiotic	O	O	I-T061
regime	O	O	I-T061
used	O	O	O
at	O	O	O
every	O	O	O
individual	O	O	B-T098
operation	O	O	B-T169
.	O	O	O

In	O	O	O
Sweden	O	O	B-T083
,	O	O	O
when	O	O	O
there	O	O	O
is	O	O	O
allergy	O	O	B-T046
to	O	O	O
penicillin	O	O	B-T195
,	O	O	O
clindamycin	O	O	B-T195
has	O	O	O
been	O	O	O
the	O	O	O
recommended	O	O	B-T078
alternative	O	O	B-T077
.	O	O	O

We	O	O	O
examined	O	O	O
whether	O	O	O
there	O	O	O
were	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
revision	O	O	B-T079
due	O	O	O
to	O	O	O
infection	O	O	B-T046
depending	O	O	O
on	O	O	O
which	O	O	O
antibiotic	O	O	B-T195
was	O	O	O
used	O	O	O
as	O	O	O
systemic	O	O	B-T169
prophylaxis	O	O	B-T061
.	O	O	O

Patients	O	O	B-T101
and	O	O	O
methods	O	O	O
-	O	O	O
Patients	O	O	O
who	O	O	O
had	O	O	O
a	O	O	O
total	O	O	B-T061
knee	O	O	I-T061
arthroplasty	O	O	I-T061
(	O	O	O
TKA	O	O	B-T061
)	O	O	O
performed	O	O	O
due	O	O	O
to	O	O	O
osteoarthritis	O	O	B-T047
(	O	O	O
OA	O	O	B-T047
)	O	O	O
during	O	O	O
the	O	O	O
years	O	O	O
2009	O	O	O
-	O	O	O
2015	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
study	O	O	O
.	O	O	O

Information	O	O	O
on	O	O	O
which	O	O	O
antibiotic	O	O	B-T195
was	O	O	O
used	O	O	O
was	O	O	O
available	O	O	O
for	O	O	O
80,018	O	O	O
operations	O	O	B-T169
(	O	O	O
55,530	O	O	O
patients	O	O	B-T101
)	O	O	O
.	O	O	O

Survival	O	O	B-T170
statistics	O	O	I-T170
were	O	O	O
used	O	O	O
to	O	O	O
calculate	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
revision	O	O	B-T079
due	O	O	O
to	O	O	O
infection	O	O	B-T046
until	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
2015	O	O	O
,	O	O	O
comparing	O	O	O
the	O	O	O
group	O	O	O
of	O	O	O
patients	O	O	B-T101
who	O	O	O
received	O	O	O
cloxacillin	O	O	B-T195
with	O	O	O
those	O	O	O
who	O	O	O
received	O	O	O
clindamycin	O	O	B-T195
as	O	O	O
systemic	O	O	B-T169
prophylaxis	O	O	B-T061
.	O	O	O

Results	O	O	O
-	O	O	O
Cloxacillin	O	O	B-T195
was	O	O	O
used	O	O	O
in	O	O	O
90	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
cases	O	O	O
,	O	O	O
clindamycin	O	O	B-T195
in	O	O	O
7	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
cephalosporins	O	O	B-T195
in	O	O	O
2	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
risk	O	O	O
of	O	O	O
being	O	O	O
revised	O	O	O
due	O	O	O
to	O	O	O
infection	O	O	B-T046
was	O	O	O
higher	O	O	O
when	O	O	O
clindamycin	O	O	B-T195
was	O	O	O
used	O	O	O
than	O	O	O
when	O	O	O
cloxacillin	O	O	B-T195
was	O	O	O
used	O	O	O
(	O	O	O
RR	O	O	O
=	O	O	O
1.5	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.2	O	O	O
-	O	O	O
2.0	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	O
difference	O	O	O
in	O	O	O
the	O	O	O
revision	O	O	B-T079
rate	O	O	O
for	O	O	O
other	O	O	O
causes	O	O	B-T169
(	O	O	O
p	O	O	O
=	O	O	O
0.2	O	O	O
)	O	O	O
.	O	O	O

Interpretation	O	O	B-T170
-	O	O	O
We	O	O	O
advise	O	O	O
that	O	O	O
patients	O	O	B-T101
reporting	O	O	O
allergic	O	O	B-T046
reaction	O	O	I-T046
to	O	O	O
penicillin	O	O	B-T195
should	O	O	O
have	O	O	O
their	O	O	O
allergic	O	O	B-T184
history	O	O	I-T184
explored	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
a	O	O	O
clear	O	O	O
history	O	O	B-T184
of	O	O	O
type-I	O	O	B-T046
allergic	O	O	I-T046
reaction	O	O	I-T046
(	O	O	O
e.g.	O	O	O
urticaria	O	O	B-T047
,	O	O	O
anaphylaxis	O	O	B-T047
,	O	O	O
or	O	O	O
bronchospasm	O	O	B-T047
)	O	O	O
,	O	O	O
we	O	O	O
suggest	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
a	O	O	O
third-generation	O	O	B-T195
cephalosporin	O	O	I-T195
instead	O	O	O
of	O	O	O
clindamycin	O	O	B-T195
as	O	O	O
perioperative	O	O	B-T079
prophylaxis	O	O	B-T061
when	O	O	O
undergoing	O	O	O
a	O	O	O
TKR	O	O	B-T061
.	O	O	O

No	O	O	O
recommendation	O	O	B-T078
can	O	O	O
be	O	O	O
given	O	O	O
regarding	O	O	O
patients	O	O	B-T101
with	O	O	O
type-1	O	O	B-T046
allergy	O	O	I-T046
.	O	O	O

-DOCSTART- (28492483)

PCVMZM	O	O	B-T062
:	O	O	O
Using	O	O	O
the	O	O	O
Probabilistic	O	O	B-T062
Classification	O	O	I-T062
Vector	O	O	I-T062
Machines	O	O	I-T062
Model	O	O	I-T062
Combined	O	O	I-T062
with	O	O	I-T062
a	O	O	I-T062
Zernike	O	O	I-T062
Moments	O	O	I-T062
Descriptor	O	O	O
to	O	O	O
Predict	O	O	B-T078
Protein-Protein	O	O	B-T044
Interactions	O	O	I-T044
from	O	O	O
Protein	O	O	O
Sequences	O	O	O

Protein-protein	O	O	B-T044
interactions	O	O	I-T044
(	O	O	O
PPIs	O	O	B-T044
)	O	O	O
are	O	O	O
essential	O	O	O
for	O	O	O
most	O	O	O
living	O	O	B-T001
organisms	O	O	I-T001
'	O	O	O
process	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
detecting	O	O	O
PPIs	O	O	B-T044
is	O	O	O
extremely	O	O	O
important	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
molecular	O	O	B-T080
mechanisms	O	O	B-T169
of	O	O	O
biological	O	O	B-T169
systems	O	O	I-T169
.	O	O	O

Although	O	O	O
many	O	O	O
PPIs	O	O	B-T044
data	O	O	O
have	O	O	O
been	O	O	O
generated	O	O	O
by	O	O	O
high-throughput	O	O	B-T170
technologies	O	O	I-T170
for	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
organisms	O	O	B-T001
,	O	O	O
the	O	O	O
whole	O	O	O
interatom	O	O	O
is	O	O	O
still	O	O	O
far	O	O	O
from	O	O	O
complete	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
high-throughput	O	O	B-T170
technologies	O	O	I-T170
for	O	O	O
detecting	O	O	O
PPIs	O	O	B-T044
has	O	O	O
some	O	O	O
unavoidable	O	O	B-T169
defects	O	O	I-T169
,	O	O	O
including	O	O	O
time	O	O	B-T079
consumption	O	O	I-T079
,	O	O	O
high	O	O	O
cost	O	O	B-T081
,	O	O	O
and	O	O	O
high	O	O	O
error	O	O	B-T081
rate	O	O	I-T081
.	O	O	O

In	O	O	O
recent	O	O	O
years	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
machine	O	O	B-T066
learning	O	O	I-T066
,	O	O	O
computational	O	O	B-T062
methods	O	O	I-T062
have	O	O	O
been	O	O	O
broadly	O	O	O
used	O	O	O
to	O	O	O
predict	O	O	O
PPIs	O	O	B-T044
,	O	O	O
and	O	O	O
can	O	O	O
achieve	O	O	O
good	O	O	O
prediction	O	O	B-T078
rate	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
here	O	O	O
PCVMZM	O	O	B-T062
,	O	O	O
a	O	O	O
computational	O	O	B-T062
method	O	O	I-T062
based	O	O	O
on	O	O	O
a	O	O	O
Probabilistic	O	O	B-T081
Classification	O	O	I-T081
Vector	O	O	I-T081
Machines	O	O	I-T081
(	O	O	I-T081
PCVM	O	O	I-T081
)	O	O	I-T081
model	O	O	I-T081
and	O	O	O
Zernike	O	O	B-T081
moments	O	O	I-T081
(	O	O	I-T081
ZM	O	O	I-T081
)	O	O	I-T081
descriptor	O	O	I-T081
for	O	O	O
predicting	O	O	B-T078
the	O	O	O
PPIs	O	O	B-T044
from	O	O	O
protein	O	O	B-T116
amino	O	O	B-T087
acids	O	O	I-T087
sequences	O	O	I-T087
.	O	O	O

Specifically	O	O	O
,	O	O	O
a	O	O	O
Zernike	O	O	B-T081
moments	O	O	I-T081
(	O	O	I-T081
ZM	O	O	I-T081
)	O	O	I-T081
descriptor	O	O	I-T081
is	O	O	O
used	O	O	O
to	O	O	O
extract	O	O	O
protein	O	O	B-T116
evolutionary	O	O	O
information	O	O	B-T078
from	O	O	O
Position-Specific	O	O	B-T081
Scoring	O	O	I-T081
Matrix	O	O	I-T081
(	O	O	O
PSSM	O	O	B-T081
)	O	O	O
generated	O	O	O
by	O	O	O
Position-Specific	O	O	B-T170
Iterated	O	O	I-T170
Basic	O	O	I-T170
Local	O	O	I-T170
Alignment	O	O	I-T170
Search	O	O	I-T170
Tool	O	O	I-T170
(	O	O	I-T170
PSI-BLAST	O	O	I-T170
)	O	O	I-T170
.	O	O	O

Then	O	O	O
,	O	O	O
PCVM	O	O	B-T081
classifier	O	O	I-T081
is	O	O	O
used	O	O	O
to	O	O	O
infer	O	O	O
the	O	O	O
interactions	O	O	B-T044
among	O	O	O
protein	O	O	B-T116
.	O	O	O

When	O	O	O
performed	O	O	O
on	O	O	O
PPIs	O	O	B-T044
datasets	O	O	O
of	O	O	O
Yeast	O	O	B-T004
and	O	O	O
H.	O	O	B-T007
Pylori	O	O	I-T007
,	O	O	O
the	O	O	O
proposed	O	O	O
method	O	O	O
can	O	O	O
achieve	O	O	O
the	O	O	O
average	O	O	O
prediction	O	O	B-T078
accuracy	O	O	B-T080
of	O	O	O
94.48	O	O	O
%	O	O	O
and	O	O	O
91.25	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
further	O	O	O
evaluate	O	O	O
the	O	O	O
performance	O	O	O
of	O	O	O
the	O	O	O
proposed	O	O	O
method	O	O	O
,	O	O	O
the	O	O	O
state-of-the-art	O	O	B-T170
support	O	O	B-T081
vector	O	O	I-T081
machines	O	O	I-T081
(	O	O	O
SVM	O	O	B-T081
)	O	O	I-T081
classifier	O	O	I-T081
is	O	O	O
used	O	O	O
and	O	O	O
compares	O	O	O
with	O	O	O
the	O	O	O
PCVM	O	O	B-T081
model	O	O	I-T081
.	O	O	O

Experimental	O	O	B-T033
results	O	O	I-T033
on	O	O	O
the	O	O	O
Yeast	O	O	B-T004
dataset	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
performance	O	O	O
of	O	O	O
PCVM	O	O	B-T081
classifier	O	O	I-T081
is	O	O	O
better	O	O	O
than	O	O	O
that	O	O	O
of	O	O	O
SVM	O	O	B-T081
classifier	O	O	I-T081
.	O	O	O

The	O	O	O
experimental	O	O	B-T033
results	O	O	I-T033
indicate	O	O	O
that	O	O	O
our	O	O	O
proposed	O	O	O
method	O	O	O
is	O	O	O
robust	O	O	O
,	O	O	O
powerful	O	O	O
and	O	O	O
feasible	O	O	O
,	O	O	O
which	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
helpful	O	O	O
tool	O	O	O
for	O	O	O
proteomics	O	O	B-T062
research	O	O	I-T062
.	O	O	O

-DOCSTART- (28493125)

Conditional	O	O	B-T080
Knockdown	O	O	B-T063
of	O	O	O
Endogenous	O	O	B-T169
MicroRNAs	O	O	B-T114
in	O	O	O
CHO	O	O	B-T025
Cells	O	O	I-T025
Using	O	O	O
TET-ON-SanDI	O	O	O
Sponge	O	O	O
Vectors	O	O	O

MicroRNAs	O	O	B-T114
(	O	O	O
miRNAs	O	O	B-T114
)	O	O	O
are	O	O	O
small	O	O	O
,	O	O	O
noncoding	O	O	B-T114
RNAs	O	O	I-T114
of	O	O	O
about	O	O	O
22	O	O	O
nucleotides	O	O	B-T114
in	O	O	O
length	O	O	O
and	O	O	O
have	O	O	O
proven	O	O	O
to	O	O	O
be	O	O	O
useful	O	O	O
targets	O	O	B-T169
for	O	O	O
genetic	O	O	B-T063
modifications	O	O	I-T063
for	O	O	O
desirable	O	O	O
phenotype	O	O	B-T032
in	O	O	O
the	O	O	O
biotech	O	O	B-T091
industry	O	O	B-T057
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
constitutively	O	O	O
expressed	O	O	O
"	O	O	O
miRNA	O	O	B-T114
sponge	O	O	I-T114
"	O	O	I-T114
vectors	O	O	I-T114
in	O	O	O
which	O	O	O
multiple	O	O	O
,	O	O	O
tandem	O	O	B-T114
miRNA	O	O	I-T114
binding	O	O	B-T192
sites	O	O	I-T192
containing	O	O	O
transcripts	O	O	B-T114
are	O	O	O
transcriptionally	O	O	B-T045
regulated	O	O	I-T045
by	O	O	O
a	O	O	O
constitutive	O	O	O
promoter	O	O	B-T114
for	O	O	O
down	O	O	B-T044
regulating	O	O	I-T044
the	O	O	O
levels	O	O	O
of	O	O	O
endogenous	O	O	B-T169
microRNAs	O	O	B-T114
in	O	O	O
Chinese	O	O	B-T025
hamster	O	O	I-T025
ovary	O	O	I-T025
(	O	O	I-T025
CHO	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
has	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
more	O	O	O
advantageous	O	O	O
than	O	O	O
using	O	O	O
synthetic	O	O	O
antisense	O	O	B-T114
oligonucleotides	O	O	I-T114
.	O	O	O

The	O	O	O
application	O	O	O
of	O	O	O
miRNA	O	O	B-T114
sponges	O	O	I-T114
in	O	O	O
biotechnological	O	O	B-T091
processes	O	O	B-T067
,	O	O	O
however	O	O	O
,	O	O	O
could	O	O	O
be	O	O	O
more	O	O	O
effective	O	O	B-T080
,	O	O	O
if	O	O	O
expression	O	O	B-T045
of	O	O	O
miRNA	O	O	O
sponges	O	O	O
could	O	O	O
be	O	O	O
tuned	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
chapter	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
a	O	O	O
method	O	O	O
for	O	O	O
the	O	O	O
generation	O	O	O
of	O	O	O
stable	O	O	O
CHO	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
expressing	O	O	B-T045
a	O	O	O
TET-ON-SanDI-miRNA-sponge	O	O	B-T114
that	O	O	O
is	O	O	O
in	O	O	O
theory	O	O	O
expressed	O	O	O
only	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
an	O	O	O
inducer	O	O	B-T167
.	O	O	O

-DOCSTART- (28494421)

Forest	O	O	B-T070
protected	O	O	B-T083
areas	O	O	I-T083
governance	O	O	B-T080
in	O	O	O
Zimbabwe	O	O	B-T083
:	O	O	O
Shift	O	O	B-T067
needed	O	O	O
away	O	O	O
from	O	O	O
a	O	O	O
long	O	O	B-T033
history	O	O	I-T033
of	O	O	O
local	O	O	B-T082
community	O	O	B-T096
exclusion	O	O	O

In	O	O	O
this	O	O	O
literature	O	O	O
review	O	O	O
based	O	O	O
paper	O	O	O
we	O	O	O
explored	O	O	O
the	O	O	O
concept	O	O	B-T078
of	O	O	O
exclusion	O	O	B-T052
of	O	O	O
local	O	O	B-T082
communities	O	O	B-T096
from	O	O	O
accessing	O	O	B-T078
resources	O	O	B-T078
in	O	O	O
forest	O	O	B-T070
protected	O	O	B-T083
areas	O	O	I-T083
(	O	O	O
FPAs	O	O	B-T083
)	O	O	O
in	O	O	O
Zimbabwe	O	O	B-T083
.	O	O	O

We	O	O	O
discussed	O	O	O
the	O	O	O
colonial	O	O	B-T170
and	O	O	O
post	O	O	B-T079
-	O	O	O
colonial	O	O	B-T170
forms	O	O	I-T170
,	O	O	O
causes	O	O	O
and	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
exclusion	O	O	B-T052
and	O	O	O
their	O	O	O
social	O	O	B-T078
,	O	O	O
economic	O	O	B-T081
and	O	O	O
ecological	O	O	B-T077
outcomes	O	O	I-T077
.	O	O	O

We	O	O	O
examined	O	O	B-T033
the	O	O	O
range	O	O	B-T081
of	O	O	O
powers	O	O	B-T068
embodied	O	O	O
in	O	O	O
and	O	O	O
exercised	O	O	O
through	O	O	O
various	O	O	O
mechanisms	O	O	O
,	O	O	O
processes	O	O	B-T067
and	O	O	O
social	O	O	B-T054
relations	O	O	I-T054
and	O	O	O
their	O	O	O
impact	O	O	B-T080
on	O	O	O
local	O	O	B-T082
communities	O	O	B-T096
'	O	O	O
access	O	O	B-T078
to	O	O	O
FPA	O	O	B-T083
resources	O	O	B-T078
and	O	O	O
associated	O	O	O
benefits	O	O	B-T081
along	O	O	O
the	O	O	O
historical	O	O	B-T079
trajectory	O	O	B-T169
of	O	O	O
forest	O	O	B-T070
governance	O	O	B-T080
in	O	O	O
Zimbabwe	O	O	B-T083
.	O	O	O

Results	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
forms	O	O	B-T080
and	O	O	O
extent	O	O	B-T082
of	O	O	O
exclusion	O	O	B-T052
changed	O	O	B-T081
over	O	O	B-T079
time	O	O	B-T079
in	O	O	O
tandem	O	O	O
with	O	O	O
the	O	O	O
shifting	O	O	B-T169
political	O	O	B-T078
and	O	O	O
economic	O	O	B-T064
landscape	O	O	I-T064
.	O	O	O

During	O	O	O
the	O	O	O
colonial	O	O	B-T079
period	O	O	I-T079
,	O	O	O
it	O	O	O
was	O	O	O
total	O	O	O
exclusion	O	O	B-T052
whereby	O	O	O
people	O	O	B-T098
were	O	O	O
evicted	O	O	B-T052
from	O	O	O
forest	O	O	B-T070
land	O	O	B-T073
as	O	O	O
well	O	O	O
as	O	O	O
being	O	O	O
denied	O	O	B-T080
access	O	O	B-T078
to	O	O	O
basic	O	O	B-T169
resources	O	O	B-T078
for	O	O	O
their	O	O	O
livelihoods	O	O	O
.	O	O	O

Local	O	O	B-T082
communities	O	O	B-T096
'	O	O	O
access	O	O	B-T078
to	O	O	O
low	O	O	B-T080
value	O	O	B-T081
FPA	O	O	B-T083
resources	O	O	B-T078
improved	O	O	B-T033
during	O	O	O
the	O	O	O
post-colonial	O	O	B-T079
period	O	O	I-T079
but	O	O	O
access	O	O	O
to	O	O	O
high	O	O	B-T080
value	O	O	O
resources	O	O	O
like	O	O	O
commercial	O	O	B-T167
timber	O	O	I-T167
as	O	O	O
well	O	O	O
as	O	O	O
sharing	O	O	B-T054
income	O	O	B-T081
benefits	O	O	B-T081
derived	O	O	B-T080
from	O	O	O
FPA	O	O	O
commercial	O	O	B-T052
activities	O	O	I-T052
remained	O	O	O
a	O	O	O
pipe	O	O	B-T077
dream	O	O	I-T077
.	O	O	O

Regulation	O	O	B-T064
,	O	O	O
legitimation	O	O	B-T064
,	O	O	O
force	O	O	O
and	O	O	O
markets	O	O	O
constituted	O	O	O
the	O	O	O
mixture	O	O	O
of	O	O	O
the	O	O	O
power	O	O	O
elements	O	O	O
that	O	O	O
FPA	O	O	B-T083
governing	O	O	B-T080
authorities	O	O	B-T054
used	O	O	O
to	O	O	O
exclude	O	O	B-T052
local	O	O	B-T082
communities	O	O	B-T096
.	O	O	O

These	O	O	O
powers	O	O	O
remained	O	O	O
intact	O	O	B-T080
despite	O	O	O
attempts	O	O	O
at	O	O	O
collaborative	O	O	B-T054
governance	O	O	B-T080
in	O	O	O
the	O	O	O
1990s	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
from	O	O	O
the	O	O	O
year	O	O	O
2000	O	O	O
,	O	O	O
local	O	O	B-T082
communities	O	O	B-T096
expressed	O	O	B-T055
their	O	O	O
dissatisfaction	O	O	B-T041
with	O	O	O
the	O	O	O
centralised	O	O	B-T064
exclusionary	O	O	I-T064
governance	O	O	I-T064
system	O	O	I-T064
by	O	O	O
invading	O	O	O
the	O	O	O
FPAs	O	O	B-T083
rendering	O	O	O
them	O	O	O
ungovernable	O	O	B-T033
.	O	O	O

There	O	O	O
is	O	O	O
therefore	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
policy	O	O	B-T170
reform	O	O	B-T169
within	O	O	O
the	O	O	O
FPA	O	O	B-T083
sector	O	O	B-T083
to	O	O	O
improve	O	O	B-T033
the	O	O	O
current	O	O	B-T079
dire	O	O	B-T067
situation	O	O	I-T067
.	O	O	O

-DOCSTART- (28495504)

Renal	O	O	B-T047
arterial	O	O	I-T047
mycotic	O	O	I-T047
aneurysm	O	O	I-T047
after	O	O	O
kidney	O	O	O
transplantation	O	O	O

Mycotic	O	O	B-T047
aneurysm	O	O	I-T047
is	O	O	O
a	O	O	O
rare	O	O	O
condition	O	O	O
mostly	O	O	O
attributable	O	O	B-T078
to	O	O	O
Candida	O	O	B-T004
or	O	O	O
Aspergillus	O	O	B-T004
species	O	O	I-T004
.	O	O	O

About	O	O	O
20	O	O	O
cases	O	O	O
of	O	O	O
Candida	O	O	B-T004
-related	O	O	O
arteritis	O	O	B-T046
have	O	O	O
been	O	O	O
reported	O	O	O
in	O	O	O
kidney	O	O	B-T061
transplant	O	O	I-T061
patients	O	O	B-T101
.	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
report	O	O	B-T170
the	O	O	O
case	O	O	O
of	O	O	O
a	O	O	O
40-year-	O	O	O
old	O	O	O
man	O	O	O
who	O	O	O
received	O	O	O
a	O	O	O
kidney	O	O	B-T023
from	O	O	O
a	O	O	O
deceased	O	O	O
donor	O	O	B-T098
in	O	O	O
whom	O	O	O
an	O	O	O
accidental	O	O	B-T169
digestive	O	O	B-T037
wound	O	O	I-T037
was	O	O	O
made	O	O	O
during	O	O	O
organ	O	O	B-T058
retrieval	O	O	I-T058
.	O	O	O

He	O	O	O
presented	O	O	O
with	O	O	O
sudden	O	O	O
anuria	O	O	B-T047
47	O	O	O
days	O	O	O
after	O	O	O
renal	O	O	B-T061
transplantation	O	O	I-T061
revealing	O	O	O
a	O	O	O
large	O	O	O
mycotic	O	O	B-T047
aneurysm	O	O	I-T047
of	O	O	O
the	O	O	O
kidney	O	O	B-T024
graft	O	O	I-T024
renal	O	O	B-T023
artery	O	O	I-T023
.	O	O	O

Organs	O	O	B-T023
derived	O	O	O
from	O	O	O
donors	O	O	B-T098
in	O	O	O
whom	O	O	O
a	O	O	O
digestive	O	O	B-T037
breach	O	O	I-T037
is	O	O	O
noticed	O	O	O
should	O	O	O
be	O	O	O
used	O	O	B-T169
with	O	O	I-T169
caution	O	O	I-T169
.	O	O	O

-DOCSTART- (28496002)

Risk	O	O	B-T081
of	O	O	I-T081
cancer	O	O	I-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
who	O	O	O
use	O	O	O
digoxin	O	O	B-T109
:	O	O	O
a	O	O	O
10-year	O	O	O
follow-up	O	O	B-T062
study	O	O	I-T062
and	O	O	O
cell	O	O	B-T025
-based	O	O	O
verification	O	O	O

Heart	O	O	B-T047
failure	O	O	I-T047
(	O	O	O
HF	O	O	B-T047
)	O	O	O
is	O	O	O
the	O	O	O
leading	O	O	O
cause	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
in	O	O	O
the	O	O	O
world	O	O	B-T098
and	O	O	O
digoxin	O	O	B-T109
remains	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
oldest	O	O	O
therapies	O	O	B-T061
for	O	O	O
HF	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
its	O	O	O
safety	O	O	B-T068
and	O	O	O
efficacy	O	O	B-T080
have	O	O	O
been	O	O	O
controversial	O	O	O
since	O	O	O
its	O	O	O
initial	O	O	O
use	O	O	B-T169
and	O	O	O
there	O	O	O
is	O	O	O
uncertainty	O	O	B-T033
about	O	O	O
its	O	O	O
long-term	O	O	B-T079
efficacy	O	O	O
and	O	O	O
safety	O	O	O
.	O	O	O

Recently	O	O	O
,	O	O	O
the	O	O	O
repositioning	O	O	B-T061
of	O	O	O
cardiac	O	O	B-T109
glycosides	O	O	I-T109
is	O	O	O
to	O	O	O
function	O	O	B-T169
in	O	O	O
anti-tumor	O	O	B-T061
activity	O	O	I-T061
via	O	O	O
multiple	O	O	B-T081
working	O	O	B-T077
pathways	O	O	I-T077
.	O	O	O

It	O	O	O
is	O	O	O
interesting	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
potential	O	O	B-T080
effects	O	O	B-T080
of	O	O	O
digoxin	O	O	B-T109
in	O	O	O
clinical	O	O	B-T080
patients	O	O	B-T101
and	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
.	O	O	O

First	O	O	O
,	O	O	O
we	O	O	O
analyze	O	O	O
patient	O	O	B-T170
information	O	O	I-T170
retrieved	O	O	O
from	O	O	O
the	O	O	O
National	O	O	B-T170
Health	O	O	I-T170
Insurance	O	O	I-T170
Research	O	O	I-T170
database	O	O	I-T170
of	O	O	O
Taiwan	O	O	B-T083
between	O	O	O
January	O	O	O
1	O	O	O
,	O	O	O
2000	O	O	O
and	O	O	O
December	O	O	O
31	O	O	O
,	O	O	O
2000	O	O	O
.	O	O	O

This	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
included	O	O	O
a	O	O	O
study	O	O	O
cohort	O	O	B-T098
(	O	O	O
1,219	O	O	O
patients	O	O	B-T101
)	O	O	O
and	O	O	O
a	O	O	O
comparison	O	O	B-T052
cohort	O	O	O
.	O	O	O

Our	O	O	O
analytical	O	O	B-T078
data	O	O	I-T078
suggested	O	O	O
that	O	O	O
patients	O	O	B-T101
taking	O	O	O
digoxin	O	O	B-T109
are	O	O	O
at	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T081
of	O	O	I-T081
cancers	O	O	I-T081
,	O	O	O
including	O	O	O
breast	O	O	B-T191
,	O	O	O
liver	O	O	B-T191
,	O	O	O
and	O	O	O
lung	O	O	B-T191
cancers	O	O	I-T191
,	O	O	O
during	O	O	O
the	O	O	O
10-year	O	O	O
follow-up	O	O	B-T058
period	O	O	I-T058
.	O	O	O

In	O	O	O
contrast	O	O	O
to	O	O	O
the	O	O	O
anti-tumor	O	O	B-T061
function	O	O	I-T061
of	O	O	O
digoxin	O	O	B-T109
,	O	O	O
we	O	O	O
further	O	O	O
examined	O	O	O
the	O	O	O
potential	O	O	B-T080
pathway	O	O	B-T169
of	O	O	O
digoxin	O	O	O
via	O	O	O
the	O	O	O
cell	O	O	B-T025
-based	O	O	O
strategy	O	O	B-T041
using	O	O	O
several	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
cell	O	O	B-T025
lines	O	O	I-T025
,	O	O	O
including	O	O	O
MCF-7	O	O	B-T025
,	O	O	O
BT-474	O	O	B-T025
,	O	O	O
MAD-MB-231	O	O	B-T025
,	O	O	O
and	O	O	O
ZR-75	O	O	B-T025
-	O	O	I-T025
1	O	O	I-T025
.	O	O	O

Digoxin	O	O	B-T109
consistently	O	O	O
exerted	O	O	O
its	O	O	O
cytotoxicity	O	O	B-T049
to	O	O	O
these	O	O	O
four	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
with	O	O	O
various	O	O	O
range	O	O	O
of	O	O	O
concentration	O	O	B-T081
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
proliferation	O	O	B-T169
of	O	O	O
ZR-75	O	O	B-T025
-	O	O	I-T025
1	O	O	I-T025
cells	O	O	I-T025
was	O	O	O
the	O	O	O
only	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
induced	O	O	O
by	O	O	O
digoxin	O	O	B-T109
and	O	O	O
the	O	O	O
others	O	O	O
were	O	O	O
dramatically	O	O	O
suppressed	O	O	B-T169
by	O	O	O
digoxin	O	O	O
.	O	O	O

The	O	O	O
responsiveness	O	O	B-T169
of	O	O	O
SRSF3	O	O	B-T028
to	O	O	O
digoxin	O	O	B-T109
might	O	O	O
be	O	O	O
involved	O	O	O
with	O	O	O
cell-type	O	O	B-T170
differences	O	O	B-T080
.	O	O	O

In	O	O	O
summary	O	O	O
,	O	O	O
we	O	O	O
combined	O	O	O
a	O	O	O
cohort	O	O	B-T081
study	O	O	I-T081
for	O	O	O
digoxin	O	O	B-T109
treatment	O	O	B-T061
for	O	O	O
HF	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
a	O	O	O
cell	O	O	B-T025
-based	O	O	O
strategy	O	O	B-T041
that	O	O	O
addresses	O	O	O
the	O	O	O
translation	O	O	O
issue	O	O	O
,	O	O	O
which	O	O	O
revealed	O	O	O
the	O	O	O
complexity	O	O	B-T080
of	O	O	O
personalized	O	O	B-T061
medicine	O	O	I-T061
.	O	O	O

-DOCSTART- (28496419)

Comparison	O	O	O
and	O	O	O
Outcome	O	O	O
Analysis	O	O	B-T058
of	O	O	I-T058
Patients	O	O	I-T058
with	O	O	O
Takotsubo	O	O	B-T047
Cardiomyopathy	O	O	I-T047
Triggered	O	O	B-T080
by	O	O	I-T080
Emotional	O	O	B-T048
Stress	O	O	I-T048
or	O	O	O
Physical	O	O	O
Stress	O	O	O

Background	O	O	O
:	O	O	O
Previous	O	O	O
studies	O	O	O
revealed	O	O	O
that	O	O	O
takotsubo	O	O	B-T047
cardiomyopathy	O	O	I-T047
(	O	O	O
TTC	O	O	B-T047
)	O	O	O
is	O	O	O
triggered	O	O	B-T080
by	O	O	I-T080
physical	O	O	B-T046
and	O	O	O
emotional	O	O	B-T048
stresses	O	O	I-T048
.	O	O	O

This	O	O	O
study	O	O	O
was	O	O	O
performed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
short-	O	O	B-T079
and	O	O	O
long-term	O	O	B-T079
prognostic	O	O	O
impact	O	O	O
of	O	O	O
emotional-	O	O	B-T048
and	O	O	O
physical	O	O	B-T046
stress	O	O	I-T046
associated	O	O	B-T080
with	O	O	I-T080
TTC	O	O	B-T047
.	O	O	O

Methods	O	O	O
and	O	O	O
results	O	O	O
:	O	O	O
Our	O	O	O
institutional	O	O	B-T170
database	O	O	I-T170
constituted	O	O	O
a	O	O	O
collective	O	O	O
of	O	O	O
84	O	O	O
patients	O	O	B-T101
diagnosed	O	O	B-T033
with	O	O	O
TTC	O	O	B-T047
between	O	O	O
2003	O	O	O
and	O	O	O
2015	O	O	O
.	O	O	O

The	O	O	O
patients	O	O	B-T101
were	O	O	O
divided	O	O	O
into	O	O	O
two	O	O	O
groups	O	O	B-T078
as	O	O	O
per	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
emotional	O	O	B-T048
stress	O	O	I-T048
(	O	O	O
n	O	O	O
=	O	O	O
24	O	O	O
,	O	O	O
21	O	O	O
%	O	O	O
)	O	O	O
or	O	O	O
physical	O	O	B-T046
stress	O	O	I-T046
(	O	O	O
n	O	O	O
=	O	O	O
60	O	O	O
,	O	O	O
52.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
endpoint	O	O	B-T080
was	O	O	O
a	O	O	O
composite	O	O	B-T080
of	O	O	O
in-hospital	O	O	B-T033
events	O	O	I-T033
(	O	O	O
thromboembolic	O	O	B-T046
events	O	O	I-T046
and	O	O	O
life-threatening	O	O	B-T033
arrhythmias	O	O	B-T033
)	O	O	O
,	O	O	O
myocardial	O	O	B-T047
infarction	O	O	I-T047
,	O	O	O
all-	O	O	O
cause	O	O	B-T033
of	O	O	I-T033
mortality	O	O	I-T033
,	O	O	O
re-hospitalization	O	O	B-T058
due	O	O	O
to	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
,	O	O	O
stroke	O	O	B-T047
,	O	O	O
and	O	O	O
recurrence	O	O	B-T067
of	O	O	O
TTC	O	O	B-T047
.	O	O	O

A	O	O	O
Kaplan-Meier	O	O	B-T081
analysis	O	O	I-T081
indicated	O	O	O
a	O	O	O
significantly	O	O	O
lower	O	O	O
event-free	O	O	O
survival	O	O	B-T081
rate	O	O	I-T081
over	O	O	O
a	O	O	O
mean	O	O	O
follow-up	O	O	B-T058
of	O	O	O
5	O	O	O
years	O	O	O
in	O	O	O
the	O	O	O
emotional	O	O	B-T048
group	O	O	B-T078
than	O	O	O
the	O	O	O
physical	O	O	B-T046
stress	O	O	I-T046
group	O	O	O
(	O	O	O
log-rank	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Multivariate	O	O	B-T170
Cox	O	O	I-T170
regression	O	O	I-T170
analysis	O	O	I-T170
revealed	O	O	O
only	O	O	O
emotional	O	O	B-T048
stress	O	O	I-T048
(	O	O	O
HR	O	O	O
0.4	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.2	O	O	O
-	O	O	O
0.9	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
as	O	O	O
a	O	O	O
negative	O	O	B-T033
independent	O	O	I-T033
predictor	O	O	I-T033
of	O	O	O
the	O	O	O
primary	O	O	O
endpoint	O	O	B-T080
.	O	O	O

Conclusion	O	O	O
:	O	O	O
Rates	O	O	O
of	O	O	O
in-hospital	O	O	B-T033
events	O	O	I-T033
and	O	O	O
short-	O	O	B-T079
as	O	O	O
well	O	O	O
as	O	O	O
long-term	O	O	B-T079
events	O	O	O
were	O	O	O
significantly	O	O	O
lower	O	O	O
in	O	O	O
TTC	O	O	B-T047
patients	O	O	B-T101
suffering	O	O	B-T048
from	O	O	O
emotional	O	O	B-T048
stress	O	O	I-T048
as	O	O	O
compared	O	O	O
to	O	O	O
patients	O	O	O
with	O	O	O
physical	O	O	B-T046
stress	O	O	I-T046
.	O	O	O

-DOCSTART- (28497887)

Surviving	O	O	B-T169
moment	O	O	B-T079
to	O	O	O
moment	O	O	O
:	O	O	O
The	O	O	O
experience	O	O	B-T041
of	O	O	O
living	O	O	B-T078
in	O	O	O
a	O	O	O
state	O	O	B-T033
of	O	O	O
ambivalence	O	O	B-T041
for	O	O	O
those	O	O	O
with	O	O	O
recurrent	O	O	B-T079
suicide	O	O	O
attempts	O	O	O

This	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
aimed	O	O	O
to	O	O	O
capture	O	O	O
the	O	O	O
experience	O	O	B-T041
of	O	O	O
living	O	O	B-T078
in	O	O	O
the	O	O	O
ambivalent	O	O	B-T041
space	O	O	I-T041
between	O	O	O
life	O	O	B-T078
and	O	O	O
death	O	O	B-T078
for	O	O	O
adults	O	O	B-T100
with	O	O	O
recurrent	O	O	B-T079
suicide	O	O	B-T033
attempts	O	O	I-T033
(	O	O	O
RSA	O	O	B-T033
)	O	O	O
.	O	O	O

It	O	O	O
sought	O	O	O
to	O	O	O
expand	O	O	B-T082
upon	O	O	O
an	O	O	O
earlier	O	O	O
study	O	O	B-T062
that	O	O	O
explored	O	O	O
the	O	O	O
processes	O	O	B-T041
involved	O	O	B-T169
in	O	O	O
transitioning	O	O	B-T052
away	O	O	O
from	O	O	O
RSA	O	O	B-T033
among	O	O	O
adults	O	O	B-T100
,	O	O	O
which	O	O	O
revealed	O	O	B-T080
that	O	O	O
occupying	O	O	O
this	O	O	O
ambivalent	O	O	B-T041
space	O	O	I-T041
is	O	O	O
a	O	O	O
crucial	O	O	O
part	O	O	O
of	O	O	O
this	O	O	O
process	O	O	B-T067
.	O	O	O

Interpretive	O	O	B-T062
phenomenological	O	O	I-T062
analysis	O	O	I-T062
(	O	O	O
IPA	O	O	B-T062
)	O	O	O
was	O	O	O
used	O	O	O
.	O	O	O

This	O	O	O
methodology	O	O	B-T078
was	O	O	O
designed	O	O	B-T052
to	O	O	O
explore	O	O	O
the	O	O	O
lived	O	O	B-T041
experiences	O	O	B-T041
and	O	O	O
meaning	O	O	B-T041
making	O	O	I-T041
and	O	O	O
enabled	O	O	O
interpretation	O	O	B-T062
of	O	O	O
the	O	O	O
multidimensional	O	O	B-T082
subjective	O	O	B-T080
experiences	O	O	O
of	O	O	O
RSA	O	O	B-T033
participants	O	O	B-T098
.	O	O	O

In-depth	O	O	O
semi-structured	O	O	B-UnknownType
interviews	O	O	I-UnknownType
were	O	O	O
conducted	O	O	B-T052
with	O	O	O
eight	O	O	O
adult	O	O	B-T098
women	O	O	I-T098
with	O	O	O
a	O	O	O
history	O	O	B-T169
of	O	O	O
RSA	O	O	B-T033
who	O	O	O
had	O	O	O
participated	O	O	B-T169
in	O	O	O
a	O	O	O
therapeutic	O	O	B-T061
intervention	O	O	I-T061
at	O	O	O
the	O	O	O
research	O	O	B-T062
site	O	O	B-T082
(	O	O	O
Skills	O	O	B-T055
for	O	O	O
Safer	O	O	B-T078
Living	O	O	I-T078
:	O	O	O
A	O	O	O
Psychosocial	O	O	B-T169
/	O	O	O
Psychoeducational	O	O	B-T065
Intervention	O	O	I-T065
for	O	O	O
People	O	O	B-T098
with	O	O	O
Recurrent	O	O	B-T079
Suicide	O	O	B-T033
Attempts	O	O	I-T033
[	O	O	O
SfSL	O	O	B-T078
/	O	O	O
PISA	O	O	B-T033
]	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
six	O	O	O
stages	O	O	B-T079
of	O	O	O
IPA	O	O	B-T062
were	O	O	O
followed	O	O	O
to	O	O	O
analyse	O	O	B-T062
the	O	O	O
interview	O	O	B-T058
data	O	O	B-T078
.	O	O	O

Analysis	O	O	B-T062
revealed	O	O	B-T080
the	O	O	O
superordinate	O	O	B-UnknownType
theme	O	O	I-UnknownType
,	O	O	O
'	O	O	O
surviving	O	O	B-T169
moment	O	O	B-T079
to	O	O	O
moment	O	O	O
'	O	O	O
,	O	O	O
which	O	O	O
refers	O	O	O
to	O	O	O
a	O	O	O
precarious	O	O	B-T033
state	O	O	I-T033
of	O	O	O
making	O	O	B-T041
decisions	O	O	I-T041
about	O	O	O
one	O	O	O
's	O	O	O
life	O	O	B-T078
and	O	O	O
destiny	O	O	B-T079
on	O	O	O
a	O	O	O
moment	O	O	O
-to-	O	O	O
moment	O	O	O
basis	O	O	O
without	O	O	O
clear	O	O	O
commitment	O	O	B-T041
to	O	O	O
either	O	O	O
life	O	O	O
or	O	O	O
death	O	O	B-T078
.	O	O	O

Two	O	O	O
subordinate	O	O	B-UnknownType
themes	O	O	I-UnknownType
were	O	O	O
identified	O	O	B-T080
:	O	O	O
'	O	O	O
deciding	O	O	B-T080
not	O	O	O
to	O	O	O
die	O	O	B-T033
in	O	O	O
the	O	O	O
moment	O	O	B-T079
'	O	O	O
when	O	O	O
the	O	O	O
participants	O	O	B-T098
were	O	O	O
more	O	O	O
invested	O	O	B-T169
in	O	O	O
dying	O	O	B-T033
than	O	O	O
living	O	O	B-T078
and	O	O	O
'	O	O	O
deciding	O	O	O
to	O	O	O
live	O	O	B-T078
in	O	O	O
the	O	O	O
moment	O	O	O
'	O	O	O
when	O	O	O
they	O	O	O
were	O	O	O
more	O	O	O
invested	O	O	O
in	O	O	O
living	O	O	O
than	O	O	O
dying	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
illuminated	O	O	O
the	O	O	O
complex	O	O	B-T080
process	O	O	B-T067
of	O	O	O
making	O	O	B-T041
decisions	O	O	I-T041
about	O	O	O
ones	O	O	O
'	O	O	O
destiny	O	O	B-T079
on	O	O	O
a	O	O	O
moment	O	O	B-T079
-to-	O	O	O
moment	O	O	O
basis	O	O	O
.	O	O	O

It	O	O	O
revealed	O	O	B-T080
the	O	O	O
torment	O	O	O
experienced	O	O	B-T041
when	O	O	O
occupying	O	O	O
this	O	O	O
state	O	O	B-T033
,	O	O	O
while	O	O	O
paradoxically	O	O	B-T080
,	O	O	O
also	O	O	O
revealing	O	O	O
how	O	O	O
indecision	O	O	B-T033
about	O	O	O
life	O	O	B-T078
and	O	O	O
death	O	O	B-T078
provided	O	O	B-T052
a	O	O	O
lifeline	O	O	B-T078
opportunity	O	O	B-T080
for	O	O	O
those	O	O	O
with	O	O	O
RSA	O	O	B-T033
.	O	O	O

Clinicians	O	O	B-T097
who	O	O	O
recognize	O	O	O
the	O	O	O
subtle	O	O	O
distinctions	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
this	O	O	O
in-between	O	O	O
state	O	O	B-T033
can	O	O	O
tailor	O	O	O
their	O	O	O
interventions	O	O	B-T061
accordingly	O	O	O
.	O	O	O

Surviving	O	O	B-T169
moment	O	O	B-T079
to	O	O	O
moment	O	O	O
is	O	O	O
characterized	O	O	B-T052
by	O	O	O
a	O	O	O
state	O	O	B-T033
of	O	O	O
emotional	O	O	B-T033
flux	O	O	I-T033
and	O	O	O
uncertainty	O	O	B-T033
about	O	O	O
one	O	O	O
's	O	O	O
destiny	O	O	B-T079
,	O	O	O
where	O	O	O
the	O	O	O
person	O	O	B-T098
has	O	O	O
not	O	O	O
fully	O	O	O
committed	O	O	O
to	O	O	O
either	O	O	O
life	O	O	B-T078
or	O	O	O
death	O	O	B-T078
.	O	O	O

Within	O	O	O
this	O	O	O
state	O	O	B-T033
,	O	O	O
there	O	O	O
are	O	O	O
two	O	O	O
interlinked	O	O	B-T041
subprocesses	O	O	I-T041
,	O	O	O
whereby	O	O	O
the	O	O	O
person	O	O	B-T098
is	O	O	O
leaning	O	O	B-T078
more	O	O	O
towards	O	O	O
death	O	O	B-T078
or	O	O	O
life	O	O	B-T078
.	O	O	O

A	O	O	O
critical	O	O	O
feature	O	O	B-T080
in	O	O	O
working	O	O	B-T057
with	O	O	O
this	O	O	O
client	O	O	B-T096
group	O	O	I-T096
is	O	O	O
to	O	O	O
recognize	O	O	O
their	O	O	O
ambiguity	O	O	B-T080
and	O	O	O
the	O	O	O
fragility	O	O	B-T033
and	O	O	O
temporality	O	O	B-T041
of	O	O	O
their	O	O	O
decisions	O	O	B-T041
about	O	O	O
their	O	O	O
destiny	O	O	B-T079
.	O	O	O

The	O	O	O
practitioner	O	O	B-T097
has	O	O	O
an	O	O	O
opportunity	O	O	B-T080
to	O	O	O
be	O	O	O
a	O	O	O
catalyst	O	O	O
in	O	O	O
the	O	O	O
momentum	O	O	O
towards	O	O	O
life	O	O	B-T078
by	O	O	O
demonstrating	O	O	O
understanding	O	O	B-T041
of	O	O	O
this	O	O	O
survival	O	O	B-T169
struggle	O	O	B-T033
and	O	O	O
tailoring	O	O	B-T061
intervention	O	O	I-T061
to	O	O	O
fit	O	O	O
with	O	O	O
the	O	O	O
nuanced	O	O	B-T041
processes	O	O	I-T041
within	O	O	O
this	O	O	O
state	O	O	B-T033
.	O	O	O

-DOCSTART- (28500997)

Does	O	O	O
a	O	O	O
policy	O	O	B-T170
of	O	O	O
earlier	O	O	B-T061
induction	O	O	I-T061
affect	O	O	O
labour	O	O	B-T040
outcomes	O	O	B-T169
in	O	O	O
women	O	O	B-T098
induced	O	O	B-T169
for	O	O	O
postmaturity	O	O	B-T047
?	O	O	O
A	O	O	O
retrospective	O	O	B-T080
analysis	O	O	B-T062
in	O	O	O
a	O	O	O
tertiary	O	O	B-T093
hospital	O	O	I-T093
in	O	O	O
the	O	O	O
North	O	O	B-T082
of	O	O	O
England	O	O	O

A	O	O	O
retrospective	O	O	B-T080
analysis	O	O	B-T062
in	O	O	O
a	O	O	O
tertiary	O	O	B-T093
hospital	O	O	I-T093
in	O	O	O
the	O	O	O
North	O	O	B-T082
of	O	O	O
England	O	O	B-T083
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
a	O	O	O
change	O	O	B-T169
in	O	O	O
the	O	O	O
management	O	O	B-T057
of	O	O	O
postmature	O	O	B-T046
pregnancy	O	O	I-T046
to	O	O	O
earlier	O	O	B-T061
induction	O	O	I-T061
affects	O	O	O
the	O	O	O
length	O	O	B-T201
of	O	O	I-T201
labour	O	O	I-T201
and	O	O	O
the	O	O	O
induction	O	O	B-T061
process	O	O	I-T061
.	O	O	O

Secondly	O	O	O
,	O	O	O
to	O	O	O
assess	O	O	B-T052
the	O	O	O
feasibility	O	O	B-T062
of	O	O	O
the	O	O	O
research	O	O	B-T062
process	O	O	I-T062
to	O	O	O
inform	O	O	O
a	O	O	O
future	O	O	B-T079
larger	O	O	B-T062
study	O	O	I-T062
.	O	O	O

a	O	O	O
change	O	O	B-T169
in	O	O	O
management	O	O	B-T057
of	O	O	O
postmature	O	O	B-T046
pregnancy	O	O	I-T046
in	O	O	O
an	O	O	O
NHS	O	O	B-T058
hospital	O	O	B-T093
in	O	O	O
October	O	O	B-T079
2013	O	O	O
,	O	O	O
from	O	O	O
induction	O	O	B-T061
at	O	O	O
42	O	O	O
weeks	O	O	B-T079
gestation	O	O	B-T040
to	O	O	O
induction	O	O	O
between	O	O	O
41	O	O	O
-	O	O	O
42	O	O	O
weeks	O	O	O
,	O	O	O
provided	O	O	B-T052
an	O	O	O
opportunity	O	O	B-T062
to	O	O	O
conduct	O	O	O
a	O	O	O
retrospective	O	O	B-T080
analysis	O	O	B-T062
.	O	O	O

Pre-existing	O	O	B-T080
data	O	O	B-T078
from	O	O	O
the	O	O	O
maternity	O	O	B-T054
database	O	O	B-T170
and	O	O	O
casenotes	O	O	B-T170
were	O	O	O
collected	O	O	B-T169
and	O	O	O
primary	O	O	B-T062
outcomes	O	O	I-T062
analysed	O	O	B-T062
using	O	O	O
the	O	O	O
Mann-Whitney	O	O	B-T170
test	O	O	I-T170
and	O	O	O
the	O	O	O
Hodges-Lehman	O	O	B-T081
confidence	O	O	I-T081
interval	O	O	I-T081
for	O	O	O
differences	O	O	B-T080
in	O	O	O
medians	O	O	B-T081
.	O	O	O

a	O	O	O
large	O	O	B-T083
city	O	O	I-T083
based	O	O	O
tertiary	O	O	B-T093
referral	O	O	I-T093
hospital	O	O	I-T093
in	O	O	O
the	O	O	O
North	O	O	B-T082
of	O	O	O
England	O	O	B-T083
.	O	O	O
125	O	O	O
women	O	O	B-T098
induced	O	O	B-T169
before	O	O	O
the	O	O	O
change	O	O	B-T169
in	O	O	O
policy	O	O	B-T170
were	O	O	O
compared	O	O	B-T052
with	O	O	O
309	O	O	O
women	O	O	O
induced	O	O	O
after	O	O	O
the	O	O	O
change	O	O	O
.	O	O	O

primary	O	O	B-T062
outcomes	O	O	I-T062
were	O	O	O
length	O	O	B-T081
of	O	O	O
1st	O	O	B-T079
and	O	O	O
2nd	O	O	B-T079
stage	O	O	I-T079
of	O	O	I-T079
labour	O	O	B-T040
,	O	O	O
overall	O	O	O
length	O	O	B-T201
of	O	O	I-T201
labour	O	O	I-T201
,	O	O	O
length	O	O	O
of	O	O	O
induction	O	O	B-T061
to	O	O	O
established	O	O	B-T080
labour	O	O	O
and	O	O	O
length	O	O	O
of	O	O	O
induction	O	O	O
to	O	O	O
birth	O	O	B-T040
.	O	O	O

the	O	O	O
median	O	O	B-T081
overall	O	O	O
length	O	O	B-T201
of	O	O	I-T201
labour	O	O	I-T201
for	O	O	O
women	O	O	B-T098
induced	O	O	B-T169
at	O	O	O
42	O	O	O
weeks	O	O	B-T079
was	O	O	O
6.5	O	O	O
hours	O	O	B-T079
,	O	O	O
while	O	O	O
for	O	O	O
women	O	O	O
induced	O	O	O
at	O	O	O
41	O	O	O
-	O	O	O
42	O	O	O
weeks	O	O	O
this	O	O	O
was	O	O	O
5.2	O	O	O
hours	O	O	O
.	O	O	O

The	O	O	O
difference	O	O	B-T080
was	O	O	O
not	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
(	O	O	O
p=0.15	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
for	O	O	O
median	O	O	B-T081
difference	O	O	O
-0.27	O	O	O
to	O	O	O
1.93	O	O	O
hours	O	O	B-T079
)	O	O	O
with	O	O	O
a	O	O	O
small	O	O	B-T081
effect	O	O	I-T081
size	O	O	I-T081
(	O	O	O
Pearson	O	O	B-T081
's	O	O	I-T081
r=-0.08	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
median	O	O	B-T081
length	O	O	B-T081
of	O	O	O
induction	O	O	B-T061
to	O	O	O
birth	O	O	B-T040
was	O	O	O
13.6	O	O	O
hours	O	O	B-T079
for	O	O	O
women	O	O	B-T098
induced	O	O	B-T169
at	O	O	O
42	O	O	O
weeks	O	O	B-T079
and	O	O	O
16.5	O	O	O
hours	O	O	O
for	O	O	O
women	O	O	O
induced	O	O	O
at	O	O	O
41	O	O	O
-	O	O	O
42	O	O	O
weeks	O	O	O
.	O	O	O

This	O	O	O
difference	O	O	B-T080
was	O	O	O
also	O	O	O
not	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
(	O	O	O
p=0.14	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
for	O	O	O
median	O	O	B-T081
difference	O	O	O
-7.25	O	O	O
to	O	O	O
1.20	O	O	O
hours	O	O	B-T079
)	O	O	O
with	O	O	O
a	O	O	O
small	O	O	B-T081
effect	O	O	I-T081
size	O	O	I-T081
(	O	O	O
Pearson	O	O	B-T081
's	O	O	I-T081
r=-0.13	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
demonstrated	O	O	O
no	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
difference	O	O	B-T080
s	O	O	O
in	O	O	O
length	O	O	B-T201
of	O	O	I-T201
labour	O	O	I-T201
and	O	O	O
induction	O	O	B-T061
following	O	O	O
a	O	O	O
change	O	O	B-T169
in	O	O	O
the	O	O	O
management	O	O	B-T057
of	O	O	O
postmature	O	O	B-T046
pregnancy	O	O	I-T046
to	O	O	O
earlier	O	O	B-T061
induction	O	O	I-T061
.	O	O	O

A	O	O	O
large	O	O	B-T062
study	O	O	I-T062
is	O	O	O
needed	O	O	O
to	O	O	O
establish	O	O	B-T080
definitively	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
earlier	O	O	B-T061
induction	O	O	I-T061
on	O	O	O
labour	O	O	B-T040
outcomes	O	O	B-T169
.	O	O	O

-DOCSTART- (28501006)

Liquid	O	O	B-T059
chromatography-mass	O	O	I-T059
spectrometry	O	O	I-T059
-based	O	O	O
quantitative	O	O	B-T059
proteomics	O	O	B-T091
analysis	O	O	I-T059
reveals	O	O	O
chondroprotective	O	O	B-T033
effects	O	O	I-T033
of	O	O	O
astragaloside	O	O	B-T109
IV	O	O	I-T109
in	O	O	O
interleukin-1β	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
SW1353	O	O	O
chondrocyte-like	O	O	O
cells	O	O	O

Chondrocyte	O	O	B-T025
apoptosis	O	O	B-T043
played	O	O	O
a	O	O	O
key	O	O	O
role	O	O	O
on	O	O	O
the	O	O	O
progression	O	O	B-T046
of	O	O	O
Osteoarthritis	O	O	B-T047
(	O	O	O
OA	O	O	B-T047
)	O	O	O
.	O	O	O

Safe	O	O	O
and	O	O	O
effective	O	O	O
drugs	O	O	B-T061
are	O	O	O
urgently	O	O	O
needed	O	O	O
for	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
OA	O	O	B-T047
.	O	O	O

Previous	O	O	O
study	O	O	B-T077
reported	O	O	O
that	O	O	O
Astragaloside	O	O	B-T109
IV	O	O	I-T109
(	O	O	O
ASG-IV	O	O	B-T109
)	O	O	O
had	O	O	O
exerted	O	O	O
a	O	O	O
protective	O	O	B-UnknownType
effect	O	O	I-UnknownType
against	O	O	O
articular	O	O	B-T047
cartilage	O	O	I-T047
degeneration	O	O	I-T047
by	O	O	O
promoting	O	O	O
rapid	O	O	O
proliferation	O	O	B-T169
of	O	O	O
chondrocyte	O	O	B-T025
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
our	O	O	O
study	O	O	B-T077
is	O	O	O
to	O	O	O
explore	O	O	O
the	O	O	O
effects	O	O	B-T169
and	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
ASG-IV	O	O	B-T109
in	O	O	O
chondrocyte	O	O	B-T025
apoptosis	O	O	B-T043
.	O	O	O

Isobaric	O	O	B-T059
Tags	O	O	I-T059
For	O	O	I-T059
Relative	O	O	I-T059
And	O	O	I-T059
Absolute	O	O	I-T059
Quantitation	O	O	I-T059
(iTRAQ)-based	O	O	I-T059
quantitative	O	O	I-T059
proteomics	O	O	B-T091
was	O	O	O
used	O	O	O
to	O	O	O
quantitatively	O	O	O
detect	O	O	B-T033
and	O	O	O
map	O	O	B-T052
proteins	O	O	B-T116
in	O	O	O
SW1353	O	O	B-T025
chondrocyte-like	O	O	I-T025
cells	O	O	I-T025
pre-treated	O	O	B-T169
with	O	O	O
ASG-IV	O	O	B-T109
or	O	O	O
interleukin-1β	O	O	B-T116
(	O	O	O
IL-1β	O	O	B-T116
)	O	O	O
or	O	O	O
ASG-IV	O	O	O
+	O	O	O
IL-1β	O	O	O
.	O	O	O

The	O	O	O
iTRAQ-labeled	O	O	B-T116
peptides	O	O	I-T116
were	O	O	O
fractionated	O	O	B-T080
by	O	O	O
high-accuracy	O	O	B-T059
liquid	O	O	I-T059
chromatography-mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	O
LC-MS	O	O	B-T059
)	O	O	O
.	O	O	O

Cell	O	O	B-T043
apoptosis	O	O	I-T043
and	O	O	O
differentially	O	O	B-T116
expressed	O	O	I-T116
proteins	O	O	I-T116
was	O	O	O
detected	O	O	B-T033
by	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
(	O	O	O
FCM	O	O	B-T059
)	O	O	O
,	O	O	O
quantitative	O	O	B-T063
real-time	O	O	I-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(	O	O	O
qRT-PCR	O	O	B-T063
)	O	O	O
,	O	O	O
and	O	O	O
western	O	O	B-T059
blotting	O	O	I-T059
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
apoptosis	O	O	B-T043
of	O	O	O
the	O	O	O
IL-1β	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
SW1353	O	O	B-T025
cells	O	O	I-T025
treated	O	O	B-T169
with	O	O	O
ASG-IV	O	O	B-T109
was	O	O	O
greatly	O	O	O
inhibited	O	O	B-T080
.	O	O	O

Bioinformatics	O	O	B-T091
analysis	O	O	O
revealed	O	O	O
that	O	O	O
gamma	O	O	B-T116
actin	O	O	I-T116
1	O	O	I-T116
(	O	O	O
ACTG1	O	O	B-T116
)	O	O	O
and	O	O	O
Yes	O	O	B-T116
Associated	O	O	I-T116
Protein	O	O	I-T116
1	O	O	I-T116
(	O	O	O
YAP1	O	O	B-T116
)	O	O	O
,	O	O	O
participating	O	O	O
in	O	O	O
the	O	O	O
Hippo	O	O	B-T043
signaling	O	O	I-T043
pathway	O	O	I-T043
and	O	O	O
Vitronectin	O	O	B-T116
(	O	O	O
VTN	O	O	B-T116
)	O	O	O
and	O	O	O
Collagen	O	O	B-T116
Type	O	O	I-T116
I	O	O	I-T116
Alpha	O	O	I-T116
1	O	O	I-T116
Chain	O	O	I-T116
(	O	O	O
COL1A1	O	O	B-T116
)	O	O	O
,	O	O	O
involving	O	O	O
in	O	O	O
the	O	O	O
extracellular	O	O	B-T169
matrix	O	O	I-T169
(ECM)-receptor	O	O	I-T169
interaction	O	O	I-T169
signaling	O	O	I-T169
pathway	O	O	I-T169
,	O	O	O
were	O	O	O
all	O	O	O
significantly	O	O	O
up-regulated	O	O	B-T044
in	O	O	O
the	O	O	O
IL-1β	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
SW1353	O	O	B-T025
cells	O	O	I-T025
after	O	O	O
treatment	O	O	B-T169
with	O	O	O
ASG-IV	O	O	B-T109
.	O	O	O

The	O	O	O
qRT-PCR	O	O	B-T063
and	O	O	O
Western	O	O	B-T059
blotting	O	O	I-T059
results	O	O	O
confirmed	O	O	O
the	O	O	O
up-regulation	O	O	B-T044
of	O	O	O
these	O	O	O
four	O	O	O
genes	O	O	B-T028
.	O	O	O

ASG-IV	O	O	B-T109
played	O	O	O
a	O	O	O
positive	O	O	B-T033
role	O	O	I-T033
in	O	O	O
human	O	O	B-T016
osteoarthritic	O	O	B-T043
chondrocyte	O	O	B-T025
apoptosis	O	O	I-T043
,	O	O	O
possibly	O	O	O
through	O	O	O
modulation	O	O	B-UnknownType
of	O	O	O
the	O	O	O
Hippo	O	O	B-T043
signaling	O	O	I-T043
pathway	O	O	I-T043
by	O	O	O
up-regulating	O	O	B-T044
YAP1	O	O	B-T116
and	O	O	O
ACTG1	O	O	B-T116
expression	O	O	B-T045
,	O	O	O
and	O	O	O
also	O	O	O
by	O	O	O
up-regulating	O	O	O
VTN	O	O	B-T116
and	O	O	O
COL1A1	O	O	B-T116
,	O	O	O
which	O	O	O
are	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
ECM-receptor	O	O	B-T169
interaction	O	O	I-T169
pathway	O	O	I-T169
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
all	O	O	O
the	O	O	O
results	O	O	O
suggested	O	O	O
that	O	O	O
ASG-IV	O	O	B-T109
had	O	O	O
a	O	O	O
novel	O	O	O
therapeutic	O	O	B-T169
potential	O	O	B-T080
for	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
OA	O	O	B-T047
.	O	O	O

-DOCSTART- (28501764)

Open-label	O	O	B-T062
,	O	O	I-T062
multicentre	O	O	I-T062
safety	O	O	I-T062
study	O	O	I-T062
of	O	O	O
vemurafenib	O	O	B-T109
in	O	O	O
3219	O	O	O
patients	O	O	B-T101
with	O	O	O
BRAF(V600	O	O	B-T049
)	O	O	I-T049
mutation	O	O	I-T049
-	O	O	O
positive	O	O	B-T033
metastatic	O	O	B-T191
melanoma	O	O	I-T191
:	O	O	O
2-year	O	O	O
follow-up	O	O	B-T058
data	O	O	B-T078
and	O	O	O
long-term	O	O	B-T079
responders	O	O	O
'	O	O	O
analysis	O	O	O

The	O	O	O
orally	O	O	B-T082
available	O	O	O
BRAF	O	O	B-T116
kinase	O	O	I-T116
inhibitor	O	O	I-T116
vemurafenib	O	O	B-T109
is	O	O	O
an	O	O	O
effective	O	O	B-T080
and	O	O	O
tolerable	O	O	B-T080
treatment	O	O	B-T061
option	O	O	I-T061
for	O	O	O
patients	O	O	B-T101
with	O	O	O
metastatic	O	O	B-T191
melanoma	O	O	I-T191
harbouring	O	O	O
BRAF(V600	O	O	B-T049
)	O	O	I-T049
mutations	O	O	I-T049
.	O	O	O

We	O	O	O
assessed	O	O	B-T052
the	O	O	O
safety	O	O	B-T080
of	O	O	O
vemurafenib	O	O	B-T109
in	O	O	O
a	O	O	O
large	O	O	B-T081
population	O	O	B-T098
of	O	O	O
patients	O	O	B-T101
with	O	O	O
few	O	O	O
alternative	O	O	B-T077
treatment	O	O	B-T061
options	O	O	I-T061
;	O	O	O
we	O	O	O
report	O	O	O
updated	O	O	O
2-year	O	O	O
safety	O	O	O
.	O	O	O

This	O	O	O
was	O	O	O
an	O	O	O
open-label	O	O	B-T062
,	O	O	I-T062
multicentre	O	O	I-T062
study	O	O	I-T062
of	O	O	O
vemurafenib	O	O	B-T109
(	O	O	O
960	O	O	O
mg	O	O	O
bid	O	O	O
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
previously	O	O	O
treated	O	O	B-T169
or	O	O	O
untreated	O	O	B-T033
BRAF	O	O	B-T049
mutation	O	O	I-T049
-	O	O	O
positive	O	O	B-T033
metastatic	O	O	B-T191
melanoma	O	O	I-T191
(	O	O	O
cobas	O	O	B-T074
(	O	O	I-T074
®	O	O	I-T074
)	O	O	I-T074
4800	O	O	I-T074
BRAF	O	O	B-T059
V600	O	O	I-T059
Mutation	O	O	I-T059
Test	O	O	I-T059
)	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	B-T080
end-point	O	O	B-T080
was	O	O	O
safety	O	O	B-T080
;	O	O	O
efficacy	O	O	O
end-points	O	O	B-T080
were	O	O	O
secondary	O	O	B-T080
.	O	O	O

An	O	O	O
exploratory	O	O	B-T062
analysis	O	O	I-T062
was	O	O	O
performed	O	O	O
to	O	O	O
assess	O	O	B-T058
safety	O	O	B-T080
outcomes	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
long	O	O	B-T080
duration	O	O	B-T079
of	O	O	I-T079
response	O	O	I-T079
(	O	O	O
DOR	O	O	B-T079
)	O	O	O
(	O	O	O
≥12	O	O	O
or	O	O	O
≥24	O	O	O
months	O	O	B-T079
)	O	O	O
.	O	O	O

After	O	O	O
a	O	O	O
median	O	O	B-T082
follow-up	O	O	B-T058
of	O	O	O
32.2	O	O	O
months	O	O	B-T079
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
31.1	O	O	O
-	O	O	O
33.2	O	O	O
months	O	O	O
)	O	O	O
,	O	O	O
3079/3219	O	O	O
patients	O	O	B-T101
(	O	O	O
96	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
discontinued	O	O	B-T033
treatment	O	O	I-T033
.	O	O	O

Adverse	O	O	B-T046
events	O	O	I-T046
(	O	O	O
AEs	O	O	B-T046
)	O	O	O
were	O	O	O
largely	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
previous	O	O	O
reports	O	O	O
;	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
all-grade	O	O	O
treatment	O	O	B-T169
-related	O	O	O
AEs	O	O	O
were	O	O	O
arthralgia	O	O	B-T184
(	O	O	O
37	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
alopecia	O	O	B-T047
(	O	O	O
25	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
hyperkeratosis	O	O	B-T047
(	O	O	O
23	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
grade	O	O	O
3/4	O	O	O
treatment	O	O	O
-related	O	O	O
AEs	O	O	O
were	O	O	O
squamous	O	O	B-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
of	O	O	I-T191
the	O	O	I-T191
skin	O	O	I-T191
(	O	O	O
8	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
keratoacanthoma	O	O	B-T191
(	O	O	O
8	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
exploratory	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
patients	O	O	B-T101
with	O	O	O
DOR	O	O	B-T079
≥12	O	O	O
months	O	O	B-T079
(	O	O	O
n	O	O	O
=	O	O	O
287	O	O	O
)	O	O	O
or	O	O	O
≥24	O	O	O
months	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
133	O	O	O
)	O	O	O
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
experience	O	O	O
grade	O	O	O
3/4	O	O	O
AEs	O	O	B-T046
than	O	O	O
the	O	O	O
overall	O	O	B-T080
population	O	O	B-T098
.	O	O	O

No	O	O	O
new	O	O	O
specific	O	O	B-T080
safety	O	O	B-T073
signals	O	O	I-T073
were	O	O	O
observed	O	O	O
with	O	O	O
longer	O	O	O
vemurafenib	O	O	B-T109
exposure	O	O	O
.	O	O	O

After	O	O	O
2	O	O	O
years	O	O	O
'	O	O	O
follow-up	O	O	B-T058
,	O	O	O
safety	O	O	B-T080
was	O	O	O
maintained	O	O	O
in	O	O	O
this	O	O	O
large	O	O	B-UnknownType
group	O	O	I-UnknownType
of	O	O	O
patients	O	O	B-T101
with	O	O	O
BRAF(V600	O	O	B-T049
)	O	O	I-T049
mutation	O	O	I-T049
-	O	O	O
positive	O	O	B-T033
metastatic	O	O	B-T191
melanoma	O	O	I-T191
who	O	O	O
are	O	O	O
more	O	O	O
representative	O	O	O
of	O	O	O
routine	O	O	O
clinical	O	O	B-T057
practice	O	O	I-T057
than	O	O	O
typical	O	O	O
clinical	O	O	B-T062
trial	O	O	I-T062
populations	O	O	B-T098
.	O	O	O

These	O	O	O
data	O	O	O
suggest	O	O	O
that	O	O	O
long-term	O	O	B-T079
vemurafenib	O	O	B-T109
treatment	O	O	B-T169
is	O	O	O
effective	O	O	B-T080
and	O	O	O
tolerable	O	O	B-T080
without	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
new	O	O	O
safety	O	O	B-T073
signals	O	O	I-T073
.	O	O	O

-DOCSTART- (28502812)

Collecting	O	O	B-T062
and	O	O	O
Reporting	O	O	B-T062
Safety	O	O	I-T062
Data	O	O	I-T062
and	O	O	O
Monitoring	O	O	B-T062
Trial	O	O	I-T062
Conduct	O	O	I-T062
In	O	O	O
Pragmatic	O	O	O
Trials	O	O	O

Pragmatic	O	O	B-T062
trials	O	O	I-T062
offer	O	O	O
the	O	O	O
opportunity	O	O	B-T062
to	O	O	O
obtain	O	O	O
real-life	O	O	B-T078
data	O	O	B-T078
on	O	O	O
the	O	O	O
relative	O	O	O
effectiveness	O	O	B-T080
and	O	O	O
safety	O	O	B-T068
of	O	O	O
a	O	O	O
treatment	O	O	B-T061
before	O	O	O
or	O	O	O
after	O	O	O
market	O	O	B-T064
authorisation	O	O	I-T064
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
penultimate	O	O	B-T078
paper	O	O	I-T078
in	O	O	O
a	O	O	O
series	O	O	O
of	O	O	O
eight	O	O	O
,	O	O	O
describing	O	O	O
the	O	O	O
impact	O	O	O
of	O	O	O
design	O	O	B-T090
choices	O	O	B-T052
on	O	O	O
the	O	O	O
practical	O	O	O
implementation	O	O	B-T052
of	O	O	O
pragmatic	O	O	B-T062
trials	O	O	I-T062
.	O	O	O

This	O	O	O
paper	O	O	B-T078
focuses	O	O	O
on	O	O	O
the	O	O	O
practical	O	O	O
challenges	O	O	O
of	O	O	O
collecting	O	O	B-T062
and	O	O	O
reporting	O	O	B-T062
safety	O	O	I-T062
data	O	O	I-T062
and	O	O	O
of	O	O	O
monitoring	O	O	B-T062
trial	O	O	I-T062
conduct	O	O	I-T062
while	O	O	O
maintaining	O	O	O
routine	O	O	O
clinical	O	O	B-T061
care	O	O	I-T061
practice	O	O	I-T061
.	O	O	O

Current	O	O	O
ICH	O	O	B-T170
guidance	O	O	O
recommends	O	O	O
that	O	O	O
,	O	O	O
all	O	O	O
serious	O	O	B-T033
adverse	O	O	I-T033
events	O	O	I-T033
(	O	O	O
SAEs	O	O	B-T033
)	O	O	O
and	O	O	O
all	O	O	O
drug	O	O	B-T121
-related	O	O	O
events	O	O	O
must	O	O	O
be	O	O	O
reported	O	O	O
in	O	O	O
an	O	O	O
interventional	O	O	B-T061
trial	O	O	B-T062
.	O	O	O

In	O	O	O
line	O	O	O
with	O	O	O
current	O	O	O
guidance	O	O	O
,	O	O	O
we	O	O	O
propose	O	O	O
a	O	O	O
risk	O	O	B-T078
based	O	O	O
approach	O	O	B-T082
to	O	O	O
the	O	O	O
collection	O	O	B-T062
of	O	O	O
non	O	O	B-T033
-	O	O	O
drug	O	O	B-T121
related	O	O	O
non-serious	O	O	B-T033
AEs	O	O	I-T033
,	O	O	O
and	O	O	O
even	O	O	O
serious	O	O	B-T080
events	O	O	I-T080
not	O	O	O
related	O	O	O
to	O	O	O
treatment	O	O	B-T061
based	O	O	O
on	O	O	O
the	O	O	O
risk	O	O	O
profile	O	O	B-T169
of	O	O	O
the	O	O	O
medicine	O	O	B-T121
/class	O	O	O
in	O	O	O
the	O	O	O
patient	O	O	B-T101
population	O	O	B-T098
of	O	O	O
interest	O	O	O
.	O	O	O

Different	O	O	O
options	O	O	O
available	O	O	O
to	O	O	O
support	O	O	O
the	O	O	O
collection	O	O	B-T062
and	O	O	O
reporting	O	O	B-T062
of	O	O	I-T062
safety	O	O	I-T062
data	O	O	I-T062
whilst	O	O	O
minimizing	O	O	O
study	O	O	B-T062
-related	O	O	O
follow-up	O	O	B-T058
visits	O	O	I-T058
are	O	O	O
discussed	O	O	O
.	O	O	O

A	O	O	O
risk	O	O	B-T078
-based	O	O	O
approach	O	O	B-T082
to	O	O	O
monitoring	O	O	B-T062
trial	O	O	I-T062
conduct	O	O	I-T062
is	O	O	O
also	O	O	O
discussed	O	O	O
,	O	O	O
highlighting	O	O	O
the	O	O	O
difference	O	O	O
in	O	O	O
the	O	O	O
balance	O	O	O
of	O	O	O
risks	O	O	B-T078
likely	O	O	O
to	O	O	O
occur	O	O	O
in	O	O	O
a	O	O	O
pragmatic	O	O	B-T062
trial	O	O	I-T062
compared	O	O	O
to	O	O	O
traditional	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
,	O	O	O
and	O	O	O
the	O	O	O
careful	O	O	O
consideration	O	O	O
that	O	O	O
must	O	O	O
be	O	O	O
given	O	O	O
to	O	O	O
the	O	O	O
mitigation	O	O	B-T067
and	O	O	O
management	O	O	B-T058
of	O	O	I-T058
these	O	O	I-T058
risks	O	O	I-T058
in	O	O	O
order	O	O	O
to	O	O	O
maintain	O	O	O
routine	O	O	O
care	O	O	B-T052
.	O	O	O

-DOCSTART- (28503431)

A	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
of	O	O	O
intraocular	O	O	B-T061
lens	O	O	I-T061
explantation	O	O	I-T061
in	O	O	O
69	O	O	O
eyes	O	O	B-T023
in	O	O	O
Chinese	O	O	O
patients	O	O	O

To	O	O	O
study	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
intraocular	O	O	B-T061
lens	O	O	I-T061
(	O	O	I-T061
IOL	O	O	I-T061
)	O	O	I-T061
explantation	O	O	I-T061
and	O	O	O
demographic	O	O	B-T102
characteristics	O	O	I-T102
.	O	O	O

Retrospective	O	O	B-T080
non-comparative	O	O	B-T062
case	O	O	I-T062
series	O	O	I-T062
.	O	O	O

Clinical	O	O	B-T170
data	O	O	I-T170
recorded	O	O	O
from	O	O	O
patient	O	O	B-T073
charts	O	O	I-T073
included	O	O	O
the	O	O	O
following	O	O	O
:	O	O	O
demographic	O	O	B-T102
,	O	O	O
preoperative	O	O	B-T058
and	O	O	O
postoperative	O	O	B-T079
characteristics	O	O	B-T080
;	O	O	O
complications	O	O	B-T046
;	O	O	O
surgical	O	O	B-UnknownType
methods	O	O	I-UnknownType
,	O	O	O
and	O	O	O
changes	O	O	O
in	O	O	O
visual	O	O	B-T060
acuity	O	O	I-T060
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
69	O	O	O
eyes	O	O	B-T023
in	O	O	O
67	O	O	O
Chinese	O	O	B-T098
patients	O	O	B-T101
who	O	O	O
received	O	O	O
IOL	O	O	B-T061
explants	O	O	I-T061
were	O	O	O
studied	O	O	O
.	O	O	O

The	O	O	O
patients	O	O	B-T101
'	O	O	O
mean	O	O	O
age	O	O	B-T032
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	I-T079
explantation	O	O	I-T079
was	O	O	O
46.1	O	O	O
years	O	O	O
old	O	O	O
[	O	O	O
SD	O	O	O
22.5	O	O	O
(	O	O	O
6	O	O	O
-	O	O	O
85	O	O	O
)	O	O	O
]	O	O	O
,	O	O	O
and	O	O	O
37	O	O	O
patients	O	O	B-T032
were	O	O	I-T032
female	O	O	I-T032
(	O	O	O
55.2	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Regarding	O	O	O
employment	O	O	B-T080
,	O	O	O
47.8	O	O	O
%	O	O	O
were	O	O	O
farmers	O	O	B-T097
,	O	O	O
23.9	O	O	O
%	O	O	O
were	O	O	O
retired	O	O	B-T097
,	O	O	O
16.4	O	O	O
%	O	O	O
were	O	O	O
students	O	O	B-T098
,	O	O	O
4.5	O	O	O
%	O	O	O
were	O	O	O
unemployed	O	O	B-T033
,	O	O	O
3	O	O	O
%	O	O	O
were	O	O	O
workers	O	O	B-T098
,	O	O	O
and	O	O	O
4.5	O	O	O
%	O	O	O
were	O	O	O
other	O	O	O
(	O	O	O
including	O	O	O
staff	O	O	B-T097
members	O	O	I-T097
,	O	O	O
teachers	O	O	B-T097
and	O	O	O
officers	O	O	B-T078
)	O	O	O
.	O	O	O

The	O	O	O
main	O	O	O
reasons	O	O	O
for	O	O	O
explantation	O	O	B-T061
were	O	O	O
dislocation	O	O	B-T037
/	O	O	O
decentration	O	O	B-T033
in	O	O	O
41	O	O	O
cases	O	O	O
(	O	O	O
59.4	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
retinal	O	O	B-T047
detachment	O	O	I-T047
in	O	O	O
10	O	O	O
cases	O	O	O
(	O	O	O
14.5	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
third	O	O	O
most	O	O	O
prevalent	O	O	B-T169
cause	O	O	I-T169
was	O	O	O
incorrect	O	O	B-T033
lens	O	O	I-T033
power	O	O	I-T033
in	O	O	O
7	O	O	O
eyes	O	O	B-T023
(	O	O	O
10.1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
remaining	O	O	O
reasons	O	O	O
were	O	O	O
endophthalmitis	O	O	B-T047
in	O	O	O
6	O	O	O
cases	O	O	O
(	O	O	O
8.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
posterior	O	O	B-T047
capsular	O	O	I-T047
opacity	O	O	I-T047
in	O	O	O
3	O	O	O
eyes	O	O	B-T023
(	O	O	O
4.3	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
impacting	O	O	B-T080
retinal	O	O	B-T061
surgery	O	O	I-T061
operation	O	O	I-T061
in	O	O	O
2	O	O	O
cases	O	O	O
(	O	O	O
2.9	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
main	O	O	O
comorbidities	O	O	B-T078
were	O	O	O
high	O	O	B-T047
myopia	O	O	I-T047
in	O	O	O
18	O	O	O
eyes	O	O	B-T023
(	O	O	O
26.1	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
trauma	O	O	B-T037
in	O	O	O
8	O	O	O
eyes	O	O	O
(	O	O	O
11.6	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
retinal	O	O	B-T047
detachment	O	O	I-T047
in	O	O	O
6	O	O	O
eyes	O	O	O
(	O	O	O
8.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
congenital	O	O	B-T019
cataracts	O	O	I-T019
in	O	O	O
8	O	O	O
eyes	O	O	O
(	O	O	O
11.6	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
Marfan	O	O	B-T047
's	O	O	I-T047
syndrome	O	O	I-T047
in	O	O	O
2	O	O	O
eyes	O	O	O
(	O	O	O
2.9	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T079
time	O	O	I-T079
from	O	O	I-T079
implantation	O	O	I-T079
to	O	O	I-T079
explantation	O	O	I-T079
was	O	O	O
4.0y	O	O	O
[	O	O	O
SD	O	O	O
4.2	O	O	O
(	O	O	O
0.005	O	O	O
-	O	O	O
15	O	O	O
)	O	O	O
]	O	O	O
.	O	O	O

Treatment	O	O	B-T058
after	O	O	I-T058
explantation	O	O	I-T058
included	O	O	O
posterior	O	O	B-T061
chamber	O	O	I-T061
IOL	O	O	I-T061
implantation	O	O	I-T061
in	O	O	O
44	O	O	O
eyes	O	O	B-T023
(	O	O	O
63.8	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
aphakia	O	O	B-T190
in	O	O	O
25	O	O	O
eyes	O	O	O
(	O	O	O
36.2	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

After	O	O	B-T033
surgery	O	O	I-T033
,	O	O	O
the	O	O	O
best	O	O	B-T033
corrected	O	O	I-T033
visual	O	O	B-T201
ability	O	O	I-T201
(	O	O	O
BCVA	O	O	B-T033
)	O	O	O
was	O	O	O
improved	O	O	O
in	O	O	O
50	O	O	O
cases	O	O	O
(	O	O	O
72.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
including	O	O	O
28	O	O	O
patients	O	O	B-T101
(	O	O	O
40.6	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
whom	O	O	O
visual	O	O	O
ability	O	O	O
was	O	O	O
improved	O	O	O
by	O	O	O
more	O	O	O
than	O	O	O
two	O	O	O
lines	O	O	O
.	O	O	O

Dislocation	O	O	B-T037
/	O	O	O
decentration	O	O	B-T033
is	O	O	O
the	O	O	O
main	O	O	B-T169
cause	O	O	I-T169
for	O	O	O
explantation	O	O	B-T061
,	O	O	O
and	O	O	O
high	O	O	B-T047
myopia	O	O	I-T047
is	O	O	O
a	O	O	O
main	O	O	B-T033
risk	O	O	I-T033
factor	O	O	I-T033
.	O	O	O

Posterior	O	O	B-T061
chamber	O	O	I-T061
IOL	O	O	I-T061
implantation	O	O	I-T061
remains	O	O	O
the	O	O	O
most	O	O	O
elected	O	O	O
treatment	O	O	B-T058
after	O	O	I-T058
explantation	O	O	I-T058
.	O	O	O

-DOCSTART- (28505472)

Improvement	O	O	B-T077
of	O	O	O
older	O	O	B-T098
-	O	O	O
person	O	O	B-T098
-	O	O	O
specific	O	O	B-T080
QOL	O	O	B-T078
after	O	O	O
hearing	O	O	B-T074
aid	O	O	I-T074
fitting	O	O	B-T061
and	O	O	O
its	O	O	O
relation	O	O	B-T080
to	O	O	O
social	O	O	O
interaction	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	B-T078
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
hearing	O	O	B-T074
aids	O	O	I-T074
use	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
improvement	O	O	B-T077
of	O	O	O
older	O	O	B-T098
-	O	O	O
person	O	O	B-T098
-	O	O	O
specific	O	O	B-T080
QOL	O	O	B-T078
and	O	O	O
whether	O	O	O
social	O	O	B-T033
interactions	O	O	I-T033
modify	O	O	B-T169
the	O	O	O
association	O	O	B-T080
.	O	O	O

The	O	O	O
WHOQOL-OLD	O	O	B-T170
questionnaire	O	O	I-T170
was	O	O	O
answered	O	O	B-T170
by	O	O	O
105	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
aged	O	O	B-T032
60	O	O	O
to	O	O	O
90	O	O	O
years	O	O	O
who	O	O	O
were	O	O	O
newly	O	O	B-T078
fitted	O	O	B-T061
hearing	O	O	B-T074
aids	O	O	I-T074
on	O	O	O
the	O	O	O
day	O	O	O
of	O	O	O
fitting	O	O	B-T061
and	O	O	O
at	O	O	O
2	O	O	O
-	O	O	O
6	O	O	O
months	O	O	O
afterward	O	O	B-T079
.	O	O	O

The	O	O	O
associations	O	O	B-T080
between	O	O	O
the	O	O	O
daily	O	O	O
hours	O	O	O
of	O	O	O
hearing	O	O	B-T074
aid	O	O	I-T074
usage	O	O	B-T169
and	O	O	O
social	O	O	B-UnknownType
relations	O	O	I-UnknownType
with	O	O	O
changes	O	O	B-T169
in	O	O	O
the	O	O	O
WHOQOL-OLD	O	O	B-T170
total	O	O	B-T081
score	O	O	I-T081
after	O	O	O
hearing	O	O	B-T074
aids	O	O	I-T074
fitting	O	O	B-T061
were	O	O	O
estimated	O	O	B-T081
adjusting	O	O	B-T061
for	O	O	O
possible	O	O	B-T033
confounders	O	O	B-T169
.	O	O	O

Older	O	O	B-T098
persons	O	O	B-T098
with	O	O	O
hearing	O	O	B-T033
loss	O	O	I-T033
experienced	O	O	B-T052
significant	O	O	B-T078
increases	O	O	B-T169
in	O	O	O
WHOQOL-OLD	O	O	B-T170
total	O	O	B-T081
score	O	O	I-T081
after	O	O	O
hearing	O	O	B-T074
aid	O	O	I-T074
fitting	O	O	B-T061
.	O	O	O

Regular	O	O	B-T080
use	O	O	B-T169
of	O	O	I-T169
hearing	O	O	B-T074
aid	O	O	I-T074
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
greater	O	O	B-T081
increase	O	O	B-T169
in	O	O	O
the	O	O	O
total	O	O	B-T081
score	O	O	I-T081
.	O	O	O

The	O	O	O
combined	O	O	B-T080
categorical	O	O	B-T170
variable	O	O	B-T080
of	O	O	O
social	O	O	B-UnknownType
relations	O	O	I-UnknownType
and	O	O	O
hearing	O	O	B-T074
aid	O	O	I-T074
usage	O	O	B-T169
revealed	O	O	B-T080
no	O	O	O
separate	O	O	B-T080
effects	O	O	B-T080
of	O	O	O
these	O	O	O
two	O	O	O
variables	O	O	B-T080
,	O	O	O
but	O	O	O
a	O	O	O
combined	O	O	O
effect	O	O	B-T080
;	O	O	O
only	O	O	O
those	O	O	O
with	O	O	O
frequent	O	O	B-T079
social	O	O	B-T033
interactions	O	O	I-T033
who	O	O	O
used	O	O	O
their	O	O	O
hearing	O	O	O
aid	O	O	O
regularly	O	O	B-T080
had	O	O	O
a	O	O	O
significantly	O	O	B-T078
greater	O	O	B-T081
increase	O	O	B-T169
in	O	O	O
WHOQOL-OLD	O	O	B-T170
total	O	O	B-T081
score	O	O	I-T081
.	O	O	O

This	O	O	O
study	O	O	B-T062
's	O	O	I-T062
findings	O	O	B-T169
indicate	O	O	B-T080
that	O	O	O
hearing	O	O	B-T039
aid	O	O	I-T074
fitting	O	O	B-T061
may	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
subsequent	O	O	B-T079
improvement	O	O	B-T077
in	O	O	O
older	O	O	B-T098
-	O	O	O
person	O	O	B-T098
-	O	O	O
specific	O	O	B-T080
QOL	O	O	B-T078
by	O	O	O
improvements	O	O	B-T077
in	O	O	O
hearing	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
hearing	O	O	B-T074
aid	O	O	I-T074
,	O	O	O
and	O	O	O
possibly	O	O	B-T033
enhanced	O	O	B-T052
communication	O	O	B-T054
opportunities	O	O	B-T080
.	O	O	O

-DOCSTART- (28506958)

Enhancing	O	O	O
Comparative	O	O	B-T062
Effectiveness	O	O	I-T062
Research	O	O	I-T062
With	O	O	O
Automated	O	O	B-T169
Pediatric	O	O	B-T080
Pneumonia	O	O	B-T047
Detection	O	O	B-T061
in	O	O	O
a	O	O	O
Multi-Institutional	O	O	B-T093
Clinical	O	O	B-T080
Repository	O	O	B-T073
:	O	O	O
A	O	O	O
PHIS	O	O	B-T170
+	O	O	O
Pilot	O	O	O
Study	O	O	O

Community-acquired	O	O	B-T047
pneumonia	O	O	I-T047
is	O	O	O
a	O	O	O
leading	O	O	O
cause	O	O	O
of	O	O	O
pediatric	O	O	B-T080
morbidity	O	O	B-T081
.	O	O	O

Administrative	O	O	B-T169
data	O	O	B-T078
are	O	O	O
often	O	O	O
used	O	O	O
to	O	O	O
conduct	O	O	O
comparative	O	O	B-T062
effectiveness	O	O	I-T062
research	O	O	I-T062
(	O	O	O
CER	O	O	B-T062
)	O	O	O
with	O	O	O
sufficient	O	O	O
sample	O	O	B-T081
sizes	O	O	I-T081
to	O	O	O
enhance	O	O	O
detection	O	O	B-T033
of	O	O	O
important	O	O	B-T080
outcomes	O	O	B-T169
.	O	O	O

However	O	O	O
,	O	O	O
such	O	O	O
studies	O	O	O
are	O	O	O
prone	O	O	O
to	O	O	O
misclassification	O	O	B-T080
errors	O	O	I-T080
because	O	O	O
of	O	O	O
the	O	O	O
variable	O	O	B-T080
accuracy	O	O	B-T080
of	O	O	O
discharge	O	O	B-T033
diagnosis	O	O	I-T033
codes	O	O	B-T170
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
develop	O	O	O
an	O	O	O
automated	O	O	B-T169
,	O	O	O
scalable	O	O	B-T169
,	O	O	O
and	O	O	O
accurate	O	O	B-T080
method	O	O	B-T170
to	O	O	O
determine	O	O	B-T080
the	O	O	O
presence	O	O	B-T033
or	O	O	O
absence	O	O	B-T169
of	O	O	O
pneumonia	O	O	B-T047
in	O	O	O
children	O	O	B-T100
using	O	O	O
chest	O	O	B-T060
imaging	O	O	I-T060
reports	O	O	B-T170
.	O	O	O

The	O	O	O
multi-institutional	O	O	B-T093
PHIS	O	O	B-T170
+	O	O	O
clinical	O	O	B-T080
repository	O	O	B-T073
was	O	O	O
developed	O	O	O
to	O	O	O
support	O	O	O
pediatric	O	O	B-T080
CER	O	O	B-T062
by	O	O	O
expanding	O	O	O
an	O	O	O
administrative	O	O	B-T169
database	O	O	B-T170
of	O	O	O
children	O	O	B-T093
's	O	O	I-T093
hospitals	O	O	I-T093
with	O	O	O
detailed	O	O	O
clinical	O	O	O
data	O	O	B-T078
.	O	O	O

To	O	O	O
develop	O	O	O
a	O	O	O
scalable	O	O	B-T169
approach	O	O	O
to	O	O	O
find	O	O	B-T033
patients	O	O	B-T101
with	O	O	O
bacterial	O	O	B-T047
pneumonia	O	O	I-T047
more	O	O	O
accurately	O	O	O
,	O	O	O
we	O	O	O
developed	O	O	O
a	O	O	O
Natural	O	O	B-T066
Language	O	O	I-T066
Processing	O	O	I-T066
(	O	O	O
NLP	O	O	B-T066
)	O	O	O
application	O	O	B-T080
to	O	O	O
extract	O	O	O
relevant	O	O	B-T080
information	O	O	B-T078
from	O	O	O
chest	O	O	B-T060
diagnostic	O	O	I-T060
imaging	O	O	I-T060
reports	O	O	B-T170
.	O	O	O

Domain	O	O	B-T169
experts	O	O	B-T097
established	O	O	B-T080
a	O	O	O
reference	O	O	B-T081
standard	O	O	I-T081
by	O	O	O
manually	O	O	B-T033
annotating	O	O	B-T169
282	O	O	O
reports	O	O	B-T170
to	O	O	O
train	O	O	O
and	O	O	O
then	O	O	O
test	O	O	O
the	O	O	O
NLP	O	O	B-T066
application	O	O	B-T080
.	O	O	O

Findings	O	O	O
of	O	O	O
pleural	O	O	B-T047
effusion	O	O	I-T047
,	O	O	O
pulmonary	O	O	B-T033
infiltrate	O	O	I-T033
,	O	O	O
and	O	O	O
pneumonia	O	O	B-T047
were	O	O	O
automatically	O	O	B-T033
extracted	O	O	O
from	O	O	O
the	O	O	O
reports	O	O	B-T170
and	O	O	O
then	O	O	O
used	O	O	O
to	O	O	O
automatically	O	O	O
classify	O	O	B-T185
whether	O	O	O
a	O	O	O
report	O	O	B-T170
was	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
bacterial	O	O	B-T047
pneumonia	O	O	I-T047
.	O	O	O

Compared	O	O	B-T052
with	O	O	O
the	O	O	O
annotated	O	O	O
diagnostic	O	O	B-T060
imaging	O	O	I-T060
reports	O	O	B-T170
reference	O	O	B-T081
standard	O	O	I-T081
,	O	O	O
the	O	O	O
most	O	O	O
accurate	O	O	B-T080
implementation	O	O	B-T052
of	O	O	O
machine	O	O	B-T066
learning	O	O	I-T066
algorithms	O	O	B-T170
in	O	O	O
our	O	O	O
NLP	O	O	B-T066
application	O	O	B-T080
allowed	O	O	O
extracting	O	O	O
relevant	O	O	B-T080
findings	O	O	B-T169
with	O	O	O
a	O	O	O
sensitivity	O	O	B-T081
of	O	O	O
.939	O	O	O
and	O	O	O
a	O	O	O
positive	O	O	B-T033
predictive	O	O	B-T080
value	O	O	I-T080
of	O	O	O
.925	O	O	O
.	O	O	O

It	O	O	O
allowed	O	O	O
classifying	O	O	B-T185
reports	O	O	B-T170
with	O	O	O
a	O	O	O
sensitivity	O	O	B-T081
of	O	O	O
.71	O	O	O
,	O	O	O
a	O	O	O
positive	O	O	B-T033
predictive	O	O	B-T080
value	O	O	I-T080
of	O	O	O
.86	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
specificity	O	O	B-T081
of	O	O	O
.962	O	O	O
.	O	O	O

When	O	O	O
compared	O	O	B-T052
with	O	O	O
each	O	O	O
of	O	O	O
the	O	O	O
domain	O	O	B-T169
experts	O	O	B-T097
manually	O	O	B-T033
annotating	O	O	B-T169
these	O	O	O
reports	O	O	B-T170
,	O	O	O
the	O	O	O
NLP	O	O	B-T066
application	O	O	B-T080
allowed	O	O	O
for	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
sensitivity	O	O	B-T081
(	O	O	O
.71	O	O	O
vs	O	O	O
.527	O	O	O
)	O	O	O
and	O	O	O
similar	O	O	O
positive	O	O	B-T033
predictive	O	O	B-T080
value	O	O	I-T080
and	O	O	O
specificity	O	O	B-T081
.	O	O	O

NLP	O	O	B-T066
-based	O	O	O
pneumonia	O	O	B-T047
information	O	O	B-T078
extraction	O	O	O
of	O	O	O
pediatric	O	O	B-T080
diagnostic	O	O	B-T060
imaging	O	O	I-T060
reports	O	O	B-T170
performed	O	O	B-T169
better	O	O	O
than	O	O	O
domain	O	O	B-T169
experts	O	O	B-T097
in	O	O	O
this	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
.	O	O	O

NLP	O	O	B-T066
is	O	O	O
an	O	O	O
efficient	O	O	O
method	O	O	O
to	O	O	O
extract	O	O	O
information	O	O	B-T078
from	O	O	O
a	O	O	O
large	O	O	O
collection	O	O	B-T169
of	O	O	O
imaging	O	O	B-T170
reports	O	O	I-T170
to	O	O	O
facilitate	O	O	O
CER	O	O	B-T062
.	O	O	O

-DOCSTART- (28507202)

Determination	O	O	B-T058
of	O	O	O
volatile	O	O	B-T109
organic	O	O	I-T109
compounds	O	O	I-T109
exhaled	O	O	B-T040
by	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
derived	O	O	B-T080
from	O	O	O
hematological	O	O	O
malignancies	O	O	O

Background	O	O	O
:	O	O	O
The	O	O	O
gas	O	O	B-T104
human	O	O	B-T016
exhaled	O	O	B-T040
contains	O	O	O
many	O	O	O
volatile	O	O	B-T109
organic	O	O	I-T109
compounds	O	O	I-T109
(	O	O	O
VOCs	O	O	B-T109
)	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
health	O	O	B-T080
status	O	O	I-T080
of	O	O	O
body	O	O	B-T016
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
VOCs	O	O	B-T109
has	O	O	O
been	O	O	O
proposed	O	O	O
as	O	O	O
a	O	O	O
noninvasive	O	O	B-T185
diagnostic	O	O	B-T060
tool	O	O	I-T060
for	O	O	O
certain	O	O	O
cancers	O	O	B-T191
.	O	O	O

Detailed	O	O	O
research	O	O	O
on	O	O	O
the	O	O	O
VOCs	O	O	B-T109
in	O	O	O
gas	O	O	B-T104
exhaled	O	O	B-T040
by	O	O	O
cell	O	O	B-T025
can	O	O	O
characterize	O	O	O
cell	O	O	B-T170
type	O	O	I-T170
specific	O	O	O
metabolites	O	O	B-T123
and	O	O	O
may	O	O	O
be	O	O	O
helpful	O	O	O
to	O	O	O
detect	O	O	O
the	O	O	O
cancer	O	O	B-T123
markers	O	O	I-T123
in	O	O	O
clinical	O	O	B-T057
practice	O	O	I-T057
.	O	O	O

Methods	O	O	O
:	O	O	O
Solid	O	O	B-T059
phase	O	O	I-T059
microextraction	O	O	I-T059
-	O	O	O
gas	O	O	B-T059
chromatography	O	O	I-T059
-	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
was	O	O	O
used	O	O	O
to	O	O	O
detect	O	O	O
VOCs	O	O	B-T109
in	O	O	O
the	O	O	O
headspace	O	O	O
of	O	O	O
tissue	O	O	B-T074
culture	O	O	I-T074
flask	O	O	I-T074
in	O	O	O
non-Hodgkin	O	O	B-T191
's	O	O	I-T191
lymphoma	O	O	I-T191
cell	O	O	B-T025
line	O	O	I-T025
JEKO	O	O	I-T025
and	O	O	O
acute	O	O	B-T191
mononuclear	O	O	I-T191
leukemia	O	O	I-T191
cell	O	O	B-T025
line	O	O	I-T025
SHI-1	O	O	I-T025
,	O	O	O
to	O	O	O
elaborate	O	O	O
the	O	O	O
characteristic	O	O	O
gaseous	O	O	B-T104
biomarkers	O	O	B-T123
of	O	O	O
hematological	O	O	B-T191
malignancies	O	O	I-T191
.	O	O	O

While	O	O	O
macrophage	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
lymphocytic	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
acted	O	O	O
as	O	O	O
control	O	O	B-T096
.	O	O	O

The	O	O	O
blank	O	O	B-T078
group	O	O	I-T078
was	O	O	O
only	O	O	O
the	O	O	O
RPMI	O	O	B-T130
1640	O	O	I-T130
medium	O	O	I-T130
containing	O	O	O
10	O	O	O
%	O	O	O
fetal	O	O	B-T130
calf	O	O	I-T130
serum	O	O	I-T130
that	O	O	O
without	O	O	O
cells	O	O	B-T025
.	O	O	O

Results	O	O	O
:	O	O	O
Comparing	O	O	O
to	O	O	O
control	O	O	B-T096
group	O	O	I-T096
,	O	O	O
the	O	O	O
concentration	O	O	B-T081
of	O	O	O
dimethyl	O	O	B-T123
sulphide	O	O	I-T123
,	O	O	O
2,4-dimethyl-heptane	O	O	B-T123
,	O	O	O
methylbenzene	O	O	B-T109
,	O	O	O
o-xylene	O	O	B-T109
,	O	O	O
dodecane	O	O	B-T109
and	O	O	O
1,3-ditert-butylbenzene	O	O	B-T123
in	O	O	O
JEKO	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
relatively	O	O	O
higher	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
concentration	O	O	O
of	O	O	O
ethanol	O	O	B-T109
,	O	O	O
hexanal	O	O	B-T109
and	O	O	O
benzaldehyde	O	O	B-T109
was	O	O	O
lower	O	O	O
.	O	O	O

In	O	O	O
SHI-1	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
2,4-dimethyl-heptane	O	O	B-T123
,	O	O	O
benzene	O	O	B-T109
,	O	O	O
4-methyldecane	O	O	B-T123
,	O	O	O
chloroform	O	O	B-T109
,	O	O	O
3,7-dimethyl	O	O	B-T123
dodecane	O	O	I-T123
and	O	O	O
hexadecane	O	O	B-T109
were	O	O	O
significantly	O	O	O
elevated	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
hexanol	O	O	B-T109
and	O	O	O
cyclohexanol	O	O	B-T109
were	O	O	O
distinctly	O	O	O
reduced	O	O	O
.	O	O	O

Conclusions	O	O	O
:	O	O	O
This	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
revealed	O	O	O
that	O	O	O
the	O	O	O
malignant	O	O	B-T191
hematological	O	O	I-T191
cells	O	O	B-T025
could	O	O	O
change	O	O	O
the	O	O	O
components	O	O	O
of	O	O	O
VOCs	O	O	B-T109
in	O	O	O
the	O	O	O
cell	O	O	B-T059
culture	O	O	I-T059
flask	O	O	I-T059
in	O	O	O
a	O	O	O
cell	O	O	B-T170
type	O	O	I-T170
specific	O	O	O
pattern	O	O	O
.	O	O	O

The	O	O	O
traits	O	O	O
of	O	O	O
VOCs	O	O	B-T109
in	O	O	O
our	O	O	O
setting	O	O	O
offered	O	O	O
new	O	O	O
strategy	O	O	O
for	O	O	O
hematological	O	O	B-T191
malignancies	O	O	I-T191
tracing	O	O	O
,	O	O	O
and	O	O	O
would	O	O	O
act	O	O	O
as	O	O	O
potential	O	O	O
biomarkers	O	O	B-T123
in	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
malignant	O	O	B-T080
hematological	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

-DOCSTART- (28511890)

Intratympanic	O	O	B-T169
steroid	O	O	B-T109
delivery	O	O	I-T169
by	O	O	O
an	O	O	O
indwelling	O	O	B-T074
catheter	O	O	I-T074
in	O	O	O
refractory	O	O	O
severe	O	O	O
sudden	O	O	O
sensorineural	O	O	O
hearing	O	O	O
loss	O	O	O

Many	O	O	O
studies	O	O	O
over	O	O	O
the	O	O	O
last	O	O	O
decade	O	O	B-T081
showed	O	O	O
favorable	O	O	O
outcomes	O	O	B-T080
with	O	O	O
intratympanic	O	O	B-T169
(	O	O	O
IT	O	O	B-T169
)	O	O	O
steroid	O	O	B-T109
treatment	O	O	O
,	O	O	O
alone	O	O	O
as	O	O	O
salvage	O	O	B-T061
treatment	O	O	I-T061
or	O	O	O
in	O	O	O
combination	O	O	O
with	O	O	O
conventional	O	O	O
systemic	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
ST	O	O	B-T061
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
severe	O	O	O
to	O	O	O
profound	O	O	O
sensorineural	O	O	B-T047
hearing	O	O	I-T047
loss	O	O	I-T047
resistant	O	O	B-T169
to	O	O	O
ST	O	O	B-T061
,	O	O	O
the	O	O	O
optimal	O	O	O
infusion	O	O	B-T061
mode	O	O	I-T061
,	O	O	O
the	O	O	O
type	O	O	B-T080
and	O	O	O
concentration	O	O	B-T081
of	O	O	O
the	O	O	O
solution	O	O	B-T167
,	O	O	O
the	O	O	O
preferable	O	O	O
drug	O	O	B-T121
,	O	O	O
its	O	O	O
total	O	O	B-T081
amount	O	O	I-T081
,	O	O	O
and	O	O	O
the	O	O	O
duration	O	O	B-T079
and	O	O	O
fractionation	O	O	B-T061
of	O	O	O
the	O	O	O
treatment	O	O	B-T061
are	O	O	O
still	O	O	O
debated	O	O	O
.	O	O	O

Aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
feasibility	O	O	O
and	O	O	O
the	O	O	O
outcomes	O	O	B-T080
of	O	O	O
a	O	O	O
direct	O	O	B-T169
and	O	O	I-T169
constant	O	O	I-T169
IT	O	O	I-T169
delivery	O	O	I-T169
of	O	O	O
dexamethasone	O	O	B-T109
(	O	O	O
DEX	O	O	B-T109
)	O	O	O
by	O	O	O
means	O	O	O
of	O	O	O
a	O	O	O
new	O	O	O
indwelling	O	O	B-T074
catheter	O	O	I-T074
.	O	O	O

A	O	O	O
prospective	O	O	B-T062
case-control	O	O	I-T062
study	O	O	I-T062
in	O	O	O
a	O	O	O
tertiary	O	O	B-T093
referral	O	O	I-T093
university	O	O	I-T093
hospital	O	O	I-T093
.	O	O	O

Ninety-nine	O	O	O
subjects	O	O	B-T098
treated	O	O	B-T169
with	O	O	O
ST	O	O	B-T061
only	O	O	O
and	O	O	O
28	O	O	O
with	O	O	O
additional	O	O	O
IT	O	O	B-T169
DEX	O	O	B-T109
have	O	O	O
been	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
study	O	O	O
.	O	O	O

A	O	O	O
4	O	O	B-T074
Fr	O	O	I-T074
catheter	O	O	I-T074
inserted	O	O	B-T058
in	O	O	O
a	O	O	O
sub-annular	O	O	B-T080
fashion	O	O	I-T080
with	O	O	O
a	O	O	O
minimal	O	O	O
postero-inferior	O	O	B-T082
tympanotomy	O	O	B-T061
through	O	O	O
and	O	O	O
endocanalar	O	O	B-T082
approach	O	O	I-T082
under	O	O	O
local	O	O	B-T061
anesthesia	O	O	I-T061
.	O	O	O

DEX	O	O	B-T109
4mg/ml	O	O	O
delivered	O	O	O
daily	O	O	O
,	O	O	O
up	O	O	O
to	O	O	O
7	O	O	O
days	O	O	B-T079
.	O	O	O

Daily	O	O	O
bone	O	O	B-T060
and	O	O	I-T060
air-conducted	O	O	I-T060
pure	O	O	I-T060
tone	O	O	I-T060
and	O	O	O
speech	O	O	B-T060
audiometry	O	O	I-T060
were	O	O	O
performed	O	O	O
with	O	O	O
a	O	O	O
follow-up	O	O	O
at	O	O	O
1	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
6	O	O	O
months	O	O	B-T079
after	O	O	O
treatment	O	O	B-T061
.	O	O	O

Twenty-one	O	O	O
out	O	O	O
of	O	O	O
28	O	O	O
patients	O	O	B-T101
(	O	O	O
75	O	O	O
%	O	O	O
)	O	O	O
refractory	O	O	B-T169
to	O	O	O
ST	O	O	B-T061
gained	O	O	O
on	O	O	O
average	O	O	O
24.0dB±20.5dB	O	O	O
HL	O	O	B-T033
after	O	O	O
IT	O	O	B-T169
-	O	O	O
DEX	O	O	B-T109
,	O	O	O
compared	O	O	O
to	O	O	O
35.4	O	O	O
%	O	O	O
(	O	O	O
average	O	O	O
6.7dB±16.6dB	O	O	O
HL	O	O	O
)	O	O	O
of	O	O	O
those	O	O	O
receiving	O	O	O
only	O	O	O
medical	O	O	O
ST	O	O	O
(	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
significant	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
were	O	O	O
noted	O	O	O
.	O	O	O

In	O	O	O
severe	O	O	O
to	O	O	O
profound	O	O	O
sudden	O	O	B-T184
deafness	O	O	I-T184
refractory	O	O	B-T169
to	O	O	O
conventional	O	O	O
ST	O	O	B-T061
,	O	O	O
the	O	O	O
daily	O	O	O
perfusion	O	O	B-T061
of	O	O	O
4mg/ml	O	O	O
DEX	O	O	B-T109
through	O	O	O
an	O	O	O
intratympanic	O	O	B-T169
catheter	O	O	B-T074
is	O	O	O
an	O	O	O
easy	O	O	O
,	O	O	O
well	O	O	O
accepted	O	O	O
procedure	O	O	O
that	O	O	O
enables	O	O	O
patients	O	O	B-T101
to	O	O	O
receive	O	O	O
a	O	O	O
drug	O	O	B-T121
in	O	O	O
the	O	O	O
middle	O	O	B-T030
ear	O	O	I-T030
in	O	O	O
a	O	O	O
repeatable	O	O	B-T061
or	O	O	O
sustained	O	O	B-T122
form	O	O	I-T122
,	O	O	O
with	O	O	O
minimal	O	O	O
discomfort	O	O	B-T062
and	O	O	I-T062
a	O	O	I-T062
partial	O	O	I-T062
rescue	O	O	I-T062
(	O	O	O
67.86	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
speech	O	O	B-T041
recognition	O	O	I-T041
gain	O	O	O
of	O	O	O
39	O	O	O
%	O	O	O
.	O	O	O

-DOCSTART- (28511906)

Design	O	O	B-T052
,	O	O	O
synthesis	O	O	B-T052
and	O	O	O
anti-tumor	O	O	B-T044
activity	O	O	I-T044
study	O	O	B-T062
of	O	O	O
novel	O	O	O
histone	O	O	B-T116
deacetylase	O	O	I-T116
inhibitors	O	O	I-T116
containing	O	O	O
isatin	O	O	B-T109
-based	O	O	O
caps	O	O	B-T104
and	O	O	O
o-phenylenediamine	O	O	B-T109
-based	O	O	O
zinc	O	O	O
binding	O	O	O
groups	O	O	O

As	O	O	O
a	O	O	O
hot	O	O	O
topic	O	O	O
of	O	O	O
epigenetic	O	O	B-T091
studies	O	O	I-T091
,	O	O	O
histone	O	O	B-T116
deacetylases	O	O	I-T116
(	O	O	O
HDACs	O	O	B-T116
)	O	O	O
are	O	O	O
related	O	O	O
to	O	O	O
lots	O	O	O
of	O	O	O
diseases	O	O	B-T047
,	O	O	O
especially	O	O	O
cancer	O	O	B-T191
.	O	O	O

Further	O	O	O
researches	O	O	B-T062
indicated	O	O	O
that	O	O	O
different	O	O	B-T080
HDAC	O	O	B-T116
isoforms	O	O	I-T116
played	O	O	O
various	O	O	O
roles	O	O	B-T077
in	O	O	O
a	O	O	O
wide	O	O	O
range	O	O	O
of	O	O	O
tumor	O	O	B-T033
types	O	O	I-T033
.	O	O	O

Herein	O	O	O
a	O	O	O
novel	O	O	O
series	O	O	B-T081
of	O	O	O
HDAC	O	O	B-T116
inhibitors	O	O	I-T116
with	O	O	O
isatin	O	O	B-T109
-based	O	O	O
caps	O	O	B-T104
and	O	O	O
o-phenylenediamine	O	O	B-T109
-based	O	O	O
zinc	O	O	B-T104
binding	O	O	I-T104
groups	O	O	I-T104
have	O	O	O
been	O	O	O
designed	O	O	B-T052
and	O	O	O
synthesized	O	O	B-T052
through	O	O	B-T169
scaffold	O	O	B-T059
hopping	O	O	I-T059
strategy	O	O	I-T059
.	O	O	O

Among	O	O	O
these	O	O	O
compounds	O	O	B-T103
,	O	O	O
the	O	O	O
most	O	O	O
potent	O	O	O
compound	O	O	B-T103
9n	O	O	I-T103
exhibited	O	O	O
similar	O	O	O
if	O	O	O
not	O	O	O
better	O	O	B-T080
HDAC	O	O	B-T116
inhibition	O	O	B-T039
and	O	O	O
antiproliferative	O	O	B-T044
activities	O	O	I-T044
against	O	O	O
multiple	O	O	B-T081
tumor	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
compared	O	O	B-T052
with	O	O	O
the	O	O	O
positive	O	O	B-T077
control	O	O	I-T077
entinostat	O	O	B-T109
(	O	O	O
MS-275	O	O	B-T109
)	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
compared	O	O	B-T052
with	O	O	O
MS-275	O	O	B-T109
(	O	O	O
IC50	O	O	B-T081
values	O	O	B-T081
for	O	O	O
HDAC1	O	O	B-T116
,	O	O	O
2	O	O	B-T116
and	O	O	O
3	O	O	B-T116
were	O	O	O
0.163	O	O	O
,	O	O	O
0.396	O	O	O
and	O	O	O
0.605µM	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
,	O	O	O
compound	O	O	B-T103
9n	O	O	I-T103
with	O	O	O
IC50	O	O	O
values	O	O	O
of	O	O	O
0.032	O	O	O
,	O	O	O
0.256	O	O	O
and	O	O	O
0.311µM	O	O	O
for	O	O	O
HDAC1	O	O	O
,	O	O	O
2	O	O	O
and	O	O	O
3	O	O	O
respectively	O	O	O
,	O	O	O
showed	O	O	O
a	O	O	O
moderate	O	O	O
HDAC1	O	O	O
selectivity	O	O	B-T080
.	O	O	O

-DOCSTART- (28514486)

Efficacy	O	O	B-T080
of	O	O	O
42	O	O	O
Pharmacologic	O	O	B-T121
Cotreatment	O	O	B-T061
Strategies	O	O	O
Added	O	O	O
to	O	O	O
Antipsychotic	O	O	B-T121
Monotherapy	O	O	B-T061
in	O	O	O
Schizophrenia	O	O	B-T048
:	O	O	O
Systematic	O	O	O
Overview	O	O	O
and	O	O	O
Quality	O	O	B-T080
Appraisal	O	O	O
of	O	O	O
the	O	O	O
Meta-analytic	O	O	B-T062
Evidence	O	O	O

Limited	O	O	O
treatment	O	O	B-T061
responses	O	O	B-T032
in	O	O	O
schizophrenia	O	O	B-T048
prompted	O	O	O
the	O	O	O
testing	O	O	O
of	O	O	O
combining	O	O	O
an	O	O	O
antipsychotic	O	O	B-T121
drug	O	O	I-T121
treatment	O	O	O
with	O	O	O
a	O	O	O
second	O	O	O
psychotropic	O	O	B-T121
medication	O	O	B-T121
.	O	O	O

A	O	O	O
comprehensive	O	O	O
evaluation	O	O	B-T058
of	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
multiple	O	O	O
medication	O	O	B-T121
combinations	O	O	B-T121
is	O	O	O
missing	O	O	O
.	O	O	O

To	O	O	O
summarize	O	O	O
and	O	O	O
compare	O	O	O
the	O	O	O
meta-analytically	O	O	B-T062
determined	O	O	O
efficacy	O	O	B-T080
of	O	O	O
pharmacologic	O	O	B-T121
combination	O	O	B-T121
strategies	O	O	O
of	O	O	O
antipsychotic	O	O	B-T121
drugs	O	O	I-T121
in	O	O	O
adults	O	O	B-T100
with	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

Systematic	O	O	O
search	O	O	O
of	O	O	O
PubMed	O	O	B-T170
and	O	O	O
PsycInfo	O	O	B-T170
until	O	O	O
May	O	O	O
13	O	O	O
,	O	O	O
2016	O	O	O
.	O	O	O

Meta-analyses	O	O	B-T062
of	O	O	O
randomized	O	O	B-T062
clinical	O	O	I-T062
trials	O	O	I-T062
comparing	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
antipsychotic	O	O	B-T121
drugs	O	O	I-T121
combined	O	O	O
with	O	O	O
other	O	O	O
antipsychotic	O	O	O
or	O	O	O
nonantipsychotic	O	O	B-T121
medications	O	O	I-T121
vs	O	O	O
placebos	O	O	B-T122
or	O	O	O
antipsychotic	O	O	O
monotherapy	O	O	B-T061
among	O	O	O
adults	O	O	B-T100
with	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

Independent	O	O	O
reviewers	O	O	B-T098
extracted	O	O	O
the	O	O	O
data	O	O	B-T078
and	O	O	O
assessed	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
the	O	O	O
methods	O	O	B-T170
of	O	O	O
the	O	O	O
included	O	O	O
meta-analyses	O	O	B-T062
using	O	O	O
A	O	O	O
Measurement	O	O	B-T170
Tool	O	O	I-T170
to	O	O	I-T170
Assess	O	O	I-T170
Systematic	O	O	I-T170
Reviews	O	O	I-T170
(	O	O	O
AMSTAR	O	O	B-T170
)	O	O	O
,	O	O	O
adding	O	O	O
6	O	O	O
new	O	O	O
items	O	O	O
to	O	O	O
rate	O	O	O
their	O	O	O
quality	O	O	O
.	O	O	O

Effect	O	O	B-T081
sizes	O	O	I-T081
,	O	O	O
expressed	O	O	O
as	O	O	O
standardized	O	O	B-T201
mean	O	O	I-T201
difference	O	O	I-T201
/Hedges	O	O	O
g	O	O	O
or	O	O	O
risk	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
were	O	O	O
compared	O	O	O
separately	O	O	O
for	O	O	O
combinations	O	O	B-T121
with	O	O	O
any	O	O	O
antipsychotic	O	O	B-T121
drug	O	O	I-T121
and	O	O	O
for	O	O	O
combinations	O	O	O
with	O	O	O
clozapine	O	O	B-T109
.	O	O	O

The	O	O	O
primary	O	O	O
outcome	O	O	O
was	O	O	O
total	O	O	O
symptom	O	O	B-T184
reduction	O	O	B-T080
.	O	O	O

Secondary	O	O	O
outcomes	O	O	O
included	O	O	O
positive	O	O	B-T033
and	O	O	O
negative	O	O	B-T033
symptoms	O	O	B-T184
,	O	O	O
treatment	O	O	B-T061
recommendations	O	O	I-T058
by	O	O	O
authors	O	O	O
,	O	O	O
study-defined	O	O	O
inefficacies	O	O	B-T033
,	O	O	O
cognitive	O	O	B-T169
and	O	O	O
depressive	O	O	B-T184
symptoms	O	O	I-T184
,	O	O	O
discontinuation	O	O	B-T058
of	O	O	O
treatment	O	O	O
because	O	O	O
of	O	O	O
any	O	O	O
cause	O	O	O
,	O	O	O
and	O	O	O
inefficacies	O	O	O
or	O	O	O
intolerabilities	O	O	O
.	O	O	O

Of	O	O	O
3397	O	O	O
publications	O	O	O
,	O	O	O
29	O	O	O
meta-analyses	O	O	B-T062
testing	O	O	O
42	O	O	O
combination	O	O	B-T121
strategies	O	O	O
in	O	O	O
381	O	O	O
individual	O	O	B-T098
trials	O	O	O
and	O	O	O
among	O	O	O
19	O	O	O
833	O	O	O
participants	O	O	B-T098
were	O	O	O
included	O	O	O
.	O	O	O

For	O	O	O
total	O	O	O
symptom	O	O	B-T184
reductions	O	O	B-T061
,	O	O	O
32	O	O	O
strategies	O	O	O
that	O	O	O
augmented	O	O	O
any	O	O	O
antipsychotic	O	O	B-T121
drug	O	O	I-T121
and	O	O	O
5	O	O	O
strategies	O	O	O
that	O	O	O
augmented	O	O	O
clozapine	O	O	B-T109
were	O	O	O
examined	O	O	O
.	O	O	O

Fourteen	O	O	O
combination	O	O	B-T121
treatments	O	O	B-T061
outperformed	O	O	O
controls	O	O	O
(	O	O	O
standard	O	O	B-T201
mean	O	O	I-T201
difference	O	O	I-T201
/Hedges	O	O	O
g	O	O	O
,	O	O	O
-1.27	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
-2.35	O	O	O
to	O	O	O
-0.19	O	O	O
]	O	O	O
to	O	O	O
-0.23	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
-0.44	O	O	O
to	O	O	O
-0.02	O	O	O
]	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.05	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
combination	O	O	B-T121
strategies	O	O	O
with	O	O	O
clozapine	O	O	B-T109
outperformed	O	O	O
controls	O	O	O
.	O	O	O

The	O	O	O
quality	O	O	B-T080
of	O	O	O
the	O	O	O
methods	O	O	B-T170
of	O	O	O
the	O	O	O
meta-analyses	O	O	B-T062
was	O	O	O
generally	O	O	O
high	O	O	B-T080
(	O	O	O
mean	O	O	B-T033
score	O	O	I-T033
,	O	O	O
9	O	O	O
of	O	O	O
a	O	O	O
maximum	O	O	B-T081
score	O	O	I-T081
of	O	O	O
11	O	O	O
)	O	O	O
but	O	O	O
the	O	O	O
quality	O	O	O
of	O	O	O
the	O	O	O
meta-analyzed	O	O	B-T062
studies	O	O	I-T062
was	O	O	O
low	O	O	B-T080
(	O	O	O
mean	O	O	O
score	O	O	O
,	O	O	O
2.8	O	O	O
of	O	O	O
a	O	O	O
maximum	O	O	O
score	O	O	O
of	O	O	O
8)	O	O	O
.	O	O	O

Treatment	O	O	B-T058
recommendations	O	O	I-T058
correlated	O	O	O
with	O	O	O
the	O	O	O
effect	O	O	B-T081
size	O	O	I-T081
(	O	O	O
correlation	O	O	B-T081
coefficient	O	O	I-T081
,	O	O	O
0.22	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0.35	O	O	O
-	O	O	O
0.10	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
,	O	O	O
yet	O	O	O
effect	O	O	B-T081
sizes	O	O	I-T081
were	O	O	O
inversely	O	O	O
correlated	O	O	O
with	O	O	O
study	O	O	O
quality	O	O	B-T080
(	O	O	O
correlation	O	O	O
coefficient	O	O	O
,	O	O	O
-0.06	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.01	O	O	O
to	O	O	O
-0.12	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.02	O	O	O
)	O	O	O
.	O	O	O

Meta-analyses	O	O	B-T062
of	O	O	O
21	O	O	O
interventions	O	O	O
fully	O	O	O
or	O	O	O
partially	O	O	O
recommended	O	O	O
their	O	O	O
use	O	O	O
,	O	O	O
with	O	O	O
recommendations	O	O	B-T078
being	O	O	O
positively	O	O	B-T033
correlated	O	O	O
with	O	O	O
the	O	O	O
effect	O	O	B-T081
sizes	O	O	I-T081
of	O	O	O
the	O	O	O
pooled	O	O	O
intervention	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
effect	O	O	B-T081
sizes	O	O	I-T081
were	O	O	O
inversely	O	O	O
correlated	O	O	O
with	O	O	O
meta-analyzed	O	O	B-T062
study	O	O	I-T062
quality	O	O	B-T080
,	O	O	O
reducing	O	O	B-T080
confidence	O	O	B-T041
in	O	O	O
these	O	O	O
recommendations	O	O	B-T078
.	O	O	O

Higher	O	O	B-T080
-	O	O	O
quality	O	O	B-T080
trials	O	O	O
and	O	O	O
patient	O	O	B-T101
-based	O	O	O
meta-analyses	O	O	B-T062
are	O	O	O
needed	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
subpopulations	O	O	B-T098
might	O	O	O
benefit	O	O	O
from	O	O	O
combination	O	O	B-T121
treatment	O	O	B-T061
,	O	O	O
as	O	O	O
no	O	O	O
single	O	O	O
strategy	O	O	O
can	O	O	O
be	O	O	O
recommended	O	O	O
for	O	O	O
patients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
based	O	O	O
on	O	O	O
the	O	O	O
current	O	O	O
meta-analytic	O	O	B-T062
literature	O	O	B-T170
.	O	O	O

-DOCSTART- (28515448)

Involvement	O	O	B-T169
Of	O	O	O
Vascular	O	O	B-T023
Aldosterone	O	O	B-T116
Synthase	O	O	I-T116
In	O	O	O
Phosphate	O	O	B-T121
-	O	O	O
Induced	O	O	B-T169
Osteogenic	O	O	B-T033
Transformation	O	O	I-T033
Of	O	O	O
Vascular	O	O	O
Smooth	O	O	O
Muscle	O	O	O
Cells	O	O	O

Vascular	O	O	B-T046
calcification	O	O	I-T046
resulting	O	O	O
from	O	O	O
hyperphosphatemia	O	O	B-T047
is	O	O	O
a	O	O	O
major	O	O	O
determinant	O	O	O
of	O	O	O
mortality	O	O	B-T081
in	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CKD	O	O	B-T047
)	O	O	O
.	O	O	O

Vascular	O	O	B-T046
calcification	O	O	I-T046
is	O	O	O
driven	O	O	O
by	O	O	O
aldosterone	O	O	B-T125
-sensitive	O	O	O
osteogenic	O	O	B-T033
transformation	O	O	I-T033
of	O	O	O
vascular	O	O	B-T023
smooth	O	O	B-T025
muscle	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
VSMCs	O	O	B-T025
)	O	O	O
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
even	O	O	O
in	O	O	O
absence	O	O	B-T169
of	O	O	O
exogenous	O	O	B-T169
aldosterone	O	O	B-T125
,	O	O	O
silencing	O	O	B-T044
and	O	O	O
pharmacological	O	O	B-T044
inhibition	O	O	I-T044
(	O	O	O
spironolactone	O	O	B-T109
,	O	O	O
eplerenone	O	O	B-T109
)	O	O	O
of	O	O	O
the	O	O	O
mineralocorticoid	O	O	B-T116
receptor	O	O	I-T116
(	O	O	O
MR	O	O	B-T116
)	O	O	O
ameliorated	O	O	O
phosphate	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
osteo-	O	O	B-T033
/	O	O	O
chondrogenic	O	O	B-T033
transformation	O	O	I-T033
of	O	O	O
primary	O	O	B-T080
human	O	O	B-T016
aortic	O	O	B-T023
smooth	O	O	B-T025
muscle	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
HAoSMCs	O	O	B-T025
)	O	O	O
.	O	O	O

High	O	O	O
phosphate	O	O	B-T121
concentrations	O	O	B-T081
up-regulated	O	O	B-T044
aldosterone	O	O	B-T116
synthase	O	O	I-T116
(	O	O	O
CYP11B2	O	O	B-T116
)	O	O	O
expression	O	O	B-T045
in	O	O	O
HAoSMCs	O	O	B-T025
.	O	O	O

Silencing	O	O	B-T044
and	O	O	O
deficiency	O	O	B-T047
of	O	O	O
CYP11B2	O	O	B-T116
in	O	O	O
VSMCs	O	O	B-T025
ameliorated	O	O	O
phosphate	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
osteogenic	O	O	B-T042
reprogramming	O	O	I-T042
and	O	O	O
calcification	O	O	B-T042
.	O	O	O

Phosphate	O	O	B-T121
treatment	O	O	B-T169
was	O	O	O
followed	O	O	O
by	O	O	O
nuclear	O	O	B-T043
export	O	O	I-T043
of	O	O	O
APEX1	O	O	B-T116
,	O	O	O
a	O	O	O
CYP11B2	O	O	B-T028
transcriptional	O	O	B-T116
repressor	O	O	I-T116
.	O	O	O

APEX1	O	O	B-T116
silencing	O	O	B-T044
up-regulated	O	O	B-T044
CYP11B2	O	O	B-T028
expression	O	O	B-T045
and	O	O	O
stimulated	O	O	O
osteo-	O	O	B-T033
/	O	O	O
chondrogenic	O	O	B-T033
transformation	O	O	I-T033
.	O	O	O

APEX1	O	O	B-T116
overexpression	O	O	B-T045
blunted	O	O	O
the	O	O	O
phosphate	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
osteo-	O	O	B-T033
/	O	O	O
chondrogenic	O	O	B-T033
transformation	O	O	I-T033
and	O	O	O
calcification	O	O	B-T042
of	O	O	O
HAoSMCs	O	O	B-T025
.	O	O	O

Cyp11b2	O	O	B-T028
expression	O	O	B-T045
was	O	O	O
higher	O	O	O
in	O	O	O
aortic	O	O	B-T023
tissue	O	O	B-T024
of	O	O	O
hyperphosphatemic	O	O	B-T047
klotho-hypomorphic	O	O	B-T015
(	O	O	I-T015
kl/kl	O	O	I-T015
)	O	O	I-T015
mice	O	O	B-T015
than	O	O	O
in	O	O	O
wild-type	O	O	B-T028
mice	O	O	O
.	O	O	O

In	O	O	O
adrenalectomized	O	O	B-T015
kl/kl	O	O	I-T015
mice	O	O	I-T015
,	O	O	O
spironolactone	O	O	B-T109
treatment	O	O	B-T169
still	O	O	O
significantly	O	O	O
ameliorated	O	O	O
aortic	O	O	B-T023
osteoinductive	O	O	B-T042
reprogramming	O	O	I-T042
.	O	O	O

Our	O	O	O
findings	O	O	B-T169
suggest	O	O	O
that	O	O	O
VSMCs	O	O	B-T025
express	O	O	O
aldosterone	O	O	B-T116
synthase	O	O	I-T116
,	O	O	O
which	O	O	O
is	O	O	O
up-regulated	O	O	B-T044
by	O	O	O
phosphate	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
disruption	O	O	B-T169
of	O	O	O
APEX1	O	O	B-T116
-dependent	O	O	O
gene	O	O	B-T045
suppression	O	O	I-T045
.	O	O	O

Vascular	O	O	B-T023
CYP11B2	O	O	B-T116
may	O	O	O
contribute	O	O	O
to	O	O	O
stimulation	O	O	O
of	O	O	O
VSMCs	O	O	B-T025
osteo-	O	O	B-T033
/	O	O	O
chondrogenic	O	O	B-T033
transformation	O	O	I-T033
during	O	O	O
hyperphosphatemia	O	O	B-T047
.	O	O	O

-DOCSTART- (28516341)

Fairness	O	O	B-T080
:	O	O	O
the	O	O	O
hidden	O	O	O
challenge	O	O	B-T058
for	O	O	O
competency-based	O	O	O
postgraduate	O	O	O
medical	O	O	O
education	O	O	O
programs	O	O	O

Competency-based	O	O	B-UnknownType
medical	O	O	I-UnknownType
education	O	O	I-UnknownType
systems	O	O	I-UnknownType
allow	O	O	O
institutions	O	O	B-UnknownType
to	O	O	O
individualize	O	O	B-T169
teaching	O	O	B-T065
practices	O	O	I-T065
to	O	O	O
meet	O	O	B-T067
the	O	O	O
needs	O	O	B-T080
of	O	O	O
diverse	O	O	B-T098
learners	O	O	I-T098
.	O	O	O

Yet	O	O	O
,	O	O	O
the	O	O	O
focus	O	O	O
on	O	O	O
continuous	O	O	O
improvement	O	O	B-T077
and	O	O	O
individualization	O	O	B-T169
of	O	O	O
curricula	O	O	B-T170
does	O	O	O
not	O	O	O
exempt	O	O	O
programs	O	O	B-T169
from	O	O	O
treating	O	O	O
learners	O	O	B-T098
in	O	O	O
a	O	O	O
fair	O	O	B-T033
manner	O	O	I-T033
.	O	O	O

When	O	O	O
learners	O	O	B-T098
fail	O	O	O
to	O	O	O
meet	O	O	O
key	O	O	O
competencies	O	O	B-T080
and	O	O	O
are	O	O	O
placed	O	O	O
on	O	O	O
probation	O	O	B-T089
or	O	O	O
dismissed	O	O	B-T052
from	O	O	O
training	O	O	B-T065
programs	O	O	I-T065
,	O	O	O
issues	O	O	B-T033
of	O	O	O
fairness	O	O	B-T080
may	O	O	O
form	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
their	O	O	O
legal	O	O	B-T170
claims	O	O	I-T170
.	O	O	O

In	O	O	O
a	O	O	O
literature	O	O	O
search	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
no	O	O	O
in-depth	O	O	O
examination	O	O	B-T057
of	O	O	O
fairness	O	O	B-T080
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
utilize	O	O	O
a	O	O	O
systems	O	O	O
lens	O	O	O
to	O	O	O
examine	O	O	B-T033
fairness	O	O	B-T080
within	O	O	O
postgraduate	O	O	B-T065
medical	O	O	I-T065
education	O	O	I-T065
contexts	O	O	B-T078
,	O	O	O
focusing	O	O	O
on	O	O	O
educational	O	O	B-T033
opportunities	O	O	I-T033
,	O	O	O
assessment	O	O	B-T058
practices	O	O	I-T058
,	O	O	O
decision-making	O	O	B-T057
processes	O	O	I-T057
,	O	O	O
fairness	O	O	O
from	O	O	O
a	O	O	O
legal	O	O	B-T169
standpoint	O	O	I-T169
,	O	O	O
and	O	O	O
fairness	O	O	O
in	O	O	O
the	O	O	O
context	O	O	B-T078
of	O	O	O
the	O	O	O
learning	O	O	B-T082
environment	O	O	I-T082
.	O	O	O

While	O	O	O
we	O	O	O
provide	O	O	O
examples	O	O	O
of	O	O	O
fairness	O	O	B-T080
issues	O	O	B-T033
within	O	O	O
US	O	O	B-T083
training	O	O	B-T065
programs	O	O	I-T065
,	O	O	O
concerns	O	O	O
regarding	O	O	O
fairness	O	O	O
are	O	O	O
relevant	O	O	O
in	O	O	O
any	O	O	O
medical	O	O	B-UnknownType
education	O	O	I-UnknownType
system	O	O	I-UnknownType
which	O	O	O
utilizes	O	O	O
a	O	O	O
competency-based	O	O	B-T078
education	O	O	I-T078
framework	O	O	I-T078
.	O	O	O

Assessment	O	O	B-T057
oversight	O	O	O
committees	O	O	B-T097
and	O	O	O
annual	O	O	B-T057
programmatic	O	O	I-T057
evaluations	O	O	I-T057
,	O	O	O
while	O	O	O
recommended	O	O	O
,	O	O	O
will	O	O	O
not	O	O	O
guarantee	O	O	O
fairness	O	O	B-T080
within	O	O	O
postgraduate	O	O	B-T065
medical	O	O	I-T065
education	O	O	I-T065
programs	O	O	I-T065
,	O	O	O
but	O	O	O
they	O	O	O
can	O	O	O
provide	O	O	O
a	O	O	O
window	O	O	O
into	O	O	O
'	O	O	O
hidden	O	O	O
'	O	O	O
threats	O	O	O
to	O	O	O
fairness	O	O	O
,	O	O	O
as	O	O	O
everything	O	O	O
from	O	O	O
training	O	O	B-T065
experiences	O	O	I-T065
to	O	O	O
assessment	O	O	B-T058
practices	O	O	I-T058
may	O	O	O
be	O	O	O
examined	O	O	B-T033
by	O	O	O
these	O	O	O
committees	O	O	O
.	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
first	O	O	O
steps	O	O	O
programs	O	O	B-T169
can	O	O	O
take	O	O	O
is	O	O	O
to	O	O	O
recognize	O	O	O
that	O	O	O
threats	O	O	O
to	O	O	O
fairness	O	O	B-T080
may	O	O	O
exist	O	O	O
in	O	O	O
any	O	O	O
educational	O	O	B-T065
program	O	O	I-T065
,	O	O	O
including	O	O	O
their	O	O	O
own	O	O	O
,	O	O	O
and	O	O	O
begin	O	O	O
conversations	O	O	B-T054
about	O	O	O
how	O	O	O
to	O	O	O
address	O	O	O
these	O	O	O
issues	O	O	B-T033
.	O	O	O

-DOCSTART- (28516841)

Us3	O	O	B-T116
and	O	O	O
Us9	O	O	B-T116
proteins	O	O	B-T116
contribute	O	O	O
to	O	O	O
the	O	O	O
stromal	O	O	B-T033
invasion	O	O	I-T033
of	O	O	O
bovine	O	O	B-T005
herpesvirus	O	O	I-T005
1	O	O	I-T005
in	O	O	O
the	O	O	O
respiratory	O	O	O
mucosa	O	O	O

Bovine	O	O	B-T047
herpesvirus	O	O	I-T047
1	O	O	I-T047
(	O	O	I-T047
BHV-1	O	O	I-T047
)	O	O	I-T047
infection	O	O	I-T047
may	O	O	O
lead	O	O	O
to	O	O	O
conjunctivitis	O	O	B-T047
,	O	O	O
upper	O	O	B-T023
respiratory	O	O	I-T023
tract	O	O	I-T023
problems	O	O	B-T033
,	O	O	O
pneumonia	O	O	B-T047
,	O	O	O
genital	O	O	B-T047
disorders	O	O	I-T047
and	O	O	O
abortion	O	O	B-T033
.	O	O	O

BHV-1	O	O	B-T005
is	O	O	O
able	O	O	O
to	O	O	O
spread	O	O	B-T080
quickly	O	O	O
in	O	O	O
a	O	O	O
plaque	O	O	B-T033
-wise	O	O	O
manner	O	O	B-T169
and	O	O	O
invade	O	O	B-T169
by	O	O	O
breaching	O	O	B-T037
the	O	O	O
basement	O	O	B-T024
membrane	O	O	I-T024
(	O	O	B-T024
BM	O	O	I-T024
)	O	O	I-T024
barrier	O	O	B-UnknownType
in	O	O	O
the	O	O	O
respiratory	O	O	B-T024
mucosa	O	O	I-T024
.	O	O	O

BHV-1	O	O	B-T005
Us3	O	O	B-T116
,	O	O	O
a	O	O	O
serine/threonine	O	O	B-T116
kinase	O	O	I-T116
,	O	O	O
induces	O	O	B-T169
a	O	O	O
dramatic	O	O	O
cytoskeletal	O	O	B-T043
reorganization	O	O	I-T043
and	O	O	O
BHV-1	O	O	O
Us9	O	O	B-T116
,	O	O	O
a	O	O	O
tail-anchored	O	O	B-T116
membrane	O	O	I-T116
protein	O	O	I-T116
,	O	O	O
is	O	O	O
required	O	O	O
for	O	O	O
axonal	O	O	B-T043
transport	O	O	I-T043
of	O	O	O
viruses	O	O	B-T005
in	O	O	O
neurons	O	O	B-T025
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
role	O	O	B-T077
of	O	O	O
Us3	O	O	B-T116
and	O	O	O
Us9	O	O	B-T116
during	O	O	O
BHV-1	O	O	B-T047
infection	O	O	I-T047
in	O	O	O
the	O	O	O
respiratory	O	O	B-T024
mucosa	O	O	I-T024
.	O	O	O

First	O	O	O
,	O	O	O
we	O	O	O
constructed	O	O	O
and	O	O	O
characterized	O	O	B-T052
BHV-1	O	O	B-T005
Us3	O	O	B-T028
null	O	O	B-T005
,	O	O	O
Us9	O	O	B-T028
null	O	O	O
and	O	O	O
revertant	O	O	B-T005
viruses	O	O	I-T005
.	O	O	O

Then	O	O	O
,	O	O	O
we	O	O	O
analysed	O	O	B-T062
the	O	O	O
viral	O	O	B-T043
replication	O	O	I-T043
and	O	O	O
plaque	O	O	B-T033
size	O	O	B-T082
(	O	O	O
latitude	O	O	O
)	O	O	O
in	O	O	O
Madin-Darby	O	O	B-T025
bovine	O	O	I-T025
kidney	O	O	I-T025
(	O	O	O
MDBK	O	O	B-T025
)	O	O	O
cells	O	O	B-T025
and	O	O	O
the	O	O	O
respiratory	O	O	B-T024
mucosa	O	O	I-T024
as	O	O	O
well	O	O	O
as	O	O	O
viral	O	O	B-T043
penetration	O	O	I-T043
depth	O	O	O
underneath	O	O	O
the	O	O	O
BM	O	O	B-T024
of	O	O	O
the	O	O	O
respiratory	O	O	O
mucosa	O	O	O
when	O	O	O
inoculated	O	O	B-T061
with	O	O	O
these	O	O	O
recombinant	O	O	B-T005
viruses	O	O	I-T005
.	O	O	O

Knockout	O	O	B-T050
of	O	O	O
Us3	O	O	B-T028
resulted	O	O	O
in	O	O	O
a	O	O	O
1	O	O	O
log10	O	O	O
reduction	O	O	B-T080
in	O	O	O
viral	O	O	B-T081
titre	O	O	I-T081
and	O	O	O
plaque	O	O	B-T033
size	O	O	B-T082
(	O	O	O
latitude	O	O	B-T081
)	O	O	O
in	O	O	O
MDBK	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
the	O	O	O
trachea	O	O	B-T023
mucosa	O	O	I-T023
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
defects	O	O	B-T169
in	O	O	O
the	O	O	O
cell-to-cell	O	O	B-T040
spread	O	O	I-T040
observed	O	O	B-T169
for	O	O	O
BHV-1	O	O	B-T005
Us9	O	O	B-T028
null	O	O	B-T005
virus	O	O	I-T005
.	O	O	O

Both	O	O	O
BHV-1	O	O	B-T005
Us3	O	O	B-T028
null	O	O	B-T005
and	O	O	O
Us9	O	O	B-T028
null	O	O	B-T005
viruses	O	O	I-T005
showed	O	O	O
a	O	O	O
significant	O	O	B-T078
reduction	O	O	B-T080
of	O	O	O
plaque	O	O	B-T033
penetration	O	O	B-T169
underneath	O	O	O
the	O	O	O
BM	O	O	B-T024
;	O	O	O
however	O	O	O
,	O	O	O
penetration	O	O	O
was	O	O	O
not	O	O	O
completely	O	O	O
inhibited	O	O	B-T052
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
,	O	O	O
the	O	O	O
current	O	O	O
findings	O	O	B-T062
demonstrated	O	O	O
that	O	O	O
Us3	O	O	B-T028
and	O	O	O
Us9	O	O	B-T028
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	B-T077
in	O	O	O
the	O	O	O
invasion	O	O	B-T033
of	O	O	O
BHV-1	O	O	B-T005
through	O	O	O
the	O	O	O
BM	O	O	B-T024
of	O	O	O
the	O	O	O
respiratory	O	O	B-T024
mucosa	O	O	I-T024
,	O	O	O
which	O	O	O
shows	O	O	O
the	O	O	O
way	O	O	O
forward	O	O	O
for	O	O	O
research	O	O	B-T062
-based	O	O	O
attenuation	O	O	B-T052
of	O	O	O
viruses	O	O	B-T005
in	O	O	O
order	O	O	O
to	O	O	O
make	O	O	O
safer	O	O	O
and	O	O	O
better	O	O	B-T080
-	O	O	O
performing	O	O	B-T169
vaccines	O	O	B-T129
.	O	O	O

-DOCSTART- (28520661)

Traumatic	O	O	B-T037
Brain	O	O	I-T037
Injury	O	O	I-T037
and	O	O	O
Depression	O	O	B-T048
in	O	O	O
a	O	O	O
Community	O	O	B-T096
-	O	O	O
Based	O	O	B-T169
Sample	O	O	O
:	O	O	O
A	O	O	O
Cohort	O	O	B-T081
Study	O	O	I-T081
Across	O	O	O
the	O	O	O
Adult	O	O	B-T100
Life	O	O	O
Span	O	O	O

To	O	O	O
determine	O	O	O
whether	O	O	O
self-reported	O	O	O
traumatic	O	O	B-T037
brain	O	O	I-T037
injuries	O	O	I-T037
(	O	O	O
TBIs	O	O	B-T037
)	O	O	O
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
"	O	O	O
cases	O	O	B-T077
"	O	O	O
of	O	O	O
clinically	O	O	B-T033
significant	O	O	I-T033
depression	O	O	B-T048
in	O	O	O
the	O	O	O
general	O	O	B-T096
community	O	O	I-T096
.	O	O	O

To	O	O	O
examine	O	O	O
interactions	O	O	B-T169
between	O	O	O
variables	O	O	B-T081
previously	O	O	O
linked	O	O	O
to	O	O	O
depression	O	O	B-T048
after	O	O	O
a	O	O	O
TBI	O	O	B-T037
.	O	O	O

Population	O	O	B-T098
-based	O	O	O
community	O	O	B-T096
study	O	O	B-T062
(	O	O	O
Canberra	O	O	B-T083
and	O	O	O
Queanbeyan	O	O	B-UnknownType
,	O	O	O
Australia	O	O	B-T083
)	O	O	O
.	O	O	O

Three	O	O	B-T081
age	O	O	B-T098
cohorts	O	O	I-T098
:	O	O	O
young	O	O	B-T079
,	O	O	O
middle-aged	O	O	B-T100
,	O	O	O
and	O	O	O
older	O	O	B-T098
adults	O	O	B-T100
(	O	O	O
aged	O	O	B-T032
20	O	O	O
-	O	O	O
24	O	O	O
,	O	O	O
40	O	O	O
-	O	O	O
44	O	O	O
,	O	O	O
and	O	O	O
60	O	O	B-T100
-	O	O	I-T100
64	O	O	I-T100
years	O	O	I-T100
at	O	O	O
baseline	O	O	B-T081
)	O	O	O
randomly	O	O	B-T080
selected	O	O	B-T052
from	O	O	O
the	O	O	O
electoral	O	O	O
roll	O	O	O
and	O	O	O
followed	O	O	B-T079
across	O	O	O
3	O	O	O
waves	O	O	O
(	O	O	O
4	O	O	O
years	O	O	B-T079
apart	O	O	I-T079
)	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
7397	O	O	O
,	O	O	O
6621	O	O	O
,	O	O	O
and	O	O	O
6042	O	O	O
people	O	O	B-T098
provided	O	O	O
their	O	O	O
TBI	O	O	B-T037
history	O	O	O
in	O	O	O
waves	O	O	O
1	O	O	O
to	O	O	O
3	O	O	O
.	O	O	O

Lifetime	O	O	B-T079
(	O	O	O
TBIlifetime	O	O	O
:	O	O	O
sustained	O	O	B-T169
at	O	O	O
any	O	O	O
time	O	O	B-T079
since	O	O	B-T079
birth	O	O	B-T040
)	O	O	O
,	O	O	O
recent	O	O	B-T079
(	O	O	O
TBIrecent	O	O	O
:	O	O	O
in	O	O	O
the	O	O	O
preceding	O	O	B-T079
4	O	O	O
years	O	O	B-T079
)	O	O	O
,	O	O	O
and	O	O	O
multiple	O	O	B-T081
(	O	O	O
TBImultiple	O	O	O
:	O	O	O
more	O	O	O
than	O	O	O
1	O	O	O
)	O	O	O
TBIs	O	O	B-T037
,	O	O	O
current	O	O	B-T079
depression	O	O	B-T048
,	O	O	O
and	O	O	O
known	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
depression	O	O	O
(	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
marital	O	O	B-T102
/	O	O	O
employment	O	O	B-T033
status	O	O	I-T033
,	O	O	O
prior	O	O	B-T033
history	O	O	I-T033
of	O	O	O
depression	O	O	O
,	O	O	O
medical	O	O	B-T033
conditions	O	O	I-T033
,	O	O	O
recent	O	O	O
life	O	O	B-T051
events	O	O	I-T051
,	O	O	O
alcohol	O	O	B-T055
consumption	O	O	I-T055
,	O	O	O
social	O	O	B-T054
support	O	O	I-T054
,	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
)	O	O	O
.	O	O	O

Generalized	O	O	O
estimating	O	O	O
equations	O	O	B-T077
demonstrated	O	O	O
a	O	O	O
significant	O	O	O
association	O	O	B-T080
between	O	O	O
sustaining	O	O	O
a	O	O	O
TBI	O	O	B-T037
and	O	O	O
experiencing	O	O	O
clinically	O	O	B-T033
significant	O	O	I-T033
depression	O	O	B-T048
(	O	O	O
cases	O	O	B-T077
)	O	O	O
,	O	O	O
even	O	O	O
after	O	O	O
controlling	O	O	B-T067
for	O	O	O
multiple	O	O	B-T081
demographic	O	O	B-T078
and	O	O	O
health	O	O	B-T078
/	O	O	O
lifestyle	O	O	B-T054
factors	O	O	B-T169
.	O	O	O

There	O	O	O
is	O	O	O
an	O	O	O
enduring	O	O	O
association	O	O	B-T080
between	O	O	O
depression	O	O	B-T048
and	O	O	O
TBI	O	O	B-T037
,	O	O	O
suggesting	O	O	O
that	O	O	O
,	O	O	O
following	O	O	O
a	O	O	O
TBI	O	O	O
,	O	O	O
individuals	O	O	B-T098
should	O	O	O
be	O	O	O
monitored	O	O	B-T097
and	O	O	O
supported	O	O	O
to	O	O	O
optimize	O	O	O
their	O	O	O
long-term	O	O	B-T079
psychological	O	O	B-T041
health	O	O	I-T041
.	O	O	O

-DOCSTART- (28521254)

CS	O	O	B-T109
-	O	O	O
PEG	O	O	B-T109
decorated	O	O	O
PLGA	O	O	B-T109
nano-prototype	O	O	I-T109
for	O	O	O
delivery	O	O	B-T070
of	O	O	O
bioactive	O	O	B-T123
compounds	O	O	I-T123
:	O	O	O
A	O	O	O
novel	O	O	B-T080
approach	O	O	B-T082
for	O	O	O
induction	O	O	B-T169
of	O	O	O
apoptosis	O	O	B-T043
in	O	O	O
HepG2	O	O	O
cell	O	O	O
line	O	O	O

Polymer	O	O	B-T122
-	O	O	O
based	O	O	B-T169
nanoparticles	O	O	B-T073
are	O	O	O
used	O	O	B-T169
as	O	O	O
vectors	O	O	B-T082
for	O	O	O
cancer	O	O	B-T191
drug	O	O	B-T169
delivery	O	O	I-T169
.	O	O	O

The	O	O	O
bioactive	O	O	B-T123
compounds	O	O	I-T123
(	O	O	O
quercetin	O	O	B-T127
,	O	O	O
ellagic	O	O	B-T109
acid	O	O	I-T109
and	O	O	O
gallic	O	O	B-T109
acid	O	O	I-T109
)	O	O	O
are	O	O	O
well	O	O	O
known	O	O	O
to	O	O	O
be	O	O	O
not	O	O	O
only	O	O	O
antioxidants	O	O	B-T121
but	O	O	O
also	O	O	O
chemopreventive	O	O	B-T121
candidates	O	O	I-T121
against	O	O	B-T080
various	O	O	B-T081
types	O	O	B-T080
of	O	O	O
cancers	O	O	B-T191
.	O	O	O

To	O	O	O
circumvent	O	O	O
the	O	O	O
low	O	O	B-T080
bioavailability	O	O	B-T081
and	O	O	O
the	O	O	O
short	O	O	B-T081
half-life	O	O	B-T079
time	O	O	B-T079
obstacles	O	O	B-T169
,	O	O	O
we	O	O	O
hypothesized	O	O	O
a	O	O	O
novel	O	O	B-T080
PLGA	O	O	B-T109
nano-platform	O	O	I-T109
functionalized	O	O	B-T169
with	O	O	O
CS	O	O	B-T109
and	O	O	O
PEG	O	O	B-T109
to	O	O	O
encapsulate	O	O	B-T080
these	O	O	O
phytochemicals	O	O	B-T109
.	O	O	O

This	O	O	O
encapsulation	O	O	B-T067
will	O	O	O
protect	O	O	B-T033
the	O	O	O
compounds	O	O	B-T121
from	O	O	O
the	O	O	O
phagocytic	O	O	B-T043
uptake	O	O	I-T043
and	O	O	O
deliver	O	O	B-T070
PLGA-CS-PEG	O	O	B-T121
nano-prototype	O	O	I-T121
with	O	O	O
high	O	O	O
biodegradability	O	O	B-T080
and	O	O	O
biosafety	O	O	B-T080
.	O	O	O

Three	O	O	O
consequent	O	O	O
types	O	O	B-T080
of	O	O	O
PLGA-based	O	O	B-T121
nanocomposites	O	O	I-T121
were	O	O	O
prepared	O	O	B-T052
and	O	O	O
characterized	O	O	B-T052
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
newly	O	O	O
synthesized	O	O	B-T052
nano-formulations	O	O	B-T073
against	O	O	B-T080
human	O	O	B-T016
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
(	O	O	O
HepG2	O	O	B-T025
)	O	O	O
and	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
HCT	O	O	B-T025
116	O	O	I-T025
)	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
using	O	O	B-T169
cell	O	O	B-T043
growth	O	O	I-T043
inhibition	O	O	I-T043
assays	O	O	B-T059
,	O	O	O
followed	O	O	B-T079
by	O	O	I-T079
apoptosis	O	O	B-T043
and	O	O	O
necrosis	O	O	B-T042
assays	O	O	O
using	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
to	O	O	O
detect	O	O	B-T059
the	O	O	O
underlying	O	O	O
mechanism	O	O	B-T169
of	O	O	O
HepG2	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
.	O	O	O

Through	O	O	O
Malvern	O	O	O
Zeta	O	O	O
Sizer	O	O	O
,	O	O	O
we	O	O	O
recorded	O	O	O
that	O	O	O
the	O	O	O
average	O	O	B-T081
diameters	O	O	B-T081
of	O	O	O
the	O	O	O
nano-prototypes	O	O	B-T073
ranged	O	O	O
from	O	O	O
150	O	O	O
to	O	O	O
300	O	O	O
nm	O	O	O
.	O	O	O

The	O	O	O
cytotoxic	O	O	B-T059
activity	O	O	I-T059
of	O	O	O
quercetin	O	O	B-T127
,	O	O	O
ellagic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
and	O	O	O
gallic	O	O	B-T109
acid	O	O	I-T109
-	O	O	O
encapsulated	O	O	B-T080
PLGA	O	O	B-T109
,	O	O	O
PLGA-CS	O	O	B-T121
,	O	O	O
and	O	O	O
PLGA-CS-PEG	O	O	B-T121
nano-prototypes	O	O	I-T121
it	O	O	O
has	O	O	O
been	O	O	O
found	O	O	B-T033
that	O	O	O
they	O	O	O
reduce	O	O	B-T080
the	O	O	O
IC50s	O	O	B-T081
of	O	O	O
the	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
values	O	O	B-T081
by	O	O	O
2.2	O	O	O
,	O	O	O
2.9	O	O	O
,	O	O	O
2.8-	O	O	O
folds	O	O	B-T081
,	O	O	O
1	O	O	O
,	O	O	O
1.5	O	O	O
,	O	O	O
2.7-	O	O	O
folds	O	O	O
,	O	O	O
and	O	O	O
0.9	O	O	O
,	O	O	O
0.7	O	O	O
,	O	O	O
1.5-	O	O	O
folds	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Mechanistically	O	O	O
,	O	O	O
the	O	O	O
nano-platforms	O	O	O
of	O	O	O
quercetin	O	O	B-T127
seem	O	O	O
to	O	O	O
be	O	O	O
dependent	O	O	B-T080
on	O	O	O
both	O	O	O
apoptosis	O	O	B-T043
and	O	O	O
necrosis	O	O	B-T042
,	O	O	O
while	O	O	O
those	O	O	O
of	O	O	O
ellagic	O	O	B-T109
acid	O	O	I-T109
and	O	O	O
gallic	O	O	B-T109
acid	O	O	I-T109
are	O	O	O
mainly	O	O	O
dependent	O	O	O
on	O	O	O
apoptosis	O	O	O
.	O	O	O

CS	O	O	B-T109
-	O	O	O
PEG	O	O	B-T109
-blended	O	O	O
PLGA	O	O	B-T109
nano-delivery	O	O	B-T169
system	O	O	I-T169
of	O	O	O
quercetin	O	O	B-T127
,	O	O	O
ellagic	O	O	B-T109
acid	O	O	I-T109
and	O	O	O
gallic	O	O	B-T109
acid	O	O	I-T109
can	O	O	O
potentiate	O	O	B-T052
apoptosis-mediated	O	O	B-T043
cell	O	O	B-T043
death	O	O	I-T043
in	O	O	O
HepG2	O	O	B-T025
cell	O	O	I-T025
line	O	O	I-T025
.	O	O	O

-DOCSTART- (28521617)

Fingerprint	O	O	B-T073
-based	O	O	O
background	O	O	B-T033
checks	O	O	I-T033
for	O	O	O
personal	O	O	B-T097
care	O	O	I-T097
workers	O	O	I-T097
:	O	O	O
Stakeholder	O	O	B-T098
views	O	O	B-T078
of	O	O	O
policy	O	O	B-T170
criteria	O	O	O

Decision	O	O	B-T098
makers	O	O	I-T098
face	O	O	O
difficult	O	O	O
choices	O	O	O
when	O	O	O
tasked	O	O	O
with	O	O	O
identifying	O	O	O
and	O	O	O
implementing	O	O	B-T052
appropriate	O	O	O
mechanisms	O	O	B-T169
for	O	O	O
protecting	O	O	B-T033
the	O	O	O
elderly	O	O	B-T098
and	O	O	O
other	O	O	O
vulnerable	O	O	B-T033
adults	O	O	I-T033
from	O	O	O
abuse	O	O	B-T051
.	O	O	O

A	O	O	O
pilot	O	O	B-T062
project	O	O	I-T062
involving	O	O	O
fingerprint	O	O	B-T073
-based	O	O	O
criminal	O	O	B-T098
history	O	O	O
background	O	O	B-T033
checks	O	O	I-T033
for	O	O	O
personal	O	O	B-T097
care	O	O	I-T097
workers	O	O	I-T097
in	O	O	O
Michigan	O	O	B-T083
has	O	O	O
supplied	O	O	O
an	O	O	O
opportunity	O	O	B-T062
to	O	O	O
examine	O	O	O
one	O	O	O
such	O	O	O
mechanism	O	O	B-T169
.	O	O	O

In	O	O	O
conjunction	O	O	B-T078
with	O	O	O
the	O	O	O
pilot	O	O	B-T062
project	O	O	I-T062
,	O	O	O
we	O	O	O
have	O	O	O
conducted	O	O	O
a	O	O	O
stakeholder	O	O	B-T097
analysis	O	O	B-T062
with	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
informing	O	O	O
decision	O	O	B-T098
makers	O	O	I-T098
about	O	O	O
stakeholder	O	O	O
perceptions	O	O	B-T041
of	O	O	O
standard	O	O	B-T170
policy	O	O	B-T170
criteria	O	O	B-T078
like	O	O	O
effectiveness	O	O	B-T080
,	O	O	O
efficiency	O	O	B-T081
,	O	O	O
and	O	O	O
equity	O	O	B-T080
.	O	O	O

We	O	O	O
employed	O	O	O
focus	O	O	B-UnknownType
groups	O	O	I-UnknownType
and	O	O	O
a	O	O	O
web-based	O	O	B-T170
survey	O	O	I-T170
to	O	O	O
collect	O	O	B-T062
data	O	O	B-T078
from	O	O	O
stakeholders	O	O	B-T098
.	O	O	O

While	O	O	O
stakeholders	O	O	B-T098
generally	O	O	O
see	O	O	O
fingerprint	O	O	B-T073
-based	O	O	O
background	O	O	B-T033
checks	O	O	I-T033
for	O	O	O
personal	O	O	B-T097
care	O	O	I-T097
workers	O	O	I-T097
as	O	O	O
potentially	O	O	O
effective	O	O	B-T080
and	O	O	O
as	O	O	O
a	O	O	O
net	O	O	B-T081
benefit	O	O	I-T081
,	O	O	O
they	O	O	O
also	O	O	O
point	O	O	O
to	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
contingencies	O	O	B-T051
.	O	O	O

They	O	O	O
also	O	O	O
recognize	O	O	O
difficulties	O	O	B-T033
and	O	O	O
constraints	O	O	B-T169
for	O	O	O
government	O	O	B-T092
involvement	O	O	B-T169
.	O	O	O

This	O	O	O
preliminary	O	O	B-T062
analysis	O	O	I-T062
provides	O	O	O
solid	O	O	O
foundational	O	O	B-T078
information	O	O	I-T078
for	O	O	O
decision	O	O	B-T098
makers	O	O	I-T098
and	O	O	O
for	O	O	O
more	O	O	O
extensive	O	O	O
benefit-cost	O	O	B-T057
analysis	O	O	I-T057
.	O	O	O

-DOCSTART- (28523090)

Penetrating	O	O	B-T169
Craniomaxillofacial	O	O	B-T037
Injury	O	O	I-T037
Caused	O	O	O
by	O	O	O
a	O	O	O
Pneumatic	O	O	O
Nail	O	O	O
Gun	O	O	O

Craniomaxillofacial	O	O	O
injuries	O	O	O
can	O	O	O
be	O	O	O
complex	O	O	O
,	O	O	O
requiring	O	O	O
a	O	O	O
multidisciplinary	O	O	O
approach	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	O
survey	O	O	O
is	O	O	O
always	O	O	O
the	O	O	O
first	O	O	O
step	O	O	O
in	O	O	O
trauma	O	O	O
management	O	O	O
prior	O	O	O
to	O	O	O
proceeding	O	O	O
with	O	O	O
further	O	O	O
evaluation	O	O	O
and	O	O	O
treatment	O	O	B-T169
.	O	O	O

A	O	O	O
26-	O	O	O
year	O	O	O
-old	O	O	O
man	O	O	O
presented	O	O	O
with	O	O	O
a	O	O	O
penetrating	O	O	B-T169
nail	O	O	O
gun	O	O	O
injury	O	O	O
through	O	O	O
the	O	O	O
oral	O	O	B-T030
and	O	O	O
nasal	O	O	B-T030
cavities	O	O	I-T030
.	O	O	O

He	O	O	O
did	O	O	O
not	O	O	O
present	O	O	O
in	O	O	O
extremis	O	O	O
but	O	O	O
required	O	O	O
elective	O	O	O
endotracheal	O	O	O
intubation	O	O	O
for	O	O	O
intraoperative	O	O	O
assessment	O	O	O
and	O	O	O
treatment	O	O	B-T169
.	O	O	O

Airway	O	O	O
management	O	O	O
was	O	O	O
enhanced	O	O	B-T052
by	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
lingual	O	O	B-T061
nerve	O	O	I-T061
and	O	O	O
inferior	O	O	B-T061
alveolar	O	O	I-T061
nerve	O	O	I-T061
blocks	O	O	I-T061
via	O	O	O
the	O	O	O
Vazirani-Akinosi	O	O	O
technique	O	O	O
to	O	O	O
maintain	O	O	B-T052
spontaneous	O	O	B-T033
respiration	O	O	I-T033
while	O	O	O
the	O	O	O
tongue	O	O	B-T023
was	O	O	O
distracted	O	O	B-T033
from	O	O	O
the	O	O	O
palate	O	O	B-T023
.	O	O	O

The	O	O	O
nail	O	O	O
was	O	O	O
removed	O	O	O
and	O	O	O
rapid	O	O	O
sequence	O	O	O
induction	O	O	O
initiated	O	O	O
for	O	O	O
orotracheal	O	O	O
intubation	O	O	O
.	O	O	O

Local	O	O	O
nerve	O	O	O
blocks	O	O	O
can	O	O	O
be	O	O	O
an	O	O	O
effective	O	O	O
tool	O	O	O
in	O	O	O
the	O	O	O
armamentarium	O	O	O
of	O	O	O
the	O	O	O
craniomaxillofacial	O	O	O
trauma	O	O	O
surgeon	O	O	O
in	O	O	O
managing	O	O	O
blunt	O	O	O
and	O	O	O
penetrating	O	O	O
injuries	O	O	O
.	O	O	O

We	O	O	O
demonstrate	O	O	O
its	O	O	O
utility	O	O	O
in	O	O	O
airway	O	O	O
management	O	O	O
when	O	O	O
a	O	O	O
penetrating	O	O	O
foreign	O	O	O
body	O	O	O
in	O	O	O
the	O	O	O
upper	O	O	B-T023
airway	O	O	I-T023
precludes	O	O	O
orotracheal	O	O	O
or	O	O	O
nasotracheal	O	O	O
intubation	O	O	O
.	O	O	O

-DOCSTART- (28523722)

Design	O	O	O
of	O	O	O
a	O	O	O
candidate	O	O	O
vibrational	O	O	B-T067
signal	O	O	I-T067
for	O	O	O
mating	O	O	B-T040
disruption	O	O	B-T169
against	O	O	O
the	O	O	O
glassy-winged	O	O	B-T204
sharpshooter	O	O	I-T204
,	O	O	O
Homalodisca	O	O	O
vitripennis	O	O	O

The	O	O	O
glassy-winged	O	O	B-T204
sharpshooter	O	O	I-T204
(	O	O	O
GWSS	O	O	B-T204
)	O	O	O
,	O	O	O
Homalodisca	O	O	B-T204
vitripennis	O	O	I-T204
,	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
pest	O	O	B-T204
of	O	O	O
grapevines	O	O	B-T002
due	O	O	O
to	O	O	O
its	O	O	O
ability	O	O	O
to	O	O	O
transmit	O	O	B-T169
Xylella	O	O	B-T007
fastidiosa	O	O	I-T007
,	O	O	O
the	O	O	O
causal	O	O	B-T001
agent	O	O	I-T001
of	O	O	O
Pierce	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

GWSS	O	O	B-T204
mating	O	O	B-T040
communication	O	O	B-T054
is	O	O	O
based	O	O	O
on	O	O	O
vibrational	O	O	B-T080
signals	O	O	I-T067
;	O	O	O
therefore	O	O	O
,	O	O	O
vibrational	O	O	O
mating	O	O	O
disruption	O	O	B-T169
could	O	O	O
be	O	O	O
an	O	O	O
alternative	O	O	B-T077
to	O	O	O
insecticides	O	O	B-T131
for	O	O	O
suppression	O	O	B-UnknownType
of	O	O	O
GWSS	O	O	O
population	O	O	B-T098
.	O	O	O

Our	O	O	O
objectives	O	O	B-T170
were	O	O	O
to	O	O	O
identify	O	O	O
spectral	O	O	B-T081
features	O	O	B-T080
of	O	O	O
female	O	O	B-T032
signal	O	O	B-T067
that	O	O	O
elicit	O	O	O
male	O	O	B-T032
signaling	O	O	B-T040
,	O	O	O
design	O	O	O
disruptive	O	O	B-T080
signals	O	O	B-T067
able	O	O	O
to	O	O	O
alter	O	O	B-T169
male	O	O	O
perception	O	O	B-T041
and	O	O	O
acceptance	O	O	B-T055
of	O	O	O
a	O	O	O
female	O	O	O
,	O	O	O
and	O	O	O
determine	O	O	O
the	O	O	O
signal	O	O	B-T081
intensity	O	O	I-T081
required	O	O	O
for	O	O	O
future	O	O	O
field	O	O	O
applications	O	O	O
.	O	O	O

Results	O	O	B-T033
showed	O	O	O
that	O	O	O
male	O	O	B-T032
responses	O	O	B-T032
to	O	O	O
playback	O	O	B-T052
of	O	O	O
modified	O	O	B-T169
female	O	O	B-T032
signals	O	O	B-T067
were	O	O	O
significantly	O	O	B-T078
reduced	O	O	B-T080
by	O	O	O
60	O	O	O
-	O	O	O
75%when	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
female	O	O	O
signal	O	O	B-T077
spectral	O	O	I-T077
components	O	O	I-T077
above	O	O	O
or	O	O	O
below	O	O	O
400	O	O	O
Hz	O	O	O
were	O	O	O
deleted	O	O	O
.	O	O	O

Playback	O	O	B-T052
bioassays	O	O	B-T059
showed	O	O	O
that	O	O	O
transmission	O	O	B-T070
of	O	O	O
an	O	O	O
80	O	O	O
Hz	O	O	O
pure	O	O	O
frequency	O	O	B-T079
tone	O	O	I-T079
to	O	O	O
plants	O	O	B-T002
completely	O	O	O
suppressed	O	O	B-T169
male	O	O	B-T032
signaling	O	O	B-T040
to	O	O	O
female	O	O	B-T032
signal	O	O	B-T052
playback	O	O	I-T052
,	O	O	O
even	O	O	O
if	O	O	O
the	O	O	O
disruptive	O	O	B-T080
signal	O	O	B-T082
amplitude	O	O	I-T082
was	O	O	O
10	O	O	O
dB	O	O	O
lower	O	O	O
than	O	O	O
the	O	O	O
female	O	O	O
signal	O	O	O
playback	O	O	O
.	O	O	O

Although	O	O	O
the	O	O	O
mechanism	O	O	B-T169
underlying	O	O	O
cessation	O	O	B-T052
of	O	O	O
male	O	O	B-T032
signaling	O	O	B-T040
activity	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
disruption	O	O	B-T169
is	O	O	O
not	O	O	O
yet	O	O	O
understood	O	O	O
,	O	O	O
results	O	O	B-T033
suggest	O	O	O
that	O	O	O
an	O	O	O
80	O	O	O
Hz	O	O	O
vibrational	O	O	B-T067
signal	O	O	I-T067
should	O	O	O
be	O	O	O
tested	O	O	O
in	O	O	O
laboratory	O	O	B-T093
and	O	O	O
field	O	O	B-T062
experiments	O	O	I-T062
to	O	O	O
assess	O	O	B-T052
its	O	O	O
efficacy	O	O	B-T080
in	O	O	O
disrupting	O	O	O
mating	O	O	B-T040
of	O	O	O
GWSS	O	O	B-T204
.	O	O	O

-DOCSTART- (28526000)

Barriers	O	O	B-T080
and	O	O	O
facilitators	O	O	B-T080
to	O	O	O
smoking	O	O	B-T055
cessation	O	O	I-T055
in	O	O	O
a	O	O	O
cancer	O	O	B-T191
context	O	O	B-T078
:	O	O	O
A	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
of	O	O	O
patient	O	O	B-T101
,	O	O	O
family	O	O	B-T099
and	O	O	O
professional	O	O	B-T097
views	O	O	O

Continued	O	O	B-T078
smoking	O	O	B-T055
after	O	O	O
cancer	O	O	B-T191
adversely	O	O	B-T046
affects	O	O	I-T046
quality	O	O	B-T184
of	O	O	I-T184
life	O	O	I-T184
and	O	O	O
survival	O	O	B-T169
,	O	O	O
but	O	O	O
one	O	O	O
fifth	O	O	O
of	O	O	O
cancer	O	O	O
survivors	O	O	B-T101
still	O	O	O
smoke	O	O	B-T055
.	O	O	O

Despite	O	O	O
its	O	O	O
demands	O	O	O
,	O	O	O
cancer	O	O	B-T191
presents	O	O	O
an	O	O	O
opportunity	O	O	O
for	O	O	O
positive	O	O	B-T033
behaviour	O	O	B-T055
change	O	O	I-T055
.	O	O	O

Smoking	O	O	B-T055
often	O	O	O
occurs	O	O	O
in	O	O	O
social	O	O	B-T098
groups	O	O	I-T098
,	O	O	O
therefore	O	O	O
interventions	O	O	B-T061
which	O	O	O
target	O	O	B-T169
families	O	O	B-T099
and	O	O	O
individuals	O	O	B-T098
may	O	O	O
be	O	O	O
more	O	O	O
successful	O	O	B-T080
.	O	O	O

This	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
explored	O	O	O
patients	O	O	B-T101
,	O	O	O
family	O	O	B-T099
members	O	O	I-T099
and	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
'	O	O	O
views	O	O	B-T080
and	O	O	O
experiences	O	O	B-T041
of	O	O	O
smoking	O	O	B-T055
and	O	O	O
smoking	O	O	B-T055
cessation	O	O	I-T055
after	O	O	O
cancer	O	O	B-T191
,	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
inform	O	O	O
future	O	O	O
interventions	O	O	B-T061
.	O	O	O

In-depth	O	O	B-T058
qualitative	O	O	I-T058
interviews	O	O	I-T058
(	O	O	O
n	O	O	O
=	O	O	O
67	O	O	O
)	O	O	O
with	O	O	O
29	O	O	O
patients	O	O	B-T101
,	O	O	O
14	O	O	O
family	O	O	B-T099
members	O	O	I-T099
and	O	O	O
24	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analysed	O	O	O
using	O	O	O
the	O	O	O
'	O	O	B-T169
Framework	O	O	I-T169
'	O	O	I-T169
method	O	O	I-T169
.	O	O	O

Few	O	O	O
patient	O	O	B-T101
s	O	O	O
and	O	O	O
family	O	O	B-T099
members	O	O	I-T099
had	O	O	O
used	O	O	O
National	O	O	B-T058
Health	O	O	I-T058
Service	O	O	I-T058
(	O	O	O
NHS	O	O	B-T058
)	O	O	O
smoking	O	O	B-T055
cessation	O	O	I-T055
services	O	O	B-T058
and	O	O	O
more	O	O	O
than	O	O	O
half	O	O	O
still	O	O	O
smoked	O	O	B-T055
.	O	O	O

Most	O	O	O
recalled	O	O	O
little	O	O	O
'	O	O	O
smoking	O	O	B-T055
-related	O	O	O
'	O	O	O
discussion	O	O	B-T061
with	O	O	O
clinicians	O	O	B-T097
but	O	O	O
were	O	O	O
receptive	O	O	O
to	O	O	O
talking	O	O	O
openly	O	O	O
.	O	O	O

Clinicians	O	O	B-T097
revealed	O	O	O
several	O	O	O
barriers	O	O	B-T080
to	O	O	O
discussion	O	O	B-T061
.	O	O	O

Participants	O	O	B-T098
'	O	O	O
continued	O	O	B-T078
smoking	O	O	B-T055
was	O	O	O
explained	O	O	O
by	O	O	O
the	O	O	O
stress	O	O	B-T033
of	O	O	O
diagnosis	O	O	B-T060
;	O	O	O
desire	O	O	O
to	O	O	O
maintain	O	O	O
personal	O	O	B-T032
control	O	O	B-T080
;	O	O	O
and	O	O	O
lack	O	O	B-T080
of	O	O	O
connection	O	O	O
between	O	O	O
smoking	O	O	O
,	O	O	O
cancer	O	O	B-T191
and	O	O	O
health	O	O	B-T078
.	O	O	O

A	O	O	O
range	O	O	O
of	O	O	O
barriers	O	O	B-T080
to	O	O	O
smoking	O	O	B-T055
cessation	O	O	I-T055
exist	O	O	O
for	O	O	O
patients	O	O	B-T101
and	O	O	O
family	O	O	B-T099
members	O	O	I-T099
.	O	O	O

These	O	O	O
are	O	O	O
insufficiently	O	O	B-T080
assessed	O	O	B-T052
and	O	O	O
considered	O	O	O
by	O	O	O
clinicians	O	O	B-T097
.	O	O	O

Interventions	O	O	B-T061
must	O	O	O
be	O	O	O
more	O	O	O
effectively	O	O	O
integrated	O	O	O
into	O	O	O
routine	O	O	O
practice	O	O	O
.	O	O	O

-DOCSTART- (28526485)

Improving	O	O	B-T080
the	O	O	O
Sexual	O	O	B-T032
Health	O	O	I-T032
of	O	O	O
Young	O	O	B-T100
People	O	O	I-T100
With	O	O	O
Mobility	O	O	B-T033
Impairments	O	O	I-T033
:	O	O	O
Challenges	O	O	B-T058
and	O	O	O
Recommendations	O	O	O

This	O	O	O
mixed-method	O	O	B-T062
study	O	O	I-T062
(	O	O	O
a	O	O	O
)	O	O	O
describes	O	O	O
challenges	O	O	B-T058
to	O	O	O
providing	O	O	B-T052
sexual	O	O	B-T032
health	O	O	I-T032
services	O	O	B-T058
to	O	O	O
youth	O	O	B-T100
with	O	O	O
mobility	O	O	B-T033
impairments	O	O	I-T033
from	O	O	O
the	O	O	O
perspective	O	O	B-T082
of	O	O	O
health	O	O	B-T097
care	O	O	I-T097
providers	O	O	I-T097
and	O	O	O
experts	O	O	B-T097
and	O	O	O
(	O	O	O
b	O	O	O
)	O	O	O
describes	O	O	O
and	O	O	O
compares	O	O	B-T052
sexual	O	O	O
health	O	O	O
-related	O	O	O
experiences	O	O	B-T041
of	O	O	O
youth	O	O	O
with	O	O	O
mobility	O	O	O
impairments	O	O	O
.	O	O	O

Secondary	O	O	B-UnknownType
data	O	O	I-UnknownType
analysis	O	O	I-UnknownType
of	O	O	I-UnknownType
My	O	O	I-UnknownType
Path	O	O	I-UnknownType
,	O	O	O
a	O	O	O
study	O	O	B-T062
focused	O	O	B-T169
on	O	O	O
the	O	O	O
transition	O	O	B-T052
to	O	O	O
adulthood	O	O	B-T079
for	O	O	O
youth	O	O	B-T100
with	O	O	O
mobility	O	O	B-T033
impairments	O	O	I-T033
.	O	O	O

Using	O	O	O
an	O	O	O
exploratory	O	O	B-T062
sequential	O	O	I-T062
design	O	O	I-T062
,	O	O	O
qualitative	O	O	B-UnknownType
data	O	O	I-UnknownType
(	O	O	O
n	O	O	O
=	O	O	O
10	O	O	O
)	O	O	O
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
systematic	O	O	B-T169
content	O	O	B-T062
analysis	O	O	I-T062
followed	O	O	O
by	O	O	O
quantitative	O	O	B-UnknownType
analysis	O	O	I-UnknownType
of	O	O	I-UnknownType
survey	O	O	I-UnknownType
data	O	O	I-UnknownType
(	O	O	O
N	O	O	O
=	O	O	O
337	O	O	O
)	O	O	O
.	O	O	O

Challenges	O	O	B-T058
included	O	O	B-T169
not	O	O	B-T080
talking	O	O	I-T080
about	O	O	O
sex	O	O	B-T032
,	O	O	O
managing	O	O	O
sexual	O	O	B-T040
development	O	O	I-T040
,	O	O	O
adaptation	O	O	B-T040
and	O	O	O
instruction	O	O	B-T170
,	O	O	O
parent	O	O	B-T054
roles	O	O	I-T054
,	O	O	O
and	O	O	O
safety	O	O	B-T068
.	O	O	O

Survey	O	O	B-T170
data	O	O	B-T078
showed	O	O	O
that	O	O	O
youth	O	O	B-T100
with	O	O	O
mobility	O	O	B-T033
impairments	O	O	I-T033
are	O	O	O
diverse	O	O	B-T080
in	O	O	O
their	O	O	O
experiences	O	O	B-T041
with	O	O	O
sexual	O	O	B-T053
behavior	O	O	I-T053
and	O	O	O
sources	O	O	B-T033
of	O	O	O
sexual	O	O	B-T032
health	O	O	I-T032
information	O	O	B-T078
.	O	O	O

Although	O	O	O
connected	O	O	B-T052
with	O	O	O
primary	O	O	B-T097
care	O	O	I-T097
providers	O	O	I-T097
,	O	O	O
few	O	O	O
received	O	O	B-T080
information	O	O	B-T078
about	O	O	O
sexual	O	O	B-T032
health	O	O	I-T032
.	O	O	O

Interventions	O	O	B-T058
to	O	O	O
improve	O	O	B-T033
youths	O	O	B-T100
'	O	O	O
well-being	O	O	B-T078
should	O	O	O
include	O	O	B-T052
comprehensive	O	O	B-T058
care	O	O	I-T058
and	O	O	O
education	O	O	B-T065
that	O	O	O
promotes	O	O	B-T052
and	O	O	O
supports	O	O	B-T077
healthy	O	O	B-T080
sexual	O	O	B-T040
development	O	O	I-T040
.	O	O	O

-DOCSTART- (28526692)

Understanding	O	O	B-T041
the	O	O	O
interrelationship	O	O	B-T080
between	O	O	O
the	O	O	O
synthesis	O	O	B-T038
of	O	O	O
urea	O	O	B-T109
and	O	O	O
gluconeogenesis	O	O	B-T044
by	O	O	O
formulating	O	O	O
an	O	O	O
overall	O	O	B-T080
balanced	O	O	O
equation	O	O	O

It	O	O	O
is	O	O	O
well	O	O	O
known	O	O	O
that	O	O	O
a	O	O	O
strong	O	O	O
metabolic	O	O	B-T169
interrelationship	O	O	B-T080
exists	O	O	O
between	O	O	O
ureagenesis	O	O	B-T044
and	O	O	O
gluconeogenesis	O	O	B-T044
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
a	O	O	O
detailed	O	O	O
,	O	O	O
overall	O	O	B-T080
equation	O	O	B-T077
,	O	O	O
describing	O	O	O
a	O	O	O
possible	O	O	O
metabolic	O	O	B-T169
link	O	O	B-T082
between	O	O	O
ureagenesis	O	O	B-T044
and	O	O	O
gluconeogenesis	O	O	B-T044
.	O	O	O

We	O	O	O
adopted	O	O	O
a	O	O	O
guided	O	O	B-T082
approach	O	O	I-T082
in	O	O	O
which	O	O	O
we	O	O	O
strongly	O	O	O
suggest	O	O	O
that	O	O	O
students	O	O	B-T098
,	O	O	O
when	O	O	O
faced	O	O	O
with	O	O	O
the	O	O	O
problem	O	O	B-T033
of	O	O	O
obtaining	O	O	B-T052
the	O	O	O
overall	O	O	B-T080
equation	O	O	B-T077
of	O	O	O
a	O	O	O
metabolic	O	O	B-T169
pathway	O	O	I-T169
,	O	O	O
carefully	O	O	O
account	O	O	O
for	O	O	O
all	O	O	O
atoms	O	O	B-T196
and	O	O	O
charges	O	O	B-T032
of	O	O	O
the	O	O	O
single	O	O	O
reactions	O	O	B-T169
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
cellular	O	O	B-T043
localizations	O	O	I-T043
of	O	O	O
the	O	O	O
substrates	O	O	B-T167
,	O	O	O
and	O	O	O
the	O	O	O
related	O	O	O
transport	O	O	B-T044
systems	O	O	B-T169
.	O	O	O

If	O	O	O
this	O	O	O
suggestion	O	O	O
is	O	O	O
always	O	O	O
taken	O	O	O
into	O	O	O
account	O	O	O
,	O	O	O
a	O	O	O
balanced	O	O	B-T169
,	O	O	O
overall	O	O	B-T080
equation	O	O	B-T077
of	O	O	O
a	O	O	O
metabolic	O	O	B-T169
pathway	O	O	I-T169
will	O	O	O
be	O	O	O
obtained	O	O	O
,	O	O	O
which	O	O	O
strongly	O	O	O
facilitates	O	O	O
the	O	O	O
discussion	O	O	O
of	O	O	O
its	O	O	O
physiological	O	O	B-T169
role	O	O	O
.	O	O	O

Unfortunately	O	O	O
,	O	O	O
textbooks	O	O	B-T073
often	O	O	O
report	O	O	B-T170
unbalanced	O	O	O
overall	O	O	B-T080
equations	O	O	B-T077
of	O	O	O
metabolic	O	O	B-T169
pathways	O	O	I-T169
,	O	O	O
including	O	O	O
ureagenesis	O	O	B-T044
and	O	O	O
gluconeogenesis	O	O	B-T044
.	O	O	O

Most	O	O	O
likely	O	O	O
the	O	O	O
reason	O	O	O
is	O	O	O
that	O	O	O
metabolism	O	O	B-T040
and	O	O	O
enzymology	O	O	B-T169
have	O	O	O
been	O	O	O
neglected	O	O	O
for	O	O	O
about	O	O	O
three	O	O	O
decades	O	O	O
,	O	O	O
owing	O	O	O
to	O	O	O
the	O	O	O
remarkable	O	O	O
advances	O	O	O
of	O	O	O
molecular	O	O	B-T091
biology	O	O	I-T091
and	O	O	O
molecular	O	O	B-T091
genetics	O	O	I-T091
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	B-T170
,	O	O	O
we	O	O	O
strongly	O	O	O
suggest	O	O	O
that	O	O	O
students	O	O	B-T098
,	O	O	O
when	O	O	O
faced	O	O	O
with	O	O	O
the	O	O	O
problem	O	O	O
of	O	O	O
obtaining	O	O	O
the	O	O	O
overall	O	O	B-T080
reaction	O	O	B-T169
of	O	O	O
a	O	O	O
metabolic	O	O	B-T169
pathway	O	O	I-T169
,	O	O	O
carefully	O	O	O
control	O	O	O
if	O	O	O
the	O	O	O
single	O	O	O
reactions	O	O	B-T169
are	O	O	O
properly	O	O	O
balanced	O	O	B-T169
for	O	O	O
atoms	O	O	B-T196
and	O	O	O
charges	O	O	B-T032
.	O	O	O

Following	O	O	O
this	O	O	O
suggestion	O	O	B-T078
,	O	O	O
we	O	O	O
were	O	O	O
able	O	O	O
to	O	O	O
obtain	O	O	O
an	O	O	O
overall	O	O	B-T080
equation	O	O	B-T077
describing	O	O	O
the	O	O	O
metabolic	O	O	B-T169
interrelationship	O	O	B-T080
between	O	O	O
ureagenesis	O	O	B-T044
and	O	O	O
gluconeogenesis	O	O	B-T044
,	O	O	O
in	O	O	O
which	O	O	O
urea	O	O	B-T109
and	O	O	O
glucose	O	O	B-T109
are	O	O	O
the	O	O	O
final	O	O	B-T079
products	O	O	B-T071
.	O	O	O

The	O	O	O
aim	O	O	O
is	O	O	O
to	O	O	O
better	O	O	O
rationalize	O	O	B-T169
this	O	O	O
topic	O	O	B-T078
and	O	O	O
to	O	O	O
convince	O	O	O
students	O	O	B-T098
and	O	O	O
teachers	O	O	B-T097
that	O	O	O
metabolism	O	O	B-T040
is	O	O	O
an	O	O	O
important	O	O	O
and	O	O	O
rewarding	O	O	O
chapter	O	O	B-T078
of	O	O	O
human	O	O	B-T091
physiology	O	O	I-T091
.	O	O	O

-DOCSTART- (28526816)

Delineation	O	O	O
of	O	O	O
B-cell	O	O	B-T025
Epitopes	O	O	B-T129
of	O	O	O
Salmonella	O	O	B-T007
enterica	O	O	I-T007
serovar	O	O	I-T007
Typhi	O	O	I-T007
Hemolysin	O	O	B-T116
E	O	O	I-T116
:	O	O	O
Potential	O	O	B-T080
antibody	O	O	B-T116
therapeutic	O	O	B-T061
target	O	O	O

Hemolysin	O	O	B-T116
E	O	O	I-T116
(	O	O	O
HlyE	O	O	B-T116
)	O	O	O
is	O	O	O
an	O	O	O
immunogenic	O	O	B-T169
novel	O	O	B-T080
pore	O	O	B-T026
-forming	O	O	O
toxin	O	O	B-T109
involved	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
typhoid	O	O	B-T047
fever	O	O	I-T047
.	O	O	O

Thus	O	O	O
,	O	O	O
mapping	O	O	B-T052
of	O	O	O
B-cell	O	O	B-T025
epitopes	O	O	B-T129
of	O	O	O
Salmonella	O	O	B-T007
enterica	O	O	I-T007
serovar	O	O	I-T007
Typhi	O	O	I-T007
(	O	O	O
S.	O	O	B-T007
Typhi	O	O	I-T007
)	O	O	O
is	O	O	O
critical	O	O	B-T080
to	O	O	O
identify	O	O	O
key	O	O	O
immunogenic	O	O	B-T082
regions	O	O	I-T082
of	O	O	O
HlyE.	O	O	O
A	O	O	O
random	O	O	O
20-mer	O	O	O
peptide	O	O	B-T116
library	O	O	I-T116
was	O	O	O
used	O	O	O
for	O	O	O
biopanning	O	O	O
with	O	O	O
enriched	O	O	O
anti-HlyE	O	O	B-T116
polyclonal	O	O	I-T116
antibodies	O	O	I-T116
from	O	O	O
typhoid	O	O	B-T047
patient	O	O	B-T101
sera	O	O	B-T031
.	O	O	O

Bioinformatic	O	O	B-T091
tools	O	O	B-T170
were	O	O	O
used	O	O	O
to	O	O	O
refine	O	O	O
,	O	O	O
analyze	O	O	B-T062
and	O	O	O
map	O	O	B-T052
the	O	O	O
enriched	O	O	O
peptide	O	O	B-T087
sequences	O	O	I-T087
against	O	O	O
the	O	O	O
protein	O	O	B-T116
to	O	O	O
identify	O	O	O
the	O	O	O
epitopes	O	O	B-T129
.	O	O	O

The	O	O	O
analysis	O	O	B-T062
identified	O	O	O
both	O	O	O
linear	O	O	B-T082
and	O	O	O
conformational	O	O	B-T082
epitopes	O	O	B-T129
on	O	O	O
the	O	O	O
HlyE	O	O	B-T116
protein	O	O	I-T116
.	O	O	O

The	O	O	O
predicted	O	O	B-T078
linear	O	O	B-T082
GAAAGIVAG	O	O	B-T087
and	O	O	O
conformational	O	O	B-T082
epitope	O	O	B-T129
PYSQESVLSADSQNQK	O	O	B-T087
were	O	O	O
further	O	O	O
validated	O	O	O
against	O	O	O
the	O	O	O
pooled	O	O	O
sera	O	O	B-T031
.	O	O	O

The	O	O	O
identified	O	O	O
epitopes	O	O	B-T129
were	O	O	O
then	O	O	O
used	O	O	O
to	O	O	O
isolate	O	O	B-T061
epitope	O	O	B-T129
specific	O	O	O
monoclonal	O	O	B-T116
antibodies	O	O	I-T116
by	O	O	O
antibody	O	O	B-T116
phage	O	O	B-T063
display	O	O	I-T063
.	O	O	O

Monoclonal	O	O	B-T116
scFv	O	O	I-T116
antibodies	O	O	B-T116
were	O	O	O
enriched	O	O	O
for	O	O	O
both	O	O	O
linear	O	O	B-T082
and	O	O	O
conformational	O	O	B-T082
epitopes	O	O	B-T129
.	O	O	O

Molecular	O	O	B-T170
docking	O	O	I-T170
was	O	O	O
performed	O	O	O
to	O	O	O
elucidate	O	O	O
the	O	O	O
antigen-antibody	O	O	B-T039
interaction	O	O	I-T039
of	O	O	O
the	O	O	O
monoclonal	O	O	B-T116
antibodies	O	O	I-T116
against	O	O	O
the	O	O	O
epitopes	O	O	B-T129
on	O	O	O
the	O	O	O
HlyE	O	O	B-T116
monomer	O	O	B-T116
and	O	O	O
oligomer	O	O	B-T087
structure	O	O	I-T087
.	O	O	O

An	O	O	O
in-depth	O	O	O
view	O	O	O
of	O	O	O
the	O	O	O
mechanistic	O	O	O
and	O	O	O
positional	O	O	B-T033
characteristics	O	O	B-T080
of	O	O	O
the	O	O	O
antibodies	O	O	B-T116
and	O	O	O
epitope	O	O	B-T129
for	O	O	O
HlyE	O	O	B-T116
was	O	O	O
successfully	O	O	O
accomplished	O	O	O
by	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
phage	O	O	B-T063
display	O	O	I-T063
and	O	O	O
bioinformatic	O	O	B-T091
analysis	O	O	B-T062
.	O	O	O

The	O	O	O
predicted	O	O	B-T078
function	O	O	B-T169
and	O	O	O
structure	O	O	B-T082
of	O	O	O
the	O	O	O
antibodies	O	O	B-T116
highlights	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
utilizing	O	O	O
the	O	O	O
antibodies	O	O	O
as	O	O	O
neutralizing	O	O	B-T121
agents	O	O	I-T121
for	O	O	O
typhoid	O	O	B-T047
fever	O	O	I-T047
.	O	O	O

-DOCSTART- (28532107)

Comparison	O	O	B-T052
of	O	O	O
electrospun	O	O	B-T067
and	O	O	O
solvent	O	O	B-T067
cast	O	O	I-T067
polylactic	O	O	B-T109
acid	O	O	I-T109
(PLA)/	O	O	O
poly(vinyl	O	O	B-T122
alcohol	O	O	I-T122
)	O	O	I-T122
(	O	O	O
PVA	O	O	B-T122
)	O	O	O
inserts	O	O	B-T122
as	O	O	O
potential	O	O	O
ocular	O	O	B-T023
drug	O	O	O
delivery	O	O	O
vehicles	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
work	O	O	O
was	O	O	O
to	O	O	O
develop	O	O	O
,	O	O	O
characterize	O	O	O
and	O	O	O
compare	O	O	O
electrospun	O	O	B-T073
nanofiber	O	O	I-T073
inserts	O	O	B-T122
(	O	O	O
ENIs	O	O	B-T073
)	O	O	O
and	O	O	O
solvent	O	O	B-T067
cast	O	O	I-T067
polymeric	O	O	B-T122
inserts	O	O	O
(	O	O	O
SCIs	O	O	B-T122
)	O	O	O
for	O	O	O
ocular	O	O	B-T023
drug	O	O	B-T074
delivery	O	O	I-T074
.	O	O	O

ENI	O	O	B-T073
and	O	O	O
SCI	O	O	B-T122
of	O	O	O
1	O	O	O
%	O	O	O
,	O	O	O
5	O	O	O
%	O	O	O
and	O	O	O
10	O	O	O
%	O	O	O
w/w	O	O	O
dexamethasone	O	O	B-T109
were	O	O	O
fabricated	O	O	B-T067
using	O	O	O
a	O	O	O
blend	O	O	B-T068
of	O	O	O
poly-lactic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
PLA	O	O	B-T109
)	O	O	O
and	O	O	O
poly-vinyl	O	O	B-T122
alcohol	O	O	I-T122
(	O	O	O
PVA	O	O	B-T122
)	O	O	O
.	O	O	O

Inserts	O	O	B-T122
were	O	O	O
characterized	O	O	O
for	O	O	O
morphology	O	O	B-T080
,	O	O	O
thickness	O	O	B-T080
,	O	O	O
pH	O	O	B-T081
,	O	O	O
drug	O	O	B-T077
content	O	O	B-T077
,	O	O	O
drug	O	O	B-T080
crystallinity	O	O	I-T080
,	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
drug	O	O	B-T070
release	O	O	I-T070
,	O	O	O
sterility	O	O	B-T080
,	O	O	O
dimethylformamide	O	O	B-T109
(	O	O	O
DMF	O	O	B-T109
)	O	O	O
and	O	O	O
chloroform	O	O	B-T109
content	O	O	O
,	O	O	O
and	O	O	O
cytotoxicity	O	O	B-T049
.	O	O	O

The	O	O	O
thickness	O	O	B-T080
of	O	O	O
1	O	O	O
%	O	O	O
,	O	O	O
5	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
10	O	O	O
%	O	O	O
dexamethasone	O	O	B-T109
-loaded	O	O	O
ENIs	O	O	B-T073
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
50μm	O	O	O
,	O	O	O
62.5μm	O	O	O
,	O	O	O
and	O	O	O
93.3μm	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
with	O	O	O
good	O	O	O
folding	O	O	B-T033
endurance	O	O	I-T033
.	O	O	O

SCIs	O	O	B-T122
were	O	O	O
brittle	O	O	B-T033
,	O	O	O
with	O	O	O
thickness	O	O	B-T080
values	O	O	O
>	O	O	O
200μm	O	O	O
.	O	O	O

Drug	O	O	B-T070
release	O	O	I-T070
rates	O	O	B-T081
from	O	O	O
1	O	O	O
%	O	O	O
,	O	O	O
5	O	O	O
%	O	O	O
and	O	O	O
10	O	O	O
%	O	O	O
ENIs	O	O	B-T073
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
0.62μg/h	O	O	O
,	O	O	O
1.46μg/h	O	O	O
,	O	O	O
and	O	O	O
2.30μg/h	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
while	O	O	O
those	O	O	O
from	O	O	O
SCIs	O	O	B-T122
were	O	O	O
erratic	O	O	O
.	O	O	O

DMF	O	O	B-T109
content	O	O	B-T077
in	O	O	O
ENIs	O	O	B-T073
and	O	O	O
SCIs	O	O	B-T122
were	O	O	O
0.007	O	O	O
%	O	O	O
w/w	O	O	O
and	O	O	O
0.123	O	O	O
%	O	O	O
w/w	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
while	O	O	O
chloroform	O	O	B-T109
was	O	O	O
not	O	O	B-T033
detected	O	O	I-T033
.	O	O	O

No	O	O	B-T033
cytotoxicity	O	O	B-T049
was	O	O	O
observed	O	O	O
from	O	O	O
ENIs	O	O	B-T073
in	O	O	O
cultured	O	O	B-T025
bovine	O	O	B-T015
corneal	O	O	B-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
for	O	O	O
up	O	O	O
to	O	O	O
24h	O	O	O
.	O	O	O

We	O	O	O
conclude	O	O	O
that	O	O	O
ENIs	O	O	B-T073
are	O	O	O
better	O	O	O
than	O	O	O
SCIs	O	O	B-T122
and	O	O	O
could	O	O	O
be	O	O	O
utilized	O	O	O
as	O	O	O
a	O	O	O
potential	O	O	O
delivery	O	O	B-T074
system	O	O	I-T074
for	O	O	O
treating	O	O	B-T169
anterior	O	O	B-T082
segment	O	O	I-T082
ocular	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

-DOCSTART- (28532323)

Quantitative	O	O	B-T081
regulation	O	O	B-T038
of	O	O	O
histone	O	O	B-T116
variant	O	O	I-T116
H2A.Z	O	O	I-T116
during	O	O	B-T079
cell	O	O	B-T043
cycle	O	O	I-T043
by	O	O	O
ubiquitin	O	O	B-T044
proteasome	O	O	I-T044
system	O	O	I-T044
and	O	O	O
SUMO-targeted	O	O	O
ubiquitin	O	O	O
ligases	O	O	O

Quantitative	O	O	B-T081
control	O	O	B-T169
of	O	O	O
histones	O	O	B-T116
and	O	O	O
histone	O	O	B-T116
variants	O	O	I-T116
during	O	O	B-T079
cell	O	O	B-T043
cycle	O	O	I-T043
is	O	O	O
relevant	O	O	B-T080
to	O	O	O
their	O	O	O
epigenetic	O	O	B-T043
functions	O	O	I-T043
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
yeast	O	O	B-T116
histone	O	O	I-T116
variant	O	O	I-T116
H2A.Z	O	O	I-T116
in	O	O	O
the	O	O	O
G2/M-phase	O	O	B-T043
is	O	O	O
actively	O	O	B-T169
kept	O	O	O
low	O	O	O
by	O	O	O
the	O	O	O
ubiquitin	O	O	B-T044
proteasome	O	O	I-T044
system	O	O	I-T044
and	O	O	O
SUMO-targeted	O	O	B-T026
ubiquitin	O	O	I-T026
ligases	O	O	I-T026
.	O	O	O

Overexpression	O	O	B-T045
of	O	O	O
H2A.Z	O	O	B-T116
induced	O	O	B-T043
defects	O	O	I-T043
in	O	O	I-T043
mitotic	O	O	I-T043
progression	O	O	I-T043
,	O	O	O
suggesting	O	O	B-T078
functional	O	O	B-T169
importance	O	O	B-T080
of	O	O	O
this	O	O	O
quantitative	O	O	B-T081
control	O	O	B-T169
.	O	O	O

-DOCSTART- (28532624)

Tyrphostin	O	O	B-T121
AG-related	O	O	I-T121
compounds	O	O	I-T121
attenuate	O	O	O
H2O2	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
TRPM2	O	O	B-T116
-	O	O	O
dependent	O	O	B-T080
and	O	O	O
-	O	O	O
independent	O	O	B-T169
cellular	O	O	B-T025
responses	O	O	O

TRPM2	O	O	B-T116
is	O	O	O
a	O	O	O
Ca(2+)-permeable	O	O	B-T116
channel	O	O	I-T116
that	O	O	O
is	O	O	O
activated	O	O	B-T052
by	O	O	O
H2O2	O	O	B-T121
.	O	O	O

TRPM2	O	O	B-T116
-mediated	O	O	O
Ca(2	O	O	B-T043
+	O	O	I-T043
)	O	O	I-T043
signaling	O	O	I-T043
has	O	O	O
been	O	O	O
implicated	O	O	O
in	O	O	O
the	O	O	O
aggravation	O	O	B-T033
of	O	O	O
inflammatory	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
TRPM2	O	O	B-T116
inhibitors	O	O	B-T121
to	O	O	O
prevent	O	O	O
the	O	O	O
aggravation	O	O	B-T033
of	O	O	O
these	O	O	O
diseases	O	O	B-T047
is	O	O	O
expected	O	O	O
.	O	O	O

We	O	O	O
recently	O	O	O
reported	O	O	O
that	O	O	O
some	O	O	O
Tyrphostin	O	O	B-T121
AG-related	O	O	I-T121
compounds	O	O	I-T121
inhibited	O	O	B-T080
the	O	O	O
H2O2	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
activation	O	O	B-T052
of	O	O	O
TRPM2	O	O	B-T116
by	O	O	O
scavenging	O	O	B-T044
the	O	O	I-T044
intracellular	O	O	I-T044
hydroxyl	O	O	I-T044
radical	O	O	I-T044
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
AG-related	O	O	B-T121
compounds	O	O	I-T121
on	O	O	O
H2O2	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
cellular	O	O	B-T025
responses	O	O	B-T032
in	O	O	O
human	O	O	B-T016
monocytic	O	O	B-T025
U937	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
which	O	O	O
functionally	O	O	B-T169
express	O	O	B-T045
TRPM2	O	O	B-T116
.	O	O	O

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
AG-related	O	O	B-T121
compounds	O	O	I-T121
on	O	O	O
H2O2	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
changes	O	O	B-T169
in	O	O	O
intracellular	O	O	B-T082
Ca(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
concentrations	O	O	B-T081
,	O	O	O
extracellular	O	O	B-T116
signal-regulated	O	O	I-T116
kinase	O	O	I-T116
(	O	O	O
ERK	O	O	B-T116
)	O	O	O
activation	O	O	B-T052
,	O	O	O
and	O	O	O
CXCL8	O	O	B-T116
secretion	O	O	B-T043
were	O	O	O
assessed	O	O	O
using	O	O	O
U937	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Ca(2	O	O	B-T043
+	O	O	I-T043
)	O	O	I-T043
influxes	O	O	I-T043
via	O	O	O
TRPM2	O	O	B-T116
in	O	O	O
response	O	O	O
to	O	O	O
H2O2	O	O	B-T121
were	O	O	O
blocked	O	O	B-T046
by	O	O	O
AG-related	O	O	B-T121
compounds	O	O	I-T121
.	O	O	O

AG-related	O	O	B-T121
compounds	O	O	I-T121
also	O	O	O
inhibited	O	O	B-T080
the	O	O	O
H2O2	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
activation	O	O	B-T052
of	O	O	O
ERK	O	O	B-T116
,	O	O	O
and	O	O	O
subsequent	O	O	O
secretion	O	O	B-T043
of	O	O	O
CXCL8	O	O	B-T116
mediated	O	O	O
by	O	O	O
TRPM2	O	O	B-T116
-	O	O	O
dependent	O	O	B-T080
and	O	O	O
-	O	O	O
independent	O	O	B-T169
mechanisms	O	O	B-T169
.	O	O	O

Our	O	O	O
results	O	O	O
show	O	O	O
that	O	O	O
AG-related	O	O	B-T121
compounds	O	O	I-T121
inhibit	O	O	B-T080
H2O2	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
CXCL8	O	O	B-T116
secretion	O	O	B-T043
following	O	O	O
ERK	O	O	B-T116
activation	O	O	B-T052
,	O	O	O
which	O	O	O
is	O	O	O
mediated	O	O	O
by	O	O	O
TRPM2	O	O	B-T116
-	O	O	O
dependent	O	O	B-T080
and	O	O	O
-	O	O	O
independent	O	O	B-T169
mechanisms	O	O	B-T169
in	O	O	O
U937	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

We	O	O	O
previously	O	O	O
reported	O	O	O
that	O	O	O
AG-related	O	O	B-T121
compounds	O	O	I-T121
blocked	O	O	B-T046
H2O2	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
TRPM2	O	O	B-T116
activation	O	O	B-T052
by	O	O	O
scavenging	O	O	B-T044
the	O	O	I-T044
hydroxyl	O	O	I-T044
radical	O	O	I-T044
.	O	O	O

The	O	O	O
inhibitory	O	O	B-T052
effects	O	O	B-T080
of	O	O	O
AG-related	O	O	B-T121
compounds	O	O	I-T121
on	O	O	O
TRPM2	O	O	B-T116
-	O	O	O
independent	O	O	B-T169
responses	O	O	B-T032
may	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
scavenging	O	O	B-T044
of	O	O	I-T044
the	O	O	I-T044
hydroxyl	O	O	I-T044
radical	O	O	I-T044
.	O	O	O

-DOCSTART- (28532629)

Shared	O	O	B-T041
decision	O	O	I-T041
making	O	O	I-T041
in	O	O	O
the	O	O	O
UK	O	O	B-T083
:	O	O	O
Moving	O	O	O
towards	O	O	O
wider	O	O	O
uptake	O	O	O

Shared	O	O	B-T041
decision	O	O	I-T041
making	O	O	I-T041
(	O	O	O
SDM	O	O	B-T041
)	O	O	O
is	O	O	O
firmly	O	O	O
on	O	O	O
the	O	O	O
policy	O	O	B-T170
agenda	O	O	B-T170
in	O	O	O
the	O	O	O
UK	O	O	B-T083
and	O	O	O
a	O	O	O
recent	O	O	O
legal	O	O	B-T169
ruling	O	O	B-T064
has	O	O	O
confirmed	O	O	O
its	O	O	O
importance	O	O	O
.	O	O	O

Policymakers	O	O	B-T097
,	O	O	O
ethicists	O	O	B-T097
,	O	O	O
professional	O	O	B-T097
regulators	O	O	I-T097
and	O	O	O
societies	O	O	B-T092
,	O	O	O
patient	O	O	B-T092
organisations	O	O	I-T092
and	O	O	O
now	O	O	O
the	O	O	O
courts	O	O	B-T092
are	O	O	O
committed	O	O	O
to	O	O	O
ensuring	O	O	O
that	O	O	O
SDM	O	O	B-T041
becomes	O	O	O
the	O	O	O
norm	O	O	B-T080
throughout	O	O	O
the	O	O	O
NHS	O	O	B-T058
,	O	O	O
but	O	O	O
an	O	O	O
unfavourable	O	O	O
economic	O	O	B-UnknownType
climate	O	O	I-UnknownType
makes	O	O	O
this	O	O	O
especially	O	O	O
challenging	O	O	O
.	O	O	O

Considerable	O	O	O
progress	O	O	B-T169
has	O	O	O
been	O	O	O
made	O	O	O
over	O	O	O
the	O	O	O
last	O	O	O
few	O	O	O
years	O	O	B-T079
,	O	O	O
with	O	O	O
new	O	O	O
learning	O	O	B-T041
from	O	O	O
demonstration	O	O	B-T054
sites	O	O	B-T082
,	O	O	O
various	O	O	O
initiatives	O	O	B-T041
in	O	O	O
capacity	O	O	B-T058
building	O	O	I-T058
and	O	O	O
training	O	O	B-T065
,	O	O	O
wider	O	O	O
availability	O	O	O
of	O	O	O
patient	O	O	B-T101
decision	O	O	B-T170
aids	O	O	I-T170
,	O	O	O
and	O	O	O
important	O	O	O
leadership	O	O	B-T054
initiatives	O	O	O
.	O	O	O

Enthusiasm	O	O	B-T041
for	O	O	O
this	O	O	O
way	O	O	O
of	O	O	O
working	O	O	B-T057
is	O	O	O
growing	O	O	O
among	O	O	O
clinicians	O	O	B-T097
,	O	O	O
patients	O	O	B-T101
and	O	O	O
managers	O	O	B-T097
,	O	O	O
but	O	O	O
it	O	O	O
could	O	O	O
be	O	O	O
undermined	O	O	O
if	O	O	O
SDM	O	O	B-T041
comes	O	O	O
to	O	O	O
be	O	O	O
seen	O	O	O
primarily	O	O	O
as	O	O	O
a	O	O	O
means	O	O	B-T077
of	O	O	O
cost	O	O	B-T064
control	O	O	I-T064
.	O	O	O

-DOCSTART- (28536031)

Lactate	O	O	B-T109
induces	O	O	O
osteoblast	O	O	B-T043
differentiation	O	O	I-T043
by	O	O	O
stabilization	O	O	B-T044
of	O	O	O
HIF1α	O	O	O

Aerobic	O	O	B-T044
glycolysis	O	O	I-T044
is	O	O	O
involved	O	O	O
in	O	O	O
osteoblast	O	O	B-T043
differentiation	O	O	I-T043
induced	O	O	O
by	O	O	O
Wnt	O	O	B-T044
signaling	O	O	I-T044
or	O	O	O
PTH	O	O	B-T116
treatment	O	O	B-T169
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
still	O	O	O
unclear	O	O	O
whether	O	O	O
lactate	O	O	B-T109
,	O	O	O
the	O	O	O
end	O	O	O
product	O	O	O
of	O	O	O
aerobic	O	O	B-T044
glycolysis	O	O	I-T044
,	O	O	O
plays	O	O	O
any	O	O	O
role	O	O	O
in	O	O	O
osteoblast	O	O	B-T043
differentiation	O	O	I-T043
.	O	O	O

Herein	O	O	O
we	O	O	O
report	O	O	O
that	O	O	O
in	O	O	O
cultures	O	O	B-T059
of	O	O	O
osteoblast-lineage	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
lactate	O	O	B-T109
promoted	O	O	O
alkaline	O	O	B-T116
phosphatase	O	O	I-T116
-positive	O	O	O
cell	O	O	B-T043
formation	O	O	I-T043
,	O	O	O
increased	O	O	O
the	O	O	O
activity	O	O	B-T044
of	O	O	O
alkaline	O	O	O
phosphatase	O	O	O
,	O	O	O
and	O	O	O
induced	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
osteocalcin	O	O	B-T116
.	O	O	O

This	O	O	O
osteoblast	O	O	B-T043
differentiation	O	O	I-T043
-inducing	O	O	O
effect	O	O	O
of	O	O	O
lactate	O	O	B-T109
can	O	O	O
be	O	O	O
inhibited	O	O	B-T080
by	O	O	O
blocking	O	O	B-T169
its	O	O	O
entry	O	O	O
into	O	O	O
cells	O	O	B-T025
with	O	O	O
MCT1	O	O	B-T116
siRNA	O	O	B-T114
or	O	O	O
inhibitors	O	O	B-T121
,	O	O	O
and	O	O	O
by	O	O	O
interfering	O	O	O
with	O	O	O
its	O	O	O
metabolism	O	O	B-T040
by	O	O	O
using	O	O	O
specific	O	O	O
siRNAs	O	O	B-T114
for	O	O	O
LDHB	O	O	B-T116
and	O	O	O
PDH	O	O	B-T116
.	O	O	O

Moreover	O	O	O
,	O	O	O
lactate	O	O	B-T109
stabilized	O	O	O
HIF1α	O	O	B-T116
expression	O	O	B-T045
and	O	O	O
inhibited	O	O	B-T080
HIF1α	O	O	O
activity	O	O	B-T044
,	O	O	O
with	O	O	O
BAY87	O	O	B-T121
-	O	O	I-T121
2243	O	O	I-T121
lowering	O	O	O
the	O	O	O
osteoblast	O	O	B-T043
differentiation	O	O	I-T043
-inducing	O	O	O
effect	O	O	O
of	O	O	O
lactate	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
these	O	O	O
findings	O	O	B-T033
reveal	O	O	O
an	O	O	O
unrecognized	O	O	O
role	O	O	O
for	O	O	O
aerobic	O	O	B-T044
glycolysis	O	O	I-T044
in	O	O	O
osteoblast	O	O	B-T043
differentiation	O	O	I-T043
via	O	O	O
its	O	O	O
end	O	O	O
product	O	O	O
,	O	O	O
lactate	O	O	B-T109
.	O	O	O

-DOCSTART- (28538491)

Committee	O	O	B-T096
Opinion	O	O	O
No.	O	O	O
701	O	O	O
Summary	O	O	O
:	O	O	O
Choosing	O	O	O
The	O	O	O
Route	O	O	B-T082
Of	O	O	O
Hysterectomy	O	O	B-T061
For	O	O	O
Benign	O	O	B-T080
Disease	O	O	O

Hysterectomy	O	O	B-T061
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
frequently	O	O	O
performed	O	O	O
surgical	O	O	B-T061
procedures	O	O	I-T061
in	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
.	O	O	O

Selection	O	O	B-T052
of	O	O	O
the	O	O	O
route	O	O	B-T082
of	O	O	O
hysterectomy	O	O	B-T061
for	O	O	O
benign	O	O	B-T080
causes	O	O	O
can	O	O	O
be	O	O	O
influenced	O	O	O
by	O	O	O
the	O	O	O
size	O	O	B-T082
and	O	O	O
shape	O	O	B-T082
of	O	O	O
the	O	O	O
vagina	O	O	B-T023
and	O	O	O
uterus	O	O	B-T023
;	O	O	O
accessibility	O	O	O
to	O	O	O
the	O	O	O
uterus	O	O	O
;	O	O	O
extent	O	O	O
of	O	O	O
extrauterine	O	O	B-T047
disease	O	O	I-T047
;	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
concurrent	O	O	O
procedures	O	O	O
;	O	O	O
surgeon	O	O	B-T097
training	O	O	B-T065
and	O	O	O
experience	O	O	B-T041
;	O	O	O
average	O	O	O
case	O	O	B-T081
volume	O	O	I-T081
;	O	O	O
available	O	O	O
hospital	O	O	B-T093
technology	O	O	B-T058
,	O	O	O
devices	O	O	B-T074
,	O	O	O
and	O	O	O
support	O	O	O
;	O	O	O
whether	O	O	O
the	O	O	O
case	O	O	O
is	O	O	O
emergent	O	O	O
or	O	O	O
scheduled	O	O	O
;	O	O	O
and	O	O	O
preference	O	O	O
of	O	O	O
the	O	O	O
informed	O	O	O
patient	O	O	B-T101
.	O	O	O

Vaginal	O	O	B-T061
and	O	O	O
laparoscopic	O	O	B-T061
procedures	O	O	I-T061
are	O	O	O
considered	O	O	O
"	O	O	O
minimally	O	O	B-T169
invasive	O	O	I-T169
"	O	O	O
surgical	O	O	B-T169
approaches	O	O	I-T169
because	O	O	O
they	O	O	O
do	O	O	O
not	O	O	O
require	O	O	O
a	O	O	O
large	O	O	O
abdominal	O	O	B-T061
incision	O	O	I-T061
and	O	O	O
,	O	O	O
thus	O	O	O
,	O	O	O
typically	O	O	O
are	O	O	O
associated	O	O	O
with	O	O	O
shortened	O	O	O
hospitalization	O	O	B-T058
and	O	O	O
postoperative	O	O	B-T033
recovery	O	O	I-T033
times	O	O	I-T033
compared	O	O	O
with	O	O	O
open	O	O	O
abdominal	O	O	B-T061
hysterectomy	O	O	I-T061
.	O	O	O

Minimally	O	O	B-T169
invasive	O	O	I-T169
approaches	O	O	I-T169
to	O	O	O
hysterectomy	O	O	B-T061
should	O	O	O
be	O	O	O
performed	O	O	O
,	O	O	O
whenever	O	O	O
feasible	O	O	O
,	O	O	O
based	O	O	O
on	O	O	O
their	O	O	O
well-documented	O	O	O
advantages	O	O	O
over	O	O	O
abdominal	O	O	B-T061
hysterectomy	O	O	I-T061
.	O	O	O

The	O	O	O
vaginal	O	O	B-T082
approach	O	O	I-T082
is	O	O	O
preferred	O	O	O
among	O	O	O
the	O	O	O
minimally	O	O	B-T169
invasive	O	O	I-T169
approaches	O	O	I-T169
.	O	O	O

Laparoscopic	O	O	B-T061
hysterectomy	O	O	I-T061
is	O	O	O
a	O	O	O
preferable	O	O	O
alternative	O	O	O
to	O	O	O
open	O	O	O
abdominal	O	O	B-T061
hysterectomy	O	O	I-T061
for	O	O	O
those	O	O	O
patients	O	O	B-T101
in	O	O	O
whom	O	O	O
a	O	O	O
vaginal	O	O	B-T061
hysterectomy	O	O	I-T061
is	O	O	O
not	O	O	O
indicated	O	O	O
or	O	O	O
feasible	O	O	O
.	O	O	O

Although	O	O	O
minimally	O	O	B-T169
invasive	O	O	I-T169
approaches	O	O	I-T169
to	O	O	O
hysterectomy	O	O	B-T061
are	O	O	O
the	O	O	O
preferred	O	O	O
route	O	O	B-T082
,	O	O	O
open	O	O	B-T061
abdominal	O	O	B-T061
hysterectomy	O	O	I-T061
remains	O	O	O
an	O	O	O
important	O	O	O
surgical	O	O	O
option	O	O	O
for	O	O	O
some	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
obstetrician	O	O	B-T097
-	O	O	O
gynecologist	O	O	B-T097
should	O	O	O
discuss	O	O	O
the	O	O	O
options	O	O	O
with	O	O	O
patients	O	O	B-T101
and	O	O	O
make	O	O	O
clear	O	O	O
recommendations	O	O	O
on	O	O	O
which	O	O	O
route	O	O	B-T082
of	O	O	O
hysterectomy	O	O	B-T061
will	O	O	O
maximize	O	O	O
benefits	O	O	B-T081
and	O	O	O
minimize	O	O	O
risks	O	O	B-T078
given	O	O	O
the	O	O	O
specific	O	O	O
clinical	O	O	O
situation	O	O	O
.	O	O	O

The	O	O	O
relative	O	O	O
advantages	O	O	O
and	O	O	O
disadvantages	O	O	O
of	O	O	O
the	O	O	O
approaches	O	O	B-T169
to	O	O	O
hysterectomy	O	O	B-T061
should	O	O	O
be	O	O	O
discussed	O	O	O
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	O
values	O	O	O
and	O	O	O
preferences	O	O	B-T080
,	O	O	O
and	O	O	O
the	O	O	O
patient	O	O	O
and	O	O	O
health	O	O	B-T097
care	O	O	I-T097
provider	O	O	I-T097
should	O	O	O
together	O	O	O
determine	O	O	O
the	O	O	O
best	O	O	O
course	O	O	O
of	O	O	O
action	O	O	O
after	O	O	O
this	O	O	O
discussion	O	O	O
.	O	O	O

-DOCSTART- (28538990)

Measuring	O	O	B-T080
nonlinear	O	O	B-T080
signal	O	O	B-T067
combination	O	O	B-T080
using	O	O	O
EEG	O	O	O

Relatively	O	O	B-T080
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
processes	O	O	B-T067
,	O	O	O
both	O	O	O
linear	O	O	B-T082
and	O	O	O
nonlinear	O	O	B-T080
,	O	O	O
by	O	O	O
which	O	O	O
signals	O	O	B-T067
are	O	O	O
combined	O	O	B-T080
beyond	O	O	O
V1	O	O	B-T029
.	O	O	O

By	O	O	O
presenting	O	O	O
two	O	O	O
stimulus	O	O	B-T067
components	O	O	B-T077
simultaneously	O	O	B-T079
,	O	O	O
flickering	O	O	B-T033
at	O	O	O
different	O	O	B-T080
temporal	O	O	B-T079
frequencies	O	O	B-T081
(	O	O	O
frequency	O	O	B-T081
tagging	O	O	B-T074
)	O	O	O
while	O	O	O
measuring	O	O	B-T080
steady-state	O	O	B-T070
visual	O	O	B-T042
evoked	O	O	I-T042
potentials	O	O	I-T042
,	O	O	O
we	O	O	O
can	O	O	O
assess	O	O	B-T058
responses	O	O	B-T032
to	O	O	O
the	O	O	O
individual	O	O	O
components	O	O	O
,	O	O	O
including	O	O	O
direct	O	O	B-T080
measurements	O	O	B-T169
of	O	O	O
suppression	O	O	B-T046
on	O	O	O
each	O	O	O
other	O	O	O
,	O	O	O
and	O	O	O
various	O	O	O
nonlinear	O	O	B-T080
responses	O	O	O
to	O	O	O
their	O	O	O
combination	O	O	B-T080
found	O	O	O
at	O	O	O
intermodulation	O	O	B-T080
frequencies	O	O	O
.	O	O	O

The	O	O	O
result	O	O	B-T034
is	O	O	O
a	O	O	O
rather	O	O	O
rich	O	O	O
dataset	O	O	B-T170
of	O	O	O
frequencies	O	O	B-T081
at	O	O	O
which	O	O	O
responses	O	O	B-T032
can	O	O	O
be	O	O	O
found	O	O	O
.	O	O	O

We	O	O	O
presented	O	O	O
pairs	O	O	B-T080
of	O	O	O
sinusoidal	O	O	B-T082
gratings	O	O	I-T082
at	O	O	O
different	O	O	B-T080
temporal	O	O	B-T079
frequencies	O	O	I-T079
,	O	O	O
forming	O	O	O
plaid	O	O	B-T033
patterns	O	O	I-T033
that	O	O	O
were	O	O	O
"	O	O	O
coherent	O	O	B-T033
"	O	O	O
(	O	O	O
looking	O	O	B-T082
like	O	O	I-T082
a	O	O	I-T082
checkerboar	O	O	I-T082
d	O	O	O
)	O	O	O
and	O	O	O
"	O	O	O
noncoherent	O	O	B-T033
"	O	O	O
(	O	O	O
looking	O	O	O
like	O	O	O
a	O	O	O
pair	O	O	B-T080
of	O	O	O
transparently	O	O	B-T080
overlaid	O	O	B-T082
gratings	O	O	I-T082
)	O	O	O
,	O	O	O
and	O	O	O
found	O	O	O
clear	O	O	O
intermodulation	O	O	B-T080
responses	O	O	B-T032
to	O	O	O
compound	O	O	B-T080
stimuli	O	O	B-T067
,	O	O	O
indicating	O	O	O
nonlinear	O	O	B-T080
summation	O	O	B-T042
.	O	O	O

This	O	O	O
might	O	O	O
have	O	O	O
been	O	O	O
attributed	O	O	O
to	O	O	O
cross-orientation	O	O	B-T082
suppression	O	O	B-T046
except	O	O	O
that	O	O	O
the	O	O	O
pattern	O	O	B-T082
of	O	O	O
intermodulation	O	O	B-T080
responses	O	O	B-T032
differed	O	O	B-T080
for	O	O	O
coherent	O	O	B-T033
and	O	O	O
noncoherent	O	O	B-T033
patterns	O	O	B-T082
,	O	O	O
whereas	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
suppression	O	O	O
(	O	O	O
measured	O	O	O
at	O	O	O
the	O	O	O
component	O	O	B-T077
frequencies	O	O	B-T081
)	O	O	O
did	O	O	O
not	O	O	O
.	O	O	O

A	O	O	O
two-stage	O	O	B-T170
model	O	O	I-T170
of	O	O	O
nonlinear	O	O	B-T080
summation	O	O	B-T042
involving	O	O	O
conjunction	O	O	B-T078
detection	O	O	B-T061
with	O	O	O
a	O	O	O
logical	O	O	B-T077
AND	O	O	B-T170
gate	O	O	I-T170
described	O	O	O
the	O	O	O
data	O	O	B-T078
well	O	O	O
,	O	O	O
capturing	O	O	O
the	O	O	O
difference	O	O	B-T081
between	O	O	O
coherent	O	O	B-T033
and	O	O	O
noncoherent	O	O	B-T033
plaids	O	O	B-T082
over	O	O	O
a	O	O	O
wide	O	O	O
array	O	O	B-T082
of	O	O	O
possible	O	O	B-T033
response	O	O	B-T079
frequencies	O	O	I-T079
.	O	O	O

Multistimulus	O	O	B-T080
frequency	O	O	B-T081
-tagged	O	O	O
EEG	O	O	B-T060
in	O	O	O
combination	O	O	B-T080
with	O	O	O
computational	O	O	B-T066
modeling	O	O	I-T066
may	O	O	O
be	O	O	O
a	O	O	O
very	O	O	O
valuable	O	O	O
tool	O	O	O
in	O	O	O
studying	O	O	O
the	O	O	O
conjunction	O	O	B-T078
of	O	O	O
these	O	O	O
signals	O	O	B-T067
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	O
study	O	O	B-T062
the	O	O	O
results	O	O	B-T034
suggest	O	O	O
a	O	O	O
second-order	O	O	B-T042
mechanism	O	O	I-T042
responding	O	O	O
selectively	O	O	B-T080
to	O	O	O
coherent	O	O	B-T033
plaid	O	O	B-T033
patterns	O	O	I-T033
.	O	O	O

-DOCSTART- (28539349)

Sleep	O	O	B-T033
Loss	O	O	I-T033
Promotes	O	O	B-T052
Astrocytic	O	O	B-T029
Phagocytosis	O	O	B-T043
and	O	O	O
Microglial	O	O	B-T043
Activation	O	O	I-T043
in	O	O	O
Mouse	O	O	O
Cerebral	O	O	O
Cortex	O	O	O

We	O	O	O
previously	O	O	O
found	O	O	O
that	O	O	O
Mertk	O	O	B-T116
and	O	O	O
its	O	O	O
ligand	O	O	B-T116
Gas6	O	O	I-T116
,	O	O	O
astrocytic	O	O	B-T029
genes	O	O	B-T028
involved	O	O	O
in	O	O	O
phagocytosis	O	O	B-T043
,	O	O	O
are	O	O	O
upregulated	O	O	B-T044
after	O	O	B-T079
acute	O	O	B-T079
sleep	O	O	B-T033
deprivation	O	O	I-T033
.	O	O	O

These	O	O	O
results	O	O	O
suggested	O	O	O
that	O	O	O
astrocytes	O	O	B-T025
may	O	O	O
engage	O	O	O
in	O	O	O
phagocytic	O	O	B-T043
activity	O	O	I-T043
during	O	O	B-T079
extended	O	O	B-T082
wake	O	O	B-T039
,	O	O	O
but	O	O	O
direct	O	O	B-T080
evidence	O	O	B-T078
was	O	O	O
lacking	O	O	B-T080
.	O	O	O

Studies	O	O	B-T062
in	O	O	O
humans	O	O	B-T016
and	O	O	O
rodents	O	O	B-T015
also	O	O	O
found	O	O	B-T033
that	O	O	O
sleep	O	O	B-T033
loss	O	O	I-T033
increases	O	O	B-T169
peripheral	O	O	B-T082
markers	O	O	B-T201
of	O	O	O
inflammation	O	O	B-T046
,	O	O	O
but	O	O	O
whether	O	O	O
these	O	O	O
changes	O	O	B-T169
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
neuroinflammation	O	O	B-UnknownType
and/or	O	O	O
activation	O	O	B-T043
of	O	O	O
microglia	O	O	B-T025
,	O	O	O
the	O	O	O
brain	O	O	B-T023
's	O	O	I-T023
resident	O	O	O
innate	O	O	B-T025
immune	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
was	O	O	O
unknown	O	O	B-T080
.	O	O	O

Here	O	O	O
we	O	O	O
used	O	O	B-T169
serial	O	O	B-T059
block-face	O	O	I-T059
scanning	O	O	I-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
to	O	O	O
obtain	O	O	O
3D	O	O	O
volume	O	O	B-T081
measurements	O	O	B-T169
of	O	O	O
synapses	O	O	B-T030
and	O	O	O
surrounding	O	O	B-T082
astrocytic	O	O	B-T029
processes	O	O	B-T038
in	O	O	O
mouse	O	O	B-T015
frontal	O	O	B-T023
cortex	O	O	I-T023
after	O	O	B-T079
6	O	O	O
-	O	O	O
8	O	O	O
h	O	O	O
of	O	O	O
sleep	O	O	B-T040
,	O	O	O
spontaneous	O	O	B-T169
wake	O	O	B-T039
,	O	O	O
or	O	O	O
sleep	O	O	B-T033
deprivation	O	O	I-T033
(	O	O	O
SD	O	O	B-T033
)	O	O	O
and	O	O	O
after	O	O	O
chronic	O	O	B-T169
(	O	O	I-T169
∼5	O	O	I-T169
d	O	O	I-T169
)	O	O	I-T169
sleep	O	O	I-T169
restriction	O	O	I-T169
(	O	O	O
CSR	O	O	B-T169
)	O	O	O
.	O	O	O

Astrocytic	O	O	B-T029
phagocytosis	O	O	B-T043
,	O	O	O
mainly	O	O	O
of	O	O	O
presynaptic	O	O	B-T026
components	O	O	I-T026
of	O	O	I-T026
large	O	O	I-T026
synapses	O	O	I-T026
,	O	O	O
increased	O	O	B-T081
after	O	O	B-T079
both	O	O	B-T080
acute	O	O	B-T079
and	O	O	O
chronic	O	O	B-T079
sleep	O	O	B-T040
loss	O	O	I-T033
relative	O	O	B-T080
to	O	O	O
sleep	O	O	O
and	O	O	O
wake	O	O	B-T039
.	O	O	O

MERTK	O	O	B-T116
expression	O	O	B-T045
and	O	O	O
lipid	O	O	B-T044
peroxidation	O	O	I-T044
in	O	O	O
synaptoneurosomes	O	O	B-T026
also	O	O	O
increased	O	O	B-T081
to	O	O	O
a	O	O	O
similar	O	O	B-T080
extent	O	O	B-T082
after	O	O	B-T079
short	O	O	B-T081
and	O	O	O
long	O	O	B-T080
sleep	O	O	B-T033
loss	O	O	I-T033
,	O	O	O
suggesting	O	O	O
that	O	O	O
astrocytic	O	O	B-T029
phagocytosis	O	O	B-T043
may	O	O	O
represent	O	O	B-T052
the	O	O	O
brain	O	O	B-T023
's	O	O	I-T023
response	O	O	B-T032
to	O	O	O
the	O	O	O
increase	O	O	B-T169
in	O	O	O
synaptic	O	O	B-T043
activity	O	O	I-T043
associated	O	O	B-T080
with	O	O	I-T080
prolonged	O	O	B-T079
wake	O	O	B-T039
,	O	O	O
clearing	O	O	B-T080
worn	O	O	O
components	O	O	O
of	O	O	O
heavily	O	O	O
used	O	O	B-T169
synapses	O	O	B-T030
.	O	O	O

Using	O	O	B-T169
confocal	O	O	B-T059
microscopy	O	O	I-T059
,	O	O	O
we	O	O	O
then	O	O	O
found	O	O	B-T033
that	O	O	O
CSR	O	O	B-T169
but	O	O	O
not	O	O	B-T169
SD	O	O	B-T033
mice	O	O	B-T015
show	O	O	O
morphological	O	O	B-T082
signs	O	O	B-T184
of	O	O	O
microglial	O	O	B-T029
activation	O	O	I-T043
and	O	O	O
enhanced	O	O	B-T052
microglial	O	O	O
phagocytosis	O	O	B-T043
of	O	O	O
synaptic	O	O	B-T026
elements	O	O	I-T026
,	O	O	O
without	O	O	B-T080
obvious	O	O	O
signs	O	O	O
of	O	O	O
neuroinflammation	O	O	B-UnknownType
in	O	O	O
the	O	O	O
CSF	O	O	B-T031
.	O	O	O

Because	O	O	O
low	O	O	B-T080
-	O	O	O
level	O	O	B-T080
sustained	O	O	B-T169
microglia	O	O	B-T025
activation	O	O	I-T043
can	O	O	O
lead	O	O	O
to	O	O	O
abnormal	O	O	B-T033
responses	O	O	B-T032
to	O	O	O
a	O	O	O
secondary	O	O	B-T080
insult	O	O	B-T037
,	O	O	O
these	O	O	O
results	O	O	B-T169
suggest	O	O	B-T078
that	O	O	O
chronic	O	O	B-T079
sleep	O	O	B-T033
loss	O	O	I-T033
,	O	O	O
through	O	O	B-T169
microglia	O	O	O
priming	O	O	B-T043
,	O	O	O
may	O	O	O
predispose	O	O	O
the	O	O	O
brain	O	O	B-T023
to	O	O	O
further	O	O	B-T082
damage	O	O	B-T169
.SIGNIFICANCE	O	O	O
STATEMENT	O	O	O
We	O	O	O
find	O	O	B-T033
that	O	O	O
astrocytic	O	O	B-T029
phagocytosis	O	O	B-T043
of	O	O	O
synaptic	O	O	B-T026
elements	O	O	I-T026
,	O	O	O
mostly	O	O	O
of	O	O	O
presynaptic	O	O	B-T026
origin	O	O	I-T026
and	O	O	O
in	O	O	O
large	O	O	B-T081
synapses	O	O	B-T030
,	O	O	O
is	O	O	O
upregulated	O	O	B-T044
already	O	O	O
after	O	O	B-T079
a	O	O	O
few	O	O	B-T081
hours	O	O	B-T079
of	O	O	O
sleep	O	O	B-T033
deprivation	O	O	I-T033
and	O	O	O
shows	O	O	O
a	O	O	O
further	O	O	O
significant	O	O	B-T078
increase	O	O	B-T169
after	O	O	O
prolonged	O	O	B-T079
and	O	O	O
severe	O	O	B-T080
sleep	O	O	O
loss	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
it	O	O	O
may	O	O	O
promote	O	O	B-T052
the	O	O	O
housekeeping	O	O	B-T057
of	O	O	O
heavily	O	O	O
used	O	O	B-T169
and	O	O	O
strong	O	O	B-T080
synapses	O	O	O
in	O	O	O
response	O	O	B-T032
to	O	O	O
the	O	O	O
increased	O	O	B-T081
neuronal	O	O	B-T025
activity	O	O	B-T043
of	O	O	O
extended	O	O	B-T082
wake	O	O	B-T039
.	O	O	O

By	O	O	O
contrast	O	O	B-T080
,	O	O	O
chronic	O	O	B-T169
sleep	O	O	I-T169
restriction	O	O	I-T169
but	O	O	O
not	O	O	B-T169
acute	O	O	B-T079
sleep	O	O	B-T033
loss	O	O	I-T033
activates	O	O	B-T043
microglia	O	O	B-T025
,	O	O	O
promotes	O	O	B-T052
their	O	O	O
phagocytic	O	O	B-T043
activity	O	O	I-T043
,	O	O	O
and	O	O	O
does	O	O	O
so	O	O	O
in	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
overt	O	O	O
signs	O	O	B-T184
of	O	O	O
neuroinflammation	O	O	B-UnknownType
,	O	O	O
suggesting	O	O	O
that	O	O	O
like	O	O	O
many	O	O	O
other	O	O	B-T080
stressors	O	O	B-T078
,	O	O	O
extended	O	O	B-T082
sleep	O	O	B-T033
disruption	O	O	I-T033
may	O	O	O
lead	O	O	O
to	O	O	O
a	O	O	O
state	O	O	B-T169
of	O	O	O
sustained	O	O	B-T169
microglia	O	O	B-T043
activation	O	O	I-T043
,	O	O	O
perhaps	O	O	O
increasing	O	O	B-T169
the	O	O	O
brain	O	O	B-T023
's	O	O	I-T023
susceptibility	O	O	B-T169
to	O	O	O
other	O	O	O
forms	O	O	B-T169
of	O	O	O
damage	O	O	B-T169
.	O	O	O

-DOCSTART- (28540341)

Reflections	O	O	B-T062
on	O	O	O
Hip	O	O	B-T061
Fracture	O	O	I-T061
Recovery	O	O	I-T061
From	O	O	O
Older	O	O	B-T098
Adults	O	O	I-T098
Enrolled	O	O	O
in	O	O	O
a	O	O	O
Clinical	O	O	O
Trial	O	O	O

This	O	O	O
study	O	O	B-T062
describes	O	O	O
patients	O	O	B-T101
'	O	O	I-T101
perspectives	O	O	B-UnknownType
on	O	O	O
recovery	O	O	B-T052
during	O	O	O
participation	O	O	B-T169
in	O	O	O
a	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
that	O	O	O
tested	O	O	B-T170
a	O	O	O
postoperative	O	O	B-T079
hip	O	O	B-T037
fracture	O	O	I-T037
management	O	O	B-T169
program	O	O	I-T169
(	O	O	O
B4	O	O	B-T093
Clinic	O	O	I-T093
)	O	O	O
,	O	O	O
compared	O	O	B-T052
with	O	O	O
usual	O	O	B-T058
care	O	O	I-T058
,	O	O	O
on	O	O	O
mobility	O	O	B-T080
.	O	O	O

Semistructured	O	O	B-T082
qualitative	O	O	B-T080
interviews	O	O	B-T052
were	O	O	O
conducted	O	O	O
with	O	O	O
50	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
with	O	O	O
hip	O	O	B-T037
fracture	O	O	I-T037
(	O	O	O
from	O	O	O
both	O	O	O
groups	O	O	B-T098
)	O	O	O
twice	O	O	O
over	O	O	O
12	O	O	O
months	O	O	O
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
32	O	O	O
women	O	O	B-T098
(	O	O	O
64	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
18	O	O	O
men	O	O	B-T098
(	O	O	O
36	O	O	O
%	O	O	O
)	O	O	O
participated	O	O	B-T169
in	O	O	O
the	O	O	O
study	O	O	B-T062
with	O	O	O
a	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
at	O	O	O
baseline	O	O	B-T081
of	O	O	O
82	O	O	O
(	O	O	O
range	O	O	B-T081
=	O	O	O
65	O	O	O
-	O	O	O
98	O	O	O
)	O	O	O
years	O	O	O
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
40	O	O	O
participants	O	O	B-T098
reported	O	O	B-T058
recovery	O	O	B-T052
goals	O	O	B-T170
at	O	O	O
some	O	O	O
point	O	O	O
during	O	O	O
their	O	O	O
recovery	O	O	O
from	O	O	O
hip	O	O	B-T037
fracture	O	O	I-T037
but	O	O	O
only	O	O	O
18	O	O	O
participants	O	O	O
realized	O	O	B-T078
their	O	O	O
goals	O	O	O
within	O	O	O
12	O	O	O
months	O	O	O
.	O	O	O

Recovering	O	O	B-T040
mobility	O	O	B-T080
,	O	O	O
returning	O	O	B-T080
to	O	O	O
prefracture	O	O	B-T052
activities	O	O	I-T052
,	O	O	O
and	O	O	O
obtaining	O	O	B-T169
stable	O	O	B-T080
health	O	O	B-T078
were	O	O	O
the	O	O	O
most	O	O	B-T081
commonly	O	O	B-T081
reported	O	O	B-T058
goals	O	O	B-T170
.	O	O	O

Participants	O	O	B-T098
described	O	O	O
good	O	O	B-T080
social	O	O	B-T058
support	O	O	I-T058
,	O	O	O
access	O	O	B-T082
to	O	O	O
physiotherapy	O	O	B-T061
,	O	O	O
and	O	O	O
positive	O	O	B-T033
perspective	O	O	B-UnknownType
as	O	O	O
most	O	O	B-T081
important	O	O	B-T080
to	O	O	O
recovery	O	O	B-T052
.	O	O	O

These	O	O	O
factors	O	O	B-T169
were	O	O	O
influenced	O	O	B-T077
by	O	O	O
participants	O	O	B-T098
'	O	O	O
knowledge	O	O	B-T170
,	O	O	O
resources	O	O	B-T078
,	O	O	O
and	O	O	O
monthly	O	O	O
contact	O	O	B-T078
with	O	O	O
study	O	O	B-T062
staff	O	O	B-T097
(	O	O	O
perceived	O	O	B-T041
as	O	O	O
a	O	O	O
form	O	O	O
of	O	O	O
social	O	O	B-T058
support	O	O	I-T058
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	B-T081
frequently	O	O	B-T079
reported	O	O	B-T058
barriers	O	O	B-T080
to	O	O	O
participants	O	O	B-T098
'	O	O	O
recovery	O	O	B-T052
were	O	O	O
the	O	O	O
onset	O	O	B-T080
of	O	O	I-T080
complications	O	O	B-T046
,	O	O	O
pain	O	O	B-T184
,	O	O	O
and	O	O	O
limited	O	O	B-T033
access	O	O	I-T033
to	O	O	O
physiotherapy	O	O	B-T061
.	O	O	O

Potential	O	O	B-T080
implications	O	O	B-T078
of	O	O	O
these	O	O	O
findings	O	O	B-T033
include	O	O	B-T052
design	O	O	B-T052
and	O	O	O
modification	O	O	B-T033
of	O	O	O
new	O	O	O
or	O	O	O
preexisting	O	O	B-T080
fracture	O	O	B-T037
programs	O	O	B-T169
,	O	O	O
prioritizing	O	O	B-T079
patient	O	O	B-T058
engagement	O	O	I-T058
and	O	O	O
enhanced	O	O	B-T052
knowledge	O	O	B-T170
for	O	O	O
future	O	O	B-T079
clinical	O	O	B-T062
research	O	O	I-T062
in	O	O	O
hip	O	O	B-T061
fracture	O	O	I-T061
recovery	O	O	I-T061
.	O	O	O

-DOCSTART- (28542333)

It	O	O	O
takes	O	O	O
biking	O	O	O
to	O	O	O
learn	O	O	B-T041
:	O	O	O
Physical	O	O	B-T056
activity	O	O	I-T056
improves	O	O	B-T033
learning	O	O	B-T041
a	O	O	O
second	O	O	O
language	O	O	O

Recent	O	O	O
studies	O	O	B-T062
have	O	O	O
shown	O	O	O
that	O	O	O
concurrent	O	O	B-T079
physical	O	O	B-T056
activity	O	O	I-T056
enhances	O	O	B-T052
learning	O	O	B-T041
a	O	O	O
completely	O	O	O
unfamiliar	O	O	O
L2	O	O	B-T033
vocabulary	O	O	B-T170
as	O	O	O
compared	O	O	O
to	O	O	O
learning	O	O	O
it	O	O	O
in	O	O	O
a	O	O	O
static	O	O	B-T080
condition	O	O	B-T080
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
we	O	O	O
report	O	O	O
a	O	O	O
study	O	O	B-T062
whose	O	O	O
aim	O	O	O
is	O	O	O
twofold	O	O	O
:	O	O	O
to	O	O	O
test	O	O	O
for	O	O	O
possible	O	O	B-T033
positive	O	O	B-T033
effects	O	O	B-T080
of	O	O	I-T080
physical	O	O	B-T056
activity	O	O	I-T056
when	O	O	O
L2	O	O	B-T033
learning	O	O	B-T041
has	O	O	O
already	O	O	O
reached	O	O	O
some	O	O	O
level	O	O	B-T080
of	O	O	O
proficiency	O	O	B-T080
,	O	O	O
and	O	O	O
to	O	O	O
test	O	O	O
whether	O	O	O
the	O	O	O
assumed	O	O	O
better	O	O	B-T080
performance	O	O	B-T052
when	O	O	O
engaged	O	O	O
in	O	O	O
physical	O	O	O
activity	O	O	O
is	O	O	O
limited	O	O	O
to	O	O	O
the	O	O	O
linguistic	O	O	B-T090
level	O	O	O
probed	O	O	O
at	O	O	O
training	O	O	B-T080
(	O	O	O
i.e.	O	O	O
L2	O	O	O
vocabulary	O	O	B-T170
tested	O	O	B-T169
by	O	O	O
means	O	O	O
of	O	O	O
a	O	O	O
Word-Picture	O	O	B-T062
Verification	O	O	I-T062
task	O	O	I-T062
)	O	O	O
,	O	O	O
or	O	O	O
whether	O	O	O
it	O	O	O
extends	O	O	O
also	O	O	O
to	O	O	O
the	O	O	O
sentence	O	O	B-T170
level	O	O	O
(	O	O	O
which	O	O	O
was	O	O	O
tested	O	O	O
by	O	O	O
means	O	O	O
of	O	O	O
a	O	O	O
Sentence	O	O	B-T062
Semantic	O	O	I-T062
Judgment	O	O	I-T062
Task	O	O	I-T062
)	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
show	O	O	O
that	O	O	O
Chinese	O	O	B-T098
speakers	O	O	I-T098
with	O	O	O
basic	O	O	B-T033
knowledge	O	O	I-T033
of	O	O	O
English	O	O	B-T171
benefited	O	O	B-T081
from	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
while	O	O	O
learning	O	O	B-T041
a	O	O	O
set	O	O	O
of	O	O	O
new	O	O	O
words	O	O	B-T170
.	O	O	O

Furthermore	O	O	O
,	O	O	O
their	O	O	O
better	O	O	B-T080
performance	O	O	B-T052
emerged	O	O	O
also	O	O	O
at	O	O	O
the	O	O	O
sentential	O	O	B-T170
level	O	O	B-T080
,	O	O	I-T080
as	O	O	O
shown	O	O	O
by	O	O	O
their	O	O	O
performance	O	O	O
in	O	O	O
a	O	O	O
Semantic	O	O	B-T062
Judgment	O	O	I-T062
task	O	O	I-T062
.	O	O	O

Finally	O	O	O
,	O	O	O
an	O	O	O
interesting	O	O	O
temporal	O	O	O
asymmetry	O	O	O
between	O	O	O
the	O	O	O
lexical	O	O	B-T078
and	O	O	O
the	O	O	O
sentential	O	O	B-T170
level	O	O	B-T080
emerges	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
difference	O	O	O
between	O	O	O
the	O	O	O
experimental	O	O	B-T078
and	O	O	O
control	O	O	B-T096
group	O	O	I-T096
emerging	O	O	O
from	O	O	O
the	O	O	O
1st	O	O	O
testing	O	O	B-T051
session	O	O	I-T051
at	O	O	O
the	O	O	O
lexical	O	O	O
level	O	O	O
but	O	O	O
after	O	O	O
several	O	O	O
weeks	O	O	O
at	O	O	O
the	O	O	O
sentential	O	O	O
level	O	O	O
.	O	O	O

-DOCSTART- (28543041)

The	O	O	O
added	O	O	B-T169
value	O	O	B-T081
of	O	O	O
cardiac	O	O	B-T033
index	O	O	I-T033
and	O	O	O
pulse	O	O	B-T040
pressure	O	O	I-T040
variation	O	O	B-T080
monitoring	O	O	B-T058
to	O	O	O
mean	O	O	B-T033
arterial	O	O	I-T033
pressure	O	O	I-T033
-	O	O	O
guided	O	O	B-T061
volume	O	O	I-T061
therapy	O	O	I-T061
in	O	O	O
moderate-risk	O	O	B-T061
abdominal	O	O	I-T061
surgery	O	O	I-T061
(	O	O	O
COGUIDE	O	O	B-T061
):	O	O	O
a	O	O	O
pragmatic	O	O	B-T062
multicentre	O	O	B-T062
randomised	O	O	O
controlled	O	O	O
trial	O	O	O

There	O	O	O
is	O	O	O
disagreement	O	O	B-UnknownType
regarding	O	O	O
the	O	O	O
benefits	O	O	B-T081
of	O	O	O
goal-directed	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
moderate-risk	O	O	B-T061
abdominal	O	O	I-T061
surgery	O	O	I-T061
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
tested	O	O	B-T170
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
the	O	O	O
addition	O	O	B-T169
of	O	O	O
non-invasive	O	O	B-T169
cardiac	O	O	B-T033
index	O	O	I-T033
and	O	O	O
pulse	O	O	B-T040
pressure	O	O	I-T040
variation	O	O	B-T080
monitoring	O	O	B-T058
to	O	O	O
mean	O	O	B-T033
arterial	O	O	I-T033
pressure	O	O	I-T033
-based	O	O	O
goal-directed	O	O	B-T061
therapy	O	O	I-T061
would	O	O	O
reduce	O	O	B-T080
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
postoperative	O	O	B-T046
complications	O	O	I-T046
in	O	O	O
patients	O	O	B-T101
having	O	O	O
moderate-risk	O	O	B-T061
abdominal	O	O	I-T061
surgery	O	O	I-T061
.	O	O	O

In	O	O	O
this	O	O	O
pragmatic	O	O	B-T062
multicentre	O	O	B-T062
randomised	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
,	O	O	O
we	O	O	O
randomly	O	O	B-T062
allocated	O	O	I-T062
244	O	O	O
patients	O	O	B-T101
by	O	O	O
envelope	O	O	B-T170
drawing	O	O	I-T170
in	O	O	O
a	O	O	O
1:1	O	O	O
fashion	O	O	O
,	O	O	O
stratified	O	O	B-T080
per	O	O	O
centre	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
had	O	O	O
mean	O	O	B-T033
arterial	O	O	I-T033
pressure	O	O	I-T033
,	O	O	O
cardiac	O	O	B-T033
index	O	O	I-T033
and	O	O	O
pulse	O	O	B-T040
pressure	O	O	I-T040
variation	O	O	B-T080
measured	O	O	B-T080
continuously	O	O	B-T078
.	O	O	O

In	O	O	O
one	O	O	O
group	O	O	B-T078
,	O	O	O
healthcare	O	O	B-T097
professionals	O	O	I-T097
were	O	O	O
blinded	O	O	B-T062
to	O	O	O
cardiac	O	O	B-T033
index	O	O	I-T033
and	O	O	O
pulse	O	O	B-T040
pressure	O	O	I-T040
variation	O	O	B-T080
values	O	O	B-T081
and	O	O	O
were	O	O	O
asked	O	O	O
to	O	O	O
guide	O	O	O
haemodynamic	O	O	B-T061
therapy	O	O	I-T061
only	O	O	O
based	O	O	O
on	O	O	O
mean	O	O	B-T033
arterial	O	O	I-T033
pressure	O	O	I-T033
(	O	O	O
control	O	O	B-T096
group	O	O	I-T096
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
second	O	O	O
group	O	O	B-T078
,	O	O	O
cardiac	O	O	B-T033
index	O	O	I-T033
and	O	O	O
pulse	O	O	B-T040
pressure	O	O	I-T040
variation	O	O	B-T080
values	O	O	B-T081
were	O	O	O
displayed	O	O	B-T169
and	O	O	O
kept	O	O	O
within	O	O	O
target	O	O	B-T169
ranges	O	O	B-T081
following	O	O	O
a	O	O	O
pre-defined	O	O	B-T170
algorithm	O	O	I-T170
(	O	O	O
CI-PPV	O	O	B-T078
group	O	O	I-T078
)	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	B-T130
endpoint	O	O	I-T130
was	O	O	O
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
postoperative	O	O	B-T046
complications	O	O	I-T046
within	O	O	B-T033
30	O	O	I-T033
days	O	O	I-T033
.	O	O	O

One	O	O	O
hundred	O	O	O
and	O	O	O
seventy-five	O	O	O
patients	O	O	B-T101
were	O	O	O
eligible	O	O	B-T080
for	O	O	O
final	O	O	B-T079
analysis	O	O	B-T062
.	O	O	O

Overall	O	O	B-T080
complication	O	O	B-T046
rates	O	O	I-T046
were	O	O	O
similar	O	O	O
(	O	O	O
42/94	O	O	O
(	O	O	O
44.7	O	O	O
%	O	O	O
)	O	O	O
vs.	O	O	O
38/81	O	O	O
(	O	O	O
46.9	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
and	O	O	O
CI-PPV	O	O	B-T078
groups	O	O	I-T078
,	O	O	O
respectively	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.95	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
CI-PPV	O	O	B-T078
group	O	O	I-T078
had	O	O	O
lower	O	O	B-T080
mean	O	O	B-T081
(	O	O	O
SD	O	O	B-T081
)	O	O	O
pulse	O	O	B-T040
pressure	O	O	I-T040
variation	O	O	B-T080
values	O	O	B-T081
(	O	O	O
9.5	O	O	O
(2.0)%	O	O	O
vs.	O	O	O
11.9	O	O	O
(4.6)%	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.003	O	O	O
)	O	O	O
and	O	O	O
higher	O	O	B-T080
mean	O	O	O
(	O	O	O
SD	O	O	O
)	O	O	O
cardiac	O	O	B-T033
indices	O	O	I-T033
(	O	O	O
2.76	O	O	O
(	O	O	O
0.62	O	O	O
)	O	O	O
l	O	O	O
min(-1	O	O	O
)	O	O	O
.m(-2	O	O	O
)	O	O	O
vs.	O	O	O
2.53	O	O	O
(	O	O	O
0.66	O	O	O
)	O	O	O
l	O	O	O
min(-1	O	O	O
)	O	O	O
.m(-2	O	O	O
)	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.004	O	O	O
)	O	O	O
than	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

In	O	O	O
moderate-risk	O	O	B-T061
abdominal	O	O	I-T061
surgery	O	O	I-T061
,	O	O	O
we	O	O	O
observed	O	O	B-T169
no	O	O	O
additional	O	O	B-T170
value	O	O	I-T170
of	O	O	O
cardiac	O	O	B-T033
index	O	O	I-T033
and	O	O	O
pulse	O	O	B-T040
pressure	O	O	I-T040
variation	O	O	B-T080
-	O	O	O
guided	O	O	B-T061
haemodynamic	O	O	I-T061
therapy	O	O	I-T061
to	O	O	O
mean	O	O	B-T033
arterial	O	O	I-T033
pressure	O	O	I-T033
-	O	O	O
guided	O	O	B-T061
volume	O	O	I-T061
therapy	O	O	I-T061
with	O	O	O
regard	O	O	O
to	O	O	O
postoperative	O	O	B-T046
complications	O	O	I-T046
.	O	O	O

-DOCSTART- (28544215)

Anterior	O	O	B-T074
single	O	O	I-T074
implants	O	O	I-T074
with	O	O	O
different	O	O	O
neck	O	O	B-T082
designs	O	O	B-T052
:	O	O	O
5	O	O	O
Year	O	O	B-T079
results	O	O	O
of	O	O	O
a	O	O	O
randomized	O	O	O
clinical	O	O	O
trial	O	O	O

The	O	O	O
design	O	O	B-T052
of	O	O	O
the	O	O	O
implant	O	O	B-T074
neck	O	O	I-T074
might	O	O	O
be	O	O	O
significant	O	O	O
for	O	O	O
preservation	O	O	B-T059
of	O	O	O
marginal	O	O	B-T082
bone	O	O	B-T024
.	O	O	O

To	O	O	O
compare	O	O	O
the	O	O	O
5-year	O	O	B-T079
radiographic	O	O	B-T070
and	O	O	O
clinical	O	O	B-T080
outcome	O	O	B-T169
of	O	O	O
single	O	O	B-T074
anterior	O	O	I-T074
implants	O	O	I-T074
provided	O	O	O
with	O	O	O
a	O	O	O
smooth	O	O	B-T080
neck	O	O	O
,	O	O	O
a	O	O	O
rough	O	O	B-T082
neck	O	O	I-T082
or	O	O	O
a	O	O	O
scalloped	O	O	O
rough	O	O	O
neck	O	O	O
.	O	O	O

93	O	O	O
Patients	O	O	B-T101
with	O	O	O
a	O	O	O
missing	O	O	O
anterior	O	O	B-T082
tooth	O	O	B-T023
in	O	O	O
the	O	O	O
maxilla	O	O	B-T023
were	O	O	O
included	O	O	O
.	O	O	O

At	O	O	O
random	O	O	O
,	O	O	O
patients	O	O	B-T101
received	O	O	O
an	O	O	O
implant	O	O	B-T074
with	O	O	O
a	O	O	O
1.5	O	O	O
mm	O	O	O
smooth	O	O	B-T080
neck	O	O	B-T082
(	O	O	O
"	O	O	O
smooth	O	O	B-T078
group	O	O	I-T078
"	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
rough	O	O	B-T082
neck	O	O	I-T082
with	O	O	O
grooves	O	O	O
(	O	O	O
"	O	O	O
rough	O	O	B-T078
group	O	O	I-T078
"	O	O	O
)	O	O	O
or	O	O	O
a	O	O	O
scalloped	O	O	O
rough	O	O	O
neck	O	O	O
with	O	O	O
grooves	O	O	O
(	O	O	O
"	O	O	O
scalloped	O	O	B-T078
group	O	O	I-T078
"	O	O	O
)	O	O	O
.	O	O	O

Implants	O	O	B-T074
were	O	O	O
installed	O	O	O
in	O	O	O
healed	O	O	B-T029
sites	O	O	I-T029
.	O	O	O

Follow-up	O	O	B-T058
visits	O	O	I-T058
were	O	O	O
conducted	O	O	O
after	O	O	O
final	O	O	O
crown	O	O	B-T169
delivery	O	O	I-T169
and	O	O	O
1	O	O	O
year	O	O	B-T079
and	O	O	O
5	O	O	O
years	O	O	B-T079
later	O	O	O
.	O	O	O

Scalloped	O	O	O
implants	O	O	B-T074
showed	O	O	O
significantly	O	O	O
more	O	O	O
initial	O	O	O
marginal	O	O	B-T082
bone	O	O	B-T042
resorption	O	O	I-T042
.	O	O	O

The	O	O	O
total	O	O	O
amount	O	O	O
of	O	O	O
bone	O	O	B-T042
loss	O	O	I-T042
was	O	O	O
1.26	O	O	O
±	O	O	O
0.90	O	O	O
mm	O	O	O
in	O	O	O
the	O	O	O
smooth	O	O	B-T078
group	O	O	I-T078
,	O	O	O
1.20	O	O	O
±	O	O	O
1.1	O	O	O
mm	O	O	O
in	O	O	O
the	O	O	O
rough	O	O	B-T078
group	O	O	I-T078
and	O	O	O
2.28	O	O	O
±	O	O	O
0.97	O	O	O
mm	O	O	O
in	O	O	O
the	O	O	O
scalloped	O	O	B-T078
group	O	O	I-T078
(	O	O	O
P	O	O	O
<	O	O	O
.05	O	O	O
)	O	O	O
.	O	O	O

Survival	O	O	B-T081
rates	O	O	I-T081
were	O	O	O
96.2	O	O	O
%	O	O	O
for	O	O	O
the	O	O	O
smooth	O	O	B-T078
and	O	O	O
scalloped	O	O	B-T078
group	O	O	I-T078
and	O	O	O
100	O	O	O
%	O	O	O
for	O	O	O
the	O	O	O
rough	O	O	B-T078
group	O	O	I-T078
.	O	O	O

Scalloped	O	O	O
implants	O	O	B-T074
showed	O	O	O
deeper	O	O	B-T082
pocket	O	O	I-T082
depths	O	O	I-T082
,	O	O	O
more	O	O	O
bleeding	O	O	B-T046
and	O	O	O
more	O	O	O
technical	O	O	O
complications	O	O	B-T078
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
differences	O	O	O
in	O	O	O
esthetic	O	O	B-T169
outcome	O	O	I-T169
nor	O	O	O
in	O	O	O
patient	O	O	B-T080
satisfaction	O	O	I-T080
.	O	O	O

For	O	O	O
anterior	O	O	B-T082
single	O	O	O
tooth	O	O	B-T042
replacements	O	O	I-T042
,	O	O	O
scalloped	O	O	O
implants	O	O	B-T074
show	O	O	O
less	O	O	O
favorable	O	O	O
radiographic	O	O	B-T070
and	O	O	O
clinical	O	O	B-T080
outcome	O	O	B-T169
compared	O	O	O
to	O	O	O
regular	O	O	O
implants	O	O	O
with	O	O	O
a	O	O	O
smooth	O	O	B-T080
neck	O	O	B-T082
or	O	O	O
rough	O	O	B-T082
neck	O	O	I-T082
.	O	O	O

-DOCSTART- (28544275)

Recessive	O	O	B-T045
mutations	O	O	I-T045
in	O	O	O
MSTO1	O	O	B-T116
cause	O	O	O
mitochondrial	O	O	B-T043
dynamics	O	O	I-T043
impairment	O	O	B-T169
,	O	O	O
leading	O	O	O
to	O	O	O
myopathy	O	O	B-T047
and	O	O	O
ataxia	O	O	O

We	O	O	O
report	O	O	O
here	O	O	O
the	O	O	O
first	O	O	O
families	O	O	B-T099
carrying	O	O	O
recessive	O	O	O
variants	O	O	B-T080
in	O	O	O
the	O	O	O
MSTO1	O	O	B-T028
gene	O	O	I-T028
:	O	O	O
compound	O	O	B-T033
heterozygous	O	O	I-T033
mutations	O	O	B-T045
were	O	O	O
identified	O	O	B-T080
in	O	O	O
two	O	O	O
sisters	O	O	B-T099
and	O	O	O
in	O	O	O
an	O	O	O
unrelated	O	O	B-T033
singleton	O	O	B-T099
case	O	O	O
,	O	O	O
who	O	O	O
presented	O	O	B-T078
a	O	O	O
multisystem	O	O	O
complex	O	O	B-T080
phenotype	O	O	B-T032
mainly	O	O	O
characterized	O	O	B-T052
by	O	O	O
myopathy	O	O	B-T047
and	O	O	O
cerebellar	O	O	B-T184
ataxia	O	O	I-T184
.	O	O	O

Human	O	O	B-T116
MSTO1	O	O	I-T116
is	O	O	O
a	O	O	O
poorly	O	O	O
studied	O	O	O
protein	O	O	O
,	O	O	O
suggested	O	O	B-T078
to	O	O	O
have	O	O	O
mitochondrial	O	O	B-T038
localization	O	O	I-T038
and	O	O	O
to	O	O	O
regulate	O	O	B-T038
morphology	O	O	B-T080
and	O	O	O
distribution	O	O	B-T043
of	O	O	I-T043
mitochondria	O	O	I-T043
.	O	O	O

As	O	O	O
for	O	O	O
other	O	O	O
mutations	O	O	B-T045
affecting	O	O	B-T169
genes	O	O	B-T028
involved	O	O	O
in	O	O	O
mitochondrial	O	O	B-T043
dynamics	O	O	I-T043
,	O	O	O
no	O	O	O
biochemical	O	O	B-T169
defects	O	O	B-T169
typical	O	O	O
of	O	O	O
mitochondrial	O	O	B-T047
disorders	O	O	I-T047
were	O	O	O
reported	O	O	B-T058
.	O	O	O

Studies	O	O	O
in	O	O	O
patients	O	O	B-T101
'	O	O	O
fibroblasts	O	O	B-T025
revealed	O	O	B-T080
that	O	O	O
MSTO1	O	O	B-T116
protein	O	O	I-T116
levels	O	O	B-T080
were	O	O	O
strongly	O	O	O
reduced	O	O	B-T080
,	O	O	O
the	O	O	O
mitochondrial	O	O	B-T033
network	O	O	I-T033
was	O	O	I-T033
fragmented	O	O	I-T033
and	O	O	O
the	O	O	O
fusion	O	O	B-T169
events	O	O	O
among	O	O	O
mitochondria	O	O	B-T026
were	O	O	O
decreased	O	O	B-T081
,	O	O	O
confirming	O	O	O
the	O	O	O
deleterious	O	O	B-T049
effect	O	O	I-T049
of	O	O	O
the	O	O	O
identified	O	O	B-T080
variants	O	O	B-T080
and	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
MSTO1	O	O	O
in	O	O	O
modulating	O	O	B-T082
mitochondrial	O	O	B-T043
dynamics	O	O	I-T043
.	O	O	O

We	O	O	O
also	O	O	O
found	O	O	O
that	O	O	O
MSTO1	O	O	O
is	O	O	O
mainly	O	O	O
a	O	O	O
cytosolic	O	O	B-T116
protein	O	O	I-T116
.	O	O	O

These	O	O	O
findings	O	O	O
indicate	O	O	O
recessive	O	O	B-T045
mutations	O	O	I-T045
in	O	O	O
MSTO1	O	O	B-T116
as	O	O	O
a	O	O	O
new	O	O	O
cause	O	O	O
for	O	O	O
inherited	O	O	B-T169
neuromuscular	O	O	B-T047
disorders	O	O	I-T047
with	O	O	O
multisystem	O	O	O
features	O	O	O
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
protected	O	O	O
by	O	O	O
copyright	O	O	O
.	O	O	O

All	O	O	O
rights	O	O	O
reserved	O	O	O
.	O	O	O

-DOCSTART- (28545217)

A	O	O	O
miniature	O	O	O
bird	O	O	B-T012
-borne	O	O	O
passive	O	O	B-T074
air	O	O	I-T074
sampler	O	O	I-T074
for	O	O	O
monitoring	O	O	B-T058
halogenated	O	O	O
flame	O	O	O
retardants	O	O	O

Birds	O	O	B-T012
have	O	O	O
been	O	O	O
used	O	O	O
intensively	O	O	O
as	O	O	O
biomonitors	O	O	B-T074
of	O	O	O
halogenated	O	O	B-T120
flame	O	O	I-T120
retardants	O	O	I-T120
(	O	O	O
HFRs	O	O	B-T120
)	O	O	O
,	O	O	O
and	O	O	O
several	O	O	O
studies	O	O	B-T062
have	O	O	O
reported	O	O	O
elevated	O	O	O
tissue	O	O	B-T024
concentrations	O	O	B-T081
and	O	O	O
inter-	O	O	O
individual	O	O	B-T098
variability	O	O	B-T077
for	O	O	O
these	O	O	O
contaminants	O	O	B-T167
.	O	O	O

While	O	O	O
diet	O	O	B-T168
is	O	O	O
known	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
important	O	O	O
exposure	O	O	B-T080
pathway	O	O	B-T077
for	O	O	O
HFRs	O	O	B-T120
in	O	O	O
birds	O	O	B-T012
,	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
suggested	O	O	B-T078
that	O	O	O
exposure	O	O	O
through	O	O	O
air	O	O	B-T167
may	O	O	O
represent	O	O	B-T052
an	O	O	O
underestimated	O	O	O
source	O	O	B-T033
of	O	O	O
HFRs	O	O	O
for	O	O	O
certain	O	O	O
species	O	O	B-T185
.	O	O	O

However	O	O	O
,	O	O	O
a	O	O	O
method	O	O	B-T170
was	O	O	O
not	O	O	B-T080
available	O	O	I-T080
for	O	O	O
measuring	O	O	B-T080
the	O	O	O
atmospheric	O	O	B-T070
exposure	O	O	B-T080
of	O	O	O
individual	O	O	B-T098
birds	O	O	B-T012
to	O	O	O
HFRs	O	O	B-T120
or	O	O	O
other	O	O	O
semi-volatile	O	O	B-T080
contaminants	O	O	B-T167
.	O	O	O

The	O	O	O
goal	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
develop	O	O	O
a	O	O	O
bird	O	O	B-T012
-borne	O	O	O
passive	O	O	B-T074
air	O	O	I-T074
sampler	O	O	I-T074
(	O	O	O
PAS	O	O	B-T074
)	O	O	O
enabling	O	O	O
the	O	O	O
determination	O	O	B-T059
of	O	O	O
individual	O	O	B-T098
atmospheric	O	O	B-T070
exposure	O	O	B-T080
to	O	O	O
gas	O	O	B-T104
-	O	O	O
and	O	O	O
particle-phase	O	O	B-T104
HFRs	O	O	B-T120
using	O	O	O
the	O	O	O
ring-billed	O	O	B-T012
gull	O	O	I-T012
(	O	O	O
Larus	O	O	B-T012
delawarensis	O	O	I-T012
)	O	O	O
nesting	O	O	B-T053
in	O	O	O
the	O	O	O
Montreal	O	O	B-UnknownType
area	O	O	I-UnknownType
(	O	O	O
QC	O	O	B-T083
,	O	O	O
Canada	O	O	B-T083
)	O	O	O
.	O	O	O

The	O	O	O
new	O	O	O
miniaturized	O	O	O
elliptical-shaped	O	O	B-T082
PAS	O	O	B-T074
(	O	O	O
mean	O	O	B-T081
weight	O	O	I-T081
:	O	O	O
2.72	O	O	O
g	O	O	O
)	O	O	O
was	O	O	O
tested	O	O	B-T169
using	O	O	O
two	O	O	B-T059
sorbent	O	O	I-T059
types	O	O	I-T059
during	O	O	O
three	O	O	O
exposure	O	O	B-T079
periods	O	O	I-T079
(	O	O	O
one	O	O	O
,	O	O	O
two	O	O	O
and	O	O	O
three	O	O	O
weeks	O	O	O
)	O	O	O
.	O	O	O

Results	O	O	B-T169
showed	O	O	O
that	O	O	O
PAS	O	O	B-T074
using	O	O	O
polyurethane	O	O	B-T109
foam	O	O	I-T109
(	O	O	O
PUF	O	O	B-T109
)	O	O	O
combined	O	O	O
with	O	O	O
a	O	O	O
glass	O	O	B-T122
fiber	O	O	I-T122
filter	O	O	B-UnknownType
collected	O	O	I-UnknownType
all	O	O	O
major	O	O	O
polybrominated	O	O	B-T109
diphenyl	O	O	I-T109
ethers	O	O	I-T109
(	O	O	O
PBDEs	O	O	B-T109
)	O	O	O
and	O	O	O
exhibited	O	O	O
better	O	O	B-T052
performance	O	O	I-T052
for	O	O	O
collecting	O	O	B-T169
highly	O	O	B-T080
hydrophobic	O	O	I-T080
DecaBDE	O	O	B-T109
mixture	O	O	B-T167
congeners	O	O	B-T104
compared	O	O	B-T052
to	O	O	I-T052
the	O	O	O
PAS	O	O	O
using	O	O	O
polydimethylsiloxane	O	O	B-T109
(	O	O	O
PDMS	O	O	B-T109
)	O	O	O
.	O	O	O

Emerging	O	O	O
HFRs	O	O	B-T120
including	O	O	O
hexabromobenzene	O	O	B-T109
,	O	O	O
Dechlorane	O	O	B-T109
604	O	O	I-T109
Component	O	O	I-T109
B	O	O	I-T109
,	O	O	O
and	O	O	O
Dechlorane	O	O	B-T109
plus	O	O	I-T109
(	O	O	O
DP	O	O	B-T109
)	O	O	O
isomers	O	O	B-T070
also	O	O	O
were	O	O	O
sampled	O	O	B-T060
by	O	O	O
the	O	O	O
PUF	O	O	B-T109
-based	O	O	O
PAS	O	O	B-T074
.	O	O	O

Sampling	O	O	B-T060
rates	O	O	B-T081
for	O	O	O
most	O	O	O
HFRs	O	O	B-T120
were	O	O	O
comparable	O	O	B-T052
between	O	O	O
the	O	O	O
three	O	O	O
exposure	O	O	B-T079
periods	O	O	I-T079
.	O	O	O

This	O	O	O
novel	O	O	O
bird	O	O	B-T012
-borne	O	O	O
PAS	O	O	B-T074
provides	O	O	O
valuable	O	O	B-T078
information	O	O	I-T078
on	O	O	O
the	O	O	O
non-dietary	O	O	B-T080
exposure	O	O	I-T080
of	O	O	O
free-ranging	O	O	B-T033
birds	O	O	B-T012
to	O	O	O
HFRs	O	O	B-T120
.	O	O	O

-DOCSTART- (28545437)

Post	O	O	B-T079
endodontic	O	O	B-T184
pain	O	O	I-T184
following	O	O	O
single-visit	O	O	O
root	O	O	B-T061
canal	O	O	I-T061
preparation	O	O	I-T061
with	O	O	O
rotary	O	O	B-T074
vs	O	O	O
reciprocating	O	O	B-T074
instruments	O	O	I-T074
:	O	O	O
a	O	O	O
meta-analysis	O	O	B-T062
of	O	O	O
randomized	O	O	O
clinical	O	O	O
trials	O	O	O

In	O	O	O
endodontic	O	O	B-T061
therapy	O	O	I-T061
,	O	O	O
continuous	O	O	O
rotary	O	O	B-UnknownType
instrumentation	O	O	I-UnknownType
reduced	O	O	O
debris	O	O	B-T167
compared	O	O	O
to	O	O	O
reciprocal	O	O	B-UnknownType
instrumentation	O	O	I-UnknownType
,	O	O	O
which	O	O	O
might	O	O	O
affect	O	O	O
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
post-endodontic	O	O	B-T184
pain	O	O	I-T184
(	O	O	O
PP	O	O	B-T184
)	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
our	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
assess	O	O	O
whether	O	O	O
PP	O	O	B-T184
incidence	O	O	B-T081
and	O	O	O
levels	O	O	O
were	O	O	O
influenced	O	O	O
by	O	O	O
the	O	O	O
choice	O	O	O
of	O	O	O
rotary	O	O	B-T074
or	O	O	O
reciprocal	O	O	B-T074
instruments	O	O	I-T074
.	O	O	O

In	O	O	O
this	O	O	O
meta-analysis	O	O	B-T062
the	O	O	O
Pubmed	O	O	B-T170
and	O	O	O
EM	O	O	B-T170
databases	O	O	I-T170
were	O	O	O
searched	O	O	O
for	O	O	O
prospective	O	O	O
clinical	O	O	B-T062
randomized	O	O	I-T062
trials	O	O	I-T062
published	O	O	O
before	O	O	O
April	O	O	O
20	O	O	O
,	O	O	O
2016	O	O	O
,	O	O	O
using	O	O	O
combinations	O	O	O
of	O	O	O
the	O	O	O
keywords	O	O	O
:	O	O	O
root	O	O	B-T061
canal	O	O	I-T061
preparation	O	O	I-T061
/	O	O	O
instrumentation	O	O	B-UnknownType
/	O	O	O
treatment	O	O	B-T061
/	O	O	O
therapy	O	O	B-T061
;	O	O	O
post-operative	O	O	B-T079
/	O	O	O
endodontic	O	O	B-T184
pain	O	O	I-T184
;	O	O	O
reciprocal	O	O	B-T074
and	O	O	O
rotary	O	O	B-T074
instruments	O	O	I-T074
.	O	O	O

Three	O	O	O
studies	O	O	B-T062
were	O	O	O
included	O	O	O
,	O	O	O
involving	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
1,317	O	O	O
patients	O	O	B-T101
,	O	O	O
659	O	O	O
treated	O	O	O
with	O	O	O
reciprocating	O	O	B-T074
instruments	O	O	I-T074
and	O	O	O
658	O	O	O
treated	O	O	O
with	O	O	O
rotary	O	O	B-T074
instruments	O	O	I-T074
.	O	O	O

PP	O	O	B-T184
was	O	O	O
reported	O	O	O
in	O	O	O
139	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
reciprocating	O	O	B-T098
group	O	O	I-T098
and	O	O	O
172	O	O	O
in	O	O	O
the	O	O	O
rotary	O	O	B-T098
group	O	O	I-T098
.	O	O	O

The	O	O	O
PP	O	O	B-T184
incidence	O	O	B-T081
odds	O	O	O
ratio	O	O	O
was	O	O	O
1.27	O	O	O
with	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
(	O	O	O
0.25	O	O	O
,	O	O	O
6.52	O	O	O
)	O	O	O
favoring	O	O	O
rotary	O	O	B-T074
instruments	O	O	I-T074
.	O	O	O

The	O	O	O
mild	O	O	B-T080
,	O	O	O
moderate	O	O	B-T080
and	O	O	O
severe	O	O	B-T080
PP	O	O	B-T184
levels	O	O	O
odds	O	O	O
ratios	O	O	O
were	O	O	O
0.31	O	O	O
(	O	O	O
0.11	O	O	O
,	O	O	O
0.84	O	O	O
)	O	O	O
,	O	O	O
2.24	O	O	O
(	O	O	O
0.66	O	O	O
,	O	O	O
7.59	O	O	O
)	O	O	O
and	O	O	O
11.71	O	O	O
(	O	O	O
0.63	O	O	O
,	O	O	O
218.15	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

No	O	O	O
evidence	O	O	O
of	O	O	O
publication	O	O	O
bias	O	O	O
was	O	O	O
found	O	O	O
.	O	O	O

Rotary	O	O	B-T074
instrument	O	O	I-T074
choice	O	O	O
in	O	O	O
endodontic	O	O	B-T061
therapy	O	O	I-T061
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
lower	O	O	O
incidence	O	O	B-T081
of	O	O	O
PP	O	O	B-T184
than	O	O	O
reciprocating	O	O	B-T074
instruments	O	O	I-T074
,	O	O	O
while	O	O	O
reciprocating	O	O	O
instruments	O	O	O
are	O	O	O
associated	O	O	O
with	O	O	O
less	O	O	O
mild	O	O	O
PP	O	O	O
incidence	O	O	O
.	O	O	O

-DOCSTART- (28546554)

High	O	O	O
throughput	O	O	O
resistance	O	O	B-T039
profiling	O	O	B-T169
of	O	O	O
Plasmodium	O	O	B-T204
falciparum	O	O	I-T204
infections	O	O	O
based	O	O	O
on	O	O	O
custom	O	O	B-T062
dual	O	O	I-T062
indexing	O	O	I-T062
and	O	O	O
Illumina	O	O	O
next	O	O	O
generation	O	O	O
sequencing-technology	O	O	O

Genetic	O	O	B-T045
polymorphisms	O	O	I-T045
in	O	O	O
P.	O	O	B-T204
falciparum	O	O	I-T204
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
indicate	O	O	O
the	O	O	O
parasite	O	O	B-T204
's	O	O	I-T204
susceptibility	O	O	B-T033
to	O	O	O
antimalarial	O	O	B-T121
drugs	O	O	I-T121
as	O	O	O
well	O	O	O
as	O	O	O
its	O	O	O
geographical	O	O	B-T082
origin	O	O	I-T082
.	O	O	O

Both	O	O	O
of	O	O	O
these	O	O	O
factors	O	O	O
are	O	O	O
key	O	O	O
to	O	O	O
monitoring	O	O	B-T058
development	O	O	B-T169
and	O	O	O
spread	O	O	B-T080
of	O	O	O
antimalarial	O	O	B-T038
drug	O	O	I-T038
resistance	O	O	I-T038
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
combine	O	O	O
multiplex	O	O	B-T059
PCR	O	O	I-T059
,	O	O	O
custom	O	O	B-T062
designed	O	O	I-T062
dual	O	O	I-T062
indexing	O	O	I-T062
and	O	O	O
Miseq	O	O	B-T170
sequencing	O	O	B-T059
for	O	O	O
high	O	O	O
throughput	O	O	O
SNP	O	O	B-T086
-	O	O	O
profiling	O	O	B-T169
of	O	O	O
457	O	O	O
malaria	O	O	B-T047
infections	O	O	B-T046
from	O	O	O
Guinea-Bissau	O	O	B-T083
,	O	O	O
at	O	O	O
the	O	O	O
cost	O	O	B-T081
of	O	O	O
10	O	O	O
USD	O	O	O
per	O	O	O
sample	O	O	O
.	O	O	O

By	O	O	O
amplifying	O	O	B-T045
and	O	O	O
sequencing	O	O	B-T059
15	O	O	O
genetic	O	O	B-T169
fragments	O	O	B-T080
,	O	O	O
we	O	O	O
cover	O	O	O
20	O	O	O
resistance	O	O	B-T039
-conferring	O	O	O
SNPs	O	O	B-T086
occurring	O	O	O
in	O	O	O
pfcrt	O	O	B-T028
,	O	O	O
pfmdr1	O	O	B-T028
,	O	O	O
pfdhfr	O	O	B-T028
,	O	O	O
pfdhps	O	O	B-T028
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
entire	O	O	O
length	O	O	B-T081
of	O	O	O
pfK13	O	O	B-T028
,	O	O	O
and	O	O	O
the	O	O	O
mitochondrial	O	O	B-T026
barcode	O	O	B-T170
for	O	O	O
parasite	O	O	B-T204
origin	O	O	B-T033
.	O	O	O

SNPs	O	O	B-T086
of	O	O	O
interest	O	O	O
were	O	O	O
sequenced	O	O	O
with	O	O	O
an	O	O	O
average	O	O	B-T081
depth	O	O	O
of	O	O	O
2,043	O	O	O
reads	O	O	O
,	O	O	O
and	O	O	O
bases	O	O	O
were	O	O	O
called	O	O	O
for	O	O	O
the	O	O	O
various	O	O	O
SNP	O	O	B-T086
-	O	O	O
positions	O	O	B-T082
with	O	O	O
a	O	O	O
p-value	O	O	O
below	O	O	O
0.05	O	O	O
,	O	O	O
for	O	O	O
89.8	O	O	O
-	O	O	O
100	O	O	O
%	O	O	O
of	O	O	O
samples	O	O	O
.	O	O	O

The	O	O	O
SNP	O	O	B-T086
data	O	O	O
indicates	O	O	O
that	O	O	O
artemisinin	O	O	B-T109
resistance	O	O	O
-conferring	O	O	O
SNPs	O	O	B-T086
in	O	O	O
pfK13	O	O	B-T028
are	O	O	O
absent	O	O	B-T169
from	O	O	O
the	O	O	O
studied	O	O	O
area	O	O	O
of	O	O	O
Guinea-Bissau	O	O	B-T083
,	O	O	O
while	O	O	O
the	O	O	O
pfmdr1	O	O	B-T028
86	O	O	O
N	O	O	O
allele	O	O	O
is	O	O	O
found	O	O	O
at	O	O	O
a	O	O	O
high	O	O	O
prevalence	O	O	B-T081
.	O	O	O

The	O	O	O
mitochondrial	O	O	B-T026
barcodes	O	O	B-T170
are	O	O	O
unanimous	O	O	O
and	O	O	O
accommodate	O	O	O
a	O	O	O
West	O	O	B-T098
African	O	O	I-T098
origin	O	O	O
of	O	O	O
the	O	O	O
parasites	O	O	B-T204
.	O	O	O

With	O	O	O
this	O	O	O
method	O	O	B-T170
,	O	O	O
very	O	O	O
reliable	O	O	B-T170
high	O	O	O
throughput	O	O	O
surveillance	O	O	B-T061
of	O	O	O
antimalarial	O	O	B-T038
drug	O	O	I-T038
resistance	O	O	I-T038
becomes	O	O	O
more	O	O	O
affordable	O	O	O
than	O	O	O
ever	O	O	O
before	O	O	O
.	O	O	O

-DOCSTART- (28549399)

A	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
investigating	O	O	B-T169
psychosocial	O	O	B-T078
aspects	O	O	I-T078
of	O	O	O
egg	O	O	B-T061
sharing	O	O	I-T061
in	O	O	O
the	O	O	O
United	O	O	B-T083
Kingdom	O	O	I-T083
and	O	O	O
their	O	O	O
potential	O	O	B-T080
effects	O	O	B-T080
on	O	O	O
egg	O	O	B-T061
donation	O	O	I-T061
numbers	O	O	O

This	O	O	O
review	O	O	B-T170
aims	O	O	O
to	O	O	O
provide	O	O	O
an	O	O	O
up-to-date	O	O	O
knowledge	O	O	B-T170
of	O	O	O
the	O	O	O
psychosocial	O	O	B-T078
aspects	O	O	I-T078
of	O	O	O
egg	O	O	B-T061
donation	O	O	I-T061
from	O	O	O
the	O	O	O
perspectives	O	O	O
of	O	O	O
the	O	O	O
egg	O	O	B-T098
share	O	O	I-T098
donor	O	O	I-T098
and	O	O	O
their	O	O	O
recipient	O	O	B-T098
.	O	O	O

It	O	O	O
explores	O	O	O
the	O	O	O
motives	O	O	B-UnknownType
,	O	O	O
experiences	O	O	B-T041
and	O	O	O
attitudes	O	O	B-T041
of	O	O	O
egg	O	O	B-T098
sharers	O	O	I-T098
and	O	O	O
their	O	O	O
views	O	O	O
towards	O	O	O
donor	O	O	B-T098
anonymity	O	O	B-T078
and	O	O	O
disclosure	O	O	B-T055
.	O	O	O

Conclusions	O	O	B-T078
are	O	O	O
made	O	O	O
on	O	O	O
how	O	O	O
these	O	O	O
findings	O	O	B-T033
can	O	O	O
guide	O	O	B-T170
clinical	O	O	I-T170
practice	O	O	I-T170
and	O	O	O
improve	O	O	O
egg	O	O	B-T061
sharing	O	O	I-T061
numbers	O	O	B-T081
.	O	O	O

A	O	O	O
systematic	O	O	B-T169
search	O	O	B-T052
of	O	O	O
peer-reviewed	O	O	B-T170
journals	O	O	I-T170
of	O	O	O
four	O	O	O
computerized	O	O	B-T170
databases	O	O	I-T170
was	O	O	O
undertaken	O	O	O
.	O	O	O

Eleven	O	O	O
studies	O	O	B-T062
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
review	O	O	B-T170
.	O	O	O

Psychosocial	O	O	B-T078
aspects	O	O	I-T078
towards	O	O	O
donation	O	O	B-T061
were	O	O	O
positive	O	O	B-T033
from	O	O	O
the	O	O	O
egg	O	O	B-T098
share	O	O	I-T098
donor	O	O	I-T098
and	O	O	O
recipient	O	O	B-T098
.	O	O	O

Concerns	O	O	B-T078
raised	O	O	B-T080
were	O	O	O
whether	O	O	O
participating	O	O	B-T169
in	O	O	O
the	O	O	O
egg	O	O	B-T061
sharing	O	O	I-T061
scheme	O	O	B-T170
would	O	O	O
impact	O	O	B-T080
on	O	O	O
their	O	O	O
success	O	O	B-T080
rates	O	O	B-T081
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
frustration	O	O	B-T041
expressed	O	O	B-T078
by	O	O	O
a	O	O	O
minority	O	O	B-T098
regarding	O	O	O
the	O	O	O
lack	O	O	B-T033
of	O	O	I-T033
knowledge	O	O	I-T033
of	O	O	O
egg	O	O	O
sharing	O	O	O
outside	O	O	O
of	O	O	O
fertility	O	O	B-T040
clinics	O	O	B-T093
.	O	O	O

The	O	O	O
2005	O	O	O
legislative	O	O	B-T170
changes	O	O	B-T169
in	O	O	O
the	O	O	O
UK	O	O	B-T083
have	O	O	O
not	O	O	O
caused	O	O	O
the	O	O	O
anticipated	O	O	O
dramatic	O	O	O
decrease	O	O	B-T081
in	O	O	O
egg	O	O	B-T061
donation	O	O	I-T061
;	O	O	O
however	O	O	O
,	O	O	O
oocyte	O	O	B-T061
donation	O	O	I-T061
still	O	O	O
falls	O	O	O
short	O	O	O
of	O	O	O
demand	O	O	B-T061
.	O	O	O

Egg	O	O	B-T061
sharing	O	O	I-T061
provides	O	O	O
a	O	O	O
practical	O	O	B-T169
option	O	O	I-T169
for	O	O	O
more	O	O	O
patients	O	O	B-T101
to	O	O	O
access	O	O	B-T169
IVF	O	O	B-T061
,	O	O	O
whilst	O	O	O
also	O	O	O
providing	O	O	O
more	O	O	O
donor	O	O	B-T098
oocytes	O	O	I-T098
.	O	O	O

Improved	O	O	O
information	O	O	B-UnknownType
provision	O	O	I-UnknownType
will	O	O	O
result	O	O	B-T169
in	O	O	O
greater	O	O	O
awareness	O	O	B-T041
of	O	O	O
egg	O	O	B-T061
sharing	O	O	I-T061
,	O	O	O
with	O	O	O
the	O	O	O
potential	O	O	B-T080
to	O	O	O
recruit	O	O	B-T052
more	O	O	O
donors	O	O	O
and	O	O	O
meet	O	O	B-T067
the	O	O	O
needs	O	O	O
of	O	O	O
recipients	O	O	B-T098
currently	O	O	B-T079
on	O	O	O
long	O	O	O
waiting	O	O	B-T170
lists	O	O	I-T170
.	O	O	O

-DOCSTART- (28550348)

Medication	O	O	B-T061
regimen	O	O	I-T061
complexity	O	O	B-T078
and	O	O	O
prevalence	O	O	B-T081
of	O	O	O
potentially	O	O	B-T080
inappropriate	O	O	I-T080
medicines	O	O	I-T080
in	O	O	O
older	O	O	B-T098
patients	O	O	B-T101
after	O	O	O
hospitalisation	O	O	O

Background	O	O	O
There	O	O	O
is	O	O	O
a	O	O	O
relative	O	O	B-T080
paucity	O	O	O
of	O	O	O
information	O	O	B-T078
to	O	O	O
characterise	O	O	O
potential	O	O	B-T080
changes	O	O	B-T169
in	O	O	O
medication	O	O	B-T061
regimen	O	O	I-T061
complexity	O	O	B-T078
and	O	O	O
prevalence	O	O	B-T081
of	O	O	O
prescribing	O	O	B-T058
of	O	O	O
potentially	O	O	B-T080
inappropriate	O	O	I-T080
medications	O	O	I-T080
after	O	O	O
hospitalisation	O	O	B-T058
,	O	O	O
both	O	O	O
in	O	O	O
Australia	O	O	B-T083
and	O	O	O
elsewhere	O	O	O
.	O	O	O

Objective	O	O	B-T170
To	O	O	O
evaluate	O	O	B-T058
medication	O	O	B-T061
regimen	O	O	I-T061
complexity	O	O	B-T078
and	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
potentially	O	O	B-T080
inappropriate	O	O	I-T080
medications	O	O	I-T080
before	O	O	B-T079
and	O	O	O
after	O	O	O
admission	O	O	B-T058
to	O	O	I-T058
hospital	O	O	I-T058
.	O	O	O

Setting	O	O	O
General	O	O	B-T093
medical	O	O	I-T093
units	O	O	I-T093
of	O	O	O
a	O	O	O
tertiary	O	O	B-T093
care	O	O	I-T093
hospital	O	O	I-T093
in	O	O	O
Australia	O	O	B-T083
.	O	O	O

Methods	O	O	O
Retrospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
of	O	O	O
patients	O	O	B-T101
aged	O	O	B-T032
65	O	O	O
years	O	O	O
and	O	O	O
above	O	O	O
.	O	O	O

Medication	O	O	B-T058
complexity	O	O	B-T078
was	O	O	O
measured	O	O	B-T080
by	O	O	O
using	O	O	O
the	O	O	O
Medication	O	O	B-T170
Regimen	O	O	I-T170
Complexity	O	O	I-T170
Index	O	O	I-T170
(	O	O	O
MRCI	O	O	B-T170
)	O	O	O
.	O	O	O

Main	O	O	B-T080
outcome	O	O	I-T080
measure	O	O	I-T080
The	O	O	O
primary	O	O	B-T080
outcome	O	O	I-T080
was	O	O	O
the	O	O	O
change	O	O	B-T169
in	O	O	O
the	O	O	O
Medication	O	O	B-T170
Regimen	O	O	I-T170
Complexity	O	O	I-T170
Index	O	O	I-T170
for	O	O	O
all	O	O	O
prescribed	O	O	B-T121
medications	O	O	I-T121
after	O	O	O
hospitalization	O	O	B-T058
.	O	O	O

Results	O	O	B-T034
A	O	O	O
convenience	O	O	B-T062
sample	O	O	I-T062
of	O	O	O
100	O	O	O
patients	O	O	B-T101
was	O	O	O
included	O	O	B-T169
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	B-T078
change	O	O	B-T169
in	O	O	O
the	O	O	O
mean	O	O	B-T081
medication	O	O	B-T058
complexity	O	O	B-T078
score	O	O	B-T081
(	O	O	O
as	O	O	O
measured	O	O	B-T080
using	O	O	O
the	O	O	O
MRCI	O	O	B-T170
)	O	O	O
,	O	O	O
increasing	O	O	B-T081
from	O	O	O
29	O	O	O
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	I-T079
admission	O	O	I-T079
to	O	O	O
32	O	O	O
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	I-T079
discharge	O	O	I-T079
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Factors	O	O	B-T169
such	O	O	O
as	O	O	O
baseline	O	O	B-T081
medication	O	O	B-T058
regimen	O	O	I-T061
complexity	O	O	B-T078
(	O	O	O
pre-admission	O	O	B-T079
MRCI	O	O	B-T170
)	O	O	O
and	O	O	O
length	O	O	B-T079
of	O	O	I-T079
stay	O	O	I-T079
in	O	O	I-T079
the	O	O	I-T079
hospitals	O	O	I-T079
appear	O	O	B-T080
to	O	O	O
influence	O	O	B-T077
the	O	O	O
change	O	O	B-T169
in	O	O	O
medication	O	O	O
complexity	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
proportion	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
prescribed	O	O	B-T058
at	O	O	O
least	O	O	O
one	O	O	O
potentially	O	O	B-T080
inappropriate	O	O	I-T080
medicine	O	O	I-T080
(	O	O	O
PIM	O	O	B-T080
)	O	O	O
decreased	O	O	B-T081
significantly	O	O	I-T081
,	O	O	O
from	O	O	O
52	O	O	O
%	O	O	O
pre-hospitalization	O	O	B-T058
to	O	O	O
42	O	O	O
%	O	O	O
at	O	O	B-T079
discharge	O	O	I-T079
(	O	O	O
p	O	O	O
=	O	O	O
0.04	O	O	O
)	O	O	O
.	O	O	O

Conclusions	O	O	O
Relative	O	O	B-T080
to	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	I-T079
admission	O	O	I-T079
,	O	O	O
overall	O	O	B-T080
medication	O	O	B-T058
complexity	O	O	B-T078
increased	O	O	B-T081
and	O	O	O
the	O	O	O
proportion	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
who	O	O	O
were	O	O	O
prescribed	O	O	B-T058
PIMs	O	O	B-T080
decreased	O	O	B-T081
after	O	O	O
hospitalisation	O	O	B-T058
.	O	O	O

